nct_id,overallStatus,study_type,why_stopped
NCT00000105,TERMINATED,OBSERVATIONAL,Replaced by another study.
NCT00000270,WITHDRAWN,INTERVENTIONAL,Study never opened; never enrolled participants
NCT00000305,TERMINATED,INTERVENTIONAL,Original P.I. left the institution
NCT00000309,TERMINATED,INTERVENTIONAL,Unable to recruit adequate number of subjects
NCT00000340,WITHDRAWN,INTERVENTIONAL,Study was never funded.
NCT00000372,WITHDRAWN,INTERVENTIONAL,"Pairing D-Cycloserine with Clozapine was found to worsen negative side effects in patients with Schizophrenia, so the study was suspended."
NCT00000460,WITHDRAWN,OBSERVATIONAL,due to lack of enrollment
NCT00000577,WITHDRAWN,INTERVENTIONAL,Record is an ACRN grant summary \& not reflective of an individual trial. All ACTs conducted by ACRN were individually registered on the PRS.
NCT00001080,WITHDRAWN,INTERVENTIONAL,as of 4/23/97
NCT00001151,TERMINATED,INTERVENTIONAL,Terminated because of lack of drug supply
NCT00001219,TERMINATED,OBSERVATIONAL,protocol has not been used for many years and has outlived it utility
NCT00001349,TERMINATED,OBSERVATIONAL,Closed at the request of the IRBO
NCT00001651,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT00001703,TERMINATED,INTERVENTIONAL,Due to poor accrual and lack of peptide vaccine
NCT00001788,TERMINATED,OBSERVATIONAL,Investigator left NIH
NCT00001803,TERMINATED,OBSERVATIONAL,IRB approval lapsed and PI has not responded to requests to submit CR.
NCT00001850,TERMINATED,OBSERVATIONAL,Terminated at the direction of the NIH IRBO.
NCT00001880,TERMINATED,INTERVENTIONAL,Study was closed early due to lack of accrual
NCT00001962,TERMINATED,INTERVENTIONAL,DSMB recommended closing the study and publishing the results
NCT00001978,TERMINATED,OBSERVATIONAL,All analysis with identifiable specimens/data is complete or site has no identifiers linked to the specimens/data
NCT00002525,TERMINATED,INTERVENTIONAL,The study was stopped before reaching its accrual goal due to slow accrual
NCT00002664,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT00002668,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00002735,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual.
NCT00002761,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT00002772,TERMINATED,INTERVENTIONAL,poor accrual
NCT00002778,TERMINATED,INTERVENTIONAL,subject accrual and data analysis is completed.
NCT00002796,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00002863,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00002899,TERMINATED,INTERVENTIONAL,Low accrual
NCT00002921,TERMINATED,INTERVENTIONAL,Permanently Closed Due to Lack of Accrual
NCT00002934,TERMINATED,INTERVENTIONAL,This study was terminated when the accrual goal for the low/intermediate grade stratum was reached. The high grade stratum was closed due to slow accrual.
NCT00002961,TERMINATED,INTERVENTIONAL,poor accrual
NCT00003009,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00003040,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00003056,TERMINATED,INTERVENTIONAL,Interim analysis indicated study should be terminated
NCT00003060,TERMINATED,INTERVENTIONAL,lack of patient accrual
NCT00003085,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00003086,TERMINATED,INTERVENTIONAL,no participants enrolled in a three year period
NCT00003094,WITHDRAWN,INTERVENTIONAL,"Study was halted prematurely, prior to enrollment of first participant"
NCT00003147,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00003152,TERMINATED,INTERVENTIONAL,low accrual
NCT00003194,TERMINATED,INTERVENTIONAL,Study enrollment did not meet expected goals
NCT00003223,TERMINATED,INTERVENTIONAL,Closed due to poor accrual.
NCT00003292,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00003365,TERMINATED,INTERVENTIONAL,Study completed
NCT00003381,TERMINATED,OBSERVATIONAL,companion study to CALGB-9781 which closed administratively due to poor accrual
NCT00003405,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT00003407,WITHDRAWN,INTERVENTIONAL,The P.I deceased.
NCT00003432,TERMINATED,INTERVENTIONAL,low accrual
NCT00003452,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00003453,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00003454,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003469,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003471,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003472,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003476,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003479,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003483,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003485,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003487,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003489,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003491,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003492,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003494,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003495,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003496,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003497,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003498,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003500,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003501,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003508,TERMINATED,INTERVENTIONAL,Withdrawn due to slow enrollment
NCT00003509,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003511,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003512,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT00003513,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003515,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003516,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003520,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003521,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003522,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003524,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003525,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003526,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003530,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003531,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003532,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003533,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003534,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT00003535,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00003564,WITHDRAWN,INTERVENTIONAL,Study withdrawn.
NCT00003567,TERMINATED,INTERVENTIONAL,slow accrual
NCT00003599,WITHDRAWN,INTERVENTIONAL,Withdrawn study.
NCT00003605,WITHDRAWN,INTERVENTIONAL,no patient accrual
NCT00003622,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT00003640,TERMINATED,INTERVENTIONAL,low accrual
NCT00003642,TERMINATED,INTERVENTIONAL,low accrual
NCT00003645,TERMINATED,INTERVENTIONAL,Per PI request
NCT00003663,WITHDRAWN,INTERVENTIONAL,no patient accrual
NCT00003682,TERMINATED,INTERVENTIONAL,lack of inclusions
NCT00003686,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual.
NCT00003714,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT00003715,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT00003726,TERMINATED,INTERVENTIONAL,Study funding was dropped.
NCT00003729,TERMINATED,INTERVENTIONAL,low accrual
NCT00003777,TERMINATED,INTERVENTIONAL,PI left institution
NCT00003786,WITHDRAWN,INTERVENTIONAL,NO participants
NCT00003803,TERMINATED,INTERVENTIONAL,low accrual
NCT00003824,TERMINATED,INTERVENTIONAL,Permanently Closed Due to Poor Accrual
NCT00003843,TERMINATED,OBSERVATIONAL,Study terminated due to poor accrual
NCT00003851,TERMINATED,INTERVENTIONAL,Approval lapse
NCT00003852,TERMINATED,INTERVENTIONAL,lack of patient inclusion
NCT00003858,WITHDRAWN,INTERVENTIONAL,The study was not activated.
NCT00003911,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00003926,TERMINATED,INTERVENTIONAL,Withdrawn due to slow accrual
NCT00004039,WITHDRAWN,INTERVENTIONAL,No patient accruals
NCT00004040,WITHDRAWN,INTERVENTIONAL,no patient accruals
NCT00004050,TERMINATED,INTERVENTIONAL,Development in prostate cancer indication halted
NCT00004058,TERMINATED,INTERVENTIONAL,At this time it is felt that we will not gain further information from an additional patients.
NCT00004093,TERMINATED,INTERVENTIONAL,Original Principal Investigator left the institution.
NCT00004099,TERMINATED,INTERVENTIONAL,low accrual
NCT00004106,TERMINATED,INTERVENTIONAL,Per Data Monitoring Committee given the poor/inadequate accrual.
NCT00004114,WITHDRAWN,INTERVENTIONAL,Study never opened
NCT00004239,TERMINATED,INTERVENTIONAL,poor accrual
NCT00004261,TERMINATED,INTERVENTIONAL,Lack of patient accrual
NCT00004418,TERMINATED,INTERVENTIONAL,"No funding, move to expanded access"
NCT00004465,TERMINATED,INTERVENTIONAL,Lack of efficacy at review by DSMB using pre-specified monitoring criteria
NCT00004466,TERMINATED,INTERVENTIONAL,Very poor enrollment
NCT00004468,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT00004500,TERMINATED,INTERVENTIONAL,Slow enrollment and administrative reasons
NCT00004859,TERMINATED,INTERVENTIONAL,Trial was stopped early for futility
NCT00004874,TERMINATED,INTERVENTIONAL,lack of FDA approval
NCT00004878,WITHDRAWN,INTERVENTIONAL,study never opened
NCT00004897,TERMINATED,INTERVENTIONAL,Institutional Review Board requested termination - all patients deceased and no new accrual.
NCT00004933,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00004935,TERMINATED,INTERVENTIONAL,Trial is Life long follow-up: to reduce ressources and costs - trial terminated prematurely.
NCT00005009,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00005030,WITHDRAWN,INTERVENTIONAL,No enrollment.
NCT00005039,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005047,TERMINATED,INTERVENTIONAL,Accrual was halted on the basis of the Data and Safety Monitoring Board review of a futility analysis.
NCT00005067,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005072,TERMINATED,INTERVENTIONAL,Development in prostate cancer indication halted
NCT00005075,TERMINATED,INTERVENTIONAL,Withdrawn because Ablatherm devices were not available anymore at trial centers
NCT00005083,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT00005090,TERMINATED,INTERVENTIONAL,poor accrual
NCT00005097,TERMINATED,INTERVENTIONAL,terminated due to the low conditional power for a positive study
NCT00005113,TERMINATED,INTERVENTIONAL,Inability to meet the accrual target of 213.
NCT00005286,TERMINATED,OBSERVATIONAL,Not a clinical Trial and inadvertently entered in the system.
NCT00005290,TERMINATED,OBSERVATIONAL,Not a clinical trial \& was inadvertently entered into the system.
NCT00005295,TERMINATED,OBSERVATIONAL,Not a clinical Trial \& inadvertently entered in the system.
NCT00005341,TERMINATED,OBSERVATIONAL,Not a clinical trial and was inadvertently entered in the system.
NCT00005427,TERMINATED,OBSERVATIONAL,Not a clinical trial.
NCT00005595,TERMINATED,INTERVENTIONAL,Unable to accrue subjects in a timely fashion.
NCT00005608,TERMINATED,INTERVENTIONAL,Drug was pulled from the market.
NCT00005612,TERMINATED,INTERVENTIONAL,Low accrual
NCT00005614,WITHDRAWN,INTERVENTIONAL,no accrual
NCT00005641,TERMINATED,INTERVENTIONAL,low study accrual
NCT00005712,TERMINATED,OBSERVATIONAL,Not a clinical trial and was inadvertently entered in the system.
NCT00005773,TERMINATED,INTERVENTIONAL,Halted after 3 years because of a persistent decline in enrollment
NCT00005774,TERMINATED,INTERVENTIONAL,The trial was stopped after 7 months for lack of recruitment.
NCT00005776,TERMINATED,INTERVENTIONAL,Results showed statistically significant benefit in the experimental group
NCT00005777,TERMINATED,INTERVENTIONAL,The trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy.
NCT00005786,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005787,TERMINATED,INTERVENTIONAL,Per PI due to poor/inadequate accrual.
NCT00005788,TERMINATED,INTERVENTIONAL,Low/inadequate rate of accrual.
NCT00005790,WITHDRAWN,INTERVENTIONAL,Unable to accrue subjects.
NCT00005808,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005812,TERMINATED,INTERVENTIONAL,"No objective response documented, protocol terminated after 12 patients."
NCT00005834,TERMINATED,INTERVENTIONAL,poor accrual
NCT00005841,TERMINATED,INTERVENTIONAL,Toxicity/Side Effects
NCT00005852,TERMINATED,INTERVENTIONAL,low accrual
NCT00005856,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005944,TERMINATED,INTERVENTIONAL,insuffisient recruitment
NCT00005950,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005969,WITHDRAWN,INTERVENTIONAL,Study withdrawn.
NCT00005982,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00005983,TERMINATED,INTERVENTIONAL,due to lack of accrual
NCT00005984,TERMINATED,INTERVENTIONAL,Study terminated as principal investigator \[PI\] left the university.
NCT00005986,TERMINATED,INTERVENTIONAL,Principal investigator left the university.
NCT00005987,TERMINATED,INTERVENTIONAL,Withdrawn because treatment guidelines changed
NCT00005997,TERMINATED,INTERVENTIONAL,slow accrual for Cohort II
NCT00005998,WITHDRAWN,INTERVENTIONAL,Withdrawn because study never enrolled patients
NCT00006001,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00006003,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00006015,TERMINATED,INTERVENTIONAL,lack of sufficient accrual
NCT00006032,TERMINATED,INTERVENTIONAL,low accrual
NCT00006037,TERMINATED,INTERVENTIONAL,Drug not available
NCT00006046,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00006090,WITHDRAWN,INTERVENTIONAL,No enrollment.
NCT00006091,WITHDRAWN,INTERVENTIONAL,No enrollment.
NCT00006092,TERMINATED,INTERVENTIONAL,low accrual
NCT00006099,TERMINATED,INTERVENTIONAL,low study accrual
NCT00006113,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00006121,TERMINATED,INTERVENTIONAL,low accrual
NCT00006123,WITHDRAWN,INTERVENTIONAL,Never started
NCT00006126,WITHDRAWN,INTERVENTIONAL,Unable to accrue subjects.
NCT00006220,TERMINATED,INTERVENTIONAL,Study drug became commercially available.
NCT00006222,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00006247,TERMINATED,INTERVENTIONAL,The pharmaceutical company discontinued further development of SU5416.
NCT00006262,TERMINATED,INTERVENTIONAL,Unable to accrue patients to the study.
NCT00006267,WITHDRAWN,INTERVENTIONAL,Never activated.
NCT00006289,TERMINATED,INTERVENTIONAL,difficulty in the recruitment of patients
NCT00006321,TERMINATED,OBSERVATIONAL,PI left the university
NCT00006344,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT00006356,TERMINATED,INTERVENTIONAL,low accrual
NCT00006371,TERMINATED,INTERVENTIONAL,low accrual
NCT00006374,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT00006451,WITHDRAWN,INTERVENTIONAL,Terminated (due to no accrual)
NCT00006478,TERMINATED,INTERVENTIONAL,"Genitope suspend drug development by decision made by the FDA March 6, 2008."
NCT00006497,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00006708,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00006773,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00006916,TERMINATED,INTERVENTIONAL,Low accrual
NCT00006994,TERMINATED,INTERVENTIONAL,Withdrawn due to drug availability and funding
NCT00008216,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT00009919,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00010101,TERMINATED,OBSERVATIONAL,Poor accrual
NCT00010153,TERMINATED,INTERVENTIONAL,low accrual
NCT00010205,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00010322,TERMINATED,INTERVENTIONAL,Withdrawn due to change in standard of care - new protocol required
NCT00011492,TERMINATED,OBSERVATIONAL,Closed by Sponsor/Data Safety monitoring Board/IRB
NCT00012246,TERMINATED,INTERVENTIONAL,Administratively Terminated
NCT00012298,TERMINATED,INTERVENTIONAL,Trial completed prematurely.
NCT00012675,WITHDRAWN,OBSERVATIONAL,This study was withdrawn prior to enrollment.
NCT00014131,TERMINATED,INTERVENTIONAL,change in corporate priorities
NCT00014196,TERMINATED,INTERVENTIONAL,This study was closed early due to poor accrual.
NCT00014313,TERMINATED,INTERVENTIONAL,low accrual
NCT00014326,TERMINATED,INTERVENTIONAL,low accrual
NCT00014443,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00014560,TERMINATED,INTERVENTIONAL,Medarex (supplier of BsAb) stopped study due to toxicities experienced at other sites on unrelated trials halting manufacturing of BsAb
NCT00014586,TERMINATED,INTERVENTIONAL,low accrual
NCT00014651,TERMINATED,INTERVENTIONAL,Teminated by the DSMB because there are no differences between the control group and the Vapreotide group
NCT00014872,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was inadvertently entered into CT.gov
NCT00015002,TERMINATED,INTERVENTIONAL,Concerns regarding neonatal data
NCT00015912,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00016276,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00016523,TERMINATED,INTERVENTIONAL,Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm
NCT00017134,TERMINATED,INTERVENTIONAL,Withdrawn due to poor accrual
NCT00017173,TERMINATED,INTERVENTIONAL,Terminated for poor accrual.
NCT00017277,TERMINATED,INTERVENTIONAL,low accrual
NCT00019604,TERMINATED,INTERVENTIONAL,Principal investigator left the institution.
NCT00019747,TERMINATED,INTERVENTIONAL,DSMB recommended closure of the protocol due to slow accrual.
NCT00020670,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00020683,TERMINATED,INTERVENTIONAL,Cancer Therapy Evaluation Program's (CTEP's) termination of drug supply
NCT00020722,TERMINATED,INTERVENTIONAL,Lack of funding to continue study.
NCT00020839,TERMINATED,INTERVENTIONAL,low accrual
NCT00021112,TERMINATED,INTERVENTIONAL,low accrual
NCT00021229,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00021307,WITHDRAWN,INTERVENTIONAL,Study not activated.
NCT00022230,WITHDRAWN,INTERVENTIONAL,PI left Institution
NCT00022633,TERMINATED,INTERVENTIONAL,Permanently Closed Due to Poor Accrual
NCT00022802,TERMINATED,INTERVENTIONAL,Grant expired
NCT00022841,TERMINATED,INTERVENTIONAL,Inadequate eligible subjects to expect sufficient numbers to analyse outcomes.
NCT00023244,TERMINATED,INTERVENTIONAL,"Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative disorder"
NCT00023504,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT00023634,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00023790,TERMINATED,INTERVENTIONAL,slow accrual
NCT00023868,TERMINATED,INTERVENTIONAL,redesign
NCT00023881,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00023920,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00024128,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to initiation.
NCT00024167,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT00024674,WITHDRAWN,INTERVENTIONAL,Support withdrawn - Study continued by NCI - see record NCT00006981
NCT00024687,WITHDRAWN,INTERVENTIONAL,Support withdrawn - Study continued by NCI - see record NCT00006981
NCT00025298,TERMINATED,INTERVENTIONAL,low accrual
NCT00025493,TERMINATED,INTERVENTIONAL,poor accrual
NCT00026468,WITHDRAWN,INTERVENTIONAL,Principle Investigator has left the University.
NCT00027131,TERMINATED,INTERVENTIONAL,difficulty with accrual
NCT00027508,TERMINATED,INTERVENTIONAL,Enrolment halted prematurely and not resumed. 2 patients enrolled. No data was obtained.
NCT00027521,WITHDRAWN,INTERVENTIONAL,Program terminated
NCT00027911,TERMINATED,INTERVENTIONAL,Departure of PI
NCT00028561,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00028704,TERMINATED,INTERVENTIONAL,low accrual
NCT00028782,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00029146,TERMINATED,INTERVENTIONAL,Pre-specified futility boundary was reached.
NCT00030381,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00030511,TERMINATED,INTERVENTIONAL,low accrual
NCT00030693,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00031174,TERMINATED,OBSERVATIONAL,Due to technical and logistical constraints and a change in the study team's focus of research
NCT00031551,TERMINATED,INTERVENTIONAL,It was not feasible to recruit required sample size from two clinical sites.
NCT00031577,TERMINATED,INTERVENTIONAL,Administrative closure 9/22/2006. Decline in enrollment at CHOP. due to competing protocols with new agents.
NCT00031590,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to slow accrual.
NCT00031798,TERMINATED,INTERVENTIONAL,low accrual; loss of funding
NCT00032084,TERMINATED,INTERVENTIONAL,This study was closed early due to poor accrual
NCT00032643,TERMINATED,INTERVENTIONAL,Funding support withdrawn (much slower than expected enrollment)
NCT00033449,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00033774,TERMINATED,OBSERVATIONAL,There is another active NHLBI protocol for the collection of stem cells for research from healthy volunteers and no need for this separate Protocol.
NCT00034138,TERMINATED,INTERVENTIONAL,closed by sponser
NCT00034372,TERMINATED,INTERVENTIONAL,closed by sponser
NCT00034528,TERMINATED,INTERVENTIONAL,Due to slow recruitment
NCT00034697,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00034788,TERMINATED,INTERVENTIONAL,Slow recruitment; Study did not address safety concern raised by European Medicines Agency
NCT00035919,WITHDRAWN,INTERVENTIONAL,"Never received final IRB approval for amendments, so never opened officially"
NCT00035958,TERMINATED,INTERVENTIONAL,Incorporating the recommendations of the NIH-formed DSMB in the study procedures would make the project budget over the limit for this funding mechanism.
NCT00036686,TERMINATED,INTERVENTIONAL,low accrual
NCT00036816,TERMINATED,INTERVENTIONAL,low accrual
NCT00036855,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00037115,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00037622,TERMINATED,INTERVENTIONAL,Safety concerns from other studies.
NCT00038038,WITHDRAWN,INTERVENTIONAL,"No participants enrolled, study terminated."
NCT00038142,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00038389,TERMINATED,INTERVENTIONAL,Unavailability of study drug.
NCT00038415,TERMINATED,INTERVENTIONAL,Vaccine unavailable.
NCT00038649,TERMINATED,INTERVENTIONAL,Sponsor discontinued providing study drug.
NCT00038701,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00038766,TERMINATED,INTERVENTIONAL,Unable to enroll into study.
NCT00038779,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT00038792,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00038818,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00038870,WITHDRAWN,INTERVENTIONAL,Slow accrual.
NCT00039078,WITHDRAWN,INTERVENTIONAL,Record created in error - not a research study
NCT00039455,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00039754,TERMINATED,INTERVENTIONAL,business reasons
NCT00040144,TERMINATED,INTERVENTIONAL,Safety concerns
NCT00040157,TERMINATED,INTERVENTIONAL,Safety concerns
NCT00040404,TERMINATED,INTERVENTIONAL,Unlikely to provide evidence of significant effect
NCT00040417,TERMINATED,INTERVENTIONAL,unable to accrue patients
NCT00040456,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00040469,TERMINATED,INTERVENTIONAL,accrual was slow and sporadic so the study was closed
NCT00040768,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00041171,WITHDRAWN,INTERVENTIONAL,The study was not activated.
NCT00041288,TERMINATED,INTERVENTIONAL,Poor accrual and difficulty with multicenter logistics
NCT00041353,WITHDRAWN,INTERVENTIONAL,Study was not activated at Fox Chase Cancer Center
NCT00041470,TERMINATED,INTERVENTIONAL,Sponsor withdrew the study
NCT00041548,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00041561,TERMINATED,INTERVENTIONAL,Study stopped due to poor enrollment
NCT00041574,TERMINATED,INTERVENTIONAL,Closed for lack of enrollment
NCT00042796,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00042835,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00042887,TERMINATED,INTERVENTIONAL,low accrual
NCT00042952,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00043004,TERMINATED,INTERVENTIONAL,low accrual
NCT00043212,WITHDRAWN,INTERVENTIONAL,Redirection of company goals
NCT00043355,TERMINATED,INTERVENTIONAL,Futility
NCT00044083,TERMINATED,INTERVENTIONAL,Scientific Director request to use resources for other studies
NCT00045617,TERMINATED,INTERVENTIONAL,Closed due to lack of drug availability.
NCT00045721,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00045838,WITHDRAWN,INTERVENTIONAL,The study product was revised. PI withdrew the study without enrolling participants..
NCT00046163,TERMINATED,INTERVENTIONAL,Study was terminated due to poor enrollment
NCT00046709,TERMINATED,INTERVENTIONAL,Discontinued due to non-enrollment.
NCT00046813,TERMINATED,INTERVENTIONAL,Interim data analysis showed no effect between treatment groups
NCT00047333,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00047554,TERMINATED,OBSERVATIONAL,Study objectives met
NCT00047606,TERMINATED,INTERVENTIONAL,Management Decision
NCT00047632,TERMINATED,INTERVENTIONAL,futility
NCT00047827,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT00048087,WITHDRAWN,INTERVENTIONAL,Slow accrual.
NCT00048100,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00048399,TERMINATED,INTERVENTIONAL,accrual was slow
NCT00048750,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT00048893,TERMINATED,INTERVENTIONAL,The study was closed to accrual due to very poor enrollment.
NCT00049088,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00049608,TERMINATED,INTERVENTIONAL,Principal investigator \[PI\] has left institution.
NCT00049660,TERMINATED,INTERVENTIONAL,low accrual
NCT00050375,TERMINATED,INTERVENTIONAL,Study closed by sponser
NCT00052039,TERMINATED,INTERVENTIONAL,Study design changes were needed based on GIPF-001 results
NCT00052377,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00052403,WITHDRAWN,INTERVENTIONAL,Study was not successful at recruiting particpants
NCT00052585,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00052715,TERMINATED,INTERVENTIONAL,prematurely discontinued after results of the EORTC phase-3 study defined the SOC for newly diagnosed GMB pts as RT plus concomitant and adjuvant TMZ
NCT00052884,TERMINATED,INTERVENTIONAL,Slow accrual and changes in clinical practice
NCT00053014,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00053040,WITHDRAWN,INTERVENTIONAL,Withdrawal of pharmaceutical company support for the investigational drug
NCT00053339,WITHDRAWN,INTERVENTIONAL,The study was not activated.
NCT00053508,TERMINATED,INTERVENTIONAL,"CDC's decision to down-select vaccine development to single candidate, ACAM2000"
NCT00053833,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00053950,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00054392,WITHDRAWN,INTERVENTIONAL,Not opened at Fox Chase Cancer Center
NCT00054405,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00054704,TERMINATED,INTERVENTIONAL,Placebo was better than active drug.
NCT00054834,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00055198,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment
NCT00055887,WITHDRAWN,INTERVENTIONAL,Study never started. No patients were enrolled.
NCT00056056,TERMINATED,INTERVENTIONAL,poor accrual
NCT00057447,TERMINATED,INTERVENTIONAL,administrative reasons
NCT00057655,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT00057928,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT00057954,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00057993,WITHDRAWN,INTERVENTIONAL,Unable to accrue subjects to the study after 2 years - closed per request by Data Monitoring Committee.
NCT00058188,TERMINATED,INTERVENTIONAL,Closed by the research committee
NCT00058214,TERMINATED,INTERVENTIONAL,Did not meet interim stopping criteria for continuation to the second stage.
NCT00058266,TERMINATED,INTERVENTIONAL,Data Monitoring Committee cited poor accrual.
NCT00058448,TERMINATED,INTERVENTIONAL,Study terminated due to poor patient recruitment.
NCT00058747,TERMINATED,INTERVENTIONAL,Business decision of the sponsor
NCT00058825,TERMINATED,INTERVENTIONAL,Slow accrual due to practice changes meant study would take too long to finish
NCT00059202,TERMINATED,INTERVENTIONAL,DSMB reviewed interim analysis and terminated the study due to futility.
NCT00060008,TERMINATED,INTERVENTIONAL,Study was closed early due to poor accrual.
NCT00060112,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00060294,TERMINATED,INTERVENTIONAL,no accrual
NCT00060346,TERMINATED,INTERVENTIONAL,slow accrual
NCT00060385,TERMINATED,INTERVENTIONAL,low accrual
NCT00060450,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00060554,WITHDRAWN,INTERVENTIONAL,Drug sold to Sanofi-Aventis who sold it to GSK; OBS no longer owns study and does not have data.
NCT00061178,WITHDRAWN,INTERVENTIONAL,"No patients were enrolled, study cancelled before start"
NCT00061282,TERMINATED,INTERVENTIONAL,Funding Horizon
NCT00061646,TERMINATED,INTERVENTIONAL,Enrollment suspended based upon interim analysis; subjects allowed to stay on study until disease progression.
NCT00061958,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00062023,TERMINATED,INTERVENTIONAL,Study closed by the NCI.
NCT00062231,TERMINATED,INTERVENTIONAL,low accrual
NCT00062335,TERMINATED,INTERVENTIONAL,low accrual
NCT00062387,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00062972,WITHDRAWN,INTERVENTIONAL,Study terminated/withdrawn
NCT00063258,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT00063362,TERMINATED,INTERVENTIONAL,Funding Expiration
NCT00063544,WITHDRAWN,OBSERVATIONAL,CI left institution
NCT00064259,TERMINATED,INTERVENTIONAL,Discontinued development of G3139 (oblimersen)
NCT00064649,TERMINATED,INTERVENTIONAL,Inability to recruit required sample size.
NCT00064688,WITHDRAWN,OBSERVATIONAL,This protocol was created to support work as part of an NIH-funded study.
NCT00064987,TERMINATED,INTERVENTIONAL,Recruitment was at a standstill. We are currently preparing our results for publication.
NCT00065728,TERMINATED,INTERVENTIONAL,Management decision
NCT00066417,TERMINATED,INTERVENTIONAL,Trial was withdrawn for drug availability issues.
NCT00066625,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00066677,TERMINATED,INTERVENTIONAL,Stopped accordining to early stopping rule for futility
NCT00066807,TERMINATED,INTERVENTIONAL,"Poor accrual, patients were followed until completion of 5 yrs treatment"
NCT00067340,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient number of subjects
NCT00067574,WITHDRAWN,INTERVENTIONAL,The study was never opened for enrollment; concept became irrelevant as other study results became available.
NCT00068185,TERMINATED,INTERVENTIONAL,"PI left institution, study did not continue, funding stopped"
NCT00068302,TERMINATED,INTERVENTIONAL,Recruiting/enrolling participants halted prematurely but potentially will resume
NCT00068744,TERMINATED,INTERVENTIONAL,low accrual
NCT00068770,TERMINATED,INTERVENTIONAL,EORTC trail showed TMZ \& RT conferred significant survivial in this population
NCT00068887,WITHDRAWN,OBSERVATIONAL,NOT A CLINICAL TRIAL
NCT00068900,WITHDRAWN,OBSERVATIONAL,NOT A CLINICAL TRIAL
NCT00069329,TERMINATED,INTERVENTIONAL,data submitted for Food and Drug Administration (FDA) approval
NCT00069810,WITHDRAWN,OBSERVATIONAL,The study is not a clinical trial.
NCT00069927,TERMINATED,INTERVENTIONAL,Only 12 subjects enrolled. DSMB recommended closing due to lack of feasibility
NCT00069992,TERMINATED,INTERVENTIONAL,Closed due to competing protocols
NCT00070122,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00070265,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00070291,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00070434,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT00071552,TERMINATED,INTERVENTIONAL,Very poor enrollment
NCT00072098,TERMINATED,INTERVENTIONAL,limited funding
NCT00072189,TERMINATED,INTERVENTIONAL,Early termination for discouraging results
NCT00072215,TERMINATED,INTERVENTIONAL,poor accrual
NCT00072280,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00072449,TERMINATED,INTERVENTIONAL,slow accrual and lack of resources and priority due to combining 2 consortia
NCT00072540,WITHDRAWN,INTERVENTIONAL,drug issues
NCT00073008,TERMINATED,INTERVENTIONAL,"Based on interim analysis at the end of Stage 1, and predefined stopping rules for futility, further enrollment was stopped due to lack of efficacy"
NCT00073294,WITHDRAWN,INTERVENTIONAL,Trial was not funded
NCT00073372,TERMINATED,INTERVENTIONAL,"Based on the data and observed benefit-risk profile, the trial's independent oversight committee recommended that enrollment not resume."
NCT00073970,TERMINATED,INTERVENTIONAL,Study stopped due to increased cardiovascular risks associated with Celebrex
NCT00074139,WITHDRAWN,INTERVENTIONAL,No patients were enrolled
NCT00074165,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00074269,TERMINATED,INTERVENTIONAL,Terminated early due to poor enrollment
NCT00074295,TERMINATED,INTERVENTIONAL,closed due to lack of availability of vaccine
NCT00074334,TERMINATED,INTERVENTIONAL,Drug company withdrawal of support for investigational agent in this indication.
NCT00074490,TERMINATED,INTERVENTIONAL,"Premature closure due to inability to accrue to ARM IVD, cohorts 1 and 2"
NCT00074750,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00074763,TERMINATED,INTERVENTIONAL,Terminated due to low recruitment.
NCT00075023,TERMINATED,INTERVENTIONAL,unable to enroll adequate subjects
NCT00075179,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00075413,WITHDRAWN,INTERVENTIONAL,Unable to identify qualified subjects willing to participate in this study
NCT00075491,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00075608,TERMINATED,INTERVENTIONAL,poor accrual
NCT00075998,TERMINATED,INTERVENTIONAL,test drug showed lack of benefit at interim analysis
NCT00076635,TERMINATED,INTERVENTIONAL,program discontinued based on GIPF-007 results
NCT00076726,TERMINATED,INTERVENTIONAL,"Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative glucocorticosteroid dosage"
NCT00076804,TERMINATED,INTERVENTIONAL,DSMB stopped trial for futility
NCT00077064,TERMINATED,INTERVENTIONAL,Due to unmet accrual/randomization goals
NCT00077103,TERMINATED,INTERVENTIONAL,slow accrual
NCT00077233,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00077493,SUSPENDED,INTERVENTIONAL,protocol development and Amended protocol revision
NCT00078806,TERMINATED,INTERVENTIONAL,the study was terminated because of slow enrollment
NCT00078897,TERMINATED,INTERVENTIONAL,Concluded - Terminated by PI
NCT00079326,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00079911,TERMINATED,INTERVENTIONAL,Terminated
NCT00080119,TERMINATED,INTERVENTIONAL,Data Safety Monitoring Board (DSMB) recommended stopping study due to futility
NCT00080626,TERMINATED,INTERVENTIONAL,low accrual
NCT00080639,WITHDRAWN,OBSERVATIONAL,Terminated for administrative reasons and becuase there were no enrollments
NCT00080782,TERMINATED,INTERVENTIONAL,Low accrual due to competing trial.
NCT00081211,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00081887,TERMINATED,INTERVENTIONAL,low accrual
NCT00081900,TERMINATED,INTERVENTIONAL,This study was terminated early by Genzyme because there were insufficient data to support clinical benefit to HCC patients on the study.
NCT00082017,TERMINATED,INTERVENTIONAL,IND was withdrawn by CTEP due to low accrual and cost of maintaining the IND.
NCT00082095,TERMINATED,INTERVENTIONAL,The study was terminated due to poor recruitment (after enrolling 62 of planned 300 patients in 20 months
NCT00082212,TERMINATED,INTERVENTIONAL,Due to lack of sufficient efficacy.
NCT00082459,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00082667,TERMINATED,INTERVENTIONAL,PI left VICC
NCT00083044,WITHDRAWN,OBSERVATIONAL,Funding ended and will not be renewed
NCT00083434,TERMINATED,INTERVENTIONAL,This study was stopped because of an inadequate rate of enrollment.
NCT00083447,WITHDRAWN,INTERVENTIONAL,This study has been withdrawn because the drug would not meet trial criteria for efficacy
NCT00083564,TERMINATED,INTERVENTIONAL,For business reasons
NCT00083759,TERMINATED,INTERVENTIONAL,The biological effect seen with natalizumab was not sufficient to warrant further development in RA.
NCT00083980,TERMINATED,INTERVENTIONAL,European reports of liver toxicity from kava meant that the study had to stop
NCT00084240,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00084435,WITHDRAWN,INTERVENTIONAL,Poor accrual and suspension of head and neck committee
NCT00084565,WITHDRAWN,INTERVENTIONAL,Study was never activated at Fox Chase Cancer Center.
NCT00084578,WITHDRAWN,INTERVENTIONAL,Withdrawn due to drug toxicity
NCT00084864,TERMINATED,INTERVENTIONAL,sample size is too small to draw a conclusion
NCT00084890,TERMINATED,INTERVENTIONAL,slow accrual
NCT00085059,TERMINATED,INTERVENTIONAL,low accrual
NCT00085384,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00085410,TERMINATED,INTERVENTIONAL,The trial was discontinued early due to no confirmed partial responses.
NCT00085449,WITHDRAWN,INTERVENTIONAL,"Funding cut, no patients enrolled"
NCT00085631,TERMINATED,INTERVENTIONAL,Study was closed because of slow accrual
NCT00085761,TERMINATED,INTERVENTIONAL,Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes
NCT00086632,TERMINATED,INTERVENTIONAL,closed by sponser
NCT00086684,TERMINATED,INTERVENTIONAL,Interim Analysis showed that study continuation was futile. No safety concerns were raised during the trial.
NCT00086840,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00086970,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00087009,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT00087048,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00087191,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00087256,TERMINATED,INTERVENTIONAL,"For scientific, logistic, and administrative reasons."
NCT00087295,TERMINATED,INTERVENTIONAL,Permanently Closed Due to Poor Accrual
NCT00087334,TERMINATED,INTERVENTIONAL,Withdrawn due to poor/low accrual
NCT00087464,WITHDRAWN,INTERVENTIONAL,study was withdrawn before any participants were recruited and enrolled
NCT00088829,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT00088907,TERMINATED,INTERVENTIONAL,It was unlikely that the primary endpoint would be reached based on the fifth interim analysis results.
NCT00088972,TERMINATED,INTERVENTIONAL,Study closed due to poor accrual.
NCT00088985,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT00089102,TERMINATED,INTERVENTIONAL,Low accrual
NCT00089115,TERMINATED,INTERVENTIONAL,Withdrawn as company has shut down and filed for bankruptcy
NCT00089128,TERMINATED,INTERVENTIONAL,Low accrual
NCT00089141,TERMINATED,INTERVENTIONAL,Low probability of positive outcome
NCT00089245,TERMINATED,INTERVENTIONAL,Corporate business decision. No safety or efficacy concerns.
NCT00089284,TERMINATED,INTERVENTIONAL,"Due to lack of funding, phase II of study was not completed."
NCT00089388,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00089414,TERMINATED,INTERVENTIONAL,Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of protocol.
NCT00089778,TERMINATED,INTERVENTIONAL,"fewer tumors than expected expressed FGF-5, led to end of accrual to cohorts A\&B"
NCT00089804,TERMINATED,INTERVENTIONAL,Interim efficacy analysis indicated it would be futile to continue study.
NCT00089856,TERMINATED,INTERVENTIONAL,Based on futility analysis showing \<30% chance of meeting primary endpoint.
NCT00090025,TERMINATED,INTERVENTIONAL,Futility reasons after Independent Data Monitoring Committee interim analysis
NCT00090129,TERMINATED,INTERVENTIONAL,The risk-benefit ratio for the use of onercept in this condition was not sufficiently favorable to justify continued development
NCT00090480,TERMINATED,INTERVENTIONAL,Enrollment goals unable to be reached.
NCT00090532,TERMINATED,INTERVENTIONAL,This study was terminated due to a lack of efficacy.
NCT00090675,WITHDRAWN,INTERVENTIONAL,No patients randomised
NCT00090688,WITHDRAWN,INTERVENTIONAL,IND was terminated for being inactive for more than five years
NCT00090779,TERMINATED,INTERVENTIONAL,The DSMB concluded that the findings regarding the primary analysis would persist and that no additional study goals would be achieved by continuing the study.
NCT00090844,TERMINATED,INTERVENTIONAL,Early closure due to low accrual
NCT00090870,TERMINATED,INTERVENTIONAL,Pharmaceutical collaborator pulled funding.
NCT00090961,TERMINATED,INTERVENTIONAL,Closed early due to poor accrual.
NCT00091156,TERMINATED,INTERVENTIONAL,low accrual
NCT00091195,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00091286,TERMINATED,INTERVENTIONAL,Slow accruals
NCT00091611,TERMINATED,INTERVENTIONAL,This study was terminated due to low accrual.
NCT00091845,TERMINATED,INTERVENTIONAL,Due to limited pool of eligble WNV patients
NCT00092274,WITHDRAWN,INTERVENTIONAL,Acquired asset
NCT00093132,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study drug development.
NCT00093314,WITHDRAWN,INTERVENTIONAL,Acquired asset
NCT00093704,TERMINATED,INTERVENTIONAL,study could not recruit any more patients
NCT00094250,WITHDRAWN,INTERVENTIONAL,Study was closed due to administrative reasons; study did not enroll any participants.
NCT00095329,TERMINATED,INTERVENTIONAL,Due to slow recruitment.
NCT00095641,WITHDRAWN,INTERVENTIONAL,no longer studying this disease site
NCT00095888,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00096109,TERMINATED,INTERVENTIONAL,Closed to accrual before all 12 planned patients were enrolled.
NCT00096148,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00096304,TERMINATED,INTERVENTIONAL,Low accrual
NCT00096369,TERMINATED,INTERVENTIONAL,accrual goal not met
NCT00096460,TERMINATED,INTERVENTIONAL,lower than anticipated accrual
NCT00097344,TERMINATED,INTERVENTIONAL,Identical study Biomed 777-CLP-029 did not meet superiority endpoint
NCT00097370,TERMINATED,INTERVENTIONAL,Study terminated by sponsor (29 Sep 2010). Subjects eligible to continue mepolizumab treatment were transferred into the compassionate use program (MHE104317)
NCT00098111,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00098371,TERMINATED,INTERVENTIONAL,CTEP Initiated Action.
NCT00098462,WITHDRAWN,INTERVENTIONAL,Withdrawn as study never opened
NCT00099372,TERMINATED,OBSERVATIONAL,resource and prioritization change as Network transition to a new funding cycle
NCT00099723,TERMINATED,INTERVENTIONAL,The hypothesis that probiotics would reduce hepatic steatosis in humans was not supported
NCT00100347,TERMINATED,INTERVENTIONAL,terminated due to corporate transaction.
NCT00100828,TERMINATED,INTERVENTIONAL,Closed due to early stopping rule
NCT00100971,TERMINATED,INTERVENTIONAL,Protocol is withdrawn due to inadequate accrual
NCT00100984,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00101062,TERMINATED,INTERVENTIONAL,study drug unavailable
NCT00101075,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00101244,TERMINATED,INTERVENTIONAL,Administratively Complete.
NCT00101361,TERMINATED,INTERVENTIONAL,futility analysis showed low probability of detecting a significant difference
NCT00101907,TERMINATED,INTERVENTIONAL,Study terminated per recommendation of Data Review Team
NCT00102128,TERMINATED,INTERVENTIONAL,DMC recommended stop
NCT00102622,TERMINATED,INTERVENTIONAL,Phase I/II study that did not progress to Phase II
NCT00102635,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00102791,TERMINATED,INTERVENTIONAL,Because of the low probability of achieving the primary endpoint.
NCT00102895,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00103376,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00103519,TERMINATED,INTERVENTIONAL,Study terminated for reasons unrelated to safety or efficacy.
NCT00104169,TERMINATED,INTERVENTIONAL,No subject accrual
NCT00104468,TERMINATED,INTERVENTIONAL,Trial stopped June 2007
NCT00104624,TERMINATED,INTERVENTIONAL,Toxicity issues
NCT00104728,TERMINATED,INTERVENTIONAL,Early Stopping Rule: Would not meet interim analysis goal to proceed with enrollment
NCT00104806,TERMINATED,INTERVENTIONAL,sponsor discontinues support
NCT00104819,TERMINATED,INTERVENTIONAL,Withdrawn as company has shut down and filed for bankruptcy
NCT00104884,TERMINATED,INTERVENTIONAL,"The study was terminated on May 17, 2006 due to slow accrual."
NCT00104936,TERMINATED,INTERVENTIONAL,low accrual
NCT00105313,TERMINATED,INTERVENTIONAL,After review of safety events and have decided that further dose escalation of MEDI-507 as a single agent is not feasible.
NCT00106054,TERMINATED,INTERVENTIONAL,After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could be performed.
NCT00106262,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00106938,TERMINATED,INTERVENTIONAL,Business decision and not a result of any patient or product safety issues.
NCT00107081,TERMINATED,INTERVENTIONAL,Accrual goal for interventional part not achievable
NCT00107315,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT00107471,TERMINATED,INTERVENTIONAL,The unpromising experience of the French group with topotecan given at a dosage of 0.4 mg/m2/day over 30 mins w/in 1 hr of radiation (Cancer 2005; 104: 2792).
NCT00107614,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual.
NCT00108108,TERMINATED,INTERVENTIONAL,Slow enrollment and minimal preliminary biological and clinical efficacy.
NCT00108186,WITHDRAWN,INTERVENTIONAL,Couldn't accrue patients
NCT00108316,WITHDRAWN,INTERVENTIONAL,Study PI resigned
NCT00108342,TERMINATED,INTERVENTIONAL,Common comorbidities of Veterans precluded sufficient recruitment and enrollment.
NCT00108433,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00108485,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient study subjects
NCT00108602,WITHDRAWN,INTERVENTIONAL,This study of the overall grant was not pursued as the aims were changed
NCT00109291,TERMINATED,INTERVENTIONAL,Due to slow enrollment
NCT00109304,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT00109577,TERMINATED,INTERVENTIONAL,Unable to recruit large enough sample; large expectancy effects but no adverse events
NCT00109772,TERMINATED,INTERVENTIONAL,Interim analysis showed the primary outcome was not reached
NCT00109798,WITHDRAWN,INTERVENTIONAL,Sub-Investigator reloacted to another institution
NCT00109850,TERMINATED,INTERVENTIONAL,Closed due to poor accrual
NCT00109889,TERMINATED,INTERVENTIONAL,poor accrual
NCT00110006,WITHDRAWN,INTERVENTIONAL,No accrual
NCT00110032,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00110123,TERMINATED,INTERVENTIONAL,low accrual
NCT00110136,TERMINATED,INTERVENTIONAL,Stopped due to concerns about interaction between St. John's wort and Tamoxifen.
NCT00110149,TERMINATED,INTERVENTIONAL,Company withdrew drug supply
NCT00110526,WITHDRAWN,INTERVENTIONAL,No participants met eligibility requirements
NCT00110721,TERMINATED,INTERVENTIONAL,Study protocol amended to a new treatment regimen: study DAVFU-006.
NCT00111150,TERMINATED,INTERVENTIONAL,Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial
NCT00111488,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00111917,TERMINATED,INTERVENTIONAL,Not enough patients meeting criteria to enroll in the time period
NCT00112164,TERMINATED,INTERVENTIONAL,Per recommendation of the NHLBI DSMB
NCT00112398,TERMINATED,INTERVENTIONAL,Inadequate recruitment rate combined with a high rate of patients dropping in to the treatment group from standard care
NCT00112619,TERMINATED,INTERVENTIONAL,Slow accrual and company withdrawing support to supply the drug
NCT00112723,TERMINATED,INTERVENTIONAL,Administratively Complete
NCT00112749,TERMINATED,INTERVENTIONAL,Recruitment stopped due to slow accrual and lack of evidence of need for further continuation of protocol in inpatient setting.
NCT00112866,TERMINATED,INTERVENTIONAL,due to poor accrual
NCT00113022,TERMINATED,INTERVENTIONAL,Terminated due to concerns about adverse events in separate study.
NCT00113321,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00113386,TERMINATED,INTERVENTIONAL,This study terminated early due to low accrual.
NCT00113399,TERMINATED,INTERVENTIONAL,Terminated early due to low accrual.
NCT00113503,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00113646,TERMINATED,INTERVENTIONAL,Expiration of MEDI-507
NCT00113698,TERMINATED,INTERVENTIONAL,lower than expected enrollment
NCT00113802,TERMINATED,INTERVENTIONAL,low accrual
NCT00113828,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00113919,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00114712,TERMINATED,OBSERVATIONAL,"Per the Division of Project Management, Office of Regulatory Operations, Office of Generic Drugs, FDA there is no regulatory requirement to continue this Registry."
NCT00114959,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00115063,TERMINATED,INTERVENTIONAL,ethical issues of continuing control group without treatment
NCT00115336,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00115349,TERMINATED,INTERVENTIONAL,due to low enrollment
NCT00115453,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00115661,TERMINATED,INTERVENTIONAL,Due to the meta-analysis about CV adverse effects of rosiglitazone.
NCT00115687,TERMINATED,INTERVENTIONAL,Efficacy rates did not show large enough differences between treatments
NCT00115739,TERMINATED,INTERVENTIONAL,Study was closed early due to slow accrual
NCT00116389,TERMINATED,INTERVENTIONAL,FDA Hold May 2007
NCT00116623,TERMINATED,INTERVENTIONAL,Funding completed
NCT00116974,TERMINATED,INTERVENTIONAL,Protocol Expired. Terminated by IRB
NCT00116987,TERMINATED,INTERVENTIONAL,Unable to recruit adequate number of participants in required time frame.
NCT00117260,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT00117312,TERMINATED,INTERVENTIONAL,After 190 weeks \[7 patients left\] it was terminated for administrative reasons
NCT00117351,TERMINATED,INTERVENTIONAL,insufficient efficacy
NCT00117416,WITHDRAWN,INTERVENTIONAL,No subjects recruited
NCT00117702,TERMINATED,INTERVENTIONAL,safety reasons
NCT00117845,TERMINATED,INTERVENTIONAL,Premature closure as study drug is no longer available from the manufacturer.
NCT00117884,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00118053,TERMINATED,INTERVENTIONAL,slow accrual
NCT00118066,TERMINATED,INTERVENTIONAL,"Slow accruaL, lack of scientific progress"
NCT00118105,WITHDRAWN,INTERVENTIONAL,Budget Constraints
NCT00118131,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00118196,TERMINATED,INTERVENTIONAL,Due to limited resources available to conduct study
NCT00118300,WITHDRAWN,INTERVENTIONAL,Competing studies
NCT00118573,TERMINATED,INTERVENTIONAL,lower than anticipated events;slow recruitment;larger than predicted sample size
NCT00118989,TERMINATED,INTERVENTIONAL,Could not be completed due to technology problems and cost constraints
NCT00119015,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT00119028,WITHDRAWN,INTERVENTIONAL,This study was withdrawn prior to enrollment.
NCT00119093,TERMINATED,INTERVENTIONAL,Terminated by IRB for non-compliance with human subject regulations.
NCT00119184,TERMINATED,INTERVENTIONAL,Multiparas study terminated due to poor recruitment. Randomization revealed only after decision recorded on clinicaltrials.gov
NCT00119210,TERMINATED,INTERVENTIONAL,We were unable to recruit sufficient numbers of patients and decided that the study protocol was not feasible to implement
NCT00119314,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT00119366,TERMINATED,INTERVENTIONAL,Funding ended before target accrual was reached; participants are no longer being examined or receiving intervention.
NCT00120172,TERMINATED,INTERVENTIONAL,positive results from a larger study with same regimen was released.
NCT00120198,TERMINATED,INTERVENTIONAL,slow accrual
NCT00120289,TERMINATED,INTERVENTIONAL,AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.
NCT00120380,TERMINATED,INTERVENTIONAL,Futility analysis
NCT00120640,WITHDRAWN,INTERVENTIONAL,funding
NCT00120731,WITHDRAWN,INTERVENTIONAL,Determined not feasible
NCT00120770,TERMINATED,INTERVENTIONAL,The study was halted in January 2007 due to safety concerns.
NCT00120796,TERMINATED,INTERVENTIONAL,poor patient recrutment
NCT00120952,WITHDRAWN,INTERVENTIONAL,No funding
NCT00120965,TERMINATED,INTERVENTIONAL,DSMB recommended termination due to lower survival to discharge in primary population and worse discharge CPC scores in the treatment arm than control arm.
NCT00121186,TERMINATED,INTERVENTIONAL,poor accrual
NCT00121459,WITHDRAWN,INTERVENTIONAL,PI left and no data or information is available.
NCT00121537,TERMINATED,INTERVENTIONAL,"terminated, due to lack enrollment,"
NCT00121745,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00121784,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00121875,TERMINATED,OBSERVATIONAL,Enrollment was too low.
NCT00121953,WITHDRAWN,INTERVENTIONAL,Due to the recent meta-analysis about CV adverse effects.
NCT00122252,TERMINATED,OBSERVATIONAL,Study abandoned.
NCT00122525,TERMINATED,INTERVENTIONAL,following DSMB recommandation.
NCT00122915,TERMINATED,INTERVENTIONAL,Based on a consistently low enrolment rate and procedural challenges that were unknown at study start. It was not based on safety or efficacy concerns.
NCT00122980,TERMINATED,INTERVENTIONAL,The study has been stopped due to safety and futility concerns.
NCT00123175,WITHDRAWN,INTERVENTIONAL,Study has never received funding and has never been initiated
NCT00123188,TERMINATED,INTERVENTIONAL,enrollment of participants has halted prematurely; difficulty with recruitment
NCT00123266,TERMINATED,INTERVENTIONAL,Sponsor's decision not to pursue development of uPLi for vascular conditions.
NCT00123292,TERMINATED,INTERVENTIONAL,Sponsor's decision not to pursue development of uPLi for vascular conditions
NCT00123539,TERMINATED,INTERVENTIONAL,DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome.
NCT00123578,WITHDRAWN,INTERVENTIONAL,Unable to recruit adaquate number of GHB dependent subjects
NCT00123786,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT00123799,TERMINATED,INTERVENTIONAL,sufficient enrollment reached
NCT00123890,TERMINATED,INTERVENTIONAL,The study was terminated due to hepatoxicity of compound
NCT00123942,TERMINATED,INTERVENTIONAL,After review of safety events and have decided that further dose escalation of MEDI-507 as a single agent is not feasible.
NCT00124579,TERMINATED,INTERVENTIONAL,poor accrual
NCT00124644,TERMINATED,INTERVENTIONAL,"Withdrawn due to ""toxicity"" problems"
NCT00124748,TERMINATED,INTERVENTIONAL,This study was prematurely discontinued because no improvement was observed in the 800mg dose compared to 400mg dose
NCT00124839,TERMINATED,INTERVENTIONAL,Difficulties in recruiting enough subjects
NCT00124865,WITHDRAWN,INTERVENTIONAL,Sponsor
NCT00124917,TERMINATED,INTERVENTIONAL,Study closed due to unanticipated toxicity/risks to subjects.
NCT00124930,TERMINATED,INTERVENTIONAL,Study suspended due to low enrollment
NCT00125229,TERMINATED,OBSERVATIONAL,Dr. Hladky died Sept 2006 prior to study completion
NCT00125268,TERMINATED,INTERVENTIONAL,Unable to enroll enough patients
NCT00125346,TERMINATED,INTERVENTIONAL,per Data Monitoring Committee recommendation
NCT00125411,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study drug development.
NCT00125437,TERMINATED,INTERVENTIONAL,Poor compliance with the therapy and lot of patients were lost to follow up.
NCT00125606,TERMINATED,INTERVENTIONAL,insufficient patient recruitement
NCT00125801,TERMINATED,INTERVENTIONAL,Lack of patients
NCT00126087,TERMINATED,INTERVENTIONAL,no further funding available for recruiting and testing participants
NCT00126139,TERMINATED,INTERVENTIONAL,Higher hemorrhage rates of Abciximab in ABESST II trial
NCT00126191,TERMINATED,INTERVENTIONAL,closed due to slow accrual
NCT00126217,TERMINATED,INTERVENTIONAL,A cluster of deaths in the BCG-arm compared with controls
NCT00126308,TERMINATED,INTERVENTIONAL,no change in primary endpoint at week 48
NCT00126607,TERMINATED,INTERVENTIONAL,Poor accrual.
NCT00126763,TERMINATED,INTERVENTIONAL,PK results suggested product did not meet requirement for further development.
NCT00126789,TERMINATED,INTERVENTIONAL,"Based on PK data, product did not meet requirement for further development."
NCT00126867,TERMINATED,OBSERVATIONAL,Insufficient accrual and no funding
NCT00127036,TERMINATED,INTERVENTIONAL,drug now on market
NCT00127101,TERMINATED,INTERVENTIONAL,The study was stopped due to low enrollment.
NCT00127114,WITHDRAWN,INTERVENTIONAL,No funding and exclusion criteria were to stringent.
NCT00127335,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00127374,WITHDRAWN,OBSERVATIONAL,withdrawn due to non-response. PI left university
NCT00127387,TERMINATED,INTERVENTIONAL,PI moved to Oregon
NCT00127517,TERMINATED,INTERVENTIONAL,Company shifted focus
NCT00127543,WITHDRAWN,INTERVENTIONAL,Not completed
NCT00127881,TERMINATED,INTERVENTIONAL,"New sponsor, other treatments available"
NCT00128258,TERMINATED,INTERVENTIONAL,study no longer at pittsburgh
NCT00128362,TERMINATED,INTERVENTIONAL,After initiation of study many studies reported an equivalence of SNB and ALND which led to widespread adoption of the former as standard procedure.
NCT00128817,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00128908,TERMINATED,INTERVENTIONAL,Did not recruit
NCT00128921,TERMINATED,INTERVENTIONAL,study terminated due to low accrual
NCT00129415,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00129753,WITHDRAWN,INTERVENTIONAL,Terminated due to slow accrual.
NCT00129870,TERMINATED,INTERVENTIONAL,Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition of Ca/Mg in pooled population. Further analysis pending.
NCT00129974,TERMINATED,INTERVENTIONAL,failure to accrue
NCT00130260,TERMINATED,INTERVENTIONAL,unsatisfactory efficacy data from preceding trial
NCT00130312,TERMINATED,INTERVENTIONAL,No difference in protein excretion at 6\&12 months. No safety issues.
NCT00130390,TERMINATED,INTERVENTIONAL,terminated due to slow recruitment
NCT00130494,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00130507,TERMINATED,INTERVENTIONAL,A new alternative treatment caused the decrease in the rhythm of recruitment.
NCT00131391,TERMINATED,INTERVENTIONAL,The overall profile does not support development for obesity
NCT00131404,TERMINATED,INTERVENTIONAL,The overall profile does not support development for obesity
NCT00131482,TERMINATED,INTERVENTIONAL,Treatment with Chrysalin did not demonstrate benefit compared to placebo.
NCT00131508,TERMINATED,INTERVENTIONAL,Due to slow participant accrual
NCT00131612,TERMINATED,OBSERVATIONAL,did not apply for ethics renewal
NCT00131924,TERMINATED,INTERVENTIONAL,Data Monitoring Committee recommended closure due to poor accrual.
NCT00132002,TERMINATED,INTERVENTIONAL,Early termination for discouraging results
NCT00132509,TERMINATED,INTERVENTIONAL,End of promotion by the sponsor
NCT00133016,WITHDRAWN,INTERVENTIONAL,no funding
NCT00133172,TERMINATED,INTERVENTIONAL,Varience of supply chain from that required by protocol
NCT00133224,TERMINATED,INTERVENTIONAL,Accrual and treatment with CG1940/CG8711 stopped due to IDMC recommendation.
NCT00133679,TERMINATED,INTERVENTIONAL,"Change in clinical practice allowing chronic therapy at 6 weeks of age, incompatible with possibility of placebo beyond 6 weeks of age on study protocol"
NCT00133796,TERMINATED,INTERVENTIONAL,Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.
NCT00134381,TERMINATED,INTERVENTIONAL,Principal Investigator left institution before study could complete.
NCT00134628,TERMINATED,INTERVENTIONAL,Discontinued cystitis study due to poor recruitment. To continue the trial under these circumstances is considered non-viable.
NCT00134849,TERMINATED,OBSERVATIONAL,Inadequate number of records screened; primary investigator left institution.
NCT00134953,TERMINATED,INTERVENTIONAL,The Principal Investigator left the clinic and there was no one who could take over this study.
NCT00135070,TERMINATED,INTERVENTIONAL,No documentation with MHRA to support clinical trial of a medicinal product.
NCT00135252,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT00135499,TERMINATED,INTERVENTIONAL,Recruitment too low
NCT00135733,TERMINATED,INTERVENTIONAL,Pharmaceutical sponsor withdrew financial support.
NCT00136305,TERMINATED,INTERVENTIONAL,PI moved to a different institution
NCT00136591,TERMINATED,INTERVENTIONAL,An arm closed due to lack of efficacy
NCT00136916,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00137046,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00137319,TERMINATED,INTERVENTIONAL,"Aims of the study re-evaluated, did not justify allocation of resources."
NCT00137358,WITHDRAWN,INTERVENTIONAL,unable to obtain funding to conduct study
NCT00137501,TERMINATED,INTERVENTIONAL,The trial was terminated because of difficulties in recruitement.
NCT00137865,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate the study early so they could begin a second dose-escalation study of EGEN-001 in combination with standard chemotherapy.
NCT00138073,TERMINATED,INTERVENTIONAL,The study was terminated because of lack of resources to complete it.
NCT00138125,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT00138151,TERMINATED,INTERVENTIONAL,Slow accrual and lack of study drug
NCT00138671,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00138957,WITHDRAWN,INTERVENTIONAL,too few patients included
NCT00139074,TERMINATED,INTERVENTIONAL,terminated due to very low recruitment rate (27 June 2006)
NCT00139256,TERMINATED,INTERVENTIONAL,Slow enrollment and lack of funds.
NCT00139607,TERMINATED,INTERVENTIONAL,Please see detailed description for termination reason.
NCT00139646,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00140140,TERMINATED,INTERVENTIONAL,Unable to determine the optimum tolerated dose
NCT00140660,TERMINATED,INTERVENTIONAL,Low acrual
NCT00140790,TERMINATED,INTERVENTIONAL,"The number of actual events was extremely low. We extended the study period, but it was still not enough. Also, many patients were loss of follow up."
NCT00140855,TERMINATED,INTERVENTIONAL,Study discontinued due to poor accrual.
NCT00140920,TERMINATED,INTERVENTIONAL,Recruitment/study discontinued after withdrawal of marketing authorisation. No data entered.
NCT00141011,TERMINATED,INTERVENTIONAL,Futility
NCT00141310,TERMINATED,INTERVENTIONAL,Study prematurely discont'd 20-Apr-2006 after interim analysis suggested sample size could be reduced without losing power. No safety concerns led to decision.
NCT00141544,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00141557,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00141583,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT00141596,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT00141700,TERMINATED,INTERVENTIONAL,enrollment completed
NCT00141895,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT00142051,TERMINATED,INTERVENTIONAL,"18 or 20 enrolled, stopped due to paucity of available participants"
NCT00142168,TERMINATED,INTERVENTIONAL,Toxicity
NCT00142727,TERMINATED,INTERVENTIONAL,Study terminated due to halt in funding; may resume recruiting in future
NCT00142883,TERMINATED,INTERVENTIONAL,Study has been completed
NCT00142974,TERMINATED,INTERVENTIONAL,This study was terminated early in April 2005 due to low patient enrollment
NCT00143039,TERMINATED,OBSERVATIONAL,No metabolic disordered ID'd by TMS in either control/test group at \>50%enrolled
NCT00143078,TERMINATED,OBSERVATIONAL,Close-out of the grant - study ceased on 1/1/2010
NCT00143091,TERMINATED,INTERVENTIONAL,See Detailed Description for termination reason.
NCT00143247,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00143728,SUSPENDED,INTERVENTIONAL,Enrollment.
NCT00143819,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00144404,WITHDRAWN,OBSERVATIONAL,this was not a clinical trial
NCT00144443,TERMINATED,INTERVENTIONAL,Not completed
NCT00144833,TERMINATED,INTERVENTIONAL,Incomplete data
NCT00144924,TERMINATED,INTERVENTIONAL,"The aim was to recruit 200 infants (100 per group); however, the data monitoring and ethics committee recommended halting the trial before full recruitment because of significant treatment benefit in one group at interim analysis."
NCT00145145,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT00145158,TERMINATED,INTERVENTIONAL,Availability of Investigational agent
NCT00145184,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00145418,TERMINATED,INTERVENTIONAL,low enrollment
NCT00145587,TERMINATED,INTERVENTIONAL,Due to the principal investigator having left the institution.
NCT00145665,TERMINATED,INTERVENTIONAL,no accrual achieved
NCT00145704,TERMINATED,INTERVENTIONAL,"due to low enrollment, participants are no longer being examined or treated"
NCT00145873,TERMINATED,INTERVENTIONAL,Unable to complete study
NCT00145886,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00145938,TERMINATED,INTERVENTIONAL,Unable to complete study
NCT00145951,TERMINATED,OBSERVATIONAL,Lost funding
NCT00146263,WITHDRAWN,INTERVENTIONAL,Difficulty in enrolling subjects in the proposed crossover study design
NCT00146406,TERMINATED,INTERVENTIONAL,IRB terminated due to no continuation request.
NCT00147238,TERMINATED,INTERVENTIONAL,Terminated at request of sponsor.
NCT00147355,TERMINATED,INTERVENTIONAL,"28 of 168 patients only were enrolled, numbers too low to be conclusive"
NCT00147485,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00147550,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00148135,TERMINATED,INTERVENTIONAL,recruitment goals met
NCT00148252,TERMINATED,INTERVENTIONAL,To high rejection rate in CsA withdrawal arm
NCT00148720,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00148980,WITHDRAWN,INTERVENTIONAL,the PI is no longer work at Hadassah
NCT00148993,WITHDRAWN,INTERVENTIONAL,PI (Prof. Slavin) not longer work at Hadassah
NCT00149019,WITHDRAWN,INTERVENTIONAL,the PI is no longer work at Hadassah
NCT00149305,TERMINATED,OBSERVATIONAL,Non significative preliminary data
NCT00149318,TERMINATED,OBSERVATIONAL,Difficulties in the patient's enrolment
NCT00149357,TERMINATED,OBSERVATIONAL,Funding withdrawn due to low enrollment
NCT00149539,TERMINATED,INTERVENTIONAL,Funding ended for the study
NCT00150306,TERMINATED,INTERVENTIONAL,Please see Detailed Description below for termination reason.
NCT00150319,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00150878,TERMINATED,INTERVENTIONAL,Insurance coverage reached
NCT00151099,WITHDRAWN,INTERVENTIONAL,There is no possibility to reach the target patient number within the set time frame
NCT00151164,TERMINATED,INTERVENTIONAL,"Due to failure to control sufficient patients in the active arm, this study has now been closed."
NCT00151307,TERMINATED,INTERVENTIONAL,Could not recruit any more people.
NCT00151476,TERMINATED,OBSERVATIONAL,See Detailed Description
NCT00151632,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00151671,TERMINATED,INTERVENTIONAL,insufficient enrollment rate
NCT00152308,TERMINATED,INTERVENTIONAL,Slow enrolement
NCT00152529,TERMINATED,OBSERVATIONAL,Study completed
NCT00152555,TERMINATED,INTERVENTIONAL,study completed
NCT00152607,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00152620,TERMINATED,INTERVENTIONAL,study completed
NCT00152633,WITHDRAWN,INTERVENTIONAL,No patient could be recruited.
NCT00152815,TERMINATED,INTERVENTIONAL,Not enough eligible patients available
NCT00152841,TERMINATED,INTERVENTIONAL,Lack of patients
NCT00153777,TERMINATED,INTERVENTIONAL,IDMC recommendation
NCT00153842,TERMINATED,INTERVENTIONAL,other trials show no survival benefit of bexarotene with platinum-based chemo
NCT00154427,TERMINATED,INTERVENTIONAL,Trial terminated after recruiting 172 patients but without proceeding to the highest dosing cohort as this no longer reflects common clinical practice
NCT00154934,TERMINATED,OBSERVATIONAL,difficult to enroll subjects
NCT00155402,WITHDRAWN,INTERVENTIONAL,Short of supply of fibrin glue
NCT00155610,TERMINATED,OBSERVATIONAL,No clinical significant
NCT00155714,WITHDRAWN,INTERVENTIONAL,We can't obtained the test drug (Vadenafil) from Bayer. They decided not to carry out this trail in Taiwan. Therefore this trail has never been started.
NCT00155883,TERMINATED,INTERVENTIONAL,slow a accrul due to many competitive trials.
NCT00156000,WITHDRAWN,OBSERVATIONAL,This study was stopped because of insufficient enrollment.
NCT00156299,TERMINATED,INTERVENTIONAL,Replaced by another study
NCT00156429,TERMINATED,OBSERVATIONAL,Preliminary analyses did not reveal significant associations.
NCT00156455,WITHDRAWN,OBSERVATIONAL,lack of study personel
NCT00156572,TERMINATED,INTERVENTIONAL,decreasing rate of enrollment
NCT00156598,TERMINATED,OBSERVATIONAL,Resident graduated; faculty mentor retired
NCT00156936,TERMINATED,INTERVENTIONAL,Business decision
NCT00156962,TERMINATED,INTERVENTIONAL,Regulatory decision not to proceed
NCT00157794,TERMINATED,INTERVENTIONAL,Protocol pre-specified interim analysis showed that difference between groups was too small to reach significance.
NCT00157807,TERMINATED,INTERVENTIONAL,no eligible patients can be found
NCT00157846,TERMINATED,INTERVENTIONAL,Due to existing evidence eligible patients receive CRT treatment in first place
NCT00158704,TERMINATED,INTERVENTIONAL,The study stopped due to marketing approval by the FDA.
NCT00159016,WITHDRAWN,INTERVENTIONAL,the PI is no longer work at Hadassah
NCT00159055,WITHDRAWN,INTERVENTIONAL,the PI is no longer work at Hadassah
NCT00159146,TERMINATED,INTERVENTIONAL,lack of participants fulfilling inclusion criteria
NCT00159198,TERMINATED,OBSERVATIONAL,Completed
NCT00159211,TERMINATED,INTERVENTIONAL,inclusion was finished
NCT00159237,WITHDRAWN,OBSERVATIONAL,Lead Research left the Institute
NCT00159289,WITHDRAWN,INTERVENTIONAL,No resources available
NCT00159302,WITHDRAWN,OBSERVATIONAL,Lead Researcher left the Department
NCT00159458,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00159471,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00159510,TERMINATED,INTERVENTIONAL,Inability to recruit the patients due to the short supply and changed local hospital protocol
NCT00159575,TERMINATED,INTERVENTIONAL,Slow patient recruitment and expiry of study medication(aug2009)
NCT00159757,TERMINATED,INTERVENTIONAL,See Detailed Description for Termination Reason
NCT00159926,TERMINATED,INTERVENTIONAL,For financial and logistical reasons
NCT00159978,TERMINATED,OBSERVATIONAL,Problems with FMISO supply
NCT00160004,TERMINATED,INTERVENTIONAL,problems with including patients and a large multicenter Trial is now starting as follow-up
NCT00160147,TERMINATED,INTERVENTIONAL,The study was discontinued prematurely on 25 February 2008 due to slow enrollment
NCT00160290,TERMINATED,INTERVENTIONAL,This trial discontinued on 30 JUN 2006 due to a lack of enrolment
NCT00160485,WITHDRAWN,INTERVENTIONAL,Active Duty principle investigator currently deployed
NCT00160563,TERMINATED,INTERVENTIONAL,The predecessor study A00309 (NCT00152464) did not show statistical significance in time to onset of asthma between the levocetirizine and placebo groups.
NCT00160797,WITHDRAWN,INTERVENTIONAL,10/2005 PI assigned duties as trauma physician in addition other duties
NCT00161200,TERMINATED,INTERVENTIONAL,slow accrual
NCT00161226,TERMINATED,OBSERVATIONAL,Principal investigator left institution
NCT00161239,TERMINATED,INTERVENTIONAL,toxicity
NCT00161278,TERMINATED,INTERVENTIONAL,recruitment has ended
NCT00161356,TERMINATED,INTERVENTIONAL,Budget issues
NCT00161694,TERMINATED,INTERVENTIONAL,results did not show intervention was beneficial
NCT00162071,TERMINATED,INTERVENTIONAL,Sponsor decided not to continue with the development program
NCT00162084,TERMINATED,INTERVENTIONAL,Business decision to stop the program
NCT00162513,WITHDRAWN,INTERVENTIONAL,PI is no longer work at Hadassah
NCT00162526,WITHDRAWN,INTERVENTIONAL,the PI is no longer work at Hadassah
NCT00162773,TERMINATED,INTERVENTIONAL,PI left institution
NCT00162812,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT00163241,TERMINATED,INTERVENTIONAL,Please see detailed description for termination reason.
NCT00164099,TERMINATED,INTERVENTIONAL,Patients would not take product
NCT00164788,TERMINATED,INTERVENTIONAL,No suitable patients and many patients refused the study
NCT00164801,TERMINATED,INTERVENTIONAL,Funding ended
NCT00164814,TERMINATED,OBSERVATIONAL,Funding ended
NCT00164905,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00165009,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00165087,TERMINATED,INTERVENTIONAL,Terminated by IRB for continuing review
NCT00165373,TERMINATED,INTERVENTIONAL,Lack of drug supply
NCT00165503,TERMINATED,INTERVENTIONAL,lack of acurral
NCT00165581,TERMINATED,INTERVENTIONAL,Due to continuing review
NCT00165594,TERMINATED,INTERVENTIONAL,Study was completed.
NCT00165750,TERMINATED,INTERVENTIONAL,Lack of patients to enroll.
NCT00165880,TERMINATED,INTERVENTIONAL,This study was stopped prematurely due to lack of efficacy.
NCT00165919,WITHDRAWN,OBSERVATIONAL,Not a clinical trial; human specimens from treatment site for basic research.
NCT00165997,TERMINATED,OBSERVATIONAL,sufficient data collected for significant conclusive results
NCT00166010,WITHDRAWN,INTERVENTIONAL,Observational study that DSMB placed on hold (withdrew 4 subjects). Protocol revised and received IND to become interventional PK study (no subjects enrolled).
NCT00166127,TERMINATED,INTERVENTIONAL,Unable to renegotiate an expired contract w/sponsor providing study med
NCT00166166,TERMINATED,INTERVENTIONAL,Limited clinical staff
NCT00166647,WITHDRAWN,OBSERVATIONAL,Observational Study should not be in CT.gov
NCT00166686,WITHDRAWN,INTERVENTIONAL,Study was never initiated
NCT00166712,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy \& funding.
NCT00166803,SUSPENDED,INTERVENTIONAL,no fund
NCT00167180,TERMINATED,INTERVENTIONAL,Accrual Goal Met
NCT00167206,TERMINATED,INTERVENTIONAL,"Treatment with thymic shielding found safe, another study started."
NCT00167440,WITHDRAWN,OBSERVATIONAL,Personelle changes mandated suspension.
NCT00167557,WITHDRAWN,INTERVENTIONAL,The PI left the institution.
NCT00167596,TERMINATED,INTERVENTIONAL,recruitment was stopped as consequence of cessation of funding (economic crisis)
NCT00167661,TERMINATED,INTERVENTIONAL,Enrollment suspended pending protocol revision to change study to observational
NCT00167765,TERMINATED,INTERVENTIONAL,Higher hemorrhage rates of Abciximab in ABESST II trial
NCT00167791,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00168220,WITHDRAWN,OBSERVATIONAL,Insufficient recruitment
NCT00169104,TERMINATED,INTERVENTIONAL,Closed due to achievement of primary study endpoint
NCT00169221,TERMINATED,INTERVENTIONAL,Toxicity in an independent study IMEX. The trial was subsequently terminated (54 pts instead of 140) despite safety analyses showing no excess of toxicity
NCT00169767,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT00169923,WITHDRAWN,INTERVENTIONAL,it was not possible to recruit any patient in the study
NCT00169949,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment.
NCT00170313,TERMINATED,INTERVENTIONAL,Ventricular rate during AF in CRT-patients much lower than expected
NCT00170742,TERMINATED,INTERVENTIONAL,"trial stopped on Sept 24, 2007"
NCT00170950,TERMINATED,INTERVENTIONAL,The study was terminated early because of significant efficacy results for the primary endpoint in favor of benazepril/amlodipine treatment.
NCT00171431,TERMINATED,INTERVENTIONAL,This study was terminated early in May 2006 due to low patient enrollment
NCT00171925,TERMINATED,INTERVENTIONAL,Recruitment in study could not be reached after 8 yrs of recruiting
NCT00172367,WITHDRAWN,INTERVENTIONAL,"This study was for National Science Council project. The study was not funded, so the study was withdrawn."
NCT00174187,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00174239,TERMINATED,INTERVENTIONAL,See Detailed Description for termination reason.
NCT00174291,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00174369,TERMINATED,INTERVENTIONAL,Terminated \[See Detailed Description for Termination Reason.\]
NCT00174382,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00174603,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT00174811,TERMINATED,INTERVENTIONAL,Pediatric development program terminated by sponsor
NCT00175162,WITHDRAWN,INTERVENTIONAL,No financing possible
NCT00175604,WITHDRAWN,INTERVENTIONAL,Not able to recruit any subjects for the study and was closed in February 2008
NCT00176241,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00176280,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT00176293,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00176371,WITHDRAWN,INTERVENTIONAL,Head of the study has left the institution. Study never started.
NCT00176475,TERMINATED,INTERVENTIONAL,slow accrual
NCT00176488,TERMINATED,INTERVENTIONAL,Competing studies
NCT00176501,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00176514,TERMINATED,INTERVENTIONAL,slow accrual
NCT00176527,TERMINATED,INTERVENTIONAL,accrual goal met
NCT00176540,TERMINATED,INTERVENTIONAL,slow accrual
NCT00176553,TERMINATED,INTERVENTIONAL,slow accrual
NCT00176566,TERMINATED,INTERVENTIONAL,Transitioned into a national study through ECOG
NCT00176618,TERMINATED,INTERVENTIONAL,principal Investigator left institution
NCT00176631,TERMINATED,INTERVENTIONAL,slow accrual
NCT00176644,TERMINATED,INTERVENTIONAL,Treatment ineffective
NCT00176657,TERMINATED,INTERVENTIONAL,Inability to attain sufficient numbers of subjects
NCT00176683,TERMINATED,OBSERVATIONAL,study was suspended because of difficluty maintaining equipment
NCT00176696,TERMINATED,OBSERVATIONAL,Principal Investigator has left the UMDNJ
NCT00176722,TERMINATED,OBSERVATIONAL,Principal Investigator is leaving the UMDNJ
NCT00176787,TERMINATED,INTERVENTIONAL,recruitment goals met
NCT00176826,TERMINATED,INTERVENTIONAL,Replaced by another protocol
NCT00176839,TERMINATED,INTERVENTIONAL,Replaced by a different study
NCT00176930,TERMINATED,INTERVENTIONAL,replaced by another study ; Trial re-written as MT2015-29
NCT00176956,TERMINATED,INTERVENTIONAL,IRB approval has lapsed.
NCT00177060,TERMINATED,INTERVENTIONAL,No funding available.
NCT00177138,TERMINATED,INTERVENTIONAL,The clinical use of Campath for transplant patients was temporarily suspended.
NCT00177255,TERMINATED,INTERVENTIONAL,Roche has withdrawn support
NCT00177411,WITHDRAWN,INTERVENTIONAL,Protocol design was changed so it no longer fit the description of this study.
NCT00177424,TERMINATED,INTERVENTIONAL,Recruitment goals could not be met.
NCT00177749,TERMINATED,INTERVENTIONAL,Study is complete Analysis is complete
NCT00177775,TERMINATED,INTERVENTIONAL,Study is completed and analysis completed
NCT00177853,TERMINATED,INTERVENTIONAL,terminated
NCT00177866,TERMINATED,INTERVENTIONAL,We were unable to get additional funding to complete study.
NCT00177879,WITHDRAWN,INTERVENTIONAL,Funding was never granted for this study. No participants were ever enrolled.
NCT00177970,TERMINATED,INTERVENTIONAL,We were unable to receive IVIG free from phamaceutical company.
NCT00178282,TERMINATED,INTERVENTIONAL,The study was terminated early due to poor subject enrollment.
NCT00178477,TERMINATED,INTERVENTIONAL,Drs Okunieff and ODell have left the University of Rochester
NCT00178542,TERMINATED,OBSERVATIONAL,Insufficient enrollment
NCT00178711,TERMINATED,INTERVENTIONAL,Futility
NCT00178750,WITHDRAWN,INTERVENTIONAL,Study did not start due to investigator time constraints
NCT00178854,WITHDRAWN,INTERVENTIONAL,failed recruitment efforts
NCT00179010,TERMINATED,INTERVENTIONAL,Study was terminated because funding could not be secured
NCT00179166,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00179192,WITHDRAWN,INTERVENTIONAL,non-enrollment
NCT00179205,TERMINATED,INTERVENTIONAL,funding exhausted
NCT00179582,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00179634,TERMINATED,INTERVENTIONAL,Expired for lack of continuing review
NCT00179933,TERMINATED,INTERVENTIONAL,"Unable to fulfill intention of study, lost investigators."
NCT00179972,TERMINATED,OBSERVATIONAL,Lack of resources and loss of personnel precluded study progress. No adverse events or unanticipated problems involving risks to subjects.
NCT00180219,WITHDRAWN,OBSERVATIONAL,recruitment failure
NCT00180232,WITHDRAWN,OBSERVATIONAL,"Clinical partner left University,"
NCT00180388,TERMINATED,INTERVENTIONAL,terminated for logistical reasons
NCT00180401,TERMINATED,OBSERVATIONAL,no longer interest from medical community
NCT00180414,TERMINATED,INTERVENTIONAL,low enrolment rate
NCT00180544,TERMINATED,INTERVENTIONAL,"Device superceded by next generation device. Enrollment stopped, long term follow up was completed in August of 2004."
NCT00180622,WITHDRAWN,OBSERVATIONAL,No resources available
NCT00180739,WITHDRAWN,INTERVENTIONAL,Recruitment not possible worldwide
NCT00180765,WITHDRAWN,OBSERVATIONAL,No funding for the study
NCT00180778,WITHDRAWN,INTERVENTIONAL,Literature highlighted unnecessary side effects from the relevant combination.
NCT00180843,TERMINATED,INTERVENTIONAL,lack of resources research fellow left
NCT00181181,TERMINATED,INTERVENTIONAL,Coronary flow by echo Doppler was obtainable in about 50% of subjects. The study was stopped early because of insufficient sample size to achieve adequate power
NCT00181220,WITHDRAWN,INTERVENTIONAL,PI left JHU and is not able to be reached for updates
NCT00181272,TERMINATED,INTERVENTIONAL,Principal Investigator moved institutions
NCT00181649,WITHDRAWN,INTERVENTIONAL,Not able to recruit any subjects.
NCT00181753,WITHDRAWN,INTERVENTIONAL,State of Mass. tightened regulations for making intravenous solutions for research subjects. Study was withdrawn and no participants were enrolled.
NCT00181896,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of recruitment
NCT00182039,TERMINATED,INTERVENTIONAL,Please see detailed description for reason why study was terminated.
NCT00182455,TERMINATED,INTERVENTIONAL,loss of funding
NCT00182533,TERMINATED,INTERVENTIONAL,Study drug could not be re-supplied
NCT00183430,TERMINATED,INTERVENTIONAL,Insufficient Enrollment
NCT00183807,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00183950,TERMINATED,INTERVENTIONAL,No funding
NCT00183963,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00183976,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00183989,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00184028,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT00184054,TERMINATED,INTERVENTIONAL,Competing studies
NCT00184067,TERMINATED,INTERVENTIONAL,Primary PI left institution
NCT00184145,WITHDRAWN,INTERVENTIONAL,approval of ethical committee was denied
NCT00184171,TERMINATED,INTERVENTIONAL,insufficient data quality
NCT00184210,TERMINATED,OBSERVATIONAL,the actual primary goal - establishment of an approved tissue biobank - was reached. 1000 tissue samples were collected. No motivation at this time for continuation as originally planned
NCT00184249,WITHDRAWN,INTERVENTIONAL,Collaborators did not enter patients into the study
NCT00184288,WITHDRAWN,OBSERVATIONAL,no patients recruited
NCT00184366,TERMINATED,OBSERVATIONAL,efalizumab was withdrawn from market; full 2 years follow-up only 14 patients
NCT00184405,TERMINATED,OBSERVATIONAL,Terminated due to financial cut
NCT00184548,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00184925,TERMINATED,INTERVENTIONAL,Analysis was frustrated by inadequate PhD's....
NCT00185679,TERMINATED,INTERVENTIONAL,This study was superseded by the subsequent study IRB-15919 (NCT01050764)
NCT00185705,TERMINATED,INTERVENTIONAL,Primary investigator moved to different university
NCT00185874,TERMINATED,INTERVENTIONAL,Study closed due to lack of funding
NCT00186095,WITHDRAWN,INTERVENTIONAL,"Closed, never started."
NCT00186693,WITHDRAWN,OBSERVATIONAL,never received funding
NCT00186745,TERMINATED,INTERVENTIONAL,Funding ceased
NCT00186927,SUSPENDED,INTERVENTIONAL,"voluntary Hold because of COVID-19, all participants were off study prior to the hold."
NCT00187005,TERMINATED,INTERVENTIONAL,Toxicity
NCT00187135,TERMINATED,INTERVENTIONAL,The study was terminated due to slow accrual.
NCT00187304,WITHDRAWN,INTERVENTIONAL,Study replaced by an observational study
NCT00187590,TERMINATED,INTERVENTIONAL,Intervention was taken up as a standard of care.
NCT00187746,WITHDRAWN,INTERVENTIONAL,Budget exceeded for project.
NCT00188487,SUSPENDED,INTERVENTIONAL,no funding
NCT00188526,WITHDRAWN,INTERVENTIONAL,Unknown Reason
NCT00188552,TERMINATED,INTERVENTIONAL,May 2007: No annual renewal
NCT00188656,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT00188669,TERMINATED,INTERVENTIONAL,date: August 2006. No annual renewal
NCT00189423,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding. Follow-up completed for all enrolled subjects.
NCT00189878,TERMINATED,INTERVENTIONAL,unable to recruit
NCT00190034,SUSPENDED,INTERVENTIONAL,opposite result
NCT00190151,TERMINATED,INTERVENTIONAL,terminated
NCT00190203,TERMINATED,INTERVENTIONAL,the study is publiched
NCT00190216,TERMINATED,INTERVENTIONAL,terminated
NCT00191477,TERMINATED,INTERVENTIONAL,The study was stopped early for futility reasons.
NCT00192946,WITHDRAWN,INTERVENTIONAL,The study population is smaller than expected. No subjects were included.
NCT00193726,TERMINATED,INTERVENTIONAL,The accrual was very slow and there were many competing studies ongoing/initiated .
NCT00194064,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00194415,TERMINATED,INTERVENTIONAL,An interim data analysis found no significant difference between testing groups.
NCT00194597,TERMINATED,INTERVENTIONAL,Illness of PI forced termination.
NCT00194623,TERMINATED,INTERVENTIONAL,Reorganization of personnel forced termination.
NCT00194636,SUSPENDED,INTERVENTIONAL,PI health issues
NCT00194831,WITHDRAWN,OBSERVATIONAL,No data. Study never completed.
NCT00194961,TERMINATED,INTERVENTIONAL,Funding was not approved
NCT00194974,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00195897,TERMINATED,OBSERVATIONAL,No patients; only 6 enrolled after 2 years
NCT00196677,TERMINATED,INTERVENTIONAL,The trial was terminated due to investigator's decision
NCT00197197,TERMINATED,INTERVENTIONAL,The study was terminated due to hepatoxicity of compound
NCT00197366,TERMINATED,OBSERVATIONAL,Difficulties in data collection
NCT00197925,TERMINATED,INTERVENTIONAL,all patients recruited
NCT00198081,TERMINATED,INTERVENTIONAL,Lack of funding and personnel to conduct study.
NCT00198172,TERMINATED,INTERVENTIONAL,Accrual Goal Met
NCT00198315,TERMINATED,INTERVENTIONAL,Enrollment was stopped based on the Data Monitoring Committee's recommendation.
NCT00198328,TERMINATED,INTERVENTIONAL,Enrollment was stopped based on the Data Monitoring Committee's recommendation.
NCT00199342,TERMINATED,INTERVENTIONAL,Occurrence of 2 dose-limiting toxicities at the initial dose level (60 mg/m2) in Part I.
NCT00199381,TERMINATED,INTERVENTIONAL,Additional long-term safety data no longer needed
NCT00199524,TERMINATED,INTERVENTIONAL,Enrollment was slower than anticipated.
NCT00200044,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00200382,TERMINATED,INTERVENTIONAL,The study did not achieve the statistical success to continue.
NCT00200408,TERMINATED,OBSERVATIONAL,unable to obtain funding
NCT00200590,TERMINATED,INTERVENTIONAL,More important number of SAE in one arms
NCT00200629,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00200694,TERMINATED,INTERVENTIONAL,difficulty in patients's inclusion
NCT00200746,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00201448,TERMINATED,INTERVENTIONAL,Suspended due to lack of funding
NCT00201487,WITHDRAWN,OBSERVATIONAL,We chose to use an exsisting NMR pulse sequence already established and available at the hospital.
NCT00201656,TERMINATED,INTERVENTIONAL,This trial was terminated following a futility analysis confirming futility of continuing the study
NCT00201734,TERMINATED,INTERVENTIONAL,Due to lack of funding provided for Phase II portion of trial
NCT00202371,WITHDRAWN,INTERVENTIONAL,Too few inclusions
NCT00202384,TERMINATED,OBSERVATIONAL,Few participants enrolled
NCT00202449,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT00202670,TERMINATED,OBSERVATIONAL,Positive Predictive value not related to follow up duration.
NCT00202891,WITHDRAWN,INTERVENTIONAL,No further local interest in pursuing the study.
NCT00202930,TERMINATED,INTERVENTIONAL,Closed early due to low accrual.
NCT00202995,TERMINATED,INTERVENTIONAL,Slow enrollment decreased sample size No unexpected safety issues.
NCT00203047,TERMINATED,INTERVENTIONAL,Slow enrollment decreased sample size; No unexpected safety issues.
NCT00203151,TERMINATED,INTERVENTIONAL,TV-4710/201 did not meet its primary endpoints in patients with SLE
NCT00203281,WITHDRAWN,OBSERVATIONAL,funding withdrawn
NCT00203307,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT00203385,TERMINATED,INTERVENTIONAL,Funding expired
NCT00203489,TERMINATED,INTERVENTIONAL,Reallocation of funding.
NCT00203541,TERMINATED,INTERVENTIONAL,Reallocation of funding.
NCT00203593,SUSPENDED,INTERVENTIONAL,No Resources - No Personnel
NCT00203632,TERMINATED,INTERVENTIONAL,Terminated at 50% enrollment due to recent concerns about rosiglitazone
NCT00203866,TERMINATED,INTERVENTIONAL,Study completed
NCT00203931,TERMINATED,INTERVENTIONAL,Slow accrual and evidence from other studies showing benefit of early initiation of pemetrexed after first-line therapy
NCT00203996,TERMINATED,INTERVENTIONAL,Did not meet target patient accrual goals
NCT00204152,TERMINATED,INTERVENTIONAL,PI left U of C
NCT00204763,TERMINATED,INTERVENTIONAL,We determined that the results would not be worth reporting.
NCT00204997,TERMINATED,INTERVENTIONAL,slow accrual
NCT00205049,TERMINATED,INTERVENTIONAL,lack of funding
NCT00205062,TERMINATED,INTERVENTIONAL,No Accrual
NCT00205140,TERMINATED,OBSERVATIONAL,The program responsible for recruitment was dismantled in 2006.
NCT00205413,TERMINATED,OBSERVATIONAL,low accrual
NCT00205439,TERMINATED,OBSERVATIONAL,low accrual
NCT00205517,TERMINATED,INTERVENTIONAL,End point reached at interim analysis
NCT00205907,TERMINATED,INTERVENTIONAL,Change in Formulation
NCT00205920,TERMINATED,INTERVENTIONAL,Change in formulation
NCT00205998,TERMINATED,INTERVENTIONAL,Study completed
NCT00206037,TERMINATED,INTERVENTIONAL,"Interim analysis showed significant results, thus study was stopped"
NCT00206063,TERMINATED,INTERVENTIONAL,Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.
NCT00206089,TERMINATED,INTERVENTIONAL,Melagatran/ximelagatran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.
NCT00206414,TERMINATED,INTERVENTIONAL,Difficulty accruing subjects the study accrual was closed
NCT00206440,TERMINATED,INTERVENTIONAL,Accrual was not optimized
NCT00206453,TERMINATED,INTERVENTIONAL,accrual too difficult to meet
NCT00206492,TERMINATED,INTERVENTIONAL,halted by the PI only 3 of 45 subjects were accrued.
NCT00206687,TERMINATED,INTERVENTIONAL,"Study was completed, only life long extended follow-up phase was discontinued after 12 years."
NCT00206856,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00206947,TERMINATED,INTERVENTIONAL,No more funding
NCT00207389,TERMINATED,OBSERVATIONAL,Insufficient funding
NCT00207831,TERMINATED,INTERVENTIONAL,Terminated after interim analysis
NCT00207948,TERMINATED,OBSERVATIONAL,no measurable response was detected at the 50% increase threshold.
NCT00208078,TERMINATED,INTERVENTIONAL,Not enough patient recruited
NCT00208104,TERMINATED,INTERVENTIONAL,PI left institution
NCT00208117,TERMINATED,INTERVENTIONAL,Unable to enroll subjects
NCT00208221,TERMINATED,INTERVENTIONAL,Not enough recruitment
NCT00208286,TERMINATED,INTERVENTIONAL,Primary study outcome achieved; investigator decided to conduct the study without sponsor support after 2009.
NCT00208325,TERMINATED,INTERVENTIONAL,The study was terminated at the point the primary endpoint and early milestones were reached and because long term outcomes were available from other sources
NCT00208351,TERMINATED,INTERVENTIONAL,The final assessments were conducted late and in a reduced format due to resource limitations at the site.
NCT00208364,TERMINATED,INTERVENTIONAL,Study terminated early due to business reasons
NCT00208377,TERMINATED,INTERVENTIONAL,DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all clinical studies for this product and decided to close this Study.
NCT00208390,TERMINATED,INTERVENTIONAL,Study closed after the 5 year end-point was reached after a review of the status further to a request from the investigators to discontinue participation.
NCT00208416,TERMINATED,INTERVENTIONAL,Combination of departure of Investigator from one site and slow recruitment rate
NCT00208429,WITHDRAWN,INTERVENTIONAL,"Site Principal Investigator became seriously ill, so study abandoned before the start of recruitment"
NCT00208455,TERMINATED,INTERVENTIONAL,"DePuy discontinued this product in 2013, the clinical program was reviewed and this Study was closed."
NCT00208468,TERMINATED,INTERVENTIONAL,"Slow recruitment, investigators not wishing to continue with randomisation and a decision to rationalise this product from the Sponsors portfolio."
NCT00208611,TERMINATED,INTERVENTIONAL,Funding ended and enrollment not completed within a certain time period
NCT00208663,WITHDRAWN,OBSERVATIONAL,Resources
NCT00208949,TERMINATED,INTERVENTIONAL,slow accrual
NCT00208975,TERMINATED,INTERVENTIONAL,slow accrual
NCT00209001,TERMINATED,INTERVENTIONAL,"Principal investigator Peter Johnstone, MD relocated to another institution"
NCT00209014,TERMINATED,INTERVENTIONAL,Celgene unable to continue funds.
NCT00209027,TERMINATED,INTERVENTIONAL,"difficulty with technical aspect of fMRI, resources to complete the study ran out"
NCT00209079,TERMINATED,INTERVENTIONAL,Terminated 4/17/07. Drug sponsor withdrew.
NCT00209131,TERMINATED,INTERVENTIONAL,Due to frequent turnover of research coordinators and thus poor study accrual.
NCT00209287,TERMINATED,INTERVENTIONAL,Recruitment problematic
NCT00209417,TERMINATED,INTERVENTIONAL,Supported by preliminary interim analysis. Not based on any safety signals in study or any quality issues that could affect efficacy of the product.
NCT00209586,TERMINATED,INTERVENTIONAL,Patient enrollment was stopped prior to completion of the study in order to re-evaluate the dosing regimen.
NCT00209612,WITHDRAWN,INTERVENTIONAL,due to strong side effect
NCT00209677,SUSPENDED,INTERVENTIONAL,"Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in Japan.

h"
NCT00209729,SUSPENDED,INTERVENTIONAL,Registration is less
NCT00209898,TERMINATED,INTERVENTIONAL,Low inclusion rate
NCT00210340,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT00210366,TERMINATED,INTERVENTIONAL,due to slow accrual
NCT00210392,TERMINATED,INTERVENTIONAL,"After IELSG25A study amendment, patients subject of the present study were eligible for inclusion in the IELSG25A study"
NCT00210561,TERMINATED,INTERVENTIONAL,Study was stopped shortly after initiation due to change in strategic direction of the company; no safety concerns were observed that impacted this decision.
NCT00210730,TERMINATED,INTERVENTIONAL,This study was stopped early due to slow enrollment.
NCT00210795,TERMINATED,INTERVENTIONAL,This study was stopped due to slow enrollment after enrolling only 12 of 80 patients over 14 months time.
NCT00210977,WITHDRAWN,OBSERVATIONAL,The study never started due to zero enrolment
NCT00211120,TERMINATED,INTERVENTIONAL,Stopped by the DSMB due to a trend toward more adverse events in the higher hemoglobin (Hb) arm and \<5% chance that the study would show benefit for higher Hb.
NCT00211302,TERMINATED,INTERVENTIONAL,Enrollment too difficult
NCT00211354,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT00211367,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00211380,TERMINATED,INTERVENTIONAL,Recruitment was too difficult
NCT00211471,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00211614,WITHDRAWN,INTERVENTIONAL,No enrollment.
NCT00211809,TERMINATED,INTERVENTIONAL,low enrollment
NCT00211822,TERMINATED,OBSERVATIONAL,Enrollments closed after former PI Eric Hollander left institution. There are no results.
NCT00212004,TERMINATED,INTERVENTIONAL,Limited budget to continue this study
NCT00212017,TERMINATED,INTERVENTIONAL,We obtained the final results due to the interim analysis.
NCT00212212,TERMINATED,INTERVENTIONAL,Insufficient funds to complete study.
NCT00212407,TERMINATED,INTERVENTIONAL,Study NCT01656603 supersedes this study; FDA IND 6637
NCT00212472,TERMINATED,INTERVENTIONAL,The DSMB recommended stopping the study due to safety concerns.
NCT00212511,WITHDRAWN,OBSERVATIONAL,Pending more information from PI
NCT00213330,WITHDRAWN,OBSERVATIONAL,patients with inflammatory colitis not included
NCT00213343,TERMINATED,OBSERVATIONAL,dyspnea
NCT00213356,WITHDRAWN,OBSERVATIONAL,patients with neurological disease not included
NCT00213408,TERMINATED,INTERVENTIONAL,end of the follow-up period
NCT00213577,TERMINATED,INTERVENTIONAL,the study has concluded normally;
NCT00213720,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT00214149,TERMINATED,INTERVENTIONAL,lost funding
NCT00214305,WITHDRAWN,INTERVENTIONAL,low accrual
NCT00214565,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00214591,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00214760,TERMINATED,INTERVENTIONAL,On of the liners has been taken from the market
NCT00215033,TERMINATED,OBSERVATIONAL,sufficient data gathered to support conclusion
NCT00215059,TERMINATED,OBSERVATIONAL,Lack of funding
NCT00215072,TERMINATED,OBSERVATIONAL,insufficient number of patient charts to support hypothesis
NCT00215085,TERMINATED,OBSERVATIONAL,insufficient data
NCT00215098,TERMINATED,OBSERVATIONAL,insufficient data
NCT00215527,TERMINATED,INTERVENTIONAL,Due to slow enrolment.
NCT00215540,TERMINATED,INTERVENTIONAL,Concerns related to availability of drug product
NCT00215553,TERMINATED,INTERVENTIONAL,Slow enrollment and administrative reasons
NCT00215631,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00215657,TERMINATED,INTERVENTIONAL,The doses were not effective in maintaining testosterone suppression
NCT00215735,TERMINATED,INTERVENTIONAL,"inconclusive results, market feasiblity"
NCT00215748,TERMINATED,INTERVENTIONAL,slow accrual
NCT00215943,TERMINATED,INTERVENTIONAL,"Poor accrual, changes in management of newly diagnosed myeloma patients, new drugs/more effective regimens."
NCT00216008,TERMINATED,INTERVENTIONAL,IRB Closure
NCT00216047,TERMINATED,INTERVENTIONAL,Low patient enrollment; toxicities
NCT00216060,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT00216073,TERMINATED,INTERVENTIONAL,Lack of patient accrual
NCT00216086,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT00216138,TERMINATED,INTERVENTIONAL,Interim analysis results did not meet criteria for second stage of trial
NCT00216151,TERMINATED,INTERVENTIONAL,Study terminated due to low patient enrollment.
NCT00216164,TERMINATED,INTERVENTIONAL,Study terminated due to lack of response at the first efficacy analysis
NCT00216216,TERMINATED,INTERVENTIONAL,The results from the interim analysis were not favorable to continue this trial.
NCT00216424,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00216437,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00216762,TERMINATED,INTERVENTIONAL,Full Clinical Hold
NCT00216814,TERMINATED,OBSERVATIONAL,No funding and data was not appropriate to consider continuing.
NCT00216931,WITHDRAWN,INTERVENTIONAL,No patients enrolled after three years
NCT00216983,WITHDRAWN,OBSERVATIONAL,State of Mass. tightened regulations for making intravenous solutions for research subjects. Study was withdrawn and no participants were enrolled.
NCT00216996,WITHDRAWN,OBSERVATIONAL,This study was withdrawn (see NCT00181753).
NCT00217009,TERMINATED,INTERVENTIONAL,Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided to halt the study and not publish the results.
NCT00217022,TERMINATED,INTERVENTIONAL,"Study closed early, because of low enrollment."
NCT00217035,WITHDRAWN,OBSERVATIONAL,State of Mass. tightened regulations for making intravenous solutions for research subjects. Study was withdrawn and no participants were enrolled.
NCT00217152,TERMINATED,INTERVENTIONAL,Roche decided to prematurely terminate study.
NCT00217217,TERMINATED,INTERVENTIONAL,Study was terminated for lack of recruitment.
NCT00217308,WITHDRAWN,INTERVENTIONAL,Tightly defined inclusion criteria were making recruitment very slow.
NCT00217464,TERMINATED,INTERVENTIONAL,Closed for futility
NCT00217659,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT00217724,TERMINATED,INTERVENTIONAL,Only able to accrue just 18 of the 40 target \& funds were limited.
NCT00218036,TERMINATED,INTERVENTIONAL,"PI left institution, end of funding, clinic relocation, recruitment issues"
NCT00218049,TERMINATED,INTERVENTIONAL,Issue of priority of resources
NCT00218686,WITHDRAWN,INTERVENTIONAL,In ability to obtain Indian governmental approval from the study from NACO
NCT00219479,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects
NCT00219505,TERMINATED,INTERVENTIONAL,no eligible subjects identified during recruitment
NCT00219518,TERMINATED,OBSERVATIONAL,inadequate no of constip patients
NCT00219531,TERMINATED,OBSERVATIONAL,"inadequate number of patients, study completed with normal subjects"
NCT00219830,WITHDRAWN,INTERVENTIONAL,no invited participants agreed to undertake the proposed intervention
NCT00219947,TERMINATED,OBSERVATIONAL,Blood drawing protocol for RUH/ADARC. ADARC ceasing operations at RUH
NCT00220519,TERMINATED,INTERVENTIONAL,Study stopped due to low enrollment
NCT00220675,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00220831,TERMINATED,INTERVENTIONAL,interim analysis showed significant differences between two treatment groups
NCT00220844,TERMINATED,INTERVENTIONAL,Futility; study coordinator left and were unable to continue data collection; missing data
NCT00220909,TERMINATED,INTERVENTIONAL,Recruitment slow
NCT00221182,TERMINATED,INTERVENTIONAL,slow recruitment of the study subjects
NCT00221286,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00221481,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT00221494,WITHDRAWN,INTERVENTIONAL,PI move
NCT00221507,TERMINATED,INTERVENTIONAL,Expiration of IRB Approval
NCT00221637,TERMINATED,INTERVENTIONAL,slow recruitment and treatments beyond expiry date
NCT00221663,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00221689,TERMINATED,INTERVENTIONAL,very slow recruitment and treatments beyond expiry date
NCT00221728,TERMINATED,INTERVENTIONAL,lack of patients
NCT00222079,TERMINATED,INTERVENTIONAL,"Project canceled due to the implementation of IMRT, fewer patients reporting xerostomia."
NCT00222183,WITHDRAWN,INTERVENTIONAL,Head of the study has left the institution. Study never started.
NCT00222651,TERMINATED,INTERVENTIONAL,competitor study about to start
NCT00222742,TERMINATED,INTERVENTIONAL,Futility
NCT00222989,WITHDRAWN,INTERVENTIONAL,Study never started.
NCT00223041,TERMINATED,INTERVENTIONAL,No possibilty to receive all plened patients for this study
NCT00223119,TERMINATED,INTERVENTIONAL,Study recruitment very slow.
NCT00223587,TERMINATED,INTERVENTIONAL,slow recruitment rate
NCT00223938,TERMINATED,INTERVENTIONAL,The study was terminated because of significant enrollment challenges
NCT00224328,TERMINATED,OBSERVATIONAL,The results were not able to be consistantly reproduced. Thus the trial was terminated
NCT00224419,TERMINATED,INTERVENTIONAL,was terminated due to meeting a priori stopping rule set by DSMB
NCT00224575,TERMINATED,INTERVENTIONAL,End of recruitment period
NCT00224939,TERMINATED,INTERVENTIONAL,Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show primary endpoint
NCT00225004,TERMINATED,OBSERVATIONAL,Recruiting problems
NCT00225056,TERMINATED,INTERVENTIONAL,Terminated due to lack of accrual
NCT00225225,TERMINATED,INTERVENTIONAL,due to published data on Rosiglitazone
NCT00225290,TERMINATED,INTERVENTIONAL,slowly recruitment rate
NCT00225381,WITHDRAWN,OBSERVATIONAL,Non Applicable clinical trial
NCT00225758,TERMINATED,INTERVENTIONAL,slow accrual
NCT00225888,TERMINATED,INTERVENTIONAL,Investigators left Joslin
NCT00225966,TERMINATED,INTERVENTIONAL,Study design was changed and is now InSite trial #1634 - See NCT00547378
NCT00225992,TERMINATED,INTERVENTIONAL,terminated due to lack of accrual.
NCT00226083,WITHDRAWN,OBSERVATIONAL,PI returned to India
NCT00226109,SUSPENDED,INTERVENTIONAL,Problems recruting patients
NCT00226200,TERMINATED,INTERVENTIONAL,Completed
NCT00226330,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00226512,WITHDRAWN,INTERVENTIONAL,the PI is no longer work at Hadassah
NCT00226668,WITHDRAWN,INTERVENTIONAL,Alternate study projected to assess imaging endpoints versus clinical endpoints.
NCT00226824,TERMINATED,INTERVENTIONAL,Unable to recruit subjects into the trial.
NCT00226889,TERMINATED,INTERVENTIONAL,failure of recruiting a sufficient number of patients
NCT00226941,TERMINATED,INTERVENTIONAL,The response rate observed in the phase 1 portion of the study did not merit further evaluation in phase 2 portion of the study.
NCT00227032,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00227292,WITHDRAWN,INTERVENTIONAL,Mutual agreement between Sponsor and Investigator.
NCT00227344,TERMINATED,INTERVENTIONAL,Study prematurely terminated due to randomization imbalance.
NCT00227474,WITHDRAWN,INTERVENTIONAL,SWOG has decided to not pursue this trial
NCT00227617,TERMINATED,INTERVENTIONAL,Low accrual
NCT00227656,TERMINATED,INTERVENTIONAL,Study slow to accrue.
NCT00227682,TERMINATED,INTERVENTIONAL,Terminated early due to funding suspension by grant sponsor.
NCT00228176,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00228345,TERMINATED,INTERVENTIONAL,Study Completed
NCT00228371,TERMINATED,INTERVENTIONAL,insufficent enrolement
NCT00228683,WITHDRAWN,INTERVENTIONAL,"national study, local site not responsible for any analysis/results/etc"
NCT00228696,WITHDRAWN,INTERVENTIONAL,"national study, local site not responsible for results/analysis"
NCT00228813,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00228865,TERMINATED,INTERVENTIONAL,Administrative
NCT00228878,TERMINATED,INTERVENTIONAL,Administrative
NCT00228891,TERMINATED,INTERVENTIONAL,Administrative
NCT00228904,WITHDRAWN,INTERVENTIONAL,Administrative
NCT00228995,TERMINATED,INTERVENTIONAL,This study was stopped due to slow enrollment after enrolling only 9 of 80 patients over 14 months time.
NCT00229151,TERMINATED,INTERVENTIONAL,recruiting problems
NCT00229229,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00229567,TERMINATED,INTERVENTIONAL,insufficient numbers of eligible patients as laparscopic surgery increased and open surgery decreased.
NCT00229684,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00229710,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00229749,TERMINATED,INTERVENTIONAL,Limited viral load reduction in HCV subjects
NCT00229801,WITHDRAWN,INTERVENTIONAL,"No funds available, hard to enroll patients-Terminated in 2008"
NCT00229814,WITHDRAWN,OBSERVATIONAL,There were technical difficulties and the study was terminated in 2008
NCT00229827,TERMINATED,OBSERVATIONAL,sufficient data was collected
NCT00229853,TERMINATED,OBSERVATIONAL,sufficient data gathered to support hypothesis
NCT00229866,TERMINATED,OBSERVATIONAL,sufficient data gathered for study conclusion
NCT00229879,TERMINATED,OBSERVATIONAL,sufficient data gathered to support conclusion
NCT00229892,TERMINATED,OBSERVATIONAL,"after 90 charts reviewed, insufficient data to support conclusion"
NCT00229905,TERMINATED,OBSERVATIONAL,sufficient data
NCT00230035,WITHDRAWN,INTERVENTIONAL,Recommended by DSMB due to lack of accrual
NCT00230334,TERMINATED,INTERVENTIONAL,terminated by PI due to insufficient accrual
NCT00230373,WITHDRAWN,INTERVENTIONAL,Study never started.
NCT00230490,TERMINATED,INTERVENTIONAL,Adverse findings from nonclinical carcinogenicity studies.
NCT00230607,TERMINATED,INTERVENTIONAL,"Per FDA decision, the 2003 Post Marketing commitment has been fulfilled."
NCT00231192,WITHDRAWN,INTERVENTIONAL,Unable to recruit any subjects
NCT00231374,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting patients for the study.
NCT00231621,TERMINATED,INTERVENTIONAL,The study was terminated prior to completion to focus on the development of a controlled release formulation.
NCT00231634,TERMINATED,INTERVENTIONAL,Program discontinued
NCT00231829,TERMINATED,INTERVENTIONAL,Due to reported toxicity of Celecoxib at high doses
NCT00232167,TERMINATED,INTERVENTIONAL,Please see Detailed Description below for termination reason.
NCT00232206,TERMINATED,INTERVENTIONAL,study terminated due to slow accrual
NCT00232271,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00232349,TERMINATED,INTERVENTIONAL,Study terminated due to no apparent benefit.
NCT00232362,WITHDRAWN,INTERVENTIONAL,This study was not conducted as the Principal Investigator left the institution
NCT00232388,TERMINATED,OBSERVATIONAL,"PI left institution; Data collected from 45 participants, but no results are available."
NCT00233090,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00233207,TERMINATED,INTERVENTIONAL,"Unable to meet enrollment number to complete study, study stopped June 30, 2007"
NCT00233246,WITHDRAWN,INTERVENTIONAL,Study never activated
NCT00233467,WITHDRAWN,OBSERVATIONAL,Funding expired; no subjects enrolled as this was a retrospective chart review
NCT00233558,TERMINATED,INTERVENTIONAL,Study terminated due to low subject enrollment. Safety results consistent with product label.
NCT00233727,TERMINATED,INTERVENTIONAL,PI left University
NCT00233948,TERMINATED,INTERVENTIONAL,Drug availability issues
NCT00234000,TERMINATED,INTERVENTIONAL,The study was closed due to poor enrollment
NCT00234130,TERMINATED,INTERVENTIONAL,The patient population was not enough to complete enrollment
NCT00234208,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00234273,TERMINATED,INTERVENTIONAL,recrutment
NCT00234442,TERMINATED,INTERVENTIONAL,Closed due to insufficient recruitment.
NCT00234468,TERMINATED,INTERVENTIONAL,Closed due to insufficient recruitment
NCT00234481,TERMINATED,INTERVENTIONAL,Study closed due to slow enrollment
NCT00234559,WITHDRAWN,INTERVENTIONAL,Study terminated due to no subject enrollment.
NCT00235235,TERMINATED,OBSERVATIONAL,Funding terminated
NCT00235365,WITHDRAWN,INTERVENTIONAL,problems recruiting patients
NCT00235495,TERMINATED,INTERVENTIONAL,Recruitment halted by DSMB following interim analysis.
NCT00235651,TERMINATED,INTERVENTIONAL,study completed
NCT00236002,TERMINATED,INTERVENTIONAL,Slow accrual than anticipated.
NCT00236158,TERMINATED,INTERVENTIONAL,Not able to recruit the estimated number of patients
NCT00236223,TERMINATED,INTERVENTIONAL,Structural changes that stopped the type of operations used in the study
NCT00236301,TERMINATED,INTERVENTIONAL,terminated
NCT00236327,TERMINATED,INTERVENTIONAL,Sponsor discontinued the study following the discovery of a number of incompletely sealed batches that were unusable.
NCT00236405,TERMINATED,INTERVENTIONAL,The study was terminated due to poor enrollment.
NCT00236678,TERMINATED,INTERVENTIONAL,"This study was terminated due to slow enrollment, despite protocol amendments to change the entrance criteria."
NCT00236912,TERMINATED,INTERVENTIONAL,This study was terminated due to low enrollment.
NCT00237471,TERMINATED,INTERVENTIONAL,difficulty recruiting patients
NCT00237653,TERMINATED,INTERVENTIONAL,difficulty to include patients
NCT00237679,TERMINATED,INTERVENTIONAL,Terminated due to funding loss.
NCT00237783,TERMINATED,INTERVENTIONAL,Unable to recruit enough subjects
NCT00238173,TERMINATED,INTERVENTIONAL,OHSU IRB closed study to further enrollment 2/17/2006
NCT00238277,TERMINATED,INTERVENTIONAL,Terminated - due to low accrual
NCT00238355,TERMINATED,INTERVENTIONAL,competing study at site
NCT00238563,WITHDRAWN,INTERVENTIONAL,Funding not secured
NCT00238615,TERMINATED,INTERVENTIONAL,low accrual
NCT00239200,TERMINATED,INTERVENTIONAL,notification from sponsor
NCT00239681,TERMINATED,INTERVENTIONAL,See detailed description for reason.
NCT00239720,TERMINATED,INTERVENTIONAL,Study team decision-impact(s) of change in hOKT31 (Ala-Ala) manufacturer during study.
NCT00239733,TERMINATED,INTERVENTIONAL,failure to enroll additional subjects
NCT00240162,TERMINATED,INTERVENTIONAL,investigator letter from drug manufacturer stating animal studies showed increased risk of cancer which was an unknown adverse event
NCT00240227,TERMINATED,INTERVENTIONAL,Experimental procedure did not induce sufficient craving to determine any possible effect of medication.
NCT00240357,WITHDRAWN,INTERVENTIONAL,Study cancelled prior to FSI
NCT00240396,WITHDRAWN,INTERVENTIONAL,We were not able to enroll patients.
NCT00240513,TERMINATED,INTERVENTIONAL,"Too much difficulty recruiting and retaining patients, PI decided to stop."
NCT00240734,TERMINATED,INTERVENTIONAL,This study was stopped for slow enrollment after enrolling only 11 of 180 patients in six months time.
NCT00240981,TERMINATED,INTERVENTIONAL,"Higher incidence of cardiovascular events in the testosterone arm of the trial. Decision taken by the DSMB on December 31st, 2009."
NCT00241345,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT00241371,TERMINATED,INTERVENTIONAL,No response seen in patients
NCT00241462,TERMINATED,OBSERVATIONAL,Due to poor patient enrollment
NCT00241956,TERMINATED,OBSERVATIONAL,poor data collection
NCT00242359,WITHDRAWN,INTERVENTIONAL,could not find subject population
NCT00242372,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00242463,TERMINATED,INTERVENTIONAL,drug no longer available in canada
NCT00242645,TERMINATED,INTERVENTIONAL,Administratively terminated.
NCT00242931,WITHDRAWN,INTERVENTIONAL,Unable to successfully recruit subjects to this study.
NCT00243009,TERMINATED,INTERVENTIONAL,"Due to a lack of a referal base, study was terminated."
NCT00243022,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00243204,TERMINATED,INTERVENTIONAL,FDA Hold May 2007
NCT00243308,TERMINATED,INTERVENTIONAL,Third dose group not recruited due to slow enrollment.
NCT00243490,WITHDRAWN,INTERVENTIONAL,"The Trial could not get permit from Department of Health, Taiwan; Furthermore, no research fund could support the expensive (photosensitizer) photosan"
NCT00243646,TERMINATED,INTERVENTIONAL,poor accrual
NCT00243672,WITHDRAWN,INTERVENTIONAL,"The study chair changed his employment, the realization of the study was not possible"
NCT00243802,TERMINATED,OBSERVATIONAL,Terminated.
NCT00243828,TERMINATED,INTERVENTIONAL,Very low rate of recruitment anticipated futility of pursuing the study
NCT00243984,SUSPENDED,INTERVENTIONAL,Study was discontinued because of high drop out rate.
NCT00244218,TERMINATED,INTERVENTIONAL,The FDA has approved Kuvan (BH4) as a therapeutic agent for phenylketonuria
NCT00244257,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment.
NCT00244348,WITHDRAWN,INTERVENTIONAL,Investigator has left institution
NCT00244504,TERMINATED,INTERVENTIONAL,Study was stopped after pre-definied interim analysis because of no effects
NCT00244517,TERMINATED,INTERVENTIONAL,Part II was not performed as we could not include enough patients fulfilling the inclusion criteria.
NCT00244920,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew drug.
NCT00245115,TERMINATED,INTERVENTIONAL,Expiration of study supply
NCT00245128,TERMINATED,INTERVENTIONAL,"Per PI, results from another similar study were published prior to study analysis. Negative study results were published therefore analysis was not completed"
NCT00245440,TERMINATED,INTERVENTIONAL,Sponsor Terminated
NCT00245453,WITHDRAWN,INTERVENTIONAL,Terminated by sponsor
NCT00245466,TERMINATED,INTERVENTIONAL,The maintenance doses were too low to maintain testosterone suppression
NCT00245505,TERMINATED,INTERVENTIONAL,Study terminated due to lack of eligible patients
NCT00245583,TERMINATED,INTERVENTIONAL,low enrollment
NCT00245778,TERMINATED,OBSERVATIONAL,All the patients were included
NCT00246038,WITHDRAWN,INTERVENTIONAL,"Sponsor cancelled the development program, and never conducted the study."
NCT00246298,TERMINATED,INTERVENTIONAL,OBI business decision not to complete any additional research in HIV.
NCT00246558,WITHDRAWN,OBSERVATIONAL,The study stopped due to unforeseen circumstances.
NCT00246597,TERMINATED,INTERVENTIONAL,Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those specified in current labeling.
NCT00246675,WITHDRAWN,INTERVENTIONAL,The study has ceased recruiting as Ethics approval has lapsed and the investigator availability reduced.
NCT00247026,WITHDRAWN,INTERVENTIONAL,No funding
NCT00247130,WITHDRAWN,INTERVENTIONAL,Superiority of iv omeprazole to ranitidine has already been proven by others.
NCT00247286,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00247403,WITHDRAWN,INTERVENTIONAL,Pharmaceutical company no longer manufactures drug
NCT00247468,WITHDRAWN,INTERVENTIONAL,Never received IRB approval
NCT00247806,TERMINATED,OBSERVATIONAL,Too few patients completed the study once enrolled.
NCT00247936,WITHDRAWN,INTERVENTIONAL,"Prior to recruitment, study terminated lack of recruitment interest."
NCT00247949,TERMINATED,OBSERVATIONAL,"We had got enough data, therefore we stopped the study and published the data."
NCT00247975,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00247988,TERMINATED,INTERVENTIONAL,"Regulatory issues(trial temporarily suspended December 28, 2005. Permanently suspended January 19, 2007. Institutional Reveiw Board informed April 18, 2007"
NCT00248053,WITHDRAWN,INTERVENTIONAL,Subsequent data generated by our collaborators have shown efficacy with curcumin and quercetin in 5 patients in a non placebo controlled trial.
NCT00248118,TERMINATED,INTERVENTIONAL,PI left NIH
NCT00248157,TERMINATED,INTERVENTIONAL,Inconsistent treatment benefit
NCT00248261,TERMINATED,OBSERVATIONAL,High rate of early drop-outs
NCT00248274,TERMINATED,OBSERVATIONAL,Staffing and departmental changes at our site made it difficult to enroll subjects.
NCT00248534,TERMINATED,INTERVENTIONAL,slow accrual/lack of resources/low priority due to combining 2 consortia
NCT00249002,TERMINATED,INTERVENTIONAL,Terminated due to pipeline prioritization
NCT00249067,TERMINATED,OBSERVATIONAL,data collection completed
NCT00249379,TERMINATED,INTERVENTIONAL,Not enough sugjects enrolled before funding ran out
NCT00249431,TERMINATED,INTERVENTIONAL,Inability to recruit patients.
NCT00249678,WITHDRAWN,INTERVENTIONAL,Investigator left the institution before enrolling any participants
NCT00249704,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00249847,TERMINATED,INTERVENTIONAL,Unable to complete accrual; elected to close the study in April 2008.
NCT00249899,TERMINATED,INTERVENTIONAL,Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents
NCT00250016,WITHDRAWN,OBSERVATIONAL,UNM did not proceed with research
NCT00250055,TERMINATED,INTERVENTIONAL,This is not Clinical Trial and was inadvertently entered in this system.
NCT00250081,TERMINATED,INTERVENTIONAL,Accrual is complete.
NCT00250133,TERMINATED,OBSERVATIONAL,Unable to obtain funding to complete study never started study
NCT00250692,WITHDRAWN,INTERVENTIONAL,unknown - no record of study conduct in departmental archive
NCT00250718,TERMINATED,INTERVENTIONAL,Low rate of accrual
NCT00250757,TERMINATED,OBSERVATIONAL,Study was not renewed timely with IRB of record.
NCT00250809,TERMINATED,INTERVENTIONAL,This does not meet the requirement date to be entered into CT.gov.
NCT00250835,TERMINATED,INTERVENTIONAL,Low accrual
NCT00250848,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was inadvertently entered into the system.
NCT00250861,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment.
NCT00250965,TERMINATED,INTERVENTIONAL,Terminated by DSMB; futility analysis showing Mg treatment not efficacious
NCT00251095,TERMINATED,INTERVENTIONAL,Failed primary endpoint
NCT00251186,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT00251433,TERMINATED,INTERVENTIONAL,EGF100161 (NCT00251433) was terminated in Phase I (Phase II expansion portion of the study was never initiated) by sponsor decision.
NCT00251511,TERMINATED,INTERVENTIONAL,Sponsor terminated trial
NCT00251589,TERMINATED,INTERVENTIONAL,"This trial is being closed based on lack of substantive efficacy, slow accrual and overall tolerance in patients treated to date."
NCT00251940,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00251953,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00252122,TERMINATED,INTERVENTIONAL,Recruitment was very slow.
NCT00252174,TERMINATED,INTERVENTIONAL,Lack of funds and insufficient patient population for study enrollment.
NCT00252213,TERMINATED,INTERVENTIONAL,recruitment of subjects was halted prematurely. recruiting subjects halted prematurely
NCT00252239,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00252369,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT00252434,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00252499,TERMINATED,INTERVENTIONAL,Protocol drug change required new clinicaltrails.gov entry
NCT00252551,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00252772,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00252837,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00252876,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00252967,TERMINATED,INTERVENTIONAL,Insufficient power to show therapy difference at interim analysis.
NCT00253292,TERMINATED,OBSERVATIONAL,Unable to recruit necessary sample size
NCT00253318,TERMINATED,INTERVENTIONAL,Toxicity and Lack of Efficacy
NCT00253461,TERMINATED,INTERVENTIONAL,Drugs unavailable:unable to make radioactive topotecan
NCT00253552,TERMINATED,INTERVENTIONAL,Terminated at request of PI as study was outdated.
NCT00253721,TERMINATED,INTERVENTIONAL,Other competing clinical trials affecting enrollment
NCT00253981,TERMINATED,INTERVENTIONAL,Enrollment not achieved succesfully
NCT00254228,TERMINATED,INTERVENTIONAL,Terminated due to slow recruitment
NCT00254358,TERMINATED,OBSERVATIONAL,It was decided to use a different protocol with a different radioligand
NCT00254553,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT00254618,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT00254852,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00254891,TERMINATED,INTERVENTIONAL,See Termination Reason in Detailed Description
NCT00254904,TERMINATED,INTERVENTIONAL,See Termination Reason in Detailed Description
NCT00255008,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00255034,TERMINATED,INTERVENTIONAL,Recruitment targets were unachievable in the currently available population.
NCT00255333,TERMINATED,INTERVENTIONAL,Development of this compound was discontinued.
NCT00255541,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00255645,TERMINATED,OBSERVATIONAL,The development program has been terminated
NCT00255684,TERMINATED,INTERVENTIONAL,low accrual
NCT00255983,TERMINATED,INTERVENTIONAL,financial reasons
NCT00256022,WITHDRAWN,INTERVENTIONAL,Due to delays with logistics and protocol revision not viable to continue.
NCT00256061,WITHDRAWN,OBSERVATIONAL,Due to the publication of significant literature in this area since commencement of the project which has now rendered the project unnecessary.
NCT00256074,TERMINATED,INTERVENTIONAL,Decision was made to terminate the project due to slower than anticipated recruitment and many of the investigators no longer being available.
NCT00256100,TERMINATED,INTERVENTIONAL,Teh Priincipal investigator responsible for the trial no longer employed at the study site.
NCT00256269,TERMINATED,INTERVENTIONAL,Study was terminated by funding entity
NCT00256295,TERMINATED,INTERVENTIONAL,Low accrual
NCT00256308,TERMINATED,INTERVENTIONAL,Halted prematurely due to slow accrual
NCT00256321,TERMINATED,INTERVENTIONAL,Closed due to poor accrual
NCT00256841,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00256906,TERMINATED,OBSERVATIONAL,lack of funding
NCT00256997,TERMINATED,INTERVENTIONAL,Inability to recruit number of planned patients
NCT00257192,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00257309,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00257335,WITHDRAWN,INTERVENTIONAL,Due to no patient enrollment this study was withdrawn/closed
NCT00257361,WITHDRAWN,INTERVENTIONAL,PI left the university
NCT00257543,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00257699,TERMINATED,INTERVENTIONAL,Inadequate recruitment to meet completion date
NCT00257829,WITHDRAWN,INTERVENTIONAL,This study was closed due to lack of funding.
NCT00257894,TERMINATED,INTERVENTIONAL,Enrollment was completed with insufficient sample size for publishable results
NCT00257946,TERMINATED,INTERVENTIONAL,poor accrual
NCT00258258,TERMINATED,INTERVENTIONAL,Withdrawn due to low accrual
NCT00258297,TERMINATED,INTERVENTIONAL,Withdrawn for lack of funding and accrual
NCT00258440,TERMINATED,INTERVENTIONAL,Sponsor discontinued funding of the study
NCT00258765,TERMINATED,INTERVENTIONAL,Poor recruitment \& not feasible to continue
NCT00258791,WITHDRAWN,INTERVENTIONAL,first postponed then cancelled as national drug authority changed requirements
NCT00259142,TERMINATED,INTERVENTIONAL,Study never started
NCT00259285,TERMINATED,INTERVENTIONAL,Trial was stopped early due to low enrollment.
NCT00259363,TERMINATED,INTERVENTIONAL,Study cancelled because recruitment rate was too slow
NCT00259519,TERMINATED,INTERVENTIONAL,The DSMB supported termination of the trial due to slow recruitment.
NCT00259571,WITHDRAWN,INTERVENTIONAL,Missing financial sponsorship
NCT00259636,WITHDRAWN,INTERVENTIONAL,Logistical problems prevented enrollment
NCT00259714,TERMINATED,INTERVENTIONAL,Protocol was not feasible - only 1 of 18 enrollees completed procedures.
NCT00260052,WITHDRAWN,INTERVENTIONAL,PI has left institution
NCT00260208,TERMINATED,INTERVENTIONAL,Study was prematurely terminated due to poor recruitment.
NCT00260234,TERMINATED,INTERVENTIONAL,Stopped in December 2007
NCT00260299,TERMINATED,OBSERVATIONAL,Not enough participants
NCT00260377,TERMINATED,INTERVENTIONAL,The researcher had left the hospital and the project was stopped
NCT00260494,TERMINATED,INTERVENTIONAL,No difference in primary outcomes at interim analysis.
NCT00260546,WITHDRAWN,INTERVENTIONAL,No patients enrolled for 6 months.
NCT00260598,TERMINATED,INTERVENTIONAL,LIFE Bronchoscopy equipment no longer functioning and cannot be repaired.
NCT00260741,TERMINATED,INTERVENTIONAL,Discontinued due to non-enrollment.
NCT00261196,WITHDRAWN,INTERVENTIONAL,IND moved to sponsor.
NCT00261352,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00261417,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00261781,TERMINATED,INTERVENTIONAL,"20 subjects completed for a pilot, further funding required to continue study"
NCT00261898,TERMINATED,INTERVENTIONAL,This study has been terminated. (Interim analysis of preliminary results indicated the need for protocol re-design).
NCT00261989,TERMINATED,OBSERVATIONAL,"data insignificant, study terminated"
NCT00262353,WITHDRAWN,INTERVENTIONAL,study never started because of safety alerts in literature regarding the topic to be examined
NCT00262457,WITHDRAWN,INTERVENTIONAL,It was found that the devices were not suitable for the application.
NCT00262509,TERMINATED,INTERVENTIONAL,Intervention worsened performance for first 17 of 24 planned participants.
NCT00262652,TERMINATED,INTERVENTIONAL,Patients did not respond to therapy
NCT00262665,WITHDRAWN,INTERVENTIONAL,protocol cancelled
NCT00262821,TERMINATED,INTERVENTIONAL,Study drug no longer available resulting in lack of study drug for participants.
NCT00262925,TERMINATED,INTERVENTIONAL,slow accrual
NCT00262951,TERMINATED,INTERVENTIONAL,Closed at a planned interim analysis by meeting a predefined toxicity endpoint
NCT00263016,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00263042,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00263081,TERMINATED,INTERVENTIONAL,Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents
NCT00263146,TERMINATED,INTERVENTIONAL,Lack of inclusion due to changed medical practice
NCT00263198,TERMINATED,INTERVENTIONAL,unacceptable toxicity
NCT00263211,TERMINATED,INTERVENTIONAL,Stopped due to low percentage of patients with detectable CTCs at baseline.
NCT00263445,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT00263497,TERMINATED,INTERVENTIONAL,"No update for several year, confermed ended by Odd Edvardsen i march 2020."
NCT00263562,TERMINATED,INTERVENTIONAL,"poor enrollment, availability of more effective medications"
NCT00263874,TERMINATED,INTERVENTIONAL,The decision to terminate was completely related to efficacy and there were no safety concerns.
NCT00263965,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00264472,SUSPENDED,INTERVENTIONAL,Lack of funds
NCT00264706,TERMINATED,INTERVENTIONAL,Reformulation of test compound
NCT00264979,TERMINATED,INTERVENTIONAL,Stop recommended following the last sequential analysis
NCT00265005,TERMINATED,INTERVENTIONAL,difficulty in recruiting subjects
NCT00265200,TERMINATED,INTERVENTIONAL,funding discontinued by sponsor
NCT00265382,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00265616,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00265785,TERMINATED,INTERVENTIONAL,Closed due to poor accrual
NCT00265863,TERMINATED,INTERVENTIONAL,Withdrawn due to slow accrual
NCT00265902,TERMINATED,INTERVENTIONAL,low accrual
NCT00265928,TERMINATED,INTERVENTIONAL,Withdrawn for poor accrual
NCT00265980,TERMINATED,INTERVENTIONAL,Closed by sponsor. Lack of funding.
NCT00266214,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00266812,TERMINATED,INTERVENTIONAL,Patient target could not be reached within the planned timeframe.
NCT00266916,TERMINATED,OBSERVATIONAL,data collection sufficient
NCT00266942,TERMINATED,OBSERVATIONAL,data collection ended
NCT00266955,TERMINATED,OBSERVATIONAL,insufficient number of eligible subjects
NCT00267007,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00267332,TERMINATED,INTERVENTIONAL,Low accrual
NCT00267371,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00267397,TERMINATED,OBSERVATIONAL,sufficient data collected
NCT00267553,TERMINATED,INTERVENTIONAL,This was a follow-on study to Biomed 777-CLP-029 which did not meet superiority endpoint
NCT00267683,TERMINATED,INTERVENTIONAL,This trial was terminated due to low recruitment
NCT00267982,TERMINATED,OBSERVATIONAL,significant conclusive data has been collected
NCT00268099,TERMINATED,OBSERVATIONAL,study not started
NCT00268112,TERMINATED,OBSERVATIONAL,sufficient data collected for analysis
NCT00268151,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of funding.
NCT00268164,TERMINATED,INTERVENTIONAL,Inclusion was difficult and to slow
NCT00268242,TERMINATED,INTERVENTIONAL,"If \</= 5 of the initial 18 patients had a CR, the study would be stopped. Only 5 patients (21%) of 24 enrolled patients had a CR so the study was terminated."
NCT00268255,WITHDRAWN,INTERVENTIONAL,Study never moved forward with accrual.
NCT00268372,TERMINATED,INTERVENTIONAL,SWOG eliminated its head and neck committee
NCT00268437,TERMINATED,INTERVENTIONAL,"Trial closed early because, during an interim analysis, the primary endpoint fell short."
NCT00268463,TERMINATED,INTERVENTIONAL,The study was terminated due to low accrual.
NCT00269607,TERMINATED,INTERVENTIONAL,Recruitment difficulties. Reframed as pilot study
NCT00270257,TERMINATED,INTERVENTIONAL,DSMB halted the study due to futility as a result of lower than anticipated HIV incidence rates
NCT00270322,TERMINATED,INTERVENTIONAL,"We believe regional anesth better for TKR,90% patients got epidural. Last year we started spinal morphine one shot, and found it very promissing."
NCT00270725,WITHDRAWN,OBSERVATIONAL,"Enrollment never initiated, study withdrawn."
NCT00270829,TERMINATED,INTERVENTIONAL,Funding not available
NCT00271011,TERMINATED,INTERVENTIONAL,The study was discontinued due to the death of a co-investigator and a second co-investigator leaving the institution.
NCT00271167,TERMINATED,INTERVENTIONAL,It was determined that the study was not appropriate for demonstrating therapeutic benefit in the cardiopulmonary bypass patient population.
NCT00271245,TERMINATED,INTERVENTIONAL,Insufficient funds to complete study.
NCT00271362,TERMINATED,INTERVENTIONAL,This project is no longer active with DVA.
NCT00271804,TERMINATED,INTERVENTIONAL,New study with lenalidomide pending
NCT00271947,TERMINATED,INTERVENTIONAL,"The PI, who was sponsor got retired"
NCT00272025,TERMINATED,INTERVENTIONAL,Lundbeck withdrew committment - expiring patents and prolonged inactivity
NCT00272181,TERMINATED,INTERVENTIONAL,Slow accrual in North America
NCT00272870,TERMINATED,INTERVENTIONAL,Slow accrual; drug availability
NCT00272961,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00272987,TERMINATED,INTERVENTIONAL,Enrollment was closed after the open label stage due to poor recruitment rate (randomized stage never opened).
NCT00273234,WITHDRAWN,INTERVENTIONAL,Lack of financial support. Study criteria severly limited enrollment.
NCT00273338,TERMINATED,INTERVENTIONAL,DSMB
NCT00273624,WITHDRAWN,INTERVENTIONAL,Study withdrawn before inclusion of first participant for administrative reasons
NCT00273741,TERMINATED,INTERVENTIONAL,difficulty of recrutement
NCT00273858,TERMINATED,OBSERVATIONAL,The study was terminated because at least one year follow-up was achieved for each patient and the achievement of 965 exposure years to the drug.
NCT00274157,TERMINATED,OBSERVATIONAL,Low enrollment
NCT00274651,TERMINATED,INTERVENTIONAL,"Enrollment stopped prior to reaching expected number of patients, study had accumulated sufficient data to allow a registration study in PTCL (PXD101-CLN-19)"
NCT00275106,TERMINATED,INTERVENTIONAL,Withdrawn due to an excess of toxic deaths
NCT00275314,TERMINATED,INTERVENTIONAL,Study never started at our site Funding issue
NCT00275405,SUSPENDED,INTERVENTIONAL,Results inconclusive
NCT00276146,WITHDRAWN,INTERVENTIONAL,The NHLBI BSMB recommended closure due to poor enrollment.
NCT00276159,TERMINATED,INTERVENTIONAL,Drug was not available.
NCT00276263,WITHDRAWN,INTERVENTIONAL,lack of participants
NCT00276367,WITHDRAWN,OBSERVATIONAL,is involved in NIH study
NCT00276419,TERMINATED,INTERVENTIONAL,"Lack of funds; FDA approved a topical form of diclofenac during study, no need to continue study of pharmacy-compounded drug."
NCT00276744,TERMINATED,INTERVENTIONAL,Because there was no longer an active laboratory component to this study.
NCT00276822,TERMINATED,INTERVENTIONAL,Preliminary findings did not support purpose.
NCT00276861,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00276978,WITHDRAWN,INTERVENTIONAL,Initiation of study was stopped due to administrative reasons before first subject was enrolled.
NCT00276991,TERMINATED,INTERVENTIONAL,Lack of funding prevented the recruitment of 1000 HIV Patients all over India
NCT00277004,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was entered in the system in error.
NCT00277056,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was entered in the system in error.
NCT00277290,TERMINATED,INTERVENTIONAL,Study was terminated due to cardiac toxicities in the subjects
NCT00277303,TERMINATED,INTERVENTIONAL,Study was terminated due to cardiac toxicities in the subjects
NCT00277316,TERMINATED,INTERVENTIONAL,Development of XL999 was stopped due to cardiac toxicities in the subjects
NCT00277329,TERMINATED,INTERVENTIONAL,Study was terminated due to cardiac toxicities in the subejcts
NCT00277420,WITHDRAWN,INTERVENTIONAL,PI has left institution after losing funding for this PI-initiated study
NCT00277524,TERMINATED,OBSERVATIONAL,Ended follow-up after four years
NCT00277758,TERMINATED,INTERVENTIONAL,Insufficient rate of volunteer accrual.
NCT00277927,TERMINATED,OBSERVATIONAL,sufficient data collected for significant study results
NCT00277966,WITHDRAWN,OBSERVATIONAL,"No enrollment as this was a retrospective review, not a clinical trial."
NCT00277979,TERMINATED,OBSERVATIONAL,project withdrawn
NCT00278005,TERMINATED,OBSERVATIONAL,completed
NCT00278018,TERMINATED,INTERVENTIONAL,Because there were no responses
NCT00278200,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00278265,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00278434,TERMINATED,INTERVENTIONAL,Accrual was insufficient to meet study endpoints
NCT00278486,TERMINATED,INTERVENTIONAL,First subject over five years after the transplant. The second subject is not in compliance with follow ups. We do not plan to enroll more subjects.
NCT00278512,TERMINATED,INTERVENTIONAL,No participant enrolled over five years. No plan to continue the study.
NCT00278564,TERMINATED,INTERVENTIONAL,high relapse rate
NCT00278590,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT00278642,TERMINATED,INTERVENTIONAL,sponsor stopped the study because of lack of elligible participants
NCT00278824,TERMINATED,INTERVENTIONAL,Difficulty identifying and enrolling eligible patients
NCT00278928,TERMINATED,INTERVENTIONAL,Manufacturing change in one of the two lipid emulsion products being studied.
NCT00279071,TERMINATED,INTERVENTIONAL,exhausted personel after a long recruiting period
NCT00279266,WITHDRAWN,INTERVENTIONAL,inadequate recruitment
NCT00279409,TERMINATED,INTERVENTIONAL,Recruitment Rate too slow
NCT00279422,TERMINATED,INTERVENTIONAL,"DMC recommendation, no efficacy"
NCT00279435,TERMINATED,INTERVENTIONAL,company decision based on other studies
NCT00279461,WITHDRAWN,INTERVENTIONAL,Dr. Levy terminated from IU in December 2009. Indiana University has no record that this study was initiated prior to his termination.
NCT00279539,WITHDRAWN,INTERVENTIONAL,Study never started.
NCT00279565,TERMINATED,INTERVENTIONAL,The trial was terminated because of deviations from the protocol.
NCT00279591,TERMINATED,INTERVENTIONAL,Lack of technical support and supplies
NCT00279773,TERMINATED,INTERVENTIONAL,Study was stopped due to time dependent drug accumulation
NCT00280007,TERMINATED,INTERVENTIONAL,Safety concerns in the treatment arm
NCT00280085,TERMINATED,INTERVENTIONAL,Explanation provided in detailed descriptiong section of record.
NCT00280215,WITHDRAWN,INTERVENTIONAL,"Inadequate number of patients, lack of funding"
NCT00280280,TERMINATED,INTERVENTIONAL,low patient accrual
NCT00280579,WITHDRAWN,OBSERVATIONAL,Not sufficient time to conduct the study
NCT00280748,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00281021,TERMINATED,INTERVENTIONAL,Interim analysis revealed that only 1 patient had a partial response.
NCT00281099,TERMINATED,INTERVENTIONAL,Inability to reach statistical significance toward primary endpoint
NCT00281125,TERMINATED,INTERVENTIONAL,Suspended due to data issues revealed at DSMB meeting. Planned amendment but was never submitted. Study was then closed.
NCT00281255,WITHDRAWN,INTERVENTIONAL,Infeasible
NCT00281294,TERMINATED,INTERVENTIONAL,Terminated early because the first phase didn't meet the endpoint.
NCT00281307,TERMINATED,INTERVENTIONAL,Due to a substantial response to placebo an interim analysis indicated the need for a larger than expected study population to achieve the level of significance
NCT00281333,TERMINATED,INTERVENTIONAL,logistics
NCT00281528,TERMINATED,INTERVENTIONAL,sufficient mature data to complete a final analysis
NCT00281671,TERMINATED,INTERVENTIONAL,Slow patient enrollment.
NCT00281723,SUSPENDED,INTERVENTIONAL,The company which holds the patent was not interested.
NCT00281827,TERMINATED,INTERVENTIONAL,Due to drug unavailability
NCT00281996,TERMINATED,INTERVENTIONAL,Closed to accrual to allow enrollment on another more promising trial.
NCT00282165,TERMINATED,INTERVENTIONAL,Required number of subjects to be included could not be accomplished
NCT00282412,TERMINATED,INTERVENTIONAL,No participant enrolled for three years. No plan to continue study.
NCT00282425,TERMINATED,INTERVENTIONAL,No subject enrolled since 2009
NCT00282438,TERMINATED,INTERVENTIONAL,No plan to continue enrollment
NCT00282503,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00282581,TERMINATED,INTERVENTIONAL,Senior managemnt decision
NCT00282815,TERMINATED,INTERVENTIONAL,Poor recruitment. Funding expired.
NCT00282841,TERMINATED,INTERVENTIONAL,Study terminated due to slow recruitment and funding ended.
NCT00282945,TERMINATED,INTERVENTIONAL,See statement in Detailed Description.
NCT00282971,TERMINATED,INTERVENTIONAL,Terminated as marketing of this product will be discontinued
NCT00283049,TERMINATED,INTERVENTIONAL,Due to technical issues relating to the Electronic diary data.
NCT00283309,TERMINATED,INTERVENTIONAL,Study finished enrollment but data was never sent for publishing.
NCT00283400,TERMINATED,INTERVENTIONAL,Study met safety endpoints
NCT00283426,TERMINATED,INTERVENTIONAL,Slow patient recruitment
NCT00283530,TERMINATED,OBSERVATIONAL,The PI is no longer with Kentuckiana Cancer Institute. All current subjects completed. No further subjects will be enrolled. Terminated with IRB.
NCT00283634,TERMINATED,INTERVENTIONAL,insufficient efficacy
NCT00283842,TERMINATED,INTERVENTIONAL,business reasons
NCT00284024,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT00284440,WITHDRAWN,OBSERVATIONAL,enrollment problems
NCT00284531,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00285051,TERMINATED,INTERVENTIONAL,Study drug expiry date not extended
NCT00285090,TERMINATED,INTERVENTIONAL,Lack of volunteers
NCT00285168,TERMINATED,OBSERVATIONAL,Inadequate recruitment
NCT00285363,WITHDRAWN,OBSERVATIONAL,Unable to reconcile record due to age
NCT00285415,TERMINATED,INTERVENTIONAL,Investigator abruptly left Carilion.
NCT00285454,WITHDRAWN,INTERVENTIONAL,no funding
NCT00285493,WITHDRAWN,INTERVENTIONAL,"Withdrawn: study halted prematurely, prior to enrollment of first participant"
NCT00285779,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00285857,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00285987,WITHDRAWN,INTERVENTIONAL,Study has never started
NCT00286026,WITHDRAWN,INTERVENTIONAL,Prevalence of infection for screened population too low (\<7%) to enroll anyone.
NCT00286195,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to a business decision.
NCT00286403,WITHDRAWN,INTERVENTIONAL,The study was terminated due to logistics at a local hospital.
NCT00286559,WITHDRAWN,INTERVENTIONAL,echo contrast agents no longer allowed in CAD patients.
NCT00286663,TERMINATED,OBSERVATIONAL,"Principal Investigator moving out of state, no other staff to lead research."
NCT00286689,WITHDRAWN,INTERVENTIONAL,Record Owner no longer with the institution
NCT00286936,TERMINATED,INTERVENTIONAL,Slow inclusion resulting in premature termination due to logistics
NCT00286988,TERMINATED,INTERVENTIONAL,Insufficient potential subjects
NCT00287066,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00287144,WITHDRAWN,OBSERVATIONAL,the doctor performing the study suddenly changed work and moved
NCT00287326,TERMINATED,INTERVENTIONAL,terminated by PI
NCT00287378,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00287430,WITHDRAWN,INTERVENTIONAL,"D Hardin not at institution, IRB has no record, no other investigators for study information"
NCT00287443,WITHDRAWN,INTERVENTIONAL,PI no longer with the University
NCT00287651,TERMINATED,INTERVENTIONAL,Administrative
NCT00287664,SUSPENDED,INTERVENTIONAL,because in a preliminary analysis we would need 1000 patients per group to achieve significative differences in the main end point.
NCT00287742,TERMINATED,INTERVENTIONAL,A decision was made to discontinue the study due to a change in the strategic direction of the company.
NCT00287859,TERMINATED,INTERVENTIONAL,Withdrawn due to low accrual
NCT00288054,TERMINATED,INTERVENTIONAL,Study closed early due to poor accrual.
NCT00288067,TERMINATED,INTERVENTIONAL,NCI stopped supplying fenretinide in November of 2012.
NCT00288106,TERMINATED,OBSERVATIONAL,Poor accrual resulted in lack of feasibility to evaluate endpoints.
NCT00288171,WITHDRAWN,INTERVENTIONAL,insufficient number of eligible subjects
NCT00288353,TERMINATED,INTERVENTIONAL,unable to secure additional funding
NCT00288457,TERMINATED,OBSERVATIONAL,Because no staff to consent or enroll subjects
NCT00288808,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00288964,WITHDRAWN,INTERVENTIONAL,Sponsor no longer pursuing regulatory approval of investigational device
NCT00289055,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00289081,TERMINATED,INTERVENTIONAL,Business reasons
NCT00289601,TERMINATED,INTERVENTIONAL,Sponsor support withdrawn
NCT00290017,TERMINATED,INTERVENTIONAL,FDA Hold May 2007
NCT00290082,TERMINATED,INTERVENTIONAL,2 complications with midazolam
NCT00290186,TERMINATED,INTERVENTIONAL,Terminated for futility.
NCT00290199,TERMINATED,INTERVENTIONAL,Gathering information from the PI records to provide this response.
NCT00290238,TERMINATED,INTERVENTIONAL,Slow recruitment and high dropout rates
NCT00290407,TERMINATED,INTERVENTIONAL,terminated due to lack of accrual
NCT00290420,WITHDRAWN,INTERVENTIONAL,"important delays and malaria season missed, due to political changes"
NCT00290537,TERMINATED,INTERVENTIONAL,Accrual was suboptimal and increasing the number of patients was not feasible.
NCT00290628,TERMINATED,INTERVENTIONAL,Replaced with another study
NCT00290654,TERMINATED,INTERVENTIONAL,Unable to recruit further patients.
NCT00290706,TERMINATED,INTERVENTIONAL,Closed per Data Monitoring Committee due to lack of efficacy
NCT00290719,TERMINATED,INTERVENTIONAL,low enrollment
NCT00290771,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00291057,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00291174,TERMINATED,OBSERVATIONAL,Unforeseen difficulty identifying and enrolling eligible subjects
NCT00291408,WITHDRAWN,INTERVENTIONAL,Researchers left the institute
NCT00291551,TERMINATED,INTERVENTIONAL,Resources unavailable to continue study follow-up.
NCT00291850,TERMINATED,INTERVENTIONAL,no patient recruitment
NCT00292097,TERMINATED,INTERVENTIONAL,Difficulty obtaining enrollment
NCT00292201,TERMINATED,INTERVENTIONAL,Lack of funding to complete subject recruitment and testing
NCT00292292,TERMINATED,INTERVENTIONAL,Economic and business reasons
NCT00292318,TERMINATED,INTERVENTIONAL,Unable to continue due to medical equipment necessary for research study was removed from facility.
NCT00292500,TERMINATED,INTERVENTIONAL,Cardica has terminated the development of the product for Business Reason.
NCT00292747,TERMINATED,INTERVENTIONAL,early termination due to loss of interest and low enrollment of patient
NCT00293137,TERMINATED,OBSERVATIONAL,safety concerns regarding use of rosiglitazone
NCT00293150,TERMINATED,INTERVENTIONAL,Lack of eligible patients
NCT00293202,TERMINATED,INTERVENTIONAL,We were unable to recruit sufficient patients within the confines of our budget considering the restrains on our recruitment criteria
NCT00293215,TERMINATED,INTERVENTIONAL,Abnormal distribution and lack of tumor targeting were observed.
NCT00293332,TERMINATED,INTERVENTIONAL,Terminated due to low subject accrual
NCT00293371,TERMINATED,INTERVENTIONAL,low accrual
NCT00293527,WITHDRAWN,INTERVENTIONAL,"Withdrawn in October 2006, no longer of interest"
NCT00293735,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00294060,TERMINATED,OBSERVATIONAL,"Preliminary analysis determined there was sufficient data to support objectives and allow early completion. The last patient visit occurred on November 6, 2007."
NCT00294437,TERMINATED,INTERVENTIONAL,underfunding
NCT00294541,TERMINATED,INTERVENTIONAL,Lack of efficacy demonstrated in study ICA-17043-10
NCT00294723,TERMINATED,INTERVENTIONAL,The trial was terminated at week 195 due to an insufficient number of subjects remaining to obtain reasonable statistical power
NCT00294905,TERMINATED,INTERVENTIONAL,recruitment of patients did not reach sufficient numbers
NCT00295230,SUSPENDED,OBSERVATIONAL,suboptimal enrollment after 18 months.
NCT00295438,TERMINATED,INTERVENTIONAL,No diagnosis of visceral lesion was placed on 18 included patients. The study is thus stopped prematurely for ethical reasons.
NCT00295490,TERMINATED,INTERVENTIONAL,unexpected withdrawal of funding
NCT00295737,TERMINATED,INTERVENTIONAL,proof of mechanism achieved with fewer subjects than anticipated
NCT00295776,TERMINATED,INTERVENTIONAL,enrollment difficult due to inclusion/exclusion criteria/protocol requirements
NCT00295880,TERMINATED,INTERVENTIONAL,Time to engraftment would not be improved compared to historical controls.
NCT00296010,TERMINATED,INTERVENTIONAL,Accrual rate was too low
NCT00296062,TERMINATED,INTERVENTIONAL,Trial did not move to Phase II portion due to poor tolerance of treatment
NCT00296088,TERMINATED,OBSERVATIONAL,PI left institution
NCT00296166,TERMINATED,INTERVENTIONAL,Patients with permanent AF are seldomly symptomatic enough to justify intervention. We decided to stop inclusion due to low recruitment rate.
NCT00296205,WITHDRAWN,INTERVENTIONAL,I am changing locations to Johns Hopkins Medical Center
NCT00296556,TERMINATED,INTERVENTIONAL,terminated
NCT00296686,TERMINATED,INTERVENTIONAL,Study is no longer funded.
NCT00296959,TERMINATED,INTERVENTIONAL,early termination due to slow recruitment
NCT00296972,TERMINATED,INTERVENTIONAL,not funded
NCT00297193,TERMINATED,INTERVENTIONAL,For safety reasons the recruitment was halted prematurely. Patients on the trial continute to receive treatment and are being followed up as part the protocol.
NCT00297635,WITHDRAWN,INTERVENTIONAL,Decided not to participate in study per Leslie Padron-Massaro
NCT00298142,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00298272,TERMINATED,INTERVENTIONAL,Sponsor decided to end long term extension phase for business reasons unrelated to safety.
NCT00298298,TERMINATED,INTERVENTIONAL,Suspended until capitalization is completed
NCT00298324,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00298454,TERMINATED,INTERVENTIONAL,Number included has been reached
NCT00298467,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT00298753,WITHDRAWN,INTERVENTIONAL,no patients could be recruited
NCT00298805,TERMINATED,OBSERVATIONAL,Study terminated due to expiration of IRB approval
NCT00298857,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00299169,TERMINATED,INTERVENTIONAL,insufficient recruitment/enrollment
NCT00299234,TERMINATED,INTERVENTIONAL,Insufficient number of interested potentital subjects
NCT00299273,TERMINATED,INTERVENTIONAL,PI left institution
NCT00299390,TERMINATED,INTERVENTIONAL,"Since only 1 of the first 10 subjects responded to the study treatment, it was decided to stop the trial due to lack of efficacy ."
NCT00299585,SUSPENDED,INTERVENTIONAL,manufacturer could not finance the study
NCT00299611,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate the study due to budget consideration
NCT00299949,TERMINATED,OBSERVATIONAL,Insufficient subject enrollment
NCT00300040,TERMINATED,INTERVENTIONAL,Very slow enrollment.Study entry criteria not in line w/local standards of care
NCT00300105,TERMINATED,INTERVENTIONAL,The development program has been terminated
NCT00300196,TERMINATED,INTERVENTIONAL,Futility
NCT00300300,TERMINATED,INTERVENTIONAL,Study temporarily suspended until funding can be secured.
NCT00300326,TERMINATED,INTERVENTIONAL,problems with planned computer
NCT00300391,TERMINATED,INTERVENTIONAL,Insufficient recruitment to meet aims.
NCT00300495,TERMINATED,INTERVENTIONAL,Unable to accrual total number of participants during study period.
NCT00300573,TERMINATED,INTERVENTIONAL,Development program ended due to inability to pair with other cytidine analogs and higher risk of hyperlipasemia when not used with 3TC/FTC.
NCT00300638,TERMINATED,OBSERVATIONAL,The study was terminated prematurely because of restrictions imposed by COVID-19.
NCT00300885,TERMINATED,INTERVENTIONAL,"Based on the results of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early."
NCT00300898,WITHDRAWN,INTERVENTIONAL,Unable to enroll
NCT00301080,TERMINATED,INTERVENTIONAL,Funding for the study fell through.
NCT00301106,TERMINATED,INTERVENTIONAL,"protocol underwent significant revisions, decision made to terminate study and open as new study listed NCT00849459"
NCT00301379,TERMINATED,OBSERVATIONAL,Low accrual
NCT00301405,TERMINATED,INTERVENTIONAL,Study closed. Difficult enrollment of patients with prostatitis.
NCT00301587,WITHDRAWN,INTERVENTIONAL,Company decision to not fund further development of women's health new drug development programs.
NCT00301860,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT00301886,WITHDRAWN,INTERVENTIONAL,withdrawn support for study
NCT00301912,WITHDRAWN,INTERVENTIONAL,Withdrawn because study never opened to accrual
NCT00302211,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment
NCT00302341,TERMINATED,INTERVENTIONAL,FDA Clinical Hold as of 12/21/07 due to safety concerns
NCT00302536,WITHDRAWN,INTERVENTIONAL,There was less patients recruited.
NCT00302601,TERMINATED,INTERVENTIONAL,Logistics failure and staff/scanner shortage
NCT00302770,TERMINATED,INTERVENTIONAL,This study was terminated due to poor enrollment
NCT00302952,TERMINATED,INTERVENTIONAL,Slow enrollment \&Study Drug Expiration (Target: 40 randomized participants /arm)
NCT00303082,TERMINATED,INTERVENTIONAL,Limitation of funding
NCT00303134,TERMINATED,INTERVENTIONAL,poor intermediate-term results
NCT00303303,TERMINATED,INTERVENTIONAL,Study terminated due to declining enrollment; data analysis proceeding.
NCT00303355,TERMINATED,OBSERVATIONAL,Study completed
NCT00303420,TERMINATED,INTERVENTIONAL,Unable to enrol enough people to achieve the full sample size
NCT00303615,TERMINATED,INTERVENTIONAL,Low accrural
NCT00303628,TERMINATED,INTERVENTIONAL,The study was terminated before reaching its accrual goal due to slow accrual.
NCT00303719,TERMINATED,INTERVENTIONAL,IRB Study Closure
NCT00303966,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00304200,TERMINATED,INTERVENTIONAL,Funding was inadequate to continue; Companies requested closure.
NCT00304213,WITHDRAWN,INTERVENTIONAL,"Study never started, PI relocation"
NCT00304252,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT00304317,WITHDRAWN,INTERVENTIONAL,PI is no longer at the University of Minnesota
NCT00304590,TERMINATED,INTERVENTIONAL,Study was terminated due to cardiac toxicities in the subjects
NCT00304772,WITHDRAWN,INTERVENTIONAL,Subjects were not recruited as intended.
NCT00304863,WITHDRAWN,INTERVENTIONAL,The assistant who was going to do this study moved to a different med center
NCT00305162,TERMINATED,INTERVENTIONAL,Insufficient evidence of the clinical effectiveness of cangrelor
NCT00305201,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of study participants
NCT00305292,TERMINATED,INTERVENTIONAL,This study should be terminated as the study closed prior to 2007 and the investigator has since retired. No records are available.
NCT00305331,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT00305383,TERMINATED,INTERVENTIONAL,Dose levels were determined to be subtherapeutic
NCT00305526,TERMINATED,INTERVENTIONAL,lack of enrolment
NCT00305643,TERMINATED,INTERVENTIONAL,Terminated due to low accrual. No data analyzed.
NCT00306020,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to difficulties in recruiting appropriate patients in community clinic setting
NCT00306059,WITHDRAWN,INTERVENTIONAL,Investigators decision
NCT00306267,TERMINATED,INTERVENTIONAL,Study stopped as it would not address important survival concerns raised in other recently conducted clinical studies.
NCT00306332,TERMINATED,INTERVENTIONAL,Interim analysis has shown that the objectives of this study can not be reached
NCT00306462,TERMINATED,INTERVENTIONAL,"No enrollment in past year, lack of interest"
NCT00306670,TERMINATED,INTERVENTIONAL,Sponsor no longer funding study.
NCT00306826,WITHDRAWN,INTERVENTIONAL,financial support withdrawn
NCT00306917,TERMINATED,INTERVENTIONAL,Terminated due to limited enrollment and follow up.
NCT00307398,TERMINATED,INTERVENTIONAL,Management decision
NCT00307476,WITHDRAWN,INTERVENTIONAL,Unable to recruit target enrollment numbers
NCT00307723,TERMINATED,INTERVENTIONAL,poor accrual
NCT00307775,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00307827,TERMINATED,INTERVENTIONAL,Study Canceled
NCT00307853,TERMINATED,INTERVENTIONAL,lack of patients
NCT00307892,SUSPENDED,INTERVENTIONAL,Inability to recruit patients
NCT00307905,WITHDRAWN,INTERVENTIONAL,Anticipation of inadequate recruitment according to current format.
NCT00307918,TERMINATED,INTERVENTIONAL,lack of patients
NCT00307931,TERMINATED,INTERVENTIONAL,Study was terminated early because of slow recruitment
NCT00308022,WITHDRAWN,INTERVENTIONAL,The PI is no longer with the University
NCT00308087,TERMINATED,INTERVENTIONAL,Terminated by sponsor due to low enrollment; see details below
NCT00308100,TERMINATED,INTERVENTIONAL,Study is prematurely ended due to poor patient recruitment rate.
NCT00308113,TERMINATED,INTERVENTIONAL,"New enrollment has been suspended, currently following previously enrolled participants"
NCT00308204,WITHDRAWN,INTERVENTIONAL,inadequate number of enrolled study subjects
NCT00308464,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00308594,TERMINATED,INTERVENTIONAL,Study terminated due to withdrawl of participating co-investigators.
NCT00308620,TERMINATED,INTERVENTIONAL,Insufficient financial support; lack of efficacy for primary endpoint
NCT00308776,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT00308789,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00309231,WITHDRAWN,OBSERVATIONAL,no funding
NCT00310050,TERMINATED,INTERVENTIONAL,slow accrual
NCT00310128,WITHDRAWN,INTERVENTIONAL,Drug supply unavailable
NCT00310232,TERMINATED,INTERVENTIONAL,"Recommendation of DSMB for safety issue, increased mortality with study drug."
NCT00310388,TERMINATED,INTERVENTIONAL,No longer any benefit in collecting data since retigabine has been withdrawn from market.
NCT00310661,TERMINATED,INTERVENTIONAL,Funding
NCT00310765,TERMINATED,INTERVENTIONAL,Study was terminated by the sponsor due to low accrual.
NCT00310830,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00310882,WITHDRAWN,OBSERVATIONAL,the PI is no longer work at Hadassah
NCT00311064,WITHDRAWN,INTERVENTIONAL,because of lack of funding and recruitment problems the study has been closed.
NCT00311246,TERMINATED,INTERVENTIONAL,Difficulty in recruiting subjects
NCT00311311,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00311467,TERMINATED,INTERVENTIONAL,no patient recruitment
NCT00311545,WITHDRAWN,INTERVENTIONAL,withdrawal of support for drug supply
NCT00311766,TERMINATED,INTERVENTIONAL,Lack of patient availability and expiration of study drug
NCT00311896,TERMINATED,INTERVENTIONAL,Sponsor stopped due to difficulties to recruit 402 patients required by protocol
NCT00311987,TERMINATED,INTERVENTIONAL,Curtailment of funding by sponsor
NCT00312221,TERMINATED,INTERVENTIONAL,terminated early for administrative reasons unrelated to safety or efficacy
NCT00312286,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00312442,TERMINATED,INTERVENTIONAL,STEBA decided to develop WST11 that is soluble in aqueous solutions. The property of WST 11 make it safer and better candidate for therapeutic applications.
NCT00312637,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT00312754,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00312793,TERMINATED,INTERVENTIONAL,the study stopped becaust the sponsor did not wish to proceede with the study
NCT00312871,TERMINATED,INTERVENTIONAL,Study was stopped due to restrictions in labeling for the subcutaneous route of administration of EPREX.
NCT00313014,TERMINATED,INTERVENTIONAL,Terminated early due to administrative reasons unrelated to efficacy or safety.
NCT00313092,TERMINATED,OBSERVATIONAL,recruiting problems
NCT00313118,WITHDRAWN,OBSERVATIONAL,Problems with recruiting
NCT00313144,TERMINATED,INTERVENTIONAL,Study terminated early due to Aralast being phased out of the market.
NCT00313196,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00313365,WITHDRAWN,INTERVENTIONAL,Study was never started because Dr. Hammerberg left before it could be started.
NCT00313456,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study drug development
NCT00313482,TERMINATED,INTERVENTIONAL,Low accrual
NCT00313534,TERMINATED,INTERVENTIONAL,Ran out of drug
NCT00313547,TERMINATED,INTERVENTIONAL,Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).
NCT00313690,WITHDRAWN,INTERVENTIONAL,Recruitment difficulties
NCT00313768,TERMINATED,INTERVENTIONAL,See Termination Reason in Detailed Description.
NCT00313807,WITHDRAWN,INTERVENTIONAL,Abandoned due to lack of recruitment Oct 2006
NCT00314002,TERMINATED,INTERVENTIONAL,"After treatment of 7 patients, it was decided that the handling characteristics of the test device should be upgraded before continuing the trial as planned."
NCT00314327,TERMINATED,INTERVENTIONAL,Recruitment for the study was limited.
NCT00314353,TERMINATED,INTERVENTIONAL,The study was closed early due to low enrollment and new information regarding the benefit of the study regimen.
NCT00314457,TERMINATED,INTERVENTIONAL,Bupivacaine has recently been shown to inhibit osteoclast formation in vitro.
NCT00314691,TERMINATED,INTERVENTIONAL,Leaving of the person responsible for the data collection
NCT00314847,TERMINATED,INTERVENTIONAL,The study was stopped prematurely due to insufficient recruitment
NCT00314938,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00315003,TERMINATED,INTERVENTIONAL,Pediatric development program terminated by sponsor
NCT00315042,TERMINATED,INTERVENTIONAL,Pediatric development program terminated by sponsor
NCT00315211,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00315458,TERMINATED,INTERVENTIONAL,Administrative reasons.
NCT00315549,TERMINATED,INTERVENTIONAL,Pediatric development program terminated by sponsor
NCT00315601,TERMINATED,INTERVENTIONAL,Sanofi-Aventis wanted the study terminated.
NCT00315614,TERMINATED,INTERVENTIONAL,We did not achieve a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.
NCT00315822,TERMINATED,INTERVENTIONAL,Study was terminated due to futility
NCT00315900,TERMINATED,INTERVENTIONAL,Investigator closed study and left VAMC.
NCT00315913,WITHDRAWN,INTERVENTIONAL,Lack of feasibility
NCT00316004,TERMINATED,INTERVENTIONAL,Futility
NCT00316017,TERMINATED,INTERVENTIONAL,"Futility \& potential safety concern (increased early mortality in the HS/HSD arms for those with no PRBC in 1st 24 hr, post-randomization subgp)"
NCT00316134,TERMINATED,OBSERVATIONAL,The study was terminated on completion of the Pilot Study phase.
NCT00316537,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT00316550,TERMINATED,INTERVENTIONAL,Animal Safety Data
NCT00316576,TERMINATED,OBSERVATIONAL,The study was stopped on november 2006 after inclusion was fulfilled
NCT00316745,SUSPENDED,INTERVENTIONAL,"Because of approval of Bevacizumab, it was difficult to perform clinical study in 1st line setting."
NCT00317018,WITHDRAWN,INTERVENTIONAL,This study was withdrawn prior to enrollment.
NCT00317070,TERMINATED,INTERVENTIONAL,"Poor recruitment, poor patient compliance, lack of funding"
NCT00317356,TERMINATED,INTERVENTIONAL,Efficacy was not cleared at US study
NCT00317369,TERMINATED,INTERVENTIONAL,Efficacy was not cleared at US study
NCT00317382,TERMINATED,INTERVENTIONAL,We could not get physicians in the ED to enroll patients.
NCT00317434,TERMINATED,INTERVENTIONAL,"Due to unacceptable non-dose limiting toxicities, excessive treatment delays and limited clinical responses."
NCT00317629,TERMINATED,INTERVENTIONAL,An interim analysis showed that nitric oxide patches are not enough effective
NCT00317837,WITHDRAWN,INTERVENTIONAL,"Recruitment was too slow, primary investigator has left the organisation"
NCT00318110,TERMINATED,INTERVENTIONAL,Unable to meet subject enrollment goal.
NCT00318214,TERMINATED,INTERVENTIONAL,The study had poor enrollment with only 16 patients randomized across 19 study centers over an 18-month period.
NCT00318331,TERMINATED,INTERVENTIONAL,Unable to meet enrollment numbers
NCT00318474,TERMINATED,INTERVENTIONAL,DSMB recommended stopping the trial because of lack of effect.
NCT00318682,TERMINATED,OBSERVATIONAL,enough patients have been enrolled for the statistic analysis
NCT00318747,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00319150,TERMINATED,INTERVENTIONAL,New evidence and trouble recruiting
NCT00319202,TERMINATED,INTERVENTIONAL,Difficulties in completing the required sample size
NCT00319332,WITHDRAWN,INTERVENTIONAL,This study has been cancelled prior to enrollment
NCT00319384,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00319631,WITHDRAWN,OBSERVATIONAL,Under the discretion of the PI the study has been withdrawn.
NCT00319683,TERMINATED,INTERVENTIONAL,Lack of funds
NCT00319839,TERMINATED,INTERVENTIONAL,slow accrual
NCT00319930,TERMINATED,INTERVENTIONAL,Discontinuation of program
NCT00320190,TERMINATED,INTERVENTIONAL,Terminated due to slow participant accrual
NCT00320320,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00320801,TERMINATED,INTERVENTIONAL,This study was terminated early due to administrative reasons.
NCT00320892,TERMINATED,INTERVENTIONAL,Difficulties in recruiting appropriate participants to the study
NCT00320918,TERMINATED,OBSERVATIONAL,This was a Chart Review only and was entered in the system in error.
NCT00320996,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was entered in the system in error.
NCT00321087,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00321100,TERMINATED,INTERVENTIONAL,Enrollment closed 10/15/2008 based on data about KRAS.
NCT00321204,TERMINATED,OBSERVATIONAL,Terminated: We are no longer recruiting.
NCT00321282,TERMINATED,INTERVENTIONAL,The study never started.
NCT00321308,TERMINATED,INTERVENTIONAL,See Termination Reason in Detailed Description.
NCT00321347,WITHDRAWN,INTERVENTIONAL,No patients enrolled and clinician no longer at institution.
NCT00321958,TERMINATED,OBSERVATIONAL,The sponsor determined that adequate data had been acquired.
NCT00322036,TERMINATED,INTERVENTIONAL,Myriad has discontinued the development of Flurizan.
NCT00322218,TERMINATED,INTERVENTIONAL,due to low recruitment rate that would have led to a long study duration.
NCT00322257,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00322296,TERMINATED,INTERVENTIONAL,The response rate (5/8) had reached a statistical significant endpoint.
NCT00322582,TERMINATED,OBSERVATIONAL,no financial resources were available to complete the study
NCT00322673,TERMINATED,INTERVENTIONAL,Study was terminated due to cardiac toxicities
NCT00322712,TERMINATED,OBSERVATIONAL,This is only a chart review. This is not a clinical trial and was inadvertently entered in the system.
NCT00322725,TERMINATED,OBSERVATIONAL,This is a chart review only and not a clinical trial. This was inadvertently entered in the system.
NCT00322855,TERMINATED,OBSERVATIONAL,Low accrual
NCT00322881,TERMINATED,INTERVENTIONAL,Early closure based on audit by study investigators after 3 patients died on study.
NCT00322920,TERMINATED,INTERVENTIONAL,Low accrual
NCT00323011,TERMINATED,INTERVENTIONAL,drug not available
NCT00323063,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00323076,TERMINATED,INTERVENTIONAL,Retirement of former Qualified Investigator and lack of resources to complete study.
NCT00323180,WITHDRAWN,OBSERVATIONAL,PI left institution and no subjects enrolled and this is not a clinical trial.
NCT00323310,TERMINATED,INTERVENTIONAL,Adequate statistical power at 92 dosed pts to meet study objectives.
NCT00323362,TERMINATED,INTERVENTIONAL,Toxicity
NCT00323388,WITHDRAWN,OBSERVATIONAL,No subjects enrolled and this is not a clinical trial. Was inadvertently entered in the system.
NCT00323440,WITHDRAWN,OBSERVATIONAL,Collaboration could not be established
NCT00323609,TERMINATED,INTERVENTIONAL,"Due to high number of patients terminating study early, low patient enrollment and difficulty in patient/investigator willingness for randomization"
NCT00323635,TERMINATED,INTERVENTIONAL,New department chairman instructed PI to discontinue study.
NCT00323700,WITHDRAWN,OBSERVATIONAL,Merged with the study NCT00307268
NCT00323726,WITHDRAWN,OBSERVATIONAL,The study was limited to IRB Exempt chart review; not an applicable trial.
NCT00323791,TERMINATED,INTERVENTIONAL,slow accrual
NCT00324077,WITHDRAWN,INTERVENTIONAL,Insufficient Enrollment
NCT00324142,WITHDRAWN,INTERVENTIONAL,Study Terminated Prematurely
NCT00324558,TERMINATED,INTERVENTIONAL,Sponsor stopped due to difficulties to recruit 130 patients required by protocol
NCT00324987,TERMINATED,INTERVENTIONAL,The trial failed to accrue
NCT00325078,TERMINATED,INTERVENTIONAL,Insufficient patient participation
NCT00325572,TERMINATED,INTERVENTIONAL,Lack of efficacy to proceed to Phase 2
NCT00325650,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00325741,TERMINATED,INTERVENTIONAL,Difficulty with recruiting participants
NCT00325754,TERMINATED,INTERVENTIONAL,low recruitment
NCT00325910,TERMINATED,INTERVENTIONAL,Insufficient study participants
NCT00326196,TERMINATED,INTERVENTIONAL,Lack of participant enrollment
NCT00326690,WITHDRAWN,INTERVENTIONAL,Unable to recruit and enroll patients
NCT00326872,TERMINATED,INTERVENTIONAL,Closed due to slow accrual prior to interim analysis.
NCT00326911,TERMINATED,INTERVENTIONAL,The planned enrollment was 130 patients and the study was halted prematurely due to lack of efficacy in both arms. Enrolled patients continued treatment.
NCT00327093,TERMINATED,INTERVENTIONAL,The scientific commitee decided to stop the inclusions and exploit the results.
NCT00327197,TERMINATED,INTERVENTIONAL,The study was truncated due to the long period of enrollment and the collection of a sufficient amount of data that allowed the scientific objectives to be met
NCT00327301,WITHDRAWN,OBSERVATIONAL,was replaced by an other study
NCT00327470,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00327626,WITHDRAWN,INTERVENTIONAL,study was never started due to regional geopolitical conflict
NCT00327899,TERMINATED,OBSERVATIONAL,Per PI instruction.
NCT00327951,TERMINATED,OBSERVATIONAL,sufficient data collected for significant conclusion
NCT00328081,TERMINATED,OBSERVATIONAL,Principal Investigator left the institution
NCT00328094,TERMINATED,INTERVENTIONAL,The recruitment rate slowed considerably
NCT00328185,TERMINATED,OBSERVATIONAL,unable to gather sufficient data
NCT00328341,TERMINATED,OBSERVATIONAL,Slow to enroll.
NCT00328354,WITHDRAWN,OBSERVATIONAL,Ran out of time/ funding
NCT00328757,WITHDRAWN,INTERVENTIONAL,"Before starting the recruitment process, new data from literature were available. The investigators considered that this study was no longer needed."
NCT00328809,WITHDRAWN,INTERVENTIONAL,personnel shortage
NCT00328887,WITHDRAWN,INTERVENTIONAL,No funding was obtained for this study. No subject were receruited.
NCT00328926,TERMINATED,INTERVENTIONAL,"Please see ""Purpose"" statement"
NCT00329017,WITHDRAWN,OBSERVATIONAL,No patients enrolled
NCT00329108,TERMINATED,INTERVENTIONAL,Please see Brief Summary for Termination Reason.
NCT00329199,TERMINATED,INTERVENTIONAL,Trial was rewritten and will no longer focus on the link between smoking and depression.
NCT00329316,WITHDRAWN,INTERVENTIONAL,Study withdrawn for financial problems. We didnwt get a grant we needed for purchesing the medication for the study.
NCT00329329,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study drug development
NCT00329472,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT00329485,TERMINATED,INTERVENTIONAL,Poor recruitment and through put
NCT00329511,WITHDRAWN,INTERVENTIONAL,Feasibility of study. PI termination
NCT00329732,TERMINATED,INTERVENTIONAL,Study terminated due to inadequate recruitment
NCT00329862,TERMINATED,INTERVENTIONAL,study size reached
NCT00330200,TERMINATED,INTERVENTIONAL,Due to poor enrollment
NCT00330291,WITHDRAWN,INTERVENTIONAL,terminated due to inability to recruit subjects
NCT00330434,WITHDRAWN,INTERVENTIONAL,Study was a F32 Fellowship. Trial was proposed however Principle Investigator does not believe trial took place.
NCT00330564,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00330642,WITHDRAWN,OBSERVATIONAL,HandyLab device did not work for the science
NCT00330668,TERMINATED,INTERVENTIONAL,Unacceptable frequency of hypoglycemia observed at and above 200 ug/kg/day
NCT00331019,WITHDRAWN,OBSERVATIONAL,HandyLab device determined to not work for the science
NCT00331045,TERMINATED,INTERVENTIONAL,Subject registration did not proceed as expected; difficult to complete within scheduled time frame; prematurely terminated w/ 21 subjects randomized.
NCT00331058,TERMINATED,INTERVENTIONAL,The study was truncated due to the long period of enrollment and the collection of a sufficient amount of data that allowed the scientific objectives to be met
NCT00331422,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of available funding.
NCT00331604,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00331708,TERMINATED,INTERVENTIONAL,Lack of suitable participants
NCT00331721,TERMINATED,INTERVENTIONAL,Scientific data called into question the viability of the substance class
NCT00331890,TERMINATED,INTERVENTIONAL,"With 2078 patients, a statistical stopping boundary has now been crossed"
NCT00332085,TERMINATED,INTERVENTIONAL,Issues w/recruitment
NCT00332215,TERMINATED,INTERVENTIONAL,Dr. Milla has left University of Minnesota. The study is no longer being conducted at this site.
NCT00332280,TERMINATED,INTERVENTIONAL,Lack of efficacy. Stopped at first interim evaluation point
NCT00332371,TERMINATED,INTERVENTIONAL,The study was prematurely interrupted for futility.
NCT00332657,TERMINATED,INTERVENTIONAL,Management Decision
NCT00332670,TERMINATED,INTERVENTIONAL,"End of research time, time-resources"
NCT00332826,TERMINATED,INTERVENTIONAL,Non-safety related business decision to combine special population protocols
NCT00332839,TERMINATED,INTERVENTIONAL,The trial was terminated early due to slow enrollment. It was determined that the planned sample size of 300 could not be achieved.
NCT00333216,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00333229,TERMINATED,INTERVENTIONAL,"Due to rare patient population, planned number of patients could not be recruited in a reasonable timeframe. Recruitment was stopped prematurely."
NCT00333424,TERMINATED,INTERVENTIONAL,Vaccines safe but not immunogenic in 8 participants; trial closed to further recruitment by the protocol steering committee \& DSMB.
NCT00334100,WITHDRAWN,INTERVENTIONAL,Difficulty with recruiting
NCT00334204,TERMINATED,INTERVENTIONAL,run out of independent funding
NCT00334217,TERMINATED,INTERVENTIONAL,The intervention could not be successfully carried out in the SADP setting because of issues independent of the cognitive training intervention.
NCT00334243,TERMINATED,INTERVENTIONAL,stopped due to limited enrollment. 2 subjects were enrolled. There was NO enrollment after November 2007.
NCT00334568,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00334646,TERMINATED,INTERVENTIONAL,compound terminated
NCT00334685,TERMINATED,INTERVENTIONAL,The Data Monitoring Committee terminated the study on the basis of futility (insufficient clinical response).
NCT00334724,WITHDRAWN,INTERVENTIONAL,Patients were not appropriately enrolled
NCT00334763,TERMINATED,INTERVENTIONAL,Principal Investigator felt risk to patients was too high.
NCT00334867,WITHDRAWN,INTERVENTIONAL,withdrawn
NCT00334984,WITHDRAWN,INTERVENTIONAL,Withdrawn due to inability to reach an acceptable agreement with industry sponsor
NCT00335036,TERMINATED,INTERVENTIONAL,Lead was recalled and manufacturing halted
NCT00335101,WITHDRAWN,INTERVENTIONAL,Sponsor Decision to withdraw study (comparative product withdrawn from the market)
NCT00335140,TERMINATED,INTERVENTIONAL,slow accrual
NCT00335231,WITHDRAWN,INTERVENTIONAL,Protocol changes underway. Trial never started
NCT00335335,TERMINATED,INTERVENTIONAL,Sponsor decision due to low subject recrcuitment
NCT00335621,WITHDRAWN,INTERVENTIONAL,Study terminated prior to recruitment - recruitment proved impossible
NCT00335660,TERMINATED,INTERVENTIONAL,Animal Safety Data
NCT00335959,TERMINATED,INTERVENTIONAL,Closed due to slow accrual
NCT00335972,TERMINATED,INTERVENTIONAL,Closed due to lack of enrollment
NCT00336414,WITHDRAWN,INTERVENTIONAL,the study is withdrawn due to low and unexpected enrollment rate
NCT00336700,TERMINATED,INTERVENTIONAL,Study published November 2010 and no further work will be done
NCT00337116,WITHDRAWN,INTERVENTIONAL,LOGISTIC DIFFICULTIES
NCT00337259,TERMINATED,INTERVENTIONAL,poor accrual and response less than expected on interim analysis
NCT00337272,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT00337740,TERMINATED,INTERVENTIONAL,From the interim analysis resulted that more than 1000 patients were required to demonstrate a significant difference between the 2 treatments.
NCT00337792,TERMINATED,INTERVENTIONAL,"DSMB review at 50% recruitment, further recruitment unlikely to change result"
NCT00338455,TERMINATED,INTERVENTIONAL,"DSMC acknowledged no safety concerns with the trial, recommending that the trial be terminated due to slow enrollment"
NCT00338468,TERMINATED,INTERVENTIONAL,The study was stopped early due to slow enrollment.
NCT00338585,TERMINATED,INTERVENTIONAL,Based upon preliminary safety and efficacy results from a similar study.
NCT00338702,WITHDRAWN,INTERVENTIONAL,Industry support and funding not forthcoming
NCT00340548,TERMINATED,OBSERVATIONAL,lapse in IRB review
NCT00342173,TERMINATED,OBSERVATIONAL,classified by the IRB as non human subjects research
NCT00342862,TERMINATED,OBSERVATIONAL,"The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing, distribution and sales of Amevive"
NCT00342940,WITHDRAWN,INTERVENTIONAL,Lack of Vaccine Supplies
NCT00343096,TERMINATED,INTERVENTIONAL,The buccal arm of the study was 30% less effective in stopping seizures within 10 minutes compared with the IV dose. This met a stopping rule for the study
NCT00343187,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00343395,TERMINATED,INTERVENTIONAL,FDA concerns regarding Avandamet
NCT00343499,TERMINATED,INTERVENTIONAL,Inability to recruit
NCT00343512,TERMINATED,INTERVENTIONAL,closed due to competing neoadjuvant studies for a small patient population
NCT00343655,TERMINATED,INTERVENTIONAL,"The study was terminated on June 22, 2007 for inability to enroll patients within an appropriate timeframe. There were no efficacy/safety concerns."
NCT00343980,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00344019,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00344448,TERMINATED,INTERVENTIONAL,Increased risk of PML associated with raptiva in other studies
NCT00344487,TERMINATED,INTERVENTIONAL,Inability to enroll subjects.
NCT00344604,WITHDRAWN,OBSERVATIONAL,PI decided to terminate the study at this time
NCT00344708,WITHDRAWN,INTERVENTIONAL,Potential subjects did not meet eligibility criteria
NCT00344786,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00344864,TERMINATED,OBSERVATIONAL,Terminated due to lack of patient recruitment
NCT00344942,TERMINATED,INTERVENTIONAL,patient's recruitment too difficult
NCT00345059,TERMINATED,INTERVENTIONAL,slow accrual
NCT00345111,WITHDRAWN,INTERVENTIONAL,Verified with former investigator that recruitment activity did not take place
NCT00345306,SUSPENDED,INTERVENTIONAL,no patient was recruited till 1/2008
NCT00345527,WITHDRAWN,INTERVENTIONAL,Study moved to British Columbia
NCT00346099,WITHDRAWN,INTERVENTIONAL,Protocol closed based on new (and as yet unpublished) information from a phase II clinical trial.
NCT00346112,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT00346151,TERMINATED,INTERVENTIONAL,Stopping rule-acute rejection threshold-was met based on local biopsy results
NCT00346177,WITHDRAWN,INTERVENTIONAL,Funding not obtained. No subjects enrolled.
NCT00346229,TERMINATED,INTERVENTIONAL,Funding
NCT00346268,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00346372,TERMINATED,OBSERVATIONAL,low accrual
NCT00346502,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT00346632,TERMINATED,INTERVENTIONAL,Terminated due to suboptimal dosing schedule
NCT00346645,TERMINATED,INTERVENTIONAL,stopped after planned interim analysis for lack of efficacy
NCT00346710,WITHDRAWN,OBSERVATIONAL,Information was entered by mistake by a Research Assistant. Study never went beyond the initial discussion phase.
NCT00346749,TERMINATED,INTERVENTIONAL,The study was terminated due to difficulties with finding sites and subjects willing to participate.
NCT00346879,WITHDRAWN,INTERVENTIONAL,Funding withdrawn; study closed due to lack of accrual.
NCT00346983,TERMINATED,INTERVENTIONAL,Difficulty enrolling eligible subjects
NCT00347438,TERMINATED,INTERVENTIONAL,a result of slow accrual
NCT00347646,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT00347750,WITHDRAWN,OBSERVATIONAL,lack of participants
NCT00347906,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients
NCT00347997,WITHDRAWN,INTERVENTIONAL,"Decision made by B\&L to cancel the study, no subjects enrolled."
NCT00348166,WITHDRAWN,INTERVENTIONAL,Stringent eligibility criterion caused difficulties in recruiting patients.
NCT00348439,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT00348556,TERMINATED,INTERVENTIONAL,"Company providing catheter bought out, funding and supplies terminated"
NCT00348608,TERMINATED,INTERVENTIONAL,Sponsor decision (due to low subject recruitment)
NCT00348634,TERMINATED,INTERVENTIONAL,Terminated early due to regulatory action suspending tegaserod use in 2007
NCT00348712,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00348816,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00348829,TERMINATED,INTERVENTIONAL,"not enough patients to e recruited, problems with the conductance catheter"
NCT00348894,TERMINATED,INTERVENTIONAL,- Study was terminated due to insufficient clinical efficacy observed in previous studies conducted in postherpetic neuralgia.
NCT00348907,TERMINATED,INTERVENTIONAL,decision to stop the study because of enrollment difficulties.
NCT00349271,TERMINATED,INTERVENTIONAL,Change the sample size due to smaller variance than expected
NCT00349388,TERMINATED,INTERVENTIONAL,"none enrolled in second arm, therfore no analysis"
NCT00349401,WITHDRAWN,INTERVENTIONAL,Study was not initiated. No subjects were screened or enrolled.
NCT00349752,TERMINATED,INTERVENTIONAL,"Recruitment was stopped early due to slow enrolment of this population. With no safety concerns, the study continued normally for subjects already recruited"
NCT00349986,TERMINATED,INTERVENTIONAL,prematurely terminated due to loss of interest
NCT00350077,WITHDRAWN,INTERVENTIONAL,Inadequate resources to submit for approval
NCT00350090,TERMINATED,INTERVENTIONAL,This study was stopped early due to slow enrollment.
NCT00350506,TERMINATED,INTERVENTIONAL,Sponsor decision (due to low subject enrollment)
NCT00350519,TERMINATED,INTERVENTIONAL,The study was stopped due to slow enrollment
NCT00350688,TERMINATED,INTERVENTIONAL,More advanced treatments superceded study design
NCT00350714,TERMINATED,INTERVENTIONAL,"Due to FDA comments, protocol changed; new trial will be proposed shortly"
NCT00350766,TERMINATED,INTERVENTIONAL,Slow recruitment rate and consequent financial exhaustion.
NCT00350844,TERMINATED,INTERVENTIONAL,Low subject accrual
NCT00350948,TERMINATED,INTERVENTIONAL,Business reasons
NCT00351039,TERMINATED,INTERVENTIONAL,slow accrual
NCT00351195,TERMINATED,INTERVENTIONAL,Did not meet the criteria for continuation to second stage
NCT00351221,TERMINATED,INTERVENTIONAL,Terminated due to a patent legal settlement
NCT00351364,TERMINATED,INTERVENTIONAL,Diffic;ulty recruiting
NCT00351637,TERMINATED,INTERVENTIONAL,Study suspended due to low accrual
NCT00351715,TERMINATED,INTERVENTIONAL,Study stopped due to low accrual
NCT00351858,TERMINATED,INTERVENTIONAL,company focus on other projects
NCT00352079,TERMINATED,INTERVENTIONAL,terminated due to poor accrual
NCT00352118,TERMINATED,INTERVENTIONAL,Low dose radiation treatment was not appropriate for these patients.
NCT00352651,TERMINATED,INTERVENTIONAL,"This study should be terminated as the study has been closed for years and the investigator has since retired. No records are available.

Thank you, Marlene"
NCT00352664,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT00352690,TERMINATED,INTERVENTIONAL,Safety of patients
NCT00352729,WITHDRAWN,INTERVENTIONAL,PI decided to use another product
NCT00352755,TERMINATED,INTERVENTIONAL,after interim analysis it was determined that the risks were too great in comparision to the results
NCT00352768,TERMINATED,INTERVENTIONAL,This study was prematurely terminated (26 June 2009) due to slow recruitment
NCT00352872,TERMINATED,OBSERVATIONAL,This study has been difficult to recruit.
NCT00353184,TERMINATED,INTERVENTIONAL,Results of the interim analysis suggested no significant diff between study groups.
NCT00353275,TERMINATED,INTERVENTIONAL,Difficulty in enrolling eligible patients
NCT00353327,SUSPENDED,INTERVENTIONAL,low recruitment
NCT00353379,TERMINATED,INTERVENTIONAL,low enrollment
NCT00353444,SUSPENDED,OBSERVATIONAL,Technical Conflicts
NCT00353457,TERMINATED,INTERVENTIONAL,new studies were finding that Erbitux was not beneficial
NCT00353574,TERMINATED,INTERVENTIONAL,Study DAR-312 did not meet primary co-endpoints
NCT00353743,TERMINATED,INTERVENTIONAL,"Rate of cure was higher than expected, IRB suspended for no additional benefit"
NCT00353808,TERMINATED,INTERVENTIONAL,This study has been terminated early as the esreboxetine development program is being discontinued. There are no safety or efficacy concerns.
NCT00354094,TERMINATED,INTERVENTIONAL,The study was stopped due to business/operational issues.
NCT00354172,TERMINATED,INTERVENTIONAL,Competing study was started.
NCT00354198,TERMINATED,INTERVENTIONAL,short of participants
NCT00354224,TERMINATED,INTERVENTIONAL,due to low accrual
NCT00354419,TERMINATED,INTERVENTIONAL,Low accrual
NCT00354432,TERMINATED,INTERVENTIONAL,Stopped by the DSMB for lack of effect per interim stopping rule.
NCT00354523,TERMINATED,INTERVENTIONAL,"Study closed following Phase I portion, insufficient activity to continue to Phase II."
NCT00354601,TERMINATED,INTERVENTIONAL,funding withdrawn
NCT00354822,TERMINATED,INTERVENTIONAL,Inability to recruit in time a sufficient number of patients
NCT00354900,TERMINATED,INTERVENTIONAL,"The FDA changed the labeling for this agent, and we felt we could not offer it to patients on a non-surgical study."
NCT00355251,TERMINATED,INTERVENTIONAL,"On the basis of published results of SMART study, it has been observed that the results are worse in patients who have interrupted their treatments."
NCT00355459,WITHDRAWN,INTERVENTIONAL,The PI has elected to terminate study at this time
NCT00355511,WITHDRAWN,INTERVENTIONAL,unable to recruit patients
NCT00355758,TERMINATED,OBSERVATIONAL,Lack of personnel
NCT00356057,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT00356187,TERMINATED,INTERVENTIONAL,"Slow enrollment, end of funding"
NCT00356200,TERMINATED,INTERVENTIONAL,Enrollment criteria met
NCT00356265,TERMINATED,INTERVENTIONAL,Futility: Impossible to recruit enough hypertensive participants to match Chronic Kidney Disease (CKD) participants on needed parameters.
NCT00356421,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00356434,TERMINATED,INTERVENTIONAL,PI assigned to a different hospital;difficulty recruiting patients
NCT00356525,TERMINATED,INTERVENTIONAL,Stopped early due to low enrollment
NCT00356616,TERMINATED,INTERVENTIONAL,terminated
NCT00356629,TERMINATED,OBSERVATIONAL,Technical problem
NCT00356655,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00356681,TERMINATED,INTERVENTIONAL,Sponsor decision to close study
NCT00356837,TERMINATED,INTERVENTIONAL,IRB terminated study due to non compliance with continuing review date.
NCT00356928,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00356941,TERMINATED,INTERVENTIONAL,Withdrawn due to lack of accrual
NCT00357591,TERMINATED,INTERVENTIONAL,Projected neutral significance for primary composite efficacy endpoint.
NCT00357929,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT00357981,WITHDRAWN,INTERVENTIONAL,Both sponsor and UCSF decided this study was not clinical relevant at this time
NCT00358007,TERMINATED,INTERVENTIONAL,Administratively Terminated by PI
NCT00358111,TERMINATED,INTERVENTIONAL,PMA withdrawn
NCT00358241,WITHDRAWN,INTERVENTIONAL,PI left JHU and is not able to be reached for updates
NCT00358319,TERMINATED,INTERVENTIONAL,PI left Moffitt
NCT00358397,TERMINATED,INTERVENTIONAL,Design Problem
NCT00358423,TERMINATED,INTERVENTIONAL,Difficulty enrolling eligible subjects
NCT00358514,TERMINATED,INTERVENTIONAL,Large sample size and change in Orthopaedic practice to use of CCPM in conjunction with Clinical Monitoring rendered project less timely.
NCT00358566,TERMINATED,INTERVENTIONAL,Preliminary data showed no survival benefit in the GV1001 group compared to the gemcitabine group.
NCT00358657,TERMINATED,INTERVENTIONAL,Low accrual
NCT00358670,TERMINATED,INTERVENTIONAL,"Infusion reactions during re-induction cycles after a period of no treatment. Please see ""Purpose"" section."
NCT00358722,TERMINATED,INTERVENTIONAL,Limited number of subjects
NCT00359034,WITHDRAWN,OBSERVATIONAL,Could not resolve technical difficulties
NCT00359151,TERMINATED,INTERVENTIONAL,This study was terminated early due to slow enrollment.
NCT00359268,TERMINATED,OBSERVATIONAL,Slow/insufficient accrual
NCT00359294,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00359320,TERMINATED,INTERVENTIONAL,Terminated by IRB
NCT00359385,WITHDRAWN,INTERVENTIONAL,incomplete enrollment
NCT00359398,TERMINATED,INTERVENTIONAL,"Funding expired, low recruitment"
NCT00359424,TERMINATED,INTERVENTIONAL,"NINDS/NIH-DSMB recommended halting trial due to futility, no safety concerns."
NCT00359632,TERMINATED,INTERVENTIONAL,Study was stopped due to poor enrollment on 28 Feb 2012. Reason for termination was not due to safety concerns.
NCT00360022,TERMINATED,INTERVENTIONAL,problems with subject accrual
NCT00360087,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00360308,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy.
NCT00360412,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy.
NCT00360828,TERMINATED,INTERVENTIONAL,Principal Investigator left Moffitt and study had low accrual.
NCT00360867,TERMINATED,INTERVENTIONAL,Amgen decision
NCT00360971,TERMINATED,INTERVENTIONAL,Due to positive preliminary results from other palifermin studies.
NCT00361088,TERMINATED,INTERVENTIONAL,Initial Principal Investigator left Moffitt
NCT00361114,TERMINATED,INTERVENTIONAL,SP arms were stopped due to high levels of treatment failure.CD not available.
NCT00361244,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00361257,TERMINATED,INTERVENTIONAL,This study was terminated early due to futility.
NCT00361296,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00361413,TERMINATED,INTERVENTIONAL,company withdrawal of the drug
NCT00361426,WITHDRAWN,OBSERVATIONAL,No need
NCT00361439,TERMINATED,INTERVENTIONAL,Study stopped early due to slow accrual.
NCT00361621,TERMINATED,INTERVENTIONAL,Closed due to slow accrual
NCT00361660,WITHDRAWN,INTERVENTIONAL,project was only internally funded and would complete for subjects with 2 newer externally funded projects
NCT00361868,TERMINATED,INTERVENTIONAL,The study was discontinued prematurely at the end of March 2007 due to slow enrolment.
NCT00361907,TERMINATED,INTERVENTIONAL,Administrative - Suspended by IRB
NCT00361933,WITHDRAWN,INTERVENTIONAL,Research never begun.
NCT00361972,TERMINATED,INTERVENTIONAL,limited recruitment
NCT00361985,WITHDRAWN,INTERVENTIONAL,Insufficient enrollment
NCT00361998,WITHDRAWN,INTERVENTIONAL,recruitment failed
NCT00362219,WITHDRAWN,INTERVENTIONAL,no patients were recrueted
NCT00362245,WITHDRAWN,INTERVENTIONAL,lack of participants
NCT00362388,TERMINATED,INTERVENTIONAL,low enrollling
NCT00362466,TERMINATED,INTERVENTIONAL,Insufficient Enrollment
NCT00362661,TERMINATED,INTERVENTIONAL,Recruitment: Insufficient number of patients eligible for enrollment
NCT00362765,TERMINATED,INTERVENTIONAL,"The study was prematurely terminated, due to difficulties in the recruitment of T2DM patients who are not under statin therapy at inclusion."
NCT00363467,TERMINATED,INTERVENTIONAL,Low accrual
NCT00363610,TERMINATED,INTERVENTIONAL,No recommended Phase II dose was determined.
NCT00363636,TERMINATED,INTERVENTIONAL,Enrollment challenges due to changes in standards of care resulted in premature termination. No safety or efficacy events factored into this action.
NCT00363675,TERMINATED,INTERVENTIONAL,"This was a pilot study, but the larger study was not funded."
NCT00363779,TERMINATED,INTERVENTIONAL,Study terminated due to low accrual and the investigator left the NIH.
NCT00363883,TERMINATED,INTERVENTIONAL,Trial stopped early for futility
NCT00364000,WITHDRAWN,INTERVENTIONAL,Limitted financial resources
NCT00364117,WITHDRAWN,INTERVENTIONAL,No patients were enrolled
NCT00364364,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00364429,TERMINATED,INTERVENTIONAL,terminated
NCT00364481,WITHDRAWN,INTERVENTIONAL,Not enough subjects enrolled
NCT00364494,TERMINATED,INTERVENTIONAL,difficult enrollment after the primary investigator left the centre
NCT00364533,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00364689,TERMINATED,INTERVENTIONAL,Difficult to recruit participants
NCT00364845,TERMINATED,INTERVENTIONAL,The reason for the discontinuation of the study is difficulty with recruitment and timely enrolment and is not related to safety concerns
NCT00364975,WITHDRAWN,INTERVENTIONAL,Was not funded
NCT00365027,WITHDRAWN,INTERVENTIONAL,Enrollment difficulties
NCT00365222,TERMINATED,INTERVENTIONAL,IRB Study Closure
NCT00365534,WITHDRAWN,INTERVENTIONAL,The study was incorporated in another study.
NCT00365820,TERMINATED,INTERVENTIONAL,This study was terminated early as a result of regulatory action suspending tegaserod use in 2007
NCT00365833,TERMINATED,OBSERVATIONAL,difficulty obtaining required data
NCT00365937,TERMINATED,INTERVENTIONAL,New regulatories of the peptides by the pharmaceutical company (the seller)
NCT00366041,TERMINATED,INTERVENTIONAL,not appropriate to carry on the study
NCT00366080,TERMINATED,INTERVENTIONAL,Study was terminated based on the interim results of a futility test.
NCT00366106,TERMINATED,INTERVENTIONAL,Study was closed to enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed.
NCT00366301,TERMINATED,INTERVENTIONAL,"Interim analyses demonstrated futility. Thus, recruitment curtailed 10/08."
NCT00366353,TERMINATED,INTERVENTIONAL,Difficulty obtaining enrollment
NCT00366613,WITHDRAWN,INTERVENTIONAL,We wish to wait until there is more data available using this substance.
NCT00366795,TERMINATED,INTERVENTIONAL,Study was terminated due to safety reason.
NCT00366912,TERMINATED,INTERVENTIONAL,No longer recruiting: participants are no longer being recruited or enrolled
NCT00367198,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00367328,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted.
NCT00367354,TERMINATED,OBSERVATIONAL,Lack of funding
NCT00367497,TERMINATED,INTERVENTIONAL,The stopping rule was applied because of low response rates.
NCT00367718,WITHDRAWN,INTERVENTIONAL,PI left JHU and is not able to be reached for updates
NCT00367783,TERMINATED,INTERVENTIONAL,See Detailed Description for termination reason.
NCT00368017,TERMINATED,INTERVENTIONAL,unable to replace Fellow conducting the study who left institution in 2007
NCT00368121,TERMINATED,INTERVENTIONAL,Lack of recruitable patients
NCT00368264,TERMINATED,INTERVENTIONAL,Failure to recruit patients with membranous lupus nephritis not previously treated with azathioprine .
NCT00368329,TERMINATED,INTERVENTIONAL,low accrual
NCT00368381,WITHDRAWN,INTERVENTIONAL,Study closed for PI failure to submit renewal paperwork
NCT00368602,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT00368641,TERMINATED,INTERVENTIONAL,Enrollment
NCT00368693,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment.
NCT00368719,WITHDRAWN,INTERVENTIONAL,withdrawn due to contractual issues
NCT00369031,TERMINATED,INTERVENTIONAL,Safety issues
NCT00369265,TERMINATED,INTERVENTIONAL,Pharmaceutical company purchased by another company and funding was terminated.
NCT00369291,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00369330,WITHDRAWN,INTERVENTIONAL,withdrawn because of insufficient financial capacities
NCT00369395,TERMINATED,INTERVENTIONAL,Insufficient clinical activity
NCT00369447,TERMINATED,INTERVENTIONAL,The study was closed due to slow accrual.
NCT00369499,TERMINATED,INTERVENTIONAL,Not enough patients/ ethical concerns
NCT00369538,SUSPENDED,INTERVENTIONAL,"principle investigator moved, new investigators will join, insurance expired - project needs to be re-examined by an ethic committee"
NCT00369603,TERMINATED,INTERVENTIONAL,Reduced access to AchEI medication-naive mild AD patients.
NCT00369629,TERMINATED,INTERVENTIONAL,"This was planned as a phase I/II study originally, but due to a lack of funding, the phase II portion was never conducted."
NCT00369954,WITHDRAWN,INTERVENTIONAL,Trial was never activated
NCT00369967,TERMINATED,INTERVENTIONAL,difficulty in subject recruitment
NCT00370123,WITHDRAWN,OBSERVATIONAL,The study was withrawn do to logistic difficulties
NCT00370149,TERMINATED,INTERVENTIONAL,Blinded interim analysis resulted in early termination of the study.
NCT00370188,WITHDRAWN,INTERVENTIONAL,Change to investigator's research affiliation and other employment.
NCT00370474,TERMINATED,INTERVENTIONAL,Procedure protocol improved - study protocol became obsolete
NCT00370526,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00370695,TERMINATED,INTERVENTIONAL,Insufficient Data Collected
NCT00370773,TERMINATED,INTERVENTIONAL,Slow Enrolling
NCT00370942,TERMINATED,INTERVENTIONAL,Safety issue
NCT00371228,WITHDRAWN,INTERVENTIONAL,PI left university
NCT00371462,TERMINATED,INTERVENTIONAL,PI no longer has an appointment and has seperated from Hines VAH and project was not transferred to another PI?
NCT00371579,WITHDRAWN,INTERVENTIONAL,no actual patients recruited within year 1 after ethical committee approval
NCT00371605,TERMINATED,OBSERVATIONAL,Enrolled requested number of patients and completed study. In analysis
NCT00372450,WITHDRAWN,INTERVENTIONAL,low accrual
NCT00372489,TERMINATED,INTERVENTIONAL,Due to more robust long-term data generated in other active-controlled studies
NCT00372528,TERMINATED,INTERVENTIONAL,"This study was terminated on April 8, 2011 as Pfizer Canada could no longer supply study drug. No efficacy or safety concerns factored into this decision."
NCT00372567,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00372723,WITHDRAWN,INTERVENTIONAL,slow enrollment
NCT00372762,WITHDRAWN,INTERVENTIONAL,Due to changes within the research program this study is not feasible at this time
NCT00372905,TERMINATED,INTERVENTIONAL,Study was closed permanently before the accrual goal was met due to slow accrual
NCT00372996,TERMINATED,INTERVENTIONAL,This study was closed to enrollment as of 13 May 2011 due to business reasons. Premature closure was not prompted by any safety or efficacy concerns.
NCT00373074,WITHDRAWN,INTERVENTIONAL,Lack of subject population for PI
NCT00373113,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00373152,WITHDRAWN,INTERVENTIONAL,No patient accrual
NCT00373217,TERMINATED,INTERVENTIONAL,Slow enrollment rate.
NCT00373581,TERMINATED,INTERVENTIONAL,Funding ran out
NCT00373633,TERMINATED,INTERVENTIONAL,terminated due to diminishing frequency of thorocotomies and slow enrollment
NCT00373711,WITHDRAWN,OBSERVATIONAL,Abandoned
NCT00373763,WITHDRAWN,INTERVENTIONAL,No patients could be recruited and randomized due to other center offering backdoor for treatment.
NCT00373789,TERMINATED,INTERVENTIONAL,higher than anticipated rate of increased post-void residual in subjects who received botulinum toxin A injection
NCT00373815,TERMINATED,INTERVENTIONAL,"high incidence of TTP, poor recrual"
NCT00374205,TERMINATED,INTERVENTIONAL,Interim analysis showed more LCFs in one of the treatment arms
NCT00374257,TERMINATED,INTERVENTIONAL,Low/slow accrual
NCT00374296,TERMINATED,INTERVENTIONAL,The Clinical Development Program for MGCD0103 is being re-evaluated
NCT00374413,TERMINATED,INTERVENTIONAL,Economic and business factors
NCT00374543,TERMINATED,INTERVENTIONAL,Recruitment goal could not be achieved
NCT00374712,TERMINATED,OBSERVATIONAL,terminated
NCT00374972,WITHDRAWN,OBSERVATIONAL,difficulty in recruitment. lack of sponsorship
NCT00375011,TERMINATED,OBSERVATIONAL,Company restructured and protocol restructured. Resubmitted with IDE approval under new company name-Exalenz
NCT00375141,TERMINATED,INTERVENTIONAL,"Inclusion, treatments and follow-up are finished"
NCT00375154,WITHDRAWN,INTERVENTIONAL,major difficulties in training investigators in other centers
NCT00375401,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00375440,WITHDRAWN,INTERVENTIONAL,Study halted prematurely as investigator left the institution.
NCT00375531,WITHDRAWN,INTERVENTIONAL,protocol revisions were deemed unable to be completed by 8/2007
NCT00375596,WITHDRAWN,INTERVENTIONAL,Study withdrawn without starting or enrolling subjects due to a business decision to not proceed with the project.
NCT00375804,TERMINATED,OBSERVATIONAL,Funding and logistical difficuties resulted in the withdrawl of the study.
NCT00375882,TERMINATED,INTERVENTIONAL,as specified in the protocol
NCT00375895,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00376103,TERMINATED,INTERVENTIONAL,Loss of funding from sponsor
NCT00376181,TERMINATED,INTERVENTIONAL,Combination formulation concerns
NCT00376259,TERMINATED,INTERVENTIONAL,The study was not completed as planned and was terminated early with agreement from the European Medicines Agency (EMEA)
NCT00376337,TERMINATED,INTERVENTIONAL,Study was stopped due to difficulties in recruitment and changes in standard care for invasive aspergillosis
NCT00376493,TERMINATED,INTERVENTIONAL,The rate of cure in both arms was higher than expected
NCT00376519,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00376649,WITHDRAWN,INTERVENTIONAL,funding was not granted
NCT00376766,TERMINATED,INTERVENTIONAL,recruitment recruitment recruitment recruitment difficulties
NCT00376805,TERMINATED,INTERVENTIONAL,Withdrawn due to toxicity
NCT00377091,WITHDRAWN,INTERVENTIONAL,Study pulled due to a grant disagreement between the U of M and SMDC
NCT00377143,WITHDRAWN,INTERVENTIONAL,similar large study planned by NHLBI
NCT00377247,TERMINATED,INTERVENTIONAL,study closed to accrual due to slow accrual
NCT00377325,WITHDRAWN,INTERVENTIONAL,Study terminated by the DSMB due to low recruitment
NCT00377455,TERMINATED,INTERVENTIONAL,Study was terminated due to inadequate enrolment
NCT00377507,TERMINATED,INTERVENTIONAL,difficult to achieve the sufficient subjects
NCT00377780,TERMINATED,INTERVENTIONAL,wothdrawal of sponsor
NCT00377832,TERMINATED,INTERVENTIONAL,Poor recruitment and lack of funding
NCT00377884,WITHDRAWN,OBSERVATIONAL,"Lack of patients, lack of funding for analysis"
NCT00378027,WITHDRAWN,OBSERVATIONAL,enrollment criteria not met by PI patient population
NCT00378235,WITHDRAWN,INTERVENTIONAL,There was a change of sponsor. The new sponsor company did not wish to conduct the study after all.
NCT00378300,WITHDRAWN,INTERVENTIONAL,Inadequate funding to support this fellow-in-training initiated study.
NCT00378339,WITHDRAWN,INTERVENTIONAL,Withdrawn because of lack of approvement from local medical authorities
NCT00378404,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00378430,TERMINATED,OBSERVATIONAL,poor response to questionnaire
NCT00378495,TERMINATED,INTERVENTIONAL,accrual criteria being reviewed
NCT00378547,TERMINATED,INTERVENTIONAL,ENT surgery stopped at the recruiting hospital
NCT00378573,TERMINATED,INTERVENTIONAL,Incidence of GI Perforation
NCT00378781,WITHDRAWN,INTERVENTIONAL,Study withdrawn.
NCT00379119,TERMINATED,OBSERVATIONAL,low accrual
NCT00379197,TERMINATED,INTERVENTIONAL,slow accrual
NCT00379223,TERMINATED,INTERVENTIONAL,lack of recruting
NCT00379366,TERMINATED,INTERVENTIONAL,lack of patients
NCT00379626,TERMINATED,INTERVENTIONAL,too few patients participated
NCT00379912,TERMINATED,INTERVENTIONAL,Insufficient response rate
NCT00380042,TERMINATED,INTERVENTIONAL,Study terminated as a result of the dissolution of the Sponsor.
NCT00380198,TERMINATED,INTERVENTIONAL,Business decision to end program
NCT00380276,TERMINATED,INTERVENTIONAL,Myriad has discontinued the development of Flurizan.
NCT00380458,WITHDRAWN,INTERVENTIONAL,No patients enrolled. Study did not start.
NCT00380666,WITHDRAWN,INTERVENTIONAL,Technical problems.
NCT00380835,WITHDRAWN,INTERVENTIONAL,Study Never Initiated
NCT00380874,TERMINATED,INTERVENTIONAL,See detailed description for termination reason
NCT00381017,WITHDRAWN,INTERVENTIONAL,Non-protocol feasibility
NCT00381095,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00381225,WITHDRAWN,INTERVENTIONAL,Administratively withdrawn by the IRB prior to IRB approval
NCT00381602,TERMINATED,INTERVENTIONAL,Lack of enrolment
NCT00381654,TERMINATED,INTERVENTIONAL,Study did not meet pre-specified objectives.
NCT00381693,TERMINATED,INTERVENTIONAL,Due to lack of accrual and trial has demonstrated too little clinical benefit
NCT00381810,TERMINATED,INTERVENTIONAL,"During a safety review of studies U2970g and U2971g, the Data Monitoring Committee recommended that enrollment in this extension trial be terminated."
NCT00381836,TERMINATED,INTERVENTIONAL,Terminated by sponsor due to general risk that aranesp caused tumor progression
NCT00382161,WITHDRAWN,INTERVENTIONAL,not enough patients meeting inclusion criteria
NCT00382278,TERMINATED,INTERVENTIONAL,"Other authors showed the same metabolic effect may be obtained when BMMC are delivered peripherally, with lower risk and cost than through hepatic artery."
NCT00382382,WITHDRAWN,INTERVENTIONAL,Study was completed but there were no participants. It was completed as a theoretical study. Requests for final progress report can be sent to Dr. Liu.
NCT00382447,WITHDRAWN,INTERVENTIONAL,Unable to put forth the human resources for patient enrollment
NCT00382473,TERMINATED,INTERVENTIONAL,lack of funding
NCT00382746,WITHDRAWN,OBSERVATIONAL,No need
NCT00382863,TERMINATED,INTERVENTIONAL,Resources unavailable to continue study follow-up.
NCT00383006,WITHDRAWN,INTERVENTIONAL,Difficulties in finding enough study participants.
NCT00383071,TERMINATED,INTERVENTIONAL,Cannot get enough plasma to manufacture IVIG for human trials
NCT00383097,TERMINATED,INTERVENTIONAL,The trial was terminated in 2010 due to lack of enrollment.
NCT00383266,TERMINATED,INTERVENTIONAL,Low accrual
NCT00383331,TERMINATED,INTERVENTIONAL,Trial was stopped early due to low enrollment
NCT00383487,TERMINATED,INTERVENTIONAL,Extreme toxicity
NCT00383630,TERMINATED,INTERVENTIONAL,Terminated due to logistical barriers to cell processing and poor enrollment
NCT00383799,TERMINATED,INTERVENTIONAL,Steering Committee decision after inclusion of 74 patients after 6 years and very slow inclusion rate
NCT00383942,TERMINATED,INTERVENTIONAL,Change in treatment plan for this population terminated the project
NCT00384111,TERMINATED,INTERVENTIONAL,Study was terminated early as per the Sponsor's decision.
NCT00384150,TERMINATED,INTERVENTIONAL,Enrollment challenges due to changes in standards of care resulted in premature termination. No safety or efficacy events factored into this action.
NCT00384163,TERMINATED,OBSERVATIONAL,sufficient data collected
NCT00384371,TERMINATED,INTERVENTIONAL,Funding was unable to be secured for this study
NCT00384527,TERMINATED,INTERVENTIONAL,Study was terminated early due to slow recruitment.
NCT00384566,WITHDRAWN,INTERVENTIONAL,In order to join forces with another study already running which aims to answer the same question.
NCT00384579,TERMINATED,INTERVENTIONAL,No eligible candidates in 2 years of recruiting
NCT00384605,TERMINATED,INTERVENTIONAL,The overall profile does not support development for obesity
NCT00384657,WITHDRAWN,INTERVENTIONAL,"Lack of cooperation among centers, Financial reasons"
NCT00384891,TERMINATED,INTERVENTIONAL,slow accrual
NCT00384995,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00385138,TERMINATED,INTERVENTIONAL,Insufficient evidence of the clinical effectiveness of cangrelor
NCT00385398,WITHDRAWN,INTERVENTIONAL,lack of funding and drug supply
NCT00385450,TERMINATED,INTERVENTIONAL,Study closed at Mayo prior to completion
NCT00385554,WITHDRAWN,INTERVENTIONAL,Study product is no longer being considered for further development.
NCT00385567,TERMINATED,INTERVENTIONAL,Difficulty recruiting eligible patients in timely fashion
NCT00385775,TERMINATED,INTERVENTIONAL,Dosing cohort (650mg) exceeded current 350mg dosing in other trials.
NCT00385827,TERMINATED,INTERVENTIONAL,Prematurely stopped after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.
NCT00386152,TERMINATED,INTERVENTIONAL,No safety signals were noted. The study was stopped because it was no longer consistent with the company's scientific and strategic focus.
NCT00386321,TERMINATED,INTERVENTIONAL,Participants are no longer being examined or treated.
NCT00386399,WITHDRAWN,INTERVENTIONAL,"All consented subjects tested negative for the BRCA2 mutation, therefore, did not meet criteria to start the study, resulting in withdrawal by PI"
NCT00386477,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT00386516,WITHDRAWN,INTERVENTIONAL,Financing and re-organization
NCT00386555,WITHDRAWN,INTERVENTIONAL,Study was cancelled before patient enrollment
NCT00386724,TERMINATED,INTERVENTIONAL,Insufficient Data Collected
NCT00386997,TERMINATED,INTERVENTIONAL,Study closed due to recruitment challenges.
NCT00387010,TERMINATED,INTERVENTIONAL,The sponsor felt enough information was available for the exploratory assessment of the effect of treatment with FBT on pain anxiety
NCT00387036,TERMINATED,INTERVENTIONAL,Termininated for business reasons
NCT00387101,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT00387153,TERMINATED,INTERVENTIONAL,Last subject enrolled experienced bradycardia; study was terminated by Sponsor.
NCT00387192,TERMINATED,INTERVENTIONAL,Due to slow recruitment and a significant delay in reaching the recruitment target.
NCT00387244,TERMINATED,INTERVENTIONAL,Insufficient Data Collected
NCT00387296,WITHDRAWN,INTERVENTIONAL,Funding nonavailability and principal investigator move
NCT00387348,TERMINATED,INTERVENTIONAL,DSMB stopped study because placebo arm had more adverse events
NCT00387478,TERMINATED,INTERVENTIONAL,"Enrollement target could not be achieved, study will not resume"
NCT00387686,TERMINATED,INTERVENTIONAL,Decision was taken by Wyeth Sr. Management to early terminate the 3100N7-210 study (terminate enrollment but complete follow-up).
NCT00387738,TERMINATED,INTERVENTIONAL,"Interim data indicated that subjects exhibited no meaningful allergic disease during the first ragweed season, making it impossible to measure treatment effect."
NCT00387829,TERMINATED,INTERVENTIONAL,Sponsor voluntarily terminated study
NCT00387894,TERMINATED,INTERVENTIONAL,Insufficient accrual of population likely to benefit; progression in 6 patients
NCT00387972,WITHDRAWN,INTERVENTIONAL,Study cancelled before enrollment
NCT00388271,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00388375,TERMINATED,INTERVENTIONAL,"Not feasible, did not have the study population."
NCT00388388,TERMINATED,INTERVENTIONAL,"Few subjects recruited, sponsor withdrew support."
NCT00388700,WITHDRAWN,INTERVENTIONAL,Financing and re-organization
NCT00388739,WITHDRAWN,INTERVENTIONAL,Different study was designed
NCT00388804,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00388843,WITHDRAWN,OBSERVATIONAL,PI has left institution
NCT00389090,TERMINATED,INTERVENTIONAL,AOI Pharma terminated the license agreement. IND Transferred to NCI
NCT00389103,WITHDRAWN,INTERVENTIONAL,Senior management decision
NCT00389519,TERMINATED,INTERVENTIONAL,"A planned interim analysis was performed after approx. 240 subjects completed the trial. The study was stopped, as permitted by protocol, after the analysis."
NCT00389675,TERMINATED,INTERVENTIONAL,Study DAR-312 did not meet its primary co-endpoints.
NCT00389688,TERMINATED,INTERVENTIONAL,low accrual
NCT00389753,WITHDRAWN,INTERVENTIONAL,study never started
NCT00389766,WITHDRAWN,INTERVENTIONAL,Withdrawn because protocol has been discontinued. It was never opened.
NCT00390013,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00390026,WITHDRAWN,INTERVENTIONAL,"Lucentis, a treatment superior to PDT, has become available i Sweden."
NCT00390247,WITHDRAWN,INTERVENTIONAL,Fail of applying funding
NCT00390286,WITHDRAWN,OBSERVATIONAL,no funding
NCT00390364,TERMINATED,INTERVENTIONAL,Withdrawn due to low accrual
NCT00390923,TERMINATED,INTERVENTIONAL,Preliminary results did not support the utility of combining selegeline + NRT.
NCT00390975,TERMINATED,INTERVENTIONAL,This study was terminated early as a result of regulatory action suspending tegaserod use in 2007
NCT00391196,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00391313,TERMINATED,INTERVENTIONAL,Terminated Chikungunya diseases has regressed and no more patients was suffering
NCT00391430,TERMINATED,INTERVENTIONAL,Difficulty enrolling subjects
NCT00391534,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT00391586,TERMINATED,INTERVENTIONAL,PI left institution.
NCT00391703,TERMINATED,INTERVENTIONAL,enrolment difficulties
NCT00391755,TERMINATED,INTERVENTIONAL,Failure to recruit necessary number of patients.
NCT00392028,WITHDRAWN,INTERVENTIONAL,no recruitment
NCT00392106,SUSPENDED,INTERVENTIONAL,voluntarily by Sponsor to investigate an anticipated SAE
NCT00392132,WITHDRAWN,OBSERVATIONAL,Sufficient study funding was not obtained.
NCT00392223,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00392301,WITHDRAWN,OBSERVATIONAL,Not funded - and PI left for another position in 2012
NCT00392665,TERMINATED,INTERVENTIONAL,slow accrual
NCT00393094,TERMINATED,INTERVENTIONAL,Terminated due to the limitations of accrual.
NCT00393224,TERMINATED,OBSERVATIONAL,Determined not to be human subject reseach
NCT00393380,TERMINATED,INTERVENTIONAL,Study stopped because of toxicity concerns.
NCT00393549,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate.
NCT00393562,WITHDRAWN,INTERVENTIONAL,Unable to recruit any subjects for this study
NCT00393653,TERMINATED,INTERVENTIONAL,Funding ended early
NCT00393796,TERMINATED,INTERVENTIONAL,Low accrual
NCT00394147,TERMINATED,INTERVENTIONAL,stopped for lack of efficacy
NCT00394212,TERMINATED,INTERVENTIONAL,For business reasons
NCT00394303,TERMINATED,INTERVENTIONAL,"Trial suspended on 26 February, following the publication of a trial with negative results (Ann Intern Med 146(4), 2007). Pending ethics committee re-approval."
NCT00394485,TERMINATED,INTERVENTIONAL,Difficulty in recruting patients
NCT00394550,TERMINATED,INTERVENTIONAL,insufficient institutional support
NCT00394589,TERMINATED,INTERVENTIONAL,Study enrollment was stopped due to insufficient subject accrual.
NCT00394602,TERMINATED,OBSERVATIONAL,Requested by PI during yearly Continuing Review
NCT00394615,TERMINATED,INTERVENTIONAL,Protocol approval expired
NCT00394706,TERMINATED,INTERVENTIONAL,Terminated because preliminary data suggested no difference in the strategies.
NCT00394784,WITHDRAWN,OBSERVATIONAL,Study terminated due to no enrollment.
NCT00394992,TERMINATED,INTERVENTIONAL,Data from the C08 study and Avant study
NCT00395057,TERMINATED,INTERVENTIONAL,The study was terminated early due to company decision (non-safety related).
NCT00395083,TERMINATED,INTERVENTIONAL,The DMC detected an imbalance in safety outcomes between the two groups.
NCT00395161,TERMINATED,INTERVENTIONAL,Terminated for futility on 11/30/09 based on the recommendation of the DSMB
NCT00395226,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects
NCT00395239,TERMINATED,INTERVENTIONAL,This project will resume upon the completion of other research committments.
NCT00395538,TERMINATED,INTERVENTIONAL,Pharmacy temporarily suspended by FDA
NCT00395603,TERMINATED,INTERVENTIONAL,This study was terminated early due to poor recruitment.
NCT00395785,TERMINATED,INTERVENTIONAL,Sponsor elected to not pursue this indication for the study device.
NCT00395967,TERMINATED,INTERVENTIONAL,Enrollment terminated in 2005 to focus on Phase 3 study enrollment.
NCT00396058,TERMINATED,INTERVENTIONAL,Recruitment of patients proved much too difficult based on the chosen criteria.
NCT00396214,TERMINATED,INTERVENTIONAL,This trial discontinued on 2 May 2008 due to lack of enrolment
NCT00396240,WITHDRAWN,INTERVENTIONAL,study cancelled prior to FSI
NCT00396383,TERMINATED,INTERVENTIONAL,Insufficient cell mobilization for tandem transplants
NCT00396448,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00396474,WITHDRAWN,OBSERVATIONAL,Study design no longer relevant and no patients were recruited.
NCT00396487,TERMINATED,INTERVENTIONAL,"Only one patient included as per Feb. 4, 2008."
NCT00396734,SUSPENDED,INTERVENTIONAL,Grant was not renewed
NCT00396812,TERMINATED,INTERVENTIONAL,The perceived risk-benefit ratio for individuals with early active RA
NCT00396955,TERMINATED,INTERVENTIONAL,imbalance of gastrointestinal and the lipase events
NCT00397098,TERMINATED,INTERVENTIONAL,reprioritization of indications
NCT00397319,TERMINATED,OBSERVATIONAL,Inadequate retention of GHD adults to maintain power to study the effect of GH on fibrinolysis. A comparison between GHD adults and controls was completed.
NCT00397358,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00397501,WITHDRAWN,INTERVENTIONAL,"after original approval, IRB closed enrollment; major revisions required to re-open."
NCT00397605,WITHDRAWN,INTERVENTIONAL,study was never started and no patients were ever enrolled
NCT00397657,TERMINATED,INTERVENTIONAL,"Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns."
NCT00397878,TERMINATED,INTERVENTIONAL,The study was terminated after all enrolled participants progressed.
NCT00398008,WITHDRAWN,INTERVENTIONAL,Study was never able to start in IRAN
NCT00398034,WITHDRAWN,INTERVENTIONAL,The original PI (David Siegel) Left the VA
NCT00398047,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00398333,TERMINATED,INTERVENTIONAL,Impossibility to accomplish the sample size in assigned time.
NCT00398528,TERMINATED,OBSERVATIONAL,rate of enrollment
NCT00398632,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT00398775,TERMINATED,INTERVENTIONAL,Very low recruitment
NCT00399009,TERMINATED,INTERVENTIONAL,One of the instruments in the study was withdrawn from the market before the calculated number of persons were included.
NCT00399022,WITHDRAWN,INTERVENTIONAL,Funding was not recieved
NCT00399204,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00399659,TERMINATED,INTERVENTIONAL,This study was terminated early as a result of regulatory action suspending tegaserod use in 2007
NCT00399841,TERMINATED,INTERVENTIONAL,Investigator Resigned
NCT00399893,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT00400088,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT00400127,TERMINATED,INTERVENTIONAL,"poor recruitment, pilot outcome measures inappropriate"
NCT00400205,TERMINATED,INTERVENTIONAL,Safety reasons
NCT00400452,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00400933,TERMINATED,INTERVENTIONAL,shortage of experienced health care personnel after reorganisation of units
NCT00401310,TERMINATED,INTERVENTIONAL,Termination date was 20-Oct-2008. Subjects were monitored during the post treatment 90 day follow-up period (per protocol) resulting in LPLV 19-Jan-2009.
NCT00401401,TERMINATED,INTERVENTIONAL,MTD was established and patients completed 16 months safety f-up and response assessments. It is considered of limited value to follow patients for 3 years.
NCT00401882,TERMINATED,INTERVENTIONAL,Difficult accrual
NCT00401895,TERMINATED,INTERVENTIONAL,An interim analysis revealed a significantly higher persistence/recurrence of complications of portal hypertension in the 8 mm-stent group.
NCT00401921,WITHDRAWN,INTERVENTIONAL,PI moved to a new facility
NCT00401947,TERMINATED,INTERVENTIONAL,Nephrotoxicity
NCT00401960,TERMINATED,INTERVENTIONAL,inadequate enrollment
NCT00402298,TERMINATED,INTERVENTIONAL,This study was terminated after enrolling five subjects due to staff turnover and its effects on quality of data collection.
NCT00402662,TERMINATED,INTERVENTIONAL,unexpected level of toxicity
NCT00402818,TERMINATED,OBSERVATIONAL,The study was terminated after the EMEA recommended to suspend the marketing authorisation of Raptiva in the EU
NCT00402883,TERMINATED,INTERVENTIONAL,Terminated due to bevacizumab and chemoradiotherapy toxicity
NCT00402896,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00402935,WITHDRAWN,OBSERVATIONAL,slow accrual
NCT00402948,TERMINATED,INTERVENTIONAL,Lack of substantial enrollment
NCT00403052,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT00403156,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT00403182,WITHDRAWN,INTERVENTIONAL,"study halted prematurely, prior to enrollment of first participant"
NCT00403234,TERMINATED,INTERVENTIONAL,due to administrative reasons not related to efficacy or safety.
NCT00403780,TERMINATED,INTERVENTIONAL,low inclusion rate
NCT00403806,TERMINATED,INTERVENTIONAL,drug-related harm
NCT00403988,TERMINATED,INTERVENTIONAL,"The results of a same study design have shown low response with important side effects. Accordingly \& ethicly, the study has been stopped."
NCT00404287,TERMINATED,INTERVENTIONAL,Funding not enough to complete the study
NCT00404300,TERMINATED,INTERVENTIONAL,Due to slow recruitment and a delay in reaching the recruitment target.
NCT00404521,TERMINATED,INTERVENTIONAL,Low rate recruitment
NCT00404690,TERMINATED,INTERVENTIONAL,Change in referral pattern changed the population we were studying
NCT00404703,TERMINATED,INTERVENTIONAL,Primary (safety) endpoint reached
NCT00405561,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00405808,TERMINATED,INTERVENTIONAL,EMEA recommendation to suspend Acomplia marketing authorisation
NCT00405873,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00406120,WITHDRAWN,OBSERVATIONAL,It has come to our attention that the site was not necessary for our research project.
NCT00406276,TERMINATED,INTERVENTIONAL,data analysis showed insufficient drug efficacy
NCT00406419,TERMINATED,INTERVENTIONAL,"Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA."
NCT00406653,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT00406822,TERMINATED,INTERVENTIONAL,Terminated due to the change of supplier and sponsor
NCT00406874,TERMINATED,INTERVENTIONAL,reports indicating that increased folic acid intake may increase colin cancer
NCT00407147,TERMINATED,INTERVENTIONAL,termination due to futility (very slow patient enrollment)
NCT00407407,TERMINATED,INTERVENTIONAL,MTD not determined
NCT00407641,WITHDRAWN,INTERVENTIONAL,Financial and administrative matters did not allow collaboration among centers.
NCT00408018,TERMINATED,INTERVENTIONAL,The decision to terminate this study after 202 mg/m2 cohort was taken as MTD achieved in other study at 185 mg/m2
NCT00408070,TERMINATED,INTERVENTIONAL,Did not meet accrual goals.
NCT00408148,TERMINATED,INTERVENTIONAL,Company decision has been taken in light of recent demands by certain national health authorities
NCT00408252,TERMINATED,INTERVENTIONAL,Too frequent grade 3-4 toxicities
NCT00408772,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT00408967,WITHDRAWN,INTERVENTIONAL,Th trial got cancelled and no subjects signed informed consent form (ICF); study design not appropriate any longer.
NCT00409019,WITHDRAWN,INTERVENTIONAL,Study cancelled: Withdrawn before enrollment of any participants
NCT00409084,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00409110,TERMINATED,OBSERVATIONAL,methodological problems
NCT00409266,WITHDRAWN,INTERVENTIONAL,Investigator medical practice didn't allow to move forward with the study.
NCT00409331,TERMINATED,INTERVENTIONAL,Study terminated by Principal Investigator; no patients completed study.
NCT00409344,TERMINATED,INTERVENTIONAL,Surgical approach changed therefore subject enrollment not possible.
NCT00409526,TERMINATED,INTERVENTIONAL,Sub-Investigator left U of C
NCT00409591,TERMINATED,INTERVENTIONAL,Change in National PMTCT guidelines in Thailand
NCT00409630,WITHDRAWN,INTERVENTIONAL,Sponsor decided against going forward with the study.
NCT00409695,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT00410150,TERMINATED,INTERVENTIONAL,Study was stopped after interim analysis and slow enrollment.
NCT00410267,TERMINATED,OBSERVATIONAL,low recruitment
NCT00410566,TERMINATED,INTERVENTIONAL,Terminated by sponsor - Single dose safety objective achieved.
NCT00410774,TERMINATED,INTERVENTIONAL,low accrual-no data available
NCT00410865,TERMINATED,INTERVENTIONAL,Sponsor withdrawl prior to study completion.
NCT00410995,TERMINATED,INTERVENTIONAL,Study never initiated.
NCT00411281,WITHDRAWN,INTERVENTIONAL,Per Group Chair: This study will not move forward.
NCT00411372,WITHDRAWN,INTERVENTIONAL,No subjects enrolled. Study was canceled before active
NCT00411593,WITHDRAWN,INTERVENTIONAL,Lack of Patient Accrual
NCT00411658,WITHDRAWN,INTERVENTIONAL,Submission converted to 510(k)
NCT00411801,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00411892,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00412217,TERMINATED,INTERVENTIONAL,The study was terminated because recruitment was too slow.
NCT00412295,WITHDRAWN,INTERVENTIONAL,Lack of resources and not because of any concern with the safety or effectiveness of the procedures studied.
NCT00412698,TERMINATED,INTERVENTIONAL,Company decision has been taken in light of recent demands by certain national health authorities
NCT00412750,TERMINATED,INTERVENTIONAL,Enrollment stopped for safety issues
NCT00412776,TERMINATED,INTERVENTIONAL,Corporate reasons unrelated to safety and efficacy
NCT00412919,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00413127,TERMINATED,INTERVENTIONAL,"Less patients than expected for inclusion, therefore patient recruitment is to low"
NCT00413478,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00413543,TERMINATED,INTERVENTIONAL,enrollment insufficient: lack of motivated patients
NCT00413933,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of funding
NCT00414024,TERMINATED,INTERVENTIONAL,This study was terminated early as a result of regulatory action suspending tegaserod use in 2007
NCT00414037,TERMINATED,INTERVENTIONAL,"Funding terminated by sponsor, insufficient data collection"
NCT00414076,TERMINATED,INTERVENTIONAL,Low accrual
NCT00414089,WITHDRAWN,INTERVENTIONAL,Funding will not be provided for the drug
NCT00414206,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00414284,TERMINATED,INTERVENTIONAL,One subject's HIV RNA rebounded at week 12. A repeat PhenoSense GT combination resistance assay at week 12 revealed evolution in protease inhibitor resistance.
NCT00414414,WITHDRAWN,INTERVENTIONAL,Funding not awarded
NCT00414453,TERMINATED,INTERVENTIONAL,Did not reach enrollment goals
NCT00414466,TERMINATED,INTERVENTIONAL,Study closed and subject follow-up completed following analysis of blinded study data.
NCT00414570,TERMINATED,INTERVENTIONAL,Retirement of former Qualified Investigator and lack of resources to complete study
NCT00414726,TERMINATED,INTERVENTIONAL,Imbalance in deaths favoring control arm; deaths not attributed to treatment by the blinded external medical monitor.
NCT00414804,WITHDRAWN,INTERVENTIONAL,Investigator decided to withdraw participation in the study
NCT00414843,TERMINATED,OBSERVATIONAL,Decreasing interest in using samples; department infrastructure waned
NCT00414869,TERMINATED,INTERVENTIONAL,Preliminary analysis of 11 patients did not demonstrate the efficacy required.
NCT00415077,TERMINATED,INTERVENTIONAL,Change in excimer laser systems prior to completion of study
NCT00415155,WITHDRAWN,INTERVENTIONAL,Trial cancelled
NCT00415246,TERMINATED,INTERVENTIONAL,The preliminary data do not support the expected sustainable blood levels of triptorelin for a duration of 4 months in all patients.
NCT00415272,TERMINATED,INTERVENTIONAL,Inadequate enrollment.
NCT00415311,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study
NCT00415376,WITHDRAWN,INTERVENTIONAL,Unable to accrue subjects
NCT00415389,TERMINATED,INTERVENTIONAL,Approval lapse
NCT00415454,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00415467,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate study.
NCT00415558,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00415584,TERMINATED,INTERVENTIONAL,low enrollment
NCT00415857,TERMINATED,INTERVENTIONAL,Vaccine sponsor ceased operations.
NCT00415909,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00416338,TERMINATED,INTERVENTIONAL,We encounter technical problems to continue with the study. (Notably difficulty in teaching the patients to use the dressing set involved in the study.)
NCT00416364,TERMINATED,OBSERVATIONAL,Inadequate accrural rates
NCT00416793,TERMINATED,INTERVENTIONAL,Study was terminated due to poor accrual
NCT00416884,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00416910,TERMINATED,INTERVENTIONAL,low recruitment
NCT00416949,TERMINATED,INTERVENTIONAL,Study was terminated due to loss of funding.
NCT00417248,TERMINATED,INTERVENTIONAL,Negative sorafenib results from ESCAPE trial and safety concerns of regimen
NCT00417287,TERMINATED,INTERVENTIONAL,Investigator decision
NCT00417508,TERMINATED,INTERVENTIONAL,It was not possible to recruite sufficient number of participants
NCT00417677,TERMINATED,INTERVENTIONAL,Decision was made not to attempt a lower dose
NCT00417690,TERMINATED,INTERVENTIONAL,Efforts at recruitment have halted as recruitment was poor.
NCT00417768,TERMINATED,INTERVENTIONAL,Change in patient population no longer fit study criteria.
NCT00417885,TERMINATED,INTERVENTIONAL,See Detailed Description for Termination Reason
NCT00418093,TERMINATED,INTERVENTIONAL,THe study was terminated early due to a lack of accural
NCT00418132,TERMINATED,INTERVENTIONAL,Study terminated early due to difficulties in subject recruitment
NCT00418145,TERMINATED,INTERVENTIONAL,low enrollment - data was not analyzed for this study
NCT00418470,TERMINATED,INTERVENTIONAL,impossibility to find volunteers
NCT00418574,TERMINATED,INTERVENTIONAL,No benefit on primary end point (RFS); no rationale to collect survival data
NCT00418678,TERMINATED,INTERVENTIONAL,Enrollment was too slow
NCT00418691,TERMINATED,INTERVENTIONAL,Closed early due to slow accrual.
NCT00418782,TERMINATED,INTERVENTIONAL,Results of interim analysis indicate lack of efficacy when compared to placebo.
NCT00418821,TERMINATED,INTERVENTIONAL,Study was conducted to fulfill a post marketing commitment (PMC). FDA acknowledged closure of PMC.
NCT00418873,TERMINATED,INTERVENTIONAL,Study was stopped due to difficulty in patient enrollment
NCT00419055,TERMINATED,OBSERVATIONAL,Stopped early due to inability to recruit full 100 subjects over 2 years
NCT00419081,TERMINATED,INTERVENTIONAL,Issues with Manufacturing
NCT00419107,TERMINATED,OBSERVATIONAL,Completed
NCT00419120,TERMINATED,INTERVENTIONAL,36 months follow up without change to profile. No further studies planned.
NCT00419549,TERMINATED,INTERVENTIONAL,Because one of the drugs Valdecoxib was withdrawn due to safety concerns.
NCT00419653,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT00419913,TERMINATED,INTERVENTIONAL,Failure to recruit sufficient participants.
NCT00419978,TERMINATED,INTERVENTIONAL,Slow accrural to study.
NCT00420355,TERMINATED,INTERVENTIONAL,Unexpected adverse event
NCT00420407,TERMINATED,INTERVENTIONAL,accrual rate
NCT00420537,TERMINATED,INTERVENTIONAL,A cluster of adverse events in everolimus arm was noted.
NCT00420589,TERMINATED,INTERVENTIONAL,The overall profile does not support development for obesity
NCT00420732,TERMINATED,INTERVENTIONAL,Enrollment goals unable to be reached.
NCT00420797,WITHDRAWN,INTERVENTIONAL,"Terminated, new protocol to be developed"
NCT00420875,WITHDRAWN,INTERVENTIONAL,Did not meet enrollment goals
NCT00420914,TERMINATED,INTERVENTIONAL,Stopped at the request of the Data Safety Monitoring Board for safety reasons.
NCT00421096,TERMINATED,INTERVENTIONAL,Problems of recruitment
NCT00421187,TERMINATED,INTERVENTIONAL,Unable to recruit subjects in the Turkey site.
NCT00421252,TERMINATED,INTERVENTIONAL,Difficult to enroll patients; limited resources available
NCT00421317,TERMINATED,INTERVENTIONAL,Study stopped at the end of the first step
NCT00421421,TERMINATED,INTERVENTIONAL,Incomplete information
NCT00421941,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goal
NCT00421967,TERMINATED,INTERVENTIONAL,Interim analysis
NCT00422513,TERMINATED,INTERVENTIONAL,Strategic decision unrelated to safety or efficacy
NCT00422565,TERMINATED,INTERVENTIONAL,The recruitment rate was much slower than expected.
NCT00422669,TERMINATED,INTERVENTIONAL,Study enrollment significantly below protocol expectations
NCT00422877,TERMINATED,INTERVENTIONAL,"Sponsor suspended development of the drug on September 3, 2008."
NCT00422942,TERMINATED,INTERVENTIONAL,Study was terminated after enrollment of 3 participants due to recruitment difficulties.
NCT00423163,WITHDRAWN,INTERVENTIONAL,An alternative joint industry effort will provide information on combination versus single agent therapy for treatment of aspergillosis
NCT00423176,TERMINATED,INTERVENTIONAL,Based on business priorities. Not related to any safety or efficacy issue \& took place before data were unblinded or analyzed
NCT00423189,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00423241,TERMINATED,INTERVENTIONAL,Market dynamics including other technologies made the project not viable.
NCT00423345,TERMINATED,OBSERVATIONAL,One of the examinations (double contrast baium enema) became outdated in Norway
NCT00423683,TERMINATED,INTERVENTIONAL,Study accrual stopped due to poor accrual.
NCT00423800,TERMINATED,INTERVENTIONAL,The study was terminated due to difficulty in recruiting participants.
NCT00424138,TERMINATED,INTERVENTIONAL,Recruitment obstacles; data to be combined with other resources for analysis
NCT00424294,TERMINATED,INTERVENTIONAL,See Detailed Description field
NCT00424489,TERMINATED,INTERVENTIONAL,No participants enrolled for more than two years. No plan to continue study.
NCT00424567,TERMINATED,INTERVENTIONAL,Closed early for business reasons (not safety reasons)
NCT00424645,TERMINATED,INTERVENTIONAL,Sponsor terminated due to low accrual.
NCT00424684,WITHDRAWN,INTERVENTIONAL,unable to obtain contract with sponsor
NCT00424749,TERMINATED,INTERVENTIONAL,Company providing study drug terminated study due to lack of funds
NCT00424801,TERMINATED,INTERVENTIONAL,Due to recent findings relating MRI contrast to nephrogenic systemic fibrosis
NCT00424840,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00425230,TERMINATED,INTERVENTIONAL,No patients were enrolled in this study. The study onset was delayed due to problems with drug acquisition.
NCT00425295,WITHDRAWN,INTERVENTIONAL,too much cross over bias between small numbers of participants
NCT00425438,TERMINATED,INTERVENTIONAL,Study was terminated early for administrative reasons.
NCT00425581,WITHDRAWN,OBSERVATIONAL,Did not receive budget needed.
NCT00425633,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00425711,TERMINATED,INTERVENTIONAL,Recruitment barriers.
NCT00425815,WITHDRAWN,INTERVENTIONAL,Study terminated at Sponsor's request.
NCT00425906,WITHDRAWN,INTERVENTIONAL,No patient enrollment occurred.
NCT00425919,TERMINATED,INTERVENTIONAL,Study terminated as a result of interim analysis not meeting predetermined criteria.
NCT00426114,WITHDRAWN,INTERVENTIONAL,never started due to logistic issues
NCT00426127,TERMINATED,INTERVENTIONAL,Inadequate number of eligible patients
NCT00426829,TERMINATED,INTERVENTIONAL,Low Accural
NCT00426985,TERMINATED,INTERVENTIONAL,Sufficient number of subjects accrued to conduct analysis
NCT00427011,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy.
NCT00427102,TERMINATED,INTERVENTIONAL,No subjects enrolled and PI went to another facility
NCT00427154,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00427297,TERMINATED,INTERVENTIONAL,There is no longer equipoise. DSMB recommended termination.
NCT00427323,SUSPENDED,INTERVENTIONAL,recruitment has been put on hold until a future date
NCT00427401,TERMINATED,INTERVENTIONAL,"This study was terminated May 7, 2007. The study stopped due to tablet formulation issues. No safety issues were involved in the termination decision."
NCT00427414,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00427427,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00427583,TERMINATED,INTERVENTIONAL,stopped due to slow recruitment and no effect
NCT00427609,TERMINATED,INTERVENTIONAL,Not enough enrollees to obtain a valid conclusion
NCT00427648,TERMINATED,INTERVENTIONAL,"funding ran out, poor accrual."
NCT00427674,TERMINATED,INTERVENTIONAL,Scan results to date did not show reason to continue with study
NCT00427778,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00427934,TERMINATED,INTERVENTIONAL,See Detailed Description.
NCT00427947,TERMINATED,INTERVENTIONAL,lack of patients
NCT00427960,TERMINATED,INTERVENTIONAL,Due to inadequate recruitment
NCT00427973,TERMINATED,INTERVENTIONAL,The study was stopped prior to 2nd stage.
NCT00427986,TERMINATED,INTERVENTIONAL,No sufficient increase in plasma osmolarity by galactose (one patient included)
NCT00428025,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00428051,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT00428077,TERMINATED,INTERVENTIONAL,"Withdrawn because there were no dramatic changes in the main endpoint, as well as low enrollment numbers. The data are not interpretable in terms of efficacy."
NCT00428116,TERMINATED,INTERVENTIONAL,DSMB recommended termination because TI was safe but not durable.
NCT00428129,TERMINATED,INTERVENTIONAL,Sponsor's decision to not pursue uPLi for vascular conditions including DVT.
NCT00428168,TERMINATED,INTERVENTIONAL,Interim Analysis result indicated the study will not show a significant benefit of the study medication on the primary endpoint.
NCT00428194,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of accrual
NCT00428207,TERMINATED,INTERVENTIONAL,Treatment differences not detected with 7 point fingerstick monitoring
NCT00428441,TERMINATED,INTERVENTIONAL,Enrolment was halted prematurely because of the observed excess in recurrences
NCT00428597,TERMINATED,INTERVENTIONAL,Refer to Detailed Description.
NCT00428805,TERMINATED,INTERVENTIONAL,"Based on the primary study completion date, this research does not meet the former definition of a clinical trial."
NCT00429013,TERMINATED,INTERVENTIONAL,principal criteria was achieved with the intermediate statistical analysis
NCT00429026,TERMINATED,INTERVENTIONAL,"Slow accrual, study terminated."
NCT00429039,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00429052,TERMINATED,OBSERVATIONAL,"PI left institution,inability to enroll and analyze data due to software/technical limitations, pt enrollment terminated early with no data generated"
NCT00429078,WITHDRAWN,INTERVENTIONAL,low accrual
NCT00429169,TERMINATED,INTERVENTIONAL,Interim analysis showed differential treatment effects.
NCT00429338,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00429403,TERMINATED,INTERVENTIONAL,Study stopped due to low accrual.
NCT00429702,TERMINATED,INTERVENTIONAL,Closed due to poor accrual and lack of feasibility to finish study per DSMB
NCT00429754,WITHDRAWN,INTERVENTIONAL,change of study population and chemotherapeutic regimen
NCT00429858,TERMINATED,INTERVENTIONAL,"Study accrual rate is very slow, it was mandated by NCI to be terminated."
NCT00430014,TERMINATED,INTERVENTIONAL,Sponsor Withdrew
NCT00430027,TERMINATED,INTERVENTIONAL,This study was terminated due slow accrual.
NCT00430079,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00430313,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT00430443,TERMINATED,INTERVENTIONAL,Participants are no longer being examined or treated.
NCT00430469,WITHDRAWN,INTERVENTIONAL,Strategic company decision
NCT00430573,TERMINATED,INTERVENTIONAL,The investigators failed to recruit participants as originally projected.
NCT00430677,TERMINATED,INTERVENTIONAL,Terminated due to failure to meet the primary efficacy endpoint in the Short-term Period
NCT00430716,TERMINATED,INTERVENTIONAL,This study was terminated at the recommendation of an independent Data Monitoring Committee. The decision was not based on any safety concerns.
NCT00430742,TERMINATED,INTERVENTIONAL,The overall profile does not support development for obesity
NCT00430794,TERMINATED,INTERVENTIONAL,Difficulties with recruitment.
NCT00431002,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT00431028,TERMINATED,INTERVENTIONAL,Terminated
NCT00431340,TERMINATED,INTERVENTIONAL,Terminated due to dose limiting toxicity
NCT00431379,WITHDRAWN,INTERVENTIONAL,"drug has expired, no enrollments in study. Company pulled funding"
NCT00431613,TERMINATED,INTERVENTIONAL,Due to Poor Accrual
NCT00431626,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00431795,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00432328,TERMINATED,INTERVENTIONAL,"Futility analysis undertaken, determined that study was underpowered."
NCT00432341,TERMINATED,INTERVENTIONAL,Study was terminated early due to difficulties with patient recruitment
NCT00432419,TERMINATED,INTERVENTIONAL,only one patient enrolled
NCT00432445,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00433017,TERMINATED,INTERVENTIONAL,Study was terminated based on the results of analyses performed as planned at Month 12.
NCT00433043,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00433173,SUSPENDED,INTERVENTIONAL,Primary investigator is taking a leave of absence
NCT00433472,WITHDRAWN,INTERVENTIONAL,not enough interest
NCT00433953,TERMINATED,INTERVENTIONAL,No longer following patient and no plans to publish.
NCT00434031,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00434096,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00434226,TERMINATED,INTERVENTIONAL,"Based on data collected, the combination appeared to be poorly tolearated."
NCT00434278,TERMINATED,INTERVENTIONAL,This study was terminated for administrative reasons. There were no safety concerns.
NCT00434356,TERMINATED,INTERVENTIONAL,"Based on data collected, the combination appeared to be poorly tolearated."
NCT00434499,WITHDRAWN,INTERVENTIONAL,Not funded
NCT00434538,TERMINATED,INTERVENTIONAL,Due to Sponsor's financial reasons
NCT00434590,TERMINATED,INTERVENTIONAL,The study has been stopped because of the lack of enrollment
NCT00434941,TERMINATED,INTERVENTIONAL,Due to the slow rate of recruitment the study was stopped.
NCT00434993,TERMINATED,INTERVENTIONAL,Stopped for futility by DSMB
NCT00435071,TERMINATED,INTERVENTIONAL,Investigator initiated suspension to focus on other studies.
NCT00435123,TERMINATED,INTERVENTIONAL,Increased use of commercial product; less eligible patients \& poor enrollment.
NCT00435227,TERMINATED,INTERVENTIONAL,The study was terminated early due to an inability to enroll the planned number of participants
NCT00435305,TERMINATED,OBSERVATIONAL,"difficulties by enrolling patients fundings consumed, no staff could be recruited and payed to continue enrolling patients,"
NCT00435318,WITHDRAWN,INTERVENTIONAL,Study approval deferred by the IRB.
NCT00435487,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00436124,TERMINATED,INTERVENTIONAL,"poor recruitment, no patients were enrolled"
NCT00436345,TERMINATED,INTERVENTIONAL,recruitment issues
NCT00436436,TERMINATED,INTERVENTIONAL,Study closed to accrual after the company chose to stop development of the drug.
NCT00436722,TERMINATED,INTERVENTIONAL,Experimental arm (induction + low dose tacrolimus) not effective.
NCT00436748,TERMINATED,INTERVENTIONAL,FDA and EMA agreed that the information that had been submitted to date was acceptable to meet the requirements of the post-marketing commitment.
NCT00437034,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00437073,TERMINATED,INTERVENTIONAL,Lapatinib-topotecan arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.
NCT00437164,TERMINATED,INTERVENTIONAL,Company decision not related to safety.
NCT00437203,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00437294,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00437346,TERMINATED,INTERVENTIONAL,The project leader left our hospital and the project were shut down.
NCT00437398,TERMINATED,INTERVENTIONAL,"The study was terminated early due to difficulty in recruiting subjects, and ran short of funds."
NCT00437489,TERMINATED,INTERVENTIONAL,"This protocol was terminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007."
NCT00437606,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00437671,TERMINATED,INTERVENTIONAL,Study terminated for cGCP non-compliance. Analyses could not be performed.
NCT00437749,TERMINATED,INTERVENTIONAL,slow accrual rate; interim accrual objective met
NCT00437892,TERMINATED,INTERVENTIONAL,Competitive trials and slow recruitment rate
NCT00437957,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00437970,WITHDRAWN,INTERVENTIONAL,Unable to secure supply of the study medication
NCT00438204,TERMINATED,INTERVENTIONAL,All data collection has completed.
NCT00438243,WITHDRAWN,INTERVENTIONAL,Principal Investigator left institution
NCT00438321,TERMINATED,INTERVENTIONAL,PI relocated
NCT00438412,SUSPENDED,OBSERVATIONAL,It was not possible to recruit enough patients with obstructive sleep apnea.
NCT00439140,TERMINATED,INTERVENTIONAL,In agreement with FDA the study was terminated based on data available.
NCT00439192,TERMINATED,INTERVENTIONAL,side effect profile did not match expectations
NCT00439218,TERMINATED,INTERVENTIONAL,Extremely slow enrollment
NCT00439296,TERMINATED,INTERVENTIONAL,The study was stopped due to poor accrual and lack of funding.
NCT00439309,TERMINATED,INTERVENTIONAL,Business Decision
NCT00439374,TERMINATED,INTERVENTIONAL,Halted by NICHD after recommendation by DSMC to stop for futility
NCT00439569,TERMINATED,INTERVENTIONAL,Due to poor compliance with study drug administration.
NCT00439634,TERMINATED,INTERVENTIONAL,Following a pre-specified interim analysis and Data Monitoring Committee recommendation due to insufficient level of efficacy
NCT00439946,TERMINATED,INTERVENTIONAL,Study closed due to limited availability of eligible subjects and competition by for enrollment by other studies
NCT00439985,TERMINATED,INTERVENTIONAL,decreased enrollment. (there are no data results for this study)
NCT00440076,TERMINATED,INTERVENTIONAL,Low accrual
NCT00440180,TERMINATED,INTERVENTIONAL,Not able meet target enrollment.
NCT00440440,WITHDRAWN,INTERVENTIONAL,study merged with another study
NCT00440544,TERMINATED,INTERVENTIONAL,Safety Issues
NCT00440622,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00440791,TERMINATED,OBSERVATIONAL,Interim analysis
NCT00440921,WITHDRAWN,INTERVENTIONAL,No agreement between investigator and sponsor
NCT00440934,TERMINATED,INTERVENTIONAL,Poor patient accrual
NCT00440973,TERMINATED,INTERVENTIONAL,contract issues
NCT00441025,TERMINATED,INTERVENTIONAL,a lack of a potential patient.
NCT00441038,WITHDRAWN,INTERVENTIONAL,"Pilot study showed recruitment rates were lower than expected,and number of losses to follow-up, much higher."
NCT00441168,TERMINATED,INTERVENTIONAL,TRIAL STOPPED due to a change in standard of care and the required patient numbers could no longer be achieved
NCT00441194,TERMINATED,OBSERVATIONAL,Study terminated due to resources
NCT00441363,TERMINATED,INTERVENTIONAL,Failure to Recruit in a Timely manner
NCT00441558,TERMINATED,INTERVENTIONAL,terminated for administrative reasons
NCT00441584,TERMINATED,INTERVENTIONAL,Subject accrual was prematurely terminated due slow enrollment.
NCT00441714,WITHDRAWN,INTERVENTIONAL,new insights have let us to expect marginal annexin targeting with a 10 minutes delay between reperfusion and administration of Annexin A5
NCT00441766,TERMINATED,INTERVENTIONAL,Study was terminated due to company decision after Part A. Part B was never conducted
NCT00441779,TERMINATED,OBSERVATIONAL,"A separate study (similar subjects) identified transfusion-associated microchimerism only rarely, making this observational study impractical to conduct."
NCT00441805,WITHDRAWN,INTERVENTIONAL,Terminated- the study was not started (per Investigator's/sponsor decision)
NCT00441935,TERMINATED,OBSERVATIONAL,Shift in department's research interest
NCT00442026,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00442104,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00442299,SUSPENDED,INTERVENTIONAL,Major side-effects
NCT00442351,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00442403,SUSPENDED,INTERVENTIONAL,"At the end of the year 2002, Cameroon switched from chloroquine to amodiaquine as first-line therapy for of uncomplicated malaria."
NCT00442416,TERMINATED,INTERVENTIONAL,Strategic decision unrelated to safety or efficacy
NCT00442494,TERMINATED,INTERVENTIONAL,Study has been completed as planned
NCT00442507,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00442676,WITHDRAWN,INTERVENTIONAL,No patients were recruited. Treatment drug expired.
NCT00442741,WITHDRAWN,INTERVENTIONAL,pts. will be captured in core
NCT00442923,WITHDRAWN,INTERVENTIONAL,This study was withdrawn for lack of progress. No subjects were recruited.
NCT00443040,TERMINATED,INTERVENTIONAL,poor enrollment (31 of a planned 114 subjects were randomized and evaluable)
NCT00443261,TERMINATED,INTERVENTIONAL,Accrual problems
NCT00443300,TERMINATED,OBSERVATIONAL,Terminated due to low accrual.
NCT00443573,SUSPENDED,INTERVENTIONAL,Company suspended development of product.
NCT00443703,TERMINATED,INTERVENTIONAL,primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus lopinavir (+) ritonavir
NCT00443729,TERMINATED,INTERVENTIONAL,Primary efficacy analysis at Week 24 did not demonstrate non-inferiority of raltegravir versus lopinavir (+) ritonavir
NCT00443859,TERMINATED,OBSERVATIONAL,Interim analysis showed greater variablility in NT-proBNP findings than anticipated.
NCT00443963,WITHDRAWN,INTERVENTIONAL,The study was not approved by the Human Studies Subcommittee.
NCT00444093,TERMINATED,INTERVENTIONAL,bad recruitment
NCT00444223,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00444236,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study due to slow enrollment.
NCT00444249,TERMINATED,INTERVENTIONAL,Because only a few patients follow the inclusion and exclusion criteria.
NCT00444262,TERMINATED,INTERVENTIONAL,termination of the study due to difficulties to include patients
NCT00444405,WITHDRAWN,OBSERVATIONAL,PI left Health System
NCT00444639,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00444808,TERMINATED,INTERVENTIONAL,Medication expired
NCT00444821,TERMINATED,INTERVENTIONAL,Interim analysis of Primary Endpoint completed
NCT00444834,TERMINATED,INTERVENTIONAL,IMP supply
NCT00445211,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00445263,TERMINATED,INTERVENTIONAL,Because of inclusion delay
NCT00445328,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00445471,TERMINATED,INTERVENTIONAL,Mifne began treating younger patients who could not be diagnosed with the ADOS used in the study
NCT00445549,TERMINATED,INTERVENTIONAL,The study closed because of inadequate early activity.
NCT00445705,TERMINATED,INTERVENTIONAL,This study was terminated early due to company decision. Part B was never conducted.
NCT00445757,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT00446121,WITHDRAWN,OBSERVATIONAL,No funding for the project
NCT00446173,WITHDRAWN,INTERVENTIONAL,Terminated due to low accrual.
NCT00446277,SUSPENDED,OBSERVATIONAL,The present study was joining 2005-41-4933 into one study
NCT00446329,TERMINATED,INTERVENTIONAL,due to financial problems
NCT00446589,TERMINATED,INTERVENTIONAL,due to financial problems
NCT00446602,WITHDRAWN,INTERVENTIONAL,"Due to company decision to focus resources on a larger, controlled study in this patient population."
NCT00446667,WITHDRAWN,INTERVENTIONAL,Failed to recruit
NCT00447031,WITHDRAWN,INTERVENTIONAL,Insufficient patients who met inclusion criteria
NCT00447096,WITHDRAWN,INTERVENTIONAL,"No results, funding terminated and PI no longer at institution"
NCT00447122,TERMINATED,INTERVENTIONAL,slow enrollment and lack of funding
NCT00447187,TERMINATED,INTERVENTIONAL,The primary efficacy endpoint was not met
NCT00447226,TERMINATED,INTERVENTIONAL,The study had failed to meet the primary objective of tumor response rate at 12 weeks from first dose.
NCT00447265,TERMINATED,INTERVENTIONAL,The perceived risk-benefit ratio for individuals with early active RA
NCT00447291,TERMINATED,INTERVENTIONAL,"Zone Labs, Inc discontinue utilizing their fish oil supplement and frozen foods"
NCT00447356,WITHDRAWN,INTERVENTIONAL,There were no patient enrolled in this study at this site
NCT00447369,WITHDRAWN,INTERVENTIONAL,Because we did not find funds to do it
NCT00447421,TERMINATED,INTERVENTIONAL,Interim results of another trial showed inferior activity of treatment
NCT00447473,TERMINATED,INTERVENTIONAL,PI decision
NCT00447603,TERMINATED,INTERVENTIONAL,Achieving site readiness and enrolling the trial within a reasonable time
NCT00447616,TERMINATED,OBSERVATIONAL,Lack of funding
NCT00447642,TERMINATED,INTERVENTIONAL,The primary efficacy endpoint was not met
NCT00448097,TERMINATED,INTERVENTIONAL,lack of patient population - slow accrual
NCT00448162,SUSPENDED,OBSERVATIONAL,no enough fund
NCT00448240,TERMINATED,INTERVENTIONAL,"Low Accrual, Funding"
NCT00448266,TERMINATED,INTERVENTIONAL,Activation of a similar multicenter study for same population
NCT00448448,TERMINATED,INTERVENTIONAL,Stopped for efficacy
NCT00448526,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted and will not resume because low protein diet is not feasible nor efficious.
NCT00448539,TERMINATED,INTERVENTIONAL,The study was terminated early by the sponsor due to the discontinuation of clinical development for rufinamide.
NCT00448708,TERMINATED,INTERVENTIONAL,Due to an imbalance in graft infections between groups.
NCT00448864,TERMINATED,INTERVENTIONAL,Experience gained from this study is sufficient to design and facilitate the follow-on study.
NCT00448994,WITHDRAWN,OBSERVATIONAL,Method development/validation
NCT00449007,TERMINATED,INTERVENTIONAL,recruitment of this population was not feasible
NCT00449150,TERMINATED,INTERVENTIONAL,Trial did not meet primary efficacy endpoint for double blind phase.
NCT00449163,TERMINATED,INTERVENTIONAL,Study terminated by University of Miami Institutional Review Board
NCT00449332,TERMINATED,OBSERVATIONAL,PI left University
NCT00449423,TERMINATED,INTERVENTIONAL,due to slow recruitment
NCT00449605,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00449618,TERMINATED,INTERVENTIONAL,Not enough recruitment during the proposed period.
NCT00449657,TERMINATED,INTERVENTIONAL,"Poor accrual, change in standard of care."
NCT00449813,TERMINATED,INTERVENTIONAL,Inclusion-rate does not seem feasible anymore to obtain te required number of patients before the end of the trial.
NCT00449865,TERMINATED,INTERVENTIONAL,Futility
NCT00450008,TERMINATED,INTERVENTIONAL,PI decision
NCT00450242,TERMINATED,INTERVENTIONAL,lack of funding
NCT00450333,TERMINATED,INTERVENTIONAL,The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA
NCT00450385,TERMINATED,INTERVENTIONAL,Investigator Decision due to insufficient accrual.
NCT00450515,WITHDRAWN,INTERVENTIONAL,Study was dropped prior to opening.
NCT00450970,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study drug development.
NCT00451256,TERMINATED,INTERVENTIONAL,Protocol-defined outcome in terms of efficacy would not be achieved.
NCT00451295,TERMINATED,INTERVENTIONAL,This study was stopped because of insufficient enrollment.
NCT00451490,WITHDRAWN,INTERVENTIONAL,This study not get the approval by the drug company
NCT00451542,TERMINATED,OBSERVATIONAL,Sample too small in retrospective chart review to conduct analysis
NCT00451633,WITHDRAWN,INTERVENTIONAL,The study group changed from patients to a healthy volunteers. A healthy-volunteer study is being planned to replace 213.
NCT00451698,TERMINATED,INTERVENTIONAL,Inadequate patient enrollment
NCT00451841,TERMINATED,OBSERVATIONAL,IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study suspended pending analysis
NCT00451867,TERMINATED,INTERVENTIONAL,The major and primary reason for the study termination is the observed reduced efficacy of CellCept compared to placebo.
NCT00452075,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00452114,TERMINATED,INTERVENTIONAL,interim analysis indicates statistical futility for primary outcomes
NCT00452140,TERMINATED,INTERVENTIONAL,company focus on other projects
NCT00452153,TERMINATED,INTERVENTIONAL,Too much difficulties to includ patient
NCT00452166,TERMINATED,INTERVENTIONAL,it was not possible to recruit new patients anymore
NCT00452387,TERMINATED,INTERVENTIONAL,Early stopping rule
NCT00452478,TERMINATED,INTERVENTIONAL,This study was stopped by the sponsor based on a non-safety related corporate decision
NCT00452582,TERMINATED,INTERVENTIONAL,Failure to recruit in expected time period.
NCT00452647,TERMINATED,OBSERVATIONAL,data did not indicate any meaningful information
NCT00452738,WITHDRAWN,INTERVENTIONAL,PI left university. Did not start study
NCT00452842,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT00453193,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00453219,WITHDRAWN,OBSERVATIONAL,"prior to participant recruitment, PI left Emory, study stopped"
NCT00453258,TERMINATED,OBSERVATIONAL,Stopped due to low enrollment
NCT00453414,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of enrollment
NCT00453635,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00453817,TERMINATED,INTERVENTIONAL,Feasibility issues
NCT00453856,TERMINATED,INTERVENTIONAL,The study was terminated because of Early Treatment Failure in child.The justification for this decision are concerns about safety of children.
NCT00453869,TERMINATED,OBSERVATIONAL,Few prevalence of liver fibrosis in subjects
NCT00453908,TERMINATED,INTERVENTIONAL,The study was early terminated due to slow and difficult recruitment
NCT00453934,TERMINATED,INTERVENTIONAL,Endpoint no longer deemed meaningful
NCT00453973,TERMINATED,INTERVENTIONAL,Due to more robust long-term data generated in other active-controlled studies
NCT00454012,TERMINATED,INTERVENTIONAL,poor enrolment
NCT00454025,TERMINATED,OBSERVATIONAL,Stopped due to low enrollment
NCT00454155,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00454246,TERMINATED,INTERVENTIONAL,Strategic decision unrelated to safety or efficacy
NCT00454324,TERMINATED,INTERVENTIONAL,slow accrual
NCT00454402,TERMINATED,INTERVENTIONAL,Discontinued due to incomplete recruitment
NCT00454701,TERMINATED,OBSERVATIONAL,"The Sponsor has made a decision, driven by business needs, to cease promotion, manufacturing, distribution and sales of Amevive"
NCT00454714,WITHDRAWN,INTERVENTIONAL,Study not started
NCT00455039,WITHDRAWN,INTERVENTIONAL,This is a duplicate record and the sponsor has submitted under NCT00206427.
NCT00455091,TERMINATED,OBSERVATIONAL,No cases enrollment
NCT00455143,TERMINATED,INTERVENTIONAL,Pilot study initiated to provide support data for main grant GCO 06-0217 funded. only baseline characteristic data collected. no results for this study.
NCT00455182,WITHDRAWN,INTERVENTIONAL,Inability to enroll subjects who were willing to be randomized to control group
NCT00455364,TERMINATED,INTERVENTIONAL,Protocol never received funding.
NCT00455429,TERMINATED,INTERVENTIONAL,The study was stopped due to a non-clinical safety finding.
NCT00455572,TERMINATED,INTERVENTIONAL,Study early termination was due to slow recruitment and difficulties at achieving the required enrolment for the study.
NCT00455611,WITHDRAWN,INTERVENTIONAL,No patients enrolled in the study
NCT00455637,TERMINATED,INTERVENTIONAL,Low levels of recruitment
NCT00455897,TERMINATED,INTERVENTIONAL,Accrual was too slow. Trial terminated
NCT00456105,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of resources of the study coordinator's time
NCT00456248,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00456313,WITHDRAWN,INTERVENTIONAL,lack of data
NCT00456339,TERMINATED,INTERVENTIONAL,Problems recruiting; patient relapse following treatment
NCT00456378,TERMINATED,INTERVENTIONAL,"Business decision, no safety concerns"
NCT00456482,TERMINATED,INTERVENTIONAL,SARS epidemic in Asia and Canada
NCT00456612,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00456638,WITHDRAWN,INTERVENTIONAL,Difficulty aquiring investigational drug
NCT00456703,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00456963,TERMINATED,INTERVENTIONAL,"Because of delay in approval of the protocol by a number of Ethics Commitees the trial was terminated on March 4, 2010. No patient had received any study drug."
NCT00457327,TERMINATED,INTERVENTIONAL,RCT with same hypothesis ended and showed a superiority for protective ileostomy after lower anterior rectum resection.
NCT00457431,TERMINATED,INTERVENTIONAL,interim analysis with stopping for futility
NCT00457470,WITHDRAWN,INTERVENTIONAL,Cancelled before first patient enrolled
NCT00457574,WITHDRAWN,INTERVENTIONAL,Study terminated prematurely due to financial constraints.
NCT00457678,WITHDRAWN,INTERVENTIONAL,Site did not enroll any patients to the study.
NCT00457899,TERMINATED,INTERVENTIONAL,Study terminated due to poor recruitment
NCT00457951,TERMINATED,INTERVENTIONAL,Interim analysis: safety without efficacy ODSH in patients with acute COPD.
NCT00458042,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT00458081,TERMINATED,INTERVENTIONAL,Company decision has been taken in light of recent demands by certain national health authorities
NCT00458159,TERMINATED,INTERVENTIONAL,"The compound has a benign safety profile with short-term use, clinically sig efficacy responses have not been demonstrated, or if so, have not been sustained."
NCT00458276,TERMINATED,INTERVENTIONAL,6 month vital status report not collected after 28 day follow up analysis indicated no difference between placebo \& tezosentan
NCT00458315,WITHDRAWN,INTERVENTIONAL,never been started
NCT00458445,WITHDRAWN,INTERVENTIONAL,This study was stopped by the sponsor before enrollment based on a non-safety related corporate decision.
NCT00458497,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00458549,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00458575,TERMINATED,INTERVENTIONAL,Internal Business Decision
NCT00458744,WITHDRAWN,INTERVENTIONAL,Study withdrawn because of toxicity reported on the adult phase 1 trial.
NCT00458796,TERMINATED,INTERVENTIONAL,Lower than expected recruitment
NCT00458861,TERMINATED,INTERVENTIONAL,Interim analysis of data failed to meet primary endpoint.
NCT00459108,TERMINATED,INTERVENTIONAL,Halted early for futility.
NCT00459225,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting subjects
NCT00459472,TERMINATED,INTERVENTIONAL,Principal investigator left institution.
NCT00459563,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT00459602,TERMINATED,OBSERVATIONAL,Principal Investigator left institution.
NCT00459641,WITHDRAWN,INTERVENTIONAL,Stopped before any site initiation or any recruitment due to change in overall product development plan
NCT00459901,TERMINATED,INTERVENTIONAL,Study halted by drug manufacturer
NCT00460161,SUSPENDED,INTERVENTIONAL,Lack of patients
NCT00460200,WITHDRAWN,OBSERVATIONAL,no patient accrual
NCT00460278,SUSPENDED,INTERVENTIONAL,Enrollment suspended due to low drug exposure.
NCT00460317,TERMINATED,INTERVENTIONAL,Amgen discontinued the development of AMG706 because 20050201 did not meet its primary objective.
NCT00460460,TERMINATED,INTERVENTIONAL,Study was terminated due to low enrollment
NCT00460473,TERMINATED,INTERVENTIONAL,The incidence of post-operative delirium observed from interim blinded data was significantly lower than the current literature in this population.
NCT00460551,TERMINATED,INTERVENTIONAL,Due to considerations regarding the appropriate therapeutic regimen for these patients.
NCT00460824,WITHDRAWN,OBSERVATIONAL,Not a Clinical trial. Retrospective Data review only.
NCT00460837,WITHDRAWN,INTERVENTIONAL,Supply of adequate label was not provided to the MHRA
NCT00460850,TERMINATED,INTERVENTIONAL,Low recruitment rate due to treatment regimen change
NCT00460889,WITHDRAWN,OBSERVATIONAL,Principal Investigator left institution
NCT00460967,SUSPENDED,INTERVENTIONAL,In light of the company's current financial position we have indefinately suspended the Rheo-AMD trial.
NCT00460980,WITHDRAWN,INTERVENTIONAL,Principal investigator left institution.
NCT00461266,WITHDRAWN,INTERVENTIONAL,Slow recruitment
NCT00461344,TERMINATED,INTERVENTIONAL,due to slow recruitment of patients
NCT00461773,TERMINATED,INTERVENTIONAL,Lack of recrual
NCT00461812,TERMINATED,INTERVENTIONAL,by sponsor due to failure to recruit patients who had mild persistent asthma who were not already on Advair 250/50 or 500/50.
NCT00461929,TERMINATED,INTERVENTIONAL,study terminated 12Feb09 due to low recruitment
NCT00462202,TERMINATED,INTERVENTIONAL,Interim analysis of efficacy trial showed no drug efficacy.
NCT00462228,TERMINATED,INTERVENTIONAL,The study was stopped due to a lack of additional subjects.
NCT00462254,TERMINATED,INTERVENTIONAL,Study discontinued.
NCT00462384,TERMINATED,INTERVENTIONAL,Strategic decision unrelated to safety or efficacy
NCT00462865,TERMINATED,INTERVENTIONAL,DSMB determined toxicity of regimen more than originally thought. Slow accrual.
NCT00462904,TERMINATED,INTERVENTIONAL,Xoma to no longer supply drug for the study
NCT00463736,TERMINATED,INTERVENTIONAL,enrollment proceeding too slowly
NCT00463775,WITHDRAWN,INTERVENTIONAL,Recruitment not progressing as planned.
NCT00463801,TERMINATED,INTERVENTIONAL,Because of inadequate accrual.
NCT00463840,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00463853,WITHDRAWN,INTERVENTIONAL,inability to recruit due to administrative difficulties at the site
NCT00464061,TERMINATED,INTERVENTIONAL,Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems
NCT00464113,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00464178,TERMINATED,INTERVENTIONAL,The study was closed early due to poor accrual
NCT00464191,TERMINATED,INTERVENTIONAL,The study has been terminated because too few patients have been recruited
NCT00464347,TERMINATED,INTERVENTIONAL,Study was terminated because of poor enrollment.
NCT00464373,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00464386,TERMINATED,INTERVENTIONAL,Study device required infeasible modifications. No patients received device.
NCT00464451,WITHDRAWN,INTERVENTIONAL,Unable to obtain approval from FDA for use of chloral hydrate
NCT00464490,TERMINATED,INTERVENTIONAL,Lack of eligible participants
NCT00464763,WITHDRAWN,INTERVENTIONAL,The incidence of post-operative delirium observed from interim blinded data in DEX-06-09 was significantly lower than the current literature in this population.
NCT00464854,TERMINATED,INTERVENTIONAL,The study was started before the official request for protocol registration
NCT00464958,TERMINATED,INTERVENTIONAL,Study was stopped as the sponsor is no longer funding this project
NCT00465114,WITHDRAWN,OBSERVATIONAL,"Feasibility issues, only 1 patient recruited."
NCT00465244,WITHDRAWN,INTERVENTIONAL,Inability to recruit subjects
NCT00465257,SUSPENDED,INTERVENTIONAL,Due to lack of malaria patients in Zanzibar the study has been suspended.
NCT00465296,TERMINATED,INTERVENTIONAL,Funding Discontinued
NCT00465348,WITHDRAWN,OBSERVATIONAL,investigator withdrew
NCT00465673,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00465842,TERMINATED,OBSERVATIONAL,Loss of funding due to difficulty with recruitment and participant retention.
NCT00465907,TERMINATED,INTERVENTIONAL,Low accrual
NCT00466713,TERMINATED,INTERVENTIONAL,concern over safety of rosiglitazone in heart failure
NCT00466856,TERMINATED,INTERVENTIONAL,due to slow accrual
NCT00466869,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00466882,WITHDRAWN,OBSERVATIONAL,No patients were enrolled.
NCT00467077,TERMINATED,INTERVENTIONAL,Protocol was closed due to slow accrual.
NCT00467246,WITHDRAWN,INTERVENTIONAL,Ethics approval denied
NCT00467337,TERMINATED,INTERVENTIONAL,Terminated
NCT00467350,TERMINATED,INTERVENTIONAL,concern patients in oral cleaout arm had worse outcome
NCT00467454,WITHDRAWN,INTERVENTIONAL,Funding allocation to different clinical trials.
NCT00467584,TERMINATED,INTERVENTIONAL,Interim analysis indicated treatment unlikely effective;slow recruitment
NCT00467610,TERMINATED,INTERVENTIONAL,lack of efficacy.
NCT00467636,TERMINATED,INTERVENTIONAL,Difficulty recruiting (early discharge scheme initiated)
NCT00467831,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00467896,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00467987,TERMINATED,INTERVENTIONAL,Company no longer making same drug doses.
NCT00468221,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00468260,TERMINATED,INTERVENTIONAL,pts. will be captured in core
NCT00468299,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00468442,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00468611,TERMINATED,INTERVENTIONAL,Negative efficacy results of the MAESTRO-01 study
NCT00468624,TERMINATED,INTERVENTIONAL,recruitment completed
NCT00469053,TERMINATED,INTERVENTIONAL,The trail end was achived according to the definition in the trial protocol
NCT00469118,WITHDRAWN,INTERVENTIONAL,Financial concerns with device manufacturer.
NCT00469404,TERMINATED,INTERVENTIONAL,The trial end was achieved according to the definition in the trial protocol
NCT00469469,WITHDRAWN,INTERVENTIONAL,unable to enroll subjects into the study
NCT00469586,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00469599,TERMINATED,INTERVENTIONAL,"Terminated after 86 pt included, because of recruitment problems"
NCT00469612,TERMINATED,INTERVENTIONAL,Study was stopped due to lack of resources on part of investigators.
NCT00469625,WITHDRAWN,INTERVENTIONAL,Investigator left the Institution.
NCT00469703,TERMINATED,INTERVENTIONAL,Terminated
NCT00469820,TERMINATED,INTERVENTIONAL,low accrual
NCT00469846,TERMINATED,INTERVENTIONAL,Recruitment and follow-up has been completed.
NCT00469937,TERMINATED,INTERVENTIONAL,low accrual
NCT00469963,TERMINATED,INTERVENTIONAL,slow accrual
NCT00469976,WITHDRAWN,INTERVENTIONAL,ECOG will not proceed with activation
NCT00470028,TERMINATED,INTERVENTIONAL,Low recruitment.
NCT00470067,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT00470093,TERMINATED,INTERVENTIONAL,Low accrual
NCT00470249,TERMINATED,INTERVENTIONAL,Due to difficulty in recruitment
NCT00470340,TERMINATED,INTERVENTIONAL,during the study
NCT00470353,TERMINATED,INTERVENTIONAL,Withdrawn due to poor accrual/lack of funding
NCT00470392,TERMINATED,INTERVENTIONAL,Recruiting complete and administrative termination
NCT00470535,TERMINATED,INTERVENTIONAL,This study was terminated earlier due to a phase III study that showed this drug inferior to sorafenib
NCT00470548,TERMINATED,INTERVENTIONAL,Practice patterns with pemetrexed have evolved.
NCT00470639,WITHDRAWN,INTERVENTIONAL,Poor recruitment
NCT00470743,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT00470795,SUSPENDED,INTERVENTIONAL,Protocol to be re-designed (primary outome still GCSI)
NCT00471068,TERMINATED,INTERVENTIONAL,Question raised by Ethics Committee
NCT00471120,TERMINATED,INTERVENTIONAL,Study terminated due to protocol deficiencies.
NCT00471237,TERMINATED,INTERVENTIONAL,Terminated for futility by sponsor after a pre-planned interim review of data
NCT00471367,TERMINATED,INTERVENTIONAL,Part B of the study was terminated early due to a lack of enrollment.
NCT00471653,TERMINATED,OBSERVATIONAL,low accrual
NCT00471692,TERMINATED,INTERVENTIONAL,Due to high incidence of neurological complication in those with ilioinguinal block
NCT00471718,TERMINATED,INTERVENTIONAL,pharmaceutical company closed study because the treatment was not effective
NCT00471744,TERMINATED,INTERVENTIONAL,low patient number after 2 years recruiting
NCT00471809,TERMINATED,INTERVENTIONAL,"The CARE Network DSMB recommended to the NHLBI that the MARS trial be terminated, based on a futility analysis with 55 randomized children."
NCT00472082,TERMINATED,INTERVENTIONAL,This study was terminated at the request of the drug manufacturer.
NCT00472186,TERMINATED,INTERVENTIONAL,Poor compliance with returning of logbooks by families. Two patients were enrolled. Only one returned the logbook and therefore not analyzed
NCT00472264,TERMINATED,OBSERVATIONAL,"Study terminated on Nov 7, 2008 as a result of poor recruitment and changes in business priorities. The decision was not based on safety concerns."
NCT00472355,WITHDRAWN,INTERVENTIONAL,Insufficient study materials
NCT00472433,TERMINATED,INTERVENTIONAL,no eligible patient
NCT00472498,TERMINATED,OBSERVATIONAL,Terminated: No longer recruiting.
NCT00472628,WITHDRAWN,OBSERVATIONAL,Change in company strategy
NCT00472680,TERMINATED,INTERVENTIONAL,Funding didn't support further recruitment
NCT00472706,TERMINATED,INTERVENTIONAL,Study stopped because of disappointing inclusion rates
NCT00472771,WITHDRAWN,INTERVENTIONAL,Terminated due to clinical trial material production delays
NCT00472784,WITHDRAWN,OBSERVATIONAL,Study no longer being conducted.
NCT00472953,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00473005,TERMINATED,INTERVENTIONAL,Principal Investigator (Dr. Guardino) left Stanford
NCT00473408,TERMINATED,OBSERVATIONAL,"Moved to another country, not possible to recruit from abroad."
NCT00473486,TERMINATED,INTERVENTIONAL,Sorafenib administered in the combination with pemetrexed-carboplatin appears to enhance thrombocytopenia compared to historical data.
NCT00473551,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00473616,TERMINATED,INTERVENTIONAL,Termination of the study was made after a full review of program data and assessment of the current risk-benefit profile.
NCT00473824,TERMINATED,INTERVENTIONAL,New sponsor's decision to pursue a redesigned clinical study
NCT00473850,TERMINATED,OBSERVATIONAL,"This study is recruiting under a different title - ""Genotype-Phenotype Correlation of Multiple Hereditary Exostoses: Multicentre Project"" NCT00474331"
NCT00473889,TERMINATED,INTERVENTIONAL,The study was terminated based on the recommendation by the DSMB following a pre-planned protocol interim analysis because the endpoint was not achieved.
NCT00473967,TERMINATED,INTERVENTIONAL,Occurrence of unacceptable adverse events.
NCT00474110,WITHDRAWN,INTERVENTIONAL,Clinical practice had changed between time of initial protocol development and subject recruitment. We were not able to find eligible patients.
NCT00474188,TERMINATED,INTERVENTIONAL,Business decision
NCT00474331,SUSPENDED,OBSERVATIONAL,Due to unavailability of testing for gene mutation
NCT00474409,WITHDRAWN,INTERVENTIONAL,"Due to poor enrollment, this study was withdrawn/ terminated."
NCT00474565,WITHDRAWN,INTERVENTIONAL,Suspended failure to follow Conflict of Interest Management Plan
NCT00474695,TERMINATED,OBSERVATIONAL,IND holder relocated from the University of Utah
NCT00475124,TERMINATED,INTERVENTIONAL,Redundant in-clinic visits increased the workload in virtual follow-up group. An interim analysis showed that the study would not support the primary hypothesis
NCT00475332,TERMINATED,INTERVENTIONAL,PI left our institution
NCT00475527,WITHDRAWN,INTERVENTIONAL,problem of accrual
NCT00475592,WITHDRAWN,INTERVENTIONAL,study failed to recruit
NCT00475605,TERMINATED,OBSERVATIONAL,"Terminated early, endorsed by the FDA based on futility of continuation."
NCT00475631,WITHDRAWN,OBSERVATIONAL,The person who started the study joined medical school
NCT00475657,TERMINATED,INTERVENTIONAL,Terminated due to lack of efficacy
NCT00476255,WITHDRAWN,INTERVENTIONAL,Unfunded
NCT00476515,WITHDRAWN,INTERVENTIONAL,Protocol to be revised
NCT00476554,TERMINATED,INTERVENTIONAL,slow accrual and financial resource limitation
NCT00476580,WITHDRAWN,OBSERVATIONAL,Study terminated.
NCT00476619,TERMINATED,INTERVENTIONAL,The exclusion criteria were stringent and enrollment was slow.
NCT00476697,TERMINATED,INTERVENTIONAL,inactivity
NCT00476827,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00476866,TERMINATED,INTERVENTIONAL,The number of patients desired has been reached
NCT00476983,WITHDRAWN,INTERVENTIONAL,No funding
NCT00476996,TERMINATED,INTERVENTIONAL,"Recruitment was fully completed for this study; however, the study was terminated during conduct after the primary endpoint analysis was completed."
NCT00477087,TERMINATED,INTERVENTIONAL,Low accrual
NCT00477191,TERMINATED,INTERVENTIONAL,Difficulty in recruitment.
NCT00477230,TERMINATED,INTERVENTIONAL,Study terminated based on decision of Sponsor.
NCT00477347,TERMINATED,INTERVENTIONAL,lack of recrutment
NCT00477477,TERMINATED,INTERVENTIONAL,Inadequate enrollment and lack of funds.
NCT00477503,TERMINATED,INTERVENTIONAL,"One participant enrolled, study terminated ."
NCT00477802,TERMINATED,INTERVENTIONAL,Intervention did not appear to be effective in most enrolled patients.
NCT00477867,WITHDRAWN,INTERVENTIONAL,Trial was never activated
NCT00477932,WITHDRAWN,OBSERVATIONAL,Physician's chose to not follow through with the study.
NCT00478036,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00478062,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00478140,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00478244,TERMINATED,INTERVENTIONAL,Competing studies
NCT00478439,TERMINATED,INTERVENTIONAL,Study terminated: Recruitment delay due to equipment malfunction
NCT00478595,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00478673,TERMINATED,INTERVENTIONAL,Enrollment was terminated in June 2008 due to market withdrawal of the NexStent Carotid Stent System.
NCT00478972,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00479011,TERMINATED,INTERVENTIONAL,significant reduction in length of hospital stay (primary endpoint)
NCT00479089,TERMINATED,INTERVENTIONAL,Study halted due to drug sponsor decision to not continue.
NCT00479167,TERMINATED,INTERVENTIONAL,Lack of accrual and interest in study
NCT00479245,TERMINATED,INTERVENTIONAL,"Recruitment rate, lower than expected. Organizational changes made it impossible for recruiting centers to continue"
NCT00479258,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00479466,TERMINATED,INTERVENTIONAL,Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort of the study to assess the safety and efficacy
NCT00479635,TERMINATED,INTERVENTIONAL,Sponsor could no longer support; enrollment stopped August 2008.
NCT00479765,TERMINATED,INTERVENTIONAL,"Sponsor business decision, not based on safety or efficacy data"
NCT00479856,TERMINATED,INTERVENTIONAL,Study was terminated due to difficulty in identifying eligible subjects
NCT00480012,WITHDRAWN,INTERVENTIONAL,"Due to administrative issues, the study was withdrawn."
NCT00480025,TERMINATED,INTERVENTIONAL,The study was terminated following assessment of the lack of efficacy of the study product by the Independent Data monitoring Committee for the study.
NCT00480038,TERMINATED,INTERVENTIONAL,"Recruitment was so slow, that it made the study impossible. Organizational changes made it impossible for recruiting centers to continue recruitment"
NCT00480077,TERMINATED,INTERVENTIONAL,Low enrollment rates
NCT00480103,TERMINATED,INTERVENTIONAL,INHERENT MODIFICATIONS NEEDED BEFORE PROCEEDING
NCT00480311,TERMINATED,OBSERVATIONAL,"Recruitment was so slow, that it made the study impossible. Organizational changes made it impossible for recruiting centers to continue recruitment"
NCT00480545,WITHDRAWN,OBSERVATIONAL,IRB Approval lapsed
NCT00480623,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study drug development
NCT00480857,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT00480935,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00480948,TERMINATED,INTERVENTIONAL,Study design changes were needed due to change of protocol to a multisite trial and updated set up
NCT00480987,TERMINATED,INTERVENTIONAL,Lack of support.
NCT00481429,WITHDRAWN,OBSERVATIONAL,Unable to recruit enough participants
NCT00481585,TERMINATED,OBSERVATIONAL,"study team failed to complete timely reviews, study suspended"
NCT00481624,WITHDRAWN,INTERVENTIONAL,The study was stopped because of lack of funding.
NCT00481832,TERMINATED,INTERVENTIONAL,Accrual Factor
NCT00481845,TERMINATED,INTERVENTIONAL,Low accrual
NCT00481936,TERMINATED,INTERVENTIONAL,Corporate reasons unrelated to safety and efficacy
NCT00482040,TERMINATED,INTERVENTIONAL,Recruiting took longer than expected due to a lack of eligible patients (very strong inclusion and exclusion criterias)
NCT00482053,TERMINATED,INTERVENTIONAL,Low accrual
NCT00482066,TERMINATED,INTERVENTIONAL,Funders withdrew funding due to slow recruitment
NCT00482105,TERMINATED,INTERVENTIONAL,Withdrawn per sponsor and Investigator
NCT00482274,TERMINATED,INTERVENTIONAL,Drug supplier stopped funding due to loss of study drug (docetaxel) patent.
NCT00482287,WITHDRAWN,INTERVENTIONAL,Site did not recruit any patients
NCT00482547,TERMINATED,INTERVENTIONAL,Terminated for futility reasons.
NCT00482625,TERMINATED,INTERVENTIONAL,"The protocol has been completed prematurely (e.g., due to poor accrual, insufficient drug supply, IND closure)."
NCT00482690,TERMINATED,INTERVENTIONAL,primary analyses found unfeasible
NCT00482742,TERMINATED,INTERVENTIONAL,product development was cancelled
NCT00482911,TERMINATED,INTERVENTIONAL,Investigator left the institute.
NCT00483041,TERMINATED,INTERVENTIONAL,Study is replaced by MI-CP198 per CPM.
NCT00483119,TERMINATED,INTERVENTIONAL,Study was terminated due to the death of the PI.
NCT00483171,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00483210,WITHDRAWN,INTERVENTIONAL,The study goals were accomplished by a similar study at UAMS. (W.J. Evans)
NCT00483236,WITHDRAWN,OBSERVATIONAL,Lack of patient recruitment.
NCT00483275,WITHDRAWN,INTERVENTIONAL,No final agreement with sponsor
NCT00483561,TERMINATED,INTERVENTIONAL,PI left UNMC
NCT00483600,WITHDRAWN,INTERVENTIONAL,unable to enroll
NCT00483951,TERMINATED,OBSERVATIONAL,"Per IRB recommendation, a separate protocol will be prepared for retrospective data analysis. The current protocol does not have specific hypotheses."
NCT00483977,TERMINATED,INTERVENTIONAL,Met criteria for study futility at interim analysis
NCT00484146,TERMINATED,OBSERVATIONAL,anticipated number of patients could not be reached
NCT00484172,WITHDRAWN,OBSERVATIONAL,Study Withdrawn due to Investigator leaving
NCT00484536,TERMINATED,INTERVENTIONAL,The study was discontinued due to unfavorable interim analysis
NCT00484601,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00484666,WITHDRAWN,OBSERVATIONAL,PI withdrew from study protocol participation
NCT00484718,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00484822,TERMINATED,INTERVENTIONAL,The study has been halted prematurely due to a low recruitment.
NCT00484887,TERMINATED,OBSERVATIONAL,PI left institution
NCT00485290,TERMINATED,INTERVENTIONAL,"No eligible patients were found, the study stopped without including any patients"
NCT00485472,TERMINATED,INTERVENTIONAL,"Based on the outcome of the planned first interim analysis, it was decided not to continue the trial. No safety concerns were identified."
NCT00485563,TERMINATED,INTERVENTIONAL,Changes in treatment paradigm resulted in a lower than expected rate of accrual.
NCT00485589,TERMINATED,INTERVENTIONAL,"Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA."
NCT00485654,TERMINATED,OBSERVATIONAL,study was terminated because study conclusions varied.
NCT00485966,WITHDRAWN,INTERVENTIONAL,This study was withdrawn prior to patient enrollment
NCT00485992,TERMINATED,OBSERVATIONAL,sufficient data has been collected for significant conclusion
NCT00486057,TERMINATED,OBSERVATIONAL,sufficient data collected for conclusion of retrospective study
NCT00486070,TERMINATED,OBSERVATIONAL,"conclusions drawn, manuscript written"
NCT00486096,TERMINATED,OBSERVATIONAL,sufficient data collected.
NCT00486174,WITHDRAWN,INTERVENTIONAL,primary site withdrew due to competing study: never enrolled any subjects.
NCT00486213,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00486265,TERMINATED,INTERVENTIONAL,AML assess. of response in Part B patients find treatment failure in all 8 evaluable for marrow response following a maximum of 2 induction courses of therapy
NCT00486343,TERMINATED,INTERVENTIONAL,Slower than anticipated enrollment
NCT00486395,TERMINATED,INTERVENTIONAL,Decreasing recruitment
NCT00486447,TERMINATED,INTERVENTIONAL,Accrual
NCT00486512,TERMINATED,INTERVENTIONAL,The overall program was terminated
NCT00486655,TERMINATED,INTERVENTIONAL,Change of Focus for the company
NCT00486759,TERMINATED,INTERVENTIONAL,Due to an unfavorable benefit/risk ratio.
NCT00486798,TERMINATED,INTERVENTIONAL,study was not ethically acceptable to continue and therefore it was finally stopped
NCT00486980,WITHDRAWN,INTERVENTIONAL,"This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised""."
NCT00487071,TERMINATED,INTERVENTIONAL,No financial support
NCT00487162,TERMINATED,INTERVENTIONAL,potential harm of insulin infusion outweights the benefit.
NCT00487279,TERMINATED,INTERVENTIONAL,Study terminated early due to inability to enroll.
NCT00487461,TERMINATED,INTERVENTIONAL,Study PI left the institution and study was stopped at that time.
NCT00487552,TERMINATED,INTERVENTIONAL,Failure to achieve one of the primary endpoints.
NCT00487578,TERMINATED,INTERVENTIONAL,Terminated October 2009 (in 4th year) due to low enrollment and anticipated drug expiration November 2009.
NCT00487799,WITHDRAWN,INTERVENTIONAL,Facet no longer has ownership of ularitide.
NCT00487851,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT00487903,TERMINATED,INTERVENTIONAL,Discontinued PB127 development program for business reasons
NCT00487981,TERMINATED,INTERVENTIONAL,Insufficient Data Collected
NCT00488059,TERMINATED,INTERVENTIONAL,This study was terminated early due to poor enrollment.
NCT00488332,TERMINATED,OBSERVATIONAL,Terminated due to slow accrual.
NCT00488384,WITHDRAWN,INTERVENTIONAL,lack of subjects
NCT00488553,WITHDRAWN,OBSERVATIONAL,"No participants recruited, study discontinued."
NCT00488605,WITHDRAWN,INTERVENTIONAL,This is a duplicate record and the sponsor has registered the study.
NCT00488644,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00488670,TERMINATED,INTERVENTIONAL,Dr. Rabheru left VCH last year and the study was cancelled according to his research coordinator.
NCT00488774,TERMINATED,INTERVENTIONAL,"Protocol was cancelled by company based on overall efficacy, no safety concern"
NCT00488891,TERMINATED,OBSERVATIONAL,The study was terminated because it was not enrolling at the expected rate
NCT00488930,TERMINATED,OBSERVATIONAL,Terminated due to a lack of recruitment and decision by the PI not to continue.
NCT00489216,TERMINATED,INTERVENTIONAL,insufficient accrual/funding withdrawn
NCT00489281,TERMINATED,INTERVENTIONAL,Initiation of CMS BMT study for sickle-cell disease operating under NCT01166009 made further accrual to this study impossible.
NCT00489398,WITHDRAWN,INTERVENTIONAL,Protocol changes
NCT00489658,TERMINATED,INTERVENTIONAL,"Because of unexpectedly reduced disease prevalence in the study area, a pragmatic decision was taken to terminate recruitment in March 2003."
NCT00489710,WITHDRAWN,INTERVENTIONAL,safety reasons
NCT00490061,TERMINATED,INTERVENTIONAL,Poor accrual.
NCT00490100,TERMINATED,INTERVENTIONAL,Insufficient patient participation
NCT00490113,WITHDRAWN,INTERVENTIONAL,Drug unavailable
NCT00490126,TERMINATED,OBSERVATIONAL,Not enough staff
NCT00490490,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00490568,TERMINATED,INTERVENTIONAL,Based on preliminary parent study results
NCT00490776,TERMINATED,INTERVENTIONAL,Recruitment was stopped on 15 June 2009 (early termination date) due to low prevalence of study population and slow accrual.
NCT00491075,TERMINATED,INTERVENTIONAL,Closed early for poor accrual.
NCT00491153,TERMINATED,OBSERVATIONAL,due to low recruitment rate secondary to very stringent inclusion criteria
NCT00491348,TERMINATED,INTERVENTIONAL,Change of MRI mode
NCT00491374,TERMINATED,INTERVENTIONAL,Very poor enrollment
NCT00491387,TERMINATED,INTERVENTIONAL,Adverse events reported with beta-blockers as primary therapy.
NCT00491400,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00491621,TERMINATED,INTERVENTIONAL,No enough inclusion. The aim is no longer relevant. The sponsor decided to stop this study.
NCT00491699,TERMINATED,INTERVENTIONAL,The study was stopped due to safety concerns
NCT00491738,TERMINATED,INTERVENTIONAL,"Based on the data collected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated."
NCT00491751,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00491907,TERMINATED,INTERVENTIONAL,recruitment is finished
NCT00491959,TERMINATED,INTERVENTIONAL,Due to unstalbe cell sheet quality. We didn't use this tech on patients.
NCT00492154,TERMINATED,OBSERVATIONAL,the study stopped because we could not recruit enough patients.
NCT00492219,TERMINATED,INTERVENTIONAL,No longer have access to equipment used for functional data collection
NCT00492271,TERMINATED,INTERVENTIONAL,Unfavourable Pharmakokinetics
NCT00492388,TERMINATED,INTERVENTIONAL,Business decision not to continue development
NCT00492531,TERMINATED,INTERVENTIONAL,Subjects on drug were more likely to have severe pain crises requiring hospitalization.
NCT00492843,TERMINATED,INTERVENTIONAL,It is too difficult to recruit suitable patients.
NCT00492947,WITHDRAWN,INTERVENTIONAL,major amendments in progress
NCT00493025,TERMINATED,INTERVENTIONAL,Closed due to early stopping rule-Low accrual
NCT00493038,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to slow enrollment beyond the planned study timelines.
NCT00493376,TERMINATED,OBSERVATIONAL,This study was a companion study to another one. The other study closed early so this one did as well.
NCT00493428,WITHDRAWN,INTERVENTIONAL,The study have been stoped because the protocol is going to be modify.
NCT00493454,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00493584,TERMINATED,INTERVENTIONAL,Due to insufficient patient inclusion the study has been stopped prematurely.
NCT00493610,SUSPENDED,INTERVENTIONAL,"Collaborator no longer interested, short of funds"
NCT00493675,WITHDRAWN,INTERVENTIONAL,Difficulties in getting suitable applicators for biodegradable stents.
NCT00493766,TERMINATED,INTERVENTIONAL,Because of a strategic decision by Novartis
NCT00493805,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00493831,TERMINATED,INTERVENTIONAL,primary analyses found futile
NCT00493857,TERMINATED,INTERVENTIONAL,Cohort 2 not going forward. Manadate changes in Company
NCT00493896,TERMINATED,INTERVENTIONAL,low enrollment
NCT00493974,TERMINATED,INTERVENTIONAL,Lack of feasibility due to low recruitment
NCT00494026,TERMINATED,INTERVENTIONAL,"Study stopped early based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC."
NCT00494156,WITHDRAWN,INTERVENTIONAL,Study halted prematurely prior to enrollment of first participant.
NCT00494338,TERMINATED,INTERVENTIONAL,due to celecoxib safety issues
NCT00494533,TERMINATED,INTERVENTIONAL,Safety issues related to outpatient intravenous infusion in India
NCT00494611,TERMINATED,INTERVENTIONAL,Unable to recruit subjects in timely fashion for the study
NCT00494637,TERMINATED,INTERVENTIONAL,Not reaching recruitment and endpoint goals
NCT00494663,TERMINATED,INTERVENTIONAL,Program Terminated
NCT00495053,TERMINATED,INTERVENTIONAL,Slow enrollment and financial issues
NCT00495365,TERMINATED,INTERVENTIONAL,This study was stopped due to slow enrollment
NCT00495378,TERMINATED,INTERVENTIONAL,This study was stopped due to slow enrollment after enrolling 25 of 200 patients.
NCT00495521,TERMINATED,INTERVENTIONAL,Efforts at recruitment have halted as recruitment was poor
NCT00495716,TERMINATED,INTERVENTIONAL,Investigator relocated and study funding ended.
NCT00496002,TERMINATED,INTERVENTIONAL,The study was terminated in the interest of patient safety.
NCT00496067,TERMINATED,INTERVENTIONAL,Data required further pilot work to be undertaken.
NCT00496080,TERMINATED,INTERVENTIONAL,Trial terminated early due to results from a similar study.
NCT00496158,TERMINATED,INTERVENTIONAL,The study was terminated in the interest of patient safety.
NCT00496223,TERMINATED,INTERVENTIONAL,toxicities required dose reduction compromising effectiveness and PI left Moffitt
NCT00496314,TERMINATED,OBSERVATIONAL,Terminated for lack of resources to complete.
NCT00496379,TERMINATED,INTERVENTIONAL,This study has closed to accrual early due to slow accrual.
NCT00496431,TERMINATED,INTERVENTIONAL,Study accrual was stopped earlier than planned by the Sponsor for 2 main reasons: very slow recruitment rate; lower than estimated efficacy of the drug when delivered as single agent.
NCT00496743,TERMINATED,INTERVENTIONAL,The study was discontinued after the first 10 patients because of discouraging results.
NCT00496756,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT00496782,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00496899,TERMINATED,OBSERVATIONAL,The study was stopped prematurally due to low recruiting
NCT00496964,TERMINATED,INTERVENTIONAL,Insufficient recruitment in a reasonable time + expiration of study medication
NCT00497471,TERMINATED,INTERVENTIONAL,Follow-up end in 1999
NCT00497640,WITHDRAWN,INTERVENTIONAL,"Study was terminated due to lack of interest from subjects and no funding, only 1 subject signed consent but did not participate."
NCT00497679,TERMINATED,INTERVENTIONAL,Study is now terminated due to technical difficulties with administration of study drug in this patient population with this schedule
NCT00497731,TERMINATED,INTERVENTIONAL,Efficacy seen in the solid tumour patient population was not sufficient to continue research with AZD1152 monotherapy in solid tumors at that time.
NCT00497926,TERMINATED,INTERVENTIONAL,living donor kidney program terminated due to slow pace of phase 3 study enrollment
NCT00497952,WITHDRAWN,INTERVENTIONAL,all clinical development programs terminated by sponsor
NCT00498004,TERMINATED,INTERVENTIONAL,difficult to recruit subject
NCT00498121,TERMINATED,OBSERVATIONAL,One of the principal investigators has moved to a different institution
NCT00498212,TERMINATED,INTERVENTIONAL,Voluntary halt due to an FDA Clinical Hold issued in relation to DV2-HBV-10.
NCT00498433,TERMINATED,INTERVENTIONAL,Early termination resulted from interim analysis of the ALTITUDE trial
NCT00498485,TERMINATED,INTERVENTIONAL,Withdrawal of support.
NCT00498810,TERMINATED,INTERVENTIONAL,patients had to be converted to the other study arm
NCT00498914,TERMINATED,INTERVENTIONAL,Futility boundary at interim analysis not met
NCT00498940,TERMINATED,INTERVENTIONAL,Accrual too slow; grant renewal unlikely; AAI as effective as BiV in Phase III
NCT00499174,TERMINATED,INTERVENTIONAL,Not meeting accrual target.
NCT00499239,TERMINATED,INTERVENTIONAL,Unacceptable safety profile
NCT00499369,TERMINATED,INTERVENTIONAL,"Due to inadequate accrual, study was terminated and limited outcome data was reported."
NCT00499382,TERMINATED,OBSERVATIONAL,Slow accrual; study terminated.
NCT00499551,WITHDRAWN,INTERVENTIONAL,The drug needed for the study is not available in Mexico anymore.
NCT00499668,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT00499681,TERMINATED,INTERVENTIONAL,slow accrual
NCT00499733,TERMINATED,INTERVENTIONAL,The study was terminated per PI decision.
NCT00499889,TERMINATED,INTERVENTIONAL,Support issue.
NCT00499902,TERMINATED,INTERVENTIONAL,CO Phase 2 data did not show sufficient improvement in cath opening at higher dose/concentration evaluated. Nuvelo ended further clinical dev of alfimeprase.
NCT00500045,TERMINATED,INTERVENTIONAL,The PI retired/left the institution. Efforts were made to contact the PI but were unsuccessful.
NCT00500084,TERMINATED,INTERVENTIONAL,Sponsor decision.
NCT00500240,TERMINATED,INTERVENTIONAL,Terminated early due to futility.
NCT00500500,TERMINATED,INTERVENTIONAL,Inability to recruit sufficient number of patients
NCT00500669,TERMINATED,INTERVENTIONAL,Recruitement too slow
NCT00500890,TERMINATED,INTERVENTIONAL,PI has left the institution
NCT00501345,TERMINATED,INTERVENTIONAL,"Low accrual, study terminated."
NCT00501371,TERMINATED,INTERVENTIONAL,"Study terminated for re-design. A new IND study (US FDA, July 2009) will be conducted in US and Taiwan. Termination not related to safety concerns."
NCT00502268,WITHDRAWN,INTERVENTIONAL,study never initiated
NCT00502372,TERMINATED,INTERVENTIONAL,VA never granted approval following suspension of enrollment.
NCT00502554,TERMINATED,INTERVENTIONAL,insufficient patient recruitment and ECP capacity
NCT00502619,TERMINATED,INTERVENTIONAL,Inadequate recruitment of study subjects and inadequate retention.
NCT00502814,TERMINATED,OBSERVATIONAL,Sample size too small for data analysis.
NCT00502918,TERMINATED,OBSERVATIONAL,The study was terimnated - low rate of cases
NCT00503009,TERMINATED,INTERVENTIONAL,lack of data
NCT00503100,TERMINATED,OBSERVATIONAL,Difficulties in recruiting
NCT00503321,TERMINATED,INTERVENTIONAL,Patients' enrollment was not sufficient.
NCT00503516,TERMINATED,INTERVENTIONAL,Difficulties to recruit the patients following the inclusion criteria
NCT00503672,WITHDRAWN,OBSERVATIONAL,Data from the Actigraph devices could no longer be read/analyzed
NCT00503698,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00503763,WITHDRAWN,INTERVENTIONAL,We found out that there is another study on the same issue
NCT00503776,TERMINATED,INTERVENTIONAL,funding became unavailable
NCT00503841,TERMINATED,INTERVENTIONAL,"All enrolled participants were screen failures, no data were collected for outcome measures."
NCT00503867,TERMINATED,INTERVENTIONAL,Low patient recruitment
NCT00503880,TERMINATED,INTERVENTIONAL,Genzyme discontinued Funding
NCT00503919,WITHDRAWN,INTERVENTIONAL,Study closed early with no enrollment.
NCT00503932,WITHDRAWN,INTERVENTIONAL,No participant enrollment.
NCT00503984,TERMINATED,INTERVENTIONAL,Withdrawal of Funding
NCT00504088,TERMINATED,INTERVENTIONAL,Company decision to halt study
NCT00504101,WITHDRAWN,INTERVENTIONAL,Temporarily closed to accrual pending availablity of drug.
NCT00504205,TERMINATED,INTERVENTIONAL,Withdrawn as trial was never activated by SuperGen
NCT00504244,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00504322,WITHDRAWN,INTERVENTIONAL,No funding available.
NCT00504452,TERMINATED,INTERVENTIONAL,"Corroboration of supporting in vitro data

- Data successfully corroborated 2009"
NCT00504491,WITHDRAWN,INTERVENTIONAL,IMP new owner decision
NCT00504699,TERMINATED,INTERVENTIONAL,The PI left the Institution.
NCT00504842,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00504855,TERMINATED,INTERVENTIONAL,"Staffing changes resulted in the expiration of IRB approval (2/15/12), and recruitment halted (n=84). IRB approval is now current for retrospective analysis."
NCT00504894,TERMINATED,INTERVENTIONAL,One study drug (thiopental) became commercially unavailable
NCT00504985,TERMINATED,OBSERVATIONAL,Low Accrual
NCT00505258,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to lack of an appropriate patient population.
NCT00505414,TERMINATED,INTERVENTIONAL,"Recall of rescue medication, alternative rescue medication availability issues."
NCT00505492,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00505531,TERMINATED,OBSERVATIONAL,Not enough data to analyze the results.
NCT00505622,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy.
NCT00505635,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00505648,TERMINATED,INTERVENTIONAL,Side effects valuation
NCT00505661,TERMINATED,INTERVENTIONAL,Terminated due to slow patient accrual.
NCT00505791,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients
NCT00505856,TERMINATED,OBSERVATIONAL,Resident project--resident left institution and was not picked up by anyone else
NCT00505921,TERMINATED,INTERVENTIONAL,Slow Accrual.
NCT00505947,TERMINATED,INTERVENTIONAL,The number of the anticipated participants was not achieved
NCT00506012,TERMINATED,INTERVENTIONAL,Slow Recruitment of eligible patients
NCT00506064,TERMINATED,INTERVENTIONAL,Terminated due to low accrual.
NCT00506090,WITHDRAWN,INTERVENTIONAL,Because of unsatisfactory results of previous trial which assessed the effect of different onset times of PDL on surgical scars.
NCT00506168,TERMINATED,INTERVENTIONAL,The study drugs are not covered anymore by insurance.
NCT00506324,TERMINATED,OBSERVATIONAL,Physician deceased
NCT00506363,TERMINATED,INTERVENTIONAL,The trial was terminated on May 2008 after inclusion of 10 patients due to low recruitment and patient compliance.
NCT00506662,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00506675,TERMINATED,INTERVENTIONAL,Poor enrollment and infeasibility of ever reaching the necessary sample size
NCT00506701,WITHDRAWN,INTERVENTIONAL,due to lack of finance
NCT00506779,TERMINATED,INTERVENTIONAL,the study was terminated early due to poor enrollment
NCT00506909,TERMINATED,INTERVENTIONAL,Break in funding
NCT00506948,TERMINATED,INTERVENTIONAL,Halted due to high incidence of veno-oclusive disease of the liver.
NCT00507312,TERMINATED,INTERVENTIONAL,Suspended while we determine if usable data can be collected from this device.
NCT00507325,TERMINATED,OBSERVATIONAL,Per PI
NCT00507390,WITHDRAWN,INTERVENTIONAL,funding not secured
NCT00507429,TERMINATED,INTERVENTIONAL,Low rate of subject accrual
NCT00507637,TERMINATED,INTERVENTIONAL,primary efficacy endpoint not attainable.
NCT00507702,TERMINATED,OBSERVATIONAL,Improving assay methods
NCT00507806,TERMINATED,INTERVENTIONAL,for administrative reasons
NCT00507897,TERMINATED,OBSERVATIONAL,The received reliability with increase in quantity of participants of research did not vary
NCT00508118,TERMINATED,INTERVENTIONAL,3/7 subjects experienced hypotension. Study was terminated.
NCT00508157,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00508248,WITHDRAWN,INTERVENTIONAL,Funding
NCT00508274,TERMINATED,INTERVENTIONAL,Primary analysis was completed in 2015 and data collection post 1-Jul-2019 was not reportable due to local regulations in China.
NCT00508313,WITHDRAWN,OBSERVATIONAL,Study closed early without enrollment.
NCT00508430,TERMINATED,INTERVENTIONAL,An independent DMC determined continuation was unlikely to demonstrate a statistically significant advantage of ASP8825 over placebo on the primary endpoint
NCT00508456,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00508560,TERMINATED,INTERVENTIONAL,Stopped due to low recruitment.
NCT00508651,TERMINATED,INTERVENTIONAL,The study was closed prior to enrollment of Cohort 2 due to a non-safety related sponsor decision.
NCT00508872,TERMINATED,INTERVENTIONAL,"Slow accrual, study terminated."
NCT00508898,WITHDRAWN,INTERVENTIONAL,Funding problem; trial abandoned.
NCT00509119,WITHDRAWN,OBSERVATIONAL,"Change of workplace for leading investigator, not replaced"
NCT00509197,TERMINATED,INTERVENTIONAL,Inability to complete the recruitment.
NCT00509249,TERMINATED,INTERVENTIONAL,Early termination for discouraging results
NCT00509340,TERMINATED,INTERVENTIONAL,Inability to recruit enough eligible participants at study site.
NCT00509366,TERMINATED,INTERVENTIONAL,Study terminated due to reproducibility issues with genomics prediction model.
NCT00509496,TERMINATED,INTERVENTIONAL,Low accrual
NCT00509600,TERMINATED,INTERVENTIONAL,Slow enrollment; study terminated.
NCT00509756,TERMINATED,INTERVENTIONAL,Please see termination statement in the detailed description.
NCT00509834,WITHDRAWN,INTERVENTIONAL,Patient population not available
NCT00509847,WITHDRAWN,INTERVENTIONAL,conduct (recruitment) not feasible within timeframe
NCT00509925,TERMINATED,INTERVENTIONAL,See detailed description
NCT00510081,WITHDRAWN,INTERVENTIONAL,The study was not executed. No subjects were enrolled.
NCT00510198,TERMINATED,INTERVENTIONAL,Study enrollment significantly below protocol expectation
NCT00510224,TERMINATED,INTERVENTIONAL,Stopped at interim analyses phase due to lack of efficacy
NCT00510289,TERMINATED,INTERVENTIONAL,Early closure of study due to poor response
NCT00510627,WITHDRAWN,INTERVENTIONAL,Boston Scientific has decided to close the Study.
NCT00510731,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT00510887,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00511017,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00511043,TERMINATED,INTERVENTIONAL,Manufacturer stopped drug development
NCT00511134,TERMINATED,INTERVENTIONAL,Study has been terminated due low recruitment of participant population.
NCT00511160,TERMINATED,INTERVENTIONAL,Study suspended due to logistical/personnel difficulties
NCT00511186,TERMINATED,INTERVENTIONAL,sufficient POC to switch development from bovine AP to recombinant AP
NCT00511212,WITHDRAWN,INTERVENTIONAL,No eligible patient.
NCT00511329,TERMINATED,INTERVENTIONAL,PI left the institution
NCT00511563,WITHDRAWN,INTERVENTIONAL,Cancelled before active due to the results of emerging scientific data
NCT00511576,TERMINATED,INTERVENTIONAL,Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103. All Celgene-sponsored trials with MGCD0103 will be closed.
NCT00511628,TERMINATED,OBSERVATIONAL,Due to the achievement of minimum required sample size and new changes in local regulations.
NCT00511745,TERMINATED,OBSERVATIONAL,Due to the achievement of minimum required sample size and new changes in local regulations.
NCT00511758,TERMINATED,OBSERVATIONAL,Low accrual rate.
NCT00511888,TERMINATED,OBSERVATIONAL,is finish
NCT00511901,TERMINATED,INTERVENTIONAL,Study enrollment was suspended in response to an FDA alert regarding the study drug. The study was subsequently terminated
NCT00511966,TERMINATED,OBSERVATIONAL,Due to the achievement of minimum required sample size and new changes in local regulations.
NCT00512031,TERMINATED,OBSERVATIONAL,Investigator left institution
NCT00512044,WITHDRAWN,INTERVENTIONAL,"slow recruitment, internal problems with the study protocol"
NCT00512148,TERMINATED,INTERVENTIONAL,24 months follow up completed without substantial change to the profile.
NCT00512369,TERMINATED,OBSERVATIONAL,Investigator left institution
NCT00512460,TERMINATED,INTERVENTIONAL,Study was closed due to loss of industry sponsorship
NCT00512538,TERMINATED,INTERVENTIONAL,Interruption of business relations between Study Sponsor and Device Manufacturer
NCT00512577,TERMINATED,INTERVENTIONAL,Study was terminated by Trial Steering Committee.
NCT00512655,TERMINATED,INTERVENTIONAL,Extremely difficult recruitment. Preliminary analysis showed no effect of the intervention.
NCT00512798,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of efficacy
NCT00512980,TERMINATED,INTERVENTIONAL,lower recruitment rates as expected
NCT00513253,WITHDRAWN,INTERVENTIONAL,It was determined not to be needed based on the clinical development plan of Tykerb.
NCT00513305,TERMINATED,INTERVENTIONAL,Study has been stopped by sponsor decision
NCT00513318,TERMINATED,OBSERVATIONAL,Insufficient enrollment to justify keeping open.
NCT00513513,TERMINATED,INTERVENTIONAL,Poor recruitment.
NCT00513552,WITHDRAWN,INTERVENTIONAL,No patient
NCT00513747,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00513864,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00514189,TERMINATED,INTERVENTIONAL,Terminated early due to slow accrual.
NCT00514202,TERMINATED,INTERVENTIONAL,Investigator left UTHSC-Houston
NCT00514332,TERMINATED,INTERVENTIONAL,enrolling participants stopped
NCT00514566,TERMINATED,INTERVENTIONAL,Unacceptable incidence of wound dehiscence in the PDS group
NCT00514618,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00514722,TERMINATED,INTERVENTIONAL,low accrual
NCT00514813,TERMINATED,INTERVENTIONAL,The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA
NCT00514891,TERMINATED,INTERVENTIONAL,Reccomended by DSMB after review of planned interim analyses.
NCT00514917,TERMINATED,INTERVENTIONAL,"Company decision to discontinue the study, not due to any safety or efficacy concerns"
NCT00515086,TERMINATED,INTERVENTIONAL,Early termination due to slow enrollment and protocol-defined stopping rule.
NCT00515099,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00515112,TERMINATED,INTERVENTIONAL,This study has been terminated due to poor accrual
NCT00515138,TERMINATED,INTERVENTIONAL,Investigator left institution. 7 patients accrued and there is insufficient data to analyze.
NCT00515255,TERMINATED,INTERVENTIONAL,Recruitment Goal of 20 Not Met
NCT00515489,TERMINATED,OBSERVATIONAL,Due to the achievement of minimum required sample size and new changes in local regulations.
NCT00515528,TERMINATED,INTERVENTIONAL,The immune monitoring data failed to demonstrate an improvement in any biologic endpoint with denileukin diftitox.
NCT00515580,TERMINATED,INTERVENTIONAL,"Results from first few subjects was not significantly improved over standard, traditional procedures."
NCT00515684,WITHDRAWN,INTERVENTIONAL,Side effect can increase the risk of the research
NCT00515736,TERMINATED,INTERVENTIONAL,enrollment was completed
NCT00515788,TERMINATED,INTERVENTIONAL,Study terminated due to slow accrual with no expansion to additional phase.
NCT00515970,SUSPENDED,INTERVENTIONAL,Problems with the electronic data collection program
NCT00516191,WITHDRAWN,INTERVENTIONAL,low accrual
NCT00516269,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00516282,TERMINATED,INTERVENTIONAL,"The pharmaceutical collaborator filed for bankruptcy and as a result, the study was unable to move into the phase II portion."
NCT00516308,TERMINATED,INTERVENTIONAL,Other
NCT00516399,TERMINATED,INTERVENTIONAL,The DSMC decided it appeared futile to attempt to demonstrate non-inferiority of povidone-iodine to Natamycin.
NCT00516516,TERMINATED,INTERVENTIONAL,"Low interest in study, slow recruitment"
NCT00516542,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of accrual
NCT00516685,TERMINATED,INTERVENTIONAL,"Due to inability of patient enrollment, decision taken to terminate in the interests of patients and later Malaysia is incorporated into global Phase 3 trial."
NCT00516750,TERMINATED,INTERVENTIONAL,Withdrawn due to lack of enrollment.
NCT00516841,TERMINATED,INTERVENTIONAL,Decision to terminate recruitment based on lack of efficacy
NCT00517075,TERMINATED,INTERVENTIONAL,Unable to adequately recruit subjects.
NCT00517231,WITHDRAWN,OBSERVATIONAL,The investigator left the research center and the study was not carried out
NCT00517361,TERMINATED,INTERVENTIONAL,This study has been terminated due to poor accrual
NCT00517491,WITHDRAWN,INTERVENTIONAL,Administrative reasons
NCT00517582,TERMINATED,INTERVENTIONAL,This study was stopped to allow initiation of a mult-center study
NCT00517699,TERMINATED,INTERVENTIONAL,Study was terminated early due to lack of enrollment.
NCT00517751,TERMINATED,INTERVENTIONAL,Due to Medtronic's voluntary withdrawal of PMA P040001 for X-STOP systems; post-approval study costs outweighed business benefits for marketing X-STOP in US.
NCT00517881,TERMINATED,INTERVENTIONAL,The study was terminated due to the slow recruitment rate.
NCT00518193,TERMINATED,INTERVENTIONAL,high rate of medullar aplasia with infectious troubles.
NCT00518245,TERMINATED,INTERVENTIONAL,Low rate of patient recruitment. Cannot achieve sample size.
NCT00518284,TERMINATED,INTERVENTIONAL,"Study was terminated due to changing sponsor priorities, and was not based on safety or outcomes data."
NCT00518869,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00519090,TERMINATED,INTERVENTIONAL,This study was terminated due to limited enrollment.
NCT00519272,TERMINATED,OBSERVATIONAL,Requested by PI during yearly Continuing Review
NCT00519493,TERMINATED,INTERVENTIONAL,Issues with application of Clozex intervention
NCT00519532,TERMINATED,INTERVENTIONAL,Due to clinical trial supplies shortage
NCT00519584,TERMINATED,INTERVENTIONAL,Collected study data was not usable due to process miscommunications
NCT00519831,TERMINATED,INTERVENTIONAL,Drug unavailable
NCT00520026,TERMINATED,INTERVENTIONAL,number of enrolled individuals after 5 years still off the estimated sample size
NCT00520325,WITHDRAWN,INTERVENTIONAL,Sponsor decision to terminate the study
NCT00520364,TERMINATED,OBSERVATIONAL,PI left the Institution.
NCT00520533,TERMINATED,INTERVENTIONAL,Closed prematurely due to toxicity
NCT00520624,WITHDRAWN,INTERVENTIONAL,No patients willing to join
NCT00520845,TERMINATED,INTERVENTIONAL,slow accrual
NCT00520975,TERMINATED,INTERVENTIONAL,Closed early due to slow accrual
NCT00521092,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT00521274,TERMINATED,INTERVENTIONAL,Oxford BioMedica halted TroVax injections
NCT00521391,TERMINATED,INTERVENTIONAL,End of the recruitment
NCT00521781,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00521820,TERMINATED,INTERVENTIONAL,Higher incidence of hospitalization for congestive heart failure in pioglitazone-treated subjects compared to glyburide treated subjects.
NCT00521885,TERMINATED,INTERVENTIONAL,Study stopped due to lack of accrual
NCT00521924,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00521963,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT00521989,TERMINATED,INTERVENTIONAL,"CRx-102-006 study results, negative"
NCT00522080,TERMINATED,OBSERVATIONAL,terminated study
NCT00522171,TERMINATED,OBSERVATIONAL,This study was terminated early due to lack of adequate enrollment.
NCT00522249,TERMINATED,INTERVENTIONAL,PI decision
NCT00522392,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00522418,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00522444,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00522457,TERMINATED,INTERVENTIONAL,"change in development plan, not due to safety concerns."
NCT00522548,TERMINATED,INTERVENTIONAL,enrollment halted in order to have all patients complete follow-up by Jan 2011
NCT00522574,TERMINATED,INTERVENTIONAL,Due to emerging safety data
NCT00522639,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00522691,WITHDRAWN,INTERVENTIONAL,slow recruitment
NCT00522808,TERMINATED,INTERVENTIONAL,Need for re-formulation
NCT00522938,TERMINATED,INTERVENTIONAL,Very poor recruitment of patients to the study
NCT00522990,TERMINATED,INTERVENTIONAL,Recommended Phase II dose determined
NCT00523042,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00523055,TERMINATED,INTERVENTIONAL,Clinical volume of patients for recruitment stopped.
NCT00523094,SUSPENDED,OBSERVATIONAL,Enrollment was too slow and principal investigator moved to another country
NCT00523328,TERMINATED,INTERVENTIONAL,Analysis of data from 104RA203 failed to meet primary endpoint.
NCT00523367,TERMINATED,INTERVENTIONAL,terminated due to enrollment
NCT00523458,TERMINATED,INTERVENTIONAL,"A delay in protocol approval and approval of laboratory sites in Salvador, Brazil left too little time for completion of enrollment into the study."
NCT00523497,TERMINATED,INTERVENTIONAL,Interim analysis of the present study showed a significant decrease in mortality rate (p= 0.04) as well as in the number of days at the ICU p=0.0002.
NCT00523640,TERMINATED,INTERVENTIONAL,Too slow accrual
NCT00523705,TERMINATED,INTERVENTIONAL,Enrollment too slow.
NCT00523809,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00523939,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00524030,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00524069,WITHDRAWN,INTERVENTIONAL,Withdrawn due to no accrual
NCT00524095,TERMINATED,INTERVENTIONAL,we decided not to go on treatment phase
NCT00524134,TERMINATED,INTERVENTIONAL,PI left the institution.
NCT00524186,TERMINATED,INTERVENTIONAL,PI left institute
NCT00524225,TERMINATED,INTERVENTIONAL,Recruitment slow as single center conducting in rare disease
NCT00524316,TERMINATED,INTERVENTIONAL,low accrual
NCT00524394,TERMINATED,OBSERVATIONAL,recruitment not possible
NCT00524459,TERMINATED,INTERVENTIONAL,Terminated by sponsor due to lack of funding
NCT00524485,TERMINATED,INTERVENTIONAL,Withdrawn due to low accrual
NCT00524511,TERMINATED,INTERVENTIONAL,"Poor enrollment, much data was missing as patients were lost to follow up"
NCT00524589,TERMINATED,INTERVENTIONAL,closed due to futility
NCT00524667,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual.
NCT00524862,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00525083,TERMINATED,OBSERVATIONAL,PI left for another institution
NCT00525109,TERMINATED,OBSERVATIONAL,Unable to complete enrollment due lack of family interest.
NCT00525135,TERMINATED,INTERVENTIONAL,PI left university and study was halted prematurely. No data was analyzed.
NCT00525161,TERMINATED,INTERVENTIONAL,Slow accrual and loss of funding
NCT00525408,TERMINATED,INTERVENTIONAL,Interim Analysis report indicates trial futility
NCT00525434,TERMINATED,INTERVENTIONAL,sponsor has decide to pospone this study
NCT00525928,WITHDRAWN,INTERVENTIONAL,insufficient recuirment
NCT00525941,WITHDRAWN,INTERVENTIONAL,Study discontinued due to Approvable decision
NCT00526071,TERMINATED,INTERVENTIONAL,The Sponsor (Amicus Therapeutics) terminated this study for logistical reasons.
NCT00526344,WITHDRAWN,OBSERVATIONAL,"No funding, study not done"
NCT00526591,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00526604,TERMINATED,INTERVENTIONAL,"The study was stopped, as the another multicentre-RCT on the same patients started."
NCT00526643,TERMINATED,INTERVENTIONAL,scarce enrolment and presentation of positive results of similar study in June 2012.
NCT00526786,TERMINATED,INTERVENTIONAL,Business Reasons
NCT00526799,TERMINATED,INTERVENTIONAL,Study closed to accrual due unfavorable interim analysis
NCT00526838,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00526890,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT00527124,TERMINATED,INTERVENTIONAL,Closure was recommended by CTEP due to slow accrual.
NCT00527397,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00527410,TERMINATED,INTERVENTIONAL,Business Decision
NCT00527436,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00527644,TERMINATED,INTERVENTIONAL,Insufficient funding to complete study
NCT00527670,TERMINATED,OBSERVATIONAL,PI left institution
NCT00527696,TERMINATED,INTERVENTIONAL,statistical Significance was reached for primary outcome
NCT00527709,WITHDRAWN,OBSERVATIONAL,The study was a retrospective chart review and was mistakenly registered in ClinicalTrials.gov
NCT00527748,TERMINATED,INTERVENTIONAL,Investigator left institution. No data analysis completed.
NCT00527878,TERMINATED,INTERVENTIONAL,Failure to enroll adequate patient numbers due to small number of eligible patients
NCT00527943,TERMINATED,INTERVENTIONAL,The trial was terminated at the request of the Data and Safety Monitoring Board.
NCT00527982,TERMINATED,INTERVENTIONAL,Termination due to poor accrual.
NCT00528008,TERMINATED,INTERVENTIONAL,Study was stopped following interim analysis.
NCT00528203,TERMINATED,OBSERVATIONAL,"Funds for study ended September 30, 2008."
NCT00528255,WITHDRAWN,INTERVENTIONAL,PK portion will be included in a future protocol
NCT00528294,TERMINATED,INTERVENTIONAL,Study status unknown Investigator retired and no longer working in the institution.
NCT00528450,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00528502,WITHDRAWN,INTERVENTIONAL,Terminated due to no patient enrollment.
NCT00528580,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT00528593,WITHDRAWN,INTERVENTIONAL,lack of pharmaceutical support
NCT00528775,TERMINATED,INTERVENTIONAL,drug cannot be prepared commercially
NCT00528827,WITHDRAWN,INTERVENTIONAL,"Due to the sale of Cardene IV, the sponsor has stopped enrollment and withdrawn the study. No safety issues were identified."
NCT00529061,TERMINATED,OBSERVATIONAL,"Funds for study ended September 30, 2008."
NCT00529074,WITHDRAWN,INTERVENTIONAL,never activated
NCT00529113,TERMINATED,INTERVENTIONAL,To pursue other indications
NCT00529204,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00529230,TERMINATED,OBSERVATIONAL,Low accrual rate.
NCT00529282,TERMINATED,INTERVENTIONAL,Study discontinued due to administrative reasons unrelated to safety
NCT00529334,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT00529464,TERMINATED,INTERVENTIONAL,"Two participants enrolled, both inevaluable."
NCT00529633,TERMINATED,INTERVENTIONAL,Low enrollment -- We could not recruit patients willing to be enrolled
NCT00529932,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00529997,TERMINATED,INTERVENTIONAL,Company has ceased operation
NCT00530088,TERMINATED,INTERVENTIONAL,new competing studies
NCT00530166,TERMINATED,INTERVENTIONAL,Lack of efficacy following an interim analysis
NCT00530270,TERMINATED,INTERVENTIONAL,"Study was closed June 23, 2008 due to low enrollment."
NCT00530361,WITHDRAWN,INTERVENTIONAL,Study was withdrawn prior to patient dosing based on a business decision.
NCT00530413,WITHDRAWN,INTERVENTIONAL,IRB needs updated
NCT00530634,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00530751,WITHDRAWN,OBSERVATIONAL,PI left
NCT00531076,TERMINATED,INTERVENTIONAL,Study terminated due to toxicity
NCT00531102,TERMINATED,INTERVENTIONAL,Slow enrolment
NCT00531115,TERMINATED,INTERVENTIONAL,"According to the study design, in the first step the number of responses was lower than the number required (\< 7)."
NCT00531297,TERMINATED,INTERVENTIONAL,low recruitment
NCT00531310,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00531349,WITHDRAWN,INTERVENTIONAL,Lack of study population
NCT00531505,TERMINATED,OBSERVATIONAL,Surgeon mistakenly removed liver and fat tissue from a non-LABS2a participant
NCT00531687,TERMINATED,INTERVENTIONAL,slow accrual
NCT00531778,TERMINATED,OBSERVATIONAL,insufficient funding and resource
NCT00531856,WITHDRAWN,INTERVENTIONAL,Clinical Hold pending additional data review and protocol amendment
NCT00531986,TERMINATED,INTERVENTIONAL,Unexpectedely high rates of treatment-failure
NCT00532038,TERMINATED,INTERVENTIONAL,Corporate decision
NCT00532064,TERMINATED,OBSERVATIONAL,Terminated per PI's request
NCT00532285,TERMINATED,INTERVENTIONAL,terminated
NCT00532311,TERMINATED,INTERVENTIONAL,Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents
NCT00532376,WITHDRAWN,OBSERVATIONAL,Enrollment by invitation only
NCT00532441,TERMINATED,INTERVENTIONAL,Terminated due to funding issues.
NCT00532454,TERMINATED,INTERVENTIONAL,planned to design a prospective study
NCT00532558,TERMINATED,INTERVENTIONAL,Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents
NCT00532584,WITHDRAWN,INTERVENTIONAL,Study not initiated due to funding.
NCT00532636,TERMINATED,INTERVENTIONAL,Recruitment completed
NCT00532883,TERMINATED,INTERVENTIONAL,Enrollment has been terminated due to a slow rate of enrollment.
NCT00533169,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT00533234,TERMINATED,OBSERVATIONAL,There was a lack of business need to continue this data collection.
NCT00533351,TERMINATED,INTERVENTIONAL,This study was terminated early due to low enrollment.
NCT00533390,TERMINATED,INTERVENTIONAL,Lack of financial support and low inclusion rate
NCT00533455,TERMINATED,INTERVENTIONAL,Failure to recruit due to polypharmacy
NCT00533546,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00533572,TERMINATED,OBSERVATIONAL,Study was suspended until FDA approved the IND. Study has since been terminated and a new screening process has been implemented.
NCT00533767,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was inadvertently added to the system.
NCT00534209,TERMINATED,INTERVENTIONAL,Per request of Principal Investigator this study was closed.
NCT00534313,TERMINATED,INTERVENTIONAL,Lack of efficacy with respect to skin-related lesions in the short-term phase
NCT00534339,WITHDRAWN,INTERVENTIONAL,This study was withdrawn to further optimize the device. No patients were enrolled in the trial.
NCT00534456,TERMINATED,INTERVENTIONAL,Study terminated
NCT00534547,WITHDRAWN,INTERVENTIONAL,business reasons
NCT00534703,TERMINATED,INTERVENTIONAL,Early termination following Trial Steering Committee recommendation
NCT00534872,WITHDRAWN,INTERVENTIONAL,The study was stoppend before recruitment start for preclinical safety finding in rats.
NCT00534898,WITHDRAWN,INTERVENTIONAL,The study withdrawn due to lack financial support
NCT00534937,TERMINATED,INTERVENTIONAL,Ineffective Recruitment (Business Decision)
NCT00535015,TERMINATED,INTERVENTIONAL,Objectives of study could not be met within a reasonable timeframe.
NCT00535158,TERMINATED,OBSERVATIONAL,Because of departure of study personnel and lack of funding
NCT00535210,TERMINATED,INTERVENTIONAL,"Unsuccessful recruiting patients, never got beyond pilot testing of patients"
NCT00535262,TERMINATED,INTERVENTIONAL,Current lack of medication support.
NCT00535275,TERMINATED,INTERVENTIONAL,"Final analysis done, follow-up of patients no more necessary"
NCT00535340,TERMINATED,INTERVENTIONAL,reprioritization of indications
NCT00535821,TERMINATED,INTERVENTIONAL,slow enrollement unavailable technology
NCT00535899,TERMINATED,OBSERVATIONAL,unable to find subjects meeting inclusion criteria
NCT00536211,WITHDRAWN,INTERVENTIONAL,protocol not approved by VA R\&D
NCT00536328,TERMINATED,OBSERVATIONAL,"due to very low recruitment. For this reason, there will be no further analysis and reporting of this study."
NCT00536445,WITHDRAWN,INTERVENTIONAL,Another institution performed the study
NCT00536497,WITHDRAWN,INTERVENTIONAL,Compound terminated
NCT00536523,TERMINATED,OBSERVATIONAL,Funding unavailable
NCT00536770,SUSPENDED,INTERVENTIONAL,DSMB
NCT00536822,WITHDRAWN,OBSERVATIONAL,Study withdrawn due to hospital emphasis on funded studies.
NCT00536939,TERMINATED,INTERVENTIONAL,Study has been terminated due to slow enrollment
NCT00536991,TERMINATED,INTERVENTIONAL,difficult to recruit
NCT00537134,TERMINATED,INTERVENTIONAL,The CIHR Financial support was withdrawn because of insufficient recruitment.
NCT00537173,TERMINATED,OBSERVATIONAL,Lack of Accrual
NCT00537199,TERMINATED,INTERVENTIONAL,"Study terminated early as per request by sponsor, Zila Biotechnology, Inc."
NCT00537316,TERMINATED,INTERVENTIONAL,"Infusion reactions during re-induction cycles after a period of no treatment in another study \[P04563, NCT0358670\]"
NCT00537446,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00537511,TERMINATED,INTERVENTIONAL,This study was terminated for administrative reasons.
NCT00537602,TERMINATED,INTERVENTIONAL,Methodology applied did not meet all criteria required per guidelines
NCT00537667,TERMINATED,INTERVENTIONAL,The safety profile of combination therapy became unacceptable.
NCT00537732,TERMINATED,INTERVENTIONAL,recruitment problems
NCT00537823,TERMINATED,INTERVENTIONAL,Poor accrual.
NCT00537849,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew request to conduct study
NCT00538096,WITHDRAWN,INTERVENTIONAL,Replacing this trial with a new trial.
NCT00538291,TERMINATED,INTERVENTIONAL,Study was terminated early due to lack of efficacy.
NCT00538343,TERMINATED,INTERVENTIONAL,Business Decision
NCT00538369,TERMINATED,INTERVENTIONAL,Lack of equipoise
NCT00538460,TERMINATED,OBSERVATIONAL,Lack of staff and funding.
NCT00538538,WITHDRAWN,INTERVENTIONAL,This condition can now be managed in the office with an injection of Lucentis.
NCT00538564,WITHDRAWN,INTERVENTIONAL,Trial closed just prior to study receiving Investigational Review Board approval
NCT00538681,TERMINATED,INTERVENTIONAL,Terminated due to lack of efficacy demonstrated in relevant participant population in other clinical trials.
NCT00538759,TERMINATED,INTERVENTIONAL,Funding shortfall
NCT00538824,TERMINATED,INTERVENTIONAL,low enrollment
NCT00538980,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of efficacy.
NCT00539019,WITHDRAWN,OBSERVATIONAL,indirect calorimetry no longer employed at the institution; calorimeter is not accurate/reliable
NCT00539097,TERMINATED,INTERVENTIONAL,change in donor site care protocol; donor site healing is a study endpoint
NCT00539188,TERMINATED,INTERVENTIONAL,Study terminated due to poor subject compliance.
NCT00539318,TERMINATED,OBSERVATIONAL,Low Recruitment
NCT00539370,TERMINATED,OBSERVATIONAL,The investigator is no longer employed at NIH.
NCT00539409,TERMINATED,INTERVENTIONAL,Administrative
NCT00539435,WITHDRAWN,INTERVENTIONAL,Administrative
NCT00539500,TERMINATED,INTERVENTIONAL,Slow Accrual.
NCT00539513,TERMINATED,INTERVENTIONAL,Researchers terminated study due to limited enrollment.
NCT00539617,TERMINATED,INTERVENTIONAL,For slow accrual
NCT00539656,TERMINATED,INTERVENTIONAL,The manufacturer discontinued necessary reagents.
NCT00539799,WITHDRAWN,INTERVENTIONAL,Local pharmacy unwilling to comply with study protocol
NCT00539838,TERMINATED,INTERVENTIONAL,The study was terminated prematurely when the decision was made that ocrelizumab was not likely to benefit this patient population.
NCT00539942,TERMINATED,INTERVENTIONAL,Problems with accrual
NCT00540033,TERMINATED,INTERVENTIONAL,terminated because of enough case number
NCT00540189,TERMINATED,INTERVENTIONAL,Unable to adequatly recruit
NCT00540280,SUSPENDED,INTERVENTIONAL,Follow up only
NCT00540332,WITHDRAWN,INTERVENTIONAL,The 20070201 study was terminated based on evaluation of Palifermin solid tumor data.
NCT00540501,WITHDRAWN,INTERVENTIONAL,Contract agreement not reached
NCT00540540,WITHDRAWN,OBSERVATIONAL,"According to NIH definition of clinical trial studies, this study does not meet requirement for clinical trial study."
NCT00540683,WITHDRAWN,OBSERVATIONAL,Not NIH defined clinical trials.
NCT00540735,TERMINATED,INTERVENTIONAL,Big difficulties to enroll patients
NCT00540839,WITHDRAWN,INTERVENTIONAL,"Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes."
NCT00540969,TERMINATED,INTERVENTIONAL,Low accrual
NCT00540995,TERMINATED,INTERVENTIONAL,"Unable to safely escalate to TMLI doses that were hypothesized to be effective and less toxic than FTBI. Likely due to the giving of Busulfan prior to radiation delivery. Therefore, the study was abandoned and no further patients were accrued."
NCT00541112,TERMINATED,INTERVENTIONAL,Toxicity and lack of efficacy
NCT00541320,WITHDRAWN,INTERVENTIONAL,No longer viable
NCT00541333,SUSPENDED,INTERVENTIONAL,Reviewing data
NCT00541424,WITHDRAWN,OBSERVATIONAL,No study recruitment due to time constraints and lack of support.
NCT00541593,TERMINATED,INTERVENTIONAL,SurgAssist device is no longer clinically available.
NCT00541619,WITHDRAWN,OBSERVATIONAL,No patients could be recruited.
NCT00541632,TERMINATED,OBSERVATIONAL,performance variability
NCT00541671,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT00541892,WITHDRAWN,INTERVENTIONAL,senior coworker retired
NCT00541918,WITHDRAWN,INTERVENTIONAL,study suspended due to staff indisposition
NCT00542191,TERMINATED,INTERVENTIONAL,Enrollment Completed
NCT00542269,TERMINATED,INTERVENTIONAL,Early termination of the study due to slow recruitment.
NCT00542347,TERMINATED,INTERVENTIONAL,Enrollment target not met due to high number of disqualified studies.
NCT00542594,TERMINATED,OBSERVATIONAL,No results are avaialble as the study did not complete according to the protocol
NCT00542711,WITHDRAWN,INTERVENTIONAL,Technical difficulties
NCT00542828,TERMINATED,INTERVENTIONAL,Study terminated due to slow enrollment.
NCT00543114,TERMINATED,INTERVENTIONAL,lack of efficacy and tolerability
NCT00543127,TERMINATED,INTERVENTIONAL,Unjustified decision of company that funded the trial.
NCT00543205,TERMINATED,INTERVENTIONAL,Terminated due to very slow enrollment
NCT00543309,TERMINATED,INTERVENTIONAL,DSMB recommended termination based on interim outcomes analysis
NCT00543335,TERMINATED,INTERVENTIONAL,Lack of Accrual.
NCT00543582,TERMINATED,INTERVENTIONAL,Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103. All Celgene-sponsored trials with MGCD0103 will be closed.
NCT00543608,TERMINATED,INTERVENTIONAL,Trial terminated due to financial resource limitations
NCT00543712,TERMINATED,INTERVENTIONAL,Efficacy not evident in this population.
NCT00543933,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT00543959,TERMINATED,INTERVENTIONAL,This study is being discontinued based on data suggesting that none of the doses tested demonstrated both glycemic \& body fluid benefits vs. the comparitor
NCT00543972,TERMINATED,INTERVENTIONAL,due to absence of evidence of clinical activity up to toxic doses
NCT00544076,TERMINATED,INTERVENTIONAL,Accrual too slow
NCT00544180,TERMINATED,INTERVENTIONAL,The trial was terminated due to lack of compliance with GCP regulations.
NCT00544401,TERMINATED,INTERVENTIONAL,Lack of participants
NCT00544427,WITHDRAWN,OBSERVATIONAL,Doesn't meet NIH clinical trial definition.
NCT00544453,TERMINATED,INTERVENTIONAL,Preliminary data showed \[123I\] MNI-308 not a useful tool in detection of AD.
NCT00544635,TERMINATED,INTERVENTIONAL,Study personnel left institution before study completion.
NCT00544648,TERMINATED,INTERVENTIONAL,Ph I completed. Funding became unavailable causing Ph II to cease after two patients were enrolled.
NCT00544674,TERMINATED,INTERVENTIONAL,Terminated early due to discovery of new mechanism of activation.
NCT00544700,TERMINATED,INTERVENTIONAL,"Data collection is completed. As no changes in the endpoints were expected in the future, no further data is needed."
NCT00544778,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to withdrawal of support by the sponsor.
NCT00544908,TERMINATED,INTERVENTIONAL,Toxicity
NCT00545298,TERMINATED,INTERVENTIONAL,Strategic direction of the sponsor changed
NCT00545506,TERMINATED,INTERVENTIONAL,lack of eligible patients
NCT00545597,TERMINATED,INTERVENTIONAL,Upon recommendation of DSMB
NCT00545636,WITHDRAWN,INTERVENTIONAL,unfortunately lacked manpower to carry out the study
NCT00545662,TERMINATED,INTERVENTIONAL,Trial stopped due to futility.
NCT00545831,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT00545948,TERMINATED,INTERVENTIONAL,Study terminated due to reproducibility issues with genomics prediction model.
NCT00546013,TERMINATED,OBSERVATIONAL,all patients required included
NCT00546065,TERMINATED,INTERVENTIONAL,"Intermediate results have shown a significant difference in the outcome of ablation and non-ablation patients. Therefore, the study was stopped."
NCT00546234,WITHDRAWN,INTERVENTIONAL,No subjects enrolled and no ongoing funding.
NCT00546260,TERMINATED,INTERVENTIONAL,Administrative reasons.
NCT00546364,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00546455,SUSPENDED,INTERVENTIONAL,This study was terminated due to expired drug with possibility of re-starting in the future.
NCT00546598,TERMINATED,INTERVENTIONAL,Sponsor withdrew PMA
NCT00546611,WITHDRAWN,INTERVENTIONAL,No enrolement
NCT00546949,TERMINATED,INTERVENTIONAL,analysis at 50% inclusion showed 4 times larger reoperation rate in X-stop group
NCT00546975,TERMINATED,INTERVENTIONAL,Compliance unacceptably low.
NCT00547118,TERMINATED,INTERVENTIONAL,Withdrawn due to medication withdrawal from the EMEA
NCT00547261,TERMINATED,INTERVENTIONAL,Due to lack of supply of the investigational product.
NCT00547326,WITHDRAWN,INTERVENTIONAL,Ethics Committee approval denied
NCT00547404,WITHDRAWN,INTERVENTIONAL,Not to expose the patients to subtherapeutic dose
NCT00547443,WITHDRAWN,INTERVENTIONAL,Withdrawn as the sponsor has stopped the drug for NSCLC population
NCT00547482,TERMINATED,INTERVENTIONAL,Protocol design under review.
NCT00547690,TERMINATED,INTERVENTIONAL,Expired IRB approval
NCT00547703,TERMINATED,INTERVENTIONAL,Not enough participants - only 5 since the study started
NCT00547716,WITHDRAWN,INTERVENTIONAL,Lack of study enrollment.
NCT00547794,TERMINATED,OBSERVATIONAL,Difficulty in patient enrollment
NCT00547911,TERMINATED,INTERVENTIONAL,Study terminated due to contamination droxidopa
NCT00548106,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to the company decision
NCT00548327,TERMINATED,INTERVENTIONAL,The scientific director decided to terminate: low priority study with slow accrual
NCT00548366,TERMINATED,INTERVENTIONAL,Failure to recruit.
NCT00548496,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00548522,TERMINATED,OBSERVATIONAL,Difficulty in finding staff to help with study
NCT00548717,TERMINATED,INTERVENTIONAL,"First two patients enrolled after trial reopened, developed grade III-IV acute GVHD and subsequently passed away."
NCT00548730,WITHDRAWN,OBSERVATIONAL,Insufficient enrollment
NCT00548886,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00548912,WITHDRAWN,INTERVENTIONAL,study ended
NCT00548938,TERMINATED,INTERVENTIONAL,Principal Investigator has left the institution
NCT00549263,WITHDRAWN,INTERVENTIONAL,"No subjects enrolled, bio equivalence study, canceled before active."
NCT00549328,TERMINATED,INTERVENTIONAL,Study enrolment was delayed in starting and too slow to support further development in this setting
NCT00549471,TERMINATED,INTERVENTIONAL,no funding
NCT00549575,TERMINATED,INTERVENTIONAL,terminated
NCT00549627,SUSPENDED,INTERVENTIONAL,New funding sources being sought
NCT00549757,TERMINATED,INTERVENTIONAL,Lack of benefit and safety concern
NCT00549822,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00549835,WITHDRAWN,INTERVENTIONAL,Inadequate funding
NCT00550108,TERMINATED,INTERVENTIONAL,Inability to enroll subjects.
NCT00550199,TERMINATED,INTERVENTIONAL,Study terminated due to LBH589 toxicity.
NCT00550420,TERMINATED,INTERVENTIONAL,Based on preliminary parent study results
NCT00550498,TERMINATED,INTERVENTIONAL,No improvement obtained in 3 cases. Retinal detachment observed in 2 cases
NCT00550654,TERMINATED,INTERVENTIONAL,Study was terminated due to poor accrual.
NCT00550758,TERMINATED,INTERVENTIONAL,"the study has recently ended, all information gathred as planed"
NCT00550849,TERMINATED,INTERVENTIONAL,Enrollment discontinued after second cohort completed.
NCT00550862,TERMINATED,INTERVENTIONAL,Study stopped by sponsor due to administrative reasons
NCT00551395,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00551603,WITHDRAWN,INTERVENTIONAL,"Logistic reasons, financial contrastraints"
NCT00551759,TERMINATED,INTERVENTIONAL,"The study used a two-stage design. After stage one, the study was terminated due to excess toxicity."
NCT00551785,TERMINATED,OBSERVATIONAL,The marketing authorization for Intrinsa was withdrawn.
NCT00551902,WITHDRAWN,INTERVENTIONAL,Efficacy study indicated that further study is not warranted
NCT00551941,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT00552422,TERMINATED,INTERVENTIONAL,Lack of perceived need for domperidone in this population
NCT00552448,TERMINATED,INTERVENTIONAL,Continuing review not submitted to IRB within 365 days.
NCT00552578,TERMINATED,INTERVENTIONAL,"""Tapering doses"" protocol arm was not effective for treatment retention outcome."
NCT00552604,TERMINATED,INTERVENTIONAL,due to recruitment problems / based on recommendation of Independent Review Board
NCT00553163,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient numbers of patinets in the time available
NCT00553514,TERMINATED,INTERVENTIONAL,The study was terminated after Merck Serono had taken the decision not to pursue the development of AS900672-enriched in ovulation induction
NCT00553527,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate the project due to low multi-center enrollment.
NCT00553709,TERMINATED,INTERVENTIONAL,Unexpected difficult recruitment. Study drug expired
NCT00553735,TERMINATED,INTERVENTIONAL,"High number of withdrawals, appt. no-shows, or those lost to follow-up."
NCT00553813,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT00553891,WITHDRAWN,INTERVENTIONAL,No enrollment because of war in the study country.
NCT00553917,TERMINATED,OBSERVATIONAL,Poor recruitment to experimental arms and study remained unfunded
NCT00554073,SUSPENDED,OBSERVATIONAL,It was not possible to perform 2 MRI studies in each patient due to practical problems. The study was not suspended due to safety issues.
NCT00554112,TERMINATED,INTERVENTIONAL,"PI left the VA, per Central Office"
NCT00554307,WITHDRAWN,OBSERVATIONAL,Not able to enroll patients
NCT00554476,TERMINATED,INTERVENTIONAL,Because the sample volume was completed during three years.
NCT00554541,TERMINATED,OBSERVATIONAL,Lack of study subjects
NCT00554697,TERMINATED,OBSERVATIONAL,Unable to recruit subjects
NCT00554736,WITHDRAWN,INTERVENTIONAL,Sponsor suspended study do to funding
NCT00554762,WITHDRAWN,INTERVENTIONAL,Compound terminated
NCT00554775,TERMINATED,INTERVENTIONAL,IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was not met.
NCT00554814,SUSPENDED,INTERVENTIONAL,insufficient recruitment
NCT00554944,WITHDRAWN,INTERVENTIONAL,not progressing as anticipated
NCT00555009,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00555048,TERMINATED,INTERVENTIONAL,Low accrual
NCT00555126,SUSPENDED,INTERVENTIONAL,Not enough patients
NCT00555217,TERMINATED,INTERVENTIONAL,It was stopped primarily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.
NCT00555464,TERMINATED,INTERVENTIONAL,The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas
NCT00555477,TERMINATED,INTERVENTIONAL,The study was stopped after 69 subjects were enrolled because of poor accrual.
NCT00555529,WITHDRAWN,OBSERVATIONAL,Lead researcher left the Department
NCT00555646,TERMINATED,INTERVENTIONAL,Change of dose regimen (new protocol)
NCT00555711,WITHDRAWN,OBSERVATIONAL,no subject
NCT00555841,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00555867,TERMINATED,OBSERVATIONAL,High drop-out rate leads to the conclusion: not enough data will be available to perform proper analyses of data collected after follow-up month 24 visit
NCT00555984,WITHDRAWN,INTERVENTIONAL,PI decision to terminate. No usable data collected
NCT00556075,TERMINATED,INTERVENTIONAL,Clinical hold for safety
NCT00556153,WITHDRAWN,OBSERVATIONAL,No participants ever enrolled.
NCT00556166,TERMINATED,INTERVENTIONAL,Principal investigator left institution.
NCT00556205,WITHDRAWN,INTERVENTIONAL,Toxicity of combination from other trials
NCT00556387,WITHDRAWN,INTERVENTIONAL,This study has been withdraw from the IRB. The PI has transferred to another university. The IND was transferred.
NCT00556400,TERMINATED,INTERVENTIONAL,Early termination because of insufficient accrual.
NCT00556686,WITHDRAWN,OBSERVATIONAL,We are currently modifying the study
NCT00556790,TERMINATED,INTERVENTIONAL,interim analysis
NCT00556907,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT00556972,TERMINATED,INTERVENTIONAL,Due to numerous delays in study start-up process...
NCT00557206,TERMINATED,INTERVENTIONAL,Funding was terminated
NCT00557219,TERMINATED,INTERVENTIONAL,Main cooperator finished cooperation
NCT00557427,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00557518,TERMINATED,INTERVENTIONAL,Study has been terminated early due to financial constraints.
NCT00557622,TERMINATED,INTERVENTIONAL,difficulty in achieving target enrollment numbers
NCT00557635,SUSPENDED,INTERVENTIONAL,no recruited patients
NCT00557752,TERMINATED,INTERVENTIONAL,Review Board stopped the study after interim analysis reaching stopping rule for efficacy.
NCT00557791,WITHDRAWN,INTERVENTIONAL,Study never initiated
NCT00557830,TERMINATED,INTERVENTIONAL,The study was closed to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.
NCT00557843,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT00557921,TERMINATED,INTERVENTIONAL,Terminated by Sponsor
NCT00558194,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT00558376,TERMINATED,INTERVENTIONAL,Study terminated due to FDA alert regarding Fleet phosphosoda
NCT00558532,WITHDRAWN,OBSERVATIONAL,Investigator Retired.
NCT00558545,TERMINATED,INTERVENTIONAL,Avastin approved for first-in-line treatment.
NCT00558558,TERMINATED,INTERVENTIONAL,Study terminated due to low recruitment.
NCT00558636,TERMINATED,INTERVENTIONAL,Terminated early when the results from Study NCT00300885 showed an overall lack of efficacy in NSCLC and increased mortality in subjects with squamous subtype.
NCT00558857,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00558870,TERMINATED,INTERVENTIONAL,Low Accrual.
NCT00558922,TERMINATED,INTERVENTIONAL,Unacceptable Neurotoxicity (2 cases)
NCT00558935,TERMINATED,INTERVENTIONAL,It was found that 20g of alcohol daily had no effect on ABCA1 expression or HDL levels.
NCT00558961,TERMINATED,INTERVENTIONAL,Unsatisfactory enrollment
NCT00559143,WITHDRAWN,INTERVENTIONAL,No patients enrolled for long period of time. No scientific interest any more
NCT00559169,WITHDRAWN,INTERVENTIONAL,protocol changed and a new study using verapamil in epilepsy will be started in the near future
NCT00559286,TERMINATED,INTERVENTIONAL,"logistic reasons, patients could not be recruited"
NCT00559351,TERMINATED,INTERVENTIONAL,difficulty in recruitment
NCT00559481,WITHDRAWN,INTERVENTIONAL,Withdrawn due to low accrual
NCT00559897,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00560248,TERMINATED,OBSERVATIONAL,Loss of funding
NCT00560547,WITHDRAWN,INTERVENTIONAL,"The study was cancelled before any patients were enrolled, due to operational reasons."
NCT00560625,TERMINATED,OBSERVATIONAL,recruiting subjects did not start.
NCT00560716,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00560807,WITHDRAWN,INTERVENTIONAL,The study was stopped because the study never received funding
NCT00560846,TERMINATED,INTERVENTIONAL,Insufficient recruitment over time.
NCT00560924,TERMINATED,INTERVENTIONAL,Trial prematurely discontinued due to slow recruitment
NCT00561067,TERMINATED,INTERVENTIONAL,Italian Medicines Agency decision
NCT00561197,TERMINATED,INTERVENTIONAL,Drug not being developed for this indication
NCT00561366,WITHDRAWN,INTERVENTIONAL,Not moving forward with program.
NCT00561912,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00562016,TERMINATED,INTERVENTIONAL,"Futility on primary endpoint.Study confounded by statistically significant differences between the two arms re: atherectomy, duration of support."
NCT00562042,TERMINATED,OBSERVATIONAL,Study was stopped due to slow accrual of patients.
NCT00562055,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to business reasons.
NCT00562081,TERMINATED,INTERVENTIONAL,Poor recruitment.
NCT00562185,WITHDRAWN,INTERVENTIONAL,Funding source withdrew funding
NCT00562198,TERMINATED,INTERVENTIONAL,Illogistical results found in interim evaluation.
NCT00562237,TERMINATED,INTERVENTIONAL,This trial discontinued on 20 JUN 2008 because the interim immunogenicity results do not justify these formulations as pandemic vaccine candidates
NCT00562341,WITHDRAWN,OBSERVATIONAL,enrollment challenges
NCT00562510,TERMINATED,INTERVENTIONAL,recruitment lower than estimated
NCT00562601,TERMINATED,OBSERVATIONAL,Closed by the Sponsor/DSMB/IRB
NCT00562692,TERMINATED,INTERVENTIONAL,Recruitment very difficult. Study drug expired so we have stopped the study.
NCT00562731,TERMINATED,INTERVENTIONAL,Company strategic decision
NCT00562965,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00563407,TERMINATED,OBSERVATIONAL,accrual goal met
NCT00563459,TERMINATED,INTERVENTIONAL,Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this indication were terminated.
NCT00564018,TERMINATED,INTERVENTIONAL,Presumed loss of clinical equipoise between the agents being investigated
NCT00564174,TERMINATED,INTERVENTIONAL,interim analysis found no difference in LB rate and lower than expected event rate
NCT00564460,WITHDRAWN,INTERVENTIONAL,Change of practice pattern. Green light laser
NCT00564720,TERMINATED,INTERVENTIONAL,Due to poor accrual of the study
NCT00564876,TERMINATED,INTERVENTIONAL,"Lack of accrual, study closed."
NCT00564980,TERMINATED,INTERVENTIONAL,Inability to recruit required number of subjects.
NCT00565227,TERMINATED,INTERVENTIONAL,closed due to toxicity
NCT00565630,WITHDRAWN,INTERVENTIONAL,Replaced with ongoing study
NCT00565799,TERMINATED,INTERVENTIONAL,Conflicting interim data
NCT00565916,TERMINATED,INTERVENTIONAL,Atypically high dropout rate.
NCT00566007,TERMINATED,INTERVENTIONAL,It has proved extremely difficult
NCT00566046,TERMINATED,INTERVENTIONAL,Sponsor decision because of to small enrollment
NCT00566111,TERMINATED,INTERVENTIONAL,Early indication of an unfavorable risk/benefit ratio.
NCT00566215,TERMINATED,INTERVENTIONAL,Benefit of duodenal exclusion alone less than expected for treatment of type 2 diabetes; an additional effect of combination with omentectomy not observed
NCT00566241,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00566462,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy.
NCT00566514,SUSPENDED,INTERVENTIONAL,Protocol Under Review
NCT00566540,TERMINATED,INTERVENTIONAL,Recruitment problems with study
NCT00566579,TERMINATED,INTERVENTIONAL,Lack of additional funding
NCT00566644,TERMINATED,INTERVENTIONAL,Withdrawn due to poor accrual
NCT00566956,TERMINATED,INTERVENTIONAL,The study was terminated because it is very difficult to recruit more patients.
NCT00567229,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT00567424,WITHDRAWN,INTERVENTIONAL,No longer viable
NCT00567437,TERMINATED,INTERVENTIONAL,Poor patient enrollment from clinic secondary to investigator illness.
NCT00567463,TERMINATED,INTERVENTIONAL,Completed
NCT00567528,TERMINATED,INTERVENTIONAL,Study was not producing meaningful data.
NCT00567658,WITHDRAWN,INTERVENTIONAL,The decision of terminate the study was reached due to difficulties surrounding recruitment and enrollment of subjects since the inception of the study.
NCT00567866,TERMINATED,INTERVENTIONAL,Study was terminated due to insufficient funds
NCT00567879,TERMINATED,INTERVENTIONAL,The study was terminated early due to insufficient evidence of clinical benefit.
NCT00568009,TERMINATED,OBSERVATIONAL,additional enrolment criteria made patients' recruitment not feasible anymore
NCT00568061,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00568243,TERMINATED,OBSERVATIONAL,Low enrollment
NCT00568308,TERMINATED,INTERVENTIONAL,Commercial decision to discontinue the study
NCT00568360,TERMINATED,OBSERVATIONAL,Research cancelled; equipment broke
NCT00568373,WITHDRAWN,INTERVENTIONAL,this is not a clinical trial and does not require registration
NCT00568425,TERMINATED,OBSERVATIONAL,Inadequate response to Scientific Review Committee.
NCT00568451,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00568464,TERMINATED,INTERVENTIONAL,The enrollment is slower than expected
NCT00568477,TERMINATED,INTERVENTIONAL,lacking recruitment
NCT00568529,SUSPENDED,INTERVENTIONAL,There are not enough patients enrolled.
NCT00568633,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00568672,WITHDRAWN,INTERVENTIONAL,Withdrawn because of personal ressources before inclusion of the first patient
NCT00568854,TERMINATED,INTERVENTIONAL,Additional funding was not secured
NCT00568971,TERMINATED,INTERVENTIONAL,The study has finished.
NCT00569062,TERMINATED,INTERVENTIONAL,Negative data from a GSK PoC study in RA combined with evidence of greater sensitivity of toll-like receptor pathways to p38 inhibition.
NCT00569179,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00569296,TERMINATED,INTERVENTIONAL,Funding ended
NCT00569465,TERMINATED,INTERVENTIONAL,End of the study
NCT00569686,WITHDRAWN,INTERVENTIONAL,No subject meeting criteria
NCT00570258,TERMINATED,INTERVENTIONAL,"FDA approved higher dose of study drug. Dose used in protocol lower than SOC - enrollment stopped, those on treatment were given option to opt out."
NCT00570375,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT00570531,TERMINATED,INTERVENTIONAL,The study was unable the accrue the required number of patients within a reasonable time.
NCT00570674,TERMINATED,INTERVENTIONAL,The study did not continue to phase II due to the importance of HPV status as a prognostic factor to guide treatment decisions.
NCT00570908,TERMINATED,INTERVENTIONAL,Due to poor accrual this study is being closed to accrual
NCT00570960,TERMINATED,INTERVENTIONAL,drug product became unavilable
NCT00571116,TERMINATED,INTERVENTIONAL,Halted because of slow accrual and lack of study funding
NCT00571415,TERMINATED,OBSERVATIONAL,Due to competing studies no further subjects could be recruited.
NCT00571467,TERMINATED,INTERVENTIONAL,Terminated due to recruitment not meeting expectations.
NCT00571519,TERMINATED,INTERVENTIONAL,"DSPD focusing on Study 301 to confirm the clinical profile before proceeding. Daiichi Sankyo Pharma Development terminated this study on 23 Apr 2008 because of changes in the clinical development plan with 94 of 2600 planned, randomized participants."
NCT00571714,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00571740,WITHDRAWN,INTERVENTIONAL,The study was not activated
NCT00571753,TERMINATED,INTERVENTIONAL,Enrolling participants has halted prematurely due to a low recruitment rate.
NCT00571792,TERMINATED,OBSERVATIONAL,Insufficient enrollment
NCT00572156,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to strategic reasons.
NCT00572182,TERMINATED,INTERVENTIONAL,"This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK."
NCT00572260,TERMINATED,INTERVENTIONAL,Study closed. PI left the institution.
NCT00572286,WITHDRAWN,OBSERVATIONAL,sponsor funding
NCT00572299,TERMINATED,OBSERVATIONAL,Terminated due to recruitment problems
NCT00572377,TERMINATED,INTERVENTIONAL,The investigator at Cedars stopped this study due to problems collecting payment from the sponsor.
NCT00572429,WITHDRAWN,INTERVENTIONAL,"no subjects enrolled,study never started"
NCT00572442,WITHDRAWN,OBSERVATIONAL,sponsor funding
NCT00572715,WITHDRAWN,OBSERVATIONAL,Investigator's decision:Did not open to enrollment
NCT00572767,TERMINATED,INTERVENTIONAL,Intended length of study ended
NCT00572845,TERMINATED,INTERVENTIONAL,Unable to recruit enough participants.
NCT00572949,WITHDRAWN,OBSERVATIONAL,sponsor funding
NCT00573092,WITHDRAWN,OBSERVATIONAL,Withdrawn
NCT00573105,TERMINATED,INTERVENTIONAL,slow inclusion rate
NCT00573131,TERMINATED,INTERVENTIONAL,OncoGel did not show any impact on overall tumor response
NCT00573157,TERMINATED,INTERVENTIONAL,The study was terminated due to unanticipated safety issues
NCT00573391,TERMINATED,INTERVENTIONAL,low accrual
NCT00573404,TERMINATED,INTERVENTIONAL,slow accrual
NCT00573547,WITHDRAWN,INTERVENTIONAL,Principal Investigator decided not to initiate the study.
NCT00573664,TERMINATED,INTERVENTIONAL,Interim analysis showed a significant reduction in the pain scores
NCT00573755,TERMINATED,INTERVENTIONAL,lack of participant accrual
NCT00573937,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00573989,TERMINATED,INTERVENTIONAL,Drug Supply Issue
NCT00574002,WITHDRAWN,OBSERVATIONAL,Low study enrollment; re-evaluating study protocol and study selection criteria.
NCT00574041,TERMINATED,INTERVENTIONAL,Terminated due to poor recruitment
NCT00574080,TERMINATED,INTERVENTIONAL,low accrual
NCT00574236,TERMINATED,INTERVENTIONAL,no additional funding
NCT00574275,TERMINATED,INTERVENTIONAL,Data Monitoring Committee concluded after a planned interim analysis that aflibercept added to gemcitabine would be unable to demonstrate improved survival
NCT00574314,TERMINATED,OBSERVATIONAL,No more funding
NCT00574444,WITHDRAWN,INTERVENTIONAL,Investigator moved to another institution.
NCT00574483,WITHDRAWN,INTERVENTIONAL,reevaluation of compound development
NCT00574561,WITHDRAWN,OBSERVATIONAL,sponsor funding
NCT00574717,TERMINATED,INTERVENTIONAL,"Lack of funding support for continued recruitment, enrollment, treatment"
NCT00574756,TERMINATED,INTERVENTIONAL,no funding
NCT00574821,WITHDRAWN,OBSERVATIONAL,sponsor funding
NCT00574834,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00574860,TERMINATED,INTERVENTIONAL,Additional research
NCT00574951,TERMINATED,INTERVENTIONAL,Study was stopped for severe toxicity causing concern for patients
NCT00574964,TERMINATED,INTERVENTIONAL,PI left the institution.
NCT00575016,TERMINATED,INTERVENTIONAL,The study was terminated early due to enrollment challenges.
NCT00575302,WITHDRAWN,INTERVENTIONAL,36 cases were included and the 4 centers and they are unable to increase their recruitment to obtain the 400 cases necessary to reach statistical significance.
NCT00575328,TERMINATED,INTERVENTIONAL,Only N=8 subjects randomized; funding ran out; too small N to yield useful data.
NCT00575419,TERMINATED,INTERVENTIONAL,Low accrual
NCT00575445,TERMINATED,OBSERVATIONAL,Nitric Oxide analyzer not functioning properly
NCT00575640,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT00575822,TERMINATED,INTERVENTIONAL,Sponsoring company ceased business operations.
NCT00575848,TERMINATED,INTERVENTIONAL,Slow enrollment and due to personnel change there was no viable way to quantify glycine levels through imaging
NCT00575965,TERMINATED,INTERVENTIONAL,Slow accrual led to early study termination.
NCT00575978,WITHDRAWN,INTERVENTIONAL,IRB request
NCT00576056,TERMINATED,INTERVENTIONAL,Bayer Healthcare is no supplying the study drug
NCT00576160,TERMINATED,INTERVENTIONAL,This was a dosing study to determine acceptability. Participants found protocol burdensome and so we terminated.
NCT00576212,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant."
NCT00576524,TERMINATED,INTERVENTIONAL,Completion not feasible. THERE ARE NO RESULTS FROM THIS TRIAL
NCT00576602,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00576667,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00576901,TERMINATED,INTERVENTIONAL,The sample for statistical analysis of results could not be recruited within the specified timeframe upon retirement of the original principal investigator.
NCT00576992,TERMINATED,OBSERVATIONAL,Recruitment not being met
NCT00577109,WITHDRAWN,INTERVENTIONAL,Study was cancelled before patient enrollment
NCT00577148,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00577161,WITHDRAWN,INTERVENTIONAL,closed to enrollment
NCT00577187,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00577226,TERMINATED,OBSERVATIONAL,IRB has requested additional information regarding IDE
NCT00577343,WITHDRAWN,OBSERVATIONAL,study lacked funding to recruit
NCT00577356,TERMINATED,INTERVENTIONAL,"Safety reasons, though no safety issues arose."
NCT00577434,TERMINATED,OBSERVATIONAL,Sluggish enrollment
NCT00577499,TERMINATED,OBSERVATIONAL,Recruitment was suboptimal
NCT00577668,WITHDRAWN,INTERVENTIONAL,Poor accrual
NCT00577694,TERMINATED,INTERVENTIONAL,funding unavailable
NCT00577772,TERMINATED,INTERVENTIONAL,Enrollment Goal Not Met
NCT00577980,WITHDRAWN,INTERVENTIONAL,Zero accrual and failure to generate multicenter interest.
NCT00578045,WITHDRAWN,INTERVENTIONAL,no accrual
NCT00578097,TERMINATED,INTERVENTIONAL,The study was terminated early due to poor recruitment.
NCT00578188,WITHDRAWN,OBSERVATIONAL,Study redesigned and re-submitted to UAMS IRB under different study title and IRB number.
NCT00578292,TERMINATED,INTERVENTIONAL,Stem cell transplant was determined SOC for this disease (study is not relevant)
NCT00578344,TERMINATED,INTERVENTIONAL,Terminated due to no new subject enrollment during the last 3 year period.
NCT00578396,WITHDRAWN,INTERVENTIONAL,Non applicable clinical trial
NCT00578578,TERMINATED,INTERVENTIONAL,CRP is no longer SOC - enrollment halted and will analyze available data.
NCT00578591,WITHDRAWN,INTERVENTIONAL,No eligible patients were identified so the study was terminated.
NCT00578799,WITHDRAWN,INTERVENTIONAL,Non applicable clinical trial
NCT00578890,WITHDRAWN,INTERVENTIONAL,not enough recruitment
NCT00579020,TERMINATED,INTERVENTIONAL,Management decision
NCT00579046,WITHDRAWN,INTERVENTIONAL,no patient recruiting
NCT00579059,TERMINATED,INTERVENTIONAL,The study sponsor canceled the study.
NCT00579111,TERMINATED,INTERVENTIONAL,slow accrual
NCT00579137,TERMINATED,INTERVENTIONAL,slow accrual
NCT00579254,TERMINATED,OBSERVATIONAL,See the termination reason in detailed description.
NCT00579319,WITHDRAWN,OBSERVATIONAL,There were no subjects ever enrolled. Study was closed at the IRB.
NCT00579358,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00579371,TERMINATED,INTERVENTIONAL,Per Coordinator: study was closed and no cadaveric implants were performed
NCT00579592,TERMINATED,INTERVENTIONAL,Higher than expected rate of acute rejection
NCT00579735,WITHDRAWN,OBSERVATIONAL,No subjects were ever enrolled. This study was closed at the IRB.
NCT00579761,WITHDRAWN,OBSERVATIONAL,Per PI on 12/9/15 - No patients were ever enrolled in this study
NCT00579969,TERMINATED,INTERVENTIONAL,Study stopped and data not analyzed
NCT00579995,TERMINATED,INTERVENTIONAL,Technical measurement problems led to unreliable or uninterpretable data.
NCT00580073,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00580099,WITHDRAWN,INTERVENTIONAL,Non applicable clinical trial
NCT00580151,TERMINATED,INTERVENTIONAL,Closed due to no response from PI to IRB
NCT00580164,WITHDRAWN,OBSERVATIONAL,"Very few subjects were enrolled. Therefore, the study was terminated."
NCT00580190,TERMINATED,INTERVENTIONAL,"Date of termination was Feb. 7, 2008. Reasons of termination were due to elevation of liver function tests and long elimination half-life of the compound."
NCT00580216,TERMINATED,INTERVENTIONAL,early discontinuation based on strategic sponsor decision not driven by any safety concern
NCT00580255,WITHDRAWN,OBSERVATIONAL,resources not available
NCT00580307,TERMINATED,INTERVENTIONAL,slow accrual
NCT00580346,WITHDRAWN,INTERVENTIONAL,Study never started
NCT00580697,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00580749,TERMINATED,INTERVENTIONAL,not meeting enrollment criteria
NCT00580762,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00580866,TERMINATED,INTERVENTIONAL,low accrual
NCT00580892,WITHDRAWN,OBSERVATIONAL,Not a clinical trial study
NCT00580905,TERMINATED,INTERVENTIONAL,Not enough volunteer recruited before funding could be secured.
NCT00580918,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00580944,WITHDRAWN,INTERVENTIONAL,No participant enrolled
NCT00581061,TERMINATED,INTERVENTIONAL,Study subjects were not compliant with study protocols.
NCT00581113,TERMINATED,INTERVENTIONAL,New research priorities
NCT00581152,WITHDRAWN,OBSERVATIONAL,IRB suspension
NCT00581217,TERMINATED,OBSERVATIONAL,"Study Investigator has suddenly died, study has no results."
NCT00581269,TERMINATED,INTERVENTIONAL,the Fellow conducting the study left the institution in 2009
NCT00581282,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00581477,TERMINATED,INTERVENTIONAL,1. enrollment slower than anticipated; 2. FDA approval of droxidopa so no longer need to treat patients on research basis; 3. personnel who were primarily responsible for the study are no longer at Vanderbilt.
NCT00581503,WITHDRAWN,OBSERVATIONAL,Not NIH defined clinical trial
NCT00581529,TERMINATED,INTERVENTIONAL,The trial was terminated early because fair/poor cosmesis developed in 7 of 32 women.
NCT00581594,TERMINATED,INTERVENTIONAL,"Could not meet recruitment, technology advancement."
NCT00581997,TERMINATED,INTERVENTIONAL,Concerns about risk of bronchoscopy procedure in the selected patient population and frequency of SAEs observed to date.
NCT00582036,TERMINATED,INTERVENTIONAL,study terminated due to lack of enrollment
NCT00582114,TERMINATED,INTERVENTIONAL,Stopped by data safety monitoring board
NCT00582166,TERMINATED,INTERVENTIONAL,See 'Limitations and Caveats' section
NCT00582205,TERMINATED,INTERVENTIONAL,Study completed per investigator.
NCT00582374,WITHDRAWN,OBSERVATIONAL,PI passed away unexpectedly
NCT00582400,TERMINATED,INTERVENTIONAL,recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT00582582,TERMINATED,INTERVENTIONAL,Lack of drug supply for doxercalciferol for this study
NCT00582608,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00582712,TERMINATED,INTERVENTIONAL,Budget/Funding
NCT00582790,TERMINATED,INTERVENTIONAL,slow accrual
NCT00582816,TERMINATED,INTERVENTIONAL,toxicity
NCT00582868,TERMINATED,OBSERVATIONAL,Insufficient subject enrollment
NCT00583102,TERMINATED,INTERVENTIONAL,"Slow accrual, PI left institution"
NCT00583115,TERMINATED,INTERVENTIONAL,Unable to enroll subjects
NCT00583284,TERMINATED,OBSERVATIONAL,key study staff left foundation
NCT00583310,TERMINATED,INTERVENTIONAL,PI left institution
NCT00583388,WITHDRAWN,OBSERVATIONAL,"PI is leaving the Institution, IRB will close the protocol."
NCT00583427,WITHDRAWN,INTERVENTIONAL,This study put on inactive status due to no identifiable subjects to enter the protocol.
NCT00583531,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00583557,TERMINATED,INTERVENTIONAL,Sponsor decision - not related to safety
NCT00583622,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00583648,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00583895,TERMINATED,INTERVENTIONAL,Recruitment problems; insufficient number of new recruits
NCT00583921,WITHDRAWN,OBSERVATIONAL,no subjects enrolled
NCT00583960,WITHDRAWN,OBSERVATIONAL,PI chose not to proceed with study.
NCT00584012,TERMINATED,INTERVENTIONAL,Funding issues
NCT00584025,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to personnel limitations.
NCT00584051,TERMINATED,OBSERVATIONAL,investigator closed study
NCT00584090,WITHDRAWN,INTERVENTIONAL,"Study withdrawn with intent of persuing larger, multi-site study."
NCT00584155,WITHDRAWN,INTERVENTIONAL,PI left the university.
NCT00584207,TERMINATED,INTERVENTIONAL,Unsufficient referrals for recruitment
NCT00584246,WITHDRAWN,INTERVENTIONAL,Study stopped due to budget (personnel) limitations.
NCT00584337,WITHDRAWN,OBSERVATIONAL,It was decided to not proceed with the study at this time.
NCT00584389,TERMINATED,INTERVENTIONAL,Suspension of licence for rimonabant by European Medicines Agency
NCT00584545,WITHDRAWN,OBSERVATIONAL,Study never got started.
NCT00584623,WITHDRAWN,OBSERVATIONAL,Did not find interested patients.
NCT00584636,WITHDRAWN,INTERVENTIONAL,study halted prematurely before enrollment of first patient
NCT00584649,TERMINATED,INTERVENTIONAL,Study closed out when PI left the university.
NCT00584675,WITHDRAWN,INTERVENTIONAL,Funding was never received so no patients were enrolled.
NCT00584688,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT00584714,TERMINATED,OBSERVATIONAL,Discontinued PB127 development program for business reasons
NCT00584740,TERMINATED,INTERVENTIONAL,The study was terminated prematurely after futility criterion was met at planned interim analysis of 41 patients.
NCT00584753,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00584779,TERMINATED,INTERVENTIONAL,See detailed description for termination reason
NCT00584896,TERMINATED,INTERVENTIONAL,Discontinued PB127 development program for business reasons
NCT00584909,TERMINATED,INTERVENTIONAL,low accrual
NCT00585000,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00585026,TERMINATED,INTERVENTIONAL,PI left UAB; protocol administratively terminated by UAB IRB.
NCT00585052,TERMINATED,INTERVENTIONAL,"Slow accrual, PI left the institution"
NCT00585117,TERMINATED,INTERVENTIONAL,change in imaging priorities
NCT00585156,TERMINATED,INTERVENTIONAL,New clinical finding with Celebrex and cardiac concerns.
NCT00585208,TERMINATED,INTERVENTIONAL,sponsor terminated study
NCT00585221,TERMINATED,INTERVENTIONAL,PI terminated at the recommendation of DSMC \& IRB
NCT00585234,WITHDRAWN,OBSERVATIONAL,Study has been withdrawn.
NCT00585312,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00585403,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00585416,TERMINATED,INTERVENTIONAL,Further evaluation of phase I dosing
NCT00585429,WITHDRAWN,OBSERVATIONAL,key personnel left institution
NCT00585442,TERMINATED,INTERVENTIONAL,Lack of quality data
NCT00585455,TERMINATED,OBSERVATIONAL,PI change in institution
NCT00585546,TERMINATED,INTERVENTIONAL,No longer could obtain clenbuterol
NCT00585585,TERMINATED,INTERVENTIONAL,Lack of participants
NCT00585611,TERMINATED,INTERVENTIONAL,Unable to recruit into the study
NCT00585819,WITHDRAWN,INTERVENTIONAL,lack of interest
NCT00585858,TERMINATED,OBSERVATIONAL,PI leaving institution
NCT00585871,WITHDRAWN,INTERVENTIONAL,could not recruit
NCT00585923,TERMINATED,INTERVENTIONAL,Due to lack of follow-up information
NCT00586170,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00586209,TERMINATED,INTERVENTIONAL,Inadequate clinical supplies and Emmaus business decision.
NCT00586261,TERMINATED,INTERVENTIONAL,Low enrollment because of the specifics of the inclusion criteria
NCT00586274,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00586365,WITHDRAWN,INTERVENTIONAL,Too difficult to satisfy all the inclusion criteria.
NCT00586404,TERMINATED,OBSERVATIONAL,lack of enrollment
NCT00586716,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00586807,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00586859,TERMINATED,INTERVENTIONAL,Sponsoring company ceased business operations.
NCT00586976,TERMINATED,INTERVENTIONAL,Stopped by DSMB due to increased wound infection rate.
NCT00587015,TERMINATED,INTERVENTIONAL,Due to a lack of IP supply and then terminated because they were combined into one new study with the new IP formulation.
NCT00587028,TERMINATED,OBSERVATIONAL,Administrative closed due to funding
NCT00587119,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00587132,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00587171,TERMINATED,INTERVENTIONAL,This study was stopped due to insufficient recruitment.
NCT00587223,TERMINATED,INTERVENTIONAL,Insufficient patient enrollment
NCT00587275,TERMINATED,INTERVENTIONAL,Terminated for lack of enrollment
NCT00587379,WITHDRAWN,INTERVENTIONAL,Study closed per the request of PI due to lack of participant accrual
NCT00587457,TERMINATED,INTERVENTIONAL,The study is terminated early due to unavailability of investigational product.
NCT00587548,TERMINATED,INTERVENTIONAL,Decided not pursue the study
NCT00587730,TERMINATED,INTERVENTIONAL,Recruiting or enrolling participants has halted prematurely and will not resume.
NCT00587795,TERMINATED,INTERVENTIONAL,Inability to enroll subjects
NCT00587847,TERMINATED,INTERVENTIONAL,Insufficient recruitment.
NCT00587899,TERMINATED,INTERVENTIONAL,enrollment has been lower than anticipated due to growth in the minimally invasive mitral valve repair practice.
NCT00587990,TERMINATED,INTERVENTIONAL,Difficulty in recruitment.
NCT00588146,TERMINATED,INTERVENTIONAL,Schering-Plough discontinued supplying study drug.
NCT00588172,WITHDRAWN,INTERVENTIONAL,No funding
NCT00588250,TERMINATED,INTERVENTIONAL,Implantation rate significantly lower in treatment group than Controls.
NCT00588263,WITHDRAWN,OBSERVATIONAL,Data from MSK-IMPACT is sufficient for relevant analyses going forward
NCT00588354,TERMINATED,INTERVENTIONAL,Targeted enrollment was not reached.
NCT00588458,WITHDRAWN,INTERVENTIONAL,There is no participant enrolled in this study since developing this trial and other cholangiographic techniques are more available in our institute.
NCT00588471,TERMINATED,INTERVENTIONAL,The study was terminated because not enough subjects could be recruited.
NCT00588588,WITHDRAWN,INTERVENTIONAL,Due to inability to get support for the study
NCT00588822,TERMINATED,INTERVENTIONAL,Discontinuation due to the high response rate at the 1st stage and slow accrual.
NCT00588848,TERMINATED,INTERVENTIONAL,Difficulty with enrollment
NCT00588861,TERMINATED,INTERVENTIONAL,Study was terminated due to insufficient data and lack of patient follow-up
NCT00589251,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00589303,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00589316,TERMINATED,INTERVENTIONAL,Terminated due to loss of funding
NCT00589329,TERMINATED,INTERVENTIONAL,published data suggest potential harm in other investigations.
NCT00589407,TERMINATED,OBSERVATIONAL,there is a problem in recruting the paricipents
NCT00589485,WITHDRAWN,OBSERVATIONAL,Sponsor did not fund the study
NCT00589524,WITHDRAWN,INTERVENTIONAL,Difficult recruitment -
NCT00589550,TERMINATED,INTERVENTIONAL,low accrual
NCT00589602,TERMINATED,INTERVENTIONAL,slow accrual
NCT00589693,TERMINATED,INTERVENTIONAL,Observed lower cure rates and higher mortality rates in one of the treatment groups.
NCT00589862,WITHDRAWN,INTERVENTIONAL,Failure to secure adequate funding
NCT00590135,TERMINATED,INTERVENTIONAL,Poor Reducibility - primary endpoint measure not obtainable
NCT00590291,TERMINATED,OBSERVATIONAL,Sequencing completed early
NCT00590369,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT00590408,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00590460,TERMINATED,INTERVENTIONAL,slow accrual
NCT00590538,TERMINATED,INTERVENTIONAL,12/15/2008 Voluntarily placed on inactive status-requested by the PI
NCT00590551,TERMINATED,INTERVENTIONAL,unable to recruit patients for study
NCT00590603,TERMINATED,INTERVENTIONAL,Poor accrual - terminated during Phase I; Phase II never started.
NCT00590720,TERMINATED,INTERVENTIONAL,Study is replaced by MI-CP198 per CPM.
NCT00590889,TERMINATED,INTERVENTIONAL,A post-PMA begun in 1998; enrollment halted in 2000 due to an anomaly in one study arm. The protocol required annual study visits after 2000.
NCT00590967,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT00591019,TERMINATED,INTERVENTIONAL,Terminated early due to lack of change in primary and secondary outcome measures.
NCT00591149,TERMINATED,INTERVENTIONAL,Study was stopped due to termination of funding
NCT00591162,TERMINATED,INTERVENTIONAL,terminated due to PI lab/duties affected by natural disaster.
NCT00591305,TERMINATED,INTERVENTIONAL,insufficient resource for recruitment
NCT00591318,TERMINATED,INTERVENTIONAL,Study was terminated after enrolling 12 patients due to poor enrollment rates
NCT00591357,SUSPENDED,INTERVENTIONAL,Lack of personnel to complete trial
NCT00591461,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT00591474,TERMINATED,INTERVENTIONAL,Participant lost to followup
NCT00591539,TERMINATED,OBSERVATIONAL,Slow Accrual.
NCT00591604,WITHDRAWN,INTERVENTIONAL,hurricane caused closure of hospital with PI not associated with Shriners Hospital for children
NCT00591669,TERMINATED,INTERVENTIONAL,Data storage damage plus unexpected loss of funding
NCT00591877,WITHDRAWN,INTERVENTIONAL,"Unable to enroll elegible subjects. No subjects enrolled, study closed."
NCT00591916,WITHDRAWN,INTERVENTIONAL,"Donor site material (scarlet red ) came back on the market, therefore new treatements for donor sites was not needed."
NCT00592007,TERMINATED,INTERVENTIONAL,Study was terminated due to slow subject accrual
NCT00592085,WITHDRAWN,INTERVENTIONAL,No patients registered; study terminated.
NCT00592228,TERMINATED,INTERVENTIONAL,due to slow enrollment
NCT00592280,TERMINATED,INTERVENTIONAL,Logistic problems with adequately timely organ collection and transport
NCT00592306,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00592319,TERMINATED,INTERVENTIONAL,"03/01/2009,due to date close to termination of this funding/study period"
NCT00592358,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT00592410,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT00592423,TERMINATED,INTERVENTIONAL,Preliminary data was inconclusive to warrant keeping the study open.
NCT00592436,TERMINATED,OBSERVATIONAL,New protocol developed for recruitment of children for all child studies
NCT00592566,TERMINATED,INTERVENTIONAL,Numbe of eligible patients has been decreased over time.
NCT00592631,TERMINATED,INTERVENTIONAL,Key investigator resigned
NCT00592683,TERMINATED,INTERVENTIONAL,Supply Omega-3 Fatty Acids expired and supplier no longer made same composition.
NCT00592800,TERMINATED,OBSERVATIONAL,Lack of study funding \& resources
NCT00592852,TERMINATED,INTERVENTIONAL,Slow subject recruitment.
NCT00593021,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT00593164,WITHDRAWN,INTERVENTIONAL,Funding for study is currently unavailable.
NCT00593229,TERMINATED,OBSERVATIONAL,"study stopped at this site, as investigator left the institution"
NCT00593320,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT00593541,TERMINATED,OBSERVATIONAL,Principal Investigator is deceased
NCT00593554,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00593619,SUSPENDED,INTERVENTIONAL,Interim Analysis and review by Data Safety Monitoring Board
NCT00593645,TERMINATED,INTERVENTIONAL,toxicities were worse than expected
NCT00593658,TERMINATED,INTERVENTIONAL,Poor tolerability of drug and side effects
NCT00593853,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00593905,WITHDRAWN,OBSERVATIONAL,study not started not an ACT
NCT00593931,TERMINATED,INTERVENTIONAL,Principal Investigator is deceased
NCT00593957,TERMINATED,INTERVENTIONAL,Study changed to a placebo controlled trial of dextromethorphan
NCT00594009,TERMINATED,INTERVENTIONAL,due to loss of key personnel due to illness and sabbatical of thePI
NCT00594074,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT00594139,WITHDRAWN,INTERVENTIONAL,Reprioritization of study programs
NCT00594230,TERMINATED,INTERVENTIONAL,"Per protocol, the results of a planned interim analysis demonstrated insufficient efficacy and led to early termination of the study."
NCT00594308,TERMINATED,INTERVENTIONAL,Treatment ineffective
NCT00594321,WITHDRAWN,INTERVENTIONAL,Sponsor closed the trial before it began
NCT00594334,WITHDRAWN,INTERVENTIONAL,Never started
NCT00594555,WITHDRAWN,INTERVENTIONAL,"Principal Investigator resigned position with the University of Cincinnati, closing study at this site will reopen study in new position"
NCT00594594,TERMINATED,INTERVENTIONAL,Unable to recruit enough patients to continue on with the study.
NCT00594620,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual and without sufficient patients or data to report on any outcomes.
NCT00594685,TERMINATED,OBSERVATIONAL,Low accrual rate
NCT00594750,SUSPENDED,OBSERVATIONAL,The restrictions on research imposed for the COVID-19 pandemic prevented us from continuing recruitment and visits. At this stage our funding is not sufficient to continue enrollment so we will put the study in a hold pattern.
NCT00594854,TERMINATED,INTERVENTIONAL,POZEN agreed with FDA to stop study due to low and inadequate enrollment
NCT00594906,TERMINATED,INTERVENTIONAL,The study was terminated due to poor enrollment.
NCT00594971,WITHDRAWN,INTERVENTIONAL,Recruitment problems has forced us to change the design of this study from a clinical trial to a comparative study of 3 different groups of patients.
NCT00595023,TERMINATED,OBSERVATIONAL,GeneSearch BLN Assay has been voluntarily withdrawn from the US market.
NCT00595166,TERMINATED,OBSERVATIONAL,"Design changed to observational, not RCT. PI left USF; study closed."
NCT00595296,TERMINATED,OBSERVATIONAL,GeneSearch BLN Assay has been voluntarily withdrawn from the US market.
NCT00595530,TERMINATED,INTERVENTIONAL,Lack of enrollment and patient interest in study
NCT00595582,TERMINATED,INTERVENTIONAL,For various reasons.
NCT00595634,TERMINATED,OBSERVATIONAL,Could not power primary endpoint due to lost to follow-up rate
NCT00595647,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00595920,TERMINATED,INTERVENTIONAL,Financial Constraints
NCT00595985,TERMINATED,INTERVENTIONAL,"low response rate, no evidence of PFS or OS improved."
NCT00596024,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00596336,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT00596453,TERMINATED,INTERVENTIONAL,Unable to recruit enough patients
NCT00596492,TERMINATED,INTERVENTIONAL,Terminated due to reasons unrelated to safety
NCT00596544,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT00596778,TERMINATED,INTERVENTIONAL,terminated
NCT00596830,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00596856,WITHDRAWN,INTERVENTIONAL,Published study provided evidence that intervention would provide little effect; study not approved by provider community.
NCT00596947,TERMINATED,INTERVENTIONAL,due to low study enrollment
NCT00596973,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT00597116,TERMINATED,INTERVENTIONAL,Recruitment stopped according to early stopping rule (by protocol)
NCT00597181,TERMINATED,INTERVENTIONAL,Patient population limited
NCT00597441,TERMINATED,INTERVENTIONAL,accrual of evaluable subjects too low
NCT00597480,TERMINATED,INTERVENTIONAL,no more inclusions
NCT00597545,TERMINATED,INTERVENTIONAL,Half of DM patients had EEG changes and therefore were excluded.
NCT00597597,TERMINATED,INTERVENTIONAL,not enough patients enrolled
NCT00597649,TERMINATED,INTERVENTIONAL,The 001 trial did not show benefit versus placebo
NCT00597792,TERMINATED,INTERVENTIONAL,Sponsoring company ceased business operations
NCT00597909,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of enrollment and business decisions.
NCT00598091,TERMINATED,INTERVENTIONAL,"Low accrual, unable to meet endpoint in timely manner"
NCT00598104,WITHDRAWN,INTERVENTIONAL,"Due to the lack of enrolment and complexity of design, this study in asthma was terminated. No subjects have been dosed for this study."
NCT00598429,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of recruitment
NCT00598494,TERMINATED,OBSERVATIONAL,Main bedrest study moved to Texas. No enrollment at Cleveland Clinic.
NCT00598598,TERMINATED,OBSERVATIONAL,funding issues
NCT00598754,WITHDRAWN,OBSERVATIONAL,Funding issues
NCT00598767,TERMINATED,OBSERVATIONAL,funding issues
NCT00598858,WITHDRAWN,INTERVENTIONAL,Halted due to zero accrual and lack of funding
NCT00598871,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00598910,TERMINATED,INTERVENTIONAL,The study was discontinued prematurely on December 18 2008 due to slow recruitment
NCT00598923,TERMINATED,INTERVENTIONAL,End of funding and low enrollment
NCT00598936,TERMINATED,OBSERVATIONAL,Investigator considered the device with no clinical utility.
NCT00598988,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT00599053,TERMINATED,INTERVENTIONAL,Enrollment was terminated early due to a change in practice on the obstetrical side that included administering azithromycin to women with preterm labor.
NCT00599131,TERMINATED,INTERVENTIONAL,The study was discontinued prematurely due to early stopping rules.
NCT00599287,TERMINATED,INTERVENTIONAL,Inclusion rate too low due to a lack of eligible patients and difficulties obtaining informed consent.
NCT00599534,WITHDRAWN,INTERVENTIONAL,Principal Investigator has transferred to another Institution
NCT00599651,TERMINATED,INTERVENTIONAL,Study was closed due to extremely low enrollment
NCT00599963,WITHDRAWN,INTERVENTIONAL,Funding problem.
NCT00600093,TERMINATED,INTERVENTIONAL,PI leaving the institute for a fellowship.
NCT00600145,WITHDRAWN,INTERVENTIONAL,PI decision
NCT00600210,WITHDRAWN,INTERVENTIONAL,low patient accrual
NCT00600691,TERMINATED,INTERVENTIONAL,Did not achieve enrollment goal and decided to terminate early
NCT00600730,WITHDRAWN,INTERVENTIONAL,Funding not available. Could not start this study.
NCT00600743,TERMINATED,INTERVENTIONAL,Drug expired before was completed.
NCT00601120,WITHDRAWN,INTERVENTIONAL,This protocol was never officially opened and no patients were recruited.
NCT00601198,TERMINATED,INTERVENTIONAL,Funding support withdrawn
NCT00601289,WITHDRAWN,INTERVENTIONAL,funding term ended
NCT00601341,TERMINATED,INTERVENTIONAL,Anticipated that results would not be conclusive
NCT00601614,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT00601848,TERMINATED,INTERVENTIONAL,Poor accrual and change in standards of care
NCT00601861,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT00601926,TERMINATED,INTERVENTIONAL,Poor patient accrual. Attempts to open at other sites unsuccessful.
NCT00601978,WITHDRAWN,INTERVENTIONAL,Business decision brand strategy; no patients enrolled
NCT00601991,WITHDRAWN,INTERVENTIONAL,Another study was opened.
NCT00602147,TERMINATED,OBSERVATIONAL,"The original PI on this study left VICC, thus study was closed."
NCT00602329,TERMINATED,INTERVENTIONAL,Due to Poor accrual
NCT00602446,TERMINATED,INTERVENTIONAL,Due to slow accrual of patients
NCT00602680,TERMINATED,INTERVENTIONAL,Insufficient expected benefit risk
NCT00602745,TERMINATED,INTERVENTIONAL,Following the termination of development and commercialization agreement for S-1 with Taiho Pharmaceutical
NCT00603109,TERMINATED,INTERVENTIONAL,Drug side effects leading to premature stop
NCT00603200,WITHDRAWN,OBSERVATIONAL,Principal Investigator left institution
NCT00603408,TERMINATED,INTERVENTIONAL,Study was discontinued due to lack of accrual.
NCT00603525,TERMINATED,INTERVENTIONAL,Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.
NCT00603564,TERMINATED,INTERVENTIONAL,The study was prematurely interrupted because patients randomized to CPAP reached the endpoint quicker than anticipated in the protocol
NCT00603577,TERMINATED,INTERVENTIONAL,development of product discontinued
NCT00603655,TERMINATED,INTERVENTIONAL,Higher drop out than expected. Lower Statistical Power.
NCT00603785,WITHDRAWN,INTERVENTIONAL,Insufficient funds available
NCT00603824,WITHDRAWN,INTERVENTIONAL,PI relocated
NCT00603941,TERMINATED,INTERVENTIONAL,"Due to low enrollment, no participant had a dose limiting toxicity, therefore a maximum tolerated dose could not be established"
NCT00604305,WITHDRAWN,INTERVENTIONAL,Company could not supply the accommodating intraocular lenses for the study
NCT00604461,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00604474,WITHDRAWN,INTERVENTIONAL,Not sufficient enrollment
NCT00604552,TERMINATED,INTERVENTIONAL,Mutual agreement between FDA closed the 522 postmarket surveillance Registry.
NCT00604565,TERMINATED,INTERVENTIONAL,major planned changes to study design
NCT00604942,TERMINATED,INTERVENTIONAL,prototype catheter never delivered
NCT00605046,TERMINATED,INTERVENTIONAL,Scans showed no visual difference between affected subjects \& healthy volunteers
NCT00605059,TERMINATED,INTERVENTIONAL,Scans showed no visual difference between affected subjects \& healthy volunteers
NCT00605189,TERMINATED,INTERVENTIONAL,Study no longer met business objectives
NCT00605384,TERMINATED,INTERVENTIONAL,Business Objectives Have Changed
NCT00605800,WITHDRAWN,OBSERVATIONAL,Study was closed due to logistical issues.
NCT00605995,TERMINATED,INTERVENTIONAL,Enrollment was slower than anticipated by the investigators and the funding research foundation.
NCT00606099,WITHDRAWN,INTERVENTIONAL,study was cancelled
NCT00606151,TERMINATED,OBSERVATIONAL,subject enrollment goals not met
NCT00606333,TERMINATED,INTERVENTIONAL,The NEVO stent will not be commercialized. Cordis have decided to close the study after 3 years. This decision took the absence of safety signals into account.
NCT00606463,TERMINATED,INTERVENTIONAL,Abbott funding allocated to a different project.
NCT00606541,TERMINATED,INTERVENTIONAL,The study was terminated by the sponsor due to budgetary issues
NCT00606554,TERMINATED,INTERVENTIONAL,Slow recruitment of subjects
NCT00606606,WITHDRAWN,INTERVENTIONAL,This is not a human subject's study. Protocol registered in error. This protocol studied nursing homes as a unit.
NCT00606736,WITHDRAWN,OBSERVATIONAL,it's difficult to recruit enough participants eligible for this study
NCT00606788,SUSPENDED,INTERVENTIONAL,Interim analysis indicated that sample size of study patients had to be highly increased to obtain significant outcomes.
NCT00606970,WITHDRAWN,INTERVENTIONAL,FDA sent letter to IRB stating it should be done under new drug application
NCT00607152,TERMINATED,INTERVENTIONAL,the patient enrollment is too difficult
NCT00607425,TERMINATED,OBSERVATIONAL,Change in isolation method
NCT00607438,TERMINATED,INTERVENTIONAL,Low accrual
NCT00607477,TERMINATED,INTERVENTIONAL,Study has been terminated due to poor accrual.
NCT00607711,SUSPENDED,INTERVENTIONAL,IND was withdrawn
NCT00607841,TERMINATED,INTERVENTIONAL,Trial stopped for administrative reasons prior to official determination of MTD.
NCT00607867,TERMINATED,INTERVENTIONAL,The funding ended before the study was completed.
NCT00607971,TERMINATED,INTERVENTIONAL,Terminated due to insufficient efficacy over placebo in Study ATL1251/038/CL.
NCT00608140,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient numbers of patients.
NCT00608231,WITHDRAWN,INTERVENTIONAL,Intraoperative recording could not be maintained for required period
NCT00608465,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00608517,TERMINATED,INTERVENTIONAL,slow accrual
NCT00608595,TERMINATED,INTERVENTIONAL,low accrual
NCT00608751,TERMINATED,INTERVENTIONAL,Lack of accrual and software issues
NCT00608777,TERMINATED,INTERVENTIONAL,Withdrawal of marketing autorization of efalizumab by the EMEA.
NCT00608881,TERMINATED,INTERVENTIONAL,Futility analysis failed to showed likelihoo of benefit of CoQ 2400 mg/day.
NCT00608894,TERMINATED,INTERVENTIONAL,Study was discontinued due to slow enrollment
NCT00609154,TERMINATED,INTERVENTIONAL,Per source documents the study was terminated well in advance of targeted enrollment. A method for the analysis of insulin and proinsulin samples was never fully developed and validated. Study terminated upon expiration of IRB approval
NCT00609180,TERMINATED,INTERVENTIONAL,The Omega arm of this study was stopped for futility. The EDEN arm continues to recruit patients as a separate independent study.
NCT00609440,TERMINATED,INTERVENTIONAL,terminated
NCT00609544,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients
NCT00609622,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00609661,WITHDRAWN,OBSERVATIONAL,Assay for stem cell analysis not available
NCT00609739,TERMINATED,INTERVENTIONAL,Low accrual
NCT00609765,TERMINATED,INTERVENTIONAL,Development of new chemotherapy standard of care for treatment rendered the trial obsolete.
NCT00609817,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00610207,TERMINATED,INTERVENTIONAL,Study stopped early due to staffing changes at the site.
NCT00610298,WITHDRAWN,INTERVENTIONAL,Another institution conducted and published this study.No subjects enrolled.
NCT00610311,TERMINATED,INTERVENTIONAL,The study was terminated due to low accrual.
NCT00610337,WITHDRAWN,INTERVENTIONAL,Due to a change of sponsor
NCT00610467,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00610532,TERMINATED,INTERVENTIONAL,Investigators decided not to continue
NCT00610623,TERMINATED,INTERVENTIONAL,The sponsor decided to stop the study prematurely because of financial issues
NCT00610662,WITHDRAWN,OBSERVATIONAL,Study modified and has been running as CDR0000581286 instead.
NCT00610701,TERMINATED,INTERVENTIONAL,Extremely low enrollment and very little follow-up for meaningful data
NCT00610792,WITHDRAWN,INTERVENTIONAL,Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.
NCT00610818,TERMINATED,OBSERVATIONAL,We did not see any effect of Palifermin on benign or malignant tumor growth
NCT00610831,WITHDRAWN,INTERVENTIONAL,Funding Issues
NCT00610935,TERMINATED,INTERVENTIONAL,This study was terminated for administrative reasons.
NCT00611052,TERMINATED,INTERVENTIONAL,"Unsuccessful recruitment, failed training of the group leaders leading into lack of study groups"
NCT00611065,WITHDRAWN,INTERVENTIONAL,There is no funding to proceed.
NCT00611455,TERMINATED,INTERVENTIONAL,Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.
NCT00611637,TERMINATED,INTERVENTIONAL,low accrual
NCT00611650,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00611715,TERMINATED,INTERVENTIONAL,low accrual
NCT00611858,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00611871,TERMINATED,INTERVENTIONAL,"Low enrollment, grant term expired"
NCT00612066,TERMINATED,INTERVENTIONAL,Low accrual and funding term ended
NCT00612222,TERMINATED,INTERVENTIONAL,The study was terminated due to low accrual.
NCT00612521,TERMINATED,INTERVENTIONAL,"At half the sample size, the results were negative with no benefit demonstrated with adenosine."
NCT00612677,TERMINATED,INTERVENTIONAL,slow accrual - the 1 patient accrued did not go on treatment
NCT00612833,TERMINATED,INTERVENTIONAL,FHI 360 participation in the study was terminated due to lack of funding
NCT00612846,TERMINATED,INTERVENTIONAL,Terminated early due to slow recruitment
NCT00612872,TERMINATED,INTERVENTIONAL,Results did not show reason to continue with study.
NCT00612898,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00612911,TERMINATED,OBSERVATIONAL,finish study as protocol
NCT00613392,TERMINATED,INTERVENTIONAL,Supplement expired and unable to obtain more from company manufacturing
NCT00613418,WITHDRAWN,INTERVENTIONAL,study did not move forward due to change in clinical strategy
NCT00613444,WITHDRAWN,INTERVENTIONAL,Study was never started due to logistical issues.
NCT00613509,TERMINATED,INTERVENTIONAL,"No safety concerns, the study was terminated due to slow enrollment. All enrolled patients were followed per protocol."
NCT00613535,TERMINATED,INTERVENTIONAL,"The correlation coefficient at the interim analysis with results for all three groups pooled, did not reach the level of statistical significance of (p\<0.05)."
NCT00613730,TERMINATED,INTERVENTIONAL,APPRISE closure prompted by SWOG S0205 not meeting primary endpoint-improving OS. APPRISE enrollment closure due to similar design;no unexpected safety data
NCT00613860,WITHDRAWN,INTERVENTIONAL,complicated patient enrollment
NCT00613886,TERMINATED,INTERVENTIONAL,Funding was withdrawn as number of subjects enrolled did not meet expectation
NCT00613977,WITHDRAWN,OBSERVATIONAL,Withdrawn
NCT00614458,TERMINATED,INTERVENTIONAL,Due to insufficient funds
NCT00614484,TERMINATED,INTERVENTIONAL,Low participant enrollment rates. Significant comparative data not obtained.
NCT00614601,TERMINATED,INTERVENTIONAL,Sponsor proceeded with a phase III study for same indication.
NCT00614666,TERMINATED,INTERVENTIONAL,Recruitment challenges and lack of funding caused an early end to this study
NCT00615160,TERMINATED,INTERVENTIONAL,Substance was withdrawn from further development.
NCT00615186,TERMINATED,INTERVENTIONAL,Due to delay in site initiation and funding considerations
NCT00615329,TERMINATED,OBSERVATIONAL,Huntmans Cancer Institute terminated study
NCT00615381,WITHDRAWN,INTERVENTIONAL,Study was not initiated and has been withdrawn due to lack of appropriate cases
NCT00615407,WITHDRAWN,OBSERVATIONAL,Dr. Holguin is relocating.
NCT00615472,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00615524,WITHDRAWN,INTERVENTIONAL,Cancelled Before Enrollment
NCT00615589,TERMINATED,INTERVENTIONAL,Low accrual
NCT00615628,TERMINATED,OBSERVATIONAL,low enrollment low enrollment
NCT00615719,TERMINATED,OBSERVATIONAL,Enrollment rate was too slow.
NCT00615784,TERMINATED,INTERVENTIONAL,Study terminated. Eisai's Targretin acquired by another pharmaceutical company.
NCT00616122,TERMINATED,INTERVENTIONAL,Risk to benefit ratio not acceptable
NCT00616304,SUSPENDED,INTERVENTIONAL,Local circumstances \& difficulties in site access has prevented continuation
NCT00616343,TERMINATED,INTERVENTIONAL,"Principal Investigator left the study site on December 28, 2012."
NCT00616577,TERMINATED,INTERVENTIONAL,PI is no longer here.
NCT00616603,TERMINATED,INTERVENTIONAL,PI is no longer here.
NCT00616642,TERMINATED,INTERVENTIONAL,low patient recruitment
NCT00616850,WITHDRAWN,INTERVENTIONAL,Orthopedic surgeon that does our knee surgeries moved to a different location
NCT00616902,TERMINATED,INTERVENTIONAL,This study was prematurely terminated due to low enrollment
NCT00616954,TERMINATED,INTERVENTIONAL,low recruitment
NCT00617045,WITHDRAWN,INTERVENTIONAL,poor patient recruitment
NCT00617058,TERMINATED,INTERVENTIONAL,"Terminated in lieu of similar,competing large, multi-site study."
NCT00617162,TERMINATED,INTERVENTIONAL,Business reasons
NCT00617214,TERMINATED,OBSERVATIONAL,Difficulty finding eligible sites/patients:current situation in health policy cause negative effects on existing/planned contracts for integrated care programs
NCT00617279,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment
NCT00617656,TERMINATED,INTERVENTIONAL,No safety reasons. Interim analysis shows that the hypothesis superiority of the experimental arm over the control arm- would not be confirmed.
NCT00617864,WITHDRAWN,INTERVENTIONAL,The syndrome of hyperstimulation is so rare that after one year no patients were eligible.The study was withdrawn and never started.
NCT00617890,TERMINATED,INTERVENTIONAL,"The study was prematurely terminated for strategic reasons, not for a safety concern."
NCT00617929,TERMINATED,INTERVENTIONAL,Replaced by another protocol
NCT00618293,WITHDRAWN,INTERVENTIONAL,No patient met the criteria for inclusion in the study.
NCT00618358,TERMINATED,INTERVENTIONAL,Sponsor - Confluent Surgical terminated study re: surgical techniques Letter dated 4/31/2008
NCT00618397,TERMINATED,INTERVENTIONAL,Poor recruitement
NCT00618514,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00618540,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00618644,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of eligible participants
NCT00618696,TERMINATED,INTERVENTIONAL,Replaced with another study
NCT00618917,TERMINATED,INTERVENTIONAL,MnSOD longer available during Phase II
NCT00619021,TERMINATED,INTERVENTIONAL,Funding and study drugs unavailable
NCT00619151,TERMINATED,INTERVENTIONAL,Study stopped due to lack of elegible patient enrollment
NCT00619229,TERMINATED,INTERVENTIONAL,Interim Analysis: Optimization of study design required.
NCT00619242,TERMINATED,INTERVENTIONAL,Low accrual
NCT00619346,TERMINATED,INTERVENTIONAL,"FDA Full Clinical Hold due to safety concerns, as of 12/21/07"
NCT00619515,TERMINATED,INTERVENTIONAL,Prematurely terminated at institution request
NCT00619983,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment
NCT00620048,TERMINATED,INTERVENTIONAL,Study terminated due to lack of funding.
NCT00620074,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00620100,TERMINATED,INTERVENTIONAL,the study was early terminated due to lack of recruitment.
NCT00620607,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT00620737,WITHDRAWN,INTERVENTIONAL,Company Decision
NCT00620919,TERMINATED,INTERVENTIONAL,Poor patient enrollment due to logistical issues.
NCT00620945,TERMINATED,INTERVENTIONAL,New protocol now being used for cardiopulmonary bypass
NCT00621036,WITHDRAWN,INTERVENTIONAL,MyVax did not meet its primary endpoints
NCT00621257,TERMINATED,INTERVENTIONAL,Maintenance phase outcome unattenable
NCT00621283,TERMINATED,INTERVENTIONAL,Poor patient enrollment due to logistical issues
NCT00621413,WITHDRAWN,OBSERVATIONAL,Study never moved forward due to no accrual
NCT00621439,WITHDRAWN,INTERVENTIONAL,no funding- study never began
NCT00621530,TERMINATED,INTERVENTIONAL,Terminated due to discontinuation of Acular PF (investigational medication)
NCT00621556,TERMINATED,INTERVENTIONAL,Poor patient enrollment due to logistical issues
NCT00621803,TERMINATED,INTERVENTIONAL,Recruiting or enrolling participants has halted and will not resume
NCT00622011,TERMINATED,INTERVENTIONAL,inadequate participant
NCT00622089,TERMINATED,INTERVENTIONAL,Program terminated
NCT00622141,WITHDRAWN,INTERVENTIONAL,The study was never started because the sponsor decided not to manufacture the investigational product.
NCT00622167,TERMINATED,INTERVENTIONAL,"Subject recruitment was slow, so enrollment has been closed."
NCT00622245,TERMINATED,INTERVENTIONAL,Human metabolite not yet covered sufficiently by nonclinical data
NCT00622362,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00622466,TERMINATED,INTERVENTIONAL,Study sponsor requested that the study be permanently closed by letter.
NCT00622531,TERMINATED,OBSERVATIONAL,Study terminated due to insufficient enrollment
NCT00622570,TERMINATED,INTERVENTIONAL,Slowly recruitment rate. Intermediate analysis
NCT00622687,TERMINATED,INTERVENTIONAL,sufficient number to reach the primary endpoint and as planned
NCT00622804,WITHDRAWN,INTERVENTIONAL,It was very difficult to enroll patients in this study.
NCT00622947,TERMINATED,INTERVENTIONAL,Too few patients included
NCT00623012,TERMINATED,INTERVENTIONAL,Low accrual
NCT00623025,TERMINATED,INTERVENTIONAL,Discontinued prematurely due to low enrollment
NCT00623077,TERMINATED,INTERVENTIONAL,Replaced by another study
NCT00623129,TERMINATED,INTERVENTIONAL,Slow accrual; did not meet accrual goal
NCT00623909,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institution
NCT00623948,WITHDRAWN,INTERVENTIONAL,Suitable implanted technolgy was not available
NCT00623974,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00624299,WITHDRAWN,INTERVENTIONAL,"A similar study had already been conducted, therefore pursuing this trial would have been unethical"
NCT00624468,TERMINATED,INTERVENTIONAL,EMD Serono voluntarily decided to terminate this trial after observing increased MS disease activity in trial 28063 ATAMS \[Please refer to ATAMS\]
NCT00624520,TERMINATED,INTERVENTIONAL,"Exhaustion of subject population pool, greater than expected drop-out rates . Data analysis approved by DMC for study completions"
NCT00624546,TERMINATED,OBSERVATIONAL,Expected recruitment numbers have not been achieved.
NCT00624962,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT00624975,TERMINATED,INTERVENTIONAL,one of site was not able to get an approval from the national regulatory authority.
NCT00625040,TERMINATED,OBSERVATIONAL,Not enough patients in the follow-up period
NCT00625079,WITHDRAWN,INTERVENTIONAL,inclusion/exclusion criteria limited enrollment
NCT00625183,TERMINATED,INTERVENTIONAL,Withdrawn due to poor/low accrual
NCT00625469,WITHDRAWN,INTERVENTIONAL,competing studies did not allow enrollment
NCT00625586,TERMINATED,INTERVENTIONAL,Corporate decision
NCT00625729,TERMINATED,INTERVENTIONAL,No patients exhibited natural killer cell expansion (primary endpoint).
NCT00625742,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00625833,TERMINATED,INTERVENTIONAL,Study was terminated for futility following the planned interim analysis.
NCT00625872,TERMINATED,INTERVENTIONAL,The study terminated on 19-Jan-2011 due to insufficient recruitment of patients. No safety reasons contributed to the termination of the study.
NCT00626197,TERMINATED,INTERVENTIONAL,Study was terminated due to an imbalance of serious and opportunistic infections in the ocrelizumab treated patients versus the placebo arm.
NCT00626444,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00626548,TERMINATED,INTERVENTIONAL,early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints
NCT00626561,TERMINATED,INTERVENTIONAL,Due to slow accrual.
NCT00626574,TERMINATED,INTERVENTIONAL,This study is terminated as a result of data from a study that showed increased mortality in stroke patients.
NCT00626600,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00626626,TERMINATED,INTERVENTIONAL,Investigator decision
NCT00627419,TERMINATED,INTERVENTIONAL,Study closed \& recruitment will not recommence
NCT00627471,TERMINATED,INTERVENTIONAL,Low recruitment in spite of strategies implemented
NCT00627497,TERMINATED,INTERVENTIONAL,slow patient recruitment
NCT00627627,WITHDRAWN,INTERVENTIONAL,Redirect focus of the indication
NCT00627783,TERMINATED,INTERVENTIONAL,Poor recruiting status
NCT00627835,WITHDRAWN,INTERVENTIONAL,Site decided not to open this study
NCT00627861,TERMINATED,INTERVENTIONAL,The renin laboratory used in the study is no longer available.
NCT00627913,TERMINATED,INTERVENTIONAL,Study terminated due to insufficient subject participation
NCT00628264,TERMINATED,INTERVENTIONAL,The study was terminated due to a considerably lower recruitment rate than anticipated
NCT00628303,WITHDRAWN,INTERVENTIONAL,Study never officially opened for enrollment
NCT00628355,TERMINATED,INTERVENTIONAL,Lidocaine injection group showed significant improvement in pain
NCT00628797,TERMINATED,INTERVENTIONAL,lack of recruitement
NCT00629187,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of adequate enrollment.
NCT00629252,TERMINATED,INTERVENTIONAL,Not enough subjects have been recruited in the expected period.
NCT00629330,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution.
NCT00629356,WITHDRAWN,OBSERVATIONAL,The study had been revised and made a new application.
NCT00629577,TERMINATED,INTERVENTIONAL,no funding
NCT00629850,TERMINATED,INTERVENTIONAL,unable to recruit participants.
NCT00629876,TERMINATED,INTERVENTIONAL,Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.
NCT00629993,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution
NCT00630279,TERMINATED,INTERVENTIONAL,"This trial discontinued March 7,2009 due to high screen failure rate."
NCT00630292,TERMINATED,INTERVENTIONAL,Existing vessel analysis software could not be applied to breast MRI data.
NCT00630318,TERMINATED,INTERVENTIONAL,Unable to accrue enough subjects to analyze data.
NCT00630383,WITHDRAWN,INTERVENTIONAL,superceded by another similar study
NCT00630448,WITHDRAWN,OBSERVATIONAL,Prinicipal Investigator initiated study closure.
NCT00630461,TERMINATED,INTERVENTIONAL,Data collected under different protocol; funding exhuasted
NCT00630487,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00630565,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00630708,TERMINATED,INTERVENTIONAL,Significant differences observed between groups.
NCT00630760,TERMINATED,INTERVENTIONAL,Sponsor withdrew study. Accrual not completed
NCT00630890,TERMINATED,INTERVENTIONAL,investigator left UCSF and study was closed prematurely in 2008. No results to report.
NCT00630903,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00630994,TERMINATED,INTERVENTIONAL,Stopped due to slow accrual
NCT00631059,TERMINATED,INTERVENTIONAL,Haluted due to slow accrual
NCT00631137,TERMINATED,INTERVENTIONAL,Study terminated due to low accrual.
NCT00631267,TERMINATED,INTERVENTIONAL,Due to poor patient accrual
NCT00631683,WITHDRAWN,OBSERVATIONAL,Terms for legal agreements between institution and Sponsor could not be made.
NCT00632034,WITHDRAWN,INTERVENTIONAL,No funding
NCT00632294,TERMINATED,OBSERVATIONAL,Low accrual.
NCT00632424,TERMINATED,INTERVENTIONAL,Business Objectives Changed
NCT00632437,WITHDRAWN,OBSERVATIONAL,Terminated due to poor enrollment.
NCT00632541,TERMINATED,INTERVENTIONAL,Significant Toxicities Experienced
NCT00632801,TERMINATED,INTERVENTIONAL,Change in procedure nd medication used instead of gum
NCT00632827,TERMINATED,INTERVENTIONAL,Manufacturing shortage of both Diftitox and Doxil
NCT00632970,TERMINATED,INTERVENTIONAL,no patients completed
NCT00633061,TERMINATED,INTERVENTIONAL,Futility; unable to complete screening due to clinical practice change
NCT00633087,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00633230,WITHDRAWN,INTERVENTIONAL,No funding secured
NCT00633308,WITHDRAWN,INTERVENTIONAL,No coordinator available to work on study.
NCT00633477,TERMINATED,INTERVENTIONAL,Business Decision; No Safety Or Efficacy Concerns.
NCT00633568,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00633776,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew funding prior to study initiation
NCT00633958,TERMINATED,INTERVENTIONAL,Large phase II opened to accue same patients
NCT00633997,TERMINATED,INTERVENTIONAL,"After analysis of the existing data, it was determined that additional skin biopsy samples would not be required to determine study outcome."
NCT00634010,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00634088,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00634101,TERMINATED,INTERVENTIONAL,Study was resurrected as NCT00727558 (CR-0808)
NCT00634140,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to lack of funding support.
NCT00634166,TERMINATED,INTERVENTIONAL,FDA request as study could not serve as the confirmatory trial.
NCT00634322,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00634465,WITHDRAWN,OBSERVATIONAL,low enrollment
NCT00634478,WITHDRAWN,INTERVENTIONAL,Difficulty in recruitment. Funding issues.
NCT00634517,TERMINATED,INTERVENTIONAL,"IND voluntarily withdrawn, without prejudice"
NCT00634582,TERMINATED,INTERVENTIONAL,slow accrual
NCT00634790,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00634829,TERMINATED,INTERVENTIONAL,"IND voluntarily withdrawn, without prejudice"
NCT00634868,TERMINATED,INTERVENTIONAL,Slow patients recruitment
NCT00634894,WITHDRAWN,INTERVENTIONAL,"Study halted with no registration, the drug company sponsor withdrew support."
NCT00634933,TERMINATED,INTERVENTIONAL,The study was terminated on 21 June 2010 due to results not meeting the primary endpoint. No safety reasons contributed to the termination of the study.
NCT00634972,TERMINATED,INTERVENTIONAL,The study could not be completed as the company producing this product interrupted their supply of this medication
NCT00635024,TERMINATED,INTERVENTIONAL,"Due to competing trials, this study is permanenlty closed to patient acrrual."
NCT00635063,TERMINATED,INTERVENTIONAL,Termination is due to a combination of a device defect potentially impacting the quality of the AD 923 IMP and a major change in corporate strategy.
NCT00635076,TERMINATED,INTERVENTIONAL,Please see Detailed Description for the termination reason.
NCT00635167,TERMINATED,INTERVENTIONAL,Closed by PI final report submitted
NCT00635297,SUSPENDED,INTERVENTIONAL,Problems with patient recruitement
NCT00635362,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00635505,TERMINATED,INTERVENTIONAL,"IND voluntarily withdrawn, without prejudice"
NCT00635518,WITHDRAWN,INTERVENTIONAL,Funding was canceled and no resources are available.
NCT00635531,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00635687,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT00635726,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00636155,TERMINATED,INTERVENTIONAL,funding
NCT00636298,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00636324,TERMINATED,INTERVENTIONAL,Difficulties in recruitment - will require longer time to achieve sample size
NCT00636441,TERMINATED,INTERVENTIONAL,Study terminated due to reproducibility issues with genomics prediction model
NCT00636597,TERMINATED,OBSERVATIONAL,Not able to find enough eligible patients (200) in last 4 years.
NCT00636753,SUSPENDED,OBSERVATIONAL,this study has not finding place
NCT00636805,TERMINATED,INTERVENTIONAL,Study was halted early after 63 subjects were enrolled due to slow accrual.
NCT00636883,TERMINATED,INTERVENTIONAL,slow accrual rate
NCT00636935,WITHDRAWN,INTERVENTIONAL,No patient completed protocol
NCT00637117,WITHDRAWN,INTERVENTIONAL,The study never opened and not sure if it ever will.
NCT00637312,TERMINATED,INTERVENTIONAL,Greater-than-anticipated rate of revisions
NCT00637338,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00637364,SUSPENDED,INTERVENTIONAL,Sponsor is not proceeding with USA human trial at this time
NCT00637390,TERMINATED,INTERVENTIONAL,Genzyme will no longer supply the study drug for this trial as it does not believe the study will not fully enroll within an appropriate time frame.
NCT00637403,TERMINATED,INTERVENTIONAL,Difficulty finding the required subject population
NCT00637416,TERMINATED,INTERVENTIONAL,Enrollment challenges
NCT00637468,TERMINATED,INTERVENTIONAL,Due to results of conditional power analysis performed at the first interim analysis and due to observed spectrum of adverse events.
NCT00637494,TERMINATED,INTERVENTIONAL,DRC recommended stopping study as it had missed its primary endpoint
NCT00637624,TERMINATED,INTERVENTIONAL,Unable to recruit enough patients
NCT00637728,TERMINATED,INTERVENTIONAL,Difficulty finding the required patient population
NCT00637767,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00637780,TERMINATED,INTERVENTIONAL,Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study
NCT00637806,TERMINATED,INTERVENTIONAL,Difficulty finding the required patient population
NCT00637832,TERMINATED,INTERVENTIONAL,no information
NCT00637858,TERMINATED,INTERVENTIONAL,difficulty to enroll more subjects
NCT00637962,TERMINATED,INTERVENTIONAL,IMP expired prior to completion of recruitment
NCT00638040,WITHDRAWN,OBSERVATIONAL,the study has stopped due to no recruitment
NCT00638053,TERMINATED,INTERVENTIONAL,See reason for termination in detailed description.
NCT00638131,TERMINATED,INTERVENTIONAL,problem of recruitment
NCT00638157,TERMINATED,INTERVENTIONAL,commitment completed
NCT00638196,TERMINATED,INTERVENTIONAL,funding stopped due to slow enrollment.
NCT00638222,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00638326,TERMINATED,INTERVENTIONAL,Greater differences between randomized patients than previously anticipated
NCT00638378,TERMINATED,INTERVENTIONAL,"According to the protocol, the sponsor terminated the study after it was determined that less than 2 of the first 22 patients showed a PSA50 response."
NCT00638404,TERMINATED,OBSERVATIONAL,Further evaluation determined it was not feasible to enroll the post-partum tubal ligation group at our facility
NCT00638482,TERMINATED,INTERVENTIONAL,terminated
NCT00638625,WITHDRAWN,OBSERVATIONAL,Due to specimen collection difficulties; this study has been terminated
NCT00638820,TERMINATED,INTERVENTIONAL,Excess toxicity
NCT00638833,TERMINATED,INTERVENTIONAL,Unexpected side-effects: reversible and mild to moderate neurological impairment
NCT00638963,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual
NCT00639353,TERMINATED,INTERVENTIONAL,English to Japanese translation issues caused enrollment of incorrect and unqualified subjects; error applied to all subjects enrolled prior to termination.
NCT00639392,WITHDRAWN,INTERVENTIONAL,Ended early due to inability to identify eligible subjects
NCT00639405,TERMINATED,OBSERVATIONAL,Subject population not available.
NCT00639600,TERMINATED,INTERVENTIONAL,a new study has began recently
NCT00639626,TERMINATED,INTERVENTIONAL,PI left the institution
NCT00639795,TERMINATED,INTERVENTIONAL,inadequate sample population
NCT00639951,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT00640016,TERMINATED,INTERVENTIONAL,The study was terminated prematurely by the sponsor due to slow recruitment.
NCT00640029,TERMINATED,INTERVENTIONAL,Insuffisent recruitment
NCT00640497,WITHDRAWN,INTERVENTIONAL,Unavailability of investigational product
NCT00640549,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00640679,TERMINATED,INTERVENTIONAL,Due to slow enrollment the study was stopped prematurely.
NCT00640692,WITHDRAWN,OBSERVATIONAL,Insufficient enrollment
NCT00640705,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00640952,WITHDRAWN,INTERVENTIONAL,PI left site
NCT00640965,WITHDRAWN,INTERVENTIONAL,STUDY WAS NOT STARTED
NCT00640978,TERMINATED,INTERVENTIONAL,Significant Adverse Effects - Futility
NCT00641173,WITHDRAWN,INTERVENTIONAL,Withdrawn by funding source
NCT00641342,TERMINATED,INTERVENTIONAL,Lack of recruitment from different study sites and due to structural changes in the included centers
NCT00641511,WITHDRAWN,INTERVENTIONAL,Houston site withdrew as a study site.
NCT00641654,TERMINATED,INTERVENTIONAL,Recruitment problems in Denmark and Norway
NCT00641849,TERMINATED,INTERVENTIONAL,Terminated by PI r/t lack of funding and retirement of study personel.
NCT00642083,TERMINATED,INTERVENTIONAL,slow inclusion
NCT00642109,TERMINATED,INTERVENTIONAL,higher incidence of pain related sexual dysfunction in the TO arm
NCT00642135,TERMINATED,INTERVENTIONAL,The total number of patients has been reached.
NCT00642226,TERMINATED,INTERVENTIONAL,Due to recruiting problems and the introduction of new treatment strategies (ranibizumab and dexamethasone implant).
NCT00642356,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00642382,TERMINATED,INTERVENTIONAL,For safety concerns
NCT00642421,TERMINATED,INTERVENTIONAL,Commercial reasons
NCT00642616,TERMINATED,INTERVENTIONAL,Terminated upon recommendation of the Data Safety Monitoring Board (DSMB)
NCT00642694,TERMINATED,INTERVENTIONAL,Enrollment discontinued based on mutually agreed upon decision by PI and funding sponsor
NCT00642733,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00642746,TERMINATED,INTERVENTIONAL,Terminated due to poor enrollment and grade 3 toxicities noted during an interim analysis.
NCT00642824,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment. No statistical analyses were performed.
NCT00642902,TERMINATED,INTERVENTIONAL,Sponsor voluntarily decided to terminate trial due to increased MS disease activity in atacicept arms as compared to placebo during a routine IDMC review.
NCT00642941,TERMINATED,INTERVENTIONAL,The study was closed to further enrollment due to the decision by the Sponsor to discontinue development of R1507.
NCT00643058,TERMINATED,INTERVENTIONAL,Funding period completed.
NCT00643110,WITHDRAWN,INTERVENTIONAL,Not funded
NCT00643162,TERMINATED,INTERVENTIONAL,Interim analysis indicated recruitment was necessary beyond study capabilities.
NCT00643175,TERMINATED,OBSERVATIONAL,"Dr. Grose has left this practice, this study is terminated"
NCT00643240,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00643357,WITHDRAWN,INTERVENTIONAL,No patient recruited due to current guidelines for the pain related to burn
NCT00643591,TERMINATED,OBSERVATIONAL,Patient compliance was low.
NCT00643604,TERMINATED,INTERVENTIONAL,Due to availability of eligible subjects at center and enrollment competition with other studies.
NCT00643721,TERMINATED,OBSERVATIONAL,Record owner left institution
NCT00643864,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00643890,TERMINATED,INTERVENTIONAL,Due to financial reasons
NCT00644280,TERMINATED,INTERVENTIONAL,low recruitment
NCT00644306,TERMINATED,INTERVENTIONAL,survival advantage demonstrated
NCT00644514,TERMINATED,INTERVENTIONAL,grant funding no longer available
NCT00644592,TERMINATED,INTERVENTIONAL,supply issues with the formulation of fenofibrate that was used.
NCT00644878,TERMINATED,INTERVENTIONAL,Slower than expected enrollment
NCT00645229,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00645359,TERMINATED,OBSERVATIONAL,"Insufficient resources to evaluate pilot, second to shift in research priorities"
NCT00645450,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects and loss of study physician for new job
NCT00645515,TERMINATED,INTERVENTIONAL,"This study was terminated on November 20, 2003 because of poor recruitment. This study was not terminated due to safety/efficacy."
NCT00645619,WITHDRAWN,OBSERVATIONAL,PI is no longer with the University
NCT00646087,WITHDRAWN,INTERVENTIONAL,Pilot study determined that this study would not be feasible.
NCT00646165,TERMINATED,INTERVENTIONAL,Poor recruitment and change in development strategy
NCT00646282,TERMINATED,INTERVENTIONAL,slow enrollment and discontinued once original principal investigator left Emory
NCT00646308,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT00646373,TERMINATED,INTERVENTIONAL,"Protocol was comparing to standard of practice, which has changed over the course of slow recruitment and no longer can be used as a comparator."
NCT00646659,TERMINATED,INTERVENTIONAL,Recruitment was suspended prematurely for safety concerns and closed after IDMC review
NCT00646763,TERMINATED,INTERVENTIONAL,Accrual goal met
NCT00646893,SUSPENDED,INTERVENTIONAL,lack of appropriate funding
NCT00646971,TERMINATED,INTERVENTIONAL,Insuffisent recrutment
NCT00647140,TERMINATED,INTERVENTIONAL,Insuffisent recruitment
NCT00647192,TERMINATED,INTERVENTIONAL,Inclusion rate too low. Recruitment of further study centers too costly.
NCT00647465,TERMINATED,INTERVENTIONAL,End of the study
NCT00647972,TERMINATED,INTERVENTIONAL,"during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced to 5 mg due to safety concerns."
NCT00648375,TERMINATED,INTERVENTIONAL,inadequate recruitment
NCT00648414,TERMINATED,INTERVENTIONAL,due to multiple subjects reporting pain and burning at the phlebotomy sites after 38hr
NCT00648479,TERMINATED,INTERVENTIONAL,the company does not want to proceed yet with the study
NCT00648739,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor for administrative reasons and not due to any safety concerns.
NCT00648869,WITHDRAWN,INTERVENTIONAL,Drug was not sent
NCT00649220,TERMINATED,INTERVENTIONAL,Study terminated due to too slow enrollment
NCT00649311,TERMINATED,INTERVENTIONAL,Poor enrollment; termination not due to safety reasons.
NCT00649584,TERMINATED,INTERVENTIONAL,Sponsor decision not to enroll cohorts of combined SGN-35 and gemcitabine therapy.
NCT00650559,TERMINATED,INTERVENTIONAL,post-surgical complications in the last 2 patients
NCT00650637,TERMINATED,INTERVENTIONAL,"The study was prematurely discontinued due to administrative reasons on August 18, 2003. There were no safety concerns that led to the decision to terminate."
NCT00650754,TERMINATED,INTERVENTIONAL,Failure to recruit designed nuimebrt of subjects
NCT00650949,TERMINATED,INTERVENTIONAL,Strategic
NCT00650975,TERMINATED,INTERVENTIONAL,Slow enrollment rate.
NCT00651014,TERMINATED,INTERVENTIONAL,slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.
NCT00651131,TERMINATED,INTERVENTIONAL,terminated due to slow enrollment
NCT00651300,TERMINATED,INTERVENTIONAL,See Detailed Description field.
NCT00651326,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00651339,TERMINATED,OBSERVATIONAL,recruiting or enrolling participants has halted prematurely and will not resume
NCT00651365,TERMINATED,INTERVENTIONAL,Early termination due to increase in serum creatinine levels and minimal PD activity.
NCT00651378,TERMINATED,INTERVENTIONAL,Slow enrollment \[HIGH SCREEN FAILURE RATE\]
NCT00651391,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00651443,TERMINATED,INTERVENTIONAL,A company's strategic decision to focus on areas whereit believes it can be competitive and decided to exit Oncology
NCT00651482,TERMINATED,INTERVENTIONAL,slow accrual
NCT00651677,WITHDRAWN,INTERVENTIONAL,funding issues
NCT00651716,TERMINATED,OBSERVATIONAL,Funding unavailable
NCT00651807,TERMINATED,INTERVENTIONAL,Business Reasons
NCT00651950,WITHDRAWN,OBSERVATIONAL,Withdrawn due to lack of enrollment.
NCT00651976,TERMINATED,INTERVENTIONAL,funding unavailable
NCT00652015,WITHDRAWN,OBSERVATIONAL,Recruitment numbers could not at all been achieved in an acceptable period of time
NCT00652093,TERMINATED,INTERVENTIONAL,Removal of Darvocet from US market
NCT00652236,TERMINATED,OBSERVATIONAL,Study was terminated according the study protocol end of 2007
NCT00652249,WITHDRAWN,OBSERVATIONAL,Due to lack of enrollment.
NCT00652678,TERMINATED,OBSERVATIONAL,Lack of funding
NCT00652756,WITHDRAWN,INTERVENTIONAL,Unable to recruit adequately
NCT00652899,TERMINATED,INTERVENTIONAL,Withdrawn due to toxicity
NCT00653029,TERMINATED,OBSERVATIONAL,Difficulties with recruitment and MRI scanner became unavailable.
NCT00653107,TERMINATED,INTERVENTIONAL,The study was closed prematurely due to slow recruitment
NCT00653328,TERMINATED,INTERVENTIONAL,Abbott (drug manufacturer) discontinued manufacture of ABT-627
NCT00653536,WITHDRAWN,INTERVENTIONAL,No Patients enrolled; sponsor not providing devices anymore
NCT00653679,WITHDRAWN,INTERVENTIONAL,A paper on the same topic came out just before we wanted to start our study.
NCT00653887,TERMINATED,INTERVENTIONAL,Procedure needs to be changed
NCT00653900,WITHDRAWN,OBSERVATIONAL,insufficient funding
NCT00653952,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00654433,TERMINATED,INTERVENTIONAL,Terminated - Sponsor Decision
NCT00654641,TERMINATED,INTERVENTIONAL,Poor enrollment. No apparent treatment effect.
NCT00654667,WITHDRAWN,INTERVENTIONAL,no participant enrollment
NCT00655122,TERMINATED,INTERVENTIONAL,See Detailed Description.
NCT00655226,TERMINATED,INTERVENTIONAL,low enrollment
NCT00655642,TERMINATED,INTERVENTIONAL,Conditional analysis showed observed differences were significantly less than power calculations
NCT00655668,TERMINATED,INTERVENTIONAL,Decision not to pursue as single agent in the study population.
NCT00655694,WITHDRAWN,OBSERVATIONAL,Lead Researcher left the Department
NCT00655824,TERMINATED,INTERVENTIONAL,"The clinical development of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor."
NCT00655915,TERMINATED,OBSERVATIONAL,Study was terminated by principal investigator
NCT00655967,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT00656266,TERMINATED,INTERVENTIONAL,insufficient funding
NCT00656318,TERMINATED,OBSERVATIONAL,Funding withdrawn from study sponsor.
NCT00656916,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00657098,TERMINATED,OBSERVATIONAL,slow inclusion rate
NCT00657137,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00657228,WITHDRAWN,INTERVENTIONAL,Study did not start.
NCT00657384,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT00657449,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00657514,WITHDRAWN,INTERVENTIONAL,Insufficient enrollment
NCT00657553,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00657813,TERMINATED,INTERVENTIONAL,Data did not evidence \[123I\]MNI-330 as a useful tool in the detection of AD.
NCT00657826,TERMINATED,INTERVENTIONAL,Business decision to end study due to limited enrollment and study population
NCT00657917,TERMINATED,INTERVENTIONAL,No subjects were enrolled since the first subject completed the study 08Jun2007
NCT00658008,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00658372,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00658411,TERMINATED,INTERVENTIONAL,Closed due to slow patient accrual
NCT00658593,TERMINATED,INTERVENTIONAL,due to poor accrual
NCT00658645,TERMINATED,INTERVENTIONAL,Interim analysis showed inadequate efficacy of bifeprunox
NCT00658762,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00658801,TERMINATED,INTERVENTIONAL,difficult to register
NCT00658957,TERMINATED,INTERVENTIONAL,Business Decision
NCT00659126,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00659334,TERMINATED,INTERVENTIONAL,"AMAG not continuing with Combidex, the study drug"
NCT00659399,WITHDRAWN,INTERVENTIONAL,Low accrual
NCT00659776,TERMINATED,INTERVENTIONAL,Due to staffing shortages and lack of funding during Covid.
NCT00659867,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT00660036,TERMINATED,INTERVENTIONAL,due to new safety information
NCT00660062,TERMINATED,INTERVENTIONAL,Slow inclusion
NCT00660348,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00660595,TERMINATED,INTERVENTIONAL,To difficult to recruit patients in the acute setting
NCT00660855,TERMINATED,INTERVENTIONAL,See Detailed Description.
NCT00661011,TERMINATED,INTERVENTIONAL,The study was terminated due to too slow recruitment
NCT00661050,WITHDRAWN,OBSERVATIONAL,Terminated due to low enrollment.
NCT00661336,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to lack of patients.
NCT00661349,TERMINATED,INTERVENTIONAL,It has been impossible to achieve the number of patients defined by protocol
NCT00661466,TERMINATED,INTERVENTIONAL,Business decision
NCT00661531,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00661570,TERMINATED,INTERVENTIONAL,"Primary endpoint reached, slow accrual, leakage around"
NCT00661921,WITHDRAWN,INTERVENTIONAL,Program Development discontinued
NCT00661973,WITHDRAWN,INTERVENTIONAL,The study was withdrawn for administrative reasons
NCT00662077,WITHDRAWN,INTERVENTIONAL,Financial difficulties
NCT00662116,TERMINATED,INTERVENTIONAL,Study has been terminated early due to financial constraints.
NCT00662220,TERMINATED,INTERVENTIONAL,Due to the arrival of DAAs replacing standard of care for genotype 1 patients the VIRID study had to be terminated.
NCT00662688,TERMINATED,INTERVENTIONAL,recruitment prematurely stopped due to a lack of eligible patients.
NCT00662779,WITHDRAWN,INTERVENTIONAL,High number of screen failures-couldn't find qualified subjects in timely manner
NCT00663234,TERMINATED,INTERVENTIONAL,The study was prematurely discontinued due to administrative reasons.
NCT00663455,TERMINATED,INTERVENTIONAL,Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to methodological reasons.
NCT00663468,TERMINATED,OBSERVATIONAL,Lead surgeon retired.
NCT00663507,TERMINATED,OBSERVATIONAL,"Only 1 patient was enrolled. No funding, small number of eligible patients so would not achieve statistical power."
NCT00663624,WITHDRAWN,INTERVENTIONAL,Lack of funding for the study at the Emory site
NCT00663715,WITHDRAWN,OBSERVATIONAL,No subjects were enrolled. Sciatic blocks infrequently used for pain control.
NCT00663819,TERMINATED,INTERVENTIONAL,Per SAP
NCT00663910,TERMINATED,INTERVENTIONAL,"Of the 8 histologically proven tumors, detection of PpIX proved to be ambiguous."
NCT00663975,WITHDRAWN,INTERVENTIONAL,Study not being conducted
NCT00664066,TERMINATED,OBSERVATIONAL,The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA
NCT00664079,TERMINATED,OBSERVATIONAL,Sluggish enrollment.
NCT00664105,TERMINATED,INTERVENTIONAL,Treatment became standard.
NCT00664144,TERMINATED,INTERVENTIONAL,due to poor enrollment
NCT00664183,TERMINATED,INTERVENTIONAL,"slow enrollment , interim analysis conducted."
NCT00664196,SUSPENDED,INTERVENTIONAL,Funding
NCT00664209,TERMINATED,INTERVENTIONAL,Prevalence of H Pylori in the study population was much lower than anticipated
NCT00664378,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT00664430,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT00664469,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00664573,TERMINATED,INTERVENTIONAL,Analysis of data from 104RA202 failed to meet primary endpoint
NCT00664586,TERMINATED,INTERVENTIONAL,Funding constraints
NCT00664677,TERMINATED,INTERVENTIONAL,Funding constraints
NCT00665418,TERMINATED,INTERVENTIONAL,"Recruitment finished earlier, because all 40 patients enrolled"
NCT00665444,TERMINATED,INTERVENTIONAL,The study was terminated by the sponser due to low study enrollment.
NCT00665457,TERMINATED,INTERVENTIONAL,study drug was removed from the market and low enrollment.
NCT00665522,TERMINATED,OBSERVATIONAL,Study was terminated at the request of the company due to the recall of marketed product in Europe.
NCT00665574,TERMINATED,INTERVENTIONAL,Business decision
NCT00665652,TERMINATED,INTERVENTIONAL,The study has been suspended for slower than anticipated enrollment to date.
NCT00665665,TERMINATED,INTERVENTIONAL,The trial is terminated due to re-evaluation of the compound
NCT00665730,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment.
NCT00665769,TERMINATED,INTERVENTIONAL,Recruitment was proceeding too slowly
NCT00665821,TERMINATED,INTERVENTIONAL,From Sept./08 to April/09 only 30 subjects were recruited. It has proved extremely difficult to recruit subjects.
NCT00665964,WITHDRAWN,INTERVENTIONAL,Not funded at this time.
NCT00666081,WITHDRAWN,INTERVENTIONAL,Study Cancelled before enrollment
NCT00666393,WITHDRAWN,INTERVENTIONAL,Program Cancelled.
NCT00666419,WITHDRAWN,OBSERVATIONAL,Recruiting at schools was slower than planned. Missing data higher than acceptable.
NCT00666471,TERMINATED,INTERVENTIONAL,one PI (BM) no longer felt he had clinical equipoise regarding the intervention. No adverse events.
NCT00666497,TERMINATED,INTERVENTIONAL,Celgene terminated its collaboration agreement with MethylGene for the development of MGCD0103. All Celgene-sponsored trials with MGCD0103 with be closed.
NCT00666861,TERMINATED,OBSERVATIONAL,Pilot study superseded by a larger NHMRC funded trial
NCT00667017,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00667095,TERMINATED,INTERVENTIONAL,Study terminated early due to PI's extended medical leave.
NCT00667238,WITHDRAWN,OBSERVATIONAL,Study never started due to resource related challenges
NCT00667277,TERMINATED,INTERVENTIONAL,lack of response activity in the setting of an unacceptable toxicity profile
NCT00667420,TERMINATED,INTERVENTIONAL,Closed due to slow accrual
NCT00667472,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT00667589,TERMINATED,INTERVENTIONAL,Study was halted due to poor subject accrual.
NCT00667628,TERMINATED,INTERVENTIONAL,Terminated due to safety concerns.
NCT00667784,TERMINATED,OBSERVATIONAL,Slow accrual.
NCT00667810,TERMINATED,INTERVENTIONAL,"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns."
NCT00667849,TERMINATED,INTERVENTIONAL,Study was terminated due to futility
NCT00667901,TERMINATED,INTERVENTIONAL,"All enrollment, treatment, follow-up \& data analysis completed"
NCT00667953,TERMINATED,INTERVENTIONAL,Difficulty enrolling subjects
NCT00668265,TERMINATED,INTERVENTIONAL,"The study was not completed, the funding sponsor lost interest."
NCT00668317,TERMINATED,INTERVENTIONAL,Primary care physicians began prescribing antacid therapy for chronic cough
NCT00668356,SUSPENDED,INTERVENTIONAL,questions of the benefit efficacy/risks of ddI during the meal not resolved
NCT00668499,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew support
NCT00668564,TERMINATED,INTERVENTIONAL,Replaced by another study
NCT00668681,WITHDRAWN,INTERVENTIONAL,"Company business decision, IDE closed, no commercialization planned"
NCT00668785,TERMINATED,INTERVENTIONAL,Study was terminated due to low enrollment
NCT00669071,TERMINATED,INTERVENTIONAL,Enrollment closed
NCT00669136,TERMINATED,INTERVENTIONAL,Poor accrual and limited target patient population for future accrual. Did not complete the Phase 1 portion of the trial.
NCT00669149,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT00669461,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00669474,TERMINATED,INTERVENTIONAL,Study never started
NCT00669669,TERMINATED,INTERVENTIONAL,Terminated due to loss in funding.
NCT00669695,TERMINATED,INTERVENTIONAL,Interim analysis performed without efficient results
NCT00669799,WITHDRAWN,INTERVENTIONAL,UNABLE TO PROCEED WITH STUDY DUE TO STAFFING OF COLLABORATIVE INVESTIGATORS
NCT00669890,TERMINATED,INTERVENTIONAL,PI left institution
NCT00669903,TERMINATED,INTERVENTIONAL,"Since AZD0328 is unlikely to meet the current Target Product Profile, Astrazeneca decided to stop further development of AZD0328"
NCT00670046,TERMINATED,INTERVENTIONAL,The study was terminated per the PI decision.
NCT00670059,TERMINATED,INTERVENTIONAL,At the first prespecified interim analysis
NCT00670111,TERMINATED,INTERVENTIONAL,Difficulty in enrollment
NCT00670150,WITHDRAWN,INTERVENTIONAL,sponsor withdrew support
NCT00670202,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00670228,TERMINATED,INTERVENTIONAL,Due to Negative feasibility assessment of recruiting the planned number of subjects within the study timelines
NCT00670384,WITHDRAWN,INTERVENTIONAL,No funding.
NCT00670397,TERMINATED,INTERVENTIONAL,safety issues
NCT00670410,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00670696,WITHDRAWN,INTERVENTIONAL,No longer sponsor of trial
NCT00670748,TERMINATED,INTERVENTIONAL,A more highly selected protocol with ESO TCR opened for pts with melanoma
NCT00670956,TERMINATED,INTERVENTIONAL,Recruitment has been poor. Study drug is being offered as part of standard care of women carrying a pregnancy diagnosed with CCAM
NCT00671112,TERMINATED,INTERVENTIONAL,Treatment ineffective
NCT00671281,WITHDRAWN,INTERVENTIONAL,Study was cancelled
NCT00671333,TERMINATED,INTERVENTIONAL,Study fatigue
NCT00671463,WITHDRAWN,INTERVENTIONAL,Anticipated high risk of pancreatitis
NCT00671528,TERMINATED,INTERVENTIONAL,terminated early due to lack of recruitment \[only 3 of 207 subjects were enrolled\]
NCT00671541,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institution requested study terminated.
NCT00671554,TERMINATED,INTERVENTIONAL,Due to business considerations; not due to toxicities or adverse events.
NCT00671593,TERMINATED,INTERVENTIONAL,funding terminated
NCT00671606,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00671645,TERMINATED,INTERVENTIONAL,reaching of step 1 (recruitment of 8 patients) per protocol -\> risk assessment -\> termination because of occurance of toxicity Grade 3 and 4
NCT00671801,TERMINATED,INTERVENTIONAL,Toxicity
NCT00671983,WITHDRAWN,INTERVENTIONAL,not adequate resources
NCT00672009,TERMINATED,INTERVENTIONAL,The sponsor terminated funding for the study.
NCT00672152,TERMINATED,INTERVENTIONAL,low accrual
NCT00672178,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00672204,TERMINATED,INTERVENTIONAL,Raptiva was withdrawn from the market
NCT00672451,TERMINATED,INTERVENTIONAL,unable to meet recruitment goal
NCT00672464,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT00672568,TERMINATED,INTERVENTIONAL,"Study has been halted after completing Stage 1, for corporate reasons. No future patients will be enrolled or treated."
NCT00672633,TERMINATED,INTERVENTIONAL,Very slow recruitment.
NCT00672672,WITHDRAWN,INTERVENTIONAL,Study closed with no subjects accrued. PI decided to stop study.
NCT00672698,WITHDRAWN,OBSERVATIONAL,NOT ENOUGH DATA AVAILABLE
NCT00672724,TERMINATED,INTERVENTIONAL,Issues with data collection tool
NCT00672750,TERMINATED,OBSERVATIONAL,did not have resources to continue this study
NCT00672763,WITHDRAWN,INTERVENTIONAL,Unable to recruit adequate trial participants
NCT00673049,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00673179,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00673322,TERMINATED,INTERVENTIONAL,This study will be incorporated into another study.
NCT00673439,TERMINATED,INTERVENTIONAL,study terminated due to low accrual
NCT00673582,TERMINATED,INTERVENTIONAL,Sponsor has withdrawn the funding
NCT00673595,TERMINATED,INTERVENTIONAL,Difficulty with recruiting sujects and subjects complying with the protocol
NCT00673816,TERMINATED,INTERVENTIONAL,Inability to recruit and adequate number of participants
NCT00673829,SUSPENDED,INTERVENTIONAL,Funding
NCT00673920,TERMINATED,INTERVENTIONAL,"Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA."
NCT00673972,WITHDRAWN,INTERVENTIONAL,difficulty in recruiting patients
NCT00674011,TERMINATED,OBSERVATIONAL,Slow accrual
NCT00674037,TERMINATED,INTERVENTIONAL,default inclusion
NCT00674128,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00674141,WITHDRAWN,INTERVENTIONAL,was not approved by the ministry of health
NCT00674206,TERMINATED,INTERVENTIONAL,Sponsor funding stopped
NCT00674414,TERMINATED,INTERVENTIONAL,IDMC decision due to accrual issue (82 pts accrued / 120 expected)
NCT00674427,TERMINATED,INTERVENTIONAL,Insufficient funds
NCT00674557,TERMINATED,INTERVENTIONAL,Withdrawn as the clinical development of ATN-224 was terminated by the drug company who was providing ATN-224 for the study
NCT00674999,WITHDRAWN,INTERVENTIONAL,Hurricane- terminated study due to skin bank being destroyed
NCT00675025,TERMINATED,INTERVENTIONAL,Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.
NCT00675272,TERMINATED,INTERVENTIONAL,Routine use of corticoids became standard therapy
NCT00675324,TERMINATED,INTERVENTIONAL,The bowel was not clean when the colonoscopy was performed
NCT00675428,TERMINATED,INTERVENTIONAL,Sponsor decision due to low enrollment and not safety concerns.
NCT00675441,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00675532,WITHDRAWN,INTERVENTIONAL,Resources
NCT00675714,TERMINATED,INTERVENTIONAL,"At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data."
NCT00675727,TERMINATED,INTERVENTIONAL,DSMB reviewed data of 1st 10 subjects; determined no safety concerns. Efficacy as a single agent in this patient population was unlikely. Voluntary Termination
NCT00675753,TERMINATED,OBSERVATIONAL,Study site did not have sufficient subjects for the case group
NCT00675922,TERMINATED,INTERVENTIONAL,Data inconclusive.
NCT00676000,WITHDRAWN,INTERVENTIONAL,Due to decrease in Avaulta mesh kit usage \& inability to recruit study subjects.
NCT00676013,TERMINATED,INTERVENTIONAL,Unable to continue study following Hurricane Ike.
NCT00676143,TERMINATED,INTERVENTIONAL,"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns."
NCT00676455,TERMINATED,OBSERVATIONAL,"Low participant enrollment, Insufficient findings for data analysis"
NCT00676559,WITHDRAWN,INTERVENTIONAL,Unrelated serious adverse events involving one of the proposed medications
NCT00676650,TERMINATED,INTERVENTIONAL,Study A6181120 was prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.
NCT00676728,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT00676806,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00676871,WITHDRAWN,INTERVENTIONAL,Replacing this trial with a new trial.
NCT00677183,WITHDRAWN,OBSERVATIONAL,PI did not receive funding for this PI-initiated study. PI subsequently left the institution.
NCT00677287,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT00677326,TERMINATED,INTERVENTIONAL,Difficulty in recruiting
NCT00677521,TERMINATED,INTERVENTIONAL,poor recruitment and no student currently interested in working on this project.
NCT00677612,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT00677924,TERMINATED,INTERVENTIONAL,Due to changes in portfolio review
NCT00678002,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT00678015,TERMINATED,INTERVENTIONAL,Per protocol - interim analysis showed no significant PSA declines among the first 12 patients after 3 cycles of treatment
NCT00678041,TERMINATED,INTERVENTIONAL,Inadequate patient recruitment
NCT00678483,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00678509,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT00678548,WITHDRAWN,INTERVENTIONAL,Due to other projects priority
NCT00678587,TERMINATED,INTERVENTIONAL,GSK decision
NCT00678717,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00679029,TERMINATED,INTERVENTIONAL,drug toxicity
NCT00679055,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00679068,TERMINATED,INTERVENTIONAL,lack of recruitment of patients
NCT00679484,TERMINATED,INTERVENTIONAL,Lack of subject recruitment
NCT00679627,TERMINATED,INTERVENTIONAL,"Due to a pre-specified imbalance of deaths between treatment groups, the DSMB recommended early termination of the trial"
NCT00679666,WITHDRAWN,INTERVENTIONAL,Investigator no longer at university
NCT00679744,WITHDRAWN,INTERVENTIONAL,Due to lack of funding
NCT00679874,TERMINATED,OBSERVATIONAL,No subjects indentifiable
NCT00679926,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00680316,TERMINATED,INTERVENTIONAL,"Most patients were unable to perform the test being used to measure lung function, thus it became clear the study would not yield clinically meaningful data"
NCT00680459,TERMINATED,INTERVENTIONAL,inability to enroll adequate number of patients
NCT00680628,TERMINATED,INTERVENTIONAL,PI changed institution and impossible to solve problem with contract's sites
NCT00681044,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00681148,WITHDRAWN,INTERVENTIONAL,No funding
NCT00681174,TERMINATED,INTERVENTIONAL,Failure to enroll sufficient patients by expected deadline.
NCT00681512,TERMINATED,INTERVENTIONAL,slow accrual
NCT00681629,TERMINATED,INTERVENTIONAL,Difficulty finding eligible sites/patients; current situation in health policy cause negative effect on existing/planned contracts for integrated care program
NCT00681668,TERMINATED,INTERVENTIONAL,"Recruitment behind plan, no increase expected"
NCT00681811,TERMINATED,INTERVENTIONAL,Terminated prior to planned completion date due to lack of efficacy.
NCT00681863,TERMINATED,INTERVENTIONAL,Terminated for slow enrollment.
NCT00681876,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00682084,TERMINATED,OBSERVATIONAL,Recruitment problems
NCT00682175,TERMINATED,OBSERVATIONAL,Project not initiated
NCT00682279,WITHDRAWN,INTERVENTIONAL,Cancelled before enrollment
NCT00682500,TERMINATED,INTERVENTIONAL,Expected mortality rates in placebo and treatment groups lower than predicted
NCT00682591,WITHDRAWN,OBSERVATIONAL,Study had to be withdrawn because financial support was cancelled.
NCT00682656,TERMINATED,INTERVENTIONAL,Efficacy issues on test arm
NCT00682721,WITHDRAWN,INTERVENTIONAL,Sponsor has withdrawn support for this study and it will not be performed
NCT00682747,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00682890,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00682929,TERMINATED,INTERVENTIONAL,Unable to complete subject recruitment
NCT00683085,TERMINATED,INTERVENTIONAL,Lack of eligible patient
NCT00683254,WITHDRAWN,OBSERVATIONAL,Principal Investigator left institution. Project never started.
NCT00683267,TERMINATED,INTERVENTIONAL,Enrollment of patients has halted prematurely and will not resume. No future patients will be enrolled or treated.
NCT00683449,TERMINATED,INTERVENTIONAL,"Data from Dose Groups 1,2 and other MN-221 studies resulted in the determination of a more appropriate dosing scheme for MN-221 in subjects with asthma."
NCT00683553,TERMINATED,INTERVENTIONAL,Lack of an available patient population
NCT00683787,TERMINATED,INTERVENTIONAL,low accrual
NCT00683917,TERMINATED,INTERVENTIONAL,Repros stopped the study for safety and FDA put the study on hold for safety.
NCT00684164,WITHDRAWN,INTERVENTIONAL,Unable to complete a contract with the Sponsor
NCT00684216,TERMINATED,INTERVENTIONAL,acrual too slow
NCT00684229,WITHDRAWN,INTERVENTIONAL,investigator could not identify any patients
NCT00684242,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00684255,TERMINATED,INTERVENTIONAL,inactive
NCT00684294,TERMINATED,INTERVENTIONAL,"Since no safety issues have been reported to date in association with TAG vaccine, no further survival follow-up will be done."
NCT00684931,TERMINATED,INTERVENTIONAL,Difficulties in the organisation
NCT00684957,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00685217,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00685750,TERMINATED,INTERVENTIONAL,Slow enrolment over the last 2 years with none in the past 1 year. No increase in the number of completed subjects for 1 year and no more ongoing study subjects
NCT00685880,TERMINATED,INTERVENTIONAL,Unable to recruit adequate numbers of patients
NCT00686036,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00686270,WITHDRAWN,INTERVENTIONAL,Study was withdrawn owing to Sponsor decision
NCT00686478,WITHDRAWN,INTERVENTIONAL,The trial is not being done at this time
NCT00686699,TERMINATED,INTERVENTIONAL,The study was terminated after 9 participants completed due to lack of enrollment for 6 months.
NCT00686842,TERMINATED,INTERVENTIONAL,Drug supply unavailable.
NCT00686881,TERMINATED,INTERVENTIONAL,This study was terminated due to low enrollment
NCT00686894,TERMINATED,INTERVENTIONAL,Poor Enrollment
NCT00686972,TERMINATED,INTERVENTIONAL,PI left JHU
NCT00687388,WITHDRAWN,INTERVENTIONAL,in order to prepare a new clinical trial to evaluate with pathological change
NCT00687583,WITHDRAWN,OBSERVATIONAL,Research question deemed not of enough clinical importance to proceed.
NCT00687596,TERMINATED,INTERVENTIONAL,Terminated due to safety concerns
NCT00687609,TERMINATED,INTERVENTIONAL,"The study was discontinued early, owing to difficulties in recruiting the target sample after seven patients had been recruited."
NCT00687674,TERMINATED,INTERVENTIONAL,"Due to study design (and toxicity), this trial closed to accrual prior to opening the phase II portion."
NCT00687986,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00688220,TERMINATED,OBSERVATIONAL,PI closed study due to lack of enrollment
NCT00688545,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT00688597,TERMINATED,INTERVENTIONAL,"Per protocol, 3 sequential dose cohorts were planned. Study discontinued by Sponsor based upon serious adverse events in first 2 of 3 participants in Cohort 1."
NCT00688766,TERMINATED,INTERVENTIONAL,Based on Independent Data Monitoring Committee (IDMC) recommendation.
NCT00688935,TERMINATED,INTERVENTIONAL,Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
NCT00688948,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00689390,TERMINATED,INTERVENTIONAL,The study was terminated due to satisfaction of post-marketing commitments
NCT00689585,TERMINATED,INTERVENTIONAL,Recruitment difficult and enrolment low: decision was made to stop the study.
NCT00689767,TERMINATED,INTERVENTIONAL,Terminated ahead of schedule after completion of the 3-year follow-up time point due to Sponsor decision.
NCT00689806,WITHDRAWN,INTERVENTIONAL,Study never opened
NCT00689884,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT00690118,TERMINATED,INTERVENTIONAL,The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.
NCT00690222,TERMINATED,INTERVENTIONAL,Funding
NCT00690456,TERMINATED,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00690846,WITHDRAWN,INTERVENTIONAL,Dr. Jorizzo has withdrawn from this study due to time it is taking to start
NCT00690885,TERMINATED,INTERVENTIONAL,Insufficient patient accrual
NCT00690911,WITHDRAWN,INTERVENTIONAL,Dr. Jorizzo has decided to withdraw from this study due to the time it is taking to get the study started.
NCT00691119,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT00691288,TERMINATED,INTERVENTIONAL,Unable to enroll sufficient patients
NCT00691340,WITHDRAWN,OBSERVATIONAL,was replaced by another study. Problems with recruitment.
NCT00691418,WITHDRAWN,INTERVENTIONAL,decision made not to proceed -- no subjects were ever enrolled
NCT00691444,TERMINATED,INTERVENTIONAL,Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
NCT00691574,TERMINATED,INTERVENTIONAL,Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
NCT00691652,TERMINATED,INTERVENTIONAL,Funding ended when only one subject enrolled and subject withdrew early.
NCT00691795,WITHDRAWN,INTERVENTIONAL,Study was recently terminated due to poor enrollment - never enrolled.
NCT00691821,TERMINATED,INTERVENTIONAL,"Patients not meeting inclusion criteria, therefore recruitment rate low, terminated due to the lack of feasibility to complete the study in a timely manner."
NCT00691834,WITHDRAWN,INTERVENTIONAL,Study never received IRB approval. Study was never pursued.
NCT00691886,WITHDRAWN,INTERVENTIONAL,PI left institution prior to enrollment
NCT00691899,WITHDRAWN,INTERVENTIONAL,Withdrawn for administrative reasons
NCT00691912,TERMINATED,INTERVENTIONAL,Study was stopped due because recrutation.was much slower as anticipated.
NCT00691977,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT00692003,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00692094,TERMINATED,INTERVENTIONAL,Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
NCT00692380,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT00692458,WITHDRAWN,INTERVENTIONAL,Withdrawn for administrative reasons
NCT00692692,TERMINATED,INTERVENTIONAL,higher rate of post-operative infection in the Dermal Matrix arm of the study
NCT00692783,TERMINATED,OBSERVATIONAL,Dr. Vindas completed his fellowship + low enrollment
NCT00693017,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00693043,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institution requested termination
NCT00693082,TERMINATED,INTERVENTIONAL,recruitment and pilot funding issues
NCT00693160,TERMINATED,INTERVENTIONAL,the manufacturing of preservative free ketorolac (Acular-PF) was discontinued
NCT00693342,WITHDRAWN,INTERVENTIONAL,"Never opened to accrual, a GOG working number, not developed into a clinical trial."
NCT00693628,TERMINATED,INTERVENTIONAL,Terminated due to lack of enrollment
NCT00693953,WITHDRAWN,OBSERVATIONAL,grant was not approved.
NCT00694200,TERMINATED,INTERVENTIONAL,Not reached the statistical hypothesis at the interim analysis
NCT00694408,TERMINATED,INTERVENTIONAL,Study terminated due to withdrawal from market of Daclizumab
NCT00694603,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00694720,TERMINATED,INTERVENTIONAL,Termination following reassessment of the potential benefit-risk of AVE0657
NCT00694746,TERMINATED,INTERVENTIONAL,Study closed for slow recruitment
NCT00694785,WITHDRAWN,INTERVENTIONAL,Sponsor decided not to go forward with the study.
NCT00694967,TERMINATED,INTERVENTIONAL,Interim analysis showed no difference in outcome between treatment groups.
NCT00695058,WITHDRAWN,INTERVENTIONAL,Failure to include
NCT00695214,SUSPENDED,INTERVENTIONAL,Transfer to another institution
NCT00695370,TERMINATED,INTERVENTIONAL,Recruiting or enrolling participants has halted and will not resume
NCT00695396,TERMINATED,INTERVENTIONAL,The study was stopped due to low subject enrollment. No safety issue or other concern factored into this decision.
NCT00695448,TERMINATED,INTERVENTIONAL,This study was terminated prematurely due to lack of sufficient exposure following single- and repeat-dosing.
NCT00695487,TERMINATED,INTERVENTIONAL,"In the intermediate analysis, no effect could be shown, not even a tendency."
NCT00695552,TERMINATED,INTERVENTIONAL,The recruitment process were slower than expected. Not enough money to continoue
NCT00695604,WITHDRAWN,INTERVENTIONAL,"Study was not able to be completed, no results analyzed."
NCT00695773,TERMINATED,OBSERVATIONAL,Insufficient findings for data analysis
NCT00695903,TERMINATED,INTERVENTIONAL,terminated due to lack of enrollment
NCT00695916,WITHDRAWN,INTERVENTIONAL,PI
NCT00695968,TERMINATED,OBSERVATIONAL,low accrual
NCT00696007,WITHDRAWN,INTERVENTIONAL,Study was unable to recruit subjects meeting the study requirements.
NCT00696189,TERMINATED,OBSERVATIONAL,PI is no longer at this institution
NCT00696319,SUSPENDED,INTERVENTIONAL,Study was suspended due to lack of resources.
NCT00696462,WITHDRAWN,INTERVENTIONAL,Study terminated for lack of funds to initiate study
NCT00696501,TERMINATED,OBSERVATIONAL,One of the investigators left the Institution
NCT00696631,TERMINATED,INTERVENTIONAL,Terminated as the active treatment was associated with an increased hazard
NCT00696943,TERMINATED,INTERVENTIONAL,Replaced by a global study protocol NST-CA004
NCT00697034,TERMINATED,INTERVENTIONAL,Lack of qualified and willing volunteers.
NCT00697060,WITHDRAWN,INTERVENTIONAL,Study cancelled prior to start due to change in company priorities.
NCT00697476,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT00697593,TERMINATED,INTERVENTIONAL,The study was terminated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union
NCT00697606,TERMINATED,INTERVENTIONAL,lack of funding
NCT00697697,TERMINATED,INTERVENTIONAL,Corporate decision
NCT00697762,TERMINATED,INTERVENTIONAL,The trial was stopped based on information from the global phase 3 studies.
NCT00697827,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment.
NCT00698009,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00698139,TERMINATED,INTERVENTIONAL,Closed by Sponsor
NCT00698347,TERMINATED,OBSERVATIONAL,Centers would not continue follow-up; two centers transitioned patients to a new study.
NCT00698503,TERMINATED,OBSERVATIONAL,due to low follow up
NCT00698542,TERMINATED,OBSERVATIONAL,The study design failed and the data was not able to be analyzed.
NCT00698581,TERMINATED,INTERVENTIONAL,An interim analysis revealed the study was unlikely to attain a positive outcome for the efficacy analysis. No safety concerns were detected.
NCT00698633,TERMINATED,OBSERVATIONAL,due to low follow up
NCT00698685,TERMINATED,INTERVENTIONAL,Pentostatin/alemtuzumab regimen had greater risk of graft failure.
NCT00698750,TERMINATED,OBSERVATIONAL,Sponsor terminated study early due to limited enrollment and follow-up.
NCT00698789,TERMINATED,INTERVENTIONAL,Study ended after diabetes development plan review. .
NCT00699127,WITHDRAWN,INTERVENTIONAL,"After a discussion, we decided to withdraw the study."
NCT00699270,WITHDRAWN,OBSERVATIONAL,Business need changed.
NCT00699283,TERMINATED,INTERVENTIONAL,An interim analysis revealed the study was unlikely to attain a positive outcome for the efficacy analysis. No safety concerns were detected
NCT00699361,WITHDRAWN,INTERVENTIONAL,Study withdrawn for financial issues
NCT00699374,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00699413,TERMINATED,INTERVENTIONAL,Sponsor decided to withdraw from study.
NCT00699842,TERMINATED,INTERVENTIONAL,Administratively terminated per FDA recommendation
NCT00699894,WITHDRAWN,INTERVENTIONAL,Logistical difficulties running the study
NCT00700011,TERMINATED,INTERVENTIONAL,poor accrual
NCT00700154,TERMINATED,INTERVENTIONAL,participants are no longer being examined or receiving intervention
NCT00700362,WITHDRAWN,OBSERVATIONAL,Local regulations
NCT00700492,TERMINATED,INTERVENTIONAL,Change in Belgian law on the use of hMG in IUI
NCT00700609,TERMINATED,INTERVENTIONAL,The PI moved to another city and position
NCT00700622,TERMINATED,INTERVENTIONAL,Sponsor stopped development of the MedTone inhaler in favor of an improved device (Gen2 inhaler)
NCT00700674,TERMINATED,OBSERVATIONAL,Progress report requested by Dr. Abboud decided to close it.
NCT00700700,TERMINATED,INTERVENTIONAL,Stopped due to an inability to recruit eligible subjects.
NCT00700739,TERMINATED,INTERVENTIONAL,study progress and recruitment rate too low
NCT00700778,TERMINATED,INTERVENTIONAL,Unable to recruit volunteers
NCT00700791,TERMINATED,INTERVENTIONAL,The PI moved to another Institution
NCT00700843,TERMINATED,OBSERVATIONAL,Difficulty recruiting
NCT00700947,TERMINATED,INTERVENTIONAL,Funding terminated
NCT00701077,TERMINATED,INTERVENTIONAL,recruitments issues
NCT00701181,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00701233,WITHDRAWN,INTERVENTIONAL,Unable to generate MD's and patients for this study
NCT00701701,TERMINATED,INTERVENTIONAL,Study was conducted to fulfill a post marketing commitment (PMC 6). FDA acknowledged fulfillment of PMC.
NCT00701714,TERMINATED,INTERVENTIONAL,investigation of adverse events
NCT00701753,TERMINATED,OBSERVATIONAL,Insufficient subject recruitment.
NCT00701870,TERMINATED,INTERVENTIONAL,Study TLK199.2102 was terminated for lack of enrollment.
NCT00701935,TERMINATED,INTERVENTIONAL,"Enrollment was much slower than anticipated, leading to a decision to terminate the study early for enrollment futility."
NCT00701974,SUSPENDED,INTERVENTIONAL,Sponsor's strategy
NCT00702156,TERMINATED,INTERVENTIONAL,Inadequate patient recruitment
NCT00702221,TERMINATED,INTERVENTIONAL,Dose limiting adverse effects
NCT00702572,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT00702611,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00702702,TERMINATED,INTERVENTIONAL,Repros stopped study for safety and FDA put study on hold because of safety.
NCT00702793,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT00702819,TERMINATED,INTERVENTIONAL,Low enrollment due to the stringent enrollment criteria. Unable to answer study questions
NCT00702923,TERMINATED,INTERVENTIONAL,Enrollment was halted prematurely due to slow accrual.
NCT00702962,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00703092,TERMINATED,INTERVENTIONAL,P.I. left University. Study terminated
NCT00703157,TERMINATED,INTERVENTIONAL,"Enrollments slowed down significantly, despite several attempts to re-launch."
NCT00703339,TERMINATED,INTERVENTIONAL,Lack of enrollment to the trial. Very difficult population to recruit.
NCT00703443,WITHDRAWN,OBSERVATIONAL,Non applicable clinical trial
NCT00703950,TERMINATED,INTERVENTIONAL,Sample size was re- calculated considering sucking pattern parameters
NCT00704119,TERMINATED,INTERVENTIONAL,"Following an SAE, study was put on hold. After performing preclinical follow-up studies, volunteers were no longer available for continuation."
NCT00704197,TERMINATED,OBSERVATIONAL,"Study has not been updated since 2016 and PI (Steven R Smith, M.D.) left PBRC. Angela 09/13/2022"
NCT00704210,WITHDRAWN,INTERVENTIONAL,Study withdrawn by sponsor
NCT00704301,TERMINATED,INTERVENTIONAL,The study is prematurely terminated due to a safety issue
NCT00704327,TERMINATED,OBSERVATIONAL,Investigator left the Institution
NCT00704392,WITHDRAWN,INTERVENTIONAL,Study not initiated
NCT00704509,TERMINATED,INTERVENTIONAL,Interim analysis showed inadequate efficacy of bifeprunox
NCT00704652,TERMINATED,OBSERVATIONAL,Patient recruitment was not sufficient to achieve the needed patient numbers.
NCT00704691,TERMINATED,INTERVENTIONAL,Closed due to futility with only 1 patient accrued
NCT00704782,TERMINATED,INTERVENTIONAL,The study was halted after a Phase 3 study of dimebon failed to show efficacy.
NCT00704847,TERMINATED,INTERVENTIONAL,Male subjects were terminated due to an imbalance in prostate cancer events
NCT00704938,TERMINATED,INTERVENTIONAL,Terminated due to withdrawal of support from our collaborator.
NCT00705237,TERMINATED,INTERVENTIONAL,Insufficient findings for data analysis
NCT00705354,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institution requested termination.
NCT00705471,TERMINATED,OBSERVATIONAL,Study stopped prematurely due to enrolment challenges.
NCT00705549,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00705601,TERMINATED,OBSERVATIONAL,See Detailed Description
NCT00705770,WITHDRAWN,INTERVENTIONAL,Change in study design
NCT00705796,WITHDRAWN,INTERVENTIONAL,financial constraints
NCT00705822,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT00706173,WITHDRAWN,INTERVENTIONAL,Unable to recruit eligible subjects for the trial.
NCT00706186,TERMINATED,INTERVENTIONAL,"Withdrawn by Investigator, protocol in revision"
NCT00706238,TERMINATED,INTERVENTIONAL,"The study was terminated early due to difficulties in recruiting subjects, not following concerns for the safety or absence of clinical activity in patients."
NCT00706329,TERMINATED,INTERVENTIONAL,The study was terminated prematurely by the IRB due to data integrity and protocol compliance issues
NCT00706355,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00706446,TERMINATED,INTERVENTIONAL,Funding was terminated
NCT00706459,TERMINATED,OBSERVATIONAL,"Due to funding issue, study has been terminated."
NCT00706485,TERMINATED,INTERVENTIONAL,New device for dural plaque irradiation was approved by FDA.
NCT00706615,WITHDRAWN,INTERVENTIONAL,no accrual
NCT00706667,TERMINATED,INTERVENTIONAL,Not being able to recuit sufficient patients due to a lack of complience
NCT00706784,TERMINATED,INTERVENTIONAL,Sponsor making changes to manufacturing of vaginal ring.
NCT00706914,TERMINATED,INTERVENTIONAL,Actual sample size of 156 was sufficient to estimate the clinical outcomes.
NCT00706992,TERMINATED,INTERVENTIONAL,\<11 subjects were enrolled to each Arm
NCT00707161,TERMINATED,INTERVENTIONAL,discontinued due to low enrollment
NCT00707213,TERMINATED,INTERVENTIONAL,Funding from the NIH ended and not all patients had been accrued
NCT00707239,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00707252,TERMINATED,INTERVENTIONAL,Phase II not initiated due to cancellation of supply of Poly E by collaborator.
NCT00707434,TERMINATED,INTERVENTIONAL,Research administration changes.
NCT00707512,TERMINATED,OBSERVATIONAL,Sponsor's decision.
NCT00707564,WITHDRAWN,INTERVENTIONAL,unable to enroll patient population
NCT00707655,TERMINATED,INTERVENTIONAL,The decision is based on company re-evaluation of indications to be pursued within SCCHN
NCT00708474,WITHDRAWN,INTERVENTIONAL,Planning new study protocol
NCT00708721,TERMINATED,INTERVENTIONAL,Data analysis revealed sufficient data for safety and efficacy
NCT00708760,TERMINATED,OBSERVATIONAL,Vastly under enrolled due to delays in software development
NCT00708799,TERMINATED,INTERVENTIONAL,Safety evaluation due to recent publications.
NCT00708877,TERMINATED,INTERVENTIONAL,study procedures have become standard of care as patients seeking Model for End-Stage Liver Disease (MELD) exception points for cholangiocarcinoma
NCT00708942,TERMINATED,INTERVENTIONAL,"Slow recruitment, study stopped with only 13 of 70 patients included in second part of the study"
NCT00709007,WITHDRAWN,INTERVENTIONAL,No participants satisfied eligibility criteria and were enrolled into the study since July 2008.
NCT00709137,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00709293,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT00709397,TERMINATED,OBSERVATIONAL,lack of accrual
NCT00709618,TERMINATED,INTERVENTIONAL,Evolving standard of care practices in this disease setting was limiting enrolment and leading to a delay in delivering this study information to the public.
NCT00710216,WITHDRAWN,INTERVENTIONAL,Sponsor withdraw
NCT00710281,WITHDRAWN,INTERVENTIONAL,Investigator is no longer at study site
NCT00710541,TERMINATED,INTERVENTIONAL,The publication of a national guideline on NPPV precluded further recruitment.
NCT00710567,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00710905,TERMINATED,INTERVENTIONAL,Postmarket study terminated as the SN6AD3 is no longer promoted.
NCT00711087,TERMINATED,INTERVENTIONAL,Funds no longer available
NCT00711204,WITHDRAWN,INTERVENTIONAL,No patients were enrolled in the study.
NCT00711451,TERMINATED,INTERVENTIONAL,unable to recruit patients
NCT00711542,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00711698,WITHDRAWN,INTERVENTIONAL,technical difficulties coordinating study
NCT00711763,TERMINATED,OBSERVATIONAL,failure to recruit more patients and lack of supporting personnel.
NCT00711841,TERMINATED,INTERVENTIONAL,The speed of recruitment was slower than anticipated.
NCT00711906,TERMINATED,INTERVENTIONAL,"Malaria prev. fell in the study area, so we cannot evaluate the primary endpoint"
NCT00712062,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT00712075,TERMINATED,INTERVENTIONAL,Loss of funding
NCT00712257,TERMINATED,INTERVENTIONAL,Due to safety concerns
NCT00712270,TERMINATED,INTERVENTIONAL,Study terminated due to failure to meet sufficient enrollment for valid analysis
NCT00712322,TERMINATED,INTERVENTIONAL,Due to extremely difficult enrollment.
NCT00712413,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT00712426,TERMINATED,INTERVENTIONAL,Results of an interim analysis showed that it was unlikely that creatine was effective in slowing loss of function in early symptomatic Huntington's Disease.
NCT00712452,TERMINATED,INTERVENTIONAL,problems of insuffisant recruitment
NCT00712517,TERMINATED,INTERVENTIONAL,Enrolling of participants has halted and the results are being gathered
NCT00712621,WITHDRAWN,INTERVENTIONAL,Study is withdrawn due to unavailability of eligible subject population. We will request the sponsors to extend the time for enrollment.
NCT00712998,TERMINATED,OBSERVATIONAL,"Beacuse of unexpected administrative barriers, only 5 cases were enrolled in a year."
NCT00713011,WITHDRAWN,INTERVENTIONAL,Study was stopped by sponsor prior to first patient assignment to groups due to operational reasons.
NCT00713050,TERMINATED,INTERVENTIONAL,Protocol expired; PI retired
NCT00713154,TERMINATED,INTERVENTIONAL,Major planned study protocol modifications
NCT00713258,TERMINATED,INTERVENTIONAL,Slow enrolment
NCT00713557,TERMINATED,OBSERVATIONAL,"devices applied in the study were no more available in the market, and medical intervention section was completed."
NCT00713596,TERMINATED,INTERVENTIONAL,Lead investigator moved to a new medical center; study was stopped when he left.
NCT00713674,WITHDRAWN,INTERVENTIONAL,Lack of patient recruitment.
NCT00713687,WITHDRAWN,INTERVENTIONAL,recruiting failed
NCT00713765,TERMINATED,INTERVENTIONAL,Ended prematurely - The trial never commenced.
NCT00713908,TERMINATED,OBSERVATIONAL,The Co-Principal Investigator has moved and is no longer interested in continuing this study at this site.
NCT00713921,WITHDRAWN,INTERVENTIONAL,Lack of enrollment and loss of funding
NCT00713947,WITHDRAWN,INTERVENTIONAL,no inclusion
NCT00714220,TERMINATED,OBSERVATIONAL,Lack of funding and support staff.
NCT00714246,TERMINATED,INTERVENTIONAL,Low accrual
NCT00714259,TERMINATED,INTERVENTIONAL,Accrual goals could not be met within a timely manner
NCT00714272,TERMINATED,INTERVENTIONAL,Primary outcome not achieved.
NCT00714376,TERMINATED,INTERVENTIONAL,Prematurely terminated due to financial considerations
NCT00714519,WITHDRAWN,INTERVENTIONAL,The study was terminated due to the inability to enroll subjects. No subjects were or ever will be enrolled into this study.
NCT00714883,TERMINATED,INTERVENTIONAL,The NEVO stent will not be commercialized. Cordis decided to close the study after 3 years. This decision took the absence of safety signals into account.
NCT00714948,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00715026,TERMINATED,INTERVENTIONAL,Sponsor business decision unrelated to clinical performance.
NCT00715065,WITHDRAWN,OBSERVATIONAL,Could not get funding for fMRI studies at this time.
NCT00715143,TERMINATED,INTERVENTIONAL,Exactech withdrew the PMA associated with the study device due to low market utilization
NCT00715338,TERMINATED,OBSERVATIONAL,poor enrollment
NCT00715377,TERMINATED,INTERVENTIONAL,Insufficient subject accrual
NCT00715429,TERMINATED,INTERVENTIONAL,"We exhausted potential candidates before reaching goal of 70; recruited 29, 13 completed the study"
NCT00715559,TERMINATED,INTERVENTIONAL,Change in resources available for study procedures.
NCT00715715,WITHDRAWN,INTERVENTIONAL,Withdrawn studies.
NCT00715845,TERMINATED,INTERVENTIONAL,ran out of funding
NCT00715923,TERMINATED,INTERVENTIONAL,funding
NCT00716404,WITHDRAWN,OBSERVATIONAL,FlowMedica was purchased by AngioDynamics. Study will be re-started by AngioDynamics.
NCT00716443,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00716469,TERMINATED,INTERVENTIONAL,The study is terminated due to expiration of study materials.
NCT00716495,TERMINATED,INTERVENTIONAL,problems in funding
NCT00716508,TERMINATED,INTERVENTIONAL,Our PI left our institutions as we could not longer continue.
NCT00716560,TERMINATED,OBSERVATIONAL,Administratively terminated.
NCT00716677,WITHDRAWN,OBSERVATIONAL,Life shirt technology no longer available
NCT00716807,TERMINATED,INTERVENTIONAL,Unable to recruit a sufficient number of subjects.
NCT00716833,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00716989,TERMINATED,INTERVENTIONAL,Third group realisation has not been necessary regarding the results of the first two groups (no sufficient modifications in the immune response)
NCT00717171,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00717275,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00717431,TERMINATED,INTERVENTIONAL,insufficient enrolment
NCT00717522,TERMINATED,INTERVENTIONAL,Study enrollment was terminated due to a corporate strategic decision unrelated to patient safety.
NCT00717535,WITHDRAWN,OBSERVATIONAL,Funding unavailable
NCT00717639,TERMINATED,INTERVENTIONAL,Required contrast media (Vasovist) withdrawn from market
NCT00717808,WITHDRAWN,INTERVENTIONAL,Due to unforeseen circumstances this study will not now start.
NCT00717990,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT00718003,TERMINATED,OBSERVATIONAL,Terminated due to difficulty enrolling subjects.
NCT00718016,TERMINATED,OBSERVATIONAL,New protocol was developed based on preliminary results from this study.
NCT00718107,TERMINATED,OBSERVATIONAL,The study was discontinued due to low enrollment. A survey has been implemented in place of a formal study.
NCT00718185,TERMINATED,OBSERVATIONAL,Similar study completed.
NCT00718328,TERMINATED,INTERVENTIONAL,"Poor recruitment, trial terminated"
NCT00718445,TERMINATED,OBSERVATIONAL,Terminated due to lack of funding and support staff
NCT00718523,TERMINATED,INTERVENTIONAL,The steering committee of the TRIO014 study has taken the decision to stop the TRIO014 trial.
NCT00718575,TERMINATED,INTERVENTIONAL,too few patients meeting current eligibility criteria
NCT00718588,TERMINATED,INTERVENTIONAL,Study had completed enrollment but drug injection was halted due to an unacceptable incidence of rash.
NCT00718640,TERMINATED,INTERVENTIONAL,Study stopped due to lagging enrolment.
NCT00718965,TERMINATED,INTERVENTIONAL,AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy
NCT00718991,TERMINATED,INTERVENTIONAL,too slow enrollment
NCT00719082,WITHDRAWN,OBSERVATIONAL,Lack of Funding
NCT00719199,TERMINATED,INTERVENTIONAL,Sponsor will discontinue further development of EMD 1201081
NCT00719537,TERMINATED,INTERVENTIONAL,inability to find qualifying participants
NCT00719849,TERMINATED,INTERVENTIONAL,"A new protocol was developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration."
NCT00719901,TERMINATED,INTERVENTIONAL,"This trial was terminated due to slow accrual and the drug supply of Obatoclax during the phase I; therefore, the phase II portion will never open."
NCT00719914,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00720083,TERMINATED,INTERVENTIONAL,Withdrawal of drug supply.
NCT00720096,TERMINATED,INTERVENTIONAL,"Funds for this project have been spent, and it is thereby terminated."
NCT00720252,TERMINATED,INTERVENTIONAL,TECHNICAL ISSUES
NCT00720330,TERMINATED,INTERVENTIONAL,Enrollment challenges prohibited study progression.
NCT00720343,TERMINATED,INTERVENTIONAL,PI left the institution.
NCT00720395,WITHDRAWN,OBSERVATIONAL,Withdrawn \[Funding was never granted for this study. No participants were ever enrolled.\]
NCT00720720,WITHDRAWN,INTERVENTIONAL,Recruitment and organizational difficulties
NCT00720837,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00720850,TERMINATED,INTERVENTIONAL,"Low recruitment, scientific rationale not applicable anymore to all patients and possible induction of GvHD by the study drug"
NCT00720902,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00721032,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT00721097,TERMINATED,OBSERVATIONAL,Number of included patients is sufficient.
NCT00721110,TERMINATED,INTERVENTIONAL,Futility
NCT00721149,TERMINATED,INTERVENTIONAL,"Enrollment stopped after CDRH Advisory Panel (Nov 20, 2008) recommended NAVISTAR THERMOCOOL catheter approval."
NCT00721422,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00721539,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00721981,TERMINATED,OBSERVATIONAL,Low Recruitment
NCT00722072,TERMINATED,INTERVENTIONAL,Sponsor pulled funding and low accrual
NCT00722098,TERMINATED,INTERVENTIONAL,"Early termination due to lesser accrual, and data analysis not done."
NCT00722254,TERMINATED,OBSERVATIONAL,This study was stopped due to poor enrollment numbers
NCT00722280,TERMINATED,INTERVENTIONAL,loss of funding
NCT00722436,TERMINATED,INTERVENTIONAL,Study dose changed based on recent publications
NCT00722462,TERMINATED,INTERVENTIONAL,Recent abstract publication questioning the need for our study
NCT00722800,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00722865,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00722917,TERMINATED,INTERVENTIONAL,Animal Toxicity Findings
NCT00723203,TERMINATED,INTERVENTIONAL,Terminated early due to a lack of efficacy
NCT00723411,TERMINATED,INTERVENTIONAL,The primary endpoint at 15 months was not met.
NCT00723554,TERMINATED,INTERVENTIONAL,sponsor's decision
NCT00723658,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT00723879,TERMINATED,OBSERVATIONAL,"Because of slow recruitment; Despite the study was started long time ago (Oct 2004), we have not reached the projected number of patients (150 patients)"
NCT00723918,WITHDRAWN,INTERVENTIONAL,Withdrawal of pharmaceutical support from Novartis - no participants randomized
NCT00724061,TERMINATED,INTERVENTIONAL,Closed early due to poor accrual.
NCT00724100,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT00724256,TERMINATED,INTERVENTIONAL,other upcoming studies; patients refusal of invasive follow up (DMSA)
NCT00724321,WITHDRAWN,INTERVENTIONAL,PI has left the institution. We are unable to locate any study records to determine if subjects were enrolled.
NCT00724360,TERMINATED,INTERVENTIONAL,Difficulties of recruitment
NCT00724425,TERMINATED,INTERVENTIONAL,"Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus exclusively on retaspimycin"
NCT00724841,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to financial contraints.
NCT00725023,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00725062,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00725270,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT00725400,WITHDRAWN,INTERVENTIONAL,Study is withdrawn due to unavailability of eligible subject population. We will request the sponsors to extend the time for enrollment.
NCT00725842,TERMINATED,OBSERVATIONAL,Low enrollment
NCT00725972,WITHDRAWN,INTERVENTIONAL,termination of funding by sponsors
NCT00726037,TERMINATED,INTERVENTIONAL,Collaborator withdrew support due to a drug supply interruption.
NCT00726154,WITHDRAWN,INTERVENTIONAL,This study did not receive funding
NCT00726180,TERMINATED,INTERVENTIONAL,Due to low enrollment
NCT00726193,TERMINATED,OBSERVATIONAL,"Slow enrollment, lack of follow up"
NCT00726232,TERMINATED,INTERVENTIONAL,Termination of the clinical trial by sponsor.
NCT00726271,TERMINATED,INTERVENTIONAL,Record owner left institution
NCT00726466,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT00726544,TERMINATED,INTERVENTIONAL,Enrollment into study was slower than expected.
NCT00726570,TERMINATED,INTERVENTIONAL,Failed to reach the expected enrollment rates by the end of 2010
NCT00726791,WITHDRAWN,INTERVENTIONAL,patient did not enroll
NCT00726804,TERMINATED,INTERVENTIONAL,It was not possible to recruit patients
NCT00726830,TERMINATED,INTERVENTIONAL,Low Accrual.
NCT00726843,TERMINATED,INTERVENTIONAL,Enrollment proceeded too slowly to conduct study as RCT.
NCT00726869,TERMINATED,INTERVENTIONAL,Enrollment has been halted
NCT00726973,WITHDRAWN,INTERVENTIONAL,Unable to recruit study participants
NCT00726986,TERMINATED,INTERVENTIONAL,Extreme toxicity
NCT00727038,WITHDRAWN,INTERVENTIONAL,Company withdrew funding/sponsorship
NCT00727051,WITHDRAWN,OBSERVATIONAL,No funding
NCT00727077,TERMINATED,OBSERVATIONAL,Study halted due to low recruitment. The 3 participants at time of termination transferred into study P04538 (NCT00727077). See NCT00727077 for details/results.
NCT00727090,TERMINATED,INTERVENTIONAL,Enrollment below goal.
NCT00727142,TERMINATED,INTERVENTIONAL,observed benefit of treatment larger than expected
NCT00727207,TERMINATED,INTERVENTIONAL,Lack of participations (8 of 25)
NCT00727363,TERMINATED,INTERVENTIONAL,We are underpowered to find a difference in the primary outcome.
NCT00727454,TERMINATED,INTERVENTIONAL,Difficulty of recruiting patients and cost limitations.
NCT00727480,TERMINATED,INTERVENTIONAL,No longer acruing data for this study.
NCT00727532,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00727701,TERMINATED,INTERVENTIONAL,"Study delayed for over a year by research shutdown at Seattle VA and other issues. Study designer moved to Ann Arbor in the interim, so the study was closed."
NCT00728000,WITHDRAWN,INTERVENTIONAL,study withdrawn due to lack of enrollment
NCT00728104,WITHDRAWN,OBSERVATIONAL,No funding
NCT00728312,WITHDRAWN,INTERVENTIONAL,PI left the VA.
NCT00728429,TERMINATED,INTERVENTIONAL,slow accrual
NCT00728507,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT00728533,WITHDRAWN,INTERVENTIONAL,Terminated due to awaiting data from Phase II study.
NCT00728585,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT00728845,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00729027,TERMINATED,INTERVENTIONAL,AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy
NCT00729274,WITHDRAWN,INTERVENTIONAL,Was not approved by funding organization
NCT00729365,TERMINATED,INTERVENTIONAL,Data from other studies showed that study could not be completef successfully
NCT00729560,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00729781,TERMINATED,INTERVENTIONAL,Strategic Business Decision
NCT00729807,TERMINATED,INTERVENTIONAL,Study was closed at the suggestion of DSMB prior to obtaining target enrollment
NCT00729833,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00729989,TERMINATED,INTERVENTIONAL,Project not funded
NCT00730041,TERMINATED,INTERVENTIONAL,"Medtronic acquisition of Restore Medical, business decision"
NCT00730067,WITHDRAWN,INTERVENTIONAL,"As a single center, it was not possible to recruit enough patients with pulmonary hypertension"
NCT00730119,WITHDRAWN,OBSERVATIONAL,Terminated due to lack of enrollment at target sites
NCT00730262,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00730483,TERMINATED,INTERVENTIONAL,High incidence of biloma and liver abscess after TACE
NCT00730522,TERMINATED,INTERVENTIONAL,"To conserve remaining capital, Sponsor decided to terminate the study early."
NCT00730574,TERMINATED,INTERVENTIONAL,completed patient rectuitment
NCT00730587,WITHDRAWN,OBSERVATIONAL,This study will not be conducted. A new study is replacing this one.
NCT00730652,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT00730665,TERMINATED,INTERVENTIONAL,This study has been placed on clinical hold by the sponsor due to operational reasons.
NCT00730847,TERMINATED,INTERVENTIONAL,GSK received exemption from PDFDA on conduct of this post-marketing surveillance (PMS) study.
NCT00731315,TERMINATED,INTERVENTIONAL,"Funding Period ended, did not reach full sample size due to limited numbers of eligible patients"
NCT00731432,SUSPENDED,INTERVENTIONAL,Failure to recruit
NCT00731692,TERMINATED,INTERVENTIONAL,The extension study was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression
NCT00731796,SUSPENDED,OBSERVATIONAL,Lack of funding
NCT00731835,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00731874,TERMINATED,INTERVENTIONAL,A higher rate of late rejection was seen in the low tacrolimus arm.
NCT00731887,WITHDRAWN,OBSERVATIONAL,Personnel involved in this protocol are no longer associated with this study
NCT00732082,TERMINATED,INTERVENTIONAL,Company manufacturing study drug was unable to continue production.
NCT00732108,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT00732147,WITHDRAWN,INTERVENTIONAL,Sponsor could not fund.
NCT00732251,TERMINATED,INTERVENTIONAL,The outpatient area of the department of psychiatry at CSMC closed.
NCT00732303,TERMINATED,INTERVENTIONAL,Study terminated due to withdrawal of pharmaceutical funding
NCT00732355,TERMINATED,OBSERVATIONAL,insufficient patient populations
NCT00732485,WITHDRAWN,INTERVENTIONAL,Principal Investigator Changed
NCT00732628,TERMINATED,OBSERVATIONAL,Physician is no longer associated with the Univ. of Michigan Medical Center
NCT00732680,TERMINATED,INTERVENTIONAL,Lead investigator moved to a new medical center; study was stopped when he left.
NCT00732732,TERMINATED,INTERVENTIONAL,Closed by US IRB due to lack of an adequate system for continuing review by the Indian IRB. No subjects enrolled in US.
NCT00732745,TERMINATED,INTERVENTIONAL,Lost funding for Phase II portion of study
NCT00732927,TERMINATED,INTERVENTIONAL,slow recruitment rate
NCT00732940,TERMINATED,INTERVENTIONAL,Sponsor terminated study for business reasons.
NCT00733031,TERMINATED,INTERVENTIONAL,PK results demonstrate low and variable plasma concentrations so that achieving therapeutic concentrations is unlikely.
NCT00733070,TERMINATED,INTERVENTIONAL,no interest to develop the product
NCT00733252,WITHDRAWN,OBSERVATIONAL,Low interest
NCT00733330,TERMINATED,INTERVENTIONAL,A sample size recalculation indicated an increase from 154 to 1500 subjects was required so the study stopped as new target was considered unfeasible.
NCT00733369,TERMINATED,INTERVENTIONAL,This study was closed for the reason of slow recruitment with only 16% of the target subjects recruited over a 29 month period.
NCT00733486,TERMINATED,INTERVENTIONAL,The study was terminated at 2 years as investigators were unable to continue participation in the study.
NCT00733629,WITHDRAWN,OBSERVATIONAL,Technical reasons- unable to process samples therefore did not recruit
NCT00733681,TERMINATED,INTERVENTIONAL,Subjects were no longer able to remain compliant with follow-up intervals
NCT00733759,WITHDRAWN,OBSERVATIONAL,Unable to recruit patients due to technical issues following submission
NCT00733798,TERMINATED,INTERVENTIONAL,For Strategic Reasons
NCT00733967,WITHDRAWN,INTERVENTIONAL,No longer active
NCT00734084,TERMINATED,INTERVENTIONAL,"After a review of status, request of investigators \& since similar data was available from other sources"
NCT00734110,TERMINATED,INTERVENTIONAL,The study achieved the stated objective to record pre \& post operative outcomes at a minimum 5 years.
NCT00734136,TERMINATED,INTERVENTIONAL,Insufficient findings for data analysis
NCT00734435,TERMINATED,INTERVENTIONAL,Sponsor Decision- Financial Considerations
NCT00734695,WITHDRAWN,INTERVENTIONAL,couldn't recruit patients
NCT00734773,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00734786,WITHDRAWN,INTERVENTIONAL,Study cancelled.
NCT00734812,WITHDRAWN,INTERVENTIONAL,Study was withdrawn prior to any enrollment.
NCT00734851,TERMINATED,INTERVENTIONAL,Dose Limiting Toxicities
NCT00734864,WITHDRAWN,INTERVENTIONAL,Study drug supplier withdrew support for the study. Study was withdrawn from the Duke IRB.
NCT00735085,TERMINATED,INTERVENTIONAL,This study was stopped 20 May 2010 due to strategic considerations
NCT00735124,TERMINATED,INTERVENTIONAL,Changes to surgical practices led to the loss of eligible patients
NCT00735241,WITHDRAWN,INTERVENTIONAL,Withdrawn by the study sponsor.
NCT00735254,TERMINATED,INTERVENTIONAL,PI decision
NCT00735267,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00735332,TERMINATED,INTERVENTIONAL,License termination.
NCT00735345,TERMINATED,INTERVENTIONAL,because of safety concerns the study was terminated prematurely
NCT00735436,TERMINATED,INTERVENTIONAL,Study enrollment was halted due to slow accrual.
NCT00735553,TERMINATED,INTERVENTIONAL,Repros stopped the study for safety and FDA put the study on hold for safety.
NCT00735722,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00735878,TERMINATED,INTERVENTIONAL,data from a similar did not show efficacy.
NCT00735943,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT00736112,WITHDRAWN,INTERVENTIONAL,The investigator left the institution
NCT00736164,WITHDRAWN,INTERVENTIONAL,No accrual
NCT00736177,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT00736216,WITHDRAWN,OBSERVATIONAL,PI left the institution
NCT00736281,TERMINATED,INTERVENTIONAL,"Due to recently published research, this is no longer a novel study."
NCT00736294,TERMINATED,INTERVENTIONAL,Difficulty to include patients
NCT00736411,TERMINATED,INTERVENTIONAL,Adjustments to ensure clear outcomes and scientific merit integrated. Study closed at 14 subjects. New protocol submitted to IRB.
NCT00736450,TERMINATED,INTERVENTIONAL,Manufacturer is no longer making the drug.
NCT00736528,TERMINATED,INTERVENTIONAL,See Detailed Description for termination reason.
NCT00736788,TERMINATED,INTERVENTIONAL,AZD1704 has essentially similar PK profile in Japanese subjects as in Caucasians. One of the main purposes of the study has thereby been achieved.
NCT00737035,WITHDRAWN,INTERVENTIONAL,Recruitment difficulties
NCT00737061,TERMINATED,INTERVENTIONAL,Product Pre-Market Approval withdrawn
NCT00737087,TERMINATED,INTERVENTIONAL,Study was stopped due to low follow-up compliance at study sites.
NCT00737113,TERMINATED,INTERVENTIONAL,Study was terminated early due to low accrual.
NCT00737139,TERMINATED,INTERVENTIONAL,Prohibitively expensive and efficacy of tranexamic acid rendered topic clinically less relevant.
NCT00737191,WITHDRAWN,INTERVENTIONAL,No accrual; No patients enrolled
NCT00737282,TERMINATED,INTERVENTIONAL,Repros stopped study for safety and FDA put study on hold.
NCT00737295,TERMINATED,INTERVENTIONAL,"PI left institution, study interest wained-so stopped."
NCT00737321,TERMINATED,OBSERVATIONAL,investigator moved institutions and did not transfer study
NCT00737594,TERMINATED,INTERVENTIONAL,Failure to enroll a suitable number of qualified subjects.
NCT00737633,TERMINATED,INTERVENTIONAL,Limited regulatory value to uncontrolled trials. No safety/efficacy concerns.
NCT00737724,TERMINATED,INTERVENTIONAL,Other published trials showed definitive expected superiority of Group 1
NCT00737763,WITHDRAWN,INTERVENTIONAL,drug withdrawn from market
NCT00737802,TERMINATED,OBSERVATIONAL,Was not able to recruit the total anticipated number of subjects
NCT00737984,TERMINATED,INTERVENTIONAL,Because very low number of patients were enrolled
NCT00738088,TERMINATED,INTERVENTIONAL,"Following Regulator inspection in 2009, study terminated as inadequate approvals were in place"
NCT00738491,TERMINATED,OBSERVATIONAL,Study performed in alternative location (Beijing China)
NCT00738517,WITHDRAWN,INTERVENTIONAL,PI left center
NCT00738699,TERMINATED,INTERVENTIONAL,study did not meet pre-specified criteria for continuation following interim futility analysis
NCT00738738,WITHDRAWN,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00738777,SUSPENDED,INTERVENTIONAL,in preparation for an amendment
NCT00738881,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00738972,TERMINATED,INTERVENTIONAL,"Study terminated early due to sample size, not possible to perform further statistical analysis."
NCT00738985,WITHDRAWN,INTERVENTIONAL,The study was cancelled due to budget limitations
NCT00738998,TERMINATED,INTERVENTIONAL,Requested by PI
NCT00739024,TERMINATED,INTERVENTIONAL,Recruitment slow and administrative reasons
NCT00739063,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT00739089,WITHDRAWN,OBSERVATIONAL,Study stopped due to a lack of enrollment.
NCT00739128,TERMINATED,INTERVENTIONAL,Believed that a better study was to compare the response to engerix B vs Sci-B-Vac vaccine in this patient group.
NCT00739206,TERMINATED,INTERVENTIONAL,In accordance with protocol's predefined criteria and Data Monitoring Committee recommendation due to insufficient level of efficacy
NCT00739219,TERMINATED,INTERVENTIONAL,Study terminated due to lack of care guidelines in the protocol.
NCT00739557,WITHDRAWN,OBSERVATIONAL,"Investigator left the institution, another PI has not been named."
NCT00739609,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT00739687,TERMINATED,INTERVENTIONAL,Study has been termination early due to financial constraints.
NCT00739882,TERMINATED,INTERVENTIONAL,The study was terminated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union
NCT00739960,TERMINATED,INTERVENTIONAL,Funding has been pulled
NCT00740181,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00740272,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00740376,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00740545,TERMINATED,INTERVENTIONAL,Stopped for futility
NCT00740597,TERMINATED,INTERVENTIONAL,No patients were enrolled on the study
NCT00740662,TERMINATED,OBSERVATIONAL,Recruiting problems
NCT00740714,TERMINATED,INTERVENTIONAL,"The investigational drug is unlikely to demonstrate efficacy over placebo for this indication. However, no safety issues were discovered."
NCT00740961,TERMINATED,OBSERVATIONAL,low accrual
NCT00741117,TERMINATED,INTERVENTIONAL,Study stopped due to insufficient personnel required to conduct trial.
NCT00741611,TERMINATED,INTERVENTIONAL,Business reasons
NCT00741715,TERMINATED,INTERVENTIONAL,AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy
NCT00741741,TERMINATED,INTERVENTIONAL,Strategic decision
NCT00741767,WITHDRAWN,INTERVENTIONAL,Study subject enrollment difficulties
NCT00741845,TERMINATED,INTERVENTIONAL,"Terminated for site documentation and monitoring issues - not safety, study drug, or adverse event issues."
NCT00742001,TERMINATED,INTERVENTIONAL,An endpoint difference between 3 energies was not observed at interim analysis
NCT00742014,TERMINATED,INTERVENTIONAL,absorption of oral sildenafil not consistent
NCT00742053,TERMINATED,INTERVENTIONAL,Enrollment rate was too slow.
NCT00742157,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT00742313,TERMINATED,INTERVENTIONAL,No statistical differences on study endpoints between groups.
NCT00742326,TERMINATED,INTERVENTIONAL,Enrollment stopped prior to complete enrollment due to slow accrual
NCT00742339,TERMINATED,INTERVENTIONAL,Decision of independent monitoring committee: Risk of non-response to treatment significantly higher in midodrine group than in terlipressin group.
NCT00742482,TERMINATED,INTERVENTIONAL,A 300 patient safety analysis by the Data Monitoring Committee showed a trend towards higher mortality in the treatment group.
NCT00742495,TERMINATED,INTERVENTIONAL,Slow Recruitment
NCT00742534,WITHDRAWN,INTERVENTIONAL,Study never began
NCT00742612,TERMINATED,INTERVENTIONAL,Enrollment slower than expected
NCT00742807,WITHDRAWN,INTERVENTIONAL,No investigator to follow-up
NCT00742846,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT00742872,TERMINATED,INTERVENTIONAL,"Poor recruitment, high drop out rate"
NCT00743106,TERMINATED,INTERVENTIONAL,Executive committee determined to close study after interim analysis.
NCT00743158,WITHDRAWN,OBSERVATIONAL,PI determination
NCT00743197,TERMINATED,INTERVENTIONAL,Terminated due to departure of PI from institution.
NCT00743327,TERMINATED,OBSERVATIONAL,No Participants completed study
NCT00743535,TERMINATED,INTERVENTIONAL,Low recruitment rate.
NCT00743743,WITHDRAWN,INTERVENTIONAL,PI has left institution
NCT00743756,TERMINATED,INTERVENTIONAL,slow patient enrollment
NCT00743769,WITHDRAWN,INTERVENTIONAL,Study never initiated due to contract manufacturing issues
NCT00744003,WITHDRAWN,OBSERVATIONAL,"PI no longer at Emory; no participants enrolled, study not conducted"
NCT00744185,TERMINATED,INTERVENTIONAL,Study halted prematurely due to some difficulties in recruitment of patients
NCT00744250,TERMINATED,INTERVENTIONAL,No longer required study by FDA for NDA approval.
NCT00744328,TERMINATED,INTERVENTIONAL,Recruitment Issues
NCT00744341,TERMINATED,INTERVENTIONAL,This study was stopped 29OCT2009 due to strategic drug development considerations
NCT00744354,TERMINATED,INTERVENTIONAL,Drugs unavailable- study terminated 1/2/18
NCT00744393,WITHDRAWN,INTERVENTIONAL,Sponsor pulled funding secondary to economy issues
NCT00744614,TERMINATED,OBSERVATIONAL,Principal Investigator (central contact) has left the organization and requests the study be terminated
NCT00744653,TERMINATED,INTERVENTIONAL,Primary endpoint measure not suitable for evaluation
NCT00744861,TERMINATED,INTERVENTIONAL,Terminated following interim analysis
NCT00744913,WITHDRAWN,INTERVENTIONAL,Discontinued due to difficulty in recruitment
NCT00745030,TERMINATED,INTERVENTIONAL,Low subject recruitment and enrollment.
NCT00745134,TERMINATED,INTERVENTIONAL,The trial was stopped early because there was only one patient with pCR among the first 15 patients randomized to the curcumin arm.
NCT00745316,TERMINATED,INTERVENTIONAL,Company Decision
NCT00745602,WITHDRAWN,INTERVENTIONAL,Could not get funding
NCT00745615,TERMINATED,INTERVENTIONAL,Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose.
NCT00745641,WITHDRAWN,OBSERVATIONAL,because of the presence of unexpected administrative barrier to interfere the collection of case
NCT00745732,TERMINATED,INTERVENTIONAL,Sponsor withdrew support.
NCT00745797,TERMINATED,INTERVENTIONAL,this trial enroll extremely slow and No funding support
NCT00745823,TERMINATED,INTERVENTIONAL,Primary efficacy analysis at Week 48 did not demonstrate non-inferiority of raltegravir 800 mg once daily versus raltegravir 400 mg twice daily
NCT00746057,TERMINATED,INTERVENTIONAL,The number of included patients is sufficient.
NCT00746239,TERMINATED,INTERVENTIONAL,Funding for continuation was not received.
NCT00746252,TERMINATED,INTERVENTIONAL,Due low rate of participation and lack of funding
NCT00746382,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to business decisions. No subjects were treated.
NCT00746421,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding
NCT00746434,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to business decisions. No subjects were treated.
NCT00746486,TERMINATED,INTERVENTIONAL,Study stopped based on the recommendation of the IDMC after a planned Interim Analysis
NCT00746590,TERMINATED,INTERVENTIONAL,Study terminated prematurely by sponsor for business reason. One patient was enrolled.
NCT00746603,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00746655,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT00746720,TERMINATED,INTERVENTIONAL,Patient recruitment difficulties
NCT00746824,TERMINATED,INTERVENTIONAL,The IND was withdrawn.
NCT00746941,TERMINATED,INTERVENTIONAL,Primary endpoint not achieved
NCT00746954,TERMINATED,INTERVENTIONAL,Patient recruitment and Funding inadequate to finish trial
NCT00746980,WITHDRAWN,INTERVENTIONAL,Newly identified safety concerns have changed the risk and benefit considerations
NCT00747006,TERMINATED,INTERVENTIONAL,Business reasons
NCT00747032,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to business decisions. No subjects were treated.
NCT00747071,WITHDRAWN,INTERVENTIONAL,Sponsors decision
NCT00747084,TERMINATED,INTERVENTIONAL,"Instruments necessary to continue project have been removed via medical center staff. Therefore, the project cannot continue until they have been replaced."
NCT00747136,TERMINATED,OBSERVATIONAL,Study has been terminated for inadequate results
NCT00747162,WITHDRAWN,INTERVENTIONAL,incorporated into other study
NCT00747305,TERMINATED,INTERVENTIONAL,Study terminated early due to low accrual.
NCT00747461,TERMINATED,INTERVENTIONAL,Business Reasons
NCT00747604,TERMINATED,OBSERVATIONAL,Shortage of Increlex supply
NCT00747630,TERMINATED,INTERVENTIONAL,This project was not a clinical trial requiring registration
NCT00747669,SUSPENDED,INTERVENTIONAL,Difficulty with enrollment
NCT00747812,TERMINATED,INTERVENTIONAL,Sponsor closed enrollment early based on interim data from the PRISM US Pivotal Study.
NCT00747838,TERMINATED,OBSERVATIONAL,Low enrollment.
NCT00747916,TERMINATED,INTERVENTIONAL,Business Reasons
NCT00748085,TERMINATED,INTERVENTIONAL,Business Reasons
NCT00748124,TERMINATED,INTERVENTIONAL,Interim analysis results were not supportive of primary endpoint
NCT00748163,WITHDRAWN,INTERVENTIONAL,Study has been abandoned for lack of available funding.
NCT00748189,TERMINATED,INTERVENTIONAL,"Majority of patients (62%) had been treated with next line therapies, including new highly effective therapies confounding the interpretation of the OS results."
NCT00748228,TERMINATED,INTERVENTIONAL,This study is being replaced by another protocol.
NCT00748371,TERMINATED,INTERVENTIONAL,Funding issue
NCT00748397,TERMINATED,INTERVENTIONAL,"Decision to modify the product under study as a result of feedback regarding subjective feeling during installation procedure. For more info, see brief summary."
NCT00748410,TERMINATED,INTERVENTIONAL,SB-656933 is no longer being developed for ulcerative colitis.
NCT00748449,TERMINATED,INTERVENTIONAL,No more inclusions
NCT00748527,TERMINATED,INTERVENTIONAL,"The study was ""withdrawn"" due to certain adverse events \[hypersensitivity\]."
NCT00748566,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00748579,TERMINATED,INTERVENTIONAL,Decision to discontinue due to challenges of trial design and constraints on enrolling eligible and consenting patients.
NCT00748631,TERMINATED,INTERVENTIONAL,the data collected are enough to obtain a qualitative analysis.
NCT00748670,TERMINATED,INTERVENTIONAL,"Decision to modify the product under study as a result of feedback regarding subjective feeling during installation procedure. For more info, see brief summary."
NCT00748787,TERMINATED,INTERVENTIONAL,"It was very difficult to fulfill the inclusion criteria, therefore the expected time of inclusion was delayed so much time."
NCT00748930,TERMINATED,OBSERVATIONAL,Challenging data collection
NCT00748969,TERMINATED,INTERVENTIONAL,Insufficient recruitment.
NCT00749099,TERMINATED,INTERVENTIONAL,No longer required study by FDA for NDA approval.
NCT00749177,TERMINATED,INTERVENTIONAL,Primary investigator left program: unable to recruit a replacement
NCT00749229,TERMINATED,INTERVENTIONAL,the number of patients recruited at present is sufficient for analysis.
NCT00749255,TERMINATED,OBSERVATIONAL,not enough personnel to conduct study at site
NCT00749554,TERMINATED,INTERVENTIONAL,Primary Investigator Retired.
NCT00749567,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00749671,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00749762,WITHDRAWN,OBSERVATIONAL,Computers/hardware for data collection/storage are outdated and unserviceable.
NCT00749827,WITHDRAWN,INTERVENTIONAL,No funding received
NCT00749853,SUSPENDED,INTERVENTIONAL,PI left the institution
NCT00749905,TERMINATED,INTERVENTIONAL,was not able to recruit enough patients
NCT00750204,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00750334,TERMINATED,INTERVENTIONAL,"Terminated to focus on comparable trial, CLOMDS02507"
NCT00750516,WITHDRAWN,OBSERVATIONAL,Insufficient patient enrolled
NCT00750555,TERMINATED,INTERVENTIONAL,PI Law left Geisinger-study terminated prematurely - 4 patients enrolled
NCT00750581,TERMINATED,INTERVENTIONAL,Study medication was no longer available for study
NCT00750685,TERMINATED,INTERVENTIONAL,Sponsor Terminated
NCT00750698,TERMINATED,INTERVENTIONAL,"Due to business reasons, enrollment on the study was halted and the study terminated. The decision to close enrollment was not due to any safety concern."
NCT00750776,TERMINATED,OBSERVATIONAL,Due to lack of financial support
NCT00750906,TERMINATED,OBSERVATIONAL,Study on hold since 2009. Awaiting FDA approval of Sugammdex to complete second arm of study.
NCT00750919,TERMINATED,INTERVENTIONAL,This trial was stopped prematurely due to the Sponsor's decision not to continue the development of esmertazapine for this indication.
NCT00750997,TERMINATED,OBSERVATIONAL,Enrollment in the clinical trial was stopped for futility
NCT00751101,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00751166,TERMINATED,INTERVENTIONAL,Study could not be re-supplied with study medication in a timely manner.
NCT00751283,WITHDRAWN,INTERVENTIONAL,Data was inconclusive
NCT00751296,TERMINATED,INTERVENTIONAL,Seven years of follow-up \& final analysis done in Dec 2012.
NCT00751309,TERMINATED,OBSERVATIONAL,Restructuring and refocus of company.
NCT00751673,TERMINATED,OBSERVATIONAL,No more data collected.
NCT00751842,TERMINATED,INTERVENTIONAL,Based on other clinical trial results it was unlikely the study would meet the efficacy endpoints
NCT00751920,TERMINATED,INTERVENTIONAL,The sponsor-investigator relocated to a different institution and was not able to continue the study.
NCT00751933,TERMINATED,INTERVENTIONAL,Lack of patients compatible with the protocols criteria
NCT00752206,TERMINATED,INTERVENTIONAL,The Data Safety Monitoring Board (DSMB) recommended study termination for slow accrual and futility.
NCT00752375,WITHDRAWN,INTERVENTIONAL,No participants
NCT00752479,TERMINATED,INTERVENTIONAL,Necessity of major revision of the protocol
NCT00752622,TERMINATED,INTERVENTIONAL,"Factors that led to termination: recruitment challenges and a lower incidence of flares than estimated, causing a high risk of the study being underpowered."
NCT00752934,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00752999,WITHDRAWN,INTERVENTIONAL,Study was withdrawn for business reasons before study start.
NCT00753220,TERMINATED,INTERVENTIONAL,Withdrew the IND with the FDA.
NCT00753441,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT00753623,TERMINATED,INTERVENTIONAL,Recruitment did not accrue as expected.
NCT00753740,WITHDRAWN,INTERVENTIONAL,Poor trial recruitment
NCT00753766,TERMINATED,INTERVENTIONAL,Inadequate participant recruitment
NCT00753870,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00754013,TERMINATED,INTERVENTIONAL,Sufficient evidence of efficacy not met.
NCT00754052,TERMINATED,INTERVENTIONAL,Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns.
NCT00754221,TERMINATED,INTERVENTIONAL,This study has been terminated early as the esreboxetine development program is being discontinued. There are no safety or efficacy concerns.
NCT00754260,TERMINATED,INTERVENTIONAL,Primary Investigator left recruiting center.
NCT00754299,WITHDRAWN,OBSERVATIONAL,Study could not get funding; research never initiated.
NCT00754364,TERMINATED,INTERVENTIONAL,low enrollment rate
NCT00754416,TERMINATED,OBSERVATIONAL,Product no more sold
NCT00754637,WITHDRAWN,OBSERVATIONAL,The study was withdrawn because it no longer fit the business need.
NCT00754689,WITHDRAWN,INTERVENTIONAL,Company decision taken in light of demands by certain national health authorities
NCT00754702,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00754767,TERMINATED,INTERVENTIONAL,unable to accrue study participants
NCT00754793,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00754884,WITHDRAWN,INTERVENTIONAL,Study drug was not longer available in our country.
NCT00755001,TERMINATED,OBSERVATIONAL,The site decided to stop the study
NCT00755118,TERMINATED,INTERVENTIONAL,Due to poor Accrual
NCT00755261,TERMINATED,INTERVENTIONAL,The study has been terminated due to low accrual.
NCT00755534,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT00755937,TERMINATED,OBSERVATIONAL,Satisfied a post-marketing commitment to Canadian Health Authorities.
NCT00755950,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00756041,TERMINATED,INTERVENTIONAL,Lack of Efficacy.
NCT00756106,TERMINATED,INTERVENTIONAL,Funding ended
NCT00756197,WITHDRAWN,INTERVENTIONAL,Considering more robust design.
NCT00756262,TERMINATED,INTERVENTIONAL,"Insufficient recruitment, no additional funding available"
NCT00756431,WITHDRAWN,INTERVENTIONAL,No data so far
NCT00756470,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00756691,WITHDRAWN,OBSERVATIONAL,Limited scanner availability
NCT00756782,WITHDRAWN,INTERVENTIONAL,Terminated due to safety concerns.
NCT00756795,WITHDRAWN,INTERVENTIONAL,PI chose not to continue with this unfunded study
NCT00756834,TERMINATED,OBSERVATIONAL,No longer pursuing FDA submission/approval.
NCT00756912,TERMINATED,INTERVENTIONAL,"This study was terminated in November 2008 due to ""a business decision (resources)""."
NCT00757055,WITHDRAWN,INTERVENTIONAL,Difficulty recruit pts with PSHF HR \> 70 \& high BNP.
NCT00757250,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects to dosing cohort 5.
NCT00757510,TERMINATED,OBSERVATIONAL,Insufficient funding
NCT00757653,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00757666,TERMINATED,INTERVENTIONAL,Difficulty enrollment; higher than planned patient attrition and data attrition
NCT00757913,TERMINATED,INTERVENTIONAL,Insufficient recruitment rate
NCT00757926,WITHDRAWN,INTERVENTIONAL,Replaced with an alternate study
NCT00758121,TERMINATED,OBSERVATIONAL,Inappropriate therapy associated with certain right ventricular (RV) lead complications may occur more frequently if the Respiratory Sensor is programmed On
NCT00758134,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00758329,WITHDRAWN,OBSERVATIONAL,No further contact with the site
NCT00758342,TERMINATED,INTERVENTIONAL,difficulty of enrolling patients
NCT00758368,WITHDRAWN,INTERVENTIONAL,Inadequate support to conduct the study
NCT00758667,TERMINATED,INTERVENTIONAL,preliminary analysis showed no difference
NCT00758693,WITHDRAWN,INTERVENTIONAL,Funding was withdrawn due to insufficient accrual
NCT00758732,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00758797,TERMINATED,INTERVENTIONAL,Study was not renewed during annual Northwestern Cancer Center review.
NCT00758901,TERMINATED,OBSERVATIONAL,Site Decision
NCT00758940,WITHDRAWN,INTERVENTIONAL,Primary Investigator resigned from Hospital
NCT00758966,TERMINATED,INTERVENTIONAL,Sponsor Decision- Financial Considerations
NCT00759057,TERMINATED,INTERVENTIONAL,PMA not approved. FDA granted permission to close the study.
NCT00759083,WITHDRAWN,INTERVENTIONAL,The study was discontinued early due to inadequate patient enrollment. No patients were enrolled.
NCT00759278,WITHDRAWN,OBSERVATIONAL,No participants
NCT00759577,TERMINATED,INTERVENTIONAL,difficulty with enrollment
NCT00759642,TERMINATED,INTERVENTIONAL,IRB decision
NCT00759655,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00759720,TERMINATED,INTERVENTIONAL,Potential hepatic safety signal
NCT00759733,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT00759876,TERMINATED,INTERVENTIONAL,Terminated early because similar study with Ataluren (PTC124-GD-007-DMD; NCT00592553) exhibited lack of efficacy at the high dose (not due to safety concerns).
NCT00759993,TERMINATED,INTERVENTIONAL,inability to recruit and retain
NCT00760032,WITHDRAWN,INTERVENTIONAL,was not possible to measure LBP levels because we cannot found the kit
NCT00760058,WITHDRAWN,INTERVENTIONAL,Enrollment not initiated for study.
NCT00760188,WITHDRAWN,OBSERVATIONAL,No patients recruited into study.
NCT00760318,TERMINATED,INTERVENTIONAL,Sponsor decided to stop enrollment to review data.
NCT00760461,TERMINATED,INTERVENTIONAL,Enrolled subjects were unable to receive drug from dispensing pharmacy.
NCT00760604,TERMINATED,INTERVENTIONAL,Closed due to slow patient accrual.
NCT00760630,SUSPENDED,INTERVENTIONAL,"IRB Approval on study expired May 28, 2009"
NCT00760708,TERMINATED,OBSERVATIONAL,Persantine is no longer being used at UCHC for pharmacological stress testing
NCT00760773,TERMINATED,INTERVENTIONAL,Funding ended and fewer than required number of patients enrolled.
NCT00760903,WITHDRAWN,OBSERVATIONAL,Study was not started due to PI concentrating on other studies
NCT00760916,WITHDRAWN,INTERVENTIONAL,Study stopped prior to subject enrollment.
NCT00760929,TERMINATED,INTERVENTIONAL,The study was terminated due to the termination of the clinical development program.
NCT00761046,WITHDRAWN,OBSERVATIONAL,No data have been obtained at all in this time.
NCT00761176,TERMINATED,INTERVENTIONAL,Protocol Violations noted for 6 of 8 patients
NCT00761254,TERMINATED,INTERVENTIONAL,PI withdrew due to increased responsibilities in clinical department.
NCT00761280,TERMINATED,INTERVENTIONAL,"Unable to recruit the projected patient number. All analyses are descriptive, only."
NCT00761410,TERMINATED,INTERVENTIONAL,Study was terminated early due to prolonged recruitment period.
NCT00761436,TERMINATED,INTERVENTIONAL,"Study was completed, only life long extended follow-up phase was discontinued after 12 years"
NCT00761488,WITHDRAWN,INTERVENTIONAL,Primary Investigator resigned from hospital
NCT00761514,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment.
NCT00761683,TERMINATED,OBSERVATIONAL,Anticipated number of patients not achieved. All Patients recruited in the study completed all study visits.
NCT00761839,WITHDRAWN,INTERVENTIONAL,Study was withdrawn because of a problem with the software used for generating the aftercare summary.
NCT00761865,TERMINATED,INTERVENTIONAL,low enrollment
NCT00762112,TERMINATED,INTERVENTIONAL,Hepatic safety signal identified.
NCT00762138,TERMINATED,INTERVENTIONAL,Discontinued due to favorable results
NCT00762190,TERMINATED,INTERVENTIONAL,Hepatic safety signal identified.
NCT00762242,TERMINATED,OBSERVATIONAL,Study enrollment was no adequate.
NCT00762359,TERMINATED,INTERVENTIONAL,AG-1749 superior to Gefarnate in ulcer prevention
NCT00762554,WITHDRAWN,INTERVENTIONAL,Uncertain safety of one of the study medications.
NCT00762684,TERMINATED,INTERVENTIONAL,Hepatic safety signal identified.
NCT00762723,TERMINATED,INTERVENTIONAL,Study was stopped due to slow enrollment
NCT00762801,WITHDRAWN,OBSERVATIONAL,Principal Investigator left institution.
NCT00762814,TERMINATED,INTERVENTIONAL,There was no funding for the device to be used in the study.
NCT00762918,WITHDRAWN,INTERVENTIONAL,Recruitment
NCT00762957,TERMINATED,INTERVENTIONAL,Hepatic Safety Signal Identified.
NCT00763009,TERMINATED,INTERVENTIONAL,Limited numbers of patients qualified for trial
NCT00763035,TERMINATED,INTERVENTIONAL,Potential participants with COPD/asthma unwilling to participate.
NCT00763191,TERMINATED,INTERVENTIONAL,departure of the principal investigator and nobody else was able to continue this study.
NCT00763347,TERMINATED,INTERVENTIONAL,Voluntarily terminated based on preliminary non-clinical findings.
NCT00763594,TERMINATED,INTERVENTIONAL,Too slow recruiting of patients/therapists to the study
NCT00763685,TERMINATED,INTERVENTIONAL,The gynecological laparoscopic surgery transition to day surgery made following the study protocol not possible.
NCT00763776,TERMINATED,INTERVENTIONAL,difficulty for the patient recruiting
NCT00763880,TERMINATED,INTERVENTIONAL,Recruitment was taking longer than originally anticipated.
NCT00763893,TERMINATED,INTERVENTIONAL,"A similar publication has been released, suggesting a beneficial effect of sartans, and only 15 patients remained to be seen for their visit at 36 months."
NCT00764062,TERMINATED,INTERVENTIONAL,The trial was stopped earlier than planned because of the slow accrual rate.
NCT00764179,TERMINATED,INTERVENTIONAL,"difficulties of recruitment, high number of patients lost to follow-up"
NCT00764348,WITHDRAWN,OBSERVATIONAL,withdrawn as MSU approval obained
NCT00764413,TERMINATED,INTERVENTIONAL,Low inclusion frequency and not enough human resources for completing study
NCT00764582,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment.
NCT00764608,WITHDRAWN,OBSERVATIONAL,"No Participants enrolled, per PI discretion"
NCT00764660,TERMINATED,INTERVENTIONAL,"Based on the outcome of a planned interim analysis, the study was stopped early due to futility."
NCT00764699,TERMINATED,INTERVENTIONAL,PI left institution
NCT00764764,TERMINATED,INTERVENTIONAL,PI left institution
NCT00764803,TERMINATED,OBSERVATIONAL,Corporate decision to discontinue distribution of MJS Knee.
NCT00764842,TERMINATED,OBSERVATIONAL,Enrollment and data collection insufficient to continue study.
NCT00764894,TERMINATED,OBSERVATIONAL,Enrollment and data collection insufficient to continue study.
NCT00764959,TERMINATED,OBSERVATIONAL,Enrollment and data collection insufficient to continue study.
NCT00765102,TERMINATED,INTERVENTIONAL,There was a change in the Sponsor's research strategy; safety concerns were not a factor.
NCT00765141,WITHDRAWN,OBSERVATIONAL,No participants enrolled per PI discretion
NCT00765154,TERMINATED,INTERVENTIONAL,Difficulties in recruitment due to a change in the nature of practice.
NCT00765375,TERMINATED,INTERVENTIONAL,Investigator decision
NCT00765401,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT00765466,TERMINATED,INTERVENTIONAL,Study transferred out of McGill because PI relocted to another insitution.
NCT00765544,TERMINATED,INTERVENTIONAL,Study re-design
NCT00765570,TERMINATED,INTERVENTIONAL,Accrual too slow - would not enroll enough subjects to determine outcome
NCT00765726,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00765765,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00765856,TERMINATED,INTERVENTIONAL,Terminated new protocol developed which incorporated Pharmacokinetics
NCT00765960,WITHDRAWN,OBSERVATIONAL,Prinicipal Investigator separating employment from University.
NCT00766142,TERMINATED,INTERVENTIONAL,"In 2008, new data highlighted that Cetuximab had no efficacy in case of KRAS mutation. As such, eligibility criteria were revised and limited to KRAS wild-type. Inclusions were thus slown down considerably, and the trial was stopped."
NCT00766181,TERMINATED,OBSERVATIONAL,Product withdrawn from distribution
NCT00766194,TERMINATED,OBSERVATIONAL,slow enrollment
NCT00766220,WITHDRAWN,INTERVENTIONAL,Slow Accrual and withdrawn/exclusion of 2 participants.
NCT00766246,TERMINATED,INTERVENTIONAL,Withdrawal of funding support
NCT00766272,TERMINATED,INTERVENTIONAL,Study re-designed
NCT00766441,TERMINATED,INTERVENTIONAL,inadequate recruitment
NCT00766506,TERMINATED,INTERVENTIONAL,Product class one recall
NCT00766636,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00766688,TERMINATED,INTERVENTIONAL,AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy
NCT00766779,TERMINATED,INTERVENTIONAL,Recommendation of DMC
NCT00766870,TERMINATED,INTERVENTIONAL,Study was previously paused and is now terminated
NCT00767039,TERMINATED,INTERVENTIONAL,"Slow recruitment,changes in protocols, larger than anticipated differences"
NCT00767234,TERMINATED,OBSERVATIONAL,Accrual issues - Low Accrual
NCT00767338,TERMINATED,INTERVENTIONAL,"The DSMB recommended stopping the study because of concerns about the dismal recruitment, the drain on network resources, and the need for a study redesign."
NCT00767390,WITHDRAWN,OBSERVATIONAL,The required results were obtained through alternate methodology
NCT00767468,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT00767481,TERMINATED,INTERVENTIONAL,Project Cancelled
NCT00767494,TERMINATED,INTERVENTIONAL,Project Cancelled
NCT00767533,TERMINATED,OBSERVATIONAL,PI left
NCT00767572,TERMINATED,INTERVENTIONAL,low enrollment
NCT00767689,TERMINATED,INTERVENTIONAL,incomplete enrollment
NCT00767715,TERMINATED,INTERVENTIONAL,Trial discontinued due to low enrollment
NCT00767845,WITHDRAWN,OBSERVATIONAL,No subjects were enrolled here or at UCSF.
NCT00767884,TERMINATED,OBSERVATIONAL,Low subject recruitment
NCT00767988,WITHDRAWN,INTERVENTIONAL,Withdrawn by PI
NCT00768001,TERMINATED,OBSERVATIONAL,low accrual
NCT00768027,SUSPENDED,OBSERVATIONAL,Seeking additional funds
NCT00768040,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT00768248,TERMINATED,INTERVENTIONAL,"No longer enrolling patients, not enough enrollment"
NCT00768300,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00768313,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT00768339,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00768482,TERMINATED,INTERVENTIONAL,This study was terminated for reasons not related to efficacy or safety
NCT00768742,WITHDRAWN,INTERVENTIONAL,study revised and reinitiated under another protocol
NCT00768989,TERMINATED,INTERVENTIONAL,"Efficacy endpoint met, but overall experimental dosing regimen not considered optimal to support further clinical development in this population."
NCT00769093,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT00769262,TERMINATED,INTERVENTIONAL,insufficient resources to conduct study
NCT00769600,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00769626,TERMINATED,INTERVENTIONAL,Unable to recruit patients
NCT00769652,TERMINATED,INTERVENTIONAL,slow accrual
NCT00769834,WITHDRAWN,OBSERVATIONAL,All investigators have moved to different oranizations
NCT00769847,WITHDRAWN,OBSERVATIONAL,Study was withdrawn due to lack of resources.
NCT00769873,TERMINATED,INTERVENTIONAL,Recruitment was slower than anticipated. Insufficient funding to expand to multi-centered trial.
NCT00769925,WITHDRAWN,INTERVENTIONAL,PI is transitioning to another institution
NCT00769990,WITHDRAWN,INTERVENTIONAL,No patient accrual.
NCT00770016,TERMINATED,INTERVENTIONAL,no longer interested in doing the study
NCT00770419,WITHDRAWN,OBSERVATIONAL,Slow accrual
NCT00770679,TERMINATED,INTERVENTIONAL,"Delayed recruitment, funding exhausted"
NCT00770705,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT00770718,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00771043,WITHDRAWN,INTERVENTIONAL,Sponsor decision to withdraw study at this time.
NCT00771056,TERMINATED,INTERVENTIONAL,study suspended while data is reviewed for safety and efficacy.
NCT00771134,TERMINATED,INTERVENTIONAL,Study was previously suspended and is now terminated
NCT00771316,TERMINATED,INTERVENTIONAL,feasibility and low enrollment
NCT00771355,TERMINATED,OBSERVATIONAL,Lack of study staff.
NCT00771368,TERMINATED,INTERVENTIONAL,limited recruitment
NCT00771381,TERMINATED,INTERVENTIONAL,Retirement of former Qualified Investigator and lack of resources to complete study
NCT00771511,WITHDRAWN,INTERVENTIONAL,Study never started
NCT00771602,TERMINATED,INTERVENTIONAL,Lack of accrual.
NCT00771654,WITHDRAWN,INTERVENTIONAL,Low enrollment
NCT00771706,WITHDRAWN,INTERVENTIONAL,"This study was not activated, no data was collected."
NCT00771719,TERMINATED,INTERVENTIONAL,Study closed due to lack of enrollment; challenging patient population.
NCT00771797,WITHDRAWN,INTERVENTIONAL,investigator took study to university hospital duesseldorf
NCT00771862,TERMINATED,INTERVENTIONAL,Could not secure funding to complete the study.
NCT00772629,TERMINATED,INTERVENTIONAL,See detailed description for termination reason
NCT00772668,TERMINATED,INTERVENTIONAL,Funding
NCT00772785,TERMINATED,INTERVENTIONAL,This study was terminated for reasons not related to efficacy or safety
NCT00772954,TERMINATED,INTERVENTIONAL,Issues with CTM stability.
NCT00773084,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting patients and then the PI left the institution
NCT00773110,TERMINATED,INTERVENTIONAL,"Recruitment under target, Finding"
NCT00773318,TERMINATED,INTERVENTIONAL,1 patient has been enrolled. No complications reported. The research team decided to terminate the clinical trial due to insufficient patients' accrual.
NCT00773435,WITHDRAWN,INTERVENTIONAL,Decided to conduct study in adults first
NCT00773474,TERMINATED,INTERVENTIONAL,funding terminated
NCT00773552,WITHDRAWN,INTERVENTIONAL,Investigator Left Institution
NCT00773591,WITHDRAWN,INTERVENTIONAL,"The BfArM (CA)approved the trial in Nov 2008. However, the responsible EC refused approval in March 2009."
NCT00773890,TERMINATED,INTERVENTIONAL,Study was stopped due to perceived futility because the baseline pain score in first 40 patients was too low to be able demonstrate an improvement
NCT00774033,TERMINATED,INTERVENTIONAL,Not enough patients included
NCT00774059,WITHDRAWN,INTERVENTIONAL,No EC approval obtained
NCT00774241,WITHDRAWN,INTERVENTIONAL,Study was put on hold then out of Medical Plan therefore cancelled
NCT00774306,TERMINATED,INTERVENTIONAL,study no longer consistent with current clinical practice
NCT00774631,TERMINATED,INTERVENTIONAL,The sponsor stoppes the study for the security problem.
NCT00774657,WITHDRAWN,OBSERVATIONAL,Unable to identify and recruit suitable study subjects
NCT00774878,TERMINATED,INTERVENTIONAL,"Company decision to discontinue the AVE1642 development program, not due to any safety or efficacy concerns"
NCT00774891,WITHDRAWN,OBSERVATIONAL,difficulty enrolling patients into this study
NCT00775164,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT00775190,TERMINATED,INTERVENTIONAL,"unale to recruit , progress report not filed by PI"
NCT00775216,TERMINATED,INTERVENTIONAL,grant funding ended and lack of sufficient participants to complete trial
NCT00775320,TERMINATED,OBSERVATIONAL,Study closed by institutional review board
NCT00775502,TERMINATED,INTERVENTIONAL,lack of efficacy in Multiple myeloma
NCT00775541,TERMINATED,INTERVENTIONAL,Insufficient dose for MRI scanning
NCT00775554,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT00775606,TERMINATED,INTERVENTIONAL,Study stopped 12/2010 due to poor enrollment. Only 15 of 60 needed enrolled.
NCT00775749,WITHDRAWN,INTERVENTIONAL,The study is not feasible with the number of subjects needed to complete it.
NCT00775957,TERMINATED,OBSERVATIONAL,Terminated by institutional review board
NCT00776087,TERMINATED,INTERVENTIONAL,it is unethical to continue a study with deactivation of HM in the control arm although a reduced risk of all-cause death has been shown in previous trials
NCT00776100,TERMINATED,INTERVENTIONAL,Study was terminated prematurely due to slow accrual.
NCT00776191,TERMINATED,INTERVENTIONAL,al study sites stoped on 15/05/2012 because of insufficient recrutement.
NCT00776295,TERMINATED,INTERVENTIONAL,Low accrual
NCT00776555,TERMINATED,INTERVENTIONAL,The study was stopped by the sponsor based on a non-safety related business priority decision.
NCT00776659,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT00776802,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00776945,TERMINATED,OBSERVATIONAL,no funding
NCT00777192,TERMINATED,OBSERVATIONAL,Terminated at continuing review
NCT00777218,WITHDRAWN,INTERVENTIONAL,Enrollment criteria was too challenging and Investigators changed Institutions
NCT00777335,TERMINATED,INTERVENTIONAL,Very low recruitement rate.
NCT00777387,TERMINATED,INTERVENTIONAL,Studies emerged that demonstrated the superiority of vitrification
NCT00777400,WITHDRAWN,INTERVENTIONAL,New safety information reported in the post-marketing setting with efalizumab for treatment of chronic plaque psoriasis and trial conduct feasibility issues.
NCT00777842,TERMINATED,INTERVENTIONAL,In this feasibility study device did not perform as well as expected.
NCT00778063,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT00778089,TERMINATED,INTERVENTIONAL,Closed incomplete due to Artes Medical Closing
NCT00778479,TERMINATED,INTERVENTIONAL,Terminated by Sponsor: see details below
NCT00778505,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT00778817,TERMINATED,INTERVENTIONAL,The trial was permanently halted due to futility concerns.
NCT00778856,TERMINATED,INTERVENTIONAL,Principal Investigator relocated to another institution
NCT00778947,WITHDRAWN,INTERVENTIONAL,Study abandoned and was never started
NCT00779038,TERMINATED,INTERVENTIONAL,Stopped prematurely in 2008 due to IONSYS withdrawal off the market globally
NCT00779142,TERMINATED,INTERVENTIONAL,recent research indicates Lucentis to be an effictive treatment
NCT00779311,TERMINATED,INTERVENTIONAL,Dose limiting toxicity at the lowest planned dose level.
NCT00779480,TERMINATED,INTERVENTIONAL,Failure to demonstrate a tolerable dose that had potential for efficacy.
NCT00779844,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT00780143,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00780156,TERMINATED,OBSERVATIONAL,No more information will be given. No consequences on security and treatment of patients: standard therapy is already performed for all patients.
NCT00780325,TERMINATED,INTERVENTIONAL,"A total of three parts were planned for this study. The sponsor funded only Part 1, so that neither Part 2 nor Part 3 of this study has been conducted."
NCT00780377,WITHDRAWN,INTERVENTIONAL,"Unable to perform study due to unavailable drug, then unable to partner with cath lab"
NCT00780390,TERMINATED,INTERVENTIONAL,Lack of enrollment and discontinued funding
NCT00780481,TERMINATED,INTERVENTIONAL,Lack of enrollment due to strict inclusion/exclusion criteria. Bradykinin shortage
NCT00780637,WITHDRAWN,INTERVENTIONAL,"Bradykinin Shortage, SCCOR expired prior to BK availability, lack of enrollment."
NCT00780676,TERMINATED,INTERVENTIONAL,Closed early for futility.
NCT00780832,TERMINATED,INTERVENTIONAL,Insufficient elligible patients available in a reasonable time frame.
NCT00780975,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00781287,TERMINATED,INTERVENTIONAL,Enrollment too slow.
NCT00781326,TERMINATED,INTERVENTIONAL,"Final cost of study medication was significantly greater than initial estimate,"
NCT00781469,TERMINATED,OBSERVATIONAL,struggled to recruit and the synovial tissue samples obtained were so poor that we had to end the study prematurely without data from the primary outcomes
NCT00781482,WITHDRAWN,INTERVENTIONAL,Sponsor elected not to conduct study at this time.
NCT00781755,WITHDRAWN,INTERVENTIONAL,Study design was altered such that a treatment component was removed through the VA IRB. We did not and will not begin this clinical trial.
NCT00781781,TERMINATED,INTERVENTIONAL,Inability to recruit the number of patients established in the study protocol (34 of 40)
NCT00781833,TERMINATED,INTERVENTIONAL,Participation of single subject enrolled was terminated.
NCT00782041,TERMINATED,INTERVENTIONAL,protocol violation
NCT00782236,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00782483,TERMINATED,INTERVENTIONAL,PI moved out of state.
NCT00782613,TERMINATED,INTERVENTIONAL,Study has been termination early due to financial contraints.
NCT00782639,TERMINATED,INTERVENTIONAL,This study was terminated early due to slow enrollment.
NCT00782652,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00782834,TERMINATED,INTERVENTIONAL,"Stopped early for futility, unable to meet accrual goals"
NCT00783172,TERMINATED,INTERVENTIONAL,Problems with IRB
NCT00783250,TERMINATED,INTERVENTIONAL,Problems with data collection
NCT00783471,TERMINATED,INTERVENTIONAL,The low accrual rate of the study (30% of the expected accrual rate)/Low efficacy in both treatment arms.
NCT00783575,WITHDRAWN,OBSERVATIONAL,PI has left institution
NCT00783614,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00783679,WITHDRAWN,INTERVENTIONAL,Understaffing and inadequate funding
NCT00783796,TERMINATED,INTERVENTIONAL,Study stopped at 3 years. Funding for trial withdrawn by sponsor.
NCT00783952,TERMINATED,INTERVENTIONAL,Inability to recruit subjects
NCT00784485,TERMINATED,INTERVENTIONAL,Terminated due to poor enrollment.
NCT00784524,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00784602,TERMINATED,OBSERVATIONAL,Shift in department's research interests
NCT00784693,TERMINATED,INTERVENTIONAL,"Further recruitment into the study was ceased on 10th December 2009, not attributed to safety. All patients recruited in the study completed all study visits."
NCT00784836,TERMINATED,INTERVENTIONAL,Terminated early by Sponsor for business reasons unrelated to safety.
NCT00784966,WITHDRAWN,INTERVENTIONAL,University decision.
NCT00785135,TERMINATED,INTERVENTIONAL,Unable to recruit - multiple reasons.- inclusion/exclusion criteria too strict was th emain reason.
NCT00785239,WITHDRAWN,OBSERVATIONAL,Business Reasons
NCT00785252,WITHDRAWN,INTERVENTIONAL,Sponsor termination
NCT00785356,TERMINATED,INTERVENTIONAL,Repros stopped the study for safety and FDA put the study on hold for safety.
NCT00785551,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00785694,WITHDRAWN,INTERVENTIONAL,Rejected ethics approval in UK and Holland
NCT00785772,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00785798,TERMINATED,INTERVENTIONAL,sponsor requested
NCT00785811,TERMINATED,INTERVENTIONAL,Required by the investigator. The site could not recruit patients anymore.
NCT00785967,WITHDRAWN,INTERVENTIONAL,Unexpected and severe difficulties in recruitment.
NCT00786318,WITHDRAWN,INTERVENTIONAL,Sponsor terminated
NCT00786578,WITHDRAWN,OBSERVATIONAL,not funded
NCT00786682,TERMINATED,INTERVENTIONAL,"Lack of improved efficacy compared to historical controls, competing studies"
NCT00786968,TERMINATED,INTERVENTIONAL,Due to slow enrolment.
NCT00787072,TERMINATED,INTERVENTIONAL,"After reports of turbidity in urine in 4 of 8 volunteers in the 4th cohort, the study was halted temporarily."
NCT00787137,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00787176,TERMINATED,INTERVENTIONAL,Study concluded prematurely prior to meeting intended goal recruitment.
NCT00787267,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00787293,SUSPENDED,INTERVENTIONAL,Company ended operations January 2011
NCT00787332,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00787358,WITHDRAWN,INTERVENTIONAL,Change in company direction
NCT00787462,TERMINATED,INTERVENTIONAL,Restrictive inclusion criteria/limited pool of suitable subjects with SFN.
NCT00787488,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT00787618,TERMINATED,INTERVENTIONAL,Increased LFTs
NCT00787644,TERMINATED,INTERVENTIONAL,new safety concerns which emerged about pioglitazone during the trial
NCT00787852,TERMINATED,INTERVENTIONAL,for efficacy and safety reasons
NCT00788125,TERMINATED,INTERVENTIONAL,Terminated early due a shift in resources after lackluster performance of the drug.
NCT00788190,WITHDRAWN,INTERVENTIONAL,The inclusion/Exclusion criteria was too strict which restricted recruitment
NCT00788307,TERMINATED,INTERVENTIONAL,closed early due to poor accrual
NCT00788320,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT00788385,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT00788424,WITHDRAWN,INTERVENTIONAL,Sponsor's considerations
NCT00788515,TERMINATED,INTERVENTIONAL,Sponsor's decision due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems
NCT00788541,TERMINATED,INTERVENTIONAL,Project cancellation
NCT00788580,WITHDRAWN,INTERVENTIONAL,Study was discontinued.
NCT00788606,TERMINATED,INTERVENTIONAL,Toxicity and efficacy data from another trial
NCT00788619,TERMINATED,INTERVENTIONAL,difficulty with recruitment
NCT00789100,WITHDRAWN,OBSERVATIONAL,Nottingham PCT withdrew for financial reasons
NCT00789282,TERMINATED,INTERVENTIONAL,Recruitment challenges.
NCT00789399,TERMINATED,INTERVENTIONAL,Principal Investigator moved to another region of the country
NCT00789464,WITHDRAWN,INTERVENTIONAL,Withdrawn by PI
NCT00789646,TERMINATED,INTERVENTIONAL,Very slow in enrolling participants
NCT00789659,WITHDRAWN,INTERVENTIONAL,PI did not want to go forward with study at this time
NCT00789789,TERMINATED,OBSERVATIONAL,stopped prematurely due to the absence of safety signal
NCT00790296,TERMINATED,INTERVENTIONAL,Interim analyses showed statistically and clinically significant results.
NCT00790439,WITHDRAWN,INTERVENTIONAL,Due to funding limitations
NCT00790452,TERMINATED,INTERVENTIONAL,Low accrual.
NCT00790504,WITHDRAWN,OBSERVATIONAL,Difficulty recruiting patient. Lack of research assistant.
NCT00790608,TERMINATED,INTERVENTIONAL,Limited recruitment
NCT00790699,TERMINATED,INTERVENTIONAL,Lack of patient population
NCT00790725,TERMINATED,INTERVENTIONAL,"The patient population in RACU has changed significantly, we can not find potential subjects to recruit. The enrollment rate has reached zero."
NCT00790764,SUSPENDED,INTERVENTIONAL,Suspended due to lack of funding.
NCT00790842,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00790855,TERMINATED,INTERVENTIONAL,Lack of Response
NCT00790894,TERMINATED,INTERVENTIONAL,The low accrual rate of the study (25% of the expected accrual rate)
NCT00790972,WITHDRAWN,INTERVENTIONAL,Company went out of business.
NCT00791076,TERMINATED,INTERVENTIONAL,PI left JHU
NCT00791089,TERMINATED,INTERVENTIONAL,unable to secure funding and long term follow up
NCT00791336,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT00791544,TERMINATED,INTERVENTIONAL,"Company decision to discontinue the AVE1642 development program, not due to any safety or efficacy concerns"
NCT00791986,TERMINATED,INTERVENTIONAL,End of study time and budget permission
NCT00792480,TERMINATED,INTERVENTIONAL,Resident research project limited by restrictions of residency program.
NCT00792506,TERMINATED,INTERVENTIONAL,The study was prematurely discontinued for lack of recruitement.
NCT00792662,WITHDRAWN,INTERVENTIONAL,No Subjects enrolled
NCT00792740,TERMINATED,INTERVENTIONAL,"As no safety warnings were detected, Interim analysis from the first 40 patients recommends to stop the trial for futility"
NCT00792792,WITHDRAWN,OBSERVATIONAL,Not a clinical trial study.
NCT00792831,TERMINATED,INTERVENTIONAL,Protocol needs complete restructuring in order to make it feasible and to complete the enrollment of 23 patients.
NCT00793013,WITHDRAWN,INTERVENTIONAL,IRB approval lapsed.
NCT00793078,SUSPENDED,OBSERVATIONAL,Awaiting decision on financial support by Deutsche Forschungsgemeinschaft (DFG)
NCT00793104,TERMINATED,INTERVENTIONAL,Slow enrolment \& potential regulatory changes for allograft in cartilage repair
NCT00793182,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00793208,TERMINATED,INTERVENTIONAL,study closed due to low enrollment
NCT00793338,WITHDRAWN,INTERVENTIONAL,The project was not funded and could not be initiated.
NCT00793416,WITHDRAWN,INTERVENTIONAL,Loss of study staffing
NCT00793468,WITHDRAWN,INTERVENTIONAL,Study halted prior to enrollment of patients
NCT00793494,TERMINATED,INTERVENTIONAL,Recruitment impossible
NCT00793546,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00793858,WITHDRAWN,INTERVENTIONAL,Cost prohibitive and company withdrew support.
NCT00793884,SUSPENDED,OBSERVATIONAL,Enrollment and study activities are temporarily suspended pending additional funding.
NCT00794183,TERMINATED,INTERVENTIONAL,funding difficulty
NCT00794313,TERMINATED,INTERVENTIONAL,Funding Ended
NCT00794339,TERMINATED,INTERVENTIONAL,transfer of funding
NCT00794963,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT00794989,TERMINATED,INTERVENTIONAL,low accrual
NCT00795106,WITHDRAWN,INTERVENTIONAL,Difficulty finding a monitor
NCT00795197,WITHDRAWN,OBSERVATIONAL,No recruitment of patients
NCT00795236,TERMINATED,INTERVENTIONAL,Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
NCT00795353,TERMINATED,OBSERVATIONAL,The study was terminated early due to insufficient subject enrolment in order to meet the primary and secondary endpoints
NCT00795470,WITHDRAWN,INTERVENTIONAL,Not pursuing the study due to funding issues
NCT00795587,TERMINATED,INTERVENTIONAL,evolution of patient's care allows no more recruitment
NCT00795639,TERMINATED,INTERVENTIONAL,"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury."
NCT00796055,TERMINATED,INTERVENTIONAL,MI-CP177 study closed per sponsor decision.
NCT00796107,TERMINATED,INTERVENTIONAL,"Due to the discontinuation of compound development, this study has been terminated."
NCT00796250,TERMINATED,INTERVENTIONAL,"Due to poor patient recruitment, a decision was made to terminate this trial."
NCT00796328,TERMINATED,INTERVENTIONAL,"Results Invalid, study closed, analysis cannot proceed."
NCT00796445,TERMINATED,INTERVENTIONAL,The study was terminated early following assessment of the two co-primary endpoints showing the lack of efficacy of the study product.
NCT00796484,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00796510,TERMINATED,INTERVENTIONAL,"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury"
NCT00796575,TERMINATED,INTERVENTIONAL,Safety concerns
NCT00796627,TERMINATED,INTERVENTIONAL,unable to recruit enough patients
NCT00796666,TERMINATED,INTERVENTIONAL,"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury."
NCT00796705,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT00796848,WITHDRAWN,INTERVENTIONAL,withdrawn because the research efforts at that time followed another path
NCT00796861,TERMINATED,INTERVENTIONAL,Phycisican decided to terminate study due to slow patient accrual.
NCT00796874,WITHDRAWN,INTERVENTIONAL,PI decided to terminate study.
NCT00796900,TERMINATED,INTERVENTIONAL,organizationally not possible
NCT00797043,TERMINATED,OBSERVATIONAL,"Slow enrollment, feasibility issues"
NCT00797082,TERMINATED,INTERVENTIONAL,default of inclusion
NCT00797290,TERMINATED,OBSERVATIONAL,"Slow enrollment, Feasibility issues"
NCT00797446,TERMINATED,OBSERVATIONAL,"Slow enrollment, feasibility issues"
NCT00797550,TERMINATED,INTERVENTIONAL,Study was terminated early for business reasons (not safety reasons).
NCT00797667,TERMINATED,INTERVENTIONAL,The study was terminated based on a recommendation of the DSMB following the identification of two patients with significant elevations in serum transaminases
NCT00797940,WITHDRAWN,INTERVENTIONAL,No funding for study
NCT00798031,WITHDRAWN,INTERVENTIONAL,As of 2017 study was terminated since investigators retired. No subjects recruited.
NCT00798057,TERMINATED,OBSERVATIONAL,Due to slow enrollment and feasibility issues.
NCT00798187,TERMINATED,OBSERVATIONAL,Terminated at time of CR - 3.26.2019 - JA
NCT00798304,TERMINATED,INTERVENTIONAL,"Following program review within Pfizer, decision was made not to go ahead with this study. This study is cancelled"
NCT00798460,TERMINATED,INTERVENTIONAL,could not enroll patients
NCT00798525,TERMINATED,INTERVENTIONAL,"Supply of Lepirudin ended on 01. April 2012, thus trial terminated on 31. March 2012"
NCT00798590,TERMINATED,INTERVENTIONAL,PI left JHU
NCT00798616,WITHDRAWN,INTERVENTIONAL,We were unable to enroll a sufficient number of patients due to manpower.
NCT00798798,WITHDRAWN,INTERVENTIONAL,Inability to recruit eligible subjects
NCT00798837,TERMINATED,INTERVENTIONAL,Excess risk in rectal bleeding of first 10 patients
NCT00799201,TERMINATED,INTERVENTIONAL,Naloxone became unavailable due to manufacturing shortatges requiring the study to be terminated.
NCT00799435,TERMINATED,INTERVENTIONAL,Inability to recruit adequate Sample Size who met the entry criteria
NCT00799448,TERMINATED,INTERVENTIONAL,Low recruitment status
NCT00799760,TERMINATED,INTERVENTIONAL,Just Terminated for the end of the pandemia
NCT00799773,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT00799838,TERMINATED,INTERVENTIONAL,Recruitment challenges despite several attenpts to increase enrollment
NCT00800137,TERMINATED,INTERVENTIONAL,At time of pre-specified 2nd interim analysis
NCT00800150,TERMINATED,INTERVENTIONAL,Protocol objective could not be met. A new study with amended eligibility criteria will be developed.
NCT00800280,TERMINATED,INTERVENTIONAL,Please see Detailed Description for termination reason.
NCT00800514,WITHDRAWN,INTERVENTIONAL,Principal investigator took a position at another institution. No subjects enrolled.
NCT00800566,WITHDRAWN,INTERVENTIONAL,Sponsor terminated.
NCT00800670,TERMINATED,INTERVENTIONAL,Study was terminated after the low dose cohort had been enrolled
NCT00800696,WITHDRAWN,INTERVENTIONAL,this study was not initiated due to lack of funding
NCT00800787,WITHDRAWN,INTERVENTIONAL,New sponsor's existing product under evaluation for this indication
NCT00801125,WITHDRAWN,INTERVENTIONAL,Study sponsor decided to withdraw the current study prior to enrollment of first participant.
NCT00801138,TERMINATED,INTERVENTIONAL,A strong primary outcome crosses the efficacy boundary at the interim analysis
NCT00801268,TERMINATED,INTERVENTIONAL,high rate of drop-out
NCT00801567,WITHDRAWN,INTERVENTIONAL,Departure of essential Co-Investigator from McLean Hospital
NCT00801736,TERMINATED,INTERVENTIONAL,The antibody used did not appear prognostic/predictive based on interim results.
NCT00801775,TERMINATED,OBSERVATIONAL,The study was stopped march 2009 due to recruitment problems.
NCT00801801,TERMINATED,INTERVENTIONAL,Sponsors withdrew funding; preliminary efficacy data was not encouraging.
NCT00801918,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00801931,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00801996,WITHDRAWN,OBSERVATIONAL,Closed by Investigator
NCT00802191,TERMINATED,OBSERVATIONAL,"Lack of study participants, no data published."
NCT00802217,TERMINATED,INTERVENTIONAL,PK results demonstrated no systemic absorption
NCT00802633,TERMINATED,INTERVENTIONAL,Enrollment was stopped after eighty patients were enrolled.
NCT00802646,WITHDRAWN,INTERVENTIONAL,study moved to alternate site
NCT00802659,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT00802685,TERMINATED,INTERVENTIONAL,Lack of availability of IV ibuprofen as of 8/10 due to a manufacturer's recall
NCT00802711,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00802893,TERMINATED,INTERVENTIONAL,"We were unable to recruit any subjects into this study so no subjects completed the protocol. Therefore, we are unable to provide any conclusions."
NCT00803088,WITHDRAWN,INTERVENTIONAL,Current treatment regimen of 3 procedures considered acceptable.
NCT00803140,TERMINATED,INTERVENTIONAL,Slow accrual of subject enrollment.
NCT00803179,TERMINATED,INTERVENTIONAL,"Poor enrollment, patients were lost to follow up"
NCT00803270,TERMINATED,INTERVENTIONAL,Feasibility Period ended.
NCT00803309,TERMINATED,INTERVENTIONAL,At the end of the planned recruitment period the expected number of subjects could not be included in the trial.
NCT00803530,TERMINATED,INTERVENTIONAL,difficulties of enrollement
NCT00803842,WITHDRAWN,INTERVENTIONAL,Investigator left the institution and decided not to continue with the study.
NCT00803868,TERMINATED,INTERVENTIONAL,The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.
NCT00804050,TERMINATED,INTERVENTIONAL,Difficulties of enrollment
NCT00804180,WITHDRAWN,INTERVENTIONAL,Lack of recruitment/participants
NCT00804310,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00804479,TERMINATED,OBSERVATIONAL,Funding for the CALM-PD Cohort Study was terminated by sponsor.
NCT00804544,TERMINATED,INTERVENTIONAL,4 patients have been enrolled into the pilot study. No complications reported. Another clinical trial has been designed.
NCT00804557,TERMINATED,OBSERVATIONAL,pending design changes to the device
NCT00804726,TERMINATED,INTERVENTIONAL,Test lens did not meet near visual efficacy endpoints
NCT00804830,TERMINATED,INTERVENTIONAL,lack of response
NCT00804882,WITHDRAWN,OBSERVATIONAL,Principal investigator is leaving the institution to obtain further training.
NCT00804960,WITHDRAWN,INTERVENTIONAL,lack of recruitment at this site
NCT00804973,TERMINATED,INTERVENTIONAL,Due to efficacy results of interim analysis
NCT00805012,TERMINATED,INTERVENTIONAL,slow accrual rate
NCT00805116,TERMINATED,INTERVENTIONAL,"Recruitment to slow, most patients to well for treatment"
NCT00805285,TERMINATED,INTERVENTIONAL,Study terminated due to insufficient enrollment
NCT00805311,TERMINATED,INTERVENTIONAL,Due to the clear advantage of carotid endarterectomy
NCT00805467,TERMINATED,INTERVENTIONAL,AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.
NCT00805493,TERMINATED,INTERVENTIONAL,Insufficient recruitment of participants
NCT00805597,TERMINATED,INTERVENTIONAL,The recuiting was to slow to complete the study
NCT00805610,WITHDRAWN,INTERVENTIONAL,Investigator taking position at another university-0 enrolled under this protocol.
NCT00805740,TERMINATED,INTERVENTIONAL,"The study was terminated prematurely on May 18, 2012 due to slow enrollment. The study was not terminated due to any safety issues or concerns."
NCT00805779,TERMINATED,INTERVENTIONAL,Major protocol changes needeed
NCT00805844,TERMINATED,OBSERVATIONAL,Sponsor terminated the study
NCT00805948,TERMINATED,INTERVENTIONAL,Study device discontinued \& insufficient sample size for statistical results.
NCT00805974,TERMINATED,INTERVENTIONAL,difficulties for including diabetic patients
NCT00806273,WITHDRAWN,INTERVENTIONAL,Manufacturer changed device so no study will be done; ie it was never started
NCT00806351,TERMINATED,INTERVENTIONAL,"The study was prematurely terminated on May 18, 2012 due to slow enrollment. The study was not terminate due to any safety issues or concerns."
NCT00806390,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00806468,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT00806572,TERMINATED,INTERVENTIONAL,Adverse events related to drug lot
NCT00806910,WITHDRAWN,INTERVENTIONAL,Sponsor support withdrawn
NCT00807170,TERMINATED,INTERVENTIONAL,Very slow recruitment
NCT00807209,TERMINATED,INTERVENTIONAL,Sponsor decision unrelated to safety
NCT00807235,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00807274,WITHDRAWN,OBSERVATIONAL,Alternative trial planned
NCT00807365,TERMINATED,INTERVENTIONAL,PI left JHU
NCT00807521,WITHDRAWN,INTERVENTIONAL,Research question was integrated in other study protocol
NCT00807612,TERMINATED,INTERVENTIONAL,Study was closed due to administrative decision
NCT00807755,TERMINATED,INTERVENTIONAL,Number of known toxicities observed despite a treatment-nave population
NCT00808080,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00808145,WITHDRAWN,INTERVENTIONAL,"Lack of enrollment, many screen failures and non eligible study participants"
NCT00808210,TERMINATED,INTERVENTIONAL,"Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA."
NCT00808561,TERMINATED,INTERVENTIONAL,Slow enrollment due to multiple screen failures
NCT00808613,WITHDRAWN,INTERVENTIONAL,Study withdrawn prior to initiation
NCT00808626,WITHDRAWN,INTERVENTIONAL,Lack of funding to complete trial. A lead member of research team retired.
NCT00808652,TERMINATED,OBSERVATIONAL,not enough recruits
NCT00808899,TERMINATED,INTERVENTIONAL,Voluntarily closed and terminated by the PI due to lack of feasibility
NCT00808990,TERMINATED,INTERVENTIONAL,Time table was unfulfilled due to incompetent research coordinator. Inaccurate results and No conclusions can be withdrawn
NCT00809185,TERMINATED,INTERVENTIONAL,slow accrual
NCT00809302,TERMINATED,INTERVENTIONAL,Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns identified.
NCT00809341,TERMINATED,INTERVENTIONAL,Low accrual
NCT00809354,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00809380,TERMINATED,INTERVENTIONAL,Study ws terminated because of a too low recruitment rate.
NCT00809458,TERMINATED,INTERVENTIONAL,Low rate of accrual.
NCT00809536,TERMINATED,INTERVENTIONAL,Please Detailed Description for termination reason.
NCT00809679,TERMINATED,INTERVENTIONAL,"Some patients experienced asymptomatic, transient elevations in liver transaminases"
NCT00809692,WITHDRAWN,INTERVENTIONAL,Study withdrawn and combined with a new protocol
NCT00809783,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00809887,TERMINATED,INTERVENTIONAL,Inability to enroll subjects
NCT00810017,TERMINATED,INTERVENTIONAL,Terminated due to difficulty in accruing patients
NCT00810134,TERMINATED,INTERVENTIONAL,Due to the results of interim analysis at the time 44 patients were recruited.
NCT00810212,WITHDRAWN,INTERVENTIONAL,Sponsor preferred a better study design
NCT00810576,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00810706,TERMINATED,INTERVENTIONAL,Publication of MA17 results (similar trial in the extented adjuvant setting with letrozole)
NCT00810862,TERMINATED,INTERVENTIONAL,Lack of subject enrollment over the past two years.
NCT00810875,TERMINATED,OBSERVATIONAL,Terminated due to lack of enrollment
NCT00811018,TERMINATED,INTERVENTIONAL,"This trial was prematurely terminated on Dec 9 2010 due to safety concerns, specifically emerging evidence of hepatic injury."
NCT00811044,WITHDRAWN,OBSERVATIONAL,"PI, Dr. K. Polonsky has moved to the University of Chicago."
NCT00811122,TERMINATED,INTERVENTIONAL,A Fluorine-18 labeled version of the radiopharmaceutical (Flutemetamol) became available. This version is far superior to the Carbon-11 PiB. There is no need to make this compound available any longer.
NCT00811174,TERMINATED,INTERVENTIONAL,"Due to limited data available, efficacy, and PK analyses were not performed."
NCT00811304,WITHDRAWN,OBSERVATIONAL,We are unable to find a clip used to stabilize the epidural needle on the ultrasound probe to allow adequate epidural catheter placement.
NCT00811356,TERMINATED,INTERVENTIONAL,safety issues (toxicity)
NCT00811382,TERMINATED,INTERVENTIONAL,Criterion according study protocol to end study prematurely was fulfilled.
NCT00811434,TERMINATED,INTERVENTIONAL,funding period ended
NCT00811486,WITHDRAWN,INTERVENTIONAL,"Only 1 patient recruited, and he withdrew"
NCT00811590,TERMINATED,INTERVENTIONAL,The study was ended early due to low enrollment.
NCT00811655,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT00811863,WITHDRAWN,OBSERVATIONAL,Study drug currently unavailable
NCT00812240,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT00812266,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00812721,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT00813111,TERMINATED,INTERVENTIONAL,"Sponsor decision, unrelated to safety"
NCT00813371,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institution before subjects were enrolled
NCT00813501,TERMINATED,OBSERVATIONAL,Terminated at the request of the study sponsor
NCT00813592,TERMINATED,INTERVENTIONAL,Original PI left and company withdrew support.
NCT00813839,WITHDRAWN,INTERVENTIONAL,for inability to enroll subjects.
NCT00813878,TERMINATED,OBSERVATIONAL,Closed due to low accrual
NCT00814112,WITHDRAWN,OBSERVATIONAL,Lack of personell
NCT00814164,TERMINATED,INTERVENTIONAL,Sponsor withdrew support
NCT00814333,TERMINATED,INTERVENTIONAL,Product supplier change - bought out. Unable to enroll patients.
NCT00814372,TERMINATED,INTERVENTIONAL,MBX-102 did not meet the target efficacy profile of HbA1c change.
NCT00814398,TERMINATED,INTERVENTIONAL,Change in cryopreservation protocol
NCT00814437,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT00814463,TERMINATED,INTERVENTIONAL,Early analysis indicated SRS not as beneficial post-op as pre-op
NCT00814528,WITHDRAWN,INTERVENTIONAL,The study never started due to the Principal Investigator leaving the institution
NCT00814593,WITHDRAWN,INTERVENTIONAL,Hoag Hospital ceased support.
NCT00814606,WITHDRAWN,INTERVENTIONAL,no one ever enrolled
NCT00814775,TERMINATED,INTERVENTIONAL,"recruitment challenges, device no longer available"
NCT00814892,TERMINATED,INTERVENTIONAL,Study was terminated due to funding issues.
NCT00814983,TERMINATED,INTERVENTIONAL,IND approval for naive T-cell depletion not obtained
NCT00815152,TERMINATED,INTERVENTIONAL,PI transferred to new institution.
NCT00815230,WITHDRAWN,OBSERVATIONAL,"because of unexpected administrative barrier, it was very difficult to enroll case."
NCT00815347,TERMINATED,INTERVENTIONAL,Difficulty in recruitment.
NCT00815373,WITHDRAWN,INTERVENTIONAL,no participants recruded.
NCT00815386,SUSPENDED,INTERVENTIONAL,Company ended operations in January 2011
NCT00815438,WITHDRAWN,INTERVENTIONAL,Study personnel left institution
NCT00815516,TERMINATED,INTERVENTIONAL,It was decided to discontinue the study due to insufficient recruitment.
NCT00815633,TERMINATED,INTERVENTIONAL,Failed to enroll patients. There is no data or results for this study.
NCT00815932,WITHDRAWN,INTERVENTIONAL,Due to unfixable problem in the research machine we had to withdrawn from the study
NCT00815958,TERMINATED,INTERVENTIONAL,administrative reasons
NCT00816010,TERMINATED,INTERVENTIONAL,Due to lack of manpower at the various study sites
NCT00816179,TERMINATED,INTERVENTIONAL,Helical CT scans at our institution preclude the necessity for diagnostic laparoscopy in most cases at our institution.
NCT00816192,TERMINATED,INTERVENTIONAL,The production of the device used in this study has been suspended.
NCT00816270,TERMINATED,INTERVENTIONAL,Experimental results were unsatisfatory compared with control.
NCT00816296,WITHDRAWN,OBSERVATIONAL,PI has left institution
NCT00816413,WITHDRAWN,INTERVENTIONAL,Screenings yielded inadequate eligible subjects to enroll.
NCT00816478,TERMINATED,INTERVENTIONAL,Study closed by Institutional Review Board
NCT00816504,WITHDRAWN,INTERVENTIONAL,Under additional IRB Review
NCT00816556,TERMINATED,INTERVENTIONAL,Funding
NCT00816582,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00816647,TERMINATED,INTERVENTIONAL,Stopped for benefit of the MPFL reconstruction arm and due to safety concerns of the medial reefing arm.
NCT00816686,TERMINATED,INTERVENTIONAL,Trial was terminated due to the need to re-formulate the study drug.
NCT00816777,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00816790,TERMINATED,INTERVENTIONAL,Study stopped because of study personel movement to another institution.
NCT00816829,TERMINATED,INTERVENTIONAL,The study was prematurely terminated because of slow recruitment
NCT00817323,WITHDRAWN,INTERVENTIONAL,Recruitment did not take place for this research due to several delays and then one of the PIs moved out of the country and the project was closed
NCT00817362,TERMINATED,INTERVENTIONAL,Limited efficacy response observed during interim analysis.
NCT00817453,TERMINATED,OBSERVATIONAL,All subjects transferred to long term study NCT00817726 RBD Longitudinal
NCT00817531,TERMINATED,INTERVENTIONAL,terminated due to futility after interim analysis
NCT00817713,TERMINATED,INTERVENTIONAL,Terminated prematurely due to recruitment difficulties. Expansion to more study sites not planned.
NCT00817830,WITHDRAWN,INTERVENTIONAL,Difficulty in patient recruitment
NCT00818090,TERMINATED,INTERVENTIONAL,marginal statistical significance
NCT00818233,WITHDRAWN,OBSERVATIONAL,Difficulty recruiting patients. PI left research facility.
NCT00818259,TERMINATED,INTERVENTIONAL,Study terminated early prior to completing targeted enrollment of participants \<6 months of age due to recruitment challenges.
NCT00818389,TERMINATED,INTERVENTIONAL,NINDS DSMB recommended trial be terminated for futility after reviewing an interim analysis of 84 subjects.
NCT00818649,TERMINATED,INTERVENTIONAL,"Met protocol stop rule \[i.e., extreme toxicity\]"
NCT00818701,TERMINATED,INTERVENTIONAL,started a NIH study that is competing for same subjects
NCT00818714,WITHDRAWN,INTERVENTIONAL,There was no patient accrual nor study activity due to inability to fund PFTs.
NCT00818961,TERMINATED,INTERVENTIONAL,terminated early due to meeting end point with fewer patients than anticipated
NCT00819169,TERMINATED,INTERVENTIONAL,Sponsor decision - subjects rolled over to protocol 20101116
NCT00819260,TERMINATED,INTERVENTIONAL,Significant result achieved after enrollment of 31 of planned 50 subjects.
NCT00819637,TERMINATED,INTERVENTIONAL,Unable to enroll r/t study design \& staffing issues. The trial terminated.
NCT00819819,TERMINATED,INTERVENTIONAL,A similar study was conducted and subsequently published in Italy.
NCT00819832,TERMINATED,INTERVENTIONAL,Terminated by sponsor.
NCT00819910,TERMINATED,INTERVENTIONAL,Slow recruitment and increase in deployment overseas limiting follow up
NCT00820040,TERMINATED,INTERVENTIONAL,Slow enrollment due to strict eligibility criteria
NCT00820105,TERMINATED,INTERVENTIONAL,Incidence of abnormalities of liver function tests is higher than expected in this population.
NCT00820274,TERMINATED,INTERVENTIONAL,clinical trial have encountered difficulties enrolling a sufficient number of patients
NCT00820443,TERMINATED,INTERVENTIONAL,not move forward with the commercialization of this product based on marketing needs and there is not a known safety issue or concern
NCT00820456,TERMINATED,OBSERVATIONAL,Study did not meet enrollment goals.
NCT00820586,SUSPENDED,INTERVENTIONAL,No more funding support for additional procedures
NCT00820612,TERMINATED,INTERVENTIONAL,Stopped by DSMB for overwhelming benefit of indomethacin (unethical to withhold indomethacin from patients)
NCT00820703,TERMINATED,INTERVENTIONAL,For business reasons
NCT00820716,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patient
NCT00820807,TERMINATED,INTERVENTIONAL,Stopped due to a non-safety-related issue with the beverage (test vehicle).
NCT00821145,WITHDRAWN,INTERVENTIONAL,inability to recruit sufficient number of patients
NCT00821184,TERMINATED,INTERVENTIONAL,Insufficient subject availability/findings for data analysis
NCT00821561,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to recruitment for business reasons.
NCT00821717,TERMINATED,INTERVENTIONAL,"Positive FAIR-HF study data are available, this study is identical as EFFICACY-HF. Due to low recruitment in EFFICACY-HF the decision was made to terminate it."
NCT00822016,TERMINATED,OBSERVATIONAL,PI left institution. Insufficient enrollment for analysis.
NCT00822029,TERMINATED,INTERVENTIONAL,only 2 patients inclued and Study Principal Investigator has left the hospital
NCT00822159,TERMINATED,INTERVENTIONAL,Interim analysis showed statistically significant results
NCT00822653,WITHDRAWN,INTERVENTIONAL,Original principal investigator left the university before enrollment started
NCT00822796,TERMINATED,INTERVENTIONAL,Difficulty in obtaining surrogate consent on critically ill subjects.
NCT00822874,TERMINATED,INTERVENTIONAL,Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by other system
NCT00822900,TERMINATED,INTERVENTIONAL,futility: low conditional power to demonstrate benefit of progesterone
NCT00823017,WITHDRAWN,INTERVENTIONAL,study withdrawn from IRB
NCT00823095,TERMINATED,INTERVENTIONAL,Subject recuitment halted and won't resume; subjects are no longer being treated.
NCT00823225,TERMINATED,INTERVENTIONAL,Insufficient recruitment of study patients
NCT00823290,TERMINATED,INTERVENTIONAL,Investigator left site
NCT00823329,SUSPENDED,INTERVENTIONAL,lack of funding
NCT00823342,TERMINATED,INTERVENTIONAL,safety aspects
NCT00823420,TERMINATED,INTERVENTIONAL,The Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) has been replaced by a different formulation
NCT00823433,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT00823472,TERMINATED,INTERVENTIONAL,"Inclusion of the study didn't go as fast as expected. Expect: 234 patients in 1 year in 2 centers. After 1,5 year only 147 patients were recruited."
NCT00823641,TERMINATED,INTERVENTIONAL,Higher toxicity rate than observed in studies in Rheumatoid arthritis
NCT00823771,TERMINATED,OBSERVATIONAL,Data review showed that the study was underpowered to draw clear conlcusions
NCT00823810,TERMINATED,INTERVENTIONAL,Recruitment promlems
NCT00823953,WITHDRAWN,INTERVENTIONAL,IP could not be made available in sufficient quantity for the expected enrollment
NCT00823979,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00824369,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00824395,WITHDRAWN,OBSERVATIONAL,Non applicable clinical trial
NCT00824538,TERMINATED,INTERVENTIONAL,Closed prematurely due to emerging data on toxicity and competing trials.
NCT00824681,TERMINATED,INTERVENTIONAL,Music therapist left position.
NCT00824733,TERMINATED,INTERVENTIONAL,Inaccurate patient accrual for trial
NCT00824759,WITHDRAWN,INTERVENTIONAL,Because it seemed not of interest based on the current literature
NCT00824785,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00824811,WITHDRAWN,INTERVENTIONAL,Slow accrual.
NCT00824902,TERMINATED,INTERVENTIONAL,Technical Issues
NCT00824928,TERMINATED,OBSERVATIONAL,Study was ended due to low enrollment
NCT00825136,TERMINATED,INTERVENTIONAL,The main limitations were the small sample size and low completion rate.
NCT00825188,TERMINATED,INTERVENTIONAL,funding to complete was inadequate
NCT00825266,TERMINATED,INTERVENTIONAL,difficulty in finding eligible subjects
NCT00825331,WITHDRAWN,OBSERVATIONAL,Change of location for Investigators
NCT00825604,WITHDRAWN,INTERVENTIONAL,Because of poor inclusion difficulties to find patient
NCT00825747,WITHDRAWN,INTERVENTIONAL,study was closed
NCT00825968,TERMINATED,OBSERVATIONAL,PI stopped study to make a more substantial database.
NCT00826553,TERMINATED,INTERVENTIONAL,poor recruitment
NCT00826566,WITHDRAWN,INTERVENTIONAL,Suitable subjects could not be recruited within the estimated time frame.
NCT00826709,SUSPENDED,INTERVENTIONAL,The 2008-09 North American peak influenza season ended prior to study completion.
NCT00826748,TERMINATED,INTERVENTIONAL,Funding
NCT00826800,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00826839,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT00826930,TERMINATED,INTERVENTIONAL,"Sponsor business decision, not based on safety or efficacy data."
NCT00827099,TERMINATED,INTERVENTIONAL,Unacceptable morbidity \& mortality
NCT00827151,WITHDRAWN,INTERVENTIONAL,The study was not funded
NCT00827281,WITHDRAWN,INTERVENTIONAL,Study was not funded and pilot work proved impractical.
NCT00827567,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00827645,WITHDRAWN,OBSERVATIONAL,never funded and never started
NCT00827671,TERMINATED,INTERVENTIONAL,Experimental treatment not feasible due to high rate of drop out
NCT00827762,TERMINATED,OBSERVATIONAL,Too few participants recruited within timeframe
NCT00828100,SUSPENDED,INTERVENTIONAL,Study currently suspended due to a lack of available funding.
NCT00828230,TERMINATED,INTERVENTIONAL,Study was prematurely stopped due to slow recruitment after 17 of 32 anticipated patients were recruited.
NCT00828386,TERMINATED,INTERVENTIONAL,Low accrual
NCT00828620,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT00829049,TERMINATED,INTERVENTIONAL,Study enrollment was terminated due to company decision before the target enrollment of 220 patients was reached.
NCT00829062,WITHDRAWN,INTERVENTIONAL,No participants met inclusion criteria.
NCT00829127,WITHDRAWN,INTERVENTIONAL,"Due to termination of study D3801C00001, due to reports of turbid urine."
NCT00829608,WITHDRAWN,INTERVENTIONAL,investigator has left the institution
NCT00829647,WITHDRAWN,INTERVENTIONAL,Unable to enroll
NCT00830037,TERMINATED,INTERVENTIONAL,"Terminated by the DSMB based on low chance of finding differences in mGFR slopes, but higher risk of serious adverse events in the IV iron group (aIRR = 1.60)"
NCT00830245,TERMINATED,INTERVENTIONAL,low accrual rate
NCT00830401,TERMINATED,INTERVENTIONAL,Abnormality prevalence revealed to be much lower than expected.
NCT00830479,WITHDRAWN,INTERVENTIONAL,unable to enroll patients for randomization
NCT00830882,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00830921,TERMINATED,OBSERVATIONAL,Lack of patients
NCT00831233,TERMINATED,INTERVENTIONAL,Poor recruitment due to rare targeted population
NCT00831480,TERMINATED,INTERVENTIONAL,Difficulty in accrual and by the order of the cancer center.
NCT00831493,TERMINATED,INTERVENTIONAL,Slow Accrual.
NCT00831649,TERMINATED,INTERVENTIONAL,The biological effect seen with natalizumab was not sufficient to warrant further development in RA.
NCT00831831,WITHDRAWN,INTERVENTIONAL,The team wasn't able to work effectively with the social worker at the site
NCT00832065,WITHDRAWN,OBSERVATIONAL,No patients enrolled in study
NCT00832299,TERMINATED,INTERVENTIONAL,terminated for lack of enrollment
NCT00832312,TERMINATED,INTERVENTIONAL,Because of technical problems (researcher moved to different city).
NCT00832338,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT00832364,WITHDRAWN,INTERVENTIONAL,Business decision. No patients were enrolled
NCT00832403,SUSPENDED,OBSERVATIONAL,lack of new patients
NCT00832520,TERMINATED,INTERVENTIONAL,Low accrual rate.
NCT00832559,TERMINATED,INTERVENTIONAL,Poor recruitment rate.
NCT00832572,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00832624,TERMINATED,INTERVENTIONAL,Business Reasons
NCT00832637,TERMINATED,INTERVENTIONAL,Low accrual
NCT00832650,TERMINATED,INTERVENTIONAL,"Protocol A0221057 was terminated on December 25, 2009 for futility. There were no safety concerns related to this decision."
NCT00832728,WITHDRAWN,INTERVENTIONAL,To focus on another clinical indication.
NCT00832871,TERMINATED,INTERVENTIONAL,Low accrual; 4 patients enrolled between 2008-2015
NCT00833053,TERMINATED,INTERVENTIONAL,"In Amendment 1 of P05319 \[NCT 00779675\], the option to enroll into this study, was discontinued due to low numbers of participants with suboptimal response."
NCT00833287,TERMINATED,OBSERVATIONAL,Enrollment process not efficient
NCT00833365,TERMINATED,INTERVENTIONAL,Study drug not available
NCT00833534,WITHDRAWN,INTERVENTIONAL,No patient enrolled on study. Did not get patients in timely fashion. All referrals for study when assessed were not eligible.
NCT00833768,TERMINATED,INTERVENTIONAL,"After an extensive review,the ASPIRE in CKD study was terminated because it was not possible to complete the study in an appropriate time frame."
NCT00833859,TERMINATED,INTERVENTIONAL,Abandoned - Lack of funding after only 2 patients enrolled
NCT00834314,TERMINATED,INTERVENTIONAL,extended obligations of amended medical device law in Germany 2010 did not allow to continue and complete the trial due to budget limitation
NCT00834327,TERMINATED,INTERVENTIONAL,Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety concerns identified.
NCT00834899,TERMINATED,INTERVENTIONAL,Slow accrual and no cost extension not approved by NHLBI
NCT00835055,WITHDRAWN,OBSERVATIONAL,never started several reasons
NCT00835328,TERMINATED,INTERVENTIONAL,Study stopped prematurely to test a new formulation of Exendin (9-39)
NCT00835783,TERMINATED,OBSERVATIONAL,Study logistics proved difficult and enrollment never moved beyond the pilot phase.
NCT00835874,TERMINATED,INTERVENTIONAL,Difficulty in recruitment. Mothers of infants preferred to take probiotics bought over-the-counter over the possibility of being in a placebo group
NCT00835887,WITHDRAWN,INTERVENTIONAL,"no patients recruited, responsible physician left clinic"
NCT00836043,TERMINATED,OBSERVATIONAL,Study terminated due to low enrollment.
NCT00836069,TERMINATED,INTERVENTIONAL,Pfizer has terminated the execution of this protocol
NCT00836173,WITHDRAWN,INTERVENTIONAL,Gallium is no longer available for the conduct of this study.
NCT00836355,TERMINATED,INTERVENTIONAL,Too few acute stroke patients available to meet enrollment requirements.
NCT00836394,WITHDRAWN,INTERVENTIONAL,No potential participants met entry criteria
NCT00836498,TERMINATED,INTERVENTIONAL,Strategic business decision not to pursue indication due to lack of demonstrable medical need
NCT00836628,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT00836875,TERMINATED,INTERVENTIONAL,"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any safety issues or concerns."
NCT00837096,TERMINATED,INTERVENTIONAL,Business objectives changed.
NCT00837109,TERMINATED,INTERVENTIONAL,Primary investigator is no longer a part of the VA
NCT00837135,WITHDRAWN,INTERVENTIONAL,Withdrawn due to transfer of Investigator
NCT00837174,WITHDRAWN,INTERVENTIONAL,Study never activated/opened as funding source and other support not available.
NCT00837200,TERMINATED,INTERVENTIONAL,PI said to close accrual do to funding
NCT00837291,WITHDRAWN,INTERVENTIONAL,The company has decided not to conduct the study
NCT00837382,TERMINATED,INTERVENTIONAL,Primary investigator is no longer a part of the VA.
NCT00837395,TERMINATED,OBSERVATIONAL,"Co-investigator left the university and another co-investigator died several years ago, making it impossible to complete the study as planned."
NCT00837421,TERMINATED,OBSERVATIONAL,Lack of resources has prevented the study from continuation.
NCT00837590,TERMINATED,INTERVENTIONAL,Preliminary results indicated no measurable benefit.
NCT00837655,WITHDRAWN,INTERVENTIONAL,PI retired
NCT00837668,TERMINATED,OBSERVATIONAL,Interim analysis
NCT00837759,TERMINATED,INTERVENTIONAL,Changes to study personnel.
NCT00837824,TERMINATED,INTERVENTIONAL,The trial was terminated early due to inadequate study design.
NCT00838227,WITHDRAWN,INTERVENTIONAL,No source of funding to implement the study.
NCT00838253,WITHDRAWN,INTERVENTIONAL,The study was not started due to a re-evaluation of the istaroxime development program
NCT00838578,TERMINATED,INTERVENTIONAL,"Per protocol, the study was terminated based on interim analysis results"
NCT00838682,TERMINATED,INTERVENTIONAL,Terminated before the complete enrollment due to slow enrollment
NCT00838851,TERMINATED,INTERVENTIONAL,no further funding
NCT00838955,TERMINATED,INTERVENTIONAL,There was lack of enrollment since January 2013
NCT00838968,WITHDRAWN,INTERVENTIONAL,we have found another marker (microRNA26) which is more sensitive to evaluate the effect of postoperative IFNa treatment in patients with HCC
NCT00839020,TERMINATED,INTERVENTIONAL,Number of patients willing to participate in the study too low
NCT00839033,TERMINATED,INTERVENTIONAL,No inclusion
NCT00839059,TERMINATED,INTERVENTIONAL,Results of an interim analysis and a hardly ongoing enrolment in the last 10 months in all six participating centres
NCT00839137,TERMINATED,OBSERVATIONAL,Study proved difficult to recruit
NCT00839436,TERMINATED,INTERVENTIONAL,Bankruptcy of Drug manufacturer: Drug not available
NCT00839488,TERMINATED,INTERVENTIONAL,the chief of GS left the hopsital and the successor did't want to keep on this study
NCT00839501,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient number of participants
NCT00839566,TERMINATED,INTERVENTIONAL,Number of eligible patients too small.
NCT00839644,TERMINATED,INTERVENTIONAL,"High dropout, problems recruiting, and smaller than expected decline in FEV1."
NCT00839670,TERMINATED,INTERVENTIONAL,departure of the investigator coordinator into other country
NCT00839748,WITHDRAWN,OBSERVATIONAL,personnel redeployment
NCT00839787,WITHDRAWN,INTERVENTIONAL,Unable to enroll more patients
NCT00839917,TERMINATED,INTERVENTIONAL,Study terminated early because of insufficient enrollment before expiration date of the investigational vaccine lot
NCT00840112,TERMINATED,INTERVENTIONAL,New data does not support a role of vitamin E in LCHAD associated neuropathy.
NCT00840294,TERMINATED,INTERVENTIONAL,Combination of futility analysis and poor accrual
NCT00840450,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00840463,TERMINATED,INTERVENTIONAL,Poor enrolment
NCT00840489,TERMINATED,INTERVENTIONAL,Preliminary analysis
NCT00840567,TERMINATED,INTERVENTIONAL,Key samples protocols will be provided by a collaborator and we were not able to produce IPS lines from human fibroblasts.
NCT00840749,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00840827,TERMINATED,INTERVENTIONAL,Lack of efficacy.
NCT00840918,TERMINATED,INTERVENTIONAL,Problem with enrollment
NCT00841035,TERMINATED,INTERVENTIONAL,Sponsor stopped due to slow enrollment
NCT00841529,TERMINATED,INTERVENTIONAL,Medtronic Business Decision
NCT00841633,TERMINATED,INTERVENTIONAL,"Our RCT recently started. The RCT is similar to the feasibility trial, so it was terminated to avoid 2 trials running simultaniously."
NCT00841802,WITHDRAWN,INTERVENTIONAL,Realized there was a design flaw.
NCT00841945,TERMINATED,INTERVENTIONAL,other drugs other studies
NCT00841984,TERMINATED,OBSERVATIONAL,not enough enrollment
NCT00842413,TERMINATED,OBSERVATIONAL,not enough enrollment
NCT00842582,WITHDRAWN,INTERVENTIONAL,No enrollment. Unable to recruit due to lack of eligible patients.
NCT00842829,TERMINATED,INTERVENTIONAL,Recruitment stopped at the end of the recruitment timeframe
NCT00842933,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goal prior to PI transfer
NCT00843050,TERMINATED,INTERVENTIONAL,The study was terminated based on interim results and all subjects were off study at that time. No major safety or tolerability concerns
NCT00843115,TERMINATED,OBSERVATIONAL,See Detailed Description.
NCT00843154,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00843310,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00843531,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00843791,TERMINATED,INTERVENTIONAL,Insufficient funds to continue.
NCT00843830,TERMINATED,INTERVENTIONAL,Study closed early secondary to inability to obtain grant funding to conduct.
NCT00843986,TERMINATED,INTERVENTIONAL,The clinical study has been terminated based on difficulties to enroll eligible subjects per protocol inclusion and exclusion criteria.
NCT00844155,WITHDRAWN,INTERVENTIONAL,Study has been withdrawn as the H1N1 epidemic made this study redundant
NCT00844363,TERMINATED,INTERVENTIONAL,Unable to isolate sufficient cells from the skin biopsy to perform study related experiments
NCT00844480,TERMINATED,INTERVENTIONAL,difficulty in enrollment
NCT00844727,TERMINATED,INTERVENTIONAL,Drug withdrawal
NCT00844766,WITHDRAWN,OBSERVATIONAL,This study was stopped as no patient asked to participate was prepared to do so
NCT00845039,TERMINATED,INTERVENTIONAL,Study terminated early 22Feb2010 with only 4 participants due to business reasons.
NCT00845104,WITHDRAWN,INTERVENTIONAL,No patients enrolled.
NCT00845338,TERMINATED,INTERVENTIONAL,The enrollment rate at most centers was unlikely to result in the recruitment of the planned sample size of 40 evaluable subjects.
NCT00845585,WITHDRAWN,INTERVENTIONAL,found not enough centers for recruitment
NCT00845598,WITHDRAWN,INTERVENTIONAL,Could not get IMP
NCT00845702,TERMINATED,INTERVENTIONAL,lack of recruitment.
NCT00845832,TERMINATED,INTERVENTIONAL,The study was terminated early because of a related decision to stop the development of ocrelizumab in rheumatoid arthritis.
NCT00845845,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment.
NCT00845910,TERMINATED,INTERVENTIONAL,To be confirmed
NCT00845949,WITHDRAWN,OBSERVATIONAL,NO available budget and difficulty in recruiting
NCT00845975,TERMINATED,INTERVENTIONAL,New information suggested a more effective treatment protocol.
NCT00846014,WITHDRAWN,INTERVENTIONAL,Subjects which fit the strict inclusion criteria were not found.
NCT00846170,WITHDRAWN,INTERVENTIONAL,sponsor decided they are not interested in the study due to finacial reasons
NCT00846313,WITHDRAWN,INTERVENTIONAL,Study was stopped due to lack of resources (clinical dietitians)
NCT00846326,WITHDRAWN,INTERVENTIONAL,The suppliers were unable to provide the investigational medicinal product (IMP)
NCT00846378,SUSPENDED,INTERVENTIONAL,Suspended for potential change in protocol to include different imaging modalities
NCT00846391,TERMINATED,INTERVENTIONAL,Study was terminated due to inability to recruit patients.
NCT00846417,TERMINATED,OBSERVATIONAL,"No funding, lost support staff, no data collected/processed"
NCT00846534,TERMINATED,OBSERVATIONAL,Insufficient patient volume
NCT00846560,WITHDRAWN,OBSERVATIONAL,Changes in the lab's focus and needs
NCT00846573,TERMINATED,INTERVENTIONAL,The study was halted prematurely as the PI was no longer an employee of UMass Medical School.
NCT00846625,WITHDRAWN,INTERVENTIONAL,Insufficient enrollment (no subjects were enrolled)
NCT00846872,WITHDRAWN,INTERVENTIONAL,Inadequate subject recruitment
NCT00847002,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT00847067,TERMINATED,INTERVENTIONAL,Funding not renewed
NCT00847223,TERMINATED,INTERVENTIONAL,Inefficiency of treatment
NCT00847392,WITHDRAWN,INTERVENTIONAL,Inability to obtain grant funding
NCT00847496,WITHDRAWN,INTERVENTIONAL,Company went out of business
NCT00847704,TERMINATED,INTERVENTIONAL,Funding not available.
NCT00847821,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT00847951,WITHDRAWN,INTERVENTIONAL,Study terminated at this time by investigator. Will create new protocol.
NCT00848107,TERMINATED,INTERVENTIONAL,"The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled TDE-DU-201 study did not meet its primary efficacy objective."
NCT00848497,TERMINATED,INTERVENTIONAL,Lack of volunteers who would consent to participate and lack of funding
NCT00848523,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT00848575,TERMINATED,OBSERVATIONAL,Low enrollment
NCT00848601,TERMINATED,INTERVENTIONAL,The dose limiting toxicity of cardiac QTc prolongation was identifiedin the phase 1 study in patients with refractory prostate and lymphoma
NCT00848783,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT00848809,WITHDRAWN,OBSERVATIONAL,PI had difficult enrollment.
NCT00849069,TERMINATED,INTERVENTIONAL,The study has been stopped for logistic reasons not related to the safety or efficacy of the vaccine.
NCT00849238,WITHDRAWN,INTERVENTIONAL,feasibility issues
NCT00849251,TERMINATED,INTERVENTIONAL,One of the study drugs is not available.
NCT00849316,WITHDRAWN,OBSERVATIONAL,Due to company decision to focus resources on the finalisation of three ongoing studies in the region
NCT00849524,TERMINATED,INTERVENTIONAL,drug supply became unavailable
NCT00849589,WITHDRAWN,INTERVENTIONAL,Grant application was not funded
NCT00849667,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00849745,TERMINATED,INTERVENTIONAL,low accrual
NCT00849771,WITHDRAWN,OBSERVATIONAL,Joined another larger group of same study
NCT00849810,TERMINATED,INTERVENTIONAL,Difficulty with recruiting willing participants.
NCT00849875,TERMINATED,INTERVENTIONAL,Early end of trial notification after termination of long term follow up due to lack of scientific justification to continue collect information.
NCT00849888,TERMINATED,INTERVENTIONAL,The sponsor decided to withdraw the study.
NCT00850161,WITHDRAWN,INTERVENTIONAL,Business purposes.
NCT00850369,WITHDRAWN,INTERVENTIONAL,Slow accrual onto the study
NCT00850421,TERMINATED,INTERVENTIONAL,Recently published BOTOX efficacy data and study design deficits.
NCT00850460,TERMINATED,INTERVENTIONAL,Investigator left institution and no PI has been found to continue the study
NCT00850473,TERMINATED,INTERVENTIONAL,Sub-investigator left the university
NCT00850720,TERMINATED,OBSERVATIONAL,Inability to recruit / logistic problems.
NCT00850980,WITHDRAWN,OBSERVATIONAL,unable to recruit
NCT00850993,TERMINATED,INTERVENTIONAL,To redefine study population
NCT00851123,TERMINATED,INTERVENTIONAL,Due to recruitment difficulties the trial was stopped after an interim analysis at 30 patients.
NCT00851162,WITHDRAWN,INTERVENTIONAL,Study was not continued due to lack of enrollment.
NCT00851370,WITHDRAWN,INTERVENTIONAL,Unable to find eligible subjects- study closed
NCT00851474,WITHDRAWN,OBSERVATIONAL,Protocol not renewed
NCT00851552,TERMINATED,INTERVENTIONAL,Lack of sponsor support
NCT00851591,TERMINATED,INTERVENTIONAL,Low enrollment; investigator chose not to continue study
NCT00851682,TERMINATED,INTERVENTIONAL,Enrollment was stopped and will not resume. Participants are no longer being examined.
NCT00852046,WITHDRAWN,INTERVENTIONAL,PI resigned.
NCT00852059,TERMINATED,INTERVENTIONAL,"Diffculties to recruit anticipated study size, now analysis"
NCT00852124,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT00852332,TERMINATED,INTERVENTIONAL,The trial was stopped for futility in view of the results of the anticipated analysis
NCT00852397,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00852436,TERMINATED,INTERVENTIONAL,difficulty to recruit patients
NCT00852631,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to insufficient recruitment.
NCT00852644,TERMINATED,INTERVENTIONAL,poor accrual
NCT00852696,TERMINATED,INTERVENTIONAL,Investigator left Cleveland Clinic and absolutely no data is available.
NCT00852709,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00852774,WITHDRAWN,OBSERVATIONAL,terminated due to low staffing
NCT00852878,WITHDRAWN,INTERVENTIONAL,Not enough interested participants
NCT00853112,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00853125,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00853229,TERMINATED,INTERVENTIONAL,Not feasible due to low accrual
NCT00853398,TERMINATED,INTERVENTIONAL,The results obtained 1 year after surgery were clearly indicative of the outcome and the investigators decided to terminate follow-up at that point.
NCT00853411,WITHDRAWN,INTERVENTIONAL,Terminated by Investigator due to lack of eligible subjects.
NCT00853424,WITHDRAWN,INTERVENTIONAL,"""We were unable to enroll any subjects in this study due to lack of interest."""
NCT00853489,TERMINATED,INTERVENTIONAL,Enrollment too slow
NCT00853502,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT00853515,TERMINATED,INTERVENTIONAL,interim analysis incidence primary endpoint lower than anticipated. Sigicant finding based on secondary endpoint.
NCT00853541,WITHDRAWN,OBSERVATIONAL,No patients enrolled.
NCT00853567,TERMINATED,INTERVENTIONAL,Repros stopped the study for safety and FDA put the study on hold for safety.
NCT00853762,TERMINATED,INTERVENTIONAL,EMD Serono voluntarily decided to terminate this trial after observing increased MS disease activity in trial 28063 ATAMS \[Please refer to ATAMS\]
NCT00853944,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding du to lack of enrollment. Lack of enrollment was due to decrease in number of islet transplant procedures
NCT00854022,TERMINATED,OBSERVATIONAL,Funding ended
NCT00854074,WITHDRAWN,INTERVENTIONAL,"Withdrawn: study halted prematurely, prior to enrollment of first participant"
NCT00854230,WITHDRAWN,INTERVENTIONAL,"We expanded to a bigger, multi-site study \& decided to close this study."
NCT00854581,TERMINATED,INTERVENTIONAL,Investigator Decision
NCT00854750,TERMINATED,INTERVENTIONAL,Poor Enrollment- schedule of assessments too complex and time-consuming.
NCT00855049,WITHDRAWN,INTERVENTIONAL,Unable to obtain FDA approval
NCT00855062,TERMINATED,INTERVENTIONAL,The Neurologic AIDS Research Consortium Data Safety and Monitoring Board committee recommended to terminate the study early due to futility on 11/6/2009.
NCT00855075,TERMINATED,OBSERVATIONAL,Technology used to obtain/measure cerebral state index is no longer manufactured
NCT00855114,WITHDRAWN,INTERVENTIONAL,Withdrawn due to no accrual
NCT00855127,WITHDRAWN,OBSERVATIONAL,no enrollment
NCT00855153,WITHDRAWN,INTERVENTIONAL,Investigator was not able to maintain IRB approval. Study never accrued subjects.
NCT00855244,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution
NCT00855413,TERMINATED,INTERVENTIONAL,Study halted by sponsor due to slow enrollment.
NCT00855426,SUSPENDED,OBSERVATIONAL,the research is on susoension beacause the lack of manpower
NCT00855478,TERMINATED,INTERVENTIONAL,Early termination of patient enrollment based on business decision
NCT00855517,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT00855556,TERMINATED,OBSERVATIONAL,"Enrollment into this registry was not as robust as investigator envisioned. Thus, the registry was closed."
NCT00855634,TERMINATED,INTERVENTIONAL,Protocol planned interim analysis after two years showed very low recruitment in cohort 1 and low recruitment in cohort 2.
NCT00855725,TERMINATED,OBSERVATIONAL,PI wanted to discontinue study.
NCT00855842,TERMINATED,INTERVENTIONAL,inadequate enrollment
NCT00855907,TERMINATED,OBSERVATIONAL,Lack of budget
NCT00855972,WITHDRAWN,INTERVENTIONAL,The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.
NCT00856089,WITHDRAWN,INTERVENTIONAL,Study is withdrawn and no one enrolled due to changes in personnel
NCT00856258,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00856427,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00856453,TERMINATED,INTERVENTIONAL,slow accrual
NCT00856479,WITHDRAWN,INTERVENTIONAL,Study never started
NCT00856661,TERMINATED,INTERVENTIONAL,The recruitment into DIAS4 has been stopped as the result of DIAS 3 indicates that the study is unlikely to reach its primary endpoint with the current protocol
NCT00856674,TERMINATED,INTERVENTIONAL,Study terminated due to resources and slow enrollment; not due to safety
NCT00856817,TERMINATED,INTERVENTIONAL,Recruitment faillure. Similar study published by others. Not yet entered treatment phase.
NCT00857181,TERMINATED,OBSERVATIONAL,Finding to be unable to reach the primary endpoint
NCT00857233,TERMINATED,INTERVENTIONAL,Please see explanation in the Detailed Description field.
NCT00857324,TERMINATED,INTERVENTIONAL,"The Phase I of the study was completed, but Phase 2 has not been activated"
NCT00857597,TERMINATED,INTERVENTIONAL,Study was terminated after unplanned interim analysis of single centre data and results were reported
NCT00857701,TERMINATED,INTERVENTIONAL,Unrelated to trial
NCT00857714,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT00857818,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00858403,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00858559,TERMINATED,INTERVENTIONAL,Stopped due to low enrollment. Patients will be followed up for 3 months.
NCT00858598,WITHDRAWN,OBSERVATIONAL,Study never started. Study suspended indefinitely.
NCT00858754,WITHDRAWN,INTERVENTIONAL,"Withdrawn \[This study was terminated early by Wyeth, prior to dosing any subjects, for business reasons not related to safety."
NCT00858793,TERMINATED,INTERVENTIONAL,A leukaemia case was reported in patient treated with a similar vector. For safety risk we stopped recruitment
NCT00858884,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT00858936,TERMINATED,INTERVENTIONAL,Study Terminated - Company decision
NCT00859066,TERMINATED,OBSERVATIONAL,Original Principal Investigator (Andrew Trout M.D.) left the University.
NCT00859170,TERMINATED,INTERVENTIONAL,Change in priorities occurred
NCT00859339,TERMINATED,INTERVENTIONAL,Patient Toxicities
NCT00859456,TERMINATED,INTERVENTIONAL,Closed by pharmaceutical sponsor
NCT00859573,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding.
NCT00859859,TERMINATED,INTERVENTIONAL,The protocol was terminated early (prior to complete enrollment) after interim analysis proved data to be statistically insignificant
NCT00860093,TERMINATED,INTERVENTIONAL,Sponsor Corporate Business Decision
NCT00860158,TERMINATED,INTERVENTIONAL,Slow accrual; closed by funder
NCT00860171,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding
NCT00860249,TERMINATED,INTERVENTIONAL,Lack of sufficient participants meeting the eligibility criteria to complete study in proposed and acceptable time frame.
NCT00860314,TERMINATED,INTERVENTIONAL,Statistical interim analysis showed valid and significant results
NCT00860353,TERMINATED,INTERVENTIONAL,"Due to portfolio and logistical issues, this study will not be re-started at the present time. The study is not being terminated for safety reasons."
NCT00860379,TERMINATED,INTERVENTIONAL,"Due to a shift in primary responsibilities, the PI was not longer able to enroll subjects."
NCT00860990,TERMINATED,OBSERVATIONAL,"Outcome measures are included in another, similar study."
NCT00861159,WITHDRAWN,OBSERVATIONAL,Study withdrawn due to lack of staffing resources and subject interest
NCT00861237,TERMINATED,INTERVENTIONAL,"Number of patients recruited to small, no cooperation of study members"
NCT00861367,WITHDRAWN,INTERVENTIONAL,"difficult enrollment, focus of study no longer of interest"
NCT00861471,TERMINATED,INTERVENTIONAL,due to slow accrual
NCT00861497,TERMINATED,INTERVENTIONAL,The study stopped after been paused (the patients were switched in the meantime)
NCT00861523,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients
NCT00861887,WITHDRAWN,INTERVENTIONAL,Difficult enrollment
NCT00861952,WITHDRAWN,INTERVENTIONAL,"Study has received ethics approval, however funding limitations have resulted in suspending date of commencement."
NCT00861965,TERMINATED,INTERVENTIONAL,withdrawn due to poor recruitment
NCT00862082,TERMINATED,INTERVENTIONAL,PR104 plus sorafenib was poorly tolerated in patients with advanced HCC
NCT00862095,TERMINATED,INTERVENTIONAL,"inadequate enrollment, insufficient funds to continue enrollment"
NCT00862121,TERMINATED,INTERVENTIONAL,Terminated due to poor recruitment
NCT00862134,TERMINATED,INTERVENTIONAL,Interim analysis indicated low probability of clinically significant result
NCT00862147,TERMINATED,INTERVENTIONAL,the study was stopped due to failure to recruit sufficient participants
NCT00862472,WITHDRAWN,INTERVENTIONAL,Management decision not to conduct an additional efficacy study.
NCT00862563,TERMINATED,INTERVENTIONAL,Recruitment goals could not be met before ending of funding for this project.
NCT00862706,WITHDRAWN,INTERVENTIONAL,Stopped with Patients
NCT00862836,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00862862,TERMINATED,OBSERVATIONAL,lack of enrollment
NCT00862927,TERMINATED,OBSERVATIONAL,Slow accrual.
NCT00863057,TERMINATED,INTERVENTIONAL,"Due to slow rate of enrollment, which compromised the ability to meet study objectives in a timely manner."
NCT00863083,TERMINATED,INTERVENTIONAL,Study was terminated due to poor enrollment.
NCT00863096,WITHDRAWN,OBSERVATIONAL,Unable to get the vaccine on time to offer it to the study population.
NCT00863330,TERMINATED,INTERVENTIONAL,administrative decision- PI retired and treating physician left the institution
NCT00863343,TERMINATED,OBSERVATIONAL,Funding of study was exhausted prior to completion of study
NCT00863603,TERMINATED,INTERVENTIONAL,Clinical changes: graft to fistula first; enrollment of 46/132 planned. NIH approved animal model: supplemental oxygen/AV fistula.
NCT00863772,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00863811,WITHDRAWN,OBSERVATIONAL,loss of interest before enrolment started
NCT00863824,WITHDRAWN,OBSERVATIONAL,Study was not funded
NCT00863980,TERMINATED,INTERVENTIONAL,Principle investigator resigned in 2013
NCT00863993,WITHDRAWN,OBSERVATIONAL,no patients enrolled.
NCT00864097,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00864175,TERMINATED,INTERVENTIONAL,Incyte suspended development of the compound.
NCT00864513,TERMINATED,INTERVENTIONAL,At interim analysis the study did not meet the response criteria to continue
NCT00864578,WITHDRAWN,OBSERVATIONAL,loss of interest before enrolment started
NCT00864630,TERMINATED,INTERVENTIONAL,The study upon which this project depended for subjects and the intervention was terminated prematurely due to lack of funds.
NCT00864708,TERMINATED,INTERVENTIONAL,The enrollment period/study duration had exceeded The Alfred Mann Foundation's timeline.
NCT00864903,WITHDRAWN,OBSERVATIONAL,The enzymatic assay was not sensitive nor spesific for the test.
NCT00865228,TERMINATED,INTERVENTIONAL,Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents
NCT00865280,TERMINATED,INTERVENTIONAL,Terminated
NCT00865514,TERMINATED,INTERVENTIONAL,Difficulty in obtaining the solution from the compounding pharmacies caused a two year delay in start-up; the funding ended prior to study completion.
NCT00865527,TERMINATED,INTERVENTIONAL,Lack of ongoing funding
NCT00865566,TERMINATED,INTERVENTIONAL,The trial was stopped for efficacy futility
NCT00865579,TERMINATED,INTERVENTIONAL,study terminated early due to change in Sponsorship
NCT00865878,TERMINATED,INTERVENTIONAL,Orphan Drug Designation for this indication not granted
NCT00865956,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT00866008,TERMINATED,INTERVENTIONAL,Due to a very slow inclusion rate.
NCT00866034,TERMINATED,INTERVENTIONAL,Due to limited rate of patient inclusion
NCT00866086,TERMINATED,INTERVENTIONAL,low accrual
NCT00866242,TERMINATED,INTERVENTIONAL,Reactogenicity met study halting criteria
NCT00866281,TERMINATED,INTERVENTIONAL,"Despite considerable efforts to boost recruitment during the final year of the study, no new patients were enrolled."
NCT00866333,TERMINATED,INTERVENTIONAL,Terminated prior to completion of accrual per corporate decision.
NCT00866346,WITHDRAWN,INTERVENTIONAL,Study failed to accrue any patients due to regulatory issues with PR1 vaccine and T cell production.
NCT00866476,TERMINATED,INTERVENTIONAL,Reactogenicity met study halting criteria
NCT00866580,WITHDRAWN,INTERVENTIONAL,Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.
NCT00866684,TERMINATED,INTERVENTIONAL,Insufficient patient recruitment
NCT00866723,TERMINATED,INTERVENTIONAL,Recruitment has been terminated prematurely because of poor enrollment.
NCT00866892,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT00867061,WITHDRAWN,INTERVENTIONAL,Mutual decision by site and sponsor because of difficulty recruiting Patients.
NCT00867126,TERMINATED,INTERVENTIONAL,low accrual
NCT00867243,TERMINATED,OBSERVATIONAL,This project is no longer being adequately supported to allow completion
NCT00867256,TERMINATED,INTERVENTIONAL,terminated for business reasons; study closed.
NCT00867308,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00867360,TERMINATED,INTERVENTIONAL,Insufficient recruitment.
NCT00867763,SUSPENDED,INTERVENTIONAL,"investigator changed location, requires new training effort"
NCT00867776,TERMINATED,INTERVENTIONAL,We decided to alter the intervention.
NCT00867789,TERMINATED,INTERVENTIONAL,Slow enrollment due to subjects not meeting inclusion/exclusion criteria
NCT00867841,WITHDRAWN,OBSERVATIONAL,funding issues and procedural problems
NCT00868114,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00868140,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00868179,WITHDRAWN,INTERVENTIONAL,study never started
NCT00868361,TERMINATED,INTERVENTIONAL,Poor recruitment of fast and slow acetylators
NCT00868374,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment
NCT00868751,TERMINATED,INTERVENTIONAL,Hyperintensities of unclear etiology on brain MRI. Follow up revealed no progression.
NCT00868790,TERMINATED,INTERVENTIONAL,"Upon interim analysis, sufficient data was accrued to assess study hypotheses."
NCT00868855,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00868946,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00868998,TERMINATED,INTERVENTIONAL,Poor patient accrual
NCT00869115,WITHDRAWN,INTERVENTIONAL,The study was not started due to a re-evaluation of the istaroxime development program
NCT00869310,TERMINATED,INTERVENTIONAL,we terminated the study before enrolling 303/560 due to a slow accrual
NCT00869323,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT00869375,TERMINATED,INTERVENTIONAL,very low enrollment due to low access to study population
NCT00869414,TERMINATED,INTERVENTIONAL,PI deceased
NCT00869427,TERMINATED,INTERVENTIONAL,Inability to recruit sufficient number of patients
NCT00869518,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00869674,TERMINATED,INTERVENTIONAL,Investigational products has been suspended from the US market
NCT00869804,TERMINATED,INTERVENTIONAL,Could not recruit total numbers needed. PI left institution.
NCT00869856,WITHDRAWN,INTERVENTIONAL,investigation of adverse events in a related clinical study
NCT00869869,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled in this study. Funding ran out.
NCT00869973,TERMINATED,INTERVENTIONAL,We terminated the study after enrolling 580/900 patients due to a slow accrual
NCT00870155,TERMINATED,INTERVENTIONAL,Negative efficacy results of the MAESTRO-01 trial
NCT00870220,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00870298,TERMINATED,INTERVENTIONAL,four adverse events encountered
NCT00870376,WITHDRAWN,OBSERVATIONAL,no budget
NCT00870441,TERMINATED,INTERVENTIONAL,Study terminated due to treatment-emergent serious adverse events
NCT00870519,TERMINATED,INTERVENTIONAL,"Assessment of data shows inadequate brain uptake, suggesting the tracer is inadequate as an imaging biomarker of brain amyloid."
NCT00870701,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT00870818,TERMINATED,INTERVENTIONAL,Business decision
NCT00870831,TERMINATED,OBSERVATIONAL,PI left University
NCT00870961,TERMINATED,INTERVENTIONAL,PI changed institutions and accrual was not completed.
NCT00871039,WITHDRAWN,INTERVENTIONAL,Due to logistical purposes
NCT00871065,WITHDRAWN,INTERVENTIONAL,PI decision
NCT00871208,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT00871273,TERMINATED,INTERVENTIONAL,1. Slow recruitment; 2. Change to clinical environment reducing the pool of potentially eligible patients; 3. Availability of data from another similar study
NCT00871312,TERMINATED,INTERVENTIONAL,Low recruitment rate meaning unable to complete the study in a timely manner
NCT00871442,WITHDRAWN,INTERVENTIONAL,would not substantially add to existing contributions in the literature
NCT00871689,TERMINATED,INTERVENTIONAL,Due to graft failure.
NCT00871741,TERMINATED,INTERVENTIONAL,Study stopped due to non-approval of IEC to proposed change in locations. Study discontinuation not due to safety/efficacy reasons related to the vaccine.
NCT00871845,TERMINATED,INTERVENTIONAL,Protocol expired and not renewed
NCT00871884,TERMINATED,INTERVENTIONAL,"Poor enrollment, low recruitment."
NCT00871975,TERMINATED,INTERVENTIONAL,Low enrollment exceeding trial deadlines
NCT00872079,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT00872222,TERMINATED,INTERVENTIONAL,Study terminated early due to business reasons
NCT00872300,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT00872404,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT00872482,TERMINATED,INTERVENTIONAL,Study closed due to low enrollment
NCT00872547,TERMINATED,INTERVENTIONAL,DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all clinical studies for this product and decided to close this Study
NCT00872573,TERMINATED,INTERVENTIONAL,Technical issues with RSA at main site and departure of Principal Investigator
NCT00872638,WITHDRAWN,INTERVENTIONAL,lack of participation
NCT00872794,TERMINATED,INTERVENTIONAL,DePuy discontinued this product in 4Q 2009.At the time of this decision DePuy reviewed all clinical studies for this product and decided to close this Study.
NCT00872976,WITHDRAWN,INTERVENTIONAL,Business Objectives Changed
NCT00873002,TERMINATED,INTERVENTIONAL,Dose Limiting Toxicity
NCT00873132,WITHDRAWN,OBSERVATIONAL,No Funding
NCT00873158,TERMINATED,INTERVENTIONAL,Unrelated to trial
NCT00873366,TERMINATED,OBSERVATIONAL,Funding issues
NCT00873444,TERMINATED,INTERVENTIONAL,Study progress very slow therefore terminated as other projects underway to investigate the same research question which will deliver results earlier
NCT00873600,WITHDRAWN,OBSERVATIONAL,No accrual
NCT00873743,SUSPENDED,OBSERVATIONAL,Study was stopped because of ineffectiveness of one investigated Drug
NCT00873808,WITHDRAWN,OBSERVATIONAL,lack of accrual
NCT00873834,WITHDRAWN,INTERVENTIONAL,Withdrawn for problem of logistics with the associated laboratories
NCT00873886,WITHDRAWN,INTERVENTIONAL,We will focus on other Tamiflu research studies. No subjects were enrolled.
NCT00874133,TERMINATED,INTERVENTIONAL,Completed due to low number of eligible patients
NCT00874302,WITHDRAWN,INTERVENTIONAL,Study terminated for safety and the FDA put the study on hold for safety.
NCT00874315,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT00874497,TERMINATED,INTERVENTIONAL,Sponsor Terminated
NCT00874796,TERMINATED,INTERVENTIONAL,Reports of significant laboratory abnormalities and adverse events in a number of clinical study participants.
NCT00875004,TERMINATED,INTERVENTIONAL,"After two years of trial initiation, only 27 out of 300 patients were included. During this period, the international recommendations for the use of COOL were modified."
NCT00875095,TERMINATED,OBSERVATIONAL,Study funding was withdrawn by the sponsor following agreement that slow patient recruitment warranted a new approach.
NCT00875160,TERMINATED,INTERVENTIONAL,Subject Recruitment
NCT00875342,TERMINATED,INTERVENTIONAL,Trial is no longer enrolling due to priority of other non-pharmacologic PTSD trials.
NCT00875602,WITHDRAWN,INTERVENTIONAL,NO need
NCT00875628,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00875797,TERMINATED,INTERVENTIONAL,"Termination due to interim analysis results, inclusion problems in small ICUs."
NCT00875823,WITHDRAWN,OBSERVATIONAL,Study was combined with Mayo protocol 07-003476
NCT00875862,TERMINATED,INTERVENTIONAL,procedure no longer being done
NCT00875875,WITHDRAWN,INTERVENTIONAL,No study population in Mexico (H1N1). Study withdrawn from IRB consideration.
NCT00875888,TERMINATED,INTERVENTIONAL,"based on interim analysis statistical significance in primary endpoint cannot be achieved with planned sample size, no safety concerns"
NCT00876174,WITHDRAWN,OBSERVATIONAL,no accrual
NCT00876278,WITHDRAWN,INTERVENTIONAL,Due to internal reasons study was not performed.
NCT00876317,TERMINATED,INTERVENTIONAL,Change in current areas of research interest of the collaborator
NCT00876850,WITHDRAWN,INTERVENTIONAL,Terminated
NCT00876876,WITHDRAWN,INTERVENTIONAL,Created Extension study - This study was no longer feasible
NCT00876915,TERMINATED,INTERVENTIONAL,slow enrollment and lack of continuing funds
NCT00877240,WITHDRAWN,INTERVENTIONAL,lack of complaince
NCT00877318,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT00877513,TERMINATED,INTERVENTIONAL,Funding expired
NCT00877617,WITHDRAWN,OBSERVATIONAL,Slow accrual
NCT00877773,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00878046,TERMINATED,INTERVENTIONAL,The Silent Hip has been rationalized for business reasons only
NCT00878124,TERMINATED,INTERVENTIONAL,Very low recruitment rate
NCT00878202,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT00878215,TERMINATED,INTERVENTIONAL,The image-guidance system became commercially available
NCT00878345,WITHDRAWN,INTERVENTIONAL,Study was never opened
NCT00878501,TERMINATED,INTERVENTIONAL,The study was terminated after the planned interim analysis.
NCT00878579,TERMINATED,INTERVENTIONAL,Sponsor Termination
NCT00878592,TERMINATED,INTERVENTIONAL,PI left institution
NCT00878605,TERMINATED,INTERVENTIONAL,Unable to reach accrual target.
NCT00878657,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00878683,WITHDRAWN,INTERVENTIONAL,Never received IRB approval; Withdrawn before enrollment ever started
NCT00878839,WITHDRAWN,INTERVENTIONAL,Product availability
NCT00878969,TERMINATED,INTERVENTIONAL,insufficient enrollment and retention
NCT00879021,TERMINATED,INTERVENTIONAL,lack of funding and patients
NCT00879073,TERMINATED,INTERVENTIONAL,Principal Investigator is leaving Moffitt
NCT00879112,WITHDRAWN,INTERVENTIONAL,Study terminated prior to initiation
NCT00879450,TERMINATED,INTERVENTIONAL,Clinical department where study was held was unable to continue collaboration
NCT00879528,TERMINATED,OBSERVATIONAL,Failure of accrual achievement
NCT00879619,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT00879645,TERMINATED,INTERVENTIONAL,unable to develop a rapid \& reliable assay to detect sulfide concentrations
NCT00879957,WITHDRAWN,INTERVENTIONAL,A study was published regarding the same question this study had.
NCT00879970,TERMINATED,INTERVENTIONAL,FDA has placed the trial on full clinical hold.
NCT00880009,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00880048,TERMINATED,INTERVENTIONAL,To allow assessment of isolated events of seizure during program
NCT00880373,TERMINATED,INTERVENTIONAL,The funding withdrawal and early termination of the trial is based upon lack of suitable recruitment figures in order to reach the required trial endpoints.
NCT00880386,WITHDRAWN,INTERVENTIONAL,Study concept was not approved by NCI. Study was never activated. No enrollment
NCT00880399,TERMINATED,INTERVENTIONAL,To allow assessment of isolated events of seizure during program
NCT00880529,TERMINATED,INTERVENTIONAL,"low enrollment, 2 pts enrolled no data every analyzed investigator left the institution"
NCT00880542,TERMINATED,INTERVENTIONAL,The study lost funding.
NCT00880854,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT00880867,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00881023,TERMINATED,INTERVENTIONAL,Study was terminated because of very low enrollment rate.
NCT00881114,WITHDRAWN,INTERVENTIONAL,Investigator decided it was not feasible to conduct this study
NCT00881205,TERMINATED,INTERVENTIONAL,Termination of study due to low enrollment
NCT00881257,TERMINATED,INTERVENTIONAL,Data was inconclusive
NCT00881283,TERMINATED,OBSERVATIONAL,Decision made to close study early.
NCT00881413,WITHDRAWN,INTERVENTIONAL,problems in funding
NCT00881439,TERMINATED,INTERVENTIONAL,Futility
NCT00881504,TERMINATED,INTERVENTIONAL,It was not possible to get insurance companies to cover bevacizumab.
NCT00881595,WITHDRAWN,INTERVENTIONAL,No patients accrued since study opened
NCT00881608,TERMINATED,INTERVENTIONAL,Repros stopped study for safety and the FDA put the study on hold for safety.
NCT00881621,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00881673,WITHDRAWN,INTERVENTIONAL,Management decision
NCT00881712,TERMINATED,INTERVENTIONAL,projected enrollment rate not feasible
NCT00881725,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00881777,TERMINATED,INTERVENTIONAL,Unable to recruit suitable subjects within a reasonable time period.
NCT00882076,TERMINATED,INTERVENTIONAL,study closed prematurely
NCT00882193,TERMINATED,INTERVENTIONAL,new medications with improved response released
NCT00882206,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00882414,TERMINATED,INTERVENTIONAL,Main objective of study was met. Further recruitment was difficult.
NCT00882583,TERMINATED,INTERVENTIONAL,Low accrual
NCT00882622,WITHDRAWN,INTERVENTIONAL,Endpoints were investigated in parallel in NCT00877305
NCT00882765,WITHDRAWN,INTERVENTIONAL,Study has been closed due to no accrual.
NCT00883116,TERMINATED,INTERVENTIONAL,Interim analysis results showed that ixabepilone did not improve survival compared with control chemotherapies.
NCT00883636,TERMINATED,OBSERVATIONAL,study stopped due to lack of activity
NCT00883805,WITHDRAWN,OBSERVATIONAL,PI moved
NCT00884039,TERMINATED,INTERVENTIONAL,Preliminary data analysis showed insufficient efficacy to justify continuation.
NCT00884390,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00884403,TERMINATED,OBSERVATIONAL,"This study is a retrospective chart review study, not a clinical trial."
NCT00884533,WITHDRAWN,INTERVENTIONAL,The whole project was terminated
NCT00884715,TERMINATED,INTERVENTIONAL,Program was terminated for business reasons
NCT00884819,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00884988,SUSPENDED,INTERVENTIONAL,Study recruiter withdrew from study. Suspended until replacement found.
NCT00885183,TERMINATED,INTERVENTIONAL,Difficult to recruit participants
NCT00885547,TERMINATED,INTERVENTIONAL,low-rate of enrollment
NCT00885560,TERMINATED,OBSERVATIONAL,"Collecting data for the population involved was very difficult. Over 3 years, only 19 participants were recruited."
NCT00885677,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT00885690,TERMINATED,INTERVENTIONAL,Due to recruitment problems
NCT00885924,TERMINATED,INTERVENTIONAL,to include required number of patients took too much time
NCT00885963,TERMINATED,INTERVENTIONAL,Limitation in financial resources.
NCT00886249,WITHDRAWN,OBSERVATIONAL,The PI has determined not to continue the study.
NCT00886366,TERMINATED,INTERVENTIONAL,Part A reached a predefined stopping criteria. Relevant doses for part B could not be established based on A and subsequently study was stopped.
NCT00886457,TERMINATED,INTERVENTIONAL,low accrual
NCT00886470,TERMINATED,INTERVENTIONAL,This study was terminated early due to slow accrual of patients.
NCT00886496,WITHDRAWN,INTERVENTIONAL,No participants enrolled. IND withdrawn.
NCT00886548,WITHDRAWN,OBSERVATIONAL,Delayed inclusion
NCT00886743,TERMINATED,INTERVENTIONAL,"Business reason, Pfizer's requested withdrawal of the Biologics License Application (BLA) . This study is not being discontinued for efficacy or safety reason"
NCT00886769,TERMINATED,INTERVENTIONAL,recommendation by Data Monitoring Committee
NCT00886951,TERMINATED,INTERVENTIONAL,There seemed to be no uptake of the ligand in the areas of the brain expected for subjects with amyloid.
NCT00887055,WITHDRAWN,OBSERVATIONAL,never started
NCT00887315,TERMINATED,INTERVENTIONAL,Slow accrual and loss of sponsor
NCT00887445,TERMINATED,INTERVENTIONAL,"The study was terminated on June 25th, 2009 due to strategic decision"
NCT00887497,TERMINATED,INTERVENTIONAL,terminated due to failure to enroll patients after two years of approval
NCT00887731,TERMINATED,OBSERVATIONAL,slow enrollment
NCT00887848,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT00887926,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00888017,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT00888329,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT00888667,TERMINATED,OBSERVATIONAL,Patient population was not available
NCT00888680,WITHDRAWN,INTERVENTIONAL,No patients enrolled. Delay due to optimisation of drug product formulation.
NCT00888810,TERMINATED,INTERVENTIONAL,lack of efficacy (intermediate analysis)
NCT00889083,WITHDRAWN,OBSERVATIONAL,no patients to include
NCT00889187,TERMINATED,INTERVENTIONAL,Excess toxicity was identified intraoperatively
NCT00889421,TERMINATED,INTERVENTIONAL,Investigator discretion due to lack of efficacy in three subjects enrolled
NCT00889512,TERMINATED,INTERVENTIONAL,Drug no longer available by manufacturer
NCT00889590,TERMINATED,INTERVENTIONAL,low recruitment with registration denosumab
NCT00889733,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT00889876,TERMINATED,INTERVENTIONAL,"hard to recruite, no funding"
NCT00890097,TERMINATED,INTERVENTIONAL,Treatment ineffective
NCT00890149,TERMINATED,INTERVENTIONAL,Difficulty recruiting target sample
NCT00890630,TERMINATED,INTERVENTIONAL,Inadequate Patient Recruitment.
NCT00890643,WITHDRAWN,INTERVENTIONAL,Primary investigator left VA employment
NCT00890695,TERMINATED,INTERVENTIONAL,New provision of supplementary feeds for moderately malnourished children
NCT00891033,TERMINATED,INTERVENTIONAL,This study was terminated because the drug company stopped making the study drug
NCT00891085,TERMINATED,OBSERVATIONAL,unable to enroll patients adequately
NCT00891397,TERMINATED,INTERVENTIONAL,Unable to recruit patients
NCT00891631,WITHDRAWN,INTERVENTIONAL,Grant application was not funded
NCT00891761,WITHDRAWN,INTERVENTIONAL,This study has been cancelled prior to enrollment.
NCT00891800,TERMINATED,INTERVENTIONAL,Lack of study patients
NCT00891904,TERMINATED,INTERVENTIONAL,Low accrual
NCT00891917,WITHDRAWN,INTERVENTIONAL,no funding
NCT00891969,TERMINATED,OBSERVATIONAL,Slow accrual
NCT00891995,TERMINATED,INTERVENTIONAL,Primary outcome evaluation determined lack of treatment group difference
NCT00892216,TERMINATED,INTERVENTIONAL,Not enough participants for study to be completed
NCT00892242,TERMINATED,INTERVENTIONAL,Principal Investigator decided to close the study early.
NCT00892268,TERMINATED,INTERVENTIONAL,Poor accural
NCT00892346,SUSPENDED,INTERVENTIONAL,No avaliability of melphlan in mainland China
NCT00892632,TERMINATED,INTERVENTIONAL,Difficult (slow) Enrollment
NCT00892801,TERMINATED,INTERVENTIONAL,Terminated due to low accrual. Study was closed to accrual prematurely and did not continue on to Phase II.
NCT00893048,WITHDRAWN,INTERVENTIONAL,Study never enrolled any subjects before auto-terminated by the internal IRB.
NCT00893516,TERMINATED,INTERVENTIONAL,Portfolio consolidation.
NCT00893620,TERMINATED,INTERVENTIONAL,"Due to less than expected enrollment rates, Cook has reevaluated the need for this clinical study."
NCT00893776,TERMINATED,INTERVENTIONAL,Insufficient time for study extenuating personal circumstances of PI
NCT00893789,TERMINATED,INTERVENTIONAL,Study has been stopped by sponsor decision.
NCT00893867,TERMINATED,INTERVENTIONAL,The result of a pre-planned interim futility analysis
NCT00893984,TERMINATED,INTERVENTIONAL,Lack of patient recruitment
NCT00893997,TERMINATED,INTERVENTIONAL,The trial was ended per sponsor due to slow accrual rates.
NCT00894023,TERMINATED,INTERVENTIONAL,the study was stopped because the sample size was very difficult to achieve.
NCT00894075,WITHDRAWN,INTERVENTIONAL,Withdrawn pending further review of clinical design.
NCT00894101,WITHDRAWN,INTERVENTIONAL,The main sponsor of this multi-center trial has submitted this protocol. A single participating site should not register this study.
NCT00894361,TERMINATED,INTERVENTIONAL,PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed
NCT00894465,TERMINATED,INTERVENTIONAL,Most pts requested to be treated with versed. It was difficult to randomize pts.
NCT00894491,WITHDRAWN,OBSERVATIONAL,Nonapplicable clinical trial
NCT00894751,TERMINATED,INTERVENTIONAL,low enrollment and high participant withdraw
NCT00894790,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00895024,TERMINATED,OBSERVATIONAL,PRMS No Slow Accrual
NCT00895245,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy in first 6 patients
NCT00895284,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00895297,TERMINATED,INTERVENTIONAL,Slow recruitment. No safety concerns during this study.
NCT00895336,WITHDRAWN,INTERVENTIONAL,IND for this study remained on clinical hold
NCT00895479,TERMINATED,INTERVENTIONAL,Strategic reasons. Seeking partner for future development.
NCT00895531,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT00895557,WITHDRAWN,INTERVENTIONAL,"This study never started, no funding."
NCT00895648,TERMINATED,INTERVENTIONAL,low accrual due to competing study for same group of patients
NCT00895791,WITHDRAWN,INTERVENTIONAL,major protocol changes: new study submitted
NCT00895895,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00895960,TERMINATED,INTERVENTIONAL,Sponsor withdrew support; Study did not progress to Phase II.
NCT00896025,TERMINATED,INTERVENTIONAL,"This observational study was stopped after 140 patients were enrolled, no more funds available to continue."
NCT00896402,WITHDRAWN,INTERVENTIONAL,Funding inadequate
NCT00896441,TERMINATED,INTERVENTIONAL,Funding ended
NCT00896610,TERMINATED,OBSERVATIONAL,All analysis with identifiable specimens/data is complete or site has no identifiers linked to the specimens/data
NCT00896688,WITHDRAWN,OBSERVATIONAL,The PI has been unable to continue with the study.
NCT00896961,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00897143,WITHDRAWN,OBSERVATIONAL,PI Left
NCT00897312,TERMINATED,OBSERVATIONAL,slow accrual
NCT00897377,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT00897806,TERMINATED,OBSERVATIONAL,Terminated due to slow accrual.
NCT00897858,WITHDRAWN,OBSERVATIONAL,"This non-therapeutic study was registered in error. The PRS team doesn't delete studies once registered, so they recommended changing the status to Withdrawn"
NCT00897910,TERMINATED,OBSERVATIONAL,Funding unavailable
NCT00898027,TERMINATED,OBSERVATIONAL,slow accrual
NCT00898209,TERMINATED,OBSERVATIONAL,This study competed with another VICC study
NCT00898430,TERMINATED,OBSERVATIONAL,Study closed prematurely upon PI's departure
NCT00898547,TERMINATED,OBSERVATIONAL,Poor accrual
NCT00898612,WITHDRAWN,OBSERVATIONAL,No Patients enrolled
NCT00898742,TERMINATED,OBSERVATIONAL,study closed prematurely upon PI's departure from VICC
NCT00898781,TERMINATED,OBSERVATIONAL,Due to poor accrual
NCT00898833,TERMINATED,OBSERVATIONAL,The proposed work could not be completed.
NCT00898937,TERMINATED,OBSERVATIONAL,Funding ended
NCT00899002,WITHDRAWN,OBSERVATIONAL,slow accrual
NCT00899132,TERMINATED,OBSERVATIONAL,Study due for continuing review
NCT00899288,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00899353,TERMINATED,INTERVENTIONAL,Original Principal Investigator left the institution.
NCT00899431,TERMINATED,INTERVENTIONAL,Terminated per PI's request at the time of continuing review
NCT00899639,WITHDRAWN,OBSERVATIONAL,"not ""applicable clinical trial"""
NCT00899678,TERMINATED,INTERVENTIONAL,higher than projected discontinuation rate during Maintenance Phase
NCT00899704,WITHDRAWN,OBSERVATIONAL,Study was never published
NCT00899808,WITHDRAWN,OBSERVATIONAL,"not ""applicable clinical trial"""
NCT00899860,TERMINATED,OBSERVATIONAL,PI left institution
NCT00899951,TERMINATED,OBSERVATIONAL,poor accrual
NCT00899977,TERMINATED,INTERVENTIONAL,Business reasons
NCT00900081,WITHDRAWN,OBSERVATIONAL,"no accrual, PI left institution"
NCT00900120,WITHDRAWN,OBSERVATIONAL,Will be replaced by honest broker program
NCT00900146,TERMINATED,INTERVENTIONAL,Numerically modest lowering of HbA1c with canakinumab in combination with metformin was inadequate to continue patients with T2DM into Period IV of this study.
NCT00900510,WITHDRAWN,INTERVENTIONAL,Recruitment of this population in the hospital setting not practical.
NCT00900549,TERMINATED,INTERVENTIONAL,"Futility reason, no difference between study groups"
NCT00900562,TERMINATED,INTERVENTIONAL,Slow and poor recruitment.
NCT00900666,TERMINATED,INTERVENTIONAL,Original subject recruitment goal was unrealistic. Study was terminated at N=19.
NCT00901108,TERMINATED,INTERVENTIONAL,Slow study recruitment and lack of clinical equipoise over time
NCT00901160,TERMINATED,OBSERVATIONAL,Unable to get funding
NCT00901290,SUSPENDED,INTERVENTIONAL,suspended pending data analysis
NCT00901303,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of accrual.
NCT00901420,TERMINATED,OBSERVATIONAL,Terminated due to slow accrual.
NCT00901537,TERMINATED,INTERVENTIONAL,Sponsor terminated due to no enrollments within last 4 months.
NCT00901693,TERMINATED,INTERVENTIONAL,Internal business decision
NCT00901823,WITHDRAWN,INTERVENTIONAL,Did not support the planned development of DCCR in the new indication
NCT00901836,TERMINATED,INTERVENTIONAL,Study closed due to feasability
NCT00901927,TERMINATED,INTERVENTIONAL,Study was closed early due to toxicity
NCT00902317,TERMINATED,INTERVENTIONAL,No funding
NCT00902525,TERMINATED,INTERVENTIONAL,After enrolling 25 patients an interim analysis was done.The study was discontinued in the absence of the minimum number of 6 patients free of events
NCT00902603,TERMINATED,OBSERVATIONAL,low enrollment and difficulty recruiting eligible patients in adequate time
NCT00902668,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00902863,TERMINATED,INTERVENTIONAL,Unable to keep patients attending yoga sessions
NCT00903006,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00903214,WITHDRAWN,INTERVENTIONAL,Funding ended
NCT00903279,WITHDRAWN,INTERVENTIONAL,Funding
NCT00903396,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00903461,TERMINATED,INTERVENTIONAL,drug supply issues
NCT00903630,TERMINATED,INTERVENTIONAL,lack of funding
NCT00903656,TERMINATED,INTERVENTIONAL,Caelyx was not available anymore
NCT00903695,TERMINATED,INTERVENTIONAL,"Risk/benefit ratio did not indicate further study would be useful, or fair to future subjects."
NCT00903838,TERMINATED,INTERVENTIONAL,"The study was terminated on 31 May, 2011, due to strategic considerations."
NCT00903942,WITHDRAWN,INTERVENTIONAL,funding was withdrawn from Drug company
NCT00904137,TERMINATED,INTERVENTIONAL,We were unable to recruit the appropriate numbers as parents did not want to randomize their child for the treatments options.
NCT00904189,TERMINATED,INTERVENTIONAL,PI has relocated
NCT00904345,TERMINATED,INTERVENTIONAL,Stopped early for funding and efficacy reasons.
NCT00904397,TERMINATED,INTERVENTIONAL,Rofecoxib was withdrawn from the market due to safety concerns.
NCT00904423,TERMINATED,INTERVENTIONAL,Low accrual
NCT00904488,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT00904605,TERMINATED,INTERVENTIONAL,Safety concerns with the COX-2 specific inhibitor class of drug.
NCT00905021,TERMINATED,INTERVENTIONAL,Sponsor withdrew support
NCT00905229,WITHDRAWN,INTERVENTIONAL,Enrollment problems
NCT00905294,TERMINATED,OBSERVATIONAL,Funding withdrawn
NCT00905398,TERMINATED,INTERVENTIONAL,The study was terminated due to excessive toxicity and low compliance to the protocol scheme.
NCT00905437,TERMINATED,INTERVENTIONAL,The Study was terminated on May 24th 2012 due to a slow recruitment rate. The study was not terminated for reasons of safety or efficacy.
NCT00905775,TERMINATED,OBSERVATIONAL,Failure of recruitment
NCT00905801,TERMINATED,INTERVENTIONAL,"Co-PI left institution, PI not pursuing"
NCT00906035,TERMINATED,INTERVENTIONAL,Could not enroll subjects who met the stringent inclusion/exclusion criteria.
NCT00906048,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT00906100,WITHDRAWN,OBSERVATIONAL,"Dr Obel is deceased and no other investigators on study to provide information. old record, IRB has no information; outside of retention period."
NCT00906243,TERMINATED,INTERVENTIONAL,Study Closed after completion of Phase I
NCT00906477,TERMINATED,INTERVENTIONAL,"The study was extended for 2.5 years. A further extension could not be funded. When the study was halted in June 2012, 47 subjects were included."
NCT00906776,TERMINATED,INTERVENTIONAL,Difficulty to recruit patients fulfilling inclusion criteria
NCT00906841,TERMINATED,INTERVENTIONAL,completed recruitment of patients on 15 december 2010
NCT00907166,TERMINATED,INTERVENTIONAL,Suspended trial was not restarted.
NCT00907179,TERMINATED,INTERVENTIONAL,Widespread use firstline Pemetrexed; slow recruitment; funding withdrawn..
NCT00907218,TERMINATED,INTERVENTIONAL,extremely slow enrollment
NCT00907231,WITHDRAWN,OBSERVATIONAL,Business Decision
NCT00907413,TERMINATED,INTERVENTIONAL,PI relocated and reopened trial in new university
NCT00907582,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00907595,WITHDRAWN,INTERVENTIONAL,unable to recruit subjects for study.Collaborator stopped funding for study as of 3/31/2010
NCT00907608,TERMINATED,INTERVENTIONAL,Due to difficulty in patient recruitment
NCT00907634,WITHDRAWN,OBSERVATIONAL,"Study closed by IRB because a Continuing Review and/or Close-Out have not been submitted.

Study closed by IRB"
NCT00907699,WITHDRAWN,OBSERVATIONAL,Slow Accrual
NCT00907712,WITHDRAWN,INTERVENTIONAL,Department difficulties
NCT00907764,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00907829,WITHDRAWN,INTERVENTIONAL,Methods unexpectedly required additional refinement that precluded subject enrollment.
NCT00907946,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00907985,TERMINATED,INTERVENTIONAL,Slow recruitment; trial unlikely to reach completion
NCT00908063,TERMINATED,INTERVENTIONAL,futility
NCT00908206,WITHDRAWN,INTERVENTIONAL,Study not approved by BfARM
NCT00908219,WITHDRAWN,INTERVENTIONAL,Accrual closed by sponsor due to lack of accrual and study progress
NCT00908414,WITHDRAWN,INTERVENTIONAL,strategic decision
NCT00908531,TERMINATED,INTERVENTIONAL,Poor recruitement
NCT00908622,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00908739,WITHDRAWN,OBSERVATIONAL,PI left
NCT00908856,WITHDRAWN,INTERVENTIONAL,Not funded
NCT00908947,TERMINATED,INTERVENTIONAL,Unable to enroll the required number of subjects
NCT00908986,WITHDRAWN,INTERVENTIONAL,Terminated by sponsor
NCT00909272,WITHDRAWN,OBSERVATIONAL,One of the investigators has left the institution
NCT00909363,TERMINATED,INTERVENTIONAL,retirement of PI
NCT00909584,TERMINATED,INTERVENTIONAL,Study TLK199.2103 was terminated for business reasons.
NCT00909662,TERMINATED,OBSERVATIONAL,Funding unavailable
NCT00909935,TERMINATED,OBSERVATIONAL,unable to enroll enough patients
NCT00909948,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00910000,TERMINATED,INTERVENTIONAL,Terminated due to unacceptable toxicity
NCT00910039,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00910299,TERMINATED,INTERVENTIONAL,Due to the low rate of primary endpoint events experienced in the study to date
NCT00910325,TERMINATED,INTERVENTIONAL,"The alternative laparoscopic chole, has so little morbidity very few patients opt for a transvaginal approach when presented with the alternative"
NCT00910416,TERMINATED,OBSERVATIONAL,Differences between BIS and Neurosense are important. This study can be terminated.
NCT00910494,TERMINATED,INTERVENTIONAL,No longer practical to deliver treatment
NCT00910780,WITHDRAWN,INTERVENTIONAL,Study was not funded.
NCT00911027,TERMINATED,INTERVENTIONAL,Failure to meet primary objective
NCT00911053,TERMINATED,INTERVENTIONAL,Unique provision in the American Recovery and Reinvestment Act prevented approval of second year no-cost-extension in which completion of analyses were planned.
NCT00911079,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00911131,WITHDRAWN,INTERVENTIONAL,Loss of funding
NCT00911209,TERMINATED,INTERVENTIONAL,Terminated because funding was not found
NCT00911326,TERMINATED,INTERVENTIONAL,The trial was terminated early based on an interim review by the Data and Safety Monitoring Committee for positive efficacy outcome and no safety concerns.
NCT00911339,TERMINATED,INTERVENTIONAL,prematurely interrupted because of difficulty in enrolment of patients.
NCT00912054,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00912236,TERMINATED,OBSERVATIONAL,Investigator left institution
NCT00912288,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00912366,TERMINATED,OBSERVATIONAL,Slow Enrollment
NCT00912444,TERMINATED,INTERVENTIONAL,"TAC treatment was associated with better survial outcome compared with TC treatment, we terminated recruiting and waiting for longer follow up period."
NCT00912509,TERMINATED,INTERVENTIONAL,insufficient efficacy
NCT00912561,TERMINATED,INTERVENTIONAL,slow recruiting
NCT00912899,TERMINATED,INTERVENTIONAL,Terminated early due to lack of clinical response.
NCT00912912,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00912990,TERMINATED,INTERVENTIONAL,Adequate subjects numbers not enrolled in study timeframe.
NCT00913003,TERMINATED,INTERVENTIONAL,PI terminated employment with the University
NCT00913159,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00913393,TERMINATED,INTERVENTIONAL,Study was terminated early for business purposes and as a result of a strategic decision to shift focus to another indication.
NCT00913601,TERMINATED,INTERVENTIONAL,"Prematurely stopped, as no beneficial effect was evident for bilateral stimulation after interim analysis of the first 20 patients."
NCT00913692,TERMINATED,INTERVENTIONAL,Terminated due to slow recruitment.
NCT00913861,TERMINATED,INTERVENTIONAL,affiliation's change of the principal investigator need a new review bord
NCT00913900,TERMINATED,INTERVENTIONAL,Failure to mobilize adequate CD34+ stem cells for minimum study treatment dose.
NCT00913913,TERMINATED,INTERVENTIONAL,low accrual not allowing site to meeting statistical endpoints
NCT00913978,TERMINATED,INTERVENTIONAL,Study terminated due to financial status of sponsor.
NCT00914043,WITHDRAWN,OBSERVATIONAL,Withdrawn as NCI rescinded approval for parent study NSABP-B-45
NCT00914069,TERMINATED,INTERVENTIONAL,Funding Stopped
NCT00914433,WITHDRAWN,INTERVENTIONAL,Drug development suspended
NCT00914628,TERMINATED,INTERVENTIONAL,"EMA withdrew the marketing Authorisation at the request of AGC Biologics S.p.A (formerly MolMed S.p.A), which decided to permanently discontinue the marketing of the product for commercial reasons"
NCT00914719,WITHDRAWN,INTERVENTIONAL,PI left the institution and no subjects enrolled.
NCT00914836,WITHDRAWN,INTERVENTIONAL,difficulties in the department
NCT00914940,TERMINATED,INTERVENTIONAL,Did not reach one of the primary endpoints of decreased total acute GVHD
NCT00914979,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients
NCT00915278,TERMINATED,INTERVENTIONAL,The study was terminated on 26 February 2013. Risk-benefit assessment is no longer positive and does not support further development
NCT00915317,WITHDRAWN,OBSERVATIONAL,"Before we could start the study, we realized that many of the patients were already getting ergocalciferol. Therefore, the study was closed."
NCT00915447,WITHDRAWN,OBSERVATIONAL,Investigator left the institution prior to enrollment of first participant
NCT00915668,WITHDRAWN,INTERVENTIONAL,The trial is postponed pending the completion of other ongoing pre-clinical and clinical work.
NCT00915681,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT00915694,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT00915811,TERMINATED,INTERVENTIONAL,FB ATG is now a standard for sib allo MDS patients
NCT00915928,TERMINATED,INTERVENTIONAL,No effect of the ACE inhibitor evaluated halfway in the study
NCT00916045,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT00916617,TERMINATED,INTERVENTIONAL,"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns."
NCT00916669,WITHDRAWN,INTERVENTIONAL,sponsor withdrew funding prior to patient enrollment
NCT00916890,SUSPENDED,INTERVENTIONAL,difficulties in patients enrolment
NCT00916903,TERMINATED,OBSERVATIONAL,Lack of funding.
NCT00917007,WITHDRAWN,OBSERVATIONAL,PI no longer at institution
NCT00917163,TERMINATED,INTERVENTIONAL,due to unavoidable circumstances relating to logistic issues and regulatory processes in various countries causing unacceptable delays.
NCT00917293,TERMINATED,INTERVENTIONAL,modified formulation under investigation
NCT00917683,TERMINATED,OBSERVATIONAL,Lack of enrollment.
NCT00917865,TERMINATED,INTERVENTIONAL,Optimal histolgic verification support such as whole mount analysis could not be made available.
NCT00918008,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT00918385,TERMINATED,INTERVENTIONAL,Permanent closure of trial to further accrual based on IDE disapproval
NCT00918450,WITHDRAWN,INTERVENTIONAL,Sponsor has decided to not proceed with this study.
NCT00918463,TERMINATED,INTERVENTIONAL,The study was terminated early due to lack of accrual.
NCT00918554,TERMINATED,INTERVENTIONAL,insufficient number of inclusion
NCT00918593,WITHDRAWN,INTERVENTIONAL,No recruitment of patients
NCT00918658,TERMINATED,OBSERVATIONAL,PI closed lab
NCT00918970,TERMINATED,OBSERVATIONAL,Angioscanners in excess of the SNA group because of use of thiopental
NCT00919126,TERMINATED,INTERVENTIONAL,Enrollment rate
NCT00919360,TERMINATED,OBSERVATIONAL,"PI is no longer at University of Rochester, has moved to University of Florida, Gainesville. PI email now homonq@ufl.edu. Phone is 352-273-7675"
NCT00919412,TERMINATED,OBSERVATIONAL,"Original Principal Investigator, G. Ashmead, MD left the Institution"
NCT00919464,TERMINATED,INTERVENTIONAL,low enrollment
NCT00919945,TERMINATED,INTERVENTIONAL,Reduced enrollment rate for SV patients due to high competition for studies
NCT00919984,TERMINATED,INTERVENTIONAL,This study stopped due to slow accrual.
NCT00920153,TERMINATED,INTERVENTIONAL,Other new drugs
NCT00920309,TERMINATED,INTERVENTIONAL,This study was stopped after larger studies published in the NEJM failed to show a benefit in treating ADPKD
NCT00920322,TERMINATED,INTERVENTIONAL,Technical issues impeded recruitment.
NCT00920556,TERMINATED,INTERVENTIONAL,Study terminated.24 subjects enrolled;provided adequate data for decision making.
NCT00920569,TERMINATED,OBSERVATIONAL,Study site collaborators withdrew from participating due to time constraints.
NCT00920582,TERMINATED,INTERVENTIONAL,Business decision
NCT00921258,TERMINATED,OBSERVATIONAL,Financial problem (not enough budget to continue the study)
NCT00921310,TERMINATED,INTERVENTIONAL,Withdrawal of funding from sponsor
NCT00921765,TERMINATED,INTERVENTIONAL,Problems with patient recruitment
NCT00922129,WITHDRAWN,INTERVENTIONAL,Study did not start up as planned.
NCT00922467,TERMINATED,INTERVENTIONAL,lack of effectiveness
NCT00922532,WITHDRAWN,INTERVENTIONAL,Company decision not to pursue prior to submission
NCT00922571,TERMINATED,INTERVENTIONAL,Sponsor decided not to pursue market release of prototype device used in this study
NCT00922714,TERMINATED,INTERVENTIONAL,"Slow recruitment, stopped after 4 years"
NCT00922818,WITHDRAWN,OBSERVATIONAL,recruitment issues
NCT00922831,WITHDRAWN,OBSERVATIONAL,Funding not available
NCT00922844,TERMINATED,INTERVENTIONAL,too slow recruitment; lack of funding
NCT00922948,WITHDRAWN,INTERVENTIONAL,"Cryoablation is no longer offered at our hospital, and likely won't be offered in the near future."
NCT00923117,TERMINATED,INTERVENTIONAL,The study was terminated based on results of an interim analysis for futility.
NCT00923234,TERMINATED,INTERVENTIONAL,The primary objective has already been answered with the number of recruited patients.
NCT00923247,TERMINATED,INTERVENTIONAL,"Terminated due to slow accrual,primary endpoint reached \& investigator left NIH."
NCT00923273,TERMINATED,INTERVENTIONAL,Premature closure - investigator left the National Institutes of Health.
NCT00923494,WITHDRAWN,INTERVENTIONAL,Unable to enroll. Change in patient population.
NCT00923793,TERMINATED,INTERVENTIONAL,"Recruitment was stopped, due to slow recruitment rate"
NCT00923806,TERMINATED,INTERVENTIONAL,Study was terminated due to poor accrual.
NCT00923949,TERMINATED,INTERVENTIONAL,Study never published; terminated early due to low accrual.
NCT00924001,TERMINATED,INTERVENTIONAL,study was stopped due to low accrual
NCT00924040,TERMINATED,INTERVENTIONAL,The supply of BL22 has expired and MedImmune the sponsor is not interested in producing any new supply.
NCT00924066,TERMINATED,INTERVENTIONAL,Premature closure due to slow/insufficient accrual.
NCT00924209,TERMINATED,INTERVENTIONAL,Study was terminated due to poor accrual.
NCT00924287,TERMINATED,INTERVENTIONAL,This study was terminated after the first patient treated on study died as a result of the treatment.
NCT00924417,TERMINATED,INTERVENTIONAL,Fellow unable to complete enrollment before completing training.
NCT00924508,TERMINATED,INTERVENTIONAL,Loss of Funding
NCT00924664,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00924794,TERMINATED,OBSERVATIONAL,"This complex study included a pilot and a main part. As the results of the pilot study were satisfying and conclusive, the main study was not performed."
NCT00924807,TERMINATED,INTERVENTIONAL,Sponsor closed the trial
NCT00924963,WITHDRAWN,INTERVENTIONAL,Study ended due to lack of funding.
NCT00925093,WITHDRAWN,INTERVENTIONAL,Primary investigator left institution
NCT00925132,TERMINATED,INTERVENTIONAL,Change in the number of approved drugs for metastatic melanoma
NCT00925405,TERMINATED,OBSERVATIONAL,Low accrual
NCT00925509,TERMINATED,INTERVENTIONAL,"Insufficient recruitment, too much selective inclusion criteria, feasibility problems"
NCT00925522,TERMINATED,INTERVENTIONAL,Study data no longer needed
NCT00925548,TERMINATED,INTERVENTIONAL,See termination reason in the below Purpose statement
NCT00925652,TERMINATED,INTERVENTIONAL,The study was terminated early due to slow accrual.
NCT00926107,TERMINATED,INTERVENTIONAL,The study ended prematurely due to the low accrual rate (24% of the expected accrual rate) in the first two years of patients enrolment
NCT00926250,TERMINATED,INTERVENTIONAL,Sponsor changed their study product and halted study.
NCT00926263,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00926354,TERMINATED,INTERVENTIONAL,Sponsor's considerations
NCT00926575,TERMINATED,INTERVENTIONAL,An independent Data Safety Monitoring Board recommended the study be stopped due to futility
NCT00926627,TERMINATED,INTERVENTIONAL,Not enough patients with the specified criteria could not
NCT00926835,TERMINATED,INTERVENTIONAL,due to patient recruitment difficulties
NCT00926913,WITHDRAWN,OBSERVATIONAL,Project has ended
NCT00926978,TERMINATED,INTERVENTIONAL,Institutional RDRC dissolved
NCT00927017,TERMINATED,INTERVENTIONAL,"When 9 subjects of targeted 12 subjects had been studied, no changes in plasma potassium were detected and it was deemed futile to continue with enrolment."
NCT00927147,TERMINATED,INTERVENTIONAL,The neutron facility closed down for financial reasons.
NCT00927212,TERMINATED,INTERVENTIONAL,The trial started and halted due sponsor's considerations.
NCT00927290,TERMINATED,INTERVENTIONAL,Suspension of use of medicine containing Pioglitazone by French regulatory agency
NCT00927329,WITHDRAWN,INTERVENTIONAL,Original PI left institution.
NCT00927459,TERMINATED,INTERVENTIONAL,Potential for immune stimulation to interfere with further dose escalation.
NCT00927602,TERMINATED,INTERVENTIONAL,study was stopped after enrolment of about 200 patients for slow recruitment
NCT00927732,TERMINATED,INTERVENTIONAL,"insufficient recruitment, a lot of premature study discontinuations"
NCT00927784,TERMINATED,INTERVENTIONAL,The enrollment has been terminated by the NHLBI for administrative reasons.
NCT00927953,TERMINATED,INTERVENTIONAL,Early termination due to the inability to enroll (13 of 120 subjects enrolled)
NCT00928200,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of accrual.
NCT00928317,TERMINATED,INTERVENTIONAL,Corporate re-prioritization
NCT00928772,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT00928811,TERMINATED,INTERVENTIONAL,Investigator left University 04/2010
NCT00928941,TERMINATED,INTERVENTIONAL,"The PI has left the project and the VA, as of 3/2011"
NCT00929019,TERMINATED,INTERVENTIONAL,slow accrual
NCT00929162,TERMINATED,INTERVENTIONAL,Primary objective of the trial was not met and so there was no benefit in collecting further information
NCT00929370,TERMINATED,INTERVENTIONAL,Study has now been terminated due to changes in project strategy. Current available data will be analysed and reported in a synoptic study report.
NCT00929409,TERMINATED,INTERVENTIONAL,Stopped prematurely because too few patients were recruited.
NCT00929435,TERMINATED,OBSERVATIONAL,Minimal enrollment
NCT00929630,TERMINATED,INTERVENTIONAL,Evident advantages of one treatment (seton) over the other (Tissucol Glue)
NCT00929669,TERMINATED,INTERVENTIONAL,unable to identify a third subject
NCT00929747,WITHDRAWN,INTERVENTIONAL,Management Decision
NCT00929825,WITHDRAWN,INTERVENTIONAL,The Hospital had the Unit of Stem cells Tranplantion suspended
NCT00930020,TERMINATED,INTERVENTIONAL,interim analysis shows futility
NCT00930046,TERMINATED,INTERVENTIONAL,The institution transitioned from open surgical procedure to Robotic procedure
NCT00930072,TERMINATED,INTERVENTIONAL,Poor Enrollment
NCT00930241,TERMINATED,INTERVENTIONAL,"logistic reasons (insufficient funding, technical problems with MEMS)"
NCT00930332,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00930358,TERMINATED,INTERVENTIONAL,This study was stopped due to low inclusion
NCT00930527,TERMINATED,INTERVENTIONAL,Closed by sponsor.
NCT00930748,TERMINATED,OBSERVATIONAL,The MRI company forbidded additional scans with endorectal colil in this machine
NCT00930787,TERMINATED,INTERVENTIONAL,Stopped early
NCT00930969,TERMINATED,OBSERVATIONAL,Low observed spontaneous coronary event rate among enrolled subjects
NCT00930995,WITHDRAWN,INTERVENTIONAL,Not Awarded
NCT00931255,TERMINATED,INTERVENTIONAL,The trial was stopped because of slow recruitment.
NCT00931398,WITHDRAWN,INTERVENTIONAL,Study was not initiated due to lack of funding by the sponsor
NCT00931411,TERMINATED,INTERVENTIONAL,Patients would improve naturally due to weather conditions
NCT00931606,TERMINATED,INTERVENTIONAL,administrative reasons (slow patient enrollment)
NCT00931996,TERMINATED,INTERVENTIONAL,Study was terminated due to low accrual.
NCT00932035,TERMINATED,INTERVENTIONAL,Loss of principal investigator
NCT00932126,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00932152,TERMINATED,INTERVENTIONAL,Poor enrollment/suspended to accrual; will close per AstraZeneca request
NCT00932191,TERMINATED,INTERVENTIONAL,Stopped for lack of funds
NCT00932386,WITHDRAWN,INTERVENTIONAL,unable to secure funding for analysis of laboratory data.
NCT00932464,WITHDRAWN,INTERVENTIONAL,Study withdrawn as it no longer is deemed necessary per project status.
NCT00932672,TERMINATED,INTERVENTIONAL,"slow recruitment, lack of funding and PI transferred"
NCT00932724,TERMINATED,INTERVENTIONAL,The sponsor declared the early termination of the study due to poor recruitment of patients.
NCT00932841,TERMINATED,INTERVENTIONAL,PI has re-located. PI terminated FDA IND # and closed study.
NCT00933023,WITHDRAWN,INTERVENTIONAL,Patient numbers estimated to be too low to complete the trial in less than 10 years
NCT00933088,TERMINATED,OBSERVATIONAL,due to slow accrual and lack of funding
NCT00933114,TERMINATED,OBSERVATIONAL,Funding ceased
NCT00933322,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT00933348,SUSPENDED,INTERVENTIONAL,Slow recruitment caused rethink on the study design
NCT00933374,TERMINATED,INTERVENTIONAL,delayed recruitment
NCT00933426,TERMINATED,INTERVENTIONAL,Terminated early due to slow accrual as Phase I dose escalation study.
NCT00934076,WITHDRAWN,INTERVENTIONAL,Study was never activated
NCT00934232,TERMINATED,INTERVENTIONAL,PI left the institution
NCT00934297,TERMINATED,OBSERVATIONAL,The study was terminated as the PI left the institution.
NCT00934401,WITHDRAWN,OBSERVATIONAL,poor accrual
NCT00934518,WITHDRAWN,INTERVENTIONAL,Inadequate patient accrual
NCT00934661,TERMINATED,INTERVENTIONAL,Drug was discontinued by manufacturer
NCT00934791,TERMINATED,INTERVENTIONAL,Terminated due to inadequate enrollment
NCT00934804,TERMINATED,INTERVENTIONAL,Principal Investigator separating employment from University.
NCT00934895,TERMINATED,INTERVENTIONAL,Closed early due to slow accrual
NCT00934934,TERMINATED,INTERVENTIONAL,slow enrollment
NCT00934960,TERMINATED,OBSERVATIONAL,PI separated employment from the university.
NCT00935090,SUSPENDED,INTERVENTIONAL,The Investigator is negotiating with other company to use FLT PET
NCT00935207,TERMINATED,OBSERVATIONAL,Poor enrollment and data collection
NCT00935558,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT00935727,TERMINATED,INTERVENTIONAL,images obtained were non-diagnostic
NCT00935753,WITHDRAWN,INTERVENTIONAL,Contractual issues
NCT00935766,TERMINATED,INTERVENTIONAL,The study was discontinued early due to lack of funding and slow enrollment
NCT00935857,TERMINATED,INTERVENTIONAL,Significant difference at interim analysis
NCT00936195,WITHDRAWN,INTERVENTIONAL,faillure to obtain insurance because of refusal from insurance companies
NCT00936234,WITHDRAWN,INTERVENTIONAL,insufficient recruitment
NCT00936247,TERMINATED,INTERVENTIONAL,organizational reasons at sites: low recruitment
NCT00936494,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00936520,TERMINATED,INTERVENTIONAL,Preliminary analysis showed little or no bioactivity.
NCT00936559,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00936585,TERMINATED,INTERVENTIONAL,Study halted by the sponsor
NCT00936598,TERMINATED,INTERVENTIONAL,Investigator-initiated termination of approval due to problems with recruitment.
NCT00936663,TERMINATED,INTERVENTIONAL,lack of funding
NCT00936767,WITHDRAWN,INTERVENTIONAL,Did not get approval
NCT00936780,TERMINATED,INTERVENTIONAL,market demand from paclitaxel to sirolimus drug-eluting stent
NCT00936832,WITHDRAWN,INTERVENTIONAL,because the sunitinib showed futility in anotehr trial
NCT00936923,WITHDRAWN,INTERVENTIONAL,The study was withdrawn prior to enrollment of first participant.
NCT00937053,TERMINATED,INTERVENTIONAL,3 unexpected Serious Adverse Events (veno-occlusive disease (VOD))
NCT00937144,WITHDRAWN,INTERVENTIONAL,we didnt recieved the medicine
NCT00937300,WITHDRAWN,INTERVENTIONAL,The patients eligible for this trial do not exist anymore due to change in procedures.
NCT00937417,WITHDRAWN,INTERVENTIONAL,Withdrawn because SWOG no longer pursuing this study at this time
NCT00937482,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT00937612,TERMINATED,INTERVENTIONAL,Study group showed better results. Poor Accrual.
NCT00937664,TERMINATED,INTERVENTIONAL,Termination of the study was made after a full review of program data and assessment of the current risk-benefit profile.
NCT00937729,TERMINATED,OBSERVATIONAL,difficult to include patients
NCT00938119,TERMINATED,OBSERVATIONAL,the product was delisted.
NCT00938236,TERMINATED,INTERVENTIONAL,Parent study CIS001 was completed
NCT00938314,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT00938353,TERMINATED,INTERVENTIONAL,possibility to discriminate the active drug from placebo
NCT00938457,TERMINATED,INTERVENTIONAL,poor accrual
NCT00938561,WITHDRAWN,OBSERVATIONAL,Non availability of funding
NCT00938925,WITHDRAWN,INTERVENTIONAL,No funds
NCT00939042,TERMINATED,INTERVENTIONAL,PI left institution
NCT00939055,TERMINATED,INTERVENTIONAL,"Based on futility analysis, study would not meet primary endpoint."
NCT00939159,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00939276,TERMINATED,INTERVENTIONAL,Patient recruitment difficulties
NCT00939328,WITHDRAWN,INTERVENTIONAL,question was no longer committee priority
NCT00939549,WITHDRAWN,INTERVENTIONAL,Study revised to retrospective chart review
NCT00939653,TERMINATED,INTERVENTIONAL,Due to insufficient research institution participation and patient enrollment
NCT00939783,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00939887,TERMINATED,INTERVENTIONAL,"This study was terminated on January 6, 2010, due to toxicology findings in animals exposed to PF-04455242 for three months."
NCT00939939,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT00940095,TERMINATED,INTERVENTIONAL,Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2)
NCT00940615,TERMINATED,INTERVENTIONAL,Primary Investigator is no longer employeed by the VA
NCT00940641,SUSPENDED,INTERVENTIONAL,Study withdrawn prior to enrollment due to AZ business decision unrelated to safety.
NCT00940784,WITHDRAWN,INTERVENTIONAL,Could not get drug
NCT00940875,TERMINATED,INTERVENTIONAL,Study was stopped due to slower than expected recruitment.
NCT00940979,TERMINATED,INTERVENTIONAL,Interim analyses showed insufficient result. Termination for reasons of futility
NCT00941356,WITHDRAWN,INTERVENTIONAL,Unable to recruit patients to continue on with the study.
NCT00941707,TERMINATED,INTERVENTIONAL,"Due to a single, unexpected serious event, the trial was stopped."
NCT00941928,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00942058,TERMINATED,OBSERVATIONAL,Difficult for recruiting
NCT00942383,TERMINATED,OBSERVATIONAL,low accrual
NCT00942396,WITHDRAWN,INTERVENTIONAL,FDA changed classification of device and no longer requires this type of clinical data
NCT00942409,TERMINATED,INTERVENTIONAL,drug supply was no longer available
NCT00942422,TERMINATED,INTERVENTIONAL,Low accrual and early termination
NCT00942474,WITHDRAWN,INTERVENTIONAL,Medtronic made a business decision to discontinue the study and withdraw the IDE.
NCT00942617,WITHDRAWN,INTERVENTIONAL,funding issue
NCT00942643,TERMINATED,INTERVENTIONAL,Poor patient recruitment
NCT00942838,WITHDRAWN,INTERVENTIONAL,PI decision due to under accrual.
NCT00943293,TERMINATED,INTERVENTIONAL,Poor accrual; did not enter phase 2
NCT00943462,WITHDRAWN,OBSERVATIONAL,No eligible patients could be recruited.
NCT00943553,WITHDRAWN,INTERVENTIONAL,Terminated by Sponsor
NCT00943566,WITHDRAWN,INTERVENTIONAL,funding for project discontinued
NCT00943605,TERMINATED,INTERVENTIONAL,Termination due to acquisition of PEAK Surgical by Medtronic
NCT00943709,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT00944125,TERMINATED,INTERVENTIONAL,"for administrative reasons (no safety concerns), no analysis completed"
NCT00944151,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT00944216,TERMINATED,INTERVENTIONAL,terminated due to administrative reasons.
NCT00944229,TERMINATED,INTERVENTIONAL,PI left the institution
NCT00944333,TERMINATED,INTERVENTIONAL,STOP due to recent data in literature questioning the need to continue DAP beyond six months in patients with stable coronary artery stenting with DES.
NCT00944372,TERMINATED,INTERVENTIONAL,Enrollment was difficult
NCT00944437,TERMINATED,INTERVENTIONAL,Failed to reach expected enrollment by anticipated dates.
NCT00944476,TERMINATED,OBSERVATIONAL,Software issues not resolved.
NCT00944580,WITHDRAWN,INTERVENTIONAL,unexpectedly low screening results leading to poor accrual
NCT00944593,WITHDRAWN,INTERVENTIONAL,Principle Investigator moved to another institution. Research funds transferred. Study to be performed at new institution
NCT00944606,WITHDRAWN,INTERVENTIONAL,inability to recruit subjects
NCT00945126,TERMINATED,INTERVENTIONAL,Poor accrural
NCT00945178,TERMINATED,INTERVENTIONAL,The study was terminated due to results in another study (NCT00878501).
NCT00945243,TERMINATED,INTERVENTIONAL,This study was terminated early due to lower than expected enrollment rates.
NCT00945269,TERMINATED,INTERVENTIONAL,"ONTAK has been pulled off the market for further testing. Subsequently, EISAI will no longer be supporting clinical trials that utilize this drug."
NCT00945360,WITHDRAWN,INTERVENTIONAL,Inability to recruit patients
NCT00945399,TERMINATED,INTERVENTIONAL,Manufacturing stopped
NCT00945412,WITHDRAWN,INTERVENTIONAL,PI moving to another institution
NCT00945425,TERMINATED,INTERVENTIONAL,Decided to stop development of this compound globally
NCT00945477,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT00945620,WITHDRAWN,INTERVENTIONAL,PI was unable to locate appropriate population
NCT00946023,TERMINATED,INTERVENTIONAL,Funding was unavailable to complete the study as originally planned.
NCT00946088,TERMINATED,INTERVENTIONAL,lower than expected enrollment
NCT00946127,TERMINATED,OBSERVATIONAL,Unable to recruit patients and lack of efficacy in ETV arm
NCT00946166,WITHDRAWN,INTERVENTIONAL,Investigator left institution.
NCT00946283,TERMINATED,INTERVENTIONAL,slow accrual
NCT00946361,TERMINATED,OBSERVATIONAL,PI left institution
NCT00946426,WITHDRAWN,OBSERVATIONAL,PI left institution
NCT00946517,TERMINATED,OBSERVATIONAL,PI left the institution
NCT00946712,TERMINATED,INTERVENTIONAL,terminated at pre-planned futility analysis
NCT00946907,TERMINATED,INTERVENTIONAL,"This study was suspended by principal investigator's decision. All the sites were not opened, and the recruitment was so slow."
NCT00946972,TERMINATED,INTERVENTIONAL,"No safety signals were noted. The study completed the main phase, additional potential study cohorts not required."
NCT00946985,TERMINATED,INTERVENTIONAL,The recruitment rate for the study was inadequate to achieve its enrollment goals.
NCT00947011,TERMINATED,INTERVENTIONAL,PI left JHU
NCT00947037,WITHDRAWN,INTERVENTIONAL,The sponsor decided to postpone the performance of this study to after phase 3
NCT00947167,TERMINATED,INTERVENTIONAL,Extreme toxicity of Pertuzumab and Erlotinib combination
NCT00947193,TERMINATED,INTERVENTIONAL,Study was terminated early due to Sponsor decision and not reflective of adverse safety findings.
NCT00947284,TERMINATED,INTERVENTIONAL,Experimental pain model didn't work as anticipated.
NCT00947375,TERMINATED,INTERVENTIONAL,All of the mentioned aim and objectives were achieved before the February 2007
NCT00947388,TERMINATED,INTERVENTIONAL,No more eligible patients
NCT00947466,TERMINATED,INTERVENTIONAL,25 patients have been recruited and it was considered that further recruitment would add no extra PK information
NCT00947648,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT00947674,TERMINATED,INTERVENTIONAL,short of enrollment
NCT00947791,TERMINATED,INTERVENTIONAL,Change in available resources for study procedures
NCT00947895,TERMINATED,INTERVENTIONAL,Study reached halfway point in approximately one year time period and was halted to analyze data.
NCT00947934,WITHDRAWN,INTERVENTIONAL,probleme of feasibility
NCT00948025,TERMINATED,INTERVENTIONAL,transitioning from 361 HCT/P Tissue to a Biologic (BLA)
NCT00948194,TERMINATED,INTERVENTIONAL,This study was terminated when the P.I. left the university.
NCT00948233,WITHDRAWN,OBSERVATIONAL,Military related changes led to to no initiation of recruitment.
NCT00948285,TERMINATED,INTERVENTIONAL,Difficult accrual
NCT00948389,TERMINATED,INTERVENTIONAL,Inability to meet protocol objectives
NCT00948688,TERMINATED,INTERVENTIONAL,Funding was withdrawn after only 10 participants were enrolled
NCT00948857,TERMINATED,INTERVENTIONAL,Lack of recruitment.
NCT00949026,WITHDRAWN,INTERVENTIONAL,No accrual
NCT00949052,TERMINATED,OBSERVATIONAL,Low accrual
NCT00949065,WITHDRAWN,INTERVENTIONAL,No more interest to follow this study
NCT00949117,TERMINATED,INTERVENTIONAL,study not feasible with low accrual. DSMB recommended closure
NCT00949299,TERMINATED,INTERVENTIONAL,Not enough could be recruted
NCT00949377,WITHDRAWN,INTERVENTIONAL,Unable to recruit enough patients at a single center.
NCT00949897,WITHDRAWN,INTERVENTIONAL,Funding terminated
NCT00949962,TERMINATED,INTERVENTIONAL,Poorly recruiting
NCT00949988,TERMINATED,INTERVENTIONAL,Three subjects were enrolled and all three subjects withdrew.
NCT00950183,TERMINATED,INTERVENTIONAL,recruitment feasability
NCT00950261,WITHDRAWN,INTERVENTIONAL,A competing trial has been initiated.
NCT00950274,TERMINATED,INTERVENTIONAL,Recruitment stopped due to slow recruitment
NCT00950391,WITHDRAWN,INTERVENTIONAL,PI unable to secure funding for the project so study was not pursued.
NCT00950443,TERMINATED,INTERVENTIONAL,No inclusion
NCT00950534,TERMINATED,INTERVENTIONAL,due to poor recruitment
NCT00950820,TERMINATED,INTERVENTIONAL,Recruitment rate to low; changed environment made protocol in its current state obsolete
NCT00951067,WITHDRAWN,INTERVENTIONAL,Funding not available to continue with study.
NCT00951132,WITHDRAWN,INTERVENTIONAL,Failure to include patients
NCT00951158,TERMINATED,INTERVENTIONAL,Administrative suspension. PI/grant holder transferred to new institution.
NCT00951171,TERMINATED,INTERVENTIONAL,Randomization flawed. Results were poor in the innovative catheter group
NCT00951223,WITHDRAWN,OBSERVATIONAL,Lack of Enrollment
NCT00951301,TERMINATED,INTERVENTIONAL,"Significantly lower accrual rate than anticipated, time constraints."
NCT00951379,TERMINATED,INTERVENTIONAL,Due to slow accrual.
NCT00951444,WITHDRAWN,INTERVENTIONAL,The study was not activated.
NCT00952016,TERMINATED,INTERVENTIONAL,Lack of recruitment - only 2 patients recruited.
NCT00952055,TERMINATED,OBSERVATIONAL,1) A delay in obtaining immunoassays to measure serum neopterin 2)altered relevance of the expected experimental results to clinical practice
NCT00952185,TERMINATED,INTERVENTIONAL,"Very low enrollment and follow-up, cannot meet study objectives"
NCT00952211,TERMINATED,INTERVENTIONAL,problems with recruitment
NCT00952510,TERMINATED,OBSERVATIONAL,Respond was to low.
NCT00952549,WITHDRAWN,INTERVENTIONAL,Investigator no longer at Cleveland Clinic
NCT00952601,TERMINATED,INTERVENTIONAL,Insufficient interest and recruitment - study ended prematurely by investigators
NCT00952627,TERMINATED,INTERVENTIONAL,Not able to recruit qualified patents
NCT00952666,TERMINATED,INTERVENTIONAL,The number of participants needed for this study has been met.
NCT00952861,WITHDRAWN,INTERVENTIONAL,Stopped due to poor recruitment
NCT00953160,TERMINATED,INTERVENTIONAL,The preliminary data from this pilot study did not indicate efficacy.
NCT00953290,TERMINATED,INTERVENTIONAL,The study was terminated because the preliminary data did not indicate efficacy.
NCT00953329,TERMINATED,INTERVENTIONAL,Subjects declined enrollment; sponsor/PI elected to close study.
NCT00953459,TERMINATED,INTERVENTIONAL,poorly recruiting
NCT00953563,WITHDRAWN,INTERVENTIONAL,Budgetary
NCT00953576,TERMINATED,INTERVENTIONAL,The study terminated early due to concerns about drug toxicity.
NCT00953615,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00953641,WITHDRAWN,INTERVENTIONAL,"Principle Investigator retired, Resident moved away"
NCT00953706,TERMINATED,INTERVENTIONAL,Following review of results obtained from a pre-specified 6-month analysis of Part B data the study was terminated on the basis of futility.
NCT00953771,TERMINATED,INTERVENTIONAL,low enrollment
NCT00953940,TERMINATED,INTERVENTIONAL,An external board recommended to close the study for futility after the interin analysis
NCT00954005,TERMINATED,INTERVENTIONAL,Predefined termination criterion of \> 10 patients without CR or PR was matched.
NCT00954070,TERMINATED,OBSERVATIONAL,Difficulty in recruiting subjects for study
NCT00954148,TERMINATED,INTERVENTIONAL,1st years Enrollment #s showed study was not going to meet criteria randomization.
NCT00954187,TERMINATED,INTERVENTIONAL,PI left institution
NCT00954486,WITHDRAWN,INTERVENTIONAL,Difficulty in identifying interested subjects.
NCT00954512,TERMINATED,INTERVENTIONAL,This study was terminated for business reasons.
NCT00954603,TERMINATED,INTERVENTIONAL,few delirious patients were enrolled.
NCT00954668,WITHDRAWN,INTERVENTIONAL,No funding
NCT00954759,TERMINATED,INTERVENTIONAL,Abandoned due to poor recruitment
NCT00954785,WITHDRAWN,INTERVENTIONAL,The study was terminated by Merck USA. The company did not supply drugs for the study.
NCT00954837,WITHDRAWN,INTERVENTIONAL,administrative delays too long
NCT00954850,WITHDRAWN,OBSERVATIONAL,Subjects not entered into electronic database due to current construct of database and associated privacy legislations within Alberta.
NCT00954876,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT00954915,TERMINATED,INTERVENTIONAL,Injection site reaction met protocol-defined stopping criteria.
NCT00954993,TERMINATED,INTERVENTIONAL,This study was stopped for business and program changes. At no time was the safety of any participants at risk.
NCT00955097,TERMINATED,INTERVENTIONAL,No funding for this study
NCT00955136,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to many implementation difficulties.
NCT00955240,TERMINATED,INTERVENTIONAL,Inadequate toxicity
NCT00955266,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT00955292,TERMINATED,INTERVENTIONAL,Modified dose schedule presented no advantage over previously studied schedule
NCT00955305,TERMINATED,INTERVENTIONAL,The study was closed to accrual due to the end of the clinical development program with cixutumumab.
NCT00955474,TERMINATED,INTERVENTIONAL,AstraZeneca halted funding; patent expired for Seroquel (Quetiapine) in 2012
NCT00955708,TERMINATED,OBSERVATIONAL,Early termination was granted by FDA based on study results meeting the post approval requirements.
NCT00955721,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT00955877,TERMINATED,INTERVENTIONAL,The manufacturer decided to stop drug production.
NCT00955890,TERMINATED,INTERVENTIONAL,Enrolled too slow
NCT00955929,TERMINATED,INTERVENTIONAL,The study was interrupted because of failure to recruit the target study population in a reasonable timeframe.
NCT00955942,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT00956072,TERMINATED,INTERVENTIONAL,low accrual
NCT00956124,WITHDRAWN,OBSERVATIONAL,Technical issue
NCT00956293,TERMINATED,INTERVENTIONAL,The study was terminated because the required sample size of 240-260 de novo senior renal transplant patients was not achieved within a reasonable time.
NCT00956748,WITHDRAWN,INTERVENTIONAL,"Lack of staff, time, and resources"
NCT00956852,TERMINATED,OBSERVATIONAL,Poor subject recruitment
NCT00956904,TERMINATED,INTERVENTIONAL,IRB approval expired.
NCT00957034,TERMINATED,INTERVENTIONAL,Due to difficult patient enrollment.
NCT00957242,TERMINATED,INTERVENTIONAL,Excess of mortality in the treatment group created safety concerns.
NCT00957255,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT00957320,WITHDRAWN,INTERVENTIONAL,"no patients enrolled, decided not to pursue study"
NCT00957398,TERMINATED,OBSERVATIONAL,Not possible to include patients.
NCT00957489,TERMINATED,INTERVENTIONAL,Study stopped due to increased harm and slow progress in the intervention group.
NCT00957580,TERMINATED,INTERVENTIONAL,The trial has been terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)
NCT00957736,TERMINATED,OBSERVATIONAL,study closed prematurely upon PI's departure from VICC
NCT00957749,WITHDRAWN,INTERVENTIONAL,"IND application was withdrawn, and therefore study listing is being withdrawn."
NCT00957827,TERMINATED,INTERVENTIONAL,Not enough subject enrolled
NCT00958022,TERMINATED,INTERVENTIONAL,Based on the tolerabilty challenges of the combination
NCT00958074,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT00958139,TERMINATED,INTERVENTIONAL,"After year 1, there was insufficient statistical power to detect a difference in the primary outcome measure during planned study period."
NCT00958269,TERMINATED,INTERVENTIONAL,Technical/operational issues
NCT00958321,TERMINATED,INTERVENTIONAL,Low levels of recruitment
NCT00958347,TERMINATED,INTERVENTIONAL,Terminated due to lagging follow-up
NCT00958373,WITHDRAWN,OBSERVATIONAL,Didn't have the resources necessary to carry out the study
NCT00958412,TERMINATED,INTERVENTIONAL,Repros stopped the study for safety and FDA put the study on hold for safety.
NCT00958425,SUSPENDED,INTERVENTIONAL,Failure of funding
NCT00958542,SUSPENDED,INTERVENTIONAL,This study is coordinated by the Harms Study Group. It is already registered on this website
NCT00958711,TERMINATED,INTERVENTIONAL,Budgetary
NCT00958776,TERMINATED,INTERVENTIONAL,This study was terminated for futility
NCT00958841,TERMINATED,INTERVENTIONAL,Slow recruitment rate into this study with rare tumors of neuroendocrine origin (enrollment issues)
NCT00958893,TERMINATED,INTERVENTIONAL,Repros stopped the study for safety and FDA put the study on hold for safety.
NCT00958906,WITHDRAWN,INTERVENTIONAL,PI left institution (there are no data results for this study)
NCT00959738,TERMINATED,INTERVENTIONAL,"Difference found in interim analysis, not ethical to continue"
NCT00959985,TERMINATED,INTERVENTIONAL,low accrual
NCT00960063,TERMINATED,INTERVENTIONAL,Study was terminated for business reasons.
NCT00960154,TERMINATED,INTERVENTIONAL,Termination due to acquisition of PEAK Surgical by Medtronic
NCT00960297,TERMINATED,INTERVENTIONAL,Study was terminated due to slow accrual
NCT00960427,WITHDRAWN,INTERVENTIONAL,No surgeon available to perfrom gastroscopy
NCT00960544,WITHDRAWN,INTERVENTIONAL,Principal Investigator departed from institution
NCT00960726,WITHDRAWN,INTERVENTIONAL,Study withdrawn at sponsor request.
NCT00960804,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00960921,WITHDRAWN,INTERVENTIONAL,Study never started.
NCT00961142,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00961168,WITHDRAWN,INTERVENTIONAL,Budgetary restrictions
NCT00961207,TERMINATED,INTERVENTIONAL,Altitude trial which used similar drugs was terminated due to increased ADR.
NCT00961376,TERMINATED,INTERVENTIONAL,PI Discretion
NCT00961571,TERMINATED,INTERVENTIONAL,Unanticipated side effects and futility
NCT00961623,WITHDRAWN,OBSERVATIONAL,funding
NCT00961701,TERMINATED,OBSERVATIONAL,sample size was not enrolled
NCT00961714,TERMINATED,INTERVENTIONAL,Withdrew study
NCT00961753,TERMINATED,INTERVENTIONAL,"FDA drug recall on July 30, 2010"
NCT00961844,TERMINATED,INTERVENTIONAL,Logistical problems
NCT00962130,WITHDRAWN,INTERVENTIONAL,No patients enrolled.
NCT00962143,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT00962221,TERMINATED,OBSERVATIONAL,Recruiting difficulties
NCT00962234,TERMINATED,OBSERVATIONAL,ethics approval not renewed by Study Group
NCT00962273,TERMINATED,INTERVENTIONAL,low participation and retention rates
NCT00962286,TERMINATED,INTERVENTIONAL,The blood pressure did not decrease following furosemide administration
NCT00962299,TERMINATED,INTERVENTIONAL,"recruitment was unsuccesfull, only 7 patient have been included untill 2012"
NCT00962572,WITHDRAWN,OBSERVATIONAL,Investigator decided not to pursue
NCT00962884,WITHDRAWN,INTERVENTIONAL,"No volunteers were enrolled, study was closed"
NCT00963196,WITHDRAWN,INTERVENTIONAL,End of allotted time for subject recruiting.
NCT00963300,WITHDRAWN,INTERVENTIONAL,Project Never Initiated - no human subjects were enrolled and no data regarding humans was collected or studied
NCT00963664,WITHDRAWN,INTERVENTIONAL,Modifications will be necessary before full IRB approval will be secured.
NCT00963690,TERMINATED,INTERVENTIONAL,Lack of funding
NCT00963872,TERMINATED,INTERVENTIONAL,Lack of efficacy after interim analysis
NCT00964015,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT00964119,TERMINATED,OBSERVATIONAL,Principal Investigator has left Sponsoring Instiution
NCT00964288,TERMINATED,INTERVENTIONAL,"During treatment session 3, a subject had a pattern of AEs of severe intensity, suggestive of brainstem toxicity/encephalopathy during lidocaine/saline infusion"
NCT00964561,SUSPENDED,INTERVENTIONAL,On partial hold for clinical investigation into AE and SAE reported.
NCT00964691,TERMINATED,INTERVENTIONAL,"Low prevalence of malaria, high prevalence of reported allergy to sulphur drugs, high proportion of women not meeting the inclusion criterea."
NCT00964704,WITHDRAWN,INTERVENTIONAL,No patients have been recruited therefore study has been cancelled
NCT00964743,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00964834,TERMINATED,INTERVENTIONAL,Sister trial has SAE investigation underway - sponsor elected to withdraw as study expected to be repeated later
NCT00964990,TERMINATED,INTERVENTIONAL,Logistic reasons associated with the FDA-imposed clinical hold.
NCT00965003,TERMINATED,INTERVENTIONAL,Absence of key personnel to conduct study
NCT00965055,TERMINATED,INTERVENTIONAL,The study was terminated due to inability to recruit subjects. A total of 2/100 anticipated were radomized.
NCT00965146,TERMINATED,INTERVENTIONAL,Terminated due to lagging follow-up.
NCT00965302,TERMINATED,INTERVENTIONAL,"Investigator did not submit an annual continuation report with the Institutional Review Board and the study was officially removed from IRB regulatory oversight on Sep 2014, based on 32 CFR 219.109e. The study officially expired/terminated."
NCT00965419,TERMINATED,INTERVENTIONAL,Terminated due to low 5 year completer number and not meeting primary objective.
NCT00965458,TERMINATED,INTERVENTIONAL,Manufacturer discontinued production of Amevive: business decision.
NCT00965510,TERMINATED,INTERVENTIONAL,insufficient recruitment of control and study patients
NCT00965770,TERMINATED,OBSERVATIONAL,"This study is a retrospective chart review study, not a clinical trial."
NCT00965861,TERMINATED,OBSERVATIONAL,Replaced by a study with a similar design.
NCT00966251,TERMINATED,INTERVENTIONAL,The study was stopped because of slow accrual
NCT00966342,WITHDRAWN,INTERVENTIONAL,New studies are being offered
NCT00966498,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00966654,TERMINATED,INTERVENTIONAL,PI left JHU
NCT00966823,TERMINATED,INTERVENTIONAL,Device no longer available
NCT00966979,TERMINATED,INTERVENTIONAL,Enrollment goals not being met.
NCT00966992,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT00967226,TERMINATED,INTERVENTIONAL,"Serious adverse events with prednisolone, primarily temporary growth retardation, \<5th percentile."
NCT00967291,TERMINATED,INTERVENTIONAL,lack of activity and G3-4 toxicity at interim analysis
NCT00967356,TERMINATED,INTERVENTIONAL,Terminated (halted prematurely) due to tolerability issues.
NCT00967512,WITHDRAWN,INTERVENTIONAL,Study Was Terminated due to lack of Funding.
NCT00967525,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00967590,WITHDRAWN,INTERVENTIONAL,No patients dosed
NCT00967759,WITHDRAWN,INTERVENTIONAL,The study was designed again in compliance with the regulatory agency.
NCT00967798,TERMINATED,INTERVENTIONAL,Could not achieve target enrollment
NCT00967837,TERMINATED,INTERVENTIONAL,Administrative
NCT00967928,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00967967,SUSPENDED,INTERVENTIONAL,Awaiting results from sub analysis to decide if study continues
NCT00968097,TERMINATED,INTERVENTIONAL,Early Phase I study of \[123I\]MNI-340 did not evidence as marker of disease
NCT00968331,TERMINATED,INTERVENTIONAL,The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)
NCT00968383,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to low enrollment.
NCT00968604,WITHDRAWN,INTERVENTIONAL,Stability of the DNA when admixed with the liposome failed
NCT00968721,TERMINATED,OBSERVATIONAL,lack of support
NCT00968799,TERMINATED,INTERVENTIONAL,poor patient accrual
NCT00968864,TERMINATED,INTERVENTIONAL,"Sponsor/ PI leaving institution, no plans to continue this research at this time"
NCT00969189,TERMINATED,OBSERVATIONAL,Initial number of 250 was not based on sample size. Most airway studies use n=100 therefore trial stopped when 120 children recruited
NCT00969306,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00969332,TERMINATED,INTERVENTIONAL,study intervention was approved by the FDA
NCT00969397,WITHDRAWN,INTERVENTIONAL,We have decided not to pursue the study
NCT00969423,TERMINATED,INTERVENTIONAL,unable to recruit
NCT00969722,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT00969917,WITHDRAWN,INTERVENTIONAL,Company decision not to start the study
NCT00969956,TERMINATED,OBSERVATIONAL,Local regulations
NCT00970086,TERMINATED,INTERVENTIONAL,Groin surgery was changed to a laparoscopic technique; recruitable patients ceased.
NCT00970255,SUSPENDED,INTERVENTIONAL,Difficulty in recruiting participants
NCT00970476,WITHDRAWN,OBSERVATIONAL,limited enrollment
NCT00970515,TERMINATED,INTERVENTIONAL,lack of recrutment
NCT00970541,TERMINATED,INTERVENTIONAL,Recruitment
NCT00970606,TERMINATED,INTERVENTIONAL,Inability to recruit participants since H1N1 epidemic resolved.
NCT00970645,TERMINATED,INTERVENTIONAL,Similar study published results
NCT00971074,WITHDRAWN,INTERVENTIONAL,Patients did not meet inclusion criteria.
NCT00971126,TERMINATED,INTERVENTIONAL,Two patients in the first dose level be counted as reaching DLT. DSMB recommend terminated early this trial.
NCT00971191,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00971438,TERMINATED,INTERVENTIONAL,Failing recruitement and more exclusions than anticipated.
NCT00971503,WITHDRAWN,INTERVENTIONAL,Principal Investigator moved to Chile from Argentina
NCT00971776,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment and change in business priority
NCT00972101,WITHDRAWN,INTERVENTIONAL,Development of other studies led to termination without recruitment.
NCT00972218,WITHDRAWN,INTERVENTIONAL,Difficulty with enrollment
NCT00972270,TERMINATED,INTERVENTIONAL,Study closed due to insufficient enrollment
NCT00972335,TERMINATED,INTERVENTIONAL,Study terminated early due to slow accrual
NCT00972543,TERMINATED,INTERVENTIONAL,The study was terminated after the European Medicines Evaluation Agency recommended to suspend the marketing authorisation of Raptiva in the European Union
NCT00972647,WITHDRAWN,INTERVENTIONAL,Lack of personnel
NCT00972842,TERMINATED,INTERVENTIONAL,slow recruitment
NCT00972868,WITHDRAWN,INTERVENTIONAL,Inability to enrole subjucts.
NCT00973024,TERMINATED,INTERVENTIONAL,"Based on lack of efficacy in PAI2003, sponsor made the decision to discontinue the trial."
NCT00973089,WITHDRAWN,INTERVENTIONAL,recruiting or enrolling participants has halted prematurely and will not resume
NCT00973141,TERMINATED,INTERVENTIONAL,Logistic reasons associated with the FDA-imposed clinical hold.
NCT00973193,TERMINATED,INTERVENTIONAL,The intermediate analyses did not allowed to continue the clinical study.
NCT00973271,WITHDRAWN,INTERVENTIONAL,Did not continue with development of DCCR in Very High Triglycerides
NCT00974129,WITHDRAWN,OBSERVATIONAL,"no subjects were enrolled, study was halted due to study staff departure"
NCT00974597,TERMINATED,INTERVENTIONAL,Management Decision
NCT00974623,TERMINATED,OBSERVATIONAL,Parent sponsor company (Baxter Healthcare) company cut funding
NCT00974662,TERMINATED,INTERVENTIONAL,Early end of enrolment with regards to difficulty met to enrol patients.
NCT00974675,TERMINATED,INTERVENTIONAL,Study recruitment was terminated before the planned number of subjects was enrolled in CAT-354 10 mg/kg group due to the slow recruitment rate.
NCT00974740,TERMINATED,INTERVENTIONAL,for lack of recruitment
NCT00974818,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT00974922,TERMINATED,INTERVENTIONAL,Administrative/Sponsor Business Decision - terminated - study was not completed
NCT00975039,TERMINATED,INTERVENTIONAL,Early end of enrolment with regards to difficulty met to enrol patients .
NCT00975104,WITHDRAWN,INTERVENTIONAL,Amgen has chosen at this time not to continue with AMG 745 study 20080733
NCT00975234,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT00975468,SUSPENDED,INTERVENTIONAL,Financial shortages due to lack of funderx
NCT00975611,TERMINATED,INTERVENTIONAL,The sponsor withdrew support due to slow accrual of eligible subjects.
NCT00975767,TERMINATED,INTERVENTIONAL,"The study was terminated due to a need for a reformulation of the study drug. Phase 1 completed, no patients enrolled in Phase 2."
NCT00975806,TERMINATED,INTERVENTIONAL,MTD determined sub-optimal as efficacious treatment for renal cell carcinoma.
NCT00976027,TERMINATED,INTERVENTIONAL,"No safety concerns, study terminated due to lack of primary endpoint cases in 2009-2010 Flu season (coincided with H1N1 Pandemic) Subjects followed per-protocol"
NCT00976183,TERMINATED,INTERVENTIONAL,toxicities
NCT00976430,TERMINATED,INTERVENTIONAL,Adequate no. of patients could not be recruited in the set time frame.
NCT00976508,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00976534,TERMINATED,INTERVENTIONAL,The study was terminated due to results in another study (NCT00878501).
NCT00976781,WITHDRAWN,OBSERVATIONAL,Decision not to move forward. Lack of funding.
NCT00977054,TERMINATED,INTERVENTIONAL,Novel HCV DAA approved by FDA
NCT00977067,TERMINATED,INTERVENTIONAL,The study was terminated early by the Sponsor for reasons unrelated to patient safety or anti-tumor activity.
NCT00977132,TERMINATED,INTERVENTIONAL,delayed recruitment
NCT00977145,TERMINATED,INTERVENTIONAL,"Closed short of the enrollment goal, due to slow enrollment and adequate data to address endpoints"
NCT00977158,WITHDRAWN,OBSERVATIONAL,No problems with planned study- insufficient funding for this study to proceed.
NCT00977171,TERMINATED,INTERVENTIONAL,Enrollment issues.
NCT00977379,TERMINATED,INTERVENTIONAL,Due to an insufficient number of participants enrolled.
NCT00977522,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00977561,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00977587,WITHDRAWN,INTERVENTIONAL,unable to get MHRA approval for formulation in present form
NCT00977795,WITHDRAWN,INTERVENTIONAL,PI moving to Southern Illinois University to start new protocol
NCT00978133,TERMINATED,INTERVENTIONAL,"Difficulty in accrual of study subjects, small numbers of potential subjects"
NCT00978146,WITHDRAWN,INTERVENTIONAL,Study was administratively withdrawn by the IRB; no subjects were enrolled
NCT00978224,SUSPENDED,INTERVENTIONAL,Decision of the investigator
NCT00978276,WITHDRAWN,OBSERVATIONAL,Personal changes in the company
NCT00978341,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT00978354,TERMINATED,INTERVENTIONAL,Feasibility of target enrollment within the context of available funding resources.
NCT00978432,TERMINATED,INTERVENTIONAL,The toxicity seemed to outweigh the benefit.
NCT00978536,TERMINATED,INTERVENTIONAL,Difficulties of recruitment in a randomization arm
NCT00978809,WITHDRAWN,INTERVENTIONAL,major difficulties recruiting patients
NCT00978822,TERMINATED,INTERVENTIONAL,"Difficult enrollment parameters, subsequently low enrollment. Decision to terminate trial."
NCT00978874,TERMINATED,INTERVENTIONAL,The PI is no longer with our institution
NCT00979004,TERMINATED,INTERVENTIONAL,"The study was terminated on September 12, 2010 per protocol following a serious adverse event that occurred with the first subject dosed at 600 mg."
NCT00979121,TERMINATED,INTERVENTIONAL,stopped for futility
NCT00979134,TERMINATED,INTERVENTIONAL,"Termination of study enrolment to Part C, Cohort 3 (08 July 2013) was based on the analysis of data from Study D2610C00004.

Data were available from 33 patient"
NCT00979147,TERMINATED,INTERVENTIONAL,PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed
NCT00979186,WITHDRAWN,INTERVENTIONAL,"Study Terminated - No enrollment, business decision."
NCT00979485,TERMINATED,OBSERVATIONAL,initial results suggest no significant trends will be observed with completion of study
NCT00979550,TERMINATED,INTERVENTIONAL,Failure to enroll enough participants
NCT00979641,TERMINATED,INTERVENTIONAL,Participants are no longer being examined. The results are published 2016 Anticancer Research 36: 6431-6438
NCT00979667,TERMINATED,INTERVENTIONAL,Decreased Influenza activity; thus decrease/no eligible patient to recruit
NCT00979693,WITHDRAWN,INTERVENTIONAL,"The study was suspended because the PI was unable to get permission from his department to submit the protocol to the local IRB?"""
NCT00979771,WITHDRAWN,INTERVENTIONAL,Cancelled Before Active
NCT00979836,SUSPENDED,INTERVENTIONAL,The financial support was withdrawn.
NCT00979940,TERMINATED,INTERVENTIONAL,Slower than anticipated enrollment for pilot study.
NCT00980031,TERMINATED,INTERVENTIONAL,Funding ended prior to study completion
NCT00980551,WITHDRAWN,INTERVENTIONAL,No enrollment and competing studies
NCT00980681,TERMINATED,INTERVENTIONAL,Lack of recruitment.
NCT00980993,WITHDRAWN,OBSERVATIONAL,Lack of enrollment.
NCT00981266,WITHDRAWN,INTERVENTIONAL,Business decision. Study never started
NCT00981318,TERMINATED,INTERVENTIONAL,unable to enroll expected number of subjects
NCT00981331,TERMINATED,INTERVENTIONAL,"Investigators and resources are no longer available for completion of the study due to retirements, relocations and reassignments."
NCT00981370,TERMINATED,INTERVENTIONAL,"1 consented patient never started on study drug, lost to follow up"
NCT00981578,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment.
NCT00981591,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT00981747,TERMINATED,INTERVENTIONAL,Funding was withdrawn.
NCT00981773,TERMINATED,INTERVENTIONAL,Recruitment problem
NCT00981799,TERMINATED,INTERVENTIONAL,Slow accrual rate
NCT00981903,TERMINATED,INTERVENTIONAL,Tinzaparin will no longer be available in the United States
NCT00981929,TERMINATED,INTERVENTIONAL,Unexpected non-serious adverse events
NCT00982150,TERMINATED,INTERVENTIONAL,Core study unsuccessful
NCT00982241,WITHDRAWN,INTERVENTIONAL,Difficulty in enrolling participants
NCT00982280,TERMINATED,INTERVENTIONAL,Slow Recruitment and supply of Investigational Medicinal Product Issues
NCT00982293,TERMINATED,INTERVENTIONAL,Difficulty in Recruitment
NCT00982540,TERMINATED,INTERVENTIONAL,Low accrual
NCT00982657,TERMINATED,INTERVENTIONAL,Refer to statement in Summary Section/Detailed Description
NCT00982696,TERMINATED,INTERVENTIONAL,Deemed ineffective
NCT00982787,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT00982813,TERMINATED,INTERVENTIONAL,Difficulties of internal organization
NCT00982852,TERMINATED,OBSERVATIONAL,Lack of funding
NCT00982995,TERMINATED,INTERVENTIONAL,site terminated due to lack of enrollment
NCT00983008,TERMINATED,INTERVENTIONAL,Too few interns willing to consent to wear the actigraph watches.
NCT00983047,TERMINATED,INTERVENTIONAL,The sponsor decide to terminate
NCT00983346,TERMINATED,INTERVENTIONAL,"Lab Staff that was required left the institution, therefore accrual closed prematurely"
NCT00983437,TERMINATED,INTERVENTIONAL,Study has been stopped by sponsor decision
NCT00983502,TERMINATED,OBSERVATIONAL,IRB ended and NIH study ended
NCT00983528,TERMINATED,INTERVENTIONAL,Support withdrawn due to slow accrual
NCT00983541,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00983645,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT00983736,TERMINATED,INTERVENTIONAL,This study was terminated because of recruitment difficulties.
NCT00983762,TERMINATED,OBSERVATIONAL,No continued funding.
NCT00983944,WITHDRAWN,INTERVENTIONAL,Inadequate Accrual
NCT00984087,WITHDRAWN,INTERVENTIONAL,Difficulty with recruitment and therefore funding has been pulled.
NCT00984113,TERMINATED,INTERVENTIONAL,For administrative reasons. Enrollment was sufficient to have statistical power without compromising the integrity of the study data
NCT00984152,WITHDRAWN,INTERVENTIONAL,Decision not to go forth with study.
NCT00984165,TERMINATED,INTERVENTIONAL,"Terminated due to slow accrual, PI left NIH and primary endpoint not met."
NCT00984217,WITHDRAWN,INTERVENTIONAL,Decided not to pursue at UPCI
NCT00984438,WITHDRAWN,INTERVENTIONAL,No accrual
NCT00984490,TERMINATED,INTERVENTIONAL,slow accrual
NCT00984568,TERMINATED,INTERVENTIONAL,Due to slow recruitment the study was stopped prematurely.
NCT00984594,TERMINATED,INTERVENTIONAL,Slow enrolment \& potential regulatory changes for allograft in cartilage repair
NCT00984828,TERMINATED,INTERVENTIONAL,Very slow recruitment
NCT00985010,TERMINATED,OBSERVATIONAL,The authors finished their jobs in the hospitals where the study was begun.
NCT00985140,TERMINATED,OBSERVATIONAL,Competing studies
NCT00985413,TERMINATED,OBSERVATIONAL,The company DNage is in receivership and no longer functional
NCT00985478,TERMINATED,INTERVENTIONAL,Terminated on 14 Sep 2010 due to strategic considerations
NCT00985530,TERMINATED,INTERVENTIONAL,Supporting agency withdrew funding for study.
NCT00985569,WITHDRAWN,OBSERVATIONAL,Enrollment was never begun.
NCT00985621,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00985738,TERMINATED,INTERVENTIONAL,Low recruitment
NCT00985907,TERMINATED,INTERVENTIONAL,Low Accrual
NCT00985946,TERMINATED,INTERVENTIONAL,Study did not meet statistical requirements to continue.
NCT00985998,WITHDRAWN,INTERVENTIONAL,no paticipants enrolled
NCT00986089,WITHDRAWN,OBSERVATIONAL,Principal Investigator left the University of Kentucky before enrollment could begin.
NCT00986115,WITHDRAWN,INTERVENTIONAL,our site was unable to enroll any qualified subjects
NCT00986141,TERMINATED,OBSERVATIONAL,PI left the University
NCT00986193,TERMINATED,INTERVENTIONAL,By recommendation from the Data and safety monitoring board
NCT00986258,TERMINATED,INTERVENTIONAL,"This clinical trial was terminated early, due to slow recruitment and study drug shortages."
NCT00986284,SUSPENDED,INTERVENTIONAL,Lack of patients and some progressed disease soon after surgery
NCT00986440,TERMINATED,INTERVENTIONAL,Due to changes to the standard of care within the proposed market for CS-7017.
NCT00986778,WITHDRAWN,INTERVENTIONAL,Business Objectives Changed
NCT00986856,TERMINATED,INTERVENTIONAL,Enrollment failed
NCT00986960,WITHDRAWN,INTERVENTIONAL,Difficult to recruit due to protocol requirements - participant burden.
NCT00986999,TERMINATED,INTERVENTIONAL,poor enrollment
NCT00987129,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT00987428,TERMINATED,INTERVENTIONAL,Insufficient number of participants
NCT00987545,TERMINATED,INTERVENTIONAL,Negative pharmacodynamics due to lack of Interleukin-13 signature in biomarker data from Part I of the study.
NCT00987662,WITHDRAWN,INTERVENTIONAL,no funding
NCT00987818,WITHDRAWN,INTERVENTIONAL,No MEC approval
NCT00988052,TERMINATED,INTERVENTIONAL,Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose.
NCT00988442,TERMINATED,INTERVENTIONAL,This study was closed to recruitment and follow-up early due to low recruitment.
NCT00988468,TERMINATED,INTERVENTIONAL,Study failed to recruit a sufficient number of subjects in the time anticipated.
NCT00988481,WITHDRAWN,INTERVENTIONAL,Difficulty with enrollment.
NCT00988507,TERMINATED,INTERVENTIONAL,Company decision to modify the ferroquine development strategy; discontinuation not due to safety or activity unexpected findings
NCT00988663,WITHDRAWN,INTERVENTIONAL,PI deceased; study did not start.
NCT00988793,WITHDRAWN,INTERVENTIONAL,Protocol needed major revisions; lack of money to institute changes
NCT00988845,TERMINATED,INTERVENTIONAL,Slow accrual in the high BMI group
NCT00988988,WITHDRAWN,INTERVENTIONAL,Not approved by IRB
NCT00989092,TERMINATED,INTERVENTIONAL,slow enrollment and change in product development strategy
NCT00989274,WITHDRAWN,INTERVENTIONAL,"Late approval by the Secretariat of Health, and expiration of vaccine"
NCT00989339,WITHDRAWN,INTERVENTIONAL,Sub-investigator left facility prior to study initiation
NCT00989820,TERMINATED,INTERVENTIONAL,"Recruitment problems, patients refused to participate"
NCT00989937,TERMINATED,INTERVENTIONAL,Break in funding
NCT00990119,WITHDRAWN,INTERVENTIONAL,Pilot enrollment criteria did not yield intended population.
NCT00990197,SUSPENDED,INTERVENTIONAL,Difficulties with enrollment.
NCT00990366,TERMINATED,INTERVENTIONAL,"Interim analysis results, study terminated 5/2010"
NCT00990392,WITHDRAWN,INTERVENTIONAL,Change of practice to antibiotic impregnated catheters and large study published showing their efficacy. Made topical antibiotics obselete.
NCT00990496,TERMINATED,INTERVENTIONAL,Accrual goals not met
NCT00990509,TERMINATED,INTERVENTIONAL,Enrollment was stopped due to low recruitment and the PI's move to a different institution.
NCT00990522,WITHDRAWN,INTERVENTIONAL,"No participants enrolled, per PI discretion"
NCT00990574,WITHDRAWN,INTERVENTIONAL,device not found to be adequate
NCT00990795,TERMINATED,INTERVENTIONAL,PI left institution.
NCT00990834,WITHDRAWN,INTERVENTIONAL,Unable to recruit subjects.
NCT00990951,SUSPENDED,INTERVENTIONAL,The study was interrupted by recruitment failure.
NCT00991016,TERMINATED,INTERVENTIONAL,"B1411001 was terminated after completion of 4 cohorts of the multiple ascending dose phase, as additional data were deemed unnecessary. No safety concerns."
NCT00991029,TERMINATED,INTERVENTIONAL,The trial was halted by the DSMB.
NCT00991315,TERMINATED,OBSERVATIONAL,Specimens are now collected through the BRS protocol.
NCT00991328,TERMINATED,INTERVENTIONAL,low enrollment
NCT00991510,TERMINATED,INTERVENTIONAL,Slow recruitment and lack of time to product launch
NCT00991601,SUSPENDED,INTERVENTIONAL,New ultra sound technology have made this present study design less relevant and force us to change the design of the study.
NCT00991744,SUSPENDED,INTERVENTIONAL,Sterility problems in DepoCyte production
NCT00991887,TERMINATED,INTERVENTIONAL,there was an unacceptably high adverse event rate in the treatment group.
NCT00991939,TERMINATED,INTERVENTIONAL,The study was closed due to accrual futility there were only a total of 8 subjects enrolled.
NCT00991991,TERMINATED,OBSERVATIONAL,Not enough tissue for analysis
NCT00992030,TERMINATED,INTERVENTIONAL,Low recruitment and difficulty in having study data
NCT00992108,TERMINATED,INTERVENTIONAL,Lack of eligible patients willing and able to participate
NCT00992940,WITHDRAWN,INTERVENTIONAL,Funds needed to carry on the project were not secured.
NCT00992966,SUSPENDED,OBSERVATIONAL,Study initiation has been delayed due to Sponsor decision
NCT00993018,TERMINATED,INTERVENTIONAL,Logistic reasons associated with the FDA-imposed clinical hold.
NCT00993421,TERMINATED,INTERVENTIONAL,Clinical trial terminated due to results from recent nonclinical studies
NCT00993629,WITHDRAWN,INTERVENTIONAL,PI turned down funding.
NCT00993642,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT00993733,WITHDRAWN,INTERVENTIONAL,This study has never been started
NCT00993785,TERMINATED,INTERVENTIONAL,CoStar Stent IDE failed to meet primary endpoint
NCT00993928,TERMINATED,INTERVENTIONAL,Poor accrual
NCT00994058,WITHDRAWN,INTERVENTIONAL,The Investigator has changed institutions.
NCT00994201,TERMINATED,OBSERVATIONAL,Study never accrued sufficient subjects
NCT00994214,TERMINATED,INTERVENTIONAL,Preliminary data from this study does not support expected inhibition of GH and IGF-1
NCT00994240,TERMINATED,INTERVENTIONAL,"slow enrollment, lack of funding"
NCT00994253,WITHDRAWN,INTERVENTIONAL,Due to safety concerns re: the concomitant use of aliskiren with an ACEi or ARB.
NCT00994331,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment.
NCT00994630,SUSPENDED,OBSERVATIONAL,fail to get funding
NCT00994890,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00995384,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT00995449,TERMINATED,INTERVENTIONAL,Program refocus
NCT00995488,TERMINATED,INTERVENTIONAL,Terminated prematurely due to low accrual.
NCT00995501,TERMINATED,INTERVENTIONAL,"Per interim analysis, for futility."
NCT00995514,TERMINATED,OBSERVATIONAL,Administrative reasons
NCT00995540,TERMINATED,INTERVENTIONAL,Preserve clinical supplies
NCT00995566,TERMINATED,OBSERVATIONAL,"The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury."""
NCT00995605,TERMINATED,INTERVENTIONAL,Reached sufficient pharmacokinetic exposures
NCT00995722,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT00996008,TERMINATED,INTERVENTIONAL,"Due to slow recruitment, study was stopped before target enrollment was achieved"
NCT00996346,TERMINATED,INTERVENTIONAL,Original PI left institution and sponsor decided to end support.
NCT00996359,TERMINATED,INTERVENTIONAL,Slow accrual
NCT00996424,TERMINATED,INTERVENTIONAL,Insufficient recruitment.
NCT00996502,TERMINATED,INTERVENTIONAL,Poor enrollment; PI left the institution
NCT00996554,TERMINATED,INTERVENTIONAL,Feasibility reasons; recruitment was too slow.
NCT00996749,WITHDRAWN,INTERVENTIONAL,No Participants enrolled; slow accrual
NCT00996827,TERMINATED,OBSERVATIONAL,Sufficient samples collected when 73% of target enrollment was reached.
NCT00996866,TERMINATED,INTERVENTIONAL,Enable to further recruit study subjects
NCT00996892,TERMINATED,INTERVENTIONAL,A recommended Phase 2 dose and schedule was not identified and the study was terminated before initiation of Stage 2B.
NCT00996918,TERMINATED,INTERVENTIONAL,"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns."
NCT00996944,TERMINATED,INTERVENTIONAL,Because GSK concluded that it was impossible to recruit sufficient participants within a reasonable timeframe.
NCT00997087,TERMINATED,INTERVENTIONAL,Study completed and data was inconclusive.
NCT00997243,TERMINATED,INTERVENTIONAL,Drug no longer being supplied by sponsor
NCT00997490,TERMINATED,INTERVENTIONAL,Clearly identifiable benefits 50% of patients included
NCT00997516,TERMINATED,INTERVENTIONAL,Planned interim analysis showed worse outcomes in experimental group
NCT00997581,WITHDRAWN,INTERVENTIONAL,Colaborator withdrew support.
NCT00997672,TERMINATED,INTERVENTIONAL,Data Monitoring Committee decision on 22nd August 2011 for safety issues
NCT00997828,TERMINATED,INTERVENTIONAL,Problem with recruitment of subjects
NCT00998101,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due issuses related to the science
NCT00998166,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT00998582,TERMINATED,INTERVENTIONAL,Low enrollment
NCT00998608,TERMINATED,INTERVENTIONAL,terminated
NCT00998738,TERMINATED,INTERVENTIONAL,lack of accrual
NCT00998764,TERMINATED,INTERVENTIONAL,"The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns."
NCT00998816,WITHDRAWN,INTERVENTIONAL,No funding
NCT00999245,TERMINATED,INTERVENTIONAL,Inability to meet target enrollment prior to ending of network in March 2011.
NCT00999479,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT00999518,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT00999557,WITHDRAWN,INTERVENTIONAL,Study was never opened
NCT00999856,TERMINATED,INTERVENTIONAL,Two cohorts successfully completed; further cohorts not needed; no safety issue!
NCT00999960,SUSPENDED,INTERVENTIONAL,Decision of sponsor
NCT01000064,TERMINATED,INTERVENTIONAL,unable to meet recruitment goals
NCT01000155,TERMINATED,INTERVENTIONAL,The study terminated early due to slow accrual.
NCT01000181,SUSPENDED,OBSERVATIONAL,Difficulty producing tracer
NCT01000870,TERMINATED,INTERVENTIONAL,Results did not show reason to continue with study
NCT01000896,WITHDRAWN,INTERVENTIONAL,AstraZeneca has discontinued the development of AZD0530. No new AstraZeneca-sponsored clinical studies will be initiated..
NCT01000948,TERMINATED,INTERVENTIONAL,A consequence of the results of the ENTHUSE phase III study program
NCT01001221,TERMINATED,INTERVENTIONAL,Maximum tolerated dose not able to be determined
NCT01001260,TERMINATED,OBSERVATIONAL,Unable to find subjects that met inclusion/exclusion criteria.
NCT01001312,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01001390,TERMINATED,INTERVENTIONAL,The study closed due to poor accrual and difficulty with participant compliance.
NCT01001585,TERMINATED,INTERVENTIONAL,"However, no intervention reduced the risk of major morbidity or 1 yr mortality"
NCT01001598,TERMINATED,INTERVENTIONAL,Study was terminated due to under enrollment
NCT01001637,TERMINATED,INTERVENTIONAL,lack of support
NCT01001715,TERMINATED,INTERVENTIONAL,Business decision due to low subject recruitment and enrollment
NCT01001780,WITHDRAWN,INTERVENTIONAL,Study stopped early due to poor accrual.
NCT01001793,TERMINATED,INTERVENTIONAL,Commercial considerations relating to required device modifications.
NCT01001923,TERMINATED,INTERVENTIONAL,Business decision due to low subject recruitment and enrollment
NCT01002118,TERMINATED,INTERVENTIONAL,Unable to recruit eligible subjects; no data analyzed
NCT01002183,WITHDRAWN,INTERVENTIONAL,Drug combination is no longer pursued
NCT01002209,WITHDRAWN,INTERVENTIONAL,Changes in the organisation
NCT01002287,TERMINATED,INTERVENTIONAL,"Study was terminated for business purposes, not for safety or efficacy reasons."
NCT01002339,TERMINATED,INTERVENTIONAL,Terminated: higher rate of acute rejection in the Cyclosporin A group
NCT01002495,WITHDRAWN,INTERVENTIONAL,The study was never initiated at any sites.
NCT01002534,TERMINATED,INTERVENTIONAL,not yet started
NCT01002625,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01002638,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT01002859,TERMINATED,INTERVENTIONAL,difficulties to include patients
NCT01003002,WITHDRAWN,OBSERVATIONAL,Funding not secured.
NCT01003249,TERMINATED,INTERVENTIONAL,recruitment was going too slowly
NCT01003418,TERMINATED,INTERVENTIONAL,"The study was terminated prematurely for logistic reasons, not related to safety or efficacy of the vaccine."
NCT01003444,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01003626,WITHDRAWN,INTERVENTIONAL,Slow accrual.
NCT01003678,TERMINATED,INTERVENTIONAL,Drug provider withdrew support
NCT01003730,TERMINATED,INTERVENTIONAL,PI has left the UMDNJ but may resume the study in her new place of employment.
NCT01003769,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01003795,WITHDRAWN,OBSERVATIONAL,Not Funded
NCT01003912,WITHDRAWN,INTERVENTIONAL,Patients were consented to screening but none were enrolled and proceeded with transplant.
NCT01003938,TERMINATED,INTERVENTIONAL,due to administrative issue and financial sponsor decision to suspend ovarian cancer studies
NCT01004159,TERMINATED,INTERVENTIONAL,former PI left institute
NCT01004185,TERMINATED,INTERVENTIONAL,Pediatric enrollment very slow.
NCT01004302,TERMINATED,INTERVENTIONAL,"Our Co sources were in a state of advanced decay. That prolonged our surgical procedures, making them inconveniently and perhaps dangerously long (\> 12 hours)"
NCT01004419,WITHDRAWN,INTERVENTIONAL,Support for investigational products has been withdrawn.
NCT01004510,TERMINATED,INTERVENTIONAL,failure to accrue projected number of patients
NCT01004822,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01005095,TERMINATED,INTERVENTIONAL,Interim analysis showed that the odds for proving primary hypothesis are low.
NCT01005147,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01005238,TERMINATED,INTERVENTIONAL,unsufficient patient recruitment
NCT01005316,TERMINATED,OBSERVATIONAL,Inability to meet accrual goals within the funding period.
NCT01005394,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT01005420,WITHDRAWN,INTERVENTIONAL,"No participants were enrolled and was closed in IRB February 24, 2015"
NCT01005459,TERMINATED,INTERVENTIONAL,feasibility /drug availability issues - No study drug sources available
NCT01005511,TERMINATED,INTERVENTIONAL,The population described via ex- and inclusion criteria did not excisit
NCT01005615,TERMINATED,INTERVENTIONAL,Funding expired and we were unable to gain new funding
NCT01005641,WITHDRAWN,INTERVENTIONAL,Study not started for administrative reasons
NCT01005667,WITHDRAWN,INTERVENTIONAL,Lack of funding for the company has resulted in termination of the study.
NCT01005849,TERMINATED,INTERVENTIONAL,because of low rate recruitment and the inability to reach the target expected
NCT01005875,TERMINATED,INTERVENTIONAL,"Sponsor(Bayer)did not wish to continue with study due to slow accrual. Therefore, there is insufficient data and will not be any study results/outcomes."
NCT01005914,TERMINATED,INTERVENTIONAL,Increased rate of bacterial infections
NCT01005979,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01006018,TERMINATED,INTERVENTIONAL,Unanticipated delays due to sterilization/stabilization testing of GLP-1.
NCT01006096,WITHDRAWN,INTERVENTIONAL,IND not obtained
NCT01006148,WITHDRAWN,INTERVENTIONAL,"problems obtaining the investigational agent, Allogenix(TM) Plus"
NCT01006226,WITHDRAWN,INTERVENTIONAL,Withdrawn due to funding issues
NCT01006252,TERMINATED,INTERVENTIONAL,More possibly treatment-related deaths on tasisulam-sodium arm.
NCT01006785,TERMINATED,INTERVENTIONAL,The study was terminated due to difficulty of find eligible subjects
NCT01006902,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT01007006,WITHDRAWN,INTERVENTIONAL,Unable to gain approval from commanding Army and Navy officers to conduct study.
NCT01007084,WITHDRAWN,INTERVENTIONAL,Lack of eligible patient recruits/feasibility considerations.
NCT01007136,TERMINATED,INTERVENTIONAL,Funding limit reached due to slower then anticipated recruitment.
NCT01007214,TERMINATED,INTERVENTIONAL,Not able to meet accrual
NCT01007357,TERMINATED,INTERVENTIONAL,Principal Investigator left institution; did not complete the study
NCT01007422,WITHDRAWN,OBSERVATIONAL,Issues with Hospice
NCT01007461,WITHDRAWN,INTERVENTIONAL,Company decision. Non-safety related
NCT01007474,WITHDRAWN,OBSERVATIONAL,"The One Hospital ClinicalService project involves the provision of services to hospitals, and is not a clinical study. As such, this service offering should not be listed on ClinicalTrials.gov."
NCT01007643,TERMINATED,INTERVENTIONAL,Difficulty in recruitment of study participants in alloted time and funding
NCT01007695,TERMINATED,INTERVENTIONAL,Enrollment was going slowly and needed to be closed.
NCT01007773,WITHDRAWN,INTERVENTIONAL,Study will not be intiated
NCT01007851,TERMINATED,INTERVENTIONAL,Lower than anticipated recruitment
NCT01007929,TERMINATED,INTERVENTIONAL,Future development of AZD1236 is currently under review by the project team and no new studies will be started until this review is completed.
NCT01007981,WITHDRAWN,OBSERVATIONAL,investigator left the institution
NCT01008111,WITHDRAWN,INTERVENTIONAL,study never initiated
NCT01008124,WITHDRAWN,INTERVENTIONAL,Never recruited/started study
NCT01008371,WITHDRAWN,OBSERVATIONAL,No recruitment
NCT01008397,WITHDRAWN,INTERVENTIONAL,Manufacturer unable to produce
NCT01008436,TERMINATED,INTERVENTIONAL,Lack of product due to industrial changes in the manufacturing process altering the final product.
NCT01008449,TERMINATED,INTERVENTIONAL,"New studies were reporting that sutures are beneficial, hindering the possibility of enrollment."
NCT01008514,WITHDRAWN,INTERVENTIONAL,funding issues and Principal Investigator leaving the institution
NCT01008579,WITHDRAWN,OBSERVATIONAL,Redundant with another study
NCT01008592,TERMINATED,OBSERVATIONAL,Mediators of interest were not consistently detectable with the analytical methods employed.
NCT01008709,TERMINATED,INTERVENTIONAL,poor enrollment
NCT01008956,WITHDRAWN,INTERVENTIONAL,Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.
NCT01009203,TERMINATED,INTERVENTIONAL,High patient withdrawal rate
NCT01009294,TERMINATED,INTERVENTIONAL,Terminated early because a similar study with Ataluren exhibited lack of efficacy at the high dose (not due to safety concerns).
NCT01009346,TERMINATED,INTERVENTIONAL,Toxicity
NCT01009502,TERMINATED,INTERVENTIONAL,"Lack of funding, never moved into the phase II portion that was originally planned."
NCT01009515,TERMINATED,INTERVENTIONAL,Low accrual; target accrual not met
NCT01009593,TERMINATED,INTERVENTIONAL,See termination reason in detailed description
NCT01009801,TERMINATED,INTERVENTIONAL,due to slow patient recruitement.
NCT01009866,TERMINATED,INTERVENTIONAL,low accrual
NCT01009879,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled
NCT01009931,TERMINATED,INTERVENTIONAL,Study was terminated early due to lack of experimental medication (supply issues)
NCT01009944,WITHDRAWN,INTERVENTIONAL,Not funded.
NCT01009957,TERMINATED,INTERVENTIONAL,"After primary completition date, experimental drug was no longer available"
NCT01009983,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01009996,WITHDRAWN,OBSERVATIONAL,Funding issues
NCT01010087,TERMINATED,INTERVENTIONAL,Patient population no longer available.
NCT01010256,TERMINATED,OBSERVATIONAL,PI moved institutions
NCT01010334,TERMINATED,INTERVENTIONAL,PI deparature and very low (\<2%) accrual rate.(No results required)
NCT01010373,SUSPENDED,INTERVENTIONAL,The sponsor is currently focusing on different indications
NCT01010464,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01010542,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01010568,TERMINATED,INTERVENTIONAL,Unable to accrue patients due to change in standard CLL therapy
NCT01010594,TERMINATED,INTERVENTIONAL,PI changed job and project was not economically viable and therefor terminated
NCT01010685,WITHDRAWN,INTERVENTIONAL,Specialised equipment required withdrawn from market
NCT01010854,TERMINATED,INTERVENTIONAL,Premature closure for lack of efficacy.
NCT01010958,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01011114,TERMINATED,INTERVENTIONAL,Study was not renewed with the IRB
NCT01011231,TERMINATED,INTERVENTIONAL,low accrual
NCT01011257,WITHDRAWN,INTERVENTIONAL,No funding secured.
NCT01011283,TERMINATED,INTERVENTIONAL,The study was stopped due to insufficient enrollment.
NCT01011439,TERMINATED,INTERVENTIONAL,For the 2 last patients still on treated nominal therapeutic use of the Milciclib was approved at INT Milano.
NCT01011634,TERMINATED,INTERVENTIONAL,7% enrollment. Study terminated after a small number of recruited patients
NCT01011647,TERMINATED,OBSERVATIONAL,Inadequate recruitment
NCT01011686,TERMINATED,INTERVENTIONAL,Few subject enrolled
NCT01011699,TERMINATED,INTERVENTIONAL,Financial problem
NCT01011777,TERMINATED,INTERVENTIONAL,Due to participants withdrawal prior to anticipated end of study.
NCT01011816,TERMINATED,INTERVENTIONAL,Stopped prior to last subject's last extended follow-up visit (78 weeks) due to lack of efficacy at the primary study endpoint (26 weeks)
NCT01011855,WITHDRAWN,INTERVENTIONAL,Study never developed due to a change in business priority.
NCT01011998,WITHDRAWN,INTERVENTIONAL,"Withdrawn due to lack of accrual per Center DSMP, with PI concurrence"
NCT01012128,WITHDRAWN,OBSERVATIONAL,Closed: logistical problems that could not be resolved.
NCT01012297,TERMINATED,INTERVENTIONAL,"The study was targeted to accrue 130 patients, but closed early for futility."
NCT01012362,TERMINATED,INTERVENTIONAL,PI left institution.
NCT01012414,TERMINATED,INTERVENTIONAL,"Futility in enrollment as of May 31, 2011"
NCT01012440,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01012570,TERMINATED,OBSERVATIONAL,not enough patients enrolled
NCT01012726,TERMINATED,INTERVENTIONAL,not enough patients enrolled
NCT01012999,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT01013168,TERMINATED,INTERVENTIONAL,Achievement of feasibility and safety without achievement of clinical response.
NCT01013480,TERMINATED,INTERVENTIONAL,all active subjects rolled into 209FX303/NCT01013480
NCT01013506,WITHDRAWN,INTERVENTIONAL,Study was abandoned before opening to accrual. Replaced by another study.
NCT01013623,TERMINATED,INTERVENTIONAL,"Lack of accrual, lack of continued funding."
NCT01013701,TERMINATED,INTERVENTIONAL,Terminated based on mutual agreement between PI and sponsor (Glaxo Smith Kline)
NCT01013792,TERMINATED,INTERVENTIONAL,Expired study materials; low subject recruitment
NCT01013818,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT01013870,TERMINATED,INTERVENTIONAL,inability to recruit adequate numbers of subjects
NCT01013961,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01014000,WITHDRAWN,INTERVENTIONAL,On reviewing of new data
NCT01014260,WITHDRAWN,INTERVENTIONAL,We could not get funding for study.
NCT01014364,TERMINATED,INTERVENTIONAL,"the H1N1 pandemic is now over, and fewer cases than expected were observed"
NCT01014481,TERMINATED,INTERVENTIONAL,this study was ended prematurely by ethical committees with a reason of the final outcome was achieved with no longer recruitment was needed.
NCT01014546,TERMINATED,INTERVENTIONAL,low accrual
NCT01014559,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01014611,TERMINATED,OBSERVATIONAL,Difficulties of recruitement
NCT01014767,TERMINATED,INTERVENTIONAL,PI departure from coordinating institution
NCT01014858,TERMINATED,INTERVENTIONAL,Due to low recruitment
NCT01014884,TERMINATED,INTERVENTIONAL,Terminated by Sponsor
NCT01015066,WITHDRAWN,INTERVENTIONAL,"Study personnel left institution, anticipated funding did not occur"
NCT01015300,TERMINATED,INTERVENTIONAL,Study terminated due to low accrual.
NCT01015443,TERMINATED,INTERVENTIONAL,The study is terminated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC.
NCT01015456,TERMINATED,INTERVENTIONAL,Data Safety Monitoring Board concerning of the participants' safety
NCT01015495,WITHDRAWN,INTERVENTIONAL,Not enough patients within the time frame to allow for a meaningful study.
NCT01015521,WITHDRAWN,INTERVENTIONAL,Study was not initiated as planned
NCT01016028,WITHDRAWN,OBSERVATIONAL,Study assessment tool development delayed.
NCT01016054,TERMINATED,INTERVENTIONAL,Trial was terminated to allow sponsors to evaluate the future development of the drug program
NCT01016067,TERMINATED,INTERVENTIONAL,Difficulty in patient recruitment
NCT01016262,TERMINATED,INTERVENTIONAL,"The decision was taken solely for business/administrative reasons, no safety considerations entered into this. Ongoing randomized patients to complete."
NCT01016314,WITHDRAWN,INTERVENTIONAL,Protocol amended to NCT01549366 and participants rolled into study
NCT01016327,TERMINATED,INTERVENTIONAL,Discontinuation of clinical investigation with NMS-1116354
NCT01016340,TERMINATED,INTERVENTIONAL,no safety issues
NCT01016561,TERMINATED,INTERVENTIONAL,Poor accrual/enrollments
NCT01016717,WITHDRAWN,INTERVENTIONAL,Since the published data resolved the study goals we decided not to start it
NCT01016795,TERMINATED,INTERVENTIONAL,"Study closed Nov 2000 by Amgen, who stopped drug delivery"
NCT01016847,TERMINATED,INTERVENTIONAL,Unable to enroll enough study subjects. Study has been terminated
NCT01016860,TERMINATED,INTERVENTIONAL,This study was discontinued due to a shown lack of efficacy in the investigational agent
NCT01016951,TERMINATED,INTERVENTIONAL,Study stopped since it was considered that one of the pre-defined stopping criterion was met.
NCT01017237,TERMINATED,INTERVENTIONAL,Protocol proved to be ineffective for adequate sedation for third molar surgery.
NCT01017263,TERMINATED,INTERVENTIONAL,"Due very high screen fail rate, pre study feasibility not consistent with screened population."
NCT01017601,TERMINATED,INTERVENTIONAL,Interim analysis declared futility.
NCT01017653,TERMINATED,INTERVENTIONAL,study did not reach benchmark efficacy rule at 16 subjects
NCT01017809,WITHDRAWN,INTERVENTIONAL,NYU 03-67 reached accrual prior to this study opening.
NCT01017822,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to study agent availability.
NCT01017887,WITHDRAWN,OBSERVATIONAL,Unable to recruit any subjects
NCT01017965,TERMINATED,OBSERVATIONAL,intermediary analysis was performed and significant results were found for the main objective
NCT01017991,TERMINATED,INTERVENTIONAL,The study has been terminated as a result of low enrollment.
NCT01018069,TERMINATED,INTERVENTIONAL,Failed to reach endpoints
NCT01018199,WITHDRAWN,INTERVENTIONAL,Changes in the profile of patients assisted by the hospital
NCT01018225,WITHDRAWN,INTERVENTIONAL,Study was cancelled due to lack of enrollment
NCT01018238,WITHDRAWN,INTERVENTIONAL,See detailed description
NCT01018290,TERMINATED,OBSERVATIONAL,Recruitment goals not met
NCT01018355,TERMINATED,INTERVENTIONAL,Dissatisfactory enrollment rate
NCT01018563,TERMINATED,INTERVENTIONAL,Study was terminated by sponsor due to futile results in NCT00849667 study.
NCT01018576,TERMINATED,INTERVENTIONAL,Inadequate numbers of babies enrolled and departure of co-investigator
NCT01018810,TERMINATED,INTERVENTIONAL,"The trial was terminated for several reasons, including complexities in development of LY2525623, but not because of safety concerns"
NCT01018836,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01018927,TERMINATED,OBSERVATIONAL,PI does not have time to continue study
NCT01018953,TERMINATED,INTERVENTIONAL,Preliminary data from study NCT00994214 do not support expected inhibition of GH and IGF-1
NCT01019564,WITHDRAWN,INTERVENTIONAL,Business decision
NCT01019681,TERMINATED,INTERVENTIONAL,Only patient enrolled on study died -the cause of death not study related
NCT01019707,TERMINATED,INTERVENTIONAL,End in funding
NCT01019980,TERMINATED,INTERVENTIONAL,Placebo - Active Drug Not Available. No patients received drug. There are no study results to disclose.
NCT01020305,TERMINATED,INTERVENTIONAL,Decision by funding sponsor due to poor accrual
NCT01020461,TERMINATED,INTERVENTIONAL,"Arm ""placement periph iv cath"" COMPLETED - Arm ""blood sampling"" : study will not be performed because of the results of the arm ""placement periph. iv cath"""
NCT01020513,WITHDRAWN,OBSERVATIONAL,This study was closed before accrual due to FDA recall of Medication
NCT01020812,TERMINATED,INTERVENTIONAL,enrollment was too low
NCT01021202,TERMINATED,INTERVENTIONAL,unexpectedly slow recruitment
NCT01021423,TERMINATED,INTERVENTIONAL,Terminated by sponsor due to new unpublished data that rendered the current design of the study no longer clinically relevant. There were no safety concerns.
NCT01021917,TERMINATED,OBSERVATIONAL,"Given the length of time data was collected (i.e. 5 1/3 years), we do not anticipate a change any potential conclusions by completing the final survey."
NCT01021956,TERMINATED,INTERVENTIONAL,Retinal vascular occlusion in 2 patients
NCT01022398,TERMINATED,INTERVENTIONAL,"Recruitment slow, funding ended."
NCT01022606,TERMINATED,INTERVENTIONAL,Stopped for one complication event (arterial occlusion)
NCT01022710,WITHDRAWN,OBSERVATIONAL,We did not enroll any subjects because we realized we needed to establish the technique more definitively before proceeding to human testing.
NCT01022983,WITHDRAWN,INTERVENTIONAL,Not finding patients for including
NCT01023191,WITHDRAWN,INTERVENTIONAL,Did not pass set-up phase
NCT01023269,TERMINATED,INTERVENTIONAL,difficulty in the enrolment
NCT01023412,TERMINATED,INTERVENTIONAL,interim review of the data indicated that the hypothesis put forth on the efficacy of a 3 day regimen was not met.
NCT01023438,TERMINATED,INTERVENTIONAL,Up to sponsor decision
NCT01023503,WITHDRAWN,OBSERVATIONAL,"Changes affecting Post Authorization Study Regulatory effective from Dec09, impacted the requirements for Spanish studies at National and Regional level."
NCT01023568,TERMINATED,INTERVENTIONAL,The study was stopped for futility at the first interim analysis
NCT01023854,TERMINATED,INTERVENTIONAL,No more potentiel patients for study
NCT01023984,WITHDRAWN,INTERVENTIONAL,scarce interest of centres
NCT01024244,TERMINATED,INTERVENTIONAL,Terminated due to nonclinical safety findings
NCT01024322,TERMINATED,OBSERVATIONAL,Terminated to initiate FDA IND-cleared study protocol
NCT01024842,TERMINATED,INTERVENTIONAL,Slow recruitment therefore study was stopped after 95% volunteers were enrolled.
NCT01025180,TERMINATED,INTERVENTIONAL,65 patients were included after 2 years instead of 140
NCT01025193,TERMINATED,INTERVENTIONAL,has not demonstrated efficacy in primary goal
NCT01025232,TERMINATED,INTERVENTIONAL,The last remaining subject withdrew consent because the collaborator Genentech stopped supplying study drug.
NCT01025271,TERMINATED,INTERVENTIONAL,unable to enroll subjects study stopped due to lack of enrollment
NCT01025310,WITHDRAWN,OBSERVATIONAL,Administartive and technical problems
NCT01025323,TERMINATED,INTERVENTIONAL,"The study was terminated due to difficult recruitment and retention of subjects, these were attributed by subjects to conflict with their job schedule."
NCT01025401,TERMINATED,INTERVENTIONAL,departure of a collaborator in charge of the data collection
NCT01025492,TERMINATED,INTERVENTIONAL,Collaborator/corporate sponsor withdrew funding and permission to continue.
NCT01025570,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT01025648,TERMINATED,INTERVENTIONAL,Optimization of protocol
NCT01025713,WITHDRAWN,INTERVENTIONAL,Development program terminated.
NCT01025739,WITHDRAWN,INTERVENTIONAL,No funding source for device purchasing
NCT01025869,TERMINATED,INTERVENTIONAL,Terminated following completion of 2 year time point: Sponsor decision
NCT01025882,TERMINATED,INTERVENTIONAL,DSMC closed due to patient deaths
NCT01026025,WITHDRAWN,INTERVENTIONAL,Sponsor is no longer pursuing this study
NCT01026051,TERMINATED,INTERVENTIONAL,Financial/Business Reasons
NCT01026090,TERMINATED,INTERVENTIONAL,"'Sponsor decision following recruitment issues, not related to any safety concerns in the study"
NCT01026207,TERMINATED,OBSERVATIONAL,the data was completed.
NCT01026324,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01026363,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT01026441,TERMINATED,INTERVENTIONAL,Product was not developed and study was cancelled
NCT01026480,TERMINATED,OBSERVATIONAL,Researchers leading this study have left BMC
NCT01026727,TERMINATED,INTERVENTIONAL,For strategic buisness reasons.
NCT01026844,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01026909,TERMINATED,INTERVENTIONAL,low recruitment
NCT01026961,WITHDRAWN,INTERVENTIONAL,Study is no longer required by Brazil health authority.
NCT01027078,TERMINATED,OBSERVATIONAL,Due to insufficient grant funding
NCT01027234,TERMINATED,INTERVENTIONAL,Pre-Clinical Safety Tox Findings
NCT01027520,TERMINATED,INTERVENTIONAL,Insufficient enrollment numbers
NCT01027702,TERMINATED,INTERVENTIONAL,"Sponsor/ PI leaving institution, no plans to continue this research at this time"
NCT01027806,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01027923,TERMINATED,INTERVENTIONAL,Withdrawal of support from sponsor
NCT01028105,TERMINATED,INTERVENTIONAL,"Enrollment did not reach power, therefore study was administratively closed in 2013"
NCT01028300,TERMINATED,INTERVENTIONAL,Terminated due to enrollment failure
NCT01028313,WITHDRAWN,INTERVENTIONAL,A decision was made to not move forward with the study. No participants were enrolled or treated.
NCT01028339,TERMINATED,INTERVENTIONAL,No patients enrolled during 2 years
NCT01028586,TERMINATED,INTERVENTIONAL,Trial is terminated due to a company decision to return all rights for Safinamide back to Newron Pharmaceuticals
NCT01028612,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01028716,TERMINATED,INTERVENTIONAL,The study experienced lower accrual rates after the onset of COVID. Upon review of the collected data it was deemed that an adequate amount of subjects has been enrolled to date to assess study aims.
NCT01028781,TERMINATED,INTERVENTIONAL,Difficulty finding eligible participants and lack of funding.
NCT01028911,TERMINATED,INTERVENTIONAL,This study terminated 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.
NCT01028937,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01029106,TERMINATED,OBSERVATIONAL,Study design required a change in device
NCT01029184,TERMINATED,INTERVENTIONAL,difficult to enrol and as a pilot study sample size was not powered anyway
NCT01029418,TERMINATED,INTERVENTIONAL,The phase II portion was not conducted due to funding issue.
NCT01029444,TERMINATED,INTERVENTIONAL,Administrative
NCT01029509,TERMINATED,INTERVENTIONAL,Colloborator-Sponsor decision to terminate.
NCT01029639,WITHDRAWN,INTERVENTIONAL,Administrative
NCT01029795,TERMINATED,INTERVENTIONAL,Terminated due to nonclinical safety findings
NCT01029925,TERMINATED,INTERVENTIONAL,"DSMB determined, due to higher than expected risk/safety concerns, study should be closed."
NCT01029977,WITHDRAWN,OBSERVATIONAL,Re-definition of MIRA technology goals.
NCT01030120,WITHDRAWN,INTERVENTIONAL,Unable to complete agreement with sponsor
NCT01030198,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01030263,TERMINATED,INTERVENTIONAL,The investigators left the institution.
NCT01030328,TERMINATED,INTERVENTIONAL,Lack of patient population
NCT01030471,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT01030666,TERMINATED,INTERVENTIONAL,shelf life of investigational drug ran out before 90 patients could be included
NCT01030744,WITHDRAWN,OBSERVATIONAL,This is quality improvement review and should not have been registered. No participants were enrolled
NCT01030757,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT01031056,WITHDRAWN,OBSERVATIONAL,Change in research focus
NCT01031212,WITHDRAWN,INTERVENTIONAL,The investigator has left the institution (UCSF) prior to study start-up
NCT01031329,WITHDRAWN,OBSERVATIONAL,Key aspects linked to sample management and analysis were not met during feasibility assessment limiting the ability of the study to reach its objectives.
NCT01031342,TERMINATED,INTERVENTIONAL,Change in ER rules (no longer allowed endoscopies in ER) prevented ability to perform study according to protocol
NCT01031537,TERMINATED,INTERVENTIONAL,Manufacturer discontinued support of the study
NCT01031550,TERMINATED,INTERVENTIONAL,We no longer had an appropriate patient population.Study closed
NCT01031628,TERMINATED,INTERVENTIONAL,Lack of feasibility secondary to slow accrual
NCT01031810,TERMINATED,INTERVENTIONAL,Needed PET facility closed
NCT01031849,TERMINATED,INTERVENTIONAL,patient sample not reached
NCT01031940,TERMINATED,INTERVENTIONAL,Insufficient Recruitment. Findings of concurrent study in low risk population not supportive of hypotheses in this study.
NCT01031953,TERMINATED,INTERVENTIONAL,Drug contract timelines and inadequate enrollment
NCT01032070,TERMINATED,INTERVENTIONAL,"In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety concerns. As a result, it has been stopped."
NCT01032122,TERMINATED,INTERVENTIONAL,"the only reason is that recruitment was not sufficient to meet the planned patient numbers, because complete remissions are still infrequent."
NCT01032148,TERMINATED,INTERVENTIONAL,lack of funding
NCT01032226,TERMINATED,OBSERVATIONAL,Difficulty to include more patients
NCT01032291,TERMINATED,INTERVENTIONAL,A business decision not to continue with Phase 2b based on non-safety observations during proof of concept phase.
NCT01032512,WITHDRAWN,INTERVENTIONAL,impossibility to include patients in the study
NCT01032590,WITHDRAWN,INTERVENTIONAL,"Trial was only opened at RCINJ for analysis of data, no patient enrollment took place here."
NCT01032694,TERMINATED,OBSERVATIONAL,"This study was terminated January 11, 2011 due to low enrollment. This study is not being terminated because of safety or efficacy concerns."
NCT01032837,TERMINATED,INTERVENTIONAL,Study closed prematurely due to the end of the influenza (H1N1) 2009 pandemic
NCT01032850,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT01032915,TERMINATED,INTERVENTIONAL,Results of a planned interim analysis did not show significant effects for any of the 3 AIN dose regimens versus placebo on any primary or secondary endpoint
NCT01033019,TERMINATED,INTERVENTIONAL,The data from participants with sBCCs showed insufficient efficacy with current formulation and treatment conditions.
NCT01033227,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01033357,TERMINATED,INTERVENTIONAL,Imbalance in the # graft infections between the tx's (graft vs. graft + wrap)
NCT01033370,TERMINATED,INTERVENTIONAL,Project lacked funding.
NCT01033474,WITHDRAWN,OBSERVATIONAL,NW Center for Reproductive Sciences was sold and is no longer open
NCT01033500,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT01033565,TERMINATED,INTERVENTIONAL,Unsuccessful in recruiting appropriate subjects.
NCT01033955,TERMINATED,INTERVENTIONAL,H1N1 pandemic concluded in early 2010
NCT01033981,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01034514,TERMINATED,INTERVENTIONAL,business decision
NCT01034566,WITHDRAWN,INTERVENTIONAL,Failure to accrue
NCT01034592,TERMINATED,INTERVENTIONAL,Poor accrual related to rarity of Diamond-Blackfan anemia (DBA)
NCT01034657,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy of single agent LBH589 in the 4 month open label core phase and due to enrollment difficulties.
NCT01034813,TERMINATED,OBSERVATIONAL,New PI discovered that some of previously collected data may not be accurate
NCT01035177,TERMINATED,OBSERVATIONAL,"Difficulties of recruitment, lack of elligible patients"
NCT01035216,TERMINATED,INTERVENTIONAL,This study has been terminated.
NCT01035255,TERMINATED,INTERVENTIONAL,Early termination was approved due to compelling efficacy of LCZ696 in patients with HF \& reduced EF after final pre-specified interim analysis 28-Mar-2014.
NCT01035268,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT01035437,WITHDRAWN,INTERVENTIONAL,no accrual
NCT01035593,WITHDRAWN,INTERVENTIONAL,Recent improvements in clinical practice have reduced the apparent incidence of AMR in renal transplantation.
NCT01035658,TERMINATED,INTERVENTIONAL,"Based on analyses in Phase I, the study did not advance to Phase II."
NCT01035801,TERMINATED,INTERVENTIONAL,This study was temporarily paused due to an unanticipated bioanalytical issue.
NCT01035944,TERMINATED,INTERVENTIONAL,Unable to meet enrollment milestones
NCT01036113,TERMINATED,INTERVENTIONAL,Program suspended and divested
NCT01036399,TERMINATED,INTERVENTIONAL,The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)
NCT01036529,TERMINATED,INTERVENTIONAL,Closed due to continued slow enrollment.
NCT01036724,TERMINATED,OBSERVATIONAL,Enrollment challenges
NCT01036802,TERMINATED,INTERVENTIONAL,Difficulty in accruing subjects
NCT01037296,TERMINATED,INTERVENTIONAL,Based on interim analysis study felt unlikely to reach the primary aim
NCT01037335,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01037400,WITHDRAWN,OBSERVATIONAL,No patients recruited
NCT01037712,TERMINATED,INTERVENTIONAL,not enough inclusion
NCT01037764,TERMINATED,INTERVENTIONAL,"The PI resigned the institute, and the rest investigators at the institute decided to terminate the study."
NCT01037907,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01037959,TERMINATED,INTERVENTIONAL,lack of recruitement
NCT01038037,TERMINATED,INTERVENTIONAL,"1. Very low enrollment rate.
2. Recent studies question the effect of adding panitumumab in this category of patients.
3. Too high toxicity rate"
NCT01038141,TERMINATED,INTERVENTIONAL,Due to lack of time.
NCT01038505,WITHDRAWN,INTERVENTIONAL,Lost funding source
NCT01038531,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01038739,TERMINATED,INTERVENTIONAL,Stopped due to futility.
NCT01038856,TERMINATED,INTERVENTIONAL,The study was terminated by the sponsor
NCT01039038,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01039129,WITHDRAWN,INTERVENTIONAL,unable to recruit participants
NCT01039311,TERMINATED,OBSERVATIONAL,Unable to enroll subjects
NCT01039350,TERMINATED,INTERVENTIONAL,It was stopped due to a lack of recruitment after 48 patients included
NCT01039376,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01039545,TERMINATED,INTERVENTIONAL,New power calculation (reduction of necessary patient number)
NCT01039610,WITHDRAWN,INTERVENTIONAL,Internal decision to progress alternate molecule with more preferable profile
NCT01039844,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT01039857,TERMINATED,INTERVENTIONAL,Project end after 3 years; prolongation was rejected
NCT01039909,WITHDRAWN,INTERVENTIONAL,Subjects were never screened/enrolled
NCT01040039,TERMINATED,OBSERVATIONAL,Investigator left Rockefeller University
NCT01040208,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor for administrative reasons prior to completion
NCT01040247,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT01040338,TERMINATED,OBSERVATIONAL,Issues \& unreliability with \[11C\]Carfentanil production
NCT01040455,TERMINATED,INTERVENTIONAL,failure to recruit enough patients
NCT01040650,TERMINATED,OBSERVATIONAL,Principal Investigator left institution
NCT01041027,TERMINATED,INTERVENTIONAL,Due to slow accrual. Results from the PORTEC3 the study rendered the hypothesis no longer valid.
NCT01041391,TERMINATED,OBSERVATIONAL,Slow/low enrollment
NCT01041495,TERMINATED,INTERVENTIONAL,ran out of funding short of enrollment expected
NCT01041534,WITHDRAWN,OBSERVATIONAL,This study did not enroll any participants
NCT01041781,TERMINATED,INTERVENTIONAL,DSMB recommendation
NCT01042028,TERMINATED,INTERVENTIONAL,Emergence of FOLFIRINOX and slow recruitment
NCT01042067,SUSPENDED,OBSERVATIONAL,Enrolling participants has halted due to lack of investigator.
NCT01042366,TERMINATED,INTERVENTIONAL,Closed to accrual in March 2009 for slow accrual.
NCT01042574,WITHDRAWN,INTERVENTIONAL,Unable to secure funding
NCT01042678,TERMINATED,INTERVENTIONAL,The study was terminated due to a company decision.
NCT01042795,TERMINATED,INTERVENTIONAL,Study closed due to poor accrual
NCT01042912,WITHDRAWN,OBSERVATIONAL,PI left inistitution
NCT01043211,WITHDRAWN,INTERVENTIONAL,Did not have the research staff necessary to follow through with this study.
NCT01043406,TERMINATED,INTERVENTIONAL,Sponsor restructuring.
NCT01043549,TERMINATED,INTERVENTIONAL,lake of efficacy
NCT01043601,WITHDRAWN,INTERVENTIONAL,"Similar data obtained in another study \[see NCT01085045\], therefore study not implemented."
NCT01043757,WITHDRAWN,INTERVENTIONAL,The study was stopped prior to recruitment due to logistical issues with the company in which it was going to be run.
NCT01043848,WITHDRAWN,INTERVENTIONAL,"Poor patient recruitment, necessary number of patients could not be included within the required time frame"
NCT01043952,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT01044108,TERMINATED,INTERVENTIONAL,See detailed description
NCT01044134,TERMINATED,INTERVENTIONAL,"We achieved n=38, due to slow recruitment (=2/3 of target)."
NCT01044225,TERMINATED,INTERVENTIONAL,Results of the phase III RTOG0525 trial made the manufacturer of cilengitide decide to end their support to the trial
NCT01044368,SUSPENDED,INTERVENTIONAL,To focus on a similar study NCT01175408 prior to recruiting participants.
NCT01044394,WITHDRAWN,INTERVENTIONAL,A phase III RCT was published showing this approach is effective
NCT01044589,TERMINATED,INTERVENTIONAL,The study was stopped due to low enrollment
NCT01044667,TERMINATED,INTERVENTIONAL,poor enrollment and lack of study staff
NCT01044745,TERMINATED,INTERVENTIONAL,Study was closed to accrual for safety related to the frequency of BK infections.
NCT01044966,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of adequate patient enrollment into trial.
NCT01045044,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT01045174,TERMINATED,INTERVENTIONAL,change in availability of study investigators
NCT01045226,TERMINATED,INTERVENTIONAL,participants are no longer being followed up.
NCT01045382,TERMINATED,INTERVENTIONAL,recruitment too slow
NCT01045486,WITHDRAWN,INTERVENTIONAL,failed to enroll patients
NCT01045512,TERMINATED,INTERVENTIONAL,unsufficient recruitment
NCT01045564,WITHDRAWN,INTERVENTIONAL,Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.
NCT01045694,TERMINATED,INTERVENTIONAL,Unable to acquire additional funding needed to continue this study.
NCT01045759,TERMINATED,OBSERVATIONAL,Investigator left the institution
NCT01045798,TERMINATED,INTERVENTIONAL,Low participant enrollment: 15 enrolled of 114 planned
NCT01045811,WITHDRAWN,INTERVENTIONAL,No participants were recruited at this study site. Study has been conducted and monitored with ClinicalTrials.gov ID: NCT01044563.
NCT01045863,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01045876,WITHDRAWN,INTERVENTIONAL,Lack of resources
NCT01045915,TERMINATED,INTERVENTIONAL,The study has been halted due to the low enrolment rate.
NCT01045928,TERMINATED,INTERVENTIONAL,"Extreme toxicity in Phase I, study did not proceed to Phase II"
NCT01045941,WITHDRAWN,INTERVENTIONAL,The study was never initiated
NCT01046097,TERMINATED,OBSERVATIONAL,Local authorities no longer require routine PMS studies;GSK does not believe the study would add meaningfully to the safety data already available for Synflorix
NCT01046149,WITHDRAWN,INTERVENTIONAL,No participants were recruited at this study site. Study has been conducted and monitored at ClinicalTrials.gov ID: NCT01044563.
NCT01046175,WITHDRAWN,INTERVENTIONAL,Lack of patients. Investigator changed job.
NCT01046201,WITHDRAWN,OBSERVATIONAL,To revise protocol for a more concise inclusion/exclusion criteria
NCT01046214,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT01046279,TERMINATED,OBSERVATIONAL,"Problems with enrollement of patients, less patients than expected"
NCT01046383,TERMINATED,INTERVENTIONAL,Slower than anticipated recruitment
NCT01046773,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01047007,TERMINATED,INTERVENTIONAL,The study has been terminated due to business reasons.
NCT01047137,WITHDRAWN,INTERVENTIONAL,No patients enrolled. A pilot study variation of this study was done instead.
NCT01047319,TERMINATED,INTERVENTIONAL,Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose
NCT01047774,TERMINATED,INTERVENTIONAL,Difficulty with recruitment - few eligible for enrolment.
NCT01048060,TERMINATED,OBSERVATIONAL,Business Decision
NCT01048086,WITHDRAWN,INTERVENTIONAL,No patients were enrolled because the company that pledged the drug does not yet have it available.
NCT01048125,TERMINATED,INTERVENTIONAL,Due to difficulty in recruitment and resource restraints
NCT01048138,TERMINATED,INTERVENTIONAL,"Recruitment and funding issues, together with the event of the SARS-CoV-2 pandemic prompted an adjustment in the study design to stop enrollment at 123 patients."
NCT01048177,WITHDRAWN,INTERVENTIONAL,This trial was never started
NCT01048229,TERMINATED,INTERVENTIONAL,recruitment
NCT01048385,TERMINATED,INTERVENTIONAL,A new study had shown that polar body biopsies might negatively effect the implantation potential of the embryo.
NCT01048567,TERMINATED,INTERVENTIONAL,Insufficient resources to meet enrollment target
NCT01048593,TERMINATED,INTERVENTIONAL,Study was terminated in order to examine study data.
NCT01048723,TERMINATED,INTERVENTIONAL,Novartis terminated funding
NCT01048983,WITHDRAWN,INTERVENTIONAL,No accrual.
NCT01048996,WITHDRAWN,OBSERVATIONAL,PI has left institution
NCT01049113,TERMINATED,INTERVENTIONAL,Lack of available clinical drug supply
NCT01049178,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01049204,TERMINATED,INTERVENTIONAL,"The data from the first 48 patients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives."
NCT01049217,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01049776,TERMINATED,INTERVENTIONAL,Study was terminated due to positive results seen in statistical analysis. Adequate patient enrollment was achieved.
NCT01049919,TERMINATED,INTERVENTIONAL,"Primary endpoint not met, remaining long-term follow-up not needed."
NCT01049932,TERMINATED,INTERVENTIONAL,Trial closed due to additional safety information.
NCT01050075,TERMINATED,INTERVENTIONAL,Unable to recruit patients in the 6 month extension allowed.
NCT01050192,WITHDRAWN,OBSERVATIONAL,Lack of enrollment
NCT01050218,TERMINATED,INTERVENTIONAL,Business reasons
NCT01050244,TERMINATED,INTERVENTIONAL,Funding ran out_difficulties with study product (delays in authorization).
NCT01050426,TERMINATED,INTERVENTIONAL,Data from other trials failed to demonstrate meaningful survival advantage
NCT01050439,TERMINATED,INTERVENTIONAL,PI left the institution
NCT01050491,TERMINATED,INTERVENTIONAL,sitaxentan is not commercialized anymore
NCT01050712,TERMINATED,INTERVENTIONAL,"According to retired PI, resident graduated and next resident never carried it to fruition."
NCT01050725,SUSPENDED,OBSERVATIONAL,On hold: pending grant funding for further enrollment
NCT01050764,TERMINATED,INTERVENTIONAL,Safety
NCT01050933,TERMINATED,INTERVENTIONAL,resident left and no one to take over
NCT01050946,TERMINATED,INTERVENTIONAL,Only one patient was enrolled. Due to low accrual study was terminated
NCT01051011,TERMINATED,INTERVENTIONAL,high discontinuation rates mainly due to GI tolerability and implementation of risk mitigation plan to address hypersensitivity reactions
NCT01051128,WITHDRAWN,INTERVENTIONAL,Study was never started. Full IDE-approval not obtained. new IDE will be submitted
NCT01051180,TERMINATED,OBSERVATIONAL,Doppler device company wanted hospital to stop recruiting
NCT01051297,TERMINATED,OBSERVATIONAL,Investigator left the institution
NCT01051401,TERMINATED,INTERVENTIONAL,slow accrual
NCT01051427,TERMINATED,INTERVENTIONAL,Now we use better procedures for the patient instead of nasal catheter for epistaxis. So it would be unethical to use the nasal catheter to complete the trial.
NCT01051440,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01051544,WITHDRAWN,INTERVENTIONAL,complete per PI
NCT01051856,TERMINATED,INTERVENTIONAL,The trial closed early due to poor accrual.
NCT01051947,WITHDRAWN,INTERVENTIONAL,Similar study already published
NCT01052259,TERMINATED,INTERVENTIONAL,Insufficient patient enrollment
NCT01052311,TERMINATED,INTERVENTIONAL,The sponsor decided to withdraw study drug from market
NCT01052363,WITHDRAWN,INTERVENTIONAL,No funding
NCT01052766,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01052896,WITHDRAWN,INTERVENTIONAL,Unable to recruit subjects - unworkable
NCT01053052,WITHDRAWN,INTERVENTIONAL,Study cancelled without recruitment
NCT01053117,TERMINATED,INTERVENTIONAL,Unable to enrol patients
NCT01053221,TERMINATED,INTERVENTIONAL,Funding loss
NCT01053507,TERMINATED,INTERVENTIONAL,Enrollment rate was slower than anticipated.
NCT01053546,TERMINATED,INTERVENTIONAL,slow accrual
NCT01053663,TERMINATED,INTERVENTIONAL,The study was terminated prematurely after three influenza seasons.
NCT01053702,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01053884,TERMINATED,INTERVENTIONAL,"reduced recruitment rate due to non infectious, but competitive trials at our institution"
NCT01053923,WITHDRAWN,OBSERVATIONAL,Patient eligibility has limited accrual and patient sample has changed with the change in referral patients.
NCT01053975,TERMINATED,OBSERVATIONAL,"Based on analyses of studies separately of the SCORE study, sponsor has decided to discontinue the Study. Data collected during the study will not be analyzed"
NCT01054404,TERMINATED,INTERVENTIONAL,Concern for volume depletion and electrolyte abnormalities in furosemide arm.
NCT01054443,TERMINATED,INTERVENTIONAL,This study was terminated before the planned sample size was enrolled because results indicated that a higher dose was necessary to elicit an efficacy effect.
NCT01054534,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding
NCT01054612,WITHDRAWN,OBSERVATIONAL,The study was closed due to the departure of several of the co-investigators.
NCT01054703,TERMINATED,INTERVENTIONAL,Interim assessment performed after 14 patients provided evidence that further enrollment was not required to achieve intended endpoints of the study.
NCT01054911,TERMINATED,INTERVENTIONAL,poor accrual
NCT01055028,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01055067,TERMINATED,INTERVENTIONAL,The study was terminated early for futility according to the stopping rule of the Simon 2-stage design.
NCT01055275,TERMINATED,OBSERVATIONAL,Terminated due to low enrollment.
NCT01055301,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT01055574,TERMINATED,OBSERVATIONAL,Unanticipated study design flaw; PCO evaluator interrater reliability was not performed.
NCT01055600,WITHDRAWN,INTERVENTIONAL,"Protocol opened to recruitment in Nov 2009. No potential subjects identified in 5 years; therefore, study was terminated in Jul 2014 due to lack of feasibility"
NCT01055678,WITHDRAWN,INTERVENTIONAL,PI left Duke
NCT01056315,TERMINATED,INTERVENTIONAL,Trial was stopped due to difficult enrolment
NCT01056380,TERMINATED,INTERVENTIONAL,"Insufficient enrollment during 2009-2010 flu season, new study initiated."
NCT01056601,TERMINATED,INTERVENTIONAL,Funding not available
NCT01056757,TERMINATED,INTERVENTIONAL,Study closed because of new overlapping study with ribavirin.
NCT01056809,TERMINATED,INTERVENTIONAL,Too slow recruitment
NCT01057017,TERMINATED,INTERVENTIONAL,possible lack of efficacy
NCT01057212,TERMINATED,INTERVENTIONAL,Lack of support from pharmaceutical collaborator.
NCT01057277,TERMINATED,INTERVENTIONAL,Pharmaceutical co- re aligned their specialties- no longer will fund H\&N ca
NCT01057355,WITHDRAWN,INTERVENTIONAL,slow accural
NCT01057394,TERMINATED,INTERVENTIONAL,Sponsor stopped study for business reasons; not for clinical or clinical outcomes reasons.
NCT01057641,TERMINATED,INTERVENTIONAL,low enrollment
NCT01057745,TERMINATED,OBSERVATIONAL,This treatment is now considered standard of care
NCT01057758,TERMINATED,INTERVENTIONAL,stopped for futility
NCT01057901,TERMINATED,INTERVENTIONAL,Study terminated for administrative reasons.
NCT01058005,TERMINATED,INTERVENTIONAL,"Due to significantly slower than expected enrollment, the Sponsor decided to terminate the study."
NCT01058317,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01058369,TERMINATED,INTERVENTIONAL,Insufficient patient recruitment (only 2 patients)
NCT01058759,TERMINATED,INTERVENTIONAL,The external funding (pharmaceutical company) was stopped and could not be substituded by internal funding.
NCT01058850,TERMINATED,INTERVENTIONAL,Resources can be better spent on higher enrolling studies
NCT01058902,WITHDRAWN,INTERVENTIONAL,failed to achive funding
NCT01059006,WITHDRAWN,INTERVENTIONAL,Lead researcher completed fellowship and never got study off ground
NCT01059045,TERMINATED,INTERVENTIONAL,Recruitement was much slower than anticipated.
NCT01059084,WITHDRAWN,INTERVENTIONAL,We were unable to enroll any participants into this study.
NCT01059110,TERMINATED,INTERVENTIONAL,Difficulty to enrollment patients
NCT01059123,TERMINATED,INTERVENTIONAL,Insufficient number of inclusion
NCT01059149,TERMINATED,INTERVENTIONAL,sponsor decision
NCT01059253,WITHDRAWN,INTERVENTIONAL,equipment not functional
NCT01059279,TERMINATED,OBSERVATIONAL,unable to recruit patients
NCT01059305,TERMINATED,INTERVENTIONAL,Lack of primary outcome efficacy.
NCT01059409,TERMINATED,INTERVENTIONAL,"Insufficient number of patients included compared to the expected duration of inclusion.

sponsor's decision"
NCT01059448,TERMINATED,INTERVENTIONAL,Lack of efficacy for Brodalumab in Rheumatoid Arthritis (RA)
NCT01059656,TERMINATED,INTERVENTIONAL,Decision of Study Principal Investigator
NCT01059682,TERMINATED,INTERVENTIONAL,Termination of the clinical development program by the Sponsor
NCT01059708,TERMINATED,OBSERVATIONAL,Low enrollment.
NCT01059929,TERMINATED,INTERVENTIONAL,drug and placebo unavailable
NCT01060241,SUSPENDED,INTERVENTIONAL,Other projects warranted more attention
NCT01060254,TERMINATED,INTERVENTIONAL,Logistic reasons associated with the FDA-imposed clinical hold.
NCT01060293,TERMINATED,INTERVENTIONAL,Safety issues in the LDFD-group (higher heart rate with dopamine)
NCT01060306,WITHDRAWN,OBSERVATIONAL,Funding issues
NCT01060319,WITHDRAWN,OBSERVATIONAL,Business Decision
NCT01060345,TERMINATED,INTERVENTIONAL,Drug no longer available
NCT01060423,TERMINATED,INTERVENTIONAL,Terminated due to poor subject enrolment
NCT01060514,TERMINATED,INTERVENTIONAL,Lack of timely accrual.
NCT01060865,TERMINATED,INTERVENTIONAL,The participants signed an old version of the informed consent.
NCT01061606,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01061671,TERMINATED,INTERVENTIONAL,Futility
NCT01061853,TERMINATED,INTERVENTIONAL,Per protocol intermediate analyses of 76 patients and enrollment difficulties.
NCT01061931,TERMINATED,INTERVENTIONAL,reason
NCT01061996,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT01062022,TERMINATED,INTERVENTIONAL,Loss of funding
NCT01062191,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01062230,TERMINATED,INTERVENTIONAL,Slow accrual; PI left primary institution
NCT01062373,TERMINATED,INTERVENTIONAL,difficulties of recruitement
NCT01062412,TERMINATED,INTERVENTIONAL,No improvement in near vision was detected
NCT01062659,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT01062672,WITHDRAWN,OBSERVATIONAL,PI left institution and no participants were enrolled
NCT01062698,TERMINATED,INTERVENTIONAL,Efficacy
NCT01062789,WITHDRAWN,INTERVENTIONAL,Closed due to funding and never enrolled a subject
NCT01062815,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT01062828,TERMINATED,OBSERVATIONAL,Terminated: participants are no longer being enrolled
NCT01062893,TERMINATED,INTERVENTIONAL,lack of subjects and manpower issues
NCT01062919,TERMINATED,INTERVENTIONAL,Low recruitment rate - \>70% of colorectal procedures are done laparoscopically
NCT01063010,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01063400,TERMINATED,OBSERVATIONAL,lack of funding
NCT01063452,WITHDRAWN,INTERVENTIONAL,This trial was never initiated due to inability to obtain the device
NCT01063478,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01063686,WITHDRAWN,INTERVENTIONAL,Insufficient Funding
NCT01063868,TERMINATED,INTERVENTIONAL,Business decision
NCT01063959,WITHDRAWN,INTERVENTIONAL,No Enrollment
NCT01063998,TERMINATED,OBSERVATIONAL,Preliminary data did not show expected outcomes.
NCT01064050,TERMINATED,INTERVENTIONAL,Difficulty to include patient
NCT01064973,TERMINATED,INTERVENTIONAL,all active subjects were rolled into study 209AS209/NCT01706523
NCT01065545,WITHDRAWN,INTERVENTIONAL,Due to funding issues.
NCT01065623,TERMINATED,INTERVENTIONAL,The study was terminated due to safety reasons
NCT01065675,TERMINATED,INTERVENTIONAL,Statistical analysis of 153 enrolled Phase 1 patients showed that specific patients could not be targeted for medication histories by discipline.
NCT01065740,TERMINATED,INTERVENTIONAL,Recruitment Difficulties and Financing Limited and exhausted
NCT01065805,TERMINATED,INTERVENTIONAL,Retirement of former Qualified Investigator and lack of resources to complete study
NCT01065818,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01066143,TERMINATED,INTERVENTIONAL,The underwriter stopped the funding
NCT01066273,WITHDRAWN,INTERVENTIONAL,Principal Investigator no longer at institution
NCT01066416,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01066533,TERMINATED,INTERVENTIONAL,immunohistochemistry markers are not recieved yet
NCT01066546,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01066598,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT01066702,TERMINATED,INTERVENTIONAL,company dissolution
NCT01066741,TERMINATED,INTERVENTIONAL,"insufficient recruitment, the planed sample size appears not achievable"
NCT01066871,TERMINATED,INTERVENTIONAL,The study was discontinued due to low recruitment.
NCT01066897,TERMINATED,INTERVENTIONAL,Lack of funding prevented further recruitment
NCT01067066,TERMINATED,INTERVENTIONAL,"Phase I/II study halted as Phase I, Low Response Rate"
NCT01067118,WITHDRAWN,INTERVENTIONAL,The study was suspended due to lack of study drug
NCT01067144,TERMINATED,INTERVENTIONAL,Trial met futility stopping point
NCT01067274,WITHDRAWN,INTERVENTIONAL,Study abandoned
NCT01067326,TERMINATED,INTERVENTIONAL,Novartis ended all studies regarding Aliskiren.
NCT01067352,TERMINATED,INTERVENTIONAL,This study was discontinued prematurely due to difficulty in participant recruitment.
NCT01067677,WITHDRAWN,INTERVENTIONAL,We do not have the funding or resources to complete the study at this time
NCT01067911,TERMINATED,INTERVENTIONAL,"Not enough enrollment, study needs to be revised"
NCT01067989,TERMINATED,INTERVENTIONAL,No satisfactory acrual
NCT01068119,TERMINATED,INTERVENTIONAL,Slow enrollment and high number of screen failures
NCT01068171,WITHDRAWN,INTERVENTIONAL,no patients who met enrollment criteria
NCT01068184,TERMINATED,INTERVENTIONAL,temporary hold in May 2010 due to an emerging PK profile that could not be aligned to the known pharmaceutical properties of the IMP (AZD6553).
NCT01068288,TERMINATED,INTERVENTIONAL,Unable to recruit adequate number of patients
NCT01068366,TERMINATED,OBSERVATIONAL,PI re-located.
NCT01068470,TERMINATED,OBSERVATIONAL,PI left the institution
NCT01068496,TERMINATED,OBSERVATIONAL,Other and future studies on lipiview in pterygium will cover this current trial sufficiently.
NCT01068873,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01069120,TERMINATED,INTERVENTIONAL,Repros stopped study due to safety and FDA placed study on hold
NCT01069276,WITHDRAWN,OBSERVATIONAL,"Changes in preclinical treatment of stroke patients, no more emergency physician will met this patients"
NCT01069432,WITHDRAWN,OBSERVATIONAL,IRB delayed their review for an extensive period of time. Funding for this protocol is no longer available.
NCT01069601,TERMINATED,INTERVENTIONAL,End of H1N1 Swine Flu Pandemic
NCT01069796,TERMINATED,INTERVENTIONAL,The number of inclusion was reached normally
NCT01069861,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01069965,TERMINATED,INTERVENTIONAL,Funding support withdrawn.
NCT01070186,WITHDRAWN,INTERVENTIONAL,No participants were enrolled.
NCT01070745,WITHDRAWN,INTERVENTIONAL,Changes in approach to PDA therapy
NCT01070888,TERMINATED,INTERVENTIONAL,Unable to reach target goal
NCT01071135,TERMINATED,INTERVENTIONAL,Planned number of 30 subjects could not be recruited during recruitment phase.
NCT01071434,TERMINATED,OBSERVATIONAL,PI left
NCT01071486,WITHDRAWN,INTERVENTIONAL,lack of participants
NCT01071694,WITHDRAWN,OBSERVATIONAL,Study Manager could not embark on it during the timeline.
NCT01071733,WITHDRAWN,OBSERVATIONAL,study was never initiated due to logistic causes
NCT01071902,TERMINATED,INTERVENTIONAL,Management decision
NCT01071928,WITHDRAWN,INTERVENTIONAL,Lack of efficacy of experimental treatment
NCT01071993,TERMINATED,INTERVENTIONAL,Sponsor can not supply drugs anymore.
NCT01072227,TERMINATED,OBSERVATIONAL,The study was terminated for logistic reasons
NCT01072526,TERMINATED,INTERVENTIONAL,Study personnel left institution before study completion
NCT01072591,TERMINATED,INTERVENTIONAL,Amended clinical development plan.
NCT01072643,TERMINATED,INTERVENTIONAL,Study was terminated due to increased PVR in one subject from T0-T1 reaching the level of a predetermined stopping rule
NCT01072812,TERMINATED,INTERVENTIONAL,Business decision based on funding
NCT01073189,WITHDRAWN,INTERVENTIONAL,withdrew due to funding
NCT01073436,TERMINATED,OBSERVATIONAL,Closed prematurely due to low accrual.
NCT01073644,TERMINATED,OBSERVATIONAL,The study was prematurely discontinued due to poor recruitment on 18th April 2013. There were no safety concerns that led to the decision to terminate.
NCT01073813,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01073852,WITHDRAWN,INTERVENTIONAL,"withdrawn, not funded"
NCT01074099,TERMINATED,INTERVENTIONAL,"Pilot results in change to protocol, new study needed."
NCT01074333,TERMINATED,OBSERVATIONAL,This study was terminated due to low recruitment
NCT01074359,TERMINATED,INTERVENTIONAL,Terminated for Commercial Reasons. There were no safety issues involved in the decision to terminate the study.
NCT01074437,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01074502,TERMINATED,INTERVENTIONAL,lack of funding due to Celgene administrative decision
NCT01074580,TERMINATED,OBSERVATIONAL,Did not get enough patients
NCT01074606,TERMINATED,INTERVENTIONAL,The study was terminated based on a business decision.
NCT01074749,TERMINATED,INTERVENTIONAL,Interim analysis indicated that endpoints can not be analysed with current dataset.
NCT01074918,WITHDRAWN,INTERVENTIONAL,none enrolled per PI
NCT01075126,WITHDRAWN,INTERVENTIONAL,key investigator relocated.
NCT01075165,WITHDRAWN,INTERVENTIONAL,IRB closed study due to no enrollment over 4 yrs
NCT01075230,TERMINATED,INTERVENTIONAL,Intended as multi-center. 1 of 2 sites could not participate. Enrollment discontinued after 50/100. Subjects followed per protocol.
NCT01075412,TERMINATED,INTERVENTIONAL,Study was closed and reopened as NCT01717391
NCT01075607,TERMINATED,OBSERVATIONAL,Halted prematurely due to lack of funding.
NCT01075776,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01075789,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT01075841,WITHDRAWN,OBSERVATIONAL,"After loss of orphan drug status in Korea, study was withdrawn due to Regulatory Authority request. Patients will be enrolled into NCT01075828 instead."
NCT01076049,TERMINATED,INTERVENTIONAL,Suboptimal Recruitment
NCT01076140,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01076270,TERMINATED,INTERVENTIONAL,Funding withdrawal
NCT01076400,TERMINATED,INTERVENTIONAL,The sponsor permanently suspended new enrollment into the trial and discontinued the study; which was not related to any concerns over product safety.
NCT01076699,SUSPENDED,INTERVENTIONAL,recruiting/enrolling participants has halted prematurely but potentially will resume Oct
NCT01076751,TERMINATED,OBSERVATIONAL,delay in recruitment
NCT01076816,TERMINATED,INTERVENTIONAL,Poor inclusion rate.
NCT01076907,TERMINATED,INTERVENTIONAL,Necessary equipment to perform the study arms was removed by the medical center administration.
NCT01077063,TERMINATED,INTERVENTIONAL,Study was closed by PI because of low enrollment.
NCT01077154,TERMINATED,INTERVENTIONAL,Terminated: Amgen decision following Primary Analysis. Not due to safety reason
NCT01077167,WITHDRAWN,INTERVENTIONAL,Study cancelled due to sponsor's decision to redesign the study
NCT01077193,TERMINATED,INTERVENTIONAL,Study was terminated due to commercial considerations and potential patient attrition at 3 years. There were no patient safety or procedure efficacy reasons.
NCT01077245,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01077297,TERMINATED,INTERVENTIONAL,"Due to slow recruitment, the study was prematurely discontinued"
NCT01077440,TERMINATED,OBSERVATIONAL,PI leaving institution
NCT01077518,TERMINATED,INTERVENTIONAL,The study was terminated early as it did not meet the Primary efficacy objective after primary analysis.
NCT01077531,TERMINATED,INTERVENTIONAL,"The risk-benefit ratio for patients has changed since we initiated the study, and that the study in its current form cannot be justified"
NCT01077778,TERMINATED,OBSERVATIONAL,the number of patients will be included is reach
NCT01077791,TERMINATED,INTERVENTIONAL,no reponse of the of the treatment
NCT01077869,TERMINATED,OBSERVATIONAL,poor recruitment rate
NCT01077947,WITHDRAWN,INTERVENTIONAL,Internal
NCT01078051,TERMINATED,INTERVENTIONAL,at sponsor's discretion : Benefit is not guaranteed
NCT01078064,TERMINATED,OBSERVATIONAL,the study failed in recruiting the required number of subjects (sample size) during its period
NCT01078272,TERMINATED,INTERVENTIONAL,Recruitment inadequate
NCT01078376,TERMINATED,INTERVENTIONAL,Business Decision (see below)
NCT01078441,TERMINATED,INTERVENTIONAL,"The study was closed early due to weak accrual on June 26, 2012."
NCT01078493,WITHDRAWN,INTERVENTIONAL,Protocol revision necessary.
NCT01078610,WITHDRAWN,OBSERVATIONAL,Study stopped prior to enrollment.
NCT01078844,TERMINATED,INTERVENTIONAL,Sponsor withdrew funds
NCT01078922,TERMINATED,INTERVENTIONAL,Study terminated due to slow acrual
NCT01078974,TERMINATED,INTERVENTIONAL,Safety concerns (IgM Flare)
NCT01078987,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01079091,TERMINATED,INTERVENTIONAL,The foundations of our pilotstudy planning has changed.
NCT01079104,TERMINATED,INTERVENTIONAL,The foundations of our pilotstudy planning has changed.
NCT01079169,TERMINATED,INTERVENTIONAL,Terminated early due to recruitment difficulties
NCT01079364,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01079429,TERMINATED,OBSERVATIONAL,sponsor and investigator 's decision
NCT01079598,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01079637,TERMINATED,INTERVENTIONAL,The study was stopped because there were not enough eligible patients to complete the study.
NCT01079767,TERMINATED,INTERVENTIONAL,The study treminated early according to DSMB recommendantions
NCT01079793,WITHDRAWN,INTERVENTIONAL,"Overlapping study, PI preferred to enroll in alternate trial."
NCT01079845,TERMINATED,INTERVENTIONAL,"For this pilot, we constructed conditional power curves and noted that we would not substantially enhance power by enrolling additional participants."
NCT01079949,TERMINATED,INTERVENTIONAL,Trial was terminated due to low recruitment rate
NCT01080105,WITHDRAWN,INTERVENTIONAL,This is withdrawn because we started working on studies that are funded.
NCT01080222,TERMINATED,INTERVENTIONAL,Study discontinued
NCT01080248,TERMINATED,INTERVENTIONAL,Closed due to delay by GSK
NCT01080339,TERMINATED,OBSERVATIONAL,Unable to recruit participants.
NCT01080664,TERMINATED,INTERVENTIONAL,Please see Purpose Statement below
NCT01080768,TERMINATED,INTERVENTIONAL,Publication of data from a similar study made the current study redundant.
NCT01081808,TERMINATED,INTERVENTIONAL,Funding ended
NCT01081886,TERMINATED,INTERVENTIONAL,Termination due to acquisition of PEAK Surgical by Medtronic
NCT01081938,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT01081964,TERMINATED,INTERVENTIONAL,Financial considerations
NCT01082536,WITHDRAWN,OBSERVATIONAL,0
NCT01082601,WITHDRAWN,OBSERVATIONAL,no enrollment
NCT01082653,SUSPENDED,INTERVENTIONAL,Suspended due to lack of funding.
NCT01082718,WITHDRAWN,INTERVENTIONAL,Logistical difficulties
NCT01082731,TERMINATED,INTERVENTIONAL,Extremely slow enrollment
NCT01082861,TERMINATED,INTERVENTIONAL,Due to recent strategic policy developments in the national vaccination program it is uncertain preadolescent girls will receive the HBV vaccin.
NCT01082965,TERMINATED,INTERVENTIONAL,The study was terminated because of slow enrollment. The decision to terminate the trial was not based on any safety or efficacy concerns.
NCT01083160,TERMINATED,OBSERVATIONAL,The study was terminated due to low enrollment because inclusion criteria are obsolete.
NCT01083277,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01083355,WITHDRAWN,OBSERVATIONAL,"No participants were enrolled, no funding obtained to perform study"
NCT01083472,TERMINATED,INTERVENTIONAL,Surgical practice evolution changed acceptable standard of care and lead to potential enrollment bias.
NCT01083537,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01083563,TERMINATED,OBSERVATIONAL,Funding has ended prior to complete enrollment
NCT01083615,TERMINATED,INTERVENTIONAL,Unable to enroll due to criteria for stable baseline pain
NCT01083641,TERMINATED,INTERVENTIONAL,did not meet efficacy goals after interim analysis
NCT01084369,TERMINATED,INTERVENTIONAL,Withdrawal of sponsorship
NCT01084408,TERMINATED,INTERVENTIONAL,no suitable patients
NCT01085175,WITHDRAWN,INTERVENTIONAL,Sponsor is re-evaluating the clinical development path
NCT01085331,TERMINATED,INTERVENTIONAL,Conduct the randomized Phase 2 part not recommended due to the achieved MTD for pimasertib (45mg/day) in combination with FOLFIRI
NCT01085396,TERMINATED,OBSERVATIONAL,Ran out of funding
NCT01085448,TERMINATED,INTERVENTIONAL,lack of timely recruitment of subjects
NCT01086332,TERMINATED,INTERVENTIONAL,"Toxicities, lack of funding"
NCT01086345,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01086371,WITHDRAWN,INTERVENTIONAL,Study being redesigned in anticipation of new study protocol.
NCT01086761,TERMINATED,INTERVENTIONAL,The study was terminated due to a company decision following completion of Part A.
NCT01086813,WITHDRAWN,INTERVENTIONAL,The compound is being re-evaluated
NCT01086852,TERMINATED,INTERVENTIONAL,Closed early due to difficulties in enrolling the target number of 10 surgical procedures.
NCT01087203,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01087411,WITHDRAWN,INTERVENTIONAL,2010 represented complications recruiting. The team suffered from sick-leave.
NCT01087450,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT01087593,TERMINATED,INTERVENTIONAL,Due to ethical concerns regard to the results from the WHI study
NCT01088035,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01088126,WITHDRAWN,INTERVENTIONAL,It was difficult to enrol patients.
NCT01088308,TERMINATED,INTERVENTIONAL,No enrollements for more than 6 months in Phase II
NCT01088334,TERMINATED,OBSERVATIONAL,"Terminated because of futility to continue, after planned interim analysis."
NCT01088620,SUSPENDED,INTERVENTIONAL,the DSMB stopped the trial due to unacceptable side effects in the experimental arm which has not yet been verified
NCT01088698,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients;
NCT01088906,TERMINATED,INTERVENTIONAL,No safety reasons. Low recruitment.
NCT01088997,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT01089075,TERMINATED,INTERVENTIONAL,Insufficient recruitment of suitable patients.
NCT01089140,TERMINATED,INTERVENTIONAL,Inadequate number of potential participants
NCT01089257,TERMINATED,OBSERVATIONAL,Delayed inclusion at more than 14 years from the start of the study
NCT01089374,TERMINATED,INTERVENTIONAL,Low disease incidence rate
NCT01089452,WITHDRAWN,INTERVENTIONAL,Study not started due to administrative reasons.
NCT01089478,TERMINATED,OBSERVATIONAL,Principal Investigator passed away.
NCT01089491,WITHDRAWN,OBSERVATIONAL,PI chose not to conduct the study; no data collected.
NCT01089504,TERMINATED,INTERVENTIONAL,Inadequate rate of enrollment
NCT01089595,TERMINATED,INTERVENTIONAL,Novartis is ending their research program for Nilotinib in GIST.
NCT01089621,WITHDRAWN,INTERVENTIONAL,Terminated due to study design changes; zero patients enrolled.
NCT01089725,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01090128,TERMINATED,INTERVENTIONAL,Drug Manufacturer withdrew support for studies not in metastatic breast cancer
NCT01090791,TERMINATED,OBSERVATIONAL,Major change in protocol anticipated
NCT01090830,TERMINATED,INTERVENTIONAL,Principal Investigator has left institution. IND withdrawn.
NCT01090973,TERMINATED,INTERVENTIONAL,Pharmaceutical company request.
NCT01091051,TERMINATED,INTERVENTIONAL,Manufacturer ceased to produce vials used for this study.
NCT01091064,WITHDRAWN,INTERVENTIONAL,The study was stopped because it was not approved for funding
NCT01091233,WITHDRAWN,OBSERVATIONAL,logistical problems
NCT01091519,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01091610,WITHDRAWN,OBSERVATIONAL,no collaboration
NCT01091701,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT01091870,WITHDRAWN,INTERVENTIONAL,Absence of inclusion criteria
NCT01092052,TERMINATED,INTERVENTIONAL,Discontinuation of clinical investigation with NMS-1116354
NCT01092312,TERMINATED,INTERVENTIONAL,No difference in outcome between the two groups
NCT01092546,TERMINATED,INTERVENTIONAL,Changed focus of the program
NCT01092572,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01092624,TERMINATED,INTERVENTIONAL,sponsor closed study due to poor enrollment
NCT01092689,WITHDRAWN,INTERVENTIONAL,Needed New IND per FDA
NCT01092728,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT01092832,TERMINATED,INTERVENTIONAL,"This protocol terminated prematurely on July 8, 2013 due to slow enrollment, not because of any safety issues or concerns."
NCT01092975,TERMINATED,INTERVENTIONAL,formulation/dose changes; planned changes to safety monitoring/reporting
NCT01093066,TERMINATED,INTERVENTIONAL,Difficulties in the inclusion and follow-up of patients
NCT01093092,TERMINATED,INTERVENTIONAL,Study transferring to INOVA Health
NCT01093105,WITHDRAWN,OBSERVATIONAL,Study halted prior to enrollment of first participant
NCT01093118,TERMINATED,INTERVENTIONAL,Business decision
NCT01093131,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT01093170,WITHDRAWN,INTERVENTIONAL,"Study was not conducted, no subjects recruited."
NCT01093183,TERMINATED,INTERVENTIONAL,study sponsors withdrew support for the study drug.
NCT01093677,WITHDRAWN,INTERVENTIONAL,no subjects enrolled
NCT01093781,WITHDRAWN,INTERVENTIONAL,Manufacturer asked to close study due to AEs experienced by subjects in other studies.
NCT01093846,TERMINATED,INTERVENTIONAL,Core Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint
NCT01093963,TERMINATED,INTERVENTIONAL,Enrollment goals not met
NCT01094067,TERMINATED,INTERVENTIONAL,"Due to slow recruitment, the study was prematurely discontinued."
NCT01094197,WITHDRAWN,OBSERVATIONAL,Investigators could not identify subjects who met all inclusion criteria.
NCT01094262,TERMINATED,INTERVENTIONAL,Logistic reasons associated with the FDA-imposed clinical hold.
NCT01094496,TERMINATED,INTERVENTIONAL,Portfolio prioritization due to slow enrollment
NCT01094535,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT01094587,TERMINATED,INTERVENTIONAL,Enrollment difficulty
NCT01094613,TERMINATED,INTERVENTIONAL,Sponsor withdrew support of study due to reorganization and project prioritization
NCT01094626,WITHDRAWN,INTERVENTIONAL,Pharmaceutical company did not decide to renew contract
NCT01094717,TERMINATED,INTERVENTIONAL,lack of efficacy and lack of funding
NCT01094977,SUSPENDED,INTERVENTIONAL,Inadequate funding
NCT01095094,TERMINATED,INTERVENTIONAL,Study did not meet its primary objective
NCT01095107,WITHDRAWN,INTERVENTIONAL,Couldn't offer patients a high/low fat meal plan because food service changes
NCT01095237,TERMINATED,INTERVENTIONAL,Study has been halted due to safety reasons
NCT01095250,TERMINATED,INTERVENTIONAL,Terminated: Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint.
NCT01095367,TERMINATED,INTERVENTIONAL,due to company changes and lack of funding-unlikely to have sufficient numbers to analyze meaningfully
NCT01095445,TERMINATED,INTERVENTIONAL,Unlikely to recruit the adequate number of patients within a reasonable timeline
NCT01095783,WITHDRAWN,INTERVENTIONAL,My main collaborator got sick and cannot continue the project. The study ended.
NCT01095809,TERMINATED,INTERVENTIONAL,New intraocular steroid in the market. Recruitment no longer ethical.
NCT01095887,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01096095,WITHDRAWN,INTERVENTIONAL,Regulatory authorities did not allow the entrance of the study drug in the country
NCT01096121,TERMINATED,INTERVENTIONAL,Not enough inclusions
NCT01096290,TERMINATED,INTERVENTIONAL,Number of needed participants could not be obtained
NCT01096381,TERMINATED,OBSERVATIONAL,funding withdrawn due to fellow's departure from VICC
NCT01096407,TERMINATED,OBSERVATIONAL,slow accrual
NCT01096446,TERMINATED,INTERVENTIONAL,To many infants in the experimental group developed hypertriglyceridemia
NCT01096459,WITHDRAWN,INTERVENTIONAL,Protocol as presented by investigator was not approved by the NIDDK.
NCT01096563,TERMINATED,INTERVENTIONAL,Sponsor has taken the decision to terminate further development of the compound
NCT01096693,SUSPENDED,INTERVENTIONAL,Awaiting supply of peptide from a different company
NCT01096732,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01096745,TERMINATED,INTERVENTIONAL,Planning for randomized phase III trial for this issue.
NCT01096771,TERMINATED,INTERVENTIONAL,"Unable to secure product from international source, low recruitment rate."
NCT01096810,TERMINATED,INTERVENTIONAL,The research is permanently closed to enrollment.
NCT01096953,WITHDRAWN,INTERVENTIONAL,Not human subject research
NCT01097239,WITHDRAWN,INTERVENTIONAL,Failure to recruit.
NCT01097330,TERMINATED,INTERVENTIONAL,Anticipated non-feasibility of recruitment objectives
NCT01097369,TERMINATED,OBSERVATIONAL,business decision due to low subject recruitment
NCT01097447,TERMINATED,OBSERVATIONAL,Terminated to initiate FDA IND-cleared study protocol
NCT01097707,TERMINATED,INTERVENTIONAL,Terminated due to insufficient efficacy
NCT01097850,WITHDRAWN,INTERVENTIONAL,No subject accrual.
NCT01097941,WITHDRAWN,INTERVENTIONAL,Live H1N1 vaccine expired and unable to get new supply
NCT01098214,WITHDRAWN,OBSERVATIONAL,Decided not to pursue study at this time. Resources not available
NCT01098227,WITHDRAWN,OBSERVATIONAL,The equipment to be used for the study was inoperable and not repairable.
NCT01098240,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01098331,TERMINATED,INTERVENTIONAL,Closed early due to poor recruitment
NCT01098422,TERMINATED,INTERVENTIONAL,Halted due to slow enrollment
NCT01098565,TERMINATED,INTERVENTIONAL,"The goal of collecting proof-of-concept information was met through additional modeling studies, new published evidence and information collected from the study"
NCT01098643,TERMINATED,INTERVENTIONAL,not enough pts for available to reach goal
NCT01098656,TERMINATED,INTERVENTIONAL,recruitment prematurely halted following company's decision to stop financial support to the study
NCT01098864,WITHDRAWN,INTERVENTIONAL,Study was withdrawn prior to the first subject being enrolled due to the Co-Investigator leaving the university
NCT01099020,TERMINATED,OBSERVATIONAL,Funding for project was withdrawn
NCT01099345,TERMINATED,OBSERVATIONAL,Slow Enrollment
NCT01099592,TERMINATED,INTERVENTIONAL,inability to recruit
NCT01099644,TERMINATED,INTERVENTIONAL,Corporate business decision. Not due to safety or efficacy concerns
NCT01099761,TERMINATED,INTERVENTIONAL,Based on preliminary safety data.
NCT01099995,TERMINATED,INTERVENTIONAL,the study was halted after the first interim analysis as there were significantly more patients who recovered at one month in the control arm
NCT01100190,TERMINATED,INTERVENTIONAL,Change in business priorities.
NCT01100203,TERMINATED,INTERVENTIONAL,It was not possible within the time frame to recruit the planned no. of patients.
NCT01100216,WITHDRAWN,INTERVENTIONAL,Funding expired prior to implementing subject recruitment.
NCT01100242,TERMINATED,INTERVENTIONAL,Low accrual
NCT01100437,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01100489,WITHDRAWN,INTERVENTIONAL,No accrual
NCT01100515,TERMINATED,INTERVENTIONAL,this study was suspended for futility
NCT01100658,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT01100749,TERMINATED,OBSERVATIONAL,Low recruitment
NCT01100866,TERMINATED,INTERVENTIONAL,due to slow enrollment
NCT01100879,TERMINATED,INTERVENTIONAL,Lack of Recruitment
NCT01100944,TERMINATED,INTERVENTIONAL,Principal investigator left the National Institutes of Health (NIH).
NCT01101100,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT01101126,TERMINATED,INTERVENTIONAL,An excess of all-cause acute health services utilization in the intervention arm
NCT01101269,TERMINATED,INTERVENTIONAL,Slow Recruitment
NCT01101347,WITHDRAWN,INTERVENTIONAL,Product received Approval for Commercial Distribution
NCT01101412,WITHDRAWN,INTERVENTIONAL,Study was not opened.
NCT01101477,TERMINATED,INTERVENTIONAL,Hypoxemia(SPaO2\<80%) episodes occured significantly in the arm titration by 0.5ug/ml
NCT01101581,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT01101594,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of efficacy
NCT01101906,TERMINATED,INTERVENTIONAL,Company decided not to pursue the development of this drug in this patient population at this time
NCT01102140,TERMINATED,INTERVENTIONAL,Investigator left University of Michigan
NCT01102218,TERMINATED,INTERVENTIONAL,Lack of statistical difference between both arms of the trial.
NCT01102504,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01102816,TERMINATED,INTERVENTIONAL,"We failed to recruit enough patients by regular recruitment methods (i.e., newspaper ads, hospital postings, radios and television ads)."
NCT01103024,WITHDRAWN,INTERVENTIONAL,Core study in non-infectious active uveitis was terminated
NCT01103037,TERMINATED,INTERVENTIONAL,Terminated by sponsor
NCT01103063,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01103141,TERMINATED,INTERVENTIONAL,This original design is no longer consistent with current clinical practice.
NCT01103180,TERMINATED,INTERVENTIONAL,Funding withdrawn due to inability to accrue
NCT01103193,TERMINATED,INTERVENTIONAL,"Need of change to the protocol. As the Principal Investigator has left the University Hospital Ghent end 2010, the change of protocol was never submitted."
NCT01103219,TERMINATED,INTERVENTIONAL,A planned interim-analysis revealed increased number of infections in the intervention arm.
NCT01103362,TERMINATED,INTERVENTIONAL,administrative reasons
NCT01103375,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01103388,TERMINATED,INTERVENTIONAL,Closed early due to slow patient accrual and sponsor's withdrawal of support.
NCT01103583,TERMINATED,INTERVENTIONAL,No efficacy (interim.analysis)
NCT01103674,TERMINATED,INTERVENTIONAL,"enrollment challenges, only one patient enrolled"
NCT01103713,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01103895,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT01103908,TERMINATED,OBSERVATIONAL,Site PI left position and lack of a suitable replacement PI.
NCT01103947,WITHDRAWN,INTERVENTIONAL,Not able to finalize funding
NCT01104103,TERMINATED,INTERVENTIONAL,Pre-determined stopping point met with signficant difference between intervention and control groups.
NCT01104116,TERMINATED,INTERVENTIONAL,Poor enrollment; PI left the institution
NCT01104298,TERMINATED,INTERVENTIONAL,Interim analysis did not show good results for main objective
NCT01104311,TERMINATED,INTERVENTIONAL,The enrollment was not done actively even though enrollment period was extended due to poor enrollment.
NCT01104363,WITHDRAWN,INTERVENTIONAL,Ethical commentate has not be obtained by the institution.
NCT01104389,WITHDRAWN,INTERVENTIONAL,Study was never started
NCT01104480,WITHDRAWN,INTERVENTIONAL,"Tocilizumab was licenced in Canada for children, so the study was not necessary"
NCT01104597,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled into the study
NCT01104610,WITHDRAWN,INTERVENTIONAL,Stopped by the sponsor
NCT01104662,TERMINATED,INTERVENTIONAL,Cubist has reached an agreement with the FDA that enrollment in the DAP-RENSE-08-05 study can stop.
NCT01104831,TERMINATED,INTERVENTIONAL,Inadequate recruitment.
NCT01104844,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to administrative reason
NCT01104961,WITHDRAWN,INTERVENTIONAL,"Other projects took precedence, no mechanism of funding establed"
NCT01105260,TERMINATED,OBSERVATIONAL,Difficulty to include patients
NCT01105325,TERMINATED,OBSERVATIONAL,due to poor patient recruitment
NCT01105390,WITHDRAWN,INTERVENTIONAL,withdrawn
NCT01105468,TERMINATED,OBSERVATIONAL,"Sponsor quit partnership in Oncotyrol-Center for Personalized Medicine, and consequential loss of public funding."
NCT01105702,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT01105884,WITHDRAWN,INTERVENTIONAL,Due to administrative reason
NCT01105962,TERMINATED,OBSERVATIONAL,new regulatory requirements will require funding for restart as a new study
NCT01105988,TERMINATED,INTERVENTIONAL,Funding ended
NCT01106027,TERMINATED,INTERVENTIONAL,Difficulty enrolling; competing industry-funded multi-center clinical trial
NCT01106053,WITHDRAWN,INTERVENTIONAL,No participants were recruited and study has been closed.
NCT01106066,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients
NCT01106209,SUSPENDED,OBSERVATIONAL,Seeking further funding
NCT01106378,TERMINATED,OBSERVATIONAL,Early termination of patient enrollment based on business decision
NCT01106443,TERMINATED,INTERVENTIONAL,Poor patient accrual
NCT01106612,TERMINATED,INTERVENTIONAL,low recruitment
NCT01106846,TERMINATED,INTERVENTIONAL,Resources not available to complete.
NCT01106950,TERMINATED,INTERVENTIONAL,study drug (Ontak) no longer available
NCT01107145,TERMINATED,INTERVENTIONAL,Extremely slow enrollment
NCT01107158,TERMINATED,OBSERVATIONAL,Inclusion curve too slow.
NCT01107184,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01107366,WITHDRAWN,INTERVENTIONAL,The study never started since our Medical Ethic Commeettee did not approved it
NCT01107600,WITHDRAWN,INTERVENTIONAL,Principal investigator and sponsor did not reach an agreement.
NCT01107795,TERMINATED,OBSERVATIONAL,Participant attrition before final follow-up visit was greater than anticipated.
NCT01107808,WITHDRAWN,INTERVENTIONAL,Poor recruitment to the study
NCT01107899,TERMINATED,INTERVENTIONAL,Terminated due to Enrollment futility
NCT01107990,TERMINATED,OBSERVATIONAL,PI time constraints
NCT01108003,TERMINATED,INTERVENTIONAL,low accrual
NCT01108263,TERMINATED,INTERVENTIONAL,Sponsor Terminated
NCT01108276,WITHDRAWN,INTERVENTIONAL,Study never started and therefore terminated.
NCT01108302,WITHDRAWN,INTERVENTIONAL,PATH withdrew IRB approval
NCT01108458,TERMINATED,INTERVENTIONAL,Extreme toxicity of Pertuzumab and Erlotinib combination
NCT01108523,TERMINATED,INTERVENTIONAL,Business decision
NCT01108627,WITHDRAWN,INTERVENTIONAL,Drug supply sponsor sent outdated drug
NCT01108666,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT01108744,WITHDRAWN,INTERVENTIONAL,Timeline to consent prior to intervention start was unfeasible.
NCT01108757,TERMINATED,INTERVENTIONAL,Unfeasible because of low accrual
NCT01109381,TERMINATED,INTERVENTIONAL,Poor efficacy (2 of 31 completing participants with H.pylori eradication)
NCT01109407,TERMINATED,OBSERVATIONAL,PI Left before primary outcome was established
NCT01109615,TERMINATED,INTERVENTIONAL,Lacking effect of treatment
NCT01109888,WITHDRAWN,INTERVENTIONAL,there was no percipitant enrolled
NCT01109953,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT01110044,WITHDRAWN,INTERVENTIONAL,Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.
NCT01110070,TERMINATED,INTERVENTIONAL,Enrollment suspended; follow up continue
NCT01110083,TERMINATED,INTERVENTIONAL,"Please see ""Purpose"" statement below."
NCT01110187,TERMINATED,INTERVENTIONAL,Lack of enrollement
NCT01110226,TERMINATED,INTERVENTIONAL,Toxicity was not felt to be acceptable for further development.
NCT01110330,TERMINATED,INTERVENTIONAL,Unexpected discordant results between the KOH microscopy and mycological culture tests at three study sites in the UK.
NCT01110382,TERMINATED,INTERVENTIONAL,Trial terminated early per business decision
NCT01110408,TERMINATED,INTERVENTIONAL,Trial terminated early per business decision
NCT01110421,TERMINATED,INTERVENTIONAL,Trial terminated early per business decision
NCT01110642,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to lack of eligible population for study
NCT01110876,TERMINATED,INTERVENTIONAL,Unanticipated Toxicities
NCT01110954,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01111058,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01111292,TERMINATED,INTERVENTIONAL,The study was closed prematurely due to poor accrual.
NCT01111448,TERMINATED,INTERVENTIONAL,Unfavourable Risk-Benefit-Ratio
NCT01111539,TERMINATED,INTERVENTIONAL,"The study was terminated early due to Sponsor decision, closure of this combination therapy program is unrelated to any safety issues, no signals of concern."
NCT01111552,TERMINATED,INTERVENTIONAL,"The study was terminated early due to Sponsor decision, closure of this combination therapy program is unrelated to any safety issues, no signals of concern."
NCT01111565,TERMINATED,INTERVENTIONAL,"The study was terminated early due to Sponsor decision, closure of this combination therapy program is unrelated to any safety issues, no signals of concern."
NCT01111682,TERMINATED,INTERVENTIONAL,A significant reduction in head injuries coupled with more frequent use of crainectomy reduced the number of potential subjects.
NCT01111877,TERMINATED,OBSERVATIONAL,Management Decision
NCT01111942,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01112319,WITHDRAWN,INTERVENTIONAL,not patient recruitment
NCT01112397,TERMINATED,INTERVENTIONAL,Decision to stop development of AZD1480
NCT01112553,TERMINATED,OBSERVATIONAL,Study was closed due to low enrollment numbers.
NCT01112761,TERMINATED,INTERVENTIONAL,Lack of resources to run the trial
NCT01112774,TERMINATED,INTERVENTIONAL,Funding ended
NCT01112878,WITHDRAWN,INTERVENTIONAL,Several studies going on at the same time.
NCT01112969,TERMINATED,INTERVENTIONAL,Project end after 3 years; prolongation was rejected
NCT01113229,TERMINATED,INTERVENTIONAL,reason of halt prematurely: futility of the trial
NCT01113463,TERMINATED,INTERVENTIONAL,Low Accrual
NCT01113541,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01113567,TERMINATED,INTERVENTIONAL,"erminated \[The study was withdrawn because of the reconversion of the hospital to care for patients with COVID19. For this reason, it was not possible to continue recruiting and monitoring patients for this clinical study.\]"
NCT01113658,WITHDRAWN,INTERVENTIONAL,"The study was terminated by Spiracur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful."
NCT01113801,TERMINATED,INTERVENTIONAL,Interim Assessment: Lack of Efficacy
NCT01113905,TERMINATED,OBSERVATIONAL,Insufficient recruitment was obtained
NCT01114113,WITHDRAWN,INTERVENTIONAL,Lack of interest in participation by patients locally and lack of funding.
NCT01114178,TERMINATED,OBSERVATIONAL,recruitment problem due to administrative process being too long
NCT01114243,WITHDRAWN,OBSERVATIONAL,The PI has left Stanford University.
NCT01114295,WITHDRAWN,INTERVENTIONAL,The study was stopped before the first patient was enetered due to logistical issues and lack of funding.
NCT01114451,TERMINATED,INTERVENTIONAL,Funding limits exceeded prior to complete enrollment.
NCT01114464,TERMINATED,OBSERVATIONAL,end of normal study
NCT01114503,TERMINATED,INTERVENTIONAL,Clinical study in Graves' ophthalmopathy terminated until there is a better understanding of an efficacious dose with Otelixizumab from other clinical studies.
NCT01114698,TERMINATED,INTERVENTIONAL,Study was terminated due to sponsor portfolio decision.
NCT01114711,TERMINATED,OBSERVATIONAL,A sister study using Frova at a 10 mg dose had adverse effects.
NCT01114984,WITHDRAWN,OBSERVATIONAL,Bad design.
NCT01114997,TERMINATED,INTERVENTIONAL,The early report didn't show any benefit.
NCT01115010,TERMINATED,INTERVENTIONAL,Colonoscope being used in study not repairable at economic cost.
NCT01115036,WITHDRAWN,INTERVENTIONAL,"No subjects were enrolled on this study, so study was closed and IND withdrawn."
NCT01115244,TERMINATED,INTERVENTIONAL,poor enrollment and lack of funding
NCT01115530,WITHDRAWN,INTERVENTIONAL,Insufficient subject recruitment.
NCT01115699,TERMINATED,INTERVENTIONAL,Stopped due to funding constraints and recruitment was slower than was expected
NCT01115803,TERMINATED,INTERVENTIONAL,Primary objective has been met; safety and pharmacokinetics have been characterized.
NCT01116037,TERMINATED,INTERVENTIONAL,Business decision to end study due to limited enrollment and study population
NCT01116102,TERMINATED,INTERVENTIONAL,Strategic business decision (not related to safety or efficacy concerns)
NCT01116128,TERMINATED,INTERVENTIONAL,difficulty in enrolling patients
NCT01116154,TERMINATED,INTERVENTIONAL,Sponsor withdrew support for the study
NCT01116232,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT01116245,TERMINATED,INTERVENTIONAL,Study stopped due to lack of enrollment
NCT01116284,TERMINATED,INTERVENTIONAL,no patients to recruit
NCT01116349,TERMINATED,INTERVENTIONAL,Difficulties to recruit participants A similar Canadian multicentric study started at about the same.
NCT01116479,TERMINATED,INTERVENTIONAL,low accrual
NCT01116557,TERMINATED,INTERVENTIONAL,Biosense stopped Study enrollment following publications that reported PVAC ablation is linked with a higher incidence of asymptomatic cerebral embolic lesions
NCT01116661,TERMINATED,INTERVENTIONAL,The primary objective for high grade gliomas has been met and the FDA has now approved the drug (Gleolan) for use in the United States.
NCT01116791,TERMINATED,INTERVENTIONAL,Insufficient enrollment in Pancreatic \& Biliary arm
NCT01116973,TERMINATED,INTERVENTIONAL,Change in guidelines by the manufacturer.
NCT01117051,TERMINATED,INTERVENTIONAL,The study was stopped by the sponsor based on a non-safety related business priority decision
NCT01117129,TERMINATED,INTERVENTIONAL,This study was prematurely terminated as 2 patients were recruited and both of them withdrawn from the study before reaching the primary end point.
NCT01117376,TERMINATED,INTERVENTIONAL,The study was prematurely terminated because of unavailibility of Methylnaltrexone in the region
NCT01117571,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT01117662,TERMINATED,INTERVENTIONAL,The planned recruitment number of 180 Patient could not been achieved.
NCT01117688,WITHDRAWN,INTERVENTIONAL,Withdrawn. Not enough time to go through with the study.
NCT01117714,TERMINATED,INTERVENTIONAL,Accrual was poor at two other sites and manuscript was published which describing another study which accomplished the goals of this project.
NCT01117727,TERMINATED,INTERVENTIONAL,Performance of BCI switch insufficient in pilot testing.
NCT01117779,TERMINATED,OBSERVATIONAL,Boston Scientific acquisition of BTG/Galil Medical - business decision made to stop follow-up early
NCT01117948,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT01117987,TERMINATED,INTERVENTIONAL,Novartis discontinued the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.
NCT01118403,WITHDRAWN,INTERVENTIONAL,He could not be started due to lack of funds
NCT01118455,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01118650,WITHDRAWN,OBSERVATIONAL,No interest from school district
NCT01118715,TERMINATED,INTERVENTIONAL,Impractical to enroll the #s needed for statistical significance; project manager relocated
NCT01118728,TERMINATED,INTERVENTIONAL,Lack of benefit on efficacy
NCT01118819,TERMINATED,INTERVENTIONAL,This study was terminated. An IT injection study of C. novyi-NT in patients with treatment refractory solid tumor malignancies may be viewed at NCT01924689.
NCT01118975,TERMINATED,INTERVENTIONAL,Lost sponsorship for study drug
NCT01119027,TERMINATED,OBSERVATIONAL,slow accrual
NCT01119040,TERMINATED,INTERVENTIONAL,Low accrual
NCT01119053,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT01119079,WITHDRAWN,INTERVENTIONAL,PI unable to recruit appropriate patients
NCT01119417,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT01119430,TERMINATED,INTERVENTIONAL,interim analysis suggested no differences with whole sample
NCT01119547,WITHDRAWN,INTERVENTIONAL,Investigator no longer at LU.
NCT01119742,TERMINATED,INTERVENTIONAL,Insufficient number of baseline eligible patient
NCT01119794,TERMINATED,INTERVENTIONAL,lack of accrual
NCT01120158,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT01120171,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT01120275,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT01120431,WITHDRAWN,INTERVENTIONAL,Strategic business decision (not related to safety or efficacy concerns)
NCT01120613,WITHDRAWN,INTERVENTIONAL,primary investigator left institution; not enough patients
NCT01120769,WITHDRAWN,INTERVENTIONAL,Funding issue
NCT01121081,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT01121185,TERMINATED,INTERVENTIONAL,The study was terminated due to slower than anticipated subject accrual.
NCT01121328,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT01121380,TERMINATED,INTERVENTIONAL,Sponsor strategy change
NCT01121510,WITHDRAWN,INTERVENTIONAL,medical center difficulties in recruiting patients for the study in a timely fashion
NCT01121536,TERMINATED,INTERVENTIONAL,"Business decision related to efficacy rather than tolerability limitations, not stopped for any safety reasons."
NCT01121549,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01121588,TERMINATED,INTERVENTIONAL,Termination of further treatment on the study due to the availability of commercial supply or a rollover study (NCT05160922) that will allow active subjects to continue receiving treatment.
NCT01121601,TERMINATED,INTERVENTIONAL,Practices in surgery have evolved and the study has not interest yet
NCT01121757,TERMINATED,INTERVENTIONAL,"The study closed temporarily in February 2012 pending analysis of samples collected. In October, 2012, Celgene requested closure of the study."
NCT01122342,SUSPENDED,INTERVENTIONAL,Evaluating outcomes of current subjects pre further enrollment/dose reduction.
NCT01122381,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01122511,TERMINATED,INTERVENTIONAL,The study was terminated early due to difficulties with patient recruitment.
NCT01122719,TERMINATED,INTERVENTIONAL,"slow inclusion, due to difficulties in obtaining the patients consent for the 2 months invasive follow-up, as required by protocol design."
NCT01122901,TERMINATED,INTERVENTIONAL,Stopped prematurely by Company due to decision to terminate all CTEP supplied drug for further development of RO4929097.
NCT01122927,TERMINATED,INTERVENTIONAL,The trial was terminated early as the objective of the Aripiprazole Pediatric Investigational Plan was met and provided 2 years of safety data.
NCT01123005,TERMINATED,INTERVENTIONAL,Logistical
NCT01123031,WITHDRAWN,INTERVENTIONAL,The study was terminated and the PI has left the institution.
NCT01123135,WITHDRAWN,INTERVENTIONAL,Unable to determine a suitable placebo.
NCT01123161,TERMINATED,INTERVENTIONAL,The ICTuS 2 portion of the trial has been halted and data will be analyzed.
NCT01123304,TERMINATED,INTERVENTIONAL,This study has been terminated due to lack of availability of investigational product.
NCT01123317,WITHDRAWN,INTERVENTIONAL,Never started
NCT01123473,TERMINATED,INTERVENTIONAL,company withdrew interest
NCT01123486,WITHDRAWN,INTERVENTIONAL,PI relocated to new university
NCT01123499,TERMINATED,OBSERVATIONAL,Slow/Insufficient accrual
NCT01123707,TERMINATED,INTERVENTIONAL,The study was terminated early due to Sponsor decision; no safety issues.
NCT01123850,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01124227,TERMINATED,INTERVENTIONAL,"Due to very specific inclusion criteria the anticipated number of patients was not reached. Inclusion stopped at N=26, allowing for analyzing primary outcomes."
NCT01124474,TERMINATED,INTERVENTIONAL,This study was stopped because of lack of posterior only major spine surgeries.
NCT01124656,TERMINATED,INTERVENTIONAL,Formulation issues.
NCT01124825,WITHDRAWN,INTERVENTIONAL,No subjects enrolled. Funding withdrawn by sponsor.
NCT01125059,WITHDRAWN,INTERVENTIONAL,Unable to fulfill recruitment
NCT01125072,WITHDRAWN,OBSERVATIONAL,PI no longer with institution
NCT01125293,TERMINATED,INTERVENTIONAL,"Per protocol, Phase II is to be terminated early if a less than 5% of the Phase II participants observe a Very Good Partial Response or Better in the first 23 participants enrolled to Phase II."
NCT01125358,TERMINATED,INTERVENTIONAL,The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.
NCT01125384,WITHDRAWN,INTERVENTIONAL,stopped due to protocol mistakes
NCT01125449,SUSPENDED,INTERVENTIONAL,Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche (Ireland).
NCT01125501,WITHDRAWN,INTERVENTIONAL,funding not available
NCT01125683,TERMINATED,INTERVENTIONAL,Poor recruitment.
NCT01125735,WITHDRAWN,INTERVENTIONAL,Contract negotiations were terminated and study never started.
NCT01125787,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01125917,TERMINATED,INTERVENTIONAL,Terminated early due to administrative reasons.
NCT01125930,TERMINATED,INTERVENTIONAL,Due to slow recruitment and sponsor request study ended early
NCT01126216,TERMINATED,INTERVENTIONAL,"After an Interims analysis the Data Safety Monitoring board recommended this because no significant difference between the two arms was seen and was not expected with an reasonable recruitment of patients.

No interruptions of the trial were made."
NCT01126255,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01126411,WITHDRAWN,INTERVENTIONAL,PI left center
NCT01126450,TERMINATED,INTERVENTIONAL,"low accrual,loss of funding and results from EU study showing drug ineffective."
NCT01126502,TERMINATED,INTERVENTIONAL,Administratively Complete.
NCT01126632,WITHDRAWN,OBSERVATIONAL,Caps became unavailable by manufacturer
NCT01126749,TERMINATED,INTERVENTIONAL,Study was terminated as per sponsor's decision
NCT01126801,TERMINATED,INTERVENTIONAL,Stopped enrolling subjects due to challenge of identifying eligible participants
NCT01126866,TERMINATED,INTERVENTIONAL,recruiting inadequate
NCT01126879,TERMINATED,INTERVENTIONAL,Closed due to low accrual
NCT01126944,WITHDRAWN,INTERVENTIONAL,No patients recruted since recruiting is open
NCT01126957,TERMINATED,INTERVENTIONAL,Investigator left institution.
NCT01127321,TERMINATED,INTERVENTIONAL,Business reasons
NCT01127334,WITHDRAWN,OBSERVATIONAL,Principal Investigator terminated study
NCT01127399,TERMINATED,OBSERVATIONAL,Funding revoked
NCT01127425,TERMINATED,INTERVENTIONAL,Due to reorganisation in the hospital structure
NCT01127503,TERMINATED,INTERVENTIONAL,"Enrollment, study-design and execution challenges."
NCT01127542,TERMINATED,INTERVENTIONAL,Potential safety issue of second primary malignancies in patients treated with lenalidomide.
NCT01127633,TERMINATED,INTERVENTIONAL,Solanezumab did not meet the primary endpoint in study H8A-MC-LZAX.
NCT01127646,TERMINATED,INTERVENTIONAL,Due to lack of availability of study participants to accommodate the study design
NCT01127724,TERMINATED,INTERVENTIONAL,difficulties in recruiting participants
NCT01127789,WITHDRAWN,INTERVENTIONAL,test device not approved to be used
NCT01127893,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01127971,TERMINATED,OBSERVATIONAL,"administrative reasons (no impact/concern of subject rights, welfare, safety)"
NCT01128036,TERMINATED,OBSERVATIONAL,Terminated due to software issues.
NCT01128114,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01128387,TERMINATED,INTERVENTIONAL,slow accrual
NCT01128413,TERMINATED,INTERVENTIONAL,lack of resources
NCT01128452,TERMINATED,INTERVENTIONAL,Evotec has indicated that this study was discontinued due to a clinical hold issued by the FDA
NCT01128673,WITHDRAWN,OBSERVATIONAL,No funding
NCT01128712,TERMINATED,INTERVENTIONAL,lack of enrollment. terminated in 2014. no data analysis.
NCT01128777,TERMINATED,INTERVENTIONAL,Terminated due to difficuly recruiting participants
NCT01128816,TERMINATED,INTERVENTIONAL,"Philips Global Field Safety Notice for PAP Devices \& Ventilators, June 14, 2021 (June 15, 2021 censor date for trial). Patient final visits and collection of endpoints prior to censor date continued to March 31, 2022."
NCT01129024,TERMINATED,INTERVENTIONAL,The study was terminated due to cessation of clinical development of S-888711 for chronic ITP based on a business decision by the Sponsor.
NCT01129232,TERMINATED,INTERVENTIONAL,Complications to procedure
NCT01129323,WITHDRAWN,INTERVENTIONAL,This study did not accrue any subjects and due to this will be closed.
NCT01129609,TERMINATED,OBSERVATIONAL,Low subject enrollment due to obseleted product.
NCT01129674,TERMINATED,INTERVENTIONAL,The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.
NCT01129778,TERMINATED,INTERVENTIONAL,change in the business strategy of the sponsor
NCT01129830,TERMINATED,INTERVENTIONAL,Suboptimal recruitment
NCT01129947,WITHDRAWN,INTERVENTIONAL,very poor patient recruitement
NCT01130246,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01130324,WITHDRAWN,OBSERVATIONAL,Released by he FDA from this Post-Marketing Commitment
NCT01130363,TERMINATED,OBSERVATIONAL,Poor Enrollment
NCT01130376,TERMINATED,INTERVENTIONAL,"Data from the 12 patients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives."
NCT01130649,WITHDRAWN,OBSERVATIONAL,not funded
NCT01130688,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01130701,WITHDRAWN,INTERVENTIONAL,Study never went beyond FDA application for an IND #. FDAA required institutional DSMC which this institution then lacked.
NCT01130909,TERMINATED,INTERVENTIONAL,The benefit of halting the study to analyze the available data outweighs the benefit of delaying the analysis to include data from remaining treatment periods
NCT01131039,WITHDRAWN,INTERVENTIONAL,PI left Emory
NCT01131247,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT01131351,TERMINATED,INTERVENTIONAL,The study was terminated early due to lack of efficacy after 10 participants enrolled.
NCT01131455,TERMINATED,INTERVENTIONAL,Study was terminated due to the untimely death of the investigator
NCT01131481,WITHDRAWN,INTERVENTIONAL,lack of recruitment
NCT01131559,TERMINATED,INTERVENTIONAL,Sponsor halted study.
NCT01131585,TERMINATED,INTERVENTIONAL,European drug approval.
NCT01131637,TERMINATED,INTERVENTIONAL,Sponsor has designed another study to replace the current study
NCT01131884,TERMINATED,INTERVENTIONAL,Only 1 participant enrolled since the beginning of this study
NCT01132144,TERMINATED,INTERVENTIONAL,Stopped after safety analysis because of significant benefit of intervention.
NCT01132404,TERMINATED,INTERVENTIONAL,Developing new formulation of study drug. New study to open next year under a new protocol.
NCT01132417,SUSPENDED,OBSERVATIONAL,researchers delay
NCT01132521,SUSPENDED,INTERVENTIONAL,Revised project
NCT01132547,TERMINATED,INTERVENTIONAL,The study was terminated due to slow accrual.
NCT01132664,TERMINATED,INTERVENTIONAL,Due to the rare patient population and challenges to enroll patients.
NCT01132768,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01133262,WITHDRAWN,OBSERVATIONAL,Feasibility/pilot study of 5 subjects registration not required
NCT01133288,TERMINATED,INTERVENTIONAL,The funder never paid for the study.
NCT01133574,TERMINATED,INTERVENTIONAL,"Part A completed successfully 22 July 2010, Part B will be separate PET study"
NCT01133600,TERMINATED,INTERVENTIONAL,Lack of patient enrollment
NCT01133639,TERMINATED,INTERVENTIONAL,"PI no longer with the institution, funding issues, poor accrual"
NCT01133678,TERMINATED,INTERVENTIONAL,Primary endpoint reached futility boundary
NCT01133756,TERMINATED,INTERVENTIONAL,poor accrual
NCT01133769,WITHDRAWN,OBSERVATIONAL,Institutional issues Institution issues
NCT01133990,TERMINATED,INTERVENTIONAL,"The study was terminated early as the combination of E7820 and FOLFIRI was deemed to be not tolerable, hence no efficacy analysis was conducted."
NCT01134133,WITHDRAWN,INTERVENTIONAL,"Slow recruitment (preemptive treatment of gurglers, after association was published)"
NCT01134315,TERMINATED,OBSERVATIONAL,Terminated after FDA agreement.
NCT01134445,TERMINATED,INTERVENTIONAL,Study terminated early for business reasons
NCT01134497,WITHDRAWN,INTERVENTIONAL,New information on IMP affected the cost/benefit ratio
NCT01134601,TERMINATED,INTERVENTIONAL,"As per Cancer Therapy Evaluation Program (CTEP), this protocol has only enrolled one participant and it is unlikely that the study will be able to be completed successfully. CTEP slated the protocol to be administratively closed."
NCT01134666,TERMINATED,OBSERVATIONAL,The study was discontinued due to slow recruitment and subjects not completing follow up period.
NCT01134796,TERMINATED,OBSERVATIONAL,failure to recruit
NCT01134835,TERMINATED,INTERVENTIONAL,safety concerns with pioglitazone
NCT01134926,TERMINATED,INTERVENTIONAL,The principal investigator left the organization
NCT01134991,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT01135199,WITHDRAWN,INTERVENTIONAL,FDA did not accept sponsor's animal toxicology data to support proposed dosing.
NCT01135290,WITHDRAWN,INTERVENTIONAL,"Business decision, formulation will not be pursued."
NCT01135329,TERMINATED,INTERVENTIONAL,The stopping rule was met and hence the study was closed
NCT01135524,TERMINATED,INTERVENTIONAL,This study was terminated early for administrative reasons.
NCT01135537,TERMINATED,INTERVENTIONAL,The study was closed before 2017 due to inconclusive results from Lab
NCT01135550,TERMINATED,INTERVENTIONAL,premature closure due to lack of accrual
NCT01135758,TERMINATED,INTERVENTIONAL,End of funding of study
NCT01135979,WITHDRAWN,OBSERVATIONAL,Unable to recruit
NCT01136122,TERMINATED,INTERVENTIONAL,The study was stopped due to low recruitment.
NCT01136486,TERMINATED,OBSERVATIONAL,slow accrual
NCT01136668,TERMINATED,INTERVENTIONAL,Unable to recruit adequate number of subjects
NCT01136746,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01136811,TERMINATED,INTERVENTIONAL,Study was terminated. P.I. left the institution before completing study
NCT01136915,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01137071,TERMINATED,INTERVENTIONAL,Total number of pts expected to be enrolled would not be met.
NCT01137136,SUSPENDED,OBSERVATIONAL,"Because of economic issue, we could just enrolled total 150 patients."
NCT01137162,TERMINATED,OBSERVATIONAL,Low Accrual
NCT01137448,WITHDRAWN,INTERVENTIONAL,The site did not have enough funds to complete study arrengments and start to enrolling. The site was not able to enroll subjects.
NCT01137500,WITHDRAWN,OBSERVATIONAL,host site logistical problems
NCT01137552,TERMINATED,INTERVENTIONAL,"Part A, the dose escalation and primary objective of the study, was completed. Part B, the dose expansion, was not conducted due to a business decision."
NCT01137591,WITHDRAWN,INTERVENTIONAL,Unable to recruit sufficient participants due to lack of funding; PI has left the institution.
NCT01137773,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01137799,TERMINATED,INTERVENTIONAL,Efficacy signals were insufficiently strong to justify recruitment of additional patients.
NCT01137877,TERMINATED,INTERVENTIONAL,The control product was recalled.
NCT01137929,WITHDRAWN,OBSERVATIONAL,Difficulty identifying eligible candidates
NCT01138137,WITHDRAWN,INTERVENTIONAL,No funding was available for the cost of the IV N-acetylcysteine (NAC).
NCT01138410,TERMINATED,INTERVENTIONAL,Product availability
NCT01138540,TERMINATED,INTERVENTIONAL,Steering Committee accepted DSMB advise to terminate the study after review of data analysis at second interim analysis
NCT01138553,TERMINATED,INTERVENTIONAL,Inadequate subject accrual
NCT01138579,WITHDRAWN,INTERVENTIONAL,"Recruitment delayed, trial medication no loner available"
NCT01138722,TERMINATED,INTERVENTIONAL,Poor recruitment rate.
NCT01138761,TERMINATED,INTERVENTIONAL,Enrollment was significantly under target.
NCT01139125,TERMINATED,INTERVENTIONAL,The study was stopped after 4 years of recruitment difficulties.
NCT01139164,TERMINATED,INTERVENTIONAL,Study halted prematurely due to low accrual.
NCT01139359,WITHDRAWN,INTERVENTIONAL,Study enrollment was withdrawn as it is no longer the sponsor's intention to study this indication under this protocol.
NCT01139996,TERMINATED,INTERVENTIONAL,Difficulty in enrolling participants
NCT01140191,TERMINATED,INTERVENTIONAL,This study was closed due to lack of enrollment (only one subject enrolled)
NCT01140399,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01140412,TERMINATED,INTERVENTIONAL,"The trial prematurely terminated on November 1, 2010, due to healthy volunteer participants experiencing non-serious fosamprenavir-related skin rash."
NCT01140503,TERMINATED,INTERVENTIONAL,Slow recruitment of participants
NCT01140529,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01140555,TERMINATED,INTERVENTIONAL,Further internal evaluation of the device was required.
NCT01140802,TERMINATED,OBSERVATIONAL,Due to study plan
NCT01140984,TERMINATED,INTERVENTIONAL,technical issues
NCT01141075,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment and unclear pharmacologic effect in available pharmacodynamic data (not due to any safety concerns).
NCT01141218,TERMINATED,OBSERVATIONAL,slow accrual
NCT01141296,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01141478,TERMINATED,INTERVENTIONAL,due to low enrollment
NCT01141530,WITHDRAWN,OBSERVATIONAL,Study withdrawn due to inability to enroll subjects.
NCT01141621,TERMINATED,OBSERVATIONAL,Insufficient staff to continue pursuing project
NCT01141764,TERMINATED,INTERVENTIONAL,"Very slow and infrequent recruitment, availability of the imaging procedure at Adult Centre"
NCT01141868,WITHDRAWN,INTERVENTIONAL,The study never opened due to technical upgrades that were needed for the SHUTi computer system.
NCT01141881,TERMINATED,INTERVENTIONAL,"occurrence of retinal hemorrhage , increase in macular edema of some patients in TPA group"
NCT01141894,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01142128,TERMINATED,INTERVENTIONAL,Viokase was taken off market during study and remained off over a year.
NCT01142869,TERMINATED,OBSERVATIONAL,The study was discontinued due to slow recruitment and subjects not completing follow up period.
NCT01142921,TERMINATED,INTERVENTIONAL,Issue regarding the stent design
NCT01143272,TERMINATED,INTERVENTIONAL,Masked independent interim analysis: completion of the trial was unlikely.
NCT01143545,TERMINATED,INTERVENTIONAL,Closed accrual due to unpromising results and the opening of study 14C0053 targeting the same population.
NCT01144169,TERMINATED,INTERVENTIONAL,barriers to accrual: delay until surgery and additional pre-operative visits
NCT01144221,TERMINATED,INTERVENTIONAL,funding issues
NCT01144442,TERMINATED,INTERVENTIONAL,PI Request
NCT01144520,TERMINATED,OBSERVATIONAL,researchers moved to new institution and did not transfer project
NCT01144741,TERMINATED,OBSERVATIONAL,Insufficient patient enrolment
NCT01144754,TERMINATED,OBSERVATIONAL,Low Accrual
NCT01144858,TERMINATED,OBSERVATIONAL,40 patients
NCT01144910,WITHDRAWN,OBSERVATIONAL,Due to few capacities 2011 to 2016 the study was withdrawn.
NCT01145326,WITHDRAWN,INTERVENTIONAL,"The device is undergoing further study in China, per FDA requirements."
NCT01145404,TERMINATED,INTERVENTIONAL,Changes of SoC for third line therapy resulting in poor recruitment
NCT01145417,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01145508,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01145703,TERMINATED,INTERVENTIONAL,Investigator terminated study due to low enrollment of eligible subjects
NCT01145937,TERMINATED,INTERVENTIONAL,during anticipated study duration trial power was not attained.
NCT01146184,WITHDRAWN,INTERVENTIONAL,the manufacturer never released the instruments
NCT01146353,WITHDRAWN,OBSERVATIONAL,Peramivir EUA terminated by FDA.
NCT01146457,TERMINATED,INTERVENTIONAL,Principal Investigator
NCT01146561,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01146587,SUSPENDED,INTERVENTIONAL,GangTrainer GT1 is not state of the art anymore for the principal Invesigator
NCT01146821,TERMINATED,INTERVENTIONAL,Low enrollment/ expiration of the grant
NCT01147016,TERMINATED,INTERVENTIONAL,Primary co-investigator leaving the institution \& funding transfer.
NCT01147029,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT01147042,TERMINATED,INTERVENTIONAL,Early termination due to only 2 subjects completing trial.
NCT01147393,TERMINATED,INTERVENTIONAL,closed to enrollment due to slow patient accrual
NCT01147458,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01147471,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01147536,TERMINATED,INTERVENTIONAL,Sponsor's business decision
NCT01147796,TERMINATED,INTERVENTIONAL,defect of inclusion
NCT01147835,TERMINATED,INTERVENTIONAL,Study was stopped and not completed
NCT01148030,TERMINATED,OBSERVATIONAL,Outcome measures for pre-intervention were much lower than anticipated.
NCT01148056,TERMINATED,INTERVENTIONAL,The study was closed to enrollment due to slow accrual.
NCT01148082,WITHDRAWN,OBSERVATIONAL,Business decision
NCT01148134,TERMINATED,OBSERVATIONAL,Analysis of the first 10 patients did not show anyt trend toward differences in PK profiles between imatinib vs no imatinib groups.
NCT01148186,TERMINATED,INTERVENTIONAL,Study funding period reached conclusion. Sample size sufficient to complete the analysis on benzodiazepines.
NCT01148238,WITHDRAWN,OBSERVATIONAL,changed research plan
NCT01148264,TERMINATED,INTERVENTIONAL,poor enrolment
NCT01148810,TERMINATED,INTERVENTIONAL,Trial was prematurely terminated due to enrollment challenges.
NCT01148901,WITHDRAWN,INTERVENTIONAL,No patient enrolled after 6 months from the start. The decision to withdraw the study was based on a feasibility reevaluation conducted with investigators.
NCT01148940,TERMINATED,OBSERVATIONAL,insufficent enrollment
NCT01149252,TERMINATED,INTERVENTIONAL,Difficulties arouse in recruiting new patients
NCT01149356,TERMINATED,INTERVENTIONAL,Manufacturer discontinued drug development.
NCT01149434,TERMINATED,INTERVENTIONAL,Lack of drug efficacy
NCT01149603,WITHDRAWN,INTERVENTIONAL,Lack of Enrollement
NCT01149616,TERMINATED,INTERVENTIONAL,"investigators changed jobs, no longer affiliated with institution"
NCT01149993,WITHDRAWN,INTERVENTIONAL,"FDA clinical hold, IND withdrawn."
NCT01150149,WITHDRAWN,INTERVENTIONAL,funding application unsuccessful
NCT01150409,TERMINATED,INTERVENTIONAL,Difficulty in recruiting eligible subjects
NCT01150617,TERMINATED,INTERVENTIONAL,end-point reached
NCT01150812,TERMINATED,INTERVENTIONAL,The study pharmacodynamic stopping criteria were met after the first dosing group
NCT01150890,TERMINATED,INTERVENTIONAL,The study was terminated early based on an imbalance in worsening Crohn's disease in active treatment groups
NCT01151137,TERMINATED,INTERVENTIONAL,The study was stopped because of safety concerns
NCT01151176,SUSPENDED,INTERVENTIONAL,Administrative problems makes changes in hospital staff New clinical research team will restart
NCT01151215,TERMINATED,INTERVENTIONAL,Futility
NCT01151449,TERMINATED,INTERVENTIONAL,Administratively Complete
NCT01151462,WITHDRAWN,OBSERVATIONAL,The study was terminated prior to enrollment
NCT01151501,WITHDRAWN,INTERVENTIONAL,We anticipated that we could not complete this study.
NCT01151553,TERMINATED,INTERVENTIONAL,"No funding, lost support staff. No data collected/processed"
NCT01151592,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT01151735,WITHDRAWN,INTERVENTIONAL,PennState would not allow the study to move forward
NCT01151748,WITHDRAWN,INTERVENTIONAL,Study abandoned; Could not obtain final SRC approval due to IND disagreements
NCT01151761,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01151774,WITHDRAWN,OBSERVATIONAL,"study entered twice, please see protocol 0120110047"
NCT01151787,TERMINATED,INTERVENTIONAL,Study was never initiated under new location/provider group. Contract to continue was never signed between TEVA and Kennedy Headache Center
NCT01151904,TERMINATED,INTERVENTIONAL,Difficulty with patient recruitment
NCT01151943,TERMINATED,INTERVENTIONAL,The study has been halted prematurely beacuse of the occurence of convulsions in one case after TAP block.
NCT01152021,TERMINATED,INTERVENTIONAL,Publication of a similar study. Not ethical to continue.
NCT01152333,WITHDRAWN,INTERVENTIONAL,This study is delayed. It was not funded.
NCT01152944,TERMINATED,OBSERVATIONAL,The affiliated study SAMMPRIS (Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis) has stopped enrollment.
NCT01153061,TERMINATED,INTERVENTIONAL,The study was terminated because the rate of prothesis dislocation was too high.
NCT01153113,WITHDRAWN,INTERVENTIONAL,IND has been withdrawn and the study is closed.
NCT01153698,TERMINATED,OBSERVATIONAL,This trial was prematurely discontinued due to low enrolment.
NCT01153919,TERMINATED,INTERVENTIONAL,Approval of several new agents for the treatment of HCV infection would mitigate the future need for interferon HCV treatment
NCT01153945,WITHDRAWN,OBSERVATIONAL,The sponsor stopped the study.
NCT01154504,WITHDRAWN,INTERVENTIONAL,"We randomized 18 patients, but was impossible to measure adrenomedullin in Brazil. However, we analysed some interesting clinical and laboratorial results."
NCT01154751,TERMINATED,INTERVENTIONAL,"Slow enrollment,increased loss to follow-ups and general lack of interest."
NCT01154868,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew funding of study.
NCT01155063,TERMINATED,OBSERVATIONAL,See Detailed Description
NCT01155310,TERMINATED,INTERVENTIONAL,the observed event rate is lower than expected by the protocol hypothesis.
NCT01155336,TERMINATED,INTERVENTIONAL,Only 5 individuals were able to be recruited.
NCT01155375,TERMINATED,INTERVENTIONAL,Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-251 study as designed.
NCT01155388,TERMINATED,INTERVENTIONAL,Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-252 study as designed.
NCT01155479,TERMINATED,INTERVENTIONAL,Termininated for business reasons
NCT01155518,TERMINATED,INTERVENTIONAL,lack of funding
NCT01155544,WITHDRAWN,INTERVENTIONAL,Seems to have simply stopped.
NCT01155752,WITHDRAWN,INTERVENTIONAL,Never funded
NCT01155869,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01155986,TERMINATED,INTERVENTIONAL,Trial was stopped due to difficult enrolment
NCT01156051,TERMINATED,INTERVENTIONAL,extended beyond completion date; chose to close out rather than renew IRB review
NCT01156220,WITHDRAWN,INTERVENTIONAL,Study was never implemented.
NCT01156272,WITHDRAWN,OBSERVATIONAL,Study terminated prematurely.
NCT01156298,TERMINATED,OBSERVATIONAL,low enrollment
NCT01156324,WITHDRAWN,INTERVENTIONAL,Loss of funding.
NCT01156441,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT01156480,TERMINATED,INTERVENTIONAL,low enrollment
NCT01156519,TERMINATED,INTERVENTIONAL,Number of patients with a serum cortisol \> 18 ng/ml reached
NCT01156532,TERMINATED,OBSERVATIONAL,This study was prematurely terminated due to low enrollment and not for safety reasons.
NCT01156922,TERMINATED,INTERVENTIONAL,"Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up)"
NCT01156961,WITHDRAWN,INTERVENTIONAL,Absence of patient's recruitment in the study due to administrative reasons
NCT01157039,WITHDRAWN,INTERVENTIONAL,abandoned
NCT01157533,TERMINATED,INTERVENTIONAL,Low Accrual.
NCT01157546,TERMINATED,INTERVENTIONAL,"Low recruitment rate. In our center, open radical prostatectomies have been almost completely replaced by robotic prostatectomies."
NCT01157949,WITHDRAWN,INTERVENTIONAL,PI not planning to pursue this study and it was never IRB approved.
NCT01157975,WITHDRAWN,INTERVENTIONAL,Study was completed in another site
NCT01158417,TERMINATED,INTERVENTIONAL,"FDA clinical hold requiring IND submission, product not available in the market anymore"
NCT01158703,TERMINATED,INTERVENTIONAL,poor recruitment and reduction in CT surgery support
NCT01158729,TERMINATED,INTERVENTIONAL,"Grant funding expired, poor patient enrollment"
NCT01158885,TERMINATED,INTERVENTIONAL,Study terminated for lack of accrual.
NCT01158937,TERMINATED,INTERVENTIONAL,Inadequate enrolment and lack of resources
NCT01159054,TERMINATED,INTERVENTIONAL,The funding source is not going to fund this anymore. Only two subjects completed the study therefore meaningful analysis not possible.
NCT01159067,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01159236,WITHDRAWN,INTERVENTIONAL,Recent developments lead to re-evaluation of study.
NCT01159314,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT01159327,TERMINATED,INTERVENTIONAL,low enrolling participants
NCT01159548,TERMINATED,INTERVENTIONAL,Population of interest was no longer available
NCT01159795,TERMINATED,OBSERVATIONAL,Awaiting further funding
NCT01159873,TERMINATED,INTERVENTIONAL,Study has been stopped by sponsor decision
NCT01159964,TERMINATED,INTERVENTIONAL,Study termination due to negative Phase III of another study product from same technology platform.
NCT01160055,WITHDRAWN,OBSERVATIONAL,Key aspects linked to sample management and analysis were not met during feasibility assessment limiting the ability of the study to reach its objectives.
NCT01160237,TERMINATED,INTERVENTIONAL,The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.
NCT01160354,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01160445,TERMINATED,INTERVENTIONAL,The study was terminated because we were not able to obtain the study drug.
NCT01160653,WITHDRAWN,INTERVENTIONAL,Never funded
NCT01160926,TERMINATED,INTERVENTIONAL,2 DLTs had been reported from first 4 patients on lowest possible dose cohort.
NCT01160965,WITHDRAWN,INTERVENTIONAL,Not able provide staff for recruting at present
NCT01161368,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01161498,TERMINATED,INTERVENTIONAL,The changing aetiology of squamous cell carcinoma of the head and neck (SCCHN).
NCT01161641,TERMINATED,INTERVENTIONAL,Extremely slow accural due to rarity of medical condition studied.
NCT01162031,WITHDRAWN,INTERVENTIONAL,no accrual
NCT01162304,TERMINATED,INTERVENTIONAL,unable to enroll subjects meeting Eligibility criteria
NCT01162369,WITHDRAWN,OBSERVATIONAL,Lack of funding.
NCT01162382,TERMINATED,INTERVENTIONAL,Grant support ended following which the key personnel (PI) left the institution.
NCT01162694,SUSPENDED,INTERVENTIONAL,Study was expanded and included in another study.
NCT01162720,TERMINATED,INTERVENTIONAL,The risk of donor blood transfusion was unacceptably high in the Short Duration Group
NCT01162889,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01162915,SUSPENDED,INTERVENTIONAL,Suspended due to lack of funding.
NCT01163201,WITHDRAWN,INTERVENTIONAL,Replaced by a new study
NCT01163448,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT01163526,TERMINATED,OBSERVATIONAL,accrual
NCT01163786,TERMINATED,INTERVENTIONAL,Study was closed due to low accrual before the accrual goal was reached
NCT01163799,TERMINATED,INTERVENTIONAL,"Noted increased risks, greater than expected for standard of care therapy."
NCT01163838,WITHDRAWN,INTERVENTIONAL,Study was redesigned based on FDA feedback.
NCT01163929,WITHDRAWN,INTERVENTIONAL,Study closed by Protocol Review Monitoring Committee because of lack of accrual
NCT01163942,TERMINATED,INTERVENTIONAL,"Ceased production of the study drug, Lymphoglobulin. Recruitment of patients onto the trial was too slow."
NCT01164046,TERMINATED,INTERVENTIONAL,Due to slow inclusion of patients
NCT01164098,TERMINATED,INTERVENTIONAL,Voluntarily terminated by PI due to lack of feasibility.
NCT01164540,WITHDRAWN,INTERVENTIONAL,Due to discussion regarding the design of the study.
NCT01164566,TERMINATED,INTERVENTIONAL,Inadequate Recruitment
NCT01164917,TERMINATED,INTERVENTIONAL,The 16 subjects enrolled in the study should enable Amgen to adequately assess safety and tolerabili
NCT01164956,TERMINATED,INTERVENTIONAL,Insufficient Resources
NCT01164982,WITHDRAWN,INTERVENTIONAL,No resources available at the clinic
NCT01165450,TERMINATED,INTERVENTIONAL,Drug manufacturer could not supply study drug.
NCT01165619,TERMINATED,OBSERVATIONAL,the Principal Investigator left the institution
NCT01165645,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT01165658,TERMINATED,INTERVENTIONAL,Requested by PI during yearly Continuing Review
NCT01166529,WITHDRAWN,INTERVENTIONAL,Unable to identify appropriate patients.
NCT01166581,TERMINATED,OBSERVATIONAL,Not enough data collected to work with
NCT01166724,TERMINATED,INTERVENTIONAL,Collaborator stopped study
NCT01166828,WITHDRAWN,INTERVENTIONAL,Project not funded - withdrawn by VA
NCT01166880,WITHDRAWN,OBSERVATIONAL,Unable to find grant fundingsupport to continue builds the study device.
NCT01166919,WITHDRAWN,INTERVENTIONAL,Laser company cannot provide laser unit for the study.
NCT01167088,TERMINATED,INTERVENTIONAL,This study has been terminated due to poor participant recruitment
NCT01167374,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT01167738,TERMINATED,INTERVENTIONAL,concern of detrimental effect
NCT01167777,TERMINATED,OBSERVATIONAL,Siemens Management decided not to release the product in the USA.
NCT01167816,TERMINATED,INTERVENTIONAL,The study was terminated as the Prinicipal Investigator left the site- all previous subjects enrolled are deceased
NCT01168024,TERMINATED,INTERVENTIONAL,Study closed by sponsor prior to completing enrollment goal.
NCT01168856,TERMINATED,OBSERVATIONAL,This study was terminated due to the decrease in percentage of participants.
NCT01168882,WITHDRAWN,INTERVENTIONAL,Sponsor decision to not initiate clinical trial at this time
NCT01168908,TERMINATED,INTERVENTIONAL,As recommended by the DSMB.
NCT01169064,TERMINATED,INTERVENTIONAL,Interim analysis showed no statistical significance achieved.
NCT01169116,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT01169129,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT01169246,TERMINATED,OBSERVATIONAL,Low recruitement rate
NCT01169350,TERMINATED,INTERVENTIONAL,funding source ended earlier than anticipated
NCT01169415,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT01169493,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01169753,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT01169857,WITHDRAWN,INTERVENTIONAL,No participants were enrolled.
NCT01169870,WITHDRAWN,INTERVENTIONAL,withdrawn studies
NCT01169922,WITHDRAWN,INTERVENTIONAL,The study did not begin and is being terminated from the system.
NCT01169948,WITHDRAWN,OBSERVATIONAL,Not funded.
NCT01170052,WITHDRAWN,INTERVENTIONAL,insufficient enrollment
NCT01170247,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01170364,TERMINATED,INTERVENTIONAL,Terminated due to sibutramine being withdrawn from the market.
NCT01170442,TERMINATED,INTERVENTIONAL,In adequate enrollment
NCT01170468,TERMINATED,INTERVENTIONAL,inadequate enrollement
NCT01170507,WITHDRAWN,INTERVENTIONAL,No funding
NCT01170624,TERMINATED,INTERVENTIONAL,Field Safety Notice related to potential ventricular oversensing associated to the PhD feature on Paradym ICDs
NCT01170650,TERMINATED,INTERVENTIONAL,DSMB decision
NCT01170728,TERMINATED,OBSERVATIONAL,The study has been terminated due to lack of subject enrollment.
NCT01170871,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew support
NCT01170949,TERMINATED,INTERVENTIONAL,Study medication expired
NCT01171157,TERMINATED,OBSERVATIONAL,In the context of the World Health Organization's (WHO) Phase 6 pandemic influenza declaration the conduct of the study was deemed no longer feasible
NCT01171352,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT01171456,WITHDRAWN,INTERVENTIONAL,Insufficient funding for enrollment of patients. The invesitgators realized the study could not be performed.
NCT01171482,TERMINATED,INTERVENTIONAL,There were problems with national reimbursement policies.
NCT01171521,TERMINATED,INTERVENTIONAL,enrollment did not meet projections and numerous lost to follow-up
NCT01171534,TERMINATED,INTERVENTIONAL,Study determined not to be feasible to continue.
NCT01171690,TERMINATED,INTERVENTIONAL,Funding problems
NCT01171755,TERMINATED,INTERVENTIONAL,The objective response rate by more than two people are confirmed.
NCT01172197,TERMINATED,INTERVENTIONAL,Terminated prior to its planned completion as anticipated by the protocol).
NCT01172262,WITHDRAWN,OBSERVATIONAL,"Study did not recieve funding, currenlty undergoing protocol revision."
NCT01172444,TERMINATED,INTERVENTIONAL,Enrollment difficulties
NCT01172509,TERMINATED,INTERVENTIONAL,too much variability in the TMS measures
NCT01172717,WITHDRAWN,INTERVENTIONAL,Study never began
NCT01172743,TERMINATED,OBSERVATIONAL,Lack of funding.
NCT01172756,TERMINATED,INTERVENTIONAL,Recruitment was only stopped after the statistical power of the study was reached and the study objectives could be met despite the premature discontinuation.
NCT01172990,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01173146,WITHDRAWN,OBSERVATIONAL,Costs for antibody production rose; supplemental funding request not approved.
NCT01173263,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01173276,TERMINATED,INTERVENTIONAL,"The field has changed, and we have decided to develop a PrEP program."
NCT01173419,WITHDRAWN,INTERVENTIONAL,Business decision to reevaluate clinical needs.
NCT01173484,TERMINATED,OBSERVATIONAL,Principal investigator has left the Institution
NCT01173510,WITHDRAWN,INTERVENTIONAL,This study was not feasible due to facility budget and contractual issues.
NCT01173679,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01173939,TERMINATED,INTERVENTIONAL,"With recommendation from IDMC, Steering Committee terminated this trial due to ethical concerns raised by J-ART study."
NCT01174082,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01174199,TERMINATED,INTERVENTIONAL,no value in finding efficacy
NCT01174316,WITHDRAWN,INTERVENTIONAL,difficulty recruiting
NCT01174979,SUSPENDED,INTERVENTIONAL,due to less patient the study was suspended
NCT01175278,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT01175291,WITHDRAWN,INTERVENTIONAL,treatment deemed ineffective so accrual was closed
NCT01175330,TERMINATED,INTERVENTIONAL,Interim analysis did not reveal of anticipated benefits of intervention
NCT01175499,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding to continue recruitment; no accrual
NCT01175616,WITHDRAWN,INTERVENTIONAL,Study withdrawn from ClinicalTrials.gov.
NCT01175668,TERMINATED,INTERVENTIONAL,"Based on the planned interim analysis results at 50% recruitment, after IRB reviewed the results, further enrollment was stopped."
NCT01175707,TERMINATED,INTERVENTIONAL,Business decision
NCT01175772,TERMINATED,INTERVENTIONAL,Due to change in the national policy of medications
NCT01175967,TERMINATED,OBSERVATIONAL,Unable to meet accrual due to changing practice patters
NCT01176058,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01176214,TERMINATED,INTERVENTIONAL,slow recruitment of patients
NCT01176318,WITHDRAWN,INTERVENTIONAL,grant was withdrawn no financial support to conduct the study.
NCT01176370,TERMINATED,INTERVENTIONAL,Enrollment for this study was stopped following approval of the C-Pulse System pivotal study IDE.This decision was not based on any safety concerns.
NCT01176422,WITHDRAWN,OBSERVATIONAL,lack of resources; no patient enrollment
NCT01176513,TERMINATED,INTERVENTIONAL,Lack of Subject enrollment
NCT01176565,TERMINATED,INTERVENTIONAL,Planned interim analysis: no significant outcome differences between groups
NCT01176812,WITHDRAWN,OBSERVATIONAL,Difficult to recruit subjects in the area.
NCT01177189,TERMINATED,INTERVENTIONAL,Inadequate effect size.
NCT01177215,TERMINATED,OBSERVATIONAL,Interim analysis showed that the tested protocol did not improve treatment
NCT01177501,TERMINATED,INTERVENTIONAL,choice of the principal investigator
NCT01177540,TERMINATED,INTERVENTIONAL,The study was terminated early due to enrollment difficulties and the futility of observing differences in remission rate between treatment arms.
NCT01177592,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT01177670,TERMINATED,OBSERVATIONAL,Hologic made business decision to no longer sell or manufacture Adiana device.
NCT01177683,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01177709,TERMINATED,INTERVENTIONAL,PI moved to different institution. Decided to concentrate on different studies.
NCT01178047,TERMINATED,INTERVENTIONAL,payments stopped by grant provider
NCT01178151,WITHDRAWN,INTERVENTIONAL,No patients
NCT01178255,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01179100,WITHDRAWN,INTERVENTIONAL,Patient population require high amount of opioids.
NCT01179113,TERMINATED,INTERVENTIONAL,The preliminary result didn't show any benefit.
NCT01179191,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01179269,WITHDRAWN,INTERVENTIONAL,The study was stopped because the research team was unable to enroll any participants
NCT01179308,TERMINATED,INTERVENTIONAL,The principal investigator decided to close this study site.
NCT01179542,WITHDRAWN,OBSERVATIONAL,recruiting problems
NCT01179594,WITHDRAWN,INTERVENTIONAL,This study was canceled for operational reasons.
NCT01179737,TERMINATED,INTERVENTIONAL,Study was terminated due to serious adverse event (SAE)
NCT01179932,WITHDRAWN,OBSERVATIONAL,Never started
NCT01180062,TERMINATED,INTERVENTIONAL,"Study terminated early due to manufacturer not replenishing study site supply of inserts, despite repeated requests for more inserts."
NCT01180764,WITHDRAWN,INTERVENTIONAL,Withdrawn for administrative reasons.
NCT01181596,TERMINATED,OBSERVATIONAL,Images not adequate to visualize catheter penetration or obtain measurements
NCT01181791,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01181843,TERMINATED,OBSERVATIONAL,departmental financial support withdrawn
NCT01181921,TERMINATED,INTERVENTIONAL,The recruitment rate was very low (one screening failure and one early withdrawal patient)
NCT01181947,TERMINATED,OBSERVATIONAL,"CIP was amended to include long-term FU but, not all sites accepted it so the nr. of pts participating in the extended FU will be small."
NCT01182233,TERMINATED,INTERVENTIONAL,low enrollment
NCT01182298,TERMINATED,OBSERVATIONAL,small number of patients enrolled
NCT01182350,TERMINATED,INTERVENTIONAL,Per design: Stop if fewer than 3 cohorts by molecular classification were with 10 participants or only 1 cohort enrolled at least 15 participants of 50.
NCT01182467,TERMINATED,OBSERVATIONAL,PI left the institution
NCT01182610,TERMINATED,INTERVENTIONAL,Safety concern in a similar trial enrolling the same patient population
NCT01182675,TERMINATED,INTERVENTIONAL,Insufficient evidence of efficacy
NCT01182974,SUSPENDED,INTERVENTIONAL,Difficulty in patient enrollment
NCT01183130,WITHDRAWN,INTERVENTIONAL,The technology planned to be used in the study got outdated and therefore the study will not be conducted according to the initial protocol.
NCT01183377,TERMINATED,OBSERVATIONAL,the study terminated last week
NCT01183442,TERMINATED,INTERVENTIONAL,unable to recruit
NCT01183455,WITHDRAWN,INTERVENTIONAL,Sponsor decision-lack of mechanistic signal and competing industry studies
NCT01183468,TERMINATED,INTERVENTIONAL,Due to lack of mechanistic signal and competing industry studies
NCT01183481,TERMINATED,INTERVENTIONAL,Study was stopped due to inadequate accrual.
NCT01183637,TERMINATED,INTERVENTIONAL,Study enrollment rate was far slower than anticipated. Study was stopped for business purposes.
NCT01183819,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01183884,TERMINATED,INTERVENTIONAL,Low participant accrual
NCT01183962,TERMINATED,INTERVENTIONAL,"slow enrollment, funding ended"
NCT01184027,WITHDRAWN,OBSERVATIONAL,The study did not receive funding.
NCT01184053,TERMINATED,INTERVENTIONAL,Accrual was very low. No subject had been enrolled in a year.
NCT01184196,TERMINATED,INTERVENTIONAL,ChloroPrep Wipes no longer available
NCT01184287,WITHDRAWN,INTERVENTIONAL,Program discontinued
NCT01184443,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01184508,TERMINATED,INTERVENTIONAL,Elevation of ALT and AST in some patients.
NCT01184911,WITHDRAWN,INTERVENTIONAL,Research plan changed; no longer conducting clinical trial.
NCT01185509,TERMINATED,INTERVENTIONAL,Not enough confirmed responses to continue treatment.
NCT01185548,TERMINATED,INTERVENTIONAL,Terminated based on safety results from another trial
NCT01185691,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01186029,WITHDRAWN,INTERVENTIONAL,It didn't get IRB approval.
NCT01186185,TERMINATED,INTERVENTIONAL,"PI moved to new institution, unable to complete study"
NCT01186289,WITHDRAWN,INTERVENTIONAL,Principal Investigator decided not to pursue enrollment due to changes in standard of care.
NCT01186328,TERMINATED,INTERVENTIONAL,Enzon Pharmaceuticals decided to end its development of EZN-3042.
NCT01186406,TERMINATED,INTERVENTIONAL,Study ended early due to toxicity
NCT01186458,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01186705,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01187381,TERMINATED,OBSERVATIONAL,Study was prematurely terminated because of missing data collection.
NCT01187446,TERMINATED,INTERVENTIONAL,Business decision by funding source
NCT01187576,WITHDRAWN,INTERVENTIONAL,Never started
NCT01187680,TERMINATED,INTERVENTIONAL,Financial and organisational reasons
NCT01187810,TERMINATED,INTERVENTIONAL,drug supply
NCT01187888,TERMINATED,INTERVENTIONAL,IMP used off label by phys. in pat. with PSP. Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion
NCT01187992,TERMINATED,INTERVENTIONAL,Interim analysis showed significant effect in favour of full-dose atorvastatin.
NCT01188109,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01188226,TERMINATED,INTERVENTIONAL,Enrollment difficulties and drop outs
NCT01188369,TERMINATED,INTERVENTIONAL,Terminated prematurely due to high incidence of postoperative atrial fibrillation.
NCT01188408,WITHDRAWN,INTERVENTIONAL,Study shut-down in 12/2010 when NeoPharm merged with Insys.
NCT01188473,WITHDRAWN,INTERVENTIONAL,Pilot early noninvasive ventilation on all children who met the criteria was effective.
NCT01188486,TERMINATED,INTERVENTIONAL,Business decision
NCT01188707,TERMINATED,INTERVENTIONAL,Dose over MTD reached
NCT01188889,WITHDRAWN,INTERVENTIONAL,Unable to obtain sufficient funding.
NCT01188915,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01188954,WITHDRAWN,INTERVENTIONAL,The recruitment process was slower than expected.
NCT01189019,TERMINATED,INTERVENTIONAL,Drug dose became unavailable
NCT01189071,TERMINATED,INTERVENTIONAL,Co-Investigator left institution. No data analysis occurred.
NCT01189227,TERMINATED,INTERVENTIONAL,The study was terminated due to low accrual.
NCT01189240,TERMINATED,INTERVENTIONAL,Company decided to stop development of drug - 7/31/12
NCT01189253,TERMINATED,INTERVENTIONAL,Results of step1: none of the experimental arms fulfills expectations and the study will not continue as a phase III.
NCT01189409,TERMINATED,INTERVENTIONAL,This study was terminated based on results of interim analysis.
NCT01189435,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01189513,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT01189708,TERMINATED,INTERVENTIONAL,"Treatment without success, low enrollment, one serious adverse event"
NCT01189864,TERMINATED,OBSERVATIONAL,Terminated to initiate FDA IND-cleared study protocol
NCT01190111,TERMINATED,INTERVENTIONAL,CYTHERISSA filed for banckcuptcy in June 2013.Subjects treated by CYT 107 were followed up for at the least 3 months.
NCT01190163,TERMINATED,INTERVENTIONAL,Study was early terminated due to problems enrolling adequate number of patients
NCT01190306,TERMINATED,INTERVENTIONAL,The sponsor terminated the study prior to data analysis for financial reasons.
NCT01190644,TERMINATED,INTERVENTIONAL,Isotope needed to conduct RBC/PV analysis (primary endpoint) no longer available from manufacturer. No alternatives available for use.
NCT01190722,WITHDRAWN,INTERVENTIONAL,The study site was closed down
NCT01190839,TERMINATED,INTERVENTIONAL,Study is terminated as per Sponsor's Decision.
NCT01190969,WITHDRAWN,INTERVENTIONAL,difficulty in recruiting elderly subjects
NCT01191034,TERMINATED,INTERVENTIONAL,Completion after 2 patients then stop due to end of validity of vaccine peptide
NCT01191177,WITHDRAWN,INTERVENTIONAL,no subjects recruited
NCT01191307,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT01191385,WITHDRAWN,OBSERVATIONAL,Study is officially cancelled bevore FPFV.
NCT01191567,TERMINATED,INTERVENTIONAL,insufficient recruitement speed
NCT01191749,TERMINATED,INTERVENTIONAL,Low Accrual
NCT01191970,WITHDRAWN,OBSERVATIONAL,Withdrawn from IRB
NCT01192074,TERMINATED,OBSERVATIONAL,Lack of personnel/research time to recruit participants.
NCT01192321,TERMINATED,INTERVENTIONAL,Business decision to close study based on low enrollment
NCT01192503,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01192685,TERMINATED,INTERVENTIONAL,Neuronavigation system equipment failure caused unreliable data
NCT01192776,TERMINATED,INTERVENTIONAL,The trial closed for emerging safety profile and futility analysis and will not resume.
NCT01192815,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT01193036,TERMINATED,OBSERVATIONAL,Low accrual.
NCT01193166,WITHDRAWN,INTERVENTIONAL,This study was stopped due to an internal reconsideration of priorities of the product portfolio.
NCT01193192,TERMINATED,OBSERVATIONAL,Inadequate number of charts available for Test Group
NCT01193491,TERMINATED,INTERVENTIONAL,"Drug exposure of retaspimycin HCl was superior to IPI-493, Infinity will focus on Retaspimycin HCL"
NCT01193530,TERMINATED,INTERVENTIONAL,Low Accrual
NCT01193556,TERMINATED,INTERVENTIONAL,Termination due to acquisition of PEAK Surgical by Medtronic
NCT01193712,WITHDRAWN,INTERVENTIONAL,too limited number of eligible patients
NCT01193777,TERMINATED,INTERVENTIONAL,Study stopped to open expanded phase II study
NCT01193868,TERMINATED,INTERVENTIONAL,Study drug production halted.
NCT01194167,WITHDRAWN,INTERVENTIONAL,Inability to identify eligible patients
NCT01194193,WITHDRAWN,INTERVENTIONAL,Amendment to study compound development programme
NCT01194206,WITHDRAWN,INTERVENTIONAL,Study being rewritten
NCT01194232,WITHDRAWN,INTERVENTIONAL,"Funding, MedWatch change to study drug"
NCT01194284,TERMINATED,OBSERVATIONAL,Regulatory agency commitment fulfilled.
NCT01194297,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01194427,TERMINATED,INTERVENTIONAL,Difficulty meeting patient accrual goals
NCT01194531,TERMINATED,INTERVENTIONAL,Slow enrollment and Natera is transitioning to a new PGS testing platform.
NCT01194609,TERMINATED,INTERVENTIONAL,No further enrollment after two patients
NCT01194674,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT01194856,TERMINATED,INTERVENTIONAL,Closed due to low enrollment
NCT01194869,TERMINATED,INTERVENTIONAL,"Slow accrual, availability of other clinical options"
NCT01194908,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01195103,TERMINATED,INTERVENTIONAL,Funding terminated by funding source.
NCT01195129,TERMINATED,INTERVENTIONAL,"Due to results shown by the Cerecyte Clinical Trial, HCAT stopped enrolling."
NCT01195220,WITHDRAWN,INTERVENTIONAL,We could not obtain proper funding to complete this study.
NCT01195285,TERMINATED,INTERVENTIONAL,Investigator decisions based on slow enrollment.
NCT01195428,WITHDRAWN,INTERVENTIONAL,Minimal enrollment
NCT01195480,TERMINATED,INTERVENTIONAL,Due to lack of biological efficacy and CD19 CAR CTL persistence
NCT01195779,TERMINATED,INTERVENTIONAL,The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.
NCT01195844,TERMINATED,OBSERVATIONAL,Inadequate recruitment
NCT01195974,TERMINATED,INTERVENTIONAL,"In a Phase II study in HIV-infected patients there were a number of seizures, although exact causality could not be assessed phase 1 activity was terminated."
NCT01196000,WITHDRAWN,INTERVENTIONAL,The study has never been opened to accrual at COH. Study to be closed at COH due to the lack of qualified robotic colorectal surgeons.
NCT01196104,TERMINATED,INTERVENTIONAL,For Business Reasons
NCT01196169,TERMINATED,INTERVENTIONAL,The study is closed to accrual. Enrollment of new patients stopped at the request of CUBIST Pharmaceuticals due to slow rate of enrollment.
NCT01196845,TERMINATED,INTERVENTIONAL,Enrollment difficulty
NCT01197209,WITHDRAWN,INTERVENTIONAL,Suspended due to change in development plans and investigator
NCT01197235,TERMINATED,INTERVENTIONAL,difficult to enroll targeted participants
NCT01197482,TERMINATED,OBSERVATIONAL,"6 out of 20 patients were included. The trend towards the treatment of severe asthma has meanwhile developed in a different direction, so that there is no longer any intention to pursue the study objective mentioned here."
NCT01197664,TERMINATED,INTERVENTIONAL,Study terminated due to funding issues
NCT01197963,TERMINATED,INTERVENTIONAL,IRB temporarily halted enrollment
NCT01197989,TERMINATED,INTERVENTIONAL,Unable to recruit suitable subjects within a reasonable time period.
NCT01198002,TERMINATED,INTERVENTIONAL,"Terminated not based on safety concerns, but due to insufficient efficacy."
NCT01198119,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01198379,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01198522,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01198548,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01198626,TERMINATED,INTERVENTIONAL,Enrollment would not have been met prior to the end of the pneumonia season. Termination is based on slow enrollment and not related to safety or efficacy.
NCT01198652,TERMINATED,OBSERVATIONAL,Study discontinued following 57 subjects enrolled over 2 years
NCT01199133,TERMINATED,INTERVENTIONAL,Following the DSMB recommendation. Study population being insufficiently symptomatic to enable differentiation between treatment and placebo. No safety concerns
NCT01199211,TERMINATED,OBSERVATIONAL,IRB approval expired
NCT01199302,TERMINATED,INTERVENTIONAL,The study was terminated early based on an imbalance in worsening Crohn's disease in active treatment groups.
NCT01199367,TERMINATED,INTERVENTIONAL,The results of the dose escalation phase did not identify a well-tolerated dose that would permit further study in Phase 2.
NCT01199731,TERMINATED,INTERVENTIONAL,The study was stopped due to safety concerns
NCT01199783,TERMINATED,INTERVENTIONAL,"Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made."
NCT01199991,TERMINATED,OBSERVATIONAL,"Limited funding, change in research priorities."
NCT01200004,TERMINATED,INTERVENTIONAL,Slow Accrual.
NCT01200069,TERMINATED,INTERVENTIONAL,unable to increase to target enrollment
NCT01200082,TERMINATED,OBSERVATIONAL,Institutional Review Board approval not maintained
NCT01200147,WITHDRAWN,INTERVENTIONAL,Manufacturer stopped producing rings
NCT01200212,TERMINATED,INTERVENTIONAL,"A planed interim analysis shows no benefits, but higher adverse event rates for the experimental arm."
NCT01200264,WITHDRAWN,INTERVENTIONAL,Contract never executed; withdrawn by sponsor
NCT01200342,TERMINATED,INTERVENTIONAL,Pharmaceutical company no longer manufacturing investigational product.
NCT01200407,TERMINATED,OBSERVATIONAL,The requirement for Post Marketing Surveillance was lifted by the Philippine FDA
NCT01200537,WITHDRAWN,INTERVENTIONAL,Change in staffing
NCT01200563,WITHDRAWN,INTERVENTIONAL,Study site compliance
NCT01200589,TERMINATED,INTERVENTIONAL,The study stopped due to futility.
NCT01200602,TERMINATED,INTERVENTIONAL,The study closed due to slow accrual.
NCT01200797,TERMINATED,INTERVENTIONAL,Slow accrual was the reason for study termination.
NCT01200810,TERMINATED,INTERVENTIONAL,Drug was no longer available
NCT01200914,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01200992,TERMINATED,INTERVENTIONAL,Lack of Recruitment
NCT01201213,TERMINATED,INTERVENTIONAL,Audit pre regulatory inspection
NCT01201291,TERMINATED,INTERVENTIONAL,Due to slow recruitment the study was terminated
NCT01201434,TERMINATED,INTERVENTIONAL,Severe allergic reaction in one patient
NCT01201538,TERMINATED,INTERVENTIONAL,Study PI passed away We had trouble recruiting for the drug arm
NCT01201564,TERMINATED,INTERVENTIONAL,Recruiting problems
NCT01201629,TERMINATED,INTERVENTIONAL,Slow accrual over 6 year period
NCT01201707,TERMINATED,INTERVENTIONAL,Inability to enroll adequate number of patients
NCT01201850,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01201928,TERMINATED,OBSERVATIONAL,Parent trials were either not initiated or terminated
NCT01202058,TERMINATED,INTERVENTIONAL,The NEVO stent will not be commercialized. Cordis decided to close the study after 1 years. This decision took the absence of safety signals into account.
NCT01202266,TERMINATED,INTERVENTIONAL,"The study was terminated on October 29, 2010 due to gastrointestinal adverse events."
NCT01202318,WITHDRAWN,OBSERVATIONAL,The study design was changed to a prospective cohort study due to difficulties in using a randomized approach in an emergency setting
NCT01202344,SUSPENDED,INTERVENTIONAL,lack of funding
NCT01202500,TERMINATED,INTERVENTIONAL,Fansidar marketing discontinued
NCT01202513,WITHDRAWN,INTERVENTIONAL,regulatory reasons
NCT01202539,WITHDRAWN,OBSERVATIONAL,Enrollment challenges
NCT01202630,SUSPENDED,INTERVENTIONAL,The site is unable to recruit patients.
NCT01202643,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01202721,TERMINATED,INTERVENTIONAL,Terminated early due to lack of study feasibility and poor patient recruitment
NCT01202773,TERMINATED,INTERVENTIONAL,"Terminated not based on safety concerns, but due to insufficient efficacy."
NCT01202890,TERMINATED,INTERVENTIONAL,Terminated due to inadequate rate of accrual.
NCT01202929,WITHDRAWN,OBSERVATIONAL,Principal investigator has left the Institution
NCT01203163,WITHDRAWN,OBSERVATIONAL,Sponsor cancelled the study
NCT01203254,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01203397,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01203579,WITHDRAWN,OBSERVATIONAL,Due to lack of funding
NCT01203618,WITHDRAWN,INTERVENTIONAL,Trial terminated due to focus of primary therapeutic areas.
NCT01203878,TERMINATED,INTERVENTIONAL,Unable to reach target enrollment of 60 subjects
NCT01203943,TERMINATED,INTERVENTIONAL,The benefit/ risk profile does not support continuation of this study.
NCT01204138,WITHDRAWN,INTERVENTIONAL,decision of sponsor to withdraw before initiation; 0 patients enrolled
NCT01204216,TERMINATED,INTERVENTIONAL,technical barriers to completing the original design within the funding period
NCT01204411,WITHDRAWN,INTERVENTIONAL,The ethics committee did not approve the pharmacokinetic part of the study.
NCT01204450,TERMINATED,INTERVENTIONAL,Funding has become unavailable
NCT01204502,TERMINATED,INTERVENTIONAL,Changes in the clinical practice
NCT01204788,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT01204853,TERMINATED,INTERVENTIONAL,"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury."
NCT01205204,WITHDRAWN,INTERVENTIONAL,This study was registered with Clinical Trials.gov by mistake.
NCT01205217,WITHDRAWN,INTERVENTIONAL,Data presented at SABCS 2010 showing that dual blockade is superior to monotherapy
NCT01205334,TERMINATED,INTERVENTIONAL,poor accrual
NCT01205516,TERMINATED,INTERVENTIONAL,Funding agency withdrew funding due to slow recruitment
NCT01205555,TERMINATED,INTERVENTIONAL,sufficient participants for analysis
NCT01205633,SUSPENDED,OBSERVATIONAL,9/12/12 FDA stopped enrollment pending device exemption(IDE)application.
NCT01205685,TERMINATED,INTERVENTIONAL,"PI closed study early, all patients experienced severe toxicities and progressed"
NCT01205828,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01206101,TERMINATED,INTERVENTIONAL,The decision to close the NN2211-3619 trial was based on the very low recruitment rate as well as challenges relating to trial execution and study completion.
NCT01206166,TERMINATED,INTERVENTIONAL,Low enrollment rates.
NCT01206296,TERMINATED,INTERVENTIONAL,Study suspended
NCT01206439,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01206699,TERMINATED,INTERVENTIONAL,after 4 years of recruitment only 16 patients have been included. Due to this low rate of recruitment it was decided to stop the study
NCT01206907,WITHDRAWN,INTERVENTIONAL,The study is no longer required for the PREA for this product.
NCT01206998,WITHDRAWN,INTERVENTIONAL,Withdrawal of support of the drug company for drug and placebo
NCT01207076,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01207102,TERMINATED,INTERVENTIONAL,Low enrollment and there is insufficient data to publish.
NCT01207128,WITHDRAWN,INTERVENTIONAL,None enrolled
NCT01207154,WITHDRAWN,OBSERVATIONAL,Difficulty in Recruitment due to lack of investigators and suitable patients
NCT01207622,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT01207726,TERMINATED,INTERVENTIONAL,Slow Accrual due to patients not wanting daily clinic administration of 5AZA and/or 6 months of treatment after surgery.
NCT01207765,TERMINATED,INTERVENTIONAL,changes in practice
NCT01208064,TERMINATED,INTERVENTIONAL,based on IDMC decision
NCT01208142,TERMINATED,INTERVENTIONAL,Unrelated to trial
NCT01208220,TERMINATED,INTERVENTIONAL,Low enrollment of qualified subjects
NCT01208233,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01208402,TERMINATED,INTERVENTIONAL,Baxter has terminated the study for inadequate enrollment rate accrual.
NCT01208740,TERMINATED,INTERVENTIONAL,Concerns about safety at the first interim analysis
NCT01209013,WITHDRAWN,INTERVENTIONAL,Sponsor cancelled the study
NCT01209390,TERMINATED,OBSERVATIONAL,Slow recruitment rate
NCT01209546,TERMINATED,INTERVENTIONAL,The protocol finished.
NCT01209559,WITHDRAWN,OBSERVATIONAL,Study never initiated.
NCT01209663,TERMINATED,INTERVENTIONAL,30th November 2012. Please see breif summary.
NCT01209689,TERMINATED,INTERVENTIONAL,Clinical development program terminated due to failure to achieve efficacy
NCT01209702,TERMINATED,INTERVENTIONAL,Recruitment halted: Failed to achieve efficacy
NCT01209715,WITHDRAWN,INTERVENTIONAL,"Due to the ubiquitous use of ICS in the treatment of COPD in 2012, it was hard to find the study population."
NCT01209832,TERMINATED,INTERVENTIONAL,Terminated based on safety results from another trial
NCT01210066,TERMINATED,INTERVENTIONAL,Unable to recruit prescription opioid abusers; ultimately no potential POA recruit passed the pre-screening process
NCT01210144,TERMINATED,INTERVENTIONAL,Study terminated due to recruitment failure
NCT01210365,TERMINATED,INTERVENTIONAL,EF decided suspended the study because the investigational product was changed.
NCT01210378,TERMINATED,INTERVENTIONAL,Accrual stopped
NCT01210443,TERMINATED,INTERVENTIONAL,"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury."
NCT01210508,TERMINATED,OBSERVATIONAL,low enrollment
NCT01210521,WITHDRAWN,INTERVENTIONAL,Sponsor terminated study due to inability to enroll subjects.
NCT01210547,TERMINATED,OBSERVATIONAL,"Lack of funding, departure of key personnel"
NCT01210677,WITHDRAWN,INTERVENTIONAL,No funding obtained.
NCT01211314,TERMINATED,INTERVENTIONAL,sponsor decision
NCT01211431,WITHDRAWN,INTERVENTIONAL,No inclusions.
NCT01211639,TERMINATED,OBSERVATIONAL,Due to lack of enrollment.
NCT01211665,TERMINATED,INTERVENTIONAL,This study was stopped prematurely due to lack of enrollment within a 1-5-year period.
NCT01211691,SUSPENDED,INTERVENTIONAL,KaloBios to Wind Down Operations
NCT01211704,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01211756,TERMINATED,INTERVENTIONAL,Break in funding
NCT01211782,WITHDRAWN,INTERVENTIONAL,Study never started. Study was redesgined.
NCT01212029,SUSPENDED,INTERVENTIONAL,Premature suspension of the research by the institution due to audit findings.
NCT01212094,TERMINATED,INTERVENTIONAL,The efficacy on CSF biomarkers failed to reach criteria for continuation of the trial
NCT01212237,WITHDRAWN,OBSERVATIONAL,There were no patients enrolled on this study.
NCT01212276,TERMINATED,INTERVENTIONAL,Sponsor terminated protocol
NCT01212588,TERMINATED,INTERVENTIONAL,Funding ended
NCT01212627,TERMINATED,INTERVENTIONAL,Determination to stop enrollment made due to funding
NCT01212835,TERMINATED,INTERVENTIONAL,lack of follow up
NCT01212887,TERMINATED,INTERVENTIONAL,due to safety concerns and lack of efficacy
NCT01212939,TERMINATED,OBSERVATIONAL,No advantage seen during continued animal studies. Difficult recruitment.
NCT01212965,TERMINATED,INTERVENTIONAL,"The investigators chose to terminate the study due to participant attrition. Of the limited data evaluable, none of the patients experienced adverse events."
NCT01213277,SUSPENDED,INTERVENTIONAL,a pilot study of 7 patients did not reveal a temperature dependent difference in glycation rates
NCT01213342,TERMINATED,INTERVENTIONAL,Researchers left institution
NCT01213394,TERMINATED,INTERVENTIONAL,Poor recruitment.
NCT01213563,TERMINATED,INTERVENTIONAL,Data were published that superseded this study.
NCT01213576,TERMINATED,INTERVENTIONAL,Introduction of National Mass Drug Administration Campaign and failure to identify appropriate participants.
NCT01213823,TERMINATED,OBSERVATIONAL,"The study was terminated on May 5, 2011, due to methodological issues. The decision to terminate the study was not based on any safety or efficacy concerns."
NCT01213888,TERMINATED,INTERVENTIONAL,Low enrollment \& superior treatments available for diabetic macular edema including anti-VEFG therapies such as bevacizumab and ranibizumab.
NCT01214018,TERMINATED,OBSERVATIONAL,No recruitment
NCT01214057,TERMINATED,INTERVENTIONAL,the study was terminated for patient recruitment difficulty and interim power analysis
NCT01214070,TERMINATED,INTERVENTIONAL,Administrative Closure
NCT01214096,TERMINATED,INTERVENTIONAL,The same protocol has been launched in United States.
NCT01214174,TERMINATED,INTERVENTIONAL,Study C11-01 started
NCT01214291,WITHDRAWN,INTERVENTIONAL,cost of conducting the study and increased burden on the clinical trial professionals make it impossible for us to proceed with the development of the drug.
NCT01214473,TERMINATED,INTERVENTIONAL,DSMB stopped the study due to early effectiveness
NCT01214655,TERMINATED,INTERVENTIONAL,Primary objective has been met in the absence of clinically meaningful remissions
NCT01215019,WITHDRAWN,INTERVENTIONAL,Lack of funding; not subjects enrolled
NCT01215032,TERMINATED,INTERVENTIONAL,"slow accrual, competing clinical trials"
NCT01215136,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT01215266,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01215409,TERMINATED,OBSERVATIONAL,Slow recruitment
NCT01215552,TERMINATED,INTERVENTIONAL,The experimental design was not sufficient to answer the proposed questions. A new study design is now being considered.
NCT01215565,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT01215578,TERMINATED,INTERVENTIONAL,lack of recruitement
NCT01215838,TERMINATED,OBSERVATIONAL,Unable to meet enrollment expectations.
NCT01215942,TERMINATED,INTERVENTIONAL,Insufficient efficacy observed in study BCDM (NCT01198002) and BCDV (NCT01202773).
NCT01215981,TERMINATED,INTERVENTIONAL,Lack of patients and no longer influenza vaccine season.
NCT01216020,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01216241,TERMINATED,INTERVENTIONAL,The study has shown futility and the objectives could not be reached without enrolling a very large number of subjects.
NCT01216436,TERMINATED,INTERVENTIONAL,The PI retired
NCT01216449,TERMINATED,INTERVENTIONAL,loss of funding
NCT01216501,TERMINATED,OBSERVATIONAL,Recruiting was not as anticipated.
NCT01216631,TERMINATED,INTERVENTIONAL,Unable to recruit
NCT01216657,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01216787,WITHDRAWN,INTERVENTIONAL,Study drug not available.
NCT01217047,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01217099,TERMINATED,INTERVENTIONAL,terminated
NCT01217411,TERMINATED,INTERVENTIONAL,Slow accrual coupled with discontinuation of study drug.
NCT01217580,WITHDRAWN,INTERVENTIONAL,The study was not feasible to perform at one institution with the amount of subjects that were needed to complete it.
NCT01217632,TERMINATED,INTERVENTIONAL,Study terminated due to an unexpected prominent effect of entecavir alone in this patient population.
NCT01217814,TERMINATED,INTERVENTIONAL,"Due to delay in the study and the impact on the development timelines, not due to any identified safety concerns"
NCT01218009,TERMINATED,INTERVENTIONAL,Change to study required.
NCT01218087,TERMINATED,INTERVENTIONAL,Study discontinued by DSMB due to loss of equipoise.
NCT01218230,WITHDRAWN,INTERVENTIONAL,Funding did not come through as the product was sold to another company.
NCT01218490,SUSPENDED,INTERVENTIONAL,qualitative analysis of the study database
NCT01218815,TERMINATED,INTERVENTIONAL,Due to very low enrollment rate the study was terminated.
NCT01218867,TERMINATED,INTERVENTIONAL,No objective responses were observed.
NCT01218919,WITHDRAWN,OBSERVATIONAL,Business reasons
NCT01219049,TERMINATED,INTERVENTIONAL,"Due to FDA comments, changes required unavailable resources. There are no results for this study."
NCT01219062,TERMINATED,INTERVENTIONAL,"Surgeon team were not happy with the study protocol, the periarticular injection of local anesthetics"
NCT01219114,WITHDRAWN,OBSERVATIONAL,Inability to recruit patients within the specified time period. No patients have been enrolled in the study.
NCT01219543,TERMINATED,INTERVENTIONAL,Compound development discontinued
NCT01219673,TERMINATED,INTERVENTIONAL,Low accrual.
NCT01219686,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01219894,WITHDRAWN,OBSERVATIONAL,Number of patients to meet individual IDE requirements was not obtained.
NCT01220128,TERMINATED,INTERVENTIONAL,Study termination due to negative Ph III of another study product from same technology platform.
NCT01220297,TERMINATED,INTERVENTIONAL,Low accrual
NCT01220739,TERMINATED,INTERVENTIONAL,Device sponsor no longer in business.
NCT01221116,TERMINATED,INTERVENTIONAL,The study was stopped due to difficulties in including patients
NCT01221389,WITHDRAWN,INTERVENTIONAL,Lack of funding to afford plasma
NCT01221415,WITHDRAWN,OBSERVATIONAL,not enough manpower
NCT01221714,TERMINATED,OBSERVATIONAL,Ameriscience went bankrupt.
NCT01221740,WITHDRAWN,INTERVENTIONAL,Company decided to discontinue
NCT01221753,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT01221961,TERMINATED,OBSERVATIONAL,"We completed the 62% of the cases, enough data to get a conclusion of the study."
NCT01222013,SUSPENDED,INTERVENTIONAL,"Study was suspended before recruitment, due to logistic issues."
NCT01222078,TERMINATED,INTERVENTIONAL,A Phase 3 study recently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.
NCT01222195,TERMINATED,INTERVENTIONAL,Low accrual.
NCT01222377,TERMINATED,INTERVENTIONAL,P.I. left
NCT01222416,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01222572,TERMINATED,INTERVENTIONAL,Slow accrual due to restrictive eligibility criteria
NCT01222819,TERMINATED,INTERVENTIONAL,Physycians' refusal to continue the study
NCT01222871,TERMINATED,INTERVENTIONAL,not enough particpants
NCT01223001,TERMINATED,INTERVENTIONAL,Most potential subjects had already been prescribed Cymbalta.
NCT01223053,WITHDRAWN,INTERVENTIONAL,Revised Development Program
NCT01223066,WITHDRAWN,OBSERVATIONAL,no patients recruited
NCT01223105,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01223430,TERMINATED,INTERVENTIONAL,"The IRB considered our trial risky. Although there were debates between investigators and IRB, we terminated our trial in accordance with the suggestion of IRB."
NCT01223443,TERMINATED,INTERVENTIONAL,The trial was prematurely stopped due to slow patient enrolment.
NCT01223456,TERMINATED,OBSERVATIONAL,Inability to recruit adequate number of patients within the specified time period.
NCT01223638,WITHDRAWN,OBSERVATIONAL,written here by mistake
NCT01223651,TERMINATED,INTERVENTIONAL,Suspended awaiting Ministry of Defence ethics approval.
NCT01223755,TERMINATED,INTERVENTIONAL,safety and efficacy reason
NCT01224509,TERMINATED,INTERVENTIONAL,Longer than expected recruitment period.
NCT01224522,TERMINATED,INTERVENTIONAL,protocol deviations
NCT01224795,TERMINATED,INTERVENTIONAL,This study was terminated for administrative reasons
NCT01224964,TERMINATED,INTERVENTIONAL,A lot of patients recruited in our center were already on montelukast treatment. It was not possible to recruit sufficient patients for the study.
NCT01225016,WITHDRAWN,INTERVENTIONAL,"Due to lack of funding and issues with ability to complete all procedures, it was decided that this study could not be carried out and therefore withdrawn."
NCT01225146,TERMINATED,INTERVENTIONAL,"The collaborator, Genentech, stopped supplying the study drug to the site."
NCT01225159,TERMINATED,INTERVENTIONAL,Hypoglycaemia is significantly higher in TGC
NCT01225172,TERMINATED,INTERVENTIONAL,Business objectives have changed.
NCT01225276,TERMINATED,INTERVENTIONAL,Study Terminated.priority changes in product development.
NCT01225341,TERMINATED,INTERVENTIONAL,Too many patients withdrew/lost to follow up
NCT01225705,WITHDRAWN,INTERVENTIONAL,no pts recruited
NCT01225757,WITHDRAWN,INTERVENTIONAL,Logistical problems prior to the recruitment phase
NCT01226056,SUSPENDED,INTERVENTIONAL,toxicity (protocol amendment under approval)
NCT01226121,TERMINATED,INTERVENTIONAL,difficulty enrolling additional patients
NCT01226290,TERMINATED,INTERVENTIONAL,Investigational device changes; adequate enrollment achieved
NCT01226420,TERMINATED,INTERVENTIONAL,Discontinuation of drug supply from Astellas.
NCT01226524,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01226745,TERMINATED,INTERVENTIONAL,Merck has decided to not pursue phase 3 development of ceralifimod (ONO-4641). The decision was not related to any safety and efficacy findings
NCT01226797,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01226823,WITHDRAWN,INTERVENTIONAL,Modified insurance requests by a new law released after its approval.
NCT01226888,TERMINATED,OBSERVATIONAL,Slow accrual
NCT01226992,TERMINATED,INTERVENTIONAL,Unavailable study resources
NCT01227018,TERMINATED,INTERVENTIONAL,interim analysis found the study drug to be ineffective
NCT01227408,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew due to funding issues
NCT01227512,TERMINATED,INTERVENTIONAL,"Recruitment challenges and results of interim futility analysis, which showed less than likely to achieve primary endpoint goal-length of hospital stay."
NCT01227681,TERMINATED,INTERVENTIONAL,Difficulty in Recruitment
NCT01228019,TERMINATED,OBSERVATIONAL,"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs"
NCT01228266,TERMINATED,INTERVENTIONAL,Ended the recruitment in June 2012 for low enrollement accrual
NCT01228435,TERMINATED,INTERVENTIONAL,slow accrual
NCT01228474,TERMINATED,INTERVENTIONAL,"Due to the high number of multiples pregnancies in the double embryo transfer group, we have decided to stop the enrollment of patients at 07/31/2012"
NCT01228864,TERMINATED,INTERVENTIONAL,low accrual
NCT01228890,WITHDRAWN,INTERVENTIONAL,no one enrolled; PI left institution
NCT01228929,TERMINATED,INTERVENTIONAL,The study was terminated.
NCT01228942,WITHDRAWN,INTERVENTIONAL,Lack of funding/resources
NCT01228994,TERMINATED,INTERVENTIONAL,The study was terminated because of difficulties recruiting subjects.
NCT01229046,WITHDRAWN,INTERVENTIONAL,No enrollment occured. Subjects will be enrolled under a new protocol.
NCT01229111,TERMINATED,INTERVENTIONAL,Lack of Drug Supply
NCT01229488,WITHDRAWN,INTERVENTIONAL,I withdrew from this study
NCT01229553,WITHDRAWN,INTERVENTIONAL,protocol was never implemented as procedures became standard of care
NCT01229592,TERMINATED,INTERVENTIONAL,"The non significative reduction of CRBSI adverse events,the need for a high frecuency of catheter manipulations"
NCT01229605,WITHDRAWN,INTERVENTIONAL,Study was not a good fit for the patient population seen at this hospital.
NCT01230151,WITHDRAWN,INTERVENTIONAL,"Sponsor (Intelect Medical, Inc.) was acquired by Boston Scientific and study was canceled."
NCT01230190,WITHDRAWN,INTERVENTIONAL,Because of safety issues/support concerning the multispecies probiotic mixture
NCT01230216,TERMINATED,INTERVENTIONAL,Slow patients enrollment
NCT01230242,TERMINATED,INTERVENTIONAL,Suspended to determine if Mirena device could be charged to patient insurance
NCT01230307,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient number of patients.
NCT01230489,TERMINATED,INTERVENTIONAL,Breakdown of communication between departments involved
NCT01230502,TERMINATED,INTERVENTIONAL,insufficient study population to meet study objective
NCT01230684,TERMINATED,INTERVENTIONAL,Due to low enrollment
NCT01230788,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01230827,TERMINATED,INTERVENTIONAL,Trial has failed to meet primary - and major secondary endpoints
NCT01230918,TERMINATED,INTERVENTIONAL,Costs of study procedures has changed and escalated and became prohibitive.
NCT01230931,TERMINATED,INTERVENTIONAL,Study team left institution; no one remaining to finish study
NCT01230970,TERMINATED,INTERVENTIONAL,The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.
NCT01231191,WITHDRAWN,INTERVENTIONAL,study not funded
NCT01231347,TERMINATED,INTERVENTIONAL,Planned independent DMC Interim review: ended for futility w/no safety concerns
NCT01231451,WITHDRAWN,INTERVENTIONAL,Ethics board said the study could not be fully justified.
NCT01231724,WITHDRAWN,INTERVENTIONAL,"study halted prematurely, prior to enrollment of first participant"
NCT01231750,TERMINATED,INTERVENTIONAL,Unable to identify study population to achieve number expected
NCT01231854,TERMINATED,INTERVENTIONAL,"delayed start of the trial, both treatment options already have market authorizations, study medication expired"
NCT01232153,WITHDRAWN,INTERVENTIONAL,departure without replacement of the principal investigator
NCT01232400,WITHDRAWN,INTERVENTIONAL,Funding withdrawn. Design not feasible.
NCT01232556,TERMINATED,INTERVENTIONAL,"The study was terminated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified."
NCT01232777,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01232881,TERMINATED,OBSERVATIONAL,funding terminated
NCT01232959,WITHDRAWN,INTERVENTIONAL,Subjects not interested
NCT01232972,TERMINATED,INTERVENTIONAL,Study technique has been declared part of standard care
NCT01233479,WITHDRAWN,INTERVENTIONAL,"This non-therapeutic study was registered in error. The PRS team doesn't delete studies once registered, so they recommended changing the status to Withdrawn"
NCT01233492,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT01233544,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01233635,TERMINATED,INTERVENTIONAL,inadequate enrollment rate
NCT01234090,TERMINATED,OBSERVATIONAL,Funding stopped
NCT01234103,TERMINATED,INTERVENTIONAL,Due to lack of continue funding
NCT01234285,WITHDRAWN,INTERVENTIONAL,"Sara Cheng, MD has left the Univ. of Colorado and the study has been closed."
NCT01234298,WITHDRAWN,INTERVENTIONAL,Study was discontinued due to non-safety related business prioritization decisions
NCT01234480,TERMINATED,INTERVENTIONAL,Decided not to pursue commercialization of the product
NCT01234519,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01234532,TERMINATED,INTERVENTIONAL,low accrual
NCT01234805,TERMINATED,INTERVENTIONAL,Slow Accruals
NCT01234883,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01234909,TERMINATED,OBSERVATIONAL,Not meeting enrollment goals.
NCT01234922,TERMINATED,INTERVENTIONAL,slow accrual
NCT01234974,WITHDRAWN,INTERVENTIONAL,Study never undertaken
NCT01235273,SUSPENDED,INTERVENTIONAL,insufficient enrollment
NCT01235468,WITHDRAWN,INTERVENTIONAL,loss of support
NCT01235741,TERMINATED,INTERVENTIONAL,Results from previous study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.
NCT01235793,TERMINATED,INTERVENTIONAL,The clinical trial was terminated due to poor enrollment
NCT01235910,TERMINATED,INTERVENTIONAL,Study was stopped early due to difficulty finding patients who met I/E criteria.
NCT01236092,TERMINATED,INTERVENTIONAL,Inadequate patient enrollment
NCT01236313,TERMINATED,OBSERVATIONAL,Insufficient recruitment to complete study
NCT01236339,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01236352,TERMINATED,INTERVENTIONAL,Due to portfolio/business decisions by the sponsor
NCT01236456,WITHDRAWN,INTERVENTIONAL,I am relocating to Johns Hopkins Medical Center
NCT01236508,TERMINATED,INTERVENTIONAL,difficulties recruiting this population for study population
NCT01236573,TERMINATED,INTERVENTIONAL,"Unexpected toxicities, likely due to TIL/IL-12 \& low % of durable responses."
NCT01236664,WITHDRAWN,INTERVENTIONAL,The sponsor is no longer developing this program and therefore has withdrawn the funding.
NCT01237041,TERMINATED,INTERVENTIONAL,Study Medication unavailable
NCT01237171,WITHDRAWN,OBSERVATIONAL,Study never moved past ideation phase
NCT01237340,TERMINATED,INTERVENTIONAL,The Sponsor voluntarily terminated this trial because compliance to strict Good Clinical Practice (GCP) requirements was not ensured - No safety concerns
NCT01237470,TERMINATED,INTERVENTIONAL,protocol completed
NCT01237613,TERMINATED,INTERVENTIONAL,Sponsoring company declared bankrupty
NCT01237678,TERMINATED,INTERVENTIONAL,Study was stopped early due to lack of efficacy signal and safety concerns
NCT01237938,TERMINATED,INTERVENTIONAL,test
NCT01238016,TERMINATED,INTERVENTIONAL,Replaced by new study
NCT01238029,TERMINATED,INTERVENTIONAL,"new methods of treatment, no more patients appilicable for study"
NCT01238146,WITHDRAWN,INTERVENTIONAL,No patients accrued.
NCT01238224,TERMINATED,INTERVENTIONAL,Durability of study medications could not be guaranteed after the expire date.
NCT01238315,WITHDRAWN,INTERVENTIONAL,Lack of timely patient accrual
NCT01238484,TERMINATED,INTERVENTIONAL,Centers could not meet enrollment goals
NCT01238588,TERMINATED,INTERVENTIONAL,The study stopped due to lack of funding.
NCT01238653,TERMINATED,OBSERVATIONAL,Slow enrollment with limited population for study parameters.
NCT01238679,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01238887,TERMINATED,INTERVENTIONAL,Some capsules used in this study were been found to be cracked and leaking.
NCT01238913,WITHDRAWN,OBSERVATIONAL,No one met the inclusion/exclusion criteria
NCT01238965,TERMINATED,INTERVENTIONAL,Adverse Events
NCT01239108,WITHDRAWN,INTERVENTIONAL,The dose limiting toxicity of cardiac QTc prolongation was identified and demonstrated unsafe to continue clinical development of this molecule.
NCT01239160,TERMINATED,INTERVENTIONAL,Futility and underpowering of endpoint data
NCT01239173,TERMINATED,INTERVENTIONAL,Study stopped by promoter for lack of inclusion
NCT01239355,TERMINATED,INTERVENTIONAL,Early termination for discouraging results
NCT01239368,TERMINATED,INTERVENTIONAL,Terminated due to insufficient accrual.
NCT01239628,TERMINATED,OBSERVATIONAL,Participant enrolment was lower than expected
NCT01239745,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01239758,TERMINATED,INTERVENTIONAL,This study was terminated based on preliminary safety data.
NCT01239992,TERMINATED,INTERVENTIONAL,negative endpoint study resulting in withdrawal of study drug
NCT01240304,TERMINATED,INTERVENTIONAL,no subjects enrolled
NCT01240694,TERMINATED,INTERVENTIONAL,Business Decision; there were no safety issues
NCT01240928,WITHDRAWN,INTERVENTIONAL,"Funding not available, study did not open to accrual and will not open in future"
NCT01240941,WITHDRAWN,INTERVENTIONAL,Funding was not available
NCT01240954,TERMINATED,INTERVENTIONAL,CA approval not obtained
NCT01241279,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment
NCT01241513,TERMINATED,INTERVENTIONAL,Results of preliminary analyses showed no reason to continue the study
NCT01241604,TERMINATED,INTERVENTIONAL,Sub par recruitment performance
NCT01241617,TERMINATED,INTERVENTIONAL,Covidien is conducting a voluntary recall of DuetTRS use in the thoracic cavity. IFU is revised to contraindicate use in adult and pediatric thoracic surgeries
NCT01241643,TERMINATED,INTERVENTIONAL,Terminated \[CYTHERISSA filed for banckcuptcy in June 2013.Subjects treated by CYT107 were followed up for at the least 3 months.\]
NCT01241786,TERMINATED,INTERVENTIONAL,The study was closed early due to poor accrual
NCT01241838,TERMINATED,INTERVENTIONAL,Insufficient no of patients eligible for enrollment.
NCT01241942,TERMINATED,INTERVENTIONAL,Funding exhausted.
NCT01242020,TERMINATED,INTERVENTIONAL,"Unable to reliably reproduce, visualize, or quantify microvascular flow in the subcutaneous tissue, the skeletal muscle or peri-adventitia"
NCT01242046,WITHDRAWN,INTERVENTIONAL,Key personnel were reassigned to different project
NCT01242514,TERMINATED,INTERVENTIONAL,AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.
NCT01242579,WITHDRAWN,INTERVENTIONAL,"In order to focus efforts on the combination ring formulation, IPM decided not to move forward with this trial."
NCT01242748,TERMINATED,INTERVENTIONAL,Inadequate recruitment resulting in a too low patient number for collection of long term efficacy data.
NCT01242943,TERMINATED,INTERVENTIONAL,"With the determination of the RD and a well established understanding of the safety and tolerability profile, the main endpoints of the study have been met."
NCT01242956,TERMINATED,INTERVENTIONAL,Problem to recruit sufficient patient number
NCT01242982,TERMINATED,INTERVENTIONAL,"problems to include patients, patients not showing up at check-up"
NCT01242995,WITHDRAWN,OBSERVATIONAL,The device was withdrawn from clinical use
NCT01243216,WITHDRAWN,INTERVENTIONAL,Lack of personnel/research time
NCT01243541,TERMINATED,INTERVENTIONAL,PI decision due to low accrual and lack of funding
NCT01243762,TERMINATED,INTERVENTIONAL,The study was terminated for business reasons and not due to any safety or efficacy concerns related to dalotuzumab.
NCT01243892,TERMINATED,OBSERVATIONAL,The study was closed due to the slow enrollment rate.
NCT01243918,TERMINATED,INTERVENTIONAL,Difficulty of recruitment
NCT01243970,TERMINATED,INTERVENTIONAL,Change in clinical practice since the start of the trial in 2011 (phenylephrine superior)
NCT01244009,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01244191,TERMINATED,INTERVENTIONAL,Sponsor decision due to the protocol-defined stopping boundary for futility was met based on the interim OS data.
NCT01244269,TERMINATED,INTERVENTIONAL,"Inadequate enrolment, protocol too challenging for participants, lack of observable benefit after analysis of 6 patients."
NCT01244412,TERMINATED,OBSERVATIONAL,The PI wanted to make additional changes to the hand held camera therefore he terminated the study rather than continue with an outdated camera design.
NCT01244438,WITHDRAWN,INTERVENTIONAL,"Study FP1039-002 was not feasible. The original assumption was at least 5% of patients screened would qualify, but after screening 70 patients, none qualified."
NCT01244503,TERMINATED,INTERVENTIONAL,Budgetary Issues
NCT01244542,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01244620,TERMINATED,INTERVENTIONAL,"Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury."
NCT01244659,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01244711,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted prematurely
NCT01244724,TERMINATED,INTERVENTIONAL,Unable to recruit targeted #
NCT01244880,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01245023,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01245088,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew support after no patients enrolled
NCT01245101,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT01245478,WITHDRAWN,OBSERVATIONAL,Retrospective record review only (no subject enrollment). Contract never executed between Sponsor and Site.
NCT01245543,WITHDRAWN,INTERVENTIONAL,Clinical investigations have been discontinued and transfer to BMS 3/24/2015
NCT01245660,TERMINATED,INTERVENTIONAL,The rythm of enrollment was not compatible with the objective of recruitement in the research.
NCT01245725,WITHDRAWN,INTERVENTIONAL,"Study was not initiated, change in clinical development"
NCT01245907,TERMINATED,INTERVENTIONAL,Unacceptable high drop-out rate.
NCT01245920,WITHDRAWN,INTERVENTIONAL,Inadequate number of patients whou could meet inclusion criteria.
NCT01245985,TERMINATED,INTERVENTIONAL,slow recruitment (only 8 patients recruited and treated until 12/2012)
NCT01246011,TERMINATED,INTERVENTIONAL,Enrollment was too slow.
NCT01246310,TERMINATED,INTERVENTIONAL,The number of patients enrolled was insufficient to match the calculated sample size and to carry out statistical analyses
NCT01246609,TERMINATED,OBSERVATIONAL,"the doctor who ran this study, left"
NCT01246635,TERMINATED,INTERVENTIONAL,The study was terminated early due to slow and insufficient total enrollment.
NCT01246726,TERMINATED,INTERVENTIONAL,MRI scanner de-commissioned and there was no suitable alternative.
NCT01246739,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01246752,TERMINATED,INTERVENTIONAL,decreased recrucial rate as the likelihood of achieving the envisioned patient number in a realistic time-frame was very low.
NCT01246869,TERMINATED,INTERVENTIONAL,"PI retired, study closed"
NCT01247025,WITHDRAWN,OBSERVATIONAL,Study should not have been listed on ClinicalTrials.gov
NCT01247038,TERMINATED,INTERVENTIONAL,Biomet's focus has changed and we no longer expect further developments
NCT01247649,TERMINATED,INTERVENTIONAL,sponsor decision
NCT01247688,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to low accrual.
NCT01247922,TERMINATED,INTERVENTIONAL,"In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety concerns. As a result, the companion trial, OSI-774-206 has been stopped"
NCT01247961,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT01248130,TERMINATED,INTERVENTIONAL,Due to a change in the research priorities of the principal investigator in combination with low subject interest.
NCT01248182,TERMINATED,OBSERVATIONAL,Study was terminated by investigator
NCT01248234,WITHDRAWN,INTERVENTIONAL,Did not begin
NCT01248455,TERMINATED,INTERVENTIONAL,Lack of patients meeting the defined primary obj. (50% decline in M-protein).
NCT01248845,TERMINATED,INTERVENTIONAL,Difficulties to enroll patients
NCT01248858,TERMINATED,INTERVENTIONAL,The reason for termination was lack of tolerability and efficacy of the combination treatment
NCT01249001,TERMINATED,INTERVENTIONAL,lack of eligible participants to enrol
NCT01249105,WITHDRAWN,INTERVENTIONAL,"Merck (supplier of study drug \& funding) has undergone a large reprioritization, in which they had to terminate many oncology trials, including this one."
NCT01249144,TERMINATED,INTERVENTIONAL,Sponsor stopped study to re-design trial
NCT01249157,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01249443,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT01250418,TERMINATED,INTERVENTIONAL,Monitor manufacturer stopped marketing plan for the product.
NCT01250457,WITHDRAWN,INTERVENTIONAL,"Unknown, PI has left the institution. There was no enrollment."
NCT01250496,TERMINATED,INTERVENTIONAL,Due to nationwide shortage of Aminophylline. Enrolled subjects did not complete study.
NCT01251003,WITHDRAWN,INTERVENTIONAL,Unable to identify eligible subjects with traumatic brain injury who also have banked umbilical cord blood at CBR.
NCT01251120,TERMINATED,INTERVENTIONAL,The study was stopped prematurely due to lack of enrollment.
NCT01251172,WITHDRAWN,INTERVENTIONAL,Lack of Drug Supply
NCT01251250,WITHDRAWN,INTERVENTIONAL,lost sponsor support
NCT01251354,TERMINATED,INTERVENTIONAL,The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.
NCT01251601,WITHDRAWN,OBSERVATIONAL,Withdrawn due to inability to recruit eligible participants
NCT01251952,TERMINATED,INTERVENTIONAL,Drug unavailable
NCT01251965,TERMINATED,INTERVENTIONAL,Study was stopped by the principal investigator due to nonsatisfactory clinical benefit even in patients treated at the highest dose (200 mg ).
NCT01252095,TERMINATED,INTERVENTIONAL,Unexpected injection site reactions.
NCT01252108,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01252238,TERMINATED,INTERVENTIONAL,Study sponsor terminated study due to AE's reported with valsartan and aliskiren
NCT01252329,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01252342,WITHDRAWN,INTERVENTIONAL,"Proposed doses were too large, bolus oxytocin may cause cases of arrythmias, and some even advocate slowing down the infusion rates that are currently used."
NCT01252355,TERMINATED,INTERVENTIONAL,"Sponsor decision to prematurely stop the study, not linked to any safety concern."
NCT01252836,WITHDRAWN,INTERVENTIONAL,P.I decided to prematurely end this study.
NCT01253109,TERMINATED,OBSERVATIONAL,"Law agreement between Triggerfish signal and GAT IOP during both sessions. However, an increase in the Triggerfish signal was observed during jogging phase."
NCT01253356,TERMINATED,INTERVENTIONAL,Only 1 patient recruited and deemed ineligible.
NCT01253460,TERMINATED,INTERVENTIONAL,Accrual not met
NCT01253590,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT01253642,TERMINATED,INTERVENTIONAL,low enrollment
NCT01253668,TERMINATED,INTERVENTIONAL,"In November 2012, this study was permanently closed to new accrual at the request of the drug manufacturer (BMS), who decided not to pursue additional research activity in this patient population."
NCT01253798,TERMINATED,INTERVENTIONAL,recruitement unsuccessful
NCT01253915,TERMINATED,INTERVENTIONAL,Low enrollment and lack of funding for study
NCT01254136,TERMINATED,INTERVENTIONAL,Incyte has suspended development of the compound.
NCT01254656,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01254708,SUSPENDED,INTERVENTIONAL,Study has been placed on hold due to unavailability of funding.
NCT01254721,TERMINATED,INTERVENTIONAL,Difficulty of recruitment.
NCT01254734,TERMINATED,INTERVENTIONAL,The study will be rewritten as a data registry study
NCT01255163,TERMINATED,INTERVENTIONAL,AstraZeneca withdrew support for the study.
NCT01255371,WITHDRAWN,INTERVENTIONAL,drug procurement issues
NCT01255553,WITHDRAWN,INTERVENTIONAL,No patients enrolled.
NCT01255631,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01255683,WITHDRAWN,OBSERVATIONAL,Lack of proposed funding.
NCT01256203,WITHDRAWN,INTERVENTIONAL,Sponsor cancelled the study
NCT01256281,TERMINATED,INTERVENTIONAL,lack of resources
NCT01256346,WITHDRAWN,OBSERVATIONAL,Study completed by another institution prior to enrollment of first subject.
NCT01256489,WITHDRAWN,INTERVENTIONAL,Steven Johnson's Syndrome (SJS) and Toxic Epidermal Necrolysis Syndrome (TENS) are rare (\~3 in 1 million). No eligible subjects have been identified.
NCT01256580,WITHDRAWN,INTERVENTIONAL,Lack of eligible subjects.
NCT01256710,TERMINATED,OBSERVATIONAL,The study was terminated approximately 6 months earlier than planned because 227 subjects (59% more than anticipated) had already completed 10-Year Visits due to lower than expected subject attrition.
NCT01256788,TERMINATED,INTERVENTIONAL,"Insurance now covers post-op HA injections, drastically decreasing enrollment."
NCT01256905,WITHDRAWN,INTERVENTIONAL,PI departure from institution
NCT01257035,TERMINATED,OBSERVATIONAL,The logistics of this trial (incl. supply of tracer) in connection with the patients' treatment course caused the inclusion rate to be very slow.
NCT01257100,TERMINATED,OBSERVATIONAL,Determined not to be Human Subject Research
NCT01257178,TERMINATED,INTERVENTIONAL,Trial was Terminated prior to subjects receiving study drug; no trial results
NCT01257412,SUSPENDED,INTERVENTIONAL,FSI delayed until 15 January 2013
NCT01257464,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01257542,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01257659,TERMINATED,INTERVENTIONAL,Unable to find enough patients who accept randomization of surgical procedures.
NCT01257867,TERMINATED,INTERVENTIONAL,This study was terminated by the Principal Investigator
NCT01257932,WITHDRAWN,OBSERVATIONAL,"According to the NIH definition of clinical trial studies, this study does not meet requirement to be a clinical trial study."
NCT01258179,TERMINATED,OBSERVATIONAL,low recruitment
NCT01258283,TERMINATED,OBSERVATIONAL,Inclusion rate too slow / infeasible.
NCT01258517,SUSPENDED,OBSERVATIONAL,principle investigator moved to an another hospital
NCT01258634,TERMINATED,INTERVENTIONAL,PI no longer affiliated with institution; only 2 subjects enrolled
NCT01259024,TERMINATED,INTERVENTIONAL,inability to obtain CMS approval
NCT01259076,TERMINATED,OBSERVATIONAL,Study was closed early due to slow accrual.
NCT01259284,TERMINATED,INTERVENTIONAL,Terminated due to low accrual.
NCT01259297,TERMINATED,INTERVENTIONAL,Terminated early in agreement with Health Authorities for feasibility reasons
NCT01259986,TERMINATED,INTERVENTIONAL,"3 patients enrolled, no meaningful repigmentation observed. Recruitment halted."
NCT01260090,WITHDRAWN,INTERVENTIONAL,"When Hurricane Sandy hit the area, the funding was pulled."
NCT01260103,WITHDRAWN,INTERVENTIONAL,"Withdrawn: study halted prematurely, prior to enrollment of first participant"
NCT01260207,TERMINATED,INTERVENTIONAL,Terminated due to unachievable sample size and lack of resource availability
NCT01260246,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01260610,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT01260649,TERMINATED,INTERVENTIONAL,lack of funding to cover staff salary (clinician and research coordinator)
NCT01260714,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT01260844,WITHDRAWN,INTERVENTIONAL,Study stopped
NCT01260870,TERMINATED,INTERVENTIONAL,Bayer terminated the program and sold the IP to Medronic
NCT01260909,WITHDRAWN,OBSERVATIONAL,Business decision
NCT01261299,TERMINATED,INTERVENTIONAL,Contract ended
NCT01261377,WITHDRAWN,INTERVENTIONAL,the fellow interested in this project left the institution
NCT01261403,TERMINATED,INTERVENTIONAL,Enrollment terminated pending additional Phase 1 data
NCT01261624,TERMINATED,INTERVENTIONAL,The primary reason for the decision to discontinue the study is lack of enrolment; this decision is not related to any tolerability concerns with Givinostat
NCT01261650,TERMINATED,INTERVENTIONAL,There could not be enough patients recruited
NCT01261702,TERMINATED,INTERVENTIONAL,not include patient anymore
NCT01261767,TERMINATED,INTERVENTIONAL,Trial discontinued due to apparent lack of response in psoriasis measures. No safety concerns were present
NCT01262183,TERMINATED,INTERVENTIONAL,low recruitment numbers
NCT01262274,TERMINATED,INTERVENTIONAL,Due to an adverse event revelation.
NCT01262339,TERMINATED,INTERVENTIONAL,low enrollment; principal investigator left sponsoring institution
NCT01262547,TERMINATED,INTERVENTIONAL,The study sponsor was acquired by a company that focuses on chronic wounds.
NCT01262625,TERMINATED,INTERVENTIONAL,Funding timeline completed
NCT01262664,TERMINATED,INTERVENTIONAL,Terminated per PI's request
NCT01262690,TERMINATED,INTERVENTIONAL,The study was terminated on 21-Sept-2011 due to the emergent safety concern of sensory symptoms.
NCT01262729,TERMINATED,INTERVENTIONAL,Feasibility and Recruitment problems
NCT01262833,TERMINATED,OBSERVATIONAL,data suggesting pudendal artery stenosis rarely being cause of ED
NCT01262859,WITHDRAWN,INTERVENTIONAL,PI relocated to another institution. No subjects went on treatment.
NCT01263028,TERMINATED,INTERVENTIONAL,Strong enrollment efforts resulted in few eligible subjects and high screen failures due to CKD patients with higher vitamin D levels than anticipated.
NCT01263366,TERMINATED,INTERVENTIONAL,Enrollment issues
NCT01263418,WITHDRAWN,INTERVENTIONAL,No patients enrolled and funding has been withdrawn.
NCT01263574,WITHDRAWN,INTERVENTIONAL,No participants. IND denied by FDA.
NCT01263652,WITHDRAWN,INTERVENTIONAL,inability to complete recruitment as planned
NCT01263821,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01264081,TERMINATED,INTERVENTIONAL,Protocol would not be able to reach stated accrual.
NCT01264094,TERMINATED,INTERVENTIONAL,Enrollment
NCT01264159,TERMINATED,INTERVENTIONAL,The principle investigator decided to change the protocol
NCT01264341,TERMINATED,INTERVENTIONAL,"Based on the developments in the treatment of recurrent metastatic renal cancer, the study treatment is no longer considered to be the best treatment option"
NCT01264484,TERMINATED,OBSERVATIONAL,The primary objective was considered sufficient for follow-up.
NCT01264510,WITHDRAWN,INTERVENTIONAL,reason unknown
NCT01264679,TERMINATED,INTERVENTIONAL,Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-253 study as designed.
NCT01264770,TERMINATED,INTERVENTIONAL,AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.
NCT01264835,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT01264861,TERMINATED,INTERVENTIONAL,The Dopamine transporter brain imaging trial is terminated due to a company decision to return all rights for Safinamide back to Newron Pharmaceuticals
NCT01264874,TERMINATED,INTERVENTIONAL,poor accrual rate
NCT01264887,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT01264913,TERMINATED,OBSERVATIONAL,impossible to retain participants in 3-year longitudinal study
NCT01264965,TERMINATED,INTERVENTIONAL,recruitment problems
NCT01264991,TERMINATED,INTERVENTIONAL,Recruitment stalled. Study terminated before inclusion of sufficient number of participants included
NCT01265017,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT01265199,TERMINATED,INTERVENTIONAL,Study was terminated before a MTD was determined for administrative reasons
NCT01265225,WITHDRAWN,OBSERVATIONAL,no finance
NCT01265381,TERMINATED,OBSERVATIONAL,This protocol was determined to be not human subjects research.
NCT01266018,TERMINATED,INTERVENTIONAL,Lack of efficacy in Cohort 2; slow enrollment in Cohort 1
NCT01266070,TERMINATED,INTERVENTIONAL,Trial met toxicity stopping rule
NCT01266187,TERMINATED,INTERVENTIONAL,Recruitment difficulities
NCT01266291,TERMINATED,INTERVENTIONAL,Was not possible to enroll sufficient number of subjects to draw any worthwhile conclusions from the study.
NCT01266551,TERMINATED,INTERVENTIONAL,Intended number of patients reached
NCT01266785,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01266811,WITHDRAWN,INTERVENTIONAL,"Study canceled based on results of different study with similar hypothesis, investigational agent, \& patient"
NCT01266824,TERMINATED,INTERVENTIONAL,Recruitment for the study has been terminated due to poor enrollment
NCT01267032,TERMINATED,INTERVENTIONAL,Terminated after two years by CSRD
NCT01267240,TERMINATED,INTERVENTIONAL,Study treatment did not show clinical activity.
NCT01267266,TERMINATED,INTERVENTIONAL,"Per protocol, study was terminated due to low rate of randomized patients."
NCT01267318,TERMINATED,OBSERVATIONAL,"Sponsor decided to terminate the entire project, and therefore there was no use for the samples collected in the study."
NCT01267500,TERMINATED,INTERVENTIONAL,Difficulty to keep children in randomly assigned groups.
NCT01267643,TERMINATED,INTERVENTIONAL,Study drug not available at this time
NCT01267825,TERMINATED,INTERVENTIONAL,Study terminated early due to low enrollment. No data collected.
NCT01268059,TERMINATED,INTERVENTIONAL,"In conjunction with the overall risk-benefit assessment, study was terminated prematurely due to safety concerns."
NCT01268072,TERMINATED,OBSERVATIONAL,Study was completed with 69 subjects enrolled due to difficult enrolment and adequate biomarker data was avaible with 69 subjects in the study.
NCT01268085,TERMINATED,INTERVENTIONAL,Error in randomization resulted in early study termination.
NCT01268280,TERMINATED,INTERVENTIONAL,Closed after complete treatment of 32 patients after 21 months' recruitment.
NCT01268592,TERMINATED,INTERVENTIONAL,Study technique has been declared part of standard care
NCT01268644,TERMINATED,INTERVENTIONAL,Sponsor request
NCT01268670,SUSPENDED,INTERVENTIONAL,This study is currently suspended due to transition of the investigator.
NCT01268995,TERMINATED,INTERVENTIONAL,It was impossible to recruit the scheduled number of patients
NCT01269320,WITHDRAWN,INTERVENTIONAL,Sponsors decision
NCT01269411,TERMINATED,INTERVENTIONAL,Administratively complete.
NCT01269450,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01269671,WITHDRAWN,INTERVENTIONAL,PI has left institution
NCT01269684,WITHDRAWN,INTERVENTIONAL,No patient has never been included in the trial
NCT01270061,WITHDRAWN,INTERVENTIONAL,We did not receive proper funding to complete this study
NCT01270477,TERMINATED,INTERVENTIONAL,"Lack of People to follow up the study, work overload"
NCT01270581,TERMINATED,INTERVENTIONAL,lack of sufficient enrollment
NCT01270633,TERMINATED,INTERVENTIONAL,Business Decision
NCT01270685,WITHDRAWN,OBSERVATIONAL,Not a Clinical Trial requirement per VA HSR\&D
NCT01270893,WITHDRAWN,INTERVENTIONAL,No particapnt recruitment.
NCT01271049,TERMINATED,INTERVENTIONAL,"Due to a business decision to stop the project, the study was terminated early."
NCT01271114,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT01271465,SUSPENDED,OBSERVATIONAL,Change in PI
NCT01271816,TERMINATED,OBSERVATIONAL,inadequate recruitment
NCT01271907,TERMINATED,INTERVENTIONAL,Study was terminated due to withdrawal of CRADA partner.
NCT01272141,TERMINATED,INTERVENTIONAL,"Slow accrual, Funding stopped"
NCT01272258,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01272388,TERMINATED,INTERVENTIONAL,We designed a different pilot trial based on data obtained after this study started - the 2 studies were too overlapping to continue both.
NCT01272414,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01272752,WITHDRAWN,INTERVENTIONAL,Study did not get started.
NCT01272765,WITHDRAWN,INTERVENTIONAL,Study did not get started.
NCT01273064,TERMINATED,INTERVENTIONAL,Risk-benefit ratio
NCT01273103,WITHDRAWN,INTERVENTIONAL,GSK2248761 development program is on clinical hold.
NCT01273402,WITHDRAWN,INTERVENTIONAL,A new study is being designed. No patients were enrolled.
NCT01273428,WITHDRAWN,INTERVENTIONAL,The device test article is no longer available
NCT01273779,SUSPENDED,INTERVENTIONAL,Data Safety Monitoring Board recommendation
NCT01274013,WITHDRAWN,OBSERVATIONAL,"Non Hep C study arm has been completed, Hep C study arm has not been completed."
NCT01274104,WITHDRAWN,INTERVENTIONAL,PI resigned.
NCT01274117,TERMINATED,INTERVENTIONAL,"PRIMARY EFFICACY OUTCOME MEASURE (MATURATION) WAS SIGNIFICANT, IN FAVOR OF THE TW0-STAGE PROCEDURE"
NCT01274221,WITHDRAWN,INTERVENTIONAL,Cancellation was not safety related but a shift in study priorities for Shire.
NCT01274247,TERMINATED,INTERVENTIONAL,The study ethics committee recommended concluding the study for longer crying time with benzocaine and very short crying time in all participants.
NCT01274429,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01274559,TERMINATED,INTERVENTIONAL,"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs"
NCT01274572,WITHDRAWN,OBSERVATIONAL,Drug became available with insurance reimbursement
NCT01274585,TERMINATED,INTERVENTIONAL,Study was terminated due to low recruitment rates
NCT01275027,WITHDRAWN,INTERVENTIONAL,Sponsor recalled the study
NCT01275235,TERMINATED,OBSERVATIONAL,We were unable to recruit enough sibling pairs in a timely manner.
NCT01275248,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT01275261,TERMINATED,INTERVENTIONAL,Investigator no longer at institution-no data analyzed
NCT01275274,WITHDRAWN,INTERVENTIONAL,no subject enrolled in nearly 2 years
NCT01275287,WITHDRAWN,INTERVENTIONAL,the study failed to enroll any patient and sponsor wished to stop.
NCT01275339,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients and PI moved institutions.
NCT01275352,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01275391,WITHDRAWN,INTERVENTIONAL,This project was not funded.
NCT01275430,TERMINATED,INTERVENTIONAL,Phase I completed. Phase II is cancelled.
NCT01275612,WITHDRAWN,INTERVENTIONAL,Patients evaluated so far could not be enrolled because they did not meet the primary criterion of acute renal failure provided by the study protocol
NCT01275651,WITHDRAWN,OBSERVATIONAL,Trial closure for NCI NCTN Transition
NCT01275664,TERMINATED,INTERVENTIONAL,Study terminated due to no patient population available
NCT01275690,WITHDRAWN,OBSERVATIONAL,The PI closed this study and went to another institution.
NCT01275703,WITHDRAWN,OBSERVATIONAL,"The PI left this institution, and the study was closed."
NCT01275781,WITHDRAWN,INTERVENTIONAL,Withdrawn due to the local Radiation Safety Committee refusing to approve it.
NCT01275833,TERMINATED,INTERVENTIONAL,Difficult subject recruitment
NCT01275976,TERMINATED,INTERVENTIONAL,Futility and limited feasibility
NCT01276002,WITHDRAWN,INTERVENTIONAL,No appropriate participants
NCT01276054,TERMINATED,INTERVENTIONAL,P.I. left
NCT01276093,TERMINATED,INTERVENTIONAL,DSMB recommendation; enrollment too slow
NCT01276184,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient sample for study completion.
NCT01276249,TERMINATED,OBSERVATIONAL,Medtronic terminated the study since Foretevo product was no longer marketed
NCT01276392,WITHDRAWN,OBSERVATIONAL,A main person involved left the site
NCT01276613,TERMINATED,INTERVENTIONAL,Per memo from study team
NCT01276704,TERMINATED,INTERVENTIONAL,accrual rate lower than anticipated; funding expired
NCT01276782,WITHDRAWN,INTERVENTIONAL,Withdraw the study because further analysis showed that it would be futile.
NCT01276834,TERMINATED,INTERVENTIONAL,insufficient patients enrolled
NCT01277120,TERMINATED,OBSERVATIONAL,Contract terminated with Site Management Organization
NCT01277263,WITHDRAWN,OBSERVATIONAL,Not a Clinical Trial study
NCT01277276,WITHDRAWN,OBSERVATIONAL,no participant enrolled
NCT01277289,TERMINATED,INTERVENTIONAL,due to the big difficulty to enrol suitable patients
NCT01277328,TERMINATED,OBSERVATIONAL,Contract terminated with Site Management Organization
NCT01277354,TERMINATED,INTERVENTIONAL,Loss of funding
NCT01277458,WITHDRAWN,OBSERVATIONAL,Unable to recruit participants
NCT01277497,TERMINATED,INTERVENTIONAL,low enrollment
NCT01277510,TERMINATED,INTERVENTIONAL,Study was put on clinical hold on 30 Jan 2013 following a subject fatality. Study was never restarted and was closed.
NCT01277575,TERMINATED,INTERVENTIONAL,recruitment efforts did not result in a sufficient number of patients
NCT01277874,WITHDRAWN,INTERVENTIONAL,PI has left Institution
NCT01278511,WITHDRAWN,INTERVENTIONAL,Not feasible
NCT01278615,TERMINATED,INTERVENTIONAL,Closed Prematurely.
NCT01278680,WITHDRAWN,INTERVENTIONAL,Enrollment has not begun; study suspended indefinitely due to change in management at company where we were going to conduct the study.
NCT01278745,TERMINATED,INTERVENTIONAL,Due to inability to meet accrual goals within the funding period
NCT01278862,TERMINATED,INTERVENTIONAL,product no longer on market
NCT01279187,TERMINATED,INTERVENTIONAL,Study was terminated due to patient complications unrelated to study drugs
NCT01279291,TERMINATED,INTERVENTIONAL,The study was stopped due to the inability to determine an acceptable dose with the potential for further study
NCT01279369,TERMINATED,OBSERVATIONAL,Quantitative assessment of fFN only able to be performed at one laboratory.
NCT01279395,TERMINATED,OBSERVATIONAL,Could not recruit adequate number of subjectsa
NCT01279616,TERMINATED,INTERVENTIONAL,PI moving to a different institution.
NCT01279681,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01279772,TERMINATED,OBSERVATIONAL,due to slow accrual (only 1 patient entered)
NCT01279785,WITHDRAWN,OBSERVATIONAL,Similar study to be completd once kit for new formulation becomes available.
NCT01280045,TERMINATED,INTERVENTIONAL,No grant was received then we stopped the recruitment
NCT01280383,WITHDRAWN,INTERVENTIONAL,Study does not meet the new legal requirements set forth in the Human Research Act
NCT01280565,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT01280578,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT01280643,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01280669,WITHDRAWN,INTERVENTIONAL,Never started due to sponsor decision
NCT01280708,TERMINATED,OBSERVATIONAL,This database did not have the desired inclusions or results and is therefore not sufficiently usable. This base is therefore abandoned in favor of a base on the pancreas much more promising both nationally and internationally.
NCT01280747,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01280864,TERMINATED,OBSERVATIONAL,the study PI left the university of iowa
NCT01281254,TERMINATED,INTERVENTIONAL,Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.
NCT01281397,TERMINATED,OBSERVATIONAL,"After 148 patients enrolled, interim analysis revealed positive results in regard to primary hypothesis."
NCT01281540,TERMINATED,INTERVENTIONAL,Sponsor request
NCT01281553,TERMINATED,INTERVENTIONAL,Sponsor request
NCT01281566,TERMINATED,INTERVENTIONAL,Sponsor request
NCT01281748,TERMINATED,INTERVENTIONAL,Low rate of enrollment
NCT01281943,WITHDRAWN,INTERVENTIONAL,Doxil Shortage
NCT01282151,TERMINATED,INTERVENTIONAL,Difficulty in recruitment due to approval of maintenance pemetrexed treatment
NCT01282216,TERMINATED,INTERVENTIONAL,Low accrual and loss of funding.
NCT01282476,TERMINATED,INTERVENTIONAL,slow accrual
NCT01282879,TERMINATED,INTERVENTIONAL,"In interim analysis, this study met the primary hypothesis."
NCT01283100,WITHDRAWN,INTERVENTIONAL,"In a Phase II study in HIV-infected patients there were a number of seizures, although exact causality could not be assessed phase 1 activity was terminated."
NCT01283178,TERMINATED,INTERVENTIONAL,The study was terminated. The data analysis was futile with only 3 accruals. PI opted to terminate with IRB and withdraw FDA IND.
NCT01283321,TERMINATED,INTERVENTIONAL,Insufficient funding to complete total projected enrollment
NCT01283763,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01283971,TERMINATED,INTERVENTIONAL,The study was closed due to the slow enrollment rate.
NCT01284075,TERMINATED,INTERVENTIONAL,Low accrual
NCT01284166,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to company decision. No study subjects were ever enrolled or treated.
NCT01284179,TERMINATED,INTERVENTIONAL,Unable to enroll
NCT01284205,WITHDRAWN,INTERVENTIONAL,This indication is not being pursued at this point in time.
NCT01284270,WITHDRAWN,INTERVENTIONAL,Study not to be initiated
NCT01284335,TERMINATED,INTERVENTIONAL,Study was terminated due to the termination of tasisulam development.
NCT01284348,TERMINATED,INTERVENTIONAL,Persistent low enrollment made study continuation no longer feasible
NCT01284491,TERMINATED,INTERVENTIONAL,Termination due to acquisition of PEAK Surgical by Medtronic
NCT01284504,TERMINATED,INTERVENTIONAL,low accrual rate; the only participant withdrew after signing consent
NCT01284907,WITHDRAWN,INTERVENTIONAL,No Participants
NCT01285063,WITHDRAWN,INTERVENTIONAL,We were not successful in raising money for this project
NCT01285102,TERMINATED,INTERVENTIONAL,This study was closed early by the DSMB due to increased toxicity.
NCT01285310,TERMINATED,INTERVENTIONAL,Study is terminated due to lack of efficacy
NCT01285557,TERMINATED,INTERVENTIONAL,"Due to significant changes in investigational and clinical practice landscape of frontline advanced gastric cancer, which challenged viability of trial and increased use of modified chemotherapeutic triplets led to slow participant accrual in study."
NCT01285635,TERMINATED,INTERVENTIONAL,drug is no longer manufactured
NCT01285934,WITHDRAWN,INTERVENTIONAL,No participant enrolled
NCT01286038,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01286090,TERMINATED,INTERVENTIONAL,Sponsor request
NCT01286116,TERMINATED,INTERVENTIONAL,Company closed
NCT01286220,TERMINATED,INTERVENTIONAL,the study was terminated due to participant drop out
NCT01286246,TERMINATED,INTERVENTIONAL,Trial investigators were unable to recruit the estimated sample
NCT01286870,TERMINATED,INTERVENTIONAL,Sponsor terminated
NCT01286883,TERMINATED,OBSERVATIONAL,PI left Institution
NCT01286974,TERMINATED,INTERVENTIONAL,"Terminated early, Sponsor Decision"
NCT01287013,TERMINATED,INTERVENTIONAL,Investigator left NIH
NCT01287221,TERMINATED,INTERVENTIONAL,DSMB recommended stopping the study after an interim analysis of the primary endpoint revealed that futility criteria were met.
NCT01287338,TERMINATED,INTERVENTIONAL,Lack of definitive clinical results.
NCT01287741,TERMINATED,INTERVENTIONAL,The study was closed by the Sponsor according to the protocol-specified minimum post-treatment follow-up period of 3 years.
NCT01287832,TERMINATED,INTERVENTIONAL,Low patient enrollment
NCT01287910,TERMINATED,INTERVENTIONAL,Lack of patient population
NCT01288053,TERMINATED,INTERVENTIONAL,No participant enrolled more than two years. No plan to continue study.
NCT01288131,TERMINATED,INTERVENTIONAL,We observed \>90 % efficacy in cyclophosphamide and Prednisolone group for treatment of anti-i-HuEpo associated PRCA
NCT01288430,TERMINATED,INTERVENTIONAL,The trial was terminated as per Sponsor decision.
NCT01288495,TERMINATED,INTERVENTIONAL,PI moved institutions and changed study protocol
NCT01288625,WITHDRAWN,INTERVENTIONAL,There were IP availability issues due to which the study could not be started.
NCT01288664,WITHDRAWN,INTERVENTIONAL,sponsor withdraw from this study
NCT01288937,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01289210,TERMINATED,INTERVENTIONAL,The study was stopped due to slow rate of recruitment.
NCT01289223,TERMINATED,INTERVENTIONAL,Ongoing challenges to successfully recruit the required number of subjects
NCT01289483,WITHDRAWN,INTERVENTIONAL,sponsor has decided not to support this study.
NCT01289639,TERMINATED,INTERVENTIONAL,Low recruitment in intervention study. Baseline data published.
NCT01289678,TERMINATED,INTERVENTIONAL,Unable to meet accrual goals
NCT01289808,TERMINATED,INTERVENTIONAL,changes were made to the which needed an entireley new submission
NCT01289938,TERMINATED,INTERVENTIONAL,"To unsuccessful recruitment of rare UM-genotype. All other planned genotype groups are completed (EM, IM and PM)."
NCT01290146,TERMINATED,INTERVENTIONAL,Due to lack of enrollment
NCT01290237,TERMINATED,INTERVENTIONAL,"PI leaving institution, slow enrollment"
NCT01290328,TERMINATED,INTERVENTIONAL,"low enrollment, termination of funding"
NCT01290393,TERMINATED,OBSERVATIONAL,Low accrual of subjects primarily attributable to the low uptake of Cervarix in the US and Canada in women aged 15 to 25 years of age.
NCT01290523,TERMINATED,INTERVENTIONAL,Off study clinical use of Y90 glass microspheres (TheraSphere)
NCT01290601,TERMINATED,INTERVENTIONAL,Failure to meet pre-specified endpoint for the day 28 cure rate
NCT01290666,TERMINATED,OBSERVATIONAL,Sufficient patient population achieved; decision not due to product complaints.
NCT01290718,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01290822,TERMINATED,INTERVENTIONAL,Slow accrual and anticipated loss of funding
NCT01290887,TERMINATED,INTERVENTIONAL,Business decision
NCT01291134,TERMINATED,OBSERVATIONAL,Product is no longer on the market
NCT01291264,TERMINATED,OBSERVATIONAL,Abbott Molecular stopped funding of study
NCT01291498,TERMINATED,INTERVENTIONAL,The manufacturer is not currently supporting research in this indication.
NCT01291784,TERMINATED,INTERVENTIONAL,Early termination when the drug was no longer made available by the pharmaceutical company due to unanticipated management and administrative decisions.
NCT01291797,TERMINATED,OBSERVATIONAL,due to inability to recruit sufficient sample size in reasonable time frame.
NCT01292070,TERMINATED,INTERVENTIONAL,Futility
NCT01292083,WITHDRAWN,INTERVENTIONAL,No accrual last 2 years
NCT01292213,TERMINATED,OBSERVATIONAL, Long delay due to challenges with sample analysis at local labs;  Low recruitment of case and control subjects;  Constant staff turn-over in the sites.
NCT01292265,TERMINATED,INTERVENTIONAL,Termination of study due to low enrollment. There were no safety issues.
NCT01292525,TERMINATED,INTERVENTIONAL,Difficulties of recruitment
NCT01292564,WITHDRAWN,INTERVENTIONAL,Insufficient resources at test site for recruitment.
NCT01292694,TERMINATED,INTERVENTIONAL,"Could not enroll enough participants, and lost funding."
NCT01292733,TERMINATED,INTERVENTIONAL,Closed per local IRB due to advancements in standard ovarian cancer screening.
NCT01292746,TERMINATED,INTERVENTIONAL,Recruitment and subject study compliance was difficult
NCT01292811,TERMINATED,INTERVENTIONAL,Financial assistance from agency withdrawn due to financial issues at their end.
NCT01292863,WITHDRAWN,INTERVENTIONAL,Study was modified to in vitro design and no longer involves participants
NCT01292941,WITHDRAWN,INTERVENTIONAL,Product development project closed prematurely
NCT01293123,TERMINATED,INTERVENTIONAL,Did not meet enrollment goals
NCT01293227,TERMINATED,INTERVENTIONAL,Funding was withdrawn due to inadequete enrollment.
NCT01293539,TERMINATED,INTERVENTIONAL,IAC is now recognized as part of standard of care treatment options in the US.
NCT01293864,TERMINATED,OBSERVATIONAL,This is not a clinical trials study
NCT01293981,TERMINATED,OBSERVATIONAL,Product no longer on the market
NCT01293994,WITHDRAWN,OBSERVATIONAL,Do not have necessary resources to continue
NCT01294007,TERMINATED,INTERVENTIONAL,Product no longer on the market
NCT01294098,TERMINATED,INTERVENTIONAL,Patients were not willing to be randomized and therefore recruitment could not continue.
NCT01294397,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT01294501,TERMINATED,INTERVENTIONAL,PI left the institution
NCT01294904,WITHDRAWN,OBSERVATIONAL,Not active
NCT01295060,TERMINATED,INTERVENTIONAL,Program was terminated for business reasons
NCT01295073,WITHDRAWN,INTERVENTIONAL,appropriate study medication supply could not be identified
NCT01295125,TERMINATED,INTERVENTIONAL,Sponsor chose not to move forward with study
NCT01295164,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01295216,TERMINATED,INTERVENTIONAL,No significant change for the primary objective at 12 months
NCT01295268,TERMINATED,INTERVENTIONAL,enrollment volume due to placebo arm of trial
NCT01295697,TERMINATED,INTERVENTIONAL,Program suspended and divested
NCT01295970,WITHDRAWN,INTERVENTIONAL,Recruitment challenges
NCT01296035,TERMINATED,INTERVENTIONAL,Newer technologies available; poor accrual to study.
NCT01296061,TERMINATED,OBSERVATIONAL,Funding ended.
NCT01296230,TERMINATED,INTERVENTIONAL,Failure to recruit participants
NCT01296659,WITHDRAWN,INTERVENTIONAL,Principal Investigator left institution.
NCT01296698,TERMINATED,INTERVENTIONAL,Study terminated due to a technical issue (randomization error).
NCT01296711,TERMINATED,INTERVENTIONAL,Decision to out-license the compound for further development
NCT01296789,TERMINATED,INTERVENTIONAL,Problems implementing the trial
NCT01296854,TERMINATED,INTERVENTIONAL,The feasability of inclusions has proven very low.
NCT01296971,WITHDRAWN,INTERVENTIONAL,study was not started due to an administrative reason on the part of the local Health Authority
NCT01297231,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT01297426,WITHDRAWN,OBSERVATIONAL,funding expired
NCT01297439,TERMINATED,INTERVENTIONAL,the study stopped due to the lack of inclusion.
NCT01297712,TERMINATED,INTERVENTIONAL,"enrollment terminated, analysis ongoing"
NCT01298505,TERMINATED,INTERVENTIONAL,This study was stopped due to lack of evidence for clinical efficacy.
NCT01298752,TERMINATED,INTERVENTIONAL,Recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated.
NCT01298791,WITHDRAWN,INTERVENTIONAL,Inability to recruit participants
NCT01298830,TERMINATED,INTERVENTIONAL,Need for improvement of study medication. Safety data collected sufficient. No further gain in knowledge expected.
NCT01298921,TERMINATED,INTERVENTIONAL,PI left Geisinger-study terminated prematurely - 4 patients enrolled
NCT01298986,WITHDRAWN,INTERVENTIONAL,No subjects were ever enrolled.
NCT01299220,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects by sponsor deadline
NCT01299402,TERMINATED,INTERVENTIONAL,Financial Reasons
NCT01299441,TERMINATED,OBSERVATIONAL,unable to complete statistical analysis
NCT01299545,TERMINATED,OBSERVATIONAL,Recruitment difficulties
NCT01299727,TERMINATED,INTERVENTIONAL,Completion of follow-up period
NCT01299922,WITHDRAWN,INTERVENTIONAL,IT was impossible to find patients
NCT01300091,WITHDRAWN,OBSERVATIONAL,Recruitment not started
NCT01300221,WITHDRAWN,OBSERVATIONAL,Study did not receive IRB approval.
NCT01300299,WITHDRAWN,INTERVENTIONAL,Unable to enroll
NCT01300520,TERMINATED,INTERVENTIONAL,Enough surgeon use to validate the usefulness of the device
NCT01300585,TERMINATED,INTERVENTIONAL,Lack of patient population
NCT01300702,TERMINATED,OBSERVATIONAL,recruitment problems
NCT01300793,TERMINATED,INTERVENTIONAL,closed for low accrual and no data is available.
NCT01300858,TERMINATED,INTERVENTIONAL,Sites could not enroll patients.
NCT01300871,TERMINATED,OBSERVATIONAL,Poor patient accrual
NCT01301040,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01301118,SUSPENDED,OBSERVATIONAL,Technical problems with protocol.
NCT01301378,TERMINATED,INTERVENTIONAL,kerasys had more erosions than tutoplast
NCT01301391,TERMINATED,INTERVENTIONAL,For the last patient still on treated nominal therapeutic use of the Milciclib was approved at INT Milano.
NCT01301482,TERMINATED,INTERVENTIONAL,"Study is no longer necessary (outmoded, outdated, science has changed)"
NCT01301495,WITHDRAWN,INTERVENTIONAL,No participants enrolled for more than 1 year.
NCT01301573,TERMINATED,OBSERVATIONAL,Due to financial reasons
NCT01301612,WITHDRAWN,INTERVENTIONAL,Regulatory requirement. A phase III study is being designed.
NCT01301625,TERMINATED,OBSERVATIONAL,As recruitment rate was lower than anticipated
NCT01301768,WITHDRAWN,INTERVENTIONAL,the intervention could not be performed. All participants received Usual clinical practice
NCT01301846,WITHDRAWN,OBSERVATIONAL,Need to recruit research staff
NCT01301963,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01302106,WITHDRAWN,INTERVENTIONAL,"For increased induction mortality in older patients due to specific combinations of drugs, other clinical factors such as patient age and comorbidities."
NCT01302236,WITHDRAWN,INTERVENTIONAL,We could not find patients who agreed to enrolled this clinical study.
NCT01302327,WITHDRAWN,INTERVENTIONAL,"Very rare disease, we were unable to recruit patients"
NCT01302366,TERMINATED,INTERVENTIONAL,due to lack of funding
NCT01302405,TERMINATED,INTERVENTIONAL,"closing due to low enrollment, no safety issues"
NCT01302444,TERMINATED,INTERVENTIONAL,One subject enrolled and completed this study. The study was stopped due to poor recruitment.
NCT01302548,TERMINATED,INTERVENTIONAL,Study did not accrue the required number of study subjects.
NCT01302613,WITHDRAWN,INTERVENTIONAL,Drug shortage
NCT01302717,WITHDRAWN,INTERVENTIONAL,Difficulty in enrollment
NCT01302743,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01302899,TERMINATED,INTERVENTIONAL,In consequence of termination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.
NCT01302938,TERMINATED,INTERVENTIONAL,Stop date for randomization: 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.
NCT01303107,WITHDRAWN,INTERVENTIONAL,The Sponsor has no interest in continuing the study.
NCT01303159,TERMINATED,INTERVENTIONAL,EndoHPB probe is FDA approved and considered standard of care
NCT01303211,WITHDRAWN,OBSERVATIONAL,No cases on NmA meningitis were recorded following vaccination with MenAfriVac
NCT01303237,TERMINATED,OBSERVATIONAL,The study was discontinued due to slow recruitment and subjects not completing follow up period.
NCT01303250,TERMINATED,INTERVENTIONAL,The final decision of the review of HES-containing solution shall be awaited.
NCT01303315,TERMINATED,INTERVENTIONAL,Company strategic decision
NCT01303419,TERMINATED,INTERVENTIONAL,Sponsor determined there was sufficient material collected to answer the study questions.
NCT01303679,TERMINATED,INTERVENTIONAL,Not reveal any significant difference between the 2 treatment arms
NCT01303718,TERMINATED,INTERVENTIONAL,Futility of Primary Efficacy Endpoint
NCT01303965,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01304056,WITHDRAWN,OBSERVATIONAL,Administrative reasons
NCT01304082,TERMINATED,INTERVENTIONAL,Insufficient Enrollment
NCT01304628,WITHDRAWN,INTERVENTIONAL,Sponsor terminated study prior to initiation.
NCT01305122,TERMINATED,INTERVENTIONAL,Recruitment too low
NCT01305148,SUSPENDED,INTERVENTIONAL,Sponsor is raising funds for the remainder of the study
NCT01305174,TERMINATED,INTERVENTIONAL,Delayed recruitment
NCT01305239,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01305278,TERMINATED,INTERVENTIONAL,We unfortunately experienced recruitment difficulties with this study for the past few years.
NCT01305382,WITHDRAWN,OBSERVATIONAL,PI left institution
NCT01305395,WITHDRAWN,INTERVENTIONAL,"Due in part, to reduced transplant volume and enrollment has been difficult."
NCT01305486,TERMINATED,OBSERVATIONAL,"Sponsor decision, not safety related."
NCT01305681,WITHDRAWN,INTERVENTIONAL,It appears Dr. Vanderbrink left Nationwide Children's Hospital in 2011 and efforts to reach Dr. Vanderbrink have been unsuccessful.
NCT01305707,TERMINATED,INTERVENTIONAL,Difficulties in recruiting
NCT01305772,TERMINATED,INTERVENTIONAL,This study was terminated for low accrual.
NCT01306240,TERMINATED,INTERVENTIONAL,recruiting problems
NCT01306604,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT01306994,WITHDRAWN,OBSERVATIONAL,Lack of patient interest
NCT01307228,WITHDRAWN,INTERVENTIONAL,Insufficient participants recruited for the trial
NCT01307475,TERMINATED,OBSERVATIONAL,"Most study procedures incorporated into NCT01144741, some in NCT01306994"
NCT01307605,TERMINATED,INTERVENTIONAL,It was decided by the trial team to stop the collection of follow up data in trial SAKK 35/10.
NCT01307618,TERMINATED,INTERVENTIONAL,"Due to lack of clinical efficacy and lack of drug supply, trial was closed early and correlative studies were not pursued further."
NCT01307800,TERMINATED,INTERVENTIONAL,The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.
NCT01307839,WITHDRAWN,INTERVENTIONAL,Study was stopped due to non-availability of the lidocaine placebo patches.
NCT01307917,WITHDRAWN,INTERVENTIONAL,No funding ever received
NCT01307956,TERMINATED,INTERVENTIONAL,"Drug manufacturer - Amgen requested study stop, per DSMB observation in POWER trial"
NCT01308047,WITHDRAWN,INTERVENTIONAL,The Sponsor has no interest in continuing the study.
NCT01308203,TERMINATED,INTERVENTIONAL,Merck has decided to discontinue all studies with extended-release niacin/laropiprant.because the HPS2-THRIVE did not meet its primary endpoint
NCT01308216,TERMINATED,INTERVENTIONAL,Based in the negative of patients to shave de hair.
NCT01308294,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT01308346,TERMINATED,INTERVENTIONAL,"Due to a challenging protocol inclusion/ exclusion criteria, only one subject was enrolled since the trial was initiated in June 2011."
NCT01308437,TERMINATED,INTERVENTIONAL,Business reasons
NCT01308463,TERMINATED,OBSERVATIONAL,Study terminated due to change in sponsorship
NCT01308489,TERMINATED,INTERVENTIONAL,Lack of subject response
NCT01308502,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting patients due to logistics
NCT01308515,WITHDRAWN,INTERVENTIONAL,Could not find interested researchers/clinicians to complete study protocol.
NCT01308827,SUSPENDED,OBSERVATIONAL,Study recruitment was suspended due to lack of funding
NCT01309074,WITHDRAWN,INTERVENTIONAL,No subjects could be enrolled and therefore we decided to withdraw/stop the study.
NCT01309126,TERMINATED,INTERVENTIONAL,"Due to enrollment challenges resulting from changing treatment patterns in the use of cetuximab, the study has been terminated. No patients remain on study."
NCT01309412,TERMINATED,INTERVENTIONAL,Protocol was stopped due to the safety issue in Global
NCT01309581,TERMINATED,INTERVENTIONAL,limited enrollment
NCT01309659,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT01309750,TERMINATED,OBSERVATIONAL,logistics
NCT01310114,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT01310140,TERMINATED,OBSERVATIONAL,PI left Massachusetts General Hospital Inpatient service
NCT01310517,TERMINATED,OBSERVATIONAL,Study was stopped due to low enrollment.
NCT01310738,TERMINATED,INTERVENTIONAL,DSMB recommendation based on programmed interim analysis.
NCT01310855,TERMINATED,INTERVENTIONAL,closed to recruitment early due to AstraZeneca not developing cediranib further
NCT01311128,TERMINATED,OBSERVATIONAL,PI left institution
NCT01311167,TERMINATED,INTERVENTIONAL,Recruitment problems (not enough patients were found who met eligibility criteria)
NCT01311219,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT01311271,TERMINATED,INTERVENTIONAL,"Only two subjects have been recruited from start of the study. We decided to start the study in this topic, after revising the study protocol."
NCT01311414,WITHDRAWN,INTERVENTIONAL,The study was suspended due to organizational problems
NCT01311518,WITHDRAWN,INTERVENTIONAL,Trial never initiated
NCT01311674,TERMINATED,INTERVENTIONAL,Prematurely terminated due to failure to meet study objectives.
NCT01311869,TERMINATED,INTERVENTIONAL,IRB Decision
NCT01312064,TERMINATED,INTERVENTIONAL,Difficulty collecting
NCT01312389,TERMINATED,INTERVENTIONAL,Did not meet criteria laid out in Phase 1 to continue to Phase 2
NCT01312428,TERMINATED,INTERVENTIONAL,Lagging enrollment
NCT01312441,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01312454,TERMINATED,INTERVENTIONAL,Management decision
NCT01312493,WITHDRAWN,INTERVENTIONAL,Funding source was terminated before enrollment of first subject
NCT01312506,WITHDRAWN,OBSERVATIONAL,"Trial experienced funding issues, was never opened to accrual."
NCT01312623,TERMINATED,INTERVENTIONAL,"Terminated, because it is not possible to recruit enough participants"
NCT01312675,TERMINATED,INTERVENTIONAL,"Study stopped for operational futility. Due to very small numbers of subjects, insufficient data was available for results to provide meaningful conclusions."
NCT01312818,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01312844,TERMINATED,INTERVENTIONAL,"This was an inpatient study, but PI left inpatient service at MGH"
NCT01312870,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01312935,TERMINATED,INTERVENTIONAL,PolyMedix decided to stop enrollment in both clinical trials due to observations of reductions in blood pressure.
NCT01313026,TERMINATED,INTERVENTIONAL,Difficult to recruit participants
NCT01313104,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01313273,TERMINATED,INTERVENTIONAL,Poor enrolment
NCT01313364,TERMINATED,INTERVENTIONAL,The objective of the study has been achieved with fewer subjects than planned.
NCT01313390,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01313416,TERMINATED,INTERVENTIONAL,Drug supply issues
NCT01313429,TERMINATED,INTERVENTIONAL,"Per stopping rule if 12 patients underwent immune response analysis after 6 vaccinations and none developed a response, the protocol would stop accrual."
NCT01313559,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01313611,TERMINATED,INTERVENTIONAL,"Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured."
NCT01313884,TERMINATED,INTERVENTIONAL,Study did not reach primary objective; study did not accrue enough patients.
NCT01313923,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01314027,TERMINATED,INTERVENTIONAL,low recruitment
NCT01314066,WITHDRAWN,INTERVENTIONAL,No funding
NCT01314092,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects.
NCT01314417,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of recruitment.
NCT01314495,WITHDRAWN,INTERVENTIONAL,Halt in funding
NCT01314508,WITHDRAWN,INTERVENTIONAL,The sponsor has notified us that they are not funding the study
NCT01314664,TERMINATED,OBSERVATIONAL,"Business decision, not safety related"
NCT01314677,WITHDRAWN,INTERVENTIONAL,No subjects have been accrued to this trial. The PI will no longer be at COH and requests a study withdrawal/closure.
NCT01314846,TERMINATED,OBSERVATIONAL,difficulty to include patients
NCT01315158,TERMINATED,INTERVENTIONAL,- The research team is not able to obtain the necessary support to continue the study.
NCT01315574,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT01315626,WITHDRAWN,OBSERVATIONAL,Sponsor did not move forward with study
NCT01315730,WITHDRAWN,INTERVENTIONAL,Patent being pursued prior to trial initiation
NCT01315808,TERMINATED,OBSERVATIONAL,Due to lack of funds to continue this study.
NCT01315873,TERMINATED,INTERVENTIONAL,PI left the institution before all data analysis was completed
NCT01315886,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01315899,TERMINATED,INTERVENTIONAL,Recommendation by study DSMC to the sponsor following interim analysis of 8 subjects.
NCT01316042,TERMINATED,INTERVENTIONAL,poor recruitment at collaborating sites
NCT01316133,TERMINATED,INTERVENTIONAL,Study terminated due to poor patient recruitment.
NCT01316146,WITHDRAWN,INTERVENTIONAL,Study never truly opened to accrual at UNC. Study and data were transfered to UNC as the IND for the study was transfered to UNC. IRB closed the study.
NCT01316185,TERMINATED,INTERVENTIONAL,the enrollment was slow and never completed.
NCT01316263,TERMINATED,INTERVENTIONAL,Trial terminated strategically due to poor accrual.
NCT01316445,TERMINATED,INTERVENTIONAL,Funding agency no longer provide support.
NCT01316536,TERMINATED,INTERVENTIONAL,inability to recruit participants despite numerous attempts
NCT01316692,TERMINATED,INTERVENTIONAL,low accrual
NCT01316770,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01316939,TERMINATED,INTERVENTIONAL,This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.
NCT01316965,TERMINATED,INTERVENTIONAL,enrollment of patients insufficient
NCT01317017,TERMINATED,INTERVENTIONAL,Unable to isolate sufficient cells from the skin biopsy to perform study experiments.
NCT01317030,TERMINATED,OBSERVATIONAL,Study was terminated due to a business decision to cancel the entire project.
NCT01317212,WITHDRAWN,INTERVENTIONAL,Sufficient funding could not be secured for the study
NCT01317433,TERMINATED,INTERVENTIONAL,The study stopped due to a lack of recruitment
NCT01317472,TERMINATED,INTERVENTIONAL,Principal investigator left institution
NCT01317771,WITHDRAWN,OBSERVATIONAL,PI decided to not activate
NCT01317810,WITHDRAWN,OBSERVATIONAL,Corporate decision not to initiate the trial
NCT01317849,WITHDRAWN,INTERVENTIONAL,financial assistance financial assistance financial assistance financial assistance financial assistance without financial assistance
NCT01317966,WITHDRAWN,OBSERVATIONAL,No eligible patients were enrolled.
NCT01318161,TERMINATED,INTERVENTIONAL,Difficulty in recruiting
NCT01318447,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01318590,TERMINATED,INTERVENTIONAL,Closed by CHUM REB for incomplete documentation of research activities.
NCT01318642,TERMINATED,INTERVENTIONAL,NCT01318642: Planned independent DMC Interim review: ended for futility w/no safety concerns
NCT01318811,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01318915,TERMINATED,INTERVENTIONAL,The stopping rule for incidence of acute rejection was met.
NCT01318993,TERMINATED,INTERVENTIONAL,This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.
NCT01319045,TERMINATED,INTERVENTIONAL,enrollment was too slow
NCT01319188,TERMINATED,INTERVENTIONAL,The study was terminated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology
NCT01319526,TERMINATED,OBSERVATIONAL,Parent protocol (SWOG S0816 / AMC-073) discontinued
NCT01319539,TERMINATED,INTERVENTIONAL,"terminated early, due to toxicity"
NCT01319669,TERMINATED,INTERVENTIONAL,recruiting too slowly
NCT01319747,TERMINATED,INTERVENTIONAL,Inclusion rate insufficient
NCT01319760,TERMINATED,INTERVENTIONAL,Change in business priority
NCT01319838,WITHDRAWN,INTERVENTIONAL,no patient enrollment
NCT01319851,TERMINATED,INTERVENTIONAL,drug company is no longer making the drug
NCT01320072,TERMINATED,OBSERVATIONAL,Study discontinued and closed out by IRB. PI left the institution.
NCT01320267,WITHDRAWN,INTERVENTIONAL,Industry Funding Withdrawn
NCT01320280,TERMINATED,INTERVENTIONAL,unexpectedly slow recruitment
NCT01320306,TERMINATED,OBSERVATIONAL,Could not be implemented
NCT01320475,TERMINATED,INTERVENTIONAL,Difficulty of Recruitment
NCT01320488,SUSPENDED,OBSERVATIONAL,Difficulty in enrolling patients
NCT01320501,SUSPENDED,INTERVENTIONAL,Difficulty in enrolling patients
NCT01320683,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT01320813,TERMINATED,INTERVENTIONAL,Unable to find enough patients who accept randomization of surgical procedures.
NCT01321008,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01321268,TERMINATED,INTERVENTIONAL,sponsor stopped study due to recruitment problems
NCT01321411,WITHDRAWN,OBSERVATIONAL,Not started and now discontinued
NCT01321476,WITHDRAWN,OBSERVATIONAL,Study was never initiated and internal decision to discontinue initiation process
NCT01321697,TERMINATED,OBSERVATIONAL,Principal Investigator Request
NCT01321866,TERMINATED,INTERVENTIONAL,Inclusion curve too slow.
NCT01321918,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01321970,WITHDRAWN,INTERVENTIONAL,Impossible to start to the study.
NCT01321996,TERMINATED,INTERVENTIONAL,enrollment failure (only 29 patients were enrolled during the study period)
NCT01322100,TERMINATED,INTERVENTIONAL,Due to slow patient recruitment
NCT01322243,TERMINATED,INTERVENTIONAL,Due to mechanical issue with device
NCT01322256,TERMINATED,INTERVENTIONAL,The study has proven to be infeasible.
NCT01322815,TERMINATED,INTERVENTIONAL,Poor accrual rate
NCT01322971,TERMINATED,INTERVENTIONAL,Disease prevalence lower than expected in population.
NCT01323582,TERMINATED,INTERVENTIONAL,"Original investigator left this institution, replacement investigator retired."
NCT01323595,TERMINATED,INTERVENTIONAL,Interim analysis demonstrated significant benefit in intervention arm
NCT01323907,WITHDRAWN,INTERVENTIONAL,Omegaven is now FDA approved.
NCT01324115,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT01324141,TERMINATED,INTERVENTIONAL,"Slow, insufficient accrual and failure to meet endpoints."
NCT01324297,TERMINATED,OBSERVATIONAL,"Unable to secure funding for second phase of study (i.e., niacin skin flush test in early psychosis patients)."
NCT01324544,WITHDRAWN,INTERVENTIONAL,Due to change in development plan.
NCT01324609,TERMINATED,OBSERVATIONAL,Could not recruit enough patients
NCT01324622,TERMINATED,INTERVENTIONAL,terminated due to failure to meet enrolment goals
NCT01324635,TERMINATED,INTERVENTIONAL,Arm A - reached goal; Arm B - poor accrual
NCT01324908,TERMINATED,INTERVENTIONAL,Low accrual
NCT01324934,TERMINATED,INTERVENTIONAL,Recruitment became very slow.
NCT01325012,TERMINATED,INTERVENTIONAL,Surgeon doing procedures amenable to this study left institution.
NCT01325584,TERMINATED,INTERVENTIONAL,Alternative product is now approved and available for use.
NCT01325740,SUSPENDED,INTERVENTIONAL,pending further evaluation
NCT01325779,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT01325805,TERMINATED,INTERVENTIONAL,"Difficult to recruit, very poor compliance with interventions"
NCT01326065,TERMINATED,OBSERVATIONAL,Study had to be terminated due to lack of funding
NCT01326078,WITHDRAWN,INTERVENTIONAL,The Sponsor has no interest in continuing the study.
NCT01326091,TERMINATED,INTERVENTIONAL,Insufficient study support
NCT01326117,WITHDRAWN,INTERVENTIONAL,lack of patients who meet inclusion criteria; there was one screen failure
NCT01326234,WITHDRAWN,INTERVENTIONAL,Due to staff changes the study never started.
NCT01326312,TERMINATED,INTERVENTIONAL,FDA Clinical Hold
NCT01326429,WITHDRAWN,OBSERVATIONAL,Job change of responsible investigators
NCT01326468,WITHDRAWN,INTERVENTIONAL,funding
NCT01326585,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01326676,WITHDRAWN,INTERVENTIONAL,Funding never attained
NCT01326728,TERMINATED,OBSERVATIONAL,A replacement protocol was created to replace this current version of protocol.
NCT01326845,TERMINATED,INTERVENTIONAL,The trial was terminated due to insufficient enrollment.
NCT01326923,TERMINATED,INTERVENTIONAL,Principle Investigator left the institution.
NCT01327287,TERMINATED,OBSERVATIONAL,inability to recruit participants despite numerous attempts
NCT01327508,TERMINATED,INTERVENTIONAL,Primary endpoint voided. Dosimeters did not capture radiation dose as expected.
NCT01327521,WITHDRAWN,INTERVENTIONAL,Accrual below target levels
NCT01327625,TERMINATED,INTERVENTIONAL,Preliminary reports of this study was too bad.
NCT01327664,WITHDRAWN,INTERVENTIONAL,Study will not be initiated as planned.
NCT01327963,TERMINATED,INTERVENTIONAL,The sponsor is focusing on prospective randomized studies
NCT01328093,TERMINATED,INTERVENTIONAL,The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.
NCT01328106,WITHDRAWN,INTERVENTIONAL,The study was cancelled by the sponsor prior to initiation of study enrollment. No subjects were accrued.
NCT01328262,TERMINATED,INTERVENTIONAL,"Few patients, time consuming to find suiting blood bags with the ""right"" weight."
NCT01328392,WITHDRAWN,INTERVENTIONAL,The sponsor did not fund the study.
NCT01328730,WITHDRAWN,INTERVENTIONAL,the Cypher SES is now withdrawing in China market
NCT01328860,TERMINATED,INTERVENTIONAL,"Principal Investigator relocated to Orlando, Florida."
NCT01329211,TERMINATED,OBSERVATIONAL,"PI left institution,replacement PI not able to do study."
NCT01329250,TERMINATED,INTERVENTIONAL,slow enrolment of patients and new insights
NCT01329289,WITHDRAWN,INTERVENTIONAL,Clinical trial being transferred to Columbia University with the Investigator.
NCT01329341,TERMINATED,INTERVENTIONAL,Study concluded prematurly
NCT01329627,TERMINATED,INTERVENTIONAL,Toxicity
NCT01329666,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT01329679,TERMINATED,INTERVENTIONAL,Unable to recruit enough subjects
NCT01329692,TERMINATED,INTERVENTIONAL,The PI has left Duke-the primary study site and the sponsor retreat the support
NCT01329926,WITHDRAWN,OBSERVATIONAL,insufficient funding
NCT01330277,TERMINATED,OBSERVATIONAL,Study no longer pursued.
NCT01330355,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01330576,TERMINATED,INTERVENTIONAL,End of funding
NCT01330589,WITHDRAWN,INTERVENTIONAL,Inability to enroll subjects and changes in standard of care for PCI
NCT01330654,WITHDRAWN,INTERVENTIONAL,no patients were enrolled. Study was closed prior to study start.
NCT01330667,WITHDRAWN,INTERVENTIONAL,funding not available
NCT01330823,SUSPENDED,INTERVENTIONAL,"after interims analysis standard errors for inflammatory and nutritional markers varied widely, that the power calculation required unattainable goals"
NCT01331122,WITHDRAWN,INTERVENTIONAL,Never initiated. Withdrawn by sponsor.
NCT01331395,TERMINATED,INTERVENTIONAL,Enrollment rate slower than anticipated.
NCT01331499,TERMINATED,INTERVENTIONAL,Study terminated due to Medtronic acquisition
NCT01331642,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT01331785,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01331824,TERMINATED,INTERVENTIONAL,due to a development decision by the funder
NCT01332279,WITHDRAWN,INTERVENTIONAL,Pharmaceutical co. withdrew support. Study was never activated and did not accrue any patients.
NCT01332331,TERMINATED,INTERVENTIONAL,Ongoing juvenile rat toxicology studies.
NCT01332552,TERMINATED,INTERVENTIONAL,Terminated due to unfavorable human pharmacokinetic properties
NCT01332617,WITHDRAWN,INTERVENTIONAL,Investigators no longer interested in activating study
NCT01332643,TERMINATED,INTERVENTIONAL,Not enough patients enrolling
NCT01332799,TERMINATED,INTERVENTIONAL,Study was not funded
NCT01332916,TERMINATED,INTERVENTIONAL,lack of patient
NCT01333059,TERMINATED,INTERVENTIONAL,Unable to adequately enroll over a reasonable enrollment period.
NCT01333124,TERMINATED,INTERVENTIONAL,Recruitment delay
NCT01333449,TERMINATED,INTERVENTIONAL,Poor subject accrual
NCT01333488,TERMINATED,INTERVENTIONAL,Low accrual
NCT01333761,TERMINATED,INTERVENTIONAL,1)new FDS device design 2)improved Valsalva procedure 3)improved headbands and earpads.
NCT01333852,TERMINATED,INTERVENTIONAL,Low accrual
NCT01334047,TERMINATED,INTERVENTIONAL,The study needed to be terminated due to new knowledge about cancer vaccines. A new protocol with an expected more efficient vaccine is currently being written.
NCT01334099,TERMINATED,INTERVENTIONAL,Contract with drug supplier expired and was not renewed.
NCT01334255,TERMINATED,INTERVENTIONAL,Sponsor decision; not safety related
NCT01334281,TERMINATED,OBSERVATIONAL,Technical difficulties perfecting laboratory test used on blood samples.
NCT01334489,TERMINATED,INTERVENTIONAL,Interim analysis unfavorable to continue the study
NCT01334606,TERMINATED,INTERVENTIONAL,This study was terminated due to unanticipated recruitment difficulties.
NCT01334632,WITHDRAWN,INTERVENTIONAL,Change of practice in the department (Nerve stimulation technique abandoned)
NCT01334710,TERMINATED,INTERVENTIONAL,safety issue observed on another hepatocellular study using OSI906
NCT01334775,TERMINATED,INTERVENTIONAL,"Inclusion speed too slow, no longer relevant and takeover"
NCT01334892,TERMINATED,INTERVENTIONAL,"Interim analysis results revealed substantial increase of patient number, with unfeasible study prolongation."
NCT01335113,TERMINATED,OBSERVATIONAL,Unable to get accurate measurements with existing technology
NCT01335165,TERMINATED,INTERVENTIONAL,Inability to reach enrollment as planned
NCT01335204,TERMINATED,INTERVENTIONAL,lack of funding
NCT01335867,TERMINATED,INTERVENTIONAL,interim analysis of efficacy completed and termination recommended
NCT01335919,WITHDRAWN,OBSERVATIONAL,Company is redesigning measuring tool.
NCT01335945,TERMINATED,INTERVENTIONAL,Low enrollment \& subjects didn't survive to study end due to cancer progression.
NCT01335997,TERMINATED,INTERVENTIONAL,Business Reasons
NCT01336075,TERMINATED,INTERVENTIONAL,Too few participants
NCT01336231,TERMINATED,OBSERVATIONAL,lack of recruitment
NCT01336530,TERMINATED,INTERVENTIONAL,"The study stopped prematurely due to and administrative reasons, not based on grounds of safety."
NCT01336543,WITHDRAWN,INTERVENTIONAL,"Low accrual, small patient population at center."
NCT01336673,TERMINATED,OBSERVATIONAL,The study was scheduled for completion February 2013. Because of difficulties encountered in completing the trial the study was terminated by sponsor June 2013.
NCT01336894,TERMINATED,INTERVENTIONAL,recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT01336907,WITHDRAWN,OBSERVATIONAL,never started
NCT01337011,TERMINATED,INTERVENTIONAL,study was stopped due to funding issues
NCT01337154,TERMINATED,INTERVENTIONAL,Interim analysis showed that the primary endpoint would not be met.
NCT01337180,WITHDRAWN,OBSERVATIONAL,The industry plant from which we should recruit was closed down.
NCT01337193,TERMINATED,INTERVENTIONAL,Principal investigator has decided not to continue her PhD studies.
NCT01337323,TERMINATED,OBSERVATIONAL,Insufficient number of patient records met inclusion criteria
NCT01337349,WITHDRAWN,INTERVENTIONAL,Did not enroll
NCT01337414,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT01337427,WITHDRAWN,INTERVENTIONAL,The study was not feasible to conduct in the US and abroad.
NCT01337492,TERMINATED,INTERVENTIONAL,slow accrual
NCT01337518,SUSPENDED,INTERVENTIONAL,Reassessment of strategic direction
NCT01337544,TERMINATED,INTERVENTIONAL,"The parents of two patients enrolled who died, presented a claim against the hospital and the study was halted."
NCT01337609,TERMINATED,INTERVENTIONAL,"Because the study sponsor chose to discontinue funding for this protocol following a change in leadership, the study was terminated early."
NCT01337635,TERMINATED,INTERVENTIONAL,Not meeting enrollment goals.
NCT01337739,TERMINATED,INTERVENTIONAL,The study drug delayed time of discharge which is clinically impracticable.
NCT01337895,WITHDRAWN,INTERVENTIONAL,"Grant not funded, study will not launch"
NCT01337921,WITHDRAWN,INTERVENTIONAL,Pending further safety information regarding polysaccharides and premature infants
NCT01338012,TERMINATED,INTERVENTIONAL,Administrative reasons.
NCT01338025,TERMINATED,INTERVENTIONAL,Study was halted for lack of accrual
NCT01338857,TERMINATED,INTERVENTIONAL,Sorafenib ineffective for tx of recurrent or progressive PLGA
NCT01338935,TERMINATED,INTERVENTIONAL,Pharmacokinetic stopping criteria for the study were met.
NCT01339000,TERMINATED,INTERVENTIONAL,"Company supplying drug declared bankruptcy, thus there was no drug supply."
NCT01339026,TERMINATED,INTERVENTIONAL,Change in guidelines favouring newer antiplatelet drugs in ACS
NCT01339039,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT01339455,TERMINATED,INTERVENTIONAL,recruitment failure
NCT01339910,TERMINATED,INTERVENTIONAL,Accrual terminated as recommended by the data and safety monitoring board.
NCT01339949,WITHDRAWN,INTERVENTIONAL,Sponsor decision to withdraw study to pursue others.
NCT01340274,WITHDRAWN,INTERVENTIONAL,Could not get participants
NCT01340573,TERMINATED,OBSERVATIONAL,Terminated early due to low enrollment.
NCT01340599,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01340690,TERMINATED,INTERVENTIONAL,The sample size of the planned interims analysis was achieved
NCT01340794,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01341106,TERMINATED,INTERVENTIONAL,insufficient patient numbers have been recruited
NCT01341288,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01341340,TERMINATED,INTERVENTIONAL,Discontinued due to poor enrollment. Insufficient number of patients enrolled to permit a statistically rigorous assessment of safety and efficacy.
NCT01341379,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01341444,TERMINATED,INTERVENTIONAL,Enrollment Difficulties
NCT01341483,TERMINATED,OBSERVATIONAL,Sufficient information gathered
NCT01341587,TERMINATED,INTERVENTIONAL,participants lost to follow-up;
NCT01341769,WITHDRAWN,INTERVENTIONAL,Test ingredient production did not meet specification
NCT01341873,WITHDRAWN,INTERVENTIONAL,The protocol was not funded by the NCI
NCT01342016,TERMINATED,INTERVENTIONAL,Due to safety concern of active control drug
NCT01342172,TERMINATED,INTERVENTIONAL,low accrual
NCT01342276,TERMINATED,INTERVENTIONAL,Due to futility of recruitment.
NCT01342627,TERMINATED,INTERVENTIONAL,low enrollment rate
NCT01342653,SUSPENDED,INTERVENTIONAL,unable to reach planned recruitment
NCT01342705,TERMINATED,INTERVENTIONAL,delayed recruitment as compared to that expected
NCT01343069,WITHDRAWN,INTERVENTIONAL,insufficient quality of data
NCT01343095,TERMINATED,INTERVENTIONAL,Loss of study staff
NCT01343316,TERMINATED,OBSERVATIONAL,lack of funding
NCT01343329,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects that fit study criteria.
NCT01343394,WITHDRAWN,INTERVENTIONAL,UT-IRB insists on protocol design change -Not rel to any pt. safety/non-compliance-Recruiting halted at UT/MHHS but may resume at FLHosp for Children-OrlandoFL
NCT01343537,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01343628,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding
NCT01343641,WITHDRAWN,INTERVENTIONAL,Could not obtain drug supply from manufacturer
NCT01343680,TERMINATED,INTERVENTIONAL,Poor patient accrual
NCT01343823,TERMINATED,INTERVENTIONAL,Interim analysis suggested a trend favoring ecallantide; observed response rate to placebo was substantially higher than described in medical literature.
NCT01344109,WITHDRAWN,OBSERVATIONAL,Lab company that was to do testing was sold
NCT01344486,TERMINATED,INTERVENTIONAL,Investigator no longer works fulltime at investigational site
NCT01344902,TERMINATED,INTERVENTIONAL,The study was stopped due to inadequate efficacy after 13 patients were evaluated.
NCT01345084,WITHDRAWN,INTERVENTIONAL,change company strategy
NCT01345136,TERMINATED,INTERVENTIONAL,slow accrual
NCT01345214,TERMINATED,INTERVENTIONAL,The study was terminated due to slow accrual of subjects.
NCT01345383,TERMINATED,OBSERVATIONAL,the physician responsable for this protocol left our hospital
NCT01345422,WITHDRAWN,INTERVENTIONAL,The study never started since it did not receive IRB approval
NCT01345539,TERMINATED,INTERVENTIONAL,Participant enrollment was negatively impacted by medical oncology treatment with systemic therapy alone and accrual to other clinical trials.
NCT01345565,WITHDRAWN,INTERVENTIONAL,A funding mechanism is not identified at this time
NCT01345578,TERMINATED,INTERVENTIONAL,seeking additional funding
NCT01345630,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01345812,TERMINATED,INTERVENTIONAL,Lack of patients for recruitment
NCT01345864,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01345903,WITHDRAWN,INTERVENTIONAL,The protocol needs to be re-designed.
NCT01345968,TERMINATED,INTERVENTIONAL,"Less patients than expected for inclusion, therefore recruitment is too low"
NCT01346059,TERMINATED,INTERVENTIONAL,Technical issues with catheter placement; researcher left institution
NCT01346579,TERMINATED,OBSERVATIONAL,Study closed prematurely.
NCT01346605,WITHDRAWN,OBSERVATIONAL,No funding
NCT01346631,WITHDRAWN,INTERVENTIONAL,We didn't start the study
NCT01346865,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT01346930,WITHDRAWN,INTERVENTIONAL,Due to Protocol AC-055B201 (MUSIC) not meeting it's primary end point
NCT01347125,TERMINATED,INTERVENTIONAL,CorAssist believes that certain improvements are needed to the device
NCT01347528,WITHDRAWN,INTERVENTIONAL,logistic and financial accounting reasons
NCT01347541,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT01347645,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI
NCT01347684,WITHDRAWN,INTERVENTIONAL,PI left University of Minnesota
NCT01347840,TERMINATED,OBSERVATIONAL,Study was terminated for business reasons.
NCT01347866,TERMINATED,INTERVENTIONAL,Refer to Detailed Description for documentaion of Termination Statement.
NCT01347918,SUSPENDED,OBSERVATIONAL,Technical problems
NCT01348087,TERMINATED,INTERVENTIONAL,Study treatment AFQ056 failed to demonstrate efficacy in the adult patient with Fragile X Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)
NCT01348230,WITHDRAWN,OBSERVATIONAL,Investigator left institution
NCT01348503,TERMINATED,INTERVENTIONAL,Treatment was ineffective
NCT01348607,TERMINATED,INTERVENTIONAL,Study only randomized 1 subject and was determined not feasible by DSMB
NCT01348698,TERMINATED,OBSERVATIONAL,Slow/insufficient accrual
NCT01348711,TERMINATED,OBSERVATIONAL,Shortness inclusions of patients
NCT01348997,WITHDRAWN,INTERVENTIONAL,Study ended prior to completion of planning stage. No participants enrolled.
NCT01349036,TERMINATED,INTERVENTIONAL,Business Decision
NCT01349114,TERMINATED,INTERVENTIONAL,Sponsor requested termination.
NCT01349192,TERMINATED,INTERVENTIONAL,Interim review showed a statistically significant treatment effect and the DMC recommended that the study be stopped with ongoing follow-up of enrolled subjects
NCT01349205,TERMINATED,INTERVENTIONAL,The study medication was no longer available in the market
NCT01349426,TERMINATED,INTERVENTIONAL,diffculty to include patients
NCT01349491,TERMINATED,INTERVENTIONAL,low recruitement rates
NCT01349556,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to volunteer disinterest in participating.
NCT01349595,TERMINATED,INTERVENTIONAL,Study halted due to lack of funding
NCT01349673,TERMINATED,INTERVENTIONAL,Terminated for non-safety reasons when Sponsor felt that sufficient long-term safety data was obtained.
NCT01349764,TERMINATED,OBSERVATIONAL,Unable to recruit required sample size
NCT01349894,WITHDRAWN,OBSERVATIONAL,"The study was terminated by Spiracur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful."
NCT01350102,TERMINATED,INTERVENTIONAL,study closed due to recruitment problems
NCT01350232,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01350258,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01350401,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01350583,TERMINATED,INTERVENTIONAL,PI Left Moffitt
NCT01350622,WITHDRAWN,INTERVENTIONAL,Study never initiated
NCT01351038,TERMINATED,INTERVENTIONAL,REAL trial showed a significant difference in OS for reduced EOX and standard EOX
NCT01351168,WITHDRAWN,INTERVENTIONAL,study not funded
NCT01351519,TERMINATED,INTERVENTIONAL,Limited staff available for enrollment and limited availability of drug
NCT01351558,TERMINATED,INTERVENTIONAL,Recruitment difficulties.
NCT01351675,TERMINATED,INTERVENTIONAL,IDMC recommendation for safety concerns
NCT01351753,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01351844,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient patients
NCT01352026,WITHDRAWN,INTERVENTIONAL,Several therapeutic have been developed making more difficult the eligibility of patients - Recruitment of new centers wasn't possible due to competing trials
NCT01352208,TERMINATED,INTERVENTIONAL,It was decided to discontinue the development in consideration of the results of a P1 study
NCT01352312,TERMINATED,INTERVENTIONAL,Insufficient accrual over 12 mo period
NCT01352416,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01352611,WITHDRAWN,INTERVENTIONAL,No subjects enrolled.
NCT01352663,WITHDRAWN,INTERVENTIONAL,Business strategy decision
NCT01352702,TERMINATED,INTERVENTIONAL,Slow recruitment; Study was terminated for futility reasons
NCT01353222,TERMINATED,INTERVENTIONAL,Administrative reasons.
NCT01353378,WITHDRAWN,INTERVENTIONAL,The study was not approved by Hospital's Medical Ethics Committee.
NCT01353482,WITHDRAWN,INTERVENTIONAL,UCL CTC were informed by Merck Sharp \& Dohme on 22.08.11 that support for the trial had been withdrawn in light of results from another trial with trial drug.
NCT01353638,TERMINATED,INTERVENTIONAL,Primary endpoint (HSP) could not be analyzed with the specified method in the planned interim analysis; a method of increased sensitivity had to be established.
NCT01353937,WITHDRAWN,INTERVENTIONAL,Never Activated
NCT01354119,TERMINATED,INTERVENTIONAL,Not enough participants enrolled
NCT01354275,TERMINATED,INTERVENTIONAL,". The trial would be continued if there was a difference of 3 % between trial arms. However, the difference between ongoing pregnancy rates was \<1 %"
NCT01354652,TERMINATED,INTERVENTIONAL,Tenofovir has become available in Korea.
NCT01354678,TERMINATED,INTERVENTIONAL,Terminated due to inefficacy of the tested method
NCT01354756,TERMINATED,OBSERVATIONAL,device was stolen
NCT01354951,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01355003,TERMINATED,OBSERVATIONAL,Merck Sharp \& Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing surveillance (PMS) study
NCT01355302,TERMINATED,INTERVENTIONAL,Sites not recruiting
NCT01355523,TERMINATED,INTERVENTIONAL,Inclusion rate not as expected. Not financially possible to involve other centres.
NCT01355562,WITHDRAWN,INTERVENTIONAL,Primary Investigator is no longer employed at LLU as of 02/29/12.
NCT01355575,TERMINATED,INTERVENTIONAL,Primary endpoint data review concluded no further patients required.
NCT01355601,TERMINATED,INTERVENTIONAL,Terminated due to slow recruitment. 41 of 50 participants had enrolled at time of termination.
NCT01355809,TERMINATED,INTERVENTIONAL,Due to low recruitment rate the sponsor decided to discontinue the study.
NCT01355861,WITHDRAWN,INTERVENTIONAL,Project has been withdrawn from funding consideration
NCT01355874,TERMINATED,INTERVENTIONAL,The primary endpoint was not met on the double blind data
NCT01356303,SUSPENDED,INTERVENTIONAL,Difficulty in enrolling patients
NCT01356329,SUSPENDED,INTERVENTIONAL,Difficulty in enrolling patients
NCT01356368,TERMINATED,INTERVENTIONAL,slow accrual rate
NCT01356420,TERMINATED,INTERVENTIONAL,NICHD cut funding
NCT01356667,TERMINATED,INTERVENTIONAL,Study period is over and recruitment was stopped due to time constraints.
NCT01356992,TERMINATED,INTERVENTIONAL,Change in strategy regarding the product by the company
NCT01357148,TERMINATED,OBSERVATIONAL,"Completion of MK-0431A-235 was rendered unnecessary, as the local oversight authority accepted in its stead the results of another study \[MK-0431-234\]."
NCT01357174,TERMINATED,OBSERVATIONAL,Merck Sharp \& Dohme Corp (MSD) received exemption from PFDA on conduct of post-marketing surveillance (PMS) study
NCT01357408,TERMINATED,OBSERVATIONAL,enrollment futility
NCT01357447,WITHDRAWN,INTERVENTIONAL,No patients enrolled.
NCT01357460,TERMINATED,INTERVENTIONAL,difficult patient recruitment
NCT01357499,WITHDRAWN,OBSERVATIONAL,PI left center
NCT01357629,TERMINATED,OBSERVATIONAL,The Study could not be done for every potential participant as planned in the protocol for organizational reasons.
NCT01357655,TERMINATED,INTERVENTIONAL,"No participants enrolled in this trial could receive the SMO antagonist as a recommended phase 2 dose was not determined by a different, concurrently-run trial."
NCT01357746,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01357863,TERMINATED,OBSERVATIONAL,This study was terminated because the National Ethics Committee has not approved the protocol.
NCT01358214,TERMINATED,OBSERVATIONAL,major recruitment failure
NCT01358552,TERMINATED,OBSERVATIONAL,Insufficient number of participants
NCT01358708,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT01358799,WITHDRAWN,OBSERVATIONAL,Assay not evaluated for purpose of clearance
NCT01359007,TERMINATED,INTERVENTIONAL,The principal investigator terminated the study due to inactivity and low enrollment
NCT01359072,TERMINATED,INTERVENTIONAL,This study is currently terminated due to low recruitment rate.
NCT01359254,TERMINATED,INTERVENTIONAL,did not accrue enough patients.
NCT01359410,TERMINATED,INTERVENTIONAL,The 3rd interim analysis found superiority in the mesh reinforcement arm
NCT01359579,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01359618,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate
NCT01359813,TERMINATED,INTERVENTIONAL,"decision of independent monitoring committee:Risk of death at 3 months higher in Albumin group than in control group, without reaching significance level."
NCT01359826,WITHDRAWN,INTERVENTIONAL,PI has let the institution. We are unable to locate any study documents that would indicate study enrollment
NCT01359865,TERMINATED,INTERVENTIONAL,change in clinical practice- both surgeons have left the institution
NCT01360372,WITHDRAWN,INTERVENTIONAL,No eligible subjects identified
NCT01360450,TERMINATED,INTERVENTIONAL,The study was treminated because of low accural
NCT01360801,TERMINATED,OBSERVATIONAL,"enrollment moved very slowly which was not anticipated, and, funding issues"
NCT01360827,TERMINATED,INTERVENTIONAL,Study terminated due to potential safety concerns in combination with platinum-based therapies
NCT01360905,TERMINATED,OBSERVATIONAL,Difficulty in recruiting
NCT01360918,TERMINATED,INTERVENTIONAL,Inclusion rate insufficint
NCT01360957,WITHDRAWN,INTERVENTIONAL,Mahnaz Kazemipoor has not handed over human subject review board approval letter to her colleague.
NCT01361087,WITHDRAWN,INTERVENTIONAL,No outside recruitment of subjects from Main Atenolol VS Losartan NIH study
NCT01361256,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01361282,TERMINATED,OBSERVATIONAL,The DSAEK procedure was discontinued as the standard of care for the intended cohort.
NCT01361555,TERMINATED,INTERVENTIONAL,Failure to meet primary endpoint
NCT01361750,TERMINATED,INTERVENTIONAL,higher occurrence of complication than expected for both groups
NCT01361945,WITHDRAWN,INTERVENTIONAL,Closed due to no enrollment
NCT01362036,TERMINATED,INTERVENTIONAL,"Enrollment feasibility issues, new study in design"
NCT01362075,TERMINATED,INTERVENTIONAL,"After 3 years of recruitment, the study was stopped due to time constraints."
NCT01362205,TERMINATED,INTERVENTIONAL,DSMB recommendation for slow enrollment
NCT01362218,TERMINATED,INTERVENTIONAL,Per sponsor's decision
NCT01362348,TERMINATED,INTERVENTIONAL,Lack of efficacy identified during a preliminary analysis
NCT01362686,TERMINATED,INTERVENTIONAL,Low study accrual caused the study to be ended early.
NCT01362699,WITHDRAWN,INTERVENTIONAL,Re-prioritization lead to study cancellation.
NCT01362712,TERMINATED,INTERVENTIONAL,Unable to enroll breast cancer patients with current I/E criteria.
NCT01362868,TERMINATED,INTERVENTIONAL,Too low effect on the output and low rate of responders
NCT01362998,TERMINATED,INTERVENTIONAL,Lack of time and help to continue the study
NCT01363154,TERMINATED,INTERVENTIONAL,terminated
NCT01363310,TERMINATED,INTERVENTIONAL,Termination of sponsorship
NCT01363349,TERMINATED,INTERVENTIONAL,pre-planned interim analysis of the Phase II/III CLARITY trial of BL-1020 indicate that the trial would not meet the pre-specified primary efficacy endpoint.
NCT01363466,TERMINATED,INTERVENTIONAL,low recruitment
NCT01363557,TERMINATED,INTERVENTIONAL,Decision of Sponsor
NCT01363882,TERMINATED,INTERVENTIONAL,Insufficient enrollment \& high rate of failure to complete protocol
NCT01363908,TERMINATED,INTERVENTIONAL,This study was terminated due to treatment stop resulting in an inability to draw conclusions from the data. Evaluation of nonclinical rat findings is ongoing.
NCT01363921,TERMINATED,INTERVENTIONAL,insufficient patient recruiting
NCT01363986,TERMINATED,INTERVENTIONAL,Study was prematurely terminated due to difficulties experienced in recruiting patients in a reasonable timeframe.
NCT01364220,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01364259,TERMINATED,INTERVENTIONAL,Patterns of practice changed and this technique is no longer used.
NCT01364389,TERMINATED,INTERVENTIONAL,Data did not show that the two biologic treatments impacted PMR disease activity to the same degree as steroid treatment within a 2-week treatment period.
NCT01364636,TERMINATED,OBSERVATIONAL,problems with the stability of samples collected
NCT01365130,TERMINATED,INTERVENTIONAL,As of 12/12/12 study closed to enrollment because study was determined to be ineffective.
NCT01365143,TERMINATED,INTERVENTIONAL,Closing due to slow enrollment
NCT01365195,TERMINATED,INTERVENTIONAL,recruitment failure
NCT01365312,TERMINATED,INTERVENTIONAL,Primary investigator relocated
NCT01365468,TERMINATED,INTERVENTIONAL,Poor patients' accrual
NCT01365780,SUSPENDED,INTERVENTIONAL,"nump

acceptence by patient too low"
NCT01365884,TERMINATED,OBSERVATIONAL,Low subject recruitment
NCT01365910,TERMINATED,INTERVENTIONAL,Interim analysis determined the study did not meet criteria to proceed
NCT01366066,TERMINATED,INTERVENTIONAL,Failure to recruit participants
NCT01366508,TERMINATED,INTERVENTIONAL,Results of the study would unfortunately no longer be of any scientific interest to the sponsor and would not be used to inform future studies.
NCT01366612,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT01366651,TERMINATED,INTERVENTIONAL,Trial terminated early per business decision.
NCT01366729,TERMINATED,INTERVENTIONAL,Unable to recruite enough subjects to reach statistical power
NCT01366833,TERMINATED,INTERVENTIONAL,Low accrual
NCT01366989,TERMINATED,OBSERVATIONAL,The retrospective data review did not provide adequate information to continue the investigation.
NCT01367210,TERMINATED,INTERVENTIONAL,Because a higher rate of virological failures in study versus control arm.
NCT01367275,TERMINATED,INTERVENTIONAL,Sponsor closed study
NCT01367301,TERMINATED,INTERVENTIONAL,Lack of accrual. PI left the institution
NCT01367405,TERMINATED,INTERVENTIONAL,only 1 inclusion in 1.5 years due to strict exclusion criteria
NCT01367444,TERMINATED,INTERVENTIONAL,"Study stopped not for safety reasons. Due to review of clinical development plans and priorities, Sponsor decided to stop development of the product."
NCT01367769,TERMINATED,OBSERVATIONAL,insufficient recruitment
NCT01367990,TERMINATED,INTERVENTIONAL,Study site has terminated the study due to the complexity of the study
NCT01368003,WITHDRAWN,INTERVENTIONAL,Loss of funding.
NCT01368068,TERMINATED,INTERVENTIONAL,Difficulty in recruiting
NCT01368211,TERMINATED,INTERVENTIONAL,"Part 1 completed, part 2 not done due to slow enrollment"
NCT01368263,TERMINATED,INTERVENTIONAL,Due to funding source and lack of accrual
NCT01368315,WITHDRAWN,INTERVENTIONAL,Strategic decision
NCT01368536,TERMINATED,INTERVENTIONAL,"Based on results from an ALTITUDE study interim analysis, testing aliskiren concomitantly with an ACE inhibitor or ARB, in diabetics with renal impairment"
NCT01368666,TERMINATED,INTERVENTIONAL,"5 years follow up completed in October 2018, long-term follow up terminated because of low data return"
NCT01368718,TERMINATED,INTERVENTIONAL,low inclusion and adherence rates
NCT01368887,SUSPENDED,INTERVENTIONAL,Sponsor seeking additional financial support before starting the study
NCT01369043,TERMINATED,INTERVENTIONAL,"Lack of successful recruiting, budget cuts, and potential study flaws."
NCT01369121,TERMINATED,INTERVENTIONAL,Single subject remained on study - transferred to compassionate use
NCT01369147,TERMINATED,INTERVENTIONAL,"This study was halted pending additional funding and ultimately was terminated due to difficulties with ongoing recruitment, etc."
NCT01369316,WITHDRAWN,INTERVENTIONAL,study abandoned
NCT01369433,TERMINATED,INTERVENTIONAL,Lack of new studies contributing subjects to this study
NCT01369628,TERMINATED,INTERVENTIONAL,Please see Purpose Statement below
NCT01369641,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01369875,TERMINATED,INTERVENTIONAL,Premature closure. Protocol did not meet its primary objective.
NCT01369888,TERMINATED,INTERVENTIONAL,Closed this protocol due to autoimmune toxicity.
NCT01370044,TERMINATED,INTERVENTIONAL,results of interim analysis (not safety relevant)
NCT01370057,TERMINATED,INTERVENTIONAL,Failure of Subject Recruitment
NCT01370096,TERMINATED,INTERVENTIONAL,Difficulty with patient recruitment
NCT01370239,TERMINATED,INTERVENTIONAL,futility
NCT01370486,WITHDRAWN,INTERVENTIONAL,"The study did not received the approbation from Swissmedic. Therefore, the recruitment of participants never started."
NCT01370512,SUSPENDED,INTERVENTIONAL,Plan to increase enrollment due to preliminary data having lower statistical power than anticipated.
NCT01370694,TERMINATED,INTERVENTIONAL,The study was terminated for business reasons.
NCT01370759,TERMINATED,INTERVENTIONAL,Terminated due to sponsor desicioun
NCT01370863,TERMINATED,INTERVENTIONAL,This study was terminated early due to recruitment difficulties. There were no safety concerns.
NCT01370876,TERMINATED,INTERVENTIONAL,company policy
NCT01371110,TERMINATED,INTERVENTIONAL,no funding
NCT01371240,WITHDRAWN,INTERVENTIONAL,Study never started
NCT01371344,TERMINATED,INTERVENTIONAL,Trial will not complete until at least 2025 and evolution of immunosuppressant therapy has made it unlikely that patients will convert from Modigraf to Prograf.
NCT01371422,TERMINATED,INTERVENTIONAL,There was no resources to complete the study at this time
NCT01371929,TERMINATED,OBSERVATIONAL,NIH funding ended prior to full enrollment in the clinical study
NCT01372163,TERMINATED,INTERVENTIONAL,B3301002 was discontinued on 18 April 2012 for strategic reasons.There were no safety concerns leading to discontinuation of this study.
NCT01372202,TERMINATED,INTERVENTIONAL,Study stopped due to early stopping rule
NCT01372215,TERMINATED,OBSERVATIONAL,Referral physician no longer available
NCT01372228,TERMINATED,INTERVENTIONAL,company did not pursue this indication
NCT01372618,TERMINATED,INTERVENTIONAL,PI has passed away. Requested by department to terminate study.
NCT01372657,TERMINATED,OBSERVATIONAL,slow recruitment
NCT01372670,WITHDRAWN,INTERVENTIONAL,"Due to unforseen recruiting difficulties, the study was closed."
NCT01372722,WITHDRAWN,INTERVENTIONAL,"Other stimulation target (slMFB) more efficacious, unethical to continue with Nucleus Accumbens"
NCT01372813,TERMINATED,INTERVENTIONAL,Terminated for insufficient accrual.
NCT01372943,TERMINATED,INTERVENTIONAL,Research priorities and focus have shifted
NCT01373372,WITHDRAWN,INTERVENTIONAL,Funding not obtained.
NCT01373463,TERMINATED,INTERVENTIONAL,Investigator left site
NCT01373918,TERMINATED,INTERVENTIONAL,The study was terminated due to slow enrollment.
NCT01374009,TERMINATED,OBSERVATIONAL,Participants were consented but registry was not developed due to low numbers
NCT01374035,WITHDRAWN,INTERVENTIONAL,Were not able to conduct the intervention.
NCT01374061,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01374087,TERMINATED,INTERVENTIONAL,Slow enrollment of patients.
NCT01374100,TERMINATED,INTERVENTIONAL,"Slow accrual, and revised power calculation for primary end-points"
NCT01374165,WITHDRAWN,OBSERVATIONAL,Study cancelled.
NCT01374217,TERMINATED,INTERVENTIONAL,early stopping rule
NCT01374386,WITHDRAWN,INTERVENTIONAL,The study did not receive funding.
NCT01374451,TERMINATED,INTERVENTIONAL,The study was stopped for not meeting the primary endpoint for PFS.
NCT01374503,TERMINATED,INTERVENTIONAL,Proof of principle established with completed SAD part
NCT01374555,TERMINATED,OBSERVATIONAL,Inconsistent data taken from Phase I cohort
NCT01374568,TERMINATED,INTERVENTIONAL,Study closed by sponsor. Funding ended.
NCT01374633,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01374789,TERMINATED,INTERVENTIONAL,The study was terminated due to insufficient recruitment.
NCT01374828,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01374945,WITHDRAWN,INTERVENTIONAL,Withdrawn for business reasons
NCT01375023,TERMINATED,INTERVENTIONAL,Very low accrual rate
NCT01375166,TERMINATED,OBSERVATIONAL,not enough subjects recruited
NCT01375335,SUSPENDED,INTERVENTIONAL,Insufficient patient eligible for recruitment
NCT01375361,WITHDRAWN,INTERVENTIONAL,Low enrollment.
NCT01375374,TERMINATED,INTERVENTIONAL,"Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate."
NCT01375816,TERMINATED,INTERVENTIONAL,efficacy interim analysis as per protocol
NCT01375985,TERMINATED,INTERVENTIONAL,The study was halted after enrollment of the first cohort because of lack of funding
NCT01376050,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01376310,TERMINATED,INTERVENTIONAL,Company Decision
NCT01376661,TERMINATED,OBSERVATIONAL,Early termination due to PI's decision to discontinue research activities.
NCT01376700,TERMINATED,INTERVENTIONAL,It became unlikely to achieve the study objective of 50% reduction over published inhibitor rates. The Data Monitoring Committee supported this decision.
NCT01377038,WITHDRAWN,INTERVENTIONAL,Funding
NCT01377129,TERMINATED,INTERVENTIONAL,Patient enrolment proved to be more difficult than foreseen and was stopped at 46 inclusions.
NCT01377311,TERMINATED,INTERVENTIONAL,We didn't use this tech in patient.
NCT01377389,TERMINATED,INTERVENTIONAL,Due to adverse events
NCT01377441,TERMINATED,INTERVENTIONAL,Samples lost during Hurricane Sandy. Study now taking place at other medical centers.
NCT01377545,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01377805,WITHDRAWN,OBSERVATIONAL,No participants
NCT01377909,TERMINATED,INTERVENTIONAL,Principal Investigator retiring
NCT01377961,WITHDRAWN,INTERVENTIONAL,FDA needs more information from the manufacturing company of the supplements.
NCT01378351,TERMINATED,OBSERVATIONAL,"Inadequate recruitment, investigator left institution"
NCT01378377,TERMINATED,INTERVENTIONAL,The trial was stopped due to the toxicities observed with the combination of pimasertib and temsirolimus.
NCT01378390,TERMINATED,INTERVENTIONAL,After the investigators and experts in the field imput it became apparent that the protocol was not reflective of clinical reality. No safety issues reported.
NCT01378754,WITHDRAWN,INTERVENTIONAL,Loss of funding before enrollment.
NCT01378793,TERMINATED,INTERVENTIONAL,Inadequate enrollement
NCT01378871,TERMINATED,INTERVENTIONAL,IND withdrawn
NCT01378897,WITHDRAWN,INTERVENTIONAL,PI decided to not initiate this study.
NCT01379196,WITHDRAWN,INTERVENTIONAL,Patients were not interested in enrolling
NCT01379274,TERMINATED,INTERVENTIONAL,Loss of funding.
NCT01379521,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment. This resulted in the study being underpowered and inconclusive.
NCT01379885,TERMINATED,INTERVENTIONAL,Estimated sample size not achieved due to decline in number of eligible patients and difficulty recruiting and retaining research staff.
NCT01379976,TERMINATED,INTERVENTIONAL,Recruitment was prematurely stopped due to difficulty of recruitment encountered by the experimental centers
NCT01380028,TERMINATED,INTERVENTIONAL,successfull Interim Analysis
NCT01380041,TERMINATED,OBSERVATIONAL,Results obtained are sufficient for a publication.
NCT01380236,WITHDRAWN,INTERVENTIONAL,Protocol not progressed. Study not implemented.
NCT01380301,TERMINATED,INTERVENTIONAL,Low efficacy rates
NCT01381003,WITHDRAWN,INTERVENTIONAL,"Study is withdrawn before recruting participants, new trial will be multi centre, sponsored by different organisation."
NCT01381146,WITHDRAWN,INTERVENTIONAL,"Results from Phase II Study did not support ""dismantling"""
NCT01381211,TERMINATED,INTERVENTIONAL,based on interim analysis results
NCT01381549,TERMINATED,INTERVENTIONAL,Microbiological findings of resistance on therapy in patients with complicated urinary tract infection
NCT01381562,TERMINATED,INTERVENTIONAL,Microbiological findings of resistance on therapy in patients with complicated urinary tract infection
NCT01381640,WITHDRAWN,INTERVENTIONAL,Study was cancelled prior to enrolling any subjects.
NCT01381926,TERMINATED,INTERVENTIONAL,unavailability of study drug and matching placebo
NCT01382290,WITHDRAWN,INTERVENTIONAL,"No patients were enrolled, due to logistic difficulties, no funding was acquired."
NCT01382394,WITHDRAWN,OBSERVATIONAL,No Patients were recruited during the study period
NCT01382615,TERMINATED,OBSERVATIONAL,Unable to fill cohort
NCT01382706,TERMINATED,INTERVENTIONAL,Trial not progressing toward scientific goals
NCT01382745,TERMINATED,INTERVENTIONAL,low recruitment
NCT01382888,TERMINATED,INTERVENTIONAL,The Sponsor decided to terminate the study due to the low patient recruitment.
NCT01383044,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01383122,TERMINATED,INTERVENTIONAL,Planned interim analysis-no statistical significance for the primary outcome.
NCT01383200,TERMINATED,INTERVENTIONAL,eyes that received gel had slightly thinner than intended flaps
NCT01383278,TERMINATED,INTERVENTIONAL,Insufficient sample size to complete study and merged with parent grant funded study
NCT01383408,TERMINATED,INTERVENTIONAL,Inconsistent training status of sniffer dogs
NCT01383434,TERMINATED,INTERVENTIONAL,New revised SAA BMT study opened to take over this study
NCT01383447,TERMINATED,INTERVENTIONAL,This study was halted prematurely by the NCI for low accrual.
NCT01383668,WITHDRAWN,INTERVENTIONAL,lack of access to study drug
NCT01383746,TERMINATED,INTERVENTIONAL,Not enough inclusion
NCT01383824,TERMINATED,INTERVENTIONAL,Rationalization of the Silent Hip Prosthesis for business reasons only
NCT01383876,TERMINATED,INTERVENTIONAL,Enrollment too slow
NCT01384162,TERMINATED,INTERVENTIONAL,Issues with development and supply of infusion system for delivery of IMP. Lack of favorable benefit risk ratio in sNN0029-003 study (review of interim data).
NCT01384240,TERMINATED,INTERVENTIONAL,Study is closed as the PI transferred to another institution.
NCT01384292,TERMINATED,INTERVENTIONAL,The study was stopped early due to recruitment challenges
NCT01384500,WITHDRAWN,INTERVENTIONAL,Workforce issues precluding study completion.
NCT01384578,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT01384695,TERMINATED,INTERVENTIONAL,Low/no enrollment. No subjects were enrolled over the past year.
NCT01384981,TERMINATED,INTERVENTIONAL,major problems in recruiting patients due to very strict inclusion criteria
NCT01385293,TERMINATED,INTERVENTIONAL,The trial was stopped at the first stage due to futility
NCT01385306,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01385345,TERMINATED,INTERVENTIONAL,"Recommended by DMEC. Poor recruitment, changes in current clinical management of Vit D deficiency. Research question no longer relevant"
NCT01385449,TERMINATED,INTERVENTIONAL,The study was halted prematurely due to low enrollment and anticipation of future barriers to enrollment.
NCT01385527,WITHDRAWN,INTERVENTIONAL,"study was never initiated, No participants enrolled"
NCT01385540,TERMINATED,OBSERVATIONAL,Study tasks to difficult for subjects to complete.
NCT01385774,TERMINATED,INTERVENTIONAL,Study terminated after 240 patients because of slow accrual and lack of additional funding
NCT01385839,TERMINATED,INTERVENTIONAL,low enrollment
NCT01385943,WITHDRAWN,OBSERVATIONAL,Study not launched due to logistical issues that could not be resolved.
NCT01386008,TERMINATED,INTERVENTIONAL,unexpected adverse events
NCT01386190,WITHDRAWN,INTERVENTIONAL,Non applicable clinical trial
NCT01386255,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT01386372,TERMINATED,INTERVENTIONAL,futility
NCT01386398,WITHDRAWN,INTERVENTIONAL,Company withdrew interest
NCT01386710,SUSPENDED,INTERVENTIONAL,PI left previous institution study will reopen at new institution.
NCT01386879,TERMINATED,INTERVENTIONAL,The study was terminated because of slower than anticipated enrollment
NCT01387126,WITHDRAWN,INTERVENTIONAL,No grant funding for this trial.
NCT01387659,TERMINATED,INTERVENTIONAL,Study terminated due to slow enrollment
NCT01387776,TERMINATED,OBSERVATIONAL,The technique has been approved and validated
NCT01387932,TERMINATED,INTERVENTIONAL,The clinical study was terminated due to the inability to meet target enrollment.
NCT01387958,TERMINATED,INTERVENTIONAL,Terminated early due to futility
NCT01388179,TERMINATED,INTERVENTIONAL,Sponsor decision to stop the study
NCT01388647,TERMINATED,INTERVENTIONAL,Closed early due to increased hematologic toxicity and possible reduced efficacy
NCT01388777,TERMINATED,INTERVENTIONAL,Early termination leading to small number of subjects analyzed
NCT01388920,TERMINATED,INTERVENTIONAL,The study was terminated based on a non-safety related corporate decision.
NCT01388933,TERMINATED,INTERVENTIONAL,Study stopped due to low enrollment
NCT01389076,TERMINATED,INTERVENTIONAL,Bexxar isn't being produced by the manufacturer as of Feb. 2014
NCT01389154,WITHDRAWN,INTERVENTIONAL,Product Enhancements completed
NCT01389453,WITHDRAWN,INTERVENTIONAL,There were not enough number of patients recruited till DEC 31th in 2012.
NCT01389700,TERMINATED,INTERVENTIONAL,Difficulty in patient recruitment in the participating sites
NCT01389817,TERMINATED,INTERVENTIONAL,"Unable to record n95 pERG peak (primary measure), as LHON subjects are unable to focus on target."
NCT01389856,TERMINATED,INTERVENTIONAL,To be compliant with the timelines as agreed with Paediatric Committee (PC) within the Paediatric Investigational Plan
NCT01389895,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01389999,TERMINATED,OBSERVATIONAL,difficult recruitment curve
NCT01390090,WITHDRAWN,OBSERVATIONAL,The Principal Investigator left the University
NCT01390181,TERMINATED,INTERVENTIONAL,Due to low enrollment the decision was made to terminate study prior to final data collection for any individual.
NCT01390441,TERMINATED,INTERVENTIONAL,The study was terminated early by the Sponsor for business reasons.
NCT01390506,WITHDRAWN,INTERVENTIONAL,The company did not provide the study product
NCT01390545,TERMINATED,INTERVENTIONAL,Trial re-design; no safety issues identified
NCT01390584,TERMINATED,INTERVENTIONAL,slow accrual
NCT01390636,TERMINATED,OBSERVATIONAL,The study was a collaboration that could not be effectively run.
NCT01391039,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01391117,TERMINATED,INTERVENTIONAL,Antiviral activity was considered insufficient to warrant further clinical development of TMC649128.
NCT01391130,TERMINATED,INTERVENTIONAL,Study Terminated due to Insufficient Efficacy
NCT01391377,TERMINATED,INTERVENTIONAL,Tredaptive has been suspended worldwide
NCT01391520,WITHDRAWN,INTERVENTIONAL,Sponsor encountered funding issues for this study.
NCT01391611,TERMINATED,INTERVENTIONAL,Lack of efficacy - Futility endpoint reached
NCT01391715,WITHDRAWN,INTERVENTIONAL,patients could not be recuited within study duration
NCT01392170,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01392196,TERMINATED,INTERVENTIONAL,No evidence of a physiological response; no significant safety concerns; post 24-month follow-up; Data Monitoring Committee agreed
NCT01392248,TERMINATED,OBSERVATIONAL,funding and recruiting problems
NCT01392352,TERMINATED,INTERVENTIONAL,"Following DMC review, due to slow recruitment of evaluable patients."
NCT01392495,TERMINATED,INTERVENTIONAL,Novartis discontinued the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.
NCT01392586,TERMINATED,INTERVENTIONAL,due to low accrual rate
NCT01393028,TERMINATED,INTERVENTIONAL,Insufficient funds
NCT01393119,TERMINATED,INTERVENTIONAL,FDA Clinical Hold
NCT01393431,TERMINATED,OBSERVATIONAL,"IRB recommended to stop the trial becasue none of the 4 procedures showed a predictive value for VAP, duration of MV or mortality."
NCT01393769,TERMINATED,INTERVENTIONAL,Only 5 subjects could be enrolled. Sample of 25 pat. not be achieved (rare disease).
NCT01393834,TERMINATED,INTERVENTIONAL,difficulty with enrollment
NCT01393873,TERMINATED,OBSERVATIONAL,Investigator has moved to other state.
NCT01394003,TERMINATED,INTERVENTIONAL,The pharmacokinetic properties of the molecule do not allow for further dose escalation or development.
NCT01394133,WITHDRAWN,OBSERVATIONAL,Lack of enrollment
NCT01394211,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01394523,TERMINATED,INTERVENTIONAL,Interim power analysis was prohibitive to continuing the study
NCT01394536,WITHDRAWN,INTERVENTIONAL,The study was closed prior to enrollment of any subjects. No subjects were enrolled in this study.
NCT01394588,WITHDRAWN,OBSERVATIONAL,"On further investigation, it was found that the continuous glucose monitors required a calibration period that precluded reliable data collection."
NCT01394848,TERMINATED,INTERVENTIONAL,Previous other study including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis)
NCT01394913,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01394926,TERMINATED,INTERVENTIONAL,Lack of Subject Recruitment
NCT01395238,TERMINATED,INTERVENTIONAL,Grant ended and faculty has left the institution
NCT01395264,TERMINATED,OBSERVATIONAL,Lack of available clinical time to complete
NCT01395381,WITHDRAWN,INTERVENTIONAL,not funded
NCT01395394,TERMINATED,INTERVENTIONAL,Difficulty with recruitment and agreed with Sponsor to report completed data as case reports
NCT01395485,WITHDRAWN,INTERVENTIONAL,The study had been cancelled and replaced with protocol 20130250.
NCT01395537,TERMINATED,INTERVENTIONAL,Research Cancelled
NCT01395576,TERMINATED,INTERVENTIONAL,statistical significance of the results was reached for the 34 subjects who participated in teh study.
NCT01395797,TERMINATED,INTERVENTIONAL,The funding period ended.
NCT01395953,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to competing research interests and slow recruitment.
NCT01396304,TERMINATED,INTERVENTIONAL,slow accrual
NCT01397149,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01397175,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01397292,TERMINATED,OBSERVATIONAL,funding/ enrollment
NCT01397331,TERMINATED,INTERVENTIONAL,Technical problems with data acquisition and interpretation; problems with recruitment
NCT01397500,TERMINATED,INTERVENTIONAL,Recruitment problems due to change of patient population at site.
NCT01397552,TERMINATED,INTERVENTIONAL,"Low enrollment, too many subjects getting second injection"
NCT01397591,TERMINATED,INTERVENTIONAL,Study closed by PI due to lower than expected accrual.
NCT01397630,TERMINATED,INTERVENTIONAL,"Due to budgetary concerns, the TSC decided it best to adjust sample size as there was sufficient data to assess feasibility. Recruitment was terminated early."
NCT01397643,TERMINATED,INTERVENTIONAL,Complication rate in operative group on interim analysis and safety monitoring.
NCT01397734,TERMINATED,INTERVENTIONAL,Lack of enrollment and limited funding
NCT01398033,WITHDRAWN,INTERVENTIONAL,Study stopped due to lack of patient inclusion
NCT01398124,WITHDRAWN,INTERVENTIONAL,We will not be pursuing this study.
NCT01398553,WITHDRAWN,INTERVENTIONAL,the human resources in the organisation are to limited to do the trial
NCT01398670,WITHDRAWN,INTERVENTIONAL,Study was not initiated
NCT01398774,TERMINATED,OBSERVATIONAL,study expired
NCT01398995,TERMINATED,INTERVENTIONAL,Recruitment was terminated due to elevated levels of hypoglycaemia
NCT01399138,WITHDRAWN,INTERVENTIONAL,"This study was closed on February 24, 2015."
NCT01399255,WITHDRAWN,INTERVENTIONAL,Study was not initiated
NCT01399593,TERMINATED,INTERVENTIONAL,Did not achieve statistical significance for primary endpoint
NCT01400009,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT01400256,WITHDRAWN,INTERVENTIONAL,lack of recruitment/patient population
NCT01400308,TERMINATED,INTERVENTIONAL,"The differences seen between treatments led to recalculation of the sample, unattainable in a reasonable time"
NCT01400451,TERMINATED,INTERVENTIONAL,More than 2 of 6 patients treated experienced dose limiting toxicities.
NCT01400542,TERMINATED,OBSERVATIONAL,End of the study because of the inclusions were too difficult
NCT01400607,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01400672,TERMINATED,INTERVENTIONAL,Treatment ineffective; Extreme toxicity
NCT01400789,WITHDRAWN,INTERVENTIONAL,Study was not initiated
NCT01400802,WITHDRAWN,INTERVENTIONAL,Study was not initiated
NCT01400958,TERMINATED,INTERVENTIONAL,"Slow Accrual, Initiating Principal Investigator (PI) left Moffitt"
NCT01401036,TERMINATED,INTERVENTIONAL,Insufficient data collection
NCT01401322,TERMINATED,INTERVENTIONAL,low accrual
NCT01401387,WITHDRAWN,INTERVENTIONAL,study never started
NCT01401569,TERMINATED,INTERVENTIONAL,Difficulties for recruiting patients
NCT01401608,TERMINATED,OBSERVATIONAL,Difficult to recruit eligible subjects
NCT01401660,TERMINATED,OBSERVATIONAL,Principal Investigator withdrew from the study.
NCT01401673,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01401777,WITHDRAWN,OBSERVATIONAL,On hold pending product development
NCT01401829,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding required to continue the study.
NCT01402167,WITHDRAWN,INTERVENTIONAL,Patients refuse randomization.
NCT01402219,TERMINATED,INTERVENTIONAL,There were few eligible subjects from other centers.
NCT01402414,TERMINATED,INTERVENTIONAL,Difficulties with the Recruitement
NCT01402440,TERMINATED,INTERVENTIONAL,Study terminated due to enrolment challenges and availability of other options for DLBCL patients. The termination is not a consequence of any safety concern.
NCT01402544,TERMINATED,INTERVENTIONAL,Per study sponsor decision.
NCT01402596,WITHDRAWN,INTERVENTIONAL,"Institution decided on starting a new protocol of sedation, with another methods and thats why this study has not started."
NCT01402739,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to futility
NCT01402752,WITHDRAWN,INTERVENTIONAL,20131209 Regulatory authorization is currently blocked at the ANSM.
NCT01402817,TERMINATED,INTERVENTIONAL,1 patient died of uncertain cause but possibly related to drug.
NCT01402908,TERMINATED,INTERVENTIONAL,Due to Interim Analysis and business concerns
NCT01403064,TERMINATED,INTERVENTIONAL,due to lack of efficacy
NCT01403103,WITHDRAWN,INTERVENTIONAL,Slow Accrual
NCT01403168,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01403194,TERMINATED,INTERVENTIONAL,Analysis was not done because only 1 subject was able to come back for the 3 month follow up visit.
NCT01403246,TERMINATED,INTERVENTIONAL,"Slow patient enrollment and new molecules for chronic lymphoid leukemia, have importantly reduced the interest of conducting the phase II of this study."
NCT01403259,TERMINATED,INTERVENTIONAL,poor accrual of eligible patients
NCT01403285,TERMINATED,INTERVENTIONAL,Due to poor accrual. This decision was taken without any safety reasons. Since beginning of the study (June 2011) only six patients were enrolled.
NCT01403324,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01403389,TERMINATED,INTERVENTIONAL,"After interim analysis, the pilot study was terminated and modified to a larger multicenter study (NCT01919346) to better assess efficacy."
NCT01403428,WITHDRAWN,INTERVENTIONAL,"In a pilot of early noninvasive positive pressure ventilation, the children did so well that early NPPV is now used in all children who meet criteria."
NCT01403441,TERMINATED,INTERVENTIONAL,Potential AE
NCT01403714,WITHDRAWN,INTERVENTIONAL,Inability to recruit eligible subjects
NCT01403870,TERMINATED,OBSERVATIONAL,Company no longer has funding for the study.
NCT01403909,WITHDRAWN,INTERVENTIONAL,We need somebody to replace the principal inestigator.
NCT01403922,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate
NCT01404039,TERMINATED,INTERVENTIONAL,Study was halted due to lack of funding.
NCT01404065,TERMINATED,INTERVENTIONAL,Recruitment difficulties and stopped funding
NCT01404117,WITHDRAWN,INTERVENTIONAL,Study is being redesigned
NCT01404221,TERMINATED,OBSERVATIONAL,No safety issues. Need to rewrite protocol
NCT01404351,WITHDRAWN,INTERVENTIONAL,Study terminated due to the acquisition of PEAK Surgical by Medtronic
NCT01404702,TERMINATED,INTERVENTIONAL,Accrual slower than anticipated
NCT01404767,TERMINATED,INTERVENTIONAL,Enrollment slow over 2 years a change in the population less on metoprolol than initially anticipated
NCT01404832,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT01405417,TERMINATED,INTERVENTIONAL,not enough data collected
NCT01405443,TERMINATED,OBSERVATIONAL,invalid data
NCT01405573,TERMINATED,INTERVENTIONAL,lack of enrolment
NCT01405742,TERMINATED,INTERVENTIONAL,study was non-feasible per DSMB
NCT01405846,TERMINATED,INTERVENTIONAL,Futility
NCT01405924,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01405950,TERMINATED,INTERVENTIONAL,Please see 'Further study details as provided by Acorda Therapeutics' for explanation of why study stopped.
NCT01406197,WITHDRAWN,INTERVENTIONAL,Investigator left organization prior to study initiation
NCT01406236,TERMINATED,INTERVENTIONAL,Study stopped for Statistical Futility. Low rate of bleeding events made it unlikely there would be statistical power to show a difference in the 2 arms.
NCT01406340,TERMINATED,INTERVENTIONAL,Difficulty enrolling last cohort of subjects
NCT01406522,WITHDRAWN,INTERVENTIONAL,"One of the study medications, tacrine, is no longer clinically available"
NCT01406639,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to lack of study population.
NCT01406704,TERMINATED,INTERVENTIONAL,because of withdrawal of Avandia sale due to its risks outweigh its benefits
NCT01406795,TERMINATED,INTERVENTIONAL,Poor enrollment and advances in venoplasty only techniques of the femoral vein
NCT01406860,TERMINATED,INTERVENTIONAL,lack of enrollment/drug shortages
NCT01407081,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01407185,TERMINATED,INTERVENTIONAL,Lack of enrollment. Difficult to obtain Physician approval.
NCT01407341,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01407614,TERMINATED,INTERVENTIONAL,patient enrollment too slow
NCT01407900,WITHDRAWN,INTERVENTIONAL,"New technique for administration of drug, this is the old technique of administration."
NCT01407991,TERMINATED,INTERVENTIONAL,"Study terminated due to change in clinical practice affecting recruitment. For majority of patients, NJ tubes are now used instead of NG tubes."
NCT01408043,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01408056,WITHDRAWN,INTERVENTIONAL,Difficulty with recruitment
NCT01408069,WITHDRAWN,INTERVENTIONAL,Study canceled by decision strategically.
NCT01408095,WITHDRAWN,INTERVENTIONAL,Trial terminated no patients were screened or enrolled
NCT01408134,TERMINATED,INTERVENTIONAL,PI/Project director no longer at facility
NCT01408212,TERMINATED,INTERVENTIONAL,low recruiting
NCT01408641,TERMINATED,INTERVENTIONAL,Principal Investigator was deployed overseas
NCT01408745,TERMINATED,INTERVENTIONAL,terminatedd due to insufficient recruitment
NCT01408836,TERMINATED,INTERVENTIONAL,Completed
NCT01408849,TERMINATED,INTERVENTIONAL,Lack of adherence and huge loss of follow up.
NCT01408953,TERMINATED,INTERVENTIONAL,Very low accrual rate.
NCT01409031,TERMINATED,INTERVENTIONAL,This trial was terminated early due to lack of recruitment.
NCT01409174,TERMINATED,INTERVENTIONAL,"Slow accrual, closed in Phase I."
NCT01409226,WITHDRAWN,INTERVENTIONAL,Due to slow accrual
NCT01409408,WITHDRAWN,INTERVENTIONAL,Due to preliminary results of Altitude Trial.
NCT01409681,TERMINATED,OBSERVATIONAL,PI decided to terminate the study
NCT01409772,WITHDRAWN,OBSERVATIONAL,PI decided to withdraw study
NCT01409811,TERMINATED,INTERVENTIONAL,Study closed after it became too difficult to interest patients in participating.
NCT01409850,TERMINATED,INTERVENTIONAL,Very slow enrollment of participants
NCT01409863,WITHDRAWN,INTERVENTIONAL,PI has left University of Minnesota.
NCT01409993,TERMINATED,INTERVENTIONAL,Aim 1 was stopped by DSMB. Aim 2 was stopped due to ending of funding.
NCT01410071,TERMINATED,OBSERVATIONAL,Analysis of designed comparison groups not viable
NCT01410136,TERMINATED,INTERVENTIONAL,Inadequate enrollment and decreased need for clinical data to support product
NCT01410201,TERMINATED,INTERVENTIONAL,recruitment not met
NCT01410565,TERMINATED,INTERVENTIONAL,Business reason
NCT01410695,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT01410799,TERMINATED,INTERVENTIONAL,Funding ended
NCT01410903,TERMINATED,INTERVENTIONAL,"inadequately recruitment rate, funding is not secured"
NCT01411098,TERMINATED,INTERVENTIONAL,Low accrual
NCT01411215,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01411462,WITHDRAWN,OBSERVATIONAL,Funding issues
NCT01411475,WITHDRAWN,OBSERVATIONAL,Funding issues
NCT01411514,TERMINATED,INTERVENTIONAL,Difficulties to recruit patients
NCT01411904,WITHDRAWN,INTERVENTIONAL,"The NPs that we have been buying from a vendor show lot to lot variation. We are making our own NPs, need to characterize them before we enroll new patients."
NCT01411917,TERMINATED,INTERVENTIONAL,Recruitment Difficulties due to some factors
NCT01412216,TERMINATED,INTERVENTIONAL,Funding Depleted.
NCT01412437,WITHDRAWN,INTERVENTIONAL,poor recruitment
NCT01412502,TERMINATED,OBSERVATIONAL,no recruitment
NCT01412515,TERMINATED,INTERVENTIONAL,results from interim analysis conducted to study interruption
NCT01412528,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01412684,WITHDRAWN,OBSERVATIONAL,Never activated
NCT01412749,TERMINATED,OBSERVATIONAL,Low Accrual
NCT01412918,TERMINATED,INTERVENTIONAL,Lack of support to continue
NCT01412970,WITHDRAWN,INTERVENTIONAL,received no funding
NCT01413087,TERMINATED,INTERVENTIONAL,"Due to Sponsor's decision, only 12 patients were randomized \& completed study."
NCT01413386,TERMINATED,INTERVENTIONAL,Delayed subject enrollment
NCT01413581,TERMINATED,INTERVENTIONAL,Primary endpoint showed no stat significant difference. FU \> M12 terminated.
NCT01413607,TERMINATED,INTERVENTIONAL,There was an error made in recruitment therefore patients were not randomized correctly. This was identified in February 2012 and the study was cancelled.
NCT01413685,TERMINATED,INTERVENTIONAL,no patient corresponding to criteria
NCT01413750,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01413854,WITHDRAWN,INTERVENTIONAL,Not enough recources.
NCT01413945,TERMINATED,OBSERVATIONAL,Not able to enroll enough patients in this study
NCT01414166,TERMINATED,INTERVENTIONAL,"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs"
NCT01414309,TERMINATED,OBSERVATIONAL,Change in company priorities
NCT01414387,TERMINATED,INTERVENTIONAL,Therapy for carotid disease has recently changed. Carotid stenting is now restricted to high risk patients that are not eligible for the study.
NCT01414829,WITHDRAWN,OBSERVATIONAL,difficulty in recruiting parients
NCT01415141,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01415271,TERMINATED,INTERVENTIONAL,Preliminary exploration of research concept did not prove to be viable.
NCT01415453,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT01415648,TERMINATED,INTERVENTIONAL,Recruitment time expired.
NCT01415739,WITHDRAWN,OBSERVATIONAL,Trial closure due to NCI NCTN transition
NCT01415908,TERMINATED,INTERVENTIONAL,Due to study design challenges including DMC enrollment suspension as required by the protocol stopping rules and recommended changes to the surgical technique
NCT01415947,TERMINATED,INTERVENTIONAL,Company business decision
NCT01415986,TERMINATED,INTERVENTIONAL,"The patient was ""lost to follow-up"" and the PI left the institution."
NCT01416181,TERMINATED,INTERVENTIONAL,The ASCEND Study did not achieve statistical significance on the primary or secondary endpoints.
NCT01416272,TERMINATED,INTERVENTIONAL,Study was terminated due to a business decision to cancel the entire project.
NCT01416298,TERMINATED,INTERVENTIONAL,Production of biomarker test discontinued by manufacturer
NCT01416415,TERMINATED,INTERVENTIONAL,Not practical to continue due interim results
NCT01416428,TERMINATED,INTERVENTIONAL,A program evaluation identified that the safety profile and pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required further optimization and thus enrollment in 2011-001 was halted.
NCT01416558,TERMINATED,INTERVENTIONAL,Study was terminated because of extrem low recruitment
NCT01416701,WITHDRAWN,INTERVENTIONAL,It was not possible to enroll the planned amount of subjects. Many patients with chronic obstructive pulmonary disease already took large doses of vitamin D.
NCT01416714,SUSPENDED,OBSERVATIONAL,Per IRB Request.
NCT01416740,WITHDRAWN,INTERVENTIONAL,"difficulty with recruitment, PI left the institution"
NCT01416844,WITHDRAWN,INTERVENTIONAL,Change in the development plan for the anti-OX40 antibody.
NCT01416948,TERMINATED,INTERVENTIONAL,"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the end of the grant."
NCT01416961,WITHDRAWN,INTERVENTIONAL,Neutron therapy has become unavailable
NCT01417013,WITHDRAWN,INTERVENTIONAL,Management Decision
NCT01417104,TERMINATED,INTERVENTIONAL,Safety concerns with approved medication identified in an unrelated trial
NCT01417208,WITHDRAWN,OBSERVATIONAL,"The study was terminated by Spiraur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful."
NCT01417299,WITHDRAWN,INTERVENTIONAL,This record is an additional copy of the study listed above
NCT01417364,WITHDRAWN,INTERVENTIONAL,Unable to identify any qualifying subjects willing to enroll into this study.
NCT01417403,TERMINATED,INTERVENTIONAL,Recently published data that has shown HCQ to be safe when combined with chemo and or radiation at even higher doses than what is used in this study.
NCT01417481,TERMINATED,INTERVENTIONAL,Some of the researchers finished their participation in the study.
NCT01417988,TERMINATED,INTERVENTIONAL,Study was terminated prematurely due to insufficient enrolment.
NCT01418001,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01418651,TERMINATED,INTERVENTIONAL,Lack of subjects
NCT01418742,TERMINATED,INTERVENTIONAL,Recruitement did not meet expectations. Prev. differentiation of RAS-wild-type and mutated RAS are not in accordance with the scientific rank anymore.
NCT01418781,WITHDRAWN,OBSERVATIONAL,Funding withdrawn by the funding agency; study could not be performed.
NCT01419002,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01419483,TERMINATED,INTERVENTIONAL,poor accrual
NCT01419587,TERMINATED,INTERVENTIONAL,Poor accrual and compliance
NCT01419704,WITHDRAWN,INTERVENTIONAL,"Study completed at site, no active participants."
NCT01419743,TERMINATED,OBSERVATIONAL,Low recruitment numbers
NCT01419795,TERMINATED,INTERVENTIONAL,Low accrual
NCT01419964,WITHDRAWN,INTERVENTIONAL,The Brazilian regulatory agency - ANVISA has requested the cancellation of the phase 3 study for conducting a phase 1 study first.
NCT01420081,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01420354,TERMINATED,OBSERVATIONAL,The study was combined with our Urine and Stool Study (NCT01637506).
NCT01420575,TERMINATED,INTERVENTIONAL,Low enrollment rate.
NCT01420666,WITHDRAWN,INTERVENTIONAL,The study was withdrawn for administrative reason
NCT01420861,TERMINATED,INTERVENTIONAL,FDA Clinical Hold
NCT01420965,TERMINATED,INTERVENTIONAL,Drug supply issues
NCT01421160,WITHDRAWN,INTERVENTIONAL,PI left the institution prior to any data being collected
NCT01421316,TERMINATED,INTERVENTIONAL,No reduction in hair loss 1 month after treatment
NCT01421446,TERMINATED,OBSERVATIONAL,Insufficient subject recruitment
NCT01421784,TERMINATED,INTERVENTIONAL,PI left the institution
NCT01421849,WITHDRAWN,INTERVENTIONAL,Single implant in the mandible was finally not indicated due to lack of stability of the denture
NCT01422096,WITHDRAWN,INTERVENTIONAL,The study team decided not to pursue this study.
NCT01422174,WITHDRAWN,OBSERVATIONAL,Study stopped due to lost of interest.
NCT01422226,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT01422252,TERMINATED,INTERVENTIONAL,no more inclusions
NCT01422343,WITHDRAWN,OBSERVATIONAL,Shortage of personnel / main study initiator no longer available
NCT01422473,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual.
NCT01422486,TERMINATED,INTERVENTIONAL,Study TLK199.2107 was terminated for business reasons.
NCT01422525,TERMINATED,OBSERVATIONAL,short of study staff
NCT01422564,TERMINATED,INTERVENTIONAL,Components were recalled by Depuy
NCT01422707,WITHDRAWN,INTERVENTIONAL,The study team decided not to pursue this study.
NCT01422733,WITHDRAWN,INTERVENTIONAL,The study team decided not to pursue this study.
NCT01422928,WITHDRAWN,INTERVENTIONAL,Study was not approved by research ethics board.
NCT01423448,WITHDRAWN,INTERVENTIONAL,Recruitment of participants did not commence due to lack of available staff to run the trial.
NCT01423487,WITHDRAWN,INTERVENTIONAL,Difficult to obtain informed consent
NCT01423539,WITHDRAWN,INTERVENTIONAL,The NAVIGATE study has been terminated due to non-safety related reasons.
NCT01423630,TERMINATED,INTERVENTIONAL,Lack of eligible patients and study staff
NCT01423760,TERMINATED,INTERVENTIONAL,The study is terminated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC.
NCT01423786,TERMINATED,INTERVENTIONAL,Dr. Kumar left Nationwide Children's Hospital. The study expired with the Nationwide Children's Hospital on 7/16/14.
NCT01424033,TERMINATED,INTERVENTIONAL,Departure of study team
NCT01424267,TERMINATED,OBSERVATIONAL,The registry was discontinued due to significant resources required.
NCT01424345,TERMINATED,INTERVENTIONAL,The PI is relocating to another State/ another hospital
NCT01424475,TERMINATED,INTERVENTIONAL,"Following extensive efforts to increase recruitment, it will not be possible to complete the study protocol within a reasonable time"
NCT01424501,TERMINATED,INTERVENTIONAL,"Due to a safety signal found at a planned interim safety review, further conduct of this safety study is not recommended hence the study was terminated."
NCT01424657,TERMINATED,INTERVENTIONAL,The study was terminated before reaching the estimated sample size because of trial fatigue.
NCT01424852,WITHDRAWN,INTERVENTIONAL,Too few of the invited subjects wanted to participate
NCT01424917,WITHDRAWN,OBSERVATIONAL,Investigator Left university
NCT01425190,TERMINATED,INTERVENTIONAL,The US FDA and the EU CHMP provided guidance indicating preference for intereferon-free regimens in pediatric studies of HCV infection.
NCT01425216,TERMINATED,INTERVENTIONAL,IND application was not approved by the US FDA - Project was never started
NCT01425242,TERMINATED,INTERVENTIONAL,Insufficient number of participants
NCT01425255,WITHDRAWN,OBSERVATIONAL,Enrollment finished and a paper was published.
NCT01425294,TERMINATED,OBSERVATIONAL,The study has been decided to be early terminated for the FAS 500 mg has launched in 2015. The use mothod of 250mg per month in clinical practice is off-label.
NCT01425307,TERMINATED,INTERVENTIONAL,The study was stopped early due to successfully meeting the primary endpoint
NCT01425320,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to company decision. No study subjects were ever enrolled or dosed.
NCT01425424,TERMINATED,INTERVENTIONAL,The PI was leaving Pennington
NCT01425437,TERMINATED,OBSERVATIONAL,Poor Enrollment
NCT01425489,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT01425970,TERMINATED,INTERVENTIONAL,Termination of study was due to safety reasons
NCT01426035,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT01426113,TERMINATED,INTERVENTIONAL,Study terminated due to corporate decision.
NCT01426165,TERMINATED,INTERVENTIONAL,Issues with recruitment. PI decided to terminate study
NCT01426516,TERMINATED,INTERVENTIONAL,Invalid data collection
NCT01426555,TERMINATED,INTERVENTIONAL,Incomplete data set \& analysis
NCT01426620,TERMINATED,INTERVENTIONAL,slow accrual
NCT01426724,WITHDRAWN,INTERVENTIONAL,Difficult to enroll eligible subjects.
NCT01427322,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01427374,TERMINATED,OBSERVATIONAL,low recruitment
NCT01427465,WITHDRAWN,INTERVENTIONAL,PI left University of Florida
NCT01428102,TERMINATED,OBSERVATIONAL,Terminiated for trial redesign
NCT01428154,WITHDRAWN,INTERVENTIONAL,Difficulty in recruitment. PDCO in the Day 30 summary report agrred to remove the PK study in children \<1 year of age.
NCT01428193,TERMINATED,INTERVENTIONAL,Haven't enrolled participants since 2010
NCT01428219,TERMINATED,INTERVENTIONAL,Closed due to slowing enrollment and negative results of a phase III trial using cabozantinib.
NCT01428245,TERMINATED,INTERVENTIONAL,The research questions was changed/de-prioritized. Only one subject completed.
NCT01428440,TERMINATED,INTERVENTIONAL,The study was terminated early as the results did not support study objectives and were not as significant as expected.
NCT01428505,TERMINATED,INTERVENTIONAL,The Study was terminated because there was insufficient data to complete the study objectives
NCT01428648,WITHDRAWN,INTERVENTIONAL,Recruitment slow
NCT01428843,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01429519,TERMINATED,INTERVENTIONAL,Due to slow recruitment
NCT01429597,WITHDRAWN,OBSERVATIONAL,University of Rostock terminated participation in the study conduct; Study Sponsorship is moved to Centogene AG
NCT01429870,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT01430182,TERMINATED,INTERVENTIONAL,"Shortages of study drug, difficulty enrolling patients"
NCT01430273,TERMINATED,OBSERVATIONAL,recruiting centers do not have the patient potential
NCT01430585,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01430832,TERMINATED,OBSERVATIONAL,Recruitment Status
NCT01430988,TERMINATED,OBSERVATIONAL,The trial was terminated prematurely following a suspected data processing concern in the study device. The concern did not pose a patient safety issue.
NCT01431157,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01431378,TERMINATED,OBSERVATIONAL,"Feasibility study, sufficient amount of data collected."
NCT01431586,TERMINATED,INTERVENTIONAL,No further subjects will be enrolled due to adverse events.
NCT01431794,TERMINATED,INTERVENTIONAL,Study was terminated due to cease in manufacturing of study drug.
NCT01432054,WITHDRAWN,OBSERVATIONAL,business decision
NCT01432080,TERMINATED,INTERVENTIONAL,Not meeting recruitment targets
NCT01432106,WITHDRAWN,INTERVENTIONAL,Novartis terminated all projects involving aliskiren. Findings of the DMC overseeing the ALTITUDE clinical trial found a higher incidence of adverse events.
NCT01432314,WITHDRAWN,INTERVENTIONAL,Another phase 2 randomized study has been started by other investigators.
NCT01432496,TERMINATED,INTERVENTIONAL,There was insuficient recruitment in two centers
NCT01433003,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT01433016,TERMINATED,INTERVENTIONAL,"Due to budgetary issues, the company has decided to focus on other applications at this stage."
NCT01433133,TERMINATED,INTERVENTIONAL,Company strategic decision
NCT01433159,TERMINATED,INTERVENTIONAL,Business decision
NCT01433198,WITHDRAWN,INTERVENTIONAL,finances and feasibility
NCT01433328,TERMINATED,INTERVENTIONAL,Safety considerations
NCT01433354,TERMINATED,INTERVENTIONAL,The study treatment failed to demonstrate efficacy in target population in two other clinical studies (CAFQ056B2214 and CAFQ056A2212).
NCT01433367,TERMINATED,OBSERVATIONAL,Marketing of CE marked device has been discontinued.
NCT01433432,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew support for study due to reorganization and project prioritization
NCT01433536,TERMINATED,OBSERVATIONAL,"Guillaume Grenier, principal investigator is no longer working at the lab. The lab is now closed."
NCT01433770,WITHDRAWN,INTERVENTIONAL,The drug will no longer be available in the United States.
NCT01433861,TERMINATED,INTERVENTIONAL,We planed to study later
NCT01433978,TERMINATED,INTERVENTIONAL,Study was terminated early due to significant enrollment challenges.
NCT01433991,TERMINATED,INTERVENTIONAL,Study was terminated by the sponsor early at the end of Phase 1b due to a change in corporate strategy.
NCT01434459,TERMINATED,INTERVENTIONAL,PI moved to different institution
NCT01434472,TERMINATED,INTERVENTIONAL,Terminated due to insufficient funding
NCT01434550,WITHDRAWN,INTERVENTIONAL,research cancelled
NCT01434576,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew study for business reasons
NCT01434654,TERMINATED,OBSERVATIONAL,Slower than expected recruitment
NCT01434745,TERMINATED,INTERVENTIONAL,poor enrollment (only one subject enrolled)
NCT01434771,WITHDRAWN,OBSERVATIONAL,Sponsor never funded study.
NCT01434849,TERMINATED,INTERVENTIONAL,Difficulty with enrolled patients to complete trial.
NCT01434862,TERMINATED,INTERVENTIONAL,Modified study; created new study as a result of these modifications
NCT01434914,TERMINATED,INTERVENTIONAL,early termination due to poor recruitment
NCT01434953,TERMINATED,INTERVENTIONAL,PI left institution
NCT01435733,SUSPENDED,OBSERVATIONAL,Recruitment Status
NCT01435746,WITHDRAWN,INTERVENTIONAL,No patients could be recruited for this study
NCT01435772,TERMINATED,INTERVENTIONAL,The study was terminated because BioMarin decided to end the overall development program based on competing corporate priorities.
NCT01435902,WITHDRAWN,INTERVENTIONAL,Study was cancelled prior to enrolling any subjects
NCT01436084,TERMINATED,INTERVENTIONAL,Colloborating sponsor decision.
NCT01436123,TERMINATED,INTERVENTIONAL,The study was terminated under the political pressure of the Federal Security Service of the Russian Federation (FSB) and the Russian Society of Cardiology
NCT01436175,TERMINATED,INTERVENTIONAL,SPD489 failed to demonstrate a benefit as adjunctive treatment to antidepressants. Termination was not related to any new safety findings.
NCT01436266,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01436292,WITHDRAWN,INTERVENTIONAL,No funding
NCT01436305,TERMINATED,INTERVENTIONAL,Secondary to safety concerns plus change in Campath (alemtuzumab) availability.
NCT01436604,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01436643,TERMINATED,INTERVENTIONAL,Due to slow enrollment the study was terminated early
NCT01437020,WITHDRAWN,INTERVENTIONAL,Drug Product no longer available.
NCT01437605,TERMINATED,INTERVENTIONAL,Treatment Ineffective
NCT01437761,TERMINATED,OBSERVATIONAL,Change of Institutional Affliation \& Funding Changes
NCT01437774,SUSPENDED,INTERVENTIONAL,DSMB recommendation to suspend trial due to control device
NCT01437826,TERMINATED,INTERVENTIONAL,50% of eligible patients refused to enter the study
NCT01437878,TERMINATED,INTERVENTIONAL,low recruitment
NCT01437943,TERMINATED,INTERVENTIONAL,Novartis has have decided to terminate all clinical investigator-initiated research projects involving aliskiren
NCT01438008,TERMINATED,INTERVENTIONAL,Feasibility of study at single site; changes in clinical practice in opioid use
NCT01438021,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01438047,WITHDRAWN,OBSERVATIONAL,The study was closed due to a shift in research priorities and a lack of resources available for the project.
NCT01438112,TERMINATED,INTERVENTIONAL,Change in study design
NCT01438151,TERMINATED,INTERVENTIONAL,terminated due to poor enrollment
NCT01438177,TERMINATED,INTERVENTIONAL,PI left institution.
NCT01438372,WITHDRAWN,INTERVENTIONAL,The study was terminated prior to enrolling patients as we were unable to secure enough funding to complete the study.
NCT01438502,WITHDRAWN,OBSERVATIONAL,Changes in staff resulted in logistic difficulties to perform the study
NCT01438671,WITHDRAWN,INTERVENTIONAL,Facility where study was taking place closed.
NCT01438684,SUSPENDED,INTERVENTIONAL,due to lack of supply of medication and technical problems with the MRI
NCT01438801,WITHDRAWN,INTERVENTIONAL,Participant enrollment was not feasible
NCT01439334,WITHDRAWN,INTERVENTIONAL,PI left UF
NCT01439347,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01439542,TERMINATED,INTERVENTIONAL,Higher then expected Gr3 GU/GI toxicity
NCT01439685,WITHDRAWN,OBSERVATIONAL,"A single cohort, alternative trial was started."
NCT01439789,TERMINATED,INTERVENTIONAL,Sponsor has designed another study with different endpoint to replace the current study
NCT01439828,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01439867,TERMINATED,INTERVENTIONAL,Amgen decided to terminate the study early to be able to meet US regulatory timelines fo filing. Subjects in treatment were rolled over to the 20140159 study.
NCT01439893,TERMINATED,INTERVENTIONAL,Sponsor has designed another study with different endpoint to replace the current study
NCT01439919,TERMINATED,INTERVENTIONAL,due to strategic reasons
NCT01439958,TERMINATED,INTERVENTIONAL,Core study 12011.201 was terminated.
NCT01440127,TERMINATED,INTERVENTIONAL,"Unable to accrue all planned subjects in a timely fashion, but data collected will still be analyzed."
NCT01440179,TERMINATED,INTERVENTIONAL,The study is stopped due to very modest activity compared to competitors
NCT01440192,TERMINATED,INTERVENTIONAL,Study Terminated by Sponsor
NCT01440361,WITHDRAWN,INTERVENTIONAL,This study was Cancelled Before Active
NCT01440517,TERMINATED,INTERVENTIONAL,Lack of Subject Recruitment
NCT01440595,TERMINATED,INTERVENTIONAL,Preliminary results of MK-5172 PN003 (NCT01353911) suggested a possible dose relationship to elevated transaminase levels in treatment with grazoprevir.
NCT01441115,TERMINATED,INTERVENTIONAL,"A trial using ECI301 \& radiation was initiated in Japan in 2012. This tested the primary endpoint in a duplicate trial, thus the study was closed."
NCT01441193,TERMINATED,INTERVENTIONAL,"Enrollments were suspended due to delta-V2 Env unavailability, following the EMA/CHMP/BWP/534898/2008 guideline, not allowing the use of a retest date"
NCT01441206,TERMINATED,INTERVENTIONAL,Study to be redesigned.
NCT01441219,TERMINATED,INTERVENTIONAL,Results were obtained in another project.
NCT01441271,TERMINATED,INTERVENTIONAL,Numer of eligible patients markedly decreased since the initiation of the study.
NCT01441284,WITHDRAWN,INTERVENTIONAL,Lack of financial support
NCT01441388,WITHDRAWN,INTERVENTIONAL,Business/Operational issues
NCT01441414,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01441531,WITHDRAWN,INTERVENTIONAL,Unable to recruit patient due to surgical case type. Not worth continuing study.
NCT01441570,TERMINATED,INTERVENTIONAL,due to slow enrollment
NCT01441765,TERMINATED,INTERVENTIONAL,Funding
NCT01441999,WITHDRAWN,INTERVENTIONAL,principal investigator decision
NCT01442207,WITHDRAWN,INTERVENTIONAL,Lack of randomized participants
NCT01442337,TERMINATED,INTERVENTIONAL,Study was terminated by sponsor decision
NCT01442363,TERMINATED,INTERVENTIONAL,"Lack of recruitment, discontinuation of program"
NCT01442402,TERMINATED,OBSERVATIONAL,Lack of funding/resources
NCT01442415,TERMINATED,INTERVENTIONAL,Unable to achieve enrollment goal.
NCT01442428,WITHDRAWN,INTERVENTIONAL,"2011 Thailand flooding led to loss of GMP pharmacy, project delays, and further regulatory challenges."
NCT01442454,TERMINATED,OBSERVATIONAL,The PI left and then the PI who would be taking over has left. No other investigator wanted to take the study since not sponsored
NCT01442467,TERMINATED,OBSERVATIONAL,Subject accrual too difficult
NCT01442714,TERMINATED,INTERVENTIONAL,Lack of efficacy - Inability to meet the primary response endpoint
NCT01442766,WITHDRAWN,INTERVENTIONAL,No financial support
NCT01442844,TERMINATED,INTERVENTIONAL,The study sponsor was acquired by a company that focuses on chronic wounds
NCT01443351,WITHDRAWN,OBSERVATIONAL,failure to recruit patients
NCT01443546,TERMINATED,INTERVENTIONAL,Unable to complete accrual
NCT01443559,SUSPENDED,INTERVENTIONAL,there was not enough patients recruited in this study
NCT01443754,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT01443819,TERMINATED,INTERVENTIONAL,recruitment problem
NCT01443923,TERMINATED,INTERVENTIONAL,Unable to complete enrollment due to newly approved treatment options.
NCT01444014,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT01444066,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01444118,TERMINATED,INTERVENTIONAL,The early termination is not related to safety/toxicity but to initiate new Phase III with biomarker to enrich population \& to further strengthen OS benefit
NCT01444209,TERMINATED,INTERVENTIONAL,Failure to accrue
NCT01444911,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01445041,TERMINATED,INTERVENTIONAL,Funding Period Ended
NCT01445236,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01445327,TERMINATED,OBSERVATIONAL,"Slow, insufficient accrual."
NCT01445587,WITHDRAWN,INTERVENTIONAL,"Based on the clinical activity, not safety data, of the AKT inhibitor, GSK has decided at this time to suspend further development of GSK2110183 as monotherapy."
NCT01445821,TERMINATED,INTERVENTIONAL,Developed a better regimen: DIAD. Cast. 2018 NCT03593902
NCT01445847,TERMINATED,INTERVENTIONAL,Patient Safety Concerns
NCT01445938,TERMINATED,INTERVENTIONAL,Data Monitoring Committee recommendation
NCT01446211,TERMINATED,INTERVENTIONAL,Change of design consideration
NCT01446588,WITHDRAWN,INTERVENTIONAL,No Funding was acquired.
NCT01446796,TERMINATED,INTERVENTIONAL,Recruitment futility
NCT01446874,TERMINATED,INTERVENTIONAL,Slow patient accrual and plans to perform multi-center study
NCT01446900,TERMINATED,INTERVENTIONAL,low rate in patient accrual
NCT01447303,TERMINATED,OBSERVATIONAL,Inability to recruit subjects
NCT01447589,WITHDRAWN,INTERVENTIONAL,"failed to recruit, no suitable patients"
NCT01447771,TERMINATED,INTERVENTIONAL,Lack of funds to continue and volunteer recruitment member left position
NCT01447901,TERMINATED,OBSERVATIONAL,Business reason
NCT01447953,TERMINATED,INTERVENTIONAL,Organizational changes in health care made further recruitment to the treatment options unpossible.
NCT01448005,TERMINATED,OBSERVATIONAL,Enrollment
NCT01448486,TERMINATED,INTERVENTIONAL,Funding withdrawn based on unacceptably slow recruitment rate.
NCT01448629,WITHDRAWN,INTERVENTIONAL,The study was withdrawn because of problems found with the baseplate
NCT01449357,WITHDRAWN,INTERVENTIONAL,Trial never initiated
NCT01449448,WITHDRAWN,INTERVENTIONAL,PI didn't have time to finish approval process
NCT01449539,TERMINATED,INTERVENTIONAL,Study was terminated early because the site that administered the hyperbaric oxygen treatment closed and an alternative site could not be identified.
NCT01449916,TERMINATED,INTERVENTIONAL,High mortality rate in intervention arm for patients with RR \>40 AND SpO2 \< 90%.
NCT01450241,WITHDRAWN,INTERVENTIONAL,"slow recruitment, no funding"
NCT01450410,TERMINATED,INTERVENTIONAL,Study terminated (halted prematurely) as recomended by the drug supplier and medical agencies
NCT01450683,TERMINATED,INTERVENTIONAL,Low accrual
NCT01450696,TERMINATED,INTERVENTIONAL,futility following planned interim analysis
NCT01450735,TERMINATED,INTERVENTIONAL,Enrollment did not reach our intended sample size due to availability of CTR with MANOS outside of the study.
NCT01450787,TERMINATED,OBSERVATIONAL,Principle investigator changed practice location and discontinued study
NCT01450878,TERMINATED,INTERVENTIONAL,Lack of patients eligible for the study.
NCT01451060,WITHDRAWN,INTERVENTIONAL,We didn't have enough financial support
NCT01451411,TERMINATED,INTERVENTIONAL,Enrollment goals were not met.
NCT01451437,TERMINATED,INTERVENTIONAL,The study was terminated early due to business reasons.
NCT01451489,TERMINATED,INTERVENTIONAL,The recruitment of subject is very difficult
NCT01451528,WITHDRAWN,INTERVENTIONAL,"The research fund, which is yet to be raised and expected to take for a while"
NCT01451606,TERMINATED,INTERVENTIONAL,Adequate recruitment was not achieved in the time frame allowed.
NCT01451723,TERMINATED,INTERVENTIONAL,Unusual high frequency of elevated liver function tests.
NCT01451944,WITHDRAWN,INTERVENTIONAL,no one enrolled
NCT01452009,WITHDRAWN,INTERVENTIONAL,Management Decision
NCT01452100,TERMINATED,INTERVENTIONAL,Inclusion default
NCT01452126,TERMINATED,INTERVENTIONAL,Departure of principal investigator
NCT01452152,TERMINATED,INTERVENTIONAL,Terminated by study sponsor.
NCT01452295,WITHDRAWN,INTERVENTIONAL,Subjects from lead-in study VTI-206 - NCT00973817 lost to follow-up before enrollment in VTI-207 (NCT1452295)
NCT01452386,WITHDRAWN,OBSERVATIONAL,no sufficient subjects
NCT01452516,TERMINATED,INTERVENTIONAL,Study was terminated due to slow accrual rate.
NCT01452581,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01452854,TERMINATED,OBSERVATIONAL,"Low recruitment, sponsor withdrew funding."
NCT01453049,TERMINATED,INTERVENTIONAL,"US FDA/EMA/SFDA decisions to rosiglitazone-containing medicines, ethic"
NCT01453088,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT01453140,TERMINATED,INTERVENTIONAL,Dose Limiting Toxicities
NCT01453361,TERMINATED,INTERVENTIONAL,Business Decision to pursue other indications
NCT01453387,TERMINATED,INTERVENTIONAL,Due to an administrative reason
NCT01453595,TERMINATED,INTERVENTIONAL,"Given the number of toxicities seen and the difficulty with patient retention in the dose escalation portion, the sponsor decided to close the trial."
NCT01453634,WITHDRAWN,INTERVENTIONAL,The company is no longer pursuing this study.
NCT01453751,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT01453764,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT01453777,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01453803,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT01453816,WITHDRAWN,INTERVENTIONAL,No participants and no longer working with off shore center
NCT01453829,WITHDRAWN,INTERVENTIONAL,no enrolled participants
NCT01454206,WITHDRAWN,INTERVENTIONAL,The project was not funded
NCT01454271,WITHDRAWN,INTERVENTIONAL,We have decided to design a comparative study which is ongoing
NCT01454440,TERMINATED,INTERVENTIONAL,The study was stopped prematurely due to slow enrolment without code breaking.
NCT01454453,TERMINATED,INTERVENTIONAL,Failure to recruit people with very late onset schizophrenia like psychosis
NCT01454869,WITHDRAWN,INTERVENTIONAL,Due to insufficient funds
NCT01455025,TERMINATED,INTERVENTIONAL,no recruitment on time
NCT01455116,TERMINATED,INTERVENTIONAL,Futility
NCT01455246,TERMINATED,INTERVENTIONAL,Decision of independent monitoring committee after interim analysis: Risk of failure significantly higher in ceftazidime group.
NCT01455311,TERMINATED,OBSERVATIONAL,funding unavailable
NCT01455389,TERMINATED,INTERVENTIONAL,Trial terminated by sponsor after decision to evaluate combination of quaratusugene ozeplasmid and osimertinib instead of further evaluating quaratusugene ozeplasmid and erlotinib.
NCT01456143,TERMINATED,INTERVENTIONAL,"PI left, study to be re-open with new PI, no planned data analysis"
NCT01456208,TERMINATED,OBSERVATIONAL,Funding stopped
NCT01456234,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01457053,TERMINATED,INTERVENTIONAL,Population not available for enrollment
NCT01457326,TERMINATED,OBSERVATIONAL,Loss to follow-up rate too high for publication and data on completed patients does not allow for a powered analysis.
NCT01457443,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT01457456,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT01457742,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01457820,TERMINATED,INTERVENTIONAL,slow recruitment: stopped early
NCT01457976,WITHDRAWN,OBSERVATIONAL,protocol never approved by local IRB
NCT01458119,TERMINATED,INTERVENTIONAL,Amicus Therapeutics discontinued Study AT1001-041 for logistical reasons.
NCT01458405,TERMINATED,INTERVENTIONAL,"On February 28, 2019, Capricor ceased ongoing follow-up activities and terminated the ALLSTAR trial to focus resourcing on its active CAP-1002 program, HOPE-2."
NCT01458418,TERMINATED,INTERVENTIONAL,Inability to complete enrollment due to difficulty in finding subjects
NCT01458548,TERMINATED,INTERVENTIONAL,This study had an major amendment in 12/2006 introducing risk stratified sequential treatment (RSST). The modified protocol is registered with NCT00590447.
NCT01458561,TERMINATED,INTERVENTIONAL,Sponsor terminated due to signif. difficulty with pilot investigation enrollment
NCT01458613,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT01458639,TERMINATED,INTERVENTIONAL,Decision to change trial design.
NCT01458925,TERMINATED,INTERVENTIONAL,All trials ojectives were met
NCT01458938,TERMINATED,OBSERVATIONAL,Study will need to be redesigned for improved efficacy.
NCT01459133,WITHDRAWN,INTERVENTIONAL,Unable to register Treatment IND with the US Food And Drug Administration's new process of establishing TLS encryption for email correspondence.
NCT01459159,TERMINATED,INTERVENTIONAL,Study TLK199.2108 was terminated for business reasons.
NCT01459666,TERMINATED,INTERVENTIONAL,Investigator left institution for private practice
NCT01459718,TERMINATED,INTERVENTIONAL,The study terminated due to low enrollment.
NCT01459861,TERMINATED,INTERVENTIONAL,Administratively closed early
NCT01459913,TERMINATED,INTERVENTIONAL,The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.
NCT01460602,WITHDRAWN,INTERVENTIONAL,Investigator has relocated to MD Anderson
NCT01460823,TERMINATED,INTERVENTIONAL,Currently in the process of submitting IDE to the FDA
NCT01460849,WITHDRAWN,OBSERVATIONAL,company decision
NCT01460862,WITHDRAWN,OBSERVATIONAL,company decision
NCT01461005,TERMINATED,INTERVENTIONAL,"FDA reclassified so all 522 studies were stopped,"
NCT01461252,WITHDRAWN,INTERVENTIONAL,No patients were treated due to enrollment challenges.
NCT01461772,TERMINATED,INTERVENTIONAL,Because of very slow rate of enrollement
NCT01462240,WITHDRAWN,OBSERVATIONAL,Suspended pending internal review/direction of the company's focus.
NCT01462656,TERMINATED,OBSERVATIONAL,This study was halted as the preliminary analysis revealed that the numbers were too low to warrant continuing the project
NCT01462916,TERMINATED,OBSERVATIONAL,problem with the candidate (investigator)
NCT01462968,WITHDRAWN,INTERVENTIONAL,The study never started due to problems with Laboratory facilities in collaborating center
NCT01463345,WITHDRAWN,INTERVENTIONAL,PI left and closed study at Hackensack went to RUTGERS
NCT01463410,TERMINATED,OBSERVATIONAL,The required number of banked samples could not be met due to limited availability. There is no realistic possibility to complete the study succesfully.
NCT01463566,WITHDRAWN,OBSERVATIONAL,Suspended pending internal review/direction of the company's focus.
NCT01463800,TERMINATED,INTERVENTIONAL,low inclusion rate
NCT01463852,TERMINATED,INTERVENTIONAL,Enrollment underperformance.
NCT01463878,TERMINATED,INTERVENTIONAL,Unlikely to show statistical significance and slow recruitment.
NCT01463943,WITHDRAWN,INTERVENTIONAL,Change company strategy
NCT01464021,TERMINATED,OBSERVATIONAL,This study was prematurely terminated due to low enrollment
NCT01464034,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01464164,TERMINATED,INTERVENTIONAL,Supporter terminated the study due to no active patients (secondary to travel restrictions due to COVID).
NCT01464294,TERMINATED,OBSERVATIONAL,not a required sutudy to be posted
NCT01464359,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01464593,TERMINATED,INTERVENTIONAL,trial design contingent on RFA optimization
NCT01464632,WITHDRAWN,OBSERVATIONAL,Unable to enroll any study participants.
NCT01464658,TERMINATED,INTERVENTIONAL,Due to complexity and cost of study (no outside funding)
NCT01464671,TERMINATED,INTERVENTIONAL,DSMB halted the study early due to futility. There were no safety concerns.
NCT01464684,WITHDRAWN,OBSERVATIONAL,determined not enough participants would be able to be enrolled and not enough data collected for good analyses
NCT01464788,TERMINATED,INTERVENTIONAL,The study was halted prematurely at 90 of 105 planned patients due to the beneficial results of embolectomy clinical trials.
NCT01464853,TERMINATED,INTERVENTIONAL,Interim analysis indicated significant additional subjects needed to demonsate statistical difference in primary outcome.
NCT01465074,TERMINATED,INTERVENTIONAL,Limited staff and operating resources
NCT01465100,TERMINATED,INTERVENTIONAL,Study was funded by NIH grant; grant funding ended in June 2023 without enrollment of additional subjects; the only subject enrolled was in 2011.
NCT01465165,TERMINATED,OBSERVATIONAL,Study procedures were not feasible.
NCT01465230,TERMINATED,INTERVENTIONAL,This study was unsuccessful in enrolling the target number of subjects during the funding period.
NCT01465334,TERMINATED,INTERVENTIONAL,Terminated early due to change in practice.
NCT01465386,TERMINATED,INTERVENTIONAL,Closed early due to slow enrollment
NCT01465516,TERMINATED,OBSERVATIONAL,The study was terminated and recruitment was capped because of the new changes in hepatitis C market
NCT01465581,TERMINATED,OBSERVATIONAL,Insufficient patient accrual.
NCT01465789,TERMINATED,OBSERVATIONAL,Loss of participants to follow-up
NCT01465815,WITHDRAWN,INTERVENTIONAL,"Drug manufacturer, Astellas Pharma, informed us that safety and efficacy of Erlotinib and OSI-906 in other oncology studies was determined to be unfavorable."
NCT01465919,TERMINATED,INTERVENTIONAL,Due to the recent change in standard of care for hepatitis C.
NCT01466101,WITHDRAWN,INTERVENTIONAL,PI left the institution. No subjects screened or enrolled.
NCT01466504,TERMINATED,OBSERVATIONAL,Accrual did not meet expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable.
NCT01466725,TERMINATED,INTERVENTIONAL,The benefit/risk profile does not support continuation of this study.
NCT01466764,TERMINATED,INTERVENTIONAL,Due to inability to demonstrate benefit in this patient population.
NCT01466855,TERMINATED,INTERVENTIONAL,Competing studies
NCT01466868,TERMINATED,INTERVENTIONAL,"Regarding the comments of the iDSMB, the sponsor decided to stop the inclusions"
NCT01466894,WITHDRAWN,INTERVENTIONAL,Sponsor administrative decision
NCT01467076,TERMINATED,INTERVENTIONAL,The study was halted due to futility concerns based on the unmet benchmarks as specified in the pilot study protocol.
NCT01467414,TERMINATED,INTERVENTIONAL,This trial was terminated due to low recruitment
NCT01467479,TERMINATED,INTERVENTIONAL,It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.
NCT01467492,TERMINATED,INTERVENTIONAL,It was decided by Sponsor on 13 January 2014 to terminate study early at primary efficacy endpoint as part of a decision to modify drug development plan.
NCT01467505,TERMINATED,INTERVENTIONAL,The study was terminated early by the sponsor on 13 January 2014 due to a decision to modify the drug development plan.
NCT01467635,WITHDRAWN,INTERVENTIONAL,Manufacturer did not develop and deliver the necessary biopsy forceps needles in time
NCT01467700,TERMINATED,INTERVENTIONAL,Business Decision; No Safety Concerns
NCT01467713,TERMINATED,INTERVENTIONAL,Business Decision; No Safety Concerns.
NCT01468311,TERMINATED,INTERVENTIONAL,Poor enrollment and ability to radioconjugate Daclizumab. Neither Center for Cancer Research (CCR) or Nuclear Medicine/Radiology wanted to do the facilities upgrade and hire personnel needed to radioconjugate the drug at the Clinical Center.
NCT01468376,TERMINATED,INTERVENTIONAL,Sponsor company was acquired and new owner chose not to proceed with clinical study
NCT01468623,TERMINATED,INTERVENTIONAL,Study terminated due to slow enrollment.
NCT01468636,TERMINATED,INTERVENTIONAL,There was no clear benefit but numerous side effects.
NCT01468818,TERMINATED,INTERVENTIONAL,Study was closed prematurely due to slow and insufficient accrual.
NCT01469091,TERMINATED,INTERVENTIONAL,Lack of patient inclusion
NCT01469221,TERMINATED,INTERVENTIONAL,Business reason
NCT01469260,TERMINATED,INTERVENTIONAL,resources
NCT01469338,TERMINATED,INTERVENTIONAL,lack of funding
NCT01469663,TERMINATED,OBSERVATIONAL,software problem
NCT01469806,WITHDRAWN,OBSERVATIONAL,Suspended pending internal review/direction of the company's focus. No sites ever engaged or collected data.
NCT01469975,TERMINATED,INTERVENTIONAL,Too slow accrual.
NCT01469988,TERMINATED,INTERVENTIONAL,Feasibility
NCT01470131,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT01470313,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01470651,TERMINATED,INTERVENTIONAL,European Medicines Agency issued a drug/drug interaction: sofosbuvir/modafinil
NCT01470742,WITHDRAWN,INTERVENTIONAL,We stop because of problems such as insurance.
NCT01470768,WITHDRAWN,INTERVENTIONAL,Sponsor cancelled study
NCT01470846,TERMINATED,INTERVENTIONAL,Lack of patients eligible for the study
NCT01471054,TERMINATED,INTERVENTIONAL,Could not enroll enough patients.
NCT01471197,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT01471249,TERMINATED,OBSERVATIONAL,Insuffisant personnel
NCT01471379,TERMINATED,INTERVENTIONAL,Due to recruitment difficulties the study is terminated.
NCT01471418,WITHDRAWN,INTERVENTIONAL,29-Apr-14 UPENN IRB granted approval to close study due to lack of funding
NCT01471431,TERMINATED,INTERVENTIONAL,Futility analysis by DSMC recommended termination.
NCT01471509,SUSPENDED,INTERVENTIONAL,Lack of funding
NCT01471652,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT01471925,WITHDRAWN,INTERVENTIONAL,Change company strategy
NCT01471964,TERMINATED,INTERVENTIONAL,Phase I portion completed. Phase II will open pending amendment approval.
NCT01472211,TERMINATED,INTERVENTIONAL,Zn released from vehicle led to fortification levels higher than planned. New filter will be developed.
NCT01472237,TERMINATED,INTERVENTIONAL,Randomization was stopped early because a significant beneficial effect of nutritional intervention was found in the interim analysis
NCT01472445,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01472809,SUSPENDED,INTERVENTIONAL,Not achieved the objective till 4 mg single dose
NCT01472861,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01472978,WITHDRAWN,INTERVENTIONAL,Too difficult to enroll patients.
NCT01473225,WITHDRAWN,INTERVENTIONAL,Funding was pulled after unsuccessful pilot study
NCT01473290,WITHDRAWN,INTERVENTIONAL,The study was not activated.
NCT01473303,WITHDRAWN,INTERVENTIONAL,CALGB 81003 closed about a week after it was activated because of withdrawal of support. No patients were registered on this study.
NCT01473446,TERMINATED,INTERVENTIONAL,High exclusion rate
NCT01473667,TERMINATED,INTERVENTIONAL,change in practice occured
NCT01473693,TERMINATED,OBSERVATIONAL,Lack of Accrual
NCT01473732,TERMINATED,INTERVENTIONAL,terminated after 2 patients due to difficulty in enrollment
NCT01473758,TERMINATED,INTERVENTIONAL,Company decision: No Safety or Efficacy Concerns
NCT01474031,TERMINATED,OBSERVATIONAL,Main investigator has left the department and therefore the study had ended
NCT01474122,TERMINATED,INTERVENTIONAL,company decision
NCT01474200,TERMINATED,INTERVENTIONAL,Closed due to patient recruitment challenges. No interim analyses were completed; study closure was not related to any concerns about safety or futility.
NCT01474434,TERMINATED,INTERVENTIONAL,The study was terminated based on interim analysis. See detailed description.
NCT01474551,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01474824,TERMINATED,OBSERVATIONAL,Unable to recruit sufficient participants
NCT01474902,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT01474954,TERMINATED,OBSERVATIONAL,Low enrollment
NCT01475162,TERMINATED,INTERVENTIONAL,The DSMB felt the risks of the study now outweighed the potential benefits.
NCT01475175,TERMINATED,INTERVENTIONAL,Unable to reach sample size to satisfy the primary objective
NCT01475253,TERMINATED,INTERVENTIONAL,This study was not enrolled completely and was terminated.
NCT01475266,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT01475305,TERMINATED,INTERVENTIONAL,The study was terminated as it was determined to not be feasible to complete enrollment and the study within the required timeline and budget.
NCT01475383,WITHDRAWN,INTERVENTIONAL,See termination reason in detailed description.
NCT01475565,TERMINATED,OBSERVATIONAL,Only 2 participants were enrolled
NCT01475604,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01475656,TERMINATED,OBSERVATIONAL,difficulty with recruitment
NCT01475864,WITHDRAWN,OBSERVATIONAL,no subjects were found who met criteria
NCT01475929,TERMINATED,INTERVENTIONAL,Protocol violations
NCT01476085,TERMINATED,INTERVENTIONAL,Study terminated as ongoing analysis suggested objectives not practical to achieve with study as implemented
NCT01476111,TERMINATED,OBSERVATIONAL,Study termination due to negative Phase III of another study product from same technology platform.
NCT01476514,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01476553,TERMINATED,INTERVENTIONAL,Prematurely halted after interim data analysis
NCT01476566,WITHDRAWN,INTERVENTIONAL,"the study was terminated before study start, no researcher was attached to the study"
NCT01476631,TERMINATED,INTERVENTIONAL,not enough patients consented during the funding period
NCT01476657,TERMINATED,INTERVENTIONAL,The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.
NCT01477060,TERMINATED,INTERVENTIONAL,The study was stopped due to insufficient accrual
NCT01477177,TERMINATED,INTERVENTIONAL,"enrollment much slower than anticipated, and, funding issues"
NCT01477476,WITHDRAWN,INTERVENTIONAL,"funding loss, no data was ever collected"
NCT01477697,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment and interim analysis showing no difference between treatment arms.
NCT01477723,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01477788,WITHDRAWN,OBSERVATIONAL,The researcher Left the organization
NCT01477853,TERMINATED,INTERVENTIONAL,The study was terminated early by the Sponsor for business reasons.
NCT01477866,SUSPENDED,INTERVENTIONAL,the study has never started
NCT01478035,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01478074,WITHDRAWN,INTERVENTIONAL,The treatment planned was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects
NCT01478087,TERMINATED,INTERVENTIONAL,Sponsor terminated due to business reasons
NCT01478113,TERMINATED,INTERVENTIONAL,PI left the institution and was no funding to continue study.
NCT01478243,TERMINATED,OBSERVATIONAL,Lack of institutional support and IRB related issues.
NCT01478308,WITHDRAWN,INTERVENTIONAL,"No accrual in initial period, PI decided to close study."
NCT01478321,TERMINATED,INTERVENTIONAL,Slow accrual to some cohorts
NCT01478360,TERMINATED,INTERVENTIONAL,"Further investigations would require changes in study design; the use of different endpoints, a different IL-17 antibody or a different patient population."
NCT01478386,TERMINATED,INTERVENTIONAL,The study was terminated due to poor enrollment
NCT01478555,WITHDRAWN,INTERVENTIONAL,Project postponed
NCT01478698,TERMINATED,INTERVENTIONAL,Insufficient budget for further study agents
NCT01478802,TERMINATED,INTERVENTIONAL,"Low rate of enrollment, in conjunction with inability of continuation of funding"
NCT01478828,TERMINATED,INTERVENTIONAL,The study was stopped due to an unanticipated serious adverse event.
NCT01478932,TERMINATED,INTERVENTIONAL,PI left University
NCT01479010,TERMINATED,INTERVENTIONAL,"recruitment issues, critical investigators left institution"
NCT01479023,TERMINATED,INTERVENTIONAL,treatment was not working
NCT01479179,WITHDRAWN,INTERVENTIONAL,Drug sponsor decision to discontinue study.
NCT01479192,TERMINATED,INTERVENTIONAL,very low rate of patient accrual
NCT01479231,WITHDRAWN,INTERVENTIONAL,Souces of funding have been terminated
NCT01479348,TERMINATED,INTERVENTIONAL,"Slow, insufficient accrual."
NCT01479946,WITHDRAWN,INTERVENTIONAL,ECT equipment not available at study center
NCT01479998,TERMINATED,INTERVENTIONAL,Reevaluating recruitment strategies
NCT01480141,WITHDRAWN,INTERVENTIONAL,"PI left MUSC, no patient enrollments"
NCT01480167,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01480232,TERMINATED,INTERVENTIONAL,Study has been put on clinical hold by FDA
NCT01480245,TERMINATED,INTERVENTIONAL,The study was formally terminated given that GSK is not submitting an application for regulatory approval for drisapersen in Duchenne Muscular Dystrophy.
NCT01480388,WITHDRAWN,INTERVENTIONAL,Study was terminated prematurely due to 2 cases of agranulocytosis in a different clinical trial with this same drug.
NCT01480453,TERMINATED,OBSERVATIONAL,"Business decision was made to remove the CE mark from this product, thus prompting the closing of this study."
NCT01480531,WITHDRAWN,INTERVENTIONAL,We elected to stop this study due to our inability to recruit suitable subjects.
NCT01480791,WITHDRAWN,INTERVENTIONAL,"Because of results of Altitude trial, this trial was cancelled."
NCT01480817,TERMINATED,INTERVENTIONAL,Difficulty of participant enrollment.
NCT01481012,TERMINATED,OBSERVATIONAL,Slow enrollment - terminated for futility.
NCT01481090,TERMINATED,INTERVENTIONAL,IRB violations
NCT01481103,TERMINATED,INTERVENTIONAL,PI cited personal reasons
NCT01481116,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01481233,WITHDRAWN,INTERVENTIONAL,Due to funding
NCT01481441,TERMINATED,INTERVENTIONAL,New study protocol started including targeted biopsies
NCT01481610,TERMINATED,INTERVENTIONAL,Interim analysis shows harma to one of the study arms.
NCT01481753,TERMINATED,INTERVENTIONAL,"last patient recruited Feb 2015,completion of data review; study data do not meet statistical significance to answer proposed study question"
NCT01482286,TERMINATED,INTERVENTIONAL,Poor recruitment and enrollment.
NCT01482325,TERMINATED,INTERVENTIONAL,The business decided not to pursue the study at this time.
NCT01482559,TERMINATED,INTERVENTIONAL,Study ceased enrolling due to poor overall recruitment. Long-term follow up of enrolled participants ongoing.
NCT01482780,TERMINATED,INTERVENTIONAL,"Logistic reasons, lack of funding"
NCT01482897,TERMINATED,INTERVENTIONAL,"Enrolment stopped on December 01, 2014 since after 3 years, only 13 patients were included (instead of 274) (Date of last visit last patient : October 3, 2013)."
NCT01482949,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01483066,TERMINATED,INTERVENTIONAL,FDA recall - Canadian system did voluntary suspension of study; Investigators subsequently decided to terminate the study
NCT01483170,TERMINATED,INTERVENTIONAL,poor tolerability at highest dose
NCT01483183,TERMINATED,INTERVENTIONAL,Enrollment Difficulty
NCT01483209,TERMINATED,INTERVENTIONAL,Low accrual
NCT01483274,WITHDRAWN,INTERVENTIONAL,Adult patient population barriers.
NCT01483313,WITHDRAWN,OBSERVATIONAL,No patients enrolled.
NCT01483573,TERMINATED,INTERVENTIONAL,Insufficient recruitment over time
NCT01483586,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01483638,TERMINATED,INTERVENTIONAL,The trial was prematurely closed due to lack of accrual
NCT01483690,TERMINATED,INTERVENTIONAL,Toxicity
NCT01483820,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01483872,TERMINATED,INTERVENTIONAL,The study was stopped due to poor enrollment.
NCT01484041,TERMINATED,INTERVENTIONAL,Decision by company to cease development of dovitinib
NCT01484314,TERMINATED,INTERVENTIONAL,Low accrual.
NCT01484353,WITHDRAWN,INTERVENTIONAL,This study was cancelled.
NCT01484366,TERMINATED,INTERVENTIONAL,Low enrollment. Treament no longer used by researchers.
NCT01484379,WITHDRAWN,INTERVENTIONAL,difficulties in Recruiting patients
NCT01484405,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT01484626,TERMINATED,INTERVENTIONAL,Celgene would no longer supply lenalidomide for the study
NCT01485055,TERMINATED,INTERVENTIONAL,Sponsor withdrew support
NCT01485094,TERMINATED,INTERVENTIONAL,The trial was early terminated after it was concluded that there was no added benefit from exposing further participants after an unblinded interim analysis.
NCT01485354,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01485432,TERMINATED,OBSERVATIONAL,Low recruitment of patients.
NCT01485471,WITHDRAWN,OBSERVATIONAL,No paticipants enrolled
NCT01485497,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01485536,TERMINATED,INTERVENTIONAL,Study halted early due to limited response.
NCT01485757,TERMINATED,INTERVENTIONAL,Technical difficulty with Endo-PAT machine
NCT01485822,TERMINATED,OBSERVATIONAL,Study objectives met
NCT01485874,TERMINATED,INTERVENTIONAL,Funding withdrawn due to drug unavailability
NCT01486043,TERMINATED,INTERVENTIONAL,The research project was terminated due to lower than projected patient recruitment within the period of time allowed for the study.
NCT01486134,TERMINATED,INTERVENTIONAL,For technical reasons
NCT01486407,TERMINATED,OBSERVATIONAL,For poor enrollment
NCT01486459,TERMINATED,INTERVENTIONAL,Insufficient recruits
NCT01486550,TERMINATED,INTERVENTIONAL,Lack of patient enrollment
NCT01486732,WITHDRAWN,INTERVENTIONAL,Difficulty in obtaining specific isotope tracer
NCT01486966,TERMINATED,INTERVENTIONAL,Trial terminated prematurely due to slow recruitment.
NCT01487083,TERMINATED,INTERVENTIONAL,The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population.
NCT01487174,TERMINATED,INTERVENTIONAL,Kadmon has made a business decision to terminate the study due to slow enrollment. Note the decision to terminate the study was not related to safety issues
NCT01487499,TERMINATED,INTERVENTIONAL,Unable to enroll adequate number of participants
NCT01488110,TERMINATED,INTERVENTIONAL,Too slow recruitment rate. The study has been terminated and will be re-started with an improved and more suitable study design.
NCT01488149,WITHDRAWN,OBSERVATIONAL,Study never started
NCT01488175,WITHDRAWN,INTERVENTIONAL,Funding problems
NCT01488253,TERMINATED,INTERVENTIONAL,We could not receive the support from the national medical insurance owing to the changed policy of the government for clincal trials.
NCT01488318,TERMINATED,INTERVENTIONAL,PI leaving the institution
NCT01488383,WITHDRAWN,INTERVENTIONAL,not i
NCT01488695,WITHDRAWN,INTERVENTIONAL,Device withdrawn from the market
NCT01488708,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01488864,TERMINATED,INTERVENTIONAL,Low drop-out rate and slow recruitment rate
NCT01488877,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01488981,TERMINATED,INTERVENTIONAL,low enrollment
NCT01489319,TERMINATED,INTERVENTIONAL,The PI left Indiana University. The findings served as preliminary data for a recently awarded NIH R01 grant.
NCT01489410,WITHDRAWN,INTERVENTIONAL,Insufficient staff
NCT01489501,WITHDRAWN,INTERVENTIONAL,Change of strategic priorities in the sponsor's clinical development sector.
NCT01489605,WITHDRAWN,INTERVENTIONAL,Device Withdrawn from market
NCT01489618,TERMINATED,INTERVENTIONAL,End of production
NCT01489657,WITHDRAWN,OBSERVATIONAL,"The results were not significant, therfore the study ended prematurily"
NCT01489956,TERMINATED,INTERVENTIONAL,"Due to futility, identified after 5 subjects completed treatment in Part B"
NCT01490021,TERMINATED,INTERVENTIONAL,Study stopped for scientific reasons. Another study with a new design is in course of authorization and implementation
NCT01490216,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01490775,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of funding
NCT01490827,TERMINATED,OBSERVATIONAL,Sponsor discontinued the Argus II product
NCT01490840,TERMINATED,INTERVENTIONAL,The study stopped due to slow enrollment and low participant compliance.
NCT01490983,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding
NCT01491139,WITHDRAWN,INTERVENTIONAL,Study stopped due to issues surrounding development and formulation of olaparib
NCT01491490,TERMINATED,INTERVENTIONAL,The Chief Investigator and the Sponsor have concluded that it will not be possible to complete the enrolment in any meaningful timeframe.
NCT01491594,TERMINATED,INTERVENTIONAL,Unable to accrue subjects to the study.
NCT01491633,TERMINATED,INTERVENTIONAL,Safety issues/concerns per DF/HCC PI
NCT01491854,TERMINATED,INTERVENTIONAL,"in accordance with the request to close study EP00-402 ""EMEA/H/C/000607/MEA 10.2"" submitted and adopted by the EMA"
NCT01492062,WITHDRAWN,INTERVENTIONAL,Study halted prior to enrollment of first participant.
NCT01492322,TERMINATED,OBSERVATIONAL,UPenn suspended production of the ligand necessary to produce the tracer TRODAT.
NCT01492465,TERMINATED,INTERVENTIONAL,Decision by Sponsor
NCT01492569,WITHDRAWN,INTERVENTIONAL,low accrual
NCT01492725,TERMINATED,INTERVENTIONAL,"On DSMB advice, trial recruitment has been halted for efficacy. F/U continues"
NCT01492881,WITHDRAWN,INTERVENTIONAL,Doxil is currently unavailable
NCT01492894,WITHDRAWN,INTERVENTIONAL,study terminated due to low enrollment
NCT01492920,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT01493102,TERMINATED,INTERVENTIONAL,Futility by interim analysis
NCT01493154,TERMINATED,INTERVENTIONAL,Study Funding Terminated
NCT01493258,WITHDRAWN,INTERVENTIONAL,PI left JHU and is not able to be reached for updates
NCT01493323,TERMINATED,INTERVENTIONAL,difficult to patient inclusion
NCT01493375,SUSPENDED,OBSERVATIONAL,Study principal investigator left the organization
NCT01493453,TERMINATED,INTERVENTIONAL,Investigation into serious breach
NCT01493505,TERMINATED,INTERVENTIONAL,Amgen Administrative Decision - termination of LTFU
NCT01493518,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01493882,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to 2 cases of agranulocytosis in a different clinical trial with this same drug.
NCT01494012,TERMINATED,INTERVENTIONAL,low accrual
NCT01494090,TERMINATED,INTERVENTIONAL,Decision of the Steering Committee. Recruitment more difficult and slower than expected.
NCT01494350,TERMINATED,INTERVENTIONAL,This study was closed prematurely due study team travel restrictions.
NCT01494584,TERMINATED,INTERVENTIONAL,Terminated after placing the study on hold at the request of the FDA
NCT01494792,TERMINATED,OBSERVATIONAL,Performance did not meet sponsor requirements.
NCT01494896,TERMINATED,OBSERVATIONAL,due to slow enrollment. United Therapeutics and Dr. Bajwa MD decided to terminate study
NCT01495247,TERMINATED,INTERVENTIONAL,Study did not meet Phase Ib primary objective to establish the maximum tolerated dose/recommended dose for Phase II
NCT01495273,WITHDRAWN,INTERVENTIONAL,"Study never started, no subjects enrolled"
NCT01495299,WITHDRAWN,OBSERVATIONAL,Due to staff departures we were unable to execute this study
NCT01495312,WITHDRAWN,INTERVENTIONAL,Due to staff departures unable to execute this study so requested closure. There were no study procedures performed \& no participants enrolled.
NCT01495572,TERMINATED,INTERVENTIONAL,"Due to slow accrual, the investigator decided to close the study."
NCT01495624,TERMINATED,INTERVENTIONAL,Accrual insufficient to complete study in a feasible time frame
NCT01495871,WITHDRAWN,INTERVENTIONAL,PI decided not to pursue this study.
NCT01495884,TERMINATED,INTERVENTIONAL,Slower than anticipated accrual
NCT01495988,TERMINATED,INTERVENTIONAL,Slow accrual; toxicity; change in priorities
NCT01496235,TERMINATED,INTERVENTIONAL,Difficulties with the patient recruitment
NCT01496430,TERMINATED,INTERVENTIONAL,Business Decision; No Safety Or Efficacy Concerns. (See below)
NCT01496534,TERMINATED,INTERVENTIONAL,toxicity of combination of medications
NCT01496560,WITHDRAWN,OBSERVATIONAL,study terminated due toTechnical issue pre -recruiting
NCT01496794,TERMINATED,OBSERVATIONAL,poor enrollment
NCT01497119,TERMINATED,INTERVENTIONAL,This study was terminated prematurely due to 2 cases of agranulocytosis.
NCT01497171,TERMINATED,INTERVENTIONAL,Early termination of study due to changes in funding.
NCT01497197,TERMINATED,INTERVENTIONAL,Study was terminated as per sponsor's decision
NCT01497275,TERMINATED,INTERVENTIONAL,Low accrual due to the approval of new drugs for use in Mantle cell lymphoma.
NCT01497340,TERMINATED,INTERVENTIONAL,difficulties with the center
NCT01497509,WITHDRAWN,INTERVENTIONAL,Study never started
NCT01497626,TERMINATED,INTERVENTIONAL,Drug support withdrawn
NCT01497665,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01497678,WITHDRAWN,INTERVENTIONAL,Funding issues. 0 subjects enrolled
NCT01497691,WITHDRAWN,INTERVENTIONAL,unable to recruit participants
NCT01498237,WITHDRAWN,INTERVENTIONAL,Need to obtain IDE prior to commencement of study
NCT01498406,TERMINATED,INTERVENTIONAL,secondary to funding issues and low enrollment
NCT01498445,TERMINATED,INTERVENTIONAL,The study was terminated early during the phase II portion of the study due to slow enrollment.
NCT01498471,WITHDRAWN,OBSERVATIONAL,longterm abscence of investigator
NCT01498588,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01498614,TERMINATED,INTERVENTIONAL,Investigator no longer at LU.
NCT01498666,TERMINATED,INTERVENTIONAL,The recruitment rate was too slow according to study protocol and agreement.
NCT01498705,WITHDRAWN,OBSERVATIONAL,Anticipated grant was withdrawn and additional funding was unable to be obtained
NCT01498744,TERMINATED,INTERVENTIONAL,The study was closed due to poor enrollment and lack of interest.
NCT01498757,WITHDRAWN,OBSERVATIONAL,Registration poor
NCT01498796,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01499017,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01499043,TERMINATED,INTERVENTIONAL,Business decision.
NCT01499160,TERMINATED,INTERVENTIONAL,low accrual
NCT01499251,TERMINATED,INTERVENTIONAL,Results did not clearly support continuing development in recurrent GBM
NCT01499355,TERMINATED,INTERVENTIONAL,Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.
NCT01499654,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01499667,TERMINATED,INTERVENTIONAL,"Based on recent publications, determination of natalizumub washout period was no longer relevant."
NCT01499901,WITHDRAWN,INTERVENTIONAL,"Recommendations of HAS have changed, the study is now useless"
NCT01499940,TERMINATED,INTERVENTIONAL,Research cancelled - no funding identified.
NCT01500018,WITHDRAWN,INTERVENTIONAL,Sponsor decision to withdraw.
NCT01500161,TERMINATED,INTERVENTIONAL,Insufficient accruals
NCT01500382,TERMINATED,INTERVENTIONAL,This study was terminated early due to insufficient recruitment.
NCT01500473,TERMINATED,INTERVENTIONAL,"Only one subject was studied, who did not respond."
NCT01500538,TERMINATED,INTERVENTIONAL,Poor recruitment rate
NCT01500603,TERMINATED,INTERVENTIONAL,lack of inclusion in the study
NCT01500785,TERMINATED,INTERVENTIONAL,Change of schedule
NCT01500798,TERMINATED,INTERVENTIONAL,IDMC recommendation for safety concerns
NCT01501383,TERMINATED,INTERVENTIONAL,Terminated by Sponsor
NCT01501461,WITHDRAWN,INTERVENTIONAL,Company dissolved
NCT01501474,TERMINATED,OBSERVATIONAL,No suitable case available and many techinical error
NCT01501604,WITHDRAWN,INTERVENTIONAL,The study has been closed due to lack of accrual
NCT01501643,TERMINATED,INTERVENTIONAL,decision of the promoter
NCT01501838,WITHDRAWN,OBSERVATIONAL,By the moment nvestigators are not recuiting because logistics issues
NCT01501890,WITHDRAWN,INTERVENTIONAL,never started
NCT01502228,TERMINATED,INTERVENTIONAL,No further funding
NCT01502501,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01502514,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01502605,TERMINATED,INTERVENTIONAL,PI leaving institution
NCT01502709,TERMINATED,INTERVENTIONAL,recruiting difficulties
NCT01502748,TERMINATED,INTERVENTIONAL,FAST-Mag study finished
NCT01502761,TERMINATED,INTERVENTIONAL,No safety issues. Low enrollment secondary to negative stroke studies 2013
NCT01502839,TERMINATED,OBSERVATIONAL,Unable to complete the data collection for this study.
NCT01502865,WITHDRAWN,OBSERVATIONAL,Should not have been listed on ClinicalTrials
NCT01503125,TERMINATED,OBSERVATIONAL,PI left the institution
NCT01503268,WITHDRAWN,INTERVENTIONAL,Study methodology redesigned
NCT01503528,TERMINATED,INTERVENTIONAL,Shortage of required study drug.
NCT01504308,TERMINATED,INTERVENTIONAL,It was not possible to enroll patients into the study in a realistic timeframe.
NCT01504386,TERMINATED,INTERVENTIONAL,"Due to local restructering, further recruting was not possible"
NCT01504477,TERMINATED,INTERVENTIONAL,Low accrual--unable to meet accrual goals
NCT01504490,TERMINATED,INTERVENTIONAL,Drug no longer available
NCT01504542,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01504568,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT01504594,SUSPENDED,INTERVENTIONAL,Suspended because the lack of patients among the time this clinical trial was running.
NCT01504659,TERMINATED,INTERVENTIONAL,Administrative issues
NCT01504737,TERMINATED,INTERVENTIONAL,"Slow inclusion rate, failure to recruit a priori determined no of patients."
NCT01504945,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT01505062,TERMINATED,INTERVENTIONAL,"Study stopped not for safety reasons. Due to review of clinical development plans and priorities, Sponsor decided to stop development of the product."
NCT01505166,TERMINATED,INTERVENTIONAL,Terminated (Business Decision to pursue other indications)
NCT01505283,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01505296,WITHDRAWN,INTERVENTIONAL,Never initiated
NCT01505556,WITHDRAWN,OBSERVATIONAL,Problems to recruit individuals with diaphragm paresis.
NCT01505608,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT01505764,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01505933,TERMINATED,INTERVENTIONAL,finding it difficult to recruit.
NCT01506206,WITHDRAWN,OBSERVATIONAL,Study was not funded and never enrolled participants.
NCT01506232,TERMINATED,OBSERVATIONAL,Due to slow enrollment and lack of funding the study was terminated prior to completion.
NCT01506349,TERMINATED,INTERVENTIONAL,enrollment
NCT01506401,TERMINATED,INTERVENTIONAL,Enrolment halted by Steering Committee on advice from Data Monitoring Committee.
NCT01506674,TERMINATED,OBSERVATIONAL,The study was terminated prematurely due to slow recruitment.
NCT01506700,TERMINATED,OBSERVATIONAL,additional recruitment not needed
NCT01506726,TERMINATED,INTERVENTIONAL,Study drug expiration and supply shortage
NCT01506934,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01506960,TERMINATED,INTERVENTIONAL,It was felt that a sufficient number of subjects were enrolled.
NCT01507220,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01507233,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT01507467,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01507532,WITHDRAWN,INTERVENTIONAL,did not enroll a patient
NCT01507545,TERMINATED,INTERVENTIONAL,By the sponsor at the end of Stage 1 due to futility.
NCT01507675,WITHDRAWN,OBSERVATIONAL,Study should not have been listed on ClinicalTrials
NCT01507740,TERMINATED,OBSERVATIONAL,Study was stopped 04.10.2014 prematurly after recruitment of HCC and RCC patients. NSCLC (2 of 10 patients planned) and CRC patients recruitment was stopped
NCT01507818,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01507909,TERMINATED,OBSERVATIONAL,Equipment Failure
NCT01507935,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to change of the study product formulation.
NCT01508000,TERMINATED,INTERVENTIONAL,Low or poor accrual
NCT01508078,SUSPENDED,OBSERVATIONAL,The restrictions on research imposed for the COVID-19 pandemic prevented us from continuing recruitment and visits. At this stage our funding is not sufficient to continue enrollment so we will put the study in a hold pattern.
NCT01508104,TERMINATED,INTERVENTIONAL,funding
NCT01508117,TERMINATED,INTERVENTIONAL,transferred study sponsor
NCT01508598,TERMINATED,OBSERVATIONAL,Not enough subjects enrolled to be able to analyze data.
NCT01508780,WITHDRAWN,INTERVENTIONAL,"Due to complex study protocol, no patients have been enrolled in the study."
NCT01509339,WITHDRAWN,INTERVENTIONAL,Lab unable to measure vancomycin levels in Sputum
NCT01509495,TERMINATED,INTERVENTIONAL,Enrollment rate too low; rate much under estimation of sponsor and investigators
NCT01510236,WITHDRAWN,INTERVENTIONAL,a feasibility study showed low recruitment and adherence
NCT01510288,TERMINATED,INTERVENTIONAL,The study was terminated because Cell Genesys stopped all activities for GVAX.
NCT01510561,WITHDRAWN,INTERVENTIONAL,no subjects enrolled
NCT01510691,WITHDRAWN,OBSERVATIONAL,Difficulties in recruiting participants
NCT01510756,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01510847,TERMINATED,INTERVENTIONAL,Unable to reach the target recruitment within timeline
NCT01511055,TERMINATED,INTERVENTIONAL,"Accrual temporarily suspended, followed by study closure due to technical problems with investigational camera."
NCT01511081,TERMINATED,INTERVENTIONAL,Low Accrual
NCT01511107,TERMINATED,INTERVENTIONAL,The primary objective of the study was met.
NCT01511211,WITHDRAWN,INTERVENTIONAL,Other researchers have published results on a similar trial
NCT01511627,WITHDRAWN,INTERVENTIONAL,Research question was answered by Acta Anaesthesiol Scand 2012; 56: 102-109.
NCT01511666,TERMINATED,INTERVENTIONAL,DSMB recommendation to stop
NCT01511679,WITHDRAWN,OBSERVATIONAL,The project was not funded.
NCT01512160,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01512199,TERMINATED,INTERVENTIONAL,"Improved, different standard of care caused business decision to terminate"
NCT01512303,TERMINATED,INTERVENTIONAL,Study terminated due to funding issues
NCT01512316,WITHDRAWN,INTERVENTIONAL,Study was cancelled
NCT01512381,TERMINATED,INTERVENTIONAL,Absence of patients for recruitment
NCT01512394,WITHDRAWN,INTERVENTIONAL,Study was never started.
NCT01512446,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT01512472,TERMINATED,INTERVENTIONAL,acrrual target was not being met
NCT01512888,SUSPENDED,INTERVENTIONAL,voluntary hold
NCT01513031,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01513317,TERMINATED,INTERVENTIONAL,The study was stopped after the interim analysis based on lack of sufficient efficacy. There were no safety concerns.
NCT01513447,TERMINATED,INTERVENTIONAL,low qualified candidate enrollment
NCT01514058,TERMINATED,INTERVENTIONAL,new clinical strategies have rendered the question posed by this study less relevant
NCT01514149,TERMINATED,INTERVENTIONAL,Business decision
NCT01514357,TERMINATED,INTERVENTIONAL,"Original PI left the institution, and lack of funding."
NCT01514721,TERMINATED,INTERVENTIONAL,low enrollment
NCT01514734,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT01514838,TERMINATED,INTERVENTIONAL,Discontinued due to company's strategic reason
NCT01514864,TERMINATED,INTERVENTIONAL,Lack of efficacy and slow accrual
NCT01514981,TERMINATED,INTERVENTIONAL,Administrative decision
NCT01515020,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT01515046,TERMINATED,INTERVENTIONAL,Standard of care changed to FOLFIRINOX; poor accrual.
NCT01515059,TERMINATED,OBSERVATIONAL,Slow recruitment and sufficient data available to analyse
NCT01515085,TERMINATED,OBSERVATIONAL,PI elected to close study
NCT01515371,TERMINATED,INTERVENTIONAL,"Due to lack of sufficient eligible subjects, no safety concerns"
NCT01515813,WITHDRAWN,INTERVENTIONAL,"On 05/08/12, team working on revising protocol and re-open study under version 2.0"
NCT01515826,WITHDRAWN,INTERVENTIONAL,Management decision
NCT01515969,TERMINATED,INTERVENTIONAL,Patient safety - Unacceptable toxicity
NCT01516034,TERMINATED,INTERVENTIONAL,Sponsor decided that the results were not significant enough to continue.
NCT01516554,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01516697,WITHDRAWN,INTERVENTIONAL,unable to enrollment subjects due to early departure of study personele
NCT01516957,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01517126,TERMINATED,OBSERVATIONAL,slow accrual
NCT01517308,WITHDRAWN,INTERVENTIONAL,Time elapsed to require permissions and a recent paper showed a high efficacy of a 48-week regimen in this setting. It seems non-ethical to start this trial
NCT01517347,TERMINATED,INTERVENTIONAL,"Because the conditional power was 0.083, the Data and Safety Monitoring Board recommended halting the study due to futility after the 1st interim analysis."
NCT01517542,WITHDRAWN,INTERVENTIONAL,low availability of professionals to recruit the participants
NCT01517763,TERMINATED,INTERVENTIONAL,"The site closed down, therefore the study has been terminated."
NCT01517776,TERMINATED,INTERVENTIONAL,due to an altered benefit/risk assessment.
NCT01517854,TERMINATED,INTERVENTIONAL,Poor recruitment.
NCT01517984,TERMINATED,INTERVENTIONAL,Absence of equipoise on the basis of predetermined stopping rules.
NCT01518153,TERMINATED,INTERVENTIONAL,Objectives not met.
NCT01518348,WITHDRAWN,INTERVENTIONAL,Study has been updated with new protocol number
NCT01518465,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT01518595,TERMINATED,INTERVENTIONAL,too slow patient recruitment
NCT01518621,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01518881,TERMINATED,INTERVENTIONAL,Corporate decision to reformulate the investigational product.
NCT01518933,TERMINATED,INTERVENTIONAL,when a blind review highlighted that at least 43% of patients had a virological response
NCT01518959,TERMINATED,INTERVENTIONAL,Insufficient recruitment rate; technical issues with sample storage
NCT01519076,TERMINATED,INTERVENTIONAL,Sponsor Request
NCT01519297,SUSPENDED,INTERVENTIONAL,Pending funding
NCT01519323,TERMINATED,INTERVENTIONAL,Study was terminated due to low enrollment.
NCT01519427,TERMINATED,INTERVENTIONAL,Study terminated due to slow accrual
NCT01519765,TERMINATED,INTERVENTIONAL,Poor Enrollment
NCT01519882,TERMINATED,INTERVENTIONAL,"Due to major recruitment issues, a decision was made to terminate this trial"
NCT01519973,TERMINATED,INTERVENTIONAL,Recruitment base changed due to change in clinical acquisition procedures
NCT01520025,TERMINATED,INTERVENTIONAL,Continued recruitment of study participants was not feasible
NCT01520168,SUSPENDED,OBSERVATIONAL,Because of the product recall 2005/2006.
NCT01520298,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting subjects for the trial.
NCT01520311,TERMINATED,INTERVENTIONAL,Company closed
NCT01520350,TERMINATED,INTERVENTIONAL,recruitment issues
NCT01520636,TERMINATED,INTERVENTIONAL,difficulty of inclusion
NCT01520714,TERMINATED,INTERVENTIONAL,Lower enrollment rate than expected
NCT01521143,TERMINATED,INTERVENTIONAL,The study was terminated due to company restructuring and changes in drug development priorities.
NCT01521299,WITHDRAWN,INTERVENTIONAL,Insufficient population of eligible patients.
NCT01521442,WITHDRAWN,INTERVENTIONAL,Did not have funding or resources to carry out study
NCT01521936,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01522027,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01522053,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01522066,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01522092,WITHDRAWN,INTERVENTIONAL,Study was not given ethical approval- a alternative protocol required
NCT01522105,TERMINATED,INTERVENTIONAL,Insufficient patient recruitment
NCT01522170,TERMINATED,OBSERVATIONAL,"Remaining patients were offered a similar observational study (Alexion M11-001) to allow for robust, high quality data collection in a larger, single database"
NCT01522196,TERMINATED,INTERVENTIONAL,change in company plans
NCT01522300,TERMINATED,INTERVENTIONAL,No more inclusions since august 2013
NCT01522378,TERMINATED,INTERVENTIONAL,The study was terminated because the funding was withdrawn.
NCT01522443,TERMINATED,INTERVENTIONAL,Stopped after the outcome of cabozantinib Phase 3 CRPC study XL184-307.
NCT01522534,TERMINATED,INTERVENTIONAL,not enough inclusions
NCT01522586,TERMINATED,INTERVENTIONAL,change development strategy
NCT01522599,TERMINATED,INTERVENTIONAL,Financial hardship
NCT01522612,TERMINATED,INTERVENTIONAL,poor accrual
NCT01522677,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01522716,TERMINATED,INTERVENTIONAL,New requirements for study approval with the Swedish Medical Products Agency
NCT01523158,TERMINATED,INTERVENTIONAL,R and D approval not forthcoming
NCT01523275,TERMINATED,INTERVENTIONAL,"Due to poor patient accrual, the study was closed prior to reaching the desired study size"
NCT01523444,WITHDRAWN,INTERVENTIONAL,Study not funded.
NCT01523548,WITHDRAWN,INTERVENTIONAL,Lack of funding and subject acuity
NCT01523600,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01523639,TERMINATED,INTERVENTIONAL,Prematurely due to slow recruitment (07/08/2013). Newly defined study end=LPLV=05/11/2013. ABCSG guaranteed completed treatment period for ethical reasons.
NCT01524185,WITHDRAWN,INTERVENTIONAL,There were not enough eligible families and trained clinicians to conduct RCT.
NCT01524575,WITHDRAWN,INTERVENTIONAL,the trial was never opened and then withdrawn permanently
NCT01524887,TERMINATED,INTERVENTIONAL,The study was terminated because the first Phase 3 did not demonstrate efficacy on the co-primary endpoints. The known safety profile remained unchanged.
NCT01525069,TERMINATED,INTERVENTIONAL,Equipment that was used in the study was discontinued
NCT01525225,TERMINATED,INTERVENTIONAL,Release of Post Marketing Requirement for this study. Terminated November 2013.
NCT01525329,TERMINATED,INTERVENTIONAL,study drug no longer available in the United States
NCT01525446,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01525498,WITHDRAWN,OBSERVATIONAL,No subject accrual
NCT01525706,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01525745,TERMINATED,INTERVENTIONAL,Local IRB decision due to poor accrual
NCT01525927,TERMINATED,INTERVENTIONAL,Principal Investigator left institution. IRB approval lapsed.
NCT01526018,TERMINATED,OBSERVATIONAL,Inadequate recruitment
NCT01526109,WITHDRAWN,INTERVENTIONAL,The study was finished since the University has been closed
NCT01526148,TERMINATED,INTERVENTIONAL,Ran out of funding
NCT01526174,TERMINATED,INTERVENTIONAL,House Research no longer conducting research.
NCT01526408,TERMINATED,INTERVENTIONAL,HRI no longer conducting research.
NCT01526590,WITHDRAWN,INTERVENTIONAL,Lack of support
NCT01526785,TERMINATED,INTERVENTIONAL,Terminated due to approved label expansion
NCT01526837,TERMINATED,INTERVENTIONAL,Investigators decision
NCT01526876,WITHDRAWN,INTERVENTIONAL,Terminated by Sponsor
NCT01527019,WITHDRAWN,INTERVENTIONAL,the company suspended the persecution of this combination
NCT01527097,WITHDRAWN,INTERVENTIONAL,We strongly feel that the ability to recruit the required number of patients is very low and thus decided to stop the study.
NCT01527292,TERMINATED,INTERVENTIONAL,Unable to enroll
NCT01527747,SUSPENDED,INTERVENTIONAL,Funding
NCT01527942,TERMINATED,INTERVENTIONAL,Study Terminated per Principal Investigator's request
NCT01528072,TERMINATED,INTERVENTIONAL,Terminated at request of FDA
NCT01528137,TERMINATED,INTERVENTIONAL,Negative data from another trial led to termination of this trial by sponsor.
NCT01528293,TERMINATED,INTERVENTIONAL,slow recruitment - unable to meet enrollment goals
NCT01528345,TERMINATED,INTERVENTIONAL,Slow and low enrollment
NCT01528501,TERMINATED,INTERVENTIONAL,medical/ethical reasons
NCT01528670,WITHDRAWN,OBSERVATIONAL,Administrative barriers
NCT01528696,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT01528865,WITHDRAWN,INTERVENTIONAL,Funding was removed.
NCT01528930,WITHDRAWN,INTERVENTIONAL,"Although this study was approved at the Institutional Review Board, Korea Food \& Drug Administration (KFDA) did not approve this study due to safety concern."
NCT01529008,TERMINATED,INTERVENTIONAL,the interim results suggest that it is unlikely that the primary objective will be achieved at the final analysis
NCT01529242,TERMINATED,INTERVENTIONAL,By sponsor decision due to difficulty of recruitment
NCT01530074,TERMINATED,INTERVENTIONAL,we have not succeeded in recruiting patients
NCT01530087,TERMINATED,INTERVENTIONAL,Inability of site to recruit/enroll target population
NCT01530191,WITHDRAWN,OBSERVATIONAL,No subject accrual
NCT01530256,TERMINATED,INTERVENTIONAL,The trial was terminated in line with the endpoint committee charter.
NCT01530347,TERMINATED,INTERVENTIONAL,Per sponsor decision to stop the development of the study device
NCT01530399,TERMINATED,INTERVENTIONAL,Safety
NCT01530425,TERMINATED,OBSERVATIONAL,sufficient info
NCT01530451,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT01530477,TERMINATED,INTERVENTIONAL,Early termination due to inability to meet enrollment for \>350lb weight class
NCT01530880,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01530984,WITHDRAWN,INTERVENTIONAL,Unable to execute contract
NCT01531205,TERMINATED,INTERVENTIONAL,low accrual
NCT01531387,TERMINATED,INTERVENTIONAL,inability to reach a satisfactory endpoint with respect to adequate recruitment
NCT01531517,TERMINATED,INTERVENTIONAL,inability to recruit patients
NCT01531686,TERMINATED,OBSERVATIONAL,Slow rate of enrollment
NCT01531712,TERMINATED,INTERVENTIONAL,Due to a low recruitment rate since start of recruitment period.
NCT01531764,TERMINATED,INTERVENTIONAL,The recruitment was discontinued because of failure to meet expected enrolment goals
NCT01531803,TERMINATED,INTERVENTIONAL,"Per FDA CBER letter dated July 15, 2015, Kedrion SpA was released from the PMC to perform the study with Kedbumin 25% in pediatric patients."
NCT01532076,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01532154,TERMINATED,OBSERVATIONAL,"Due to low enrollment, registration closed in agreement with the Regulatory Agency"
NCT01532206,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01532232,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT01532245,WITHDRAWN,INTERVENTIONAL,No participants
NCT01532258,WITHDRAWN,INTERVENTIONAL,Online program required re-design
NCT01532362,TERMINATED,INTERVENTIONAL,Drug sponsor stopped drug manufacture due to toxicity issues from other studies
NCT01532453,TERMINATED,INTERVENTIONAL,"For futility reasons and potential ""loss of chance"" for MD 3511356 group"
NCT01532544,TERMINATED,INTERVENTIONAL,"Difficulty recruiting patients, company closed down"
NCT01532635,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01532765,TERMINATED,INTERVENTIONAL,Resident Project which was not followed through after graduation
NCT01532804,TERMINATED,INTERVENTIONAL,too slow recruiting
NCT01532908,TERMINATED,INTERVENTIONAL,The study was terminated due to funding constraints
NCT01532960,TERMINATED,INTERVENTIONAL,"Futility for immune responses to the vaccine. Also, a component of study drug was in short supply."
NCT01533545,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01533714,TERMINATED,INTERVENTIONAL,Decision to out-license the compound for further development
NCT01533727,WITHDRAWN,INTERVENTIONAL,"Few patients would like to participate ,since CIK cell transfusion was a new treatment and its efficacy was doubted."
NCT01533753,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01533818,TERMINATED,INTERVENTIONAL,The study was stopped by DSMB based on high treatment failure rate in placebo compared to active drug.
NCT01533844,TERMINATED,OBSERVATIONAL,Terminated due to the fact that the required number of trial subjects was not met.
NCT01533948,TERMINATED,INTERVENTIONAL,low accrual
NCT01534091,TERMINATED,INTERVENTIONAL,Lack of cooperation by the participants
NCT01534143,TERMINATED,INTERVENTIONAL,"Data was not collected, because funding was unavailable to continue study."
NCT01534286,TERMINATED,INTERVENTIONAL,Unable to recruit patients
NCT01534351,TERMINATED,INTERVENTIONAL,Business Reasons
NCT01534455,TERMINATED,INTERVENTIONAL,very slow patient recruitment and concerns about the actuality of the study design
NCT01534676,TERMINATED,INTERVENTIONAL,"Difficulty recruiting donors and recipients, looking for alternative sites"
NCT01534806,WITHDRAWN,INTERVENTIONAL,Drug is backordered;
NCT01535092,TERMINATED,INTERVENTIONAL,when realized that the target 60% of patients with SVR was no more achievable
NCT01535157,TERMINATED,INTERVENTIONAL,drug combination not providing any efficacy. Will use this data in opening new trial
NCT01535196,TERMINATED,INTERVENTIONAL,financial reasons / insufficient enrollment activity
NCT01535404,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01535456,TERMINATED,INTERVENTIONAL,funding
NCT01535755,TERMINATED,INTERVENTIONAL,Enough patients has been enrolled.
NCT01535781,TERMINATED,INTERVENTIONAL,Recruiting slower than expected.
NCT01535937,TERMINATED,INTERVENTIONAL,An analysis demonstrated that running the final participants was unnecessary.
NCT01536015,TERMINATED,INTERVENTIONAL,The study was stopped due to low enrollment.
NCT01536067,TERMINATED,INTERVENTIONAL,funding was withdrawn
NCT01536327,WITHDRAWN,OBSERVATIONAL,Transitioned to BioMetabol
NCT01536483,TERMINATED,INTERVENTIONAL,The second intermediary analysis showed no significant difference between both arms
NCT01536782,TERMINATED,INTERVENTIONAL,PI left the company
NCT01537094,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding to initiate the study. No subjects were enrolled.
NCT01537315,TERMINATED,INTERVENTIONAL,lack of funding
NCT01537341,WITHDRAWN,INTERVENTIONAL,Funding was not received for this study.
NCT01537354,WITHDRAWN,INTERVENTIONAL,Sponsor discontinued clinical trial before enrollment of subjects.
NCT01537861,TERMINATED,INTERVENTIONAL,Unexpected toxicity (2 early deaths)
NCT01538004,WITHDRAWN,OBSERVATIONAL,Not funded
NCT01538251,TERMINATED,INTERVENTIONAL,Evidence of very low probability to success. No safety issues.
NCT01538901,TERMINATED,INTERVENTIONAL,prolonged recruitment phase
NCT01538966,TERMINATED,INTERVENTIONAL,Review of the 12-month data showed patients who deviated from protocol with full IRB monitoring and reporting could not be optimally analyzed. Reopening the study for new enrollment is not feasible and the study was terminated with IRB approval.
NCT01538992,WITHDRAWN,INTERVENTIONAL,we could not fined enough patients for the study
NCT01539018,TERMINATED,INTERVENTIONAL,After interim results data showed no evidence of a difference between both groups
NCT01539161,TERMINATED,INTERVENTIONAL,Extremely low enrollment rate
NCT01539174,WITHDRAWN,INTERVENTIONAL,No Funding Source and Competing Trials
NCT01539187,TERMINATED,INTERVENTIONAL,Investigational device changes
NCT01539811,TERMINATED,INTERVENTIONAL,Principal investigator decided to terminate the study.
NCT01539876,WITHDRAWN,INTERVENTIONAL,Disease Site Team changed research focus unlikely to have sufficient support to complete study
NCT01539954,WITHDRAWN,OBSERVATIONAL,The project was not funded.
NCT01540227,TERMINATED,OBSERVATIONAL,Low enrollment.
NCT01540279,TERMINATED,OBSERVATIONAL,insufficient enrollment
NCT01540344,TERMINATED,INTERVENTIONAL,Slow recruitment.
NCT01540435,WITHDRAWN,INTERVENTIONAL,insufficient recruitment
NCT01540669,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01540786,TERMINATED,INTERVENTIONAL,It was decided to discontinue the study due to insufficient recruitment
NCT01540981,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01541072,TERMINATED,INTERVENTIONAL,Number of enrolled patients was insufficient during planned inclusion time.
NCT01541202,TERMINATED,INTERVENTIONAL,Sponsor has designed another study to replace the current study
NCT01541358,TERMINATED,INTERVENTIONAL,Low accrual and no funding
NCT01541527,WITHDRAWN,OBSERVATIONAL,Promoter's change
NCT01541722,TERMINATED,OBSERVATIONAL,DSMB suggested closure due to low enrollment
NCT01541813,TERMINATED,OBSERVATIONAL,rare overload and low recruitment
NCT01541904,WITHDRAWN,INTERVENTIONAL,Reformulation
NCT01542047,TERMINATED,INTERVENTIONAL,Low rate of accrual
NCT01542203,WITHDRAWN,OBSERVATIONAL,study is classified as ancillary / correlative
NCT01542216,WITHDRAWN,INTERVENTIONAL,Recruitment challenges
NCT01542242,TERMINATED,INTERVENTIONAL,Subject withdrew
NCT01542255,TERMINATED,INTERVENTIONAL,Low accrual not allowing to support statistical endpoints
NCT01542372,TERMINATED,INTERVENTIONAL,Inadequate flow of patients
NCT01542606,WITHDRAWN,INTERVENTIONAL,Internal decision of the sponsor
NCT01542684,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01542827,TERMINATED,INTERVENTIONAL,Lack of resources to perform the study
NCT01542853,SUSPENDED,OBSERVATIONAL,problems with recruitment and funding
NCT01542983,WITHDRAWN,INTERVENTIONAL,Study never funded
NCT01543009,SUSPENDED,INTERVENTIONAL,Difficulty in recruiting
NCT01543048,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT01543074,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01543126,TERMINATED,OBSERVATIONAL,it's too slow to enroll suitable patients into this study
NCT01543139,WITHDRAWN,INTERVENTIONAL,The research project has been cancelled before any participants were enrolled.
NCT01543204,TERMINATED,INTERVENTIONAL,Business decision due to slow enrollment
NCT01543230,TERMINATED,INTERVENTIONAL,Sponsor withdrew PMA
NCT01543269,TERMINATED,INTERVENTIONAL,Safety concerns
NCT01543347,WITHDRAWN,INTERVENTIONAL,No patient has been included in 9 months because of strict incl/excl criteria
NCT01543464,TERMINATED,INTERVENTIONAL,Diminished rectruitment
NCT01543607,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01543724,WITHDRAWN,INTERVENTIONAL,The research project has been cancelled before any participants were enrolled.
NCT01543737,TERMINATED,INTERVENTIONAL,post transfer of company ownership from Smith \& Nephew to Bioventus LLC
NCT01543802,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01544244,TERMINATED,INTERVENTIONAL,Inclusion curve too slow.
NCT01544452,TERMINATED,INTERVENTIONAL,Lack of MR scanning capacity
NCT01544465,TERMINATED,INTERVENTIONAL,"Difficulty recruiting, funding lapsed"
NCT01544504,WITHDRAWN,INTERVENTIONAL,The principal investigator withdrew from the study. The study was withdrawn because a qualified replacement was not available.
NCT01544530,TERMINATED,INTERVENTIONAL,Lack of funding and other logistic reasons
NCT01544842,TERMINATED,INTERVENTIONAL,Lack of resources
NCT01545050,TERMINATED,INTERVENTIONAL,due to sponsor decision
NCT01545427,TERMINATED,INTERVENTIONAL,Frequent adverse events occurred early in treatment with poor tolerability.
NCT01545518,TERMINATED,INTERVENTIONAL,"Futility criteria, unable for Phase 2 of study, \& phase 1 was terminated."
NCT01545635,TERMINATED,INTERVENTIONAL,The Interim analysis (100 patients) revealed a possible harm to patients randomised to the fresh frozen plasma (FFP) treatment arm.
NCT01545648,TERMINATED,INTERVENTIONAL,Low Accrual
NCT01545674,TERMINATED,OBSERVATIONAL,"Non-invasive Prenatal Screening CLIA test performance validated in other cohort. Decided samples not required, study aims achieved through other studies."
NCT01545817,TERMINATED,INTERVENTIONAL,"As the therapeutic landscape in renal cell carcinoma is changing, it has become apparent that information gained so far by CATChEz study is sufficient."
NCT01545882,TERMINATED,INTERVENTIONAL,Negative study; Principal Investigator chose to prematurely terminate the study.
NCT01545921,TERMINATED,INTERVENTIONAL,End of inclusions without reaching the expected number of patients
NCT01545960,SUSPENDED,OBSERVATIONAL,Adjusting minor software glitches
NCT01545973,SUSPENDED,OBSERVATIONAL,Repair of minor software glitches
NCT01546012,WITHDRAWN,INTERVENTIONAL,Too difficult to select patient according to the investigator
NCT01546168,TERMINATED,INTERVENTIONAL,Interim analysis: no statistically significant difference in the 2 study arms.
NCT01546207,TERMINATED,INTERVENTIONAL,low enrollment
NCT01546350,SUSPENDED,INTERVENTIONAL,not enough patients recruited on time
NCT01546571,TERMINATED,INTERVENTIONAL,"Planned interim analysis showed a strong signal of efficacy in a pre-specified patient population. Fast track designation was granted and a new, redesigned pivotal trial will be conducted."
NCT01546857,TERMINATED,INTERVENTIONAL,No longer able to recruit subjects due to unavailability of orthopedic surgeon.
NCT01546870,WITHDRAWN,OBSERVATIONAL,never approved by IRB
NCT01546883,TERMINATED,INTERVENTIONAL,Not enough patients in time period allotted for study
NCT01546935,WITHDRAWN,INTERVENTIONAL,Study drugs (Oseltamivir suspension from Roche) were unavailable
NCT01547065,TERMINATED,OBSERVATIONAL,Enrollment lower than anticipated
NCT01547143,TERMINATED,INTERVENTIONAL,"The PI resigned the institute, and the rest investigators at the institute decided to terminate the study."
NCT01547390,TERMINATED,INTERVENTIONAL,Terminated after Aspirin was recommended by the USPTF to Prevent Preeclampsia.
NCT01547403,WITHDRAWN,OBSERVATIONAL,Protocol no longer meeting sponsor objectives
NCT01547468,WITHDRAWN,INTERVENTIONAL,inactivity and unable to complete due to manpower issues
NCT01547676,TERMINATED,INTERVENTIONAL,P.I. decided to terminate study due to multiple unresolved issues
NCT01547728,TERMINATED,INTERVENTIONAL,Too many barriers to enroll participants.
NCT01547923,TERMINATED,INTERVENTIONAL,The study stopped due to a death in the arm control
NCT01548144,TERMINATED,INTERVENTIONAL,PI request
NCT01548339,TERMINATED,INTERVENTIONAL,Intermediary analysis showing increased morbidity in the delayed group
NCT01548534,TERMINATED,INTERVENTIONAL,Judicial liquidation of the society providing dietary supplementation.
NCT01548573,TERMINATED,INTERVENTIONAL,Met study stopping rules
NCT01548651,TERMINATED,INTERVENTIONAL,difficulty with enrollment of subjects
NCT01548846,TERMINATED,INTERVENTIONAL,lack of recrutment
NCT01548924,TERMINATED,INTERVENTIONAL,Drug toxicity
NCT01549158,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01549379,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT01549392,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT01549496,WITHDRAWN,INTERVENTIONAL,Investigator left this hospital
NCT01549769,TERMINATED,INTERVENTIONAL,IDMC recommendation for safety concerns
NCT01549847,WITHDRAWN,INTERVENTIONAL,Study was not approved by Health Surveillance Agency
NCT01549886,TERMINATED,INTERVENTIONAL,Due to business reasons.
NCT01549964,TERMINATED,INTERVENTIONAL,Due to concerns about potential liver safety (See Detailed Description)
NCT01549977,TERMINATED,INTERVENTIONAL,Business Decision (please see below)
NCT01550185,TERMINATED,INTERVENTIONAL,Sponsor wanted study rewritten
NCT01550198,TERMINATED,OBSERVATIONAL,Problems with availability of cardiac output monitoring system
NCT01550302,TERMINATED,INTERVENTIONAL,Unable to continue enrollment due to lack of resources (research coordinator no longer available).
NCT01550328,TERMINATED,OBSERVATIONAL,Protocol no longer meets sponsor objectives
NCT01550510,TERMINATED,INTERVENTIONAL,"Closed: low enrollment, many treatment options available for Colorectal Cancer"
NCT01550562,TERMINATED,INTERVENTIONAL,In \>9 months only 1 patient enrolled. Study stopped because design was too cumbersome and subjects not willing to participate
NCT01550705,TERMINATED,INTERVENTIONAL,Interim analysis demonstrated the treatment was not effective
NCT01550861,TERMINATED,INTERVENTIONAL,Low accrual
NCT01551043,TERMINATED,INTERVENTIONAL,Administrative Reasons
NCT01551082,TERMINATED,OBSERVATIONAL,Poor accrual
NCT01551095,TERMINATED,INTERVENTIONAL,Proof of principle was achieved after inclusion of 7 patients
NCT01551134,TERMINATED,INTERVENTIONAL,Fewer patients than anticipated were referred
NCT01551368,TERMINATED,INTERVENTIONAL,small number of patients got recruited
NCT01551381,TERMINATED,INTERVENTIONAL,Interim review indicated that the dose selected was too high for diabetics
NCT01551407,TERMINATED,INTERVENTIONAL,slow inclusion rate
NCT01551446,WITHDRAWN,INTERVENTIONAL,IDMC recommendation for safety concerns
NCT01551472,TERMINATED,OBSERVATIONAL,Lack of sufficient enrollment
NCT01551537,WITHDRAWN,OBSERVATIONAL,Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it was concluded GSK will submit local PSURs
NCT01551628,TERMINATED,INTERVENTIONAL,slow patient recruitment
NCT01551680,TERMINATED,INTERVENTIONAL,end of study of this product
NCT01551693,TERMINATED,INTERVENTIONAL,due to weak accrual
NCT01552421,TERMINATED,INTERVENTIONAL,For logistic reasons in the department and due to very low inclusion rates.
NCT01552577,TERMINATED,OBSERVATIONAL,Expiration of funding
NCT01552616,TERMINATED,INTERVENTIONAL,Enrollment
NCT01552668,WITHDRAWN,INTERVENTIONAL,Study not performed
NCT01552681,TERMINATED,INTERVENTIONAL,"Expired experimental study agent, no additional supply available."
NCT01552993,TERMINATED,INTERVENTIONAL,the chosen intervention was obviously ineffective
NCT01553071,TERMINATED,INTERVENTIONAL,drug supply issues during COVID-19
NCT01553240,TERMINATED,INTERVENTIONAL,Principal Investigator (Dr. Sporn) left the sponsoring institution.
NCT01553487,WITHDRAWN,INTERVENTIONAL,We did not found voluntary subjects
NCT01553630,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT01554020,WITHDRAWN,INTERVENTIONAL,Change of CRO
NCT01554085,TERMINATED,INTERVENTIONAL,ALS-2158 showed insufficient antiviral activity to warrant proceeding with further clinical development.
NCT01554176,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT01554254,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01554306,TERMINATED,OBSERVATIONAL,difficulty to include enough subjects
NCT01554488,TERMINATED,INTERVENTIONAL,Low subject accrual
NCT01554644,WITHDRAWN,INTERVENTIONAL,Lack of Enrollment
NCT01555021,TERMINATED,OBSERVATIONAL,"The study was an inpatient, but PI left inpatient at MGH on July 1, 2012"
NCT01555073,TERMINATED,INTERVENTIONAL,Subjects did not meet inclusion criteria
NCT01555216,WITHDRAWN,INTERVENTIONAL,Lack of participant recruitment
NCT01555229,TERMINATED,INTERVENTIONAL,Enrolment difficulties
NCT01555281,TERMINATED,INTERVENTIONAL,"In connection with the restructuring of SAKK, older ongoing studies were analyzed to determine whether a continuation of the trial would still add value to the data analysis, or whether they do not and could therefore be prematurely terminated."
NCT01555489,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01555515,TERMINATED,INTERVENTIONAL,New protocol to start with improved product
NCT01555554,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goals.
NCT01555632,WITHDRAWN,INTERVENTIONAL,Other more favorable treatments are now available.
NCT01555723,WITHDRAWN,OBSERVATIONAL,New study created.
NCT01555853,TERMINATED,INTERVENTIONAL,"completed accrual to phase I but drug did not show activity, so halted before initiation of phase II"
NCT01555905,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01556152,WITHDRAWN,INTERVENTIONAL,"Due to new scientific evidence assessment, the study design was revised before the study started recruitment"
NCT01556334,WITHDRAWN,INTERVENTIONAL,Terminated before starting due to need for IND determined by FDA.
NCT01556347,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01556464,WITHDRAWN,INTERVENTIONAL,Difficulty with enrollment.
NCT01556568,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to scientific and business considerations.
NCT01556958,TERMINATED,OBSERVATIONAL,Device revised
NCT01557023,WITHDRAWN,INTERVENTIONAL,Change Company strategy
NCT01557114,TERMINATED,INTERVENTIONAL,"New compounds available in the indication (nivolumab/pembrolizumab), toxicity of ipilimumab"
NCT01557192,SUSPENDED,INTERVENTIONAL,on hold indefinitely due to lack of funding
NCT01557452,TERMINATED,INTERVENTIONAL,Previous study DSC/08/2357/36 did not show efficacy for Givinostat in JIA. Sponsor decision to stop development of Givinostat in polyarticular course Juvenile Idiopathic Arthritis wasn't related to any tolerability concerns.
NCT01557881,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT01557933,WITHDRAWN,OBSERVATIONAL,"Due to a lack of participants, this study has been closed."
NCT01558011,TERMINATED,INTERVENTIONAL,The budget issues.
NCT01558115,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01558128,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT01558232,TERMINATED,INTERVENTIONAL,Study was terminated base on Sponsor's decision.
NCT01558492,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01558531,SUSPENDED,OBSERVATIONAL,slow enrollment
NCT01558635,TERMINATED,INTERVENTIONAL,Prematurely closed due to ongoing challenging enrollment requirements.
NCT01558674,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01558687,TERMINATED,INTERVENTIONAL,Discontinuation of development program
NCT01558778,WITHDRAWN,INTERVENTIONAL,device not available
NCT01558882,TERMINATED,OBSERVATIONAL,Trouble with recruting
NCT01558960,TERMINATED,INTERVENTIONAL,Sufficient findings to draw conclusions
NCT01559051,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT01559129,TERMINATED,INTERVENTIONAL,Enrollment was stopped early (see limitations and caveats section).
NCT01559155,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT01559350,TERMINATED,OBSERVATIONAL,Poor recruiting rate
NCT01559818,TERMINATED,INTERVENTIONAL,"Sponsor considered no further meaningful data was being collected, nor were likely to be collected in the future."
NCT01559974,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01560091,WITHDRAWN,INTERVENTIONAL,accrual of subjects did not occur as anticipated
NCT01560273,TERMINATED,OBSERVATIONAL,Will answer study question through other research means.
NCT01560312,TERMINATED,INTERVENTIONAL,"Based on analysis of our data after the Symplicity-3 trial announcement, decision for study termination was done."
NCT01560468,TERMINATED,INTERVENTIONAL,Financial Reasons
NCT01560507,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT01560585,TERMINATED,INTERVENTIONAL,Adverse events in 2/3 participants; study was halted but not restarted after this due to insufficnet funds as well
NCT01560962,TERMINATED,INTERVENTIONAL,research staffs unable to continue.
NCT01561092,WITHDRAWN,INTERVENTIONAL,Study medication could not be supplied. An alternative project will be conducted
NCT01561404,TERMINATED,INTERVENTIONAL,lack of potential patients
NCT01561430,TERMINATED,INTERVENTIONAL,Study terminated due to abnormal liver biochemical tests in some participants.
NCT01561482,WITHDRAWN,INTERVENTIONAL,Study closed due to slow/low enrollment; no subjects were enrolled.
NCT01561495,TERMINATED,INTERVENTIONAL,Sponsor Request- Global low enrollment
NCT01561508,WITHDRAWN,INTERVENTIONAL,Unable to obtain IND currently
NCT01561755,TERMINATED,INTERVENTIONAL,Difficulty with enrollment
NCT01561989,TERMINATED,INTERVENTIONAL,low accrual
NCT01562093,TERMINATED,INTERVENTIONAL,Investigational drugs no longer available
NCT01562132,TERMINATED,INTERVENTIONAL,Stopped in accordance with pre-specified stopping rules for poor recruitment.
NCT01562522,TERMINATED,INTERVENTIONAL,Poor enrolment; only 6 subjects enrolled and they were all screen failures.
NCT01562769,TERMINATED,OBSERVATIONAL,enrollment difficulties
NCT01562873,TERMINATED,INTERVENTIONAL,Not enough responses to continue treatment.
NCT01562899,TERMINATED,INTERVENTIONAL,Study was withdrawn due to scientific and business considerations.
NCT01562951,TERMINATED,INTERVENTIONAL,Not enough patient population according to selection criteria to complete the study
NCT01562964,WITHDRAWN,INTERVENTIONAL,No funding
NCT01563588,TERMINATED,INTERVENTIONAL,Enrollment lasted longer than expected and expected number of patients could not be matched in time.
NCT01563601,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT01563614,TERMINATED,INTERVENTIONAL,No patients can be recruited for this trial anymore due to other therapeutical approaches that became available.
NCT01563640,TERMINATED,INTERVENTIONAL,Insecticidal treatment of school uniforms did not last through a dengue season
NCT01563653,TERMINATED,INTERVENTIONAL,Not enough inclusions.
NCT01563835,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT01563900,WITHDRAWN,INTERVENTIONAL,Was unable to recruit subjects
NCT01563939,TERMINATED,INTERVENTIONAL,Difficult recruitment.
NCT01564095,TERMINATED,INTERVENTIONAL,Missing evidence of the effectiveness of the study medication
NCT01564277,TERMINATED,INTERVENTIONAL,low accrual
NCT01564316,TERMINATED,OBSERVATIONAL,The study has been terminated due to difficulties in gathering the patient samples.
NCT01564407,TERMINATED,INTERVENTIONAL,Study Terminated due to lack of Funding
NCT01564472,WITHDRAWN,OBSERVATIONAL,De-identified PSGs were to be scored by a vendor prior to being sent to the sponsor. Issues occurred with vendor and no PSGs were analyzed by the sponsor.
NCT01564524,TERMINATED,OBSERVATIONAL,Funding ended
NCT01564563,TERMINATED,INTERVENTIONAL,Trial enrollment was prematurely terminated due to excessively slow patient recruitment
NCT01564641,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT01564732,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding.
NCT01565070,WITHDRAWN,INTERVENTIONAL,The local authorities did not authorize the use of biofreeze in Chile.
NCT01565148,TERMINATED,INTERVENTIONAL,Patient's disease progressed and Vision Dropped which led to exit from the study
NCT01565278,TERMINATED,INTERVENTIONAL,No more eligible patients could be identified.
NCT01565395,WITHDRAWN,INTERVENTIONAL,"Could not recruit ALS participants, hence ALS arm discontinued"
NCT01565512,WITHDRAWN,INTERVENTIONAL,"Lack of funding, PI left the institution, poor enrollment"
NCT01565590,TERMINATED,INTERVENTIONAL,"Slow enrollment along with new competing studies, investigators decided to stop study"
NCT01565772,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01565993,TERMINATED,INTERVENTIONAL,The unexpected increase in morbidity of the hemoclip group
NCT01566370,TERMINATED,INTERVENTIONAL,recruitment infeasible
NCT01566383,TERMINATED,INTERVENTIONAL,unable to meet recruitment goals
NCT01566422,WITHDRAWN,INTERVENTIONAL,unable to enroll any participants
NCT01566630,TERMINATED,INTERVENTIONAL,"Novartis terminated this study due to internal, strategic decisions."
NCT01567384,WITHDRAWN,INTERVENTIONAL,The sponsor withdrew support for the study before any patients were enrolled.
NCT01567540,TERMINATED,INTERVENTIONAL,"New treatments available, which prevents additional recruitment."
NCT01567553,TERMINATED,OBSERVATIONAL,"terminated ( Halted prematurely,expiration of investigationnal product)"
NCT01567722,TERMINATED,OBSERVATIONAL,Sponsor directive
NCT01567787,WITHDRAWN,INTERVENTIONAL,Feasibility issues
NCT01567904,TERMINATED,INTERVENTIONAL,Decision from Sanofi to withdraw on a worldwide basis the Marketing Authorisation Applications for Semuloparin sodium in the adult indication
NCT01567956,TERMINATED,INTERVENTIONAL,Evidence of very low probability to success. No safety issues
NCT01568086,TERMINATED,OBSERVATIONAL,The study could not be performed as planned for organizational reasons.
NCT01568203,TERMINATED,INTERVENTIONAL,Amgen decision (business)
NCT01568216,TERMINATED,INTERVENTIONAL,Toxic Epidermal Necrolysis
NCT01568229,TERMINATED,INTERVENTIONAL,Toxic Epidermal Necrolysis
NCT01568346,TERMINATED,INTERVENTIONAL,Slow Accural
NCT01568736,WITHDRAWN,OBSERVATIONAL,never started
NCT01569074,TERMINATED,INTERVENTIONAL,AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.
NCT01569282,WITHDRAWN,INTERVENTIONAL,Difficulties to recruit patients
NCT01569373,WITHDRAWN,OBSERVATIONAL,Resources needed to complete the study were not able to be obtained.
NCT01569477,WITHDRAWN,INTERVENTIONAL,Not able to recruit participants
NCT01569633,WITHDRAWN,INTERVENTIONAL,very poor enrollment
NCT01569698,TERMINATED,OBSERVATIONAL,sponsor and investigator's decision
NCT01569854,WITHDRAWN,OBSERVATIONAL,Insufficient recruitment
NCT01570192,TERMINATED,INTERVENTIONAL,NIAID terminated the study due to low subject enrollment
NCT01570348,TERMINATED,INTERVENTIONAL,Annual accrual goal not met
NCT01570361,TERMINATED,INTERVENTIONAL,"The sponsor decided to terminate the study early due to enrolment not proceeding in accordance with expectations, independently from the study outcome."
NCT01570465,TERMINATED,OBSERVATIONAL,low interest
NCT01570530,TERMINATED,INTERVENTIONAL,End of finantial support
NCT01570543,WITHDRAWN,OBSERVATIONAL,After over a year no subjects were identified
NCT01570634,TERMINATED,INTERVENTIONAL,"Study was stopped for slow enrollment - only 2 patients, no evaluable results"
NCT01570725,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting the selected subjects
NCT01570803,WITHDRAWN,INTERVENTIONAL,Study could not be initiated due to lack of research funding from the sponsors.
NCT01570868,TERMINATED,INTERVENTIONAL,Closed due to slow accrual
NCT01571635,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT01571791,SUSPENDED,INTERVENTIONAL,No enough recruited cases
NCT01571895,TERMINATED,INTERVENTIONAL,Lack of efficacy observed at 1/3 of the enrollment at investigated dosage. No results available.
NCT01572168,TERMINATED,INTERVENTIONAL,slow accrual
NCT01572194,TERMINATED,INTERVENTIONAL,no more recruitment in the centers
NCT01572636,TERMINATED,OBSERVATIONAL,Research Cancelled
NCT01572974,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT01572987,TERMINATED,INTERVENTIONAL,Recruitment goals not being met
NCT01573156,TERMINATED,INTERVENTIONAL,Concerns about post VTP MRI results being conclusive
NCT01573169,TERMINATED,INTERVENTIONAL,The trial has been terminated prematurely after the randomization of 73 patients due to a lack of funding.
NCT01573247,TERMINATED,INTERVENTIONAL,During the study two patients have experienced serious liver events related to AKN-028. The risk-benefit balance was judged to be negative.
NCT01573286,TERMINATED,INTERVENTIONAL,GLP-2 Drug product stability concerns
NCT01573299,TERMINATED,INTERVENTIONAL,The required number of patients was not reached. The sites were not able to include more patients.Despite several actions the stop of the study has been decided
NCT01573390,WITHDRAWN,OBSERVATIONAL,most of the study team left the institution prior to study initiation
NCT01573780,TERMINATED,INTERVENTIONAL,Sponsor did not have funds to continue study
NCT01573806,WITHDRAWN,INTERVENTIONAL,No funding
NCT01573897,TERMINATED,OBSERVATIONAL,Difficulty including subjects corresponding to the criteria.
NCT01573988,TERMINATED,INTERVENTIONAL,Difficulties in recruiting of volunteers with a BMI (Body Mass Index) between 30 and 35 kg/m2
NCT01574014,TERMINATED,INTERVENTIONAL,Recruiting problems
NCT01574118,TERMINATED,INTERVENTIONAL,COVID-19
NCT01574131,TERMINATED,INTERVENTIONAL,lost funding; Shriner Burn Hosp has revoked access to study records. No updates or results can be submitted
NCT01574222,TERMINATED,INTERVENTIONAL,Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)
NCT01574248,TERMINATED,INTERVENTIONAL,DSMC recommended discontinuation for futility and feasibility
NCT01574300,TERMINATED,OBSERVATIONAL,interim assessment by sponsor
NCT01574443,TERMINATED,OBSERVATIONAL,Feasibility issues for subject recruitment and PI left the institution
NCT01574573,TERMINATED,INTERVENTIONAL,Closed due to lack of recruitment
NCT01574599,TERMINATED,INTERVENTIONAL,poor subject recruitment
NCT01574664,WITHDRAWN,OBSERVATIONAL,Not required to be registered
NCT01574872,WITHDRAWN,INTERVENTIONAL,"Changes in the sponsorship, design and locations of the study"
NCT01575015,TERMINATED,INTERVENTIONAL,Insufficient funding.
NCT01575028,TERMINATED,INTERVENTIONAL,The study was allowed to expire due to changes in standard care for the patient population within the NCH institution.
NCT01575275,TERMINATED,INTERVENTIONAL,Drugs unavailable
NCT01575444,TERMINATED,OBSERVATIONAL,Investigator left University No results are possible
NCT01575769,TERMINATED,INTERVENTIONAL,The study was terminated prior to the planned final on-treatment efficacy assessments due to commercial availability of tocilizumab in Russia and Poland.
NCT01575782,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01575899,TERMINATED,INTERVENTIONAL,Early termination due to efficacy
NCT01576042,TERMINATED,INTERVENTIONAL,Main objectives of the study were met; consensus among investigators that continuing the study would not add new information beyond that already learned.
NCT01576146,TERMINATED,INTERVENTIONAL,Study was terminated early to allow subjects to roll over to study NCT02102204.
NCT01576432,TERMINATED,INTERVENTIONAL,The data showed that pain was higher for our standardized method of sampling
NCT01576549,TERMINATED,INTERVENTIONAL,Insufficient efficacy observed in study BCDM(NCT01198002) and BCDV(NCT01202773).
NCT01576679,TERMINATED,INTERVENTIONAL,very slow accrual.
NCT01576757,WITHDRAWN,OBSERVATIONAL,There were no funds for the study.
NCT01576887,WITHDRAWN,INTERVENTIONAL,IDMC recommendation for safety concerns
NCT01577199,WITHDRAWN,INTERVENTIONAL,no subjects recruited
NCT01577212,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01577264,TERMINATED,OBSERVATIONAL,Study is replaced by some Risk Manag. Activities covering the whole Russian Federation. Primary objectives could not be met due to critical missing information.
NCT01577381,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01577524,TERMINATED,INTERVENTIONAL,We had very low recruitment rates that would have resulted in several years being added to the study to achieve an appropriate sample size.
NCT01577576,TERMINATED,OBSERVATIONAL,Inclusion curve too slow.
NCT01577628,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT01577706,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01578291,TERMINATED,INTERVENTIONAL,"Recruitment was not on target, evised AAP guidelines may have contributed to the decrease in the number of potential participants"
NCT01578343,TERMINATED,INTERVENTIONAL,we collected data of a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.
NCT01578551,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01579058,TERMINATED,INTERVENTIONAL,The sponsor discontinued to support the study.
NCT01579136,TERMINATED,INTERVENTIONAL,Lack of subjects
NCT01579279,TERMINATED,INTERVENTIONAL,Study Stopped
NCT01579318,TERMINATED,INTERVENTIONAL,Due to company resource constraints
NCT01579396,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first patient, due to recruiting problems."
NCT01579578,TERMINATED,INTERVENTIONAL,AstraZeneca sponsored trials of AZD8931 have been halted
NCT01579864,TERMINATED,INTERVENTIONAL,recent publication (Ghezel-Ahmadi. Thorac Cardiovasc Surg. 2014 Nov 21)
NCT01579942,TERMINATED,OBSERVATIONAL,The study was ultimately not funded by the sponsor. No subjects were enrolled.
NCT01580215,TERMINATED,OBSERVATIONAL,Inability to reach desired recruitment goal; Sponsor executed other RCTs
NCT01580319,TERMINATED,INTERVENTIONAL,Difficulty in selecting the sample and follow-up lost.
NCT01580618,TERMINATED,INTERVENTIONAL,Unable to accrue patients at a reasonable rate
NCT01580683,WITHDRAWN,INTERVENTIONAL,No funding obtained to support patient recruitment
NCT01580800,TERMINATED,OBSERVATIONAL,"Low enrollment, incomplete participant data, and follow-up information"
NCT01581060,TERMINATED,INTERVENTIONAL,Study terminated for business reasons
NCT01581255,TERMINATED,OBSERVATIONAL,Parent study (OSCILLATE) stopped by the Data Monitoring Committee
NCT01581281,TERMINATED,INTERVENTIONAL,Interim assessment provided sufficient data to answer study questions
NCT01581541,TERMINATED,INTERVENTIONAL,The study closed prematurely due to discontinuation of drug supply.
NCT01581736,TERMINATED,INTERVENTIONAL,PI job change
NCT01581905,TERMINATED,INTERVENTIONAL,Trial was redesigned as a new trial
NCT01582009,TERMINATED,INTERVENTIONAL,"pts off study, PI left institute"
NCT01582048,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01582087,TERMINATED,OBSERVATIONAL,"At the request of the PI, the Collaborating PI left the university"
NCT01582100,TERMINATED,INTERVENTIONAL,study was terminated by investigator due to low enrollment
NCT01582152,TERMINATED,INTERVENTIONAL,Phase 2 part of the trial will no longer continue since the protocol competes with another TPI287 protocol in outside institution supported by the sponsor.
NCT01582282,TERMINATED,INTERVENTIONAL,due to slow enrollment
NCT01582568,TERMINATED,OBSERVATIONAL,Not enough subjects to reach accrual goals.
NCT01582594,TERMINATED,OBSERVATIONAL,Sponsor's decision
NCT01582620,TERMINATED,INTERVENTIONAL,"Principal investigator moved, and the study should have been taken out of UNN Clincaltrial.gov account 5-6 years back in time."
NCT01582646,TERMINATED,INTERVENTIONAL,difficulty of recruitment
NCT01582672,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01582685,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT01583062,TERMINATED,INTERVENTIONAL,Limited number of patients
NCT01583088,TERMINATED,INTERVENTIONAL,in the absence of benefits and because of a statistically significant excess mortality in the group of patients receiving active stimulation.
NCT01583114,TERMINATED,INTERVENTIONAL,recruitement problem
NCT01583179,TERMINATED,INTERVENTIONAL,The study was closed prematurely due to low enrollment and anticipation of future barriers in enrollment
NCT01583205,WITHDRAWN,INTERVENTIONAL,The study was not funded.
NCT01583439,TERMINATED,INTERVENTIONAL,Low Accrual.
NCT01583647,TERMINATED,INTERVENTIONAL,"In HPS2-THRIVE, MK-0524A did not meet the primary efficacy objective and there was a significant increase in incidence of some types of non-fatal SAEs."
NCT01583686,TERMINATED,INTERVENTIONAL,Study terminated due to slow/insufficient accrual.
NCT01583842,TERMINATED,INTERVENTIONAL,Funding
NCT01583881,TERMINATED,INTERVENTIONAL,Slow inclusion
NCT01583998,WITHDRAWN,INTERVENTIONAL,UTSW Family Medicine refused to comply with agreement to implement study after department head left university. Attempts to implement elsewhere failed.
NCT01584193,WITHDRAWN,INTERVENTIONAL,Logistical reasons (institutional reorganization of ambulatory surgery)
NCT01584245,TERMINATED,INTERVENTIONAL,Enough participants enrolled to provide adequate statistical power
NCT01584297,TERMINATED,INTERVENTIONAL,Insufficient recruitment rate
NCT01584362,WITHDRAWN,INTERVENTIONAL,study conducted under Clinical Trials Agreement as NIAID registration NCT02234570
NCT01584375,TERMINATED,INTERVENTIONAL,Due to low patient recruitment
NCT01584752,TERMINATED,OBSERVATIONAL,Recruitment not satisfactory
NCT01584934,WITHDRAWN,INTERVENTIONAL,incompatibilities over intellectual property
NCT01584947,TERMINATED,INTERVENTIONAL,Because of a very slow patient recruitment.
NCT01585103,TERMINATED,INTERVENTIONAL,Device was recalled by company
NCT01585129,TERMINATED,INTERVENTIONAL,Futility in patient enrollment
NCT01585441,TERMINATED,INTERVENTIONAL,This study was terminated early due to lack of enrollment.
NCT01585688,TERMINATED,INTERVENTIONAL,"Study was terminated due to lack of efficacy, as a result, the stability program for the drug product was discontinued"
NCT01586026,TERMINATED,OBSERVATIONAL,Insufficient number of adverse events
NCT01586182,WITHDRAWN,INTERVENTIONAL,Local IRB closed the study due to poor accural.
NCT01586195,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT01586286,WITHDRAWN,INTERVENTIONAL,No patients were recruited over a 12 month period
NCT01586325,TERMINATED,INTERVENTIONAL,"Because of many competing trials using the same mechanism of action, but being further advanced in development"
NCT01586546,TERMINATED,INTERVENTIONAL,"Encountered significant recruitment challenges, and it was decided to terminate the study without recruiting participants."
NCT01586728,TERMINATED,INTERVENTIONAL,lack of inclusion in the study
NCT01586858,TERMINATED,OBSERVATIONAL,Loss of Funding
NCT01587053,TERMINATED,OBSERVATIONAL,Difficulty recruiting
NCT01587144,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT01587222,WITHDRAWN,INTERVENTIONAL,the sponsor did not provide the treatment
NCT01587261,WITHDRAWN,INTERVENTIONAL,This potential study was held up at the level of the FDA as they wouldn't approve and IND for the dose of vitamin C we wanted to use.
NCT01587495,TERMINATED,INTERVENTIONAL,study terminated due to low subject accrual
NCT01587508,WITHDRAWN,INTERVENTIONAL,The comparator product was withdrawn from the brazilian market not being possible to conduct the design regarding initially planned.
NCT01587547,TERMINATED,OBSERVATIONAL,ORIGIO a/s acquired by Cooper Surgical Inc. who decided to withdraw from the project
NCT01587664,TERMINATED,INTERVENTIONAL,Due to lack of recruitment and loss of the French principal investigator.
NCT01587820,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01587872,TERMINATED,INTERVENTIONAL,"Slow patient recruitment, not enough patients willing to participate within the prespecified time frame."
NCT01587963,TERMINATED,INTERVENTIONAL,PI's add. responsibilities and time commitment prevent him from completing trial
NCT01588158,TERMINATED,INTERVENTIONAL,The PI of this study is leaving the institution and enrollment was progressing slowly so we decided to close the study.
NCT01588249,TERMINATED,INTERVENTIONAL,Revisiting product options
NCT01588314,WITHDRAWN,INTERVENTIONAL,No patients were enrolled. No data \& no study results to report.
NCT01588340,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT01588717,TERMINATED,INTERVENTIONAL,PI left institution
NCT01588951,TERMINATED,INTERVENTIONAL,Low accrual
NCT01589029,TERMINATED,INTERVENTIONAL,The results of the interim analysis showed that the primary endpoint was not met
NCT01589055,WITHDRAWN,INTERVENTIONAL,No subjects were ever enrolled; study not initiated
NCT01589068,WITHDRAWN,INTERVENTIONAL,Clinical studies never started; funds never received.
NCT01589081,WITHDRAWN,INTERVENTIONAL,Clinical studies never started; funding not received.
NCT01589211,TERMINATED,INTERVENTIONAL,Necessary number of participants not achieved and high drop out rate
NCT01589237,TERMINATED,INTERVENTIONAL,Interim analysis suggested that size of benefit anticipated from continued participation of patients in Part B no longer supported trial extension beyond Part A
NCT01589679,TERMINATED,INTERVENTIONAL,Unrelated to Trial
NCT01589705,TERMINATED,OBSERVATIONAL,Patients recruitment and analysis were terminated
NCT01589718,WITHDRAWN,INTERVENTIONAL,No patients were enrolled
NCT01589744,TERMINATED,INTERVENTIONAL,Non adequation between the medical device and the study population
NCT01589861,SUSPENDED,INTERVENTIONAL,Data analysis
NCT01589926,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01590082,TERMINATED,INTERVENTIONAL,Accrual slow due to alternate trials and treatment options.
NCT01590342,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT01590394,TERMINATED,INTERVENTIONAL,Difficulty in enrolling subjects and transporting scope for sterilization
NCT01590979,TERMINATED,INTERVENTIONAL,The study was terminated due to slow rate of accrual resulting in a sample size.
NCT01591096,TERMINATED,INTERVENTIONAL,Lack of patient accrual
NCT01591265,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01591291,WITHDRAWN,INTERVENTIONAL,Grant was transferred to University of Maryland and results were reported under NCT02354703.
NCT01591343,TERMINATED,INTERVENTIONAL,Study halted by Sponsor
NCT01591473,TERMINATED,INTERVENTIONAL,The CDC indicated nasal spray flu vaccine should not be used during 2016-2017
NCT01591512,TERMINATED,OBSERVATIONAL,Decision was made by Sponsor to stop the trial.
NCT01591759,WITHDRAWN,INTERVENTIONAL,Our citicoline supply expired and the exact product has discontinued.
NCT01591954,TERMINATED,INTERVENTIONAL,3rd party proprietary software issue
NCT01591980,WITHDRAWN,INTERVENTIONAL,Pfizer Canada and the SMH ORA could not come into an agreement on responsibility to be the Importer of Record for the trial.
NCT01592006,TERMINATED,INTERVENTIONAL,Low accrual
NCT01592201,TERMINATED,INTERVENTIONAL,This study was early terminated due to insufficient enrollment required for hypothesis testing.
NCT01592487,WITHDRAWN,OBSERVATIONAL,"Study never started, and there are no plans to initiate."
NCT01592630,WITHDRAWN,INTERVENTIONAL,Investigator Left Institution
NCT01592656,TERMINATED,INTERVENTIONAL,Lack of budget
NCT01592773,TERMINATED,INTERVENTIONAL,Terminated because primary efficacy parameter failed to demonstrate statistically significant difference between memantine and placebo in controlled trials
NCT01593059,TERMINATED,OBSERVATIONAL,low enrollment
NCT01593072,WITHDRAWN,INTERVENTIONAL,Terminated for convenience of the Government due to funding constraits
NCT01593137,WITHDRAWN,INTERVENTIONAL,Lack of patients with the criteria established in the protocol.
NCT01593384,WITHDRAWN,OBSERVATIONAL,Funding unavailable
NCT01593579,WITHDRAWN,OBSERVATIONAL,Planned parent study never enrolled
NCT01594021,TERMINATED,INTERVENTIONAL,Difficulty of realization of the study
NCT01594372,TERMINATED,INTERVENTIONAL,"Laproscopic procedure not offered at this time; will not be offered for the foreseeable, thus we are unable to randomize participants between the two arms."
NCT01594476,TERMINATED,INTERVENTIONAL,Incomplete study enrollment prior to depletion of funding
NCT01594645,WITHDRAWN,INTERVENTIONAL,PI moved from Hadassah
NCT01595412,TERMINATED,INTERVENTIONAL,2 patients enrolled lost of follow-up after completing 1st year visits.PI decided to close
NCT01595503,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01595711,TERMINATED,OBSERVATIONAL,Difficulties of recrutment
NCT01595893,TERMINATED,INTERVENTIONAL,Difficulties in recruiting the planned number of patients
NCT01596049,TERMINATED,OBSERVATIONAL,recruitment was not going well.
NCT01596127,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01596153,WITHDRAWN,INTERVENTIONAL,The study was not initiated
NCT01596413,WITHDRAWN,INTERVENTIONAL,The company currently does not have plans to conduct this study
NCT01596426,WITHDRAWN,INTERVENTIONAL,The company currently does not have plans to conduct this study
NCT01596530,TERMINATED,INTERVENTIONAL,All AstraZeneca sponsored clinical trials of AZD8931 have been halted
NCT01596699,TERMINATED,INTERVENTIONAL,Triggering of futility rule; Interim analysis suggested no statistical superiority over historic controls
NCT01596829,TERMINATED,INTERVENTIONAL,low incidence
NCT01597180,WITHDRAWN,OBSERVATIONAL,Could not find subjects who met all the enrollment criteria so the study was stopped.
NCT01597284,TERMINATED,OBSERVATIONAL,Loss of recruitment
NCT01597440,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01597518,TERMINATED,INTERVENTIONAL,Enrollment challenges/ slow enrollment.
NCT01597531,TERMINATED,INTERVENTIONAL,Difficulty recruiting patients
NCT01597596,TERMINATED,INTERVENTIONAL,Study was stopped due to approved label expansion of alglucosidase alfa.
NCT01597791,TERMINATED,INTERVENTIONAL,Change in procedure.US technically challenging.
NCT01597921,TERMINATED,OBSERVATIONAL,The study was stopped due to unbalanced side effects
NCT01598025,TERMINATED,INTERVENTIONAL,Closed due to poor accrual
NCT01598168,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01598259,TERMINATED,INTERVENTIONAL,"lack or enrollment, funding depletion"
NCT01598285,TERMINATED,OBSERVATIONAL,Due to the low rate of recruitment.
NCT01598324,TERMINATED,OBSERVATIONAL,Clinical trial from which subjects were recruited closed to enrollment
NCT01598558,WITHDRAWN,INTERVENTIONAL,Accrual issues - Low Accrual
NCT01598584,WITHDRAWN,INTERVENTIONAL,Gemcitabine is not the first choice for most pancreatic cancer patients nowdays
NCT01598662,TERMINATED,INTERVENTIONAL,Unable to secure funding
NCT01598792,TERMINATED,INTERVENTIONAL,Patient 2 suffered DLT post-vaccination. The vaccine manufacturers withdrew support for the study on commercial grounds.
NCT01598896,TERMINATED,INTERVENTIONAL,low enrollment due to limited resources
NCT01599195,TERMINATED,OBSERVATIONAL,Enrollment did not progress as anticipated
NCT01599208,WITHDRAWN,INTERVENTIONAL,no IRB
NCT01599260,TERMINATED,INTERVENTIONAL,Funding ended.
NCT01599429,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT01599442,TERMINATED,OBSERVATIONAL,recrution number was not reached
NCT01599754,TERMINATED,INTERVENTIONAL,Primary endpoint did not reach statistical significance
NCT01599832,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01599910,WITHDRAWN,OBSERVATIONAL,Funding not received
NCT01600053,TERMINATED,INTERVENTIONAL,interim analysis showed that the trial will not meet the interim endpoint.
NCT01600417,TERMINATED,OBSERVATIONAL,principal investigator has left the institution
NCT01600443,TERMINATED,INTERVENTIONAL,Planned interim analysis showed study was underpowered
NCT01600677,TERMINATED,INTERVENTIONAL,"Terminated on 2/28/13, low enrollment; last participant med visit 5/13/13."
NCT01600742,TERMINATED,INTERVENTIONAL,Sponsor stops to provide the study drug.
NCT01600807,WITHDRAWN,INTERVENTIONAL,"Study was pending major changes and was on hold, pending activation; administratively withdrawn; will be submitted as a new protocol if study is revised."
NCT01600963,WITHDRAWN,INTERVENTIONAL,PhIII program revised; TMC207-C210 cancelled
NCT01601093,SUSPENDED,INTERVENTIONAL,other project got priority
NCT01601184,TERMINATED,INTERVENTIONAL,The number of successes is not reached at the end of first stage of the phase II. The study is stopped.
NCT01601249,WITHDRAWN,INTERVENTIONAL,PI moved from Hadassah
NCT01601431,TERMINATED,INTERVENTIONAL,Study was inactivated by the IRB since PI left institution.
NCT01601483,TERMINATED,INTERVENTIONAL,Unmasked without Sponsor's prior knowledge or authorization by the PI.
NCT01601496,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT01601626,TERMINATED,INTERVENTIONAL,The study was stopped early due to feasibility concerns.
NCT01601782,TERMINATED,INTERVENTIONAL,It was determined that the volume imaging was not working.
NCT01601873,TERMINATED,INTERVENTIONAL,Results from futility analysis conducted at planned interim time-point did not meet the study criteria for continuation.
NCT01601899,TERMINATED,INTERVENTIONAL,DSMB decision to begin closeout process in view of April 2010 SA HAART guideline
NCT01601938,WITHDRAWN,INTERVENTIONAL,We failed to obtain study drugs from the company
NCT01602016,TERMINATED,INTERVENTIONAL,Non-compliance
NCT01602120,TERMINATED,INTERVENTIONAL,The study was terminated early by the Sponsor due to lack of efficacy.
NCT01602172,TERMINATED,INTERVENTIONAL,Recruitment challenges. Extensive remedial recruitment strategies unsuccessful
NCT01602198,TERMINATED,INTERVENTIONAL,Study revised to use a different study medication and patient population.
NCT01602276,TERMINATED,INTERVENTIONAL,Difficulty identifying appropriate patients
NCT01602302,TERMINATED,INTERVENTIONAL,low recruitment
NCT01602315,TERMINATED,INTERVENTIONAL,early termination due to Sponsor decision (slow recruitment)
NCT01602432,WITHDRAWN,OBSERVATIONAL,Project did not meet criteria of a research study and was confirmed as a Quality Initiative Project
NCT01602471,TERMINATED,INTERVENTIONAL,Sponsor decided to develop the product in collaboration
NCT01602627,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01602679,TERMINATED,INTERVENTIONAL,Interim analysis suggested futility.
NCT01602783,TERMINATED,INTERVENTIONAL,Slow accrual; no further funding
NCT01602822,TERMINATED,INTERVENTIONAL,Grade 3 elevation in liver function tests
NCT01602991,WITHDRAWN,INTERVENTIONAL,difficulty obtaining funding
NCT01603043,TERMINATED,INTERVENTIONAL,Management Decision
NCT01603121,TERMINATED,INTERVENTIONAL,Unable to enroll sufficient number of subjects
NCT01603355,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01603394,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01603420,TERMINATED,INTERVENTIONAL,enrollment goals not met
NCT01604005,TERMINATED,INTERVENTIONAL,"CI Decision:That once the last patient has reached 1 year follow-up, no further follow up needs to be completed on patients recruited in PIT"""
NCT01604200,WITHDRAWN,OBSERVATIONAL,Funding unsuccessful
NCT01604252,TERMINATED,OBSERVATIONAL,The study was terminated early by the Sponsor due to the high rate of discontinuation of subjects unrelated to patient safety.
NCT01604421,WITHDRAWN,INTERVENTIONAL,no personnel available to enroll patients- decision made to not complete study
NCT01604434,WITHDRAWN,INTERVENTIONAL,no personnel available to enroll in study- decision made to not complete
NCT01604863,SUSPENDED,INTERVENTIONAL,Study suspended prior to enrollment
NCT01604889,TERMINATED,INTERVENTIONAL,Further development of this compound with ipilimumab in the treatment of melanoma is no longer being pursued.
NCT01604941,TERMINATED,INTERVENTIONAL,This study was terminated due to treatment stop resulting in an inability to draw conclusions from the data. Evaluation of nonclinical rat findings is ongoing.
NCT01605019,TERMINATED,INTERVENTIONAL,funding for study stopped
NCT01605344,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to lack of patient enrollment.
NCT01605357,WITHDRAWN,INTERVENTIONAL,Never started.
NCT01605370,TERMINATED,INTERVENTIONAL,Difficulty in identifying subjects satisfying the inclusion criteria.
NCT01605617,TERMINATED,INTERVENTIONAL,"Low recruitment rate, and study patients were removed prior to completion"
NCT01605747,TERMINATED,INTERVENTIONAL,Study was stopped due to inavailability of subjects meeting eligibility criteria.
NCT01605838,WITHDRAWN,OBSERVATIONAL,"A series of administrative delays on all sides involved, combined with funding problems."
NCT01605929,WITHDRAWN,INTERVENTIONAL,withdrawn before IRB approval
NCT01605942,TERMINATED,INTERVENTIONAL,Study terminated due to corporate decision.
NCT01605968,TERMINATED,INTERVENTIONAL,The rate of subject recruitment is too slow.
NCT01606111,TERMINATED,INTERVENTIONAL,Poor patient recruitment
NCT01606124,TERMINATED,INTERVENTIONAL,pending expiration of the supply of study agent.
NCT01606150,TERMINATED,INTERVENTIONAL,Investigator left the insititution
NCT01606566,TERMINATED,INTERVENTIONAL,Business reasons
NCT01606618,TERMINATED,OBSERVATIONAL,Sponsor and investigator's decision
NCT01606709,TERMINATED,INTERVENTIONAL,Difficult to recruit patients
NCT01606800,TERMINATED,INTERVENTIONAL,The trial was terminated due to change in new standard of therapy during the study period.
NCT01607268,TERMINATED,OBSERVATIONAL,"Could not enroll enough participants, and lost funding."
NCT01607320,TERMINATED,INTERVENTIONAL,"Over budget, slow recruitment, and personnel change"
NCT01607359,WITHDRAWN,OBSERVATIONAL,Withdrawn: It was decided not to proceed with the study at this time.
NCT01607554,TERMINATED,INTERVENTIONAL,Inadequate enrollment (2 subjects in 4 years)
NCT01607645,TERMINATED,INTERVENTIONAL,The study was terminated early because there were other competing protocols.
NCT01607671,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants from recruiting sites.
NCT01607866,WITHDRAWN,INTERVENTIONAL,Lack of enrollment of eligible patients for randomization.
NCT01607983,WITHDRAWN,INTERVENTIONAL,Poor accrual
NCT01608282,TERMINATED,INTERVENTIONAL,Unable to reach recruitment target
NCT01608321,TERMINATED,INTERVENTIONAL,Did not meet recruitment goals
NCT01608451,TERMINATED,INTERVENTIONAL,Slow accrual implies that clinical questions being questioned have lost its significance.
NCT01608464,TERMINATED,INTERVENTIONAL,poor accrual
NCT01608490,TERMINATED,INTERVENTIONAL,FDA approval of supplementation to IDE to terminate subject long term follow up
NCT01608776,TERMINATED,INTERVENTIONAL,"Enrollment delays, business re-allocation of resources"
NCT01608919,TERMINATED,INTERVENTIONAL,"Sara Cheng, MD has left the University of Colorado and we have closed this study."
NCT01609231,TERMINATED,INTERVENTIONAL,This trial was halted prematurely for business reasons and low enrollment.
NCT01609530,TERMINATED,INTERVENTIONAL,Unable to accrue the projected number of patients required.
NCT01609582,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01609673,TERMINATED,INTERVENTIONAL,The inclusion of proposed sample turned to be infeasible due to Ethical Non-approval of 2 research sites and another site no transplant activity since 2012.
NCT01609816,TERMINATED,INTERVENTIONAL,Low accrual. No Analyses were performed
NCT01609881,WITHDRAWN,INTERVENTIONAL,Due to lack of funding
NCT01609920,TERMINATED,INTERVENTIONAL,Manufacturer recently halted production of gadofosveset.
NCT01610570,TERMINATED,INTERVENTIONAL,Study was closed to enrollment before dose level one was completed.
NCT01610739,WITHDRAWN,INTERVENTIONAL,never initiated; did not recruit patients
NCT01610765,WITHDRAWN,INTERVENTIONAL,Study terminated because unable to obtain access to study drug for study population.
NCT01610999,TERMINATED,INTERVENTIONAL,Unavailability of study article
NCT01611207,TERMINATED,INTERVENTIONAL,"The patient recruitment was behind target, no successful completion of the planned patient numbers within trial period could be expected"
NCT01611506,TERMINATED,INTERVENTIONAL,Outcome of EXPAND study (no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer in the overall patient population)
NCT01611584,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT01611662,TERMINATED,INTERVENTIONAL,Extreme Toxicity
NCT01611675,TERMINATED,INTERVENTIONAL,Adverse Events
NCT01611779,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01612091,WITHDRAWN,INTERVENTIONAL,Replaced with updated protocol as H16-02361
NCT01612299,WITHDRAWN,INTERVENTIONAL,Funding was withdrawn for this study by the sponsor.
NCT01612377,TERMINATED,INTERVENTIONAL,"missed endpoint of meaningful clinical benefit, compared to prednisolone 2.7mg"
NCT01612481,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01612728,WITHDRAWN,INTERVENTIONAL,The grant application for this project was rejected.
NCT01612806,TERMINATED,INTERVENTIONAL,Site selection
NCT01612819,TERMINATED,OBSERVATIONAL,No more enrollment
NCT01612884,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01612910,WITHDRAWN,INTERVENTIONAL,Research cancelled.
NCT01612975,TERMINATED,INTERVENTIONAL,Recruitment futile
NCT01612988,TERMINATED,INTERVENTIONAL,Other drugs others studies
NCT01613235,TERMINATED,INTERVENTIONAL,As advised by the DSMB the study was stopped due to slow recruitment.
NCT01613469,TERMINATED,INTERVENTIONAL,Re-eval of patient population
NCT01613482,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01613521,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01613820,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01613833,SUSPENDED,OBSERVATIONAL,"need new PI, i moved"
NCT01613924,WITHDRAWN,INTERVENTIONAL,Lack of funding and resources
NCT01614067,TERMINATED,INTERVENTIONAL,Slow enrollment resulted in withdraw of funding
NCT01614171,WITHDRAWN,INTERVENTIONAL,it was never started because it was never funded
NCT01614652,TERMINATED,INTERVENTIONAL,Company is closed
NCT01614704,TERMINATED,OBSERVATIONAL,End of study
NCT01614925,TERMINATED,INTERVENTIONAL,Due to change in strategy and decision not to expand indication.
NCT01614977,WITHDRAWN,INTERVENTIONAL,Technical problems.
NCT01615016,TERMINATED,INTERVENTIONAL,Delay due to infrastructural reasons. Funding withdrawn
NCT01615042,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01615055,WITHDRAWN,INTERVENTIONAL,Study withdrawn. No participants enrolled.
NCT01615146,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01615211,TERMINATED,INTERVENTIONAL,No access to study drug Trilostan. Company closed down
NCT01615224,TERMINATED,INTERVENTIONAL,No funding
NCT01615536,WITHDRAWN,INTERVENTIONAL,Inability to recruit subjects
NCT01615562,TERMINATED,OBSERVATIONAL,Difficulty in enrolling suitable subjects
NCT01615627,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT01615666,WITHDRAWN,OBSERVATIONAL,This was never a clinical trial and should never have been approved.
NCT01615692,WITHDRAWN,OBSERVATIONAL,Sub study was not pursued as overall trial was negative
NCT01615822,TERMINATED,INTERVENTIONAL,Decision taken to halt progression of mefloquine as a potential partner for OZ439 as a single dose cure due to low probability of success
NCT01615926,TERMINATED,OBSERVATIONAL,Student related research project. Completion of allotted time.
NCT01615939,TERMINATED,INTERVENTIONAL,The study has been terminiated due to minimal subject recruitment
NCT01615952,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT01616043,TERMINATED,INTERVENTIONAL,"delay in recruitment, lack of additional funding"
NCT01616160,TERMINATED,INTERVENTIONAL,Inability to recruit additional subjects.
NCT01616199,TERMINATED,INTERVENTIONAL,slow accrual
NCT01616225,TERMINATED,INTERVENTIONAL,Insufficient/slow patient recruitment
NCT01616719,WITHDRAWN,INTERVENTIONAL,study was never started due to lack of resources
NCT01617057,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT01617213,TERMINATED,INTERVENTIONAL,Study is no longer needed as recent data have answered the primary hypotheses for this study.
NCT01617291,TERMINATED,INTERVENTIONAL,A similar study was recently published with definitive results.
NCT01617473,WITHDRAWN,INTERVENTIONAL,patients' reluctance
NCT01617707,TERMINATED,INTERVENTIONAL,because of difficulties for participants enrollment
NCT01617733,TERMINATED,INTERVENTIONAL,Inadequate patient recruitment
NCT01617798,WITHDRAWN,INTERVENTIONAL,Investigator departed organization
NCT01617980,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01618227,TERMINATED,INTERVENTIONAL,"Due to a lack of resources and the principal investigator leaving the institution, we stopped the study prior to reaching enrollment target."
NCT01618253,WITHDRAWN,INTERVENTIONAL,Closed due to poor accrual.
NCT01618357,SUSPENDED,INTERVENTIONAL,final subject consented to dose level 4
NCT01618383,TERMINATED,INTERVENTIONAL,Lack of patients
NCT01618539,TERMINATED,OBSERVATIONAL,PI retired prior to final N number reached
NCT01618591,TERMINATED,INTERVENTIONAL,AWD arm was completed. ADF diarrhea arm was unable to fill completely and there are no funds remaining to continue recruiting/enrolling.
NCT01618721,TERMINATED,OBSERVATIONAL,Low recruiting rate and fulfill requirements
NCT01618838,TERMINATED,INTERVENTIONAL,"The study only accrued 4 patients in 2 years, far below target (40). It was closed with no subject reached the primary endpoint, thus no results to publish."
NCT01619410,TERMINATED,INTERVENTIONAL,slow accrual
NCT01619449,WITHDRAWN,INTERVENTIONAL,Research never begun and no subjects enrolled. Protocol term with IRB in Dec 2014
NCT01619566,WITHDRAWN,INTERVENTIONAL,Sponsor related
NCT01619696,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01619800,TERMINATED,INTERVENTIONAL,The study was terminated due to poor enrollment.
NCT01620216,TERMINATED,INTERVENTIONAL,Unable to recruit enough eligible subjects
NCT01620268,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01620320,WITHDRAWN,OBSERVATIONAL,No Funding
NCT01620411,WITHDRAWN,INTERVENTIONAL,Site was never activated by sponsor
NCT01620736,WITHDRAWN,INTERVENTIONAL,The clinical trial did not receive any funding.
NCT01620775,TERMINATED,INTERVENTIONAL,Principal Investigator was unable to fulfill his responsibilities.
NCT01620788,SUSPENDED,INTERVENTIONAL,Substancial amendment
NCT01620944,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT01621165,WITHDRAWN,INTERVENTIONAL,unable to recruit subjects given short length of stay in hospital
NCT01621243,TERMINATED,INTERVENTIONAL,The study was terminated after a pre-planned futility analyses showed an insufficient level of efficacy in the study population to warrant continuation.
NCT01621477,TERMINATED,INTERVENTIONAL,Study was terminated in August 2016 due to replacement by a new study.
NCT01621737,TERMINATED,INTERVENTIONAL,Break in funding
NCT01622010,TERMINATED,INTERVENTIONAL,There is a lower recruitment rate than projected.
NCT01622088,TERMINATED,INTERVENTIONAL,The Initial Phase 3 Study (NCTO1281189) did not meet its primary efficacy endpoint.
NCT01622153,TERMINATED,INTERVENTIONAL,Use of Formocresol for pulpotomies ws discontinued.
NCT01622322,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT01622387,WITHDRAWN,INTERVENTIONAL,No funding
NCT01622413,WITHDRAWN,INTERVENTIONAL,"Patients did not consent to randomization in any study center, since they preferred endoscopic surgery. The recruitment of patients was impossible."
NCT01622595,WITHDRAWN,OBSERVATIONAL,Principal Investigator has left the institution.
NCT01622621,TERMINATED,INTERVENTIONAL,Unable to enroll to the randomized arm.
NCT01622660,TERMINATED,INTERVENTIONAL,Safety reasons
NCT01622764,WITHDRAWN,INTERVENTIONAL,No funding from the sponsor
NCT01622803,WITHDRAWN,INTERVENTIONAL,Patients enrollment problem
NCT01623219,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT01623232,WITHDRAWN,INTERVENTIONAL,FDA hold on the project
NCT01623271,TERMINATED,INTERVENTIONAL,Due to limited population of research participants.
NCT01623427,TERMINATED,INTERVENTIONAL,Difficulty recruiting enough patients
NCT01623453,TERMINATED,OBSERVATIONAL,Difficulty recruiting subjects
NCT01623583,TERMINATED,INTERVENTIONAL,limited qualifying patient population
NCT01623726,WITHDRAWN,INTERVENTIONAL,To be submitted for grant application
NCT01623804,TERMINATED,INTERVENTIONAL,funding to support alternate feasible recruitment strategy was not acquired
NCT01623882,WITHDRAWN,OBSERVATIONAL,"The study was terminated by Spiracur (original sponsor). Efforts were made to contact the PI/study team members, but were unsuccessful."
NCT01624090,TERMINATED,INTERVENTIONAL,Study closed due to low accrual.
NCT01624337,TERMINATED,INTERVENTIONAL,Medication safety concern
NCT01624493,WITHDRAWN,INTERVENTIONAL,Phase I was conducted Australia. Phase II not conducted and no US pts enrolled.
NCT01624558,WITHDRAWN,INTERVENTIONAL,Measurement device not performing to standard in study environment
NCT01624701,TERMINATED,INTERVENTIONAL,Funding expired
NCT01624831,TERMINATED,OBSERVATIONAL,Lack of funding
NCT01625208,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01625455,TERMINATED,INTERVENTIONAL,Difficulty recruiting.
NCT01625741,TERMINATED,INTERVENTIONAL,Stopped by Principal Investigator decision
NCT01625780,TERMINATED,INTERVENTIONAL,Not a significant difference in outcomes between groups
NCT01625793,WITHDRAWN,INTERVENTIONAL,"New medication coming on the market, made study obsolete."
NCT01625923,TERMINATED,INTERVENTIONAL,Inadequate recruitment numbers
NCT01626131,TERMINATED,INTERVENTIONAL,"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the end of the grant."
NCT01626313,WITHDRAWN,INTERVENTIONAL,Proposed studies were not funded
NCT01626391,TERMINATED,INTERVENTIONAL,This study has been terminated for administrative reasons only.
NCT01626690,TERMINATED,INTERVENTIONAL,Surgeons change in preference for perioperative warming.
NCT01626755,TERMINATED,INTERVENTIONAL,Lack of funding and recruitment.
NCT01626924,TERMINATED,INTERVENTIONAL,Recruitment too slow and site decided to use hypothermia (exclusion criteria)
NCT01627067,TERMINATED,INTERVENTIONAL,Komen Foundation Funding Terminated
NCT01627223,TERMINATED,INTERVENTIONAL,Slow progress in recruiting study patients
NCT01627314,TERMINATED,INTERVENTIONAL,Business decision
NCT01627353,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT01627379,TERMINATED,INTERVENTIONAL,Sponsor decision due to recommendation of the IDMC.
NCT01627548,WITHDRAWN,INTERVENTIONAL,Proposed studies were not funded
NCT01627899,TERMINATED,INTERVENTIONAL,Business decision to terminate trial
NCT01628055,WITHDRAWN,INTERVENTIONAL,difficult recruitment and new black box warning for IVIG
NCT01628198,TERMINATED,INTERVENTIONAL,recommendation by the study's DSMB due to insufficient data to determine efficacy.
NCT01628445,TERMINATED,INTERVENTIONAL,Error made by local pharmacy caused mixed randomization of 20 participants
NCT01628874,TERMINATED,INTERVENTIONAL,"Due to low recruitment numbers, the study was terminated."
NCT01628887,TERMINATED,INTERVENTIONAL,Proposal will not be submitted and low accrual.
NCT01628913,TERMINATED,INTERVENTIONAL,This trial was terminated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.
NCT01629095,TERMINATED,OBSERVATIONAL,Slow/insufficient accrual
NCT01629329,TERMINATED,INTERVENTIONAL,no difference found between two groups in a preliminary analysis
NCT01629667,TERMINATED,INTERVENTIONAL,Early termination of the study due to lack of efficacy.
NCT01629914,WITHDRAWN,INTERVENTIONAL,study close-out
NCT01630408,WITHDRAWN,INTERVENTIONAL,Investigator decided not to pursue.
NCT01630538,TERMINATED,INTERVENTIONAL,"After March 2015, unable to enroll due to patients meeting exclusion criteria."
NCT01630551,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01630694,TERMINATED,INTERVENTIONAL,study stopped due to not meeting enrollment goal.
NCT01631188,TERMINATED,INTERVENTIONAL,lost nurse researcher support
NCT01631279,TERMINATED,INTERVENTIONAL,Study was prematurely discontinued due to unacceptable toxicity.
NCT01631409,WITHDRAWN,OBSERVATIONAL,The study has been withdrawn due to organizational problems
NCT01631513,WITHDRAWN,INTERVENTIONAL,It was a business decision to cancel this study in Aug. 2012.
NCT01631539,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT01631578,WITHDRAWN,INTERVENTIONAL,PI moved from medical center
NCT01631630,TERMINATED,INTERVENTIONAL,The study was closed to recruitment due to feasibility problems.
NCT01631643,WITHDRAWN,INTERVENTIONAL,Business decision to withdraw trial
NCT01631877,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT01631916,WITHDRAWN,INTERVENTIONAL,Unable to find patients matching inclusion criteria
NCT01631929,TERMINATED,INTERVENTIONAL,Monitoring Committee found significant \& meaningful difference on main outcome
NCT01631942,TERMINATED,INTERVENTIONAL,See detailed description
NCT01631994,TERMINATED,INTERVENTIONAL,No support to run the study
NCT01632020,TERMINATED,INTERVENTIONAL,Inadequate accrual
NCT01632202,TERMINATED,INTERVENTIONAL,No subjects were recruited at the Weill Cornell site.
NCT01632306,TERMINATED,INTERVENTIONAL,Study has been terminated due to slow enrollment.
NCT01632384,WITHDRAWN,INTERVENTIONAL,study close-out
NCT01632436,WITHDRAWN,INTERVENTIONAL,No eligible patients enrolled
NCT01632566,TERMINATED,INTERVENTIONAL,Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.
NCT01632592,WITHDRAWN,INTERVENTIONAL,No funding available
NCT01632696,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01632943,TERMINATED,INTERVENTIONAL,Study Enrollment was stopped pending review of another study in the same therapeutic area.
NCT01632969,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT01633060,TERMINATED,INTERVENTIONAL,"Novartis decided not to pursue further development of buparlisib program (assessment of moderate PFS benefit with know, but manageable, buparlisib profile)."
NCT01633112,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01633281,TERMINATED,INTERVENTIONAL,poor recruitment and expiry of funding
NCT01633593,TERMINATED,INTERVENTIONAL,Difficulty in recruiting subjects for the trial.
NCT01633658,WITHDRAWN,INTERVENTIONAL,Protocol has changed
NCT01633710,TERMINATED,OBSERVATIONAL,Redesigned sensor to be subjected to a new protocol
NCT01633814,TERMINATED,INTERVENTIONAL,PI left institution prior to completion of study. Data unavailable..
NCT01633892,TERMINATED,INTERVENTIONAL,funding ended
NCT01634360,TERMINATED,INTERVENTIONAL,Due to termination of clinical program for Parkinson's Disease
NCT01634646,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient local qualifying volunteers for study.
NCT01634789,TERMINATED,INTERVENTIONAL,This study was terminated on 10 December 2012 due to low enrollment. The decision to terminate the study was not based on safety or efficacy issues.
NCT01634815,TERMINATED,INTERVENTIONAL,Enrollment difficulties
NCT01634867,WITHDRAWN,OBSERVATIONAL,No subject enrollment.
NCT01634880,WITHDRAWN,INTERVENTIONAL,Lack of accrual.
NCT01635543,WITHDRAWN,OBSERVATIONAL,This study was terminated due to some challenges in recruitment process
NCT01635621,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to delay in timelines. There were no safety concerns regarding the study or the compound in the decision to withdraw the trial.
NCT01636063,TERMINATED,INTERVENTIONAL,Poor subject enrollment
NCT01636128,WITHDRAWN,INTERVENTIONAL,Funding and staffing
NCT01636310,SUSPENDED,INTERVENTIONAL,"Clinical studies stopped, pending funding"
NCT01636323,SUSPENDED,INTERVENTIONAL,"Clinical studies stopped, pending funding"
NCT01636336,SUSPENDED,INTERVENTIONAL,"Clinical studies are stopped, pending funding"
NCT01636388,TERMINATED,INTERVENTIONAL,funding ended
NCT01636466,TERMINATED,INTERVENTIONAL,Feasibility
NCT01636609,TERMINATED,INTERVENTIONAL,In 2013 the FDA put a temporary hold on the trial and the Phase II portion of this study was cancelled.
NCT01636648,TERMINATED,OBSERVATIONAL,Device was sunset from the market in May2015. No longer need for long term data.
NCT01636960,TERMINATED,INTERVENTIONAL,"The study was terminated after 118 weeks from the study start, during the maintenance phase, due to regulatory approval in Japan."
NCT01637090,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01637168,WITHDRAWN,INTERVENTIONAL,Canceled \[By sponsor decision)
NCT01637376,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT01637545,TERMINATED,INTERVENTIONAL,Principal Investigator is away on business
NCT01637571,WITHDRAWN,INTERVENTIONAL,Sponsor could not fund
NCT01637610,TERMINATED,OBSERVATIONAL,Lack of support with enrollment.
NCT01637896,TERMINATED,INTERVENTIONAL,the study was halted after an interim analysis perfomed for a perceived excess of target vessel revascularization in the DEB+BMS arm
NCT01637987,TERMINATED,INTERVENTIONAL,"Combination of insufficient research staff support, insufficient subjects meeting enrollment criteria, and investigators changing role responsibilities. Administratively closed (continuing review or completion report not submitted)."
NCT01638260,TERMINATED,INTERVENTIONAL,Terminated because of insufficient number of subjects included.
NCT01638377,TERMINATED,INTERVENTIONAL,Recruitment proved to be extremely difficult.
NCT01638468,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT01638585,TERMINATED,INTERVENTIONAL,recruition number was not reached
NCT01638767,TERMINATED,INTERVENTIONAL,Difficulty to recruit patient due to lack of eligible patient
NCT01638806,TERMINATED,INTERVENTIONAL,slow recuritment
NCT01638988,WITHDRAWN,INTERVENTIONAL,Previous studies have been done regarding same condition
NCT01639118,TERMINATED,OBSERVATIONAL,"Perception of an increased incidence of C-Qur V-patch mesh infection, with need for removal, compared to other meshes used for umbilical hernia repair."
NCT01639456,WITHDRAWN,INTERVENTIONAL,study was abandoned and a new study was written to replace this one
NCT01639521,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01639547,TERMINATED,INTERVENTIONAL,early termination due to difficult collection of patients
NCT01639573,WITHDRAWN,OBSERVATIONAL,The study has stopped due to no patient enrollment unable to meet the study criteria
NCT01639664,TERMINATED,INTERVENTIONAL,"The interim analysis requested by the EDSMC shows higher mortality for the CPFA group compared to the controls, particularly in the first days of treatment."
NCT01639937,TERMINATED,OBSERVATIONAL,"PI is leaving NHLBI, sample size is too small."
NCT01640015,WITHDRAWN,INTERVENTIONAL,"Study did not get ethical approval, therefore study was not initiated"
NCT01640054,TERMINATED,INTERVENTIONAL,AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.
NCT01640106,TERMINATED,INTERVENTIONAL,Recruitment very difficult; only preliminary data usable.
NCT01640249,TERMINATED,INTERVENTIONAL,Study terminated due to unacceptable pharmacokinetic (PK) profile.
NCT01640301,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT01640587,TERMINATED,INTERVENTIONAL,No adequate malaria patient
NCT01640730,TERMINATED,INTERVENTIONAL,poor enrollment
NCT01640886,TERMINATED,OBSERVATIONAL,Results did not meet study requirements.
NCT01641419,WITHDRAWN,INTERVENTIONAL,Inability to recruit subjects at our hospital due to change in surgical patient population. Not worth to continue.
NCT01641484,TERMINATED,INTERVENTIONAL,unreached recruitment objectives
NCT01641497,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01641575,TERMINATED,INTERVENTIONAL,Registrational study did not meet endpoint so entire program (including CO-101-011) was terminated.
NCT01641601,TERMINATED,INTERVENTIONAL,Inadequate enrollment. Key study personnel transitioned to a different role.
NCT01641848,TERMINATED,INTERVENTIONAL,Lack of patient enrollment
NCT01641926,TERMINATED,INTERVENTIONAL,This study was terminated early due to poor recruitment
NCT01642017,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT01642342,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01642459,TERMINATED,INTERVENTIONAL,The patients enrolled are limited.
NCT01642563,TERMINATED,INTERVENTIONAL,Patient enrolment below planned schedule
NCT01642732,TERMINATED,INTERVENTIONAL,"Lack of accrual and funding expires in June, 2014."
NCT01642823,TERMINATED,OBSERVATIONAL,Logistics
NCT01642862,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT01642927,WITHDRAWN,OBSERVATIONAL,PI left University
NCT01643161,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT01643252,WITHDRAWN,INTERVENTIONAL,This study was withdrawn for business reasons.
NCT01643291,TERMINATED,INTERVENTIONAL,We were unable to recruit subjects for this study.
NCT01643525,TERMINATED,INTERVENTIONAL,Insufficient Subject Recruitment
NCT01643564,TERMINATED,OBSERVATIONAL,Subject Recruitment
NCT01643603,TERMINATED,INTERVENTIONAL,Study terminated due to slow accrual.
NCT01643681,WITHDRAWN,INTERVENTIONAL,No longer willing to continue clinical trials
NCT01643733,TERMINATED,INTERVENTIONAL,Not enough recruitment
NCT01643746,WITHDRAWN,INTERVENTIONAL,the study has never started. The sponsor has decided to not move forward
NCT01643837,WITHDRAWN,INTERVENTIONAL,unable to free investigators; time constraints
NCT01644097,WITHDRAWN,INTERVENTIONAL,issues with obtaining study product
NCT01644136,TERMINATED,INTERVENTIONAL,PI left institution
NCT01644201,TERMINATED,INTERVENTIONAL,Too slow recruitment
NCT01644240,TERMINATED,INTERVENTIONAL,For business reasons
NCT01644253,TERMINATED,INTERVENTIONAL,Business decision
NCT01644526,TERMINATED,INTERVENTIONAL,An enhanced device has been developed
NCT01644864,WITHDRAWN,INTERVENTIONAL,No participants were enrolled. The PI left the institution.
NCT01645007,WITHDRAWN,OBSERVATIONAL,The study was not carried out due to lack of funding and budget problems
NCT01645124,TERMINATED,INTERVENTIONAL,Low accrual rate not allowing planned sample size leads to a futility condition
NCT01645709,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate study
NCT01645826,WITHDRAWN,INTERVENTIONAL,no participants agreed to enroll since study start
NCT01646125,TERMINATED,INTERVENTIONAL,"An interim analysis was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility."
NCT01646502,WITHDRAWN,INTERVENTIONAL,Project was discontinued. Ran into difficulties with purification at the protein production stage
NCT01646515,TERMINATED,INTERVENTIONAL,Substantial benefit was observed in the active treatment group
NCT01646580,TERMINATED,INTERVENTIONAL,Low recruitment rate. with the final sample primary endpoint could be assessed.
NCT01646762,TERMINATED,INTERVENTIONAL,Did not pass the Stage 1 interim analysis.
NCT01647256,TERMINATED,INTERVENTIONAL,Insufficient # subjects available for 2nd group; evaluating alternate study site
NCT01647308,TERMINATED,INTERVENTIONAL,The study was terminated for business planning purposes. Assessments of APOCIIIRx in this population will be explored in a larger efficacy study
NCT01647334,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01647412,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT01647477,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01647542,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01647620,TERMINATED,INTERVENTIONAL,Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study
NCT01647880,TERMINATED,INTERVENTIONAL,delayed recruitment
NCT01648101,TERMINATED,INTERVENTIONAL,"Registration of the medicine is no longer being pursued in South Korea, Taiwan or Vietnam"
NCT01648218,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01648699,TERMINATED,INTERVENTIONAL,the study was stopped due to non-availability of 4mg
NCT01648712,TERMINATED,INTERVENTIONAL,for difficulty to enroll patients in the study
NCT01648959,TERMINATED,OBSERVATIONAL,Lack of funding
NCT01649037,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT01649180,TERMINATED,INTERVENTIONAL,Closed due to prolonged enrollment timelines
NCT01649258,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT01649388,WITHDRAWN,INTERVENTIONAL,study terminated by sponsor
NCT01649453,TERMINATED,OBSERVATIONAL,Terminated by sponsor.
NCT01649479,TERMINATED,INTERVENTIONAL,Impossible to include patients at a correct rate; patients don't want to come back so they refuse participation.
NCT01649505,TERMINATED,INTERVENTIONAL,Low patient enrollment and no clinical findings.
NCT01649544,TERMINATED,INTERVENTIONAL,End of commercialization of the medical device
NCT01650220,TERMINATED,OBSERVATIONAL,"The funding agency, DoD, determined that the study could not meet its enrollment numbers by the end of the grant"
NCT01650285,TERMINATED,INTERVENTIONAL,slow recruitment and lost funding
NCT01650298,TERMINATED,INTERVENTIONAL,Due to slow enrollment.
NCT01650350,TERMINATED,INTERVENTIONAL,Study stopped 10/24/13 secondary to lack of patients/slow enrollment
NCT01650467,WITHDRAWN,OBSERVATIONAL,"Funding is late, unforseeable."
NCT01650740,TERMINATED,INTERVENTIONAL,Poor recruitment results.
NCT01650805,TERMINATED,INTERVENTIONAL,Study terminated based on evaluation of safety data.
NCT01650909,WITHDRAWN,OBSERVATIONAL,Withdrawn due to no funding
NCT01651338,TERMINATED,INTERVENTIONAL,This study was completed.
NCT01651468,WITHDRAWN,INTERVENTIONAL,The collaborator lost interest in a clinical study.
NCT01651702,WITHDRAWN,INTERVENTIONAL,Poor recruit rate
NCT01651767,TERMINATED,INTERVENTIONAL,"Because of many competing trials using the same mechanism of action, but being further advanced in development"
NCT01651910,TERMINATED,OBSERVATIONAL,Recruitment issues.
NCT01652014,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT01652157,TERMINATED,OBSERVATIONAL,Strategic considerations
NCT01652261,WITHDRAWN,INTERVENTIONAL,Study closed due to lack of recruitment
NCT01652417,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01652534,TERMINATED,INTERVENTIONAL,Due to lack of recruitment
NCT01652768,TERMINATED,INTERVENTIONAL,Research Cancelled
NCT01653366,TERMINATED,INTERVENTIONAL,primary goal not achievable
NCT01653418,TERMINATED,INTERVENTIONAL,Due to the high rate of morbidity and mortality
NCT01653483,WITHDRAWN,INTERVENTIONAL,FDA advised that study is no longer required
NCT01653522,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01653977,TERMINATED,INTERVENTIONAL,recrutment difficulties
NCT01654003,TERMINATED,INTERVENTIONAL,recrutment difficulties
NCT01654042,WITHDRAWN,INTERVENTIONAL,No funding obtained
NCT01654068,TERMINATED,INTERVENTIONAL,low participant accrual
NCT01654081,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01654328,TERMINATED,INTERVENTIONAL,slow inclusion
NCT01654406,TERMINATED,INTERVENTIONAL,"because 1 patient's scar becomes more severe than before, and most patient have satificated outcome"
NCT01654562,TERMINATED,INTERVENTIONAL,The study has been terminated due to limited participant enrollment.
NCT01654640,TERMINATED,INTERVENTIONAL,Failure to recruit the planned number of participants
NCT01654861,TERMINATED,INTERVENTIONAL,recruiting or enrolling participants has halted prematurely and will not resume
NCT01655186,WITHDRAWN,INTERVENTIONAL,IDMC recommendation for safety concerns
NCT01655212,TERMINATED,INTERVENTIONAL,1 Indication for further investigations (brain ultrasound). 2 Change of study design to efficacy study with historical control group.
NCT01655433,TERMINATED,INTERVENTIONAL,"Sponsor business decision, not safety related"
NCT01655524,WITHDRAWN,INTERVENTIONAL,Due to nationwide shortage of Aminophylline. No subjects enrolled.
NCT01655823,TERMINATED,INTERVENTIONAL,Interim analysis completed and decided to terminate and proceed to Phase 3 trial.
NCT01655875,TERMINATED,INTERVENTIONAL,lack of patient enrollment
NCT01655992,TERMINATED,INTERVENTIONAL,The sponsor decided to stop the study.
NCT01656252,TERMINATED,INTERVENTIONAL,Study stopped per Novartis request due to futility from another study.
NCT01656434,TERMINATED,INTERVENTIONAL,Business reasons
NCT01656590,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT01656629,TERMINATED,INTERVENTIONAL,Inability to analyze collected samples due to no funds.
NCT01657149,TERMINATED,INTERVENTIONAL,"a cardinal member of The research team withdrawn from study, the study has beem terminated."
NCT01657240,WITHDRAWN,INTERVENTIONAL,Formula Reformulation
NCT01657318,TERMINATED,OBSERVATIONAL,challenges encountered in the methodology and concerns with the gold standard of treatment
NCT01657435,TERMINATED,OBSERVATIONAL,Adequate data to satisfy PAS as agreed to with FDA 02OCT2019
NCT01658007,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01658332,TERMINATED,INTERVENTIONAL,unavailability of the investigator due to an overloaded planning
NCT01658527,WITHDRAWN,INTERVENTIONAL,Pharmaceutical company has terminated orteronel (TAK-700) development for Prostate Cancer
NCT01658605,WITHDRAWN,INTERVENTIONAL,Study CCX115383 has been terminated prior to enrolment of any patients. A decision was made by GSK to delay pursuit of this indication as the biology evolves.
NCT01658748,WITHDRAWN,INTERVENTIONAL,Funding not finalized
NCT01658852,WITHDRAWN,INTERVENTIONAL,Because of difficulties on recruiting participants
NCT01658904,TERMINATED,INTERVENTIONAL,study closed prematurely because investigator left National Institutes of Health
NCT01659099,TERMINATED,INTERVENTIONAL,experimental treatment not Superior to standard - no need to continue the follow-up
NCT01659138,TERMINATED,INTERVENTIONAL,Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.
NCT01659177,WITHDRAWN,INTERVENTIONAL,The decision to stop the trial was based on efficacy results in the overall schizophrenia patient population.
NCT01659346,WITHDRAWN,INTERVENTIONAL,Due to high mortality
NCT01659424,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT01659528,WITHDRAWN,OBSERVATIONAL,A similar article was already published by another investigator.
NCT01659554,TERMINATED,INTERVENTIONAL,Principal Investigator left institution
NCT01659658,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT01660009,TERMINATED,INTERVENTIONAL,Insufficient Funding
NCT01660243,TERMINATED,INTERVENTIONAL,This study has been terminated because of insufficient patient recruitment.
NCT01660347,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01660867,WITHDRAWN,INTERVENTIONAL,there was no eligible patients
NCT01661322,TERMINATED,INTERVENTIONAL,Trial reached a definitive answer ahead of full recruitment.
NCT01661348,WITHDRAWN,OBSERVATIONAL,Did not receive funding.
NCT01661387,TERMINATED,OBSERVATIONAL,Takeda submitted 900 patient years Interim Analysis to PRAC and requested study to be closed since primary objective had been fulfilled. PRAC agreed and on 17Sep2020 approved closure of EU-AIR Registry. Takeda announced study closure on 31Oct2020.
NCT01661465,TERMINATED,OBSERVATIONAL,The Principal Investigator left the site.
NCT01661517,TERMINATED,INTERVENTIONAL,incomplete data
NCT01661608,TERMINATED,INTERVENTIONAL,FDA indicated study should have had prior IDE submission \& approval
NCT01661868,WITHDRAWN,INTERVENTIONAL,Drug not available.
NCT01662102,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01662115,TERMINATED,INTERVENTIONAL,Study has been terminated due linability to recruit the targeted participants. Aimed for 300 participants and only 4 were enrolled after 1 year.
NCT01662154,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01662258,WITHDRAWN,INTERVENTIONAL,Decision by NIH
NCT01662284,TERMINATED,OBSERVATIONAL,Sponsor determined this trial does not support their anticipated clinical development program.
NCT01662297,TERMINATED,INTERVENTIONAL,it became clear that recruitment was infeasible
NCT01662349,TERMINATED,INTERVENTIONAL,The study was stopped due to other research priorities.
NCT01662726,TERMINATED,INTERVENTIONAL,Recruitment challenging: lack of suitable pts; recruiting so soon after diagnosis; competing studies. Funding ended despite extensions to grant.
NCT01662895,TERMINATED,INTERVENTIONAL,"By DSMB on October 18, 2013 due to increased incidence of ARDS. See modified protocol \[NCT02175225"
NCT01663090,WITHDRAWN,INTERVENTIONAL,Inability to accrue.
NCT01663285,TERMINATED,INTERVENTIONAL,Low study participant enrollment.
NCT01663415,WITHDRAWN,INTERVENTIONAL,A business decision was made to not initiate this study.
NCT01663428,WITHDRAWN,INTERVENTIONAL,It was decided to change the study from a cohort to a randomized controlled trial.
NCT01663467,WITHDRAWN,INTERVENTIONAL,there was no participants who were enrolled in this study
NCT01663558,WITHDRAWN,INTERVENTIONAL,funding not available
NCT01663571,TERMINATED,OBSERVATIONAL,Study is permanently closed to enrollment .Collection of private identifiable information is complete Analysis of private identifiable information is complete
NCT01663584,WITHDRAWN,OBSERVATIONAL,"Samples were not needed for test development, therefore subjects were not recruited or enrolled"
NCT01663662,WITHDRAWN,INTERVENTIONAL,Lack of eligible patients
NCT01663766,TERMINATED,INTERVENTIONAL,"PIs agreed no safety signals were shown, drug did not appear to lessen the risk of preventing GVHD no further patients would be enrolled"
NCT01663779,TERMINATED,INTERVENTIONAL,Inability to recruit further.
NCT01663935,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01663948,TERMINATED,OBSERVATIONAL,Loss of staff combined with low study enrollment and a change in lab/PI priorities
NCT01664026,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT01664260,WITHDRAWN,INTERVENTIONAL,The research project has been cancelled before any participants were enrolled.
NCT01664273,TERMINATED,INTERVENTIONAL,Production of the IMP (plasmid AMEP) has been terminated by the supplier (BioAlliance Pharma)
NCT01664637,TERMINATED,INTERVENTIONAL,Insufficient efficacy in planned interim futility analysis
NCT01664663,TERMINATED,INTERVENTIONAL,Safety analysis showed increased grade 5 toxicity in experimental arm.
NCT01665274,TERMINATED,INTERVENTIONAL,"we are working on a larger similar multicenter cinical trials as a participant.so in order to avoid conflicts of interest, we have to suspended this project."
NCT01665430,TERMINATED,INTERVENTIONAL,Study was terminated by sponsor due to market authorization of tocilizumab for the study population.
NCT01665651,WITHDRAWN,INTERVENTIONAL,Hard to enroll participants
NCT01665950,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01666015,TERMINATED,INTERVENTIONAL,Due to inability to recruit participants.
NCT01666132,TERMINATED,INTERVENTIONAL,Due to the slow recruitment process and the progress of newer cell types we decided to stop the trial after the phase 1 (after 10 patients included)
NCT01666236,WITHDRAWN,INTERVENTIONAL,Lack of resources
NCT01666249,SUSPENDED,INTERVENTIONAL,Suspended for indetermined period.
NCT01666275,WITHDRAWN,OBSERVATIONAL,We are closing the study because of lack of enrollment.
NCT01666288,WITHDRAWN,OBSERVATIONAL,We are closing the study because of lack of enrollment.
NCT01666405,TERMINATED,INTERVENTIONAL,business reasons
NCT01666600,TERMINATED,INTERVENTIONAL,Interim Analysis for Feasibility
NCT01666665,TERMINATED,INTERVENTIONAL,"At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data."
NCT01666743,WITHDRAWN,INTERVENTIONAL,Change in strategy.
NCT01667029,TERMINATED,INTERVENTIONAL,poor enrollment
NCT01667107,TERMINATED,INTERVENTIONAL,Study terminated due to an unfavorable risk-benefit analysis
NCT01667146,TERMINATED,INTERVENTIONAL,Halted by the Management Committee after the publication of the ART Trial
NCT01667289,TERMINATED,INTERVENTIONAL,unexpected high grade of mucositis observed
NCT01667666,TERMINATED,INTERVENTIONAL,low enrollment and loss of funding
NCT01667744,WITHDRAWN,INTERVENTIONAL,unfunded
NCT01667874,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients for the study
NCT01667913,TERMINATED,INTERVENTIONAL,Due to low inclusion rate we terminated this study with n=20 participants instead of n=50.
NCT01668017,TERMINATED,INTERVENTIONAL,The sponsor decided not to conduct the expansion part of trial (part 2)
NCT01668173,TERMINATED,INTERVENTIONAL,patient safety
NCT01668225,TERMINATED,OBSERVATIONAL,Recruitment difficulties
NCT01668550,TERMINATED,INTERVENTIONAL,"Single agent phase completed, insufficient supportive preclinical data to proceed with combination phase"
NCT01668576,TERMINATED,OBSERVATIONAL,Loss of funding
NCT01668654,TERMINATED,INTERVENTIONAL,FDA placed a clinical hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.
NCT01668680,TERMINATED,INTERVENTIONAL,No satisfactory acrual
NCT01668901,WITHDRAWN,INTERVENTIONAL,Financial problem
NCT01668940,TERMINATED,INTERVENTIONAL,The study PI left the institution in early 2015.
NCT01668953,TERMINATED,INTERVENTIONAL,Did not analyze data
NCT01669187,WITHDRAWN,INTERVENTIONAL,Study withdrawn.
NCT01669668,WITHDRAWN,INTERVENTIONAL,Lack of referrals.
NCT01669720,TERMINATED,INTERVENTIONAL,Lack of efficacy and enrollment
NCT01669850,TERMINATED,INTERVENTIONAL,minimal accrual
NCT01669876,TERMINATED,INTERVENTIONAL,Administrative status of active ingredient anatabine
NCT01670071,TERMINATED,INTERVENTIONAL,The study was terminated due to insufficient sample size and protocol compliance issue.
NCT01670084,WITHDRAWN,INTERVENTIONAL,No Accrual
NCT01670188,TERMINATED,INTERVENTIONAL,Interim analysis: patients treated with SCD had higher incidence of DVT.
NCT01670253,TERMINATED,INTERVENTIONAL,Not enough facilities to study
NCT01670994,TERMINATED,INTERVENTIONAL,Patient population did not benefit from single agent treatment.
NCT01671033,TERMINATED,INTERVENTIONAL,The drop-out rate was too high.
NCT01671111,TERMINATED,INTERVENTIONAL,This study was terminated due to treatment stop resulting in an inability to draw conclusions from the data. Evaluation of nonclinical rat findings is ongoing.
NCT01671163,TERMINATED,OBSERVATIONAL,Insufficient enrollment.
NCT01671215,WITHDRAWN,OBSERVATIONAL,no enrollment
NCT01671371,TERMINATED,INTERVENTIONAL,unable to meet enrollment projections
NCT01671488,TERMINATED,INTERVENTIONAL,pilot data to be used for upcoming larger trial.
NCT01671579,TERMINATED,INTERVENTIONAL,PI changed institutions
NCT01671735,WITHDRAWN,INTERVENTIONAL,Not considered a clinical trial because both treatment protocols have been approved as usual care
NCT01671813,WITHDRAWN,INTERVENTIONAL,Terminated by pharmaceutical sponsor - no accrual
NCT01671852,WITHDRAWN,INTERVENTIONAL,Could not obtain funding.
NCT01672034,WITHDRAWN,OBSERVATIONAL,no patient enrolled
NCT01672086,TERMINATED,OBSERVATIONAL,Product is no longer being manufactured and marketed.
NCT01672320,WITHDRAWN,OBSERVATIONAL,No patients will be recruited at Massachsetts General hospital. IRB approval changed to core center.
NCT01672736,TERMINATED,INTERVENTIONAL,The Sponsor decided to stop further manufacture the study drug 'Linsitinib' in Nov 2015.
NCT01673061,TERMINATED,INTERVENTIONAL,Vapocoolant not effective controlling pain compared with Lidocaine.
NCT01673360,TERMINATED,OBSERVATIONAL,Sponsor is winding down business operations
NCT01673386,TERMINATED,INTERVENTIONAL,Sponsor
NCT01673425,TERMINATED,INTERVENTIONAL,Low accrual(4 completed subjects over 2 months)\& inconclusive nasal wash assays.
NCT01673490,TERMINATED,INTERVENTIONAL,The sole investigative site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.
NCT01673672,TERMINATED,INTERVENTIONAL,primary endpoint missed
NCT01673984,TERMINATED,INTERVENTIONAL,The study was discontinued prematurely by the sponsor due to non-medical reasons
NCT01674010,TERMINATED,INTERVENTIONAL,Business Decision
NCT01674283,WITHDRAWN,INTERVENTIONAL,Uterine contractility not possible to visualize with our ultrasound machines
NCT01674348,TERMINATED,INTERVENTIONAL,"Due to non-recruitment, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far."
NCT01674413,WITHDRAWN,INTERVENTIONAL,Unable to recruit; all patients interested simply wanted to stop medication
NCT01674738,WITHDRAWN,INTERVENTIONAL,"Decision of the Sponsor, as the funding of the study was no longer guaranteed."
NCT01674829,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01674868,WITHDRAWN,INTERVENTIONAL,unable to find patients meeting inclusion/exclusion criteria
NCT01675011,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT01675037,TERMINATED,OBSERVATIONAL,Recruitment failure
NCT01675050,TERMINATED,INTERVENTIONAL,"Due to the wide availability of the drug in clinical practice, it was impossible to recruit adequate numbers for scientific power."
NCT01675141,TERMINATED,INTERVENTIONAL,Original investigator left the NIH and the primary outcome was not reached
NCT01675154,TERMINATED,INTERVENTIONAL,Due to unavailability of the drug.
NCT01675388,WITHDRAWN,INTERVENTIONAL,No funding
NCT01675466,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT01675674,TERMINATED,OBSERVATIONAL,Funding withdrawn due to insufficient enrollment rate
NCT01675934,WITHDRAWN,INTERVENTIONAL,PI has left institution
NCT01675947,TERMINATED,INTERVENTIONAL,"On May 30, 2014, study injections were discontinued at the request of the DSMC. No further recruitment will occur."
NCT01675960,TERMINATED,INTERVENTIONAL,unable to enroll
NCT01675973,TERMINATED,INTERVENTIONAL,Study met stopping criteria specified within protocol.
NCT01676090,TERMINATED,OBSERVATIONAL,Participant enrolment was lower than expected
NCT01676194,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01676311,TERMINATED,INTERVENTIONAL,Insufficient accrual rate: 14 participants enrolled (target of 30).
NCT01676363,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT01676415,TERMINATED,INTERVENTIONAL,participants are no longer receiving intervention due to clinical logistics
NCT01676441,TERMINATED,INTERVENTIONAL,sponsor decision (confidential)
NCT01676454,WITHDRAWN,OBSERVATIONAL,Study closed without enrollment .
NCT01676493,TERMINATED,INTERVENTIONAL,Decision to stop study due to low recruitment.
NCT01676701,TERMINATED,INTERVENTIONAL,Insufficient efficacy observed in study BCDM(NCT01198002) and BCDV(NCT01202773)
NCT01676766,TERMINATED,OBSERVATIONAL,Flavoprotein fluorescence machine for the trial is not working so the trial was terminated. No study data was collected prior to termination.
NCT01676935,TERMINATED,INTERVENTIONAL,Data obtained from the M11-427 study is not critical to the continued evaluation of ABT-126.
NCT01676961,TERMINATED,INTERVENTIONAL,PI left the institution
NCT01677182,TERMINATED,INTERVENTIONAL,"Business Decision; Terminated due to futility, with no safety concerns (see below)"
NCT01677494,TERMINATED,OBSERVATIONAL,lack of recruitment
NCT01677572,TERMINATED,INTERVENTIONAL,Study was discontinued based on futility analysis conducted on Phase 3 trials (NCT02477800 and NCT02484547) and not based on safety concerns.
NCT01677650,WITHDRAWN,INTERVENTIONAL,Investigator moved to new institution
NCT01677845,TERMINATED,INTERVENTIONAL,PI no longer with the institution
NCT01677949,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01677988,TERMINATED,INTERVENTIONAL,Study was terminated due to low accrual.
NCT01678053,WITHDRAWN,INTERVENTIONAL,Was not able to recruit patients for randomization.
NCT01678144,TERMINATED,INTERVENTIONAL,Strategic decision by Sponsor
NCT01678443,TERMINATED,INTERVENTIONAL,Terminated due to low accrual.
NCT01678560,TERMINATED,INTERVENTIONAL,Recruitment was halted due to the difficulties in recruiting.
NCT01678625,TERMINATED,OBSERVATIONAL,Company making the device no longer in existence. Did not finish supplying data to research team
NCT01678820,TERMINATED,INTERVENTIONAL,Merck terminated the study for business reasons in November 2013.
NCT01678911,TERMINATED,INTERVENTIONAL,Study ended due to difficulties in recruitment and low enrollment.
NCT01679041,TERMINATED,INTERVENTIONAL,Insufficient accruals; PI leaving site
NCT01679080,TERMINATED,INTERVENTIONAL,Eli Lilly has withdrawn support to the study of teriparatide and placebo pens. The study was not able to continue as a randomized study without the supply of placebo pens.
NCT01679106,TERMINATED,INTERVENTIONAL,Study closed because of low enrolment
NCT01679132,SUSPENDED,INTERVENTIONAL,Company resources only allows adequate oversight for one pivotal trial at a time
NCT01679184,TERMINATED,OBSERVATIONAL,Lack of staff to enroll patients in this study
NCT01679405,TERMINATED,INTERVENTIONAL,No sufficient clinical or molecular signals for efficacy were observed.
NCT01679535,TERMINATED,INTERVENTIONAL,Not an applicable clinical trial (ACT).
NCT01679678,TERMINATED,INTERVENTIONAL,Business considerations
NCT01679691,WITHDRAWN,INTERVENTIONAL,Till IRB renewal
NCT01679951,TERMINATED,INTERVENTIONAL,The decision was made to prematurely discontinue this trial due to lack of efficacy.
NCT01680029,TERMINATED,INTERVENTIONAL,Too slow recruitment rate
NCT01680055,WITHDRAWN,OBSERVATIONAL,No eligible patient was enrolled.
NCT01680081,TERMINATED,INTERVENTIONAL,Slow recruitment of target subjects and difficulty registering subjects
NCT01680172,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01680237,TERMINATED,INTERVENTIONAL,"Retirement of one of the PIs and participation in another multi center study, within which the same patient inclusion criteria were used."
NCT01680354,WITHDRAWN,INTERVENTIONAL,Institution changed surgical method to small incision lenticule extraction. Study never started.
NCT01680380,WITHDRAWN,OBSERVATIONAL,Superseded by larger funded study
NCT01680692,TERMINATED,INTERVENTIONAL,Principal Investigator left institution--no subjects completed the study
NCT01680757,WITHDRAWN,INTERVENTIONAL,This study has been withdrawn prior to enrollment
NCT01680796,WITHDRAWN,INTERVENTIONAL,"The target drug, dovitinib, failed as a single agent in prior studies in patients with heavily treated multiple myeloma."
NCT01680809,WITHDRAWN,INTERVENTIONAL,Study never started
NCT01680822,TERMINATED,OBSERVATIONAL,"PI left institution, not able to contact; data destroyed"
NCT01681368,TERMINATED,INTERVENTIONAL,Accrual was terminated for lack of a clinical benefit.
NCT01681407,TERMINATED,OBSERVATIONAL,Insufficient microRNA for the analysis
NCT01681433,TERMINATED,INTERVENTIONAL,lack of accrual
NCT01681485,TERMINATED,OBSERVATIONAL,Inability to recruit adequate number of patients
NCT01681498,TERMINATED,OBSERVATIONAL,Indeterminate performance during the first half of the trial.
NCT01681511,TERMINATED,INTERVENTIONAL,Business Reasons
NCT01681524,WITHDRAWN,INTERVENTIONAL,delayed study start
NCT01681797,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of inclusion
NCT01681888,WITHDRAWN,INTERVENTIONAL,"The PI for this trial, which has been terminated, is no longer employed by USC. After repeated attempts of contact, we are unable to identify the PI's current employment. We would therefore request close out of this clinical trial record."
NCT01681901,WITHDRAWN,OBSERVATIONAL,no patient accrual
NCT01682031,TERMINATED,INTERVENTIONAL,Due to a lack of funding
NCT01682148,TERMINATED,INTERVENTIONAL,The study was terminated early due to slow recruitment.
NCT01682252,TERMINATED,OBSERVATIONAL,investigators felt sufficient data has been collected
NCT01682434,WITHDRAWN,INTERVENTIONAL,Institution changed surgical method to small-incision lenticule extraction. Study never started.
NCT01682512,TERMINATED,INTERVENTIONAL,substance discontinued
NCT01682928,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01683188,TERMINATED,INTERVENTIONAL,slow accrual led to early closure.
NCT01683422,TERMINATED,INTERVENTIONAL,Updated chemotherapy regimens currently evaluated in clinical trials due to lack of progress in treating this condition; analysis continues in the realm of patterns of failure and increasing quality of life
NCT01683656,TERMINATED,INTERVENTIONAL,Withdrawal of IMP from the market. Data on risk-benefit ratio pending.
NCT01683747,TERMINATED,INTERVENTIONAL,Lower than anticipated enrollment
NCT01683825,TERMINATED,INTERVENTIONAL,Slow recruitment into the study due to competing study protocols
NCT01683864,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01684254,TERMINATED,OBSERVATIONAL,Lack of funding
NCT01684267,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01684657,SUSPENDED,INTERVENTIONAL,Study transferring to another facility
NCT01684696,WITHDRAWN,INTERVENTIONAL,unable to secure funding
NCT01684969,WITHDRAWN,INTERVENTIONAL,lack of accrual and funding is about to expire.
NCT01685034,WITHDRAWN,INTERVENTIONAL,Researcher deployed before approval
NCT01685151,WITHDRAWN,INTERVENTIONAL,Business Decision (please see below)
NCT01685255,TERMINATED,INTERVENTIONAL,Study was terminated by the sponsor for lack of evidence of superiority and slow study accrual.
NCT01685346,TERMINATED,INTERVENTIONAL,Research Cancelled
NCT01685489,WITHDRAWN,INTERVENTIONAL,funding sequestered
NCT01685606,TERMINATED,INTERVENTIONAL,Lack of accrual and low efficacy
NCT01685658,WITHDRAWN,INTERVENTIONAL,same study already published
NCT01685840,TERMINATED,INTERVENTIONAL,Project was stopped due to futility
NCT01686737,WITHDRAWN,INTERVENTIONAL,Recruitment problems
NCT01686880,TERMINATED,INTERVENTIONAL,poor recruitment and an unexpected low treatment rate
NCT01687413,TERMINATED,INTERVENTIONAL,Slow accrual and funding issues
NCT01687478,TERMINATED,INTERVENTIONAL,Interim assessment: Lack of efficacy
NCT01687543,TERMINATED,INTERVENTIONAL,Too low inclusion rate and several sites did not comply
NCT01687751,WITHDRAWN,INTERVENTIONAL,Study design determined to be not likely feasible
NCT01687972,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01687998,TERMINATED,INTERVENTIONAL,Study termination due to insufficient efficacy.
NCT01688336,TERMINATED,INTERVENTIONAL,Results unlikely to impact treatment patterns. Time to complete not justified.
NCT01688362,TERMINATED,INTERVENTIONAL,Did not meet target enrollment deadlines.
NCT01688414,WITHDRAWN,INTERVENTIONAL,PI left Stanford
NCT01688674,TERMINATED,INTERVENTIONAL,There was more benefit from the infusion arm compared to the bolus arm.
NCT01688752,WITHDRAWN,OBSERVATIONAL,Funding unavailable
NCT01688882,TERMINATED,INTERVENTIONAL,This study was stopped after Part 1 completed and was terminated because the predefined criteria of efficacy was not reached ( \>50% better then placebo)
NCT01689168,TERMINATED,INTERVENTIONAL,Funding ran out
NCT01689337,TERMINATED,INTERVENTIONAL,The study was discontinued due to low recruitment.
NCT01689415,TERMINATED,OBSERVATIONAL,Based on results from SYMPLICITY HTN-3
NCT01689506,TERMINATED,INTERVENTIONAL,Study stopped due to low recruitment
NCT01689597,WITHDRAWN,INTERVENTIONAL,Withdrawn - no participants enrolled
NCT01689883,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01689896,WITHDRAWN,INTERVENTIONAL,Difficult to obtain placebo
NCT01689922,TERMINATED,OBSERVATIONAL,slow enrollment
NCT01689948,TERMINATED,INTERVENTIONAL,difficulties of recruitment
NCT01689974,TERMINATED,INTERVENTIONAL,Study terminated because PI left institution. Planned Statistical analysis not available
NCT01690156,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was inadvertently entered in the system.
NCT01690195,TERMINATED,INTERVENTIONAL,Data obtained from the M11-428 study is not critical to the continued evaluation of ABT-126.
NCT01690325,TERMINATED,INTERVENTIONAL,Therapy of HER2+ patients according to protocol was no longer appropriate. Patient enrolment behind planned schedule and challenges of site performance
NCT01690468,TERMINATED,INTERVENTIONAL,"Enrollment stopped prior to Phase 1b, change in strategic focus"
NCT01690572,TERMINATED,INTERVENTIONAL,recruitment was not sufficient.
NCT01690637,TERMINATED,INTERVENTIONAL,Slower than anticipated participant accrual
NCT01690715,TERMINATED,OBSERVATIONAL,There was recruted subject
NCT01690910,TERMINATED,INTERVENTIONAL,Patient enrollment to low to support an analysis
NCT01691014,TERMINATED,OBSERVATIONAL,The study was terminated on 10DEC2014 due to the inability to enroll the planned number of patients. There were no safety concerns.
NCT01691196,WITHDRAWN,OBSERVATIONAL,Study not initiated
NCT01691235,WITHDRAWN,OBSERVATIONAL,No subjects enrolled due to delay in device production
NCT01691352,WITHDRAWN,INTERVENTIONAL,lack of sufficient population for recruitment
NCT01691443,TERMINATED,INTERVENTIONAL,Technical problem with one of the medical device used for the study.
NCT01691872,WITHDRAWN,INTERVENTIONAL,Development plan of retigabine XR in Japan was readjusted.
NCT01691963,WITHDRAWN,INTERVENTIONAL,"Main investigators (Pieters/van Zundert) changed institutions. Therefore, they were not able to start the study and decided to withdraw the study for now."
NCT01691976,WITHDRAWN,INTERVENTIONAL,No one recruited due to resource limitations. Issues with how complicated the study could be for patients so the study was later modified and turned into a different study.
NCT01692132,WITHDRAWN,OBSERVATIONAL,The company decided to cancel this study in conformity with PH FDA Circular 2013-004
NCT01692379,TERMINATED,INTERVENTIONAL,Following DSMB advice after first interim analysis (n=174)
NCT01692457,WITHDRAWN,OBSERVATIONAL,The company decided to cancel the study in conformity with Philippine FDA Circular 2013-004
NCT01692470,WITHDRAWN,OBSERVATIONAL,The company decided to cancel this study in conformity with Philippines FDA Circular 2013-004
NCT01692483,WITHDRAWN,OBSERVATIONAL,Sponsor determined study is not required according to PFDA Circular 2013-004
NCT01692626,TERMINATED,INTERVENTIONAL,Interim analysis shows no efficacy
NCT01692691,TERMINATED,INTERVENTIONAL,PI decision
NCT01692912,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT01693094,SUSPENDED,INTERVENTIONAL,Not adequate number of staff to continue study at the moment.
NCT01693120,TERMINATED,INTERVENTIONAL,The study was stopped solely based on lower than expected enrollment rate.
NCT01693276,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01693367,TERMINATED,INTERVENTIONAL,The medical device has been withdrawn from the market due to technical issues.
NCT01693484,TERMINATED,INTERVENTIONAL,Resource availability
NCT01693653,TERMINATED,INTERVENTIONAL,low enrollment
NCT01693887,TERMINATED,OBSERVATIONAL,The study difficulty is more serious than expected. The budget isn't enough.
NCT01693913,WITHDRAWN,INTERVENTIONAL,IRB approval canceled
NCT01694069,TERMINATED,INTERVENTIONAL,Recruitment was not sufficient to complete the study
NCT01694199,TERMINATED,INTERVENTIONAL,IDMC recommendation
NCT01694264,TERMINATED,INTERVENTIONAL,"Delayed recruitment, unable to meet calculated sample size"
NCT01694576,TERMINATED,INTERVENTIONAL,slow patient enrollment
NCT01694589,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT01694641,TERMINATED,INTERVENTIONAL,A general TL algorithm with higher predicting power became available in 2015 (Petersen et al.) and speed of recruitment was slower than expected.
NCT01694693,WITHDRAWN,OBSERVATIONAL,Business objectives have changed
NCT01695057,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01695330,TERMINATED,INTERVENTIONAL,Terminated by Sponsor of this study.
NCT01695473,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT01695707,WITHDRAWN,INTERVENTIONAL,Insufficient Funding.
NCT01695733,TERMINATED,INTERVENTIONAL,no longer had funding to continue
NCT01696045,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01696175,TERMINATED,OBSERVATIONAL,Researcher stopped activity at institution
NCT01696383,WITHDRAWN,INTERVENTIONAL,Management decision
NCT01696643,TERMINATED,INTERVENTIONAL,A review of blinded data indicates that the number of participant exposures needed to reach ICH standards has been met
NCT01696851,WITHDRAWN,OBSERVATIONAL,no more interested in this issue
NCT01696890,TERMINATED,INTERVENTIONAL,"lack of inclusions, sudden withdrawal of study coordinator"
NCT01696942,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01697072,TERMINATED,INTERVENTIONAL,All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data Monitoring Committee safety review of study 20070622.
NCT01697293,TERMINATED,INTERVENTIONAL,criteria for continuing enrollment in Phase 2 portion was not met
NCT01697332,TERMINATED,INTERVENTIONAL,Funding ended prior to resolution of all equipment (polarizer) issues.
NCT01697514,WITHDRAWN,INTERVENTIONAL,Trial stopped early for poor accrual.
NCT01697735,TERMINATED,INTERVENTIONAL,Because of lack of participants and funds
NCT01698125,TERMINATED,OBSERVATIONAL,Practical circumstances made it too difficult to carry out as planned.
NCT01698229,TERMINATED,OBSERVATIONAL,Study interest shifted
NCT01698281,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01698567,TERMINATED,INTERVENTIONAL,Challenges enrolling subjects in study
NCT01698606,TERMINATED,INTERVENTIONAL,Phase 1 (Feasibility) completed. Currently no funding to launch Phase 2 (RCT).
NCT01698710,TERMINATED,INTERVENTIONAL,expiration of IRB approval
NCT01698892,TERMINATED,INTERVENTIONAL,End study
NCT01698944,TERMINATED,INTERVENTIONAL,The trial was prematurely terminated due to low recruitment
NCT01698983,TERMINATED,OBSERVATIONAL,data not as expected
NCT01699581,TERMINATED,INTERVENTIONAL,Research cancelled following interim analysis
NCT01699646,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01699672,TERMINATED,INTERVENTIONAL,"Problems recruiting patients (not willing, travel time, no respons)"
NCT01699854,TERMINATED,INTERVENTIONAL,Expiration of the placebo patch
NCT01700010,WITHDRAWN,INTERVENTIONAL,Funding issues.
NCT01700114,TERMINATED,OBSERVATIONAL,FDA withdrew requirement to complete study
NCT01700166,WITHDRAWN,INTERVENTIONAL,"Principal Investigator relocated; Study may resume in Fl Hosp. for Children, Orlando FL"
NCT01700348,TERMINATED,INTERVENTIONAL,Terminated by financier due to low accrual \& high number of protocol deviations.
NCT01700491,TERMINATED,INTERVENTIONAL,Difficulty in recruiting and maintenance of blinding necessary for the trial
NCT01700569,TERMINATED,INTERVENTIONAL,changing the standard of care
NCT01700790,TERMINATED,INTERVENTIONAL,No Further Funding
NCT01700816,TERMINATED,INTERVENTIONAL,Low incidence of delirium.
NCT01700972,WITHDRAWN,INTERVENTIONAL,The study did not recruit/no study activity occurred.
NCT01701037,TERMINATED,INTERVENTIONAL,"PI leaving VICC, low future accrual predicted, continued funding improbable,"
NCT01701128,TERMINATED,INTERVENTIONAL,Protocol is completed
NCT01701297,TERMINATED,INTERVENTIONAL,Unable to obtain QP release certification from the manufacturer (VSL3) for shipment of IMP
NCT01701349,WITHDRAWN,INTERVENTIONAL,Expected inability to recruit study participants in a reasonable amount of time.
NCT01701375,TERMINATED,INTERVENTIONAL,Material sponsor withdrew support
NCT01701531,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT01701622,TERMINATED,INTERVENTIONAL,unable to enroll participants
NCT01701843,TERMINATED,INTERVENTIONAL,prematurely terminated because of low recruitment
NCT01701856,TERMINATED,INTERVENTIONAL,Problems to recruit the needed number of patients in the planned time
NCT01701934,TERMINATED,INTERVENTIONAL,The recruitment of the study was prematurely stopped in July 2014 for the following reason; no more study medication.
NCT01701960,WITHDRAWN,OBSERVATIONAL,no time
NCT01702350,TERMINATED,INTERVENTIONAL,Study was terminated in March 2012 due to lack of eficacy in a seperate Phase II study in patients.
NCT01702415,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01702558,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate study after 70% of participants had experienced a progression-free survival event.
NCT01702714,WITHDRAWN,INTERVENTIONAL,Project Team decision
NCT01702792,TERMINATED,INTERVENTIONAL,Investigator is leaving Dartmouth
NCT01702896,TERMINATED,INTERVENTIONAL,PI Decision
NCT01702909,TERMINATED,INTERVENTIONAL,PI Decision
NCT01703039,TERMINATED,INTERVENTIONAL,"PI departure, slow recruitment"
NCT01703065,TERMINATED,INTERVENTIONAL,Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.
NCT01703182,TERMINATED,OBSERVATIONAL,Stopped due to feasibility
NCT01703208,TERMINATED,INTERVENTIONAL,The study was terminated for business reasons and not due to any safety or efficacy concerns related to omarigliptin
NCT01703260,TERMINATED,INTERVENTIONAL,Company decision; No safety or efficacy concerns (see detailed description)
NCT01703767,WITHDRAWN,OBSERVATIONAL,We did not have sufficient funds to conduct the study.
NCT01704027,TERMINATED,INTERVENTIONAL,termination of the trial after interim analysis. the main criterion could not be reached
NCT01704209,TERMINATED,INTERVENTIONAL,Company stopped making product for cosmetic use. All consented subjects withdrew before any study interventions were performed.
NCT01704599,TERMINATED,INTERVENTIONAL,side effect and poor clinical outcome
NCT01704690,TERMINATED,INTERVENTIONAL,The enrollment of the study is much slower than expected.
NCT01704742,WITHDRAWN,OBSERVATIONAL,Protocol not considered a clinical trial for registration purposes; no subjects enrolled to date pending further grant funding
NCT01704885,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01704924,WITHDRAWN,INTERVENTIONAL,"No study subjects enrolled, Investigator decided to cancel the project"
NCT01705080,TERMINATED,OBSERVATIONAL,Abbott made a decision to not further develop the RDN program.
NCT01705106,TERMINATED,INTERVENTIONAL,The study was terminated early due to slow accrual.
NCT01705262,TERMINATED,OBSERVATIONAL,Phophoral was no longer used as a preparation before coloscopies at OUH
NCT01705353,TERMINATED,OBSERVATIONAL,study stopped because patient access became extremely limited for the initial data entry point.
NCT01705366,TERMINATED,OBSERVATIONAL,Changes in funding.
NCT01705392,TERMINATED,INTERVENTIONAL,Lack of financing of the study drug. Not sufficient financial support.
NCT01705405,TERMINATED,INTERVENTIONAL,due to a problem of device
NCT01705470,WITHDRAWN,INTERVENTIONAL,"PI left the medical center, no replacement assigned"
NCT01705483,TERMINATED,INTERVENTIONAL,"Based on the results of the Phase 1 data, the company decided not to pursue the development of this drug at this time."
NCT01705496,TERMINATED,INTERVENTIONAL,The sensitivity and specificity were not able to be assessed in this study due to the poor image quality.
NCT01705509,TERMINATED,INTERVENTIONAL,Study terminated due to lack of resources.
NCT01705652,TERMINATED,INTERVENTIONAL,loss of funding
NCT01705834,WITHDRAWN,OBSERVATIONAL,The study protocol has been replaced with a two-glove protocol NCT02026245
NCT01705899,SUSPENDED,INTERVENTIONAL,Pausing of allotransplant program due to logistic issues.
NCT01706107,TERMINATED,OBSERVATIONAL,Due to on-going enrollment challenges
NCT01706159,TERMINATED,INTERVENTIONAL,Trial screening data did not support the medical hypothesis
NCT01706237,WITHDRAWN,INTERVENTIONAL,Nexis Vision was unable to provide the shields to continue with the study.
NCT01706822,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01706887,TERMINATED,INTERVENTIONAL,end of recruitment period was reach
NCT01707680,TERMINATED,OBSERVATIONAL,Halted due to slow recruitment
NCT01707758,WITHDRAWN,OBSERVATIONAL,Trial terminated - Nanoscale Company out of business
NCT01707823,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT01707875,TERMINATED,OBSERVATIONAL,Difficulties in recruiting
NCT01708109,TERMINATED,INTERVENTIONAL,Lack of recruting patients to the study
NCT01708187,TERMINATED,INTERVENTIONAL,Protocol halted due to less than anticipated recruitment.
NCT01708265,TERMINATED,INTERVENTIONAL,low inclusion rate
NCT01708590,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01708603,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01708629,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01708798,TERMINATED,INTERVENTIONAL,Futility
NCT01708811,TERMINATED,OBSERVATIONAL,Few biopsies showed the expected pattern We suspect erroeneous method.
NCT01709006,TERMINATED,INTERVENTIONAL,Not enough patients to conclude
NCT01709136,TERMINATED,INTERVENTIONAL,Sirolimus usage discontinued since black box warning
NCT01709162,TERMINATED,INTERVENTIONAL,Discontinued early due to enrollment challenges and changes in treatment standards
NCT01709201,WITHDRAWN,INTERVENTIONAL,Study did not receive funding and was administratively withdrawn.
NCT01709240,WITHDRAWN,INTERVENTIONAL,Internal decision
NCT01709396,SUSPENDED,INTERVENTIONAL,initial on hold due to space but now permanently suspended due to futility.
NCT01709474,TERMINATED,INTERVENTIONAL,Due to slow enrollment
NCT01709526,TERMINATED,INTERVENTIONAL,Study couldnt start due to investigator
NCT01709734,TERMINATED,INTERVENTIONAL,"Study was terminated prematurely in all investigational study centers upon recommendation from the study's Data Monitoring Committee (DMC).

Study was stopped due to lack of efficacy."
NCT01709968,TERMINATED,INTERVENTIONAL,"Blinded interim analysis Recommendation, submitted April 1, 2014, was early termination for futility."
NCT01710150,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01710228,WITHDRAWN,INTERVENTIONAL,sponsor stopped
NCT01710293,WITHDRAWN,INTERVENTIONAL,Unable to obtain data needed to run the RCT; project never began recruitment
NCT01710410,WITHDRAWN,INTERVENTIONAL,Funding
NCT01710462,WITHDRAWN,INTERVENTIONAL,Change of company's strategy
NCT01710683,WITHDRAWN,OBSERVATIONAL,No participants were enrolled.
NCT01710865,WITHDRAWN,INTERVENTIONAL,withdrawn
NCT01711450,WITHDRAWN,INTERVENTIONAL,"Institutional Ethics Board concern regarding sham procedure, requiring modifications that are not feasible within the man-power limitations of our institution."
NCT01711580,WITHDRAWN,OBSERVATIONAL,Another study was commenced for this patient group
NCT01711619,TERMINATED,INTERVENTIONAL,Challenges to recruit qualified participants
NCT01711996,WITHDRAWN,OBSERVATIONAL,Difficulty in purchasing reagents and receiving consent from the subject
NCT01712074,TERMINATED,INTERVENTIONAL,"The study was terminated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns."
NCT01712087,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT01712269,TERMINATED,INTERVENTIONAL,PI and main Co-I (Dr Edwards) relocated locations
NCT01712399,TERMINATED,INTERVENTIONAL,"The study was terminated after approximately 3 years due to future clinical development plans, including ethical considerations."
NCT01712412,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01712477,TERMINATED,INTERVENTIONAL,Difficulty in recruiting
NCT01712633,TERMINATED,OBSERVATIONAL,Changes to funding
NCT01712659,TERMINATED,INTERVENTIONAL,The adult T-cell leukemia (ATL) research program was terminated after the death of the T-cell malignancy group Lead investigator.
NCT01712685,TERMINATED,INTERVENTIONAL,Study was closed to accrual because imaging agent was no longer available.
NCT01712815,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT01712854,TERMINATED,INTERVENTIONAL,Closed by study sponsor; PI left the institution; responsible party changed to Columbia
NCT01712880,WITHDRAWN,INTERVENTIONAL,The study was not feasible.
NCT01712945,TERMINATED,INTERVENTIONAL,interim anlaysis failed: palifermin does not promote thymopoeisis after alemtuzumab
NCT01713127,TERMINATED,INTERVENTIONAL,declined enrollment
NCT01713569,TERMINATED,INTERVENTIONAL,Slow subject enrollment; study to be obtained is no longer required.
NCT01713595,WITHDRAWN,INTERVENTIONAL,difficult getting subjects
NCT01713803,WITHDRAWN,INTERVENTIONAL,FDA did not require a clinical trial for indication.
NCT01713907,TERMINATED,INTERVENTIONAL,Inadequate study staff to appropriately manage trial.
NCT01714128,WITHDRAWN,INTERVENTIONAL,Study Funding no longer available
NCT01714622,WITHDRAWN,OBSERVATIONAL,Canceled study due to delay of progress procedure and failure to obtain research funds.
NCT01714648,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT01714791,TERMINATED,INTERVENTIONAL,Lack of new inclusions due to a significant change in surgery technique. An endoscopic a-traumatic coronary artery bypass (endo-ACAB) approach is now used.
NCT01714817,TERMINATED,INTERVENTIONAL,Inability to meet protocol objectives.
NCT01714986,WITHDRAWN,INTERVENTIONAL,Not active
NCT01715012,TERMINATED,INTERVENTIONAL,Enrollment futility
NCT01715051,WITHDRAWN,INTERVENTIONAL,Funding was not received
NCT01715103,TERMINATED,INTERVENTIONAL,Results of primary outcome are not satisfactory in terms of RNA quality
NCT01715311,WITHDRAWN,INTERVENTIONAL,withdrawn prior to patient recruitment
NCT01715363,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01715571,TERMINATED,INTERVENTIONAL,Unable to obtain adequate recruitment
NCT01715610,WITHDRAWN,INTERVENTIONAL,unsuccessful recruitment
NCT01715883,TERMINATED,INTERVENTIONAL,Lack of support staff
NCT01716039,TERMINATED,INTERVENTIONAL,Unable to achieve recruitment target.
NCT01716052,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT01716182,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT01716234,TERMINATED,INTERVENTIONAL,Study was terminated early (10 July 2015) based on preliminary analysis of pharmacokinetic data.
NCT01716429,WITHDRAWN,INTERVENTIONAL,No participants were recruited over the course of the study time period
NCT01716546,TERMINATED,INTERVENTIONAL,Not reached the primary endpoint target according to the statistical design
NCT01716650,TERMINATED,OBSERVATIONAL,no available participants
NCT01717040,TERMINATED,INTERVENTIONAL,The study ended early due to budgetary issues
NCT01717079,TERMINATED,INTERVENTIONAL,Protocol stopped for safety reason
NCT01717378,TERMINATED,OBSERVATIONAL,This is a voluntary registry formerly managed by a unit within CTSI that was disbanded in 2013. The registry has been dormant since that time.
NCT01717456,TERMINATED,INTERVENTIONAL,Low enrollment led sponsor to terminate study early.
NCT01717482,TERMINATED,INTERVENTIONAL,Poor accrual and funding ended
NCT01717651,TERMINATED,OBSERVATIONAL,slow accrual made study completion unfeasible
NCT01717677,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT01717846,WITHDRAWN,INTERVENTIONAL,The PI has left UCLA and we do not plan to pursue this study.
NCT01717898,TERMINATED,INTERVENTIONAL,Dose limiting toxicities on lowest dose level
NCT01717937,TERMINATED,OBSERVATIONAL,insufficient enrollment
NCT01718223,WITHDRAWN,INTERVENTIONAL,implementation issues
NCT01718444,TERMINATED,INTERVENTIONAL,"The primary investigator moved from academic practice to join a private group, and could not get any one to take over as PI for the study."
NCT01718704,WITHDRAWN,INTERVENTIONAL,Study was stopped due to inability to accrue patients because of competing trials.
NCT01718756,SUSPENDED,INTERVENTIONAL,No enough fund or cases
NCT01718782,WITHDRAWN,INTERVENTIONAL,Other studies with the same protocol have already published.
NCT01718795,TERMINATED,INTERVENTIONAL,"Recruiting too slow, down to 1-0 patients per month"
NCT01718808,TERMINATED,INTERVENTIONAL,FU for 3 years from randomization as initially planned is stopped as we do not expect any changes to the endpoints in the future after one year of FU.
NCT01719042,WITHDRAWN,INTERVENTIONAL,No recruitment was achievable
NCT01719471,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT01719588,WITHDRAWN,OBSERVATIONAL,The company decided to cancel this study in conformity with PH FDA Circular 2013-004
NCT01719601,WITHDRAWN,OBSERVATIONAL,The company decided to cancel this study in conformity with PH FDA Circular 2013-004
NCT01719809,TERMINATED,OBSERVATIONAL,Enrollment Goals not met
NCT01719861,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01720017,TERMINATED,INTERVENTIONAL,Difficulty was encountered with the subjects completing their required 20 intubations in patients with at least one predictor of difficult intubation.
NCT01720043,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01720056,TERMINATED,INTERVENTIONAL,Objective of study achieved after interim analysis.
NCT01720563,TERMINATED,INTERVENTIONAL,Change study drug dosage form
NCT01720693,TERMINATED,INTERVENTIONAL,Low accrual
NCT01720745,TERMINATED,OBSERVATIONAL,PI no longer at University of Minnesota
NCT01720901,SUSPENDED,INTERVENTIONAL,Accrual limitations
NCT01721135,WITHDRAWN,INTERVENTIONAL,Study was terminated due to toxicology findings after screening started but before first subject first dose.
NCT01721174,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01721317,TERMINATED,INTERVENTIONAL,"After reevaluation of the benefit: risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate."
NCT01721330,TERMINATED,INTERVENTIONAL,Competing studies
NCT01721577,TERMINATED,INTERVENTIONAL,Investigator went to another institution.
NCT01721603,TERMINATED,INTERVENTIONAL,Low accrual
NCT01721616,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT01721694,WITHDRAWN,INTERVENTIONAL,withdrawn by industry
NCT01721707,WITHDRAWN,INTERVENTIONAL,withdrawn by industry
NCT01721850,TERMINATED,INTERVENTIONAL,Trial insurance could not be prolonged any more and expired
NCT01721902,TERMINATED,INTERVENTIONAL,The study was terminiated due the lack of recruitment.
NCT01722175,WITHDRAWN,INTERVENTIONAL,Safety concerns.
NCT01722227,WITHDRAWN,INTERVENTIONAL,No Funding Received from ADA
NCT01722292,TERMINATED,INTERVENTIONAL,Change in clinical strategy.
NCT01722461,TERMINATED,INTERVENTIONAL,Sponsor decision; unexpectedly high sham response at primary outcome time point.
NCT01722474,TERMINATED,INTERVENTIONAL,"Minor device modifications required, move revised device to clinical site in USA."
NCT01722890,TERMINATED,OBSERVATIONAL,"As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up."
NCT01723085,TERMINATED,OBSERVATIONAL,It has been put on hold for the moment due to logistic problems
NCT01723124,TERMINATED,INTERVENTIONAL,Dose specified in protocol was not adequate to achieve optimal resolution.
NCT01723176,WITHDRAWN,OBSERVATIONAL,"study never got off the ground, no pts ever recruited"
NCT01723306,SUSPENDED,INTERVENTIONAL,Funding
NCT01723371,WITHDRAWN,INTERVENTIONAL,Due to lack of enrollment.
NCT01723397,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01723488,TERMINATED,INTERVENTIONAL,Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.
NCT01723501,WITHDRAWN,INTERVENTIONAL,The study was not started and prematurely closed.
NCT01723631,TERMINATED,INTERVENTIONAL,The number of patients achieved is sufficient to evaluate the diagnostic performance of the test TRAP-myelin
NCT01723813,TERMINATED,INTERVENTIONAL,due to end of validity of peptide vaccine
NCT01724073,WITHDRAWN,INTERVENTIONAL,Approval denied by national ethical committee of Burkina Faso
NCT01724242,WITHDRAWN,INTERVENTIONAL,Inability to recruit patients
NCT01724619,TERMINATED,INTERVENTIONAL,Study tracer can no longer be obtained at our institution
NCT01724918,TERMINATED,INTERVENTIONAL,Time limitation for recruitment exceeded. 72 of 90 estimated sample recruited.
NCT01725113,TERMINATED,INTERVENTIONAL,Nationwide shortage of study meds in 2013 loss of funding \& competing studies
NCT01725256,TERMINATED,INTERVENTIONAL,Terminated early dt to acquisition of Sponsor and change in corporate priorities
NCT01725269,TERMINATED,INTERVENTIONAL,Terminated early dt acquisition of Sponsor and change in corporate priorities
NCT01725334,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01725672,TERMINATED,INTERVENTIONAL,Due to changes in EMA guidelines on modified release dosage forms (Feb 2013; EMA/CHMP/EWP/280/96). The Part B formulation would not meet the new guidelines.
NCT01725854,TERMINATED,INTERVENTIONAL,Loss of staff for completion
NCT01725880,TERMINATED,OBSERVATIONAL,Based on a business decision unrelated to any safety concerns.
NCT01726166,TERMINATED,INTERVENTIONAL,Slow recruitment over 3 yrs (n=47). No chance to reach sample size (n=\~160).
NCT01726309,TERMINATED,OBSERVATIONAL,"As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up."
NCT01726322,TERMINATED,OBSERVATIONAL,"As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up."
NCT01726348,WITHDRAWN,OBSERVATIONAL,The company decided to cancel this study in conformity with PH FDA Circular 2013-004
NCT01726361,WITHDRAWN,INTERVENTIONAL,We were not able to recruit families
NCT01726465,TERMINATED,INTERVENTIONAL,The first phase was completed
NCT01726569,WITHDRAWN,INTERVENTIONAL,study sites were reconsidered.
NCT01726660,WITHDRAWN,INTERVENTIONAL,Unfunded
NCT01726907,WITHDRAWN,INTERVENTIONAL,Stopped due to failure to recruit appropriate target patients
NCT01726920,WITHDRAWN,INTERVENTIONAL,"Due to budget limitations, the company decided to withdraw this study."
NCT01727154,TERMINATED,OBSERVATIONAL,Administrative reasons
NCT01727167,TERMINATED,INTERVENTIONAL,Lack of funding and low accrual.
NCT01727336,TERMINATED,INTERVENTIONAL,The study was terminated by the sponsor following unblinding of the Progression Free Survival endpoint.
NCT01727401,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT01727544,WITHDRAWN,INTERVENTIONAL,Changed to a retrospective chart review
NCT01727557,TERMINATED,INTERVENTIONAL,Low Accural Rate
NCT01727908,TERMINATED,INTERVENTIONAL,guideline developed
NCT01728103,TERMINATED,OBSERVATIONAL,Corporate decision to spend money on other development programs.
NCT01728116,TERMINATED,INTERVENTIONAL,Higher than anticipated rate of Hepatic abscess (N=7)
NCT01728181,WITHDRAWN,INTERVENTIONAL,Stopped before approval due to ineffective drug
NCT01728207,TERMINATED,INTERVENTIONAL,Study was stopped due to insufficient efficacy and very slow accrual
NCT01728259,TERMINATED,INTERVENTIONAL,"FDA placed the study on a clinical hold, due to the concerns by the FDA and Health Canada, Celgene decided to permanently close the study."
NCT01728480,WITHDRAWN,INTERVENTIONAL,Financial Sponsor requested termination
NCT01728519,TERMINATED,INTERVENTIONAL,Recruitment was stopped before start of the pollen season
NCT01728649,WITHDRAWN,INTERVENTIONAL,unable to be funded
NCT01728961,TERMINATED,INTERVENTIONAL,Slow accrual and funding limitations.
NCT01728987,WITHDRAWN,INTERVENTIONAL,study stopped due to Financial problems
NCT01729104,TERMINATED,INTERVENTIONAL,Low response
NCT01729312,TERMINATED,OBSERVATIONAL,Not enough participants to validate study.
NCT01729884,TERMINATED,INTERVENTIONAL,Study ended early due to slow enrollment
NCT01729923,TERMINATED,INTERVENTIONAL,Funding ended
NCT01730001,WITHDRAWN,INTERVENTIONAL,"Withdrawn, no patients included"
NCT01730157,TERMINATED,INTERVENTIONAL,Research Cancelled
NCT01730248,TERMINATED,INTERVENTIONAL,Decision by Sponsor to to terminate the study early.
NCT01730313,WITHDRAWN,INTERVENTIONAL,Did not get approval from the collaborating partners in-country
NCT01730443,TERMINATED,OBSERVATIONAL,Parent trial (ProTECT III) stopped for futility
NCT01730495,TERMINATED,INTERVENTIONAL,"After inclusion of four patients, two experienced moderate worsening of symptoms"
NCT01731028,WITHDRAWN,OBSERVATIONAL,Change of local requirements
NCT01731106,TERMINATED,OBSERVATIONAL,Slow recruitment rate
NCT01731210,TERMINATED,INTERVENTIONAL,Study stopped due to investigational device deficiency
NCT01731535,WITHDRAWN,OBSERVATIONAL,It was a project initiated by a trainee but did not progress to subject accrual.
NCT01731587,WITHDRAWN,INTERVENTIONAL,The objectives of this trial are no longer deemed appropriate for the clinical development of L-BLP25 therefore this trial is withdrawn
NCT01731691,TERMINATED,INTERVENTIONAL,Blinded review of the data suggested no significant diferences in outcomes.
NCT01731704,WITHDRAWN,INTERVENTIONAL,Insufficient staff
NCT01731964,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01731990,TERMINATED,INTERVENTIONAL,The study got terminated based on result from primary endpoint analysis
NCT01732055,TERMINATED,INTERVENTIONAL,Study ended because recruitment goals unmet and further funding unlikely
NCT01732107,TERMINATED,INTERVENTIONAL,Development of dovitinib was stopped.
NCT01732211,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01732341,TERMINATED,INTERVENTIONAL,Decision to discontinue patient follow-up at 2 years.
NCT01732510,TERMINATED,INTERVENTIONAL,The study was prematurely stopped due to business reasons.
NCT01732549,TERMINATED,INTERVENTIONAL,Development of tasquinimod in prostate cancer discontinued
NCT01732640,TERMINATED,INTERVENTIONAL,Slow accrual and high levels of toxicity lead to early termination.
NCT01732887,TERMINATED,INTERVENTIONAL,We were not able to recruit enough participants during the funding period.
NCT01733043,WITHDRAWN,INTERVENTIONAL,Failure to secure funding
NCT01733095,WITHDRAWN,INTERVENTIONAL,slow recruitment
NCT01733355,TERMINATED,INTERVENTIONAL,Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals.
NCT01733615,TERMINATED,OBSERVATIONAL,Original PI relocated to another institution
NCT01733641,TERMINATED,OBSERVATIONAL,Limited eligible sample size for study outcomes
NCT01733654,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01733680,TERMINATED,INTERVENTIONAL,Study stopped due to lack of recruitment
NCT01733836,WITHDRAWN,INTERVENTIONAL,The reason for this decision is that this study is being merged with a larger multi-centre study using the same agent in the same population.
NCT01733966,TERMINATED,INTERVENTIONAL,difficulties to recruit patients who suffer from this pathology
NCT01734057,WITHDRAWN,INTERVENTIONAL,No eligible patient was enrolled.
NCT01734174,WITHDRAWN,OBSERVATIONAL,Unable to obtain 3D TTE to complete study procedure.
NCT01734694,TERMINATED,INTERVENTIONAL,Independent biostatistician recommended early termination of the trial due to low probability of success.
NCT01734824,SUSPENDED,INTERVENTIONAL,no patients randomized
NCT01734941,TERMINATED,INTERVENTIONAL,Well tolerated but failed to demonstrate significant activity. So it did not meet its primary endpoint or key secondary endpoints.
NCT01735396,TERMINATED,INTERVENTIONAL,poor accrual
NCT01735474,SUSPENDED,INTERVENTIONAL,Sample size was not completed
NCT01735552,TERMINATED,OBSERVATIONAL,Unable to recruit participants
NCT01735916,TERMINATED,INTERVENTIONAL,The study was terminated early due to low enrollment.
NCT01736007,WITHDRAWN,INTERVENTIONAL,was not able to recruit participants
NCT01736215,TERMINATED,OBSERVATIONAL,This study was terminated regarding to slow enrollment.
NCT01736267,TERMINATED,INTERVENTIONAL,Closed by IRB
NCT01736358,TERMINATED,INTERVENTIONAL,Interim analysis showed futility of primary endpoint
NCT01736579,TERMINATED,INTERVENTIONAL,The study was terminated because the first Phase 3 did not demonstrate efficacy on the co-primary endpoints. The known safety profile remained unchanged.
NCT01736722,WITHDRAWN,INTERVENTIONAL,"PI change and no enrollment ever, therefore no data available."
NCT01736800,WITHDRAWN,INTERVENTIONAL,No enrollment and PI requested study termination per IRB system.
NCT01736878,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to unanticipated hassle in patient recruitment.
NCT01737073,WITHDRAWN,INTERVENTIONAL,This study was unable to overcome IT and contracting barriers which prevented the study's data collection system from being implemented.
NCT01737086,TERMINATED,INTERVENTIONAL,Terminated due to lack of eligible patients.
NCT01737151,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01737541,TERMINATED,INTERVENTIONAL,Study recruitment was suspended due to lack of funding
NCT01737593,TERMINATED,INTERVENTIONAL,Interim analysis revealed a negative effect.
NCT01737645,TERMINATED,OBSERVATIONAL,Difficulty in enrolling subjects.
NCT01737788,TERMINATED,INTERVENTIONAL,Due to slow recruitment and an interim analysis showing no benefit of occlusion.
NCT01737827,TERMINATED,INTERVENTIONAL,The study recruitment was ended due to difficulties in identifying subjects who meet the eligibility criteria and therefore the study never reached its planned sample size per protocol. The study termination was not due to any safety concerns.
NCT01737879,TERMINATED,INTERVENTIONAL,"Terminated: Test article, Omontys, was recalled from the market; Enrollment has halted prematurely and will not resume; participants are no longer being treated"
NCT01737892,TERMINATED,INTERVENTIONAL,unable to validate analytical method
NCT01738243,TERMINATED,INTERVENTIONAL,recruitment challenges
NCT01738360,TERMINATED,INTERVENTIONAL,Difficulty of inclusions and a sufficient number of relevant clinical information
NCT01738594,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01738620,TERMINATED,INTERVENTIONAL,In October 2015 ICU's setting completely changed from an open concept 8-beds unit to a single bed isolated room.
NCT01738633,TERMINATED,INTERVENTIONAL,Surgical Unit closed and moved.
NCT01738685,WITHDRAWN,INTERVENTIONAL,No funding.
NCT01738698,TERMINATED,INTERVENTIONAL,Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized.
NCT01738724,TERMINATED,INTERVENTIONAL,PI went for a post-doc course and when he came back he moved for another job
NCT01738841,WITHDRAWN,OBSERVATIONAL,Local authorities no longer require routine PMS studies; GSK does not believe the study would add meaningfully to the safety data already available for MMRV.
NCT01739400,TERMINATED,INTERVENTIONAL,Primary endpoint of parent study AC-055-305/MAESTRO (NCT01743001) not met.
NCT01739439,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01739491,WITHDRAWN,OBSERVATIONAL,The study is cancelled. FDA Circular 2013-004 mandates that PMSs like this are not required
NCT01739504,TERMINATED,INTERVENTIONAL,company dissolved
NCT01739556,TERMINATED,INTERVENTIONAL,"An interim analysis showed that there is no difference in the primary endpoint, given the small number of events in the groups examined."
NCT01739738,WITHDRAWN,OBSERVATIONAL,Study did not start
NCT01739790,TERMINATED,INTERVENTIONAL,PI discretion
NCT01739842,WITHDRAWN,INTERVENTIONAL,Funding was not received for this study.
NCT01740154,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01740180,TERMINATED,OBSERVATIONAL,No recruitment
NCT01740375,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01740388,TERMINATED,INTERVENTIONAL,Strategic business decision
NCT01740401,TERMINATED,INTERVENTIONAL,Primary Endpoint not met
NCT01740596,TERMINATED,INTERVENTIONAL,The study was stopped early due to a business decision to no longer pursue commercialization of the C-PULSE System. This decision was not based on any safety concerns.
NCT01740726,TERMINATED,INTERVENTIONAL,Lack of success with recruitment
NCT01740739,SUSPENDED,OBSERVATIONAL,Evaluating cohort for value
NCT01740947,TERMINATED,INTERVENTIONAL,Superiority was no longer attainable
NCT01740999,TERMINATED,INTERVENTIONAL,Non achievement of the estimated sample size of the group silicone arthroplasty in a reasonable recruitment time.
NCT01741038,WITHDRAWN,INTERVENTIONAL,moved study to USA
NCT01741103,WITHDRAWN,INTERVENTIONAL,"Study funding was for 1 year to a fellow who graduated in early stages of enrollment. While 6 patients were enrolled, many patients didn't finish the study and therefore little data was collected and no results will be entered."
NCT01741142,TERMINATED,INTERVENTIONAL,Decision based on strategic determination; not safety.
NCT01741155,TERMINATED,INTERVENTIONAL,The study did not meet efficacy end point and did not enroll patients in the randomized phase.
NCT01741376,WITHDRAWN,INTERVENTIONAL,All clinical trials within the Department of Psychiatry at UMN were suspended and this study was withdrawn due to no enrollment.
NCT01741597,WITHDRAWN,INTERVENTIONAL,PI chose to close the study
NCT01741753,TERMINATED,INTERVENTIONAL,Due to slow accrual the supllier of BKM120 asked we cease further enrollment.
NCT01741805,WITHDRAWN,OBSERVATIONAL,Slow recruitment of patients
NCT01741909,WITHDRAWN,INTERVENTIONAL,Due to recruiting issues
NCT01741948,WITHDRAWN,OBSERVATIONAL,the study has never started. my grant request was denied.
NCT01742156,TERMINATED,OBSERVATIONAL,inadequate number of recruita
NCT01742273,TERMINATED,INTERVENTIONAL,Termination stopped due to low recruitment rates
NCT01742338,TERMINATED,INTERVENTIONAL,Lack of research staff to recruit participants
NCT01742754,TERMINATED,INTERVENTIONAL,IND required by the FDA for all future FMTs.
NCT01742793,TERMINATED,INTERVENTIONAL,"The study was terminated due to withdrawal of institutional support, Phase II never began."
NCT01742858,WITHDRAWN,OBSERVATIONAL,The study was halted due to logistical reasons.
NCT01743170,SUSPENDED,INTERVENTIONAL,Recruitment by GPs proved to be impossible
NCT01743313,TERMINATED,OBSERVATIONAL,Primary researcher not able to continue research at the moment.
NCT01743547,TERMINATED,INTERVENTIONAL,The investigators concluded that it is not feasible due to the lack of participation and difficulty in recruiting patients.
NCT01743807,TERMINATED,INTERVENTIONAL,SBI Biotech who provided the drug for this study has decided to no longer support the study or GNKG168.
NCT01743937,TERMINATED,INTERVENTIONAL,Sponsor terminated due to budgetary issue
NCT01743976,TERMINATED,INTERVENTIONAL,Failure to recruit subjects
NCT01744015,WITHDRAWN,INTERVENTIONAL,We did not receive funding
NCT01744054,TERMINATED,INTERVENTIONAL,Logistics regarding PET/CT portion of study
NCT01744080,WITHDRAWN,INTERVENTIONAL,Logistic issues could not be resolved - study closed without any patients recruited
NCT01744145,TERMINATED,INTERVENTIONAL,not enough enrollment
NCT01744171,TERMINATED,INTERVENTIONAL,Study was Suspended since 2018; PI decided to terminate.
NCT01744210,WITHDRAWN,OBSERVATIONAL,Decided not tostart study because of unavailability of staff
NCT01744275,SUSPENDED,INTERVENTIONAL,Lack of funding
NCT01744522,TERMINATED,OBSERVATIONAL,We were not able to recruit enough patients for this study within a given time frame.
NCT01744639,WITHDRAWN,INTERVENTIONAL,Unable to find patients
NCT01744821,TERMINATED,INTERVENTIONAL,Inability to recruit study subjects
NCT01744886,TERMINATED,INTERVENTIONAL,Inacceptable oxygen saturation values in one study group
NCT01744912,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT01745224,TERMINATED,INTERVENTIONAL,The study stopped because patient enrollment requirements were not met.
NCT01745354,TERMINATED,INTERVENTIONAL,Accrual issues - Slow accrual
NCT01745367,TERMINATED,INTERVENTIONAL,low enrollment
NCT01745536,WITHDRAWN,INTERVENTIONAL,NO RECRUITMENT
NCT01745692,TERMINATED,INTERVENTIONAL,"IDMC decision - recommended on basis of results from other relevant clinical trials, there were not safety concerns"
NCT01745718,WITHDRAWN,INTERVENTIONAL,The study was stopped for technical reasons
NCT01745809,WITHDRAWN,OBSERVATIONAL,Contractual issues
NCT01745913,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01746173,TERMINATED,INTERVENTIONAL,Slow accrual and futility
NCT01746290,WITHDRAWN,INTERVENTIONAL,The intervention (PulsePoint application) could not be implemented in Toronto as planned
NCT01746641,TERMINATED,INTERVENTIONAL,Occurrence of severe respiratory depression in the remifentanil group.
NCT01746810,TERMINATED,INTERVENTIONAL,Closed study as requested by PI due to lack of accruals
NCT01746875,TERMINATED,INTERVENTIONAL,treatment effects not as desired
NCT01746940,TERMINATED,INTERVENTIONAL,Trial operational issues.
NCT01747239,TERMINATED,INTERVENTIONAL,Too low inclusion rate. Only 4 patients included over 16 months
NCT01747408,TERMINATED,INTERVENTIONAL,The study met the pre-specified criteria for stopping the trial
NCT01747499,TERMINATED,INTERVENTIONAL,Enrolling 8 more patients would be statistically unlikely that the primary endpoint would be reached (reduce day 180 grade II-IV GVHD rates to 20% or less)
NCT01747512,WITHDRAWN,INTERVENTIONAL,Study was not initiated
NCT01747525,WITHDRAWN,OBSERVATIONAL,It was decided not to proceed with the study at this time.
NCT01747785,TERMINATED,OBSERVATIONAL,Study stopped for administrative reasons.
NCT01747876,TERMINATED,INTERVENTIONAL,Lack of efficacy caused enrollment to be stopped at the end of dose escalation
NCT01747954,TERMINATED,INTERVENTIONAL,Terminated
NCT01747993,TERMINATED,INTERVENTIONAL,low inclusion
NCT01748032,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT01748045,TERMINATED,INTERVENTIONAL,Enrollenment has been suspended due to poor enrollment
NCT01748110,WITHDRAWN,INTERVENTIONAL,Funding could not be secured
NCT01748123,WITHDRAWN,INTERVENTIONAL,Slow enrollment
NCT01748240,TERMINATED,INTERVENTIONAL,inefficiency
NCT01748305,TERMINATED,INTERVENTIONAL,Recruitment issues.
NCT01748591,TERMINATED,OBSERVATIONAL,Terminated due to problems enrolling adequate number of patients.
NCT01748708,WITHDRAWN,INTERVENTIONAL,The protocol has undergone significant changes and the investigator feels that it is reasonable to submit a new protocol for review and approval.
NCT01748851,TERMINATED,INTERVENTIONAL,Poor enrollment of patients
NCT01748890,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01749111,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01749241,WITHDRAWN,INTERVENTIONAL,no participant enrolled
NCT01749280,TERMINATED,OBSERVATIONAL,Study being continued as a multi centre MA3RS study.The patients will be followed up under MA3RS and AAA PET.
NCT01749293,TERMINATED,INTERVENTIONAL,The protocol design is being reconfigured in order to open a new study.
NCT01749423,WITHDRAWN,OBSERVATIONAL,Company decision due to enrollment challenges.
NCT01749488,WITHDRAWN,INTERVENTIONAL,The intervention becomes obsolete for participating centres pending regulatories.
NCT01749735,TERMINATED,INTERVENTIONAL,The study was terminated because of lack of funding.
NCT01749800,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01749826,TERMINATED,INTERVENTIONAL,The cytokines in the samples were undetectable.
NCT01750034,WITHDRAWN,INTERVENTIONAL,Feasibility issues
NCT01750164,TERMINATED,OBSERVATIONAL,discontinued funding
NCT01750476,TERMINATED,OBSERVATIONAL,PI and lab have re-located study to The Ohio State University
NCT01750684,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor due to insufficient enrollment.
NCT01750840,TERMINATED,OBSERVATIONAL,Slow enrollment and poor patient follow-up following enrollment
NCT01750866,WITHDRAWN,INTERVENTIONAL,No accrual
NCT01751100,WITHDRAWN,INTERVENTIONAL,We did not receive proper funding to complete this study.
NCT01751282,TERMINATED,INTERVENTIONAL,Left Institution where study was approved
NCT01751412,TERMINATED,INTERVENTIONAL,Slow accrual rates/ lack of funding
NCT01751425,TERMINATED,INTERVENTIONAL,Per PI Request. 2) No additional benefit was noted with the addition of Ruxolitinib.
NCT01751503,TERMINATED,INTERVENTIONAL,investigator no longer available on site
NCT01751633,TERMINATED,OBSERVATIONAL,Administrative reason. Lack of funding.
NCT01751724,TERMINATED,INTERVENTIONAL,Safety
NCT01751802,TERMINATED,INTERVENTIONAL,Study terminated for commercial reasons
NCT01751828,WITHDRAWN,INTERVENTIONAL,This was an initial unfunded pilot project stopped after similar studies were funded.
NCT01752023,TERMINATED,INTERVENTIONAL,Low Accrual
NCT01752231,TERMINATED,OBSERVATIONAL,Feasibility issues.
NCT01752569,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01752608,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01752790,WITHDRAWN,INTERVENTIONAL,The study will be part of a European multicenter trial (Infliximab Top-down Study in Kids with Crohn's disease)
NCT01752985,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT01753102,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01753388,WITHDRAWN,INTERVENTIONAL,The study was never initiated
NCT01753492,TERMINATED,INTERVENTIONAL,The results were disappointing.
NCT01753674,TERMINATED,INTERVENTIONAL,non-compliance issues
NCT01753830,TERMINATED,INTERVENTIONAL,Study terminated early due to decision by sponsor
NCT01753869,TERMINATED,INTERVENTIONAL,Challenges with recruitment
NCT01754376,TERMINATED,INTERVENTIONAL,changes in available treatments for melanoma
NCT01754519,TERMINATED,INTERVENTIONAL,IDE not submitted
NCT01754545,WITHDRAWN,INTERVENTIONAL,altered situation in study population; not enough patients meeting enrollment criteria
NCT01754623,TERMINATED,INTERVENTIONAL,Lack of pre-treatment tissue to make the study plan feasible.
NCT01754753,TERMINATED,INTERVENTIONAL,Due to lack of volunteer facilitators to deliver the intervention
NCT01754870,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT01755130,TERMINATED,INTERVENTIONAL,due to lack of funding
NCT01755169,TERMINATED,INTERVENTIONAL,Inability to enroll sufficient patients
NCT01755182,TERMINATED,INTERVENTIONAL,"difficulty enrollment, no patients received treatment"
NCT01755208,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT01755312,TERMINATED,INTERVENTIONAL,Research site no longer available
NCT01755325,SUSPENDED,INTERVENTIONAL,not enough patients
NCT01755442,TERMINATED,INTERVENTIONAL,Amgen determined no further need for this study.
NCT01755520,TERMINATED,INTERVENTIONAL,DSMB Interim Analyses
NCT01755650,TERMINATED,INTERVENTIONAL,"6 patients were recuited. Due to inability of the tracer to detect regions of interest sufficiently, the trial was closed early."
NCT01755702,TERMINATED,INTERVENTIONAL,Study was terminated due to unforeseen difficulties with subject recruitment. No safety issues were identified in the study with this new formulation.
NCT01755871,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01756053,TERMINATED,INTERVENTIONAL,Trial discontinued based on the results of an interim futility analysis.
NCT01756092,WITHDRAWN,INTERVENTIONAL,"Because funding was not secured, the study was never initiated. 0 subjects enrolled"
NCT01756326,TERMINATED,INTERVENTIONAL,focus resources in the allogeneic platform and provide optimal value for patients
NCT01756560,TERMINATED,INTERVENTIONAL,Unable to continue research due to time constraints
NCT01756573,TERMINATED,INTERVENTIONAL,Unable to continue study due to time constraints
NCT01756586,TERMINATED,INTERVENTIONAL,no logistical support to carry out the study fairly
NCT01756690,TERMINATED,OBSERVATIONAL,Recruitment
NCT01756729,TERMINATED,INTERVENTIONAL,Amendment of Study Protocol
NCT01756820,WITHDRAWN,INTERVENTIONAL,The principal investigator of the study relocated to another institution.
NCT01756924,TERMINATED,INTERVENTIONAL,This study has been terminated; alternative study designs are being considered. Fusidic acid remains available under an Expanded Access Protocol.
NCT01757067,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient participants
NCT01757197,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01757223,WITHDRAWN,INTERVENTIONAL,Closure due to lack of funding.
NCT01757249,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient participants
NCT01757314,TERMINATED,OBSERVATIONAL,already several publications in the literature
NCT01757327,WITHDRAWN,INTERVENTIONAL,Poor accrual
NCT01757496,TERMINATED,INTERVENTIONAL,Difficulties with patient inclusion
NCT01757574,WITHDRAWN,INTERVENTIONAL,"At the request of the global principal investigator, no subjects were enrolled in this study at any site."
NCT01757691,TERMINATED,INTERVENTIONAL,Discontinuation of this study was based on Novartis decision to discontinue development of fingolimod for the treatment of ADON
NCT01757899,WITHDRAWN,INTERVENTIONAL,Technical problems
NCT01757951,SUSPENDED,INTERVENTIONAL,Partly due to financial issues and changes in study staff work placements
NCT01758289,TERMINATED,OBSERVATIONAL,Changes in country regulation
NCT01758458,TERMINATED,INTERVENTIONAL,A Phase I/II study (NCT01758458) is now recruiting
NCT01758588,TERMINATED,INTERVENTIONAL,This study was suspended due to insufficient subject accrual.
NCT01758887,WITHDRAWN,OBSERVATIONAL,administrative reason
NCT01758991,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01759017,TERMINATED,OBSERVATIONAL,slow enrollment
NCT01759095,TERMINATED,INTERVENTIONAL,Difficulties with patient recruitement
NCT01759212,TERMINATED,INTERVENTIONAL,Lack of eligible patients
NCT01759238,TERMINATED,INTERVENTIONAL,unexpectedly slow recruitment
NCT01759303,TERMINATED,INTERVENTIONAL,low accrual
NCT01759381,TERMINATED,INTERVENTIONAL,PI leaving institution
NCT01759407,TERMINATED,INTERVENTIONAL,Interim analysis showed no significant difference between study arms.
NCT01759511,TERMINATED,INTERVENTIONAL,The Study was terminated due to lack of efficacy.
NCT01759550,TERMINATED,OBSERVATIONAL,The Sponsor terminated the study.
NCT01759745,WITHDRAWN,OBSERVATIONAL,Organisatory reason
NCT01759784,WITHDRAWN,INTERVENTIONAL,The stereotaxis can be threatful for the patients because of respiratory insufficiency
NCT01759914,TERMINATED,OBSERVATIONAL,Unable to recruit sufficient number of subjects in required timeline.
NCT01760161,TERMINATED,INTERVENTIONAL,No signal on pain-score
NCT01760174,WITHDRAWN,INTERVENTIONAL,Because of logistic and practical reasons.
NCT01760304,TERMINATED,INTERVENTIONAL,Sponsor decided to stop the study due to expiration of blinded placebo .
NCT01760330,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding
NCT01760616,TERMINATED,INTERVENTIONAL,difficult to recruit patients
NCT01760694,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01760889,TERMINATED,INTERVENTIONAL,Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized
NCT01760941,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01760980,WITHDRAWN,INTERVENTIONAL,Development halted by management
NCT01760993,TERMINATED,INTERVENTIONAL,Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized.
NCT01761006,TERMINATED,OBSERVATIONAL,"Study was activated initially. However, the necessary resources were not available to complete the research."
NCT01761201,TERMINATED,INTERVENTIONAL,Recruitment rythm not sufficent to reach the simple size needed.
NCT01761591,TERMINATED,INTERVENTIONAL,Difficulty to identify eligible patients: 8 centers contributed 54 patients in 6 months.
NCT01761682,TERMINATED,OBSERVATIONAL,"The PI resigned the institute, and the rest investigators at the institute decided to terminate the study."
NCT01761695,TERMINATED,OBSERVATIONAL,The PI resigned the institute. The rest investigators at the institute decided to terminate the study.
NCT01761747,TERMINATED,INTERVENTIONAL,FDA hold and toxicity associated with study drug
NCT01761760,TERMINATED,INTERVENTIONAL,There were a number of bugs in the game that meant the participants were not getting the intended intervention.
NCT01761812,TERMINATED,INTERVENTIONAL,Inadequate accrual
NCT01762007,WITHDRAWN,OBSERVATIONAL,"Due to difficulty in purchasing reagents, study canceled without subject registration"
NCT01762111,WITHDRAWN,OBSERVATIONAL,Recruitment difficulties
NCT01762137,TERMINATED,INTERVENTIONAL,Rarity of disease and current practice in the field made enrollment challenging.
NCT01762410,SUSPENDED,INTERVENTIONAL,Sponsor decision not related to patient safety
NCT01762423,WITHDRAWN,INTERVENTIONAL,Funding issues.
NCT01762592,WITHDRAWN,INTERVENTIONAL,new sponsor
NCT01762605,TERMINATED,INTERVENTIONAL,inadequate enrollment
NCT01762644,WITHDRAWN,INTERVENTIONAL,This study was withdrawn prior to enrollment.
NCT01762657,WITHDRAWN,INTERVENTIONAL,Study stopped prior to Patient Enrollment
NCT01762670,TERMINATED,INTERVENTIONAL,Company decided to stop study for reasons other than safety
NCT01762852,WITHDRAWN,INTERVENTIONAL,"Withdrawn due to difficulties in to recruiting due to competing studies, changing treatment practices, unavailability of eligible study population"
NCT01762956,TERMINATED,INTERVENTIONAL,Unobtainable sample size
NCT01763359,TERMINATED,OBSERVATIONAL,The original PI moved on from this facility as did other key personnel. The current PI decided to discontinue the study.
NCT01763437,WITHDRAWN,INTERVENTIONAL,Investigator left the institution
NCT01763489,WITHDRAWN,INTERVENTIONAL,lack of recruitment
NCT01763684,TERMINATED,INTERVENTIONAL,Due to slow enrollment and not being able to reach the primary endpoint
NCT01763736,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01764009,WITHDRAWN,INTERVENTIONAL,Study stopped due to low enrolment rate.
NCT01764139,TERMINATED,OBSERVATIONAL,Lack of patients with recruitment criteria
NCT01764308,TERMINATED,INTERVENTIONAL,insufficient staff to complete recruitment
NCT01764451,TERMINATED,INTERVENTIONAL,"Research was completed before January 18, 2017, \& does not meet the Applicable Clinical Trial requirement to register \& report results per the guidance provided in ""Clinical Trials Registration \& Results Information Submission"" dated 09/21/2016."
NCT01764568,TERMINATED,INTERVENTIONAL,The full sample could not be collected due to loss of funds to complete the imaging component.
NCT01764607,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01764685,TERMINATED,INTERVENTIONAL,We terminated the study due to problems recruiting alcoholic subjects with HIV.
NCT01764750,TERMINATED,INTERVENTIONAL,awaiting FDA approval for next dose group
NCT01764893,TERMINATED,INTERVENTIONAL,Enrolling too slowly due to insurance plans no longer covering the cost of the Percutaneous Tibial Nerve Stimulation treatment.
NCT01764919,TERMINATED,INTERVENTIONAL,No correlation between FIAU uptake and bone biopsy results.
NCT01764997,TERMINATED,INTERVENTIONAL,Due to small number of participants entering randomization. Not a safety issue.
NCT01765114,TERMINATED,INTERVENTIONAL,insufficient patient recruitment
NCT01765218,TERMINATED,INTERVENTIONAL,The study was stopped early due to changes in the UC Davis guidelines on who qualified for therapeutic hypothermia and significant difficulty in recruitment of patients following the COVID19 pandemic.
NCT01765270,TERMINATED,INTERVENTIONAL,The study was stopped due to poor enrollment.
NCT01765738,WITHDRAWN,INTERVENTIONAL,Project never received funding.
NCT01765803,TERMINATED,INTERVENTIONAL,Primary objective not met after planned interim analysis
NCT01765842,TERMINATED,INTERVENTIONAL,The recruitment period has finished without reaching sample size
NCT01766128,WITHDRAWN,INTERVENTIONAL,Practical problems
NCT01766505,TERMINATED,INTERVENTIONAL,lack of the subjects
NCT01766544,TERMINATED,INTERVENTIONAL,Insufficient recruitment of physicians to participate to the study.
NCT01766856,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT01766869,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT01767831,TERMINATED,OBSERVATIONAL,study team will review the collected data and make any necessary changes to the educational tool.
NCT01767857,TERMINATED,INTERVENTIONAL,The study crossed the prospective futility boundary of primary endpoint
NCT01767935,TERMINATED,INTERVENTIONAL,Slow Accruals
NCT01767961,WITHDRAWN,INTERVENTIONAL,Unable to secure funding.
NCT01767987,TERMINATED,INTERVENTIONAL,Sponsor terminated study due to lack of enrollment
NCT01768715,SUSPENDED,OBSERVATIONAL,Low rate of recruitment (only one patient up to May 2014)
NCT01768767,WITHDRAWN,INTERVENTIONAL,No funding
NCT01768871,TERMINATED,OBSERVATIONAL,low enrollment
NCT01768988,TERMINATED,INTERVENTIONAL,Change of PI. Former PI changed from Research Center and Promoter obliged unexpectedly to change the PI.
NCT01769027,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01769053,TERMINATED,INTERVENTIONAL,Rate of recruitment
NCT01769092,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT01769196,TERMINATED,INTERVENTIONAL,The Study was terminated due to lack of efficacy.
NCT01769222,TERMINATED,INTERVENTIONAL,Planned Future Study
NCT01769300,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT01769443,TERMINATED,INTERVENTIONAL,Inability to enroll within funding period
NCT01769508,TERMINATED,INTERVENTIONAL,Study closed due to slow accrual.
NCT01769534,TERMINATED,OBSERVATIONAL,Administratively inactivated
NCT01769547,TERMINATED,INTERVENTIONAL,Stage 1 accrual completed. Study did not proceed to Stage 2 accrual.
NCT01770158,TERMINATED,OBSERVATIONAL,Recruitment goal cannot be achieved any more as only 8 patients have been recruited since start of the study in 2012.
NCT01770236,TERMINATED,INTERVENTIONAL,Study medication no longer available at institution
NCT01770340,TERMINATED,INTERVENTIONAL,"Poor recruitment, Interim analysis: The rates of pts who reached primary and secondary endpoints were lower than expected."
NCT01770574,TERMINATED,INTERVENTIONAL,Interim results showed that the HATCP material was not non-inferior to the AUTO graft.
NCT01770600,WITHDRAWN,INTERVENTIONAL,"never initiated, did different study"
NCT01770613,WITHDRAWN,INTERVENTIONAL,"Corporate business decision, may consider different subject population"
NCT01770665,TERMINATED,OBSERVATIONAL,Assay being revised and re-validated.
NCT01770717,WITHDRAWN,OBSERVATIONAL,Not NIH defined clinical trial study.
NCT01770756,TERMINATED,INTERVENTIONAL,IRB terminated study
NCT01770821,WITHDRAWN,INTERVENTIONAL,Lack of resource
NCT01771133,TERMINATED,INTERVENTIONAL,recruiting or enrolling participants has halted prematurely by Life-Moms Consortium and will not resume; participants are no longer being examined or treated.
NCT01771198,TERMINATED,INTERVENTIONAL,Lack of efficacy with one month of treatement
NCT01771471,TERMINATED,INTERVENTIONAL,Change in clinical strategy
NCT01771484,TERMINATED,INTERVENTIONAL,Not enough volunteer recruited before funding could be secured.
NCT01771575,WITHDRAWN,INTERVENTIONAL,No funding received
NCT01771614,WITHDRAWN,INTERVENTIONAL,PI relocated to a different country.
NCT01772017,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue study for business reasons.
NCT01772056,TERMINATED,INTERVENTIONAL,"Patient recruitment is very slow, economic grant has ended and the number of patients is enough according to sample size (22 children/ arm)."
NCT01772108,TERMINATED,INTERVENTIONAL,As recruitment rate was lower than anticipated
NCT01772537,TERMINATED,INTERVENTIONAL,The data did not show clear results
NCT01772589,WITHDRAWN,INTERVENTIONAL,Comparator sawblade no longer available
NCT01772641,TERMINATED,INTERVENTIONAL,difficulty recruiting and retaining participants
NCT01772719,TERMINATED,INTERVENTIONAL,Principal Investigator left institution-study not continued
NCT01772875,WITHDRAWN,INTERVENTIONAL,no clinical investigator present
NCT01773083,TERMINATED,INTERVENTIONAL,insufficient recruitment of patients and high costs associated with the purchase and blinding of study medication
NCT01773252,TERMINATED,INTERVENTIONAL,Business decision to perform a market withdrawal of the product
NCT01773330,TERMINATED,INTERVENTIONAL,Study has been halted per PI and IRB recommendation
NCT01773395,TERMINATED,INTERVENTIONAL,Recommendation by the Data and Safety Monitoring Board due to efficacy concerns
NCT01773460,TERMINATED,INTERVENTIONAL,Study was stopped terminated early due to low recruitment.
NCT01773486,WITHDRAWN,INTERVENTIONAL,Not funded
NCT01773499,TERMINATED,OBSERVATIONAL,Unable to enroll significant number of patients.
NCT01773551,WITHDRAWN,OBSERVATIONAL,Not NIH defined clinical trial study
NCT01773603,TERMINATED,INTERVENTIONAL,No statistical difference observed for outcomes.
NCT01773616,TERMINATED,INTERVENTIONAL,Study assessments for patients recruited continuing per protocol so patients receive a minimum of 6 months follow up. No safety concerns have been raised.
NCT01773746,TERMINATED,INTERVENTIONAL,Poor Recruitment
NCT01773785,TERMINATED,INTERVENTIONAL,The study completed the first phase and did not meet efficacy end point to enter into the randomized phase.
NCT01773837,TERMINATED,INTERVENTIONAL,Slow accrual. 100 patients included
NCT01773889,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01774110,TERMINATED,INTERVENTIONAL,Very limited enrollment
NCT01774253,TERMINATED,INTERVENTIONAL,Lack of enrollment and commercial availability of drug
NCT01774331,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT01774487,TERMINATED,INTERVENTIONAL,"Target enrollment was not reached because the medication, pentoxifylline, has a taste that is not well tolerated by infants. The study team decided to end the study before meeting the enrollment goal because of the medication taste."
NCT01774604,TERMINATED,INTERVENTIONAL,Futility
NCT01774708,TERMINATED,OBSERVATIONAL,Difficulty in recruiting participants
NCT01774747,TERMINATED,INTERVENTIONAL,This program was terminated for financial reasons
NCT01774851,TERMINATED,INTERVENTIONAL,DSMB recommendation due to lack of efficacy. There were no safety signals.
NCT01775098,WITHDRAWN,INTERVENTIONAL,because of a lack of funding
NCT01775176,TERMINATED,OBSERVATIONAL,Parent Study stopped due to poor recruitment and enrollment
NCT01775215,WITHDRAWN,OBSERVATIONAL,Abandoned
NCT01775267,TERMINATED,INTERVENTIONAL,Study stopped due to safety concerns in both study arms
NCT01775280,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01775397,TERMINATED,INTERVENTIONAL,Study terminated due to difficulty in enrollment
NCT01775410,TERMINATED,INTERVENTIONAL,Study was terminated by sponsor without any AEs to review the device design.
NCT01775488,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT01775605,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01775670,TERMINATED,INTERVENTIONAL,"Due to the principal investigator leaving the institution and slow enrollment, we have decided to close the study prior to study completion"
NCT01775709,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01776008,TERMINATED,INTERVENTIONAL,Study did not pass Stage 1 interim analysis.
NCT01776086,WITHDRAWN,INTERVENTIONAL,no subjects agreed to participate
NCT01776203,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT01776320,WITHDRAWN,INTERVENTIONAL,No medication
NCT01776775,WITHDRAWN,INTERVENTIONAL,due to lack of finace
NCT01776957,TERMINATED,OBSERVATIONAL,"This study is a retrospective chart review study, not a clinical trial."
NCT01777048,TERMINATED,INTERVENTIONAL,Low recruitment numbers
NCT01777217,TERMINATED,INTERVENTIONAL,Terminated
NCT01777230,WITHDRAWN,OBSERVATIONAL,Unable to get required research materials
NCT01777256,TERMINATED,INTERVENTIONAL,This study met a protocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.
NCT01777464,TERMINATED,INTERVENTIONAL,analysing images ongoing
NCT01777724,TERMINATED,INTERVENTIONAL,The study was terminated due to time constraints and the withdrawal of Stress Control from the NHS Greater Glasgow and Clyde services.
NCT01777737,TERMINATED,INTERVENTIONAL,Changes in standards of care
NCT01777776,TERMINATED,INTERVENTIONAL,Study was withdrawn due to scientific and business considerations.
NCT01777789,TERMINATED,OBSERVATIONAL,This is a basic research study with no clinical data to report
NCT01777854,TERMINATED,INTERVENTIONAL,Lack of patient interest in the study.
NCT01778335,TERMINATED,INTERVENTIONAL,"On DSMB advice, trial recruitment has been halted for efficacy. F/U continues."
NCT01778530,TERMINATED,INTERVENTIONAL,Study was terminated due to poor accrual.
NCT01778647,TERMINATED,INTERVENTIONAL,Co-Investigators left the Institution.
NCT01778894,TERMINATED,OBSERVATIONAL,Administratively closed because no Continuing Review submitted
NCT01779050,TERMINATED,INTERVENTIONAL,Loss of study funding
NCT01779154,WITHDRAWN,OBSERVATIONAL,funding not available
NCT01779167,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01779219,TERMINATED,INTERVENTIONAL,Primary investigator has changed his employee and the country of residence.
NCT01779336,SUSPENDED,INTERVENTIONAL,Sponsor decision not related to patient safety
NCT01779349,SUSPENDED,INTERVENTIONAL,sensor calibration and other R\&D activities
NCT01779427,WITHDRAWN,INTERVENTIONAL,"Based on data from pilot study, the PI and program officer have determined that this study was not feasible."
NCT01779466,TERMINATED,INTERVENTIONAL,Terminated due to lack of eligible patients
NCT01780532,WITHDRAWN,INTERVENTIONAL,Insufficient resources
NCT01780636,TERMINATED,INTERVENTIONAL,POOR RECRUITMENT
NCT01781247,TERMINATED,INTERVENTIONAL,Population of eligible patients smaller than anticipated
NCT01781325,WITHDRAWN,INTERVENTIONAL,Grant ended before study could be initiated
NCT01781546,TERMINATED,INTERVENTIONAL,"suspeded due to slow recruitment, terminated due to interim analysis"
NCT01781585,WITHDRAWN,OBSERVATIONAL,"Inclusion criteria difficulties to receive the case, it is taken off the case to apply"
NCT01781611,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01781819,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT01781962,TERMINATED,OBSERVATIONAL,Study terminated due to corporate decision.
NCT01782027,SUSPENDED,INTERVENTIONAL,Lack of funding
NCT01782196,TERMINATED,INTERVENTIONAL,Leakage
NCT01782391,WITHDRAWN,INTERVENTIONAL,Lack of appropriate participants
NCT01782469,TERMINATED,OBSERVATIONAL,Study stopped due to low enrollment
NCT01782560,WITHDRAWN,INTERVENTIONAL,Unable to recruit a sufficient amount of subjects
NCT01783015,TERMINATED,INTERVENTIONAL,"This study was prematurely terminated on June 25, 2014 due to lack of enrollment."
NCT01783054,TERMINATED,INTERVENTIONAL,Study terminated due to low accrual
NCT01783132,TERMINATED,INTERVENTIONAL,Changing conditions for the device in one of the participation companies
NCT01783249,WITHDRAWN,INTERVENTIONAL,We were unable to find patients that fit the eligibility criteria.
NCT01783340,WITHDRAWN,INTERVENTIONAL,No funding
NCT01783431,TERMINATED,INTERVENTIONAL,The study was terminated early due to low accrual.
NCT01783522,TERMINATED,INTERVENTIONAL,Research Cancelled
NCT01783873,TERMINATED,INTERVENTIONAL,recruitement difficulty
NCT01784016,WITHDRAWN,INTERVENTIONAL,Technical complications.
NCT01784042,WITHDRAWN,INTERVENTIONAL,No funding
NCT01784081,WITHDRAWN,OBSERVATIONAL,study was closed by PI due to no accrual
NCT01784159,TERMINATED,INTERVENTIONAL,"Terminated: The study was stopped prematurely and will not be resumed due to the higher number of bleeding cases in the intervention group, as recomended by the Data Safety Monitoring Board on February 7, 2023."
NCT01784523,TERMINATED,INTERVENTIONAL,low recruitment rate exacerbated by manufacturing shortage and price increase of hydroxychloroquine.
NCT01784601,SUSPENDED,OBSERVATIONAL,Lack of human resources
NCT01784627,WITHDRAWN,INTERVENTIONAL,No funding
NCT01784653,WITHDRAWN,INTERVENTIONAL,No funding obtained.
NCT01784666,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT01784861,TERMINATED,INTERVENTIONAL,Pharmaceutical company decision
NCT01784887,TERMINATED,INTERVENTIONAL,Did not have study population to continue
NCT01784978,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01784991,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT01785030,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01785069,TERMINATED,INTERVENTIONAL,There was no indication that long-term follow-up would differ between any of the studies that have evaluated devices within the 410 Style Matrix.
NCT01785459,TERMINATED,INTERVENTIONAL,Unable to enroll adequate number of patients.
NCT01785771,TERMINATED,INTERVENTIONAL,Decision by Sponsor
NCT01785836,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to company decision. No study subjects were ever enrolled or dosed.
NCT01785979,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01786161,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01786824,TERMINATED,INTERVENTIONAL,Patient pathway has become infeasible due to pressure for shorter hospital stays. Not enough inclusions.
NCT01786837,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01786863,TERMINATED,OBSERVATIONAL,PI returned to her home country of Japan
NCT01787214,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT01787240,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01787422,TERMINATED,INTERVENTIONAL,Investigator has left the university
NCT01787565,TERMINATED,OBSERVATIONAL,See termination reason in detailed description.
NCT01787578,WITHDRAWN,INTERVENTIONAL,revisions to original study protocol underway
NCT01787721,TERMINATED,INTERVENTIONAL,Unable to recruit more than 2 subjects
NCT01787773,WITHDRAWN,INTERVENTIONAL,IDE was withdrawn. Veniti no longer owns the rights to this device.
NCT01787786,WITHDRAWN,OBSERVATIONAL,Unable to align the study questions with a complementary trial
NCT01787851,WITHDRAWN,INTERVENTIONAL,"eIRB closed, no patient enrolled"
NCT01788202,TERMINATED,OBSERVATIONAL,unable to enroll patients
NCT01788280,WITHDRAWN,INTERVENTIONAL,"Unable to get materials from GE, study not proceeding and never opened to accrual"
NCT01788293,TERMINATED,INTERVENTIONAL,Problem with recruiting
NCT01788462,WITHDRAWN,OBSERVATIONAL,Lack of funding.
NCT01788475,TERMINATED,INTERVENTIONAL,Study withdrawn by Investigator
NCT01788930,TERMINATED,INTERVENTIONAL,Recommendations changing
NCT01789047,TERMINATED,INTERVENTIONAL,Sponsor withdrew support
NCT01789190,TERMINATED,OBSERVATIONAL,The study has concluded normally
NCT01789463,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01789489,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01789697,TERMINATED,INTERVENTIONAL,Not sufficient staff to complete the trial.
NCT01789840,TERMINATED,INTERVENTIONAL,510(K) Approval Gained for Product
NCT01789892,WITHDRAWN,INTERVENTIONAL,no patient accrual
NCT01790035,TERMINATED,INTERVENTIONAL,Low accrual
NCT01790113,TERMINATED,INTERVENTIONAL,"Eclipse Shoulder System received 510(k) clearance on July 26, 2019."
NCT01790516,TERMINATED,INTERVENTIONAL,low accruals--2 patients were enrolled in over a year
NCT01790594,TERMINATED,INTERVENTIONAL,Slow accrual within enrollment time period: projected accrual goal not achieved.
NCT01790763,WITHDRAWN,INTERVENTIONAL,Due to lack of funding from the sponsor this study is being withdrawn.
NCT01790854,TERMINATED,INTERVENTIONAL,Low events rate. Scarce economical resources
NCT01790971,SUSPENDED,INTERVENTIONAL,competing studies
NCT01791127,TERMINATED,OBSERVATIONAL,"On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing SIELLO Post Approval Registry to a new EP PASSION real-world data methodology."
NCT01791218,TERMINATED,INTERVENTIONAL,Not enough patients for study arms
NCT01791426,WITHDRAWN,INTERVENTIONAL,Adjustment of company focus due to acquision by Valeant Pharmaceuticals
NCT01791465,TERMINATED,INTERVENTIONAL,This study was terminated after 6 patients due to loss of funding
NCT01791686,TERMINATED,INTERVENTIONAL,Portfolio prioritization due to slow enrollment and variable spectrum of potential complement abnormalities in DDD patients.
NCT01791998,WITHDRAWN,INTERVENTIONAL,Funding was time sensitive and expired. No subjects enrolled.
NCT01792466,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT01792583,TERMINATED,OBSERVATIONAL,The study is no longer feasible.
NCT01792635,TERMINATED,INTERVENTIONAL,The study was terminated prematurely on 16 May 2014 due to a safety concern.
NCT01793298,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01793506,WITHDRAWN,OBSERVATIONAL,Never funded or completed
NCT01793636,TERMINATED,INTERVENTIONAL,Inferior efficacy of study drug in renal indication.
NCT01793896,TERMINATED,INTERVENTIONAL,"Serious difficulties for patient recruitment

to recruit patients"
NCT01794000,TERMINATED,INTERVENTIONAL,The study is being terminated for lack of efficacy.
NCT01794169,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01794247,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT01794338,TERMINATED,INTERVENTIONAL,Lack of incorporation with patients
NCT01794455,TERMINATED,INTERVENTIONAL,Enrollment difficulties
NCT01794559,SUSPENDED,INTERVENTIONAL,No site recruitment due to Covid-19
NCT01794572,TERMINATED,INTERVENTIONAL,Low patient recruitement rate and modification of the therapeutic standard
NCT01794598,TERMINATED,INTERVENTIONAL,Terminated
NCT01794637,WITHDRAWN,OBSERVATIONAL,Disposables required for the measurements in short supply and not provided by the company / supplier
NCT01794767,SUSPENDED,INTERVENTIONAL,difficult recruiting
NCT01794845,TERMINATED,INTERVENTIONAL,Early termination due to lack of efficacy (overall response)
NCT01794936,TERMINATED,INTERVENTIONAL,PI left the institution
NCT01795170,WITHDRAWN,OBSERVATIONAL,The study couldn't be initiated as we did not secure funding.
NCT01795196,WITHDRAWN,OBSERVATIONAL,Lack of subjects to participate
NCT01795209,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01795274,WITHDRAWN,INTERVENTIONAL,Administrative barriers
NCT01795300,WITHDRAWN,INTERVENTIONAL,Organizational reasons
NCT01795365,TERMINATED,INTERVENTIONAL,Participants are no longer being examined and receiving intervention.
NCT01795430,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT01795638,TERMINATED,INTERVENTIONAL,The unit's standard nutrition practices change which impacted our methodology.
NCT01795924,TERMINATED,INTERVENTIONAL,Difficulty of patient enrollment
NCT01795976,TERMINATED,INTERVENTIONAL,Withdrawal of funding
NCT01796106,TERMINATED,INTERVENTIONAL,Recruitment slower than expected.
NCT01796158,WITHDRAWN,INTERVENTIONAL,not funded
NCT01796340,TERMINATED,INTERVENTIONAL,Insufficient number of participants
NCT01796470,TERMINATED,INTERVENTIONAL,Study was terminated due to safety measures.
NCT01796522,WITHDRAWN,INTERVENTIONAL,have been published new studies that it showed the ineffectiveness of the treatments proposed in this study.
NCT01796548,TERMINATED,INTERVENTIONAL,Slow rate of participant's enrollment
NCT01796743,WITHDRAWN,OBSERVATIONAL,No patients
NCT01796795,SUSPENDED,INTERVENTIONAL,Budget issue.
NCT01796860,TERMINATED,INTERVENTIONAL,"Modifications were made to protocol, new IRB pending"
NCT01796977,TERMINATED,INTERVENTIONAL,inability to enroll in this subject population
NCT01797107,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01797315,TERMINATED,INTERVENTIONAL,no adequate recruitment
NCT01797380,TERMINATED,INTERVENTIONAL,Failure to recruit.
NCT01797679,WITHDRAWN,INTERVENTIONAL,Lack of agreement between the participants and lack og funding
NCT01797952,WITHDRAWN,INTERVENTIONAL,PI was away on sabbatical for 2 years.Protocol is being revised before starting the study.
NCT01797965,TERMINATED,INTERVENTIONAL,Study terminated because of differences in the participant population under study compared with indicated Zinbryta use in most countries.
NCT01798043,TERMINATED,INTERVENTIONAL,Due to slow enrolment
NCT01798277,WITHDRAWN,INTERVENTIONAL,Low Enrolment
NCT01798316,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution
NCT01798485,TERMINATED,INTERVENTIONAL,The study was stopped after the first Interim Analysis due to futility.
NCT01798511,WITHDRAWN,INTERVENTIONAL,No funding
NCT01798602,TERMINATED,INTERVENTIONAL,H1N1 pandemic concluded
NCT01798693,TERMINATED,INTERVENTIONAL,Poor subject compliance and inadequate recruitment
NCT01798745,WITHDRAWN,INTERVENTIONAL,study not required for development
NCT01798836,TERMINATED,INTERVENTIONAL,Obtained results were not good. Protocol was proved ineffective.
NCT01798927,TERMINATED,INTERVENTIONAL,Modifications are being made to protocol
NCT01799057,TERMINATED,INTERVENTIONAL,The trial has been terminated due to difficulties with recruitment.
NCT01799135,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01799161,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT01799395,TERMINATED,OBSERVATIONAL,"Staff constraints made it impossibile to enroll consecutive patients, making the sample not representative of the true cancer population"
NCT01799499,WITHDRAWN,INTERVENTIONAL,Change in the company clinical trials priority
NCT01799629,TERMINATED,INTERVENTIONAL,Recruitment issue
NCT01799746,WITHDRAWN,OBSERVATIONAL,"The Airways Biology Initiative closed in December, 2015. This study was closed with the Penn IRB at that time. No subjects were recruited for this trial."
NCT01799889,TERMINATED,INTERVENTIONAL,Sponsor's decision to discontinue development of entospletinib.
NCT01800097,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01800162,TERMINATED,INTERVENTIONAL,A new protocol was written to replace this protocol.
NCT01800331,TERMINATED,INTERVENTIONAL,My post-doctoral fellow did not return from her mat leave and I have no other students to take on this project.
NCT01800500,TERMINATED,INTERVENTIONAL,Difficulty accruing
NCT01801020,WITHDRAWN,INTERVENTIONAL,The investigator left the organization
NCT01801046,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT01801085,TERMINATED,OBSERVATIONAL,Slow recruitment pace
NCT01801163,WITHDRAWN,INTERVENTIONAL,Trial had no patients accrued while open
NCT01801228,WITHDRAWN,INTERVENTIONAL,difficulties to include patients
NCT01801358,TERMINATED,INTERVENTIONAL,The trial was terminated for scientific reasons.
NCT01801488,TERMINATED,OBSERVATIONAL,Low enrollment
NCT01801553,TERMINATED,INTERVENTIONAL,problem of recruitment (not enough patients)
NCT01801670,WITHDRAWN,OBSERVATIONAL,"Enrollment was too slow, so no participants were ever enrolled."
NCT01801878,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting research subjects
NCT01801943,TERMINATED,INTERVENTIONAL,participants are no longer being examined or receiving intervention
NCT01802047,WITHDRAWN,INTERVENTIONAL,d/t changes in routine modality of milk expression by electric pump.
NCT01802099,TERMINATED,INTERVENTIONAL,stopped on Data Safety and Monitoring Board 's request
NCT01802164,TERMINATED,INTERVENTIONAL,Recruitment problems due to very restricted inclusion criteria
NCT01802190,TERMINATED,OBSERVATIONAL,No convincing results
NCT01802255,WITHDRAWN,INTERVENTIONAL,Lack of recruitment in the Centres
NCT01802307,WITHDRAWN,INTERVENTIONAL,Study was withdrawn
NCT01802359,TERMINATED,OBSERVATIONAL,This prodect will be transferred to another company.
NCT01802515,TERMINATED,INTERVENTIONAL,No funding stopped recruitment march 2014 with only 14 enrolled
NCT01802593,TERMINATED,INTERVENTIONAL,lack of budget and failure to reach milestones
NCT01802658,TERMINATED,INTERVENTIONAL,Recruiting Difficulty
NCT01803165,WITHDRAWN,OBSERVATIONAL,Inadequate patient population
NCT01803269,TERMINATED,INTERVENTIONAL,Due to lack of activity and slow accrual
NCT01803334,TERMINATED,INTERVENTIONAL,Not enough participants could be enrolled and so the PI decided to close the study. No participants completed the study
NCT01803399,WITHDRAWN,INTERVENTIONAL,Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen that changed the risk: benefit profile and led to a termination
NCT01803425,WITHDRAWN,OBSERVATIONAL,Lack of clarity regarding the PMS study requirement from the RA and Ethics committee hence it was concluded GSK will submit local PSURs.
NCT01803607,TERMINATED,INTERVENTIONAL,Study halted prematurely due to low enrollment.
NCT01803698,WITHDRAWN,INTERVENTIONAL,never started
NCT01803711,TERMINATED,INTERVENTIONAL,Lack of recruitment and no resources
NCT01803750,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT01803880,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goals
NCT01803919,TERMINATED,INTERVENTIONAL,Difficulties in recruitment
NCT01803945,TERMINATED,INTERVENTIONAL,First milestone was not met.
NCT01804270,TERMINATED,INTERVENTIONAL,"Study \& IDE was converted to Industry held, as opposed to initial investigator held."
NCT01804296,TERMINATED,INTERVENTIONAL,"Study \& IDE was converted to Industry held, as opposed to initial investigator held."
NCT01804426,WITHDRAWN,OBSERVATIONAL,Lack of funding.
NCT01804530,TERMINATED,INTERVENTIONAL,Discontinued
NCT01804673,TERMINATED,INTERVENTIONAL,The study was prematurely discontinued since study medication was no longer available.
NCT01804777,TERMINATED,INTERVENTIONAL,Currently closed for data analysis.
NCT01805037,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01805206,WITHDRAWN,INTERVENTIONAL,PI left institution prior to receiving funding
NCT01805388,WITHDRAWN,INTERVENTIONAL,Lack of pediatric recruitment ability
NCT01805479,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants. Sponsor requested study closure.
NCT01805505,TERMINATED,INTERVENTIONAL,slow recruitment rate
NCT01805791,TERMINATED,INTERVENTIONAL,Interim futility analysis results
NCT01805804,TERMINATED,INTERVENTIONAL,Recall of some valsartan preparations. 88 patients enrolled and completed the observation. All patients are in continuous observation and are well.
NCT01805908,TERMINATED,INTERVENTIONAL,Accrual is very poor
NCT01806051,TERMINATED,INTERVENTIONAL,Participants found the study procedures to be too cumbersome and no longer wanted to participate
NCT01806064,TERMINATED,INTERVENTIONAL,The study did not meet endpoint.
NCT01806584,TERMINATED,INTERVENTIONAL,Development of SRM003 was discontinued based on portfolio prioritization.
NCT01806649,TERMINATED,INTERVENTIONAL,Sponsor terminated to continue any clinical trials with study drug
NCT01806740,TERMINATED,INTERVENTIONAL,The planned number of enrolled patients was not reached.
NCT01806961,TERMINATED,OBSERVATIONAL,sponsor decision
NCT01806974,TERMINATED,INTERVENTIONAL,"as the recruitment rate was very low, a futility study was conducted and it was decided to discontinue inclusions"
NCT01807130,TERMINATED,INTERVENTIONAL,"We observed a very high referral rate for patients with HF in the Duke Health System, eliminating the need for an automated referral process."
NCT01807156,TERMINATED,INTERVENTIONAL,Primary endpoint not met
NCT01807286,TERMINATED,INTERVENTIONAL,Sponsor requested termination
NCT01807663,TERMINATED,INTERVENTIONAL,Healthy volonteers study results show that the device is not enough reliable
NCT01807741,TERMINATED,INTERVENTIONAL,funding ended due to recruitment delays
NCT01807767,WITHDRAWN,INTERVENTIONAL,funding was withdrawn
NCT01807910,WITHDRAWN,INTERVENTIONAL,The study was not funded
NCT01807962,TERMINATED,INTERVENTIONAL,Slower than planned recruitement
NCT01808261,TERMINATED,INTERVENTIONAL,This study was terminated for futility.
NCT01808482,TERMINATED,INTERVENTIONAL,GSK confirmed misrepresentation of preclinical data that supported the rationale for GSK2618960 in MS. This decreased benefit assessment for MS
NCT01808534,TERMINATED,INTERVENTIONAL,Due to Low Accrual
NCT01808625,TERMINATED,INTERVENTIONAL,Tecnical problem
NCT01808950,TERMINATED,INTERVENTIONAL,safety issues
NCT01808989,TERMINATED,OBSERVATIONAL,end of inclusing period
NCT01809171,TERMINATED,INTERVENTIONAL,Inclusion problems
NCT01809340,TERMINATED,INTERVENTIONAL,study team decision because of IP supply issue and necessary amendment to protocol
NCT01809496,TERMINATED,INTERVENTIONAL,Funding ended
NCT01809730,WITHDRAWN,OBSERVATIONAL,no participants enrolled
NCT01809756,TERMINATED,INTERVENTIONAL,bad taste of Caphosol - early stop of intake by patients
NCT01809899,TERMINATED,INTERVENTIONAL,Time and funding ran out prior to full recruitment
NCT01810016,TERMINATED,INTERVENTIONAL,Low recruitment due to change in standard of care
NCT01810185,WITHDRAWN,INTERVENTIONAL,Low patient enrollment
NCT01810237,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT01810263,TERMINATED,INTERVENTIONAL,The study does not seem to provide benefits to patients.
NCT01810276,TERMINATED,INTERVENTIONAL,Patient population not available
NCT01810302,TERMINATED,INTERVENTIONAL,Unable to secure drug.
NCT01810510,WITHDRAWN,INTERVENTIONAL,Not subjects enrolled
NCT01810523,WITHDRAWN,INTERVENTIONAL,The study was stopped due to methodological issues that require additional consideration prior to resuming the trial.
NCT01810536,TERMINATED,INTERVENTIONAL,It was impossible for us to include patients
NCT01810562,WITHDRAWN,INTERVENTIONAL,Not able to include enough participants.
NCT01810575,TERMINATED,INTERVENTIONAL,Re-assessment of study
NCT01810640,TERMINATED,INTERVENTIONAL,Complications encountered with biopsy in first 6 patients
NCT01810679,TERMINATED,INTERVENTIONAL,FDA approval
NCT01810731,WITHDRAWN,INTERVENTIONAL,Scientific review positive from 3 manufacturers; internal committees did not support due to deploying new flu vaccines in HIV+ pregnant women in Kenya.
NCT01810848,TERMINATED,INTERVENTIONAL,Enrollment too low.
NCT01811693,TERMINATED,INTERVENTIONAL,The funding period for the study has ended.
NCT01811810,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT01811875,TERMINATED,INTERVENTIONAL,Study no longer required as Optivate German license expired in Sep-2017.
NCT01812005,TERMINATED,INTERVENTIONAL,Slow patient enrollment and study discontinued after 14 patients enrolled
NCT01812135,WITHDRAWN,INTERVENTIONAL,"Based on the previous study results, inactivated EV71 vaccine with aluminum adjuvant was elected to be used for the efficacy Phase III study."
NCT01812174,TERMINATED,INTERVENTIONAL,The study was terminated due to low/slow enrollment.
NCT01812239,WITHDRAWN,INTERVENTIONAL,inability to retain study drug with comparable placebo.
NCT01812343,TERMINATED,INTERVENTIONAL,Inclusions objectives raised but patient follow-up reduced to 6 months (impossible to raised secondary objectives)
NCT01812434,WITHDRAWN,INTERVENTIONAL,PI Left University
NCT01812460,WITHDRAWN,INTERVENTIONAL,The Study had to stop due to organizational changes in Nordsjllands Hospital
NCT01812512,WITHDRAWN,INTERVENTIONAL,Never funded.
NCT01812655,TERMINATED,INTERVENTIONAL,Early termination of study due to fewer subjects available than expected resulting in small sample size.
NCT01812772,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01812863,WITHDRAWN,INTERVENTIONAL,Our anesthesiologist was no longer available to assist.
NCT01813019,TERMINATED,INTERVENTIONAL,Study was prematurely terminated at the time of the first Interim Analysis (IA) as the study did not meet its primary efficacy objective.
NCT01813149,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. There is no data collected
NCT01813214,TERMINATED,INTERVENTIONAL,Recruitment difficulties.
NCT01813565,TERMINATED,INTERVENTIONAL,No benefit of intravesical instillation of Hyaluronic Acid/Chondroitin Sulfate
NCT01813643,TERMINATED,INTERVENTIONAL,Effects of aripiprazole was not obvious and showed adverse reaction obviously
NCT01813656,TERMINATED,INTERVENTIONAL,"Aripiprazole arm had obvious adverse reactions,especially akathisia."
NCT01813838,TERMINATED,INTERVENTIONAL,Renal toxicity
NCT01813955,TERMINATED,INTERVENTIONAL,Patient recruitment insufficient
NCT01814046,TERMINATED,INTERVENTIONAL,Investigator left the National Institutes of Health (NIH)
NCT01814254,TERMINATED,OBSERVATIONAL,Change of Institutional Affiliation \& Funding
NCT01814293,WITHDRAWN,INTERVENTIONAL,loss of funding. No data was collected.
NCT01814618,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting
NCT01814631,WITHDRAWN,OBSERVATIONAL,Closed at PI discretion
NCT01814696,TERMINATED,INTERVENTIONAL,Slow enrollment and reached number needed for analysis.
NCT01814722,TERMINATED,OBSERVATIONAL,The trial was terminated early due to slow recruitment.
NCT01814813,TERMINATED,INTERVENTIONAL,DSMB futility analysis
NCT01814865,WITHDRAWN,INTERVENTIONAL,Funding was not acquired
NCT01814904,TERMINATED,INTERVENTIONAL,This study has been terminated because of insufficient patient recruitment.
NCT01814917,TERMINATED,INTERVENTIONAL,This study has been terminated because of insufficient patient recruitment.
NCT01814956,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01814982,TERMINATED,INTERVENTIONAL,reprioritization of company activities
NCT01815099,TERMINATED,INTERVENTIONAL,The remaining eligible participants declined to participate.
NCT01815112,TERMINATED,INTERVENTIONAL,Administrative re-organization of the department. Referent physician left the hospital.
NCT01815346,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01815463,TERMINATED,OBSERVATIONAL,"Local PI did not submit annual renewal, still active in Detroit, not recruiting."
NCT01815671,TERMINATED,INTERVENTIONAL,Increased number of oxygen desaturation in tilt down position
NCT01815970,WITHDRAWN,INTERVENTIONAL,This study never initiated.
NCT01816048,TERMINATED,INTERVENTIONAL,Study supporter (Takeda) ended study drug for prostate cancer; enrollment ended prematurely.
NCT01816217,TERMINATED,INTERVENTIONAL,The interim analysis has shown a significative difference between the two groups of patients.
NCT01816555,TERMINATED,INTERVENTIONAL,Study closed due to low accrual.
NCT01816633,TERMINATED,INTERVENTIONAL,Protocol study design was re-done in collaboration with CMS
NCT01816659,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01816672,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01816789,TERMINATED,INTERVENTIONAL,"Optimal response: 63% nomogram, 42% controls, overcoming the stopping rule for interim analysis"
NCT01817153,TERMINATED,INTERVENTIONAL,not enough recruitment
NCT01817205,TERMINATED,INTERVENTIONAL,poor case accrual
NCT01817257,TERMINATED,INTERVENTIONAL,Early findings showed trial was not feasible
NCT01817387,TERMINATED,INTERVENTIONAL,Due to participants not completing the cognitive training requirement.
NCT01817543,TERMINATED,INTERVENTIONAL,Protocol study design was re-done in collaboration with CMS
NCT01817660,TERMINATED,INTERVENTIONAL,Due to unsuccessful trial accrual
NCT01817699,TERMINATED,INTERVENTIONAL,The independent Data Monitoring Committee recommended an early termination.
NCT01817738,TERMINATED,INTERVENTIONAL,Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome
NCT01817777,TERMINATED,INTERVENTIONAL,It's no longer feasible to continue to recruit patients into the study as severe recruitment difficulties have been experienced since the study start
NCT01818011,TERMINATED,INTERVENTIONAL,Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen that changed the risk: benefit profile and led to a termination
NCT01818076,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate study (not due to safety reasons)
NCT01818154,WITHDRAWN,INTERVENTIONAL,study did not start
NCT01818193,TERMINATED,OBSERVATIONAL,Recruitment difficulties
NCT01818219,TERMINATED,INTERVENTIONAL,Only half recruitment : restrictive respiratory mechanics group not achievable for technical problems
NCT01818297,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01818414,TERMINATED,INTERVENTIONAL,Concerns for safety
NCT01818466,WITHDRAWN,OBSERVATIONAL,Dr. Higgins does not have a sub-investigator that can complete the study.
NCT01818479,TERMINATED,INTERVENTIONAL,Trial discontinued prior to starting Phase II portion due to low accrual.
NCT01818648,WITHDRAWN,INTERVENTIONAL,Study was withdrawn by PI due to decision to study a different medication.
NCT01818687,TERMINATED,INTERVENTIONAL,This study has been terminated because of insufficient patient recruitment.
NCT01818726,TERMINATED,INTERVENTIONAL,Failure to meet the schedule of patient recruitment
NCT01818882,TERMINATED,INTERVENTIONAL,Inclusion curve too slow.
NCT01818999,WITHDRAWN,INTERVENTIONAL,low accrual
NCT01819142,TERMINATED,INTERVENTIONAL,Protocol study design was re-worked in collaboration with CMS
NCT01819428,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01819467,TERMINATED,INTERVENTIONAL,"Slow to accrue, lack of qualified participants"
NCT01819532,TERMINATED,INTERVENTIONAL,"extremely poor recruitment \& since the study was approved, medical practice has evolved to where cord milking is now common practice."
NCT01819623,WITHDRAWN,INTERVENTIONAL,Financial issues (no participants enrolled)
NCT01819675,TERMINATED,INTERVENTIONAL,exposure to radiation due to repetitive PET evaluation
NCT01820078,TERMINATED,INTERVENTIONAL,Recruitment not reached
NCT01820130,WITHDRAWN,INTERVENTIONAL,end of inclusion period without patient enrolled
NCT01820169,TERMINATED,INTERVENTIONAL,Only 2 patients screened but none of them were enrolled.
NCT01820221,TERMINATED,INTERVENTIONAL,Low enrollment and Pi had no time.
NCT01820273,WITHDRAWN,OBSERVATIONAL,Study no longer at LU.
NCT01820312,WITHDRAWN,INTERVENTIONAL,Due to no enrollment.
NCT01820325,TERMINATED,INTERVENTIONAL,Due to DLTs/AEs safety profile considered challenging.
NCT01820364,TERMINATED,INTERVENTIONAL,Study was withdrawn due to scientific and business considerations.
NCT01820390,WITHDRAWN,OBSERVATIONAL,Funding discontinued.
NCT01820416,TERMINATED,INTERVENTIONAL,Analysis showed no clinically or statistically significant effects
NCT01820468,WITHDRAWN,INTERVENTIONAL,This study was terminated before any participants were enrolled due to unforseen problems with participant enrollment and study design.
NCT01820507,TERMINATED,INTERVENTIONAL,"Slow recruitment, interim analysis"
NCT01820650,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT01820676,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT01820793,TERMINATED,INTERVENTIONAL,Not enought inclusion
NCT01820962,TERMINATED,INTERVENTIONAL,Because the inclusion rate was lower than expected.
NCT01821196,WITHDRAWN,INTERVENTIONAL,due to insufficient quality of biopsy samples
NCT01821261,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT01821430,TERMINATED,INTERVENTIONAL,poor recruitment
NCT01821443,TERMINATED,INTERVENTIONAL,Loss of funding
NCT01821625,TERMINATED,INTERVENTIONAL,"Interferon use for hepatitis C plummeted, eliminating the need for study drug."
NCT01821768,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT01821859,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment
NCT01821898,TERMINATED,INTERVENTIONAL,Recruitment was below expectation
NCT01821963,TERMINATED,INTERVENTIONAL,Low referral rate due to new therapeutic options.
NCT01822171,TERMINATED,INTERVENTIONAL,Unable to enroll and study intended patient population.
NCT01822275,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01822379,WITHDRAWN,INTERVENTIONAL,This study was never initiated.
NCT01822756,TERMINATED,INTERVENTIONAL,"Dose escalation ended after Cohort B1, RUX 10 mg BID - GCSF in October 2014."
NCT01822860,WITHDRAWN,INTERVENTIONAL,Study subjects were not able to be recruited
NCT01823120,TERMINATED,INTERVENTIONAL,Resignation of critical volunteer staff and lack of funding
NCT01823211,TERMINATED,OBSERVATIONAL,Problems with ensuring patient examinations defined in the protocol of the study
NCT01823237,SUSPENDED,INTERVENTIONAL,Study is temporarily suspended pending additional funding to continue subject recruitment.
NCT01823393,TERMINATED,INTERVENTIONAL,Difficulty of inclusion
NCT01823679,TERMINATED,INTERVENTIONAL,Low accrual
NCT01823809,TERMINATED,INTERVENTIONAL,"Problems with inclusion, \>80% of patients included"
NCT01823835,TERMINATED,INTERVENTIONAL,"The Sponsor decided to halt the development of GDC-0810, but not due to any safety concerns."
NCT01823952,TERMINATED,OBSERVATIONAL,The study was closed early due to slow enrollment.
NCT01824095,TERMINATED,INTERVENTIONAL,Unable to recruit enough subjects to attain the minimum sample size.
NCT01824199,WITHDRAWN,INTERVENTIONAL,funding
NCT01824303,TERMINATED,INTERVENTIONAL,This study was terminated early due to company decision.
NCT01824394,TERMINATED,INTERVENTIONAL,Business Decision
NCT01824576,TERMINATED,INTERVENTIONAL,Enrollment was slower than anticipated.
NCT01824602,TERMINATED,INTERVENTIONAL,Due to a slow recruitment rate
NCT01824823,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01825083,WITHDRAWN,INTERVENTIONAL,Change in personnel
NCT01825239,WITHDRAWN,INTERVENTIONAL,Problems with execution
NCT01825369,WITHDRAWN,INTERVENTIONAL,Changes to cardiac surgery program
NCT01825421,WITHDRAWN,INTERVENTIONAL,No funding obtained
NCT01825564,TERMINATED,OBSERVATIONAL,Insufficient patient population \& problems with device use in subjects enrolled.
NCT01825577,TERMINATED,INTERVENTIONAL,Administrative Reasons
NCT01825655,TERMINATED,INTERVENTIONAL,Unable to recruit patients
NCT01826175,WITHDRAWN,INTERVENTIONAL,Study terminated mutually by sponsor \& PI due to no enrollment
NCT01826292,WITHDRAWN,OBSERVATIONAL,Principle Investigator was not able to proceed with the study
NCT01826435,WITHDRAWN,INTERVENTIONAL,Collaborator was not clear on how best to proceed with this project.
NCT01826448,TERMINATED,INTERVENTIONAL,No activity was observed. BRAFi-nave participants should have received triple combination treatment (including MEK inhibitor). Continuation was not justified.
NCT01826630,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT01826656,WITHDRAWN,INTERVENTIONAL,Unable to recruit suitable patients
NCT01826838,WITHDRAWN,INTERVENTIONAL,Lack of patients
NCT01826864,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01826942,TERMINATED,INTERVENTIONAL,Cooperation stooped with PI
NCT01827033,TERMINATED,INTERVENTIONAL,The Principal Investigator is leaving Johns Hopkins.
NCT01827592,TERMINATED,INTERVENTIONAL,Terminated due to a distribution issue with the trial medication
NCT01827709,TERMINATED,INTERVENTIONAL,poor accrual
NCT01827930,TERMINATED,INTERVENTIONAL,Difficulties of enrolment of Patient
NCT01827969,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01828255,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT01828294,TERMINATED,INTERVENTIONAL,Study stopped by sponsor due to difficulty enrolling at site
NCT01828476,TERMINATED,INTERVENTIONAL,The Investigator left the organization.
NCT01828502,WITHDRAWN,INTERVENTIONAL,The study was closed due to poor accrual. No patients were enrolled.
NCT01829009,WITHDRAWN,INTERVENTIONAL,Financial issues
NCT01829061,TERMINATED,OBSERVATIONAL,Data for Study Devices vs. Predicate not within allowable ranges.
NCT01829347,TERMINATED,INTERVENTIONAL,"Due to results from the VTI-208 study, the ELAD plan is being re-evaluated."
NCT01829464,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01829477,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01829867,TERMINATED,INTERVENTIONAL,Issues with development and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.
NCT01829906,TERMINATED,INTERVENTIONAL,too few candidates for enrollment
NCT01829971,TERMINATED,INTERVENTIONAL,Five immune related serious adverse events
NCT01830062,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01830088,TERMINATED,INTERVENTIONAL,Funding period expired before reaching recruitment goal.
NCT01830101,WITHDRAWN,INTERVENTIONAL,This study will not be proceeding due to lack of funding from anticipated sources
NCT01830608,WITHDRAWN,OBSERVATIONAL,Could not find a Sponsor for the study
NCT01830738,TERMINATED,INTERVENTIONAL,Inclusion curve too poor.
NCT01830790,TERMINATED,INTERVENTIONAL,Inadequate support to complete recruitment/data analysis.
NCT01830829,TERMINATED,INTERVENTIONAL,Difficulty in enrolling particpants
NCT01831037,WITHDRAWN,OBSERVATIONAL,Unable to obtain funding
NCT01831596,TERMINATED,INTERVENTIONAL,"The study was terminated by Spiracur. Efforts were made to contact the PI/study team members, but were unsuccessful."
NCT01831713,TERMINATED,OBSERVATIONAL,Changing staff
NCT01832350,TERMINATED,INTERVENTIONAL,Sponsor decided to stop study early
NCT01832571,WITHDRAWN,INTERVENTIONAL,Study is closed early due to withdrawal of funding. No study procedures were implemented.
NCT01832727,TERMINATED,INTERVENTIONAL,Enrollment halted during phase 2 to reformulate the investigational product
NCT01832766,TERMINATED,INTERVENTIONAL,Unable to find subjects with schizophrenia that were using only cannabis
NCT01832818,TERMINATED,INTERVENTIONAL,This study has been terminated early due to slow enrolment.
NCT01832831,TERMINATED,OBSERVATIONAL,The study was completed as planned
NCT01832896,WITHDRAWN,INTERVENTIONAL,"PI indicated departure from institution, inability to complete study."
NCT01832974,TERMINATED,INTERVENTIONAL,Business decision by the sponsor during Phase 1.
NCT01833065,TERMINATED,INTERVENTIONAL,Terminated due to a distribution issue with the trial medication
NCT01833221,TERMINATED,INTERVENTIONAL,The study reach enough significance at the intermediary analysis
NCT01833312,TERMINATED,INTERVENTIONAL,"Slow recruitment, cessation of funding"
NCT01833338,TERMINATED,INTERVENTIONAL,The study was terminated based on an included stopping rule in the study protocol
NCT01833455,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT01833767,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01833845,TERMINATED,INTERVENTIONAL,due to failure to recruit subjects
NCT01834144,TERMINATED,INTERVENTIONAL,Funding for the study was not renewed
NCT01834183,WITHDRAWN,INTERVENTIONAL,Sponsor Aveo has withdrawn support for this trial.
NCT01834196,TERMINATED,INTERVENTIONAL,No active study enrollment for a 2 years.
NCT01834235,TERMINATED,INTERVENTIONAL,DSMB terminated the trial for futility.
NCT01834274,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01834326,TERMINATED,INTERVENTIONAL,The funding period for the study ended. The study did not reach full enrollment.
NCT01834339,TERMINATED,INTERVENTIONAL,Loss of cGMP facility to manufacture product used in clinical trial.
NCT01834352,WITHDRAWN,INTERVENTIONAL,Concern for cross contamination in weighing tree nuts in facility with peanuts
NCT01834625,TERMINATED,OBSERVATIONAL,not recruiting
NCT01834638,TERMINATED,INTERVENTIONAL,Study endpoint in preceding base study M10-855 not met.
NCT01834937,TERMINATED,OBSERVATIONAL,Enrollment Difficulties
NCT01835080,TERMINATED,OBSERVATIONAL,low enrollment
NCT01835106,WITHDRAWN,INTERVENTIONAL,The study was proposed but never started due to other commitments
NCT01835327,TERMINATED,OBSERVATIONAL,PI no longer at institution
NCT01836055,TERMINATED,OBSERVATIONAL,The study didn't have sufficient flow of subjects (discontinued by the Sponsor)
NCT01836211,TERMINATED,INTERVENTIONAL,low recruitment
NCT01836289,WITHDRAWN,INTERVENTIONAL,Too difficult to recruit given new Crohn's medications approved
NCT01836432,TERMINATED,INTERVENTIONAL,Company decision
NCT01836549,TERMINATED,INTERVENTIONAL,Due to several intracranial hemorrhages and recommendation by the PBTC DSMB.
NCT01836614,WITHDRAWN,INTERVENTIONAL,Study was closed due to recommendations of performing a PK study first.
NCT01836640,TERMINATED,OBSERVATIONAL,Primary goal not achievable
NCT01836770,TERMINATED,OBSERVATIONAL,lack of enrollment; terminated by the Principal Investigator
NCT01836809,TERMINATED,INTERVENTIONAL,Futility for enrollment
NCT01837030,WITHDRAWN,INTERVENTIONAL,not feasible due to funding
NCT01837069,TERMINATED,INTERVENTIONAL,Low recruitment / DSMB approval to halt recruitment
NCT01837082,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT01837797,TERMINATED,INTERVENTIONAL,The study was terminated because of recruitment challenges
NCT01838044,TERMINATED,INTERVENTIONAL,Recruitment terminated on 3Apr2015 due to slow recruitment rate and lack of operational feasibility. Study was not terminated for reasons of safety/efficacy.
NCT01838057,TERMINATED,OBSERVATIONAL,The study was terminated on 02-Jun-2014 due to slow enrollment. The study was not terminated for reasons of either safety or efficacy.
NCT01838174,TERMINATED,INTERVENTIONAL,Sponsor requested
NCT01838200,TERMINATED,INTERVENTIONAL,Slow recruitment due to changes in standard of care
NCT01838265,WITHDRAWN,OBSERVATIONAL,Unlikely to Accrue
NCT01838369,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT01838499,TERMINATED,INTERVENTIONAL,"At the planned IA for decision making, no evidence was demonstrated of MEDI8968 activity in reducing (HS) severity or pain over that seen with placebo."
NCT01838642,TERMINATED,INTERVENTIONAL,Recruiting halted prematurely and will not resume. New study to open soon.
NCT01838863,TERMINATED,INTERVENTIONAL,Futility
NCT01839136,TERMINATED,INTERVENTIONAL,Low pregnancy rates in both groups
NCT01839526,TERMINATED,INTERVENTIONAL,Enrollment period not extended and screening stopped for slow recruitment and in accordance with provisions of the protocol. Not linked to any safety concern
NCT01839552,WITHDRAWN,INTERVENTIONAL,Site chose to close due to lack of enrollment
NCT01839669,TERMINATED,INTERVENTIONAL,Not possible to enroll enough patients in reasonable time.
NCT01839864,WITHDRAWN,INTERVENTIONAL,Funding for the study was not received. No recruitment ever occurred.
NCT01840033,TERMINATED,INTERVENTIONAL,difficulty of selection of inclusion
NCT01840189,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01840228,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT01840696,WITHDRAWN,INTERVENTIONAL,PI leaving facility
NCT01840943,TERMINATED,INTERVENTIONAL,the study was terminated due to medication supply issue from current manufacturer
NCT01841021,TERMINATED,INTERVENTIONAL,"Slow accrual, loss of sponsor support"
NCT01841307,TERMINATED,INTERVENTIONAL,Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation.
NCT01841463,SUSPENDED,INTERVENTIONAL,Sponsor decision not related to patient safety
NCT01841502,TERMINATED,INTERVENTIONAL,"Telaprevir will not be used in NL, no more inclusions are expected."
NCT01841814,WITHDRAWN,INTERVENTIONAL,physician departure
NCT01841892,WITHDRAWN,INTERVENTIONAL,Dr. Sirgusson moved to another institution = Florida Institute of Technology in June 2013
NCT01841931,TERMINATED,INTERVENTIONAL,Principal Investigator is no longer at this site
NCT01842113,TERMINATED,INTERVENTIONAL,PI Initiated study - PI left facility
NCT01842178,WITHDRAWN,INTERVENTIONAL,Principal investigator retired from the project
NCT01842217,TERMINATED,INTERVENTIONAL,Not enough participants
NCT01842282,TERMINATED,INTERVENTIONAL,"Due to limited funding, trial was suspended, intending to restart with additional funds; then preliminary results were obtained, and research moved on to placebo controlled trial. Results for both have been published."
NCT01842334,TERMINATED,INTERVENTIONAL,left institution protocol closed
NCT01842373,WITHDRAWN,INTERVENTIONAL,Funding not secured
NCT01842399,TERMINATED,INTERVENTIONAL,The protocol experienced slow accrual.
NCT01842542,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01842594,TERMINATED,INTERVENTIONAL,Most patients completed only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.
NCT01842698,TERMINATED,INTERVENTIONAL,The study was stopped because there was a technical problem with the ultrasound used in the trial.
NCT01842789,TERMINATED,INTERVENTIONAL,Results to date adequately demonstrated user preference and recovery time. Time to target (Part II) was not studied. .
NCT01842971,TERMINATED,INTERVENTIONAL,Main reason: negative echo in the literature after the first publications.
NCT01843062,TERMINATED,INTERVENTIONAL,Study was terminated based on the findings of primary analysis at 18 months post-RAI treatment. Patients pending 3 year follow up had end of study phone call.
NCT01843179,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT01843309,TERMINATED,INTERVENTIONAL,Not possible to complete the sample within the estimated time by the use of new antifungals
NCT01843335,TERMINATED,OBSERVATIONAL,recruitment too slow
NCT01843413,SUSPENDED,INTERVENTIONAL,Administrative hold
NCT01843452,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01843491,WITHDRAWN,INTERVENTIONAL,Did not go forward with study.
NCT01843569,WITHDRAWN,INTERVENTIONAL,Institutional approval of study has expired.
NCT01843738,WITHDRAWN,INTERVENTIONAL,Competing Trials
NCT01844076,TERMINATED,INTERVENTIONAL,The single Quinacrine manufacture facility in the US was shut down by the FDA
NCT01844206,TERMINATED,INTERVENTIONAL,Slow recruitment of subjects
NCT01844700,TERMINATED,INTERVENTIONAL,"very slow recruitment, no sufficient results"
NCT01844726,TERMINATED,INTERVENTIONAL,Study sponsor was acquired by another company.
NCT01845012,TERMINATED,INTERVENTIONAL,Study has been prematurely halted because of failure of patient recruitment.
NCT01845025,TERMINATED,INTERVENTIONAL,Due to the action to withdraw the Foradil Aerolizer NDA in US; study was discontinued. This was a commercial reason and not due to any change in benefit-risk.
NCT01845103,TERMINATED,OBSERVATIONAL,Due to the product being discontinued
NCT01845441,TERMINATED,INTERVENTIONAL,The principal investigator left employment at the sponsoring Institution
NCT01845454,TERMINATED,INTERVENTIONAL,poor enrollment and study design
NCT01845467,WITHDRAWN,OBSERVATIONAL,Unable to enroll participants
NCT01845792,TERMINATED,INTERVENTIONAL,Low accrual
NCT01845974,TERMINATED,INTERVENTIONAL,Interim evaluation of data after internal safety report from sponsor.
NCT01846026,WITHDRAWN,INTERVENTIONAL,At the planned study start new treatment guidelines for this disease with new drugs were implemented in clinical practice.
NCT01846182,TERMINATED,INTERVENTIONAL,Terminated by Funder
NCT01846364,TERMINATED,INTERVENTIONAL,Lack of sufficient enrollment
NCT01846429,TERMINATED,INTERVENTIONAL,Drugs unavailable. Study did not progress to Phase 2.
NCT01846624,TERMINATED,INTERVENTIONAL,Accrual factor
NCT01846663,TERMINATED,INTERVENTIONAL,Study was determined to be infeasible.
NCT01846715,TERMINATED,INTERVENTIONAL,lack of funding
NCT01846806,TERMINATED,INTERVENTIONAL,PI no longer at NYUMC
NCT01847014,TERMINATED,INTERVENTIONAL,Protocol-defined criterion of macitentan availability achieved.
NCT01847196,TERMINATED,INTERVENTIONAL,IDE approval received for larger Pivotal Study
NCT01847222,TERMINATED,INTERVENTIONAL,Terminated due to completion of competing study.
NCT01847300,WITHDRAWN,INTERVENTIONAL,not funded
NCT01847495,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT01847573,TERMINATED,INTERVENTIONAL,Dosing stopped
NCT01847599,TERMINATED,INTERVENTIONAL,interim analysis : discontinuation for efficacy of the intervention
NCT01847716,TERMINATED,OBSERVATIONAL,numbers recruited to show adequate association but not primary outcome
NCT01847768,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT01848106,TERMINATED,INTERVENTIONAL,Clinical Hold
NCT01848301,TERMINATED,INTERVENTIONAL,loss of funding
NCT01848431,WITHDRAWN,OBSERVATIONAL,staff change and lack of ressources
NCT01848548,TERMINATED,OBSERVATIONAL,Unable to continue recruit subjects
NCT01848600,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01848652,TERMINATED,INTERVENTIONAL,"The laboratory's partner on this study decides to terminate the contract with the CHRU Brest, because of the difficulty of the recruitment."
NCT01848756,TERMINATED,INTERVENTIONAL,Business reasons
NCT01849081,WITHDRAWN,INTERVENTIONAL,"Change in priorities, study closed prior to enrollment"
NCT01849276,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01849588,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01849640,SUSPENDED,INTERVENTIONAL,Poor efficacy of DHA-piperaquine due to likely drug resistance.
NCT01849744,TERMINATED,INTERVENTIONAL,Sponsor's decision to deprioritize the program.
NCT01849757,WITHDRAWN,INTERVENTIONAL,Pentaspan is no longer used at our institution. Pentaspan was an arm of the study
NCT01849796,TERMINATED,INTERVENTIONAL,Investigators moved to other institutions
NCT01849874,TERMINATED,INTERVENTIONAL,"Per recommendation of the DMC, enrollment into the study was discontinued in April 2016 after the planned interim efficacy analysis showed the hazard ratio for PFS crossed the predefined futility boundary."
NCT01849887,WITHDRAWN,INTERVENTIONAL,Study was never started
NCT01850251,TERMINATED,INTERVENTIONAL,Recruiting problems.
NCT01850576,WITHDRAWN,INTERVENTIONAL,We did not receive proper funding to complete this study
NCT01850589,TERMINATED,INTERVENTIONAL,Use of bupropion with counseling works better to help patients quit smoking.
NCT01850771,TERMINATED,INTERVENTIONAL,Difficulties in recruitment
NCT01850888,SUSPENDED,INTERVENTIONAL,Drugs unavailable. Seeking new supplier.
NCT01850992,WITHDRAWN,INTERVENTIONAL,This study is non-funded study and experienced difficulty in recruitment.
NCT01851161,TERMINATED,OBSERVATIONAL,Data analysis completed
NCT01851174,TERMINATED,INTERVENTIONAL,PI Leaving Site
NCT01851408,WITHDRAWN,INTERVENTIONAL,No progression of Phase 1 trial to Phase 2.
NCT01851421,TERMINATED,OBSERVATIONAL,Slow/Insufficient accrual
NCT01851434,TERMINATED,OBSERVATIONAL,The original analyses could not be performed due to data inconsistencies across the study sites.
NCT01851460,WITHDRAWN,INTERVENTIONAL,PI choose to close the study
NCT01851486,WITHDRAWN,INTERVENTIONAL,Labortory focus was changed and study was not opened at all
NCT01851603,TERMINATED,INTERVENTIONAL,PI left institution
NCT01851720,TERMINATED,INTERVENTIONAL,Inclusion criteria were too strict and therefore we were not able to recruit more patients.
NCT01851798,TERMINATED,OBSERVATIONAL,Staffing changes precluded sleep study interpretation
NCT01851954,TERMINATED,INTERVENTIONAL,declined enrollment
NCT01852110,TERMINATED,INTERVENTIONAL,Stage 1 interim analysis of efficacy met the criteria for early trial termination (futility). The trial was terminated at Stage 1; did not proceed to Stage 2.
NCT01852305,TERMINATED,INTERVENTIONAL,due to lack resources
NCT01852526,TERMINATED,INTERVENTIONAL,device failure
NCT01852747,TERMINATED,INTERVENTIONAL,The sponsor merged with another company and decided they did not want to continue with the study.
NCT01852773,WITHDRAWN,OBSERVATIONAL,Only observational retrospective study performed. No enrollees collected.
NCT01852916,SUSPENDED,INTERVENTIONAL,Poor recruitment rate
NCT01853176,TERMINATED,INTERVENTIONAL,required documentation too onerous
NCT01853228,TERMINATED,INTERVENTIONAL,EMA/PDCO acknowledged that available results from this study do not support further clinical studies in relapsed/refractory AML paediatric patients.
NCT01853241,TERMINATED,OBSERVATIONAL,SE system by Spirus Medical withdrawn from market in 2011
NCT01853293,WITHDRAWN,INTERVENTIONAL,Grant was not funded
NCT01853384,TERMINATED,INTERVENTIONAL,based on outcome of trial NCT01656889.
NCT01853436,TERMINATED,INTERVENTIONAL,Lifecell became part of Allergan; company deciscion
NCT01853605,TERMINATED,INTERVENTIONAL,The study was discontinued following product approval.
NCT01853683,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01853891,WITHDRAWN,INTERVENTIONAL,The study was stopped due to lack of funding.
NCT01853982,TERMINATED,INTERVENTIONAL,Terminated to focus on a larger study within the clinical development program.
NCT01854099,WITHDRAWN,INTERVENTIONAL,Investigator decided not to open study.
NCT01854307,TERMINATED,INTERVENTIONAL,Low inclusion rate
NCT01855334,WITHDRAWN,INTERVENTIONAL,change of funding leading to major redesign
NCT01855386,TERMINATED,OBSERVATIONAL,Expired with the IRB
NCT01855607,TERMINATED,INTERVENTIONAL,Lack of feasibility
NCT01855672,TERMINATED,INTERVENTIONAL,Business strategic decision not related to safety.
NCT01856023,TERMINATED,INTERVENTIONAL,slow accrual \& early closure
NCT01856036,TERMINATED,INTERVENTIONAL,PI left institute and contacted IRB to close study.
NCT01856101,TERMINATED,INTERVENTIONAL,Novartis decided to stop the marketing of BEZ235
NCT01856127,TERMINATED,INTERVENTIONAL,PI left institution
NCT01856257,TERMINATED,INTERVENTIONAL,Safety: Stopping rule not met.
NCT01856322,TERMINATED,INTERVENTIONAL,The trial was prematurely closed due to lack of accrual.
NCT01856361,TERMINATED,INTERVENTIONAL,We did not accrue as much as anticipated and the PI (Dabaja) is no longer at Weill Cornell.
NCT01856439,TERMINATED,INTERVENTIONAL,"As a result of termination of development of Prosavin, it is no longer possible for Sio to either commence or to continue any related clinical trials."
NCT01856582,TERMINATED,INTERVENTIONAL,"CliniMACS CD34 Reagent System was FDA approved for clinical use; therefore, patients were treated clinically."
NCT01856647,TERMINATED,OBSERVATIONAL,Low enrollment
NCT01856738,TERMINATED,INTERVENTIONAL,"enrollment to slow, insufficient funds"
NCT01856881,TERMINATED,INTERVENTIONAL,"This study was terminated on August 29th, 2014 due to a business decision by the Sponsor. The study was not terminated due to a safety reason."
NCT01857271,TERMINATED,INTERVENTIONAL,low accrual
NCT01857492,WITHDRAWN,INTERVENTIONAL,Inactive
NCT01857505,WITHDRAWN,OBSERVATIONAL,Funding
NCT01857557,TERMINATED,INTERVENTIONAL,Challenges with participant recruitment as a result of COVID-19 pandemic
NCT01857726,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT01857752,TERMINATED,INTERVENTIONAL,accrual
NCT01857765,WITHDRAWN,INTERVENTIONAL,The resident in charge of the project has graduated so we decided to close this study
NCT01857817,TERMINATED,INTERVENTIONAL,Low patient recruitment
NCT01858038,WITHDRAWN,INTERVENTIONAL,Not enough subjects interested in this study
NCT01858064,WITHDRAWN,INTERVENTIONAL,Competing Departmental Studies
NCT01858454,TERMINATED,INTERVENTIONAL,The study enrollment is not enough
NCT01858480,WITHDRAWN,INTERVENTIONAL,Terminated due to slow enrollment
NCT01858532,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT01858662,TERMINATED,INTERVENTIONAL,due to poor recrutment
NCT01858753,TERMINATED,INTERVENTIONAL,unable to enroll
NCT01859052,TERMINATED,INTERVENTIONAL,Study team was unable to effectively conduct the study.
NCT01859104,WITHDRAWN,INTERVENTIONAL,App to be used in study needs revision.
NCT01859169,SUSPENDED,OBSERVATIONAL,Modifying the clinnicaltrials
NCT01859260,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT01859338,TERMINATED,OBSERVATIONAL,Slow accrual
NCT01859351,TERMINATED,INTERVENTIONAL,Study terminated for business reasons
NCT01859468,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT01859637,TERMINATED,INTERVENTIONAL,Additional pharmacovigilance activity was considered as fulfilled by the EMA.
NCT01859689,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01859741,TERMINATED,INTERVENTIONAL,OMP-59R5 did not improve PFS.
NCT01860027,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT01860040,TERMINATED,INTERVENTIONAL,"Poor accrual, no data to analyze"
NCT01860092,TERMINATED,OBSERVATIONAL,Manufacturing ceased for all Argus II and Argus 2s devices (FDA notified of and subsequently approved discontinuation of post approval study in Oct 2021)
NCT01860443,TERMINATED,INTERVENTIONAL,Because there are enough data to present the conclusions
NCT01860560,WITHDRAWN,INTERVENTIONAL,this was an error. Study never initiated
NCT01860664,TERMINATED,INTERVENTIONAL,The Sponsor has stopped responding to calls and emails
NCT01861028,TERMINATED,OBSERVATIONAL,Not enough patient volume to continue the study.
NCT01861054,TERMINATED,INTERVENTIONAL,Enrollment target not reached
NCT01861145,WITHDRAWN,INTERVENTIONAL,Unable to sufficiently enroll or collect follow-up
NCT01861249,TERMINATED,INTERVENTIONAL,Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.
NCT01861444,TERMINATED,OBSERVATIONAL,Terminated due to financial reasons.
NCT01861561,TERMINATED,INTERVENTIONAL,The duration of the study is longer than 5 years and we can not recruit the participants to the target number.
NCT01861639,TERMINATED,INTERVENTIONAL,Timeframe of the IMI project couldn't be expended
NCT01861652,WITHDRAWN,INTERVENTIONAL,sponsor withdrew support
NCT01861665,TERMINATED,INTERVENTIONAL,Investigator no longer recruiting subjects.
NCT01861717,TERMINATED,INTERVENTIONAL,Didn't enroll enough subjects
NCT01861743,TERMINATED,INTERVENTIONAL,data was not collected accurately
NCT01861990,WITHDRAWN,INTERVENTIONAL,Feasibility of the trial was proven to be absent.
NCT01862224,TERMINATED,INTERVENTIONAL,"The study was stopped due to lack of efficacy in a study conducted in a similar population,38518168ARA2002-NCT01679951."
NCT01862458,WITHDRAWN,INTERVENTIONAL,funding difficulty
NCT01862718,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT01863004,TERMINATED,INTERVENTIONAL,insufficient enrollment rate
NCT01863329,TERMINATED,OBSERVATIONAL,"The investigator resigned on February 28, 2014."
NCT01863381,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT01863498,TERMINATED,INTERVENTIONAL,Institution converted to an alternative strategy for pain control
NCT01863719,TERMINATED,INTERVENTIONAL,"Completion of cohort 3, safety concerns"
NCT01863940,TERMINATED,INTERVENTIONAL,Political unrest in study country
NCT01864291,TERMINATED,INTERVENTIONAL,Closed by IRB
NCT01864421,TERMINATED,OBSERVATIONAL,New data in public domain suggested continuing study not ethical
NCT01864512,WITHDRAWN,OBSERVATIONAL,No eligible patient was enrolled.
NCT01864538,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01864616,TERMINATED,INTERVENTIONAL,We couldn't recruit the sample the we required
NCT01864798,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01865084,TERMINATED,INTERVENTIONAL,The study is being terminated for lack of efficacy
NCT01865175,WITHDRAWN,INTERVENTIONAL,"Institution required IND, although FDA did not, so institution did not allow enrollment"
NCT01865240,TERMINATED,INTERVENTIONAL,No new participants enrolled. Protocol has been superseded
NCT01865253,TERMINATED,INTERVENTIONAL,No new participants enrolled. Protocol superseded.
NCT01865539,TERMINATED,INTERVENTIONAL,Difficulty with recruitment/funding
NCT01865630,WITHDRAWN,INTERVENTIONAL,PI moved to another institution
NCT01865695,TERMINATED,INTERVENTIONAL,Lack of participant enrolment
NCT01865838,TERMINATED,INTERVENTIONAL,safety issue
NCT01865864,TERMINATED,OBSERVATIONAL,Difficulty Recruiting subjects
NCT01865903,TERMINATED,OBSERVATIONAL,To Low recruitment and competing studies
NCT01866189,WITHDRAWN,INTERVENTIONAL,default recruitment
NCT01866345,WITHDRAWN,INTERVENTIONAL,Cannot find subjects to particpate
NCT01866423,TERMINATED,INTERVENTIONAL,Not progressing toward scientific goals
NCT01866553,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01866657,TERMINATED,INTERVENTIONAL,Funding
NCT01866709,TERMINATED,INTERVENTIONAL,Risk/benefit determination showed study revealed negative safety issues.
NCT01866735,TERMINATED,INTERVENTIONAL,Results from trial in another population lead investigators to determine study outcome may not reach statistical significance.
NCT01866774,TERMINATED,INTERVENTIONAL,Primary Investigator (AJN) left institution
NCT01866904,TERMINATED,OBSERVATIONAL,Study was terminated in order to secure the data quality of the study in terms of follow-up rates and data completeness.
NCT01866917,TERMINATED,INTERVENTIONAL,Pharmacy stopped dispensing study medication
NCT01866930,TERMINATED,INTERVENTIONAL,Sponsor decision not based on any new unexpected safety findings or efficacy observations.
NCT01867047,TERMINATED,INTERVENTIONAL,Following an interim analysis the study team felt that there was enough data that showed no significant difference.
NCT01867203,WITHDRAWN,OBSERVATIONAL,No patients enrolled
NCT01867645,TERMINATED,INTERVENTIONAL,The trial was terminated early due to futility in reaching the primary endpoint.
NCT01867918,TERMINATED,INTERVENTIONAL,Insuffisient recruitment
NCT01868139,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT01868243,TERMINATED,INTERVENTIONAL,because a significant decrease of viable candidates for the study.
NCT01868360,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01868503,TERMINATED,INTERVENTIONAL,Protocol modification
NCT01868620,TERMINATED,INTERVENTIONAL,The investigator decided to stop the trial due to a lack of inclusion.
NCT01868880,WITHDRAWN,INTERVENTIONAL,difficulties in recruiting patients
NCT01868906,TERMINATED,INTERVENTIONAL,Isotope (FMISO) production is no longer available in our country.
NCT01868932,WITHDRAWN,INTERVENTIONAL,Funding declined. Study never initiated.
NCT01868984,TERMINATED,INTERVENTIONAL,catheters no longer available - difficult to recruit subjects
NCT01869049,WITHDRAWN,OBSERVATIONAL,No eligible patient was enrolled.
NCT01869153,TERMINATED,OBSERVATIONAL,Study expired; PI failed to submit study to IRB for continuing review
NCT01869361,WITHDRAWN,INTERVENTIONAL,"Due to much lower than expected numbers of eligible patients and lack of PI time, the study was not started."
NCT01869478,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01869738,TERMINATED,INTERVENTIONAL,low enrollment rate
NCT01869751,WITHDRAWN,OBSERVATIONAL,failure to recruit patients
NCT01870089,TERMINATED,INTERVENTIONAL,Enough data to conclude
NCT01870141,SUSPENDED,INTERVENTIONAL,Study halted prematurely but potentially will resume
NCT01870284,WITHDRAWN,INTERVENTIONAL,Due to unexpected operational issues outside of Lilly's control the study has been closed
NCT01870453,WITHDRAWN,OBSERVATIONAL,Participants recruitment failure
NCT01870492,TERMINATED,OBSERVATIONAL,Principle Investigator relocated to a new institution
NCT01870518,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01870609,TERMINATED,INTERVENTIONAL,Interim analysis-DSMB stated good safety profile but lack of efficacy
NCT01870661,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01870791,TERMINATED,INTERVENTIONAL,Interim analysis
NCT01870856,TERMINATED,INTERVENTIONAL,Primary efficacy was not demonstrated in Stage 1
NCT01870869,TERMINATED,INTERVENTIONAL,There was no indication that long-term follow-up would differ between any of the studies that have evaluated devices within the 410 Style Matrix.
NCT01871168,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01871181,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT01871246,TERMINATED,OBSERVATIONAL,The study was not funded and we ran out of resources to complete the data analysis. This was a qualitative study and requires substantial time and effort to conduct data analysis.
NCT01871259,TERMINATED,OBSERVATIONAL,Finished
NCT01871311,TERMINATED,INTERVENTIONAL,Primary investigator left the institution.
NCT01871324,WITHDRAWN,INTERVENTIONAL,technical issues
NCT01871441,TERMINATED,INTERVENTIONAL,Trial was closed due to poor accrual.
NCT01871532,TERMINATED,INTERVENTIONAL,Study was terminated because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays.
NCT01871740,WITHDRAWN,INTERVENTIONAL,The sponsor and the PIs both agreed that the CSPPT-CKD should be a sub-study of the CSPPT insted of an independent randomized trial.
NCT01872000,TERMINATED,INTERVENTIONAL,Difficulties with recruitment.
NCT01872104,SUSPENDED,INTERVENTIONAL,Modifying the clinnicaltrials
NCT01872169,WITHDRAWN,INTERVENTIONAL,Study was withdrawn prior to commencement
NCT01872234,TERMINATED,INTERVENTIONAL,The study encountered significant difficulties in patient enrollment.
NCT01872273,WITHDRAWN,OBSERVATIONAL,Project never funded. No subjects were recruited.
NCT01872312,WITHDRAWN,INTERVENTIONAL,Not sure. PI is no longer at OSU.
NCT01872351,WITHDRAWN,OBSERVATIONAL,PI left the institution
NCT01872377,TERMINATED,INTERVENTIONAL,No longer recruiting patients to this study
NCT01872988,TERMINATED,INTERVENTIONAL,Difficult in patient enrollment
NCT01873534,TERMINATED,INTERVENTIONAL,Unable to recruit patients meeting the inclusion criteria
NCT01873651,WITHDRAWN,INTERVENTIONAL,The study has been withdrawn due to too few patients
NCT01873690,TERMINATED,INTERVENTIONAL,Due to the low recruitment rate and the large number lost to follow-up
NCT01873833,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT01874119,TERMINATED,INTERVENTIONAL,Enrollment issues
NCT01874236,TERMINATED,INTERVENTIONAL,Data could not be interpreted. Re-design efforts failed.
NCT01874288,TERMINATED,INTERVENTIONAL,"Clinical benefit was noted in the earlier portion of the trial; hence, participants were not enrolled in 2 expansion cohorts and the study was terminated early."
NCT01874340,TERMINATED,INTERVENTIONAL,Study terminated early based upon development of another anti-IL17 fully human monoclonal antibody with better potential for treating MS patients
NCT01874730,TERMINATED,INTERVENTIONAL,Very slow accrual because sites have few open colorectal surgery
NCT01874756,TERMINATED,INTERVENTIONAL,Funding ended
NCT01874821,TERMINATED,INTERVENTIONAL,Unrelated to trial
NCT01875068,TERMINATED,INTERVENTIONAL,Unable to recruit adequate numbers for study
NCT01875107,WITHDRAWN,INTERVENTIONAL,Time constraints of primary investigator.
NCT01875185,TERMINATED,INTERVENTIONAL,Lack of funds for specimen management and data analysis
NCT01875198,TERMINATED,INTERVENTIONAL,because of difficulties of enrolling appropriate participants
NCT01875263,TERMINATED,INTERVENTIONAL,Not participants inclusion
NCT01875549,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT01875770,TERMINATED,OBSERVATIONAL,"The study was terminated as patients could not be followed-up during the COVID pandemic. Since this was a non-intervention study, as per Johns Hopkins University policy, we had to hold off the patient visits during the pandemic."
NCT01875848,TERMINATED,INTERVENTIONAL,Data safety monitoring board recommended due to low recruitment yield.
NCT01875874,TERMINATED,INTERVENTIONAL,"Due to VTI-208 results, the ELAD clinical plan is being re-evaluated."
NCT01876251,TERMINATED,INTERVENTIONAL,"The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014 development. There were no safety/efficacy concerns behind the decision."
NCT01876264,WITHDRAWN,INTERVENTIONAL,Study abandoned
NCT01876641,TERMINATED,INTERVENTIONAL,Loss of funding
NCT01876693,TERMINATED,INTERVENTIONAL,slow accrual in experiment arm
NCT01876953,TERMINATED,INTERVENTIONAL,"Due to the budget issues, the study discontinued at Phase II."
NCT01876979,TERMINATED,INTERVENTIONAL,Extended study duration
NCT01876992,TERMINATED,INTERVENTIONAL,All investigators/co-investigators relocating to other institutions.
NCT01877343,TERMINATED,INTERVENTIONAL,"Challenges associated with study enrollment due to stress test, study terminated"
NCT01877356,TERMINATED,INTERVENTIONAL,intermittent evaluation of results: high incendence of complications
NCT01877473,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT01877486,WITHDRAWN,OBSERVATIONAL,funding not available
NCT01877928,TERMINATED,INTERVENTIONAL,Most OSA patients were not obese and/or admitted over night so the study was not feasible.
NCT01878045,SUSPENDED,OBSERVATIONAL,This study is on a temporary Administrative Hold pending further discussion for NIDDK and Tribal Leadership.
NCT01878136,WITHDRAWN,INTERVENTIONAL,Time constraints
NCT01878578,TERMINATED,INTERVENTIONAL,prematurely terminated due to impossibility of recruiting the planned number of patients by the study centre.
NCT01878708,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01878786,TERMINATED,INTERVENTIONAL,Interim results suggested a concern for patient outcomes and safety
NCT01878851,WITHDRAWN,OBSERVATIONAL,New data was published in the literature
NCT01878864,TERMINATED,INTERVENTIONAL,Too slow patient inclusion and superior effect of the injection
NCT01879280,WITHDRAWN,INTERVENTIONAL,low enrollment
NCT01879670,TERMINATED,OBSERVATIONAL,Withdrawal of CircuLite Synergy from clinical use
NCT01879930,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01879943,TERMINATED,INTERVENTIONAL,Operational difficulties related to medical staff turnover (investigators departure and sickness leave).
NCT01880073,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01880112,WITHDRAWN,INTERVENTIONAL,There is no longer need for this study.
NCT01880307,TERMINATED,INTERVENTIONAL,Not enough study subjects
NCT01880372,TERMINATED,INTERVENTIONAL,Low number of patients enrolled
NCT01880996,WITHDRAWN,INTERVENTIONAL,The deparment failed to detect patients that were willing to participate in this study
NCT01881035,TERMINATED,INTERVENTIONAL,Recruiting of the whole study population not possible.
NCT01881165,WITHDRAWN,INTERVENTIONAL,Sponsor declined funding
NCT01881412,TERMINATED,INTERVENTIONAL,Funding complete
NCT01881451,TERMINATED,OBSERVATIONAL,Due to slow accrual and access to the study drug.
NCT01881789,TERMINATED,INTERVENTIONAL,A program evaluation identified that the safety profile and pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required further optimization and thus enrollment in OPZ003 was halted during dose-escalation.
NCT01881932,TERMINATED,INTERVENTIONAL,"The PI has moved to another institution, which resulted in significant changes in the study design and study title."
NCT01881958,WITHDRAWN,INTERVENTIONAL,the manufacturer decided to halt manufacturing the vaccine
NCT01881997,WITHDRAWN,INTERVENTIONAL,IRB modifications made study impractical.
NCT01882049,WITHDRAWN,INTERVENTIONAL,study never started due to funding issues
NCT01882075,TERMINATED,INTERVENTIONAL,Dysfonction of the device
NCT01882101,WITHDRAWN,INTERVENTIONAL,"Too small included patients and, not enough cost for PTNS and biofeedback."
NCT01882127,WITHDRAWN,INTERVENTIONAL,No eligible patient was enrolled.
NCT01882166,TERMINATED,INTERVENTIONAL,"principal investigator left for another job, project leader retired"
NCT01882218,WITHDRAWN,INTERVENTIONAL,Not feasable at this site
NCT01882231,TERMINATED,INTERVENTIONAL,Slow accrual and lack of funding
NCT01882374,WITHDRAWN,INTERVENTIONAL,Change in drug product development strategy
NCT01882387,WITHDRAWN,INTERVENTIONAL,Change in drug product development strategy
NCT01882530,TERMINATED,INTERVENTIONAL,Practice on postoperative pain management changed
NCT01882660,TERMINATED,INTERVENTIONAL,Inclusion of patients was slow. Could not reach the target within the studyperiod.
NCT01882764,TERMINATED,INTERVENTIONAL,Futility interim analysis of the Induction Study HMPL-004-03.
NCT01882855,WITHDRAWN,OBSERVATIONAL,Dr. Sigal no longer with NYUMC
NCT01882972,WITHDRAWN,INTERVENTIONAL,investigator left Loyola
NCT01883011,TERMINATED,INTERVENTIONAL,This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.
NCT01883063,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT01883245,TERMINATED,INTERVENTIONAL,We decided to stopped the study because we have difficulties in recruiting subjects phase.
NCT01883414,TERMINATED,INTERVENTIONAL,Lack of resources to manage trial; lack of efficacy.
NCT01883492,TERMINATED,INTERVENTIONAL,Enrollment of the subject could not reach statistically required number.
NCT01883648,TERMINATED,INTERVENTIONAL,Funding limitations and enrollment was too low.
NCT01883908,TERMINATED,INTERVENTIONAL,The project is terminated due to that fact that the PI has moved to another institution and there are no resources to keep the study open in either institution.
NCT01883921,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT01883947,TERMINATED,INTERVENTIONAL,too long inclusion phase due to difficulties to find eligible participants.
NCT01884077,TERMINATED,INTERVENTIONAL,slow recruitment and poor follow up
NCT01884129,TERMINATED,OBSERVATIONAL,participants are no longer being examined or treated
NCT01884324,TERMINATED,INTERVENTIONAL,Study was stoped according to preliminary analysis.
NCT01884740,TERMINATED,INTERVENTIONAL,The study was prematurely closed in December 2021 due to low accrual.
NCT01885611,WITHDRAWN,INTERVENTIONAL,There was a problem with funding and with the acquisition of the lab assays
NCT01885650,TERMINATED,INTERVENTIONAL,Based upon results of interim data analysis
NCT01885819,WITHDRAWN,INTERVENTIONAL,per sponsor decision
NCT01885832,WITHDRAWN,INTERVENTIONAL,per sponsor decision
NCT01886105,TERMINATED,INTERVENTIONAL,Low accrual and loss of funding
NCT01886131,TERMINATED,INTERVENTIONAL,Recruitment
NCT01886287,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01886300,TERMINATED,OBSERVATIONAL,Due to out-of-date design and non-compliance.
NCT01886391,WITHDRAWN,INTERVENTIONAL,Major changes in study required new IRB application and approval
NCT01886625,WITHDRAWN,INTERVENTIONAL,No local inclusions
NCT01886742,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01886794,TERMINATED,INTERVENTIONAL,Collaborator moved and not able to recreate full study team
NCT01887002,TERMINATED,INTERVENTIONAL,The study was terminated due to slow accrual of subjects.
NCT01887041,TERMINATED,INTERVENTIONAL,Recruiting problems
NCT01887067,TERMINATED,INTERVENTIONAL,Slow recruitment and change in clinical evidence
NCT01887119,TERMINATED,INTERVENTIONAL,Failure to recruit sufficient participants
NCT01887288,TERMINATED,INTERVENTIONAL,PI Leaving Site
NCT01887353,TERMINATED,INTERVENTIONAL,Difficultly in enrolling
NCT01887444,WITHDRAWN,INTERVENTIONAL,Never started
NCT01887457,SUSPENDED,INTERVENTIONAL,Transfer of management of study
NCT01887483,TERMINATED,INTERVENTIONAL,"Slow recruitment, high drop-out"
NCT01887509,TERMINATED,INTERVENTIONAL,"Difficulties with patients recruitment, study acceptance and protocol implementation."
NCT01887522,TERMINATED,INTERVENTIONAL,the results of the interim analysis are clear with a significant advantage in terms of PFS in favor of the control arm (Vinblastine alone) over the investigational arm (Vinblastine + Nilotinib).
NCT01887587,TERMINATED,INTERVENTIONAL,SAE- risk of overall protocol treatment outweighs benefits
NCT01887717,TERMINATED,INTERVENTIONAL,Poor Accrual.
NCT01887730,SUSPENDED,INTERVENTIONAL,Organizational changes and lack of resources
NCT01887756,TERMINATED,INTERVENTIONAL,Halted before intervention due to approval of service.
NCT01887899,WITHDRAWN,INTERVENTIONAL,Not funded
NCT01887912,TERMINATED,INTERVENTIONAL,The Independent Data Monitoring Committee (IDMC) concluded that the probability that the study will meet its primary objective is low.
NCT01888029,WITHDRAWN,INTERVENTIONAL,Not funded
NCT01888055,WITHDRAWN,INTERVENTIONAL,Not funded
NCT01888081,TERMINATED,INTERVENTIONAL,Protocol replaced with combination therapy adding KEYTRUDA (pembrolizumab)
NCT01888133,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01888562,WITHDRAWN,INTERVENTIONAL,Could not obtain an IDE on the FGFR2 assay
NCT01888614,WITHDRAWN,OBSERVATIONAL,Unable to secure equipment to proceed
NCT01888692,TERMINATED,OBSERVATIONAL,Poor accural
NCT01888796,TERMINATED,INTERVENTIONAL,"bad recruitment of suitable participants, just 8 patients in one year"
NCT01888965,TERMINATED,INTERVENTIONAL,Adverse Event issues.
NCT01889212,TERMINATED,INTERVENTIONAL,Due to technical problems
NCT01889420,TERMINATED,INTERVENTIONAL,Low accrual
NCT01889472,TERMINATED,INTERVENTIONAL,Inability to further include additional patients
NCT01889654,TERMINATED,OBSERVATIONAL,recrutment difficulty
NCT01889797,TERMINATED,INTERVENTIONAL,Closed due prolonged enrollment timelines
NCT01889992,TERMINATED,INTERVENTIONAL,PI left University and project not continued
NCT01890044,WITHDRAWN,OBSERVATIONAL,Never proceeded with trial. Failure initiate protocol among other centers.
NCT01890083,TERMINATED,INTERVENTIONAL,Lack of eligible patients due to introduction of new drugs for Hepatitis C
NCT01890304,TERMINATED,INTERVENTIONAL,Available MRI scan unable to collect required data elements.
NCT01890408,TERMINATED,INTERVENTIONAL,promoter decision
NCT01890577,TERMINATED,OBSERVATIONAL,Study was terminated due to slow enrolment with no reasonable expectation of attaining a meaningful sample size
NCT01890707,TERMINATED,INTERVENTIONAL,Change in procedure.
NCT01890733,TERMINATED,INTERVENTIONAL,Very low recruitment rate
NCT01890798,WITHDRAWN,INTERVENTIONAL,Rights for the further development of drisapersen have been transferred to Prosensa. Therefore this study has been cancelled before enrollment.
NCT01890811,WITHDRAWN,INTERVENTIONAL,Recruitment challenges
NCT01891357,TERMINATED,INTERVENTIONAL,Early termination due to significant lack of relevant patient data for evaluation of objectives.
NCT01891383,WITHDRAWN,OBSERVATIONAL,New data published showing EPO to be ineffective in TBI
NCT01891500,WITHDRAWN,INTERVENTIONAL,Difficult to identify subjects who meet enrollment criteria.
NCT01891604,WITHDRAWN,INTERVENTIONAL,Study Never Initiated due to Impact approval from institution not being obtinaed
NCT01891643,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT01891669,TERMINATED,INTERVENTIONAL,"The study was terminated on June 23, 2015 due to the company's change in prioritization for the portfolio and is not due to any safety concerns."
NCT01891695,TERMINATED,INTERVENTIONAL,Study had very specific inclusion/exclusion criteria and difficult to recruit
NCT01891812,TERMINATED,INTERVENTIONAL,Enrollment issues.
NCT01891825,SUSPENDED,INTERVENTIONAL,Internal protocol review
NCT01891890,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01891981,TERMINATED,INTERVENTIONAL,Ph I Exempt as it did not proceed to the Phase II terminated early by the supporter
NCT01892267,TERMINATED,INTERVENTIONAL,Study was terminated prematurely as costs incurred were more than the available funds.
NCT01892293,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT01892644,WITHDRAWN,INTERVENTIONAL,Failure to recruit patients with hemochromatosis to the Deferasirox arm
NCT01892917,TERMINATED,OBSERVATIONAL,Sponsors Decision. The collected data are available in a significant proportion and sufficiently enough for an adequate analysis.
NCT01893450,TERMINATED,INTERVENTIONAL,Efficacy demonstrated on a preliminary analysis
NCT01893580,TERMINATED,INTERVENTIONAL,"Due to low recruiment rate, the study design is chanced to a feasibility study"
NCT01893632,TERMINATED,INTERVENTIONAL,"Insufficient recruitment, funding terminated from sponsor"
NCT01893658,WITHDRAWN,INTERVENTIONAL,Lack of patients with a condition of interest that resulted in failure to recruit
NCT01893723,TERMINATED,INTERVENTIONAL,Changes of usual clinical practices
NCT01893814,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01893879,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT01894204,TERMINATED,INTERVENTIONAL,The maximum of inclusions was reached
NCT01894594,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT01894633,TERMINATED,INTERVENTIONAL,terminated
NCT01894646,TERMINATED,INTERVENTIONAL,We terminated the study due to lack of funding
NCT01894984,TERMINATED,OBSERVATIONAL,The study was terminated because of high dropout rate.
NCT01895075,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT01895127,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01895140,TERMINATED,INTERVENTIONAL,Manufacturer updated device technology.
NCT01895400,TERMINATED,INTERVENTIONAL,Participant enrollment is much delayed. The whole design needs to be revised.
NCT01895582,TERMINATED,OBSERVATIONAL,lack of recruitment of participants
NCT01895647,TERMINATED,INTERVENTIONAL,slow recruitment and high drop-out rate
NCT01895790,WITHDRAWN,INTERVENTIONAL,We could not find any candidate eligible for recruitment
NCT01895829,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume
NCT01895881,WITHDRAWN,INTERVENTIONAL,Unable to Recruit Participants
NCT01896401,TERMINATED,INTERVENTIONAL,Initiated a new study with improved device
NCT01896440,WITHDRAWN,INTERVENTIONAL,FDA did not approve
NCT01896947,WITHDRAWN,OBSERVATIONAL,Cost
NCT01896973,TERMINATED,INTERVENTIONAL,Study stopped due to business decision
NCT01896986,TERMINATED,OBSERVATIONAL,recruitment problems
NCT01896999,SUSPENDED,INTERVENTIONAL,Other - Results of adult patient cohort released
NCT01897077,TERMINATED,INTERVENTIONAL,"Study product manufacturing suspended due to manufacturing problems, before initiation of study intervention."
NCT01897090,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT01897454,TERMINATED,INTERVENTIONAL,Study was terminated due to slower than anticipated accrual
NCT01897519,TERMINATED,INTERVENTIONAL,Topline results from study M13-796 showed an overall lack of efficacy. There were no safety concerns.
NCT01897714,TERMINATED,INTERVENTIONAL,The study was terminated at median 46-48 months long term follow-up and mature overall survival follow-up data.
NCT01897792,TERMINATED,INTERVENTIONAL,Inability to recruit patients that meet inclusion criteria.
NCT01897948,TERMINATED,INTERVENTIONAL,Non-compliance
NCT01898156,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT01898286,TERMINATED,INTERVENTIONAL,A corporate decision to suspend development of DiaPep277
NCT01898377,TERMINATED,INTERVENTIONAL,New treatment option introduced for patients with the study indication
NCT01898793,TERMINATED,INTERVENTIONAL,Insufficient funding/staff
NCT01898806,TERMINATED,INTERVENTIONAL,The PI left the Columbia University Medical Center. Study was not Completed.
NCT01898975,WITHDRAWN,OBSERVATIONAL,The investigators decided not to proceed this study because of some internal matters.
NCT01899170,TERMINATED,INTERVENTIONAL,Device for multi coil TMS no longer supported
NCT01899235,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01899326,TERMINATED,INTERVENTIONAL,The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States.
NCT01899391,WITHDRAWN,OBSERVATIONAL,Recuritment Challenges
NCT01899508,TERMINATED,INTERVENTIONAL,"The study has been terminated, due to technically difficulties."
NCT01899690,WITHDRAWN,INTERVENTIONAL,The study was withdrawn prior to IRB approval.
NCT01900327,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT01900496,TERMINATED,INTERVENTIONAL,Low accrual
NCT01900522,TERMINATED,INTERVENTIONAL,Business Decision; No Safety or Efficacy Concerns
NCT01900626,TERMINATED,INTERVENTIONAL,Study was unable to meet patient enrollment goals. PI chose to terminate the study early.
NCT01900665,TERMINATED,INTERVENTIONAL,Solanezumab did not meet the study's primary endpoint.
NCT01900730,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT01900795,TERMINATED,INTERVENTIONAL,Terminated early due to administrative reasons not related to safety.
NCT01900847,TERMINATED,INTERVENTIONAL,concern of side effects
NCT01901055,TERMINATED,INTERVENTIONAL,The study did not reach 50% of the proposed sample size. Recruitment slow because persons not interested in being randomized to a sham-control CPAP device or not CPAP nave.
NCT01901224,TERMINATED,INTERVENTIONAL,study was not funded
NCT01901302,TERMINATED,INTERVENTIONAL,Sponsor decision due to lack of enrollment.
NCT01901328,TERMINATED,INTERVENTIONAL,Sponsor decision due to lack of enrollment.
NCT01901341,TERMINATED,INTERVENTIONAL,"Due to difficulties with enrollment, the study was terminated early."
NCT01901354,TERMINATED,INTERVENTIONAL,Lead Investigator no longer at Institution
NCT01901562,TERMINATED,INTERVENTIONAL,Could not identify collaborator and secure additional funding following transfer of study to Montefiore Medical Center
NCT01901601,WITHDRAWN,INTERVENTIONAL,Modifying procedure.
NCT01901614,TERMINATED,INTERVENTIONAL,Modifying procedure
NCT01901718,TERMINATED,OBSERVATIONAL,Enrollment was more challenging than anticipated.
NCT01901887,TERMINATED,INTERVENTIONAL,low recruitment
NCT01901939,WITHDRAWN,INTERVENTIONAL,not funded
NCT01902186,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01902290,TERMINATED,INTERVENTIONAL,Study terminated early due to lack of efficacy observed following interim analysis in Q2 2015. Study Closed once all sites were closed in eClinical
NCT01902368,TERMINATED,INTERVENTIONAL,No funding was obtained.
NCT01902381,TERMINATED,INTERVENTIONAL,Drug sponsor suspended study prematurely then study was terminated. Expected enrollment was not met.
NCT01902433,TERMINATED,INTERVENTIONAL,We were unable to recruit participants to the study
NCT01902550,WITHDRAWN,INTERVENTIONAL,Trial was stopped because study not required for development.
NCT01902602,TERMINATED,OBSERVATIONAL,Lack of compliance of the clinical site
NCT01902771,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT01902810,TERMINATED,INTERVENTIONAL,"At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data."
NCT01902823,TERMINATED,INTERVENTIONAL,Clinicians were not offering the study to eligible potential subjects.
NCT01902862,TERMINATED,INTERVENTIONAL,Recruitment too slow
NCT01902888,TERMINATED,OBSERVATIONAL,Closed due to internal and external factors.
NCT01902966,TERMINATED,INTERVENTIONAL,low accrual and lack of funding
NCT01903057,WITHDRAWN,INTERVENTIONAL,"As of November 2013, the security situation in rural Northern Mozambique is no longer suitable for this clinical trial."
NCT01903187,TERMINATED,INTERVENTIONAL,There were no safety or effectiveness concerns. There were concerns about completing enrollment due to a competitive device's potential approval.
NCT01903317,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT01903473,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01903486,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants.
NCT01903850,WITHDRAWN,INTERVENTIONAL,Withdrawn for business reasons
NCT01904253,TERMINATED,INTERVENTIONAL,"The preliminary data does not suggest any safety signal, but an ad hoc interim analysis showed an imbalance of PFS between the two arms"
NCT01904643,TERMINATED,INTERVENTIONAL,Accrual factor
NCT01904708,TERMINATED,INTERVENTIONAL,Current design not able to measure the outcomes anticipated.
NCT01904786,WITHDRAWN,INTERVENTIONAL,Lack of enrollment of suitable candidates
NCT01905124,WITHDRAWN,INTERVENTIONAL,The company has decided not to conduct the study
NCT01905527,TERMINATED,OBSERVATIONAL,The study was terminated as per the Sponsor's decision.
NCT01905592,TERMINATED,INTERVENTIONAL,The study was terminated due to futility.
NCT01905605,WITHDRAWN,INTERVENTIONAL,Funding not secured. IRB approval has been withdrawn as of January 2017.
NCT01905696,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01905761,WITHDRAWN,OBSERVATIONAL,Project abandoned
NCT01906112,WITHDRAWN,INTERVENTIONAL,Low accrual and no further funding.
NCT01906229,TERMINATED,OBSERVATIONAL,Slow enrollment and therefore not possible to reach the estimated enrollment
NCT01906294,TERMINATED,OBSERVATIONAL,Representativeness and results about treatment and health condition available
NCT01906307,TERMINATED,INTERVENTIONAL,Corporate decision
NCT01906437,WITHDRAWN,OBSERVATIONAL,Funding
NCT01906957,TERMINATED,INTERVENTIONAL,Not sufficient financial - staff resources
NCT01907009,TERMINATED,INTERVENTIONAL,Early termination
NCT01907308,WITHDRAWN,INTERVENTIONAL,Sponsor's decision to terminate the study
NCT01907425,TERMINATED,INTERVENTIONAL,futility
NCT01907594,WITHDRAWN,INTERVENTIONAL,Ran out of funding
NCT01907815,TERMINATED,INTERVENTIONAL,Lack of efficacy.
NCT01908387,TERMINATED,INTERVENTIONAL,Due to Slow Accrual study was terminated.
NCT01908452,WITHDRAWN,INTERVENTIONAL,Not funded
NCT01908543,TERMINATED,INTERVENTIONAL,Technical issues with availability of relevant personnel
NCT01908569,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01908751,TERMINATED,INTERVENTIONAL,Continuing beyond the pilot phase of the trial was deemed unfeasible
NCT01908764,WITHDRAWN,INTERVENTIONAL,Management Decision
NCT01908803,TERMINATED,INTERVENTIONAL,Management decision
NCT01909167,WITHDRAWN,INTERVENTIONAL,CI had other commitments
NCT01909479,TERMINATED,INTERVENTIONAL,Main Study was completed. LT-OLE was discontinued as sufficient safety data has been generated.
NCT01909635,WITHDRAWN,INTERVENTIONAL,Decision was made not to start the study before it was initiated.
NCT01909908,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01910129,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01910155,TERMINATED,INTERVENTIONAL,FDA's draft guidance (March 2015) provided option of in-vitro or in-vivo studies for bioequivalence. Small study size resulted in negative culture rates.
NCT01910246,WITHDRAWN,INTERVENTIONAL,No funding
NCT01910298,TERMINATED,INTERVENTIONAL,The study is being terminated due to no enrollment in over one year in the control arm
NCT01910389,TERMINATED,INTERVENTIONAL,terminated by funding agency
NCT01910428,TERMINATED,INTERVENTIONAL,Sponsor decision based off site/PI feedback about
NCT01910441,TERMINATED,INTERVENTIONAL,The study was terminated due to the unavailability of Continuous Glucose Monitoring sensors (CGMS) which were required to assess the primary end-point.
NCT01910532,WITHDRAWN,INTERVENTIONAL,Sponsor discontinued the research
NCT01910558,WITHDRAWN,INTERVENTIONAL,Cancelled by Sponsor
NCT01910649,TERMINATED,INTERVENTIONAL,"Regulatory approval was not obtained for drisapersen, hence BioMarin is stopping the development of all exon skipping oligonucleotides in DMD."
NCT01910675,WITHDRAWN,INTERVENTIONAL,Impossible to get a written informed consent beforehand
NCT01910753,TERMINATED,INTERVENTIONAL,Not enough patients
NCT01910844,TERMINATED,INTERVENTIONAL,Because of difficulties in recruting
NCT01910870,TERMINATED,INTERVENTIONAL,Because of difficulties in recruiting
NCT01911117,WITHDRAWN,OBSERVATIONAL,No man power
NCT01911182,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT01911273,TERMINATED,INTERVENTIONAL,See termination reason in detailed description.
NCT01911325,TERMINATED,INTERVENTIONAL,Review of safety and preliminary efficacy data showed marginal anti-tumor activity.
NCT01911377,TERMINATED,INTERVENTIONAL,"12 SCI volunteers completed the study. As the data analysis was negative, the decision was made not to proceed with MS recruitment."
NCT01911403,TERMINATED,INTERVENTIONAL,Low enrollment rate.
NCT01911416,WITHDRAWN,INTERVENTIONAL,No accrual
NCT01911793,TERMINATED,INTERVENTIONAL,Not enough staff resource to complete study.
NCT01912040,WITHDRAWN,OBSERVATIONAL,Issues with obtaining precursor materials for synthesis
NCT01912261,TERMINATED,INTERVENTIONAL,The study was stopped due to time constraints and resources
NCT01912378,WITHDRAWN,INTERVENTIONAL,unable to launch the study due to lack of participation with Autism Clinic
NCT01912404,TERMINATED,INTERVENTIONAL,Due to concern for high systemic drug levels that could exceed levels in toxicology studies.
NCT01912625,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT01912872,TERMINATED,INTERVENTIONAL,Termination was due to identified errors in data management handling after an internal audit by the sponsor performed by third party.
NCT01912924,WITHDRAWN,INTERVENTIONAL,"Difficult enrollment, no subjects identified to enroll"
NCT01912963,TERMINATED,INTERVENTIONAL,The study terminated early due to weak accrual.
NCT01913015,TERMINATED,INTERVENTIONAL,"After enrollment of the first 3 subjects, an interim assessment was conducted. Comparing DBS sampling to plasma PK levels yielded unconvincing results."
NCT01913067,WITHDRAWN,INTERVENTIONAL,Scientific rationale is deemed obsolete. Funders lost interest in the trial.
NCT01913197,TERMINATED,INTERVENTIONAL,low enrollment
NCT01913249,WITHDRAWN,INTERVENTIONAL,Unable to get MRI of patients within reasonable time on a local hospital.
NCT01913275,WITHDRAWN,INTERVENTIONAL,Lack of interest
NCT01913301,TERMINATED,INTERVENTIONAL,Sponsor lost funding
NCT01913327,TERMINATED,INTERVENTIONAL,Insufficient Funds and Inadequate Subject Recruitment
NCT01913444,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients into study.
NCT01913535,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01913704,WITHDRAWN,INTERVENTIONAL,Company turnover
NCT01914146,WITHDRAWN,INTERVENTIONAL,"Study was changed to Insulin, hypotension and sarcopenia"
NCT01914575,WITHDRAWN,INTERVENTIONAL,Site never got up and running due to institutional issues
NCT01914679,TERMINATED,INTERVENTIONAL,Sponsor terminated the study
NCT01914705,TERMINATED,INTERVENTIONAL,Too few patients who met enrollment criteria.
NCT01914718,TERMINATED,INTERVENTIONAL,Poor accrual of eligible patients
NCT01915472,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01915524,TERMINATED,INTERVENTIONAL,Slow recruitment in stratum 3: enrolled only 2 instead of 8 pts. within predicted time
NCT01915654,TERMINATED,OBSERVATIONAL,Retrospective study from December 2007 to May 2010
NCT01916109,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT01916187,WITHDRAWN,INTERVENTIONAL,drug company withdrew support following re-examination of benefit-risk assessment for the investigational use of imetelstat in this population
NCT01916200,WITHDRAWN,INTERVENTIONAL,This study was Cancelled Before Active
NCT01916590,TERMINATED,INTERVENTIONAL,lack of patients
NCT01916798,TERMINATED,INTERVENTIONAL,Not able to recruit the number required and due to financial difficulty to pay for intralipids
NCT01916876,WITHDRAWN,INTERVENTIONAL,Funding shortage
NCT01916902,WITHDRAWN,INTERVENTIONAL,"Despite a large number of patients screened, very few met eligibility guidelines."
NCT01917006,TERMINATED,INTERVENTIONAL,Strategic business decision was made to terminate the program. There were no safety concerns.
NCT01917058,WITHDRAWN,INTERVENTIONAL,Unfortunately we did not receive funding and therefore were not able to begin the trial.
NCT01917318,TERMINATED,INTERVENTIONAL,"Enrollment challenges - Single participant discontinued after placebo, no relevant outcome measure data was recorded."
NCT01917539,WITHDRAWN,INTERVENTIONAL,Trouble enrolling patients
NCT01917669,WITHDRAWN,OBSERVATIONAL,Funding was never available to conduct the proposed series of experiments.
NCT01917981,WITHDRAWN,INTERVENTIONAL,Failure to recruit.
NCT01918059,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01918111,TERMINATED,INTERVENTIONAL,The study terminated early due to the difficulty of recruiting candidates.
NCT01918306,TERMINATED,INTERVENTIONAL,"company stopped production of study drug due to excessive toxicities, lack of efficacy"
NCT01918605,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT01918657,WITHDRAWN,INTERVENTIONAL,Unable to get an IND from the FDA for the walnut powder
NCT01918761,TERMINATED,INTERVENTIONAL,poor accrual
NCT01918904,WITHDRAWN,INTERVENTIONAL,PI decided not to proceed with this project. No participants were enrolled.
NCT01918930,TERMINATED,INTERVENTIONAL,Unable to accrue as planned for optional biopsies
NCT01919190,TERMINATED,INTERVENTIONAL,Due to reasons unrelated to safety; primary endpoint signal seen during pre-specified interim analysis.
NCT01919229,TERMINATED,INTERVENTIONAL,"Due to low recruitment, it was decided to terminate the study."
NCT01919346,TERMINATED,INTERVENTIONAL,Based on results from Alexion PROTECT DGF study
NCT01919541,WITHDRAWN,INTERVENTIONAL,difficulty in recruiting patients
NCT01919606,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01919658,TERMINATED,INTERVENTIONAL,"Difficulty enrolling, aim already examined in literature."
NCT01919840,TERMINATED,INTERVENTIONAL,Low recruitment after the expected time to finish the study
NCT01919996,TERMINATED,INTERVENTIONAL,See Termination Statement in the Detailed Description below
NCT01920074,WITHDRAWN,INTERVENTIONAL,Study stopped due to study enrollment challenges that impacted the feasibility of conducting the study.
NCT01920178,TERMINATED,INTERVENTIONAL,"Financial support of the Study withdrawn by Nuvolase, Inc ( PinPointe FootLaser) due to delayed start of the Study and inadequate subjects enrolled"
NCT01920373,WITHDRAWN,INTERVENTIONAL,The study was cancelled.
NCT01920451,TERMINATED,INTERVENTIONAL,PI started new position.
NCT01920477,TERMINATED,INTERVENTIONAL,Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.
NCT01920607,SUSPENDED,INTERVENTIONAL,recruitment difficulties
NCT01920763,WITHDRAWN,OBSERVATIONAL,Lack of recruitment.
NCT01920841,WITHDRAWN,INTERVENTIONAL,Study Design changed and will be resubmitted as a new study
NCT01920945,TERMINATED,INTERVENTIONAL,Difficult enrollment
NCT01921062,TERMINATED,INTERVENTIONAL,Severe difficulties with recruiting participants
NCT01921101,TERMINATED,INTERVENTIONAL,greater mortality in intervention group
NCT01921114,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01921296,TERMINATED,INTERVENTIONAL,Accrual terminated early because of poor accrual
NCT01921348,TERMINATED,INTERVENTIONAL,Target enrollment not met within specific time period.
NCT01921543,TERMINATED,INTERVENTIONAL,Patient inclusion was very tedious and slower than expected. (7 patients in 5 years)
NCT01921569,TERMINATED,INTERVENTIONAL,Study closed by sponsor
NCT01921595,TERMINATED,INTERVENTIONAL,It ended early because it would not be possible to meet the target number.
NCT01921751,TERMINATED,INTERVENTIONAL,Trial would not be completed in a reasonable timeframe per CTEP guidelines
NCT01921829,TERMINATED,INTERVENTIONAL,Due to futility due to lower than expected recruitment
NCT01921985,TERMINATED,INTERVENTIONAL,Interim analysis revealed that no statistical difference will be identified after inclusion of the patient cohort as foreseen in the sample size calculation
NCT01921998,SUSPENDED,OBSERVATIONAL,Trial has been suspended due to lack of resource and staff
NCT01922635,TERMINATED,INTERVENTIONAL,Modification the study with a new questionnaire was not successful.
NCT01922895,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01922908,WITHDRAWN,INTERVENTIONAL,Plan to change the trial design
NCT01922960,WITHDRAWN,INTERVENTIONAL,investigators decided not to move forward with project
NCT01923233,WITHDRAWN,INTERVENTIONAL,interventional radiologist suffered stroke and unable to perform RFA procedure
NCT01923272,WITHDRAWN,INTERVENTIONAL,"Similar study being conducted, Sponsor decided to not duplicate study"
NCT01923376,WITHDRAWN,INTERVENTIONAL,Not enough staff to collect data
NCT01923389,TERMINATED,INTERVENTIONAL,"The study was terminated on December 19th, 2013 due to a business decision by the Sponsor. No safety concerns have been observed in this study."
NCT01923623,WITHDRAWN,INTERVENTIONAL,Study was redesigned and taken over by a ph.D-student
NCT01923675,WITHDRAWN,INTERVENTIONAL,no funding
NCT01923753,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient patients within reasonable timeframe
NCT01923805,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT01923909,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT01924039,TERMINATED,INTERVENTIONAL,Not enough study participants
NCT01924169,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01924182,TERMINATED,INTERVENTIONAL,Amendment changes were significant enough to warrant a new study.
NCT01924377,WITHDRAWN,INTERVENTIONAL,PI changed work place
NCT01924806,TERMINATED,INTERVENTIONAL,Lower than expected accrual rate and desire to reassess overall study strategy.
NCT01924845,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01924858,TERMINATED,INTERVENTIONAL,Study objectives met so study concluded earlier than planned hence we terminated the study.
NCT01925001,WITHDRAWN,INTERVENTIONAL,Sangart ceased operations
NCT01925092,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT01925118,TERMINATED,INTERVENTIONAL,Ineffectiveness
NCT01925274,TERMINATED,INTERVENTIONAL,Enrollment to the study was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.
NCT01925378,WITHDRAWN,INTERVENTIONAL,The study is going to open in a new site
NCT01925443,SUSPENDED,INTERVENTIONAL,technical problems with equipment from the main outcome
NCT01925495,TERMINATED,INTERVENTIONAL,slow recruitment and adverse events
NCT01925573,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01925612,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization and changing treatment landscape in frontline DLBCL
NCT01925781,TERMINATED,INTERVENTIONAL,IND required
NCT01925885,TERMINATED,INTERVENTIONAL,Terminated: recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT01925950,TERMINATED,INTERVENTIONAL,The study was stopped due to patient enrollment challenges.
NCT01926054,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT01926769,TERMINATED,INTERVENTIONAL,Slow accrual rate
NCT01927055,TERMINATED,INTERVENTIONAL,Due to potential competition with a post-marketing study requested by FDA
NCT01927393,WITHDRAWN,INTERVENTIONAL,Study was not funded
NCT01927406,WITHDRAWN,INTERVENTIONAL,Funding source unavailable
NCT01927458,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT01927484,TERMINATED,INTERVENTIONAL,due to COVID-19 Pandemic
NCT01927575,TERMINATED,INTERVENTIONAL,Sponsor decision to close trial
NCT01927601,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT01927718,TERMINATED,INTERVENTIONAL,Poor Response Rate
NCT01927757,TERMINATED,INTERVENTIONAL,Business decision due to slow enrollment
NCT01927913,WITHDRAWN,INTERVENTIONAL,This study was withdrawn until the evaluation of the nonclinical rat findings is complete.
NCT01927952,WITHDRAWN,INTERVENTIONAL,Study withdrawn from IRB approval process by PI
NCT01928030,TERMINATED,INTERVENTIONAL,Low accrual
NCT01928043,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT01928082,TERMINATED,INTERVENTIONAL,The fellow conducting the recruitment and screening left the institution
NCT01928160,WITHDRAWN,INTERVENTIONAL,study not accruing
NCT01928173,TERMINATED,INTERVENTIONAL,Lack of participants
NCT01928446,TERMINATED,INTERVENTIONAL,terminated early due to non-safety related DMC recommendations
NCT01928485,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01928615,TERMINATED,INTERVENTIONAL,Problems with drug supply
NCT01928641,WITHDRAWN,OBSERVATIONAL,Main investigator changed affiliation.
NCT01928693,TERMINATED,INTERVENTIONAL,study terminated due to slow accrual
NCT01928966,WITHDRAWN,INTERVENTIONAL,Advisor left the university and student moved to a clinical track
NCT01929239,SUSPENDED,INTERVENTIONAL,Funding
NCT01929811,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT01929850,WITHDRAWN,INTERVENTIONAL,Scientific/feasibility approval required prior to IRB review
NCT01929889,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01929941,TERMINATED,INTERVENTIONAL,Business decision.
NCT01929954,TERMINATED,INTERVENTIONAL,Changes in corporate business environment
NCT01930123,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT01930175,TERMINATED,INTERVENTIONAL,The study recruitment was terminated in Dec-2015 for strategic reasons related to the development of the compound.
NCT01930292,TERMINATED,INTERVENTIONAL,Part B was cancelled based on business decision
NCT01930448,WITHDRAWN,OBSERVATIONAL,PI relocated to another Institution
NCT01930643,TERMINATED,INTERVENTIONAL,slow recruitment and change of faculty
NCT01930877,WITHDRAWN,INTERVENTIONAL,Withdrawn by PI
NCT01930890,TERMINATED,INTERVENTIONAL,Results from pre-specified criteria in study NCT01499355 (211LE201) did not demonstrate sufficient efficacy to warrant continuation of the study
NCT01930955,WITHDRAWN,INTERVENTIONAL,no patients were included
NCT01930968,WITHDRAWN,OBSERVATIONAL,Study did not receive funding to move forward
NCT01930994,WITHDRAWN,OBSERVATIONAL,Insufficient numbers of Sino-implant users available for study participation.
NCT01931072,TERMINATED,INTERVENTIONAL,"inconclusive results, large inter-individual variation, insufficient statistical power"
NCT01931462,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT01931566,TERMINATED,INTERVENTIONAL,Lack of efficacy of the drug; no safety concern
NCT01931592,TERMINATED,INTERVENTIONAL,One of the study drugs was no longer available on a worldwide level.
NCT01931605,TERMINATED,INTERVENTIONAL,Enrolling participants has halted prematurely and will not resume due to the Departure of the principal investigator
NCT01931631,SUSPENDED,INTERVENTIONAL,Erroneously duplicated study
NCT01931709,TERMINATED,INTERVENTIONAL,Terminated due to end of funding
NCT01931722,SUSPENDED,INTERVENTIONAL,not able to find enough participants for this study
NCT01931865,TERMINATED,INTERVENTIONAL,"lost the recruiting source- no recruitment for the past 18months, PI moving"
NCT01932255,WITHDRAWN,OBSERVATIONAL,inadequate data
NCT01932541,WITHDRAWN,INTERVENTIONAL,On hold due to competing departmental studies
NCT01932554,WITHDRAWN,INTERVENTIONAL,Insufficient recruitment
NCT01932632,WITHDRAWN,INTERVENTIONAL,unable to recruit
NCT01932658,WITHDRAWN,INTERVENTIONAL,patients insurance would not cover the cost of the study procedures
NCT01933022,TERMINATED,INTERVENTIONAL,Termination due to high current screen rate failure and unreliable PSA mRNA assay.
NCT01933061,WITHDRAWN,INTERVENTIONAL,Strategic decision not to proceed with the opening of this study. There are no concerns over the safety or quality of the investigational products involved.
NCT01933230,TERMINATED,INTERVENTIONAL,Closed due to issues encountered with meeting enrollment goals at our site.
NCT01933269,WITHDRAWN,INTERVENTIONAL,Change in Principal Investigator and protocol revisions delayed study start and ultimately the decision was made to cancel the study.
NCT01933308,TERMINATED,INTERVENTIONAL,Lack of funding
NCT01933438,TERMINATED,INTERVENTIONAL,The study ended early after encountering logistics challenges and difficulties with site recruitment.
NCT01933451,TERMINATED,INTERVENTIONAL,The grant for this study was not allowed.
NCT01933633,TERMINATED,INTERVENTIONAL,Enrollment proceeded to slowly
NCT01933737,TERMINATED,INTERVENTIONAL,The collected data was finished
NCT01933815,SUSPENDED,INTERVENTIONAL,Business reasons
NCT01934101,TERMINATED,INTERVENTIONAL,"Following the emergence of an unexpected pharmacodynamic effect, the sponsor has decided to conclude the study early without fully achieving its objective"
NCT01934179,TERMINATED,OBSERVATIONAL,Low Accrual Rate
NCT01934335,TERMINATED,INTERVENTIONAL,Drugs unavailable
NCT01934439,WITHDRAWN,INTERVENTIONAL,Loss of funding; could not complete building the testing device.
NCT01934504,TERMINATED,OBSERVATIONAL,Slow accrual
NCT01934816,TERMINATED,INTERVENTIONAL,Technical Issues with intervention
NCT01934894,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of significant signal of efficacy
NCT01935141,WITHDRAWN,INTERVENTIONAL,Staffing difficulties to run project.
NCT01935232,TERMINATED,OBSERVATIONAL,Institution not able to carry out research as of 2015
NCT01935622,TERMINATED,INTERVENTIONAL,End of funding
NCT01935908,WITHDRAWN,INTERVENTIONAL,no funding
NCT01935986,TERMINATED,INTERVENTIONAL,Due to bankruptcy of the CRO company
NCT01936142,WITHDRAWN,INTERVENTIONAL,No suitable patient found
NCT01936194,WITHDRAWN,INTERVENTIONAL,Investigators don't want to conduct this study as time is limited.
NCT01936480,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT01936961,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT01936974,TERMINATED,INTERVENTIONAL,PI Decision
NCT01937130,TERMINATED,INTERVENTIONAL,Data needs met
NCT01937364,TERMINATED,INTERVENTIONAL,The enrollment in the study was too limited for meaningful data analysis.
NCT01937507,TERMINATED,INTERVENTIONAL,PI Decision
NCT01937572,TERMINATED,INTERVENTIONAL,An interim analysis found the study would not be able to reach significance without a large increase in subjects which was not feasible.
NCT01937715,TERMINATED,INTERVENTIONAL,B2151007 was prematurely discontinued due to Pfizer's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction
NCT01937884,TERMINATED,INTERVENTIONAL,Unable to enroll patients
NCT01938274,WITHDRAWN,INTERVENTIONAL,Enrollment never started
NCT01938404,TERMINATED,OBSERVATIONAL,FDA released from conducting
NCT01938456,WITHDRAWN,INTERVENTIONAL,This study was Cancelled Before Active
NCT01938547,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT01938651,TERMINATED,INTERVENTIONAL,funding ceased
NCT01938664,TERMINATED,INTERVENTIONAL,Results of interim efficacy analysis showed results were not promising.
NCT01938716,TERMINATED,INTERVENTIONAL,Early termination due to low accrual
NCT01938833,TERMINATED,INTERVENTIONAL,Closed by Sponsor
NCT01938911,TERMINATED,INTERVENTIONAL,PI moved away from Bern; lack of personnel in Bern to conduct the study within a reasonable time frame.
NCT01938924,WITHDRAWN,INTERVENTIONAL,No funding
NCT01938950,TERMINATED,INTERVENTIONAL,PI is leaving the institution
NCT01939028,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01939041,WITHDRAWN,INTERVENTIONAL,Difficult to recruit participant
NCT01939067,WITHDRAWN,INTERVENTIONAL,Application for regulatory approval withdrawn
NCT01939210,TERMINATED,INTERVENTIONAL,lack of funding to hire a dedicated study interventionist
NCT01939379,WITHDRAWN,INTERVENTIONAL,PI left institution. Efforts made to contact PI unsuccessful. No study data available.
NCT01939418,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01939431,TERMINATED,OBSERVATIONAL,Slow/Insufficient accrual
NCT01939483,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01939548,TERMINATED,INTERVENTIONAL,A pre-planned interim analysis indicated the trial was unlikely to meet the pre-specified efficacy criteria. The decision was not based on any safety concerns.
NCT01939678,TERMINATED,OBSERVATIONAL,Enrollment lower than expected
NCT01939691,TERMINATED,INTERVENTIONAL,Difficulty enrolling
NCT01939808,WITHDRAWN,INTERVENTIONAL,study never started
NCT01939834,TERMINATED,INTERVENTIONAL,Subjects preferred the 5 night overnight system in terms of ease of use.
NCT01939990,WITHDRAWN,INTERVENTIONAL,Funding was discontinued.
NCT01940237,TERMINATED,INTERVENTIONAL,Low recruitment
NCT01940315,WITHDRAWN,INTERVENTIONAL,Sponsor decision due to product manufacturing and redesign of clinical trial.
NCT01940406,WITHDRAWN,INTERVENTIONAL,Internal desicions
NCT01940536,WITHDRAWN,INTERVENTIONAL,Possible change in study protocol
NCT01940718,WITHDRAWN,INTERVENTIONAL,Funding could not be secured
NCT01940796,TERMINATED,INTERVENTIONAL,Toxicity
NCT01940809,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT01941134,WITHDRAWN,INTERVENTIONAL,Recruitment trouble
NCT01941173,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT01941277,TERMINATED,INTERVENTIONAL,funding withdrawn
NCT01941550,TERMINATED,INTERVENTIONAL,Investigator left the site. Site closed.
NCT01941849,WITHDRAWN,INTERVENTIONAL,Poor patient accrual
NCT01942083,TERMINATED,INTERVENTIONAL,Company decision
NCT01942187,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT01942395,TERMINATED,INTERVENTIONAL,study diet is no longer available to match with the previous participants.
NCT01942993,TERMINATED,INTERVENTIONAL,standard of care has changed
NCT01943019,TERMINATED,INTERVENTIONAL,Inability to obtain patients
NCT01943058,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01943240,WITHDRAWN,INTERVENTIONAL,Insufficient population of eligible patients; none enrolled
NCT01943565,TERMINATED,INTERVENTIONAL,Research question answered by another group of researchers (Sviggum et al)
NCT01944059,TERMINATED,INTERVENTIONAL,Funding Discontinued
NCT01944306,TERMINATED,OBSERVATIONAL,"Due to lack of funds, the study has been terminated upon recruiting less than desired number of subjects"
NCT01944618,TERMINATED,OBSERVATIONAL,"Participant Data obtained to 30Sep2015:

Baseline data: 447 6 month data: 253 Program terminated: recruitment target not met. No analysis will be provided."
NCT01944657,WITHDRAWN,INTERVENTIONAL,unable to enroll subjects
NCT01944709,TERMINATED,INTERVENTIONAL,Progressive Disease
NCT01944943,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT01944969,TERMINATED,INTERVENTIONAL,The study was terminated because the lead-in study (14571A) in elderly was terminated; see Detailed Description.
NCT01944982,TERMINATED,INTERVENTIONAL,The low recruitment rate makes it very difficult to complete the study within a reasonable period of time.
NCT01945229,TERMINATED,OBSERVATIONAL,Preliminary analyses of data indicated study should be terminated for futility
NCT01945281,TERMINATED,INTERVENTIONAL,Operational feasibility with low recruitment due to changing epidemiology of disease
NCT01946061,TERMINATED,INTERVENTIONAL,This study was stopped because of difficulties of supplying the drug.
NCT01946152,TERMINATED,INTERVENTIONAL,Per PI at time of CR
NCT01946399,TERMINATED,INTERVENTIONAL,enrollment not met
NCT01946490,WITHDRAWN,OBSERVATIONAL,"Not subsidized, will not start in the near future"
NCT01946542,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01946646,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01946841,WITHDRAWN,INTERVENTIONAL,No Patient recruitment
NCT01946880,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT01947036,TERMINATED,OBSERVATIONAL,Lack of enrollment.
NCT01947088,WITHDRAWN,INTERVENTIONAL,Principal Investigator left facility
NCT01947309,TERMINATED,OBSERVATIONAL,Business Decision
NCT01947400,TERMINATED,OBSERVATIONAL,The data that was critical to the study was not able to be obtained.
NCT01947699,WITHDRAWN,INTERVENTIONAL,PI decided to withdrawal study before recruitment started
NCT01947842,WITHDRAWN,INTERVENTIONAL,Funding unavailable.
NCT01947946,TERMINATED,INTERVENTIONAL,Study terminated due to sponsor decision
NCT01948180,TERMINATED,INTERVENTIONAL,Insufficient enrollment rate
NCT01948206,TERMINATED,OBSERVATIONAL,Ran out of funds
NCT01948219,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01948232,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01948271,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT01948427,TERMINATED,OBSERVATIONAL,the study was terminated due to the primary end point being met.
NCT01948700,TERMINATED,INTERVENTIONAL,Not an Applicable Clinical Trial (ACT).
NCT01948999,TERMINATED,INTERVENTIONAL,Missing ressources. The study official has left and will not be replaced
NCT01949597,WITHDRAWN,OBSERVATIONAL,IP change Hospital
NCT01949740,TERMINATED,OBSERVATIONAL,Poor accrual
NCT01949831,TERMINATED,INTERVENTIONAL,Due to inclusion problems (not recruting enough participants) recruiting participants has halted prematurely and will not resume.
NCT01949870,TERMINATED,INTERVENTIONAL,change in the development strategy
NCT01949896,TERMINATED,INTERVENTIONAL,Study is being closed due to insufficient patient population for enrollment.
NCT01949961,TERMINATED,INTERVENTIONAL,Lack of funding for researchers
NCT01949974,WITHDRAWN,INTERVENTIONAL,Dificulties in the recruitment of patients.
NCT01950104,WITHDRAWN,INTERVENTIONAL,"No started, lack of funding"
NCT01950130,WITHDRAWN,INTERVENTIONAL,No funding
NCT01950195,TERMINATED,INTERVENTIONAL,Local IRB required us to submit amendment as a separate study.
NCT01950234,TERMINATED,INTERVENTIONAL,The funding source discontinued financial support for the study.
NCT01950455,TERMINATED,INTERVENTIONAL,The entire drug development program for this molecule was sold to another company.
NCT01950468,WITHDRAWN,INTERVENTIONAL,The entire drug development program for this molecule was sold to another company.
NCT01950507,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT01950559,TERMINATED,OBSERVATIONAL,insufficient subjects recruited in allotted time
NCT01950871,TERMINATED,INTERVENTIONAL,Sponsor is bankrupt
NCT01950988,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT01951183,WITHDRAWN,INTERVENTIONAL,Cancelled due to Sponsor's decision
NCT01951209,TERMINATED,INTERVENTIONAL,Inadequate enrollment prior to expiration date of unreplaceable blinded investigational product
NCT01951378,TERMINATED,INTERVENTIONAL,No data are available for this study as the PI has left the institution.
NCT01951911,WITHDRAWN,INTERVENTIONAL,Poor patient recruitment. Vast majority of the patients have exclusions criteria
NCT01952249,TERMINATED,INTERVENTIONAL,"Phase 2 portion not initiated, no longer pursuing ovarian cancer indication"
NCT01952340,TERMINATED,INTERVENTIONAL,"Premature termination because: a) the COVID-19 pandemic stopped recruitment or participation for 2 years which limited study numbers, and, b) both PI's will retire and, therefore, will be unable to oversee the trial."
NCT01952730,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT01952743,TERMINATED,INTERVENTIONAL,Lack of efficacy with renal denervation in multicenter trials
NCT01952847,TERMINATED,INTERVENTIONAL,Per PI
NCT01952860,TERMINATED,INTERVENTIONAL,Requested by PI during yearly Continuing Review
NCT01952886,WITHDRAWN,INTERVENTIONAL,Lack of approval and funding from company
NCT01952925,WITHDRAWN,INTERVENTIONAL,unable to obtain IRB approval
NCT01953042,WITHDRAWN,INTERVENTIONAL,Lack of dedicated resources at this time.
NCT01953172,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01953289,WITHDRAWN,OBSERVATIONAL,Sub investigator is working no longer in the hospital. No participants were enrolled.
NCT01953354,TERMINATED,INTERVENTIONAL,MFR's business decision to d/c TSO production -unrelated to any safety concern.
NCT01953406,WITHDRAWN,INTERVENTIONAL,"No participants were enrolled. Therefore, we stop this study, prematurely."
NCT01953445,WITHDRAWN,INTERVENTIONAL,The study sponsor found the trial to be not viable.
NCT01953562,WITHDRAWN,OBSERVATIONAL,This protocol was closed and will be redesigned and submitted as a new protocol.
NCT01953744,TERMINATED,INTERVENTIONAL,Low cure rate in the study (fluconazole) group
NCT01953809,WITHDRAWN,INTERVENTIONAL,Emerging GSK1322322 pre-clinical data ID'd potentially reactive metabolites previously not seen that changed the risk: benefit profile and led to a termination
NCT01953874,TERMINATED,INTERVENTIONAL,SERVE-HF results showed ASV increased CV mortality in patients with reduced LVEF
NCT01953926,TERMINATED,INTERVENTIONAL,The study was terminated to align with the sponsor's current development plans for neratinib. The decision was not based on any new efficacy or safety data for neratinib.
NCT01953952,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01954030,TERMINATED,INTERVENTIONAL,Study terminated early due to funding reasons prior to completing Phase 1
NCT01954082,TERMINATED,INTERVENTIONAL,Study terminated due to safety concerns; participant follow up will continue until March 2018
NCT01954160,TERMINATED,INTERVENTIONAL,DSMB decision based upon noted lack of efficacy in manufacturers pivotal trials.
NCT01954173,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01954290,WITHDRAWN,INTERVENTIONAL,Investigator is leaving the institution.
NCT01954446,WITHDRAWN,INTERVENTIONAL,The investigational devices need alterations before validation
NCT01954459,TERMINATED,INTERVENTIONAL,unable to complete due to lack of funding
NCT01954472,WITHDRAWN,INTERVENTIONAL,This study was combined with another CIHR funded study (NCT02078635). Both studies involve the same dietary portfolio and the same study population.
NCT01954511,WITHDRAWN,INTERVENTIONAL,Project was suspended for personal issues
NCT01954524,TERMINATED,INTERVENTIONAL,The study is closed due to lack of funding to support the study.
NCT01954576,TERMINATED,INTERVENTIONAL,Poor accrual; Avastin refractory patients not feasible given treatment paradigm in these patients.
NCT01954706,TERMINATED,INTERVENTIONAL,The study was stopped due to recruitment difficulties
NCT01954732,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT01954784,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT01954875,WITHDRAWN,OBSERVATIONAL,Study no longer funded
NCT01954901,TERMINATED,INTERVENTIONAL,Failure to enroll subjects due to change in referral policy.
NCT01955226,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT01955629,TERMINATED,INTERVENTIONAL,The study enrollment was prematurely halted due to safety reasons.
NCT01955733,TERMINATED,INTERVENTIONAL,Substance discontinued
NCT01955798,WITHDRAWN,INTERVENTIONAL,IP Change Hospital
NCT01956214,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT01956513,WITHDRAWN,INTERVENTIONAL,We have finally no financial support and any patients have been included.
NCT01956604,TERMINATED,INTERVENTIONAL,"The inclusion rate was too low, due to the exclusion criteria."
NCT01956721,TERMINATED,INTERVENTIONAL,Difficulty of inclusion
NCT01956812,TERMINATED,INTERVENTIONAL,"The DSMB conducted an interim analysis on overall survival, which showed that the treatment arm did not demonstrate a sufficient improvement in OS vs. placebo."
NCT01956864,WITHDRAWN,INTERVENTIONAL,PI transferred from Georgetown to Johns Hopkins University. No participants enrolled at either site. Funding lapsed.
NCT01957254,TERMINATED,OBSERVATIONAL,The quality of Limulus Amebocyte Lysate (LAL) test was poor.
NCT01957371,WITHDRAWN,INTERVENTIONAL,Recruitment difficulty
NCT01957410,TERMINATED,INTERVENTIONAL,Clinical Team decision to terminate the study after the results from Cohort 1 did not support conducting Cohort 2.
NCT01957449,TERMINATED,INTERVENTIONAL,"At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data."
NCT01957501,TERMINATED,OBSERVATIONAL,Funding has been terminated for this study.
NCT01957514,TERMINATED,OBSERVATIONAL,Terminated due to loss of funding.
NCT01957631,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01957670,WITHDRAWN,INTERVENTIONAL,Sponsor decision due to change the clinical indication to Chronic Insomnia
NCT01957683,WITHDRAWN,INTERVENTIONAL,insufficient funds
NCT01957709,TERMINATED,INTERVENTIONAL,Enough samples were collected for data analysis.
NCT01958112,TERMINATED,INTERVENTIONAL,Drug supply
NCT01958242,WITHDRAWN,INTERVENTIONAL,Technical problems.
NCT01958580,TERMINATED,INTERVENTIONAL,Study terminated due to low accrual. PI left the institution
NCT01958593,TERMINATED,INTERVENTIONAL,This pilot study was terminated early by sponsor due to insufficient rate of accrual.
NCT01959048,TERMINATED,INTERVENTIONAL,FMT for study indication has been permitted by Israeli Ministry of Health
NCT01960023,WITHDRAWN,INTERVENTIONAL,This registry was planned to report on the Phase II portion of the study. NSABP decided not to proceed with the Phase II portion of the study.
NCT01960062,WITHDRAWN,INTERVENTIONAL,no potential participants met the inclusion criteria
NCT01960153,WITHDRAWN,INTERVENTIONAL,Award was ended by NIH for parent study
NCT01960387,TERMINATED,INTERVENTIONAL,lack of accrual
NCT01960426,TERMINATED,INTERVENTIONAL,recruitment issues
NCT01960517,WITHDRAWN,INTERVENTIONAL,Sponsor decision not to proceed with study
NCT01960621,WITHDRAWN,INTERVENTIONAL,Study has not been able to start due to difficulty in obtaining an intravenous formulation of cyclodextrin (intravenous 2HPBCD) suitable for man
NCT01960764,WITHDRAWN,INTERVENTIONAL,This sub-study was not done because main study results reached significance.
NCT01961141,WITHDRAWN,OBSERVATIONAL,review the study concept
NCT01961219,TERMINATED,INTERVENTIONAL,insufficent enrollment
NCT01961284,WITHDRAWN,INTERVENTIONAL,Sponsor company decision to terminate study
NCT01961401,TERMINATED,INTERVENTIONAL,Due to recruitment problems
NCT01961453,WITHDRAWN,INTERVENTIONAL,Funding
NCT01961492,WITHDRAWN,INTERVENTIONAL,Problems in recruiting
NCT01961583,TERMINATED,INTERVENTIONAL,Termination of \[18F\]Fluciclatide production
NCT01961648,TERMINATED,INTERVENTIONAL,Investigators were not able to continue recruiting and enrolling.
NCT01961934,WITHDRAWN,INTERVENTIONAL,Awaiting funding
NCT01962051,WITHDRAWN,OBSERVATIONAL,St. Jude Medical business decision
NCT01962337,TERMINATED,INTERVENTIONAL,We have discontinued development of FPA008 in RA
NCT01962675,TERMINATED,INTERVENTIONAL,"PI left study institution, declined to continue study at new institution"
NCT01962688,TERMINATED,INTERVENTIONAL,low enrollment
NCT01962740,TERMINATED,INTERVENTIONAL,Lack of eligible patients
NCT01962857,SUSPENDED,INTERVENTIONAL,No member of staff available for active recruitment at the moment
NCT01962896,TERMINATED,INTERVENTIONAL,Low accrual
NCT01962909,TERMINATED,INTERVENTIONAL,"From preliminary imaging data, the study was stopped due to futility."
NCT01962948,TERMINATED,INTERVENTIONAL,Study drug is no longer supplied by grantor.
NCT01962974,TERMINATED,INTERVENTIONAL,Cancelled due to low enrollment
NCT01963117,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01963403,TERMINATED,INTERVENTIONAL,Futility of recruitment
NCT01963611,TERMINATED,INTERVENTIONAL,Study was terminated based on sponsor discretion.
NCT01963650,TERMINATED,OBSERVATIONAL,Enrollment issues
NCT01963728,TERMINATED,INTERVENTIONAL,Blood sugar status of the enrolled subjects wasn't evaluable
NCT01963832,WITHDRAWN,INTERVENTIONAL,not funded
NCT01964235,WITHDRAWN,INTERVENTIONAL,Study was cancelled by Sponsor.
NCT01964300,TERMINATED,INTERVENTIONAL,Lack of efficacy (stratum 2); slow accrual (stratum 1)
NCT01964339,TERMINATED,OBSERVATIONAL,This study was stopped due to low recruitment.
NCT01964378,TERMINATED,INTERVENTIONAL,low accrual made the study no longer feasible/decision not related to safety and efficacy
NCT01964625,TERMINATED,INTERVENTIONAL,Terminated due to lack of enrollment
NCT01964755,TERMINATED,INTERVENTIONAL,Investigator Decision
NCT01964885,TERMINATED,INTERVENTIONAL,No significant results during interim analysis
NCT01965002,TERMINATED,INTERVENTIONAL,Accrual factor
NCT01965041,WITHDRAWN,INTERVENTIONAL,No patients enrolled.
NCT01965054,WITHDRAWN,INTERVENTIONAL,Logistics unresolved at the IRB at Elmhurst Hospital
NCT01965314,TERMINATED,INTERVENTIONAL,"1. The simulator lacked the fidelity required to meet training needs of the novices, 2. Recruitment of novice anesthetists more difficult than anticipated"
NCT01965730,TERMINATED,INTERVENTIONAL,the study was suspended due to shortage of the study drug (amicar).
NCT01965782,TERMINATED,INTERVENTIONAL,Due to safety results from another trial of LY3023703. No participants in this study received study drug.
NCT01965834,TERMINATED,INTERVENTIONAL,Lack of adequate accrual.
NCT01966315,TERMINATED,OBSERVATIONAL,The portable PSG machine can not be available any more.
NCT01966341,WITHDRAWN,INTERVENTIONAL,Recruiting or enrolling participants has halted prematurely and will not resume
NCT01966536,WITHDRAWN,INTERVENTIONAL,Due to fundamental changes in procedures design no patients have been enrolled
NCT01966575,WITHDRAWN,INTERVENTIONAL,Recent findings suggest that letrozole may be a superior Clomiphene Citrate.
NCT01966809,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT01966952,TERMINATED,OBSERVATIONAL,"Simplicity HTN 3 trial did meet safety endpoint, but did not meet efficacy endpoint and withdrew support for their catheter in 2014."
NCT01967017,WITHDRAWN,INTERVENTIONAL,Funding was denied.
NCT01967875,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01967927,WITHDRAWN,INTERVENTIONAL,Study has been open for 8 years with no enrollment. Procedures in 2013 protocol are outdated. Cannot make the radiopharmaceutical on campus anymore.
NCT01968226,TERMINATED,INTERVENTIONAL,Investigator left instititution
NCT01968356,TERMINATED,INTERVENTIONAL,Study discontinued due to data quality issues.
NCT01968590,TERMINATED,INTERVENTIONAL,unable to enroll
NCT01968629,WITHDRAWN,INTERVENTIONAL,No eligible subject enrolled
NCT01968785,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT01968863,TERMINATED,OBSERVATIONAL,Investigator Non Compliance
NCT01968876,TERMINATED,INTERVENTIONAL,Study had a minor contingency that could not be resolved with the IRB.
NCT01969006,WITHDRAWN,INTERVENTIONAL,"Another study has been planned, so we did not initiate this one."
NCT01969123,TERMINATED,INTERVENTIONAL,Study has been suspended due to clinical hold.
NCT01969136,TERMINATED,INTERVENTIONAL,Study has been suspended due to clinical hold.
NCT01969292,TERMINATED,INTERVENTIONAL,Stage 1 Complete; Stage 2 and 3 not pursued
NCT01969396,TERMINATED,INTERVENTIONAL,Enrollment considerations and current status of the clinical study
NCT01969565,TERMINATED,INTERVENTIONAL,Logistical reasons
NCT01969682,WITHDRAWN,INTERVENTIONAL,This study will be conducted in healthy volunteer subjects.
NCT01969890,TERMINATED,INTERVENTIONAL,Upon DSMC suggestion due to a too low enrollment rate.
NCT01969942,WITHDRAWN,INTERVENTIONAL,No subjects meeting study inclusion were enrolled.
NCT01970150,TERMINATED,INTERVENTIONAL,"1. New data from a published trial requires substantial change in study protocol
2. no funding available to carry the study further"
NCT01970345,TERMINATED,INTERVENTIONAL,Decision made to terminate due to difficulty in procurement of adequate supply of treatment drug. Decision made on April 2023 to terminate study.
NCT01970462,TERMINATED,INTERVENTIONAL,Recruitment
NCT01970527,TERMINATED,INTERVENTIONAL,Change in standard of care
NCT01970566,WITHDRAWN,INTERVENTIONAL,The project was not announced to the field and it was not funded.
NCT01970644,TERMINATED,OBSERVATIONAL,Poor accrual. Investigator decision.
NCT01970683,TERMINATED,INTERVENTIONAL,organizational problems
NCT01970800,WITHDRAWN,INTERVENTIONAL,Nature of study was changed from ACT to retrospective chart review
NCT01971060,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT01971073,TERMINATED,INTERVENTIONAL,Difficulty in financing the research
NCT01971320,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01971593,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT01971853,TERMINATED,INTERVENTIONAL,Insufficient number of participants recruited
NCT01971866,TERMINATED,OBSERVATIONAL,"Slow enrollment, feasibility issues"
NCT01971918,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT01972048,WITHDRAWN,INTERVENTIONAL,PI Left University
NCT01972061,TERMINATED,INTERVENTIONAL,Lack of continued funding
NCT01972126,TERMINATED,OBSERVATIONAL,"Manufacturer of the MFI QRS Fragmentation Systems used in the study, has filed for insolvency"
NCT01972399,WITHDRAWN,INTERVENTIONAL,Withdrawn from IRB at PI's request
NCT01972438,TERMINATED,INTERVENTIONAL,Investigational product unavailable due to manufacturing issues
NCT01972516,TERMINATED,INTERVENTIONAL,due to slow accrual
NCT01972776,TERMINATED,INTERVENTIONAL,Part 1 was completed. Part 2 was terminated for safety reasons.
NCT01972932,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT01973062,TERMINATED,INTERVENTIONAL,Funding Unavailable
NCT01973348,TERMINATED,INTERVENTIONAL,funding and personnel are lack.
NCT01973504,WITHDRAWN,INTERVENTIONAL,Sangart ceased operations
NCT01973517,WITHDRAWN,OBSERVATIONAL,Logistical factors affecting recruitment
NCT01973608,TERMINATED,INTERVENTIONAL,The study is terminated prematurely as the sponsor decided to discontinue program of NHS-IL2 \[MSB0010445\]
NCT01973764,TERMINATED,INTERVENTIONAL,Study was stopped due to slow recruitment
NCT01973985,TERMINATED,OBSERVATIONAL,Difficult to recruit to due to conflicting trials recruiting similar participants.
NCT01974063,TERMINATED,OBSERVATIONAL,Grant Ended
NCT01974128,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT01974154,TERMINATED,OBSERVATIONAL,Lack of funding.
NCT01974180,TERMINATED,OBSERVATIONAL,Closed by investigator
NCT01974284,TERMINATED,INTERVENTIONAL,Lack of patient enrollment
NCT01974479,SUSPENDED,INTERVENTIONAL,Suspended for an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.
NCT01974635,TERMINATED,INTERVENTIONAL,Device used for eye-blinks did not work as performed.
NCT01974700,TERMINATED,INTERVENTIONAL,"Lack of enrollment - since the start of the study in 2013, only 17 subjects have consented. Of those, only 8 completed the study."
NCT01974726,TERMINATED,INTERVENTIONAL,End of funding
NCT01974778,TERMINATED,INTERVENTIONAL,Participant numbers too low. Could not ingest required fat.
NCT01975181,TERMINATED,OBSERVATIONAL,No funding - program closure
NCT01975194,TERMINATED,INTERVENTIONAL,loss of research personnel
NCT01975272,TERMINATED,INTERVENTIONAL,Disapointing randomization rate
NCT01975298,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT01975376,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT01975389,TERMINATED,INTERVENTIONAL,See Detailed Description
NCT01975467,TERMINATED,OBSERVATIONAL,Low Enrollment
NCT01975597,TERMINATED,OBSERVATIONAL,held for blocking amendment then determined not to re-open
NCT01975662,TERMINATED,INTERVENTIONAL,slow accrual of participants
NCT01975688,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01975727,TERMINATED,INTERVENTIONAL,Study was halted prematurely for futility after an intermediate analysis
NCT01975766,TERMINATED,INTERVENTIONAL,Poor accrual
NCT01975844,TERMINATED,INTERVENTIONAL,Study has been terminated due to lack of financial support
NCT01976026,WITHDRAWN,INTERVENTIONAL,Rare aneurysms. No patient enrolled at site.
NCT01976195,WITHDRAWN,INTERVENTIONAL,No eligible patient was enrolled.
NCT01976221,WITHDRAWN,OBSERVATIONAL,Study withdrawn
NCT01976351,TERMINATED,OBSERVATIONAL,Insufficient research manpower
NCT01976598,TERMINATED,OBSERVATIONAL,"Protocol proved too cumbersome. Consequently, only one one patient enrolled, and completed."
NCT01976962,TERMINATED,INTERVENTIONAL,Lack of adequate sample size.
NCT01977027,TERMINATED,INTERVENTIONAL,PI left insitution
NCT01977339,WITHDRAWN,INTERVENTIONAL,"New departmental administration, loss of key study faculty"
NCT01977417,TERMINATED,INTERVENTIONAL,No funding
NCT01977586,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting suitable patients at centre
NCT01977729,TERMINATED,INTERVENTIONAL,funding
NCT01977820,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT01977911,WITHDRAWN,INTERVENTIONAL,Withdrawal of funding
NCT01978028,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT01978223,WITHDRAWN,OBSERVATIONAL,"As vaccine coverage rates have drastically improved in Venezuela, the study lost its objective to show positive impact of the vaccine to stimulate higher usage"
NCT01978236,TERMINATED,INTERVENTIONAL,This study was terminated due to the limited enrollment.
NCT01978249,TERMINATED,INTERVENTIONAL,Because of the difficulties of participant enrollment.
NCT01978301,TERMINATED,INTERVENTIONAL,Temporary hold on recruitment during staff changes at the site
NCT01978327,TERMINATED,INTERVENTIONAL,"Given the strength of CYP3A4 inhibition observed in Cohort 1, there is no rationale to investigate higher doses of GSK2647544 in the following two cohorts"
NCT01978366,TERMINATED,INTERVENTIONAL,Dosing stopped
NCT01978457,TERMINATED,INTERVENTIONAL,Not funded
NCT01978509,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT01978535,TERMINATED,INTERVENTIONAL,Difficulty in recruiting subjects.
NCT01978990,WITHDRAWN,OBSERVATIONAL,financial issues
NCT01979094,TERMINATED,OBSERVATIONAL,Process changes. New data base will be activated
NCT01979263,TERMINATED,INTERVENTIONAL,Insufficient recruitment/data collection
NCT01979276,TERMINATED,INTERVENTIONAL,"this study was terminated due to losing financial support, and enrollment challenges"
NCT01979341,WITHDRAWN,INTERVENTIONAL,treatment strategy changed
NCT01979432,TERMINATED,INTERVENTIONAL,Lack of patients
NCT01979666,TERMINATED,INTERVENTIONAL,Failure to recruit patients
NCT01980004,WITHDRAWN,INTERVENTIONAL,closure due to failure to recruit any patients that met study criteria
NCT01980160,WITHDRAWN,INTERVENTIONAL,Did not receive IRB approval from our institution therefore the study was closed.
NCT01980173,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT01980199,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01980277,TERMINATED,INTERVENTIONAL,Drug development stopped
NCT01980342,TERMINATED,INTERVENTIONAL,loss of funding
NCT01980368,WITHDRAWN,INTERVENTIONAL,No participants enrolled-slow accrual
NCT01980576,TERMINATED,OBSERVATIONAL,Lack of patients with the right criteria for inclusion
NCT01980810,TERMINATED,INTERVENTIONAL,recruit too slowly
NCT01980979,WITHDRAWN,INTERVENTIONAL,slow enrollment
NCT01981044,TERMINATED,INTERVENTIONAL,Difficulty accruing patients; business decision
NCT01981109,TERMINATED,OBSERVATIONAL,Administrative reasons
NCT01981187,TERMINATED,INTERVENTIONAL,"Due to slow enrollment and lack of response observed during the enrollment period, the Sponsor decided to close study enrollment early on 28 January 2015"
NCT01981239,WITHDRAWN,INTERVENTIONAL,no participation over the long period
NCT01981252,TERMINATED,INTERVENTIONAL,Lack of efficacy.
NCT01981499,TERMINATED,INTERVENTIONAL,The trial was prematurely terminated on 01April2014 due to safety concerns.
NCT01981668,WITHDRAWN,INTERVENTIONAL,no Canadian centre interested in conducting study in a reasonable timeframe
NCT01981707,TERMINATED,INTERVENTIONAL,enrollment default
NCT01981811,WITHDRAWN,INTERVENTIONAL,The trial was terminated because it was determined that the usability of the MIND1 System in the intended population was necessary before conducting this trial.
NCT01981902,WITHDRAWN,OBSERVATIONAL,Not a clinical trial study
NCT01982032,TERMINATED,INTERVENTIONAL,"slow enrollment, study device unavailable ( CoreValve)"
NCT01982071,TERMINATED,INTERVENTIONAL,Due to administrative reasons
NCT01982149,TERMINATED,OBSERVATIONAL,Lack of funding
NCT01982175,SUSPENDED,INTERVENTIONAL,recruiting difficulties
NCT01982253,TERMINATED,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT01982266,TERMINATED,INTERVENTIONAL,Device failure
NCT01982318,WITHDRAWN,INTERVENTIONAL,Study discontinued. Superseded by NCT02973893 VF00102.
NCT01982383,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT01982799,WITHDRAWN,INTERVENTIONAL,Not enough funding
NCT01982838,TERMINATED,INTERVENTIONAL,Low qualified candidate enrollment
NCT01982851,TERMINATED,INTERVENTIONAL,low qualified candidate enrollment
NCT01982864,TERMINATED,INTERVENTIONAL,Not enough patients
NCT01983085,TERMINATED,INTERVENTIONAL,The study was paused initially pending a review of the study design. The decision was then taken not to resume the study.
NCT01983189,TERMINATED,INTERVENTIONAL,Principal investigator (Dr. Sporn) left the sponsoring institution.
NCT01983423,TERMINATED,INTERVENTIONAL,Suboptimal subject recruitment
NCT01983462,TERMINATED,INTERVENTIONAL,Funding expired
NCT01983709,TERMINATED,INTERVENTIONAL,Study was Terminated by PI due to low accrual
NCT01983943,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT01984255,TERMINATED,INTERVENTIONAL,standard of care improved combination treatment of ipilimumab plus nivolumab.
NCT01984463,TERMINATED,INTERVENTIONAL,Increased incidence of respiratory depression in the morphine group
NCT01984866,TERMINATED,OBSERVATIONAL,Recruitment was very low.
NCT01984892,TERMINATED,INTERVENTIONAL,"PI discretion, low enrollment"
NCT01984996,TERMINATED,INTERVENTIONAL,Company was dissolved.
NCT01985022,TERMINATED,INTERVENTIONAL,Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.
NCT01985100,WITHDRAWN,INTERVENTIONAL,Unable to recruit any patients that fulfilled the narrow enrollment requirements
NCT01985477,TERMINATED,INTERVENTIONAL,Terminated Phase I due to slow accrual without progression to Phase II.
NCT01985841,TERMINATED,INTERVENTIONAL,Due to poor accrual
NCT01985893,WITHDRAWN,INTERVENTIONAL,"Due to missing patient recruitment, the financial support was stopped."
NCT01986049,WITHDRAWN,INTERVENTIONAL,We never collected data or started to recruit participants
NCT01986127,TERMINATED,INTERVENTIONAL,slow recruitment
NCT01986218,TERMINATED,INTERVENTIONAL,"(Non-safety reason, business objectives have changed)"
NCT01986348,TERMINATED,INTERVENTIONAL,Study was terminated due to Sponsor decision (all except 1 patient were off-treatment and 2 patients were in survival follow-up)
NCT01986751,TERMINATED,INTERVENTIONAL,failure to enroll
NCT01986764,WITHDRAWN,INTERVENTIONAL,Funding was not obtained for this study and no participants were enrolled.
NCT01986777,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT01986816,WITHDRAWN,OBSERVATIONAL,Investigaotr no longer at LU.
NCT01986829,TERMINATED,INTERVENTIONAL,Slow accrual
NCT01986946,TERMINATED,INTERVENTIONAL,Lack of recruitment.
NCT01987193,TERMINATED,OBSERVATIONAL,Slow accrual; funding stopped
NCT01987310,WITHDRAWN,INTERVENTIONAL,the study was stopped because of lack of interest
NCT01987375,TERMINATED,INTERVENTIONAL,logistics
NCT01987674,TERMINATED,INTERVENTIONAL,Test products expired.
NCT01987687,SUSPENDED,INTERVENTIONAL,Lack of funding
NCT01987856,WITHDRAWN,INTERVENTIONAL,loss of funding
NCT01987908,TERMINATED,INTERVENTIONAL,"Study was terminated early by the Sponsor due to unblinding between study drug and placebo groups at the subject, site and Sponsor levels."
NCT01987960,TERMINATED,INTERVENTIONAL,The study was terminated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns
NCT01988038,WITHDRAWN,OBSERVATIONAL,No participants were enrolled.
NCT01988077,TERMINATED,INTERVENTIONAL,due to toxicity of cyclophosphamide
NCT01988090,TERMINATED,INTERVENTIONAL,An interim analysis demonstrated no benefit of high dose vitamin D when compared to standard dose vitamin D in the reduction or prevention of arthralgia
NCT01988337,TERMINATED,INTERVENTIONAL,Slower than expected tooth decay in placebo group and insufficient recruitment.
NCT01988649,WITHDRAWN,INTERVENTIONAL,Duplicate Study
NCT01988701,WITHDRAWN,OBSERVATIONAL,Decision made by the PI to withdraw study
NCT01988831,SUSPENDED,INTERVENTIONAL,We must delay the study for some financial reasons
NCT01989026,TERMINATED,INTERVENTIONAL,Major structural and organizational changes at the NICU
NCT01989052,TERMINATED,INTERVENTIONAL,This study was terminated early due to funding issues prior to completion of phase I
NCT01989091,TERMINATED,INTERVENTIONAL,Did not meet predetermined primary endpoint
NCT01989858,TERMINATED,INTERVENTIONAL,lack of clinical cases
NCT01989897,WITHDRAWN,INTERVENTIONAL,Funding for the trial was lost so study was ended. No participants were enrolled.
NCT01990066,TERMINATED,INTERVENTIONAL,Difficulty recruiting adequate enrollment
NCT01990287,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT01990326,SUSPENDED,INTERVENTIONAL,Feasibility cohorts competed. Efficacy cohort not initiated for business reasons
NCT01990352,TERMINATED,INTERVENTIONAL,The PI determined that study specimens being obtained did not yield sufficient data to analyze the prespecified outcome measures and decided to terminate the study prior to meeting enrollment goals.
NCT01990404,TERMINATED,INTERVENTIONAL,inadequate recruitment
NCT01991210,TERMINATED,INTERVENTIONAL,The primary objective of PFS did not meet pre-specified criteria.
NCT01991262,WITHDRAWN,OBSERVATIONAL,the support group need to have some change
NCT01991353,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT01991366,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT01991938,TERMINATED,INTERVENTIONAL,Lack of recruitment and the company's decision to de-prioritize 5584 development
NCT01992003,TERMINATED,OBSERVATIONAL,Interim analysis indicated accuracy unchanged from previous versions
NCT01992068,TERMINATED,OBSERVATIONAL,Closure due to low accrual
NCT01992120,TERMINATED,INTERVENTIONAL,Key Personnel left institution
NCT01992276,WITHDRAWN,INTERVENTIONAL,Due to preliminary efficacy results from an influenza challenge trial
NCT01992354,TERMINATED,INTERVENTIONAL,Low enrollment
NCT01992562,WITHDRAWN,INTERVENTIONAL,Logistical issues with study process and recruitment
NCT01992770,TERMINATED,INTERVENTIONAL,Organisational changes at primary care units.
NCT01993147,TERMINATED,INTERVENTIONAL,Behavioral manipulation failed so the trial did not occur
NCT01993368,TERMINATED,INTERVENTIONAL,Not enough patient enrolled in the study
NCT01993472,TERMINATED,INTERVENTIONAL,low accrual rate
NCT01993654,TERMINATED,OBSERVATIONAL,Study was terminated due to low recruitment.
NCT01993901,WITHDRAWN,INTERVENTIONAL,Study never officially opened
NCT01994122,TERMINATED,OBSERVATIONAL,The study has been terminated because of recruitment difficulties and lack of further funding
NCT01994174,TERMINATED,OBSERVATIONAL,Limited resources; IRB approval was not maintained
NCT01994213,TERMINATED,INTERVENTIONAL,The applicant decided to close the study
NCT01994408,TERMINATED,INTERVENTIONAL,slow enrollment
NCT01994447,TERMINATED,INTERVENTIONAL,Change in study consent process at study site so that study had to be terminated
NCT01994590,TERMINATED,INTERVENTIONAL,Sponsor stopped supplying study drug
NCT01994642,TERMINATED,INTERVENTIONAL,FDA's draft guidance (revised March 2015) provided two options for determining bioequivalence: 1) in-vitro or 2) in-vivo studies
NCT01994824,TERMINATED,INTERVENTIONAL,The trend was observed toward higher mortality among the patients receiving the intervention Thymoglobulin on day 8 after hematopoietic cell transplantation.
NCT01994863,TERMINATED,INTERVENTIONAL,Problems with product performance
NCT01994967,WITHDRAWN,INTERVENTIONAL,Another regulatory way was defined.
NCT01995058,TERMINATED,INTERVENTIONAL,Study stopped after results of cabozantinib Phase 3 CRPC study XL184-307.
NCT01995227,WITHDRAWN,INTERVENTIONAL,Study site change to Thailand
NCT01995344,TERMINATED,INTERVENTIONAL,Withdrawal of funding
NCT01995396,TERMINATED,INTERVENTIONAL,Decision after interims analysis
NCT01995461,TERMINATED,INTERVENTIONAL,biostatistician determined 20 subjects would be adequate to perform statistics
NCT01995877,TERMINATED,OBSERVATIONAL,"Poor recruitment, PI leaving university"
NCT01996111,TERMINATED,INTERVENTIONAL,Change in Regulatory Status
NCT01996345,TERMINATED,INTERVENTIONAL,Study was terminated early do to a business decision by sponsor and lack of ability to recruit the needed number of participants.
NCT01996410,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT01996527,TERMINATED,INTERVENTIONAL,PI left institution
NCT01996605,TERMINATED,INTERVENTIONAL,"Cessation of funding period prior to completion, due to slow recruitment during the pandemic"
NCT01996696,TERMINATED,INTERVENTIONAL,Results of interim analysis indicate no statistically significant difference in the primary objective between the two arms at baseline and 12 months of follow-up.
NCT01996800,TERMINATED,INTERVENTIONAL,Insufficient faculty and staff.
NCT01996852,TERMINATED,INTERVENTIONAL,Premature terminated at institution request
NCT01996891,TERMINATED,INTERVENTIONAL,Unable to recruit adequate number of participants and high attrition rate
NCT01996982,TERMINATED,INTERVENTIONAL,The Prinicipal Investigator left the organization and decided to close the trial
NCT01997138,WITHDRAWN,INTERVENTIONAL,Too few recruitable patients
NCT01997203,TERMINATED,INTERVENTIONAL,complete patients samples required
NCT01997255,WITHDRAWN,INTERVENTIONAL,Site did not want to pursue study
NCT01997268,WITHDRAWN,INTERVENTIONAL,Study never initiated. IND placed on Hold
NCT01997450,SUSPENDED,OBSERVATIONAL,Study recruitment has been suspended.
NCT01997567,TERMINATED,INTERVENTIONAL,Subject recruitment is too difficult and we foresee that this will not improve
NCT01997775,TERMINATED,INTERVENTIONAL,Difficult enrollment
NCT01997827,WITHDRAWN,INTERVENTIONAL,Lack of Participants
NCT01997866,WITHDRAWN,INTERVENTIONAL,Re-evaluate inclusion/exclusion criteria
NCT01998035,TERMINATED,INTERVENTIONAL,PI left institution
NCT01998347,WITHDRAWN,INTERVENTIONAL,slow enrollment
NCT01998399,TERMINATED,INTERVENTIONAL,"poor enrollment, unable to meet recruitment goals"
NCT01998854,TERMINATED,OBSERVATIONAL,Investigational device changes
NCT01999192,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT01999335,TERMINATED,INTERVENTIONAL,A program evaluation identified that the safety profile and pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required further optimization and thus enrollment in OPZ007 was halted during dose-expansion.
NCT01999452,WITHDRAWN,INTERVENTIONAL,Recruitment problems
NCT01999660,TERMINATED,OBSERVATIONAL,PI did leave hospital (retired)
NCT01999803,TERMINATED,INTERVENTIONAL,Issues with development and supply of infusion system for delivery of IMP. Lack of favorable benefit risk ratio in sNN0029-003 study (review of interim data).
NCT01999855,TERMINATED,INTERVENTIONAL,technical problem
NCT02000037,TERMINATED,INTERVENTIONAL,The sponsor requested an early termination of the study following insufficient engagement of subjects beyond 12 months of follow-up (initial follow-up was 18 months).
NCT02000375,TERMINATED,INTERVENTIONAL,Due to slow recruitment and recent new published data
NCT02000453,TERMINATED,INTERVENTIONAL,GSK has elected to terminate development principally as a result of the statin drug-drug interaction (DDI) study.
NCT02000466,WITHDRAWN,OBSERVATIONAL,"GSK has merged all individual pregnancy registries, which are terminated, for its seasonal influenza vaccines into one combined registry, EPI-FLU-039 VS US PR."
NCT02000596,TERMINATED,INTERVENTIONAL,funding withdrawn by sponsor
NCT02000661,TERMINATED,INTERVENTIONAL,Stopped early by DSMB due to slow enrollment - obtained data to be analyzed
NCT02000713,TERMINATED,INTERVENTIONAL,Principle Investigator was unable to fulfill responsibilities.
NCT02000726,WITHDRAWN,INTERVENTIONAL,Lack of funding to complete the trial phase of the study.
NCT02000986,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT02001051,TERMINATED,INTERVENTIONAL,Study was closed due to low accrual.
NCT02001246,TERMINATED,INTERVENTIONAL,We were unable to recruit sufficient numbers of participants to complete the study.
NCT02001324,TERMINATED,INTERVENTIONAL,this pilot project is no longer funded
NCT02001701,WITHDRAWN,INTERVENTIONAL,No patients were enrolled.
NCT02001870,TERMINATED,INTERVENTIONAL,Recuitment target non obtained
NCT02001961,WITHDRAWN,OBSERVATIONAL,Study was withdrawn prior to R\&D approval
NCT02002052,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT02002234,TERMINATED,INTERVENTIONAL,Recruitment for the study was terminated due to slow recruitment
NCT02002377,TERMINATED,INTERVENTIONAL,Inadequate enrollment due to investigational product becoming newly available on the Canadian market soon after study start
NCT02002507,WITHDRAWN,OBSERVATIONAL,We faced technical problem before conducting this study
NCT02002637,TERMINATED,INTERVENTIONAL,Sponsor election
NCT02002689,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02002780,WITHDRAWN,INTERVENTIONAL,"Study not started, investigator left the institution"
NCT02003131,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02003326,TERMINATED,INTERVENTIONAL,low number of patients enrolled
NCT02003664,WITHDRAWN,INTERVENTIONAL,This study never started due to delays in medication development
NCT02003742,TERMINATED,INTERVENTIONAL,The study was stopped because in two other clinical studies the drug was not superior in comparison with placebo
NCT02003794,TERMINATED,INTERVENTIONAL,More progressive stroke in one arm
NCT02003872,TERMINATED,INTERVENTIONAL,Stopeed due to lack of recruitment
NCT02003911,TERMINATED,INTERVENTIONAL,Low accrual
NCT02004028,TERMINATED,INTERVENTIONAL,Company decided to discontinue trial to focus on development program next steps
NCT02004171,WITHDRAWN,INTERVENTIONAL,No participants enrolled. Changed requirements for studying e-cigarettes.
NCT02004184,TERMINATED,INTERVENTIONAL,Poor enrollment due to the introduction of immunotherapy
NCT02004210,WITHDRAWN,INTERVENTIONAL,No participants were enrolled.
NCT02004353,TERMINATED,OBSERVATIONAL,Original study purpose accomplished
NCT02004392,TERMINATED,INTERVENTIONAL,Study has been suspended due to clinical hold.
NCT02004496,TERMINATED,INTERVENTIONAL,Termination due to relevant update of the operation system. Adaption of the application was not foreseen in the intervention study.
NCT02004600,WITHDRAWN,INTERVENTIONAL,health statement of pre-screenined patients were too bad for being enrolled in the study
NCT02004756,TERMINATED,INTERVENTIONAL,Feasibility issues
NCT02004782,WITHDRAWN,INTERVENTIONAL,study abandoned
NCT02004951,TERMINATED,INTERVENTIONAL,Batch recall for Misago Terumo self-expanding peripheral stent systems.(withdrawal from the market)
NCT02005068,WITHDRAWN,INTERVENTIONAL,Failed to enroll any patients despite study modifications
NCT02005341,WITHDRAWN,INTERVENTIONAL,A change in research priorities after a merger
NCT02005445,TERMINATED,INTERVENTIONAL,Unable to meet recruitment target
NCT02005484,TERMINATED,INTERVENTIONAL,Study terminated due to slow patient recruitment.
NCT02005614,TERMINATED,INTERVENTIONAL,Unable to recruit patients.
NCT02005705,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT02006069,TERMINATED,INTERVENTIONAL,The steering committee had decided to discontinue enrollment because the interim analysis showed a low probability that the study would meet the primary endpoint. The interim analysis did not demonstrate any safety concerns with activating MPP.
NCT02006199,WITHDRAWN,INTERVENTIONAL,Withdrawal of the administrative reason
NCT02006251,TERMINATED,INTERVENTIONAL,Discretion of PI
NCT02006355,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02006407,TERMINATED,INTERVENTIONAL,Trial closed due to low accrual
NCT02006511,WITHDRAWN,INTERVENTIONAL,The study was never performed and closed.
NCT02006550,TERMINATED,OBSERVATIONAL,Lack of Resources and Personnel
NCT02006680,TERMINATED,OBSERVATIONAL,Inadequate Recruitment
NCT02006849,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT02006927,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT02006953,TERMINATED,INTERVENTIONAL,Difficulty recruiting due to parent declining feeding strategy
NCT02007239,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled
NCT02007252,TERMINATED,INTERVENTIONAL,The results of a third interim analysis (ad hoc) indicated a lack of efficacy and futility in continuing the trial.
NCT02007447,TERMINATED,INTERVENTIONAL,Most of our patients had no willingness to participate in the survey
NCT02007525,TERMINATED,INTERVENTIONAL,Insufficient enrollment; non-interest by target sample
NCT02007720,TERMINATED,INTERVENTIONAL,Study was terminated based on results from pivotal adult AHF study CRLX030A2301
NCT02007759,TERMINATED,INTERVENTIONAL,Difficulty with recruiting patients; poor quality of EMG
NCT02007876,WITHDRAWN,INTERVENTIONAL,Difficulty enrolling
NCT02007915,TERMINATED,INTERVENTIONAL,PI decision
NCT02007967,TERMINATED,OBSERVATIONAL,Difficulty enrolling patients
NCT02008006,TERMINATED,INTERVENTIONAL,Insufficient recruitment and unavailability of the treatment
NCT02008019,SUSPENDED,INTERVENTIONAL,The study was suspended since july 27th 2016 because of unavailability of Everolimus
NCT02008032,WITHDRAWN,INTERVENTIONAL,No patients accrued.
NCT02008123,WITHDRAWN,INTERVENTIONAL,Inclusion/Exclusion criteria was too stringent to enroll patients at this site.
NCT02008370,TERMINATED,INTERVENTIONAL,Lack of available participants that meet criteria
NCT02008409,WITHDRAWN,INTERVENTIONAL,The study was terminated. Six subjects were consented \& all were withdrawn before any study activities took place.
NCT02008513,TERMINATED,INTERVENTIONAL,Study AFF006A was early terminated by the sponsor based on the results of study AFF006.
NCT02008539,TERMINATED,INTERVENTIONAL,Enrollment terminated after 13 patients (14 planned); further patients did not meet eligibility criteria to receive autologous IMP
NCT02008617,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of subject recruitment
NCT02008786,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02008851,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02008994,TERMINATED,INTERVENTIONAL,Resignation of Principal Investigator
NCT02009384,TERMINATED,INTERVENTIONAL,low enrollment r/t requirement of prior treatment with denileukin diftitox
NCT02009423,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02009566,WITHDRAWN,INTERVENTIONAL,Initial PI Dr. Marentis left the University of Michigan hospital
NCT02009930,TERMINATED,OBSERVATIONAL,Failure to recruit enough subjects
NCT02009943,WITHDRAWN,INTERVENTIONAL,Inadequate funds
NCT02010177,SUSPENDED,OBSERVATIONAL,No recruitment
NCT02010203,TERMINATED,INTERVENTIONAL,Inability to accrue due to changing treatment landscape (PD-1 approvals)
NCT02010411,TERMINATED,INTERVENTIONAL,Technical problems with measure of CFU's. Outcomes published: PMID:16986483
NCT02010437,WITHDRAWN,INTERVENTIONAL,Study design has been substantially revised and a new registration will be made in the future.
NCT02010567,TERMINATED,INTERVENTIONAL,The study was halted prematurely at the funding partner's request.
NCT02010580,WITHDRAWN,OBSERVATIONAL,Never received necessary funding.
NCT02010645,TERMINATED,INTERVENTIONAL,PI Request
NCT02010671,TERMINATED,OBSERVATIONAL,Inadequate enrollment
NCT02011087,TERMINATED,INTERVENTIONAL,Slow Accruals
NCT02011126,WITHDRAWN,INTERVENTIONAL,IND no longer available.
NCT02011178,WITHDRAWN,INTERVENTIONAL,No subjects have been enrolled
NCT02011230,TERMINATED,INTERVENTIONAL,"IRB closed study: irregularities in documentation of informed consent, HIPAA"
NCT02011269,WITHDRAWN,INTERVENTIONAL,Study not conducted
NCT02011399,TERMINATED,OBSERVATIONAL,Training procedure was not effective.
NCT02011451,WITHDRAWN,INTERVENTIONAL,unable to enroll
NCT02011542,TERMINATED,INTERVENTIONAL,Original study product (VSL #3) became unavailable; change in study Collaborator and product
NCT02011594,WITHDRAWN,INTERVENTIONAL,There was no participants enrolled in this clinical trial.
NCT02011607,TERMINATED,OBSERVATIONAL,Lack of support
NCT02011620,WITHDRAWN,INTERVENTIONAL,The sponsor was no longer in a position to sponsor a CTIMP. Study did not open.
NCT02011646,TERMINATED,INTERVENTIONAL,The PI changed institutions
NCT02011841,WITHDRAWN,INTERVENTIONAL,We failed to recruit patients
NCT02011971,SUSPENDED,INTERVENTIONAL,We are now considering revision of the IND to determine maximum tolerated dose
NCT02012153,TERMINATED,INTERVENTIONAL,Failure to enroll the number of patients required by the protocol due to the low number of living donor transplants performed at the Clinical Center
NCT02012192,TERMINATED,INTERVENTIONAL,production of IMP has stopped
NCT02012335,WITHDRAWN,INTERVENTIONAL,Methodologicals and logistics issues.
NCT02012452,TERMINATED,INTERVENTIONAL,PI moving outside VA- grant not transferable
NCT02012608,TERMINATED,INTERVENTIONAL,Lack of funding/ PI leaving institution
NCT02012725,TERMINATED,OBSERVATIONAL,PI left institution
NCT02012777,TERMINATED,INTERVENTIONAL,Inability to recruit patients into the study.
NCT02012959,TERMINATED,INTERVENTIONAL,Issues with participant recruitment \& enrollment which made the trial impossible or highly impracticable. Trial termination was not due to safety reasons.
NCT02013141,TERMINATED,INTERVENTIONAL,FDA waived the pediatric study requirement for this application
NCT02013453,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02013505,TERMINATED,INTERVENTIONAL,Study expired; Investigator left facility.
NCT02013557,TERMINATED,INTERVENTIONAL,Resources allocated elsewhere.
NCT02013700,TERMINATED,INTERVENTIONAL,Study completed
NCT02013713,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT02013765,TERMINATED,INTERVENTIONAL,Trial was terminated prematurely because of recruitment difficulties.
NCT02013778,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02013869,TERMINATED,INTERVENTIONAL,"Two of the sites withdraw, did not have capacity to recruit patients"
NCT02013908,TERMINATED,INTERVENTIONAL,Low recruitment rate (17 patients;43% enrollment for 2 years).
NCT02014116,TERMINATED,INTERVENTIONAL,This trial was terminated early based on the lack of sufficient clinical efficacy observed.
NCT02014168,TERMINATED,INTERVENTIONAL,Futility
NCT02014545,WITHDRAWN,INTERVENTIONAL,Pending resolution of study drug issues
NCT02014597,TERMINATED,INTERVENTIONAL,funding lapse; enrollment difficulty
NCT02014649,TERMINATED,INTERVENTIONAL,Study was terminated as per BARDA decision to terminate contract.
NCT02014779,TERMINATED,INTERVENTIONAL,Only 1 participant recruited to study. Qs addressed in other ongoing studies.
NCT02014831,WITHDRAWN,INTERVENTIONAL,Industry decline to supply study drug
NCT02015325,WITHDRAWN,INTERVENTIONAL,Study was never approved by IRB so was never initiated
NCT02015533,WITHDRAWN,INTERVENTIONAL,The study was terminated due to an unexpected preliminary result obtained from the study with CR8020.
NCT02015650,TERMINATED,INTERVENTIONAL,Low Recruitment rate
NCT02015741,WITHDRAWN,OBSERVATIONAL,recruitment difficulties
NCT02015780,WITHDRAWN,INTERVENTIONAL,Due to potential concerns about liver safety (See Detailed Description)
NCT02015845,TERMINATED,INTERVENTIONAL,recrutment difficulties
NCT02015910,TERMINATED,INTERVENTIONAL,Terminated by the sponsor due to slow enrollment
NCT02015923,TERMINATED,INTERVENTIONAL,Difficulties surrounding recruiting patients
NCT02016066,WITHDRAWN,INTERVENTIONAL,Study terminated due to business decision
NCT02016534,TERMINATED,INTERVENTIONAL,Amgen decision following interim review of efficacy and safety data from the AMG 337 program.
NCT02016573,WITHDRAWN,INTERVENTIONAL,No participants enrolled into study and protocol has been superseded
NCT02016677,TERMINATED,OBSERVATIONAL,Slow enrollment rate. Low scientific value
NCT02016820,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02017366,WITHDRAWN,INTERVENTIONAL,"adapted protocol with changed outcome measures, changed recruitment number, no submission to ethical board review"
NCT02017379,TERMINATED,INTERVENTIONAL,Could not recruit any subjects
NCT02017496,TERMINATED,OBSERVATIONAL,Too low inclusion rate
NCT02017522,TERMINATED,INTERVENTIONAL,Poor initial results. Scans were of insufficient quality for study purpose.
NCT02018172,TERMINATED,OBSERVATIONAL,Terminated due to lack of recruitment and difficulty in the selection of sites
NCT02018185,SUSPENDED,INTERVENTIONAL,Recruitment has been suspended in order to perform interim data analysis.
NCT02018341,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT02018419,WITHDRAWN,INTERVENTIONAL,changing indication from breast cancer to metastatic colorectal cancer
NCT02018523,TERMINATED,INTERVENTIONAL,Study did not enroll enough subjects to make a statistically sound conclusion.
NCT02018653,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02018705,TERMINATED,OBSERVATIONAL,data income too low
NCT02019030,TERMINATED,OBSERVATIONAL,Not meeting enrollment goals
NCT02019225,TERMINATED,INTERVENTIONAL,Insufficient separation in session duration between randomized treatment groups
NCT02019238,TERMINATED,INTERVENTIONAL,PI discretion
NCT02019342,WITHDRAWN,OBSERVATIONAL,unable to implement the intervention
NCT02019498,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT02019979,TERMINATED,INTERVENTIONAL,PI left the institution
NCT02020109,WITHDRAWN,OBSERVATIONAL,Logistics and financial
NCT02020278,TERMINATED,INTERVENTIONAL,Issues with recruitment and enrollment made the trial impossible or highly impracticable. Termination of this trial was not due to safety reasons.
NCT02020460,TERMINATED,INTERVENTIONAL,low accrual
NCT02020499,TERMINATED,OBSERVATIONAL,Poor enrolment
NCT02020616,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT02020837,TERMINATED,INTERVENTIONAL,Halted prematurely due to low enrollment
NCT02020941,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02021084,WITHDRAWN,INTERVENTIONAL,no patient enroled
NCT02021149,TERMINATED,INTERVENTIONAL,Investigator transferred to the University of Wisconsin - Madison
NCT02021175,WITHDRAWN,INTERVENTIONAL,Unable to build the app for the clinical trial
NCT02021201,TERMINATED,INTERVENTIONAL,No suitable patients could be recruited in the available time period
NCT02021227,TERMINATED,INTERVENTIONAL,sufficient enrollment
NCT02021331,TERMINATED,INTERVENTIONAL,Low enrollment so sponsor stopped funding the study (did not renew)
NCT02021448,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT02021487,TERMINATED,OBSERVATIONAL,recruitment difficulty
NCT02021526,WITHDRAWN,INTERVENTIONAL,NIH funding resulted in new clinical trial
NCT02021721,TERMINATED,OBSERVATIONAL,Lack of funding
NCT02021747,WITHDRAWN,OBSERVATIONAL,Research Changed Directions
NCT02022072,TERMINATED,INTERVENTIONAL,"With 50 patients, the measure of assist vital capacity has been validated"
NCT02022293,SUSPENDED,INTERVENTIONAL,Enrollment target could not be achieved.
NCT02022358,TERMINATED,INTERVENTIONAL,"Recruitment almost complete, has been slow and challenging"
NCT02022735,TERMINATED,INTERVENTIONAL,Funding not secured
NCT02022826,TERMINATED,INTERVENTIONAL,sponsor internal decision
NCT02022969,WITHDRAWN,OBSERVATIONAL,Personell
NCT02023008,TERMINATED,INTERVENTIONAL,Study is not feasible
NCT02023047,TERMINATED,INTERVENTIONAL,Met primary endpoint
NCT02023307,TERMINATED,INTERVENTIONAL,Clinic Closed
NCT02023541,TERMINATED,INTERVENTIONAL,Lack of insurance coverage for proton beam treatment
NCT02023905,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02024074,TERMINATED,INTERVENTIONAL,Study terminated by the Sponsor due to slow enrollment
NCT02024243,TERMINATED,OBSERVATIONAL,No funding available to continue
NCT02024581,TERMINATED,INTERVENTIONAL,Sponsor chose to close
NCT02024620,WITHDRAWN,INTERVENTIONAL,The mobile phone app upon which the study was based was not available.
NCT02024685,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT02024880,TERMINATED,INTERVENTIONAL,The ET catheters were outdated.
NCT02025049,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02025231,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02025426,TERMINATED,INTERVENTIONAL,Significant challenges recruiting a difficult patient population with most surgeries occurring out of hours
NCT02025569,TERMINATED,INTERVENTIONAL,Data collection was terminated due to unavailability of additional participants.
NCT02025933,TERMINATED,OBSERVATIONAL,We were unable to recruit a sufficient number of participants
NCT02026089,WITHDRAWN,INTERVENTIONAL,Unforeseen reduction of recruitment resource.
NCT02026180,TERMINATED,INTERVENTIONAL,low incidence of primary endpoint
NCT02026232,TERMINATED,INTERVENTIONAL,COVID-19 \& loss of funding
NCT02026297,TERMINATED,INTERVENTIONAL,"funding and manpower unavailable, completion within a reasonable timeframe not possible."
NCT02026362,SUSPENDED,INTERVENTIONAL,Interim analysis
NCT02026609,TERMINATED,OBSERVATIONAL,Lack of patient accrual
NCT02026635,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT02026726,TERMINATED,OBSERVATIONAL,could not recruit
NCT02026947,WITHDRAWN,INTERVENTIONAL,We did not commence the trial because there were no patients who could fulfill the inclusion criteria.
NCT02026960,TERMINATED,INTERVENTIONAL,The sponsor's clinical program for the agent used in this study was discontinued.
NCT02027012,TERMINATED,INTERVENTIONAL,company strategic change
NCT02027155,TERMINATED,INTERVENTIONAL,Study stopping criteria was met
NCT02027272,TERMINATED,INTERVENTIONAL,"Difficulty recruiting, only one participant in 18 months, rarity of event"
NCT02027298,WITHDRAWN,INTERVENTIONAL,No Enrollment
NCT02027324,WITHDRAWN,INTERVENTIONAL,Another study with similar methods was recently published
NCT02027350,WITHDRAWN,INTERVENTIONAL,due lack of subjects
NCT02027389,WITHDRAWN,OBSERVATIONAL,"personnel change, unable to continue study"
NCT02027532,TERMINATED,INTERVENTIONAL,Could not complete study due to administrative challenges
NCT02027649,TERMINATED,OBSERVATIONAL,Absence of positive results
NCT02028000,TERMINATED,INTERVENTIONAL,Insufficient data to continue. Study will not resume.
NCT02028026,WITHDRAWN,INTERVENTIONAL,Inability to recruit eligible subjects
NCT02028052,TERMINATED,INTERVENTIONAL,similar study data published
NCT02028156,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02028260,WITHDRAWN,INTERVENTIONAL,unable to enroll
NCT02028312,WITHDRAWN,INTERVENTIONAL,Per Sponsor
NCT02028325,TERMINATED,INTERVENTIONAL,Lack of enrollment. No new subjects had been enrolled for nearly a year.
NCT02028923,TERMINATED,INTERVENTIONAL,Recruiting patients too low
NCT02029235,TERMINATED,INTERVENTIONAL,Early termination due to slower than anticipated recruitment.
NCT02029261,WITHDRAWN,OBSERVATIONAL,Insufficient recruitment
NCT02029274,TERMINATED,INTERVENTIONAL,The study was terminated prematurely after an interim analysis for futility. The study did not provide any evidence for efficacy of BAF312 in dermatomyositis.
NCT02029365,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02029417,TERMINATED,INTERVENTIONAL,Major revisions needed in study
NCT02029469,TERMINATED,INTERVENTIONAL,Study was terminated due to PI leaving the institution
NCT02029495,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02029586,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02029638,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02029703,TERMINATED,INTERVENTIONAL,Enrollment Goals not met
NCT02029768,TERMINATED,OBSERVATIONAL,Could not reach recruitment goal
NCT02029781,TERMINATED,INTERVENTIONAL,Delayed/poor inclusion rate.
NCT02029846,TERMINATED,INTERVENTIONAL,No sufficient numbers of eligible participants
NCT02029963,TERMINATED,INTERVENTIONAL,Unsuccessful in obtaining recruitment
NCT02030015,TERMINATED,INTERVENTIONAL,Efficacy
NCT02030145,WITHDRAWN,INTERVENTIONAL,PI relocated
NCT02030184,WITHDRAWN,INTERVENTIONAL,PI has left the study institution.
NCT02030314,WITHDRAWN,INTERVENTIONAL,The patient population changed. Unable to find patients that meet study criteria
NCT02030379,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT02030405,TERMINATED,INTERVENTIONAL,Regulatory
NCT02030431,TERMINATED,INTERVENTIONAL,overweight of hard-ware removals in the Dynaloc group
NCT02030444,TERMINATED,INTERVENTIONAL,due to difficulties with recruiting
NCT02030483,TERMINATED,INTERVENTIONAL,"The company providing one of the study drugs withdrew its support due to low enrollment. Therefore, we had to close the study due to lack of funding."
NCT02030548,TERMINATED,OBSERVATIONAL,enrolment behind expectation
NCT02030574,TERMINATED,INTERVENTIONAL,The study is being closed to accrual secondary to low accrual and an interest in opening up a different trial.
NCT02030886,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02030951,TERMINATED,OBSERVATIONAL,Funding completed
NCT02031029,TERMINATED,OBSERVATIONAL,Stopped by the sponsor due to discrepancies in the recruitment process.
NCT02031172,TERMINATED,OBSERVATIONAL,PI is moving to a different institution.
NCT02031211,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT02031380,WITHDRAWN,INTERVENTIONAL,Funding
NCT02031406,TERMINATED,INTERVENTIONAL,"Trial initiated, but data collection was inadequate. Analysis was terminated."
NCT02031419,TERMINATED,INTERVENTIONAL,Replaced with another clinical trial.
NCT02031445,TERMINATED,INTERVENTIONAL,Interim analysis showed lack of efficacy
NCT02031536,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02031588,TERMINATED,OBSERVATIONAL,lack of recruitement
NCT02031887,TERMINATED,INTERVENTIONAL,South African Health Authorities now promote that HIV positive mothers should receive anti-retroviral drugs and breastfeed their infants.
NCT02032056,TERMINATED,INTERVENTIONAL,Changes in study design
NCT02032134,TERMINATED,INTERVENTIONAL,recruitment failure within the interval of available CRY BC-PLTs for the study
NCT02032173,TERMINATED,INTERVENTIONAL,Study was prematurely discontinued as it was unethical to continue based on a change in ranibizumab (RFB) marketing authorization.
NCT02032238,TERMINATED,INTERVENTIONAL,The number of anticipated participants was not achieved
NCT02032511,TERMINATED,OBSERVATIONAL,No appreciable difference noted between methods of delivery
NCT02032654,TERMINATED,INTERVENTIONAL,Budget exceeded
NCT02032732,TERMINATED,OBSERVATIONAL,Principal Investigator resigned from institution
NCT02032784,TERMINATED,INTERVENTIONAL,Difficult to enroll subjects
NCT02032862,TERMINATED,INTERVENTIONAL,Insufficient recruitment rate
NCT02032940,TERMINATED,OBSERVATIONAL,COVID-19
NCT02033148,WITHDRAWN,INTERVENTIONAL,changes in study design by sponsor not acceptable for participating
NCT02033278,TERMINATED,INTERVENTIONAL,"Low recruitment rate, bibliographic evidence of lack of efficacy"
NCT02033317,TERMINATED,INTERVENTIONAL,Study terminated due to slow enrollment
NCT02033538,WITHDRAWN,INTERVENTIONAL,This clinical trial was closed due to slow recruitment of patients.
NCT02033590,WITHDRAWN,INTERVENTIONAL,Strategic priorities impacted study
NCT02033941,SUSPENDED,INTERVENTIONAL,Study has been suspended for the duration of the pandemic. We hope to re-start enrollment later this year
NCT02034097,WITHDRAWN,INTERVENTIONAL,GSK has decided to terminate the Product Development of foretinib and conclude our Development Agreement with Exelixis
NCT02034123,TERMINATED,INTERVENTIONAL,The risk benefit in relapsed refractory SCLC does not favor continuation of the study
NCT02034279,TERMINATED,INTERVENTIONAL,Low recruitment rate and expiration of the study drug
NCT02034292,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02034370,WITHDRAWN,OBSERVATIONAL,Inclusion criteria not met at preoperative clinic visit screening. No eligible participants.
NCT02034461,TERMINATED,INTERVENTIONAL,"This device feasibility study was using a microelectrode array device to determine

viability of the product. Design and operating specification of the device were established. A new IDE

trial has been initiated."
NCT02034890,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting patients
NCT02034916,TERMINATED,INTERVENTIONAL,Primary Analysis and study completed. Not stopped due to safety concerns.
NCT02034968,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT02035085,WITHDRAWN,INTERVENTIONAL,Drugs/devices discontinued
NCT02035124,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to slow accrual. No patients were enrolled.
NCT02035319,WITHDRAWN,OBSERVATIONAL,No enrollments
NCT02035345,TERMINATED,INTERVENTIONAL,Extended Carboplatin Infusion did not Reduce Frequency of Hypersensitivity Reactions
NCT02036203,WITHDRAWN,INTERVENTIONAL,The study was withdrawn prior to patients enrolment due to sponsor's decision
NCT02036307,TERMINATED,INTERVENTIONAL,This study was suspended because there is no more funds to complete the study.
NCT02036333,TERMINATED,OBSERVATIONAL,Key Personnel Left Institution Prior to Study Completion
NCT02036463,WITHDRAWN,INTERVENTIONAL,No funding for project.
NCT02036476,TERMINATED,INTERVENTIONAL,Lack of accrual.
NCT02036502,TERMINATED,INTERVENTIONAL,Business Reasons
NCT02036697,TERMINATED,INTERVENTIONAL,Difficulty with patient recruitment.
NCT02036944,TERMINATED,OBSERVATIONAL,Study stopped d/t lack of enrollment and no compelling data.
NCT02037113,TERMINATED,OBSERVATIONAL,PI left institution--only 8 subjects were enrolled.
NCT02037152,WITHDRAWN,INTERVENTIONAL,"Problems with the software intervention, PI finished training and left UCSF."
NCT02037347,TERMINATED,INTERVENTIONAL,Low enrollment numbers precluded completion of the study during a reasonable amount of time.
NCT02037373,TERMINATED,OBSERVATIONAL,FDA released requirement to complete study
NCT02037386,WITHDRAWN,INTERVENTIONAL,problem with balloon catheter
NCT02037412,TERMINATED,INTERVENTIONAL,The patient registration was not successful.
NCT02037529,SUSPENDED,INTERVENTIONAL,Total enrollment number is being lowered
NCT02037932,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT02038049,TERMINATED,INTERVENTIONAL,The study recruitment was terminated based on strategic considerations after 8 patients were enrolled.
NCT02038153,TERMINATED,INTERVENTIONAL,Low accrual
NCT02038634,TERMINATED,INTERVENTIONAL,not enough patient data
NCT02038699,WITHDRAWN,INTERVENTIONAL,Protocol not activated.
NCT02038816,TERMINATED,INTERVENTIONAL,"accrual too slow, insufficient patients"
NCT02038985,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02038998,WITHDRAWN,INTERVENTIONAL,Lack of available patients
NCT02039115,TERMINATED,INTERVENTIONAL,Closed for low enrollment and the inability to complete the study.
NCT02039167,TERMINATED,INTERVENTIONAL,The recruitment rate was very poor. The study was stopped by amendment on 2015-08-28.
NCT02039219,TERMINATED,INTERVENTIONAL,"Post-marketing reports of hepatotoxicity associated with obeticholic acid emerged in June 2017, investigators temporarily halted patient recruitment June 2017."
NCT02039778,TERMINATED,INTERVENTIONAL,Poor Accural
NCT02039869,WITHDRAWN,INTERVENTIONAL,Could not recruit patients - modifying protocol and plan resubmission to our IRB
NCT02040311,TERMINATED,INTERVENTIONAL,Study was terminated early as sponsor wanted to develop an improved formulation.
NCT02040454,WITHDRAWN,INTERVENTIONAL,required catheters not available
NCT02040818,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT02040909,TERMINATED,INTERVENTIONAL,interim results concluded no added value of additional inclusion
NCT02040961,TERMINATED,INTERVENTIONAL,"An incident, burned tube, happened before intubation. The promoter decided to stop the study."
NCT02041052,TERMINATED,INTERVENTIONAL,Terminated due to insufficient inclusion rate.
NCT02041091,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02041299,TERMINATED,INTERVENTIONAL,"Difficulties with additional recruitment as pool of potential patients was exhausted, and sufficient information for determination of study outcome measure was already obtained"
NCT02041442,TERMINATED,INTERVENTIONAL,study to be redesigned based on initial results
NCT02041494,TERMINATED,INTERVENTIONAL,Rising costs have made continuing the study untenable
NCT02041624,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT02041819,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT02042027,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02042053,TERMINATED,INTERVENTIONAL,Due to PI leaving the institution
NCT02042157,TERMINATED,INTERVENTIONAL,Equipment malfunction.
NCT02042235,TERMINATED,INTERVENTIONAL,difficulted recruiting
NCT02042456,TERMINATED,OBSERVATIONAL,"Change in study staff at the site, change in Sponsor direction"
NCT02042495,WITHDRAWN,INTERVENTIONAL,Did not obtain Health Canda approval for drug use in reasonable time and moved onward to new trial
NCT02042573,TERMINATED,INTERVENTIONAL,The study population is no longer accessible to the investigating team.
NCT02042651,WITHDRAWN,INTERVENTIONAL,study stopped because of insuficient number of comparable patients available.
NCT02042677,TERMINATED,OBSERVATIONAL,Slow recruitment of participants
NCT02042703,TERMINATED,OBSERVATIONAL,Unanticipated slow enrollment
NCT02042924,TERMINATED,INTERVENTIONAL,Updating protocol and consents
NCT02042950,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual
NCT02043535,TERMINATED,INTERVENTIONAL,The complexity of the study and the recent slow down situation hampered the ability to recruit CAD patients therefore the study has been terminated.
NCT02043587,TERMINATED,INTERVENTIONAL,Original investigator for the trial has left
NCT02043639,TERMINATED,OBSERVATIONAL,Change in technology
NCT02043860,TERMINATED,INTERVENTIONAL,low accrual
NCT02043951,TERMINATED,OBSERVATIONAL,Originally 500 patients were planned but only 59 have been enrolled
NCT02044510,TERMINATED,INTERVENTIONAL,Slow recruitment and small observed effect size
NCT02044614,TERMINATED,INTERVENTIONAL,Limited patient recruitment
NCT02044848,TERMINATED,INTERVENTIONAL,This study was terminated prematurely by the Sponsor for business reasons only.
NCT02044926,TERMINATED,OBSERVATIONAL,Because patient enrollment is so difficult.
NCT02044939,TERMINATED,INTERVENTIONAL,Not enough recruitment
NCT02044991,TERMINATED,INTERVENTIONAL,The study was halted prematurely due to poor recruitment
NCT02045030,TERMINATED,INTERVENTIONAL,Drug (Aflibercept) no longuer available for the study
NCT02045134,TERMINATED,INTERVENTIONAL,low participation rate
NCT02045238,TERMINATED,INTERVENTIONAL,Technical difficulties (reduced staff plus university strike)
NCT02045251,WITHDRAWN,INTERVENTIONAL,Unavailability of clarithromycin 250 mg in the market
NCT02045329,TERMINATED,OBSERVATIONAL,Logistically unable to recruit subjects
NCT02045355,TERMINATED,INTERVENTIONAL,Not enough patients to recruite.
NCT02045433,TERMINATED,INTERVENTIONAL,The study was prematurely closed due to unacceptable toxicity.
NCT02045732,TERMINATED,INTERVENTIONAL,"This study terminated on April 8, 2015 due to a corporate decision and not related to the safety or efficacy of the protocol."
NCT02045888,WITHDRAWN,INTERVENTIONAL,Withdrawn (No Participants Enrolled)
NCT02045927,TERMINATED,INTERVENTIONAL,study staff change
NCT02046109,WITHDRAWN,INTERVENTIONAL,"Because of logistic problems, we could not recruit any patient."
NCT02046135,TERMINATED,INTERVENTIONAL,Statistical analysis at interim analysis determined futility in continuing.
NCT02046187,TERMINATED,INTERVENTIONAL,excessive protocol deviations due to strict nature of diet requirements
NCT02046226,TERMINATED,INTERVENTIONAL,inability to meet enrollment goals in this subject population
NCT02046317,TERMINATED,INTERVENTIONAL,"No further enrolled patients, Primary researcher left the institution"
NCT02046538,WITHDRAWN,INTERVENTIONAL,Investigator terminated due to funding issues
NCT02046551,WITHDRAWN,INTERVENTIONAL,funding lost
NCT02046590,TERMINATED,INTERVENTIONAL,Recruitment too slow
NCT02046928,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02047019,WITHDRAWN,INTERVENTIONAL,GPDC decided to terminate the study
NCT02047136,TERMINATED,INTERVENTIONAL,"Unable to recruit subjects, patients want active treatment instead of placebo."
NCT02047149,TERMINATED,INTERVENTIONAL,Low accrual
NCT02047214,TERMINATED,INTERVENTIONAL,Due to lack of clinical benefit in the 17 subjects enrolled in the trial to date
NCT02047370,SUSPENDED,INTERVENTIONAL,The sample size was not completed
NCT02047422,WITHDRAWN,INTERVENTIONAL,One of the diuretic which is planned to be used in the study is no longer available.
NCT02047500,TERMINATED,INTERVENTIONAL,The trial has been terminated earlier following the company decision to discontinue the clinical development of Evofosfamide
NCT02047552,WITHDRAWN,INTERVENTIONAL,No Participants enrolled
NCT02047630,TERMINATED,INTERVENTIONAL,Problem with IP supply
NCT02047747,TERMINATED,INTERVENTIONAL,slow enrollment
NCT02047851,TERMINATED,INTERVENTIONAL,"Not enough study participants, difficulties in recruitment"
NCT02047877,WITHDRAWN,OBSERVATIONAL,Study concept vacated due to sample collection issues
NCT02048033,TERMINATED,INTERVENTIONAL,"Following the occurrence of four serious adverse events in the APOLLO group and after discussion with the investigator, we consider that this minimally invasive protocol causes an increased risk of morbidity and mortality."
NCT02048085,WITHDRAWN,INTERVENTIONAL,unable to get study up and enrolling
NCT02048111,WITHDRAWN,INTERVENTIONAL,The study was withdrawn from the IND.
NCT02048163,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT02048189,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02048475,WITHDRAWN,INTERVENTIONAL,administrative reasons.
NCT02048748,WITHDRAWN,INTERVENTIONAL,"The study was ended before any patients were enrolled. Department of Clinical Research, August 2020."
NCT02048904,TERMINATED,INTERVENTIONAL,Original Principal Investigator left institution. No data analyzed.
NCT02048943,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02048969,WITHDRAWN,INTERVENTIONAL,No subjects were able to be recruited for the study.
NCT02048982,WITHDRAWN,INTERVENTIONAL,Funding
NCT02049073,WITHDRAWN,INTERVENTIONAL,new data makes this trial unethical
NCT02049151,TERMINATED,INTERVENTIONAL,The study is terminated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC
NCT02049164,TERMINATED,INTERVENTIONAL,Study stopping criteria met with regards to vital sign measurements post dose.
NCT02049385,TERMINATED,INTERVENTIONAL,Severe side effects \& lack of target engagement
NCT02049424,TERMINATED,OBSERVATIONAL,low recruitment
NCT02049736,WITHDRAWN,INTERVENTIONAL,unable to recruit patients
NCT02049801,TERMINATED,INTERVENTIONAL,logistics
NCT02049853,TERMINATED,INTERVENTIONAL,recruitment numbers lower than expected
NCT02050009,WITHDRAWN,INTERVENTIONAL,study was never opened to accrual
NCT02050048,TERMINATED,INTERVENTIONAL,Study was closed prematurely due to low enrollment numbers.
NCT02050230,TERMINATED,INTERVENTIONAL,Protracted recruitment of patients
NCT02050256,WITHDRAWN,INTERVENTIONAL,due to organisational changes
NCT02050295,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT02050321,TERMINATED,INTERVENTIONAL,Pharmaceutical company pulled support for the trial.
NCT02050386,WITHDRAWN,OBSERVATIONAL,Resources were refocused into another project preventing this project from starting
NCT02050724,TERMINATED,INTERVENTIONAL,Ende of part 1. Only few patients in part 2 enrolled
NCT02050737,TERMINATED,OBSERVATIONAL,"As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up."
NCT02050815,TERMINATED,INTERVENTIONAL,The Sponsor is terminating the study because the primary objective was achieved after 5 of the 6 subjects were assessed in the final cohort.
NCT02050997,TERMINATED,OBSERVATIONAL,"As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up."
NCT02051075,WITHDRAWN,INTERVENTIONAL,failure to recruit
NCT02051764,TERMINATED,INTERVENTIONAL,Lower than expected enrollment
NCT02051933,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02051959,SUSPENDED,INTERVENTIONAL,Signing a contract with the company owning the equipment
NCT02052193,TERMINATED,INTERVENTIONAL,Second cohort not opened because Simon-Two_Step model failed
NCT02052297,TERMINATED,INTERVENTIONAL,The study was terminated due to challenges recruiting subjects with fibrotic interstitial lung disease associated with a connective tissue disease for Part D
NCT02052440,TERMINATED,INTERVENTIONAL,Insufficient funding to complete with low enrollment rate
NCT02052570,WITHDRAWN,OBSERVATIONAL,Unable to meet all criteria as outlined for participants
NCT02052635,TERMINATED,INTERVENTIONAL,"Patient recruitment challenges, low enrolment, and a forecasted inability to complete the study in an acceptable timeframe"
NCT02052674,WITHDRAWN,INTERVENTIONAL,Unable to enroll any patients in the study due to other on-going studies.
NCT02052921,TERMINATED,INTERVENTIONAL,"During the execution time foreseen in the project, the expected number of patients was not reached."
NCT02053103,TERMINATED,INTERVENTIONAL,"On 25April2014, study was terminated before any dosing due to an AE of safety concern that occurred in protocol B1731003 with the same drug."
NCT02053116,TERMINATED,INTERVENTIONAL,"On 25April2014, study was terminated before any dosing due to an AE of safety concern that occurred in protocol B1731003 with the same drug."
NCT02053246,TERMINATED,INTERVENTIONAL,Study funding ended before recruitment completed.
NCT02053311,WITHDRAWN,INTERVENTIONAL,"Due to former trials, drug has not demonstrated a clinical profile sufficient to move forward in mCRPC"
NCT02053324,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02053350,TERMINATED,INTERVENTIONAL,Funding ended
NCT02053545,WITHDRAWN,INTERVENTIONAL,Study closed with no enrollment.
NCT02053558,WITHDRAWN,INTERVENTIONAL,Could not obtain dedicated ultrasound device.
NCT02053597,WITHDRAWN,INTERVENTIONAL,due to evolving scientific knowledge in the field that would make the questions being addressed in the trial less relevant
NCT02053623,TERMINATED,OBSERVATIONAL,Technical issues \& lack of funds
NCT02053727,WITHDRAWN,INTERVENTIONAL,The study team did not enroll any patients due to difficulty with recruitment.
NCT02053883,WITHDRAWN,INTERVENTIONAL,Compound recently partnered with another company for continued development.
NCT02054104,TERMINATED,INTERVENTIONAL,"Vaccine production halted in 2015, thus study is terminated."
NCT02054117,TERMINATED,OBSERVATIONAL,Principal Investigator is leaving institution.
NCT02054338,TERMINATED,INTERVENTIONAL,Study was stopped before progressive disease or death of alive subjects.
NCT02054520,TERMINATED,INTERVENTIONAL,Withdrawal of IND
NCT02054559,WITHDRAWN,INTERVENTIONAL,No consensus among trial centers regarding protocol
NCT02054650,TERMINATED,INTERVENTIONAL,Scheduling and recruitment difficulties
NCT02054793,WITHDRAWN,INTERVENTIONAL,This study was never able to open due to lack of funding from the pharmaceutical company.
NCT02054819,TERMINATED,INTERVENTIONAL,"Didn't meet accrual goal, change in standard of care."
NCT02054884,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02054936,WITHDRAWN,INTERVENTIONAL,"Change in standard of care, no possibility of recruitment"
NCT02054949,WITHDRAWN,INTERVENTIONAL,no eligible subjects located
NCT02055170,TERMINATED,INTERVENTIONAL,Unable to improve on poor accrual to study.
NCT02055196,WITHDRAWN,INTERVENTIONAL,New study written
NCT02055599,WITHDRAWN,OBSERVATIONAL,PI departure.
NCT02055690,TERMINATED,INTERVENTIONAL,Safety
NCT02055755,WITHDRAWN,OBSERVATIONAL,PI departure
NCT02055846,TERMINATED,INTERVENTIONAL,Insufficient biological material for analysis
NCT02055924,TERMINATED,INTERVENTIONAL,ANSM decision due to veino occlusive disease (security alert)
NCT02055937,TERMINATED,INTERVENTIONAL,autorities vorbidden this dispositif in other trial
NCT02055963,TERMINATED,INTERVENTIONAL,Early termination due to the protocol lack of progress in improving accrual rate
NCT02056054,TERMINATED,OBSERVATIONAL,Study PI has moved institutions
NCT02056171,TERMINATED,INTERVENTIONAL,Unable to recruit subjects at our site within the past year.
NCT02056223,SUSPENDED,INTERVENTIONAL,We enrolled only 53 patients
NCT02056288,TERMINATED,INTERVENTIONAL,Enrollment was suspended due to the duration of the study and poor follow-up response by participants.
NCT02056301,TERMINATED,INTERVENTIONAL,New method of pain control pushed by surgeons.
NCT02056678,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT02056938,TERMINATED,INTERVENTIONAL,recruitment issues
NCT02057055,WITHDRAWN,INTERVENTIONAL,study not executed
NCT02057211,TERMINATED,INTERVENTIONAL,Changed regulations of culture procedure
NCT02057224,TERMINATED,INTERVENTIONAL,Renal denervation has not been used as clinical method in our hospital the last two years
NCT02057276,TERMINATED,INTERVENTIONAL,Study was terminated due to low recruitment.
NCT02057497,WITHDRAWN,OBSERVATIONAL,It has been decided by the Sponsor not to conduct the trial.
NCT02057523,TERMINATED,INTERVENTIONAL,"Unable to enroll patients, no longer at institution."
NCT02057549,TERMINATED,INTERVENTIONAL,PI left institution
NCT02057666,TERMINATED,INTERVENTIONAL,Development of tasquinimod in prostate cancer discontinued
NCT02057770,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02057874,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT02057991,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT02058017,TERMINATED,INTERVENTIONAL,Lactic and metabolic acidosis of OPB-51602 is not tolerable
NCT02058108,TERMINATED,INTERVENTIONAL,Study terminated on the recommendation of an independent Data Monitoring Committee (DMC) subsequent to an interim efficacy analysis for futility.\]
NCT02058134,TERMINATED,INTERVENTIONAL,Due to other trials in the department
NCT02058199,TERMINATED,INTERVENTIONAL,PI left the Institution; No replacement PI identified;
NCT02058238,WITHDRAWN,OBSERVATIONAL,Sponsor Decision
NCT02058290,TERMINATED,INTERVENTIONAL,Slower than expected enrollment
NCT02058303,TERMINATED,INTERVENTIONAL,PI leaving instutition
NCT02058329,TERMINATED,INTERVENTIONAL,Many patients were lost to follow-up
NCT02058407,TERMINATED,INTERVENTIONAL,Drug related AEs observed upon repeat dosing that with longer treatment duration could become worse. Required action on some biomarkers not observed.
NCT02058511,TERMINATED,INTERVENTIONAL,Preliminary results showed no ability to predict pain by measuring hippus with pupillometry
NCT02058524,TERMINATED,INTERVENTIONAL,Unable to recruit and enroll eligible subjects.
NCT02058537,TERMINATED,INTERVENTIONAL,"Initial PI left, study not continued"
NCT02058667,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT02058732,TERMINATED,INTERVENTIONAL,Principal investigator was unable to fulfill his responsibilities.
NCT02058797,TERMINATED,INTERVENTIONAL,The Coherence Therapy intervention could not be delivered in a reliable and valid way for a variety of reasons.
NCT02058810,TERMINATED,INTERVENTIONAL,"Lack of patients, PI left"
NCT02058823,TERMINATED,INTERVENTIONAL,budget constraints
NCT02058875,WITHDRAWN,INTERVENTIONAL,The study funder retracted their grant funding offer before contract signed.
NCT02059057,TERMINATED,INTERVENTIONAL,FDA approval of supplementation to IDE/protocol amendment to terminate subject long term follow up
NCT02059083,WITHDRAWN,INTERVENTIONAL,Funding not received; study was never started
NCT02059252,TERMINATED,INTERVENTIONAL,Mode of application to be reconsidered by Sponsor
NCT02059265,TERMINATED,INTERVENTIONAL,Interim monitoring
NCT02059356,TERMINATED,OBSERVATIONAL,Low patient recruitment
NCT02059889,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT02059967,WITHDRAWN,INTERVENTIONAL,Due to no accrual.
NCT02060175,WITHDRAWN,INTERVENTIONAL,Because of the problem with Cilotax stent permission
NCT02060305,TERMINATED,INTERVENTIONAL,Very slow enrollment
NCT02060331,WITHDRAWN,OBSERVATIONAL,Difficult to recruit to.
NCT02060487,TERMINATED,INTERVENTIONAL,Study was terminated by Sponsor at recommendation of Data Monitoring Committee after completion of first interim analysis as primary objective was met.
NCT02060669,TERMINATED,INTERVENTIONAL,others
NCT02060734,WITHDRAWN,INTERVENTIONAL,no participant recruited
NCT02060825,TERMINATED,OBSERVATIONAL,Difficulty in downloading and saving data from the oximetry machine.
NCT02060955,TERMINATED,INTERVENTIONAL,Substantial design modifications required.
NCT02061007,WITHDRAWN,INTERVENTIONAL,no accrual
NCT02061163,WITHDRAWN,INTERVENTIONAL,PI leaving UM at the end of the month
NCT02061228,TERMINATED,INTERVENTIONAL,"Safety concerns, apparent futility and protracted recruitment"
NCT02061449,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02061696,TERMINATED,INTERVENTIONAL,Device was modified and no longer available to investigator
NCT02061774,TERMINATED,INTERVENTIONAL,Preliminary analysis showed not clinically significant. Study ended and closed 1/11/2018
NCT02061943,WITHDRAWN,OBSERVATIONAL,Study not started
NCT02062008,TERMINATED,INTERVENTIONAL,Lack of funding to continue.
NCT02062359,TERMINATED,INTERVENTIONAL,Study was closed due to poor accrual.
NCT02062372,TERMINATED,INTERVENTIONAL,"Expectation that within the set time period insufficient patients will be included, so endpoints will not be achieved"
NCT02062606,TERMINATED,OBSERVATIONAL,The study terminated early due to slow enrollment that significantly extended the expected study duration.
NCT02062632,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02062788,TERMINATED,INTERVENTIONAL,patient enrollment was failed.
NCT02062879,TERMINATED,INTERVENTIONAL,Withdrawals from study due to anticipated effects from study drugs
NCT02062892,WITHDRAWN,INTERVENTIONAL,Patients meeting the inclusion/ exclusion criteria did not agree to participate. It became obvious that recruitment goals could not be met.
NCT02062983,SUSPENDED,OBSERVATIONAL,Difficulty in enrolling patients
NCT02062996,WITHDRAWN,INTERVENTIONAL,Could not receive FDA approval for IND
NCT02063074,TERMINATED,OBSERVATIONAL,Lack of participants and funding support
NCT02063113,TERMINATED,INTERVENTIONAL,inclusion difficulty
NCT02063191,TERMINATED,OBSERVATIONAL,Methods of activation timing measurements too imprecise
NCT02063412,WITHDRAWN,OBSERVATIONAL,Slow recruitment pace
NCT02063425,TERMINATED,INTERVENTIONAL,Not enough recruitment
NCT02063828,TERMINATED,INTERVENTIONAL,"Took too long to accrue participants, stopped for feasibility concerns"
NCT02063945,TERMINATED,INTERVENTIONAL,Major difficulties recruiting participants
NCT02064010,WITHDRAWN,INTERVENTIONAL,Funding terminated; company closed
NCT02064023,TERMINATED,INTERVENTIONAL,Some sites withdrew because no contract with insulin pump supplier
NCT02064855,TERMINATED,OBSERVATIONAL,The study was terminated early due to slow enrollment and difficulties with long-term follow-up
NCT02064868,TERMINATED,INTERVENTIONAL,Study was terminated based on results from pivotal adult AHF study CRLX030A2301
NCT02064959,TERMINATED,INTERVENTIONAL,"interim analysis revealed it was futile, we would not reach an answer at N=60."
NCT02065037,TERMINATED,INTERVENTIONAL,CO2 temperature delivered revealed that warmed CO2 was not being delivered.
NCT02065128,WITHDRAWN,OBSERVATIONAL,"Logistical challenges with research pharmacy prevented the dilution of the capsaicin. No participants were ever recruited, enrolled, or approached."
NCT02065323,WITHDRAWN,INTERVENTIONAL,Terminated due to budgetary considerations and length of development.
NCT02065336,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02065401,WITHDRAWN,INTERVENTIONAL,This study was withdrawn until the evaluation of the nonclinical rat findings is complete.
NCT02065466,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT02065869,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02066116,TERMINATED,INTERVENTIONAL,enrollment is difficult and pilot nature of this study
NCT02066311,TERMINATED,INTERVENTIONAL,Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy
NCT02066363,TERMINATED,INTERVENTIONAL,"Recruitment very time consuming, too few wanting participation"
NCT02066597,TERMINATED,INTERVENTIONAL,Recommendation from the DSMB following recurrent DVT in 3/4 participants who underwent the thrombectomy procedure.
NCT02066649,WITHDRAWN,INTERVENTIONAL,We need to revise and redesign the study
NCT02067104,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02067234,WITHDRAWN,INTERVENTIONAL,PI left institution; project closed.
NCT02067390,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT02067416,WITHDRAWN,INTERVENTIONAL,Funding agent withdrew funding
NCT02067637,WITHDRAWN,OBSERVATIONAL,Low accrual
NCT02067741,TERMINATED,INTERVENTIONAL,"The SAKK board decided to prematurely end the life-long follow-up of the trial SAKK 21/12, as 90% of the patients have died."
NCT02067858,TERMINATED,INTERVENTIONAL,slow accrual
NCT02067884,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02068157,TERMINATED,INTERVENTIONAL,Study no longer has an active IDE
NCT02068417,TERMINATED,INTERVENTIONAL,It has been decided to improve the inclusion criteria for better study outcome
NCT02068521,TERMINATED,INTERVENTIONAL,The primary endpoint of non-inferiority to daily therapy in the pediatric Phase 3 study was not achieved
NCT02068547,TERMINATED,INTERVENTIONAL,"Sponsor closed study due to low enrollment

Sponsor closed study due to low enrollment

Sponsor closed study due to low enrollment."
NCT02068625,TERMINATED,INTERVENTIONAL,Persisting recruitment difficulties
NCT02068729,TERMINATED,OBSERVATIONAL,The study was terminated early due to slow enrollment and difficulties with long-term follow-up
NCT02068768,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT02069288,WITHDRAWN,INTERVENTIONAL,Problems of drugs supply by the manufacturer
NCT02069353,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02069431,TERMINATED,INTERVENTIONAL,"This study was halted prematurely due to the COVID-19 pandemic, resulting in the inability to enroll participants. Funding for this project has also ended."
NCT02069522,TERMINATED,INTERVENTIONAL,interim analysis findings
NCT02069834,WITHDRAWN,INTERVENTIONAL,One of the both Funder partners decided to stop the study before the initiation : thus no product provided and no funding to realize the study
NCT02070042,TERMINATED,INTERVENTIONAL,Lack of participation
NCT02070107,WITHDRAWN,INTERVENTIONAL,Sponsored withdrew
NCT02070341,TERMINATED,INTERVENTIONAL,"Significant changes to protocol and study design, study stopped to further enrollment and new study designed."
NCT02070393,TERMINATED,INTERVENTIONAL,Closure of Indiana University Health Proton Center in December 2014
NCT02070406,TERMINATED,INTERVENTIONAL,low accrual
NCT02070419,WITHDRAWN,INTERVENTIONAL,Principal Investigator left institution
NCT02070445,WITHDRAWN,OBSERVATIONAL,One of the investigators left the institution.
NCT02070484,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02070588,TERMINATED,INTERVENTIONAL,Sponsor terminated early as moving to a new larger study program
NCT02070666,TERMINATED,INTERVENTIONAL,Low recruitment and published data with no benefit
NCT02070978,TERMINATED,INTERVENTIONAL,The study was terminated early due to shortage of drug supply.
NCT02071511,TERMINATED,INTERVENTIONAL,"The Sponsor appreciate the devastating impact that the results of the SYMPLICITY HTN 3 trial had on research progress for renal denervation. Based on the lack of recent progress, it is no longer practical to maintain the agreement."
NCT02071667,WITHDRAWN,OBSERVATIONAL,Unable to recruit/enroll subjects for study.
NCT02071875,TERMINATED,OBSERVATIONAL,Study recruitment was put on hold for interim data analysis and during this time period the PI requested to pre-maturely terminate the study
NCT02071966,TERMINATED,INTERVENTIONAL,slow enrollment
NCT02072057,TERMINATED,INTERVENTIONAL,Poor recruiting
NCT02072096,TERMINATED,INTERVENTIONAL,The trial was terminated per protocol because of lack of feasibility.
NCT02072187,TERMINATED,INTERVENTIONAL,Difficulties with subject enrolment.
NCT02072226,TERMINATED,INTERVENTIONAL,The study was terminated due to slow enrollment.
NCT02072252,WITHDRAWN,INTERVENTIONAL,The app was not completed in time to conduct a clinical trial on it within the funding grant's award period
NCT02072473,WITHDRAWN,OBSERVATIONAL,No enrollment
NCT02072538,WITHDRAWN,OBSERVATIONAL,no Sponsor
NCT02072993,TERMINATED,INTERVENTIONAL,Study stopping criteria has been reached
NCT02073045,TERMINATED,INTERVENTIONAL,research cancelled
NCT02073695,TERMINATED,INTERVENTIONAL,A publication released shortly after start indicating intervention not always beneficial. Fewer surgical cased thereafter.
NCT02074007,TERMINATED,INTERVENTIONAL,primary outcome measure not met
NCT02074254,WITHDRAWN,OBSERVATIONAL,Not sure. PI is no longer at OSU.
NCT02074410,TERMINATED,INTERVENTIONAL,Sponsor decision - pending further analysis of available data
NCT02074436,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02074696,TERMINATED,OBSERVATIONAL,Site unable to complete full data collection/protocol
NCT02074748,TERMINATED,OBSERVATIONAL,Surgeons chose not to provide patients for testing
NCT02074878,TERMINATED,INTERVENTIONAL,"Poor accrual so the study was halted on May 16, 2017."
NCT02074904,TERMINATED,INTERVENTIONAL,"We terminated the study to run it as a sub-study of NCT02371889, which is a 13 week, placebo controlled, double-blind, trial of topiramate in heavy drinkers."
NCT02074995,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to recruitment issues
NCT02075008,TERMINATED,INTERVENTIONAL,The study was prematurely terminated after core study CQGE031B2201 failed to meet the primary objective of demonstrating superiority for QGE031 versus placebo.
NCT02075021,TERMINATED,INTERVENTIONAL,PI left the institution
NCT02075047,TERMINATED,INTERVENTIONAL,"Based on recent input from FDA, the pre-specified final analysis will be performed at the current enrollment using a re-estimation of the sample size."
NCT02075125,TERMINATED,INTERVENTIONAL,Enrolling participants has halted prematurely and will not resume
NCT02075190,TERMINATED,INTERVENTIONAL,Dr. Gyurak is no longer doing and ended her NARSAD early.
NCT02075411,TERMINATED,INTERVENTIONAL,"Difficult to enroll, parents/subjects prefer to choose type of anesthetic block."
NCT02076243,TERMINATED,INTERVENTIONAL,Closed by sponsor
NCT02076438,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02076594,TERMINATED,INTERVENTIONAL,"The interim analysis performed on 09 November 2018, showed the failure to achieve the primary objective of effectiveness of the experimental treatment."
NCT02076893,TERMINATED,INTERVENTIONAL,Interim analysis results indicated need to recruit beyond scope of budget.
NCT02077062,TERMINATED,OBSERVATIONAL,Reagants to test mediators couldnot be procured
NCT02077179,TERMINATED,INTERVENTIONAL,"Poor retention and recruitment,changes need to be made to the program"
NCT02077309,TERMINATED,INTERVENTIONAL,"bad recruitment of suitable participants, just 4 patients in one year"
NCT02077621,WITHDRAWN,INTERVENTIONAL,Study reevaluation
NCT02077907,TERMINATED,INTERVENTIONAL,Due to Ebola virus disease outbreak
NCT02077959,TERMINATED,INTERVENTIONAL,Pharmaceutical Companies decision
NCT02077972,TERMINATED,INTERVENTIONAL,Investigator transferred to the University of Wisconsin - Madison
NCT02078089,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT02078154,TERMINATED,OBSERVATIONAL,Decision to start a new study on DVT with another protocol
NCT02078375,TERMINATED,INTERVENTIONAL,Funding ended
NCT02078635,WITHDRAWN,INTERVENTIONAL,Study was amalgamated with another study to include exercise as another intervention.
NCT02078752,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in sponsor prioritization.
NCT02078843,TERMINATED,INTERVENTIONAL,Superiority of one imaging method
NCT02078895,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment
NCT02078934,WITHDRAWN,INTERVENTIONAL,Did not receive funding for recruitment.
NCT02078960,TERMINATED,INTERVENTIONAL,Inability to accrue additional sites and enroll an adequate number of subjects.
NCT02079155,WITHDRAWN,INTERVENTIONAL,Research Cancelled
NCT02079220,WITHDRAWN,INTERVENTIONAL,"Funding for the study was withdrawn, no participants were ever recruited."
NCT02079493,TERMINATED,OBSERVATIONAL,Not enough subject enrollment
NCT02079519,TERMINATED,INTERVENTIONAL,The study was discontinued prematurely by the sponsor due to a lack of recruitment.
NCT02079818,WITHDRAWN,INTERVENTIONAL,The study was never initiated.
NCT02079948,WITHDRAWN,INTERVENTIONAL,Potential participants had concerns about taking the study drug (methotrexate).
NCT02080078,TERMINATED,INTERVENTIONAL,REB decision
NCT02080130,WITHDRAWN,INTERVENTIONAL,No participants.
NCT02080195,TERMINATED,INTERVENTIONAL,Study was unable to accrue subjects
NCT02080364,TERMINATED,INTERVENTIONAL,Not due to safety but due to a lack of efficacy at the 5 mg azeliragon dose.
NCT02080416,TERMINATED,INTERVENTIONAL,"Very slow accrual; terminated to allow resources to be utilized more effectively on other studies. No data analysis completed, nor any conclusions reached."
NCT02080611,WITHDRAWN,OBSERVATIONAL,Funding was not available from company
NCT02080702,TERMINATED,OBSERVATIONAL,Planned recruitment of 630 patients was not possible to achieve within the given time frame
NCT02080741,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT02080949,WITHDRAWN,INTERVENTIONAL,Low rate of recruitment.
NCT02080962,TERMINATED,INTERVENTIONAL,Low rate of recruitment.
NCT02081053,TERMINATED,INTERVENTIONAL,Difficulty Enrolling
NCT02081105,TERMINATED,INTERVENTIONAL,The study stopped because it was difficult to recruit the 130 expected patients
NCT02081690,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02081729,TERMINATED,OBSERVATIONAL,low enrollment rate
NCT02081989,WITHDRAWN,INTERVENTIONAL,Unable to commence study due to closure of hospital department.
NCT02082197,WITHDRAWN,INTERVENTIONAL,Other - not a safety issue
NCT02082405,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT02082522,TERMINATED,INTERVENTIONAL,Accrual rate remaining too low
NCT02082626,TERMINATED,INTERVENTIONAL,Competing study opened
NCT02082639,WITHDRAWN,INTERVENTIONAL,"Because the Russian Authorities already approved the 2-dose Cervarix schedule, the study was no longer needed for registration and hence it was cancelled."
NCT02082717,TERMINATED,INTERVENTIONAL,Terminated due to medical supplies shortages due to the 2017 hurricane season.
NCT02082756,WITHDRAWN,INTERVENTIONAL,The sponsor have not enough money to support this trial
NCT02082977,TERMINATED,INTERVENTIONAL,"The maximal dose and schedule attained with GSK2816126 has shown insufficient evidence of clinical activity, and does not justify further clinical investigation"
NCT02083003,TERMINATED,INTERVENTIONAL,End of commercialization of low polyamin diet
NCT02083146,TERMINATED,OBSERVATIONAL,Study subjects were not enrolled.
NCT02083276,TERMINATED,INTERVENTIONAL,Treatment failure on study medication observed
NCT02083536,WITHDRAWN,INTERVENTIONAL,Study voluntarily stopped by Principal Investigator due to lack of accrual.
NCT02083666,TERMINATED,INTERVENTIONAL,Transient adverse events observed
NCT02083679,TERMINATED,INTERVENTIONAL,Sponsor the return rights of the compound to the collaboration partner for further clinical development
NCT02083939,TERMINATED,OBSERVATIONAL,Recruitment failed
NCT02084004,WITHDRAWN,INTERVENTIONAL,The sponsor have not enough money to support this trial
NCT02084264,TERMINATED,OBSERVATIONAL,Administrative
NCT02084628,TERMINATED,INTERVENTIONAL,Enrollment discontinued due to rare medical condition in the age group 0 to 2 months
NCT02084719,TERMINATED,INTERVENTIONAL,Slow recruitement
NCT02084771,WITHDRAWN,INTERVENTIONAL,"The recruitment rate was very slow, and it was concluded that it was not feasible to do this trial."
NCT02085239,WITHDRAWN,INTERVENTIONAL,Study never got started; can't delete results
NCT02085304,TERMINATED,INTERVENTIONAL,met stopping rules for futility
NCT02085486,WITHDRAWN,INTERVENTIONAL,Lack of scientific interest
NCT02085525,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT02085616,TERMINATED,INTERVENTIONAL,"Interim analysis, revealed no additional effect of proactive over reactive service."
NCT02085629,TERMINATED,INTERVENTIONAL,Insufficient rate of patient recruitment and treatment.
NCT02085668,WITHDRAWN,INTERVENTIONAL,"This study was stopped after the publication of the Symplicity HTN-3 trial even before patient inclusion.

The protocol (including the renal denervation device) were revised and a new trial conducted ( NCT04947670)."
NCT02086240,WITHDRAWN,INTERVENTIONAL,No subjects recruited
NCT02086487,TERMINATED,INTERVENTIONAL,"Because of many unseen obstacles resulted in poor accrual, study is terminated."
NCT02086591,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02086708,TERMINATED,INTERVENTIONAL,The technology showed rapid acceptance in the general population and we halted our feasibility demonstration study.
NCT02086760,WITHDRAWN,INTERVENTIONAL,no subject enrolled within one year following EC and IRB approvals.
NCT02087033,TERMINATED,INTERVENTIONAL,The study is halted prematurely by sponsoring organization.
NCT02087176,TERMINATED,INTERVENTIONAL,The study was terminated early by the sponsor.
NCT02087228,TERMINATED,INTERVENTIONAL,Sponsor and Principle Investigator mutually agreed to terminate study and patients are no longer examined/treated
NCT02087241,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study.
NCT02087280,WITHDRAWN,OBSERVATIONAL,We did not receive funding
NCT02087397,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT02087527,TERMINATED,INTERVENTIONAL,Calculated sample size not achieved
NCT02087644,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02087878,WITHDRAWN,OBSERVATIONAL,Strategic considerations
NCT02088021,WITHDRAWN,INTERVENTIONAL,Business decision
NCT02088047,TERMINATED,INTERVENTIONAL,PI decided to end the study
NCT02088151,TERMINATED,INTERVENTIONAL,Suitable device for laser no longer available
NCT02088372,TERMINATED,OBSERVATIONAL,All 4 sites were terminated due to low follow-up of patients and low interest in the study
NCT02088632,TERMINATED,INTERVENTIONAL,Unable to enrolled in a timely manner.
NCT02088957,TERMINATED,INTERVENTIONAL,Termination of study due to low enrollment. There were no safety issues.
NCT02088970,TERMINATED,INTERVENTIONAL,Difficulties in reaching the desired number of patients and intermediate analysis leading to discontinuation of the study.
NCT02089139,TERMINATED,INTERVENTIONAL,The French medicines agency did not allow the continuation of the study (no patient enrolled in this study)
NCT02089178,TERMINATED,INTERVENTIONAL,"The study costed more than expected, so the investigators decided to end it."
NCT02089230,TERMINATED,INTERVENTIONAL,The trial was terminated due to slow accrual
NCT02089386,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02089425,TERMINATED,INTERVENTIONAL,Interim futility analysis
NCT02089802,TERMINATED,INTERVENTIONAL,Early termination due to lack of recruitment
NCT02090218,TERMINATED,INTERVENTIONAL,Lack of patients/centres included.
NCT02090283,TERMINATED,INTERVENTIONAL,The Sponsor voluntarily recalled SD-101 and terminated the study due to GMP deficiencies identified during an FDA inspection at the site of the manufacturer.
NCT02090296,WITHDRAWN,INTERVENTIONAL,Participant withdrew consent
NCT02090348,WITHDRAWN,INTERVENTIONAL,The study was withdrawn for business reasons. The decision to stop the TECNERGY study was not a result of any safety or efficacy concerns.
NCT02090439,TERMINATED,INTERVENTIONAL,"Following difficulties in patient recruitment, we were forced to stop the study prematurely."
NCT02090517,WITHDRAWN,INTERVENTIONAL,Study was withdrawn because the university wanted to bill study patients for use of the laser.
NCT02090569,TERMINATED,INTERVENTIONAL,recommandation of the Data Safety monitoring Board
NCT02090725,TERMINATED,INTERVENTIONAL,Drug receive FDA approval
NCT02090829,WITHDRAWN,INTERVENTIONAL,Low recruitment
NCT02090868,WITHDRAWN,OBSERVATIONAL,No patients recruited due to decreased levels of patients requiring non-invasive ventilation during the study.
NCT02090959,TERMINATED,INTERVENTIONAL,Sponsor decision due to commercial availability of ataluren.
NCT02090998,TERMINATED,INTERVENTIONAL,no patients during covid pandemic
NCT02091297,WITHDRAWN,INTERVENTIONAL,two other institutions that were in the center thought they weren't going to be able to recruit enough patients
NCT02091479,TERMINATED,INTERVENTIONAL,inclusion rate insufficient
NCT02091492,WITHDRAWN,INTERVENTIONAL,no participants
NCT02091661,SUSPENDED,INTERVENTIONAL,accrual too slow
NCT02091752,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment.
NCT02091817,SUSPENDED,INTERVENTIONAL,We are currently engaged in other behavioral study.
NCT02091856,TERMINATED,INTERVENTIONAL,We have recruited and treated 79 participants
NCT02092077,TERMINATED,INTERVENTIONAL,Business decision
NCT02092246,WITHDRAWN,INTERVENTIONAL,Difficulty enrolling subjects
NCT02092272,TERMINATED,INTERVENTIONAL,the PI left our facility and the new staff prefer alternate excersises
NCT02092389,TERMINATED,OBSERVATIONAL,Recruitment below expectation
NCT02092909,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02092961,TERMINATED,INTERVENTIONAL,AZ decision to discontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.
NCT02093182,WITHDRAWN,OBSERVATIONAL,Agreement not executed between site and sponsor
NCT02093221,TERMINATED,INTERVENTIONAL,Wk 52 primary endpoint results would be unaffected by follow-up data so trial was discontinued prior to wk 104. No safety data was collected after wk 52.
NCT02093299,TERMINATED,OBSERVATIONAL,Lack of feasiability
NCT02093364,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT02093377,TERMINATED,INTERVENTIONAL,Throughout the COVID-19 pandemic no patient could be recruited. Patients refuse to visit the hospital for study visits.
NCT02093429,TERMINATED,INTERVENTIONAL,Business decision.
NCT02093442,TERMINATED,INTERVENTIONAL,The main investigators are no longer working at the center.
NCT02093468,TERMINATED,INTERVENTIONAL,Program discontinued to persue alternate indications.
NCT02093494,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02093689,TERMINATED,INTERVENTIONAL,Pupil measurement methodology determined not appropriate in this population.
NCT02093962,TERMINATED,INTERVENTIONAL,"At the interim analysis, the futility boundary was not met and the study was stopped due to insufficient efficacy."
NCT02094027,TERMINATED,INTERVENTIONAL,New evidence came to light to indicate that study was no longer relevant
NCT02094157,TERMINATED,INTERVENTIONAL,Change of practice made further recruitment impossible
NCT02094352,TERMINATED,INTERVENTIONAL,The study was unable to enroll efficiently despite trying various technique.
NCT02094560,TERMINATED,INTERVENTIONAL,The study was terminated to be redesigned for a trial according to EMA proposal.
NCT02094651,WITHDRAWN,INTERVENTIONAL,No eligible patients were enrolled
NCT02094807,WITHDRAWN,INTERVENTIONAL,Slow inclusion rate. Awaiting results from NCT02132416.
NCT02095015,TERMINATED,OBSERVATIONAL,terminated for not meeting enrollment goals
NCT02095210,TERMINATED,INTERVENTIONAL,slow recruitment
NCT02095223,TERMINATED,INTERVENTIONAL,Difficulties with participant recruitment.
NCT02095236,WITHDRAWN,INTERVENTIONAL,Administrative barriers
NCT02095353,TERMINATED,OBSERVATIONAL,FDA safety concerns with repeated use of gadolinium-based contrast; subjects received additional dose of contrast with no direct clinical benefit
NCT02095522,WITHDRAWN,INTERVENTIONAL,The investigators did not find suiable patients
NCT02095574,WITHDRAWN,INTERVENTIONAL,This study will now be conducted in healthy volunteers.
NCT02095639,TERMINATED,OBSERVATIONAL,The study was terminated
NCT02095717,TERMINATED,INTERVENTIONAL,The trial was stopped for futility in view of the results of the interim analysis
NCT02095782,TERMINATED,INTERVENTIONAL,"Because of the very slow enrollment, this study was stopped."
NCT02095821,TERMINATED,OBSERVATIONAL,Study was stopped due to recruitment failure
NCT02095899,WITHDRAWN,INTERVENTIONAL,Poor study patient recruitment
NCT02096042,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02096133,TERMINATED,INTERVENTIONAL,difficulties with inclusion
NCT02096146,TERMINATED,INTERVENTIONAL,Lack of enrolment
NCT02096341,TERMINATED,INTERVENTIONAL,Subcutaneous administration of RRx-001 is no longer of interest.
NCT02096588,TERMINATED,INTERVENTIONAL,The Principal Investigator left Johns Hopkins
NCT02097576,WITHDRAWN,INTERVENTIONAL,Funding withdrawn.
NCT02097732,TERMINATED,INTERVENTIONAL,Study halted prematurely due to a change in the standard of care treatment
NCT02097901,SUSPENDED,INTERVENTIONAL,Insufficient patient material
NCT02098083,WITHDRAWN,OBSERVATIONAL,Unable to collect data
NCT02098148,WITHDRAWN,INTERVENTIONAL,Withdrawn. Unable to set up appropriate infrastructure to support study.
NCT02098629,WITHDRAWN,INTERVENTIONAL,Difficulty in enrollment
NCT02098785,WITHDRAWN,INTERVENTIONAL,Local resource issue - never actually started post ethics approval.
NCT02098915,TERMINATED,INTERVENTIONAL,Decision to prematurely close the trial was made because of poor recruitment.
NCT02098993,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT02099240,TERMINATED,INTERVENTIONAL,Not enough patient enrollment and lack of staffing
NCT02099331,WITHDRAWN,INTERVENTIONAL,Lack of faculty staffing
NCT02099344,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02099500,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT02099604,WITHDRAWN,INTERVENTIONAL,Study objectives were considered as obsolete regarding the new AAD arrival
NCT02099695,WITHDRAWN,INTERVENTIONAL,The company changed the strategy.
NCT02099825,TERMINATED,INTERVENTIONAL,COVID and staffing issues
NCT02100007,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT02100527,WITHDRAWN,INTERVENTIONAL,Study canceled
NCT02100618,WITHDRAWN,INTERVENTIONAL,"Due to late study start, the possibility to enroll enough subjects dropped below the limit to provide scientifically acceptable data, hence study was cancelled."
NCT02100709,TERMINATED,INTERVENTIONAL,Sample size calculation would have been overinflated; re-think study design
NCT02100735,WITHDRAWN,INTERVENTIONAL,Difficulty in with enrollment of patient
NCT02100956,TERMINATED,INTERVENTIONAL,"Cessation of funding period prior to completion, due to slow recruitment during the pandemic"
NCT02101047,WITHDRAWN,INTERVENTIONAL,lack of eligible participant
NCT02101177,WITHDRAWN,OBSERVATIONAL,Study objectives were considered as absolete regarding the arrival of new antiviral drugs in Egypt.
NCT02101242,TERMINATED,OBSERVATIONAL,Cardiac surgery group could not be measured (technical monitoring problems)
NCT02101346,TERMINATED,INTERVENTIONAL,Change in scientific information obtained resulting in early cessation of protocol.
NCT02101463,TERMINATED,INTERVENTIONAL,Principal Investigator left the organization and took the IDE/Study with him
NCT02101554,TERMINATED,INTERVENTIONAL,Pfizer released from post-marketing commitment and study terminated because too few patients in the age group; not because of efficacy or safety issues.
NCT02101684,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT02101762,TERMINATED,OBSERVATIONAL,Funding
NCT02102230,TERMINATED,INTERVENTIONAL,Principle Investigator as left government service
NCT02102243,WITHDRAWN,INTERVENTIONAL,No longer interested in study topic
NCT02102386,TERMINATED,OBSERVATIONAL,Technical issues with the device under study. Sponsor terminated.
NCT02102412,TERMINATED,INTERVENTIONAL,Changes made to device.
NCT02102438,WITHDRAWN,INTERVENTIONAL,No financial support aproved
NCT02102555,TERMINATED,INTERVENTIONAL,study closed due to difficulty enrolling subjects - no results
NCT02102594,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02102841,WITHDRAWN,INTERVENTIONAL,Recruitment no longer feasible
NCT02102971,TERMINATED,OBSERVATIONAL,Expired with UF IRB.
NCT02102997,TERMINATED,OBSERVATIONAL,Low enrolment
NCT02103166,SUSPENDED,INTERVENTIONAL,Conditions of recruitment changed
NCT02103465,TERMINATED,INTERVENTIONAL,Because the rate of recruitment was very slow
NCT02103543,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT02103998,WITHDRAWN,INTERVENTIONAL,not funded by NIH
NCT02104154,TERMINATED,OBSERVATIONAL,To conduct interim analysis and assess whether assay changes are recommended.
NCT02104336,TERMINATED,INTERVENTIONAL,Results from other studies did not support continuation of this trial
NCT02104414,TERMINATED,INTERVENTIONAL,low enrollment
NCT02105116,TERMINATED,INTERVENTIONAL,No patients were eligible to receive the experimental component of the protocol therapy.
NCT02105337,TERMINATED,OBSERVATIONAL,PI leaving institution
NCT02105350,WITHDRAWN,INTERVENTIONAL,Study was never initiated
NCT02105363,TERMINATED,OBSERVATIONAL,loss of research support
NCT02105597,WITHDRAWN,INTERVENTIONAL,Poor patient recruitment
NCT02105623,TERMINATED,INTERVENTIONAL,"Slow enrollement, Low Follow-up rate"
NCT02106091,TERMINATED,INTERVENTIONAL,Non-favorable risk/benefit profile with studied dosing regimen
NCT02106364,WITHDRAWN,INTERVENTIONAL,Lilly's decision to cancel this trial is due to regulatory uncertainty in China.
NCT02106520,TERMINATED,INTERVENTIONAL,DSMB's decision following the first step analysis
NCT02106689,TERMINATED,INTERVENTIONAL,This study is terminated due to an inability to recruit a sufficient number of participants.
NCT02106871,WITHDRAWN,INTERVENTIONAL,Study did not get funded. Study never started
NCT02107118,WITHDRAWN,INTERVENTIONAL,Contract issues
NCT02107222,WITHDRAWN,INTERVENTIONAL,This action is an internal decision that was not made because of any pending regulatory action for these products.
NCT02107378,TERMINATED,INTERVENTIONAL,sponsor decision
NCT02107495,TERMINATED,OBSERVATIONAL,Optimize calibration
NCT02107521,TERMINATED,INTERVENTIONAL,broken equipment
NCT02107560,TERMINATED,OBSERVATIONAL,"Because of small number of enrolled patients, we terminated this study."
NCT02107859,TERMINATED,INTERVENTIONAL,"Based on the results of study PTC124-GD-021-CF (NCT02139306), clinical development of ataluren in cystic fibrosis was discontinued and this study was closed."
NCT02107924,WITHDRAWN,OBSERVATIONAL,No Funding
NCT02108548,TERMINATED,INTERVENTIONAL,Gastrointestinal safety findings
NCT02108587,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT02108613,WITHDRAWN,INTERVENTIONAL,It was deemed not enough funding and the initial funding returned and study withdrawn (never opened and no recruitment happened.
NCT02108743,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02108899,SUSPENDED,INTERVENTIONAL,Difficulty in recruitment
NCT02108951,TERMINATED,INTERVENTIONAL,Study was terminated because of slow recruitment
NCT02109081,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT02109198,WITHDRAWN,INTERVENTIONAL,protocol withdrawn
NCT02109224,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT02109237,WITHDRAWN,INTERVENTIONAL,no funding
NCT02109276,WITHDRAWN,INTERVENTIONAL,not enough participants
NCT02109289,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02109432,TERMINATED,INTERVENTIONAL,Continued development of technology
NCT02109445,TERMINATED,INTERVENTIONAL,The study was terminated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination
NCT02109536,TERMINATED,OBSERVATIONAL,"As the study progressed, the intervention became more of a standard of care, thus the study has stalled and been aborted."
NCT02109627,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02109653,WITHDRAWN,INTERVENTIONAL,Study never started - transferred to Array.
NCT02109809,TERMINATED,INTERVENTIONAL,Slow Accruals
NCT02110069,TERMINATED,INTERVENTIONAL,"This study was challenged by the incidence of KHE with KMP as this continued to be extremely rare, and very sporadic. In July of 2019 grant renewal funding ended."
NCT02110212,TERMINATED,INTERVENTIONAL,"FDA approval received for product, no additional study subjects required."
NCT02110251,TERMINATED,INTERVENTIONAL,Difficulties with including patients
NCT02110277,TERMINATED,INTERVENTIONAL,"Dr Zhu, collaborator and the inventor of the photoacoustic system, is leaving the institution and it is not feasible to conduct the study without the machine."
NCT02110316,WITHDRAWN,INTERVENTIONAL,no eligible patients; study stopped without inclusion
NCT02110381,TERMINATED,INTERVENTIONAL,It was a pilot study and we enrolled sufficient numbers to evaluate the proposed outcomes.
NCT02110563,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02110784,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02110849,WITHDRAWN,OBSERVATIONAL,Closure of IU Health Proton Facility
NCT02110953,TERMINATED,INTERVENTIONAL,IRB study closure by investigator due to low enrollment
NCT02110992,TERMINATED,INTERVENTIONAL,slow accrual
NCT02111018,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02111031,WITHDRAWN,OBSERVATIONAL,The company decided not to start the study.
NCT02111096,TERMINATED,INTERVENTIONAL,The overall benefit-risk profile did not support continued development of LY2409021 for type 2 diabetes.
NCT02111304,WITHDRAWN,INTERVENTIONAL,Trial was never initiated due to PATH executive decision.
NCT02111382,WITHDRAWN,INTERVENTIONAL,The pilot study demonsttated some new concerns about methodology. So we decided to suspended temporarily to added new settings to study design.
NCT02111447,TERMINATED,INTERVENTIONAL,Not enough participants
NCT02111486,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT02111551,TERMINATED,INTERVENTIONAL,difficult to find participants and no funding
NCT02111785,TERMINATED,INTERVENTIONAL,Accrual too slow; Study P.I. passed away.
NCT02111824,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02111863,TERMINATED,INTERVENTIONAL,Study terminated due to low accrual and change in research focus.
NCT02111902,WITHDRAWN,OBSERVATIONAL,"At the direction of our IRB, this project was incorporated into an existing study, LU#200038, NCT#02925156"
NCT02112045,TERMINATED,INTERVENTIONAL,Terminated due to results of interim analysis
NCT02112162,TERMINATED,INTERVENTIONAL,Loss of funding
NCT02112240,WITHDRAWN,INTERVENTIONAL,No accrual. New study opening with modified technique.
NCT02112253,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT02112318,TERMINATED,OBSERVATIONAL,Opposite trend after interim analysis
NCT02112552,TERMINATED,INTERVENTIONAL,Low accrual. Study formally terminated by PI on 12/1/2017
NCT02112630,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT02112643,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02112682,TERMINATED,INTERVENTIONAL,slow accrual rate
NCT02112942,TERMINATED,INTERVENTIONAL,Early termination of IDX21459 was due to integration of Merck's HCV antiviral pipeline has resulted in revisions of the clinical development plan.
NCT02113007,TERMINATED,INTERVENTIONAL,Closed early due to slow accrual.
NCT02113046,TERMINATED,INTERVENTIONAL,interim analysis does not show good results
NCT02113176,WITHDRAWN,INTERVENTIONAL,Funding of minocycline
NCT02113189,TERMINATED,INTERVENTIONAL,Inadequate funding to continue the study
NCT02113215,TERMINATED,OBSERVATIONAL,PI left UTMB
NCT02113267,TERMINATED,INTERVENTIONAL,"Combination slow recruitment, short shelf life for placebo and insufficient funding for further drug production (probably anyway sufficient number included)."
NCT02113280,WITHDRAWN,INTERVENTIONAL,Failed funding application.
NCT02113397,TERMINATED,OBSERVATIONAL,Insufficient enrollment
NCT02113553,TERMINATED,INTERVENTIONAL,target population not reached
NCT02113683,TERMINATED,OBSERVATIONAL,insufficient recruitment on the part of clinic; study will not resume
NCT02113722,WITHDRAWN,INTERVENTIONAL,Study already undertaken at another centre
NCT02113735,WITHDRAWN,INTERVENTIONAL,A company decision was made not to proceed with the study.
NCT02113826,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02113891,WITHDRAWN,INTERVENTIONAL,disengagement of the sponsor Alexion Pharmaceuticals
NCT02114112,TERMINATED,INTERVENTIONAL,"Due to new respiratory quality control initiative introduced in the NICU, recruitment for the study was stopped."
NCT02114489,TERMINATED,INTERVENTIONAL,Troubles recruiting patients
NCT02114528,TERMINATED,INTERVENTIONAL,Low recruitment. Pilot trial.
NCT02114606,TERMINATED,INTERVENTIONAL,Cytosponge device availability
NCT02114697,TERMINATED,INTERVENTIONAL,The study was stopped when the original principal investigator moved to a new institution.
NCT02114827,TERMINATED,INTERVENTIONAL,study closed due to slow accrual
NCT02115035,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT02115048,TERMINATED,INTERVENTIONAL,Study was completed as per amended protocol. Protocol was amended to close enrollment earlier than initially planned (study continued as per plan).
NCT02115256,TERMINATED,INTERVENTIONAL,difficult recruitment
NCT02115386,TERMINATED,INTERVENTIONAL,Study was terminated by Novartis
NCT02115464,TERMINATED,INTERVENTIONAL,The accrual rate was not high enough to reach the target sample size.
NCT02115503,TERMINATED,OBSERVATIONAL,Insufficient enrollment
NCT02115594,WITHDRAWN,INTERVENTIONAL,Internal decision
NCT02115672,WITHDRAWN,INTERVENTIONAL,loss of support
NCT02115737,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02115919,TERMINATED,INTERVENTIONAL,Unable to enroll prospective subject for dose escalation
NCT02115971,TERMINATED,INTERVENTIONAL,The recruitment process could not provide us with enough participants
NCT02116062,TERMINATED,INTERVENTIONAL,The results concerning amniotic membrane transplantation (n=7) and robot-assisted pterygium surgery (n=5) were conclusive
NCT02116218,WITHDRAWN,INTERVENTIONAL,The study was terminated and the PI has left the institution.
NCT02116322,TERMINATED,INTERVENTIONAL,The study stopped as the used needle was difficult to maneuver in the corkscrew method being studied so no more participants were included.
NCT02116400,WITHDRAWN,OBSERVATIONAL,The primary investigator moved.
NCT02116595,WITHDRAWN,INTERVENTIONAL,not funded
NCT02116634,WITHDRAWN,INTERVENTIONAL,Because economic problems
NCT02116660,TERMINATED,INTERVENTIONAL,This study was terminated early due to poor recruitment.
NCT02116946,TERMINATED,INTERVENTIONAL,79% participant retention after 1 year
NCT02116959,TERMINATED,INTERVENTIONAL,Low accrual
NCT02117024,TERMINATED,INTERVENTIONAL,Sponsor Decision; strategic - based on changing treatment landscape
NCT02117050,TERMINATED,INTERVENTIONAL,recruitment challenges
NCT02117076,TERMINATED,INTERVENTIONAL,Recruitment unsuccessful due to overly restrictive inclusion/exclusion criteria.
NCT02117336,SUSPENDED,INTERVENTIONAL,Sponsor decision not related to patient safety
NCT02117349,TERMINATED,INTERVENTIONAL,Non-safety device related issues
NCT02117440,TERMINATED,OBSERVATIONAL,PI left institution
NCT02117466,TERMINATED,INTERVENTIONAL,Primary endpoint could no longer be reached.
NCT02117479,TERMINATED,INTERVENTIONAL,The study was terminated early based on the results of the planned interim analysis.
NCT02117817,WITHDRAWN,INTERVENTIONAL,Research cancelled
NCT02118116,WITHDRAWN,INTERVENTIONAL,unable to recruit participants due to political issues
NCT02118311,WITHDRAWN,INTERVENTIONAL,Changing study design. Will replace with a different protocol.
NCT02118493,WITHDRAWN,INTERVENTIONAL,The protocol has been withdrawn for re-evaluation.
NCT02118584,TERMINATED,INTERVENTIONAL,"The study was terminated due to program discontinuation, based on mixed efficacy results in the parent studies. There were no safety concerns."
NCT02118597,TERMINATED,OBSERVATIONAL,Study terminated due to the Sponsor's decision.
NCT02118688,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02119000,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT02119273,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02119533,TERMINATED,OBSERVATIONAL,PI has left the institution.
NCT02119650,TERMINATED,INTERVENTIONAL,The study was terminated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.
NCT02119663,TERMINATED,INTERVENTIONAL,The safety committee found no safety issues but recommended halting the study based on a lack of efficacy in a similar trial. The sponsor terminated the trial.
NCT02119676,TERMINATED,INTERVENTIONAL,Substudy 1 was terminated for futility at interim analysis and Substudy 2 was terminated per sponsor decision.
NCT02119806,WITHDRAWN,INTERVENTIONAL,Study was never initiated.
NCT02119936,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02120027,TERMINATED,INTERVENTIONAL,Because of negative results of the sister study NAK-06 and the low overall response rate at week 24.
NCT02120118,WITHDRAWN,INTERVENTIONAL,Taiwan FDA asked for seperating this protocol into one disease site per protocol.
NCT02120261,TERMINATED,INTERVENTIONAL,"lack of activity, Primary researcher moved to another institution"
NCT02120274,TERMINATED,INTERVENTIONAL,New Brazilian Guidelines for Viral Hepatitis C and Coinfetions. It does not include the treatment of chronic HCV Metavir \< F3 and abandon the use of interferon.
NCT02120339,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02120417,TERMINATED,INTERVENTIONAL,The study was terminated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.
NCT02120482,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02120755,WITHDRAWN,INTERVENTIONAL,Never Started
NCT02121158,TERMINATED,INTERVENTIONAL,Results of the pilot were not enough to justify the extension of the pilot. Results presented are from pilot.
NCT02121405,SUSPENDED,INTERVENTIONAL,DSMB stopped this trial due to the difference of 3-year DFS's rate between two groups more than 5% at the interim analysis in July 2021.
NCT02121600,TERMINATED,INTERVENTIONAL,Low accrual
NCT02121899,TERMINATED,OBSERVATIONAL,company decision to terminate
NCT02121925,TERMINATED,OBSERVATIONAL,Company decision to terminate
NCT02121977,TERMINATED,INTERVENTIONAL,Astora business is closing
NCT02122003,TERMINATED,INTERVENTIONAL,availability of new and more promising therapeutic agents than expected in the experimentation in question
NCT02122133,TERMINATED,OBSERVATIONAL,Business decision to focus on other studies. No safety concern.
NCT02122146,TERMINATED,INTERVENTIONAL,The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.
NCT02122159,WITHDRAWN,INTERVENTIONAL,Study to be revised. Future plans to be determined.
NCT02122185,SUSPENDED,INTERVENTIONAL,Enrollment halted for planned interim analysis.
NCT02122302,WITHDRAWN,INTERVENTIONAL,Study was terminated due to unsuccessful accrual.
NCT02122341,TERMINATED,INTERVENTIONAL,Study has halted prematurely as we were not able to meet our target accrual.
NCT02122835,WITHDRAWN,INTERVENTIONAL,Lack of funding/patient availability
NCT02123147,WITHDRAWN,OBSERVATIONAL,due to the lack of funding to continue
NCT02123160,TERMINATED,INTERVENTIONAL,Loss of staff
NCT02123238,WITHDRAWN,INTERVENTIONAL,no funding
NCT02123485,TERMINATED,INTERVENTIONAL,recruiting of patients difficult combined by lack of money
NCT02123498,WITHDRAWN,INTERVENTIONAL,IRB not approved
NCT02123576,TERMINATED,INTERVENTIONAL,Poor enrollment of study population
NCT02123966,TERMINATED,INTERVENTIONAL,"Due to slow accrual, study team has decided to end the study early."
NCT02123992,TERMINATED,INTERVENTIONAL,Astora business is closing
NCT02124265,TERMINATED,INTERVENTIONAL,Intervention appeared to be associated with increased nausea in some patients.
NCT02124291,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02124369,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02124447,WITHDRAWN,INTERVENTIONAL,Protocol issues. Modifications potentially will be undertaken and resubmitted to IRB
NCT02124785,WITHDRAWN,INTERVENTIONAL,This study has been cancelled before initiation due to company's prioritisation decisions linked to resources restrictions.
NCT02124902,TERMINATED,INTERVENTIONAL,Insufficient funding/staff
NCT02125266,TERMINATED,INTERVENTIONAL,Study terminated due to unacceptable frequency of drug related adverse events
NCT02125331,TERMINATED,OBSERVATIONAL,Data collection requirment complete
NCT02125617,TERMINATED,OBSERVATIONAL,Poor recruition
NCT02125643,TERMINATED,INTERVENTIONAL,Protocol was deem insufficient to answer research question
NCT02125708,WITHDRAWN,INTERVENTIONAL,no acitve participants
NCT02126020,WITHDRAWN,INTERVENTIONAL,No patients met eligibility criteria. The study has been closed.
NCT02126527,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT02127073,TERMINATED,INTERVENTIONAL,Could not identify collaborator and secure additional funding after transferring the record to Montefiore Medical Center
NCT02127151,WITHDRAWN,INTERVENTIONAL,Withdrawal of Industry support for the study
NCT02127229,WITHDRAWN,INTERVENTIONAL,No participants enrolled; study inactivated
NCT02127372,TERMINATED,INTERVENTIONAL,The study was closed due to poor accrual
NCT02127684,WITHDRAWN,INTERVENTIONAL,sponsor determined study design would not produce useful results
NCT02127892,TERMINATED,INTERVENTIONAL,Closed due to slow accrual. Nine subjects enrolled over 7 years.
NCT02127905,WITHDRAWN,INTERVENTIONAL,Study was stopped due to non-enrollment of subjects due to rarity of disease.
NCT02128230,TERMINATED,INTERVENTIONAL,Low enrollment and Futility as determined by Amgen's Carfilzomib NASCR program.
NCT02128269,TERMINATED,INTERVENTIONAL,Screening discontinued early due to slow patient enrollment
NCT02128373,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02128503,TERMINATED,INTERVENTIONAL,sample size recruited is not enough
NCT02128568,WITHDRAWN,INTERVENTIONAL,Did not receive funding
NCT02128672,WITHDRAWN,INTERVENTIONAL,stopped because of competing studies
NCT02128841,TERMINATED,INTERVENTIONAL,not enough patients
NCT02129062,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02129166,WITHDRAWN,INTERVENTIONAL,PI resigned
NCT02129205,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in sponsor prioritization.
NCT02129322,WITHDRAWN,INTERVENTIONAL,patients not enrolled
NCT02129335,TERMINATED,OBSERVATIONAL,insufficient enrollment
NCT02129400,TERMINATED,INTERVENTIONAL,The analysis of the blood samples was much expensive than calculated. The recruitment had to be stopped after 36 study participants.
NCT02129426,TERMINATED,INTERVENTIONAL,Unable to recruit the adequate number of subjects
NCT02130037,WITHDRAWN,INTERVENTIONAL,no grants
NCT02130128,TERMINATED,INTERVENTIONAL,Sufficient clinical evidence was gathered
NCT02130388,TERMINATED,INTERVENTIONAL,Slow Recruitment and funds no longer available.
NCT02130492,SUSPENDED,INTERVENTIONAL,Temporarily interrupted due to lack of funding: will re-open in the near future
NCT02130622,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02130765,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment rate.
NCT02130817,WITHDRAWN,INTERVENTIONAL,Organ transplant criteria made recruitment difficult. Closed with IRB 10/09/2015.
NCT02130934,WITHDRAWN,OBSERVATIONAL,Slow accrual
NCT02130947,WITHDRAWN,INTERVENTIONAL,We were not able to accrue any participants.
NCT02131012,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT02131207,TERMINATED,OBSERVATIONAL,Principal Investigator Left Institution
NCT02131376,TERMINATED,INTERVENTIONAL,"slow accrual, interim analysis showed no statistical significance"
NCT02131415,TERMINATED,OBSERVATIONAL,Slow enrollment combined with positive preliminary results
NCT02131506,TERMINATED,INTERVENTIONAL,Safety reasons
NCT02131818,TERMINATED,INTERVENTIONAL,The enrollment process is too difficult to complete
NCT02131896,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02132221,TERMINATED,INTERVENTIONAL,Enrollment too slow given study timeline
NCT02132403,TERMINATED,INTERVENTIONAL,Drug Recall
NCT02132429,TERMINATED,INTERVENTIONAL,The study was stopped due to an administrative decision not safety.
NCT02132598,TERMINATED,INTERVENTIONAL,Trial stopped due to slow patient accrual.
NCT02132884,TERMINATED,INTERVENTIONAL,Feasibility
NCT02133183,TERMINATED,INTERVENTIONAL,Other - Lapse in funding
NCT02133248,TERMINATED,OBSERVATIONAL,enrollment issues due to COVID-19 related research suspension and PI left the institution
NCT02133274,TERMINATED,INTERVENTIONAL,Planned interim analysis did not show the expected benefit of intervention A over B (effect size \<0.2).
NCT02133365,SUSPENDED,INTERVENTIONAL,Changes in availability of study personnel
NCT02133521,TERMINATED,INTERVENTIONAL,"Very low recruitment rate. The Study Sites classified as tertiary referral hospital. Therefore, patients being referred to the site are mostly those with comorbidities included in the exclusion criteria."
NCT02133534,TERMINATED,INTERVENTIONAL,failure to enroll
NCT02133885,WITHDRAWN,INTERVENTIONAL,This study was never started and no participants were enrolled.
NCT02134002,WITHDRAWN,INTERVENTIONAL,"Too selective recrutment criteria, none eligible patients"
NCT02134015,TERMINATED,INTERVENTIONAL,Pre-defined criteria for continuation were not reached
NCT02134080,TERMINATED,INTERVENTIONAL,no more funding available
NCT02134106,WITHDRAWN,INTERVENTIONAL,The target cannot be achieved within timeline due to delay of ethics approval
NCT02134288,TERMINATED,INTERVENTIONAL,Drug unavailability due to a manufacturing transition.
NCT02134327,WITHDRAWN,INTERVENTIONAL,Decided not to proceed
NCT02134366,TERMINATED,INTERVENTIONAL,Recruitment Issues - Lack of target population
NCT02134522,TERMINATED,INTERVENTIONAL,We were not able to recruit participants.
NCT02134652,WITHDRAWN,OBSERVATIONAL,Unable to conduct study because of political issues in host country.
NCT02134704,TERMINATED,INTERVENTIONAL,All patients were recruted but it has been difficulte to recrute all volunteers (15/30) . However data should be sufficient for analyse of data.
NCT02134717,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02134782,TERMINATED,INTERVENTIONAL,The study was closed early for poor accrual when 125/210 planned participants had been enrolled and randomized to yoga (n=62) or iPad (n=63).
NCT02134886,TERMINATED,INTERVENTIONAL,No Accrual
NCT02134912,TERMINATED,INTERVENTIONAL,science has moved forward and there is no intent to complete the study
NCT02135354,TERMINATED,INTERVENTIONAL,slow recruitment
NCT02135666,WITHDRAWN,INTERVENTIONAL,This study has been cancelled before initiation due to company's prioritisation decisions linked to resources restrictions.
NCT02135926,TERMINATED,INTERVENTIONAL,Results from other RCT made randomization unethical.
NCT02136251,WITHDRAWN,OBSERVATIONAL,Funding was not obtained to complete study
NCT02136342,TERMINATED,INTERVENTIONAL,Study site change
NCT02136537,TERMINATED,INTERVENTIONAL,Member of staff moved on to training post. Trial halted and terminated
NCT02136706,WITHDRAWN,INTERVENTIONAL,Sponsor and site were unable to complete a final contract to support the study
NCT02136758,TERMINATED,INTERVENTIONAL,Funding cut due to government sequestration
NCT02137096,TERMINATED,INTERVENTIONAL,"This is a rare disease, and enrollment was poor."
NCT02137148,WITHDRAWN,OBSERVATIONAL,Study was cancelled
NCT02137200,TERMINATED,INTERVENTIONAL,Recruitment for this study has ended and follow-up of enrolled participants is ongoing. For additional information contact the PIs.
NCT02137252,TERMINATED,INTERVENTIONAL,no enough patients
NCT02137265,WITHDRAWN,INTERVENTIONAL,No funding obtained
NCT02137343,TERMINATED,INTERVENTIONAL,All Amgen sponsored AMG102 clinical studies were terminated following a pre-planned Data Monitoring Committee safety review of study 20070622.
NCT02137408,WITHDRAWN,INTERVENTIONAL,PI no longer at Institution
NCT02137525,WITHDRAWN,INTERVENTIONAL,Study was never initiated
NCT02137564,WITHDRAWN,INTERVENTIONAL,Drug supply unavailable
NCT02137681,WITHDRAWN,INTERVENTIONAL,No eligible patient was enrolled.
NCT02137811,WITHDRAWN,OBSERVATIONAL,Company decided to remove CLIA test from Market.
NCT02137837,TERMINATED,INTERVENTIONAL,lack of accrual
NCT02137876,WITHDRAWN,OBSERVATIONAL,Subject recruitment was unsuccessful.
NCT02137889,TERMINATED,INTERVENTIONAL,Study terminated on 04Oct2013 for business reasons after being on hold for 10 months. Early termination was not due to safety concerns.
NCT02137915,TERMINATED,OBSERVATIONAL,Based on a business decision unrelated to any safety concerns.
NCT02138032,TERMINATED,INTERVENTIONAL,Student study which ended at the end of their course.
NCT02138110,TERMINATED,INTERVENTIONAL,Primary Endpoint not met in follow-up study (InVivo-100-105)
NCT02138175,WITHDRAWN,OBSERVATIONAL,Sponsor (Masimo) suspended trial due to change in corporate ownership
NCT02138357,WITHDRAWN,INTERVENTIONAL,No funding
NCT02138409,WITHDRAWN,INTERVENTIONAL,Sponsor elected not to continue with study.
NCT02138578,TERMINATED,INTERVENTIONAL,"Due to changes in scanning procedure, and infeasible biopsy and baseline imaging, the trial closed for poor accrual and inability to follow patients."
NCT02138630,WITHDRAWN,INTERVENTIONAL,Project abandoned
NCT02138656,TERMINATED,INTERVENTIONAL,Review of recruitment methods
NCT02138708,WITHDRAWN,INTERVENTIONAL,Lack of financing
NCT02138786,TERMINATED,INTERVENTIONAL,Lack of efficacy at time of interim analysis
NCT02138812,TERMINATED,INTERVENTIONAL,"As another Mps1 inhibitor was being developed in parallel, the strategic decision was to move forward with the development of the follow up compound only."
NCT02138825,TERMINATED,INTERVENTIONAL,"Study terminated per recommendation of iDMC. On iDMC request, protocol amended to include 4-month safety follow-up for patients after withdrawal of riociguat."
NCT02138838,TERMINATED,INTERVENTIONAL,Amgen decided to terminate the study early to be able to meet US regulatory timelines fo filing. Subjects in treatment were rolled over to the 20140159 study.
NCT02138942,TERMINATED,INTERVENTIONAL,non-compliance with the protocol. Arrest requested by the Monitoring Safety committee
NCT02139098,TERMINATED,INTERVENTIONAL,Recruiting problems because of the time expenditure required for participating and the strict criteria of inclusion and exclusion
NCT02139150,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT02139384,WITHDRAWN,OBSERVATIONAL,The study was withdrawn due to inability to enroll patients in a timely fashion.
NCT02139475,TERMINATED,OBSERVATIONAL,All the patients who had been targeted were registered.
NCT02139527,TERMINATED,OBSERVATIONAL,Low enrollment and follow-up data on enrolled patients.
NCT02139709,WITHDRAWN,INTERVENTIONAL,REB Approval expired.
NCT02139761,WITHDRAWN,INTERVENTIONAL,Study funding has not been established
NCT02139774,TERMINATED,OBSERVATIONAL,inadequate accrual
NCT02139852,WITHDRAWN,OBSERVATIONAL,Project abandoned
NCT02140112,TERMINATED,INTERVENTIONAL,A preliminary analysis of data from this trial failed to demonstrate any signal of activity.
NCT02140138,TERMINATED,INTERVENTIONAL,Recruitment was terminated after enrolment of 35 instead of 36 evaluable patients for administrative reasons.
NCT02140437,WITHDRAWN,INTERVENTIONAL,The progress of enrollment is too slow.
NCT02140684,SUSPENDED,OBSERVATIONAL,suspended due to lack of data.
NCT02140788,TERMINATED,INTERVENTIONAL,PI left institution
NCT02140840,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT02140879,WITHDRAWN,INTERVENTIONAL,IRB closed on 9/5/2018
NCT02141178,WITHDRAWN,INTERVENTIONAL,No IRB approval
NCT02141360,TERMINATED,INTERVENTIONAL,Sponser terminated early to start a larger feasability study
NCT02141477,TERMINATED,INTERVENTIONAL,Slow Accrual-2 patients were registered Phase I and none in Phase II
NCT02141568,TERMINATED,INTERVENTIONAL,Low patient compliance and dropout during the period defined for the study
NCT02141646,TERMINATED,INTERVENTIONAL,This research was not conducted at UNM \& not Applicable Clinical Trial.
NCT02141841,WITHDRAWN,OBSERVATIONAL,because the study is very complicated and cannot be performed in the practice
NCT02142192,TERMINATED,INTERVENTIONAL,Sponsor's decision.
NCT02142569,WITHDRAWN,INTERVENTIONAL,We were unable to procure the supplement for this study.
NCT02142725,TERMINATED,INTERVENTIONAL,IDMC recommendation
NCT02142998,SUSPENDED,INTERVENTIONAL,On hold due to poor enrollment and high drop-out rate.
NCT02143050,WITHDRAWN,INTERVENTIONAL,No participant enrollment
NCT02143141,TERMINATED,INTERVENTIONAL,feasibility of population needed to complete study
NCT02143804,WITHDRAWN,INTERVENTIONAL,Change in trial design
NCT02144142,WITHDRAWN,INTERVENTIONAL,This sub-study was not done because main study results reached significance.
NCT02144155,TERMINATED,INTERVENTIONAL,Break in funding
NCT02144233,TERMINATED,INTERVENTIONAL,Interim analysis showed benefice of one therapy over the other one.
NCT02144350,TERMINATED,INTERVENTIONAL,slow recruitment
NCT02144441,WITHDRAWN,INTERVENTIONAL,"Very few patients met eligibility criteria, none of whom elected to enroll."
NCT02144688,TERMINATED,INTERVENTIONAL,"In 14 participants who had LP, very low level viremia was found in only 1"
NCT02144753,TERMINATED,INTERVENTIONAL,"Per DSMB, study fiber had given subjects more adverse events and made their IBS symptoms worse than the psyllium group."
NCT02144831,WITHDRAWN,INTERVENTIONAL,Could not get study started
NCT02145039,TERMINATED,INTERVENTIONAL,Replaced by another study.
NCT02145078,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02145299,TERMINATED,INTERVENTIONAL,The study was stopped due to insufficient numbers of subjects to meet study design objectives.
NCT02145390,TERMINATED,INTERVENTIONAL,Investigator Decision - Insufficient Accrual
NCT02145598,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02145650,WITHDRAWN,OBSERVATIONAL,Study suspended due to company decision prior to enrollment.
NCT02145689,WITHDRAWN,INTERVENTIONAL,The study was withdrawn prior to enrollment due to corporate decision.
NCT02145702,TERMINATED,INTERVENTIONAL,Funding has expired
NCT02145910,WITHDRAWN,INTERVENTIONAL,Study was never opened to accrual. There is no clinical benefit to patients.
NCT02145988,TERMINATED,INTERVENTIONAL,Recruitment rate is unexpectedly too low (insufficient number of eligible patients).
NCT02146508,SUSPENDED,INTERVENTIONAL,Medtronic owns Covidien \& closed study 11/18/15. Will reapply through Medtronic.
NCT02146521,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02146664,WITHDRAWN,INTERVENTIONAL,The investigational cases were no longer relevant considering the recent implementation of our current national healthcare system.
NCT02146729,WITHDRAWN,INTERVENTIONAL,Research personnel changes prevented study initiation and enrollment
NCT02146833,TERMINATED,INTERVENTIONAL,Due to enrollment challenges. The termination is not a consequence of any safety concern.
NCT02146937,WITHDRAWN,INTERVENTIONAL,Due to lack of accrual for this study. PI decided to close the study.
NCT02147132,TERMINATED,INTERVENTIONAL,Difficulty recruiting eligible participants; study medication was expiring.
NCT02147301,TERMINATED,INTERVENTIONAL,Risk to benefit ratio is not acceptable
NCT02147834,TERMINATED,INTERVENTIONAL,due to futility
NCT02147873,TERMINATED,INTERVENTIONAL,Study terminated due to lack of efficacy
NCT02147964,WITHDRAWN,INTERVENTIONAL,No funding was obtained for this study.
NCT02147990,TERMINATED,INTERVENTIONAL,Sponsor discontinued development of CO-1686 for NSCLC.
NCT02148003,TERMINATED,INTERVENTIONAL,Study terminated by Principal Investigator
NCT02148055,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02148302,TERMINATED,INTERVENTIONAL,Stopped by sponsor. No interest in continuing trial due to business changes.
NCT02148367,WITHDRAWN,INTERVENTIONAL,Publication of recent trials showing no effect of EPO in TBI.
NCT02148419,TERMINATED,OBSERVATIONAL,"recruiting not successful, too few participants"
NCT02148783,TERMINATED,INTERVENTIONAL,Recruitment was slower than anticipated. Incomplete neuropsychological outcome measures obtained.
NCT02149017,TERMINATED,INTERVENTIONAL,SNUH-NM-333 ligand effect was judged to be insufficient.
NCT02149095,WITHDRAWN,INTERVENTIONAL,Study will not be conducted
NCT02149173,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT02149277,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT02149771,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT02149823,TERMINATED,INTERVENTIONAL,All study proceedings stopped prematurely due to Covid-19 restrictions for intranasal formulations
NCT02149901,TERMINATED,INTERVENTIONAL,funding terminated
NCT02150161,TERMINATED,INTERVENTIONAL,DSMB estimated futility of the trial and safety risk
NCT02150447,TERMINATED,INTERVENTIONAL,Low enroll rate
NCT02150785,WITHDRAWN,INTERVENTIONAL,Could not get study started.
NCT02150863,TERMINATED,INTERVENTIONAL,Difficulty enrolling participants due to exclusion and inclusion criteria
NCT02150941,TERMINATED,INTERVENTIONAL,Enrollment too slow to complete the trial in a reasonable amount of time.
NCT02150967,TERMINATED,INTERVENTIONAL,"The study was terminated early due to limited efficacy in Cohorts 2 and 3 (exploratory endpoints). Termination was not due to concerns about safety and had no impact on the primary efficacy analysis (ie, results reported for Cohort 1)."
NCT02151019,TERMINATED,INTERVENTIONAL,Due to futility
NCT02151331,TERMINATED,INTERVENTIONAL,Sponsor requested termination due to low recruitment numbers
NCT02151357,TERMINATED,INTERVENTIONAL,catheter occlusion events during the study drug infusion
NCT02151383,TERMINATED,INTERVENTIONAL,Study terminated early based on Adult AHF study CRLX030A2301 results
NCT02151474,TERMINATED,INTERVENTIONAL,Business decision.
NCT02151539,TERMINATED,OBSERVATIONAL,Low accrual
NCT02151903,TERMINATED,INTERVENTIONAL,Clinical benefit was noted before the scheduled completion of the trial and the extension study was terminated early.
NCT02152059,WITHDRAWN,INTERVENTIONAL,contract issues
NCT02152072,WITHDRAWN,OBSERVATIONAL,No Participant Enrolled
NCT02152514,TERMINATED,INTERVENTIONAL,Due to technical details recruitment was unreasonably slow
NCT02152566,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT02152644,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02152670,TERMINATED,INTERVENTIONAL,Study drug became unaffordable for the purposes of the research.
NCT02152930,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02152956,TERMINATED,INTERVENTIONAL,Business decision
NCT02153177,WITHDRAWN,INTERVENTIONAL,The study was withdrawn prior to any participants being enrolled.
NCT02153255,WITHDRAWN,OBSERVATIONAL,Closure of Gait Analysis Laboratory - unable to set up alternative gait laboratory in time for funders
NCT02153424,WITHDRAWN,OBSERVATIONAL,Business objectives have changed.
NCT02153593,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT02153840,TERMINATED,INTERVENTIONAL,Paitents were unwilling to be randomly assigned to a placebo group.
NCT02153905,TERMINATED,INTERVENTIONAL,"Slow, insufficient accrual."
NCT02154009,TERMINATED,OBSERVATIONAL,Training protocol with no research objectives
NCT02154087,TERMINATED,INTERVENTIONAL,based on outcome of previous study
NCT02154230,WITHDRAWN,INTERVENTIONAL,failure to enroll
NCT02154321,WITHDRAWN,OBSERVATIONAL,Funding and resource restrictions.
NCT02154529,TERMINATED,INTERVENTIONAL,Sponsor closed the study due to lack of response.
NCT02154945,WITHDRAWN,OBSERVATIONAL,Did not go through with the study for logistical reasons
NCT02154984,TERMINATED,INTERVENTIONAL,Study closed due to funding before accrual was met
NCT02155140,TERMINATED,INTERVENTIONAL,Failed to recruit full number of patients
NCT02155309,TERMINATED,INTERVENTIONAL,Business reason
NCT02155634,WITHDRAWN,INTERVENTIONAL,The study was terminated due to poor feasibility and lack of interest at the participating sites.
NCT02155712,TERMINATED,INTERVENTIONAL,"Due to the pandemic, multiple sites were unable to complete patient visits resulting in less-than-optimal postoperative follow-up occurred. Therefore, study objectives were not met and the decision was made to close the study early."
NCT02155842,WITHDRAWN,INTERVENTIONAL,Unforseen problems recruiting patients
NCT02155972,TERMINATED,INTERVENTIONAL,The trial was terminated because of inability to recruit the needed number of participants
NCT02156076,TERMINATED,INTERVENTIONAL,"Sponsor decision based on business reasons, unrelated to safety"
NCT02156115,TERMINATED,OBSERVATIONAL,Study closed before total enrollment met.
NCT02156180,SUSPENDED,OBSERVATIONAL,Awaiting funding to facilitate selected-ion flow-tube mass spectrometry (SIFT/MS)
NCT02156219,SUSPENDED,OBSERVATIONAL,The STC has had financial limitations to start implementing the intervention.
NCT02156336,TERMINATED,INTERVENTIONAL,Not enough patients met study criteria for enrollment.
NCT02156674,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02157116,TERMINATED,INTERVENTIONAL,Insufficient accrual to meet analysis goals
NCT02157272,TERMINATED,INTERVENTIONAL,Unbalance in the composite endpoint between arms.
NCT02157363,TERMINATED,INTERVENTIONAL,poor recruitment due to change of surgical technique
NCT02157415,TERMINATED,INTERVENTIONAL,After consultation with a medical expert the Notified Body confirmed premature termination of the study.
NCT02157532,SUSPENDED,INTERVENTIONAL,Sites are not recruiting.
NCT02157545,WITHDRAWN,OBSERVATIONAL,No eligible subjects identified. Study closed with IRB.
NCT02158013,TERMINATED,INTERVENTIONAL,Slow inclusion rate
NCT02158078,TERMINATED,OBSERVATIONAL,Terminated to allow continued optimization of the product.
NCT02158754,WITHDRAWN,OBSERVATIONAL,Study halted due to low investigator involvement; no patients enrolled in study.
NCT02158832,WITHDRAWN,INTERVENTIONAL,The study Principal Investigator relocated and the grant funding the trial expired.
NCT02159183,TERMINATED,INTERVENTIONAL,"5-Y FUP will not result in new perception, no diff. between groups at 1+3y FUP"
NCT02159222,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02159248,WITHDRAWN,INTERVENTIONAL,The study closed prior to enrolling any participants.
NCT02159482,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02159664,TERMINATED,INTERVENTIONAL,difficulty to recrut patients
NCT02159690,WITHDRAWN,INTERVENTIONAL,loss of funding
NCT02159794,WITHDRAWN,INTERVENTIONAL,HLT determined that design changes are necessary before reopening a study
NCT02160288,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02160301,WITHDRAWN,INTERVENTIONAL,Insufficient infrastructure/funding for enrollment
NCT02160431,TERMINATED,INTERVENTIONAL,Inadequate funding
NCT02160483,WITHDRAWN,INTERVENTIONAL,This study is not feasible to conduct as functional brain imaging capability is inadequate. CIRB acknowledged in June 2016.
NCT02160535,TERMINATED,INTERVENTIONAL,Study discontinued due to difficulty in enrolling eligible subjects
NCT02160704,WITHDRAWN,INTERVENTIONAL,Difficult eligibility and lack of funding
NCT02160730,TERMINATED,INTERVENTIONAL,NIH grant ended.
NCT02160834,WITHDRAWN,INTERVENTIONAL,study not initiated
NCT02161016,TERMINATED,INTERVENTIONAL,slow recruitment
NCT02161185,TERMINATED,INTERVENTIONAL,Study terminated due to slow enrollment. There were no safety concerns.
NCT02161354,TERMINATED,INTERVENTIONAL,safety and efficacy after cohort 5 did not warrant further dose escalation
NCT02161484,TERMINATED,INTERVENTIONAL,The computer is crushed and all data is lost (IT was not able to recover it. Last data was collected 6.17.14)
NCT02161679,WITHDRAWN,INTERVENTIONAL,FDA asked to administratively split from IND115621- to open a new IND you need to file a protocol we only drafted it to get the IND open - never initiated
NCT02161705,TERMINATED,INTERVENTIONAL,Poor accrual due to change in standard of care procedure.
NCT02161744,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02161861,TERMINATED,INTERVENTIONAL,the trial was discontinued for legislative reasons.
NCT02162004,TERMINATED,INTERVENTIONAL,Technical problems
NCT02162225,WITHDRAWN,INTERVENTIONAL,Enrollment was very slow. Hope to reopen as multi-site study
NCT02162433,TERMINATED,INTERVENTIONAL,Terminated due to a high number of protocol deviations secondary to non-study approved opioid administration.
NCT02162537,TERMINATED,INTERVENTIONAL,Slow inclusions due in part to a change in practices. The first chemotherapy become a standard for patients with NSCL with asymptomatic brain metastases.
NCT02162628,TERMINATED,OBSERVATIONAL,Device voluntarily withdrawn from commercial use by manufacturer
NCT02162641,WITHDRAWN,OBSERVATIONAL,The study was terminated early as it failed to recruit.
NCT02162758,TERMINATED,INTERVENTIONAL,Business Decisions; No Safety Concerns
NCT02162810,TERMINATED,INTERVENTIONAL,We were unable to meet our enrollment goal necessary to analyze the outcome measures.
NCT02162979,TERMINATED,INTERVENTIONAL,Not enough subjects.
NCT02163005,WITHDRAWN,INTERVENTIONAL,No patients enrolled as study did not move to enrollment stage
NCT02163187,TERMINATED,INTERVENTIONAL,Study permanently closed due to low accrual
NCT02163200,WITHDRAWN,OBSERVATIONAL,due to technical issues
NCT02163239,TERMINATED,OBSERVATIONAL,Not meeting primary objective of the study
NCT02163330,TERMINATED,INTERVENTIONAL,difficulty in recruiting participants to the study
NCT02163356,TERMINATED,INTERVENTIONAL,drug supply
NCT02163551,TERMINATED,OBSERVATIONAL,Recurrent equipment failures (used with custom EEG and ERP recording software) precluded timely data collection and analysis activities.
NCT02163785,TERMINATED,INTERVENTIONAL,insufficient recruitment rate
NCT02163876,TERMINATED,INTERVENTIONAL,Based on a business decision unrelated to any safety concerns.
NCT02163915,TERMINATED,INTERVENTIONAL,To allow evaluation of emerging non-clinical data (see detailed description below)
NCT02164058,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02164097,TERMINATED,INTERVENTIONAL,low accrual
NCT02164175,WITHDRAWN,OBSERVATIONAL,Company acquired and trial was not pursued
NCT02164318,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02164565,WITHDRAWN,INTERVENTIONAL,Enrollment difficulties
NCT02164734,TERMINATED,INTERVENTIONAL,Slow to impossible recruitment during COVID-19 pandemic
NCT02164877,TERMINATED,INTERVENTIONAL,Not enough participants enrolled
NCT02164929,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02164942,TERMINATED,OBSERVATIONAL,Futility
NCT02165644,WITHDRAWN,INTERVENTIONAL,The PI is leaving the University of Florida.
NCT02165657,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants into trial
NCT02165670,WITHDRAWN,OBSERVATIONAL,After critique raised by peers there was a risk that the study could be interpreted as a marketing tool for a specific product more than a scientific study.
NCT02165813,TERMINATED,INTERVENTIONAL,Continuation of enrolment was deemed not feasible due to very small eligibility numbers and funding exhausted.
NCT02166190,TERMINATED,INTERVENTIONAL,Enrollment was feasibly not going to be reached.
NCT02166229,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled.
NCT02166294,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02166658,TERMINATED,INTERVENTIONAL,"After a recruitment of more than 2 years, only 8 patients have been registered."
NCT02166671,TERMINATED,INTERVENTIONAL,Participants were not recruited promptly
NCT02166775,TERMINATED,OBSERVATIONAL,Departure of psychologist in charge of questionnaires and scales administered to patients as part of the evaluation of primary endpoint
NCT02166827,TERMINATED,INTERVENTIONAL,Administrative decision
NCT02166983,WITHDRAWN,INTERVENTIONAL,PI left Stanford
NCT02167360,WITHDRAWN,INTERVENTIONAL,Did not enroll
NCT02167438,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02167451,TERMINATED,INTERVENTIONAL,slow recruitment and no further drug supply
NCT02167633,TERMINATED,INTERVENTIONAL,Due to low accrual rate
NCT02167685,TERMINATED,OBSERVATIONAL,terminated due to low enrollment rate
NCT02167698,TERMINATED,INTERVENTIONAL,Increased mortality in the intervention arm at 50% enrolment
NCT02168036,TERMINATED,OBSERVATIONAL,Study was terminated due to lack of funding.
NCT02168062,TERMINATED,INTERVENTIONAL,Funding
NCT02168179,WITHDRAWN,INTERVENTIONAL,No longer pursuing study at our site.
NCT02168257,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02168283,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02168725,TERMINATED,INTERVENTIONAL,The study was placed on hold by the FDA due to manufacturing issues and was not restarted.
NCT02168816,TERMINATED,INTERVENTIONAL,"The study was stopped for feasibility (i.e., low recruitment)"
NCT02168907,TERMINATED,INTERVENTIONAL,Slow Accruals
NCT02168920,TERMINATED,INTERVENTIONAL,It was difficult to secure enrollment of the targeted number of subjects.
NCT02169076,WITHDRAWN,INTERVENTIONAL,IRB Approval withdrawn
NCT02169336,TERMINATED,INTERVENTIONAL,Lack of observed efficacy
NCT02169375,TERMINATED,INTERVENTIONAL,Insufficient improvement in primary measures under either condition.
NCT02169505,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02169687,TERMINATED,INTERVENTIONAL,Protocol's modifications requested by IRB weren't feasible to continue the study
NCT02169739,TERMINATED,INTERVENTIONAL,COVID 19 restrictions
NCT02169752,TERMINATED,INTERVENTIONAL,PI left National Jewish Health
NCT02169830,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02169869,TERMINATED,INTERVENTIONAL,Change in local healthcare policies and practices
NCT02170012,TERMINATED,INTERVENTIONAL,The study was prematurely terminated on 17th December 2014 due to safety concerns.
NCT02170025,TERMINATED,INTERVENTIONAL,"Study was terminated after completion of Part 1, because Part 2 was no longer appropriate."
NCT02170272,TERMINATED,INTERVENTIONAL,Unable to obtain funding
NCT02170298,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02170350,TERMINATED,INTERVENTIONAL,Withdrawn by PI
NCT02170389,TERMINATED,INTERVENTIONAL,sponsor having financial difficulties
NCT02170480,TERMINATED,OBSERVATIONAL,PI is moving to another university; resident researcher does not wish to continue study with another PI.
NCT02170519,TERMINATED,INTERVENTIONAL,Project was completed
NCT02170948,TERMINATED,INTERVENTIONAL,Recruitment was very low
NCT02171091,TERMINATED,OBSERVATIONAL,Principal investigator leaving Washington University and halting studies
NCT02171351,WITHDRAWN,INTERVENTIONAL,Technical issue
NCT02172001,WITHDRAWN,INTERVENTIONAL,Study design not adequate
NCT02172027,WITHDRAWN,OBSERVATIONAL,Technical problems with the device
NCT02173431,WITHDRAWN,OBSERVATIONAL,due to technical issues
NCT02173470,TERMINATED,INTERVENTIONAL,Expected futility in reaching the primary endpoint
NCT02173522,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT02173990,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02174003,TERMINATED,OBSERVATIONAL,Investigator transferred to the University of Wisconsin - Madison
NCT02174016,SUSPENDED,INTERVENTIONAL,Funding
NCT02174094,WITHDRAWN,INTERVENTIONAL,The study was terminated due to recruitment challenges
NCT02174107,TERMINATED,INTERVENTIONAL,recruitment issues due to feasability issues in centers
NCT02174263,WITHDRAWN,INTERVENTIONAL,Study never opened due to lack of funds.
NCT02174328,TERMINATED,INTERVENTIONAL,Halted prematurely due to low recruitment rate.
NCT02174445,TERMINATED,INTERVENTIONAL,very slow recruitment rate and a lot of pat. didn't fulfil BCR-ABL requirements
NCT02174575,WITHDRAWN,INTERVENTIONAL,I retired my post before enrollment
NCT02174718,WITHDRAWN,INTERVENTIONAL,Due to manufacturing problems the transdermal patch was not produced.
NCT02174770,TERMINATED,INTERVENTIONAL,Lack of resources
NCT02175082,TERMINATED,INTERVENTIONAL,Terminated prior to enrollment goals due to difficulty with recruiting subjects
NCT02175134,TERMINATED,INTERVENTIONAL,low enrollment rate
NCT02175576,TERMINATED,INTERVENTIONAL,Data no longer required to meet regulatory requirements.
NCT02175654,TERMINATED,INTERVENTIONAL,The trial was prematurely closed due to lack of accrual
NCT02175745,TERMINATED,INTERVENTIONAL,Re-evaluate indication with the referring physicians
NCT02176057,WITHDRAWN,INTERVENTIONAL,Nepal Ministry of Health implemented public drug treatment prior to the proposed start date
NCT02176122,TERMINATED,INTERVENTIONAL,Secondary to third interim analysis by the study DSMB.
NCT02176486,TERMINATED,INTERVENTIONAL,"Insufficient enrollment, no safety or efficacy concerns"
NCT02176538,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT02176551,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT02176577,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT02176720,TERMINATED,INTERVENTIONAL,PI left HMRI
NCT02176824,TERMINATED,INTERVENTIONAL,PI
NCT02177149,WITHDRAWN,INTERVENTIONAL,"PI is no longer at MCW, study has been closed"
NCT02177162,TERMINATED,INTERVENTIONAL,insufficient participants recruited in the intervention group
NCT02177266,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT02177526,TERMINATED,INTERVENTIONAL,trial logistics
NCT02177604,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02177682,TERMINATED,INTERVENTIONAL,Company decision
NCT02177734,WITHDRAWN,INTERVENTIONAL,The study was cancelled for scientifically legitimate reasons not related to safety or efficacy of the vaccine.
NCT02177760,WITHDRAWN,INTERVENTIONAL,Preliminary data suggested a better approach available
NCT02177773,TERMINATED,INTERVENTIONAL,FDA approved agent for this indication during enrollment
NCT02177812,TERMINATED,INTERVENTIONAL,The risk benefit in relapsed refractory AML does not favor continuation of the study.
NCT02177825,TERMINATED,INTERVENTIONAL,Slow accrual 5 patients out of 25 expected. Primary objectives could not be met without recruiting more patients.
NCT02177838,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02178046,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02178397,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02178566,TERMINATED,INTERVENTIONAL,Unable to enroll
NCT02178813,TERMINATED,INTERVENTIONAL,Study stopped prematurely because of multiple logistic difficulties
NCT02179060,TERMINATED,OBSERVATIONAL,Lack of study funding
NCT02179099,TERMINATED,INTERVENTIONAL,Decision to open a randomized controlled trial with two groups receiving different Botulinum Toxin in comparison to placebo group.
NCT02179138,WITHDRAWN,INTERVENTIONAL,Study no longer relevant based on change in regulatory pathway for TFV 1% gel
NCT02179151,TERMINATED,INTERVENTIONAL,FDA Clinical Hold
NCT02179177,TERMINATED,INTERVENTIONAL,funding has been exhausted
NCT02179242,TERMINATED,INTERVENTIONAL,Lower than expected accrual
NCT02179476,TERMINATED,INTERVENTIONAL,No additional enrollment
NCT02179567,TERMINATED,INTERVENTIONAL,Terminated due to poor accrual
NCT02179762,WITHDRAWN,INTERVENTIONAL,Insufficient staff
NCT02179814,SUSPENDED,INTERVENTIONAL,Conduct of the first analyses
NCT02179827,WITHDRAWN,OBSERVATIONAL,"Study never commenced, and is now closed."
NCT02179840,WITHDRAWN,INTERVENTIONAL,"Study not initiated, no participants enrolled."
NCT02179892,TERMINATED,INTERVENTIONAL,Inadequate patient population to complete enrollment
NCT02180139,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to lack of funding and staff availability.
NCT02180256,TERMINATED,INTERVENTIONAL,The main investigators are no longer working at the the center
NCT02180282,TERMINATED,INTERVENTIONAL,Low recruiting rate
NCT02180529,TERMINATED,INTERVENTIONAL,recruiting difficulties
NCT02180815,TERMINATED,OBSERVATIONAL,Sufficient follow-up information obtained to support study goals
NCT02181205,WITHDRAWN,INTERVENTIONAL,"no eligible participant , technical difficulty, feasiblity"
NCT02181387,TERMINATED,INTERVENTIONAL,funding and compounding issues
NCT02181621,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT02181699,TERMINATED,INTERVENTIONAL,Failed treatment response
NCT02181751,WITHDRAWN,OBSERVATIONAL,Study was never initiated
NCT02181790,TERMINATED,INTERVENTIONAL,Lack of subjects
NCT02183194,WITHDRAWN,INTERVENTIONAL,Slow recruitment
NCT02183727,TERMINATED,INTERVENTIONAL,"Data from LC1033 study of same product indicated lower than expected clinical outcomes; company, STR did not have funds to continue study."
NCT02183805,TERMINATED,INTERVENTIONAL,Difficulty accruing subjects the study accrual was closed
NCT02183896,WITHDRAWN,INTERVENTIONAL,PI left
NCT02184130,TERMINATED,INTERVENTIONAL,"insufficient funds and participants, thus terminated"
NCT02184793,TERMINATED,INTERVENTIONAL,not enough inclusion
NCT02185001,TERMINATED,INTERVENTIONAL,Inadequate patient recruitment and coordinator left organization
NCT02185092,WITHDRAWN,INTERVENTIONAL,Lost funding
NCT02185170,TERMINATED,INTERVENTIONAL,Results of 5 first patients show that chips' cauterization interferes the signal
NCT02185521,TERMINATED,INTERVENTIONAL,Initial main phase completed but recruitment rate was too slow to continue.
NCT02185547,TERMINATED,INTERVENTIONAL,Difficulties in recruiting participants.
NCT02185651,TERMINATED,INTERVENTIONAL,Participants not interested in enrolling.
NCT02185703,TERMINATED,INTERVENTIONAL,Too slow recruitment rate
NCT02185937,TERMINATED,INTERVENTIONAL,inclusion was too slow
NCT02186054,TERMINATED,INTERVENTIONAL,Trial Logistics
NCT02186301,TERMINATED,INTERVENTIONAL,Sponsor discontinued development of CO-1686 for NSCLC
NCT02186353,WITHDRAWN,INTERVENTIONAL,Lack of adequate funding
NCT02186405,WITHDRAWN,INTERVENTIONAL,No patient corresponding to inclusion criteria couldn't be enrolled in the study
NCT02186418,TERMINATED,INTERVENTIONAL,Sponsor decision due to funding
NCT02186821,TERMINATED,INTERVENTIONAL,Study was terminated due to low enrollment
NCT02186912,TERMINATED,INTERVENTIONAL,The study stopped as the performance of the study showed insufficient patient recruitment.
NCT02187029,TERMINATED,INTERVENTIONAL,B7911002 was prematurely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014
NCT02187367,TERMINATED,INTERVENTIONAL,Sponsor decision based on slow recruitment and new emerging drug combinations
NCT02187393,WITHDRAWN,OBSERVATIONAL,Technical difficulties with the wet bench side of proposed studies.
NCT02187809,TERMINATED,INTERVENTIONAL,The study was terminated due to recruitment challenges
NCT02187822,TERMINATED,INTERVENTIONAL,lack of funding by company providing TPI-287
NCT02188303,TERMINATED,INTERVENTIONAL,The termination criteria of the protocol was met during dose escalation.
NCT02188368,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02188511,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02188602,WITHDRAWN,OBSERVATIONAL,Researcher left institution
NCT02188719,TERMINATED,INTERVENTIONAL,The trial could not be completed within the grant timeline.
NCT02188823,TERMINATED,INTERVENTIONAL,low recruitment
NCT02189174,TERMINATED,INTERVENTIONAL,Novartis decided to terminate the study considering safety and tolerability concerns and limited clinical activity with CLR457 study drug administered once daily (qd).
NCT02189213,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02189395,TERMINATED,INTERVENTIONAL,difficulty in subject recruitment
NCT02189460,TERMINATED,OBSERVATIONAL,Not enough subjects
NCT02189551,TERMINATED,INTERVENTIONAL,"an additional intervention, amendet to the study (3rd arm, not described here), has not received clearance by regulatory authorities"
NCT02189668,TERMINATED,INTERVENTIONAL,High failure rate
NCT02189798,TERMINATED,INTERVENTIONAL,Thirty-six subjects wore the EAS processor for as long as 84 months without any significant safety issues. Sufficient data gained to support EAS technology development for safe use in subjects with residual low-frequency acoustic hearing sensitivity.
NCT02189889,TERMINATED,INTERVENTIONAL,Initial patients were seen at St Paul Hospital. Enrollment changes occurred with the move to Clements Hospital. We were unable to identify an infusion room at CUH despite an exhaustive search for alternatives and forced to terminate early.
NCT02189915,TERMINATED,INTERVENTIONAL,Received funding for the next phase of the study
NCT02190526,WITHDRAWN,INTERVENTIONAL,Study stopped due to lack of volunteer patients.
NCT02190539,WITHDRAWN,INTERVENTIONAL,Not able to recruit patients
NCT02190565,WITHDRAWN,INTERVENTIONAL,Business decision - strategy changes and budget limitations
NCT02190838,TERMINATED,INTERVENTIONAL,Preliminary terminated due to inefficacy
NCT02191501,TERMINATED,INTERVENTIONAL,Suspended as we are looking for more durable method/device
NCT02191566,TERMINATED,INTERVENTIONAL,The patient's study enrollment was too low.
NCT02191748,TERMINATED,INTERVENTIONAL,Principal investigator made the decision to close study and not submit a renewal. Lack of fixed research personnel to carry out the study effectively.
NCT02191917,TERMINATED,OBSERVATIONAL,Study was terminated early due to a company decision not based on safety concerns
NCT02192099,TERMINATED,INTERVENTIONAL,Patients from this study were rolled into RAP-MD-99.
NCT02192151,TERMINATED,OBSERVATIONAL,Not completed its inspection.(CSR completed)
NCT02192190,TERMINATED,INTERVENTIONAL,Interim assessment: Lack of efficacy
NCT02192216,TERMINATED,INTERVENTIONAL,Recruiting issues and limited personel ressources
NCT02192489,WITHDRAWN,INTERVENTIONAL,Administrative
NCT02192541,TERMINATED,INTERVENTIONAL,Drug supplier suspended further clinical development of Ganetespib
NCT02192567,TERMINATED,INTERVENTIONAL,Business decision
NCT02192697,TERMINATED,INTERVENTIONAL,"Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies."
NCT02192879,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT02193074,TERMINATED,INTERVENTIONAL,"After a positive interim analysis, the decision was made to terminate the study early to allow for participants to enroll into an open label study"
NCT02193152,TERMINATED,INTERVENTIONAL,Terminated by sponsor
NCT02193490,TERMINATED,INTERVENTIONAL,Sponsor ceased sponsorship and terminated the research citing slow accrual of subjects in this clinical trial.
NCT02193750,TERMINATED,INTERVENTIONAL,The team decided to close this study since we are not recruiting and collecting any data.
NCT02193763,SUSPENDED,INTERVENTIONAL,"PI has relocated to another institution, no other site PI to take over"
NCT02194374,WITHDRAWN,INTERVENTIONAL,Study closed with no enrollment due to unavailability of reagent.
NCT02194894,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT02194998,TERMINATED,INTERVENTIONAL,The study closed to accrual before the planned accrual goal was attained due to the availability of newer directly-acting antiviral (DAA) treatments for HCV.
NCT02195024,TERMINATED,INTERVENTIONAL,PI changed affiliation not beening allowed to continue the trial in further cooperation. The sub-investigators did not see any option to continue the trial and made the decision to terminate the study.
NCT02195219,WITHDRAWN,INTERVENTIONAL,Unable reach recruitment
NCT02195310,TERMINATED,INTERVENTIONAL,due to futility
NCT02195570,WITHDRAWN,INTERVENTIONAL,Unable to identify and recruit eligible participants
NCT02195752,TERMINATED,OBSERVATIONAL,Sponsor financial decision stemming from low recruitment
NCT02195791,TERMINATED,INTERVENTIONAL,Diffculty in participant enrollment
NCT02195817,TERMINATED,INTERVENTIONAL,The study was terminated due to enrolment challenges
NCT02196168,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT02196207,WITHDRAWN,INTERVENTIONAL,"The trial was revised to be two protocols, one Prevention, one Eradication Trials."
NCT02196259,TERMINATED,INTERVENTIONAL,Funding cessation.
NCT02196311,WITHDRAWN,OBSERVATIONAL,no patient recruited
NCT02196610,TERMINATED,OBSERVATIONAL,Limited funds available to complete full recruitment. Enrolment achieved: 90%.
NCT02196818,TERMINATED,OBSERVATIONAL,Study was closed mainly because the surgeons participating no longer had the infrastructure to support the research and weren't following their subjects
NCT02196883,WITHDRAWN,INTERVENTIONAL,PI no longer part of practice
NCT02197182,TERMINATED,INTERVENTIONAL,Not for safety reasons
NCT02197286,WITHDRAWN,INTERVENTIONAL,Personnel changes at study site.
NCT02197312,TERMINATED,INTERVENTIONAL,Business reasons
NCT02197663,TERMINATED,INTERVENTIONAL,the numbers of drop-out patients are more than we anticipate
NCT02197819,TERMINATED,INTERVENTIONAL,Slow patient enrolment
NCT02197832,TERMINATED,INTERVENTIONAL,Difficulty in recruiting participants.
NCT02197936,TERMINATED,OBSERVATIONAL,Study was suspended due to organisational difficulties.
NCT02197949,TERMINATED,OBSERVATIONAL,Slow recuitment
NCT02198209,WITHDRAWN,INTERVENTIONAL,Investigator decided not to move forward with study prior to study start date
NCT02198482,TERMINATED,INTERVENTIONAL,development program of study drug volasertib was stopped by Boehringer Ingelheim due to manufacturing problems
NCT02198521,WITHDRAWN,OBSERVATIONAL,The researcher and principal investigator working on this study left the institution.
NCT02198820,WITHDRAWN,OBSERVATIONAL,lack of investigators
NCT02198833,TERMINATED,INTERVENTIONAL,Study catheter manufacturing issues. Poor enrollment.
NCT02198937,TERMINATED,OBSERVATIONAL,Funding unclear
NCT02199041,TERMINATED,INTERVENTIONAL,The study was halted early due to slow accrual.
NCT02199067,TERMINATED,OBSERVATIONAL,technical difficulties of probe measurement
NCT02199223,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02199457,WITHDRAWN,INTERVENTIONAL,Device development not completed
NCT02199938,TERMINATED,OBSERVATIONAL,Principal Investigator has left the Institution
NCT02199964,TERMINATED,INTERVENTIONAL,Funding was terminated
NCT02200250,WITHDRAWN,OBSERVATIONAL,Study abandoned
NCT02200302,TERMINATED,OBSERVATIONAL,lack of cooperation and compliance
NCT02200328,TERMINATED,INTERVENTIONAL,Patients noncompliant with instructions and follow ups could not be completed.
NCT02200354,TERMINATED,INTERVENTIONAL,inclusion speed
NCT02200562,TERMINATED,INTERVENTIONAL,"BMS withdrew support and required this trial to stop enrolling; Phase II portion never began, only a Phase I trial."
NCT02200848,TERMINATED,INTERVENTIONAL,Recruitment difficulties and toxicity
NCT02201277,TERMINATED,INTERVENTIONAL,ODEN trial stopped due to low enrollment \& to focus on the PRESERVE Trial.
NCT02201355,TERMINATED,INTERVENTIONAL,PI LEFT THE DEPARTMENT
NCT02201368,WITHDRAWN,INTERVENTIONAL,IMP management difficulties
NCT02201381,WITHDRAWN,INTERVENTIONAL,Prospective recruitment not possible
NCT02201472,TERMINATED,INTERVENTIONAL,Change of research focus
NCT02201524,TERMINATED,INTERVENTIONAL,Study terminated 26 June 2015 due to changes in the drug development portfolio. This study was not terminated for reasons of safety and/or efficacy
NCT02201563,TERMINATED,INTERVENTIONAL,Very slow recruitment (only one patient was recruited)
NCT02201758,WITHDRAWN,INTERVENTIONAL,Researchers decided to withdrawn the study due unavialble FLC
NCT02201927,TERMINATED,INTERVENTIONAL,lack of performance
NCT02202044,TERMINATED,INTERVENTIONAL,The institution was requiring extensive changes to the protocol
NCT02202070,WITHDRAWN,INTERVENTIONAL,Funding
NCT02202096,WITHDRAWN,INTERVENTIONAL,Resources were not readily available to begin the study.
NCT02202122,WITHDRAWN,OBSERVATIONAL,lack of investigators
NCT02202135,TERMINATED,INTERVENTIONAL,"Overall study status is changed to ""Terminated"" due to low enrollment"
NCT02202304,WITHDRAWN,INTERVENTIONAL,Researcher changed jobs. Unable to carry out the project
NCT02202369,SUSPENDED,INTERVENTIONAL,Low enrollment and subject followup rates
NCT02202421,TERMINATED,INTERVENTIONAL,PI and study coordinator both left the institution.
NCT02202434,TERMINATED,INTERVENTIONAL,RCT/Roll-in completed. CAS/21mm/Nested Registry terminated (investigational device is no longer available)
NCT02202668,TERMINATED,INTERVENTIONAL,TRS probe performance does not meet primary outcome data requirements
NCT02202707,WITHDRAWN,INTERVENTIONAL,No funding obtained to conduct study
NCT02202746,TERMINATED,INTERVENTIONAL,Sponsor decision to end monotherapy development of the compound in breast cancer.
NCT02202759,TERMINATED,INTERVENTIONAL,"Business Decision, No Safety or Efficacy Concerns"
NCT02202785,TERMINATED,INTERVENTIONAL,"Business Decision, No Safety or Efficacy Concerns"
NCT02203383,SUSPENDED,OBSERVATIONAL,Pending further equipment and staff
NCT02203422,WITHDRAWN,INTERVENTIONAL,No eligible patient was enrolled.
NCT02203513,TERMINATED,INTERVENTIONAL,Eli Lilly prematurely terminated the study.
NCT02203578,TERMINATED,INTERVENTIONAL,slow accrual
NCT02203604,TERMINATED,INTERVENTIONAL,Insufficient rate of accrual
NCT02203630,TERMINATED,INTERVENTIONAL,Slow enrollment; Lack of support and equipoise
NCT02203669,WITHDRAWN,INTERVENTIONAL,Never did begin
NCT02203773,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT02204007,TERMINATED,INTERVENTIONAL,Small number of subjects
NCT02204020,WITHDRAWN,INTERVENTIONAL,Lack of interest with investigators - no subjects enrolled
NCT02204124,TERMINATED,INTERVENTIONAL,Principal Investigator and Study Sponsor decided to terminate the study early
NCT02204202,TERMINATED,OBSERVATIONAL,PI left institution
NCT02204293,TERMINATED,INTERVENTIONAL,Recruitment issues due to marketing authorization of study drug
NCT02204332,TERMINATED,INTERVENTIONAL,Interim analysis performed on the first 10 patients showed no efficacy of cabazitaxel
NCT02204371,TERMINATED,INTERVENTIONAL,The study was terminated as the asset was sold to another company who decided not to pursue this indication with this drug.
NCT02204462,TERMINATED,INTERVENTIONAL,Lock of funding
NCT02204605,WITHDRAWN,INTERVENTIONAL,The principal investigator left the institution.
NCT02204696,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT02204709,TERMINATED,INTERVENTIONAL,COVID-19 pandemic \& expiration of grant funds
NCT02204722,TERMINATED,INTERVENTIONAL,Sponsor's decision to halt the study.
NCT02204904,TERMINATED,OBSERVATIONAL,Sufficient enrollment for Month 24 safety and efficacy endpoints
NCT02204982,TERMINATED,INTERVENTIONAL,Sponsor is focusing on studies which can enable registration of duvelisib
NCT02205229,SUSPENDED,OBSERVATIONAL,Poor enrollment
NCT02205307,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02205333,TERMINATED,INTERVENTIONAL,The study was terminated early at the sponsor's discretion.
NCT02205411,TERMINATED,INTERVENTIONAL,Inability to timely enroll.
NCT02205463,WITHDRAWN,INTERVENTIONAL,IND application withdrawn
NCT02205476,TERMINATED,INTERVENTIONAL,"B5301001 study did not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified."
NCT02205645,TERMINATED,INTERVENTIONAL,Safety. Devices explanted. 12m post-explant safety f/u as agreed with UK MHRA
NCT02205723,WITHDRAWN,INTERVENTIONAL,Study was not initiated because we could not secure funding.
NCT02205775,TERMINATED,INTERVENTIONAL,difficult recruitment
NCT02206724,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients
NCT02206776,TERMINATED,INTERVENTIONAL,poor tolerability and low enrollment rate
NCT02206932,WITHDRAWN,INTERVENTIONAL,never opened
NCT02207127,WITHDRAWN,OBSERVATIONAL,Unable to refine study measurements/protocol adequately.
NCT02207270,TERMINATED,INTERVENTIONAL,Unable to meet projected enrollment
NCT02207309,TERMINATED,INTERVENTIONAL,poor recruitment
NCT02207543,TERMINATED,INTERVENTIONAL,Loss of patients
NCT02207582,TERMINATED,INTERVENTIONAL,no efficacy
NCT02207647,TERMINATED,OBSERVATIONAL,Funding used up
NCT02207712,TERMINATED,INTERVENTIONAL,Major protocol deviations compromised the study.
NCT02207764,WITHDRAWN,INTERVENTIONAL,competing priorities at the organization
NCT02207959,TERMINATED,INTERVENTIONAL,PI left institution
NCT02207985,TERMINATED,INTERVENTIONAL,Competing studies.
NCT02208063,TERMINATED,INTERVENTIONAL,Halted due to lack of statistical power. No safety concerns identified.
NCT02208258,WITHDRAWN,INTERVENTIONAL,"Hospital had initiated a conflicting study, hence the study was terminated."
NCT02208271,SUSPENDED,OBSERVATIONAL,The lab was acquired by another company and has put this study's samples on hold.
NCT02208310,TERMINATED,INTERVENTIONAL,"Unable to enroll at rate anticipated, insufft low vitamin D in clin rem @ 5 sites"
NCT02208349,TERMINATED,INTERVENTIONAL,Interim analysis suggested additional enrollment would not change outcomes
NCT02208440,TERMINATED,INTERVENTIONAL,Enrollment target has not achieved due to very slow and low recruitment rate
NCT02208947,TERMINATED,INTERVENTIONAL,failure to accure
NCT02209376,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate prior to completion to pursue combination therapies.
NCT02209506,TERMINATED,INTERVENTIONAL,Long-term animal toxicology findings (see detailed description).
NCT02209545,TERMINATED,INTERVENTIONAL,The study was prematurely closed due to low enrollment rates.
NCT02210104,WITHDRAWN,INTERVENTIONAL,Issues with tetramer staining
NCT02210299,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02210611,TERMINATED,INTERVENTIONAL,Recruition too slow
NCT02210676,WITHDRAWN,INTERVENTIONAL,"Due to the investigator leaving the institution, the study was terminated"
NCT02210949,TERMINATED,INTERVENTIONAL,Low inclusion rate
NCT02211053,TERMINATED,INTERVENTIONAL,Recruitment was too slow and we cannot anticipate to recruit the target sample size
NCT02211105,TERMINATED,OBSERVATIONAL,Unexpected low accrual
NCT02211183,TERMINATED,INTERVENTIONAL,Very Low recruitment rate
NCT02211274,WITHDRAWN,INTERVENTIONAL,"Due to issues with the study, we did not proceed with enrolling participants in the trial."
NCT02211313,TERMINATED,INTERVENTIONAL,Lack of further funding.
NCT02211508,TERMINATED,INTERVENTIONAL,"Trial terminated Feb '15. Interim analysis results missed primary endpoint, intended signal not delivered in Tx arm, sham results as expected. No safety issues."
NCT02211547,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT02211560,TERMINATED,INTERVENTIONAL,Due to difficulties in patient recruitment
NCT02212015,TERMINATED,INTERVENTIONAL,Due to interim analysis' results and definitions fixed in protocol
NCT02212210,TERMINATED,INTERVENTIONAL,PI permanently closed accrual for the study based on FDA warning issued in April 2014. Study is closed
NCT02212275,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02212574,TERMINATED,INTERVENTIONAL,Participant relapses led to abrupt stop of study.
NCT02212613,WITHDRAWN,INTERVENTIONAL,Low enrollment
NCT02212652,TERMINATED,INTERVENTIONAL,lack of support resources to complete study appropriately
NCT02212730,TERMINATED,INTERVENTIONAL,Terminated early due to low enrollment
NCT02212899,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT02213042,TERMINATED,INTERVENTIONAL,Primary analysis was completed in 2018 and continued minimal data collection from the one participant active in the study was not expected to add meaningful knowledge to the understanding of lapatinib
NCT02213133,TERMINATED,INTERVENTIONAL,Due to enrollment challenges and availability of other options for lung cancer patients. The termination is not a consequence of any safety concern.
NCT02213341,TERMINATED,OBSERVATIONAL,Lack of enrollment.
NCT02213432,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02213536,TERMINATED,OBSERVATIONAL,Poor recruitment and follow up
NCT02213744,TERMINATED,INTERVENTIONAL,Felt not to show benefit over control per DMC and confirmed via futility analysis
NCT02213757,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT02213887,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT02213952,WITHDRAWN,INTERVENTIONAL,Without recruitment
NCT02214095,TERMINATED,INTERVENTIONAL,had been finished
NCT02214537,TERMINATED,INTERVENTIONAL,Because we dont have the necessary technology anymore
NCT02214667,TERMINATED,INTERVENTIONAL,Inability to recruit enough participants
NCT02214706,TERMINATED,INTERVENTIONAL,Lack of efficacy / adverse events
NCT02215083,WITHDRAWN,INTERVENTIONAL,Insufficient Patient Population
NCT02215148,TERMINATED,OBSERVATIONAL,Slow subject enrollment and contracting issues; sponsor decided to abort study
NCT02215161,TERMINATED,INTERVENTIONAL,Risk to benefit ratio is not acceptable
NCT02215174,TERMINATED,INTERVENTIONAL,IRB approval expired
NCT02215421,WITHDRAWN,INTERVENTIONAL,Funding did not allow for completion of game programming
NCT02215876,WITHDRAWN,INTERVENTIONAL,No patients recruited.
NCT02215902,TERMINATED,INTERVENTIONAL,Adequate safety data has been accumulated and the # of patients meeting inclusion criteria has diminished.
NCT02216097,TERMINATED,INTERVENTIONAL,The study stopped based on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefit:risk assessment of PF-04457845.
NCT02216149,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02216201,WITHDRAWN,OBSERVATIONAL,Sponsor terminated study
NCT02216448,WITHDRAWN,INTERVENTIONAL,Technical problems with simulator
NCT02216513,TERMINATED,INTERVENTIONAL,Principle Investigator is moving to another institution and plans to restart this proctocol in the new location.
NCT02216539,TERMINATED,INTERVENTIONAL,Change of sponsor
NCT02216565,TERMINATED,INTERVENTIONAL,After results of other studies published : EASY study became lapsed
NCT02216669,WITHDRAWN,INTERVENTIONAL,No financial agreement
NCT02216760,WITHDRAWN,INTERVENTIONAL,Terminated prior to randomised phase
NCT02217007,WITHDRAWN,INTERVENTIONAL,"Funding stopped, company closed"
NCT02217033,TERMINATED,INTERVENTIONAL,After an interim analysis the Company providing the product decided not to continue with the study
NCT02217202,WITHDRAWN,INTERVENTIONAL,Funding withdrawn before ethical approval granted
NCT02217670,WITHDRAWN,INTERVENTIONAL,Commercial reasons
NCT02217683,WITHDRAWN,INTERVENTIONAL,This trial never started due to lack of funding.
NCT02217722,TERMINATED,INTERVENTIONAL,"We have submitted a multi center study, with the same nutritional therapy"
NCT02217969,WITHDRAWN,INTERVENTIONAL,IRB application withdrawn
NCT02217982,TERMINATED,INTERVENTIONAL,Study did not meet required enrollment numbers
NCT02218151,TERMINATED,INTERVENTIONAL,Low accrual due to covid-19 and resulting staffing shortages
NCT02218216,TERMINATED,INTERVENTIONAL,Sponsor terminated study early to start a larger feasability study
NCT02218242,TERMINATED,INTERVENTIONAL,Unable to enroll enough participants
NCT02218359,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT02218502,TERMINATED,INTERVENTIONAL,interim analysis showed incorrect use of simple rules
NCT02218567,TERMINATED,INTERVENTIONAL,inclusion difficult
NCT02218580,TERMINATED,INTERVENTIONAL,Inability to recruit study participants
NCT02218749,TERMINATED,INTERVENTIONAL,Organizational barriers
NCT02218762,WITHDRAWN,INTERVENTIONAL,It was decided that data from this study are no longer required and therefore it is not necessary to expose patients to the study medication
NCT02218775,WITHDRAWN,INTERVENTIONAL,"Funding for the study ended with one subject consented, but not randomized"
NCT02219048,TERMINATED,INTERVENTIONAL,The termination was due to business reasons. No safety or efficacy concerns contributed to the termination of the study
NCT02219139,WITHDRAWN,INTERVENTIONAL,No patients could be recruited
NCT02219321,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT02219334,TERMINATED,INTERVENTIONAL,The study was stopped due to low enrollment.
NCT02219581,TERMINATED,INTERVENTIONAL,"Terminated after considerable time in suspended state due to inadequate staffing, the COVID pandemic, and the Responsible Party leaving Emory in August 2022."
NCT02220088,TERMINATED,INTERVENTIONAL,protocol violation
NCT02220478,TERMINATED,INTERVENTIONAL,Unable to engage surgeons to participate in the study
NCT02220634,TERMINATED,INTERVENTIONAL,PI left National Jewish Health
NCT02220738,TERMINATED,INTERVENTIONAL,Slow subject enrollment
NCT02221037,TERMINATED,INTERVENTIONAL,The study was terminated on the basis that protocol defined stopping criteria had been met.
NCT02221154,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT02221232,TERMINATED,INTERVENTIONAL,"To assess product performance (test and reference products), move into further testing."
NCT02221245,TERMINATED,OBSERVATIONAL,Study terminated due to low accrual.
NCT02221648,TERMINATED,INTERVENTIONAL,PI retired and moved- funding sponsor contacted and Oked
NCT02221687,TERMINATED,INTERVENTIONAL,Recruitment of breastfed infants was very slow. Decision with PI (05/2018): Termination (80/100); no implication on primary outcome. Predetermined number of breastfed infants (n=100) was arbitray choice. Formula groups completed (460/460) 12/2017.
NCT02221713,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT02221765,TERMINATED,INTERVENTIONAL,Expected PK\&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy
NCT02221843,TERMINATED,OBSERVATIONAL,"Company dissolved, no study devices available anymore"
NCT02221947,TERMINATED,INTERVENTIONAL,"Part 2 of study replaced by NTRP-101-202, assessing 3 doses of bryostatin."
NCT02222116,WITHDRAWN,INTERVENTIONAL,Market move to DES
NCT02222363,TERMINATED,INTERVENTIONAL,Slow recruitment and lack of efficacy despite the completion of several dose steps.
NCT02222623,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02222727,TERMINATED,INTERVENTIONAL,CT scanner software incompatible
NCT02222948,TERMINATED,INTERVENTIONAL,Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any safety concern.
NCT02223299,WITHDRAWN,INTERVENTIONAL,The study was never approved by the IRB and the PI left the VA
NCT02223312,WITHDRAWN,INTERVENTIONAL,Sponsor decision to discontinue study.
NCT02223598,TERMINATED,INTERVENTIONAL,MTD determined
NCT02223975,SUSPENDED,OBSERVATIONAL,Study suspended pending further funding
NCT02224170,TERMINATED,INTERVENTIONAL,Due to difficulties in recruiting the subjects.
NCT02224235,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT02224599,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate study due to poor accrual
NCT02224859,WITHDRAWN,INTERVENTIONAL,Organization has withdrawn their 510k submission and stopped the study
NCT02224950,WITHDRAWN,INTERVENTIONAL,Withdrawn from IRB before approval
NCT02224989,TERMINATED,INTERVENTIONAL,1) Difficulties in recruiting veterans and 2) the funding was used up completely
NCT02225223,TERMINATED,INTERVENTIONAL,Difficulty Enrolling
NCT02225275,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT02225418,WITHDRAWN,INTERVENTIONAL,Change of jobs
NCT02225496,TERMINATED,INTERVENTIONAL,Another trial in the department directly competes for the the same patient population
NCT02225561,TERMINATED,INTERVENTIONAL,Discontinuation of the experimental treatment being tested
NCT02225574,TERMINATED,INTERVENTIONAL,Slow Accrual - Only 1 patient enrolled in Phase 1 - Study never went to Phase II
NCT02225795,WITHDRAWN,INTERVENTIONAL,recruitment difficulty
NCT02225951,TERMINATED,INTERVENTIONAL,Current protocol is not optimal/feasible
NCT02226094,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02226133,WITHDRAWN,INTERVENTIONAL,stopped for operational reasons
NCT02226315,TERMINATED,OBSERVATIONAL,Slow enrollment of eligible subjects
NCT02226393,TERMINATED,INTERVENTIONAL,Recruitment
NCT02226458,WITHDRAWN,INTERVENTIONAL,This study was halted prior to enrolling.
NCT02226497,TERMINATED,INTERVENTIONAL,Insufficient staff
NCT02226705,TERMINATED,INTERVENTIONAL,End of inclusion period
NCT02226744,TERMINATED,INTERVENTIONAL,"No funds to complete study as anticipated, preliminary data used for future grant"
NCT02227108,TERMINATED,INTERVENTIONAL,The study was terminated prior to a planned interim analysis based on lack of required efficacy in the first 32 participants enrolled.
NCT02227121,TERMINATED,INTERVENTIONAL,Sufficient enrollments under current protocol for further development \& studies
NCT02227134,WITHDRAWN,INTERVENTIONAL,Unable to perform the ultrasound.
NCT02227160,WITHDRAWN,INTERVENTIONAL,This study never started enrolling participants due to lack of grant funding.
NCT02227329,TERMINATED,INTERVENTIONAL,Publication of guidelines advising against the use of ethanol locks.
NCT02227563,TERMINATED,INTERVENTIONAL,Lack of participants that fit inclusion criteria
NCT02227576,TERMINATED,INTERVENTIONAL,Study halted for efficacy following the results of the interim analysis provided for in the protocol on 20 patients.
NCT02227719,WITHDRAWN,INTERVENTIONAL,Funding
NCT02227784,TERMINATED,INTERVENTIONAL,Study termination due to program termination.
NCT02227914,WITHDRAWN,INTERVENTIONAL,Study stopped due to administrative reasons
NCT02228018,WITHDRAWN,INTERVENTIONAL,Other strategies followed
NCT02228304,TERMINATED,INTERVENTIONAL,"After enrolling approximately 1/2 of the trial participants, the rescues exceeded stopping criteria."
NCT02228538,TERMINATED,OBSERVATIONAL,Not enough subject participation
NCT02228655,TERMINATED,INTERVENTIONAL,Inability to recruit patients meeting eligibilty criteria.
NCT02228785,TERMINATED,INTERVENTIONAL,Poor local tolerance to injection.
NCT02229149,TERMINATED,INTERVENTIONAL,per Sponsor request
NCT02229175,WITHDRAWN,INTERVENTIONAL,Study not feasible with current resources.
NCT02229240,WITHDRAWN,INTERVENTIONAL,Study was cancelled prior to enrolling any patients
NCT02229266,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT02229981,WITHDRAWN,INTERVENTIONAL,Study was discontinued due to lack of recruitment.
NCT02230020,TERMINATED,OBSERVATIONAL,Sponsor funding
NCT02230306,TERMINATED,INTERVENTIONAL,closed due to slow accrual
NCT02230488,TERMINATED,INTERVENTIONAL,Unable to enroll due to protocol exclusion criteria and participant population pool
NCT02230527,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02230735,WITHDRAWN,INTERVENTIONAL,Study was never started.
NCT02230930,TERMINATED,INTERVENTIONAL,Delayed inclusion - stopped when 10 patients completed the study
NCT02231515,TERMINATED,INTERVENTIONAL,departure of principal investigator from the organisation
NCT02231580,TERMINATED,INTERVENTIONAL,The study was terminated due to subject recruitment problems.
NCT02231658,TERMINATED,INTERVENTIONAL,Too challenging to recruit appropriate participants at an acceptable speed.
NCT02231710,TERMINATED,INTERVENTIONAL,due to lack of enrollment and changes to the sponsor development portfolio
NCT02232009,TERMINATED,INTERVENTIONAL,Slow/low enrollment
NCT02232256,WITHDRAWN,INTERVENTIONAL,Site unable to enrol recruited subjects
NCT02232373,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT02232438,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT02232477,TERMINATED,INTERVENTIONAL,Termination of study by investigator related to COVID pandemic.
NCT02232568,TERMINATED,INTERVENTIONAL,Insufficient numbers of participating sites and hip surgery cases.
NCT02232620,TERMINATED,INTERVENTIONAL,Low feasibility
NCT02232646,WITHDRAWN,INTERVENTIONAL,Low feasibility
NCT02232880,TERMINATED,INTERVENTIONAL,failure to recruit
NCT02232958,TERMINATED,INTERVENTIONAL,Funds depleted and Ilness of Principal Investigator
NCT02233387,TERMINATED,INTERVENTIONAL,patients did not want to participate
NCT02233569,TERMINATED,INTERVENTIONAL,The high recurrence rate and the findings during the reoperations were considered as serious adverse events and were the reason for study termination.
NCT02233595,TERMINATED,OBSERVATIONAL,Low Accrual
NCT02233621,TERMINATED,INTERVENTIONAL,not enough enrollement
NCT02233829,WITHDRAWN,INTERVENTIONAL,"No enrollment, delay with drug availability."
NCT02234011,TERMINATED,INTERVENTIONAL,Terminated due to difficulty in recruiting participants.
NCT02234037,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02234375,WITHDRAWN,INTERVENTIONAL,Gadolinium attenuation in vitro inadequate
NCT02234687,TERMINATED,INTERVENTIONAL,"The original PI, Alexander Neumeister, left NYULMC. No data was analyzed."
NCT02234752,TERMINATED,INTERVENTIONAL,Funding no longer available and PI no longer working at the institution
NCT02234869,WITHDRAWN,INTERVENTIONAL,Due to a change in Biogen Idec's medical research plans.
NCT02235064,TERMINATED,INTERVENTIONAL,"Low recruitment, completion of funding cycle"
NCT02235090,WITHDRAWN,INTERVENTIONAL,Trial was not started due to lack of funding and nobody received an intervention.
NCT02235311,TERMINATED,INTERVENTIONAL,Difficulty recruiting and consenting participants
NCT02235324,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02235545,TERMINATED,OBSERVATIONAL,Abbott received FDA approval to transition the ongoing Optisure PAS to EP a new EP-PASSION Real World Evidence methodology
NCT02235753,TERMINATED,INTERVENTIONAL,Recruitment was stopped due to lack of funding.
NCT02236091,TERMINATED,OBSERVATIONAL,Lacking algorithms led to abortion of project
NCT02236130,TERMINATED,INTERVENTIONAL,Poor response rate on follow up of patients
NCT02236364,TERMINATED,INTERVENTIONAL,No positive results were detected
NCT02236481,TERMINATED,INTERVENTIONAL,Decision of the Sponsor for Early Benefits
NCT02236546,TERMINATED,INTERVENTIONAL,loss of funding
NCT02236572,TERMINATED,INTERVENTIONAL,"Phase 2 of recruitment was contingent on 5 of 15 patients responding, which did not occur."
NCT02236702,TERMINATED,OBSERVATIONAL,"The original PI, Alexander Neumeister, left NYULMC. No data was analyzed."
NCT02236754,WITHDRAWN,INTERVENTIONAL,Could not recruit participants
NCT02236936,TERMINATED,INTERVENTIONAL,Study stopped due to low recruitment
NCT02237066,WITHDRAWN,INTERVENTIONAL,Enrollment goals were not able to be met
NCT02237287,TERMINATED,INTERVENTIONAL,Open label study part reduced from n=10 to n=6 because of insufficient number of patients under antiaggregation.
NCT02237378,TERMINATED,INTERVENTIONAL,Poor enrolment
NCT02237547,WITHDRAWN,INTERVENTIONAL,No enrollment.
NCT02237677,TERMINATED,OBSERVATIONAL,"The original PI, Alexander Neumeister, left NYULMC. No data was analyzed."
NCT02237703,TERMINATED,OBSERVATIONAL,"The original PI, Alexander Neumeister, left NYULMC. No data was analyzed."
NCT02237833,TERMINATED,OBSERVATIONAL,Too slow recruitment.
NCT02237846,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02238041,WITHDRAWN,OBSERVATIONAL,Discontinued program
NCT02238431,WITHDRAWN,INTERVENTIONAL,no patient uptake
NCT02238457,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting patients
NCT02238574,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02238730,WITHDRAWN,INTERVENTIONAL,Resources not available for the study
NCT02238938,TERMINATED,INTERVENTIONAL,insufficient recruitment of study patients
NCT02238977,TERMINATED,INTERVENTIONAL,Study stopped due to difficulty recruiting
NCT02239315,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02239354,TERMINATED,INTERVENTIONAL,Insufficient functional product engraftment
NCT02239406,TERMINATED,OBSERVATIONAL,Lack of enrollment interest.
NCT02239510,TERMINATED,INTERVENTIONAL,Not sufficient recruitment
NCT02239627,TERMINATED,INTERVENTIONAL,based on interim anaylsis
NCT02239926,TERMINATED,INTERVENTIONAL,Difficulty in enrolling subjects
NCT02240108,TERMINATED,INTERVENTIONAL,The study was terminated early due to difficulty in enrollment and lack of clinical study drug access.
NCT02240121,TERMINATED,INTERVENTIONAL,The study was terminated early due to difficulty in enrollment and lack of clinical study drug access.
NCT02240303,WITHDRAWN,OBSERVATIONAL,Consolidated study with another protocol
NCT02240355,TERMINATED,INTERVENTIONAL,"There was an unexpected toxicology finding observed in the 39 week monkey study. Dosing was suspended, the study was put on hold and eventually terminated."
NCT02240381,TERMINATED,INTERVENTIONAL,Funding expired
NCT02240446,WITHDRAWN,INTERVENTIONAL,Will no longer be conducted. We have started a different project.
NCT02240602,WITHDRAWN,INTERVENTIONAL,Lack of internal resources
NCT02240797,TERMINATED,OBSERVATIONAL,"The original PI, Alexander Neumeister, left NYULMC. No data was analyzed."
NCT02240940,TERMINATED,INTERVENTIONAL,Company closed
NCT02241096,TERMINATED,INTERVENTIONAL,Lack of available study participants.
NCT02241148,TERMINATED,INTERVENTIONAL,Required number of participants were not able to be enrolled.
NCT02241174,WITHDRAWN,INTERVENTIONAL,"study materials have expired, no patients were enrolled"
NCT02241343,TERMINATED,INTERVENTIONAL,Safety concerns
NCT02241486,TERMINATED,INTERVENTIONAL,No funding source.
NCT02241512,TERMINATED,INTERVENTIONAL,lack of funding
NCT02241525,TERMINATED,OBSERVATIONAL,The PI left the university
NCT02241551,TERMINATED,INTERVENTIONAL,Study was terminated with the IRB ended early as logistical concerns of the SBRT
NCT02241668,WITHDRAWN,INTERVENTIONAL,Withdrawn due to other initiatives
NCT02241707,WITHDRAWN,OBSERVATIONAL,"Since reorganization of the institute, this study is aborted. No patient was recruited."
NCT02241720,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02241785,TERMINATED,INTERVENTIONAL,Business Decision
NCT02241798,TERMINATED,INTERVENTIONAL,Investigator is leaving the institution and has terminated the study.
NCT02241941,WITHDRAWN,INTERVENTIONAL,Assessment of daptomycin concentrations with microdialysis technically not feasible
NCT02242409,TERMINATED,INTERVENTIONAL,Testing of combination no longer relevant
NCT02242578,TERMINATED,INTERVENTIONAL,IRB approval expired and study ceased.
NCT02242656,WITHDRAWN,INTERVENTIONAL,Transfer of IND to new marketing authorization holder
NCT02243007,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02243059,WITHDRAWN,INTERVENTIONAL,Problems with availability of study medicine in clinical center
NCT02243111,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02243124,TERMINATED,INTERVENTIONAL,Company went out of business
NCT02243189,TERMINATED,INTERVENTIONAL,Under enrollment and IP supply expiring.
NCT02243397,SUSPENDED,OBSERVATIONAL,Safety
NCT02243696,TERMINATED,OBSERVATIONAL,"On April 15, 2019, BIOTRONIK received FDA approval to transition the ongoing Protego DF4 Post Approval Registry to a new EP PASSION real-world data methodology."
NCT02243787,TERMINATED,INTERVENTIONAL,"Based on the observed safety profile of COVA322, the sponsor decided to stop the clinical study."
NCT02243917,TERMINATED,INTERVENTIONAL,MTD determined
NCT02244073,TERMINATED,INTERVENTIONAL,Data safety monitoring board decision
NCT02244112,TERMINATED,INTERVENTIONAL,"Why study stopped revised to ""A program evaluation identified that the safety profile and pharmacokinetic (PK) characteristics of the formulation used in all oprozomib studies required further optimization and thus enrollment in OPZ009 was halted"
NCT02244164,TERMINATED,INTERVENTIONAL,Recruitment too slow
NCT02244892,WITHDRAWN,OBSERVATIONAL,Recruitment
NCT02244944,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT02245074,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02245087,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT02245230,TERMINATED,INTERVENTIONAL,"We were not able to enroll adequate number of participants that met the inclusion/exclusion criteria, and we run out of funding."
NCT02245412,TERMINATED,INTERVENTIONAL,"Terminated early at the Sponsor's discretion, not due to safety concerns."
NCT02245568,TERMINATED,INTERVENTIONAL,This study has been terminated for administrative reasons only.
NCT02245737,TERMINATED,INTERVENTIONAL,"An independent assessment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility"
NCT02245971,WITHDRAWN,INTERVENTIONAL,The investigators decided to terminate the study early because there were no patient candidates available for registration in the center.
NCT02246010,TERMINATED,INTERVENTIONAL,Very slow recruitment rate. Only 6 infants were recruited over 2 years.
NCT02246075,WITHDRAWN,INTERVENTIONAL,Forum has decided not to proceed with this study at this time.
NCT02246114,TERMINATED,INTERVENTIONAL,Lack of Recruitment
NCT02246309,TERMINATED,INTERVENTIONAL,"Equipment was loaned Lifglobal, Guilford, CT, USA and had to be returned."
NCT02246348,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02246491,TERMINATED,INTERVENTIONAL,Change in research objectives.
NCT02246530,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to inability to complete recruitment of subjects for each of the trial groups (treatment and control).
NCT02246556,TERMINATED,INTERVENTIONAL,Recruitment inadequate and investigators leaving the study institution for new positions.
NCT02246816,WITHDRAWN,INTERVENTIONAL,Transfer of IND to different marketing authorization representative.
NCT02246920,TERMINATED,INTERVENTIONAL,Development Halted
NCT02247258,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02247687,TERMINATED,INTERVENTIONAL,Low recruitment of participants for the study
NCT02247895,TERMINATED,INTERVENTIONAL,difficulty meeting enrollment goals
NCT02247960,TERMINATED,INTERVENTIONAL,Interim analysis determined that the study should be concluded for futility.
NCT02248077,WITHDRAWN,INTERVENTIONAL,Study was redesigned in collaboration with CMS before it started.
NCT02248701,TERMINATED,INTERVENTIONAL,Enrollment difficulties
NCT02248740,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02248870,TERMINATED,INTERVENTIONAL,Less inclusions than expected with the given criteria
NCT02248922,TERMINATED,INTERVENTIONAL,Reason for termination was challenge with enrollment and recruitment. A significant decrease in the eligible patient population was main driver.
NCT02249156,WITHDRAWN,OBSERVATIONAL,This was an observational study. The owners of the data refused to give us the data so we could not proceed with the analyses.
NCT02249377,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02249468,TERMINATED,OBSERVATIONAL,Stop the study for futility based on recommendation from Independent Data Committee.
NCT02249481,TERMINATED,INTERVENTIONAL,A number of issues which impact on the ability to recruit patients to the study
NCT02250118,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT02250183,TERMINATED,INTERVENTIONAL,Recruitment was too slow due to strict inclusion criteria.
NCT02250313,TERMINATED,OBSERVATIONAL,Pending final analysis for termination
NCT02250378,WITHDRAWN,INTERVENTIONAL,No accrual
NCT02250404,WITHDRAWN,OBSERVATIONAL,PI left institution
NCT02250495,TERMINATED,INTERVENTIONAL,Company closed
NCT02250794,WITHDRAWN,INTERVENTIONAL,No subjects enrolled.
NCT02250924,WITHDRAWN,INTERVENTIONAL,Investigator decision - clinical practice change
NCT02251444,TERMINATED,INTERVENTIONAL,recruitment problems in the controle group
NCT02251639,WITHDRAWN,INTERVENTIONAL,Study design improvements.
NCT02252094,TERMINATED,INTERVENTIONAL,Device no longer available in Singapore
NCT02252315,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02252393,WITHDRAWN,INTERVENTIONAL,waiting on surgeon training
NCT02252432,TERMINATED,INTERVENTIONAL,"No enough recruitments, very slow enrollment over the years"
NCT02252796,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT02252978,WITHDRAWN,INTERVENTIONAL,No funding support
NCT02252991,TERMINATED,INTERVENTIONAL,Difficulty to include patients
NCT02253394,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02253576,WITHDRAWN,INTERVENTIONAL,Study not funded - never initiated
NCT02253667,WITHDRAWN,INTERVENTIONAL,"One of the investigators left the department, Master Degree in which this study was part of her thesis. No patients were enrolled."
NCT02254239,TERMINATED,INTERVENTIONAL,funding withdrawal
NCT02254382,TERMINATED,INTERVENTIONAL,Recruitment rates too low
NCT02254473,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT02254525,TERMINATED,INTERVENTIONAL,Sample not reached in traumathology arm
NCT02254551,TERMINATED,INTERVENTIONAL,Safety lead-in data did not support continuation of study.
NCT02254642,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02254681,TERMINATED,INTERVENTIONAL,lack of funding
NCT02254902,TERMINATED,INTERVENTIONAL,Changes in funding status
NCT02254915,WITHDRAWN,INTERVENTIONAL,Shortages of the active comparator drug (BCG) on the market worldwide and a growing uncertainty as to its future supply.
NCT02254928,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02254954,TERMINATED,INTERVENTIONAL,Sponsor decision due to low recruitment
NCT02255110,TERMINATED,INTERVENTIONAL,Sponsor's decision due to negative result of Phase 3 study TH-CR-406/SARC021
NCT02255162,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02255227,TERMINATED,INTERVENTIONAL,low inclusion rates
NCT02255240,WITHDRAWN,INTERVENTIONAL,Relinquished grant funding due to receipt of another incompatible grant
NCT02255305,TERMINATED,INTERVENTIONAL,"Due to personnel issues for finding and enrolling patients, performing appropriate follow-up and performing FMT procedure"
NCT02255461,TERMINATED,INTERVENTIONAL,Data for the primary objectives is complete and the MTD identified in Stratum II.
NCT02255487,TERMINATED,INTERVENTIONAL,"The study was terminated early after the Interim Analysis due, in part, to issues with the accuracy and completeness of the data collected."
NCT02255825,WITHDRAWN,INTERVENTIONAL,Awaiting verification of assay
NCT02255838,TERMINATED,INTERVENTIONAL,"slow enrollment, outdated material"
NCT02255877,WITHDRAWN,INTERVENTIONAL,Change in research plan
NCT02256007,TERMINATED,INTERVENTIONAL,Not feasible in inpatient setting
NCT02256124,TERMINATED,INTERVENTIONAL,"Due to our experience, the small number of new inclusions, and the uncertainty regarding the COVID-19 outbreak, we have decided to discontinue the study."
NCT02256280,TERMINATED,INTERVENTIONAL,Low recruiting rate due to not activation of some collaborator centers
NCT02256683,TERMINATED,INTERVENTIONAL,Recruiting problems
NCT02256982,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02257125,TERMINATED,INTERVENTIONAL,"Stopped due to futility considerations:

Sample size calculations have assumed smaller effect sizes than considered relevant now."
NCT02257307,TERMINATED,OBSERVATIONAL,expired study
NCT02257346,WITHDRAWN,INTERVENTIONAL,PI terminated study with no subjects enrolled.
NCT02257619,TERMINATED,INTERVENTIONAL,Sponsor decision to not initiate part 2 due to slow enrollment and competing trials.
NCT02257684,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02257749,TERMINATED,INTERVENTIONAL,feasibility; challenges with recruitment
NCT02257775,TERMINATED,OBSERVATIONAL,Insufficient number of eligible and interested partients
NCT02257788,WITHDRAWN,INTERVENTIONAL,Unlikely to achieve targeted accrual
NCT02257879,WITHDRAWN,OBSERVATIONAL,"due to constraints with collaborator and subject matter expert, recruitment was unable to begin"
NCT02258048,WITHDRAWN,OBSERVATIONAL,Samuel Sigal no longer with NYU
NCT02258464,TERMINATED,INTERVENTIONAL,Due to lower than expected recruitment since the start of study
NCT02258711,SUSPENDED,INTERVENTIONAL,Logistical problems.
NCT02258750,TERMINATED,INTERVENTIONAL,End of EU funding for the work package under investigation
NCT02258880,WITHDRAWN,INTERVENTIONAL,study was stopped for business/administrative reasons and not for patient safety concerns
NCT02259140,WITHDRAWN,INTERVENTIONAL,No patients have been enrolled since 2015. There has been difficulty recruiting patients for randomization. We have initiated a prospective cohort study evaluating salvage hip procedures for patients with cerebral palsy.
NCT02259348,TERMINATED,INTERVENTIONAL,Investigator's decision.
NCT02259452,TERMINATED,OBSERVATIONAL,Decision to not gather further data
NCT02259517,TERMINATED,INTERVENTIONAL,Recruitment/enrollment ended early due to the COVID-19 pandemic
NCT02259634,TERMINATED,INTERVENTIONAL,Target sample size not reached for enrollment.
NCT02260141,TERMINATED,INTERVENTIONAL,unable to get adequate enrollment
NCT02260349,WITHDRAWN,INTERVENTIONAL,Scientific coordinator left the hospital
NCT02260635,TERMINATED,INTERVENTIONAL,Study termination due to insufficient efficacy.
NCT02260648,TERMINATED,INTERVENTIONAL,Study termination due to insufficient efficacy.
NCT02260726,WITHDRAWN,INTERVENTIONAL,No funding available
NCT02260765,WITHDRAWN,INTERVENTIONAL,This study was never funded therefore no patients were enrolled.
NCT02260869,TERMINATED,INTERVENTIONAL,"Due to financial constraints, sponsor could not complete the study."
NCT02260895,TERMINATED,INTERVENTIONAL,The Investigator left the institution.
NCT02261051,WITHDRAWN,OBSERVATIONAL,Difficulty in recruitment and change in study site protocols.
NCT02261233,TERMINATED,INTERVENTIONAL,"Funding for this project ended as of August 31, 2018"
NCT02261246,TERMINATED,INTERVENTIONAL,We no longer have the resources to complete enrollment
NCT02261610,TERMINATED,INTERVENTIONAL,difficulty of recrutement
NCT02261688,TERMINATED,INTERVENTIONAL,Lack of funds
NCT02261753,TERMINATED,INTERVENTIONAL,The study oversight committees unanimously decided to stop the study early on 26/07/2017 due to poor recruitment.
NCT02261805,TERMINATED,INTERVENTIONAL,Company terminated drug support
NCT02261844,WITHDRAWN,INTERVENTIONAL,No funding
NCT02261883,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02261909,WITHDRAWN,OBSERVATIONAL,Study failed to receive final approvement
NCT02262000,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT02262169,TERMINATED,INTERVENTIONAL,This study was terminated due to internal technical issues at study site
NCT02262221,SUSPENDED,INTERVENTIONAL,Low participant accrual
NCT02262494,TERMINATED,INTERVENTIONAL,No recruitment
NCT02262936,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02263235,TERMINATED,INTERVENTIONAL,end of the inclusion period
NCT02263287,TERMINATED,INTERVENTIONAL,recruitment problems
NCT02263365,TERMINATED,INTERVENTIONAL,Unable to meet study requirements
NCT02263547,TERMINATED,INTERVENTIONAL,PK time points were not being met as expected. Determination that risks outweighed benefit.
NCT02263573,TERMINATED,INTERVENTIONAL,"* Interim analysis on 60 randomized subjects showed significant result for the main outcome (VT1)
* Enrollment difficulty"
NCT02263638,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02263677,WITHDRAWN,INTERVENTIONAL,Technical difficulties have caused this study to be terminated
NCT02263729,TERMINATED,INTERVENTIONAL,The study was terminated due to difficulty identifying eligible participants and the expiration of funding.
NCT02263898,WITHDRAWN,INTERVENTIONAL,closed without enrollment
NCT02264236,WITHDRAWN,INTERVENTIONAL,Inability to enroll subjects under current iteration of the protocol
NCT02264288,TERMINATED,INTERVENTIONAL,Business decision with all subjects completing at least 1 year follow-up
NCT02265146,WITHDRAWN,OBSERVATIONAL,0
NCT02265380,TERMINATED,INTERVENTIONAL,Inability to recruit patients sufficiently
NCT02265445,TERMINATED,INTERVENTIONAL,The study was stopped for recruitment defect
NCT02265900,TERMINATED,INTERVENTIONAL,Covid Restrictions have impacted longitudinal assessments for the effect of the intervention
NCT02266004,TERMINATED,INTERVENTIONAL,difficult to recruit participants
NCT02266095,WITHDRAWN,INTERVENTIONAL,Study closed prior to enrolling patients
NCT02266121,TERMINATED,INTERVENTIONAL,lack of recruitement
NCT02266147,TERMINATED,INTERVENTIONAL,The sponsor terminated the trial early because there was sufficient data to make a decision about SD-101 in the lymphoma development program.
NCT02266433,TERMINATED,INTERVENTIONAL,due to PI's change to private practice
NCT02266654,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants
NCT02266849,TERMINATED,INTERVENTIONAL,Insuficcient recruiting
NCT02266862,WITHDRAWN,OBSERVATIONAL,No funding
NCT02267213,TERMINATED,INTERVENTIONAL,Current study design couldn't support futher development on this indication
NCT02267317,TERMINATED,INTERVENTIONAL,Study drug expired
NCT02267408,TERMINATED,INTERVENTIONAL,Terminated by sponsor
NCT02267551,TERMINATED,INTERVENTIONAL,low enrollment
NCT02267707,TERMINATED,INTERVENTIONAL,Study population more infrequent than estimated. No study-related safety issues and no safety concerns were identified for the study.
NCT02267772,TERMINATED,INTERVENTIONAL,Difficulties in recruitment
NCT02267863,TERMINATED,INTERVENTIONAL,Drug manufacturing process and procedure review
NCT02268201,TERMINATED,INTERVENTIONAL,Due to difficulty enrolling patients
NCT02268435,WITHDRAWN,INTERVENTIONAL,Dovitinib Production stopped
NCT02268591,WITHDRAWN,INTERVENTIONAL,PI left institution and no subjects enrolled.
NCT02268825,TERMINATED,INTERVENTIONAL,Merck requested to change MK-3475 dosing schedule; PI decided to close instead
NCT02269072,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02269085,TERMINATED,INTERVENTIONAL,slow accrual
NCT02269111,TERMINATED,INTERVENTIONAL,Change in PI and funding
NCT02269345,TERMINATED,INTERVENTIONAL,Unworkable. This study had several PIs and attempted several avenues of recruitment. Still were only able to recruit 34 out of the 120 needed.
NCT02269436,TERMINATED,INTERVENTIONAL,Issues with development and supply of infusion system for delivery of IMP. Lack of favorable benefit risk ratio in sNN0029-003 study (review of interim data).
NCT02269553,WITHDRAWN,INTERVENTIONAL,Study redesigned into three separate trials.
NCT02269566,TERMINATED,INTERVENTIONAL,The number of enrolled subjects did not meet the goal during the study
NCT02269670,TERMINATED,INTERVENTIONAL,Slow to accrual
NCT02269683,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02269696,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT02269761,TERMINATED,OBSERVATIONAL,The patients were too sick to consent and we couldn't recruit enough to continue the study
NCT02269774,TERMINATED,INTERVENTIONAL,Due to the strict in- and exclusion criteria only few patients could be enrolled into the study.
NCT02270164,WITHDRAWN,INTERVENTIONAL,Sponsor discontinued funding due to higher than anticipated manufacturer costs
NCT02270632,TERMINATED,INTERVENTIONAL,Approvals of new agents for the same indication have significantly slowed down the recruitment in this trial making the prosecution of the present investigation extremely difficult.
NCT02270684,TERMINATED,INTERVENTIONAL,Recruitment and retention difficulties
NCT02270710,WITHDRAWN,OBSERVATIONAL,Research direction changed
NCT02270827,TERMINATED,OBSERVATIONAL,Study was set up by an MSc student who left her post.
NCT02271165,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT02271178,TERMINATED,INTERVENTIONAL,The study was stopped after interim analysis due to futility.
NCT02271295,SUSPENDED,INTERVENTIONAL,Premature discontinuation of inclusions by the sponsor for low inclusion
NCT02271347,WITHDRAWN,INTERVENTIONAL,Suspended Development Program
NCT02271516,TERMINATED,INTERVENTIONAL,Some concerns arose for the accumulation of radioactivity in liver and spleen.
NCT02271789,WITHDRAWN,OBSERVATIONAL,Not a clinical trial study
NCT02271880,TERMINATED,INTERVENTIONAL,This study was stopped prematurely due to low enrollment.
NCT02271893,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02271906,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT02272348,TERMINATED,INTERVENTIONAL,Change in methodology too important - end of randomization
NCT02272387,TERMINATED,INTERVENTIONAL,Low enrollment and limited research staffing
NCT02272686,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02272699,WITHDRAWN,INTERVENTIONAL,"Because there are questions about adjuvant radiotherapy in this study, the clinical trial is under re-design."
NCT02272881,WITHDRAWN,INTERVENTIONAL,We have not been able to enroll patients.
NCT02272933,WITHDRAWN,INTERVENTIONAL,No Study Enrollment
NCT02273089,TERMINATED,OBSERVATIONAL,Recruitment stopped due to time restrains
NCT02273284,TERMINATED,INTERVENTIONAL,we identified that the device tested in this study was not approved by Health canada
NCT02273752,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02273856,TERMINATED,OBSERVATIONAL,The study was terminated due to insufficient subject enrollment and very slow enrollment.
NCT02274012,WITHDRAWN,INTERVENTIONAL,Former PI left institution and had plans to continue at another institution.
NCT02274038,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT02274077,WITHDRAWN,INTERVENTIONAL,funding for the study was terminated
NCT02274233,TERMINATED,INTERVENTIONAL,Changes in renal function parameters.
NCT02274506,WITHDRAWN,INTERVENTIONAL,"PI's response to ePAAC, has withdrawn the protocol acknowledging the PI's action."
NCT02274740,TERMINATED,INTERVENTIONAL,Sponsor decision not related to safety reasons
NCT02274896,WITHDRAWN,INTERVENTIONAL,Project No Longer in Development
NCT02275260,TERMINATED,INTERVENTIONAL,The required number of endpoints will be obtained with a sample size lower than initially planned.
NCT02275481,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT02275585,WITHDRAWN,OBSERVATIONAL,other studies with more patients already publicated
NCT02275806,TERMINATED,INTERVENTIONAL,PI decided to terminate study
NCT02275858,TERMINATED,INTERVENTIONAL,The study was stopped due to carry over effect in the cross over study design.
NCT02275871,TERMINATED,INTERVENTIONAL,Didn't have funding to support the study design
NCT02275923,TERMINATED,INTERVENTIONAL,Study terminated as sufficient data was collected to determine if impedance measurements with the LINQ device could track body fluid changes.
NCT02276170,TERMINATED,OBSERVATIONAL,insufficient rate of accrual
NCT02276560,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of funding.
NCT02276599,TERMINATED,OBSERVATIONAL,Recruitment was too slow and data collected would not add to already published studies.
NCT02276651,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT02276794,TERMINATED,INTERVENTIONAL,Time and funding constraints
NCT02276820,WITHDRAWN,INTERVENTIONAL,The sponsor is pursuing a different product for this indication
NCT02276911,TERMINATED,INTERVENTIONAL,No enrollment
NCT02276989,WITHDRAWN,INTERVENTIONAL,poor recruitment
NCT02277093,TERMINATED,INTERVENTIONAL,FDA issued a clinical hold as pacritinib had increased side effects
NCT02277132,TERMINATED,INTERVENTIONAL,Results of interim analysis
NCT02277184,TERMINATED,INTERVENTIONAL,the investigator left the institution
NCT02277210,TERMINATED,INTERVENTIONAL,poor recruitment
NCT02277223,WITHDRAWN,INTERVENTIONAL,Difficulty to enroll patients
NCT02277366,TERMINATED,OBSERVATIONAL,"We have recruited some patients, but we haven't found any significant result by bronchoscopy in the high risk population."
NCT02277522,TERMINATED,INTERVENTIONAL,unable to meet enrollment goal
NCT02277561,WITHDRAWN,INTERVENTIONAL,IRB approved but never implemented
NCT02277756,TERMINATED,INTERVENTIONAL,autistic recruitment problems
NCT02277782,TERMINATED,INTERVENTIONAL,"Study drug shortage, COVID related suspension of recruitment"
NCT02278445,WITHDRAWN,INTERVENTIONAL,No patients
NCT02278575,WITHDRAWN,INTERVENTIONAL,impossible to recruit participants due to organization changes
NCT02278783,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02279342,TERMINATED,INTERVENTIONAL,Entry were insufficient as expected.
NCT02279576,TERMINATED,INTERVENTIONAL,The low recruitment of patients will not allow to complete the study with the required number of patients within reasonable time.
NCT02279693,TERMINATED,INTERVENTIONAL,feasibility problem
NCT02279836,TERMINATED,INTERVENTIONAL,Study was stopped due to the expected introduction of a next product generation.
NCT02279992,TERMINATED,INTERVENTIONAL,Unable to accrue to the study. Original PI no longer with the institute.
NCT02280239,TERMINATED,INTERVENTIONAL,Only enrolled 10 participants over 9 months which is less then anticipated (75).
NCT02280395,TERMINATED,INTERVENTIONAL,Company merger resulted in business decision to terminate the study.
NCT02281006,TERMINATED,INTERVENTIONAL,poor accrual
NCT02281292,WITHDRAWN,INTERVENTIONAL,Management Decision
NCT02281344,TERMINATED,INTERVENTIONAL,Inconsistent and unpredictable exposures were observed. Drug needed to be reformulated.
NCT02281695,WITHDRAWN,INTERVENTIONAL,Withdrawal of Primary investigators
NCT02281721,TERMINATED,OBSERVATIONAL,Internal decision
NCT02281799,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT02281812,TERMINATED,INTERVENTIONAL,Increased local adverse effect (breast inflamation and infection)
NCT02281981,WITHDRAWN,INTERVENTIONAL,Project abandoned
NCT02282111,TERMINATED,INTERVENTIONAL,Equality of results between the two groups at interim analysis
NCT02282163,TERMINATED,INTERVENTIONAL,FDA agreed to early termination due to difficulties enrolling patients.
NCT02282241,WITHDRAWN,INTERVENTIONAL,Project never began
NCT02282358,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02282384,WITHDRAWN,INTERVENTIONAL,Sites were unable to recruit participants
NCT02282423,TERMINATED,INTERVENTIONAL,PI job change
NCT02282514,TERMINATED,INTERVENTIONAL,"Could not predict who would respond, relapse or go into remission"
NCT02282891,WITHDRAWN,INTERVENTIONAL,No subjects were ever recruited and enrolled.
NCT02282917,TERMINATED,INTERVENTIONAL,Drug manufacturing logistics; lack of access to drug supply
NCT02283216,WITHDRAWN,INTERVENTIONAL,Lack of funding and personnel
NCT02283359,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution
NCT02283398,WITHDRAWN,INTERVENTIONAL,administrative issues
NCT02283619,TERMINATED,OBSERVATIONAL,Study was found to be non-feasible. Not enough patients to perform an adequate study in the allocated time period.
NCT02283905,TERMINATED,INTERVENTIONAL,Poor enrollment numbers of patients
NCT02283931,SUSPENDED,INTERVENTIONAL,Awaiting New CoInvestigator with TTE Expertise
NCT02283944,WITHDRAWN,INTERVENTIONAL,Device for multi coil TMS no longer supported
NCT02284230,WITHDRAWN,INTERVENTIONAL,Inability to recruit participants
NCT02284373,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT02284737,TERMINATED,INTERVENTIONAL,Lack of subjects.
NCT02284906,TERMINATED,INTERVENTIONAL,Lack of efficacy of the drug; no safety concern
NCT02284971,TERMINATED,INTERVENTIONAL,Low accruals
NCT02285153,TERMINATED,INTERVENTIONAL,Recruitment of planned number of Subjects was not feasible.
NCT02285244,WITHDRAWN,INTERVENTIONAL,Decision made by the Principal Investigator
NCT02285283,TERMINATED,INTERVENTIONAL,Recruitment failure.
NCT02285296,TERMINATED,INTERVENTIONAL,Enrollment problem
NCT02285465,WITHDRAWN,INTERVENTIONAL,Study terminated due to sponsor decision
NCT02285543,TERMINATED,INTERVENTIONAL,No new participants could be enrolled.
NCT02285855,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT02286258,TERMINATED,INTERVENTIONAL,The study was suspended after a suspected unexpected serious adverse event.
NCT02286284,TERMINATED,INTERVENTIONAL,Safety of patients : CSI recommandation and promotor decision
NCT02286401,TERMINATED,OBSERVATIONAL,Recruitment lagged behind goal;exhaustion of funding.
NCT02286882,TERMINATED,INTERVENTIONAL,"The trial was terminated prematurely on June 19, 2015 for business reasons. There were no safety concerns in the study which led to the decision."
NCT02286999,WITHDRAWN,INTERVENTIONAL,Study did not open for enrollment.
NCT02287337,TERMINATED,INTERVENTIONAL,IRB approval expired when PI left UNLV
NCT02287506,TERMINATED,INTERVENTIONAL,Pilot feasibility for full trial: NCT03737799
NCT02287714,WITHDRAWN,INTERVENTIONAL,Low (no) enrollment.
NCT02287974,TERMINATED,INTERVENTIONAL,Patients' numebr randomized not achieved. Investigators team with lack of interest and commitment. The sponsor closed prematurely patients' recruitment.
NCT02288208,TERMINATED,INTERVENTIONAL,Due to cranial nerve palsies observed
NCT02288351,WITHDRAWN,INTERVENTIONAL,The PI decided to withdraw the study. No patient interaction took place.
NCT02288377,TERMINATED,INTERVENTIONAL,Because of slow recruitment
NCT02288507,WITHDRAWN,INTERVENTIONAL,Closed due to no accrual
NCT02288702,TERMINATED,OBSERVATIONAL,lack of recruitment
NCT02288728,TERMINATED,INTERVENTIONAL,Not enough paticipants enroll in this study.
NCT02288780,TERMINATED,OBSERVATIONAL,"It was difficult to proceed with the study according to the protocol, the research was terminated early."
NCT02288819,TERMINATED,INTERVENTIONAL,Slow recruitment and a lack of funding to complete further follow-up
NCT02288897,TERMINATED,INTERVENTIONAL,Inadequate rate of enrollment
NCT02289144,WITHDRAWN,INTERVENTIONAL,study was on hold for protocol redesign; decided to not move forward with study.
NCT02289222,TERMINATED,INTERVENTIONAL,"Due to the inclusion of an IMid in combination with pembrolizumab, Study Sponsor terminated the study."
NCT02289274,WITHDRAWN,INTERVENTIONAL,internal decision
NCT02289287,TERMINATED,INTERVENTIONAL,Due to difficulties in recruitment and academic time constrains we terminated the study after 60 participants instead of 90 as planned.
NCT02289300,WITHDRAWN,INTERVENTIONAL,At sponsor's discretion
NCT02289482,TERMINATED,INTERVENTIONAL,Study prematurely terminated due to safety concerns leading to clinical hold
NCT02289989,TERMINATED,INTERVENTIONAL,Lack of response to recruitment
NCT02290028,TERMINATED,INTERVENTIONAL,BIOTRONIK received FDA approval to transition the ongoing Sentus QP Study to a new EP PASSION real-world data methodology.
NCT02290119,TERMINATED,INTERVENTIONAL,as a result of Orthosensor's acquisition by Stryker in July 2018.No final mutually agreed (signed) protocol was found and no clear records of the study data can be retrieved. No accurate and reliable results of this study can be posted.
NCT02290366,WITHDRAWN,INTERVENTIONAL,Principal Investigator decision
NCT02290574,TERMINATED,INTERVENTIONAL,slow accrual
NCT02290626,WITHDRAWN,INTERVENTIONAL,Study protocol was changed.
NCT02290717,WITHDRAWN,INTERVENTIONAL,Difficulty including patients
NCT02290769,SUSPENDED,INTERVENTIONAL,Hospital administrative problems
NCT02291419,TERMINATED,INTERVENTIONAL,Enrollment expectations were not met
NCT02291614,TERMINATED,INTERVENTIONAL,The study was terminated because of immunogenicity and business decision.
NCT02291978,WITHDRAWN,INTERVENTIONAL,No patients met eligibility.
NCT02292121,TERMINATED,INTERVENTIONAL,lack of surgical controls
NCT02292225,TERMINATED,INTERVENTIONAL,The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.
NCT02292680,WITHDRAWN,OBSERVATIONAL,Unable to enroll
NCT02292706,TERMINATED,OBSERVATIONAL,The study stopped early because the study objectives were met.
NCT02292771,TERMINATED,INTERVENTIONAL,The study was stopped due to the feasibility of recruiting the study in a timely manner
NCT02292823,TERMINATED,OBSERVATIONAL,Enrolment rate
NCT02293096,TERMINATED,INTERVENTIONAL,Study was terminated due to the change in funding.
NCT02293408,TERMINATED,OBSERVATIONAL,The Sponsor's decision to terminate the SBC-103 program was reached after review of the data from all interventional clinical studies of SBC-103.
NCT02293525,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled and the sponsor suspended support at this time
NCT02293681,TERMINATED,OBSERVATIONAL,The project was stopped by 31-May-2017 because of internal owner decision from out of balance enrollment from two groups.
NCT02293720,WITHDRAWN,INTERVENTIONAL,This was the cross over study for 09-1 which was terminated early
NCT02293811,TERMINATED,INTERVENTIONAL,the tissue mass of each biopsy sample was not sufficient to perform an exploratory analysis to assess the level of expression of the P2RX7 protein.
NCT02293941,TERMINATED,INTERVENTIONAL,Completed stage I without pursuing stage II
NCT02294045,WITHDRAWN,OBSERVATIONAL,Unable to get the correct software.
NCT02294162,WITHDRAWN,INTERVENTIONAL,Terminated by IRB
NCT02294201,WITHDRAWN,INTERVENTIONAL,Sponsors
NCT02294214,WITHDRAWN,INTERVENTIONAL,Sponsors
NCT02294344,TERMINATED,INTERVENTIONAL,The recruitment of subject is very difficult.
NCT02294357,TERMINATED,INTERVENTIONAL,Early termination due to the difficulties to enroll subjects.
NCT02294669,TERMINATED,INTERVENTIONAL,Strategic reasons
NCT02294812,TERMINATED,INTERVENTIONAL,lack of funding and staff to conduct the study
NCT02294981,TERMINATED,INTERVENTIONAL,Protocol was changed to make it easier for treating doctors. No safety concerns
NCT02295163,WITHDRAWN,INTERVENTIONAL,no participants
NCT02295358,WITHDRAWN,OBSERVATIONAL,Project never got initiated
NCT02295501,TERMINATED,INTERVENTIONAL,The study was terminated on expiry of the frozen and stored plasma components.
NCT02295540,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT02295683,TERMINATED,OBSERVATIONAL,The study was prematurely discontinued due to the low rate of enrollment.
NCT02295722,TERMINATED,INTERVENTIONAL,It did not show a significant benefit to justify completing the full target accrual.
NCT02295787,WITHDRAWN,INTERVENTIONAL,No funding
NCT02295943,TERMINATED,INTERVENTIONAL,Could not meet primary and secondary outcome measures
NCT02296034,WITHDRAWN,OBSERVATIONAL,Unable to recruit participants
NCT02296346,TERMINATED,INTERVENTIONAL,Low enrollment/PI relocated. New site couldn't reach agreement with manufacturer
NCT02296359,TERMINATED,OBSERVATIONAL,Insufficient enrollment
NCT02296476,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of clinical activity and not due to safety reasons.
NCT02296528,TERMINATED,INTERVENTIONAL,PI decided to close study
NCT02296554,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02296671,WITHDRAWN,INTERVENTIONAL,Was unable to accrue any patients
NCT02296788,WITHDRAWN,INTERVENTIONAL,Study wasn't stopped. It wasn't started. Funding.
NCT02297087,TERMINATED,INTERVENTIONAL,PI no longer at site and he does
NCT02297178,WITHDRAWN,OBSERVATIONAL,Unable to recruit resaerch staff for study
NCT02297230,TERMINATED,INTERVENTIONAL,PI Left Institution prior to reaching accrual goal and analyzing data.
NCT02297490,TERMINATED,INTERVENTIONAL,The study was terminated due to the interim Analysis results indicating a weaker correlation than anticipated and reported by other study groups.
NCT02297607,TERMINATED,INTERVENTIONAL,Poor accrual. Patients were reluctant to agree if they would need tube feeding for a month.
NCT02297906,TERMINATED,INTERVENTIONAL,Enrolment issues
NCT02298153,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
NCT02298166,TERMINATED,INTERVENTIONAL,The manufacturer Arog Pharmaceuticals Inc has terminated the Agreement Concerning the Support of an Investigator Initiated Trial this became valid on 2020/03/09
NCT02298374,WITHDRAWN,INTERVENTIONAL,no funding
NCT02298634,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT02298647,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT02298673,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT02298686,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT02298699,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT02298712,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT02298816,WITHDRAWN,OBSERVATIONAL,No patients enrolled
NCT02299115,WITHDRAWN,INTERVENTIONAL,Most centres are now using oral steroids as 1st line treatment so question of efficacy is no longer of high interest.
NCT02299206,TERMINATED,INTERVENTIONAL,Principal Investigator and sponsor agreed to termination.
NCT02299271,TERMINATED,INTERVENTIONAL,Preliminary analysis showed no difference between groups.
NCT02299635,TERMINATED,INTERVENTIONAL,"The study was terminated on June 24th, 2015 due to change in strategy of PF-03084014 development. There were no safety/efficacy concerns behind the decision."
NCT02299726,WITHDRAWN,INTERVENTIONAL,Study was not funded
NCT02299765,TERMINATED,INTERVENTIONAL,the research data is not statistically significant
NCT02299934,TERMINATED,INTERVENTIONAL,lack of support
NCT02299947,TERMINATED,INTERVENTIONAL,Slow inclusion
NCT02300194,WITHDRAWN,INTERVENTIONAL,Withdrawn by investigators
NCT02300285,TERMINATED,INTERVENTIONAL,Insufficient eligible participants to meet recruitment goal
NCT02300714,TERMINATED,INTERVENTIONAL,Terminated due to lack of assistance and time to carry out the research.
NCT02300727,TERMINATED,INTERVENTIONAL,Protocol failed to accrue sufficient subject to complete meaningful analysis.
NCT02300922,TERMINATED,INTERVENTIONAL,Premature termination of recruitment due to the discontinuation of product supply by the project's industrial partner.
NCT02300935,WITHDRAWN,INTERVENTIONAL,Study concept was terminated.
NCT02301000,TERMINATED,INTERVENTIONAL,Slow recruitment in pilot phase. A follow-up trial is launched (NCT03796650).
NCT02301338,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT02301390,TERMINATED,INTERVENTIONAL,could not meet enrollment goal
NCT02301429,TERMINATED,INTERVENTIONAL,"Low implant success rate(46%). For the successfull implants, 3month FU and available electrical data showed an increase in threshold values for the left atrium"
NCT02301494,WITHDRAWN,INTERVENTIONAL,No participants were enrolled in the study.
NCT02301585,TERMINATED,INTERVENTIONAL,The study was stopped because of futility due to unexpected low weight gain in both groups.
NCT02301845,WITHDRAWN,INTERVENTIONAL,IRB disapproval
NCT02302092,TERMINATED,INTERVENTIONAL,Study was prematurely terminated due to administrative and strategic reasons
NCT02302339,TERMINATED,INTERVENTIONAL,Development of glembatumumab vedotin was discontinued
NCT02302508,WITHDRAWN,INTERVENTIONAL,Funding
NCT02302755,WITHDRAWN,INTERVENTIONAL,no recruitment
NCT02302846,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02302859,TERMINATED,INTERVENTIONAL,At the request of the PI
NCT02303041,TERMINATED,INTERVENTIONAL,Business Decision
NCT02303158,TERMINATED,OBSERVATIONAL,futility of the sample
NCT02303405,TERMINATED,INTERVENTIONAL,Investigator decision
NCT02303834,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02303951,TERMINATED,INTERVENTIONAL,The main reason for the early termination is the low recruitment rate.
NCT02303964,WITHDRAWN,INTERVENTIONAL,Low patient enrollment is the primary reason
NCT02304289,TERMINATED,INTERVENTIONAL,slow recruitment of patients
NCT02304445,WITHDRAWN,INTERVENTIONAL,Necessary equipment could not be obtained.
NCT02304705,TERMINATED,INTERVENTIONAL,Difficulty meeting enrollment goal
NCT02305199,WITHDRAWN,INTERVENTIONAL,impossible to enroll participants
NCT02305563,TERMINATED,INTERVENTIONAL,"Business objectives have changed, slow accrual, the standard of care for the patient population changed and we were unable to accrue any longer."
NCT02305992,WITHDRAWN,INTERVENTIONAL,Looking for funding opportunities
NCT02306070,WITHDRAWN,INTERVENTIONAL,insufficient funding
NCT02306460,TERMINATED,OBSERVATIONAL,Changes in personnel
NCT02306512,WITHDRAWN,INTERVENTIONAL,PI is leaving the University of Miami
NCT02306811,TERMINATED,INTERVENTIONAL,Study discontinued based on planned interim analysis of the primary endpoint. Not linked to any safety concern.
NCT02306876,TERMINATED,INTERVENTIONAL,Study recruitment was terminated on 14 June 2016 due to a Pfizer business decision. This study was not terminated for reasons of safety.
NCT02307084,TERMINATED,INTERVENTIONAL,Departure of Chief Investigator/Principal Investigator
NCT02307448,TERMINATED,INTERVENTIONAL,Lack of patient enrollment and lack of reimbursement
NCT02307474,WITHDRAWN,INTERVENTIONAL,Funding Unavailable
NCT02307552,TERMINATED,INTERVENTIONAL,"The probe could not be anchored in place and would rotate about its axis, thus comparison was difficult."
NCT02307591,WITHDRAWN,INTERVENTIONAL,The Study could not be started due to an insufficient number of new EVD cases.
NCT02307604,WITHDRAWN,OBSERVATIONAL,"This study has been merged with 1553 SPECTA, in which brain patients are enrolled"
NCT02307708,TERMINATED,INTERVENTIONAL,"recruitment difficulties (few patients meeting inclusion criteria, refusal of patients to stop sport activities during 6 weeks,...)"
NCT02308111,TERMINATED,INTERVENTIONAL,The DMC made the recommendation to not pursue further enrollment given the lack of feasibility for this post-marketing study as designed.
NCT02308358,WITHDRAWN,OBSERVATIONAL,New study initiated to replace this one
NCT02308436,WITHDRAWN,INTERVENTIONAL,Study is not realised.
NCT02308475,TERMINATED,INTERVENTIONAL,New study with a similar endpoint/protocol was developed (see NCT03103061).
NCT02308735,TERMINATED,OBSERVATIONAL,Technology has advanced beyond the applicability of the study
NCT02308865,TERMINATED,INTERVENTIONAL,sponsor decision
NCT02309203,WITHDRAWN,INTERVENTIONAL,Study not initiated at our site.
NCT02309268,WITHDRAWN,OBSERVATIONAL,The principal linvestigator decided not to continue the registry. No patient were enrolled. CLosure to the registry was done October 2014
NCT02309333,TERMINATED,OBSERVATIONAL,Previous principal investigators left institution
NCT02309450,WITHDRAWN,INTERVENTIONAL,BMS decision
NCT02309463,WITHDRAWN,OBSERVATIONAL,EC did not accept measurement of patient's activity for the primary end-point with a non-validated activity tracking device
NCT02309476,WITHDRAWN,INTERVENTIONAL,The PI decided to close the study early as patients with diffused macular oedema without any previous treatment are uncommon.
NCT02309515,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02309593,TERMINATED,OBSERVATIONAL,"PI change, hospital change and covid -19 caused lost-to-follow up of most of the subjects"
NCT02309632,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02309645,TERMINATED,INTERVENTIONAL,Study completed the required elements (40 paediatric subjects) per regulatory requirement. The study enrolled 40/42 subjects. No safety signals were identified. No changes required to the statistical analysis as described in the protocol.
NCT02309697,TERMINATED,OBSERVATIONAL,Study goals rolled into a broader study
NCT02309736,WITHDRAWN,OBSERVATIONAL,On going discussions with FDA
NCT02310009,WITHDRAWN,INTERVENTIONAL,PI relocated to a different country and coI moved to a different lab.
NCT02310373,TERMINATED,INTERVENTIONAL,Responsible Party/PI passed away. All subjects enrolled completed study prior to termination.
NCT02310568,TERMINATED,INTERVENTIONAL,"Study recruitment was terminated on 24 June 2015, due to a Pfizer business decision. This study was not terminated for reasons of safety or efficacy"
NCT02310581,TERMINATED,INTERVENTIONAL,Business decision
NCT02310594,TERMINATED,OBSERVATIONAL,Slow accrual
NCT02310763,TERMINATED,INTERVENTIONAL,Termination Date 30AUG2018: Reason for termination: Lack of Efficacy
NCT02310971,WITHDRAWN,INTERVENTIONAL,The trial has been terminated per Sponsor direction due to longer than expected clinical and regulatory approvals.
NCT02310997,TERMINATED,INTERVENTIONAL,Trial closed early due to poor recruitment
NCT02311023,TERMINATED,INTERVENTIONAL,Difficulties recruiting
NCT02311088,TERMINATED,INTERVENTIONAL,Too low enrolment rate
NCT02311192,WITHDRAWN,INTERVENTIONAL,Department chair choose not to participate
NCT02311296,WITHDRAWN,OBSERVATIONAL,Study registered to wrong sponsor.
NCT02311322,TERMINATED,OBSERVATIONAL,PI left NIH
NCT02311465,WITHDRAWN,INTERVENTIONAL,Feasibility issues
NCT02311491,WITHDRAWN,INTERVENTIONAL,Funding terminated
NCT02311777,WITHDRAWN,INTERVENTIONAL,Preoperative period is very short time
NCT02311985,TERMINATED,INTERVENTIONAL,Low inclusion rate
NCT02312115,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02312206,TERMINATED,INTERVENTIONAL,The VITAL study was terminated due to futility analysis
NCT02312752,WITHDRAWN,INTERVENTIONAL,Electrodes required gas sterilization before re-use which was not feasible
NCT02312804,WITHDRAWN,INTERVENTIONAL,Drug not available.
NCT02313207,WITHDRAWN,INTERVENTIONAL,No appropriate participants
NCT02313246,TERMINATED,INTERVENTIONAL,Principal investigator left the institution
NCT02313350,WITHDRAWN,INTERVENTIONAL,faisability
NCT02313844,WITHDRAWN,INTERVENTIONAL,Not developing product
NCT02313896,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02313909,TERMINATED,INTERVENTIONAL,Study halted early due to no efficacy improvement over aspirin at an interim analysis and very little chance of showing overall benefit if study were completed
NCT02313987,WITHDRAWN,OBSERVATIONAL,Study never began
NCT02314052,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02314143,TERMINATED,INTERVENTIONAL,The study was terminated early due to slow enrollment and limited numbers of viable tissue samples.
NCT02314247,TERMINATED,INTERVENTIONAL,Due to enrollment challenges
NCT02314455,TERMINATED,INTERVENTIONAL,Early analysis showed negative results. It was decided to halt the study.
NCT02314468,WITHDRAWN,INTERVENTIONAL,No funding
NCT02314598,TERMINATED,OBSERVATIONAL,No chance to meet the foreseen target of patients with study endpoint
NCT02314611,TERMINATED,OBSERVATIONAL,"The primary reason for this study was to collect safety and performance data to meet regulatory requirements. However, these requirements have changed over time. Our recentassessment has determined that now there is sufficient data on this product."
NCT02314793,TERMINATED,INTERVENTIONAL,The study has been terminated because of operational reasons.
NCT02314962,TERMINATED,OBSERVATIONAL,Slow enrolment
NCT02315131,TERMINATED,INTERVENTIONAL,Business decision
NCT02315144,TERMINATED,INTERVENTIONAL,Business decision
NCT02315157,WITHDRAWN,INTERVENTIONAL,Withdrawn by PI
NCT02315235,WITHDRAWN,INTERVENTIONAL,Do not have a sutable subjects.
NCT02315378,TERMINATED,INTERVENTIONAL,"The original PI, Alexander Neumeister, left NYULMC. No data was analyzed."
NCT02315404,TERMINATED,INTERVENTIONAL,Poor Enrollment
NCT02315625,TERMINATED,INTERVENTIONAL,Study closed due to poor accrual.
NCT02315638,TERMINATED,OBSERVATIONAL,Long term safety follow-up no longer required
NCT02315781,TERMINATED,INTERVENTIONAL,Resources to conduct study withdrawn
NCT02315937,SUSPENDED,OBSERVATIONAL,logistic reasons; amendment pending with IRB
NCT02316132,WITHDRAWN,INTERVENTIONAL,No appropriate participants
NCT02316249,WITHDRAWN,INTERVENTIONAL,the study was not feasible
NCT02316548,TERMINATED,INTERVENTIONAL,Trial will not meet CTEP Early Phase Trial Slow Accrual Guidelines
NCT02316652,TERMINATED,INTERVENTIONAL,Study stopped and was not completed
NCT02316925,WITHDRAWN,INTERVENTIONAL,This study will never recruit. The protocol was renamed and will be resubmitted.
NCT02316951,TERMINATED,OBSERVATIONAL,Logistical and enrollment issues
NCT02317029,TERMINATED,INTERVENTIONAL,A major adverse event occured (pulsed biphasic waveform arm).
NCT02317042,TERMINATED,INTERVENTIONAL,Phase II not initiated for commercial reasons (no safety related issues)
NCT02317055,TERMINATED,INTERVENTIONAL,enrollment problem
NCT02317185,TERMINATED,OBSERVATIONAL,For business reasons / product no longer available from Sponsor
NCT02317250,WITHDRAWN,INTERVENTIONAL,Study withdrawn. No participants enrolled.
NCT02317263,WITHDRAWN,INTERVENTIONAL,NIH did not fund the study so it never started
NCT02317276,TERMINATED,INTERVENTIONAL,Unable to meet the study's recruitment goals
NCT02317289,TERMINATED,INTERVENTIONAL,end of inclusion period and recruitment difficulties
NCT02317302,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02317419,TERMINATED,INTERVENTIONAL,The study was prematurely terminated because the emerging benefit:risk ratio did not justify continuing dosing patients.
NCT02317549,TERMINATED,INTERVENTIONAL,Inability to enroll
NCT02317562,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02317731,TERMINATED,INTERVENTIONAL,PI relocated
NCT02318056,WITHDRAWN,INTERVENTIONAL,Due to reorganization.
NCT02318368,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02318537,WITHDRAWN,INTERVENTIONAL,Sponsor elected not to continue with study.
NCT02318563,WITHDRAWN,INTERVENTIONAL,Sponsor elected not to continue with study.
NCT02318901,TERMINATED,INTERVENTIONAL,PI no longer at sight. Results not collected
NCT02319200,TERMINATED,INTERVENTIONAL,Decision of investigator
NCT02319265,WITHDRAWN,INTERVENTIONAL,Study registered elsewhere and is not covered by FDA
NCT02319304,TERMINATED,INTERVENTIONAL,"Slow accrual, PI left instituion"
NCT02319369,TERMINATED,INTERVENTIONAL,This study was terminated based on a business decision by the Sponsor.
NCT02319512,TERMINATED,INTERVENTIONAL,Due to a radical change in postoperative care as well as surgical technique.
NCT02319564,WITHDRAWN,INTERVENTIONAL,Study population too narrow - unable to recruit any patients.
NCT02319616,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02319681,WITHDRAWN,INTERVENTIONAL,PI relocated to UNCP; Study is not being transferred
NCT02319720,TERMINATED,INTERVENTIONAL,Lack of funds
NCT02319733,TERMINATED,INTERVENTIONAL,insufficient eligable subjects and new data on BVS
NCT02319889,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT02320201,WITHDRAWN,INTERVENTIONAL,Not enough patients enrolled for analysis.
NCT02320968,TERMINATED,INTERVENTIONAL,low recruitment
NCT02321306,WITHDRAWN,INTERVENTIONAL,"The study stopped early, before enrolling its first participant."
NCT02321319,TERMINATED,INTERVENTIONAL,Business decision - product discontinued
NCT02321566,TERMINATED,INTERVENTIONAL,Device manufacturer no longer supports implant covered under the IDE.
NCT02321982,WITHDRAWN,INTERVENTIONAL,Study topic is no longer being pursued by study team members
NCT02322021,TERMINATED,INTERVENTIONAL,This study was terminated early by the sponsor on the recommendation of an independent data safety monitoring board following review of unblinded data from the Phase 3 studies E2609-G000-301 (NCT02956486) and E2609-G000-302 (NCT03036280).
NCT02322099,TERMINATED,INTERVENTIONAL,Due to the COVID-19 pandemic the study was terminated prematurely
NCT02322190,TERMINATED,INTERVENTIONAL,Due to slow/insufficient accrual and Principal Investigator left the NIH
NCT02322281,TERMINATED,INTERVENTIONAL,Sponsor discontinued development of CO-1686 for NSCLC
NCT02322541,WITHDRAWN,INTERVENTIONAL,This study was suspended due to additional time needed for method development.
NCT02322723,WITHDRAWN,OBSERVATIONAL,No enrollment
NCT02322814,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02322853,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02322996,WITHDRAWN,OBSERVATIONAL,never started
NCT02323009,TERMINATED,INTERVENTIONAL,Minimal recruitment. very few patients available with eligibility criteria
NCT02323100,TERMINATED,INTERVENTIONAL,funding ended
NCT02323113,TERMINATED,INTERVENTIONAL,Business Decision; No Safety or Efficacy Concerns.
NCT02323126,TERMINATED,INTERVENTIONAL,Sponsor decision due to low patient recruitment caused by the change in the treatment landscape of NSCLC.
NCT02323230,TERMINATED,INTERVENTIONAL,new study
NCT02323269,TERMINATED,OBSERVATIONAL,109MS415 ImPROve study was terminated due to patient enrollment challenges and feasibility . The decision was not a result of safety concerns.
NCT02323360,TERMINATED,INTERVENTIONAL,too slow enrollment
NCT02323477,TERMINATED,INTERVENTIONAL,Due to budget limitations as allocated for a given period.
NCT02323659,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02323711,WITHDRAWN,INTERVENTIONAL,Investigator Preference.
NCT02323906,TERMINATED,INTERVENTIONAL,Slow enrollment and business decision. No safety concerns were identified for the study drugs.
NCT02324205,TERMINATED,INTERVENTIONAL,Sponsor met enroll. need for planned second study before meeting enroll. ceiling in protocol
NCT02324465,TERMINATED,INTERVENTIONAL,Closed due to low enrollment
NCT02324491,TERMINATED,INTERVENTIONAL,Sponsor decision to analyze available safety and efficacy data
NCT02324556,TERMINATED,OBSERVATIONAL,Patients are currently being operated in the robot instead due to logistics
NCT02324699,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT02324712,WITHDRAWN,INTERVENTIONAL,PI relocated to another institution; study may be resubmitted at a later date.
NCT02324868,TERMINATED,INTERVENTIONAL,logistic problems
NCT02324894,WITHDRAWN,INTERVENTIONAL,Was never initiated.
NCT02324933,WITHDRAWN,INTERVENTIONAL,"insufficient population, unable to recruit"
NCT02325063,TERMINATED,INTERVENTIONAL,Stop production PRB kit
NCT02325336,WITHDRAWN,INTERVENTIONAL,Technical difficulties
NCT02325349,TERMINATED,INTERVENTIONAL,Change in protocol strategy
NCT02325427,TERMINATED,INTERVENTIONAL,short of funding support.
NCT02325492,TERMINATED,INTERVENTIONAL,Protocol redesign
NCT02326077,SUSPENDED,OBSERVATIONAL,Equipment and personnel discontinuity
NCT02326142,TERMINATED,INTERVENTIONAL,Enrolment difficulties.
NCT02326155,TERMINATED,OBSERVATIONAL,Terminated
NCT02326207,TERMINATED,INTERVENTIONAL,very low enrolled participants
NCT02326285,TERMINATED,INTERVENTIONAL,"Due to low patient enrollment was stopped. Only one patient could be enrolled. 37 patients were pre-screened, but not into the inclusion criteria (wt-EGFR)"
NCT02326350,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02326402,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT02326675,TERMINATED,INTERVENTIONAL,Interim analysis: results of the analysis showed no significant difference between the two study groups
NCT02326779,WITHDRAWN,INTERVENTIONAL,The study could not be performed.
NCT02326844,TERMINATED,INTERVENTIONAL,Study was closed by the Cancer Therapy Evaluation Program (CTEP)
NCT02327182,TERMINATED,INTERVENTIONAL,This study was terminated due to the benefit-risk balance of MT-4666.
NCT02327390,TERMINATED,INTERVENTIONAL,PI Left
NCT02327455,WITHDRAWN,INTERVENTIONAL,Study was never started.
NCT02327637,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02328027,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02328300,WITHDRAWN,OBSERVATIONAL,FLT production not available
NCT02328560,TERMINATED,OBSERVATIONAL,Loss of recrutement
NCT02328625,WITHDRAWN,OBSERVATIONAL,Corporate decision
NCT02328664,TERMINATED,INTERVENTIONAL,Interim analysis showed no added value of second look endoscopy
NCT02328703,TERMINATED,INTERVENTIONAL,Study closed due to substantial decrease in the desired patient population.
NCT02328742,WITHDRAWN,OBSERVATIONAL,Feasibility issues require solutions.
NCT02328846,WITHDRAWN,OBSERVATIONAL,Insufficient equipment
NCT02328911,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting qualified subjects.
NCT02329171,TERMINATED,INTERVENTIONAL,Insufficient number of participants.
NCT02329379,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02329535,TERMINATED,INTERVENTIONAL,Results from similar research were already published
NCT02329756,WITHDRAWN,INTERVENTIONAL,More preparation needed prior to collecting data.
NCT02329795,TERMINATED,OBSERVATIONAL,Slow accrual
NCT02330146,TERMINATED,INTERVENTIONAL,"* slower than anticipated rate of enrollment
* need to obtain safety and efficacy data in a timely manner
* pending expiry of manufacturing materials/reagents"
NCT02330328,WITHDRAWN,INTERVENTIONAL,Collaborator withdrew closing the study prematurely with no participants enrolled
NCT02330809,WITHDRAWN,INTERVENTIONAL,Study investigator retired and study not funded
NCT02331095,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02331212,WITHDRAWN,OBSERVATIONAL,Logistical Issues
NCT02331251,TERMINATED,INTERVENTIONAL,PI not longer at site.
NCT02331316,WITHDRAWN,INTERVENTIONAL,PI Retired study unfunded
NCT02331355,WITHDRAWN,OBSERVATIONAL,unable to find appropriate candidates
NCT02331381,TERMINATED,INTERVENTIONAL,Low accrual
NCT02331563,WITHDRAWN,INTERVENTIONAL,"patients should have assurance to attend this study, money is the main problem"
NCT02331771,TERMINATED,INTERVENTIONAL,Lack of sufficient enrollment
NCT02331875,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02332187,TERMINATED,INTERVENTIONAL,No longer have resources to complete this work.
NCT02332577,TERMINATED,INTERVENTIONAL,The sponsor stopped the study due to low recruitment with no safety concerns
NCT02332694,WITHDRAWN,INTERVENTIONAL,Investigator transferred to the University of Wisconsin - Madison
NCT02332837,WITHDRAWN,INTERVENTIONAL,Not funded
NCT02332889,TERMINATED,INTERVENTIONAL,Transition to a different immunotherapy strategy in the future at our institution
NCT02332928,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02333045,TERMINATED,INTERVENTIONAL,Minimal efficacy of maraviroc alone was found in preliminary data analysis of another study.
NCT02333123,TERMINATED,INTERVENTIONAL,Recruitment halted following TSC meeting due to poor recruitment and study unlikely to complete. Funders withdrew continued support
NCT02333136,TERMINATED,OBSERVATIONAL,insufficient enrollment
NCT02333149,WITHDRAWN,INTERVENTIONAL,Issues surrounding the current COVID-19 pandemic.
NCT02333266,WITHDRAWN,OBSERVATIONAL,The bioassay development is too difficult.
NCT02333344,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant, for strategic reasons"
NCT02333409,TERMINATED,INTERVENTIONAL,Expertise resigned
NCT02333851,TERMINATED,INTERVENTIONAL,Safety reasons
NCT02333916,TERMINATED,INTERVENTIONAL,Recruitment target could not be met
NCT02333955,WITHDRAWN,INTERVENTIONAL,Corporate decision
NCT02334319,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02334332,WITHDRAWN,INTERVENTIONAL,No accrual
NCT02334527,TERMINATED,INTERVENTIONAL,Data from first 12 subjects-primary endpoint not met. Data analysis underway.
NCT02334566,TERMINATED,INTERVENTIONAL,Inability to complete study according to protocol
NCT02334644,TERMINATED,INTERVENTIONAL,drug expired
NCT02334696,TERMINATED,OBSERVATIONAL,similar study in USA published with same protocol
NCT02334826,TERMINATED,INTERVENTIONAL,slow enrollment in one site and withdrawal of the second site prior to enrollment of first participant;
NCT02335060,TERMINATED,INTERVENTIONAL,Feasibility pilot was completed
NCT02335489,TERMINATED,OBSERVATIONAL,"A significant local issue has to led to the suspension of recruitment, this study will be terminated in the coming months"
NCT02335723,TERMINATED,INTERVENTIONAL,Problem to find eligible patients to include
NCT02335814,TERMINATED,INTERVENTIONAL,Dose escalation completed; Sponsor decision
NCT02335944,TERMINATED,INTERVENTIONAL,Company decision
NCT02336048,TERMINATED,INTERVENTIONAL,This study was terminated early because premedication with tocilizumab was unlikely to reduce the risk of IRR.
NCT02336061,TERMINATED,OBSERVATIONAL,Sponsor decision due to the low recruitment rate
NCT02336308,WITHDRAWN,INTERVENTIONAL,Standard of care for dressing changes at the institution now includes treatment intervention
NCT02336373,TERMINATED,INTERVENTIONAL,low enrollment
NCT02336425,TERMINATED,INTERVENTIONAL,This study was terminated due to the efficacy results from an interim analysis (at the end of treatment epoch) of the Phase II study CQGE031B2201 (NCT01716754).
NCT02336763,TERMINATED,INTERVENTIONAL,Closed due to lack of accrual
NCT02336906,WITHDRAWN,INTERVENTIONAL,Changes in departmental staff have led to a cut in research alotments.
NCT02336984,WITHDRAWN,INTERVENTIONAL,PI left Abramson Cancer Center and study never opened at Moffitt Cancer Center.
NCT02337088,TERMINATED,INTERVENTIONAL,Logistical reasons
NCT02337309,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT02337348,TERMINATED,INTERVENTIONAL,Stopped due to slow inclusion
NCT02337387,TERMINATED,INTERVENTIONAL,Protocol stopping criteria (safety) were met.
NCT02337413,WITHDRAWN,INTERVENTIONAL,Changes in departmental staff have led to a cut in research alotments.
NCT02337478,TERMINATED,INTERVENTIONAL,The study was stopped early due to futility.
NCT02337699,TERMINATED,OBSERVATIONAL,The Principal investigator retired without replacement. Only one patient was enrolled and completed the entire study without adverse events.
NCT02337803,WITHDRAWN,INTERVENTIONAL,A similar study was funded by PCORI so PI decided to not begin this study.
NCT02338141,TERMINATED,INTERVENTIONAL,Funding unavailable to perform study.
NCT02338232,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT02338466,WITHDRAWN,INTERVENTIONAL,Departure of the principal investigator and lack of succession
NCT02338531,WITHDRAWN,INTERVENTIONAL,Due to the discontinuation of the development of the Notch inhibitor PF-03084014-04
NCT02338570,TERMINATED,INTERVENTIONAL,"Stopped on November 16th 2016, because of recruitment failure."
NCT02338817,TERMINATED,OBSERVATIONAL,The device often failed to detect hypoglycemic episodes in glycogen storage disease patients and the rate of false positive alarms was high.
NCT02339311,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was inadvertently entered into the system.
NCT02339766,TERMINATED,INTERVENTIONAL,Not feasible due to difficulty with recruitment.
NCT02339961,WITHDRAWN,INTERVENTIONAL,No patients
NCT02339987,TERMINATED,OBSERVATIONAL,"original PI left institute, no plan to continue using samples"
NCT02340221,TERMINATED,INTERVENTIONAL,The Sponsor discontinued the manufacturing and development of taselisib due to modest clinical benefit and limited tolerability.
NCT02340299,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02340377,TERMINATED,OBSERVATIONAL,investigator transferred institutions
NCT02340455,WITHDRAWN,INTERVENTIONAL,To rebalance the study plan because it is not desirable to set up comparators using placebo.
NCT02340468,WITHDRAWN,OBSERVATIONAL,Not clinical trial
NCT02340702,WITHDRAWN,OBSERVATIONAL,Unable to abstract pulmonary function and some other data from medical records.
NCT02341040,TERMINATED,OBSERVATIONAL,insufficient subjects recruited in allotted time
NCT02341079,WITHDRAWN,INTERVENTIONAL,Principal no longer interested in conducting study
NCT02341105,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT02341118,TERMINATED,OBSERVATIONAL,This study did not collect sufficient data for primary endpoint analysis.
NCT02341157,WITHDRAWN,OBSERVATIONAL,Principal Investigator left the University of Louisville.
NCT02341170,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT02341209,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02341287,TERMINATED,INTERVENTIONAL,Change in staffing and budget due to Covid-19
NCT02341300,TERMINATED,INTERVENTIONAL,Original investigator has left the institution.
NCT02341495,TERMINATED,INTERVENTIONAL,Study was terminated early due to low patient accrual.
NCT02341560,TERMINATED,INTERVENTIONAL,An interim analysis did not warrant to continue enrollment
NCT02341625,TERMINATED,INTERVENTIONAL,Study terminated for business reasons not related to safety.
NCT02341755,TERMINATED,OBSERVATIONAL,Interim analysis was sufficient to demonstrate accuracy of the evaluated test
NCT02341963,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT02341976,WITHDRAWN,INTERVENTIONAL,PI left University and no study was ever done
NCT02342002,TERMINATED,INTERVENTIONAL,lack of funding
NCT02342353,TERMINATED,INTERVENTIONAL,Drug shortage
NCT02342431,WITHDRAWN,INTERVENTIONAL,"Cardiac Catheterization no longer part of the anesthesia department A (no belonging to cardiac anesthesia, which is a different department)"
NCT02342548,TERMINATED,INTERVENTIONAL,Study terminated on 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 \& placebo. No safety concerns.
NCT02342600,WITHDRAWN,INTERVENTIONAL,Supporting company withdrew interest
NCT02342704,TERMINATED,INTERVENTIONAL,Business Decision
NCT02342977,WITHDRAWN,INTERVENTIONAL,We were unable to enroll any patients into the study.
NCT02343016,TERMINATED,OBSERVATIONAL,due to a decision by the research team not to continuos the study
NCT02343159,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02343263,TERMINATED,INTERVENTIONAL,FDA IND was not obtained
NCT02343302,TERMINATED,INTERVENTIONAL,Poor patient accrual
NCT02343315,WITHDRAWN,INTERVENTIONAL,We were unable to run the trial because of inadequate resources (staffing). The principal investigator also moved countries.
NCT02343328,TERMINATED,INTERVENTIONAL,Not enough interest
NCT02343549,TERMINATED,INTERVENTIONAL,closed to accrual due to low accrual
NCT02343575,TERMINATED,INTERVENTIONAL,We did not recruit the research assistant and terminated the study
NCT02343666,WITHDRAWN,INTERVENTIONAL,Administrative closure prior to any enrollments
NCT02343679,WITHDRAWN,INTERVENTIONAL,No accrual due to rarity of disease.
NCT02343705,TERMINATED,INTERVENTIONAL,Sponsor election
NCT02343757,TERMINATED,INTERVENTIONAL,Not enough patient enrollment
NCT02344160,WITHDRAWN,OBSERVATIONAL,Unable to recruit subjects
NCT02344342,TERMINATED,INTERVENTIONAL,The industry sponsor has discontinued the product under evaluation in the study.
NCT02344394,WITHDRAWN,INTERVENTIONAL,Patients did not want to be randomized in hybrid ablation.
NCT02344537,TERMINATED,INTERVENTIONAL,"We aimed for 40, but slow enrollment and limited funds led us to terminate the study before completing full enrollment"
NCT02344810,WITHDRAWN,INTERVENTIONAL,The study did not open to accrual. No start date and no completion dates.
NCT02345096,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02345330,TERMINATED,INTERVENTIONAL,Due to company resource constraints
NCT02345369,TERMINATED,INTERVENTIONAL,"change in surgical implant use, loss of subinvestigator"
NCT02345460,TERMINATED,INTERVENTIONAL,Competing studies
NCT02345538,WITHDRAWN,OBSERVATIONAL,Investigator did not start the project in time; study team decided it was not feasible to begin study as resident was soon graduating. No patients enrolled.
NCT02345577,TERMINATED,INTERVENTIONAL,Due to low recruitment rate
NCT02345746,WITHDRAWN,INTERVENTIONAL,patient population
NCT02345772,TERMINATED,INTERVENTIONAL,PI no longer at site. Data was not collected
NCT02346370,TERMINATED,INTERVENTIONAL,Changing standard of care therapy regimen
NCT02346422,TERMINATED,INTERVENTIONAL,Sponsor has suspended clinical development of MYDICAR for heart failure.
NCT02346617,WITHDRAWN,INTERVENTIONAL,Due to the KoreaFDA issue
NCT02346630,WITHDRAWN,INTERVENTIONAL,We didn't receive the expected funding to support the study.
NCT02346643,TERMINATED,OBSERVATIONAL,Budget Allocation Decision by Sponsor
NCT02346656,TERMINATED,OBSERVATIONAL,Inadequate Enrolment
NCT02346877,TERMINATED,INTERVENTIONAL,Business Decision
NCT02347033,TERMINATED,INTERVENTIONAL,Difficulties with recruitment during the internal pilot phase
NCT02347163,TERMINATED,INTERVENTIONAL,The study stopped prematurely due to the low accrual rate
NCT02347280,TERMINATED,INTERVENTIONAL,Low accrual
NCT02347462,WITHDRAWN,INTERVENTIONAL,we were not able to work through the logistics of the study to support enrolment in ER
NCT02347709,WITHDRAWN,OBSERVATIONAL,PI departure
NCT02348047,TERMINATED,INTERVENTIONAL,PI resignation
NCT02348255,WITHDRAWN,INTERVENTIONAL,Poor Accrual
NCT02348281,TERMINATED,INTERVENTIONAL,it's too slow to enroll suitable patients into this study
NCT02348359,TERMINATED,INTERVENTIONAL,Interim analysis found study had achieved primary objective
NCT02349126,WITHDRAWN,INTERVENTIONAL,Company decision to pursue alternative clinical trial
NCT02349139,TERMINATED,INTERVENTIONAL,Business Decision
NCT02349178,TERMINATED,INTERVENTIONAL,Low accrual
NCT02349386,TERMINATED,INTERVENTIONAL,Inability to recruit patients
NCT02349516,WITHDRAWN,INTERVENTIONAL,Study cancelled as of 9/12/15. 0 subjects enrolled.
NCT02349633,TERMINATED,INTERVENTIONAL,"The study was ended for strategic reasons and changes in the external environment.

The safety profile and risk benefit ratio for PF-0674775 remained unchanged."
NCT02349659,TERMINATED,INTERVENTIONAL,Sponsor withdrawn due to low inclusion rate
NCT02349828,WITHDRAWN,INTERVENTIONAL,PI decided to stop due to divisional reorganization. No pts enrolled.
NCT02349932,WITHDRAWN,OBSERVATIONAL,Expired with IRB (2/2/2019).
NCT02350426,TERMINATED,INTERVENTIONAL,A decision to stop the study was made by the site and GSK project team based on pre-defined stopping criteria in the protocol
NCT02350543,TERMINATED,INTERVENTIONAL,Insufficient recruitment.
NCT02350777,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02350816,TERMINATED,INTERVENTIONAL,Completion of follow-up period
NCT02351037,TERMINATED,INTERVENTIONAL,Study data do not support development in AML.
NCT02351063,TERMINATED,INTERVENTIONAL,Sponsor's discretion to terminate study prematurely for further evaluation.
NCT02351089,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02351310,WITHDRAWN,INTERVENTIONAL,Company decided not to pursue this study.
NCT02351388,TERMINATED,INTERVENTIONAL,failure to recruit enough number of participants
NCT02351505,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT02351583,WITHDRAWN,OBSERVATIONAL,equipment difficulties
NCT02351726,TERMINATED,INTERVENTIONAL,Sponsor business decision
NCT02351869,TERMINATED,INTERVENTIONAL,This study was terminated due to COVID-19 pandemic-related halting of recruitment in the context of an upcoming replacement of the study MRI scanner.
NCT02352142,TERMINATED,INTERVENTIONAL,insufficient enrollment numbers
NCT02352350,WITHDRAWN,OBSERVATIONAL,Measurement devices unavailable at this time.
NCT02352662,WITHDRAWN,OBSERVATIONAL,Competition with another study.
NCT02352753,TERMINATED,INTERVENTIONAL,The study was stopped earlier than planned due to safety concerns about high levels of calcium in the blood of the participants
NCT02352831,TERMINATED,INTERVENTIONAL,Insufficient funding and drug supply from manufacturer
NCT02353000,TERMINATED,INTERVENTIONAL,Unable to achieve accrural within anticipated timeframe
NCT02353130,WITHDRAWN,OBSERVATIONAL,Protocol did not continue once Investigator relocated to another institution
NCT02353143,TERMINATED,INTERVENTIONAL,The Sponsor accepted the iDSMB recommendation to terminate the study due to evidence of unpredictable liver toxicity and meaningful target engagement not translating into any clinical objective response.
NCT02353351,TERMINATED,OBSERVATIONAL,The sponsor's study closure justification addressed the 522 Order's questions.
NCT02353468,TERMINATED,INTERVENTIONAL,Principle investigator left the institution
NCT02353572,TERMINATED,INTERVENTIONAL,Principle investigator left the institution
NCT02353741,TERMINATED,INTERVENTIONAL,too slow of recruitmentc
NCT02353754,TERMINATED,INTERVENTIONAL,Slow enrollment. None of the subjects received EXPAREL.
NCT02353780,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02353949,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT02354144,TERMINATED,INTERVENTIONAL,Mandated by DSMB
NCT02354326,TERMINATED,OBSERVATIONAL,No bone lesions detected and poor accrual
NCT02354443,TERMINATED,INTERVENTIONAL,Business decision
NCT02354716,TERMINATED,OBSERVATIONAL,Lack of patient population
NCT02354911,WITHDRAWN,INTERVENTIONAL,Funding for study not procured.
NCT02355041,WITHDRAWN,INTERVENTIONAL,The PI changed institutions
NCT02355275,TERMINATED,INTERVENTIONAL,large non-response rate
NCT02355288,WITHDRAWN,INTERVENTIONAL,Insufficient funding available to complete study.
NCT02355431,WITHDRAWN,INTERVENTIONAL,Study withdrawn before enrolling first patient
NCT02355574,TERMINATED,OBSERVATIONAL,Study endpoints completed with lower than anticipated enrollment. Last patient enrolled completed final visit February 2021.
NCT02355587,TERMINATED,OBSERVATIONAL,Study goals were met with smaller that expected study cohort. Last patient completed the study June 201
NCT02355652,WITHDRAWN,INTERVENTIONAL,an other study will start with new outcome measures
NCT02355691,TERMINATED,INTERVENTIONAL,Loss of Personnel
NCT02355938,TERMINATED,INTERVENTIONAL,Lost funding due to low enrollment.
NCT02356237,TERMINATED,INTERVENTIONAL,"Slower than expected recruitment rate, and larger than expected required sample."
NCT02356250,WITHDRAWN,OBSERVATIONAL,no participants enrolled
NCT02356354,TERMINATED,INTERVENTIONAL,Difficulty to recruit all the patients
NCT02356458,TERMINATED,INTERVENTIONAL,SAKK Board decision of 14th November 2020 due to financial reasons.
NCT02356614,TERMINATED,OBSERVATIONAL,Terminated is based on the availability of long-term safety and effectiveness data from the OSB Lead-HERo-002 study and published literature.
NCT02356640,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02356822,WITHDRAWN,OBSERVATIONAL,closed early with no results/no data collected.
NCT02356861,WITHDRAWN,INTERVENTIONAL,"manufacturer of the 1-of-a-kind, proprietary Treatment device went out of business. Tx. could not be delivered (see final report)"
NCT02356900,TERMINATED,INTERVENTIONAL,Lack of funding required to enroll target subject number
NCT02356939,TERMINATED,INTERVENTIONAL,Interruption of the study for safety reasons at the decision of the sponsor
NCT02356991,SUSPENDED,INTERVENTIONAL,sponsor decides to suspend this trial
NCT02357004,WITHDRAWN,INTERVENTIONAL,Change in priority of interventional protocols
NCT02357017,WITHDRAWN,INTERVENTIONAL,Change in priority of interventional protocols
NCT02357147,TERMINATED,INTERVENTIONAL,Due to business reasons
NCT02357225,TERMINATED,INTERVENTIONAL,The drug was ineffective in improving function in Pompe's disease
NCT02357277,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02357394,TERMINATED,INTERVENTIONAL,Unable to recruit patients
NCT02357433,TERMINATED,INTERVENTIONAL,Circumstances beyond the course of the trial have produced a change in the conditions of recruitment unacceptable to the ROMPA researchers
NCT02357719,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT02357732,WITHDRAWN,INTERVENTIONAL,PI decided not to proceed
NCT02357784,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment and the investigators want to explore a different primary objective
NCT02358200,TERMINATED,INTERVENTIONAL,Funding support for the study was terminated
NCT02358252,WITHDRAWN,OBSERVATIONAL,The device was under developed with some technical bugs.
NCT02358265,TERMINATED,INTERVENTIONAL,poor recruitment
NCT02358603,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02358642,TERMINATED,INTERVENTIONAL,The interim analysis suggested that low dose lisinopril given to be tube fed older patients with neuroligical dysphagia had increased mortality.
NCT02358733,TERMINATED,INTERVENTIONAL,DIfficulties with recruitment
NCT02358811,TERMINATED,OBSERVATIONAL,change of Magnetic resonance imaging (MRI) research
NCT02358850,TERMINATED,INTERVENTIONAL,low enrollment
NCT02358863,TERMINATED,INTERVENTIONAL,Issues with recruitment.
NCT02359162,TERMINATED,INTERVENTIONAL,The study is out of date
NCT02359409,WITHDRAWN,INTERVENTIONAL,no subjects consented due to competing studies
NCT02359500,TERMINATED,INTERVENTIONAL,compound no longer available
NCT02359851,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02359864,TERMINATED,INTERVENTIONAL,Staffing and budget limitations. Administrative decision to halt enrollment due to coronavirus-19 (COVID) pandemic
NCT02360059,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02360111,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02360163,WITHDRAWN,INTERVENTIONAL,No enrollment was achieved
NCT02360358,TERMINATED,INTERVENTIONAL,slow inclusion
NCT02360436,WITHDRAWN,OBSERVATIONAL,Priorities other studies
NCT02360722,WITHDRAWN,INTERVENTIONAL,The study was cancelled due to change in food registration regulations in China.
NCT02360735,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02360852,TERMINATED,INTERVENTIONAL,(Expected) side effects
NCT02361177,WITHDRAWN,INTERVENTIONAL,Drug not available
NCT02361346,TERMINATED,INTERVENTIONAL,Sponsor decision following clinical hold
NCT02361437,TERMINATED,INTERVENTIONAL,Investigator's hospital sold and study cancelled
NCT02361580,TERMINATED,INTERVENTIONAL,The Principal Investigator left the institution so the study was stopped before completing enrollment.
NCT02361814,TERMINATED,INTERVENTIONAL,Unfavorable results
NCT02361957,SUSPENDED,INTERVENTIONAL,We recruited 25 of the 40 participants from intended study population. Recruitment in new populations requires an METC amendment.
NCT02361996,SUSPENDED,OBSERVATIONAL,Covid-19 Pandemic
NCT02362009,TERMINATED,OBSERVATIONAL,Policy approved describing all procedures as standard of care
NCT02362100,TERMINATED,INTERVENTIONAL,"Due to low recruitment, lack of funding, and challenges maintaining follow-up in this patient population, a decision was made to terminate this study."
NCT02362191,TERMINATED,INTERVENTIONAL,The study was terminated because the dense treatment schedule precluded successful recruitment of study participants.
NCT02362230,TERMINATED,INTERVENTIONAL,Difficulty accruing subjects the study accrual was closed
NCT02362282,TERMINATED,INTERVENTIONAL,unable to hire qualified personnel to run the study
NCT02362321,TERMINATED,INTERVENTIONAL,Due to serious adverse events
NCT02362451,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02362880,TERMINATED,INTERVENTIONAL,"On 15 January 2019, the sponsor decided to stop the study prematurely due to lack of patient recruitment because of supply problems with 18 F-Florbetaben."
NCT02362984,TERMINATED,INTERVENTIONAL,Major technical hindrance in recruitment.
NCT02363023,TERMINATED,OBSERVATIONAL,Lack of resources.
NCT02363543,WITHDRAWN,INTERVENTIONAL,Sponsor decision to not to proceed
NCT02363647,TERMINATED,INTERVENTIONAL,No Current Funding
NCT02363946,TERMINATED,INTERVENTIONAL,Company decision to terminate the trial
NCT02364843,TERMINATED,INTERVENTIONAL,PI has retired and had trouble recruiting babies
NCT02364960,TERMINATED,OBSERVATIONAL,Study site will join the TARGIT-US trial in lieu of this trial
NCT02365207,TERMINATED,INTERVENTIONAL,Poor accrual of subjects and lack of funding
NCT02365233,TERMINATED,INTERVENTIONAL,IRB withheld the data due to inadequate supporting documentation
NCT02365415,WITHDRAWN,INTERVENTIONAL,Unable to enroll appropriate patients
NCT02365493,TERMINATED,INTERVENTIONAL,Recommendation of the Data Safety Monitoring Committee
NCT02365584,TERMINATED,INTERVENTIONAL,The study was terminated early due to insufficient recruitment.
NCT02365662,TERMINATED,INTERVENTIONAL,Safety
NCT02365688,TERMINATED,INTERVENTIONAL,Lack of consistent reference devices
NCT02365714,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02365727,WITHDRAWN,INTERVENTIONAL,Protocol not feasible as written
NCT02365870,TERMINATED,INTERVENTIONAL,Funding cycle completed
NCT02365883,TERMINATED,OBSERVATIONAL,PI passed away
NCT02365909,TERMINATED,INTERVENTIONAL,Study stopped due to difficulty recruiting patients
NCT02366234,WITHDRAWN,OBSERVATIONAL,The investigator left the institution so the study was terminated.
NCT02366637,TERMINATED,INTERVENTIONAL,Study terminated on 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study
NCT02366663,TERMINATED,INTERVENTIONAL,Withdrawal of sponsor support
NCT02366858,WITHDRAWN,INTERVENTIONAL,PI decision was made to discontinue the study
NCT02366988,TERMINATED,INTERVENTIONAL,sponsor decision: not enough inclusion
NCT02367079,TERMINATED,INTERVENTIONAL,1 day data collection
NCT02367170,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient number of patients
NCT02367352,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02367651,WITHDRAWN,INTERVENTIONAL,Study cancelled: Withdrawn before enrollment of any participants
NCT02367690,WITHDRAWN,INTERVENTIONAL,Due to enrollment challenges \& improved SOC during run-in phase; no patients received KPT-330. Withdrawal is not a consequence of any safety concern.
NCT02368106,WITHDRAWN,OBSERVATIONAL,PI decision
NCT02368184,WITHDRAWN,OBSERVATIONAL,Sponsor decided not to go forward with study. No subjects were enrolled.
NCT02368249,WITHDRAWN,INTERVENTIONAL,no focus on this topic
NCT02368431,TERMINATED,INTERVENTIONAL,Funding ended prematurely
NCT02368639,TERMINATED,INTERVENTIONAL,The study was terminated due to recruitment slower than anticipated
NCT02368691,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT02368990,WITHDRAWN,OBSERVATIONAL,"Since the conception of the study, the competitive environment has developed and as a result this study is no longer able to generate the necessary information."
NCT02369432,TERMINATED,INTERVENTIONAL,Difficulties in enrolling patients
NCT02369497,TERMINATED,OBSERVATIONAL,PI left institution and site did not have resources to continue study
NCT02369523,TERMINATED,INTERVENTIONAL,Adequate enrollment was not reached for this study.
NCT02369614,TERMINATED,INTERVENTIONAL,Staffing issues
NCT02369744,TERMINATED,INTERVENTIONAL,due to lack of suitable patient population
NCT02369796,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study because the study did not achieve the primary efficacy objective.
NCT02369900,TERMINATED,INTERVENTIONAL,"Funding expired, low enrollments"
NCT02369913,WITHDRAWN,OBSERVATIONAL,The Study has been officially closed with the IRB
NCT02370264,TERMINATED,INTERVENTIONAL,Study not progressing toward scientific goals
NCT02370342,WITHDRAWN,INTERVENTIONAL,No funding
NCT02370355,TERMINATED,OBSERVATIONAL,Sponsor decided not to pursue study
NCT02370563,TERMINATED,INTERVENTIONAL,Business decision
NCT02370628,TERMINATED,INTERVENTIONAL,too few participants enrolled and few interested patients in three years
NCT02370719,TERMINATED,INTERVENTIONAL,"Due to the inability to recruit the required number of participants, the study has been terminated."
NCT02370823,TERMINATED,OBSERVATIONAL,Terminated early for poor study design.
NCT02370888,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02371005,TERMINATED,INTERVENTIONAL,scleroderma patients were difficult to recruit
NCT02371031,TERMINATED,INTERVENTIONAL,Funding source for study ended.
NCT02371538,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02371577,WITHDRAWN,INTERVENTIONAL,withdrawn
NCT02371590,WITHDRAWN,INTERVENTIONAL,Study Not Activated Due to Contract Issues
NCT02372240,TERMINATED,INTERVENTIONAL,Dose limiting tox is observed. Study put on full clinical hold.
NCT02372279,TERMINATED,INTERVENTIONAL,The forecast regarding the number of patients that could enter the study were not met in the designated period
NCT02372305,WITHDRAWN,INTERVENTIONAL,PI is no longer at institution. IRB closed study due to lack of response from PI
NCT02372318,TERMINATED,INTERVENTIONAL,"Anticipated nr of 25 probands was not reached in terms of full data sets (missing data, low fMRI data quality), but time frame for recruitment ended."
NCT02372539,WITHDRAWN,OBSERVATIONAL,COVID prevented accruals
NCT02372578,TERMINATED,INTERVENTIONAL,The study was terminated due to futility analysis.
NCT02372695,TERMINATED,INTERVENTIONAL,Protocol showed to be inappropriate for the evaluation of the selected patients
NCT02372721,WITHDRAWN,OBSERVATIONAL,The IRB required this protocol to be split into two different protocols
NCT02372760,WITHDRAWN,INTERVENTIONAL,The PI has relocated and the study has been closed.
NCT02373241,TERMINATED,INTERVENTIONAL,Estimated GFR was determined not to be a reliable endpoint for this study. We identified significant variabilty in annual eGFR that it became inappropriate to randomize to a medication but use EGFR as the primary endpoint.
NCT02373397,TERMINATED,INTERVENTIONAL,Study terminated due to poor patient recruitment
NCT02373462,TERMINATED,INTERVENTIONAL,The data of the paper referenced in the preparation of the protocols in this task were manipulated and the paper was withdrawn.
NCT02373787,TERMINATED,INTERVENTIONAL,Business reasons
NCT02373800,TERMINATED,OBSERVATIONAL,insufficient inclusions
NCT02373865,TERMINATED,INTERVENTIONAL,Premature termination due to insufficient patient recruitement..
NCT02373956,TERMINATED,INTERVENTIONAL,difficulties to include
NCT02374086,WITHDRAWN,INTERVENTIONAL,Enrollment slower than usual.
NCT02374294,WITHDRAWN,INTERVENTIONAL,could not come to budget agreement
NCT02374320,TERMINATED,INTERVENTIONAL,PI leaving institution
NCT02374424,TERMINATED,INTERVENTIONAL,"Interim analysis planned as per protocol didn't provide positive outcome therefore enrollment was not reopened. However, the enrolled patients concluded therapy and continued into the follow-up phase. The study was closed only after LVLP."
NCT02374489,TERMINATED,INTERVENTIONAL,ROS1 in IHC and gene rearrangement result can not matchNo tumor response
NCT02374723,WITHDRAWN,INTERVENTIONAL,This study was withdrawn to be replaced with a multi-site Phase I trial.
NCT02374853,TERMINATED,INTERVENTIONAL,the preliminary analysis of study result did not show significant benefit that was anticipate
NCT02374905,TERMINATED,INTERVENTIONAL,Staff changes and retirement of the primary investigator during the study
NCT02374931,TERMINATED,INTERVENTIONAL,PI left institution
NCT02374957,TERMINATED,INTERVENTIONAL,Original PI left institution
NCT02375048,TERMINATED,INTERVENTIONAL,number of enrollments not reached in the estimated time
NCT02375334,TERMINATED,OBSERVATIONAL,Support Staff Left Institution
NCT02375711,TERMINATED,INTERVENTIONAL,Problems in including patients in the study
NCT02375789,TERMINATED,INTERVENTIONAL,Due to insolvency of sponsor
NCT02375984,TERMINATED,INTERVENTIONAL,PI changed institutions
NCT02376413,WITHDRAWN,OBSERVATIONAL,Unavailable to recruit patients.
NCT02376543,WITHDRAWN,INTERVENTIONAL,Study stopped for change in needle usage
NCT02376634,WITHDRAWN,INTERVENTIONAL,PI left Nationwide Children's Hosp.
NCT02376647,WITHDRAWN,INTERVENTIONAL,No funding obtained so far. Project was halted.
NCT02376699,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT02376933,TERMINATED,INTERVENTIONAL,PI left the department; protocol transfer did not take place.
NCT02376946,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02376972,TERMINATED,INTERVENTIONAL,According to the Recommendation of the Indipendent Data Monitoring Committee
NCT02377219,TERMINATED,INTERVENTIONAL,Recruitment target not obtained
NCT02377336,WITHDRAWN,INTERVENTIONAL,Anticipated recruitment challenges
NCT02377362,TERMINATED,INTERVENTIONAL,Insufficient efficacy for this indication. The study stopped after Part B.
NCT02377466,TERMINATED,INTERVENTIONAL,Asset terminated by PIB
NCT02377479,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02377492,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02377518,TERMINATED,INTERVENTIONAL,Change of device used for dual energy computed tomography with Xenon
NCT02377596,WITHDRAWN,OBSERVATIONAL,Not enough participants
NCT02377609,TERMINATED,OBSERVATIONAL,DBS method not be validated against the standard of care venepuncture method due to quality of blood sample and variable tacrolimus extraction
NCT02378012,TERMINATED,INTERVENTIONAL,Competing study
NCT02378233,TERMINATED,INTERVENTIONAL,Fail to complete the recruitment due to lacking resources
NCT02378415,TERMINATED,INTERVENTIONAL,Discrepancies in medication orders
NCT02378623,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew funding - May 2016
NCT02378636,WITHDRAWN,INTERVENTIONAL,Study was never initiated
NCT02378662,TERMINATED,INTERVENTIONAL,Sponsor's decision of the Early Termination of the study.
NCT02378740,WITHDRAWN,INTERVENTIONAL,PI has left the University
NCT02378779,TERMINATED,INTERVENTIONAL,"Multiple reminders were carried out but despite these measures, the GP has not enough participated ."
NCT02378831,WITHDRAWN,OBSERVATIONAL,has not begun yet.
NCT02378870,TERMINATED,INTERVENTIONAL,Poor patient recruitment
NCT02378922,WITHDRAWN,INTERVENTIONAL,Administratively closed prior to subject enrollment
NCT02379130,TERMINATED,INTERVENTIONAL,Insufficient enrollment/retention
NCT02379390,TERMINATED,INTERVENTIONAL,Unsatisfactory patient accrual
NCT02379585,TERMINATED,INTERVENTIONAL,PI Decision
NCT02379650,WITHDRAWN,INTERVENTIONAL,Testing required by FDA for IND approval was too expensive to move forward with conduct of the study.
NCT02379858,TERMINATED,INTERVENTIONAL,Manufacturer of Alvimopam closed the study due to low enrollment.
NCT02380118,TERMINATED,INTERVENTIONAL,Primary endpoint reached based on data projection from interim analysis.
NCT02380209,TERMINATED,INTERVENTIONAL,PI has terminated study as the sequencing on patients and volunteers didn't yield the results expected. PI has no plans for scholarly/scientific presentations.
NCT02380313,WITHDRAWN,INTERVENTIONAL,Study cancelled: Withdrawn before enrollment of any participants
NCT02380534,WITHDRAWN,INTERVENTIONAL,Funding missing
NCT02380677,TERMINATED,INTERVENTIONAL,Company decision
NCT02380937,TERMINATED,INTERVENTIONAL,The study was terminated prematurely on 05May 2015 because of the unavailability of study devices.
NCT02381067,TERMINATED,INTERVENTIONAL,Departure of PI from the study facility
NCT02381106,SUSPENDED,OBSERVATIONAL,assay difficulties
NCT02381288,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study because the study did not meet the primary endpoint.
NCT02381392,TERMINATED,INTERVENTIONAL,"Insufficient enrollment, investigator left institution"
NCT02381600,TERMINATED,INTERVENTIONAL,Difficulties recruiting participant
NCT02381795,TERMINATED,INTERVENTIONAL,Terminated at the request of the financial sponsor.
NCT02381925,WITHDRAWN,OBSERVATIONAL,The study never opened due to funding issues
NCT02382068,WITHDRAWN,INTERVENTIONAL,No patients were enrolled to trial
NCT02382224,WITHDRAWN,INTERVENTIONAL,insufficient study staff
NCT02382406,TERMINATED,INTERVENTIONAL,The study was completed. It was fully accrued.
NCT02382419,WITHDRAWN,INTERVENTIONAL,Principal Investigator Decided to stop recruitment in the trial.
NCT02382523,WITHDRAWN,INTERVENTIONAL,There were no subjects enrolled locally on this study since it opened. Local IRB closure has been requested.
NCT02382549,TERMINATED,INTERVENTIONAL,The study was terminated because of slow accruals.
NCT02382562,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02382588,TERMINATED,INTERVENTIONAL,There were difficulties meeting the enrollment goal within stipulated time frames.
NCT02382614,TERMINATED,INTERVENTIONAL,business reasons
NCT02382627,TERMINATED,OBSERVATIONAL,poor enrollment
NCT02382679,TERMINATED,INTERVENTIONAL,Study was halted prematurely due to enrollment issues
NCT02382965,TERMINATED,OBSERVATIONAL,PI left University no data available
NCT02383056,TERMINATED,INTERVENTIONAL,Sufficient enrollment achieved for outcome measures
NCT02383095,TERMINATED,INTERVENTIONAL,Difficulties of recruitment
NCT02383121,WITHDRAWN,OBSERVATIONAL,Changed study to an observational study
NCT02383433,TERMINATED,INTERVENTIONAL,PI discretion based on low accrual
NCT02383641,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT02383992,WITHDRAWN,INTERVENTIONAL,"Participants never enrolled, study never started."
NCT02384369,WITHDRAWN,INTERVENTIONAL,Insufficient
NCT02384629,WITHDRAWN,INTERVENTIONAL,Problem with medical device provider
NCT02384746,TERMINATED,INTERVENTIONAL,Low accrual
NCT02384954,TERMINATED,INTERVENTIONAL,Change in drug product development strategy.
NCT02385084,TERMINATED,INTERVENTIONAL,Part B of the study no longer required due to new information on the study drug.
NCT02385123,TERMINATED,INTERVENTIONAL,Study was terminated due to COVID-19 pandemic.
NCT02385162,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT02385266,TERMINATED,INTERVENTIONAL,The study was closed due to recruitment limitations
NCT02385487,WITHDRAWN,OBSERVATIONAL,Logistics and feasibility
NCT02385500,TERMINATED,INTERVENTIONAL,Insufficient or untimely patient recruitment
NCT02385669,TERMINATED,INTERVENTIONAL,why study stopped
NCT02385812,TERMINATED,INTERVENTIONAL,Low enrollment through COVID pandemic
NCT02385825,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02385903,TERMINATED,INTERVENTIONAL,Decision of the Independent Review Committee
NCT02385968,TERMINATED,OBSERVATIONAL,Not possible to recruit
NCT02386098,TERMINATED,INTERVENTIONAL,GI Intolerability
NCT02386111,TERMINATED,INTERVENTIONAL,Portfolio re-prioritization
NCT02386150,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02386241,TERMINATED,OBSERVATIONAL,PI departure without replacement
NCT02386254,WITHDRAWN,OBSERVATIONAL,The study was administratively inactivated by the IRB after the PI did not submit the annual review and did not respond to the IRB's expiration letters.
NCT02387008,TERMINATED,INTERVENTIONAL,This study was halted prematurely by UNC for low accrual.
NCT02387125,TERMINATED,INTERVENTIONAL,This study did not meet the efficacy objective
NCT02387164,TERMINATED,INTERVENTIONAL,The study was interrupted early and terminated when only 26 out of 80 patients were enrolled due to new clinical study results indicating that the current study would not be informative.
NCT02387216,TERMINATED,INTERVENTIONAL,"Based on the preliminary results seen during interim analysis, which were confirmed in the final analysis, the Sponsor terminated the study"
NCT02387229,TERMINATED,INTERVENTIONAL,Consensus BRAIN-AF Executive Steering Committee to terminate.
NCT02387242,SUSPENDED,INTERVENTIONAL,New relevant data published
NCT02387398,TERMINATED,INTERVENTIONAL,"Funded study period, including a one-year no cost extension, completed."
NCT02387697,TERMINATED,INTERVENTIONAL,Safety concerns
NCT02387840,TERMINATED,INTERVENTIONAL,technician left institution
NCT02388152,TERMINATED,INTERVENTIONAL,New data: The study was terminated based on new efficacy data from another study
NCT02388165,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT02388178,WITHDRAWN,INTERVENTIONAL,The study was stopped due to business reasons.
NCT02388321,TERMINATED,INTERVENTIONAL,"Patients meeting inclusion criteria was low, and PI went to another institution."
NCT02388477,WITHDRAWN,INTERVENTIONAL,Research idea tabled at this point.
NCT02388672,WITHDRAWN,INTERVENTIONAL,Personnel changes
NCT02388685,TERMINATED,INTERVENTIONAL,Inadequate patient recruitment
NCT02388776,TERMINATED,INTERVENTIONAL,Subject recruitment unable to be completed due to study feasibility issues.
NCT02388880,TERMINATED,INTERVENTIONAL,Slower than anticipated enrollment
NCT02388932,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02388971,WITHDRAWN,INTERVENTIONAL,Study has withdrawn.
NCT02389504,WITHDRAWN,INTERVENTIONAL,"Primary study team member left organization, study was not completed."
NCT02389543,WITHDRAWN,INTERVENTIONAL,Terminated this trial and added a Lenalidomide arm to KCP-330-017
NCT02389712,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT02389764,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02389907,WITHDRAWN,OBSERVATIONAL,The study was not developed due to the cessation of IONSYS marketing
NCT02389985,TERMINATED,INTERVENTIONAL,Company decision
NCT02390362,TERMINATED,INTERVENTIONAL,Funding associated with enrollment milestones was withdrawn by Sponsor.
NCT02390401,TERMINATED,INTERVENTIONAL,Continuation was futile per calculation recommend by data \& safety monitoring committee
NCT02390440,WITHDRAWN,INTERVENTIONAL,Did not obtain an IND.
NCT02390583,WITHDRAWN,INTERVENTIONAL,no patient
NCT02390700,TERMINATED,OBSERVATIONAL,Business decision based on lack of enrollment
NCT02391012,TERMINATED,INTERVENTIONAL,unable to recruit enough patients
NCT02391038,TERMINATED,INTERVENTIONAL,The study was terminated because preliminary PK and overall clinical data demonstrated compelling similarity between Western and Asian participant populations.
NCT02391467,SUSPENDED,OBSERVATIONAL,issue concerning safety of elastography during pregnancy
NCT02391545,TERMINATED,INTERVENTIONAL,Sponsor is focusing on studies which can enable registration of duvelisib.
NCT02391896,TERMINATED,INTERVENTIONAL,PI has left UHN. This study is no longer running at UHN.
NCT02391922,WITHDRAWN,INTERVENTIONAL,Could not recruit eligible PhD-candidate to take on the project
NCT02392039,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02392156,TERMINATED,OBSERVATIONAL,Study terminated due to recruitment challenges.
NCT02392273,TERMINATED,OBSERVATIONAL,Study unable to recruit
NCT02392286,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT02392377,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02392546,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT02392676,WITHDRAWN,INTERVENTIONAL,Study is unlikely to be feasible given the evolving ovarian cancer landscape and alternative studies have the potential to meet future clinical demand.
NCT02392689,TERMINATED,INTERVENTIONAL,At 75% patient completion overall mortality was much lower than expected and without significant difference at day 90. No chance to reach the primary endpoint.
NCT02393027,TERMINATED,INTERVENTIONAL,Enough inclusions for interpretation
NCT02393092,TERMINATED,INTERVENTIONAL,It was determined that internal resources to support this population would be better utilized in other Injury and Violence Prevention Programs.
NCT02393183,WITHDRAWN,INTERVENTIONAL,Do not access to the drug
NCT02393209,TERMINATED,INTERVENTIONAL,Lack of efficacy in combination.
NCT02393326,WITHDRAWN,INTERVENTIONAL,technical and funding issues
NCT02393378,TERMINATED,INTERVENTIONAL,Strategic decision - to understand data from psoriasis study - NCT02129777 and wait for results of formal proof of concept study - NCT02379091.
NCT02393573,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02393716,TERMINATED,INTERVENTIONAL,This study terminated enrollment due to device failures prior to enrollment completion.
NCT02393833,TERMINATED,INTERVENTIONAL,Sufficient statistical power cannot be met due to low samples size
NCT02394041,TERMINATED,INTERVENTIONAL,"insufficient recruitment: 142 patients instead of 2,220 planned"
NCT02394210,TERMINATED,OBSERVATIONAL,Bias in the study
NCT02394275,TERMINATED,INTERVENTIONAL,Lack of funding for long-term follow-up
NCT02394301,SUSPENDED,OBSERVATIONAL,Poor enrollment
NCT02394418,WITHDRAWN,INTERVENTIONAL,for technical reasons
NCT02394522,WITHDRAWN,INTERVENTIONAL,sponsors
NCT02394639,WITHDRAWN,INTERVENTIONAL,Project funding ended before reaching Phase 4.
NCT02394665,TERMINATED,INTERVENTIONAL,Lack of Accrual/Enrollment
NCT02394782,TERMINATED,OBSERVATIONAL,lower than anticipated recruitment rate
NCT02394860,TERMINATED,OBSERVATIONAL,no patient
NCT02394912,TERMINATED,INTERVENTIONAL,Unsatisfactory filter deployment in several cases
NCT02395393,WITHDRAWN,INTERVENTIONAL,This study is planned for later
NCT02395627,TERMINATED,INTERVENTIONAL,Insufficient efficacy in an unselected patient population
NCT02395692,TERMINATED,INTERVENTIONAL,Pre-specified response criteria not met to proceed to next stage of study.
NCT02395796,TERMINATED,INTERVENTIONAL,Negative results were obtained in all subjects that were analyzed (n=10)
NCT02395848,TERMINATED,INTERVENTIONAL,Insufficient resource to complete the study
NCT02395952,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT02396030,TERMINATED,INTERVENTIONAL,After recommendation because of the impossibility to end study with 1 center only. Outcomes of patients already included will be evaluated.
NCT02396095,TERMINATED,OBSERVATIONAL,"American Society of Reproductive Medicine guidelines, October 2012."
NCT02396225,TERMINATED,INTERVENTIONAL,results obtained at interrim analysis after 12 patients would not be changed by recruiting another twelwe participants
NCT02396251,TERMINATED,INTERVENTIONAL,Sponsor business reasons
NCT02396277,SUSPENDED,OBSERVATIONAL,Due to limited resources
NCT02396368,WITHDRAWN,INTERVENTIONAL,Phase III study results for the drug Tesquinimod were not promising so it was a drug development decision to stop using the drug
NCT02396420,TERMINATED,INTERVENTIONAL,IP received FDA clearance for use in PAE as treatment for BPH.
NCT02396433,WITHDRAWN,INTERVENTIONAL,lack of funding.
NCT02396446,WITHDRAWN,OBSERVATIONAL,This study was never completed because the company was not able to support the trial with devices.
NCT02396628,TERMINATED,INTERVENTIONAL,impossibility to recruit in the BAT arm
NCT02396732,TERMINATED,INTERVENTIONAL,Terminated due to futility and less subjects meeting entry criteria
NCT02396745,TERMINATED,INTERVENTIONAL,Serious Adverse Event of Patient who completed study and follow-up.
NCT02396810,TERMINATED,INTERVENTIONAL,Pending additional funding
NCT02397356,WITHDRAWN,INTERVENTIONAL,Lack of study personnel
NCT02397395,WITHDRAWN,INTERVENTIONAL,Trial has been cancelled due to availability of new therapeutic options for patient population
NCT02397746,TERMINATED,OBSERVATIONAL,Research site unable to support further study requirements
NCT02397941,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT02398136,WITHDRAWN,INTERVENTIONAL,FDA and IRB recommended different mode of medication administration
NCT02398318,WITHDRAWN,INTERVENTIONAL,A pilot study is recruiting
NCT02398500,TERMINATED,INTERVENTIONAL,Management decision
NCT02398578,TERMINATED,INTERVENTIONAL,"Company closed May 1, 2019"
NCT02398604,TERMINATED,INTERVENTIONAL,Study was closed due to Sponsor switched to Longeveron. New Identifier is NTC03525418
NCT02398617,WITHDRAWN,INTERVENTIONAL,Low enrollment and need to refine protocol
NCT02398851,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02398942,WITHDRAWN,OBSERVATIONAL,The investigator left the institution so the study was terminated.
NCT02398994,TERMINATED,INTERVENTIONAL,Continued effort did not successfully increase recruitment into the study.
NCT02399072,TERMINATED,OBSERVATIONAL,There is no longer a plan to pursue an approval of lampalizumab.
NCT02399111,TERMINATED,INTERVENTIONAL,PI Decision
NCT02399319,TERMINATED,INTERVENTIONAL,Principle Investigator left the institution
NCT02399462,WITHDRAWN,INTERVENTIONAL,Funding terminated prematurely
NCT02399800,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02399839,TERMINATED,OBSERVATIONAL,The PER objective has been integrated into the LOWER protocol.
NCT02399917,TERMINATED,INTERVENTIONAL,This study was terminated early due to response rates not meeting the anticipated minimum of 30%.
NCT02400112,TERMINATED,INTERVENTIONAL,Low enrollment; Low clinical relevance: evidence for use of vancomycin powder
NCT02400385,WITHDRAWN,INTERVENTIONAL,With recent advances in immunotherapy scientific question not significant
NCT02400424,TERMINATED,INTERVENTIONAL,Approval of adjuvant durvalumab after RT-CT (not anticipated in the study design) and small number of stage III NSLCL patients with peripheral tumor accessible to SBRT
NCT02400645,TERMINATED,INTERVENTIONAL,It was determined that one member of the team had falsified data.
NCT02400814,TERMINATED,INTERVENTIONAL,Enrollment halted due to slow accrual.
NCT02400840,WITHDRAWN,INTERVENTIONAL,"Study is not feasable yet, due to evolution in the patients' care"
NCT02401035,TERMINATED,INTERVENTIONAL,Study was terminated early due to the infeasibility of enrolling the required number of participants per protocol in the 1 \<2 years of age cohort.
NCT02401061,TERMINATED,INTERVENTIONAL,Enough data has been collected to allow analysis of safety profile and risk-benefit.
NCT02401074,WITHDRAWN,INTERVENTIONAL,"Study was withdrawn prior to patient enrollment due to COVID-19, funding termination and lack of eligible study participants."
NCT02401308,TERMINATED,INTERVENTIONAL,Lack of subject enrollment.
NCT02401542,TERMINATED,INTERVENTIONAL,program has been put on hold by the sponsor
NCT02401594,TERMINATED,INTERVENTIONAL,Remaining outdated treatments and additional costs too high for new manufacturing
NCT02401698,SUSPENDED,OBSERVATIONAL,To perform a interim analyzes
NCT02402114,WITHDRAWN,INTERVENTIONAL,Never started or submitted to IRB
NCT02402348,TERMINATED,INTERVENTIONAL,"Funding not available, PI left institution"
NCT02402725,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT02402738,TERMINATED,INTERVENTIONAL,We chose to maximize this iterative treatment development study by terminating the pilot RCT in favor of enhancing an initial open trial (increased N 12 to 14)
NCT02402803,TERMINATED,OBSERVATIONAL,No recruitment
NCT02402829,TERMINATED,OBSERVATIONAL,lack of participation or interest in other sites.
NCT02403154,TERMINATED,INTERVENTIONAL,Principle Investigator left institution
NCT02403323,TERMINATED,INTERVENTIONAL,"The study was terminated due to program discontinuation, based on mixed efficacy results in the parent studies. There were no safety concerns."
NCT02403453,TERMINATED,OBSERVATIONAL,Stryker has made the decision to remove the Rhine Cervical Disc Replacement from their product portfolio. Stryker is not aware of any safety or effectiveness concerns and this decision is not related to poor patient outcomes or known device failures.
NCT02403518,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02403622,TERMINATED,INTERVENTIONAL,for futility
NCT02403947,TERMINATED,INTERVENTIONAL,inclusion default
NCT02404363,TERMINATED,INTERVENTIONAL,recruitment problem
NCT02404428,TERMINATED,INTERVENTIONAL,Problems with recruitment
NCT02404493,TERMINATED,INTERVENTIONAL,Lack of subject enrollment and the eczema season has completed
NCT02404506,TERMINATED,INTERVENTIONAL,"The trial was prematurely terminated as of 22.07.2021 as per SAKK board decision board decision from 14th of November 2020. The trial was terminated after the primary endpoint was analyzed, which was the case end of December 2020."
NCT02404545,TERMINATED,INTERVENTIONAL,Sponsor stopped producing device
NCT02404597,WITHDRAWN,INTERVENTIONAL,Potential participants have not yet been identified.
NCT02404714,TERMINATED,OBSERVATIONAL,Study funding has been withdrawn. No adverse safety issues.
NCT02405234,TERMINATED,INTERVENTIONAL,Business Decision
NCT02405247,TERMINATED,OBSERVATIONAL,Team's request.
NCT02405403,WITHDRAWN,INTERVENTIONAL,It was more difficult than planned to find patients filling inclusion criteria and those which corresponded didn't agree to participate
NCT02405793,WITHDRAWN,INTERVENTIONAL,Internal business decision not to move forward with study
NCT02405910,WITHDRAWN,INTERVENTIONAL,PI Left Institution
NCT02405923,TERMINATED,INTERVENTIONAL,recruitment longer than expected and without the expected success
NCT02406131,SUSPENDED,INTERVENTIONAL,logistic issues - no available scans for participants at the moment need to postponed starting dates
NCT02406300,TERMINATED,INTERVENTIONAL,Organizational changes made recruitment no longer possible
NCT02406508,WITHDRAWN,INTERVENTIONAL,No enrollment in the study
NCT02406534,WITHDRAWN,OBSERVATIONAL,Study entered in error
NCT02406820,TERMINATED,OBSERVATIONAL,Strategic closure by sponsor to pursue other indications.
NCT02407184,WITHDRAWN,INTERVENTIONAL,Dr. Bello is no longer a PI at the institution. Data analysis was not completed.
NCT02407223,TERMINATED,INTERVENTIONAL,This study was stopped because ustekinumab did not achieve key endpoints in a related study. The safety profile was consistent with past ustekinumab studies.
NCT02407314,TERMINATED,INTERVENTIONAL,AZ discontinued study
NCT02407561,TERMINATED,OBSERVATIONAL,Futility - unable to secure sites and samples for participation
NCT02407587,WITHDRAWN,INTERVENTIONAL,unresolved issues with a collaborator.
NCT02407626,TERMINATED,INTERVENTIONAL,"Very low patient recruitment, changed insurance requirements"
NCT02407795,TERMINATED,INTERVENTIONAL,very slow inclusion
NCT02407821,TERMINATED,INTERVENTIONAL,Poor enrolment
NCT02408016,TERMINATED,INTERVENTIONAL,Terminated due to loss of funding
NCT02408081,WITHDRAWN,INTERVENTIONAL,not able to be completed
NCT02408159,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02408328,WITHDRAWN,INTERVENTIONAL,Transition to new position
NCT02408419,WITHDRAWN,INTERVENTIONAL,The study was completely redesigned
NCT02408458,WITHDRAWN,INTERVENTIONAL,enrollment rate
NCT02408471,TERMINATED,INTERVENTIONAL,Business Priorities
NCT02408562,TERMINATED,INTERVENTIONAL,Issues with development and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.
NCT02408757,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT02408848,TERMINATED,OBSERVATIONAL,No three dimensional transthoracic echo available currently
NCT02408887,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT02408991,WITHDRAWN,INTERVENTIONAL,PI left University
NCT02409017,TERMINATED,INTERVENTIONAL,Lack of time and participation in the study
NCT02409095,TERMINATED,INTERVENTIONAL,Due to increased rate of local injection site reactions in the DSJI group.
NCT02409147,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02409238,TERMINATED,INTERVENTIONAL,"1. Limits of grant funding reached
2. A/Prof Ng Tze Pin (P.I. \& holder of NMRC Grant (CIRG12may033) funding this study) retired in Aug 2022.
3. Resignations of staff and collaborators especially over the 1st 2 years of the COVID-19 pandemic"
NCT02409355,TERMINATED,INTERVENTIONAL,"The study was closed due to low patient enrollment and the Sponsor's decision to include patients with squamous NSCLC into the GO29431 study, NCT02409342."
NCT02409433,TERMINATED,INTERVENTIONAL,due to slow recruitment and budgetary restraints study was prematurely terminated
NCT02409693,WITHDRAWN,OBSERVATIONAL,Unable to obtain funding
NCT02409862,WITHDRAWN,INTERVENTIONAL,Technical issues preventing recruitment.
NCT02410005,TERMINATED,INTERVENTIONAL,Logistic challenges
NCT02410174,TERMINATED,INTERVENTIONAL,Poor Accural
NCT02410239,WITHDRAWN,INTERVENTIONAL,Research cancelled
NCT02410343,TERMINATED,INTERVENTIONAL,Business decision
NCT02410356,TERMINATED,INTERVENTIONAL,Business decision
NCT02410382,TERMINATED,INTERVENTIONAL,"IRB suspension, did not resume"
NCT02410564,TERMINATED,INTERVENTIONAL,insufficient staff
NCT02410655,WITHDRAWN,INTERVENTIONAL,Submission discarded. Study never enrolled subjects.
NCT02410863,TERMINATED,INTERVENTIONAL,lack of recruitment due to changed therapy options
NCT02411084,TERMINATED,INTERVENTIONAL,Insufficient rate of accrual
NCT02411188,WITHDRAWN,INTERVENTIONAL,recruitment issues; changed protocol to prospective cohort study
NCT02411565,TERMINATED,INTERVENTIONAL,Drug manufacturing issues
NCT02411643,TERMINATED,INTERVENTIONAL,Accrual incomplete/Investigator left institution
NCT02411734,TERMINATED,OBSERVATIONAL,Administrative problems with study director
NCT02411799,TERMINATED,OBSERVATIONAL,Principal investigator has left the university. Research has been discontinued prior to study completion; Registry study: no analysis
NCT02411877,WITHDRAWN,INTERVENTIONAL,It was decided that it was not feasible to continue this study.
NCT02412046,TERMINATED,INTERVENTIONAL,Departure of the PhD in charge of the study
NCT02412124,TERMINATED,INTERVENTIONAL,Feasibility issues
NCT02412371,TERMINATED,INTERVENTIONAL,"Phase 2 was not conducted due to a change in the standard of care for newly diagnosed, unresectable Stage III NSCLC"
NCT02412475,TERMINATED,INTERVENTIONAL,We opened a competing study with the TACL consortium
NCT02412631,TERMINATED,INTERVENTIONAL,Lorcaserin removed from market
NCT02412813,WITHDRAWN,INTERVENTIONAL,Overhaul of Study Design
NCT02412891,WITHDRAWN,INTERVENTIONAL,Cancelled due to financial reasons
NCT02413047,TERMINATED,INTERVENTIONAL,physician decision to stop study early due to low enrollment
NCT02413138,TERMINATED,INTERVENTIONAL,The primary endpoint of non-inferiority to daily therapy in the pediatric Phase 3 study was not achieved
NCT02413489,TERMINATED,INTERVENTIONAL,DLBCL and FL cohorts met the pre-specified futility criteria and will not proceed. The MCL cohort was terminated due to slow recruitment and aggressive disease.
NCT02413528,TERMINATED,INTERVENTIONAL,Wireless connectivity challenges with device and mobile app
NCT02413827,TERMINATED,INTERVENTIONAL,Feasibility concerns due to changes in standard of care
NCT02413853,WITHDRAWN,INTERVENTIONAL,Study drug supply issues
NCT02414100,WITHDRAWN,OBSERVATIONAL,No subjects were enrolled. Study team was not able to grow cell lines for the tumors.
NCT02414152,TERMINATED,INTERVENTIONAL,Early study termination occurred due to inability to secure funding
NCT02414165,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02414451,WITHDRAWN,INTERVENTIONAL,No need for a pilot study. New study will be opened.
NCT02414555,TERMINATED,INTERVENTIONAL,Patient Safety
NCT02414698,TERMINATED,INTERVENTIONAL,Integral investigator left study; could not continue recruiting.
NCT02414724,TERMINATED,INTERVENTIONAL,PI left institute
NCT02414750,TERMINATED,INTERVENTIONAL,Slow accrual and changing treatment landscape
NCT02414776,TERMINATED,INTERVENTIONAL,PI Leaving Site
NCT02414984,TERMINATED,OBSERVATIONAL,Insufficient enrollment (Terminated due to lack of patient recruitment)
NCT02415036,TERMINATED,INTERVENTIONAL,Limited enrollment
NCT02415504,TERMINATED,INTERVENTIONAL,"Funding problems, slow recruitment, PI location change"
NCT02415595,TERMINATED,INTERVENTIONAL,The trial ended early due to GI intolerability and treatment-emergent resistance.
NCT02415608,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02416102,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT02416128,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02416193,TERMINATED,INTERVENTIONAL,the study was halted prematurely due to slow recruitment and expiration of funding
NCT02416414,TERMINATED,OBSERVATIONAL,Sponsor decided not to go forward with study for FDA submission.
NCT02416570,TERMINATED,INTERVENTIONAL,At 6 months 1 participant recruited. Study deemed not feasible and discontinued.
NCT02416791,TERMINATED,INTERVENTIONAL,Because of low recruitment rates
NCT02417103,TERMINATED,INTERVENTIONAL,Recruiting failure
NCT02417168,TERMINATED,OBSERVATIONAL,PI left study site
NCT02417298,TERMINATED,INTERVENTIONAL,Feasibility
NCT02417402,WITHDRAWN,INTERVENTIONAL,We had many issues related to recruitment. After many attempts we want to suspend the study with 13 patients.
NCT02417753,TERMINATED,INTERVENTIONAL,Study was closed because we could not find these types of patients.
NCT02417870,TERMINATED,INTERVENTIONAL,lack of funding/resources
NCT02417974,TERMINATED,INTERVENTIONAL,Low enrollment was exacerbated by a covid policy related study suspension so the research was stopped.
NCT02418000,TERMINATED,INTERVENTIONAL,Insufficient efficacy in Phase 1 dose-escalation portion of study
NCT02418039,TERMINATED,INTERVENTIONAL,"The study was terminated because of the reconversion of the hospital to care for patients with COVID19. For this reason, it was not possible to continue recruiting and monitoring patients for this clinical study."
NCT02418273,WITHDRAWN,INTERVENTIONAL,was not funded
NCT02418325,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02418598,TERMINATED,INTERVENTIONAL,another clinical study for regulatory approval is planned
NCT02418702,WITHDRAWN,INTERVENTIONAL,PI no longer at facility.
NCT02418754,TERMINATED,INTERVENTIONAL,No additional efficacy seen with REGN2176-3 over aflibercept alone
NCT02418858,WITHDRAWN,INTERVENTIONAL,Lack of subject enrollment
NCT02419105,TERMINATED,INTERVENTIONAL,Delayed recruitment mainly due to a screening to inclusion rate much lower than expected. Due to the delayed recruitment IMP reached the end of its shelf life.
NCT02419170,WITHDRAWN,INTERVENTIONAL,Investigator who manufactured the vaccine left the university.
NCT02419339,TERMINATED,OBSERVATIONAL,Principal investigator is moving to a different institution.
NCT02419469,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02419638,WITHDRAWN,OBSERVATIONAL,Collaborative decision between study PI and sponsor.
NCT02419664,TERMINATED,INTERVENTIONAL,The hypothesis we had that we could predict the growth rate from PET uptake could not be confirmer and 3-year follow up was no longer considered motivated
NCT02419703,TERMINATED,OBSERVATIONAL,Difficulty Enrolling
NCT02419755,TERMINATED,INTERVENTIONAL,Accrual goals were no longer feasible based on restrictions imposed by the DSMB.
NCT02419781,TERMINATED,INTERVENTIONAL,Evidence of thrombectomy for acute stroke was established
NCT02419820,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02419846,TERMINATED,INTERVENTIONAL,Unable to recruit due to COVID limitations / Funding Unavailable
NCT02420028,TERMINATED,INTERVENTIONAL,Inability to recruit patients sufficiently
NCT02420080,TERMINATED,OBSERVATIONAL,Study was terminated early due to results from previous CMX study
NCT02420210,TERMINATED,INTERVENTIONAL,Trials was stopped early due to lack of funding.
NCT02420509,TERMINATED,OBSERVATIONAL,unable to accrue
NCT02420522,SUSPENDED,INTERVENTIONAL,Low recruitment rates and timeline viability analysis.
NCT02420626,WITHDRAWN,OBSERVATIONAL,"An industry-wide, alternative, post-market study has been initiated"
NCT02420652,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02420717,TERMINATED,INTERVENTIONAL,Study was closed early due to low accrual and lack of response.
NCT02420795,TERMINATED,INTERVENTIONAL,Per PI Request
NCT02420925,WITHDRAWN,INTERVENTIONAL,"enrollment ""0"""
NCT02421029,WITHDRAWN,INTERVENTIONAL,it was logistically difficult to obtain the drug needed to conduct the study
NCT02421250,WITHDRAWN,INTERVENTIONAL,PI terminated the study prior to enrolling any participants.
NCT02421419,TERMINATED,INTERVENTIONAL,Study closed; recruitment problems
NCT02421458,TERMINATED,INTERVENTIONAL,recruiting rate was to low
NCT02421575,TERMINATED,INTERVENTIONAL,slow accrual
NCT02422095,WITHDRAWN,OBSERVATIONAL,"This is project was determined to be not research, and the IRB has no oversight"
NCT02422368,WITHDRAWN,INTERVENTIONAL,Do not access to the drug
NCT02422446,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients with elevated triglycerides under statin treatment
NCT02422524,TERMINATED,INTERVENTIONAL,The TB hepatic pretomanid PK trial is closed to enrollment. There is no possibility of enrolling and completing the CSR before November 2024.
NCT02422667,WITHDRAWN,OBSERVATIONAL,Study cancelled - no results
NCT02422680,WITHDRAWN,OBSERVATIONAL,Cancelled according to PhD-protocol with insufficient time to complete the study
NCT02423018,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT02423057,SUSPENDED,INTERVENTIONAL,"The protocol was placed on Administrative hold on 3/19/19 following several instances of pulmonary infection, including a patient death on study in January 2019"
NCT02423148,WITHDRAWN,INTERVENTIONAL,Co-investigator left facility. Decided not to enroll patients therefore.
NCT02423174,WITHDRAWN,OBSERVATIONAL,Funding
NCT02423265,WITHDRAWN,INTERVENTIONAL,slow recruitment; local new issues with CMR after study start
NCT02423330,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT02423785,TERMINATED,OBSERVATIONAL,Slow recruitment
NCT02423954,TERMINATED,INTERVENTIONAL,Investigator no longer at site to enroll patients or write up data
NCT02424513,WITHDRAWN,INTERVENTIONAL,Clinical trial was postponed as a result of restructured business priorities.
NCT02424552,TERMINATED,INTERVENTIONAL,recruitment problems
NCT02424721,TERMINATED,OBSERVATIONAL,Resource constraints at participating sites
NCT02424734,TERMINATED,INTERVENTIONAL,Study was terminated on 22Dec2017 due to slow enrollment; there were no safety or efficacy concerns.
NCT02425072,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT02425215,TERMINATED,OBSERVATIONAL,Lack of resources to complete the study
NCT02425306,TERMINATED,INTERVENTIONAL,Slow accrual to part 2 of the study. Accrual to part 1 is complete.
NCT02425488,TERMINATED,INTERVENTIONAL,Feasability phase completed: Cost Evaluation
NCT02425683,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT02425813,WITHDRAWN,INTERVENTIONAL,Slow Accrual
NCT02425878,TERMINATED,INTERVENTIONAL,Lack of availibility of eligible subjects
NCT02425917,WITHDRAWN,INTERVENTIONAL,not relevant to the sponsor
NCT02426021,WITHDRAWN,INTERVENTIONAL,Business decision; No Safety or Efficacy Concerns
NCT02426164,WITHDRAWN,INTERVENTIONAL,Could not receive facility approval
NCT02426385,WITHDRAWN,OBSERVATIONAL,lack of suitable patients
NCT02426424,WITHDRAWN,INTERVENTIONAL,Failure to have funding to perform the trial
NCT02426489,TERMINATED,INTERVENTIONAL,Subcontract PI left institution.
NCT02426814,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02426827,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02426996,TERMINATED,INTERVENTIONAL,Recruiting patients difficulties
NCT02427009,TERMINATED,INTERVENTIONAL,no inclusion
NCT02427074,TERMINATED,INTERVENTIONAL,Study halted due to futility
NCT02427178,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT02427438,WITHDRAWN,INTERVENTIONAL,Not recruiting subjects currently
NCT02427581,WITHDRAWN,INTERVENTIONAL,Drugs not available
NCT02427776,TERMINATED,INTERVENTIONAL,study ended prior enrollment of the first patient because of unexpected issues in the manufacturing process prevented production of adequate clinical batches
NCT02427893,WITHDRAWN,INTERVENTIONAL,no patients were enrolled
NCT02428010,TERMINATED,INTERVENTIONAL,Site has not reliably responded Medtronic team since the transition from sponsor Twelve. No data entry completed since February 2018. Last study subject passed final study visit window. No data is expected to be entered.
NCT02428062,SUSPENDED,INTERVENTIONAL,Pending Pilot study results evaluation
NCT02428218,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT02428231,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02428309,TERMINATED,INTERVENTIONAL,Due to participant recruitment feasibility
NCT02428335,WITHDRAWN,OBSERVATIONAL,Insufficient financial resources to conduct research and complete trial.
NCT02428348,TERMINATED,INTERVENTIONAL,Project funding ended before Phase 3b could be completed.
NCT02428517,TERMINATED,OBSERVATIONAL,"The PI resigned the institute, and the rest investigators at the institute decided to terminate the study."
NCT02428621,TERMINATED,INTERVENTIONAL,the study is discarded by the sponsor.
NCT02429076,WITHDRAWN,INTERVENTIONAL,We are not going to complete this study with healthy volunteers at this time.
NCT02429089,TERMINATED,INTERVENTIONAL,Decided by the investigator due to the difficulties to recruit
NCT02429388,WITHDRAWN,INTERVENTIONAL,Principal Investigator left institution prior to subjects being enrolled
NCT02429401,TERMINATED,INTERVENTIONAL,Study terminated due to low recruitment (funding agency halted study).
NCT02429453,WITHDRAWN,INTERVENTIONAL,Lack of enrolment
NCT02429505,WITHDRAWN,OBSERVATIONAL,"This study was COMPLETED, but no patients were enrolled."
NCT02429544,WITHDRAWN,INTERVENTIONAL,Study is unfunded and lack of resources
NCT02429583,TERMINATED,INTERVENTIONAL,Unable to enroll sufficient subjects
NCT02429804,TERMINATED,INTERVENTIONAL,Accrual factor
NCT02429882,WITHDRAWN,INTERVENTIONAL,"Per Amgen's decision to discontinue co-development and co-commercialization of brodalumab, study is being cancelled/closed."
NCT02429895,TERMINATED,INTERVENTIONAL,Internal business decision
NCT02429934,TERMINATED,INTERVENTIONAL,Response rate in placebo group for primary outcome was 100% on interim analysis.
NCT02430246,TERMINATED,INTERVENTIONAL,"After completing the part of assessing lactobacilli transfer, it was decided not to proceed further with the masked part of the study."
NCT02430389,TERMINATED,INTERVENTIONAL,A priori hypothesis confirmed with interim analysis.
NCT02430532,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02430558,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02430818,TERMINATED,INTERVENTIONAL,were not able to enroll patients to a satisfactory level
NCT02431000,WITHDRAWN,OBSERVATIONAL,PI is no longer at this University.
NCT02431104,WITHDRAWN,INTERVENTIONAL,Sponsor terminated study.
NCT02431169,TERMINATED,OBSERVATIONAL,Low accrual
NCT02431221,WITHDRAWN,INTERVENTIONAL,Lack of efficacy in a preceding study.
NCT02431260,TERMINATED,INTERVENTIONAL,"As of 31 JAN 2018, the study was terminated by the sponsor due to PK variability."
NCT02431351,WITHDRAWN,INTERVENTIONAL,Trial never opened.
NCT02431364,TERMINATED,INTERVENTIONAL,Administrative reason
NCT02431494,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02431663,TERMINATED,INTERVENTIONAL,Futility
NCT02432066,WITHDRAWN,INTERVENTIONAL,Study was not started and participants were not enrolled
NCT02432118,WITHDRAWN,INTERVENTIONAL,Insufficient resources
NCT02432417,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to a lack of funding. The researchers were unable to secure the necessary financial support to continue and complete the trial.
NCT02432638,WITHDRAWN,OBSERVATIONAL,PI left institution prior to enrollment of subjects
NCT02432664,TERMINATED,INTERVENTIONAL,The study was terminated after the second cohort had completed Part II due complex PK results. There were no safety concerns.
NCT02432820,TERMINATED,OBSERVATIONAL,Business decision
NCT02432898,WITHDRAWN,OBSERVATIONAL,No subjects were enrolled in this protocol
NCT02432989,SUSPENDED,INTERVENTIONAL,Not able to get enough participants
NCT02433158,TERMINATED,INTERVENTIONAL,"The B5201003 OLE study was terminated based on the failure of the 'parent"" B5201002 study to meet its efficacy endpoints. Termination was not due to safety."
NCT02433171,TERMINATED,OBSERVATIONAL,Lack of available funding.
NCT02433236,WITHDRAWN,INTERVENTIONAL,Study withdrawn prior to enrollment of first subject
NCT02433353,WITHDRAWN,INTERVENTIONAL,PI was transferred to another base. No one else available to serve as PI.
NCT02433392,TERMINATED,INTERVENTIONAL,The decision to terminate the trial was based on the slow rate of recruitment across the programme of studies
NCT02433483,TERMINATED,INTERVENTIONAL,The study was closed due to poor accrual and because of competing protocols.
NCT02433587,WITHDRAWN,INTERVENTIONAL,Never recruited any patients.
NCT02433600,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of enrollment
NCT02433665,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT02433704,WITHDRAWN,INTERVENTIONAL,Difficulty with enrollment
NCT02434055,TERMINATED,OBSERVATIONAL,Business purposes
NCT02434146,TERMINATED,INTERVENTIONAL,A company in China has decided to license the product
NCT02434523,TERMINATED,INTERVENTIONAL,concern regarding study design
NCT02434549,TERMINATED,INTERVENTIONAL,Based on efficacy results from interim analysis
NCT02434874,WITHDRAWN,INTERVENTIONAL,"Study will no longer take place, the study did not begin or accrue subjects."
NCT02434965,WITHDRAWN,INTERVENTIONAL,Study not started
NCT02434991,WITHDRAWN,INTERVENTIONAL,No funding
NCT02435095,TERMINATED,INTERVENTIONAL,"slow patient recruitment, low patient-commpliance, high dropout rates,"
NCT02435225,TERMINATED,INTERVENTIONAL,Change in goals of PI
NCT02435251,WITHDRAWN,OBSERVATIONAL,study was no longer feasible
NCT02435303,TERMINATED,INTERVENTIONAL,Number of candidates for this study is expected to be too small.
NCT02435394,WITHDRAWN,INTERVENTIONAL,"After IRB review, this study is no longer considered a clinical trial"
NCT02435420,TERMINATED,OBSERVATIONAL,Commercial decision
NCT02435446,TERMINATED,INTERVENTIONAL,PROBLEM of inclusion
NCT02435550,TERMINATED,INTERVENTIONAL,Halted due to funding issues.
NCT02435615,TERMINATED,INTERVENTIONAL,An unexpected Zika outbreak prevented recruitment of study participants. The samples collected were subsequently destroyed and not analyzed.
NCT02435771,TERMINATED,INTERVENTIONAL,failed to meet enrollment goals
NCT02435836,TERMINATED,INTERVENTIONAL,Study terminated when aripiprazole available commercially per protocol
NCT02436109,TERMINATED,OBSERVATIONAL,study device broke
NCT02436265,TERMINATED,INTERVENTIONAL,Lack of enrollment/lack of potential subjects fitting criteria
NCT02436356,TERMINATED,INTERVENTIONAL,FDA determined study device is significant risk. Study will not seek IDE.
NCT02436434,WITHDRAWN,INTERVENTIONAL,The effect is poor
NCT02436460,TERMINATED,INTERVENTIONAL,Re-initiate a new trial per the discussion with FDA
NCT02436473,WITHDRAWN,INTERVENTIONAL,This study was cancelled. No subjects were enrolled and no data has been collected
NCT02436512,WITHDRAWN,INTERVENTIONAL,Inability meet enrollment in study population.
NCT02436642,TERMINATED,OBSERVATIONAL,business decision
NCT02437162,TERMINATED,INTERVENTIONAL,Neither dose achieved the study's primary or major secondary endpoints. The safety profile was consistent with previous ustekinumab studies.
NCT02437513,TERMINATED,OBSERVATIONAL,Recruitment rates too low to continue with the study
NCT02437552,WITHDRAWN,INTERVENTIONAL,"This study would be conducted by a master course student, nevertheless, she was unable to go forward with it."
NCT02438033,WITHDRAWN,INTERVENTIONAL,Not approved by CMS
NCT02438319,WITHDRAWN,OBSERVATIONAL,study was not started
NCT02438371,TERMINATED,INTERVENTIONAL,Study halted due to slow recruitment
NCT02438761,TERMINATED,INTERVENTIONAL,"No objective response was observed at the first step. The treatment was considered ineffective, with a complete clinical trial suspension."
NCT02438787,TERMINATED,INTERVENTIONAL,This study was stopped because ustekinumab did not achieve key endpoints in a related study. The safety profile was consistent with past ustekinumab studies.
NCT02438852,WITHDRAWN,INTERVENTIONAL,No funding
NCT02438917,TERMINATED,OBSERVATIONAL,collaborator Kinemend closed due to finances
NCT02438995,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02439008,TERMINATED,INTERVENTIONAL,Lack of patient enrollment
NCT02439047,TERMINATED,INTERVENTIONAL,difficulty of carrying out the analysis and low recruitment
NCT02439138,TERMINATED,INTERVENTIONAL,Safety issues from trials in CLL
NCT02439281,TERMINATED,INTERVENTIONAL,The patients were discharged on the day of the surgery.
NCT02439307,TERMINATED,INTERVENTIONAL,"The study was terminated because of the reconversion of the hospital to care for patients with COVID19. For this reason, it was not possible to continue recruiting and monitoring patients for this clinical study."
NCT02439346,TERMINATED,INTERVENTIONAL,Study stopped due to project prioritization
NCT02439645,TERMINATED,OBSERVATIONAL,"Study was terminated lack of recruitment, small number of eligible cases (11 enrolled, 1 found ineligible after enrollment), unlikely to be able to achieve study goals due to low recruitment."
NCT02439723,WITHDRAWN,INTERVENTIONAL,Withdrawal of supply of investigational product
NCT02439788,WITHDRAWN,INTERVENTIONAL,Based on newly available preclinical data we changed the CAR construct to a more effective version and will now study that product on a different protocol.
NCT02439944,TERMINATED,INTERVENTIONAL,full RCT funded. no need to continue pilot data collection.
NCT02439957,TERMINATED,INTERVENTIONAL,Study terminated early due to results from another CMX001 study.
NCT02439970,TERMINATED,INTERVENTIONAL,Study was terminated early due to results from another CMX001 study
NCT02440061,WITHDRAWN,INTERVENTIONAL,This protocol was replaced with a different one and therefore discontinued.
NCT02440074,WITHDRAWN,INTERVENTIONAL,Not funded Administrative formalities not completed
NCT02440529,TERMINATED,INTERVENTIONAL,Research staff decision
NCT02440542,WITHDRAWN,OBSERVATIONAL,Study enrollment not initiated due to institutional delays
NCT02440646,TERMINATED,OBSERVATIONAL,The study is terminated due to cessation of the research collaboration with Russian institutions
NCT02440685,TERMINATED,INTERVENTIONAL,Business decision
NCT02440737,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02440945,TERMINATED,INTERVENTIONAL,Inclusion of the last patient
NCT02441036,TERMINATED,INTERVENTIONAL,Terminated due to non-safety reasons
NCT02441101,TERMINATED,INTERVENTIONAL,PI left the institution
NCT02441140,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02441244,TERMINATED,INTERVENTIONAL,Recruitment potential impaired by shift in clinical care whereby practically all HIV patients receive standard treatment as soon as possible after HIV diagnosis
NCT02441270,WITHDRAWN,INTERVENTIONAL,Study was never started.
NCT02441309,TERMINATED,INTERVENTIONAL,Failed to recruit sufficient numbers of patients in the funded period
NCT02441400,TERMINATED,OBSERVATIONAL,Company no longer operational
NCT02441439,WITHDRAWN,INTERVENTIONAL,The investigators decided not to proceed with this study
NCT02441491,WITHDRAWN,INTERVENTIONAL,Inadequate accrual
NCT02441517,TERMINATED,INTERVENTIONAL,The study is closed early due to lck of enrollment.
NCT02441790,WITHDRAWN,INTERVENTIONAL,Recruitment Difficulty
NCT02441920,TERMINATED,OBSERVATIONAL,Incomplete student research project
NCT02441959,TERMINATED,INTERVENTIONAL,Investigator Moved Institutions
NCT02442102,TERMINATED,INTERVENTIONAL,slow recruitment
NCT02442180,TERMINATED,INTERVENTIONAL,failure to recruit eligible patients
NCT02442193,TERMINATED,INTERVENTIONAL,Terminated by the funder due to low recruitment rates.
NCT02442466,TERMINATED,INTERVENTIONAL,Difficulties to recruit on time the required patient population.
NCT02442492,TERMINATED,INTERVENTIONAL,Trial terminated following Dutch DSMB recommendation for their Study
NCT02442674,WITHDRAWN,INTERVENTIONAL,Trial withdrawn due to inability to meet the trial objectives (Pilot).
NCT02442739,WITHDRAWN,INTERVENTIONAL,PI voluntary closure due to low accrual
NCT02442752,WITHDRAWN,INTERVENTIONAL,Withdrawn: Business decision (no enrollment)
NCT02442999,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02443103,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02443142,WITHDRAWN,INTERVENTIONAL,Lack of study participants.
NCT02443194,TERMINATED,INTERVENTIONAL,principle investigator decision due to many adverse events in patients
NCT02443337,TERMINATED,INTERVENTIONAL,The study stopped due to lack of efficacy.
NCT02443532,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02443545,TERMINATED,INTERVENTIONAL,"Recommendation by DSMB, which felt that sufficient data had been obtained"
NCT02444286,WITHDRAWN,OBSERVATIONAL,"study did never start, may be deleted from clinicaltrials.gov if possible"
NCT02444364,WITHDRAWN,INTERVENTIONAL,Funding withdrawn; no participants enrolled.
NCT02444585,WITHDRAWN,INTERVENTIONAL,No participants enrolled in the trial
NCT02444728,TERMINATED,INTERVENTIONAL,Because of insufficient enrollement
NCT02444793,TERMINATED,INTERVENTIONAL,The study was terminated due to marginal efficacy and change in sponsor prioritization. The combination had a manageable safety profile.
NCT02445001,WITHDRAWN,INTERVENTIONAL,Withdrawn before recruitment started.
NCT02445092,TERMINATED,INTERVENTIONAL,After reviewing the interim analysis results the study was terminated as a bigger sample size was needed to find a significant difference between the groups.
NCT02445144,TERMINATED,OBSERVATIONAL,lack of funding
NCT02445170,WITHDRAWN,OBSERVATIONAL,The study is not eligible at present.
NCT02445235,TERMINATED,OBSERVATIONAL,Sponsor discretion determined no clinical benefit
NCT02445456,TERMINATED,INTERVENTIONAL,Logistical difficulties in recruiting patients led to slower than expected recruitment. Recruitment was completely suspended during Covid and will not be restarted.
NCT02445469,TERMINATED,INTERVENTIONAL,The results obtained are sufficient
NCT02445677,WITHDRAWN,INTERVENTIONAL,The study has now a correlational design: no participant recruitment is needed.
NCT02446028,SUSPENDED,INTERVENTIONAL,IND Withdrawn
NCT02446145,TERMINATED,INTERVENTIONAL,"Due to COVID-19 pandemia, recruitment was insufficient to reach required sample size in an acceptable time line. Furthermore, new drugs have recently been licensed resulting in alternative treatment regimens with a better prognosis."
NCT02446184,TERMINATED,INTERVENTIONAL,Original P.I. of this study transferred to a different institution.
NCT02446379,WITHDRAWN,OBSERVATIONAL,Technology licensed to third party. Sponsor did not proceed with study.
NCT02446769,TERMINATED,INTERVENTIONAL,Difficulty recruiting patient population.
NCT02446886,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02446925,TERMINATED,INTERVENTIONAL,Insufficient number of subjects meeting inclusion criteria
NCT02447016,TERMINATED,INTERVENTIONAL,no more participants taking atripla
NCT02447107,TERMINATED,OBSERVATIONAL,Study feasibility issues
NCT02447458,TERMINATED,INTERVENTIONAL,Site non-compliance to GCP (No safety concerns. See detailed description)
NCT02447731,WITHDRAWN,OBSERVATIONAL,Principal Investigator passed away.
NCT02447887,TERMINATED,INTERVENTIONAL,IRB study closure facilitated by Investigator
NCT02447926,TERMINATED,INTERVENTIONAL,Successful proof of concept study after 1 subject.
NCT02447939,WITHDRAWN,INTERVENTIONAL,Change in strategy
NCT02447965,TERMINATED,INTERVENTIONAL,difficult recruitment
NCT02448095,TERMINATED,OBSERVATIONAL,lack of interest
NCT02448160,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT02448810,TERMINATED,INTERVENTIONAL,Based on overall benefit-risk assessment.
NCT02449161,TERMINATED,INTERVENTIONAL,Missing fund to continue
NCT02449512,SUSPENDED,OBSERVATIONAL,Funding issues
NCT02449655,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT02449681,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02449980,TERMINATED,INTERVENTIONAL,DSMB recommended termination on the basis of poor accrual rate. We will transition to a prospective observational (non-randomized) study design.
NCT02450045,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT02450110,TERMINATED,INTERVENTIONAL,unexpectedly slow recruitment rate
NCT02450201,TERMINATED,INTERVENTIONAL,Low accrual
NCT02450227,TERMINATED,INTERVENTIONAL,It is considered non-achievable to recruit the target number of subjects in the short bowel group (n = 12). 10 participants were recruited.
NCT02450279,TERMINATED,INTERVENTIONAL,Never started
NCT02450331,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate the study early because the study did not meet its primary endpoint and because the study had met its goals of providing safety and additional exploratory efficacy information for atezolizumab monotherapy in MIBC.
NCT02450695,WITHDRAWN,INTERVENTIONAL,No participants were recruited.
NCT02451111,TERMINATED,INTERVENTIONAL,"The premature termination is based on the decision by the SAKK board on November 14, 2020 due to the lack of further financial support for the follow up period."
NCT02451462,WITHDRAWN,INTERVENTIONAL,Logistics
NCT02451540,TERMINATED,INTERVENTIONAL,No new investigational product can be delivered to the site.
NCT02451618,TERMINATED,OBSERVATIONAL,Trial was discontinued due to inadequate signal from study eeg leads.
NCT02452255,TERMINATED,INTERVENTIONAL,Shriner's Burn Hospital closed the study and access to study-related data is unavailable. We are unable to submit the additional information or results-data
NCT02452268,TERMINATED,INTERVENTIONAL,business decision
NCT02452281,WITHDRAWN,INTERVENTIONAL,"PI departure, operational issues"
NCT02452359,TERMINATED,INTERVENTIONAL,Continuing the trial was considered to be superfluous.
NCT02452385,SUSPENDED,INTERVENTIONAL,Sponsor requirements
NCT02452398,TERMINATED,INTERVENTIONAL,Study withdrawn as technology already proven with data no longer needed.
NCT02452424,TERMINATED,INTERVENTIONAL,Terminated early for insufficient evidence of clinical efficacy
NCT02452463,TERMINATED,INTERVENTIONAL,low accrual
NCT02452528,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02452567,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting participants that met the inclusion criteria
NCT02452671,TERMINATED,OBSERVATIONAL,Enrollment temporarily stopped
NCT02452710,TERMINATED,INTERVENTIONAL,Study funding was completed.
NCT02452905,WITHDRAWN,INTERVENTIONAL,The drug manufacture were unable to produce liquid formulation of the IMP within a reasonable time frame so the funding was relinquished.
NCT02452957,WITHDRAWN,OBSERVATIONAL,Contract issues
NCT02452970,TERMINATED,INTERVENTIONAL,Resensitization or clinical benefit was not observed
NCT02452983,TERMINATED,INTERVENTIONAL,This protocol is closed to further enrollment due to lack of study progress.
NCT02453035,TERMINATED,OBSERVATIONAL,slow enrollment due to change in worldwide scaffold usage
NCT02453373,TERMINATED,INTERVENTIONAL,"The study has achieved its objectives of showing feasibility, safety, and trend for improved mRS. FDA and LRS agreed that this study should be terminated, and that a new, PIVOTAL trial should be started."
NCT02453386,TERMINATED,INTERVENTIONAL,New Safety Information
NCT02453490,TERMINATED,INTERVENTIONAL,difficultly recruiting
NCT02453828,TERMINATED,INTERVENTIONAL,PI has requested for this study be closed due to technical issues
NCT02454075,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02454270,TERMINATED,INTERVENTIONAL,Recent advances in the treatment of B cell malignancies resulting in new treatments being approved for marketing and many others in late stage development
NCT02454283,TERMINATED,INTERVENTIONAL,Cardiac safety finding
NCT02454348,WITHDRAWN,INTERVENTIONAL,PI left
NCT02454426,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT02454517,TERMINATED,INTERVENTIONAL,Terminated due to insufficient funding
NCT02454530,TERMINATED,OBSERVATIONAL,The study was stopped due to the judicial liquidation of the CRO in charge of this study.
NCT02454595,TERMINATED,OBSERVATIONAL,lack of enrollment
NCT02454608,TERMINATED,INTERVENTIONAL,Evidence that the dose is insufficient.
NCT02454621,WITHDRAWN,INTERVENTIONAL,The researcher quit the study
NCT02454764,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT02454777,TERMINATED,INTERVENTIONAL,PI left
NCT02454842,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02454855,TERMINATED,INTERVENTIONAL,The study stopped for futility after the DSMB.
NCT02454894,WITHDRAWN,INTERVENTIONAL,Due to the reason that not all participants agree to have anesthesia and postoperative management at the same time
NCT02455024,TERMINATED,OBSERVATIONAL,Business Decision; Insufficient Enrollment
NCT02455167,TERMINATED,INTERVENTIONAL,Study stopped due to low accrual and availability of other treatment options
NCT02455362,WITHDRAWN,INTERVENTIONAL,'Recruitment not possible given changes to trial criteria
NCT02455466,TERMINATED,OBSERVATIONAL,not enough recruitment
NCT02455713,WITHDRAWN,OBSERVATIONAL,Needed equipment failed before the study was started.
NCT02455882,TERMINATED,OBSERVATIONAL,This study was terminated to prevent duplicative research efforts.
NCT02456051,TERMINATED,OBSERVATIONAL,enrollment was terminated because of the poor recruitment rate
NCT02456103,TERMINATED,INTERVENTIONAL,Cystic Fibrosis (CF) data from the double-blind CF Study PTC124-GD-021-CF did not meet endpoints.
NCT02456675,TERMINATED,INTERVENTIONAL,A decision was made to terminate the study due to the changing treatment landscape for the development of new agents in combination in Hodgkin lymphoma.
NCT02456922,WITHDRAWN,INTERVENTIONAL,For administraive reasons
NCT02457286,WITHDRAWN,INTERVENTIONAL,patients do not want to participate
NCT02457299,TERMINATED,INTERVENTIONAL,Standard of care was modified at the primary institution
NCT02457663,TERMINATED,OBSERVATIONAL,"At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data."
NCT02457702,TERMINATED,INTERVENTIONAL,Unable to recruit. Only 2 subjects completed.
NCT02457910,TERMINATED,INTERVENTIONAL,Interim analysis - toxicity
NCT02457949,TERMINATED,INTERVENTIONAL,"Interim analyses produced signal of intervention efficacy for primary outcomes and weaker signal of increased exposure to violence. Therefore, DSMC recommended stopping recruitment in May 2018. Enrolled participants completed intervention by Aug 2018"
NCT02457988,TERMINATED,INTERVENTIONAL,Increased recruitment difficulties
NCT02458105,WITHDRAWN,INTERVENTIONAL,Required resources not available at the moment.
NCT02458157,TERMINATED,INTERVENTIONAL,Very low recruitment rates
NCT02458170,TERMINATED,OBSERVATIONAL,Shutdown of The Department of Inflammatory Diseases at Novo Nordisk.
NCT02458391,WITHDRAWN,INTERVENTIONAL,No participants available
NCT02458482,WITHDRAWN,INTERVENTIONAL,The trainee for whom I designed the study did not begin enrollment and has left our institution.
NCT02458859,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02459015,TERMINATED,INTERVENTIONAL,The study was stopped due to slow patient recruitment and insufficient patient compliance.
NCT02459054,TERMINATED,INTERVENTIONAL,"50cc TAH-t received FDA approval March 5, 2020."
NCT02459145,WITHDRAWN,INTERVENTIONAL,PI Left Insitution - study no RCT
NCT02459275,TERMINATED,INTERVENTIONAL,Funding discontinued
NCT02459808,WITHDRAWN,OBSERVATIONAL,Inclusion according to criteria was not practical in our setting.
NCT02459912,TERMINATED,INTERVENTIONAL,Patient recruitment
NCT02459925,TERMINATED,INTERVENTIONAL,"Due to funding that was never obtained, the MOMS Grow arm was not completed."
NCT02460016,TERMINATED,INTERVENTIONAL,We switched this study design to another study per IEC's recommendations.
NCT02460055,WITHDRAWN,INTERVENTIONAL,no subject met enrollment criteria
NCT02460081,WITHDRAWN,INTERVENTIONAL,Discontinued due to significant delays in the expected availability of data.
NCT02460107,TERMINATED,INTERVENTIONAL,Enrolling failure (lack of participants)
NCT02460120,TERMINATED,INTERVENTIONAL,Updates to device
NCT02460302,WITHDRAWN,INTERVENTIONAL,Inadequate staffing and funds
NCT02460354,TERMINATED,INTERVENTIONAL,Lack of effect in initial subjects
NCT02460367,TERMINATED,INTERVENTIONAL,Lack of enrollment and changing landscape of standard of care.
NCT02460484,SUSPENDED,INTERVENTIONAL,Restructuring Cell Lab
NCT02460874,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02460991,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02461134,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02461186,WITHDRAWN,INTERVENTIONAL,Change of the study site due to the current political climate in Myanmar.
NCT02461303,TERMINATED,OBSERVATIONAL,Unable to recruit the anticipated number of subjects for this study
NCT02461355,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02461433,TERMINATED,INTERVENTIONAL,Sponsor pulled funding
NCT02461511,WITHDRAWN,OBSERVATIONAL,No funding
NCT02461524,TERMINATED,INTERVENTIONAL,This study terminated enrollment due to device failures prior to enrollment completion.
NCT02461654,TERMINATED,OBSERVATIONAL,The clinical trial was suspended for the reason that preliminary results in 20 patients didn't show a significant curative effect of observed treatment.
NCT02461680,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT02461784,TERMINATED,OBSERVATIONAL,slow enrollment per COVID-19 pandemic and staffing resources
NCT02462096,TERMINATED,INTERVENTIONAL,Device modification and simplification of procedural steps
NCT02462200,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02462213,WITHDRAWN,OBSERVATIONAL,Unable to recruit patients who had not had MRI first.
NCT02462421,TERMINATED,INTERVENTIONAL,Did not meet recruitment targets.
NCT02462473,TERMINATED,INTERVENTIONAL,Due to poor enrollment sponsor terminated early after enrolling 9 in Cohort 1 and no enrollment in Cohorts 2 and 3.
NCT02462525,TERMINATED,INTERVENTIONAL,No Go decision for ABBV-838
NCT02462538,TERMINATED,INTERVENTIONAL,"Due to slow recruitment, recruitment of new patients was stopped, FU was completed for enrolled patients"
NCT02462759,TERMINATED,INTERVENTIONAL,The study was terminated early to roll over participants to open label extension study NCT02594124.
NCT02462837,TERMINATED,INTERVENTIONAL,insufficient rate of accrual
NCT02463110,TERMINATED,INTERVENTIONAL,Investigator's decision
NCT02463175,TERMINATED,INTERVENTIONAL,Difficulties with protocol compliance in both arms. Will simplify protocol.
NCT02463305,WITHDRAWN,INTERVENTIONAL,inability to enroll
NCT02463461,WITHDRAWN,INTERVENTIONAL,Not sure if we are going to do this study now.
NCT02463669,TERMINATED,OBSERVATIONAL,COVID pandemic
NCT02463812,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02463955,WITHDRAWN,INTERVENTIONAL,study never start
NCT02464137,TERMINATED,INTERVENTIONAL,unexpected toxicities
NCT02464306,WITHDRAWN,INTERVENTIONAL,Lost funding
NCT02464332,WITHDRAWN,INTERVENTIONAL,Study did not enroll any subjects
NCT02464553,TERMINATED,INTERVENTIONAL,Patients received unplanned additional therapy during follow-up
NCT02464631,TERMINATED,INTERVENTIONAL,In view of recent approval of NS5A inhibitors for treatment of hepatitis C such as Declatasvir and Ledipasvir which have proven better efficacy in the HCV cure
NCT02464891,TERMINATED,INTERVENTIONAL,The study had accomplished its goal with the 6 patients who have been enrolled.
NCT02464904,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients due to enrollment criteria.
NCT02465008,SUSPENDED,INTERVENTIONAL,Not recruiting
NCT02465034,TERMINATED,INTERVENTIONAL,Enrollment and study activities were suspended due to COVID-19.
NCT02465099,TERMINATED,INTERVENTIONAL,Terminated due to commercial considerations with no patient safety reasons.
NCT02465112,TERMINATED,INTERVENTIONAL,"Although the relevance of this study remains, the recruitment was too slow (4 patients in 2 years)."
NCT02465138,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT02465203,TERMINATED,INTERVENTIONAL,Study was prematurely terminated.
NCT02465294,WITHDRAWN,INTERVENTIONAL,study withdrawn due to funding
NCT02465437,TERMINATED,INTERVENTIONAL,Sponsor terminated open-label extension
NCT02465619,WITHDRAWN,OBSERVATIONAL,Due to lack of funds
NCT02465723,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT02465762,SUSPENDED,INTERVENTIONAL,Study design was amended to include a control - reregistered as NCT02465775
NCT02465983,TERMINATED,INTERVENTIONAL,Lack of efficacy and funding to continue investigation
NCT02466074,TERMINATED,INTERVENTIONAL,Inadequate recruitment; termination of funding
NCT02466243,TERMINATED,INTERVENTIONAL,Sponsor terminated open-label extension.
NCT02466464,WITHDRAWN,INTERVENTIONAL,No patients were successfully recruited
NCT02466568,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT02466659,TERMINATED,INTERVENTIONAL,no fund
NCT02466763,TERMINATED,INTERVENTIONAL,Not enough interest in enrollment
NCT02466841,WITHDRAWN,OBSERVATIONAL,Could not get any patients to sign up
NCT02467075,TERMINATED,INTERVENTIONAL,Insufficient number of subjects could be enrolled.
NCT02467413,WITHDRAWN,INTERVENTIONAL,The study was withdrawn before participants were enrolled.
NCT02467634,TERMINATED,INTERVENTIONAL,Based on a business decision unrelated to any safety concerns.
NCT02468414,TERMINATED,INTERVENTIONAL,No statistical analysis was performed as only one subject was treated with MDGN201 TARGTEPO due to the Sponsor's decision to discontinue study.
NCT02468544,WITHDRAWN,INTERVENTIONAL,Investigator left the institution prior to enrollment of the first participant.
NCT02468596,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02468661,TERMINATED,INTERVENTIONAL,Major challenge for enrollment of participants.
NCT02468778,TERMINATED,INTERVENTIONAL,Abbott has decided to discontinue our percutaneous heart pump (PHP) program and the SHIELD II trial because the product was not meeting the needs of the patients it was intended to serve.
NCT02469116,TERMINATED,INTERVENTIONAL,Sponsor withdrew financial support
NCT02469168,TERMINATED,INTERVENTIONAL,lack of funding
NCT02469311,TERMINATED,INTERVENTIONAL,Preliminary results showed that the use of the cloths helped prevent infections.
NCT02469376,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02469415,TERMINATED,INTERVENTIONAL,FDA Clinical Hold
NCT02469506,TERMINATED,INTERVENTIONAL,Minimal to no inclusion.
NCT02469701,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02469974,WITHDRAWN,INTERVENTIONAL,no enrollments
NCT02470065,SUSPENDED,INTERVENTIONAL,Study never started
NCT02470312,TERMINATED,OBSERVATIONAL,Existing trials demonstrate reduction in fluoroscopy with MediGuide
NCT02470533,TERMINATED,INTERVENTIONAL,Low accrual
NCT02470559,WITHDRAWN,INTERVENTIONAL,"Study did not accrue any participants, the PI has left the institution."
NCT02470585,TERMINATED,INTERVENTIONAL,Business decision not related to patient safety
NCT02470663,WITHDRAWN,INTERVENTIONAL,company and Sheba did not reach an agreement
NCT02470728,SUSPENDED,INTERVENTIONAL,Pending funding
NCT02470819,WITHDRAWN,INTERVENTIONAL,Investigator elected to end the study
NCT02471599,SUSPENDED,INTERVENTIONAL,This study was suspended because that few participants was enrolled.
NCT02471703,TERMINATED,OBSERVATIONAL,The study was prematurely terminated by S+N due to business reasons. After an extensive review of all ongoing studies with the focus on which studies are still required for regulatory obligations S+N took the decision to close the SMF S\&E study.
NCT02472002,SUSPENDED,INTERVENTIONAL,Contamination of the Piti-Salptrire biotherapy laboratory
NCT02472080,TERMINATED,INTERVENTIONAL,inefficiency
NCT02472288,TERMINATED,INTERVENTIONAL,Difficulty in enrolling participants
NCT02472353,TERMINATED,INTERVENTIONAL,did not meet target accrual
NCT02472483,TERMINATED,INTERVENTIONAL,Difficult for recruting
NCT02472509,TERMINATED,INTERVENTIONAL,Study not feasible - very low recruitment rate
NCT02472626,WITHDRAWN,INTERVENTIONAL,Drug Supply Issues
NCT02472639,TERMINATED,INTERVENTIONAL,Patient compliance issues
NCT02472652,TERMINATED,INTERVENTIONAL,Lack of adequate enrollment
NCT02472938,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT02472977,TERMINATED,INTERVENTIONAL,Trial terminated because of lack of efficacy in the short term acute phase
NCT02473094,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02473276,SUSPENDED,INTERVENTIONAL,Temporary pause due to enrollment challenges
NCT02473445,TERMINATED,INTERVENTIONAL,Sponsor decision to end development of RP103 for mitochondrial disease due to lack of efficacy demonstrated in base study RP103-MITO-001.
NCT02473523,TERMINATED,INTERVENTIONAL,The principal investigator left the institution.
NCT02473562,TERMINATED,INTERVENTIONAL,"insufficient patient enrollment, insufficient funds for completion"
NCT02473692,WITHDRAWN,OBSERVATIONAL,Delays in start date led to termination of the study prior to recruitment of participants.
NCT02473705,WITHDRAWN,INTERVENTIONAL,Unable to find eligible participants to participate in the study.
NCT02473744,TERMINATED,INTERVENTIONAL,Not enough patients
NCT02473770,WITHDRAWN,OBSERVATIONAL,New prepositioned protocol being developed to optimize its use in the disaster setting and broaden its reach.
NCT02473848,TERMINATED,INTERVENTIONAL,Lack of enrolment
NCT02473874,WITHDRAWN,OBSERVATIONAL,Not NIH defined clinical trial study.
NCT02474056,WITHDRAWN,OBSERVATIONAL,The researcher couldnt handle it
NCT02474173,TERMINATED,INTERVENTIONAL,Drug supply issues
NCT02474485,SUSPENDED,INTERVENTIONAL,"Information of other studies with Abseb bioresorbable scaffolds showed a higher thrombotic risk than before, the risk for the Patients is estimated too high"
NCT02474706,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02474719,TERMINATED,INTERVENTIONAL,"few eligible patients, dialysate drainage problem, measurement bias : not all currently marketed laboratory instruments are able to dose peritoneal dialysate"
NCT02474888,TERMINATED,OBSERVATIONAL,failure of recruit
NCT02475252,TERMINATED,INTERVENTIONAL,Recruitment too slow; study completion not possible within frame
NCT02475304,WITHDRAWN,INTERVENTIONAL,Difficulties to enrol patients
NCT02475330,TERMINATED,INTERVENTIONAL,Lack of patient compliance
NCT02475369,TERMINATED,INTERVENTIONAL,The trial was terminated prematurely by the sponsor for administrative reasons.
NCT02475525,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02476331,WITHDRAWN,INTERVENTIONAL,Student no longer enrolled in program.
NCT02476474,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to a lack of funding
NCT02476708,TERMINATED,INTERVENTIONAL,Recruitment was not achieved as expected
NCT02476994,TERMINATED,INTERVENTIONAL,Based on feedback from FDA
NCT02477124,TERMINATED,INTERVENTIONAL,COVID-19
NCT02477540,WITHDRAWN,INTERVENTIONAL,Study was stopped by sponsers internal reason.
NCT02477657,WITHDRAWN,OBSERVATIONAL,Industry funding not received. No subjects enrolled.
NCT02477748,TERMINATED,INTERVENTIONAL,FDA Clinical hold
NCT02477787,TERMINATED,INTERVENTIONAL,upon recommendation from the Data Monitoring Committee
NCT02477800,TERMINATED,INTERVENTIONAL,Study was discontinued based on futility analysis done and not based on safety concerns. Follow-up visits and closing out study activities are completed
NCT02477813,TERMINATED,INTERVENTIONAL,Lack of eligible patient recruitment
NCT02478008,TERMINATED,INTERVENTIONAL,Edwards acquired CardiAQ and opted to terminate this study. 2 patients were enrolled and follow-up is complete. No further enrollment or follow-up will occur.
NCT02478112,SUSPENDED,INTERVENTIONAL,Lack of recruitment
NCT02478125,TERMINATED,INTERVENTIONAL,Low accrual
NCT02478229,TERMINATED,INTERVENTIONAL,difficulty recruiting patients
NCT02478320,TERMINATED,INTERVENTIONAL,Study terminated due to company's decision to discontinue drug development
NCT02478502,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02478554,WITHDRAWN,INTERVENTIONAL,Not IRB approved
NCT02478593,WITHDRAWN,INTERVENTIONAL,insufficient funding
NCT02478723,TERMINATED,OBSERVATIONAL,"Study device no longer manufactured by Sonendo. Total enrollment for the study was 20 subjects, only 3 subjects were enrolled and treated."
NCT02478762,TERMINATED,INTERVENTIONAL,very difficult recruitment
NCT02478970,WITHDRAWN,INTERVENTIONAL,Equipment/software did not work as anticipated
NCT02479009,WITHDRAWN,INTERVENTIONAL,The investigator left the institution so the study was terminated.
NCT02479204,TERMINATED,INTERVENTIONAL,"Based on results from the pilot phase, the study is terminated. No safety events leading to discontinuation were reported"
NCT02479386,TERMINATED,OBSERVATIONAL,There is no longer a plan to pursue an approval of lampalizumab.
NCT02479542,WITHDRAWN,INTERVENTIONAL,Regulatory issues
NCT02479672,WITHDRAWN,INTERVENTIONAL,This study was never started.
NCT02479906,TERMINATED,INTERVENTIONAL,The results did not demonstrate sufficient clinical benefit induced specifically by the active treatment to justify continuation of the trial.
NCT02480010,TERMINATED,INTERVENTIONAL,The study was terminated at the time of interim analysis since none of the participants showed a PSA response.
NCT02480595,SUSPENDED,OBSERVATIONAL,Recruitment on hold
NCT02481206,TERMINATED,INTERVENTIONAL,Lack of subject enrollment
NCT02481960,TERMINATED,INTERVENTIONAL,The decision to terminate the trial was based on the slow rate of recruitment across the programme of studies\]
NCT02482285,TERMINATED,OBSERVATIONAL,Difficulty recruiting. Study aims now overlap standard of care assessments and future planned studies.
NCT02482389,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT02482402,WITHDRAWN,INTERVENTIONAL,Delay in recruitment
NCT02482623,WITHDRAWN,INTERVENTIONAL,Loss of study site
NCT02482714,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT02482909,TERMINATED,INTERVENTIONAL,The post-treatment recurrence rate was expected to be different between two treatment groups.
NCT02482948,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT02483000,TERMINATED,INTERVENTIONAL,Closed early due to lack of funding
NCT02483195,WITHDRAWN,INTERVENTIONAL,PI indicating she was withdrawing her study submission due to lack of funding as of 6/20/2016
NCT02483377,TERMINATED,OBSERVATIONAL,Principal Investigator left
NCT02483416,TERMINATED,OBSERVATIONAL,Poor recruitment
NCT02483572,TERMINATED,INTERVENTIONAL,Unable to maintain a waitlist long enough to serve as a control group.
NCT02483598,TERMINATED,INTERVENTIONAL,Initial analysis of results warranted a study re-design and work on the study was suspended.
NCT02483728,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02483871,WITHDRAWN,INTERVENTIONAL,Enrollment did not meet anticipated goals. Eligibility was a challenge.
NCT02483884,TERMINATED,INTERVENTIONAL,Business decision
NCT02483897,WITHDRAWN,INTERVENTIONAL,inabililty to recruit at required rate
NCT02484183,TERMINATED,INTERVENTIONAL,By Data Safety and Monitoring Board after second interim analysis and follow-up safety check.
NCT02484209,WITHDRAWN,INTERVENTIONAL,Inclusion criteria too strict making it difficult to recruit in primary care
NCT02484261,TERMINATED,INTERVENTIONAL,Contractual/Funding/Accrual
NCT02484287,TERMINATED,INTERVENTIONAL,PI left institution prior to study completion
NCT02484547,TERMINATED,INTERVENTIONAL,Study was discontinued based on futility analysis done and not based on safety concerns. Follow-up visits and closing out study activities are completed
NCT02484638,TERMINATED,INTERVENTIONAL,Business decision non-safety related.
NCT02484703,TERMINATED,INTERVENTIONAL,Study was terminated due to data from another study showing no efficacy. There were no safety issues of concern.
NCT02484768,WITHDRAWN,INTERVENTIONAL,as per GCP sponsor/company decision
NCT02484937,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT02485080,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of resources
NCT02485132,TERMINATED,OBSERVATIONAL,Patients corresponding to the inclusion/exclusion criteria not found.
NCT02485249,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02485353,TERMINATED,INTERVENTIONAL,Safety concerns
NCT02485366,WITHDRAWN,INTERVENTIONAL,Product unavailability
NCT02485457,TERMINATED,INTERVENTIONAL,Difficulties of recrutment
NCT02485496,TERMINATED,OBSERVATIONAL,Due to product change.
NCT02485639,TERMINATED,INTERVENTIONAL,Study was terminated due to CoronaVIrus Disease of 2019 (COVID-19) pandemic.
NCT02485652,TERMINATED,INTERVENTIONAL,Study termination by the Sponsor
NCT02485834,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02485990,TERMINATED,INTERVENTIONAL,Withdrawal of sponsor support
NCT02486224,TERMINATED,INTERVENTIONAL,COVID-19 shutdown prevented study enrollment. Staff was subsequently lost to execute trial aims.
NCT02486380,TERMINATED,INTERVENTIONAL,Recruitment terminated permanently due to limited resource to recruit.
NCT02486510,TERMINATED,INTERVENTIONAL,Futility criteria
NCT02486744,TERMINATED,INTERVENTIONAL,Recruitment challenges and unforseen costs to continue
NCT02486796,TERMINATED,INTERVENTIONAL,Operational barriers prevent critical specimen analyses from being performed.
NCT02487082,TERMINATED,INTERVENTIONAL,too few subjects enrolled
NCT02487277,TERMINATED,INTERVENTIONAL,Low accrual
NCT02487394,TERMINATED,OBSERVATIONAL,NIH Funded Grant Expired
NCT02487823,TERMINATED,INTERVENTIONAL,Defect of recruitment
NCT02487849,WITHDRAWN,INTERVENTIONAL,actually limited personnel ressources
NCT02487953,WITHDRAWN,INTERVENTIONAL,Study design changed significantly; was submitted as a different protocol.
NCT02488122,SUSPENDED,INTERVENTIONAL,Because the study has not yet sponsorship.
NCT02488304,TERMINATED,INTERVENTIONAL,the lung transplantation program at the site is on hold
NCT02488486,TERMINATED,INTERVENTIONAL,Intermediate analysis
NCT02488512,TERMINATED,INTERVENTIONAL,critical low recruitment rate
NCT02488525,TERMINATED,INTERVENTIONAL,deficient inclusion
NCT02488616,WITHDRAWN,INTERVENTIONAL,Medtronic support terminated
NCT02488694,TERMINATED,INTERVENTIONAL,unsufficient recruitment
NCT02488746,TERMINATED,OBSERVATIONAL,According to study protocol the trial was terminated because the recruitment of trial participants was insufficient.
NCT02488889,WITHDRAWN,INTERVENTIONAL,Investigator left institution prior to enrollment of study participants
NCT02488954,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02489097,TERMINATED,INTERVENTIONAL,Interim analysis results showed futility
NCT02489123,TERMINATED,INTERVENTIONAL,Accrual goal not met
NCT02489175,TERMINATED,INTERVENTIONAL,The device used was removed from the market
NCT02489201,TERMINATED,INTERVENTIONAL,Corporate policy adjustments
NCT02489214,TERMINATED,INTERVENTIONAL,Corporate policy adjustments
NCT02489500,TERMINATED,INTERVENTIONAL,Enrollment held for toxicity evaluation; then closed due to competing trial
NCT02489825,TERMINATED,INTERVENTIONAL,Death of study initiator
NCT02490098,WITHDRAWN,INTERVENTIONAL,Funding terminated
NCT02490332,TERMINATED,INTERVENTIONAL,Failed to include the required number of participants
NCT02490384,TERMINATED,INTERVENTIONAL,due to significant decrease of perinatal mortality in the cerclage group
NCT02490397,TERMINATED,INTERVENTIONAL,not enough participants
NCT02490722,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02490813,TERMINATED,INTERVENTIONAL,the study has been on hold throughout 3/10/2020-18/2/2023 due to the hospital regulations for COVID-19
NCT02490878,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02491372,WITHDRAWN,INTERVENTIONAL,Unable to recruit sufficient number of participants in the time available.
NCT02491411,TERMINATED,INTERVENTIONAL,The study is terminated due to lower enrollment
NCT02491775,TERMINATED,OBSERVATIONAL,Changes in treatment plan affecting drug therapy choices
NCT02491827,TERMINATED,OBSERVATIONAL,Study stopped by local authorities
NCT02491970,TERMINATED,INTERVENTIONAL,Difficulty of patients enrollments
NCT02492295,TERMINATED,INTERVENTIONAL,Due to logistic reason
NCT02492360,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02492451,TERMINATED,INTERVENTIONAL,Problems in recruitment
NCT02492477,TERMINATED,INTERVENTIONAL,poor recruitment
NCT02492685,WITHDRAWN,INTERVENTIONAL,The study plan was cancelled because patient registration was delayed for the trials.
NCT02492854,TERMINATED,INTERVENTIONAL,PI decided not to proceed with the major amendment and switching to the new generation of the device due to lack of funding.
NCT02492997,TERMINATED,INTERVENTIONAL,Trial was terminated early due to slow enrollment.
NCT02493062,TERMINATED,INTERVENTIONAL,Enrollment below the target goal; statistical analysis unable to be completed.
NCT02493374,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02493920,WITHDRAWN,INTERVENTIONAL,"Technical problems, unreliability of the measured parameters"
NCT02494284,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02494544,TERMINATED,INTERVENTIONAL,Decision of investigational team
NCT02494635,TERMINATED,OBSERVATIONAL,The PI left institution
NCT02494713,TERMINATED,INTERVENTIONAL,slow enrollment; resource re-allocation
NCT02494778,TERMINATED,INTERVENTIONAL,This study served its purpose in providing considerable safety data.
NCT02494973,SUSPENDED,INTERVENTIONAL,Recruitment too slow
NCT02495103,TERMINATED,INTERVENTIONAL,Vandetanib is no longer available as Sanofi has decided not to provide additional drug. All subjects are off-study.
NCT02495233,TERMINATED,INTERVENTIONAL,Study terminated due to adverse events related to the combination therapy
NCT02495259,TERMINATED,INTERVENTIONAL,PI is leaving the institution
NCT02495454,TERMINATED,INTERVENTIONAL,Primary objective not obtained after interim analysis
NCT02495636,WITHDRAWN,INTERVENTIONAL,Study closed due to lack of enrollment
NCT02495662,TERMINATED,INTERVENTIONAL,Slow inclusion
NCT02495701,TERMINATED,OBSERVATIONAL,main outcome could not be ekstracted from database
NCT02495805,WITHDRAWN,INTERVENTIONAL,Study never officially began- currently closed with IRB.
NCT02495896,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02496039,TERMINATED,INTERVENTIONAL,The study was terminated prematurely because of difficulty with recruiting.
NCT02496286,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT02496364,WITHDRAWN,INTERVENTIONAL,Dismissal from the institution
NCT02496559,TERMINATED,INTERVENTIONAL,Lower prevalence than expected and the inclusion was difficult.
NCT02496598,TERMINATED,INTERVENTIONAL,Results were not promising
NCT02496715,WITHDRAWN,INTERVENTIONAL,Development terminated.
NCT02496832,WITHDRAWN,INTERVENTIONAL,Study was never initiated
NCT02496975,WITHDRAWN,INTERVENTIONAL,Recent studies suggest that cyclosporine A has a very sharp biphasic dose-response problem that is going to make further clinical translation difficult.
NCT02497183,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02497560,TERMINATED,INTERVENTIONAL,Role of calcium in menopause is not clear. Product maybe reformulated and the study relaunched.
NCT02497612,TERMINATED,INTERVENTIONAL,"All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped."
NCT02497638,WITHDRAWN,INTERVENTIONAL,Drug intervention no longer relevant for the proposed population
NCT02498444,TERMINATED,INTERVENTIONAL,Interim futility analysis
NCT02498483,TERMINATED,INTERVENTIONAL,Understaffing
NCT02498496,WITHDRAWN,INTERVENTIONAL,financing delays
NCT02498535,TERMINATED,INTERVENTIONAL,Terminated for the safety of cystic fibrosis clinical trial subjects due to Covid-19.
NCT02498977,TERMINATED,INTERVENTIONAL,Primary endpoint not reached.
NCT02499172,TERMINATED,INTERVENTIONAL,Financial reason
NCT02499185,TERMINATED,INTERVENTIONAL,No patients with renal failure
NCT02499315,TERMINATED,INTERVENTIONAL,Study has stopped due to a decision by Amgen to terminate the program
NCT02499380,TERMINATED,OBSERVATIONAL,Study enrollment was prematurely stopped.
NCT02499523,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT02499549,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02499575,TERMINATED,INTERVENTIONAL,Logistical issues prevent efficient enrollment
NCT02499627,TERMINATED,INTERVENTIONAL,expected accrual not reached
NCT02499666,TERMINATED,OBSERVATIONAL,difficulty recruiting patients
NCT02499705,TERMINATED,INTERVENTIONAL,Prematurely unblinded based on outcome in other trial. 2 out of 3 particpants in one arm had clinically elevated fasting insulin. Adverse event was reported.
NCT02499887,TERMINATED,INTERVENTIONAL,Exclusion criteria prevented enrollment of adequate # of participants
NCT02499952,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT02500017,TERMINATED,INTERVENTIONAL,Difficulty recruiting appropriate participants
NCT02500173,TERMINATED,OBSERVATIONAL,"General Informed Consent has been introduced at the Hospital, no need for study anymore"
NCT02500459,TERMINATED,INTERVENTIONAL,PI Left institution
NCT02500524,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02500784,WITHDRAWN,INTERVENTIONAL,"Funding ran out before study started, prior PI left institution."
NCT02500901,TERMINATED,INTERVENTIONAL,Suspended by funder
NCT02500914,TERMINATED,INTERVENTIONAL,Strategic Considerations
NCT02500927,TERMINATED,INTERVENTIONAL,"Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies."
NCT02501005,TERMINATED,INTERVENTIONAL,The study was stopped due to futility
NCT02501213,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02501278,WITHDRAWN,INTERVENTIONAL,company (Inovio) is no longer able to support the study
NCT02501473,TERMINATED,INTERVENTIONAL,Business reasons
NCT02501707,TERMINATED,OBSERVATIONAL,The study is prematurely terminated due to bad inclusion and the fact that examinations are already being used in standard care.
NCT02501759,TERMINATED,INTERVENTIONAL,Low enrollment and funding loss.
NCT02502006,TERMINATED,INTERVENTIONAL,Funding was not available to complete enrollment
NCT02502058,WITHDRAWN,OBSERVATIONAL,Principal Investigator left her employment at the University.
NCT02502201,TERMINATED,INTERVENTIONAL,Difficulty finding participants who fit all criteria
NCT02502318,TERMINATED,INTERVENTIONAL,lack of inclusions
NCT02502435,SUSPENDED,OBSERVATIONAL,COVID-19
NCT02502747,WITHDRAWN,INTERVENTIONAL,slow enrolment
NCT02503111,TERMINATED,INTERVENTIONAL,"Results from ANCHOR study showed benefit of Treatment over Surveillance in preventing anal cancer.

That study was similar to the current one."
NCT02503124,TERMINATED,INTERVENTIONAL,COVID-19 and re-organisation at the hospital
NCT02503176,TERMINATED,INTERVENTIONAL,Discontinuation of the development
NCT02503280,WITHDRAWN,INTERVENTIONAL,Study has never enrolled any subjects
NCT02503319,WITHDRAWN,INTERVENTIONAL,Authorization denied
NCT02503410,TERMINATED,INTERVENTIONAL,Lack of funding to continue the study
NCT02503462,TERMINATED,INTERVENTIONAL,No additional patients fulfilling the inclusion criteria
NCT02503501,TERMINATED,INTERVENTIONAL,Study will not have power to show a difference between groups.
NCT02503527,TERMINATED,INTERVENTIONAL,Low Recruitment rate
NCT02503631,TERMINATED,OBSERVATIONAL,Changes in development plan
NCT02503683,TERMINATED,INTERVENTIONAL,"Observation of low incidence of asymptomatic, transiently elevated liver enzymes in a subset of study subjects"
NCT02503735,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goal
NCT02503878,TERMINATED,OBSERVATIONAL,There was to much artifact on the readings and could not be interpreted
NCT02504086,TERMINATED,INTERVENTIONAL,Difficulty recruiting participants
NCT02504099,TERMINATED,INTERVENTIONAL,Study stopped due to low enrollment
NCT02504203,TERMINATED,INTERVENTIONAL,Due to fewer than expected children enrolled and lower than expected overall mortality rate.
NCT02504411,WITHDRAWN,INTERVENTIONAL,Funding was not secured
NCT02504619,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02504866,TERMINATED,INTERVENTIONAL,Study was terminated early due to the COVID-19 pandemic.
NCT02504892,TERMINATED,INTERVENTIONAL,"Study was terminated due to slow, insufficient accrual."
NCT02505022,TERMINATED,OBSERVATIONAL,Recruitment issues
NCT02505178,WITHDRAWN,INTERVENTIONAL,Substantial changes were made to the study protocol and a new ethics application will be submitted.
NCT02505607,TERMINATED,INTERVENTIONAL,feasibility issues
NCT02505698,WITHDRAWN,OBSERVATIONAL,Study initiation at this site fell through
NCT02505867,TERMINATED,INTERVENTIONAL,lack of funding
NCT02506010,WITHDRAWN,OBSERVATIONAL,Sponsor decided not to run this study.
NCT02506101,TERMINATED,INTERVENTIONAL,Lack of enrollment and staff availability to administer treatment.
NCT02506114,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02506374,WITHDRAWN,OBSERVATIONAL,Never able to get any subjects enrolled
NCT02506855,WITHDRAWN,INTERVENTIONAL,The investigator decided not to continue the study.
NCT02507011,TERMINATED,INTERVENTIONAL,Recruitment
NCT02507050,WITHDRAWN,INTERVENTIONAL,Funding not yet achieved
NCT02507076,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT02507232,TERMINATED,INTERVENTIONAL,low enrollment
NCT02507258,WITHDRAWN,OBSERVATIONAL,Sponsor decision to not renew CE mark on product. Therefore study not needed.
NCT02507323,WITHDRAWN,INTERVENTIONAL,collaborator withdrew the study
NCT02507531,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02507947,WITHDRAWN,OBSERVATIONAL,Study closed
NCT02507973,TERMINATED,OBSERVATIONAL,Unable to successfully recruit patients for study.
NCT02507986,TERMINATED,INTERVENTIONAL,no personnel for recruitment
NCT02508051,WITHDRAWN,INTERVENTIONAL,Never received funding
NCT02508077,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT02508194,TERMINATED,INTERVENTIONAL,Year 1 of study completed. No enrollment planned for Year 2 of study.
NCT02508324,TERMINATED,INTERVENTIONAL,Slow accrual and change in direction of cord blood program
NCT02508441,TERMINATED,INTERVENTIONAL,Part 1 of the study was completed and the maximum tolerated dose determined. Part 2 of the study was terminated and will be conducted under a new protocol.
NCT02508636,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02508649,TERMINATED,INTERVENTIONAL,Terminated due to futility
NCT02508740,TERMINATED,INTERVENTIONAL,Development of compound has been put on hold.
NCT02508935,TERMINATED,INTERVENTIONAL,Business decision
NCT02509182,WITHDRAWN,INTERVENTIONAL,Study never officially began
NCT02509273,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02509338,TERMINATED,INTERVENTIONAL,The medical device arrived at expirationand it was not possible to have new one
NCT02509403,WITHDRAWN,INTERVENTIONAL,The company responsible for funding has filed for bankruptcy
NCT02509533,TERMINATED,INTERVENTIONAL,difficulties to recruit patients.
NCT02509585,TERMINATED,INTERVENTIONAL,low accrual
NCT02509663,TERMINATED,INTERVENTIONAL,the manufacturer of the device has been bought and the new company does not want to continue the study anymore
NCT02510300,TERMINATED,OBSERVATIONAL,The study stopped early because the study objectives were met.
NCT02510508,TERMINATED,INTERVENTIONAL,Not enough participants were included
NCT02510534,TERMINATED,INTERVENTIONAL,unable to enroll participants who meet the criteria
NCT02510885,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19
NCT02510911,TERMINATED,INTERVENTIONAL,lack of effect at interims analysis
NCT02510950,TERMINATED,INTERVENTIONAL,Low accrual
NCT02511067,WITHDRAWN,INTERVENTIONAL,Funding lost and study never started
NCT02511184,TERMINATED,INTERVENTIONAL,"Decision based on the low enrollment mainly due to high efficacy drugs available in 1st line ALK-positive NSCLC (eg alectinib), not due to any safety concerns"
NCT02511275,TERMINATED,INTERVENTIONAL,this type of surgery is now performed with a surgical robot that no longer allows the realization of microdialysis
NCT02511379,TERMINATED,INTERVENTIONAL,Discontinuation of product development
NCT02511483,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT02511613,WITHDRAWN,INTERVENTIONAL,Company decision
NCT02511691,TERMINATED,INTERVENTIONAL,"Enough data for a publication, decision of Sponsor-PI"
NCT02511756,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02511912,WITHDRAWN,INTERVENTIONAL,Study was canceled
NCT02512120,WITHDRAWN,INTERVENTIONAL,The backgroud of this study was not well discussed.
NCT02512237,TERMINATED,INTERVENTIONAL,Replace with a new trial
NCT02512367,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT02512601,TERMINATED,INTERVENTIONAL,Poor inclusion
NCT02512679,TERMINATED,INTERVENTIONAL,Optimal dose obtained for engraftment and minimizing toxicity
NCT02512783,TERMINATED,INTERVENTIONAL,Interim analysis indicated treatment was effective and statistically significant
NCT02512809,TERMINATED,INTERVENTIONAL,PI moving to another institution.
NCT02513589,TERMINATED,INTERVENTIONAL,Negativity of the first results of in vivo binding of 18F-PBR06
NCT02513667,TERMINATED,INTERVENTIONAL,The study was terminated after UTSW was informed by Novartis that further support for the study would not be provided
NCT02513823,TERMINATED,INTERVENTIONAL,Reached power analysis goal and funds depleted
NCT02513992,WITHDRAWN,INTERVENTIONAL,no patient met inclusion criteria
NCT02514031,TERMINATED,INTERVENTIONAL,The study placed on temporarily hold to enrollment due to quality testing necessary for the study drug.
NCT02514057,WITHDRAWN,OBSERVATIONAL,investigator emigrated
NCT02514109,TERMINATED,OBSERVATIONAL,Start of a new study concerning the same patients
NCT02514408,WITHDRAWN,OBSERVATIONAL,No funding
NCT02514447,TERMINATED,INTERVENTIONAL,Primary Analysis and survival follow up completed per protocol. Not stopped due to safety concerns.
NCT02514616,TERMINATED,INTERVENTIONAL,Early termination due to a suspension of financial support
NCT02514733,TERMINATED,OBSERVATIONAL,"Due to a lack of laboratory resources, the study was abandoned."
NCT02514837,WITHDRAWN,OBSERVATIONAL,No funding
NCT02514967,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume. Subjects were seen until February 2017
NCT02515513,WITHDRAWN,INTERVENTIONAL,Original PI left the institution. No subjects enrolled
NCT02515539,WITHDRAWN,INTERVENTIONAL,Edwards Lifesciences terminated the IDE associated with this study. No patients enrolled.
NCT02515669,TERMINATED,INTERVENTIONAL,A pre-planned futility analysis indicated lack of efficacy in study NCT03039686 and led to discontinuation of both ongoing studies in DMD.
NCT02515851,TERMINATED,INTERVENTIONAL,Unable to find sufficient drug naive patients
NCT02515916,TERMINATED,OBSERVATIONAL,Not enough subjects
NCT02515968,WITHDRAWN,INTERVENTIONAL,"The paper is about to publish on the same subject abroad, so the investigator decieded to stopped the study."
NCT02516228,TERMINATED,INTERVENTIONAL,Business decision to discontinue development of this investigational device
NCT02516319,TERMINATED,INTERVENTIONAL,Business decision to discontinue product development.
NCT02516397,TERMINATED,INTERVENTIONAL,Study was terminated because of conflicting results from intermediate analysis.
NCT02516436,WITHDRAWN,INTERVENTIONAL,FDA did not require a clinical trial for indication.
NCT02516670,TERMINATED,INTERVENTIONAL,insufficient clinical response per DSMB
NCT02516696,TERMINATED,INTERVENTIONAL,low enrollment
NCT02516774,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT02517359,TERMINATED,INTERVENTIONAL,Preset pharmacokinetic stopping criteria met at lower doses than expected.
NCT02517671,WITHDRAWN,INTERVENTIONAL,PI failed to file continuation report.
NCT02517697,WITHDRAWN,INTERVENTIONAL,We will not initiate recruitment for this protocol due to lack of funding to support this placebo-controlled trial.
NCT02517931,WITHDRAWN,INTERVENTIONAL,No funding for the project
NCT02517996,TERMINATED,INTERVENTIONAL,Preliminary results were promising when interim analysis performed but terminated due to primary investigators left recruitment site.
NCT02518022,WITHDRAWN,INTERVENTIONAL,unexpected low willingness of patient to participate on the study
NCT02518750,TERMINATED,INTERVENTIONAL,Due to slow accrual
NCT02518971,TERMINATED,INTERVENTIONAL,interim analysis revealed no significant difference between study groups \& increased sample size required to gain significance.
NCT02519192,WITHDRAWN,INTERVENTIONAL,Research personal no longer available
NCT02519270,TERMINATED,INTERVENTIONAL,Strategic Reasons
NCT02519335,TERMINATED,INTERVENTIONAL,PI no longer at this facility
NCT02519439,TERMINATED,INTERVENTIONAL,Ganaxolone missed its primary endpoint in the double-blind portion of the 1042-0603 study. Due to this outcome Marinus discontinued this extension study.
NCT02519712,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02519738,TERMINATED,INTERVENTIONAL,enrollment difficulties
NCT02519842,TERMINATED,INTERVENTIONAL,Further data are no longer required to support an application for use in pediatric patients. The decision to terminate was not based on any new safety findings
NCT02519985,SUSPENDED,INTERVENTIONAL,Devices currently awaiting software updates
NCT02520011,TERMINATED,INTERVENTIONAL,"Due to slow enrollment, the extensive time projected to conclude the study hypothesis rendered the study no longer reasonably feasible to complete."
NCT02520102,WITHDRAWN,INTERVENTIONAL,Company has fulfilled post-marketing requirements
NCT02520427,TERMINATED,INTERVENTIONAL,Amgen prioritization decision
NCT02520505,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT02520518,TERMINATED,INTERVENTIONAL,Designed a new modified/simplified protocol see NCT 03180489
NCT02520557,TERMINATED,OBSERVATIONAL,The study was not terminated for safety reasons. The sponsor was released from the postmarketing requirement to conduct the study
NCT02520726,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02521077,WITHDRAWN,INTERVENTIONAL,Manufacturer unwilling to provide information needed for IND application.
NCT02521090,WITHDRAWN,INTERVENTIONAL,Due to lack of funding and a primary co-investigator of the trial leaving the institution.
NCT02521194,TERMINATED,INTERVENTIONAL,PI requested
NCT02521233,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02521246,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02521324,WITHDRAWN,INTERVENTIONAL,Decided to redesign the study.
NCT02521480,WITHDRAWN,INTERVENTIONAL,Study not feasible or convenient for the subject
NCT02521558,TERMINATED,INTERVENTIONAL,Enrollment was halted early because of low adherence to the intervention.
NCT02521753,SUSPENDED,INTERVENTIONAL,Recruitment was no longer possible due to the SAR-Cov-2 contingency
NCT02521792,TERMINATED,INTERVENTIONAL,"Subjects were enrolled into a different Phase 2 study (PVO-1A-202, NCT02279095)."
NCT02521870,TERMINATED,INTERVENTIONAL,A strategic restructuring including the planned conclusion of clinical oncology development programs and no further sponsoring of the development of SD-101.
NCT02521935,WITHDRAWN,INTERVENTIONAL,"The PI is deceased, decision was made to withdraw."
NCT02522143,WITHDRAWN,INTERVENTIONAL,No funding
NCT02522247,WITHDRAWN,INTERVENTIONAL,"No patients have been enrolled, and will not. The study was never started"
NCT02522429,TERMINATED,INTERVENTIONAL,COVID-19 restrictions placed on the study.
NCT02522676,SUSPENDED,INTERVENTIONAL,Due to surgeons' unwillingness to randomize patients into different treatments
NCT02522936,WITHDRAWN,INTERVENTIONAL,Due to lack of funding and necessary personnel we determined that the study could not be done.
NCT02523248,TERMINATED,INTERVENTIONAL,Because of Covid 19 pandemic situation delay in recruiting patients
NCT02523690,TERMINATED,INTERVENTIONAL,Slow recruitment of eligible patients
NCT02523716,TERMINATED,INTERVENTIONAL,Failure to maintain access to Altitude Facility
NCT02523768,TERMINATED,INTERVENTIONAL,Difficulties for recruting patients
NCT02523794,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02523859,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02523911,WITHDRAWN,INTERVENTIONAL,investigator graduated and is not longer at this institution
NCT02524106,TERMINATED,INTERVENTIONAL,Industry won't be moving forward with production of bococizumab
NCT02524119,TERMINATED,INTERVENTIONAL,This study was terminated after the sponsor withdrew our support
NCT02524249,TERMINATED,INTERVENTIONAL,Frequent protocol violations
NCT02524275,TERMINATED,INTERVENTIONAL,low enrollment
NCT02524288,TERMINATED,INTERVENTIONAL,This study was terminated by the Sponsor due to a business decision to discontinue product development for reasons unrelated to safety or efficacy outcomes.
NCT02524327,TERMINATED,INTERVENTIONAL,Material issues. Re-start in assessment
NCT02524366,WITHDRAWN,INTERVENTIONAL,This study was withdrawn on November 2017 due to no subject accrual. No subjects were enrolled in this study.
NCT02524379,TERMINATED,INTERVENTIONAL,Principal investigator has left the university; there were not enough participants to analyze the data.
NCT02524431,WITHDRAWN,INTERVENTIONAL,Unable to obtain mitochondrial samples
NCT02524639,WITHDRAWN,INTERVENTIONAL,Due to strict inclusion and exclusion criteria no subjects were enrolled
NCT02524847,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02524886,TERMINATED,INTERVENTIONAL,It was not possible to recruit and include a sufficient number of patients within the timeframe.
NCT02524938,TERMINATED,INTERVENTIONAL,Failure to recruit due to human resourcing
NCT02524951,TERMINATED,INTERVENTIONAL,lack of interest by sponsor
NCT02524990,TERMINATED,INTERVENTIONAL,Integrated into another study
NCT02525211,TERMINATED,INTERVENTIONAL,Recruitment defect
NCT02525263,TERMINATED,INTERVENTIONAL,The single patient enrolled began hemodialysis treatments.
NCT02525302,TERMINATED,INTERVENTIONAL,Dosing stopped
NCT02525367,TERMINATED,INTERVENTIONAL,All Parkinson's disease patients have finished training. The MS and ECT groups have not finished as these groups had trouble including 20 patients.
NCT02525562,TERMINATED,INTERVENTIONAL,Terminated
NCT02525640,WITHDRAWN,INTERVENTIONAL,No participants recrui
NCT02525835,WITHDRAWN,INTERVENTIONAL,funding
NCT02525887,TERMINATED,OBSERVATIONAL,Study cancelled
NCT02525900,TERMINATED,INTERVENTIONAL,"slow enrollment, and unusable data"
NCT02525913,WITHDRAWN,INTERVENTIONAL,Study was withdrawn from the IRB and never opened. No subjects were enrolled.
NCT02525926,TERMINATED,INTERVENTIONAL,Refusal of CPP to extend the period of inclusion
NCT02526069,TERMINATED,INTERVENTIONAL,No uptake from potential participants
NCT02526329,WITHDRAWN,INTERVENTIONAL,Logistics
NCT02526537,TERMINATED,OBSERVATIONAL,Similar study has revealed result of no benefit for participants
NCT02526719,WITHDRAWN,INTERVENTIONAL,"Study design changed, no longer a randomized trial design"
NCT02526992,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02527174,WITHDRAWN,INTERVENTIONAL,Volasertib no longer available
NCT02527213,TERMINATED,INTERVENTIONAL,Company decision
NCT02527343,TERMINATED,INTERVENTIONAL,Study terminated early at a time point when sufficient data had been accumulated to inform a decision on further development of volanesoresen in participants with FPL.
NCT02527421,TERMINATED,INTERVENTIONAL,Not able to recruit patients with the current enrollment criteria.
NCT02527577,TERMINATED,INTERVENTIONAL,difficulties to recruit patients
NCT02527590,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT02527642,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02527681,TERMINATED,INTERVENTIONAL,"on July 07, 2020 due to slow enrollment; there were no safety concerns."
NCT02527772,WITHDRAWN,INTERVENTIONAL,It doesn't meet the requirements of randomized trials
NCT02527876,WITHDRAWN,INTERVENTIONAL,Researcher left University
NCT02527954,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT02528071,TERMINATED,OBSERVATIONAL,lack of inclusion
NCT02528318,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate after 3 dosing groups
NCT02528331,TERMINATED,INTERVENTIONAL,PI has left Duke
NCT02528474,TERMINATED,INTERVENTIONAL,"As it is difficult to recruit any more subjects, the investigators decided to terminate the study."
NCT02528487,SUSPENDED,OBSERVATIONAL,Pending financial support
NCT02528617,WITHDRAWN,INTERVENTIONAL,No subjects accrued and no potential subjects were identified..
NCT02528708,WITHDRAWN,INTERVENTIONAL,The study never began.
NCT02528877,WITHDRAWN,INTERVENTIONAL,The study design was revised so a new protocol will be opened.
NCT02528994,WITHDRAWN,INTERVENTIONAL,The PI will be leaving the institution and not continuing the study
NCT02529098,WITHDRAWN,INTERVENTIONAL,default recruitment
NCT02529475,TERMINATED,INTERVENTIONAL,recruitment problem-covid-
NCT02529696,TERMINATED,OBSERVATIONAL,"Low enrollment, unable to power adequately"
NCT02529891,TERMINATED,OBSERVATIONAL,Lack of inclusion
NCT02530086,WITHDRAWN,INTERVENTIONAL,Study was closed due to lack of personnel for recruitment/enrollment purposes.
NCT02530125,TERMINATED,INTERVENTIONAL,sponsor decided to discontinue development of the study drug.
NCT02530203,TERMINATED,INTERVENTIONAL,Due to a change in medication guidelines it became practically impossible to recruit patients
NCT02530307,TERMINATED,INTERVENTIONAL,Administrative
NCT02530437,TERMINATED,INTERVENTIONAL,The sponsor sold the drug TALADEGIB to another company during the trial and thereafter no drug was available. The sponsor made a decision to stop development of this drug Taladegib.
NCT02530502,TERMINATED,INTERVENTIONAL,The protocol was amendment to be stopped after phase I (phase 2 removed from protocol)
NCT02530567,TERMINATED,INTERVENTIONAL,recruitment defect
NCT02530606,WITHDRAWN,INTERVENTIONAL,Efficacy
NCT02530775,WITHDRAWN,INTERVENTIONAL,The study did not receive IRB approval and was withdrawn
NCT02530879,WITHDRAWN,INTERVENTIONAL,Inability to recruit patients
NCT02530931,TERMINATED,INTERVENTIONAL,Recruitment problem-covid
NCT02531139,WITHDRAWN,INTERVENTIONAL,Study was not feasible.
NCT02531295,TERMINATED,INTERVENTIONAL,Pause on clinical trial enrollment due to grant funding cuts after COVID-19
NCT02531308,TERMINATED,INTERVENTIONAL,poor accrual
NCT02531321,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT02531633,TERMINATED,INTERVENTIONAL,GSK decision to return rights to sirukumab to Janssen and discontinue sirukumab development in giant cell arteritis.
NCT02531854,WITHDRAWN,INTERVENTIONAL,Study was withdrawn per sponsor decision
NCT02532010,TERMINATED,INTERVENTIONAL,"The study was put on clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints."
NCT02532036,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02532062,TERMINATED,INTERVENTIONAL,"lost funding, limited eligibility due to pre-existing vitamin D supplementation"
NCT02532075,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02532088,WITHDRAWN,INTERVENTIONAL,Project terminated
NCT02532101,TERMINATED,INTERVENTIONAL,Study was terminated due to futility.
NCT02532153,WITHDRAWN,INTERVENTIONAL,No funding.
NCT02532192,WITHDRAWN,INTERVENTIONAL,Withdrawal of study support.
NCT02532322,WITHDRAWN,INTERVENTIONAL,not enough patients meeting criteria
NCT02532400,TERMINATED,INTERVENTIONAL,Hard to enroll expected number of eligible patients.
NCT02532426,TERMINATED,OBSERVATIONAL,Lack of inclusion
NCT02532517,TERMINATED,INTERVENTIONAL,No safety issues; change in innovation strategy
NCT02532543,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT02532660,TERMINATED,INTERVENTIONAL,Recruitment difficulties due to monocentric study
NCT02532972,TERMINATED,INTERVENTIONAL,Closed by IRB
NCT02533050,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT02533141,WITHDRAWN,INTERVENTIONAL,no funding
NCT02533336,TERMINATED,INTERVENTIONAL,futility ground
NCT02533531,TERMINATED,INTERVENTIONAL,Study was halted to make device updates
NCT02533570,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02533687,SUSPENDED,INTERVENTIONAL,Due to unwillingness of surgeons to use monopolar energy \& technical problems
NCT02533778,SUSPENDED,INTERVENTIONAL,Similar large international competing trial with results of strong positive statistically benefit
NCT02534038,TERMINATED,INTERVENTIONAL,The study was terminated prematurely because of difficulty with recruiting.
NCT02534116,WITHDRAWN,INTERVENTIONAL,Study never began
NCT02534129,TERMINATED,INTERVENTIONAL,Insufficient dermatitis was seen in the controls to allow any determination of protection by Difinsa53
NCT02534181,WITHDRAWN,INTERVENTIONAL,Logistical issues
NCT02534337,WITHDRAWN,INTERVENTIONAL,It doesn't meet the requirements of randomized trials
NCT02534883,TERMINATED,INTERVENTIONAL,not able to meet enrollment
NCT02535247,TERMINATED,INTERVENTIONAL,Merck no longer providing drug for study
NCT02535260,WITHDRAWN,OBSERVATIONAL,"Study not started, no longer required"
NCT02535351,TERMINATED,INTERVENTIONAL,low enrolment
NCT02535364,TERMINATED,INTERVENTIONAL,Safety reasons
NCT02535780,TERMINATED,INTERVENTIONAL,Study procedures and time not feasible due to patient schedule
NCT02535806,TERMINATED,INTERVENTIONAL,Funding source discontinued
NCT02535845,TERMINATED,INTERVENTIONAL,Halted early due to poor accrual and lack of time to receive intervention procedures adjacent to a clinic visit post randomization.
NCT02535962,WITHDRAWN,INTERVENTIONAL,sponsor withdrawal
NCT02535988,WITHDRAWN,INTERVENTIONAL,No recruitment.
NCT02536092,WITHDRAWN,INTERVENTIONAL,Sponsor terminated study
NCT02536183,TERMINATED,INTERVENTIONAL,low accrual
NCT02536300,TERMINATED,INTERVENTIONAL,Gilead has made the decision to close the study due to enrollment challenges
NCT02536495,WITHDRAWN,INTERVENTIONAL,PI decision due to funding support
NCT02537080,TERMINATED,INTERVENTIONAL,higher POCD in nimodipine Group
NCT02537145,TERMINATED,OBSERVATIONAL,Not enough obese subjects could be recruited.
NCT02537561,WITHDRAWN,INTERVENTIONAL,The pharmaceutical company did not want to follow through with support for the study.
NCT02537964,TERMINATED,INTERVENTIONAL,funding not available
NCT02538081,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT02538146,TERMINATED,INTERVENTIONAL,Older participants could not tolerate the acidity of the product and withdrew.
NCT02538315,TERMINATED,OBSERVATIONAL,lack of patients due to COVID
NCT02538406,TERMINATED,OBSERVATIONAL,Local IRB in process to close down study.
NCT02538432,WITHDRAWN,INTERVENTIONAL,PI No Longer at University of Maryland. Now at Fox Chase
NCT02538471,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of patient accrual.
NCT02538627,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02538822,TERMINATED,INTERVENTIONAL,low inclusion rates
NCT02538887,WITHDRAWN,OBSERVATIONAL,Sponsor dissolved before study started
NCT02538913,TERMINATED,INTERVENTIONAL,too slow recruitment; lack of resources
NCT02538926,WITHDRAWN,INTERVENTIONAL,Drugs unavailable
NCT02539017,WITHDRAWN,INTERVENTIONAL,"because of safety problem, this trial was stopped in the hospital"
NCT02539303,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects
NCT02539342,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02539459,TERMINATED,INTERVENTIONAL,"Extreme toxicity, met toxicity stopping rules"
NCT02539563,TERMINATED,INTERVENTIONAL,"During interim analysis, it appeared there were no difference in groups"
NCT02539680,TERMINATED,INTERVENTIONAL,insufficiant recruitment
NCT02539719,TERMINATED,INTERVENTIONAL,Strategic Considerations
NCT02539992,TERMINATED,INTERVENTIONAL,Product discontinued in November 2014
NCT02540057,WITHDRAWN,INTERVENTIONAL,Abandoned following local ethics review.
NCT02540083,TERMINATED,INTERVENTIONAL,Sponsor has obtained sufficient case load prematurely.
NCT02540135,WITHDRAWN,INTERVENTIONAL,The investigators decided not to move forward with this study at this time.
NCT02540200,WITHDRAWN,INTERVENTIONAL,"Never started, no longer funded"
NCT02540291,TERMINATED,INTERVENTIONAL,"Terminated due to, licensing agreement granting exclusive rights of research, development, manufacture and marketing of Eisai's E7046 to Adlai Nortye Biopharma."
NCT02540330,TERMINATED,INTERVENTIONAL,Business decision (See Detailed Description)
NCT02540434,TERMINATED,INTERVENTIONAL,Feasibility issues prevent completion of recruitment.
NCT02540512,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02540551,TERMINATED,INTERVENTIONAL,low detection of the SN in patients included so far (n=11)
NCT02540616,WITHDRAWN,INTERVENTIONAL,Study hypothesis was faulty
NCT02540629,TERMINATED,INTERVENTIONAL,Human resource change in Research investigators and Seoul Fire Department
NCT02540928,TERMINATED,INTERVENTIONAL,Safety Reasons
NCT02541045,WITHDRAWN,INTERVENTIONAL,lack of resources to finance the project
NCT02541162,TERMINATED,INTERVENTIONAL,The study was suspended because the oncology service decided to adopt the procedure in routine
NCT02541227,TERMINATED,OBSERVATIONAL,The goal to match 1000 patients per group could not be achieved with reasonable effort and in reasonable time.
NCT02541357,TERMINATED,INTERVENTIONAL,Recruitment insufficient
NCT02541604,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate because limited investigational agent activity was observed.
NCT02541617,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02541630,WITHDRAWN,INTERVENTIONAL,Attempts to recruit eligible subjects revealed that it would not be possible to enroll adequate numbers. Thus- no subjects were enrolled.
NCT02541721,TERMINATED,INTERVENTIONAL,New study design will be made
NCT02541838,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02541851,TERMINATED,OBSERVATIONAL,Insufficient recruitment leading to selection bias and insufficient data
NCT02541903,TERMINATED,INTERVENTIONAL,poor overall accrual
NCT02541994,TERMINATED,INTERVENTIONAL,Disparate corneal thickness readings from two measurement techniques employed.
NCT02542098,WITHDRAWN,INTERVENTIONAL,Study has been updated with a new protocol number
NCT02542137,WITHDRAWN,INTERVENTIONAL,No recruitment.
NCT02542241,TERMINATED,INTERVENTIONAL,lack of funds to continue recruitment
NCT02542397,TERMINATED,INTERVENTIONAL,Early study closure due to limited internal resources to continue enrollment.
NCT02542540,TERMINATED,INTERVENTIONAL,difficulty to include patients
NCT02542566,TERMINATED,INTERVENTIONAL,Study was stopped prematurely due to the lack of eligible participants.
NCT02542930,WITHDRAWN,INTERVENTIONAL,No recruitment.
NCT02543177,TERMINATED,INTERVENTIONAL,not enough patients recruited
NCT02543385,WITHDRAWN,INTERVENTIONAL,Change of protocol title
NCT02543632,TERMINATED,OBSERVATIONAL,Company closed
NCT02543645,TERMINATED,INTERVENTIONAL,Portfolio re-prioritization
NCT02543931,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT02543957,WITHDRAWN,OBSERVATIONAL,Funding not received.
NCT02544256,WITHDRAWN,INTERVENTIONAL,higher mortality in another published study
NCT02544269,TERMINATED,INTERVENTIONAL,After pilot study no difference in the primary end point was found between the two primary. Non-inferiority trial not deemed feasible.
NCT02544386,TERMINATED,OBSERVATIONAL,Inclusion rhythm too slow
NCT02544503,TERMINATED,INTERVENTIONAL,"The study was suspended in 2020 due to COVID-19 safety measures. Follow up with those previously enrolled later resumed, but not all subjects returned due to the ongoing pandemic. The study closed after attempting to obtain as much data as possible."
NCT02545114,TERMINATED,INTERVENTIONAL,"Major protocol revision needed, current project terminated after enrollment of 25 patients."
NCT02545127,TERMINATED,INTERVENTIONAL,The trial was prematurely terminated. Termination was not because of safety concerns but due to slow recruitment.
NCT02545205,TERMINATED,INTERVENTIONAL,Stopped due to limited access to medical technology devices.
NCT02545283,TERMINATED,INTERVENTIONAL,The study was stopped for futility based on efficacy results at the interim analysis; no unexpected safety findings were observed.
NCT02545361,WITHDRAWN,INTERVENTIONAL,Program de-prioritized
NCT02545387,WITHDRAWN,OBSERVATIONAL,Logistical problems
NCT02545413,WITHDRAWN,INTERVENTIONAL,Investigator (Dr Amit) not interested to carry out the study
NCT02545582,SUSPENDED,OBSERVATIONAL,Sponsor decision
NCT02546024,SUSPENDED,OBSERVATIONAL,Revision of recruitment strategies due to difficulties in recruitment
NCT02546076,WITHDRAWN,INTERVENTIONAL,Lack of patients
NCT02546102,SUSPENDED,INTERVENTIONAL,Company is discussing with FDA to reinitiate the trial now.
NCT02546193,TERMINATED,INTERVENTIONAL,Unable to recruit/accrue adequate numbers of participants within funding period.
NCT02546336,WITHDRAWN,INTERVENTIONAL,Staff for the study is no longer available.
NCT02546427,WITHDRAWN,INTERVENTIONAL,PI left UCSF and the study was closed without any accruals.
NCT02546492,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT02546869,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to an internal decision.
NCT02547116,WITHDRAWN,INTERVENTIONAL,Administrative delay
NCT02547129,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients as patients wanted articulating spacers.
NCT02547142,TERMINATED,INTERVENTIONAL,Study futility with regards to recruitment
NCT02547168,TERMINATED,INTERVENTIONAL,Trial futility
NCT02547207,TERMINATED,OBSERVATIONAL,Slow recruitment
NCT02547220,TERMINATED,INTERVENTIONAL,"Following a pre-scheduled interim analysis performed by the DMC, it was determined that the study met the pre-specified criteria for futility."
NCT02547298,TERMINATED,OBSERVATIONAL,"Previous PI left, staffing changes especially in setting of COVID pandemic meant we no longer wanted to proceed with further recruitment. There were no adverse events or concerns leading to the termination of the study. Simply logistical concerns"
NCT02547324,TERMINATED,INTERVENTIONAL,Study results were too significant
NCT02547376,TERMINATED,OBSERVATIONAL,Covid-19
NCT02547688,WITHDRAWN,INTERVENTIONAL,Study sponsor discontinued
NCT02547961,WITHDRAWN,INTERVENTIONAL,Project terminated due to revision of local regulations
NCT02548117,WITHDRAWN,INTERVENTIONAL,Funding was not available.
NCT02548169,TERMINATED,INTERVENTIONAL,The study was stopped because of loss of funding and no safety issues
NCT02548351,TERMINATED,INTERVENTIONAL,The FDA issued a CRL in response to Intercept's NDA for OCA for the treatment of NASH. The FDA indicated the review was complete and determined it cannot be approved. Sponsor decided to terminate 747-303 before the planned completion date.
NCT02548390,TERMINATED,INTERVENTIONAL,Company decision
NCT02548468,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT02548494,TERMINATED,INTERVENTIONAL,Project terminated due to insufficient resources for recruitment.
NCT02548533,TERMINATED,INTERVENTIONAL,Not enough patients eligible for recruitment.
NCT02548572,WITHDRAWN,INTERVENTIONAL,Could not recruit patients
NCT02548611,TERMINATED,INTERVENTIONAL,Due to low recruitment
NCT02548624,WITHDRAWN,OBSERVATIONAL,Protocol is being reevaluated by sponsor
NCT02548689,TERMINATED,OBSERVATIONAL,Original lead investigator left Northwestern University
NCT02548962,TERMINATED,INTERVENTIONAL,"After completing Phase 1, the Sponsor elected not to move forward with Phase 2."
NCT02549573,TERMINATED,INTERVENTIONAL,Subject enrollment is unsatisfactory
NCT02549716,TERMINATED,INTERVENTIONAL,Funding was stopped
NCT02549755,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02549781,TERMINATED,INTERVENTIONAL,difficulties of inclusion of subjects
NCT02549924,TERMINATED,INTERVENTIONAL,no financial support
NCT02550028,TERMINATED,INTERVENTIONAL,"The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT02550041,TERMINATED,INTERVENTIONAL,Difficulties for inclusions
NCT02550054,TERMINATED,INTERVENTIONAL,"The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT02550119,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT02550509,TERMINATED,INTERVENTIONAL,Difficulties to include patients
NCT02550691,TERMINATED,INTERVENTIONAL,Financial sponsor difficulties
NCT02550743,TERMINATED,INTERVENTIONAL,lack of accural
NCT02550860,TERMINATED,INTERVENTIONAL,problem of enrollment
NCT02550886,TERMINATED,OBSERVATIONAL,Lost many participants to follow-up.
NCT02551003,WITHDRAWN,INTERVENTIONAL,"The study did not commence due to unforeseen challenges in securing adequate funding and resources, coupled with logistical constraints."
NCT02551055,TERMINATED,INTERVENTIONAL,Business Decision; No Safety Or Efficacy Concerns.
NCT02551107,TERMINATED,INTERVENTIONAL,Inadequate resources
NCT02551146,TERMINATED,INTERVENTIONAL,Difficulties concerning the recruitment of participants
NCT02551458,TERMINATED,INTERVENTIONAL,"sub-optimal inclusion rate, additional 9 years to finalize inclusion and follow-up of all patients."
NCT02551484,TERMINATED,INTERVENTIONAL,The patient population presenting in the department has evolved and no longer allows for the recruitment of the necessary number of patients.
NCT02551601,TERMINATED,OBSERVATIONAL,No new participants
NCT02551731,TERMINATED,INTERVENTIONAL,Sponsor elected not to continue with study
NCT02551783,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT02552225,TERMINATED,INTERVENTIONAL,Funding was not obtained so the study could not be continued after the Covid pause.
NCT02552550,TERMINATED,OBSERVATIONAL,rate of inclusion too low
NCT02552732,TERMINATED,INTERVENTIONAL,Study terminated due to change in business of US site.
NCT02552862,WITHDRAWN,INTERVENTIONAL,No candidates during recruiting time. There were no candidates meeting the inclusion criteria
NCT02553122,WITHDRAWN,INTERVENTIONAL,Data has been published on this study (this would have been a duplicate study)
NCT02553174,TERMINATED,OBSERVATIONAL,unable to recruit sufficient patients to satisfy study protocols
NCT02553239,TERMINATED,INTERVENTIONAL,insufficient patient recruitment
NCT02553252,WITHDRAWN,INTERVENTIONAL,A pilot study is currently in progress.
NCT02553330,TERMINATED,INTERVENTIONAL,The study was terminated early based on the results of a planned interim analysis.
NCT02553499,TERMINATED,INTERVENTIONAL,Enrollment prematurely discontinued due to program prioritization \& not due to any safety concerns.
NCT02553564,TERMINATED,INTERVENTIONAL,Lack of enrollment as expected
NCT02553876,TERMINATED,OBSERVATIONAL,"Stopped 1 jan 2017, logistical reasons"
NCT02554188,WITHDRAWN,INTERVENTIONAL,USC has an ICOI because the university owns the patent of the interventional dietary supplement.
NCT02554552,WITHDRAWN,INTERVENTIONAL,This study has been withdrawn prior to enrollment.
NCT02554565,TERMINATED,INTERVENTIONAL,Study in competition with another so it was decided to stop recruitment
NCT02554591,TERMINATED,OBSERVATIONAL,Changes in treatment plans affecting drug therapy choices
NCT02554812,TERMINATED,INTERVENTIONAL,The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the Investigational treatments have been moved to a continuation study (NCT05059522)
NCT02555085,TERMINATED,INTERVENTIONAL,Clinical study terminated due to preclinical safety findings in non-human primates.
NCT02555293,TERMINATED,INTERVENTIONAL,Prematurely terminated due to organisational reasons
NCT02555384,WITHDRAWN,INTERVENTIONAL,"Inclusion and Exclusion criteria too stringent, no patient coluld be recruited"
NCT02556138,TERMINATED,INTERVENTIONAL,Unable to obtain a timely newly requested IDE
NCT02556203,TERMINATED,INTERVENTIONAL,Imbalance in the efficacy and safety endpoints between treatment arms in favor of comparator
NCT02556346,WITHDRAWN,INTERVENTIONAL,The patient population (CLL \& SLL) was included in another ongoing study involving NHL patients.
NCT02556463,TERMINATED,INTERVENTIONAL,Company strategy
NCT02556853,TERMINATED,INTERVENTIONAL,The Thoracic Surgery Department has almost stopped completely its surgical activities and the completion of the study doesn't seem to be feasible.
NCT02556866,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02556970,WITHDRAWN,INTERVENTIONAL,Study never started and was abandoned.
NCT02557191,TERMINATED,OBSERVATIONAL,Difficulty recruiting patients
NCT02557295,TERMINATED,OBSERVATIONAL,Terminated
NCT02557412,WITHDRAWN,INTERVENTIONAL,Limitations to recruitment related to COVID
NCT02557516,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02557529,TERMINATED,INTERVENTIONAL,Slow recruition
NCT02557542,TERMINATED,INTERVENTIONAL,Very poor recruitment
NCT02557828,TERMINATED,INTERVENTIONAL,Principal Investigator retired
NCT02557854,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02557880,WITHDRAWN,INTERVENTIONAL,Could not get teenagers to enroll
NCT02557945,TERMINATED,INTERVENTIONAL,Combination of insufficient funding and lack of compelling findings
NCT02558023,TERMINATED,INTERVENTIONAL,no candidats
NCT02558114,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02558205,WITHDRAWN,OBSERVATIONAL,unable to rectuir
NCT02558309,WITHDRAWN,OBSERVATIONAL,The Primary Investigator is no longer with UPMC. No patients have been enrolled.
NCT02558348,TERMINATED,INTERVENTIONAL,Sponsor termination
NCT02558361,WITHDRAWN,INTERVENTIONAL,FDA approved synovial biopsy device unavailable
NCT02558764,WITHDRAWN,INTERVENTIONAL,Dr. Alwayn is leaving NSHA and Canada for a new appointment in Europe
NCT02559024,TERMINATED,INTERVENTIONAL,Drug expired and access to additional supply ended. PI left the institution shortly afterwards and the study will not be re-activated. Only 4 patients were enrolled.
NCT02559193,WITHDRAWN,OBSERVATIONAL,Loss of funding for the continuation of the Study
NCT02559258,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02559427,WITHDRAWN,INTERVENTIONAL,no patients randomized after more than one year sponsor decided to withdrawn the study.
NCT02559596,WITHDRAWN,OBSERVATIONAL,Linked data not available for research within requisite time period
NCT02559882,TERMINATED,OBSERVATIONAL,The Enterprise decided to stop the production of the catheter used for the clinical indicated renal denervation
NCT02560012,TERMINATED,INTERVENTIONAL,Loss of laboratory performing molecular analysis
NCT02560038,TERMINATED,INTERVENTIONAL,slow enrollment; resource re-allocation
NCT02560051,TERMINATED,INTERVENTIONAL,Slow accrual; resource re-allocation
NCT02560363,WITHDRAWN,INTERVENTIONAL,Has been terminated before FSFV.
NCT02560597,TERMINATED,INTERVENTIONAL,Lack of recruitement and finalisation of research on this topic by investigator
NCT02560714,TERMINATED,OBSERVATIONAL,No additional enrollment
NCT02560740,TERMINATED,INTERVENTIONAL,Subjects' not-well compliance due to diarrhea and softening stool after taking PerOx Quench 4 sachets a day.
NCT02560805,SUSPENDED,INTERVENTIONAL,Enrollment and study activities are temporarily suspended due to COVID-19.
NCT02561013,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT02561117,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02561208,WITHDRAWN,INTERVENTIONAL,Because lack of funding
NCT02561507,TERMINATED,OBSERVATIONAL,This is not a clinical trial and was inadvertently entered into the system.
NCT02561520,WITHDRAWN,INTERVENTIONAL,Study did not enroll participants is being withdrawn from the system.
NCT02561598,WITHDRAWN,OBSERVATIONAL,Research Staffing issues
NCT02561715,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02561728,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT02561832,TERMINATED,INTERVENTIONAL,This decision was based upon strategic considerations impacting the clinical development of olaparib in this indication.
NCT02561897,TERMINATED,INTERVENTIONAL,Did not meet enrolment target for phase 1
NCT02562092,TERMINATED,INTERVENTIONAL,The study was not able to be completed due to the COVID-19 pandemic.
NCT02562339,WITHDRAWN,INTERVENTIONAL,"Due to the departure of study staff and lack of interest by potential subjects and the sponsor, the investigators decided to end the study."
NCT02562417,WITHDRAWN,INTERVENTIONAL,Change of practice in the department
NCT02562443,TERMINATED,INTERVENTIONAL,Top line analysis indicated that the study had failed to achieve its primary endpoint.
NCT02562534,TERMINATED,INTERVENTIONAL,There was sufficient data to verify the primary endpoint
NCT02562560,TERMINATED,INTERVENTIONAL,no more patient
NCT02562612,WITHDRAWN,INTERVENTIONAL,Study was never initiated. Never established sites or enrolled subjects.
NCT02562625,TERMINATED,INTERVENTIONAL,Slow Recruitment
NCT02562820,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT02563015,TERMINATED,INTERVENTIONAL,Covid19 pandemic prevented continuation of study visits
NCT02563314,TERMINATED,INTERVENTIONAL,departure of the coordinating investigator from another institution
NCT02563522,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02563665,WITHDRAWN,OBSERVATIONAL,Lack of funds
NCT02563782,WITHDRAWN,INTERVENTIONAL,Changes to the study design and the cell line
NCT02563964,TERMINATED,OBSERVATIONAL,Logistical reasons and slow recruitment
NCT02563990,TERMINATED,INTERVENTIONAL,Unable to recruit additional patients due to transfer of surgical service (ortho sports medicine) and recruitable cases to another institution.
NCT02564016,TERMINATED,INTERVENTIONAL,"Of 36 participants only 8 participants able to fully complete the study procedures. At this time, the study will be closed due to poor enrollment numbers."
NCT02564133,TERMINATED,INTERVENTIONAL,We have discovered a too low prevalence of Patent Foramen Ovale compared to the theoretical % of around 20-25%.
NCT02564380,TERMINATED,INTERVENTIONAL,Since trial start in Jan. 2016 only 41 patients could be recruited until planned date of end of follow up period. Under consideration of this fact the recruitment of the planned 130 patients was not possible within a reasonable recruitment period.
NCT02564484,SUSPENDED,OBSERVATIONAL,this study remains on voluntary hold
NCT02564536,WITHDRAWN,INTERVENTIONAL,Lack of funding following full FDA clinical hold
NCT02564549,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume
NCT02564796,TERMINATED,INTERVENTIONAL,COVID
NCT02564874,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02564887,TERMINATED,INTERVENTIONAL,Enrollment goals not met in efficient timeframe.
NCT02564965,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02565147,TERMINATED,INTERVENTIONAL,Futility at the interim analysis.
NCT02565199,SUSPENDED,INTERVENTIONAL,Study is temporarily suspended pending additional funding to continue subject recruitment.
NCT02565433,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02565563,WITHDRAWN,INTERVENTIONAL,No participants recruited
NCT02565745,TERMINATED,INTERVENTIONAL,Recommendation after interim analysis
NCT02565901,TERMINATED,INTERVENTIONAL,Terminated due to insufficient funding
NCT02566109,TERMINATED,INTERVENTIONAL,Funding Issues
NCT02566122,TERMINATED,OBSERVATIONAL,not enough patients
NCT02566161,TERMINATED,OBSERVATIONAL,protocol qualifies as not human subjects research
NCT02566278,TERMINATED,INTERVENTIONAL,Data collection has been halted. We are not recruiting any more subjects.
NCT02566382,TERMINATED,INTERVENTIONAL,Insufisciency of recruitment
NCT02566421,TERMINATED,INTERVENTIONAL,Assessing Feasibility
NCT02566499,WITHDRAWN,INTERVENTIONAL,"Improved algorithms have resulted in a proposed redesign of detection system. Once completed, a new trial will be planned."
NCT02566577,TERMINATED,INTERVENTIONAL,Difficulties in recruiting.
NCT02566603,TERMINATED,INTERVENTIONAL,Enough data has been collected to allow analysis of the safety profile and risk-benefit.
NCT02566616,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02566707,TERMINATED,INTERVENTIONAL,"due to introduction of another integrase inhibitor, recruitement was not feasible anymore."
NCT02566759,TERMINATED,INTERVENTIONAL,The study was terminated by Takeda due to the discomfort observed in the study participants from the CSF collection procedure in Part 3 of the study.
NCT02566811,TERMINATED,INTERVENTIONAL,Withdrawal of funding by CR UK due to poor recruitment
NCT02566850,TERMINATED,INTERVENTIONAL,"Preliminary results acceptable, investigators moved attention to different project"
NCT02566889,TERMINATED,INTERVENTIONAL,Study was terminated due to the inability to enroll a sufficient number of the required subject population
NCT02566941,WITHDRAWN,INTERVENTIONAL,Lack of human ressources
NCT02567123,TERMINATED,INTERVENTIONAL,Not Applicable Clinical Trial.
NCT02567149,WITHDRAWN,INTERVENTIONAL,No funding
NCT02567279,TERMINATED,INTERVENTIONAL,"Great difficulties were encountered during recruitment, for fear Denozumab. Only 2 patients have been included since the study start."
NCT02567396,WITHDRAWN,INTERVENTIONAL,Other- Protocol moved to Disapproved
NCT02567448,TERMINATED,INTERVENTIONAL,Failed to accrue
NCT02567578,TERMINATED,INTERVENTIONAL,Technology transfer
NCT02567877,TERMINATED,OBSERVATIONAL,poor enrollment
NCT02568007,TERMINATED,INTERVENTIONAL,Unable to enroll adequate participants
NCT02568046,TERMINATED,INTERVENTIONAL,Discontinued development of Sym004 in combination with FOLFIRI
NCT02568163,TERMINATED,INTERVENTIONAL,"The number of subjects were underestimated, which implies a reduction in the number of subjects required."
NCT02568189,TERMINATED,INTERVENTIONAL,Lack of resources
NCT02568540,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT02568618,TERMINATED,INTERVENTIONAL,Sponsor pulled funding related to enrollment pace.
NCT02568826,WITHDRAWN,INTERVENTIONAL,No patients enrolled in the study.
NCT02568891,WITHDRAWN,INTERVENTIONAL,No funding obtained
NCT02568917,SUSPENDED,INTERVENTIONAL,There was a problem with the municipality and they have choose to suspend it.
NCT02569073,WITHDRAWN,INTERVENTIONAL,Funding
NCT02569125,WITHDRAWN,INTERVENTIONAL,Change in supply of study medication
NCT02569177,WITHDRAWN,OBSERVATIONAL,Due to lack of funding
NCT02569216,WITHDRAWN,INTERVENTIONAL,FDA/IRB approved but hospital administration vetoed the study fearing litigation of a preterm birth though the electrical uterine pacemaker/EI is not the cause.
NCT02569359,TERMINATED,INTERVENTIONAL,participants were not recruited enough
NCT02569398,TERMINATED,INTERVENTIONAL,Change in benefit-risk profile for individuals with early sporadic Alzheimer Disease because of elevations in liver enzymes in subjects receiving atabecestat
NCT02569437,TERMINATED,INTERVENTIONAL,A high percentage of patients were dropping out of the study and were not able to complete the protocol.
NCT02569489,WITHDRAWN,INTERVENTIONAL,Reconsideration of Study Design; plan for alternative protocol
NCT02569749,TERMINATED,OBSERVATIONAL,Administrative reasons
NCT02569788,TERMINATED,INTERVENTIONAL,Slow accrual of patients.
NCT02569801,TERMINATED,INTERVENTIONAL,"The Sponsor decided to halt the development of GDC-0810, but not due to any safety concerns."
NCT02569827,WITHDRAWN,INTERVENTIONAL,The investigational drug celgosivir will not be developed due to lack of VC funding.
NCT02569957,TERMINATED,INTERVENTIONAL,The trial was halted prematurely due to slow accrual.
NCT02570100,TERMINATED,INTERVENTIONAL,The failures of the culture and immunostaining techniques for ALDH do not allow the main objective of the study to be met.
NCT02570139,TERMINATED,INTERVENTIONAL,"Low enrollment, short stay; lacked statistically powered evaluation for efficacy."
NCT02570386,TERMINATED,INTERVENTIONAL,very slow recruitment
NCT02570438,TERMINATED,OBSERVATIONAL,This study was terminated prior to its planned enrollment due to low recruitment rates at the time that the funding for the study was completed.
NCT02570503,TERMINATED,INTERVENTIONAL,"Study's primary aims are no longer clinically impactful, as intrathecal morphine has fallen out of favor and replaced with different agents so that outpatient/23 hr surgery is more predictably achievable."
NCT02570529,WITHDRAWN,INTERVENTIONAL,Investigator decided to stop the study because it was difficult to proceed with the study.
NCT02570711,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02570763,WITHDRAWN,INTERVENTIONAL,The co-investigator and recipient of funding for the project left the department and we were unable to complete the study without her as a co-investigator.
NCT02570789,TERMINATED,INTERVENTIONAL,not enough accrual
NCT02570958,WITHDRAWN,INTERVENTIONAL,Funding was not received
NCT02571283,WITHDRAWN,INTERVENTIONAL,PI decided to focus on more current topics of interest.
NCT02571322,WITHDRAWN,INTERVENTIONAL,Lack of funding; logistics of conducting study were very complex.
NCT02571530,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02571608,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT02571738,TERMINATED,INTERVENTIONAL,Company's desire to allocate more research and development resources to other clinical programs. Decision not driven by any safety concerns.
NCT02572011,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02572063,TERMINATED,OBSERVATIONAL,"Terminated, prior to its planned completion as anticipated by the protocol."
NCT02572206,TERMINATED,INTERVENTIONAL,NIMH terminated study
NCT02572453,TERMINATED,INTERVENTIONAL,Drug supply issues
NCT02572570,TERMINATED,INTERVENTIONAL,Attrition rate complicated by COVID-19 led to termination.
NCT02572973,TERMINATED,INTERVENTIONAL,Rate of recruitment deemed insufficient by study sponsor
NCT02573116,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02573207,TERMINATED,OBSERVATIONAL,low enrollment
NCT02573220,WITHDRAWN,INTERVENTIONAL,Study terminated by PI due to inability to accrue.
NCT02573389,SUSPENDED,INTERVENTIONAL,lack of accrual due to competing study
NCT02573480,TERMINATED,INTERVENTIONAL,Loss of Funding
NCT02573519,TERMINATED,INTERVENTIONAL,Renewal of PET/CT scanners and slow recruitment
NCT02573545,TERMINATED,INTERVENTIONAL,Difficulty recruiting patients
NCT02573597,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT02573740,TERMINATED,INTERVENTIONAL,Insufficient target engagement of ABT-957 (preclinical data)
NCT02573818,TERMINATED,OBSERVATIONAL,franchise closed; no safety concerns
NCT02573935,TERMINATED,INTERVENTIONAL,"Suspected side effects to the combination of clarithromycin and VCD (bortezomib, cyclophosphamide and dexamethasone)"
NCT02573961,WITHDRAWN,INTERVENTIONAL,This was a topic for a thesis project where the topic was changed
NCT02574156,TERMINATED,INTERVENTIONAL,Finished
NCT02574247,TERMINATED,INTERVENTIONAL,PI change of institution
NCT02574442,TERMINATED,OBSERVATIONAL,Funding has run out
NCT02574546,WITHDRAWN,OBSERVATIONAL,Difficulty acquiring fresh tissue from mastectomy specimens.
NCT02574611,WITHDRAWN,INTERVENTIONAL,No reportable findings are possible. The PI/Co-PI were unable to recruit participants for this study. One participant was consented but did not undergo any study procedure.
NCT02574624,TERMINATED,INTERVENTIONAL,Difficulty in finding patients with complex retinal pathology to enroll in this study.
NCT02574637,TERMINATED,INTERVENTIONAL,Study was terminated for business reasons; not due to safety or efficacy concerns.
NCT02574832,TERMINATED,INTERVENTIONAL,planned surgical procedures decreased
NCT02574910,SUSPENDED,INTERVENTIONAL,Need to update IND
NCT02575066,TERMINATED,INTERVENTIONAL,stopping rule
NCT02575313,TERMINATED,INTERVENTIONAL,Lack of participant recruitment.
NCT02575339,TERMINATED,INTERVENTIONAL,Funder Decision
NCT02575365,TERMINATED,INTERVENTIONAL,The trial was terminated due to low enrollment.
NCT02575391,TERMINATED,INTERVENTIONAL,Lack of participant recruitment.
NCT02575508,WITHDRAWN,INTERVENTIONAL,drug supply issues
NCT02575534,WITHDRAWN,INTERVENTIONAL,No enrollment in study.
NCT02575807,TERMINATED,INTERVENTIONAL,Study was stopped due to low enrollment and lack of clinical activity.
NCT02575820,WITHDRAWN,OBSERVATIONAL,Sample size was too small to evaluate the clinical implications.
NCT02576119,TERMINATED,INTERVENTIONAL,This study was terminated early due to neuropsychiatric serious adverse events reported by 2 participants.
NCT02576275,WITHDRAWN,INTERVENTIONAL,The scope of the program has been reduced to focus resources on studies which can potentially enable the registration of duvelisib.
NCT02576444,TERMINATED,INTERVENTIONAL,"The study was paused during COVID and without the ability to initiate the 4th arm in the study, the decision was to terminate the study in 2022."
NCT02576457,TERMINATED,INTERVENTIONAL,Business Objectives Have Changed
NCT02576470,TERMINATED,INTERVENTIONAL,Expired with IRB.
NCT02576665,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02576977,TERMINATED,INTERVENTIONAL,The study was terminated early due to business reasons
NCT02577029,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02577172,TERMINATED,INTERVENTIONAL,Unexpected events
NCT02577367,WITHDRAWN,INTERVENTIONAL,Lost interest in current study
NCT02577445,TERMINATED,OBSERVATIONAL,Commercial distribution of the remed System stopped by LivaNova.
NCT02577588,TERMINATED,INTERVENTIONAL,not feasible
NCT02577653,WITHDRAWN,INTERVENTIONAL,Logistics reason at the data collection site
NCT02577796,WITHDRAWN,OBSERVATIONAL,Lack of time and personnel needed to complete study
NCT02577913,TERMINATED,OBSERVATIONAL,MA of product has been withdrawn from the European market due to stability data
NCT02578121,WITHDRAWN,INTERVENTIONAL,Investigator decided to close study without enrollment
NCT02578147,TERMINATED,INTERVENTIONAL,Funding not available to continue enrollment beyond study completion date.
NCT02578290,TERMINATED,INTERVENTIONAL,"Due to an error in the implementation of the project, CDS was provided to all providers, rather than to the intended random sample of providers."
NCT02578459,WITHDRAWN,INTERVENTIONAL,The study was never initiated by sponsor. Patients where never recruited.
NCT02578511,WITHDRAWN,INTERVENTIONAL,"No enrollment, another competing study and difficult to find the right person to enroll on this study."
NCT02578628,TERMINATED,INTERVENTIONAL,Data source became unavailable
NCT02578667,WITHDRAWN,INTERVENTIONAL,study cancelled
NCT02578719,WITHDRAWN,INTERVENTIONAL,Local Drug Authority didn't give permission to start.
NCT02578836,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to PI decision
NCT02579005,SUSPENDED,INTERVENTIONAL,Lack of ressources
NCT02579122,TERMINATED,OBSERVATIONAL,Poor recruitment
NCT02579187,WITHDRAWN,INTERVENTIONAL,withdrawn study from IRB
NCT02579265,TERMINATED,INTERVENTIONAL,Outcome of a planned interim analysis was that the sample size required to show superiority was too high to be feasible. Fresenius Kabi requested termination to the FDA on 17 Jan 2020. FDA accepted termination by written response on 16 Apr 2020.
NCT02579694,TERMINATED,OBSERVATIONAL,Difficulties finding subjects meeting enrollment criteria
NCT02579733,TERMINATED,INTERVENTIONAL,Not enough number of enrolling patient
NCT02579824,TERMINATED,INTERVENTIONAL,stopped prematurely
NCT02579863,TERMINATED,INTERVENTIONAL,The study was terminated early due to business reasons
NCT02579889,TERMINATED,INTERVENTIONAL,Stopping criterion met (N. adjudicated EP1)
NCT02579993,TERMINATED,INTERVENTIONAL,Preliminar results not favorable
NCT02580045,TERMINATED,OBSERVATIONAL,Inadequate Accrual
NCT02580136,WITHDRAWN,OBSERVATIONAL,Lack of accrual
NCT02580253,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT02580266,WITHDRAWN,OBSERVATIONAL,funding withdrew
NCT02580422,TERMINATED,OBSERVATIONAL,Low accrual
NCT02580669,TERMINATED,INTERVENTIONAL,Inclusion period ended
NCT02580708,TERMINATED,INTERVENTIONAL,Discontinued development of rociletinib in NSCLC. Stopped enrollment of new patients into all studies involving rociletinib.
NCT02580981,TERMINATED,INTERVENTIONAL,Staffing
NCT02581059,TERMINATED,INTERVENTIONAL,Funder terminated.
NCT02581332,WITHDRAWN,INTERVENTIONAL,Due to insufficient interest in the study and enrollment has been closed
NCT02581384,TERMINATED,INTERVENTIONAL,"The study closed primarily due to weak accrual, as well as study design limitations."
NCT02581397,TERMINATED,INTERVENTIONAL,The study stopped because after monitoring visits and data analysis we noticed a high number of protocol deviation that made impossible the results analysis.
NCT02581501,WITHDRAWN,INTERVENTIONAL,"Due to no enrollment, Celgene (sponsor) withdrew funding"
NCT02581709,TERMINATED,INTERVENTIONAL,Very low recruitment and funding was unavailable to support further research.
NCT02582008,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02582190,WITHDRAWN,INTERVENTIONAL,Investigational Medicinal Product Supplies
NCT02582294,TERMINATED,OBSERVATIONAL,Difficulty in patient recruitment
NCT02582476,TERMINATED,INTERVENTIONAL,Slow enrolment and end of funding
NCT02582528,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02582749,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT02582801,TERMINATED,INTERVENTIONAL,The cyclotron in our hospital has a serious malfunction and can not be repaired. It will take a long time to purchase and install the new cyclotron.
NCT02582827,WITHDRAWN,INTERVENTIONAL,Enrollment not initiated
NCT02582996,SUSPENDED,INTERVENTIONAL,Strategic reasons of the company
NCT02583113,WITHDRAWN,OBSERVATIONAL,Alternate Research Pursued
NCT02583191,TERMINATED,INTERVENTIONAL,Recruitment was not as expected.
NCT02583906,TERMINATED,INTERVENTIONAL,Not enough participants
NCT02583945,WITHDRAWN,INTERVENTIONAL,Study medication without approval and stop of financial support
NCT02584049,TERMINATED,INTERVENTIONAL,"The study was stopped prematurely because of the low inclusion rate (1 inclusion in 16 months), the low patient potential and the difficulty of finding new recruiting centres."
NCT02584153,WITHDRAWN,INTERVENTIONAL,Did not obtain IND or IRB approval to initiate study.
NCT02584335,TERMINATED,INTERVENTIONAL,Difficulties with the recruitment
NCT02584400,TERMINATED,INTERVENTIONAL,patients did not want to participate
NCT02584413,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02584517,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02584595,WITHDRAWN,OBSERVATIONAL,Business decision
NCT02584634,TERMINATED,INTERVENTIONAL,The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the Investigational treatments have been moved to a continuation study (NCT05059522)
NCT02584829,TERMINATED,INTERVENTIONAL,Terminated due to loss in funding
NCT02585167,TERMINATED,INTERVENTIONAL,The significantly higher recurrence rate in the intervention group led to a serious ethical consideration of a premature closing of the study which was decided due to safety and benefit concerns
NCT02585271,TERMINATED,INTERVENTIONAL,We can not get enough sample size.
NCT02585388,TERMINATED,INTERVENTIONAL,Treatment toxicity
NCT02585479,WITHDRAWN,INTERVENTIONAL,It doesn't meet the requirements of randomized trials
NCT02585687,TERMINATED,INTERVENTIONAL,problems with enrollment
NCT02585752,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02585765,WITHDRAWN,INTERVENTIONAL,an alternate plan of investigation was developed.
NCT02585791,TERMINATED,INTERVENTIONAL,"due to recent release reports from CDC about lung injury due to vaping, the PI and IRB decided to terminate the study"
NCT02585921,TERMINATED,INTERVENTIONAL,Enrollment completed.
NCT02586012,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02586415,TERMINATED,INTERVENTIONAL,Interim analysis showed a high likelihood of benefit in the endovascular group
NCT02586428,TERMINATED,OBSERVATIONAL,"difficult to enroll, Pi decision to closed"
NCT02586519,TERMINATED,INTERVENTIONAL,"During the unavoidable gap resulting from the global pandemic, the technologies being used in this study have significantly improved and it is no longer optimal to provide patients with the old technology when improved technology is available."
NCT02586558,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT02586610,WITHDRAWN,INTERVENTIONAL,Dr. Rahma decided to run the study through a different group
NCT02586818,WITHDRAWN,OBSERVATIONAL,Product was discontinued.
NCT02586909,TERMINATED,INTERVENTIONAL,Intepirdine did't meet primary efficacy endpoints in lead-in study RVT-101-3001
NCT02586961,TERMINATED,INTERVENTIONAL,Removal of Adrnaline lots for safety reasons.
NCT02587026,TERMINATED,OBSERVATIONAL,"Study team has decided to close enrollment, and all subjects are being rolled into a different clinical trial: Total Cancer Care"
NCT02587078,WITHDRAWN,INTERVENTIONAL,treatment substance not labled for sepsis anymore
NCT02587130,TERMINATED,INTERVENTIONAL,difficulted recruiting
NCT02587351,TERMINATED,INTERVENTIONAL,Futility
NCT02587377,TERMINATED,INTERVENTIONAL,The current rate of recruitment is insufficient.
NCT02587559,WITHDRAWN,INTERVENTIONAL,Could not recruit subjects as they routinely chose surgical option
NCT02587572,WITHDRAWN,INTERVENTIONAL,Sponsor has made decision not to conduct this clinical trial.
NCT02587650,TERMINATED,INTERVENTIONAL,Funding
NCT02587871,WITHDRAWN,INTERVENTIONAL,PI decided not to pursue study
NCT02587962,TERMINATED,INTERVENTIONAL,"Based on a futility analysis, the data monitoring committee recommended to stop enrollment."
NCT02588040,TERMINATED,OBSERVATIONAL,Not enough sites available to complete enrollment in a timely manner
NCT02588092,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02588248,TERMINATED,INTERVENTIONAL,Sponsor/Investigator has decided to close out the study
NCT02588261,TERMINATED,INTERVENTIONAL,"Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies"
NCT02588430,WITHDRAWN,OBSERVATIONAL,Manufacturer of the investigational device has ceased all business activities
NCT02588456,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of efficacy
NCT02588482,TERMINATED,INTERVENTIONAL,Recruitment and feasability issues
NCT02588742,TERMINATED,INTERVENTIONAL,Terminate the study because it is difficult to recruit the subject.
NCT02588807,WITHDRAWN,INTERVENTIONAL,The sponsor and hospital did not reach agreement
NCT02588846,WITHDRAWN,INTERVENTIONAL,Abandoned. No resources
NCT02588950,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02589145,TERMINATED,INTERVENTIONAL,Closed due to very slow accrual
NCT02589184,WITHDRAWN,INTERVENTIONAL,Logistics reason at the data collection site
NCT02589223,TERMINATED,INTERVENTIONAL,Our enrollment numbers were low - very few eligible study subjects.
NCT02589275,TERMINATED,INTERVENTIONAL,"For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia development with TNX102 SL."
NCT02589314,TERMINATED,OBSERVATIONAL,We could not achieve the number of participants necessary to continue with the study and limited money to continue with the study
NCT02589340,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02589509,WITHDRAWN,INTERVENTIONAL,No one was recruited
NCT02589860,WITHDRAWN,OBSERVATIONAL,No accrual
NCT02589964,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT02590003,TERMINATED,INTERVENTIONAL,Trial was stopped after non-response to treatment.
NCT02590068,TERMINATED,INTERVENTIONAL,PI at new institution and no further enrollment to take place.
NCT02590107,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02590159,TERMINATED,INTERVENTIONAL,delay in enrollment
NCT02590380,WITHDRAWN,INTERVENTIONAL,Study was not started
NCT02590497,WITHDRAWN,INTERVENTIONAL,PI made decision
NCT02590523,SUSPENDED,INTERVENTIONAL,Lack of antibiotic availability
NCT02590588,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02590601,WITHDRAWN,INTERVENTIONAL,Not enough patients
NCT02590783,TERMINATED,INTERVENTIONAL,study question was not suitable
NCT02590861,WITHDRAWN,INTERVENTIONAL,Internal staffing issues
NCT02590978,TERMINATED,INTERVENTIONAL,Interim analysis (n=52) with significantly differences in primary outcome (LOS)
NCT02591017,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT02591056,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02591108,WITHDRAWN,INTERVENTIONAL,No Funding
NCT02591173,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT02591199,TERMINATED,INTERVENTIONAL,Prematurely terminated based on interim study analysis
NCT02591381,TERMINATED,INTERVENTIONAL,Study was started but closed prior to completion because we could not meet enrollment numbers
NCT02591394,TERMINATED,INTERVENTIONAL,Funding period ended and slow enrollment
NCT02591433,WITHDRAWN,INTERVENTIONAL,Slow Accrual
NCT02591654,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02591693,TERMINATED,INTERVENTIONAL,Trial OT left post due to significant personal circumstances. Study team unable to recruit new OT to post in time frame available.
NCT02591888,TERMINATED,INTERVENTIONAL,Difficult to enroll; since a similar research project on a different population showed no significance the study has been closed.
NCT02591953,TERMINATED,INTERVENTIONAL,Unable to meet enrollment and follow up criteria
NCT02592395,WITHDRAWN,INTERVENTIONAL,PI transferred to another institution and did not take this study with him.
NCT02592629,TERMINATED,INTERVENTIONAL,Lack of time to enroll due to additional responsibilities of the PI and research coordinator.
NCT02592707,TERMINATED,INTERVENTIONAL,Terminated (Due to small number of ongoing patients. Patients ongoing at time of termination could choose to join study D-FR-01072-004 for long term follow-up.
NCT02592759,TERMINATED,INTERVENTIONAL,The trial was prematurely terminated due to slow recruitment.
NCT02592850,WITHDRAWN,INTERVENTIONAL,Problems for satellite centers in obtaining ethical clearance.
NCT02592876,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02592967,TERMINATED,INTERVENTIONAL,"Development of JNJ-64041757 discontinued due to lack of efficacy. No further follow up data will be collected after October 22, 2018."
NCT02593279,TERMINATED,INTERVENTIONAL,difficulties of enrollment
NCT02593708,TERMINATED,INTERVENTIONAL,toxicity
NCT02593838,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT02593851,TERMINATED,INTERVENTIONAL,Trial was cancelled due to availability of clinical supplies.
NCT02593981,WITHDRAWN,INTERVENTIONAL,Unable to obtain study agent
NCT02594163,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02594332,TERMINATED,INTERVENTIONAL,recruitment problems
NCT02594358,WITHDRAWN,INTERVENTIONAL,Could not recruit
NCT02594748,SUSPENDED,INTERVENTIONAL,The voluntary attendance rate for intervention is low.
NCT02594852,TERMINATED,INTERVENTIONAL,Too few patients enrolling + laser no longer available
NCT02594943,WITHDRAWN,INTERVENTIONAL,Too narrow inclusion criteria. Impossible to recruit patients.
NCT02595580,TERMINATED,INTERVENTIONAL,skin irritation caused by device
NCT02595840,TERMINATED,INTERVENTIONAL,Futility
NCT02595918,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT02595996,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02596165,TERMINATED,INTERVENTIONAL,Stopp because of FDA concrns regarding recruitment.
NCT02596178,WITHDRAWN,INTERVENTIONAL,Research team no longer available.
NCT02596334,TERMINATED,INTERVENTIONAL,5 patients on tivicay had virological failure
NCT02596477,TERMINATED,INTERVENTIONAL,Terminated for administrative reasons not related to safety or efficacy
NCT02596555,TERMINATED,INTERVENTIONAL,"1. Interim results suggested a reduction of sample size.
2. Anticipated length of enrolment period with resulting funding issues to pose a threat to the study."
NCT02596646,TERMINATED,INTERVENTIONAL,Interim analysis recommended terminating the study
NCT02596867,TERMINATED,INTERVENTIONAL,poor accrual
NCT02596919,TERMINATED,INTERVENTIONAL,"After review, recruitment was halted as the images obtained needed improvement. To be presented at the British Oculoplastic Surgery Society in Jun 17"
NCT02597075,TERMINATED,INTERVENTIONAL,Feasibility (low patient accrual and financial reasons)
NCT02597153,TERMINATED,INTERVENTIONAL,Just one subject enrolled in this trial during one and a half years.
NCT02597283,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT02597465,WITHDRAWN,INTERVENTIONAL,Sponsor decided not to initiate the study for alternate commercial strategy
NCT02597504,TERMINATED,INTERVENTIONAL,Loss of funding.
NCT02597556,WITHDRAWN,INTERVENTIONAL,The prevalence of worm infections in the site is significantly lower than expected
NCT02597660,WITHDRAWN,INTERVENTIONAL,PI decided not to enroll
NCT02597894,WITHDRAWN,INTERVENTIONAL,P. I. left the Institution. Study never opened
NCT02597972,TERMINATED,INTERVENTIONAL,project opened under new PI
NCT02598011,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02598297,TERMINATED,INTERVENTIONAL,Unresolvable inability to recruit the patients.
NCT02598427,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT02598479,WITHDRAWN,OBSERVATIONAL,The IRB which was overseeing the study stopped overseeing it
NCT02598622,TERMINATED,INTERVENTIONAL,Drug availability
NCT02598674,WITHDRAWN,OBSERVATIONAL,Expired IRB
NCT02598687,WITHDRAWN,INTERVENTIONAL,"2 Phase 3 trials didn't meet their primary endpoint, so further development and testing of TH-302 is uncertain"
NCT02598778,TERMINATED,INTERVENTIONAL,Study discontinued early due to time constraints and lack of selectivity in agar used in the identification of the target (Streptococcus mutans). Only 12 participants out of a planned 40 were enrolled.
NCT02598999,TERMINATED,INTERVENTIONAL,Financial issues
NCT02599090,WITHDRAWN,INTERVENTIONAL,Multi phase study did not progress to Phase II. Phase I registered as NCT00734526.
NCT02599129,TERMINATED,INTERVENTIONAL,low enrollment
NCT02599571,TERMINATED,INTERVENTIONAL,sponsor discontinued funding
NCT02599649,TERMINATED,INTERVENTIONAL,Enrollment was stopped after the sponsor's decision not to pursue the development of lirilumab for myeloid malignancies.
NCT02599701,TERMINATED,INTERVENTIONAL,Gabapentin increased hypopnea-apnea index in the first 8 recruited subjects.
NCT02599727,WITHDRAWN,INTERVENTIONAL,Logistics reason at the data collection site
NCT02599857,WITHDRAWN,INTERVENTIONAL,never started
NCT02599961,TERMINATED,INTERVENTIONAL,Study was halted prematurely due to lack of efficacy
NCT02600351,TERMINATED,INTERVENTIONAL,"Due to lack of feasibility of enrolling participants, the study was terminated early."
NCT02600429,TERMINATED,INTERVENTIONAL,Business decision
NCT02600572,WITHDRAWN,INTERVENTIONAL,Logistics reason at the data collection site
NCT02600663,TERMINATED,OBSERVATIONAL,insufficient recruitment
NCT02601079,TERMINATED,INTERVENTIONAL,Interim analysis showed very low possibility for significant differences between the two instruments.
NCT02601209,TERMINATED,INTERVENTIONAL,Interim monitoring
NCT02601274,TERMINATED,INTERVENTIONAL,the change of clinical development plan
NCT02601365,WITHDRAWN,INTERVENTIONAL,Clinical Hold FDA
NCT02601378,TERMINATED,INTERVENTIONAL,The combination part of the study was terminated early due to business reasons
NCT02601391,WITHDRAWN,INTERVENTIONAL,Not able to run research in the service. Research terminated.
NCT02601443,WITHDRAWN,INTERVENTIONAL,never started
NCT02601664,TERMINATED,INTERVENTIONAL,Due to lack of eligible patients.
NCT02601690,TERMINATED,OBSERVATIONAL,Lack of funding
NCT02602067,TERMINATED,INTERVENTIONAL,Uptake of drug into the tumour lesion was negligible
NCT02602132,TERMINATED,INTERVENTIONAL,Not enough participants. very slow and poor recruitment
NCT02602145,TERMINATED,OBSERVATIONAL,Study team did not maintain IRB approval
NCT02602210,TERMINATED,INTERVENTIONAL,low inclusion rate
NCT02602236,TERMINATED,INTERVENTIONAL,Investigational product needs improvements
NCT02602665,WITHDRAWN,INTERVENTIONAL,Design was not feasible
NCT02602756,TERMINATED,INTERVENTIONAL,insufficient quality of data collection
NCT02603042,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT02603068,WITHDRAWN,INTERVENTIONAL,Study design was inadequate and would not achieve study endpoints
NCT02603146,TERMINATED,INTERVENTIONAL,"Enrollment was closed before reaching the target. In the 1st interim analysis after enrollment closure, the follow up \& treatment of active participants were stopped early due to evidence of futility."
NCT02603172,TERMINATED,INTERVENTIONAL,A new study will be initiated in order to specifically investigate cardiac safety
NCT02603419,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of recruitment.
NCT02603458,WITHDRAWN,INTERVENTIONAL,The study was withdrawn by the sponsor.
NCT02603549,SUSPENDED,OBSERVATIONAL,Study protocol needs to be amended. Recruitment is halted until amendment is completed and approved by IRB.
NCT02604043,TERMINATED,INTERVENTIONAL,Lack of support to complete
NCT02604199,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02604212,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02604355,TERMINATED,INTERVENTIONAL,Molecule Development was Terminated
NCT02604459,TERMINATED,INTERVENTIONAL,Limited availability of subjects meeting inclusion criteria resulting in early termination (lack of funding) before meeting target enrollment.
NCT02604589,TERMINATED,INTERVENTIONAL,resource reallocation
NCT02605044,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02605070,TERMINATED,INTERVENTIONAL,UNDER RECRUITMENT
NCT02605083,TERMINATED,INTERVENTIONAL,"The study was terminated after determination of the RP2D, prior to opening expansion cohorts)"
NCT02605096,TERMINATED,INTERVENTIONAL,Recruitment strategy not working. This information was really useful to design a randomised controlled trial.
NCT02605122,TERMINATED,INTERVENTIONAL,Development not proceeding
NCT02605304,TERMINATED,INTERVENTIONAL,The study experienced enrollment difficulties.
NCT02605356,WITHDRAWN,INTERVENTIONAL,Study restarted under new study number 18987
NCT02605408,WITHDRAWN,OBSERVATIONAL,Management Decision
NCT02605538,WITHDRAWN,INTERVENTIONAL,Time and resource deficiency at the Stockholm CF Center.
NCT02605551,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT02605616,TERMINATED,INTERVENTIONAL,Astra Zeneca notified Dr. Rita Basu that they will not manufacture new drug due to business reasons and study was stopped.
NCT02605694,WITHDRAWN,INTERVENTIONAL,Sponsor is focusing on studies which can enable registration of duvelisib
NCT02605824,TERMINATED,INTERVENTIONAL,The study was closed after we determined that this albuterol/NAC regimen may be associated with excessive bronchoconstriction.
NCT02605863,TERMINATED,INTERVENTIONAL,"Low enrollment, sponsor withdrew support for study"
NCT02606006,WITHDRAWN,INTERVENTIONAL,Removing from ClinicalTrials.gov as this is not really a clinical trial.
NCT02606045,TERMINATED,INTERVENTIONAL,The study stopped early due to slow recruitment.
NCT02606110,WITHDRAWN,OBSERVATIONAL,PI decided no longer to pursue
NCT02606123,TERMINATED,INTERVENTIONAL,At end of Phase 1 excessive high pill burden (18 capsules/day)
NCT02606136,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02606214,TERMINATED,INTERVENTIONAL,Clinical Hold from FDA
NCT02606266,TERMINATED,INTERVENTIONAL,No eligibles patients
NCT02606279,TERMINATED,INTERVENTIONAL,Change in study design and inability to recruit participants
NCT02606552,TERMINATED,INTERVENTIONAL,The number of patients registered for the study was low and it was expected to be difficult to derive the study results.
NCT02606578,TERMINATED,OBSERVATIONAL,Study's original Principal Investigator no longer at the institution.
NCT02606591,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02606630,TERMINATED,INTERVENTIONAL,Company decision
NCT02606786,WITHDRAWN,INTERVENTIONAL,Difficulty with participant recruitment and retainment
NCT02606799,TERMINATED,INTERVENTIONAL,No further recruitment possible due to changed conditions
NCT02606994,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02607124,TERMINATED,INTERVENTIONAL,A competing trial was opened for patient population with combination of ribociclib and everolimus.
NCT02607241,TERMINATED,INTERVENTIONAL,The product used in the comparator arm (BRS) has become unavailable in April 2017. The recruitment has been stopped.
NCT02607423,WITHDRAWN,INTERVENTIONAL,The study failed to meet its accrual targets.
NCT02607488,SUSPENDED,INTERVENTIONAL,No fund no enough recruiting centers
NCT02607501,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT02607709,SUSPENDED,INTERVENTIONAL,Slow inclusions
NCT02608060,TERMINATED,INTERVENTIONAL,Due to poor enrollment this study was terminated prematurely.
NCT02608125,TERMINATED,INTERVENTIONAL,focus portfolio on immune-mediated diseases
NCT02608229,TERMINATED,INTERVENTIONAL,Adverse events
NCT02608242,TERMINATED,INTERVENTIONAL,sponsor decision
NCT02608268,TERMINATED,INTERVENTIONAL,Business reasons
NCT02608307,TERMINATED,OBSERVATIONAL,Slow accrual and COVID-19 restrictions
NCT02608359,WITHDRAWN,OBSERVATIONAL,No subjects recruited in the study
NCT02608411,TERMINATED,INTERVENTIONAL,Safety results (applied in METIV-HCC trial) have led early termination
NCT02608528,TERMINATED,OBSERVATIONAL,Poor Accrual
NCT02608905,TERMINATED,INTERVENTIONAL,Due to difficulty with enrollment of subjects
NCT02608931,WITHDRAWN,INTERVENTIONAL,Unable to begin study with drug provider
NCT02608944,WITHDRAWN,INTERVENTIONAL,MRI perfusion techniques development took longer than expected.
NCT02608957,TERMINATED,INTERVENTIONAL,Sponsor elected to terminate the study prior to subject treatment.
NCT02609048,TERMINATED,INTERVENTIONAL,Study stopped early after review of safety and efficacy demonstrated efficacy proof-of-concept and need for dose reduction.
NCT02609100,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02609152,WITHDRAWN,INTERVENTIONAL,logistical difficulties
NCT02609451,TERMINATED,INTERVENTIONAL,Evidence of bad outcome after interims analysis
NCT02609607,TERMINATED,INTERVENTIONAL,"Poor enrollment; funding ending Dec 31, 2018."
NCT02609984,TERMINATED,INTERVENTIONAL,This study did not meet the efficacy objective
NCT02610049,TERMINATED,INTERVENTIONAL,Investigator has retired.
NCT02610062,TERMINATED,INTERVENTIONAL,Business decision by sponsor
NCT02610244,TERMINATED,INTERVENTIONAL,Original sponsor withdrew funding.
NCT02610335,TERMINATED,INTERVENTIONAL,"The recruitment of participants was very difficult despite a change in the organisation. The inclusion criteria did not result in the expected number of participants, and the credits ran out."
NCT02610543,TERMINATED,INTERVENTIONAL,Study stopped prematurely due to enrolment challenges.
NCT02610608,TERMINATED,OBSERVATIONAL,RECRUITMENT DIFFICULTIES
NCT02610621,WITHDRAWN,INTERVENTIONAL,Study may not be clinically relevant at this time.
NCT02610920,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects
NCT02611050,TERMINATED,INTERVENTIONAL,Enrollment was not feasible
NCT02611128,SUSPENDED,OBSERVATIONAL,temporarily closed to enrollment due to COVID
NCT02611310,TERMINATED,OBSERVATIONAL,Recruitment Target not met
NCT02611583,WITHDRAWN,INTERVENTIONAL,Never initiated due to lack of funding and IRB Approval
NCT02611661,TERMINATED,INTERVENTIONAL,Principal Investigator left the university.
NCT02611908,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02611934,TERMINATED,INTERVENTIONAL,Due to insufficient enrollment
NCT02612038,TERMINATED,INTERVENTIONAL,No funding was available for the study
NCT02612194,TERMINATED,INTERVENTIONAL,Study closed to accrual due to low accrual numbers.
NCT02612285,TERMINATED,INTERVENTIONAL,Recruitment very slow - study could not be enrolled
NCT02612428,TERMINATED,INTERVENTIONAL,"VTL-308 failed to meet its primary endpoint, all follow up studies were terminated"
NCT02612519,TERMINATED,INTERVENTIONAL,low recruitement rate
NCT02612701,TERMINATED,INTERVENTIONAL,Due to the pandemic we decided to terminate this project.
NCT02613182,TERMINATED,INTERVENTIONAL,NEOD001 program terminated due to lack of clinical benefit
NCT02613442,WITHDRAWN,OBSERVATIONAL,Due to uveitis specialist leaving our University
NCT02613793,TERMINATED,OBSERVATIONAL,unable to recruit in suitable time frame
NCT02613910,TERMINATED,INTERVENTIONAL,Novartis has acquired the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.
NCT02614079,TERMINATED,INTERVENTIONAL,Lack of enrollment. Futility.
NCT02614131,TERMINATED,INTERVENTIONAL,New data suggests that insufficient target engagement would be achieved for efficacy.
NCT02614157,TERMINATED,INTERVENTIONAL,The enrollment was too low
NCT02614664,WITHDRAWN,OBSERVATIONAL,Principal Investigator moved to another institution.
NCT02614703,TERMINATED,INTERVENTIONAL,Sample was under-powered
NCT02614807,WITHDRAWN,INTERVENTIONAL,Difficult Recruitment
NCT02614898,TERMINATED,OBSERVATIONAL,Terminated for administrative reasons before enrollment was complete.
NCT02615210,TERMINATED,INTERVENTIONAL,Difficulty with contracting
NCT02615379,WITHDRAWN,INTERVENTIONAL,Administrative reasons
NCT02615509,TERMINATED,INTERVENTIONAL,Discontinuation of development of device.
NCT02615574,WITHDRAWN,INTERVENTIONAL,Due to inadequate supply of drug
NCT02615808,WITHDRAWN,INTERVENTIONAL,Change to study design.
NCT02615834,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02615938,SUSPENDED,INTERVENTIONAL,Correction of inspection findings
NCT02615990,TERMINATED,INTERVENTIONAL,Vendor equipment agreement expired
NCT02616055,TERMINATED,INTERVENTIONAL,Sponsor opened Phase 2 Study.
NCT02616146,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.
NCT02616172,SUSPENDED,INTERVENTIONAL,Restructuring Cell Lab
NCT02616185,TERMINATED,INTERVENTIONAL,"Due to strategic evaluation of PF-06753512 (VBIR-1) within context of Pfizer's oncology portfolio, decision not based on any safety or regulatory concerns."
NCT02616224,WITHDRAWN,OBSERVATIONAL,Resource constraints
NCT02616328,TERMINATED,OBSERVATIONAL,Planned recruitment target not reached
NCT02616367,WITHDRAWN,INTERVENTIONAL,Study never initiated
NCT02616757,WITHDRAWN,INTERVENTIONAL,Ultrasound machine was no longer approved for use by Health Canada therefore study was closed prior to patients being enrolled on study.
NCT02616887,TERMINATED,OBSERVATIONAL,not sufficient patients enrolled
NCT02617095,TERMINATED,INTERVENTIONAL,recruitment rate too slow
NCT02617160,TERMINATED,INTERVENTIONAL,The required data was obtained and there was no need to collect further data
NCT02617394,TERMINATED,INTERVENTIONAL,PI no longer at institution
NCT02617706,WITHDRAWN,INTERVENTIONAL,financial reasons
NCT02617862,TERMINATED,INTERVENTIONAL,Proposed comparison (RetCam vs. COSMOS) was unfeasible. Device is now licensed in Canada.
NCT02617914,WITHDRAWN,OBSERVATIONAL,No approval from EC obtained. More details for study were required by EC.
NCT02617979,TERMINATED,INTERVENTIONAL,Patients are receiving detailed packet from department and do not feel they need to go online for additional support.
NCT02618109,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02618447,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02618499,TERMINATED,INTERVENTIONAL,Futility suggested by DSMC
NCT02618512,TERMINATED,INTERVENTIONAL,The Sponsor's decision to terminate the SBC-103 program was reached after review of the data from all interventional clinical studies of SBC-103.
NCT02618577,TERMINATED,INTERVENTIONAL,following a recommendation from the data safety and monitoring board due to safety concerns and a tendency towards futility.
NCT02618915,TERMINATED,INTERVENTIONAL,Sponsor decision; not due to any safety concerns related to DTX101.
NCT02618980,TERMINATED,INTERVENTIONAL,Slow enrollment speed due to the incidence of UGI bleeding in ACS patient is lower than expected.
NCT02619006,TERMINATED,OBSERVATIONAL,Lack of Funding
NCT02619487,WITHDRAWN,INTERVENTIONAL,"Due to limited staff resources, we were unable to start enrolling participants."
NCT02619617,TERMINATED,INTERVENTIONAL,Novartis decision based on Cohort 1 results
NCT02619669,WITHDRAWN,INTERVENTIONAL,"The study was withdrawn, because no participants were enrolled in two years."
NCT02619747,TERMINATED,INTERVENTIONAL,Problems with recruitment
NCT02619812,TERMINATED,INTERVENTIONAL,Difficulty recruiting; pill burden and nausea were barriers
NCT02620007,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT02620111,WITHDRAWN,INTERVENTIONAL,Due to difficulties in recruiting frail subjects.
NCT02620202,TERMINATED,OBSERVATIONAL,It was no longer possible to include patients due to logistic challanges occuring during the Covid-19 pandemic
NCT02620319,SUSPENDED,INTERVENTIONAL,"The protocol turned out to be not quite suitable for most patients. Apart from Thomayer's hospital, 2 other centers could not cooperate. The introduction of stents continued at the Thomayer Hospital. Publication of results is planned in 2024."
NCT02620384,TERMINATED,INTERVENTIONAL,Limited resources available to met accrual goal.
NCT02620761,TERMINATED,INTERVENTIONAL,Inability to recruit patients
NCT02620839,TERMINATED,INTERVENTIONAL,Funding
NCT02620904,TERMINATED,INTERVENTIONAL,"unable to recruit. Projected completion was 2018 however, enrollment and recruitment were difficult. The study was terminated due to inability to enroll."
NCT02621021,SUSPENDED,INTERVENTIONAL,The team is revising the protocol design and has chosen to put the study on hold until those changes are approved.
NCT02621073,TERMINATED,INTERVENTIONAL,Enrollment was more difficult than expected. It was mutually agreed upon that we would close the study. No results to report.
NCT02621099,WITHDRAWN,OBSERVATIONAL,The study was withdrawn due to the CE mark of the device was not yet granted during the specified period.
NCT02621190,WITHDRAWN,INTERVENTIONAL,no approval
NCT02621333,TERMINATED,INTERVENTIONAL,As there are so many clinical trials in progress and the number of patients enrolled limited.
NCT02621515,TERMINATED,INTERVENTIONAL,In the Netherlands we wanted to add pilimumab to nivolumab. This resulted in a very long METC procedure which resulted in a to slow inclusion rate.
NCT02621684,WITHDRAWN,INTERVENTIONAL,Not able to enroll any participants due to disinterest
NCT02621749,TERMINATED,INTERVENTIONAL,Futility
NCT02621866,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02622100,TERMINATED,OBSERVATIONAL,Due to stop BVS supply discontinuation
NCT02622308,TERMINATED,INTERVENTIONAL,Terminated due to lack of recruitment
NCT02622724,TERMINATED,INTERVENTIONAL,Day 90 results indicate IMP did not reduce mortality or ventilator free days
NCT02622737,TERMINATED,INTERVENTIONAL,The recruitment site changed their admission policy to only more severely affected patients.
NCT02622763,TERMINATED,INTERVENTIONAL,low recruitment
NCT02622828,TERMINATED,INTERVENTIONAL,Unable to recruit needed participants
NCT02622945,WITHDRAWN,INTERVENTIONAL,Study could not recruit any participant
NCT02623023,WITHDRAWN,INTERVENTIONAL,"Terminated prior to enrollment, lack of support."
NCT02623439,SUSPENDED,INTERVENTIONAL,On hold for toxicitiy
NCT02623452,WITHDRAWN,INTERVENTIONAL,Change in clinical strategy
NCT02623465,WITHDRAWN,INTERVENTIONAL,Change in clinical strategy
NCT02623478,WITHDRAWN,INTERVENTIONAL,Change in clinical strategy
NCT02623504,TERMINATED,INTERVENTIONAL,No apparent therapeutic effects that was superior to placebo
NCT02623582,TERMINATED,INTERVENTIONAL,This study was terminated due to lack of funding.
NCT02623595,WITHDRAWN,INTERVENTIONAL,Patient enrollment was hard mainly due to we need at least three lesions suitable for SBRT
NCT02623920,WITHDRAWN,INTERVENTIONAL,Pharmaceutical company supplying the drug withdraw financial support. PI has decided to close study prior to enrollment of any patients.
NCT02623959,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02624141,TERMINATED,INTERVENTIONAL,The study was terminated due to low recruitment
NCT02624258,TERMINATED,INTERVENTIONAL,Principal Investigator decision to stop trial
NCT02624388,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02624479,WITHDRAWN,INTERVENTIONAL,Formulations could never be successfully produced
NCT02624544,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02624622,TERMINATED,INTERVENTIONAL,Lack of funds
NCT02624635,TERMINATED,INTERVENTIONAL,Because of the lack of personnel and the recruitment failure of participants.
NCT02624661,TERMINATED,INTERVENTIONAL,technical problems
NCT02624739,TERMINATED,INTERVENTIONAL,Funding for study was withdrawn.
NCT02624856,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02624960,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew and updated study design. Refer to NCT03183895.
NCT02624986,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.
NCT02624999,WITHDRAWN,INTERVENTIONAL,PI changed institution
NCT02625077,WITHDRAWN,INTERVENTIONAL,Ethical concerns with efficacy of technique.
NCT02625090,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizure"
NCT02625779,WITHDRAWN,INTERVENTIONAL,The research project has been cancelled before any participants were enrolled.
NCT02625922,TERMINATED,INTERVENTIONAL,"In view of outcome of RELAX-AHF-2 trial, the entire RLX030A project was decided to be terminated."
NCT02626169,WITHDRAWN,INTERVENTIONAL,Pharmaceutical company sponsor withdrew support prior to enrollment of subjects.
NCT02626377,TERMINATED,INTERVENTIONAL,inclusions problems
NCT02626455,TERMINATED,INTERVENTIONAL,"The study did not meet the primary endpoint. The addition of copanlisib to standard immunochemo therapy did not improve progression-free survival compared to the control arm. Base on the study results, company decided to terminate the study."
NCT02626520,TERMINATED,INTERVENTIONAL,Study team felt toxicity of study regimen outweighed potential benefit.
NCT02626663,WITHDRAWN,OBSERVATIONAL,"PI left the University, sponsor pulled funding"
NCT02626702,TERMINATED,OBSERVATIONAL,Lab close down
NCT02626754,TERMINATED,INTERVENTIONAL,In most sites had difficult to recruitting subjects.
NCT02626845,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02627430,WITHDRAWN,INTERVENTIONAL,Other - Protocol moved to Withdrawn
NCT02627573,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02627677,TERMINATED,INTERVENTIONAL,The study was stopped due to operational feasibility and not due to any safety concerns
NCT02627794,TERMINATED,INTERVENTIONAL,Due to financial issues of Restora spacer company.
NCT02628028,TERMINATED,INTERVENTIONAL,The trial was terminated after an interim analysis of efficacy and safety data did not warrant continuation of the trial.
NCT02628496,WITHDRAWN,INTERVENTIONAL,Lost funding/staff
NCT02628535,TERMINATED,INTERVENTIONAL,Business decision (not for safety reasons)
NCT02628691,TERMINATED,OBSERVATIONAL,All patients were started on HCV treatment
NCT02628847,TERMINATED,INTERVENTIONAL,Recruitment was problematic
NCT02628873,TERMINATED,INTERVENTIONAL,Essure no longer sold in the US after Dec 2018; Sponsor requested trial be ended
NCT02628912,WITHDRAWN,OBSERVATIONAL,Lack of accrual
NCT02629029,TERMINATED,INTERVENTIONAL,We are closing this study due to the focus on other research projects and there is no time or personnel tofurther pursue the completion of this project
NCT02629055,TERMINATED,INTERVENTIONAL,Insufficient recruitment during the predefined time frame for the study
NCT02629068,WITHDRAWN,INTERVENTIONAL,No participants were enrolled in the pilot phase of the study due to lack of interest from parents. Completion dates reflect the end of funding for the study.
NCT02629237,WITHDRAWN,INTERVENTIONAL,study sites were reconsidered.
NCT02629471,SUSPENDED,INTERVENTIONAL,Analyzing data
NCT02629549,TERMINATED,INTERVENTIONAL,Recruitment Fulfilled
NCT02629601,WITHDRAWN,INTERVENTIONAL,Change plans and no longer testing these interventions
NCT02629848,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study because the study did not meet the primary endpoint.
NCT02629887,WITHDRAWN,INTERVENTIONAL,Study design changed for recruitment purposes; no participants enrolled
NCT02630043,TERMINATED,INTERVENTIONAL,Lack of study enrollment
NCT02630134,TERMINATED,INTERVENTIONAL,"Study stopped, recruitment difficult, subject compliance very difficult."
NCT02630186,TERMINATED,INTERVENTIONAL,The study terminated before Phase 1 was completed. This study was reprioritized within the rociletinib development program.
NCT02630251,TERMINATED,INTERVENTIONAL,"In 2017, GSK2820151 was terminated due to development of another BET Inhibitor (GSK525762) with a better understanding of the risk benefit profile."
NCT02630355,TERMINATED,INTERVENTIONAL,The study was terminated prematurely after ad-interim analysis for the primary outcome.
NCT02630394,WITHDRAWN,INTERVENTIONAL,Principal Investigator has moved to another institution
NCT02630420,WITHDRAWN,INTERVENTIONAL,The study never officially funded and therefore never began.
NCT02630472,TERMINATED,INTERVENTIONAL,Institutional decision
NCT02630498,TERMINATED,INTERVENTIONAL,It was not practical to continue recruiting due to lack of human resources
NCT02630563,TERMINATED,INTERVENTIONAL,"Due to extremely slow recruitment, infrequent use of combination triple therapy (MMF, cyclosporine, steroids), study was discontinued; Part 2 was not conducted."
NCT02630719,TERMINATED,INTERVENTIONAL,Unable to enroll sufficient participants
NCT02630784,TERMINATED,INTERVENTIONAL,lack of enrollement
NCT02630927,TERMINATED,INTERVENTIONAL,"Agios is no longer developing its second pyruvate kinase-R (PKR) activator, AG-519, and withdrew its investigational new drug (IND) application in December 2016"
NCT02631148,TERMINATED,INTERVENTIONAL,"International shortage of the chemical para-aminohippuric acid (PAH) due to manufacturing changes, led to inability to perform key measurements to meet trial objectives"
NCT02631187,WITHDRAWN,INTERVENTIONAL,Inability to recruit any trial partcipants
NCT02631252,TERMINATED,INTERVENTIONAL,Inability to accrue
NCT02631473,SUSPENDED,INTERVENTIONAL,Study is on hold whilst a grant application for further funding is put together
NCT02631603,SUSPENDED,INTERVENTIONAL,funding pending
NCT02632253,TERMINATED,INTERVENTIONAL,Insufficient patients recruited due to a lack of GUCH patients enrolling in cardiac Rehabilitation.
NCT02632279,TERMINATED,INTERVENTIONAL,"* Insufficient rates of participant accrual
* Effects in opposite direction of hypothesis
* Study was not feasible"
NCT02632292,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02632903,WITHDRAWN,INTERVENTIONAL,"While the clinical need for and the scientific merit remain valid, this regulated drug trial was not feasible logistically due to limited funds."
NCT02633085,WITHDRAWN,OBSERVATIONAL,Lack of enrollment
NCT02633293,TERMINATED,INTERVENTIONAL,Inhaled treprostinil became commercially available in the US following its approval for PH-ILD
NCT02633384,TERMINATED,INTERVENTIONAL,One of the intravenous lipid emulsions was retired from the market
NCT02633540,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02633644,TERMINATED,INTERVENTIONAL,The company shut down
NCT02633657,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT02633761,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02633800,TERMINATED,INTERVENTIONAL,Trial was terminated by sponsor due to lack of efficacy.
NCT02634021,WITHDRAWN,INTERVENTIONAL,The investigator had no more scientific interest about this issue.
NCT02634138,TERMINATED,INTERVENTIONAL,Halted prematurely
NCT02634385,WITHDRAWN,INTERVENTIONAL,No funding to start project.
NCT02634398,WITHDRAWN,OBSERVATIONAL,Lack of enrollments
NCT02634424,TERMINATED,INTERVENTIONAL,lack of inclusion and prophylaxy plateform being free to use for everyone in septembre 2016
NCT02634606,TERMINATED,INTERVENTIONAL,Unable to obtain supplement for this study. Unable to recruit.
NCT02634619,TERMINATED,INTERVENTIONAL,Patient enrollment was slow and we were not able to accrue participants at a decent pace.
NCT02634892,WITHDRAWN,INTERVENTIONAL,Funding
NCT02634905,TERMINATED,INTERVENTIONAL,end of recruitment
NCT02634957,TERMINATED,INTERVENTIONAL,Due to change in available resources
NCT02635074,TERMINATED,INTERVENTIONAL,safety
NCT02635100,TERMINATED,INTERVENTIONAL,PI has left the institution
NCT02635113,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02635412,WITHDRAWN,INTERVENTIONAL,Never approved by the IRB
NCT02635633,TERMINATED,INTERVENTIONAL,Difficulty identifying and including eligible patients
NCT02636062,WITHDRAWN,OBSERVATIONAL,PI - lack of funding
NCT02636205,SUSPENDED,INTERVENTIONAL,Primary investigator changed. Study protocol may under go change with addition of new investigators.
NCT02636283,TERMINATED,INTERVENTIONAL,Recruitment
NCT02636387,TERMINATED,OBSERVATIONAL,Low recruitment
NCT02636738,TERMINATED,INTERVENTIONAL,strategy change
NCT02636803,WITHDRAWN,INTERVENTIONAL,not going to be conducted
NCT02637375,WITHDRAWN,INTERVENTIONAL,Study never opened (terminated as study drug no longer available)
NCT02637466,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT02637713,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02637947,TERMINATED,INTERVENTIONAL,"In the post-market environment, the RCT design did not allow achievement of enrollment goals"
NCT02637986,WITHDRAWN,INTERVENTIONAL,The investigatore decided not to proceed with this study
NCT02638168,TERMINATED,INTERVENTIONAL,challenge in recruitment
NCT02638324,TERMINATED,INTERVENTIONAL,Because of the lack of the candidates and because of restrictions of denervation at the completion date.
NCT02638506,TERMINATED,INTERVENTIONAL,Covid restrictions
NCT02638909,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT02639390,TERMINATED,INTERVENTIONAL,Administrative challenges made it impossible to recruit enough subjects to achieve the study goals.
NCT02639468,TERMINATED,INTERVENTIONAL,protocol not fully appropriate technical issues with EIT device
NCT02639624,WITHDRAWN,INTERVENTIONAL,07/27/2017 Unable to contact research team to confirm reason for withdrawing study.
NCT02639767,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT02639819,WITHDRAWN,INTERVENTIONAL,Study was withdrawn from IRB review on 03/08/16
NCT02640209,TERMINATED,INTERVENTIONAL,Study is terminated due to administrative reasons.
NCT02640248,WITHDRAWN,OBSERVATIONAL,"Original PI left NCH, study never started then"
NCT02640326,WITHDRAWN,INTERVENTIONAL,Research question no longer useful/feasible due to shifts in standards of care
NCT02640495,WITHDRAWN,OBSERVATIONAL,Due to the relative low incidence of severe malaria in Southeast Asia.
NCT02640534,TERMINATED,INTERVENTIONAL,"The decision is based on the fact that with the current follow up of around 10 years, the relevant secondary endpoints can adequately be addressed according to protocol. The addition of follow up data will not significantly impact these results."
NCT02640573,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT02640651,SUSPENDED,INTERVENTIONAL,Lack of study staff
NCT02640833,WITHDRAWN,INTERVENTIONAL,Study Stopped
NCT02641002,TERMINATED,INTERVENTIONAL,Preliminary monotherapy data in relapsed/refractory AML and high-risk MDS did not offer a sufficiently encouraging profile for further dose escalation/expansion
NCT02641171,TERMINATED,OBSERVATIONAL,Too slow recruitment and no staff availability
NCT02641275,WITHDRAWN,INTERVENTIONAL,We could not enrole or recruite enough participants.
NCT02641392,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor following a recommendation from external DMC based on lack of emerging benefit; there were no new emergent safety findings
NCT02641444,TERMINATED,OBSERVATIONAL,Study team finished their analysis.
NCT02641639,TERMINATED,INTERVENTIONAL,Interim analysis failed to show efficacy benefit
NCT02641782,TERMINATED,INTERVENTIONAL,Antibody supply was discontinued by United Therapeutics Corporation.
NCT02641795,TERMINATED,INTERVENTIONAL,Insufficient enrollment and extended study duration
NCT02642094,TERMINATED,INTERVENTIONAL,The study was terminated early according to the protocol due to efficacy.
NCT02642146,TERMINATED,OBSERVATIONAL,We decided to terminate recruit earlier because patient recruiting was not active as expected at the beginning of the study.
NCT02642380,WITHDRAWN,INTERVENTIONAL,No eligible patient was enrolled.
NCT02642523,WITHDRAWN,INTERVENTIONAL,Preliminary data run on rat samples showed that this study question and design would not produce conclusive results. The PI decided not to carry out the study.
NCT02642549,WITHDRAWN,INTERVENTIONAL,Study funding
NCT02642588,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02642939,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02643524,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02643719,WITHDRAWN,INTERVENTIONAL,Study team missed continuing review and study lapsed with out recruiting any subjects.
NCT02643758,TERMINATED,INTERVENTIONAL,A corporate decision to terminate the study
NCT02643979,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT02644057,WITHDRAWN,INTERVENTIONAL,Could not enroll patients
NCT02644122,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02644252,TERMINATED,INTERVENTIONAL,The trial was ended prematurely because of a poor accrual rate
NCT02644473,WITHDRAWN,INTERVENTIONAL,"Study did not receive IRB approval, so did not start"
NCT02644486,TERMINATED,INTERVENTIONAL,difficulty in enrollment
NCT02644525,TERMINATED,INTERVENTIONAL,Planned interim analysis demonstrated futility of intervention
NCT02644837,TERMINATED,INTERVENTIONAL,Unsuccessful attempts to recruit participants
NCT02645175,TERMINATED,INTERVENTIONAL,Business Decision
NCT02645201,WITHDRAWN,INTERVENTIONAL,The research protocol was completely changed.
NCT02645942,WITHDRAWN,INTERVENTIONAL,Study stopped due to organization reasons.
NCT02646774,TERMINATED,INTERVENTIONAL,Due to administrative reasons
NCT02646800,TERMINATED,INTERVENTIONAL,Due to administrative reasons
NCT02646878,WITHDRAWN,INTERVENTIONAL,Business decision
NCT02647073,WITHDRAWN,INTERVENTIONAL,Ongoing issues with the device and software that were provided by the sponsor.
NCT02647242,TERMINATED,INTERVENTIONAL,Inclusion of the Last patient
NCT02647255,TERMINATED,INTERVENTIONAL,"Due to the rarity and rapid progressive course of the disease, patients were less likely to participate in randomization."
NCT02647528,WITHDRAWN,INTERVENTIONAL,funding withdrawn
NCT02647645,TERMINATED,INTERVENTIONAL,Pilot study protocol terminated to begin expanded study.
NCT02647762,TERMINATED,INTERVENTIONAL,Interim analysis results
NCT02647892,TERMINATED,INTERVENTIONAL,"IRB protocol administratively closed, Continuing Review or Study Completion Report not submitted"
NCT02647983,WITHDRAWN,INTERVENTIONAL,Lack of participants
NCT02648191,TERMINATED,INTERVENTIONAL,Lack of inclusion and departure of the investigator
NCT02648594,WITHDRAWN,INTERVENTIONAL,A retrospective study has already been conducted on the same topic
NCT02648633,TERMINATED,INTERVENTIONAL,"The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early."
NCT02648711,TERMINATED,INTERVENTIONAL,Company decision
NCT02648867,TERMINATED,INTERVENTIONAL,Device was unacceptable to patients and did not provide expected outputs
NCT02648919,TERMINATED,INTERVENTIONAL,low accrual
NCT02648932,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02649010,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT02649023,TERMINATED,OBSERVATIONAL,low accrual
NCT02649075,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT02649270,TERMINATED,INTERVENTIONAL,company strategy
NCT02649530,WITHDRAWN,INTERVENTIONAL,funding withdrawn
NCT02649673,TERMINATED,INTERVENTIONAL,Clinical program was discontinued by Novartis
NCT02649751,TERMINATED,INTERVENTIONAL,"The centers have no longer patients. In September 2018, set up of a competitive international study."
NCT02649933,TERMINATED,OBSERVATIONAL,one investigator left the study site
NCT02649998,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02650050,TERMINATED,INTERVENTIONAL,Number of eligible patients too low
NCT02650284,TERMINATED,INTERVENTIONAL,Participant recruitment difficulties. Ruling to terminate study made Oct 2019
NCT02650492,TERMINATED,INTERVENTIONAL,Study was stopped in agreement with investigator due to slow patient recruitment.
NCT02650570,TERMINATED,OBSERVATIONAL,Funding Ended
NCT02650635,TERMINATED,INTERVENTIONAL,permanently closed per sponsor's request
NCT02651090,WITHDRAWN,INTERVENTIONAL,Sponsor terminated study before enrollment Sponsor terminated study before enrollment
NCT02651116,TERMINATED,INTERVENTIONAL,The study was prematurely discontinued due to slow enrollment during the 2019/2020 cold season. No safety or efficacy concerns led to the decision to terminate
NCT02651207,WITHDRAWN,OBSERVATIONAL,decided not to do study. This will be run as a service evaluation instead
NCT02651272,TERMINATED,INTERVENTIONAL,Unable to enroll IRB approved sample of participants.
NCT02651480,SUSPENDED,INTERVENTIONAL,Sponsor put plans on hold
NCT02651675,TERMINATED,INTERVENTIONAL,Terminated by Sponsor for Business Reasons
NCT02651727,TERMINATED,INTERVENTIONAL,the company's decision to de-prioritize 4718 development
NCT02652143,TERMINATED,INTERVENTIONAL,Terminated due to difficult recruitment
NCT02652156,TERMINATED,INTERVENTIONAL,Operational barriers at the site.
NCT02652247,TERMINATED,INTERVENTIONAL,We did not have the funding to complete the study enrollment.
NCT02652702,TERMINATED,INTERVENTIONAL,Not enough patients recruited
NCT02652845,TERMINATED,INTERVENTIONAL,Study Design was changed - no longer prospectively assigning participants
NCT02653027,WITHDRAWN,INTERVENTIONAL,Potential subjects were already on the combination therapy.
NCT02653131,TERMINATED,INTERVENTIONAL,too many side-effects
NCT02653196,TERMINATED,INTERVENTIONAL,The Principal Investigator left the institution.
NCT02653222,TERMINATED,INTERVENTIONAL,patient recruitment is difficult
NCT02653417,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT02653495,TERMINATED,INTERVENTIONAL,Target accrual not met
NCT02653612,WITHDRAWN,INTERVENTIONAL,"This study has been terminated, without having enrolled any participants"
NCT02653833,TERMINATED,INTERVENTIONAL,PI passed away
NCT02654041,TERMINATED,INTERVENTIONAL,Drug manufacturer no longer could supply for study
NCT02654067,WITHDRAWN,OBSERVATIONAL,Lack of available personnel to conduct data acquisition and analysis
NCT02654314,TERMINATED,INTERVENTIONAL,Lack of resources to complete the study. Descriptive statistics for the outcome measures collected are provided.
NCT02654340,TERMINATED,OBSERVATIONAL,Study no longer pursued.
NCT02654405,WITHDRAWN,INTERVENTIONAL,Nathan Kline Institute (NKI) decided not to accept study grant from Stanley Medical Research Foundation. because of budget considerations.
NCT02654587,TERMINATED,INTERVENTIONAL,due to COVID-19
NCT02654639,TERMINATED,INTERVENTIONAL,Principal investigator left the institution
NCT02654704,TERMINATED,OBSERVATIONAL,There was insufficient enrollment of subjects.
NCT02654730,TERMINATED,INTERVENTIONAL,Enrollment took longer than anticipated; it was financially and logistically impossible to recruit the final cohort (G6PDd 0.4mg/kg PQ).
NCT02654782,TERMINATED,INTERVENTIONAL,"Student performing study left Mayo Clinic, no funds to continue study."
NCT02654899,TERMINATED,INTERVENTIONAL,Trial discontinued on 04Apr2016 as a strategic business decision not to pursue the indication. Decision to terminate not due to safety or efficacy concerns.
NCT02655042,WITHDRAWN,OBSERVATIONAL,Study conduct does not meet corporate objectives of sponsor
NCT02655068,TERMINATED,INTERVENTIONAL,due to non-feasibility
NCT02655120,TERMINATED,INTERVENTIONAL,stopping the marketing of BMP7
NCT02655159,TERMINATED,OBSERVATIONAL,"Given the infeasibility to achieve the study population together with the loss of originality in the scientific rationale, it was considered to cancel the study"
NCT02655211,WITHDRAWN,INTERVENTIONAL,Due to staff shortages we are closing the study.
NCT02655432,WITHDRAWN,OBSERVATIONAL,waiting for ethic board approval
NCT02655523,WITHDRAWN,INTERVENTIONAL,lack of recruitment
NCT02655562,SUSPENDED,INTERVENTIONAL,There are difficulties in recruiting patients
NCT02656199,TERMINATED,OBSERVATIONAL,IRB approval expired
NCT02656303,TERMINATED,INTERVENTIONAL,Strategic/Business Decision
NCT02656329,TERMINATED,INTERVENTIONAL,Sponsor discretion (low recruitment rate)
NCT02656615,TERMINATED,INTERVENTIONAL,Lack of Patient accrual
NCT02656628,WITHDRAWN,OBSERVATIONAL,Due to the voluntary recall of the study device (DLS 3.7mm and DLS 5.0mm)
NCT02656849,WITHDRAWN,INTERVENTIONAL,Development of BAY1000394 has been terminated by Bayer.
NCT02656888,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02656914,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02657356,TERMINATED,INTERVENTIONAL,Exposure of these high-risk patients to clinic or in-person visits during the pandemic presented an unacceptable risk to their health
NCT02657369,TERMINATED,INTERVENTIONAL,Overall response rate was 3% (only 1 out of 33 participants had confirmed PR).
NCT02657421,TERMINATED,OBSERVATIONAL,Business Decision
NCT02657447,WITHDRAWN,INTERVENTIONAL,Study is no longer relevant
NCT02657850,WITHDRAWN,OBSERVATIONAL,study approval lapsed
NCT02657941,TERMINATED,INTERVENTIONAL,inclusion problem
NCT02658084,TERMINATED,INTERVENTIONAL,Terminated due to low accrual and toxicity concerns.
NCT02658123,TERMINATED,INTERVENTIONAL,"Decline in enrollment, lack of efficacy, and completion of funding accrual"
NCT02658396,WITHDRAWN,INTERVENTIONAL,Study was never open due to lack of funding
NCT02658526,WITHDRAWN,OBSERVATIONAL,Problems in organization
NCT02658786,WITHDRAWN,OBSERVATIONAL,Lack of Funds
NCT02658812,TERMINATED,INTERVENTIONAL,Per PI
NCT02658877,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects
NCT02658916,TERMINATED,INTERVENTIONAL,251PP301(NCT03068468) primary endpoint was not met;further development of Gosuranemab BIIB092 in progressive supranuclear palsy will not be pursued.
NCT02659124,WITHDRAWN,INTERVENTIONAL,The current protocol did not satisfy IRB requirements
NCT02659150,TERMINATED,INTERVENTIONAL,Terminated by sponsor owing to slow enrollment
NCT02659449,TERMINATED,OBSERVATIONAL,No inclusion
NCT02659644,WITHDRAWN,INTERVENTIONAL,Principal Investigator moved to another institution
NCT02659800,TERMINATED,INTERVENTIONAL,Terminated \[NCI decided to terminate ABTC Consortium due to NCI moving in different direction for Brain Cancer\]
NCT02660138,TERMINATED,INTERVENTIONAL,Low recruitment of patients
NCT02660359,TERMINATED,INTERVENTIONAL,Slow recruitment of patients
NCT02660476,TERMINATED,OBSERVATIONAL,The study has been closed by our IRB due to the PI's departure from the Institution.
NCT02660528,TERMINATED,INTERVENTIONAL,Study staff change.
NCT02661061,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT02661087,WITHDRAWN,INTERVENTIONAL,Principal investigator departure
NCT02661100,WITHDRAWN,INTERVENTIONAL,Drug unavailable
NCT02661295,TERMINATED,INTERVENTIONAL,"38 enrolled, 19 completed the study when loss of funding occurred"
NCT02661334,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT02661347,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting patients who met the eligibility criteria.
NCT02661464,TERMINATED,INTERVENTIONAL,"Due to the pandemic with only one participant in follow up, as the impact on the safety was determined to be negligible, the study was terminated early."
NCT02661620,TERMINATED,OBSERVATIONAL,The study was prematurely terminated by S+N due to business reasons. After an extensive review of all ongoing studies with the focus on which studies are still required for regulatory obligations S+N took the decision to close the REDAPT 15 study.
NCT02661646,TERMINATED,OBSERVATIONAL,Due to slow enrollment during COVID
NCT02661659,WITHDRAWN,INTERVENTIONAL,PI stopped study due to inability to accrue.
NCT02661815,TERMINATED,INTERVENTIONAL,Company decided not to move forward with further accrual.
NCT02661828,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT02662036,TERMINATED,INTERVENTIONAL,Interim analysis showed that there was no difference between the two drugs
NCT02662205,WITHDRAWN,INTERVENTIONAL,We did not get adequate referrals.
NCT02662296,WITHDRAWN,INTERVENTIONAL,Low enrollment
NCT02662894,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02663206,WITHDRAWN,INTERVENTIONAL,Eligible candidate for recruitment was not found
NCT02663271,TERMINATED,INTERVENTIONAL,stagnant enrollment
NCT02663414,WITHDRAWN,INTERVENTIONAL,Study never started and will never be started
NCT02663518,TERMINATED,INTERVENTIONAL,Pfizer decided terminating study for administrative reasons on 22Mar2022 (stopping enrollment as of 15Apr2022). The decision wasn't due to safety concerns or requests from regulatory authorities.
NCT02663648,WITHDRAWN,OBSERVATIONAL,No eligible patient was enrolled.
NCT02663674,TERMINATED,INTERVENTIONAL,Study terminated due to lack of feasibility of study design.
NCT02663908,TERMINATED,INTERVENTIONAL,"Recruitment rate; a lower than anticipated observed cardiovascular event rate. The Sponsor decision to stop the trial was not based on any safety concerns or any knowledge of the results, or influenced by issues imposed by the COVID-19 pandemic."
NCT02663934,TERMINATED,INTERVENTIONAL,COVID-19 Risk
NCT02663947,WITHDRAWN,OBSERVATIONAL,"Because the investigator's workplace and department have been changed, this study cannot be carried out."
NCT02664077,TERMINATED,INTERVENTIONAL,Due to the significantly lower than expected accrual it was impossible to evaluate the endpoint in a timely fashion.
NCT02664155,TERMINATED,INTERVENTIONAL,recruiting difficulties
NCT02664298,TERMINATED,OBSERVATIONAL,Registry of patients registry has been discontinued
NCT02664311,TERMINATED,INTERVENTIONAL,under enrollment
NCT02664337,SUSPENDED,INTERVENTIONAL,Suspended currently as we plan for the next musculoskeletal condition to collect data on.
NCT02664363,TERMINATED,INTERVENTIONAL,Study funding ended
NCT02664519,TERMINATED,INTERVENTIONAL,No funding support and not adequate number of subjects are recruited for the study
NCT02664571,WITHDRAWN,INTERVENTIONAL,experimental drug prohibited by the ANSM (French competent authority)
NCT02664922,TERMINATED,INTERVENTIONAL,Poor study design and too many study groups.
NCT02664961,TERMINATED,INTERVENTIONAL,"Rare tumor type, patients eligible via expanded access."
NCT02665221,TERMINATED,INTERVENTIONAL,It was decided on 9/21/2016 to terminate this study early because LogPad devices the patients used to record their injection data was flawed
NCT02665338,TERMINATED,INTERVENTIONAL,"We planned to enroll more participants but we could not recruit more participants. In addition, the covid-19 pandemic made the recruitment worse than the previous years."
NCT02665364,TERMINATED,INTERVENTIONAL,Reorganization proceedings of the sponsor
NCT02665689,TERMINATED,INTERVENTIONAL,Enrollment pace was far below target.
NCT02665780,WITHDRAWN,INTERVENTIONAL,funding was not secured
NCT02665962,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02665988,TERMINATED,INTERVENTIONAL,We terminated the study because the Pain Management Program closed in January 2018.
NCT02666365,WITHDRAWN,INTERVENTIONAL,Investigator decided not to proceed.
NCT02666404,TERMINATED,INTERVENTIONAL,Volume resuscitation procotol has changed around 2017/2018 to less volume/more vasopressors.
NCT02666911,WITHDRAWN,INTERVENTIONAL,Equipment to run the study was not available
NCT02667223,TERMINATED,INTERVENTIONAL,"The study was terminated early on July 8, 2016 due to business priorities regarding study execution."
NCT02667327,TERMINATED,INTERVENTIONAL,Sponsor Decision (No safety or efficacy concerns)
NCT02667457,TERMINATED,INTERVENTIONAL,Sponsor Decision based on strategic considerations
NCT02667496,WITHDRAWN,INTERVENTIONAL,Slow recruitment
NCT02667535,WITHDRAWN,INTERVENTIONAL,Study has been cancelled and it has not been initiated.
NCT02667561,WITHDRAWN,INTERVENTIONAL,Study has been cancelled and it has not been initiated.
NCT02667717,TERMINATED,INTERVENTIONAL,difficulties in including patients
NCT02667925,WITHDRAWN,INTERVENTIONAL,Because of the obsolescence of the study
NCT02667977,WITHDRAWN,INTERVENTIONAL,"Difficulty getting labs in this setting. After pilot study, this study was not continued."
NCT02668211,WITHDRAWN,INTERVENTIONAL,Not feasible - RSA machine not available. RSA images needed for study endpoints
NCT02668432,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT02668705,TERMINATED,INTERVENTIONAL,Interim analysis showed no difference between either arm of the intervention.
NCT02668783,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.
NCT02668822,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.
NCT02669043,TERMINATED,INTERVENTIONAL,Funding ended.
NCT02669108,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02669134,WITHDRAWN,INTERVENTIONAL,no record of study starting
NCT02669238,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT02669264,TERMINATED,INTERVENTIONAL,The study was early terminated prior to part 2 because of slow accrual.
NCT02669290,TERMINATED,INTERVENTIONAL,PI left institution
NCT02669303,TERMINATED,INTERVENTIONAL,low recruitment rate and high rate of loss-to-followup
NCT02669537,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02669914,TERMINATED,INTERVENTIONAL,"Low accrual, funding withdrawn by AstraZeneca, and change in clinical practice"
NCT02670083,TERMINATED,INTERVENTIONAL,"This study was discontinued due to an interim analysis in this study, which indicated that Crenezumab was unlikely to meet its primary endpoint."
NCT02670317,TERMINATED,INTERVENTIONAL,GA101-CHOP not advantage from rituximab-CHOP
NCT02670330,TERMINATED,INTERVENTIONAL,The Sponsor voluntarily recalled SD-101 and terminated the study due to GMP deficiencies identified during an FDA inspection at the site of the manufacturer.
NCT02670356,TERMINATED,INTERVENTIONAL,Study stopped by the company funding the study
NCT02670720,TERMINATED,INTERVENTIONAL,preceding efficacy study of avoralstat in its current formulation was not significant and does not support continued development
NCT02670746,TERMINATED,OBSERVATIONAL,Due to slow recruitment study is being terminated.
NCT02670759,TERMINATED,INTERVENTIONAL,A 30% decrease in opioid use was obeserved in the paravertebral analgesia group.
NCT02670798,TERMINATED,INTERVENTIONAL,Expiration of funding
NCT02670941,TERMINATED,INTERVENTIONAL,Slow accrual; Received grant funding for a similar but different study.
NCT02671045,TERMINATED,OBSERVATIONAL,Insufficient accrual to Horizon Bluecross Blueshield cohort
NCT02671084,TERMINATED,INTERVENTIONAL,interim analysis suggests futility
NCT02671136,TERMINATED,INTERVENTIONAL,Lack of subjects
NCT02671188,WITHDRAWN,INTERVENTIONAL,"This study was stopped before any subjects were treated, consequently there are no results for the study."
NCT02671240,TERMINATED,OBSERVATIONAL,Investigator's decision
NCT02671331,TERMINATED,OBSERVATIONAL,Principal investigator terminated study due to low enrollment.
NCT02671344,TERMINATED,OBSERVATIONAL,could not be obtained enough sperm RNA is highly fragmented and very difficult to purify.
NCT02671552,WITHDRAWN,INTERVENTIONAL,Terminated by the IRB
NCT02671656,WITHDRAWN,OBSERVATIONAL,faisability
NCT02671916,TERMINATED,OBSERVATIONAL,insufficient number of replies by patients
NCT02671955,TERMINATED,INTERVENTIONAL,Janssen business decision
NCT02672033,TERMINATED,INTERVENTIONAL,slow enrollment
NCT02672202,TERMINATED,INTERVENTIONAL,Recruitment rate was slow so we could not complete the study.
NCT02672358,WITHDRAWN,INTERVENTIONAL,Company Decision
NCT02672371,WITHDRAWN,INTERVENTIONAL,Study was not approved for the IRB; we then had no funds to reapply
NCT02673021,TERMINATED,INTERVENTIONAL,Funding suspended prior to completing enrollment of all participants.
NCT02673450,WITHDRAWN,OBSERVATIONAL,Lack of lab ressources
NCT02673541,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02673684,TERMINATED,INTERVENTIONAL,Lost funding from sponsor
NCT02673697,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02673736,TERMINATED,INTERVENTIONAL,Discontinued
NCT02673866,WITHDRAWN,INTERVENTIONAL,reassessment of phase 2 study indication
NCT02673892,TERMINATED,INTERVENTIONAL,"Recommendation of DMC - challenges recruiting, statistical considerations"
NCT02673957,TERMINATED,OBSERVATIONAL,Funding withdrawn
NCT02673983,WITHDRAWN,INTERVENTIONAL,The study was never started
NCT02674113,WITHDRAWN,INTERVENTIONAL,determined not to be feasible at our site
NCT02674204,TERMINATED,INTERVENTIONAL,Closed due to low accrual
NCT02674269,WITHDRAWN,INTERVENTIONAL,UroGen's RTGelTM delivery system technology for use with neurotoxins licensed to Allergan plc before the activation of this trial.
NCT02674451,TERMINATED,INTERVENTIONAL,poor enrollment
NCT02674555,WITHDRAWN,INTERVENTIONAL,"Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies."
NCT02674893,TERMINATED,INTERVENTIONAL,"Exploratory protocol, convincing results, robust analysis"
NCT02674945,TERMINATED,OBSERVATIONAL,"Low enrollment, unable to power adequately"
NCT02674958,TERMINATED,INTERVENTIONAL,Covid-19 pandemic
NCT02675218,TERMINATED,OBSERVATIONAL,No more inclusion
NCT02675413,WITHDRAWN,INTERVENTIONAL,Principal Investigator decided to withdraw.
NCT02675439,TERMINATED,INTERVENTIONAL,No substantial anti-tumor activity was observed.
NCT02675556,TERMINATED,INTERVENTIONAL,Difficulty in recruitment and funding.
NCT02675673,WITHDRAWN,INTERVENTIONAL,Logistical issues
NCT02675816,TERMINATED,INTERVENTIONAL,"Study halted due to low recruitment. Reimbursement changes require a larger study with additional centers and therefore, a new study planned as replacement."
NCT02675842,WITHDRAWN,INTERVENTIONAL,funding
NCT02675933,TERMINATED,INTERVENTIONAL,"Seton IRB administratively closed this study on January 6, 2017"
NCT02676050,TERMINATED,INTERVENTIONAL,C-met marker expired
NCT02676323,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02676544,TERMINATED,INTERVENTIONAL,Device approved for this use
NCT02676622,WITHDRAWN,INTERVENTIONAL,PI moved to a different institution.
NCT02676765,TERMINATED,INTERVENTIONAL,Intellectual property issues with drug manufacture.
NCT02677220,TERMINATED,INTERVENTIONAL,No enrolled subjects
NCT02677246,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02677311,TERMINATED,INTERVENTIONAL,Unable to recruit required numbers for study.
NCT02677350,WITHDRAWN,INTERVENTIONAL,Study is permanently closed to enrollment
NCT02677688,TERMINATED,INTERVENTIONAL,completed inclusions
NCT02677714,TERMINATED,INTERVENTIONAL,Sponsor Decision based on strategic considerations
NCT02677818,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT02677857,TERMINATED,INTERVENTIONAL,Recruitment efforts were not effective.
NCT02677909,WITHDRAWN,OBSERVATIONAL,Did not receive sensors from device company and did not initiate enrollment.
NCT02677948,WITHDRAWN,INTERVENTIONAL,FDA has placed all trials involving Pacritinib on Full Clinical Hold
NCT02678026,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT02678143,TERMINATED,INTERVENTIONAL,Closed early due to competing studies
NCT02678234,WITHDRAWN,INTERVENTIONAL,The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's decision.
NCT02678273,WITHDRAWN,INTERVENTIONAL,Unable to secure grant funding
NCT02678403,TERMINATED,INTERVENTIONAL,principal investigator left Toulouse hospital
NCT02678429,TERMINATED,INTERVENTIONAL,Unable to fully enroll no data analysis planned
NCT02678520,WITHDRAWN,INTERVENTIONAL,PI no longer at institution. Study terminated prior to enrolling subjects.
NCT02678715,TERMINATED,INTERVENTIONAL,Recruitment period too long
NCT02678754,TERMINATED,OBSERVATIONAL,Business decision to move away from this study
NCT02678871,TERMINATED,INTERVENTIONAL,Device was withdrawn from the market
NCT02679066,TERMINATED,INTERVENTIONAL,"lack of consistent enrollment, follow up and results"
NCT02679092,WITHDRAWN,INTERVENTIONAL,Funding changes.
NCT02679131,TERMINATED,INTERVENTIONAL,Close out study w/o Cohort D; Severe Impairment (eGFR=15 to \<30mL/min/1.73m)
NCT02679248,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02679274,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT02679339,TERMINATED,INTERVENTIONAL,Limited patient enrollment
NCT02679404,TERMINATED,OBSERVATIONAL,Less data return than expected. The new Medical Device Regulation (MDR) implementation prompted the Sponsor to set up a broader scope post-market registry for all Corcym cardiovascular products (MANTRA).
NCT02679430,WITHDRAWN,INTERVENTIONAL,The study was deferred and never approved by the Maimonides Medical Center IRB.
NCT02679560,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02680054,TERMINATED,INTERVENTIONAL,No eligible participants left to approach/ recruit
NCT02680483,TERMINATED,OBSERVATIONAL,"No interested parties agreed to enroll. Poor enrolling rate. In March 2018, the study was terminated."
NCT02680496,TERMINATED,INTERVENTIONAL,Difficulties patient recruitment
NCT02680626,TERMINATED,INTERVENTIONAL,Pfannenstiel hysterectomies are now rarely performed so cannot recruit eligible patients
NCT02680639,TERMINATED,INTERVENTIONAL,"Study had a high screen fail rate, enrollment was open over a year, only 3 completed."
NCT02680704,TERMINATED,INTERVENTIONAL,Departure of PI
NCT02680717,WITHDRAWN,INTERVENTIONAL,Unable to obtain IRB approval at all sites
NCT02680834,TERMINATED,INTERVENTIONAL,The ACT was re-designed per physician feedback and patient compliance \& not because of safety.
NCT02680847,TERMINATED,INTERVENTIONAL,The trial was terminated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.
NCT02680951,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of participants.
NCT02681185,TERMINATED,INTERVENTIONAL,enrollment not satisfied
NCT02681419,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT02681523,TERMINATED,INTERVENTIONAL,Slow patient recruitment
NCT02681601,TERMINATED,INTERVENTIONAL,low accrual
NCT02681809,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT02682082,TERMINATED,INTERVENTIONAL,Closed by CHUM REB for incomplete documentation of research activities.
NCT02682095,TERMINATED,OBSERVATIONAL,"Only part three, the individual interviews, has been carried out. We have not been able to get funding to complete the rest of the study."
NCT02682420,TERMINATED,INTERVENTIONAL,Company acquisition
NCT02682485,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02682615,WITHDRAWN,OBSERVATIONAL,Due to problems regarding methodology.
NCT02682940,TERMINATED,INTERVENTIONAL,Insufficient Resources
NCT02682953,WITHDRAWN,INTERVENTIONAL,subject recruitment not feasible due to standard care changes
NCT02683018,WITHDRAWN,INTERVENTIONAL,funding
NCT02683148,TERMINATED,INTERVENTIONAL,The trial did not show any positive effects.
NCT02683161,TERMINATED,INTERVENTIONAL,Inability to adequately recruit participants during pre-post operative period.
NCT02683343,WITHDRAWN,OBSERVATIONAL,"PI is away, will hopefully perform the study at another institution."
NCT02683356,TERMINATED,INTERVENTIONAL,Company stopped selling BVS/ No 5 year FUP will be done
NCT02683395,TERMINATED,INTERVENTIONAL,Business Decision
NCT02683941,TERMINATED,INTERVENTIONAL,"National Comprehensive Cancer Network \& European Neuroendocrine Tumor Society guidelines (2015/2016) led to prescription of somatostatin analogues (SSAs) in this setting, thereby limiting recruitment."
NCT02684071,TERMINATED,INTERVENTIONAL,Lack of additional funding; patients (3) no longer receiving intervention.
NCT02684084,TERMINATED,INTERVENTIONAL,Study revised significantly. New trial to be launched.
NCT02684136,TERMINATED,INTERVENTIONAL,reduced ability to recruit sufficient number of patients
NCT02684344,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02684487,WITHDRAWN,INTERVENTIONAL,"PI left institution. Protocol not submitted to IRB, contract not executed, and study was not done."
NCT02684539,WITHDRAWN,INTERVENTIONAL,project weill not be realized for organisational reasons
NCT02684617,TERMINATED,INTERVENTIONAL,Business Reasons
NCT02684786,WITHDRAWN,INTERVENTIONAL,IRB did not approve
NCT02685046,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02685189,TERMINATED,OBSERVATIONAL,Study stopped for business reasons and not for any safety reasons.
NCT02685202,TERMINATED,INTERVENTIONAL,Funding depleted
NCT02685293,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02685683,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor following a recommendation from external DMC to terminate the ongoing Phase 3 CD studies; there were no new emergent safety findings
NCT02685735,TERMINATED,INTERVENTIONAL,lack of continued funding support
NCT02685904,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02686008,WITHDRAWN,INTERVENTIONAL,The study was stopped due to lack of funding.
NCT02686281,TERMINATED,INTERVENTIONAL,Business reason
NCT02686385,TERMINATED,INTERVENTIONAL,Steroids were given for 2 patients who had biopsy proven Drug induced Liver Injury and both have them developed sepsis.
NCT02686424,SUSPENDED,OBSERVATIONAL,paperwork delay
NCT02686489,TERMINATED,INTERVENTIONAL,Unable to enroll enough subjects to answer the research questions
NCT02686580,TERMINATED,INTERVENTIONAL,Unable to recruit participants for this study
NCT02686723,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02686749,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT02687009,TERMINATED,INTERVENTIONAL,low accrual
NCT02687100,WITHDRAWN,INTERVENTIONAL,"Due to instillation site of the cortisone and the development of the related SARS-Cov2 infection, it was preferred to terminate the trial and develop it again without beclomethasone"
NCT02687165,TERMINATED,INTERVENTIONAL,Slow recruitment due to strict inclusion/exclusion criteria
NCT02687191,TERMINATED,INTERVENTIONAL,B2341002 was terminated on 26-OCT-2017 for strategic reasons. The decision to terminate the trial was not based on any safety concerns.
NCT02687230,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02687269,WITHDRAWN,INTERVENTIONAL,Inability to produce placebo tablets similar to the drug tested
NCT02687360,SUSPENDED,INTERVENTIONAL,funding not received
NCT02687386,TERMINATED,INTERVENTIONAL,Study medication no longer in production
NCT02687451,TERMINATED,INTERVENTIONAL,Released from PMR
NCT02687477,TERMINATED,INTERVENTIONAL,Lack of patients meeting the criteria for admission
NCT02687542,TERMINATED,INTERVENTIONAL,Terminated 25Sep17 due to insufficient efficacy. Not due to safety reasons.
NCT02687581,TERMINATED,INTERVENTIONAL,Enrollment is challenging and study materials were not produced any more.
NCT02687815,TERMINATED,INTERVENTIONAL,Futility of vitamin D supplementation based on protocol threshold: \<30% conditional power to detect pre-specified effect- 16% reduction in severe exacerbations.
NCT02687880,WITHDRAWN,OBSERVATIONAL,"Prior to start up, study was discontinued for feasibility reasons"
NCT02688166,TERMINATED,OBSERVATIONAL,Unable to meet accrual goal
NCT02688309,TERMINATED,OBSERVATIONAL,Enrollment was affected due to the COVID-19 pandemic
NCT02688335,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT02688413,TERMINATED,INTERVENTIONAL,"slow recruitment, evolution of investigational device, differences in healthcare models affecting trial"
NCT02688764,TERMINATED,INTERVENTIONAL,The study was prematurely ended due to the modification of study requirements by the US Food and Drug Administration and the European Medicines Agency
NCT02688907,TERMINATED,INTERVENTIONAL,change regimen
NCT02689024,TERMINATED,INTERVENTIONAL,recruitment too slow; intervention was standard care in patients who were not included; acute care pathways changed due to policy regarding hip fracture patients
NCT02689219,TERMINATED,INTERVENTIONAL,lack of funding/ benefit
NCT02689310,WITHDRAWN,INTERVENTIONAL,No patients recruited. Study didn't get off the ground. PI left.
NCT02689336,WITHDRAWN,INTERVENTIONAL,Could not recruit any participants
NCT02689388,TERMINATED,INTERVENTIONAL,Feasibility
NCT02689401,WITHDRAWN,INTERVENTIONAL,Awaiting additional safety data
NCT02689635,TERMINATED,INTERVENTIONAL,PI transferred to a new institution
NCT02689713,WITHDRAWN,INTERVENTIONAL,Inability to recruit subjects at the study site.
NCT02689726,TERMINATED,INTERVENTIONAL,Lack of efficacy in European Phase 2 study
NCT02689817,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to technical limitations to the device
NCT02690350,TERMINATED,INTERVENTIONAL,Program discontinued for business reasons (not safety).
NCT02690428,TERMINATED,INTERVENTIONAL,Patient recruitment slow
NCT02690623,WITHDRAWN,INTERVENTIONAL,"The step-wedge implementation of the study has proved not to be feasible due to uncertainty about funding, hiring, and staffing the new hospitalist service."
NCT02691026,TERMINATED,INTERVENTIONAL,Slow enrollment as a result of low incidence of MPNST and the COVID-19 pandemic.
NCT02691117,TERMINATED,INTERVENTIONAL,Lack of efficacy of the study medication
NCT02691455,TERMINATED,INTERVENTIONAL,Difficulty in recruiting participants
NCT02691780,WITHDRAWN,INTERVENTIONAL,not enrolled
NCT02692066,WITHDRAWN,OBSERVATIONAL,Funding not acquired
NCT02692157,WITHDRAWN,INTERVENTIONAL,The study was discontinued by the sponsor. No results to report
NCT02692547,WITHDRAWN,INTERVENTIONAL,Study Cancelled
NCT02692638,TERMINATED,INTERVENTIONAL,Low enrollment; PI left institution
NCT02693002,TERMINATED,INTERVENTIONAL,Enrollment goals not being met
NCT02693171,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT02693353,TERMINATED,OBSERVATIONAL,Recent publication makes current study obsolete.
NCT02693444,WITHDRAWN,INTERVENTIONAL,Low pool of subjects
NCT02693717,TERMINATED,INTERVENTIONAL,The trial was closed due to the changing efficacy of treatments for metastatic urothelial cancer.
NCT02693743,TERMINATED,INTERVENTIONAL,Study terminated early due to slow accrual or other non-safety related issues
NCT02693769,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT02694016,TERMINATED,INTERVENTIONAL,Insufficient recruitment pace
NCT02694042,TERMINATED,INTERVENTIONAL,Recruitment challenges and lack of intervention engagement by participants.
NCT02694250,WITHDRAWN,INTERVENTIONAL,study not started due to lack of resources
NCT02694289,WITHDRAWN,INTERVENTIONAL,failure to enroll participants
NCT02694341,WITHDRAWN,INTERVENTIONAL,No participants shared
NCT02694380,TERMINATED,OBSERVATIONAL,Low accrual
NCT02694666,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT02694757,TERMINATED,INTERVENTIONAL,Unable to enroll
NCT02694770,WITHDRAWN,INTERVENTIONAL,corporate decision
NCT02694952,WITHDRAWN,INTERVENTIONAL,Ministry of Health in country did not authorized the conduct of the study
NCT02695264,WITHDRAWN,INTERVENTIONAL,Clinical Trial Agreement not executed
NCT02695602,TERMINATED,INTERVENTIONAL,Unable to recruit enough patients
NCT02695641,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients for the trial.
NCT02695667,TERMINATED,OBSERVATIONAL,This was inadvertently entered in the system and is not a clinical trial.
NCT02696226,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02696278,TERMINATED,INTERVENTIONAL,Study product voluntarily recalled by sponsor. Listeria identified at the manufacturing facility (not in tested finished product).
NCT02696291,TERMINATED,INTERVENTIONAL,Product development halted for business reasons.
NCT02696720,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT02696759,TERMINATED,INTERVENTIONAL,PI left institution in 2019. Study was placed on hold at that time and will not be resuming. No data analysis was performed.
NCT02696928,WITHDRAWN,INTERVENTIONAL,Lack of ethical approval in Ethiopia
NCT02697136,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02697162,WITHDRAWN,INTERVENTIONAL,Withdrawal of research institution from participating
NCT02697279,TERMINATED,INTERVENTIONAL,Unable to enroll the appropriate number of subjects within a reasonable timeframe.
NCT02697851,TERMINATED,INTERVENTIONAL,"Insufficient enrolment and ""business reasons"""
NCT02697942,TERMINATED,INTERVENTIONAL,closure of dialysis center where study was being conducted
NCT02698098,TERMINATED,OBSERVATIONAL,1) Policy change affecting C\&Cs; 2) interm analysis revealing overt differences
NCT02698111,TERMINATED,INTERVENTIONAL,Corporate policy adjustments
NCT02698176,TERMINATED,INTERVENTIONAL,This study was terminated due to limited efficacy and not due to safety reasons.
NCT02698189,TERMINATED,INTERVENTIONAL,This study was terminated due to limited efficacy and not due to safety reasons
NCT02698228,WITHDRAWN,INTERVENTIONAL,Study did not occur
NCT02698293,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT02698384,TERMINATED,OBSERVATIONAL,The study was terminated early due to insufficient potential for recruitment.
NCT02698761,TERMINATED,INTERVENTIONAL,Standard of care changed
NCT02698865,TERMINATED,INTERVENTIONAL,"The results of the interim analysis indicate the futility criterion have been met, therefore enrollment was terminated."
NCT02699034,TERMINATED,INTERVENTIONAL,Recommendation by BfArM after interim analysis
NCT02699138,WITHDRAWN,INTERVENTIONAL,Research fellow left institution
NCT02699229,WITHDRAWN,OBSERVATIONAL,no particpants enrolled
NCT02699385,TERMINATED,INTERVENTIONAL,Study prematurely terminated upon recommendation of IDMC due to lack of efficacy.
NCT02699671,TERMINATED,OBSERVATIONAL,current BVS safety issue
NCT02699723,WITHDRAWN,INTERVENTIONAL,Logistics
NCT02699788,WITHDRAWN,INTERVENTIONAL,"No patients enrolled, sponsor refused to pay site invoices."
NCT02699853,TERMINATED,INTERVENTIONAL,PI decided to revamp the protocol completely and will submit as new study.
NCT02699905,WITHDRAWN,OBSERVATIONAL,"data was received from another source, therefore phlebotomy was not necessary"
NCT02699918,WITHDRAWN,INTERVENTIONAL,failure in regulatory statements
NCT02700022,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02700048,TERMINATED,INTERVENTIONAL,research grant for the trial was not funded
NCT02700139,TERMINATED,INTERVENTIONAL,A corporate decision to terminate the study
NCT02700191,WITHDRAWN,INTERVENTIONAL,Lack of interest by Investigators
NCT02700308,TERMINATED,INTERVENTIONAL,DECISION OF THE SPONSOR AND THE COORDINATING INVESTIGATOR DUE TO RECRUITMENT DIFFICULTIES AND CHANGES IN INTERVENTIONAL RADIOLOGY PRACTICES
NCT02700555,TERMINATED,OBSERVATIONAL,The patient's study enrollment was too low.
NCT02700724,TERMINATED,INTERVENTIONAL,poor enrollment
NCT02700763,TERMINATED,INTERVENTIONAL,Due to the very low inlcusion rate and the current COVID-19 pandemic.
NCT02700802,WITHDRAWN,INTERVENTIONAL,This research described in this protocol was not funded.
NCT02700841,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to poor recruitment.
NCT02701257,TERMINATED,INTERVENTIONAL,The study was terminated prior to completing the planned cohorts and analysis because of problems with the infusion set resulting in inadequate insulin delivery
NCT02701322,TERMINATED,INTERVENTIONAL,machine malfunction and updated work rutines
NCT02701426,TERMINATED,INTERVENTIONAL,end of funding granted
NCT02701517,TERMINATED,INTERVENTIONAL,The trial was stopped before the targeted number of patients was reached due to lack of support.
NCT02702115,TERMINATED,INTERVENTIONAL,All three subjects dosed in the study have rolled over to the Long-Term Follow-up Study IVPRP-LT01 (NCT04628871)
NCT02702167,TERMINATED,INTERVENTIONAL,COVID-19 pandemic restrictions.
NCT02702427,WITHDRAWN,INTERVENTIONAL,unsuccessful recruitment
NCT02702492,TERMINATED,INTERVENTIONAL,sponsor decision
NCT02702518,TERMINATED,INTERVENTIONAL,"The DSMB committee recommended closing the trial because of the COVID-19 risk in this ""at-risk"" oGVHD population if they came for study visits."
NCT02702700,TERMINATED,INTERVENTIONAL,Drug supply issue
NCT02702713,TERMINATED,INTERVENTIONAL,The funding agency set a mandatory deadline for the study in order to be able to conclude the project.
NCT02702778,TERMINATED,INTERVENTIONAL,lack of study recruitment
NCT02702960,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to lack of necessary resources from the liver transplant surgical group.
NCT02703233,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT02703246,WITHDRAWN,INTERVENTIONAL,investigator left the institution- no plan on having another PI take over
NCT02703272,TERMINATED,INTERVENTIONAL,"IDMC recommended that enrolment be stoped, as the EFS hazard ratio and associated p-value crossed the futility boundary specified in protocol (July 2020)."
NCT02703311,TERMINATED,INTERVENTIONAL,Edwards acquired Valtech Cardio Ltd in 2017 and opted to replace this study with NCT03600688.11 patients were enrolled in REPAIR and follow-up is complete.
NCT02703558,WITHDRAWN,INTERVENTIONAL,Limited interest from colleagues/time constraints
NCT02703571,TERMINATED,INTERVENTIONAL,Company decision
NCT02703610,WITHDRAWN,INTERVENTIONAL,No participants were enrolled and the study will not be conducted.
NCT02704130,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02704312,TERMINATED,INTERVENTIONAL,Start of the Principal Investigatoir
NCT02704403,TERMINATED,INTERVENTIONAL,"Study did not meet the predefined primary surrogate efficacy endpoint, no safety issues identified"
NCT02704481,TERMINATED,INTERVENTIONAL,Funding mechanism compromised
NCT02704689,TERMINATED,INTERVENTIONAL,Lack of subject enrollment
NCT02704871,TERMINATED,OBSERVATIONAL,Recruitment considerations only and not because of safety or outcomes issues
NCT02704910,TERMINATED,INTERVENTIONAL,Not more patient with lateral deviation
NCT02704936,WITHDRAWN,OBSERVATIONAL,Difficulty recruiting patients
NCT02705339,WITHDRAWN,INTERVENTIONAL,Clovis Oncology discontinued rociletinib.
NCT02705378,WITHDRAWN,INTERVENTIONAL,"PI left institution. Protocol never submitted to the IRB, no contract executed only Confidentiality Agreement, and study not done."
NCT02705404,TERMINATED,OBSERVATIONAL,Additional mechanisms/trials to enroll these patients exist and competed with the trial.
NCT02705703,WITHDRAWN,INTERVENTIONAL,Sponsor decision to discontinue study.
NCT02705872,WITHDRAWN,INTERVENTIONAL,Change in guidelines
NCT02705924,TERMINATED,INTERVENTIONAL,COVID19 crisis prevents from organizing the last seminar
NCT02706015,WITHDRAWN,INTERVENTIONAL,Strategic reasons of the company
NCT02706197,TERMINATED,INTERVENTIONAL,Study halted prematurely but potentially will resume
NCT02706236,WITHDRAWN,INTERVENTIONAL,no funding was awarded
NCT02706392,TERMINATED,INTERVENTIONAL,Terminated due to slow accruals.
NCT02706405,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT02706626,TERMINATED,INTERVENTIONAL,Did not meet enrollment objectives.
NCT02706691,TERMINATED,INTERVENTIONAL,Study stopped due to poor enrollment.
NCT02706730,TERMINATED,INTERVENTIONAL,Negative Efficacy Results from the recently completed Phase 3 study 104-201506
NCT02706756,WITHDRAWN,INTERVENTIONAL,Similar studies already published by other researchers
NCT02706769,TERMINATED,INTERVENTIONAL,Funding was terminated early due to slow recruitment.
NCT02706899,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02707055,TERMINATED,INTERVENTIONAL,Early termination of the study due to the COVID-19 pandemic
NCT02707198,TERMINATED,INTERVENTIONAL,Study was not feasible to complete at study site
NCT02707276,TERMINATED,INTERVENTIONAL,Limited resources and funding resulted in a decision to prematurely halt study and redirect remaining funds to partner study Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression (Protocol #2017P002783).
NCT02707328,TERMINATED,INTERVENTIONAL,Closed after being on administrative hold
NCT02707770,TERMINATED,INTERVENTIONAL,Funding for the study finished before anticipated participants enrolled
NCT02707900,TERMINATED,INTERVENTIONAL,Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided.
NCT02707926,WITHDRAWN,OBSERVATIONAL,"COVID-19 required halting recruitment into new clinical protocols. Following the allowed opening to clinical research, our assessment of site and investigator interest and time frame of available grant funding resulted in a judgment of futility."
NCT02707978,WITHDRAWN,INTERVENTIONAL,Problems with contracts .
NCT02708160,WITHDRAWN,INTERVENTIONAL,Withdrawn due to business reasons
NCT02708303,TERMINATED,OBSERVATIONAL,Study's original Principal Investigator no longer at the institution.
NCT02708407,TERMINATED,INTERVENTIONAL,Inability to recruit adequate number of participants
NCT02708472,WITHDRAWN,INTERVENTIONAL,This study never moved forward due to funding constraints.
NCT02708563,WITHDRAWN,INTERVENTIONAL,Inadequate funds allocated for study completion
NCT02709083,TERMINATED,INTERVENTIONAL,Original principal investigator left institution
NCT02709200,WITHDRAWN,OBSERVATIONAL,Unable to enroll subjects.
NCT02709811,TERMINATED,INTERVENTIONAL,Enrollment at study center below rate compatible with study completion.
NCT02709889,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT02709993,WITHDRAWN,INTERVENTIONAL,Study unable to enroll patients
NCT02710266,TERMINATED,INTERVENTIONAL,This study was closed earlier than planned because targeted participant recruitment is not smooth.
NCT02710279,TERMINATED,INTERVENTIONAL,difficulties in recruitment
NCT02710383,TERMINATED,OBSERVATIONAL,Study no longer pursued.
NCT02710396,TERMINATED,INTERVENTIONAL,Frontline pembrolizumab approved in NSCLC as monotherapy and in combination with chemotherapy representing a new standard of care.
NCT02710422,TERMINATED,INTERVENTIONAL,Lack of Accrual and Inadequate Funding
NCT02710669,TERMINATED,INTERVENTIONAL,Study halted/terminated prematurely due to COVID.
NCT02710695,TERMINATED,INTERVENTIONAL,Lack of available time
NCT02710877,TERMINATED,INTERVENTIONAL,Stopped funding by Regional Healthcare System.
NCT02711059,WITHDRAWN,INTERVENTIONAL,studien skjuts p framtiden
NCT02711137,TERMINATED,INTERVENTIONAL,Study terminated due to safety issues.
NCT02711241,TERMINATED,INTERVENTIONAL,Not enough patients
NCT02711345,TERMINATED,INTERVENTIONAL,"considering the limited clinical activity observed with LTT462, the decision was made to not open the dose expansion phase of the study"
NCT02711462,TERMINATED,INTERVENTIONAL,The study was prematurely terminated on 06 October 2016 due to the potential risk of further dosing in healthy subjects
NCT02711514,TERMINATED,OBSERVATIONAL,COVID-19
NCT02711592,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02711605,WITHDRAWN,INTERVENTIONAL,Study never got underway due to sponsor re-organization.
NCT02711735,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02711813,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT02712138,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT02712164,WITHDRAWN,INTERVENTIONAL,Lack of resources.
NCT02712437,TERMINATED,INTERVENTIONAL,The study was terminated because of low accrual.
NCT02712775,WITHDRAWN,INTERVENTIONAL,Study logistics
NCT02712788,TERMINATED,INTERVENTIONAL,Completion not feasible due to lack of eligible subjects.
NCT02712840,TERMINATED,INTERVENTIONAL,recruitment challenge
NCT02712905,TERMINATED,INTERVENTIONAL,Strategic Business Decision
NCT02712944,TERMINATED,INTERVENTIONAL,Study stopped for procedural difficulties and lack of personnel
NCT02713035,TERMINATED,INTERVENTIONAL,moved to new institution
NCT02713139,WITHDRAWN,INTERVENTIONAL,"Due to budget limitations, the company decided to withdraw this study."
NCT02713633,TERMINATED,INTERVENTIONAL,"Changes in staffing, original PI no longer at our institution."
NCT02713828,TERMINATED,INTERVENTIONAL,Company discontinued further development of study drug for this indication
NCT02713880,WITHDRAWN,OBSERVATIONAL,University of Rostock terminated participation in the study conduct; Study Sponsorship is moved to Centogene AG
NCT02713906,TERMINATED,INTERVENTIONAL,Investigational device not available anymore.
NCT02713919,TERMINATED,INTERVENTIONAL,insufficient enrollment rate
NCT02713984,WITHDRAWN,INTERVENTIONAL,Reform CAR structure due to safety consideration
NCT02714049,TERMINATED,INTERVENTIONAL,Investor Initiated Grant support stopped when drug was sold.
NCT02714374,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02714530,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02714556,WITHDRAWN,OBSERVATIONAL,Ethical approval not obtained yet as questioning the danger of providing 100% oxygen to parturients.
NCT02714985,WITHDRAWN,OBSERVATIONAL,not able to recruit participants
NCT02715102,TERMINATED,OBSERVATIONAL,Patient accrual was slow due to exclusion of patients with prior cancers
NCT02715466,TERMINATED,INTERVENTIONAL,recommended by DSMB
NCT02715505,WITHDRAWN,INTERVENTIONAL,This study was cancelled with no patients
NCT02715713,WITHDRAWN,OBSERVATIONAL,"Principal Investigator left the institution in August, 2016;"
NCT02715765,TERMINATED,INTERVENTIONAL,"PI left university, the grant could not be transferred, no data was collected"
NCT02715804,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02715856,TERMINATED,INTERVENTIONAL,Due to software issues and depletion of funds the protocol was terminated early
NCT02716077,TERMINATED,INTERVENTIONAL,low recruitment due to changing treatment landscape for subject population
NCT02716090,WITHDRAWN,INTERVENTIONAL,"Due to budget limitations, the company decided to withdraw this study."
NCT02716519,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT02716597,TERMINATED,INTERVENTIONAL,difficulty enrolling
NCT02716688,WITHDRAWN,INTERVENTIONAL,No patients enrolled.
NCT02716701,TERMINATED,INTERVENTIONAL,lack of funding
NCT02716740,TERMINATED,INTERVENTIONAL,not enough patient
NCT02716805,TERMINATED,INTERVENTIONAL,FDA placed on partial hold due to additional data
NCT02716896,TERMINATED,INTERVENTIONAL,Study ended due to lack of eligible subjects and funding not renewing
NCT02717013,TERMINATED,INTERVENTIONAL,Lack of recruitment of subjects.
NCT02717065,WITHDRAWN,INTERVENTIONAL,Personnel and funding was no longer available
NCT02717130,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of enrollment.
NCT02717247,TERMINATED,INTERVENTIONAL,the princcipal investigator went abroad
NCT02717390,TERMINATED,INTERVENTIONAL,Lack of funding to recruit target sample size
NCT02717442,TERMINATED,INTERVENTIONAL,Negative Efficacy Results from the recently completed Phase 3 study 104-201506
NCT02717585,WITHDRAWN,INTERVENTIONAL,Lack of funding available
NCT02717728,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02717949,TERMINATED,INTERVENTIONAL,failure to recruit
NCT02718027,TERMINATED,OBSERVATIONAL,Study no longer pursued.
NCT02718092,WITHDRAWN,INTERVENTIONAL,Decided not to pursue study
NCT02718131,TERMINATED,INTERVENTIONAL,Insufficient enrollment to meet the statistical requirements
NCT02718196,WITHDRAWN,INTERVENTIONAL,App stopped development before minimum viable product created
NCT02718391,TERMINATED,INTERVENTIONAL,The randomization to the observational arm of the trial was no longer ethical
NCT02718404,TERMINATED,INTERVENTIONAL,following the non-renewal of the loan agreement for the medical device
NCT02718417,TERMINATED,INTERVENTIONAL,The study was terminated based on the results of a planned interim analysis that showed futility of efficacy.
NCT02718482,TERMINATED,INTERVENTIONAL,Not adequate enrollment (sample size not possible to reach)
NCT02718625,TERMINATED,INTERVENTIONAL,Business Decision
NCT02718677,WITHDRAWN,OBSERVATIONAL,Company decision to not conduct study
NCT02718755,WITHDRAWN,INTERVENTIONAL,Problem with drug supply
NCT02719015,WITHDRAWN,INTERVENTIONAL,No IND Serial #
NCT02719392,SUSPENDED,INTERVENTIONAL,"Due to limited study staff and the COVID-19 pandemic, enrollment has been paused as staff hours for this project have been reduced and reallocated to other projects."
NCT02719405,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02719730,TERMINATED,INTERVENTIONAL,Change in study design to be a pilot with no randomization to intervention/control
NCT02719990,TERMINATED,INTERVENTIONAL,Phase 3 clinical trial of somavaratan in pediatric growth hormone deficiency (PGHD) did not meet its primary endpoint of non-inferiority.
NCT02720029,WITHDRAWN,INTERVENTIONAL,Difficulty with enrollment
NCT02720120,TERMINATED,INTERVENTIONAL,The overall benefit risk profile of ocrelizumab was not favorable in RA
NCT02720185,TERMINATED,INTERVENTIONAL,Study terminated early due to COVID-19 related slow enrollment and funding
NCT02720211,TERMINATED,INTERVENTIONAL,Too difficult to enroll according to inclusion/exclusion criteria
NCT02720341,TERMINATED,INTERVENTIONAL,Doctoral students on project defended their thesis.
NCT02720484,TERMINATED,INTERVENTIONAL,Study did not meet first stage requirements of interim analysis
NCT02720510,TERMINATED,INTERVENTIONAL,A study was terminated due to low enrollment.
NCT02720601,WITHDRAWN,INTERVENTIONAL,Study was never submitted to the IRB \& never opened. PI is leaving institution.
NCT02720757,TERMINATED,OBSERVATIONAL,Recruitment failure
NCT02720796,TERMINATED,INTERVENTIONAL,Recruitment barriers
NCT02720926,TERMINATED,INTERVENTIONAL,Unafavourable toxicity profile
NCT02721056,TERMINATED,INTERVENTIONAL,"The RP2D for intratumoral injection was determined. With the changing practice of medicine for HCC, it was decided to design an independent Phase II clinical study."
NCT02721251,TERMINATED,INTERVENTIONAL,Behind enrollment targets
NCT02721381,TERMINATED,INTERVENTIONAL,COVID-19
NCT02721511,WITHDRAWN,INTERVENTIONAL,Investigator decision based on new device information.
NCT02721550,TERMINATED,INTERVENTIONAL,The number of enrollment cases is too small.
NCT02721576,TERMINATED,INTERVENTIONAL,The number of enrolled cases is too small.
NCT02721888,TERMINATED,INTERVENTIONAL,Failure of inclusion
NCT02721979,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT02722109,TERMINATED,OBSERVATIONAL,Not enough patients signed up
NCT02722369,TERMINATED,INTERVENTIONAL,"Low recruitment, lack of efficacy and increased adverse events in investigational arm."
NCT02722512,TERMINATED,INTERVENTIONAL,Lack of substantial evidence for immune responses in response to vaccination.
NCT02722603,TERMINATED,INTERVENTIONAL,The study was early terminated due to insufficient recruitment
NCT02722616,TERMINATED,INTERVENTIONAL,Ultrasound vendor cannot support the study
NCT02722902,TERMINATED,INTERVENTIONAL,No effect of carnitine on lipid induced insulin resistance after n=8 (p=1.00)
NCT02722928,TERMINATED,INTERVENTIONAL,Variability of the pneumocephalus volume mean was higher than initially assumed
NCT02723006,TERMINATED,INTERVENTIONAL,Business decision: Protocol efficacy futility met
NCT02723435,WITHDRAWN,INTERVENTIONAL,Logistical and administrative issues
NCT02723786,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02723838,WITHDRAWN,INTERVENTIONAL,Company has reprioritized clinical plans to focus on later-stage studies.
NCT02723942,WITHDRAWN,INTERVENTIONAL,Project terminated due to revision of local regulations
NCT02723981,WITHDRAWN,INTERVENTIONAL,Regulatory authority approval for the initial study design could not be obtained
NCT02724033,TERMINATED,INTERVENTIONAL,PI has left Riley Anesthesia. Lack of staff for continued recruitment
NCT02724150,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02724189,TERMINATED,OBSERVATIONAL,Lack of logistic capabilities at the study site
NCT02724553,WITHDRAWN,INTERVENTIONAL,A recent publication answered the study question being asked
NCT02724904,WITHDRAWN,INTERVENTIONAL,Drug logistics
NCT02724917,SUSPENDED,INTERVENTIONAL,Study halted by sponsor for business reasons
NCT02724995,WITHDRAWN,OBSERVATIONAL,Responsible party left the university of kentucky without enrolling any participants
NCT02725372,TERMINATED,INTERVENTIONAL,Trial stopped for futility
NCT02725541,WITHDRAWN,INTERVENTIONAL,loss of funding support
NCT02725658,WITHDRAWN,INTERVENTIONAL,This study doesn't meet NIH criteria of clinical trial study
NCT02725671,TERMINATED,INTERVENTIONAL,Poor enrollment due to insufficient study support.
NCT02725697,TERMINATED,OBSERVATIONAL,too few participans available
NCT02725788,TERMINATED,INTERVENTIONAL,Due to futility
NCT02726035,WITHDRAWN,INTERVENTIONAL,PI deceased
NCT02726048,TERMINATED,INTERVENTIONAL,"Fisher \& Paykel Healthcare placed an administrative hold on the Simplus and Eson Non-Invasive Ventilation Evaluation study being conducted at Charite, Berlin"
NCT02726139,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT02726191,WITHDRAWN,INTERVENTIONAL,Study Lapsed
NCT02726282,WITHDRAWN,OBSERVATIONAL,funding not available
NCT02726334,TERMINATED,INTERVENTIONAL,Monotherapy arm completed. Combination arm did not proceed (sponsor decision).
NCT02726399,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02726490,TERMINATED,INTERVENTIONAL,Lack of Recruitment
NCT02726659,TERMINATED,INTERVENTIONAL,Difficulty recruiting participants because principal investigator noticed that the participants in the population were responding well to low doses of mood stabilizers and therefor would not be recruited into the study.
NCT02726672,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02726867,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02727049,WITHDRAWN,INTERVENTIONAL,no college athlete availability
NCT02727101,TERMINATED,INTERVENTIONAL,slow enrollment
NCT02727127,TERMINATED,OBSERVATIONAL,Lost funding due to low enrollment
NCT02727777,TERMINATED,INTERVENTIONAL,Poor Accrual
NCT02727985,WITHDRAWN,INTERVENTIONAL,Site did not meet recruitment goals and target numbers
NCT02727998,TERMINATED,INTERVENTIONAL,Study ran out of funding
NCT02728037,TERMINATED,INTERVENTIONAL,"Low Enrollment, Adoption of investigational treatment into standard practice at our center."
NCT02728167,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02728245,WITHDRAWN,INTERVENTIONAL,Placebo cannot be prepared
NCT02728271,TERMINATED,INTERVENTIONAL,PI left the institution
NCT02728284,SUSPENDED,INTERVENTIONAL,COVID-19
NCT02728310,TERMINATED,INTERVENTIONAL,Terminated
NCT02728323,TERMINATED,INTERVENTIONAL,Terminated
NCT02728336,SUSPENDED,INTERVENTIONAL,COVID-19
NCT02728453,TERMINATED,INTERVENTIONAL,Insufficient recruitment.
NCT02728700,TERMINATED,INTERVENTIONAL,Accrual factor
NCT02728960,WITHDRAWN,INTERVENTIONAL,Study under review. Temporarily suspended
NCT02728999,TERMINATED,INTERVENTIONAL,Did not want to expose additional subjects to Arterial Line placement
NCT02729207,TERMINATED,INTERVENTIONAL,Due to lack of patients number
NCT02729233,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT02729558,TERMINATED,INTERVENTIONAL,Too limited accrual
NCT02729805,SUSPENDED,INTERVENTIONAL,Not enough patients
NCT02729870,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT02729883,TERMINATED,INTERVENTIONAL,Funding Issue
NCT02729961,WITHDRAWN,INTERVENTIONAL,Administrative closure
NCT02730052,WITHDRAWN,INTERVENTIONAL,Centers recruited poorly
NCT02730325,TERMINATED,INTERVENTIONAL,Study terminated due to limited enrollment.
NCT02730364,WITHDRAWN,INTERVENTIONAL,The clinical phase of the study (from FSFV to LSLV) was never initiated due to the sponsor's decision.
NCT02730715,TERMINATED,OBSERVATIONAL,Insufficient amount of T Cell collection
NCT02730793,TERMINATED,INTERVENTIONAL,terminated due to an inability to recruit study subjects
NCT02730871,TERMINATED,INTERVENTIONAL,Enrollment Challenges
NCT02730884,TERMINATED,INTERVENTIONAL,Terminated Per PIs request due to low accrual
NCT02730936,WITHDRAWN,INTERVENTIONAL,Sponsor decision to discontinue the study.
NCT02730962,TERMINATED,INTERVENTIONAL,Delays in IND approval caused a lack of funding to conduct the trial.
NCT02731118,TERMINATED,INTERVENTIONAL,Difficulty recruiting patients and no effect on preliminary analysis
NCT02731144,TERMINATED,INTERVENTIONAL,The protocol was modified substantially and will be resubmitted to Clinical Trial
NCT02731365,WITHDRAWN,INTERVENTIONAL,Study stopped to await new generation of device anticipated to be released 2018.
NCT02731625,TERMINATED,INTERVENTIONAL,Less enrollment than expected. Would have been grossly underpowered
NCT02731742,TERMINATED,INTERVENTIONAL,The study was terminated early due to business reasons.
NCT02731846,WITHDRAWN,INTERVENTIONAL,"It has been determined on June 10th that the 205165 study will not progress. This decision has been made prior to study start, no patients were screened."
NCT02732015,TERMINATED,INTERVENTIONAL,Terminated per PI's request
NCT02732288,TERMINATED,INTERVENTIONAL,Interrupted by Covid-19
NCT02732327,TERMINATED,INTERVENTIONAL,No longer aligned with the revised clinical development plan and commercial strategy
NCT02732457,TERMINATED,OBSERVATIONAL,"5 participants recruited in 7 years (no recruitment since 2015). Due to rare patient population and due to ongoing COVID-19 demands on healthcare systems, it was decided by the Protocol Steering Committee to terminate this study."
NCT02732548,WITHDRAWN,INTERVENTIONAL,Study was never initiated
NCT02732873,WITHDRAWN,INTERVENTIONAL,Grant not received - study not started
NCT02732925,TERMINATED,INTERVENTIONAL,Difficulties with recruitment due to change in referral rates.
NCT02732938,TERMINATED,INTERVENTIONAL,"Pfizer made a business-related decision on 04May2017 to terminate study based on change in portfolio prioritization, and is not due to safety or efficacy."
NCT02733081,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02733211,WITHDRAWN,INTERVENTIONAL,Finally it was decided not to initiate the study due to logistical issues
NCT02733614,TERMINATED,INTERVENTIONAL,funding
NCT02733848,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02734147,TERMINATED,INTERVENTIONAL,The trial prematurely terminated due to the loss of funding.
NCT02734368,TERMINATED,OBSERVATIONAL,The longitudinal goal could not be completed due to CT scans not being performed at baseline.
NCT02734498,TERMINATED,INTERVENTIONAL,Unable to enroll
NCT02734576,TERMINATED,INTERVENTIONAL,Study closed due to positive interim results.
NCT02734589,TERMINATED,INTERVENTIONAL,DSMB recommendation of stopping the trial after reviewing the interim data
NCT02734615,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02734719,TERMINATED,INTERVENTIONAL,Device is not available.
NCT02734823,WITHDRAWN,OBSERVATIONAL,Lack of accrual
NCT02734940,TERMINATED,INTERVENTIONAL,Unable to find participants who met inclusion/exclusion criteria
NCT02735096,TERMINATED,INTERVENTIONAL,Funding ended at the end of 2016
NCT02735109,TERMINATED,INTERVENTIONAL,significant results after inclusion of 10 patients
NCT02735135,WITHDRAWN,INTERVENTIONAL,methodological difficulties
NCT02735343,TERMINATED,INTERVENTIONAL,study goals met
NCT02735512,TERMINATED,OBSERVATIONAL,Insufficient accrual
NCT02735551,TERMINATED,INTERVENTIONAL,Inadequate participant enrollment during recruitment period.
NCT02735681,WITHDRAWN,INTERVENTIONAL,Trouble recruiting
NCT02735694,TERMINATED,INTERVENTIONAL,Analysis of initial sample shows negative results.
NCT02735720,TERMINATED,OBSERVATIONAL,"Because of the difficulties created by COVID-19 and bringing participants on onsite, the decision was made to stop recruitment."
NCT02735759,WITHDRAWN,INTERVENTIONAL,Required revisions were unable to be made to protocol.
NCT02735798,WITHDRAWN,INTERVENTIONAL,The study was not started due to the sponsor choosing to not fund the trial.
NCT02735850,WITHDRAWN,INTERVENTIONAL,"Not yet submitted, unclear timelines"
NCT02735993,WITHDRAWN,OBSERVATIONAL,Corporate decision
NCT02736045,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT02736110,WITHDRAWN,OBSERVATIONAL,Corporate decision
NCT02736123,WITHDRAWN,INTERVENTIONAL,PI is closing the trial as he will be leaving the University of Pittsburgh Medical Center
NCT02736149,TERMINATED,INTERVENTIONAL,"Following the failure to demonstrate efficacy in EIG-UBX-001, the sponsor decided to terminate Study EIG-UBX-002."
NCT02736318,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02736357,WITHDRAWN,OBSERVATIONAL,Study restructured with Central IRB (NCT04996706); accruals reported there.
NCT02736435,WITHDRAWN,INTERVENTIONAL,Lengthy delays and inadequate support to proceed.
NCT02736539,WITHDRAWN,INTERVENTIONAL,Commercial strategy
NCT02736578,TERMINATED,INTERVENTIONAL,Logistics
NCT02736825,TERMINATED,INTERVENTIONAL,The study data to date show the required primary study endpoint will not be met.
NCT02736890,TERMINATED,INTERVENTIONAL,funding not available to continue
NCT02737124,WITHDRAWN,INTERVENTIONAL,Study is currently Lapsed
NCT02737163,TERMINATED,OBSERVATIONAL,Terminated early due to sufficient data acquired to meet our study objectives
NCT02737280,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02737293,TERMINATED,INTERVENTIONAL,Due to COVID-19 and expiration of grant funds
NCT02737306,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrolment..
NCT02737540,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT02737709,TERMINATED,INTERVENTIONAL,The study have difficulty in recruiting subjectes
NCT02737930,TERMINATED,INTERVENTIONAL,Slow recruitment and lack of funding to expand to other sites.
NCT02738008,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02738762,WITHDRAWN,INTERVENTIONAL,materials incomplete
NCT02738905,WITHDRAWN,INTERVENTIONAL,insufficient support
NCT02739178,TERMINATED,INTERVENTIONAL,Administratively inactivated by IRB due to no response for Continuing Review
NCT02739243,WITHDRAWN,INTERVENTIONAL,Enrolment slower than anticipated accrual.
NCT02739256,TERMINATED,INTERVENTIONAL,Institutional implementation of a same day discharge pathway
NCT02739347,TERMINATED,INTERVENTIONAL,Unable to recruit successfully
NCT02739477,TERMINATED,INTERVENTIONAL,End date of epidemic
NCT02739555,TERMINATED,INTERVENTIONAL,The study has been conducted until the end of the research; participants are no longer receiving an intervention or being examined; but recruitment isn't completed (15 % enrolled in the stud)
NCT02739581,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT02739594,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02739685,TERMINATED,INTERVENTIONAL,"Slow enrollment, access to devices"
NCT02739776,WITHDRAWN,OBSERVATIONAL,incomplete information
NCT02740114,TERMINATED,INTERVENTIONAL,Per PIs request
NCT02740244,TERMINATED,INTERVENTIONAL,difficulties of recruitment
NCT02740309,WITHDRAWN,INTERVENTIONAL,PI left Institution
NCT02740322,WITHDRAWN,INTERVENTIONAL,PI no longer at institution and no subjects enrolled
NCT02740387,TERMINATED,INTERVENTIONAL,Negative Efficacy Results from the recently completed Phase 3 study 104-201506
NCT02740530,TERMINATED,INTERVENTIONAL,"Unforeseen challenges that rendered Recruitment more challenging than expected. Thus, recruitment is terminated earlier to proceed with data analysis."
NCT02740673,WITHDRAWN,INTERVENTIONAL,Technical issues
NCT02740699,TERMINATED,INTERVENTIONAL,Principal Investigator resigned and closed program
NCT02741050,TERMINATED,INTERVENTIONAL,poor recruitment \& retention
NCT02741076,TERMINATED,INTERVENTIONAL,Inability to recruit sufficient no. of subjects over an acceptable time period
NCT02741141,TERMINATED,INTERVENTIONAL,the study was stopped due to a change in delivery room practices
NCT02741180,SUSPENDED,INTERVENTIONAL,COVID-19
NCT02741362,TERMINATED,INTERVENTIONAL,Primary Investigator no longer with institution
NCT02741505,WITHDRAWN,INTERVENTIONAL,Funding was not obtained
NCT02741609,TERMINATED,INTERVENTIONAL,Sponsor lack of funding
NCT02741869,WITHDRAWN,INTERVENTIONAL,Investigator moved locations.
NCT02742181,TERMINATED,INTERVENTIONAL,terminated due to lack of enrollment
NCT02742259,WITHDRAWN,OBSERVATIONAL,No enrolled participants
NCT02742428,SUSPENDED,INTERVENTIONAL,The protocol will be discussed and consulted. Potentially will resume.
NCT02742519,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT02742831,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled and the grant period is ending.
NCT02742844,TERMINATED,INTERVENTIONAL,COVID-19 pandemic and patient recruitment issues
NCT02742883,SUSPENDED,INTERVENTIONAL,Clinical Hold
NCT02743078,TERMINATED,INTERVENTIONAL,Treatment now available commercially
NCT02743104,SUSPENDED,INTERVENTIONAL,Protocol being reconsidered
NCT02743169,WITHDRAWN,OBSERVATIONAL,Could not acquire data
NCT02743208,WITHDRAWN,INTERVENTIONAL,problem due to new regulations for CE-marking of implants; lack of funding
NCT02743598,TERMINATED,INTERVENTIONAL,Lack of funding and time
NCT02743611,TERMINATED,INTERVENTIONAL,company decision
NCT02743650,TERMINATED,INTERVENTIONAL,Difficulties identifying subjects who were qualified to participate in the study
NCT02743793,TERMINATED,OBSERVATIONAL,COVID-19 pandemic and potential risks to study participants and study staff.
NCT02743806,TERMINATED,INTERVENTIONAL,Early Completed - Alternative Source of Drug Available
NCT02743975,TERMINATED,INTERVENTIONAL,Insufficient tumor-to-background ratios in the first three dose groups
NCT02744209,TERMINATED,OBSERVATIONAL,Low accrual
NCT02744235,WITHDRAWN,INTERVENTIONAL,Unable to move forward due to funding
NCT02744287,SUSPENDED,INTERVENTIONAL,Due to a Dose Limiting Toxicity.
NCT02744352,TERMINATED,INTERVENTIONAL,prior to its planned completion as anticipated by the protocol due to lack of resources
NCT02744482,TERMINATED,INTERVENTIONAL,lack of patients
NCT02744651,TERMINATED,INTERVENTIONAL,Practical circumstances making it not possible to finish the study.
NCT02744690,WITHDRAWN,INTERVENTIONAL,The necessary ethical approvals were not obtained in a timely manner.
NCT02744820,TERMINATED,INTERVENTIONAL,It was considered by the sponsor that the study objective has been met by dosing 13 instead of 15 patients
NCT02744833,TERMINATED,INTERVENTIONAL,The trial was funded in part by a grant; the trial closed when the grant ended.
NCT02745028,WITHDRAWN,INTERVENTIONAL,The protocol was cancelled becouse lack of funding
NCT02745145,TERMINATED,INTERVENTIONAL,Difficulties experienced in identifying participants who meet the eligibility criteria of the trial.
NCT02745197,WITHDRAWN,INTERVENTIONAL,change in concept
NCT02745210,TERMINATED,INTERVENTIONAL,The acquisition sequence was incompatible with MRI hardware
NCT02745353,TERMINATED,INTERVENTIONAL,Couldn't enough accrue patients
NCT02745587,TERMINATED,INTERVENTIONAL,Stopped because of poor accrual in June 2021 after the inclusion of 69 patients
NCT02745756,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT02745964,TERMINATED,INTERVENTIONAL,This study was closed earlier than planned because of lack of research staff.
NCT02746094,WITHDRAWN,INTERVENTIONAL,Change strategy
NCT02746146,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02746263,TERMINATED,INTERVENTIONAL,Business decision because enrollment was slower than expected
NCT02746328,WITHDRAWN,INTERVENTIONAL,Investigational drug development was halted.
NCT02746419,WITHDRAWN,INTERVENTIONAL,The company who was sponsoring devices and funding pulled out before we enrolled any subjects.
NCT02746523,TERMINATED,OBSERVATIONAL,Could not recruit enough subjects
NCT02746913,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02746939,WITHDRAWN,INTERVENTIONAL,Staffing change
NCT02746965,TERMINATED,INTERVENTIONAL,Problems of the MST device
NCT02747069,SUSPENDED,OBSERVATIONAL,New data available in public domain requires re-evaluation of protocol.
NCT02747238,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT02747537,WITHDRAWN,INTERVENTIONAL,Could not recruit participants for the study
NCT02747758,TERMINATED,INTERVENTIONAL,Recruitment due to CORONA
NCT02747784,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02747797,WITHDRAWN,INTERVENTIONAL,Drug Supply No Longer Available
NCT02747810,WITHDRAWN,INTERVENTIONAL,We have decided not to test the newly designed TENS device
NCT02747875,TERMINATED,INTERVENTIONAL,Drug Shortage
NCT02747914,SUSPENDED,INTERVENTIONAL,Technical problems
NCT02748122,TERMINATED,INTERVENTIONAL,PI left institution
NCT02748161,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02748174,WITHDRAWN,INTERVENTIONAL,screening survey data was not correctly collected; Study halted prematurely
NCT02748304,TERMINATED,INTERVENTIONAL,"The enrollment of this study was slow. With the approval of lenvatinib in HCC,many patients choose the new drug, so subsequent enrollment may be more difficult."
NCT02748395,WITHDRAWN,INTERVENTIONAL,No IRB approval
NCT02748564,TERMINATED,INTERVENTIONAL,Study Complete
NCT02748746,WITHDRAWN,INTERVENTIONAL,Unable to achieve device(s) which will be used in this study.
NCT02748889,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT02749006,TERMINATED,INTERVENTIONAL,Hard to enroll
NCT02749045,TERMINATED,INTERVENTIONAL,"Slow recruitment, funding period ended"
NCT02749071,TERMINATED,INTERVENTIONAL,Company no longer operational
NCT02749227,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02749292,TERMINATED,INTERVENTIONAL,"Due to the coronavirus disease 2019 (COVID-19) pandemic and the deleterious impact of rituximab on vaccination efficacy, the trial was concluded before reaching the target enrollment of 200."
NCT02749318,WITHDRAWN,INTERVENTIONAL,Company Assets Being Sold
NCT02749409,TERMINATED,INTERVENTIONAL,"Case numbers not enough, however, the funding is over"
NCT02749435,TERMINATED,OBSERVATIONAL,The study was stopped due to lack of recruitment.
NCT02749526,TERMINATED,INTERVENTIONAL,low accrual rate
NCT02749617,TERMINATED,INTERVENTIONAL,Study was stopped due to lack of enrollment.
NCT02749708,TERMINATED,INTERVENTIONAL,Study drug supply expired and could not be renewed.
NCT02749825,TERMINATED,INTERVENTIONAL,Withdrawal of funding support
NCT02750033,WITHDRAWN,OBSERVATIONAL,Protocol changed to meet IRB requirements for patient safety
NCT02750254,TERMINATED,INTERVENTIONAL,Toxicity. Only enrolled patients in phase I portion of trial.
NCT02750384,TERMINATED,INTERVENTIONAL,Sponsor strategic decision based on preliminary results
NCT02750514,TERMINATED,INTERVENTIONAL,The standard of care for the patient population changed and we were unable to accrue any longer.
NCT02750930,TERMINATED,INTERVENTIONAL,"The termination was result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct"
NCT02751112,TERMINATED,INTERVENTIONAL,Slow recruitment and preliminary observations leading to early termination
NCT02751333,WITHDRAWN,INTERVENTIONAL,The reason was the fact that the study was not clinically feasible.
NCT02751385,TERMINATED,INTERVENTIONAL,Terminated- Study halted due to low recruitment.
NCT02751424,TERMINATED,INTERVENTIONAL,Study data is currently under review.
NCT02751502,TERMINATED,INTERVENTIONAL,lack of enrollment and funding + Covid-19 pandemic
NCT02751853,TERMINATED,INTERVENTIONAL,Due to the heterogeneity in the first group.
NCT02752009,WITHDRAWN,INTERVENTIONAL,The data that would be generated is no longer clinically novel.
NCT02752230,WITHDRAWN,INTERVENTIONAL,Attending physician left network
NCT02752321,TERMINATED,INTERVENTIONAL,There was a software server issue. Investigators were no longer able to sign patients up to the software program.
NCT02752373,TERMINATED,OBSERVATIONAL,This study was terminated due to low enrollment
NCT02752607,TERMINATED,OBSERVATIONAL,The study was stopped early due to low recruitment
NCT02752841,TERMINATED,INTERVENTIONAL,Limited study funding
NCT02753218,TERMINATED,INTERVENTIONAL,"Due to tolerability issues related to the dose titration, unexpected withdrawals were observed and it was unlikely for the trial to meet its objectives"
NCT02753595,TERMINATED,INTERVENTIONAL,evolving standard of care and difficulties of enrolling participants
NCT02753816,TERMINATED,INTERVENTIONAL,Study enrollment and goals unable to be reached.
NCT02753972,TERMINATED,INTERVENTIONAL,"This research was completed before January 18, 2017, and does not meet the ACT requirement to register and report results per the guidance provided in ""Clinical Trials Registration and Results Information Submission"" dated 09/21/2016."
NCT02754206,TERMINATED,OBSERVATIONAL,PI left university and IRB protocol closed
NCT02754232,WITHDRAWN,INTERVENTIONAL,Due to resource problems in the clinic at University Hospital Odense
NCT02754362,WITHDRAWN,INTERVENTIONAL,Due to personnel changes / departure of Dr. Chi.
NCT02754453,WITHDRAWN,INTERVENTIONAL,No funding
NCT02754466,TERMINATED,INTERVENTIONAL,Children could not be examined longer than 2 years due to COVID-19 pandemic and schools closure.
NCT02755155,TERMINATED,INTERVENTIONAL,too many patients were expected and the investigative team would not be able to recruit this number
NCT02755194,TERMINATED,OBSERVATIONAL,This infrastructure project has been taken over by another study.
NCT02755480,TERMINATED,INTERVENTIONAL,PI has left UHN. This study is no longer running at UHN.
NCT02755818,TERMINATED,OBSERVATIONAL,insufficient patients with CKD willing to be injected with heparin
NCT02755948,TERMINATED,INTERVENTIONAL,Study objectives have been met.
NCT02756013,TERMINATED,INTERVENTIONAL,Lack of accrual - terminated
NCT02756130,WITHDRAWN,INTERVENTIONAL,funding was not secured
NCT02756325,WITHDRAWN,INTERVENTIONAL,PI is no longer with the institution
NCT02756533,TERMINATED,INTERVENTIONAL,pilot feasibility study completed
NCT02756728,TERMINATED,INTERVENTIONAL,Full clinical hold from FDA
NCT02756806,TERMINATED,INTERVENTIONAL,Change protocol to include multiple sites.
NCT02757053,TERMINATED,INTERVENTIONAL,This study was terminated June 28 2016 for low enrollment and PI moving away. No results were obtained
NCT02757157,TERMINATED,INTERVENTIONAL,Hydrotherapy pool has closed.
NCT02757248,WITHDRAWN,INTERVENTIONAL,Boehringer Ingelheim is discontinuing their volasertib development program
NCT02757287,WITHDRAWN,INTERVENTIONAL,Lack of financial support
NCT02757300,WITHDRAWN,INTERVENTIONAL,Study performer moved away
NCT02757326,TERMINATED,INTERVENTIONAL,Expiration of National Cancer Institute (NCI) funding of the study.
NCT02757391,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
NCT02757417,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02757521,TERMINATED,INTERVENTIONAL,Study sponsor ended trial due to low recruitment
NCT02757547,TERMINATED,INTERVENTIONAL,Business decision to discontinue development of this investigational device.
NCT02757677,TERMINATED,OBSERVATIONAL,Difficulties with recruitment
NCT02757833,WITHDRAWN,INTERVENTIONAL,A larger study collecting the same outcomes is currently being conducted by the study team.
NCT02757976,TERMINATED,INTERVENTIONAL,Consensus RAFT-LVendo Steering Committee to terminate.
NCT02758067,WITHDRAWN,INTERVENTIONAL,This study was withdrawn for administrative reasons. There were no safety concerns.
NCT02758132,TERMINATED,INTERVENTIONAL,Low accruals
NCT02758184,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT02758366,TERMINATED,INTERVENTIONAL,Study was terminated due to high heterogeneity of enrolled patients
NCT02758990,TERMINATED,INTERVENTIONAL,Recruiting and financial constraints
NCT02759120,TERMINATED,INTERVENTIONAL,Terminated for futility after review of first planned interim analysis.
NCT02759315,TERMINATED,INTERVENTIONAL,The study was terminated based on review of Phase 2 efficacy data
NCT02759562,TERMINATED,INTERVENTIONAL,Discontinuation of development for this indication
NCT02759705,WITHDRAWN,OBSERVATIONAL,no staff available to do the research
NCT02759744,SUSPENDED,INTERVENTIONAL,This study involves the use of laser fibers but our original manufacturer has discontinued their marketing of product for prostate tissue (instead focusing on b
NCT02760173,WITHDRAWN,INTERVENTIONAL,This protocol was re-written and resubmitted under a different trial number again (NCT02980419)
NCT02760602,TERMINATED,INTERVENTIONAL,Insufficient scientific evidence that solanezumab would likely demonstrate a meaningful benefit to participants with prodromal AD as defined by study protocol.
NCT02760615,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02760719,TERMINATED,INTERVENTIONAL,No relevant data
NCT02760927,TERMINATED,INTERVENTIONAL,Study product will not be commercialized.
NCT02761083,WITHDRAWN,INTERVENTIONAL,Comparator was not available in the planned setting
NCT02761694,TERMINATED,INTERVENTIONAL,Business Reasons
NCT02761928,TERMINATED,OBSERVATIONAL,"Insufficient enrollment, lack of funding to continue"
NCT02762097,WITHDRAWN,INTERVENTIONAL,Study stopped due to similar case control study already completed
NCT02762149,TERMINATED,INTERVENTIONAL,"Analysis after 20 patients was convincing for a negative result for the primary outcome, so the study was stopped."
NCT02762201,TERMINATED,INTERVENTIONAL,Sponsor and principal investigator decision
NCT02762253,TERMINATED,INTERVENTIONAL,No IND submitted to the FDA
NCT02762266,TERMINATED,INTERVENTIONAL,Business decision - funding
NCT02762318,TERMINATED,OBSERVATIONAL,Lack of funding
NCT02762331,TERMINATED,INTERVENTIONAL,Therapy shown effective by larger studies
NCT02762383,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02762448,WITHDRAWN,OBSERVATIONAL,no patient enrollment
NCT02762487,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02762617,TERMINATED,INTERVENTIONAL,Safety-related
NCT02762773,TERMINATED,INTERVENTIONAL,unable to complete recruitment
NCT02762825,TERMINATED,INTERVENTIONAL,Insufficient recruitment of eligible patients
NCT02762877,TERMINATED,OBSERVATIONAL,Business decision
NCT02763007,TERMINATED,INTERVENTIONAL,difficulty in recruiting patients
NCT02763189,TERMINATED,INTERVENTIONAL,The device did not work well enough in its current form to continue the study.
NCT02763254,TERMINATED,INTERVENTIONAL,Insufficient recruitment rate
NCT02763384,TERMINATED,INTERVENTIONAL,Low accrual
NCT02763644,TERMINATED,INTERVENTIONAL,"LFG316, had been studied in seven patients with transplantation-associated microangiopathy. Due to low confidence of clinical benefit, this study was closed."
NCT02763761,WITHDRAWN,INTERVENTIONAL,Insufficient enrollment
NCT02763813,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02764086,TERMINATED,INTERVENTIONAL,Accrual lower than anticipated and not expected to improve
NCT02764151,TERMINATED,INTERVENTIONAL,Sponsor decided to prematurely terminate the study and not to pursue marketing approval for the indication of malignant glioma.
NCT02764164,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02764229,TERMINATED,INTERVENTIONAL,Lack of efficacy of test drug
NCT02764411,TERMINATED,INTERVENTIONAL,"Poor enrollment, lack of feasibility"
NCT02764476,TERMINATED,INTERVENTIONAL,COVID emergency
NCT02764528,WITHDRAWN,INTERVENTIONAL,Donor altered priorities for available funding and eliminated the project
NCT02764736,WITHDRAWN,INTERVENTIONAL,Enrollment did not progress as anticipated. No participants enrolled.
NCT02765165,TERMINATED,INTERVENTIONAL,Business reasons not related to safety
NCT02765386,TERMINATED,INTERVENTIONAL,"After several years of trying to recruit participants, it was decided to stop the study after recruiting only 12 participants."
NCT02765425,WITHDRAWN,INTERVENTIONAL,Loss of department staff and COVID
NCT02765516,TERMINATED,INTERVENTIONAL,Inability to recruit
NCT02765737,TERMINATED,INTERVENTIONAL,"Slow enrollment, issues with inclusion/exclusion and choice of control"
NCT02765750,TERMINATED,INTERVENTIONAL,The primary investigator was transferred to another hospital
NCT02765815,WITHDRAWN,INTERVENTIONAL,competing protocol
NCT02765997,WITHDRAWN,INTERVENTIONAL,IRB Disapproval
NCT02766075,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02766140,TERMINATED,INTERVENTIONAL,difficulty in recruitment
NCT02766153,TERMINATED,OBSERVATIONAL,the investigator has left the hospital
NCT02766322,TERMINATED,OBSERVATIONAL,"Recruitment affected by COVID, then grant ended"
NCT02766478,TERMINATED,INTERVENTIONAL,Enrollment and study activities were suspended due to COVID-19.
NCT02766842,WITHDRAWN,INTERVENTIONAL,The reason was the fact that the ProCore needle was removed from clinical use
NCT02767024,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT02767232,WITHDRAWN,INTERVENTIONAL,Did not receive NIH Funding
NCT02767518,TERMINATED,INTERVENTIONAL,Transfer of main study team to another institution
NCT02767570,TERMINATED,INTERVENTIONAL,Study data collection was terminated due to COVID-19 pandemic and will not resume.
NCT02767596,TERMINATED,INTERVENTIONAL,Insufficient recruitment rate
NCT02767648,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT02767752,TERMINATED,INTERVENTIONAL,Poor accrual and change of SOC (FOLFIRINOX in adjuvant setting)
NCT02767778,TERMINATED,INTERVENTIONAL,Interim analysis showed positive results
NCT02767830,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02767843,TERMINATED,INTERVENTIONAL,Recruiting sufficient number of qualified subjects proved impossible.
NCT02767856,TERMINATED,INTERVENTIONAL,PI changed the institution.
NCT02767895,TERMINATED,INTERVENTIONAL,Difficulty with enrollment and change in available study resources
NCT02767921,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT02767934,TERMINATED,INTERVENTIONAL,Terminated due to lack of efficacy
NCT02768012,WITHDRAWN,INTERVENTIONAL,Potential participants to date all had etiological factors for their sexual dysfunction additional to the antidepressant. Thus they all had exclusion criterior
NCT02768051,WITHDRAWN,INTERVENTIONAL,Business decision of the management
NCT02768090,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT02768220,WITHDRAWN,INTERVENTIONAL,no funding
NCT02768337,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02768532,TERMINATED,INTERVENTIONAL,low inclusion rates
NCT02768558,TERMINATED,INTERVENTIONAL,Another treatment found efficacious
NCT02768662,TERMINATED,INTERVENTIONAL,Negative Efficacy Results from the recently completed Phase 3 study 104-201506
NCT02768714,WITHDRAWN,INTERVENTIONAL,Strategic changes regarding the product development
NCT02769000,TERMINATED,INTERVENTIONAL,"The study was suspended in March of 2020 due to COVID. Rather than reopen the study, the decision was made to terminate it in July of 2021."
NCT02769065,TERMINATED,INTERVENTIONAL,Terminated prematurely as data from cohort no longer needed due to indication change.
NCT02769091,WITHDRAWN,INTERVENTIONAL,Business decision
NCT02769130,SUSPENDED,INTERVENTIONAL,"Due to Health Canada losartan recall, a new formulation being added to the protocol/ temporary suspension"
NCT02769169,TERMINATED,INTERVENTIONAL,study protocol changed
NCT02769351,TERMINATED,OBSERVATIONAL,It was decided to prematurely terminate the GENTLE-UF registry as a parallel study conducted with the same device has been prematurely terminated due to low recruitment.
NCT02769494,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT02769611,WITHDRAWN,INTERVENTIONAL,No funding
NCT02769624,TERMINATED,INTERVENTIONAL,Study was stopped early due to inability to recruit additional participants
NCT02769637,TERMINATED,OBSERVATIONAL,unable to meet the target enrollment goal
NCT02769806,TERMINATED,OBSERVATIONAL,funding
NCT02769871,TERMINATED,INTERVENTIONAL,Loss of team members.
NCT02770014,TERMINATED,INTERVENTIONAL,Terminated due to Osimertinib approval
NCT02770183,WITHDRAWN,OBSERVATIONAL,Problems with grant
NCT02770300,TERMINATED,INTERVENTIONAL,"The study was prematurely terminated by the sponsor in both centers because the recruitment in the two centers was slow, and it stopped during COVID period."
NCT02770443,TERMINATED,INTERVENTIONAL,Study closed to recruitment early as endpoints were reached on several participants
NCT02770703,TERMINATED,INTERVENTIONAL,"USB is responsible party on behalf of the principal investigator (PI). As PI cannot be tracked (lost to follow-up), the USB as ""sponsor"" set ""overall recruitment status"" unless the PI can be identified or tracked."
NCT02770755,WITHDRAWN,OBSERVATIONAL,Corporate decision
NCT02770820,TERMINATED,INTERVENTIONAL,Terminated due to funding difficulties
NCT02770989,TERMINATED,INTERVENTIONAL,Design change
NCT02771158,WITHDRAWN,INTERVENTIONAL,Study never started
NCT02771444,TERMINATED,INTERVENTIONAL,"Decision by sponsor, development stopped."
NCT02771626,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT02771730,TERMINATED,INTERVENTIONAL,Study endpoints not met.
NCT02771769,TERMINATED,OBSERVATIONAL,Data review
NCT02771795,TERMINATED,OBSERVATIONAL,"Considering the life-threatening risk posed by COVID-19 disease to a fragile population, the Sponsor concluded that the benefit of continuing the study does not outweigh the risk to the safety of patients \& site staffs."
NCT02771925,TERMINATED,INTERVENTIONAL,Due to poor compliance of patients in the study.
NCT02772081,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02772120,WITHDRAWN,INTERVENTIONAL,"Before enrollment, suspended due to changing insurance coverage of study drugs."
NCT02772146,TERMINATED,INTERVENTIONAL,After 2 patients it was concluded that a large change in exclusion criteria and study design was needed to obtain the ojective for the study
NCT02772809,TERMINATED,INTERVENTIONAL,The robot was no longer available to the study.
NCT02772887,TERMINATED,INTERVENTIONAL,Inability to successfully recruit study participants
NCT02773498,TERMINATED,INTERVENTIONAL,procedure is too demanding
NCT02773550,TERMINATED,INTERVENTIONAL,Low recruiment.
NCT02773628,TERMINATED,INTERVENTIONAL,methodological concerns about study design
NCT02773732,TERMINATED,INTERVENTIONAL,slow enrollment
NCT02773771,WITHDRAWN,INTERVENTIONAL,"Per IRB submission history, submission declined and withdrawn. PI no longer at institution."
NCT02773888,SUSPENDED,INTERVENTIONAL,Recruitment temporarily held for site retraining
NCT02773966,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02774070,WITHDRAWN,INTERVENTIONAL,No financial support
NCT02774148,TERMINATED,INTERVENTIONAL,Proved difficult to consent patient population due to comorbidities
NCT02774291,TERMINATED,INTERVENTIONAL,Due to lack of accrual the study was formally terminated on 01-JUL-2020. Primary Completion and Study Completion Dates have been revised based accordingly based on respective definitions
NCT02774317,WITHDRAWN,INTERVENTIONAL,The clinical team couldn't recruit patients who met the criteria for enrollment
NCT02774512,WITHDRAWN,INTERVENTIONAL,none participant has been enrolled and recruited during the first year after competent autority autorisation.
NCT02774551,TERMINATED,INTERVENTIONAL,Closed for recruitment March 2020 due to the ongoing covid-19 situation and the termination of the study inclusion was done in August 2020.
NCT02774603,TERMINATED,INTERVENTIONAL,Due to lack of funding the study was terminated early
NCT02774681,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02774811,TERMINATED,INTERVENTIONAL,Unable to maintain a functional laser in the environment
NCT02774863,TERMINATED,OBSERVATIONAL,Not enough inclusion
NCT02775006,TERMINATED,INTERVENTIONAL,"accrual to slow, target not achievable"
NCT02775149,SUSPENDED,OBSERVATIONAL,No participants
NCT02775188,WITHDRAWN,INTERVENTIONAL,"Because of technical and feasibility issues with InterACTION, the study to investigate the system for individuals following ACL reconstruction was terminated."
NCT02775214,TERMINATED,INTERVENTIONAL,"Change in staffing structure, no longer fit original study design"
NCT02775422,TERMINATED,INTERVENTIONAL,Low inclusion rate.
NCT02775448,TERMINATED,INTERVENTIONAL,Difficulties in recruiting process
NCT02775487,WITHDRAWN,OBSERVATIONAL,Withdrawn before IRB review. Investigator no longer working at facility.
NCT02775760,TERMINATED,INTERVENTIONAL,"Suspended due to Covid-19 policies, then terminated."
NCT02775799,TERMINATED,OBSERVATIONAL,Principal Investigator has left the Institution
NCT02776111,TERMINATED,OBSERVATIONAL,Funding
NCT02776475,TERMINATED,INTERVENTIONAL,difficult to find eligible patients for enrolling
NCT02776488,WITHDRAWN,INTERVENTIONAL,The manufacturer of sodium lactate has stopped making the medication
NCT02776618,WITHDRAWN,INTERVENTIONAL,could not and did not recruit any participants
NCT02776800,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT02776891,WITHDRAWN,INTERVENTIONAL,Unexpected dose production issues prevented study start up
NCT02777164,TERMINATED,INTERVENTIONAL,"Sponsor decision, not safety related"
NCT02777190,TERMINATED,INTERVENTIONAL,Insufficient research staff to recruit and complete study
NCT02777255,WITHDRAWN,OBSERVATIONAL,PI left University
NCT02777489,TERMINATED,INTERVENTIONAL,Unproven hypothesis
NCT02777762,WITHDRAWN,INTERVENTIONAL,Lack of resources
NCT02778048,SUSPENDED,OBSERVATIONAL,Funding problems
NCT02778295,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT02778412,TERMINATED,OBSERVATIONAL,Preliminary results indicated that this test had a number of false-negative results.
NCT02778477,TERMINATED,INTERVENTIONAL,Preliminary analysis of accrued data failed to indicate any meaningful pharmacodynamic response.
NCT02778529,TERMINATED,INTERVENTIONAL,Equipment Failure
NCT02778997,SUSPENDED,OBSERVATIONAL,Responsible investigator left the team. Suspended until replacement is found.
NCT02779023,TERMINATED,INTERVENTIONAL,Methodology of subject enrollment would require significant modification.
NCT02779153,WITHDRAWN,INTERVENTIONAL,closed in agreement of the sponsor and institution due to lack of patient accrual.
NCT02779257,WITHDRAWN,INTERVENTIONAL,Subject passed away prior to enrollment
NCT02779621,WITHDRAWN,INTERVENTIONAL,Due to Chief Investigator relocating out of the United Kingdom.
NCT02779686,TERMINATED,OBSERVATIONAL,Investigator left institution
NCT02779777,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02779803,WITHDRAWN,OBSERVATIONAL,"The study team has made the decision to close this study at this time. No patient data was collected and/or analyzed. Since there was no study funds, contracts and budgets were unable to be drafted and sent to participating sites."
NCT02779816,TERMINATED,INTERVENTIONAL,"Lack of sufficient recruitment, other priorities"
NCT02780011,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02780128,TERMINATED,INTERVENTIONAL,"The goals of Part 1 (molecular screening) were met, but lack of therapies to match molecular aberrations made Part 2 (treatment) no longer feasible."
NCT02780180,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT02780479,TERMINATED,INTERVENTIONAL,insufficient number of participants met the enrollment criteria.
NCT02780518,WITHDRAWN,INTERVENTIONAL,"Airvo 2 not suitable for CO2 clearance, awaiting Optiflow THRIVE machine"
NCT02780700,TERMINATED,INTERVENTIONAL,Substance discontinued
NCT02780791,TERMINATED,INTERVENTIONAL,Insufficient recruited participants due to a lack of collaborating study centers
NCT02780830,WITHDRAWN,INTERVENTIONAL,Study D2276C00001 was not started. No patients were enrolled. The sponsor decided to pursue an alternate design.
NCT02780882,WITHDRAWN,INTERVENTIONAL,"Due to stringent inclusion/exclusion criteria, study investigator deemed it not feasible."
NCT02781103,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02781363,WITHDRAWN,INTERVENTIONAL,The principal investigator left the center in 2016.
NCT02781467,TERMINATED,INTERVENTIONAL,Business Decision
NCT02781506,TERMINATED,INTERVENTIONAL,"Since the treatment landscape for metastatic kidney cancer changed, patients were not becoming eligible for this trial and therefore, the trial was terminated."
NCT02781636,TERMINATED,INTERVENTIONAL,Replaced by US RCT
NCT02782052,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT02782182,TERMINATED,INTERVENTIONAL,Closed early due to poor accrual.
NCT02782299,TERMINATED,INTERVENTIONAL,IRB closed project as the continuing review was not submitted. PI has left WU.
NCT02782325,TERMINATED,INTERVENTIONAL,Due low efficacy of FMT in interim analysis.
NCT02782403,TERMINATED,INTERVENTIONAL,Terminated per PI's request at the time of CR. Study was closed due to low/slow accrual due to other competing studies.
NCT02782481,WITHDRAWN,INTERVENTIONAL,Decision to change the study design
NCT02782559,WITHDRAWN,INTERVENTIONAL,difficulties acquiring the drug and funding for the drug
NCT02782689,TERMINATED,INTERVENTIONAL,difficulties in enrolling patients
NCT02782715,TERMINATED,INTERVENTIONAL,slow accrual
NCT02782871,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02783105,TERMINATED,INTERVENTIONAL,inclusion difficulties
NCT02783209,TERMINATED,INTERVENTIONAL,Major difficulties of patient inclusions
NCT02783404,TERMINATED,INTERVENTIONAL,Significant results (no control neither amoxicillin new arms needed)
NCT02783495,TERMINATED,INTERVENTIONAL,Funding
NCT02783547,WITHDRAWN,INTERVENTIONAL,The trial was withdrawn due to problems with the manufacture of the investigational drug.
NCT02783573,TERMINATED,INTERVENTIONAL,"An independent assessment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility."
NCT02783716,TERMINATED,INTERVENTIONAL,Due to COVID and staffing issues study was terminated
NCT02783911,TERMINATED,INTERVENTIONAL,The resident graduated.
NCT02784067,WITHDRAWN,INTERVENTIONAL,Clinical Trial Material
NCT02784418,WITHDRAWN,INTERVENTIONAL,Funding issues due to the pandemic
NCT02784431,TERMINATED,INTERVENTIONAL,To obtain clinical data in EU for CE Mark
NCT02784483,TERMINATED,INTERVENTIONAL,Based on FDA requirements
NCT02784691,WITHDRAWN,INTERVENTIONAL,Because of logistical problems
NCT02784730,WITHDRAWN,INTERVENTIONAL,Changes of the standard adjuvant treatment which does not allow an iterative PICC placement
NCT02784834,TERMINATED,INTERVENTIONAL,lack of funding
NCT02785003,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT02785029,TERMINATED,INTERVENTIONAL,difficulty in recruiting older subjects
NCT02785042,TERMINATED,INTERVENTIONAL,difficulty in recruiting older subjects
NCT02785120,SUSPENDED,INTERVENTIONAL,Suspended due to enrollment challenges and business operations.
NCT02785198,TERMINATED,INTERVENTIONAL,due to finalizing af phd project and fundings
NCT02785276,WITHDRAWN,INTERVENTIONAL,Study not initiated
NCT02785341,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02785432,TERMINATED,INTERVENTIONAL,Difficulty controlling for confounding factors
NCT02785692,TERMINATED,OBSERVATIONAL,Principal Investigator has left the Institution
NCT02785822,TERMINATED,INTERVENTIONAL,Difficulties in recruitment
NCT02785874,TERMINATED,INTERVENTIONAL,insufficient for the fund
NCT02785900,TERMINATED,INTERVENTIONAL,"Due to safety; specifically a higher rate of deaths, including fatal infections, in the SGN33A arm versus the control arm"
NCT02786563,WITHDRAWN,OBSERVATIONAL,Strategic considerations
NCT02786732,TERMINATED,INTERVENTIONAL,Sponsor
NCT02786979,TERMINATED,INTERVENTIONAL,"Upon interim analysis, sponsor's decision due to absence of demonstration of efficacy."
NCT02787083,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02787226,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02787356,WITHDRAWN,INTERVENTIONAL,Project was not funded by FDA
NCT02787421,WITHDRAWN,INTERVENTIONAL,Study withdrawn - changing study design.
NCT02787798,TERMINATED,INTERVENTIONAL,"Today Entresto treatment has marketing authorization and is available for all patients, that is the reason why study was halted prematurely."
NCT02787928,TERMINATED,INTERVENTIONAL,Lack of reliable supply of of preservative free IV Hydromorphone for intrathecal use.
NCT02787954,TERMINATED,OBSERVATIONAL,PI transferred to another institution and did not take this study with him.
NCT02788019,TERMINATED,INTERVENTIONAL,Unable to complete the sample size needed for 80% power due to changes in surgical approach to adductor block usage.
NCT02788097,TERMINATED,INTERVENTIONAL,Large and sustained difference in pregnancy rate
NCT02788123,TERMINATED,INTERVENTIONAL,Internal reassessment of the medicinal product development strategy by Sponsor
NCT02788149,WITHDRAWN,INTERVENTIONAL,Resources did not come to fruition
NCT02788214,TERMINATED,OBSERVATIONAL,research determined not to be human subject research
NCT02788318,TERMINATED,OBSERVATIONAL,difficulty recruiting patients
NCT02788578,TERMINATED,OBSERVATIONAL,The study terminated prematurely due to insufficient recruitment.
NCT02788591,TERMINATED,INTERVENTIONAL,lack of accrual
NCT02788656,TERMINATED,INTERVENTIONAL,Inadequate Recruitment
NCT02788760,TERMINATED,INTERVENTIONAL,Only 32 patients included in 21 months
NCT02789098,SUSPENDED,INTERVENTIONAL,Technical issues.
NCT02789267,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT02789397,WITHDRAWN,INTERVENTIONAL,No funding for study.
NCT02790034,TERMINATED,INTERVENTIONAL,The study did not demonstrate evidence of efficacy on the primary or secondary efficacy variables
NCT02790242,TERMINATED,OBSERVATIONAL,Lack of funding
NCT02790528,WITHDRAWN,INTERVENTIONAL,Funding issue
NCT02790632,TERMINATED,INTERVENTIONAL,DMC review concluded study has a low probability of meeting its primary endpoint
NCT02790710,WITHDRAWN,INTERVENTIONAL,Study has been withdrawn due to reconsideration of study design.
NCT02790736,TERMINATED,INTERVENTIONAL,COVID-19 restrictions
NCT02790957,TERMINATED,INTERVENTIONAL,Safety reasons
NCT02790996,TERMINATED,INTERVENTIONAL,Planned interim analysis yielded different event rate affecting sample size and ability to recruit sufficient numbers within remaining trial time frame
NCT02791191,TERMINATED,INTERVENTIONAL,Low likelihood of identifying a statistically significant treatment effect.
NCT02791425,TERMINATED,INTERVENTIONAL,The developer of the BCI left the institution so the study could not continue
NCT02791451,TERMINATED,INTERVENTIONAL,The device did not provide sufficient quality of data
NCT02791529,TERMINATED,INTERVENTIONAL,Intervention was inferior in pilot trial.
NCT02791555,TERMINATED,OBSERVATIONAL,Study was terminated early due to low enrollment numbers.
NCT02791867,TERMINATED,INTERVENTIONAL,The study drug was not provided resulting in termination for unacceptable delays
NCT02791906,TERMINATED,INTERVENTIONAL,lack of funding
NCT02791919,WITHDRAWN,INTERVENTIONAL,Other - Protocol moved to Disapproved
NCT02792153,WITHDRAWN,INTERVENTIONAL,The study was withdrawn after 18 months due to lack of recruitment.
NCT02792192,TERMINATED,INTERVENTIONAL,The study was terminated early as the study had met its goals of providing preliminary safety and efficacy information for atezolizumab monotherapy alone and in combination with BCG in NMIBC.
NCT02792413,TERMINATED,INTERVENTIONAL,Modified study and new deposit in RECHMPL21_0451
NCT02793102,WITHDRAWN,INTERVENTIONAL,Lack of patient responding to criteria
NCT02793154,TERMINATED,INTERVENTIONAL,Early termination due to insufficient enrollment.
NCT02793219,WITHDRAWN,INTERVENTIONAL,Dendreon was sold and new company decided not to fund study.
NCT02793349,TERMINATED,INTERVENTIONAL,Company have withdrawn the product
NCT02793531,WITHDRAWN,INTERVENTIONAL,low enrollment potential in local community
NCT02793583,TERMINATED,INTERVENTIONAL,Strategic/Business Decision
NCT02793765,WITHDRAWN,INTERVENTIONAL,Dendreon was sold and new company decided not to fund study.
NCT02793778,TERMINATED,INTERVENTIONAL,enrollment
NCT02793895,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT02794142,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT02794246,TERMINATED,INTERVENTIONAL,Study was terminated due to administrative reasons.
NCT02794467,WITHDRAWN,INTERVENTIONAL,Study was prematurely discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.
NCT02794519,WITHDRAWN,INTERVENTIONAL,This study has suspended participant recruitment.
NCT02794714,WITHDRAWN,INTERVENTIONAL,unresolved budget issues
NCT02795143,WITHDRAWN,INTERVENTIONAL,PI (Responsible Party) transferred to new institution prior to enrollment and protocol was closed.
NCT02795273,WITHDRAWN,INTERVENTIONAL,Decision made to stop study following availability of results from another study
NCT02795299,WITHDRAWN,INTERVENTIONAL,Study not started due to Sponsor decision to not move forward with compound.
NCT02795338,WITHDRAWN,OBSERVATIONAL,Project did not receive funding and was never started
NCT02795520,TERMINATED,INTERVENTIONAL,slow patient accrual
NCT02795572,TERMINATED,INTERVENTIONAL,Retirement of the Principal Investigator
NCT02795598,WITHDRAWN,INTERVENTIONAL,The study protocol changed significantly and a new file was started.
NCT02795715,WITHDRAWN,INTERVENTIONAL,Cessation of funding
NCT02795819,TERMINATED,INTERVENTIONAL,Study drug no longer being clinically developed by manufacturer
NCT02795884,WITHDRAWN,INTERVENTIONAL,Because of reconsideration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim
NCT02795975,TERMINATED,OBSERVATIONAL,Sponsor business decision
NCT02796066,WITHDRAWN,INTERVENTIONAL,Protocol not approved
NCT02796144,TERMINATED,INTERVENTIONAL,The FDA advised of a possible health risk associated with lorcaserin and the drug is being withdrawn.
NCT02796235,TERMINATED,INTERVENTIONAL,Difficulties of recruitment
NCT02796287,TERMINATED,INTERVENTIONAL,The principal investigator decided to stop the study.
NCT02796300,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study.
NCT02796352,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT02796495,WITHDRAWN,INTERVENTIONAL,Study has been completed in terms of duration but no patient has been recruited during this time
NCT02796521,TERMINATED,INTERVENTIONAL,no more budget for personal to enrol participants
NCT02796547,WITHDRAWN,INTERVENTIONAL,Lack of human ressources
NCT02796729,TERMINATED,INTERVENTIONAL,Not enough enrollment
NCT02797119,TERMINATED,INTERVENTIONAL,Study will be stopped due to the impossibility of reaching the objective of inclusions within a reasonable time frame and taking into account the recommendations of the international WOMAN study
NCT02797405,TERMINATED,INTERVENTIONAL,Withdrawal of analysis study Partner.
NCT02797418,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02797431,TERMINATED,INTERVENTIONAL,failure of supply of test product
NCT02797522,TERMINATED,INTERVENTIONAL,Company decision to discontinue trial
NCT02797704,TERMINATED,INTERVENTIONAL,the treatment was found to be inefficient for all recruited patients
NCT02798107,WITHDRAWN,OBSERVATIONAL,No recruitment
NCT02798393,TERMINATED,INTERVENTIONAL,Study blind compromised.
NCT02798601,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT02798900,WITHDRAWN,INTERVENTIONAL,We did not get funding to develop the clinical trial.
NCT02798939,TERMINATED,OBSERVATIONAL,investigator choice
NCT02799108,TERMINATED,INTERVENTIONAL,inclusion difficulty
NCT02799407,WITHDRAWN,INTERVENTIONAL,Never initiated.
NCT02799589,WITHDRAWN,INTERVENTIONAL,Difficulty in recruitment
NCT02799654,WITHDRAWN,OBSERVATIONAL,Change of organizational circumstances.
NCT02799823,TERMINATED,INTERVENTIONAL,HLT Business Decision
NCT02799836,WITHDRAWN,INTERVENTIONAL,"This study never started, did not receive IRB approval and was closed administratively at the site. Therefore, no subjects were recruited or enrolled."
NCT02799914,WITHDRAWN,OBSERVATIONAL,Difficult patient recruitment. No patients enrolled.
NCT02799966,TERMINATED,INTERVENTIONAL,"Collaborator, MyndTec, withdrew from the study due to lack of resources"
NCT02800044,TERMINATED,INTERVENTIONAL,Results were not accurate; despite multiple efforts to troubleshoot.
NCT02800083,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02800135,TERMINATED,INTERVENTIONAL,departure of the coordinating investigator from another institution
NCT02800889,WITHDRAWN,INTERVENTIONAL,Study withdrawn; no participants enrolled
NCT02801097,TERMINATED,INTERVENTIONAL,Sufficient patients enrolled to end study
NCT02801162,TERMINATED,INTERVENTIONAL,"To much effort needed, high costs for an academic study"
NCT02801487,TERMINATED,INTERVENTIONAL,Slow accrual of patients.
NCT02801617,TERMINATED,INTERVENTIONAL,expiration time limit of recruitment
NCT02801656,WITHDRAWN,INTERVENTIONAL,Not funded
NCT02801799,TERMINATED,INTERVENTIONAL,"The trial was comprised of two parts. After the first part we could repudiate our hypothesis. Thus, no reason to carry on with the second part of the trial."
NCT02802124,TERMINATED,INTERVENTIONAL,"For tumor locates away from GI the planned enrolled patient had been completed, but for tumor locates closely to GI only 6 patients had been enrolled because not many eligible patients were available."
NCT02802163,WITHDRAWN,INTERVENTIONAL,study drug unavailable
NCT02802176,TERMINATED,INTERVENTIONAL,Slow enrollment and completion of screening qualifiers.
NCT02802293,TERMINATED,INTERVENTIONAL,Study temporarily suspended due to COVID-19 pandemic then closed due to low enrollment numbers
NCT02802436,WITHDRAWN,INTERVENTIONAL,Administrative changes precluded enrollment.
NCT02802592,TERMINATED,INTERVENTIONAL,Loss of funding
NCT02802774,TERMINATED,INTERVENTIONAL,Not enough study participants
NCT02802995,TERMINATED,INTERVENTIONAL,Resource issue
NCT02803073,WITHDRAWN,INTERVENTIONAL,Subjects could not be recruited
NCT02803450,WITHDRAWN,INTERVENTIONAL,The protocol will be rewritten.
NCT02803489,TERMINATED,INTERVENTIONAL,inclusion rate too low \& investigators enable to recruit new patients rapidly
NCT02803632,TERMINATED,INTERVENTIONAL,recruitment problem
NCT02804087,TERMINATED,INTERVENTIONAL,"Due to the rigorous nature of the trial and enrollment interruptions caused by COVID-19, the study enrolled only 4 of the planned 110 subjects. Due to the lack of enrollment, the study was closed."
NCT02804789,TERMINATED,OBSERVATIONAL,"No further funding available, remaining visits halted due to threat of Covid 19"
NCT02804997,TERMINATED,OBSERVATIONAL,internal recruitment difficulties and reorganization of the Intensive Care Units
NCT02805127,TERMINATED,OBSERVATIONAL,Lower recruitment rate than expected
NCT02805452,TERMINATED,INTERVENTIONAL,Target of recruitment not reachable
NCT02805517,TERMINATED,INTERVENTIONAL,"Number of kidney donors decreased, not able to enroll subjects at this time"
NCT02805660,TERMINATED,INTERVENTIONAL,The study was discontinued early because the Sponsor de-prioritized development of mocetinostat. The decision to stop was not due to any patient safety issues.
NCT02805764,WITHDRAWN,INTERVENTIONAL,No suitable candidates
NCT02805777,WITHDRAWN,INTERVENTIONAL,Study not required due to change in device
NCT02805868,WITHDRAWN,INTERVENTIONAL,Funding
NCT02805894,TERMINATED,INTERVENTIONAL,Prostate cancer treatment has greatly changed since the initiation of this trial and therefore we have stopped this trial to allow for further evaluation of the treatment landscape
NCT02806141,TERMINATED,INTERVENTIONAL,No patient included at target sample sizes
NCT02806167,WITHDRAWN,INTERVENTIONAL,Ethical approval declined
NCT02806362,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT02806726,TERMINATED,INTERVENTIONAL,Decision to discontinue product development at this time
NCT02806765,WITHDRAWN,INTERVENTIONAL,"Screened 34 participants and only 3 participants met the inclusion criteria, the study was stopped and screening data will be analyzed for associations."
NCT02806843,SUSPENDED,INTERVENTIONAL,Study stopped due resource interruption.
NCT02806960,TERMINATED,INTERVENTIONAL,Drug delivery was below target dose due to partial obstruction by aggregated particles.
NCT02807454,TERMINATED,INTERVENTIONAL,Health Authority request due to class effect
NCT02807467,TERMINATED,INTERVENTIONAL,insufficient recruitment over a long period
NCT02807571,WITHDRAWN,OBSERVATIONAL,Study underwent major protocol changes prior to planned enrollment
NCT02807753,TERMINATED,OBSERVATIONAL,Sponsor funding ended
NCT02807792,WITHDRAWN,INTERVENTIONAL,No funding
NCT02807961,TERMINATED,INTERVENTIONAL,"Transferred study to Antwerp, Belgium"
NCT02808052,TERMINATED,INTERVENTIONAL,Sponsor decision due to change in strategy
NCT02808091,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02808247,TERMINATED,INTERVENTIONAL,Exceed of pre-specified number of failures in the experimental arm
NCT02808390,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02808429,TERMINATED,INTERVENTIONAL,Study was terminated early as per sponsor decision due to unexpectedly slow enrollment.
NCT02808676,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic, in-person interventions/assessments no longer possible."
NCT02808806,TERMINATED,INTERVENTIONAL,technical difficulties
NCT02809118,TERMINATED,INTERVENTIONAL,Availability of relevant new efficacy data from another study
NCT02809248,WITHDRAWN,INTERVENTIONAL,"Due to the small number of patients, none could be included in the study."
NCT02809690,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02809703,WITHDRAWN,OBSERVATIONAL,PI departed study site. Study closed.
NCT02809755,WITHDRAWN,INTERVENTIONAL,"While 33 people signed consent, no one was enrolled in the study, because none of these patients developed shoulder pain in the recovery room."
NCT02809846,TERMINATED,INTERVENTIONAL,Unable to recruit enough participants.
NCT02810067,WITHDRAWN,INTERVENTIONAL,Study was dropped and never started.
NCT02810613,WITHDRAWN,OBSERVATIONAL,Study never started.
NCT02810873,TERMINATED,INTERVENTIONAL,Study terminated by PI
NCT02810886,WITHDRAWN,INTERVENTIONAL,Recent publications demonstrating the clinical interest in performing 68Ga-PSMA for recurrence detection of prostate cancer patients with biochemical relapse
NCT02810951,TERMINATED,INTERVENTIONAL,Subjects were all in Long-Term Follow Up and were transferred to the ongoing EB-002 study
NCT02811094,TERMINATED,INTERVENTIONAL,COVID situation
NCT02811133,WITHDRAWN,INTERVENTIONAL,Funding terminated
NCT02811159,TERMINATED,INTERVENTIONAL,Business decision
NCT02811315,WITHDRAWN,OBSERVATIONAL,Lack of interest
NCT02811484,WITHDRAWN,INTERVENTIONAL,"Inability to enroll due to the widespread use of both classes of drugs in patients with T2DM, including those on concomitant insulin therapy."
NCT02811744,TERMINATED,INTERVENTIONAL,Funding issues.
NCT02811783,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02811809,WITHDRAWN,INTERVENTIONAL,"Withdrawn due to operational issues. The study was withdrawn early, before enrolling its first participant."
NCT02811887,TERMINATED,INTERVENTIONAL,Slow recruitment of study participants
NCT02812030,WITHDRAWN,OBSERVATIONAL,Superceded by a larger trial by the pharmaceutical company
NCT02812069,WITHDRAWN,INTERVENTIONAL,Safety issue
NCT02812082,WITHDRAWN,INTERVENTIONAL,The PI is leaving MSK.
NCT02812368,WITHDRAWN,INTERVENTIONAL,Failure to recruit
NCT02812407,WITHDRAWN,INTERVENTIONAL,No linger a clinically relevant research question
NCT02812693,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT02812719,WITHDRAWN,INTERVENTIONAL,Study did not receive funding and will not be implemented.
NCT02812849,WITHDRAWN,OBSERVATIONAL,Logistic reasons
NCT02812862,WITHDRAWN,INTERVENTIONAL,Rationale obsolete
NCT02813369,TERMINATED,OBSERVATIONAL,Not feasible to reach the required number of patient cases by the defined end of data collection milestone (Q4 2022) knowing that the study completion was planned by the end of 2023
NCT02813447,TERMINATED,INTERVENTIONAL,COVID-19 hold
NCT02813577,TERMINATED,INTERVENTIONAL,FDA allowed other data to be leveraged to meet the study requirements
NCT02813590,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT02813655,TERMINATED,INTERVENTIONAL,"Interim analysis and decision of the independent committee, investigators and sponsor (futility) (2023/10/05)"
NCT02813902,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT02814019,TERMINATED,INTERVENTIONAL,Interim analysis concluded to futility
NCT02814318,TERMINATED,OBSERVATIONAL,Ancef (Cefazolin) became the new standard of care (instead of Vancomycin) for GBS prophylaxis if the patient is allergic to penicillin.
NCT02814344,TERMINATED,OBSERVATIONAL,Investigator choice
NCT02814578,TERMINATED,INTERVENTIONAL,OCT cost is high
NCT02814786,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT02815059,WITHDRAWN,INTERVENTIONAL,Termination of Investigator Initiated Studies using Ibrutinib
NCT02815111,WITHDRAWN,OBSERVATIONAL,Not IRB approved
NCT02815124,WITHDRAWN,INTERVENTIONAL,No funding secured and staffing changes resulting in no personnel to assist with study tasks.
NCT02815397,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02815462,WITHDRAWN,INTERVENTIONAL,Unable to secure grant funding
NCT02815488,TERMINATED,INTERVENTIONAL,Very poor recruitment in the Part 4 of the study
NCT02815501,WITHDRAWN,OBSERVATIONAL,Investigator choice
NCT02815540,TERMINATED,INTERVENTIONAL,"Investigator no longer at institution, and difficult recruitment; study will not resume"
NCT02816255,TERMINATED,INTERVENTIONAL,Due to budget and staff changes due to covid-19.
NCT02816333,WITHDRAWN,OBSERVATIONAL,"Due to the withdrawal of Gore Korea Co.Ltd., manufacturer of medical device, it is impossible to supply the medical device(C-TAG)."
NCT02816437,WITHDRAWN,INTERVENTIONAL,safety
NCT02816788,TERMINATED,INTERVENTIONAL,"Variety of issues, including imminent retirement of principal investigator."
NCT02817113,TERMINATED,INTERVENTIONAL,Strategy change
NCT02817165,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02817347,TERMINATED,INTERVENTIONAL,Sponsor's decision for the Drug Development.
NCT02817412,TERMINATED,INTERVENTIONAL,Principle investigator (Sylvia Herbozo) left the university.
NCT02817529,WITHDRAWN,INTERVENTIONAL,Manufacture didn't provide enough information for submitting IRB approval
NCT02817672,WITHDRAWN,INTERVENTIONAL,The dataset was not strong enough to do NLP analysis.
NCT02817815,TERMINATED,INTERVENTIONAL,Departure and non-replacement of the person in charge of the biological examinations specific to research carried out within the LIRYC IHU.
NCT02817906,TERMINATED,INTERVENTIONAL,Pre-specified Interim Analysis Indicated Futility
NCT02818023,TERMINATED,INTERVENTIONAL,Accrual to trial stopped due to high toxicity even at lowest dose of combination treatment. Patients on trial tolerating treatment at time of accrual closure still continued to receive treatment.
NCT02818049,TERMINATED,INTERVENTIONAL,Not enough patient
NCT02818088,TERMINATED,INTERVENTIONAL,The app platform was cancelled and key personnel withdrew from the project
NCT02818283,TERMINATED,INTERVENTIONAL,lack of recruitment and funding
NCT02818530,TERMINATED,INTERVENTIONAL,Two patients developed corneal laceration and hence study re-reviewed by IEC and decided to terminate the study prematurely
NCT02818764,TERMINATED,OBSERVATIONAL,COVID related limitations
NCT02818894,TERMINATED,INTERVENTIONAL,"This study was terminated due to pressing matters related to the COVID-19 pandemic - staff shortages and changes of personnel, data gaps due to the pandemic, participants not being able to continue follow-up visits, and ongoing enrollment issues."
NCT02818946,TERMINATED,INTERVENTIONAL,low enrollment
NCT02818959,TERMINATED,INTERVENTIONAL,Due to inability to recruit sufficient sample size in reasonable time frame.
NCT02819544,WITHDRAWN,INTERVENTIONAL,investigator choice
NCT02819752,TERMINATED,INTERVENTIONAL,funding pulled
NCT02819804,TERMINATED,INTERVENTIONAL,Due to funding and accrual issues
NCT02819817,WITHDRAWN,INTERVENTIONAL,MHRA CTA rejected due to no UK MHRA MA certificate or equivalent product info
NCT02819869,TERMINATED,INTERVENTIONAL,insufficient for the fund
NCT02819921,TERMINATED,INTERVENTIONAL,Difficulty in Recruiting Research Participants
NCT02819999,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT02820077,TERMINATED,INTERVENTIONAL,Global recall of Hemospray
NCT02820194,TERMINATED,INTERVENTIONAL,not sufficient patient recruited
NCT02820493,WITHDRAWN,INTERVENTIONAL,Internal problems
NCT02820519,TERMINATED,INTERVENTIONAL,Intolerable high amount of adverse events
NCT02820740,TERMINATED,INTERVENTIONAL,Terminated (failure to enroll)
NCT02820766,TERMINATED,OBSERVATIONAL,Logistics of study did not allow for consistent data collection
NCT02820831,TERMINATED,OBSERVATIONAL,Slow inclusion
NCT02821039,TERMINATED,OBSERVATIONAL,"We decided to complete our research in the 4th year, and publish the data. The data are under evaluation."
NCT02821091,TERMINATED,INTERVENTIONAL,Limitaiotn of financial support
NCT02821143,WITHDRAWN,INTERVENTIONAL,Realization not possible
NCT02821364,WITHDRAWN,INTERVENTIONAL,The study was not feasible due to logistical elements
NCT02821533,TERMINATED,INTERVENTIONAL,Poor case accrual
NCT02821650,TERMINATED,INTERVENTIONAL,"Because of COVID-19, we could complete the follow-ups"
NCT02821819,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT02822196,WITHDRAWN,INTERVENTIONAL,Critical study personnel left the institution
NCT02822482,TERMINATED,INTERVENTIONAL,futilty of the treatment
NCT02822716,TERMINATED,INTERVENTIONAL,poor case accural
NCT02822755,TERMINATED,INTERVENTIONAL,Data collection sites lost research personnel that were recruiting subjects.
NCT02822963,WITHDRAWN,OBSERVATIONAL,No funding
NCT02823106,WITHDRAWN,INTERVENTIONAL,Study put on clinical hold by FDA. Sponsor decided to no pursue the study.
NCT02823158,TERMINATED,INTERVENTIONAL,not enough patients
NCT02823262,TERMINATED,INTERVENTIONAL,Did not receive funding for the trial.
NCT02823275,TERMINATED,INTERVENTIONAL,Investigator changed jobs
NCT02823327,TERMINATED,OBSERVATIONAL,Poor accrual
NCT02823470,TERMINATED,INTERVENTIONAL,Study terminated early due to slow recruitment of patients.
NCT02823873,WITHDRAWN,OBSERVATIONAL,Study submitted in error
NCT02823977,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT02824211,WITHDRAWN,INTERVENTIONAL,Was unable to obtain funding
NCT02824354,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT02824445,TERMINATED,INTERVENTIONAL,Due to permanant change of stations of investigators.
NCT02824575,TERMINATED,INTERVENTIONAL,"Unfortunately, Deciphera management decided to not move forward with the rebastinib program and are terminating early."
NCT02824848,TERMINATED,INTERVENTIONAL,Study stopped due to COVID-19 pandemic and will not resume.
NCT02825043,TERMINATED,INTERVENTIONAL,Slow enrollment and unable to meet enrollment targets
NCT02825342,TERMINATED,INTERVENTIONAL,Primary endpoint was reached.
NCT02825446,TERMINATED,INTERVENTIONAL,a significant number of patients were not selected
NCT02825576,TERMINATED,INTERVENTIONAL,Lack of Study Personnel
NCT02825719,TERMINATED,INTERVENTIONAL,Ulipristal was withdrawal from the market
NCT02825810,WITHDRAWN,INTERVENTIONAL,"No funding issues, poor prevalence of low cervical motor control"
NCT02825849,TERMINATED,INTERVENTIONAL,Low recruitment and competing studies have published.
NCT02825901,WITHDRAWN,INTERVENTIONAL,"Due to company policy, the development of this product is suspended."
NCT02826161,TERMINATED,INTERVENTIONAL,Change of treatment landscape and evolving standard of care
NCT02826473,TERMINATED,INTERVENTIONAL,Insufficient enrollment of eligible patients
NCT02826512,TERMINATED,INTERVENTIONAL,"Not enough eligble patient can be found, too many screen failures"
NCT02826538,TERMINATED,INTERVENTIONAL,difficulties recruiting participants
NCT02826551,TERMINATED,INTERVENTIONAL,Not enough data.
NCT02826655,TERMINATED,INTERVENTIONAL,lack of funding
NCT02826681,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02826967,TERMINATED,INTERVENTIONAL,COVID-19 institutional restrictions on screening colonoscopies
NCT02827058,TERMINATED,INTERVENTIONAL,due to difficulties recruiting patients and therefore too slow progress
NCT02827279,TERMINATED,INTERVENTIONAL,end of inclusion period
NCT02827539,WITHDRAWN,INTERVENTIONAL,Change in resources to support study activities
NCT02827552,TERMINATED,INTERVENTIONAL,"The liquidation of our industrial partner NEOLYS Diagnostics, directly involved in the methodology of the study and a sub-optimal rate of inclusions which did not allow us to include all patient within the allotted time."
NCT02827747,WITHDRAWN,INTERVENTIONAL,Not enough participant interest.
NCT02828059,WITHDRAWN,OBSERVATIONAL,changed drug approval
NCT02828124,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT02828761,WITHDRAWN,INTERVENTIONAL,Study never initiated and formally withdrawn with the IRB on 9/14/2023.
NCT02828787,TERMINATED,INTERVENTIONAL,End of the inclusion period. A late start of inclusions and reduced scanner availability meant that the number of 45 participants could not be reached.
NCT02828800,TERMINATED,OBSERVATIONAL,investigator choice
NCT02828826,TERMINATED,INTERVENTIONAL,inclusion deficiency
NCT02828891,WITHDRAWN,INTERVENTIONAL,This study is being closed due to the inability to acquire the required technology to complete the study
NCT02829047,TERMINATED,INTERVENTIONAL,Study halted at interim analysis to allow the sponsor to focus on a new study with different design.
NCT02829242,TERMINATED,OBSERVATIONAL,No sufficient patient recruitment
NCT02829372,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
NCT02829749,WITHDRAWN,INTERVENTIONAL,Because of dynamics in the field of minimal invasive mitral repair and the development of newer devices
NCT02829814,TERMINATED,INTERVENTIONAL,"For business reason unrelated to safety or tolerability,Tonix has discontinued the Fibromyalgia development with TNX102 SL."
NCT02829827,TERMINATED,INTERVENTIONAL,"After reviewing the feasibility and projected completion date of the study, UCB has made the decision to stop the study"
NCT02830087,TERMINATED,INTERVENTIONAL,No patient follow-up
NCT02830100,TERMINATED,INTERVENTIONAL,no more subjects for recrutment
NCT02830334,TERMINATED,OBSERVATIONAL,this study was determined by IRB not to be humans subjects research
NCT02830412,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT02830438,TERMINATED,INTERVENTIONAL,Not enough participants recruited
NCT02830698,TERMINATED,OBSERVATIONAL,Recruitment difficulties.
NCT02831179,WITHDRAWN,INTERVENTIONAL,Loss of funding support
NCT02831205,TERMINATED,INTERVENTIONAL,Due to current BVS safety issue
NCT02831218,TERMINATED,INTERVENTIONAL,This study was merged into HOWTO-BRS study.
NCT02831491,WITHDRAWN,INTERVENTIONAL,To pursue broader program objectives in oncology.
NCT02831595,TERMINATED,OBSERVATIONAL,Enrollment stopped for missing availability of the site
NCT02831933,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02832050,WITHDRAWN,INTERVENTIONAL,"3 participants screened, all failed screening process"
NCT02832323,TERMINATED,INTERVENTIONAL,inclusion difficulties
NCT02832531,WITHDRAWN,INTERVENTIONAL,Focus on recruitment for non-inferiority trial
NCT02832687,TERMINATED,INTERVENTIONAL,The study was halted due to the worldwide COVID-19 pandemic and the cancellation of all elective cases.
NCT02832752,TERMINATED,INTERVENTIONAL,Due to changes in Hospital Protocols and COVID-19
NCT02832895,TERMINATED,INTERVENTIONAL,Conducting an interim analysis that allowed with the number of patients included of 150 to meet the objectives of this research
NCT02833207,TERMINATED,INTERVENTIONAL,"Due to COVID-19, difficulty obtaining study drugs, difficulty recruiting obese subjects, and limited access to on-call physicians."
NCT02833506,WITHDRAWN,INTERVENTIONAL,production of adjuvant to be used with vaccine was discontinued by sponsor
NCT02833766,TERMINATED,INTERVENTIONAL,the trial was prematurely terminated as per SAKK board decision from 14th of November 2020. The trial is to be terminated after primary endpoint is reached.
NCT02834247,TERMINATED,INTERVENTIONAL,Insufficient efficacy of drug; no safety concern
NCT02834455,TERMINATED,INTERVENTIONAL,Patient inclusion cannot be reached within timelimits
NCT02834481,TERMINATED,INTERVENTIONAL,too complicated recruitment
NCT02834754,WITHDRAWN,INTERVENTIONAL,Limited time for enrollment of required number of subjects
NCT02834793,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT02834819,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT02834975,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT02835001,TERMINATED,INTERVENTIONAL,change of technique
NCT02835144,TERMINATED,INTERVENTIONAL,Personnel changes; insufficient resources to continue
NCT02835209,WITHDRAWN,OBSERVATIONAL,Change in clinical practice that logistically prevented this study from being engaged.
NCT02835352,TERMINATED,INTERVENTIONAL,Too slow recruitment and study data to be recorded not available.
NCT02835417,TERMINATED,OBSERVATIONAL,This study is terminated because of problems wtih the society responsible of the data base.
NCT02835482,TERMINATED,INTERVENTIONAL,Difficulties encountered with patients inclusion and femtolaser availability
NCT02835599,TERMINATED,OBSERVATIONAL,The study sponsor requested the study be terminated as the existing study design did not meet their needs.
NCT02835794,WITHDRAWN,INTERVENTIONAL,Lack of funding to support clinical trial
NCT02836340,TERMINATED,INTERVENTIONAL,Inclusion of patients slow
NCT02836353,TERMINATED,INTERVENTIONAL,"Reached scientific goals, further recruitment would not further advance the findings of study."
NCT02837042,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02837159,WITHDRAWN,INTERVENTIONAL,removal of the Phd student due to not obtaining financing
NCT02837185,TERMINATED,INTERVENTIONAL,Inability to recruit controls and limited research staff to complete project.
NCT02837393,TERMINATED,OBSERVATIONAL,Low Recruitment and Enrollment
NCT02837523,WITHDRAWN,OBSERVATIONAL,No longer pursued
NCT02837562,WITHDRAWN,OBSERVATIONAL,0
NCT02837757,TERMINATED,INTERVENTIONAL,difficulty of patient recruitment
NCT02837783,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT02837913,TERMINATED,INTERVENTIONAL,Difficulty recruiting study subjects
NCT02837991,TERMINATED,INTERVENTIONAL,Development of CDX-014 discontinued
NCT02838017,TERMINATED,INTERVENTIONAL,"Based on results of an interim analysis, the study was halted for futility"
NCT02838030,SUSPENDED,INTERVENTIONAL,COVID-19 pandemic
NCT02838108,TERMINATED,OBSERVATIONAL,Sponsor Decision to Stop Recruitment
NCT02838355,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT02838563,TERMINATED,OBSERVATIONAL,no new location to open
NCT02838745,TERMINATED,INTERVENTIONAL,Change in research plan.
NCT02838966,TERMINATED,INTERVENTIONAL,Sponsor did not want to supply further product
NCT02839031,TERMINATED,INTERVENTIONAL,Recruitment difficulties (study stopped before the expected 80 inclusions)
NCT02839447,WITHDRAWN,OBSERVATIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT02839499,TERMINATED,INTERVENTIONAL,physician's departure
NCT02839603,TERMINATED,OBSERVATIONAL,"Aim to assess feasibility achieved, larger project starting earlier than anticipated"
NCT02839681,TERMINATED,INTERVENTIONAL,"Due to slow, insufficient accrual."
NCT02839785,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02839798,TERMINATED,INTERVENTIONAL,Lack of funding and staffing
NCT02839889,TERMINATED,INTERVENTIONAL,The study was stopped due to challenges recruiting eligible patients.
NCT02840032,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT02840084,TERMINATED,INTERVENTIONAL,adverse event
NCT02840110,TERMINATED,OBSERVATIONAL,Business Decision
NCT02840136,TERMINATED,INTERVENTIONAL,Lack of staff
NCT02840162,TERMINATED,INTERVENTIONAL,Drug safety concerns
NCT02840214,WITHDRAWN,INTERVENTIONAL,Study was never initiated.
NCT02840513,TERMINATED,INTERVENTIONAL,Due to insufficient patient recruitment and lack of funding
NCT02840591,WITHDRAWN,INTERVENTIONAL,"Stopped the study due to feasibility issues, no enrollment has taken place."
NCT02840825,TERMINATED,OBSERVATIONAL,Technical issues with microchip
NCT02840929,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02841020,WITHDRAWN,INTERVENTIONAL,Funding for study fell through
NCT02841176,TERMINATED,INTERVENTIONAL,The study was stopped due to resourcing issues.
NCT02841332,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02841540,TERMINATED,INTERVENTIONAL,The study was terminated after conducting an interim analysis of the available data where it became evident that the observed efficacy results were not in alignment with the initially set expectations.
NCT02841735,TERMINATED,OBSERVATIONAL,Protocol expired with IRB.
NCT02841878,WITHDRAWN,INTERVENTIONAL,Decision of the investigator
NCT02841891,TERMINATED,INTERVENTIONAL,Resource Constraints
NCT02841956,TERMINATED,INTERVENTIONAL,COVID-19
NCT02841969,SUSPENDED,INTERVENTIONAL,"Following consultation, neutral electrolysed water was deemed to be a medical device. A study amendment will re-submitted to NHS Ethics and the UK regulator (MHRA). These actions delayed due to the pandemic - expected to take place in June 2022."
NCT02842021,TERMINATED,INTERVENTIONAL,Failed to meet success criteria
NCT02842125,TERMINATED,INTERVENTIONAL,Arm C rolled into parallel study; Arms A and B halted for greater efficacy in Arm C
NCT02842372,WITHDRAWN,OBSERVATIONAL,Study withdrawn due to difficulties in recruiting patients
NCT02842424,SUSPENDED,INTERVENTIONAL,IRB administratively closed protocol
NCT02842541,WITHDRAWN,INTERVENTIONAL,New study planned.
NCT02842580,TERMINATED,INTERVENTIONAL,Inclusion rythm too slow.
NCT02842710,WITHDRAWN,INTERVENTIONAL,the study did not start due to a lack of staff
NCT02843243,TERMINATED,OBSERVATIONAL,slow recruitment rate. new study planned
NCT02843451,WITHDRAWN,INTERVENTIONAL,Focus on other studies
NCT02843620,WITHDRAWN,INTERVENTIONAL,Enrollment not started
NCT02843659,TERMINATED,INTERVENTIONAL,Inability to meet protocol objectives
NCT02843750,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting patients
NCT02843880,TERMINATED,OBSERVATIONAL,Problematic has become outdated in relation with current litterature advances.
NCT02843919,TERMINATED,INTERVENTIONAL,not enough subjects
NCT02843932,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02844023,TERMINATED,INTERVENTIONAL,recruitment failure
NCT02844127,WITHDRAWN,INTERVENTIONAL,Devices proposed for use in the protocol no longer used by physician
NCT02844348,WITHDRAWN,INTERVENTIONAL,Enrollment problem
NCT02844491,TERMINATED,OBSERVATIONAL,Difficulty of recruiting
NCT02844582,TERMINATED,INTERVENTIONAL,Poor accrual of subjects onto study
NCT02844647,TERMINATED,INTERVENTIONAL,Lack of participants
NCT02844712,TERMINATED,INTERVENTIONAL,"End of the period of inclusion, NSN not achieved"
NCT02844855,TERMINATED,INTERVENTIONAL,failure to recruit 83/99
NCT02844868,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT02844933,TERMINATED,INTERVENTIONAL,Insys Therapeutics filed Chapter 11 and terminated all studies.
NCT02845050,WITHDRAWN,INTERVENTIONAL,No participants found
NCT02845063,TERMINATED,INTERVENTIONAL,Study terminated
NCT02845245,TERMINATED,INTERVENTIONAL,Enrollment goal was not met.
NCT02845336,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02845349,WITHDRAWN,INTERVENTIONAL,Funding withdrawn.
NCT02845414,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT02845687,TERMINATED,OBSERVATIONAL,Per NIH request
NCT02846376,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT02846610,TERMINATED,OBSERVATIONAL,The registry has a new setpup and a new entry
NCT02846636,SUSPENDED,OBSERVATIONAL,Surgeon stopped
NCT02846740,TERMINATED,INTERVENTIONAL,No finding at halfway point of the study
NCT02846766,WITHDRAWN,INTERVENTIONAL,Unable to execute a contract agreement with the drug manufacturer.
NCT02846792,TERMINATED,INTERVENTIONAL,Immunotherapy approved for NSCLC in the first line setting
NCT02846883,TERMINATED,INTERVENTIONAL,Early Termination as required by VA DSMB due to slow enrollment
NCT02847078,TERMINATED,INTERVENTIONAL,Insufficient enrollment of patients
NCT02847468,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02847650,TERMINATED,INTERVENTIONAL,Study B7601011 was terminated on 29 Jan 2018 due to lack of efficacy in moderate/advanced Parkinson's disease.
NCT02847702,TERMINATED,INTERVENTIONAL,Company decision
NCT02847949,WITHDRAWN,INTERVENTIONAL,Strategic Reasons
NCT02848508,WITHDRAWN,INTERVENTIONAL,Investigator choice
NCT02848586,TERMINATED,INTERVENTIONAL,Recruitment failed due to lack of subjects meeting the eligibility criteria
NCT02848716,WITHDRAWN,INTERVENTIONAL,Study cancelled due to operational difficulties
NCT02848911,TERMINATED,INTERVENTIONAL,Strategic decision was made to terminate the AFM11 development
NCT02849002,TERMINATED,OBSERVATIONAL,Study was stopped at site due to insufficient funding to continue
NCT02849301,WITHDRAWN,INTERVENTIONAL,"different protocol started, new registration"
NCT02849431,WITHDRAWN,INTERVENTIONAL,Unforeseen feasibility issues arose that meant the study did not seem viable in the current form.
NCT02849613,WITHDRAWN,INTERVENTIONAL,Not authorized by Regulatory agencies - new protocol phase 1a in progress
NCT02849951,TERMINATED,INTERVENTIONAL,LT-02 did not appear to help induce remission of UC
NCT02850250,WITHDRAWN,OBSERVATIONAL,CI left the country so study has never opened
NCT02850419,WITHDRAWN,INTERVENTIONAL,Administrative
NCT02850471,SUSPENDED,INTERVENTIONAL,we need more participants to complete the research
NCT02850731,WITHDRAWN,INTERVENTIONAL,Organisation problem
NCT02850874,WITHDRAWN,INTERVENTIONAL,no accrual rate
NCT02851004,TERMINATED,INTERVENTIONAL,"On the request of the investigational drug provider. No subjects were newly enrolled in the additional cohort as they were preparing to resume enrollment in the additional cohort. Currently, it is preparing the creation of clinical study report."
NCT02851381,WITHDRAWN,INTERVENTIONAL,The patient passed before treatment could be started
NCT02851693,WITHDRAWN,INTERVENTIONAL,No open study.
NCT02851875,TERMINATED,OBSERVATIONAL,Low enrollment and no plans for analysis
NCT02851940,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT02851979,TERMINATED,INTERVENTIONAL,few inclusions - DSMB recommendation
NCT02852187,WITHDRAWN,INTERVENTIONAL,Lack of recruitement
NCT02853071,WITHDRAWN,INTERVENTIONAL,withdrawal industrial
NCT02853084,TERMINATED,INTERVENTIONAL,difficult of recruiting
NCT02853097,TERMINATED,OBSERVATIONAL,Slow accrual
NCT02853162,TERMINATED,INTERVENTIONAL,Slow inclusion
NCT02853253,WITHDRAWN,INTERVENTIONAL,scientific question reconsidered
NCT02853578,SUSPENDED,INTERVENTIONAL,The viability of the study is being analyzed
NCT02853812,TERMINATED,INTERVENTIONAL,end of inclusion period
NCT02854059,TERMINATED,INTERVENTIONAL,Sponsor review of initial results demonstrates a non-favourable risk benefit
NCT02854319,TERMINATED,INTERVENTIONAL,Investigational Medical Device is not available and the 15 patients enrolled completed their 1-yr follow-up per protocol
NCT02854397,TERMINATED,OBSERVATIONAL,Recruitment difficulties
NCT02854488,WITHDRAWN,OBSERVATIONAL,"During the study period, no participants were enrolled in the study despite extensive recruitment methods."
NCT02854670,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02854774,TERMINATED,INTERVENTIONAL,No additional funding is available to continue this pilot study at this time.
NCT02855086,TERMINATED,INTERVENTIONAL,logistics
NCT02855099,WITHDRAWN,INTERVENTIONAL,could not find eligible patients
NCT02855268,TERMINATED,INTERVENTIONAL,The results of the futility analysis led to the study termination. No unexpected safety findings were identified.
NCT02855359,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02855411,TERMINATED,INTERVENTIONAL,"Terminated prematurely Sept 22, 2016 following an internal portfolio prioritization. It is not due to any safety concern or change in benefit:risk assessment."
NCT02855710,SUSPENDED,INTERVENTIONAL,end of inclusion period
NCT02855996,TERMINATED,INTERVENTIONAL,"AVANCE (Grantee and Implementing Agency) relinquished funding. Subsequently, both program and evaluation were terminated prematurely."
NCT02856152,WITHDRAWN,INTERVENTIONAL,The molecule (GDC-276) is no longer in development.
NCT02856178,WITHDRAWN,INTERVENTIONAL,study no longer required
NCT02856373,TERMINATED,INTERVENTIONAL,Low enrollment number
NCT02856503,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT02856568,WITHDRAWN,INTERVENTIONAL,Site dropped study
NCT02856581,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02856698,TERMINATED,INTERVENTIONAL,The study was stopped because of the adverse events
NCT02856737,WITHDRAWN,INTERVENTIONAL,inadequate personel
NCT02856828,TERMINATED,INTERVENTIONAL,Closed due to slow enrollment.
NCT02856958,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02857010,TERMINATED,INTERVENTIONAL,Dificulties to recruit patients and dificulties to obtain MSCs.
NCT02857088,TERMINATED,INTERVENTIONAL,unavailable recording device and difficulty of patient inclusions
NCT02857218,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT02857244,WITHDRAWN,INTERVENTIONAL,Site did not obtain LIRB approval due to medication usage.
NCT02857309,TERMINATED,INTERVENTIONAL,Slow enrolment.
NCT02857465,WITHDRAWN,INTERVENTIONAL,French Agency for the Safety of Health Products refusal
NCT02857556,TERMINATED,INTERVENTIONAL,Lack of inclusions
NCT02857881,TERMINATED,INTERVENTIONAL,"Difficulty of inclusion of patients, impossible to reach the expected number"
NCT02857894,TERMINATED,OBSERVATIONAL,Mutations found do not modify the ATM protein+ modifications of methodology would be necessary
NCT02858245,TERMINATED,OBSERVATIONAL,Study has been terminated due to small sample size
NCT02858284,TERMINATED,INTERVENTIONAL,Sponsor request
NCT02858362,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy in Cohorts 1 and 2.
NCT02858466,TERMINATED,INTERVENTIONAL,failure to recruit
NCT02858479,TERMINATED,INTERVENTIONAL,failure to recruit
NCT02858843,TERMINATED,INTERVENTIONAL,We were unable to enroll eligible subjects for the study.
NCT02859064,TERMINATED,INTERVENTIONAL,Closed due to slow accrual
NCT02859298,WITHDRAWN,INTERVENTIONAL,Lack of human ressources
NCT02859415,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT02859428,TERMINATED,OBSERVATIONAL,Investigator left NIH
NCT02859493,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02859636,TERMINATED,OBSERVATIONAL,Not enough inclusions
NCT02859844,TERMINATED,INTERVENTIONAL,Termination after a few pilot participants due to further protocol development
NCT02860026,WITHDRAWN,INTERVENTIONAL,Raw ingredient shortage. Future study start date - TBD
NCT02860078,WITHDRAWN,INTERVENTIONAL,Insufficient drug supply
NCT02860117,WITHDRAWN,INTERVENTIONAL,change in hospital policy
NCT02860130,TERMINATED,INTERVENTIONAL,"Study halted due to low recruitment, unrelated to safety or efficacy reasons"
NCT02860169,TERMINATED,INTERVENTIONAL,Due to GSK concerns that the data collected in this study could not support reliable interpretation of assessments and conclusions on the primary objectives.
NCT02860494,WITHDRAWN,INTERVENTIONAL,Pharmaceutical and financial difficulties
NCT02860897,WITHDRAWN,INTERVENTIONAL,Unable to provide study medications due to cost.
NCT02861170,WITHDRAWN,INTERVENTIONAL,Study was a pilot and after recruitment started it was determined to not be feasible. Therefore study protocol will be reviewed to adjust for changes.
NCT02861183,WITHDRAWN,INTERVENTIONAL,Project was placed on hold indefinitely as the project resources were unavailable for this to move forward.
NCT02861495,TERMINATED,INTERVENTIONAL,Study stopped due to low enrollment.
NCT02861612,WITHDRAWN,OBSERVATIONAL,Insufficient patient recruitment
NCT02861911,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT02862145,WITHDRAWN,INTERVENTIONAL,5 immune related serious adverse events in Phase 1 study
NCT02862184,WITHDRAWN,OBSERVATIONAL,No support staff
NCT02862431,TERMINATED,INTERVENTIONAL,manufacturing-related issues
NCT02862535,TERMINATED,INTERVENTIONAL,Study was terminated due to sponsor's decision to not pursue further development of andecaliximab in oncology
NCT02862574,TERMINATED,INTERVENTIONAL,Study was terminated by sponsor and decision was not due to any safety signals.
NCT02862600,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT02862691,TERMINATED,INTERVENTIONAL,Difficulty recruiting patients
NCT02863029,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT02863042,WITHDRAWN,INTERVENTIONAL,PI pulled the study. No participants.
NCT02863146,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT02863263,TERMINATED,INTERVENTIONAL,Difficulties in meeting recruitment target
NCT02863380,TERMINATED,INTERVENTIONAL,"The research objectives are achieved, demonstrating the feasibility and superiority of the personalized approach. It was no longer justified to continue the inclusions in this 'proof of concept' type study."
NCT02863393,WITHDRAWN,INTERVENTIONAL,Couldnt find sponor for this study
NCT02863458,WITHDRAWN,OBSERVATIONAL,"Study was a data review, no patient recruitment occurred."
NCT02863497,TERMINATED,INTERVENTIONAL,Recruitment was unfeasible due to patients being unavailable to recruit.
NCT02863588,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT02863640,TERMINATED,OBSERVATIONAL,Major difficulties of patient inclusions
NCT02863744,SUSPENDED,INTERVENTIONAL,6 month follow up for the patients in progress
NCT02863822,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT02863913,WITHDRAWN,INTERVENTIONAL,No funding
NCT02864264,TERMINATED,INTERVENTIONAL,Adverse change in the risk/benefit
NCT02864290,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of efficacy.
NCT02864303,TERMINATED,INTERVENTIONAL,end of the inclusion period
NCT02864316,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02864355,TERMINATED,INTERVENTIONAL,Minimally invasive surgical methods have ceased enrollment
NCT02864368,TERMINATED,INTERVENTIONAL,Funding
NCT02864628,WITHDRAWN,INTERVENTIONAL,Protocol was withdrawn from IND
NCT02864784,WITHDRAWN,INTERVENTIONAL,Budget
NCT02864940,TERMINATED,INTERVENTIONAL,Unable to enroll
NCT02864953,TERMINATED,INTERVENTIONAL,"Early completed to operational challenges and other strategic considerations, not for efficacy or safety reasons"
NCT02865083,TERMINATED,INTERVENTIONAL,unable to reach enrollment goal
NCT02865122,TERMINATED,INTERVENTIONAL,Sponsor decision based on enrollment
NCT02865395,TERMINATED,INTERVENTIONAL,Another study published with similar results
NCT02865915,TERMINATED,INTERVENTIONAL,The risk/benefit profile no longer indicated continued development.
NCT02865928,TERMINATED,INTERVENTIONAL,We decided to terminate this study due to staffing changes and other limitations posed by the COVID-19 pandemic.
NCT02865954,WITHDRAWN,INTERVENTIONAL,No funding
NCT02866344,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02866448,WITHDRAWN,INTERVENTIONAL,Funding delayed beyond acceptable start date
NCT02866461,WITHDRAWN,OBSERVATIONAL,It was not possible to conduct this study at the University of Utah due to the inability of the PET research facility to synthesize the radiotracer central to this project. Project was transferred to another institution.
NCT02866630,WITHDRAWN,OBSERVATIONAL,No facility to measure volatile anaesthetic concentration in human blood sample
NCT02866851,TERMINATED,INTERVENTIONAL,Only one center could be open and the center could not include all patients
NCT02866916,WITHDRAWN,INTERVENTIONAL,Study cancelled
NCT02867228,TERMINATED,INTERVENTIONAL,Resources to be able to screen and enroll patients are no longer available.
NCT02867280,TERMINATED,INTERVENTIONAL,Midterm analysis showed negative results.
NCT02867332,WITHDRAWN,INTERVENTIONAL,No funding
NCT02867345,WITHDRAWN,OBSERVATIONAL,no funding or finacial support
NCT02867618,TERMINATED,INTERVENTIONAL,PI left institution
NCT02867644,TERMINATED,INTERVENTIONAL,Results not achievable after interim analysis conclusions and recruting difficulty
NCT02867696,TERMINATED,INTERVENTIONAL,Unable to recruit
NCT02867722,WITHDRAWN,INTERVENTIONAL,The PI decided to not proceed with the trial due to lack of funding.
NCT02867878,TERMINATED,INTERVENTIONAL,inability to recruiti a sufficient number of patients
NCT02867904,TERMINATED,INTERVENTIONAL,It was difficult to recruit patients to get the appropriate sample size.
NCT02868164,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT02868632,WITHDRAWN,INTERVENTIONAL,termination because of low accrual; four subjects enrolled and four screen failures.
NCT02868827,TERMINATED,INTERVENTIONAL,The initial plan was 2 years but due to slow recruitment. We were able to screen 635 patients in 4 years and recruited only 127 patients.
NCT02868892,TERMINATED,INTERVENTIONAL,departure of PI from institution and poor population for study participation
NCT02869425,WITHDRAWN,INTERVENTIONAL,suspended due to inability to enroll subjects
NCT02870647,WITHDRAWN,INTERVENTIONAL,Strategy changes.
NCT02870855,WITHDRAWN,INTERVENTIONAL,"Entry criteria were changed, investigator have registrated a new trials."
NCT02871024,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT02871050,WITHDRAWN,OBSERVATIONAL,An alternative Biobank Project was initiated.
NCT02871102,TERMINATED,INTERVENTIONAL,"The ART Trial was published suggesting harm by the intervention protocol, which was closely related to the protocol in this study, so the study was terminated."
NCT02871271,WITHDRAWN,INTERVENTIONAL,Stopped product production
NCT02871297,TERMINATED,INTERVENTIONAL,The study was terminated based on new efficacy data from another study.
NCT02871310,WITHDRAWN,INTERVENTIONAL,Study discontinued
NCT02871323,WITHDRAWN,INTERVENTIONAL,PI decided to withdraw the study after it opened for enrollment but before any patients were enrolled
NCT02871427,TERMINATED,INTERVENTIONAL,Changes to the overall development program for the study medication
NCT02872298,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02872363,TERMINATED,INTERVENTIONAL,The screening service moved to a pan-London service and the trial was not able to be continued.
NCT02872428,TERMINATED,INTERVENTIONAL,at request of funding group because of failure to enroll more than one patient
NCT02872506,WITHDRAWN,INTERVENTIONAL,investigator decision
NCT02872519,WITHDRAWN,INTERVENTIONAL,No funding
NCT02872649,TERMINATED,INTERVENTIONAL,safety reasons
NCT02872727,TERMINATED,OBSERVATIONAL,Inclusion of the last patient
NCT02872766,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT02872831,TERMINATED,INTERVENTIONAL,PI Departure from the institution
NCT02872844,WITHDRAWN,INTERVENTIONAL,Investigator closed study-no accrual
NCT02873325,TERMINATED,OBSERVATIONAL,Lack of study recruitment
NCT02873351,WITHDRAWN,INTERVENTIONAL,Decided to do studies in patients with AMD
NCT02873507,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02873624,TERMINATED,OBSERVATIONAL,No patients recruited
NCT02873650,TERMINATED,INTERVENTIONAL,Study was terminated due to continued enrolment difficulties.
NCT02873702,TERMINATED,INTERVENTIONAL,Compound is not expected to change the current treatment practice or fill significant clinical need for patients in China over currently available EE agents.
NCT02874053,WITHDRAWN,OBSERVATIONAL,PI left the NIH
NCT02874105,TERMINATED,INTERVENTIONAL,Difficulties for enrollment
NCT02874183,WITHDRAWN,INTERVENTIONAL,Collaborating site had difficulty with approval
NCT02874651,TERMINATED,INTERVENTIONAL,Unacceptable toxicity (nasopharynx necrosis and massive hemorrhage)
NCT02874677,TERMINATED,INTERVENTIONAL,material issues in study centres
NCT02874820,TERMINATED,INTERVENTIONAL,Patient recruitment issues.
NCT02875041,WITHDRAWN,INTERVENTIONAL,"Study required back-to-back physical therapy (PT) and TMS Experimental sessions; as our practice move to another building, away from PT"
NCT02875067,TERMINATED,INTERVENTIONAL,Merck's decision for early termination of the data
NCT02875093,TERMINATED,INTERVENTIONAL,Study Termination
NCT02875223,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT02875236,TERMINATED,INTERVENTIONAL,Changing the study design
NCT02875613,TERMINATED,INTERVENTIONAL,Slow patient accrual
NCT02875678,TERMINATED,INTERVENTIONAL,recruitment challenges
NCT02875704,TERMINATED,OBSERVATIONAL,There was no significant difference in our outcome measures between patients with disease versus controls suggesting that our hypothesis is not substantiated. Since this was the major objective of the study we decided to terminate the study.
NCT02876003,WITHDRAWN,INTERVENTIONAL,This study has been withdrawn prior to enrollment.
NCT02876081,WITHDRAWN,INTERVENTIONAL,medical decision
NCT02876094,TERMINATED,INTERVENTIONAL,Terminated: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
NCT02876822,TERMINATED,INTERVENTIONAL,Step 1 enrollment complete.
NCT02877641,TERMINATED,INTERVENTIONAL,low accrual
NCT02877732,TERMINATED,INTERVENTIONAL,The funding sponsor elected to terminate the study.
NCT02877836,TERMINATED,INTERVENTIONAL,end of inclusion period and difficulties on recruitment of one patient group
NCT02877966,WITHDRAWN,INTERVENTIONAL,Change of Trial Sponsor
NCT02878083,TERMINATED,INTERVENTIONAL,the CELLVIZIO device required to analyse biopsy is available until september 2020
NCT02878538,WITHDRAWN,INTERVENTIONAL,Study was withdrawn before IRB approval
NCT02878694,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT02878980,WITHDRAWN,INTERVENTIONAL,Feasibility issues
NCT02879019,WITHDRAWN,INTERVENTIONAL,Study was not started due to lack of funding
NCT02879058,TERMINATED,INTERVENTIONAL,Due to inadequate enrollment.
NCT02880111,TERMINATED,OBSERVATIONAL,only one patient was included
NCT02880241,TERMINATED,INTERVENTIONAL,Due to a Medicines for Malaria Venture (MMV) strategic business decision
NCT02880345,WITHDRAWN,INTERVENTIONAL,Insufficient accrual
NCT02880371,TERMINATED,INTERVENTIONAL,Study was halted prematurely due to insufficient efficacy. Not due to safety reasons.
NCT02880410,TERMINATED,INTERVENTIONAL,Terminated (failure to enroll)
NCT02880904,TERMINATED,OBSERVATIONAL,Investigator is no longer at Northwestern University
NCT02881229,TERMINATED,OBSERVATIONAL,Investigator is no longer at Northwestern University
NCT02881528,WITHDRAWN,INTERVENTIONAL,Poor Recruitment prior to end of funding timelines.
NCT02881541,WITHDRAWN,INTERVENTIONAL,The investigator abandoned the project.
NCT02881567,TERMINATED,INTERVENTIONAL,Study terminated in line with Biogen decision to withdraw Zinbryta from the market and not to pursue further studies of daclizumab in MS.
NCT02881593,WITHDRAWN,OBSERVATIONAL,The investiagtor abandoned the project.
NCT02882022,WITHDRAWN,INTERVENTIONAL,Study closed due to lack of participants
NCT02882048,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02882087,TERMINATED,INTERVENTIONAL,"Lack of trial population, unable to recruit subjects"
NCT02882126,WITHDRAWN,INTERVENTIONAL,Business decision
NCT02882230,TERMINATED,OBSERVATIONAL,Unfavourable opinion of ethical comittee for Amendment Nr 3
NCT02882295,TERMINATED,OBSERVATIONAL,recrutement difficulties
NCT02882321,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor for apparent lack of effectiveness.
NCT02882334,TERMINATED,INTERVENTIONAL,"Difficults d'inclure, les patients sont rares"
NCT02882373,WITHDRAWN,INTERVENTIONAL,Principal Investigator's Request
NCT02882646,WITHDRAWN,INTERVENTIONAL,Temporarily suspended due to equipment issues
NCT02882711,TERMINATED,INTERVENTIONAL,Increasing off-label practice of IV ketamine administration for treatment-resistant depression.
NCT02882841,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02883010,WITHDRAWN,INTERVENTIONAL,Business decision
NCT02883283,WITHDRAWN,INTERVENTIONAL,It was decided that this study was not feasible at our institution.
NCT02883439,WITHDRAWN,INTERVENTIONAL,no available patients
NCT02883712,TERMINATED,OBSERVATIONAL,defect inclusion
NCT02883751,WITHDRAWN,INTERVENTIONAL,The PI is no longer working at UniNove
NCT02883790,TERMINATED,INTERVENTIONAL,Low enrolment rate
NCT02883972,WITHDRAWN,INTERVENTIONAL,Ethical approval was withdrawn by the National Research Ethics Service as they were unable to make contact with the research team despite trying many times.
NCT02884492,TERMINATED,INTERVENTIONAL,Stopped due to published data regarding THK-5351 non-specificity in Tau imaging
NCT02884830,WITHDRAWN,INTERVENTIONAL,the protocol is too complex and we are not able to recruit appropriate patients
NCT02884882,TERMINATED,INTERVENTIONAL,difficulty to recrut
NCT02885012,TERMINATED,INTERVENTIONAL,Study ending due to lack of enrollment.
NCT02885051,TERMINATED,INTERVENTIONAL,"At the end of the inclusion period, the observed correlations were much lower than expected. Thus, it did not seem relevant to prolong the inclusions."
NCT02885142,TERMINATED,INTERVENTIONAL,difficulties to recruit all the patients
NCT02885285,TERMINATED,INTERVENTIONAL,Recruitment goal not met
NCT02885324,TERMINATED,INTERVENTIONAL,Failure to meet accrual goals.
NCT02885428,TERMINATED,OBSERVATIONAL,Difficulties in the inclusion of patients with cardiacly asymptomatic type 2 diabetes and with at least two cardiovascular risk factors.
NCT02885467,TERMINATED,INTERVENTIONAL,Terminated by IRB
NCT02885545,WITHDRAWN,INTERVENTIONAL,Failure to recruit any participants in more than one year of recruiting.
NCT02885571,TERMINATED,INTERVENTIONAL,Due to suggestions of IRB committee in our institution
NCT02885649,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT02885727,WITHDRAWN,INTERVENTIONAL,Funding issues caused the study to not be opened the at local IRB
NCT02885896,WITHDRAWN,OBSERVATIONAL,Principal investigator left the Hospices Civils de Lyon and has not been replaced
NCT02885987,WITHDRAWN,INTERVENTIONAL,decided not to go ahead with study at this time
NCT02886078,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02886663,TERMINATED,INTERVENTIONAL,Major inclusion difficulties
NCT02886858,TERMINATED,INTERVENTIONAL,investigator and sponsor decided by mutual agreement to stop study prematurely
NCT02887118,TERMINATED,OBSERVATIONAL,The recruiting centre was no longer presenting new patients for inclusion
NCT02887196,TERMINATED,OBSERVATIONAL,Saturation of a particular breast cancer treatment regimen enrolled. We will need to reexamine inclusion/exclusion criteria in future studies.
NCT02887248,TERMINATED,INTERVENTIONAL,Enrollment issues
NCT02887521,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02887677,TERMINATED,INTERVENTIONAL,On February 2019 Astra-Zeneca Greece decided to stop the financial support of the study.
NCT02888041,TERMINATED,INTERVENTIONAL,Not enough patients
NCT02888067,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02888301,TERMINATED,OBSERVATIONAL,slow accrual
NCT02888444,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02888548,TERMINATED,INTERVENTIONAL,unsuitable method
NCT02888730,TERMINATED,INTERVENTIONAL,No suffisant recruitment
NCT02888756,TERMINATED,INTERVENTIONAL,Interim analysis did not show sufficient immunogenicity of IMP compared to placebo
NCT02888782,TERMINATED,INTERVENTIONAL,Program Restructured
NCT02889042,TERMINATED,INTERVENTIONAL,not enough patients
NCT02889055,TERMINATED,OBSERVATIONAL,Safety profile was not satisfying with sevolflurane
NCT02889211,TERMINATED,INTERVENTIONAL,Principal Investigator Left University
NCT02889250,WITHDRAWN,INTERVENTIONAL,did not receive funding
NCT02889276,TERMINATED,INTERVENTIONAL,Only 4 participants were recruited from 130 potential participants.
NCT02889861,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02890212,SUSPENDED,INTERVENTIONAL,due to COVID19 pandemic
NCT02890381,TERMINATED,INTERVENTIONAL,Interim data indicated this vaccine will not meet the protocol criteria for a good vaccine candidate.
NCT02890576,WITHDRAWN,OBSERVATIONAL,study was stopped du to of patient lack
NCT02890719,WITHDRAWN,INTERVENTIONAL,impossibility of supplying the medication in research of the study by the pharmaceutical company that gave it to the trial
NCT02890797,TERMINATED,INTERVENTIONAL,"The inclusions have been suspended from 03/18/2020 during the confinement period.

In the meantime, a publication has appeared showing that the chest ultrasound has entered the common practice in the management of bronchiolitis."
NCT02890875,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02890888,TERMINATED,INTERVENTIONAL,Depletion of Funds and Illness of principal investigator
NCT02891265,TERMINATED,INTERVENTIONAL,study stopped due to the difficulty in patient compliance for follow up visits
NCT02891317,TERMINATED,OBSERVATIONAL,Technical \& Logistical issues
NCT02891616,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02891733,WITHDRAWN,OBSERVATIONAL,The principal investigator decided to stop the study.
NCT02891746,WITHDRAWN,OBSERVATIONAL,recent publications have made this study obsolete
NCT02891772,WITHDRAWN,OBSERVATIONAL,The investigator's workplace and department were changed so that the study could no longer be carried out.
NCT02891863,TERMINATED,INTERVENTIONAL,Futility
NCT02891941,TERMINATED,OBSERVATIONAL,Funding withdrawn
NCT02892071,WITHDRAWN,INTERVENTIONAL,Our fellow completed the program before we were able to start the study
NCT02892097,TERMINATED,INTERVENTIONAL,"Enrolled 1 participant, PI left the institution."
NCT02892201,TERMINATED,INTERVENTIONAL,Low enrollment
NCT02892487,TERMINATED,INTERVENTIONAL,"For financial reasons and speed of recruitment was much slower than expected, inclusions weren't resumed after it was suspended during COVID-19 confinment."
NCT02892500,TERMINATED,INTERVENTIONAL,Inability to enroll subjects
NCT02892578,TERMINATED,INTERVENTIONAL,The Study halted prematurely because the potential for recruitment into the associated center was reached.
NCT02892604,TERMINATED,INTERVENTIONAL,not enough participants
NCT02892682,TERMINATED,INTERVENTIONAL,no more inclusion
NCT02892734,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02892864,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT02893059,WITHDRAWN,OBSERVATIONAL,the investigator has left the facility
NCT02893280,WITHDRAWN,OBSERVATIONAL,Due to an incompatibility with the local procedures
NCT02893332,TERMINATED,INTERVENTIONAL,"After interim analysis, IRB recommend termination."
NCT02893371,TERMINATED,OBSERVATIONAL,"Per PI, this study is not a clinical trial and was inadvertently entered in the system"
NCT02893423,TERMINATED,INTERVENTIONAL,A better study with a better drug was started and thus this study was terminated
NCT02893527,TERMINATED,INTERVENTIONAL,"An IDMC validated the premature termination of the study on 19/02/2016 for lack of inclusion, with continuation of the FU initially planned for women included"
NCT02893579,TERMINATED,INTERVENTIONAL,"were not able to find enough eligible patients. We recruited 6, with incomplete data on those participants."
NCT02893696,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT02893748,WITHDRAWN,INTERVENTIONAL,unable to agree on budget terms
NCT02893826,TERMINATED,INTERVENTIONAL,Based on DMC recommendation to discontinue EG-01-1962-03
NCT02893982,TERMINATED,INTERVENTIONAL,Study was closed due to poor accrual
NCT02893995,WITHDRAWN,INTERVENTIONAL,Business decision
NCT02894086,WITHDRAWN,OBSERVATIONAL,Investigator choice
NCT02894515,WITHDRAWN,INTERVENTIONAL,The study was withdrawn based on new efficacy data from another study
NCT02894554,TERMINATED,INTERVENTIONAL,clinical myalgia
NCT02894567,TERMINATED,INTERVENTIONAL,"This study was structured in 2 phases, and was stopped after the first phase. The collected data will be used to improve the device and prepare future studies."
NCT02894658,WITHDRAWN,INTERVENTIONAL,lack of equipment
NCT02894697,TERMINATED,INTERVENTIONAL,"Due to a problem with the supply and demand of the stent used in the study, it is difficult to register the target so the study ends early."
NCT02894749,WITHDRAWN,INTERVENTIONAL,Investigator departure (and wish not set up study)
NCT02895035,TERMINATED,INTERVENTIONAL,Data analysis was never performed by sub-investigator
NCT02895100,TERMINATED,INTERVENTIONAL,Data Monitoring Committee discontinued the trial due to futility-based outcome
NCT02895373,TERMINATED,INTERVENTIONAL,After completion of pilot study (n=50) no effect on primary outcome and limited feasibility of recruitment and study procedures
NCT02895386,TERMINATED,INTERVENTIONAL,Company/Sponsor has discontinued business
NCT02895490,TERMINATED,INTERVENTIONAL,Grant ended/funding unavailable
NCT02895503,TERMINATED,INTERVENTIONAL,Lack of accrual/Slow accrual
NCT02895529,TERMINATED,INTERVENTIONAL,"Study is a commitment for license renew, we target on Apr19 submission, considering timeline, a cut off should be scheduled in Apr18."
NCT02895815,WITHDRAWN,INTERVENTIONAL,Company business decision
NCT02895919,WITHDRAWN,OBSERVATIONAL,IRB expired
NCT02895945,TERMINATED,INTERVENTIONAL,Takeda has determined that the benefit/risk profile does not support continuation of the surgery Study for this specific Congenital Hemophilia A with Inhibitors patient population.
NCT02895958,TERMINATED,INTERVENTIONAL,Insufficient study participants enrolled
NCT02896049,WITHDRAWN,OBSERVATIONAL,no inclusion has been performed
NCT02896387,TERMINATED,OBSERVATIONAL,"Laboratory change, stem cell circuit stopped"
NCT02896426,TERMINATED,INTERVENTIONAL,Study halted prematurely due to low recruitment and will not resume.
NCT02896439,TERMINATED,INTERVENTIONAL,The principal investigator decided to stop the research.
NCT02896517,WITHDRAWN,OBSERVATIONAL,The investigator abandoned the project.
NCT02896816,TERMINATED,INTERVENTIONAL,No more funding
NCT02897115,TERMINATED,INTERVENTIONAL,The study was terminated due to slow recruitment.
NCT02897505,WITHDRAWN,INTERVENTIONAL,Difficulty enrolling subjects
NCT02897648,TERMINATED,OBSERVATIONAL,PI's decision
NCT02897713,SUSPENDED,INTERVENTIONAL,Similar study has been published.
NCT02897830,TERMINATED,INTERVENTIONAL,negatives results
NCT02898259,TERMINATED,INTERVENTIONAL,Funding was eliminated.
NCT02898753,TERMINATED,INTERVENTIONAL,Company closure due to lack of funding
NCT02898896,TERMINATED,INTERVENTIONAL,Departure of the coordinating investigator
NCT02898909,TERMINATED,INTERVENTIONAL,Major inclusion difficulties
NCT02899026,WITHDRAWN,INTERVENTIONAL,GSK decision to return rights to sirukumab to Janssen and discontinue sirukumab development in polymyalgia rheumatica.
NCT02899156,TERMINATED,INTERVENTIONAL,A planned interim analysis led to the trial being stopped early based on the observed size effect and power analysis.
NCT02899325,WITHDRAWN,OBSERVATIONAL,PIs will not pursue trial due to staff and time constraints
NCT02899481,TERMINATED,INTERVENTIONAL,Data Safety Monitoring Committee recommended stopping the trial due to futility.
NCT02899520,TERMINATED,INTERVENTIONAL,Change in the clinical practices
NCT02899533,TERMINATED,OBSERVATIONAL,The method did not help with assessing PAH and so the trial was terminated early.
NCT02899598,WITHDRAWN,INTERVENTIONAL,NEVER STARTED
NCT02899650,TERMINATED,INTERVENTIONAL,This was a research project that was conducted by a visiting scholar and his time for departure came earlier than the study completion.
NCT02899702,WITHDRAWN,INTERVENTIONAL,no EC approval obtained
NCT02899728,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT02899780,WITHDRAWN,INTERVENTIONAL,Poor recruitment
NCT02899858,WITHDRAWN,INTERVENTIONAL,Funding stopped and no one met IRB approved enrollment criteria
NCT02900079,WITHDRAWN,OBSERVATIONAL,delays in obtaining study materials
NCT02900183,WITHDRAWN,INTERVENTIONAL,Company decision to not initiate trial
NCT02900196,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02900222,TERMINATED,INTERVENTIONAL,Resources no longer available
NCT02900248,TERMINATED,OBSERVATIONAL,"Registry was built to handle Medicare coverage decision on NGS, but CMS decided to not require data."
NCT02900404,WITHDRAWN,OBSERVATIONAL,due to release of competing App
NCT02900781,TERMINATED,INTERVENTIONAL,Participants were unable to use the device. No data was collected
NCT02900794,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02901067,TERMINATED,INTERVENTIONAL,COVID-19 pandemic and high proportion of patients meeting exclusion criteria.
NCT02901106,TERMINATED,INTERVENTIONAL,"Another surveillance protocol was initiated by the OFSEP (OFSEP cohort) which allows to follow all the patients, whatever their treatment."
NCT02901405,TERMINATED,INTERVENTIONAL,The study was unable to meet recruitment targets
NCT02901431,TERMINATED,INTERVENTIONAL,The 24-week analysis indicated no clinical or statistical benefit for the primary endpoint for the overall study population. No new safety concerns identified.
NCT02901483,TERMINATED,INTERVENTIONAL,bussiness reason
NCT02901548,TERMINATED,INTERVENTIONAL,Study closed early due to futility
NCT02901626,TERMINATED,INTERVENTIONAL,The study was stopped per the recommendation of the DSMB and NICHD.
NCT02902055,SUSPENDED,INTERVENTIONAL,COVID
NCT02902133,WITHDRAWN,INTERVENTIONAL,No participants were identified per inclusion/exclusion criteria
NCT02902172,TERMINATED,INTERVENTIONAL,Unable to recruit necessary number of patients
NCT02902588,TERMINATED,INTERVENTIONAL,The tests have been completed
NCT02902744,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to difficult recruitment of patients for the study; No participants were enrolled in the study.
NCT02902809,TERMINATED,INTERVENTIONAL,The study was terminated due to the discontinuation of the tralokinumab asthma program (as per the results of the Phase III study \[D2210C00008\])
NCT02902835,TERMINATED,INTERVENTIONAL,Grant Funding Ended
NCT02903303,TERMINATED,INTERVENTIONAL,end of recruitment period
NCT02903407,TERMINATED,INTERVENTIONAL,All enrolled participants completed the study protocol but the study was terminated prior to the goal number of participants due to low recruitment
NCT02903862,WITHDRAWN,INTERVENTIONAL,Could not meet enrollment requirement.
NCT02903901,WITHDRAWN,INTERVENTIONAL,Investigator found that a new study drug that is FDA approved would be superior to melatonin
NCT02904148,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02904265,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02904304,SUSPENDED,INTERVENTIONAL,the viability of the study is being analyzed
NCT02904343,WITHDRAWN,INTERVENTIONAL,The sponsors want to stop the study.
NCT02904356,TERMINATED,INTERVENTIONAL,PI left institution
NCT02904434,WITHDRAWN,OBSERVATIONAL,IRB terminated the study
NCT02904746,WITHDRAWN,INTERVENTIONAL,Unable to successfully recruit participants using current study design.
NCT02904772,WITHDRAWN,INTERVENTIONAL,"uniQure, has decided not to renew the Marketing Authorization of Glybera in the EU. This decision is not related to any safety, efficacy or quality issue"
NCT02904993,TERMINATED,INTERVENTIONAL,PI left the institution.
NCT02905201,WITHDRAWN,OBSERVATIONAL,The protocol was cancelled due timelines be not compatible with business strategy in Colombia.
NCT02905253,TERMINATED,INTERVENTIONAL,The study has been terminated due to difficulties in recruiting subjects into Part C. No safety concerns contributed to the termination of the study
NCT02905279,TERMINATED,INTERVENTIONAL,Doctoral student running the study left for internship and did not finish the study
NCT02905396,TERMINATED,INTERVENTIONAL,"Only 1 inclusion in 2,5 years"
NCT02905617,TERMINATED,OBSERVATIONAL,Low enrollment
NCT02905643,TERMINATED,OBSERVATIONAL,Investigator left institution
NCT02905981,TERMINATED,INTERVENTIONAL,"Limited subjects, patient compliance"
NCT02905994,WITHDRAWN,INTERVENTIONAL,Funding Withdrawn
NCT02906020,TERMINATED,INTERVENTIONAL,"The topline results of the 52-week double-blind placebo-controlled period were analyzed. The study did not meet the primary or secondary endpoints. Based on these results, the decision was made to halt the long-term follow-up period of the study"
NCT02906332,TERMINATED,INTERVENTIONAL,FDA Hold Due to Updated Risks
NCT02906462,TERMINATED,INTERVENTIONAL,Investigator's decision (departure from institution)
NCT02906605,WITHDRAWN,INTERVENTIONAL,Study start delayed due to pending collection and analysis of additional phase 1 data.
NCT02906670,TERMINATED,INTERVENTIONAL,Business reasons
NCT02906696,TERMINATED,INTERVENTIONAL,Terminated per PI's request due to competing priorities.
NCT02906722,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT02906774,TERMINATED,OBSERVATIONAL,This observational study has been transitioned to a clinical trial and is now registered at (NCT04181112).
NCT02906891,TERMINATED,INTERVENTIONAL,Insufficient resources to complete study
NCT02906904,WITHDRAWN,INTERVENTIONAL,Material needed for study was not available
NCT02907073,TERMINATED,INTERVENTIONAL,pursuing IND
NCT02907177,TERMINATED,INTERVENTIONAL,sponsor decision due to low recruitment
NCT02907294,TERMINATED,INTERVENTIONAL,change in the therapeutic indication
NCT02907307,WITHDRAWN,INTERVENTIONAL,Development project stopped
NCT02907619,TERMINATED,INTERVENTIONAL,Termination Date: 30Aug2018; Reason for termination: Lack of Efficacy
NCT02907736,WITHDRAWN,OBSERVATIONAL,replaced by a new study
NCT02907801,TERMINATED,INTERVENTIONAL,"After a reliability pilot, main study stopped due to unrelated clinic closure."
NCT02907814,TERMINATED,INTERVENTIONAL,Lack of administrative support
NCT02907879,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT02907918,TERMINATED,INTERVENTIONAL,Futility
NCT02907983,SUSPENDED,INTERVENTIONAL,IRB Audit Review
NCT02908126,TERMINATED,INTERVENTIONAL,No approval CA (MPA) of protocol amendment
NCT02908165,WITHDRAWN,INTERVENTIONAL,A future study will be taking place using the same patient population.
NCT02908334,WITHDRAWN,INTERVENTIONAL,failure to enroll
NCT02908386,WITHDRAWN,OBSERVATIONAL,At the moment no participants are enrolled untill a new agreement is made
NCT02908451,TERMINATED,INTERVENTIONAL,"COVID-19 pandemic has caused a huge operational difficulty for this ongoing clinical trial, as many hospitals have set limitations on onsite staff, patient visits, study related procedures and onsite monitoring visits."
NCT02908490,TERMINATED,INTERVENTIONAL,"Slow recruitment, lack of continued funding"
NCT02908516,TERMINATED,INTERVENTIONAL,Study was terminated due to inability to recruit and collect follow up outcome data.
NCT02908698,TERMINATED,INTERVENTIONAL,Primary outcome was met in the 16 patients that completed the study per protocol
NCT02909140,TERMINATED,INTERVENTIONAL,insufficient patient recruitment
NCT02909231,TERMINATED,OBSERVATIONAL,Failed to recruit sufficient subjects
NCT02909257,TERMINATED,INTERVENTIONAL,inadequate methodology to determine primary outcome
NCT02909504,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02909569,WITHDRAWN,INTERVENTIONAL,Contract could not be agreed on.
NCT02909634,WITHDRAWN,OBSERVATIONAL,No devices currently available for study.
NCT02909660,TERMINATED,INTERVENTIONAL,Recruitment difficulties / lack of participants
NCT02910297,WITHDRAWN,OBSERVATIONAL,unable to recruit enough subjects on CBD
NCT02910752,SUSPENDED,INTERVENTIONAL,Low enrollment
NCT02910843,TERMINATED,INTERVENTIONAL,due to structural financial deficit of SAKK
NCT02910882,TERMINATED,INTERVENTIONAL,Safety
NCT02911220,TERMINATED,INTERVENTIONAL,not enough available families to get significant genetic results
NCT02911467,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02911480,WITHDRAWN,INTERVENTIONAL,Study/financial issues
NCT02911558,TERMINATED,OBSERVATIONAL,Investigator's decision (departure from Institution)
NCT02911662,TERMINATED,INTERVENTIONAL,Inability to enroll patients at anticipated rate.
NCT02911675,WITHDRAWN,OBSERVATIONAL,"Due to the lack of approval from the Air Force IRB patient enrollment was never initiated. Thus, no clinical results could be examined or can be reported"
NCT02911740,WITHDRAWN,INTERVENTIONAL,Not IRB approved
NCT02911909,TERMINATED,INTERVENTIONAL,Recruitment was unsuccessful
NCT02911922,TERMINATED,INTERVENTIONAL,Lack of patient accruals.
NCT02911961,WITHDRAWN,INTERVENTIONAL,Due to lack of enrollment and organizational desire to focus recruitment efforts on other studies.
NCT02912013,TERMINATED,INTERVENTIONAL,Recruitment rate was not sufficient
NCT02912026,WITHDRAWN,INTERVENTIONAL,Major change to study design
NCT02912169,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT02912182,TERMINATED,INTERVENTIONAL,Placebo medication expired
NCT02912390,TERMINATED,INTERVENTIONAL,On Internal Hold
NCT02912403,WITHDRAWN,OBSERVATIONAL,Unable to enroll
NCT02912455,TERMINATED,INTERVENTIONAL,Study was terminated due to difficulty with reaching enrollment goals
NCT02912637,SUSPENDED,OBSERVATIONAL,Technical and administrative problems
NCT02912858,WITHDRAWN,INTERVENTIONAL,study withdrawn
NCT02912910,WITHDRAWN,OBSERVATIONAL,PI withdrew protocol
NCT02913131,TERMINATED,INTERVENTIONAL,Low Accrual
NCT02913274,TERMINATED,INTERVENTIONAL,"The study was temporarily suspended after a meta-analysis suggesting higher mortality risks among patients treated with Paclitaxel-coated balloons. When the study was open again, no new patient accepted to be included. The study stopped on 18AUG2023."
NCT02913729,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02913742,WITHDRAWN,INTERVENTIONAL,"IRB determined need for an IDE, which was not approved"
NCT02913807,WITHDRAWN,INTERVENTIONAL,Study was ended due to lack of available participants who met criteria.
NCT02914015,TERMINATED,INTERVENTIONAL,we change the study protocol
NCT02914327,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02914600,TERMINATED,INTERVENTIONAL,development program for filgotinib for participants with Crohn's disease has been stopped
NCT02914821,TERMINATED,INTERVENTIONAL,"Harvard University dining workers went on strike, we hope to relaunch in Fall 2017."
NCT02914834,TERMINATED,INTERVENTIONAL,Research activity halted due to the Coronavirus Disease 2019 (COVID-19) pandemic. We were obliged to stop the in-person study in March 2020 due to the mandated lockdowns as a result of COVID.
NCT02914938,TERMINATED,INTERVENTIONAL,discontinuation of zandelisib program
NCT02915042,WITHDRAWN,INTERVENTIONAL,Recruitment concerns
NCT02915081,TERMINATED,INTERVENTIONAL,low anticipated recruitment
NCT02915133,SUSPENDED,OBSERVATIONAL,study changed waiting renew
NCT02915263,TERMINATED,INTERVENTIONAL,Funding withdrawn in the midst of the COVID pandemic
NCT02915484,TERMINATED,INTERVENTIONAL,Difficulty with recruitment.
NCT02915666,WITHDRAWN,INTERVENTIONAL,No subjects consented for enrollment on this study.
NCT02915679,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT02915692,TERMINATED,OBSERVATIONAL,Withdrawn funding
NCT02915991,TERMINATED,OBSERVATIONAL,slow recruitment and change in regulatory landscape
NCT02916056,TERMINATED,INTERVENTIONAL,Not due to safety but due to a lack of efficacy at the 5 mg azeliragon dose.
NCT02916485,SUSPENDED,INTERVENTIONAL,Awaiting National Pharmaceutical Pricing Authority (NPPA) review of ceiling prices for innovative products in India.
NCT02916498,TERMINATED,INTERVENTIONAL,Stopped due to a business decision
NCT02916550,TERMINATED,INTERVENTIONAL,"Recruitment rate was lower than anticipated, preventing the study from achieving target sample size."
NCT02916836,WITHDRAWN,OBSERVATIONAL,Withdrawal of the associated centers
NCT02917044,TERMINATED,INTERVENTIONAL,Recruitment issues due to competing studies. Higher than expected PVI on first pass. Sample would have to be increased which was not feasible.
NCT02917122,TERMINATED,INTERVENTIONAL,Funding is insufficient.
NCT02917148,WITHDRAWN,OBSERVATIONAL,Lack of Funding
NCT02917265,TERMINATED,INTERVENTIONAL,poor recruitment
NCT02917629,TERMINATED,INTERVENTIONAL,Low accrual combined with expiration of study drug
NCT02917850,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT02918227,TERMINATED,INTERVENTIONAL,Not enough patient
NCT02918266,TERMINATED,INTERVENTIONAL,Terminated prematurely due to indication change.
NCT02918383,TERMINATED,INTERVENTIONAL,PI has decided to close the study.
NCT02918396,TERMINATED,INTERVENTIONAL,Due to low enrollment of participants meeting eligibility criteria
NCT02918500,TERMINATED,INTERVENTIONAL,Due to recruitment challenges.
NCT02918708,WITHDRAWN,INTERVENTIONAL,funding channel amended by UK department of health
NCT02919072,TERMINATED,INTERVENTIONAL,The doctors involved in the study did not enroll any patients
NCT02919332,WITHDRAWN,OBSERVATIONAL,No participants were enrolled
NCT02919449,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02919462,TERMINATED,INTERVENTIONAL,low recruitement rate
NCT02919553,WITHDRAWN,INTERVENTIONAL,decided not to proceed with study at this time
NCT02920177,TERMINATED,INTERVENTIONAL,low enrollment
NCT02920190,WITHDRAWN,INTERVENTIONAL,Lack of funds to cover the costs of the study medications
NCT02920242,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment
NCT02920333,TERMINATED,INTERVENTIONAL,The grant funding has expired
NCT02920424,WITHDRAWN,INTERVENTIONAL,The decision is based on a change in the benefit risk assessment of this drug for the lupus population targeted in this study.
NCT02920437,TERMINATED,INTERVENTIONAL,The study cannot recruit the expected number of participants. Only 19 participants were recruited and no more new participant was recruited after that.
NCT02920450,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02920710,WITHDRAWN,INTERVENTIONAL,Difficulty with recruitment
NCT02920996,TERMINATED,INTERVENTIONAL,Funding was pulled
NCT02921594,WITHDRAWN,INTERVENTIONAL,NCT02921594 was not a RCT but a secondary pilot study designed to establish a fluoroscopic test-set up on 10 selected patients from another RCT.
NCT02921620,WITHDRAWN,INTERVENTIONAL,Protocol not feasible
NCT02921646,TERMINATED,INTERVENTIONAL,Protocol is not adapted to cancer pancreas disease as progression is very fast and patients stopped the study before 1st study assessment
NCT02921737,TERMINATED,INTERVENTIONAL,insufficient time to accrue sufficient subjects before end of funding
NCT02922023,TERMINATED,INTERVENTIONAL,Subjects lost to follow-up
NCT02922283,TERMINATED,INTERVENTIONAL,"After an interim analysis of the data, it became clear that the imaging results did not correlate to the primary outcome measures in this subset of patients."
NCT02922413,TERMINATED,INTERVENTIONAL,Low accrual
NCT02922530,WITHDRAWN,INTERVENTIONAL,Principal Investigator departed for another position.
NCT02922582,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT02922725,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT02922816,TERMINATED,INTERVENTIONAL,This study was paused and was not resumed due to the COVID-19 pandemic.
NCT02922842,TERMINATED,INTERVENTIONAL,underenrollment
NCT02923024,WITHDRAWN,INTERVENTIONAL,Project was cancelled before any participants were enrolled.
NCT02923037,TERMINATED,INTERVENTIONAL,Insufficient staff and funding
NCT02923232,TERMINATED,INTERVENTIONAL,Funding organization requested to stop the study
NCT02923531,TERMINATED,INTERVENTIONAL,"Due to low enrollment, the study was terminated early."
NCT02923739,TERMINATED,INTERVENTIONAL,The study was terminated early by the Sponsor
NCT02923830,TERMINATED,INTERVENTIONAL,"We stopped inserting BioFlo ports, no more patients to recruit"
NCT02923986,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02924194,TERMINATED,INTERVENTIONAL,The study was halted prematurely due to lack of interested participants.
NCT02924233,WITHDRAWN,INTERVENTIONAL,Symphogen made a business decision to no longer perform the clinical study
NCT02924298,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02924389,TERMINATED,INTERVENTIONAL,This study terminated early due to the ongoing covid-19 pandemic making it unsafe to recruit participants for in-person visits. Participants are living with HIV who are antiretroviral therapy-naive and are at high risk of COVID-19 complications.
NCT02924428,TERMINATED,INTERVENTIONAL,not commenced
NCT02924506,TERMINATED,INTERVENTIONAL,Moving of coordinator.
NCT02924675,TERMINATED,INTERVENTIONAL,not sufficiency recruitment
NCT02924714,SUSPENDED,INTERVENTIONAL,Slow accrual
NCT02924961,TERMINATED,INTERVENTIONAL,Mobile-bearing insert dislocation
NCT02925364,TERMINATED,OBSERVATIONAL,Slow recruitment
NCT02925507,WITHDRAWN,OBSERVATIONAL,Problems with biosensor not working properly and not functional for study
NCT02925533,TERMINATED,INTERVENTIONAL,Terminated due to safety concerns.
NCT02925676,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT02925780,WITHDRAWN,INTERVENTIONAL,Organisational and regulatory challenges.
NCT02925884,TERMINATED,INTERVENTIONAL,The sponsor failed to provide financial support as promised.
NCT02926040,TERMINATED,OBSERVATIONAL,PI left hospital
NCT02926092,TERMINATED,OBSERVATIONAL,Development of SHP630 was discontinued based on lack of preclinical efficacy.
NCT02926209,TERMINATED,INTERVENTIONAL,Further development needed to facilitate easier polypectomy - device improvement
NCT02926248,SUSPENDED,INTERVENTIONAL,Continuing IRB review was not submitted. Study was inactivated with the institutional IRB.
NCT02926404,TERMINATED,OBSERVATIONAL,Early terminated for administrative reasons
NCT02926495,WITHDRAWN,INTERVENTIONAL,The study was stopped before start because the project was not fully-funded.
NCT02926521,WITHDRAWN,INTERVENTIONAL,COVID 19 RELATED FACTORS
NCT02926638,TERMINATED,INTERVENTIONAL,Drug company decided to terminate all sponsored clinical studies involving rilotumumab.
NCT02926872,TERMINATED,OBSERVATIONAL,Study scope re-assessed.
NCT02926963,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT02927080,TERMINATED,INTERVENTIONAL,Study was discontinued as it did not achieve functional secondary endpoints.
NCT02927249,TERMINATED,INTERVENTIONAL,DSMB review
NCT02927366,TERMINATED,INTERVENTIONAL,Study was terminated early for strategic reasons. Only Part I of the study was completed.
NCT02927405,WITHDRAWN,INTERVENTIONAL,"Did not get the study to take off, did not recruit any subjects, and then closed the study."
NCT02927431,TERMINATED,INTERVENTIONAL,The study was stopped early due to lack of enrollment.
NCT02927470,WITHDRAWN,INTERVENTIONAL,Investigators are no longer at NYU Langone Health
NCT02927860,TERMINATED,OBSERVATIONAL,Fitbit was not giving the necessary data.
NCT02927938,TERMINATED,INTERVENTIONAL,Study terminated 7/23/2019 due to limited participation and testing challenges.
NCT02928029,TERMINATED,INTERVENTIONAL,Due to the changes of standard of care and the slow recruitment of participants.
NCT02928263,WITHDRAWN,OBSERVATIONAL,Business objectives have changed
NCT02928289,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02928302,WITHDRAWN,INTERVENTIONAL,new protocol started 31/18
NCT02928393,TERMINATED,INTERVENTIONAL,Low participant enrolment
NCT02928419,TERMINATED,INTERVENTIONAL,"""the study has been closed due to a low rate of patient enrollment (2 patients since the start of the trial)"""
NCT02928445,TERMINATED,INTERVENTIONAL,Intepirdine did not meet its primary efficacy endpoints in the lead-in study RVT-101-2001.
NCT02928458,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT02928510,TERMINATED,OBSERVATIONAL,withdrawn by sponsor
NCT02928744,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02928887,WITHDRAWN,INTERVENTIONAL,Cardiac surgeon collaborator has left the institution
NCT02929056,TERMINATED,INTERVENTIONAL,grant funding ended
NCT02929316,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02929394,TERMINATED,INTERVENTIONAL,Poor accrual
NCT02929407,TERMINATED,INTERVENTIONAL,Trial terminated due to difficult recruitment
NCT02929498,TERMINATED,INTERVENTIONAL,The risk benefit in the study population does not favor continuation of the study
NCT02929576,WITHDRAWN,INTERVENTIONAL,Further understanding about the role of androgen signaling in TNBC was required
NCT02929589,TERMINATED,INTERVENTIONAL,The use of robotic surgery made this study obsolete.
NCT02930122,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02930161,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02930343,TERMINATED,INTERVENTIONAL,"Due to time constraints, the study was halted prematurely"
NCT02930499,SUSPENDED,INTERVENTIONAL,Investigator relocation
NCT02930538,WITHDRAWN,OBSERVATIONAL,PI left the institution
NCT02930564,TERMINATED,INTERVENTIONAL,It is not possible to continue the study
NCT02930811,WITHDRAWN,INTERVENTIONAL,The Investigator-Coordinator has moved to Rennes University Hospital. It will be done under the sponsor of Rennes University Hospital : NCT03686306
NCT02930941,TERMINATED,INTERVENTIONAL,Terminate due to slow enrollment rate.
NCT02931110,TERMINATED,INTERVENTIONAL,Business reasons
NCT02931253,TERMINATED,INTERVENTIONAL,Recruitment issue: Enrollment expectation not met
NCT02931266,TERMINATED,OBSERVATIONAL,Lack of inclusions
NCT02931565,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to enrollment challenges.
NCT02931578,TERMINATED,INTERVENTIONAL,"PI unexpectedly passed away, study future to be determined"
NCT02931682,TERMINATED,OBSERVATIONAL,Sponsor decision not related to safety concerns
NCT02932111,TERMINATED,INTERVENTIONAL,Futility
NCT02932176,SUSPENDED,OBSERVATIONAL,COVID-19 and lack of staff
NCT02932202,WITHDRAWN,INTERVENTIONAL,The trial was stopped due to no recruitment
NCT02932293,WITHDRAWN,INTERVENTIONAL,The collaborating pharmaceutical company will not wish to continue with the trial due to the internal issues in the company.
NCT02932319,TERMINATED,INTERVENTIONAL,Deficient Inclusions
NCT02932345,TERMINATED,OBSERVATIONAL,"Due to strategic decision, AZ has applied to terminate study at all participating sites and has committed that the data generated during the course of the study will not be submitted to China National Medical Products Administration."
NCT02932371,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02932475,TERMINATED,INTERVENTIONAL,Recommendation by the DSMB that the study be stopped for futility
NCT02932488,TERMINATED,INTERVENTIONAL,Pilot study with sumatriptan found no significant changes in the primary outcome parameter (change in CBF)
NCT02932553,WITHDRAWN,INTERVENTIONAL,BVS was withdrawn from the market
NCT02932579,TERMINATED,INTERVENTIONAL,Study was halted permanently due to enrollment and logistic issues.
NCT02932982,TERMINATED,OBSERVATIONAL,No more patients to include
NCT02933073,TERMINATED,INTERVENTIONAL,Study recruitment is temporary on hold by the sponsor due to patient recruitment challenges and the ongoing review of the investigational adjuvant.
NCT02933593,WITHDRAWN,INTERVENTIONAL,PI withdrew the protocol
NCT02933671,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving any intervention.
NCT02933684,WITHDRAWN,INTERVENTIONAL,Unable to access components necessary to be able to run the study.
NCT02933801,TERMINATED,INTERVENTIONAL,Decision Board no further financial support after 3 years of follow-up as remaining patients in follow-up phase would not relevantly change the endpoints.
NCT02933814,WITHDRAWN,INTERVENTIONAL,Inadequate number of subjects meet study criteria
NCT02933840,WITHDRAWN,INTERVENTIONAL,Target patient population reevaluated prior to enrollment
NCT02933944,TERMINATED,INTERVENTIONAL,Changing priorities
NCT02934503,TERMINATED,INTERVENTIONAL,"This study was terminated as the standard of care for small cell lung cancer changed in 2018 to include immunotherapy in the front line setting, making this study no longer clinically relevant."
NCT02934854,WITHDRAWN,OBSERVATIONAL,Transition into BioMetabol
NCT02934932,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment.
NCT02935101,TERMINATED,INTERVENTIONAL,difficulties in recruiting study participants
NCT02935387,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT02935465,TERMINATED,INTERVENTIONAL,Synthesis of the chemical precursor for the neuroimaging radiotracer could not be produced in a stable fashion.
NCT02935478,SUSPENDED,INTERVENTIONAL,IRB reviewing study conduct and adverse events
NCT02935543,TERMINATED,INTERVENTIONAL,Study is terminated because of administrative reasons.
NCT02935556,TERMINATED,OBSERVATIONAL,Low Accrual
NCT02935569,TERMINATED,INTERVENTIONAL,Results with 4 subjects suggest a redesign of Compression system is required.
NCT02935673,TERMINATED,INTERVENTIONAL,sponsor decision
NCT02936037,TERMINATED,INTERVENTIONAL,Sponsor decision for business purposes
NCT02936063,WITHDRAWN,INTERVENTIONAL,PI left the institution before any participants were enrolled.
NCT02936115,TERMINATED,INTERVENTIONAL,Osiris decision
NCT02936128,TERMINATED,INTERVENTIONAL,Osiris decision
NCT02936206,TERMINATED,INTERVENTIONAL,low accrual rate
NCT02936466,TERMINATED,INTERVENTIONAL,difficulties encountered in recruiting and stop of funding
NCT02936726,TERMINATED,INTERVENTIONAL,Recruitment Completed
NCT02936947,TERMINATED,INTERVENTIONAL,due to Covid19 restrictions
NCT02936999,TERMINATED,INTERVENTIONAL,Terminated for lack of patient samples and funding
NCT02937038,TERMINATED,OBSERVATIONAL,COVID-19 difficulties recruiting
NCT02937168,TERMINATED,INTERVENTIONAL,The study was terminated early due to challenges in recruitment. The decision to terminate the study was not related to any safety issues or concerns.
NCT02937402,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02937675,TERMINATED,INTERVENTIONAL,patient recruitment
NCT02937766,TERMINATED,INTERVENTIONAL,The Sponsor elected to discontinue the study prematurely due to business reasons
NCT02937909,TERMINATED,INTERVENTIONAL,Due to Inadequate patient recruitment
NCT02939365,WITHDRAWN,INTERVENTIONAL,Because of inability to get FDA approval for
NCT02939469,WITHDRAWN,INTERVENTIONAL,The PI passed away.
NCT02939599,TERMINATED,INTERVENTIONAL,Study was terminated early for strategic reasons. Only Part I of the study was completed.
NCT02939742,TERMINATED,INTERVENTIONAL,Low study recruitment
NCT02939781,TERMINATED,OBSERVATIONAL,Unable to recruit to protocol
NCT02939807,WITHDRAWN,INTERVENTIONAL,study is being rewritten for different disease population
NCT02939846,WITHDRAWN,INTERVENTIONAL,Change in strategy
NCT02939859,WITHDRAWN,INTERVENTIONAL,Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]
NCT02939976,TERMINATED,INTERVENTIONAL,Funding for this study has been discontinued.
NCT02940015,WITHDRAWN,OBSERVATIONAL,Closed by PI.
NCT02940041,TERMINATED,OBSERVATIONAL,Not enough patients included
NCT02940106,TERMINATED,INTERVENTIONAL,"enrollment too slow, too many variables included in the study"
NCT02940223,TERMINATED,INTERVENTIONAL,PI is requesting termination (closure) of this study.
NCT02940457,WITHDRAWN,INTERVENTIONAL,The employe for the study quit and a new grant proposal was not financed
NCT02940509,TERMINATED,INTERVENTIONAL,Change in practice of medicine. There were no longer sufficient patients to enroll in the study that met criteria.
NCT02940548,TERMINATED,INTERVENTIONAL,The patient recruitment and follow-ups were influenced with the pandemic of COVID-19
NCT02940587,WITHDRAWN,INTERVENTIONAL,"New record created in clinical trials due to company re-branding, and inability to list new name as the sponsor."
NCT02940626,TERMINATED,INTERVENTIONAL,As a result of a pre-planned interim analysis for futility
NCT02940691,TERMINATED,INTERVENTIONAL,Poor recruitment due to new treatments becoming available.
NCT02940769,TERMINATED,INTERVENTIONAL,Funding no longer available
NCT02941016,WITHDRAWN,INTERVENTIONAL,Logistic reasons
NCT02941510,WITHDRAWN,INTERVENTIONAL,Stopped prior to enrollment per PI and DSMB decision.
NCT02941601,WITHDRAWN,INTERVENTIONAL,This was a strategic decision for business planning purposes and not out of concern for patient safety.
NCT02941666,TERMINATED,OBSERVATIONAL,Study staff was unable to collect proper samples to meet study goals
NCT02941835,TERMINATED,INTERVENTIONAL,slow inclusion rate
NCT02942056,WITHDRAWN,INTERVENTIONAL,Could not obtain appropriate funding or standardized manufacturing for cinnamon tablets
NCT02942212,WITHDRAWN,INTERVENTIONAL,No activties have occurred and no participants have enrolled in this protocol
NCT02942485,TERMINATED,INTERVENTIONAL,Extremely slow enrollment
NCT02942758,TERMINATED,INTERVENTIONAL,Due to financial reasons.
NCT02943096,TERMINATED,INTERVENTIONAL,Study stopped due to funding limitations
NCT02943317,TERMINATED,INTERVENTIONAL,"The study was terminated upon completion of escalation phase, prior to opening expansion cohorts"
NCT02943447,TERMINATED,INTERVENTIONAL,The study was terminated because of the availability of alternate therapies for primary biliary cholangitis (PBC).
NCT02943473,TERMINATED,INTERVENTIONAL,Poor accrual and risk/benefit ratio.
NCT02943603,WITHDRAWN,INTERVENTIONAL,No participants enrolled. PI/Sponsor left UPitt. IND withdrawn \& revised protocol submitted through the new institution. New study recruiting under NCT03488667.
NCT02943616,WITHDRAWN,INTERVENTIONAL,Abbott has decided to stop selling the Absorb stent which was the product under evaluation in this study.
NCT02943629,WITHDRAWN,INTERVENTIONAL,Lack of feasibility
NCT02943668,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT02943733,TERMINATED,INTERVENTIONAL,"closed per sponsor request, for slow enrollment"
NCT02943837,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT02944578,SUSPENDED,INTERVENTIONAL,The study activities are on hold due to COVID-19
NCT02944721,WITHDRAWN,INTERVENTIONAL,change of sponsor
NCT02945046,TERMINATED,INTERVENTIONAL,Study was terminated as a result of a pre-specified futility analysis at the interim of 150 participants completing the efficacy analysis of the study.
NCT02945280,TERMINATED,INTERVENTIONAL,COVID-19 resource allocation
NCT02945423,WITHDRAWN,OBSERVATIONAL,funding issues
NCT02945527,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02945605,TERMINATED,INTERVENTIONAL,Because of recruitment challenges
NCT02945644,SUSPENDED,INTERVENTIONAL,COVID19 pandemic
NCT02945696,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT02945813,TERMINATED,INTERVENTIONAL,Trial was prematurely closed for accrual by the SAKK Board and the follow-up period shortened to one year after last RT fraction of the last patient
NCT02945839,WITHDRAWN,INTERVENTIONAL,Significant changes have been made to the protocol.
NCT02946138,WITHDRAWN,INTERVENTIONAL,enrollment was too slow
NCT02946268,WITHDRAWN,INTERVENTIONAL,Insufficient staff
NCT02946346,TERMINATED,INTERVENTIONAL,Difficulty to continue follow-up during the coronavirus epidemic
NCT02946437,WITHDRAWN,INTERVENTIONAL,Patients failed to be enrolled because of tight exclusion criteria.
NCT02946580,TERMINATED,INTERVENTIONAL,Slow recruitment and inability to extend funding.
NCT02946918,TERMINATED,INTERVENTIONAL,Terminating study as sponsor has sold the drug to another company
NCT02947022,TERMINATED,INTERVENTIONAL,PI left institution.
NCT02947100,TERMINATED,INTERVENTIONAL,manufacturing problem with study drug
NCT02947113,WITHDRAWN,INTERVENTIONAL,New studies available with immunotherapy so recruitment is no longer acceptable.
NCT02947243,WITHDRAWN,INTERVENTIONAL,Major changes to protocol (new study design and comparator)
NCT02947399,TERMINATED,INTERVENTIONAL,Institutional RDRC dissolved
NCT02947516,WITHDRAWN,INTERVENTIONAL,Funding n/a
NCT02947581,TERMINATED,INTERVENTIONAL,"Albendazole and albendazole placebo are not available in our local suppliers or in the international market. Consequently, it is no possible to re-initiate the enrollment to complete the original sample size."
NCT02947880,WITHDRAWN,INTERVENTIONAL,the recently feasibility study shows that the number of patients is insufficient in the centers
NCT02947919,WITHDRAWN,INTERVENTIONAL,Problems with samples handling
NCT02948049,TERMINATED,OBSERVATIONAL,Principal Investigator resigned from institution
NCT02948062,WITHDRAWN,OBSERVATIONAL,Funding unavailable
NCT02948101,WITHDRAWN,INTERVENTIONAL,PI's request
NCT02948114,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT02948140,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT02948192,TERMINATED,OBSERVATIONAL,Inability to obtain final specimen routinely
NCT02948426,TERMINATED,INTERVENTIONAL,Study was closed to accrual due to lack of drug supply.
NCT02948634,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT02948712,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT02948855,WITHDRAWN,OBSERVATIONAL,Improper design of the trial and no participants enrolled.
NCT02949232,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT02949375,TERMINATED,INTERVENTIONAL,Administrative decision
NCT02949479,TERMINATED,INTERVENTIONAL,"STUDY INVESTIGATORS HAVE LEFT THE INSTITUTION, THE DEPARTMENT NO LONGER HAS TIME TO INCLUDE"
NCT02949492,TERMINATED,INTERVENTIONAL,Safety concerns
NCT02949609,TERMINATED,INTERVENTIONAL,investigator
NCT02949661,WITHDRAWN,INTERVENTIONAL,Loss of interest in the subject
NCT02949687,WITHDRAWN,INTERVENTIONAL,investigator institution change
NCT02949843,TERMINATED,INTERVENTIONAL,"Slow accrual, closed by IRB"
NCT02949908,TERMINATED,OBSERVATIONAL,Delay in site selection and recruitment.
NCT02949947,TERMINATED,INTERVENTIONAL,Terminated per PI's request
NCT02950025,TERMINATED,INTERVENTIONAL,Low accrual
NCT02950116,TERMINATED,INTERVENTIONAL,Availabe time for inclusion ended (master thesis)
NCT02950181,TERMINATED,INTERVENTIONAL,"Concerns over standard of care and recruiting process. Investigator left UAMS, therefore study halted immediately"
NCT02950233,TERMINATED,INTERVENTIONAL,Recruitment was slower than expected and study drug reached expiry
NCT02950311,WITHDRAWN,INTERVENTIONAL,On clinical hold with the FDA. Insufficient funds to conduct the study
NCT02950480,TERMINATED,INTERVENTIONAL,Low accrual.
NCT02950506,WITHDRAWN,INTERVENTIONAL,Lack of resources
NCT02950649,TERMINATED,OBSERVATIONAL,PI left institution 10/01/2020 and no further subjects were enrolled and no further data was collected.
NCT02950792,WITHDRAWN,INTERVENTIONAL,Investigator Decision
NCT02950896,TERMINATED,OBSERVATIONAL,Appropriate devices for fetal heart rate monitoring were not available.
NCT02950935,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT02950948,WITHDRAWN,INTERVENTIONAL,inability to recruit an adequate number of subjects.
NCT02951117,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02951156,TERMINATED,INTERVENTIONAL,Study was terminated due to closure of study arms following futility analysis and difficulty in enrolling participants due to evolving treatment landscape
NCT02951338,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT02951377,TERMINATED,INTERVENTIONAL,Recruitment
NCT02951572,TERMINATED,INTERVENTIONAL,Recruitment problem
NCT02951845,WITHDRAWN,INTERVENTIONAL,JNJ-54416076 program has been stopped for strategic business reasons.
NCT02951884,TERMINATED,INTERVENTIONAL,The study was stopped for feasibility (low enrollment)
NCT02951936,WITHDRAWN,INTERVENTIONAL,Difficulties in recrutment
NCT02951975,TERMINATED,OBSERVATIONAL,Business decision to stop the program.
NCT02952066,WITHDRAWN,INTERVENTIONAL,"Prior to any participant enrollment, the PI opted to not move forward with the study."
NCT02952196,WITHDRAWN,INTERVENTIONAL,Funding
NCT02952287,TERMINATED,INTERVENTIONAL,Logistically recruitment was not applicable after trial of a few patients
NCT02952573,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT02952586,TERMINATED,INTERVENTIONAL,The trial prematurely terminated as recommended by the E-DMC because the boundary for futility has been crossed.
NCT02952742,WITHDRAWN,INTERVENTIONAL,Lack of funding support
NCT02952859,TERMINATED,OBSERVATIONAL,PI left hospital
NCT02952989,TERMINATED,INTERVENTIONAL,Due to overall benefit/risk profile
NCT02953067,TERMINATED,INTERVENTIONAL,Unable to reach the required sample size
NCT02953106,TERMINATED,INTERVENTIONAL,The company providing study IMP was unable to supply further batches of IMP.
NCT02953119,TERMINATED,INTERVENTIONAL,Difficulty recruiting patients
NCT02953145,WITHDRAWN,INTERVENTIONAL,Lack of support
NCT02953366,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02953379,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT02953418,TERMINATED,INTERVENTIONAL,Enrollment taking longer than expected.
NCT02953444,TERMINATED,INTERVENTIONAL,Insufficient personnel to complete the study.
NCT02953496,WITHDRAWN,INTERVENTIONAL,Change in operating plans
NCT02953561,TERMINATED,INTERVENTIONAL,PDOL request
NCT02953613,TERMINATED,OBSERVATIONAL,unable to identify sufficient eligible patients to meet enrollment goals
NCT02953691,WITHDRAWN,INTERVENTIONAL,Lack of Study Substance
NCT02953769,TERMINATED,OBSERVATIONAL,Principal Investigator left the Hospital and did not transfer the study
NCT02954159,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT02954185,TERMINATED,INTERVENTIONAL,Recruitment/Financial Issues
NCT02954211,WITHDRAWN,INTERVENTIONAL,Researcher left University
NCT02954380,WITHDRAWN,INTERVENTIONAL,Funding
NCT02954406,TERMINATED,INTERVENTIONAL,"Business decision, insufficient enrollment, no safety or efficacy concerns."
NCT02954653,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in sponsor prioritization.
NCT02954796,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT02954991,TERMINATED,INTERVENTIONAL,This study was terminated as a result of Sponsor portfolio reprioritization.
NCT02955095,WITHDRAWN,INTERVENTIONAL,withdrawn due to lack of funding
NCT02955121,TERMINATED,INTERVENTIONAL,Slower than anticipated recruitment
NCT02955147,TERMINATED,INTERVENTIONAL,Inefficacy
NCT02955368,WITHDRAWN,INTERVENTIONAL,Canceled
NCT02955381,TERMINATED,INTERVENTIONAL,Liquidation of Research Department
NCT02955511,TERMINATED,INTERVENTIONAL,"The blade used in the study was modified (changed) by the manufacturer, it does not longer exist."
NCT02955524,WITHDRAWN,INTERVENTIONAL,I discontinued this study because I transferred to another institution.
NCT02955654,WITHDRAWN,INTERVENTIONAL,Loss of finacial support
NCT02955771,TERMINATED,INTERVENTIONAL,Business Decision
NCT02955888,TERMINATED,INTERVENTIONAL,Unsatisfactory rate of recruitment
NCT02955979,TERMINATED,OBSERVATIONAL,Due to lack of funding
NCT02956005,TERMINATED,INTERVENTIONAL,IIS - PI left the institution. Subjects just followed to study completion
NCT02956122,TERMINATED,INTERVENTIONAL,The decision to discontinue the study was based on business reasons.
NCT02956486,TERMINATED,INTERVENTIONAL,"Due to an unfavorable risk-benefit ratio including no evidence of potential efficacy, and the adverse event profile of E2609 being worse than placebo."
NCT02956629,TERMINATED,INTERVENTIONAL,The study was terminated based on review of Phase 2 efficacy data
NCT02956785,TERMINATED,INTERVENTIONAL,Inability to recruit more women because of the COVID-19 and staffing/resources issues
NCT02956889,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT02956980,TERMINATED,INTERVENTIONAL,recruitment target not obtained
NCT02957019,TERMINATED,INTERVENTIONAL,Slow progression due to difficulties in finding eligible patients. Competitive clinical trials with innovative agents and new approved products leaddefinitive stop.
NCT02957032,TERMINATED,INTERVENTIONAL,New agents for the same indication impacted on patients' recruitment
NCT02957097,WITHDRAWN,INTERVENTIONAL,Original PI left institution and the PI who took over was not able to initiate the study so it was never started.
NCT02957435,WITHDRAWN,INTERVENTIONAL,Study has been cancelled and it has not been initiated.
NCT02957617,TERMINATED,INTERVENTIONAL,The parent study did not meet its primary or secondary efficacy endpoints and therefore Sponsor decision to discontinue development in this indication.
NCT02957825,TERMINATED,INTERVENTIONAL,Covid pandemic
NCT02958098,TERMINATED,OBSERVATIONAL,Sponsor withdrew funding
NCT02958163,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02958202,TERMINATED,INTERVENTIONAL,"Regulatory approval was not obtained for drisapersen, hence BioMarin is stopping the development of all exon skipping oligonucleotides in DMD."
NCT02958254,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT02958358,WITHDRAWN,INTERVENTIONAL,inability to recruit subjects
NCT02958917,TERMINATED,INTERVENTIONAL,covid-19 pandemic
NCT02958982,TERMINATED,INTERVENTIONAL,Significant recruitment delay in POC part
NCT02959073,TERMINATED,OBSERVATIONAL,Company's strategic reasons
NCT02959112,TERMINATED,INTERVENTIONAL,"Because previous studies had found no difference, and one recent study even reported a higher incidence of PEP in treatment arm"
NCT02959281,WITHDRAWN,INTERVENTIONAL,Enrollement failure
NCT02959294,WITHDRAWN,INTERVENTIONAL,COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]\]
NCT02959359,WITHDRAWN,INTERVENTIONAL,The supplies of study drug were halted by Gilead Sciences Ltd.
NCT02959411,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT02959437,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor
NCT02960139,TERMINATED,INTERVENTIONAL,Protocol updates resulted in new protocol/study
NCT02960191,TERMINATED,INTERVENTIONAL,recruitment difficult
NCT02960217,TERMINATED,INTERVENTIONAL,Study was halted prematurely due to lack of efficacy.
NCT02960282,TERMINATED,OBSERVATIONAL,Slow accrual
NCT02960399,TERMINATED,INTERVENTIONAL,PI has terminated the study at this time.
NCT02960503,WITHDRAWN,INTERVENTIONAL,"Key personnel moved to new location. Therefore, we had insufficient resources to initiate the trial."
NCT02961114,WITHDRAWN,INTERVENTIONAL,COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform
NCT02961283,TERMINATED,INTERVENTIONAL,reformulation
NCT02961322,TERMINATED,INTERVENTIONAL,not enough inclusions
NCT02961686,WITHDRAWN,OBSERVATIONAL,None patient was enrolled
NCT02961816,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT02962154,WITHDRAWN,OBSERVATIONAL,Our physician researcher left WCM after the trial was approved.
NCT02962245,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT02962362,TERMINATED,OBSERVATIONAL,Unable to complete enrollment of subjects.
NCT02962388,TERMINATED,INTERVENTIONAL,not enough recruitment
NCT02962427,TERMINATED,INTERVENTIONAL,Decided to participate in a multicenter trial researching the same issue
NCT02962674,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT02962804,WITHDRAWN,INTERVENTIONAL,Due to competing trials. Stopped before IRB approval.
NCT02962973,SUSPENDED,INTERVENTIONAL,Occurrence of a quality issue affecting some of its prostheses
NCT02963051,TERMINATED,INTERVENTIONAL,Study stopped due to lack of efficacy.
NCT02963090,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02963103,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study because subject enrollment was difficult.
NCT02963181,TERMINATED,INTERVENTIONAL,PI leaving
NCT02963363,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT02963610,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to funding/support being withdrawn by grantor
NCT02964325,TERMINATED,INTERVENTIONAL,"Based interim analysis results, Data Monitoring Committee did not believe the primary efficacy endpoint would be met. No patient safety concerns."
NCT02964338,TERMINATED,INTERVENTIONAL,Futility analysis revealed that the primary endpoint is unlikely to be met. There were no safety concerns observed with fremanezumab treatment in the trial.
NCT02964481,TERMINATED,OBSERVATIONAL,Lack of funding to enroll additional participants
NCT02964507,TERMINATED,INTERVENTIONAL,This study has been terminated due to meeting protocol defined futility.
NCT02964546,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT02964741,TERMINATED,INTERVENTIONAL,due to COVID-19
NCT02964962,WITHDRAWN,INTERVENTIONAL,Currently not moving forward with the study
NCT02964988,TERMINATED,INTERVENTIONAL,Recruitment issues and interim results
NCT02965014,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic, this health department-based trial ended early to limit utilizing clinic services and resources and to ensure participant and staff safety. This termination primarily affected the 12-month follow-up appointments."
NCT02965417,WITHDRAWN,INTERVENTIONAL,Symphogen made a business decision to no longer perform the clinical study.
NCT02965443,TERMINATED,INTERVENTIONAL,Low patient recruitment
NCT02965508,TERMINATED,INTERVENTIONAL,The Data Safety Monitoring Board determined that the serious adverse event rate was higher among patients awaiting enrollment in the home-based primary care intervention compared to those who had initiated home-based primary care.
NCT02965599,TERMINATED,INTERVENTIONAL,The study was terminated following an internal review of the company's current research and development portfolio.
NCT02965768,WITHDRAWN,INTERVENTIONAL,"Study was temporarily suspended to focus on other projects, but was never resumed. No participants were determined eligible and none started the protocol."
NCT02965911,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT02966002,TERMINATED,INTERVENTIONAL,This study was terminated due to inability to recruit sufficient patients.
NCT02966080,WITHDRAWN,INTERVENTIONAL,"No participants enrolled, study will not be conducted."
NCT02966106,WITHDRAWN,INTERVENTIONAL,The study design was not compatible with recruiting patients to the investigation
NCT02966119,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT02966171,TERMINATED,INTERVENTIONAL,The study was terminated on 23AUG2018 for safety reasons.
NCT02966184,TERMINATED,INTERVENTIONAL,Study Drug Backorder
NCT02966223,TERMINATED,INTERVENTIONAL,Sponsor prematurely withdrew financial support.
NCT02966288,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT02966431,TERMINATED,INTERVENTIONAL,Strict study protocol and lack of participant reimbursement was not advantageous and feasible as evidenced by the high rate of attrition.
NCT02966470,TERMINATED,OBSERVATIONAL,Due to accrual not met and PI no longer at the institution
NCT02966587,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to opening to enrollment
NCT02966730,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT02966899,WITHDRAWN,INTERVENTIONAL,Never initiated
NCT02967133,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT02967380,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT02967445,WITHDRAWN,INTERVENTIONAL,never started
NCT02967770,WITHDRAWN,INTERVENTIONAL,Issues with patient recruitment.
NCT02967835,WITHDRAWN,INTERVENTIONAL,not able to recruit
NCT02968121,TERMINATED,INTERVENTIONAL,Part A of study was completed per protocol. Conduct of Part B of the study (confirmatory phase) was not necessary.
NCT02968160,TERMINATED,INTERVENTIONAL,Due to poor enrollment rate
NCT02968459,WITHDRAWN,INTERVENTIONAL,The pandemic resulted in no enrollments.
NCT02968511,WITHDRAWN,INTERVENTIONAL,Lack of eligible patients
NCT02968641,WITHDRAWN,INTERVENTIONAL,"This study was initially planned to enroll patients in Mongolia. However, due to challenges in setting it up in Mongolia, this study was later determined not to be initiated."
NCT02968680,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT02968784,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT02968966,WITHDRAWN,INTERVENTIONAL,no patients recruited
NCT02969265,WITHDRAWN,INTERVENTIONAL,Business reasons unrelated to product safety
NCT02969824,TERMINATED,INTERVENTIONAL,"The study was terminated prematurely due to COVID pandemic in July 2020 in Toronto, Canada. Our institution did not allow for in-person research, making continuation of the study untenable."
NCT02969876,TERMINATED,INTERVENTIONAL,Site was unable to reach Sponsor recruitment goals.
NCT02970097,WITHDRAWN,INTERVENTIONAL,lack of resources
NCT02970331,WITHDRAWN,INTERVENTIONAL,FDA requested us to stop the study
NCT02970435,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02970474,WITHDRAWN,INTERVENTIONAL,Lack of enrollment and loss of co-investigator.
NCT02970500,TERMINATED,INTERVENTIONAL,We decided to close recruitment in December 2022 as we were having trouble recruiting participants who met our inclusion criteria and the study funding was coming to an end.
NCT02970773,WITHDRAWN,INTERVENTIONAL,insufficient recruitment; sponsor-investigator has left the institution
NCT02970851,TERMINATED,OBSERVATIONAL,Slow patient recruitment after arrival of macitentan on the market
NCT02970903,WITHDRAWN,INTERVENTIONAL,We were unable to secure funding for the triaging experiment. The participatory design process ran its course as intended.
NCT02971033,TERMINATED,INTERVENTIONAL,Study Funding ended
NCT02971410,WITHDRAWN,INTERVENTIONAL,PI no longer interested in pursuing study.
NCT02971436,TERMINATED,INTERVENTIONAL,project progression decision was able to be made with the data already gathered
NCT02971839,TERMINATED,INTERVENTIONAL,Decision by Sponsor.
NCT02972281,TERMINATED,INTERVENTIONAL,deficient inclusions
NCT02972294,TERMINATED,INTERVENTIONAL,1year inclusion hold due to PV new fact (Monofer hold for risk revaluation) DSMB Interim analysis : 1treatment with important transfusion risk reduction/inclusions issues (COVID)/sites change of practice if study continue=\>stop inclusions
NCT02972450,TERMINATED,INTERVENTIONAL,"Due to the bankruptcy of FITBiotech, the provider of the GTU DNA vaccine."
NCT02972502,TERMINATED,INTERVENTIONAL,PI lapsed institutional training
NCT02972658,TERMINATED,INTERVENTIONAL,"As the feeder study (AZES) was stopped for futility after an independent assessment, this trial was also stopped."
NCT02972866,WITHDRAWN,INTERVENTIONAL,Regulatory strategy
NCT02973009,WITHDRAWN,OBSERVATIONAL,investigator choice
NCT02973074,TERMINATED,INTERVENTIONAL,no enough partcipants enrolled in the 1 year planned for recruitment
NCT02973191,WITHDRAWN,INTERVENTIONAL,Development of JCAR015 has been discontinued. No subjects were enrolled/treated under protocol JCAR015-ALL-001
NCT02973269,TERMINATED,INTERVENTIONAL,New trial with same indication initiated
NCT02973295,WITHDRAWN,INTERVENTIONAL,Sponsor withdrawn their agreement
NCT02973399,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02973711,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT02974023,WITHDRAWN,OBSERVATIONAL,Study not started due to the Regulatory and administrative issues of Universities in Vietnam
NCT02974140,TERMINATED,INTERVENTIONAL,Management Decision
NCT02974257,TERMINATED,INTERVENTIONAL,Study stopped early after consultation with DSMB
NCT02974322,WITHDRAWN,INTERVENTIONAL,Sponsor decision not to start trial
NCT02974673,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT02974686,TERMINATED,INTERVENTIONAL,low recruitment
NCT02974777,WITHDRAWN,INTERVENTIONAL,not started due to regulatory reasons
NCT02974790,TERMINATED,OBSERVATIONAL,Not enough patient
NCT02974803,TERMINATED,INTERVENTIONAL,Very slow accrual
NCT02975011,TERMINATED,OBSERVATIONAL,This study was prematurely terminated due to delayed patient enrollment.
NCT02975128,TERMINATED,INTERVENTIONAL,Needle production stopped
NCT02975271,TERMINATED,INTERVENTIONAL,Business Reasons
NCT02975336,TERMINATED,INTERVENTIONAL,Study is completed; primary analysis completed.
NCT02975505,SUSPENDED,INTERVENTIONAL,Due to challenges in recruitment and holding visits during COVID
NCT02975557,TERMINATED,INTERVENTIONAL,Slow accrual of subjects. May take longer than expected to complete the trial.
NCT02975570,WITHDRAWN,INTERVENTIONAL,The study could not be conducted since funding was not obtained.
NCT02975583,WITHDRAWN,INTERVENTIONAL,We could not secure adequate medication
NCT02975713,TERMINATED,OBSERVATIONAL,"no participants were recruited,study stopped"
NCT02975739,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02975778,TERMINATED,INTERVENTIONAL,Budgetary and operational issues
NCT02975921,WITHDRAWN,INTERVENTIONAL,The site decided not to proceed with the protocol.
NCT02975999,WITHDRAWN,INTERVENTIONAL,"Pilot study is finished, multi centered is not moving forward"
NCT02976038,TERMINATED,INTERVENTIONAL,Registration trial did not meet the primary end points
NCT02976441,WITHDRAWN,INTERVENTIONAL,Physician decided not to go through with study
NCT02976558,TERMINATED,INTERVENTIONAL,"Due to organisational issues, the study had to be completed prematurely."
NCT02976701,TERMINATED,INTERVENTIONAL,The investigational cases were no longer relevant considering the recent implementation of our current national healthcare system.
NCT02976766,TERMINATED,INTERVENTIONAL,Low enrolment
NCT02976948,TERMINATED,OBSERVATIONAL,Inclusion of the last patient
NCT02977039,WITHDRAWN,INTERVENTIONAL,no funding
NCT02977286,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02977585,TERMINATED,INTERVENTIONAL,COVID 19 PANDEMIA
NCT02977611,WITHDRAWN,INTERVENTIONAL,FDA Clinical Hold
NCT02977689,WITHDRAWN,INTERVENTIONAL,Novartis paused all study start-up activities due to safety evaluation of IDH305 compound.
NCT02977741,WITHDRAWN,OBSERVATIONAL,Inability to recruit patients
NCT02977767,WITHDRAWN,INTERVENTIONAL,Participants do not accept hypnosis.
NCT02978222,TERMINATED,INTERVENTIONAL,Futility analysis did not support continuation of the trial
NCT02978235,TERMINATED,INTERVENTIONAL,The trial was put on Clinical Hold and subsequently terminated prior to Phase 2 due to cases of drug induced liver injury meeting the criteria for Hy's Law
NCT02978378,TERMINATED,OBSERVATIONAL,insufficient patients to satisfy study protocol(s) inclusion criteria
NCT02978443,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT02978560,WITHDRAWN,OBSERVATIONAL,Funding was never obtained
NCT02978651,WITHDRAWN,INTERVENTIONAL,Strategic decision of Sponsor
NCT02978716,TERMINATED,INTERVENTIONAL,Primary Analysis and survival follow up completed per protocol. Not stopped due to safety concerns
NCT02978742,WITHDRAWN,INTERVENTIONAL,Study not funded.
NCT02978833,TERMINATED,INTERVENTIONAL,"slow enrollment, lack of patients"
NCT02978885,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02979093,TERMINATED,INTERVENTIONAL,Unable to recruit proposed study sample size due to COVID restrictions.
NCT02980198,WITHDRAWN,INTERVENTIONAL,reorganization proceedings with a potential risk of company liquidation
NCT02980484,TERMINATED,INTERVENTIONAL,Investigators left the institution for unrelated reasons
NCT02980705,TERMINATED,INTERVENTIONAL,Study terminated-Sponsor's decision
NCT02980874,TERMINATED,INTERVENTIONAL,"Primary, 8-week efficacy endpoint not achieved. No additional benefit for subjects receiving a corticosteroid together with an intravitreal anti-VEGF agent."
NCT02981017,WITHDRAWN,INTERVENTIONAL,Decided to do a different clinical trial opportunity.
NCT02981082,TERMINATED,INTERVENTIONAL,Low recruitment
NCT02981134,WITHDRAWN,OBSERVATIONAL,This study will be revived with retrospective design.
NCT02981160,WITHDRAWN,INTERVENTIONAL,Pending Organization approval
NCT02981355,TERMINATED,INTERVENTIONAL,Lack of funding
NCT02981394,WITHDRAWN,OBSERVATIONAL,No active enrollment of patients.
NCT02981459,WITHDRAWN,INTERVENTIONAL,Withdrawn by Sponsor
NCT02981550,WITHDRAWN,OBSERVATIONAL,2 NaNose devices provided inconsistent results in lab calibration testing
NCT02982291,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting patients
NCT02982499,TERMINATED,OBSERVATIONAL,Principal investigator's decision due to lack of resources
NCT02982551,WITHDRAWN,INTERVENTIONAL,Principal Investigator Departed University
NCT02982642,WITHDRAWN,INTERVENTIONAL,Sponsor cannot conduct research due to insufficient funding supportment
NCT02982668,TERMINATED,INTERVENTIONAL,Significantly higher mortality
NCT02982694,TERMINATED,INTERVENTIONAL,"The results of the interim analysis showed that the efficacy in the MSS subgroup (MSI like) is inferior to the expected, and this situation is very unlikely to be reversed if the trial is fully completed."
NCT02982720,TERMINATED,INTERVENTIONAL,Manufacturer discontinued Sylatron
NCT02983058,TERMINATED,INTERVENTIONAL,To obtain funding for a larger study
NCT02983097,TERMINATED,INTERVENTIONAL,Phase II: no scientific interests are given anymore
NCT02983266,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT02983903,TERMINATED,INTERVENTIONAL,Interim analysis also showed a lack of benefit in the experimental arm.
NCT02984033,WITHDRAWN,OBSERVATIONAL,No patient enrolled
NCT02984085,TERMINATED,INTERVENTIONAL,Replaced by new study in progress
NCT02984618,TERMINATED,INTERVENTIONAL,High recurrence of headache in SPG group.
NCT02984683,TERMINATED,INTERVENTIONAL,Study discontinued considering the limited clinical benefit combined with a higher than expected rate of known non-serious ophthalmological event.
NCT02984813,TERMINATED,INTERVENTIONAL,Investigator left the institution
NCT02984891,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT02985021,TERMINATED,INTERVENTIONAL,Competing studies
NCT02985177,WITHDRAWN,INTERVENTIONAL,We couldn't obtain funds for this study
NCT02985203,TERMINATED,INTERVENTIONAL,No participants were enrolled as schedule.
NCT02985242,TERMINATED,INTERVENTIONAL,difficulties to recruit planned numbers of patients within reasonable time frame
NCT02985489,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT02985554,TERMINATED,INTERVENTIONAL,Study stopped early due to slow accrual and safety concerns.
NCT02985632,WITHDRAWN,INTERVENTIONAL,Business objectives have changed.
NCT02985801,TERMINATED,INTERVENTIONAL,Study was terminated due to difficulty in recruiting subjects.
NCT02985840,TERMINATED,INTERVENTIONAL,Unable to access EMR for patients enrolled prior to 8/2015 for data collection
NCT02985879,TERMINATED,INTERVENTIONAL,This study was prematurely discontinued because the program for progressive supranuclear palsy was discontinued due to lack of efficacy of study drug.
NCT02985918,TERMINATED,INTERVENTIONAL,"The trial has been terminated by the DSMB and the trial steering committee, based on the interim analysis results and the impracticality of continuing the trial in the context of the coronavirus disease 2019 (COVID-19) pandemic."
NCT02986217,TERMINATED,INTERVENTIONAL,PI Left institution and did not transfer study to another PI
NCT02986477,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT02986646,TERMINATED,OBSERVATIONAL,Low enrollment
NCT02986685,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT02986711,TERMINATED,INTERVENTIONAL,Funding exhausted
NCT02986815,TERMINATED,INTERVENTIONAL,low enrollment
NCT02986919,WITHDRAWN,INTERVENTIONAL,Lack of enrollment.
NCT02986971,TERMINATED,INTERVENTIONAL,Minor design modifications to device to be investigated in new trial
NCT02987010,WITHDRAWN,INTERVENTIONAL,Sponsor did not want to move forward with protocol; study was never opened.
NCT02987309,TERMINATED,OBSERVATIONAL,Equipment failure
NCT02987660,TERMINATED,INTERVENTIONAL,management decision; non patient safety related reason
NCT02987764,TERMINATED,INTERVENTIONAL,Subject recruitment and enrollment was low throughout the three years the study was active.
NCT02987855,WITHDRAWN,INTERVENTIONAL,Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]
NCT02987920,TERMINATED,INTERVENTIONAL,The surgeon changed pain control protocol for all patients. Continued enrollment impossible under approved protocol.
NCT02987959,TERMINATED,INTERVENTIONAL,Closed to accrual due to Funding Sponsor withdrawing support due to low accrual
NCT02987998,TERMINATED,INTERVENTIONAL,higher than expected rate of toxicity \& unrealistic timeline to complete trial under company's proposed plan to reopen
NCT02988063,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT02988076,SUSPENDED,INTERVENTIONAL,Lack of recruiting at primary study site
NCT02988258,SUSPENDED,INTERVENTIONAL,Protocol being re-written to allow inclusion of more patients
NCT02988609,TERMINATED,INTERVENTIONAL,difficulty in enrollment and changes in methodology
NCT02988648,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to lack of enrollment.
NCT02988726,TERMINATED,INTERVENTIONAL,Slow accrual
NCT02988778,WITHDRAWN,INTERVENTIONAL,regulatory strategy
NCT02988843,TERMINATED,INTERVENTIONAL,Funding Unavailable
NCT02988947,TERMINATED,INTERVENTIONAL,Unavailability of the clinical team
NCT02989129,WITHDRAWN,INTERVENTIONAL,FDA IND Approval
NCT02989168,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of clinically meaningful benefit
NCT02989597,TERMINATED,INTERVENTIONAL,Due to personnel loss and logistical issues the study was unable to be completed as planned.
NCT02989649,TERMINATED,OBSERVATIONAL,Business Decision; No Safety Or Efficacy Concerns
NCT02989870,WITHDRAWN,INTERVENTIONAL,No Interest. Investigator was unable to enroll any participants on study.
NCT02990078,TERMINATED,OBSERVATIONAL,Sufficient sample size enrolled to demonstrate scientific goals of the study
NCT02990091,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT02990143,TERMINATED,INTERVENTIONAL,Investigator left the Institution
NCT02990273,TERMINATED,INTERVENTIONAL,No funding source available which was required for IRB approval
NCT02990312,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT02990546,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects before PI left institution
NCT02990832,WITHDRAWN,INTERVENTIONAL,The study was deemed unfeasible to complete.
NCT02990845,TERMINATED,INTERVENTIONAL,"The enrolment became difficult, as most of the premenopausal women decided to receive ovarian ablation for health insurance reimbursement for CDK4/6 inhibitor for the first-line treatment, making them ineligible for joining the study."
NCT02990949,TERMINATED,INTERVENTIONAL,Stopped due to lack of enrollement
NCT02991027,WITHDRAWN,INTERVENTIONAL,No subjects needed for enrollment anymore
NCT02991131,TERMINATED,OBSERVATIONAL,Company decision
NCT02991196,TERMINATED,INTERVENTIONAL,Business Decision
NCT02991430,TERMINATED,INTERVENTIONAL,Inability to supply and maintain treatment device. No safety concerns occurred.
NCT02991547,TERMINATED,OBSERVATIONAL,Initial Principal Investigator no longer at institution.
NCT02991651,SUSPENDED,INTERVENTIONAL,Limited IRX4204 Study Drug Supply
NCT02991768,TERMINATED,INTERVENTIONAL,Enrollment not continued
NCT02991898,TERMINATED,INTERVENTIONAL,Considering new technology for product.
NCT02991950,TERMINATED,INTERVENTIONAL,Difficulty with patient enrollment
NCT02992054,TERMINATED,OBSERVATIONAL,The number of patients were enough for statistic treatment
NCT02992340,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate the study and not proceed to Phase 2.
NCT02992418,TERMINATED,INTERVENTIONAL,No answer received from the Philippines Food and Drug Administration on protocol amendment issued due to IDMC recommendations. CYD vaccine 3rd dose not given.
NCT02992860,TERMINATED,INTERVENTIONAL,"Enrollement was stopped due to a recommendation by the IDMC/FDA for a parallel clinical trial with TALA, where potentielly no efficancy could be determined."
NCT02992964,TERMINATED,INTERVENTIONAL,Withdrawal of drug supply/funding
NCT02992977,TERMINATED,INTERVENTIONAL,To enable development of an enhanced version of the vaccine.
NCT02993003,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT02993094,TERMINATED,INTERVENTIONAL,"Due to slow recruitment, the study had to be terminated prematurely."
NCT02993263,TERMINATED,INTERVENTIONAL,The study was withdrawn as there was an ECG equipment and software malfunction. There is no results for this study because of the equipment malfunction.
NCT02993328,WITHDRAWN,INTERVENTIONAL,Study location changed
NCT02993458,TERMINATED,INTERVENTIONAL,safety risks to youth in the study required early termination of the study
NCT02993536,WITHDRAWN,OBSERVATIONAL,Low likelihood to usedrug in clinic practice based on emergining AE profile and data from front line clinical trials
NCT02993783,TERMINATED,INTERVENTIONAL,Lack of efficacy of the drug; no safety concern
NCT02993991,WITHDRAWN,INTERVENTIONAL,The study has been terminated due to a change in internal prioritization and not due to any safety concerns.
NCT02994186,WITHDRAWN,OBSERVATIONAL,funding
NCT02994251,TERMINATED,INTERVENTIONAL,Study terminated due to low enrollment making it unlikely to meet recruitment goals.
NCT02994433,TERMINATED,INTERVENTIONAL,remaining visits and enrollment terminated due to the pandemic
NCT02994563,TERMINATED,INTERVENTIONAL,Subject recruitment problem due to Covid pandemic
NCT02994589,WITHDRAWN,INTERVENTIONAL,Study was never started
NCT02994771,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT02994784,TERMINATED,INTERVENTIONAL,"Slow Accrual during COVID pandemic, alternative treatments available. Study halted early."
NCT02994823,TERMINATED,OBSERVATIONAL,prolonged device failure after just 10 participants and too long to resume
NCT02994914,TERMINATED,INTERVENTIONAL,Low rythm of inclusions
NCT02994953,TERMINATED,INTERVENTIONAL,The study got discontinued due to lack of efficacy
NCT02995083,WITHDRAWN,INTERVENTIONAL,Study deemed not feasible
NCT02995330,TERMINATED,INTERVENTIONAL,lack of accrual
NCT02995382,WITHDRAWN,INTERVENTIONAL,Funding was not received and the study could not proceed without this support.
NCT02995512,WITHDRAWN,INTERVENTIONAL,feasibility
NCT02995642,WITHDRAWN,INTERVENTIONAL,Resources not secured
NCT02995681,TERMINATED,INTERVENTIONAL,COVID-19 pandemic restrictions
NCT02995746,TERMINATED,INTERVENTIONAL,Terminated due to lack of drug efficacy. 2017 study did not show benefit.
NCT02995967,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT02996149,TERMINATED,OBSERVATIONAL,Technique no longer available
NCT02996162,WITHDRAWN,OBSERVATIONAL,The research never began; the PI has chosen to no longer pursue this project.
NCT02996266,TERMINATED,INTERVENTIONAL,Futility
NCT02996448,TERMINATED,INTERVENTIONAL,Safety concerns led to early termination.
NCT02996760,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT02996942,WITHDRAWN,OBSERVATIONAL,Not active
NCT02997059,TERMINATED,INTERVENTIONAL,Limited recourse to intestinal resection due to new management of CD
NCT02997098,WITHDRAWN,OBSERVATIONAL,Study design changed to clinical database only with no research question to be studied.
NCT02997150,WITHDRAWN,INTERVENTIONAL,no treatment available
NCT02997189,TERMINATED,INTERVENTIONAL,Negative Efficacy Results from the recently completed Phase 3 study 104-201506
NCT02997527,WITHDRAWN,INTERVENTIONAL,Completed very similar study
NCT02997540,TERMINATED,OBSERVATIONAL,Successfully obtained sufficient data to complete this research project.
NCT02997670,WITHDRAWN,INTERVENTIONAL,"Work focused in other areas, other groups working on this."
NCT02997696,TERMINATED,INTERVENTIONAL,The study was stopped for business reasons. No safety issues were reported.
NCT02997722,TERMINATED,INTERVENTIONAL,Staffing and space deficiencies prevented completion of the study.
NCT02997839,TERMINATED,INTERVENTIONAL,Change in design to observational study
NCT02997956,WITHDRAWN,INTERVENTIONAL,funding issues
NCT02998008,TERMINATED,INTERVENTIONAL,due to difficulties to attract participants
NCT02998047,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT02998060,WITHDRAWN,INTERVENTIONAL,Change in study design \[Randomization not feasible\]
NCT02998372,TERMINATED,OBSERVATIONAL,Not reaching targeted enrollment
NCT02998541,TERMINATED,INTERVENTIONAL,"Sponsor decision, unrelated to safety"
NCT02998554,TERMINATED,INTERVENTIONAL,"Sponsor decision, unrelated to safety"
NCT02998606,TERMINATED,INTERVENTIONAL,Investigator left Institution
NCT02999100,TERMINATED,INTERVENTIONAL,"Inability to reliably measure plasma oxytocin levels during third stage labour, regardless of administration method (intramuscular or inhaled)."
NCT02999152,TERMINATED,INTERVENTIONAL,"Low rythm of inclusions, financial support terminated"
NCT02999165,TERMINATED,OBSERVATIONAL,Failure to recruit participants due to change in local clinical practice.
NCT02999243,TERMINATED,INTERVENTIONAL,"IRB expired, PI no longer at institution."
NCT02999633,TERMINATED,INTERVENTIONAL,"Due to an unsatisfactory benefit/risk ratio, as specified in \& 14.8.1 of the protocol, Sanofi decided to stop enrollment and terminate ACT14596 prematurely"
NCT02999854,TERMINATED,INTERVENTIONAL,"Insufficient efficacy, terminated by Sponsor"
NCT02999893,TERMINATED,INTERVENTIONAL,Funding ceased
NCT02999906,WITHDRAWN,INTERVENTIONAL,For business reasons.
NCT02999932,TERMINATED,INTERVENTIONAL,Slow inclusion
NCT02999945,WITHDRAWN,INTERVENTIONAL,no funding
NCT03000127,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03000153,TERMINATED,INTERVENTIONAL,Organisational changes at site meant that recruitment was no longer feasible.
NCT03000179,TERMINATED,INTERVENTIONAL,Low accrual
NCT03000595,WITHDRAWN,INTERVENTIONAL,Study location changed
NCT03000634,WITHDRAWN,INTERVENTIONAL,Study was not and will not be initiated due to lack of funding.
NCT03000660,TERMINATED,INTERVENTIONAL,partial clinical hold per FDA
NCT03000686,TERMINATED,INTERVENTIONAL,"Study terminated for technical feasibility, operational considerations and futility in line with pre-specified criteria."
NCT03000868,WITHDRAWN,INTERVENTIONAL,No participants were enrolled.
NCT03001037,SUSPENDED,OBSERVATIONAL,Pending internal study review and potential protocol modification
NCT03001050,WITHDRAWN,INTERVENTIONAL,"Investigator requested to close, lack of equipment available."
NCT03001141,TERMINATED,OBSERVATIONAL,Ethic Comitte (CONEP) determinated the prematurely terminated.
NCT03001219,TERMINATED,INTERVENTIONAL,The trial was prematurely terminated due to a lack of efficacy of the investigational drug.
NCT03001323,TERMINATED,INTERVENTIONAL,Enrollment was too low to provide statistically significant data
NCT03001349,TERMINATED,INTERVENTIONAL,Per PI Request
NCT03001505,WITHDRAWN,OBSERVATIONAL,Study design changed to clinical database only with no research question to be studied.
NCT03001583,WITHDRAWN,INTERVENTIONAL,The investigators hadn't got funding to support the study
NCT03002012,TERMINATED,INTERVENTIONAL,"SAEs with n=1 serotonin syndrome, n=2 SAEs after sertraline interruption."
NCT03002103,SUSPENDED,INTERVENTIONAL,study design reconsideration
NCT03002454,TERMINATED,INTERVENTIONAL,Altered biodistribution in investigational images versus standard images.
NCT03002467,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT03002480,WITHDRAWN,INTERVENTIONAL,Study never opened.
NCT03002506,TERMINATED,INTERVENTIONAL,Much slower recruitment than anticipated
NCT03002597,TERMINATED,INTERVENTIONAL,Issue reaching target enrollement
NCT03002623,TERMINATED,INTERVENTIONAL,Study was closed because investigator left the National Institutes of Health.
NCT03002831,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume
NCT03003195,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03003273,TERMINATED,INTERVENTIONAL,poor accrual
NCT03003338,TERMINATED,INTERVENTIONAL,The recruitment was stopped prematurely by the sponsor in accordance with the principal investigator because of the difficulties to recruit patients and to achieve the planned numbers of patients within a reasonable time frame.
NCT03003390,TERMINATED,INTERVENTIONAL,Met protocol defined stopping rule for futility
NCT03003728,WITHDRAWN,INTERVENTIONAL,Withdrawal of study support
NCT03003949,TERMINATED,INTERVENTIONAL,In-person visit restrictions due to COVID-19
NCT03004001,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT03004105,WITHDRAWN,INTERVENTIONAL,Inadequate funding
NCT03004235,TERMINATED,OBSERVATIONAL,IRB is reviewing all studies at the institution and are on hold
NCT03004430,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03004443,TERMINATED,INTERVENTIONAL,The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.
NCT03004482,SUSPENDED,OBSERVATIONAL,lack of Funding
NCT03004560,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03004599,TERMINATED,INTERVENTIONAL,Due to the business issues. Manufacturer has been acquired by other company.
NCT03004677,TERMINATED,INTERVENTIONAL,To difficult to recruit.
NCT03004885,TERMINATED,INTERVENTIONAL,Insufficient CO2 removal obtained with the PrismaLung membrane oxygenator
NCT03005015,WITHDRAWN,INTERVENTIONAL,supporting company (Eisai) withdrew their interest
NCT03005054,TERMINATED,INTERVENTIONAL,Protracted enrollment and limited wound closure in the first three subjects
NCT03005184,WITHDRAWN,INTERVENTIONAL,Study is being redesigned and submitted as a new study.
NCT03005379,TERMINATED,INTERVENTIONAL,Study is terminated for futility per protocol-specified interim analysis and DMC recommendation.
NCT03005587,WITHDRAWN,OBSERVATIONAL,Lack of Funds
NCT03005639,WITHDRAWN,INTERVENTIONAL,Sponsor has decided to close study.
NCT03005860,WITHDRAWN,INTERVENTIONAL,"Funding could not be arranged, so the study was prematurely terminated"
NCT03005899,TERMINATED,INTERVENTIONAL,Clinical trial was terminated due to discontinuation of drug product by the investigational drug supplier.
NCT03005912,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03006562,TERMINATED,INTERVENTIONAL,Early stopping point based on 2nd interim analysis (planned per protocol)
NCT03006679,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03006744,WITHDRAWN,INTERVENTIONAL,"Unfavourable opinion from NHS ethics. Due to low recruitment from NHS sources in another study, it was decided not to reapply but to withdraw the study."
NCT03007381,WITHDRAWN,INTERVENTIONAL,No funding.
NCT03007511,SUSPENDED,INTERVENTIONAL,Due to limited financial resource
NCT03007537,TERMINATED,INTERVENTIONAL,lack of funds
NCT03007719,TERMINATED,INTERVENTIONAL,Low Accrual
NCT03007771,WITHDRAWN,INTERVENTIONAL,Decision was made to not go forward with the study
NCT03008213,TERMINATED,INTERVENTIONAL,PI is leaving UCSD
NCT03008395,WITHDRAWN,INTERVENTIONAL,Unable to secure clinic support for conducting research
NCT03008512,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03008616,TERMINATED,INTERVENTIONAL,"Following a recommendation from the Data and Safety Monitoring Board (DSMB), the study was stopped early for futility. There were no safety concerns raised."
NCT03008772,WITHDRAWN,OBSERVATIONAL,Not funded
NCT03009058,TERMINATED,INTERVENTIONAL,Commercial reasons
NCT03009110,TERMINATED,INTERVENTIONAL,DSMB recommendation following interim analysis
NCT03009799,WITHDRAWN,INTERVENTIONAL,Study stopped following management decision
NCT03009877,WITHDRAWN,INTERVENTIONAL,withdrawn prior to IRB approval
NCT03010046,TERMINATED,INTERVENTIONAL,ANX005 well tolerated at doses studied; study discontinued and initiated in patient population
NCT03010137,TERMINATED,INTERVENTIONAL,Lack of staff resources to properly consent and enroll patients into the study.
NCT03010423,TERMINATED,INTERVENTIONAL,"The study was terminated early, due to the lack of approval of data exportation from the Office of Human Genetic Resource Administration (OHGRA) China."
NCT03010761,TERMINATED,INTERVENTIONAL,all participants finished the trial
NCT03010865,WITHDRAWN,INTERVENTIONAL,sponsor withdrew the funds because the smell of sodium butyrate made blinding impossible
NCT03010995,WITHDRAWN,INTERVENTIONAL,Study discontinued due to lack of study funding.
NCT03011073,WITHDRAWN,OBSERVATIONAL,investigator decision
NCT03011229,WITHDRAWN,INTERVENTIONAL,Slow enrollment
NCT03011307,TERMINATED,INTERVENTIONAL,"Cessation of funding period prior to completion, due to slow recruitment during the pandemic."
NCT03011619,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03011645,TERMINATED,INTERVENTIONAL,Lack of participants
NCT03012282,TERMINATED,INTERVENTIONAL,Termination due to slow accrual
NCT03012646,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03012737,TERMINATED,INTERVENTIONAL,Difficulty in finding suitable patients.
NCT03013127,TERMINATED,INTERVENTIONAL,Inclusion of patients was stopped because 2 patients had clinical benefit.
NCT03013192,TERMINATED,INTERVENTIONAL,IRB and institutional re-assessment
NCT03013387,WITHDRAWN,INTERVENTIONAL,This project has undergone a significant amount of updates and has been resubmitted under IRB# 201708778
NCT03013426,WITHDRAWN,INTERVENTIONAL,NuvOx Pharma suspended the clinical program related to this study.
NCT03013608,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT03013673,TERMINATED,OBSERVATIONAL,Due to the ongoing conflict in the Tigray region
NCT03013842,TERMINATED,INTERVENTIONAL,Principal Investigator no longer at Site
NCT03013855,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT03014141,WITHDRAWN,INTERVENTIONAL,Study supply issues
NCT03014219,WITHDRAWN,INTERVENTIONAL,FDA approval was not obtained until adult trial completes accrual
NCT03014284,WITHDRAWN,OBSERVATIONAL,"Military collaborator sample supplier was transferred, no samples obtained"
NCT03014297,TERMINATED,INTERVENTIONAL,Part I completed. Part 2 will not be done due to sponsor decision.
NCT03014323,WITHDRAWN,INTERVENTIONAL,No fundings
NCT03014804,WITHDRAWN,INTERVENTIONAL,Final contract negotiations
NCT03015051,TERMINATED,INTERVENTIONAL,Difficulty in recruiting subjects who meet the inclusion/exclusion criteria
NCT03015519,WITHDRAWN,INTERVENTIONAL,The study did not start recruiting as albiglutide would have been withdrawn from the market prior to study end.
NCT03015792,TERMINATED,INTERVENTIONAL,Per CS0139535 -submitter stated we can update status to Admin complete- low accrual reasoning
NCT03015831,TERMINATED,INTERVENTIONAL,Statistical analysis of interim data showed no advantage of colchicine
NCT03015961,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03016104,WITHDRAWN,INTERVENTIONAL,The problems of MST device
NCT03016195,TERMINATED,OBSERVATIONAL,Poor return rate/high dropout rate requiring alteration to study methodology
NCT03016468,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03016949,WITHDRAWN,INTERVENTIONAL,Regulatory timelines for approval expired
NCT03016975,TERMINATED,INTERVENTIONAL,Procedure and device development
NCT03017014,TERMINATED,OBSERVATIONAL,Low enrollment
NCT03017040,TERMINATED,INTERVENTIONAL,Not enough research staff
NCT03017105,TERMINATED,INTERVENTIONAL,Logistical difficulties leading to an extremely slow recruitment rate
NCT03017287,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03017547,WITHDRAWN,INTERVENTIONAL,seeking funding
NCT03017612,TERMINATED,INTERVENTIONAL,Change of inlay from no bevel to bevel design
NCT03017898,SUSPENDED,INTERVENTIONAL,"Study halted due to lower success rates than expected, under evaluation, will potentially resume at a later date."
NCT03018067,TERMINATED,INTERVENTIONAL,Sponsor stopped program\]
NCT03018106,TERMINATED,INTERVENTIONAL,Obstacles with recruitment
NCT03018704,TERMINATED,INTERVENTIONAL,In ability to recruit
NCT03019094,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03019107,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goal
NCT03019120,WITHDRAWN,INTERVENTIONAL,"Due to administrative reasons, it was not possible to enroll subjects."
NCT03019159,WITHDRAWN,OBSERVATIONAL,Support funding of the regional health authority stopped
NCT03019588,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03020121,TERMINATED,INTERVENTIONAL,Lower than anticipated rate of subject enrollment
NCT03020264,TERMINATED,INTERVENTIONAL,COVID-19
NCT03020446,TERMINATED,INTERVENTIONAL,Provider of product no longer wished to continue with site. No data available.
NCT03020472,TERMINATED,INTERVENTIONAL,Due to low enrollment
NCT03020563,WITHDRAWN,INTERVENTIONAL,no longer necessary
NCT03020784,TERMINATED,INTERVENTIONAL,The study was terminated on 16JUN2017 for safety reasons
NCT03020797,TERMINATED,INTERVENTIONAL,1) Enrolment below study target and 2) too many subjects had early termination due to disease progression.
NCT03020823,TERMINATED,INTERVENTIONAL,withdrawal by sponsor
NCT03020927,SUSPENDED,INTERVENTIONAL,Currently do not have resources/staff to enroll new participants.
NCT03021083,WITHDRAWN,INTERVENTIONAL,Contract not reached with sponsor
NCT03021252,TERMINATED,INTERVENTIONAL,Because of the SARS-COV2 pandemic. Recruitment stopped at 48 patients
NCT03021395,SUSPENDED,INTERVENTIONAL,The previous data needs to be analyzed.
NCT03021538,TERMINATED,OBSERVATIONAL,Failure to enroll
NCT03021590,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT03021616,TERMINATED,INTERVENTIONAL,Results from sister study at University of the Pacific were conclusive.
NCT03021915,SUSPENDED,INTERVENTIONAL,"OvaScience, Inc. is no longer study sponsor as it is undergoing a merger. Follow-up will be conducted by sponsor-investigator Dr. Bob Casper."
NCT03021941,WITHDRAWN,INTERVENTIONAL,"In a communication dated June 12, 2019 the FDA has released Pfizer from the Postmarketing Commitment (PMC 2767-2) that was associated with study B3031003."
NCT03022019,TERMINATED,INTERVENTIONAL,Futility
NCT03022565,WITHDRAWN,INTERVENTIONAL,Investigator Decision
NCT03022578,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03022630,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03022656,SUSPENDED,INTERVENTIONAL,COVID Pandemic
NCT03022838,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to poor recruitment.
NCT03022877,WITHDRAWN,INTERVENTIONAL,Rationale obsolete
NCT03023072,TERMINATED,OBSERVATIONAL,Site no longer met criteria
NCT03023397,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03023527,TERMINATED,INTERVENTIONAL,Safety
NCT03023657,TERMINATED,INTERVENTIONAL,difficulties to realize the protocol
NCT03023709,TERMINATED,INTERVENTIONAL,Due to the ACIP guidelines halting the use of LAIV
NCT03023813,TERMINATED,INTERVENTIONAL,Study was terminated on 2/17/2021 due to on-going and uncertain nature of COVID-19 pandemic; this was not a suspension of IRB approval.
NCT03023904,WITHDRAWN,INTERVENTIONAL,Research cancelled
NCT03024060,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to corporate business decision
NCT03024177,WITHDRAWN,INTERVENTIONAL,Study is withdrawn due to company decision
NCT03024372,WITHDRAWN,INTERVENTIONAL,Study did not get started. Investigator is no longer at this institution
NCT03024437,SUSPENDED,INTERVENTIONAL,Major review underway
NCT03024632,WITHDRAWN,OBSERVATIONAL,Closed study. Study is retrospective in nature and never enrolled any subjects.
NCT03024944,WITHDRAWN,INTERVENTIONAL,18F-THK5351 was reported non-specific binding of MAO receptors.
NCT03024996,TERMINATED,INTERVENTIONAL,"The sponsor decided to terminate this study before the protocol-defined end-of-study, as permitted per protocol."
NCT03025152,TERMINATED,INTERVENTIONAL,High attrition rate up to 37.7% at one year's follow-up
NCT03025386,TERMINATED,INTERVENTIONAL,inclusions stopped
NCT03025412,TERMINATED,INTERVENTIONAL,recruitment difficulties due to recently introduced new surgical procedure
NCT03025425,TERMINATED,INTERVENTIONAL,Difficulty in finding suitable patients
NCT03025464,TERMINATED,INTERVENTIONAL,Study was discontinued prematurely due to funding insecurity
NCT03025529,TERMINATED,INTERVENTIONAL,Investigator leaving institution
NCT03026023,WITHDRAWN,INTERVENTIONAL,moved forward with another protocol utilizing pan genotypic treatment once it became commercially available and FDA approved
NCT03026049,TERMINATED,INTERVENTIONAL,it was not possible to recruit the required amount of participants within a reseanable timefram.
NCT03026088,TERMINATED,INTERVENTIONAL,"Limited beta-blocker naive participants among newly diagnosed heart failure participants, which led barrier to the recruitments."
NCT03026101,SUSPENDED,INTERVENTIONAL,IRB approval has elapsed effective 9/20/2023. Uncertain as to whether study will continue. Would need to receive continuing IRB approval by 3/2024. Until a determination has been made Primary and Study Completion Dates have been pushed out.
NCT03026166,TERMINATED,INTERVENTIONAL,Enrollment was stopped after the dose-limiting toxicity (DLT) evaluation phase of Cohort 2.
NCT03026192,TERMINATED,OBSERVATIONAL,not enough patients enrolled in study
NCT03026231,WITHDRAWN,INTERVENTIONAL,study will be started under a new modified protocol
NCT03026647,WITHDRAWN,OBSERVATIONAL,Not moving forward staff shortage
NCT03026673,WITHDRAWN,OBSERVATIONAL,staff shortage
NCT03026686,TERMINATED,OBSERVATIONAL,Insufficient personel
NCT03026803,TERMINATED,INTERVENTIONAL,"Due to Sorafenib became first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue to support"
NCT03026829,TERMINATED,INTERVENTIONAL,Number of subjects could not be achieved due to slow recruitment
NCT03027076,WITHDRAWN,OBSERVATIONAL,Funding for project not secured
NCT03027323,WITHDRAWN,INTERVENTIONAL,Study not funded; no participants enrolled
NCT03027401,WITHDRAWN,OBSERVATIONAL,closed by PI and FDA
NCT03027635,TERMINATED,INTERVENTIONAL,Slow recruitment and limited funding. The treatment intervention is instituted in clinical practice as and end-stage treatment option at hospitals in Denmark
NCT03027700,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT03027804,WITHDRAWN,OBSERVATIONAL,This study has been changed in systematic review and meta-analysis
NCT03027934,WITHDRAWN,INTERVENTIONAL,Study population difficult to recruit
NCT03027973,WITHDRAWN,INTERVENTIONAL,PI made the decision to not continue the study. It was at the Health Canada review stage.
NCT03028012,TERMINATED,INTERVENTIONAL,Poor enrollment.
NCT03028129,TERMINATED,INTERVENTIONAL,Interim analysis showed efficacy less than 2.5%.
NCT03028272,WITHDRAWN,INTERVENTIONAL,Lack of qualified participants
NCT03028324,TERMINATED,INTERVENTIONAL,Difficulty recruiting participants and lost personnel.
NCT03028571,WITHDRAWN,INTERVENTIONAL,The investigators decided not to perform the study. No participants have been enrolled.
NCT03028740,TERMINATED,INTERVENTIONAL,This study was terminated early due to lack of efficacy based on the results of the planned interim analysis of Part 1 data.
NCT03028753,WITHDRAWN,INTERVENTIONAL,study coordinator left / no other current resources to complete
NCT03028805,TERMINATED,INTERVENTIONAL,Trend toward increased readmissions in the auto-delivery arm.
NCT03028909,WITHDRAWN,INTERVENTIONAL,Study is withdrawn due to company decision.
NCT03028987,TERMINATED,INTERVENTIONAL,LAIV was no longer recommended by ACIP
NCT03029000,TERMINATED,INTERVENTIONAL,Study was terminated due to low enrollment
NCT03029104,TERMINATED,INTERVENTIONAL,Sufficient clinical results obtained to support study endpoints.
NCT03029351,TERMINATED,INTERVENTIONAL,termination by sponsor
NCT03029416,WITHDRAWN,INTERVENTIONAL,PRMC Administrative Disapproval - Slow accrual
NCT03029442,TERMINATED,INTERVENTIONAL,Study ended early due to COVID-19
NCT03029585,TERMINATED,INTERVENTIONAL,Business reasons
NCT03029611,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding
NCT03029832,TERMINATED,INTERVENTIONAL,The study was prematurely terminated due to slow patient accrual and discontinuation of clinical development of MOXR0916 due to Sponsor's strategic priorities.
NCT03029845,TERMINATED,INTERVENTIONAL,The funding ended.
NCT03029871,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT03029923,WITHDRAWN,INTERVENTIONAL,Funding for this pilot transitioned into funding for a fully powered study.
NCT03029988,TERMINATED,INTERVENTIONAL,Lack of effect in Cohort 1
NCT03030131,TERMINATED,INTERVENTIONAL,Definitive discontinuation according to safety monitoring of death from the 46th patient onwards.
NCT03030326,WITHDRAWN,INTERVENTIONAL,"No funding to hire staff, could not find student to do project"
NCT03031080,WITHDRAWN,INTERVENTIONAL,Intervention (Xiapex) was removed from the market
NCT03031132,SUSPENDED,INTERVENTIONAL,Transferring study to another University
NCT03031145,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03031340,TERMINATED,INTERVENTIONAL,Incidence of AE
NCT03031821,TERMINATED,INTERVENTIONAL,Manufacturer discontinued the production of study drugs.
NCT03031964,TERMINATED,OBSERVATIONAL,"Closed the single investigator initiated study at request of Stryker, to begin collecting as a multicenter study."
NCT03032042,WITHDRAWN,INTERVENTIONAL,We were not able to secure IRB approval in the timeline necessary to do this study.
NCT03032081,WITHDRAWN,INTERVENTIONAL,"PI relocated, unable to complete the study. No replacement PI identified."
NCT03032198,TERMINATED,INTERVENTIONAL,Revision to over all corporate strategy
NCT03032211,WITHDRAWN,INTERVENTIONAL,Change in company strategy
NCT03032263,TERMINATED,INTERVENTIONAL,Not enough participants enrolled
NCT03032432,WITHDRAWN,INTERVENTIONAL,Principle Investigator is no longer at Loma Linda University Medical Center
NCT03032471,TERMINATED,OBSERVATIONAL,COVID-restrictions on clinical research in Switzerland
NCT03032536,TERMINATED,INTERVENTIONAL,Sponsor decision.
NCT03032614,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03033017,WITHDRAWN,OBSERVATIONAL,Funding c hange
NCT03033316,TERMINATED,INTERVENTIONAL,Patient enrolment issues
NCT03033511,TERMINATED,INTERVENTIONAL,Independent Data Monitoring Committee recommendation
NCT03033862,WITHDRAWN,OBSERVATIONAL,Stent taken off market due to safety concerns
NCT03034083,WITHDRAWN,OBSERVATIONAL,No subjects recruited
NCT03034109,TERMINATED,INTERVENTIONAL,Negative interim analysis.
NCT03034161,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT03034213,TERMINATED,INTERVENTIONAL,Cease of Funding
NCT03034317,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03034421,TERMINATED,INTERVENTIONAL,difficult patient recruitment
NCT03034512,TERMINATED,OBSERVATIONAL,Research focus has changed.
NCT03034538,SUSPENDED,INTERVENTIONAL,Site staffing
NCT03034551,WITHDRAWN,INTERVENTIONAL,Insufficient recruitment
NCT03034564,TERMINATED,INTERVENTIONAL,Site staffing
NCT03034733,TERMINATED,INTERVENTIONAL,Principal investigator (M.K.) left for another workplace. Patient recruitment more difficult than expected.
NCT03034759,WITHDRAWN,INTERVENTIONAL,Investigator has moved to another institution
NCT03034902,TERMINATED,INTERVENTIONAL,The collaborating investigator has moved and cannot collect further data.
NCT03035006,TERMINATED,INTERVENTIONAL,Current study design couldn't support futher development on this indication.
NCT03035227,TERMINATED,INTERVENTIONAL,Investigator left Institution.
NCT03035279,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT03035357,WITHDRAWN,INTERVENTIONAL,PI's Request
NCT03035578,WITHDRAWN,INTERVENTIONAL,research project has been abandoned primarily because of the excessive delays associated with past challenges in obtaining approval from Health Canada
NCT03035630,WITHDRAWN,INTERVENTIONAL,Principal investigator left lead institution and efforts to open the protocol at another institution were not successful.
NCT03035734,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT03035838,WITHDRAWN,INTERVENTIONAL,Alternate study commenced using different drug
NCT03036046,WITHDRAWN,INTERVENTIONAL,Study no longer required
NCT03036111,SUSPENDED,INTERVENTIONAL,Unavailability of Triembutine maleate
NCT03036566,TERMINATED,INTERVENTIONAL,Loss of funding due to COVID-19
NCT03036579,TERMINATED,INTERVENTIONAL,"COVID, loss of funding"
NCT03036735,TERMINATED,INTERVENTIONAL,Sponsor withdrew funds
NCT03036826,WITHDRAWN,OBSERVATIONAL,due to organisational changes
NCT03036878,TERMINATED,INTERVENTIONAL,Closed for lack of enrollment
NCT03037268,WITHDRAWN,OBSERVATIONAL,Device is no longer available
NCT03037450,TERMINATED,INTERVENTIONAL,"The reasons for stopping the research are :

* Inclusion difficulties (demanding inclusion and exclusion criteria),
* The Covid-19 pandemic"
NCT03037554,TERMINATED,INTERVENTIONAL,"Technical difficulties with ambulatory equipment led to unacceptably high levels of data loss. As we would have had to suspend data collection under Covid precautions in any case, we decided to terminate in March of this year."
NCT03037580,TERMINATED,INTERVENTIONAL,Terminated by sponsor
NCT03037593,WITHDRAWN,INTERVENTIONAL,Failure to recruit adequate patients
NCT03037645,TERMINATED,INTERVENTIONAL,"Phase 1b portion completed. Sponsor decided not to proceed with P2 portion of study. Vecabrutinib was very well tolerated, there was insufficient evidence of activity at the doses tested in the Phase 1b to advance to Phase 2."
NCT03037736,WITHDRAWN,INTERVENTIONAL,Funding not received.
NCT03038009,WITHDRAWN,INTERVENTIONAL,A new registration has been submitted due to a redesign of the study protocol.
NCT03038191,TERMINATED,OBSERVATIONAL,Sponsor stopped funding
NCT03038243,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03038477,WITHDRAWN,INTERVENTIONAL,Cancelled by PI
NCT03038750,TERMINATED,OBSERVATIONAL,"The delay due to suspending the study due to covid, subsequent problems in synthesis, supply and yield of BQ123, prevented completion of the study as planned."
NCT03038828,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03038971,TERMINATED,INTERVENTIONAL,Sponsor withdrew IND from FDA
NCT03038997,TERMINATED,OBSERVATIONAL,IRB approval expired
NCT03039127,TERMINATED,INTERVENTIONAL,Study was stopped in agreement with investigator due to slow recruitment.
NCT03039218,TERMINATED,INTERVENTIONAL,Commercial decision
NCT03039296,TERMINATED,OBSERVATIONAL,The low number of participants was enrolled in to the clinical trial
NCT03039517,WITHDRAWN,INTERVENTIONAL,staffing change and lack of resources to conduct the study.
NCT03039738,TERMINATED,INTERVENTIONAL,Medtronic shift in strategic direction for study device
NCT03039764,WITHDRAWN,INTERVENTIONAL,Paused due to COVID and the study has expired. The PI left the institution in 2021 and another PI has not been assigned.
NCT03039868,TERMINATED,OBSERVATIONAL,results were not as hypothesized
NCT03040024,TERMINATED,INTERVENTIONAL,Halted due to COVID 19; we believe we have adequate data for analysis
NCT03040076,TERMINATED,INTERVENTIONAL,"Data collection suggested that more work was needed to validate the theoretical connections between the constructs of interest, before doing a treatment trial."
NCT03040323,TERMINATED,INTERVENTIONAL,Insufficient patient recruitment. Data lost following departure of key personnel
NCT03040427,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03040453,WITHDRAWN,INTERVENTIONAL,poor recruitment
NCT03040505,TERMINATED,OBSERVATIONAL,The number of subjects needed was overestimated (from assumptions made in the litterature).
NCT03040765,TERMINATED,INTERVENTIONAL,failed to recruit eligible subjects
NCT03040804,TERMINATED,INTERVENTIONAL,Infeasibility to continue study.
NCT03040856,WITHDRAWN,INTERVENTIONAL,Problems executing the study
NCT03041116,TERMINATED,INTERVENTIONAL,The study was terminated since fosmetpantotenate did not show statistically significant effects or clinical benefits during the double-blind period.
NCT03041168,TERMINATED,OBSERVATIONAL,Study was stopped due to suspension of funding from CVR Global.
NCT03041181,TERMINATED,INTERVENTIONAL,Funder decision - lack of accrual
NCT03041220,WITHDRAWN,OBSERVATIONAL,PI no longer at institution
NCT03041285,TERMINATED,INTERVENTIONAL,have difficulty finding eligible participants
NCT03041311,TERMINATED,INTERVENTIONAL,Primary Analysis and survival follow up completed per protocol. Not stopped due to safety concerns.
NCT03041324,TERMINATED,INTERVENTIONAL,All nine subjects dosed in the study have rolled over to the Long-Term Follow-up Study IVPRP-LT01 \[NCT04628871\]
NCT03041493,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT03041571,WITHDRAWN,OBSERVATIONAL,PI is no longer with UF. No New PI assigned to date.
NCT03041701,TERMINATED,INTERVENTIONAL,The pharmaceutical company discontinued availability of the drug and we were forced to close the study before phase II was completed. Only one participant was enrolled on phase II.
NCT03042013,WITHDRAWN,INTERVENTIONAL,"Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies."
NCT03042117,WITHDRAWN,OBSERVATIONAL,Insufficient funds
NCT03042130,WITHDRAWN,INTERVENTIONAL,no recruitment
NCT03042312,TERMINATED,INTERVENTIONAL,Recruitment was stopped before the target sample size was achieved.
NCT03042325,WITHDRAWN,INTERVENTIONAL,"Business decision, no safety or efficacy concerns"
NCT03042533,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Low enrollment and PI leaving institution
NCT03042546,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Low enrollment and PI leaving institution
NCT03042637,SUSPENDED,OBSERVATIONAL,Bb
NCT03042780,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03042897,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03043027,WITHDRAWN,INTERVENTIONAL,cost of medicine too expensive to continue without funding
NCT03043144,WITHDRAWN,OBSERVATIONAL,Investigator leaving the institution
NCT03043222,WITHDRAWN,INTERVENTIONAL,Withdrawn from IRB
NCT03043339,SUSPENDED,OBSERVATIONAL,Pending approval of protocol amendment
NCT03043430,TERMINATED,INTERVENTIONAL,Research manpower shortage
NCT03043651,TERMINATED,INTERVENTIONAL,Terminated by Sponsor
NCT03043703,WITHDRAWN,INTERVENTIONAL,Study has no principal investigator at the moment.
NCT03043898,TERMINATED,OBSERVATIONAL,COVID-19
NCT03043976,TERMINATED,INTERVENTIONAL,Study terminated early due to ligistic reasons with study staff
NCT03043989,TERMINATED,INTERVENTIONAL,Low accrual
NCT03044249,TERMINATED,INTERVENTIONAL,Statistical futility; totality of evidence suggests study unlikely to meet endpoint
NCT03044314,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03044353,TERMINATED,INTERVENTIONAL,Change in benefit/risk profile
NCT03044379,WITHDRAWN,INTERVENTIONAL,"Current program is on hold, not for safety reason"
NCT03044600,TERMINATED,OBSERVATIONAL,At the request of the Principal Investigator
NCT03044691,TERMINATED,INTERVENTIONAL,confounding factors impacted the ability to fully complete the aims of this study
NCT03044795,WITHDRAWN,INTERVENTIONAL,The study never started
NCT03044821,TERMINATED,INTERVENTIONAL,We now offer the repair as standard of care up to BMI of 40.
NCT03045250,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03045302,TERMINATED,INTERVENTIONAL,Early termination is a sponsor decision. No new safety signal or serious adverse event has been observed.
NCT03045393,WITHDRAWN,INTERVENTIONAL,Inadequate enrollment
NCT03045679,TERMINATED,INTERVENTIONAL,"Hospital changed in 2019, no recruitment performed"
NCT03045705,WITHDRAWN,INTERVENTIONAL,Problem with patient recruitment
NCT03045848,TERMINATED,OBSERVATIONAL,Impossible device delivery because of sponsor change
NCT03046485,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT03046654,TERMINATED,INTERVENTIONAL,Difficulty in patient recruitment
NCT03046875,WITHDRAWN,INTERVENTIONAL,The study was never initiated because of lack of funding and research priorities have been shifted elsewhere.
NCT03046901,WITHDRAWN,INTERVENTIONAL,0 subjects enrolled
NCT03047200,WITHDRAWN,INTERVENTIONAL,There were not patients that meet inclusion/exclusion criteria. Site decided to close study.
NCT03047239,WITHDRAWN,INTERVENTIONAL,strategic change
NCT03047538,WITHDRAWN,INTERVENTIONAL,Insufficient funds
NCT03047577,TERMINATED,INTERVENTIONAL,Recruiting stopped due to slow recruitment particularly due to COVID
NCT03047694,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT03047941,WITHDRAWN,OBSERVATIONAL,Lack of participants
NCT03048019,TERMINATED,OBSERVATIONAL,study terminated per PI
NCT03048136,WITHDRAWN,INTERVENTIONAL,Business objective has changed
NCT03048227,TERMINATED,INTERVENTIONAL,"CGM Navigator isn't longer available (October 11, 2019)"
NCT03048461,WITHDRAWN,INTERVENTIONAL,Did not want to enroll and proceed with this study concept.
NCT03048565,TERMINATED,INTERVENTIONAL,recruitment challenges
NCT03048955,WITHDRAWN,INTERVENTIONAL,FDA and Sponsor closed trial. New post-marketing approval trial in development.
NCT03049111,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19 pandemic.
NCT03049124,WITHDRAWN,INTERVENTIONAL,We were unable to enroll participants into the study.
NCT03049215,TERMINATED,INTERVENTIONAL,Study terminated due to low/difficulty enrollment
NCT03049293,TERMINATED,INTERVENTIONAL,Difficulty in recruiting participants
NCT03049319,WITHDRAWN,INTERVENTIONAL,The sponsor did not provide the equipment needed to do study.
NCT03049358,TERMINATED,INTERVENTIONAL,Accrual factor
NCT03049397,TERMINATED,INTERVENTIONAL,Pilot deemed not feasible based on predetermined stopping rules
NCT03049787,WITHDRAWN,INTERVENTIONAL,The study was never started as the PI was working on another clinical trial.
NCT03050060,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT03050372,TERMINATED,INTERVENTIONAL,Funding no longer available
NCT03050398,TERMINATED,INTERVENTIONAL,GCP issues.
NCT03050450,TERMINATED,INTERVENTIONAL,Lack of feasibility to accrue patients in allotted time.
NCT03050554,TERMINATED,INTERVENTIONAL,Funding
NCT03050632,WITHDRAWN,INTERVENTIONAL,"With change of personnel and lab resources, this study was not feasible without independent funding"
NCT03050814,TERMINATED,INTERVENTIONAL,Terminated after an unplanned interim efficacy analysis.
NCT03051035,TERMINATED,INTERVENTIONAL,Due to a strategic business decision Kura has stopped development of KO-947. Neither safety nor efficacy reasons were the cause of study termination.
NCT03051139,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03051165,TERMINATED,INTERVENTIONAL,Study was terminated due to funding issues.
NCT03051451,SUSPENDED,INTERVENTIONAL,Business decision
NCT03051516,TERMINATED,INTERVENTIONAL,The study was terminated early due to futility.
NCT03051607,TERMINATED,INTERVENTIONAL,New Safety Information
NCT03051672,TERMINATED,INTERVENTIONAL,"Based on two-stage design, the study ended at stage 1 with no evidence of promise based on pre-specified decision rule."
NCT03051698,TERMINATED,INTERVENTIONAL,Interim analysis showed no differences between groups
NCT03051711,TERMINATED,INTERVENTIONAL,Sponsor discontinued IPF Program on 23-Oct. 2017 based on POC studies
NCT03051802,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03051932,WITHDRAWN,INTERVENTIONAL,Not funded
NCT03051945,WITHDRAWN,INTERVENTIONAL,Unable to perform brain imaging
NCT03051971,WITHDRAWN,INTERVENTIONAL,Study was abandoned.
NCT03052218,TERMINATED,INTERVENTIONAL,difficulties in recruitment
NCT03052270,TERMINATED,INTERVENTIONAL,Former PI Left the Institution
NCT03052361,TERMINATED,INTERVENTIONAL,The recruitment was much slower than expected and the COVID pandemic added new barriers to recruitment.
NCT03052400,TERMINATED,INTERVENTIONAL,End of Funding
NCT03052517,TERMINATED,INTERVENTIONAL,Company Decision
NCT03052712,TERMINATED,INTERVENTIONAL,not enough patients
NCT03052725,TERMINATED,INTERVENTIONAL,Parent Studies didn't meet their primary endpoint so study was terminated.
NCT03052790,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03052894,TERMINATED,INTERVENTIONAL,Data collection issues from the electronic health record.
NCT03052972,TERMINATED,INTERVENTIONAL,study terminated due to lower than expected enrollment
NCT03053050,TERMINATED,INTERVENTIONAL,This study was terminated early due to lack of efficacy based on the results of the Week 48 analysis as prespecified in the clinical study protocol.
NCT03053063,TERMINATED,INTERVENTIONAL,This study was terminated early due to lack of efficacy based on the results of the Week 48 analysis as prespecified in the clinical study protocol.
NCT03053271,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03053284,WITHDRAWN,INTERVENTIONAL,Funding was withdrawn by Sponsor prior to start of study
NCT03053297,TERMINATED,OBSERVATIONAL,"Cancelled due to changes in the scientific landscape. Decision was made after thorough evaluation of of pros\&cons, ethical as well as regulatory consideration"
NCT03053414,WITHDRAWN,INTERVENTIONAL,change in study design before recruitment began
NCT03053453,TERMINATED,INTERVENTIONAL,Departure of study surgeon investigator.
NCT03053518,TERMINATED,INTERVENTIONAL,Protocol Withdrawn
NCT03053531,WITHDRAWN,INTERVENTIONAL,Did not meet enrollment
NCT03053700,WITHDRAWN,INTERVENTIONAL,"During study new treatments were available, which may be more effective than proposed study treatment."
NCT03053765,TERMINATED,INTERVENTIONAL,Conflict of Interest (COI) cannot be managed
NCT03053934,TERMINATED,INTERVENTIONAL,Trial no longer feasible
NCT03053960,TERMINATED,OBSERVATIONAL,Terminated by IRB
NCT03054025,TERMINATED,INTERVENTIONAL,funding discontinued
NCT03054038,TERMINATED,INTERVENTIONAL,Low accrual
NCT03054207,TERMINATED,INTERVENTIONAL,difficulty to recruit
NCT03054636,TERMINATED,OBSERVATIONAL,"After data review of enrolled pts, it was determined that initial study objectives would not be met w/ continuation of enrollment"
NCT03054870,TERMINATED,INTERVENTIONAL,Trial met primary efficacy endpoint target. No additional subjects necessary.
NCT03054948,WITHDRAWN,INTERVENTIONAL,Redesign of study protocol.
NCT03055195,TERMINATED,INTERVENTIONAL,Study reached pre-determined futility criteria following interim analysis. No safety concerns were noted.
NCT03055208,SUSPENDED,INTERVENTIONAL,suspended due to low accrual rates
NCT03055234,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03055481,TERMINATED,INTERVENTIONAL,it was estimated that the recruitment of the planned number of patients could not be completed within further 5 years.
NCT03055572,WITHDRAWN,INTERVENTIONAL,Staffing issues resulted in the closure of the study prior to any participants being enrolled.
NCT03055585,TERMINATED,INTERVENTIONAL,Distancing and movement restrictions of the COVID-19 emergency response made continuation of clinic-based and field entomological trial activities infeasible
NCT03055819,TERMINATED,INTERVENTIONAL,Company no longer exists
NCT03055884,WITHDRAWN,INTERVENTIONAL,low numbers of participants
NCT03056014,TERMINATED,INTERVENTIONAL,COVID
NCT03056144,TERMINATED,INTERVENTIONAL,All potential participants opt to a simultaneous pharmacological clinical trial
NCT03056183,WITHDRAWN,INTERVENTIONAL,not funded
NCT03056378,WITHDRAWN,INTERVENTIONAL,No patients enrolled. Study withdrawn.
NCT03056495,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT03056508,TERMINATED,INTERVENTIONAL,"Due to COVID-19, recruitment and enrollment was suspended and never resumed. COVID-related changes have been made to the clinical program which houses our intervention, and we could not compare new participants with our previous cohort."
NCT03056742,WITHDRAWN,INTERVENTIONAL,Form 46 from DCGI for the manufacturing \& commercial marketing of Stempeucel directs Stempeutics to conduct PMS study. Hence this study is being terminated.
NCT03057067,TERMINATED,INTERVENTIONAL,difficulties recruiting
NCT03057132,TERMINATED,INTERVENTIONAL,Slow enrollment of patients
NCT03057197,TERMINATED,INTERVENTIONAL,The results of the interim analysis showed significant results.
NCT03057314,TERMINATED,INTERVENTIONAL,Slow recreuitment
NCT03057509,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT03057587,WITHDRAWN,OBSERVATIONAL,The research never began.
NCT03057639,TERMINATED,OBSERVATIONAL,Slow accrual
NCT03057678,WITHDRAWN,INTERVENTIONAL,No participants have been enrolled. The PI Is leaving the institution and we wish to close the study at this time.
NCT03057743,TERMINATED,OBSERVATIONAL,Difficulty enrolling subjects
NCT03057769,TERMINATED,INTERVENTIONAL,This study was terminated because of an interim analysis suggesting futility of papillary epinephrine spraying in PEP prevention.
NCT03057990,WITHDRAWN,INTERVENTIONAL,Study never opened; closed on 06/29/2021 due to no enrllment
NCT03058068,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT03058094,WITHDRAWN,INTERVENTIONAL,Considiering to change the Chemotherapy into Gefitinib
NCT03058146,TERMINATED,INTERVENTIONAL,COVID-19 shut down of research operations
NCT03058211,TERMINATED,OBSERVATIONAL,due to COVID-19 pandemia
NCT03058393,TERMINATED,INTERVENTIONAL,Extenuating circumstances
NCT03058614,WITHDRAWN,INTERVENTIONAL,The research team submitted grants over the course of several years to gain funds to support this research but were unsuccessful in securing the funds. The research team will now focus on other funded studies.
NCT03058653,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT03058822,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT03058939,WITHDRAWN,INTERVENTIONAL,Study never activated to enrollment.
NCT03059082,TERMINATED,INTERVENTIONAL,Principal Investigator surrendered funding and left institution.
NCT03059147,TERMINATED,INTERVENTIONAL,Lack of recruitment and sponsor's priority changes
NCT03059277,WITHDRAWN,INTERVENTIONAL,Site investigator decided to not move forward with study.
NCT03059303,TERMINATED,INTERVENTIONAL,"Decision to discontinue development of investigational Hep C treatment regimen JNJ-4178: 3 direct acting antivirals - AL-335, ODV \& SMV."
NCT03059355,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic and lack of funding
NCT03059446,TERMINATED,INTERVENTIONAL,This study was terminated early due to lack of efficacy based on the results of Part I of the AURORA study.
NCT03059511,TERMINATED,INTERVENTIONAL,"We conclude that the doses we administered were safe, but too low. We plan to continue the study with higher doses (0.1 mg/kg iv and 0.2 mg/kg intranasal)."
NCT03059563,TERMINATED,INTERVENTIONAL,Global pandemic
NCT03059615,WITHDRAWN,INTERVENTIONAL,No recruitment since initiation
NCT03059628,TERMINATED,INTERVENTIONAL,The number of participants included and especially who connected to the application (less than 50% of the target) does not meet the objective set by the study.
NCT03059849,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03059888,TERMINATED,INTERVENTIONAL,Mutual decision of sponsor and investigator due to logistical challenges
NCT03060109,TERMINATED,OBSERVATIONAL,Diagnostic platform no longer under development; study termination not related to any safety issues
NCT03060356,TERMINATED,INTERVENTIONAL,Halt in funding
NCT03060460,TERMINATED,INTERVENTIONAL,slow recruitment
NCT03060499,WITHDRAWN,OBSERVATIONAL,Luck of interest
NCT03060629,TERMINATED,INTERVENTIONAL,Study was terminated by the sponsor after the last participant completed the Month 24 visit as the pre-specified criteria to continue the study were not met.
NCT03060772,TERMINATED,INTERVENTIONAL,"Study was suspended in 2020 due to COVID-19 pandemic as a result of recruitment challenges and the inability to conduct all study procedures (e.g., bronchoscopy) per protocol. In late 2021 the decision was made to not re-open the study."
NCT03060954,TERMINATED,INTERVENTIONAL,The clinical study is closed to further enrolment based on the lack of perceived need to compare the study device with the control device.
NCT03060980,TERMINATED,INTERVENTIONAL,Decision by Sponsor
NCT03061019,TERMINATED,INTERVENTIONAL,a RCT was started
NCT03061045,WITHDRAWN,INTERVENTIONAL,PI is leaving the institution
NCT03061110,WITHDRAWN,INTERVENTIONAL,Internal funding not awarded.
NCT03061136,WITHDRAWN,INTERVENTIONAL,Delays in equipment procurement prevented the start of the study in time
NCT03061279,TERMINATED,INTERVENTIONAL,Problem negotiating other sites
NCT03061708,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT03061838,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03062007,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03062098,WITHDRAWN,INTERVENTIONAL,"Primary investigator retired, rest of staff cannot continue"
NCT03062111,TERMINATED,INTERVENTIONAL,Study was stopped due to low enrollment.
NCT03062176,WITHDRAWN,INTERVENTIONAL,We screened over 200 patients but were ultimately unable to enroll anyone
NCT03062540,TERMINATED,INTERVENTIONAL,Stopped early due to inadequate separation on primary efficacy endpoint at Week 12 according to Interim Analysis conducted on the first 274 (50%) patients.
NCT03062553,WITHDRAWN,INTERVENTIONAL,Testing for this study remained in the pilot stages due to optimization of the tACS equipment. There are no clinical results to report.
NCT03062657,TERMINATED,INTERVENTIONAL,"Study terminated prematurely as agreed by the FDA. The FDA were satisfied that no further data was required, despite the total number of patients who completed the study in full not being the agreed upon number."
NCT03062995,WITHDRAWN,INTERVENTIONAL,Study design not adequate anymore
NCT03063190,WITHDRAWN,INTERVENTIONAL,the main research is no longer in the Institution
NCT03063203,TERMINATED,INTERVENTIONAL,Futility
NCT03063229,TERMINATED,INTERVENTIONAL,Unable to recruit participants due to lack of patients eligible at the time
NCT03063242,TERMINATED,INTERVENTIONAL,Insufficient resources necessary for completion.
NCT03063333,TERMINATED,INTERVENTIONAL,Head of project stopped
NCT03063359,TERMINATED,INTERVENTIONAL,The new pain protocols imposed by the HAS make it difficult to include new patients in the study
NCT03063775,TERMINATED,INTERVENTIONAL,Lack of suitable patients for recruitment
NCT03063840,WITHDRAWN,INTERVENTIONAL,NO participants enrolled
NCT03063905,TERMINATED,OBSERVATIONAL,funding expired
NCT03064009,TERMINATED,OBSERVATIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Low enrollment and PI leaving institution
NCT03064139,SUSPENDED,INTERVENTIONAL,Study disrupted due to COVID-19. Interim data analyses in progress.
NCT03064152,TERMINATED,INTERVENTIONAL,"slow enrollment, outcome measures collected but actual enrollment is below target enrollment"
NCT03064854,TERMINATED,INTERVENTIONAL,Recruitment halted prematurely due to competitive landscape for lung cancer therapies
NCT03065023,TERMINATED,INTERVENTIONAL,Group B not started for business reasons.
NCT03065101,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03065218,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03065296,WITHDRAWN,INTERVENTIONAL,The Investigator left the institution and was withdrarwn
NCT03065348,TERMINATED,INTERVENTIONAL,lack of study participants
NCT03065374,TERMINATED,INTERVENTIONAL,Study was stopped due to slow recruitment. All subjects completed their participation including follow up period per protocol. No safety issues.
NCT03065634,TERMINATED,INTERVENTIONAL,insufficient recruitment rate
NCT03065712,WITHDRAWN,INTERVENTIONAL,Competing clinical trial
NCT03065790,TERMINATED,OBSERVATIONAL,Adequate recruitment was not reached to continue the study.
NCT03065894,TERMINATED,INTERVENTIONAL,Lack of subject enrollment
NCT03065959,TERMINATED,INTERVENTIONAL,Lack of efficacy determined at interim analysis
NCT03066115,WITHDRAWN,INTERVENTIONAL,"This study was never funded, never fully IRB approved, and thus never enrolled anyone."
NCT03066336,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting subjects
NCT03066388,TERMINATED,INTERVENTIONAL,insufficient inclusion rate
NCT03066401,TERMINATED,OBSERVATIONAL,insufficient inclusion rate
NCT03066440,TERMINATED,INTERVENTIONAL,Shortage of potassium acetate for study intravenous fluids
NCT03066453,TERMINATED,INTERVENTIONAL,new treatment that changes the management of the disease
NCT03066466,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT03066726,TERMINATED,OBSERVATIONAL,Unable to meet recruitment target
NCT03066817,SUSPENDED,INTERVENTIONAL,Waiting for annual IRB progress report to be reviewed and approved
NCT03066908,SUSPENDED,INTERVENTIONAL,Change in study design
NCT03066999,TERMINATED,INTERVENTIONAL,There was no enough subject
NCT03067363,TERMINATED,INTERVENTIONAL,Part 1 completed successfully. Part 2 not conducted.
NCT03067480,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03067558,TERMINATED,OBSERVATIONAL,Device incorrect colour-coded classification of fast breathing for RR
NCT03067571,TERMINATED,INTERVENTIONAL,Study terminated early because of lack of efficacy
NCT03067974,TERMINATED,INTERVENTIONAL,Initial results did not show benefit.
NCT03068130,TERMINATED,INTERVENTIONAL,The company determined that continued exposure of these high-risk PH patients to clinic or in-person visits during the COVID pandemic presented an unacceptable risk.
NCT03068247,WITHDRAWN,INTERVENTIONAL,Institution was unable to manufacture radiotracer that was central to the protocol. Study transferred to another institution.
NCT03068286,TERMINATED,INTERVENTIONAL,recruitment issues
NCT03068468,TERMINATED,INTERVENTIONAL,251PP301(PASSPORT) primary endpoint was not met;Biogen decision to close the study early. There were no safety concerns with the PASSPORT study.
NCT03068676,TERMINATED,INTERVENTIONAL,Paused due to technical issues
NCT03068754,TERMINATED,INTERVENTIONAL,As recommended by the study's independent Data and Safety Monitoring Board (DSMB)
NCT03068832,WITHDRAWN,INTERVENTIONAL,Made the decision to not go forward with the study
NCT03068975,TERMINATED,INTERVENTIONAL,"This study was terminated due to failure to enroll, a low volume of patients met criteria."
NCT03069287,WITHDRAWN,INTERVENTIONAL,Lack of funding and resources
NCT03069495,TERMINATED,OBSERVATIONAL,Lack of research assistant to work on study
NCT03069599,TERMINATED,OBSERVATIONAL,PI left hospital
NCT03069612,TERMINATED,INTERVENTIONAL,Terminated
NCT03069768,WITHDRAWN,INTERVENTIONAL,Unable to obtain varenicline to provide to participants
NCT03069781,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03069911,TERMINATED,INTERVENTIONAL,Unable to recruit required participants
NCT03069950,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT03069989,TERMINATED,INTERVENTIONAL,Sufficient information was gathered from cohort 1 to terminate the study without proceeding to optional cohort 2.
NCT03070002,TERMINATED,INTERVENTIONAL,Low accrual
NCT03070132,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03070314,WITHDRAWN,INTERVENTIONAL,no participants could be recruited who were eager to donate blood for bioavailability despite prolongation of the study period.
NCT03070574,TERMINATED,INTERVENTIONAL,Due to poor patient recruitment and insufficient financing.
NCT03070704,WITHDRAWN,OBSERVATIONAL,Request for the study waived by Indian Health Authorities
NCT03070730,TERMINATED,INTERVENTIONAL,Recruitment was slow and subjects declined participation after signing the ICF.
NCT03070964,TERMINATED,INTERVENTIONAL,The main reason that motivated the study termination was the slow recruitment of the trial.
NCT03071094,TERMINATED,INTERVENTIONAL,"The decision was taken to stop prematurely the trial due to the failure of Pexa-Vec and nivolumab in their respective pivotal trials (i.e., PHOCUS and CheckMate 459)."
NCT03071276,TERMINATED,INTERVENTIONAL,Due to slow enrollment
NCT03071354,WITHDRAWN,INTERVENTIONAL,Principal Investigator is Moving Institutions
NCT03071614,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03071627,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03071653,SUSPENDED,INTERVENTIONAL,COVID and Funding
NCT03071692,TERMINATED,INTERVENTIONAL,The study was stopped for futility based on efficacy results at the interim analysis; no unexpected safety findings were observed.
NCT03071744,TERMINATED,INTERVENTIONAL,PI is leaving UCSD
NCT03071809,TERMINATED,OBSERVATIONAL,Accrual difficulties
NCT03071939,WITHDRAWN,INTERVENTIONAL,the investigator left our institution
NCT03072511,TERMINATED,INTERVENTIONAL,PI is relocating to another institution.
NCT03072901,TERMINATED,OBSERVATIONAL,GID terminated the Registry due to evolving registry requirements
NCT03072953,TERMINATED,INTERVENTIONAL,Terminated \[Sponsor decision to terminate the study\]
NCT03073096,TERMINATED,INTERVENTIONAL,Not enough resources to continue the study especially with Covid-19
NCT03073369,WITHDRAWN,INTERVENTIONAL,Study didn't materialize for various reasons.
NCT03073460,WITHDRAWN,INTERVENTIONAL,Not able to recruit any participants
NCT03073473,TERMINATED,OBSERVATIONAL,Poor accrual
NCT03073512,WITHDRAWN,INTERVENTIONAL,Unable to locate the resources necessary to complete participant recruitment.
NCT03073629,TERMINATED,INTERVENTIONAL,Found not to be feasible
NCT03073759,TERMINATED,INTERVENTIONAL,Not enough participants
NCT03073850,TERMINATED,INTERVENTIONAL,Majority of enrolled patients have withdrawn.
NCT03074305,WITHDRAWN,INTERVENTIONAL,cannot use bioabsorbable scaffold
NCT03074318,TERMINATED,INTERVENTIONAL,Terminated due to PI leaving institution
NCT03074786,WITHDRAWN,INTERVENTIONAL,Study was transferred to partner who will conduct under its own IND
NCT03074825,TERMINATED,INTERVENTIONAL,The results fell short of expectations.
NCT03075163,TERMINATED,INTERVENTIONAL,recruitment futility
NCT03075176,TERMINATED,INTERVENTIONAL,Because of the bias in who qualified for the study it became apparent we would not get any statistically valid results.
NCT03075228,TERMINATED,OBSERVATIONAL,Low recruitment rate; high proportion of screening failures.
NCT03075345,WITHDRAWN,INTERVENTIONAL,NHS service understaffing which made study unable to begin.
NCT03075475,TERMINATED,INTERVENTIONAL,Very few children and adolescents identified who met intake criteria.
NCT03075527,SUSPENDED,INTERVENTIONAL,Criteria not met for second stage at time of interim analysis
NCT03075553,TERMINATED,INTERVENTIONAL,due to poor response
NCT03075878,TERMINATED,INTERVENTIONAL,Focus resources on a planned phase 2/3 study
NCT03075904,TERMINATED,INTERVENTIONAL,Study objectives achieved
NCT03076242,TERMINATED,OBSERVATIONAL,Competing trial
NCT03076515,TERMINATED,INTERVENTIONAL,Study was prematurely stop based on DMC recommendation
NCT03076606,TERMINATED,OBSERVATIONAL,recruiting issues and unavailable ophtalmologists
NCT03076632,WITHDRAWN,INTERVENTIONAL,Funding obtained to conduct expanded study - to be posted to ClinicalTrials.gov.
NCT03076684,WITHDRAWN,INTERVENTIONAL,Preliminary data collected and diets developed. Funding has ended and data used to support a larger application to test the hypothesis.
NCT03076710,WITHDRAWN,OBSERVATIONAL,No participants were identified per inclusion/exclusion criteria
NCT03076723,TERMINATED,INTERVENTIONAL,Acceptable duration exceeded. Enrolment too slow due to covid pandemic and extensive protocol.
NCT03076905,WITHDRAWN,INTERVENTIONAL,study no longer required in current format
NCT03076918,TERMINATED,INTERVENTIONAL,decision of the investigator in the face of new scientific knowledge
NCT03076931,TERMINATED,INTERVENTIONAL,0 subjects completed all study visits. Due to noncompliance and recruitment difficulties study was terminated.
NCT03077087,TERMINATED,INTERVENTIONAL,Study was stopped due to feasibility issues with completing the study procedure.
NCT03077347,TERMINATED,INTERVENTIONAL,Stimulation did not show any evidence of the anticipated effect after 6 participants completed the study. Study was thus halted.
NCT03077477,WITHDRAWN,INTERVENTIONAL,"Change in FDA required patient population decision prior to study start, new protocol developed, this protocol withdrawn"
NCT03077633,WITHDRAWN,INTERVENTIONAL,Financial/business decision by Sponsor to not proceed with this study
NCT03077698,TERMINATED,INTERVENTIONAL,The study was discontinued due to a change in development strategy and not due safety concern.
NCT03077997,TERMINATED,INTERVENTIONAL,logistics recruitment
NCT03078270,TERMINATED,INTERVENTIONAL,study terminated due to low recruitment
NCT03078465,WITHDRAWN,INTERVENTIONAL,"Competitive studies were conducted at the same time, and enrollment was suspended."
NCT03078504,TERMINATED,INTERVENTIONAL,Failure to recruit patients further
NCT03078725,WITHDRAWN,INTERVENTIONAL,"Research was competing with other projects in the department, and no patients were recruited."
NCT03078829,TERMINATED,OBSERVATIONAL,investigator has left UCSF
NCT03078868,TERMINATED,INTERVENTIONAL,lack of accrual and PI left institution
NCT03079102,TERMINATED,INTERVENTIONAL,Slow enrollment and planned change of institution by PI
NCT03079297,TERMINATED,INTERVENTIONAL,Covid-19
NCT03079505,TERMINATED,INTERVENTIONAL,Protocol Deviation
NCT03079661,TERMINATED,OBSERVATIONAL,investigator choice
NCT03079778,WITHDRAWN,INTERVENTIONAL,"Opened up a separate Clinicaltrials.gov trial form, study ID TACE"
NCT03079908,WITHDRAWN,INTERVENTIONAL,Not enough resources to start the study
NCT03079973,WITHDRAWN,INTERVENTIONAL,Project development priorities changed.
NCT03080337,TERMINATED,INTERVENTIONAL,This study is being closed prematurely due to resource availability and agreement constraints with the collaborating research site.
NCT03080389,TERMINATED,OBSERVATIONAL,Study staff not available to complete the trial
NCT03080428,WITHDRAWN,INTERVENTIONAL,The study has been withdrawn because of lack of funding
NCT03080480,TERMINATED,INTERVENTIONAL,The results are negtive.
NCT03080753,TERMINATED,INTERVENTIONAL,"Study halted due to lower success rates than expected, after evaluation we have decided not to resume the study."
NCT03080792,TERMINATED,INTERVENTIONAL,Recruitment difficult
NCT03080844,TERMINATED,INTERVENTIONAL,COVID-19
NCT03080935,TERMINATED,INTERVENTIONAL,Amgen business decision to close study early
NCT03081039,WITHDRAWN,INTERVENTIONAL,Competing study
NCT03081117,TERMINATED,INTERVENTIONAL,"On 3/15/2020 study visits were suspended due to COVID-19 pandemic. With safety concerns surrounding COVID-19 and difficulty recruiting, the investigators decided to close enrollment 10/16/2020 after interim data were reviewed by the DSMB and NIH."
NCT03081169,WITHDRAWN,INTERVENTIONAL,Recruitment not started due to potential conflicting study at same institution. May renew study in the future.
NCT03081234,WITHDRAWN,INTERVENTIONAL,Withdrawn due to change in plan for this study and not due to safety reasons.
NCT03081247,WITHDRAWN,INTERVENTIONAL,Internal Study team decision not to proceed.
NCT03081598,TERMINATED,INTERVENTIONAL,Failure to meet recruitment target during the recruitment period
NCT03081897,SUSPENDED,INTERVENTIONAL,for organizational reasons
NCT03081923,TERMINATED,INTERVENTIONAL,loss of accrual
NCT03082014,TERMINATED,INTERVENTIONAL,"completed for the primary study group of sporadic SVD patients, halted prematurely for the additional study group due to slow recruitment at 26 of 30 CADASIL patients in December 2022"
NCT03082157,WITHDRAWN,INTERVENTIONAL,Transfer of grant to new institution
NCT03082300,TERMINATED,INTERVENTIONAL,"Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies."
NCT03082833,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT03083340,WITHDRAWN,INTERVENTIONAL,Feasibility concerns regarding recruitment
NCT03083366,TERMINATED,INTERVENTIONAL,The study was unable to meet enrollment goals
NCT03083444,WITHDRAWN,OBSERVATIONAL,Grant not funded so clinical trial not started.
NCT03083600,TERMINATED,INTERVENTIONAL,The Study was not recruiting
NCT03083977,TERMINATED,INTERVENTIONAL,pandemic related difficulties for recruitment
NCT03084263,WITHDRAWN,INTERVENTIONAL,Withdrawn (No Participants Enrolled)
NCT03084510,WITHDRAWN,INTERVENTIONAL,study device was recalled.
NCT03084614,TERMINATED,OBSERVATIONAL,Slow/insufficient accrual
NCT03084666,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT03084835,TERMINATED,INTERVENTIONAL,Low Study Accrual
NCT03084861,TERMINATED,INTERVENTIONAL,Low recruitment. No safety issue associated.
NCT03084978,WITHDRAWN,INTERVENTIONAL,Study was never approved by the IRB
NCT03085394,TERMINATED,INTERVENTIONAL,"Enrollment stopped, patients refuse to participate."
NCT03085420,TERMINATED,INTERVENTIONAL,Participating site withdrew prior to any enrollment and lead site with slow enrollment. Not expected to meet enrollment goals.
NCT03085641,TERMINATED,INTERVENTIONAL,Side effects
NCT03086252,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT03086395,WITHDRAWN,INTERVENTIONAL,Funding Unavailable
NCT03086889,TERMINATED,INTERVENTIONAL,The trials were stopped after recruiting 60% of the planned sample after a median of 3 months follow-up and one interim analysis. The immersive virtual reality based training has proven to work.
NCT03087058,TERMINATED,INTERVENTIONAL,The study was terminated on 13 May 2022 due to a modification to the PIP/PSP
NCT03087097,TERMINATED,INTERVENTIONAL,COVID-19 pandemic and resource constraints
NCT03087305,WITHDRAWN,OBSERVATIONAL,low enrollment rate
NCT03087370,WITHDRAWN,OBSERVATIONAL,Company Decision
NCT03087448,TERMINATED,INTERVENTIONAL,Low Accrual
NCT03087500,WITHDRAWN,OBSERVATIONAL,Funding fell through
NCT03087578,WITHDRAWN,INTERVENTIONAL,Study never started
NCT03087708,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT03087747,WITHDRAWN,OBSERVATIONAL,poor accrual
NCT03087968,WITHDRAWN,INTERVENTIONAL,No longer a sub-study - Changing to an independent parallel study
NCT03088189,TERMINATED,OBSERVATIONAL,Assessments were stopped in February 2020 due to COVID pandemic
NCT03088293,WITHDRAWN,INTERVENTIONAL,recruiting difficulties
NCT03088501,TERMINATED,INTERVENTIONAL,The PERTH RCT was nested within the MAASTHI birth cohort. PERTH study was stopped as MAASTHI has completed it's recruitment.
NCT03088735,TERMINATED,INTERVENTIONAL,Due to the clinically and statistically significant inferior results for the D3 group following evaluation by the institutional review board.
NCT03088774,WITHDRAWN,INTERVENTIONAL,"The primary trial was stopped. Since, a feasibility study showed that recruitment was not feasible. We obtain a recruitment rate of 15 %."
NCT03089047,TERMINATED,INTERVENTIONAL,Reagent shortage
NCT03089073,TERMINATED,OBSERVATIONAL,Enrollment challenges
NCT03089164,TERMINATED,OBSERVATIONAL,Recruitment challenges and difficulties performing upright hemodynamic measurements using current cath lab setup lead to termination.
NCT03089463,SUSPENDED,OBSERVATIONAL,The study has not managed to recruit adequate number of participants.
NCT03089476,WITHDRAWN,INTERVENTIONAL,Study will not go forward
NCT03089502,TERMINATED,INTERVENTIONAL,Limited recruitment
NCT03089567,WITHDRAWN,INTERVENTIONAL,Study was not conducted. No participants were enrolled
NCT03089619,TERMINATED,INTERVENTIONAL,"Difficulties in recruiting of suitable patients, bad compliance of patients"
NCT03089697,TERMINATED,INTERVENTIONAL,Enrollment into this study was terminated by the Sponsor prior to completion for strategic reasons.
NCT03089749,TERMINATED,OBSERVATIONAL,This study has been administratively closed by the IRB as of 5/20/2019. This administrative closure was required because of the study expiration on 4/29/2019 and a continuing review application for re-approval of the study was not submitted.
NCT03090126,WITHDRAWN,OBSERVATIONAL,No possibility to recruit.
NCT03090269,WITHDRAWN,INTERVENTIONAL,feasibility reasons.
NCT03090412,TERMINATED,INTERVENTIONAL,low accrual
NCT03090880,TERMINATED,INTERVENTIONAL,"The rate of inclusion is too low to hope to reach the target of 800 patients. 59 patients were included, and their data will not meet the research objectives.

The sponsor has decided to prematurely stop inclusions on January 13, 2022."
NCT03090893,WITHDRAWN,INTERVENTIONAL,PI passed away
NCT03090919,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT03090932,TERMINATED,OBSERVATIONAL,"Study recruitment, data and sample collection terminated due to COVID-19. Data analysis continues."
NCT03091205,WITHDRAWN,OBSERVATIONAL,Unable to obtain funding source
NCT03091413,WITHDRAWN,OBSERVATIONAL,not recruitment
NCT03091439,TERMINATED,INTERVENTIONAL,Business decision outlined by the corporation.
NCT03091478,TERMINATED,INTERVENTIONAL,Low Accrual
NCT03091491,TERMINATED,INTERVENTIONAL,"Slow recruitment due to general pessimism for immunotherapy in NSCLC, availability of alternative therapy and clinician's choice to put patient on immunotherapy outside of trial setting."
NCT03091803,WITHDRAWN,OBSERVATIONAL,No accrual
NCT03091842,WITHDRAWN,INTERVENTIONAL,PI left
NCT03091855,TERMINATED,OBSERVATIONAL,Terminated due to low enrollment
NCT03091998,WITHDRAWN,INTERVENTIONAL,No funding available
NCT03092297,TERMINATED,OBSERVATIONAL,COVID-19 pandemic
NCT03092349,TERMINATED,OBSERVATIONAL,Principal Investigator has left study site
NCT03092635,TERMINATED,INTERVENTIONAL,Original principal investigator departed institution and concluded the study upon departure.
NCT03092687,TERMINATED,OBSERVATIONAL,Not considered to be human subjects research
NCT03092765,TERMINATED,INTERVENTIONAL,Sponsor's decision (non-safety related)
NCT03092791,TERMINATED,INTERVENTIONAL,Planned immunogenicity outcomes not reached
NCT03093025,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03093051,TERMINATED,INTERVENTIONAL,Sponsor ceased operations
NCT03093077,WITHDRAWN,INTERVENTIONAL,Unanswered questions regarding indications for device.
NCT03093090,WITHDRAWN,INTERVENTIONAL,Study never officially began
NCT03093272,TERMINATED,INTERVENTIONAL,Safety concerns
NCT03093740,WITHDRAWN,INTERVENTIONAL,"Withdrew IRB application, never approved and no subjects enrolled"
NCT03093831,TERMINATED,INTERVENTIONAL,Study did not meet the objectives and terminated early on 17 Jul 2020 due to poor recruitment
NCT03093935,TERMINATED,INTERVENTIONAL,Lack of subject participation
NCT03093948,TERMINATED,INTERVENTIONAL,Overlap with other RCT
NCT03094013,TERMINATED,OBSERVATIONAL,PI moved. Unable to recruit
NCT03094039,WITHDRAWN,INTERVENTIONAL,no patient available for 18 months
NCT03094065,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03094091,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03094117,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03094130,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03094169,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT03094195,TERMINATED,INTERVENTIONAL,The study was terminated early due to pre-clinical toxicity data that became available after start of trial
NCT03094468,WITHDRAWN,INTERVENTIONAL,Project development priorities changed
NCT03094559,WITHDRAWN,INTERVENTIONAL,Investigator leaving institution
NCT03094611,TERMINATED,INTERVENTIONAL,the study was closed early due to competing trials
NCT03094715,TERMINATED,INTERVENTIONAL,Publication of results of competing trials SELECT2 \& Angel Aspect
NCT03094832,TERMINATED,INTERVENTIONAL,Early termination due to business reasons
NCT03094858,WITHDRAWN,INTERVENTIONAL,The smartwatches we planned to use were discontinued.
NCT03095170,TERMINATED,INTERVENTIONAL,IRB Closure
NCT03095222,WITHDRAWN,INTERVENTIONAL,The study never screened or enrolled any subjects due to stalled recruitment efforts.
NCT03095287,TERMINATED,INTERVENTIONAL,Terminated due to limited enrollment (non-safety related decision)
NCT03095404,WITHDRAWN,INTERVENTIONAL,No funding available.
NCT03095547,WITHDRAWN,INTERVENTIONAL,study no longer required in current format
NCT03095664,SUSPENDED,INTERVENTIONAL,"Study stopped due to COVID-19 pandemic, as conducting a behaviour-change programme in groups was not recommended to prevent the spread of the virus."
NCT03095794,TERMINATED,INTERVENTIONAL,Insufficient on-site staff to manage study
NCT03095833,TERMINATED,INTERVENTIONAL,Insufficient on-site staff to manage study
NCT03095911,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03095924,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03095950,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT03096340,TERMINATED,INTERVENTIONAL,Terminated by sponsor.
NCT03096431,TERMINATED,INTERVENTIONAL,PI leaving institution: Will not continue study.
NCT03096444,TERMINATED,INTERVENTIONAL,Efficacy was not seen after interim analysis
NCT03096483,TERMINATED,INTERVENTIONAL,Sponsor determination
NCT03096600,WITHDRAWN,OBSERVATIONAL,The principal investigator has left the hospital.
NCT03096899,WITHDRAWN,OBSERVATIONAL,The investigator conducting the study determined that the entry criteria for the proposed subjects was too difficult to determine in a retrospective review.
NCT03097107,SUSPENDED,INTERVENTIONAL,Management decision to suspend the study due to recruitment issues
NCT03097159,WITHDRAWN,OBSERVATIONAL,"Surgeon refuse the proposal, so we can's enroll the patients"
NCT03097536,SUSPENDED,INTERVENTIONAL,COVID-19 impact
NCT03097731,WITHDRAWN,OBSERVATIONAL,Preliminary tests found that some newborns heel blood amount could not meet the test needs.
NCT03097757,TERMINATED,INTERVENTIONAL,Unable to recruit patients for this study due to time constraints and personnel limitations.
NCT03097796,WITHDRAWN,INTERVENTIONAL,Development plan revised
NCT03098355,WITHDRAWN,INTERVENTIONAL,The company did not offer the appropriate CART services.
NCT03098394,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03098420,TERMINATED,INTERVENTIONAL,Low enrollment; recruitment challenges due to competing studies in women and infant center
NCT03098680,TERMINATED,INTERVENTIONAL,Unable to recruit in time before end of PhD studentship
NCT03098732,SUSPENDED,INTERVENTIONAL,Strategic hold
NCT03098927,WITHDRAWN,INTERVENTIONAL,"Two subjects finally recruited 11/17, but not enough time to complete their studies before the funding terminated on November 30, 2017"
NCT03099070,TERMINATED,INTERVENTIONAL,"Recruitment was severely delayed during COVID, and Grant support ended"
NCT03099135,TERMINATED,INTERVENTIONAL,Recruitment prematurely stopped based on decision to stop HPC program (not due to safety or efficacy results) + On 31 Jan 2018 decision to stop the study
NCT03099161,TERMINATED,INTERVENTIONAL,The data did not support study endpoints
NCT03099265,TERMINATED,INTERVENTIONAL,Paused due to COVID. A determination was made to stop the study because it would be impossible to reach the 65% resection rate as outlined in the protocol.
NCT03099486,TERMINATED,INTERVENTIONAL,Administrative change
NCT03099499,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03100006,TERMINATED,INTERVENTIONAL,The study had poor efficacy.
NCT03100097,TERMINATED,INTERVENTIONAL,Difficulties recruiting patients
NCT03100123,TERMINATED,INTERVENTIONAL,Pilot deemed not feasible by Steering Committee due to recruitment rate.
NCT03100240,TERMINATED,INTERVENTIONAL,It is difficult to recruit patients.
NCT03100253,TERMINATED,INTERVENTIONAL,Slow recrutiment
NCT03100370,TERMINATED,INTERVENTIONAL,Study halted prematurely due to COVID-19 pandemic.
NCT03100409,TERMINATED,INTERVENTIONAL,The study was closed prematurely because the interim analysis found that subjects in the experimental group had less gastrointestinal toxicity.
NCT03100877,WITHDRAWN,INTERVENTIONAL,Feasibility Issues
NCT03101098,SUSPENDED,INTERVENTIONAL,IRB did not approve this study.
NCT03101501,TERMINATED,INTERVENTIONAL,The manufacturing company of the Raindrop Corneal Inlay has stopped distribution or sales of the product.
NCT03101527,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03101540,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03101592,TERMINATED,INTERVENTIONAL,Enrollment completed. Outcomes measured after only 1 yr due to loss of funding.
NCT03101826,TERMINATED,INTERVENTIONAL,Insufficient resources
NCT03102060,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03102190,TERMINATED,INTERVENTIONAL,Phase II funding not available
NCT03102437,TERMINATED,INTERVENTIONAL,The primary objective of the protocol was to allow ongoing access to treatment of patients suffering from moderate to severe heart failure at selected investigational sites until the PMA was approved by the FDA for the OPTIMIZER System.
NCT03102827,TERMINATED,INTERVENTIONAL,Unavailability of PI and Deputy
NCT03102892,TERMINATED,INTERVENTIONAL,COVID-19 pandemics
NCT03103126,WITHDRAWN,INTERVENTIONAL,No participants volunteered despite two recruitment rounds.
NCT03103464,WITHDRAWN,INTERVENTIONAL,No one consented for this study.
NCT03103490,TERMINATED,INTERVENTIONAL,Loss of funding
NCT03103503,TERMINATED,OBSERVATIONAL,Collection of long term lead performance is being transferred to an alternate data collection methodology.
NCT03103971,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment and end of funding
NCT03104270,TERMINATED,INTERVENTIONAL,The study was terminated early by Funding Sponsor due to low enrollment.
NCT03104335,WITHDRAWN,INTERVENTIONAL,Not enough patients
NCT03104348,TERMINATED,INTERVENTIONAL,Very important delay in the pace of inclusions. Likely overestimation of the potential for inclusion. Lack of involvement of some health professionals.
NCT03104725,TERMINATED,INTERVENTIONAL,"Difficulty with recruitment and participant accrual due to study eligibility criteria and required study procedures (e.g., multiple lumbar punctures)."
NCT03104816,TERMINATED,INTERVENTIONAL,Could not get an approval from Department Reviewer for the study continuation.
NCT03104959,TERMINATED,INTERVENTIONAL,unable to enroll sufficient number of participants
NCT03104998,WITHDRAWN,INTERVENTIONAL,No further patient enrollment
NCT03105219,WITHDRAWN,INTERVENTIONAL,Shortfall in funding
NCT03105349,WITHDRAWN,INTERVENTIONAL,No availability of investigational medication.
NCT03105362,TERMINATED,INTERVENTIONAL,Issues w/ sponsor and recruitment
NCT03105401,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT03105479,TERMINATED,INTERVENTIONAL,"Study suspended in October 2017 and terminated April 17, 2018 after decision to discontinue the study drug development"
NCT03105609,TERMINATED,OBSERVATIONAL,The delay between diagnosis and initiation of treatment was no longer consistent with standard of care
NCT03105674,WITHDRAWN,INTERVENTIONAL,Not yet IRB approved and PI will be leaving institution in September.
NCT03105882,WITHDRAWN,INTERVENTIONAL,Study did not enroll any subjects.
NCT03106090,TERMINATED,INTERVENTIONAL,Unable to meet accrual goals.
NCT03106155,TERMINATED,INTERVENTIONAL,Decision of IP support organization
NCT03106220,TERMINATED,INTERVENTIONAL,slow patient accrual
NCT03106285,WITHDRAWN,INTERVENTIONAL,Cannot perform the study due to practical issues
NCT03106376,WITHDRAWN,INTERVENTIONAL,Study team has decided to focus on other projects
NCT03106454,SUSPENDED,INTERVENTIONAL,Investigator leave of absence
NCT03106571,TERMINATED,INTERVENTIONAL,Deemed unable to enroll targeted participants in part due to COVID-19 shut downs
NCT03106597,TERMINATED,INTERVENTIONAL,Difficulty in enrolling subjects
NCT03106610,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT03106753,TERMINATED,INTERVENTIONAL,Interim analysis to assess concern for spinal anesthesia and increased cesarean delivery rate.
NCT03106766,TERMINATED,INTERVENTIONAL,Decision from the Sponsor
NCT03106805,WITHDRAWN,INTERVENTIONAL,no participants
NCT03107052,TERMINATED,INTERVENTIONAL,The study was terminated after the episodic cluster study was terminated due to a pre specified futility analyses
NCT03107325,WITHDRAWN,INTERVENTIONAL,No subjects who met the study criteria agreed to participate in two years prior to the COVID-19 crisis.
NCT03107390,TERMINATED,INTERVENTIONAL,investigator choice
NCT03107806,TERMINATED,INTERVENTIONAL,Blood withdrawal problems despite use of different catheters.
NCT03108417,WITHDRAWN,INTERVENTIONAL,no eligible subjects were available for recruitment
NCT03108690,WITHDRAWN,INTERVENTIONAL,Logistics
NCT03108729,WITHDRAWN,INTERVENTIONAL,The study was not withdrawn for safety reasons. The sponsor received approval for the treatment of partial-onset seizures in patients 4 years of age and older
NCT03108885,TERMINATED,OBSERVATIONAL,Study's Principal Investigator no longer at the institution.
NCT03108911,TERMINATED,INTERVENTIONAL,limited resources
NCT03109301,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT03109418,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT03109470,WITHDRAWN,OBSERVATIONAL,Insufficient enrollment potential
NCT03109613,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT03109743,TERMINATED,INTERVENTIONAL,The funding for the study was relinquished and so study terminated early.
NCT03109795,TERMINATED,INTERVENTIONAL,Funding ended
NCT03110263,TERMINATED,INTERVENTIONAL,practicality reasons; recruitment slower than expected
NCT03110354,TERMINATED,INTERVENTIONAL,This study was terminated due to slow accrual.
NCT03110445,WITHDRAWN,INTERVENTIONAL,not sufficiently staff available to perform trial
NCT03110510,WITHDRAWN,INTERVENTIONAL,institution problem
NCT03110523,WITHDRAWN,INTERVENTIONAL,Strategic business decision
NCT03110549,TERMINATED,INTERVENTIONAL,Drug development suspended by current holder of IND
NCT03110575,TERMINATED,INTERVENTIONAL,"Stopped early due to inadequate separation on primary efficacy endpoint in the lead-in HONOR study, TNX-CY-P301"
NCT03110588,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT03110900,TERMINATED,INTERVENTIONAL,Sponsor Withdrawal
NCT03110939,WITHDRAWN,INTERVENTIONAL,The principal investigator Dr.YinLi is working in other Hospital
NCT03110952,WITHDRAWN,INTERVENTIONAL,"lack of materials, not moving forward"
NCT03111069,WITHDRAWN,INTERVENTIONAL,PI withdrew study
NCT03111238,TERMINATED,INTERVENTIONAL,Stopped due to inactivity
NCT03111264,TERMINATED,INTERVENTIONAL,Covid-19 Closures \& Lockdown
NCT03111758,TERMINATED,INTERVENTIONAL,Reaching total sample size was not feasible within the anticipated time frame.
NCT03111823,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT03111888,WITHDRAWN,INTERVENTIONAL,Investigator decision
NCT03111901,WITHDRAWN,INTERVENTIONAL,funding was withdrawn
NCT03111914,TERMINATED,INTERVENTIONAL,Budgetary Issues
NCT03111979,SUSPENDED,INTERVENTIONAL,Time restrictions on leading investigator
NCT03112122,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT03112642,TERMINATED,INTERVENTIONAL,covid pandemic limited participation
NCT03112720,TERMINATED,INTERVENTIONAL,no enrollment after covid pandemic
NCT03112902,TERMINATED,INTERVENTIONAL,Compelling insights impacting the scientific rationale
NCT03113071,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03113084,SUSPENDED,INTERVENTIONAL,Delay in the R\&D stage
NCT03113149,TERMINATED,OBSERVATIONAL,"Recruitment too slow, probably due to the procedure considered too complicated."
NCT03113370,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting patients given a 1 year funding period
NCT03113383,TERMINATED,INTERVENTIONAL,Device recalled by the manufacturer
NCT03113409,TERMINATED,INTERVENTIONAL,no funding available to continue
NCT03113604,WITHDRAWN,OBSERVATIONAL,The study has been stopped because no one is
NCT03113864,TERMINATED,INTERVENTIONAL,Recruiting Issue
NCT03113877,TERMINATED,OBSERVATIONAL,"Difficulty in recruitment, Funding has run out."
NCT03114280,WITHDRAWN,INTERVENTIONAL,MSD would not able to support the study's continuation after protocol modifications required by ANSM through dose de-escalation of pembrolizumab
NCT03114345,TERMINATED,INTERVENTIONAL,Departure of the PhD in charge of the study
NCT03114566,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT03114657,TERMINATED,INTERVENTIONAL,"This study was discontinued due to an interim analysis in the BN29552 study, which indicated that Crenezumab was unlikely to meet its primary endpoint."
NCT03114787,TERMINATED,INTERVENTIONAL,The patient recruiting was stopped after 17 inclusions because of a reorganization of Intensive Care Units at the recruiting center.
NCT03114956,WITHDRAWN,INTERVENTIONAL,Not able to secure funding
NCT03115138,TERMINATED,INTERVENTIONAL,investigator choice
NCT03115151,TERMINATED,INTERVENTIONAL,The surgical team has difficulty to find level 1 and 2 fusions for the study.
NCT03115190,TERMINATED,INTERVENTIONAL,The Philips Minicare has been taken off the market due to financial company issues that have nothing to do with the safety of the Minicare or the URGENT trial.
NCT03115216,WITHDRAWN,INTERVENTIONAL,withdrawn during planning stages
NCT03115320,TERMINATED,INTERVENTIONAL,High cancellation rate in LH test group in interim analysis
NCT03115385,TERMINATED,INTERVENTIONAL,Funds ended.
NCT03115476,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined.
NCT03115489,WITHDRAWN,INTERVENTIONAL,"Low eligibility of patients, no successful recruitment"
NCT03115528,WITHDRAWN,OBSERVATIONAL,Terminated at Continuing Review
NCT03115554,TERMINATED,INTERVENTIONAL,Patients did not want to be randomized in their procedure.
NCT03115567,TERMINATED,INTERVENTIONAL,Low enrollment accrual
NCT03115593,WITHDRAWN,INTERVENTIONAL,Lack of human ressources
NCT03115697,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT03115749,TERMINATED,INTERVENTIONAL,end of inclusion period and recruitment difficulties
NCT03115801,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT03116009,TERMINATED,INTERVENTIONAL,Former PI Left the Institution
NCT03116165,TERMINATED,INTERVENTIONAL,Organisational changes in hospital which changed recruitment rates
NCT03116386,WITHDRAWN,INTERVENTIONAL,Inability of the ETOLYA's manufacturer to furnish the promised functionalities as those which had to be recorded for assessment of the study's end points
NCT03116581,TERMINATED,INTERVENTIONAL,Insufficient on-site staff to manage study
NCT03116971,TERMINATED,INTERVENTIONAL,Enrollment in the study was prematurely terminated due to recruitment challenges and not due to concerns of safety for the participants.
NCT03117166,TERMINATED,INTERVENTIONAL,multidisciplinary participation could not be overcome.
NCT03117361,TERMINATED,INTERVENTIONAL,PharmaMar has decided to end this study due to the slow recruitment rate of the trial
NCT03117504,SUSPENDED,OBSERVATIONAL,lack of funding
NCT03117530,SUSPENDED,INTERVENTIONAL,COVID
NCT03117556,WITHDRAWN,INTERVENTIONAL,no subjects enrolled
NCT03117777,WITHDRAWN,OBSERVATIONAL,REB approval denied
NCT03117855,WITHDRAWN,INTERVENTIONAL,Company no longer interested in supporting this trial
NCT03117959,WITHDRAWN,INTERVENTIONAL,no longer RCT - same surgical technique and implant used
NCT03117985,TERMINATED,INTERVENTIONAL,no interesting results
NCT03118154,TERMINATED,OBSERVATIONAL,Recruitment
NCT03118206,TERMINATED,INTERVENTIONAL,Two authors changed their jobs.
NCT03118271,TERMINATED,INTERVENTIONAL,Two authors changed their jobs.
NCT03118284,TERMINATED,OBSERVATIONAL,Principal Investigator is leaving university and halting studies
NCT03118349,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03118375,TERMINATED,OBSERVATIONAL,Could not adequately recruit enough subjects to reach appropriate sample size
NCT03118479,TERMINATED,INTERVENTIONAL,Because the PI left the institution.
NCT03118544,TERMINATED,OBSERVATIONAL,Competing clinical trial priorities
NCT03118661,WITHDRAWN,INTERVENTIONAL,No accrual to the study
NCT03118700,TERMINATED,INTERVENTIONAL,Researcher left
NCT03118713,TERMINATED,INTERVENTIONAL,Business decision due to enrollment challenges
NCT03118921,TERMINATED,INTERVENTIONAL,suggestion of an accentuation of the bias of overestimating the silhouette in one of the avatar exposure modalities in virtual reality
NCT03119012,TERMINATED,INTERVENTIONAL,cannot use bioabsorbable scaffold
NCT03119038,WITHDRAWN,INTERVENTIONAL,Investigator no longer actively pursuing this study.
NCT03119064,TERMINATED,INTERVENTIONAL,lack of response to study therapy
NCT03119077,TERMINATED,INTERVENTIONAL,Study early terminated due to lower drug exposure
NCT03119428,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03119467,TERMINATED,INTERVENTIONAL,Study has been stopped after reviewing PK and safety results
NCT03119571,TERMINATED,INTERVENTIONAL,"Low enrollment, funding withdrawn"
NCT03119623,WITHDRAWN,INTERVENTIONAL,Lost funding prior to study commencing
NCT03119662,TERMINATED,INTERVENTIONAL,The trial was discontinued due to a lower than anticipated recruitment rate. The decision has not been made due to any safety reasons.
NCT03119701,TERMINATED,INTERVENTIONAL,IDMC recommendation. Unexpectedly high use of concomitant corticosteroid treatment.
NCT03119714,TERMINATED,INTERVENTIONAL,Due to results from other studies regarding efficacy of pemirolast
NCT03120000,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT03120078,TERMINATED,OBSERVATIONAL,The PI has requested to close this study.
NCT03120130,SUSPENDED,INTERVENTIONAL,Delay in the R \& D stage
NCT03120325,TERMINATED,INTERVENTIONAL,Recruitment challenges due to the COVID19 pandemic and funding not available to restart.
NCT03120390,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03120676,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT03120767,WITHDRAWN,INTERVENTIONAL,Due to inability to enroll patients
NCT03120793,TERMINATED,OBSERVATIONAL,Failure to recruit/enroll
NCT03120897,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate study.
NCT03121079,WITHDRAWN,INTERVENTIONAL,there was almost no patient would enroll in this study.
NCT03121092,TERMINATED,INTERVENTIONAL,Due to difficulty with recruiting patients meeting the inclusion criteria the PI decided to retire this project.
NCT03121417,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT03121508,WITHDRAWN,INTERVENTIONAL,not enough funding to complete the project as planned
NCT03121534,TERMINATED,INTERVENTIONAL,The study was closed for slow accrual
NCT03121599,TERMINATED,INTERVENTIONAL,"Delayed study materials, poor recruitment"
NCT03121612,TERMINATED,INTERVENTIONAL,insufficient number of subjects
NCT03121677,TERMINATED,INTERVENTIONAL,Vaccine manufacturing has been suspended
NCT03121911,WITHDRAWN,INTERVENTIONAL,technical problems in equipment
NCT03121937,TERMINATED,INTERVENTIONAL,No longer able to recruit participants
NCT03121963,WITHDRAWN,INTERVENTIONAL,"This protocol was difficult to enroll into, and changes to personnel have made it difficult to main this study. Data collection was not completed and therefore, no data analysis was performed. The PI has made the decision to close this study."
NCT03121989,WITHDRAWN,INTERVENTIONAL,Funding completed
NCT03122002,TERMINATED,OBSERVATIONAL,Limited number of participants enrolled.
NCT03122106,TERMINATED,INTERVENTIONAL,Loss of funding
NCT03122301,TERMINATED,INTERVENTIONAL,Study stopped due to inadequate enrollment.
NCT03122470,WITHDRAWN,INTERVENTIONAL,PI departure - study not conducted.
NCT03122548,TERMINATED,INTERVENTIONAL,Low enrollment and lack of clinical activity in other CRS-207 studies.
NCT03122613,TERMINATED,INTERVENTIONAL,Decision made by team of investigators
NCT03122678,WITHDRAWN,INTERVENTIONAL,No participant enrolled
NCT03122912,TERMINATED,INTERVENTIONAL,Enrollment and interactions/interventions paused due to COVID-19. Not expected to resume in the future. This is not a suspension of IRB approval
NCT03123055,TERMINATED,INTERVENTIONAL,program has been put on hold by the sponsor
NCT03123159,TERMINATED,OBSERVATIONAL,Business decision
NCT03123289,TERMINATED,INTERVENTIONAL,PI left the institute and the funding expired.
NCT03123315,WITHDRAWN,INTERVENTIONAL,per PI request
NCT03123393,TERMINATED,INTERVENTIONAL,Lack of efficacy of the drug; no safety concern
NCT03123419,WITHDRAWN,INTERVENTIONAL,Departmental research hold
NCT03123588,TERMINATED,INTERVENTIONAL,Enrollment issues
NCT03123744,WITHDRAWN,INTERVENTIONAL,No study funding available.
NCT03123822,TERMINATED,INTERVENTIONAL,Not enough interest/participants. Recruitment was more difficult due to pandemic
NCT03124329,TERMINATED,INTERVENTIONAL,The PI left the institution
NCT03124459,TERMINATED,INTERVENTIONAL,(Investigation of ACE-083 for use in patients with CMT is being discontinued as it did not achieve functional secondary endpoints in the A083-03 trial.
NCT03124628,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03125187,SUSPENDED,INTERVENTIONAL,Delay in the R\&D stage
NCT03125200,TERMINATED,INTERVENTIONAL,Safety
NCT03125213,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT03125408,TERMINATED,OBSERVATIONAL,Business decision
NCT03125434,TERMINATED,INTERVENTIONAL,funding problems
NCT03125551,WITHDRAWN,INTERVENTIONAL,Study requires Medicines Control council approval
NCT03125876,TERMINATED,INTERVENTIONAL,Company strategy adjustment
NCT03126097,TERMINATED,INTERVENTIONAL,Study stopping rules were met.
NCT03126461,WITHDRAWN,INTERVENTIONAL,"the project was never initiated and no participants were enrolled, it was closed permanently"
NCT03126487,WITHDRAWN,INTERVENTIONAL,study do not start due to concurrential trial
NCT03126539,TERMINATED,INTERVENTIONAL,"For administrative reasons, we started a new study"
NCT03126760,TERMINATED,INTERVENTIONAL,Recruitment difficulties and COVID-19 logistical challenges; no safety concerns
NCT03126864,TERMINATED,INTERVENTIONAL,Terminated per the PI's request.
NCT03126903,TERMINATED,INTERVENTIONAL,KeraMed is being discontinued because it is no longer feasible due to the slow pace of recruitment and insufficient financial resources.
NCT03127124,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to no enrollment
NCT03127254,WITHDRAWN,INTERVENTIONAL,Research cancelled
NCT03127332,WITHDRAWN,INTERVENTIONAL,Sponsor decision; lack of research sites
NCT03127345,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03127371,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT03127592,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT03127787,TERMINATED,OBSERVATIONAL,Business decision
NCT03127800,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT03127813,TERMINATED,INTERVENTIONAL,After recruiting just over 50% of target an interim review conclude a larger sample size was highly unlikely to alter the study outcomes
NCT03128034,SUSPENDED,INTERVENTIONAL,Administrative - FDA Comments
NCT03128060,TERMINATED,INTERVENTIONAL,Study enrollment was terminated due to inability to recruit participants
NCT03128086,TERMINATED,INTERVENTIONAL,Because the principal investigator has moved to another hospital
NCT03128281,WITHDRAWN,INTERVENTIONAL,Sponsor issue
NCT03128294,TERMINATED,OBSERVATIONAL,Data was not sufficiently complete and reliable for analysis (retrospective chart research)
NCT03128489,WITHDRAWN,INTERVENTIONAL,The study is cancelled due to reassessment of the medical need for the vaccine in India. Cancellation is not related to vaccine's safety and/or efficacy.
NCT03128554,TERMINATED,INTERVENTIONAL,Funding was withdrawn in January 2020. Covid-19 pandemic prevented the study from continuing to a point where it would need to be restarted. Multiple participants dropped out throughout pandemic.
NCT03128580,TERMINATED,OBSERVATIONAL,"After an interim analysis, it was decided to discontinue the study after a stochastic curtailment analysis."
NCT03128619,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT03128775,SUSPENDED,INTERVENTIONAL,no fundng was provided by the financial agency
NCT03128931,TERMINATED,INTERVENTIONAL,Study was terminated as enrollment rate did not meet the requirement of the Sponsor.
NCT03129074,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT03129776,TERMINATED,INTERVENTIONAL,Lack of participants
NCT03130348,WITHDRAWN,INTERVENTIONAL,Study was dropped at site before participation
NCT03130439,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03130543,TERMINATED,INTERVENTIONAL,Focusing on observational cohort study due to limited enrollment in trial
NCT03130647,WITHDRAWN,INTERVENTIONAL,PI Left university
NCT03130764,WITHDRAWN,INTERVENTIONAL,PI Transferred
NCT03130829,WITHDRAWN,INTERVENTIONAL,target population is insufficient
NCT03130946,SUSPENDED,INTERVENTIONAL,Slow recruiting rate.
NCT03131011,TERMINATED,INTERVENTIONAL,Reliable and consistent method of UV Tattoo application was not able to be achieved.
NCT03131115,WITHDRAWN,INTERVENTIONAL,Not able to enroll patient
NCT03131206,TERMINATED,INTERVENTIONAL,Study closed due to slow accrual and lack of efficacy.
NCT03131453,TERMINATED,INTERVENTIONAL,The study was terminated due to safety issues.
NCT03131635,TERMINATED,INTERVENTIONAL,Terminated (halted prematurely) due to COVID-19.
NCT03131674,WITHDRAWN,INTERVENTIONAL,Ongoing insights required a different approach
NCT03131700,WITHDRAWN,INTERVENTIONAL,Decision of the Sponsor
NCT03132064,SUSPENDED,OBSERVATIONAL,COVID-19
NCT03132155,TERMINATED,INTERVENTIONAL,Prematurely terminated due to lack of therapeutic effect
NCT03132272,TERMINATED,INTERVENTIONAL,"slow recruiting, difficulties in finding eligible patients"
NCT03132324,TERMINATED,INTERVENTIONAL,This study is terminated due to a business decision not to pursue INCB059782 in Sickle Cell Disease indication.
NCT03132428,TERMINATED,OBSERVATIONAL,Positive results at interim analysis
NCT03132441,WITHDRAWN,INTERVENTIONAL,Major changes to study that were better suited to creating a whole new study
NCT03132571,TERMINATED,INTERVENTIONAL,Study discontinued due to funding.
NCT03132584,TERMINATED,INTERVENTIONAL,slow accrual
NCT03132818,WITHDRAWN,OBSERVATIONAL,investigator choice
NCT03132896,WITHDRAWN,OBSERVATIONAL,Investigational device no longer has Health Canada approval.
NCT03132961,TERMINATED,OBSERVATIONAL,"Despite recruitment of healthy volunteers, participants from the population of interest were unable to be recruited."
NCT03133117,TERMINATED,INTERVENTIONAL,not enough patients
NCT03133533,WITHDRAWN,INTERVENTIONAL,PI on an extended leave of absence.
NCT03133559,SUSPENDED,OBSERVATIONAL,Protocol Modification is pending
NCT03133715,WITHDRAWN,INTERVENTIONAL,Study not IRB approved.
NCT03133897,TERMINATED,INTERVENTIONAL,"it was felt by the sponsoring institution that the current standard of oversight expected by the Health Canada regulations, would not be possible to achieve"
NCT03133962,WITHDRAWN,INTERVENTIONAL,Decision of the investigator
NCT03134027,SUSPENDED,OBSERVATIONAL,Initially suspended due to COVID-19. Currently suspended while awaiting generation of new PDXs.
NCT03134105,WITHDRAWN,INTERVENTIONAL,Sponsor/funding source decided to not move forward.
NCT03134404,WITHDRAWN,OBSERVATIONAL,study did not start
NCT03134638,TERMINATED,INTERVENTIONAL,Business Decision
NCT03134703,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT03134989,TERMINATED,INTERVENTIONAL,slow enrolment
NCT03135028,TERMINATED,INTERVENTIONAL,No signal of efficacy with Entospletinib
NCT03135262,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.
NCT03135392,WITHDRAWN,INTERVENTIONAL,Research cancelled because of inadequate staffing.
NCT03135470,TERMINATED,OBSERVATIONAL,"Phase II recruitment unsuccesful, phase III lacking personnel resources"
NCT03135652,WITHDRAWN,INTERVENTIONAL,Inadequate patient enrollment
NCT03135860,TERMINATED,INTERVENTIONAL,This was an exploratory open-label study and has met its initial objectives
NCT03135990,TERMINATED,INTERVENTIONAL,The study was terminated due to the start of the COVID-19 pandemic.
NCT03136458,WITHDRAWN,INTERVENTIONAL,No resources
NCT03136900,TERMINATED,INTERVENTIONAL,Recuitment to slow
NCT03137017,WITHDRAWN,INTERVENTIONAL,program discontinued
NCT03137030,WITHDRAWN,INTERVENTIONAL,program discontinued
NCT03137199,TERMINATED,INTERVENTIONAL,First cohort completed. Per sponsor decision.
NCT03137225,TERMINATED,INTERVENTIONAL,Insufficient resources available to complete the study
NCT03137329,TERMINATED,INTERVENTIONAL,Did not meet enrollment requirements with limited funding
NCT03137537,TERMINATED,INTERVENTIONAL,Funding terminated
NCT03137576,TERMINATED,INTERVENTIONAL,Poor recruiting and transfer of the PI to another center
NCT03137693,TERMINATED,INTERVENTIONAL,no responders/lack of efficacy
NCT03137706,TERMINATED,OBSERVATIONAL,Insufficient accrual
NCT03137758,TERMINATED,INTERVENTIONAL,Reformulation of study drug to help reduce the pill burden as higher doses are evaluated.
NCT03138083,TERMINATED,INTERVENTIONAL,strategic reasons (not due to lack of efficacy or safety issues)
NCT03138278,WITHDRAWN,INTERVENTIONAL,No longer priority in the research group.
NCT03138369,TERMINATED,INTERVENTIONAL,High drop out rate due to subjects needing to record details of every meal
NCT03138395,WITHDRAWN,OBSERVATIONAL,Study design modified to collect specimens from a bank requiring a separate IRB-approved protocol.
NCT03138408,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT03138434,TERMINATED,OBSERVATIONAL,"Sufficient acquisitions for DCE-MRI and 4D flow, but not for T1/T2-mapping due to lack of ILT in some participants."
NCT03138499,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT03138538,TERMINATED,INTERVENTIONAL,"As part of a portfolio-level management of the company's oncology pipeline, it was decided to stop the next phase of internal development of the MetAP2 (M8891) program to enable realization of other opportunities within the oncology portfolio."
NCT03138590,TERMINATED,INTERVENTIONAL,No relevant anymore
NCT03138889,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03139032,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study
NCT03139084,WITHDRAWN,OBSERVATIONAL,Updated results by guidelines and bibliography
NCT03139227,WITHDRAWN,INTERVENTIONAL,PI decision
NCT03139318,TERMINATED,INTERVENTIONAL,"Due to COVID-19 and the resulting administrative issues, it is not feasible to continue the study."
NCT03139357,TERMINATED,OBSERVATIONAL,"Tech changes made it impossible to consent patients. Not a flaw in design, practice changes caused the study end."
NCT03139370,TERMINATED,INTERVENTIONAL,The study was terminated due to the sponsor's decision to discontinue the clinical trial.
NCT03139500,TERMINATED,INTERVENTIONAL,Terminated due to nonclinical findings
NCT03139747,SUSPENDED,INTERVENTIONAL,lack of accrual reevaluating feasibility
NCT03139825,WITHDRAWN,INTERVENTIONAL,Not accepted
NCT03140072,TERMINATED,INTERVENTIONAL,Terminated based on interim review
NCT03140098,WITHDRAWN,OBSERVATIONAL,Decision not to pursue
NCT03140124,TERMINATED,INTERVENTIONAL,Feasibility - unable to recruit therapists to enter the study
NCT03140150,TERMINATED,INTERVENTIONAL,decision by the promoter and funder following recruitment difficulties
NCT03140176,TERMINATED,OBSERVATIONAL,The study was terminated early due to the inability to recruit the planned number of patients
NCT03140384,WITHDRAWN,INTERVENTIONAL,no regulatory approval
NCT03140579,WITHDRAWN,OBSERVATIONAL,Study not undertaken due to COVID and capacity
NCT03140670,TERMINATED,INTERVENTIONAL,Loss of funding
NCT03140722,TERMINATED,INTERVENTIONAL,Revised study design.
NCT03140735,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03141086,TERMINATED,INTERVENTIONAL,CLML134X2201 was terminated due to business reasons and not to safety findings
NCT03141398,WITHDRAWN,OBSERVATIONAL,Due to issues with study design
NCT03141736,WITHDRAWN,INTERVENTIONAL,Staff not available to commence study.
NCT03141996,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT03142191,TERMINATED,INTERVENTIONAL,Business objectives have changed.
NCT03142217,WITHDRAWN,INTERVENTIONAL,decision of investigator
NCT03142867,TERMINATED,OBSERVATIONAL,"Study complete but no analysis, publications or presentations of any collected data will be performed. Investigator left the site and study was halted."
NCT03142958,SUSPENDED,INTERVENTIONAL,"Prematurely terminated -Sponsor decision not due to adverse events, complications, or device issues. Final data collection underway."
NCT03142984,TERMINATED,INTERVENTIONAL,"The study has been on hold due to the COVID-19 pandemic. As of Mar 23, 2022, the Sponsor has decided to terminate the study for administrative reasons."
NCT03143491,WITHDRAWN,INTERVENTIONAL,Study never initiated
NCT03143530,WITHDRAWN,INTERVENTIONAL,Extensive protocol revisions initiated.
NCT03143543,TERMINATED,INTERVENTIONAL,FDA removal of drug from the market due to cancer risks
NCT03143790,SUSPENDED,INTERVENTIONAL,Capacity problems
NCT03143842,WITHDRAWN,INTERVENTIONAL,Not enough participants
NCT03143894,TERMINATED,INTERVENTIONAL,Poor accrual (inability to enroll participants)
NCT03143920,TERMINATED,INTERVENTIONAL,No funding to continue
NCT03143998,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT03144375,TERMINATED,INTERVENTIONAL,inability to promptly see local allergists as part of medical maximization which lead to delays in care for these patients
NCT03144466,TERMINATED,INTERVENTIONAL,Slow recruitment.
NCT03144661,TERMINATED,INTERVENTIONAL,Strategic Business Decision
NCT03145116,TERMINATED,INTERVENTIONAL,recruitment rate
NCT03145480,TERMINATED,INTERVENTIONAL,Investigator decision to close study
NCT03145558,SUSPENDED,INTERVENTIONAL,on hold by sponsor
NCT03145779,WITHDRAWN,OBSERVATIONAL,Funding
NCT03145831,TERMINATED,INTERVENTIONAL,The primary endpoint of non-inferiority to daily therapy in the pediatric Phase 3 study was not achieved
NCT03145870,WITHDRAWN,INTERVENTIONAL,investigator choice
NCT03145909,TERMINATED,INTERVENTIONAL,Safety
NCT03145948,TERMINATED,INTERVENTIONAL,Safety reason
NCT03146039,WITHDRAWN,INTERVENTIONAL,Patient enrollment goal will not be met
NCT03146117,TERMINATED,OBSERVATIONAL,Recruit completed
NCT03146221,WITHDRAWN,INTERVENTIONAL,investigator wish
NCT03146247,WITHDRAWN,INTERVENTIONAL,recruitment was not started
NCT03146325,WITHDRAWN,INTERVENTIONAL,Study was not funded and PI has left the institution
NCT03146403,TERMINATED,INTERVENTIONAL,2017 business decision to cease GEN-003 spending.
NCT03146663,TERMINATED,INTERVENTIONAL,"Despite promising efficacy and a good tolerability profile in Part I, it was decided not to initiate Part II as the pre-specified boundary for efficacy was uncertain to be met in this heavily pre-treated population with significant co-morbidities"
NCT03146819,TERMINATED,OBSERVATIONAL,Unable to identify sufficient number of patients to enroll
NCT03146871,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03147040,TERMINATED,INTERVENTIONAL,At interim analysis insufficient benefit was observed to continu the study
NCT03147196,WITHDRAWN,INTERVENTIONAL,lack of accrual
NCT03147209,WITHDRAWN,INTERVENTIONAL,Never received funding.
NCT03147534,WITHDRAWN,INTERVENTIONAL,Not able to recruit patients
NCT03147690,TERMINATED,INTERVENTIONAL,Stopped for futility
NCT03147976,WITHDRAWN,INTERVENTIONAL,Enrollment not initiated
NCT03148093,TERMINATED,OBSERVATIONAL,Competing clinical trials and slower than expected patient enrollment
NCT03148119,TERMINATED,INTERVENTIONAL,It was decided to use the QRH for a new study.
NCT03148288,TERMINATED,INTERVENTIONAL,low enrollment
NCT03148431,TERMINATED,INTERVENTIONAL,due to business decisions
NCT03148496,TERMINATED,INTERVENTIONAL,COVID-19 pandemic and the halt to elective surgeries hindered enrollment; PI left insitution
NCT03148652,WITHDRAWN,INTERVENTIONAL,An alternative smoking cessation study received funding and will be completed instead
NCT03148756,TERMINATED,INTERVENTIONAL,Study stopped due to business reasons.
NCT03148821,WITHDRAWN,OBSERVATIONAL,Loss of promised funding
NCT03148847,TERMINATED,OBSERVATIONAL,Only the first part of the study was done.
NCT03148977,TERMINATED,OBSERVATIONAL,IRB expired
NCT03149107,TERMINATED,INTERVENTIONAL,Recruitment not sufficient
NCT03149120,WITHDRAWN,INTERVENTIONAL,No patient enrolled as new similar study will be in system within 3 months
NCT03149159,WITHDRAWN,INTERVENTIONAL,This study is withdrawn due to feasibility issues.
NCT03149211,WITHDRAWN,INTERVENTIONAL,project adjustment
NCT03149380,WITHDRAWN,INTERVENTIONAL,PI withdrawn
NCT03149549,TERMINATED,INTERVENTIONAL,Covid Pandemic; Business Decision to separate Phase 2 to new study
NCT03149575,TERMINATED,INTERVENTIONAL,Change in clinical development plan
NCT03149679,TERMINATED,INTERVENTIONAL,The study was discontinued after the first pre-planned interim analysis due to insufficient response rates.
NCT03149952,WITHDRAWN,INTERVENTIONAL,investigator choice
NCT03150056,TERMINATED,INTERVENTIONAL,This study has been terminated due to meeting protocol defined futility.
NCT03150303,TERMINATED,OBSERVATIONAL,Lack of budget
NCT03150420,TERMINATED,INTERVENTIONAL,"Inability to accrue subjects that met the exclusion criterion ""Any prior (within the past 30 days) or current Sodium Thiosulfate treatment""."
NCT03150524,WITHDRAWN,INTERVENTIONAL,Failure to recruit patients meeting inclusion criteria.
NCT03150628,TERMINATED,INTERVENTIONAL,Conflicting recruitment with PERISCOPE II study (NCT03348150)
NCT03150693,SUSPENDED,INTERVENTIONAL,Unacceptable Toxicity
NCT03150797,TERMINATED,INTERVENTIONAL,Insufficient Fund
NCT03150836,WITHDRAWN,INTERVENTIONAL,Co-PI Albert Chang relocating to UCLA. IND will transfer to UCLA. UCSF will not participate.
NCT03151057,TERMINATED,INTERVENTIONAL,Safety endpointreached
NCT03151096,TERMINATED,INTERVENTIONAL,The target population with available genotype traveled outside study area and study duration of 19 weeks was long for some participants.
NCT03151135,TERMINATED,OBSERVATIONAL,Funding period expired before all subjects could be recrutied
NCT03151200,WITHDRAWN,INTERVENTIONAL,The study was terminated during COVID as the testing and treatment centres were closed.
NCT03151226,TERMINATED,INTERVENTIONAL,Technical difficulty and feasibility issues
NCT03151304,TERMINATED,INTERVENTIONAL,"Sponsor's decision as at the completion of the primary analysis, the data were considered mature"
NCT03151408,TERMINATED,INTERVENTIONAL,The IDMC recommended to stop the study prematurely due to a lack of efficacy.
NCT03151655,WITHDRAWN,INTERVENTIONAL,"Funding was not secured for the project as expected, so we were unable to proceed with the project."
NCT03151707,TERMINATED,INTERVENTIONAL,Lack of funding and appropriate staff
NCT03151746,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03151772,TERMINATED,INTERVENTIONAL,Problems with including patients
NCT03151811,TERMINATED,INTERVENTIONAL,Sponsor assessed all endpoints and collected Overall Survival data for another two years following the primary completion date of 03Feb2021.
NCT03151863,TERMINATED,INTERVENTIONAL,Lack of budget
NCT03152084,TERMINATED,INTERVENTIONAL,Poor recruitment.
NCT03152162,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT03152292,TERMINATED,OBSERVATIONAL,Study follow-up duration impacted by COVID-19pandemic and Sponsor terminated for business reasons
NCT03152409,TERMINATED,INTERVENTIONAL,Inadequate resources to complete the study
NCT03152448,TERMINATED,OBSERVATIONAL,"Myriad has sufficient data to do an analysis on the primary objective, durability, and has made the decision not to continue collecting data for the other study objectives."
NCT03152526,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03152552,TERMINATED,INTERVENTIONAL,This study terminated prematurely because of slow enrollment
NCT03152786,TERMINATED,INTERVENTIONAL,PIs not interested in continuing with the trial.
NCT03152929,TERMINATED,INTERVENTIONAL,Standards of care changed at the institution so that PEC procedures were no longer common or preferred as a method of pain control for breast surgery.
NCT03153072,WITHDRAWN,INTERVENTIONAL,decision of the investigator
NCT03153514,TERMINATED,INTERVENTIONAL,Prematurely terminated due to poor accrual
NCT03153540,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03153618,WITHDRAWN,INTERVENTIONAL,Funding and proposal withdrawn
NCT03153826,TERMINATED,INTERVENTIONAL,Lack of patient recruitment
NCT03153956,TERMINATED,INTERVENTIONAL,Halt in funding
NCT03154047,TERMINATED,INTERVENTIONAL,NEOD001 program terminated due to lack of clinical benefit
NCT03154307,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT03154333,TERMINATED,INTERVENTIONAL,Futility
NCT03154684,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT03154710,TERMINATED,INTERVENTIONAL,Negative interim analysis
NCT03154827,TERMINATED,INTERVENTIONAL,Due to lack of enrollment
NCT03155321,TERMINATED,OBSERVATIONAL,Study was complete
NCT03155399,TERMINATED,INTERVENTIONAL,PI transferred to another Institution
NCT03155464,WITHDRAWN,INTERVENTIONAL,The device that was going to be studied was removed by Duke University shortly after the study was approved.
NCT03155828,WITHDRAWN,OBSERVATIONAL,Lack of enrollment
NCT03155932,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03156127,WITHDRAWN,INTERVENTIONAL,Problem of Investigational Products
NCT03156686,TERMINATED,INTERVENTIONAL,Investigator couldn't include enough patients
NCT03156764,TERMINATED,OBSERVATIONAL,More than 100 invasive and non-invasive QpQs data were collected
NCT03157271,WITHDRAWN,INTERVENTIONAL,Did not receive funding
NCT03157453,TERMINATED,OBSERVATIONAL,Recruitment difficulty
NCT03157765,WITHDRAWN,INTERVENTIONAL,Change in research site
NCT03157856,TERMINATED,OBSERVATIONAL,Results obtained on the first 8 patients shown an expected glandular membrane specific labeling associated with non-specific labeling of fibro-muscular tissue.
NCT03157882,TERMINATED,OBSERVATIONAL,loss of funding
NCT03157947,WITHDRAWN,INTERVENTIONAL,Study Team did not respond to requests for continuing review approval.
NCT03158116,TERMINATED,INTERVENTIONAL,IRB application expired.
NCT03158298,TERMINATED,OBSERVATIONAL,due to lack of recruitment
NCT03158441,WITHDRAWN,OBSERVATIONAL,for technical and funding issues
NCT03158467,WITHDRAWN,OBSERVATIONAL,Did not enroll
NCT03158610,TERMINATED,INTERVENTIONAL,Difficult to enrollment patient
NCT03158636,SUSPENDED,OBSERVATIONAL,More funding required
NCT03158857,WITHDRAWN,OBSERVATIONAL,Long local IRB process to meet with the treatment deadline
NCT03158974,TERMINATED,INTERVENTIONAL,Sponsor terminated study due to financial constraints.
NCT03159000,WITHDRAWN,INTERVENTIONAL,Project never started - lack of resources and no subjects enrolled
NCT03159130,WITHDRAWN,OBSERVATIONAL,PI dropped the study
NCT03159182,WITHDRAWN,INTERVENTIONAL,First required to complete a proof of principle study for a new outcome measure.
NCT03159429,TERMINATED,INTERVENTIONAL,Staff no longer available.
NCT03159598,WITHDRAWN,INTERVENTIONAL,"PI left institution, never submitted to IRB"
NCT03159806,WITHDRAWN,OBSERVATIONAL,No funding
NCT03159936,TERMINATED,INTERVENTIONAL,unable to identify additional subjects to qualify for enrollment
NCT03159975,WITHDRAWN,INTERVENTIONAL,Unconfirmed research expenses
NCT03159988,SUSPENDED,INTERVENTIONAL,Slow enrollment
NCT03160157,WITHDRAWN,OBSERVATIONAL,No enrollment
NCT03160170,TERMINATED,INTERVENTIONAL,Resources no longer available
NCT03160339,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03160508,TERMINATED,OBSERVATIONAL,PCI decision due to technical issues
NCT03160625,WITHDRAWN,INTERVENTIONAL,Lack of eligible patient.
NCT03160729,TERMINATED,INTERVENTIONAL,"Slow recruitment, schanges in standard treatment"
NCT03160742,TERMINATED,OBSERVATIONAL,Study device is incorrect size for pediatric patients
NCT03161041,WITHDRAWN,INTERVENTIONAL,CHU Lyon will join as a participating center (and as national French coordinator) as a part of the BEV-IP study ongoing study EudraCT-number 2014-004257-14.
NCT03161106,WITHDRAWN,INTERVENTIONAL,due lack of funds
NCT03161158,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03161444,TERMINATED,INTERVENTIONAL,Active circulation of dengue virus in the region of the study that may affect the result of zika serology
NCT03161457,TERMINATED,INTERVENTIONAL,The development was stopped due to company's strategy consideration
NCT03161470,TERMINATED,INTERVENTIONAL,Physicians/audiologists preferred to manage patients with BPPV immediately rather than enrolling in study except for difficult to treat cases.
NCT03161509,TERMINATED,INTERVENTIONAL,publication of better study
NCT03161548,TERMINATED,INTERVENTIONAL,Diffiult patient recruitment
NCT03161574,WITHDRAWN,INTERVENTIONAL,No participants were recruited
NCT03161613,WITHDRAWN,OBSERVATIONAL,Business objectives have changed
NCT03161834,WITHDRAWN,OBSERVATIONAL,IRB Study Closure
NCT03161847,WITHDRAWN,OBSERVATIONAL,No subjects were enrolled
NCT03161964,TERMINATED,INTERVENTIONAL,Statistical power could not be achieved due to low enrollment.
NCT03162120,WITHDRAWN,INTERVENTIONAL,"new study type, it will be re-organiZed as an Investigator Initiated Study (IIS)"
NCT03162419,WITHDRAWN,INTERVENTIONAL,Lack of Funds.
NCT03162562,TERMINATED,INTERVENTIONAL,Sponsor Decision to discontinue long-term follow-up
NCT03162666,WITHDRAWN,OBSERVATIONAL,The participating party (Rush) stopped the study because of logistic issues.
NCT03162744,TERMINATED,OBSERVATIONAL,"Inclusion difficulties, Investigator lack of time for the study completion"
NCT03163134,TERMINATED,INTERVENTIONAL,Due to the fact data results were statistically significant among the two groups
NCT03163277,TERMINATED,INTERVENTIONAL,Sloww accrual and COVID-19 related problems (impossible to perform LPs)
NCT03163394,TERMINATED,OBSERVATIONAL,Did not enroll enough patients for study
NCT03163459,SUSPENDED,INTERVENTIONAL,Interim analysis
NCT03163485,WITHDRAWN,INTERVENTIONAL,Application to CA withdrawn due to technical reasons of the manufacturer
NCT03163784,WITHDRAWN,INTERVENTIONAL,The study closed because of shifting research priorities and interests.
NCT03163810,WITHDRAWN,INTERVENTIONAL,Difficulty with recruitment
NCT03164083,WITHDRAWN,INTERVENTIONAL,not approved by sponsor
NCT03164551,TERMINATED,INTERVENTIONAL,Participant enrollment has remained significantly behind plan despite increased site enrollment activity.
NCT03164642,WITHDRAWN,INTERVENTIONAL,Determined feasibility was needed before conducting this trial
NCT03164889,TERMINATED,INTERVENTIONAL,no enough participant can be enrolled
NCT03164954,TERMINATED,OBSERVATIONAL,"no recruitement possible for \>12 months due to highly reduced surgical activity because of the COVID pandemic, all elective surgery was transferred to private hospitals for several months"
NCT03165188,TERMINATED,OBSERVATIONAL,The IND was withdrawn
NCT03165214,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT03165292,TERMINATED,INTERVENTIONAL,"The Sponsor has been notified of an interruption in the international supply, and there is a possibility that 131I-mlBG would be unavailable to patients randomised to arm A of the trial"
NCT03165435,WITHDRAWN,INTERVENTIONAL,Not enough participating centres to complete recruitment in a timely manner.
NCT03165695,WITHDRAWN,INTERVENTIONAL,Never funded
NCT03165721,TERMINATED,INTERVENTIONAL,Study closed to enrollment due to low accrual.
NCT03165747,TERMINATED,INTERVENTIONAL,Investigator terminated trial pursuant to research contract rights.
NCT03165825,WITHDRAWN,INTERVENTIONAL,funding
NCT03165968,SUSPENDED,OBSERVATIONAL,"COVID19 epidemic, and institutional guidelines for halt of recruitment during epidemic"
NCT03166176,WITHDRAWN,INTERVENTIONAL,lack of efficacy
NCT03166254,WITHDRAWN,INTERVENTIONAL,Lost funding
NCT03166371,WITHDRAWN,INTERVENTIONAL,Study was withdrawn prior to enrolling participants after being suspended due to funding and staffing issues.
NCT03166462,WITHDRAWN,INTERVENTIONAL,Lack of funding and clinical resources
NCT03166488,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT03166618,TERMINATED,INTERVENTIONAL,Business decision to stop the program.
NCT03166631,TERMINATED,INTERVENTIONAL,Not due to safety reasons.
NCT03166761,TERMINATED,INTERVENTIONAL,recruitment and staffing
NCT03166774,WITHDRAWN,OBSERVATIONAL,The study stopped because the the project was abandoned.
NCT03166787,TERMINATED,INTERVENTIONAL,Due to the Pandemic and the nature of this study we decided to terminate this study.
NCT03166800,TERMINATED,INTERVENTIONAL,Lack of adequate funding
NCT03166904,WITHDRAWN,INTERVENTIONAL,Lack of efficacy
NCT03167151,TERMINATED,INTERVENTIONAL,The study failed to recruit within the permitted timeframe
NCT03167164,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03167177,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03167190,TERMINATED,INTERVENTIONAL,Failed to meet target enrollment
NCT03167281,WITHDRAWN,INTERVENTIONAL,lack of adequate recruitment
NCT03167788,WITHDRAWN,INTERVENTIONAL,Manufacturing Issues
NCT03167892,TERMINATED,INTERVENTIONAL,We did not manage to recruit enough participants
NCT03167957,WITHDRAWN,INTERVENTIONAL,No longer target indication
NCT03168100,WITHDRAWN,INTERVENTIONAL,No study population. No subjects enrolled.
NCT03168152,WITHDRAWN,INTERVENTIONAL,No patients were accrued to the trial
NCT03168178,WITHDRAWN,INTERVENTIONAL,Participant enrollment was much more challenging than anticipated.
NCT03168282,TERMINATED,OBSERVATIONAL,Enrollment goal could not be met.
NCT03168438,TERMINATED,INTERVENTIONAL,The study was terminated following an internal review of the company's research and development portfolio
NCT03168464,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03168594,TERMINATED,INTERVENTIONAL,The enrollment was terminated early because the premature analysis found similar response in the two arms.
NCT03168906,TERMINATED,INTERVENTIONAL,Futility
NCT03168919,TERMINATED,INTERVENTIONAL,PI is leaving institution
NCT03169114,TERMINATED,INTERVENTIONAL,Poor recruitment and terminated during COVID-19 pandemic
NCT03169309,TERMINATED,INTERVENTIONAL,Study modified to a two-group crossover design and transferred to new location.
NCT03169530,TERMINATED,INTERVENTIONAL,NIH decision
NCT03169621,TERMINATED,OBSERVATIONAL,Low patient enrolment during the recruiting period
NCT03169738,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03169764,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03169777,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03169790,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03169829,WITHDRAWN,INTERVENTIONAL,Due to lack of funding
NCT03169868,TERMINATED,INTERVENTIONAL,Enrollment rate insufficient to fully enroll study within the planned timeline.
NCT03169894,TERMINATED,INTERVENTIONAL,Strategic reasons
NCT03170011,WITHDRAWN,INTERVENTIONAL,Unable to enroll any participants.
NCT03170115,TERMINATED,INTERVENTIONAL,Aspirin added to chemoradiotherapy was safe but did not improve response to total neoadjuvant treatment. The study was closed due absence of benefit.
NCT03170219,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03170232,TERMINATED,INTERVENTIONAL,Terminated based on lack of efficacy seen in participants taking danirixin in dose ranging study and Sponsor decision to stop development of danirixin for COPD
NCT03170258,TERMINATED,INTERVENTIONAL,unanticipated difficulty with enrollment
NCT03170557,TERMINATED,INTERVENTIONAL,"After a first stop due to acupuncturists unavailability, the Covid-19 pandemic also impacted on the study time schedule for acupuncture administration and outcomes evaluation."
NCT03170583,TERMINATED,OBSERVATIONAL,Abbott received FDA approval to transition the ongoing Brady MRI PAS study to EP a new EP-Passion Real World Evidence methodology
NCT03170869,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding
NCT03170908,TERMINATED,OBSERVATIONAL,Conflict of Interest (COI) cannot be managed
NCT03171051,TERMINATED,INTERVENTIONAL,device development placed on hold
NCT03171168,TERMINATED,INTERVENTIONAL,Insufficient recruitment and end of funding
NCT03172026,TERMINATED,INTERVENTIONAL,"Poor recruitment for each site, partly related to Covid epidemic."
NCT03172143,TERMINATED,INTERVENTIONAL,Accrual not met
NCT03172403,TERMINATED,INTERVENTIONAL,The study was stopped prematurely by decision of the sponsor due to lack of inclusion.
NCT03172468,SUSPENDED,OBSERVATIONAL,inadequate inclusion
NCT03172520,TERMINATED,INTERVENTIONAL,Limitations in timing and personnel
NCT03172533,TERMINATED,INTERVENTIONAL,Difficulties in recruitment
NCT03172546,TERMINATED,OBSERVATIONAL,not sufficiency inclusion
NCT03172559,WITHDRAWN,INTERVENTIONAL,Investigator decided not to pursue the study due to other competing studies.
NCT03172741,WITHDRAWN,INTERVENTIONAL,Did not pursue study
NCT03172832,TERMINATED,INTERVENTIONAL,Slow accrual; recommended by DSMB.
NCT03172858,WITHDRAWN,INTERVENTIONAL,The IRB identified too many safety issues and the study did not move ahead.
NCT03172897,SUSPENDED,INTERVENTIONAL,The trial was stopped because of difficulty in recruiting patients (another trial had similar inclusion/exclusion criteria). No patients was recruited in this trial.
NCT03172936,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03172988,TERMINATED,INTERVENTIONAL,Protocol violation occurred frequently during the postoperative period.
NCT03173053,TERMINATED,INTERVENTIONAL,Results interim-analysis
NCT03173274,TERMINATED,INTERVENTIONAL,Grant funding ended for pilot work
NCT03173326,TERMINATED,INTERVENTIONAL,Staffing changes at site. No longer feasible at site.
NCT03173365,TERMINATED,INTERVENTIONAL,It is no longer practicable to complete the trial
NCT03173430,TERMINATED,INTERVENTIONAL,PI decided to close study due to slow accrual.
NCT03173794,WITHDRAWN,INTERVENTIONAL,This trial was a duplicate entry. Recruitment was never open and no participants were enrolled.
NCT03173807,WITHDRAWN,INTERVENTIONAL,Unable to find adequate funding
NCT03173859,WITHDRAWN,INTERVENTIONAL,Delayed initiation
NCT03173885,TERMINATED,INTERVENTIONAL,Due to the slow recruitment of patients
NCT03173963,WITHDRAWN,INTERVENTIONAL,"Original drug sponsor withdrew from study, replacement sponsor not obtained."
NCT03174522,TERMINATED,INTERVENTIONAL,Independent Data Monitoring Committee recommendation to stop due to futility
NCT03174782,TERMINATED,INTERVENTIONAL,The study was terminated due to not enough power and research staff assistance.
NCT03174808,TERMINATED,INTERVENTIONAL,"PI unexpectedly passed away, study closed."
NCT03175172,TERMINATED,INTERVENTIONAL,Study was stopped due to low enrollment and lack of clinical activity.
NCT03175523,TERMINATED,INTERVENTIONAL,BioResorbable Scaffold is not available in South Korea
NCT03175653,WITHDRAWN,INTERVENTIONAL,Feasibility - could not operationalize prior to PI leaving the institution.
NCT03175666,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03175744,SUSPENDED,INTERVENTIONAL,"Patient enrollment impacted by COVID-19 pandemic and other business challenges. Patient enrollment discontinued, but follow-ups will continue according to protocol."
NCT03175887,WITHDRAWN,INTERVENTIONAL,PI's discretion due to needing to modify study protocol.
NCT03175926,WITHDRAWN,INTERVENTIONAL,Refusal by the ethics committee
NCT03175978,TERMINATED,INTERVENTIONAL,Funding
NCT03176030,WITHDRAWN,OBSERVATIONAL,Study team submitted IRAS form and the ethic committee advised that this pilot study is more service evaluation and no REC ethical approval was required.
NCT03176160,WITHDRAWN,OBSERVATIONAL,Failure to enroll
NCT03176264,TERMINATED,INTERVENTIONAL,The study was terminated early due to company decision.
NCT03176277,TERMINATED,INTERVENTIONAL,Protocol defined futility criteria
NCT03176394,TERMINATED,INTERVENTIONAL,trouble with enrollment
NCT03176420,WITHDRAWN,INTERVENTIONAL,"Study is not funded, PI has left the institution"
NCT03176498,SUSPENDED,INTERVENTIONAL,Others
NCT03176537,WITHDRAWN,INTERVENTIONAL,No eligible participants for the RCT were found
NCT03176888,WITHDRAWN,INTERVENTIONAL,Logistical problems meant that the study was no longer feasible.
NCT03177187,TERMINATED,INTERVENTIONAL,Discontinuation of production of IMP
NCT03177252,WITHDRAWN,INTERVENTIONAL,Investigator decided not to go forward with the trial.
NCT03177421,TERMINATED,INTERVENTIONAL,Study technology decommissioned at clinical site.
NCT03177499,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03177681,WITHDRAWN,INTERVENTIONAL,0 patient accrual
NCT03177941,WITHDRAWN,INTERVENTIONAL,The company decided not to enroll subjects. The app was never developed.
NCT03178175,TERMINATED,INTERVENTIONAL,This study will be terminated due to poor patient recruitments.
NCT03178201,TERMINATED,INTERVENTIONAL,PI left institution
NCT03178955,WITHDRAWN,OBSERVATIONAL,The Investigator decided not to pursue this study.
NCT03179059,TERMINATED,INTERVENTIONAL,Difficulties in field coordination
NCT03179163,TERMINATED,INTERVENTIONAL,COVID shut down human subjects research and then the grant funding expired
NCT03179228,WITHDRAWN,INTERVENTIONAL,"FDA approved Embospheres for prostate embolization, so IDE not needed"
NCT03179397,TERMINATED,INTERVENTIONAL,Sponsor did not recruit enough subjects to file PMA.
NCT03179449,WITHDRAWN,INTERVENTIONAL,Accrual Factor
NCT03179501,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT03179605,TERMINATED,INTERVENTIONAL,Difficulty in enrollment
NCT03179956,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03179995,TERMINATED,INTERVENTIONAL,Grantor closed study
NCT03180385,TERMINATED,INTERVENTIONAL,Very small percentage of enrolled patients needing non-invasive support and small chance of us reaching target enrollment within funding period.
NCT03180398,TERMINATED,INTERVENTIONAL,PI left institution
NCT03180450,SUSPENDED,INTERVENTIONAL,Others
NCT03180463,SUSPENDED,INTERVENTIONAL,Others
NCT03180762,TERMINATED,INTERVENTIONAL,"Trial stopped: A SAE has occured. As a measure of precaution, the trial has been stopped."
NCT03180788,WITHDRAWN,INTERVENTIONAL,The study was never started
NCT03180853,TERMINATED,OBSERVATIONAL,Completion of study in orig timeframe not feasible considering evolving treatments for MM in US.
NCT03181061,WITHDRAWN,OBSERVATIONAL,PI confirmed that this is not a clinical trial and was inadvertently entered in the system
NCT03181087,WITHDRAWN,INTERVENTIONAL,The pandemic resulted in no enrollments.
NCT03181464,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT03181581,TERMINATED,INTERVENTIONAL,because the study had to be redesigned and restarted as clinical device study
NCT03181685,TERMINATED,INTERVENTIONAL,27 couples were recruited. This unexpected poor recruitment was due to more clinical pregnancies (for a better patients' selection) and more freeze-all cycles.
NCT03181737,TERMINATED,INTERVENTIONAL,low adherence rate; need to revise online interventions
NCT03181828,TERMINATED,INTERVENTIONAL,The incidence of AEs was higher than the IB reported.
NCT03181880,WITHDRAWN,INTERVENTIONAL,Study stopped early as AZ have re-prioritised to focus on research to help bring existing and innovative medicines to more patients with asthma and COPD.
NCT03182049,WITHDRAWN,OBSERVATIONAL,Funding was not able to be secured for the study and no participants enrolled.
NCT03182257,TERMINATED,INTERVENTIONAL,The study was stopped for commercial reasons. No safety issues were reported.
NCT03182465,TERMINATED,INTERVENTIONAL,poor recruitment
NCT03182673,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT03182894,WITHDRAWN,INTERVENTIONAL,Study will not be conducted due to changes related to the investigational agent.
NCT03182933,TERMINATED,INTERVENTIONAL,Terminated due to surgeon preferences
NCT03183492,WITHDRAWN,INTERVENTIONAL,Sponsor cancelled the study as real life impact data has already shown the value of HepA vaccination \& as no critical need to gather additional data in Israel.
NCT03183596,WITHDRAWN,INTERVENTIONAL,Principal investigator determination
NCT03183869,TERMINATED,INTERVENTIONAL,Primary Investigator passed away.
NCT03184415,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT03184558,TERMINATED,INTERVENTIONAL,Based on planned futility assessment
NCT03184584,TERMINATED,INTERVENTIONAL,Terminated early due to redeployment of study site staff during Covid-19 pandemic
NCT03184805,TERMINATED,INTERVENTIONAL,Investigator judged that this study can not be maintained because participant registration rate is low.
NCT03184935,SUSPENDED,INTERVENTIONAL,Others
NCT03185117,TERMINATED,OBSERVATIONAL,Low patient retention rate
NCT03185169,TERMINATED,INTERVENTIONAL,"Study design change required protocol/ICF changes, deemed more appropriate to terminate study and apply knowledge gained to potential future study design"
NCT03185182,TERMINATED,INTERVENTIONAL,"Due to ""early stopping rule"" as defined in the study protocol"
NCT03185416,WITHDRAWN,INTERVENTIONAL,PI leaving University
NCT03185481,TERMINATED,INTERVENTIONAL,Terminated 25Sep17 due to parent study insufficient efficacy. Not due to safety
NCT03185559,TERMINATED,INTERVENTIONAL,Investigator retierment
NCT03185780,WITHDRAWN,INTERVENTIONAL,Unable to attain funding
NCT03185871,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT03186157,TERMINATED,OBSERVATIONAL,departure of one of the investigator
NCT03186417,TERMINATED,INTERVENTIONAL,slow enrollment during covid and lack of funds to continue
NCT03186456,SUSPENDED,INTERVENTIONAL,Others
NCT03186560,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT03186794,TERMINATED,INTERVENTIONAL,Research activities were suspended due to the COVID-19 pandemic
NCT03186911,WITHDRAWN,INTERVENTIONAL,Study team decided not to move forward with study
NCT03186937,TERMINATED,INTERVENTIONAL,funding and slow enrollment
NCT03187080,SUSPENDED,INTERVENTIONAL,per Research Hold
NCT03187171,WITHDRAWN,INTERVENTIONAL,Funding
NCT03187405,SUSPENDED,INTERVENTIONAL,Slow recruitment rate
NCT03187522,TERMINATED,INTERVENTIONAL,Post Market Study terminated early due to the launch and subsequent incorporation of the study into the Terumo Aortic Endovascular Registry (TiGER-001).
NCT03187587,TERMINATED,INTERVENTIONAL,Study was stopped in agreement with investigator due to slow recruitment.
NCT03187691,WITHDRAWN,INTERVENTIONAL,Protocol redundancy
NCT03187756,TERMINATED,INTERVENTIONAL,Procedure has become standard of care - protocol is no longer necessary
NCT03187860,TERMINATED,INTERVENTIONAL,Inclusions was stopped at 30 patients. Investigators did not wish to extend inclusions.
NCT03187899,WITHDRAWN,INTERVENTIONAL,Principal investigator was unable to pursue research further due to time constraints.
NCT03188016,WITHDRAWN,INTERVENTIONAL,"Unfavourable ethical opinion, principally on grounds of inadequate sample size"
NCT03188328,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT03188393,SUSPENDED,INTERVENTIONAL,Phase I analysis
NCT03188458,TERMINATED,INTERVENTIONAL,"As similar local evidence recently available, present study will not add new information; no ethical justification exists to continue study procedures."
NCT03188653,TERMINATED,INTERVENTIONAL,Investigator left university
NCT03188822,TERMINATED,INTERVENTIONAL,Study enrollment was too slow to complete the study in a reasonable time
NCT03188978,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT03189030,TERMINATED,INTERVENTIONAL,Study terminated due to business realignment
NCT03189147,TERMINATED,INTERVENTIONAL,Due to low recruitment rate
NCT03189186,WITHDRAWN,INTERVENTIONAL,"This study was closed due to extremely low accrual, as well as a change in care when using the study drug."
NCT03189316,TERMINATED,INTERVENTIONAL,Absence of BReg Lymphocytes in peritoneum
NCT03189433,TERMINATED,INTERVENTIONAL,Limited enrollment
NCT03189667,TERMINATED,INTERVENTIONAL,slow recruitment and recent concerns of safety of Paclitaxel coated balloons and associated increased risk death
NCT03189836,TERMINATED,INTERVENTIONAL,Business decision
NCT03190213,TERMINATED,INTERVENTIONAL,"Update on clinical development: after discussions with the drug manufacturer, the PI has decided to discontinue the trial."
NCT03190239,WITHDRAWN,INTERVENTIONAL,abandon
NCT03190356,TERMINATED,OBSERVATIONAL,Business Decision
NCT03190473,TERMINATED,INTERVENTIONAL,"Company financial insolvency, not due to safety or efficacy concerns"
NCT03190655,TERMINATED,INTERVENTIONAL,Stopped by the Sponsor due to their change in product development priorities.
NCT03190798,WITHDRAWN,INTERVENTIONAL,Study has been withdrawn from IRB review pending IND revision
NCT03190967,TERMINATED,INTERVENTIONAL,The phase II portion was never started as we could no longer get the drug from the manufacturer.
NCT03191201,TERMINATED,INTERVENTIONAL,The reason for early termination is difficulties recruiting that caused a premature ending of financial resources ensuring protected time for research.
NCT03191383,WITHDRAWN,INTERVENTIONAL,Study was canceled due to instability of the PreF antigen during manufacturing. No safety concern has been identified in past or ongoing studies.
NCT03191487,WITHDRAWN,INTERVENTIONAL,no Financial agreement
NCT03191526,TERMINATED,INTERVENTIONAL,Due to not achieving the primary outcome.
NCT03191890,WITHDRAWN,OBSERVATIONAL,Sponsor stopped the study due to poor enrollment
NCT03191981,WITHDRAWN,INTERVENTIONAL,Withdrawal of pharma support prior to opening to recruitment
NCT03192215,TERMINATED,INTERVENTIONAL,The DSMB halted the trial prematurely due to futility without any safety concerns.
NCT03192345,TERMINATED,INTERVENTIONAL,Occurrence of objective responses in multiple indications in the Phase 1b was not enough to warrant further exploration in view of competitive landscape and some toxicity (mostly bleeding events).
NCT03192371,WITHDRAWN,INTERVENTIONAL,"Due to supply constraints \& prioritization according to medical need (availability of alternative rabies vaccines), Rabipur will no longer be supplied to China."
NCT03192514,TERMINATED,INTERVENTIONAL,Recruiting of family doctors below our goal
NCT03192904,TERMINATED,INTERVENTIONAL,One treatment policy showed an advantage at a very high significance level.
NCT03192969,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT03192995,TERMINATED,INTERVENTIONAL,FDA alert regarding study drug safety
NCT03193073,SUSPENDED,INTERVENTIONAL,problem in funding which will be solved by the end of August
NCT03193164,SUSPENDED,INTERVENTIONAL,This study had to be suspended due to COVID-19 Pandemic.
NCT03193346,WITHDRAWN,INTERVENTIONAL,Corporation Decision
NCT03193359,WITHDRAWN,INTERVENTIONAL,Corporate Decision
NCT03193437,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT03193463,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03193814,WITHDRAWN,INTERVENTIONAL,Inadequate patient enrollment
NCT03193931,TERMINATED,INTERVENTIONAL,A very low recruitment rate made it impossible to reach the recruitment goal wthin an acceptable timeframe.
NCT03194581,TERMINATED,OBSERVATIONAL,"Profissional reasons, not related with the study"
NCT03194828,TERMINATED,INTERVENTIONAL,Lack of sufficient recruitment
NCT03195010,TERMINATED,INTERVENTIONAL,Terminated because of slow recruitment and lack of funding support
NCT03195088,TERMINATED,INTERVENTIONAL,Terminated (Business Reasons)
NCT03195387,WITHDRAWN,INTERVENTIONAL,Repositioning of target indication.
NCT03195465,TERMINATED,INTERVENTIONAL,PI left institution. Efforts made to contact PI unsuccessful. No study data available.
NCT03195530,TERMINATED,OBSERVATIONAL,"Out of funding, no differences between groups"
NCT03195660,TERMINATED,INTERVENTIONAL,Funding for study was withdrawn
NCT03195764,TERMINATED,INTERVENTIONAL,The study was terminated before the primary endpoint (determination of MTD) was reached because the OPC form is to be replaced with the newly developed capsule form in all subsequent clinical trials.
NCT03195920,TERMINATED,INTERVENTIONAL,Interim data was sufficient for study purpose
NCT03196063,TERMINATED,INTERVENTIONAL,Study stopped because we could not recruit patients in the available time
NCT03196115,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT03196141,WITHDRAWN,INTERVENTIONAL,not able to recruit enough participants.
NCT03196258,TERMINATED,INTERVENTIONAL,Feasibility issues with the study treatment (in-person CBT) resulted in the study ending earlier than anticipated.
NCT03196349,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03196375,TERMINATED,INTERVENTIONAL,Sponsor
NCT03196401,WITHDRAWN,INTERVENTIONAL,FDA recommendation
NCT03196765,WITHDRAWN,INTERVENTIONAL,No funding
NCT03196921,WITHDRAWN,INTERVENTIONAL,Protocol redundancy
NCT03196947,TERMINATED,INTERVENTIONAL,The study was terminated early due to sponsors decision
NCT03197025,TERMINATED,INTERVENTIONAL,The study was closed due to investigator discretion based on the lack of perceived clinical activity observed in the study.
NCT03197090,TERMINATED,INTERVENTIONAL,poor patient recruitment and limited resources
NCT03197311,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding for this research.
NCT03197506,SUSPENDED,INTERVENTIONAL,Temporary closure per protocol design
NCT03197571,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03197584,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03197805,TERMINATED,INTERVENTIONAL,Take care recommendations for Her2 equivok patients has changed.
NCT03197948,TERMINATED,OBSERVATIONAL,slow accrual
NCT03198117,TERMINATED,INTERVENTIONAL,Difficulty in patient recruitment
NCT03198143,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT03198156,TERMINATED,INTERVENTIONAL,Funding Stopped
NCT03198169,TERMINATED,INTERVENTIONAL,Inconsistent results in pilot phase
NCT03198221,TERMINATED,INTERVENTIONAL,Low enrollment due to difficult eligibility criteria and participant prep logistics
NCT03198247,WITHDRAWN,INTERVENTIONAL,low participation
NCT03198390,TERMINATED,OBSERVATIONAL,Investigator left university
NCT03198559,TERMINATED,INTERVENTIONAL,A re-evaluation of research risks to participants were greater than originally anticipated
NCT03198897,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT03198988,TERMINATED,INTERVENTIONAL,Due to the company's intent to conduct a new study under a different protocol with the smART+ System which is a more advanced version of the smART System.
NCT03199040,TERMINATED,INTERVENTIONAL,Drugs/equipment unavailable and insufficient funding
NCT03199144,WITHDRAWN,INTERVENTIONAL,difficulties to recruit patients
NCT03199352,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT03199404,TERMINATED,OBSERVATIONAL,Lead site preference
NCT03199417,TERMINATED,INTERVENTIONAL,Terminated prematurely due to feasibility issues with rate of recruitment
NCT03199755,WITHDRAWN,INTERVENTIONAL,"Withdrawn in 2018 because clinicians did not follow protocols, issues with communication and also with tablet processing, nearby Ebola outbreak in 2018 (in the N Kivu area) confounded efforts."
NCT03199963,TERMINATED,INTERVENTIONAL,Administrative - change in development strategy
NCT03200080,TERMINATED,INTERVENTIONAL,New Safety Information
NCT03200093,TERMINATED,INTERVENTIONAL,Low recruitment due to few eligible participants.
NCT03200223,TERMINATED,INTERVENTIONAL,Study was completed
NCT03200327,TERMINATED,INTERVENTIONAL,withdrawal of vaginal prosthesis from the market
NCT03200522,TERMINATED,INTERVENTIONAL,"Funding completion date passed, inadequate enrollment"
NCT03200548,TERMINATED,INTERVENTIONAL,Low participant recruitment and retention
NCT03200600,TERMINATED,INTERVENTIONAL,Protocol violation occurred frequently during the postoperative period.
NCT03200613,TERMINATED,INTERVENTIONAL,study not feasible due to too slow recruitment
NCT03201042,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT03201159,WITHDRAWN,INTERVENTIONAL,Drug manufacturer ceased operations
NCT03201250,TERMINATED,INTERVENTIONAL,"Phase I response to treatment was not as expected and the myeloma field in treatment has changed since initiating the study, so investigators felt the study should not be pursued into Phase II."
NCT03201445,TERMINATED,INTERVENTIONAL,Early Termination for Reasons other than Safety
NCT03201536,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT03201809,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT03201939,SUSPENDED,INTERVENTIONAL,DSMB recommendations--lab QC issues relate to urine albumin measurement (\>2-year pause). DSMB approval obtained (3/24/2023) to re-open but will not enroll participants until new/separate funding obtained as this award ends in Feb. 2024.
NCT03201952,TERMINATED,INTERVENTIONAL,Difficulty in participant recruitment
NCT03201978,WITHDRAWN,INTERVENTIONAL,"The whole project was discontinued within GSK, hence this study was cancelled before enrolment."
NCT03202004,WITHDRAWN,INTERVENTIONAL,The decision not to progress the planned Phase 3 studies is a business decision based on the need to prioritise and focus resources within GSK.
NCT03202108,WITHDRAWN,INTERVENTIONAL,Product manufacturing issues.
NCT03202147,WITHDRAWN,INTERVENTIONAL,Study halted prematurely prior to initiation but potentially will resume in the future.
NCT03202186,TERMINATED,INTERVENTIONAL,Inability to recruit subjects
NCT03202264,TERMINATED,OBSERVATIONAL,Difficulty with recruitment and staff retention.
NCT03202355,TERMINATED,INTERVENTIONAL,Sponsor terminated due to clinical staffing changes and enrolment
NCT03202498,TERMINATED,INTERVENTIONAL,"COVID-19 pandemic prevents patients from making in-hospital visits, which are mandatory to assessment of safety in this study"
NCT03202524,WITHDRAWN,INTERVENTIONAL,Study was never approved by the IRB
NCT03202745,WITHDRAWN,INTERVENTIONAL,Intervention never conducted
NCT03203304,TERMINATED,INTERVENTIONAL,Study stopped due to poor accrual.
NCT03203369,TERMINATED,INTERVENTIONAL,The trial was discontinued due to sponsor's decision and not a consequence of any safety concern.
NCT03203447,TERMINATED,INTERVENTIONAL,"The early termination is due to the results obtained from the sister study, SAPPHIRE (CLS1003-301), which did not meet the 8-week primary efficacy endpoint."
NCT03203616,WITHDRAWN,INTERVENTIONAL,"As most HER2+ patient develop brain mets while on/after having received TDM1, it has proven to be an insurmountable challenge to recruit patients"
NCT03203837,TERMINATED,OBSERVATIONAL,Funding Discontinued due to low accrual rate
NCT03203993,TERMINATED,OBSERVATIONAL,Failure to obtain HGR approval.
NCT03204149,TERMINATED,INTERVENTIONAL,Project termination
NCT03204201,TERMINATED,INTERVENTIONAL,Technique failed
NCT03204409,WITHDRAWN,OBSERVATIONAL,No ZIKA cases at study site
NCT03204448,WITHDRAWN,OBSERVATIONAL,Evaluation halted
NCT03204539,TERMINATED,INTERVENTIONAL,Termination of funding from sponsor.
NCT03204604,WITHDRAWN,INTERVENTIONAL,Unable to obtain intervention materials
NCT03204695,TERMINATED,INTERVENTIONAL,Study closed due to device design modifications.
NCT03204994,TERMINATED,INTERVENTIONAL,Not able to recruit
NCT03205046,TERMINATED,INTERVENTIONAL,Sponsor's decision not to pursue further development of the combination in DLBCL
NCT03205137,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT03205553,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03205722,WITHDRAWN,OBSERVATIONAL,Business objectives have changed
NCT03205891,WITHDRAWN,INTERVENTIONAL,Change in treatment priorities for these disease types as well as staffing concerns.
NCT03205943,WITHDRAWN,OBSERVATIONAL,logistical challenges
NCT03206008,TERMINATED,INTERVENTIONAL,hard to get an informed concent because of small number of indiaiton of surgery
NCT03206112,TERMINATED,OBSERVATIONAL,PI leaving the NIH
NCT03206125,TERMINATED,OBSERVATIONAL,determined not to be human subjects research
NCT03206216,TERMINATED,INTERVENTIONAL,Business decision
NCT03206463,TERMINATED,INTERVENTIONAL,Feasibility pilot was completed
NCT03206736,TERMINATED,INTERVENTIONAL,Low study enrollment
NCT03206788,TERMINATED,INTERVENTIONAL,due to slow enrollment and approval of the Trikafta for CF patients
NCT03206879,TERMINATED,OBSERVATIONAL,Several sites did not manage to recruit patients.
NCT03207230,WITHDRAWN,INTERVENTIONAL,Funding not secured
NCT03207256,TERMINATED,INTERVENTIONAL,Strategic/Business Decision
NCT03207334,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT03207373,TERMINATED,INTERVENTIONAL,The study aim was not relevant anymore because other studies became available recently on the same topic
NCT03207399,TERMINATED,INTERVENTIONAL,Enrollment terminated due to not having any other eligible participants.
NCT03207477,TERMINATED,INTERVENTIONAL,Principal Investigator not available anymore (Sabbatical)
NCT03207542,WITHDRAWN,INTERVENTIONAL,PI request
NCT03207646,TERMINATED,INTERVENTIONAL,The company that provided the intervention shut down \& withdrew the intervention
NCT03207815,TERMINATED,INTERVENTIONAL,Development program terminated
NCT03207867,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03208023,TERMINATED,INTERVENTIONAL,Futility
NCT03208127,TERMINATED,INTERVENTIONAL,"Protocol transitioned to standard of care, no funding available to continue support of research work or data analysis"
NCT03208244,TERMINATED,INTERVENTIONAL,"Protocol transitioned to standard of care, no funding available to support research work"
NCT03208296,SUSPENDED,INTERVENTIONAL,Study did not start. Another protocol is being developed. Recruitment on hold.
NCT03208322,WITHDRAWN,OBSERVATIONAL,There was a change in the strategy to complete the RMP with HA.
NCT03208361,TERMINATED,INTERVENTIONAL,Lack of financial support to continue with the study recruitment. Independent study financially supported by a national grant with a 4.5 years duration.
NCT03208543,TERMINATED,INTERVENTIONAL,failure rate 91.1%
NCT03208712,TERMINATED,INTERVENTIONAL,Low accrual
NCT03209128,TERMINATED,OBSERVATIONAL,diffciculties to recruit patients and a lot of patients prematurely terminated
NCT03209232,TERMINATED,INTERVENTIONAL,Difficulty to recruit patients and as high dose infliximab for severe UC is now the rule rather than the exception
NCT03209401,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT03209778,TERMINATED,INTERVENTIONAL,The research was stopped because of recruitment difficulties at the end of the study due to a high drop-out rate for one of the two tasks included in the protocol.
NCT03209869,WITHDRAWN,INTERVENTIONAL,resources limited due to COVID-19
NCT03209882,TERMINATED,INTERVENTIONAL,IRB approval terminated
NCT03210155,TERMINATED,INTERVENTIONAL,Early termination due to change in recruitment site and search team members
NCT03210324,TERMINATED,INTERVENTIONAL,It is difficult to recruit enough participants
NCT03210480,TERMINATED,INTERVENTIONAL,Sponsor's decision due to slow enrollment rate.
NCT03210870,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT03211052,TERMINATED,INTERVENTIONAL,IMP no longer available
NCT03211169,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT03211260,TERMINATED,INTERVENTIONAL,Iterim analysis did not detect a clinically meaningful change in the primary endpoint
NCT03211273,WITHDRAWN,OBSERVATIONAL,no funding
NCT03211494,TERMINATED,INTERVENTIONAL,Unexpected low recruitment rate
NCT03211780,TERMINATED,INTERVENTIONAL,Terminated due to the inability to enroll and carry out study intervention.
NCT03211910,WITHDRAWN,INTERVENTIONAL,Funding issue of the sponsor
NCT03211988,TERMINATED,INTERVENTIONAL,Lack of funding and drug supply
NCT03212144,TERMINATED,INTERVENTIONAL,poor enrollment
NCT03212300,TERMINATED,INTERVENTIONAL,Inadequate data analysis
NCT03212313,TERMINATED,INTERVENTIONAL,New Safety Information
NCT03212339,WITHDRAWN,INTERVENTIONAL,Study was halted due to challenges with recruitment and enrollment.
NCT03212352,TERMINATED,INTERVENTIONAL,"Advised by DSMB based on interim-analysis, highly significant difference."
NCT03212534,WITHDRAWN,INTERVENTIONAL,This trial did not start. No participants enrolled
NCT03212690,TERMINATED,INTERVENTIONAL,Study stopped early following termination of associated clinical development program (due to lack of efficacy)
NCT03212716,TERMINATED,INTERVENTIONAL,rate of inclusion and study affected by covid-19 epidemic
NCT03212807,WITHDRAWN,INTERVENTIONAL,FDA Hold for Combination Studies using Imids and PD1/PDL1 Compounds
NCT03212963,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT03213080,WITHDRAWN,OBSERVATIONAL,Not initiated
NCT03213119,SUSPENDED,INTERVENTIONAL,number of planned study inclusions not achievable
NCT03213210,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03213418,TERMINATED,INTERVENTIONAL,"Due to delay in recruitment during COVID and cost considerations, the study will need to end without meeting its recruitment target and meeting compliance requirements."
NCT03213561,TERMINATED,INTERVENTIONAL,We have not succeeded in developing an approach that uses hdEEG to control a communication interface at an accuracy needed to complete the protocol.
NCT03213574,WITHDRAWN,INTERVENTIONAL,Principal Investigator is making changes to the protocol.
NCT03213600,WITHDRAWN,INTERVENTIONAL,One of the investigators went abroad
NCT03213626,TERMINATED,INTERVENTIONAL,There were no objective responses by patient 7.
NCT03214627,TERMINATED,INTERVENTIONAL,Standard clinical practice at site caused unforeseen issues for the use of the ACM
NCT03214666,TERMINATED,INTERVENTIONAL,"Development of GTB-3550 halted due to development of the second generation camelid nanobody TriKE drug product, GTB-3650."
NCT03214809,TERMINATED,INTERVENTIONAL,Slow inclusion rate (partly due to Covid-19)
NCT03214835,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant."
NCT03214887,WITHDRAWN,INTERVENTIONAL,Incomplete enrollment process
NCT03215238,TERMINATED,OBSERVATIONAL,enrollment too slow
NCT03215355,WITHDRAWN,INTERVENTIONAL,Not approved
NCT03215589,TERMINATED,OBSERVATIONAL,"due to a change in surgical personnel, the operative technique changed, precluding the examination of bypass-related bi-hemispheric saturation differences."
NCT03215667,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03216486,WITHDRAWN,INTERVENTIONAL,Administrative Reason
NCT03216772,WITHDRAWN,INTERVENTIONAL,"Study was withdrawn for organizational reasons, not due to safety concerns."
NCT03216876,WITHDRAWN,INTERVENTIONAL,Lack of feasibility
NCT03217175,TERMINATED,INTERVENTIONAL,Lack of appropriate funds
NCT03217253,WITHDRAWN,INTERVENTIONAL,Other - Drug Manufacturer decision to close study
NCT03217370,SUSPENDED,INTERVENTIONAL,the pilot study (before the intervention) is completed.
NCT03217513,WITHDRAWN,OBSERVATIONAL,never started
NCT03217708,WITHDRAWN,OBSERVATIONAL,"Non compliance from sponsor regarding applicable documentation to proceed with trial, therefore decision to permanently halt trial"
NCT03217838,TERMINATED,INTERVENTIONAL,strategic decision
NCT03218163,TERMINATED,INTERVENTIONAL,MEDI-551 removed from oncology by pharmaceutical company due to change in research target.
NCT03218202,TERMINATED,OBSERVATIONAL,To focus on STRIDENT intervention studies as this study population is heterogenous
NCT03218384,TERMINATED,INTERVENTIONAL,Unable to complete enrollment as planned.
NCT03218475,SUSPENDED,INTERVENTIONAL,On hold pending amendment approval
NCT03218683,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03218735,WITHDRAWN,INTERVENTIONAL,It was discovered that the patient population would not be large enough to adequately recruit.
NCT03218800,TERMINATED,INTERVENTIONAL,not enough participants due to COVID19 pandemia
NCT03219073,TERMINATED,INTERVENTIONAL,Principal Investigator is taking appointment with another institution.
NCT03219164,TERMINATED,INTERVENTIONAL,Study was terminated early by sponsor due to the challenges and risks introduced by Coronavirus disease 2019 (COVID-19) pandemic.
NCT03219372,TERMINATED,INTERVENTIONAL,Study discontinued due to low accrual.
NCT03219567,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03219736,WITHDRAWN,INTERVENTIONAL,PI could not get support for project. PI left UAMS
NCT03219866,TERMINATED,INTERVENTIONAL,Lower enrollment than Sponsor expected - Sponsor stopped study
NCT03219918,TERMINATED,INTERVENTIONAL,Practically difficult to inroll the number of patients anticipated
NCT03220009,WITHDRAWN,INTERVENTIONAL,The study was never approved by CTEP neither was it ever activated
NCT03220100,TERMINATED,INTERVENTIONAL,Received funding for larger randomized study so terminated pilot study
NCT03220178,TERMINATED,INTERVENTIONAL,"Due to COVID-19 pandemic, study cannot be finished in planned timeframe."
NCT03220282,SUSPENDED,INTERVENTIONAL,Difficulty enrolling due to COVID-related restrictions.
NCT03220399,WITHDRAWN,INTERVENTIONAL,Decided to stop drug development
NCT03220438,TERMINATED,INTERVENTIONAL,Principal Investigator took another position elsewhere
NCT03220711,TERMINATED,INTERVENTIONAL,Study terminated due to equipment breakage and lack of funding.
NCT03220867,WITHDRAWN,INTERVENTIONAL,"CFDA announced Xi'An Risperdal as reference drug, no need for this BE trial from both scientific and ethical perspective."
NCT03221166,TERMINATED,INTERVENTIONAL,Difficulty in recruiting subjects who meet the inclusion/exclusion criteria
NCT03221582,TERMINATED,INTERVENTIONAL,Site unable to recruit the agreed upon number of participants
NCT03221634,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT03221751,TERMINATED,INTERVENTIONAL,staffing issues and COVID
NCT03221842,TERMINATED,INTERVENTIONAL,The study was terminated early due to futility of enrolment and not for safety reasons.
NCT03222089,WITHDRAWN,INTERVENTIONAL,Another study enrolling the similar group of patient are ongoing
NCT03222401,TERMINATED,INTERVENTIONAL,"Interim analysis suggested that the trial, as designed, was not adequately powered to detect a therapeutic effect."
NCT03222414,TERMINATED,INTERVENTIONAL,Changes in standard of care have altered the feasibility of the study.
NCT03222622,TERMINATED,INTERVENTIONAL,The efficacy failed to meet the primary efficacy endpoint
NCT03222752,TERMINATED,INTERVENTIONAL,Participant recruitment insufficient to complete study
NCT03222804,WITHDRAWN,INTERVENTIONAL,Withdrawn due to loss of funding
NCT03222908,TERMINATED,INTERVENTIONAL,Slow enrollment and lack of interest
NCT03222921,TERMINATED,OBSERVATIONAL,"Technical issues, COVID-19"
NCT03222973,TERMINATED,INTERVENTIONAL,The top-line results from the Part 1 did not meet the pre-specified primary endpoint nor the key secondary endpoints. The decision to discontinue study 215MS202 Part 2 was not based on safety concerns.
NCT03223194,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03223662,TERMINATED,INTERVENTIONAL,Principal Investigator left the NIH.
NCT03223701,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to contracting issues
NCT03224182,TERMINATED,INTERVENTIONAL,Suspended development
NCT03224208,TERMINATED,INTERVENTIONAL,low enrolment rate
NCT03224559,WITHDRAWN,OBSERVATIONAL,Enrollment never began.
NCT03224585,TERMINATED,INTERVENTIONAL,Study was terminated because dramatic benefits seen during the first 24 hours of drug administration combined with COVID restrictions on research activities suggested it was both unethical and unnecessary to complete the planned enrollment
NCT03224715,WITHDRAWN,INTERVENTIONAL,Project was withdrawn and never began at Loyola University Medical Center.
NCT03224754,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT03224819,TERMINATED,INTERVENTIONAL,Priortization of other Programs
NCT03224923,TERMINATED,INTERVENTIONAL,Competing study to be started in November 2018
NCT03224975,TERMINATED,INTERVENTIONAL,failure to recruit
NCT03225079,TERMINATED,OBSERVATIONAL,Insufficient recruiting
NCT03225092,WITHDRAWN,INTERVENTIONAL,Unable to recruit enough study participants
NCT03225105,TERMINATED,INTERVENTIONAL,The study was terminated early per sponsor decision to halt further development of M3541 due to pharmaceutical and PK/pharmacodynamics properties that precluded further clinical development.
NCT03225287,TERMINATED,INTERVENTIONAL,"After careful consideration, UCB has decided to no longer pursue PNH as a potential indication for zilucoplan."
NCT03225781,TERMINATED,INTERVENTIONAL,Logistic reasons
NCT03225833,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT03225846,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03225924,TERMINATED,INTERVENTIONAL,Stop of drug development
NCT03226054,TERMINATED,INTERVENTIONAL,Not logistically feasible to continue enrolling patients.
NCT03226080,WITHDRAWN,INTERVENTIONAL,Study terminated with IRB on 20Feb2019 due to lack of enrollment.
NCT03226197,SUSPENDED,INTERVENTIONAL,Change in local policy affected feasibility of patient recruitment
NCT03226236,WITHDRAWN,INTERVENTIONAL,No patients enrolled due to change in standard practice
NCT03226899,TERMINATED,INTERVENTIONAL,"This action was a business decision \& not related to any efficacy, safety or clinical concerns with lesinurad."
NCT03227185,TERMINATED,INTERVENTIONAL,No patients populations included ==\> could not be recruited in meaningful numbers to allow conclusions.
NCT03227393,WITHDRAWN,INTERVENTIONAL,Study was not opened at site.
NCT03227432,WITHDRAWN,INTERVENTIONAL,Withdrawn before enrollment due to issues around the FDA hold on PD-1/PD-L1 drugs in combination with IMIDs.
NCT03227562,TERMINATED,INTERVENTIONAL,not enough patient
NCT03227627,WITHDRAWN,INTERVENTIONAL,We decided to go to another direction.
NCT03227744,TERMINATED,INTERVENTIONAL,Study has been terminated
NCT03227822,TERMINATED,INTERVENTIONAL,Unable to include the number of patients
NCT03228043,WITHDRAWN,INTERVENTIONAL,It's not possible to complete in our hospital.
NCT03228121,WITHDRAWN,INTERVENTIONAL,Enrollment did not meet expectations
NCT03228186,TERMINATED,INTERVENTIONAL,Pharmaceutical company discontinued the study drug.
NCT03228576,TERMINATED,OBSERVATIONAL,No recruitment
NCT03228602,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT03228654,TERMINATED,INTERVENTIONAL,No available device in the hospital to complete study
NCT03228940,WITHDRAWN,INTERVENTIONAL,Changed development priorities
NCT03228953,TERMINATED,INTERVENTIONAL,Investigator retired.
NCT03229031,SUSPENDED,INTERVENTIONAL,low recruitment rate
NCT03229382,TERMINATED,INTERVENTIONAL,Very slow recruitment due to lack of relapse in the observed group of patients
NCT03229421,WITHDRAWN,OBSERVATIONAL,Unable to enroll eligible participants
NCT03229811,TERMINATED,INTERVENTIONAL,The PI left academic practice
NCT03229850,SUSPENDED,INTERVENTIONAL,Study was suspended due to current COVID 19 research curtailment
NCT03229876,SUSPENDED,INTERVENTIONAL,Sponsor decision
NCT03230097,TERMINATED,INTERVENTIONAL,disruption due to COVID-19
NCT03230266,TERMINATED,INTERVENTIONAL,Inclusion of the last patient
NCT03230279,WITHDRAWN,INTERVENTIONAL,"Was not financed, Sponsor withdrawn"
NCT03230370,WITHDRAWN,INTERVENTIONAL,No adequate funding
NCT03230669,TERMINATED,INTERVENTIONAL,Recruitment and data collection issues
NCT03230773,WITHDRAWN,INTERVENTIONAL,Postponed
NCT03230864,TERMINATED,INTERVENTIONAL,New data; the study was terminated based on new efficacy data from another study
NCT03231046,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03231228,TERMINATED,INTERVENTIONAL,Stopped with agreement from FDA.
NCT03231397,TERMINATED,INTERVENTIONAL,We were unable to recruit more subjects who met the inclusion/exclusion criteria and we have closed the study.
NCT03231475,WITHDRAWN,INTERVENTIONAL,Board decision
NCT03231527,WITHDRAWN,OBSERVATIONAL,research group's decision
NCT03232021,WITHDRAWN,INTERVENTIONAL,All patients during the study period were subjected to peripheral blocks or were excluded from the study due to exclusion criteria
NCT03232307,WITHDRAWN,INTERVENTIONAL,Sponsor does not wish to proceed
NCT03232385,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03232450,WITHDRAWN,INTERVENTIONAL,No funding or enrollment
NCT03232580,TERMINATED,INTERVENTIONAL,Sponsor Decision based on strategic considerations.
NCT03232632,TERMINATED,INTERVENTIONAL,intervention programming
NCT03232749,TERMINATED,INTERVENTIONAL,The physician in charge is leaving the University of Florida
NCT03232814,WITHDRAWN,INTERVENTIONAL,No participants were recruited due to a lack of referrals.
NCT03232892,TERMINATED,INTERVENTIONAL,Low Accrual
NCT03233074,TERMINATED,OBSERVATIONAL,Achievement of scientific objectives
NCT03233724,TERMINATED,INTERVENTIONAL,Study terminated due to drug supply issues.
NCT03233828,TERMINATED,INTERVENTIONAL,Low enrollment numbers.
NCT03234153,TERMINATED,INTERVENTIONAL,low accrual
NCT03234192,TERMINATED,INTERVENTIONAL,Recruiting was halted due to methodology issues
NCT03234309,WITHDRAWN,INTERVENTIONAL,No enrollments
NCT03234387,TERMINATED,OBSERVATIONAL,Poor recruitment
NCT03234465,TERMINATED,INTERVENTIONAL,"No efficacy could be demonstrated, sponsor decided to prematurely end the study."
NCT03234634,TERMINATED,INTERVENTIONAL,"As the guideline for the acute stroke endovascular treatment of the AHA/ASA was changed, DSMB recommended an end to the study."
NCT03234842,WITHDRAWN,INTERVENTIONAL,non-accrual
NCT03235180,TERMINATED,INTERVENTIONAL,Unable to secure funding.
NCT03235492,WITHDRAWN,INTERVENTIONAL,The study team did not receive the necessary study equipment from our international partners.
NCT03235869,WITHDRAWN,INTERVENTIONAL,The company pulled durvalumab from heme malignancies
NCT03235934,WITHDRAWN,OBSERVATIONAL,Logistical Issues
NCT03235986,TERMINATED,INTERVENTIONAL,Change in the benefit-risk balance
NCT03236090,WITHDRAWN,INTERVENTIONAL,Problems to recruit patients due to exclusion criteria
NCT03236181,TERMINATED,INTERVENTIONAL,PI is retiring from Center. Research will not continue with a new PI.
NCT03236285,WITHDRAWN,INTERVENTIONAL,Facilities for the exercise training program were not available for the study.
NCT03236311,TERMINATED,INTERVENTIONAL,(Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.)
NCT03236415,WITHDRAWN,INTERVENTIONAL,"Global sales of the Absorb BVS halted effective September 14, 2017."
NCT03236558,WITHDRAWN,INTERVENTIONAL,lack of Financial support
NCT03236649,TERMINATED,INTERVENTIONAL,Because the clinical development plan has been changed.
NCT03236766,WITHDRAWN,INTERVENTIONAL,No intervention or clinical trial necessitating participants ultimately needed or required for this study.
NCT03236805,TERMINATED,INTERVENTIONAL,285 patients have recruited instead on 496 but we don't want to continue to prolonge the study. Analysis will be performed on the data we have.
NCT03237143,TERMINATED,OBSERVATIONAL,The research question was resolved in a metanalysis
NCT03237182,TERMINATED,INTERVENTIONAL,WHO 2022 guidelines for DR-TB treatment are set to change. These guidelines recommend the use of an all-oral short course BPAL regimen.Therefore ongoing implementation of the study is considered futile.
NCT03237260,WITHDRAWN,INTERVENTIONAL,No patient accrual
NCT03237572,TERMINATED,INTERVENTIONAL,Low rate of enrollment
NCT03237611,TERMINATED,INTERVENTIONAL,Expired IRB approval on 2/11/21
NCT03237754,TERMINATED,INTERVENTIONAL,Recruitment problems (especially for chronic migraine patients)
NCT03237767,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT03237897,WITHDRAWN,OBSERVATIONAL,Study withdrawn due to staff unavailability and limited resources
NCT03237910,TERMINATED,INTERVENTIONAL,low rate recruitment
NCT03238157,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03238469,TERMINATED,INTERVENTIONAL,Negative clinical outcomes
NCT03238638,WITHDRAWN,INTERVENTIONAL,PI did not attempt to open the study.
NCT03238651,TERMINATED,INTERVENTIONAL,Termination of the study by the sponsor due to business decision.
NCT03238664,WITHDRAWN,INTERVENTIONAL,No funding
NCT03238703,WITHDRAWN,INTERVENTIONAL,"Administrative closure based on sponsor recommendation, prior to subject enrollment"
NCT03238716,TERMINATED,INTERVENTIONAL,Inability to recruit an adequate number of patients with stress urinary incontinence (based on inclusion / exclusion criteria) to participate in the study
NCT03238937,WITHDRAWN,INTERVENTIONAL,No eligible subjects were identified.
NCT03238950,WITHDRAWN,INTERVENTIONAL,This study has never actually started as waiting on funding
NCT03239054,WITHDRAWN,INTERVENTIONAL,IRB issues
NCT03239197,WITHDRAWN,OBSERVATIONAL,Sponsor request
NCT03239236,WITHDRAWN,INTERVENTIONAL,no funding available
NCT03239418,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03239470,TERMINATED,INTERVENTIONAL,"Lack of recruitment, ongoing and new feasibility issues, and the impact of the coronavirus infectious disease 19 (COVID-19) pandemic"
NCT03239587,WITHDRAWN,OBSERVATIONAL,No participants
NCT03239600,WITHDRAWN,INTERVENTIONAL,The study is stopped for Portfolio prioritization.
NCT03239860,TERMINATED,INTERVENTIONAL,"Based on R\&D strategic reasons, our co-development Partner financing the study disengaged from the development of GNbAC1."
NCT03239951,TERMINATED,INTERVENTIONAL,Due to the COVID-19 outbreak and the overall low recruitment
NCT03240003,SUSPENDED,INTERVENTIONAL,funding unavailable
NCT03240068,TERMINATED,INTERVENTIONAL,Study funding ended prior to completion.
NCT03240393,WITHDRAWN,INTERVENTIONAL,Company Decision
NCT03240523,TERMINATED,INTERVENTIONAL,"Due to a change in the development program, the study was closed prematurely."
NCT03240614,TERMINATED,INTERVENTIONAL,Pandemic and loss of funding
NCT03240679,TERMINATED,INTERVENTIONAL,Difficulty obtaining investigational product and study support.
NCT03240822,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03240861,TERMINATED,INTERVENTIONAL,slow accrual
NCT03241004,TERMINATED,INTERVENTIONAL,change in study staffing
NCT03241017,WITHDRAWN,INTERVENTIONAL,Celgene withdrew the support for this study (Durvalumab cannot be provided)
NCT03241056,TERMINATED,INTERVENTIONAL,Funding used up; recruitment slow.
NCT03241147,TERMINATED,INTERVENTIONAL,New data; the study was terminated based on new efficacy data
NCT03241238,TERMINATED,INTERVENTIONAL,No effect was found
NCT03241446,WITHDRAWN,INTERVENTIONAL,This study was combined with another trial that was on-going.
NCT03241667,WITHDRAWN,OBSERVATIONAL,IRB application withdrawn
NCT03241719,TERMINATED,INTERVENTIONAL,"No participants are currently receiving therapy under this protocol, funding is coming to an end and the PI is leaving the institution."
NCT03241810,TERMINATED,INTERVENTIONAL,Merrimack Inc. terminated the trial early due to business decision
NCT03241836,WITHDRAWN,OBSERVATIONAL,3Dtransvaginal probe is not available at this time
NCT03241927,TERMINATED,INTERVENTIONAL,difficult enrollment
NCT03242005,WITHDRAWN,INTERVENTIONAL,Sponsor decision to not proceed with study - no subjects enrolled
NCT03242265,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03242434,TERMINATED,INTERVENTIONAL,"This trial was supporting the development of an asset which was terminated, thus the data from the study were no longer required."
NCT03242720,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT03242772,TERMINATED,INTERVENTIONAL,The study stopped recruitment of new participants due to COVID. A substudy was developed with adaptations to the main design.
NCT03242967,WITHDRAWN,INTERVENTIONAL,Revised study design.
NCT03243032,WITHDRAWN,INTERVENTIONAL,IRB requirements to start study could not be met in a timely manner
NCT03243058,WITHDRAWN,INTERVENTIONAL,Funding withdrawal and COVID-19 environment.
NCT03243149,WITHDRAWN,INTERVENTIONAL,Insufficient staff and equipment challenges
NCT03243201,WITHDRAWN,INTERVENTIONAL,IND not approved
NCT03243513,TERMINATED,OBSERVATIONAL,PI has confirmed that this is not a clinical trial and was entered in error in the system.
NCT03243760,TERMINATED,INTERVENTIONAL,The trial is terminated before investigation of repeat escalating doses as these will be conducted with the new formulation instead.
NCT03244358,TERMINATED,INTERVENTIONAL,Difficulty accruing subjects the study accrual was closed
NCT03244592,WITHDRAWN,INTERVENTIONAL,Investigator left institution prior to enrollment of study participants
NCT03244683,TERMINATED,INTERVENTIONAL,Closed due to low enrollment
NCT03244852,WITHDRAWN,OBSERVATIONAL,Data was analyzed from a previously collected dataset so no new participants were enrolled.
NCT03244969,WITHDRAWN,OBSERVATIONAL,Study was registered in another clinicaltrials.gov entry
NCT03244982,SUSPENDED,INTERVENTIONAL,Additional data may be required once preliminary data is analyzed.
NCT03245177,WITHDRAWN,INTERVENTIONAL,Funding withdrawn.
NCT03245320,TERMINATED,OBSERVATIONAL,"Terminated by the Sponsor. Decision not due to adverse events, complications, or device issues."
NCT03245385,TERMINATED,INTERVENTIONAL,Sponsors decision
NCT03245619,TERMINATED,INTERVENTIONAL,The study was terminated as relationship between GSK3335065 and ventricular tachycardia could not be excluded.
NCT03245658,WITHDRAWN,INTERVENTIONAL,Organization was changed. The staff was relocated.
NCT03245671,WITHDRAWN,INTERVENTIONAL,Unable to address regulatory concerns.
NCT03245827,TERMINATED,INTERVENTIONAL,not enough recruitment
NCT03245840,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03245970,WITHDRAWN,INTERVENTIONAL,Investigator retired. Other investigators did not want to continue study.
NCT03246113,TERMINATED,INTERVENTIONAL,Lack of subject interest due to study design
NCT03246243,TERMINATED,OBSERVATIONAL,Difficulties in recruitment.
NCT03246282,SUSPENDED,INTERVENTIONAL,Lack of Funding
NCT03246399,TERMINATED,INTERVENTIONAL,"Study stopped due to business reasons, following full enrollment of the first dose cohort."
NCT03246568,TERMINATED,INTERVENTIONAL,no funding to purchase study device
NCT03246620,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to difficulties in patient recruitment and associated potential for selection bias.
NCT03246685,TERMINATED,INTERVENTIONAL,"Due to enrollment challenges resulting in changing treatment patterns, the study has been terminated. No patients remain on study."
NCT03246854,TERMINATED,INTERVENTIONAL,No more funding
NCT03246919,TERMINATED,INTERVENTIONAL,PI left Loyola and Sub-I graduated.
NCT03247023,TERMINATED,OBSERVATIONAL,Sponsor decision not related to safety
NCT03247205,WITHDRAWN,INTERVENTIONAL,Funding ran out and no subjects recruited.
NCT03247231,TERMINATED,OBSERVATIONAL,Due to SARS-CoV2 (Covid-19) pandemia
NCT03247244,TERMINATED,INTERVENTIONAL,Recruitment/enrollment took too long
NCT03247413,TERMINATED,INTERVENTIONAL,Study has been halted prematurely
NCT03247465,WITHDRAWN,INTERVENTIONAL,"The deadlines of the ethics committee being very long, the investigator finally wished not to carry out the project."
NCT03247907,TERMINATED,INTERVENTIONAL,Trial was terminated by investigators due to equipment difficulties
NCT03247972,TERMINATED,OBSERVATIONAL,Research group transferred to another hospital
NCT03248141,TERMINATED,OBSERVATIONAL,"Study recruitment was stopped due to difficulty in enrolling the targeted number of patients on March 21, 2018. See details in Description section."
NCT03248154,WITHDRAWN,INTERVENTIONAL,did not receive funding
NCT03248271,WITHDRAWN,OBSERVATIONAL,"Study design was changed to the study was changed to Insulin, hypotension and sarcopenia."
NCT03248479,TERMINATED,INTERVENTIONAL,This study has been discontinued due to futility based on the results of a planned analysis of the ENHANCE trial.
NCT03248596,TERMINATED,OBSERVATIONAL,Obsolete study
NCT03248674,TERMINATED,OBSERVATIONAL,Difficulty with recruitment in this patient population.
NCT03248713,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03248739,TERMINATED,INTERVENTIONAL,Preliminary data did not show a difference. PI decided to terminate study.
NCT03248765,TERMINATED,OBSERVATIONAL,Insufficient patient enrollment.
NCT03249129,WITHDRAWN,OBSERVATIONAL,sponsor decision
NCT03249220,SUSPENDED,INTERVENTIONAL,Administrative reasons
NCT03249272,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding
NCT03249675,WITHDRAWN,OBSERVATIONAL,No participant were enrolled
NCT03249727,TERMINATED,INTERVENTIONAL,Recruiting issues
NCT03249844,WITHDRAWN,INTERVENTIONAL,discontinuation of the trial
NCT03249922,TERMINATED,OBSERVATIONAL,Inadequate enrollment
NCT03250117,TERMINATED,INTERVENTIONAL,This study was terminated for reasons not related to efficacy or safety
NCT03250169,TERMINATED,OBSERVATIONAL,Under recruitment
NCT03250195,TERMINATED,INTERVENTIONAL,Insufficient inclusion of patients
NCT03250299,TERMINATED,INTERVENTIONAL,Due to the National Cancer Institute's (NCI)-mandated termination of the Adult Brain Tumor Consortium which was conducting the study
NCT03250312,TERMINATED,INTERVENTIONAL,Study Partner Left. Samples degraded before analysis.
NCT03250468,TERMINATED,INTERVENTIONAL,Poor follow/up rates and data.
NCT03250689,TERMINATED,INTERVENTIONAL,Study terminated due to a change in the benefit-risk profile for danirixin in COPD.
NCT03250767,TERMINATED,OBSERVATIONAL,"Sponsor decision not due to adverse events, complications, or device issues."
NCT03251326,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT03251417,TERMINATED,INTERVENTIONAL,"Because PD-1 antibodies had been proved to be a standard second-line treatment in esophageal cancer, the potential benefit of present intervention is under re-evaluation."
NCT03251586,WITHDRAWN,INTERVENTIONAL,"Due to time constraints, the study will not be able to be completed as outlined"
NCT03251872,TERMINATED,INTERVENTIONAL,OPTION pilot trial merged with the new NCT03782818 - OPTION multicenter trial
NCT03251911,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03251924,TERMINATED,INTERVENTIONAL,Study CA021-002 was terminated because the Sponsor discontinued further development of BMS-986226 due to a change in business objectives. The decision for the study closure was not related to any safety concerns associated with BMS-986226.
NCT03251989,SUSPENDED,OBSERVATIONAL,Strategic planning for the types of tumors is being done. Temp hold until AM is submitted.
NCT03252093,SUSPENDED,INTERVENTIONAL,Due to funding
NCT03252119,TERMINATED,INTERVENTIONAL,High flow oxygen therapy became available as standard care
NCT03252171,WITHDRAWN,INTERVENTIONAL,Project terminated due to revision of local regulations
NCT03252561,WITHDRAWN,INTERVENTIONAL,Study no longer feasible
NCT03252691,WITHDRAWN,OBSERVATIONAL,Site closure and no patient enrolled
NCT03252834,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT03253029,WITHDRAWN,INTERVENTIONAL,Withdrawal of institutional support
NCT03253185,TERMINATED,INTERVENTIONAL,Benefit/Risk Imbalance
NCT03253224,TERMINATED,INTERVENTIONAL,"Because the principle investigator will participate a visiting scholar program for one year in other country, this study has been terminated."
NCT03253328,SUSPENDED,INTERVENTIONAL,No one is currently receiving treatment and enrollment is of course on hold. Subjects being unblinded to perform interim analysis.
NCT03253419,WITHDRAWN,INTERVENTIONAL,Change in staffing and not able to do study
NCT03253471,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue further development of investigational compounds for the treatment of hepatitis C.
NCT03253523,WITHDRAWN,INTERVENTIONAL,Patients did not want to take part in the experimental arm of the study as all have opted for the current standard of care procedure.
NCT03253575,SUSPENDED,OBSERVATIONAL,"Mitra is temporarily suspending enrollment in the ANCERS-2 clinical utility study due to unexpected test performance results, to analyze the test performance."
NCT03253718,WITHDRAWN,OBSERVATIONAL,"Study withdrawn due to limited personnel, time, resources."
NCT03253731,WITHDRAWN,OBSERVATIONAL,Investigator left the NIH.
NCT03253809,TERMINATED,INTERVENTIONAL,Issue with trial administration/conduct
NCT03253991,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03254017,TERMINATED,INTERVENTIONAL,logistics reasons
NCT03254160,TERMINATED,INTERVENTIONAL,Administrative
NCT03254186,WITHDRAWN,INTERVENTIONAL,No participants
NCT03254199,TERMINATED,INTERVENTIONAL,Sponsor
NCT03254264,TERMINATED,INTERVENTIONAL,one inclusion and not others
NCT03254342,TERMINATED,OBSERVATIONAL,Unable to obtain a reliable MRS signal
NCT03254680,WITHDRAWN,INTERVENTIONAL,Funding
NCT03254732,TERMINATED,INTERVENTIONAL,Changing Corporate Priorities
NCT03254862,TERMINATED,INTERVENTIONAL,Initial difficulties recruiting + main researcher had to withdraw from the study
NCT03254927,TERMINATED,INTERVENTIONAL,Sponsor decision based on emerging risk-benefit profile
NCT03255057,TERMINATED,INTERVENTIONAL,Lack of enrollment post COVID-19 pandemic
NCT03255083,TERMINATED,INTERVENTIONAL,This study was terminated based on a business decision by the Sponsor.
NCT03255330,WITHDRAWN,INTERVENTIONAL,no participant enrolled
NCT03255681,WITHDRAWN,INTERVENTIONAL,USAF Regulatory Concerns
NCT03255798,TERMINATED,INTERVENTIONAL,Business decision
NCT03255889,WITHDRAWN,INTERVENTIONAL,Expiry of grant funding
NCT03256045,TERMINATED,INTERVENTIONAL,Terminated due to loss of funding and former PI left the institution
NCT03256149,WITHDRAWN,INTERVENTIONAL,Not enough patients recruted
NCT03256318,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT03256331,TERMINATED,INTERVENTIONAL,In the light of the on-going COVID-19 pandemic and the resulted difficulty in patient recruitment.
NCT03256617,TERMINATED,INTERVENTIONAL,"Recruiting beyond September 10, 2018 would mean that the training occurred more than a year in the past. For this reason, we terminated recruitment."
NCT03256630,TERMINATED,OBSERVATIONAL,Business decision to discontinue development of the IsoPSA assay.
NCT03256721,TERMINATED,INTERVENTIONAL,Due to the enrollment was slow and exceeded the expected enrollment time
NCT03257215,SUSPENDED,INTERVENTIONAL,Recruitment very slow \& funding difficult - exacerbated by COVID-19 pandemic
NCT03257332,WITHDRAWN,OBSERVATIONAL,Not possible to include participants
NCT03257540,TERMINATED,OBSERVATIONAL,Low enrollment
NCT03257592,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03257683,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT03257722,TERMINATED,INTERVENTIONAL,The study was terminated due to poor accrual.
NCT03258008,TERMINATED,INTERVENTIONAL,Closed the trial for infeasibility due to slow accrual
NCT03258060,TERMINATED,INTERVENTIONAL,release of other trial indicating futility of this study after recruitment of 1 patient
NCT03258112,WITHDRAWN,INTERVENTIONAL,I have changed my center and gone to another center
NCT03258281,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03258476,WITHDRAWN,INTERVENTIONAL,Contract terminated
NCT03258541,TERMINATED,INTERVENTIONAL,Surgical access not facilitated- residues of hydrogel.
NCT03258723,TERMINATED,INTERVENTIONAL,COVID-19 led to changes in study design and an early end to data collection.
NCT03258801,WITHDRAWN,OBSERVATIONAL,Clinical evaluation plan outdated and obsolete due to altered clinical routine
NCT03258814,TERMINATED,OBSERVATIONAL,Low or No Enrollment
NCT03259165,TERMINATED,INTERVENTIONAL,"COVID-19 pandemic. Initially had planned to resume study, but ultimately decided to close."
NCT03259178,TERMINATED,OBSERVATIONAL,We were unable to recruit patients because the clinician doing the testing was no longer available between Sep 15 2017 and Mar 1 2018.
NCT03259308,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for inflammatory bowel diseases (IBD) early.
NCT03259334,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for inflammatory bowel diseases (IBD) early.
NCT03259386,TERMINATED,OBSERVATIONAL,"Problem with obtaining microarrays, which are essential components needed to conduct this study."
NCT03259425,TERMINATED,INTERVENTIONAL,DSMC Recommendation
NCT03259451,WITHDRAWN,OBSERVATIONAL,No recruitment
NCT03259516,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT03259568,TERMINATED,INTERVENTIONAL,Slow enrollment due to Covid-19.
NCT03259659,TERMINATED,OBSERVATIONAL,Principal Investigator was leaving the institution.
NCT03259893,TERMINATED,INTERVENTIONAL,"Initially suspended due to COVID-19 policies, it will not be possible to restart."
NCT03259906,TERMINATED,INTERVENTIONAL,Lack of performance
NCT03259932,WITHDRAWN,INTERVENTIONAL,The study could not be set up due to recruitment and feasibility problems
NCT03260335,WITHDRAWN,INTERVENTIONAL,Favourable ethical opinion not obtained
NCT03260413,WITHDRAWN,OBSERVATIONAL,Could not get IRB approval
NCT03260504,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT03260699,TERMINATED,INTERVENTIONAL,"Study terminated per Ongoing Care Solutions, Inc."
NCT03260868,TERMINATED,INTERVENTIONAL,"Due to ""prolonged low participant recruitment"""
NCT03260972,WITHDRAWN,INTERVENTIONAL,Withdrawn by IRB
NCT03261180,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT03261219,WITHDRAWN,INTERVENTIONAL,Not renewed with IRB
NCT03261323,WITHDRAWN,INTERVENTIONAL,insufficient staff
NCT03261336,TERMINATED,INTERVENTIONAL,can not meet enrollment
NCT03261388,TERMINATED,OBSERVATIONAL,Change in subject population/ABLE POWER program
NCT03261479,TERMINATED,OBSERVATIONAL,Research stopped after lab-based data using mouse model did not support use of technology.
NCT03261531,TERMINATED,INTERVENTIONAL,Device failure
NCT03261596,WITHDRAWN,INTERVENTIONAL,"In light of new evidence, the decision was made by the sponsor to not proceed."
NCT03261726,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled.
NCT03261817,TERMINATED,INTERVENTIONAL,No financial support
NCT03262038,TERMINATED,INTERVENTIONAL,Interim analysis showed no difference between groups
NCT03262064,TERMINATED,OBSERVATIONAL,Changing of specialty
NCT03262116,TERMINATED,INTERVENTIONAL,Devices are not available
NCT03262142,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03262194,TERMINATED,OBSERVATIONAL,The introduction of new recommendations for early neonatal infection has drastically reduced the need for gastric aspiration at birth.
NCT03262571,TERMINATED,INTERVENTIONAL,Because at the interim analysis the pre-specified stopping boundary for an overwhelming benefit had been crossed.
NCT03262701,TERMINATED,INTERVENTIONAL,COVID
NCT03263000,TERMINATED,OBSERVATIONAL,Protocol could not be carried out to achieve the aims of the study
NCT03263091,TERMINATED,INTERVENTIONAL,Study did not meet its primary efficacy endpoint.
NCT03263390,TERMINATED,OBSERVATIONAL,Study terminated by study partners
NCT03263533,WITHDRAWN,INTERVENTIONAL,PIs were unable to recruit any participants
NCT03263767,TERMINATED,INTERVENTIONAL,Security criteria (MTD)
NCT03263806,TERMINATED,INTERVENTIONAL,Terminated due to lack of enrollment
NCT03263897,TERMINATED,INTERVENTIONAL,Manufacturer's decision
NCT03264040,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT03264092,TERMINATED,INTERVENTIONAL,Preliminary analysis of the results showed no statistically significant difference
NCT03264274,WITHDRAWN,INTERVENTIONAL,Funding restrictions - study never opened to recruitment
NCT03264326,TERMINATED,INTERVENTIONAL,Principal Investigator left institution and not enough resources to support at MTF
NCT03264742,TERMINATED,OBSERVATIONAL,recruitment too low
NCT03264820,TERMINATED,INTERVENTIONAL,investigator decision
NCT03265080,TERMINATED,INTERVENTIONAL,Business decision
NCT03265132,TERMINATED,INTERVENTIONAL,Meeting enrolment target (81 pat) will not be feasible within reasonable time.
NCT03265249,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03265301,WITHDRAWN,INTERVENTIONAL,The randomization could not be done
NCT03265496,TERMINATED,INTERVENTIONAL,The number of recruted patient was not sufficient
NCT03265717,TERMINATED,INTERVENTIONAL,sponsor decision
NCT03265951,WITHDRAWN,INTERVENTIONAL,Lack of response
NCT03265977,WITHDRAWN,INTERVENTIONAL,"Design, sponsorship changed prior to initiation. No study procedures done."
NCT03266081,WITHDRAWN,INTERVENTIONAL,No patients
NCT03266159,WITHDRAWN,INTERVENTIONAL,Study withdrawn before active to fully evaluate impact of changing practice in target population.
NCT03266562,WITHDRAWN,INTERVENTIONAL,unable to recruit patients due to competing studies
NCT03266692,TERMINATED,INTERVENTIONAL,Business reasons
NCT03266900,TERMINATED,INTERVENTIONAL,Difficulties with accrual
NCT03266991,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT03267108,TERMINATED,INTERVENTIONAL,"The trial did not meet its primary endpoint, hence was terminated due to futility."
NCT03267199,WITHDRAWN,OBSERVATIONAL,Another study was done instead
NCT03267251,WITHDRAWN,INTERVENTIONAL,Parallel record under the prime awardee (Klein Buendel)
NCT03267368,TERMINATED,INTERVENTIONAL,Low enrollment. 1 pt. enrolled \& withdrew at 6 wk follow-up. No further enrollment
NCT03267550,WITHDRAWN,INTERVENTIONAL,The sponsor terminated industrial support
NCT03267628,WITHDRAWN,INTERVENTIONAL,We at the Sunshine Coast University Hospital are unable to cope with the extra effort/time needed to complete this trial properly.
NCT03267810,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT03267836,TERMINATED,INTERVENTIONAL,Study sponsor wanted to terminate enrollment.
NCT03267940,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03267992,TERMINATED,OBSERVATIONAL,Study enrollment was prematurely stopped for business reasons.
NCT03268278,TERMINATED,INTERVENTIONAL,Loss of interest
NCT03268304,WITHDRAWN,OBSERVATIONAL,The software modules were not completed.
NCT03268694,TERMINATED,INTERVENTIONAL,Competition with other ongoing projects with this population.
NCT03269318,TERMINATED,INTERVENTIONAL,Change to Primary Endpoint resulted in development of new protocol
NCT03269383,WITHDRAWN,INTERVENTIONAL,Lack of funding and other logistical issues
NCT03269409,TERMINATED,INTERVENTIONAL,Logistical delays from device manufacturer due to COVID
NCT03269552,TERMINATED,INTERVENTIONAL,Terminated due to low accrual.
NCT03269695,TERMINATED,INTERVENTIONAL,The Sponsor changed R\&D strategy and priority.
NCT03269968,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT03270189,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT03270202,TERMINATED,INTERVENTIONAL,discontinuation of financial support
NCT03270709,TERMINATED,INTERVENTIONAL,Study terminated early due to lack of funding and the COVID-19 pandemic.
NCT03270722,WITHDRAWN,INTERVENTIONAL,We did not enroll any patients for logistic reasons.
NCT03271086,WITHDRAWN,INTERVENTIONAL,The study was never started.
NCT03271229,WITHDRAWN,INTERVENTIONAL,Funding
NCT03271580,TERMINATED,OBSERVATIONAL,Insufficient Staff
NCT03271645,WITHDRAWN,INTERVENTIONAL,logistics
NCT03271801,TERMINATED,INTERVENTIONAL,Recruitment Challenges
NCT03271814,WITHDRAWN,INTERVENTIONAL,PI moved to another institution before enrollment could start.
NCT03271853,SUSPENDED,OBSERVATIONAL,Trial temporarily halted to conduct additional device testing to verify cooling data. This temporary halt is NOT due to a potential risk to subject safety.
NCT03271970,WITHDRAWN,OBSERVATIONAL,PI no longer wishes to conduct the study. No participants were enrolled.
NCT03272087,TERMINATED,INTERVENTIONAL,Patient inclusion cannot be completed within time limits
NCT03272191,WITHDRAWN,INTERVENTIONAL,company dissolved
NCT03272217,TERMINATED,INTERVENTIONAL,Funder decision
NCT03272360,WITHDRAWN,OBSERVATIONAL,company decision to suspend project
NCT03272464,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03272555,TERMINATED,INTERVENTIONAL,"Failed study, participants showed no improvements"
NCT03272633,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03272659,WITHDRAWN,INTERVENTIONAL,"Long process and due to strict deadline, project was stopped."
NCT03272815,TERMINATED,INTERVENTIONAL,Device requires further modification
NCT03272971,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03273153,TERMINATED,INTERVENTIONAL,This study was terminated due to benefit/risk analysis.
NCT03273257,TERMINATED,INTERVENTIONAL,"The study was stopped due to slower than expected recruitment and the additional limitations on clinical research imposed by the COVID-19 pandemic, both of which made study completion within a reasonable timeframe appear unlikely."
NCT03273816,TERMINATED,INTERVENTIONAL,insufficient recruitment rate
NCT03273907,TERMINATED,INTERVENTIONAL,Voluntary market withdrawal
NCT03274323,WITHDRAWN,INTERVENTIONAL,Difficulty obtaining IDE by the FDA. Currently not worthwhile to pursue further.
NCT03274401,TERMINATED,INTERVENTIONAL,Due to Covid-19
NCT03274544,TERMINATED,INTERVENTIONAL,Difficulty in recruiting eligible patients
NCT03274778,WITHDRAWN,INTERVENTIONAL,Recruitment difficulty due to eligibility criteria.
NCT03274817,TERMINATED,INTERVENTIONAL,Insufficient Enrollment
NCT03274973,TERMINATED,OBSERVATIONAL,"Insufficient, delayed recruitment of participants"
NCT03274999,TERMINATED,INTERVENTIONAL,Based on interim review and decision to re-design the study.
NCT03275012,WITHDRAWN,INTERVENTIONAL,Study not started
NCT03275246,TERMINATED,INTERVENTIONAL,"The clinical study was stopped due to very low enrolment numbers. Due to the very slow enrolment, the goal of the study cannot be reached within a reasonable time frame."
NCT03275298,SUSPENDED,OBSERVATIONAL,enrolment temporariliy stopped for budget considerations
NCT03275376,TERMINATED,INTERVENTIONAL,Slow in patient enrollment
NCT03275402,TERMINATED,INTERVENTIONAL,Corporate business decision. Not due to safety or efficacy concerns.
NCT03275558,WITHDRAWN,INTERVENTIONAL,Study halted prior to enrollment of first participant. (It has been determined on 2018 May 15 that the NCT03275558 study will be stopped by sponsor decision)
NCT03275571,TERMINATED,INTERVENTIONAL,"Low recruitment rate, parent study has ended"
NCT03275597,TERMINATED,INTERVENTIONAL,slow accrual
NCT03275688,TERMINATED,OBSERVATIONAL,Interim analysis showed sample size sufficient for final analysis
NCT03275740,TERMINATED,INTERVENTIONAL,The Sponsor has decided to terminate the above referenced clinical study for business reasons. There were no safety concerns that led to this decision and there was no impact to participant safety.
NCT03275792,WITHDRAWN,INTERVENTIONAL,Funding not obtained.
NCT03275831,TERMINATED,INTERVENTIONAL,Business decision
NCT03276026,TERMINATED,INTERVENTIONAL,PI left the Institution.
NCT03276208,TERMINATED,INTERVENTIONAL,Terminated due to lack of enrollment.
NCT03276260,TERMINATED,OBSERVATIONAL,PI decided not to continue
NCT03276676,TERMINATED,INTERVENTIONAL,poor accrual and PI retired
NCT03276728,TERMINATED,INTERVENTIONAL,Terminated (Decision by the Sponsor. The study was not terminated due to a safety reason.)
NCT03276741,TERMINATED,INTERVENTIONAL,Unable to recruit to enrollment target
NCT03276754,TERMINATED,OBSERVATIONAL,The study was terminated prematurely due to the inability to recruit the planned number of subjects and the interim analysis indicated that the number of included patients did not allow draw any valid conclusion about the main objective of the study
NCT03276819,TERMINATED,INTERVENTIONAL,"Early termination of the study, since July 31, 2020 for insufficient recruitment"
NCT03277183,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03277209,TERMINATED,INTERVENTIONAL,terminated due to slow accrual
NCT03277222,TERMINATED,INTERVENTIONAL,Unable to find further eligible participants
NCT03277352,TERMINATED,INTERVENTIONAL,The study was terminated due to emergent data from another study and unrelated to safety.
NCT03277482,TERMINATED,INTERVENTIONAL,Expansion cohort was not open
NCT03277586,TERMINATED,INTERVENTIONAL,COVID-19
NCT03277612,TERMINATED,OBSERVATIONAL,Study halted prematurely and will not resume; participants are no longer being examined
NCT03277742,WITHDRAWN,INTERVENTIONAL,Due to safety reasons. The region was considered too dangerous.
NCT03277755,WITHDRAWN,INTERVENTIONAL,Development program of JNJ-4178 was discontinued.
NCT03277989,TERMINATED,OBSERVATIONAL,Business Decision
NCT03278236,TERMINATED,INTERVENTIONAL,Insufficient funding to complete pilot.
NCT03278353,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03278366,TERMINATED,INTERVENTIONAL,Suspended secondary to COVID-19 and decreased access to school setting
NCT03278626,TERMINATED,INTERVENTIONAL,The study was stopped earlier than anticipated due to slow accrual
NCT03278639,WITHDRAWN,INTERVENTIONAL,We could not fund the study
NCT03278704,TERMINATED,INTERVENTIONAL,Enrollment goal not met in allotted recruitment period
NCT03278808,WITHDRAWN,INTERVENTIONAL,The IND has been withdrawn from FDA
NCT03278912,WITHDRAWN,OBSERVATIONAL,Funding completed.
NCT03278938,WITHDRAWN,INTERVENTIONAL,PI Retired and no data was collected
NCT03278990,TERMINATED,INTERVENTIONAL,Did not meet recruitment goals
NCT03279029,SUSPENDED,INTERVENTIONAL,2 patients included only
NCT03279068,TERMINATED,OBSERVATIONAL,Civil unrest in region/country of study
NCT03279133,WITHDRAWN,INTERVENTIONAL,Unable to find eligible patients with untreated hepatitis C virus.
NCT03279718,TERMINATED,INTERVENTIONAL,Recruitment challenges due to COVID pandemic
NCT03279731,TERMINATED,INTERVENTIONAL,The study was not meeting recruitment goals.
NCT03279809,TERMINATED,INTERVENTIONAL,One grade 4 adverse event (AE) and common (47.2%) grade 3 AEs
NCT03279861,WITHDRAWN,INTERVENTIONAL,protocol change
NCT03280121,TERMINATED,INTERVENTIONAL,Slow enrollment and Covid-19
NCT03280199,WITHDRAWN,INTERVENTIONAL,Was not feasible
NCT03280277,TERMINATED,INTERVENTIONAL,low accrual
NCT03280342,WITHDRAWN,INTERVENTIONAL,Sponsor terminated study
NCT03280628,TERMINATED,INTERVENTIONAL,The COVID-19 pandemic made prospective enrollment no longer possible
NCT03280992,TERMINATED,OBSERVATIONAL,Study not feasible in practise
NCT03281044,TERMINATED,INTERVENTIONAL,"Although not observed in our patients (4 enrolled), SAEs have been reported in other patients receiving the same product."
NCT03281083,TERMINATED,INTERVENTIONAL,Difficult recruitment and end of funding.
NCT03281122,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT03281239,TERMINATED,INTERVENTIONAL,"Due to the difficulties of inclusion, it was decided not to extend this period"
NCT03281304,TERMINATED,INTERVENTIONAL,"The study terminated early due to business reasons, with the study already meeting its primary objective. The decision to terminate the trial was not based on any safety and/or efficacy concerns."
NCT03281681,WITHDRAWN,INTERVENTIONAL,Alternate study design for ovarian cancer under discussion
NCT03281694,WITHDRAWN,INTERVENTIONAL,Drug supplier did not come through.
NCT03281746,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03282084,WITHDRAWN,OBSERVATIONAL,insufficient funding
NCT03282188,WITHDRAWN,INTERVENTIONAL,Withdrawn by Sponsor
NCT03282292,WITHDRAWN,INTERVENTIONAL,Co-PI responsible for study procedures moved to another hospital
NCT03282669,WITHDRAWN,INTERVENTIONAL,Change in institutional policy. Change in resources available.
NCT03283033,TERMINATED,INTERVENTIONAL,"COVID-19 closed schools in March 2020. Data collection for all elementary schools was completed pre-pandemic. For middle and high schools, the marketing phase was halted. Results will solely reflect the salad bar intervention."
NCT03283046,WITHDRAWN,INTERVENTIONAL,Similar to another study.
NCT03283150,TERMINATED,INTERVENTIONAL,"Due to a decrease in scheduled study-eligible patients, we terminated the study prematurely"
NCT03283410,WITHDRAWN,INTERVENTIONAL,"Local problems with BIS monitor, we wont have it anymore."
NCT03283592,WITHDRAWN,INTERVENTIONAL,did not receive funding to conduct study
NCT03283631,TERMINATED,INTERVENTIONAL,We are halting enrollment of this study.
NCT03283709,TERMINATED,INTERVENTIONAL,Study terminated because PI left the institution.
NCT03283826,TERMINATED,INTERVENTIONAL,Study was terminated as primary endpoint was not achieved
NCT03283865,WITHDRAWN,INTERVENTIONAL,doesnt meet criteria for clinical trial reporting
NCT03284021,WITHDRAWN,INTERVENTIONAL,The study did not start.
NCT03284047,WITHDRAWN,INTERVENTIONAL,The study never started.
NCT03284060,TERMINATED,INTERVENTIONAL,inclusion difficulties
NCT03284099,TERMINATED,INTERVENTIONAL,No funding obtained. The ABPM machines are being used for another project
NCT03284203,TERMINATED,INTERVENTIONAL,"The aims represented in this study are also included in another, larger study of at-home COPD care. There was insufficient research team support to complete both protocols and the work would have been duplicative. Thus, we have terminated this study."
NCT03284281,WITHDRAWN,INTERVENTIONAL,Study never initiated; withdrawn prior to receiving IRB approval
NCT03284346,TERMINATED,INTERVENTIONAL,PI left
NCT03284437,WITHDRAWN,INTERVENTIONAL,Logistical difficulties with implementing study.
NCT03284476,WITHDRAWN,OBSERVATIONAL,No inclusion
NCT03284489,WITHDRAWN,OBSERVATIONAL,No inclusion
NCT03284606,TERMINATED,INTERVENTIONAL,Recruitment default
NCT03284658,WITHDRAWN,OBSERVATIONAL,Transition to BioMetabol
NCT03285087,SUSPENDED,INTERVENTIONAL,dexmedetomidine is unavailable in this time
NCT03285165,SUSPENDED,INTERVENTIONAL,NO AVAILABLE FUND
NCT03285256,TERMINATED,INTERVENTIONAL,Unable to recruit participants before funding period ended.
NCT03285269,WITHDRAWN,OBSERVATIONAL,Study was not initiated because it was not approved by KPSC IRB.
NCT03285308,TERMINATED,INTERVENTIONAL,The Relamorelin program is being terminated solely based on a business decision.
NCT03285607,WITHDRAWN,INTERVENTIONAL,Drug provider decided not to move forward with the study.
NCT03285646,TERMINATED,INTERVENTIONAL,"Due to implementation of an urgent safety measure, enrollment and dosing in R475-PN-1612 was stopped; enrolled participants entered the 20-week safety follow-up"
NCT03285724,TERMINATED,INTERVENTIONAL,Edwards Lifesciences acquired Harpoon Medical in December 2017 and a decision has been made to close enrollment in the HMEFS-2000 protocol
NCT03285841,TERMINATED,OBSERVATIONAL,No funding
NCT03285880,TERMINATED,INTERVENTIONAL,The pandemic halted the study protocol temporarily. We continued to collect what we could but the study ran out of time/funds.
NCT03286062,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03286075,TERMINATED,INTERVENTIONAL,The department in charge of this research is no longer able to follow this project. Only two inclusions this study is close
NCT03286114,TERMINATED,INTERVENTIONAL,Lack of patient population
NCT03286166,WITHDRAWN,OBSERVATIONAL,due to funding issues
NCT03286205,WITHDRAWN,INTERVENTIONAL,IP unavailable at site.
NCT03286426,TERMINATED,INTERVENTIONAL,COVID
NCT03286582,TERMINATED,INTERVENTIONAL,Terminated with partial enrollment completed
NCT03286972,TERMINATED,OBSERVATIONAL,Slow accrual
NCT03287050,TERMINATED,INTERVENTIONAL,due to changing therapeutic landscape in metastatic bladder cancer and lack of radiation/immunotherapy systemic synergy in other malignancies
NCT03287063,SUSPENDED,OBSERVATIONAL,Enrollment and/or interactions/interventions temporarily paused due to pending funding and expected to resume in the future. This is not a suspension of IRB approval.
NCT03287180,WITHDRAWN,INTERVENTIONAL,unable to enroll any participants
NCT03287245,TERMINATED,INTERVENTIONAL,The Sponsor decided to discontinue the development of idasanutlin in the polycythemia vera indication.
NCT03287414,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03287804,TERMINATED,INTERVENTIONAL,Preliminary efficacy seen to date following treatment with AUTO2 has been determined not sufficient to warrant further development
NCT03287908,TERMINATED,INTERVENTIONAL,"business decision, not safety reasons."
NCT03287947,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03288389,SUSPENDED,INTERVENTIONAL,until further notice due to COVID-19 pandemic.
NCT03288493,TERMINATED,INTERVENTIONAL,Phase I portion of the study was completed. The phase II portion of the study was terminated early to focus on an Allogeneic BCMA CAR-T program.
NCT03288766,TERMINATED,OBSERVATIONAL,Low enrollment
NCT03288792,TERMINATED,INTERVENTIONAL,"Sponsor decision, not safety related"
NCT03288818,WITHDRAWN,INTERVENTIONAL,Funding discontinued
NCT03288935,WITHDRAWN,INTERVENTIONAL,A substantial decrease in refugee arrivals in Virginia didn't allow the investigator to continue the study as planned.
NCT03289039,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03289078,WITHDRAWN,INTERVENTIONAL,No financing
NCT03289104,WITHDRAWN,INTERVENTIONAL,Study terminated due to inadequate funding.
NCT03289143,TERMINATED,INTERVENTIONAL,Study was terminated during Open Label Extension period because analyses of placebo-controlled Blinded portion of study did not show any evidence of clinical efficacy or modulation of accumulation of tau PET signal at any of the doses studied.
NCT03289624,WITHDRAWN,INTERVENTIONAL,Lost Funding
NCT03289754,TERMINATED,INTERVENTIONAL,Decision of investigational team
NCT03290053,TERMINATED,INTERVENTIONAL,Poor inclusion rate \& lack of funding
NCT03290092,TERMINATED,INTERVENTIONAL,"In accordance with the protocol, following the occurrence of two SUSARs, the TOTEM trial was stopped early for safety reasons."
NCT03290196,SUSPENDED,INTERVENTIONAL,Patients pain was not regulated well with this product.
NCT03290508,TERMINATED,OBSERVATIONAL,There is sufficient follow-up data to meet the endpoints of the study.
NCT03290963,WITHDRAWN,INTERVENTIONAL,"Principal Investigator moved to Jacksonville, FL campus."
NCT03291158,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03291249,WITHDRAWN,INTERVENTIONAL,Due to MOH request.
NCT03291327,WITHDRAWN,INTERVENTIONAL,Due to recruitment issues
NCT03291340,SUSPENDED,OBSERVATIONAL,Recruitment temporarily suspended due to COVID-19 pandemic.
NCT03291353,WITHDRAWN,INTERVENTIONAL,This study has closed due to slow accrual.
NCT03291431,TERMINATED,INTERVENTIONAL,Recruitment difficulties due to Covid-19 pandemic
NCT03291691,SUSPENDED,OBSERVATIONAL,for organizational reasons
NCT03291743,TERMINATED,INTERVENTIONAL,Death of Principal Investigator
NCT03291795,TERMINATED,INTERVENTIONAL,feasibility challenges
NCT03291899,TERMINATED,INTERVENTIONAL,poor accrual
NCT03291912,WITHDRAWN,INTERVENTIONAL,"This registration has moved to a local ICTRP (CRIS; https://cris.nih.go.kr, KCT0002565)."
NCT03292159,TERMINATED,INTERVENTIONAL,funding not continued
NCT03292172,TERMINATED,INTERVENTIONAL,Portfolio prioritization
NCT03292393,WITHDRAWN,INTERVENTIONAL,Not enough sample list at participating healthcare facility.
NCT03292536,TERMINATED,INTERVENTIONAL,Enrollment incomplete by the end of the contracted enrollment period
NCT03292653,TERMINATED,INTERVENTIONAL,"1st two cohorts provided the required data, therefore 3rd cohort was not deemed necessary"
NCT03292679,WITHDRAWN,OBSERVATIONAL,There was lack of internal staff support and could not enroll participants.
NCT03292731,TERMINATED,INTERVENTIONAL,grant funding cycle ended
NCT03292835,SUSPENDED,OBSERVATIONAL,Political Issues in Algeria and now Covod-19 lock-down
NCT03293602,WITHDRAWN,INTERVENTIONAL,the team has changed. the new team did not have the perosnnel to set up the study
NCT03293667,TERMINATED,INTERVENTIONAL,Default of recrutement / no more PI on this study
NCT03293719,TERMINATED,OBSERVATIONAL,"Monocentric Study, Site reorganised, could no longer participate in study"
NCT03293888,TERMINATED,OBSERVATIONAL,PI Relocation
NCT03293927,WITHDRAWN,INTERVENTIONAL,No participants enrolled in study.
NCT03294174,TERMINATED,OBSERVATIONAL,Responsible Investigator left institution
NCT03294200,TERMINATED,INTERVENTIONAL,As per sponsor
NCT03294252,TERMINATED,INTERVENTIONAL,The 34 patients included had all completed their treatment period under the protocol and the data could be collected to assess the main objective and the secondary objectives before the last theoretical follow-up.
NCT03294694,TERMINATED,INTERVENTIONAL,Safety Implications
NCT03294941,TERMINATED,INTERVENTIONAL,Primary study stopped early
NCT03294993,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03295175,WITHDRAWN,OBSERVATIONAL,The project never started and contact with the main researcher was lost.
NCT03295266,TERMINATED,INTERVENTIONAL,Business and program changes
NCT03295552,TERMINATED,INTERVENTIONAL,Slow enrollment.
NCT03295656,WITHDRAWN,INTERVENTIONAL,Unanticipated delays.
NCT03295695,WITHDRAWN,INTERVENTIONAL,closure of radiolaboratory
NCT03295942,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03296033,TERMINATED,INTERVENTIONAL,enrollment proved to be a challenge due to the changing of the guidelines for bridging off the new anticoagulants that are being prescribed
NCT03296085,TERMINATED,OBSERVATIONAL,"Principle investigator changed academic affiliation, then later retired. Study terminated after intra-observer validation, but inter-observer validation not completed."
NCT03296098,SUSPENDED,INTERVENTIONAL,Awaiting FDA approval to continue
NCT03296111,TERMINATED,OBSERVATIONAL,Difficulties for patients inclusion
NCT03296124,WITHDRAWN,OBSERVATIONAL,This project currently does not have any subjects enrolled due to other PI priorities.
NCT03296436,WITHDRAWN,INTERVENTIONAL,Sponsor decision - sponsor will be initiating a phase 3 mid-2019
NCT03296631,TERMINATED,OBSERVATIONAL,The Pi has estimated that he has received sufficiently biological samples and associated data. it's no longer worth following up.
NCT03297294,TERMINATED,INTERVENTIONAL,Study was terminated due to animal toxicity data
NCT03297333,TERMINATED,INTERVENTIONAL,Covid/19
NCT03297359,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03297398,TERMINATED,INTERVENTIONAL,study terminated by sponsor decision
NCT03297450,TERMINATED,INTERVENTIONAL,Difficult patient recruitment
NCT03297463,WITHDRAWN,INTERVENTIONAL,Replaced by another study.
NCT03297554,WITHDRAWN,INTERVENTIONAL,"Study closed on May 30, 2018 and no participants were enrolled."
NCT03297762,TERMINATED,INTERVENTIONAL,Enrollment challenges
NCT03297957,TERMINATED,INTERVENTIONAL,Low accrual
NCT03298009,WITHDRAWN,INTERVENTIONAL,end of contract negociations
NCT03298022,TERMINATED,INTERVENTIONAL,As a consequence of operational difficulties at the clinical sites associated with the COVID-19 pandemic
NCT03298048,TERMINATED,INTERVENTIONAL,Investigators are no longer considering FMT product development for C. difficile.
NCT03298113,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03298399,WITHDRAWN,INTERVENTIONAL,Study stopped due to a competing trial.
NCT03298412,TERMINATED,INTERVENTIONAL,Early Closure due to rare patient population
NCT03298581,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03298958,WITHDRAWN,INTERVENTIONAL,"No funding was received, no subjects were enrolled"
NCT03299140,TERMINATED,INTERVENTIONAL,"Difficult recruitment, and investigators did not want to extend the recruitment period, so study stopped at theoretical date but number of subjects not reached"
NCT03299387,WITHDRAWN,INTERVENTIONAL,Study never recruited
NCT03299764,SUSPENDED,INTERVENTIONAL,Devices not available at the moment.
NCT03299842,TERMINATED,INTERVENTIONAL,The study was stopped due to low enrollment.
NCT03299881,TERMINATED,INTERVENTIONAL,Early termination due to technical problems with the device.
NCT03300024,TERMINATED,INTERVENTIONAL,Funding ended
NCT03300128,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT03300167,WITHDRAWN,INTERVENTIONAL,Delivery of equipment. PI not had any further interaction with the company so closed study.
NCT03300258,TERMINATED,INTERVENTIONAL,Original study plan required re-evaluation and the decision was made to pivot to developing tests and exercises on healthy population
NCT03300310,TERMINATED,INTERVENTIONAL,"Despite an extension of the planned duration of inclusion and an enrolled patient number inferior than planned, coordinating investigator considered that it was more reasonable to stop inclusions in order to analyze the data already available"
NCT03300362,TERMINATED,INTERVENTIONAL,Change to recommended season flu vaccine in UK
NCT03300401,WITHDRAWN,INTERVENTIONAL,Accrual issue
NCT03300479,WITHDRAWN,INTERVENTIONAL,No patient enrolled. No study conduct due to lack of human resources.
NCT03300505,TERMINATED,INTERVENTIONAL,Cancelled by the sponsor
NCT03300609,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT03300843,TERMINATED,INTERVENTIONAL,slow accrual
NCT03300921,TERMINATED,INTERVENTIONAL,Newer research suggested that paricalcitol may be harmful to a subset of pancreatic cancer patients and it is not feasible to subtype patients in the short time frame before surgery
NCT03301415,TERMINATED,INTERVENTIONAL,Safety signal
NCT03301480,TERMINATED,OBSERVATIONAL,An interim review of the data revealed that there was broad inter-participant variability.The study was stopped due to futility.
NCT03301558,WITHDRAWN,INTERVENTIONAL,study not started due to organizational reasons
NCT03301597,TERMINATED,INTERVENTIONAL,Development plan under review.
NCT03301636,TERMINATED,INTERVENTIONAL,"Sponsor termination, not related to efficacy, safety or feasibility."
NCT03301701,WITHDRAWN,INTERVENTIONAL,Lack of accruals
NCT03301766,WITHDRAWN,INTERVENTIONAL,Delay for subject recruitment and then not feasible with COVID\>
NCT03301896,TERMINATED,INTERVENTIONAL,Business reasons
NCT03301909,TERMINATED,INTERVENTIONAL,Study purposes and objectives have shifted
NCT03302156,TERMINATED,INTERVENTIONAL,Slow accrual following suspension per COVID-19
NCT03302221,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03302247,TERMINATED,INTERVENTIONAL,Unable to accrue subjects
NCT03302390,WITHDRAWN,OBSERVATIONAL,PI failed to submit study for continuing review by IRB
NCT03302481,WITHDRAWN,INTERVENTIONAL,no ethic committee autorization
NCT03302494,TERMINATED,INTERVENTIONAL,Study closed due to device design modification
NCT03302650,SUSPENDED,INTERVENTIONAL,The drug is not available
NCT03302949,TERMINATED,INTERVENTIONAL,Study enrollment stopped before reaching sample size due to time constraints. Follow up visits and intervention was given per protocol to all included participants.
NCT03303235,WITHDRAWN,INTERVENTIONAL,Collaborators left the institution.
NCT03303261,TERMINATED,OBSERVATIONAL,The principal investigator decided to stop the study.
NCT03303313,WITHDRAWN,INTERVENTIONAL,Study terminated early due to lack of enrollment.
NCT03303391,TERMINATED,INTERVENTIONAL,Funding Expired
NCT03303469,TERMINATED,INTERVENTIONAL,study was terminated due to poor enrollment
NCT03303664,WITHDRAWN,INTERVENTIONAL,System-wide implementation of intervention prevented randomized trial design
NCT03303677,WITHDRAWN,INTERVENTIONAL,Withdrawn by sponsor
NCT03303690,TERMINATED,INTERVENTIONAL,Arthrex stopped manufacturing the device
NCT03303794,TERMINATED,INTERVENTIONAL,Interim Analysis showed no significance
NCT03303911,TERMINATED,INTERVENTIONAL,It has been difficult to recruit participants meeting study entry criteria that are \>65 years of age and not for any safety reasons.
NCT03303950,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03304028,TERMINATED,INTERVENTIONAL,recruitment and search completed
NCT03304184,TERMINATED,INTERVENTIONAL,COVID
NCT03304990,WITHDRAWN,OBSERVATIONAL,PI has left our Inst.
NCT03305055,TERMINATED,INTERVENTIONAL,Funding withdrawn - slow enrollment
NCT03305393,TERMINATED,INTERVENTIONAL,Only one subject was enrolled and that subject was Lost to Follow Up. Decision was made to terminate the study.
NCT03305549,TERMINATED,INTERVENTIONAL,Study stopped because sufficient pilot data collected to proceed to next clinical trial.
NCT03305562,TERMINATED,OBSERVATIONAL,Study was a pilot study and the investigators received funding to initiate the main study
NCT03305614,TERMINATED,INTERVENTIONAL,Reason unknown
NCT03305926,TERMINATED,INTERVENTIONAL,Early termination due to changes in care management following the COVID context (remote/connected rehabilitation)
NCT03306329,TERMINATED,INTERVENTIONAL,Administrative
NCT03306420,TERMINATED,INTERVENTIONAL,The study was terminated early due to lackluster pharmacodynamic data that showed no significant reduction of plasma kynurenine at steady state of M4112.
NCT03306628,WITHDRAWN,INTERVENTIONAL,Dr. Hazen is no longer full-time faculty / was not able to find an appropriate PI to take over study.
NCT03306693,TERMINATED,INTERVENTIONAL,insufficient inclusions
NCT03306966,WITHDRAWN,OBSERVATIONAL,Design modification
NCT03307278,WITHDRAWN,INTERVENTIONAL,The research project cannot be implemented because the project has not received funding subsidies
NCT03307317,SUSPENDED,OBSERVATIONAL,Premature suspension of the research by the institution due to audit findings.
NCT03307512,TERMINATED,INTERVENTIONAL,Termination due to incomplete enrollment; planned data analysis not performed
NCT03307603,WITHDRAWN,INTERVENTIONAL,Sponsor chose not to continue
NCT03307941,WITHDRAWN,INTERVENTIONAL,Suspended collaboration with the company providing the study drug
NCT03307993,TERMINATED,INTERVENTIONAL,The study was terminated for strategic reasons.
NCT03308331,WITHDRAWN,INTERVENTIONAL,We originally had a collaboration with a PI but he has left the University.
NCT03308435,TERMINATED,OBSERVATIONAL,futility
NCT03308734,WITHDRAWN,INTERVENTIONAL,Lack of resource from collaborating organisation
NCT03308786,TERMINATED,INTERVENTIONAL,There were 3 instances of adverse events which were discussed with external safety monitoring committee and it was recommended that the study be terminated.
NCT03308851,TERMINATED,INTERVENTIONAL,Due to difficulties related to COVID
NCT03309098,WITHDRAWN,OBSERVATIONAL,IRB's initial review of this study was not completed and study was withdrawn
NCT03309358,TERMINATED,INTERVENTIONAL,Successful completion of Part A. Company decision to end early.
NCT03309514,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT03309592,WITHDRAWN,INTERVENTIONAL,Lack of eligible participants and failure to meeting study enrollment.
NCT03309696,TERMINATED,INTERVENTIONAL,Funding issues
NCT03309774,TERMINATED,INTERVENTIONAL,failing of recruitment
NCT03309865,WITHDRAWN,INTERVENTIONAL,Not enough patients to enroll.
NCT03310034,TERMINATED,INTERVENTIONAL,Concluded study following COVID19 outbreak and inability to complete study as designed.
NCT03310320,TERMINATED,INTERVENTIONAL,The study is temporarily suspended due to preclinical findings that are currently under evaluation
NCT03310567,WITHDRAWN,INTERVENTIONAL,Sponsors pulled out of the study
NCT03310593,TERMINATED,INTERVENTIONAL,It was interrupted due to the coronavirus pandemic outbreak.
NCT03311074,WITHDRAWN,INTERVENTIONAL,Replaced with new observational study design
NCT03311126,TERMINATED,INTERVENTIONAL,slow accrual
NCT03311178,TERMINATED,INTERVENTIONAL,Substudy 001B is not required at this stage of the PIP
NCT03311191,TERMINATED,OBSERVATIONAL,Ran out of funding
NCT03311269,TERMINATED,INTERVENTIONAL,Study was terminated for administrative reasons
NCT03311295,TERMINATED,INTERVENTIONAL,Lagging enrollment
NCT03311334,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate development of the program.
NCT03311490,TERMINATED,INTERVENTIONAL,"The decision to halt the trial in October was made in June, as the anticipated no. of events(ankle sprains) required for the analyses was almost reached in June"
NCT03311568,TERMINATED,INTERVENTIONAL,"Researcher has quit. Question still unanswered. A related study (observational, not to be registered) has started recently."
NCT03311672,WITHDRAWN,INTERVENTIONAL,Low Accrual
NCT03311750,TERMINATED,INTERVENTIONAL,It was considered that the recruitment of the remaining 10 patients required of the trial will not be possible soon.
NCT03312114,TERMINATED,INTERVENTIONAL,low accrual
NCT03312127,TERMINATED,INTERVENTIONAL,End of inclusion period
NCT03312192,WITHDRAWN,INTERVENTIONAL,poor recruitment
NCT03312244,SUSPENDED,INTERVENTIONAL,"Due to COVID-19, effective 3/19/2020 recruitment is halted until further notice"
NCT03312387,TERMINATED,INTERVENTIONAL,There is no longer any funding to support the study
NCT03312725,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT03312868,TERMINATED,INTERVENTIONAL,Burocracy and funding
NCT03312894,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03313076,TERMINATED,INTERVENTIONAL,"COVID-19 global pandemic, and study funding period ended 7/31/2020."
NCT03313258,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03313375,TERMINATED,INTERVENTIONAL,Loss of funding and personnel
NCT03313414,WITHDRAWN,INTERVENTIONAL,"No participant enrollment, funding withdrawn."
NCT03313947,WITHDRAWN,INTERVENTIONAL,PI was unable to perform ultrasound of airway.
NCT03313999,WITHDRAWN,INTERVENTIONAL,Technical difficulties with instrument
NCT03314415,WITHDRAWN,INTERVENTIONAL,Study will not be implemented and did not enroll participants.
NCT03314675,TERMINATED,INTERVENTIONAL,Unsuccessful enrollment
NCT03314948,TERMINATED,OBSERVATIONAL,"Due to lack of resources and changes in current practice, the study was terminated"
NCT03315052,WITHDRAWN,INTERVENTIONAL,Delay in IRB approval
NCT03315143,TERMINATED,INTERVENTIONAL,study terminated due to business decision
NCT03315182,TERMINATED,INTERVENTIONAL,Abeona has decided to discontinue development activities for Product ABO-101 due to a lack of drug supply and for business reasons unrelated to the product safety profile and/or signs of efficacy
NCT03315663,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to budgetary and other constraints.
NCT03315832,WITHDRAWN,INTERVENTIONAL,problem of faisability
NCT03316066,WITHDRAWN,INTERVENTIONAL,Not able to recruit enough patients
NCT03316105,TERMINATED,INTERVENTIONAL,Electrical device malfunction; recruitment was stopped.
NCT03316118,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT03316222,TERMINATED,INTERVENTIONAL,"only phase 1b was completed and the phase 2 will be an another study, finally"
NCT03316339,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03316573,SUSPENDED,INTERVENTIONAL,Low accrual
NCT03316729,WITHDRAWN,INTERVENTIONAL,Product development cancelled.
NCT03316742,WITHDRAWN,INTERVENTIONAL,Study has not yet been approved by the local IRB in Guinea Bissau.
NCT03316794,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT03316833,SUSPENDED,OBSERVATIONAL,Waiting for a protocol amendment to extend follow-up lenght
NCT03316898,WITHDRAWN,INTERVENTIONAL,Business decision to stop the study.
NCT03316963,TERMINATED,INTERVENTIONAL,PI is moving the a new institution and ended the study early.
NCT03317314,WITHDRAWN,OBSERVATIONAL,Study was considered not useful and competing with another study in clinical context
NCT03317392,SUSPENDED,INTERVENTIONAL,Other - evaluation of enrolled patients
NCT03317496,TERMINATED,INTERVENTIONAL,The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522).
NCT03317665,TERMINATED,OBSERVATIONAL,Premature termination due to cease of funding
NCT03318107,TERMINATED,INTERVENTIONAL,Low accrual
NCT03318172,TERMINATED,INTERVENTIONAL,difficulty in recruting of patients
NCT03318237,TERMINATED,OBSERVATIONAL,PI moved to a different institution.
NCT03318367,TERMINATED,INTERVENTIONAL,The study expired at the IRB
NCT03318484,WITHDRAWN,INTERVENTIONAL,Re-registered
NCT03318523,TERMINATED,INTERVENTIONAL,SPARK did not meet it's primary outcome measure for year 1 and failed to meet secondary outcome measures resulting in the development of BIIB054 (cinpanemab) for Parkinson's disease to be discontinued and SPARK study was closed.
NCT03318562,TERMINATED,INTERVENTIONAL,The study was terminated due to change in focus of the development program
NCT03318627,WITHDRAWN,INTERVENTIONAL,No capacity to conduct the study
NCT03318640,TERMINATED,INTERVENTIONAL,low inclusion rates
NCT03318757,WITHDRAWN,INTERVENTIONAL,The research could not be conducted as it was denied by the IRB.
NCT03318861,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy
NCT03318939,TERMINATED,INTERVENTIONAL,Strategic business decision (unrelated to safety)
NCT03318952,WITHDRAWN,INTERVENTIONAL,The research did not start and the PI transitioned to another institution.
NCT03319316,WITHDRAWN,INTERVENTIONAL,Interest withdrawn
NCT03319407,TERMINATED,INTERVENTIONAL,Funding support unavailable
NCT03319537,TERMINATED,INTERVENTIONAL,Sponsor terminated study agreement
NCT03319771,TERMINATED,INTERVENTIONAL,Termination of study funding due to COVID-19
NCT03319784,WITHDRAWN,INTERVENTIONAL,never initiated
NCT03319823,WITHDRAWN,INTERVENTIONAL,"Due to the Pandemic, we decided to end this study."
NCT03319914,TERMINATED,OBSERVATIONAL,Subjects did not receive Hope Pharmaceuticals' Sodium Thiosulfate Injection.
NCT03320265,TERMINATED,INTERVENTIONAL,Terminated
NCT03320395,WITHDRAWN,INTERVENTIONAL,Principal investigator left the institution.
NCT03320499,WITHDRAWN,OBSERVATIONAL,The principal investigator decided to stop the study.
NCT03320525,TERMINATED,INTERVENTIONAL,Issues with PK detection limits and compliance to protocol at the analytical site.
NCT03320564,TERMINATED,INTERVENTIONAL,Recruitment slow due to improved extravasation rate.
NCT03320642,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT03320785,TERMINATED,OBSERVATIONAL,Principal Investigator unable to incorporate study and recruitments into clinical routines
NCT03320876,TERMINATED,INTERVENTIONAL,development program for filgotinib for participants with psoriatic arthritis has been stopped
NCT03321604,TERMINATED,OBSERVATIONAL,Poor recruitment
NCT03321721,TERMINATED,INTERVENTIONAL,lack of recruitment and follow up
NCT03321747,TERMINATED,INTERVENTIONAL,"After completion of Phase I, it was decided not to initiate Phase II of the study."
NCT03321760,WITHDRAWN,INTERVENTIONAL,Decided not to open the study.
NCT03321864,SUSPENDED,INTERVENTIONAL,PI has left Trust currently.
NCT03321903,TERMINATED,OBSERVATIONAL,The research team is exploring device optimization
NCT03322150,TERMINATED,INTERVENTIONAL,The research was terminated because the recruitment of the study subjects was not smooth and the overseas training of the investigator was scheduled.
NCT03322215,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03322371,TERMINATED,INTERVENTIONAL,Difficulty analyzing PSG data
NCT03322813,SUSPENDED,INTERVENTIONAL,Study temporarily suspended until priorities are reassessed
NCT03323073,TERMINATED,INTERVENTIONAL,Deadline of the end date of the inclusions
NCT03323177,WITHDRAWN,INTERVENTIONAL,finally it was decided not to initiate the study due to logistical issues
NCT03323190,WITHDRAWN,INTERVENTIONAL,Withdrawn due to low feasibility.
NCT03323398,TERMINATED,INTERVENTIONAL,This study was halted prematurely because the efficacy endpoints were not met for either treatment arm.
NCT03323424,WITHDRAWN,INTERVENTIONAL,No patient enrolled during the authorized period
NCT03323645,TERMINATED,OBSERVATIONAL,change of study structure and resource allocation
NCT03323710,WITHDRAWN,INTERVENTIONAL,Poor patient recruitment.
NCT03323749,TERMINATED,INTERVENTIONAL,"Part1,double blind portion of the trial did not meet the primary end points"
NCT03323866,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT03323879,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03324243,WITHDRAWN,INTERVENTIONAL,Withdrawn: Study halted prior to enrollment of first participant
NCT03324282,TERMINATED,INTERVENTIONAL,"ANSM's refusal to validate ATU requests for avelumab in bladder cancer, Decrease in recruitment, Most investigators would like to offer avelumab for maintenance, Absence of benefit to the chemo-immuno combination (pembro+gem-platinum) in phase III"
NCT03324308,WITHDRAWN,INTERVENTIONAL,Redesign of Study.
NCT03324516,WITHDRAWN,INTERVENTIONAL,"Due to limited support staff and time, study was unable to get started"
NCT03324672,TERMINATED,INTERVENTIONAL,PI's choice
NCT03324711,TERMINATED,INTERVENTIONAL,Departure of the Principal Investigator
NCT03324828,TERMINATED,INTERVENTIONAL,COVID-19
NCT03324958,TERMINATED,INTERVENTIONAL,Enrollment difficulties
NCT03324997,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03325049,TERMINATED,INTERVENTIONAL,We have closed the study because of slow inclusion of families
NCT03325114,TERMINATED,INTERVENTIONAL,COVID restrictions prohibit further study activies
NCT03325127,WITHDRAWN,OBSERVATIONAL,"Project plan changed, study conduct was no longer needed."
NCT03325166,TERMINATED,INTERVENTIONAL,Low accrual
NCT03325192,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03325296,TERMINATED,INTERVENTIONAL,Futility
NCT03325322,SUSPENDED,INTERVENTIONAL,Due to lack of funding
NCT03325439,TERMINATED,INTERVENTIONAL,"Terminated (The study stopped prematurely due to enrolment challenges, the termination was not linked to any safety issues.)"
NCT03325465,WITHDRAWN,INTERVENTIONAL,Site decided not to move forward with trial. Study never opened to enrollment.
NCT03325491,TERMINATED,INTERVENTIONAL,"Challenges recruiting healthy, sedentary 65-75 year old males"
NCT03325725,WITHDRAWN,INTERVENTIONAL,The Competent Authority did not give the authorization to start the study.
NCT03325868,WITHDRAWN,INTERVENTIONAL,IND issues
NCT03325894,TERMINATED,INTERVENTIONAL,The study was stopped due to efficacy reasons.
NCT03325933,TERMINATED,INTERVENTIONAL,COVID-19
NCT03326128,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic, it was difficult to recruit eligible participants."
NCT03326167,TERMINATED,OBSERVATIONAL,recruitment difficulty
NCT03326219,WITHDRAWN,INTERVENTIONAL,Difficulty finding eligible patients
NCT03326258,WITHDRAWN,INTERVENTIONAL,The study itself was Disapproved on 04/20/2018 and will not be moving forward.
NCT03326518,TERMINATED,INTERVENTIONAL,Primary objective reached
NCT03326596,WITHDRAWN,INTERVENTIONAL,PI retired from Navy 2018
NCT03326674,TERMINATED,INTERVENTIONAL,The Sponsor has discontinued the development of tesetaxel
NCT03326687,WITHDRAWN,INTERVENTIONAL,Insufficient personnel
NCT03326843,TERMINATED,INTERVENTIONAL,Study was terminated due to enrollment challenges.
NCT03326869,TERMINATED,INTERVENTIONAL,Corneal Inlay supplier no longer in business
NCT03326921,SUSPENDED,INTERVENTIONAL,Pause in funding
NCT03327064,WITHDRAWN,INTERVENTIONAL,"COVID-19 pandemic, unable to enroll participants"
NCT03327272,WITHDRAWN,INTERVENTIONAL,"Did not enroll, PI decided not to proceed."
NCT03327441,TERMINATED,INTERVENTIONAL,Decision of the funder: Almond Board of California
NCT03327519,TERMINATED,INTERVENTIONAL,issue reaching target enrollment
NCT03327636,SUSPENDED,INTERVENTIONAL,not start in coming years
NCT03327662,TERMINATED,INTERVENTIONAL,Underrecruitment
NCT03327727,TERMINATED,INTERVENTIONAL,Business decision
NCT03327974,TERMINATED,INTERVENTIONAL,"Problem on the app, questioned the feasability of the study"
NCT03327987,WITHDRAWN,OBSERVATIONAL,The study was on hold and later withdrawn due to shortage of staff
NCT03328013,TERMINATED,OBSERVATIONAL,manager's decision
NCT03328065,TERMINATED,OBSERVATIONAL,lack of inclusion
NCT03328338,TERMINATED,OBSERVATIONAL,Mitochondrial respiration measurement technique faulty
NCT03328416,WITHDRAWN,INTERVENTIONAL,Expected technology was not available.
NCT03328598,TERMINATED,INTERVENTIONAL,Don't have enough funding to finish the project.
NCT03328741,SUSPENDED,INTERVENTIONAL,COVID-19
NCT03328858,TERMINATED,INTERVENTIONAL,"PI no longer available, not able to find replacement. 2 patients, lost to follow-up."
NCT03328910,WITHDRAWN,OBSERVATIONAL,because the instruments for collecting the SPI data from the monitor (S5 collector) could not be imported due to the manufacturer's problem.
NCT03328936,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03328975,WITHDRAWN,INTERVENTIONAL,PI decided to withdraw study
NCT03329053,WITHDRAWN,INTERVENTIONAL,Study research team disintegration
NCT03329222,TERMINATED,INTERVENTIONAL,slow recruitment
NCT03329378,TERMINATED,INTERVENTIONAL,"Data Safety Monitoring Board is in agreement with the study findings so far and the stopping rule has been met, which suspends the study treatment arms in March 2021."
NCT03329404,TERMINATED,INTERVENTIONAL,Study suspended due to blood supply challenges. Subsequently approved by FDA to reopen but will not do so because of changing clinical need.
NCT03329547,WITHDRAWN,INTERVENTIONAL,Change in commercial strategy
NCT03329612,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT03329885,TERMINATED,INTERVENTIONAL,Adverse change in the risk/benefit
NCT03330067,WITHDRAWN,INTERVENTIONAL,We are not performing the study and we don't plan to continue. We do not have support to complete the study.
NCT03330119,TERMINATED,INTERVENTIONAL,Lack of Funding/ Resident in charge graduated
NCT03330197,TERMINATED,INTERVENTIONAL,Sponsor decision due to slow accrual
NCT03330405,TERMINATED,INTERVENTIONAL,The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522).
NCT03330457,TERMINATED,INTERVENTIONAL,Ended prematurely
NCT03330483,TERMINATED,OBSERVATIONAL,Difficulty in recruiting patients
NCT03330639,WITHDRAWN,INTERVENTIONAL,Grant funding for study was not obtained.
NCT03330704,WITHDRAWN,INTERVENTIONAL,lack of eligible study participants
NCT03330834,TERMINATED,INTERVENTIONAL,Serious adverse events
NCT03331146,WITHDRAWN,INTERVENTIONAL,Principal Investigator made aware of similar studies that have already been published.
NCT03331445,TERMINATED,INTERVENTIONAL,Covid Incidence too low and Funding Completed
NCT03331640,TERMINATED,INTERVENTIONAL,slow recruitment
NCT03331666,TERMINATED,INTERVENTIONAL,Terminated Prematurely due to COVID-19
NCT03331848,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT03331939,TERMINATED,INTERVENTIONAL,insufficient study staff
NCT03332030,WITHDRAWN,OBSERVATIONAL,Suspended due to cessation of funding
NCT03332043,WITHDRAWN,INTERVENTIONAL,Pre-hypertension no longer exists
NCT03332082,WITHDRAWN,INTERVENTIONAL,losing of funding for the study
NCT03332355,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03332524,TERMINATED,INTERVENTIONAL,Sponsor decided to stop for lack of efficacy
NCT03332589,TERMINATED,INTERVENTIONAL,Single center study: Principal Investigator left institution.
NCT03332836,TERMINATED,INTERVENTIONAL,Sopnsor decision
NCT03333031,TERMINATED,INTERVENTIONAL,Funding ended
NCT03333070,TERMINATED,INTERVENTIONAL,The PI was ended her work in the hospital and no replacement was found.
NCT03333148,WITHDRAWN,INTERVENTIONAL,never enrolled
NCT03333317,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03333382,TERMINATED,INTERVENTIONAL,Post transplant leaks are now less frequent at VUMC and we struggled to enroll.
NCT03333434,TERMINATED,INTERVENTIONAL,Difficulties in recruiting
NCT03333551,TERMINATED,INTERVENTIONAL,slow recruitment.
NCT03333694,TERMINATED,INTERVENTIONAL,The study fully enrolled and completed after last patient completed the study
NCT03333720,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT03333746,TERMINATED,INTERVENTIONAL,Study was discontinued due to FDA recommendations of the potential toxicities of the combination of drugs.
NCT03333759,WITHDRAWN,INTERVENTIONAL,Difficult recruiting participants
NCT03334162,SUSPENDED,INTERVENTIONAL,study temporarily paused due to an Amendment request
NCT03334227,TERMINATED,INTERVENTIONAL,low recruitment
NCT03334240,TERMINATED,INTERVENTIONAL,Lack of effect in interim analysis
NCT03334409,TERMINATED,INTERVENTIONAL,Due to loss of funding from the private foundation source
NCT03334487,WITHDRAWN,INTERVENTIONAL,Strategic considerations
NCT03334578,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT03334669,SUSPENDED,INTERVENTIONAL,"The primary trial was halted due to covid-19 in the last 6 months of the trial; as a result, the intervention was not fully implemented and the final outcomes were not measured. Outcomes will be assessed with the data available (BL, Y1, Y2)."
NCT03334734,TERMINATED,INTERVENTIONAL,Very slow enrollment
NCT03334786,TERMINATED,INTERVENTIONAL,Development of Current Formulation has Ceased
NCT03334812,TERMINATED,INTERVENTIONAL,"This study was terminated early based on an interim analysis of 14 subjects, which demonstrated a favorable safety and tolerability profile."
NCT03335020,WITHDRAWN,INTERVENTIONAL,Closed by Investigator
NCT03335059,TERMINATED,INTERVENTIONAL,poor enrollment
NCT03335124,TERMINATED,INTERVENTIONAL,Due to insufficient recruitment
NCT03335254,TERMINATED,INTERVENTIONAL,Incomplete effect
NCT03335280,TERMINATED,OBSERVATIONAL,Low Accrual
NCT03335293,WITHDRAWN,INTERVENTIONAL,Due to FDA constraints on the off label use of the medications we will not be able to conduct this evaluation.
NCT03335384,WITHDRAWN,INTERVENTIONAL,Study not approved
NCT03335436,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT03335501,WITHDRAWN,INTERVENTIONAL,The owner of the algorithm does not wish that this study be undertaken
NCT03335969,WITHDRAWN,INTERVENTIONAL,no patients recruited
NCT03336021,WITHDRAWN,INTERVENTIONAL,Intervention not implemented as planned
NCT03336034,TERMINATED,OBSERVATIONAL,Slow inclusion rate.
NCT03336242,TERMINATED,INTERVENTIONAL,"More patients in Cohort 1 than Cohort 2 demonstrated a clinically meaningful reduction of seizure count. Given this, enrollment of Cohort 3 was discontinued."
NCT03336372,WITHDRAWN,INTERVENTIONAL,Sponsor discontinued study on 8Sep2018
NCT03336580,TERMINATED,INTERVENTIONAL,Because of the impact of COVID-19 pandemic
NCT03336671,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT03337061,WITHDRAWN,INTERVENTIONAL,Study never started - halted by funder
NCT03337152,TERMINATED,INTERVENTIONAL,study met study halting rules
NCT03337282,TERMINATED,OBSERVATIONAL,Elderly population difficult to recruit
NCT03337776,WITHDRAWN,INTERVENTIONAL,COVID
NCT03337997,WITHDRAWN,INTERVENTIONAL,We have been unable to secure funding. Now we are in the middle of a pandemic.
NCT03338114,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03338205,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients
NCT03338257,SUSPENDED,INTERVENTIONAL,Covid 19 pandemic
NCT03338296,TERMINATED,INTERVENTIONAL,Study was terminated as Eisai agreed to voluntarily withdraw Belviq XR from US market.
NCT03338491,TERMINATED,INTERVENTIONAL,unexpected alcohol use increase identified in preliminary analysis after half of study enrollments
NCT03338660,WITHDRAWN,INTERVENTIONAL,Unable to begin study due to funding. PI has left organization.
NCT03338712,WITHDRAWN,OBSERVATIONAL,Principal Investigators no longer in business
NCT03338751,WITHDRAWN,INTERVENTIONAL,Unfunded Pilot Study
NCT03338777,TERMINATED,INTERVENTIONAL,Failure to achieve primary objective
NCT03338881,WITHDRAWN,INTERVENTIONAL,Business decision: no safety or efficacy concerns
NCT03338920,TERMINATED,INTERVENTIONAL,eDiary data collected not sufficient to utilize in the analysis of protocol endpoints
NCT03339037,TERMINATED,INTERVENTIONAL,Recruitment difficulties - patients refusal to sham controlled
NCT03339336,TERMINATED,INTERVENTIONAL,Sponsor decision to close study early; not due to safety concerns
NCT03339401,TERMINATED,INTERVENTIONAL,terminated due to low enrollment rate
NCT03339492,TERMINATED,INTERVENTIONAL,Interim results suggested that the study was not adequately powered to achieve the primary endpoint: superiority in retear rate reduction in PEMF treatment versus placebo.
NCT03339622,TERMINATED,INTERVENTIONAL,Mycotoxin potential contamination of one lot of study drug
NCT03339726,TERMINATED,INTERVENTIONAL,"did not enroll enough subjects in the 2017/2018 cold season, so the study was terminated"
NCT03339921,TERMINATED,INTERVENTIONAL,This study is being closed because it is unworkable.
NCT03339973,TERMINATED,INTERVENTIONAL,Very slow recruitment of patients and the current COVID-19 pandemic situation.
NCT03339999,TERMINATED,INTERVENTIONAL,safety reason
NCT03340103,WITHDRAWN,INTERVENTIONAL,Recruitment was not possible
NCT03340116,WITHDRAWN,OBSERVATIONAL,Unable to find any suitable patients to enroll
NCT03340207,TERMINATED,INTERVENTIONAL,"A longer time to establish the airway. potential safety issue, despite lacking no adverse event."
NCT03340233,WITHDRAWN,INTERVENTIONAL,The PI left the institution and closed the study prior to enrolling any participants
NCT03340402,WITHDRAWN,INTERVENTIONAL,Slow Accrual
NCT03340467,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03340558,WITHDRAWN,INTERVENTIONAL,Negative results in a similar study
NCT03340883,TERMINATED,INTERVENTIONAL,No objective responses observed following completion of Phase 1 dose-escalation
NCT03340909,TERMINATED,INTERVENTIONAL,Stopped because of COVID 19 pandemic
NCT03341000,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03341039,TERMINATED,OBSERVATIONAL,Termination of the study due to low enrolment
NCT03341273,TERMINATED,INTERVENTIONAL,Due to covid
NCT03341364,WITHDRAWN,INTERVENTIONAL,Central contact person ended employment
NCT03341468,WITHDRAWN,INTERVENTIONAL,"PI confirmed no subjects consented and stated study not started due to insufficient staffing and once staff on board, the COVID-19 public health emergency occurred."
NCT03341676,SUSPENDED,INTERVENTIONAL,COVID
NCT03341767,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT03341962,TERMINATED,INTERVENTIONAL,"Considering the efficacy results of the induction phase (allowed use of corticosteroids as concomitant medication) in the study population and since IMU-838 did not show superiority over placebo, the OLE was prematurely closed by the sponsor."
NCT03342079,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03342157,TERMINATED,INTERVENTIONAL,low enrollment
NCT03342235,WITHDRAWN,INTERVENTIONAL,Study not started due to lack of recruitment potential.
NCT03342300,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03342326,TERMINATED,INTERVENTIONAL,failure to recruit
NCT03342352,WITHDRAWN,INTERVENTIONAL,Study was cancelled prior to enrolling any patients.
NCT03342365,TERMINATED,OBSERVATIONAL,10 patients inclued instead of 50
NCT03342417,TERMINATED,INTERVENTIONAL,Slow patient accrual
NCT03342612,TERMINATED,INTERVENTIONAL,Difficulties in including Mild Traumatic Brain Injury (mTBI) group despite an extended inclusion period of an additional 12 months
NCT03342638,TERMINATED,INTERVENTIONAL,PI Sabbatical
NCT03342859,TERMINATED,INTERVENTIONAL,Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670)
NCT03342950,TERMINATED,INTERVENTIONAL,Low recruitment due to the COVID-19 pandemic
NCT03342989,TERMINATED,INTERVENTIONAL,Recruitment not sufficient to justify continuation
NCT03343041,WITHDRAWN,INTERVENTIONAL,Covid and lack of resources
NCT03343067,TERMINATED,INTERVENTIONAL,"The study was terminated early for business reasons, not for safety concerns."
NCT03343158,TERMINATED,OBSERVATIONAL,Significantly more resources would have been necessary to complete the study.
NCT03343210,TERMINATED,INTERVENTIONAL,due to covid pandemic
NCT03343535,TERMINATED,INTERVENTIONAL,"Enrollment in EXPAND II was stopped June 24, 2019 as a result of the FDA approval for the EXPAND indication. Therefore, no additional sites or subjects were enrolled after that time."
NCT03343600,TERMINATED,INTERVENTIONAL,The trial is terminated due to the extremely low recruitment rate.
NCT03343613,TERMINATED,INTERVENTIONAL,Study terminated due to strategic business decision by Eli Lilly and Company.
NCT03343678,WITHDRAWN,INTERVENTIONAL,Company strategic decision
NCT03343847,WITHDRAWN,INTERVENTIONAL,Study was not feasible
NCT03343977,WITHDRAWN,INTERVENTIONAL,Study withdrawn for technical reasons
NCT03344003,TERMINATED,OBSERVATIONAL,Study terminated as enrolled patients rolled over into a large international study in the same indication
NCT03344172,TERMINATED,INTERVENTIONAL,Suspected Serious Adverse Events related to treatment
NCT03344341,TERMINATED,INTERVENTIONAL,Study overall progress behind of scheduled timeline. Study was terminated early due to company decision.
NCT03344562,TERMINATED,INTERVENTIONAL,Due to lack of resources (insufficient personnel) and due to technical problems with measurement of primary and secondary outcomes.
NCT03344770,SUSPENDED,INTERVENTIONAL,Study suspended due to Covid-19 pandemic.
NCT03344978,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT03344991,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT03345225,WITHDRAWN,INTERVENTIONAL,Funding
NCT03345277,WITHDRAWN,OBSERVATIONAL,Study never reached the enrolling phase and PI has since relocated
NCT03345355,TERMINATED,OBSERVATIONAL,Departure of the project leader
NCT03345407,TERMINATED,INTERVENTIONAL,Unfavourable benefit:risk
NCT03345550,TERMINATED,INTERVENTIONAL,"Slow accrual of patients, lack of financial resources"
NCT03345732,WITHDRAWN,OBSERVATIONAL,PI has been having difficulties obtaining ICG for this project.
NCT03345784,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT03345797,TERMINATED,INTERVENTIONAL,Lack of patients and commercial reasons
NCT03345901,TERMINATED,INTERVENTIONAL,recruitment for the substudy did not meet the goals
NCT03345940,TERMINATED,INTERVENTIONAL,"termination of the study due to the slowness of the recruitment activity, according to the contract signed with the Sponsor"
NCT03345953,TERMINATED,INTERVENTIONAL,Study facing recruitment difficulties related to stringent eligibility criteria
NCT03346083,TERMINATED,INTERVENTIONAL,"After completion of Part 1 and prior to initiating Part 2, the Sponsor decided to cease developing betrixaban, prompting early study closure."
NCT03346278,TERMINATED,INTERVENTIONAL,Principal Investigator leaving institution. 38 subjects were enrolled in Aim 1. Aim 2 was not initiated.
NCT03346304,WITHDRAWN,INTERVENTIONAL,drug no longer available
NCT03346538,TERMINATED,INTERVENTIONAL,Business objectives have changed.
NCT03346577,TERMINATED,OBSERVATIONAL,Termination of collaboration
NCT03346681,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT03346850,TERMINATED,INTERVENTIONAL,"Loss of equipoise among enrolling clinicians, as well as emergence of external literature showing safety of nasogastric tube (NGT) feeds."
NCT03347123,TERMINATED,INTERVENTIONAL,A business decision made by Incyte after analysis of data from a sister study.
NCT03347253,TERMINATED,OBSERVATIONAL,As a result of change of clinical development plan.
NCT03347435,TERMINATED,INTERVENTIONAL,Ethics Committe decision
NCT03347461,WITHDRAWN,INTERVENTIONAL,Low use of Otiprio among otolaryngologists.
NCT03347487,TERMINATED,INTERVENTIONAL,7 patients were included in this study which aimed for 13 participants. Preliminary data were sufficient for developing further study.
NCT03347526,SUSPENDED,INTERVENTIONAL,Study on enrollment hold as a precaution per the pharmaceutical company.
NCT03347994,WITHDRAWN,INTERVENTIONAL,Discordance in contractual language and terms.
NCT03348111,WITHDRAWN,INTERVENTIONAL,No participant enrolled
NCT03348137,WITHDRAWN,OBSERVATIONAL,PI left
NCT03348163,TERMINATED,INTERVENTIONAL,Lack of ability to recruit due to COVID-19 pandemic
NCT03348735,TERMINATED,INTERVENTIONAL,Low inclusion rate
NCT03348826,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT03348878,TERMINATED,INTERVENTIONAL,only 4 patients
NCT03348904,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
NCT03349255,TERMINATED,INTERVENTIONAL,Will study new T-cell construct for the same indication
NCT03349346,WITHDRAWN,INTERVENTIONAL,The European Medical Agency granted a Paediatric Investigational Product-specific waiver on the grounds that idelalisib is likely to be unsafe in paediatrics
NCT03349476,TERMINATED,INTERVENTIONAL,study closed prior to meeting enrollment goal due to difficulty enrolling.
NCT03349645,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor due to absence of significant safety findings.
NCT03349775,TERMINATED,INTERVENTIONAL,"After discussion with the Data Safety Monitoring Board and NIH, the randomized clinical trial involving metformin vs. placebo is terminated due to slow enrollment in the setting of the COVID-19 pandemic."
NCT03349827,TERMINATED,INTERVENTIONAL,No enrolled patients received the second surgery.
NCT03349840,TERMINATED,INTERVENTIONAL,The study was terminated by the IRB and the Institutional Official after the MOPH and WCMQ audits
NCT03350178,TERMINATED,INTERVENTIONAL,recruitment shortened
NCT03350269,TERMINATED,INTERVENTIONAL,Study was terminated prior to full enrollment
NCT03350763,WITHDRAWN,INTERVENTIONAL,Investigators busy with other projects at the moment
NCT03351036,WITHDRAWN,OBSERVATIONAL,Change in personnel
NCT03351231,TERMINATED,INTERVENTIONAL,Inability to meet protocol objectives
NCT03351244,TERMINATED,INTERVENTIONAL,disruption due to COVID-19
NCT03351465,WITHDRAWN,INTERVENTIONAL,Trial was suspended due unanticipated funding issues.
NCT03352024,WITHDRAWN,INTERVENTIONAL,internal organizational problem and dysfunction of study material
NCT03352414,TERMINATED,INTERVENTIONAL,stopped by sponsor
NCT03352427,TERMINATED,INTERVENTIONAL,Low accrual
NCT03352453,TERMINATED,INTERVENTIONAL,Study stopped due to business reasons.
NCT03352479,WITHDRAWN,INTERVENTIONAL,this is an observational project and doesn't not meet any of the four criteria required for listing on clinical trials.gov
NCT03352557,TERMINATED,INTERVENTIONAL,The study (NCT03352557) was terminated based on lack of efficacy following the placebo-controlled period readout.
NCT03352609,TERMINATED,INTERVENTIONAL,Investigator completing residency program and leaving for a new job
NCT03352635,WITHDRAWN,OBSERVATIONAL,Study was completed at other sites
NCT03352791,TERMINATED,INTERVENTIONAL,Due to operational changes at the participating agency.
NCT03352856,SUSPENDED,INTERVENTIONAL,Recruitment challenges
NCT03352882,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03353064,TERMINATED,INTERVENTIONAL,inability to recruit subjects
NCT03353181,WITHDRAWN,INTERVENTIONAL,Failure to recruit patients
NCT03353220,TERMINATED,INTERVENTIONAL,The FDA advised of a possible health risk associated with lorcaserin and the drug is being withdrawn.
NCT03353259,TERMINATED,INTERVENTIONAL,DMC concluded that the results of 382 included patients were clear.
NCT03353428,WITHDRAWN,INTERVENTIONAL,combine with NCT03356808
NCT03353454,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to change of ownership of the study drug maralixibat. Future studies of maralixibat will be posted by Mirum Pharmaceuticals.
NCT03353610,TERMINATED,OBSERVATIONAL,Termination due to lack of adequate enrollment
NCT03353727,TERMINATED,INTERVENTIONAL,lack of Financial support
NCT03353792,TERMINATED,INTERVENTIONAL,Initial difficulty with recruitment was exasperated by COVID pause of the study and then the end of funding.
NCT03353896,WITHDRAWN,INTERVENTIONAL,Insufficient accrual
NCT03353987,TERMINATED,INTERVENTIONAL,Patients are not compliant to the daily logbook exercises before surgery. Most will only perform once during training or maximum twice.
NCT03354221,WITHDRAWN,INTERVENTIONAL,Change in literature to suggest at least 6 weeks of initial elimination is necessary to see decrease in eosinophil count.
NCT03354260,TERMINATED,INTERVENTIONAL,lack of patient intube more than 5 days
NCT03354520,WITHDRAWN,INTERVENTIONAL,PI departure from institution
NCT03354611,TERMINATED,INTERVENTIONAL,The study progress doesn't meet the sponsor's requirement
NCT03354637,TERMINATED,INTERVENTIONAL,The double-blind primary endpoint was not met. Open Label Extension period halted as a result.
NCT03354754,TERMINATED,INTERVENTIONAL,"The trial was closed as part of the out-licensure of the drug to Boston Pharmaceuticals, which will continue further clinical development of LYS228/BOS-228"
NCT03354806,WITHDRAWN,INTERVENTIONAL,january 2019
NCT03354832,TERMINATED,OBSERVATIONAL,"small number of utero death, mothers refused to participate"
NCT03354962,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT03355079,TERMINATED,INTERVENTIONAL,Low Patient Recruitment
NCT03355092,WITHDRAWN,INTERVENTIONAL,Funding
NCT03355170,WITHDRAWN,INTERVENTIONAL,The sponsor decided to continue with a different design and a different protocol.
NCT03355300,TERMINATED,INTERVENTIONAL,Insys Therapeutics filed Chapter 11 and terminated all studies.
NCT03355326,TERMINATED,INTERVENTIONAL,Unable to sufficiently recruit candidates
NCT03355482,TERMINATED,INTERVENTIONAL,"poor recruitment, funding"
NCT03355768,WITHDRAWN,INTERVENTIONAL,Study was never opened due to lack of funding
NCT03356119,TERMINATED,INTERVENTIONAL,Inufficient IMD supply due to manufacturing issue
NCT03356496,WITHDRAWN,INTERVENTIONAL,"Delays due to COVID, standard of care has changed, eliminating the need for the study"
NCT03356873,TERMINATED,INTERVENTIONAL,COVID19
NCT03357042,WITHDRAWN,INTERVENTIONAL,researchers did not find participants to meet the inclusion and exclusion criteria for the testing protocols
NCT03357133,TERMINATED,INTERVENTIONAL,The number and speed of enrollment were significantly less than expected.
NCT03357224,TERMINATED,INTERVENTIONAL,Following an urgent safety measure due to toxicity recruitment has been closed prematurely.
NCT03357419,WITHDRAWN,INTERVENTIONAL,difficulties in production placebo antibiotics
NCT03357692,WITHDRAWN,INTERVENTIONAL,no enough patients have been enrolled
NCT03357809,SUSPENDED,INTERVENTIONAL,lake of efficiency and poor tolerance of endoscopic technique
NCT03358004,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT03358095,WITHDRAWN,INTERVENTIONAL,Investigators busy with other projects at the moment.
NCT03358290,TERMINATED,INTERVENTIONAL,Difficulty faced with enrollment in the study
NCT03358407,TERMINATED,INTERVENTIONAL,Terminated due to non clinical toxicology findings and reduced safety margins.
NCT03358706,SUSPENDED,INTERVENTIONAL,unavailability of probe substrates
NCT03359161,TERMINATED,INTERVENTIONAL,Development of first generation device discontinued.
NCT03359174,TERMINATED,INTERVENTIONAL,low recruitment
NCT03359733,WITHDRAWN,INTERVENTIONAL,Business decision: no safety or efficacy concerns
NCT03359798,WITHDRAWN,INTERVENTIONAL,Change in practice patterns
NCT03359941,TERMINATED,INTERVENTIONAL,Low recruit rate
NCT03360006,TERMINATED,INTERVENTIONAL,Strategic Reasons
NCT03360097,TERMINATED,INTERVENTIONAL,No participants met the inclusion criteria in an exted period of time.
NCT03360357,WITHDRAWN,INTERVENTIONAL,Lack of participants to enroll.
NCT03360448,WITHDRAWN,INTERVENTIONAL,Clinical development plans and strategy for RT-100 being re-evaluated
NCT03360474,WITHDRAWN,INTERVENTIONAL,Changed to a QI project
NCT03360851,TERMINATED,INTERVENTIONAL,COVID-19 pandemic has changed routine diagnostic workup of patients admitted with pneumonia. Continuation of the trial was felt to invalidate the study results.
NCT03361085,TERMINATED,INTERVENTIONAL,"COVID-Epidemic with changes in patient mix, restructuring of wards/departments, new standard-precautions"
NCT03361124,WITHDRAWN,INTERVENTIONAL,Investigator no longer interested in proceeding with study
NCT03361137,TERMINATED,INTERVENTIONAL,"The Sponsor decided to terminate the study early for several reasons (low enrollment, limited variety of surgery types, and available scientific data)."
NCT03361189,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03361228,TERMINATED,INTERVENTIONAL,Study was terminated early based on emerging data with epacadostat and pembrolizumab.
NCT03361319,WITHDRAWN,INTERVENTIONAL,Withdrawal of financial support from funder
NCT03361345,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT03361709,WITHDRAWN,INTERVENTIONAL,Inability to perform the study at present time.
NCT03361774,WITHDRAWN,INTERVENTIONAL,Cancelled before Active
NCT03361800,TERMINATED,INTERVENTIONAL,Funding withdrawn.
NCT03361982,TERMINATED,INTERVENTIONAL,recruitment issues
NCT03362021,TERMINATED,OBSERVATIONAL,Primary investigator transferred in another hospital; ongoing pandemic;
NCT03362424,SUSPENDED,INTERVENTIONAL,Cryogenesis company stopped supplying mesenchymal cells
NCT03362515,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to low enrollment numbers and the development of better drugs to treat polyps (ie. Biologics) which were not available when the study began.
NCT03362593,TERMINATED,INTERVENTIONAL,The program is canceled due to company strategic reasons.
NCT03362671,TERMINATED,INTERVENTIONAL,the initial design of the novel oral appliance proved uncomfortable and thus terminated trial after three subjects.
NCT03363009,TERMINATED,INTERVENTIONAL,Logistical issues
NCT03363022,WITHDRAWN,INTERVENTIONAL,Lack of Funds
NCT03363191,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to an internal decision.
NCT03363503,TERMINATED,INTERVENTIONAL,Adequate number of patients could not be reached in the relevant centers.
NCT03363633,TERMINATED,INTERVENTIONAL,difficulty recruiting
NCT03363659,TERMINATED,INTERVENTIONAL,Investigator decision
NCT03363763,TERMINATED,INTERVENTIONAL,Terminated (The clinical trial has ended prematurely due to low patient recruitment)
NCT03363776,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT03363789,WITHDRAWN,INTERVENTIONAL,Insufficient recruitment
NCT03364010,TERMINATED,INTERVENTIONAL,END OF INCLUSIONS
NCT03364075,TERMINATED,INTERVENTIONAL,Recruitment issue
NCT03364686,TERMINATED,INTERVENTIONAL,Due to enrollment challenges related to COVID and lack of coordinator support
NCT03364738,TERMINATED,INTERVENTIONAL,The study was terminated due to Takeda commercial Natpara recall.
NCT03365076,TERMINATED,INTERVENTIONAL,Slow inclusion rate due to patients operated before intervention is implementable
NCT03365414,WITHDRAWN,INTERVENTIONAL,Withdrawal of support of product for trial
NCT03365531,TERMINATED,INTERVENTIONAL,Inadequate enrollment.
NCT03365661,WITHDRAWN,INTERVENTIONAL,Sponsor halted study.
NCT03365752,TERMINATED,INTERVENTIONAL,Study halted due to COVID-19 pandemic and terminated early per request of principal investigator as Chloroprocaine use in spinal procedures has become incorporated as standard of care at HSS.
NCT03365804,SUSPENDED,INTERVENTIONAL,COVID-19 Pandemic
NCT03366012,SUSPENDED,INTERVENTIONAL,Product recall
NCT03366103,TERMINATED,INTERVENTIONAL,Drug supply issues
NCT03366220,TERMINATED,INTERVENTIONAL,The study was halted early due to low patient accrual secondary to COVID-19 and significant heterogeneity in clinical manifestations of sepsis precluding enrollment.
NCT03366467,WITHDRAWN,INTERVENTIONAL,The clinic no longer have sensory adapted environment equipment
NCT03366519,WITHDRAWN,OBSERVATIONAL,no open study
NCT03366662,WITHDRAWN,OBSERVATIONAL,lack of resources
NCT03366675,TERMINATED,INTERVENTIONAL,Early detection of the purpose of the study.
NCT03366792,TERMINATED,INTERVENTIONAL,Investigators chose to discontinue the study based on interim findings
NCT03366961,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03367078,TERMINATED,OBSERVATIONAL,"Organizational problems, change of research priorities"
NCT03367091,TERMINATED,INTERVENTIONAL,Organisational/Recruitment Issues
NCT03367195,TERMINATED,INTERVENTIONAL,"Very low recruitment rate. The Study Site classifies as tertiary referral hospital. Therefore, GERD Patients being referred to the site are mostly those with comorbidities included in the exclusion criteria."
NCT03367234,WITHDRAWN,INTERVENTIONAL,Study experienced delays due to site recruitment. Funder terminated contract.
NCT03367429,TERMINATED,INTERVENTIONAL,too difficult to recruit subjects for the study - muscles naive to botulinum toxin were required and seems that wide availability of the toxin has severely depleted potential subjects.
NCT03367494,TERMINATED,INTERVENTIONAL,Investigator Decision
NCT03367546,TERMINATED,INTERVENTIONAL,Study no longer needed
NCT03367637,WITHDRAWN,INTERVENTIONAL,funding
NCT03367689,TERMINATED,INTERVENTIONAL,Very slow recruitment due to subject profile
NCT03367819,TERMINATED,INTERVENTIONAL,"The study was stopped after interim analysis indicated that overall result was not sufficient to satisfy per-protocol criteria to move forward in metastatic, castration-resistant prostate cancer (mCRPC) and non-small cell lung cancer (NSCLC) cohorts."
NCT03367871,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT03368209,TERMINATED,INTERVENTIONAL,Failed to recruit sufficient subjects
NCT03368417,TERMINATED,INTERVENTIONAL,Due to unforeseen delays and funding issues
NCT03368469,WITHDRAWN,INTERVENTIONAL,The study team was unable to recruit and enroll subjects. The study is now closed.
NCT03368534,WITHDRAWN,INTERVENTIONAL,Device needs modifications
NCT03368560,WITHDRAWN,INTERVENTIONAL,Funding was not received.
NCT03368794,WITHDRAWN,INTERVENTIONAL,Practical difficulties in starting active recruitment.
NCT03368833,TERMINATED,OBSERVATIONAL,Caudal blockade no longer being used in the ORs at this hospital.
NCT03368859,TERMINATED,INTERVENTIONAL,Study may continue
NCT03368976,TERMINATED,OBSERVATIONAL,Interim Goals met. Decision made to terminate in favor of completing the study as a second protocol in the future.
NCT03369184,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03369366,WITHDRAWN,INTERVENTIONAL,Funding not received.
NCT03369444,TERMINATED,INTERVENTIONAL,Terminated early due to challenges during the COVID-19 pandemic and a change in requirements of data to be submitted for marketing authorisation.
NCT03369509,TERMINATED,OBSERVATIONAL,departure of the investigator from the CHU Grenoble Alpes
NCT03369574,WITHDRAWN,OBSERVATIONAL,Study personnel diverted to other activities and the study was not commenced
NCT03369587,TERMINATED,INTERVENTIONAL,Not feasible to restarted after Covid pandemic - analysis will be on data collected before study suspended
NCT03369639,WITHDRAWN,OBSERVATIONAL,"Due to prohibitively high drug cost, physicians were not prescribing the drug."
NCT03369717,SUSPENDED,INTERVENTIONAL,Expired IRB approval since 05/07/2020
NCT03369756,TERMINATED,INTERVENTIONAL,Terminated due to prolonged subject recruitment
NCT03369782,WITHDRAWN,INTERVENTIONAL,refocusing of research priorities
NCT03369912,WITHDRAWN,INTERVENTIONAL,Company decision to withdraw before study started
NCT03369964,WITHDRAWN,INTERVENTIONAL,Business decision: no safety or efficacy concerns.
NCT03370055,WITHDRAWN,INTERVENTIONAL,Study was closed due to lack of participants
NCT03370120,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizure"
NCT03370159,WITHDRAWN,INTERVENTIONAL,Sponsor decided not to move forward
NCT03370185,WITHDRAWN,INTERVENTIONAL,Reassessing corporate priorities.
NCT03370198,TERMINATED,INTERVENTIONAL,Difficulties in patient recruitment and clinical strategy modification based on new clinical data generated in the NKR-2 early development.
NCT03370302,TERMINATED,INTERVENTIONAL,"More favorable safety profile was observed in QD schedule, therefore further enrollment in QW schedule was terminated."
NCT03370510,TERMINATED,INTERVENTIONAL,Covid-19 Pandemic
NCT03370536,TERMINATED,INTERVENTIONAL,1 patient enrolled (consented) but screen failed. Study stopped as unable to enroll.
NCT03370601,TERMINATED,INTERVENTIONAL,Not enough recruitment Lack of funding CR
NCT03370978,WITHDRAWN,INTERVENTIONAL,Study never started as no longer novel
NCT03371173,TERMINATED,INTERVENTIONAL,low recruitment rate; difficulties to achieve planned number of participants within reasonable time frame
NCT03371316,WITHDRAWN,INTERVENTIONAL,Site is no longer participating in study
NCT03371381,TERMINATED,INTERVENTIONAL,Development of JNJ-64041757 in combination with nivolumab discontinued due to lack of clinical benefit observed in the Phase 1b portion of the study
NCT03371420,TERMINATED,INTERVENTIONAL,Company has ceased operations
NCT03371498,TERMINATED,INTERVENTIONAL,Insufficient recruitment of eligible patients.
NCT03371745,TERMINATED,INTERVENTIONAL,The Reproductive Medicine Network was disbanded
NCT03371823,TERMINATED,INTERVENTIONAL,We experienced challenges recruiting unmedicated women with high blood pressure for the intervention.
NCT03371862,WITHDRAWN,INTERVENTIONAL,No participants recruited. Not able to recruit due to COVID 19.
NCT03371914,TERMINATED,INTERVENTIONAL,Due to defunding of USAID project that supported the majority of the sites selected in the randomization.
NCT03372070,WITHDRAWN,INTERVENTIONAL,Administrative reasons
NCT03372148,WITHDRAWN,INTERVENTIONAL,Study withdrawn by PI
NCT03372603,TERMINATED,INTERVENTIONAL,Study terminated due to lack of efficacy of GSK2798745 in chronic cough.
NCT03372941,TERMINATED,INTERVENTIONAL,Funding and recruitment limited by pandemic
NCT03373123,WITHDRAWN,INTERVENTIONAL,Funding issue
NCT03373305,WITHDRAWN,INTERVENTIONAL,contract not executed
NCT03373422,TERMINATED,INTERVENTIONAL,Study BAY1128688/17472 (AKRENDO 1) was terminated early on 20 July 2018 due to hepatotoxicity
NCT03373877,TERMINATED,INTERVENTIONAL,Samus is focusing all of their efforts in myelofibrosis on the new oral formulation of PU-H71.
NCT03373981,TERMINATED,INTERVENTIONAL,Did not meet target enrollment
NCT03374215,SUSPENDED,OBSERVATIONAL,New recruitment is temporarily on hold while the protocol is modified and will resume once updates are completed.
NCT03374605,WITHDRAWN,INTERVENTIONAL,"This small mechanistic pilot study was ended prior to first enrollment after considering factors related to feasibility (e.g., available time and resources)."
NCT03374670,WITHDRAWN,INTERVENTIONAL,No patients were enrolled. Study terminated for portfolio reasons.
NCT03374709,WITHDRAWN,INTERVENTIONAL,Resource and time constraints were encountered by product manufacturer and study team.
NCT03374852,WITHDRAWN,INTERVENTIONAL,PI Left institution on 8/6/2018 and study has been final reported with IRB. Never opened to accrual
NCT03375411,WITHDRAWN,INTERVENTIONAL,CHANGE TO ANOTHER PLATFORM IN STUDY.
NCT03375541,WITHDRAWN,INTERVENTIONAL,Clinical workflow was too high
NCT03375606,TERMINATED,INTERVENTIONAL,The Sponsor decided to terminate this study in favor of development of subcutaneous administration.
NCT03376139,WITHDRAWN,INTERVENTIONAL,Futility
NCT03376204,WITHDRAWN,OBSERVATIONAL,"It has been impossible to recruit any participants fulfilling both the inclusion criteria. Therefore, the current study protocol is no longer valid."
NCT03376230,TERMINATED,OBSERVATIONAL,not enough recruitment
NCT03376256,TERMINATED,INTERVENTIONAL,Difficulty in participant recruitment
NCT03376321,TERMINATED,INTERVENTIONAL,Study terminated early (date of study termination decision: 28 August 2020) as a result of the outcome of the pre-planned Interim Analysis.
NCT03376399,WITHDRAWN,OBSERVATIONAL,No participants enrolled. Study terminated at PI's discretion
NCT03376659,TERMINATED,INTERVENTIONAL,Study closed due to lack of enrollment.
NCT03376854,WITHDRAWN,INTERVENTIONAL,Competition from other studies and initiation of a larger multi center trial
NCT03376932,WITHDRAWN,INTERVENTIONAL,withdrawn due to internal reasons
NCT03376984,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT03377088,SUSPENDED,INTERVENTIONAL,Poor recruitment
NCT03377101,WITHDRAWN,INTERVENTIONAL,change in study design.
NCT03377309,TERMINATED,INTERVENTIONAL,Study halted due to adverse events
NCT03377426,WITHDRAWN,INTERVENTIONAL,The trial was terminated due to an out-licensing agreement after the new sponsor did not wish to continue the trial
NCT03377595,WITHDRAWN,INTERVENTIONAL,"Lack of resources, no data collected"
NCT03377621,WITHDRAWN,INTERVENTIONAL,"Study was not funded, and therefore not conducted"
NCT03377660,TERMINATED,OBSERVATIONAL,Funding stopped.
NCT03377725,WITHDRAWN,INTERVENTIONAL,No patient was involved.
NCT03377751,TERMINATED,INTERVENTIONAL,Majority of enrolled patients have withdrawn.
NCT03377764,TERMINATED,OBSERVATIONAL,The interim data analysis shows no significant difference between groups
NCT03378050,WITHDRAWN,INTERVENTIONAL,Study Never Began
NCT03378063,WITHDRAWN,INTERVENTIONAL,no stell cell accessed
NCT03378388,TERMINATED,OBSERVATIONAL,Business Decision; Insufficient Enrollment
NCT03378466,TERMINATED,INTERVENTIONAL,infeasible to continue due-to inability to recruit during the COVID-19 pandemic and grants coming to an end.
NCT03378492,WITHDRAWN,INTERVENTIONAL,"Study did not enroll, was closed"
NCT03378973,TERMINATED,INTERVENTIONAL,No longer clinically relevant
NCT03379025,WITHDRAWN,INTERVENTIONAL,did not start RCT due to current concerns about vaping-related lung illness
NCT03379051,TERMINATED,INTERVENTIONAL,Strategic/Business Decision
NCT03379233,TERMINATED,INTERVENTIONAL,devices malfunctioned
NCT03379259,TERMINATED,INTERVENTIONAL,Study Was Terminated Early
NCT03379272,WITHDRAWN,INTERVENTIONAL,Device evolves.
NCT03379363,TERMINATED,OBSERVATIONAL,Insufficient number of patients
NCT03379493,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT03379558,TERMINATED,OBSERVATIONAL,(due to change in the post-marketing requirement to assess alirocumab during pregnancy)
NCT03379584,TERMINATED,INTERVENTIONAL,Due to overall benefit/risk profile
NCT03379714,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT03380091,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT03380104,WITHDRAWN,INTERVENTIONAL,Unable to obtain FDA IDE approval. Currently working on additional preclinical testing.
NCT03380273,TERMINATED,INTERVENTIONAL,Patient enrollment too small and slow due to pandemic situation
NCT03380286,WITHDRAWN,OBSERVATIONAL,Funding issue
NCT03380507,TERMINATED,INTERVENTIONAL,The research is no longer funded and terminated due to futility
NCT03380689,WITHDRAWN,INTERVENTIONAL,There is no fund to support it
NCT03380767,WITHDRAWN,INTERVENTIONAL,Lack of financial support
NCT03380936,TERMINATED,INTERVENTIONAL,Slower than expected recruitment rate
NCT03381118,TERMINATED,INTERVENTIONAL,Unexpected toxicity
NCT03381144,TERMINATED,INTERVENTIONAL,Molecule development was terminated
NCT03381196,TERMINATED,INTERVENTIONAL,Based on interim Analysis outcome being futile for FLZ3001; decision was taken to stop (early terminate) both FLZ3001/3002. There was no safety concern.
NCT03381365,TERMINATED,INTERVENTIONAL,low recruitment
NCT03381677,SUSPENDED,INTERVENTIONAL,In light of the ongoing COVID-19 pandemic and its impact on clinical trials
NCT03381729,TERMINATED,INTERVENTIONAL,"Based upon overall strategic objectives within the broader intrathecal clinical development program, Novartis Gene Therapies decided to terminate the study early."
NCT03381833,TERMINATED,INTERVENTIONAL,Terminated early for lack of efficacy as determined by interim endpoint analyses
NCT03381859,WITHDRAWN,INTERVENTIONAL,HCV treatment expansion occurred in Egypt
NCT03382041,TERMINATED,INTERVENTIONAL,Original PI no longer works at UAB
NCT03382249,WITHDRAWN,INTERVENTIONAL,redesign
NCT03382574,TERMINATED,INTERVENTIONAL,"it was decided that due to lack of accrual on the trial, and low potential for accruing over the near future, the trial will be shut down."
NCT03382613,TERMINATED,OBSERVATIONAL,Operating Company decided to stop study due to strategic realignment and budgetary reasons
NCT03382665,TERMINATED,OBSERVATIONAL,"CE mark will not be renewed, PMCF data no longer required"
NCT03382769,TERMINATED,INTERVENTIONAL,"Early terminated due to COVID-19 public health emergency, with a patient population in vulnerable populations (older adults) seeking cochlear implantation as elective Standard of Care."
NCT03382886,TERMINATED,INTERVENTIONAL,PI decided to terminate due to low/slow accrual
NCT03382899,TERMINATED,INTERVENTIONAL,The CYPRESS-1 trial was closed early after the planned primary analysis because the risk benefit ratio is unfavorable.
NCT03382912,TERMINATED,INTERVENTIONAL,The CYPRESS-2 trial was closed early after the planned final analysis because the risk benefit ratio is unfavorable.
NCT03382925,TERMINATED,INTERVENTIONAL,Not enough cervical interlaminar patients who meet criteria in order to meet recruitment goals.
NCT03383146,TERMINATED,INTERVENTIONAL,The Relamorelin program is being terminated solely based on a business decision.
NCT03383198,TERMINATED,INTERVENTIONAL,Early termination due to manufacturer discontinued supplying the product for the study.
NCT03383588,TERMINATED,INTERVENTIONAL,study was published during initial recruitment that showed no difference
NCT03383666,TERMINATED,INTERVENTIONAL,No safety issues; change in innovation strategy
NCT03383861,TERMINATED,OBSERVATIONAL,This is not a clinical trial and is only a retrospective chart review. This was inadvertently entered into the system as a clinical trial.
NCT03384095,WITHDRAWN,INTERVENTIONAL,study abandoned prior to opening to accrual or study start
NCT03384524,WITHDRAWN,INTERVENTIONAL,withdrawn during planning stages
NCT03384810,WITHDRAWN,OBSERVATIONAL,Collecting data correctly according to the study protocol was not possible
NCT03384875,TERMINATED,INTERVENTIONAL,Sponsor's decision for business reasons
NCT03385057,WITHDRAWN,INTERVENTIONAL,Study design flaws; research design needed to be reconfigured
NCT03385083,TERMINATED,INTERVENTIONAL,IRB approval lapsed
NCT03385317,WITHDRAWN,INTERVENTIONAL,There was not enough manpower to complete the study.
NCT03385343,TERMINATED,INTERVENTIONAL,Device company went out of business
NCT03385395,WITHDRAWN,INTERVENTIONAL,IND has been closed.
NCT03385603,WITHDRAWN,INTERVENTIONAL,No individuals met eligibility or were enrolled.
NCT03385967,WITHDRAWN,INTERVENTIONAL,PI is leaving the University of Florida
NCT03386162,TERMINATED,INTERVENTIONAL,Study was halted Prematurely for low recruitment.
NCT03386214,TERMINATED,INTERVENTIONAL,Sponsor stopped development of pevonedistat
NCT03386227,TERMINATED,INTERVENTIONAL,The study was prematurely stopped due to extremely low recruitment and lack of feasibility to continue.
NCT03386344,TERMINATED,INTERVENTIONAL,Study terminated prematurely for financial reasons and Covid-19 pandemic.
NCT03386721,TERMINATED,INTERVENTIONAL,"The Sponsor discontinued the development of Simlukafusp alfa due to portfolio prioritization, not due to any safety, efficacy, or quality issues."
NCT03386786,TERMINATED,INTERVENTIONAL,Business decision to close study due to slow enrollment.
NCT03386838,WITHDRAWN,INTERVENTIONAL,Business objectives have changed.
NCT03386929,TERMINATED,INTERVENTIONAL,The SPRING trial had to be early terminated at the end of the Phase 1 portion of the study due to the absence of funding necessary for the performance of the Phase 2.
NCT03387033,TERMINATED,INTERVENTIONAL,enrollment closed due to lack of funding
NCT03387046,TERMINATED,INTERVENTIONAL,Study was terminated early due to slow recruitment rate.
NCT03387059,TERMINATED,INTERVENTIONAL,"The study was terminated early, due to the poor feasibility and sustainability, leading to slow recruitment rate."
NCT03387267,TERMINATED,INTERVENTIONAL,Study terminated due to futility
NCT03387332,TERMINATED,INTERVENTIONAL,The company adjusts strategy.
NCT03387514,TERMINATED,INTERVENTIONAL,Termination of funding due to low subject enrollment due to change in standard of care systemic therapy which limited available patients treated with anti-angiogenesis or combined immune and anti-angiogenesis therapy for enrollment.
NCT03388164,TERMINATED,INTERVENTIONAL,The study was terminated early based on the planned interim analysis that did not meet criteria for continuation.
NCT03388242,WITHDRAWN,OBSERVATIONAL,The research group is too busy to do this study.
NCT03388255,TERMINATED,INTERVENTIONAL,the clinical center has too much difficulty recruiting as a rare condition
NCT03388814,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03388931,WITHDRAWN,INTERVENTIONAL,lack of subject enrollment
NCT03389048,TERMINATED,INTERVENTIONAL,Protocol compliance and inability to support proper performance
NCT03389061,WITHDRAWN,INTERVENTIONAL,Lack of patients who are eligible for inclusion: less patients on treatment and not using epclusa.
NCT03389373,WITHDRAWN,INTERVENTIONAL,Saliva testing was not sensitive enough to correctly identify high risk patients
NCT03389438,TERMINATED,INTERVENTIONAL,Shortage of funds.
NCT03389685,SUSPENDED,INTERVENTIONAL,"COVID-19, Lack of Funding"
NCT03389893,TERMINATED,INTERVENTIONAL,Due to inability to meet accrual goals within the funding period.
NCT03390049,WITHDRAWN,INTERVENTIONAL,No funding
NCT03390088,WITHDRAWN,OBSERVATIONAL,The estimated number of patients could not be recorded in this study
NCT03390309,WITHDRAWN,INTERVENTIONAL,no funding
NCT03390413,WITHDRAWN,INTERVENTIONAL,Logistics and lack of funding
NCT03390530,WITHDRAWN,INTERVENTIONAL,Closed by PI prior to approval
NCT03390543,WITHDRAWN,INTERVENTIONAL,The study plan is cancelled because of difficulties in the progress of the study.
NCT03390647,WITHDRAWN,INTERVENTIONAL,Decision of Sponsor
NCT03390738,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew funding for Nivolumab
NCT03391050,TERMINATED,INTERVENTIONAL,Target patient population - difficult to find patientes
NCT03391674,WITHDRAWN,INTERVENTIONAL,Change in protocol and delay in study initiation led to new study submission
NCT03391765,TERMINATED,INTERVENTIONAL,This study was prematurely discontinued because the program for progressive supranuclear palsy was discontinued due to lack of efficacy.
NCT03391791,TERMINATED,OBSERVATIONAL,terminated after participants were enrolled
NCT03391856,TERMINATED,INTERVENTIONAL,protocol changed
NCT03392064,SUSPENDED,INTERVENTIONAL,"Study on enrollment hold, may potentially resume. No active subjects on trial."
NCT03392480,WITHDRAWN,OBSERVATIONAL,The research group cannot found time to do the project.
NCT03392571,WITHDRAWN,INTERVENTIONAL,Study was stopped due to lack of funding
NCT03393000,TERMINATED,INTERVENTIONAL,Business decision on behalf of the Sponsor.
NCT03393117,WITHDRAWN,INTERVENTIONAL,No accrual
NCT03393273,WITHDRAWN,INTERVENTIONAL,Investigator decision in accordance with the promotor
NCT03393325,WITHDRAWN,OBSERVATIONAL,Sponsor decision. The study is not anticipated to start
NCT03393481,WITHDRAWN,INTERVENTIONAL,Trial cancelled before First Patient First Visit (no patient enrolled)
NCT03393546,TERMINATED,INTERVENTIONAL,PI resigned
NCT03393806,TERMINATED,INTERVENTIONAL,Recruitment was terminated early before meeting target enrolment due to a high screen failure rate and the feasibility of completing the study in a timely way
NCT03393858,TERMINATED,INTERVENTIONAL,The number of enrolled cases is insufficient
NCT03393962,SUSPENDED,INTERVENTIONAL,combine with another trial
NCT03394040,TERMINATED,OBSERVATIONAL,PI left the NIH
NCT03394183,WITHDRAWN,INTERVENTIONAL,Insufficient study personnel
NCT03394196,TERMINATED,INTERVENTIONAL,COVID-19 and Funding
NCT03394573,TERMINATED,OBSERVATIONAL,insufficient recuritment due to covid
NCT03394664,TERMINATED,INTERVENTIONAL,The FB4 trial has been terminated due to COVID-19.
NCT03394716,TERMINATED,OBSERVATIONAL,Low inclusion rate; Change of position of principal investigator.
NCT03394768,TERMINATED,OBSERVATIONAL,Interim analysis shown futility to continue due to lack of benefit.
NCT03394781,TERMINATED,INTERVENTIONAL,poor enrollment
NCT03394937,TERMINATED,INTERVENTIONAL,Expiry of study medication
NCT03394976,WITHDRAWN,OBSERVATIONAL,Funding
NCT03395132,TERMINATED,INTERVENTIONAL,"Due to business strategic reasons, LEO Pharma has decided to close down the FCF-38 trial."
NCT03395275,WITHDRAWN,INTERVENTIONAL,lack of recruitment and funding
NCT03395288,TERMINATED,INTERVENTIONAL,Performed a futility analysis and determined that study objectives could not be met.
NCT03395314,TERMINATED,INTERVENTIONAL,assessment of project in wake of covid-19 related interruptions
NCT03395340,TERMINATED,INTERVENTIONAL,Forced to close study due to poor recruitment (company withdrew drug support).
NCT03395353,TERMINATED,INTERVENTIONAL,Business decision
NCT03395652,WITHDRAWN,OBSERVATIONAL,technical problems
NCT03395678,WITHDRAWN,INTERVENTIONAL,Sample size can not be obtained at this site.
NCT03395873,TERMINATED,INTERVENTIONAL,Recent FDA approval of a new drug for the same patient population
NCT03395925,WITHDRAWN,INTERVENTIONAL,Study was not started
NCT03396419,TERMINATED,OBSERVATIONAL,Terminated following the completion of ImpACT-24B study
NCT03396484,WITHDRAWN,INTERVENTIONAL,Study not begun due to continued laboratory work on the feasibility of outcome measures.
NCT03396666,TERMINATED,INTERVENTIONAL,Inclusion of the last Patient
NCT03396705,TERMINATED,OBSERVATIONAL,Poor recruitment
NCT03396809,WITHDRAWN,INTERVENTIONAL,PI left the institution. There are no publications for this research \& this is not Applicable Clinical Trial.
NCT03396861,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03396978,TERMINATED,INTERVENTIONAL,Investigator left the institution
NCT03397186,WITHDRAWN,INTERVENTIONAL,Administrative
NCT03397342,TERMINATED,INTERVENTIONAL,Study terminated prematurely well short of enrollment target. Only 5 health participants were enrolled
NCT03397394,TERMINATED,INTERVENTIONAL,Efficacy did not meet the continuance criteria and DMC recommended to stop enrollment.
NCT03397446,TERMINATED,INTERVENTIONAL,"Loss of resources due to COVID-19 resulted in insufficient funds to complete the trial as planned. However, sufficient data was collected to fulfill the aims of the trial. Discontinuation is not related to the drug, its use, or adverse events."
NCT03397524,WITHDRAWN,INTERVENTIONAL,This study was dependent on an IT interoperability component requiring additional development.
NCT03397550,WITHDRAWN,OBSERVATIONAL,feasibility is being questioned
NCT03397927,WITHDRAWN,INTERVENTIONAL,No response to EC questions were given
NCT03397966,TERMINATED,INTERVENTIONAL,Study drug no longer available
NCT03398018,WITHDRAWN,INTERVENTIONAL,Change of direction
NCT03398252,WITHDRAWN,INTERVENTIONAL,No funding
NCT03398434,WITHDRAWN,INTERVENTIONAL,Trial cancelled before First Patient First Visit (no patient enrolled)
NCT03398512,TERMINATED,INTERVENTIONAL,No enrolled patients received the second surgery.
NCT03398837,TERMINATED,INTERVENTIONAL,Sponsor terminated open-label extension
NCT03399097,WITHDRAWN,OBSERVATIONAL,change sites
NCT03399162,WITHDRAWN,INTERVENTIONAL,"Due to a reduction in surgical wait times, there was insufficient time to complete the intervention prior to surgery."
NCT03399227,WITHDRAWN,OBSERVATIONAL,no funding
NCT03399305,WITHDRAWN,OBSERVATIONAL,investigators have decided not to continue with the study
NCT03399435,TERMINATED,INTERVENTIONAL,The sponsor decided to stop further dosing of healthy volunteers after reviewing the obtained efficacy data. The decision is not related to any safety concern.
NCT03399448,TERMINATED,INTERVENTIONAL,Sponsor has terminated trial to pursue other targets.
NCT03399578,TERMINATED,INTERVENTIONAL,"The scientific questions proposed remain relevant, but will now be addressed in a larger phase II immunogenicity trial of the ChAdOx1 MERS vaccine given at 2 doses."
NCT03399643,TERMINATED,OBSERVATIONAL,Tecentriq label restriction for first line limited the patient population and scientific question could not be answered in an appropriate time.
NCT03399825,WITHDRAWN,OBSERVATIONAL,administrative hurdles
NCT03399838,WITHDRAWN,INTERVENTIONAL,Sponsor left the hospital
NCT03400176,TERMINATED,INTERVENTIONAL,Business reasons
NCT03400254,WITHDRAWN,INTERVENTIONAL,due to business decision regarding the study drug.
NCT03400306,WITHDRAWN,INTERVENTIONAL,Strategic considerations
NCT03400748,TERMINATED,INTERVENTIONAL,business reason
NCT03400852,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03400943,TERMINATED,INTERVENTIONAL,"Due to a change in the development program, the study was closed prematurely."
NCT03400956,TERMINATED,INTERVENTIONAL,"Due to a change in the development program, the study was closed prematurely."
NCT03401125,WITHDRAWN,OBSERVATIONAL,Results already published by another team
NCT03401580,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03401606,TERMINATED,INTERVENTIONAL,a respiratory depression in remifentanyl group
NCT03401658,WITHDRAWN,OBSERVATIONAL,Funding stopped
NCT03401710,TERMINATED,INTERVENTIONAL,For very slow recruitment
NCT03401736,WITHDRAWN,INTERVENTIONAL,Can't get enough participant
NCT03401749,TERMINATED,INTERVENTIONAL,"Funding issues, poor recruiting and compliance of the patients."
NCT03401931,WITHDRAWN,OBSERVATIONAL,another design of protocole is submitted for approuval before the start date
NCT03402178,TERMINATED,INTERVENTIONAL,Safety Review
NCT03402607,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03402737,TERMINATED,INTERVENTIONAL,Poor recrual.
NCT03402789,WITHDRAWN,INTERVENTIONAL,"Hopkins failed to review contract with company providing complimentary dha, support was withdrawn necessitating me to get more grant money to fund study which was unsucccessful."
NCT03402880,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT03403205,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the program
NCT03403361,TERMINATED,INTERVENTIONAL,Low accrual
NCT03403413,TERMINATED,INTERVENTIONAL,Funding ran out
NCT03403621,TERMINATED,INTERVENTIONAL,Funding changes.
NCT03403725,TERMINATED,INTERVENTIONAL,"Terminated after achievement of MTD, without progressing to cohort expansion for Company decision."
NCT03403751,TERMINATED,INTERVENTIONAL,Very slow enrollment of target patient population
NCT03403803,TERMINATED,OBSERVATIONAL,Were not able to meet enrollment goal due to inclusion/exclusion criteria
NCT03404089,TERMINATED,INTERVENTIONAL,insufficient inclusions
NCT03404310,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03404713,TERMINATED,INTERVENTIONAL,Participant enrollment into stepped-care model was not feasible.
NCT03404726,TERMINATED,INTERVENTIONAL,Lack of sufficient clinical benefit
NCT03404934,TERMINATED,INTERVENTIONAL,Terminated by mutual agreement between the site and sponsor
NCT03405194,WITHDRAWN,INTERVENTIONAL,"Haiti gained access to dolutegravir as first-line ART, so we cancelled the study before any patient was enrolled (we didn't want SOC group to receive EFV)"
NCT03405311,TERMINATED,INTERVENTIONAL,"The study device is not working, and there is no funding available to purchase or rent a new one."
NCT03405532,SUSPENDED,OBSERVATIONAL,Not enough eligible patients leading to slow recruitment
NCT03405636,WITHDRAWN,INTERVENTIONAL,Study not started
NCT03405727,WITHDRAWN,INTERVENTIONAL,Lack of human ressources
NCT03406052,SUSPENDED,INTERVENTIONAL,New funding required
NCT03406195,WITHDRAWN,INTERVENTIONAL,"No participants recruited, IRB closed"
NCT03406273,WITHDRAWN,INTERVENTIONAL,"No enrollment to study, study closed"
NCT03406533,TERMINATED,INTERVENTIONAL,The sample size should be re-calculated based on the first 28 cases.
NCT03406546,TERMINATED,INTERVENTIONAL,The sample size should be re-calculated based on the first 20 cases.
NCT03406715,TERMINATED,INTERVENTIONAL,Sponsor closed study
NCT03407040,TERMINATED,OBSERVATIONAL,Investigator left NIH
NCT03407079,SUSPENDED,INTERVENTIONAL,The status was on admin hold with the prev. PI. The new PI (Dr. Joseph) would like to continue to keep the study on admin hold until after reviewing the study
NCT03407170,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT03407287,TERMINATED,OBSERVATIONAL,"interim analysis, closed for additional product development"
NCT03407404,TERMINATED,INTERVENTIONAL,Futility
NCT03407430,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT03407482,TERMINATED,INTERVENTIONAL,The study was ended early due to the lack of efficacy seen in the parent study GA30044.
NCT03407950,WITHDRAWN,INTERVENTIONAL,The study stopped due to major feasibility issues and the notices was expired.
NCT03407976,TERMINATED,INTERVENTIONAL,Funding source withdrew financial support prior to start of Phase II portion of study
NCT03408015,WITHDRAWN,INTERVENTIONAL,Study timing was poor.
NCT03408405,WITHDRAWN,INTERVENTIONAL,Withdrawal of funding from primary sponsor
NCT03408561,WITHDRAWN,INTERVENTIONAL,No accrual
NCT03408613,SUSPENDED,INTERVENTIONAL,equipment recall
NCT03408652,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT03409094,WITHDRAWN,OBSERVATIONAL,equipments and staff are unavailable.
NCT03409185,TERMINATED,INTERVENTIONAL,"The study was terminated because of low recruitment/enrolment due to multiple reasons, including 1) Elderly population, often with other health issues, thus not being able to commit to all of the follow-up appointments and 2) COVID-19 restrictions."
NCT03409224,TERMINATED,OBSERVATIONAL,not enough participants
NCT03409237,WITHDRAWN,OBSERVATIONAL,No participant enrolled. The human resources to perform the study also due to the COBID emegency
NCT03409289,TERMINATED,OBSERVATIONAL,Expired IRB
NCT03409341,WITHDRAWN,OBSERVATIONAL,No enrollment
NCT03409601,TERMINATED,INTERVENTIONAL,Additional outcome measures have been developed and added to the protocol.
NCT03409679,TERMINATED,INTERVENTIONAL,Safety data review
NCT03409757,TERMINATED,OBSERVATIONAL,Insufficient Patient Recruitment
NCT03409783,WITHDRAWN,INTERVENTIONAL,Decided not to enroll into this study due to costs and other factors
NCT03410056,TERMINATED,INTERVENTIONAL,Amgen made a business decision not to proceed with Phase 2.
NCT03410082,TERMINATED,INTERVENTIONAL,extremely slow enrollment
NCT03410355,TERMINATED,INTERVENTIONAL,Health Canada no longer allowed use of BMAC
NCT03410407,TERMINATED,OBSERVATIONAL,lack of interest
NCT03410420,SUSPENDED,INTERVENTIONAL,"Study is in the process of changing institutions, and is currently being held until the process of transferring institutions, including all regulatory steps is completed."
NCT03410628,TERMINATED,INTERVENTIONAL,Company decision
NCT03410927,TERMINATED,INTERVENTIONAL,The study was stopped due to unacceptable toxicity during the dose-escalation portion (Phase 1) of the study and did not progress to Phase 2
NCT03410940,TERMINATED,OBSERVATIONAL,The production of the device was stopped due to economic reasons. Basic post-market surveillance activities will be continued.
NCT03411031,TERMINATED,INTERVENTIONAL,Sponsor no longer providing drug
NCT03411057,TERMINATED,OBSERVATIONAL,PI is leaving the institution
NCT03411252,TERMINATED,INTERVENTIONAL,inability to enroll
NCT03411421,TERMINATED,INTERVENTIONAL,The study was closed as the data received to date did not support continuation of the study.
NCT03411447,TERMINATED,INTERVENTIONAL,stopped on Data Safety and Monitoring Board 's request
NCT03411460,TERMINATED,INTERVENTIONAL,logistical difficulties
NCT03411473,TERMINATED,INTERVENTIONAL,Trial will not proceed due to changes in the treatment landscape.
NCT03411499,TERMINATED,INTERVENTIONAL,Study stopped because of low enrollment.
NCT03411837,TERMINATED,OBSERVATIONAL,Investigator moved from institution.
NCT03412253,SUSPENDED,INTERVENTIONAL,"financial causes, and the study will be continued within days."
NCT03412370,TERMINATED,OBSERVATIONAL,Insufficient Accrual
NCT03412422,WITHDRAWN,OBSERVATIONAL,The study has been stopped due to technical difficulties.
NCT03412630,TERMINATED,INTERVENTIONAL,poor accrual
NCT03412734,TERMINATED,INTERVENTIONAL,The institutional review board recommended the study stop enrollment prior to achieving its initial sample size for patient safety.
NCT03412929,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03413839,WITHDRAWN,INTERVENTIONAL,No research resources to complete study
NCT03413891,TERMINATED,INTERVENTIONAL,Advice from DSMB
NCT03413930,WITHDRAWN,INTERVENTIONAL,No funding was raised
NCT03413969,TERMINATED,INTERVENTIONAL,Study has been terminated due to recruitment challenges in targeted area.
NCT03414008,TERMINATED,INTERVENTIONAL,Preclinical finding
NCT03414281,TERMINATED,INTERVENTIONAL,we use this data as a pilot study
NCT03414307,WITHDRAWN,INTERVENTIONAL,COVID 19 Pandemic
NCT03414450,WITHDRAWN,INTERVENTIONAL,Withdrawal requested by D3
NCT03414788,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to not being able to recruit subjects.
NCT03415256,WITHDRAWN,INTERVENTIONAL,Lack of time currently.
NCT03415581,TERMINATED,INTERVENTIONAL,Study terminated by sponsor due to bad risk/benefit ratio.
NCT03415685,TERMINATED,INTERVENTIONAL,Study stopped due to pivot in company clinical strategy.
NCT03415711,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT03415776,TERMINATED,INTERVENTIONAL,"Very slow recruitment due to many challenges: 1-COVID-19 pandemic 2-Several units did not include their patients, 3-Many nephrologists left the country, 4-Severe economic crisis"
NCT03415906,WITHDRAWN,INTERVENTIONAL,Difficulties in recruiting patients
NCT03416049,TERMINATED,OBSERVATIONAL,"Dr. Siddiqui, the principal investigator, was unable to continue recruiting during and after covid."
NCT03416140,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03416192,WITHDRAWN,INTERVENTIONAL,Capacity shortage
NCT03416452,WITHDRAWN,INTERVENTIONAL,Investigator left the NIH.
NCT03416569,WITHDRAWN,INTERVENTIONAL,Unanticipated staff changes are preventing completion within funding period.
NCT03416816,TERMINATED,INTERVENTIONAL,Alternate development strategy
NCT03417024,TERMINATED,OBSERVATIONAL,Change in business strategy
NCT03417037,WITHDRAWN,INTERVENTIONAL,Business objectives have changed.
NCT03417076,WITHDRAWN,INTERVENTIONAL,Sponsor decision to not initiate study due to sufficient bioavailability information
NCT03417401,WITHDRAWN,INTERVENTIONAL,organizationally not yet possible
NCT03417492,TERMINATED,INTERVENTIONAL,"Difficulty enrolling participants due to COVID emergency, and planned start of new study to address this question in a more rigorous fashion."
NCT03417570,TERMINATED,INTERVENTIONAL,Futility
NCT03417765,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03417830,TERMINATED,INTERVENTIONAL,Change in benefit/risk profile.
NCT03417882,TERMINATED,INTERVENTIONAL,Recruitment rate too slow
NCT03417921,SUSPENDED,INTERVENTIONAL,We opened another study.
NCT03417973,TERMINATED,OBSERVATIONAL,Sponsor withdrew funding
NCT03417999,TERMINATED,INTERVENTIONAL,"All subjects who were enrolled completed the study. However, the PI left the institution and the study was terminated before all cohorts were enrolled."
NCT03418116,WITHDRAWN,INTERVENTIONAL,Company Decision
NCT03418272,WITHDRAWN,OBSERVATIONAL,Study withdrawn until time and staff allow its completion.
NCT03418532,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03418571,TERMINATED,INTERVENTIONAL,"The Sponsor decided to discontinue ALX-0171 development (due to insufficient evidence of efficacy). As a result, the ALX0171-C203 study was early terminated."
NCT03418649,WITHDRAWN,INTERVENTIONAL,Unable to recruit subjects
NCT03418805,TERMINATED,INTERVENTIONAL,Sponsor's consideration of product development strategies
NCT03419130,WITHDRAWN,INTERVENTIONAL,Study withdrawn prior to patient enrollment
NCT03419156,TERMINATED,INTERVENTIONAL,Study ended after review
NCT03419247,WITHDRAWN,INTERVENTIONAL,Study was not activated
NCT03419403,TERMINATED,INTERVENTIONAL,The study was terminated because clinical development of depatuxizumab mafodotin in glioblastoma was stopped due to lack of survival benefit.
NCT03419559,WITHDRAWN,INTERVENTIONAL,The treatment landscape for NSCLC has evolved in the past year. An additional NSCLC arm will be added to the IOV-COM-202 study using TIL + pembrolizumab.
NCT03419624,TERMINATED,INTERVENTIONAL,Delay in patient enrolment
NCT03420222,TERMINATED,INTERVENTIONAL,"Due to limited enrollment (N=10), this clinical trial was terminated by the Sponsor."
NCT03420456,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding for reasons unrelated to safety or efficacy
NCT03420521,TERMINATED,INTERVENTIONAL,Loss of funding
NCT03420781,TERMINATED,INTERVENTIONAL,The Relamorelin program is being terminated solely based on a business decision.
NCT03420846,TERMINATED,INTERVENTIONAL,Funding exhausted. Sufficient data already collected.
NCT03420976,WITHDRAWN,INTERVENTIONAL,PI no longer in practice.
NCT03421041,WITHDRAWN,INTERVENTIONAL,protocol change
NCT03421106,TERMINATED,INTERVENTIONAL,Data collection was halted prematurely due to COVID-19.
NCT03421496,TERMINATED,INTERVENTIONAL,The study was terminated due to slow enrollment and failure to identify adequate patients that met entry criteria.
NCT03421548,WITHDRAWN,INTERVENTIONAL,The product company withdrawn interest in participation in this study
NCT03421665,WITHDRAWN,OBSERVATIONAL,Sponsor decided to pursue an alternative study prior to subject enrollment.
NCT03421678,WITHDRAWN,OBSERVATIONAL,Study was completed at other sites
NCT03421756,TERMINATED,INTERVENTIONAL,Trial terminated due to low rate of enrollment
NCT03421938,WITHDRAWN,INTERVENTIONAL,I changed my PhD thesis
NCT03421951,TERMINATED,OBSERVATIONAL,Sponsor withdrew funding
NCT03422094,TERMINATED,INTERVENTIONAL,Manufacturer changed focus to cell therapy
NCT03422419,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03422523,TERMINATED,INTERVENTIONAL,Failure to reach pre-specified futility boundary
NCT03422627,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03422679,TERMINATED,INTERVENTIONAL,business reason
NCT03422744,TERMINATED,INTERVENTIONAL,not enough recruitement
NCT03422757,TERMINATED,INTERVENTIONAL,Company strategic decision
NCT03422874,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew support
NCT03423082,TERMINATED,INTERVENTIONAL,Limited subject enrollment
NCT03423147,TERMINATED,INTERVENTIONAL,"Poor enrollment, inability to achieve required number of subjects"
NCT03423355,WITHDRAWN,INTERVENTIONAL,change in sponsor
NCT03423407,TERMINATED,OBSERVATIONAL,Insufficient funding/staff
NCT03423537,TERMINATED,INTERVENTIONAL,"Inability for further recruitment, change of position of the principal investigator, COVID-19 pandemic"
NCT03423654,TERMINATED,INTERVENTIONAL,Study closed out due to recruitment complications.
NCT03424031,TERMINATED,INTERVENTIONAL,"Many study exits (many deaths, aggravations) that we had anticipated (but not enough). The patients did not stay long enough in the department to complete the protocol (many study exits that we had not anticipated)."
NCT03424278,WITHDRAWN,INTERVENTIONAL,The participants recruitment was to difficult
NCT03424317,TERMINATED,INTERVENTIONAL,"difficult in recruitment, frequent withdrawal"
NCT03424512,TERMINATED,INTERVENTIONAL,"Covid-19 halted study, reorganisation of the clincial service and staff leaving posts made recruitement to a group unfeasible"
NCT03424954,TERMINATED,INTERVENTIONAL,IRB request IRB request
NCT03425006,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT03425097,TERMINATED,INTERVENTIONAL,The study was terminated due to insufficient evidence for Fexofenadine efficacy to treat GERD symptoms after the interim analysis.
NCT03425123,WITHDRAWN,INTERVENTIONAL,The study was not started due to the lack of funding.
NCT03425331,SUSPENDED,INTERVENTIONAL,"Slow accrual, competing studies, and lack of efficacy"
NCT03425370,TERMINATED,INTERVENTIONAL,Wound dehiscence on tissue adhesive side of 1 wound which developed an infection.
NCT03425409,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03425422,TERMINATED,INTERVENTIONAL,Company decision to stop enrolling not associated with any safety concerns.
NCT03425435,TERMINATED,OBSERVATIONAL,preterm stop due to low recruitment numbers during and still ongoing pandemic
NCT03425461,TERMINATED,INTERVENTIONAL,funding
NCT03425799,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT03425851,WITHDRAWN,INTERVENTIONAL,Administrative issues precluded conducting the study.
NCT03426137,TERMINATED,INTERVENTIONAL,The focus of the project has shifted to publishing a protocol for future trials because we were unable to recruit. Three participants signed the consent forms but withdrew before the randomization.
NCT03426254,WITHDRAWN,INTERVENTIONAL,the company is liquidated
NCT03426280,TERMINATED,INTERVENTIONAL,Study closed due to Covid-19 health emergency
NCT03426345,TERMINATED,INTERVENTIONAL,The Relamorelin program is being terminated solely based on a business decision
NCT03426423,TERMINATED,INTERVENTIONAL,"Recruitment rate too low (COVID-19 pandemic), end of funding"
NCT03426800,TERMINATED,INTERVENTIONAL,Limited numbers of patients
NCT03426995,TERMINATED,INTERVENTIONAL,The trial was terminated for strategic reasons following the emergence of new data.
NCT03427008,WITHDRAWN,INTERVENTIONAL,Merged IRB Created
NCT03427021,TERMINATED,INTERVENTIONAL,final study report has been completed and submitted
NCT03427073,TERMINATED,INTERVENTIONAL,to re-evaluate biomarker strategy for recruitment to Part 2
NCT03427320,WITHDRAWN,INTERVENTIONAL,Abandoned.
NCT03427424,SUSPENDED,OBSERVATIONAL,The PI is working on making significant changes to the protocol so we will not be enrolling participants until that is completed.
NCT03428295,SUSPENDED,INTERVENTIONAL,Further software development is required.
NCT03428737,WITHDRAWN,INTERVENTIONAL,none participant included
NCT03428763,WITHDRAWN,INTERVENTIONAL,Technical problems with POC
NCT03428815,TERMINATED,INTERVENTIONAL,Pandemic response invalidated long-term outcome data collection
NCT03428854,WITHDRAWN,OBSERVATIONAL,The study never got funded so never started enrolling
NCT03428945,TERMINATED,INTERVENTIONAL,This trial has undergone a prespecified interim analysis which determined that this treatment provides no statistically significant delay in the onset of abnormal glucose tolerance or Type 1 Diabetes.
NCT03428984,TERMINATED,INTERVENTIONAL,Slow study enrollment
NCT03429062,WITHDRAWN,OBSERVATIONAL,retirement of faculty PI
NCT03429101,TERMINATED,INTERVENTIONAL,Dose limiting toxicity
NCT03429205,TERMINATED,INTERVENTIONAL,Recruiting pace too slow.
NCT03429374,TERMINATED,INTERVENTIONAL,Limited patient enrollment
NCT03429556,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate early
NCT03429712,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment.
NCT03429777,WITHDRAWN,INTERVENTIONAL,Lack of novelty of study
NCT03429985,TERMINATED,INTERVENTIONAL,"In response to the COVID pandemic, and in accordance with local and university public health restrictions, our team suspended the study. This disrupted all planned follow-up activities. With funder approval, we pivoted our project to a non-RCT design"
NCT03430063,TERMINATED,INTERVENTIONAL,Business decision
NCT03430466,TERMINATED,INTERVENTIONAL,Recruiting was not possible
NCT03430531,TERMINATED,INTERVENTIONAL,Study suspended and subsequently terminated due to Pandemic
NCT03430544,TERMINATED,INTERVENTIONAL,"Low recruitment in final grant year, halted on-site research due to COVID-19 during NCE year."
NCT03430687,WITHDRAWN,INTERVENTIONAL,Investigators prefer to pursue other studies
NCT03430791,TERMINATED,INTERVENTIONAL,Study Investigator/Sponsor decided to end enrollment earlier.
NCT03430947,TERMINATED,INTERVENTIONAL,"Due to insufficient recruitment, the clinical trial was terminated prematurely"
NCT03431129,TERMINATED,OBSERVATIONAL,Insufficient recruitment and not enough funding
NCT03431272,WITHDRAWN,INTERVENTIONAL,no longer interest / resources to start study
NCT03431311,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03431337,TERMINATED,INTERVENTIONAL,Futility found by interim analysis
NCT03431415,WITHDRAWN,INTERVENTIONAL,Accrual issues
NCT03431467,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT03431675,WITHDRAWN,INTERVENTIONAL,No epidemic of Men C in 2019
NCT03431740,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT03432208,TERMINATED,INTERVENTIONAL,Closed by CHUM REB for lack of documentation related to the recruitment of participants.
NCT03432481,TERMINATED,INTERVENTIONAL,"interruption due to the ongoing corporate restructuring, which has resulted in the cessation of our interest in

pursuing any clinical activities related to the product."
NCT03432494,TERMINATED,INTERVENTIONAL,"The trial was kept open (via administrative hold) in anticipation of a device redesign and enrollment suspended, but funding never materialized to support the redesign."
NCT03432676,WITHDRAWN,INTERVENTIONAL,Incyte (supporter of the study) is no longer going to support the study.
NCT03432741,SUSPENDED,INTERVENTIONAL,funding - sponsor filing of Chapter 11 bankruptcy
NCT03432845,WITHDRAWN,OBSERVATIONAL,PI left institution
NCT03432897,TERMINATED,INTERVENTIONAL,Lack of enrollment secondary to eligibility criteria
NCT03433144,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03433508,WITHDRAWN,INTERVENTIONAL,lack of funds
NCT03433651,WITHDRAWN,INTERVENTIONAL,Unable to locate grant funding.
NCT03433703,TERMINATED,INTERVENTIONAL,Study recruitment was stopped due to difficulty in enrolling the targeted number of participants.
NCT03433755,TERMINATED,INTERVENTIONAL,Prematurely Discontinued Amgen decision
NCT03433833,WITHDRAWN,INTERVENTIONAL,Study Not Funded
NCT03433937,TERMINATED,INTERVENTIONAL,Low inclusion
NCT03433950,SUSPENDED,OBSERVATIONAL,COVID-19 Research Restrictions
NCT03434093,WITHDRAWN,INTERVENTIONAL,Investigator left NIH
NCT03434119,TERMINATED,INTERVENTIONAL,"(""Trial terminated (recruitment delays)"")"
NCT03434223,TERMINATED,OBSERVATIONAL,Research has been discontinued - there will be no further data collection or analysis
NCT03434353,TERMINATED,INTERVENTIONAL,Study was terminated due to sponsor's decision to not pursue further development of inarigivir soproxil in chronic hepatitis B.
NCT03434366,SUSPENDED,INTERVENTIONAL,The effects are not good
NCT03434808,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03434847,TERMINATED,INTERVENTIONAL,"CMS questions to assess patient satisfaction of pain control were removed from the HCAHPS survey, leaving the study without intervention assessment."
NCT03435172,SUSPENDED,INTERVENTIONAL,"Low enrollment rate, voluntary study suspension of the study"
NCT03435250,TERMINATED,INTERVENTIONAL,Strategic reasons
NCT03435315,TERMINATED,INTERVENTIONAL,Stopped prior to enrolling anticipated sample size due to COVID-19
NCT03435458,TERMINATED,INTERVENTIONAL,interim analyses
NCT03435575,TERMINATED,INTERVENTIONAL,Inclusion rate not reached and due to the COVID-19 pandemic not enough follow up measurements of the included participants.
NCT03435640,TERMINATED,INTERVENTIONAL,Based on the overall results from the Phase 1 part of the study the sponsor decided to end the study. The decision was not due to safety reasons.
NCT03435692,TERMINATED,INTERVENTIONAL,Funding was exhausted prior to enrolling intended number of patients.
NCT03436056,TERMINATED,INTERVENTIONAL,funding pulled
NCT03436121,WITHDRAWN,INTERVENTIONAL,Ketamine shortage during the funding period of the trial
NCT03436420,TERMINATED,INTERVENTIONAL,Terminated due to lack of efficacy and safety concerns.
NCT03436433,TERMINATED,INTERVENTIONAL,Did not enroll as planned
NCT03436667,WITHDRAWN,OBSERVATIONAL,PI left the institution
NCT03436680,WITHDRAWN,INTERVENTIONAL,"Due to lack of funds, time, and staff cannot activate the study."
NCT03436706,WITHDRAWN,OBSERVATIONAL,This study does not qualify as a clinical trial under current NIH guidelines.
NCT03436732,TERMINATED,INTERVENTIONAL,Due to fatal occurrence (pneumonitis) attributed to one of the study drugs.
NCT03436771,TERMINATED,OBSERVATIONAL,Eligible subjects will be enrolled in Celgene's long-term follow-up protocol for subjects previously treated with a CAR T-cell product.
NCT03436875,WITHDRAWN,OBSERVATIONAL,Pause for preliminary data analysis
NCT03436953,WITHDRAWN,INTERVENTIONAL,The program was not initiated nor were any patients ever enrolled. The investigations detailed in the submitted protocol were incorporated into another program.
NCT03437031,TERMINATED,INTERVENTIONAL,Problems with recruitment
NCT03437070,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03437148,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT03437200,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03437460,TERMINATED,INTERVENTIONAL,Implementation issues
NCT03437512,TERMINATED,INTERVENTIONAL,"Covid-19 paused human subjects research at study site, funding expired."
NCT03437720,WITHDRAWN,INTERVENTIONAL,"Sponsor decision to cancel TRIAL, not related to safety concern."
NCT03437746,TERMINATED,INTERVENTIONAL,insufficient rate of inclusion
NCT03437915,WITHDRAWN,INTERVENTIONAL,Secondary to medicare coverage determination
NCT03437967,TERMINATED,INTERVENTIONAL,Patient withdrawal symptoms unblinded the study
NCT03438344,WITHDRAWN,INTERVENTIONAL,PI Withdrawal
NCT03438409,TERMINATED,INTERVENTIONAL,Changes in personnel at Institution.
NCT03438500,WITHDRAWN,INTERVENTIONAL,Sponsor \& PI decision
NCT03438513,WITHDRAWN,OBSERVATIONAL,"Still no inclusion 10 months after the implementation visit. The study is outdated. Since, there has been ""Alzheimer Plan"" and establishment of external structures identical to the research project."
NCT03438760,TERMINATED,INTERVENTIONAL,"with 2/3 of the data collected, we had to terminate the study because of COVID19."
NCT03438851,TERMINATED,INTERVENTIONAL,NeuroCatch Platform became commercially available (Health Canada License approved) and can now be incorporated into the ABI Wellness Program
NCT03438877,TERMINATED,INTERVENTIONAL,Patients recruited difficult.
NCT03439033,TERMINATED,INTERVENTIONAL,Study Drug was FDA approved Summer 2021
NCT03439150,TERMINATED,INTERVENTIONAL,slow enrolment
NCT03439358,SUSPENDED,INTERVENTIONAL,Could not recruit patients
NCT03439514,TERMINATED,INTERVENTIONAL,The Sponsor terminated the study due to futility. The decision to stop the study was not based on safety concerns.
NCT03439787,TERMINATED,INTERVENTIONAL,Methodological problems/problems in the study design (competing pain and a placebo effect). No serious adverse events or other safety issues
NCT03439995,TERMINATED,INTERVENTIONAL,Trial no longer feasible
NCT03440411,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03440879,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT03440944,TERMINATED,INTERVENTIONAL,The study was stopped after a pause due to COVID-19 policies and new published evidence about the effectiveness of the interventon.
NCT03441022,WITHDRAWN,INTERVENTIONAL,Unable to obtain equipment from Sponsor to be able to proceed with the study.
NCT03441139,TERMINATED,INTERVENTIONAL,Difficulty to recruit patient.
NCT03441334,TERMINATED,INTERVENTIONAL,The enrollment was not achieved within proposed timeframe.
NCT03441464,TERMINATED,INTERVENTIONAL,Interim analysis indicated a change in study design to collect in vivo data
NCT03441503,TERMINATED,INTERVENTIONAL,We were not able to enroll partner hospitals.
NCT03441542,TERMINATED,INTERVENTIONAL,"Insufficient enrollment. Reasons for low enrollment were low eligibility, and difficulty contacting patients."
NCT03441737,WITHDRAWN,INTERVENTIONAL,Did not receive funding to support this project.
NCT03442192,TERMINATED,INTERVENTIONAL,COVID erupted and change in policy making all visits throughout hospital telemedicine
NCT03442400,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT03442816,WITHDRAWN,INTERVENTIONAL,Sponsor no longer supported this study
NCT03442985,TERMINATED,INTERVENTIONAL,"Trial was terminated early to analyze the accumulated data and evaluate the efficacy, safety and future of palovarotene in MO."
NCT03443154,WITHDRAWN,OBSERVATIONAL,Industry sponsor withdrew financial support as well as the testing equipment.
NCT03443284,TERMINATED,INTERVENTIONAL,Business decision to close study due to low and slow enrollment.
NCT03443622,WITHDRAWN,INTERVENTIONAL,Another study has been started in other country.
NCT03443908,WITHDRAWN,OBSERVATIONAL,Study stopped due to lack of enrollment.
NCT03443973,TERMINATED,INTERVENTIONAL,Decision to terminate development of Gantenerumab for treatment of prodromal/mild/early stage Alzheimer's disease following results of a pre-planned analysis of the safety and efficacy of Gant in Graduate I\&II (WN29922/WN39658).
NCT03444311,TERMINATED,INTERVENTIONAL,Low tolerability of fibers included in the product
NCT03444610,WITHDRAWN,INTERVENTIONAL,Phase 1 studies are not performed in Saudi Arabia yet
NCT03444649,WITHDRAWN,INTERVENTIONAL,IMP will not be further developed
NCT03444727,TERMINATED,INTERVENTIONAL,Not enough enrollment
NCT03444753,TERMINATED,INTERVENTIONAL,business objectives have changed
NCT03444870,TERMINATED,INTERVENTIONAL,Decision to terminate development of Gantenerumab for treatment of prodromal/mild/early-stage Alzheimer's disease following results of a pre-planned analysis of the safety and efficacy of Gant in Graduate I\&II (WN29922/WN39658).
NCT03444948,SUSPENDED,INTERVENTIONAL,There was a voluntary recall from the Habib EUS RFA device manufacturer
NCT03445000,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT03445416,WITHDRAWN,INTERVENTIONAL,Study was not funded and therefore never began.
NCT03445533,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT03445611,WITHDRAWN,INTERVENTIONAL,IRB process never completed.
NCT03445663,TERMINATED,INTERVENTIONAL,Previous sponsor business decision not to proceed with the AMG 424 asset.
NCT03445767,WITHDRAWN,INTERVENTIONAL,Did not receive full funding to proceed
NCT03445780,WITHDRAWN,INTERVENTIONAL,No patients were enrolled; Senior author (Dr. Melamed) departed institution
NCT03445806,TERMINATED,OBSERVATIONAL,Difficulty recruiting patients
NCT03445923,TERMINATED,INTERVENTIONAL,Slow recruitment due to Covid-19 restrictions.
NCT03446118,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding
NCT03446144,WITHDRAWN,INTERVENTIONAL,"Business objective change, no safety or efficacy concerns"
NCT03446248,TERMINATED,INTERVENTIONAL,low recruitment
NCT03446508,WITHDRAWN,INTERVENTIONAL,Not enough participants
NCT03446599,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03446612,TERMINATED,INTERVENTIONAL,The study is terminated due to feasibility in recruitment.
NCT03446638,WITHDRAWN,INTERVENTIONAL,administratively withdrawn
NCT03446807,WITHDRAWN,INTERVENTIONAL,Sponsor Decision to terminate
NCT03446833,TERMINATED,INTERVENTIONAL,Business decision
NCT03447262,TERMINATED,INTERVENTIONAL,At Sponsor's Discretion
NCT03447405,WITHDRAWN,INTERVENTIONAL,Grant not funded
NCT03447639,TERMINATED,INTERVENTIONAL,Lack of Patient Enrollment
NCT03447730,TERMINATED,INTERVENTIONAL,Interim futility analyses identified a lack of SYNB1020 efficacy.
NCT03447769,TERMINATED,INTERVENTIONAL,"Upon review of the primary analysis results, the benefit-risk was assessed by the Steering Committee Members with the decision that the study will be closed. No new safety signals were observed for canakinumab."
NCT03448133,WITHDRAWN,INTERVENTIONAL,Because of the expiration of the previous ethical approval documents
NCT03448211,WITHDRAWN,INTERVENTIONAL,Development strategy reasons
NCT03448250,TERMINATED,INTERVENTIONAL,Participant recruitment was stopped due to corona pandemic.
NCT03448367,TERMINATED,OBSERVATIONAL,Due to lower than anticipated enrollment
NCT03448653,TERMINATED,INTERVENTIONAL,"Slow recruitment, advances in technology"
NCT03448692,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy at both tested doses on 5th December 2022. The decision to terminate the study is not related to a safety concern.
NCT03448796,TERMINATED,INTERVENTIONAL,Problems with recruiting patients.
NCT03448874,WITHDRAWN,INTERVENTIONAL,The company will design a new study
NCT03448926,SUSPENDED,OBSERVATIONAL,Part 1 of the study reached the original enrollment goal. The protocol is being amended to begin enrollment for Part 2 soon.
NCT03449030,TERMINATED,INTERVENTIONAL,Insufficient clinical benefit to participants at the selected recommended phase 2 (RP2D) dose in Part A.
NCT03449121,WITHDRAWN,INTERVENTIONAL,PI left VUMC
NCT03449160,WITHDRAWN,INTERVENTIONAL,COVID 19 which is preventing outpatient and elective procedures
NCT03449212,SUSPENDED,OBSERVATIONAL,COVID-19 pandemic
NCT03449524,TERMINATED,INTERVENTIONAL,LOE
NCT03449771,TERMINATED,INTERVENTIONAL,Inclusion of the last patient
NCT03449888,TERMINATED,OBSERVATIONAL,Terminated by the local IRB
NCT03450096,TERMINATED,INTERVENTIONAL,Too difficult to recruit patients
NCT03450382,WITHDRAWN,INTERVENTIONAL,New Principal Investigator
NCT03450616,WITHDRAWN,INTERVENTIONAL,Unable to begin study due to funding. PI has left organization
NCT03450707,TERMINATED,INTERVENTIONAL,DSMB recommendation based on differing mortality in a subgroup analysis
NCT03450824,TERMINATED,OBSERVATIONAL,Because not enough volunteers were recruited.
NCT03451006,TERMINATED,INTERVENTIONAL,difficult recruitment and not achieved
NCT03451123,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03451227,TERMINATED,INTERVENTIONAL,Unable to recruit eligible participants
NCT03451253,TERMINATED,INTERVENTIONAL,Suboptimal accrual
NCT03451474,TERMINATED,INTERVENTIONAL,PI left institution
NCT03451773,TERMINATED,INTERVENTIONAL,Study was closed after one treatment related death.
NCT03452137,TERMINATED,INTERVENTIONAL,Decision to terminate the study as its primary endpoint of investigator-assessed event free survival (INV-EFS) was not met at its final EFS analysis. No new safety signals were identified.
NCT03452163,TERMINATED,INTERVENTIONAL,Inability to support study performance
NCT03452267,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03452527,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03452540,TERMINATED,INTERVENTIONAL,Company Decision
NCT03452553,WITHDRAWN,INTERVENTIONAL,"CMS disapproval, no alternative for sites/patient, risk of financial burden."
NCT03452566,WITHDRAWN,INTERVENTIONAL,Ingenol mebutato discontinued in Brazil.
NCT03452683,WITHDRAWN,INTERVENTIONAL,Competing trials
NCT03453203,WITHDRAWN,INTERVENTIONAL,PI left
NCT03453242,TERMINATED,OBSERVATIONAL,Difficulty of recruitment due to COVID-19
NCT03453749,WITHDRAWN,INTERVENTIONAL,New study in planning
NCT03454243,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03454360,TERMINATED,OBSERVATIONAL,Sponsor business decision unrelated to product safety or efficacy.
NCT03454607,TERMINATED,INTERVENTIONAL,Difficulty in patient recruitment
NCT03454672,TERMINATED,INTERVENTIONAL,Delay in recruitment as per last protocol amendment due to Covid-19
NCT03454893,TERMINATED,INTERVENTIONAL,AVROBIO has deprioritized its Fabry disease program
NCT03454932,TERMINATED,OBSERVATIONAL,limited number of recruited patients
NCT03455374,TERMINATED,INTERVENTIONAL,PI/Sponsor mutual agreement due to poor enrollment
NCT03455556,TERMINATED,INTERVENTIONAL,slow accrual
NCT03455751,TERMINATED,INTERVENTIONAL,Failed to meet enrollment goals
NCT03455777,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to lack of available patients meeting entry criteria
NCT03455894,TERMINATED,INTERVENTIONAL,deficient inclusion
NCT03455985,TERMINATED,INTERVENTIONAL,interruption of study enrollment and procedures due to COVID-19 health crisis
NCT03456193,SUSPENDED,INTERVENTIONAL,reviewing eligibility criteria
NCT03456271,TERMINATED,OBSERVATIONAL,limited Patient recruitment
NCT03456401,TERMINATED,INTERVENTIONAL,availability of new and more promising therapeutic agents than expected in the experimentation in question
NCT03456635,SUSPENDED,INTERVENTIONAL,Due to COVID
NCT03456661,TERMINATED,INTERVENTIONAL,The surgical approach has changed.
NCT03456986,WITHDRAWN,INTERVENTIONAL,Study was never funded by NIH as anticipated.
NCT03456999,WITHDRAWN,INTERVENTIONAL,company decision
NCT03457025,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT03457051,WITHDRAWN,INTERVENTIONAL,Lack of study funding
NCT03457428,TERMINATED,OBSERVATIONAL,Inadequate enrollment without results or statistics being calculated.
NCT03457753,WITHDRAWN,INTERVENTIONAL,The Sponsor stopped the study due to a change in study plans
NCT03457818,TERMINATED,INTERVENTIONAL,Due to enrollment difficulties compounded by the COVID pandemic.
NCT03458104,WITHDRAWN,INTERVENTIONAL,Recruitment logistics
NCT03458234,TERMINATED,INTERVENTIONAL,No longer manufacturing radiotransponder beacons. No similar product available. The results are no longer expected to have a scholarly or clinical impact. Terminating the study before it reaches its target accrual.
NCT03458416,TERMINATED,INTERVENTIONAL,Insys Therapeutics filed Chapter 11 and terminated all studies.
NCT03458611,TERMINATED,INTERVENTIONAL,We recruited stroke patients over 2 years time and only achieved 2 patients per-protocol and 6 intention-to-treat patients. The recruitment rate was thus too low and therefore the study protocol as planned was not feasible.
NCT03458663,TERMINATED,INTERVENTIONAL,Interrim analysis showed no effect or a tendency towards poorer out come in the Prevena group
NCT03458728,TERMINATED,INTERVENTIONAL,no anticipated benefit over available standard therapies
NCT03458910,TERMINATED,INTERVENTIONAL,COVID-19 increased risk of participation
NCT03459443,TERMINATED,INTERVENTIONAL,The reason for terminating study early was inconclusive efficacy results. No safety findings were identified.
NCT03459651,WITHDRAWN,INTERVENTIONAL,Principal Investigator elected to end the study.
NCT03459755,WITHDRAWN,INTERVENTIONAL,investigator decision
NCT03460015,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention The study was terminated prematurely due to inclusion difficulties
NCT03460067,TERMINATED,INTERVENTIONAL,Poor accrual and opening of competing national study (NRG-BR008 (HERO))
NCT03460548,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT03460678,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT03460704,TERMINATED,INTERVENTIONAL,The study was brought to an early close in March 2022 due to major ongoing recruitment issues primarily related to the COVID-19 pandemic and concerns regarding the continued randomization and exposure of subjects to placebo in the study.
NCT03460964,TERMINATED,INTERVENTIONAL,Could not perform accurate measures due to equipment and sensor issues.
NCT03461419,SUSPENDED,INTERVENTIONAL,Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]
NCT03461458,TERMINATED,INTERVENTIONAL,Principal Investigator transition
NCT03461666,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. COVID Complications.
NCT03461705,TERMINATED,INTERVENTIONAL,"After 5 patients, realized that the standard deviation of the measurements in real life was higher than the calculated difference."
NCT03461952,TERMINATED,INTERVENTIONAL,cfDNA screening data found that the prevalence of POLE/POLD1 mutations was lower than expected. It was determined that there are no feasible options to amend this study in a fashion that would not be duplicative of other currently accruing trials.
NCT03462004,SUSPENDED,INTERVENTIONAL,On hold due to pandemic
NCT03462043,WITHDRAWN,INTERVENTIONAL,Decision to change the study design
NCT03462563,TERMINATED,INTERVENTIONAL,The study was terminated because the pre-specified study stopping criterion has been met.
NCT03462576,TERMINATED,INTERVENTIONAL,Sponsor of Trial decision
NCT03462836,WITHDRAWN,INTERVENTIONAL,"The results of the primary endpoints of this study are expected to be difficult to identify, thus canceling the study to readjust the study plan."
NCT03462940,TERMINATED,INTERVENTIONAL,The study was halted due to low enrollment exacerbated by COVID-19.
NCT03462966,TERMINATED,INTERVENTIONAL,recruitment challenges
NCT03462979,SUSPENDED,INTERVENTIONAL,covid-19 pandemic
NCT03463018,TERMINATED,INTERVENTIONAL,Recruitment error; Inclusion criteria not met
NCT03463161,TERMINATED,INTERVENTIONAL,Study stopped early due to investigator conflict of interest.
NCT03463395,WITHDRAWN,INTERVENTIONAL,Funding for this study has ended and we were unable to enroll any subjects
NCT03463460,SUSPENDED,INTERVENTIONAL,PI decision
NCT03463889,TERMINATED,INTERVENTIONAL,Funding
NCT03463902,TERMINATED,INTERVENTIONAL,Recruitment failed to enroll sufficient number of patients
NCT03463980,TERMINATED,INTERVENTIONAL,"The study was terminated during the pandemic as data collection could not be completed any further, and personnel changes did not allow for completion. At the time of termination, enough data was collected for a publication, all benchmarks were met."
NCT03464162,WITHDRAWN,INTERVENTIONAL,Recruitment failed. No sufficient interest in the study. Potential participants are not interested
NCT03464526,WITHDRAWN,INTERVENTIONAL,Strategic decision
NCT03464604,TERMINATED,OBSERVATIONAL,COVID forced the termination of this study. No impact on participants already enrolled.
NCT03464851,TERMINATED,OBSERVATIONAL,Low enrollment due to inclusion/exclusion criteria
NCT03465137,TERMINATED,INTERVENTIONAL,PI left institution
NCT03465345,WITHDRAWN,INTERVENTIONAL,Study was stopped to pursue a new treatment plan with a new study.
NCT03465540,TERMINATED,INTERVENTIONAL,Strategic decisions
NCT03465709,TERMINATED,INTERVENTIONAL,Apellis concluded that sufficient data were collected to meet the study objectives.
NCT03465735,TERMINATED,INTERVENTIONAL,Due to lack of recruitment of eligible participants
NCT03465826,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03465891,TERMINATED,INTERVENTIONAL,Low accrual and lack of funding.
NCT03466034,TERMINATED,OBSERVATIONAL,Low numbers of eligible patients and failure to successfully recruit them.
NCT03466398,WITHDRAWN,INTERVENTIONAL,Technical limitations encountered with the remote monitoring platform
NCT03466489,WITHDRAWN,INTERVENTIONAL,No participant were enrolled
NCT03466658,TERMINATED,INTERVENTIONAL,Unexpected culture contamination potentially due to a testing error
NCT03466801,TERMINATED,INTERVENTIONAL,the clinical significance is little
NCT03467217,TERMINATED,INTERVENTIONAL,Trial stopped for futility
NCT03467620,WITHDRAWN,INTERVENTIONAL,Inadequate funding
NCT03467633,TERMINATED,INTERVENTIONAL,Not enough participants recruited.
NCT03467776,SUSPENDED,OBSERVATIONAL,have to adjust recuriting paticipants projects and have to halted the research
NCT03468075,TERMINATED,INTERVENTIONAL,Stopping rules met
NCT03468101,TERMINATED,OBSERVATIONAL,COVID-19
NCT03468140,WITHDRAWN,INTERVENTIONAL,Unable to recruit due to COVID 19
NCT03468257,WITHDRAWN,INTERVENTIONAL,Study never started
NCT03468361,WITHDRAWN,INTERVENTIONAL,"The hospitals could not enroll any patients. Therefore, the authors decided to withdraw the study."
NCT03468543,TERMINATED,INTERVENTIONAL,Per protocol stopping rules
NCT03468777,TERMINATED,INTERVENTIONAL,The study has been terminated due to pending data analysis
NCT03468829,WITHDRAWN,INTERVENTIONAL,ALX-0171 development program was stopped
NCT03468894,WITHDRAWN,INTERVENTIONAL,Insufficient resources to support study
NCT03469050,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03469258,TERMINATED,INTERVENTIONAL,Sponsorship for trial was halted after company acquisition
NCT03469414,TERMINATED,OBSERVATIONAL,COVID-19 Pandemic made participant recruitment nonfeasible.
NCT03470350,WITHDRAWN,INTERVENTIONAL,No study drug available. Same concept with new study drug will be explored in M19TGA study
NCT03470948,TERMINATED,OBSERVATIONAL,No manpower to conduct the study further
NCT03471104,WITHDRAWN,INTERVENTIONAL,We have piloted the trial and concluded not to proceed to a fullscale trial.
NCT03471286,TERMINATED,INTERVENTIONAL,Deprioritization of drug in this patient population
NCT03471351,TERMINATED,INTERVENTIONAL,"At this point, the current study in HL does not fit into clinical development and regulatory strategy."
NCT03471468,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03471481,TERMINATED,OBSERVATIONAL,Closure of Drexel University Hahnemann Hospital where Referring Physician Worked
NCT03471559,TERMINATED,INTERVENTIONAL,"Two step study, step two was not feasible based on results from phase one."
NCT03471598,TERMINATED,OBSERVATIONAL,The COVID-19 pandemic held the candidates and/or participants back to join. The investigators also stopped recruiting for safety concern.
NCT03471689,WITHDRAWN,INTERVENTIONAL,Resources
NCT03471702,TERMINATED,INTERVENTIONAL,Device Review performed by Sponsor
NCT03471754,TERMINATED,INTERVENTIONAL,"Administrative reasons, and did not meet sample size requirements"
NCT03472118,TERMINATED,INTERVENTIONAL,Risk-benefit analysis
NCT03472183,WITHDRAWN,INTERVENTIONAL,no patients included
NCT03472326,TERMINATED,INTERVENTIONAL,GS-9131 did not meet the targeted antiviral response
NCT03472560,TERMINATED,INTERVENTIONAL,The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the Investigational treatments have been moved to a continuation study (NCT05059522)
NCT03472690,TERMINATED,INTERVENTIONAL,Corporate Decision to terminate study after Lead-In portion of the study completed.
NCT03472755,WITHDRAWN,INTERVENTIONAL,difficulty in setting up the study in the investigator site
NCT03472833,TERMINATED,INTERVENTIONAL,"slow recruitment, patients lost to follow-up due to Covid-19 pandemic."
NCT03472872,TERMINATED,INTERVENTIONAL,no longer recruiting or studying
NCT03472924,TERMINATED,INTERVENTIONAL,Insufficient recruitment and enrollment. Reduction in study personnel capacity.
NCT03473171,TERMINATED,INTERVENTIONAL,PI left the institution
NCT03473288,WITHDRAWN,INTERVENTIONAL,No enrollment due to COVID restrictions and funding issues
NCT03473340,TERMINATED,INTERVENTIONAL,"Slow and delayed recruitment due in part to COVID, led to a decision to end funding and terminate the trial."
NCT03473457,TERMINATED,INTERVENTIONAL,The therapeutic effect was not as expected
NCT03473483,WITHDRAWN,INTERVENTIONAL,Major study re-design prior to participant enrollment
NCT03473496,TERMINATED,INTERVENTIONAL,"After CAR-T treatment, the benefit is not significant, and it is difficult to enroll."
NCT03473665,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03473691,WITHDRAWN,INTERVENTIONAL,Pharmaceutical company decided to withdraw funding and not provide drug.
NCT03473847,SUSPENDED,INTERVENTIONAL,Devices currently awaiting software updates
NCT03474263,WITHDRAWN,INTERVENTIONAL,seeking research grant support
NCT03474419,WITHDRAWN,OBSERVATIONAL,The principal investigator decide to stop the sudy.
NCT03474458,TERMINATED,INTERVENTIONAL,difficulty in recruitment
NCT03474510,WITHDRAWN,INTERVENTIONAL,Investigator Decision
NCT03474614,TERMINATED,INTERVENTIONAL,lack of accrual
NCT03474666,TERMINATED,INTERVENTIONAL,The data safety monitoring inboard recommended stopping the study.
NCT03475537,WITHDRAWN,INTERVENTIONAL,short of euqitments
NCT03475602,TERMINATED,OBSERVATIONAL,Our center had adopted a new detection method for anti-PLA2R antibodies in all membranous nephropathy patients.
NCT03475680,TERMINATED,INTERVENTIONAL,lack of inclusions
NCT03475797,TERMINATED,INTERVENTIONAL,Sponsor's decision to stop the study prematurely due to insufficient inclusion.
NCT03476174,TERMINATED,INTERVENTIONAL,Lack of Accrual
NCT03476928,TERMINATED,INTERVENTIONAL,"Due to a change in the development program, the study was closed prematurely."
NCT03476993,TERMINATED,INTERVENTIONAL,Sponosor's decision
NCT03477006,TERMINATED,INTERVENTIONAL,"Slow enrollment, financial considerations and global pandemic"
NCT03477162,TERMINATED,INTERVENTIONAL,"Enrollment was closed as efforts had become more challenging, and the lab indicated that they were able to obtain their primary objective with the number that had already been enrolled."
NCT03477474,TERMINATED,OBSERVATIONAL,Alternative data published
NCT03477526,TERMINATED,INTERVENTIONAL,PhD Student stopped working on this project
NCT03477669,TERMINATED,INTERVENTIONAL,Unable to recruit study participants
NCT03477864,WITHDRAWN,INTERVENTIONAL,Study was not accruing
NCT03477903,TERMINATED,INTERVENTIONAL,Insufficient enrollment; No safety concerns
NCT03478163,TERMINATED,INTERVENTIONAL,Problems with recruitment
NCT03478293,TERMINATED,INTERVENTIONAL,Business Decision
NCT03478423,TERMINATED,INTERVENTIONAL,Study failed to recruit in sufficient numbers and was determined to not be feasible.
NCT03478813,WITHDRAWN,INTERVENTIONAL,The study was withdrawn because of too few eligible participants.
NCT03478904,TERMINATED,INTERVENTIONAL,Study drug is now commercially available in tablet format
NCT03478956,TERMINATED,INTERVENTIONAL,"The study was terminated due to program discontinuation, based on mixed efficacy results in the adult ulcerative colitis and Crohn's disease studies. There were no safety concerns."
NCT03479034,WITHDRAWN,OBSERVATIONAL,Investigator decided not to proceed in Australia at this stage.
NCT03479125,TERMINATED,OBSERVATIONAL,Sponsor has discontinued the development of emricasan
NCT03479151,WITHDRAWN,INTERVENTIONAL,CI of study retired on 6.10.2020 and there will be no further efforts to apply for an extension in order to recruit to this study.
NCT03479242,TERMINATED,OBSERVATIONAL,Insufficient staffing
NCT03479294,TERMINATED,OBSERVATIONAL,"Because of the difficulty of research operation, we changed to another research design."
NCT03479424,TERMINATED,OBSERVATIONAL,Slow recruitment
NCT03479463,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT03479931,TERMINATED,INTERVENTIONAL,Due to required changes in methods.
NCT03480152,TERMINATED,INTERVENTIONAL,slow accrual
NCT03480425,TERMINATED,INTERVENTIONAL,Analysis of first 10 participants showed the technique was not efficacious
NCT03480451,TERMINATED,INTERVENTIONAL,Study considered futile
NCT03480477,TERMINATED,OBSERVATIONAL,PI confirmed that this not a Clinical trial and was inadvertently entered in the system
NCT03480620,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03480659,TERMINATED,OBSERVATIONAL,Experienced technical issues with plasma blood samples collected from patients.
NCT03480724,TERMINATED,INTERVENTIONAL,Despite efforts no additional participants were able to be enrolled since March 2020.
NCT03480867,WITHDRAWN,INTERVENTIONAL,competing study was opened by the surgeon after this trial was opened
NCT03480919,TERMINATED,INTERVENTIONAL,Limited resources
NCT03481413,TERMINATED,OBSERVATIONAL,Philips decided to wind down the EPD Solutions business
NCT03481543,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT03481556,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study following an FDA request of a partial clinical hold.
NCT03481842,WITHDRAWN,INTERVENTIONAL,Change in study design and sponsor
NCT03481894,WITHDRAWN,INTERVENTIONAL,FDA released Fresenius Kabi from this post marketing requirement on 07/16/2019.
NCT03481920,TERMINATED,INTERVENTIONAL,Stopped Enrollment
NCT03481959,TERMINATED,INTERVENTIONAL,insufficient recrutement in the study
NCT03482206,WITHDRAWN,INTERVENTIONAL,Need more time to optimize the sensor
NCT03482466,TERMINATED,INTERVENTIONAL,Covid-19
NCT03482505,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03483077,TERMINATED,INTERVENTIONAL,"The trial was ended after completion of dose group 6 of the SRD part, in accordance with a predefined protocol discontinuation criteria. The planned bioavailability evaluation was not performed due to the sponsor's decision."
NCT03483298,TERMINATED,OBSERVATIONAL,recruitment issues
NCT03483753,WITHDRAWN,INTERVENTIONAL,no funding for the study
NCT03483883,TERMINATED,INTERVENTIONAL,The study was terminated due to protracted accrual and limited patient engagement in the setting of rapidly changing treatment paradigms for advanced RCC with sarcomatoid features and/or intermediate/poor risk clinical features.
NCT03483948,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT03483987,TERMINATED,INTERVENTIONAL,Difficulty in recruiting the participants
NCT03484143,SUSPENDED,INTERVENTIONAL,Recruitment has been too slow. We are considering some changes to the protocol.
NCT03484208,TERMINATED,OBSERVATIONAL,PI's choice
NCT03484234,TERMINATED,INTERVENTIONAL,At sponsor's discretion : The purpose of study is no longer maintained
NCT03484520,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT03484650,WITHDRAWN,INTERVENTIONAL,Lack of available resources to complete study
NCT03484962,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03485053,TERMINATED,INTERVENTIONAL,Sponsor terminate the trial and will conduct a phase 2b clinical trial further
NCT03485313,TERMINATED,OBSERVATIONAL,Study stopped due to slow enrollment; sufficient data collected for analysis.
NCT03485404,TERMINATED,INTERVENTIONAL,Due to slow recruiment. Only 40 patients were recruited in four years.
NCT03485651,TERMINATED,OBSERVATIONAL,Poor accrual
NCT03485742,TERMINATED,OBSERVATIONAL,We recruited a target number (740 patients) earlier than the expected day of copletion
NCT03485898,TERMINATED,OBSERVATIONAL,study director job transfer in another departement
NCT03485924,TERMINATED,INTERVENTIONAL,The study is not relevant anymore.
NCT03485937,WITHDRAWN,INTERVENTIONAL,low accrual
NCT03486002,TERMINATED,INTERVENTIONAL,Access to the devices was halted by the sponsor
NCT03486054,WITHDRAWN,INTERVENTIONAL,strategic reasons
NCT03486288,TERMINATED,OBSERVATIONAL,"Recruitment delayed because of Sars-CoV-2 pandemic, elective surgery stopped, funding for undefinite extension not available"
NCT03486353,WITHDRAWN,INTERVENTIONAL,Program terminated
NCT03486444,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT03486587,TERMINATED,INTERVENTIONAL,"Participants have better treatment selection, resulting in a slow recruitment."
NCT03487198,TERMINATED,INTERVENTIONAL,"In consideration of the progress now and the expected enrollment in the next few years,the NDA will not be acquired before the patent went out."
NCT03487380,TERMINATED,INTERVENTIONAL,"Despite an extension of the planned duration of inclusion and an enrolled patient number inferior than planned, coordinating investigator considered that it was more reasonable to stop inclusions in order to analyze the data already available"
NCT03487484,TERMINATED,OBSERVATIONAL,insufficient recruitment
NCT03487705,TERMINATED,INTERVENTIONAL,Halted Prematurely due to difficulties in inclusion.
NCT03487731,WITHDRAWN,INTERVENTIONAL,PI decided to not proceed with study
NCT03487744,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03487848,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT03488121,WITHDRAWN,INTERVENTIONAL,The study was terminated due to logistical reasons
NCT03488147,WITHDRAWN,INTERVENTIONAL,Change in Investigational Drug Service policies resulting in the need to change the operational design of the overall protocol.
NCT03488225,TERMINATED,INTERVENTIONAL,the study was closed early due to competing trials
NCT03488251,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03488433,WITHDRAWN,INTERVENTIONAL,PI institutional transition prior to enrollment
NCT03488472,TERMINATED,INTERVENTIONAL,This feasibility study only accrued one patient since site activation. We believe that the primary reason for this is low patient motivation to go on study and wear the device. We attempted to broaden this study to partner sites without success.
NCT03488654,TERMINATED,OBSERVATIONAL,Recruitement problems as single centre study
NCT03488810,WITHDRAWN,INTERVENTIONAL,Extended study timelines and additional budget could no longer be supported.
NCT03488940,WITHDRAWN,INTERVENTIONAL,Subjects were enrolled in other studies about sepsis
NCT03489096,WITHDRAWN,INTERVENTIONAL,Sponsor-Investigator left the institution
NCT03489109,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual
NCT03489122,TERMINATED,INTERVENTIONAL,"Enrollment was far from meeting target expectations, and the PO did not believe the study could achieve numbers before the end of the award"
NCT03489174,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient participants to complete study intervention
NCT03489265,WITHDRAWN,INTERVENTIONAL,Difficult to recruit severely affected patients with fecal incontinence
NCT03489382,WITHDRAWN,INTERVENTIONAL,Change in protocol design due to COVID-19 pandemic
NCT03489408,TERMINATED,OBSERVATIONAL,Study stopped due to business decision to not continue to gather clinical evidence on product
NCT03489512,WITHDRAWN,INTERVENTIONAL,Administrative issues
NCT03489577,TERMINATED,OBSERVATIONAL,Interim analysis provided enough data
NCT03489746,WITHDRAWN,INTERVENTIONAL,Study halted prematurely but potentially will resume
NCT03489811,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic introduced confounding factors that would bias the study data. Study rescheduled for future dates post-pandemic.
NCT03489876,WITHDRAWN,INTERVENTIONAL,Lack of patient enrollment.
NCT03490006,WITHDRAWN,INTERVENTIONAL,Insufficient resources to complete study requirements
NCT03490019,WITHDRAWN,INTERVENTIONAL,unrealizable wishes of national authorities
NCT03490162,TERMINATED,INTERVENTIONAL,There was toxicity in higher dose groups and a therapeutic dose level was not found in lower dose groups.
NCT03490331,TERMINATED,INTERVENTIONAL,No patient ongoing (none completed the study). Changes to the viral vector ongoing.
NCT03490396,TERMINATED,INTERVENTIONAL,low recruitment
NCT03490760,TERMINATED,INTERVENTIONAL,Slow/poor enrollment
NCT03490838,TERMINATED,INTERVENTIONAL,Recruitment for PROter A206T-G01-001 (NCT03490838) was halted in Phase I by sponsor decision. Phase II expansion portion of the study was never initiated.
NCT03490903,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT03490916,TERMINATED,INTERVENTIONAL,PI was unable to continue to gather data during the trip during to medical illness
NCT03490942,TERMINATED,INTERVENTIONAL,Primary endpoint was not met
NCT03491007,TERMINATED,INTERVENTIONAL,PI obtained outside employment that was not compatible with this award
NCT03491150,TERMINATED,INTERVENTIONAL,"This study was discontinued due to an interim analysis in the BN29552 study, which indicated that Crenezumab was unlikely to meet its primary endpoint."
NCT03491189,WITHDRAWN,INTERVENTIONAL,Protocol change
NCT03491436,WITHDRAWN,INTERVENTIONAL,No patient enrolled
NCT03491579,WITHDRAWN,INTERVENTIONAL,IMP will not be further developed
NCT03491865,WITHDRAWN,INTERVENTIONAL,unfunded
NCT03491930,WITHDRAWN,INTERVENTIONAL,Study never initiated. PI withdrew protocol with the IRB.
NCT03492138,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03492255,TERMINATED,INTERVENTIONAL,Significative difference between percentage of renal response (primary outcome) between the two study arms.
NCT03492268,WITHDRAWN,INTERVENTIONAL,Due to CART processing facility construction
NCT03492502,WITHDRAWN,INTERVENTIONAL,Slow recruitment
NCT03492710,WITHDRAWN,INTERVENTIONAL,A change in sponsor's developmental strategy
NCT03492736,TERMINATED,INTERVENTIONAL,PI leaving the laboratory
NCT03492788,TERMINATED,INTERVENTIONAL,Study lost access to ECGI
NCT03492801,TERMINATED,OBSERVATIONAL,Insufficient accrual
NCT03493009,WITHDRAWN,INTERVENTIONAL,"Difficulties to sign a contract with the hospital, due to logistic changes in the hospital."
NCT03493412,WITHDRAWN,INTERVENTIONAL,discontinued due to change in operating plans prior to study initiation and enrollment
NCT03493568,TERMINATED,INTERVENTIONAL,The futility analysis on 24-week results estimated that there was only 2% probability of verifying the study hypothesis of a higher proportion pat. with no residual viremia through 48w in arm E/C/F/TAF
NCT03493633,TERMINATED,OBSERVATIONAL,early termination - fault of inclusion
NCT03493984,WITHDRAWN,INTERVENTIONAL,"Investigator left the university prior to study approval, no patients enrolled"
NCT03494010,WITHDRAWN,OBSERVATIONAL,PI was unable to enroll anyone.
NCT03494114,TERMINATED,INTERVENTIONAL,Funding has ended and unable to recruit due to COVID 19
NCT03494231,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03494335,WITHDRAWN,OBSERVATIONAL,No participants enrolled.
NCT03494803,WITHDRAWN,OBSERVATIONAL,"No participants enrolled, leading to insufficient patient numbers to initiate the clinical trial."
NCT03494855,TERMINATED,OBSERVATIONAL,Patient accrual is slow and software renewal is costly and beyond our allocated fund for this study.
NCT03494868,SUSPENDED,INTERVENTIONAL,need additional funding
NCT03494933,TERMINATED,INTERVENTIONAL,"End of the Funding period, no further funding to complete the trial could be saved"
NCT03495063,WITHDRAWN,INTERVENTIONAL,Unable to quantify caffeine
NCT03495219,WITHDRAWN,OBSERVATIONAL,Unable to use manometry lab.
NCT03495479,WITHDRAWN,OBSERVATIONAL,No funding
NCT03495713,TERMINATED,INTERVENTIONAL,Covid-19
NCT03495921,TERMINATED,INTERVENTIONAL,"Slow accrual and as a result, a strategic business decision was made to terminate enrollment."
NCT03495999,TERMINATED,OBSERVATIONAL,The study interest was reached
NCT03496259,TERMINATED,INTERVENTIONAL,"Poor recruitment, one of investigators left institution."
NCT03496298,TERMINATED,INTERVENTIONAL,"Sponsor decision to cancel TRIAL, not related to safety concern"
NCT03496519,WITHDRAWN,INTERVENTIONAL,Contract Issues
NCT03496532,WITHDRAWN,INTERVENTIONAL,The study stoped becaus it did not even start No willing from our colleagues
NCT03496584,TERMINATED,INTERVENTIONAL,No funding to complete study
NCT03496623,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03496714,WITHDRAWN,INTERVENTIONAL,Decision made to develop different intervention
NCT03496766,TERMINATED,INTERVENTIONAL,The recruitment was closed prematurely to due to slow recruitment.
NCT03496909,WITHDRAWN,INTERVENTIONAL,Reduction in available resources
NCT03497026,TERMINATED,INTERVENTIONAL,Mutual Termination
NCT03497117,TERMINATED,INTERVENTIONAL,Enrollment barriers made study completion impossible
NCT03497234,WITHDRAWN,INTERVENTIONAL,Business Strategic Decision
NCT03497299,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03497338,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT03497455,TERMINATED,OBSERVATIONAL,COVID pandemic / Change in strategic direction
NCT03497507,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03497598,TERMINATED,INTERVENTIONAL,not enough patients
NCT03497715,TERMINATED,INTERVENTIONAL,On completion of part 1 it was felt that there would be no benefit in completing part 2
NCT03497728,TERMINATED,OBSERVATIONAL,halted prematurely
NCT03497780,TERMINATED,OBSERVATIONAL,"Due to staff departure, study is being discontinued per allocation of resources."
NCT03497793,WITHDRAWN,INTERVENTIONAL,Contractual issues have halted study set up
NCT03497988,WITHDRAWN,INTERVENTIONAL,"Grant proposal not funded, study has been withdrawn with IRB"
NCT03498014,WITHDRAWN,INTERVENTIONAL,no started
NCT03498196,TERMINATED,INTERVENTIONAL,The sponsor of this study has terminated the study due to poor enrollment.
NCT03498222,WITHDRAWN,INTERVENTIONAL,Funder and IMP manufacturer withdrew support
NCT03498274,TERMINATED,INTERVENTIONAL,Insufficient recruitmen
NCT03498391,SUSPENDED,INTERVENTIONAL,Due to the impact of COVID-19
NCT03498534,WITHDRAWN,INTERVENTIONAL,Due to administrative procedures
NCT03498781,TERMINATED,INTERVENTIONAL,Lack of interest in pool of potential participants
NCT03499002,WITHDRAWN,INTERVENTIONAL,study was discontinued
NCT03499041,WITHDRAWN,INTERVENTIONAL,Stopped for futility. Phase 3 studies not likely to meet primary endpoints.
NCT03499353,TERMINATED,INTERVENTIONAL,This study was terminated based on Pfizer's change in clinical development strategy not related to safety and efficacy.
NCT03499418,WITHDRAWN,OBSERVATIONAL,Due to changing methodology of the study
NCT03499678,TERMINATED,OBSERVATIONAL,Encountered technical issues with blood plasma samples received from the hospital.
NCT03500159,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT03500341,TERMINATED,INTERVENTIONAL,The data from the study showed good trending of Delta ORi and Delta PaO2. The study was stopped before full enrollment as a newer version of ORi was developed.
NCT03500354,WITHDRAWN,INTERVENTIONAL,PI moved to another institution and closed the study.
NCT03500393,TERMINATED,INTERVENTIONAL,feasibility of study recruitment
NCT03500406,TERMINATED,INTERVENTIONAL,PI changed subspecialties and no longer had access to main study population
NCT03500562,TERMINATED,OBSERVATIONAL,Insufficient Enrollment
NCT03500744,TERMINATED,INTERVENTIONAL,Inability to recruit due to COVID situation and protocols
NCT03500770,SUSPENDED,INTERVENTIONAL,lack of funding
NCT03500874,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to FUDR production halt in China
NCT03500939,TERMINATED,INTERVENTIONAL,Futility
NCT03500952,TERMINATED,INTERVENTIONAL,High incidence of fraudulent enrollment.
NCT03501056,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03501069,TERMINATED,INTERVENTIONAL,Business Decision; no human safety concern; evaluating preclinical toxicology finding
NCT03501927,TERMINATED,INTERVENTIONAL,Impossible patient inclusion due to the COVID-10 pandemic
NCT03501953,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT03501966,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03502135,WITHDRAWN,INTERVENTIONAL,study drug not available in time
NCT03502161,TERMINATED,OBSERVATIONAL,Business decision.
NCT03502421,WITHDRAWN,INTERVENTIONAL,"Never IRB approved, no intention to proceed with the study"
NCT03502447,TERMINATED,INTERVENTIONAL,Sponsor chose to change the study design.
NCT03502473,WITHDRAWN,INTERVENTIONAL,Sponsor decision was made not to initiate and to focus on other initiatives
NCT03502499,SUSPENDED,INTERVENTIONAL,slow enrollment
NCT03502551,WITHDRAWN,INTERVENTIONAL,Trial never received funding.
NCT03502577,TERMINATED,INTERVENTIONAL,Closed per SRC Low Accrual Policy
NCT03502681,TERMINATED,INTERVENTIONAL,Funder Decision
NCT03502694,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT03502824,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03502954,TERMINATED,INTERVENTIONAL,Halted prematurely
NCT03503279,WITHDRAWN,INTERVENTIONAL,Study was never started. PI left our institution and no other PI was identified
NCT03503435,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 we are not able to recruit in the foreseeable future
NCT03503851,WITHDRAWN,INTERVENTIONAL,Delay during study initiation. Change of MitraClip design in meantime.
NCT03503968,TERMINATED,INTERVENTIONAL,The clinical trial is terminated after the completion of phase I without moving to Phase II.
NCT03504033,WITHDRAWN,INTERVENTIONAL,A device would have had to be maintained. The maintenance company is insolvent; both another maintenance company and another serviced device were not available.
NCT03504410,TERMINATED,INTERVENTIONAL,Futile
NCT03504501,TERMINATED,INTERVENTIONAL,The study has been terminated prematurely due to recruitment difficulties. Current status: recruitment stopped and cleaning of the database is ongoing.
NCT03504566,WITHDRAWN,INTERVENTIONAL,Registered and published incorrectly
NCT03504774,TERMINATED,INTERVENTIONAL,Study discontinued due to slow enrollment during COVID-19 pandemic
NCT03504917,TERMINATED,INTERVENTIONAL,A futility analysis assessed that the study is highly unlikely to meet the pre-defined primary objective of the study. No new safety concerns were identified.
NCT03505060,WITHDRAWN,INTERVENTIONAL,One of the study products is no longer available for clinical trial use.
NCT03505372,TERMINATED,INTERVENTIONAL,Unable to recruit to study due to limited number of patients with ADH
NCT03505398,TERMINATED,INTERVENTIONAL,"Despite an extension of the planned duration of inclusion and an enrolled patient number inferior than planned, coordinating investigator considered that it was more reasonable to stop inclusions in order to analyze the data already available"
NCT03505827,WITHDRAWN,OBSERVATIONAL,No participants were successfully enrolled.
NCT03506009,TERMINATED,INTERVENTIONAL,it is very difficult to recruit qualified patients
NCT03506048,TERMINATED,INTERVENTIONAL,Study has been abandoned for lack of accrual
NCT03506139,WITHDRAWN,INTERVENTIONAL,Not funded
NCT03506399,WITHDRAWN,INTERVENTIONAL,Stopped for futility. Phase 3 studies not likely to meet primary endpoints.
NCT03506620,WITHDRAWN,INTERVENTIONAL,Unforeseen cost restrictions of the drug halted the execution of this study altogether.
NCT03506659,TERMINATED,INTERVENTIONAL,Inclusion rate too low
NCT03506802,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT03507127,TERMINATED,INTERVENTIONAL,Low rate of enrollment
NCT03507218,TERMINATED,OBSERVATIONAL,PI left and section closed.
NCT03507322,WITHDRAWN,OBSERVATIONAL,Clinic management decided to cancel the study for priority reasons
NCT03507348,TERMINATED,INTERVENTIONAL,investigateur decision
NCT03507374,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT03507881,TERMINATED,OBSERVATIONAL,Recruitment too slow
NCT03508167,WITHDRAWN,INTERVENTIONAL,Study design will be reformulated
NCT03508219,TERMINATED,INTERVENTIONAL,COVID-19
NCT03508258,WITHDRAWN,OBSERVATIONAL,Study was discontinued in 2018 as sufficient sample size was not met.
NCT03508388,TERMINATED,OBSERVATIONAL,inclusion number not sufficient
NCT03508427,TERMINATED,INTERVENTIONAL,Suspended since april 2020 as the application is temporarily unavailable
NCT03508453,WITHDRAWN,INTERVENTIONAL,Study will not be conducted due to lack of funding
NCT03508479,SUSPENDED,INTERVENTIONAL,Suspended due to COVID-19.
NCT03508518,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT03508648,WITHDRAWN,INTERVENTIONAL,Lack of efficacy from primary study
NCT03508739,SUSPENDED,INTERVENTIONAL,We do not have active funding at this time.
NCT03508804,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT03508869,TERMINATED,INTERVENTIONAL,sponsor asked site to suspend study.
NCT03508921,TERMINATED,INTERVENTIONAL,Early termination due to recruitment and follow-up challenges during the pandemic
NCT03509207,TERMINATED,INTERVENTIONAL,"The early termination was NOT due to safety reasons, terminated because of the very slow recruitment and problematic access to the study medication in Europe"
NCT03509298,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03509584,TERMINATED,INTERVENTIONAL,SAFETY
NCT03509870,TERMINATED,INTERVENTIONAL,study stopped because of lack of recruitment
NCT03510455,TERMINATED,INTERVENTIONAL,Study was stopped early due to a greater than expected incidence of ocular AEs and analysis of the data from the first 4 subjects indicating that the likelihood of permanent remission with this therapy was low.
NCT03510897,TERMINATED,INTERVENTIONAL,Study completed day 90 for primary endpoint but was terminated early for one year follow up due to results not meeting efficacy outcome at Day 90.
NCT03510988,TERMINATED,INTERVENTIONAL,Temporarily paused per study team for interim data review.
NCT03511027,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03511066,TERMINATED,INTERVENTIONAL,CT-P27 2.2 is inactivated
NCT03511079,WITHDRAWN,INTERVENTIONAL,Difficulty with recruiting due to staffing and Covid-19
NCT03511105,TERMINATED,INTERVENTIONAL,Study terminated due to low probability of achieving a positive outcome on the primary endpoint.
NCT03511144,WITHDRAWN,INTERVENTIONAL,Study not initiated
NCT03511222,TERMINATED,INTERVENTIONAL,Low accrual
NCT03511365,TERMINATED,INTERVENTIONAL,IRB haulted the study there was no evidence that the probiotic would benefit the patient
NCT03511417,WITHDRAWN,INTERVENTIONAL,Due to the delay in establishing FDA regulations for over-the-counter hearing aids
NCT03511482,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03511521,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient number of patients
NCT03511547,WITHDRAWN,INTERVENTIONAL,Personal reasons
NCT03511716,TERMINATED,OBSERVATIONAL,Could not enroll enough patients and ran out of $$ to manufacture more devices
NCT03512067,TERMINATED,INTERVENTIONAL,Administrative reasons and Overall Study PI moved to another institution.
NCT03512353,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03512483,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03513042,TERMINATED,OBSERVATIONAL,Inclusionrate dropped due to changes in clinical process
NCT03513068,TERMINATED,INTERVENTIONAL,COVID-19
NCT03513445,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03513458,WITHDRAWN,INTERVENTIONAL,\[The risk of inhaled allergen challenge and anakinra treatment outweigh benefits to participants with allergic asthma due to the COVID-19 pandemic.
NCT03513471,WITHDRAWN,INTERVENTIONAL,The risk of inhaled allergen challenge and anakinra treatment outweigh benefits to participants with allergic asthma due to the COVID-19 pandemic.
NCT03513783,TERMINATED,INTERVENTIONAL,not enough patients
NCT03514017,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT03514277,TERMINATED,INTERVENTIONAL,PI decision to close study early
NCT03514407,TERMINATED,INTERVENTIONAL,Strategic Business Decision
NCT03514563,TERMINATED,OBSERVATIONAL,Due to Covid-19 pandemic
NCT03514836,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT03514875,WITHDRAWN,INTERVENTIONAL,discontinued due to change in operating plans prior to study initiation and enrollment
NCT03514927,WITHDRAWN,INTERVENTIONAL,No funding
NCT03515005,TERMINATED,INTERVENTIONAL,Enrollment target not reached
NCT03515200,TERMINATED,INTERVENTIONAL,Due to departure of PI from St. Jude
NCT03515226,TERMINATED,INTERVENTIONAL,Challenges in recruiting eligible participants
NCT03515330,WITHDRAWN,INTERVENTIONAL,Merged IRB study created
NCT03515395,WITHDRAWN,OBSERVATIONAL,"Low recruitement, no scientific staff"
NCT03515551,TERMINATED,INTERVENTIONAL,Strategic decision to stop development and not based on any safety concerns
NCT03515603,TERMINATED,INTERVENTIONAL,Inadequate recruiting
NCT03515629,TERMINATED,INTERVENTIONAL,Business decision
NCT03515642,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant due to PI not employment at University."
NCT03515707,WITHDRAWN,INTERVENTIONAL,PI recommended closure
NCT03515785,WITHDRAWN,OBSERVATIONAL,Revisiting the availability of patients with Ph+ ALL that would meet the in-/exclusion criteria of the study led to the decision not to move forward.
NCT03515824,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03515941,TERMINATED,INTERVENTIONAL,The PI has decided to close the study due to the outdated study design.
NCT03515967,WITHDRAWN,INTERVENTIONAL,Inability to recruit
NCT03516084,TERMINATED,INTERVENTIONAL,"As the treatment model of extensive-stage small cell lung cancer changed rapidly and the enrollment speed significantly lower than expected, ZaiLab decided to terminate this study"
NCT03516318,TERMINATED,INTERVENTIONAL,Study funding ended before last round of data collection could be complete.
NCT03516383,WITHDRAWN,OBSERVATIONAL,No funding received.
NCT03516695,TERMINATED,OBSERVATIONAL,due to Sponsor's ongoing and upcoming projects and overall research priorities
NCT03516747,WITHDRAWN,INTERVENTIONAL,we gave up
NCT03516760,TERMINATED,INTERVENTIONAL,The actions and measures to be taken to restart the trial could not be implemented which made the premature termination inevitability.
NCT03516851,WITHDRAWN,INTERVENTIONAL,there are not enough participants enrolled
NCT03516903,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic. With a second wave just beginning, and considering that we are testing an immunosuppressant in patients with high risk for COVID-19 complications, we would not be able to re-start recruitment safely in the near future."
NCT03517111,TERMINATED,INTERVENTIONAL,Inability to interact with participants for intervention or data collection due to COVID-19 quarantine and social distancing restrictions.
NCT03517501,WITHDRAWN,INTERVENTIONAL,Sponsor will amend study design by incorporating reconfirmation of coagulopathy following discussion with FDA regarding findings from SCARLET1 study.
NCT03517566,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03517696,WITHDRAWN,INTERVENTIONAL,Study IRB approval expired
NCT03517709,WITHDRAWN,INTERVENTIONAL,No recruitment of subjects
NCT03517722,TERMINATED,INTERVENTIONAL,Study terminated early as a result of the outcome of the pre-planned Interim Analysis
NCT03517735,TERMINATED,INTERVENTIONAL,Modification of the device
NCT03517995,WITHDRAWN,INTERVENTIONAL,Grant not approved
NCT03518112,TERMINATED,INTERVENTIONAL,Due to Competing Studies
NCT03518164,WITHDRAWN,INTERVENTIONAL,Investigator stopped study
NCT03518229,WITHDRAWN,INTERVENTIONAL,Converted from a pilot into a larger study which we will enter as a new protocol
NCT03518320,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT03518996,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT03519061,WITHDRAWN,INTERVENTIONAL,Unable to obtain FDA exemption
NCT03519087,TERMINATED,INTERVENTIONAL,The planned 15-month recruitment period was completed.
NCT03519126,TERMINATED,INTERVENTIONAL,Due to the covid-19 pandemic
NCT03519191,TERMINATED,INTERVENTIONAL,Recruitment too low for power analysis
NCT03519256,TERMINATED,INTERVENTIONAL,Insufficient Enrollment
NCT03519308,TERMINATED,INTERVENTIONAL,The accrual goal could not be met and the drug manufacturer pulled support
NCT03519360,WITHDRAWN,INTERVENTIONAL,Logistical difficulties with contracting and with local dialysis unit policies preclueded successful recruiting/enrollment
NCT03519477,WITHDRAWN,INTERVENTIONAL,Study terminated by sponsor for commercial reasons
NCT03519490,WITHDRAWN,INTERVENTIONAL,Lack of interest and support
NCT03519880,TERMINATED,INTERVENTIONAL,COVID-19 research restrictions
NCT03519958,WITHDRAWN,OBSERVATIONAL,The study direction does not longer aligns the sponsor's strategy
NCT03519984,TERMINATED,INTERVENTIONAL,Study drug supply issue
NCT03520127,TERMINATED,OBSERVATIONAL,Product withdrawn from the market due to a shift in sponsor business focus
NCT03520153,WITHDRAWN,OBSERVATIONAL,The principal investigator is leaving Yale University and will not be continuing the work at her new institution.
NCT03520582,TERMINATED,OBSERVATIONAL,stop trial due to proposals for possible optimizations of the device by the investigators.
NCT03520751,SUSPENDED,INTERVENTIONAL,Vector has not been produced
NCT03520959,TERMINATED,INTERVENTIONAL,Study was terminated due to sponsor's decision.
NCT03520985,TERMINATED,INTERVENTIONAL,Feasibility (low patient accrual and financial reasons)
NCT03521128,WITHDRAWN,INTERVENTIONAL,"poor recruitment, no participants enrolled"
NCT03521232,TERMINATED,INTERVENTIONAL,Covid-19
NCT03521310,TERMINATED,INTERVENTIONAL,Continued randomization was questioned on ethical grounds after the WHO iKMC study reported mortality reduction in May 2021. The DSMB recommended to stop the trial after reviewing a preliminary data analysis because of benefit of the intervention.
NCT03521479,TERMINATED,INTERVENTIONAL,Study drug out of specification
NCT03521518,TERMINATED,OBSERVATIONAL,Inadequate enrollment
NCT03521804,TERMINATED,INTERVENTIONAL,Business decision
NCT03521934,TERMINATED,INTERVENTIONAL,Study terminated due to business decision
NCT03522207,TERMINATED,INTERVENTIONAL,shortstaff at sleep lab
NCT03522350,TERMINATED,INTERVENTIONAL,Device has been FDA approved.
NCT03522480,WITHDRAWN,INTERVENTIONAL,Change of Research Objectives for Grant Funded Study
NCT03522584,TERMINATED,INTERVENTIONAL,Terminated by the sponsor due to lack of efficacy in study treatment.
NCT03522753,WITHDRAWN,INTERVENTIONAL,Resolving database issues
NCT03522805,TERMINATED,INTERVENTIONAL,Failure to accrue subjects. All activity has stopped \& no analysis will be done on what has been collected.
NCT03522974,TERMINATED,INTERVENTIONAL,COVID stopped clinical research trials and industry pulled funding
NCT03522987,WITHDRAWN,INTERVENTIONAL,Decided not to perform the pilot phase
NCT03523091,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03523156,SUSPENDED,INTERVENTIONAL,Study is temporarily suspended due to COVID-19 mitigation and security issues.
NCT03523260,WITHDRAWN,INTERVENTIONAL,Never funded
NCT03523299,WITHDRAWN,INTERVENTIONAL,Principal investigator wishes to revisit design and start a new study
NCT03523429,TERMINATED,INTERVENTIONAL,Low rate of recruitment
NCT03523455,TERMINATED,INTERVENTIONAL,Unable to recruit qualified participants
NCT03523507,TERMINATED,INTERVENTIONAL,Study terminated due to COVID-19 restrictions
NCT03523533,TERMINATED,INTERVENTIONAL,Investigator Decision \& not a clinical trial.
NCT03523663,TERMINATED,OBSERVATIONAL,difficulty recruiting pediatric participants followed by a prolonged shut down due to COVID-19
NCT03523715,TERMINATED,INTERVENTIONAL,Difficulty in recruiting participants
NCT03523728,TERMINATED,INTERVENTIONAL,Interim analysis for futility of the Stage 1 of the EFC15392 study met the protocol specified stopping rule based on the primary endpoint. EFC15392 study was stopped for futility based on prespecified criteria and recommendation from DMC
NCT03523767,TERMINATED,INTERVENTIONAL,Early termination related to COVID pandemic
NCT03524001,TERMINATED,INTERVENTIONAL,"Non superiority of treatment arm (and hypothesized inferiority) before completion of enrolling, at ad interim analysis"
NCT03524248,TERMINATED,INTERVENTIONAL,Camera for study is being repaired
NCT03524261,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03524274,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03524638,WITHDRAWN,INTERVENTIONAL,Investigator decided to withdraw the study.
NCT03524820,TERMINATED,INTERVENTIONAL,By Merck
NCT03524898,TERMINATED,INTERVENTIONAL,"As Last patient last visit (LPLV) took place on 15/02/2022, the trial was ended prematurely on this date in accordance with SAKK/CI."
NCT03525392,TERMINATED,INTERVENTIONAL,"Due to agreement to transfer rights for IPN01087 to an external partner, not due to safety concerns"
NCT03525535,TERMINATED,OBSERVATIONAL,Principal investigator departure without possible replacement
NCT03525691,TERMINATED,INTERVENTIONAL,insufficient enrollment
NCT03526172,SUSPENDED,OBSERVATIONAL,Halting of all research and elective surgeries due to the Covid-19 pandemic
NCT03526185,TERMINATED,INTERVENTIONAL,lack of funds
NCT03526367,WITHDRAWN,INTERVENTIONAL,Study withdrawn for no sufficient fund support.
NCT03526497,TERMINATED,OBSERVATIONAL,Poor enrollment
NCT03526536,TERMINATED,INTERVENTIONAL,The study required more participants than anticipated for statistical significance.
NCT03527004,TERMINATED,OBSERVATIONAL,"The study was terminated prematurely after 2 years because during to the COVID-19 pandemic, the face-to-face mode of administration of the interviews in the General Adult Population Sample was not feasible."
NCT03527017,TERMINATED,OBSERVATIONAL,"The study was terminated prematurely after 2 years because during to the COVID-19 pandemic, the face-to-face mode of administration of the interviews in the General Adult Population Sample was not feasible."
NCT03527030,TERMINATED,OBSERVATIONAL,The study was terminated prematurely due to the difficulty to recruit sufficient participants to meet the target sample size in the IQOS user sample.
NCT03527056,WITHDRAWN,INTERVENTIONAL,Investigator left the institution
NCT03527264,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03527498,WITHDRAWN,INTERVENTIONAL,"The other study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT03527550,TERMINATED,INTERVENTIONAL,Data collection ended due to COVID-19 (study site closed to in-person visits)
NCT03527784,TERMINATED,INTERVENTIONAL,Parastomal Parietex withdrawn from market by the manufacturer.
NCT03527810,TERMINATED,INTERVENTIONAL,interim analysis of the data was not supportive of continuing the study.
NCT03527966,TERMINATED,INTERVENTIONAL,PI left the institution
NCT03528057,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting participants.
NCT03528343,WITHDRAWN,INTERVENTIONAL,Lost research support for enrolling patients
NCT03528512,TERMINATED,INTERVENTIONAL,Staffing for study was eliminated
NCT03528564,TERMINATED,INTERVENTIONAL,"The primary reasoning is that we were unable to demonstrate feasibility, prior to and because of the impact of COVID on our research programs."
NCT03528876,TERMINATED,INTERVENTIONAL,Combination of chemotherapy and Immunotherapy is a new Standard of care
NCT03528980,TERMINATED,OBSERVATIONAL,default inclusion
NCT03529071,TERMINATED,INTERVENTIONAL,Unable to recruit enough participants due to limited grant funding.
NCT03529084,WITHDRAWN,INTERVENTIONAL,Decision by Sponsor not to continue with the trial.
NCT03529097,WITHDRAWN,INTERVENTIONAL,No participants enrolles
NCT03529162,TERMINATED,INTERVENTIONAL,"COVID-19, followed by PI leaving institution."
NCT03529318,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT03529331,WITHDRAWN,INTERVENTIONAL,The ED physicians no longer prescribe opioids at discharge; not feasible to conduct the study
NCT03529552,TERMINATED,INTERVENTIONAL,The Dm production has been stopped
NCT03529799,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03529838,TERMINATED,INTERVENTIONAL,Early interruption caused by the COVID-19 pandemic.
NCT03529916,WITHDRAWN,OBSERVATIONAL,No eligible participants were recruited
NCT03529929,WITHDRAWN,INTERVENTIONAL,withdrawn
NCT03530241,WITHDRAWN,INTERVENTIONAL,No funding
NCT03530254,TERMINATED,INTERVENTIONAL,"Low recruitment speed, higher percentage drop-out and SARS-CoV-2 pandemic situation"
NCT03530293,TERMINATED,INTERVENTIONAL,Futility
NCT03530332,TERMINATED,INTERVENTIONAL,Inadequate resources.
NCT03530345,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03530410,WITHDRAWN,OBSERVATIONAL,The study did not recruit any participant.
NCT03530423,WITHDRAWN,OBSERVATIONAL,Principal Investigator Decision
NCT03530449,TERMINATED,OBSERVATIONAL,Management decision; not patient safety related
NCT03530527,TERMINATED,INTERVENTIONAL,The study was terminated because of difficulty in completing the study as originally planned
NCT03530605,WITHDRAWN,INTERVENTIONAL,"Study never initiated, PI left institution"
NCT03530878,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT03531112,TERMINATED,INTERVENTIONAL,Study terminated due to COVID-19
NCT03531125,TERMINATED,OBSERVATIONAL,Study was closed early due to low numbers of evaluable patients
NCT03531268,WITHDRAWN,INTERVENTIONAL,Need improve the strategy
NCT03531281,WITHDRAWN,INTERVENTIONAL,Administratively withdrawn
NCT03531437,TERMINATED,INTERVENTIONAL,problem with recruiting participants
NCT03531502,TERMINATED,INTERVENTIONAL,lack of funding
NCT03531710,TERMINATED,INTERVENTIONAL,United Neuroscience has decided to terminate V203-AD-EXT study based on a treatment assignment error
NCT03531788,TERMINATED,INTERVENTIONAL,COVID inhibited additional home visits for device installation and testing
NCT03531827,TERMINATED,INTERVENTIONAL,Study was closed for toxicity.
NCT03532009,TERMINATED,INTERVENTIONAL,Study stopped early due to the COVID-19 pandemic
NCT03532022,WITHDRAWN,INTERVENTIONAL,Protocol re-design required following EU Phase III results
NCT03532035,WITHDRAWN,INTERVENTIONAL,terminated due to low enrollment rate
NCT03532087,WITHDRAWN,INTERVENTIONAL,Due to new insights
NCT03532204,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03532308,TERMINATED,INTERVENTIONAL,Unable to meet recruitment goals.
NCT03532334,WITHDRAWN,INTERVENTIONAL,unable to accrue in subjects in a timely fashion
NCT03532425,TERMINATED,INTERVENTIONAL,Difficulties enrolling participants
NCT03532542,TERMINATED,INTERVENTIONAL,"Participants were either transitioned to a post-trial access program or another Sarepta study, or they declined further treatment. There were no safety concerns with this study."
NCT03532555,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03532750,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03532958,WITHDRAWN,INTERVENTIONAL,Transfer of study sponsor
NCT03533400,WITHDRAWN,INTERVENTIONAL,NHLBI has suggested the company focus on the other two ongoing trials
NCT03533465,TERMINATED,INTERVENTIONAL,Due to funding limitations
NCT03533686,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT03533946,TERMINATED,INTERVENTIONAL,New standard of care for study participant population
NCT03534102,WITHDRAWN,INTERVENTIONAL,"Due to limitations caused by COVID, enrollment targets could not be met."
NCT03534141,TERMINATED,INTERVENTIONAL,"Terminated 9/24/23 at 85% target enrollment due to slow accrual of subjects. The decline in enrollment was attributed to changing surgical demographics (higher MELD, more DCD grafts, and increasing use of Normothermic Perfusion technology)."
NCT03534193,SUSPENDED,INTERVENTIONAL,Site resources
NCT03534219,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03534362,TERMINATED,INTERVENTIONAL,Insufficient resources available to complete the study
NCT03534388,WITHDRAWN,INTERVENTIONAL,Enrollment difficulty
NCT03534466,TERMINATED,INTERVENTIONAL,"The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT03534505,TERMINATED,INTERVENTIONAL,cannot enroll patient
NCT03534583,TERMINATED,INTERVENTIONAL,Terminated due to Covid-19 pandemic related restrictions
NCT03534700,TERMINATED,INTERVENTIONAL,decision of the PI
NCT03534817,SUSPENDED,INTERVENTIONAL,COVID-19
NCT03535272,TERMINATED,INTERVENTIONAL,Unable to reach target sample size.
NCT03535493,TERMINATED,INTERVENTIONAL,Ethics Committee concerns.
NCT03535506,TERMINATED,INTERVENTIONAL,lack of accrual
NCT03535584,SUSPENDED,INTERVENTIONAL,Due to Covid19 pandemic at this time we are on pause
NCT03535675,TERMINATED,INTERVENTIONAL,The study was terminated by DSMB due to futility.
NCT03535688,TERMINATED,INTERVENTIONAL,Insufficient funding to complete the study
NCT03536026,WITHDRAWN,INTERVENTIONAL,Was unable to enroll any participants
NCT03536182,WITHDRAWN,INTERVENTIONAL,Due to COVID and other recruitment issues the trial could not be initiated.
NCT03536208,WITHDRAWN,INTERVENTIONAL,no accrual for over 12 months
NCT03536338,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03536390,WITHDRAWN,INTERVENTIONAL,The study was cancelled prior to the enrollment of any participants.
NCT03536559,TERMINATED,INTERVENTIONAL,COVID-19 related enrollment challenges.
NCT03537066,TERMINATED,INTERVENTIONAL,inability to include subjects on schedule
NCT03537131,TERMINATED,INTERVENTIONAL,Temporary halt due to COVID-19 pandemic
NCT03537144,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT03537157,TERMINATED,INTERVENTIONAL,The decision to prematurely close the trial recruitment period was taken due to the difficulties in the recruitment of patients. This decision has not been triggered by any unexpected safety signals identified during the study conduction.
NCT03537222,TERMINATED,OBSERVATIONAL,Not enough participants and study funding
NCT03537521,WITHDRAWN,OBSERVATIONAL,due to corona pandemic crisis
NCT03537534,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03537547,TERMINATED,INTERVENTIONAL,Per sponsor and PI institution discussions
NCT03537612,TERMINATED,INTERVENTIONAL,Do to our inability to meet recruitment targets - Sponsor stopped funding. Looking for new sponsor and protocol modifications
NCT03537716,WITHDRAWN,INTERVENTIONAL,It wasn't possible to recruit the desired number of patients.
NCT03538015,TERMINATED,INTERVENTIONAL,Sponsor was impacted by COVID-19 and did not have sufficient funds to continue.
NCT03538236,WITHDRAWN,INTERVENTIONAL,The study did not recruit any patients.
NCT03538392,WITHDRAWN,OBSERVATIONAL,"Product not available, study withdrawn"
NCT03538444,TERMINATED,INTERVENTIONAL,Recruitment stopped due to COVID19 and PI made an institution switch.
NCT03538795,TERMINATED,INTERVENTIONAL,Ran out of funds
NCT03538886,TERMINATED,INTERVENTIONAL,Impossible to involve a sufficient number of centers in the study.
NCT03539198,TERMINATED,OBSERVATIONAL,Failure to accrue.
NCT03539432,TERMINATED,INTERVENTIONAL,Funds for the study expired
NCT03539484,TERMINATED,INTERVENTIONAL,"Study terminated due to change in benefit-risk ratio, driven by high incidence GI toxicity in absence of clinically significant anti-tumor efficacy."
NCT03539601,TERMINATED,INTERVENTIONAL,This decision was made for business reasons only and is not related to any safety concerns regarding crisaborole.
NCT03539757,TERMINATED,OBSERVATIONAL,Due to lack of enrollment this study was permanatly closed March 2022. The incidence of FONTAN patients being referred for liver biospsies and occurance of COVID effected participants enrolled.
NCT03539796,TERMINATED,INTERVENTIONAL,This study was terminated early because of shortage of supplies with no foreseeable future of when they will be back in stock.
NCT03539861,TERMINATED,INTERVENTIONAL,"COVID- pandemic, nursing shortages. enrolled two patients then not enough nurses in dialysis unit to be able to attend to patients"
NCT03540095,TERMINATED,INTERVENTIONAL,"Due to staffing issues, we are unable to enroll patients at the clinical site assigned. The study is terminated."
NCT03540147,TERMINATED,INTERVENTIONAL,The number of subjects in this study was overestimated in the initial assessment.
NCT03540160,TERMINATED,INTERVENTIONAL,No longer pursuing development of serlopitant
NCT03540199,WITHDRAWN,INTERVENTIONAL,No participant enrolled
NCT03540225,WITHDRAWN,INTERVENTIONAL,Fail to sort out the logistics of study drugs due to funding problems
NCT03540368,SUSPENDED,INTERVENTIONAL,increased number of patients death
NCT03540875,TERMINATED,INTERVENTIONAL,Modification of the device
NCT03540953,TERMINATED,INTERVENTIONAL,"adverse events was observed in all of them, with intense neck pain and ulcer evelopment"
NCT03541369,TERMINATED,INTERVENTIONAL,"Premature discontinuation of study, a strategic decision."
NCT03541954,TERMINATED,INTERVENTIONAL,End of inclusions
NCT03541967,WITHDRAWN,INTERVENTIONAL,overload costs
NCT03542071,TERMINATED,INTERVENTIONAL,The study protocol was changed because of too few eligible participants. A registration with revised protocol can be found by ClinicalTrials.gov ID NCT03681054.
NCT03542110,TERMINATED,INTERVENTIONAL,Withdrawal of medication and funding support by Sponsor
NCT03542812,TERMINATED,INTERVENTIONAL,The study stopped enrollment prior to the initially projected 18 subjects per phase due to lack of funding to continue to recertify the drug and because an adequate number of subjects were enrolled for each phase to analyze pharmacokinetics.
NCT03543020,TERMINATED,OBSERVATIONAL,inadequate patient number
NCT03543033,WITHDRAWN,INTERVENTIONAL,The study was closed by the investigators due to lack of study population to enroll.
NCT03543046,TERMINATED,INTERVENTIONAL,PI left the institution
NCT03543475,TERMINATED,INTERVENTIONAL,competing trial on same population.
NCT03544034,WITHDRAWN,INTERVENTIONAL,not funded
NCT03544073,WITHDRAWN,INTERVENTIONAL,The investigators were not able to get grant funding for this study.
NCT03544099,TERMINATED,INTERVENTIONAL,Difficult to recruit Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA
NCT03544242,TERMINATED,INTERVENTIONAL,"Lack of eligible subjects, lack of staffing"
NCT03544333,TERMINATED,INTERVENTIONAL,Because of low recruitment numbers.
NCT03544788,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03544892,TERMINATED,INTERVENTIONAL,PI left the University; study will not continue.
NCT03545087,WITHDRAWN,INTERVENTIONAL,Stopped for futility. Phase 3 studies not likely to meet primary endpoints.
NCT03545165,TERMINATED,INTERVENTIONAL,Sponsor withdrawal
NCT03545633,WITHDRAWN,INTERVENTIONAL,It wasn't possible to recruit the desired number of patients.
NCT03545646,WITHDRAWN,INTERVENTIONAL,It wasn't possible to recruit the desired number of patients.
NCT03545945,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients
NCT03545997,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT03546335,SUSPENDED,INTERVENTIONAL,Lapse in study funding.
NCT03546400,WITHDRAWN,INTERVENTIONAL,The study was cancelled prior to the enrollment of any participants.
NCT03546504,TERMINATED,INTERVENTIONAL,ran out of money
NCT03546556,TERMINATED,INTERVENTIONAL,Study terminated due to COVID-19 pandemic and not being able to perform PET/MR scans on participants.
NCT03546881,TERMINATED,INTERVENTIONAL,Premature termination of the research following an internal reorganization of the team no longer allowing the necessary resources to continue the study
NCT03546933,TERMINATED,OBSERVATIONAL,A correction needs to be made to the device's algorithm.
NCT03547063,SUSPENDED,OBSERVATIONAL,COVID-19
NCT03547089,SUSPENDED,INTERVENTIONAL,Recruitment issues
NCT03547206,TERMINATED,INTERVENTIONAL,Terminated by Sponsor
NCT03547297,TERMINATED,OBSERVATIONAL,Sponsor elected not to continue with study
NCT03547349,TERMINATED,INTERVENTIONAL,COVID-19
NCT03547427,TERMINATED,INTERVENTIONAL,Clinical staffing issues and COVID-19 pandemic
NCT03547479,WITHDRAWN,INTERVENTIONAL,The PI is no longer at the University
NCT03547778,WITHDRAWN,INTERVENTIONAL,Unable to get patients interested in the study
NCT03547869,TERMINATED,INTERVENTIONAL,Funding finished
NCT03547882,WITHDRAWN,OBSERVATIONAL,Project ended in 2022 and evolved into another grant (VA PII 19-321 (050 HX003009))
NCT03547934,WITHDRAWN,INTERVENTIONAL,It wasn't possible to recruit the desired number of patients.
NCT03548051,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03548064,TERMINATED,INTERVENTIONAL,COVID 19 cases at the site
NCT03548246,WITHDRAWN,INTERVENTIONAL,This study plan has halted and was withdrawn from the IRB.
NCT03548519,WITHDRAWN,INTERVENTIONAL,Study stopped due to technical reasons
NCT03548610,WITHDRAWN,INTERVENTIONAL,None of the screened subjects were interested / eligible for enrollment.
NCT03548727,WITHDRAWN,INTERVENTIONAL,Low Accrual
NCT03548961,SUSPENDED,INTERVENTIONAL,Accrual goal met
NCT03549000,TERMINATED,INTERVENTIONAL,After review of data which showed low likelihood of efficacy in these patients Novartis decided to terminate the trial early. Termination was not safety related
NCT03549338,TERMINATED,INTERVENTIONAL,Study was terminated due to administrative reasons
NCT03549351,TERMINATED,OBSERVATIONAL,Study turned out no longer feasible
NCT03549611,WITHDRAWN,INTERVENTIONAL,elected not to proceed with the study
NCT03549650,TERMINATED,INTERVENTIONAL,"Given the updated precautions on Elmiron as well as the risk benefit profile, we have decided to terminate the study."
NCT03549689,WITHDRAWN,INTERVENTIONAL,Withdrawn by drug manufacturer
NCT03550040,TERMINATED,INTERVENTIONAL,accrual was sufficient at interim analysis to draw final conclusions needed to publish
NCT03550313,TERMINATED,INTERVENTIONAL,Study vaccinations and blood draws were halted due to adequacy of a smaller dataset and study feasibility issues. It was not based on any safety concerns.
NCT03550352,TERMINATED,INTERVENTIONAL,expiration of study product; end of study product availability
NCT03550443,TERMINATED,INTERVENTIONAL,"Based on results of double-blind parts, it was determined that it would be difficult to submit a marketing authorization application for RTA 402 for diabetic kidney disease."
NCT03550469,TERMINATED,INTERVENTIONAL,Device problem and pandemic restrictions
NCT03550521,WITHDRAWN,INTERVENTIONAL,PI left
NCT03551119,TERMINATED,INTERVENTIONAL,Covid-19 pandemic
NCT03551418,TERMINATED,INTERVENTIONAL,Interruption of COVID 19 pandemic
NCT03551522,TERMINATED,INTERVENTIONAL,unexpected histological findings
NCT03551535,WITHDRAWN,INTERVENTIONAL,Study IRB approval expired
NCT03551639,WITHDRAWN,OBSERVATIONAL,no patient meet of criteria the trial
NCT03551717,TERMINATED,OBSERVATIONAL,Lack of inclusion
NCT03551847,WITHDRAWN,INTERVENTIONAL,"Unable to enroll any subjects, closed study"
NCT03552029,TERMINATED,INTERVENTIONAL,This study was terminated based on a business decision by the Sponsor.
NCT03552120,TERMINATED,INTERVENTIONAL,Enrollment was temporarily paused due to study resources in 2019. The study was then administratively closed by the IRB due to no Continuing Review application submission prior to expiration date.
NCT03552549,TERMINATED,INTERVENTIONAL,This study was closed to enrollment prematurely due to sub-optimal accrual.
NCT03552692,TERMINATED,INTERVENTIONAL,efficacy lower than expected
NCT03552796,WITHDRAWN,INTERVENTIONAL,Budget issues
NCT03553212,TERMINATED,INTERVENTIONAL,"outdated, progress in clinical practice."
NCT03553394,TERMINATED,INTERVENTIONAL,Stopped after interim analysis
NCT03553524,WITHDRAWN,INTERVENTIONAL,Due to personnel and organizational issues.
NCT03553550,TERMINATED,OBSERVATIONAL,Enrollment futility
NCT03553576,TERMINATED,INTERVENTIONAL,Lack of continued funding
NCT03553615,WITHDRAWN,INTERVENTIONAL,Limited clinical capacity
NCT03553732,TERMINATED,OBSERVATIONAL,Lack of funding
NCT03553914,WITHDRAWN,INTERVENTIONAL,IND Inactive Status
NCT03554109,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03554161,TERMINATED,INTERVENTIONAL,The study was terminated based on its primary and secondary outcome measures in three consecutive patients.
NCT03554200,TERMINATED,INTERVENTIONAL,COVID 19
NCT03554395,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03554759,TERMINATED,OBSERVATIONAL,Study was terminated early due to enrollment challenges
NCT03555006,TERMINATED,INTERVENTIONAL,"because of the health crisis, organizational constraints and the lack of medical and paramedical staff"
NCT03555149,TERMINATED,INTERVENTIONAL,The Sponsor made the decision to terminate the study due to start up and recruitment issues caused by limited resource availability at the treating centers.
NCT03555552,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT03555656,TERMINATED,INTERVENTIONAL,Futility analysis suggested termination
NCT03555721,TERMINATED,OBSERVATIONAL,low subject recruitment
NCT03555786,TERMINATED,OBSERVATIONAL,Failure of recruitment
NCT03555968,WITHDRAWN,INTERVENTIONAL,Logistical issues
NCT03555981,TERMINATED,INTERVENTIONAL,In response to COVID pandemic
NCT03556020,TERMINATED,INTERVENTIONAL,Terminated: Study drug resupply delayed (Covid-19)
NCT03556202,TERMINATED,INTERVENTIONAL,The study was terminated due to a strategic business decision made by the Sponsor.
NCT03556501,TERMINATED,OBSERVATIONAL,Lack of enrollment numbers - participants are no longer being examined
NCT03556618,TERMINATED,INTERVENTIONAL,It was not feasible to study the WPC intervention as a clinical trial due to disruptions caused by COVID-19.
NCT03556826,TERMINATED,INTERVENTIONAL,"Study was hindered by Covid and masking, therefore was unable to be completed as intended."
NCT03556930,WITHDRAWN,INTERVENTIONAL,Project was never initiated.
NCT03557554,TERMINATED,INTERVENTIONAL,feasability and recruitment issues
NCT03557606,WITHDRAWN,OBSERVATIONAL,Collecting data as part of a Patient Registry; redundant study.
NCT03557684,TERMINATED,INTERVENTIONAL,COVID-19
NCT03557749,TERMINATED,OBSERVATIONAL,Accrual goal met
NCT03557970,TERMINATED,INTERVENTIONAL,Not enough enrollment to determine efficacy
NCT03558659,TERMINATED,INTERVENTIONAL,Low recruitment.
NCT03558672,TERMINATED,OBSERVATIONAL,Low enrollment numbers
NCT03558724,TERMINATED,INTERVENTIONAL,"Dose-escalation was finished, but no clear correlation between fluorescence and tumor grade was established"
NCT03558750,TERMINATED,INTERVENTIONAL,Low accrual
NCT03558841,TERMINATED,INTERVENTIONAL,enrollment goal not met in allotted recruitment period
NCT03558958,TERMINATED,INTERVENTIONAL,Terminated due to lack of funding.
NCT03558984,TERMINATED,INTERVENTIONAL,company prioritization reasons
NCT03559010,TERMINATED,INTERVENTIONAL,"Terminated prematurely due to issues with one of the data collection systems, no impact on subject safety"
NCT03559270,TERMINATED,INTERVENTIONAL,Terminated due to lack of alignment during regulatory negotiations.
NCT03559309,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic Measures
NCT03559387,TERMINATED,INTERVENTIONAL,Study redesign
NCT03559517,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for inflammatory bowel diseases (IBD) early.
NCT03559946,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19 pandemic
NCT03559985,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT03560011,SUSPENDED,INTERVENTIONAL,Decision of Data Safety Monitoring Board
NCT03560102,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT03560232,TERMINATED,INTERVENTIONAL,Unable to recruit patients in a timely fashion and unable to recruit sufficient patients
NCT03560349,WITHDRAWN,INTERVENTIONAL,Both Study PI's left the institution
NCT03560518,TERMINATED,INTERVENTIONAL,Business decision to stop the program.
NCT03560765,TERMINATED,INTERVENTIONAL,No longer able to recruit due to COVID lockdowns
NCT03560908,WITHDRAWN,INTERVENTIONAL,No enough eligable participants enrolled
NCT03560986,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03561038,WITHDRAWN,INTERVENTIONAL,Similar study just got done
NCT03561090,TERMINATED,INTERVENTIONAL,Parallel IW-3718 Phase III trial did not meet pre-specified criteria.
NCT03561324,WITHDRAWN,INTERVENTIONAL,PI leaving institution/no funding
NCT03561922,TERMINATED,INTERVENTIONAL,Manufacturer of the investigational device has ceased all business activities
NCT03562000,TERMINATED,INTERVENTIONAL,"The primary evalution criteria had a so few occurrence that it has been a fundamental obstacle to randomize patient. The use of mecanical aide to cough is more widly employ, creating a second limitation."
NCT03562247,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution and the study was closed with the IRB
NCT03562299,WITHDRAWN,INTERVENTIONAL,Unspecified business decision/strategic reason.
NCT03562416,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03562507,TERMINATED,INTERVENTIONAL,Lack of patient population
NCT03562520,TERMINATED,INTERVENTIONAL,The study was terminated due to the COVID-19 pandemic as no in-person study visits were permitted.
NCT03562689,SUSPENDED,OBSERVATIONAL,Not enough subjects.
NCT03562702,TERMINATED,INTERVENTIONAL,Access to Speedlyte Product no longer available.
NCT03562767,TERMINATED,INTERVENTIONAL,"A control group was intended to be added to the study, but the study team decided not complete this additional research with the pandemic. Additional funds were also not available to enroll a new control group and thus, the study was terminated."
NCT03562806,TERMINATED,INTERVENTIONAL,Tested MR sequence was inferior in preliminary evaluation
NCT03562949,TERMINATED,INTERVENTIONAL,Insufficient investigational product
NCT03563040,WITHDRAWN,INTERVENTIONAL,Lack of feasibility
NCT03563144,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03563170,WITHDRAWN,INTERVENTIONAL,Enrollment not initiated
NCT03563222,TERMINATED,INTERVENTIONAL,Prematurely stopped in agreement with authorities (FDA)
NCT03563274,TERMINATED,OBSERVATIONAL,did not meet planned recruitment expectations with a slow recruitment rate
NCT03563352,WITHDRAWN,OBSERVATIONAL,Zero accrual
NCT03563365,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT03563742,TERMINATED,INTERVENTIONAL,High SF rate (less treatment-nave subjects \& subjects with viral load \<100000). Reevaluation in scientific position in India after internal discussion.
NCT03563872,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03563885,TERMINATED,INTERVENTIONAL,Financial and Method issues suggesting that study is not feasible.
NCT03563911,WITHDRAWN,INTERVENTIONAL,COVID pandemic
NCT03564015,TERMINATED,INTERVENTIONAL,The intervention (guidance recovery app) was malfunctioning and not storing data for efficacy outcomes.
NCT03564041,TERMINATED,INTERVENTIONAL,COVID-19
NCT03564054,TERMINATED,INTERVENTIONAL,slow accrual
NCT03564145,TERMINATED,INTERVENTIONAL,"Per protocol, the Sponsor could terminate the study once 300 participants completed a total of 28 weeks of treatment and 100 participants completed a total of 52 weeks."
NCT03564756,WITHDRAWN,INTERVENTIONAL,Difficulty with enrollment
NCT03565172,TERMINATED,INTERVENTIONAL,protocol with too many constraints. long protocol
NCT03565315,TERMINATED,INTERVENTIONAL,Sponsor/PI voluntarily paused and stopped study after observing several Grade 2 and Grade 3 redness local reactogenicity reactions at 10E8VLS injection sites
NCT03565328,TERMINATED,INTERVENTIONAL,Slow/insufficient accrual and investigators have left the study.
NCT03565406,TERMINATED,INTERVENTIONAL,recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
NCT03565497,TERMINATED,INTERVENTIONAL,COVID-19 pandemic caused human subjects research to shut down and study was unable to restart.
NCT03565991,TERMINATED,INTERVENTIONAL,The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522)
NCT03566264,WITHDRAWN,OBSERVATIONAL,Program has been terminated.
NCT03566290,WITHDRAWN,INTERVENTIONAL,Development of investigational product was halted.
NCT03566303,TERMINATED,INTERVENTIONAL,Coronavirus Pandemic
NCT03566342,TERMINATED,OBSERVATIONAL,Preliminary analysis of data showed no significant findings
NCT03566407,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue the study due to poor enrollment.
NCT03566485,TERMINATED,INTERVENTIONAL,Low accrual/Loss of funding
NCT03566511,SUSPENDED,INTERVENTIONAL,Temporarily paused while the MR center develops newer study techniques. We might resume; this is not a suspension of IRB approval.
NCT03566641,TERMINATED,INTERVENTIONAL,Low enrollment. Not enough data for interim analysis.
NCT03566823,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for inflammatory bowel diseases (IBD) early.
NCT03566927,TERMINATED,INTERVENTIONAL,Terminated due to warning letters issued regarding paclitaxel
NCT03567291,TERMINATED,INTERVENTIONAL,The parent trials did not meet the primary endpoints of reduction in motor and phonic tics.
NCT03567499,WITHDRAWN,INTERVENTIONAL,The decision to end the study was made for GSK portfolio reasons. No subjects were randomised into the study.
NCT03567616,TERMINATED,INTERVENTIONAL,"Following results of the primary progression-free survival analysis from Study NCT02755597, company-sponsored MM studies were placed on partial clinical hold (PCH). Sponsor did not pursue release of the PCH for this study."
NCT03567694,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03567837,TERMINATED,INTERVENTIONAL,It was stopped due to the inability to recruit during the Covid epidemic.
NCT03567928,TERMINATED,INTERVENTIONAL,Technical problem with device in study
NCT03567954,TERMINATED,OBSERVATIONAL,Low inclusionrate due to logistic challenges
NCT03568071,TERMINATED,INTERVENTIONAL,MOR106 clinical development in atopic dermatitis was stopped for futility
NCT03568084,TERMINATED,INTERVENTIONAL,SARS-CoV-2 Pandemic
NCT03568955,WITHDRAWN,OBSERVATIONAL,"This is no longer considered a clinical trial as per the Kantonial Ethics Committee in Zurich, CH"
NCT03569007,TERMINATED,INTERVENTIONAL,Trial terminated by Sponsor
NCT03569033,TERMINATED,INTERVENTIONAL,"The data did not support study endpoints for acute cough, based on an interim efficacy analysis; not due to safety concerns."
NCT03569150,WITHDRAWN,INTERVENTIONAL,Study not funded.
NCT03569670,WITHDRAWN,INTERVENTIONAL,Study has been suspended due to inability to obtain funding.
NCT03569709,WITHDRAWN,INTERVENTIONAL,Not funded
NCT03569722,TERMINATED,OBSERVATIONAL,This study was terminated due to insufficient recruitment.
NCT03569774,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT03569800,TERMINATED,OBSERVATIONAL,investigator's decision : recruitment difficulties and lack of interest in the remote study of the crisis Levothyrox
NCT03569917,TERMINATED,INTERVENTIONAL,"143 patients have been recruited instead of 150 but the theoretical date of end of inclusions being reached, we have decided to not prolong again the study."
NCT03569943,WITHDRAWN,INTERVENTIONAL,Change in medical practice on the management of the eligible population
NCT03570411,TERMINATED,OBSERVATIONAL,The company that was contracted to conduct study specific testing was sold and new management chose to pursue interests other than CMV.
NCT03570476,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT03570489,TERMINATED,INTERVENTIONAL,Could not recruit patients because of Covid 19 restrictions and because of lack of efficacy for primary endpoint
NCT03570801,TERMINATED,INTERVENTIONAL,"We performed unplanned interim conditional power (CP) analyses for the primary endpoint. We pre-specified futility as CP\<20%. Based on 301 patients (38% of target), CP was \<20% and the independent steering committee recommended termination."
NCT03570996,TERMINATED,INTERVENTIONAL,COVID 19
NCT03571204,TERMINATED,INTERVENTIONAL,Coronavirus 2019 (COVID-19) pandemic
NCT03571594,TERMINATED,INTERVENTIONAL,The study met a pre-defined protocol study stopping criteria
NCT03571646,TERMINATED,INTERVENTIONAL,Poor recruitment rate due to difficulties in identifying suitable patients
NCT03571776,TERMINATED,INTERVENTIONAL,Low recruitment because patients and gynecologists prefer the sclerosis arm to avoid surgery
NCT03571828,TERMINATED,INTERVENTIONAL,Amgen decided to discontinue study because of a business decision and not because of safety reasons
NCT03571919,WITHDRAWN,INTERVENTIONAL,Inability to recruit during the Covid pandemic
NCT03571945,SUSPENDED,INTERVENTIONAL,"Due to Coronavirus infection decrease in elective case list , also lack of response from other centers"
NCT03572062,TERMINATED,INTERVENTIONAL,"Study halted prematurely by sponsor and will not resume, participants are no longer being examined or receiving intervention."
NCT03572257,WITHDRAWN,INTERVENTIONAL,Closed due to inability to enroll
NCT03572478,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy.
NCT03572634,TERMINATED,INTERVENTIONAL,"Given the extensive time projected to conclude the study hypothesis, it is no longer feasible to include this study of TP-0903."
NCT03572907,WITHDRAWN,OBSERVATIONAL,Investigators decision
NCT03573076,TERMINATED,INTERVENTIONAL,The second study arm including radio-frequency microneedling was withdrawn due to availability of newer treatment options.
NCT03573336,TERMINATED,INTERVENTIONAL,"Due to a change in the development program, the study was closed prematurely."
NCT03573427,WITHDRAWN,OBSERVATIONAL,No patients enrolled; Executive Committee Decision;Feasibility of recruitment
NCT03573505,TERMINATED,INTERVENTIONAL,Study was stopped because of safety concerns.
NCT03573544,TERMINATED,INTERVENTIONAL,OBI-888 no longer fulfills our goal of developing cost-effective therapies for cancer patients
NCT03573570,WITHDRAWN,INTERVENTIONAL,The Government of Tamil Nadu decided not to proceed with implementation of fortified rice through the Public Distribution (per the original study protocol)
NCT03573921,TERMINATED,INTERVENTIONAL,Poor recruitment to date.
NCT03573986,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03574181,TERMINATED,OBSERVATIONAL,Extensive changes to the watch design would be needed to produce a robust device.
NCT03574194,TERMINATED,INTERVENTIONAL,Suspended due to COVID-19 pandemic
NCT03574220,WITHDRAWN,INTERVENTIONAL,No accrual - closed by PRMC
NCT03574337,WITHDRAWN,INTERVENTIONAL,Inadequate funding
NCT03574649,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03574818,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03574857,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03574974,TERMINATED,INTERVENTIONAL,Funding ended prematurely
NCT03575078,WITHDRAWN,INTERVENTIONAL,Project Never Initiated - no human subjects were enrolled and no data regarding humans was collected or studied
NCT03575208,WITHDRAWN,INTERVENTIONAL,Slow/Insufficient accrual
NCT03575234,WITHDRAWN,INTERVENTIONAL,funding and drug were withdrawn
NCT03575494,WITHDRAWN,OBSERVATIONAL,this study does not need to get a clinicaltrials number
NCT03575507,WITHDRAWN,INTERVENTIONAL,It wasn't possible to recruit the desired number of patients.
NCT03575572,TERMINATED,INTERVENTIONAL,Staffing changes impacted by COVID-19 pandemic resulting in inadequate personnel to facilitate study.
NCT03575741,WITHDRAWN,OBSERVATIONAL,Unfortunately the recruitment process appeared to be very difficult. No participants could be recruited.
NCT03575858,WITHDRAWN,INTERVENTIONAL,Barrel shaped interdental brush went out of production
NCT03575975,TERMINATED,OBSERVATIONAL,Study was terminated due to lack of funding and unforeseen delays.
NCT03576131,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03576534,TERMINATED,INTERVENTIONAL,"Given SARS CoV2 pandemic, we had difficulty enrolling patients in the proposed time frame"
NCT03576599,TERMINATED,INTERVENTIONAL,difficult to include patients
NCT03576768,TERMINATED,INTERVENTIONAL,Study terminated due to PI leaving the institution.
NCT03576963,WITHDRAWN,INTERVENTIONAL,No funding
NCT03577028,TERMINATED,INTERVENTIONAL,Decision not to continue to the expansion portion of the study
NCT03577184,WITHDRAWN,OBSERVATIONAL,Institutions issue
NCT03577288,TERMINATED,INTERVENTIONAL,"Study had to be stopped in 2020 with the health crisis linked to COVID-19. Following this, and in view of the sanitary conditions, it was not possible to resume recruitment (research was taking place within the University of Lyon 2 and in schools)"
NCT03577418,WITHDRAWN,INTERVENTIONAL,"study never started, was not funded"
NCT03577600,WITHDRAWN,INTERVENTIONAL,suspended due to administrative problems
NCT03577691,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT03577717,TERMINATED,INTERVENTIONAL,This study was stopped due to time and budgetary constraints.
NCT03577899,TERMINATED,INTERVENTIONAL,desired primary endpoint was not met
NCT03578029,TERMINATED,INTERVENTIONAL,Business Decision
NCT03578198,TERMINATED,INTERVENTIONAL,Issues in supply of IP
NCT03578354,WITHDRAWN,INTERVENTIONAL,Funding not acquired
NCT03578432,TERMINATED,INTERVENTIONAL,UACC-PHX is no longer able to support the study and Novartis is unable to provide drug beyond December 2019.
NCT03578731,TERMINATED,OBSERVATIONAL,Mainly due to insufficient recruitment
NCT03578952,TERMINATED,INTERVENTIONAL,End of support
NCT03579043,WITHDRAWN,INTERVENTIONAL,Lack of recruitment - no eligible participants.
NCT03579147,WITHDRAWN,INTERVENTIONAL,It was not possible to recruit any patients at that time.
NCT03579160,TERMINATED,INTERVENTIONAL,Due to the insufficient accrual rate and strategic reasons to focus our efforts on higher impact research projects.
NCT03579186,WITHDRAWN,INTERVENTIONAL,Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected to resume in the future; This is not a suspension of IRB approval
NCT03579212,TERMINATED,OBSERVATIONAL,EC withdrawal with termination of the NB contract
NCT03579277,TERMINATED,INTERVENTIONAL,inadequate enrollment
NCT03579407,TERMINATED,INTERVENTIONAL,COVID limitations and staff changes
NCT03579472,TERMINATED,INTERVENTIONAL,Due to the fact that the sponsor decided not to move forward with the development of M7824
NCT03579758,WITHDRAWN,INTERVENTIONAL,This trial will open as an NCTN trial.
NCT03579888,TERMINATED,INTERVENTIONAL,Study halted prematurely
NCT03579927,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03580005,WITHDRAWN,INTERVENTIONAL,The study was cancelled prior to the enrollment of any participants.
NCT03580044,TERMINATED,INTERVENTIONAL,Recruitment of patients with serious infections caused by gram-negative bacteria producing MBL has been challenging. Date study terminated: 16-Dec-2022.
NCT03580382,TERMINATED,INTERVENTIONAL,"Per regulatory coordinator, the sponsor is no longer supporting the study."
NCT03580616,TERMINATED,INTERVENTIONAL,Study was terminated by the IRB due to continued noncompliance.
NCT03580694,TERMINATED,INTERVENTIONAL,Program reprioritization
NCT03580746,WITHDRAWN,OBSERVATIONAL,Resident working on this study left our department
NCT03580772,TERMINATED,OBSERVATIONAL,"Due to ongoing issues with recruitment, it was decided it was best to terminate the study and focus resources on other priorities."
NCT03580798,TERMINATED,INTERVENTIONAL,Not enough patients available
NCT03580967,WITHDRAWN,INTERVENTIONAL,COVID-19 Pandemic interfered with Pt recruitment
NCT03581084,TERMINATED,INTERVENTIONAL,The study was redesigned to be conducted in an outpatient setting.
NCT03581279,TERMINATED,INTERVENTIONAL,Enrollment levels insufficient to continue.
NCT03581474,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03581513,TERMINATED,INTERVENTIONAL,DSMB halted the study due to safety concerns.
NCT03582007,TERMINATED,INTERVENTIONAL,Safety data review
NCT03582033,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT03582046,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT03582085,WITHDRAWN,INTERVENTIONAL,No funding at the current time.
NCT03582150,WITHDRAWN,INTERVENTIONAL,Funding lost during COVID
NCT03582280,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03582384,WITHDRAWN,INTERVENTIONAL,Study never started
NCT03582618,TERMINATED,INTERVENTIONAL,The study has been terminated due to slow enrollment
NCT03582904,WITHDRAWN,INTERVENTIONAL,Pilot data suggested the paradigm would need significant revision.
NCT03582956,TERMINATED,INTERVENTIONAL,Covid
NCT03583736,WITHDRAWN,INTERVENTIONAL,PI decision
NCT03584009,TERMINATED,INTERVENTIONAL,"Sponsor's decision, no safety concerns."
NCT03584269,TERMINATED,INTERVENTIONAL,Recruiting difficulties
NCT03584399,TERMINATED,OBSERVATIONAL,lack of enrollment
NCT03584477,TERMINATED,INTERVENTIONAL,The study was stopped because inclusion rate was not met. No inclusion in the last 11 months.
NCT03584516,TERMINATED,INTERVENTIONAL,The study was terminated due to insufficient efficacy to support moving into Part 2 of the study; there were no safety concerns that contributed to this decision.
NCT03584737,TERMINATED,OBSERVATIONAL,Lack of funding
NCT03585062,TERMINATED,INTERVENTIONAL,The paclitaxel-albumin halt production.
NCT03585101,WITHDRAWN,INTERVENTIONAL,Funding no longer available
NCT03585192,TERMINATED,INTERVENTIONAL,Enrollment closed due to impending graduation from Fellowship
NCT03585335,TERMINATED,OBSERVATIONAL,"Due to COVID-19 restrictions and the closure of the research clinic site, the study ended prematurely. Not all data was collected on all participants."
NCT03585465,SUSPENDED,INTERVENTIONAL,Interim analysis
NCT03585595,WITHDRAWN,INTERVENTIONAL,The study was not funded.
NCT03585725,TERMINATED,INTERVENTIONAL,low accrual
NCT03585764,TERMINATED,INTERVENTIONAL,This study was halted prematurely due to recruitment barriers
NCT03585855,TERMINATED,INTERVENTIONAL,Safety reasons
NCT03585907,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03586024,WITHDRAWN,INTERVENTIONAL,poor accrual
NCT03586089,TERMINATED,INTERVENTIONAL,Difficulty recruiting patients
NCT03586232,WITHDRAWN,INTERVENTIONAL,The study could not be conducted since funding was not obtained.
NCT03586544,TERMINATED,INTERVENTIONAL,The study was halted prematurely due to COVID 19.
NCT03586687,TERMINATED,INTERVENTIONAL,insufficient rate of accrual
NCT03586778,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03586895,SUSPENDED,INTERVENTIONAL,The study is paused.
NCT03586934,WITHDRAWN,INTERVENTIONAL,Difficult to enroll patients for the study
NCT03587129,TERMINATED,INTERVENTIONAL,No patient enter this study.
NCT03587363,TERMINATED,INTERVENTIONAL,Mild/moderate hepatic impairment (HI) cohorts completed with no impact to erdafitinib exposure. Severe HI cohort enrollment stopped early.
NCT03587519,TERMINATED,INTERVENTIONAL,Adverse Event
NCT03587571,TERMINATED,INTERVENTIONAL,Insufficient patient recruitment
NCT03587896,TERMINATED,INTERVENTIONAL,12-month assessment process has been stopped prematurely due to logistic reasons.
NCT03588039,TERMINATED,INTERVENTIONAL,Study terminated due to lack of funding
NCT03588065,TERMINATED,INTERVENTIONAL,The study was stopped by insufficient funds
NCT03588728,TERMINATED,INTERVENTIONAL,Lab was shut down due to COVID as were nearing study completion
NCT03588741,TERMINATED,INTERVENTIONAL,The trial was terminated as the participant withdrew from the trial.
NCT03588806,TERMINATED,INTERVENTIONAL,Study halted permanently and will not resume; participants are no longer being examined or receiving intervention.
NCT03588936,TERMINATED,INTERVENTIONAL,Poor accrual and loss of funding.
NCT03589456,TERMINATED,OBSERVATIONAL,"Study was closed to accrual on January 15, 2020."
NCT03589742,TERMINATED,INTERVENTIONAL,Feasibility objectives were obtained
NCT03589755,WITHDRAWN,INTERVENTIONAL,unable to recruit enough candidates
NCT03589781,WITHDRAWN,INTERVENTIONAL,Covid 19 Pandemic - Unable to enroll patients
NCT03589963,TERMINATED,INTERVENTIONAL,Institutional ORE decision to stop community based research in response to COVID emergency and need to socially distance
NCT03589976,TERMINATED,INTERVENTIONAL,Interim analysis showed early evidence of futility of sirolimus. Trial stopped per DSMB recommendation.
NCT03590665,TERMINATED,INTERVENTIONAL,PI accepted a position at a new Institution and terminated the study at UIC.
NCT03590730,TERMINATED,OBSERVATIONAL,The trial stopped prematurely because of enrollment challenges.
NCT03590743,TERMINATED,INTERVENTIONAL,Lack of participant enrollment
NCT03590860,TERMINATED,INTERVENTIONAL,injection site reaction burden
NCT03591289,WITHDRAWN,INTERVENTIONAL,study never started up at site
NCT03591380,TERMINATED,INTERVENTIONAL,Recruitment complications due to COVID-19
NCT03591458,TERMINATED,INTERVENTIONAL,"Slow subject enrollment, unable to complete trial in a timely manner"
NCT03591614,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03591744,WITHDRAWN,INTERVENTIONAL,Budgetary constraints
NCT03591796,WITHDRAWN,INTERVENTIONAL,no participants were included
NCT03591861,TERMINATED,INTERVENTIONAL,Low accrual
NCT03591874,TERMINATED,INTERVENTIONAL,Primary endpoint was not met.
NCT03591926,WITHDRAWN,INTERVENTIONAL,Study withdrawn for business reasons prior to screening or enrolling any subjects.
NCT03591965,TERMINATED,INTERVENTIONAL,Based on the adjustment of clinical research and development strategysponsor decided to terminate the study
NCT03592056,TERMINATED,OBSERVATIONAL,interim analysis proved that protocol intervention had no preventive effect
NCT03592082,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT03592264,TERMINATED,INTERVENTIONAL,Little evidence of clinical activity in tumor types enrolled
NCT03592355,TERMINATED,INTERVENTIONAL,COVID19 pandemic
NCT03592407,WITHDRAWN,INTERVENTIONAL,Safety concerns
NCT03592459,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT03592641,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT03592784,TERMINATED,INTERVENTIONAL,"Lack of enrollment during Covid pandemic, however sufficient data gathered for assessment of primary outcome"
NCT03592862,WITHDRAWN,INTERVENTIONAL,Pending investigation of an unexpected animal toxicology finding.
NCT03593109,TERMINATED,INTERVENTIONAL,Suitable patients were not recruited
NCT03593213,TERMINATED,INTERVENTIONAL,FDA Released Allergan from this post marketing requirement
NCT03593421,WITHDRAWN,INTERVENTIONAL,BioInceptdecided not to pursue this drug target at this time.
NCT03593460,WITHDRAWN,INTERVENTIONAL,BioIncept changed the focus of future drug development
NCT03593564,TERMINATED,INTERVENTIONAL,The study team experienced technology challenges with the digital platform used to deliver the intervention and to collect data. Data collection surveys would be automatically sent to participants before participants completed intervention modules.
NCT03593694,TERMINATED,INTERVENTIONAL,Service provider challenges precluded intervention delivery.
NCT03593876,TERMINATED,INTERVENTIONAL,"Given the design of the study, we reached saturation with a sample of 16"
NCT03593902,TERMINATED,INTERVENTIONAL,PI Sabbatical
NCT03593915,TERMINATED,INTERVENTIONAL,The sponsor decided not to continue the study based on the overall company strategy in AML.
NCT03593980,TERMINATED,INTERVENTIONAL,Study could not be run for logistical reasons
NCT03593993,TERMINATED,OBSERVATIONAL,low accrual and lack of funds
NCT03594045,TERMINATED,INTERVENTIONAL,Withdrawal of funding by sponsor
NCT03594097,TERMINATED,INTERVENTIONAL,"Due to the study sponsor's request to prematurely terminate this study, the numbers of participants enrolled in the study discontinued or some discontinued earlier due to a screening failure."
NCT03594175,TERMINATED,INTERVENTIONAL,"Due to ongoing recruitment challenges globally, it is not possible to complete this study. The decision is not based on any reported changes in the safety profile or any concerns with the anticipated efficacy profile of the investigational product."
NCT03594331,TERMINATED,INTERVENTIONAL,Funding stopped
NCT03594955,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03595046,WITHDRAWN,INTERVENTIONAL,It was difficult to recruit subjects.
NCT03595072,WITHDRAWN,OBSERVATIONAL,Difficulty securing funding due to COVID-19
NCT03595371,TERMINATED,INTERVENTIONAL,The study was terminated due to study design issues that did not allow for determination of efficacy and safety in subjects with Schnitzler Syndrome who are currently well controlled on anakinra therapy.
NCT03595683,SUSPENDED,INTERVENTIONAL,Drug supply no longer available.
NCT03595982,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03596073,TERMINATED,INTERVENTIONAL,Interim analysis did not show the required cytokine induction by topical calcipotriene to justify continuation of the trial
NCT03596125,TERMINATED,INTERVENTIONAL,difficulty of recruitment
NCT03596151,TERMINATED,INTERVENTIONAL,To optimize device
NCT03596658,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT03596710,WITHDRAWN,INTERVENTIONAL,sponsor withdrew study
NCT03596723,TERMINATED,INTERVENTIONAL,NDA #210565 did not trigger the need for a Pediatric Research Equity Act study.
NCT03597009,TERMINATED,INTERVENTIONAL,due to slow accrual and withdrawal of funding
NCT03597022,TERMINATED,INTERVENTIONAL,Due to thrombosis
NCT03597035,TERMINATED,INTERVENTIONAL,The study could not enroll patients owing to the inclusion exclusion criteria
NCT03597282,TERMINATED,INTERVENTIONAL,Closed due to historically slow enrollment compounded by the COVID-19 pandemic.
NCT03597347,TERMINATED,INTERVENTIONAL,"Recruitment for trial stopped early due to limitations from COVID-19, additionally changes in the standard of care for CF patients during the study period resulted in confounding of the primary endpoint."
NCT03597386,WITHDRAWN,OBSERVATIONAL,The study will not be conducted
NCT03597490,TERMINATED,OBSERVATIONAL,excessive dropout
NCT03597503,TERMINATED,INTERVENTIONAL,"Business decision, not related to safety"
NCT03597971,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03598023,WITHDRAWN,INTERVENTIONAL,Sponsor discretion
NCT03598036,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT03598140,TERMINATED,INTERVENTIONAL,"PI, Dr. Josh Gaston, left the institution and the study has been stopped."
NCT03598283,WITHDRAWN,OBSERVATIONAL,The study PI has left the institution.
NCT03598777,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT03598816,WITHDRAWN,INTERVENTIONAL,FDA Contingencies unresolved
NCT03598907,TERMINATED,OBSERVATIONAL,"After interim statistical analysis, a statistician reccommended to stop study, because results are significant and in favour of POC approach."
NCT03599037,WITHDRAWN,INTERVENTIONAL,The investigators decided not to start up the study after the long Covid 19 pause dring which no participants were enrolled.
NCT03599336,TERMINATED,INTERVENTIONAL,Slower than expected enrollment.
NCT03599362,TERMINATED,INTERVENTIONAL,PI departure from institution
NCT03599518,TERMINATED,INTERVENTIONAL,This study was terminated based on a business decision by the Sponsor.
NCT03599544,TERMINATED,INTERVENTIONAL,"Study was halted prematurely and will not resume due to loss of funding and access to rehabilitation exoskeleton robot (ArmeoSpring), prohibiting completion of project as planned."
NCT03599622,TERMINATED,INTERVENTIONAL,Trial terminated because of lack of efficacy in the short term acute phase
NCT03600467,TERMINATED,INTERVENTIONAL,Sponsor
NCT03600532,TERMINATED,INTERVENTIONAL,Due to lack of participant recruitment
NCT03600623,TERMINATED,INTERVENTIONAL,PI left the institution; no further accruals
NCT03600740,TERMINATED,INTERVENTIONAL,Delays in IRB approval and interval start of a competing study
NCT03600805,TERMINATED,INTERVENTIONAL,Protracted recruitment timeline exacerbated by COVID-19 pandemic
NCT03600818,TERMINATED,INTERVENTIONAL,Protracted recruitment timeline exacerbated by COVID-19 pandemic
NCT03600896,WITHDRAWN,INTERVENTIONAL,Supply issues from Sponsor
NCT03600909,TERMINATED,INTERVENTIONAL,Accrual has been slow
NCT03600948,TERMINATED,OBSERVATIONAL,Problem with enrollment due to Covid-19
NCT03600961,TERMINATED,OBSERVATIONAL,Problem with enrollment due to Covid-19
NCT03601247,SUSPENDED,INTERVENTIONAL,"The PI suspended the study temporarily d/t COVID pandemic and did not want patients to attend follow-up visits at that time unless absolutely necessary. As such, the study was delayed and the PCD and SCD are being pushed out to new targeted dates."
NCT03601481,SUSPENDED,OBSERVATIONAL,Software update needed
NCT03601507,TERMINATED,INTERVENTIONAL,Novartis has chosen to withdraw support for this trial
NCT03601572,WITHDRAWN,OBSERVATIONAL,Abandoned research
NCT03601728,SUSPENDED,INTERVENTIONAL,Covid-19 Crisis
NCT03601819,TERMINATED,INTERVENTIONAL,Low accrual
NCT03601936,TERMINATED,INTERVENTIONAL,Additional in-house analysis and development
NCT03601962,TERMINATED,INTERVENTIONAL,Low enrolment rate
NCT03602040,SUSPENDED,INTERVENTIONAL,Awaiting advice from R\&D regarding recruitment
NCT03602066,TERMINATED,INTERVENTIONAL,Study terminated by pharmaceutical company
NCT03602118,WITHDRAWN,INTERVENTIONAL,Sponsor withdrawing the subject IND
NCT03602287,WITHDRAWN,INTERVENTIONAL,the article is not a clinical trial but is a hospital based randomized comparative study. This was inadvertently uploaded.
NCT03602456,TERMINATED,OBSERVATIONAL,"On 12/16/19, a termination request was sent to CMS to end Kentucky HEALTH by the new administration."
NCT03602495,TERMINATED,INTERVENTIONAL,"Based on IDMC's recommendations during the interim analysis""the trial has reached the goal of early termination of the trial"". the sponsor communicating with CDE, CDE agreed to unblind the trial and submit a NDA."
NCT03602716,TERMINATED,INTERVENTIONAL,"Study was recruited slowly due to the imapct of some uncontrollable factors, such as COVID19."
NCT03602781,WITHDRAWN,INTERVENTIONAL,Decision not to proceed with Study
NCT03602872,WITHDRAWN,INTERVENTIONAL,"Sponsor to start with different protocol, postponed due to COVID"
NCT03602898,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT03602976,TERMINATED,INTERVENTIONAL,Inability to adequately recruit subjects in COVID-19 pandemic
NCT03603080,TERMINATED,INTERVENTIONAL,Difficulty with enrollment and then Covid pandemic
NCT03603275,TERMINATED,OBSERVATIONAL,Insufficient data
NCT03603288,TERMINATED,INTERVENTIONAL,Interim analysis concluded to futility of main study SIDEROS (SNT-III-012)
NCT03603587,TERMINATED,INTERVENTIONAL,Organisation issues
NCT03603626,WITHDRAWN,INTERVENTIONAL,the article is not a clinical trial but is a hospital based randomized comparative study. This was inadvertently uploaded.
NCT03603639,TERMINATED,INTERVENTIONAL,The study was stopped due to efficacy reasons.
NCT03603652,TERMINATED,INTERVENTIONAL,Study originally suspended pending a protocol amendment but study now terminated.
NCT03603964,TERMINATED,INTERVENTIONAL,Early termination not due to patient safety
NCT03603990,WITHDRAWN,INTERVENTIONAL,"Inclusion difficulties, despite significant changes to inclusion criteria"
NCT03604081,WITHDRAWN,INTERVENTIONAL,PI has encountered recruitment challenges.
NCT03604185,TERMINATED,INTERVENTIONAL,COVID-19 forced the shut down of the study
NCT03604250,SUSPENDED,INTERVENTIONAL,Study protocol under revision.
NCT03604445,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03604523,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03604536,TERMINATED,OBSERVATIONAL,not able to recruit patients
NCT03604770,WITHDRAWN,OBSERVATIONAL,Due to lack of enrollment.
NCT03604783,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate further development of the program.
NCT03604991,SUSPENDED,INTERVENTIONAL,End of Initial Phase of Multi-phase protocol
NCT03605069,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03605212,TERMINATED,INTERVENTIONAL,The study was stopped as per EMA waiver granted on 20July2018.
NCT03605238,WITHDRAWN,INTERVENTIONAL,It was hard to recruit patients
NCT03605303,TERMINATED,INTERVENTIONAL,This study was terminated due to the released lenses not representing what will be made commercially available and thus the objectives could not be met
NCT03605329,TERMINATED,INTERVENTIONAL,recruitment rate lower than expected
NCT03605342,TERMINATED,INTERVENTIONAL,Early termination
NCT03605537,WITHDRAWN,INTERVENTIONAL,Study terminated due to lack of funding.
NCT03605589,WITHDRAWN,INTERVENTIONAL,Lack of enrollment due to the availability of other novel salvage therapies for relapsed/refractory B-ALL.
NCT03605693,TERMINATED,INTERVENTIONAL,Halted Prematurely
NCT03605745,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate the study due to business reasons
NCT03605758,TERMINATED,INTERVENTIONAL,The original study PI passed away. Primary and Study Completion dates revised to reflect last participant examination date.
NCT03606174,TERMINATED,INTERVENTIONAL,"The study was terminated due to sponsor decision / portfolio prioritization, and not due to safety reasons."
NCT03606304,WITHDRAWN,INTERVENTIONAL,The study was not deemed feasible to conduct.
NCT03606486,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT03606655,WITHDRAWN,INTERVENTIONAL,Terms could not be met with the FDA.
NCT03606889,TERMINATED,INTERVENTIONAL,not enough participants
NCT03606980,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03607500,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03607682,TERMINATED,INTERVENTIONAL,PI left institution and loss of funding
NCT03607708,SUSPENDED,INTERVENTIONAL,COVID-19
NCT03607864,TERMINATED,INTERVENTIONAL,because bone osteointegration is completed
NCT03607955,WITHDRAWN,INTERVENTIONAL,Trial may move forward as an NCI-sponsored trial and not an investigator initiated trial.
NCT03608020,TERMINATED,INTERVENTIONAL,Cessation of grant funding
NCT03608033,TERMINATED,INTERVENTIONAL,"IA did not show positive results. Study is terminated, and in process of closing"
NCT03608098,WITHDRAWN,INTERVENTIONAL,Key study team members working on the study are leaving the institution.
NCT03608137,TERMINATED,INTERVENTIONAL,Termine
NCT03608358,TERMINATED,INTERVENTIONAL,Sponsor decided to stop commercialization of QTERNMet/Qtrilmet and to stop all related ongoing activities/studies for business reasons.
NCT03608501,WITHDRAWN,INTERVENTIONAL,Business decision (no safety or efficacy concerns)
NCT03608540,TERMINATED,INTERVENTIONAL,Enrolment too slow
NCT03608618,TERMINATED,INTERVENTIONAL,Sponsor shift in focus
NCT03608878,TERMINATED,INTERVENTIONAL,"The biopsies in the first 5 screened patients were all negative for Globo-H, of which positive is required to include the patients."
NCT03609021,TERMINATED,OBSERVATIONAL,A211601 closed prematurely due to slow accrual.
NCT03609073,TERMINATED,INTERVENTIONAL,enrollment too slow
NCT03609138,WITHDRAWN,OBSERVATIONAL,Study aborted
NCT03609372,WITHDRAWN,INTERVENTIONAL,"With the pandemic, we needed to take a 15 month pause in between earlier RCTs. This RCT no longer made sense to conduct."
NCT03609450,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03609502,SUSPENDED,INTERVENTIONAL,research facilities temporarily closed due to COVID-19
NCT03609749,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03609957,WITHDRAWN,INTERVENTIONAL,Did not have time to complete this study
NCT03610048,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03610100,SUSPENDED,INTERVENTIONAL,Suspended to recruitment following TSC review on efficacy and toxicities
NCT03610230,TERMINATED,INTERVENTIONAL,Difficult patient recruitment due to COVID-19 epidemic
NCT03610282,WITHDRAWN,INTERVENTIONAL,We have decided to withdraw the study prior to enrollment of the first participant in order to pursue other research studies.
NCT03610347,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03610581,TERMINATED,INTERVENTIONAL,"Low enrolment and increasing COVID restrictions, following an earlier enrolment pause in April made it clear that completion of the study would not be feasible"
NCT03610932,WITHDRAWN,INTERVENTIONAL,Recruitment
NCT03611049,TERMINATED,INTERVENTIONAL,Principal Investigator (Dr. Peiris) is retiring
NCT03611205,WITHDRAWN,INTERVENTIONAL,PI decision
NCT03611530,TERMINATED,INTERVENTIONAL,low accrual
NCT03611764,TERMINATED,INTERVENTIONAL,Only 5 caregivers decided to participate
NCT03611829,TERMINATED,INTERVENTIONAL,The trial was ended prematurely due to low recruitment/enrolment.
NCT03611855,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03611972,TERMINATED,INTERVENTIONAL,PI resigned
NCT03611985,WITHDRAWN,INTERVENTIONAL,institutional conflict of interest
NCT03612167,SUSPENDED,INTERVENTIONAL,no funding
NCT03612466,WITHDRAWN,INTERVENTIONAL,Study withdrawn before any participants could be enrolled. Issues being able to effectively recruit participants into the study.
NCT03612739,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03613090,WITHDRAWN,INTERVENTIONAL,Withdrawn-was not approved by IRB
NCT03613259,WITHDRAWN,INTERVENTIONAL,Funding expired
NCT03613402,WITHDRAWN,OBSERVATIONAL,Due to slow enrollment.
NCT03613493,TERMINATED,INTERVENTIONAL,Budgetary and Timing Constraints
NCT03613558,WITHDRAWN,INTERVENTIONAL,Unable to recruit patients because the surgeon left the hospital
NCT03613571,TERMINATED,INTERVENTIONAL,Inclusion was stopped with 13 of 15 patients recruited according to protocol. Patients responded with no safety signals. Study stop was due to slow recruitment.
NCT03613792,WITHDRAWN,INTERVENTIONAL,Change in procedure means limited value for study question
NCT03613831,WITHDRAWN,OBSERVATIONAL,The sponsor has decided to stop the study
NCT03613870,WITHDRAWN,INTERVENTIONAL,Administratively closed prior enrollment of participants.
NCT03614052,TERMINATED,INTERVENTIONAL,Problems with the number of participants
NCT03614156,TERMINATED,INTERVENTIONAL,Business decision to stop the program.
NCT03614351,WITHDRAWN,INTERVENTIONAL,"lack of funding to pay for a coordinator and interventionist,"
NCT03614507,TERMINATED,INTERVENTIONAL,OXYNOV discontinues loan of FREEO2 devices
NCT03614611,TERMINATED,INTERVENTIONAL,Lack of fund
NCT03614728,TERMINATED,INTERVENTIONAL,Trial terminated due to internal review of clinical data in context of indication under investigation
NCT03615105,TERMINATED,INTERVENTIONAL,Low accrual
NCT03615144,TERMINATED,INTERVENTIONAL,Participant accrual low and the study was closed
NCT03615378,TERMINATED,INTERVENTIONAL,Difficulties with enrollment
NCT03615469,TERMINATED,INTERVENTIONAL,Low recruitment numbers
NCT03615508,TERMINATED,INTERVENTIONAL,incomplete enrollment
NCT03615924,TERMINATED,INTERVENTIONAL,Recommendation from an independent data monitoring committee (DMC) and accepted by AstraZeneca.
NCT03615989,TERMINATED,INTERVENTIONAL,COVID-19
NCT03616002,TERMINATED,INTERVENTIONAL,Due tot he Pandemic we decided to terminate this project.
NCT03616457,WITHDRAWN,OBSERVATIONAL,Change in business need.
NCT03616639,TERMINATED,INTERVENTIONAL,Insufficient inclusion of subjects
NCT03616730,TERMINATED,OBSERVATIONAL,PI leaving institution
NCT03616821,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the development of brazikumab in inflammatory bowel disease.
NCT03616912,TERMINATED,INTERVENTIONAL,Study terminated due to insufficient evidence to support a positive benefit: risk profile in systemic lupus erythematosus patients.
NCT03617146,TERMINATED,INTERVENTIONAL,Recruitment challenges.
NCT03617172,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03617224,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients that met enrollment criteria.
NCT03617380,WITHDRAWN,INTERVENTIONAL,transferred to different institution
NCT03617484,WITHDRAWN,INTERVENTIONAL,Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.
NCT03618095,TERMINATED,INTERVENTIONAL,Investigational Medical Device is no longer available
NCT03618108,TERMINATED,INTERVENTIONAL,COVID-19
NCT03618121,WITHDRAWN,INTERVENTIONAL,Primary Investigator is leaving host university (ETSU)
NCT03618134,TERMINATED,INTERVENTIONAL,slow accrual
NCT03618160,TERMINATED,INTERVENTIONAL,The results of leading Phase 2 trials did not meet all desired endpoints
NCT03618212,TERMINATED,OBSERVATIONAL,Departure of the project leader
NCT03618277,WITHDRAWN,INTERVENTIONAL,business strategy
NCT03618823,TERMINATED,INTERVENTIONAL,Early termination due to COVID-19 cases and cancelled surgeries.
NCT03618849,TERMINATED,INTERVENTIONAL,limited recruitment
NCT03618953,TERMINATED,INTERVENTIONAL,Virus potency titer of drug product as determined by an improved potency assay was lower than originally determined by the assay described in the IND.
NCT03618979,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03618992,TERMINATED,INTERVENTIONAL,Investigator left university
NCT03619005,WITHDRAWN,INTERVENTIONAL,Business decision to not continue this study (only few subjects were screened).
NCT03619044,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT03619187,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03619655,TERMINATED,INTERVENTIONAL,"Due to changing prostate cancer standard of care, the research question became obsolete as the target population for the study no longer existed. The study is deemed not clinically relevant."
NCT03619746,TERMINATED,INTERVENTIONAL,Lack of accrual. We were unable to enroll enough participants to have meaningful results.
NCT03619876,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03620149,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03620253,TERMINATED,INTERVENTIONAL,Principal Investigator left study site
NCT03620344,TERMINATED,INTERVENTIONAL,Difficulty getting parents to complete follow-up assessments
NCT03620500,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT03621124,TERMINATED,OBSERVATIONAL,COVID-19 Pandemic
NCT03621319,TERMINATED,INTERVENTIONAL,"Closure due to the COVID-19 pandemic: Protocol specified procedures could not be followed resulting in unavoidable protocol deviations. Lower enrollment than expected. Competing COVID-19 studies at study sites. No ethical, scientific, safety issues."
NCT03621397,WITHDRAWN,INTERVENTIONAL,"We are no longer recruiting research participants for this study. Also, a co-investigator is no longer working at this institution and is no longer a part of this study."
NCT03621436,TERMINATED,INTERVENTIONAL,Study was terminated due to sponsor decision
NCT03621449,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT03621605,TERMINATED,INTERVENTIONAL,Study terminated due to tolerability issues.
NCT03621787,TERMINATED,INTERVENTIONAL,Expiration of study funds.
NCT03621982,TERMINATED,INTERVENTIONAL,"Cami in combination with pembrolizumab in solid tumors showed signals of immunomodulatory activity. However, the signals were insufficiently compelling at the tested dose/schedule to justify continuation of the study."
NCT03622697,WITHDRAWN,INTERVENTIONAL,Study expired in IRB.
NCT03622840,TERMINATED,INTERVENTIONAL,Completed
NCT03622866,TERMINATED,INTERVENTIONAL,Sponsor bankruptcy
NCT03622931,TERMINATED,INTERVENTIONAL,due to lack of recruitment
NCT03623165,TERMINATED,OBSERVATIONAL,same information will be collected in upcoming IDE trial
NCT03623490,TERMINATED,INTERVENTIONAL,"Following an insufficient recruitment, the sponsor decided to halt prematurely inclusions"
NCT03623568,WITHDRAWN,INTERVENTIONAL,"did not move forward with IRB approval, competing study"
NCT03623763,SUSPENDED,OBSERVATIONAL,Financial difficulities
NCT03623984,WITHDRAWN,INTERVENTIONAL,no partipants
NCT03624036,TERMINATED,INTERVENTIONAL,Development program terminated
NCT03624192,TERMINATED,INTERVENTIONAL,Study closed in response to COVID-19 and overall program objectives.
NCT03624257,WITHDRAWN,INTERVENTIONAL,Sponsor decision: priority change (Study approved by ethics committee and Swedish competent authority)
NCT03624608,SUSPENDED,INTERVENTIONAL,Pending transfer of study to new site
NCT03624790,SUSPENDED,INTERVENTIONAL,On hold due to the pandemic.
NCT03624907,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03624985,TERMINATED,INTERVENTIONAL,"Subjects had a high dropout rate. Of 61 consented, 24 did not participate. Reasons: Surgical cancellations; changing procedure type after consent; and staffing issues. The dropout rate of 39% was considered a barrier to publication."
NCT03625089,WITHDRAWN,INTERVENTIONAL,Limited funding support
NCT03625336,WITHDRAWN,OBSERVATIONAL,study on hold for an undetermined time
NCT03625687,TERMINATED,INTERVENTIONAL,"Lack of funding, transitioned to standard of care"
NCT03625765,SUSPENDED,INTERVENTIONAL,sponsor on campus training restrictions
NCT03625947,TERMINATED,OBSERVATIONAL,Recruitment issues during pandemic (2020-2021)
NCT03625999,WITHDRAWN,INTERVENTIONAL,"Our study stopped before it could begin because of the Covid-19 pandemic. We revised the study so that it could be performed virtually, but the revised study isn't a clinical trial."
NCT03626376,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants
NCT03626545,TERMINATED,INTERVENTIONAL,The study was early terminated due to the lack of efficacy of study treatment observed in the analysis of the primary endpoint of the randomized part
NCT03626558,WITHDRAWN,INTERVENTIONAL,No participants were enrolled.
NCT03626623,TERMINATED,INTERVENTIONAL,Sponsor Discretion
NCT03626701,TERMINATED,INTERVENTIONAL,"In June 2021, the US FDA approved expanded use of the RECELL System for treatment of acute full-thickness thermal burns in patients 1-month of age and older (removing the prior limitation of use in patients younger than 18 years of age)."
NCT03626727,WITHDRAWN,INTERVENTIONAL,Target study population was extremely difficult to recruit and planned study budget was exceeded
NCT03626844,SUSPENDED,INTERVENTIONAL,Insufficient resources.
NCT03626870,WITHDRAWN,OBSERVATIONAL,does not meet criteria for clinical trial
NCT03626974,TERMINATED,INTERVENTIONAL,investigator is gone
NCT03627052,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to lack of recruitment. No patients enrolled. No safety concerns.
NCT03627091,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue the SHP647 (ontamalimab) clinical trial development program for inflammatory bowel diseases (IBD) early.
NCT03627234,WITHDRAWN,INTERVENTIONAL,Investigator left the institution
NCT03627689,TERMINATED,INTERVENTIONAL,Poor accural
NCT03628014,TERMINATED,INTERVENTIONAL,Recruitment difficulties and bad data quality
NCT03628053,WITHDRAWN,INTERVENTIONAL,Novartis is no longer pursuing this study because of planned investigation of novel CAR-T therapies in this patient population.
NCT03628079,TERMINATED,INTERVENTIONAL,Lack of effect
NCT03628144,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT03628391,TERMINATED,INTERVENTIONAL,The study was stopped because of futility of being able to reach a one-day difference between treatment groups in the primary outcome of DCFD in the intended sample size.
NCT03628560,SUSPENDED,INTERVENTIONAL,Pending equipment repair
NCT03628573,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT03629015,WITHDRAWN,INTERVENTIONAL,Corporate strategic consideration
NCT03629106,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03629119,SUSPENDED,INTERVENTIONAL,Recruitment was put on hold in March 2020 due to COVID
NCT03629210,WITHDRAWN,INTERVENTIONAL,Study funding discontinued
NCT03629249,TERMINATED,INTERVENTIONAL,Company decision
NCT03629275,TERMINATED,INTERVENTIONAL,Strategic decision to progress stroke disability programme through regional partnerships
NCT03629483,SUSPENDED,INTERVENTIONAL,Trial stopped by the sponsor because of no funding.
NCT03629613,WITHDRAWN,INTERVENTIONAL,discontinued due to change in operating plans prior to study initiation and enrollment
NCT03629652,TERMINATED,INTERVENTIONAL,it is hard to enroll the patients
NCT03629821,SUSPENDED,INTERVENTIONAL,The study has been suspended because COVID pandemic.
NCT03629899,WITHDRAWN,INTERVENTIONAL,unavailability of the investigational device
NCT03629964,WITHDRAWN,INTERVENTIONAL,PI left site.
NCT03630029,WITHDRAWN,INTERVENTIONAL,"The trial has been enhanced, a new NCT(NCT03893799) listing was created."
NCT03630120,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03630133,WITHDRAWN,INTERVENTIONAL,Combined with NCT03266107
NCT03630185,TERMINATED,INTERVENTIONAL,Did not reach the enrollment goal.
NCT03630224,TERMINATED,INTERVENTIONAL,Premature termination due to futility following interim analysis
NCT03630367,WITHDRAWN,INTERVENTIONAL,Unavailability of the medication
NCT03630393,TERMINATED,INTERVENTIONAL,PI left institution
NCT03630601,TERMINATED,INTERVENTIONAL,Diagnostic issues
NCT03630653,TERMINATED,INTERVENTIONAL,The study was stopped prematurely due to insufficient recruitment
NCT03630809,TERMINATED,INTERVENTIONAL,Quality of the data originating from prior versions of the protocol has been affected by protocol deviations triggered by the COVID-19 pandemics
NCT03630835,WITHDRAWN,INTERVENTIONAL,Problem of supply of the experimental product (radio tracer).
NCT03630952,TERMINATED,INTERVENTIONAL,desired primary endpoint was not met
NCT03631654,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding
NCT03631680,TERMINATED,OBSERVATIONAL,PI left the institution and the study was closed.
NCT03631771,WITHDRAWN,INTERVENTIONAL,It was determined that a study is no longer required because the clinical question posed by the study has been answered through published literature
NCT03631966,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT03632109,TERMINATED,INTERVENTIONAL,Efficacy
NCT03632252,WITHDRAWN,INTERVENTIONAL,The study was never completed as planned.
NCT03632317,WITHDRAWN,INTERVENTIONAL,low accrual
NCT03632369,WITHDRAWN,OBSERVATIONAL,No participants were enrolled and no data was collected for the study
NCT03632642,WITHDRAWN,INTERVENTIONAL,Study never commenced
NCT03632655,TERMINATED,INTERVENTIONAL,The study was terminated due to procurement of new funding sources.
NCT03632798,SUSPENDED,INTERVENTIONAL,Slow enrollment
NCT03632954,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT03632967,TERMINATED,INTERVENTIONAL,as per sponsor
NCT03633071,TERMINATED,OBSERVATIONAL,Low enrollment
NCT03633188,TERMINATED,INTERVENTIONAL,the study had to be stopped because the period of the Financial contract was over
NCT03633227,TERMINATED,INTERVENTIONAL,"Due to Ocaliva (obeticholic acid) US labeling update, the sponsor decided to terminate the study."
NCT03633513,TERMINATED,OBSERVATIONAL,COVID-19
NCT03633526,TERMINATED,INTERVENTIONAL,Study discontinued after Part A due to Sponsor's discretion.
NCT03633539,WITHDRAWN,INTERVENTIONAL,No research funds were raised
NCT03633669,WITHDRAWN,INTERVENTIONAL,Funding
NCT03634072,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goal
NCT03634150,WITHDRAWN,INTERVENTIONAL,Patients were screened but not enrolled
NCT03634202,TERMINATED,INTERVENTIONAL,the study was stopped for lack of inclusion
NCT03634228,TERMINATED,INTERVENTIONAL,"This study was terminated early due to lack of adequate response, and did not move to the Phase II portion of the study"
NCT03634319,TERMINATED,INTERVENTIONAL,"Significant risks (e.g., infection, endothelial cell loss) and high rate of channel plugging associated with product use."
NCT03634527,TERMINATED,INTERVENTIONAL,Funding duration ended.
NCT03634579,TERMINATED,INTERVENTIONAL,Lack of funding for continuation.
NCT03634683,WITHDRAWN,INTERVENTIONAL,Major changes in manufacturing process and investigational product
NCT03634800,TERMINATED,INTERVENTIONAL,Lack of patient accruals.
NCT03635112,TERMINATED,INTERVENTIONAL,The study was terminated by the sponsor on 16 November 2021 after a planned review by the Independent Data Monitoring Committee.
NCT03635671,TERMINATED,OBSERVATIONAL,Unexpected poor enrollment
NCT03635801,TERMINATED,OBSERVATIONAL,Due to PI's unavailability
NCT03635879,WITHDRAWN,INTERVENTIONAL,Study redesign
NCT03635996,TERMINATED,INTERVENTIONAL,Study was stopped by the Sponsor
NCT03636048,TERMINATED,INTERVENTIONAL,not enough participants
NCT03636100,TERMINATED,OBSERVATIONAL,"After enrollment of half the subjects, the trial was unlikely to yield results"
NCT03636373,TERMINATED,INTERVENTIONAL,The Sponsor has decided to stop funding this study due to lack of enrollment during COVID-19 pandemic and decreased interest in funding investigator initiated studies pertaining to the study drug
NCT03636555,WITHDRAWN,INTERVENTIONAL,PI no longer employed at Institution
NCT03636776,TERMINATED,INTERVENTIONAL,The sponsor has set up a secondary competitive study concerning the same population and whose secondary objectives are the same as those of the EPOCA study with the same endpoints.
NCT03636958,WITHDRAWN,INTERVENTIONAL,"concomitant decision of the sponsor and the PI, lack of patients"
NCT03637023,TERMINATED,INTERVENTIONAL,due to COVID-19 outbreak
NCT03637231,TERMINATED,INTERVENTIONAL,The preliminary findings render it very unlikely that the methodology can be refined further in order to yield more accurate results even if more patients would be included and the study would be continued.
NCT03637257,WITHDRAWN,INTERVENTIONAL,due to other priorities
NCT03637296,TERMINATED,INTERVENTIONAL,This study is terminated due to COVID-19 pandemic
NCT03637335,TERMINATED,INTERVENTIONAL,The study was stopped due to insufficient recruitment.
NCT03637374,TERMINATED,INTERVENTIONAL,Investigational device is no longer manufactured
NCT03637387,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03637491,TERMINATED,INTERVENTIONAL,Available clinical data has shown limited anti-tumor activity and reaching target study drug dose levels may not be feasible.
NCT03637595,TERMINATED,INTERVENTIONAL,Study lapsed due to COVID-19.
NCT03637764,TERMINATED,INTERVENTIONAL,"Study was stopped after interim analysis for 4 cohorts (HCC, SCCHN, EOC, and GBM) indicated that the results did not fulfill the preplanned interim analysis criteria to move to Phase 2 stage 2 in all 4 cohorts."
NCT03637803,TERMINATED,INTERVENTIONAL,Sponsor insolvency
NCT03637842,TERMINATED,INTERVENTIONAL,terminated due to lorcaserin recall
NCT03637868,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT03638011,TERMINATED,INTERVENTIONAL,Standard of Care changed due to COVID-19 and thus had to stop the study.
NCT03638128,TERMINATED,INTERVENTIONAL,The study was stopped earlier than planned due to safety concerns about high levels of calcium in the blood of the participants
NCT03638336,WITHDRAWN,INTERVENTIONAL,No actual DM
NCT03638466,TERMINATED,INTERVENTIONAL,Financial decision
NCT03638596,SUSPENDED,INTERVENTIONAL,Temporarily closed to enrollment
NCT03638635,TERMINATED,INTERVENTIONAL,Lack of personnel available to complete study.
NCT03638947,TERMINATED,INTERVENTIONAL,Intermediate analysis produced strong enough results that full study not needed.
NCT03639038,WITHDRAWN,OBSERVATIONAL,"PI retired, study never opened."
NCT03639129,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT03639207,WITHDRAWN,OBSERVATIONAL,Subject Research)
NCT03639298,TERMINATED,INTERVENTIONAL,Due to SARS-Cov-2 emergency we were unable to recruit the expected number of children. We will analyze the available data
NCT03639324,WITHDRAWN,INTERVENTIONAL,Slow Accrual
NCT03639415,WITHDRAWN,INTERVENTIONAL,There is no fund to support
NCT03639610,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study following an FDA request of a partial clinical hold.
NCT03639766,TERMINATED,INTERVENTIONAL,Time and resource constraints
NCT03639779,TERMINATED,INTERVENTIONAL,Time and resource constraints
NCT03639857,TERMINATED,INTERVENTIONAL,Time and resource constraints
NCT03639987,TERMINATED,INTERVENTIONAL,Study was discontinued based on futility analysis conducted on Phase 3 trials (NCT02477800 and NCT02484547) and not based on safety concerns.
NCT03640221,WITHDRAWN,INTERVENTIONAL,Study withdrawn prior to IRB approval and enrollment
NCT03640260,TERMINATED,INTERVENTIONAL,low enrollment
NCT03640338,WITHDRAWN,INTERVENTIONAL,Limiting funding sources forced us to withdraw the study.
NCT03640481,TERMINATED,INTERVENTIONAL,The sponsor has decided to prematurely terminate the study due to the challenges encountered in recruiting adolescent participants. This decision was made without any safety concerns.
NCT03640533,TERMINATED,INTERVENTIONAL,"Technical probelms led to inadequate randomization, and thus the project was terminated."
NCT03640650,TERMINATED,INTERVENTIONAL,COVID-19 pandemic leading to uncertainty in the recruitement
NCT03640988,TERMINATED,INTERVENTIONAL,Mfr of product identified in protocol to measure perfusion after treatment with sponsor device withdrew support from the study. Sponsor decided to cancel the investigation due to lack of adequate replacement.
NCT03641196,TERMINATED,INTERVENTIONAL,The study was terminated due to difficulties in the recruitment attributed to the Covid19 pandemic.
NCT03641248,WITHDRAWN,INTERVENTIONAL,Recruitment was not possible due to COVID19.
NCT03641287,TERMINATED,INTERVENTIONAL,Enrollment ended early due to the funding timeline
NCT03641326,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03641430,WITHDRAWN,INTERVENTIONAL,The study design will need to be changed completely becasue of the change of research interest. We have decided to withdraw the study.
NCT03641703,TERMINATED,INTERVENTIONAL,Freeline has decided to pause development of FLT180a for business priorities
NCT03641768,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT03641937,TERMINATED,INTERVENTIONAL,Protocol procedure did not adequately meet data needs for the study.
NCT03641963,SUSPENDED,INTERVENTIONAL,Safety questions on patients with glaucoma are in discussion by our IRB
NCT03642119,TERMINATED,OBSERVATIONAL,PI left the intuition
NCT03642132,TERMINATED,INTERVENTIONAL,"Phase 3 B9991010 study was stopped due to futility of efficacy at interim analysis on 21Dec2018, and approvals of PARP inhibitors in front-line maintenance setting, Pfizer decided stopping enrollment in the B9991030 study on 19Mar2019."
NCT03642145,WITHDRAWN,INTERVENTIONAL,Study is no longer necessary given the safety and efficacy of emflaza in this age range has already been established after review of already available data.
NCT03642184,TERMINATED,INTERVENTIONAL,Difficult in enrolling suitable participants
NCT03642457,TERMINATED,INTERVENTIONAL,PI left institution and unable to find new PI
NCT03642951,WITHDRAWN,INTERVENTIONAL,Low Enrollment
NCT03642990,TERMINATED,INTERVENTIONAL,Enrollment challenges
NCT03643042,TERMINATED,INTERVENTIONAL,The SMD SEUIL TRANSFU study was stopped prematurely because we encountered enrolment difficulties and new treatments are available on the market for patients with RARS or SFR3B1 mutation (Luspatercept).
NCT03643159,TERMINATED,INTERVENTIONAL,Difficulty in participant recruitment
NCT03643250,TERMINATED,INTERVENTIONAL,"We observed reduced intake by the fifth week, so we are shortening the study and simplifying it by using a complete factorial design with four conditions."
NCT03643562,TERMINATED,INTERVENTIONAL,Sponsor had determined that the benefit-risk profile of adrabetadex was not favorable and the clinical development program for adrabetadex was discontinued.
NCT03643679,TERMINATED,INTERVENTIONAL,Covid-19 quarantines and closures prevented recruitment and assessment of participants.
NCT03643887,WITHDRAWN,INTERVENTIONAL,No funding obtained
NCT03644082,WITHDRAWN,INTERVENTIONAL,Problems recruiting and retaining volunteer research personnel to assist with the recruitment of subjects and the study procedures
NCT03644199,WITHDRAWN,INTERVENTIONAL,Lack of resources
NCT03644251,TERMINATED,INTERVENTIONAL,Study Site Ceased all Business Operations
NCT03644342,SUSPENDED,INTERVENTIONAL,A recent change in treatment landscape may make study futile
NCT03644459,WITHDRAWN,INTERVENTIONAL,Unable to recruit individuals for the study
NCT03644511,TERMINATED,OBSERVATIONAL,The interest of potential centers is very limited.
NCT03644550,TERMINATED,INTERVENTIONAL,"Due to the Food and Drug Administration's recent approval of Nivolumab plus Ipilimumab as first line treatment for Mesothelioma, the principal investigator decided to end the study early (prior to reaching enrollment goal)."
NCT03644589,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT03644706,TERMINATED,INTERVENTIONAL,Research operation issues
NCT03644823,TERMINATED,INTERVENTIONAL,slow recruiting
NCT03644927,TERMINATED,INTERVENTIONAL,"Suspended in 2020 due to Covid-19 policies, the study has now been terminated given recruitment and intervention challenges with the pandemic surge and end of funding."
NCT03644940,WITHDRAWN,INTERVENTIONAL,study not started.
NCT03645265,TERMINATED,INTERVENTIONAL,Results showing no effect
NCT03645395,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03645408,TERMINATED,INTERVENTIONAL,Due to COVID-19 hospital-wide policies halting recruitment
NCT03645525,WITHDRAWN,INTERVENTIONAL,The certification of cell-based treatment in the settings need to be updated.
NCT03645564,TERMINATED,INTERVENTIONAL,Recruitment incomplete due to COVID
NCT03645603,TERMINATED,INTERVENTIONAL,futility reasons
NCT03645720,WITHDRAWN,INTERVENTIONAL,difficulty in performing study
NCT03645876,TERMINATED,INTERVENTIONAL,The study was terminated early due to company decision
NCT03646188,TERMINATED,INTERVENTIONAL,Application of arrays was inconsistent.
NCT03646344,TERMINATED,INTERVENTIONAL,COVID
NCT03646513,TERMINATED,OBSERVATIONAL,Product recalled. Sponsor decision to discontinue study.
NCT03646825,TERMINATED,OBSERVATIONAL,Completed study with fewer participants than expected
NCT03646916,WITHDRAWN,INTERVENTIONAL,Lack of patients
NCT03647085,TERMINATED,OBSERVATIONAL,Due to COVID-19 and resourcing challenges
NCT03647423,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT03647696,WITHDRAWN,OBSERVATIONAL,Principal Investigator left institution and took the study them.
NCT03647722,TERMINATED,OBSERVATIONAL,Study funding was terminated.
NCT03647761,TERMINATED,INTERVENTIONAL,"Covid19, lack of manpower"
NCT03647891,SUSPENDED,INTERVENTIONAL,Study on hold
NCT03647943,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic (residential treatment center closed to visitors)
NCT03647995,TERMINATED,INTERVENTIONAL,Were not able to enroll enough participants due to shortage of study staff
NCT03648047,TERMINATED,INTERVENTIONAL,COVID-19 pandemic imposed restrictions to normal study conduct
NCT03648125,TERMINATED,INTERVENTIONAL,"Limited time between the beginning and the end of the inclusions, only 7 high level rowers available within the time compatible with research realization"
NCT03648229,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT03648372,TERMINATED,INTERVENTIONAL,Enrolment Challenges
NCT03648463,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT03648502,TERMINATED,INTERVENTIONAL,The corona virus pandemic_UK national lockdown
NCT03648619,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT03648775,TERMINATED,OBSERVATIONAL,Suspension of the study upon the decision of the notified body
NCT03648840,TERMINATED,INTERVENTIONAL,"Enrollment paused when our alcohol supplier recalled and suspended manufacture of the product. When production resumed, there was not enough time remaining to successfully resume recruitment. We will examine the outcomes with the existing sample."
NCT03648983,TERMINATED,INTERVENTIONAL,Pi departure; service discontinued study
NCT03649035,WITHDRAWN,INTERVENTIONAL,Stopped for internal decisions
NCT03649321,TERMINATED,INTERVENTIONAL,Funding was terminated early because research interests were going in a different direction.
NCT03649347,TERMINATED,INTERVENTIONAL,Data collection was completed for the spider arm of the study. No participants were recruited for snake phobia data collection due to the COVID-19 pandemic halting in-person research activities.
NCT03649464,WITHDRAWN,INTERVENTIONAL,Planned to execute the new Oral OKN-007 clinical trial with modified study plan soon. This Study not proceeding and sites never opened.
NCT03649672,TERMINATED,INTERVENTIONAL,Due to Covid Crisis recruitment was stopped.
NCT03649841,TERMINATED,INTERVENTIONAL,Terminated due to low accrual.
NCT03649919,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT03650400,TERMINATED,INTERVENTIONAL,Company Decision
NCT03650413,TERMINATED,INTERVENTIONAL,This study was terminated early by the Sponsor based on the interim analysis of Study GA39925 (NCT03558152) that showed low efficacy of UTTR1147A in ulcerative colitis. Development of the drug in this indication has been terminated.
NCT03650660,TERMINATED,OBSERVATIONAL,departure of the principal recruiter in the study
NCT03650881,WITHDRAWN,INTERVENTIONAL,no eligible subjects were enrolled
NCT03651245,TERMINATED,OBSERVATIONAL,we will update quickly
NCT03651297,SUSPENDED,INTERVENTIONAL,Lab closed due to Covid 19
NCT03651531,TERMINATED,INTERVENTIONAL,Trial halted early due to limited ability to recruit participants
NCT03651804,SUSPENDED,INTERVENTIONAL,Difficulty recruiting members
NCT03652233,WITHDRAWN,INTERVENTIONAL,Low accrual
NCT03652298,TERMINATED,INTERVENTIONAL,Lack of recruitment and of study staff
NCT03652311,WITHDRAWN,INTERVENTIONAL,Suspended temporarily due to staff changes
NCT03652493,TERMINATED,INTERVENTIONAL,lack of efficacy
NCT03652701,WITHDRAWN,INTERVENTIONAL,sponsor discretion
NCT03652805,SUSPENDED,INTERVENTIONAL,Study was suspended due to IPL344 shortage and may resume once drug supply is available.
NCT03652987,SUSPENDED,OBSERVATIONAL,Covid19-related restrictions
NCT03653104,WITHDRAWN,INTERVENTIONAL,Did not initiate study intervention.
NCT03653169,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT03653533,TERMINATED,INTERVENTIONAL,Difficulties for recruitment
NCT03654014,WITHDRAWN,INTERVENTIONAL,Changes in study personnel (PI retired) and the Sponsor terminated the project
NCT03654040,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor prior to any participants receiving the investigational product.
NCT03654287,WITHDRAWN,OBSERVATIONAL,Interruption of financial support
NCT03654378,WITHDRAWN,OBSERVATIONAL,Limited participants for enrollment
NCT03654417,TERMINATED,INTERVENTIONAL,"interim analysis produced significant results, so we ended enrollment"
NCT03654443,SUSPENDED,INTERVENTIONAL,The study is currently suspended due to the COVID19 crisis
NCT03654586,TERMINATED,INTERVENTIONAL,Study halted prematurely during COVID-19 outbreak
NCT03654729,TERMINATED,INTERVENTIONAL,"On 23 January 2020, the Sponsor announced that the United States (US) Food and Drug Administration (FDA) had issued a clinical hold in the US of the POLAR program."
NCT03654755,TERMINATED,INTERVENTIONAL,Phase 2 study results
NCT03654989,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT03655080,TERMINATED,INTERVENTIONAL,Pharmaceutical company decided to close study
NCT03655119,TERMINATED,INTERVENTIONAL,Enrollment was paused due to COVID-19 restrictions related to recruitment and will not resume.
NCT03655444,TERMINATED,INTERVENTIONAL,Provider of drug decided to discontinue study.
NCT03655600,TERMINATED,INTERVENTIONAL,Difficulty recruiting and retaining participants
NCT03655613,TERMINATED,INTERVENTIONAL,Study terminated due to administrative reasons.
NCT03655821,TERMINATED,INTERVENTIONAL,"81 patients included, difficult inclusion and full inclusion would not change the results"
NCT03655860,WITHDRAWN,INTERVENTIONAL,"Never started, was replaced by NCT04150601"
NCT03655899,TERMINATED,OBSERVATIONAL,Analysis of cell phenotypes was not possible
NCT03655990,TERMINATED,OBSERVATIONAL,Impact of COVID-19 on Recruitment
NCT03656107,TERMINATED,INTERVENTIONAL,Covid-19 pandemic
NCT03656289,WITHDRAWN,INTERVENTIONAL,IND approval from FDA was rejected and IRB approval was never granted.
NCT03656510,TERMINATED,INTERVENTIONAL,Janssen made the strategic decision to discontinue the CROCuS study. This decision is not based on any safety concerns.
NCT03656627,TERMINATED,INTERVENTIONAL,low accrual
NCT03656679,TERMINATED,INTERVENTIONAL,insufficient participant population per COVID-19
NCT03656692,TERMINATED,INTERVENTIONAL,Logistical challenges; no safety concerns
NCT03656913,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT03657056,WITHDRAWN,INTERVENTIONAL,No subjects enrolled and IRB record was closed
NCT03657095,TERMINATED,INTERVENTIONAL,"The pivotal study, BPS-314d-MR-PAH-302 (NCT01908699), failed to demonstrate efficacy."
NCT03657108,TERMINATED,INTERVENTIONAL,Decision made by DSMB to terminate study in April 2023.
NCT03657251,TERMINATED,OBSERVATIONAL,"The MMRF has learned of the limitations of using a blood sample to collect genomic data, compared to a bone marrow aspirate. We decided that our resources are best served in other areas at this time."
NCT03657420,WITHDRAWN,INTERVENTIONAL,Funding withdrawn by sponsor
NCT03658018,WITHDRAWN,INTERVENTIONAL,No Enrollments
NCT03658109,TERMINATED,INTERVENTIONAL,Recruitment challenges due to COVID-19
NCT03658135,TERMINATED,INTERVENTIONAL,BIIB092 program discontinued
NCT03658148,WITHDRAWN,OBSERVATIONAL,No charts were reviewed. This study never started.
NCT03658200,TERMINATED,INTERVENTIONAL,Interim analysis showed primary outcome was not going to be achieved.
NCT03658213,WITHDRAWN,INTERVENTIONAL,"CTP of LARES has been out of the expire date, we are trying RWS pathway for the indication expend"
NCT03658239,WITHDRAWN,INTERVENTIONAL,Organizational Issues.
NCT03658382,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03658408,WITHDRAWN,INTERVENTIONAL,This record should not have been created for this study. It is under another sponsor's account.
NCT03658551,TERMINATED,OBSERVATIONAL,Inability to apply technology (Loss of technology)
NCT03658629,TERMINATED,INTERVENTIONAL,This study was terminated 182 days after initial dosing.
NCT03658720,TERMINATED,INTERVENTIONAL,Study was not feasible as designed to allow for appropriate completion
NCT03658759,WITHDRAWN,OBSERVATIONAL,Study cancelled
NCT03658798,TERMINATED,INTERVENTIONAL,Funds have not been received
NCT03659422,WITHDRAWN,INTERVENTIONAL,not funded
NCT03659565,TERMINATED,INTERVENTIONAL,Poor accrual due to Covid-19 restrictions
NCT03659669,SUSPENDED,OBSERVATIONAL,Strategic considerations
NCT03659695,TERMINATED,INTERVENTIONAL,Contract terminated
NCT03660072,WITHDRAWN,OBSERVATIONAL,Business objectives have changed
NCT03660423,TERMINATED,INTERVENTIONAL,Study suspended due to COVID-19 and decreased ability to safely dance in person
NCT03660540,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT03660553,TERMINATED,INTERVENTIONAL,PI left University of Miami
NCT03660618,TERMINATED,INTERVENTIONAL,"This study was stopped 3/2/18 as the company who supported the device went out of business and requested the device be returned. Only 1 control subject was tested, no analyzable data."
NCT03660657,TERMINATED,INTERVENTIONAL,Very low recruitment. During COVID-19 pandemic these are patients of high risk.
NCT03660683,TERMINATED,INTERVENTIONAL,Sponsor did not want to continue funding the study
NCT03660722,WITHDRAWN,INTERVENTIONAL,study not started
NCT03661047,WITHDRAWN,INTERVENTIONAL,Study will be closed due to zero enrollment in over 2 years.
NCT03661229,TERMINATED,INTERVENTIONAL,Inability to demonstrate efficacy. The reason for this is that we were unable to get the necessary information from our population of dialysis patient using the mCVI non-contact facial tracking cell phone app.
NCT03661424,TERMINATED,INTERVENTIONAL,"slow study accrual, partially due to pandemic"
NCT03661567,TERMINATED,INTERVENTIONAL,slow enrollment
NCT03661814,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT03661970,TERMINATED,OBSERVATIONAL,Insufficient recruitment due to lack of interest. Ended prematurely by PI
NCT03661983,TERMINATED,INTERVENTIONAL,Lack of feasibility for completion of the trial within a reasonable time frame.
NCT03662074,TERMINATED,INTERVENTIONAL,After interim analysis decided not to move forward with continuing the trial.
NCT03662581,TERMINATED,INTERVENTIONAL,"COVID-19 caused the program to change in its delivery to virtual, therefore it no longer followed the intervention described in the protocol."
NCT03662711,TERMINATED,INTERVENTIONAL,Contract terminated between AIFA and the Sponsor (University of Ferrara)
NCT03662841,TERMINATED,INTERVENTIONAL,poor patient accrual
NCT03663088,TERMINATED,INTERVENTIONAL,Because of the COVID-19 pandemic
NCT03663166,TERMINATED,INTERVENTIONAL,Increased SAE occurrence per PI
NCT03663699,TERMINATED,INTERVENTIONAL,grunnet COVID-19 pandemien d vi haft hg drop-out og vanskelig att rekruttere
NCT03664141,WITHDRAWN,INTERVENTIONAL,TIKUN OLAM has not received approval from the National Committee to conduct research
NCT03664206,WITHDRAWN,OBSERVATIONAL,The part on MRS could not be completed
NCT03664466,WITHDRAWN,INTERVENTIONAL,Inadequate funding
NCT03664479,TERMINATED,INTERVENTIONAL,collected data showed significant difference in two groups.
NCT03664700,TERMINATED,OBSERVATIONAL,Due to problems caused by the COVID-19 pandemic
NCT03665129,TERMINATED,INTERVENTIONAL,early termination
NCT03665233,TERMINATED,INTERVENTIONAL,not enough patients (covcid restrictions)
NCT03665259,TERMINATED,INTERVENTIONAL,Significantly increased incidence of primary endpoint in the FiO2 60% group
NCT03665298,WITHDRAWN,INTERVENTIONAL,The study was never started by the responsible party (medical student who is no longer at the institution).
NCT03665350,TERMINATED,INTERVENTIONAL,Insulin-HF study was prematurely ended due principally to low recruitment rate.
NCT03666429,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT03666728,TERMINATED,INTERVENTIONAL,changes in the R\&D strategy
NCT03666819,WITHDRAWN,INTERVENTIONAL,Manufacturer will not be supporting this study
NCT03666988,TERMINATED,INTERVENTIONAL,Overall benefit-risk profile did not support continuation of the study
NCT03667040,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03667339,TERMINATED,OBSERVATIONAL,lack of recruitment
NCT03667365,TERMINATED,INTERVENTIONAL,new US guidelines
NCT03667443,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19 restrictions, enrollment was unsuccessful"
NCT03667781,TERMINATED,OBSERVATIONAL,funding has ended and Covid has prevented us to perform followup assessment
NCT03668002,TERMINATED,INTERVENTIONAL,The study was terminated due to slow recruitment.
NCT03668106,TERMINATED,INTERVENTIONAL,no fund
NCT03668392,TERMINATED,INTERVENTIONAL,low enrollment rate
NCT03668405,TERMINATED,INTERVENTIONAL,New data: The study was terminated based on new efficacy data from another study
NCT03668600,TERMINATED,INTERVENTIONAL,Business decision to stop the program
NCT03668665,WITHDRAWN,INTERVENTIONAL,no approval by CA
NCT03668769,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT03669003,WITHDRAWN,INTERVENTIONAL,Will re-open at another time
NCT03669133,TERMINATED,INTERVENTIONAL,lack of coordinator resources and lack of access to study resources during and due to the COVID pandemic
NCT03669302,TERMINATED,INTERVENTIONAL,COVID
NCT03669549,TERMINATED,INTERVENTIONAL,"Following an interim data review, further investment in nevanimibe has been discontinued"
NCT03669640,TERMINATED,INTERVENTIONAL,This study was discontinued due to an interim analysis which indicated that ralmitaront was unlikely to meet its primary endpoint.
NCT03669692,WITHDRAWN,INTERVENTIONAL,No patients available
NCT03670017,TERMINATED,INTERVENTIONAL,Loss of Funding
NCT03670030,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03670134,WITHDRAWN,INTERVENTIONAL,The company that supported the technology (volumetric laser endomicroscopy) is no longer operational due to the pandemic.
NCT03670264,TERMINATED,INTERVENTIONAL,"Despite efforts to recruit and enroll adolescents, identifying cigarette and e-cigarette users proved challenging. The study team was unable to meet the recruitment goal of 60 adolescents."
NCT03670550,WITHDRAWN,INTERVENTIONAL,Attending surgeon on the project is moving to a different facility
NCT03670628,TERMINATED,INTERVENTIONAL,Due to COVID-19 Pandemic
NCT03670745,TERMINATED,INTERVENTIONAL,The COVID pandemic and issues with the APT platform hindered recruitment and participant completion of intervention surveys.
NCT03670888,TERMINATED,INTERVENTIONAL,The development was stopped due to company's strategy consideration
NCT03670901,TERMINATED,INTERVENTIONAL,The development was stopped due to company's strategy consideration
NCT03670914,SUSPENDED,INTERVENTIONAL,"Due to the recent COVID-19 surge the majority of our staff was pulled from sleep care to inpatient care. Thus, we have had to temporarily pause in-lab studies until our staff returns. We hope to proceed with recruitment as soon as possible."
NCT03671005,TERMINATED,INTERVENTIONAL,Due to covid restrictions the recruitment for this study has been paused after the feasibility and acceptability data was published.
NCT03671096,WITHDRAWN,INTERVENTIONAL,The sponsor determined at one study (PRO-010) was sufficient
NCT03671135,TERMINATED,INTERVENTIONAL,COVID-19
NCT03671304,TERMINATED,INTERVENTIONAL,"The study was prematurely discontinued, the application utilized with the fitbit is no longer being supported."
NCT03671473,WITHDRAWN,INTERVENTIONAL,It is difficult to enroll patients
NCT03671551,TERMINATED,OBSERVATIONAL,Recruitment too low
NCT03671655,TERMINATED,INTERVENTIONAL,The study was terminated as we plan to start a competing study sponsored through VA CSP.
NCT03671720,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03672370,TERMINATED,OBSERVATIONAL,Study terminated as CE marks of the devices used have not been renewed.
NCT03672474,TERMINATED,INTERVENTIONAL,Covid19 sanitary crisis
NCT03672500,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT03672526,TERMINATED,INTERVENTIONAL,decision of the principal investigator
NCT03672643,TERMINATED,INTERVENTIONAL,"The trial is terminated based on business decision, not due to safety concerns or regulatory requirements."
NCT03672851,TERMINATED,INTERVENTIONAL,adverse effect
NCT03673358,TERMINATED,INTERVENTIONAL,"Low compliance with CBT, and challenges with the CBT provider. Previous participants will be considered the pilot phase."
NCT03673566,WITHDRAWN,INTERVENTIONAL,Business pivot caused termination of study before enrollment.
NCT03673579,WITHDRAWN,INTERVENTIONAL,Business pivot caused termination of study before enrollment.
NCT03673605,WITHDRAWN,INTERVENTIONAL,No patients Enrollment
NCT03673735,WITHDRAWN,INTERVENTIONAL,Company withdrew interest
NCT03673774,TERMINATED,INTERVENTIONAL,RECRUITMENT ISSUES
NCT03673865,TERMINATED,INTERVENTIONAL,Enrollment and study activities were initially suspended due to COVID-19 and it has been determined that the study will not resume.
NCT03673891,WITHDRAWN,INTERVENTIONAL,Lack of resources
NCT03673969,WITHDRAWN,INTERVENTIONAL,Lack of funding to progress the study
NCT03674021,TERMINATED,INTERVENTIONAL,Due to COVID pandemic and suspension of observation unit
NCT03674190,WITHDRAWN,INTERVENTIONAL,Difficult to find patients that accepted the study
NCT03674242,TERMINATED,INTERVENTIONAL,sponsor decision
NCT03674320,WITHDRAWN,INTERVENTIONAL,No Funding
NCT03674450,WITHDRAWN,INTERVENTIONAL,This study never enrolled any subjects. It was terminated due to staffing and technology changes.
NCT03674502,TERMINATED,INTERVENTIONAL,Study terminated due to business realignment
NCT03674671,SUSPENDED,INTERVENTIONAL,insufficient funding
NCT03674827,TERMINATED,INTERVENTIONAL,The study was terminated due to the review of the asset (VBIR-2) within the Sponsor's oncology portfolio; the study was not terminated because of safety concerns.
NCT03674879,WITHDRAWN,INTERVENTIONAL,PI left facility
NCT03674892,TERMINATED,INTERVENTIONAL,Original device is now discontinued; we are changing the study device shortly
NCT03675022,TERMINATED,INTERVENTIONAL,Inability to recruit during COVID
NCT03675074,WITHDRAWN,INTERVENTIONAL,Deployment site not obtained in 5 patients with endoscopic screening and intent-to-treat. No devices implanted and no AEs through 30days.
NCT03675113,WITHDRAWN,INTERVENTIONAL,This study was a doctorate thesis and student changed the subject of her thesis.
NCT03675126,TERMINATED,INTERVENTIONAL,The sponsor has decided to integrate 5051-102 into 5051-201. Participants from 5051-102 will be eligible to enroll in 5051-201 Part B.
NCT03675269,WITHDRAWN,INTERVENTIONAL,Study was moved to another location with involvement of different researchers
NCT03675438,WITHDRAWN,INTERVENTIONAL,The sponsor determined that one study (PRO-010) was sufficient
NCT03675503,TERMINATED,INTERVENTIONAL,Interim data analysis indicated too many variables prevented the ability to drawn conclusive evidence the devices affected falls.
NCT03675568,WITHDRAWN,INTERVENTIONAL,Subject changed
NCT03675620,WITHDRAWN,INTERVENTIONAL,Principal Investigator left research facility.
NCT03675711,TERMINATED,INTERVENTIONAL,recruitment problem
NCT03675776,TERMINATED,INTERVENTIONAL,Business decision to stop the program.
NCT03675854,WITHDRAWN,INTERVENTIONAL,New data from another study show that a positive result is unlikely.
NCT03676231,TERMINATED,INTERVENTIONAL,Study terminated due to a safety event which rendered the risk-benefit profile in NASH to no longer be adequately favorable
NCT03676361,WITHDRAWN,INTERVENTIONAL,Not initiated
NCT03676543,TERMINATED,INTERVENTIONAL,This is the end of the inclusion period and only 1 patient has been recruited.
NCT03676647,WITHDRAWN,OBSERVATIONAL,Incorrect entry
NCT03676712,TERMINATED,INTERVENTIONAL,Recruitment of subjects was not successful.
NCT03676842,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03677024,WITHDRAWN,INTERVENTIONAL,This study was not approved by the Ethics Committee
NCT03677115,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03677310,WITHDRAWN,INTERVENTIONAL,Resident physician decided not to proceed with study
NCT03677830,TERMINATED,INTERVENTIONAL,Involved investigators no longer at the investigating center
NCT03677882,TERMINATED,INTERVENTIONAL,"We experienced recruitment difficulties, and the focus of the department has changed."
NCT03677960,TERMINATED,INTERVENTIONAL,Pre-Clinical Toxicology Findings
NCT03678090,WITHDRAWN,INTERVENTIONAL,"Local IRB recommended IND exemption from FDA, study timeline not able to be met."
NCT03678207,WITHDRAWN,OBSERVATIONAL,The investigator no longer desires to persue the trial. No enrollments were made.
NCT03678428,TERMINATED,INTERVENTIONAL,Production halt of FUDR in China
NCT03678480,WITHDRAWN,INTERVENTIONAL,Corporate decision
NCT03678506,TERMINATED,INTERVENTIONAL,"The study was interrupted after a planned interim analysis for the high rate of primary outcomes (7.3%; 95% confidence interval \[CI\], 4.5-11.2)"
NCT03678792,WITHDRAWN,INTERVENTIONAL,Infeasible to conduct at this time.
NCT03678948,TERMINATED,INTERVENTIONAL,Sponsor discontinuing research
NCT03679078,SUSPENDED,INTERVENTIONAL,Project suspended whilst intervention is updated
NCT03679390,TERMINATED,INTERVENTIONAL,no funding
NCT03679481,WITHDRAWN,INTERVENTIONAL,study not started due to lack of funding
NCT03679624,TERMINATED,INTERVENTIONAL,Low accrual
NCT03679845,WITHDRAWN,INTERVENTIONAL,Difficulty in recruiting patients
NCT03679975,TERMINATED,INTERVENTIONAL,The study is no longer required
NCT03680066,TERMINATED,INTERVENTIONAL,recruitment stopped due to low number of subjects
NCT03680560,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03680911,TERMINATED,INTERVENTIONAL,Poor participant compliance
NCT03680976,WITHDRAWN,INTERVENTIONAL,The study will not take place at the University of Pittsburgh
NCT03681106,TERMINATED,INTERVENTIONAL,Due to the health crisis triggered by the COVID-19 pandemic and the consequent sanitary-organizational arrangements set up for its contrast it was necessary to interrupt the study before reaching the established sample size.
NCT03681301,TERMINATED,INTERVENTIONAL,Early Terminated
NCT03681314,WITHDRAWN,INTERVENTIONAL,This study was not funded. The same study with few modifications in the trial was later funded by the NICHD. Now study started enrolling babies using new registration and identification IDs ( NCT03682042 and NCT03657394).
NCT03681392,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03681600,TERMINATED,OBSERVATIONAL,COVID 19
NCT03681782,TERMINATED,OBSERVATIONAL,departure of principal investigator with no successor
NCT03681951,TERMINATED,INTERVENTIONAL,The study was terminated following an internal review of the company's current research and development portfolio.
NCT03682055,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03682094,SUSPENDED,INTERVENTIONAL,Interim Analysis / Resource Availability
NCT03682133,TERMINATED,OBSERVATIONAL,"Retrospective part completed, prospective part response too low"
NCT03682367,TERMINATED,INTERVENTIONAL,Poor Recruitment
NCT03682393,WITHDRAWN,INTERVENTIONAL,the study never started
NCT03682497,TERMINATED,INTERVENTIONAL,Attendance at study sites carries risk of COVID-19 infection. Non-attendance at planned study site visits has unacceptable study related patient safety risk.
NCT03682601,TERMINATED,INTERVENTIONAL,pandemic
NCT03682744,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects
NCT03682822,TERMINATED,INTERVENTIONAL,Covid
NCT03682874,TERMINATED,OBSERVATIONAL,Inability to recruit during COVID-19
NCT03683095,WITHDRAWN,OBSERVATIONAL,Insufficient resources
NCT03683277,TERMINATED,INTERVENTIONAL,"Recruitment issue, 26 patients enrolled instead of 70 initially planned"
NCT03683823,TERMINATED,INTERVENTIONAL,Due to COVID-19 the study was intitially paused and eventually ended.
NCT03684187,SUSPENDED,INTERVENTIONAL,Unable to recruit and change in funding status.
NCT03684304,TERMINATED,INTERVENTIONAL,Patients no longer staying overnight in the hospital following this procedure type.
NCT03684343,TERMINATED,INTERVENTIONAL,inclusion difficulties
NCT03684369,WITHDRAWN,INTERVENTIONAL,The project was not funded.
NCT03684642,TERMINATED,INTERVENTIONAL,"Sponsor decision to cancel TRIAL, not related to safety concern."
NCT03684668,TERMINATED,INTERVENTIONAL,"Data collection could not be completed in time and it has not been possible to continue due to the pandemic. Since it is not yet known when the face-to-face classes will resume, we moved on to the data analysis phase with the existing data."
NCT03684694,TERMINATED,INTERVENTIONAL,Administrative decision
NCT03684785,TERMINATED,INTERVENTIONAL,The study was canceled for administrative reasons.
NCT03684967,WITHDRAWN,INTERVENTIONAL,the study stopped because the company's strategy.
NCT03685019,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT03685253,SUSPENDED,INTERVENTIONAL,pilot component of study completed
NCT03685344,TERMINATED,INTERVENTIONAL,"In a limited number of patients, no additional activity was evident for the combination vs. loncastuximab tesirine monotherapy."
NCT03685591,TERMINATED,INTERVENTIONAL,The decision to stop enrollment was due to strategic considerations and not due to any specific safety reasons or request from a regulatory authority.
NCT03685773,WITHDRAWN,INTERVENTIONAL,"Permanently terminated due to COVID-19 given the poor vaccine penetrance in liver transplant recipients.

This is not a suspension of IRB approval."
NCT03685955,WITHDRAWN,OBSERVATIONAL,Lack of supporting staff
NCT03686033,TERMINATED,INTERVENTIONAL,Safety Review
NCT03686176,TERMINATED,INTERVENTIONAL,Coronavirus (COVID-19)-related pause on all clinical research studies.
NCT03686514,TERMINATED,INTERVENTIONAL,The study closed prior to completing year 3 of the study due to the COVID-19 pandemic.
NCT03686644,WITHDRAWN,INTERVENTIONAL,never started
NCT03686696,TERMINATED,INTERVENTIONAL,Low inclusion rate.
NCT03686943,WITHDRAWN,OBSERVATIONAL,Abandoned project
NCT03686969,TERMINATED,INTERVENTIONAL,"Study complexity, low study recruitment"
NCT03687125,TERMINATED,INTERVENTIONAL,Sponsor decision based on adverse events limiting administration of higher doses required to achieve myeoblative conditioning necessary in this population
NCT03687164,TERMINATED,INTERVENTIONAL,Dropout rate was too high
NCT03687476,WITHDRAWN,INTERVENTIONAL,Business decision to Cancel
NCT03687697,WITHDRAWN,INTERVENTIONAL,The study was halted prior to enrollment of first participant due to non funding and recourses.
NCT03687892,TERMINATED,INTERVENTIONAL,Change in study personnel.
NCT03688230,WITHDRAWN,INTERVENTIONAL,Co-development decision
NCT03688308,WITHDRAWN,INTERVENTIONAL,Change in personnel
NCT03688464,WITHDRAWN,INTERVENTIONAL,Study never started
NCT03688477,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting patients
NCT03688568,WITHDRAWN,INTERVENTIONAL,Enrollment not feasible
NCT03688633,TERMINATED,INTERVENTIONAL,Patient Recruitment Failure
NCT03688789,WITHDRAWN,INTERVENTIONAL,Investigator leaving the hospital
NCT03688880,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03688945,TERMINATED,INTERVENTIONAL,Art gallery dissembled- no research goals with new art.
NCT03689244,TERMINATED,INTERVENTIONAL,"The study did not demonstrate efficacy on the primary endpoint, PVR vs. placebo at wk 20 at a planned interim analysis."
NCT03689582,TERMINATED,INTERVENTIONAL,due to pandemic related constraints
NCT03689829,TERMINATED,INTERVENTIONAL,MOR106 clinical development in atopic dermatitis was stopped for futility
NCT03689894,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT03690154,TERMINATED,INTERVENTIONAL,Despite demonstrated safety and tolerability the trial was terminated early due to program re-prioritization in light of the competitive landscape.
NCT03690245,WITHDRAWN,INTERVENTIONAL,unable to recruit patients
NCT03690739,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT03690869,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03691038,TERMINATED,INTERVENTIONAL,Participants couldn't be enrolled due to complain of frequent visit.
NCT03691415,TERMINATED,OBSERVATIONAL,Study discontinued due to business decisions.
NCT03692221,WITHDRAWN,INTERVENTIONAL,Stalled due to Covid
NCT03692338,TERMINATED,INTERVENTIONAL,Poor accrual
NCT03692780,WITHDRAWN,INTERVENTIONAL,At sponsor's discretion
NCT03692793,TERMINATED,INTERVENTIONAL,"Due to the Covid-19 pandemic, face-to-face activities have been suspended since March 2020, making the research unfeasible."
NCT03693118,TERMINATED,INTERVENTIONAL,the study was completed
NCT03693183,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor
NCT03693274,TERMINATED,INTERVENTIONAL,Principal investigator leaving institution.
NCT03693391,TERMINATED,INTERVENTIONAL,stopped because of a business decision
NCT03693495,WITHDRAWN,INTERVENTIONAL,Study was cancelled before enrollment for reasons not related to safety and performance.
NCT03693573,WITHDRAWN,INTERVENTIONAL,"In the context of the ongoing evaluation of our data, we have determined that there is no need to generate additional safety data at this time in the 1L mRCC pa"
NCT03693625,TERMINATED,INTERVENTIONAL,Recruitment was stopped after an interim analysis of the parent GS39684 study.
NCT03693846,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment and lack of efficacy
NCT03694197,TERMINATED,INTERVENTIONAL,The primary objective (to evaluate the long-term safety of Praluent) was adequately evaluated in other studies.
NCT03694379,TERMINATED,INTERVENTIONAL,Could not enroll enough patients
NCT03694431,TERMINATED,INTERVENTIONAL,"Low intervention uptake, lack of substitution of video for home visits, and study sites' decision to expand telehealth use in response to payment changes"
NCT03694483,SUSPENDED,OBSERVATIONAL,Staffing changes
NCT03694548,TERMINATED,INTERVENTIONAL,Study terminated due to COVID-19 pandemic.
NCT03694704,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03694821,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03694834,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03695172,TERMINATED,INTERVENTIONAL,Decline of eligible participants
NCT03695250,TERMINATED,INTERVENTIONAL,Funding source decision to terminate study.
NCT03695822,WITHDRAWN,INTERVENTIONAL,"I did not pass the 2018 Ministry of Science and Technology research project subsidy, so I applied for the project to close the case."
NCT03696082,TERMINATED,INTERVENTIONAL,Funding ended
NCT03696212,TERMINATED,INTERVENTIONAL,"Based on the totality of the generated combined safety and efficacy data in the interim period, the company decided to terminate the combination study in NSCLC patients. There are no subjects on study drug at this time or in the EOT Follow-up period."
NCT03696342,TERMINATED,INTERVENTIONAL,Sponsor's convenience
NCT03696524,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT03696537,TERMINATED,INTERVENTIONAL,Extreme toxicity
NCT03696576,TERMINATED,INTERVENTIONAL,"Due to the pandemic, recruitment ended earlier than expected and changes were required to alter data collection methods (and were approved by the IRB). Additional changes were also made to the protocol to move the study to an online platform."
NCT03696836,TERMINATED,INTERVENTIONAL,Halted prematurely
NCT03696901,TERMINATED,OBSERVATIONAL,Terminated
NCT03697031,TERMINATED,OBSERVATIONAL,Permanently terminated due to halt of recruitment due to COVID-19 pandemic
NCT03697083,TERMINATED,INTERVENTIONAL,The primary hypotheses were unsupported with half of the data collected.
NCT03697239,WITHDRAWN,INTERVENTIONAL,FDA indicated the same study could not be conducted under multiple INDs
NCT03697538,TERMINATED,INTERVENTIONAL,"Was placed on hold due to the COVID-19 pandemic, and then PI decided not to continue study."
NCT03697551,TERMINATED,INTERVENTIONAL,Recruitment challenges and not due to safety concerns.
NCT03697564,SUSPENDED,INTERVENTIONAL,Working on getting accurate information for patients interested in the study.
NCT03697824,WITHDRAWN,INTERVENTIONAL,"Internal decision, study will be replaced with a larger monotherapy trial"
NCT03697954,WITHDRAWN,OBSERVATIONAL,Work has already been published by other groups
NCT03697993,TERMINATED,INTERVENTIONAL,inadequate enrollment.
NCT03698045,WITHDRAWN,INTERVENTIONAL,the clinical study was canceled by the sponsor due to logistics and programming
NCT03698162,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03698201,TERMINATED,OBSERVATIONAL,"As per the HRBs new funding model, HRBs investment will not support costs associated with routine patient care or translational studies, biobanks, patient registries and questionnaires. Therefore, a decision was made to cease further study follow up."
NCT03698227,TERMINATED,INTERVENTIONAL,Lack of efficacy on olaratumab
NCT03698448,WITHDRAWN,INTERVENTIONAL,Determined not feasible
NCT03698747,TERMINATED,OBSERVATIONAL,PI left organization
NCT03698838,TERMINATED,OBSERVATIONAL,Principal Investigator left Institution
NCT03698916,TERMINATED,OBSERVATIONAL,Unable to recruit
NCT03699033,WITHDRAWN,INTERVENTIONAL,No patients available
NCT03699176,WITHDRAWN,INTERVENTIONAL,"No patient was recruited, study withdrawn for feasibility reasons."
NCT03699384,WITHDRAWN,INTERVENTIONAL,Study sponsor discontinued support
NCT03699410,TERMINATED,OBSERVATIONAL,failure to identify complete responders since ctDNA disappears after radiotherapy in most patients.
NCT03699475,TERMINATED,INTERVENTIONAL,"Funding, portfolio re-prioritization"
NCT03699592,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT03699618,TERMINATED,OBSERVATIONAL,Challenging Enrollment
NCT03699826,TERMINATED,INTERVENTIONAL,No funding source
NCT03699865,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT03699904,TERMINATED,INTERVENTIONAL,In light of the evolving Covid19 pandemic ongoing study recruitment was felt to pose an unacceptable risk to patient safety.
NCT03699956,TERMINATED,INTERVENTIONAL,"RRx-001 will be studied under a new global, phase 3 clinical trial"
NCT03700294,TERMINATED,INTERVENTIONAL,Change in clinical plan and drug supply
NCT03700723,TERMINATED,INTERVENTIONAL,Convenience of Government Funding Sponsor
NCT03700827,TERMINATED,INTERVENTIONAL,COVID-19
NCT03700892,TERMINATED,INTERVENTIONAL,"Covid-19 has been shown to increase risk associated with vaping. To increase participant safety and use real world vaping habits, the investigators plan to continue studying vaping effects on the airways in an observational format."
NCT03701074,TERMINATED,INTERVENTIONAL,very slow enrollment. Only one patient enrolled. Termination by PI
NCT03701165,TERMINATED,INTERVENTIONAL,VMS Medical went out of busainess
NCT03701308,SUSPENDED,INTERVENTIONAL,End of Initial Phase of Multi-phase protocol
NCT03701321,WITHDRAWN,INTERVENTIONAL,Drug supply issues
NCT03701438,TERMINATED,OBSERVATIONAL,The Swissmedic agency released Gilead from this post marketing requirement.
NCT03701711,TERMINATED,INTERVENTIONAL,Higher than expected occurrence of VTE (venous thromboembolic event)
NCT03701763,TERMINATED,INTERVENTIONAL,PPSO-003 (20200056) is closing: - Last Subject Enrolled was 30-Dec-2021 - The Recruitment Status has to be updated to Terminated. LSLV was achieved 27-Mar-2023
NCT03702062,WITHDRAWN,INTERVENTIONAL,Study never started
NCT03702192,WITHDRAWN,INTERVENTIONAL,PI withdrew protocol
NCT03702218,WITHDRAWN,INTERVENTIONAL,never started
NCT03702686,SUSPENDED,INTERVENTIONAL,evaluating feasibility
NCT03702816,TERMINATED,INTERVENTIONAL,"GE180 has limited Blood - brain barrier permeation, reducing its utility in neuroinflammation. COVID19 created supply chain issues, impacting enrollment."
NCT03702868,TERMINATED,OBSERVATIONAL,Difficulty accruing subjects the study accrual was closed
NCT03703115,WITHDRAWN,INTERVENTIONAL,There is no commitment from the patient to maintain fasting in both the control and case groups
NCT03703323,TERMINATED,INTERVENTIONAL,pandemic situation
NCT03703791,TERMINATED,INTERVENTIONAL,Sponsor terminated study; no impact on overall benefit risk evaluation of AR101
NCT03703908,TERMINATED,INTERVENTIONAL,Program not advancing
NCT03703934,SUSPENDED,OBSERVATIONAL,COVID-19
NCT03703960,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT03704077,WITHDRAWN,INTERVENTIONAL,Replaced it with another clinical trial
NCT03704168,WITHDRAWN,INTERVENTIONAL,The study was never launched.
NCT03704285,TERMINATED,OBSERVATIONAL,Outbreak COVID 19
NCT03704298,TERMINATED,INTERVENTIONAL,Development program terminated
NCT03704558,WITHDRAWN,OBSERVATIONAL,The project leader has left the institution
NCT03704584,TERMINATED,INTERVENTIONAL,Enrollment and study activities were initially suspended due to COVID-19. The investigator has also left Emory and the study will not resume.
NCT03704701,TERMINATED,OBSERVATIONAL,COVID-19 pandemic; pre-pandemic recruitment sufficient for scientific validity
NCT03704714,SUSPENDED,INTERVENTIONAL,Protocol being amended for stats/accrual changes as per PI
NCT03704974,SUSPENDED,OBSERVATIONAL,Current high clinical demands of PI.
NCT03705000,SUSPENDED,INTERVENTIONAL,"One PI has left University of Michigan; no active work is happening at this time, but when another PI who is well suited is available, the study will resume recruitment."
NCT03705013,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT03705169,TERMINATED,INTERVENTIONAL,"The study closed to enrollment and follow-up in May 2023. There had been no enrollment since October 2021, and by 2023, the available study product had reached its expiration date. Enrollment targets in Arm B had not been met."
NCT03705273,TERMINATED,INTERVENTIONAL,Dr. Arnold assisted in designing and initiating study for a pharmacology PhD candidate. The candidate left the institution and study enrollment was terminated.
NCT03705338,TERMINATED,OBSERVATIONAL,Outbreak COVID 19
NCT03705351,TERMINATED,INTERVENTIONAL,Prinicipal Investigator departure from institution
NCT03705507,TERMINATED,INTERVENTIONAL,"Poor recruitment, due to a change in the standard of care for this patient population with the use of CAR-T cells"
NCT03705637,TERMINATED,INTERVENTIONAL,"Patient population too low to reasonably continue study, pandemic had started at time of cessation, further leading to study discontinuation."
NCT03705858,WITHDRAWN,INTERVENTIONAL,Due to difficulty in finalizing the contract
NCT03705923,TERMINATED,INTERVENTIONAL,low recruitment
NCT03705962,TERMINATED,INTERVENTIONAL,Unable to continue study due to funding and personnel restraints
NCT03706053,TERMINATED,INTERVENTIONAL,No funding for the study; not enough staff
NCT03706274,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03706430,TERMINATED,INTERVENTIONAL,Sponsor requested
NCT03706521,TERMINATED,INTERVENTIONAL,The study was terminated early due to COVID-19-related issues.
NCT03706729,WITHDRAWN,INTERVENTIONAL,Due to Covid-19 pandemic
NCT03706872,TERMINATED,INTERVENTIONAL,Women's confinement for COVID-19 pandemic and changes on prenatal care.
NCT03706963,TERMINATED,INTERVENTIONAL,Intervention is no longer being used
NCT03707028,TERMINATED,INTERVENTIONAL,Terminated after completion of Part 1 due to a change in research plan.
NCT03707236,WITHDRAWN,INTERVENTIONAL,Study was planned prior to COVID-19; after pandemic teledermatology use became prevalent making the results of this study no longer necessary/relevant
NCT03707301,TERMINATED,OBSERVATIONAL,Enrollment difficulties
NCT03707314,TERMINATED,INTERVENTIONAL,Stopped due to low event rate and poor recruitment
NCT03707418,WITHDRAWN,INTERVENTIONAL,unable to secure funding
NCT03707444,WITHDRAWN,OBSERVATIONAL,The PI is dealing with recurrent cancer and multiple side effects of treatment. N o one else to do the study.
NCT03707457,TERMINATED,INTERVENTIONAL,Funding/material support withdrawn
NCT03707600,WITHDRAWN,INTERVENTIONAL,PI closing his lab
NCT03707678,WITHDRAWN,INTERVENTIONAL,"After careful review of new data on GSK2245035, GlaxoSmithKline has decided to cancel this study."
NCT03707756,WITHDRAWN,OBSERVATIONAL,systematic literature review has been completed
NCT03707860,WITHDRAWN,OBSERVATIONAL,the program couldn't be implemented
NCT03707925,TERMINATED,INTERVENTIONAL,Very slow accrual rate
NCT03708237,TERMINATED,INTERVENTIONAL,Recruitment suspended due to COVID-19 pandemic and will not resume.
NCT03708263,TERMINATED,INTERVENTIONAL,departure of Pr MORDON from the ONCOTHAI unit
NCT03708289,TERMINATED,OBSERVATIONAL,recruitment slower than expected
NCT03708354,WITHDRAWN,INTERVENTIONAL,Difficulties in Recruiting
NCT03708380,TERMINATED,INTERVENTIONAL,COVID-19
NCT03708536,WITHDRAWN,INTERVENTIONAL,There are no fund to support
NCT03708913,WITHDRAWN,INTERVENTIONAL,no participants have been able to qualify for study
NCT03708926,WITHDRAWN,INTERVENTIONAL,Inability to obtain drugs from supplier.
NCT03709004,WITHDRAWN,INTERVENTIONAL,This study was not funded and is not going to be done.
NCT03709082,TERMINATED,INTERVENTIONAL,Low accrual
NCT03709251,TERMINATED,INTERVENTIONAL,"Due to COVID-19 safety precautions and public health guidelines, the study was terminated early."
NCT03709550,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03709563,TERMINATED,INTERVENTIONAL,COVID-19
NCT03709576,TERMINATED,INTERVENTIONAL,Funding pulled
NCT03709693,TERMINATED,OBSERVATIONAL,COVID 19 Pandemic
NCT03709706,TERMINATED,INTERVENTIONAL,The study was terminated for reasons pertaining to feasibility
NCT03709771,TERMINATED,OBSERVATIONAL,Study terminated due to unmet targeted accrual goals with only 2 subjects accrued out of 80 planned due to COVID-19 and the PI on the grant leaving VUMC in October 2021.
NCT03709992,SUSPENDED,INTERVENTIONAL,Because of COVID-19 Crisis
NCT03710005,SUSPENDED,INTERVENTIONAL,Suspended
NCT03710044,WITHDRAWN,INTERVENTIONAL,Strategic decision
NCT03710161,TERMINATED,INTERVENTIONAL,Study was stopped due to the COVID pandemic
NCT03710291,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT03710564,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03710915,TERMINATED,INTERVENTIONAL,Company decision
NCT03710941,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to an internal decision
NCT03711097,WITHDRAWN,INTERVENTIONAL,Study not initiated
NCT03711162,TERMINATED,INTERVENTIONAL,The benefit-risk profile no longer supports continuing the study
NCT03711279,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT03711318,TERMINATED,INTERVENTIONAL,continuing study was no longer feasible
NCT03711422,TERMINATED,INTERVENTIONAL,Decision to close the trial made due to low recruitment.
NCT03711565,WITHDRAWN,INTERVENTIONAL,The research equipment was not available for more than a year after the study was submitted. A new trial was being done during delivery of patients that competed with the study.
NCT03711591,TERMINATED,OBSERVATIONAL,Study stopped due to business decision to not continue to gather clinical evidence on product
NCT03711812,SUSPENDED,INTERVENTIONAL,Covid-19
NCT03711929,TERMINATED,INTERVENTIONAL,Business decision
NCT03711994,TERMINATED,INTERVENTIONAL,Unable to get product at this time
NCT03712046,TERMINATED,INTERVENTIONAL,Poor patient recruitment
NCT03712345,TERMINATED,INTERVENTIONAL,Due to COVID-19 pandemic outbreak and its impact on overall study activities. All efforts were made to ensure that participants that were enrolled and/or were still in the study will continue to receive treatment and follow-up until study completion.
NCT03712371,TERMINATED,INTERVENTIONAL,Interim study results were not favorable to continue with further enrollment.
NCT03712514,TERMINATED,INTERVENTIONAL,the inclusion period ended on 23/09/2021
NCT03712605,SUSPENDED,INTERVENTIONAL,Other - Reached planned accrual; increase being considered
NCT03712787,TERMINATED,INTERVENTIONAL,Discontinued because of lack of efficacy in the parent study (Study M15-566; NCT02880956).
NCT03712826,WITHDRAWN,INTERVENTIONAL,No inclusion
NCT03712930,TERMINATED,INTERVENTIONAL,Sponsor's decision to revisit the development approach for prostate cancer.
NCT03713021,TERMINATED,INTERVENTIONAL,Equipment unavailable
NCT03713099,WITHDRAWN,INTERVENTIONAL,Changed study design prior to any patients enrolled.
NCT03713320,TERMINATED,INTERVENTIONAL,"The study was terminated early for business reasons, and not due to concerns regarding safety or lack of efficacy."
NCT03713450,TERMINATED,INTERVENTIONAL,Premature termination of the research following an internal reorganization of the team no longer allowing the necessary resources to continue the study
NCT03713463,TERMINATED,OBSERVATIONAL,COVID-19 enrollment challenges
NCT03713684,TERMINATED,INTERVENTIONAL,"Sponsor decision to cancel TRIAL, not related to safety concern"
NCT03713801,SUSPENDED,INTERVENTIONAL,"Study has been halted due to COVID-19 pandemic, immunity of the subject has been a concern. Modifications are planned for the protocol."
NCT03713944,TERMINATED,INTERVENTIONAL,"Extreme toxicity, thromboembolic events"
NCT03714334,TERMINATED,INTERVENTIONAL,Break of stock
NCT03714412,WITHDRAWN,INTERVENTIONAL,Amended and merged with AHEAD-EU study
NCT03714477,WITHDRAWN,INTERVENTIONAL,Due to funding
NCT03714555,TERMINATED,INTERVENTIONAL,Study was closed due to low subject enrollment at site.
NCT03714815,TERMINATED,INTERVENTIONAL,the absence of a positive trend in all efficacy parameters indicates that macitentan 10 mg does not have a beneficial effect in patients with HFpEF and PVD.
NCT03714854,TERMINATED,INTERVENTIONAL,recruitment difficulties due to the loss of the engineer in charge of the TMS
NCT03714867,WITHDRAWN,INTERVENTIONAL,Inability to recruit patients
NCT03714880,TERMINATED,INTERVENTIONAL,Slow recruitment compounded by COVID-19
NCT03714906,TERMINATED,INTERVENTIONAL,"Slow accrual, lack of benefit between intervention and control arms on interim analysis"
NCT03715023,TERMINATED,INTERVENTIONAL,Practical issues that could not be resolved resulting in recruitment difficulties at sites.
NCT03715153,TERMINATED,INTERVENTIONAL,The 6-month efficacy analysis did not show any significant difference between bumetanide versus placebo in the treatment of ASD in the overall studied population. No unexpected safety concerns were identified.
NCT03715166,TERMINATED,INTERVENTIONAL,The 6-month efficacy analysis did not show any significant difference between bumetanide versus placebo in the treatment of ASD in the overall studied population. No unexpected safety concerns were identified.
NCT03715270,TERMINATED,OBSERVATIONAL,Sponsor decision to end study.
NCT03715400,SUSPENDED,INTERVENTIONAL,COVID-19 Restrictions for in-person study procedures
NCT03715439,WITHDRAWN,OBSERVATIONAL,Duo to pandemic period (COVID) the surgical elective procedures were stopped
NCT03715530,TERMINATED,INTERVENTIONAL,Data collection has halted due to no further assays provided by AmniSURE
NCT03715725,TERMINATED,OBSERVATIONAL,After feasibility assessment and due to delays in data receipt study was terminated
NCT03716050,TERMINATED,INTERVENTIONAL,PI decision due to slow accrual
NCT03716219,WITHDRAWN,INTERVENTIONAL,Nonapplicable clinical trial
NCT03716258,TERMINATED,OBSERVATIONAL,COVID-19 Research Restrictions
NCT03716570,TERMINATED,INTERVENTIONAL,Affiliated study NCT03318523 did not meet its primary outcome measure of change from baseline measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and did not demonstrate efficacy on secondary outcome measures
NCT03716687,TERMINATED,INTERVENTIONAL,No chance to enroll sufficient cases. Several coinvestigator centers have never started recruiting.
NCT03716778,TERMINATED,INTERVENTIONAL,This premature end of the study is due to the lack of human resources and the fact that the forceps used to perform the biopsies for this study have not been marketed since January 2023.
NCT03717012,TERMINATED,INTERVENTIONAL,The trial was terminated prematurely due to difficulties with recruitment because of the COVID-19 pandemic.
NCT03717038,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to administrative reasons
NCT03717142,SUSPENDED,INTERVENTIONAL,Protocol requires amendment prior to continuing enrollment
NCT03717480,TERMINATED,INTERVENTIONAL,"The study was prematurely closed to enrollment due to feasibility issues, as the site has promising upcoming competing trials, and the study was already not enrolling at a rate sufficient to meet the accrual goal."
NCT03717532,TERMINATED,INTERVENTIONAL,Inadequate/low enrollment
NCT03717558,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03718143,TERMINATED,INTERVENTIONAL,Safety concerns
NCT03718156,SUSPENDED,INTERVENTIONAL,COVID-19 prevented us from continuing this study which involves active participation from long-term care front-line staff. More funding is being sought to continue our trial
NCT03718338,TERMINATED,OBSERVATIONAL,Terminated due to low accrual
NCT03718455,TERMINATED,INTERVENTIONAL,Limited operating room availability
NCT03718507,WITHDRAWN,INTERVENTIONAL,no recrutiment started
NCT03718533,TERMINATED,INTERVENTIONAL,"In the context of COVID-19 pandemic, the benefit / risk ratio of the participation of a patient with pancytopenia could be compromised. The decision of this premature termination was not the consequence of any safety reason inherent to the drug."
NCT03718650,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03718741,TERMINATED,INTERVENTIONAL,few patients enrolled
NCT03719300,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03719560,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03719898,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT03719937,SUSPENDED,INTERVENTIONAL,Surge of COVID-19 panedemic
NCT03720080,TERMINATED,OBSERVATIONAL,Enough information was gathered in order to answer the primary research question
NCT03720132,TERMINATED,INTERVENTIONAL,Emerging evidence made the trial unnecessary.
NCT03720158,TERMINATED,INTERVENTIONAL,"The activities in the study hospital were seriously impacted by the medical care of COVID patients, affecting the medical management protocol of the study population. This situation does not allow to continue with the recruitment of patients."
NCT03720210,TERMINATED,INTERVENTIONAL,Very low enrollment
NCT03720392,TERMINATED,INTERVENTIONAL,Terminated due to sponsor decision
NCT03720418,TERMINATED,INTERVENTIONAL,"As a result of termination of development of OXB-102-01, it is no longer possible for Sio to either commence or to continue any related clinical trials."
NCT03720483,WITHDRAWN,INTERVENTIONAL,The study encountered challenges during startup due to the COVID-19 epidemic and was withdrawn.
NCT03720574,TERMINATED,INTERVENTIONAL,Reassess safety risks and benefits
NCT03721042,TERMINATED,INTERVENTIONAL,no PI to continue the study
NCT03721211,WITHDRAWN,INTERVENTIONAL,Principal investigator left the study institution.
NCT03721315,TERMINATED,INTERVENTIONAL,SARS-CoV2 pandemic
NCT03721523,WITHDRAWN,OBSERVATIONAL,Unable to achieve recruitment
NCT03721679,TERMINATED,INTERVENTIONAL,Recruiting target patients is intermittent making it impracticable to enroll the required study sample. The administrative responsibilities have been met with extraordinary challenges. Current funding does not match the incurring costs.
NCT03721796,TERMINATED,OBSERVATIONAL,study design changed due to COVID-19
NCT03721835,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03721861,TERMINATED,INTERVENTIONAL,Recruitment is finished
NCT03721965,TERMINATED,INTERVENTIONAL,The study was terminated due to insufficient efficacy in a separate phase III study
NCT03722108,TERMINATED,INTERVENTIONAL,Unfavorable benefit-risk balance in the experimental arm following the IDMC for intermediate efficacy and safety analysis
NCT03722186,SUSPENDED,INTERVENTIONAL,Business Decision
NCT03722238,TERMINATED,INTERVENTIONAL,Study was terminated on 18NOV2020 after an FDA meeting where it was determined no further actual use data was needed. There were no safety concerns.
NCT03722316,TERMINATED,INTERVENTIONAL,The presentation of the pandemic made recruitment and implementation impossible for this unfunded study to be completed. We were unable to continue after the loss of key resources.
NCT03722381,WITHDRAWN,OBSERVATIONAL,"Study activities were not initiated, and we do not plan to initiate them in the future."
NCT03722485,TERMINATED,INTERVENTIONAL,Enrollment challenges and business reasons.
NCT03722498,WITHDRAWN,INTERVENTIONAL,No patients join
NCT03722745,WITHDRAWN,INTERVENTIONAL,Participant recruitment due to high rates of staff turn over at three of the four recruitment sites
NCT03722797,TERMINATED,OBSERVATIONAL,Equipment used for metabolic testing is no longer serviced and/or supported by the company. Alternative equipment is not available to the research team to continue to conduct the study.
NCT03722966,TERMINATED,INTERVENTIONAL,"Following the Chantix recall, Pfizer stopped providing medication for the study and and new study enrollments were discontinued."
NCT03723356,TERMINATED,OBSERVATIONAL,due to low enrollment
NCT03723577,WITHDRAWN,INTERVENTIONAL,No subjects enrolled at site.
NCT03723590,TERMINATED,INTERVENTIONAL,Business decision
NCT03723603,TERMINATED,INTERVENTIONAL,Study was terminated due to a re-prioritization of ongoing studies.
NCT03723824,TERMINATED,INTERVENTIONAL,COV-19 pandemic
NCT03723863,TERMINATED,INTERVENTIONAL,Study team determined that data collected was appropriate for study outcome goals.
NCT03723915,TERMINATED,INTERVENTIONAL,The total accrual goal of 34 patients was not met. Stage 1 of the study did not meet the interim analysis criteria to move onto Stage 2 of the Simon 2 stage design.
NCT03723993,WITHDRAWN,INTERVENTIONAL,Finished
NCT03724032,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03724071,TERMINATED,INTERVENTIONAL,Study has been terminated after Phase I part on 23 February 2023
NCT03724084,TERMINATED,INTERVENTIONAL,Other - Study agent no longer available
NCT03724253,TERMINATED,INTERVENTIONAL,Recruitment was stopped before the target sample size was achieved.
NCT03724357,TERMINATED,INTERVENTIONAL,lack of funding
NCT03724409,TERMINATED,INTERVENTIONAL,Pandemic
NCT03724422,TERMINATED,INTERVENTIONAL,Difficulty getting radiation therapy for patients and Low enrollment number
NCT03724435,TERMINATED,OBSERVATIONAL,Competing trial will publish similar results
NCT03724773,WITHDRAWN,INTERVENTIONAL,Decided not to enroll
NCT03724929,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of inclusions
NCT03724955,WITHDRAWN,INTERVENTIONAL,Issues with Recruitment.
NCT03724968,TERMINATED,INTERVENTIONAL,Loss of funding
NCT03725267,TERMINATED,INTERVENTIONAL,"Due to COVID 19 pandemic social isolation measures, we had to stop recruting hospitalized patients."
NCT03725358,WITHDRAWN,INTERVENTIONAL,"Problems with the Performance-Based Financing System in Cameroon, combined with the restrictions on movement brought on by the Covid-19 pandemic."
NCT03725696,TERMINATED,OBSERVATIONAL,Terminated: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
NCT03726008,TERMINATED,INTERVENTIONAL,Since the project has been terminated and there is no funding to continue the clinical trial
NCT03726112,SUSPENDED,INTERVENTIONAL,Under internal considerations
NCT03726281,WITHDRAWN,INTERVENTIONAL,End of Agreement between BMS and SGHL
NCT03726333,TERMINATED,INTERVENTIONAL,The study stopped due to lack of enrollment
NCT03726996,TERMINATED,INTERVENTIONAL,Funding exhausted
NCT03727009,TERMINATED,OBSERVATIONAL,COVID-19
NCT03727087,TERMINATED,OBSERVATIONAL,COVID-19
NCT03727165,WITHDRAWN,INTERVENTIONAL,Covid pandemia.suspended study
NCT03727503,TERMINATED,INTERVENTIONAL,Logisitic problem
NCT03727789,TERMINATED,INTERVENTIONAL,low accrual
NCT03727815,WITHDRAWN,INTERVENTIONAL,Expired IRB application
NCT03727841,TERMINATED,INTERVENTIONAL,"The pharmaceutical company decided to close their program evaluating the study agent, Marizomib."
NCT03728205,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT03728465,TERMINATED,INTERVENTIONAL,Lack of patients
NCT03728517,TERMINATED,OBSERVATIONAL,Low recruitment
NCT03728569,TERMINATED,INTERVENTIONAL,Enrollment and interactions/interventions paused due to COVID-19. Not expected to resume in the future. This is not a suspension of IRB approval
NCT03728855,TERMINATED,INTERVENTIONAL,"Difficult recruitment, despite several interventions."
NCT03728907,WITHDRAWN,INTERVENTIONAL,We did not receive the equipment from our subcontractor in a time frame that would allow us to complete the study.
NCT03728933,TERMINATED,INTERVENTIONAL,Sponsor decision; Not a safety decision
NCT03729063,TERMINATED,INTERVENTIONAL,"Difficulty in recruiting, many patients with exclusion criteria"
NCT03729141,WITHDRAWN,INTERVENTIONAL,Study had funding issues and difficulties with recruitment.
NCT03729245,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03729284,WITHDRAWN,INTERVENTIONAL,This study has been cancelled prior to FSFV due to business reasons
NCT03729297,TERMINATED,INTERVENTIONAL,safety issues
NCT03729310,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03729401,SUSPENDED,INTERVENTIONAL,Testing supplies unavailable.
NCT03729596,TERMINATED,INTERVENTIONAL,Business decision
NCT03729934,WITHDRAWN,INTERVENTIONAL,Dissertation for student changed.
NCT03730077,TERMINATED,INTERVENTIONAL,PI Left Institution
NCT03730402,TERMINATED,INTERVENTIONAL,There were not enough attendings/residents working on the study throughout the COVID-19 pandemic in order to enroll the number of patients required to meet statistical significance.
NCT03730467,WITHDRAWN,OBSERVATIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT03730519,TERMINATED,INTERVENTIONAL,Due to the pandemic
NCT03730571,TERMINATED,INTERVENTIONAL,Insufficient closure
NCT03730779,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03730870,TERMINATED,INTERVENTIONAL,This study's genetic testing laboratory has suspended operations pending discussions with the FDA concerning clinical interpretation of pharmacogenomics tests.
NCT03730896,TERMINATED,INTERVENTIONAL,Not enough viable subjects
NCT03730948,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03731078,TERMINATED,OBSERVATIONAL,Study as designed did not prove feasible with the challenges faced amidst the COVID-19 pandemic
NCT03731117,TERMINATED,INTERVENTIONAL,Study end date exceeded and insufficient number of subjects needed for analysis. 11 patients included / 70 theoretical patients
NCT03731533,WITHDRAWN,INTERVENTIONAL,Grantor withdrew from study
NCT03731598,WITHDRAWN,OBSERVATIONAL,Difficulty recruiting. Objectives from this protocol added to another protocol collecting the same information.
NCT03731702,WITHDRAWN,OBSERVATIONAL,Deemed not human subjects research
NCT03731728,TERMINATED,INTERVENTIONAL,COVID-19
NCT03731806,WITHDRAWN,OBSERVATIONAL,funding for capsule could not be secured
NCT03732014,WITHDRAWN,OBSERVATIONAL,Funding could not be secured
NCT03732196,TERMINATED,OBSERVATIONAL,Unable to recruit enough participants
NCT03732261,TERMINATED,INTERVENTIONAL,COVID 19 pandemic
NCT03732417,WITHDRAWN,OBSERVATIONAL,"The start of the study was temporarily interrupted due to the COVID-19 pandemic. Subsequently, it was not feasible to initiate the study due to changes in the healthcare system for patient follow-up. For this reason, the study was withdrawn."
NCT03732443,WITHDRAWN,OBSERVATIONAL,"Errors in study conception, e.g. sample size calculation."
NCT03732469,TERMINATED,INTERVENTIONAL,Significant change in our clinic structure prevented continued recruitment of patients to the study
NCT03732534,TERMINATED,INTERVENTIONAL,Study stopped early due to investigational drug not meeting primary endpoint in the main study T-Force GOLD (NBI-98854-TS2003); no safety concerns identified.
NCT03733067,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT03733119,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03733197,WITHDRAWN,INTERVENTIONAL,PI no longer employed at institutuion
NCT03733444,TERMINATED,INTERVENTIONAL,The benefit-risk profile no longer supports continuing the study
NCT03733691,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03734081,SUSPENDED,INTERVENTIONAL,The first cohort of 6 subjects that has been enrolled is being analyzed and evaluated on all safety parameters as described in the study protocol.
NCT03734419,WITHDRAWN,OBSERVATIONAL,IRB approval was not obtained for this study.
NCT03734458,WITHDRAWN,INTERVENTIONAL,IND application did not get approved
NCT03734484,WITHDRAWN,INTERVENTIONAL,study was not started.
NCT03734536,TERMINATED,INTERVENTIONAL,Business reasons not related to patient safety
NCT03734575,SUSPENDED,INTERVENTIONAL,Company funding
NCT03734744,TERMINATED,INTERVENTIONAL,Clinical research currently on hold
NCT03734887,TERMINATED,INTERVENTIONAL,Inability to complete enrollment caused by COVID-19 and underpowered to conduct analysis
NCT03735160,WITHDRAWN,OBSERVATIONAL,Technical problem
NCT03735290,TERMINATED,INTERVENTIONAL,Decision made not to move to Phase 2
NCT03735316,TERMINATED,INTERVENTIONAL,Insufficient recruitment over study period
NCT03735433,TERMINATED,INTERVENTIONAL,futility
NCT03735446,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03735589,WITHDRAWN,INTERVENTIONAL,new study to be created
NCT03735693,TERMINATED,OBSERVATIONAL,"missing data, little recruitment"
NCT03735758,TERMINATED,INTERVENTIONAL,problems with recruiting
NCT03735914,TERMINATED,INTERVENTIONAL,Inclusion period finished
NCT03735927,TERMINATED,INTERVENTIONAL,The pandemic caused a rising tide phenomenon on our primary outcomes 1) Delirium detection (increased by visit reduction \& masked staff) and 2) Admission duration (increased by reorganizations \& quarantines 'impact on being discharged)
NCT03735940,TERMINATED,INTERVENTIONAL,The pandemic caused a rising tide phenomenon on our primary outcomes 1) Delirium detection (increased by visit reduction \& masked staff) and 2) Admission duration (increased by reorganizations \& quarantines 'impact on being discharged)
NCT03736083,WITHDRAWN,INTERVENTIONAL,FDA approval not obtained.
NCT03736291,WITHDRAWN,INTERVENTIONAL,There are two reasons why the study was stopped. One is that the machine to opreate MRI was damaged and we could not fix it. The second reason is the main reasearch fellow has graduated and there is no one else to conitune this project.
NCT03736343,TERMINATED,INTERVENTIONAL,"The COVID-19 outbreak began, precluding further participant recruitment for this protocol, which could only be conducted in-person. A decision was made that ample data was available to end data collection earlier than anticipated."
NCT03736356,TERMINATED,OBSERVATIONAL,The study was terminated due to the current COVID-19 pandemic.
NCT03736421,SUSPENDED,OBSERVATIONAL,Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected to resume in the future; This is not a suspension of IRB approval
NCT03736629,TERMINATED,INTERVENTIONAL,"Inability to accrue patients, particularly after COVID pandemic."
NCT03736642,WITHDRAWN,OBSERVATIONAL,never started
NCT03736655,TERMINATED,INTERVENTIONAL,COVID
NCT03736707,WITHDRAWN,INTERVENTIONAL,no participants were included
NCT03736967,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03737123,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT03737331,TERMINATED,INTERVENTIONAL,Canceled
NCT03737448,SUSPENDED,INTERVENTIONAL,Lack of enrollment
NCT03737617,WITHDRAWN,INTERVENTIONAL,Cant obtain IMP
NCT03737695,SUSPENDED,OBSERVATIONAL,enrollment pause
NCT03738046,WITHDRAWN,INTERVENTIONAL,We had a change in staffing that precluded pursing this project
NCT03738111,WITHDRAWN,INTERVENTIONAL,Sponsor's commercial decision
NCT03738124,WITHDRAWN,INTERVENTIONAL,Production of the medical device was stopped
NCT03738293,WITHDRAWN,OBSERVATIONAL,Study was not started at site.
NCT03738384,SUSPENDED,INTERVENTIONAL,Due to COVID-19 all research activities including recruitment have been paused.
NCT03738423,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03738462,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT03738579,TERMINATED,INTERVENTIONAL,Enrollment
NCT03738800,TERMINATED,INTERVENTIONAL,Futility
NCT03739138,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03739281,TERMINATED,INTERVENTIONAL,Internal resources ended
NCT03739437,TERMINATED,INTERVENTIONAL,The wired carbon monoxide device (used to verify daily smoking abstinence) was discontinued by the manufacturer and replaced with a Bluetooth device which initially provided inaccurate readings.
NCT03739476,TERMINATED,INTERVENTIONAL,"Due to the crisis SARS-COV-2 pandemic: recruitment of patients for the trial is stopped, healthcare pressure generated, suspend the non-essential scheduled surgical activity and on June 30, 2020 medication expired, funding has been exhausted."
NCT03739606,WITHDRAWN,INTERVENTIONAL,RSS recommendation
NCT03739749,WITHDRAWN,INTERVENTIONAL,Multicenter failure
NCT03739801,WITHDRAWN,INTERVENTIONAL,PI left
NCT03739840,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizure"
NCT03739983,TERMINATED,INTERVENTIONAL,slow accrual as a result of COVID-19
NCT03740035,TERMINATED,OBSERVATIONAL,Pl left institution
NCT03740100,TERMINATED,INTERVENTIONAL,The trial was closed because the sponsor became insolvent.
NCT03740139,SUSPENDED,INTERVENTIONAL,The study is on pause.
NCT03740243,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT03740347,WITHDRAWN,OBSERVATIONAL,Withdrawn study
NCT03740698,TERMINATED,INTERVENTIONAL,Technical issues
NCT03740724,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03740841,TERMINATED,INTERVENTIONAL,Unsuccessful study
NCT03740880,TERMINATED,INTERVENTIONAL,insufficient data
NCT03740945,WITHDRAWN,INTERVENTIONAL,Business decision to not perform this study.
NCT03740984,TERMINATED,INTERVENTIONAL,Funding withdrawn from sponsor.
NCT03741062,TERMINATED,INTERVENTIONAL,COVID-19
NCT03741504,TERMINATED,INTERVENTIONAL,The requiered sample were not recruited due to COVID-19 pandemic
NCT03741608,TERMINATED,INTERVENTIONAL,COVID prevented us from continuing recruitment and interventions at community sites
NCT03741712,TERMINATED,INTERVENTIONAL,According to the available data from the trialthe sponsor determined to terminate this study.
NCT03741803,SUSPENDED,INTERVENTIONAL,Study paused due to COVID-19 and personnel
NCT03741933,WITHDRAWN,INTERVENTIONAL,The principal investigator left George Washington University and closed the study at their departure.
NCT03742180,WITHDRAWN,INTERVENTIONAL,Unavailable drug in Egypt.
NCT03742219,TERMINATED,INTERVENTIONAL,Low level of returning participants year by year.
NCT03742323,TERMINATED,INTERVENTIONAL,Because of low recruitment
NCT03742349,TERMINATED,INTERVENTIONAL,This was a sponsor decision and was not a consequence of any safety concern
NCT03742375,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03742401,TERMINATED,INTERVENTIONAL,"Changes to the HIFU-SURG-FA study protocol, a number of centers have decided not to continue the study, including our national coordinating center."
NCT03742596,WITHDRAWN,INTERVENTIONAL,This study was closed without recruitment
NCT03742752,TERMINATED,INTERVENTIONAL,default inclusion
NCT03742804,WITHDRAWN,INTERVENTIONAL,Study sponsor sold and the new company would not support the study.
NCT03742973,TERMINATED,INTERVENTIONAL,Study was terminated due to enrollment futility.
NCT03743025,TERMINATED,INTERVENTIONAL,The study was terminated following the Data and Safety Monitoring Board (DSMB) review due to concerns with perioperative use of the study drug.
NCT03743090,WITHDRAWN,OBSERVATIONAL,lack of PSG
NCT03743103,TERMINATED,INTERVENTIONAL,Low enrollement
NCT03743428,SUSPENDED,INTERVENTIONAL,Too slow speed for recruiting.
NCT03743558,TERMINATED,INTERVENTIONAL,difficulty of recrutement
NCT03743571,SUSPENDED,INTERVENTIONAL,recruitment suspended due to COVID-related social distancing requirements
NCT03743805,WITHDRAWN,INTERVENTIONAL,Insufficient patients
NCT03743935,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT03743961,TERMINATED,OBSERVATIONAL,Low rythm of inclusions
NCT03744247,WITHDRAWN,INTERVENTIONAL,No paritcipants enrolled
NCT03744598,TERMINATED,OBSERVATIONAL,Clinic visits stopped due to COVID19
NCT03744663,WITHDRAWN,INTERVENTIONAL,Funding for uninsured subjects could not be realized and staffing after COVID hit was also a problem.
NCT03744715,TERMINATED,INTERVENTIONAL,"Business reasons, not related to safety."
NCT03744910,TERMINATED,INTERVENTIONAL,Early stop for lack of efficacy/futility (at Interim analysis)
NCT03745014,WITHDRAWN,INTERVENTIONAL,No sites identified with IRB approval
NCT03745196,TERMINATED,INTERVENTIONAL,The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.
NCT03745222,TERMINATED,INTERVENTIONAL,"BeiGene and Celgene Corporation terminated the parties' global collaboration for the compound, pending the acquisition of Celgene by Bristol Myers Squibb"
NCT03745352,WITHDRAWN,INTERVENTIONAL,Inadequate accrual rate
NCT03745690,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT03745781,TERMINATED,INTERVENTIONAL,low enrollment
NCT03745859,SUSPENDED,OBSERVATIONAL,necessary upgrades of essential software were not delivered
NCT03745898,TERMINATED,INTERVENTIONAL,Low feasibility of completion within the study period due to delayed site activation and slow participant accrual
NCT03746002,TERMINATED,INTERVENTIONAL,Insufficient rate of patient enrollment/accrual.
NCT03746249,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03746353,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT03746587,TERMINATED,INTERVENTIONAL,COVID-19 pandemic made it impossible to assess the trial objective
NCT03746704,TERMINATED,INTERVENTIONAL,Business decision
NCT03747211,TERMINATED,INTERVENTIONAL,Issues recruiting participants during COVID-19
NCT03747328,WITHDRAWN,INTERVENTIONAL,IND withdrawn
NCT03747562,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03747718,WITHDRAWN,INTERVENTIONAL,Funding
NCT03747926,WITHDRAWN,INTERVENTIONAL,Substance discontinued.
NCT03748173,TERMINATED,INTERVENTIONAL,slowdown due to covid
NCT03748277,TERMINATED,INTERVENTIONAL,"Recruitment terminated, all follow-up visits were canceled due to quarantine"
NCT03748433,TERMINATED,INTERVENTIONAL,Terminated early after the interim analysis. It was deemed unethical to offer self-monitored blood glucose to this high risk population
NCT03748511,TERMINATED,OBSERVATIONAL,COVID-19 interrupted the recruitment process and imposed difficulties
NCT03748654,SUSPENDED,INTERVENTIONAL,COVID-19
NCT03748719,WITHDRAWN,INTERVENTIONAL,No accrual interest
NCT03748927,WITHDRAWN,OBSERVATIONAL,slow/insufficient accrual
NCT03749083,WITHDRAWN,OBSERVATIONAL,Funding
NCT03749096,WITHDRAWN,INTERVENTIONAL,Recruitment did not meet sponsors timeline
NCT03749226,TERMINATED,INTERVENTIONAL,due to COVID-19 pandemia
NCT03749278,WITHDRAWN,INTERVENTIONAL,This record was a placeholder created before trial was conducted. Trial is now described in NCT03545282.
NCT03749447,TERMINATED,INTERVENTIONAL,Discontinuation of all bardoxolone chronic kidney disease programs
NCT03749564,TERMINATED,INTERVENTIONAL,COVID-19 restrictions on research activities
NCT03749590,TERMINATED,INTERVENTIONAL,The design of the MagPEP trial is no longer in compliance with the current state of science.
NCT03749733,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03749889,TERMINATED,INTERVENTIONAL,Unable to provide OBGYN to assist with study for IRB approval
NCT03749928,WITHDRAWN,INTERVENTIONAL,Study was not funded
NCT03750240,TERMINATED,INTERVENTIONAL,technical difficulties for scans on the research MRI system
NCT03750656,TERMINATED,INTERVENTIONAL,Not accruing patients quickly enough
NCT03750708,WITHDRAWN,INTERVENTIONAL,Unsuccessful study
NCT03750760,WITHDRAWN,INTERVENTIONAL,Changes in funding decision
NCT03750773,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03751358,TERMINATED,INTERVENTIONAL,Problem with MRI interpretation
NCT03751423,SUSPENDED,INTERVENTIONAL,Study on-hold due to COVID-19 pandemic restrictions. Will resume when possible.
NCT03751449,TERMINATED,INTERVENTIONAL,lack of resources
NCT03751579,WITHDRAWN,OBSERVATIONAL,no participant enrolled
NCT03751813,TERMINATED,INTERVENTIONAL,IRB had concerns about study; terminated
NCT03751904,WITHDRAWN,INTERVENTIONAL,Sponsor is no longer pursuing the study.
NCT03751969,WITHDRAWN,INTERVENTIONAL,study canceled
NCT03752073,TERMINATED,INTERVENTIONAL,Difficulty enrolling patients
NCT03752099,TERMINATED,INTERVENTIONAL,Administrative decision
NCT03752138,WITHDRAWN,INTERVENTIONAL,The supporting pharamceutical company elected not to pursue this study at this time.
NCT03752177,TERMINATED,INTERVENTIONAL,The study was terminated during dose escalation after a determination was made that the risk:benefit ratio no longer favored continued evaluation.
NCT03752190,WITHDRAWN,INTERVENTIONAL,Change in personnel leading to inability to conduct study.
NCT03752203,TERMINATED,INTERVENTIONAL,Study cancelled by PI.
NCT03752242,TERMINATED,INTERVENTIONAL,Enrollment stopped for chemistry work on investigational product.
NCT03752372,TERMINATED,OBSERVATIONAL,COVID-19
NCT03752385,TERMINATED,INTERVENTIONAL,Lack of funding.
NCT03752541,SUSPENDED,INTERVENTIONAL,decided by the sponsor
NCT03752632,TERMINATED,INTERVENTIONAL,Business reasons not related to safety or trial conduct
NCT03752762,WITHDRAWN,INTERVENTIONAL,Funding cancelled
NCT03752814,TERMINATED,INTERVENTIONAL,Study was stopped due to administrative reasons.
NCT03753282,WITHDRAWN,OBSERVATIONAL,"difficulty enrolling patients, no patient recruited"
NCT03753698,WITHDRAWN,INTERVENTIONAL,Substantial amendment to be implemented using another device
NCT03753750,WITHDRAWN,INTERVENTIONAL,Insufficient enrollment due to COVID-19 pandemic
NCT03753789,TERMINATED,INTERVENTIONAL,Combined study endpoints with ongoing registry (NOLA/NEU_2017_04)
NCT03753854,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT03753867,WITHDRAWN,INTERVENTIONAL,The study was withdrawn.
NCT03754140,WITHDRAWN,INTERVENTIONAL,Unable to identify eligible patients within planned timeframe
NCT03754166,TERMINATED,INTERVENTIONAL,Study non feasible following changes in organisation of service
NCT03754244,TERMINATED,INTERVENTIONAL,"The enrolment task cannot be gotten within the planned time.It mainly includes patients with non-small cell lung cancer failed in standard treatment,with a short survival period.It is hard to obtain observational endpoints for bone-related events."
NCT03754296,WITHDRAWN,OBSERVATIONAL,Strategic decision
NCT03754452,TERMINATED,OBSERVATIONAL,No inclusion
NCT03755063,TERMINATED,INTERVENTIONAL,Delays and barriers secondary to covid.
NCT03755167,SUSPENDED,INTERVENTIONAL,Study was suspended due to IPL344 shortage and may resume once drug supply is available. Survival follow-up is still ongoing following participants' consent
NCT03755297,TERMINATED,INTERVENTIONAL,Default of recruitment
NCT03755362,TERMINATED,INTERVENTIONAL,The COVID-19 pandemic has disrupted our ability to continue this study. Follow-up visits were missed to the COVID-19 pandemic restrictions. We have elected to close enrollment and stop follow-up visits.
NCT03755492,TERMINATED,OBSERVATIONAL,"COVID related impact on recruitment. Change in treatment (more effective surgical technique ) eliminated the studied side effect, thus making the intervention arm obsolete."
NCT03755570,SUSPENDED,OBSERVATIONAL,PI request
NCT03756038,TERMINATED,INTERVENTIONAL,It was not feasible to enroll Emergency Department patients into this protocol
NCT03756155,WITHDRAWN,INTERVENTIONAL,PI no longer at the institution; departmental permission to deactivate study
NCT03756181,WITHDRAWN,INTERVENTIONAL,issue with project feasibility
NCT03756285,TERMINATED,INTERVENTIONAL,A decision was made to stop the study early when AstraZeneca evaluated the available data and it was considered that completing the study would provide limited additional information and unlikely to change the study conclusions.
NCT03756389,SUSPENDED,INTERVENTIONAL,Re-formulation of study product
NCT03756454,TERMINATED,INTERVENTIONAL,Difficulties with enrollment and inability to guarantee further study drug supply after current supply expired.
NCT03756779,WITHDRAWN,INTERVENTIONAL,Not enrolling subjects in the study.
NCT03756922,SUSPENDED,INTERVENTIONAL,Business reasons
NCT03757039,TERMINATED,INTERVENTIONAL,Management Decision
NCT03757351,TERMINATED,INTERVENTIONAL,Due to change in Sanofi's development strategy for DNL747/SAR443060 - not due to any safety concerns
NCT03757403,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT03757416,TERMINATED,OBSERVATIONAL,Low enrollment; Physician practice relocating
NCT03757455,TERMINATED,INTERVENTIONAL,Not enought participants
NCT03757572,TERMINATED,INTERVENTIONAL,Early termination due to COVID-19 pandemic. Suspension of elective case operations. Decreased recruitment rate. Inability to reach the estimated sample size.
NCT03757663,WITHDRAWN,INTERVENTIONAL,Study closed
NCT03757845,TERMINATED,INTERVENTIONAL,interupted by COVID-19 pandemic
NCT03757897,WITHDRAWN,INTERVENTIONAL,The investigators were unable to implement a MRI compatible EEG for use in human subjects (equipment and technical issues).
NCT03757910,TERMINATED,INTERVENTIONAL,Difficulty recruiting due to the COVID-19 pandemic and end of funding
NCT03758352,WITHDRAWN,INTERVENTIONAL,Large sample size
NCT03758378,TERMINATED,INTERVENTIONAL,Insufficient number of participants met the study eligibility criteria.
NCT03758443,TERMINATED,INTERVENTIONAL,Stopped early due to company decision. Company decision based on interim analysis results in TD-1473-0157.
NCT03758495,WITHDRAWN,OBSERVATIONAL,This study was not intended to be published as a trial.
NCT03758729,WITHDRAWN,INTERVENTIONAL,Internal Issues
NCT03759041,TERMINATED,INTERVENTIONAL,"Due to the lack of a clinical efficacy signal in the induction treatment phase, Seres closed the dosing phases of open label and maintenance portions of the study. Patients who had received prior doses were followed for safety data."
NCT03759080,WITHDRAWN,INTERVENTIONAL,due to sample problem
NCT03759184,TERMINATED,INTERVENTIONAL,The study was closed after \> 1 year of inactivity.
NCT03759249,TERMINATED,INTERVENTIONAL,"Recruitment number could not be reached, difficult conditions under Corona"
NCT03759288,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the development of brazikumab in inflammatory bowel disease.
NCT03759340,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03759704,WITHDRAWN,OBSERVATIONAL,No participants meeting inclusion criteria were found.
NCT03759834,SUSPENDED,INTERVENTIONAL,Enrollment for study is currently on hold pending additional funding and resources.
NCT03759912,TERMINATED,OBSERVATIONAL,The trial stopped prematurely because of enrollment challenges.
NCT03760159,TERMINATED,OBSERVATIONAL,Terminated because sample size achieved
NCT03760250,TERMINATED,INTERVENTIONAL,Investigator decision
NCT03760380,WITHDRAWN,INTERVENTIONAL,sponsor funding shortage
NCT03760445,WITHDRAWN,INTERVENTIONAL,It was determined that the study design may not be optimal given the changing AML treatment landscape.
NCT03760484,TERMINATED,INTERVENTIONAL,Difficulty enrolling participants/COVID pandemic/lack of continued in-kind support from product manufacturer.
NCT03760523,TERMINATED,INTERVENTIONAL,Toxicity -Two DLT events occurred
NCT03760614,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03760653,WITHDRAWN,INTERVENTIONAL,The researcher who was able to recruit the patients abandoned the project.
NCT03760666,TERMINATED,INTERVENTIONAL,"No efficacy observed, COVID-19 caused sites to shut down"
NCT03760965,TERMINATED,INTERVENTIONAL,Sanofi ended collaboration with Lexicon for Sotagliflozin. In China no regulatory pathway to transfer sponsorship during the conduct of ongoing studies.
NCT03761030,TERMINATED,INTERVENTIONAL,The project end date was reached prior to the full sample enrollment
NCT03761069,TERMINATED,INTERVENTIONAL,Sponsor terminated the study.
NCT03761134,TERMINATED,INTERVENTIONAL,Sanofi ended collaboration with Lexicon for Sotagliflozin. In China no regulatory pathway to transfer sponsorship during the conduct of ongoing studies.
NCT03761290,TERMINATED,OBSERVATIONAL,"COVID precautions prevented enrollment of healthy controls, funding ended."
NCT03761303,WITHDRAWN,INTERVENTIONAL,No eligible patients could be recruited.
NCT03761511,WITHDRAWN,INTERVENTIONAL,"Due to a temporary halt the recruitment start was delayed. A re-evaluation of the sponsor revealed, that the study is no longer feasible due to increased administrative and financial requirements."
NCT03761823,TERMINATED,OBSERVATIONAL,Organizational issues and slow inclusion rate
NCT03761836,WITHDRAWN,INTERVENTIONAL,Funding no longer available
NCT03761953,WITHDRAWN,INTERVENTIONAL,COVID 19 pandemic
NCT03762122,TERMINATED,INTERVENTIONAL,Due to financial restructure of SAKK
NCT03762265,TERMINATED,INTERVENTIONAL,Sponsor decision based on lack of efficacy
NCT03762317,TERMINATED,INTERVENTIONAL,Study was initially suspended due to IND application and later terminated due to the difficulty of obtaining consent during COVID period
NCT03762356,WITHDRAWN,OBSERVATIONAL,Study did not receive final approval however it was decided to not pursue.
NCT03762603,WITHDRAWN,INTERVENTIONAL,no funding
NCT03762655,TERMINATED,INTERVENTIONAL,Primary Endpoint not met
NCT03762681,TERMINATED,INTERVENTIONAL,The study was terminated due to program discontinuation.
NCT03762798,WITHDRAWN,INTERVENTIONAL,Not able to enroll participants.
NCT03762889,WITHDRAWN,INTERVENTIONAL,Trial no longer occurring.
NCT03762902,TERMINATED,OBSERVATIONAL,Sufficient data was collected through the app to achieve initial results
NCT03763175,TERMINATED,INTERVENTIONAL,Interim Futility Analysis
NCT03763305,WITHDRAWN,INTERVENTIONAL,"Devices for measuring SKNA are need to be re-constructed, which takes considerable time."
NCT03763357,WITHDRAWN,INTERVENTIONAL,Unable to obtain CT contrast from provider
NCT03763422,TERMINATED,INTERVENTIONAL,Poorly recruiting
NCT03763812,WITHDRAWN,INTERVENTIONAL,Nellix stent cannot be placed in patients yet.
NCT03763851,TERMINATED,INTERVENTIONAL,due to mycotoxin potential contamination of one lot of study drug
NCT03763929,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of meaningful enrollment due to the COVID-19 pandemic.
NCT03764137,WITHDRAWN,INTERVENTIONAL,Study was not able to enroll any subjects
NCT03764306,TERMINATED,INTERVENTIONAL,Problem with recruitment of patients meeting the inclusion criteria.
NCT03764566,WITHDRAWN,OBSERVATIONAL,project has been cancelled
NCT03764644,TERMINATED,INTERVENTIONAL,Interim results showed high futility to continue
NCT03764683,WITHDRAWN,INTERVENTIONAL,Study was terminated due to COVID-19.
NCT03764761,TERMINATED,INTERVENTIONAL,"COVID halted data collection in the final year. We had collected enough data that analysis was able to be conducted, albeit with a slightly smaller sample"
NCT03764774,TERMINATED,INTERVENTIONAL,Trial was terminated due to an insufficient benefit/tolerability ratio
NCT03765008,WITHDRAWN,INTERVENTIONAL,Study did not get funded
NCT03765138,TERMINATED,INTERVENTIONAL,Patient recruitment difficulties
NCT03765736,TERMINATED,OBSERVATIONAL,Low accrual
NCT03766087,WITHDRAWN,INTERVENTIONAL,The authorization of the ethics committee lapses. No patients could be included in the study until the expiry of the ethics committee's authorization. The study never started
NCT03766113,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT03766334,WITHDRAWN,INTERVENTIONAL,Project closure
NCT03766607,WITHDRAWN,INTERVENTIONAL,Competing other studies
NCT03766750,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03766971,SUSPENDED,INTERVENTIONAL,"In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023."
NCT03767192,TERMINATED,INTERVENTIONAL,Protocol Amendment
NCT03767270,WITHDRAWN,INTERVENTIONAL,Program was discontinued.
NCT03767439,WITHDRAWN,INTERVENTIONAL,Loss of funding
NCT03767491,WITHDRAWN,INTERVENTIONAL,"Study must be registered under the sponsor instead of the site, so we have created a new posting in the sponsor's account."
NCT03767686,TERMINATED,OBSERVATIONAL,Finance stop
NCT03767829,TERMINATED,INTERVENTIONAL,The sponsor decided not to proceed with Part B for business reasons.
NCT03768115,WITHDRAWN,INTERVENTIONAL,The inclusion criteria for plasmapheresis is too stringent to get any potential subjects.
NCT03768219,TERMINATED,INTERVENTIONAL,Business decision
NCT03768310,WITHDRAWN,INTERVENTIONAL,We decided to move on to another product and as a result will not be moving forward with this study.
NCT03768401,TERMINATED,INTERVENTIONAL,Funding/grant expired.
NCT03768505,TERMINATED,INTERVENTIONAL,discontinuation of zandelisib program
NCT03768531,WITHDRAWN,INTERVENTIONAL,No subjects were enrolled
NCT03768726,TERMINATED,INTERVENTIONAL,Pfizer has decided to perform the pre-specified final analysis at the current enrollment using a re-estimation of the sample size.
NCT03768869,WITHDRAWN,INTERVENTIONAL,Insufficient data to answer the study question
NCT03769181,TERMINATED,INTERVENTIONAL,Study was stopped after interim analysis for all 4 cohorts with results either not fulfilling the pre-planned interim analysis criteria or fulfilling the criteria but as per sponsor decision. It was not due to any safety concern
NCT03769350,WITHDRAWN,INTERVENTIONAL,"Study must be registered under the sponsor instead of the site, so we have created a new posting in the sponsor's account."
NCT03769467,TERMINATED,INTERVENTIONAL,"Phase 1B part was completed with review of DLTs and cumulative safety data by Safety Data Review Committee and identification of a safe RP2D. Post-internal review, sponsor decided to terminate the study, and hence, Phase 2 part was not conducted."
NCT03769610,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03769688,WITHDRAWN,INTERVENTIONAL,Replaced with different study at another site.
NCT03769961,TERMINATED,OBSERVATIONAL,Low enrollment
NCT03770195,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT03770299,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT03770377,WITHDRAWN,INTERVENTIONAL,IRB Closure
NCT03770455,TERMINATED,INTERVENTIONAL,Early signs of progression and learned experience that the assumed time period between psa progression and radiographic progression was shorter than expected
NCT03770494,TERMINATED,INTERVENTIONAL,The study was terminated for lack of sufficient efficacy.
NCT03770507,WITHDRAWN,INTERVENTIONAL,Nonapplicable clinical trial
NCT03770546,WITHDRAWN,INTERVENTIONAL,Failure of institution to reach agreement with company supplying injections
NCT03770728,TERMINATED,INTERVENTIONAL,"Sponsor decision to cancel TRIAL, not related to safety concern"
NCT03771105,SUSPENDED,INTERVENTIONAL,lack of funding
NCT03771144,TERMINATED,INTERVENTIONAL,Investigator's decision
NCT03771664,TERMINATED,INTERVENTIONAL,internal company decision
NCT03771872,TERMINATED,INTERVENTIONAL,Recruitment of subjects has been difficult.
NCT03771885,WITHDRAWN,INTERVENTIONAL,"Based on a strategic decision, the application for the trial has been withdrawn before initiation."
NCT03772145,TERMINATED,OBSERVATIONAL,Futility; recruitment to slow to justify longer study duration
NCT03772288,WITHDRAWN,INTERVENTIONAL,Business Decision: No Safety or Efficacy Concerns
NCT03772444,TERMINATED,INTERVENTIONAL,"The pilot study was set up to assess whether the used dosing regimen of beetroot juice demonstrated to reach the therapeutic objective. The study was terminated early, as the deadline for the grant application for a larger study was approaching."
NCT03772652,TERMINATED,OBSERVATIONAL,COVID-19 pandemic
NCT03772717,TERMINATED,INTERVENTIONAL,This study was terminated due to difficulties with enrollment and poor adherence to the study intervention among participants.
NCT03772886,TERMINATED,INTERVENTIONAL,Unable to complete enrollment
NCT03772912,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT03773055,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03773081,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT03773120,TERMINATED,INTERVENTIONAL,Major study protocol changes
NCT03773133,TERMINATED,INTERVENTIONAL,High number of screen failures
NCT03773172,TERMINATED,INTERVENTIONAL,Early termination due to COVID-19
NCT03773185,WITHDRAWN,OBSERVATIONAL,Low recruitment rate
NCT03773302,TERMINATED,INTERVENTIONAL,The sponsor has decided to close the study due to the discontinuation of infigratinib development in oncology within the sponsor's territory. The discontinuation of the study was not due to safety issues.
NCT03773328,WITHDRAWN,INTERVENTIONAL,Pending contract negotiations
NCT03773510,WITHDRAWN,INTERVENTIONAL,Not approved by the coordinating Ethical Committee
NCT03773744,WITHDRAWN,INTERVENTIONAL,insufficient suitable drug supply
NCT03773991,TERMINATED,OBSERVATIONAL,Recruitment issues: Restrictions associated with the COVID-19 pandemic have made much of the research procedures unfeasible due to organizational and safety issues (for both staff and patient protection).
NCT03774069,WITHDRAWN,INTERVENTIONAL,It was finally decided not to perform the study
NCT03774251,WITHDRAWN,INTERVENTIONAL,Funding not secured
NCT03774615,TERMINATED,INTERVENTIONAL,low recruitment rate; difficulties to achieve planned number of participants within reasonable time frame
NCT03774719,SUSPENDED,INTERVENTIONAL,"Change in staffing, COVID, New US curriculum being developed"
NCT03774745,TERMINATED,INTERVENTIONAL,Safety
NCT03774784,TERMINATED,OBSERVATIONAL,The study was terminated due to the impacts of COVID-19 on patient safety and enrollment.
NCT03774914,TERMINATED,OBSERVATIONAL,The sponsor stopped the study due to low recruitment with no safety concerns
NCT03775135,WITHDRAWN,OBSERVATIONAL,Changed plans
NCT03775226,TERMINATED,INTERVENTIONAL,The study objective was achieved. Patients are no longer being examined or receiving intervention.
NCT03775421,TERMINATED,INTERVENTIONAL,"As The RUBATO DB study (NCT03153137) did not show any benefit of treatment with macitentan in Fontan-palliated participants, the sponsor has decided to terminate the RUBATO OL study (NCT03775421). No new safety observations were made."
NCT03775473,TERMINATED,INTERVENTIONAL,"COVID-19 pandemic has made it increasingly difficult for ECS progastrin to ensure clinical research is maintained.

As a result, the sponsor made the decision to end patient enrollment prematurely."
NCT03775590,TERMINATED,INTERVENTIONAL,Study closed due to lack of enrollment.
NCT03775707,WITHDRAWN,INTERVENTIONAL,Protocol modification
NCT03775915,TERMINATED,INTERVENTIONAL,COVID-19 lockdown and halt of clinical trials
NCT03776357,TERMINATED,INTERVENTIONAL,funding halted
NCT03776695,WITHDRAWN,INTERVENTIONAL,Lack of Zika infected patients
NCT03776864,TERMINATED,INTERVENTIONAL,Company providing drug terminated their oncology program
NCT03776929,WITHDRAWN,INTERVENTIONAL,Study is temporarily suspended until resources are put in place for enrollment
NCT03777137,WITHDRAWN,OBSERVATIONAL,Expired in the IRB
NCT03777189,TERMINATED,INTERVENTIONAL,benefits of treatment less than expected
NCT03777319,TERMINATED,INTERVENTIONAL,Inability to recruit participants.
NCT03777514,WITHDRAWN,INTERVENTIONAL,Study wasn't started.
NCT03777579,SUSPENDED,INTERVENTIONAL,trial handovered to another sponser.
NCT03777904,TERMINATED,OBSERVATIONAL,Analysis of first 11 subjects resulted in values that were too varied to make the study feasible.
NCT03777956,TERMINATED,INTERVENTIONAL,COVID 19 and recruitment problems
NCT03778073,TERMINATED,INTERVENTIONAL,Strategic/Business Decision
NCT03778515,TERMINATED,OBSERVATIONAL,Lack of enrollment due to the pandemic
NCT03778528,TERMINATED,OBSERVATIONAL,researcher left the institution study will not continue
NCT03778749,TERMINATED,INTERVENTIONAL,Application of monitoring tools seemed inappropriate in ICU patients who were ventilated during a prolonged period.
NCT03778879,WITHDRAWN,INTERVENTIONAL,CCX872-B will not be available in sufficient quantity to conduct the study.
NCT03779100,SUSPENDED,INTERVENTIONAL,Protocol modification
NCT03779295,WITHDRAWN,INTERVENTIONAL,No subjects enrolled.
NCT03779373,WITHDRAWN,INTERVENTIONAL,Change of hospital when the study will be done. We will redo the clinical trial to have the good sponsor for the study.
NCT03779516,TERMINATED,INTERVENTIONAL,change in procedure
NCT03779555,TERMINATED,OBSERVATIONAL,Principal Investigator left the university
NCT03779659,WITHDRAWN,INTERVENTIONAL,"Prior to IRB submission, Covid-19 related logistical and personnel issues led to the decision to not move forward with this research."
NCT03779802,TERMINATED,INTERVENTIONAL,"With the current health situation, we do not anticipate a significant resumption of recruitment for several months."
NCT03779828,TERMINATED,OBSERVATIONAL,Due to logistical concerns
NCT03779958,WITHDRAWN,OBSERVATIONAL,Logistics (Research Staffing)
NCT03780101,TERMINATED,OBSERVATIONAL,recruitment difficulties due to impact of COVID-19 pandemic
NCT03780166,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to insufficient interest in study participation due to recent approval in this rare condition.
NCT03780205,TERMINATED,OBSERVATIONAL,Unable to recruit sufficient number of subjects
NCT03780387,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19 pandemic.
NCT03780465,WITHDRAWN,INTERVENTIONAL,Decision to obtain PK data at a later date
NCT03780543,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT03780634,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03780647,TERMINATED,OBSERVATIONAL,"due to Covid19 pandemic , the inclusions slow down , and the rate of occupational problems exceeding by more than 300% changing the objective and the size of the study"
NCT03780725,TERMINATED,INTERVENTIONAL,Due to company decision.
NCT03781102,SUSPENDED,INTERVENTIONAL,COVID19
NCT03781622,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT03781778,TERMINATED,INTERVENTIONAL,Terminated due to expiration of funding
NCT03781817,TERMINATED,INTERVENTIONAL,Transition/change of primary investigators
NCT03781830,WITHDRAWN,INTERVENTIONAL,Recruiting under the new mDOT clinical trial with PI D Mogul
NCT03781960,TERMINATED,INTERVENTIONAL,Safety letter from sponsor
NCT03781986,SUSPENDED,INTERVENTIONAL,"enrollment has been placed on hold, pending evaluability assessment"
NCT03782064,TERMINATED,INTERVENTIONAL,Funding
NCT03782168,TERMINATED,OBSERVATIONAL,IRB approval expired; failure to submit continuing review in time. Will re-open once IRB approval is reinstated.
NCT03782272,TERMINATED,INTERVENTIONAL,Study product bottles were found on site that did not meet product specifications. This prompted a 6-week safety review of participants (no study-related findings) and resulted in the study's termination.
NCT03782363,WITHDRAWN,INTERVENTIONAL,Initial version of the protocol not submitted and new version approved has a new sponsor and it has been added into Clinicaltrials by the new sponsor
NCT03782402,TERMINATED,INTERVENTIONAL,Funding being sought
NCT03782623,TERMINATED,OBSERVATIONAL,Slow recruitment secondary to limited capacity during Covid-19 pandemic
NCT03782831,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03783013,TERMINATED,INTERVENTIONAL,This study was halted prematurely because of research restrictions related to COVID-19
NCT03783468,WITHDRAWN,INTERVENTIONAL,decision
NCT03783650,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume due to the COVID-19 pandemic.
NCT03783689,TERMINATED,INTERVENTIONAL,"COVID-19 pandemic, Federal contract funding ended"
NCT03783715,TERMINATED,OBSERVATIONAL,Study was halted due to Covid-19 pandemic and unavailability of ketoprofen.
NCT03783728,WITHDRAWN,OBSERVATIONAL,Investigator is leaving the University
NCT03783754,TERMINATED,INTERVENTIONAL,Not feasible to continue
NCT03783884,TERMINATED,INTERVENTIONAL,Low enrollment rate.
NCT03783923,TERMINATED,INTERVENTIONAL,The study was terminated early due to low enrollment and missing efficacy assessment data due to missed visits related to COVID-19.
NCT03783975,TERMINATED,INTERVENTIONAL,Unable to obtain all survey data due to COVID delay
NCT03784222,TERMINATED,INTERVENTIONAL,Company's business decision
NCT03784417,TERMINATED,INTERVENTIONAL,device unavalaible
NCT03784443,WITHDRAWN,INTERVENTIONAL,Funder withdrawn funding.
NCT03784599,TERMINATED,INTERVENTIONAL,insufficient effectiveness
NCT03784690,WITHDRAWN,INTERVENTIONAL,"According to new guidelines, the use of vasopressors to force the MAP during CPB at values higher than 80 mmHg is not recommended."
NCT03784781,WITHDRAWN,OBSERVATIONAL,The study never started
NCT03784963,TERMINATED,INTERVENTIONAL,Low enrollment
NCT03784989,WITHDRAWN,OBSERVATIONAL,Lack of recruitment
NCT03785067,TERMINATED,INTERVENTIONAL,Contractual and financial issues.
NCT03785184,WITHDRAWN,INTERVENTIONAL,Strategic considerations
NCT03785236,TERMINATED,OBSERVATIONAL,"Suitable participants have complicated T1D, often with serious complications, participation is therefore challenging. Participants also fall within an unique group and few suitable individuals were available for inclusion."
NCT03785262,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT03785275,TERMINATED,OBSERVATIONAL,"It was not possible to include 9 study participants with unstable glucose in due time, and therefore 7 individuals with unstable glucose control were included."
NCT03785327,TERMINATED,INTERVENTIONAL,COVID disrupted data collection
NCT03785392,TERMINATED,INTERVENTIONAL,Primary investigator left the Institution
NCT03785691,TERMINATED,INTERVENTIONAL,Recruiting difficulties
NCT03785730,SUSPENDED,INTERVENTIONAL,Outbreak of COVID-19.
NCT03785769,WITHDRAWN,INTERVENTIONAL,The Outbreak of COVID-19.
NCT03785808,TERMINATED,INTERVENTIONAL,Study terminated due to lack of accrual/enrollment
NCT03786094,TERMINATED,INTERVENTIONAL,The study was halted early due to failure to meet the primary endpoint.
NCT03786107,TERMINATED,OBSERVATIONAL,The study was stopped early due to increased global access to genomic screening. It is no longer economical to continue with this particular single-gene screening protocol.
NCT03786302,TERMINATED,INTERVENTIONAL,Failure rate was 100% in one arm of the study (the intervention)
NCT03786380,TERMINATED,INTERVENTIONAL,The Relamorelin program is being terminated solely based on a business decision.
NCT03786419,WITHDRAWN,INTERVENTIONAL,Publication of study results of ICI use in MPM as first line therapy
NCT03786432,TERMINATED,INTERVENTIONAL,Could not continue enrollment due to discontinuation of funding
NCT03786536,WITHDRAWN,INTERVENTIONAL,Approval of specific study by UK MHRA not received. Study performed in different circumstances and with different clinical sites / partners.
NCT03787082,WITHDRAWN,INTERVENTIONAL,Study was never able to start after the pandemic restrictions lifted
NCT03787095,TERMINATED,INTERVENTIONAL,Stopped by monitoring committee recommendation due to adverse events
NCT03787147,WITHDRAWN,INTERVENTIONAL,Never started the study cause of the lack of funding
NCT03787212,TERMINATED,INTERVENTIONAL,Study terminated due to safety assessment of the study product
NCT03787238,WITHDRAWN,INTERVENTIONAL,Company decision
NCT03787251,WITHDRAWN,INTERVENTIONAL,"In China, apatinib has been approved as an indication drug for esophageal squamous cell carcinoma, which makes it very difficult for our clinical trial to enroll patients. We regret that we failed to implement the design as planned."
NCT03787290,SUSPENDED,INTERVENTIONAL,we were not able to get the study drug due to covid
NCT03787303,TERMINATED,INTERVENTIONAL,Relocation of Principal Investigator
NCT03787862,WITHDRAWN,OBSERVATIONAL,PI No longer with the University
NCT03787901,TERMINATED,INTERVENTIONAL,Failed to achieve sample size due to COVID19 pandemic
NCT03788070,TERMINATED,OBSERVATIONAL,"Due to COVID-19 study inclusion was halted on March 16, 2020 after 309 days."
NCT03788486,WITHDRAWN,INTERVENTIONAL,Covid
NCT03788694,WITHDRAWN,INTERVENTIONAL,"Study was never funded nor started, no participants were enrolled"
NCT03788707,WITHDRAWN,INTERVENTIONAL,Due to COVID-19. The study was never started.
NCT03788889,WITHDRAWN,INTERVENTIONAL,internal practice and policy limitations including time commitment / workflow issues
NCT03788980,TERMINATED,OBSERVATIONAL,Lack of funding and resources
NCT03789149,TERMINATED,INTERVENTIONAL,Planning to join a prospective multicentric trial after evaluation of 10 first participants
NCT03789188,TERMINATED,OBSERVATIONAL,Investigator left NIH
NCT03789487,TERMINATED,INTERVENTIONAL,the end of inclusion period
NCT03789643,WITHDRAWN,INTERVENTIONAL,"Corporate decision, priority change"
NCT03789773,WITHDRAWN,INTERVENTIONAL,"Grant ended, no accrual"
NCT03790111,TERMINATED,INTERVENTIONAL,Did not meet pre-specified Progression-Free Survival at Month 6 for Stage 2 Analysis
NCT03790436,TERMINATED,INTERVENTIONAL,We no longer have Ketogenic Dietician coverage/access.
NCT03790449,TERMINATED,INTERVENTIONAL,"Due to the worldwide Covid-19 pandemic, all Belgian fertility clinics stopped offering IVF as of March 13th 2020. We had to stop recruitment and follow-up of study subjects. We therefore adjusted our primary outcome to time to ongoing pregnancy."
NCT03790683,TERMINATED,INTERVENTIONAL,Sponsor funding limitations
NCT03790774,TERMINATED,INTERVENTIONAL,"Due to COVID-19 concerns and restrictions in our at-risk population, interactions were halted."
NCT03790852,TERMINATED,INTERVENTIONAL,All patients past planned primary endpoint; decision by Sponsor to wind down open-label follow-up activities.
NCT03790865,TERMINATED,INTERVENTIONAL,Livoletide did not result in a statistically significant improvement in hyperphagia and food-related behaviors
NCT03791060,TERMINATED,INTERVENTIONAL,Study halted prematurely due COVID-19 pandemic and did not resume; participants are no longer being examined or receiving intervention.
NCT03791398,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03791541,WITHDRAWN,INTERVENTIONAL,Pilot study results not meaningful. Students researchers graduated.
NCT03791736,TERMINATED,INTERVENTIONAL,The surgical technique is no longer used
NCT03791814,WITHDRAWN,INTERVENTIONAL,The study was stopped due to difficulty in identifying potential patients.
NCT03791918,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03792295,WITHDRAWN,INTERVENTIONAL,"no enrollment, reallocation of resources"
NCT03792360,WITHDRAWN,INTERVENTIONAL,Study closed due to lack of patient enrollment.
NCT03792503,WITHDRAWN,INTERVENTIONAL,abandon
NCT03792581,WITHDRAWN,INTERVENTIONAL,The sponsor was not the good one. We will redo the clincal trial gov to be concordant with the actual sponsor
NCT03793010,TERMINATED,INTERVENTIONAL,By Sponsor due to occurrences of incomplete study drug administration
NCT03793218,WITHDRAWN,INTERVENTIONAL,PI left institution before participants were enrolled.
NCT03793296,WITHDRAWN,INTERVENTIONAL,At sponsor's discretion
NCT03793361,SUSPENDED,INTERVENTIONAL,interim analysis
NCT03793686,TERMINATED,INTERVENTIONAL,Unable to enroll subjects
NCT03793712,TERMINATED,INTERVENTIONAL,Lack of efficacy based on interim analysis
NCT03794024,TERMINATED,OBSERVATIONAL,Manufacturer of the device filed for bankruptcy
NCT03794037,SUSPENDED,INTERVENTIONAL,no fund
NCT03794050,TERMINATED,INTERVENTIONAL,"Due to SARS-CoV-2 pandemic research restrictions placed by university, we were unable to complete enrollment of all participants in a timely manner. Data analyses and publications will occur with the participants who did complete the study."
NCT03794154,WITHDRAWN,INTERVENTIONAL,This study has been cancelled prior to FSFV due to business reasons
NCT03794206,TERMINATED,INTERVENTIONAL,Company closure
NCT03794258,WITHDRAWN,INTERVENTIONAL,Can not recruit the patients due to the pandemic of COVID-19
NCT03794297,WITHDRAWN,INTERVENTIONAL,Inadequate accrual rate
NCT03794570,WITHDRAWN,INTERVENTIONAL,Investigator separated from institution
NCT03794583,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03794596,WITHDRAWN,INTERVENTIONAL,IP breach
NCT03794609,TERMINATED,OBSERVATIONAL,The study was terminated on 18th November 2022. The decision to terminate the trial was not based on any safety and/or efficacy concerns.
NCT03794882,TERMINATED,INTERVENTIONAL,administrative challenges and complications due to the COVID-19 pandemic
NCT03794960,WITHDRAWN,INTERVENTIONAL,Modification to Clinical Development Plan
NCT03794973,WITHDRAWN,INTERVENTIONAL,Modification to Clinical Development Plan
NCT03794999,TERMINATED,OBSERVATIONAL,The decision to terminate the Fasenra pregnancy study and cancel the commitment to conduct additional pregnancy-related pharmacovigilance activities was made by the EMA following MAH's failed attempts to address patient recruitment challenges.
NCT03795012,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT03795168,TERMINATED,INTERVENTIONAL,Study center closed down
NCT03795194,TERMINATED,INTERVENTIONAL,Due to low enrollment.
NCT03795233,TERMINATED,INTERVENTIONAL,The study was terminated after a covid-related suspension and the unavailability of drug.
NCT03795272,WITHDRAWN,INTERVENTIONAL,Lack of financial support
NCT03795350,TERMINATED,INTERVENTIONAL,"In light of the cessation of non-essential clinical activities at CPU due to the COVID-19 pandemic, the sponsor has determined to terminate the study early."
NCT03795428,TERMINATED,INTERVENTIONAL,Terminated: Study drug resupply delayed (Covid-19)
NCT03796195,TERMINATED,INTERVENTIONAL,Enrollment issues
NCT03796403,TERMINATED,INTERVENTIONAL,Diclofenac is no longer recommend for intramuscular administration by the Medical Council of Thailand
NCT03796416,WITHDRAWN,INTERVENTIONAL,in error
NCT03796507,WITHDRAWN,INTERVENTIONAL,Hiring freeze of research personnel due to COVID pandemic
NCT03796702,TERMINATED,INTERVENTIONAL,High postoperative morbidity rate
NCT03797066,TERMINATED,INTERVENTIONAL,"Changing parameters in HCV management, resulted in poor recruitment; additionally onset of SARS CoV2 resulted in the cessation of all mobile clinical services."
NCT03797144,TERMINATED,INTERVENTIONAL,Delay in enrollment as compared to plan (impacted by COVID-19 pandemic) and availability of data from other data sources to support the products in scope.
NCT03797261,TERMINATED,INTERVENTIONAL,Safety
NCT03797287,WITHDRAWN,INTERVENTIONAL,IRB will be terminated
NCT03797430,WITHDRAWN,OBSERVATIONAL,NO PARTICIPANTS ENROLLED
NCT03797443,WITHDRAWN,INTERVENTIONAL,Regulatory Review needed
NCT03797612,WITHDRAWN,INTERVENTIONAL,Study initiation delayed due to COVID 19
NCT03797794,TERMINATED,INTERVENTIONAL,Logistical problems at study site
NCT03797833,SUSPENDED,INTERVENTIONAL,Slow inclusion rate. Central contact person quit for another job.
NCT03798015,WITHDRAWN,OBSERVATIONAL,resource issues on site
NCT03798145,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT03798405,TERMINATED,INTERVENTIONAL,COVID-19-related restrictions
NCT03798951,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to slow recruitment.
NCT03799523,SUSPENDED,INTERVENTIONAL,Study enrollment is temporarily halted for interim analysis to ensure adequate evaluable subjects.
NCT03799588,WITHDRAWN,INTERVENTIONAL,personnel have left the facility
NCT03800069,TERMINATED,OBSERVATIONAL,scheduling complexities
NCT03800225,TERMINATED,INTERVENTIONAL,A new scientific study shows that surgery with internal brace is worse than convensional surgery tecnic. This new knowledge stops this trial.
NCT03800420,TERMINATED,INTERVENTIONAL,to carry out the rest of the study with new CRO and modified protocol as a multi-regional study.
NCT03800446,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03800667,WITHDRAWN,INTERVENTIONAL,No funds
NCT03800784,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03800862,TERMINATED,OBSERVATIONAL,PI departure from institution + Enrollment Challenges
NCT03801031,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03801356,TERMINATED,INTERVENTIONAL,"The study was terminated early due to a number of concurrent issues: low enrollment, limited data and COVID-19."
NCT03801499,WITHDRAWN,INTERVENTIONAL,Protocol modification
NCT03801525,TERMINATED,INTERVENTIONAL,Strategic/Business decision
NCT03801616,SUSPENDED,INTERVENTIONAL,Due to the COVID-19 virus
NCT03801720,TERMINATED,INTERVENTIONAL,Study was suspended due to COVID. Investigators no long feel that completion of the study is feasible and have permanently terminated the study.
NCT03801863,TERMINATED,OBSERVATIONAL,"Study ""Administratively closed"" by Albert Einstein College of Medicine IRB as approval expired. PI no longer with institution. IRB approval expiry date used as Primary Completion date and Study Completion Date. Enrollment total derived from CTMS"
NCT03801889,WITHDRAWN,INTERVENTIONAL,Protocol suspended prior to patient enrollment
NCT03802058,TERMINATED,INTERVENTIONAL,The study was halted because enrollment was too slow
NCT03802214,TERMINATED,OBSERVATIONAL,Funding discontinued
NCT03802227,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03802422,WITHDRAWN,INTERVENTIONAL,It is hard to enroll patients due to Covid-19 pandemic.
NCT03802461,SUSPENDED,INTERVENTIONAL,Temporarily on hold due to COVID-19 pandemic
NCT03802630,TERMINATED,INTERVENTIONAL,"Study was terminated by sponsor due to increased incidences of AEs of special interest (intraocular inflammation including retinal vasculitis and retinal vascular occlusion), in patients dosed brolucizumab 6mg every 4 weeks beyond 3 initial doses"
NCT03802656,TERMINATED,INTERVENTIONAL,Device is no longer investigational. It has been approved by the FDA as an HUD under HDE H190005.
NCT03802747,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT03802994,TERMINATED,INTERVENTIONAL,Due to COVID pandemic further recruitment of subjects was unethical.
NCT03803046,TERMINATED,OBSERVATIONAL,Consequences of failing to include.
NCT03803111,WITHDRAWN,INTERVENTIONAL,Sponsoring and Screening of first patients was not sufficient
NCT03803163,TERMINATED,INTERVENTIONAL,Discontinued early due to local tolerance expectations not being met.
NCT03803254,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03803527,WITHDRAWN,INTERVENTIONAL,This study did not receive the grant that was applied for to conduct the study.
NCT03803566,WITHDRAWN,INTERVENTIONAL,The grant application has not been approved
NCT03803657,WITHDRAWN,OBSERVATIONAL,Never started
NCT03803722,TERMINATED,INTERVENTIONAL,Slow enrolment process and COVID situation worsened the situation. SIFI has developed a new product with probably a better performance. SIFI changed its marketing strategy and decided that Eyestil Protection will be not marketed anymore
NCT03803761,WITHDRAWN,INTERVENTIONAL,Inadequate accrual rate
NCT03803774,TERMINATED,INTERVENTIONAL,Drug supply issues
NCT03804125,WITHDRAWN,OBSERVATIONAL,Company decision to not conduct the study and was cancelled prior to any enrollment.
NCT03804164,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT03804255,WITHDRAWN,OBSERVATIONAL,Study closed before patients enrolled
NCT03804515,TERMINATED,INTERVENTIONAL,COVID
NCT03804606,SUSPENDED,INTERVENTIONAL,insufficient participants enrolled and study team has left Geisinger
NCT03804814,TERMINATED,INTERVENTIONAL,Pandemic impacted ability to recruit and enroll
NCT03805178,WITHDRAWN,INTERVENTIONAL,Not activated at Duke
NCT03805243,TERMINATED,INTERVENTIONAL,Change of products design
NCT03805360,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03805633,WITHDRAWN,OBSERVATIONAL,Person working on the trial left
NCT03805672,TERMINATED,INTERVENTIONAL,Terminated due to low enrollment because of decrease in DVT rates.
NCT03805698,TERMINATED,INTERVENTIONAL,COVID stopped surgeries
NCT03805711,TERMINATED,INTERVENTIONAL,Sponsor decision to stop enrollment.
NCT03805841,TERMINATED,INTERVENTIONAL,enrollment pause
NCT03806023,TERMINATED,INTERVENTIONAL,Funding expired due to grant for new project (NCT03851302)
NCT03806049,WITHDRAWN,INTERVENTIONAL,Lack of financial support
NCT03806192,TERMINATED,INTERVENTIONAL,Terminated due to insufficient funding
NCT03806231,TERMINATED,INTERVENTIONAL,Sponsor declined to provide further funding/product support.
NCT03806244,TERMINATED,INTERVENTIONAL,Departure of the two main investigators
NCT03806335,SUSPENDED,INTERVENTIONAL,Lack of patients
NCT03806556,TERMINATED,INTERVENTIONAL,"Low accrual rate, strategic reasons"
NCT03806660,SUSPENDED,OBSERVATIONAL,lack of staff
NCT03806725,WITHDRAWN,OBSERVATIONAL,Difficulty with recruitment in this patient population.
NCT03806751,WITHDRAWN,INTERVENTIONAL,The investigator decided not to pursue the study.
NCT03806985,TERMINATED,INTERVENTIONAL,Challenging to recruit qualifying subjects
NCT03807063,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT03807349,TERMINATED,INTERVENTIONAL,"Sponsor will not pursue CE mark for this product, which precludes need for large PMCF study."
NCT03807479,TERMINATED,INTERVENTIONAL,less recruting
NCT03807856,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT03808012,WITHDRAWN,INTERVENTIONAL,Unsuccessful recruitment
NCT03808168,WITHDRAWN,INTERVENTIONAL,FDA has withdrawn the IND application- requesting protocol changes
NCT03808506,WITHDRAWN,OBSERVATIONAL,no recruitment during COVID pandemic
NCT03808532,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03808545,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03808714,TERMINATED,INTERVENTIONAL,Difficulties in recruitment due to COVID-19
NCT03808766,TERMINATED,INTERVENTIONAL,Poor patient accrual
NCT03808935,TERMINATED,INTERVENTIONAL,Participants are no longer being examined or receiving intervention.
NCT03808961,TERMINATED,INTERVENTIONAL,Not enough recruitment
NCT03809039,TERMINATED,INTERVENTIONAL,Preclinical finding
NCT03809117,TERMINATED,INTERVENTIONAL,Study was halted due to obstacles faced in executing clinical procedures as a result of the COVID-19 pandemic.
NCT03809130,TERMINATED,INTERVENTIONAL,Terminated Per PI
NCT03809234,TERMINATED,INTERVENTIONAL,Adverse effects related to study procedure (not study drug)
NCT03809455,WITHDRAWN,INTERVENTIONAL,Study was cancelled by Sponsor.
NCT03809481,TERMINATED,INTERVENTIONAL,Prolonged delay as a result of impact of Covid19 pandemic
NCT03809494,TERMINATED,INTERVENTIONAL,The study has stopped early due to enrollment challenges related largely to the current pandemic
NCT03809572,TERMINATED,INTERVENTIONAL,Due to restrictions to in-person research due to COVID-19
NCT03809650,TERMINATED,INTERVENTIONAL,Due to a change in the development strategy
NCT03809663,TERMINATED,INTERVENTIONAL,Tezepelumab as a monotherapy in atopic dermatitis did not reach the targeted efficacy level pre-established for this patient population.
NCT03809832,TERMINATED,OBSERVATIONAL,Preliminary results providing sufficient data
NCT03809897,WITHDRAWN,INTERVENTIONAL,Budget not sufficient to cover the study scope proposed and recruitment rates expected to be no sufficient.
NCT03810105,TERMINATED,INTERVENTIONAL,Due to low accrual
NCT03810183,TERMINATED,INTERVENTIONAL,Company decision
NCT03810313,TERMINATED,INTERVENTIONAL,"Study was terminated by sponsor due to increased incidences of adverse events of special interest (intraocular inflammation including retinal vasculitis, and retinal vascular occlusion), in patients dosed every 4 weeks beyond 3 initial doses."
NCT03810508,TERMINATED,OBSERVATIONAL,Discontinued CMT4J development program
NCT03810690,WITHDRAWN,INTERVENTIONAL,Study was terminated before the start of dosing due to a business decision and not due to safety or efficacy reasons.
NCT03810898,TERMINATED,INTERVENTIONAL,Study terminated per protocol design post interim analysis review after Phase 2a. No SAEs or safety issues were noted.
NCT03811041,TERMINATED,INTERVENTIONAL,The decision was made not to extend the inclusions due to the low inclusion rate since the beginning of the study. The last inclusion took place on 06/22/2020.
NCT03811158,TERMINATED,INTERVENTIONAL,Difficult to recruit participants
NCT03811262,WITHDRAWN,INTERVENTIONAL,Logistic reasons (Operating room performing the surgery investigated moved to another structure)
NCT03811418,WITHDRAWN,INTERVENTIONAL,"Study approved with treatment regimen based on current guidelines. However, reimbursement of IMP was not feasible."
NCT03811769,TERMINATED,INTERVENTIONAL,"Although the planned sample size was 450, enrollment was halted early following an unplanned interim analysis recommended by the Data Safety Monitoring Board because results favoring thrombectomy were reported from other similar trials."
NCT03811951,TERMINATED,INTERVENTIONAL,Different study initiation
NCT03812107,TERMINATED,INTERVENTIONAL,The study was stopped due to COVID-19 as it interfered with the study intervention.
NCT03812159,WITHDRAWN,INTERVENTIONAL,Study members relocated after Covid and recruitment stopped
NCT03812289,TERMINATED,INTERVENTIONAL,PI decision
NCT03812341,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT03812367,WITHDRAWN,OBSERVATIONAL,The Investigator decided not to pursue this study.
NCT03812380,TERMINATED,INTERVENTIONAL,The study was terminated due to a severe decrease in enrollment over the years 2020 and 2021. The major obstacle which hindered participation of subjects was the COVID-19 pandemic. Research was halted. Remaining study patients were withdrawn.
NCT03812562,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03812679,TERMINATED,INTERVENTIONAL,Terminated for business reasons not due to scientific data. Sufficient data was acquired to transition program development to other technologies
NCT03812835,WITHDRAWN,OBSERVATIONAL,Company decision to not conduct study and was cancelled prior to any enrollment.
NCT03813108,TERMINATED,INTERVENTIONAL,"Subject withdrawals after temporal suspension of the trial (for personal, logistic reasons). At time of reinitiation the number of enrolled subjects did not meet the predefined threshold for continuation of the trial."
NCT03813316,WITHDRAWN,INTERVENTIONAL,Lack of funding availability to complete project
NCT03813355,TERMINATED,INTERVENTIONAL,lack of inclusion to meet the evaluation criteria
NCT03813979,WITHDRAWN,INTERVENTIONAL,difficult recruitment and delay due to COVID19
NCT03814096,WITHDRAWN,INTERVENTIONAL,funding not secured
NCT03814109,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03814135,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03814148,WITHDRAWN,INTERVENTIONAL,The design of this protocol was rewritten due to regulatory recommendations.
NCT03814382,TERMINATED,INTERVENTIONAL,Termination of study funding
NCT03814798,WITHDRAWN,INTERVENTIONAL,"Due to the regulatory approval of the product in this indication, a large portion of the study becomes unnecessary."
NCT03814850,WITHDRAWN,INTERVENTIONAL,No participants were identified per inclusion/exclusion criteria
NCT03815045,TERMINATED,INTERVENTIONAL,"An interim analysis was conducted, and no difference was found between traditional lumbar punctures and ultrasound-guided lumbar punctures. The study was subsequently terminated."
NCT03815266,TERMINATED,INTERVENTIONAL,The study was stopped due to lack of inclusions
NCT03815500,WITHDRAWN,INTERVENTIONAL,"PI no longer with the organization, no subjects enrolled"
NCT03815669,TERMINATED,OBSERVATIONAL,"Due to covid 19, it has not been possible to recruit enough participants to complete the study."
NCT03815682,TERMINATED,INTERVENTIONAL,Development program terminated
NCT03815721,WITHDRAWN,INTERVENTIONAL,Decision of the 2 PI's
NCT03815994,SUSPENDED,INTERVENTIONAL,This study had to be suspended due to COVID-19 Pandemic.
NCT03816228,WITHDRAWN,OBSERVATIONAL,We will capture subjects under another study
NCT03816384,WITHDRAWN,INTERVENTIONAL,Declined to pursue Study due to anticipated low enrollment numbers
NCT03816488,WITHDRAWN,INTERVENTIONAL,Unable to source salsalate.
NCT03816852,SUSPENDED,INTERVENTIONAL,Others
NCT03817034,WITHDRAWN,INTERVENTIONAL,We decided to close this study and come up with a new study design.
NCT03817190,TERMINATED,INTERVENTIONAL,Based on Interim Analysis results
NCT03817216,WITHDRAWN,INTERVENTIONAL,re-written and submitted as a new study
NCT03817281,WITHDRAWN,OBSERVATIONAL,Lack of Enrollment
NCT03817528,TERMINATED,INTERVENTIONAL,ITI-007 approved by FDA
NCT03817554,TERMINATED,INTERVENTIONAL,The recruitment of participants in the study was difficulty.
NCT03817593,WITHDRAWN,OBSERVATIONAL,"Due to COVID epidemics and the multiple lock-downs, we were unable to begin the study"
NCT03817606,TERMINATED,INTERVENTIONAL,Due to COVID-19 disruption
NCT03817827,WITHDRAWN,INTERVENTIONAL,The trial was delayed and patient recruitment was deemed high-risk during the Covid-19 pandemic
NCT03818022,WITHDRAWN,INTERVENTIONAL,Lost interest in study
NCT03818165,TERMINATED,INTERVENTIONAL,Limited enrollment.
NCT03818399,TERMINATED,INTERVENTIONAL,"Due to a financial business decision by the company supporting the research study (Indivior). The decision was not due to adverse events, safety reasons, or scientific reasons, but was a business decision."
NCT03818438,TERMINATED,OBSERVATIONAL,insufficiency inclusion; covid crisis ; sponsor decision
NCT03818542,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT03818672,TERMINATED,INTERVENTIONAL,Study determined to be infeasible.
NCT03818776,TERMINATED,INTERVENTIONAL,Safety
NCT03818789,TERMINATED,INTERVENTIONAL,COVID
NCT03818997,WITHDRAWN,INTERVENTIONAL,Company decision
NCT03819218,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03819231,SUSPENDED,INTERVENTIONAL,Study recruitment temporarily suspended due to COVID-19 pandemic.
NCT03819504,WITHDRAWN,INTERVENTIONAL,Change in the design of the study
NCT03819543,TERMINATED,INTERVENTIONAL,COVID-19
NCT03819660,TERMINATED,INTERVENTIONAL,Development of indication not being pursued
NCT03819699,TERMINATED,INTERVENTIONAL,New data: The study was terminated based on new efficacy data from another study
NCT03820258,TERMINATED,INTERVENTIONAL,SOF/VEL/VOX will not be evaluated in younger age groups.
NCT03820466,TERMINATED,INTERVENTIONAL,insufficient recruitment due to the pandemic situation
NCT03820544,TERMINATED,INTERVENTIONAL,Interest in this study changed and it was decided to end enrollment early
NCT03820648,TERMINATED,INTERVENTIONAL,no differences between the groups at the interim analysis
NCT03820934,WITHDRAWN,INTERVENTIONAL,Per Investigator study was terminated prematurely
NCT03821038,TERMINATED,INTERVENTIONAL,PK issue detected after bolus IV route administration
NCT03821337,TERMINATED,INTERVENTIONAL,COVID-19 placed all Charleston VA projects on hold. Recently gained approval to open studies with COVID-19 precautions
NCT03821584,TERMINATED,OBSERVATIONAL,Recruiting terminated
NCT03821766,WITHDRAWN,OBSERVATIONAL,Technical failure
NCT03821831,TERMINATED,OBSERVATIONAL,COVID hindered enrollment
NCT03821896,TERMINATED,INTERVENTIONAL,Ongoing COVID-19 restrictions and very low (in-person) clinical activity prevented participant recruitment.
NCT03822117,TERMINATED,INTERVENTIONAL,A business decision was made to to discontinue further enrollment. There were no safety concerns that contributed to this decision.
NCT03822195,WITHDRAWN,OBSERVATIONAL,PI changed Institution
NCT03822689,WITHDRAWN,INTERVENTIONAL,Institutional Review Board did not approve
NCT03822715,TERMINATED,INTERVENTIONAL,Low accrual
NCT03822962,TERMINATED,INTERVENTIONAL,Decrease in accrual during the COVID-19 pandemic and several sites withdrawing
NCT03823001,WITHDRAWN,INTERVENTIONAL,low accrual
NCT03823131,TERMINATED,INTERVENTIONAL,Treatment Ineffective
NCT03823378,TERMINATED,INTERVENTIONAL,Study M16-763 was terminated early as the benefit of each treatment arm from the feeder study (Study M16-063) did not provide appreciable evidence of differentiated clinical effect to warrant further long-term continuation.
NCT03823417,WITHDRAWN,INTERVENTIONAL,Investigators decided not to begin the study.
NCT03823703,TERMINATED,INTERVENTIONAL,"Suspended by sponsor, pending investigation of abnormal laboratory values in patients with NASH"
NCT03823924,TERMINATED,OBSERVATIONAL,logistic problems
NCT03824327,SUSPENDED,INTERVENTIONAL,Per an amendment
NCT03824444,WITHDRAWN,INTERVENTIONAL,End of funding and device in further development
NCT03824704,TERMINATED,INTERVENTIONAL,Sponsor made a business decision to discontinue the study due to low accrual.
NCT03824808,TERMINATED,INTERVENTIONAL,Challenges with recruitment of surgical research subjects in the target population.
NCT03824847,SUSPENDED,INTERVENTIONAL,Community recruitment suspended due to COVID-19
NCT03825302,WITHDRAWN,OBSERVATIONAL,No funding available.
NCT03825341,TERMINATED,INTERVENTIONAL,The study terminated early due to challenges with recruitment during the COVID pandemic.
NCT03825406,WITHDRAWN,OBSERVATIONAL,Dr. Bavry is recruiting the same patients for a NIH trial.
NCT03825497,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT03825783,WITHDRAWN,INTERVENTIONAL,Patients were enrolled under global Phase 1/2 protocol RP-L201-0318.
NCT03825913,TERMINATED,INTERVENTIONAL,two key faculty members are no longer part of the study and institution
NCT03825939,TERMINATED,INTERVENTIONAL,Lack of patient enrollment due to only one surgeon that was enrolling.
NCT03826368,WITHDRAWN,OBSERVATIONAL,Lack of initial funding after approval of study
NCT03826784,WITHDRAWN,INTERVENTIONAL,Combined into an international study (CAR-BHA-I21)
NCT03827044,TERMINATED,INTERVENTIONAL,POLEM encountered significant recruitment challenges. With little prospect of recruiting to target the decision to close was made.
NCT03827096,TERMINATED,INTERVENTIONAL,Primary endpoint (Safety) has been achieved
NCT03827174,TERMINATED,INTERVENTIONAL,"All clinicial studies were stopped during the Covid-19 pandemic. Interventions not possible to perform, neither at workplace nor at the gym."
NCT03827200,TERMINATED,INTERVENTIONAL,"Lack of recruitment, result of COVID-19 pandemic"
NCT03827213,TERMINATED,INTERVENTIONAL,Ran out of medication
NCT03827239,TERMINATED,INTERVENTIONAL,Lack of funding caused us to cancel the study.
NCT03827421,TERMINATED,OBSERVATIONAL,Organizational reasons and lack of enrollment
NCT03827434,WITHDRAWN,INTERVENTIONAL,We did not receive funding to conduct the study
NCT03827473,TERMINATED,INTERVENTIONAL,"The trial was closed because the changing standard of care landscape, making this trial not impactful anymore."
NCT03827564,TERMINATED,INTERVENTIONAL,Study discontinued due to business reasons.
NCT03827824,TERMINATED,INTERVENTIONAL,Complete collection of study patients
NCT03827850,TERMINATED,INTERVENTIONAL,"Study-related difficulties faced with patient enrolment, no safety-related reasons"
NCT03827889,SUSPENDED,INTERVENTIONAL,Outbreak of COVID-19.
NCT03827902,WITHDRAWN,OBSERVATIONAL,Unable to recruit participants
NCT03827993,TERMINATED,INTERVENTIONAL,PI left institution
NCT03828136,TERMINATED,INTERVENTIONAL,Sponsor business decision
NCT03828448,TERMINATED,INTERVENTIONAL,Strategic/Business Decision
NCT03828487,TERMINATED,INTERVENTIONAL,Sponsor terminated study due to project timeline.
NCT03828929,TERMINATED,INTERVENTIONAL,Recent similar studies have been completed and published showing no benefit to the intervention.
NCT03829163,WITHDRAWN,INTERVENTIONAL,IRB -- need to reframe study as a feasibility study before it being a RCT.
NCT03829215,WITHDRAWN,INTERVENTIONAL,insolvency of the sponsor
NCT03829449,TERMINATED,INTERVENTIONAL,"The early termination of this study is a business decision, Akari have made the decision to close their global Phase III PNH program. The decision was not related to any efficacy, safety or clinical concerns regarding Coversin/rVA576."
NCT03829566,WITHDRAWN,INTERVENTIONAL,Discontinued by Investigator
NCT03829618,TERMINATED,INTERVENTIONAL,COVID lack of cases/recruitment
NCT03829631,SUSPENDED,INTERVENTIONAL,Covid-19 Pandemic
NCT03829644,SUSPENDED,INTERVENTIONAL,Covid-19 Pandemic
NCT03829657,TERMINATED,INTERVENTIONAL,Stopped early due to company decision. Company decision based on analysis results in TD-9855-0169.
NCT03829696,WITHDRAWN,INTERVENTIONAL,The study is not proceeding at this time.
NCT03829735,WITHDRAWN,INTERVENTIONAL,Not started
NCT03829878,WITHDRAWN,INTERVENTIONAL,Study not started
NCT03829930,TERMINATED,INTERVENTIONAL,Sponsor discontinued the drug
NCT03830216,TERMINATED,INTERVENTIONAL,Selective inclusion/exclusion criteria led to low enrollment which was not viable for the sponsor and site.
NCT03830892,TERMINATED,INTERVENTIONAL,Study terminated due to COVID
NCT03831139,TERMINATED,INTERVENTIONAL,COVID epidemic \& measures to control it
NCT03831152,WITHDRAWN,INTERVENTIONAL,No patients enrolled. Study no longer required due to completion of long term safety study in the EU.
NCT03831191,TERMINATED,INTERVENTIONAL,The study was terminated for lack of efficacy after an interim analysis was performed
NCT03831594,WITHDRAWN,INTERVENTIONAL,We were unable to recruit any suitable patients to this study
NCT03831724,WITHDRAWN,INTERVENTIONAL,Company decision to withdraw the study
NCT03831802,TERMINATED,INTERVENTIONAL,because of technical issues
NCT03831945,TERMINATED,INTERVENTIONAL,unable to recruit due to COVID pandemic
NCT03832153,WITHDRAWN,OBSERVATIONAL,LACK OF FUNDING
NCT03832309,TERMINATED,INTERVENTIONAL,Not enough recruitment.
NCT03832478,WITHDRAWN,INTERVENTIONAL,Technical difficulty with sending device home with patients
NCT03832517,TERMINATED,INTERVENTIONAL,safety
NCT03832634,TERMINATED,INTERVENTIONAL,Lack of personnel and funding resources
NCT03832673,WITHDRAWN,INTERVENTIONAL,Regolatory National Agency (AIFA) not approved
NCT03832816,WITHDRAWN,INTERVENTIONAL,cancellation of funding contract
NCT03833063,WITHDRAWN,INTERVENTIONAL,recruitment difficulties due to COVID19
NCT03833258,TERMINATED,INTERVENTIONAL,COVID 19 resulted in cancellation of all elective surgery therefore we need to terminate the trial with 95 participants.
NCT03833323,WITHDRAWN,OBSERVATIONAL,Implantable System for Remodulin not commercially approved.
NCT03833518,TERMINATED,INTERVENTIONAL,"We only enrolled one participant, and this participant was withdrawn prior to collecting any useful data. Then, COVID. Now, Dr. Collinger's faculty tenure with the VA ended."
NCT03833596,TERMINATED,INTERVENTIONAL,Low recruitment
NCT03834012,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT03834051,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03834220,TERMINATED,INTERVENTIONAL,Due to lower antitumor activity than expected
NCT03834298,WITHDRAWN,INTERVENTIONAL,Study grant not obtained; not moving forward with study at this time.
NCT03834571,WITHDRAWN,INTERVENTIONAL,Not approved by CTEP
NCT03834584,TERMINATED,INTERVENTIONAL,Terminated due to sponsor decision.
NCT03834909,WITHDRAWN,INTERVENTIONAL,Study was not funded
NCT03834987,TERMINATED,OBSERVATIONAL,Study concluded by Stanford University
NCT03835039,TERMINATED,OBSERVATIONAL,Interim analysis not showing significant results
NCT03835052,TERMINATED,OBSERVATIONAL,COVID-19
NCT03835104,TERMINATED,INTERVENTIONAL,Covid pandemic caused recruitment to stop
NCT03835286,WITHDRAWN,INTERVENTIONAL,COVID 19
NCT03835338,WITHDRAWN,INTERVENTIONAL,Sponsor discretion
NCT03835481,TERMINATED,INTERVENTIONAL,Due to company decision.
NCT03835611,TERMINATED,INTERVENTIONAL,Lack of Recruitment
NCT03835728,TERMINATED,INTERVENTIONAL,Failed to meet target enrollment and study was discontinued
NCT03835871,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03835988,WITHDRAWN,INTERVENTIONAL,Covid department protocol prevented patient recruitment and affected funding.
NCT03836053,TERMINATED,INTERVENTIONAL,Amgen re-evaluated the portfolio and decided to discontinue clinical development activities for AMG 420.
NCT03836157,WITHDRAWN,INTERVENTIONAL,Study was not initiated.
NCT03836313,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew study
NCT03836482,SUSPENDED,INTERVENTIONAL,Study halted temporarily to obtain protocol amendment approval but potentially will resume.
NCT03836716,TERMINATED,INTERVENTIONAL,"As a consequence of the results of ORARIALS-01 which did not meet any of its efficacy endpoints. The planned duration was 152 weeks. After termination, the actual mean duration of treatment was approx. 28 weeks (range approx. 2 to 71 weeks)."
NCT03836846,WITHDRAWN,INTERVENTIONAL,Study was not initiated because it was not approved by KPSC IRB.
NCT03836872,TERMINATED,INTERVENTIONAL,"China has experienced new waves of COVID-19 since January 2021, and the Chinese government has adopted strict COVID-19 policies to control the occasional outbreaks of COVID-19."
NCT03836885,WITHDRAWN,INTERVENTIONAL,Study was terminated due to delay in enrollment.
NCT03836989,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03837353,TERMINATED,INTERVENTIONAL,Terminated early due to slow accrual in the context of changing practice patterns.
NCT03837418,WITHDRAWN,OBSERVATIONAL,Investigator is no longer at Northwestern University.
NCT03837457,TERMINATED,INTERVENTIONAL,Study no longer needed because eligible subjects may receive treatment with cobomarsen in a crossover arm of the SOLAR clinical trial (NCT03713320)
NCT03837509,TERMINATED,INTERVENTIONAL,This decision follows recruitment difficulties. No safety-related concerns impacted this decision.
NCT03837860,TERMINATED,INTERVENTIONAL,PI leaving institution
NCT03838484,TERMINATED,INTERVENTIONAL,Recruitment challenges due to Covid19.
NCT03838666,TERMINATED,INTERVENTIONAL,Primary endpoint (safety) has been achieved
NCT03838692,WITHDRAWN,INTERVENTIONAL,Closed by sponsor
NCT03838835,TERMINATED,INTERVENTIONAL,COVID-19
NCT03838848,TERMINATED,INTERVENTIONAL,"Cohort A,B,C end enrollments. Cohort D and E were considered to have no significant clinical benefit at the SMC meeting and decided to terminate enrollment."
NCT03839277,SUSPENDED,INTERVENTIONAL,One investigator is out-of-service due to carrying out another task.
NCT03839355,TERMINATED,INTERVENTIONAL,Study terminated due to slower than anticipated enrollment.
NCT03839472,WITHDRAWN,INTERVENTIONAL,Revision to improve cell recovery
NCT03839901,TERMINATED,INTERVENTIONAL,There were insufficient numbers recruited before the end of the student project
NCT03839940,TERMINATED,INTERVENTIONAL,Severe lack of accrual
NCT03840122,WITHDRAWN,INTERVENTIONAL,"The P.I. decided to cancel this study. On 10/08/19, a study closure request was submitted to the IRB."
NCT03840343,TERMINATED,INTERVENTIONAL,Principal Investigator relocation
NCT03840694,TERMINATED,INTERVENTIONAL,PI leaving for another institution.
NCT03840902,TERMINATED,INTERVENTIONAL,"Based on recommendations by an external Independent data Monitoring Committee (IDMC), Sponsor decided to discontinue this clinical study due to a low likelihood of achieving superiority in the efficacy endpoints versus standard of care."
NCT03840980,TERMINATED,OBSERVATIONAL,The BLOOM-PTN study has evolved into the ongoing BLOOM-PCS study (REB20-1442)
NCT03841448,TERMINATED,INTERVENTIONAL,Study was terminated early having identified clinically meaningful magnitude of proteinuria reduction due to cemdisiran(study goal). Participants completed DBT period\&were in OLE period. Sponsor had no concerns with safety \&integrity of participants.
NCT03841565,WITHDRAWN,INTERVENTIONAL,There are no patients enrolled on this study and all efforts are being discontinued.
NCT03841747,WITHDRAWN,INTERVENTIONAL,Funding restrictions
NCT03841760,TERMINATED,INTERVENTIONAL,Low enrollement
NCT03841773,TERMINATED,INTERVENTIONAL,Interim Analysis results
NCT03841877,WITHDRAWN,INTERVENTIONAL,There were not participants to complete sample size
NCT03842345,WITHDRAWN,OBSERVATIONAL,Study was withdrawn due to recruitment difficulties
NCT03843008,WITHDRAWN,INTERVENTIONAL,study never started
NCT03843073,TERMINATED,INTERVENTIONAL,The investigation of this device has been transitioned into a new study by the sponsor. The data generated in this study will not be used to support a marketing application
NCT03843086,WITHDRAWN,INTERVENTIONAL,Change in device and protocol
NCT03843125,TERMINATED,INTERVENTIONAL,Study terminated due to insufficient evidence to support a positive benefit: risk profile. Safety findings were consistent with previously published OLUMIANT data
NCT03843307,TERMINATED,INTERVENTIONAL,"Due to difficulties with enrollment which were complicated by pauses to clinical research from COVID, The University of Texas Southwestern has decided not to pursue the continuation of this study."
NCT03843320,SUSPENDED,OBSERVATIONAL,Reassessing study feasibility
NCT03843411,WITHDRAWN,OBSERVATIONAL,no funding
NCT03843437,WITHDRAWN,INTERVENTIONAL,Study expired in IRB.
NCT03843476,WITHDRAWN,OBSERVATIONAL,Requested by surgeons to pursue new study
NCT03843489,TERMINATED,INTERVENTIONAL,Business decision
NCT03843554,TERMINATED,INTERVENTIONAL,"Study was terminated with 50% enrollment by the sponsor due to under enrollment into specific diverse racial, ethnic, and sex/gender categories.

https://grants.nih.gov/policy/inclusion/women-and-minorities.htm"
NCT03843710,WITHDRAWN,INTERVENTIONAL,Study execution discontinued at this time.
NCT03843814,TERMINATED,INTERVENTIONAL,"Imaging results were not sufficient or of good quality; therefore, we will not move further with the project."
NCT03843853,WITHDRAWN,INTERVENTIONAL,cooperation terminated
NCT03843918,SUSPENDED,INTERVENTIONAL,"Due to clinical development plan change, to suspend this study"
NCT03844152,TERMINATED,INTERVENTIONAL,COVID-19
NCT03844477,TERMINATED,INTERVENTIONAL,We change the study protocal
NCT03844568,WITHDRAWN,INTERVENTIONAL,Hard to recruit due to COVID-19 issue.
NCT03844633,TERMINATED,INTERVENTIONAL,"Because of insufficient enrollment, we closed the RCT and replaced it with an observational design"
NCT03844646,TERMINATED,INTERVENTIONAL,COVID-19
NCT03844932,TERMINATED,INTERVENTIONAL,The Sublimity Board of Directors carefully evaluated the IA data: the 9.6% treatment remission difference for 75mg BID vs placebo (due to an increase in placebo response rate) was determined not sufficient to continue to fund the study
NCT03845257,TERMINATED,OBSERVATIONAL,difficult patient recruitment
NCT03845322,WITHDRAWN,INTERVENTIONAL,12 Screen failures and Changes in PI and loss of residency program.
NCT03845504,TERMINATED,INTERVENTIONAL,Staffing not available
NCT03845894,TERMINATED,INTERVENTIONAL,feasibility
NCT03845907,SUSPENDED,INTERVENTIONAL,Data on initial patients sufficient
NCT03846024,TERMINATED,INTERVENTIONAL,Impact of COVID-19 pandemic on COVID precautions and restrictions of research in the clinical setting; challenges with participant engagement and data collection post-discharge.
NCT03846102,TERMINATED,INTERVENTIONAL,COVID-19 crisis.
NCT03846258,WITHDRAWN,INTERVENTIONAL,Due to the fact that we were unable to find subjects who met all inclusion and exclusion criteria it was determined to withdraw this study.
NCT03846466,TERMINATED,INTERVENTIONAL,The study terminated for safety reasons.
NCT03846570,TERMINATED,INTERVENTIONAL,Insufficient inclusion rate (due to COVID-19 pandemic)
NCT03846583,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant."
NCT03846596,TERMINATED,OBSERVATIONAL,Not enough patient
NCT03846934,TERMINATED,OBSERVATIONAL,enough patients
NCT03847090,TERMINATED,INTERVENTIONAL,Interim Analysis -
NCT03847272,TERMINATED,INTERVENTIONAL,The long inclusion period meant that the question could not be answered within an appropriate timeframe.
NCT03847389,TERMINATED,INTERVENTIONAL,Difficulty in enrollment and COVID-19 pandemic.
NCT03847675,TERMINATED,INTERVENTIONAL,Poor recruitment and lack of funding
NCT03847922,TERMINATED,INTERVENTIONAL,"Due to staffing changes in the hospital, we will be unable to complete this study for the requested 84 subjects. As such, we have decided to close this study."
NCT03848182,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03848260,SUSPENDED,INTERVENTIONAL,"Six patients completed the test using device prototype before Dec 2019, but it was broken and fixed in 2020. The device was miniaturized. We have so far failed to well design the magnetic actuator for experimental needs in the testing (in March 2024)"
NCT03848403,TERMINATED,INTERVENTIONAL,"At the protocol-specified interim analysis, the sponsor decided to stop the trial."
NCT03848585,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT03848832,TERMINATED,INTERVENTIONAL,The study was terminated due to enrollment challenges and the COVID-19 pandemic.
NCT03849001,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT03849079,TERMINATED,INTERVENTIONAL,All prick tests are positive
NCT03849144,WITHDRAWN,INTERVENTIONAL,Sponsor and facility unable to reach agreement before study timeline expired
NCT03849326,WITHDRAWN,INTERVENTIONAL,Due to the health crisis and the lack of staff in the department no inclusion could be realized
NCT03849365,TERMINATED,INTERVENTIONAL,Early end of enrolment with regards to difficulty met to enrol patients
NCT03849456,TERMINATED,INTERVENTIONAL,Study terminated due to enrollment challenges during COVID-19 pandemic.
NCT03849742,WITHDRAWN,INTERVENTIONAL,Low Accrual
NCT03849820,TERMINATED,INTERVENTIONAL,Due to low enrollment the study was terminated
NCT03849859,TERMINATED,INTERVENTIONAL,The study was terminated because of difficulty in completing the study as originally planned and loss of extra-funding.
NCT03849898,TERMINATED,OBSERVATIONAL,Low recruitment
NCT03849950,TERMINATED,INTERVENTIONAL,Recruitment was halted prematurely due to the COVID-19 pandemic.
NCT03850002,WITHDRAWN,OBSERVATIONAL,PI leaving institution
NCT03850028,WITHDRAWN,INTERVENTIONAL,Closed prematurely because the accrual was not achieved
NCT03850041,TERMINATED,OBSERVATIONAL,lapse of renewal
NCT03850054,TERMINATED,OBSERVATIONAL,No further use of the divice at our department
NCT03850171,TERMINATED,INTERVENTIONAL,Due to the lack of financial and human resources the investigators were unable to continue the study. The targeted sample size was not achieved due to recruitment difficulties (mainly related to the Covid-19 pandemic).
NCT03850470,TERMINATED,OBSERVATIONAL,PI left the institution
NCT03850509,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03850522,TERMINATED,INTERVENTIONAL,Insufficient recruitment within planned enrolmentperiod.
NCT03850535,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate the study after Phase 1; will not proceed with Phase 2.
NCT03851081,WITHDRAWN,INTERVENTIONAL,no accrual
NCT03851198,WITHDRAWN,INTERVENTIONAL,No participants
NCT03851250,TERMINATED,INTERVENTIONAL,Sponsor insolvency
NCT03851263,WITHDRAWN,INTERVENTIONAL,Admisnitrative issues
NCT03851276,WITHDRAWN,INTERVENTIONAL,Administrative issues
NCT03851718,WITHDRAWN,INTERVENTIONAL,The PI leaves the study institution.
NCT03851952,WITHDRAWN,INTERVENTIONAL,Company Decision
NCT03852160,WITHDRAWN,INTERVENTIONAL,"New design was developed to better fit company strategy, a new study has replaced 5413541TRD3011 study"
NCT03852329,TERMINATED,INTERVENTIONAL,Insufficient recruitment due to Pandemic
NCT03852368,WITHDRAWN,INTERVENTIONAL,Nonapplicable clinical trial
NCT03852420,WITHDRAWN,INTERVENTIONAL,Sponsor discretion
NCT03852550,TERMINATED,INTERVENTIONAL,"The planned sample size was 264; 43 participants completed follow-up. With significant start-up delays and recruitment curtailed by the COVID-19 pandemic, the limited feasibility to recruit our sample ultimately led to the early stop of the trial."
NCT03852576,TERMINATED,INTERVENTIONAL,Study had to be terminated for lack of dimer and inability to produce more at this time.
NCT03852628,TERMINATED,INTERVENTIONAL,Futility analysis
NCT03852706,TERMINATED,INTERVENTIONAL,A national Covid-19 lockdown prevented completion of the trial
NCT03852771,TERMINATED,INTERVENTIONAL,Company closure
NCT03852836,TERMINATED,INTERVENTIONAL,COVID Pandemy - recruitment issue
NCT03852940,TERMINATED,INTERVENTIONAL,Data Safety and Monitoring Board 's request
NCT03852979,TERMINATED,INTERVENTIONAL,study is merged with CONTESSA study
NCT03852992,WITHDRAWN,INTERVENTIONAL,Study was closed with IRB on 10/22/22
NCT03853291,TERMINATED,INTERVENTIONAL,terminated due to Covid and end of funding period for key personnel
NCT03853317,TERMINATED,INTERVENTIONAL,Not meeting recruitment goal
NCT03853811,TERMINATED,INTERVENTIONAL,Insufficient resources
NCT03853876,TERMINATED,OBSERVATIONAL,Discontinued AGU development program
NCT03854071,SUSPENDED,INTERVENTIONAL,"Key delivery personnel on leave until end of 2023, recruitment to step up on their return."
NCT03854188,WITHDRAWN,INTERVENTIONAL,Principle investigator is leaving institution.
NCT03854227,TERMINATED,INTERVENTIONAL,The study has been terminated based on a strategic evaluation within the current Pfizer oncology portfolio. This decision is not due to any safety concerns or requests from any regulatory authorities.
NCT03854370,SUSPENDED,INTERVENTIONAL,COVID impact on recruitment; challenges with enrollment
NCT03854396,WITHDRAWN,INTERVENTIONAL,due to termination of ISR by PI with agreement by grant sponsor
NCT03854500,TERMINATED,INTERVENTIONAL,Per protocol safety analysis 200 patients showed a significant difference in bleeding rates between the two drug groups.
NCT03854695,WITHDRAWN,OBSERVATIONAL,Withdrawing study from PRS-this is not an actual clinical trial
NCT03854786,TERMINATED,INTERVENTIONAL,Due to Covid - 19 pandemic
NCT03854942,TERMINATED,INTERVENTIONAL,"Recruitment rate could not be met in the study period, review group was dissolved before regular end of study. Recruitment was therefore terminated."
NCT03855488,SUSPENDED,INTERVENTIONAL,No in-person testing is permitted at Ryerson University due to COVID-19.
NCT03855566,TERMINATED,INTERVENTIONAL,The study was disrupted by and results confounded by the COVID-19 pandemic and there it was not possible to meet study goals within the required timeframe.
NCT03855683,SUSPENDED,INTERVENTIONAL,Social distancing regulations related to COVID19.
NCT03855865,WITHDRAWN,INTERVENTIONAL,Business decision to stop the program.
NCT03856099,TERMINATED,INTERVENTIONAL,Subject recruitment issues and follow-up study plans
NCT03856112,WITHDRAWN,INTERVENTIONAL,"Per CTEP, Martha Khrum this study is withdrawn. Changing status to update CT.gov"
NCT03856125,WITHDRAWN,INTERVENTIONAL,Covid19 locked down
NCT03856190,TERMINATED,INTERVENTIONAL,"Covid pandemic, research halt, expiring funding"
NCT03856255,TERMINATED,INTERVENTIONAL,Covid-19 restrictions with screening/surveillance colonoscopies
NCT03856268,WITHDRAWN,OBSERVATIONAL,PI left the institution.
NCT03856398,TERMINATED,OBSERVATIONAL,not sufficient enrolment possible
NCT03857139,WITHDRAWN,INTERVENTIONAL,Grant funding not obtained
NCT03857243,TERMINATED,INTERVENTIONAL,Due to administrative difficulties caused by PI change.
NCT03857308,TERMINATED,INTERVENTIONAL,Unable to continue enrollment for dissertation study due to COVID-19
NCT03857633,WITHDRAWN,OBSERVATIONAL,Suspended
NCT03857659,TERMINATED,INTERVENTIONAL,COVID related termination
NCT03857841,TERMINATED,INTERVENTIONAL,The study was discontinued due to a business decision; no safety concerns were noted.
NCT03857867,TERMINATED,INTERVENTIONAL,Covid 19
NCT03857893,TERMINATED,INTERVENTIONAL,The study was delayed due to the Covid 19 pandemic. The study was stopped prematurely due to a lack of efficiency (reported by the patients)
NCT03858049,TERMINATED,INTERVENTIONAL,"The trend in LPS treatment tends to increase the dosage of progesterone in FET-HRT, this study was designed 5 years ago."
NCT03858166,TERMINATED,INTERVENTIONAL,Sponsor Termination
NCT03858283,TERMINATED,INTERVENTIONAL,"Due to the COVID pandemic, the lockdown in Spain began on 14 March 2020 and after two years we continue with contagion prevention measures that have not made it possible to implement face-to-face mindfulness courses or to evaluate participants."
NCT03858361,TERMINATED,OBSERVATIONAL,Philips decided to wind down the EPD Solution business
NCT03858517,TERMINATED,OBSERVATIONAL,Sponsor Terminated
NCT03858556,WITHDRAWN,OBSERVATIONAL,"Study plan was changed, this project would not be in progress"
NCT03858647,TERMINATED,OBSERVATIONAL,"device under study complication-due to PI departure, study closed and will not reopen"
NCT03858699,TERMINATED,OBSERVATIONAL,low recruitment
NCT03858764,WITHDRAWN,OBSERVATIONAL,no patients enrolled. primary investigator never started study
NCT03858816,WITHDRAWN,INTERVENTIONAL,Difficulties in recruiting participants.
NCT03858933,TERMINATED,INTERVENTIONAL,COVID-19 Regulations
NCT03858972,TERMINATED,INTERVENTIONAL,The Sponsor has discontinued the development of tesetaxel
NCT03859011,WITHDRAWN,INTERVENTIONAL,Feasability of study conduct was impacted by COVID 19 pandemic and were not able to recruit or enroll subjects
NCT03859167,TERMINATED,OBSERVATIONAL,No Enrollments after COVID
NCT03859232,WITHDRAWN,INTERVENTIONAL,Could not enroll participants
NCT03859570,WITHDRAWN,INTERVENTIONAL,Study not selected to receive funding
NCT03859648,TERMINATED,INTERVENTIONAL,Slow enrollment due to COVID-19
NCT03859661,TERMINATED,INTERVENTIONAL,Study was halted due to poor recruitment and date on the biscuits expiring
NCT03859752,SUSPENDED,INTERVENTIONAL,Financial funds were withdrawn by investors and study was stopped
NCT03859869,TERMINATED,INTERVENTIONAL,Business Considerations (difficulty with enrollment)
NCT03859908,TERMINATED,INTERVENTIONAL,Difficulties for recruitment due to COVID-19 pandemia and expiration of the material
NCT03860155,TERMINATED,INTERVENTIONAL,Very slow recruitment of patients and the current COVID-19 pandemic situation.
NCT03860207,TERMINATED,INTERVENTIONAL,study terminated due to business priorities
NCT03860285,SUSPENDED,OBSERVATIONAL,Pending changes in recruitment
NCT03860324,WITHDRAWN,INTERVENTIONAL,Cancelled
NCT03860753,TERMINATED,INTERVENTIONAL,Halted enrollment due to COVID-19
NCT03860844,TERMINATED,INTERVENTIONAL,Study was prematurely stopped due to sponsor decision (stage 2 efficacy criteria not met); not due to safety concerns.
NCT03861065,TERMINATED,INTERVENTIONAL,Slow accrual
NCT03861182,TERMINATED,INTERVENTIONAL,Lack of staff
NCT03861260,WITHDRAWN,INTERVENTIONAL,Withdrawn no participants enrolled
NCT03861403,TERMINATED,INTERVENTIONAL,Product development discontinued unrelated to safety.
NCT03861468,WITHDRAWN,INTERVENTIONAL,difficulty in recruiting
NCT03861598,TERMINATED,INTERVENTIONAL,Due to Covid
NCT03861728,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03861806,TERMINATED,INTERVENTIONAL,lack of funding
NCT03862027,TERMINATED,INTERVENTIONAL,Failure to enroll/recruit
NCT03862040,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03862053,WITHDRAWN,INTERVENTIONAL,not enough time to complete trial;covid
NCT03862066,TERMINATED,OBSERVATIONAL,Low accrual progress per internal scientific review committee
NCT03862079,WITHDRAWN,INTERVENTIONAL,Per PI's request
NCT03862170,SUSPENDED,INTERVENTIONAL,Covid-19 pandemic
NCT03862248,WITHDRAWN,INTERVENTIONAL,Feasibility of the clinical trial could not be confirmed at the different sites.
NCT03862313,TERMINATED,INTERVENTIONAL,"Primarily due to insufficient recruitment (n = 2 instead of n = 30), the study was prematurely discontinued for feasibility reasons. Neither any meaningful results on safety nor on efficacy can be reported."
NCT03862690,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT03862846,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic sufficient data gathered to achieve the study objective
NCT03862872,WITHDRAWN,INTERVENTIONAL,Altered research priorities
NCT03862989,WITHDRAWN,OBSERVATIONAL,Lack of resource at clinical site
NCT03863288,TERMINATED,INTERVENTIONAL,Per DSMB's recommendation
NCT03863301,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03863522,TERMINATED,INTERVENTIONAL,Inadequate FNA samples (low cell counts)
NCT03863587,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to the difficulty in recruiting participants caused by the COVID-19 pandemic.
NCT03863613,TERMINATED,INTERVENTIONAL,"Due to safety concerns as the PTB \<28 weeks and perinatal death rates were significantly higher in the pessary group, following the DSMC's recommendation."
NCT03863639,TERMINATED,OBSERVATIONAL,Challenging enrollment
NCT03864328,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03864367,WITHDRAWN,OBSERVATIONAL,PI decided to end the study
NCT03864419,TERMINATED,INTERVENTIONAL,Closed per SRC Low Accrual Policy
NCT03864627,TERMINATED,INTERVENTIONAL,MOR106 clinical development in atopic dermatitis was stopped for futility
NCT03864835,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03865407,TERMINATED,INTERVENTIONAL,inability to achieve recruitment goals at a single center and given the current pandemic conditions
NCT03865563,WITHDRAWN,INTERVENTIONAL,We need to make significant adjustments to proposed drug and its delivery method
NCT03865615,WITHDRAWN,INTERVENTIONAL,COVID made study visits impossible during the funding period.
NCT03865901,WITHDRAWN,OBSERVATIONAL,Further product development is needed prior to clinical study testing
NCT03866200,TERMINATED,INTERVENTIONAL,Inability to recruit target number
NCT03866317,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting participants
NCT03866421,TERMINATED,OBSERVATIONAL,Due to recruitment as we were challenged in finding patients eligible for the study.
NCT03866538,TERMINATED,INTERVENTIONAL,Study recruitment was difficult and not acheived
NCT03866577,TERMINATED,INTERVENTIONAL,Study was terminated based on Sponsor decision.
NCT03866616,TERMINATED,INTERVENTIONAL,The PI discontinued the evaluation study.
NCT03866668,SUSPENDED,INTERVENTIONAL,Temporarily stopped due to COVID-19 pandemic.
NCT03866707,TERMINATED,OBSERVATIONAL,"PI left institution, study will not resume and considered complete"
NCT03866772,TERMINATED,INTERVENTIONAL,RECRUTIMENT DIFICULTIES
NCT03866850,TERMINATED,OBSERVATIONAL,PI passed away. Ending grant and closing lab.
NCT03866954,WITHDRAWN,INTERVENTIONAL,Change of circumstances with Commercial partner
NCT03866980,TERMINATED,INTERVENTIONAL,corporate strategy adjustment
NCT03867006,TERMINATED,INTERVENTIONAL,"Stop funding by Regional Council of Auvergne-Rhne-Alpes, France"
NCT03867032,WITHDRAWN,INTERVENTIONAL,PI passed away. Ending grant and closing down lab
NCT03867045,TERMINATED,INTERVENTIONAL,"Study deemed non-essential under COVID pandemic,"
NCT03867058,TERMINATED,OBSERVATIONAL,PI passed away. Ending grant and closing lab.
NCT03867162,WITHDRAWN,INTERVENTIONAL,"Sponsor terminated this protocol on Dec17, 2021; no subjects have been enrolled"
NCT03867188,TERMINATED,INTERVENTIONAL,"Enrollment of eligible subjects, delays due to the COVID-19 Virus, and lack of funding"
NCT03867240,WITHDRAWN,INTERVENTIONAL,Study initially suspended recruitment due to COVID-19. Study withdrawn due to PI leaving institution in early 2021.
NCT03867370,TERMINATED,INTERVENTIONAL,"Enrollment is over, the study was completed"
NCT03867435,TERMINATED,OBSERVATIONAL,PI left the NIH
NCT03867500,SUSPENDED,INTERVENTIONAL,Study halted prematurely but potentially will resume.
NCT03867708,WITHDRAWN,OBSERVATIONAL,No participants found
NCT03867825,WITHDRAWN,OBSERVATIONAL,Never got medical equipment that worked properly
NCT03868423,WITHDRAWN,INTERVENTIONAL,PI decision
NCT03868540,TERMINATED,INTERVENTIONAL,Preclinical finding
NCT03868566,TERMINATED,INTERVENTIONAL,recruitment difficulties due to Covid-19
NCT03868774,WITHDRAWN,INTERVENTIONAL,Lack of ressources
NCT03868839,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03868891,TERMINATED,INTERVENTIONAL,End of funding
NCT03868943,SUSPENDED,INTERVENTIONAL,Axsome has conducted a review of the ongoing IST program and are unable to continue supporting this study
NCT03869008,TERMINATED,INTERVENTIONAL,Funding no longer available
NCT03869086,TERMINATED,INTERVENTIONAL,COVID-19 related inability to complete study
NCT03869138,SUSPENDED,INTERVENTIONAL,Suspended \[COVID-19 outbreak and to promote social distancing\]
NCT03869463,TERMINATED,INTERVENTIONAL,Challenges to recruitment
NCT03869489,WITHDRAWN,INTERVENTIONAL,Funding Goals changed
NCT03869645,TERMINATED,OBSERVATIONAL,Change in Sponsor
NCT03869671,WITHDRAWN,INTERVENTIONAL,The study design was changed and this clinical trial will not be conducted.
NCT03869684,TERMINATED,INTERVENTIONAL,The study terminated for safety reasons
NCT03869710,SUSPENDED,INTERVENTIONAL,Because of COVID pandemic
NCT03869749,TERMINATED,INTERVENTIONAL,Study was stopped early due to lack of enrollment.
NCT03869762,TERMINATED,INTERVENTIONAL,Insufficient accrual
NCT03870152,TERMINATED,INTERVENTIONAL,This decision was made due to lower than expected recruitment levels into the trial
NCT03870217,TERMINATED,OBSERVATIONAL,PI passed away. Ending grant and closing lab.
NCT03870334,TERMINATED,INTERVENTIONAL,Decision of Landos Biopharma (not related to safety or efficacy)
NCT03870477,TERMINATED,INTERVENTIONAL,Business decision to remove product from portfolio.
NCT03870529,TERMINATED,INTERVENTIONAL,Slow accruals
NCT03870763,TERMINATED,INTERVENTIONAL,Decision to stop the trial was based on long-term difficulties in fulfilling our enrolment commitments and changes in paediatric MS landscape which no longer support placebo-controlled trials.Decision to stop study was not based on safety concerns.
NCT03870841,TERMINATED,INTERVENTIONAL,The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.
NCT03870984,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT03871153,TERMINATED,INTERVENTIONAL,Investigator decided to halt study due to low accrual.
NCT03871179,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03871231,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03871309,TERMINATED,OBSERVATIONAL,PI and sponsor decision
NCT03871348,TERMINATED,INTERVENTIONAL,Sponsor terminated the study for non-safety reasons
NCT03871400,SUSPENDED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer receiving intervention due to coronavirus pandemic and unexpected enrollment delays.
NCT03871569,TERMINATED,INTERVENTIONAL,Difficulty recruiting and follow-up due to the epidemic context of COVID19
NCT03871751,TERMINATED,INTERVENTIONAL,Insufficient resources to complete study as planned
NCT03871829,TERMINATED,INTERVENTIONAL,The decision was made to discontinue the 54767414MMY2065 study as the Data Review Committee recommendation was early stop of the study for futility.
NCT03871855,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT03872089,TERMINATED,INTERVENTIONAL,Inclusion of the last patient
NCT03872115,WITHDRAWN,INTERVENTIONAL,"Device feasibility study, not clinical trial"
NCT03872336,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03872440,WITHDRAWN,OBSERVATIONAL,Did not meet the expected enrollment rate.
NCT03872492,TERMINATED,INTERVENTIONAL,The study was stopped prematurely because the total number of analyzable patients for the primary objective to be included was reached.
NCT03872505,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT03873025,WITHDRAWN,INTERVENTIONAL,There are insufficent funds to open the trial and start recruiting patients due to the impact of the COVID-19 pandemic.
NCT03873168,TERMINATED,OBSERVATIONAL,Indication withdrawn
NCT03873207,WITHDRAWN,INTERVENTIONAL,"This study (NCT03873207) was closed with the University of Pittsburgh's HRPO office (STUDY19080348) in January 2021, prior to enrolling any subjects."
NCT03873571,WITHDRAWN,OBSERVATIONAL,Modification of clinical development plan
NCT03873584,WITHDRAWN,OBSERVATIONAL,no patients enrolment
NCT03873662,TERMINATED,OBSERVATIONAL,Low inclusion rate
NCT03873792,WITHDRAWN,INTERVENTIONAL,Difficulties in recruiting participants.
NCT03874065,TERMINATED,OBSERVATIONAL,PI left institution
NCT03874169,TERMINATED,OBSERVATIONAL,Due to the COVID-19 Pandemic
NCT03874234,TERMINATED,INTERVENTIONAL,The trial was terminated early following strategic review after emergence of nonclinical data with a non-GlaxoSmithKline asset.
NCT03874325,TERMINATED,INTERVENTIONAL,lost funding
NCT03874767,WITHDRAWN,INTERVENTIONAL,Bandwidth and logistics issues exacerbated by COVID-19 pandemic
NCT03874806,WITHDRAWN,INTERVENTIONAL,Did not receive funding
NCT03874845,WITHDRAWN,INTERVENTIONAL,"Study had IRB approval from VA and began in late Feb 2020, did not enroll any participants before paused during the COVID. Final permissions from VA to restart recruitment was never received and therefore was withdrawn."
NCT03875053,WITHDRAWN,INTERVENTIONAL,No accrual
NCT03875313,TERMINATED,INTERVENTIONAL,Slow Enrollment
NCT03875365,TERMINATED,OBSERVATIONAL,PI left the institution before enrollment was complete.
NCT03875495,TERMINATED,INTERVENTIONAL,Failure to recruit patients
NCT03875560,WITHDRAWN,INTERVENTIONAL,seeking funding
NCT03875794,TERMINATED,INTERVENTIONAL,There is no one to transfer to study to and no one interested in this research study. I am taking 8 months off from being a physician so the study needs to be closed
NCT03875833,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT03875859,TERMINATED,INTERVENTIONAL,The available study medication reached expiry (logistics).
NCT03875911,TERMINATED,INTERVENTIONAL,"Problems unique to COVID-19, incomplete data due to a high rate of dropout to minimize non-essential appointments and difficult subject recruitment"
NCT03875963,TERMINATED,INTERVENTIONAL,Sponsor decided not to pursue the study.
NCT03876028,TERMINATED,INTERVENTIONAL,Business reasons
NCT03876093,WITHDRAWN,OBSERVATIONAL,The PI decided.
NCT03876132,TERMINATED,OBSERVATIONAL,The number of patients is suffisant to answer to the primary outcome
NCT03876158,WITHDRAWN,INTERVENTIONAL,The study will not be conducted by Dr Lubenow
NCT03876548,WITHDRAWN,INTERVENTIONAL,Recruitment Challenges
NCT03876808,TERMINATED,INTERVENTIONAL,Poor participant recruitment
NCT03876925,TERMINATED,INTERVENTIONAL,The effect of CT053PTSA in preciously treated patients with advanced and metastatic RCC is not as good as pre-expected
NCT03876977,TERMINATED,INTERVENTIONAL,recruitments difficulties
NCT03877094,TERMINATED,INTERVENTIONAL,"Due to restrictions imposed by the COVID-19 pandemic and difficulty of partcipants' adhesion, we chose to stop the data collection and suspend the project."
NCT03877198,TERMINATED,INTERVENTIONAL,"As a result of a slower inclusion rate than expected, competence of medical staff to work with the AVEA ventilator could no longer be guaranteed."
NCT03877250,WITHDRAWN,OBSERVATIONAL,"The primary objectives have not been met due to no patient enrollment therefore, the PI is requesting to close the study at this time."
NCT03877263,TERMINATED,INTERVENTIONAL,Principal investigator left the institution and study was not transferred to anyone else.
NCT03877536,WITHDRAWN,INTERVENTIONAL,Feeder cohort study closed.
NCT03877549,WITHDRAWN,INTERVENTIONAL,PI left Henry Ford Health before completion.
NCT03877692,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT03877822,WITHDRAWN,INTERVENTIONAL,Study protocol no longer relevant after progression of the scientific field
NCT03878095,SUSPENDED,INTERVENTIONAL,Other - Pending Data Analysis
NCT03878199,SUSPENDED,INTERVENTIONAL,Internal reporting
NCT03878524,TERMINATED,INTERVENTIONAL,Low accrual
NCT03878563,TERMINATED,OBSERVATIONAL,Sponsor-PI left Switzerland
NCT03878654,TERMINATED,INTERVENTIONAL,IRB protocol violations
NCT03878719,TERMINATED,INTERVENTIONAL,The trial was terminated early on 05 October 2022 due to non-feasibility and poor recruitment and not based on safety concerns.
NCT03878914,TERMINATED,INTERVENTIONAL,The study was terminated at all but one site because of the pandemic
NCT03878927,TERMINATED,INTERVENTIONAL,Dose limiting toxicities.
NCT03878953,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03879044,TERMINATED,INTERVENTIONAL,Funding stopped
NCT03879200,TERMINATED,INTERVENTIONAL,Limited time frame and financial resources. The anticipated increase of eligable migrant women did not occur during the period because of changes in migration policies.
NCT03879278,TERMINATED,INTERVENTIONAL,Mild infusion reactions were observed in two healthy volunteers.
NCT03879291,TERMINATED,OBSERVATIONAL,Lack of enrollment
NCT03879655,TERMINATED,INTERVENTIONAL,Terminated by previous Sponsor decision
NCT03879707,WITHDRAWN,INTERVENTIONAL,Investigator elected not to proceed with project
NCT03879811,WITHDRAWN,INTERVENTIONAL,No accrual
NCT03879824,TERMINATED,INTERVENTIONAL,The PI and co-investigators would like to terminate the study given challenges with patient enrollment.
NCT03880071,WITHDRAWN,INTERVENTIONAL,Abandoned study
NCT03880123,WITHDRAWN,INTERVENTIONAL,"Study will not proceed, no participants enrolled."
NCT03880279,WITHDRAWN,INTERVENTIONAL,"Following a change in company governance, Triumvira terminated the study prior to enrolling any subjects due to a challenging competitive landscape."
NCT03880474,TERMINATED,INTERVENTIONAL,The trial is being stopped for futility. Season 2 cancelled.
NCT03880487,TERMINATED,INTERVENTIONAL,The Study was terminated early by sponsor
NCT03880565,TERMINATED,INTERVENTIONAL,For early efficacy
NCT03880955,TERMINATED,OBSERVATIONAL,Sponsor decision to stop at 2 year follow-up
NCT03881007,TERMINATED,INTERVENTIONAL,"An interim analysis, planned because of the influence of the COVID-lockdown, showed the LCM mouthwash did not affect the incidence of Ng, Ct and syphilis."
NCT03881111,WITHDRAWN,INTERVENTIONAL,Withdrawn due to protocol amendment
NCT03881241,TERMINATED,OBSERVATIONAL,Difficulty with enrollment
NCT03881553,TERMINATED,INTERVENTIONAL,Covid halt in March; PI moved to another Institution
NCT03881735,WITHDRAWN,INTERVENTIONAL,no accrual
NCT03881748,WITHDRAWN,INTERVENTIONAL,Insufficient staff
NCT03881995,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT03882372,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT03882476,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT03882645,TERMINATED,INTERVENTIONAL,Difficulty in recruitment of the study participants
NCT03882918,TERMINATED,INTERVENTIONAL,Company decision
NCT03883321,TERMINATED,OBSERVATIONAL,few patient feedback and principal investigator disponibility
NCT03883360,WITHDRAWN,INTERVENTIONAL,not funded
NCT03883386,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT03883607,TERMINATED,INTERVENTIONAL,"Due to lack of efficacy (but not due to safety) in a Phase 3 trial of elafibranor in adult participants with NASH and fibrosis, this study in pediatric NASH was prematurely terminated"
NCT03883880,TERMINATED,INTERVENTIONAL,COVID (completed first intervention type only)
NCT03883893,WITHDRAWN,INTERVENTIONAL,Mentor for PI left institution. Study was not renewed.
NCT03883945,WITHDRAWN,INTERVENTIONAL,Sponsor deprioritization
NCT03884296,WITHDRAWN,INTERVENTIONAL,Not feasible to enroll participants
NCT03884400,WITHDRAWN,OBSERVATIONAL,We have changed our research focus
NCT03884465,TERMINATED,INTERVENTIONAL,COVID
NCT03884517,TERMINATED,INTERVENTIONAL,"Considering that the safety risk will affect the subsequent development, it is decided to terminate the test voluntarily"
NCT03884790,TERMINATED,INTERVENTIONAL,The enrolment phase was halted prematurely due to logistic issues ( SARS-CoV2 pandemic). All patients enrolled completed the follow-up visits according to the study protocol.
NCT03884959,WITHDRAWN,INTERVENTIONAL,Sponsor decided to stop enrollment
NCT03884972,WITHDRAWN,INTERVENTIONAL,Request by sponsor due to no enrollment of participants on study
NCT03885154,TERMINATED,INTERVENTIONAL,Difficulty recruiting participants
NCT03885492,TERMINATED,OBSERVATIONAL,"This was part of a University of Liverpool PhD programme, but PI suspended by University and left the programme. Also dismissed by sponsoring organisation SAfRI. Likely unreliable data so project abandoned with no plans to publish."
NCT03885908,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03886012,SUSPENDED,INTERVENTIONAL,COVID-19 general concerns.
NCT03886129,TERMINATED,OBSERVATIONAL,COVID19 affected recruitment
NCT03886337,WITHDRAWN,INTERVENTIONAL,The study never started due to administrative reasons.
NCT03886493,TERMINATED,INTERVENTIONAL,Low accrual due to COVID-19 pandemic.
NCT03886532,WITHDRAWN,OBSERVATIONAL,Lack of funding/support
NCT03886649,TERMINATED,INTERVENTIONAL,Insufficient Funding
NCT03886740,WITHDRAWN,INTERVENTIONAL,Difficulty enrolling
NCT03886753,TERMINATED,OBSERVATIONAL,Feasibility
NCT03887390,TERMINATED,INTERVENTIONAL,"First the study failed to recruit the required sample size. Second, we no longer have acess to the clinics, due to the coronavirus outbreak"
NCT03887442,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT03887533,TERMINATED,INTERVENTIONAL,Enrollment was poor due to COVID-19 pandemic
NCT03887624,TERMINATED,INTERVENTIONAL,Participates could not stand the side effects
NCT03887702,TERMINATED,INTERVENTIONAL,inability to accrue
NCT03887793,WITHDRAWN,INTERVENTIONAL,Inadequate recruitment of study clinics
NCT03888287,TERMINATED,INTERVENTIONAL,Study was put on hold due to COVID and never reopened
NCT03888534,WITHDRAWN,INTERVENTIONAL,Business decision (no safety or efficacy concerns)
NCT03888807,TERMINATED,INTERVENTIONAL,Decided not go move forward with this population as recruitment was difficult
NCT03889106,TERMINATED,OBSERVATIONAL,insufficient amount of participants
NCT03889158,TERMINATED,INTERVENTIONAL,COVID-19
NCT03889379,WITHDRAWN,INTERVENTIONAL,Team decided not to initiate study.
NCT03889496,TERMINATED,INTERVENTIONAL,"Because of the COVID-19 pandemic, funding for the trial was terminated and attempts to find alternative sources of funding were to no avail."
NCT03889600,WITHDRAWN,INTERVENTIONAL,This study was never conducted due to Covid. Key informant interviews were conducted instead.
NCT03889704,TERMINATED,INTERVENTIONAL,Pandemic
NCT03889756,TERMINATED,INTERVENTIONAL,No more funding available to continue since we could not recruit throughout the pandemic.
NCT03890120,TERMINATED,INTERVENTIONAL,"Following recommendation of the external Data Monitoring Committee, after it reviewed the results of a planned interim futility analysis."
NCT03890146,TERMINATED,OBSERVATIONAL,we submitted an amendment. The study was stopped because this amendment raised the complexity of the study.
NCT03890198,TERMINATED,INTERVENTIONAL,"the Preliminary data, progress of this study and the adjustment of the pipeline and strategy ."
NCT03890289,TERMINATED,INTERVENTIONAL,"Study was halted prematurely due to safety, since tocity stopping rules have been met"
NCT03890341,WITHDRAWN,INTERVENTIONAL,Stopped due to a strategic decision.
NCT03890380,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT03890484,TERMINATED,INTERVENTIONAL,Insufficient recruitment due to COVID pandemic; termination of funding
NCT03891173,TERMINATED,INTERVENTIONAL,Study was halted at this time due to other budgetary priorities. Completion of reporting has been delayed first due to covid restrictions and more recently due to war in Ukraine.
NCT03891264,TERMINATED,INTERVENTIONAL,Funding obtained to do a larger placebo-controlled trial
NCT03891381,TERMINATED,INTERVENTIONAL,PI left institution
NCT03891420,TERMINATED,INTERVENTIONAL,Sponsor decision to no longer pursue indications studied in this trial
NCT03891602,WITHDRAWN,OBSERVATIONAL,Closed to Enrollment Data Analysis Only. Recruitment was conducted at Kaiser Permanente and there were no MSK patients recruited
NCT03891641,TERMINATED,INTERVENTIONAL,COVID-19 continues to prevent recruitment of people over the age of 65 years.
NCT03891849,WITHDRAWN,INTERVENTIONAL,No participant enrolled. Equipment unvailable.
NCT03891979,WITHDRAWN,INTERVENTIONAL,Suspended due to Primary Investigator's decision
NCT03892018,TERMINATED,INTERVENTIONAL,STUDY HALTED DUE TO FINANCIAL CONTRAINTS
NCT03892161,TERMINATED,INTERVENTIONAL,Risks to participation
NCT03892382,WITHDRAWN,INTERVENTIONAL,Participants were not able to stay near our center for two weeks
NCT03892525,TERMINATED,INTERVENTIONAL,End of drug development
NCT03892811,WITHDRAWN,OBSERVATIONAL,IRB protocol was not approved by Boston Children's Hospital
NCT03892863,WITHDRAWN,INTERVENTIONAL,Participants were not able to stay for two weeks near our center.
NCT03892889,TERMINATED,INTERVENTIONAL,Study has stopped for having met the primary endpoint.
NCT03893110,WITHDRAWN,INTERVENTIONAL,Absence of Co-investigator
NCT03893292,WITHDRAWN,OBSERVATIONAL,Lack of participants
NCT03893331,TERMINATED,OBSERVATIONAL,Sponsor no longer performing clinical studies. Will be only a manufacturing facility
NCT03893565,TERMINATED,INTERVENTIONAL,The trial was stopped based on the assessment of clinical data.
NCT03893617,TERMINATED,INTERVENTIONAL,"Due to challenges associated with the Covid-19 pandemic, we were unable to complete recruitment as planned during the period we had funding to do so."
NCT03894007,TERMINATED,INTERVENTIONAL,Security and effect data from another ongoing study.
NCT03894098,WITHDRAWN,INTERVENTIONAL,Low interest.
NCT03894306,WITHDRAWN,OBSERVATIONAL,Unable to enroll any patients due to COVID
NCT03894319,WITHDRAWN,OBSERVATIONAL,Insufficient staff for measurement assessments
NCT03894345,SUSPENDED,INTERVENTIONAL,COVID-19
NCT03894540,TERMINATED,INTERVENTIONAL,"Following an internal portfolio review, Ipsen has made the decision to terminate study D-US-60090-001. Ipsen would like to highlight that early termination was not due to any safety or tolerability issues with IPN60090"
NCT03895086,TERMINATED,INTERVENTIONAL,impossible enrollement
NCT03895125,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume
NCT03895463,WITHDRAWN,OBSERVATIONAL,Reassessment of study feasibility
NCT03895853,TERMINATED,INTERVENTIONAL,At the request of the PI
NCT03896230,TERMINATED,INTERVENTIONAL,Due to resource limitations the study was on hold and was then terminated.
NCT03896295,TERMINATED,INTERVENTIONAL,Study was originally halted due to the COVID-19 pandemic. The study was later terminated prematurely as the participants will have the option to enter into an open-label extension portion of a planned future study. It was not due to safety concerns.
NCT03896347,WITHDRAWN,OBSERVATIONAL,Lack of enrollment
NCT03896451,WITHDRAWN,INTERVENTIONAL,Medacta GMK PS is not in use anymore
NCT03896607,TERMINATED,OBSERVATIONAL,study has ended due to internal changes
NCT03896945,TERMINATED,INTERVENTIONAL,"Based on the Interim Analysis outcome and recommendation by the DMC, Otsuka approved termination of the study based on futility."
NCT03897062,TERMINATED,INTERVENTIONAL,Recruitment problems during covid lockdowns resulted in Merck ceasing supply of suvorexant/placebo
NCT03897530,TERMINATED,INTERVENTIONAL,slow accrual
NCT03897647,WITHDRAWN,INTERVENTIONAL,Administratively closed by the IRB
NCT03897725,WITHDRAWN,INTERVENTIONAL,Contract terminated
NCT03897790,WITHDRAWN,OBSERVATIONAL,CPP requalification
NCT03898375,TERMINATED,INTERVENTIONAL,Technical problems
NCT03898388,TERMINATED,INTERVENTIONAL,sponsor discontinued study-impacted by COVID
NCT03898648,TERMINATED,INTERVENTIONAL,the follow up of the last patient has been done
NCT03898661,TERMINATED,INTERVENTIONAL,unexpected serious adverse event
NCT03898817,TERMINATED,OBSERVATIONAL,Inclusion of the last patient
NCT03898843,TERMINATED,INTERVENTIONAL,Patient enrollment and logistical problems
NCT03898973,WITHDRAWN,INTERVENTIONAL,Were not able to enroll participants
NCT03899506,TERMINATED,OBSERVATIONAL,Investigator Voluntary Pause
NCT03899701,WITHDRAWN,INTERVENTIONAL,The study was never initiated and the PI has left the institution
NCT03899753,TERMINATED,INTERVENTIONAL,Study closed by the Einstein IRB
NCT03899987,SUSPENDED,INTERVENTIONAL,IFNa2b Supply Shortage
NCT03900182,TERMINATED,INTERVENTIONAL,"Due to COVID-19 pandemic, patients can not receive hyperbaric oxygen therapy."
NCT03900585,WITHDRAWN,INTERVENTIONAL,"Due to restricted and new rules for data protection, the use of an app could not be approved"
NCT03901079,TERMINATED,OBSERVATIONAL,HGRAC approval letter had expired. The enrollment speed of FAST CTO is much slower than planning and the scientific value becomes limited due to the delayed data readout anticipation.
NCT03901378,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT03901547,WITHDRAWN,INTERVENTIONAL,Combination of no funding and time commitments on PI
NCT03901573,TERMINATED,INTERVENTIONAL,Strategic decision by sponsor
NCT03901612,WITHDRAWN,INTERVENTIONAL,covid and surgeon left
NCT03901638,TERMINATED,INTERVENTIONAL,Project replanning
NCT03901976,TERMINATED,INTERVENTIONAL,Not enough resources in place; COVID-19 pandemic impedes working on the project and travelling within the EU
NCT03902093,WITHDRAWN,INTERVENTIONAL,"Study is withdrawn due to no enrollment, due to COVID pandemic."
NCT03902275,TERMINATED,INTERVENTIONAL,SARS-CoV-2 Pandemic
NCT03902379,WITHDRAWN,INTERVENTIONAL,"The study was never initiated, no patients were enrolled. It has been closed with the IRB."
NCT03902509,TERMINATED,INTERVENTIONAL,The protocol revision is needed.
NCT03902652,WITHDRAWN,INTERVENTIONAL,Study never commenced at trial site.
NCT03902938,WITHDRAWN,INTERVENTIONAL,The trial was stopped as the benefit was challenging to determine in the preliminary usage.
NCT03902977,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT03903380,TERMINATED,INTERVENTIONAL,problems recruiting the sample; derived from pandemic situation COVID-19
NCT03903640,TERMINATED,INTERVENTIONAL,The study was terminated early on 03/09/2022 due to low accrual during the COVID-19 pandemic.
NCT03903653,WITHDRAWN,INTERVENTIONAL,unable to enroll patients due to closure of our inpatient units secondary to COVID-19.
NCT03903718,WITHDRAWN,INTERVENTIONAL,Terminated due to delay in site enrollment timelines
NCT03904069,WITHDRAWN,INTERVENTIONAL,"Following a recent cellular therapy strategy assessment, Amgen has decided to cancel study 20180091."
NCT03904108,TERMINATED,INTERVENTIONAL,insufficient patient population to complete trial as planned
NCT03904251,TERMINATED,INTERVENTIONAL,slow accrual
NCT03904316,WITHDRAWN,INTERVENTIONAL,The trial was stopped as the benefit was challenging to determine in preliminary usage.
NCT03904342,WITHDRAWN,INTERVENTIONAL,This study was not conducted due to concerns about collaboration with an outside vendor for the control condition.
NCT03904420,TERMINATED,INTERVENTIONAL,"FDA determination of Fox software as class III medical device, not CDSS."
NCT03904602,TERMINATED,INTERVENTIONAL,Patients experienced translocation of edema from lower extremities to trunk heightening concern about triggering congestive heart failure in frail elders.
NCT03904706,TERMINATED,INTERVENTIONAL,We were unable to continue field activities due to COVID-19
NCT03904784,TERMINATED,OBSERVATIONAL,"During the pandemic covid-19 the school is not in the classroom

The study cannot continue"
NCT03904849,WITHDRAWN,INTERVENTIONAL,This study was intended to produce pilot data for a center grant component that will no longer be conducted.
NCT03904862,SUSPENDED,INTERVENTIONAL,Drug Supply Issues
NCT03905083,WITHDRAWN,INTERVENTIONAL,Logistics related to research activity
NCT03905343,TERMINATED,INTERVENTIONAL,Feasibility (low patient accrual and financial reasons)
NCT03905434,SUSPENDED,OBSERVATIONAL,PI moved from OSU to VCU. Study is suspended pending credentialing and IRB approval at VCU.
NCT03905447,TERMINATED,INTERVENTIONAL,The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.
NCT03905538,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT03905564,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT03905616,WITHDRAWN,INTERVENTIONAL,abandonment
NCT03905772,SUSPENDED,INTERVENTIONAL,Dr. Karenina has to change for another projetct due to Covid pandemic.
NCT03905902,WITHDRAWN,INTERVENTIONAL,Company decision
NCT03906227,SUSPENDED,INTERVENTIONAL,study recruitment suspended due to lack of funding . Current enrolled subject continues study per protocol until Feb 2025.
NCT03906448,TERMINATED,INTERVENTIONAL,The study was terminated because the Study Chair/IDE Sponsor and Novocure determined that conducting this trial was not feasible without CMS approval.
NCT03906500,TERMINATED,INTERVENTIONAL,"Due to the corona-crisis, we asses that it is not possible to carry out the effect-measurement as planned. The lockdown has strongly affected the young people's social life and alcohol use that could hide possible effects of the intervention."
NCT03906526,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT03906565,SUSPENDED,INTERVENTIONAL,"The efficacy evaluation (based on current data) deviated too much from results of previous clinical trials. It's assumed that high dropout rate of subjects, mainly due to covid-19 epidemic in China in the past 3 years, is the main reason."
NCT03906604,TERMINATED,INTERVENTIONAL,Difficulty recruiting for open carpal tunnel study arm
NCT03906643,WITHDRAWN,INTERVENTIONAL,Funding exhausted
NCT03906812,WITHDRAWN,INTERVENTIONAL,Lack of feasibility.
NCT03906838,WITHDRAWN,INTERVENTIONAL,funding not obtained
NCT03906916,TERMINATED,INTERVENTIONAL,The study was interrupted prematurely because of the low rate of recruitment.
NCT03906994,WITHDRAWN,INTERVENTIONAL,Original study PI left institution and the new PI elected not to proceed with the study.
NCT03907033,TERMINATED,INTERVENTIONAL,Insufficient funding to continue with study activities
NCT03907072,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT03907124,WITHDRAWN,INTERVENTIONAL,PI left institution prior to recruitment.
NCT03907202,TERMINATED,INTERVENTIONAL,The trial was planned to be conducted in 4 cohorts but was terminated after completion of Cohort 2 for strategic reasons due to limited PD effects.
NCT03907319,TERMINATED,OBSERVATIONAL,Enrollment not sufficient for data analysis.
NCT03907449,SUSPENDED,OBSERVATIONAL,Recruitment rates reduced during non-Strep season
NCT03907501,TERMINATED,INTERVENTIONAL,"COVID-19 related personnel, reagent and budget related impacts"
NCT03907709,SUSPENDED,OBSERVATIONAL,Resource allocation
NCT03907813,WITHDRAWN,INTERVENTIONAL,change in design
NCT03908073,TERMINATED,INTERVENTIONAL,COVID-19
NCT03908151,TERMINATED,OBSERVATIONAL,Business Decision
NCT03908203,WITHDRAWN,INTERVENTIONAL,The Study will be conducted in another research center. The Sponsor has changed.
NCT03908255,WITHDRAWN,INTERVENTIONAL,Dr. Marshall left UMC and LSU Health Sciences Center.
NCT03908333,WITHDRAWN,INTERVENTIONAL,Request to close per funding sponsor. Site not moving forward with trial.
NCT03908827,WITHDRAWN,INTERVENTIONAL,Change of study design
NCT03908905,SUSPENDED,OBSERVATIONAL,Lack of resources
NCT03908944,WITHDRAWN,INTERVENTIONAL,PI- Dr. Jellish passed away. The study was terminated with the IRB
NCT03909295,TERMINATED,INTERVENTIONAL,This study was terminated early because the primary endpoint of PARAGON-HF was not met.
NCT03909373,WITHDRAWN,OBSERVATIONAL,Logistics (Research Staffing)
NCT03909490,TERMINATED,INTERVENTIONAL,Logistics (research personnel)
NCT03909503,WITHDRAWN,INTERVENTIONAL,Business decision
NCT03909516,WITHDRAWN,INTERVENTIONAL,Myoscience recently acquired - decided to redesign study.
NCT03909594,WITHDRAWN,INTERVENTIONAL,The COVID Pandemic delayed start of study and currently the investigators are not interested in conducting the study.
NCT03909685,WITHDRAWN,INTERVENTIONAL,Application withdrawn from the IRB.
NCT03909750,SUSPENDED,INTERVENTIONAL,Withdrawn \[COVID restrictions prevent patient enrollment or treatment. Clinical Trial facility is being closed due to viral limitations and loss of staff to perform\]
NCT03909867,SUSPENDED,OBSERVATIONAL,The emergence of SARS-CoV-2 required a temporary hold of recruitment - emailed 8.28.23
NCT03909893,WITHDRAWN,INTERVENTIONAL,This study is being closed. The protocol may be reviewed and consolidated under a new study currently in development.
NCT03910322,TERMINATED,INTERVENTIONAL,Decision made by Sponsor
NCT03910413,TERMINATED,INTERVENTIONAL,Funding ended and enrollment challenged by COVID and other factors.
NCT03910439,TERMINATED,INTERVENTIONAL,Slow/Insufficient accrual/COVID-19 pandemic
NCT03910790,WITHDRAWN,INTERVENTIONAL,A competing study made it challenging to enroll subjects.
NCT03910907,TERMINATED,OBSERVATIONAL,Covid
NCT03911063,WITHDRAWN,INTERVENTIONAL,Personnel unavailable to run the study
NCT03911336,WITHDRAWN,INTERVENTIONAL,Decided not to proceed
NCT03911518,WITHDRAWN,INTERVENTIONAL,Pilot study not necessary as new data has become available.
NCT03911869,TERMINATED,INTERVENTIONAL,"Study terminated due to lack of enrollment of the target population. There were no safety, efficacy, or regulatory interaction involved in the decision to stop enrollment."
NCT03912116,WITHDRAWN,INTERVENTIONAL,Personnel Changes
NCT03912337,TERMINATED,INTERVENTIONAL,Terminated \[Study would not complete enrollment target until 2026 with results available in 2027. The information will not be useful at that time.\]
NCT03912350,WITHDRAWN,INTERVENTIONAL,"The study is on hold due to stopping of the Autism Spectrum Disorder program with balovatpan, the study drug."
NCT03912649,TERMINATED,INTERVENTIONAL,"Although the defined success rate needed for continuation of the investigation was met, due to the overall low success rate; it was considered, particularly considering the ongoing pandemic, to discontinue the investigation prematurely."
NCT03912662,TERMINATED,INTERVENTIONAL,"Due to the high number of AE, it has been determined that it is no longer feasible to clinically interpret the evidence from this study due to the complex factors presented in this patient population, and thus an early termination is justified."
NCT03912792,WITHDRAWN,OBSERVATIONAL,Company decision
NCT03912818,TERMINATED,INTERVENTIONAL,Difficulty with enrollment
NCT03912831,TERMINATED,INTERVENTIONAL,Development program terminated
NCT03913130,TERMINATED,INTERVENTIONAL,Terminated \[Study prematurely terminated due to sponsor decision for reasons unrelated to safety\]
NCT03913533,WITHDRAWN,INTERVENTIONAL,No funding obtained
NCT03913676,TERMINATED,INTERVENTIONAL,The study was not feasible.
NCT03913702,TERMINATED,INTERVENTIONAL,Inadequate patient enrollment
NCT03914066,TERMINATED,INTERVENTIONAL,We could not continue the study and include participants because of the corona pandemic.
NCT03914079,SUSPENDED,OBSERVATIONAL,Sponsor due to COVID-19
NCT03914157,WITHDRAWN,INTERVENTIONAL,Unable to support study
NCT03914482,WITHDRAWN,INTERVENTIONAL,The qualified and Principal Investigator has moved institutes. We are in the process for finding a replacement.
NCT03914495,TERMINATED,INTERVENTIONAL,PI carefully considered multiple factors and decided to close study to any further enrollment.
NCT03914989,TERMINATED,INTERVENTIONAL,Unable to complete full enrollment due to Covid pandemic.
NCT03915236,TERMINATED,INTERVENTIONAL,It was decided to discontinuate the study due to a very low recruitment.
NCT03915405,TERMINATED,INTERVENTIONAL,Termination was based on the business decision
NCT03915535,TERMINATED,INTERVENTIONAL,Several impacts of COVID-19 on recruitment and organization
NCT03915743,TERMINATED,INTERVENTIONAL,COVID-19
NCT03915886,TERMINATED,INTERVENTIONAL,Stopped due to a strategic decision.
NCT03916068,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03916588,TERMINATED,OBSERVATIONAL,covid
NCT03916692,TERMINATED,INTERVENTIONAL,Covid-19 restrictions
NCT03916783,WITHDRAWN,INTERVENTIONAL,"We implemented Aims 1 and 2, but did not have a sufficient sample size to carry out the clinical trial portion"
NCT03916796,TERMINATED,INTERVENTIONAL,Too many barriers to enrolling well going forward
NCT03917030,WITHDRAWN,INTERVENTIONAL,Not feasible to recruit and follow-up subjects due to the pandemic
NCT03917251,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT03917355,TERMINATED,OBSERVATIONAL,Covid-19
NCT03917433,SUSPENDED,INTERVENTIONAL,temporarily suspended recruitment due to COVID-related social distancing requirements
NCT03917719,TERMINATED,INTERVENTIONAL,"The Phase 3 PolarisDMD trial did not meet the primary endpoint. As a result, activities related to the development of edasalonexent have stopped including the CAT-1004-302 Open-Label Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy"
NCT03917823,TERMINATED,INTERVENTIONAL,Revised protocol to such a significant degree that we simply closed this study and started a new study.
NCT03918122,TERMINATED,OBSERVATIONAL,Not enough enrolled
NCT03918317,WITHDRAWN,INTERVENTIONAL,Funding unavailable - Company shutting down
NCT03918447,TERMINATED,INTERVENTIONAL,Discontinuation of all bardoxolone chronic kidney disease programs
NCT03918603,TERMINATED,INTERVENTIONAL,mid-term analysis
NCT03918811,TERMINATED,INTERVENTIONAL,"Due to the outbreak of the SARS-CoV-2 pandemic in Argentina and the lack of information about the potential risks of contamination from extubation and aerosolization, we stopped recruiting patients before achieving the predefined sample size."
NCT03919045,TERMINATED,INTERVENTIONAL,Due to Covid-19 the rehabilitation unit where the trial was conducted were closed and the trial active clinician had to work at the hospital intensive care.
NCT03919214,TERMINATED,INTERVENTIONAL,"Initially suspended due to Covid-19. After much consideration, it was determined that we do not have the bandwidth to resume recruitment or any activities for this project."
NCT03919344,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT03919383,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT03919708,WITHDRAWN,OBSERVATIONAL,Funding expired
NCT03919799,TERMINATED,INTERVENTIONAL,Sponsor decision due to slow enrollment and strategic consideration; not driven by any safety concerns.
NCT03920059,TERMINATED,INTERVENTIONAL,Slow recruitment rate
NCT03920254,TERMINATED,INTERVENTIONAL,Stopped early due to company decision. Company decision based on interim analysis results in TD-1473-0157.
NCT03920345,TERMINATED,INTERVENTIONAL,Not enough participation.
NCT03920631,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT03920657,TERMINATED,INTERVENTIONAL,enrollment failed
NCT03920839,WITHDRAWN,INTERVENTIONAL,"As of November 4, 2019 the study was halted prematurely and will not resume."
NCT03920878,WITHDRAWN,INTERVENTIONAL,The study team was unable to secure sufficient funding and administrative support.
NCT03920943,WITHDRAWN,INTERVENTIONAL,unable to allocate sufficient resources in setting of pandemic
NCT03921073,TERMINATED,INTERVENTIONAL,Sponsor Terminated Funding
NCT03921177,TERMINATED,INTERVENTIONAL,Extended COVID-19 restrictions on field research and limited funding
NCT03921216,SUSPENDED,OBSERVATIONAL,Covid19
NCT03921294,TERMINATED,INTERVENTIONAL,Global COVID-19 pandemic prevented further study visits or enrollment.
NCT03921359,TERMINATED,INTERVENTIONAL,In compliance with research restrictions imposed due to the COVID-19 pandemic.
NCT03921476,WITHDRAWN,OBSERVATIONAL,Investigator left Northwestern University
NCT03921970,WITHDRAWN,INTERVENTIONAL,no participants
NCT03921996,TERMINATED,INTERVENTIONAL,Due to lack of funding.
NCT03922048,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of enrollment.
NCT03922139,TERMINATED,INTERVENTIONAL,due to COVID-19
NCT03922451,TERMINATED,OBSERVATIONAL,COVID-19 - study and recruitment not feasible
NCT03922477,TERMINATED,INTERVENTIONAL,The Sponsor decided to discontinue the development of atezolizumab in combination with magrolimab in the AML indication.
NCT03922490,TERMINATED,INTERVENTIONAL,Recruitment was suspended due to the COVID pandemic and it was decided not to resume the study.
NCT03922594,TERMINATED,OBSERVATIONAL,"The disruptions due to the impact of the ongoing COVID-19 pandemic to the implementation of the study in each of the study sites, as well as to the coordination of the study at Institut Pasteur, prevented the completion of the study"
NCT03922620,TERMINATED,INTERVENTIONAL,Additional published information on the topic since starting the study
NCT03922672,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03922711,TERMINATED,INTERVENTIONAL,COVID-19
NCT03922906,TERMINATED,INTERVENTIONAL,Stopped due to COVID-19 pandemic
NCT03922958,TERMINATED,OBSERVATIONAL,funding ended
NCT03923010,TERMINATED,INTERVENTIONAL,Further recruitment not possible due to COVID 19 impact. Hence a decision to close study was taken by the sponsor in Aug 2020
NCT03923049,TERMINATED,INTERVENTIONAL,Lack of funding and support
NCT03923257,WITHDRAWN,INTERVENTIONAL,competing clinical trial opening
NCT03923348,TERMINATED,INTERVENTIONAL,Slow Recruitment and Re-prioritizing of Sponsor-funding
NCT03923361,WITHDRAWN,INTERVENTIONAL,Change in study design based on phase 1 data collection; patient burden was not feasible
NCT03923478,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03924024,WITHDRAWN,INTERVENTIONAL,We never started the study due to logistical limitations.
NCT03924063,WITHDRAWN,INTERVENTIONAL,No suitable population available
NCT03924102,WITHDRAWN,INTERVENTIONAL,The study was not able to enroll any eligible subjects.
NCT03924154,TERMINATED,INTERVENTIONAL,Inability to enroll
NCT03924245,TERMINATED,INTERVENTIONAL,Change in participant landscape and other treatment availability
NCT03924284,WITHDRAWN,OBSERVATIONAL,Wrong entry
NCT03924297,WITHDRAWN,INTERVENTIONAL,eIRB withdrew study for concerns
NCT03924557,TERMINATED,INTERVENTIONAL,funding issues
NCT03924622,TERMINATED,INTERVENTIONAL,Unable to continue to conduct study procedures due to pandemic
NCT03924908,WITHDRAWN,INTERVENTIONAL,Not enough human resources
NCT03925116,SUSPENDED,INTERVENTIONAL,budget
NCT03925155,WITHDRAWN,INTERVENTIONAL,The study was withdrawn from the IRB
NCT03925324,TERMINATED,INTERVENTIONAL,Lack of funding/Covid-19
NCT03925428,WITHDRAWN,INTERVENTIONAL,Other - Protocol moved to Disapproved
NCT03925610,TERMINATED,OBSERVATIONAL,Lack of resources and COVID-related closure in 2020.
NCT03925818,TERMINATED,INTERVENTIONAL,Lactobacillus reuteri (Gastrus) was not anymore available in the region
NCT03925909,TERMINATED,INTERVENTIONAL,Because there was no funding
NCT03925961,TERMINATED,INTERVENTIONAL,Study expired in IRB.
NCT03926143,TERMINATED,INTERVENTIONAL,"Due to strategic company decisions, the development of anetumab ravtansine was stopped."
NCT03926156,TERMINATED,INTERVENTIONAL,COVID-19 has impacted our study recruitment
NCT03926481,TERMINATED,INTERVENTIONAL,COVID-19
NCT03926546,WITHDRAWN,INTERVENTIONAL,The former principal investigator left the institution.
NCT03926637,TERMINATED,OBSERVATIONAL,Biogen will stop any further development of the MSPT. The data collected thus far in the MSPT Feasibility Study allow us to answer the primary study objectives that are associated with assessing the feasibility of the MSPT in a clinical care setting.
NCT03927222,TERMINATED,INTERVENTIONAL,Resource shortage
NCT03927248,WITHDRAWN,INTERVENTIONAL,funding issues
NCT03927274,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT03927365,SUSPENDED,INTERVENTIONAL,COVID-19 Pandemic
NCT03927443,WITHDRAWN,INTERVENTIONAL,\[Sponsors decision\]
NCT03927573,TERMINATED,INTERVENTIONAL,business decision by sponsor
NCT03927625,WITHDRAWN,INTERVENTIONAL,IRB determination
NCT03927911,TERMINATED,INTERVENTIONAL,Due to protocol feasibility given the rapid evolution of medical practice for spinal procedure. Data from approximately 65 FUSION study subjects will be analyzed with the intent to create either a future study or registry for this patient population.
NCT03927924,TERMINATED,INTERVENTIONAL,due to funding
NCT03928015,WITHDRAWN,INTERVENTIONAL,"This trial did not enroll subjects. After initial approval we procured an appropriate placebo. Before IRB the amendment was approved, the COVID-19 pandemic placed a hold on all non-essential research activity at the enrolling hospital."
NCT03928275,WITHDRAWN,INTERVENTIONAL,Withdrawn prematurely.
NCT03928314,TERMINATED,INTERVENTIONAL,IND Withdrawn
NCT03928626,TERMINATED,INTERVENTIONAL,Study stopped due to COVID shutting down all research at Yale University.
NCT03928639,WITHDRAWN,OBSERVATIONAL,Due to logistical issues at Emory University enrollment never initiated.
NCT03928769,SUSPENDED,OBSERVATIONAL,Covid-19 Pandemics
NCT03928808,WITHDRAWN,INTERVENTIONAL,Withdrawn due to covid-19 protocols on inpatient eating disorders unit.
NCT03928834,WITHDRAWN,INTERVENTIONAL,There was a delay in getting protocol approvals and hence the study would not be completed in time.
NCT03929211,WITHDRAWN,INTERVENTIONAL,Administrative withdrawal by IRB
NCT03929315,WITHDRAWN,OBSERVATIONAL,COVID made it difficult to access the materials and participants required for this study
NCT03929380,WITHDRAWN,INTERVENTIONAL,Covid situation
NCT03929484,TERMINATED,INTERVENTIONAL,Per sponsor advice
NCT03929497,TERMINATED,INTERVENTIONAL,Lack of efficacy based on the interim analysis in the 17972A study
NCT03929822,TERMINATED,OBSERVATIONAL,Lack of accrual
NCT03929835,WITHDRAWN,INTERVENTIONAL,withdrawn due to COVID-19
NCT03929978,WITHDRAWN,OBSERVATIONAL,lack of recruitment
NCT03930225,SUSPENDED,INTERVENTIONAL,Covid 19 Break has caused the research to stop temporarily for safety of participants and conductors
NCT03930290,TERMINATED,OBSERVATIONAL,Difficulty in patient recruiting
NCT03930459,TERMINATED,INTERVENTIONAL,low recruitment
NCT03930771,TERMINATED,INTERVENTIONAL,the study had a low accrual rate
NCT03931252,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT03931551,TERMINATED,INTERVENTIONAL,Very slow recruitment due to subject profile
NCT03931655,TERMINATED,OBSERVATIONAL,There have been multiple issues getting the device repaired and then in working order. The PI's have decided to terminate the study. The termination request has been filed with the institution's IRB.
NCT03931746,TERMINATED,INTERVENTIONAL,Company discontinued production of the Porcine Xenograft
NCT03932253,SUSPENDED,INTERVENTIONAL,Sponsor R\&D strategy adjustment
NCT03932318,WITHDRAWN,INTERVENTIONAL,study postponed
NCT03932513,TERMINATED,INTERVENTIONAL,Study was halted due to suspected liver injury in another study with Inarigavir
NCT03932630,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19 related challenges and restrictions, the project could not be launched as planned. Meanwhile, the current state of research has changed and the initialisation of the project is no longer appropriate. No participants were recurited."
NCT03932656,WITHDRAWN,OBSERVATIONAL,Funding issues
NCT03933020,TERMINATED,INTERVENTIONAL,"Lack of patient interest in participating (for adult patients), and lack of parental consent to participate (for pediatric patients)"
NCT03933176,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic
NCT03933254,WITHDRAWN,OBSERVATIONAL,As a result of COVID-19 pandemics
NCT03933397,TERMINATED,INTERVENTIONAL,Due to COVID enrollment numbers needed to meet the primary endpoint will not be met.
NCT03933410,TERMINATED,INTERVENTIONAL,"Kaleido Biosciences, Inc. closed the K020-218 trial due to business reasons, and not due to any safety concerns."
NCT03933657,WITHDRAWN,INTERVENTIONAL,Replaced by CaTO-PAD/BTK Study
NCT03933761,WITHDRAWN,INTERVENTIONAL,No eligible patient identified after 18 evaluable patients underwent pre-screening over a 2 year period.
NCT03933813,TERMINATED,INTERVENTIONAL,slow accrual
NCT03933865,TERMINATED,INTERVENTIONAL,The COVID-19 pandemic and recruitment difficulties prompted the investigators to terminate study early.
NCT03933930,WITHDRAWN,INTERVENTIONAL,No patient wants to be recruited.
NCT03933956,TERMINATED,INTERVENTIONAL,Study terminated owing to challenges posed by the COVID-19 situation.
NCT03934619,WITHDRAWN,INTERVENTIONAL,change in clinical practice that led to ability to recruit subjects
NCT03934749,TERMINATED,OBSERVATIONAL,Difficulty of inclusion
NCT03934918,WITHDRAWN,INTERVENTIONAL,Lack of enrollment \& funding
NCT03935126,TERMINATED,OBSERVATIONAL,Not due to safety reasons
NCT03935178,TERMINATED,OBSERVATIONAL,funding
NCT03935269,WITHDRAWN,INTERVENTIONAL,"No accruals, DSMB/PRC closed study"
NCT03935308,WITHDRAWN,INTERVENTIONAL,The principal investigator left the institution.
NCT03935347,WITHDRAWN,INTERVENTIONAL,no accrual
NCT03935516,WITHDRAWN,INTERVENTIONAL,Study team had difficulties recruiting and enrolling patients into this study.
NCT03935555,TERMINATED,INTERVENTIONAL,Samus Therapeutics company closure
NCT03935568,TERMINATED,INTERVENTIONAL,Company ceased operations
NCT03935594,TERMINATED,INTERVENTIONAL,Intervention causing discomfort to participants
NCT03935659,WITHDRAWN,INTERVENTIONAL,not recruiting patients.
NCT03935789,TERMINATED,INTERVENTIONAL,University shutdown due to COVID
NCT03935815,TERMINATED,INTERVENTIONAL,Closed prior to completion secondary to surgeon leaving UCLA
NCT03935867,WITHDRAWN,INTERVENTIONAL,Grant applications to fund the investigation were not selected for fundin4.
NCT03935880,TERMINATED,INTERVENTIONAL,difficulty meeting recruitment goals
NCT03936192,WITHDRAWN,INTERVENTIONAL,Company decision
NCT03936413,WITHDRAWN,INTERVENTIONAL,This clinical trial will not be performed at CUIMC.
NCT03936478,SUSPENDED,INTERVENTIONAL,Interim Analysis
NCT03936595,TERMINATED,INTERVENTIONAL,There was a high drop-out rate and we were unable to recruit new subjects.
NCT03936608,TERMINATED,INTERVENTIONAL,PI left Washington University
NCT03936751,SUSPENDED,INTERVENTIONAL,COVID-19 pandemic and philips cpap machine recall
NCT03936946,WITHDRAWN,INTERVENTIONAL,Resources not secured
NCT03937141,TERMINATED,INTERVENTIONAL,No substantial anti-tumor activity was observed.
NCT03937271,WITHDRAWN,OBSERVATIONAL,Leak of research funding
NCT03937531,WITHDRAWN,INTERVENTIONAL,PI Left the Institution
NCT03937557,WITHDRAWN,INTERVENTIONAL,Insufficient funds
NCT03937765,TERMINATED,INTERVENTIONAL,Suspended per IRB
NCT03937791,TERMINATED,INTERVENTIONAL,All analysis with identifiable specimens/data is complete or site has no identifiers linked to the specimens/data. The one enrolled pt has been taken off study
NCT03937856,TERMINATED,INTERVENTIONAL,PI is leaving the institution
NCT03937908,TERMINATED,INTERVENTIONAL,Participant study visits not possible during COVID-19 pandemic. Funder not able to support a continuation at some future date.
NCT03937999,TERMINATED,INTERVENTIONAL,"Slow enrollment due to COVID19 , change in practice with standardized use of oral vancomycin prophylaxis"
NCT03938077,WITHDRAWN,INTERVENTIONAL,"Unfortunately, the co-PI and lead community partner relocated out of the target area. Therefore, recruiting participants from the target area was not feasible."
NCT03938194,TERMINATED,INTERVENTIONAL,Equipment is not available
NCT03938272,TERMINATED,INTERVENTIONAL,"Parent, pivotal study (OC5-DB-02) did not meet primary endpoint. No safety concerns for early termination."
NCT03938337,TERMINATED,INTERVENTIONAL,"Sponsor terminated study due to higher incidence of pulmonary toxicity than expected, including death"
NCT03938402,TERMINATED,INTERVENTIONAL,As a result of COVID-19 pandemics
NCT03938441,TERMINATED,INTERVENTIONAL,Slow enrollment and PI Graduating Residency in June 2021.
NCT03938545,TERMINATED,INTERVENTIONAL,Sponsor decision based on premature unblinding of treatment allocations necessitated by program-wide review
NCT03938857,TERMINATED,INTERVENTIONAL,Enrollment challenging during the pandemic COVID 19
NCT03938922,WITHDRAWN,INTERVENTIONAL,Compound will not be studied for indication
NCT03939065,TERMINATED,INTERVENTIONAL,Decreased admissions secondary to wider introduction of HEMTs along with pandemic impacted ability to enroll
NCT03939169,SUSPENDED,INTERVENTIONAL,Pending CPP validation for an extension of the study
NCT03939247,TERMINATED,INTERVENTIONAL,Too difficult to recruit patients
NCT03939351,WITHDRAWN,OBSERVATIONAL,withdrawal of the project
NCT03939364,WITHDRAWN,INTERVENTIONAL,Delays due to manufacturing and the COVID-19 pandemic
NCT03939416,SUSPENDED,INTERVENTIONAL,for pandemic covid
NCT03939650,WITHDRAWN,INTERVENTIONAL,logistics: not able to get resosurces to beginn
NCT03939728,TERMINATED,OBSERVATIONAL,Investigators on maternity leave and COVID pandemic
NCT03939780,WITHDRAWN,INTERVENTIONAL,PI moving to another institution with NIH grant relinquished.
NCT03939832,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19 pandemic, it was no possible to recruit patients for this study."
NCT03939858,TERMINATED,OBSERVATIONAL,"Funding and laboratory access issues, study is closed"
NCT03940248,WITHDRAWN,INTERVENTIONAL,"Due to insurance non-payment, no subjects were enrolled."
NCT03940287,TERMINATED,INTERVENTIONAL,Due to COVID-19 lockdown
NCT03940300,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in priorities at the host organization and the end of the grant period of support.
NCT03940339,TERMINATED,INTERVENTIONAL,Due to COVID-19 lockdown
NCT03940560,WITHDRAWN,INTERVENTIONAL,No clinical need to perform study
NCT03940651,TERMINATED,INTERVENTIONAL,Funding ended
NCT03940677,TERMINATED,INTERVENTIONAL,end of funding support
NCT03940690,SUSPENDED,INTERVENTIONAL,awaiting results of interim analysis
NCT03940807,WITHDRAWN,INTERVENTIONAL,Principal investigator departure
NCT03941119,TERMINATED,INTERVENTIONAL,All recruitment activities for this study (with acutely ill inpatients with dementia) stopped due to the COVID pandemic.
NCT03941496,WITHDRAWN,INTERVENTIONAL,The study was halted prematurely due to Bristol-Myers Squibb's (BMS) decision to withdraw support for this study.
NCT03941834,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the study based on adjusted clinical development plan. This decision is not based on any safety concerns.
NCT03942055,WITHDRAWN,OBSERVATIONAL,PI determined not enough clinical staff support for project.
NCT03942172,SUSPENDED,INTERVENTIONAL,The study protocol needed to be modified
NCT03942211,TERMINATED,INTERVENTIONAL,The sponsor decided to prematurely terminate the study due to the lower-than-expected recruitment rate
NCT03942276,TERMINATED,INTERVENTIONAL,Participants constantly reported knee pain.
NCT03942835,TERMINATED,INTERVENTIONAL,abandonment
NCT03942900,WITHDRAWN,OBSERVATIONAL,Study not submitted to regulatory authorities
NCT03943082,TERMINATED,INTERVENTIONAL,Accrual for Feasibility Met
NCT03943147,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT03943290,TERMINATED,INTERVENTIONAL,Investigation of ACE-083 for use in patients with CMT and FSHD is being discontinued in this extension study as functional secondary endpoints were not achieved in the A083-023 or A083-03 trial (the parent trials).
NCT03943303,TERMINATED,INTERVENTIONAL,Because the Pandemia COVID-19 was not possible to bring the participants to the beach.
NCT03943342,WITHDRAWN,INTERVENTIONAL,Study not feasible
NCT03943407,WITHDRAWN,INTERVENTIONAL,The Imiquimod 3.75% was ineffective
NCT03943446,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue study due to inability to recruit the expected number of subjects within the requisite time period.
NCT03943524,SUSPENDED,INTERVENTIONAL,Enrollment difficulties during the COVID pandemic
NCT03943550,TERMINATED,INTERVENTIONAL,"The decision to terminate study WP40161 was based on that treatment with RO7049665 showed trends in efficacy, however these data were below expectations and would not have supported superiority over standard of care."
NCT03943693,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT03943706,WITHDRAWN,OBSERVATIONAL,"The investigator moved to another institution, therefore the study was never initiated."
NCT03943771,WITHDRAWN,INTERVENTIONAL,Schedule issue
NCT03943823,TERMINATED,INTERVENTIONAL,Difficulties in recruiting and retaining patients due to the COVID pandemic; lack of availability of study drug trimosan; lack of study personnel
NCT03943836,TERMINATED,INTERVENTIONAL,"PI, who was a Resident, graduated, and the project was not pursued further."
NCT03943849,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03943862,TERMINATED,INTERVENTIONAL,The study was terminated due to a small number of study participants.
NCT03944161,TERMINATED,INTERVENTIONAL,"The COVID-19 pandemic increased hospital pressure and suspended hospital visits, making it impossible to continue with recruitment. The project has been terminated."
NCT03944369,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03944473,WITHDRAWN,INTERVENTIONAL,Stopped before IRB approval
NCT03944538,TERMINATED,INTERVENTIONAL,Research restrictions and recruitment challenges due to the COVID-19 pandemic
NCT03944551,TERMINATED,INTERVENTIONAL,Participant mortality rates were higher than expected.
NCT03944707,TERMINATED,INTERVENTIONAL,Company decision
NCT03944720,TERMINATED,OBSERVATIONAL,Lack of recruitment in participating centers
NCT03944733,WITHDRAWN,INTERVENTIONAL,The study was never started as a result of change of personnel and funding
NCT03944902,TERMINATED,INTERVENTIONAL,will not resume. company choosing not to continue with drug. one participant now off study.
NCT03944993,TERMINATED,INTERVENTIONAL,Premature termination due to logistical limitations.
NCT03945032,WITHDRAWN,INTERVENTIONAL,In process (technical improvements)
NCT03945227,WITHDRAWN,INTERVENTIONAL,"Due to the delay in the study shceduled, due to the start of competitive study and the approval of Durvalumab from the Ministry of Food and Drug Safety, it was judged that it was difficult to enroll subjects."
NCT03945331,TERMINATED,INTERVENTIONAL,COVID-19 disrupted interventions irrecoverably.
NCT03945630,SUSPENDED,INTERVENTIONAL,unable to recruit patients due to COVID19
NCT03945786,SUSPENDED,OBSERVATIONAL,Recuriting inclusion and exclusion criteria will be changed as COVID-19.
NCT03945799,TERMINATED,INTERVENTIONAL,The study has gotten preliminary results and stopped advanced.
NCT03946033,WITHDRAWN,INTERVENTIONAL,Canceled by Immunoscore's manufacturer
NCT03946397,TERMINATED,INTERVENTIONAL,Inclusion issues
NCT03946462,WITHDRAWN,INTERVENTIONAL,This study could not be started because of some technical issues.
NCT03946631,TERMINATED,OBSERVATIONAL,PI and Practice closed
NCT03946709,TERMINATED,INTERVENTIONAL,COVID-19 risk in older adults.
NCT03946761,WITHDRAWN,INTERVENTIONAL,One of the main investigators is leaving the University.
NCT03946865,WITHDRAWN,INTERVENTIONAL,COVID19 restrictions and study personnel retirement
NCT03946891,WITHDRAWN,INTERVENTIONAL,The study was stopped due to lack of study staff and inability to enroll subjects into the study due to restrictive inclusion criteria.
NCT03947203,WITHDRAWN,INTERVENTIONAL,Unable to staff the project
NCT03947255,TERMINATED,INTERVENTIONAL,Study stopped early due to low patient accrual.
NCT03947281,TERMINATED,INTERVENTIONAL,"After delay due to pandemic, sponsor declined to continue funding."
NCT03947294,TERMINATED,OBSERVATIONAL,No participation of centers outside Switzerland because of difficulty in recruiting during a Covid pandemic.
NCT03947671,WITHDRAWN,INTERVENTIONAL,Loss of funds
NCT03947723,WITHDRAWN,INTERVENTIONAL,PI Left Institution
NCT03947762,TERMINATED,OBSERVATIONAL,Low enrollment
NCT03947814,TERMINATED,INTERVENTIONAL,Study 63623872FLZ1014 was terminated early based on a strategic business decision by Janssen to end the clinical development program of JNJ-63623872.
NCT03947853,WITHDRAWN,OBSERVATIONAL,No active recruitment
NCT03947918,TERMINATED,INTERVENTIONAL,"Due to challenges regarding COVID-19, it was not possible to reach the study's target sample size."
NCT03948178,TERMINATED,INTERVENTIONAL,This was an open label extension for patients completing the REFALS study (3119002; NCT03505021). Study 3119002 showed lack of efficacy of ODM109 so the sponsor decided to terminate this study
NCT03948217,TERMINATED,INTERVENTIONAL,changes to buildings why study was terminated prematurely
NCT03948334,TERMINATED,INTERVENTIONAL,Core terminated due to lack of efficacy
NCT03948464,TERMINATED,INTERVENTIONAL,Study unable to proceed per protocol due to COVID-19 precautions
NCT03949023,TERMINATED,OBSERVATIONAL,unable to perform refinement of study procedures to better capture information needed
NCT03949465,WITHDRAWN,INTERVENTIONAL,Recruitment remains at zero.
NCT03949491,TERMINATED,INTERVENTIONAL,Principal Investigator left the institution.
NCT03949530,TERMINATED,INTERVENTIONAL,Due to development challenges associated with the SARS-CoV-2 pandemic and emerging nonclinical data
NCT03949673,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT03949842,WITHDRAWN,INTERVENTIONAL,The decision to end the study was based on a change in GSK strategy. No subjects were enrolled into the study.
NCT03949998,WITHDRAWN,INTERVENTIONAL,no participants
NCT03950037,WITHDRAWN,INTERVENTIONAL,Unable to complete due to SARS-CoV-2 pandemic
NCT03950206,TERMINATED,INTERVENTIONAL,PI decided to terminate the trial
NCT03950310,TERMINATED,INTERVENTIONAL,"Due to COVID19, primary PCI number reduced."
NCT03950414,TERMINATED,INTERVENTIONAL,Insufficient Patient Population
NCT03950648,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03951012,TERMINATED,OBSERVATIONAL,low enrollment and remaining oncologist workload
NCT03951363,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19
NCT03951662,WITHDRAWN,OBSERVATIONAL,Funding ended
NCT03951961,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT03952013,WITHDRAWN,OBSERVATIONAL,COVID-19 : departure of investigative staff
NCT03952156,TERMINATED,INTERVENTIONAL,Homology Medicines has discontinued the development of this program.
NCT03952182,TERMINATED,INTERVENTIONAL,Recruitment and follow up concerns during Covid-19 pandemic
NCT03952325,TERMINATED,INTERVENTIONAL,The Sponsor has discontinued the development of tesetaxel
NCT03952377,TERMINATED,INTERVENTIONAL,"Due to the impact of COVID-19 and associated enrollment difficulties, the study was terminated with a total sample size of 56 randomized patients"
NCT03952481,WITHDRAWN,INTERVENTIONAL,COVID restrictions
NCT03952494,WITHDRAWN,INTERVENTIONAL,"Due to some administrative issues, the study had to be stopped. There were 0 subjects enrolled."
NCT03952585,SUSPENDED,INTERVENTIONAL,End of Initial Phase of Multi-phase protocol
NCT03952793,TERMINATED,INTERVENTIONAL,Feasibility issues
NCT03952832,WITHDRAWN,INTERVENTIONAL,Budget issues
NCT03952858,WITHDRAWN,INTERVENTIONAL,Too few elible patients but only one gave informed consent
NCT03953027,WITHDRAWN,OBSERVATIONAL,Study is not human subjects research.
NCT03953040,WITHDRAWN,OBSERVATIONAL,Funding Issues
NCT03953170,WITHDRAWN,INTERVENTIONAL,Funding ended
NCT03953209,WITHDRAWN,INTERVENTIONAL,Conflict with funding
NCT03953261,TERMINATED,INTERVENTIONAL,COVID and lack of support staff 2. lack of support staff to conduct the study
NCT03953326,TERMINATED,INTERVENTIONAL,Futility in recruitment
NCT03953352,WITHDRAWN,INTERVENTIONAL,Study cancelled
NCT03953456,TERMINATED,INTERVENTIONAL,Continuation of the trial cannot serve a scientific purpose
NCT03953521,TERMINATED,INTERVENTIONAL,Interim analysis indicated no statistical difference between treatment arms.
NCT03953677,TERMINATED,INTERVENTIONAL,Excess mortality in one arm of the study that led to discontinuation of enrollment
NCT03953690,TERMINATED,OBSERVATIONAL,lack of support from doctors and patients
NCT03953755,SUSPENDED,INTERVENTIONAL,Slow recruitment
NCT03953794,WITHDRAWN,OBSERVATIONAL,No accrual
NCT03954002,WITHDRAWN,INTERVENTIONAL,Principal Investigator left
NCT03954028,WITHDRAWN,INTERVENTIONAL,Withdrawn with IRB
NCT03954041,TERMINATED,INTERVENTIONAL,"Early completed due to strategic considerations, not for efficacy or safety reasons."
NCT03954106,TERMINATED,INTERVENTIONAL,Primary endpoint would unlikely to be met based on the unplanned interim assessment on the first 20 efficacy evaluable patients.
NCT03954314,TERMINATED,INTERVENTIONAL,"Upon the Data Safety Monitoring Board review of the interim analysis (75% of participants have finished their follow-up) on November 17, 2023, they made a recommendation to stop recruitment into the trial."
NCT03954496,TERMINATED,INTERVENTIONAL,Insufficient study staff
NCT03954587,TERMINATED,OBSERVATIONAL,Investigator's perogative
NCT03954639,WITHDRAWN,INTERVENTIONAL,Sponsor Decision.
NCT03954704,TERMINATED,INTERVENTIONAL,"The decision to discontinue the study was made based on the totality of the clinical, pharmacokinetic, and pharmacodynamic findings. No safety concerns were observed."
NCT03954938,TERMINATED,INTERVENTIONAL,COVID-19
NCT03954951,WITHDRAWN,INTERVENTIONAL,Unable to recruit/maintain participants for intervention
NCT03954990,TERMINATED,INTERVENTIONAL,Lack of significance/futile study
NCT03955146,TERMINATED,INTERVENTIONAL,Study did not meet its primary endpoint.
NCT03955224,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of recruitment
NCT03955276,TERMINATED,OBSERVATIONAL,PI left the institution.
NCT03955432,TERMINATED,INTERVENTIONAL,not enough recruit
NCT03955458,WITHDRAWN,INTERVENTIONAL,Recruitment difficulties
NCT03955471,TERMINATED,INTERVENTIONAL,The study will not resume based on the results of a planned interim analysis that showed futility
NCT03955718,WITHDRAWN,INTERVENTIONAL,The study stopped because of delays in the development of the smartphone app intervention
NCT03955796,WITHDRAWN,INTERVENTIONAL,Changes will be made in the design of one of the study IOLs
NCT03955835,TERMINATED,INTERVENTIONAL,CREDO stent is now CE-marked for rescue stenting (new indication).
NCT03955887,TERMINATED,OBSERVATIONAL,technical difficulties
NCT03956030,TERMINATED,INTERVENTIONAL,Insufficient research staff to recruit and complete study.
NCT03956056,TERMINATED,INTERVENTIONAL,Insufficient funding/staff
NCT03956472,TERMINATED,INTERVENTIONAL,End of european funding
NCT03956550,TERMINATED,INTERVENTIONAL,"Regeneron has discontinued further clinical development of REGN5069, an antibody to GFR3, which was previously being studied in osteoarthritis pain of the knee"
NCT03956589,TERMINATED,INTERVENTIONAL,Patient inclusion has stopped after interim analysis.
NCT03956706,WITHDRAWN,INTERVENTIONAL,no partipants enrolled and investigator left the institution
NCT03956758,WITHDRAWN,OBSERVATIONAL,Reclassification by Ethics Committee
NCT03956940,TERMINATED,INTERVENTIONAL,Change of the scientific and medical context that is no longer favorable to our study. This has resulted in the termination of inclusions.
NCT03957096,TERMINATED,INTERVENTIONAL,Sponsor decision based on portfolio prioritization
NCT03957122,TERMINATED,INTERVENTIONAL,The number of responders in the test sessions was too low.
NCT03957161,WITHDRAWN,INTERVENTIONAL,Currently we are not pursuing this trial due t o limited bandwidth and have not enrolled any participants.
NCT03957226,WITHDRAWN,INTERVENTIONAL,Study was not sufficiently funded. No enrollment took place.
NCT03957278,TERMINATED,INTERVENTIONAL,Device modifications
NCT03957525,TERMINATED,INTERVENTIONAL,Recruiting process could not be completed; lack of participants
NCT03958266,WITHDRAWN,OBSERVATIONAL,COVID pandemic
NCT03958279,TERMINATED,OBSERVATIONAL,Due to covid pandemia related restrictions
NCT03958383,SUSPENDED,INTERVENTIONAL,Administrative
NCT03958630,TERMINATED,INTERVENTIONAL,PI closed the protocol
NCT03958669,TERMINATED,OBSERVATIONAL,Slow recruitment due to COVID-19 pandemic and several newly approved treatment options
NCT03958929,SUSPENDED,INTERVENTIONAL,change study sites
NCT03958955,TERMINATED,INTERVENTIONAL,Terminated due to recruitment challenges.
NCT03959033,TERMINATED,OBSERVATIONAL,Insufficient accrual
NCT03959046,WITHDRAWN,INTERVENTIONAL,The study has been withdrawn due to delays caused by COVID-19 and practical barriers to conducting the study.
NCT03959072,TERMINATED,OBSERVATIONAL,Sponsor decision due to lower than anticipated enrollment
NCT03959345,TERMINATED,INTERVENTIONAL,"Data safety and monitoring board(DSMB) have been performed when half of sample size (SS)have been reached. Recruitment was slower than expected so SS was recalculated. After analysis of data, DSMB recommended to stop study."
NCT03959384,TERMINATED,INTERVENTIONAL,"Due to COVID19 hospital admissions by patients with moderate-severe bronchiolitis have drastically decreased from 02/2020 to date. Moreover, many centers that had initially joined the study project had great difficulties in the activation phase"
NCT03959553,WITHDRAWN,INTERVENTIONAL,The study was stopped due to protocol amendment and project name change.
NCT03959592,TERMINATED,INTERVENTIONAL,Preliminary analysis showed no benefit of the investigational supplement.
NCT03959813,WITHDRAWN,OBSERVATIONAL,the ethics committee has not accepted the extension
NCT03959852,TERMINATED,INTERVENTIONAL,Residency completed.
NCT03960125,WITHDRAWN,INTERVENTIONAL,The PI decided to move in another direction with his research.
NCT03960151,WITHDRAWN,INTERVENTIONAL,Compound was sold by funder and development ceased.
NCT03960242,TERMINATED,OBSERVATIONAL,Programs strategy refining due to Covid crisis
NCT03960541,TERMINATED,INTERVENTIONAL,Business Reasons
NCT03960554,TERMINATED,INTERVENTIONAL,Study lost funding
NCT03960606,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03961048,WITHDRAWN,INTERVENTIONAL,Change in hospital protocol
NCT03961113,TERMINATED,OBSERVATIONAL,inadequate recruitment
NCT03961815,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the development of brazikumab in inflammatory bowel disease.
NCT03962036,TERMINATED,OBSERVATIONAL,Study showed no results
NCT03962400,WITHDRAWN,INTERVENTIONAL,The study did not receive anticipated funding and therefore never opened to enrollment. The study was never submitted to the IRB for approval since the funding failed.
NCT03962608,WITHDRAWN,INTERVENTIONAL,Study was not approved by Health Authorities until get the results of the previous study
NCT03962634,TERMINATED,INTERVENTIONAL,Drug is no longer being manufactured
NCT03962725,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment.
NCT03962829,TERMINATED,INTERVENTIONAL,due to the Covid 19 pandemic
NCT03963011,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT03963024,TERMINATED,INTERVENTIONAL,low rate of enrolment
NCT03963102,SUSPENDED,INTERVENTIONAL,"Lack of appropriate personnel. Dr Xie abroad on other research, current PI Dr John Frewen"
NCT03963414,TERMINATED,INTERVENTIONAL,low accrual
NCT03963492,SUSPENDED,INTERVENTIONAL,COVID-19 Pandemic
NCT03963960,TERMINATED,INTERVENTIONAL,Logistical difficulties in the department due to a lack of paramedical staff and dialysis space.
NCT03963973,TERMINATED,INTERVENTIONAL,Participants no longer receiving intervention
NCT03963999,WITHDRAWN,INTERVENTIONAL,We did not receive grant funding. We will reapply in June of 2020
NCT03964025,WITHDRAWN,INTERVENTIONAL,project stopped by the sponsor
NCT03964051,TERMINATED,INTERVENTIONAL,Finished
NCT03964155,WITHDRAWN,INTERVENTIONAL,Logistical issues
NCT03964337,TERMINATED,INTERVENTIONAL,Poor accrual.
NCT03964376,SUSPENDED,INTERVENTIONAL,due to COVID-19
NCT03964584,WITHDRAWN,OBSERVATIONAL,"Low scientific relevance due to the marketing of new treatments, and expected inclusion difficulties"
NCT03964597,WITHDRAWN,OBSERVATIONAL,Study abandoned before any submission (foreseeable organizational difficulties)
NCT03965091,TERMINATED,INTERVENTIONAL,Met pre-specified criteria for futility at interim analysis
NCT03965364,WITHDRAWN,OBSERVATIONAL,due to lack of interest
NCT03965494,TERMINATED,INTERVENTIONAL,NCI decided to terminate ABTC Consortium due to NCI moving in different direction for Brain Cancer - official close date is 10/31/23
NCT03965624,WITHDRAWN,INTERVENTIONAL,Decision of sponsor: impossibility of contract with Takeda
NCT03966053,TERMINATED,INTERVENTIONAL,Supporter terminated study due to slow subject accrual secondary to COVID pandemic limiting travel to research site.
NCT03966144,WITHDRAWN,INTERVENTIONAL,Company discontinued study and closed. No participants were enrolled.
NCT03966261,TERMINATED,OBSERVATIONAL,No more inclusion needed for primary critera analysis
NCT03966300,TERMINATED,INTERVENTIONAL,"Study was terminated due to inability to: 1) vaccinate at school, 2) control and track vaccinations, 3) continue the intervention as proposed. Data collected during fall 2019 clinics are being transferred to researchers and verified."
NCT03966547,WITHDRAWN,INTERVENTIONAL,Main study concluded before enrollment
NCT03966768,WITHDRAWN,INTERVENTIONAL,Mutual decision Walter Reed/U Maryland and Mesh Suture Inc.
NCT03966807,TERMINATED,OBSERVATIONAL,Per institutional and PI recommendation
NCT03966885,TERMINATED,INTERVENTIONAL,"COVID-19 precluded the study team from being able to complete all follow-up assessments.The study was halted on March 17, 2020 and did not resume."
NCT03966989,WITHDRAWN,INTERVENTIONAL,Withdrawn due to COVID-19 pandemic
NCT03967093,TERMINATED,INTERVENTIONAL,Bexion will not move forward with the Part 2 expansion portion of the trial in order to focus resources on the further development of BXQ-350 as an earlier treatment measure in the pediatric population.
NCT03967288,SUSPENDED,INTERVENTIONAL,Four patients required conversion to GETA (2 in each study arm)
NCT03967587,TERMINATED,INTERVENTIONAL,The clinical investigation IMPROVE has been closed after a decision by the Swedish Medical Products Agency that the trial must comply to the new European medical regulation MDR.
NCT03967730,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03968081,TERMINATED,INTERVENTIONAL,human ressources
NCT03968198,TERMINATED,INTERVENTIONAL,organizational difficulties for the collection of adipose tissue and for the supply of the experimental drug
NCT03968276,TERMINATED,INTERVENTIONAL,The PI decided to stop the study.
NCT03968419,TERMINATED,INTERVENTIONAL,Study early terminated due to low enrollment compared to the anticipated figures.
NCT03968484,WITHDRAWN,INTERVENTIONAL,COVID-19 trials gained priority
NCT03968640,WITHDRAWN,INTERVENTIONAL,Sponsor terminated award
NCT03968835,WITHDRAWN,OBSERVATIONAL,lack of enrollment
NCT03968991,TERMINATED,INTERVENTIONAL,low recruits
NCT03969056,TERMINATED,INTERVENTIONAL,Due to the COVID-19 pandemic
NCT03969095,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03969199,WITHDRAWN,INTERVENTIONAL,Study never started
NCT03969420,TERMINATED,INTERVENTIONAL,"Business decision to terminate the development of alvocidib program on 17 November 2020. Patients permitted on treatment until April 22, 2021. The last end-of-treatment follow-up completed on May 14, 2021."
NCT03969680,TERMINATED,INTERVENTIONAL,Due to government regulation
NCT03969862,TERMINATED,OBSERVATIONAL,Covid-19 sanitary crisis
NCT03969940,WITHDRAWN,OBSERVATIONAL,Lack of supply of comparator drug in country
NCT03970109,TERMINATED,INTERVENTIONAL,The study was terminated early following enrollment of n=43 due to clinically significant increases in liver enzymes in 3 women following at least 3 weeks of dosing with both doses of ANS-6637.
NCT03970200,TERMINATED,INTERVENTIONAL,Administrative reasons.
NCT03970330,TERMINATED,INTERVENTIONAL,"Original PI left institution, lack of funding to continue"
NCT03970382,SUSPENDED,INTERVENTIONAL,Business decision
NCT03970616,TERMINATED,INTERVENTIONAL,The study was terminated due to regulatory approval of newer therapeutic options and slower than anticipated accrual.
NCT03970629,TERMINATED,INTERVENTIONAL,Challenging enrollment due to COVID-19.
NCT03970642,TERMINATED,INTERVENTIONAL,Recruitment closed early due to Covid-19.
NCT03970694,TERMINATED,INTERVENTIONAL,Significant differences in conversion rate as well as R0 resection rate between the two groups.
NCT03970837,TERMINATED,INTERVENTIONAL,Only Asia cohort is early terminated.Limited efficacy demonstrated in the contRAst program does not support a suitable benefit/risk profile for otilimab as a potential treatment for RA. GSK has decided not to progress with regulatory submissions.
NCT03970863,WITHDRAWN,OBSERVATIONAL,difficulty in recruiting participants
NCT03970967,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT03971110,TERMINATED,INTERVENTIONAL,"Due to the limited potential patients pool, the enrollment goal could not be achieved. After review and communication, the decision to teminate study was made."
NCT03971149,WITHDRAWN,INTERVENTIONAL,We came across unexpected difficulty with recruitment.
NCT03971357,TERMINATED,INTERVENTIONAL,variance of outcome measures was substantially greater than anticipated in the statistical plan
NCT03971617,TERMINATED,INTERVENTIONAL,Insufficient enrollment to answer research question
NCT03971721,TERMINATED,INTERVENTIONAL,Funding stopped
NCT03971734,TERMINATED,INTERVENTIONAL,Terminated \[NCI decided to terminate ABTC Consortium due to NCI moving in different direction for Brain Cancer\]
NCT03971760,WITHDRAWN,INTERVENTIONAL,COVID pandemic
NCT03971825,TERMINATED,INTERVENTIONAL,Did not meet progression criteria
NCT03972046,WITHDRAWN,INTERVENTIONAL,Principal investigator leaving study site; no replacement PI will be sought
NCT03972111,WITHDRAWN,OBSERVATIONAL,commitment fulfilled
NCT03972449,WITHDRAWN,INTERVENTIONAL,Funding not received.
NCT03972683,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT03972696,TERMINATED,INTERVENTIONAL,"The inclusion rate of patients is too slow, so it is not possible to reach the estimated N."
NCT03972709,TERMINATED,INTERVENTIONAL,The benefit to risk balance did not support further treatment with galegenimab (FHTR2163).
NCT03972813,TERMINATED,INTERVENTIONAL,"Due to COVID-19, we were unable to continue data collection in China."
NCT03972826,TERMINATED,INTERVENTIONAL,Supplier of product went into bankruptcy proceedings
NCT03972943,TERMINATED,INTERVENTIONAL,Study terminated due to lack of funding
NCT03973021,WITHDRAWN,INTERVENTIONAL,Policy changes have contributed to the failure to carry out smoothly
NCT03973177,WITHDRAWN,INTERVENTIONAL,Covid restrictions on recruitment
NCT03973216,WITHDRAWN,INTERVENTIONAL,"COVID-19 caused the group format to shift, therefore the intervention was not delivered in the same manner as the one described in the proposal. The study was stopped as the intervention may not be delivered as planned even following COVID-19."
NCT03973333,TERMINATED,INTERVENTIONAL,The Sponsor terminated the study and there is no further enrollment. Endpoints will not be assessed for this trial.
NCT03973346,WITHDRAWN,INTERVENTIONAL,The implementation of the tool has been delayed due to technology governance issues and requests for changes in the end user design.
NCT03973580,TERMINATED,INTERVENTIONAL,The study was terminated because of the COVID-19 pandemic (Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention).
NCT03973697,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT03973710,SUSPENDED,INTERVENTIONAL,not enough intervention materials can be provided
NCT03973879,WITHDRAWN,INTERVENTIONAL,Re-submission Planned
NCT03973918,TERMINATED,INTERVENTIONAL,NCI decided to terminate ABTC Consortium due to NCI moving in different direction for Brain Cancer
NCT03974009,TERMINATED,INTERVENTIONAL,Due to COVID-19 lockdown
NCT03974152,TERMINATED,INTERVENTIONAL,"COVID concerns, funding delays led to cancellation of project"
NCT03974204,WITHDRAWN,INTERVENTIONAL,Modification of the care habits. We believe today that we are no longer able to carry out this study as initially described.
NCT03974854,TERMINATED,INTERVENTIONAL,sponsor decision
NCT03974984,WITHDRAWN,OBSERVATIONAL,Not feasable due to logistics
NCT03975101,WITHDRAWN,INTERVENTIONAL,Policy changes have contributed to the failure to carry out smoothly
NCT03975192,WITHDRAWN,INTERVENTIONAL,There was no enrollment.
NCT03975439,WITHDRAWN,OBSERVATIONAL,Decided to do smaller pilot study instead
NCT03975985,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic, recruitment was interrupted for several months. In the end, the terms of the grant obtained to conduct the trial did not allow for the extension of the recruitment period beyond one year."
NCT03976050,TERMINATED,INTERVENTIONAL,Study objective and design change
NCT03976076,TERMINATED,INTERVENTIONAL,Difficulty with patient recruitment due to COVID-19
NCT03976206,WITHDRAWN,INTERVENTIONAL,Policy changes have contributed to the failure to carry out smoothly
NCT03976219,TERMINATED,INTERVENTIONAL,Budgetary Issues
NCT03976557,TERMINATED,INTERVENTIONAL,Due to Corona/Covid19 pandemic
NCT03976596,TERMINATED,OBSERVATIONAL,Decoupler equipment used for 31P magnetic resonance is being serviced
NCT03976648,TERMINATED,INTERVENTIONAL,The benefit-risk profile no longer supports continuing the studies
NCT03977311,WITHDRAWN,INTERVENTIONAL,PI decided not to go forward with study.
NCT03977363,TERMINATED,OBSERVATIONAL,Halted Prematurely
NCT03977480,TERMINATED,INTERVENTIONAL,"Due to the difficulty to recruit enough patients, the study was terminated."
NCT03977506,TERMINATED,INTERVENTIONAL,difficulty of recrutment
NCT03977675,TERMINATED,INTERVENTIONAL,PI left the institution
NCT03977974,TERMINATED,INTERVENTIONAL,COVID-19 pandemic.
NCT03978156,TERMINATED,INTERVENTIONAL,Covid-19. Relocation of trainee/investigator. Covid-19.
NCT03978182,WITHDRAWN,INTERVENTIONAL,replaced by other study
NCT03978312,TERMINATED,OBSERVATIONAL,Recruitment was due to be extended (March 20) due to slow initial recruitment however was terminated early due to corresponding arrival of COVID-19 to UK. (16 recruited to cultural and linguistic phase and 42 to observational cohort)
NCT03978390,WITHDRAWN,INTERVENTIONAL,Change in research direction
NCT03978416,TERMINATED,INTERVENTIONAL,The study was terminated due to the SARS-CoV-2 pandemic. Aim 1 was completed.
NCT03978494,WITHDRAWN,INTERVENTIONAL,company decision
NCT03978572,SUSPENDED,INTERVENTIONAL,Temporarily paused due to COVID-19 and expected to resume. Not of IRB approval
NCT03978637,TERMINATED,INTERVENTIONAL,Business Decision
NCT03978884,WITHDRAWN,INTERVENTIONAL,Unable to effective arrange trial logistics
NCT03979066,TERMINATED,INTERVENTIONAL,Loss of funding
NCT03979196,TERMINATED,INTERVENTIONAL,Logistical Challenges
NCT03979547,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT03979560,TERMINATED,INTERVENTIONAL,Lack of inclusion of patients
NCT03979638,TERMINATED,INTERVENTIONAL,Trial was terminated due to the impact of the COVID-19 on trial activities. 68 patients with refractory chronic cough were enrolled with 52 completing treatment
NCT03979664,WITHDRAWN,INTERVENTIONAL,FDA did not provide approval of the use of the drug for the study
NCT03979820,TERMINATED,INTERVENTIONAL,Study discontinued - testing of highest dose obsolete
NCT03980236,TERMINATED,INTERVENTIONAL,Did not achieve enrollment goal
NCT03980249,WITHDRAWN,INTERVENTIONAL,No funding
NCT03980262,TERMINATED,INTERVENTIONAL,Faith-based partners were not able to recruit sufficient number of families with young children; funding agency approved shift to qualitative study to identify challenges and potential solutions for future faith-partnered health intervention studies.
NCT03980366,TERMINATED,INTERVENTIONAL,We have not obtained additional subjects and chose to terminate/close this study.
NCT03980405,TERMINATED,INTERVENTIONAL,It is not possible to continue the study
NCT03980730,TERMINATED,INTERVENTIONAL,for business reasons
NCT03980912,WITHDRAWN,OBSERVATIONAL,created a new protocol with a new study design
NCT03980938,TERMINATED,INTERVENTIONAL,"Due to the long delay because of COVID-19 and results from another study suggesting a higher dose may be more beneficial, EIP Pharma decided on October 15th, 2020, to end the trial prematurely."
NCT03981250,SUSPENDED,INTERVENTIONAL,Covid-19
NCT03981718,WITHDRAWN,INTERVENTIONAL,low/slow accrual
NCT03981744,TERMINATED,INTERVENTIONAL,The study did not meet the primary endpoint.
NCT03981757,WITHDRAWN,INTERVENTIONAL,sponsor withdrew
NCT03982004,TERMINATED,INTERVENTIONAL,Sponsor decision.
NCT03982017,TERMINATED,INTERVENTIONAL,"Patient enrollment was initially suspended due to COVID19 pandemic, then the study was closed due to institutional requirements for clinical trials."
NCT03982030,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT03982121,WITHDRAWN,INTERVENTIONAL,Study never began because of withdrawal of the industrial partner
NCT03982134,WITHDRAWN,INTERVENTIONAL,Sponsor decision to withdraw
NCT03982173,WITHDRAWN,INTERVENTIONAL,"Similar clinical trials showed not very encouraging results, which made us decide, after several modifications to the protocol and numerous difficulties encountered, to abandon the trial."
NCT03982342,TERMINATED,INTERVENTIONAL,COVID outbreak interrupted study recruitment
NCT03982537,WITHDRAWN,INTERVENTIONAL,Concept is withdrawn and a different concept will be submitted the near future.
NCT03982810,WITHDRAWN,OBSERVATIONAL,no funding
NCT03982992,WITHDRAWN,INTERVENTIONAL,Lack of potential study subjects due to a change of standard of care treatment outside of clinical trials.
NCT03983395,TERMINATED,INTERVENTIONAL,"The study was terminated during Part 1 (dose escalation), and Part 2 (expansion) of the study was not initiated. This study was voluntarily terminated due to a business decision not to proceed with the ISB 1302 asset, and not due to any safety issue."
NCT03983486,WITHDRAWN,OBSERVATIONAL,technical problem
NCT03983655,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03983668,SUSPENDED,INTERVENTIONAL,DSMC Deviation Review
NCT03983720,TERMINATED,INTERVENTIONAL,low inclusion rates
NCT03983824,SUSPENDED,INTERVENTIONAL,Scheduled Interim Monitoring
NCT03983941,TERMINATED,INTERVENTIONAL,"PI leaving the institution, no subjects enrolled since 2019, and no other PI interested in taking it over."
NCT03984019,TERMINATED,INTERVENTIONAL,Slow accrual due to COVID-19 and lower accrual than expected.
NCT03984305,TERMINATED,INTERVENTIONAL,Terminated due to significant protocol updates that resulted in initiating a new study
NCT03984383,WITHDRAWN,OBSERVATIONAL,No extension of ethic comitee
NCT03984604,TERMINATED,INTERVENTIONAL,COVID-19
NCT03984812,TERMINATED,INTERVENTIONAL,The study was terminated early (following completion of SAD Cohort 3; 80 mg) based on PK/PD modelling which demonstrated the medicine's intended target profile was not achievable.
NCT03985059,TERMINATED,OBSERVATIONAL,no need to include more patients for analysis. 40 patients initially (36 actual)
NCT03985215,WITHDRAWN,OBSERVATIONAL,Overlapping with another danish questionnaire study
NCT03985423,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT03985462,WITHDRAWN,INTERVENTIONAL,Policy changes have contributed to the failure to carry out smoothly
NCT03985878,TERMINATED,INTERVENTIONAL,"Participants were either transitioned to a post-trial access program or another Sarepta study, or they declined further treatment. There are no safety concerns with Eteplirsen."
NCT03986086,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT03986398,TERMINATED,INTERVENTIONAL,In the perioperative setting of radical cystectomy-bladder replacement no improvement of UTI was noticed in 10 patients who took Urell following the protocol
NCT03986593,TERMINATED,INTERVENTIONAL,The study achieved n=17 participants (56.6% of the initial proposition) with a mean = 18 months follow-up. All patients completed 12 months follow-up or deceased. We chose to terminate and publish the data available.
NCT03986853,TERMINATED,INTERVENTIONAL,Patient with rare disease
NCT03986944,TERMINATED,INTERVENTIONAL,Study halted due to the significant enrollment challenges encountered since its beginning. Screening and enrollment have been impacted by the COVID pandemic and more importantly by changes in the diagnosis and treatment of women with endometriosis.
NCT03986996,TERMINATED,INTERVENTIONAL,There is no feasibility to conduct the study
NCT03987347,WITHDRAWN,OBSERVATIONAL,No authorization from CLSA database scientific committee
NCT03987568,WITHDRAWN,INTERVENTIONAL,Issues in reserving MRI scanner
NCT03987672,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT03987750,WITHDRAWN,INTERVENTIONAL,drug development plan has been updated
NCT03987906,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03987932,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03987958,SUSPENDED,OBSERVATIONAL,Strategic considerations
NCT03988023,TERMINATED,INTERVENTIONAL,The AP-013 study was prematurely terminated by the sponsor after Data Safety Monitoring Board (DSMB) guidance.
NCT03988114,WITHDRAWN,INTERVENTIONAL,"Strategic decision due to emerging new data for patients with HR+, HER2- metastatic breast cancer."
NCT03988192,TERMINATED,INTERVENTIONAL,Evolution of the treatment procedures so that their is no more benefits for patients
NCT03988205,TERMINATED,INTERVENTIONAL,Low accrual
NCT03988231,WITHDRAWN,INTERVENTIONAL,Funding was not received.
NCT03988582,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT03988647,TERMINATED,INTERVENTIONAL,Business decision
NCT03988842,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT03989050,WITHDRAWN,OBSERVATIONAL,Administrative reasons
NCT03989076,WITHDRAWN,OBSERVATIONAL,unable to enroll subjects
NCT03989635,WITHDRAWN,INTERVENTIONAL,Company Decision
NCT03989713,TERMINATED,INTERVENTIONAL,Study turned out no longer feasible
NCT03989752,TERMINATED,INTERVENTIONAL,COVID-19
NCT03990038,TERMINATED,INTERVENTIONAL,Recruitment problems making the study completion unlikely
NCT03990064,TERMINATED,INTERVENTIONAL,not enough patients
NCT03990077,TERMINATED,INTERVENTIONAL,drug development strategy adjustment
NCT03990207,SUSPENDED,INTERVENTIONAL,Not moving forward with the study at this time. No subject were consented or enrolled
NCT03990597,WITHDRAWN,INTERVENTIONAL,Per PI
NCT03990740,WITHDRAWN,OBSERVATIONAL,Logistical difficulties : protocol never finalized nor submitted
NCT03990974,SUSPENDED,INTERVENTIONAL,There were difficulties in implementation
NCT03991000,TERMINATED,INTERVENTIONAL,"Due to poor recruitment largely due to the covid pandemic, no safety concerns."
NCT03991104,WITHDRAWN,INTERVENTIONAL,No eligible patients enrolled. We have to withdraw the trial.
NCT03991208,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT03991273,WITHDRAWN,INTERVENTIONAL,Grant projects were revised in response to COVID-19.
NCT03991299,TERMINATED,INTERVENTIONAL,Sponsor Decision.
NCT03992053,WITHDRAWN,INTERVENTIONAL,No subjects were recruited because of the COVID-19 pandemic. The study is now closed as sponsor milestones (not related to subjects) are completed.
NCT03992079,TERMINATED,INTERVENTIONAL,PI is no longer at institution
NCT03992131,TERMINATED,INTERVENTIONAL,"Due to a change in development priorities, no further clinical development of the lucitanib plus rucaparib or lucitanib plus sacituzumab govitecan combinations is planned at this time."
NCT03992157,TERMINATED,INTERVENTIONAL,"Medical practices have evolved and are not conform with the study procedure. Actually, all patients receive an ambulatory ECG telemetry monitoring"
NCT03992196,TERMINATED,INTERVENTIONAL,Sponsor decision; Not a safety decision
NCT03992326,TERMINATED,INTERVENTIONAL,Internal competitive study that is open
NCT03992443,WITHDRAWN,INTERVENTIONAL,Chiesi business decision
NCT03992716,TERMINATED,INTERVENTIONAL,Study had to be put on hold after the outbreak of Covid-19 in the participating countries and was terminated in September 2020 since a date for re-starting was not foreseeable.
NCT03992820,TERMINATED,INTERVENTIONAL,Stopped early due to COVID19 restrictions
NCT03993002,TERMINATED,INTERVENTIONAL,Enrollment pause due to COVID-19 exceeded funding period; This is not a suspension of IRB approval.
NCT03993210,TERMINATED,INTERVENTIONAL,Key personnel moving out
NCT03993314,TERMINATED,INTERVENTIONAL,Lack of recruitment due to COVID-19 pandemic; chloroprocaine shortage
NCT03993379,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT03993457,TERMINATED,INTERVENTIONAL,terminated during COVID due to inability to see participants in person.
NCT03993522,TERMINATED,INTERVENTIONAL,This study did not complete recruitment in the time given.
NCT03993613,TERMINATED,INTERVENTIONAL,no availability of IMP for this study
NCT03993717,TERMINATED,OBSERVATIONAL,Due to personnel changes and COVID-19.
NCT03993977,WITHDRAWN,INTERVENTIONAL,"Due to changes in the surgical technique, no potential subjects anymore"
NCT03993990,WITHDRAWN,INTERVENTIONAL,Lack of financial resources
NCT03994146,TERMINATED,INTERVENTIONAL,Recruitment rate was not compatible with study completion
NCT03994185,WITHDRAWN,INTERVENTIONAL,Study was withdrawn by the Sponsor prior to enrollment
NCT03994224,TERMINATED,OBSERVATIONAL,Decision made by team of investigators
NCT03994263,TERMINATED,INTERVENTIONAL,low recruitment
NCT03994887,WITHDRAWN,INTERVENTIONAL,study not started
NCT03994926,TERMINATED,INTERVENTIONAL,COVID-19 Pandmic halted study
NCT03994965,WITHDRAWN,INTERVENTIONAL,Drug supply withdrawn
NCT03994991,WITHDRAWN,INTERVENTIONAL,We weren't able to enroll patients due to COVID19 pandemic.
NCT03995004,SUSPENDED,INTERVENTIONAL,Unable to secure study medication supply
NCT03995212,TERMINATED,INTERVENTIONAL,Slow enrollment due primarily to Covid-19
NCT03995290,TERMINATED,OBSERVATIONAL,Loss of funding.
NCT03995407,TERMINATED,INTERVENTIONAL,Resourcing issues impacted by COVID-19 pandemic.
NCT03995550,WITHDRAWN,INTERVENTIONAL,Portfolio proritisation
NCT03995641,TERMINATED,INTERVENTIONAL,Never received appropriate formulation.
NCT03995667,TERMINATED,INTERVENTIONAL,Low accrual
NCT03995901,TERMINATED,INTERVENTIONAL,Talaris decided to discontinue living donor kidney transplant development program
NCT03995914,WITHDRAWN,OBSERVATIONAL,Reclassification by Ethics Committee
NCT03995927,TERMINATED,OBSERVATIONAL,"PI decision, technical events unrelated to study slowing down the process and ability to accrue"
NCT03996057,WITHDRAWN,INTERVENTIONAL,"Project canceled due to PI leaving institution, staff changes and COVID

Project canceled for other reason , describe: - Due to staff changes and COVID

Project canceled due to PI leaving, staff changes and COVID"
NCT03996252,TERMINATED,INTERVENTIONAL,"The study team was not able to start the study and they never completed the IRB submission, so the study was terminated."
NCT03996317,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT03996343,WITHDRAWN,INTERVENTIONAL,Investigator leaving institution
NCT03996395,TERMINATED,OBSERVATIONAL,The COVID-19 pandemic made the recruitment and follow-up of this study impractical.
NCT03996473,TERMINATED,INTERVENTIONAL,LPLV reached on 30Jan2023. Study was closed early for feasibility reasons related to enrollment of first line IO nave patients. Safety data is consistent with the known safety profile of both drugs and no new safety issues have been observed
NCT03996486,WITHDRAWN,INTERVENTIONAL,Company decision
NCT03996512,WITHDRAWN,INTERVENTIONAL,Recruitment issues. Inclusion Criteria was strict due to the experimental nature of intervention
NCT03996525,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT03996707,TERMINATED,INTERVENTIONAL,All consented subjects were lost to follow up. P.I. stopped due to lack of interest.
NCT03996863,WITHDRAWN,INTERVENTIONAL,Drexel Oncology was shut down a few days before first patient in.
NCT03997097,WITHDRAWN,INTERVENTIONAL,New sponsor
NCT03997292,WITHDRAWN,OBSERVATIONAL,The study has been terminated due to key change of protocol
NCT03997448,TERMINATED,INTERVENTIONAL,Funder decision
NCT03997487,TERMINATED,INTERVENTIONAL,Lack of funding
NCT03997526,TERMINATED,OBSERVATIONAL,CMS status changed - 3C Patch is now fully covered (NCD) - Medicare will no longer be collecting claims under CED
NCT03997604,WITHDRAWN,OBSERVATIONAL,The Dental service organization that the Sponsor was working with did not meet the Sponsor's internal requirements for performing the clinical trial. As a result the study was withdrawn without any participant enrollment.
NCT03998033,TERMINATED,INTERVENTIONAL,Reallocation of resources to new HCC study.
NCT03998189,TERMINATED,INTERVENTIONAL,Study deemed no longer feasible
NCT03998293,WITHDRAWN,INTERVENTIONAL,Newly available data suggests that measuring proinsulin clearance would not enhance predictive value of serum proinsulin
NCT03998358,WITHDRAWN,OBSERVATIONAL,Recruitment method is no longer active.
NCT03998410,TERMINATED,INTERVENTIONAL,due to the pandemic
NCT03998423,TERMINATED,INTERVENTIONAL,"SARS-CoV-2 has been detected in fecal material. Although FMT is screened for SARS-CoV-2, the team decided to end the study to minimize risk to participants."
NCT03998592,WITHDRAWN,INTERVENTIONAL,Agreement between interested partied ended
NCT03998605,WITHDRAWN,INTERVENTIONAL,no release of remaining funds
NCT03998709,WITHDRAWN,INTERVENTIONAL,results from other study suggest no good reason to proceed
NCT03998748,TERMINATED,INTERVENTIONAL,Pandemic
NCT03998917,WITHDRAWN,OBSERVATIONAL,Human subjects protection's soubmission denied
NCT03999190,WITHDRAWN,OBSERVATIONAL,investigational radiotracer was not approved
NCT03999216,WITHDRAWN,INTERVENTIONAL,Due to administrative and logistical barriers this trial has been withdrawn.
NCT03999359,TERMINATED,INTERVENTIONAL,"Due to COVID-19 recruitment was terminated prematurely following approval from the trial steering committee. Overall impact was minimal, study sample was reduced by four participants."
NCT03999515,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT03999658,WITHDRAWN,INTERVENTIONAL,Sorrento Therapeutics filed for chapter 11 bankruptcy.
NCT03999736,TERMINATED,INTERVENTIONAL,"Covid paused recruitment after the first participant was recruited. Subsequently, key study staff moved institution meaning it was no longer possible to run the trial."
NCT03999840,WITHDRAWN,INTERVENTIONAL,Due to the COVID global pandemic Sponsor has not received the economic support necessary for the study conduction.
NCT04000009,TERMINATED,INTERVENTIONAL,The study was terminated for business reasons and not due to safety concerns.
NCT04000191,WITHDRAWN,INTERVENTIONAL,Study was neer started and PI left the institution.
NCT04000269,WITHDRAWN,INTERVENTIONAL,Did not receive IRB approval
NCT04000282,TERMINATED,INTERVENTIONAL,"Terminated based on sponsor decision (for reasons unrelated to safety, in reviewing Sponsor's evolving portfolio and strategic prioritization)"
NCT04000347,WITHDRAWN,INTERVENTIONAL,"Due to covid 19 outbreaks, the study are suspended."
NCT04000529,TERMINATED,INTERVENTIONAL,Business reasons
NCT04000555,TERMINATED,INTERVENTIONAL,"The study was terminated early due to low enrollment, this was partially related to our ability to recruit during the COVID-19 pandemic."
NCT04000581,TERMINATED,INTERVENTIONAL,difficulty with equipment
NCT04000919,SUSPENDED,INTERVENTIONAL,PI left UofL and intends to reopen study at University of Alberta
NCT04001010,SUSPENDED,INTERVENTIONAL,Study is postponed
NCT04001036,TERMINATED,INTERVENTIONAL,prematurely interrupted due to significant difficulties in the completion of the sample size defined by the study protocol
NCT04001062,TERMINATED,INTERVENTIONAL,PI left institution prior to results being available.
NCT04001101,WITHDRAWN,INTERVENTIONAL,PI has decided to withdraw the study
NCT04001153,WITHDRAWN,OBSERVATIONAL,There will be no opportunity to recruit patients during the pandemic of COVID-19 and possibly even post-pandemic
NCT04001231,WITHDRAWN,INTERVENTIONAL,The study is stopped based upon strategic considerations impacting the clinical development of exenatide once-weekly suspension in China
NCT04001335,TERMINATED,OBSERVATIONAL,"No patient recruitment possible during COVID-19, inavailability RDTs"
NCT04001413,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew funding
NCT04001647,SUSPENDED,INTERVENTIONAL,IRB approval has been withdrawn
NCT04001738,TERMINATED,INTERVENTIONAL,Intermediate analysis
NCT04001855,TERMINATED,INTERVENTIONAL,Investigator left university
NCT04001933,WITHDRAWN,INTERVENTIONAL,"The onset of COVID-19 shut down San Francisco in March 2020, resulting in immediate suspension of group prenatal care at our clinic sites. This continued suspension prevented the conduct of study activities, which resulted in study termination."
NCT04001998,WITHDRAWN,INTERVENTIONAL,On hold to determine chosen formulations
NCT04002011,WITHDRAWN,INTERVENTIONAL,Submission process abandoned. No patient enrolled.
NCT04002037,TERMINATED,INTERVENTIONAL,Preliminary analysis revealed no difference
NCT04002115,TERMINATED,INTERVENTIONAL,terminated due to low accrual
NCT04002310,TERMINATED,INTERVENTIONAL,The trial was discontinued in the interests of patients considering benefit/risk balance.
NCT04002388,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to impracticalities in logistics during the COVID-19 pandemic.
NCT04002622,TERMINATED,INTERVENTIONAL,The population of target indication is small and screening is difficult.
NCT04002635,WITHDRAWN,INTERVENTIONAL,Practical issues
NCT04002726,TERMINATED,INTERVENTIONAL,Lack of funding
NCT04002804,TERMINATED,INTERVENTIONAL,Temozolomide does not favour immune response; secondary GBM to be excluded
NCT04003025,WITHDRAWN,OBSERVATIONAL,The proposed analysis was not feasible.
NCT04003233,WITHDRAWN,INTERVENTIONAL,Due to the termination of the collaboration of ApiFix ltd. and the UMC Utrecht
NCT04003428,WITHDRAWN,INTERVENTIONAL,Lapsed Authorization (no patient)
NCT04003480,SUSPENDED,INTERVENTIONAL,no patients have been enrolled. Study suspended due to change of sponsor priorities during COVID
NCT04003519,WITHDRAWN,OBSERVATIONAL,"Study timeline delay, low site feasibility and delay concerns due to COVID-19."
NCT04003610,TERMINATED,INTERVENTIONAL,The reason this study was terminated was due to a business decision. There were no safety concerns that contributed to this decision.
NCT04003623,TERMINATED,INTERVENTIONAL,The study was closed due to lack of enrollment.
NCT04003701,TERMINATED,INTERVENTIONAL,A priori calculated required sample size not feasible after 3 years of recruitment.
NCT04003818,TERMINATED,INTERVENTIONAL,"Due to COVID-19 and great challenges during patient enrolment period, current status of this study is far behind the plan. The study cannot be completed according to the plan. Sanofi decides to terminate the study upon comprehensive assessment."
NCT04003896,TERMINATED,INTERVENTIONAL,The manufacturer and funder Eli Lilly requested to terminate the study
NCT04003935,TERMINATED,OBSERVATIONAL,One of the 2 nutritional products is reformulated and withdrawn from the market
NCT04004039,WITHDRAWN,OBSERVATIONAL,Application to a CPP
NCT04004325,TERMINATED,INTERVENTIONAL,sponsor decision
NCT04004845,TERMINATED,OBSERVATIONAL,Study was temporarily paused due to COVID19 and ultimately terminated at the discretion of the PI
NCT04005027,SUSPENDED,INTERVENTIONAL,"The study is currently suspended due to ongoing risks of infection, and unknown risks to participants as a consequence of the Covid-19 pandemic."
NCT04005079,WITHDRAWN,INTERVENTIONAL,not performing Trabectomes
NCT04005144,TERMINATED,INTERVENTIONAL,Low Accrual
NCT04005209,WITHDRAWN,INTERVENTIONAL,Decided not to open study
NCT04005235,TERMINATED,OBSERVATIONAL,"Covid-19 pandemic, aerosol generating procedures"
NCT04005547,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT04005989,WITHDRAWN,INTERVENTIONAL,Due to logistic issues during COVID-19 pandemic
NCT04006002,TERMINATED,OBSERVATIONAL,Not able to recruit enough patients
NCT04006392,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT04006496,TERMINATED,INTERVENTIONAL,Recruitment issues due to COVID-19 pandemic.
NCT04006652,TERMINATED,INTERVENTIONAL,Lost funding
NCT04006691,WITHDRAWN,INTERVENTIONAL,"Due to projected low enrollment, it has decided not to move forward with the study."
NCT04006847,TERMINATED,INTERVENTIONAL,Product complaint
NCT04007003,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04007094,TERMINATED,INTERVENTIONAL,Primary Investigator left university. Site completing follow up assessments for previously enrolled subject only.
NCT04007133,TERMINATED,OBSERVATIONAL,The study was conducted in the context of a medical thesis with a deadline.
NCT04007146,TERMINATED,INTERVENTIONAL,"With Covid period, inclusions can't be efficient."
NCT04007315,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04007367,TERMINATED,INTERVENTIONAL,Internal company decision
NCT04007562,WITHDRAWN,OBSERVATIONAL,The study never started
NCT04007588,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT04007614,WITHDRAWN,OBSERVATIONAL,The study never started
NCT04007822,WITHDRAWN,OBSERVATIONAL,Unable to collect data due to COVID19
NCT04007926,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04008043,WITHDRAWN,INTERVENTIONAL,Inadequate resources to start the study at this site.
NCT04008199,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT04008303,WITHDRAWN,OBSERVATIONAL,No participants enrolled since this study open. The Primary research member (medical school student) is no longer available to do this study
NCT04008459,TERMINATED,OBSERVATIONAL,Recruitment no longer viable as spinal classes were stopped due to the COVID-19 situation.
NCT04008550,TERMINATED,INTERVENTIONAL,"* Delay in enrolment (24% at 1 year)
* Lower than estimated prevalence of PAH (15% instead of 50%)
* Refusal of patients with PAH to participate"
NCT04008602,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04008849,TERMINATED,OBSERVATIONAL,Due to low enrollment
NCT04009031,TERMINATED,INTERVENTIONAL,COVID-19 pandemic halted recruitment as of March 2020.
NCT04009460,TERMINATED,INTERVENTIONAL,Sponsor's clinical development strategy adjustment
NCT04009486,WITHDRAWN,INTERVENTIONAL,Not approved for funding
NCT04009720,TERMINATED,OBSERVATIONAL,study device Lotus Edge was removed from the market
NCT04009850,TERMINATED,INTERVENTIONAL,Study enrollment was temporarily paused in 2020 due to COVID-19. Study was closed without further enrollment in 2022.
NCT04010045,TERMINATED,OBSERVATIONAL,Sponsor stopped the study for business reasons as site recruitment and subject enrollment have not met expectations.
NCT04010136,WITHDRAWN,INTERVENTIONAL,"We were not able to recruit participants to enrol the study. As it was not able, the investigation team decided not to proced."
NCT04010175,TERMINATED,INTERVENTIONAL,Recruitment stopped for thesis defense. It was not possible to extend the period of inclusion to achieve the patient objective
NCT04010851,WITHDRAWN,INTERVENTIONAL,to much uncertainty about possibilities for recruiting
NCT04011098,TERMINATED,INTERVENTIONAL,"Unable to meet recruitment numbers, lack of participation"
NCT04011202,TERMINATED,INTERVENTIONAL,Due to COVID-19; lack of recruitment; staff turnover.
NCT04011358,WITHDRAWN,INTERVENTIONAL,"Given the health context and the work overload, this study will not be possible. We therefore abandon this project"
NCT04011449,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT04011488,TERMINATED,INTERVENTIONAL,Low patient recruitment
NCT04011592,TERMINATED,INTERVENTIONAL,Recruitment not feasible
NCT04011605,WITHDRAWN,OBSERVATIONAL,No longer moving forward with study as of May 2022
NCT04011787,WITHDRAWN,INTERVENTIONAL,Funding withdrawn for the study
NCT04011891,WITHDRAWN,INTERVENTIONAL,The Ontario government is now funding robotic partial nephrectomies.
NCT04012099,TERMINATED,INTERVENTIONAL,Internal reasons
NCT04012255,TERMINATED,INTERVENTIONAL,The trial was terminated for strategic reasons.
NCT04012333,WITHDRAWN,INTERVENTIONAL,PI left site
NCT04012697,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT04012736,TERMINATED,OBSERVATIONAL,Inability to recruit and perform study visits due to COVID19 pandemic
NCT04013100,TERMINATED,OBSERVATIONAL,Departure of the main investigator
NCT04013126,TERMINATED,INTERVENTIONAL,slow recruitment rate
NCT04013217,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04013256,SUSPENDED,INTERVENTIONAL,The human exposure facility was closed by the University.
NCT04013373,TERMINATED,OBSERVATIONAL,Covid-19 pandemic
NCT04013399,WITHDRAWN,INTERVENTIONAL,Delayed due to Covid-19
NCT04013698,WITHDRAWN,INTERVENTIONAL,"Due to the COVID epidemics, starting with patient recruitement was not possible."
NCT04013763,TERMINATED,INTERVENTIONAL,"1. Limit number of patients during COVID-19 situation
2. Too small number of wheat allergic patients who are using wheat containing soap"
NCT04013880,WITHDRAWN,INTERVENTIONAL,Loss of funding
NCT04014049,TERMINATED,OBSERVATIONAL,"This study had to halt due to covid 19 pandemy.In fact, during the pandemy the two instutitions whose were included in this study were no longer accessible so this trial couldn't resume.In addition, the main criteria was invalidated by the pandemy."
NCT04014270,TERMINATED,INTERVENTIONAL,"* Challenges experienced in recruitment.
* Shifts in the sponsor's priorities and organizational structure resulting from its integration into a larger corporate group."
NCT04014361,TERMINATED,INTERVENTIONAL,HUAA study is terminated early due to a business decision.
NCT04014400,TERMINATED,INTERVENTIONAL,We observed that using the Suprathel dressing required additional treatment of the wound and had a longer healing time than the standard of care Xeroform dressing; it did not dry the wound out properly to promote healing.
NCT04014569,TERMINATED,INTERVENTIONAL,Investigators decision
NCT04014647,SUSPENDED,OBSERVATIONAL,Study on hold due to COVID-19 research pause
NCT04014712,WITHDRAWN,INTERVENTIONAL,Unable to recruit due to COVID-19 pandemic
NCT04015011,TERMINATED,INTERVENTIONAL,study enrollment ended early due to covid and lack of continued funding
NCT04015206,TERMINATED,INTERVENTIONAL,We completed One group intervention but the COVID Pandemic forced us to pause the research. We have preliminary data from 18 participants.
NCT04015219,TERMINATED,INTERVENTIONAL,enrollment constraints
NCT04015284,WITHDRAWN,INTERVENTIONAL,"This type of surgery is no longer done at HMR, relocated to other centers"
NCT04015310,WITHDRAWN,OBSERVATIONAL,Delays due to COVID prevented the start of recruitment and funding was no longer available.
NCT04015336,TERMINATED,INTERVENTIONAL,Logistical challenges
NCT04015557,SUSPENDED,INTERVENTIONAL,Study was interrupted due to COVID-19 pandemic
NCT04015895,TERMINATED,OBSERVATIONAL,low inclusion rates
NCT04015921,WITHDRAWN,OBSERVATIONAL,COVID-19
NCT04015947,WITHDRAWN,INTERVENTIONAL,Funding
NCT04016116,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT04016363,WITHDRAWN,INTERVENTIONAL,Industrial partner was not able to provide funding
NCT04016701,WITHDRAWN,INTERVENTIONAL,limited recruitment within study timeline
NCT04016792,WITHDRAWN,INTERVENTIONAL,Study stopped before enrollment due to non-safety related corporate decision.
NCT04016805,TERMINATED,INTERVENTIONAL,Strategic/Business decision
NCT04016935,TERMINATED,OBSERVATIONAL,It was determined that we had sufficient enrollment and study data to explore the impact of the Endopredict test in endocrine therapy decision-making.
NCT04017065,TERMINATED,OBSERVATIONAL,Decision by the sponsor
NCT04017130,TERMINATED,INTERVENTIONAL,Sparse/no patient enrollment
NCT04017208,WITHDRAWN,INTERVENTIONAL,A business decision was made to not initiate this study.
NCT04017390,WITHDRAWN,INTERVENTIONAL,Lack of Funding from Sponsor
NCT04017429,WITHDRAWN,INTERVENTIONAL,Not feasible to recruit and follow-up subjects due to the pandemic
NCT04017624,WITHDRAWN,INTERVENTIONAL,"The COVID-19 pandemic impacted study methods. Therefore, the study team opted not to conduct this study as written. The study never started and no participants were enrolled."
NCT04017637,WITHDRAWN,INTERVENTIONAL,Study cancelled
NCT04017910,TERMINATED,OBSERVATIONAL,Conversion to IDE
NCT04018196,TERMINATED,INTERVENTIONAL,End of inclusions
NCT04018417,WITHDRAWN,INTERVENTIONAL,Reconsidered significance in light of newly published in vitro data.
NCT04018469,WITHDRAWN,OBSERVATIONAL,not enough staff to execute study
NCT04018508,TERMINATED,INTERVENTIONAL,"COVID19 pandemic closed in-person clinics; LVAD surgeon left institution, stopping LVAD implants"
NCT04018521,WITHDRAWN,INTERVENTIONAL,inventional part of the study is registered under NCT05195489
NCT04019054,TERMINATED,INTERVENTIONAL,COVID
NCT04019067,WITHDRAWN,INTERVENTIONAL,few patients met all the inclusion criteria
NCT04019275,TERMINATED,INTERVENTIONAL,"The COVID pandemic impeded recruitment at two sites (Pitt 80% target recruitment, Wash U 70% target recruitment) and prohibited recruitment at one site (UIC). Study was terminated when funding was spent."
NCT04019470,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT04019600,SUSPENDED,OBSERVATIONAL,Recruitment in out-patient clinic has been suspended due to COVID-19 pandemic
NCT04019613,TERMINATED,INTERVENTIONAL,Study was stopped due to funding and time constraints.
NCT04019665,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04019769,WITHDRAWN,INTERVENTIONAL,PI left NIH. No subjects enrolled.
NCT04020042,TERMINATED,INTERVENTIONAL,Manpower issues
NCT04020094,WITHDRAWN,INTERVENTIONAL,funding source withdrawn
NCT04020211,TERMINATED,OBSERVATIONAL,Limited Enrollment
NCT04020224,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT04020276,SUSPENDED,INTERVENTIONAL,Interim analysis
NCT04020419,TERMINATED,INTERVENTIONAL,Study ending early due to program transferring to another site.
NCT04020458,TERMINATED,INTERVENTIONAL,Funding lapse and poor enrollment rate
NCT04020523,WITHDRAWN,INTERVENTIONAL,Delayed start due to technical problems as well as the covid pandemic. Decision of the investigator
NCT04020549,WITHDRAWN,INTERVENTIONAL,"In collaboration with community partners, we determined that the reading level required for the intervention did not make it suitable for the adolescents."
NCT04020653,WITHDRAWN,INTERVENTIONAL,"Considering the Thai FDA requirement, changes of Malaria cases in Thailand and EC recommendation, the decision to withdrawal the study was made."
NCT04020679,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT04020757,TERMINATED,INTERVENTIONAL,Biochemical measurement techniques were deemed insufficient to continue research
NCT04020926,TERMINATED,OBSERVATIONAL,Study was stopped due to COVID-19 pandemic.
NCT04021017,WITHDRAWN,INTERVENTIONAL,PI Workload
NCT04021082,WITHDRAWN,INTERVENTIONAL,Sponsor decision to not initiate the trial
NCT04021264,WITHDRAWN,INTERVENTIONAL,Inability to enroll participants.
NCT04021316,TERMINATED,INTERVENTIONAL,"DMC noted that the primary end point of healed index ulcer at 12 weeks was reached only in 11.5%, whereas a higher figure of 42.5% had been used for the original power calculation, suggesting the trial is significantly underpowered."
NCT04021446,WITHDRAWN,INTERVENTIONAL,PI left
NCT04021550,WITHDRAWN,INTERVENTIONAL,Covid-19 Pandemic prevented this study from beginning
NCT04021797,TERMINATED,INTERVENTIONAL,Study stopped due to COVID-19
NCT04021810,TERMINATED,INTERVENTIONAL,Lack of faisability
NCT04021914,TERMINATED,INTERVENTIONAL,Enrollment and study activities were terminated due to difficulties with recruitment of participants.
NCT04021927,WITHDRAWN,INTERVENTIONAL,Study withdrawn by funding organization with no participants enrolled
NCT04022278,WITHDRAWN,OBSERVATIONAL,The PI decided it.
NCT04022356,WITHDRAWN,INTERVENTIONAL,This study was not able to start within the time limit due to Coronavirus
NCT04022720,WITHDRAWN,INTERVENTIONAL,"No patients enrolled. Also, impacted of COVID on enrolling subjects hindered recruitment."
NCT04022876,TERMINATED,INTERVENTIONAL,With a favorable safety profile the difference between treatment groups for the primary composite endpoint was not sufficient to generate statistically significant results with the targeted sample size
NCT04023006,TERMINATED,OBSERVATIONAL,"No usable data were obtained. Therefore, the study was terminated."
NCT04023058,SUSPENDED,INTERVENTIONAL,Slow recruitment
NCT04023071,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor.
NCT04023305,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT04023721,TERMINATED,INTERVENTIONAL,Safety
NCT04023825,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04023981,TERMINATED,INTERVENTIONAL,Difficulties in recruiting eligible participants
NCT04024046,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT04024384,WITHDRAWN,INTERVENTIONAL,Promotor decision
NCT04024566,WITHDRAWN,OBSERVATIONAL,Company changed strategic direction in Oct 2019 (staff changes; no one at company who participated in this study
NCT04024826,TERMINATED,INTERVENTIONAL,Covid/19
NCT04025021,TERMINATED,INTERVENTIONAL,"Inability to enroll patients, sample collection"
NCT04025177,WITHDRAWN,INTERVENTIONAL,Halted due to feasibility issues
NCT04025216,TERMINATED,INTERVENTIONAL,The sponsor finds the risk/benefit analysis unfavorable and has terminated the study.
NCT04025307,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04025567,WITHDRAWN,INTERVENTIONAL,slow/insufficient accrual.
NCT04025632,TERMINATED,INTERVENTIONAL,The study was terminated based on the primary efficacy endpoint analysis after the first data lock.
NCT04025788,TERMINATED,OBSERVATIONAL,Slow enrolment. New generation BRS available
NCT04025892,WITHDRAWN,INTERVENTIONAL,Inadequate resources to support study start-up
NCT04025983,TERMINATED,INTERVENTIONAL,Recruitment was slow and disrupted by COVID-19.
NCT04026217,SUSPENDED,OBSERVATIONAL,reduced patients enrolment
NCT04026334,TERMINATED,INTERVENTIONAL,Insufficient subject accrual rate
NCT04026347,TERMINATED,INTERVENTIONAL,Missed endpoint
NCT04026451,WITHDRAWN,INTERVENTIONAL,It was suspendend because the protocol and the aims were modified
NCT04026464,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding to support this project
NCT04026516,SUSPENDED,INTERVENTIONAL,Staff shortages
NCT04026568,TERMINATED,INTERVENTIONAL,Study investigator left Institution
NCT04026750,TERMINATED,INTERVENTIONAL,Based on scientific data collected during the trial and high screen fail rate.
NCT04026880,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT04027205,WITHDRAWN,INTERVENTIONAL,Due to Covid-19 disruption
NCT04027270,WITHDRAWN,INTERVENTIONAL,Covid
NCT04027348,TERMINATED,INTERVENTIONAL,low accrual
NCT04027504,WITHDRAWN,INTERVENTIONAL,"The biscuits contain higher than the UK recommended daily dose of vitamins C and E, and selenium."
NCT04027569,WITHDRAWN,INTERVENTIONAL,Logistics (Research Staffing)
NCT04027855,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study
NCT04027946,TERMINATED,INTERVENTIONAL,Study was terminated due to slow accrual.
NCT04028336,TERMINATED,INTERVENTIONAL,Technical difficulties
NCT04028466,TERMINATED,INTERVENTIONAL,Budget for the study was withdrawn and discontinued
NCT04028609,TERMINATED,INTERVENTIONAL,COVID-19 prevented further enrollment
NCT04028622,WITHDRAWN,INTERVENTIONAL,The insufficient development of connection networks limit the teleconsultation deployment in the Grenoble metropolitan area
NCT04028635,TERMINATED,INTERVENTIONAL,"The study was terminated with a total of 35 patients finally enrolled, due to the Sars-Cov-2 (COVID-19) global pandemic breakout and the confinement measures considered."
NCT04028713,TERMINATED,INTERVENTIONAL,Too slow inclusion rate.
NCT04028752,WITHDRAWN,OBSERVATIONAL,Grant ended
NCT04028895,TERMINATED,INTERVENTIONAL,stopped by the sponsor
NCT04028960,TERMINATED,INTERVENTIONAL,Funding was rescinded
NCT04029038,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT04029077,WITHDRAWN,OBSERVATIONAL,COVID-19 and other treatments available
NCT04029298,WITHDRAWN,INTERVENTIONAL,Recruitment challenges and personnel changes during the pandemic
NCT04029545,TERMINATED,INTERVENTIONAL,The study was placed on hold for the FDA review of revisions of the protocol. Review time resulted in roll-over subjects to be out of window for enrollment.
NCT04029857,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT04029922,TERMINATED,INTERVENTIONAL,Study Reprioritization
NCT04029961,TERMINATED,INTERVENTIONAL,The study was suspended due to the COVID-19 pandemic. The study was then terminated to prevent inconsistencies in baseline anxiety for patients enrolled before vs after the COVID-19 pandemic.
NCT04030000,WITHDRAWN,INTERVENTIONAL,could not enroll anyone due to staff changes
NCT04030052,WITHDRAWN,INTERVENTIONAL,The Emi PUPs and Nuwiq ITI study has been closed due to slow enrollment and study site startup.
NCT04030351,TERMINATED,INTERVENTIONAL,Institution shut down due to COVID-19
NCT04030377,TERMINATED,OBSERVATIONAL,"Insufficient enrollment, question addressed by other researchers"
NCT04030572,TERMINATED,INTERVENTIONAL,Not logistically feasible during the COVID pandemic
NCT04030624,WITHDRAWN,INTERVENTIONAL,Funding discontinued due to changes in corporate structures
NCT04030793,TERMINATED,INTERVENTIONAL,The study was terminated due to difficulty in recruiting subjects
NCT04030871,TERMINATED,INTERVENTIONAL,Inability to recruit study participants
NCT04031066,WITHDRAWN,INTERVENTIONAL,"Big delay on study activation (approval procedures by IRBs, hospitals contract negotiation) and on enrolment deadline due to CoViD-19; Placebo stock expires November 2021 and new batch not be available for at least one year"
NCT04031300,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to change in project strategy (new intended use)
NCT04031404,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT04031521,WITHDRAWN,OBSERVATIONAL,No eligible patient were available/ found
NCT04031885,TERMINATED,INTERVENTIONAL,Business decision based on the inability to enroll subjects into the trial
NCT04031911,TERMINATED,INTERVENTIONAL,lack of enrollment due to covid 19
NCT04032015,WITHDRAWN,INTERVENTIONAL,Funding not currently active
NCT04032158,TERMINATED,INTERVENTIONAL,"Following analysis of open label extension (OLE) data from RMS phase 2 study (MS200527- 0086), it was determined that a change in active comparator warranted in phase 3 RMS comprised of trial MS200527-0073. Consequently, this trial terminated early."
NCT04032171,TERMINATED,INTERVENTIONAL,"Following analysis of open label extension (OLE) data from RMS phase 2 study (MS200527- 0086), it was determined that a change in active comparator warranted in phase 3 RMS comprised of trial MS200527-0074. Consequently, this trial terminated early."
NCT04032444,TERMINATED,OBSERVATIONAL,Sponsor terminated. No longer needed to support business need
NCT04032652,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT04032665,WITHDRAWN,OBSERVATIONAL,study design reconsidered
NCT04032691,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04032704,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT04032717,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic, study enrollment has been prematurely terminated."
NCT04032756,TERMINATED,OBSERVATIONAL,"not enough patients recruited, Study objective could not be achieved"
NCT04032925,TERMINATED,INTERVENTIONAL,Slow recruitment trend (COVID-10 pandemic related) - impossible to reach aim target within anticipated timeframe
NCT04033159,TERMINATED,INTERVENTIONAL,"Based on tolerability findings at the low dose level thus far, continuation of dosing or even dose escalation is not possible."
NCT04033328,TERMINATED,INTERVENTIONAL,IND Withdrawn
NCT04033458,TERMINATED,INTERVENTIONAL,stopped because of a business decision
NCT04033562,TERMINATED,INTERVENTIONAL,limited enrollment and unable to enroll subjects to reach statistical significance
NCT04033692,WITHDRAWN,OBSERVATIONAL,Manufacturer decided not to proceed with study.
NCT04033978,TERMINATED,INTERVENTIONAL,Termine
NCT04034225,TERMINATED,INTERVENTIONAL,Terminated by the sponsor
NCT04034355,TERMINATED,INTERVENTIONAL,"On 01 March 2020, the Sponsor decided to place recruitment and dosing of patients on hold following interactions with the French regulatory authority, ANSM and the US clinical hold of another study (POLAR-M)."
NCT04034381,TERMINATED,OBSERVATIONAL,Study suspended due to civil unrest and corresponding safety concerns and logistical challenges.
NCT04034615,WITHDRAWN,INTERVENTIONAL,The pandemic resulted in no enrollments
NCT04034745,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT04034914,TERMINATED,INTERVENTIONAL,Funding unavailable
NCT04035109,WITHDRAWN,INTERVENTIONAL,Study stopped due to COVID-19 pandemic.
NCT04035317,WITHDRAWN,INTERVENTIONAL,The graduate student quit.
NCT04035408,WITHDRAWN,OBSERVATIONAL,Low/No Accrual
NCT04035603,WITHDRAWN,INTERVENTIONAL,Never received funding
NCT04035668,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT04035772,TERMINATED,INTERVENTIONAL,Feasibility (barriers to implantation within the institution)
NCT04035850,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic
NCT04036071,TERMINATED,OBSERVATIONAL,Business reasons. High subject attrition at the 10-year time point leading to loss of statistical power and data value. Decision finalised: 05May2023.
NCT04036279,TERMINATED,OBSERVATIONAL,"This study was originally designed to meet MDR commitments. MDR Approval was secured without this study. Therefore, this study does not fulfil its role as a regulatory body commitment."
NCT04036721,SUSPENDED,INTERVENTIONAL,SARS-CoV-2 cases stopped the recruitment in Organisation since July 2020
NCT04037072,WITHDRAWN,INTERVENTIONAL,Study was not approved for Fox Chase Cancer Center's Research Review Committee (RRC)
NCT04037098,WITHDRAWN,INTERVENTIONAL,Lack of financial support and pandemia
NCT04037241,WITHDRAWN,INTERVENTIONAL,Sponsor terminated
NCT04037254,SUSPENDED,INTERVENTIONAL,Protocol specified toxicity analysis
NCT04037306,TERMINATED,INTERVENTIONAL,Weight loss center programming suspended due to COVID-19 pandemic
NCT04037631,TERMINATED,OBSERVATIONAL,recruitment
NCT04037865,TERMINATED,INTERVENTIONAL,The study was terminated due to extensive Covid-19 delay.
NCT04037891,TERMINATED,INTERVENTIONAL,"The trial has terminated early due to the disruptions caused by the ongoing COVID-19 pandemic. The decision was not related to any efficacy, safety or clinical concerns regarding rVA576/Coversin."
NCT04037917,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04038203,WITHDRAWN,OBSERVATIONAL,IRB expired. The Study will not be resumed.
NCT04038424,SUSPENDED,INTERVENTIONAL,Due to the Pandemic of COVID-19
NCT04038463,TERMINATED,INTERVENTIONAL,Pandemic
NCT04038489,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT04038593,WITHDRAWN,INTERVENTIONAL,COVID
NCT04038645,WITHDRAWN,INTERVENTIONAL,Researcher will no longer conduct the study
NCT04038671,WITHDRAWN,INTERVENTIONAL,The funding sponsor decided to move in a different direction and terminated the study before site began patient recruitment.
NCT04039178,TERMINATED,INTERVENTIONAL,"The study was terminated at the interim point due to the covid-19 pandemic, which did not allow completing full recruitment in relevant timelines"
NCT04039477,WITHDRAWN,INTERVENTIONAL,"Clinical trial activity slowdown due to COVID-19 pandemic, high screen fail rate, and lack of enrollment led to the decision to withdraw the MARINA study."
NCT04039529,WITHDRAWN,INTERVENTIONAL,covid pandemic
NCT04039542,TERMINATED,INTERVENTIONAL,COVID-19 restrictions limited recruitment
NCT04039620,TERMINATED,OBSERVATIONAL,COVID-19 pandemic and lack of funding necessary for continuation
NCT04039867,TERMINATED,INTERVENTIONAL,Trial was terminated due to halt in funding.
NCT04039919,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures"
NCT04039984,WITHDRAWN,INTERVENTIONAL,Decided the study on this implant was no longer relevant
NCT04040049,TERMINATED,INTERVENTIONAL,Freeline has decided to pause development of FLT190 in Fabry disease to focus its resources on advancing FLT201.
NCT04040075,TERMINATED,INTERVENTIONAL,"Unable to complete enrollment goals due to unanticipated factors of screen failures, covid pandemic, and continued staffing and enrollment difficulties"
NCT04040127,WITHDRAWN,INTERVENTIONAL,Did not obtain IRB approval
NCT04040140,TERMINATED,INTERVENTIONAL,Due to Covid 19.
NCT04040244,TERMINATED,INTERVENTIONAL,The PI is requesting this study to be closed due to the departure of the Co-PI who is an integral part of the study.
NCT04040400,TERMINATED,INTERVENTIONAL,per DMSC request
NCT04040621,TERMINATED,INTERVENTIONAL,"Following regulatory consultation, the Sponsor has decided to terminate the study and analyze the current dataset. The decision to terminate was solely based on a business decision, not due to safety concerns."
NCT04040725,WITHDRAWN,INTERVENTIONAL,Withdrawn per Bayer
NCT04040790,TERMINATED,INTERVENTIONAL,"Several reasons: Financing ended before all study assessments were performed, covid-19 delayed design, production and shipment of IMD, experience gained during the study made it clear that lens design should be changed"
NCT04040829,SUSPENDED,INTERVENTIONAL,A feasibility study will be conducted to assess the online administration of the cognitive remediation program CIRCuiTS.
NCT04040985,TERMINATED,INTERVENTIONAL,"There is no regulatory or otherwise commitment to continue to follow up to the 10-year time point. The study data had met the primary objectives. After a business review, Smith+Nephew had decided to terminate the study prematurely."
NCT04041024,TERMINATED,INTERVENTIONAL,The PI has left the hospital and no one is replacing him
NCT04041037,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT04041141,WITHDRAWN,OBSERVATIONAL,replaced with other study
NCT04041258,TERMINATED,INTERVENTIONAL,the number of patients was not sufficient to support continuation of the study
NCT04041362,WITHDRAWN,INTERVENTIONAL,The study will not be submitted to authority for IND application.
NCT04041505,TERMINATED,INTERVENTIONAL,"Interim analysis (n=40 24-hr sessions) yielded biologically implausible data. We do not deem this novel, at-home, participant-led method prudent. Study will continue with only secondary objectives; primary objective (RCT) terminated."
NCT04041596,WITHDRAWN,INTERVENTIONAL,Due to a lack of enrollment
NCT04041674,WITHDRAWN,INTERVENTIONAL,Protocol undergoing additional revisions.
NCT04041830,TERMINATED,INTERVENTIONAL,The sanitary conditions and material restrictions imposed by the CHU and by the university laboratories drastically hampered the realization of this work (with restricted access to the laboratory/department).
NCT04041895,WITHDRAWN,OBSERVATIONAL,Unsuccessful in recruiting participants for that study because we needed subjects who had performed Amyloid PET imaging in the last year
NCT04041908,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04041921,TERMINATED,OBSERVATIONAL,The purpose of this study is no longer maintained
NCT04042051,TERMINATED,INTERVENTIONAL,Accrual rate to date was too low to finish the trial in a reasonable timeframe
NCT04042077,TERMINATED,INTERVENTIONAL,COVID-19 seriously affected the study execution as required by the protocol
NCT04042116,SUSPENDED,INTERVENTIONAL,Company decision
NCT04042168,WITHDRAWN,INTERVENTIONAL,No subject met criteria for enrollment and study was stopped due to the pandemic
NCT04042480,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT04042506,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients in this study
NCT04042623,TERMINATED,INTERVENTIONAL,Business reasons
NCT04042727,TERMINATED,INTERVENTIONAL,"Futility, as a result of CIVID-19 impact"
NCT04043026,TERMINATED,OBSERVATIONAL,Slow recruitment due to COVID19 pandemic
NCT04043091,WITHDRAWN,INTERVENTIONAL,Not enough patients
NCT04043117,TERMINATED,OBSERVATIONAL,Study was stopped due to covid-19 sanitary restrinction in the oncology ward and day hospital.
NCT04043377,TERMINATED,INTERVENTIONAL,Financial issues
NCT04043455,TERMINATED,INTERVENTIONAL,Business Decision
NCT04043468,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04043845,WITHDRAWN,INTERVENTIONAL,Business development reasons.
NCT04043910,TERMINATED,INTERVENTIONAL,Very difficult to include all patients
NCT04044170,TERMINATED,INTERVENTIONAL,Study termination by the Sponsor
NCT04044209,WITHDRAWN,INTERVENTIONAL,No patients were able to be screened nor enrolled.
NCT04044326,WITHDRAWN,INTERVENTIONAL,Machine cannot provide
NCT04044378,WITHDRAWN,INTERVENTIONAL,toxicity
NCT04044391,TERMINATED,OBSERVATIONAL,Study was defunded.
NCT04044430,TERMINATED,INTERVENTIONAL,Sponsor funding
NCT04044560,TERMINATED,INTERVENTIONAL,"Slow enrolment, loss of funding"
NCT04044651,WITHDRAWN,INTERVENTIONAL,Bristol-Myers Squibb company terminated this study
NCT04044742,WITHDRAWN,INTERVENTIONAL,To be replaced by a different protocol
NCT04044781,WITHDRAWN,INTERVENTIONAL,Change in Research Direction
NCT04044846,WITHDRAWN,INTERVENTIONAL,The COVID-19 pandemic caused several challenges with recruitment in the home care sector. It was not possible to proceed with the study as originally intended in this clinical trial record.
NCT04044950,WITHDRAWN,INTERVENTIONAL,The study was closed due to investigator discretion based on the lack of ability to recruit patients and research goals of the program.
NCT04045028,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04045236,WITHDRAWN,OBSERVATIONAL,no pts enrolled
NCT04045353,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT04045704,WITHDRAWN,INTERVENTIONAL,No study coordinator available. No patient recruitment possible.
NCT04045730,WITHDRAWN,INTERVENTIONAL,Halozyme isn't allowing this trial to move forward until their current clinical trial results are released.
NCT04045821,TERMINATED,INTERVENTIONAL,low enrollment
NCT04046107,WITHDRAWN,INTERVENTIONAL,Temporarily closed to enrollment
NCT04046328,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT04046406,WITHDRAWN,INTERVENTIONAL,There were issues with equipment and team fell apart due to departure of some members from the institution.
NCT04046848,TERMINATED,INTERVENTIONAL,Study was terminated due to SADRs
NCT04046887,TERMINATED,INTERVENTIONAL,Unable to proceed due to Neulasta difficulties and other complications.
NCT04046978,WITHDRAWN,INTERVENTIONAL,MOSAIC was withdrawn and the study was incorporated into EAVI2020-01 (NCT03816137) as a substantial amendment.
NCT04047537,TERMINATED,INTERVENTIONAL,Covid interference
NCT04047771,TERMINATED,INTERVENTIONAL,terminated
NCT04047836,WITHDRAWN,INTERVENTIONAL,Please see NCT04053868 for the current version of this study
NCT04047966,TERMINATED,OBSERVATIONAL,"Due to the current pandemic situation, recruitment has been disrupted by the inability to recruit more patients"
NCT04048187,WITHDRAWN,INTERVENTIONAL,"PMCF data, originally planned to be collected withthis study, are collected using another methodology"
NCT04048668,SUSPENDED,INTERVENTIONAL,Suspended due to COVID-19
NCT04048707,WITHDRAWN,INTERVENTIONAL,Funding issues; the study was never started
NCT04048746,TERMINATED,OBSERVATIONAL,The PI decided to stop.
NCT04048863,TERMINATED,INTERVENTIONAL,This study was terminated due to recruitment futility resulting from the significant impact of the COVID-19 pandemic to our intended study population and facility personnel.
NCT04048876,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT04049071,TERMINATED,OBSERVATIONAL,Covid-19
NCT04049097,TERMINATED,INTERVENTIONAL,"As a consequence of the results of IBM4809 which did not meet any of its efficacy endpoints. The planned duration of open-label treatment was 40 months. After termination, the actual mean duration of treatment was approx. 28 weeks."
NCT04049175,TERMINATED,INTERVENTIONAL,An interim analysis run by an independent data monitoring committee (DMC) to assess futility met the protocol-defined futility rules. The DMC recommended to stop the study for futility. The Sponsor issued a notification of early study termination.
NCT04049266,TERMINATED,INTERVENTIONAL,Primary Endpoint Not Met
NCT04049487,TERMINATED,INTERVENTIONAL,Covid
NCT04049500,WITHDRAWN,OBSERVATIONAL,study was never started
NCT04049578,TERMINATED,INTERVENTIONAL,Recent analysis of Phase II balovaptan data in paediatric ASD did not support the continuation of this study. No new safety concerns were identified.
NCT04049617,TERMINATED,INTERVENTIONAL,Gilead decision to terminate
NCT04049682,WITHDRAWN,OBSERVATIONAL,Study never recruited subjects
NCT04049721,WITHDRAWN,INTERVENTIONAL,Lack of manpower; logistic issues regarding the move of the in-hospital hyperbaric oxygen (HBO) chamber to an off-site location.
NCT04049981,TERMINATED,INTERVENTIONAL,COVID-19
NCT04050358,WITHDRAWN,INTERVENTIONAL,Lack of Funds
NCT04050852,WITHDRAWN,INTERVENTIONAL,no enrolled prospects
NCT04050969,TERMINATED,INTERVENTIONAL,Difficult enrollment
NCT04050982,TERMINATED,INTERVENTIONAL,Acquisition of digital messaging company and decision made to withdraw study support
NCT04051047,WITHDRAWN,INTERVENTIONAL,Withdrawn by Principal Investigator
NCT04051229,TERMINATED,INTERVENTIONAL,"Due to financial limitations and time commitments, I am requesting the closure of this research"
NCT04051242,TERMINATED,INTERVENTIONAL,Did not complete planned enrollment.
NCT04051801,WITHDRAWN,INTERVENTIONAL,Further development has been outlicensed to Acadia Pharmaceuticals
NCT04051853,TERMINATED,INTERVENTIONAL,Slow accrual.
NCT04051866,WITHDRAWN,INTERVENTIONAL,Due to a Cochrane review whose authors conclude that further trials evaluating periodontal treatment versus no treatment/usual care are unlikely to change the overall conclusion reached in this review.
NCT04051957,TERMINATED,INTERVENTIONAL,Delays due to COVID and loss of research coordinator.
NCT04051996,TERMINATED,INTERVENTIONAL,Unable to accrue patients following COVID-19 study pause.
NCT04052061,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT04052204,TERMINATED,INTERVENTIONAL,Study prematurely terminated as the experimental treatments evaluated in study B9991040 may not provide additional clinical benefit over current or future Standard of Care in the different therapeutic indications that this trial was to evaluate.
NCT04052269,SUSPENDED,INTERVENTIONAL,suspended due to COVID
NCT04052347,TERMINATED,INTERVENTIONAL,Covid related
NCT04052581,WITHDRAWN,OBSERVATIONAL,The study is not relevant anymore.
NCT04052607,TERMINATED,INTERVENTIONAL,Due to COVID19 Pandemic effect on 2020.
NCT04052672,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 Pandemic Recruitment was not started
NCT04053062,SUSPENDED,INTERVENTIONAL,Due to efficacy evaluation
NCT04053153,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT04053179,WITHDRAWN,INTERVENTIONAL,Technical and financial feasibility of the study cannot be assured by the sponsor.
NCT04053309,TERMINATED,OBSERVATIONAL,low enrollment
NCT04053491,WITHDRAWN,INTERVENTIONAL,funding not obtained
NCT04053543,TERMINATED,INTERVENTIONAL,LOE
NCT04053946,WITHDRAWN,INTERVENTIONAL,Site backed out
NCT04054115,TERMINATED,INTERVENTIONAL,Covid 19 and difficulty with recruitment
NCT04054141,TERMINATED,INTERVENTIONAL,Did not meet target enrollment
NCT04054180,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT04054245,WITHDRAWN,INTERVENTIONAL,"""Company is in a process of being taken over by another pharma and the new one has different ideas on how to pursue studies with this drug"""
NCT04054323,WITHDRAWN,INTERVENTIONAL,no physical therapist available
NCT04054427,WITHDRAWN,INTERVENTIONAL,Did not start study due to EC board rejection
NCT04054687,SUSPENDED,INTERVENTIONAL,Due to coronavirus pandemic
NCT04054752,WITHDRAWN,INTERVENTIONAL,No subjects enrolled.
NCT04054856,TERMINATED,INTERVENTIONAL,Due to COVID-19 pandemic and new regulatory requirements
NCT04054973,WITHDRAWN,INTERVENTIONAL,Study was unable to be started due to unavailability of study medication.
NCT04055155,WITHDRAWN,OBSERVATIONAL,Pandemic halt
NCT04055168,TERMINATED,INTERVENTIONAL,It was decided to not run the Japanese cohorts in the study.
NCT04055389,WITHDRAWN,INTERVENTIONAL,Challenges with recruitment
NCT04055532,WITHDRAWN,OBSERVATIONAL,Lack of regulatory approval
NCT04055896,TERMINATED,INTERVENTIONAL,COVID-19 precautions precluded recruitment in long-term care facilities
NCT04055987,WITHDRAWN,INTERVENTIONAL,PI retired and co investigator left institution.
NCT04056000,WITHDRAWN,INTERVENTIONAL,ethical and governance issues not resolved
NCT04056299,TERMINATED,INTERVENTIONAL,"The study was prematurely terminated by the Sponsor based on difficulties in meeting enrollment goals, especially during the COVID-19 pandemic, and not for reasons relating to any concerns regarding quality, safety, or efficacy."
NCT04056429,WITHDRAWN,INTERVENTIONAL,study never started and is delayed until further notice
NCT04056611,TERMINATED,INTERVENTIONAL,A strategic decision was made to discontinue the study. The decision was not based on a safety concern.
NCT04056637,TERMINATED,INTERVENTIONAL,COVID-19 Impacted Service Delivery and Research Infrastructure
NCT04056650,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04056741,SUSPENDED,INTERVENTIONAL,alteration of study required
NCT04057001,TERMINATED,OBSERVATIONAL,Unable to achieve adequate number of HCV+ donor offers
NCT04057014,WITHDRAWN,INTERVENTIONAL,No funding available for the activity
NCT04057261,WITHDRAWN,INTERVENTIONAL,"A study start is currently not foreseeable for organizational reasons. Due to the delays, research has also been focused on new compounds, which has reduced the interest in the potential results of the above-mentioned clinical trial."
NCT04057365,TERMINATED,INTERVENTIONAL,"Based on a Simon 2-stage design, this study did not meet response criteria to proceed to stage 2."
NCT04057391,SUSPENDED,OBSERVATIONAL,This study was suspended by QTultrasound as other studies were reprioritized.
NCT04057885,WITHDRAWN,INTERVENTIONAL,Lead Investigator no longer with institution
NCT04058106,WITHDRAWN,OBSERVATIONAL,NO Participants Enrolled
NCT04058132,TERMINATED,INTERVENTIONAL,"funding ran out after unanticipated length of time ( for IRB approval, CRADA, and start letter"
NCT04058145,WITHDRAWN,INTERVENTIONAL,Funding Withdrawn
NCT04058197,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT04058249,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT04058301,TERMINATED,INTERVENTIONAL,COVID-19
NCT04058964,WITHDRAWN,INTERVENTIONAL,Study withdrawn by supporter
NCT04058977,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to participant enrollment due to funding status
NCT04059042,TERMINATED,INTERVENTIONAL,Research activities suspended March 2020 due to COVID-19 pandemic.
NCT04059094,TERMINATED,INTERVENTIONAL,Not due to safety reasons
NCT04059159,TERMINATED,INTERVENTIONAL,The investigation of this device has been transitioned into a new study by the sponsor. The data generated in this study will not be used to support a marketing application
NCT04059198,TERMINATED,INTERVENTIONAL,Evidence of liver injury in a separate Inarigavir study
NCT04059302,TERMINATED,INTERVENTIONAL,Intervention services were suspended and then unavailable.
NCT04059406,TERMINATED,INTERVENTIONAL,"Favorable safety and tolerability were seen, but efficacy results in the mid-stage study did not meet Ionis' minimum target product profile to justify further development."
NCT04059445,TERMINATED,INTERVENTIONAL,Recruitment problem
NCT04059458,TERMINATED,INTERVENTIONAL,Recruitment problem
NCT04059536,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT04059653,TERMINATED,INTERVENTIONAL,COVID19 pandemic. Cannot recruit from primary care during pandemic
NCT04059666,TERMINATED,INTERVENTIONAL,Slow enrolment
NCT04059757,WITHDRAWN,INTERVENTIONAL,Drugs unavailable
NCT04059822,SUSPENDED,INTERVENTIONAL,Recruitment on hold - funding
NCT04059965,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04060147,TERMINATED,INTERVENTIONAL,The study enrollment was terminated early by the sponsor due to recruitment challenges.
NCT04060225,TERMINATED,INTERVENTIONAL,not possible to enroll during COVID pandemic
NCT04060251,TERMINATED,INTERVENTIONAL,"Due to limitations caused by COVID, enrollment targets could not be met."
NCT04060329,TERMINATED,INTERVENTIONAL,Reasons associated with COVID-19 pandemic led to cancellation of Phase 2
NCT04060342,TERMINATED,INTERVENTIONAL,No clear benefit of GB1275 was observed either as monotherapy or in combination with pembrolizumab.
NCT04060407,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT04060563,TERMINATED,INTERVENTIONAL,Enrollment too slow.
NCT04060693,WITHDRAWN,INTERVENTIONAL,Miscommunication with the CRO that was hired to help with the regulatory submission process
NCT04060849,SUSPENDED,INTERVENTIONAL,"Enrollment temporarily on hold, pending protocol and study document updates"
NCT04060862,TERMINATED,INTERVENTIONAL,The decision to not open the Phase III portion was based on a strategic sponsor decision and not driven by any safety concerns.
NCT04060888,WITHDRAWN,INTERVENTIONAL,"Pre-planned IA (global study) showed lack of efficacy in this indication. No new safety signals observed, findings consistent with known profile."
NCT04061031,WITHDRAWN,INTERVENTIONAL,COVID
NCT04061304,WITHDRAWN,INTERVENTIONAL,Challenges with funding acquisition prevented study commencement.
NCT04061317,TERMINATED,OBSERVATIONAL,COVID Restrictions in a vulnerable population.
NCT04061330,WITHDRAWN,INTERVENTIONAL,Study was terminated prior to enrollment due to lack of funding
NCT04061369,TERMINATED,INTERVENTIONAL,"After Covid-19 pandemic, room calorimeter not functional"
NCT04061499,WITHDRAWN,OBSERVATIONAL,COVID-19
NCT04061577,TERMINATED,INTERVENTIONAL,Interim Analysis
NCT04061590,WITHDRAWN,INTERVENTIONAL,Low Accrual
NCT04062383,TERMINATED,INTERVENTIONAL,In-person recruitment deemed not feasible due to COVID
NCT04062539,SUSPENDED,OBSERVATIONAL,Waiting for funding
NCT04062838,WITHDRAWN,INTERVENTIONAL,I did not receive funding to finance this study
NCT04062903,TERMINATED,INTERVENTIONAL,COVID Pandemic
NCT04063150,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT04063228,TERMINATED,INTERVENTIONAL,Lack of resources
NCT04063241,SUSPENDED,INTERVENTIONAL,Study suspended due to Covid-19
NCT04063410,WITHDRAWN,INTERVENTIONAL,"We are closing this study as our clinical partners have all relocate from OSU and we could not find continued interest. However, we demonstrated the feasibility of this imaging approach on which we also filed a patent."
NCT04063436,WITHDRAWN,INTERVENTIONAL,Clinical trial was cancelled
NCT04063618,TERMINATED,INTERVENTIONAL,Insufficient subject enrollment
NCT04063657,TERMINATED,INTERVENTIONAL,Study was slow to recruit. PI decided to close study to focus on other trials.
NCT04063865,TERMINATED,INTERVENTIONAL,Study was larger than expected and became a burden to faculty and staff resources.
NCT04063904,TERMINATED,INTERVENTIONAL,"Difficulties with recruitment, COVID 19 pandemic"
NCT04063943,WITHDRAWN,INTERVENTIONAL,Sponsor has decided there is not a business need for this study and is not required to complete.
NCT04064021,WITHDRAWN,INTERVENTIONAL,due to covid19 pandemic
NCT04064346,TERMINATED,INTERVENTIONAL,The decision is based on a thorough reassessment of the commercial potential of lixivaptan as a potential best-in-class therapy for patients with autosomal dominant polycystic kidney disease (ADPKD).
NCT04064658,SUSPENDED,INTERVENTIONAL,waiting for the ethics approval of collaborator affiliation
NCT04064684,TERMINATED,INTERVENTIONAL,Enrollment difficulties after the start of the COVID-19 pandemic.
NCT04064697,TERMINATED,INTERVENTIONAL,low of inclusions
NCT04064879,SUSPENDED,INTERVENTIONAL,Pending FDA approval
NCT04064918,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 related restrictions it was decided to close this study
NCT04065087,WITHDRAWN,INTERVENTIONAL,Canceled by the sponsor
NCT04065139,SUSPENDED,INTERVENTIONAL,It was stopped following the recommendations of the trial Independent DSMB : Permanent discontinuation of inclusions (related to a suspected higher number of deaths in the experimental ARM)
NCT04065165,WITHDRAWN,INTERVENTIONAL,Company decision
NCT04065360,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 pandemic
NCT04065568,TERMINATED,INTERVENTIONAL,The pandemic. Collected data will presented as a pilot RCT.
NCT04065685,SUSPENDED,INTERVENTIONAL,Covid-19: participants is a population at risk
NCT04065841,TERMINATED,INTERVENTIONAL,The sponsor made a business decision to stop development of the trial drugs. The decision to stop the trial early was not because of any safety concerns.
NCT04065958,SUSPENDED,INTERVENTIONAL,1st: Covid-19 pandemic. 2nd: Lack of resources
NCT04065997,TERMINATED,OBSERVATIONAL,"Due to Medtronic's decisions to stop sales and distribution of the HVAD System and subsequent stop of study enrollments, limited data will be available. Therefore it is not expected to provide new insights."
NCT04066088,WITHDRAWN,INTERVENTIONAL,PI departure from institution
NCT04066231,TERMINATED,INTERVENTIONAL,Investigational medical device no longer available
NCT04066413,TERMINATED,INTERVENTIONAL,Due to recruitment difficulties
NCT04066478,SUSPENDED,INTERVENTIONAL,Sponsor
NCT04066491,TERMINATED,INTERVENTIONAL,"Based on a review of data conducted by the Independent Data Monitoring Committee (IDMC), Sponsor decided to discontinue this study as the study was unlikely to achieve the primary objective of overall survival."
NCT04066595,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT04066647,TERMINATED,INTERVENTIONAL,Interim analysis shows results opposite of hypothesized.
NCT04066738,TERMINATED,INTERVENTIONAL,Unable to recruit
NCT04066751,WITHDRAWN,INTERVENTIONAL,Study never started due to change in availability of study drug
NCT04066790,TERMINATED,INTERVENTIONAL,We terminated this trial and initiated a new one including pertuzumab.
NCT04066894,TERMINATED,INTERVENTIONAL,Due to Issues Enrolling Patients
NCT04067102,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT04067180,TERMINATED,INTERVENTIONAL,"Delayed enrollment due to COVID-19 pandemic and other non-alterable world events, including war. The time elapsed when the study was paused has lowered the relevance of the study."
NCT04067362,TERMINATED,INTERVENTIONAL,COVID-19
NCT04067492,TERMINATED,INTERVENTIONAL,"In view of the continuing insufficient patient recruitment in the study due to the difficult epidemiological situation and the need for rational allocation of company resources, as well as based on the results of the interim analysis."
NCT04067544,TERMINATED,INTERVENTIONAL,Unforeseen complications due to COVID-19 and funding
NCT04067804,TERMINATED,INTERVENTIONAL,the project could no longer be implemented effectively and with fidelity
NCT04067856,WITHDRAWN,INTERVENTIONAL,Inadequate patient enrollment
NCT04068259,TERMINATED,INTERVENTIONAL,PK data from first 3 cohorts does not support study continuation.There was no safety concerns
NCT04068402,WITHDRAWN,INTERVENTIONAL,Company changed strategic direction in Oct 2019
NCT04068493,TERMINATED,INTERVENTIONAL,Principal investigator is transitioning to a new faculty position at another institution.
NCT04068610,TERMINATED,INTERVENTIONAL,"On 17 February 2022, the decision was made to terminate the clinical study because superior efficacy was not observed for the novel study drug combinations under investigation."
NCT04068805,TERMINATED,INTERVENTIONAL,The Sponsor chose to terminate this study for commercial reasons.
NCT04068857,WITHDRAWN,INTERVENTIONAL,Study not going forward at this time.
NCT04069000,TERMINATED,INTERVENTIONAL,We collected pre-intervention data but the COVID-19 pandemic and resulting school closures ended the intervention; thus post-intervention data were not collected. Our funding window has closed and we will not recommence this study.
NCT04069234,WITHDRAWN,INTERVENTIONAL,Sponsor decided to stop the study due to commercial reasons.
NCT04069260,TERMINATED,INTERVENTIONAL,"Due to study design limitations, this study has been discontinued and will not proceed with the 2nd cohort as contemplated in the original protocol."
NCT04069442,WITHDRAWN,OBSERVATIONAL,access to human body samples by another existing cohort
NCT04069572,SUSPENDED,INTERVENTIONAL,New investigational devices are currently under development.
NCT04069741,TERMINATED,INTERVENTIONAL,Data difficult to collect due to the COVID-19 pandemic.
NCT04069910,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT04069936,TERMINATED,INTERVENTIONAL,Resourcing
NCT04070157,SUSPENDED,INTERVENTIONAL,COVID pandemic and enrollment issues necessitating an adjustment to the study design.
NCT04070313,TERMINATED,INTERVENTIONAL,"Study treatment is to use TS-1 (mono-chemotherapy agent) in adjuvant setting for pancreatic cancer, which may be less clinical benefit compared to combination therapy according to current trend at investigators' discretion."
NCT04070508,WITHDRAWN,OBSERVATIONAL,Staff in the lab have transitioned to a new institution so there are no personnel available to recruit or resume the study.
NCT04070781,TERMINATED,INTERVENTIONAL,The primary reason for study closure is slow enrollment.
NCT04070989,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate early. Decision was not based on safety or efficacy of the study product.
NCT04071041,TERMINATED,INTERVENTIONAL,Low recruitment
NCT04071236,SUSPENDED,INTERVENTIONAL,End of Initial Phase of Multi-phase protocol
NCT04071626,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04071743,WITHDRAWN,INTERVENTIONAL,Primary Investigator left UT Southwestern and was not replaced.
NCT04071756,TERMINATED,INTERVENTIONAL,Difficulty with patient recruitment
NCT04072016,TERMINATED,INTERVENTIONAL,"Significant risks (e.g., infection, endothelial cell loss) and high rate of channel plugging associated with product use."
NCT04072055,TERMINATED,OBSERVATIONAL,recruitment difficulty in the centers
NCT04072367,WITHDRAWN,INTERVENTIONAL,The study was withdrawn due to a change in company strategy.
NCT04072406,TERMINATED,INTERVENTIONAL,Covid-19
NCT04072471,WITHDRAWN,OBSERVATIONAL,The study was withdrawn as lesinurad was withdrawn from the market in Europe by the market authorization holder. Hence the commitment to do this PASS was removed by the European Medicines Agency.
NCT04072484,TERMINATED,INTERVENTIONAL,Research at the University of Chicago was halted in March 2020.
NCT04072601,TERMINATED,INTERVENTIONAL,Study part one completed
NCT04072874,WITHDRAWN,INTERVENTIONAL,Tthe study is in the approval phase by local regulatory authorities
NCT04073017,TERMINATED,INTERVENTIONAL,Low accrual
NCT04073134,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT04073147,TERMINATED,INTERVENTIONAL,low recruitment
NCT04073160,WITHDRAWN,INTERVENTIONAL,Study will not be completed. No participants were enrolled.
NCT04073212,WITHDRAWN,INTERVENTIONAL,Withdrawn due to inability to recruit and enroll during COVID-19
NCT04073407,TERMINATED,INTERVENTIONAL,Sponsor has determined that information it would have collected would not inform future development of a therapy with AXA 1957 for NAFLD
NCT04073472,WITHDRAWN,INTERVENTIONAL,This clinical trial was entered in error. Please refer to the correct entry of this study using the following link: https://clinicaltrials.gov/ct2/show/NCT04519684
NCT04073485,TERMINATED,INTERVENTIONAL,poor patient accrual
NCT04073823,TERMINATED,INTERVENTIONAL,Due to unforeseen slow enrollment and a shift in corporate resources due to the COVID-19 impact.
NCT04074226,TERMINATED,INTERVENTIONAL,Inability to recruit patients for the past several months due to all the staffing shortages and changes to the surgeons' practice patterns
NCT04074252,WITHDRAWN,INTERVENTIONAL,Unable to complete intervention due to logistics.
NCT04074330,TERMINATED,INTERVENTIONAL,Enrolment Challenges
NCT04074590,TERMINATED,INTERVENTIONAL,Sponsor decision due to strategic considerations
NCT04074811,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04074954,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT04075071,TERMINATED,INTERVENTIONAL,Intervention and and final data collection point was not completed due to coronavirus school closures in March 2020.
NCT04075136,WITHDRAWN,INTERVENTIONAL,IRB stopped study due to safety concerns before any participants were enrolled.
NCT04075552,WITHDRAWN,INTERVENTIONAL,Disruptions due to COVID-19
NCT04075721,TERMINATED,INTERVENTIONAL,The study was early discontinued due to lack of participant enrollment.
NCT04075799,TERMINATED,INTERVENTIONAL,Due to COVID-19 restrictions.
NCT04076345,TERMINATED,OBSERVATIONAL,investigator not available
NCT04076566,WITHDRAWN,OBSERVATIONAL,Update to clinical strategy - COVID impact
NCT04076761,TERMINATED,INTERVENTIONAL,Lack of Funding
NCT04076852,TERMINATED,OBSERVATIONAL,"Satisfactory results, in terms of both clinical and statistical, were achieved."
NCT04076917,TERMINATED,OBSERVATIONAL,"This study was terminated by the sponsor since study timelines were extended significantly due to slow enrollment, partly influenced by the COVID-19 pandemic."
NCT04077021,TERMINATED,INTERVENTIONAL,Business decision
NCT04077164,TERMINATED,OBSERVATIONAL,Resources not available.
NCT04077372,TERMINATED,INTERVENTIONAL,Covid-19
NCT04077385,WITHDRAWN,INTERVENTIONAL,PI resigned from faculty position and K23 award was terminated early
NCT04077398,WITHDRAWN,INTERVENTIONAL,"covid interrupted initial start, then trainees involved finished program and no one took it on"
NCT04077450,WITHDRAWN,INTERVENTIONAL,Changed the direction and aims of the study
NCT04077749,WITHDRAWN,INTERVENTIONAL,The study never started. It was withdrawn from the IRB.
NCT04078074,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT04078438,TERMINATED,INTERVENTIONAL,Because of researcher foreign training
NCT04078581,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04078854,TERMINATED,INTERVENTIONAL,IRB approval expired on 3/16/2022. Study would need to be reapproved by the IRB with a new submission given the duration of expiration.
NCT04079088,WITHDRAWN,INTERVENTIONAL,"Decision to discontinue BIIB061 program was based on lack of stronger preclinical effects of BIIB061 on remyelination relative to opicinumab, that showed limited clinical efficacy in phase 2 clinical studies. This was not related to safety concerns."
NCT04079114,TERMINATED,OBSERVATIONAL,Stafit Acetabular System not CE marked anymore
NCT04079205,TERMINATED,INTERVENTIONAL,Due to difficulty in patient enrollment
NCT04079231,WITHDRAWN,INTERVENTIONAL,This study was cancelled due to COVID-19.
NCT04079439,TERMINATED,INTERVENTIONAL,"Because of COVID-19 the study was stopped. It has been changed to include a pilot trial, which has been conducted in 2021/2022 (trial registration: NCT04929106). The RCT will hopefully be conducted in the near future."
NCT04079491,TERMINATED,OBSERVATIONAL,Poor responce
NCT04079738,TERMINATED,INTERVENTIONAL,Funder requested termination due to halting internal development of TAK-659
NCT04079881,TERMINATED,INTERVENTIONAL,Loss of funding
NCT04080076,WITHDRAWN,INTERVENTIONAL,Study was updated and issued a new NCT number.
NCT04080791,WITHDRAWN,INTERVENTIONAL,Unable to enroll
NCT04080908,TERMINATED,INTERVENTIONAL,Unable to meet enrollment goals.
NCT04081090,TERMINATED,INTERVENTIONAL,Delay due to COVID. Lost funding.
NCT04081298,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT04081480,TERMINATED,INTERVENTIONAL,"Interim analysis showed positive results, it was difficult to include patients and also the fact that the grant for this project has ended, we have decided to complete the study before we had included the total number of 16 patients."
NCT04081506,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic
NCT04081584,TERMINATED,OBSERVATIONAL,COVID-19
NCT04081597,WITHDRAWN,INTERVENTIONAL,Change in Clinical Strategy
NCT04081623,TERMINATED,OBSERVATIONAL,COVID-19
NCT04081727,TERMINATED,INTERVENTIONAL,"After the second surgery, enrollment was stopped for reasons unrelated to the study design or test article."
NCT04082000,TERMINATED,INTERVENTIONAL,study stopped due to company strategic prioritization
NCT04082468,WITHDRAWN,OBSERVATIONAL,Never started enrollment due to logistics.
NCT04082481,WITHDRAWN,INTERVENTIONAL,"The study stopped early, before enrolling its first participant."
NCT04082715,WITHDRAWN,INTERVENTIONAL,we don't have enough research funding.
NCT04082741,WITHDRAWN,INTERVENTIONAL,The study is no longer required based on nonclinical drug data
NCT04082858,TERMINATED,INTERVENTIONAL,Inadequate recruitment due to COVID-19
NCT04082988,TERMINATED,INTERVENTIONAL,The study has been closed due to slow enrollment.
NCT04083248,TERMINATED,INTERVENTIONAL,Risks to subjects due to COVID-19
NCT04083274,WITHDRAWN,INTERVENTIONAL,no participants
NCT04083469,TERMINATED,INTERVENTIONAL,Covid-19 resulted in school closures.
NCT04083651,WITHDRAWN,INTERVENTIONAL,Due to pandemic challenges and consideration of a different study design in the future.
NCT04083898,TERMINATED,INTERVENTIONAL,Decision made to not move forward with Phase II portion of trial
NCT04084015,TERMINATED,INTERVENTIONAL,The study was prematurely stopped since enrollment was much slower than initially expected.
NCT04084093,WITHDRAWN,INTERVENTIONAL,Study will be redesigned.
NCT04084158,SUSPENDED,INTERVENTIONAL,combination arm delevelped significant poor prognosis
NCT04084366,TERMINATED,INTERVENTIONAL,Has not shown its expected therapeutic potential for the enrolled patients in this trial
NCT04084418,TERMINATED,INTERVENTIONAL,Lock down due to COVID-19 pandemic.
NCT04084431,SUSPENDED,INTERVENTIONAL,organizational reasons
NCT04084509,WITHDRAWN,OBSERVATIONAL,Change of circumstances for CI/PI.
NCT04084600,TERMINATED,INTERVENTIONAL,The study had to be stopped due to the COVID-19 pandemic. The University has been closed since the beginning of the pandemic until the present date (02/2021) due to the social distance imposed by the government.
NCT04084665,WITHDRAWN,INTERVENTIONAL,COVID-19 Pandemic
NCT04084678,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04084990,TERMINATED,INTERVENTIONAL,The study was terminated due to insufficient recruitment.
NCT04085081,WITHDRAWN,INTERVENTIONAL,Funding issue
NCT04085237,TERMINATED,INTERVENTIONAL,It was terminated because of poor recruitment rate.
NCT04085393,WITHDRAWN,INTERVENTIONAL,sponsor withdrew study
NCT04085549,TERMINATED,INTERVENTIONAL,Study was ceased due to Covid-19 epidemia.
NCT04085679,TERMINATED,OBSERVATIONAL,The local Healthcare authorities extended the planned intervention to all nursing homes of the district after the emergence of multiple outbreaks of severe COVID-19 in several nursing homes.
NCT04085978,TERMINATED,OBSERVATIONAL,The standard of care had changed during our wait for the Program Letter of Agreement between Phoenix Children's Hospital and Banner to administering IV glucose in the newborn nursery so we weren't able to meet our objective.
NCT04085991,TERMINATED,INTERVENTIONAL,Drug no longer available
NCT04086017,WITHDRAWN,INTERVENTIONAL,Because of COVID-19 we moved to a virtual format but older patients and caregivers were not open to a virtual format.
NCT04086030,WITHDRAWN,INTERVENTIONAL,Could not recruit participants for study
NCT04086069,WITHDRAWN,INTERVENTIONAL,Main clinician cancelled collaboration for personal reasons.
NCT04086121,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04086342,WITHDRAWN,INTERVENTIONAL,Changes in pipeline
NCT04086589,SUSPENDED,OBSERVATIONAL,COVID-19
NCT04086810,WITHDRAWN,INTERVENTIONAL,Study was never initiated; rather the duration of open-label study C602 (NCT03714373) was extended.
NCT04086901,TERMINATED,INTERVENTIONAL,New data show no effect of dose escalation and also poor recruitment
NCT04086914,WITHDRAWN,INTERVENTIONAL,Study withdrawn at PI's request. no patients enrolled.
NCT04086927,WITHDRAWN,INTERVENTIONAL,no funding
NCT04086953,TERMINATED,INTERVENTIONAL,Inclusion difficulties (44/100 patients) despite a 24-month extension. The population often presents with 2 concomitant diseases.
NCT04087109,WITHDRAWN,INTERVENTIONAL,Pandemic
NCT04087265,WITHDRAWN,INTERVENTIONAL,The PI requested to terminate due to his schedule
NCT04087304,WITHDRAWN,INTERVENTIONAL,"Study was never started, no participants enrolled. Study was closed at Rush"
NCT04087369,WITHDRAWN,INTERVENTIONAL,"This study was withdrawn prior to participant enrollment due to a lack of external funding, dedicated resources, and shifting organizational priorities among research collaborators"
NCT04087512,TERMINATED,INTERVENTIONAL,Due to sudden Corona pandemic related restrictions and an expiration of funding in case of further delay it was decided to prematurely terminate study recruitment and proceed evaluation with a smaller sample size than intended (n=71 instead n=111).
NCT04087993,SUSPENDED,INTERVENTIONAL,difficult recruitment - redesign in discussion
NCT04088032,WITHDRAWN,INTERVENTIONAL,Per sponsor
NCT04088123,WITHDRAWN,OBSERVATIONAL,"Inability to commence enrollment at institution, terminated on 9/23/20"
NCT04088240,TERMINATED,INTERVENTIONAL,Supplements Expired
NCT04088266,WITHDRAWN,INTERVENTIONAL,Study delayed indefinetly
NCT04088435,TERMINATED,OBSERVATIONAL,Low accrual
NCT04088487,TERMINATED,INTERVENTIONAL,Intervention includes tasks that encourage participants to interact with the social environment which is unethical due to the outbreak of COVID-19.
NCT04088500,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04088591,WITHDRAWN,INTERVENTIONAL,Recent studies suggest an increase in mortality due to high-does Vitamin C
NCT04088734,TERMINATED,INTERVENTIONAL,Terminated due to lack of efficacy seen in patients with advanced MPS IIIA disease. The patients will be followed up annually for safety until five years post dosing
NCT04088760,TERMINATED,INTERVENTIONAL,Post-transplant cyclophosphamide and abatacept can be used as standard-of-care approaches to GVHD prevention in the HLA mismatched donor-recipient setting and are simpler to use since study enrollment is not required.
NCT04088903,WITHDRAWN,INTERVENTIONAL,Protocol changed to use subcutaneous rather than intravenous daratumumab.
NCT04088942,WITHDRAWN,INTERVENTIONAL,No funding
NCT04088981,SUSPENDED,INTERVENTIONAL,The study was not initiated due to COVID-19 restrictions.
NCT04089163,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT04089202,TERMINATED,INTERVENTIONAL,Unable to enroll additional participants and funding ended.
NCT04089319,TERMINATED,INTERVENTIONAL,COVID-19 prevented us from recruiting additional participants.
NCT04089371,TERMINATED,OBSERVATIONAL,Sponsor Terminated
NCT04089709,TERMINATED,INTERVENTIONAL,Covid-19
NCT04089761,TERMINATED,INTERVENTIONAL,"Due to the outbreak of the COVID-19 pandemic in the USA on March 2020, all study sites stopped enrolling patients to the study"
NCT04089852,WITHDRAWN,INTERVENTIONAL,Not able to perform intervention in current physical clinic location
NCT04089969,WITHDRAWN,INTERVENTIONAL,Essential staff for study execution left the institution and no suitable replacement could be found.
NCT04090242,TERMINATED,INTERVENTIONAL,Enrollment halted prematurely due to the Covid-19 pandemic
NCT04090463,SUSPENDED,INTERVENTIONAL,Logistic and financial reasons
NCT04090697,SUSPENDED,INTERVENTIONAL,FDA withdrawal of Oxandrin NDA and generic ANDAs
NCT04090853,WITHDRAWN,INTERVENTIONAL,Slow enrolment and Covid19
NCT04090866,TERMINATED,OBSERVATIONAL,"PI and sponsor will re-open study at new institution, will not transfer data due to COVID-19 situation"
NCT04090918,WITHDRAWN,OBSERVATIONAL,It was not possible to ensure sufficient recruitment of patients to complete the study.
NCT04091113,TERMINATED,OBSERVATIONAL,we will update quickly
NCT04091191,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04091594,WITHDRAWN,INTERVENTIONAL,Insufficient funding was available and the study could not be started.
NCT04091711,SUSPENDED,INTERVENTIONAL,Awaiting next model of the device
NCT04091737,TERMINATED,INTERVENTIONAL,"Unanticipated delays, not for safety reasons"
NCT04091750,SUSPENDED,INTERVENTIONAL,futility stage with the first 14 subjects completed
NCT04092179,TERMINATED,INTERVENTIONAL,Insufficient Funding
NCT04092816,TERMINATED,INTERVENTIONAL,"The study was stopped prematurely due to difficulty meeting accrual and retention goals, exacerbated by the COVID-19 pandemic."
NCT04092829,TERMINATED,INTERVENTIONAL,under-recruitment
NCT04093115,WITHDRAWN,INTERVENTIONAL,The study was terminated voluntarily by the sponsor due to changes in clinical development strategy.
NCT04093401,WITHDRAWN,INTERVENTIONAL,Resources
NCT04093414,TERMINATED,INTERVENTIONAL,slow enrollment
NCT04093427,TERMINATED,INTERVENTIONAL,Insufficient recruitment in a timely manner
NCT04093505,TERMINATED,INTERVENTIONAL,Study turned out no longer feasible. End of Recruitment: 25.5.2022
NCT04093622,TERMINATED,OBSERVATIONAL,Incorporation of LTFU into the main interventional study.
NCT04093648,WITHDRAWN,INTERVENTIONAL,The key elements of this study were incorporated into another study.
NCT04093700,TERMINATED,OBSERVATIONAL,"The Sponsor decided that the CE marking would not be renewed, and therefore there was no longer a need to continue the study as the data was no longer necessary."
NCT04093739,WITHDRAWN,OBSERVATIONAL,Manufacturer decided not to proceed with study.
NCT04094077,TERMINATED,INTERVENTIONAL,Study stopped after a negative result delivred by the CPP for a substancial modification of the protocol
NCT04094129,WITHDRAWN,INTERVENTIONAL,Couldn't sign the contract
NCT04094181,TERMINATED,OBSERVATIONAL,The decision was taken after careful consideration relating to recruitment challenges that could impact the scientific value of the study.
NCT04094584,TERMINATED,INTERVENTIONAL,12 month follow up data not collected due to pandemic disruptions
NCT04094649,SUSPENDED,INTERVENTIONAL,Pending funding
NCT04094766,WITHDRAWN,INTERVENTIONAL,Production plan adjustment
NCT04094792,WITHDRAWN,INTERVENTIONAL,PI moving to another university--study will not be done at UK; Coronavirus pandemic will likely delay start at University of Texas at Arlington
NCT04094948,WITHDRAWN,INTERVENTIONAL,hasn't got the funding
NCT04095039,TERMINATED,INTERVENTIONAL,Futility of enrollment and futility of separation between study arms
NCT04095091,TERMINATED,OBSERVATIONAL,Device to be used in study is no longer available
NCT04095247,TERMINATED,OBSERVATIONAL,for few participants recruited
NCT04095416,TERMINATED,INTERVENTIONAL,challenges in recruitment due to covid-19
NCT04095533,TERMINATED,OBSERVATIONAL,Coronavirus pandemic halted in-unit enrolment and participation
NCT04095546,WITHDRAWN,OBSERVATIONAL,personal changes in study team
NCT04095689,SUSPENDED,INTERVENTIONAL,"Stopping rules met per protocol, comprehensive review needed prior to enrolling again"
NCT04095767,TERMINATED,INTERVENTIONAL,Primary efficacy endpoint achieved
NCT04095793,TERMINATED,INTERVENTIONAL,Stopped early due to company decision. Company decision based on analysis results in TD-9855-0169.
NCT04095858,TERMINATED,INTERVENTIONAL,Business Reasons
NCT04096235,TERMINATED,INTERVENTIONAL,change in clinical practice
NCT04096261,WITHDRAWN,OBSERVATIONAL,Resources had to be focused on other projects.
NCT04096482,TERMINATED,INTERVENTIONAL,Early findings identified the need to update the design of the study device.
NCT04096560,TERMINATED,INTERVENTIONAL,"A safety signal has emerged in Phase 2 studies of TAK-994. As an immediate precautionary measure, Takeda has suspended dosing of patients and has decided to stop Phase 2 studies early."
NCT04096573,WITHDRAWN,INTERVENTIONAL,company decision
NCT04096703,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants for study.
NCT04096716,TERMINATED,INTERVENTIONAL,Insufficient funding/staff
NCT04097041,WITHDRAWN,INTERVENTIONAL,Change in availability of investigators/participants
NCT04097093,WITHDRAWN,OBSERVATIONAL,Lack of feasibility
NCT04097301,TERMINATED,INTERVENTIONAL,Inability to close the study in a clinically relevant time frame
NCT04097353,TERMINATED,INTERVENTIONAL,Study recruitment of new participants was suspended during 2020 due to the Covid-19 pandemic.
NCT04097496,TERMINATED,INTERVENTIONAL,COVID-19 pandemic and related school policies.
NCT04097795,TERMINATED,OBSERVATIONAL,Inclusions lagged far behind
NCT04097977,WITHDRAWN,INTERVENTIONAL,never funded
NCT04098328,TERMINATED,OBSERVATIONAL,Study device refinement
NCT04098419,TERMINATED,INTERVENTIONAL,Discontinuing the study because of COVID-19
NCT04098835,TERMINATED,INTERVENTIONAL,slow enrollment
NCT04098887,WITHDRAWN,INTERVENTIONAL,Investigator decided to not go forward with the study.
NCT04099095,WITHDRAWN,INTERVENTIONAL,COVID epidemic
NCT04099277,TERMINATED,INTERVENTIONAL,Study terminated due to strategic business decision by Eli Lilly and Company.
NCT04099355,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT04099446,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT04099836,TERMINATED,INTERVENTIONAL,low accrual
NCT04099888,TERMINATED,INTERVENTIONAL,"Recent results from a Phase 3 study are expected to change the standard of care for patients with inoperable CCA, rendering the RELEASE study challenging to complete and potentially inadequate for NDA approval."
NCT04100083,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04100265,TERMINATED,INTERVENTIONAL,Inadequate recruitment due to COVID-19 restrictions.
NCT04100291,TERMINATED,INTERVENTIONAL,Covid-19 inclusion difficulties
NCT04100330,WITHDRAWN,INTERVENTIONAL,Urgent shift among clinical sites toward efforts to combat COVID-19 pandemic;impacted feasibility of completing study within shelf-life of current IP supply
NCT04100590,TERMINATED,INTERVENTIONAL,"During a piloting phase with our staff, the technology/eye-tracking device did not collect outcomes as expected."
NCT04100629,TERMINATED,INTERVENTIONAL,Lack of enrollment (and due to pandemic)
NCT04100681,TERMINATED,INTERVENTIONAL,The study was terminated early due to slow recruitment and inability to recruit patients during the Covid-19 situation.
NCT04101006,TERMINATED,OBSERVATIONAL,"recruitment difficulties, high postoperative drop-out rate"
NCT04101045,TERMINATED,INTERVENTIONAL,During the pandemic the funding agency stopped funding studies.
NCT04101292,WITHDRAWN,INTERVENTIONAL,"Problems with the provision of equipment encountered during the study could not be resolved, making it impossible to take the images planned for the main objective of the study."
NCT04101513,WITHDRAWN,OBSERVATIONAL,Since this project enrolls early-stage Parkinson's patients we hope to develop a registry style study that will allow us to study the progression of spinal disorders in Parkinson patients more effectively.
NCT04101682,TERMINATED,INTERVENTIONAL,Not enough enrollment
NCT04101890,TERMINATED,INTERVENTIONAL,Principal Investigator left the Institution and decision was made by funders to terminate the trial.
NCT04101955,SUSPENDED,INTERVENTIONAL,Study paused while working on logistics
NCT04102111,TERMINATED,INTERVENTIONAL,"IAC completed review of futility analysis data \& determined that futility criteria were met. As a result, Janssen made decision to stop trial immediately."
NCT04102163,TERMINATED,OBSERVATIONAL,Business Decision; No Safety or Efficacy Concerns
NCT04102202,WITHDRAWN,INTERVENTIONAL,Due to company strategic decision
NCT04102254,WITHDRAWN,INTERVENTIONAL,Lead acquisition from company \& COVID-19 restrictions
NCT04102436,WITHDRAWN,INTERVENTIONAL,Difficulty with availability of GLP-grade reagents for manufacturing.
NCT04102449,WITHDRAWN,INTERVENTIONAL,Funding stopped
NCT04102618,TERMINATED,INTERVENTIONAL,Enrollment into AWARE cohorts1-4 have concluded and the primary objective and core goals for the study were met.
NCT04103112,TERMINATED,INTERVENTIONAL,At the request of the study's funders (NIHR-HTA) the study was terminated early due to poor recruitment in the context of the COVID-19 pandemic and unprecedented pressures faced by the NHS.
NCT04103164,SUSPENDED,INTERVENTIONAL,The laser is currently being worked on
NCT04103307,WITHDRAWN,INTERVENTIONAL,recruitment was not feasible due to COVID-19 pandemic so study was stopped
NCT04103359,TERMINATED,INTERVENTIONAL,inclusion rate too low
NCT04103775,TERMINATED,INTERVENTIONAL,Recruitment and intervention halted due to Covid-19 pandemic.
NCT04103814,TERMINATED,INTERVENTIONAL,Lack of resources to continue enrollment
NCT04103827,WITHDRAWN,OBSERVATIONAL,no patient included after 6 month of enrollement
NCT04104295,WITHDRAWN,INTERVENTIONAL,Study never began.
NCT04104321,SUSPENDED,INTERVENTIONAL,"Interim analysis of data from open-label part, showed this part of the study met its objectives, therefore decided to discontinue this part.

Starting the double-blind part is being delayed due to Aramchol Meglumine being formulated."
NCT04104334,TERMINATED,INTERVENTIONAL,Change in surgical practice and chemotherapy treatment by the surgery team
NCT04104568,SUSPENDED,INTERVENTIONAL,There were issues with the technical service provider of the platform iSupport-Portugal; the platform and its backoffice should be implemented by another service provider. A pilot study was conducted following the protocol of the full trial.
NCT04104594,TERMINATED,INTERVENTIONAL,"The laboratory in which the analyses on nasosinusal polyposis were to be carried out did not want to continue the research on this subject, so it was decided to stop this study prematurely."
NCT04104646,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT04104789,WITHDRAWN,INTERVENTIONAL,Manufacture of drug discontinued before any participants could be enrolled.
NCT04104802,WITHDRAWN,OBSERVATIONAL,refusal of the ansm
NCT04104815,WITHDRAWN,INTERVENTIONAL,Study Timing
NCT04104919,WITHDRAWN,INTERVENTIONAL,Study Initiation delayed due to COVID 19
NCT04105062,WITHDRAWN,INTERVENTIONAL,One of the investigators is leaving the University.
NCT04105218,TERMINATED,INTERVENTIONAL,Personnel resources required to conduct study are no longer available. Study was terminated due to lack of resources
NCT04105374,WITHDRAWN,INTERVENTIONAL,NCI approval withdrawn
NCT04105465,TERMINATED,INTERVENTIONAL,Conflict with another study that was opened to recruitment
NCT04105673,WITHDRAWN,OBSERVATIONAL,CPP requalification
NCT04105738,TERMINATED,OBSERVATIONAL,Terminated: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
NCT04105777,TERMINATED,OBSERVATIONAL,Low recruitment
NCT04105816,WITHDRAWN,INTERVENTIONAL,COVID19 continually delayed in-person research
NCT04105985,WITHDRAWN,INTERVENTIONAL,Manufacturer discontinued drug before any participants could be enrolled.
NCT04106011,TERMINATED,OBSERVATIONAL,PI request - low enrollment
NCT04106050,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT04106076,WITHDRAWN,INTERVENTIONAL,The trial was discontinued due to sponsor's decision and not a consequence of any safety concern
NCT04106167,TERMINATED,OBSERVATIONAL,This study was terminated by the Sponsor.
NCT04106362,TERMINATED,INTERVENTIONAL,low enrollment
NCT04106505,TERMINATED,INTERVENTIONAL,Recruitment terminated prematurely due to SARS-CoV-2 pandemic
NCT04106531,TERMINATED,OBSERVATIONAL,Investigator leaving institution
NCT04106570,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT04106700,TERMINATED,INTERVENTIONAL,Low recruitment
NCT04106843,WITHDRAWN,INTERVENTIONAL,No Participants Registered
NCT04106869,WITHDRAWN,INTERVENTIONAL,PI left the institution and the study was not continued
NCT04106973,TERMINATED,OBSERVATIONAL,Recruitment suspended secondary to social distancing directive associated with Covid-19
NCT04107675,TERMINATED,INTERVENTIONAL,"Due to the low number of patients recruited and the slow enrollment pace of patients, on 18 March 2022, the sponsor decided to terminate the BOSTON-4 safety and tolerability trial ahead of time."
NCT04107714,TERMINATED,INTERVENTIONAL,The study was terminated due to a small number of study participants.
NCT04107935,TERMINATED,INTERVENTIONAL,"Due to COVID-19 pandemic, we were unable to meet our recruitment goal during the grant period."
NCT04107961,WITHDRAWN,INTERVENTIONAL,The trial will be undertaken but the protocol will be substantially revised.
NCT04108221,SUSPENDED,INTERVENTIONAL,Principal Investigator condition
NCT04108286,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to COVID-19 and country restrictions
NCT04108377,TERMINATED,INTERVENTIONAL,Enrollment stopped secondary to completion of funding
NCT04108481,SUSPENDED,INTERVENTIONAL,Working on revisions
NCT04108702,WITHDRAWN,INTERVENTIONAL,Lack of participants
NCT04108767,WITHDRAWN,OBSERVATIONAL,"We were not able to conduct this study, in fact we opened the participating center and the confinement arrived a few days later. Since then, the organization of the students' follow-up has changed and made the study as it was thought obsolete."
NCT04108858,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT04108949,TERMINATED,INTERVENTIONAL,"The study was terminated due to consequences of the Covid-19 pandemic, which made it impossible to complete the trial in a timely manner and in accordance with the study protocol"
NCT04108962,WITHDRAWN,INTERVENTIONAL,Difficult to find eligible patients willing to participate.
NCT04109092,WITHDRAWN,INTERVENTIONAL,"There was no enrolment of participants.Unscheduled Clinical Study Closure - Eisai Network Company Decision, November 12, 2020."
NCT04109144,WITHDRAWN,INTERVENTIONAL,"PI confirmed that while coordination and planning was conducted upon IRB approval, no participants were enrolled into the study"
NCT04109287,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04109482,TERMINATED,INTERVENTIONAL,Business reasons.
NCT04109521,TERMINATED,INTERVENTIONAL,The onset of the COVID-19 pandemic impeded the progression of the RCT activities as planned. Protocol activities were stopped soon after the first component of the intervention was completed.
NCT04109690,WITHDRAWN,INTERVENTIONAL,Failure to enroll
NCT04109742,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04109768,WITHDRAWN,INTERVENTIONAL,PI left university
NCT04109807,SUSPENDED,INTERVENTIONAL,Enrollment for this study was stopped due to Covid and will resume once it is determined acceptable to do inhalational challenges.
NCT04109937,WITHDRAWN,INTERVENTIONAL,Feasibility couldn't be worked out
NCT04109950,TERMINATED,INTERVENTIONAL,"Study terminated early, main goals achieved"
NCT04110015,TERMINATED,OBSERVATIONAL,New heightened internet security at HHC and VVF device no longer compliant with intranet and internet access at hospital
NCT04110249,TERMINATED,INTERVENTIONAL,equipment issues
NCT04110353,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04110496,TERMINATED,INTERVENTIONAL,The trial was discontinued by the Sponsor
NCT04110873,TERMINATED,INTERVENTIONAL,It was hard to find suitable subject due to strict enrollment criteria.
NCT04110912,WITHDRAWN,OBSERVATIONAL,No longer proceeding with application
NCT04111107,TERMINATED,INTERVENTIONAL,PI left the institution and site decided not to continue the study
NCT04111172,SUSPENDED,INTERVENTIONAL,Suspended until interim analysis is complete.
NCT04111406,TERMINATED,INTERVENTIONAL,covid19 situation
NCT04111445,TERMINATED,INTERVENTIONAL,Study discontinued due to business decision.
NCT04111497,TERMINATED,INTERVENTIONAL,Study closed to accrual early due to side effects of study drug.
NCT04112017,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT04112173,TERMINATED,INTERVENTIONAL,"Study activity has initially suspended due to COVID-19 restrictions, but it will not resume due to the confounding influence of the pandemic on the study outcomes. The feasibility of the study protocol is limited with restrictions from the pandemic."
NCT04112199,TERMINATED,INTERVENTIONAL,For reasons unrelated to safety or efficacy
NCT04112615,WITHDRAWN,OBSERVATIONAL,COVID-19
NCT04113057,TERMINATED,INTERVENTIONAL,"In-person supervised exercise therapy (SET) at this institution, a required component of this study, was halted during Covid19 and was not re-instated after clinical activities resumed."
NCT04113083,TERMINATED,OBSERVATIONAL,"Due To Covid-19 there were delays in the arrival of patients to the sites. Due to the rare disease in the study population, no patients who met the inclusion/exclusion criteria were found, and the study was terminated early due to these reasons."
NCT04113135,WITHDRAWN,INTERVENTIONAL,Unable to complete initial data collection due to tornado and then COVID-19 has limited in person data collection/intervention.
NCT04113213,SUSPENDED,INTERVENTIONAL,CV-19 pandemic
NCT04113252,WITHDRAWN,INTERVENTIONAL,Too difficult to see patients in required time intervals.
NCT04113291,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT04113525,TERMINATED,INTERVENTIONAL,"company went bankrupt, covid closed clinical research facility"
NCT04113590,WITHDRAWN,INTERVENTIONAL,no patients were enrolled
NCT04113616,TERMINATED,INTERVENTIONAL,"In September 2023, the study was terminated because of a Sponsor decision, unrelated to safety concerns."
NCT04114019,WITHDRAWN,OBSERVATIONAL,The study device became unavailable for use.
NCT04114422,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04114448,TERMINATED,INTERVENTIONAL,The Study was terminated due to lack of funding for continuing
NCT04114513,WITHDRAWN,INTERVENTIONAL,COVID-19 lockdown
NCT04114630,WITHDRAWN,INTERVENTIONAL,No patients were enrolled and global prioritization of pipeline and research strategy
NCT04114656,TERMINATED,INTERVENTIONAL,This study was terminated due to meeting protocol defined futility.
NCT04114708,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04114929,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04115020,WITHDRAWN,INTERVENTIONAL,A pilot study was negative.
NCT04115059,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT04115254,SUSPENDED,INTERVENTIONAL,MR-Linac temporarily moved off-line
NCT04115384,TERMINATED,INTERVENTIONAL,COVID - unable to restart after restrictions were lifted
NCT04115501,WITHDRAWN,INTERVENTIONAL,inability to enroll
NCT04115644,TERMINATED,INTERVENTIONAL,Covid-19 and we failed to submit annual report for 2017 and 2018
NCT04115735,TERMINATED,OBSERVATIONAL,Enrollment not feasible
NCT04115748,TERMINATED,INTERVENTIONAL,Development program terminated
NCT04115839,TERMINATED,INTERVENTIONAL,Development program terminated
NCT04115865,WITHDRAWN,OBSERVATIONAL,refusal ethics comity
NCT04115956,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study following an FDA request of a partial clinical hold.
NCT04116099,TERMINATED,OBSERVATIONAL,Covid impact - slow enrollment
NCT04116164,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
NCT04116203,SUSPENDED,INTERVENTIONAL,waiting for additional funding to complete trial
NCT04116281,SUSPENDED,INTERVENTIONAL,Pandemic situation
NCT04116359,WITHDRAWN,INTERVENTIONAL,Other - Protocol moved to Disapproved
NCT04116645,WITHDRAWN,OBSERVATIONAL,This study would not add any new information
NCT04116684,TERMINATED,INTERVENTIONAL,Difficulty with patient enrollment and carrying out the study logistics due to COVID-19
NCT04116749,TERMINATED,OBSERVATIONAL,Unavailable to collect study participants.
NCT04116762,TERMINATED,INTERVENTIONAL,All 3 participants receiving intervention in assessment phase developed seromas
NCT04117165,WITHDRAWN,INTERVENTIONAL,No funding
NCT04117295,SUSPENDED,INTERVENTIONAL,Occurrence of a quality issue affecting some of its prostheses
NCT04117373,WITHDRAWN,OBSERVATIONAL,The researchers were unable to answer the study question by utilizing the insurance claims database.
NCT04117438,WITHDRAWN,OBSERVATIONAL,"Due to COVID-19 pandemic, we will not be pursuing this study"
NCT04117477,TERMINATED,INTERVENTIONAL,A new multisite study was opened in place of this study.
NCT04117568,TERMINATED,OBSERVATIONAL,Due to Covid-19 pandemic.
NCT04117607,TERMINATED,INTERVENTIONAL,Stopped due to the formation of injection site skin nodules.
NCT04117880,WITHDRAWN,INTERVENTIONAL,Study cancelled before protocol was implemented.
NCT04117958,TERMINATED,INTERVENTIONAL,Business decision
NCT04118036,WITHDRAWN,INTERVENTIONAL,Safety concerns
NCT04118491,WITHDRAWN,INTERVENTIONAL,no funding
NCT04118673,SUSPENDED,INTERVENTIONAL,CV-19 pandemic
NCT04118777,WITHDRAWN,INTERVENTIONAL,Misregistered to wrong sponsor.
NCT04118894,TERMINATED,OBSERVATIONAL,Due to COVID the enrollment into the study was delayed. Sponsor chose to collect the data needed for MDR via retrospecitve studies instead
NCT04119115,TERMINATED,OBSERVATIONAL,Lack of resources and funding
NCT04119284,SUSPENDED,INTERVENTIONAL,IRB suspended the study.
NCT04119336,TERMINATED,INTERVENTIONAL,Study closure initiated by industry funding sponsor for commercial reasons.
NCT04119596,TERMINATED,OBSERVATIONAL,Low recruitment power
NCT04119830,WITHDRAWN,INTERVENTIONAL,implementation issues
NCT04120064,TERMINATED,INTERVENTIONAL,"Covid19, not able to finish recruitment"
NCT04120220,TERMINATED,INTERVENTIONAL,PI will be retiring from the Center. Research will not continue with a new PI.
NCT04120467,TERMINATED,INTERVENTIONAL,Difficulty of recruitment following COVID-19. Decision to stop the study of the rehabilitation center.
NCT04120610,TERMINATED,OBSERVATIONAL,Sponsor decision to terminate study prior to reaching full sample size.
NCT04120870,TERMINATED,INTERVENTIONAL,Due to difficulties in obtaining consent because of emergency situation
NCT04120987,WITHDRAWN,INTERVENTIONAL,Administrative
NCT04121143,SUSPENDED,INTERVENTIONAL,sponsor's decision
NCT04121299,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04121325,TERMINATED,OBSERVATIONAL,pandemic
NCT04121351,TERMINATED,OBSERVATIONAL,COVID-19 pandemic meant continuation of the study was unfeasible at this time.
NCT04121546,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT04121585,TERMINATED,OBSERVATIONAL,Business reasons. High subject attrition at the 10-year timepoint leading to loss of statistical power and data value. Decision finalised 24May2023.
NCT04122794,TERMINATED,OBSERVATIONAL,Impact of Covid-19 and staffing has required us to suspend this study
NCT04122898,TERMINATED,INTERVENTIONAL,Due to covid-19
NCT04122950,TERMINATED,INTERVENTIONAL,Few interested participants
NCT04123067,TERMINATED,INTERVENTIONAL,Temporarily suspended due to Pandemic.
NCT04123093,TERMINATED,INTERVENTIONAL,"Due to rigorous inclusion criteria and the constraints brought on the health care system from the COVID 19 pandemic which adversely effected enrollment, the sponsor and collaborator have decided to halt enrollment and officially close out the study."
NCT04123483,WITHDRAWN,INTERVENTIONAL,Cancellation of funding contract
NCT04123574,WITHDRAWN,INTERVENTIONAL,No longer relevant to field
NCT04123704,WITHDRAWN,INTERVENTIONAL,Withdrawn by sponsor due to lack of interest
NCT04123756,TERMINATED,OBSERVATIONAL,Recruitment issues due to the corona virus and lack of funding to continue
NCT04123808,WITHDRAWN,INTERVENTIONAL,Closed by sponsor
NCT04124016,SUSPENDED,INTERVENTIONAL,COVID
NCT04124354,TERMINATED,INTERVENTIONAL,Only 4 participants completed due to COVID-19 and the many lockdowns. We received a NIH R21 to complete a larger version of this trial and are working on launching this larger trial and submitting it to ClinicalTrials.gov.
NCT04124367,TERMINATED,INTERVENTIONAL,for strategic and pandemic reasons
NCT04124510,TERMINATED,INTERVENTIONAL,"The Contract of K-haler products had been terminated between Mundipharma and provider. Therefore, this clinical trial was terminated early."
NCT04124783,WITHDRAWN,INTERVENTIONAL,The company no longer provided the device.
NCT04124809,TERMINATED,INTERVENTIONAL,no fund for recruitment
NCT04125004,WITHDRAWN,INTERVENTIONAL,Exploratory pre-study demonstrated participants unwilling to be randomized to control arm.
NCT04125030,SUSPENDED,OBSERVATIONAL,COVID-19 pandemic
NCT04125147,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04125225,WITHDRAWN,OBSERVATIONAL,No participants enrolled.
NCT04125290,TERMINATED,OBSERVATIONAL,Study stopped due to lack of recruitment.
NCT04125498,SUSPENDED,INTERVENTIONAL,Recruitment during pandemic was impossible to achieve
NCT04125524,SUSPENDED,OBSERVATIONAL,PhD Student completed primary study. Awaiting a new student to take over the project for the secondary objective.
NCT04125719,WITHDRAWN,INTERVENTIONAL,resubmission planned
NCT04125745,TERMINATED,INTERVENTIONAL,negative study outcome from Complexa's multicenter clinical trial; no safety concerns
NCT04126031,TERMINATED,INTERVENTIONAL,"Following regulatory consultation, the Sponsor has decided to terminate the study and analyze the current dataset. The decision to terminate was solely based on a business decision, not due to safety concerns."
NCT04126044,WITHDRAWN,INTERVENTIONAL,The study was withdrawn prior to enrollment after a comprehensive review of the biosimilars market and the company's global manufacturing network.
NCT04126278,TERMINATED,INTERVENTIONAL,Enrollment difficulty.
NCT04126343,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures"
NCT04127123,WITHDRAWN,OBSERVATIONAL,Difficulty enrolling due to COVID closures
NCT04127318,WITHDRAWN,INTERVENTIONAL,lack of resources
NCT04127656,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04127695,WITHDRAWN,INTERVENTIONAL,Strategic considerations
NCT04127721,WITHDRAWN,INTERVENTIONAL,0 ACTUAL Enrollment must have Overall Recruitment Status
NCT04127942,WITHDRAWN,INTERVENTIONAL,no sufficient enrolled pateints
NCT04128020,WITHDRAWN,INTERVENTIONAL,Funder withdrew funding after not accruing any subjects after 1 year.
NCT04128098,TERMINATED,OBSERVATIONAL,"The Covid pandemic made it impossible to monitor and rehabilitate patients at the Dijon Bourgogne CHU's CCR. A new home rehabilitation programme was set up.

This new rehabilitation programme rendered the study obsolete and the project was abandoned."
NCT04128267,TERMINATED,INTERVENTIONAL,Recruitment/accrual impacted by COVID and technical issues with equipment
NCT04128293,TERMINATED,INTERVENTIONAL,GSK investigating manufacturing site malfunction and assessing impact; Study 209713 Early Terminated due to risk of potential contamination of study tablets.
NCT04128319,TERMINATED,INTERVENTIONAL,Initiated a new randomized trial per discussion with FDA
NCT04128462,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT04128475,TERMINATED,OBSERVATIONAL,Withdrawal of funding.
NCT04128514,TERMINATED,OBSERVATIONAL,Insufficient enrollment
NCT04128696,TERMINATED,INTERVENTIONAL,The trial was stopped by the sponsor based on assessment of the clinical data
NCT04128852,WITHDRAWN,INTERVENTIONAL,redirected funding
NCT04128891,WITHDRAWN,INTERVENTIONAL,Funding not approved
NCT04128956,TERMINATED,INTERVENTIONAL,Recommendation by DSMB
NCT04129320,WITHDRAWN,INTERVENTIONAL,Change in study design
NCT04129489,TERMINATED,INTERVENTIONAL,low recruitment
NCT04129541,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic
NCT04129723,WITHDRAWN,INTERVENTIONAL,No suitable case identified
NCT04129749,WITHDRAWN,OBSERVATIONAL,cancelled study
NCT04129970,WITHDRAWN,INTERVENTIONAL,COVID led to suspension of the study.New data suggest outcome measures should be revised and new approvals from research ethics committees will be needed
NCT04130282,TERMINATED,INTERVENTIONAL,Delays caused by Covid-19
NCT04130399,WITHDRAWN,INTERVENTIONAL,Study is being abandoned.
NCT04130438,SUSPENDED,INTERVENTIONAL,"Low enrollment, modifying study protocol"
NCT04130698,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19, public health guidelines prevent in-person group meetings."
NCT04130893,TERMINATED,INTERVENTIONAL,Investigator's decision
NCT04130906,WITHDRAWN,INTERVENTIONAL,COVID led to suspension of the study.New data suggest outcome measures should be revised and new approvals from research ethics committees will be needed.
NCT04130919,TERMINATED,INTERVENTIONAL,Sponsor terminated the study since a new molecular entity was able to achieve greater target coverage
NCT04130932,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04131192,TERMINATED,INTERVENTIONAL,"Combined with the analysis of the existing data of the trial, there was no obvious advantage compared with the clinical standard treatments, and the clinical trial was decided to be terminated based on the benefit of the subjects."
NCT04131322,TERMINATED,INTERVENTIONAL,Sponsor cancellation
NCT04131517,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures"
NCT04131556,TERMINATED,INTERVENTIONAL,"The study was stopped because based on the planned interim analysis of the data of Part 1, palatability of both pediatric formulations was not acceptable."
NCT04131634,TERMINATED,INTERVENTIONAL,"The trial has terminated due to changes in standard of care since its activation, which has led to poor accrual."
NCT04131673,WITHDRAWN,OBSERVATIONAL,IRB closed
NCT04131764,TERMINATED,OBSERVATIONAL,IRB closed
NCT04131959,TERMINATED,INTERVENTIONAL,Stalled study execution from the impact of the COVID-19 pandemic on the UK NHS
NCT04132011,WITHDRAWN,INTERVENTIONAL,No recruitment (Feasibility study).
NCT04132141,TERMINATED,INTERVENTIONAL,COVID-19
NCT04132180,TERMINATED,INTERVENTIONAL,Slow recruitment.
NCT04132349,TERMINATED,INTERVENTIONAL,Ulipristal Acetate was recalled
NCT04132375,TERMINATED,INTERVENTIONAL,Due to COVID pandemia enrolment was stopped on 20March2020
NCT04132388,WITHDRAWN,INTERVENTIONAL,Sponsor and site agreed the research would not happen now; several delays and other issues
NCT04132648,WITHDRAWN,INTERVENTIONAL,PI left the Institution
NCT04132700,WITHDRAWN,INTERVENTIONAL,LEEP-COVID study (NCT04350073) initiation enables inclusion of COVID-positive subjects
NCT04132739,TERMINATED,INTERVENTIONAL,COVID-19
NCT04132791,TERMINATED,INTERVENTIONAL,stopped prematurely due to too low inclusion rate
NCT04133142,WITHDRAWN,INTERVENTIONAL,No enrollement and covid
NCT04133350,TERMINATED,INTERVENTIONAL,Inability to Recruit
NCT04133480,WITHDRAWN,INTERVENTIONAL,The decision to withdraw the study was based on pandemic-related concerns of conducting a Phase IV study requiring multiple clinic visits when medication is commercially available. The study was withdrawn before any participants were recruited.
NCT04133766,TERMINATED,INTERVENTIONAL,Funding for the study withdrawn by sponsor after baseline data collected
NCT04133922,WITHDRAWN,INTERVENTIONAL,the study drug could not be obtained
NCT04133935,WITHDRAWN,INTERVENTIONAL,Due to COVID restrictions this study has been temporarily halted.
NCT04134143,TERMINATED,INTERVENTIONAL,Business decision - not related to product quality or safety concerns
NCT04134208,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04134442,WITHDRAWN,INTERVENTIONAL,A new large meta-analysis was published. The results showed the likelihood that liposomal bupivacaine and nerve blocks no longer offer significant contribution. Decision was made to terminate the study.
NCT04134468,WITHDRAWN,INTERVENTIONAL,Halozyme halted development of PEGPH20 following Phase 3 failure.
NCT04134624,TERMINATED,INTERVENTIONAL,Recruitment for this study was halted in February 2020 due to the COVID-19 pandemic. The study team was unable to continue enrollment due to decreased volumes (and the fact that COVID-19 mimics some of the signs and symptoms of severe sepsis)
NCT04135326,WITHDRAWN,INTERVENTIONAL,"Per PI termination request, no patients enrolled"
NCT04135352,TERMINATED,INTERVENTIONAL,Business Reasons
NCT04135768,WITHDRAWN,INTERVENTIONAL,COVID19 pandemic: national lockdown imposed and study centre diverted all trauma cases to surrounding hospitals
NCT04136444,TERMINATED,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures"
NCT04136496,WITHDRAWN,INTERVENTIONAL,The study was never activated / began due to hospital staff and resources being re-allocated to support the demands of the Covid-19 global pandemic.
NCT04136561,WITHDRAWN,INTERVENTIONAL,No participants enrolled. Unable to enroll
NCT04136665,TERMINATED,INTERVENTIONAL,Not enough patient
NCT04136847,WITHDRAWN,INTERVENTIONAL,Due to COVID 19 the Study did not start enrolling
NCT04137770,TERMINATED,INTERVENTIONAL,"lack of enrollment, change of OR policies due to COVID"
NCT04137809,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to logistical and safety concerns relating to Covid-19.
NCT04137887,TERMINATED,INTERVENTIONAL,Enrollment terminated due to the COVID-19 pandemic
NCT04137978,WITHDRAWN,INTERVENTIONAL,Unspecified business decision/strategic reason
NCT04138199,TERMINATED,OBSERVATIONAL,Strategic Considerations
NCT04138485,WITHDRAWN,INTERVENTIONAL,"Due to business reasons, not safety issues"
NCT04138524,TERMINATED,INTERVENTIONAL,Pandemic of SARS-CoV2
NCT04138602,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT04138875,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04139317,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate due to the lack of tolerability observed in patients treated with capmatinib and pembrolizumab in the combination arm as compared to patients treated with pembrolizumab alone in the pembrolizumab single agent arm
NCT04139330,TERMINATED,INTERVENTIONAL,Low recruitment
NCT04139382,TERMINATED,INTERVENTIONAL,"Study suspended on 31 March 2020 due to COVID-19 pandemic. Aimed to restart study early 2021, but decision taken to formally terminate the study on 31st August 2021"
NCT04139395,WITHDRAWN,INTERVENTIONAL,Not feasible at this time.
NCT04139655,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT04139694,WITHDRAWN,INTERVENTIONAL,unable to procure supplement for clinical trial use
NCT04139915,WITHDRAWN,INTERVENTIONAL,Phase 3 trial RTB-101-204 study did not meet its primary endpoint
NCT04139967,TERMINATED,INTERVENTIONAL,recruitment rates were too low
NCT04139993,TERMINATED,INTERVENTIONAL,poor accrual
NCT04140110,TERMINATED,INTERVENTIONAL,Data Safety Monitoring Board recommendation based on consistent safety concerns that recruitment be discontinued and the data analysed and reported. Protocol amendment planned.
NCT04140175,TERMINATED,OBSERVATIONAL,Strategic considerations
NCT04140279,WITHDRAWN,INTERVENTIONAL,It never started
NCT04140396,TERMINATED,INTERVENTIONAL,Lack of personnel and lack of funding for the study drug
NCT04140409,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04140474,TERMINATED,INTERVENTIONAL,Inclusion difficulties
NCT04140513,WITHDRAWN,INTERVENTIONAL,PI decision
NCT04140539,WITHDRAWN,INTERVENTIONAL,Recruitment on hold for business reasons. Study will not be performed.
NCT04140591,TERMINATED,INTERVENTIONAL,1. Most patients with liver cirrhosis already use PPI and NSBB 2. 90 % Peptic ulcer size is smaller than 5cm
NCT04140669,TERMINATED,OBSERVATIONAL,Sponsor support and funding was terminated due to pandemic
NCT04140773,TERMINATED,INTERVENTIONAL,Poor participant recruitment
NCT04140877,WITHDRAWN,INTERVENTIONAL,Strategy change
NCT04140968,TERMINATED,INTERVENTIONAL,massive recruitment problems became apparent because of the strict inclusion criteria of our study.
NCT04141293,WITHDRAWN,INTERVENTIONAL,Technical problems and employee shortage
NCT04141423,TERMINATED,INTERVENTIONAL,Part 1 completed. Part 2 not initiated
NCT04141475,TERMINATED,INTERVENTIONAL,no patient recruitment
NCT04141865,TERMINATED,OBSERVATIONAL,low enrollment
NCT04141904,TERMINATED,INTERVENTIONAL,Covid-19 pandemic
NCT04141917,TERMINATED,INTERVENTIONAL,Operational futility (i.e. near zero circulation of influenza in the community during year 2)
NCT04142060,TERMINATED,INTERVENTIONAL,Lack of effectiveness
NCT04142255,TERMINATED,INTERVENTIONAL,The review board rejected our request of changing the protocol and advised us to terminate the trial.
NCT04142359,TERMINATED,OBSERVATIONAL,Study was closed due to the recent pandemic and enrollment challenges.
NCT04142554,WITHDRAWN,INTERVENTIONAL,Funding withdrawn from funding source.
NCT04142619,TERMINATED,INTERVENTIONAL,The trial was discontinued due to sponsor's decision and not a consequence of any safety concern.
NCT04142658,TERMINATED,INTERVENTIONAL,Safety
NCT04142736,SUSPENDED,INTERVENTIONAL,low recruitment rate
NCT04142788,TERMINATED,INTERVENTIONAL,"The study was stopped due to low recruitment, which the Steering Committee and funder agreed could not be rectified."
NCT04142814,WITHDRAWN,INTERVENTIONAL,Patients case mix changed and did not match anymore with selection criteria
NCT04143113,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT04143490,SUSPENDED,INTERVENTIONAL,Due to Covid-19
NCT04143529,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04143581,WITHDRAWN,INTERVENTIONAL,Lack of funds
NCT04143776,WITHDRAWN,OBSERVATIONAL,Currently on standby until new primary investigator is found
NCT04143841,TERMINATED,INTERVENTIONAL,Financial constraints
NCT04143958,WITHDRAWN,INTERVENTIONAL,The Sponsor terminated the study due to recruitment infeasibility without having enrolled any patient.
NCT04143997,WITHDRAWN,OBSERVATIONAL,No pt enrolled
NCT04144140,TERMINATED,INTERVENTIONAL,"The study was terminated earlier due to a business decision; which was unrelated to safety. In addition, there was no clinical activity data that informed the decision."
NCT04144335,WITHDRAWN,INTERVENTIONAL,Contact issues
NCT04144530,WITHDRAWN,OBSERVATIONAL,study did not start by logistic reasons
NCT04144634,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19
NCT04145037,TERMINATED,INTERVENTIONAL,This study was voluntarily terminated by the sponsor to halt development and was not based on any safety or medical reasons.
NCT04145115,SUSPENDED,INTERVENTIONAL,Other - Evaluating accrual and study design
NCT04145193,WITHDRAWN,INTERVENTIONAL,Study withdrawn prior to enrollment due to changing standard of care landscape.
NCT04145700,TERMINATED,INTERVENTIONAL,Study terminated for meeting protocol specified futility criteria.
NCT04145869,WITHDRAWN,INTERVENTIONAL,No funding
NCT04146012,TERMINATED,INTERVENTIONAL,Company was sold and clinical trial was suspended then teminated
NCT04146389,TERMINATED,OBSERVATIONAL,Preliminary analyses of the samples provide no indication for a clinically relevant relationship between hyperprolactinemia and stimulation of adrenal steroidogenesis.
NCT04146779,TERMINATED,INTERVENTIONAL,COVID-19
NCT04146909,TERMINATED,INTERVENTIONAL,The study could not be completed as planned due to difficulty to recruit moms during COVID.
NCT04147000,TERMINATED,OBSERVATIONAL,Problem with recruiting as a consequence of COVID-19
NCT04147143,TERMINATED,OBSERVATIONAL,"Due to insufficient recruitment rate, recruitmend has been terminated after inclusion of 56 patients"
NCT04147195,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04147468,SUSPENDED,INTERVENTIONAL,The funding has expired in June 2022. This protocol will be active once more funding is secured.
NCT04147637,WITHDRAWN,INTERVENTIONAL,due to irrelevancy of the idea given the advancement in the field and COVID-19 crisis
NCT04148261,WITHDRAWN,INTERVENTIONAL,Principal Investigator left lab before study start
NCT04148690,TERMINATED,INTERVENTIONAL,Group intervention suspended due to COVID-19 risk
NCT04148742,SUSPENDED,INTERVENTIONAL,"Clinical development strategy adjustment, non-safety reason"
NCT04149145,WITHDRAWN,INTERVENTIONAL,never opened
NCT04149236,WITHDRAWN,OBSERVATIONAL,Was halted during the COVID pandemic; study continuation plans discontinued as some investigators no longer associated with the University of Colorado.
NCT04149275,WITHDRAWN,INTERVENTIONAL,Funding withdrawn by sponsor
NCT04149353,TERMINATED,INTERVENTIONAL,Low recruitment
NCT04149379,WITHDRAWN,INTERVENTIONAL,Because of the economic consequences of the COVID-19 pandemic 2020
NCT04149392,WITHDRAWN,INTERVENTIONAL,Changed to quality improvement project
NCT04149444,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew support
NCT04149522,TERMINATED,INTERVENTIONAL,The mepitel film was expired and was no longer available.
NCT04149574,TERMINATED,INTERVENTIONAL,"Insufficient enrollment, inability to meet protocol objectives, and slow accrual."
NCT04149769,WITHDRAWN,INTERVENTIONAL,COVID
NCT04149808,WITHDRAWN,INTERVENTIONAL,The study was never conducted and no parcipants were ever enrolled and study never initiated.
NCT04149821,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT04150094,WITHDRAWN,INTERVENTIONAL,Due to the covid pandemic.
NCT04150367,TERMINATED,OBSERVATIONAL,According to Sponsor decision.
NCT04150419,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT04150562,TERMINATED,INTERVENTIONAL,This study was terminated early due to manufacturer withdrawal of support (study medication) due to lack of enrollment.
NCT04150666,WITHDRAWN,INTERVENTIONAL,No subjects are willing to participating.
NCT04150692,WITHDRAWN,INTERVENTIONAL,Investigator decision
NCT04150705,TERMINATED,INTERVENTIONAL,It was determined that the trial could stop early due to surpassing the feasibility rate.
NCT04150874,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT04151225,WITHDRAWN,INTERVENTIONAL,Internal sponsor decision to terminate project in Crohn's disease due to potential narrow therapeutic window. No subjects were enrolled
NCT04151368,SUSPENDED,INTERVENTIONAL,Recruitment has been temporarily suspended since the start of the pandemic due to the need for travel for this study. Will resume when appropriate.
NCT04151446,TERMINATED,INTERVENTIONAL,Inadequate Enrollment
NCT04151563,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT04151706,SUSPENDED,INTERVENTIONAL,Interim analysis
NCT04151719,WITHDRAWN,INTERVENTIONAL,Due to pandemic challenges and consideration of a different study design in the future.
NCT04151745,WITHDRAWN,INTERVENTIONAL,"interaction with another study, not possible to include patients"
NCT04152382,TERMINATED,INTERVENTIONAL,Terminated due to liver findings
NCT04152837,TERMINATED,INTERVENTIONAL,The decision is based on a thorough reassessment of the commercial potential of lixivaptan as a potential best-in-class therapy for patients with ADPKD
NCT04152863,TERMINATED,INTERVENTIONAL,Business Reasons
NCT04153071,WITHDRAWN,INTERVENTIONAL,Per Investigator and sponsor decision
NCT04153175,TERMINATED,INTERVENTIONAL,Company Decision
NCT04153838,SUSPENDED,OBSERVATIONAL,Due to covid-19 restrictions on recruiting
NCT04153942,WITHDRAWN,INTERVENTIONAL,Study never started/initiated.
NCT04153955,WITHDRAWN,INTERVENTIONAL,Study never started/initiated.
NCT04154033,WITHDRAWN,INTERVENTIONAL,Funding
NCT04154059,SUSPENDED,INTERVENTIONAL,The recruitment of potential participants is suspended due to the covid-19 pandemic.
NCT04154150,TERMINATED,INTERVENTIONAL,"Midway through this pilot study, funding was obtained to support a much larger study of the same interventions in this clinical population. Therefore the pilot study was halted so as not to compete with enrollment for the larger study."
NCT04154579,TERMINATED,INTERVENTIONAL,COVID-19 pandemic. Unable to restart as had hoped.
NCT04154735,WITHDRAWN,INTERVENTIONAL,Discontinued by Investigator
NCT04154787,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04154826,TERMINATED,INTERVENTIONAL,non convincing results
NCT04155008,TERMINATED,INTERVENTIONAL,The trial was closed after 4 months due to slow to accrual. Only 1 participant was enrolled.
NCT04155099,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT04155177,WITHDRAWN,OBSERVATIONAL,no participants because of the sars cov 2 pandemic there is no volonteer to be recruited for the lurning curve . all the residents are busy working in COVID UNITS
NCT04155190,TERMINATED,INTERVENTIONAL,Terminated early due to low blinded event rate
NCT04155268,WITHDRAWN,INTERVENTIONAL,Unable to conduct the study due to Covid-19.
NCT04155580,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
NCT04155840,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT04155996,TERMINATED,OBSERVATIONAL,Study terminated prematurely due to COVID-19 pandemic
NCT04156022,TERMINATED,OBSERVATIONAL,PI request due to a lack of coordinator availability for study procedures.
NCT04156100,TERMINATED,INTERVENTIONAL,Strategic business decision.
NCT04156204,TERMINATED,INTERVENTIONAL,Discontinuation of study due to site staffing and resources available to conduct the study
NCT04156399,TERMINATED,INTERVENTIONAL,Due to the Coronavirus Disease 2019 (COVID-19) pandemic
NCT04156516,TERMINATED,INTERVENTIONAL,COVID-19 pandemic interfered with school-based data collection
NCT04156659,WITHDRAWN,INTERVENTIONAL,This study was cancelled before enrolling any patients for business related reasons.
NCT04156672,WITHDRAWN,OBSERVATIONAL,Study was cancelled due to reclassification of study design. No subjects enrolled in the study.
NCT04156763,TERMINATED,OBSERVATIONAL,CI has left the trust
NCT04156828,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT04156880,WITHDRAWN,OBSERVATIONAL,the collaborating party of AI system withdraw their study due to change of company policy in year of COVID-19 pandemic
NCT04157036,TERMINATED,INTERVENTIONAL,"COVID halted recruitment for 2 years. A majority of patients eligible for the study had already taken preoperative analgesics, which disqualified them for the study."
NCT04157088,TERMINATED,INTERVENTIONAL,The results of the lead-in phase did not fulfill the criteria set for moving into the randomized phase
NCT04157114,WITHDRAWN,INTERVENTIONAL,The FDA requested Mapreg conduct an alcohol interaction study which was not feasible due to the COVID-19 pandemic.
NCT04157270,TERMINATED,OBSERVATIONAL,Business decision to focus on other studies. No safety concern
NCT04157374,WITHDRAWN,INTERVENTIONAL,Lack of patients due to Covid-19 pandemic
NCT04157608,WITHDRAWN,INTERVENTIONAL,Investigational device under development
NCT04158141,TERMINATED,INTERVENTIONAL,Permanent Administrative Closure
NCT04158349,TERMINATED,INTERVENTIONAL,PI Decision
NCT04158492,TERMINATED,INTERVENTIONAL,Futility
NCT04158583,TERMINATED,INTERVENTIONAL,"Halted in order to focus on the ongoing combination of RO7296682 with Atezolizumab, evaluated in study BP42595, as a higher likelihood for efficacy is expected in combination with Atezolizumab as compared to the monotherapy setting."
NCT04158596,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT04158700,WITHDRAWN,INTERVENTIONAL,The withdrawal is due to a strategic realignment and is not related to any particular safety or efficacy concern.
NCT04158830,WITHDRAWN,INTERVENTIONAL,PI is no longer at this University.
NCT04158921,TERMINATED,INTERVENTIONAL,Lack of funding
NCT04159038,TERMINATED,INTERVENTIONAL,"Study sites were closed in March 2020, due to COVID-19 and did not re-open; follow-up data were collected for 6 months subsequently of already enrolled subjects"
NCT04159311,TERMINATED,INTERVENTIONAL,The study encountered difficulties in including patients
NCT04159493,WITHDRAWN,INTERVENTIONAL,Project terminated IND withdrawn
NCT04159701,TERMINATED,INTERVENTIONAL,The study was terminated for lack of efficacy after an interim analysis was performed
NCT04159714,TERMINATED,INTERVENTIONAL,Change in practice decreasing availability of eligible patients.
NCT04159753,TERMINATED,INTERVENTIONAL,Only 2 patients enrolled
NCT04159909,WITHDRAWN,INTERVENTIONAL,"Study site, detoxification unit at South Oaks Hospital, was closed/partially open. Northwell addiction has been unable to provide any projected/workable plan(s)."
NCT04159935,TERMINATED,INTERVENTIONAL,Cancelled due to COVID-19
NCT04160039,TERMINATED,INTERVENTIONAL,Principal Investigator left institution
NCT04160091,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to the COVID-19 pandemic creating uncertainty impacting trial progress and costs.
NCT04160182,WITHDRAWN,INTERVENTIONAL,Due to COVID this trial never got up and running.
NCT04160195,TERMINATED,INTERVENTIONAL,The original principal investigator left the National Institutes of Health (NCI) and the decision was made to close the study to enrollment.
NCT04160468,TERMINATED,INTERVENTIONAL,The independent DSMB recommended that the study be stopped for futility following interim efficacy analysis.
NCT04160559,WITHDRAWN,INTERVENTIONAL,There are no suitable participants
NCT04160663,TERMINATED,INTERVENTIONAL,Due to COVID and staffing issues study was terminated
NCT04161118,TERMINATED,INTERVENTIONAL,"Termination of the funding agreement by the financial sponsor of the study. Small number of patients enrolled, none of the planned analyses will be feasible to draw conclusions on the safety or efficacy of the therapy."
NCT04161391,TERMINATED,INTERVENTIONAL,Adverse change in the risk/benefit.
NCT04162028,WITHDRAWN,INTERVENTIONAL,Investigators not interested any more in the study
NCT04162145,TERMINATED,INTERVENTIONAL,Due to COVID-19 pandemic
NCT04162301,TERMINATED,INTERVENTIONAL,The study has been stopped for strategic and business reasons.
NCT04162366,WITHDRAWN,INTERVENTIONAL,A business decision was made to not initiate this study
NCT04162470,TERMINATED,INTERVENTIONAL,Business Decision
NCT04162639,WITHDRAWN,INTERVENTIONAL,PI is working on getting funding for the study and wishes to withdraw the study until that funding is secured.
NCT04162873,SUSPENDED,INTERVENTIONAL,Pending confirmation of additional funding
NCT04162964,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04163094,TERMINATED,INTERVENTIONAL,"Despite the extension of the original recruitment period, the target number of evaluable patients defined in the study protocol could not be reached and recruitment for the trial was stopped at that point of time."
NCT04163224,WITHDRAWN,OBSERVATIONAL,Sponsor strategy change
NCT04163510,WITHDRAWN,INTERVENTIONAL,"Because of the pandemic, this study had to be stopped and cannot be resumed."
NCT04163679,TERMINATED,INTERVENTIONAL,Enrollment issues
NCT04163718,TERMINATED,INTERVENTIONAL,Drug no longer available
NCT04163900,TERMINATED,INTERVENTIONAL,"A pre-planned futility analysis concluded that NUC-1031 plus cisplatin was unlikely to achieve its primary objective of improving overall survival. Based on the IDMC's recommendation, NuCana has closed the study."
NCT04163913,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT04163926,WITHDRAWN,INTERVENTIONAL,"The RCT part of the study has been stopped. Due to other issues, funding, other trails and policy changes, the rct will not happen. Interviews will continue but RCT part will not."
NCT04164043,TERMINATED,INTERVENTIONAL,Decision made on 8/16/2021 due to difficult enrollment because of limited access for enrollees during the pandemic and changes in staff
NCT04164563,TERMINATED,INTERVENTIONAL,We have elected to discontinue enrolling patients.
NCT04164758,TERMINATED,INTERVENTIONAL,Study enrollment impacted by COVID-19 pandemic and Sponsor terminated for business reasons
NCT04165031,TERMINATED,INTERVENTIONAL,The study was terminated due to an unexpected toxicity finding.
NCT04165148,TERMINATED,INTERVENTIONAL,There is no more material
NCT04165304,TERMINATED,INTERVENTIONAL,"Since schools are closed due to the current corona virus situation, the study cannot be continued."
NCT04165473,SUSPENDED,OBSERVATIONAL,Due to COVID-19 lockdown restrictions trainings and group sessions could not take place. As soon as trainings can take place recruiting will start.
NCT04165642,TERMINATED,OBSERVATIONAL,due to unattainability of the expected sampling unit.
NCT04165668,TERMINATED,OBSERVATIONAL,Due to the COVID-19 Pandemic.
NCT04165733,SUSPENDED,OBSERVATIONAL,Recruitment was suspended with the begin of the COVID-19 pandemic as this potentially has an incluence on our outcomes
NCT04166136,TERMINATED,INTERVENTIONAL,Because of the pandemic
NCT04166370,WITHDRAWN,INTERVENTIONAL,Stopped due to funding
NCT04166448,WITHDRAWN,OBSERVATIONAL,Never start
NCT04166552,SUSPENDED,INTERVENTIONAL,Sponsor ceasing all operations due to company's shut down
NCT04166734,TERMINATED,INTERVENTIONAL,Study terminated due to slow recruitment and insufficient further funding.
NCT04166929,TERMINATED,INTERVENTIONAL,low recruitment
NCT04167072,WITHDRAWN,INTERVENTIONAL,Unexpected difficulties recruiting and following patients
NCT04167111,WITHDRAWN,INTERVENTIONAL,Covid pandemic
NCT04167345,TERMINATED,INTERVENTIONAL,at Sponsor's discretion
NCT04167618,TERMINATED,INTERVENTIONAL,Business priorities
NCT04167852,WITHDRAWN,INTERVENTIONAL,no funding/support
NCT04168294,TERMINATED,OBSERVATIONAL,The number of subjects did not meet the requirements
NCT04168320,TERMINATED,INTERVENTIONAL,Because of the prolonged/poor patient recruitment
NCT04168671,WITHDRAWN,INTERVENTIONAL,Coronavirus pandemia
NCT04168918,TERMINATED,INTERVENTIONAL,Most participants did not complete the post-intervention questionnaire
NCT04168931,TERMINATED,INTERVENTIONAL,recruitment failure
NCT04168957,TERMINATED,INTERVENTIONAL,No need to complete the overall survival (OS) follow-up as the sample size was too small to interpret OS.
NCT04169360,WITHDRAWN,INTERVENTIONAL,"The FDA determined that there is not adequate safety information to continue clinical investigations using ANS-6637 and Amygdala Neurosciences, the product company of ANS-6637, is no longer pursuing research with this compound."
NCT04169568,SUSPENDED,OBSERVATIONAL,Audit in process
NCT04170335,WITHDRAWN,OBSERVATIONAL,No inclusion
NCT04170491,SUSPENDED,INTERVENTIONAL,Study suspended until funding is secured
NCT04170868,WITHDRAWN,INTERVENTIONAL,COVID
NCT04170959,TERMINATED,INTERVENTIONAL,Loss of external funding
NCT04171089,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 Pandemic
NCT04171141,TERMINATED,INTERVENTIONAL,Study was terminated due to strategic considerations and not due to safety.
NCT04171284,TERMINATED,INTERVENTIONAL,"Strategy adjustments, independent of the safety and efficacy of the trial medication"
NCT04171388,WITHDRAWN,INTERVENTIONAL,Trial withdrawn due to COVID-19.
NCT04171648,TERMINATED,INTERVENTIONAL,Covid-19 Pandemic halted my study due to exposure risks.
NCT04171700,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in development priorities.
NCT04171778,TERMINATED,INTERVENTIONAL,Substantially redesigning study protocol and opening a new study in the future.
NCT04171843,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of sufficient therapeutic effect
NCT04172324,TERMINATED,INTERVENTIONAL,lack of funding
NCT04172363,WITHDRAWN,INTERVENTIONAL,PI left site
NCT04172532,SUSPENDED,INTERVENTIONAL,End of Initial Phase of Multi-phase protocol
NCT04172597,TERMINATED,INTERVENTIONAL,Strategic business decision (unrelated to safety)
NCT04172909,WITHDRAWN,INTERVENTIONAL,Expired IRB approval 12/12/2020
NCT04173117,TERMINATED,INTERVENTIONAL,Major delays attributed to COVID-19 pandemic. Learnings informed design of multi-centre RCT
NCT04173325,TERMINATED,INTERVENTIONAL,Closed by the IRB 5/26/22 due to non-compliance
NCT04173338,TERMINATED,INTERVENTIONAL,Closed by IRB on 3/28/22
NCT04173611,TERMINATED,INTERVENTIONAL,Terminated for strategic and administrative reasons
NCT04173975,WITHDRAWN,INTERVENTIONAL,pandemic of coronavirus disease
NCT04174534,TERMINATED,OBSERVATIONAL,Weak enrollment rate and sanitary situation
NCT04174677,WITHDRAWN,INTERVENTIONAL,Stopped due to no enrollment
NCT04174794,TERMINATED,OBSERVATIONAL,COVID-19 Pandemic
NCT04174846,WITHDRAWN,INTERVENTIONAL,Due to COVID-19
NCT04174911,WITHDRAWN,INTERVENTIONAL,covid 19
NCT04174963,TERMINATED,INTERVENTIONAL,"Based on Initial findings and input from other researchers in the field, the investigators and sponsor decided to end this study and begin work on an updated version of this research."
NCT04175132,TERMINATED,INTERVENTIONAL,New efficacy data from another study
NCT04175392,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT04175717,TERMINATED,INTERVENTIONAL,Due to COVID pandemic
NCT04175886,TERMINATED,OBSERVATIONAL,Design has to been modified due to the results from ORAL Surveillance
NCT04176016,TERMINATED,INTERVENTIONAL,Some of the raw materials for the investigational drug are difficult to obtain and expensive.
NCT04176185,TERMINATED,INTERVENTIONAL,COVID-19
NCT04176315,TERMINATED,INTERVENTIONAL,COVID-19
NCT04176406,TERMINATED,INTERVENTIONAL,"Covid-19, Funding ended"
NCT04176445,TERMINATED,INTERVENTIONAL,The trial was stopped prematurely due to the COVID-19 pandemic
NCT04176458,TERMINATED,INTERVENTIONAL,due to COVID 19 restrictions at our site
NCT04176653,WITHDRAWN,INTERVENTIONAL,"Study stopped prior to subject administered first dose, due to COVID-19"
NCT04176900,WITHDRAWN,INTERVENTIONAL,"Closed during Covid Pandemic, and no longer supported locally"
NCT04176913,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study
NCT04176952,TERMINATED,INTERVENTIONAL,Due to funding being withdrawn
NCT04176978,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04177459,TERMINATED,INTERVENTIONAL,Covid-19
NCT04177602,TERMINATED,INTERVENTIONAL,"Due to the amended therapy strategies for rectal cancer recently, it was decided not to transfer the study to the phase II part, as superiority over standard chemoradiation and transfer to a new therapy standard are increasingly unlikely."
NCT04178460,TERMINATED,INTERVENTIONAL,This termination decision is a business decision and is not due to any safety concerns.
NCT04178525,TERMINATED,INTERVENTIONAL,COVID-19 restrictions
NCT04178564,SUSPENDED,INTERVENTIONAL,Covid-19 pandemic
NCT04178616,TERMINATED,INTERVENTIONAL,"Following the COVID-related health crisis, nasofibroscopic sampling could no longer be carried out"
NCT04178642,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04178668,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT04178746,TERMINATED,OBSERVATIONAL,Business decision to focus on other studies. No safety concern.
NCT04178772,TERMINATED,INTERVENTIONAL,"To ensure the safety of participants during the COVID-19 pandemic, this clinical trial is suspended until further notice. This study was terminated due to the lockdown requirements."
NCT04178902,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04179110,WITHDRAWN,INTERVENTIONAL,Funding was withdrawn prior to first enrollment.
NCT04179227,TERMINATED,OBSERVATIONAL,PI left institution.
NCT04179617,WITHDRAWN,INTERVENTIONAL,Enrollment was never initiated; COVID prevented participant enrollment
NCT04180202,TERMINATED,OBSERVATIONAL,Study was terminated due to inability of clinical site to enroll sufficient number of subjects
NCT04180423,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT04180475,TERMINATED,INTERVENTIONAL,Study closed due to not able to find any real stroke patients interested to participate.
NCT04180566,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT04180813,TERMINATED,OBSERVATIONAL,Study enrollment did not meet expectation.
NCT04180826,TERMINATED,OBSERVATIONAL,alll patients have been included
NCT04180969,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04181255,TERMINATED,INTERVENTIONAL,Investigator Retirement
NCT04181515,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04181762,TERMINATED,INTERVENTIONAL,Study terminated by sponsor due to futility analysis
NCT04181957,TERMINATED,INTERVENTIONAL,COVID-19
NCT04182802,WITHDRAWN,OBSERVATIONAL,Funding withdrawn due to COVID related delays.
NCT04182867,TERMINATED,INTERVENTIONAL,Participant recruitment difficulties within the time frame
NCT04182945,TERMINATED,INTERVENTIONAL,Not enough patients having fever symptoms
NCT04183010,WITHDRAWN,INTERVENTIONAL,Lack of Funding to support the study application
NCT04183153,WITHDRAWN,INTERVENTIONAL,Principal Investigator left lab
NCT04183452,TERMINATED,OBSERVATIONAL,Sponsor stopped study as the study drugs were withdrawn from the market
NCT04183634,TERMINATED,INTERVENTIONAL,Company Decision
NCT04183738,WITHDRAWN,INTERVENTIONAL,In the context of COVID-19 pandemic.
NCT04184037,TERMINATED,INTERVENTIONAL,Study recruitment was suspended due to interruption of in-person testing after the start of the COVID19 pandemic in March 2020. The current study's protocol is being revised to be delivered fully remotely.
NCT04184206,TERMINATED,INTERVENTIONAL,"Moved institutions, study terminated"
NCT04184323,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04184518,WITHDRAWN,INTERVENTIONAL,The Cediranib producer laboratory decided to stop the development of this product.
NCT04184609,WITHDRAWN,INTERVENTIONAL,Funding ran out before participants were enrolled.
NCT04184635,SUSPENDED,INTERVENTIONAL,problem with the device (dilatator of the introducer) used to introduce the intra arterial balloon
NCT04184882,TERMINATED,INTERVENTIONAL,Operational Reasons
NCT04185155,TERMINATED,INTERVENTIONAL,Halted prematurely - Covid-19 pandemic prevented recruitment/testing in ED
NCT04185311,TERMINATED,INTERVENTIONAL,enrollment
NCT04185428,SUSPENDED,INTERVENTIONAL,Pending needed additional funding/resources
NCT04185467,SUSPENDED,INTERVENTIONAL,The coronavirus broke out in China at the end of 2019
NCT04185610,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT04185727,TERMINATED,INTERVENTIONAL,Corona.
NCT04186039,WITHDRAWN,INTERVENTIONAL,Study manager's decision
NCT04186156,WITHDRAWN,INTERVENTIONAL,Study not progressing
NCT04186299,WITHDRAWN,INTERVENTIONAL,Study activities never commenced.
NCT04186364,WITHDRAWN,INTERVENTIONAL,Terminated due to COVID-19 pandemic.
NCT04186377,TERMINATED,INTERVENTIONAL,Inability to recruit subjects
NCT04186637,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04186988,WITHDRAWN,INTERVENTIONAL,Unable to recruit to study.
NCT04187365,TERMINATED,INTERVENTIONAL,Study was terminated prematurely due to challenges with recruitment and feasibility of continuing the study
NCT04187508,WITHDRAWN,INTERVENTIONAL,The reason is: emerging pre-clinical toxicology findings.
NCT04187547,WITHDRAWN,INTERVENTIONAL,Study replaced with a new study
NCT04187872,TERMINATED,INTERVENTIONAL,Sponsor terminated
NCT04187937,TERMINATED,INTERVENTIONAL,Difficulties with recruiting participants for the study due to the COVID-19 pandemic.
NCT04188288,TERMINATED,INTERVENTIONAL,Due to low enrollment from the COVID interruption.
NCT04188431,TERMINATED,INTERVENTIONAL,Lack of finance
NCT04188600,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04188769,WITHDRAWN,INTERVENTIONAL,lack of time
NCT04189263,TERMINATED,INTERVENTIONAL,"Low participant compliance, slow recruitment"
NCT04189315,WITHDRAWN,INTERVENTIONAL,R\&D portfolio review and in light of the global impact of the COVID-19 pandemic
NCT04189341,WITHDRAWN,INTERVENTIONAL,no participants
NCT04189510,WITHDRAWN,INTERVENTIONAL,ongoing concern of working with high-risk in-hospital transplant population during the various stages of the COVID-19 Pandemic.
NCT04189601,WITHDRAWN,OBSERVATIONAL,Principal Investigator Dr. Thomas Barbour passed away.
NCT04189640,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04189952,TERMINATED,INTERVENTIONAL,Investigator Decision
NCT04189991,SUSPENDED,INTERVENTIONAL,Recruitment has not started yet due to COVID pandemic.
NCT04190056,TERMINATED,INTERVENTIONAL,Change in practice patterns
NCT04190069,WITHDRAWN,INTERVENTIONAL,IRB recommended change to registry study or quality improvement project status
NCT04190082,TERMINATED,OBSERVATIONAL,No more participants enrolled.
NCT04190277,TERMINATED,INTERVENTIONAL,Covid-19
NCT04190433,WITHDRAWN,INTERVENTIONAL,Administratively closed due to low/no accrual
NCT04190498,WITHDRAWN,OBSERVATIONAL,the possibility of obtaining histological data is too low due to the lack of availability of biological samples
NCT04190875,SUSPENDED,OBSERVATIONAL,Inability to bring patients in for follow-up visits due to institutional restrictions related to COVID-19
NCT04191031,TERMINATED,INTERVENTIONAL,One of the pre-determined criteria for efficacy analysis in the interim analysis SAP for stopping the study was met.
NCT04191161,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT04191278,WITHDRAWN,INTERVENTIONAL,COVID prevented study initiation
NCT04191356,TERMINATED,OBSERVATIONAL,Collected enough data to support the Endpoints
NCT04191382,TERMINATED,INTERVENTIONAL,early discontinuation based on strategic sponsor decision not driven by any safety concerns
NCT04191733,TERMINATED,INTERVENTIONAL,Sponsor terminated study early. Data collection was sufficient to adequately assess primary endpoint.
NCT04192019,WITHDRAWN,INTERVENTIONAL,Prioritization of other projects
NCT04192110,WITHDRAWN,INTERVENTIONAL,The project has ended prior to beginning.
NCT04192318,TERMINATED,INTERVENTIONAL,"Due to COVID, enrollment and data collection was shut down. Project was funded by training grant which ended before COVID restrictions were sufficiently lifted to resume enrollment."
NCT04192448,TERMINATED,INTERVENTIONAL,Procedures not feasible due to COVID-19 and administrative concerns
NCT04192513,TERMINATED,INTERVENTIONAL,Covid-19 has shut the clinic indefinitely
NCT04192929,WITHDRAWN,INTERVENTIONAL,PI decision.
NCT04193293,TERMINATED,INTERVENTIONAL,The study was terminated due to low enrollment.
NCT04193891,SUSPENDED,OBSERVATIONAL,due to COVID-19
NCT04193904,TERMINATED,INTERVENTIONAL,Sponsor insolvency
NCT04193930,WITHDRAWN,INTERVENTIONAL,no women were recruited
NCT04194034,TERMINATED,INTERVENTIONAL,Study has been terminated after Phase I part on 23 February 2023
NCT04194476,SUSPENDED,INTERVENTIONAL,The protocol needs to be further developed.
NCT04194528,TERMINATED,INTERVENTIONAL,Study sponsor withdrew support.
NCT04194983,TERMINATED,INTERVENTIONAL,due to COVID-19 and lack of financial means to continue
NCT04195308,WITHDRAWN,INTERVENTIONAL,Logistical constraints
NCT04195373,WITHDRAWN,INTERVENTIONAL,"Study not started, no subjects recruited."
NCT04195620,TERMINATED,INTERVENTIONAL,University affiliation changed and I was unable to transfer the grant that was funding the project
NCT04195958,TERMINATED,INTERVENTIONAL,"Due to low enrollment, this study was terminated early."
NCT04196010,TERMINATED,INTERVENTIONAL,Terminated due to unfavorable risk-benefit ratio of investigational regimen.
NCT04196114,WITHDRAWN,INTERVENTIONAL,Study on-hold before first recruitment
NCT04196517,WITHDRAWN,INTERVENTIONAL,COVID-19 paused study temporarily due to no clinical encounters
NCT04197102,SUSPENDED,INTERVENTIONAL,"Suspended (The UT IRB determined that CBD oil is being used as a drug as defined by the FDA. Therefore, an IND must be obtained for the use of CBD oil in this research study in accordance with FDA regulations, 21 CFR 312.)"
NCT04197219,WITHDRAWN,INTERVENTIONAL,PI is leaving institution
NCT04197453,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT04197505,WITHDRAWN,INTERVENTIONAL,Lost funding due to COVID-19
NCT04197648,WITHDRAWN,INTERVENTIONAL,Organisational set up
NCT04197986,TERMINATED,INTERVENTIONAL,The sponsor has decided to close the study due to the discontinuation of infigratinib development. The discontinuation of the study was not due to safety reasons.
NCT04197999,TERMINATED,INTERVENTIONAL,"After demonstrating the on target effect of GMI-1359 via pharmacodynamic markers (CXCR4 and E-selectin), Sponsor terminated the trial due to COVID-related slow enrollment."
NCT04198168,TERMINATED,OBSERVATIONAL,"Due to the COVID-19 situation, it was not feasible to complete the study in our ICU."
NCT04198285,TERMINATED,INTERVENTIONAL,Due to cancellation of elective surgery (Covid-19)
NCT04198753,SUSPENDED,OBSERVATIONAL,COVID-19 pandemic
NCT04198779,TERMINATED,INTERVENTIONAL,Low recrutement rate
NCT04198818,TERMINATED,INTERVENTIONAL,Sponsor business decision
NCT04198844,WITHDRAWN,OBSERVATIONAL,Interaction term analysis result was not significant and thus comparative effectiveness for primary and secondary outcomes could not be considered per protocol.
NCT04198883,WITHDRAWN,INTERVENTIONAL,Because of the Impact of CoviD19 pandemy
NCT04199130,WITHDRAWN,INTERVENTIONAL,Closed with the IRB due to slow enrollment during COVID. Will be modifying the study with a new submission.
NCT04199221,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT04199351,TERMINATED,INTERVENTIONAL,Amgen determined the totality of the data does not support continuation of AMG 171 development program for treatment of Obesity. No safety concerns identified.
NCT04199442,TERMINATED,OBSERVATIONAL,Sanitary crisis du to Covid-19
NCT04199481,WITHDRAWN,OBSERVATIONAL,Study stopped due to product discontinuation by manufacturer
NCT04199520,WITHDRAWN,INTERVENTIONAL,"In clinical treatment, most patients with stage IV breast cancer received surgical treatment, which made it difficult to enroll this project, so this study was terminated."
NCT04199585,TERMINATED,INTERVENTIONAL,new safety data from another study
NCT04199598,TERMINATED,INTERVENTIONAL,The decision to terminate has been taken by the Sponsor. The decision is not due to safety concerns but reflects business prioritizations of the company.
NCT04199702,WITHDRAWN,INTERVENTIONAL,Study did not enroll any patients due to lack of resources.
NCT04199793,TERMINATED,INTERVENTIONAL,The device (HeartWare) was recalled and discontinued by the FDA
NCT04199806,WITHDRAWN,INTERVENTIONAL,This is a retrospective study reviewing subject questionnaires. No treatments will be administered in this study.
NCT04199910,SUSPENDED,OBSERVATIONAL,COVID pandemia hinders recruitment
NCT04200066,WITHDRAWN,INTERVENTIONAL,One of the drugs for the study is not commercially available.
NCT04200274,SUSPENDED,OBSERVATIONAL,Paused recruitment due to Covid-19 pandemic
NCT04200300,SUSPENDED,OBSERVATIONAL,Recruitment was stopped with the begin of the COVID-19 pandemic as this potentially has an incluence on our outcomes
NCT04200352,TERMINATED,INTERVENTIONAL,Failure of TV50717-CNS-30080 (parent study) to meet the primary efficacy endpoint
NCT04200365,TERMINATED,INTERVENTIONAL,Slow enrollment and PI departure
NCT04200456,TERMINATED,INTERVENTIONAL,Strategic Business Decision; Not a safety decision
NCT04200508,TERMINATED,INTERVENTIONAL,"The study was stopped due to COVID-19 in March 2022. It will not resume because the intervention, enhanced barrier precautions, has been recommended by the CDC and Prevention for nursing homes and is currently being implemented."
NCT04200651,TERMINATED,INTERVENTIONAL,COVID-19 challenges to recruitment
NCT04200846,WITHDRAWN,INTERVENTIONAL,No funding
NCT04200950,WITHDRAWN,INTERVENTIONAL,No longer conducting this retrospective research
NCT04200989,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04201080,TERMINATED,INTERVENTIONAL,Because there have been significant enrollment struggles which has been exacerbated by the COVID impact. This has caused an undue delay to the study timelines and its enrollment goals beyond the business needs.
NCT04201145,WITHDRAWN,INTERVENTIONAL,Funding complications coupled with competing scientific objectives
NCT04201743,WITHDRAWN,INTERVENTIONAL,Resources limited secondary to COVID-19 pandemic.
NCT04201782,TERMINATED,OBSERVATIONAL,"There have been no significant safety issues in any subjects exposed between 7.5 and 13.5 years ago to either SB-728-T or SB-728mR-T, including no delayed adverse events related to the investigational product."
NCT04201821,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT04202211,WITHDRAWN,INTERVENTIONAL,Protocol changed substantially enough to warrant a separate submission
NCT04202471,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic
NCT04202497,TERMINATED,INTERVENTIONAL,Study was prematurely terminated because of administrative reasons.
NCT04202510,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19 and the decrease in surgical cases, sufficient patients were not available."
NCT04202640,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT04202718,WITHDRAWN,INTERVENTIONAL,Study never started due to COVID-19 pandemic
NCT04202731,TERMINATED,INTERVENTIONAL,COVID-19 pandemic impacted recruitment
NCT04202770,SUSPENDED,INTERVENTIONAL,Pending COVID-19 pandemic; pending status of product development
NCT04202783,SUSPENDED,INTERVENTIONAL,Pending COVID-19 pandemic; pending product development
NCT04203017,TERMINATED,INTERVENTIONAL,the bio-samples are corrupted for technical reasons
NCT04203056,TERMINATED,INTERVENTIONAL,Withdraw of financial support by industry collaborator
NCT04203186,WITHDRAWN,INTERVENTIONAL,Funding was lost due to the COVID19 Pandemic
NCT04203199,TERMINATED,INTERVENTIONAL,PI left institution
NCT04203498,TERMINATED,INTERVENTIONAL,This study was terminated based on a business decision by the Sponsor.
NCT04203511,WITHDRAWN,INTERVENTIONAL,Sponsor Strategic/Business Decision
NCT04203875,TERMINATED,INTERVENTIONAL,Lack of eligible study participants.
NCT04203901,TERMINATED,INTERVENTIONAL,Strategic corporate decision
NCT04204109,TERMINATED,INTERVENTIONAL,Covid 19 and subsequent cancellation of all meeting activity
NCT04204122,WITHDRAWN,INTERVENTIONAL,Investigator decided to close study
NCT04205071,WITHDRAWN,INTERVENTIONAL,PI decision
NCT04205136,WITHDRAWN,INTERVENTIONAL,Was on hold due to Covid then we were not able to initiate the funding again after such a long hold and loss of team members.
NCT04205149,WITHDRAWN,OBSERVATIONAL,research staff leading project left institute
NCT04205240,TERMINATED,INTERVENTIONAL,Poor accrual
NCT04205435,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04205539,WITHDRAWN,INTERVENTIONAL,Pending COVID-19 pandemic
NCT04205734,SUSPENDED,OBSERVATIONAL,COVID Restrictions
NCT04205786,SUSPENDED,INTERVENTIONAL,Logistics requirements
NCT04205890,WITHDRAWN,INTERVENTIONAL,Sponsor is no longer interested in funding the study
NCT04206735,WITHDRAWN,INTERVENTIONAL,Complications to recruiting due to COVID-19 pandemic
NCT04206761,WITHDRAWN,INTERVENTIONAL,issues related to Covid-19 restrictions/shutdowns
NCT04206800,TERMINATED,INTERVENTIONAL,Difficulty in enrolling participants
NCT04206865,WITHDRAWN,INTERVENTIONAL,New study initiated
NCT04206917,TERMINATED,INTERVENTIONAL,Sponsor ceasing operations
NCT04207138,WITHDRAWN,OBSERVATIONAL,change sponsor
NCT04207268,WITHDRAWN,INTERVENTIONAL,Protocol could not be initiated due to COVID.
NCT04207424,WITHDRAWN,INTERVENTIONAL,"Patients were selected but their very condition and the resulting comorbidities did not allow their inclusion. In addition, the health crisis prevented any bariatric operation of this complexity for an indefinite period."
NCT04207476,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to COVID and computer difficulties.
NCT04207645,TERMINATED,OBSERVATIONAL,"Poor recruitment and some centers were not able to secure ethics approval/exemption. The study will be repeated all over again with additional centers, secured approvals/exemptions, and when things are ready"
NCT04207905,TERMINATED,OBSERVATIONAL,"The Healthy Michigan Plan community engagement requirement was implemented on 1/1/2020. On 3/4/2020, a US District Court judge vacated the CMS approval of this policy, thereby suspending implementation of this RCT. This was not an IRB suspension."
NCT04208009,TERMINATED,INTERVENTIONAL,Failed to meet recruitment goal and lost study staff due to COVID-19
NCT04208451,TERMINATED,INTERVENTIONAL,All required data are already collected.
NCT04208516,TERMINATED,INTERVENTIONAL,"Recruitment was unable to be obtained in a timely fashion, so the study was stopped."
NCT04208698,TERMINATED,INTERVENTIONAL,Trial was terminated due to the impact of COVID-19 on trial activities.
NCT04208893,SUSPENDED,INTERVENTIONAL,Study suspended due to COVID-19 restrictions.
NCT04208997,TERMINATED,INTERVENTIONAL,Study was terminated due to low accrual
NCT04209023,SUSPENDED,INTERVENTIONAL,Pending end of COVID-19 pandemic
NCT04209179,TERMINATED,INTERVENTIONAL,"Terminated on the basis of the currently uncertain risk-benefit balance for the patients, and the strategic position of the development program"
NCT04209452,TERMINATED,INTERVENTIONAL,COVID-19
NCT04209465,TERMINATED,INTERVENTIONAL,The development of BDTX-189 was discontinued by the sponsor.
NCT04209530,TERMINATED,INTERVENTIONAL,Study terminated due to COVID-19 impact
NCT04209556,WITHDRAWN,INTERVENTIONAL,The study was withdrawn following a strategic portfolio re-prioritization.
NCT04209621,TERMINATED,INTERVENTIONAL,Due to unexpected sudden death on study.
NCT04209725,TERMINATED,INTERVENTIONAL,Closed due to slow enrollment
NCT04210037,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04210050,WITHDRAWN,INTERVENTIONAL,Trial was not initiated due to COVID19 pandemic
NCT04210141,SUSPENDED,INTERVENTIONAL,due to current political circumstances in study site area.
NCT04210206,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT04210310,TERMINATED,INTERVENTIONAL,PI departure from the institution.
NCT04210362,TERMINATED,INTERVENTIONAL,"Due to the Covid-19 contingency, activities were suspended in March 2020. Baseline measurements were obtained for n=764 children whose caregivers enrolled in the NPECDP-UKA."
NCT04210401,WITHDRAWN,OBSERVATIONAL,Investigator did not move forward with the project due to costs.
NCT04210414,TERMINATED,INTERVENTIONAL,COVID19 Pandemic affected recruitment across 2020 and the stringent inclusion criteria makes the proposed sample size to be likely unachievable in reasonable period.
NCT04210557,TERMINATED,INTERVENTIONAL,Unable to recruit enough suitable participants.
NCT04210726,WITHDRAWN,INTERVENTIONAL,Working on complying with the Research Ethics Board requirements.
NCT04210843,TERMINATED,INTERVENTIONAL,Study was terminated due to a strategic decision by Novartis to discontinue development of ligelizumab in CSU. This decision was not based on any safety concerns.
NCT04211350,TERMINATED,INTERVENTIONAL,Global recall of the comparator device
NCT04211415,TERMINATED,INTERVENTIONAL,Company decision of termination of the clinical program.
NCT04212026,TERMINATED,INTERVENTIONAL,difficult recruitement
NCT04212065,WITHDRAWN,INTERVENTIONAL,closed due to new safety concerns of subcutaneous buprenorphine in pregnant patients
NCT04212221,TERMINATED,INTERVENTIONAL,Due to the rapid shifting of liver cancer disease landscape and the company's adjustment of development strategy.
NCT04212650,TERMINATED,INTERVENTIONAL,redesigned trial using another placebo controlled drug
NCT04213573,SUSPENDED,INTERVENTIONAL,because of corona virus epidemic
NCT04214002,WITHDRAWN,OBSERVATIONAL,"Due to the COVID-19 Pandemic, the study was withdrawn."
NCT04214093,TERMINATED,INTERVENTIONAL,Strategic change to clinical development plan
NCT04215549,WITHDRAWN,OBSERVATIONAL,"Because of COVID-19, we cann't carry out recruiting according to the original plan"
NCT04216173,TERMINATED,INTERVENTIONAL,Permanent suspension of all study activities due to COVID-19 and subsequent loss of funding.
NCT04216277,WITHDRAWN,INTERVENTIONAL,the poc test was withdrawn by manufacturer
NCT04216303,WITHDRAWN,OBSERVATIONAL,PI decided to stop the study
NCT04216628,TERMINATED,INTERVENTIONAL,Study was terminated due to difficulties in recruitment
NCT04216667,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT04216693,WITHDRAWN,INTERVENTIONAL,Administrative decision to terminate.
NCT04216797,WITHDRAWN,INTERVENTIONAL,"Enrollment was initially suspended due to COVID pandemic. As the number of cases subsided, enrollment was reopened but never regained momentum. PI has left the site."
NCT04217057,TERMINATED,INTERVENTIONAL,Insufficient funding/staff
NCT04217252,WITHDRAWN,INTERVENTIONAL,"Due to the impact of the COVID-19, the project has been suspended for a long time and cannot continue to complete."
NCT04217577,TERMINATED,INTERVENTIONAL,Restriction on in-person research due to COVID-19
NCT04217707,WITHDRAWN,INTERVENTIONAL,Study unable to be conducted due to COVID.
NCT04217720,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04217837,WITHDRAWN,OBSERVATIONAL,COVID
NCT04217850,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT04218019,WITHDRAWN,INTERVENTIONAL,Organizational reasons
NCT04218279,TERMINATED,INTERVENTIONAL,Trial enrollment terminated early due to end of funding period.
NCT04218383,SUSPENDED,INTERVENTIONAL,Coronavirus pandemic
NCT04218448,TERMINATED,INTERVENTIONAL,PI's decision
NCT04218565,TERMINATED,INTERVENTIONAL,only one patient enrolled
NCT04218643,TERMINATED,INTERVENTIONAL,Enrollment too difficult due to lost staff after COVID
NCT04218786,WITHDRAWN,INTERVENTIONAL,"Due to the pandemic, there were logistical issues in continuing the study."
NCT04218825,TERMINATED,INTERVENTIONAL,"After an extensive assessment of the study feasibility, it was decided to discontinue the clinical trial due to poor recruitment."
NCT04218838,TERMINATED,INTERVENTIONAL,Enrollment difficulties due to changes in control arm conventions
NCT04219111,WITHDRAWN,OBSERVATIONAL,"STUDY LOOKING AT SAMPLES ONLY, NO PARTICIPANT ENROLMENT REQUIRED"
NCT04219293,TERMINATED,INTERVENTIONAL,Covid-19
NCT04219319,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study
NCT04219358,TERMINATED,INTERVENTIONAL,Study terminated because of COVID19 pandemics.
NCT04219475,SUSPENDED,OBSERVATIONAL,Priority changes of the company
NCT04219501,WITHDRAWN,INTERVENTIONAL,Mutual decision between the investigators and the sponsor
NCT04219618,TERMINATED,INTERVENTIONAL,The study was stopped because the manufacturer stopped producing the HeartWare LVAD device.
NCT04219748,TERMINATED,INTERVENTIONAL,Insufficient accrual rate to achieve expected sample size in the context of a global pandemic.
NCT04219982,TERMINATED,INTERVENTIONAL,Failure to meet enrollment
NCT04220008,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT04220125,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT04220216,TERMINATED,INTERVENTIONAL,COVID pandemic
NCT04220281,TERMINATED,INTERVENTIONAL,the number of patients needed for the study have been collected
NCT04220411,TERMINATED,INTERVENTIONAL,"Due to the two AEs in Phase IIa study, recruiting was stopped for safety sake. The study was currently terminated."
NCT04220476,WITHDRAWN,INTERVENTIONAL,Initiating a new study with revised Statistics.
NCT04220489,TERMINATED,INTERVENTIONAL,Study stopped due to unexpected issues surrounding the 2020 COVID-19 pandemic
NCT04220502,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT04220619,WITHDRAWN,INTERVENTIONAL,Not enough resources to execute study
NCT04220632,TERMINATED,INTERVENTIONAL,Adverse events of the first patient
NCT04220658,SUSPENDED,OBSERVATIONAL,COVID-19
NCT04220788,WITHDRAWN,INTERVENTIONAL,No enrollment due to difficulty in recruitment of study sites
NCT04220892,WITHDRAWN,INTERVENTIONAL,One of the study drugs will no longer be supplied by manufacturer and the pembrolizumab + abemaciclib study arm is removed due to toxicity seen in other trials.
NCT04221087,TERMINATED,INTERVENTIONAL,"COVID19-pandemic, RSV surge"
NCT04221100,WITHDRAWN,INTERVENTIONAL,Not enough participants enrolled in the study
NCT04221256,WITHDRAWN,INTERVENTIONAL,Closure due to COVID-19 pandemic
NCT04221386,SUSPENDED,INTERVENTIONAL,Coronavirus
NCT04221828,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04222101,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT04222257,TERMINATED,INTERVENTIONAL,Inability to reach the estimated sample size
NCT04222309,SUSPENDED,INTERVENTIONAL,Per IRB closed and opened a new study.
NCT04222426,TERMINATED,INTERVENTIONAL,Cessation of main trial of which this study was a biomarker imaging side study.
NCT04222569,TERMINATED,INTERVENTIONAL,sufficient number of patients to meet objectives
NCT04222829,TERMINATED,OBSERVATIONAL,low participate rate
NCT04222842,SUSPENDED,INTERVENTIONAL,Day is not required for Anticipated dates.
NCT04222985,TERMINATED,INTERVENTIONAL,business reasons-Phase 2/Part B not conducted. Study terminated after last patient enrolled in Phase 1/Part A
NCT04223011,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19, recruitment was halted before we were able to enroll participants. Currently we are unable to resume recruitment due to study staff changes."
NCT04223648,WITHDRAWN,INTERVENTIONAL,Funding
NCT04223661,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04224688,TERMINATED,INTERVENTIONAL,Strategic Business Decision; Not a safety decision
NCT04224792,WITHDRAWN,INTERVENTIONAL,"Due to pandemic, unable to see patients"
NCT04224844,SUSPENDED,INTERVENTIONAL,"not recruiting, awaiting for changes in IRB"
NCT04225026,TERMINATED,INTERVENTIONAL,Lack of study enrollment
NCT04225234,TERMINATED,INTERVENTIONAL,Due to the COVID-19 pandemic
NCT04225299,WITHDRAWN,INTERVENTIONAL,FDA didn't approve the design of the protocol so we didn't start the study
NCT04225676,TERMINATED,INTERVENTIONAL,Terminated due to slow enrollment
NCT04225806,TERMINATED,INTERVENTIONAL,Project suspended by Sponsor
NCT04225819,SUSPENDED,INTERVENTIONAL,Protocol is being modified.
NCT04225897,TERMINATED,INTERVENTIONAL,Part A and Part B were completed but Pfizer terminated Part C due to strategic consideration. There were no safety concerns in the decision to stop Part C and no changes to the risk-benefit for participants who received RV521 in the study.
NCT04225949,WITHDRAWN,INTERVENTIONAL,Logistical Reasons (Research Staff)
NCT04226001,WITHDRAWN,OBSERVATIONAL,Coordinator departure
NCT04226144,TERMINATED,INTERVENTIONAL,COVID 19 pandemy
NCT04226456,TERMINATED,INTERVENTIONAL,poor recruitment
NCT04226807,TERMINATED,INTERVENTIONAL,"Low participation rate, study converted to a cohort study instead"
NCT04226924,WITHDRAWN,INTERVENTIONAL,Lack of funding for company
NCT04226976,SUSPENDED,INTERVENTIONAL,COVID-19 general concerns
NCT04227275,TERMINATED,INTERVENTIONAL,Based on the safety events and evidence of biologic activity without sustained clinical responses the Sponsor finds the risk/benefit analysis unfavorable for patients and has terminated the study.
NCT04227405,TERMINATED,INTERVENTIONAL,"The funding agency (Administration of Children and Families, US Department of Health and Human Services) discontinued the local evaluation"
NCT04227626,WITHDRAWN,INTERVENTIONAL,"The study has not started, the device is not ready so the study will be delayed"
NCT04227730,WITHDRAWN,OBSERVATIONAL,COVID 19 Pandemic disabled team involved
NCT04227938,TERMINATED,INTERVENTIONAL,Change in sponsor strategy
NCT04228003,WITHDRAWN,INTERVENTIONAL,The funding and project never started
NCT04228549,TERMINATED,INTERVENTIONAL,"Outpatient clinic site unable to provide required recruits due to COVID 19 virus. Terminated June 30 2022. Actual enrolment 126. This information entered August 24, 2022."
NCT04228666,WITHDRAWN,INTERVENTIONAL,Due to COVID 19 Pandemic
NCT04229667,TERMINATED,OBSERVATIONAL,"As a result of COVID-19, the intervention design changed and an RCT was no longer an appropriate study design for evaluation."
NCT04229771,TERMINATED,INTERVENTIONAL,slow enrollment
NCT04230031,WITHDRAWN,INTERVENTIONAL,Difficult enrollment due to changes in standard of care
NCT04230122,TERMINATED,INTERVENTIONAL,Protocol stopping criteria (safety) were met.
NCT04230135,TERMINATED,INTERVENTIONAL,"An insufficient number of participants could be recruited, and drop-out rates were very high (80%)"
NCT04230291,TERMINATED,INTERVENTIONAL,Principal investigator is not longer at this institution
NCT04230330,WITHDRAWN,INTERVENTIONAL,PI has left the institution.
NCT04230564,WITHDRAWN,OBSERVATIONAL,Study was cancelled prior to any enrollment
NCT04230720,WITHDRAWN,INTERVENTIONAL,Stopped due to COVID-19.
NCT04230746,WITHDRAWN,INTERVENTIONAL,"funding , recruitment issues"
NCT04230954,TERMINATED,INTERVENTIONAL,PI left institution
NCT04231032,TERMINATED,INTERVENTIONAL,Unable to recruit to target
NCT04231058,SUSPENDED,INTERVENTIONAL,lack of sufficient staff to conduct the study
NCT04231188,TERMINATED,OBSERVATIONAL,Delay in recruitment due to covid and a newer version of mobile app is available for testing.
NCT04231201,SUSPENDED,OBSERVATIONAL,COVID pandemic
NCT04231279,TERMINATED,INTERVENTIONAL,Data collection discontinuity and sponsor reallocation of study resources to manufacturing
NCT04231409,TERMINATED,INTERVENTIONAL,Study follow-up activities affected by COVID-19
NCT04231682,WITHDRAWN,INTERVENTIONAL,Grant support was withdrawn from Amgen Pharmaceuticals
NCT04231734,WITHDRAWN,INTERVENTIONAL,Low accrual
NCT04231864,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT04231929,WITHDRAWN,INTERVENTIONAL,Study cancelled by Sponsor decision
NCT04232072,WITHDRAWN,INTERVENTIONAL,no participants
NCT04232189,TERMINATED,OBSERVATIONAL,COVID 19 related recruitment problems
NCT04232228,TERMINATED,OBSERVATIONAL,The Care4Today IBD dashboard for HCPs and the patient app will be deactivated indefinitely and will no longer be available for use
NCT04232306,WITHDRAWN,INTERVENTIONAL,Lack of resources to continue.
NCT04232319,WITHDRAWN,INTERVENTIONAL,Due to COVID this study was never started.
NCT04232384,TERMINATED,INTERVENTIONAL,Recruitment slow due to COVID-19
NCT04232397,TERMINATED,INTERVENTIONAL,the efficency is not good enough to enroll more patients
NCT04232501,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19, Radial slowed their operations. Hence the investigational device is not available."
NCT04232709,TERMINATED,INTERVENTIONAL,"Due to unforeseen circumstances, the funder decided to discontinue all funding."
NCT04232839,TERMINATED,INTERVENTIONAL,Due to company decision.
NCT04232852,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04232878,TERMINATED,INTERVENTIONAL,Sufficient data has been obtained to meet current objectives
NCT04233073,TERMINATED,INTERVENTIONAL,Limited value as a single-arm study
NCT04233359,TERMINATED,INTERVENTIONAL,To few patients recruited to allow for study completion within ph.d. project.
NCT04233450,TERMINATED,OBSERVATIONAL,low recruitment rate
NCT04233489,TERMINATED,INTERVENTIONAL,The COVID-19 pandemic lead to halted protocols containing human subjects and in person interactions
NCT04233502,WITHDRAWN,INTERVENTIONAL,Study was not initiated it was decided to cancel this study
NCT04233554,WITHDRAWN,INTERVENTIONAL,Unable to identify enough practices and clinicians to participate in the study.
NCT04233606,WITHDRAWN,INTERVENTIONAL,PI left the university and is no longer in a full time employment role
NCT04233697,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT04233944,TERMINATED,OBSERVATIONAL,Funding constraints
NCT04234009,TERMINATED,INTERVENTIONAL,Not possible due to COVID-19
NCT04234399,TERMINATED,OBSERVATIONAL,Lack of efficacy of Axumin and resultant lack of interest in recruitment. FDA approval of PSMA also hampered enrollment.
NCT04234477,WITHDRAWN,INTERVENTIONAL,The study was not IRB approved and there were anticipated challenges in recruiting participants.
NCT04234516,WITHDRAWN,INTERVENTIONAL,PI leaving the institute
NCT04234581,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04234867,TERMINATED,INTERVENTIONAL,slow recruitment
NCT04235036,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT04235049,WITHDRAWN,INTERVENTIONAL,Department of Corrections unable to support study at this time and find agreement on publication issue.
NCT04235218,WITHDRAWN,OBSERVATIONAL,Corona pandemic
NCT04235322,TERMINATED,INTERVENTIONAL,"Labo'life decided to end prematurely HEARTH-GEN study from April 18th 2023 due to very low recruitment rates (6/100). Labo'life decided to focus all its efforts on another study using 2LHERP in herpes treatment, called HEARTH-OF (NCT04065971)"
NCT04235621,TERMINATED,OBSERVATIONAL,Sponsor decision for administrative reasons
NCT04235660,TERMINATED,INTERVENTIONAL,unable to recruit. terminated due to futility
NCT04236037,TERMINATED,INTERVENTIONAL,"It is unrealistic to succeed with sufficient inclusion within the timeframe of the study, why it is terminated."
NCT04236141,TERMINATED,INTERVENTIONAL,"Sponsor's decision, no safety concerns"
NCT04236167,TERMINATED,INTERVENTIONAL,Lack of participants to enroll. Early findings not supportive of fractionated c02 laser improving scars in population studied when used alone.
NCT04236453,TERMINATED,INTERVENTIONAL,COVID-19 pandemic impacted the BE assessment of the trial. The clinical team decided to terminate the trial in order to start a new pivotal BE trial
NCT04236583,SUSPENDED,INTERVENTIONAL,Per IRB COVID-19 guidance on conducting human subjects research
NCT04236661,WITHDRAWN,INTERVENTIONAL,study team unable to start up study at this time
NCT04237116,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04237584,TERMINATED,INTERVENTIONAL,"The study was stopped due to insurmountable enrollment challenges affecting trial accrual, resulting from the rapidly evolving treatment options for advanced prostate cancer."
NCT04237649,TERMINATED,INTERVENTIONAL,Business reasons
NCT04238013,TERMINATED,INTERVENTIONAL,"Due to the ongoing COVID-19 pandemic, my recruitment progress was delayed to the point that I had to reevaluate the feasibility of continuing data collection."
NCT04238091,WITHDRAWN,INTERVENTIONAL,Investigator is no longer interested in moving forward with this study
NCT04238390,WITHDRAWN,INTERVENTIONAL,The decision to withdraw the study was made due to delayed logistics of the supply chain of ceftolozane-tazobactam along with the immense complexities of conducting clinical research felt because of the COVID-19 pandemic.
NCT04239014,WITHDRAWN,INTERVENTIONAL,"Sponsor made the decision to terminate the DUETTE study based on the interim analysis of the VIOLETTE study (NCT03330847) investigating the combination of ceralasertib and Olaparib, where study closure was recommended due to insufficient efficacy."
NCT04239261,TERMINATED,INTERVENTIONAL,Recruitment slower than anticipated
NCT04239274,WITHDRAWN,INTERVENTIONAL,no participants enrolled due to COVID
NCT04239482,TERMINATED,INTERVENTIONAL,Due to covid-19 pandemic
NCT04239534,WITHDRAWN,INTERVENTIONAL,Start-up and enrolling activities have been suspended and study closed
NCT04239638,WITHDRAWN,OBSERVATIONAL,postponed to a later date
NCT04240158,TERMINATED,INTERVENTIONAL,Some subjects could not complete the second crossover period due to COVID-19-related site closure. The study was closed to allow analysis of all collected data.
NCT04240210,TERMINATED,INTERVENTIONAL,Lack of eligible enrollees/ Halted by Primary Sponsor
NCT04240288,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT04240457,TERMINATED,INTERVENTIONAL,Study was terminated due to enrollment and other challenges attributable to the Covid-19 public health emergency.
NCT04240483,TERMINATED,INTERVENTIONAL,"Study closed at Principal Investigator's request (study initiated, but not complete). Only 6 subjects had been recruited. The same study was just published."
NCT04240574,TERMINATED,INTERVENTIONAL,Due to pandemic we were not able to recruit patients for this study
NCT04240587,WITHDRAWN,INTERVENTIONAL,Difficulty in enrollment of study participants
NCT04240886,TERMINATED,INTERVENTIONAL,"The Sponsor (Amplyx, a Pfizer company) made a strategic decision to terminate the study, in order to prioritize a randomized comparative Phase 3 trial in the same indication. This decision was not based on any safety concerns"
NCT04241055,TERMINATED,INTERVENTIONAL,"Due to the pandemic, the primary dependent variables could not be collected as designed in the research plan"
NCT04241159,WITHDRAWN,INTERVENTIONAL,Protocol required revisions and application was withdrawn from the IRB.
NCT04241471,WITHDRAWN,INTERVENTIONAL,Study published rendering this protocol/study obsolete.
NCT04241484,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT04241588,WITHDRAWN,OBSERVATIONAL,"We did not received funding for this project, so we could not initiate enrollment."
NCT04241718,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT04241744,WITHDRAWN,INTERVENTIONAL,difficulty enrolling patients
NCT04241757,TERMINATED,OBSERVATIONAL,"The EGG study is no longer in progress, as the association that carried it out (IRMG) has had to close due to the impact of the Covid crisis on continuing education."
NCT04241913,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19 and pandemic-related mitigation strategies, we were forced to alter procedures prior to the enrolling of participants into this trial. We will submit a new protocol for our adapted trial, launching at a later date."
NCT04242147,TERMINATED,INTERVENTIONAL,Sponsor's decision.
NCT04242173,TERMINATED,INTERVENTIONAL,Lack of Interest
NCT04242329,WITHDRAWN,INTERVENTIONAL,"Not possible to recruit patients during COVID, and not possible to start enrolling after the pandemic."
NCT04242368,WITHDRAWN,INTERVENTIONAL,"COVID-19 pandemic, unable to recruit and conduct study procedures per state, local, and university policies."
NCT04242641,TERMINATED,INTERVENTIONAL,Due to Covid pandemic
NCT04242810,WITHDRAWN,INTERVENTIONAL,Never started enrollment due to COVID-19 closures
NCT04242940,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study prematurely given that patient enrollment was delayed by more than two years relative to what originally stated in the protocol.
NCT04242966,WITHDRAWN,INTERVENTIONAL,Study never started. Operational issues prevented study from rolling out
NCT04243031,WITHDRAWN,OBSERVATIONAL,Business Decision
NCT04243070,TERMINATED,INTERVENTIONAL,Insufficient enrollment rates so that proper completion of the study cannot be expected anymore.
NCT04243109,TERMINATED,INTERVENTIONAL,Low recruitment rate. Lack of interest of the sponsor.
NCT04243161,WITHDRAWN,INTERVENTIONAL,lack of time
NCT04243252,TERMINATED,INTERVENTIONAL,COVID pandemic
NCT04243278,TERMINATED,INTERVENTIONAL,Poor Recruitment Rates
NCT04243564,WITHDRAWN,INTERVENTIONAL,Device (ProSeal Laryngeal Mask Airway) no longer available
NCT04243694,WITHDRAWN,INTERVENTIONAL,Reduction in funding.
NCT04243811,WITHDRAWN,INTERVENTIONAL,"Due to the technical problem in the laser device,it has not started."
NCT04243824,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04243837,TERMINATED,INTERVENTIONAL,"Primary objective/endpoint has been established, will not pursue development of the disease indication further"
NCT04243850,WITHDRAWN,INTERVENTIONAL,COVID
NCT04243902,WITHDRAWN,INTERVENTIONAL,No participants met all the inclusion criteria required within the recruitment time period
NCT04243941,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT04244058,SUSPENDED,INTERVENTIONAL,Given CoVid-19 pandemic we could not recruit subjects/patients for the 1st year. Currently waiting for new sponsor to fulfill the aims.
NCT04244331,TERMINATED,OBSERVATIONAL,Low recruitment
NCT04244396,TERMINATED,OBSERVATIONAL,The study was terminated early by the Sponsor as sufficient data had been collected to satisfy the study objectives.
NCT04244552,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04244682,WITHDRAWN,INTERVENTIONAL,Recruitment and enrollment were suspended due to COVID-19 and ultimately the study was withdrawn due trained personnel moving on to new projects.
NCT04244825,WITHDRAWN,INTERVENTIONAL,Withdrawn due to concerns for patient safety during COVID-19 crisis
NCT04244877,WITHDRAWN,INTERVENTIONAL,Study was unable to recruit participants..
NCT04244955,TERMINATED,OBSERVATIONAL,Investigator's decision
NCT04245332,SUSPENDED,INTERVENTIONAL,COVID-19 restrictions on research at University
NCT04245449,TERMINATED,INTERVENTIONAL,Due to COVID-19 and loss of funding
NCT04245696,WITHDRAWN,INTERVENTIONAL,"Business decision, no serious AEs."
NCT04245722,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor.
NCT04245852,TERMINATED,INTERVENTIONAL,COVID pandemic disrupted subject recruitment and primary investigator no longer with our university; no additional interest in continuing the study.
NCT04245917,SUSPENDED,OBSERVATIONAL,Business Reason
NCT04246034,WITHDRAWN,INTERVENTIONAL,surgery considered elective and cant be performed within corona restrictions
NCT04246268,SUSPENDED,INTERVENTIONAL,INVO Bioscience is suspending trial per ASRM's recommendations during Covid-19 pandemic.
NCT04246294,TERMINATED,OBSERVATIONAL,Recruitment was made near impossible due to circumstances surrounding the epidemic
NCT04246411,WITHDRAWN,INTERVENTIONAL,"It was confirmed that cuffed RAE tubes with small diameter could be used, so there was no reason to use RAE cuffless tubes."
NCT04246567,SUSPENDED,INTERVENTIONAL,Ethics approval is expected from the pharmaceutical institution for the study which has received the local ethics committee approval.
NCT04246619,TERMINATED,INTERVENTIONAL,The statistical analysis will still provide relevant results with the same statistical power as initially planned.COVID-19 pandemic prolonged the recruiting period and consequently affected the costs of the clinical trial.
NCT04246892,TERMINATED,OBSERVATIONAL,"technical problem, no change of the monitors in the ICU ward"
NCT04247061,TERMINATED,INTERVENTIONAL,Due to COVID-19 policies this usability pilot study was stopped after enrolling 4 participants.
NCT04247100,TERMINATED,INTERVENTIONAL,Funding ended prior to hitting the enrollment goal
NCT04247269,WITHDRAWN,OBSERVATIONAL,Site closure due to Covid Pandemic
NCT04247321,WITHDRAWN,INTERVENTIONAL," Withdrawn: Study halted prematurely, prior to enrollment of first participant"
NCT04247594,TERMINATED,INTERVENTIONAL,Data will not inform further development of Voxelotor
NCT04247919,TERMINATED,OBSERVATIONAL,Limitations to recruitment due to COVID-19
NCT04248010,WITHDRAWN,INTERVENTIONAL,Modifications in methodology had to be made that make the current registration invalid.
NCT04248361,SUSPENDED,INTERVENTIONAL,Low enrollment due to COVID-19
NCT04248413,WITHDRAWN,INTERVENTIONAL,Too many obstacles starting study
NCT04248465,TERMINATED,INTERVENTIONAL,The IDMC recommended the study be discontinued due to lack of efficacy with ravulizumab.
NCT04248491,TERMINATED,INTERVENTIONAL,Due to low enrollment and lack of efficiency
NCT04248712,TERMINATED,INTERVENTIONAL,low enrollment
NCT04248907,WITHDRAWN,INTERVENTIONAL,"Due to Corona Virus guidelines, we have decided to withdraw the study."
NCT04249037,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT04249115,TERMINATED,INTERVENTIONAL,Study enrollment was halted due to a business decision by the Sponsor to focus resources on other clinical areas outside of dermatology.
NCT04249141,WITHDRAWN,OBSERVATIONAL,Participants were not assigned to an intervention and as such this was not considered a clinical trial.
NCT04249167,WITHDRAWN,INTERVENTIONAL,study was dropped
NCT04249180,WITHDRAWN,OBSERVATIONAL,CPP
NCT04249414,SUSPENDED,OBSERVATIONAL,"Due to a lack of resources (human and financial), it is currently unclear if the study will be counducted."
NCT04249713,WITHDRAWN,INTERVENTIONAL,Biomarker Samples Not Collected
NCT04249817,TERMINATED,INTERVENTIONAL,Usual care was no longer possible with COVID19 and we no longer had a control for this study.
NCT04249934,WITHDRAWN,INTERVENTIONAL,Due to restrictions related to patient care secondary to covid pandemic.
NCT04250168,TERMINATED,OBSERVATIONAL,Ebola epidemic in N-Kivu has ended
NCT04250311,SUSPENDED,INTERVENTIONAL,"Due to the end of the ARVI and influenza season, it was suspended until approximately October 01, 2023"
NCT04250597,TERMINATED,INTERVENTIONAL,Maximum tolerated dose reached; expansion phase not performed per Sponsor business decision.
NCT04250662,WITHDRAWN,INTERVENTIONAL,No participants enrolled. Lack of patients.
NCT04250805,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients
NCT04250818,SUSPENDED,OBSERVATIONAL,PI is moving to a new institution
NCT04251234,TERMINATED,INTERVENTIONAL,COVID shutdown
NCT04251442,WITHDRAWN,INTERVENTIONAL,Per funding institution
NCT04251520,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT04251767,WITHDRAWN,INTERVENTIONAL,Follow new disciplines on disease control from government
NCT04252040,WITHDRAWN,INTERVENTIONAL,Lack of participants. No enrollment
NCT04252248,TERMINATED,INTERVENTIONAL,Organizational reasons
NCT04252417,TERMINATED,INTERVENTIONAL,Due to other Phase 3 trial failure to meet primary endpoint
NCT04252430,TERMINATED,INTERVENTIONAL,Due to other phase 3 trial failure to meet primary endpoint
NCT04252547,SUSPENDED,INTERVENTIONAL,Data cannot be collected due to Covid-19.
NCT04252586,TERMINATED,INTERVENTIONAL,Study was terminated due to COVID-19 pandemic and recruitment challenges in the parent study (GWND18064 - NCT03848832).
NCT04252612,WITHDRAWN,INTERVENTIONAL,Poor accrual
NCT04252625,SUSPENDED,INTERVENTIONAL,Drug Supply Issue
NCT04252664,SUSPENDED,INTERVENTIONAL,"The epidemic of COVID-19 has been controlled well at present, no eligible patients can be recruitted."
NCT04252703,TERMINATED,INTERVENTIONAL,Very slow recruitment - only 3 patients randomised
NCT04252755,WITHDRAWN,INTERVENTIONAL,Study stopped prior to initiation due to COVID-19 complications
NCT04252768,WITHDRAWN,INTERVENTIONAL,Replaced by other study NCT05747794
NCT04253067,WITHDRAWN,INTERVENTIONAL,"PI decided not to open study, following review of data collected in another study"
NCT04253223,TERMINATED,INTERVENTIONAL,poor accrual
NCT04253236,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04253249,WITHDRAWN,OBSERVATIONAL,No funding was obtained.
NCT04253405,TERMINATED,INTERVENTIONAL,"Study impacted by the COVID-19 pandemic:

* slow recruitment rate
* budget constrains"
NCT04253418,TERMINATED,INTERVENTIONAL,Study enrollment was halted due to a business decision by the Sponsor to focus resources on other clinical areas outside of dermatology.
NCT04253522,TERMINATED,INTERVENTIONAL,terminated with16 included patients instead of 18
NCT04253795,SUSPENDED,INTERVENTIONAL,"not recruiting, awaiting for changes in IRB"
NCT04253860,TERMINATED,INTERVENTIONAL,"Due to pandemic od COVID-19, was difficult recruit patients"
NCT04254107,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT04254172,TERMINATED,OBSERVATIONAL,"This low-interventional study (involving no study drug) has been terminated early due to the COVID-19 pandemic, and not for any safety or efficacy reasons."
NCT04254380,WITHDRAWN,INTERVENTIONAL,"GanLee cancelled study -FDA Draft Guidance: ""Clinical Immunogenicity Considerations for Biosimilar \& Interchangeable Insulin Products"" released 11/25/2019"
NCT04254692,SUSPENDED,INTERVENTIONAL,division wide research suspension
NCT04254705,WITHDRAWN,INTERVENTIONAL,Changes in modulator landscape
NCT04254809,TERMINATED,INTERVENTIONAL,"Face-to-face appointments, which were required by the IRB for suicide risk evaluation, were suspended by the IRB during the COVID-19 pandemic. During this pause, the PI left the institution. Thus, all study activities were terminated."
NCT04255329,WITHDRAWN,INTERVENTIONAL,health context of covid-19
NCT04255862,TERMINATED,INTERVENTIONAL,Study recruitment terminated due to operational difficulties executing the study under the COVID-19 pandemic.
NCT04256148,WITHDRAWN,INTERVENTIONAL,Study is withdrawn due to the global impact of the COVID-19 pandemic.
NCT04256343,WITHDRAWN,INTERVENTIONAL,COVID and lack of funding
NCT04256655,WITHDRAWN,INTERVENTIONAL,study product composition to move from liquid to solid
NCT04256837,TERMINATED,INTERVENTIONAL,The study expired and was not renewed with the IRB
NCT04256876,TERMINATED,INTERVENTIONAL,"due to the corona pandemic, live patient contact was no longer possible. As a result, the study had to be stopped early."
NCT04257266,WITHDRAWN,INTERVENTIONAL,The funding was never received and the study was terminated in the IRB
NCT04257357,WITHDRAWN,INTERVENTIONAL,Due to Covid-19 pandemia the study was never initiated
NCT04257422,TERMINATED,INTERVENTIONAL,Enrolment for the study ended concurrently with the development of the CoViD-19 pandemic. This decision was made by the Steering Committee in consideration of the transformation of some wards participating in the study into CoVID-19 units.
NCT04257435,WITHDRAWN,INTERVENTIONAL,Unable to recruit individuals for the study
NCT04257656,TERMINATED,INTERVENTIONAL,"The epidemic of COVID-19 has been controlled well in China, no eligible patients can be enrolled at present."
NCT04257721,TERMINATED,OBSERVATIONAL,rate of inclusions too low
NCT04258020,TERMINATED,INTERVENTIONAL,Significant impact of COVID pandemic on ability to conduct study
NCT04258150,TERMINATED,INTERVENTIONAL,primary endpoint was not met
NCT04258215,WITHDRAWN,INTERVENTIONAL,COVID
NCT04258345,WITHDRAWN,INTERVENTIONAL,not yet funded
NCT04258358,WITHDRAWN,INTERVENTIONAL,Unanticipated delays including those caused by COVID-19
NCT04258410,WITHDRAWN,INTERVENTIONAL,"Per PI: ""Never went to IRB Never recruited anyone Never resubmitted the score NIH application I am leaving the institution"""
NCT04258423,TERMINATED,INTERVENTIONAL,Study was larger than expected and became a burden to faculty and staff resources.
NCT04258436,TERMINATED,INTERVENTIONAL,I believe 1 patient was enrolled. The original PI left the institution and the study was not continued after her departure.
NCT04258514,WITHDRAWN,INTERVENTIONAL,Similar study published prior to beginning enrollment and we did not anticipate adding new information based on that study
NCT04258592,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04258683,WITHDRAWN,INTERVENTIONAL,Study terminated due to changing treatment landscape
NCT04258852,WITHDRAWN,INTERVENTIONAL,Recruitment halted by pandemic
NCT04258917,WITHDRAWN,INTERVENTIONAL,Covid-19 pandemic prevented study from occuring
NCT04258969,WITHDRAWN,INTERVENTIONAL,lack of resources
NCT04259060,WITHDRAWN,INTERVENTIONAL,Decision to pursue a smaller scale pilot study instead
NCT04259099,TERMINATED,OBSERVATIONAL,Except in compulsory cases hospital admissions have been decreased significantly due to the pandemic. The study was terminated due to significant decrease in enrollment rate.
NCT04259190,WITHDRAWN,INTERVENTIONAL,Halted due to COVID-19.
NCT04259385,TERMINATED,INTERVENTIONAL,Study halted prematurely during COVID-19 outbreak (only 1 participant)
NCT04259684,WITHDRAWN,INTERVENTIONAL,revised and combined with another protocol
NCT04259775,WITHDRAWN,INTERVENTIONAL,Needed FDA approval
NCT04259840,TERMINATED,OBSERVATIONAL,COVID-19 pandemic
NCT04259892,SUSPENDED,OBSERVATIONAL,no topics to include
NCT04260009,WITHDRAWN,INTERVENTIONAL,Business reason unrelated to product safety
NCT04260061,WITHDRAWN,INTERVENTIONAL,These is understaffed to excute study now.
NCT04260087,TERMINATED,OBSERVATIONAL,Study Terminated due to COVID-19.
NCT04260191,TERMINATED,INTERVENTIONAL,Business Decision
NCT04260360,WITHDRAWN,INTERVENTIONAL,Not initiated
NCT04260386,TERMINATED,OBSERVATIONAL,The study closed early due to COVID-19
NCT04260607,TERMINATED,INTERVENTIONAL,As a busy MTF we were unable to retain a health care provider with the appropriate expertise to buy-in to this study once the initiating PI left military service.
NCT04260776,WITHDRAWN,INTERVENTIONAL,PI departure
NCT04260893,TERMINATED,INTERVENTIONAL,Due to COVID19 adequate study monitoring wasn't possible by the Sponsor
NCT04261036,WITHDRAWN,INTERVENTIONAL,"Unfortunately, the economic crisis in Lebanon precluded utilization of available funding to recruit patients at the specified institution. No patients were recruited."
NCT04261140,WITHDRAWN,INTERVENTIONAL,required license
NCT04261439,TERMINATED,INTERVENTIONAL,Business decision and not due to any safety concerns
NCT04261556,WITHDRAWN,INTERVENTIONAL,Due to organizing difficulties after COVID-19 pandemic
NCT04261582,SUSPENDED,OBSERVATIONAL,On hold due to COVID-19 outbreak
NCT04261907,TERMINATED,INTERVENTIONAL,There were no more subjects enrolled.
NCT04262375,WITHDRAWN,INTERVENTIONAL,Overall clinical activity (ORR) for oleclumab + durvalumab is minimal across tumor types and does not support further evaluation of this doublet.
NCT04262388,WITHDRAWN,INTERVENTIONAL,Overall clinical activity (ORR) for oleclumab + durvalumab is minimal across tumor types and does not support further evaluation of this doublet.
NCT04262791,TERMINATED,INTERVENTIONAL,Strategic Considerations
NCT04262869,WITHDRAWN,INTERVENTIONAL,Due to accrual issues
NCT04262895,WITHDRAWN,INTERVENTIONAL,Funding withdrawn due to delay in FDA IND submission
NCT04262947,TERMINATED,INTERVENTIONAL,COVID epidemic
NCT04263168,WITHDRAWN,INTERVENTIONAL,No participants
NCT04263207,SUSPENDED,OBSERVATIONAL,"Study halted prematurely due to the difficulties in dedicating the human resources necessary to conduct the study deriving from the COVID-19 pandemic, but potentially will resume"
NCT04263519,WITHDRAWN,INTERVENTIONAL,Covid restrictions
NCT04264013,WITHDRAWN,INTERVENTIONAL,Funding
NCT04264156,TERMINATED,INTERVENTIONAL,Corporate business reasons
NCT04264182,TERMINATED,INTERVENTIONAL,Difficult to enroll patients into the study
NCT04264208,TERMINATED,INTERVENTIONAL,Lack of accrual due to pandemic and logistics
NCT04264520,TERMINATED,INTERVENTIONAL,PI changed institutions and was no longer able to continue project.
NCT04264533,TERMINATED,INTERVENTIONAL,"the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size."
NCT04264754,TERMINATED,OBSERVATIONAL,Sponsor prioritize other clinical projects over this study
NCT04264806,WITHDRAWN,INTERVENTIONAL,The cusatuzumab MDS strategy is under revision
NCT04265014,WITHDRAWN,INTERVENTIONAL,we didn't have any patient
NCT04265079,WITHDRAWN,INTERVENTIONAL,The study could not be executed due to COVID-19 regulations.
NCT04265235,TERMINATED,INTERVENTIONAL,COVID pandemic. Recruited 31 out of target 40 patients.
NCT04265274,WITHDRAWN,INTERVENTIONAL,Poor acrual
NCT04265534,TERMINATED,INTERVENTIONAL,Lack of Clinical Benefit
NCT04265560,TERMINATED,INTERVENTIONAL,Restrictions due to COVID-19
NCT04265612,TERMINATED,INTERVENTIONAL,Lack of funds preventing further payment of the trial insurance
NCT04265690,WITHDRAWN,INTERVENTIONAL,The study never launched due to several COVID-19 related barriers.
NCT04265898,WITHDRAWN,OBSERVATIONAL,"The study did not receive IRB approval and was withdrawn by the PI on April 9, 2020."
NCT04266158,TERMINATED,INTERVENTIONAL,Sponsor stoppage of recruitment
NCT04266262,TERMINATED,INTERVENTIONAL,All research activities were suspended as a result of COVID-19.
NCT04266314,WITHDRAWN,OBSERVATIONAL,unable to enroll
NCT04266353,WITHDRAWN,INTERVENTIONAL,Due to COVID-19
NCT04266457,WITHDRAWN,OBSERVATIONAL,Study stopped after ethical approval but before first patient gave consent due to pandemic
NCT04266470,WITHDRAWN,INTERVENTIONAL,Study is no longer feasible at our site.
NCT04266613,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT04266873,SUSPENDED,INTERVENTIONAL,Due to Covid-19 pandemic
NCT04266990,TERMINATED,INTERVENTIONAL,COVID-10 outbreak forced us to cancel the study
NCT04267016,TERMINATED,OBSERVATIONAL,Sponsor decision to cancel study
NCT04267094,TERMINATED,INTERVENTIONAL,Science has changed
NCT04267237,WITHDRAWN,INTERVENTIONAL,Accrual timelines
NCT04267276,TERMINATED,INTERVENTIONAL,"Due to the COVID-19 pandemic, the recruitment of new subjects was temporarily halted in March 2020. The study was permanently discontinued in December 2020."
NCT04267393,TERMINATED,INTERVENTIONAL,Trial terminated because of lack of efficacy in the short term acute phase.
NCT04267679,WITHDRAWN,INTERVENTIONAL,Stopped due to COVID-19 pandemic.
NCT04267822,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT04267913,WITHDRAWN,INTERVENTIONAL,The pharmaceutical company sold the compound and pulled out.
NCT04267939,TERMINATED,INTERVENTIONAL,There was no anticipated benefit of the experimental combination as tested over available standard therapies; therefore Sponsor has decided to terminate the investigation.
NCT04268160,WITHDRAWN,OBSERVATIONAL,Funding issues and closed with the IRB
NCT04268329,TERMINATED,INTERVENTIONAL,The study was not providing useful information.
NCT04268355,TERMINATED,INTERVENTIONAL,In order to ensure patients and research staff safety due to COVID-19 pandemic
NCT04268693,WITHDRAWN,OBSERVATIONAL,"Study never initiated due to COVID pandemic, staffing changes"
NCT04268758,WITHDRAWN,OBSERVATIONAL,logistic and financial issues.
NCT04268810,TERMINATED,INTERVENTIONAL,too many side effect in the control arm (DMSO)
NCT04268823,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04268914,SUSPENDED,INTERVENTIONAL,The AR technology we were using is now out of business and we are trying to use a different device.
NCT04269252,TERMINATED,INTERVENTIONAL,Recruitment challenges due to COVID
NCT04269317,WITHDRAWN,INTERVENTIONAL,"Delay in opening the study due to COVID-19, and following the sponsor's decision"
NCT04269395,TERMINATED,INTERVENTIONAL,The study was terminated early as per Sponsor's decision
NCT04269655,TERMINATED,INTERVENTIONAL,COVID-19
NCT04269681,TERMINATED,INTERVENTIONAL,"Impacted by the COVID-19 pandemic:

* slow recruitment rate
* cuts in budget for non-COVID-19 related projects"
NCT04269720,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04269785,WITHDRAWN,INTERVENTIONAL,Funding
NCT04269876,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT04269993,TERMINATED,INTERVENTIONAL,Termination of study funding
NCT04270019,WITHDRAWN,INTERVENTIONAL,"lack of staff, REB closed the file due to expired renewal"
NCT04270461,WITHDRAWN,INTERVENTIONAL,Study is withdrawn because of administrative reasons
NCT04270916,SUSPENDED,OBSERVATIONAL,due to COVID-19
NCT04270929,WITHDRAWN,INTERVENTIONAL,Insufficient accrual rate
NCT04271059,TERMINATED,OBSERVATIONAL,Low recruitment
NCT04271254,TERMINATED,INTERVENTIONAL,Funding insufficiency.
NCT04271449,WITHDRAWN,INTERVENTIONAL,no inclusion
NCT04271475,TERMINATED,INTERVENTIONAL,The Sponsor decided to stop the study for futility based on a recommendation by the IDMC following a pre-planned interim analysis
NCT04271501,TERMINATED,INTERVENTIONAL,Suspended and Terminated to focus on CTP009 (NCT04547998) Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
NCT04271605,TERMINATED,INTERVENTIONAL,The duration of grands was one year.
NCT04271839,WITHDRAWN,INTERVENTIONAL,The trial has been terminated early due to the SARS-CoV-2 pandemic.
NCT04272203,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04272242,SUSPENDED,INTERVENTIONAL,"Following completion of Arm 1, A5372 is currently Temporarily Closed. Timeline for opening of Arm 2 is not available."
NCT04272333,TERMINATED,INTERVENTIONAL,Partner Termination
NCT04272645,WITHDRAWN,INTERVENTIONAL,Coordinating site change
NCT04272710,WITHDRAWN,OBSERVATIONAL,"Similar projects have been registered, and it need to be withdrawn."
NCT04272775,TERMINATED,INTERVENTIONAL,Business Decision; No Safety Or Efficacy Concerns
NCT04272814,TERMINATED,INTERVENTIONAL,The patient pathway changed resulting in less admissions for this condition.
NCT04273191,WITHDRAWN,INTERVENTIONAL,Sage Therapeutics has decided not to proceed with this study at this time
NCT04273269,TERMINATED,INTERVENTIONAL,The clinical trial is closed due to Lysogene's cessation of activities. This study closure is not due to safety reasons.
NCT04273724,TERMINATED,INTERVENTIONAL,Investigator left and research was discontinued.
NCT04273737,TERMINATED,INTERVENTIONAL,PI left institution.
NCT04273919,WITHDRAWN,INTERVENTIONAL,Due to the impact of COVID-19
NCT04274010,TERMINATED,INTERVENTIONAL,Failed to meet recruitment target due to multitude of factors (strict eligibility criteria and lack of clinician and participant engagement)
NCT04274023,TERMINATED,INTERVENTIONAL,Difficulty of enrollment
NCT04274114,TERMINATED,INTERVENTIONAL,Inhability to recruit further participants due to SARS-CoV-2 pandemics.
NCT04274166,WITHDRAWN,INTERVENTIONAL,"Contracting never completed, closed the IRB"
NCT04274192,TERMINATED,INTERVENTIONAL,PI left and study not feasible as written in the protocol
NCT04274413,WITHDRAWN,INTERVENTIONAL,Due to funding and Covid-19 pandemic
NCT04274452,WITHDRAWN,INTERVENTIONAL,The ARGX-113-1908 study will be replaced by a similar design with a subcutaneous formulation (ARGX-113-2004)
NCT04274517,TERMINATED,INTERVENTIONAL,"Preliminary analysis showed lack of positive finding, indicating a substantial number of subjects required, which is not feasible based on budget and timeline."
NCT04274686,TERMINATED,INTERVENTIONAL,Intervention was not seen to be effective on interim analysis
NCT04274699,WITHDRAWN,OBSERVATIONAL,Funding withdrawn by commercial partner before recruitment phase (change of company ownership).
NCT04274790,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT04274803,WITHDRAWN,INTERVENTIONAL,no patient enrolled
NCT04274907,TERMINATED,INTERVENTIONAL,Company Decision
NCT04274933,TERMINATED,INTERVENTIONAL,Company Decision
NCT04275011,TERMINATED,INTERVENTIONAL,The study has been terminated
NCT04275128,TERMINATED,OBSERVATIONAL,Insurance companies no longer cover this procedure
NCT04275154,WITHDRAWN,OBSERVATIONAL,"Covid-19 did suspend the study for a period, then when trying to re-open the collaborating department had restructured fees which made it impossible to do the study with the limited grant funds available for this project."
NCT04275310,TERMINATED,INTERVENTIONAL,Loss of funding
NCT04275492,TERMINATED,INTERVENTIONAL,The sponsor terminated the clinical trial
NCT04275752,WITHDRAWN,INTERVENTIONAL,Original funding for this study changed and it is no longer being pursued
NCT04276090,TERMINATED,INTERVENTIONAL,an alternate device became FDA approved
NCT04276376,SUSPENDED,INTERVENTIONAL,The manufacturer (Clovis) supplying Rucaparib has gone bankrupt and is no longer able to fund the trial and supply the product.
NCT04276415,TERMINATED,INTERVENTIONAL,The study was terminated due to a business decision.
NCT04276454,WITHDRAWN,INTERVENTIONAL,Per investigator's request.
NCT04276597,WITHDRAWN,INTERVENTIONAL,No subjects were eligible for the study. The study closed on 07-15-2021.
NCT04276610,TERMINATED,INTERVENTIONAL,COVID-19 has delayed the study recruitment beyond the available funding
NCT04276714,TERMINATED,INTERVENTIONAL,Not enough patients (difficulty in recruiting according to the inclusion criteria)
NCT04276909,WITHDRAWN,INTERVENTIONAL,Study not initiated.
NCT04277546,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the development of brazikumab in inflammatory bowel disease.
NCT04277663,TERMINATED,INTERVENTIONAL,Due to the company's development strategy adjustment Innovent Bioligics decided not to continue the study after consultation with investigators
NCT04277741,WITHDRAWN,INTERVENTIONAL,PI departure from university
NCT04277780,TERMINATED,INTERVENTIONAL,Difficulty recruiting and following more patients during Covid-19 pandemic
NCT04277936,TERMINATED,INTERVENTIONAL,Study was redesigned and submitted as a new protocol (NCT04559529).
NCT04277962,TERMINATED,INTERVENTIONAL,Sponsor did not want to pursue and COVID 19 delays
NCT04278534,TERMINATED,INTERVENTIONAL,Inadequate enrollment
NCT04278664,TERMINATED,OBSERVATIONAL,low enrollment
NCT04278755,TERMINATED,INTERVENTIONAL,Halted prematurely due to COVID-19-related enrollment challenges.
NCT04278872,TERMINATED,INTERVENTIONAL,The study was terminated early as the goal of determining a safe and efficacious dose for further development for the treatment of VMS was not met
NCT04278963,SUSPENDED,INTERVENTIONAL,There were no eligible patients in the paticipated centers.
NCT04279561,TERMINATED,INTERVENTIONAL,slow accrual
NCT04279665,WITHDRAWN,INTERVENTIONAL,Equipment changed
NCT04279925,TERMINATED,INTERVENTIONAL,Aerosol risk of COVID-19 spread resulting a slow subject recruitment
NCT04279938,WITHDRAWN,INTERVENTIONAL,Safety data on drug
NCT04280055,TERMINATED,INTERVENTIONAL,Not possible to achieve the anticipated no. of patients due to Covid-19 pandemic
NCT04280068,TERMINATED,INTERVENTIONAL,Due to COVID-19 recruitment and enrollment of participants was halted
NCT04280237,WITHDRAWN,OBSERVATIONAL,abandoned project
NCT04280276,TERMINATED,INTERVENTIONAL,"Sponsor, TGI, was acquired by Eurofins Inc. New owner requested all IIT's be terminated."
NCT04280471,WITHDRAWN,INTERVENTIONAL,The study was not opened
NCT04280588,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04280640,WITHDRAWN,OBSERVATIONAL,PI left UNC.
NCT04280913,WITHDRAWN,OBSERVATIONAL,The research project was changed.
NCT04280939,WITHDRAWN,INTERVENTIONAL,Delayed due to COVID and no longer relevant
NCT04281225,WITHDRAWN,INTERVENTIONAL,"With COVID, we are not able to conduct any in-person research at this time"
NCT04281238,SUSPENDED,INTERVENTIONAL,Because of Covid-19
NCT04281290,TERMINATED,INTERVENTIONAL,"After enrolling 3 participants the safety and efficacy of the planned treatment is questionable, thus we decided to terminate the study."
NCT04281316,TERMINATED,INTERVENTIONAL,lack enrollment
NCT04281355,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04281524,WITHDRAWN,INTERVENTIONAL,Business decision non-safety related.
NCT04281719,WITHDRAWN,INTERVENTIONAL,Unanticipated technical issues and COVID-19 related-disruptions precluded enrollment of participants before the end of the award period.
NCT04282161,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT04282174,WITHDRAWN,INTERVENTIONAL,Study was split into two new studies before the first participant was enrolled.
NCT04282226,WITHDRAWN,INTERVENTIONAL,There was a serious delay in the study due to the COVID pandemic. So the grant period was over.
NCT04282239,WITHDRAWN,INTERVENTIONAL,Did not have the staff to conduct the study
NCT04282564,TERMINATED,INTERVENTIONAL,COVID lockdown + financial problems + no inclusion since lockdown
NCT04282590,WITHDRAWN,INTERVENTIONAL,due to COVID-19 pandemic
NCT04282603,TERMINATED,INTERVENTIONAL,Grant Transfer Not Approved
NCT04282681,WITHDRAWN,OBSERVATIONAL,Sponsor decision due to clinical strategy changes
NCT04282694,TERMINATED,OBSERVATIONAL,"The worldwide surge of SARS-CoV-2 started during the first week of the study. The Investigators attempted to re-organize the project with a new agenda, but the time frame from the funding Organization did not comply with the study needs."
NCT04282733,TERMINATED,INTERVENTIONAL,No post-intervention survey completed
NCT04282798,WITHDRAWN,INTERVENTIONAL,COVID delay and subsequent unavailability of staff.
NCT04283058,WITHDRAWN,OBSERVATIONAL,Covid-19 disruption of team
NCT04283136,WITHDRAWN,INTERVENTIONAL,"Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures"
NCT04283526,WITHDRAWN,INTERVENTIONAL,This study was cancelled before enrolling any patients for business related reasons.
NCT04283617,WITHDRAWN,INTERVENTIONAL,Withdrawn due to funding issues.
NCT04283812,WITHDRAWN,INTERVENTIONAL,"Per PI discretion, study closed and no participants enrolled"
NCT04283825,WITHDRAWN,INTERVENTIONAL,We cannot enroll enough participants.
NCT04283838,WITHDRAWN,INTERVENTIONAL,We cannot enroll enough participants.
NCT04284033,WITHDRAWN,INTERVENTIONAL,Change of sponsor and trial design
NCT04284254,WITHDRAWN,INTERVENTIONAL,"Study went on hold because more pre-clinical work needs to be done per FDA feedback. However, the study never went off hold and the study team has decided to close this study without opening to enrollment."
NCT04284371,TERMINATED,OBSERVATIONAL,lack of funding - no results to report
NCT04284462,TERMINATED,INTERVENTIONAL,Sponsor decision to stop study due to COVID-19 pandemic
NCT04285008,WITHDRAWN,INTERVENTIONAL,Sponsor has terminated study due to COVID-19 related concerns
NCT04285190,WITHDRAWN,INTERVENTIONAL,"The COVID-19 pandemic in China has ended completely. As a result, patient recruiting is impossible in China."
NCT04285268,WITHDRAWN,INTERVENTIONAL,funding available
NCT04285593,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04285606,WITHDRAWN,INTERVENTIONAL,"This study was withdrawn because 1) we did not secure needed funding, and 2) the research question became less important while we were waiting for funding opportunities as a few similar studies got published. We have no plan to pursue this study."
NCT04285619,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04285632,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04285645,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04285697,SUSPENDED,INTERVENTIONAL,"Due to the COVID-19 pandemic, elevtive sugeries were temproraily delayed in our country. It's targeted to take cases again as of August 2020"
NCT04285710,WITHDRAWN,INTERVENTIONAL,This study was never started since the IRB application was not submitted and the PI left the institution.
NCT04285749,WITHDRAWN,INTERVENTIONAL,PI moving to new institution prior to study activation
NCT04285905,TERMINATED,INTERVENTIONAL,"Due to Covid-19, fnding period expired and Phase 2 was not possible."
NCT04286048,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04286061,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04286074,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04286087,WITHDRAWN,INTERVENTIONAL,"Dr Rudecki, the principal PI has left the program and is no longer in the United States therefore he failed to recruit patients for the study."
NCT04286295,TERMINATED,INTERVENTIONAL,Feasibility
NCT04286347,TERMINATED,INTERVENTIONAL,lack of funding to continue any longer
NCT04286529,TERMINATED,INTERVENTIONAL,Difficulty with study logistics due to COVID-19
NCT04286568,WITHDRAWN,INTERVENTIONAL,Disruption by Covid-19.
NCT04286594,TERMINATED,INTERVENTIONAL,Terminated by sponsor
NCT04286906,TERMINATED,OBSERVATIONAL,greatly reduced active file of potentially includible patients
NCT04287075,TERMINATED,OBSERVATIONAL,The study was terminated due to lower than expected enrollment. The decision to terminate the study was not based on any safety or efficacy concerns.
NCT04287179,WITHDRAWN,INTERVENTIONAL,"COVID19 impact on this trial was evaluated and a delay of at least 6-9 months was expected. In parallel, the development of a new type of pen injector, which was an important part of the trial, was ceased and thus this trial was cancelled."
NCT04287348,TERMINATED,INTERVENTIONAL,due to safety letter beovu from Novartis
NCT04287452,WITHDRAWN,INTERVENTIONAL,The study has been withdrawn due to the pandemic and lack of funding.
NCT04287478,TERMINATED,INTERVENTIONAL,Study terminated due to a change in development strategy.
NCT04287491,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04287543,WITHDRAWN,INTERVENTIONAL,"Due to the COVID-19 pandemic, we were unable to begin the study"
NCT04287686,WITHDRAWN,INTERVENTIONAL,Without CDE Approval
NCT04287790,TERMINATED,OBSERVATIONAL,COVID-19 disrupted recruitment
NCT04287842,WITHDRAWN,INTERVENTIONAL,technical problem
NCT04287972,WITHDRAWN,INTERVENTIONAL,Administrative issues
NCT04288076,WITHDRAWN,INTERVENTIONAL,Low eligibility rate
NCT04288180,TERMINATED,OBSERVATIONAL,COVID-19 Pandemic
NCT04288193,WITHDRAWN,OBSERVATIONAL,"Change in personnel, unable to begin project."
NCT04288336,WITHDRAWN,INTERVENTIONAL,No patient accrual
NCT04288765,WITHDRAWN,INTERVENTIONAL,incomplete recruitment
NCT04288856,TERMINATED,INTERVENTIONAL,"There was no evidence of benefit across efficacy endpoints in the randomized trial, 245AS101. Accordingly, Biogen has made the difficult decision to discontinue the BIIB078 program including this open label extension trial, 245AS102."
NCT04288960,SUSPENDED,OBSERVATIONAL,Covid and access to participants
NCT04289259,TERMINATED,OBSERVATIONAL,The funder stopped to fund this study.
NCT04289428,WITHDRAWN,OBSERVATIONAL,Funding not awarded. A new study design and protocol have been submitted
NCT04289558,WITHDRAWN,INTERVENTIONAL,"current grant expiration in May, insufficient funds remaining, travel restrictions, COVID-19 restrictions in Tanzania, etc."
NCT04289584,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04289844,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04289857,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04289883,WITHDRAWN,INTERVENTIONAL,The Covid-19 pandemic that made it impossible to conduct within the timeframe.
NCT04289948,WITHDRAWN,INTERVENTIONAL,Funding issues meant that development of the study was halted.
NCT04290065,WITHDRAWN,INTERVENTIONAL,COVID-19 Lockdown
NCT04290273,WITHDRAWN,INTERVENTIONAL,workforce issues which made practical delivery of the study impossible to do atthe current time
NCT04290442,WITHDRAWN,INTERVENTIONAL,"initially cessation due to covid, then fellow doing the study graduated with no time to complete the study; will take up again if a current fellow takes on the project"
NCT04290455,TERMINATED,INTERVENTIONAL,Lack of recruitment during COVID
NCT04290637,SUSPENDED,INTERVENTIONAL,Unable to recruit during COVID-19 crisis
NCT04290728,TERMINATED,INTERVENTIONAL,Change in the study plan
NCT04290832,TERMINATED,INTERVENTIONAL,The study was stopped prematurely due to the COVID-19 pandemic
NCT04290845,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to COVID-19. No study participants were enrolled.
NCT04290858,WITHDRAWN,INTERVENTIONAL,New coordinating center has been defined (Massachusetts General Hospital)
NCT04290871,WITHDRAWN,INTERVENTIONAL,The study will start to enroll patients soon
NCT04290962,WITHDRAWN,INTERVENTIONAL,no accrual
NCT04290988,SUSPENDED,INTERVENTIONAL,Lack of funding for the time being
NCT04291027,TERMINATED,INTERVENTIONAL,The study needed to be stopped due to the COVID-19 pandemic.
NCT04291170,WITHDRAWN,INTERVENTIONAL,Logistics (Research Staffing)
NCT04291456,TERMINATED,INTERVENTIONAL,Completion is not possible due to recruitment concerns
NCT04291950,WITHDRAWN,OBSERVATIONAL,Principal investigator is moving to a new institution. Study is closing.
NCT04292275,TERMINATED,INTERVENTIONAL,Study closed prematurely due to enrollment challenges exacerbated by COVID-19.
NCT04292392,WITHDRAWN,INTERVENTIONAL,Final protocol and ICF has not been approved by local IRB. No subjects have been enrolled. Study will not be pursued due to current COVID-19 pandemic.
NCT04292808,WITHDRAWN,INTERVENTIONAL,Covid caused too many delays
NCT04292847,SUSPENDED,INTERVENTIONAL,insufficient staff
NCT04292860,WITHDRAWN,OBSERVATIONAL,Principal Investigator decided not to move forward with the study
NCT04293120,TERMINATED,INTERVENTIONAL,COVID restrictions prevented recruitmetn
NCT04293172,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrolment of first patient."
NCT04293692,WITHDRAWN,INTERVENTIONAL,"Patients were transferred to designated hospitals for treatment as needed, the clinical trials cannot be conducted."
NCT04293744,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04293900,WITHDRAWN,OBSERVATIONAL,Study never started due to COVID pandemic and lack of study funding.
NCT04293978,SUSPENDED,INTERVENTIONAL,Recruitment and intervention provision paused due to COVID-19 situation. Planned to resume.
NCT04294030,WITHDRAWN,OBSERVATIONAL,Deprioritized by Sponsor
NCT04294082,WITHDRAWN,OBSERVATIONAL,Study stopped due to the outbreak of the covid-19 pandemic.
NCT04294277,TERMINATED,INTERVENTIONAL,Screening success and patient recruitment was much lower than projected and a clinical/scientific interpretation will not be possible.
NCT04294459,TERMINATED,INTERVENTIONAL,Terminated due to non-safety reasons
NCT04294563,TERMINATED,INTERVENTIONAL,Accrual targets not met
NCT04294823,WITHDRAWN,OBSERVATIONAL,Administrative delays were too long
NCT04294836,WITHDRAWN,INTERVENTIONAL,Issues with local regulatory authority
NCT04294875,WITHDRAWN,INTERVENTIONAL,Study held.
NCT04294940,WITHDRAWN,INTERVENTIONAL,Study suspended due to the COVID-19 pandemic. Some study procedures are not curently possible for many investigational sites.
NCT04295304,TERMINATED,INTERVENTIONAL,Lack of funds
NCT04295616,TERMINATED,INTERVENTIONAL,Due to COVID-19 situation IPV is no longer allowed in the center
NCT04295720,TERMINATED,INTERVENTIONAL,Stopped due to the risk of COVID-19 variants to our subject base of cancer patients
NCT04296110,SUSPENDED,INTERVENTIONAL,Issues with study funding
NCT04296214,WITHDRAWN,OBSERVATIONAL,Poor recruitment
NCT04296318,TERMINATED,OBSERVATIONAL,Business decision
NCT04296578,WITHDRAWN,INTERVENTIONAL,Study did not start
NCT04296838,TERMINATED,INTERVENTIONAL,"Due to inter-city travel restrictions for COVID-19, regular follow-up for most patients is not possible"
NCT04296942,TERMINATED,INTERVENTIONAL,"One participant was accrued, and the study was stopped due to new safety data from the company for M7824 and slow accrual."
NCT04297319,TERMINATED,INTERVENTIONAL,This protocol was cancelled due to the COVID pandemic restrictions in our country. It was imposible to complete the recruitment of patients to achive the study objectives.
NCT04297332,TERMINATED,INTERVENTIONAL,low accrual
NCT04297748,TERMINATED,INTERVENTIONAL,Efficacy finding
NCT04297839,SUSPENDED,INTERVENTIONAL,"DUE TO CORONAVIRUS DISEASE, ACTIVITIES INTHE HOSPITAL ARE SUPRESSED"
NCT04297904,SUSPENDED,OBSERVATIONAL,COVID-19 restrictions
NCT04298710,TERMINATED,INTERVENTIONAL,Research lab not accessible due to the pandemic.
NCT04298814,WITHDRAWN,OBSERVATIONAL,It was repeated with other studies in the same department
NCT04298840,WITHDRAWN,INTERVENTIONAL,Sponsor indicated it was unable/unwilling to support project at the present time.
NCT04298918,TERMINATED,INTERVENTIONAL,Decision to discontinue the study based on broader development and strategic prioritisation. The Sponsor concludes there is no benefit-risk impact on the CO41863 study.
NCT04299061,WITHDRAWN,INTERVENTIONAL,"Due to the pandemic, sufficient number of participants could not be received."
NCT04299282,WITHDRAWN,INTERVENTIONAL,Postponed due to COVID-19 pandemic
NCT04299295,TERMINATED,INTERVENTIONAL,Due to company's internal decision.
NCT04299373,TERMINATED,INTERVENTIONAL,In an effort to seek a more suitable method to measure alcohol clearance.
NCT04299438,TERMINATED,INTERVENTIONAL,Stopped at interim analysis
NCT04299503,WITHDRAWN,INTERVENTIONAL,Unable to identify subjects to meet inclusion criteria
NCT04299737,WITHDRAWN,OBSERVATIONAL,"Due to the COVID-19 era, clinical research was interrupted, and this study was terminated."
NCT04299776,WITHDRAWN,INTERVENTIONAL,Review of new pre-clinical data
NCT04299802,WITHDRAWN,INTERVENTIONAL,Study not being pursued
NCT04299841,WITHDRAWN,OBSERVATIONAL,lack of time
NCT04300075,WITHDRAWN,OBSERVATIONAL,Business Decision
NCT04300114,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT04300140,TERMINATED,INTERVENTIONAL,Due to business reasons
NCT04300335,SUSPENDED,INTERVENTIONAL,"Due to COVID-19 and the fact that the study participants are part of the ""high-risk"" population, the start of the recruiting process has been delayed at will."
NCT04300881,TERMINATED,INTERVENTIONAL,Enrollment
NCT04300907,WITHDRAWN,INTERVENTIONAL,Due to COVID-19
NCT04301011,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04301258,TERMINATED,OBSERVATIONAL,Duplicative data/insufficient enrollment
NCT04301284,WITHDRAWN,INTERVENTIONAL,"In January 2021 Novartis acquired Cadent Therapeutics. As part of a pipeline reassessment, the Synchrony-1 trial will not proceed as initially scheduled."
NCT04301310,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT04301388,WITHDRAWN,INTERVENTIONAL,"We unable to include the participants as we expected. Only 1 case included after 4 months of recruitment so we decided to withdrawn the study. This is because of COVID-19 pandemic, result in decreasing in the number of patient visiting our insitute."
NCT04302142,WITHDRAWN,INTERVENTIONAL,"The study was stopped due to COVID restrictions on staff, therefore enrollment was not started."
NCT04302337,WITHDRAWN,INTERVENTIONAL,technical and funding issues
NCT04302831,WITHDRAWN,INTERVENTIONAL,COVID-19 safety restrictions
NCT04302948,TERMINATED,INTERVENTIONAL,COVID-19 quarantines disrupted study and funding ended.
NCT04303377,WITHDRAWN,INTERVENTIONAL,The sponsor required early termination of the economic agreement due to a supposed extension of the enrollment period for bureaucracy reasons and for the concomitant Covid -19 Pandemic
NCT04303559,TERMINATED,INTERVENTIONAL,"The INHIBIT Trials IDSMB, in a letter dated 05-18-22, recommended, given the slow enrollment, that the INHIBIT Trials be discontinued due to futility."
NCT04303572,TERMINATED,INTERVENTIONAL,"The INHIBIT Trials IDSMB, in a letter dated 05-18-22, recommended, given the slow enrollment, that the INHIBIT Trials be discontinued due to futility."
NCT04303663,WITHDRAWN,INTERVENTIONAL,COVID
NCT04303845,TERMINATED,INTERVENTIONAL,difficulty with recruitment
NCT04304079,WITHDRAWN,INTERVENTIONAL,No funding
NCT04304092,WITHDRAWN,INTERVENTIONAL,"COVID associated costs have reduced the available budget , and the ability to recruit participants from the community. These two factors combined do not allow us to perform the trial as originally planned."
NCT04304365,WITHDRAWN,INTERVENTIONAL,Unable to implement the study due to delays from COVID-19 policies which postponed the start.
NCT04304716,WITHDRAWN,INTERVENTIONAL,Withdrawn from the IRB
NCT04304729,SUSPENDED,OBSERVATIONAL,"Recruitment for phase 1 is completed, waiting for phase 2"
NCT04304781,TERMINATED,INTERVENTIONAL,Terminated due to lack of dimer.
NCT04304833,TERMINATED,INTERVENTIONAL,Change in PI
NCT04304872,WITHDRAWN,INTERVENTIONAL,Study never started due to delays with COVID and funding reallocation.
NCT04305184,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT04305236,TERMINATED,INTERVENTIONAL,Halted due to study funding
NCT04305262,WITHDRAWN,OBSERVATIONAL,due to COVID-19 is was not possible to complete the study
NCT04305327,TERMINATED,INTERVENTIONAL,Early terminated due to difficulty recruiting participants
NCT04305379,TERMINATED,INTERVENTIONAL,"Stopped due to COVID-19 pandemic, low priority among initiatives and officially terminated."
NCT04305678,WITHDRAWN,INTERVENTIONAL,Funding lost from Sponsor.
NCT04305977,WITHDRAWN,INTERVENTIONAL,"There was enrollment in the qualitative phase that proceeded this planned open pilot trial. However, community partner experienced barriers to recruitment and enrollment in the context of COVID and needed prioritize non-research functions."
NCT04306068,WITHDRAWN,INTERVENTIONAL,COVID-19 coronavirus pandemic
NCT04306211,TERMINATED,INTERVENTIONAL,"While there were no safety concerns, the choice of endoscopic ultrasound as part of the study design limited selection of patients. Additionally, inconsistent reliable inflation of the device was experienced during treatment."
NCT04306237,SUSPENDED,INTERVENTIONAL,Coronavirus Pandemic
NCT04306562,TERMINATED,INTERVENTIONAL,The clinical study was terminated prior to completion due to challenges in enrolling a sufficient number of participants.
NCT04306692,TERMINATED,INTERVENTIONAL,clomiphene citrate is no longer being considered as standard treatment for polycystic ovary syndrome
NCT04306783,WITHDRAWN,INTERVENTIONAL,Investigator is leaving the university
NCT04306848,WITHDRAWN,INTERVENTIONAL,Software company providing devices never responded. I believe they closed.
NCT04306861,WITHDRAWN,OBSERVATIONAL,Enrollment and other trial activities have temporarily paused due to COVID-19 and are expected to resume in the future; This is not a suspension of IRB approval
NCT04306939,SUSPENDED,OBSERVATIONAL,Suspended for analysis and to consider further enrollment.
NCT04307628,WITHDRAWN,INTERVENTIONAL,Study logistics still being worked out. On hold for now.
NCT04307693,TERMINATED,INTERVENTIONAL,Terminated early because no patients were further enrolled since mid-Apr 2020.
NCT04307992,SUSPENDED,INTERVENTIONAL,Study temporary on hold due to safety event for the AneuFix product in a different study that could potentially also occur in this study.
NCT04308252,WITHDRAWN,OBSERVATIONAL,Sponsor no longer pursuing Epilepsy development.
NCT04308395,TERMINATED,INTERVENTIONAL,"Study was terminated early due to low blinded event rate and this study termination is not related to safety of the drug Patidegib Topical Gel, 2%."
NCT04308785,TERMINATED,INTERVENTIONAL,The sponsor's decision was based on the negative results of SKYSCRAPER-02.
NCT04308954,TERMINATED,INTERVENTIONAL,Difficulty with patient recruitment due to COVID-19 pandemic
NCT04309227,TERMINATED,INTERVENTIONAL,Lack of participant recruitment; closure of study based on investigator feedback
NCT04309721,TERMINATED,INTERVENTIONAL,Lack of inclusion
NCT04309734,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to study initiation.
NCT04309760,WITHDRAWN,INTERVENTIONAL,the patients are now followed in another hospital. The study is discontinued
NCT04309825,WITHDRAWN,INTERVENTIONAL,no IRB approval
NCT04309877,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04310488,WITHDRAWN,OBSERVATIONAL,PI has changed of institution. Project will be declare on the new institution ClinicalTrials.gov affiliation.
NCT04310865,SUSPENDED,INTERVENTIONAL,There were no eligible patients with CoVID-19 in the paticipated centers.
NCT04311047,TERMINATED,INTERVENTIONAL,We decided to stop inclusions and start analysis after 26 inclusions.
NCT04311112,WITHDRAWN,INTERVENTIONAL,The asset was transferred to another company
NCT04311242,WITHDRAWN,OBSERVATIONAL,Sponsor decision to not pursue epilepsy development.
NCT04311281,WITHDRAWN,OBSERVATIONAL,Insufficient Funding
NCT04311294,WITHDRAWN,INTERVENTIONAL,Project was not funded.
NCT04311489,TERMINATED,INTERVENTIONAL,Interim analysis showing safety concerns
NCT04311515,TERMINATED,INTERVENTIONAL,Samus Therapeutics company closure
NCT04311541,WITHDRAWN,OBSERVATIONAL,Business Decision; No Safety Or Efficacy Concerns
NCT04311619,SUSPENDED,INTERVENTIONAL,We are waiting for grant funding to support study enrollment.
NCT04311710,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT04311866,WITHDRAWN,INTERVENTIONAL,Lack of material for treatment of the patients
NCT04312074,TERMINATED,OBSERVATIONAL,No funding
NCT04312165,WITHDRAWN,INTERVENTIONAL,Financial
NCT04312282,TERMINATED,INTERVENTIONAL,The Sponsor has discontinued the development of tesetaxel
NCT04312763,SUSPENDED,OBSERVATIONAL,Study was suspended 4/16/2020 due to global pandemic. Plans to restart or permanently end the study are still being evaluated.
NCT04312789,WITHDRAWN,INTERVENTIONAL,Drug availability
NCT04313088,WITHDRAWN,INTERVENTIONAL,This study did not enroll any subjects
NCT04313179,TERMINATED,INTERVENTIONAL,COVID-19 pandemic prevented further enrollment. Interim analysis showed adequate power achieved.
NCT04313296,TERMINATED,INTERVENTIONAL,Staff shortage
NCT04313465,WITHDRAWN,INTERVENTIONAL,CI no longer wishes to complete this study due to Covid-19
NCT04313881,TERMINATED,INTERVENTIONAL,Study discontinued due to futility based on a planned analysis
NCT04313985,TERMINATED,INTERVENTIONAL,PI relocated
NCT04314700,TERMINATED,INTERVENTIONAL,PI left the site
NCT04314713,TERMINATED,INTERVENTIONAL,DSMB decision due to adverse events
NCT04314843,TERMINATED,INTERVENTIONAL,Development program terminated and the decision was not due to any safety concerns.
NCT04314856,WITHDRAWN,INTERVENTIONAL,Principal investigator left institution
NCT04315051,TERMINATED,INTERVENTIONAL,Covid- 19 has shut the clinic
NCT04315090,WITHDRAWN,OBSERVATIONAL,Personnel change and inadequate resources to proceed with the study.
NCT04315155,WITHDRAWN,INTERVENTIONAL,study abandoned for funding issues
NCT04315246,WITHDRAWN,INTERVENTIONAL,Business priorities
NCT04315311,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT04315350,TERMINATED,INTERVENTIONAL,We stopped recruiting having 8 in each intervention group instead of 9 due to recruitment problems due to COVID19 pandemic
NCT04315961,TERMINATED,INTERVENTIONAL,Unable to recruit participants.
NCT04316000,SUSPENDED,OBSERVATIONAL,Due to SARS-CoV2 (Covid-19) pandemia and its implications for outcomes bias.
NCT04316169,WITHDRAWN,INTERVENTIONAL,Funding and PI leaving institution
NCT04316338,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT04316468,TERMINATED,OBSERVATIONAL,Unable to find software to open saved images for analysis
NCT04316481,TERMINATED,INTERVENTIONAL,FDA Approval was received for the Model AMSG3-E IMD and therefore commercial implants could be started. There was no longer any need to implant under the CAS. CAS patients were transitioned to commercial patients.
NCT04316598,TERMINATED,INTERVENTIONAL,Terminated by the sponsor in the context of COVID-19 pandemia
NCT04316611,WITHDRAWN,INTERVENTIONAL,"As the inclusion period in the study has ended and regulatory authorizations have expired on 26/12/2023, with no inclusions conducted."
NCT04316806,TERMINATED,INTERVENTIONAL,Principal Investigator changed his job
NCT04317001,WITHDRAWN,INTERVENTIONAL,Researcher leading the study moved institutions study not feasible
NCT04317287,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT04317300,WITHDRAWN,INTERVENTIONAL,medication has not been available for the intervention
NCT04317326,WITHDRAWN,INTERVENTIONAL,"due to the ""Philips alert "" we could not get the treatment equipment and the public grands expired"
NCT04317495,TERMINATED,INTERVENTIONAL,New data has caused the principal investigator to decide that the study no longer makes sense to conduct as it is designed. This is not a suspension of IRB approval.
NCT04317586,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04317924,WITHDRAWN,INTERVENTIONAL,Resources not available to conduct the research.
NCT04318587,TERMINATED,INTERVENTIONAL,Due to COVID and staffing shortages we decided to end the study with 40 participants instead of 50.
NCT04318925,WITHDRAWN,OBSERVATIONAL,No recruitment
NCT04319679,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT04320290,WITHDRAWN,INTERVENTIONAL,New Related Protocol to be submitted
NCT04320394,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04320511,TERMINATED,OBSERVATIONAL,staffing shortage and resource prioritization
NCT04320524,WITHDRAWN,INTERVENTIONAL,"Due to Covid, the study could not be initiated as planned."
NCT04320771,TERMINATED,INTERVENTIONAL,Termination of the development project for Neladenoson bialanate
NCT04320940,TERMINATED,INTERVENTIONAL,"Insufficient participant recruitment hindered the study's progress, preventing robust data collection and compromising statistical power"
NCT04320966,WITHDRAWN,OBSERVATIONAL,Study was not funded.
NCT04321434,TERMINATED,INTERVENTIONAL,Futility
NCT04321577,WITHDRAWN,OBSERVATIONAL,"At the beginning of the study, the collaboration of several Spanish liver surgery groups was planned. However, neither group has included a valid record. Likewise, the number of patients studied in our center has been extremely low."
NCT04321603,WITHDRAWN,INTERVENTIONAL,COVID-19 prevented us from doing this human subjects study
NCT04321850,TERMINATED,INTERVENTIONAL,Health restrictions due to the COVID-19 pandemic
NCT04321928,TERMINATED,INTERVENTIONAL,"The study was terminated due to planned termination criteria (e.g., COVID-19 vaccination)"
NCT04321967,WITHDRAWN,INTERVENTIONAL,Unable to recruit patients
NCT04322227,TERMINATED,INTERVENTIONAL,Study termination due to efficacy results of another study
NCT04322253,TERMINATED,INTERVENTIONAL,The cessation of the development project for neladenoson bialanate.
NCT04322279,SUSPENDED,OBSERVATIONAL,no topics to include
NCT04322305,SUSPENDED,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research."
NCT04322396,TERMINATED,INTERVENTIONAL,Recommended by the DSMB
NCT04322682,TERMINATED,INTERVENTIONAL,"Due to several considerations (logistical, human and budgetary), the study was stopped early."
NCT04322747,WITHDRAWN,OBSERVATIONAL,COVID protocols caused extreme delays.
NCT04322773,TERMINATED,INTERVENTIONAL,The study has been terminated due to changed clinical conditions and too few patients available
NCT04322903,WITHDRAWN,INTERVENTIONAL,Due to COVID 19 restrictions and protocol could not to be implemented safely for participants and researchers.
NCT04323124,TERMINATED,INTERVENTIONAL,Study was terminated as it did not demonstrate sufficient pharmacological effect. Termination was not related to safety reasons.
NCT04323280,TERMINATED,INTERVENTIONAL,Difficulty in enrollment of patients
NCT04323423,WITHDRAWN,INTERVENTIONAL,Principal investigator moved to a different role
NCT04323436,TERMINATED,INTERVENTIONAL,Study termination based on sponsor decision due to lack of tolerability observed with capmatinib and spartalizumab combination treatment when compared to data from capmatinib single agent studies
NCT04323631,WITHDRAWN,INTERVENTIONAL,Trial not started due to accumulating evidence against HCQ for COVID
NCT04323969,TERMINATED,INTERVENTIONAL,COVID-related laboratory shutdown.
NCT04324021,TERMINATED,INTERVENTIONAL,"Standard of care evolved during the timeframe of the study and had critical impact on recruitment.

Early termination was not based on safety reasons but due to the reasons mentoined above.

The ongoing patients were completed."
NCT04324593,TERMINATED,INTERVENTIONAL,Terminated due to COVID-19
NCT04325061,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04325165,WITHDRAWN,INTERVENTIONAL,Recruitment issues
NCT04325607,TERMINATED,INTERVENTIONAL,Recruitment was affected by the previous COVID pandemic and patient referral pathway was interrupted
NCT04325633,TERMINATED,INTERVENTIONAL,Stop inclusions for insufficient recruitment
NCT04325672,WITHDRAWN,INTERVENTIONAL,Study stopped due to opening Expanded Access Protocol.
NCT04325698,TERMINATED,INTERVENTIONAL,The study was terminated as part of the decision by Pfizer to halt its biosimilars programs in China.
NCT04325802,WITHDRAWN,INTERVENTIONAL,Covid-19 pandemic
NCT04325893,TERMINATED,INTERVENTIONAL,decrease in number of eligible patients
NCT04326231,TERMINATED,INTERVENTIONAL,COVID and the Study was withdrawn (limited recruitment within study timeline)
NCT04326283,TERMINATED,INTERVENTIONAL,Terminated as it is considered that necessary data have been collected
NCT04326439,TERMINATED,INTERVENTIONAL,"Due to unforeseen circumstances, the study team was limited in enrolling patients on this trial; thus, it was terminated."
NCT04326764,TERMINATED,INTERVENTIONAL,Change of marketing authorisation holder
NCT04326790,TERMINATED,INTERVENTIONAL,Slow enrollment as a result of the rapid flattening of the curve of COVID-19 cases in Greece
NCT04327011,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04327284,WITHDRAWN,INTERVENTIONAL,Research cancelled
NCT04327310,WITHDRAWN,INTERVENTIONAL,The same drug has completed the phase I and II clinical trials for COVID-19
NCT04327362,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to delay in recruitment due to COVID-19; the PI also moved to a new institution.
NCT04327401,TERMINATED,INTERVENTIONAL,"The Data Monitoring Committee recommended to stop the trial based on the Recovery Trial results, which was accepted by the CoDEX Steering Committee."
NCT04327505,TERMINATED,INTERVENTIONAL,"Futility, change of disease due to virus mutations and/or vaccination"
NCT04327557,SUSPENDED,INTERVENTIONAL,Due to COVID-19
NCT04327596,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT04327700,SUSPENDED,INTERVENTIONAL,"Changing PIs, waiting for approval"
NCT04327934,TERMINATED,INTERVENTIONAL,Unble to complete all arms of the planned study due to Covid stoppage and difficulty with recruiting and getting enrolled participants to return post Covid.
NCT04327986,TERMINATED,INTERVENTIONAL,Study closed to accrual due to the worsening risk: benefit ratio for participants receiving bintrafusp alfa (M7824).
NCT04327999,TERMINATED,INTERVENTIONAL,Funding ended
NCT04328012,TERMINATED,INTERVENTIONAL,difficult enrollment
NCT04328246,TERMINATED,INTERVENTIONAL,Recruitment was not feasible at site.
NCT04328285,TERMINATED,INTERVENTIONAL,French authority's decision
NCT04328558,WITHDRAWN,INTERVENTIONAL,no participants
NCT04328714,SUSPENDED,INTERVENTIONAL,Study is suspended pending renovation and reopening of the facility manufacturing the study product.
NCT04329091,TERMINATED,INTERVENTIONAL,Lack of participant recruitment
NCT04329195,TERMINATED,INTERVENTIONAL,insufficient recrutment
NCT04329312,TERMINATED,OBSERVATIONAL,slow recruitment
NCT04329403,WITHDRAWN,INTERVENTIONAL,Market reasons
NCT04329442,WITHDRAWN,INTERVENTIONAL,COVID-19 caused substantial barriers to recruitment.
NCT04329572,SUSPENDED,INTERVENTIONAL,"Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this study."
NCT04329611,TERMINATED,INTERVENTIONAL,"Enrolment was suspended on 22may2020, after Mehra et al (Lancet 2020) then stopped due to lack of Covid19 cases."
NCT04329806,SUSPENDED,INTERVENTIONAL,Study being replaced by crossover design
NCT04329923,TERMINATED,INTERVENTIONAL,Cohort 1: slow accrual Cohort 2: Other studies showed no benefit Cohort 3: Study met pre-specificied futility analysis at planned second interim analysis
NCT04329949,TERMINATED,INTERVENTIONAL,"The independent data monitoring committee found no safety issues, however the observed response rate did not meet the predefined threshold for continuing the study. The study was terminated by the Sponsor."
NCT04330079,TERMINATED,INTERVENTIONAL,Slow enrollment. (Difficulty in selecting subjects)
NCT04330131,WITHDRAWN,INTERVENTIONAL,Challenges due to covid prevented implementation of this behavioral study in a hospital setting
NCT04330144,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT04330300,SUSPENDED,INTERVENTIONAL,Challenges with funding and very low incidence of COVID-19 at Irish study site
NCT04330495,WITHDRAWN,INTERVENTIONAL,"* Care pressures on the investigator team during the COVID-19 pandemic.
* Subsequent appearance of scientific evidence on the lack of efficacy of hydroxychloroquine in the treatment or prophylaxis of COVID-19 infection."
NCT04330625,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04331002,TERMINATED,INTERVENTIONAL,Funding Termination
NCT04331028,WITHDRAWN,INTERVENTIONAL,The sctrict inclusion and exclusion criteria made the study unfeasible. No patients were enrolled.
NCT04331054,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04331483,WITHDRAWN,INTERVENTIONAL,"modification of the intervention before patient's enrollment, new protocol submitted"
NCT04331561,WITHDRAWN,INTERVENTIONAL,Due to COVID
NCT04331652,TERMINATED,INTERVENTIONAL,change of practices
NCT04331665,TERMINATED,INTERVENTIONAL,"A Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients with COVID-19 did not meet its primary endpoint. With this news, recruitment was stopped for this study."
NCT04331717,WITHDRAWN,INTERVENTIONAL,accrual on hold
NCT04332003,WITHDRAWN,INTERVENTIONAL,Sponsor
NCT04332081,TERMINATED,INTERVENTIONAL,The IRB has determined that the design of this trial should be changed to a randomized controlled trial. A new record will be created for the redesigned study.
NCT04332107,TERMINATED,INTERVENTIONAL,Futility
NCT04332497,WITHDRAWN,INTERVENTIONAL,no participants
NCT04332523,TERMINATED,INTERVENTIONAL,A strategic decision was made to discontinue the study. The decision was not based on a safety concern.
NCT04332549,WITHDRAWN,INTERVENTIONAL,"After meeting with the FDA, SPARC concludes a BE study will not be required"
NCT04333147,TERMINATED,INTERVENTIONAL,Study is early terminated due to Limited efficacy demonstrated in the contRAst program does not support a suitable benefit/risk profile for otilimab as a potential treatment for RA. GSK has decided not to progress with regulatory submissions.
NCT04333355,TERMINATED,INTERVENTIONAL,Other clinical trails probed that the use of convalescent plasma for patients with COVID-19 is safe .
NCT04333407,TERMINATED,INTERVENTIONAL,Difficulty in recruiting eligible participants
NCT04333628,TERMINATED,INTERVENTIONAL,Teminated due to changes in treatment guidelines .
NCT04333654,TERMINATED,INTERVENTIONAL,Rate of enrollment too slow to allow completion in a reasonable timeframe
NCT04334018,WITHDRAWN,INTERVENTIONAL,Other studies on the same theme
NCT04334174,WITHDRAWN,INTERVENTIONAL,accrual not met
NCT04334187,WITHDRAWN,INTERVENTIONAL,"Due to the pandemic's impacts on being able to conduct the intervention for this study, unable to begin recruitment."
NCT04334369,WITHDRAWN,INTERVENTIONAL,LOSS OF FORMER PRINCIPAL INVESTIGATOR
NCT04334408,WITHDRAWN,INTERVENTIONAL,Lack of funding to support the trial.
NCT04334499,WITHDRAWN,OBSERVATIONAL,The study was never initiated; Principal Investigator determined that it was not feasible to continue with the study at this time.
NCT04334590,WITHDRAWN,OBSERVATIONAL,no enrollment
NCT04334629,WITHDRAWN,INTERVENTIONAL,Study withdrawn.
NCT04334811,WITHDRAWN,INTERVENTIONAL,The study was stopped due to participation in a multi-center randomized controlled trial with competing enrollment criteria.
NCT04334915,WITHDRAWN,INTERVENTIONAL,Industry supporter no longer supporting the study. Protocol A5415's study will run instead.
NCT04334967,SUSPENDED,INTERVENTIONAL,suspected unfavorable risk/benefit assessment
NCT04335006,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT04335071,TERMINATED,INTERVENTIONAL,"1.) Not possible to recruit the planned number of patients during the planned study period; 2.) ""Dexamethason"" was included in the standard of care for the study population during the course of the study and inclusion criteria could no longer be met."
NCT04335305,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT04335461,WITHDRAWN,INTERVENTIONAL,Study was withdrawn. Study expired in IRB system and no patients enrolled as per institutional CTMS and IRB systems. Primary and Study Completion Dates reflect date IRB approval expired.
NCT04335552,TERMINATED,INTERVENTIONAL,"Poor recruitment, strong evidence from larger trials of no therapeutic benefit"
NCT04335565,WITHDRAWN,INTERVENTIONAL,The study has been terminated due to the pandemic.
NCT04335578,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT04335695,TERMINATED,INTERVENTIONAL,Study not feasible-Not able to enroll the patient population
NCT04335747,TERMINATED,OBSERVATIONAL,Low recruitment rate
NCT04335786,TERMINATED,INTERVENTIONAL,Enrollment was stopped to facilitate successful enrollment for the ACE2RAS-domain of the REMAP-CAP trial.
NCT04335981,TERMINATED,INTERVENTIONAL,Slower than anticipated enrollment.
NCT04336163,TERMINATED,INTERVENTIONAL,"All 55 subjects enrolled in the study completed the initial study procedures, but due to the pandemic and the prolonged period where we were unable to follow up patients, we were not able to complete the aims for this protocol."
NCT04336332,TERMINATED,INTERVENTIONAL,Ineffectiveness of treatment
NCT04336748,WITHDRAWN,INTERVENTIONAL,Not feasible
NCT04336774,WITHDRAWN,INTERVENTIONAL,Technology was approved by FDA before study enrolled subjects
NCT04337385,TERMINATED,INTERVENTIONAL,COVID-19 resulted in laboratory closures and the student has changed their research project in order to progress in their degree.
NCT04337749,WITHDRAWN,INTERVENTIONAL,"After discussing within the team, the project has been withdrawn due to the anticipated insufficiency of sample size."
NCT04337827,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04337931,TERMINATED,INTERVENTIONAL,Business decision (not due to safety reason).
NCT04338074,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04338126,WITHDRAWN,INTERVENTIONAL,"Due to ongoing vaccination efforts, feasibility for recruitment is low"
NCT04338828,TERMINATED,INTERVENTIONAL,Absence of patients meeting criteria following initial COVID surge. DMSB recommended analysis of results to date and early closure.
NCT04338906,WITHDRAWN,INTERVENTIONAL,lack of public funding; planned control arm with Hydroxychloroquine treatment showed out as not being standard of care anymore as time evolved.
NCT04338997,WITHDRAWN,INTERVENTIONAL,Strategic decision by Sponsor
NCT04339413,TERMINATED,INTERVENTIONAL,Decision to terminate development of Gantenerumab for treatment of prodromal/mild/early stage Alzheimer's disease following results of a pre-planned analysis of the safety and efficacy of Gant in Graduate I\&II (WN29922/WN39658).
NCT04339426,TERMINATED,INTERVENTIONAL,Closed due to poor enrollment
NCT04339439,TERMINATED,INTERVENTIONAL,"A preliminary analysis was performed in this study halfway through enrollment and significant results were found, therefore the study was stopped."
NCT04339517,SUSPENDED,INTERVENTIONAL,Low accrual
NCT04339530,SUSPENDED,OBSERVATIONAL,This study is suspended until further notice. Recruitment should resume when COVID-19 safety restrictions are lifted.
NCT04339543,TERMINATED,INTERVENTIONAL,PI left the institution and the US
NCT04339595,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT04339621,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT04339699,SUSPENDED,INTERVENTIONAL,"Sponsor has voluntarily suspended Trial, to update Protocol and respond to observations by the FDA"
NCT04339816,TERMINATED,INTERVENTIONAL,Steering Committee decision in accordance with stopping rule 1: Emergence of new data
NCT04339920,WITHDRAWN,OBSERVATIONAL,No funding
NCT04340102,WITHDRAWN,INTERVENTIONAL,Study was not funded.
NCT04340193,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04340232,WITHDRAWN,INTERVENTIONAL,Could not make FDA required changes
NCT04340544,TERMINATED,INTERVENTIONAL,"It appeared to be impossible for the study centres to recruit the targeted number of patients, due to reduced incidence and reduced acceptance to IMP"
NCT04340583,TERMINATED,OBSERVATIONAL,organization problems
NCT04340661,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04340700,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT04340843,SUSPENDED,INTERVENTIONAL,Other - Completed stage 1 accrual
NCT04340921,WITHDRAWN,OBSERVATIONAL,Failure to recruit
NCT04340934,TERMINATED,INTERVENTIONAL,Due to funding
NCT04341285,WITHDRAWN,INTERVENTIONAL,study protocol was changed to include non-COVID patients and registered under a different ID
NCT04341311,TERMINATED,INTERVENTIONAL,Withdrawal of support from BMS
NCT04341415,TERMINATED,INTERVENTIONAL,Inclusion stopped at 50% after interim analysis: primary efficacy endpoint not significant
NCT04341441,TERMINATED,INTERVENTIONAL,"Interim analysis did not reveal any safety concerns by the DSMB, but unblinded data did not provide support to continue. Event rate did not meet projected magnitude; given low recruitment potential, it is unlikely that a positive result will occur."
NCT04341493,TERMINATED,INTERVENTIONAL,Concerns about safety of Hydroxychloroquine
NCT04341610,WITHDRAWN,INTERVENTIONAL,Not approved by ethical committee
NCT04341727,TERMINATED,INTERVENTIONAL,DSMB recommended study suspension slow accrual
NCT04341740,TERMINATED,INTERVENTIONAL,Study funding was withdrawn.
NCT04341870,SUSPENDED,INTERVENTIONAL,DSMB recommendation (futility)
NCT04341935,WITHDRAWN,INTERVENTIONAL,Logistical challenges amid COVID-19 pandemic and lack of financial support
NCT04341987,WITHDRAWN,INTERVENTIONAL,Covid-related
NCT04342000,WITHDRAWN,INTERVENTIONAL,Study was updated and is now under IRB #2023-0499
NCT04342117,TERMINATED,OBSERVATIONAL,Strategy Change
NCT04342156,WITHDRAWN,INTERVENTIONAL,The number of patients with COVID-19 in Singapore was coming down for the community and the concerns about the potential side effects particularly when the baseline ECG and serum electrolytes was not proposed.
NCT04342182,TERMINATED,INTERVENTIONAL,new insights into COVID19 pathogenesis
NCT04342221,TERMINATED,INTERVENTIONAL,Reduced acceptance of IMP
NCT04342689,TERMINATED,INTERVENTIONAL,Study was terminated due to low enrollment.
NCT04342897,TERMINATED,INTERVENTIONAL,Trial terminated for futility.
NCT04343001,WITHDRAWN,INTERVENTIONAL,Grant not obtained
NCT04343027,WITHDRAWN,INTERVENTIONAL,Withdrawn project - did not progress to enrollment.
NCT04343183,WITHDRAWN,INTERVENTIONAL,Did not receive IRB approval
NCT04343235,TERMINATED,INTERVENTIONAL,Challenges with enrollment; primary investigator left the institution
NCT04343248,TERMINATED,INTERVENTIONAL,Study recruitment was halted prematurely as widespread vaccination of the study population made completion infeasible.
NCT04343495,WITHDRAWN,OBSERVATIONAL,PI left institution and study has not begun enrollment.
NCT04343690,WITHDRAWN,INTERVENTIONAL,"Study Ended May 1, 2020 with no enrollment"
NCT04343755,TERMINATED,INTERVENTIONAL,Lack of eligible patients due to change in standard therapy
NCT04343976,TERMINATED,INTERVENTIONAL,"Unable to meet enrollment goal, lack of funding."
NCT04344093,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04344236,WITHDRAWN,INTERVENTIONAL,This study was withdrawn by the institution to minimize risk to patients and staff with regard to COVID-19.
NCT04344288,TERMINATED,INTERVENTIONAL,Competent Authority's decision
NCT04344444,TERMINATED,INTERVENTIONAL,Lack of efficacy data from other studies
NCT04344535,TERMINATED,INTERVENTIONAL,Insufficient eligible and consenting patients
NCT04344548,WITHDRAWN,INTERVENTIONAL,The study did not get financed. Never get started.
NCT04344561,TERMINATED,INTERVENTIONAL,Inability to recruit
NCT04344600,TERMINATED,INTERVENTIONAL,Single center study with low enrollment
NCT04344626,WITHDRAWN,INTERVENTIONAL,We don't have funding to proceed with this study.
NCT04344925,TERMINATED,OBSERVATIONAL,Device demonstrated to be less effective than the control mask in reducing leak
NCT04344951,TERMINATED,INTERVENTIONAL,No clinical efficacy against SARS-CoV-2 recorded
NCT04345289,TERMINATED,INTERVENTIONAL,DSMB advise due to high probability of futility
NCT04345666,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding to complete the study
NCT04345692,TERMINATED,INTERVENTIONAL,RECOVERY Trial results - no efficacy
NCT04345848,TERMINATED,INTERVENTIONAL,Low recruitement
NCT04345861,TERMINATED,INTERVENTIONAL,halted prematurely.
NCT04345952,WITHDRAWN,INTERVENTIONAL,Study was never submitted to the IRB so never received permission to or enrolled any subjects
NCT04346082,WITHDRAWN,INTERVENTIONAL,Regular mindfulness online sessions were not carried out
NCT04346329,WITHDRAWN,INTERVENTIONAL,The study did not get financed. Never got started.
NCT04346355,TERMINATED,INTERVENTIONAL,Based on interim analysis for futility and given an enrolment rate almost nil
NCT04346394,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04346511,WITHDRAWN,INTERVENTIONAL,Never initiated - KSP lost interest
NCT04346589,TERMINATED,INTERVENTIONAL,The study was closed prematurely because the hyperimmune plasma have expired
NCT04346615,TERMINATED,INTERVENTIONAL,Lack of enrollment due to evolution of COVID-19 pandemic with reduction in patients at risk for severe disease and growing number of effective alternative therapies
NCT04346667,TERMINATED,INTERVENTIONAL,Poor accrual.
NCT04347226,TERMINATED,INTERVENTIONAL,Interim analysis indicated that futility boundary was reached.
NCT04347512,WITHDRAWN,INTERVENTIONAL,"In view of the notices concerning hydroxychloroquine issued by the regulatory authorities, we withdraw the protocol"
NCT04347707,TERMINATED,INTERVENTIONAL,The trial was ended after one year due to the suspension of in-person research as a result of the COVID-19 pandemic. We have returned to the program development stage as we explore telehealth alternative options.
NCT04347889,WITHDRAWN,INTERVENTIONAL,"Evidence that HCQ ineffective, loss of HCW interest,"
NCT04347941,TERMINATED,INTERVENTIONAL,"Enrollment for trial was terminated on January 26, 2021 after a third interim analysis demonstrated that a pre-defined statistical criteria for efficacy were met as part of meta-trial study of awake prone positioning."
NCT04347980,TERMINATED,INTERVENTIONAL,ANSM RECOMMANDATION
NCT04348006,WITHDRAWN,INTERVENTIONAL,No patients were enrolled in the study
NCT04348071,WITHDRAWN,INTERVENTIONAL,Could not make FDA required changes
NCT04348292,TERMINATED,INTERVENTIONAL,Accrual goal not met.
NCT04348448,TERMINATED,OBSERVATIONAL,due to covid
NCT04348461,SUSPENDED,INTERVENTIONAL,lack of financial support
NCT04348474,SUSPENDED,INTERVENTIONAL,"Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this study."
NCT04348513,TERMINATED,INTERVENTIONAL,Due to specific inclusion criteria no more subjects could be enrolled.
NCT04348552,WITHDRAWN,OBSERVATIONAL,The study was not implemented
NCT04348656,TERMINATED,INTERVENTIONAL,Study was terminated after the planned interim analysis as the pre-defined futility threshold was met
NCT04348890,WITHDRAWN,INTERVENTIONAL,Programmatic decision
NCT04348916,TERMINATED,INTERVENTIONAL,Terminated due to Oncorus portfolio reprioritization
NCT04348968,TERMINATED,OBSERVATIONAL,The notified body does not require data anymore and recruitment did not start. The study was thus terminated after approval from the investigator and the local ethical committee.
NCT04348981,WITHDRAWN,INTERVENTIONAL,"Lack of funding, lack of support (time)"
NCT04349111,WITHDRAWN,INTERVENTIONAL,Lack of site participation
NCT04349124,TERMINATED,INTERVENTIONAL,Unable to continue recruiting
NCT04349176,TERMINATED,INTERVENTIONAL,Insufficient Recruitment
NCT04349228,WITHDRAWN,INTERVENTIONAL,- Interest in the use of HCQ is controversial.
NCT04349280,TERMINATED,INTERVENTIONAL,Primary investigator withdrew the participant due to an SAE
NCT04349371,TERMINATED,INTERVENTIONAL,Low enrollment.
NCT04349449,WITHDRAWN,OBSERVATIONAL,Business Decision (no enrollment)
NCT04349462,SUSPENDED,INTERVENTIONAL,Recruitment has been suspended during COVID19 Pandemic
NCT04349605,WITHDRAWN,INTERVENTIONAL,Withdrawn given new information indicating a new study design would be preferable
NCT04349774,WITHDRAWN,INTERVENTIONAL,Study was never initiated due to COVID-19
NCT04349891,TERMINATED,INTERVENTIONAL,PI left Johns Hopkins University
NCT04349930,WITHDRAWN,INTERVENTIONAL,Need to obtain IND approval.
NCT04349956,TERMINATED,OBSERVATIONAL,Inability to achieve primary or secondary study objectives
NCT04350086,WITHDRAWN,INTERVENTIONAL,unfavorable opinion of the ethics committee
NCT04350424,TERMINATED,OBSERVATIONAL,Lack of resources and Covid-19
NCT04350450,WITHDRAWN,INTERVENTIONAL,PI withdrew the submission to the IRB
NCT04350476,WITHDRAWN,INTERVENTIONAL,closed due to lack of interest and enrollment
NCT04350541,SUSPENDED,INTERVENTIONAL,Study suspended due to COVID-19 pandemic
NCT04350762,TERMINATED,INTERVENTIONAL,Unable to enroll due to Pandemic
NCT04350957,WITHDRAWN,INTERVENTIONAL,PI left institution due to family emergency prior to IRB approval.
NCT04351061,WITHDRAWN,INTERVENTIONAL,No participants were identified per inclusion/exclusion criteria
NCT04351191,TERMINATED,INTERVENTIONAL,Poor accrual
NCT04351230,WITHDRAWN,INTERVENTIONAL,There are no patients enrolled on this study and all efforts are being discontinued
NCT04351490,WITHDRAWN,INTERVENTIONAL,change study design and funding
NCT04351516,WITHDRAWN,INTERVENTIONAL,No Patients enrolled
NCT04351815,WITHDRAWN,INTERVENTIONAL,"As the possible regulatory deadline for the research was exceeded, due to logistical difficulties in setting up the study, and in agreement with the sponsor and the principal investigator, it was decided not to extend the study."
NCT04351919,WITHDRAWN,INTERVENTIONAL,- Interest in the use of HCQ is controversial.
NCT04352166,SUSPENDED,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research."
NCT04352413,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04352868,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04353037,TERMINATED,INTERVENTIONAL,As enrollment began external studies called into question the safety and efficacy of hydroxychloroquine as a treatment which resulted in controversy. The timing of the controversy significantly impacted our ability to enroll and retain participants.
NCT04353206,TERMINATED,INTERVENTIONAL,The initiation of the expanded access program for convalescent plasma.
NCT04353271,TERMINATED,INTERVENTIONAL,FDA recommendations to not use outside of the hospital setting or in a clinical trial due to the risk of cardiac arrhythmias
NCT04353310,WITHDRAWN,INTERVENTIONAL,No funding
NCT04353505,WITHDRAWN,INTERVENTIONAL,PI closed the study before any enrollment
NCT04353648,SUSPENDED,OBSERVATIONAL,Suspended due to COVID-19
NCT04353661,TERMINATED,INTERVENTIONAL,The study was terminated by Sponsor due to patient recruitment challenges.
NCT04353921,TERMINATED,OBSERVATIONAL,Low enrollment and inability to achieve statistical significance
NCT04353947,WITHDRAWN,OBSERVATIONAL,COVID 19
NCT04354025,WITHDRAWN,INTERVENTIONAL,Principal investigator decided not to move forward with the study.
NCT04354103,TERMINATED,INTERVENTIONAL,experimental treatment (Atomoxetine) not available
NCT04354389,WITHDRAWN,INTERVENTIONAL,No COVID-19 in EU countries - Sponsor withdraw in regulatory stage
NCT04354428,TERMINATED,INTERVENTIONAL,Low number of events contributing to primary outcome
NCT04354441,WITHDRAWN,INTERVENTIONAL,Not started
NCT04354597,WITHDRAWN,INTERVENTIONAL,New data not in favor of prophylaxis using this regimen
NCT04354714,WITHDRAWN,INTERVENTIONAL,Could not make FDA required changes
NCT04354727,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04355039,WITHDRAWN,INTERVENTIONAL,Terminated for lack of funding.
NCT04355169,TERMINATED,INTERVENTIONAL,This study was terminated before the planned sample size was enrolled due to very slow enrollment.
NCT04355364,TERMINATED,INTERVENTIONAL,No signal of benefit of treatment.
NCT04355676,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04356352,TERMINATED,INTERVENTIONAL,feasibility of enrollment
NCT04356404,TERMINATED,OBSERVATIONAL,No suitable case identified
NCT04356456,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT04356677,WITHDRAWN,INTERVENTIONAL,"Due to pandemic status changing in Canada prior to investigative sites being initiated for participation, and that concurrent participant recruitment in the global study BHC-RIB-5401-GL will achieve target enrollment across all countries."
NCT04356690,TERMINATED,INTERVENTIONAL,"Slow accrual, change in COVID prevalence, availability of effective vaccine"
NCT04357028,SUSPENDED,INTERVENTIONAL,Failure of subject recruitment
NCT04357197,WITHDRAWN,INTERVENTIONAL,We did not want to start a case series as we already finished a RCT...SO this study is now outdated
NCT04357353,TERMINATED,INTERVENTIONAL,low enrollment
NCT04357405,TERMINATED,OBSERVATIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
NCT04357496,WITHDRAWN,OBSERVATIONAL,study has never been started and was decided to be cancelled.
NCT04357704,WITHDRAWN,INTERVENTIONAL,Delay in setting up the study.
NCT04357717,TERMINATED,OBSERVATIONAL,project reprioritization
NCT04357951,WITHDRAWN,INTERVENTIONAL,Low enrollment
NCT04358042,TERMINATED,OBSERVATIONAL,Impossibility of recruitment because Covid service not renewed.
NCT04358068,TERMINATED,INTERVENTIONAL,Slow enrollment and lack of community enthusiasm
NCT04358458,TERMINATED,INTERVENTIONAL,"Due to strategic evaluation of GEN3009 within context of Genmab's portfolio, decision not based on any safety or regulatory concerns."
NCT04358471,WITHDRAWN,INTERVENTIONAL,The AAVCAGsCD59 asset has been transferred to Janssen Research and Development LLC
NCT04358835,WITHDRAWN,INTERVENTIONAL,"Study did not begin enrollment, multiple competing studies at same institution"
NCT04359017,WITHDRAWN,INTERVENTIONAL,Sponsoring staff have left institution
NCT04359329,TERMINATED,INTERVENTIONAL,Poor accrual
NCT04359459,WITHDRAWN,OBSERVATIONAL,COVID-19 pandemie ended
NCT04359511,WITHDRAWN,INTERVENTIONAL,COMPETITOR TEST (RECOVERY)
NCT04359862,TERMINATED,INTERVENTIONAL,Low recruitment ratio
NCT04359953,TERMINATED,INTERVENTIONAL,difficulty in recruiting
NCT04360096,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04360135,WITHDRAWN,INTERVENTIONAL,"The study was closed on 3/8/2021 as per final progress report issued by the IRB on 3/12/2021. No subjects were enrolled in the study following approval. Status changed to ""Withdrawn (No Participants Enrolled)"" accordingly."
NCT04360421,TERMINATED,INTERVENTIONAL,PI left institution
NCT04360512,TERMINATED,INTERVENTIONAL,Suspended due to the covid-19 pandemic.
NCT04360551,TERMINATED,INTERVENTIONAL,Decrease in COVID-19 cases locally
NCT04360759,WITHDRAWN,INTERVENTIONAL,Equipoise for hydroxychloquine was lost
NCT04360772,WITHDRAWN,OBSERVATIONAL,project cancelled
NCT04360876,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT04360967,WITHDRAWN,INTERVENTIONAL,Sponsor decision stopped in June 2017
NCT04361058,WITHDRAWN,INTERVENTIONAL,The single site that was deemed appropriate for this study was unable to enroll patients. Closed due to slow accrual.
NCT04361214,TERMINATED,INTERVENTIONAL,Terminated by PI
NCT04361253,TERMINATED,INTERVENTIONAL,Futility
NCT04361266,WITHDRAWN,INTERVENTIONAL,withdrawn
NCT04361344,TERMINATED,INTERVENTIONAL,objective of the study demonstrated by other research teams
NCT04361448,TERMINATED,INTERVENTIONAL,Insufficient sample number
NCT04361461,WITHDRAWN,INTERVENTIONAL,This study was canceled before enrollment due to a decision by the Sponsor
NCT04361552,WITHDRAWN,INTERVENTIONAL,Study abandoned due to drug billing issues
NCT04361656,WITHDRAWN,OBSERVATIONAL,Endoscopy services were suspended in March 2019 due to COVID-19 pandemic. Study was not restarted.
NCT04361669,WITHDRAWN,OBSERVATIONAL,Change in study personnel and sponsor.
NCT04361838,TERMINATED,INTERVENTIONAL,"Due to the low enrollment, this study is closed. Analysis of data is not performed."
NCT04361851,WITHDRAWN,INTERVENTIONAL,Low enrollment due to competing studies
NCT04361916,TERMINATED,INTERVENTIONAL,interrupted early due to the drastic reduction in the number of cases
NCT04362124,WITHDRAWN,INTERVENTIONAL,Study was stopped because Principal Investigator did not obtain sponsorship to carry it out
NCT04362189,TERMINATED,INTERVENTIONAL,No need to continue with the availability of the COVID-19 VACCINE
NCT04362254,TERMINATED,INTERVENTIONAL,BI's decision to terminate the development of spesolimab in fistulising and fibrostenotic Crohn's disease.
NCT04362293,SUSPENDED,INTERVENTIONAL,"We are holding enrollment, due to some recent SAEs."
NCT04362332,TERMINATED,INTERVENTIONAL,"Currently, almost no patients admitted to Dutch hospitals. If any effect of HCQ is to be expected we need more than 1000 inclusions"
NCT04363112,TERMINATED,INTERVENTIONAL,Recruitement difficulties
NCT04363203,SUSPENDED,INTERVENTIONAL,concerns related to study drug
NCT04363294,WITHDRAWN,INTERVENTIONAL,"grant was not approved, no subjects enrolled"
NCT04363372,WITHDRAWN,INTERVENTIONAL,Recruitment Issues
NCT04363385,TERMINATED,INTERVENTIONAL,No more inclusion
NCT04363437,TERMINATED,INTERVENTIONAL,"Stopped due to widespread corticosteroid use in 2020 for COVID infection, which confounds and likely supercedes the effect of colchicine."
NCT04363580,TERMINATED,OBSERVATIONAL,Inconclusive results
NCT04363840,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04363866,WITHDRAWN,INTERVENTIONAL,discontinued in favor of more promising directions that may benefit patients
NCT04364009,TERMINATED,INTERVENTIONAL,Efficiency and safety reasons
NCT04364308,SUSPENDED,OBSERVATIONAL,No found.
NCT04364633,TERMINATED,OBSERVATIONAL,"Premature termination of the study because it was dependent on the Remicrush study which ended more quickly, not allowing the inclusion of the expected number of patients."
NCT04364763,TERMINATED,INTERVENTIONAL,Enrollment feasibility
NCT04364815,WITHDRAWN,INTERVENTIONAL,Investigators opted to change the design of the study.
NCT04365231,WITHDRAWN,INTERVENTIONAL,no authorization obtained
NCT04365257,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04365400,TERMINATED,INTERVENTIONAL,Trial prematurely terminated on 03 May 2022 due to the results from an interim analysis indicating a lack of efficacy in the study population.
NCT04365478,TERMINATED,INTERVENTIONAL,The study was suspended due to difficulties in recalling participants to follow up due to restrictions related to the COVID-19 pandemic
NCT04365582,WITHDRAWN,INTERVENTIONAL,The PI decided.
NCT04365660,TERMINATED,INTERVENTIONAL,lack of accrual with no intent of continuing
NCT04365673,TERMINATED,OBSERVATIONAL,Terminated: Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Lack of data to demonstrate sufficient power.
NCT04365985,TERMINATED,INTERVENTIONAL,"Because of the decrease in COVID cases, enrollment is extremely low. Given the current study design, it is not possible to gather data necessary to answer the question about whether study treatment reduces mortality"
NCT04366232,TERMINATED,INTERVENTIONAL,investigator decision
NCT04366271,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04366310,TERMINATED,OBSERVATIONAL,Insufficient enrollment to achieve outcomes
NCT04366336,WITHDRAWN,INTERVENTIONAL,Several SubInvestigators have left Institution
NCT04366791,TERMINATED,INTERVENTIONAL,PI does not plan on putting any new patients on study. All patients completed this trial.
NCT04367116,TERMINATED,INTERVENTIONAL,"Our study hasn't been funded so far, but we will continue this study in the future."
NCT04367168,TERMINATED,INTERVENTIONAL,The intervention was not effective for the outcomes
NCT04367467,TERMINATED,OBSERVATIONAL,"Due to constraints of COVID19, we were unable to recruit on-site for this study."
NCT04367623,TERMINATED,INTERVENTIONAL,"Delays in approval process, COVID restrictions, staffing shortages"
NCT04367636,TERMINATED,INTERVENTIONAL,Due to technical difficulties with the online intervention
NCT04368000,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of adherence to the protocol in the intervention arm.
NCT04368130,WITHDRAWN,INTERVENTIONAL,The anomaly detection system is still under development and is not ready to test.
NCT04368364,TERMINATED,INTERVENTIONAL,Study was stopped early due to a conflicting study in the same patient population at the study location.
NCT04368676,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT04368702,SUSPENDED,INTERVENTIONAL,MR-Linac temporarily moved off-line
NCT04368897,WITHDRAWN,OBSERVATIONAL,Not able to recruit subjects
NCT04368910,TERMINATED,INTERVENTIONAL,Due to slow recruitment the study was terminated prematurely by the Sponsor after 30 subjects had been included
NCT04369001,WITHDRAWN,INTERVENTIONAL,"Due to covid-19 and social distancing, this study was terminated."
NCT04369157,WITHDRAWN,OBSERVATIONAL,"As a result of Covid-19, this study did not proceed."
NCT04369274,WITHDRAWN,INTERVENTIONAL,The epidemic of Covid pneumonia requiring large scale mechanical ventilation has abated and the need to explore alternate ventilatory devices has resolved.
NCT04369469,TERMINATED,INTERVENTIONAL,Met futility bar at interim analysis
NCT04369547,WITHDRAWN,INTERVENTIONAL,Resource limitations
NCT04369638,TERMINATED,INTERVENTIONAL,PI left institution
NCT04369677,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT04369742,TERMINATED,INTERVENTIONAL,Investigator decision
NCT04369989,TERMINATED,OBSERVATIONAL,Review of data revealed poor correlation with hypothesis and data quality challenges.
NCT04370041,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04370236,TERMINATED,INTERVENTIONAL,Futility
NCT04370834,TERMINATED,INTERVENTIONAL,Other - Randomized data no longer support continuation
NCT04370938,WITHDRAWN,INTERVENTIONAL,No participants were enrolled and the study was never initiated.
NCT04371003,WITHDRAWN,OBSERVATIONAL,Study proposal was not accepted for funding and therefore not further explored at this stage.
NCT04371107,SUSPENDED,INTERVENTIONAL,ANSM notifications
NCT04371302,TERMINATED,OBSERVATIONAL,"Logistical problems, administrative issues"
NCT04371393,TERMINATED,INTERVENTIONAL,"At 3d interim analysis, randomization, but not follow-up, was halted by the DSMB due to low predictive probability of achieving postulated mortality benefit (pre-specified 42.5% relative mortality reduction) were the trial to complete randomization."
NCT04371406,WITHDRAWN,INTERVENTIONAL,Regulatory approvals have not been obtained
NCT04371432,SUSPENDED,OBSERVATIONAL,The protocol was put on hold because accrual slowed significantly.
NCT04371458,WITHDRAWN,INTERVENTIONAL,PI is not moving forward with study
NCT04371523,WITHDRAWN,INTERVENTIONAL,"Study was not initiated due to evidence becoming available that did not support the use of hydroxychloroquine in this population, with potential risk of added harm"
NCT04371640,WITHDRAWN,INTERVENTIONAL,Study population not regularly admitted to hospital and approaches have shifted away from repurposing old drugs.
NCT04371666,TERMINATED,INTERVENTIONAL,Study did not meet its primary endpoint.
NCT04371926,WITHDRAWN,INTERVENTIONAL,Concerned about the adverse effects of HCQ
NCT04371952,WITHDRAWN,INTERVENTIONAL,"withdrawal due to the evolution of the epidemic, the arrival of vaccination and because the associated centres could no longer commit to the number of inclusions requested"
NCT04371978,TERMINATED,INTERVENTIONAL,End of COVID-19 outbreak in Israel
NCT04372017,TERMINATED,INTERVENTIONAL,Unlikelihood of benefit based on other studies.
NCT04372082,WITHDRAWN,INTERVENTIONAL,evidence showed chloroquine is not effective against COVID-19
NCT04372121,TERMINATED,INTERVENTIONAL,"This study is an extension of Study 18-OBE2109-002 that has been terminated due to enrolment challenges. Consequently, this study has also been terminated."
NCT04372641,WITHDRAWN,INTERVENTIONAL,Other - Clinical development of the agent has been discontinued
NCT04372706,TERMINATED,INTERVENTIONAL,"Sponsor terminated study during expansion on 11/30/22. RTX-240 was well-tolerated in multiple indications, combinations, and dose levels (69pts). No DLTs, related deaths or SAEs were reported. RTX-240 cleared circulation rapidly."
NCT04372927,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT04372940,WITHDRAWN,INTERVENTIONAL,due to COVID
NCT04372966,TERMINATED,INTERVENTIONAL,The Chief Investigator (John Keating)
NCT04372979,TERMINATED,INTERVENTIONAL,Reluctance of patients and physicians in this transfusion study setting. Blood products have expired. New variants have appeared since the plasma collection period. Some recent publications question the effectiveness of transfusion.
NCT04372992,TERMINATED,INTERVENTIONAL,Low accrual - no restart after pandemic suspension
NCT04373005,TERMINATED,OBSERVATIONAL,Participants were not testing positive for COVID-19 and were not returning onsite for visits.
NCT04373044,TERMINATED,INTERVENTIONAL,The study was terminated after the release of results of ACTT-2 (NCT04401579).
NCT04373083,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT04373252,WITHDRAWN,INTERVENTIONAL,Source of FMT preps is no longer able to provide us with necessary preps.
NCT04373603,WITHDRAWN,INTERVENTIONAL,"Study closed prior to opening to enrollment, due to funding availability for study"
NCT04373616,WITHDRAWN,INTERVENTIONAL,decision to proceed with an optimized study design and optimized vaccine formulation
NCT04373915,TERMINATED,INTERVENTIONAL,Low participation in intervention
NCT04374019,TERMINATED,INTERVENTIONAL,"slow accrual,"
NCT04374253,TERMINATED,INTERVENTIONAL,Decision to terminate development of Gantenerumab for treatment of prodromal/mild/early-stage Alzheimer's disease following results of a pre-planned analysis of the safety and efficacy of Gant in Graduate I\&II (WN29922/WN39658).
NCT04374279,WITHDRAWN,INTERVENTIONAL,Limited resources.
NCT04374435,TERMINATED,INTERVENTIONAL,The blistering device used for harvesting the third arm was discontinued by the manufacturer.
NCT04374474,WITHDRAWN,INTERVENTIONAL,Study withdrawn before any enrollment (site's research goals adjustments).
NCT04374539,TERMINATED,INTERVENTIONAL,inability to recruit more patients
NCT04374552,WITHDRAWN,INTERVENTIONAL,The investigators have decided not to go forward with this protocol
NCT04374708,TERMINATED,OBSERVATIONAL,"The funding agency, the NICHD, did not make a non-competing continuation award for the fifth and final year of the project and moved the grant into closeout."
NCT04374903,WITHDRAWN,INTERVENTIONAL,study could not be implemented at the site
NCT04374942,TERMINATED,INTERVENTIONAL,"Due to unproven issues associated with hydroxychloroquine use and safety, further complicated by media and political misinformation which in effect rendered all global studies on HCQ to stop enrolling participants."
NCT04375085,TERMINATED,INTERVENTIONAL,Enrollment was delayed and could not be completed as planned
NCT04375189,WITHDRAWN,INTERVENTIONAL,"Covid-19, funding"
NCT04375202,TERMINATED,INTERVENTIONAL,Insufficient rate of patient accrual and newly available scientific evidence
NCT04375462,WITHDRAWN,INTERVENTIONAL,PI left CCF
NCT04375514,TERMINATED,INTERVENTIONAL,Business decision
NCT04376112,WITHDRAWN,INTERVENTIONAL,withdrawn due to lack of enrollment secondary to COVID-19 and the pharmacy being sold to a non-LLU system
NCT04376424,WITHDRAWN,INTERVENTIONAL,"No data has been collected, no subjects enrolled"
NCT04376619,WITHDRAWN,INTERVENTIONAL,never was able to recruit
NCT04376736,WITHDRAWN,INTERVENTIONAL,Logistical difficulties
NCT04377087,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT04377165,TERMINATED,INTERVENTIONAL,"Engagement issues, poor recruitment to study"
NCT04377425,WITHDRAWN,OBSERVATIONAL,No acute neurological patients presented with concomitant COVID-19
NCT04377503,TERMINATED,INTERVENTIONAL,The number of critically ill patients wirh COVID-19 decrease abruptly
NCT04377516,WITHDRAWN,INTERVENTIONAL,Duplicated with another clinical trial registration.
NCT04377568,WITHDRAWN,INTERVENTIONAL,no enrollment
NCT04377620,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT04377659,TERMINATED,INTERVENTIONAL,"Based on two large, multicenter, randomized trials showed no benefit to tocilizumab in this setting and study has been closed."
NCT04377737,WITHDRAWN,INTERVENTIONAL,"Human Subjects Protection Review: submitted, denied"
NCT04377984,TERMINATED,OBSERVATIONAL,"Because of health context as well as the implementation of the RAAC caesarean section, which means that patients enter in the morning, and it is therefore no longer possible to do the QOR on D-1 and therefore to include scheduled caesarean sections"
NCT04378010,TERMINATED,INTERVENTIONAL,"Enanta Pharmaceuticals, Inc. made the strategic decision to discontinue the ARGON-2 study to prioritize combination treatment approaches. This decision was not based on safety concerns."
NCT04378062,TERMINATED,INTERVENTIONAL,inadequate enrollment
NCT04378244,WITHDRAWN,INTERVENTIONAL,Lack of Funding
NCT04378426,TERMINATED,INTERVENTIONAL,Use of VA hospital research space is indefinitely delayed due to prioritization of clinical cases delayed by COVID
NCT04379024,TERMINATED,INTERVENTIONAL,Study agent no longer available
NCT04379076,TERMINATED,INTERVENTIONAL,POOR ACCRUAL
NCT04379375,TERMINATED,INTERVENTIONAL,Slow enrollment rate
NCT04379492,WITHDRAWN,INTERVENTIONAL,Emerging evidence does not support the use of HCQ for treatment or prevention of SARS -CoV2 infection. No pts have been enrolled.
NCT04379518,SUSPENDED,INTERVENTIONAL,working on revision to protocol
NCT04379570,SUSPENDED,INTERVENTIONAL,Intervention supply interruption
NCT04379583,WITHDRAWN,OBSERVATIONAL,Study no longer required by sponsor
NCT04379830,WITHDRAWN,INTERVENTIONAL,"There were no patients recruited during the trial period. This was a result of: 1) COVID-19 pandemic; 2) MRIs were done prior to patients being seen in consultation, which made them ineligible for enrolment."
NCT04379882,WITHDRAWN,INTERVENTIONAL,Decision of alternative research to be performed
NCT04379947,WITHDRAWN,OBSERVATIONAL,research group's decision
NCT04380155,WITHDRAWN,INTERVENTIONAL,Due to COVID restrictions all human studies have been suspended and not expected to resume. The PI decided to terminate the study.
NCT04380545,SUSPENDED,INTERVENTIONAL,PI Request
NCT04381013,WITHDRAWN,INTERVENTIONAL,Different approach to be taken for the device.
NCT04381052,TERMINATED,INTERVENTIONAL,Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).
NCT04381065,WITHDRAWN,INTERVENTIONAL,Business decision
NCT04381169,TERMINATED,INTERVENTIONAL,Increased frequency of fluid overload on the aggressive fluid resuscitation arm of treatment
NCT04381182,TERMINATED,INTERVENTIONAL,Insufficient data/adherence
NCT04381325,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04381494,TERMINATED,INTERVENTIONAL,Study was not terminated for any safety concerns; it was stopped early due to inability to enroll patients in a timely manner and retain patients on study for the entire duration
NCT04381923,WITHDRAWN,INTERVENTIONAL,Unable to obtain IRB approval
NCT04381975,WITHDRAWN,INTERVENTIONAL,"Key collaborator, who would have delivered the intervention, moved abroad"
NCT04381988,TERMINATED,INTERVENTIONAL,The study was terminated based results of other studies and use of the new vaccine.
NCT04382612,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04382625,WITHDRAWN,INTERVENTIONAL,"Secondary to other study results, suspended for a scientific review"
NCT04382898,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04383509,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT04383691,TERMINATED,INTERVENTIONAL,Company's business decision
NCT04383756,WITHDRAWN,INTERVENTIONAL,Study was never started
NCT04383899,WITHDRAWN,OBSERVATIONAL,"Ibuprofen is not prescribed during coronavirus pandemic, so the study is stopped"
NCT04384328,TERMINATED,INTERVENTIONAL,rate of inclusions too low
NCT04384614,WITHDRAWN,OBSERVATIONAL,The sponsor decided to withdraw the study for funding reasons.
NCT04384679,WITHDRAWN,INTERVENTIONAL,"Due to reallocation of resources, this study could not be initiated."
NCT04384809,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04384900,WITHDRAWN,INTERVENTIONAL,Primary investigators
NCT04385264,SUSPENDED,INTERVENTIONAL,Sufficient number of subjects would probably not reach
NCT04385381,TERMINATED,INTERVENTIONAL,change of manufacterer of medical device
NCT04385433,TERMINATED,INTERVENTIONAL,Not enough patients enrolled
NCT04385524,WITHDRAWN,INTERVENTIONAL,We decided to close this study. We are unable to perform this study due to the current pandemic.
NCT04385771,SUSPENDED,INTERVENTIONAL,security concerns based on preliminary results from preceding CYCOV-I-study suggesting higer mortality in cytokine adsorption group
NCT04385862,WITHDRAWN,OBSERVATIONAL,Sponsor problem of delivering material
NCT04386239,WITHDRAWN,INTERVENTIONAL,Technical impasse from IRB
NCT04386252,WITHDRAWN,INTERVENTIONAL,"The FDA put our protocol on clinical hold and never gave an okay to start, so we decided not to proceed"
NCT04386278,TERMINATED,INTERVENTIONAL,Study stopped because slow enrolment.
NCT04386434,WITHDRAWN,INTERVENTIONAL,"Pandemic, researchers no longer have access to residents of assisted living."
NCT04386447,WITHDRAWN,INTERVENTIONAL,The study was not approved by the Italian Medicines Agency (AIFA).
NCT04386668,TERMINATED,INTERVENTIONAL,Interim analysis indicated adaptations to intervention may be required.
NCT04386811,TERMINATED,INTERVENTIONAL,"Following Yale University resuming in-person research activities, the investigators no longer had dedicated funding for the study and were unable to secure additional funding to meet the research goals."
NCT04386980,WITHDRAWN,INTERVENTIONAL,To be replaced by a different protocol
NCT04387071,TERMINATED,INTERVENTIONAL,Study drug no longer available
NCT04387240,WITHDRAWN,INTERVENTIONAL,did not get enough fund and IRB request
NCT04387448,TERMINATED,INTERVENTIONAL,Business reasons
NCT04388189,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04388202,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04388228,WITHDRAWN,INTERVENTIONAL,Study is not applicable anymore due to the Covid pandemic.
NCT04388683,TERMINATED,INTERVENTIONAL,Bellerophon requested study to be stopped.
NCT04388709,WITHDRAWN,INTERVENTIONAL,"Due to the number of competing trials at their site, the study team has closed enrollment and withdrawn this trial."
NCT04388722,WITHDRAWN,INTERVENTIONAL,Sponsor's decision to withdraw study.
NCT04388761,WITHDRAWN,INTERVENTIONAL,Challenges in recruiting participants.
NCT04389229,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04389359,WITHDRAWN,INTERVENTIONAL,Regulatory approvals not received
NCT04389450,TERMINATED,INTERVENTIONAL,"The decision to bring the Study to early clinical readout came in response to COVID-19's evolution as a disease, and the significant changes in the standard of care, leading to an increase in the severity of conditions of the intubated patients"
NCT04389840,TERMINATED,INTERVENTIONAL,Due to improvement in the Coronavirus Disease 2019 (COVID-19) pandemic and low subject accrual.
NCT04390113,TERMINATED,INTERVENTIONAL,Study discontinued as DSMB determined it was futile. No safety concerns were noted.
NCT04390191,TERMINATED,INTERVENTIONAL,Declining cases of COVID in New York due to vaccinations and new treatments for outpatient management
NCT04390217,WITHDRAWN,INTERVENTIONAL,Company focused on other clinical programs
NCT04390243,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04390503,TERMINATED,INTERVENTIONAL,Enrollment challenges
NCT04390542,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT04390867,TERMINATED,INTERVENTIONAL,"Business decision on June 2, 2022"
NCT04391192,WITHDRAWN,INTERVENTIONAL,Sponsor determined that it must be terminated
NCT04391309,TERMINATED,INTERVENTIONAL,Stopped to slow rate of enrollment
NCT04391673,WITHDRAWN,OBSERVATIONAL,Chief Investigator Moved Hospitals Before the Trial Began. Was discontinued.
NCT04391699,WITHDRAWN,INTERVENTIONAL,cancelled before initiation
NCT04391868,WITHDRAWN,INTERVENTIONAL,The project has been transferred to Viatris
NCT04391907,WITHDRAWN,INTERVENTIONAL,"Due to the covid 19, patient recruiment is not going smoothly, so the study was canceled."
NCT04392128,WITHDRAWN,INTERVENTIONAL,competent authority decision
NCT04392648,WITHDRAWN,INTERVENTIONAL,Business Decision (no enrollment)
NCT04392856,TERMINATED,INTERVENTIONAL,COVID-19 Pandemic
NCT04393038,TERMINATED,INTERVENTIONAL,Interim analysis concludes that the study is futile
NCT04393155,TERMINATED,OBSERVATIONAL,Grant application to fund this work was not funded. We won't be posting data for this study.
NCT04393311,WITHDRAWN,INTERVENTIONAL,Discontinuation of drug candidates
NCT04393454,TERMINATED,INTERVENTIONAL,Following discussion with the Cancer Center the PI elected to terminate the study. Completion dates reflect date of this decision
NCT04393597,WITHDRAWN,INTERVENTIONAL,We decided to discontinue this particular clinical study through internal discussion.
NCT04393727,TERMINATED,INTERVENTIONAL,Study was stopped because the Promoter was changed and a new study on convalescent plasma promoted by AIFA was started in Italy.
NCT04393779,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04393831,TERMINATED,INTERVENTIONAL,This study was terminated to facilitate accrual under NCT05155501
NCT04393948,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT04394104,TERMINATED,OBSERVATIONAL,Study has concluded.
NCT04394156,TERMINATED,INTERVENTIONAL,"Due to recruitment delays in the Covid-19 pandemic, alongside the need to submit the doctoral thesis this study was conducted for in a limited time frame, recruitment was halted prematurely (note that our recruitment aim was up to 13 participants)."
NCT04394182,SUSPENDED,INTERVENTIONAL,lack of recruitment
NCT04394286,TERMINATED,INTERVENTIONAL,Takeda has decided to not further develop the SHP648 (TAK-748) program. No subjects have been dosed with SHP648. The decision to terminate study SHP648-101 is not due to any safety concerns.
NCT04394832,TERMINATED,INTERVENTIONAL,Covid-19
NCT04394884,WITHDRAWN,OBSERVATIONAL,"Study never started, no subjects enrolled."
NCT04395027,WITHDRAWN,INTERVENTIONAL,Administratively closed with IRB
NCT04395092,WITHDRAWN,INTERVENTIONAL,The sponsor decided to withdraw this study
NCT04395105,TERMINATED,INTERVENTIONAL,Low rate of recruitment
NCT04395118,WITHDRAWN,INTERVENTIONAL,Study will not be conducted as a RCT due to limited project timeline.
NCT04395378,SUSPENDED,OBSERVATIONAL,COVID-19 policy of the University of Surrey
NCT04395586,WITHDRAWN,OBSERVATIONAL,Due to COVID-19 panemic
NCT04395638,SUSPENDED,INTERVENTIONAL,COVID-19 study status being reviewed on an ongoing basis.
NCT04395716,WITHDRAWN,INTERVENTIONAL,Not ever started
NCT04395807,TERMINATED,INTERVENTIONAL,"1. Few eligible patients at study start
2. Patients received HFNC prior to intermediate care ward admission
3. NIV was locally considered a step-up therapy to HFNC
4. Full-face masks replaced the Helmet interface as local NIV standard"
NCT04395950,WITHDRAWN,INTERVENTIONAL,Poor enrollment
NCT04395976,WITHDRAWN,INTERVENTIONAL,Ethical approval was denied
NCT04396106,TERMINATED,INTERVENTIONAL,Study closed out early due to evolving COVID-19 standard of care
NCT04396340,TERMINATED,INTERVENTIONAL,discontinued development program
NCT04396366,TERMINATED,INTERVENTIONAL,Strategic business decision
NCT04396470,WITHDRAWN,INTERVENTIONAL,No funding received
NCT04396535,TERMINATED,INTERVENTIONAL,EMD Serono recommendation based on three other studies that failed to show benefit for bintrafusp alfa
NCT04396626,TERMINATED,OBSERVATIONAL,"The study was prematurely discontinued due to significant data quality issues on August 26, 2021. There were no safety concerns that led to the decision to terminate."
NCT04396834,TERMINATED,INTERVENTIONAL,Medication removed from the U.S. market by the The Food and Drug Administration
NCT04396847,TERMINATED,INTERVENTIONAL,Medication removed from the U.S. market by the The Food and Drug Administration
NCT04397029,TERMINATED,INTERVENTIONAL,The benefit of completing the study was not worth exposing subjects to the risk during COVID. Delaying the return visits would make it difficult to analyze the changes in data overtime.
NCT04397042,SUSPENDED,OBSERVATIONAL,pandemic
NCT04397172,TERMINATED,OBSERVATIONAL,"Number of Covid-19 cases who need intensive care have greatly reduced, it is very difficult to find eligible patients for the study"
NCT04397185,SUSPENDED,INTERVENTIONAL,Enrollment temporarily paused while sponsor responds to questions from FDA.
NCT04397393,TERMINATED,OBSERVATIONAL,insufficient data
NCT04397458,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic and competing study that took precedence
NCT04397510,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04397692,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04398017,TERMINATED,INTERVENTIONAL,The early termination is due to an impossibility to include new candidates due to the degraded functioning of the service in connection with a chronic paramedical decrease in the number of caregivers trained in hypnosis.
NCT04398134,TERMINATED,INTERVENTIONAL,Study stopped due to a safety signal of drug-induced liver injury in subjects receiving 2158
NCT04398199,TERMINATED,INTERVENTIONAL,Low accruals
NCT04398290,WITHDRAWN,INTERVENTIONAL,IRB AND FDA REVIEWS DEFERRED
NCT04398316,TERMINATED,INTERVENTIONAL,Administrative
NCT04398368,TERMINATED,INTERVENTIONAL,Focus research efforts on other projects.
NCT04398420,TERMINATED,INTERVENTIONAL,Terminated due to low recruitment. FUP of enrolled patients will be performed until LPLV.
NCT04398667,TERMINATED,OBSERVATIONAL,The clinical research organization went out of business.
NCT04398927,WITHDRAWN,INTERVENTIONAL,no patient enrolled
NCT04398966,TERMINATED,INTERVENTIONAL,The principal investigator is leaving UNC and there is no other faculty to continue the research study.
NCT04399044,SUSPENDED,INTERVENTIONAL,per the Institutional Review Board
NCT04399239,TERMINATED,INTERVENTIONAL,"Company decision, not safety related."
NCT04399291,SUSPENDED,OBSERVATIONAL,"COVID-19, study status being reviewed on an ongoing basis."
NCT04399395,WITHDRAWN,INTERVENTIONAL,Covid-pandemic
NCT04399486,WITHDRAWN,INTERVENTIONAL,COVID-19 and prolonged pool closure
NCT04399694,SUSPENDED,OBSERVATIONAL,Temporarily suspended due to staffing issues
NCT04399733,WITHDRAWN,OBSERVATIONAL,Vaccine rollouts in UK
NCT04399824,WITHDRAWN,INTERVENTIONAL,Study did not open
NCT04399889,TERMINATED,INTERVENTIONAL,low accrual
NCT04400227,WITHDRAWN,INTERVENTIONAL,Study closed due to change in funding.
NCT04400799,TERMINATED,INTERVENTIONAL,due to results from interim analysis
NCT04400890,TERMINATED,INTERVENTIONAL,Feasibility
NCT04400903,TERMINATED,OBSERVATIONAL,Slow accrual
NCT04401410,TERMINATED,INTERVENTIONAL,"Due to trial's eligibility criteria and the low census of hospitalized COVID-19 patients meeting eligibility criteria, the Sponsor will be unable to enroll a meaningful number of patients in this single-center trial in a reasonable time frame."
NCT04401527,WITHDRAWN,INTERVENTIONAL,No recruitment
NCT04401553,WITHDRAWN,INTERVENTIONAL,The study never initiated.
NCT04401631,WITHDRAWN,OBSERVATIONAL,Sponsor financial has been stopped
NCT04401683,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic
NCT04401995,SUSPENDED,INTERVENTIONAL,"Evaluation in process, pending new trial with similar agents"
NCT04402008,TERMINATED,INTERVENTIONAL,"Business decision, not related to safety."
NCT04402385,TERMINATED,INTERVENTIONAL,Unable to recruit.
NCT04402515,WITHDRAWN,OBSERVATIONAL,not due to safety reasons
NCT04402580,TERMINATED,INTERVENTIONAL,due to unexpectedly high rate of relapse in the active comparator arm.
NCT04402593,WITHDRAWN,INTERVENTIONAL,Due to staffing changes and no potential subjects at this time.
NCT04402658,WITHDRAWN,INTERVENTIONAL,Problem with acquiring study medication and lack of resources.
NCT04402723,TERMINATED,INTERVENTIONAL,Corporate policy adjustments
NCT04402775,TERMINATED,INTERVENTIONAL,Due to a low inclusion rate
NCT04403035,WITHDRAWN,OBSERVATIONAL,Unable to get adequate resources to do the study
NCT04403282,TERMINATED,INTERVENTIONAL,Vaniqa no longer manufactured
NCT04403568,WITHDRAWN,INTERVENTIONAL,"No subjects were enrolled in this study, the PI will seek funding and revise the protocol for resubmisson at a later date"
NCT04403646,TERMINATED,INTERVENTIONAL,low rate of covid patients
NCT04403685,TERMINATED,INTERVENTIONAL,Safety
NCT04403737,WITHDRAWN,INTERVENTIONAL,Not started
NCT04403763,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04404140,TERMINATED,INTERVENTIONAL,"Despite many risk-minimization strategies, the combination of ipatasertib, atezolizumab and docetaxel was challenging due to multiple study treatment modifications required to manage toxicity, making further enrollment inappropriate."
NCT04404348,SUSPENDED,INTERVENTIONAL,Study halted due to Covid-19 precautions
NCT04404361,TERMINATED,INTERVENTIONAL,decision to close enrollment early
NCT04404452,TERMINATED,OBSERVATIONAL,Data not useful
NCT04404647,WITHDRAWN,INTERVENTIONAL,Low accrual rate
NCT04404712,TERMINATED,INTERVENTIONAL,Ligand was not effective.
NCT04404790,SUSPENDED,INTERVENTIONAL,Optimization of protocol
NCT04404998,TERMINATED,INTERVENTIONAL,Issues with recruitment due to COVID 19
NCT04405050,WITHDRAWN,INTERVENTIONAL,Project Never Initiated - no human subjects were enrolled and no data regarding humans was collected or studied.
NCT04405102,TERMINATED,INTERVENTIONAL,"Screening was stopped by the Sponsor (43/48 participants enrolled), given the very low number of eligible patients (high vaccination rate and occurrence of the Omicron variant). The last patient randomized performed his follow-up visit."
NCT04406064,WITHDRAWN,INTERVENTIONAL,The use of steroids to treat COVID prevents the use of VSTs for these patients. The Principal Investigator does not feel the study had an expectation of enrolling patients as the treatment options for COVID have evolved.
NCT04406207,WITHDRAWN,OBSERVATIONAL,COVID-19
NCT04406389,TERMINATED,INTERVENTIONAL,Low accrual
NCT04406532,WITHDRAWN,INTERVENTIONAL,The study was never started due to recruitment difficulties. The rates of COVID infections in the recruitment area declined significantly.
NCT04406610,WITHDRAWN,INTERVENTIONAL,Project terminated due to revision of local regulations
NCT04406740,TERMINATED,OBSERVATIONAL,Device malfunction
NCT04406766,TERMINATED,INTERVENTIONAL,"Context of the COVID-19 pandemic, strict eligibility criteria (especially 15 km radius from the CHUGA) significantly reducing the active file and the recruitment capacities."
NCT04406857,TERMINATED,INTERVENTIONAL,Inadequate accrual rate
NCT04407390,WITHDRAWN,INTERVENTIONAL,No volunteers where recruited to this study. Other studies were prioritised over this at the time of enrollment.
NCT04407442,TERMINATED,INTERVENTIONAL,Slow enrollment and change in sponsor direction
NCT04407546,TERMINATED,OBSERVATIONAL,enrollment
NCT04407689,TERMINATED,INTERVENTIONAL,poor accrual
NCT04408040,TERMINATED,INTERVENTIONAL,New information regarding use of plasma in covid + patients
NCT04408066,SUSPENDED,INTERVENTIONAL,Number of required participants met
NCT04408131,WITHDRAWN,INTERVENTIONAL,study not started
NCT04408183,TERMINATED,INTERVENTIONAL,No longer enrolling
NCT04408352,SUSPENDED,INTERVENTIONAL,"for business planning purposes only, and is not related to any safety or performance issues identified during the study"
NCT04408391,WITHDRAWN,OBSERVATIONAL,No Inclusion potentiel
NCT04408443,TERMINATED,INTERVENTIONAL,No enrollment due COVID PANDEMIA
NCT04408599,TERMINATED,INTERVENTIONAL,"Upon completion of the Phase 1 portion of the NC410 monotherapy trial, NextCure focused efforts on a combination trial of NC410 in solid tumors."
NCT04408664,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT04408677,TERMINATED,INTERVENTIONAL,"Investigator and Sponsor expectations for the study not aligned, along with time conflicts for study completion. Discontinuation of the study is not related to the safety and/or effectiveness of the device."
NCT04408846,WITHDRAWN,INTERVENTIONAL,The Study will be conducted in another research center. The Sponsor has changed.
NCT04408872,WITHDRAWN,INTERVENTIONAL,Study was not approved by the institution's scientific committee.
NCT04408898,WITHDRAWN,INTERVENTIONAL,Challenges with recruitment
NCT04409145,TERMINATED,INTERVENTIONAL,Part 1 complete; Part 2 will not be completed.
NCT04409184,WITHDRAWN,OBSERVATIONAL,Study was not opened.
NCT04409223,TERMINATED,INTERVENTIONAL,R\&D strategy adjustment
NCT04409288,TERMINATED,INTERVENTIONAL,Endpoint reached
NCT04409327,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT04409483,WITHDRAWN,INTERVENTIONAL,Epidemic dynamics
NCT04409808,TERMINATED,INTERVENTIONAL,because a device deficiency that occured in the Iris vitrectomy system (Alfa version)
NCT04409873,TERMINATED,INTERVENTIONAL,"The funder decided not to continue funding, causing enrollment to cease prematurely and curtailing originally planned analyses. Participants with any samples collected after the baseline pre-rinse samples were included in the analysis."
NCT04409886,TERMINATED,INTERVENTIONAL,"This study is part of a larger national study. Only 1 patient was enrolled at Maimonides; Medical Center. The study was ended by the sponsor because the PI left; funding ended; , and no time, or personnel to do the study"
NCT04410042,TERMINATED,INTERVENTIONAL,Per sponsor
NCT04410354,TERMINATED,INTERVENTIONAL,Failure to meet primary endpoint
NCT04410445,TERMINATED,INTERVENTIONAL,(Sponsor decision)
NCT04410523,TERMINATED,INTERVENTIONAL,Sponsor Desicion
NCT04410627,WITHDRAWN,INTERVENTIONAL,Covid/PI Vacancy
NCT04410874,TERMINATED,INTERVENTIONAL,Inability to recruit patients/lack of funding
NCT04411082,TERMINATED,INTERVENTIONAL,"IMR-BTL-201demonstrated that while IMR-687 was generally well-tolerated, it failed to show any meaningful benefit in transfusion burden or improvement in most disease-related biomarkers. So, the sponsor has decided to discontinue this study"
NCT04411134,WITHDRAWN,INTERVENTIONAL,Closed based on the lack of perceived clinical activity observed from a different study treating a similar patient population with same study agent.
NCT04411316,WITHDRAWN,INTERVENTIONAL,Zero Patients met criteria
NCT04411472,TERMINATED,INTERVENTIONAL,The Data Monitoring Committee (DMC) concluded that the pre-specified futility threshold was met and that there was no safety concern.
NCT04411602,WITHDRAWN,INTERVENTIONAL,No participants due to waning pandemic.
NCT04412252,WITHDRAWN,INTERVENTIONAL,"Due to the pursuit of other SARS-CoV-2-related research including alternative trials with tofacitinib, this trial was canceled prior to subject enrollment."
NCT04412460,WITHDRAWN,OBSERVATIONAL,Not feasible.
NCT04412707,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study following an FDA request of a partial clinical hold.
NCT04412837,WITHDRAWN,INTERVENTIONAL,Inadequate funding
NCT04412876,WITHDRAWN,INTERVENTIONAL,Failed to pass the Ministry of Science and Technology.
NCT04413253,TERMINATED,INTERVENTIONAL,Unable to recruit
NCT04413487,WITHDRAWN,OBSERVATIONAL,Study never started due to change in standard of care guideline
NCT04413604,TERMINATED,INTERVENTIONAL,Due to recruitment difficulties
NCT04413877,WITHDRAWN,OBSERVATIONAL,Lack of funding to iniciate and conduct the registered study
NCT04414319,TERMINATED,OBSERVATIONAL,Lack of time to realize the research
NCT04414631,TERMINATED,INTERVENTIONAL,Aim to enroll 120 patients deemed not sufficient to show a difference in the primary outcome measure. Standard of care treatment recently changed in Switzerland adding further heterogeneity to trial population when including future participants.
NCT04414657,TERMINATED,OBSERVATIONAL,sufficient patient number reached; flattening out of pandemic in Switzerland
NCT04414904,WITHDRAWN,OBSERVATIONAL,Unable to obtain approval
NCT04415073,TERMINATED,INTERVENTIONAL,"Given enrollment challenges, partly attributable to the constantly changing COVID-19 treatment landscape, the trial has been closed."
NCT04415151,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment reflecting the decrease in number of COVID infections. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.
NCT04415268,WITHDRAWN,INTERVENTIONAL,we did not receive expected funding
NCT04415281,TERMINATED,INTERVENTIONAL,Funding not secured
NCT04415307,WITHDRAWN,INTERVENTIONAL,principal investigator leave the organization
NCT04415463,TERMINATED,INTERVENTIONAL,Safety concerns
NCT04415476,WITHDRAWN,INTERVENTIONAL,Study did not proceed to IRB approval.
NCT04415541,WITHDRAWN,INTERVENTIONAL,COVID
NCT04416048,TERMINATED,INTERVENTIONAL,Due to lower COVID-19 cases and therefore difficulties with the recruitment.
NCT04416399,TERMINATED,INTERVENTIONAL,Independent statistical review advice
NCT04416893,WITHDRAWN,OBSERVATIONAL,"With the rapid evolution of COVID-19, the objective was no longer relevant"
NCT04416932,SUSPENDED,OBSERVATIONAL,data analyzation
NCT04417036,TERMINATED,INTERVENTIONAL,"Terminated (based on Part A results, Bayer decided to not continue investigating BAY 1097761 further in Part B; this was not due to any safety data for BAY 1097761)"
NCT04417114,WITHDRAWN,INTERVENTIONAL,The study was not funded.
NCT04417231,TERMINATED,INTERVENTIONAL,sufficient recruitment of study patients based on the existing (and repeatedly adjusted) inclusion and exclusion criteria is not possible within a reasonable period of time
NCT04417309,WITHDRAWN,INTERVENTIONAL,COVID-19 prevented recruitment/enrollment of participants.
NCT04417816,TERMINATED,INTERVENTIONAL,At the request of the Ethical Committee
NCT04418024,WITHDRAWN,INTERVENTIONAL,"After a careful review of the currently available treatments worldwide for patients with ATTR-polyneuropathy, Eidos has made the decision to halt the current study design."
NCT04418167,SUSPENDED,INTERVENTIONAL,Sponsor decision
NCT04418193,WITHDRAWN,OBSERVATIONAL,treatments are no longer proposed to this type of patients
NCT04418219,WITHDRAWN,INTERVENTIONAL,Funding Discontinued
NCT04418297,TERMINATED,INTERVENTIONAL,The termination criteria of the protocol was met during dose escalation
NCT04418531,WITHDRAWN,INTERVENTIONAL,Organizative problems
NCT04418752,WITHDRAWN,INTERVENTIONAL,The study is no longer feasible due to the restrictions placed on access to potential participants during the COVID-19 pandemic.
NCT04418895,WITHDRAWN,INTERVENTIONAL,lack of resources
NCT04418934,WITHDRAWN,INTERVENTIONAL,Grant application for study was rejected
NCT04419181,SUSPENDED,INTERVENTIONAL,Change in the landscape of current treatment of early stage breast cancer. Larger clinical trials answering similar questions are expected to result in the next few years.
NCT04419389,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04419415,TERMINATED,INTERVENTIONAL,covid-19 lock down
NCT04419428,WITHDRAWN,OBSERVATIONAL,Philips placed the study on hold in August 2022 due to the awareness of a potential device functionality issue. Philips has shifted business priorities and has decided to cancel the trial.
NCT04419558,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04419688,TERMINATED,INTERVENTIONAL,recruitment failure
NCT04419792,SUSPENDED,OBSERVATIONAL,Recruitment for study has been suspended due to Covid-19.
NCT04420052,WITHDRAWN,INTERVENTIONAL,"COVID, death of investigator"
NCT04420130,WITHDRAWN,INTERVENTIONAL,Failed to pass ethics committee review
NCT04420299,TERMINATED,INTERVENTIONAL,Lack of funding of the non-commercial sponsor to extend recruitment and reach the target number of patients specified in the protocol.
NCT04420364,WITHDRAWN,INTERVENTIONAL,Decline in COVID cases
NCT04420455,TERMINATED,INTERVENTIONAL,A limited number of inclusions due to the Covid-pandemic
NCT04420585,TERMINATED,INTERVENTIONAL,Study was not able to meet recruitment after 9 years of trying to enroll patients on different versions of the protocol and changing recruitment strategies.
NCT04420624,TERMINATED,INTERVENTIONAL,Inclusion period completed
NCT04420845,WITHDRAWN,INTERVENTIONAL,The study was significantly delayed due to the COVID-19 pandemic. The PI has chosen not to conduct the study.
NCT04421196,WITHDRAWN,INTERVENTIONAL,Currently does not have active IRB status.
NCT04421209,WITHDRAWN,INTERVENTIONAL,No funding source
NCT04421378,TERMINATED,INTERVENTIONAL,"Upon further consideration of the existing data and the competitive landscape, Karyopharm Therapeutics Inc has decided not to pursue the ongoing development of Selinexor in GBM at this time."
NCT04421417,SUSPENDED,INTERVENTIONAL,Study was stopped due to COVID-19 related issues. Collected data could be present as pilot trial.
NCT04421456,TERMINATED,INTERVENTIONAL,This study was terminated based on a business decision by the Sponsor.
NCT04421508,TERMINATED,INTERVENTIONAL,Futility
NCT04421664,TERMINATED,INTERVENTIONAL,Request of Health Canada after publication of https://doi.org/10.7326/M20-4207
NCT04422210,TERMINATED,INTERVENTIONAL,Decision to discontinue the study based on broader development and strategic prioritisation. The Sponsor concludes there is no benefit-risk impact on the GO41864 study.
NCT04422275,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT04422392,TERMINATED,INTERVENTIONAL,"since the CheckMate816 study is published in NEJM, enrolling patients becomes difficult"
NCT04422626,WITHDRAWN,OBSERVATIONAL,The human resources required to start enrollment were not available anymore.
NCT04422639,TERMINATED,INTERVENTIONAL,Following the EAB for NCI Designation this study was identified as having no funding and not meeting enrollment goals. It was requested by the EAB that this study be closed due to inactivity.
NCT04422691,TERMINATED,OBSERVATIONAL,lack of Covid-19 patients
NCT04422743,TERMINATED,INTERVENTIONAL,due to covid 19 pandemy
NCT04422795,WITHDRAWN,INTERVENTIONAL,"Due to reallocation of resources, this study could not be initiated"
NCT04422886,TERMINATED,INTERVENTIONAL,Low eligibility rate indicated that the study was not feasible
NCT04422951,TERMINATED,INTERVENTIONAL,Delays and complications due to the Covid pandemic
NCT04423367,TERMINATED,INTERVENTIONAL,Did not meet the anticipated outcome.
NCT04423471,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT04423588,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT04423614,WITHDRAWN,INTERVENTIONAL,Study staff were busy with other projects and unable to devote time to this study
NCT04423757,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT04423822,TERMINATED,OBSERVATIONAL,failure to recruit
NCT04423848,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume due to poor accrual.
NCT04423913,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT04423952,WITHDRAWN,OBSERVATIONAL,The study never started
NCT04424537,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of funding
NCT04424641,TERMINATED,INTERVENTIONAL,Study was terminated due to MTD was reached
NCT04424901,TERMINATED,INTERVENTIONAL,reduction of Hospitalized COVID patients at UConnHealth
NCT04424914,TERMINATED,INTERVENTIONAL,Sponsor terminated study early to not prolong timelines and to enable sharing of data collected which has potential to better support understanding of the prevalence of ATTR-CM in patients with HFpEF. Decision was not based on any safety findings.
NCT04424966,TERMINATED,INTERVENTIONAL,Study drug no longer available.
NCT04425629,TERMINATED,INTERVENTIONAL,Emerging SARS-CoV-2 variants impacting susceptibility to study drug
NCT04425655,TERMINATED,INTERVENTIONAL,Original investigator for the trial has left
NCT04425733,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT04426201,TERMINATED,INTERVENTIONAL,POOR ACCRUAL
NCT04426279,TERMINATED,OBSERVATIONAL,"Number of patients not reached during the inclusion period, end of funding."
NCT04426344,WITHDRAWN,INTERVENTIONAL,Internal decision
NCT04426357,TERMINATED,INTERVENTIONAL,company decision
NCT04427228,WITHDRAWN,INTERVENTIONAL,unable to enroll
NCT04427254,TERMINATED,INTERVENTIONAL,enrollment number not reached
NCT04427306,SUSPENDED,INTERVENTIONAL,low enrollment
NCT04427345,WITHDRAWN,OBSERVATIONAL,This study has been included in another trial within the same Sponsor
NCT04427397,TERMINATED,INTERVENTIONAL,"Study team has determined that given time and resource restraints, study is to be closed"
NCT04427540,WITHDRAWN,INTERVENTIONAL,Study was not initiated; no subjects were consented or enrolled
NCT04427774,TERMINATED,INTERVENTIONAL,"Policy change, not for security reasons"
NCT04427995,TERMINATED,OBSERVATIONAL,product expired and could not be resupplied
NCT04428047,TERMINATED,INTERVENTIONAL,Sponsor decision following information on cases of hyperprogression and early toxicities with bintrafusp alfa in other studies
NCT04428060,TERMINATED,INTERVENTIONAL,The trial prematurely terminated as a result of the COVID-19 pandemic.
NCT04428242,WITHDRAWN,OBSERVATIONAL,COVD-19
NCT04428268,WITHDRAWN,INTERVENTIONAL,evidence showed chloroquine is not effective against COVID-19
NCT04428333,TERMINATED,INTERVENTIONAL,The trial was stopped by the sponsor based on assessment of the clinical data
NCT04428437,TERMINATED,OBSERVATIONAL,The sponsor withdrawed the sponsorship to the study.
NCT04428567,TERMINATED,INTERVENTIONAL,"Due to COVID 19, the recruitment was halted."
NCT04428762,WITHDRAWN,INTERVENTIONAL,we decided to change the protocol completely to an RCT.
NCT04428775,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04428918,WITHDRAWN,OBSERVATIONAL,The study was closed due to investigator discretion based on the lack of ability to recruit patients and research goals of the program.
NCT04428931,WITHDRAWN,OBSERVATIONAL,The pandemic caused a delay in starting the study; PI is leaving.
NCT04429204,WITHDRAWN,INTERVENTIONAL,The study was not opened
NCT04429464,WITHDRAWN,INTERVENTIONAL,Due to restrictions related to COVID the sponsor has decided not to move forward with this study
NCT04429685,TERMINATED,INTERVENTIONAL,The focus of the laboratory went a different direction given extramural funding
NCT04429880,WITHDRAWN,INTERVENTIONAL,Study was not initiated; no subjects enrolled. A replacement study will be submitted
NCT04430036,TERMINATED,INTERVENTIONAL,PI left the institution
NCT04430140,WITHDRAWN,OBSERVATIONAL,Alternative study opened with ENT services.
NCT04430283,TERMINATED,INTERVENTIONAL,"The study was terminated because of difficulty identifying patients that met the inclusion criteria, as well as logistical difficulties in opening clinical ICU study sites."
NCT04430348,TERMINATED,INTERVENTIONAL,Absence of immunological response
NCT04430387,WITHDRAWN,INTERVENTIONAL,"The study initially aimed to measure droplets; however, as more was learned about COVID transmission, it became apparent that aerosol should be measured, but the method to measure aerosol was not possible for this study, so the study was withdrawn."
NCT04430907,WITHDRAWN,OBSERVATIONAL,Revising protocol.
NCT04430933,WITHDRAWN,INTERVENTIONAL,"Upon reviewing current available combo studies, the sponsor decided to prioritize different combo study."
NCT04430959,WITHDRAWN,INTERVENTIONAL,"The reason the study was withdrawn was due to lack of funds. In addition, the PI is moving to a different institution and it would not be feasible to proceed with the study under these circumstances."
NCT04430985,WITHDRAWN,INTERVENTIONAL,Problems identifying eligble patients
NCT04431193,WITHDRAWN,INTERVENTIONAL,Study will be replaced by a revised study protocol
NCT04431466,TERMINATED,INTERVENTIONAL,"Preliminary data from a pilot study suggest that the administration of ivermectin in patients with SARS-CoV-2 is safe, reducing symptoms and viral load. The antiviral effects of ivermectin appear to depend on the dose administered."
NCT04431544,TERMINATED,OBSERVATIONAL,Sponsor no longer performing clinical studies. Will only be a manufacturer
NCT04431622,WITHDRAWN,INTERVENTIONAL,This study did not receive funding
NCT04431661,TERMINATED,OBSERVATIONAL,Low patient recruitment rate and change of hopsital procedures for handling cardiac arrest patients during emergency
NCT04432103,TERMINATED,INTERVENTIONAL,There is new evidence that the Convalescent plasma is not useful for severe and critical COVID-19 Pneumonia
NCT04432272,TERMINATED,INTERVENTIONAL,"The EUA for CCP was updated by FDA, stipulating that only high titer units be used. This study required untitered units. The study became infeasible"
NCT04432298,TERMINATED,INTERVENTIONAL,The study was terminated by Sponsor due to low enrollment.
NCT04432337,WITHDRAWN,INTERVENTIONAL,Departure of the principal investigator
NCT04432350,WITHDRAWN,OBSERVATIONAL,Limitations with data.
NCT04432415,SUSPENDED,INTERVENTIONAL,Coronavirus Pandemic
NCT04432610,WITHDRAWN,INTERVENTIONAL,COVID pandemic
NCT04432766,WITHDRAWN,INTERVENTIONAL,strategic decision
NCT04432805,TERMINATED,INTERVENTIONAL,recruitment issues
NCT04433013,WITHDRAWN,INTERVENTIONAL,"Unable to find suitable site Principal Investigator. This study did not start and was withdrawn as of Aug 2020 (have updated as of Sept 2020, please proceed to update the status of study withdrawal accordingly)"
NCT04433078,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT04433507,TERMINATED,INTERVENTIONAL,Recruitment issues
NCT04433546,TERMINATED,INTERVENTIONAL,Company no longer pursing indication
NCT04433988,WITHDRAWN,INTERVENTIONAL,Institutional problems
NCT04434001,TERMINATED,INTERVENTIONAL,The study encountered unexpected difficulties in enrolling patients due to requirements for the Informed Consent. 60% of our patients comes from abroad with only one accompanying parent. The rules of our EC require both parents to sign the consent.
NCT04434118,WITHDRAWN,OBSERVATIONAL,Institutional Issue
NCT04434209,TERMINATED,INTERVENTIONAL,Highly improbable to reach recruitment objective due to impact of COVID-19 pandemic
NCT04434222,TERMINATED,INTERVENTIONAL,not enough study participants and missing compliance to perform analysis
NCT04434378,TERMINATED,INTERVENTIONAL,Significant difference not reached on interim analysis
NCT04434560,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT04434599,WITHDRAWN,INTERVENTIONAL,Funding
NCT04434872,TERMINATED,INTERVENTIONAL,Lack of budget
NCT04435015,WITHDRAWN,INTERVENTIONAL,No funding
NCT04435314,WITHDRAWN,INTERVENTIONAL,Sponsor's strategic decision
NCT04435457,TERMINATED,OBSERVATIONAL,COVID-19 natural history has changed and no further patients meet eligibility as hospitalizations are at a minimum.
NCT04435717,TERMINATED,INTERVENTIONAL,Futility
NCT04435782,TERMINATED,INTERVENTIONAL,The Sponsor decided to prematurely terminate the study due to the lower-than-expected recruitment rate.
NCT04435795,TERMINATED,INTERVENTIONAL,could not meet target enrolment
NCT04435808,TERMINATED,INTERVENTIONAL,Stopped for futility by DSMB
NCT04436055,TERMINATED,OBSERVATIONAL,Sponsor did not renew funding.
NCT04436120,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment that has been compounded by the global COVID-19 pandemic. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.
NCT04436198,TERMINATED,INTERVENTIONAL,no longer feasible
NCT04436458,WITHDRAWN,INTERVENTIONAL,Sponsor asset acquired by another pharma company who opened their own IND for this compound. First Wave Bio never started this study in the US or ex-US.
NCT04436770,SUSPENDED,INTERVENTIONAL,Due to the COVID-19 pandemic
NCT04436861,WITHDRAWN,OBSERVATIONAL,the sponsor decided to stop the study
NCT04436952,WITHDRAWN,INTERVENTIONAL,Change in Protocol
NCT04437407,TERMINATED,INTERVENTIONAL,Participant dropout and technical difficulties
NCT04437953,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT04438382,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04438473,WITHDRAWN,INTERVENTIONAL,discontinued prematurely by sponsor for strategic reasons
NCT04438551,WITHDRAWN,INTERVENTIONAL,Study is on hold until pilot study is completed
NCT04438850,TERMINATED,INTERVENTIONAL,Incidence has dramatically dropped and there is lack of eligible patients
NCT04438902,TERMINATED,INTERVENTIONAL,Many patients can't tolerate the combination treatment due to adverse events.
NCT04439071,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04439305,WITHDRAWN,INTERVENTIONAL,zero accrual
NCT04439409,TERMINATED,OBSERVATIONAL,No inclusions for 2 years
NCT04440384,WITHDRAWN,OBSERVATIONAL,0 INCLUSION
NCT04440488,WITHDRAWN,INTERVENTIONAL,Reevaluation of development strategy
NCT04440540,TERMINATED,INTERVENTIONAL,the patient recruitment was severely affected by COVID-19 pandemic
NCT04440722,SUSPENDED,OBSERVATIONAL,replaced by other study
NCT04440891,WITHDRAWN,INTERVENTIONAL,Difficulty with recruitment due to Covid. 3 subjects consented but did not start any study procedures or participate in the study.
NCT04440982,TERMINATED,INTERVENTIONAL,Required resources unavailable.
NCT04441099,TERMINATED,INTERVENTIONAL,End of Program
NCT04441164,WITHDRAWN,INTERVENTIONAL,"Submitted, denied (too much steps; project to be cut in several projects)"
NCT04441385,TERMINATED,INTERVENTIONAL,lack of viability
NCT04441398,WITHDRAWN,INTERVENTIONAL,Sponsor's strategic decision
NCT04441671,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT04441788,TERMINATED,INTERVENTIONAL,Business Decision to Terminate Study
NCT04441892,TERMINATED,INTERVENTIONAL,"COVID, lack of funding and interruption of patient recruitment led to ending the study early."
NCT04442009,WITHDRAWN,INTERVENTIONAL,No participants
NCT04442113,WITHDRAWN,INTERVENTIONAL,Study cancelled. Different direction pursued by Rhythm AI.
NCT04442126,TERMINATED,INTERVENTIONAL,A business decision was made to discontinue further enrollment. There were no safety concerns that contributed to this decision.
NCT04442178,TERMINATED,INTERVENTIONAL,POOR ACCRUAL
NCT04442230,TERMINATED,INTERVENTIONAL,Enrollment
NCT04442581,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual
NCT04442932,WITHDRAWN,OBSERVATIONAL,Sponsor financial has been stopped.
NCT04443192,TERMINATED,INTERVENTIONAL,"Based on the results observed to date, the Sponsor concluded that ZF874 was unlikely to achieve the desired target product profile."
NCT04443257,TERMINATED,OBSERVATIONAL,not enough inclusions
NCT04443608,TERMINATED,INTERVENTIONAL,Recruitment window ended
NCT04443673,TERMINATED,INTERVENTIONAL,An interim analysis showed no difference in major outcomes (n=35 glycine and n=24 control participants)
NCT04443868,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT04444141,TERMINATED,INTERVENTIONAL,"Due to difficuty of erollment and consideration of clinical guideline,The sponsor decided to stop study."
NCT04444466,TERMINATED,INTERVENTIONAL,internal company decision; not safety related
NCT04444687,WITHDRAWN,OBSERVATIONAL,No patients
NCT04444830,WITHDRAWN,INTERVENTIONAL,Study never opened to enrollment. Study never IRB approved.
NCT04445090,TERMINATED,INTERVENTIONAL,Identification of potential mutagenic metabolite in human plasma
NCT04445103,TERMINATED,OBSERVATIONAL,Due to the COVID-19 pandemic it was not possible to complete the study inclusion as originally anticipated.
NCT04445116,WITHDRAWN,INTERVENTIONAL,Insufficient funds and limited staffing to complete the pilot program.
NCT04446000,TERMINATED,INTERVENTIONAL,Lack of clinical viability
NCT04446182,TERMINATED,INTERVENTIONAL,PI left institution
NCT04446637,WITHDRAWN,INTERVENTIONAL,administrative decision
NCT04447014,TERMINATED,OBSERVATIONAL,To avoid the duplication of resources and effort associated with the PI switching branches.
NCT04447235,TERMINATED,INTERVENTIONAL,futility analysis has demonstrated no difference between arms
NCT04447404,TERMINATED,INTERVENTIONAL,low enrollment
NCT04447443,WITHDRAWN,INTERVENTIONAL,discontinued prematurely by sponsor for strategic reasons
NCT04447508,WITHDRAWN,INTERVENTIONAL,Due to restrictions pertaining to COVD study has been halted
NCT04447729,WITHDRAWN,INTERVENTIONAL,Withdrawn due to logistic reasons
NCT04448119,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT04448262,TERMINATED,OBSERVATIONAL,technical issue
NCT04448834,WITHDRAWN,INTERVENTIONAL,Study not moving forward
NCT04449328,TERMINATED,INTERVENTIONAL,lack of inclusion
NCT04449380,TERMINATED,INTERVENTIONAL,Futility
NCT04449445,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04449705,WITHDRAWN,OBSERVATIONAL,Hospital didn't use perioperative infection control bundle so study wasn't applicable.
NCT04449809,WITHDRAWN,INTERVENTIONAL,Unable to enroll due to COVID-19
NCT04449835,TERMINATED,OBSERVATIONAL,Pilot Study converted to NCT 05660512 prospective single arm cohort study
NCT04449965,TERMINATED,INTERVENTIONAL,The site struggled with patient recruitment as we were not able to reach patients with COVID-19
NCT04450212,TERMINATED,INTERVENTIONAL,Insufficient funds to complete the study.
NCT04450316,SUSPENDED,INTERVENTIONAL,Study temporarily suspended awaiting research personnel to resume recruitment
NCT04450342,TERMINATED,INTERVENTIONAL,Sponsor decision not related to safety.
NCT04450368,TERMINATED,OBSERVATIONAL,Site failed to hit recruitment targets
NCT04450654,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT04451174,TERMINATED,INTERVENTIONAL,Corticosteroid use approval
NCT04451382,TERMINATED,OBSERVATIONAL,Low recruitment
NCT04452006,TERMINATED,INTERVENTIONAL,"Based on interim analysis, the Sponsor decided to terminate the study prematurely."
NCT04452357,SUSPENDED,INTERVENTIONAL,Slow accrual
NCT04452396,TERMINATED,INTERVENTIONAL,"Due to the Covid crisis: clinical changes in staff, bed pressures and time restraints."
NCT04452474,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT04452643,WITHDRAWN,INTERVENTIONAL,Not authorized by Cofepris (Mexico Competent Regulatory Authority)
NCT04452786,WITHDRAWN,INTERVENTIONAL,Lack of participants
NCT04453046,TERMINATED,INTERVENTIONAL,Lack of Eligible subjects at study site
NCT04453371,WITHDRAWN,INTERVENTIONAL,Our local committee has denied the approval request
NCT04453553,TERMINATED,INTERVENTIONAL,Change in government policy on testing
NCT04453787,TERMINATED,INTERVENTIONAL,effected by the epidemic of COVID-19
NCT04453891,WITHDRAWN,OBSERVATIONAL,"Internal timeline was delayed, logistics delays"
NCT04454190,TERMINATED,OBSERVATIONAL,PI moved to another institution
NCT04454398,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting
NCT04454567,TERMINATED,INTERVENTIONAL,"Study stopped due to a change in the Sponsor's overall development strategy from treatment of chronic disease to finite, curative treatments, and is based partially on the advice and feedback from experts and regulators."
NCT04454749,TERMINATED,OBSERVATIONAL,Investigators perogative
NCT04455139,TERMINATED,INTERVENTIONAL,Difficulties in recruiting patients due to changing in treatment standards for the target population
NCT04455412,SUSPENDED,INTERVENTIONAL,recruitment is stopped waiting for funds
NCT04455503,TERMINATED,INTERVENTIONAL,"Based on the promising interim results of study part 1, it was decided to further accelerate the development of the 2nd generation DNA plasmid immunotherapy. Therefore enrolment of patients was completed after study part 1"
NCT04455789,SUSPENDED,INTERVENTIONAL,monitoring equipment used in the study is not available
NCT04455802,WITHDRAWN,INTERVENTIONAL,termination of funding
NCT04455815,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04455828,WITHDRAWN,OBSERVATIONAL,IRB Approval lapsed
NCT04455919,TERMINATED,INTERVENTIONAL,covid health crisis
NCT04455958,WITHDRAWN,INTERVENTIONAL,limited resources
NCT04456023,WITHDRAWN,INTERVENTIONAL,This study was cancelled before enrolling any patients for business related reasons.
NCT04456049,TERMINATED,INTERVENTIONAL,Low accrual
NCT04456088,WITHDRAWN,INTERVENTIONAL,Terminated (halted prematurely)
NCT04456400,SUSPENDED,OBSERVATIONAL,Interim Analysis in progress.
NCT04456413,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT04456426,WITHDRAWN,OBSERVATIONAL,No access to the database of healthcare workers.
NCT04456608,TERMINATED,INTERVENTIONAL,"Funding ended before the study could be completed,"
NCT04457219,TERMINATED,INTERVENTIONAL,"Pre-specified interim analysis on data from 2,000 patients by an independent DMSC: recruitment to be stopped early for overwhelming superiority of one of the 3 randomised treatment arms, in the absence of any safety concerns."
NCT04457245,TERMINATED,INTERVENTIONAL,accrual
NCT04457271,WITHDRAWN,INTERVENTIONAL,"Unfortunately, we have had to prioritize other studies and we do not have the resources required to carry out this study."
NCT04457427,WITHDRAWN,INTERVENTIONAL,Study not started
NCT04457440,SUSPENDED,INTERVENTIONAL,COVID pandemic affected recruitment.
NCT04457466,TERMINATED,OBSERVATIONAL,Covid-19
NCT04457492,TERMINATED,INTERVENTIONAL,PI Relocation
NCT04457765,WITHDRAWN,INTERVENTIONAL,The IRB did not approve the study to be conducted at the home institution.
NCT04457817,TERMINATED,OBSERVATIONAL,Lack of feasibility
NCT04457960,TERMINATED,INTERVENTIONAL,Sponsor Decision.
NCT04458116,WITHDRAWN,INTERVENTIONAL,We could not start the project
NCT04458298,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04458415,WITHDRAWN,INTERVENTIONAL,Collaborator discontinued at this site to pursue the study with a different site.
NCT04458909,TERMINATED,INTERVENTIONAL,External information
NCT04458948,TERMINATED,INTERVENTIONAL,The World Health Organization (WHO) paused Hydrochloroquinone from its Solidarity Trial in order to conduct a safety data review by the Data Safety Monitoring Board of the WHO to evaluate HCQ in its clinical trials.
NCT04459286,TERMINATED,INTERVENTIONAL,IDSMB recommendation
NCT04459299,TERMINATED,OBSERVATIONAL,Low enrollment and sponsor business decision
NCT04459702,WITHDRAWN,INTERVENTIONAL,Was never started
NCT04459936,WITHDRAWN,INTERVENTIONAL,The study has been terminated due to inclusion difficulties during the worldwide Covid-19 pandemic.
NCT04460105,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to challenges in site recruitment and lack of patient enrollment
NCT04460430,TERMINATED,INTERVENTIONAL,premature termination due to lack of funding
NCT04460495,TERMINATED,INTERVENTIONAL,insufficient accrual
NCT04460729,WITHDRAWN,INTERVENTIONAL,company decision
NCT04460807,TERMINATED,INTERVENTIONAL,"low accrual, COVID 19 emergency and the modification of the standard of care for ovarian cancer treatment"
NCT04461028,WITHDRAWN,INTERVENTIONAL,PI departed from the institution and study was closed.
NCT04461210,SUSPENDED,OBSERVATIONAL,Interim analysis
NCT04461600,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT04461730,WITHDRAWN,OBSERVATIONAL,team no more available to lead research
NCT04461886,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04461964,WITHDRAWN,INTERVENTIONAL,funding for the study has stopped
NCT04462055,TERMINATED,OBSERVATIONAL,"Not feasible to include patients (due to e.g. COVID-19, patients with severe reactions not willing to undergo 2 food challenges, lower number of eligible patients than expected)"
NCT04462341,TERMINATED,INTERVENTIONAL,COVID-19
NCT04462692,WITHDRAWN,OBSERVATIONAL,study stopped due to company decision
NCT04462757,TERMINATED,INTERVENTIONAL,Lack of patients in the trial population from which to recruit and lack of funding
NCT04462783,WITHDRAWN,INTERVENTIONAL,Not funded
NCT04464148,WITHDRAWN,INTERVENTIONAL,Feasibility study was not initiated.
NCT04464317,WITHDRAWN,OBSERVATIONAL,"Observational only, no subjects enrolled"
NCT04464460,WITHDRAWN,INTERVENTIONAL,Business Decision (no enrollment)
NCT04464512,WITHDRAWN,INTERVENTIONAL,No qualified enrollments; study cancelled due to pandemic
NCT04464525,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04464577,WITHDRAWN,INTERVENTIONAL,Business objectives have changed.
NCT04464629,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT04464889,WITHDRAWN,INTERVENTIONAL,Medigene transfered all rights to a new Sponsor
NCT04464915,WITHDRAWN,INTERVENTIONAL,"Given the COVID-19 pandemic, there has been a temporary suspension of study activities, therefore the study has not yet been initiated."
NCT04464967,WITHDRAWN,INTERVENTIONAL,Trial not initiated
NCT04465136,TERMINATED,INTERVENTIONAL,1. The results showed significant improvement after CES; 2. Run out of study grant.
NCT04465383,TERMINATED,INTERVENTIONAL,Recruitment too complicated during pandemics. Phase 2 of recruitment completed and enough data available.
NCT04465448,TERMINATED,OBSERVATIONAL,MRI issue.
NCT04465565,WITHDRAWN,INTERVENTIONAL,PI decision
NCT04465630,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04465734,WITHDRAWN,INTERVENTIONAL,The trial used sorafenib as a control drug. It's not suitable now(after the A+T has been approved).The sponsor terminated the trial.
NCT04465760,TERMINATED,INTERVENTIONAL,Insufficient accrual rate
NCT04465916,TERMINATED,INTERVENTIONAL,DSMC reviewed results of 26 subjects. New randomizations were stopped. Already randomized subjects were followed up to W40.
NCT04466280,WITHDRAWN,INTERVENTIONAL,"The financier of this research project died due to covid-19, Therefore, this project was stopped due to lack of funds"
NCT04466371,SUSPENDED,OBSERVATIONAL,Administrative problems
NCT04466410,TERMINATED,INTERVENTIONAL,Failure to enroll a sufficient number of patients.
NCT04466475,WITHDRAWN,INTERVENTIONAL,NIH terminated funding. Study was closed before any participants were enrolled.
NCT04466553,WITHDRAWN,OBSERVATIONAL,The study did not begin.
NCT04466657,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT04466826,WITHDRAWN,INTERVENTIONAL,Low enrollment
NCT04466917,WITHDRAWN,INTERVENTIONAL,Sponsor decision to early terminate the study
NCT04467034,WITHDRAWN,INTERVENTIONAL,"Schools were unable to participate due the COVID-19 pandemic, which shifted educational priorities and therefore impeded school-based recruiting efforts. No participants were enrolled."
NCT04467151,WITHDRAWN,INTERVENTIONAL,Did not obtain funding to proceed with study
NCT04467281,WITHDRAWN,INTERVENTIONAL,PI left institution and study is being transferred.
NCT04467632,WITHDRAWN,INTERVENTIONAL,The principal investigator left the hospital
NCT04467814,WITHDRAWN,INTERVENTIONAL,Due to COVID-related issues had to change study design.
NCT04467853,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study
NCT04467879,TERMINATED,INTERVENTIONAL,New Protocol and Outcome Measures in Review
NCT04468048,WITHDRAWN,OBSERVATIONAL,No participants
NCT04468191,WITHDRAWN,INTERVENTIONAL,COVID-19 pandemic restrictions for data collection
NCT04468230,TERMINATED,INTERVENTIONAL,Low Accrual Rate
NCT04468243,TERMINATED,INTERVENTIONAL,Slow Accrual
NCT04468373,TERMINATED,INTERVENTIONAL,Development of next-generation device
NCT04468490,TERMINATED,OBSERVATIONAL,Low enrollment rate
NCT04468789,WITHDRAWN,OBSERVATIONAL,The South African government decided not to implement the pilot project for which this protocol was the evaluation. It was not approved by the IRB and never started.
NCT04468828,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT04468854,TERMINATED,INTERVENTIONAL,Corona-Virus Lockdown (16th March in Switzerland)
NCT04469062,WITHDRAWN,INTERVENTIONAL,"The trial was terminated secondary to a business decision, the original scientific question rendered moot by the external scientific community."
NCT04469205,TERMINATED,INTERVENTIONAL,insufficient recruiting
NCT04469374,TERMINATED,INTERVENTIONAL,Assessed for feasibility
NCT04469452,TERMINATED,OBSERVATIONAL,Halted by sponsor
NCT04469478,WITHDRAWN,INTERVENTIONAL,Study was not approved in 2020 secondary to COVID-19 restrictions on trials
NCT04469725,TERMINATED,INTERVENTIONAL,"The termination of this study does not involve safety issues. The overall safety of KN046 is good, and no new safety signals have been found. The decision to terminate this study was made due to the adjustment of the sponsor's development strategy."
NCT04469881,TERMINATED,INTERVENTIONAL,Lost research staff - unable to enroll until new research staff is hired.
NCT04470089,TERMINATED,INTERVENTIONAL,"Due to the COVID situation by end of 2021 and therfore limited recruitment of patients diagnosis ""acute pharyngitis"" the study was terminated."
NCT04470622,TERMINATED,INTERVENTIONAL,"Study was terminated early by Heron, and was not terminated for safety reasons."
NCT04470674,WITHDRAWN,INTERVENTIONAL,Lack of Accrual
NCT04470895,WITHDRAWN,OBSERVATIONAL,The PI chose not to start the study.
NCT04470999,SUSPENDED,INTERVENTIONAL,Study suspended due to the move of clinical trial site. It will be resumed when the move is complete.
NCT04471350,WITHDRAWN,OBSERVATIONAL,Indication withdrawn
NCT04471415,TERMINATED,INTERVENTIONAL,Company decision to closing study and discontinue further patient enrollment.
NCT04471714,WITHDRAWN,INTERVENTIONAL,Study recruitment was halted due to restrictions and we have decided to not pursue it further.
NCT04471857,TERMINATED,INTERVENTIONAL,Due to COVID-19 recruitement stopped since intended sample size was an estimation and not based on power calculation
NCT04472494,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04472520,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT04472728,TERMINATED,INTERVENTIONAL,Lack of eligible patients due to lower number of Covid-19 cases in all involved sites.
NCT04473027,TERMINATED,OBSERVATIONAL,Low patient inclusion
NCT04473183,WITHDRAWN,OBSERVATIONAL,"PI left the University, and the study was not funded."
NCT04473521,WITHDRAWN,INTERVENTIONAL,Study objectives no longer met business need
NCT04473534,WITHDRAWN,INTERVENTIONAL,Study halted prematurely becauase of organisational problems.
NCT04473651,TERMINATED,INTERVENTIONAL,The study was terminated for strategic reasons.
NCT04473924,WITHDRAWN,INTERVENTIONAL,Study has never started as sponsor did not approve for funding.
NCT04473937,TERMINATED,INTERVENTIONAL,Futility
NCT04473950,TERMINATED,INTERVENTIONAL,The COVID-19 Pandemic prevented us from meeting target goals.
NCT04474210,TERMINATED,INTERVENTIONAL,Strategic Decision
NCT04474314,TERMINATED,INTERVENTIONAL,"A recently conducted Interim analysis of IMR-SCD-301 demonstrated that while IMR-687 was generally well-tolerated, it failed to meet its primary efficacy endpoint. So, the sponsor has decided to discontinue this study."
NCT04474483,TERMINATED,INTERVENTIONAL,difficult recruitment and complete first visit in person during thne hight of tne pandemic and later not enough subjects
NCT04474587,SUSPENDED,OBSERVATIONAL,COVID pandemic
NCT04474626,WITHDRAWN,INTERVENTIONAL,Trial did not activate
NCT04474652,SUSPENDED,OBSERVATIONAL,COVID-19
NCT04475185,TERMINATED,INTERVENTIONAL,Manufacturer's decision following failure of sequence 2. Protocol unadapted to the security and performance evaluation of the new MakAir device capabilities in non-invasive ventilation (NIV).
NCT04475198,TERMINATED,INTERVENTIONAL,strategic decision
NCT04475315,WITHDRAWN,INTERVENTIONAL,Difficulty with recruitment
NCT04475497,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04475549,TERMINATED,INTERVENTIONAL,Study terminated due to enrollment challenges.
NCT04475601,TERMINATED,INTERVENTIONAL,"By sponsor, based on DSMB recommendations"
NCT04475861,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04475991,TERMINATED,INTERVENTIONAL,No more patients complying the selection criteria were available for recruitment
NCT04476251,TERMINATED,INTERVENTIONAL,Multiple logistical challenges
NCT04476329,TERMINATED,INTERVENTIONAL,"Enrollment rate not sufficient to meet funding entity's corporation timeline expectations, entity terminated study's fiscal support. Termination decision was purely administrative in nature and did not involve drug or patient safety issues."
NCT04476628,WITHDRAWN,INTERVENTIONAL,"Due to COVID-19, we didn't start this study"
NCT04476797,TERMINATED,INTERVENTIONAL,Development GC4711 was halted after the lead study in pancreatic cancer was stopped early due to meeting the requirements of a futility analysis
NCT04477525,WITHDRAWN,INTERVENTIONAL,PI changed hospital center
NCT04477642,WITHDRAWN,INTERVENTIONAL,Funding
NCT04477954,TERMINATED,INTERVENTIONAL,"Investigators and Ethic Committee endorsed early suspension of the protocol because of superiority and safety. For the interim analysys, the statistical methodology presented by Pocock was followed."
NCT04477993,TERMINATED,INTERVENTIONAL,Low accrual
NCT04478136,WITHDRAWN,OBSERVATIONAL,This protocol was never initiated
NCT04478266,TERMINATED,INTERVENTIONAL,The study was terminated based on the review by an independent data monitoring committee of the prespecified interim analysis of the Phase 3 AMEERA-5 efficacy data. No new safety signals were observed.
NCT04478630,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT04478695,TERMINATED,INTERVENTIONAL,Amgen Decision
NCT04478825,TERMINATED,INTERVENTIONAL,Internal Company Decision
NCT04478994,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT04479371,WITHDRAWN,INTERVENTIONAL,Limited funding and resources to complete FDA requirements for enrollment
NCT04479436,TERMINATED,INTERVENTIONAL,Study was terminated early given the Interim Analysis for Part 1 (signal finding) did not meet pre-specified criteria and will not proceed to Part 2. Sponsor will proceed closing the study.
NCT04479904,WITHDRAWN,INTERVENTIONAL,It is difficult to screening subject
NCT04480086,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04480138,TERMINATED,INTERVENTIONAL,Due to non availability of eligible subjects and slow recruitment
NCT04480164,SUSPENDED,INTERVENTIONAL,low recruitment rate and end of study finding
NCT04480190,WITHDRAWN,INTERVENTIONAL,Difficulty accruing
NCT04480411,WITHDRAWN,INTERVENTIONAL,Unavailable IT resources
NCT04480476,WITHDRAWN,OBSERVATIONAL,study stopped due to company decision
NCT04480736,SUSPENDED,INTERVENTIONAL,The decision has been taken to PAUSE DNG2001 recruitment.
NCT04480879,TERMINATED,INTERVENTIONAL,Need for evaluation of emerging pre-clinical toxicology findings
NCT04481490,WITHDRAWN,OBSERVATIONAL,Stopped due to lack of personnel and funding support
NCT04481516,WITHDRAWN,OBSERVATIONAL,Put on hold due to COVID and then withdrawn.
NCT04481958,TERMINATED,INTERVENTIONAL,"Due to Covid-19 restrictions, handball training was only performed about 2 months at the start of the season, and intervention and evaluation could not be conducted as planned."
NCT04482036,TERMINATED,INTERVENTIONAL,"The Principle Investigator changed careers and relinquished their NIA funded career development award, which funded the MOMENT Study. Career development awards are not transferable. Thus, the study was terminated prematurely."
NCT04482699,TERMINATED,INTERVENTIONAL,Change in eligible patient population
NCT04482712,WITHDRAWN,INTERVENTIONAL,"The study was never submitted to IRB or approved, due to feasibility issues"
NCT04482842,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04483297,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04483414,WITHDRAWN,INTERVENTIONAL,Study was closed since no participants were enrolled.
NCT04483479,TERMINATED,INTERVENTIONAL,Poor recruitment/retention due to the pandemic. Data was not analyzed due to early termination.
NCT04483635,TERMINATED,INTERVENTIONAL,"A premature discontinuation was recommended by the Data Safety Monitoring Board and agreed upon by the principal investigator, because the significantly lower recruitment than planned, in the context of mass vaccination of the target population."
NCT04483687,WITHDRAWN,INTERVENTIONAL,Development program terminated
NCT04483700,WITHDRAWN,INTERVENTIONAL,Development program terminated
NCT04484428,TERMINATED,INTERVENTIONAL,Internal business decision
NCT04485026,WITHDRAWN,INTERVENTIONAL,"No enrollments, low patient population as well as a dramatic change in the insurance approval processes for oligoprogressive state with eviCore saying they do not support SBRT in this setting at all."
NCT04485052,SUSPENDED,INTERVENTIONAL,Pause for changes in development strategies
NCT04485065,SUSPENDED,INTERVENTIONAL,Suspended for changes in development strategy
NCT04485130,TERMINATED,INTERVENTIONAL,"Low COVID case numbers, competing COVID treatments available"
NCT04485182,TERMINATED,OBSERVATIONAL,Due to the COVID pandemia the tubes of the treatments baths went wrong.
NCT04485429,WITHDRAWN,INTERVENTIONAL,It was not possible to perform the study due to the availability and logistics of porcine heparin
NCT04485663,TERMINATED,INTERVENTIONAL,Lack of antiviral activity at the projected efficacious dose.
NCT04485858,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT04486222,TERMINATED,INTERVENTIONAL,difficulty in recruiting suitable candidate
NCT04486326,TERMINATED,INTERVENTIONAL,low enrollment
NCT04486846,WITHDRAWN,INTERVENTIONAL,Principal Investigator left Duke University
NCT04487262,TERMINATED,INTERVENTIONAL,Safety interim analysis
NCT04487392,WITHDRAWN,INTERVENTIONAL,The student do not start the study
NCT04487405,TERMINATED,OBSERVATIONAL,"cohort C looked at feasibility of genetics \& protein to evaluate risk with a family hx of cancer or associated variant. Since few patients show these factors, this approach would not yield sufficient information to make inferences"
NCT04487444,TERMINATED,INTERVENTIONAL,The study was terminated due to slow enrollment and the transfer of the PI to another institution.
NCT04487678,WITHDRAWN,INTERVENTIONAL,Prioritization of other projects
NCT04487691,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04487808,WITHDRAWN,INTERVENTIONAL,The study did not enroll any subjects. It was never started because of the Covid pandemic.
NCT04487912,WITHDRAWN,INTERVENTIONAL,Insufficient patient inclusion
NCT04488003,TERMINATED,INTERVENTIONAL,Enrollment challenges
NCT04488185,WITHDRAWN,INTERVENTIONAL,low recruitment
NCT04488263,TERMINATED,OBSERVATIONAL,To avoid the duplication of effort and resources associated with the PI's branch change.
NCT04488575,TERMINATED,INTERVENTIONAL,Insufficient study defined patient population
NCT04489420,TERMINATED,INTERVENTIONAL,Business decision.
NCT04489537,TERMINATED,INTERVENTIONAL,Sponsor decision (not a safety decision)
NCT04489628,WITHDRAWN,INTERVENTIONAL,Unable to overcome hurdles to study recruitment
NCT04489667,WITHDRAWN,INTERVENTIONAL,Not considered a clinical trial
NCT04489732,SUSPENDED,INTERVENTIONAL,Unanticipated event
NCT04489927,TERMINATED,OBSERVATIONAL,Patients couldn't be recruited (no patients with fewer available)
NCT04489940,TERMINATED,INTERVENTIONAL,The study was prematurely discontinued by the sponsor due to probability of success which was too low to justify the continuation of recruitment.
NCT04490096,TERMINATED,INTERVENTIONAL,Funding issues.
NCT04490356,SUSPENDED,INTERVENTIONAL,Awaiting additional funding to enroll additional participants
NCT04490382,WITHDRAWN,INTERVENTIONAL,Funding
NCT04490486,WITHDRAWN,INTERVENTIONAL,Not Funded
NCT04491071,TERMINATED,OBSERVATIONAL,The study was stopped due to lack of inclusions
NCT04491084,TERMINATED,INTERVENTIONAL,Low accrual
NCT04491136,TERMINATED,INTERVENTIONAL,Company decision
NCT04491903,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT04492059,WITHDRAWN,INTERVENTIONAL,No patients
NCT04492254,TERMINATED,INTERVENTIONAL,"Average event rate (end point) was much lower than expected. A larger sample size would have been required to maintain same statistical power, which was not achievable in a feasible time scale. No safety concerns were identified with bleeding."
NCT04492358,TERMINATED,INTERVENTIONAL,No candidates for the recruitment
NCT04492436,WITHDRAWN,INTERVENTIONAL,Study design was changed
NCT04492722,TERMINATED,INTERVENTIONAL,The Sponsor decided to terminate the study early due to lack of efficacy. There were no safety concerns related to the study.
NCT04493099,WITHDRAWN,INTERVENTIONAL,The original sponsor was acquired by a new company and has elected to end funding for all Investigator Sponsored Trials (ISTs)
NCT04493216,TERMINATED,INTERVENTIONAL,Company decision to stop compound development. The decision is not based on any safety or efficacy concerns. It reflects the company strategy for portfolio progression.
NCT04493229,WITHDRAWN,INTERVENTIONAL,study team decided not to proceed with project
NCT04493320,TERMINATED,INTERVENTIONAL,Study terminated by sponsor (NIMH)
NCT04493359,TERMINATED,INTERVENTIONAL,Dificulteis in enrolling patients
NCT04493372,SUSPENDED,INTERVENTIONAL,Transfer of institutions
NCT04493424,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04493528,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04493619,TERMINATED,INTERVENTIONAL,study terminated due to business realignment
NCT04493697,WITHDRAWN,INTERVENTIONAL,Device provider has requested withdrawal citing modifications needed for study integrity.
NCT04493957,TERMINATED,INTERVENTIONAL,new law making inclusion impossible
NCT04494035,TERMINATED,INTERVENTIONAL,Sponsor change
NCT04494061,TERMINATED,OBSERVATIONAL,"Decision related to Business Priorities, Assessment of Development Options"
NCT04494178,TERMINATED,INTERVENTIONAL,Several analytical laboratories failed to develop and validate a suitable assay of urine fumonisin (the primary endpoint) up to date. Because of missing alternatives for an analytical laboratory the objective of the study cannot be met.
NCT04494334,WITHDRAWN,OBSERVATIONAL,Study terminated by funder- terminated before CCC and recruitment- no recruitment and no data collection
NCT04495010,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT04495374,TERMINATED,INTERVENTIONAL,Due to an atypical health scenario caused by the COVID-19 pandemic
NCT04495439,TERMINATED,INTERVENTIONAL,Change in company strategy
NCT04495452,WITHDRAWN,OBSERVATIONAL,"Study initially halted due to the COVID pandemic because the research ventilator was repurposed for life saving efforts. Due to later clinical demands, the study was able to be restarted."
NCT04495738,TERMINATED,INTERVENTIONAL,Change in research focus
NCT04496505,WITHDRAWN,INTERVENTIONAL,Unable to receive clearance from HCA administration
NCT04496557,WITHDRAWN,INTERVENTIONAL,The investigators received funding for a near-identical FDA regulated trial before opening this study to enrollment - the IRB requested closure of the unfunded pilot trial to create a new submission.
NCT04496674,TERMINATED,INTERVENTIONAL,premature termination of the trial due to bad recruitment
NCT04496726,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT04496921,WITHDRAWN,INTERVENTIONAL,"Clinical care of patients with CF changed following COVID-19 pandemic (OGTT not performed at the CF clinic since March 2020); in consequence, this study is no longer feasible."
NCT04496986,WITHDRAWN,OBSERVATIONAL,This study was replaced by a new study given recent funding by the NIH.
NCT04496999,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04497610,WITHDRAWN,OBSERVATIONAL,Study was not initiated
NCT04497870,WITHDRAWN,INTERVENTIONAL,This study was superseded by NCT03295747
NCT04497909,TERMINATED,INTERVENTIONAL,The online mindfulness is no longer being offered and recruitment can no longer happen.
NCT04497948,TERMINATED,INTERVENTIONAL,"Data from the CALAVI Phase II trials for Acalabrutinib in patients hospitalized with COVID-19 did not meet their primary efficacy endpoints.

Based on this higher management made the decision to prematurely terminate the D822FC00005 PK study."
NCT04498247,TERMINATED,INTERVENTIONAL,The study was terminated based on an interim assessment of immunogenicity
NCT04498273,TERMINATED,INTERVENTIONAL,an event rate lower than anticipated
NCT04498325,WITHDRAWN,INTERVENTIONAL,Principal investigator is leaving the institution.
NCT04498377,TERMINATED,INTERVENTIONAL,There have been significant changes in the FDA guidelines and clinical standard of care
NCT04498403,TERMINATED,INTERVENTIONAL,Terminated (This decision was made for business reasons only and is not related to any safety concerns regarding crisaborole.)
NCT04498468,TERMINATED,INTERVENTIONAL,"The study was terminated prematurely due to administrative reasons; loss of several research personnel. Because of strict eligibility criteria, the investigators anticipated delays in completing enrollment and therefore decided to terminate early."
NCT04498520,WITHDRAWN,INTERVENTIONAL,Funding
NCT04498585,SUSPENDED,INTERVENTIONAL,Decreased resources due to COVID-19
NCT04499170,WITHDRAWN,INTERVENTIONAL,I left Unopar
NCT04499235,TERMINATED,INTERVENTIONAL,"The study was prematurely terminated by the Sponsor due to operational challenges stemming from the coronavirus disease 2019 (COVID-19) pandemic, treatment limitations, rarity of the disease, and drug supply considerations."
NCT04499352,WITHDRAWN,INTERVENTIONAL,Not due to safety reasons (sponsor decision).
NCT04499651,TERMINATED,INTERVENTIONAL,Insufficient enrollment numbers due to Covid-19 pandemic
NCT04499729,TERMINATED,INTERVENTIONAL,The recruitment site (Rush University Medical Center Collaborative Care Program) redefined their service objectives such that IntelliCare was no longer a good fit.
NCT04499807,TERMINATED,INTERVENTIONAL,Stopped because after we started enrolling we realized that we could not get the information that we wanted out of the current protocol. The information we wanted to compare would not be able to be collected.
NCT04500418,TERMINATED,INTERVENTIONAL,"Despite multiple efforts, no further patient could be enrolled since 03/05/2021. A continuation of the study is therefore no longer justified"
NCT04500548,WITHDRAWN,INTERVENTIONAL,Inadequate accrual rate
NCT04500795,WITHDRAWN,INTERVENTIONAL,Update in other trial results
NCT04500951,TERMINATED,INTERVENTIONAL,Descriptive studies were published based on this record. Randomized Controlled time-series study was discontinued due to infeasability. Descriptive time-series studies and methodological studies have been published.
NCT04501094,TERMINATED,INTERVENTIONAL,Because of the low accrual and the safety concerns we closed the study.
NCT04501211,WITHDRAWN,INTERVENTIONAL,Abandoned due to limited resources
NCT04501796,TERMINATED,INTERVENTIONAL,Study was halted due to lack of patient population resulting in slow enrollment.
NCT04501952,TERMINATED,INTERVENTIONAL,The study was terminated due to study enrollment feasibility and changing needs of non-hospitalized participants. This decision is not based on efficacy or safety concerns.
NCT04502069,WITHDRAWN,INTERVENTIONAL,To be replaced with a randomized placebo-controlled study.
NCT04502082,TERMINATED,INTERVENTIONAL,Directing efforts to the pediatric study (ARYA-2) for this product
NCT04502433,TERMINATED,INTERVENTIONAL,"The enrolment was extended. Nevertheless, despite the Sponsor's attempts, the infection status did not permit the identification of eligible patients for the study to complete it in a reasonable time."
NCT04502472,TERMINATED,INTERVENTIONAL,FDA gave emergency use approval to COVID-19 convalescent plasma on 08/24/2020
NCT04502706,TERMINATED,INTERVENTIONAL,Sponsor's decision to discontinue development of this molecule
NCT04502732,TERMINATED,OBSERVATIONAL,Unable to recruit sufficient participants form parent study following protocol expansion
NCT04502836,TERMINATED,INTERVENTIONAL,internal reasons
NCT04502888,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04502914,WITHDRAWN,INTERVENTIONAL,Lack of subjects enrolled
NCT04502927,TERMINATED,INTERVENTIONAL,recruitement issues related to COVID-19
NCT04503161,WITHDRAWN,INTERVENTIONAL,Investigator left institution
NCT04503538,WITHDRAWN,INTERVENTIONAL,Principal investigator decided not to pursue trial
NCT04504032,TERMINATED,INTERVENTIONAL,"Based on Data Monitoring Committee''s recommendation on 3 February 2021, the study was stopped on 4 February 2021 due to futility."
NCT04504045,TERMINATED,INTERVENTIONAL,"Slow recruitment due to COVID-19, the study was stopped when recruited numbers fulfilled the pre-defined lower sample size."
NCT04504149,WITHDRAWN,INTERVENTIONAL,"Findings from Aims 1 and 2 clarified that any future trial should involve provider- or clinic-level randomization, not patient-level randomization."
NCT04504331,TERMINATED,INTERVENTIONAL,Drug manufacturer decision to terminate development.
NCT04504591,TERMINATED,OBSERVATIONAL,Early termination due to COVID19; preliminary data can be considered significant
NCT04504682,TERMINATED,INTERVENTIONAL,Limited recruitment
NCT04504708,TERMINATED,INTERVENTIONAL,Study terminated early due to business decision.
NCT04504734,TERMINATED,INTERVENTIONAL,Met definition of futility according to DSMB
NCT04505098,TERMINATED,INTERVENTIONAL,The study was suspended by the IRB of record and subsequently terminated
NCT04505111,WITHDRAWN,INTERVENTIONAL,"Modification of the protocolo, new version was created. No patients were enrolled."
NCT04505358,WITHDRAWN,INTERVENTIONAL,Samus Therapeutics company closure
NCT04505605,TERMINATED,OBSERVATIONAL,The PI decided to stop the study due to the low number of inclusions.
NCT04505735,TERMINATED,OBSERVATIONAL,Issues with local production of 11-cPiB radiotracer
NCT04505813,SUSPENDED,INTERVENTIONAL,Lack of accrual
NCT04505878,WITHDRAWN,INTERVENTIONAL,Decided not to proceed with study
NCT04506099,WITHDRAWN,INTERVENTIONAL,Lack of study staff
NCT04506112,WITHDRAWN,INTERVENTIONAL,Principal Investigator leaving institution. Aim 3 was not initiated.
NCT04506372,TERMINATED,INTERVENTIONAL,slow recruitment rate
NCT04506554,SUSPENDED,INTERVENTIONAL,Slot availability
NCT04506619,TERMINATED,OBSERVATIONAL,"As the revised OHB-607-202 protocol extends the study's observational arm through 24 months corrective age (CA), the SHP607-203 protocol was terminated at 24 months CA."
NCT04506762,TERMINATED,INTERVENTIONAL,Surgical team resigned from our hospital
NCT04506814,WITHDRAWN,INTERVENTIONAL,Funding issues
NCT04506866,TERMINATED,INTERVENTIONAL,Due to the extension of the clinical study duration and to avoid further delaying the reporting of results.
NCT04506983,SUSPENDED,INTERVENTIONAL,Adjust the plan
NCT04507100,WITHDRAWN,INTERVENTIONAL,Trial twithdrawn due to the COVID-19 pandemic
NCT04507204,TERMINATED,INTERVENTIONAL,(due to administrative reasons not related to efficacy or safety.)
NCT04507347,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant hence study withdrawn"
NCT04507373,TERMINATED,INTERVENTIONAL,No grant obtained. Enrolled participants were not assigned to the intervention and was study terminated
NCT04507438,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04508023,TERMINATED,INTERVENTIONAL,The study was terminated prematurely due to enrollment challenges.
NCT04508140,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT04508842,TERMINATED,INTERVENTIONAL,Adjustment plan
NCT04508868,TERMINATED,INTERVENTIONAL,Study terminated due to changes in government restrictions. Collected data to be presented as a pilot study.
NCT04508933,WITHDRAWN,OBSERVATIONAL,Lack of Funding
NCT04509180,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04509336,TERMINATED,INTERVENTIONAL,COVID 19 Pandemic
NCT04509427,WITHDRAWN,INTERVENTIONAL,We did not receive the human or monetary resources to get this study off the ground.
NCT04509466,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04509739,TERMINATED,INTERVENTIONAL,COVID-19 shutdown
NCT04509999,WITHDRAWN,INTERVENTIONAL,No patients enrolled and funding withdrawn
NCT04510285,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT04510415,TERMINATED,INTERVENTIONAL,Study termination by the Sponsor
NCT04510428,WITHDRAWN,INTERVENTIONAL,Study not initiated.
NCT04510467,TERMINATED,OBSERVATIONAL,inclusion number not reached during the period
NCT04510584,WITHDRAWN,INTERVENTIONAL,"19 patients screenfailed, stopping recruitment before first patient enrollment to analyze pilot results from screening samples."
NCT04510727,WITHDRAWN,INTERVENTIONAL,device not available to initiate study.
NCT04510844,WITHDRAWN,INTERVENTIONAL,loss of funding
NCT04511026,TERMINATED,INTERVENTIONAL,Efficacy
NCT04511650,TERMINATED,INTERVENTIONAL,"After completion of Step 1 Part 1, the Sponsor discontinued the study based on challenges associated with recruiting and monitoring patients in the current pandemic environment."
NCT04511793,WITHDRAWN,INTERVENTIONAL,No subjects enrolled due to availability of device commercially.
NCT04511819,TERMINATED,INTERVENTIONAL,Study terminated due to the rapidly evolving environment for the treatment of Covid-19 and ongoing challenges to identify and enroll qualified patients to participate.
NCT04511936,WITHDRAWN,INTERVENTIONAL,COVID-related delays.
NCT04511975,SUSPENDED,INTERVENTIONAL,pause for further assessment and study adjustment
NCT04512261,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to change in treatment landscape for HER2+ metastatic breast cancer.
NCT04512378,SUSPENDED,INTERVENTIONAL,Principal Investigator medical leave
NCT04512794,WITHDRAWN,INTERVENTIONAL,Company decision
NCT04512911,WITHDRAWN,INTERVENTIONAL,IRB approval expired 1/23/2023 and eclipsed the 6 month institutional window where study can be reinitiated via progress report. No enrollment has taken place.
NCT04513067,TERMINATED,INTERVENTIONAL,Due to business decision
NCT04513314,WITHDRAWN,INTERVENTIONAL,coronavirus omicron variant infection typically not associated with delirium and agitation severely hampered recruitment.
NCT04513548,TERMINATED,INTERVENTIONAL,Company decision
NCT04513613,WITHDRAWN,OBSERVATIONAL,Sites have adjusted their participation priorities due to the pandemic. Not enough site interest at this current time to initiate the study.
NCT04513964,WITHDRAWN,OBSERVATIONAL,The project was abandoned.
NCT04514328,WITHDRAWN,INTERVENTIONAL,the study never opened for pandemic reasons
NCT04514406,TERMINATED,OBSERVATIONAL,no enrolments
NCT04514471,WITHDRAWN,INTERVENTIONAL,Replaced by another trial
NCT04514913,WITHDRAWN,OBSERVATIONAL,The restrictions on research imposed for the COVID-19 pandemic prevented us from launching study recruitment and visits. At this stage our funding is not sufficient to allow us to enroll sufficient numbers of patients so we will close the study.
NCT04515212,SUSPENDED,INTERVENTIONAL,Data evaluation is ongoing to determine if enrollment in this study will continue.
NCT04515329,WITHDRAWN,INTERVENTIONAL,No participants were enrolled. Study never started.
NCT04515394,TERMINATED,INTERVENTIONAL,The study was terminated early due to operational challenges identifying suitable participants for screening in the study.
NCT04515693,TERMINATED,INTERVENTIONAL,Due to COVID there were limitations is performing study activities and it was decided to terminate the study.
NCT04515901,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants.
NCT04515953,SUSPENDED,INTERVENTIONAL,pending
NCT04516603,WITHDRAWN,INTERVENTIONAL,Changement of study design. Restart spring 2021.
NCT04516941,TERMINATED,INTERVENTIONAL,Insufficient rate of patient accrual and newly available scientific evidence
NCT04517110,TERMINATED,INTERVENTIONAL,The COVID-19 pandemic has reduced recruitment such that the study is no longer feasible
NCT04517344,SUSPENDED,INTERVENTIONAL,protocol changes in the hospital
NCT04518137,TERMINATED,INTERVENTIONAL,"Due to the low popularity of NGS testing in China and the small number of target subjects, our company decided to adjust the research and development strategy, terminate this study and not apply for new drug registration after careful consideration."
NCT04518319,SUSPENDED,INTERVENTIONAL,The COVID-19 affects the recruitment of patients.
NCT04518449,WITHDRAWN,OBSERVATIONAL,no funds
NCT04519086,SUSPENDED,INTERVENTIONAL,"CT imaging equipment was upgraded during trial enrollment. Old imaging protocols were no longer compatible with new generation CT. As these were not comparable to previous imaging, study was suspended for analysis and reporting of imaging so far."
NCT04519411,WITHDRAWN,INTERVENTIONAL,"The study was stopped due to a very low rate of children with COVID-19 pneumonia that required endotracheal intubation, resulting in no eligible subjects to enroll."
NCT04519424,WITHDRAWN,INTERVENTIONAL,"Due to business reasons, not safety issues."
NCT04520412,SUSPENDED,INTERVENTIONAL,"The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time."
NCT04520425,TERMINATED,INTERVENTIONAL,Responsible Party left institution
NCT04520620,WITHDRAWN,INTERVENTIONAL,End of the COVID 19 epidemic in the region and decision to participate in a national study on the same subject (COVI-DOSE).
NCT04520867,WITHDRAWN,OBSERVATIONAL,PI is leaving the institution
NCT04521062,TERMINATED,INTERVENTIONAL,low recruitment
NCT04521296,TERMINATED,INTERVENTIONAL,Changes in drug development plans
NCT04521335,TERMINATED,INTERVENTIONAL,Closed at PI's Request
NCT04521621,TERMINATED,INTERVENTIONAL,Business Reasons
NCT04521777,TERMINATED,INTERVENTIONAL,Terminated early due to slow accrual
NCT04521946,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT04522219,TERMINATED,INTERVENTIONAL,difficulties in recruiting patients
NCT04522466,TERMINATED,INTERVENTIONAL,Stop of the study by competent authority (ANSM)
NCT04522817,WITHDRAWN,INTERVENTIONAL,"Acute COVID-19 treatments have improved significantly leading to decreased use of ventilatory support. This, coupled with approval of a vaccine, has changed the profile/prognosis of patients and led to a lack of patients with long-term hypoxia."
NCT04523090,TERMINATED,INTERVENTIONAL,Signal of futility at interim analysis
NCT04523792,WITHDRAWN,INTERVENTIONAL,Funder has not approved protocol
NCT04524195,TERMINATED,INTERVENTIONAL,The study is terminated because the PI left the institution.
NCT04524325,WITHDRAWN,INTERVENTIONAL,Funding never received.
NCT04524585,TERMINATED,INTERVENTIONAL,Study fellow moving back to home country
NCT04524715,WITHDRAWN,INTERVENTIONAL,Based upon feedback from IRB.
NCT04524819,SUSPENDED,OBSERVATIONAL,Covid-19 suspension
NCT04524858,TERMINATED,INTERVENTIONAL,"Due to patient enrollment challenges stemming from the COVID-19 pandemic, Aclaris has decided to focus its efforts and resources on other immuno-inflammatory diseases."
NCT04525170,WITHDRAWN,INTERVENTIONAL,It was decided by the sponsor to not proceed.
NCT04525352,TERMINATED,INTERVENTIONAL,Study discontinued due to feasibility.
NCT04525365,SUSPENDED,INTERVENTIONAL,It was not possible to achieve adequate recruitment to complete the necessary sample. The rate at which patients are recruited does not allow for continued participation
NCT04525391,TERMINATED,INTERVENTIONAL,Recommended completion of the study due to SUSAR occurring in other clinical trials conducted with the same drug.
NCT04525534,TERMINATED,OBSERVATIONAL,difficulties with enrollment
NCT04525573,WITHDRAWN,OBSERVATIONAL,Lost principal investigator. Have not picked up a new PI yet.
NCT04525586,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT04525898,TERMINATED,INTERVENTIONAL,Investigator left institution
NCT04526080,WITHDRAWN,INTERVENTIONAL,This application needs further attention in terms of FDA approval and will be reassigned under a different trial number later.
NCT04526288,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT04526717,WITHDRAWN,INTERVENTIONAL,Study was determined not to initiate.
NCT04526821,TERMINATED,INTERVENTIONAL,The study was interrupted due to the arrival and distribution of the vaccine to hospital workers in Peru
NCT04526912,TERMINATED,INTERVENTIONAL,Study met predefined futility criteria for efficacy endpoints.
NCT04526925,TERMINATED,INTERVENTIONAL,Staffing issues
NCT04527523,TERMINATED,OBSERVATIONAL,PI does not have the time and support needed to continue the study at this time.
NCT04527588,WITHDRAWN,OBSERVATIONAL,same study was published from another group
NCT04527796,TERMINATED,OBSERVATIONAL,number included
NCT04528199,TERMINATED,INTERVENTIONAL,The Principal Investigator decided to terminate the study because the PI left Hopkins.
NCT04528238,WITHDRAWN,INTERVENTIONAL,following the covid health crisis the study has not begun
NCT04528433,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04528654,TERMINATED,INTERVENTIONAL,Challenges in recruitment
NCT04528758,SUSPENDED,INTERVENTIONAL,re-evaluation of radiotracer
NCT04528862,WITHDRAWN,INTERVENTIONAL,Due to logistical issues the study as designed was determined to not be feasible.
NCT04528927,WITHDRAWN,INTERVENTIONAL,- Interest in the use of HCQ is controversial.
NCT04529291,WITHDRAWN,INTERVENTIONAL,The IP decided to stop.
NCT04529460,WITHDRAWN,OBSERVATIONAL,Funding withdrawn
NCT04529499,TERMINATED,INTERVENTIONAL,Study met pre-defined criteria for futility at interim analysis
NCT04529603,WITHDRAWN,INTERVENTIONAL,The previous studies did not show convincing results of this technology.
NCT04529928,TERMINATED,INTERVENTIONAL,"The study was not accruing subjects as expected, due to limits in hospital resources and staff as a result of the COVID pandemic in Europe."
NCT04529954,TERMINATED,INTERVENTIONAL,Company Decision
NCT04530162,WITHDRAWN,OBSERVATIONAL,No patients qualified for the study; PI left institution and current investigators lost interest in the study.
NCT04530448,TERMINATED,INTERVENTIONAL,"Unable to recruit enough subjects to complete the study. Only 3 subjects enrolled. However, those subjects did not complete the study as the PI terminated the study and data was not collected."
NCT04530474,WITHDRAWN,INTERVENTIONAL,WHO report
NCT04530617,TERMINATED,INTERVENTIONAL,Results from the interim analysis
NCT04530695,WITHDRAWN,INTERVENTIONAL,PI left institution and research was cancelled due to his departure
NCT04530747,TERMINATED,INTERVENTIONAL,Recall of positive airway pressure (PAP) device.
NCT04530877,WITHDRAWN,INTERVENTIONAL,no funding
NCT04531397,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04531579,WITHDRAWN,INTERVENTIONAL,Study terminated by the Sponsor.
NCT04531592,WITHDRAWN,INTERVENTIONAL,Study terminated by the Sponsor
NCT04531748,WITHDRAWN,INTERVENTIONAL,Funding
NCT04531839,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04531865,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04531878,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04532424,SUSPENDED,INTERVENTIONAL,Recruitment is currently suspended due to a change in PI and staff training is required.
NCT04532554,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04532723,WITHDRAWN,INTERVENTIONAL,Company lost funding
NCT04532749,TERMINATED,INTERVENTIONAL,42847922MDD3002 was stopped based on the interim analysis (IA) results as recommended by the Independent Data Monitoring Committee (IDMC)
NCT04532879,WITHDRAWN,INTERVENTIONAL,decided not to do the study due to Covid staffing restrictions
NCT04533074,TERMINATED,INTERVENTIONAL,due to the COVID-19 pandemic
NCT04533230,WITHDRAWN,INTERVENTIONAL,The study was stopped due to the COVID-19 pandemic restricting access to primary healthcare clinics.
NCT04533737,TERMINATED,INTERVENTIONAL,The recruitment was terminated early due to delays and slow recruitment that significantly jeopardized the trial timelines. There were no safety concerns related to the early termination of the trial.
NCT04534101,SUSPENDED,OBSERVATIONAL,Temporarily paused due to COVID-19 and expected to resume. Resumption timeline unclear due ongoing pandemic. This is not a suspension of IRB approval.
NCT04534140,WITHDRAWN,INTERVENTIONAL,Contract not negotiated.
NCT04534283,TERMINATED,INTERVENTIONAL,Lack of efficacy.
NCT04534803,WITHDRAWN,INTERVENTIONAL,At this time it has been decided by the study team the the study will no longer take place in the United States.
NCT04534829,WITHDRAWN,INTERVENTIONAL,Study cancelled
NCT04534881,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT04535102,WITHDRAWN,INTERVENTIONAL,Lack of sufficient patient population
NCT04535492,WITHDRAWN,INTERVENTIONAL,No further funding
NCT04535505,WITHDRAWN,OBSERVATIONAL,Not as a lead unit
NCT04535518,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04535648,WITHDRAWN,OBSERVATIONAL,This clinical trial has been terminated
NCT04535817,WITHDRAWN,INTERVENTIONAL,We are terminating due to loss of funding because of Covid-19.
NCT04535895,WITHDRAWN,INTERVENTIONAL,Treatment standard has changed
NCT04535908,TERMINATED,INTERVENTIONAL,Treatment standard has changed.
NCT04536077,TERMINATED,INTERVENTIONAL,Celldex decision
NCT04536181,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04536350,TERMINATED,INTERVENTIONAL,Difficulties recruiting participants for the Aviptadil study as there are nowadays very few hospitalized COVID patients. Continuous screening has been carried out but none of the patients met the eligibility criteria for the study.
NCT04536363,WITHDRAWN,INTERVENTIONAL,Delays in approval by the national regulatory authority
NCT04536532,SUSPENDED,INTERVENTIONAL,New investigational drug on the same target already in clinical trials
NCT04536857,SUSPENDED,OBSERVATIONAL,"The study has not been funded so far, but we will study it in the future."
NCT04536922,WITHDRAWN,INTERVENTIONAL,Subject no longer able to participate in this single pt study.
NCT04537000,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04537039,WITHDRAWN,INTERVENTIONAL,The COVID outbreak did not allow home visits
NCT04537143,WITHDRAWN,OBSERVATIONAL,Funding for staff no longer available
NCT04537806,TERMINATED,INTERVENTIONAL,Internal company decision
NCT04537832,TERMINATED,OBSERVATIONAL,The ENVISION study has generated a robust data set that shows consistency in the seizure and non-seizure manifestations of SCN1A+ Dravet syndrome.
NCT04537975,WITHDRAWN,INTERVENTIONAL,Withdrawn (Study was withdrawn by Sponsor because of change in regulatory strategy.)
NCT04538079,TERMINATED,OBSERVATIONAL,End of funding period
NCT04538092,TERMINATED,INTERVENTIONAL,PI moved to different institution
NCT04538105,WITHDRAWN,INTERVENTIONAL,Study cancelled
NCT04538196,WITHDRAWN,INTERVENTIONAL,Study staffing constraints
NCT04538261,TERMINATED,INTERVENTIONAL,Not recruiting at the rate we thought it would.
NCT04538430,TERMINATED,INTERVENTIONAL,Due to COVID-19 and other factors this study was terminated early and the patients currently enrolled are being used as a small pilot study.
NCT04538833,WITHDRAWN,INTERVENTIONAL,"In the clinical treatment, no patient with a score of less than 38(FACT Ntx Score) points after 1-2 weeks of application of albumin bound paclitaxel in this project, therefore, there is no suitable subject after screening"
NCT04539275,TERMINATED,INTERVENTIONAL,DMC recommended early termination of enrollment
NCT04539366,SUSPENDED,INTERVENTIONAL,Interim Monitoring
NCT04539483,TERMINATED,INTERVENTIONAL,stopped for futility in interim analysis
NCT04539509,WITHDRAWN,INTERVENTIONAL,Revising study protocol.
NCT04539730,WITHDRAWN,INTERVENTIONAL,Did not acquire funding to pursue study
NCT04539873,TERMINATED,INTERVENTIONAL,non-inclusion of patients in the study effectively
NCT04540120,TERMINATED,INTERVENTIONAL,Terminated due to the treatment environment for COVID-19 evolving with the pervasiveness of vaccinations and other therapeutic modalities in mitigating against severe infection that has eliminated a viable patient population for study enrollment.
NCT04540289,WITHDRAWN,INTERVENTIONAL,"trial is not feasible (very low event rates, no available risk predictor with acceptable predictive performance for discrimination of high-risk patients)"
NCT04540354,WITHDRAWN,INTERVENTIONAL,Study design needs to be updated considering the lack of a risk predictor with acceptable predictive performance for the discrimination between high- and low-risk patients and the overall low sudden cardiac death risk as found in the data analysis
NCT04540393,WITHDRAWN,INTERVENTIONAL,"The study was put on hold in September 2020 due to a safety concern in another trial but never restarted. In the meantime our clinical development program now includes a similar study with a different design, which we prefer to complete now."
NCT04540510,TERMINATED,INTERVENTIONAL,due to COVID-19
NCT04540523,WITHDRAWN,INTERVENTIONAL,Project not funded
NCT04540848,WITHDRAWN,INTERVENTIONAL,Lack of ability to communicate with the study population
NCT04540874,TERMINATED,INTERVENTIONAL,due to company decision
NCT04540952,TERMINATED,INTERVENTIONAL,COVID-19
NCT04541147,TERMINATED,INTERVENTIONAL,Lack of funding
NCT04541173,TERMINATED,INTERVENTIONAL,Due to slow accrual.
NCT04541225,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04541485,TERMINATED,INTERVENTIONAL,Enrolment was suspended since 09Dec2020 due to a lack of COVID-19 patients.
NCT04541550,WITHDRAWN,INTERVENTIONAL,Study didn't proceed to FDA submission
NCT04541576,WITHDRAWN,INTERVENTIONAL,FDA Approval
NCT04541628,TERMINATED,INTERVENTIONAL,SIG-001 programme terminated
NCT04541719,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04541875,WITHDRAWN,OBSERVATIONAL,Liquidation of sponsor
NCT04542005,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT04542083,TERMINATED,OBSERVATIONAL,Maximum recruitment reached
NCT04542395,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT04542434,WITHDRAWN,INTERVENTIONAL,Sponsor asset acquired by another pharma company who opened their own IND for this compound. First Wave Bio never started this study in the US or ex-US.
NCT04542681,WITHDRAWN,INTERVENTIONAL,Study was withdrawn and replaced by a larger study
NCT04542993,TERMINATED,INTERVENTIONAL,Difficulty accruing patients
NCT04543188,TERMINATED,INTERVENTIONAL,Pfizer has made an internal business decision to not continue further development of PF-07284890. This decision was not due to major safety concerns or requests from any regulatory authorities.
NCT04543279,TERMINATED,INTERVENTIONAL,Low accrual
NCT04543409,TERMINATED,INTERVENTIONAL,"High-level results from the MESSINA Phase III trial showed that AstraZeneca's Fasenra (benralizumab) did not meet one of the two dual-primary endpoints. Given the lack of clear benefit in this patient population, study has been terminated."
NCT04543513,WITHDRAWN,INTERVENTIONAL,Changes to protocol are necessary to optimize engagement of neural target
NCT04543526,WITHDRAWN,OBSERVATIONAL,No CEC approval
NCT04543786,TERMINATED,INTERVENTIONAL,Funding ended
NCT04543916,WITHDRAWN,INTERVENTIONAL,AbbVie decided to stop trial involving Venetoclax for safety measures needed
NCT04543955,TERMINATED,INTERVENTIONAL,Sponsor cancelled research
NCT04544267,SUSPENDED,INTERVENTIONAL,"Decision prompted due to COVID -19 pandemic challenges on:

1. Low influenza virus circulation rates on Pediatric population
2. Challenges on Recruitment/participant follow-up
3. Uncertainties on COVID-19 situation for 2022-2023 influenza season"
NCT04544709,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04544735,SUSPENDED,INTERVENTIONAL,Awaiting new funding source
NCT04544800,TERMINATED,INTERVENTIONAL,PI Relocation
NCT04544995,SUSPENDED,INTERVENTIONAL,The study was paused for enrolment to further assess clinical data
NCT04545008,TERMINATED,INTERVENTIONAL,Study was stopped due to poor accrual.
NCT04545320,WITHDRAWN,INTERVENTIONAL,No participants were enrolled in this study due to the COVID-19 pandemic.
NCT04545385,TERMINATED,INTERVENTIONAL,Met pre-specified criteria for futility at interim analysis
NCT04545528,WITHDRAWN,OBSERVATIONAL,Logistical problems in clinic
NCT04545853,WITHDRAWN,OBSERVATIONAL,Due to COVID-19
NCT04546399,SUSPENDED,INTERVENTIONAL,Other - FDA Partial Clinical Hold
NCT04546568,TERMINATED,INTERVENTIONAL,Failed to meet recruitment target
NCT04546711,WITHDRAWN,OBSERVATIONAL,decided not to process with study
NCT04546802,WITHDRAWN,INTERVENTIONAL,Recruitment will be too difficult due to available PBS funded treatment and recent Australian clinical guidelines will conflict with the premise of the study.
NCT04546828,WITHDRAWN,INTERVENTIONAL,problem of sponsor
NCT04547101,TERMINATED,INTERVENTIONAL,"Due to difficuty of erollment and consideration of clinical guideline,The sponsor decided to stop study."
NCT04547140,TERMINATED,INTERVENTIONAL,Study Stopped for Futility
NCT04547374,WITHDRAWN,OBSERVATIONAL,Principle investigator changed academic affiliation- No longer at Geisinger- Study terminated prematurely- No Participants Enrolled.
NCT04547556,TERMINATED,INTERVENTIONAL,Difficult recruitment in the context of the pandemic.
NCT04547985,TERMINATED,INTERVENTIONAL,We are terminating the study due to low accrual.
NCT04548037,TERMINATED,OBSERVATIONAL,Departure of the principal investigator
NCT04548622,TERMINATED,INTERVENTIONAL,Dr. Ralph Hoffman unexpectedly passed away.
NCT04548700,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04548791,TERMINATED,INTERVENTIONAL,Company decision (not a safety issue)
NCT04548882,WITHDRAWN,INTERVENTIONAL,Study closed based on continued restrictions around COVID-19
NCT04549129,WITHDRAWN,INTERVENTIONAL,This pilot study was planned just prior to and during the covid-19 pandemic and was not able to begin due to changes in staffing availability and clinic logistics during the pandemic.
NCT04549285,WITHDRAWN,INTERVENTIONAL,No accrual
NCT04549363,TERMINATED,INTERVENTIONAL,The study has been terminated for reasons pertaining to feasibility
NCT04549584,TERMINATED,OBSERVATIONAL,due to poor enrolled patients
NCT04550338,WITHDRAWN,INTERVENTIONAL,"With vaccination efforts ongoing, a feasibility survey indicated there would be inadequate recruitment"
NCT04551144,TERMINATED,OBSERVATIONAL,lack of recruitment
NCT04551157,TERMINATED,INTERVENTIONAL,Unable to recruit during Covid \& funding no longer available
NCT04551183,WITHDRAWN,INTERVENTIONAL,The study had to be cancelled do to the Covid-19 pandemic
NCT04551573,WITHDRAWN,INTERVENTIONAL,COVID-19 Pandemic
NCT04551885,TERMINATED,INTERVENTIONAL,This study was terminated by the Sponsor.
NCT04552015,TERMINATED,INTERVENTIONAL,There is a problem with the investigational product
NCT04552262,TERMINATED,INTERVENTIONAL,Terminated
NCT04552652,TERMINATED,INTERVENTIONAL,covid-19 pandemic complications with participants recruitment
NCT04552665,TERMINATED,OBSERVATIONAL,EPD Business was terminated
NCT04552704,TERMINATED,INTERVENTIONAL,Terminated early by the Sponsor due to business reason.
NCT04552899,TERMINATED,INTERVENTIONAL,The study was terminated by Sponsor as the futility analysis outcome indicated that the study was unlikely to meet the predefined primary objective of the study. No new safety concerns were identified.
NCT04553263,WITHDRAWN,INTERVENTIONAL,Study never initiated
NCT04553406,TERMINATED,INTERVENTIONAL,Business decision pending resolution of clinical hold with FDA
NCT04553744,WITHDRAWN,OBSERVATIONAL,0 participant accrual
NCT04554264,WITHDRAWN,INTERVENTIONAL,no participants
NCT04554420,WITHDRAWN,INTERVENTIONAL,"Given recruitment challenges for youth focus groups, we are currently finalizing the creation of the intervention based on the focus groups. We plan to submit for new grant funding to implement a different intervention at a future date."
NCT04554459,SUSPENDED,INTERVENTIONAL,slower recruitment rate;
NCT04555096,TERMINATED,INTERVENTIONAL,Participants are no longer receiving intervention
NCT04555122,WITHDRAWN,INTERVENTIONAL,Per Sponsor Request; nonACT
NCT04555135,TERMINATED,INTERVENTIONAL,Decision made based on Interim Analysis Results
NCT04555239,TERMINATED,INTERVENTIONAL,Failure to recruit sufficient numbers due to the pandemic
NCT04555564,WITHDRAWN,INTERVENTIONAL,Study withdrawn in IRB
NCT04555603,WITHDRAWN,OBSERVATIONAL,Failed at data quality assurance process before any analyses would be performed
NCT04556032,TERMINATED,INTERVENTIONAL,Sponsor terminated study due to unforeseen recruitment circumstances amidst the COVID19 pandemic.
NCT04556175,TERMINATED,INTERVENTIONAL,Safety concerns for study participants and non-feasibility of enrollment due to the COVID-19 pandemic.
NCT04556240,WITHDRAWN,OBSERVATIONAL,Study withdrawn due to COVID endemic
NCT04556266,WITHDRAWN,INTERVENTIONAL,"No patients were enrolled to this study since being open to enrollment. Due to changes in available therapies, there aren't enough people who will be eligible for the study. Therefore, the study was closed."
NCT04556383,TERMINATED,INTERVENTIONAL,Study terminated due to lack of treatment benefit.
NCT04556435,TERMINATED,OBSERVATIONAL,Change in the sponsor's business strategy (new focus on breast cancer)
NCT04556617,TERMINATED,INTERVENTIONAL,study terminated due to business realignment
NCT04556721,WITHDRAWN,INTERVENTIONAL,Difficulty and lack of recruitment of the patients
NCT04556929,TERMINATED,INTERVENTIONAL,Technical limitations of in-built operative microscope optics
NCT04557384,TERMINATED,INTERVENTIONAL,Study terminated due to inadequate PK profile associated with the subcutaneous formulation.
NCT04557475,WITHDRAWN,INTERVENTIONAL,We are modifying this trial's protocol and will resubmit a new application at a later date.
NCT04557696,TERMINATED,INTERVENTIONAL,Resident/fellow feedback indicated study factors made it difficult to participate and busy schedules did not accommodate to consent.
NCT04558034,TERMINATED,INTERVENTIONAL,Principal Investigator retired before study completed.
NCT04558125,TERMINATED,INTERVENTIONAL,Identification of eligible patients was slower than anticipated.
NCT04558216,WITHDRAWN,INTERVENTIONAL,Withdrawn due to unavailability of rifampin for clinical trial use
NCT04558281,TERMINATED,INTERVENTIONAL,Could only enroll 4 subjects in nearly 2 years
NCT04558489,WITHDRAWN,INTERVENTIONAL,"This study has withdrawn due to recruitment issues at our pediatric primary care setting. Due to the COVID-19 pandemic and other unforeseen medical absences, the study was unable to recruit participants."
NCT04558684,SUSPENDED,INTERVENTIONAL,Inadequate patient enrollment
NCT04558840,TERMINATED,INTERVENTIONAL,interim analysis completed
NCT04558892,TERMINATED,INTERVENTIONAL,The primary objectives were achieved.
NCT04559178,TERMINATED,OBSERVATIONAL,too difficult to measure sublingual microcirculation continuously during a fluid challenge
NCT04559347,SUSPENDED,INTERVENTIONAL,Reviewing randomization process
NCT04559516,WITHDRAWN,INTERVENTIONAL,Principal Investigator moved to different institution.
NCT04559867,SUSPENDED,INTERVENTIONAL,slower than expected recruitment
NCT04560010,TERMINATED,INTERVENTIONAL,Enrollment rate was slower than anticipated
NCT04560166,TERMINATED,INTERVENTIONAL,Due to business priorities
NCT04560439,WITHDRAWN,INTERVENTIONAL,Funding
NCT04560582,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT04560686,TERMINATED,INTERVENTIONAL,Per PI Request
NCT04561076,WITHDRAWN,INTERVENTIONAL,Sponsor strategy
NCT04561180,WITHDRAWN,INTERVENTIONAL,No patients COVID-19 morbidity decreased.
NCT04561375,TERMINATED,INTERVENTIONAL,For practical reasons of slow enrollment
NCT04561388,WITHDRAWN,INTERVENTIONAL,patient recruitment problem
NCT04561414,WITHDRAWN,INTERVENTIONAL,Study was registered but never started.
NCT04561583,WITHDRAWN,INTERVENTIONAL,The study was registered but never started.
NCT04561700,WITHDRAWN,INTERVENTIONAL,Unfunded
NCT04561817,WITHDRAWN,INTERVENTIONAL,Evolving data with Ipatasertib that changes the known risk / benefit background in pursuing future studies.
NCT04562233,TERMINATED,INTERVENTIONAL,PI left
NCT04562298,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study.
NCT04563195,WITHDRAWN,INTERVENTIONAL,Drug unavailable
NCT04563221,WITHDRAWN,INTERVENTIONAL,Funding not approved
NCT04563234,WITHDRAWN,INTERVENTIONAL,Trial not funded.
NCT04563299,TERMINATED,INTERVENTIONAL,Subject Enrollment
NCT04563559,WITHDRAWN,INTERVENTIONAL,PI decided not to open study
NCT04563637,TERMINATED,OBSERVATIONAL,Sponsor terminated due to lack of funding
NCT04563728,TERMINATED,INTERVENTIONAL,Covid-19
NCT04563806,TERMINATED,INTERVENTIONAL,Per PI
NCT04564196,TERMINATED,OBSERVATIONAL,Staffing and equipment complications have paused further enrollment until resolved
NCT04565249,TERMINATED,INTERVENTIONAL,Study halted and will not resume; participants are no longer being examined or receiving intervention
NCT04565327,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04565392,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04565626,WITHDRAWN,INTERVENTIONAL,PI left institution
NCT04565717,TERMINATED,INTERVENTIONAL,Study ALN-HSD-001 was terminated due to business reasons and changes in the development strategy of the product. No safety issues were found.
NCT04566133,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04566289,WITHDRAWN,OBSERVATIONAL,Study terminated due to lack of financing
NCT04566926,TERMINATED,INTERVENTIONAL,business decision
NCT04566965,TERMINATED,OBSERVATIONAL,CARES and institutional funding ended
NCT04567095,WITHDRAWN,OBSERVATIONAL,This study was cancelled before any data collection due to business reasons.
NCT04567173,TERMINATED,INTERVENTIONAL,Limited enrolment (unable to achieve target sample size)
NCT04567225,TERMINATED,INTERVENTIONAL,Stopped after internal review
NCT04567589,WITHDRAWN,OBSERVATIONAL,This study was cancelled before any data collection due to business reasons.
NCT04568174,TERMINATED,INTERVENTIONAL,Data don't support further development
NCT04569084,TERMINATED,INTERVENTIONAL,Futility was met.
NCT04569318,TERMINATED,INTERVENTIONAL,Study objectives met
NCT04569721,WITHDRAWN,INTERVENTIONAL,There was only one subject consented and it was a screen failure. No participants enrolled and study is being closed due to lack of enrollment.
NCT04569760,WITHDRAWN,INTERVENTIONAL,Project cancelled prior to commencing recruitment
NCT04569786,TERMINATED,INTERVENTIONAL,The study was terminated based on an interim assessment of immunogenicity.
NCT04570111,TERMINATED,INTERVENTIONAL,Inadequate number of eligible participants
NCT04570449,WITHDRAWN,INTERVENTIONAL,Study timeline is not feasible
NCT04570462,WITHDRAWN,INTERVENTIONAL,"The study was opened at the close of the peak of COVID. At our institution, there are significantly less COVID patients admitted who qualify for the study"
NCT04570501,WITHDRAWN,INTERVENTIONAL,Discontinuation of drug candidates
NCT04570995,TERMINATED,INTERVENTIONAL,Sponsor unable to send smaller necessary capsules
NCT04571580,TERMINATED,INTERVENTIONAL,The study enrollment is slow due to the pandemic.
NCT04572217,WITHDRAWN,INTERVENTIONAL,No available funding
NCT04572646,TERMINATED,INTERVENTIONAL,Recruitment goal not feasible
NCT04572776,WITHDRAWN,INTERVENTIONAL,To be replaced by a different protocol
NCT04572867,WITHDRAWN,INTERVENTIONAL,"Due to low enrollment, COVID-19 pandemic causing suspension of most outpatient elective procedures, and no protected research time, Dr. Gelzer Bell is unable to continue this study."
NCT04572893,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT04573634,WITHDRAWN,OBSERVATIONAL,Low accrual
NCT04573777,TERMINATED,INTERVENTIONAL,Funding Discontinued
NCT04574869,WITHDRAWN,INTERVENTIONAL,Low probability of enrolling patients prior to expiry of study drug.
NCT04574973,TERMINATED,INTERVENTIONAL,Relocation of PI
NCT04575285,WITHDRAWN,OBSERVATIONAL,Study was closed due to lack of resources
NCT04575298,TERMINATED,OBSERVATIONAL,Difficulty to recruit patients due to pandemic
NCT04575558,WITHDRAWN,INTERVENTIONAL,Withdrawn due to lack of study centers interested in participating.
NCT04575584,TERMINATED,INTERVENTIONAL,Business reasons
NCT04575610,TERMINATED,INTERVENTIONAL,Study terminated due to lack of enrollment reflecting the decrease in number of COVID infections. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.
NCT04575766,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04575818,TERMINATED,INTERVENTIONAL,Development of compound has been stopped
NCT04575909,WITHDRAWN,INTERVENTIONAL,Funding not received
NCT04576000,TERMINATED,OBSERVATIONAL,Not able to meet recruitment targets
NCT04576013,TERMINATED,INTERVENTIONAL,PI is leaving the university.
NCT04576208,WITHDRAWN,INTERVENTIONAL,Business Decision (no safety or efficacy concerns)
NCT04576247,TERMINATED,INTERVENTIONAL,Low accrual
NCT04576507,SUSPENDED,INTERVENTIONAL,"In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023."
NCT04576650,WITHDRAWN,INTERVENTIONAL,Investigational device no longer available. No subjects enrolled.
NCT04576806,WITHDRAWN,INTERVENTIONAL,Other research priorities during Covid-19 pandemic.
NCT04576923,TERMINATED,INTERVENTIONAL,Lack of coordinator resources
NCT04576936,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT04577053,TERMINATED,INTERVENTIONAL,"It was discovered during the study that Lyme Disease is a bio warfare weapon made in USA. (See ""Bitten"" by Kris Newby.) The second reason for stopping the study is lack of participant responses, likely due to lack of payment for completing surveys."
NCT04577131,TERMINATED,INTERVENTIONAL,The tracker application has been withdrawn by developer and no other suitable tracker application has been identified to replace it.
NCT04577144,TERMINATED,OBSERVATIONAL,Study re-scoped due to COVID-19 pandemic.
NCT04577547,WITHDRAWN,INTERVENTIONAL,Never started
NCT04577729,TERMINATED,INTERVENTIONAL,Agreement with project partner prematurely cancelled.
NCT04577820,WITHDRAWN,INTERVENTIONAL,Phase 2 Study R2477-FOP-1940 has been withdrawn and the next phase of the development program is being planned
NCT04577976,TERMINATED,OBSERVATIONAL,Low enrollment
NCT04578015,TERMINATED,INTERVENTIONAL,"After screening many patients for BV, it was determined that the rate of BV is less in our population that the 30% rate mentioned in the literature. It was determined that completing the study will not be feasible due to cost and time constraints."
NCT04578041,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04578093,WITHDRAWN,INTERVENTIONAL,PI No Longer at Institution
NCT04578548,TERMINATED,INTERVENTIONAL,The study was early terminated due to lack of efficacy.
NCT04578743,WITHDRAWN,INTERVENTIONAL,COVID-induced lockdowns.
NCT04578951,TERMINATED,OBSERVATIONAL,Only 19% of the expected patients have been enroled. Patient's follow-up has not been realized as expected in the protocol
NCT04579068,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT04579081,WITHDRAWN,OBSERVATIONAL,This study has not been started. The Sponsor has decided not to pursue this study.
NCT04579133,TERMINATED,INTERVENTIONAL,Not approved
NCT04579185,WITHDRAWN,INTERVENTIONAL,"Due to COVID, this study was not initiated"
NCT04579458,WITHDRAWN,OBSERVATIONAL,Not able to enroll the amount required.
NCT04579653,WITHDRAWN,INTERVENTIONAL,Staff who where to run the study left.
NCT04579666,TERMINATED,INTERVENTIONAL,"The study did not meet primary endpoint at Week 52. The study also did not meet key secondary efficacy endpoints. Pegcetacoplan (APL-2) was well tolerated in the study, and the data were consistent with the established safety profile."
NCT04579796,SUSPENDED,INTERVENTIONAL,lack of funding
NCT04579913,TERMINATED,OBSERVATIONAL,Covid-19
NCT04580004,TERMINATED,INTERVENTIONAL,Lack of personnel to run the study.
NCT04580238,WITHDRAWN,INTERVENTIONAL,Logistical issues
NCT04580277,TERMINATED,INTERVENTIONAL,low recruitment
NCT04580524,WITHDRAWN,INTERVENTIONAL,Not able to secure funding
NCT04580836,WITHDRAWN,INTERVENTIONAL,A study with 0 ACTUAL Enrollment must have Overall Recruitment Status specified as Withdrawn
NCT04581070,TERMINATED,OBSERVATIONAL,Study stopped due to low accrual
NCT04581525,TERMINATED,INTERVENTIONAL,Insufficient staff to carry out study
NCT04581733,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT04581785,TERMINATED,INTERVENTIONAL,Due to low likelihood of clinical benefit in treated participants.
NCT04581915,TERMINATED,INTERVENTIONAL,DSMB report
NCT04582071,WITHDRAWN,INTERVENTIONAL,"After further review and discussion, the scope of the study is being changed to better suit the patient population. No subjects were enrolled in the study."
NCT04582318,TERMINATED,INTERVENTIONAL,"Due to the rapidly changing therapeutic landscape in the COVID-19 space and an assessment of unmet medical need, Part 2 of the study was cancelled (per protocol Section 4.3). Meanwhile, Part 1 of the study was completed."
NCT04582357,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT04582396,TERMINATED,INTERVENTIONAL,majority of the participants had exclusion criteria of anticoagulant use
NCT04582409,TERMINATED,INTERVENTIONAL,Terminated due to business decision
NCT04582578,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting
NCT04582669,TERMINATED,INTERVENTIONAL,This study was administratively closed.
NCT04583241,TERMINATED,OBSERVATIONAL,difficulties in including patients with Staphylococcus aureus infection
NCT04583280,TERMINATED,INTERVENTIONAL,Janssen made the strategic decision to discontinue the DAISY study. This decision is not based on any safety concerns.
NCT04583397,SUSPENDED,INTERVENTIONAL,Corona
NCT04583423,TERMINATED,INTERVENTIONAL,Business reasons
NCT04583579,TERMINATED,INTERVENTIONAL,Principal investigator ended full-time appointment at university.
NCT04583748,WITHDRAWN,INTERVENTIONAL,COVID 19
NCT04583826,SUSPENDED,INTERVENTIONAL,Staff shortages
NCT04584034,WITHDRAWN,INTERVENTIONAL,Premature ending of the study due to impossibility of obtaining a suitable placebo-inhaler
NCT04584099,TERMINATED,INTERVENTIONAL,This study stopped due to a business decision.
NCT04584151,TERMINATED,INTERVENTIONAL,Surgeon left the team
NCT04584307,WITHDRAWN,INTERVENTIONAL,Funder pulled support/funding
NCT04584437,WITHDRAWN,INTERVENTIONAL,No Financial Support
NCT04584541,TERMINATED,INTERVENTIONAL,The study of the long term antibody response is no longer relative due to the introduction of Covid vaccine.
NCT04584684,TERMINATED,INTERVENTIONAL,"The team decided to terminate the trial in order to start a new trial, unrelated to safety reasons"
NCT04584697,WITHDRAWN,INTERVENTIONAL,Different study will be conducted
NCT04585022,TERMINATED,INTERVENTIONAL,High early failure rates and adverse reactions in similar devices
NCT04585243,TERMINATED,INTERVENTIONAL,"low recruitment, preliminary analyses indicates that primary endpoint has been met"
NCT04585386,TERMINATED,INTERVENTIONAL,Sponsor decision: no sufficient patient
NCT04585724,WITHDRAWN,INTERVENTIONAL,Closed due to low (0) accrual
NCT04585932,WITHDRAWN,INTERVENTIONAL,At the request of the ad interim Department Chairman due to PI is no longer at institution.
NCT04585958,SUSPENDED,INTERVENTIONAL,Other - Pending protocol amendment.
NCT04586179,TERMINATED,INTERVENTIONAL,Unable to enroll target number of participants.
NCT04586244,TERMINATED,INTERVENTIONAL,Business Decision. No safety concerns contributed to this decision.
NCT04586309,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT04586335,TERMINATED,INTERVENTIONAL,Business decision
NCT04586777,TERMINATED,INTERVENTIONAL,Relocation of PI
NCT04586920,TERMINATED,INTERVENTIONAL,Terminated due to safety findings
NCT04586998,WITHDRAWN,INTERVENTIONAL,Business decision
NCT04587193,TERMINATED,INTERVENTIONAL,COVID-19 prevented the study from being able to be completed
NCT04587531,TERMINATED,INTERVENTIONAL,Lack of financing
NCT04588207,TERMINATED,INTERVENTIONAL,Unable to recruit participants
NCT04588688,TERMINATED,INTERVENTIONAL,low recruitment
NCT04588792,TERMINATED,INTERVENTIONAL,Lack of recruitment due to decline in critically ill Covid-19 patients
NCT04588870,WITHDRAWN,INTERVENTIONAL,Was never funded.
NCT04588948,WITHDRAWN,INTERVENTIONAL,Study did not proceed due to funding issues.
NCT04589065,SUSPENDED,INTERVENTIONAL,Recruitment on hold pending amendment approval.
NCT04589260,TERMINATED,INTERVENTIONAL,The Sponsor has decided to stop the study due to business reasons. Study was terminated before initiation of part C and D (Decision to not proceed with Parts C and D was not for safety reasons and do not impact the overall risk benefit of the IMP.)
NCT04589572,SUSPENDED,INTERVENTIONAL,Because of COVID-19
NCT04589832,TERMINATED,INTERVENTIONAL,This study required dose reductions to the lower dose level (Dose level -1). But this dose level (Dose level -1) was not further explored because of lack of funding.
NCT04589884,TERMINATED,OBSERVATIONAL,Data acquisition not possible anymore
NCT04589949,TERMINATED,INTERVENTIONAL,vaccination uptake 80% in the target population/new COVID variant
NCT04590014,TERMINATED,INTERVENTIONAL,Study was not needed from trial standpoint
NCT04590274,WITHDRAWN,INTERVENTIONAL,Investigative Team no longer interested
NCT04590781,TERMINATED,INTERVENTIONAL,The study has been terminated early by the sponsor due to business decision.
NCT04591002,WITHDRAWN,INTERVENTIONAL,"Further consultation is required, we plan to submit it again as a new project and proceed."
NCT04591028,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT04591288,TERMINATED,INTERVENTIONAL,Closed by the sponsor for not fully meeting subject recruitment targets.
NCT04591730,TERMINATED,OBSERVATIONAL,Completion failure
NCT04591808,TERMINATED,INTERVENTIONAL,for strategic reasons
NCT04591834,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT04591925,TERMINATED,INTERVENTIONAL,Interim analysis
NCT04591977,TERMINATED,INTERVENTIONAL,"low recruitment, preliminary analysis indicates that primary endpoint has been met"
NCT04592159,WITHDRAWN,INTERVENTIONAL,The decision to suspend this study was based upon evaluation of pandemic-related challenges impacting both clinical trial sites and potential participants. This suspension was initiated prior to site activation and participant recruitment.
NCT04592341,TERMINATED,INTERVENTIONAL,Decision to terminate development of Gantenerumab for treatment of prodromal/mild/early-stage Alzheimer's disease following results of a pre-planned analysis of the safety and efficacy of Gant in Graduate I\&II (WN29922/WN39658).
NCT04592380,WITHDRAWN,INTERVENTIONAL,"Product was divested to Chiesi USA, who decided to not move forward with study."
NCT04592861,TERMINATED,INTERVENTIONAL,Study administratively closed out by the Einstein IRB. NO US enrolling sites.
NCT04592991,TERMINATED,INTERVENTIONAL,"We were only able to enroll 1 subject so we had no way to compare a control or other study groups and develop any kind of results. This study is essentially the same study as NCT04586452, which we would like to place focus and effort on that study."
NCT04593329,WITHDRAWN,INTERVENTIONAL,Strategy review
NCT04593602,WITHDRAWN,INTERVENTIONAL,Changed research approach
NCT04593628,WITHDRAWN,INTERVENTIONAL,The study aims changed based on the results of a earlier qualitative study.
NCT04593914,WITHDRAWN,INTERVENTIONAL,Covid-19
NCT04594031,WITHDRAWN,INTERVENTIONAL,Preference given to gene therapy approaches by the SCD research community and patients' associations
NCT04594070,TERMINATED,INTERVENTIONAL,Unable to recruit enough participants
NCT04594395,WITHDRAWN,OBSERVATIONAL,Study never initiated in Cambodia
NCT04594525,TERMINATED,INTERVENTIONAL,Principle investigator stopped the study as number of withdrawn participants was high so it couldnt be completed to postpartum period.
NCT04594681,TERMINATED,INTERVENTIONAL,"The Sponsor judged that the objectives of this Phase 1 study were satisfied, and the study was terminated after the completion of Cohort 3 Step 3."
NCT04594707,TERMINATED,INTERVENTIONAL,The study was terminated by Sponsor as the futility analysis outcome indicated that the study was unlikely to meet the predefined primary objective of the study. No new safety concerns were identified.
NCT04594811,TERMINATED,INTERVENTIONAL,Company strategic decision
NCT04595604,SUSPENDED,INTERVENTIONAL,Researchers abandoned study site
NCT04595721,WITHDRAWN,INTERVENTIONAL,Resident did not have sufficient time to start study before graduating and leaving institution
NCT04595851,TERMINATED,INTERVENTIONAL,accrual difficulties
NCT04595890,WITHDRAWN,INTERVENTIONAL,Discontinued funding
NCT04595903,TERMINATED,INTERVENTIONAL,Lack of eligible COVID-ICU patients
NCT04596033,TERMINATED,INTERVENTIONAL,Business reasons
NCT04596267,TERMINATED,INTERVENTIONAL,Study funding was exhausted prior to reaching the recruitment goal due to pandemic related delays
NCT04596644,SUSPENDED,INTERVENTIONAL,"In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023."
NCT04596995,TERMINATED,INTERVENTIONAL,Strategic Business Decision; Not a safety decision
NCT04597684,TERMINATED,INTERVENTIONAL,Enrollment volume below acceptable accrual rate.
NCT04597892,WITHDRAWN,OBSERVATIONAL,delay
NCT04598152,TERMINATED,INTERVENTIONAL,Covid restrictions prevented continuation during the funding window
NCT04598282,WITHDRAWN,INTERVENTIONAL,No patient enrollment
NCT04598321,TERMINATED,INTERVENTIONAL,termination of research grant agreement
NCT04598516,WITHDRAWN,OBSERVATIONAL,delay
NCT04599023,TERMINATED,OBSERVATIONAL,Decision of company to no longer develop the device.
NCT04599101,TERMINATED,INTERVENTIONAL,Due to difficulty enrolling
NCT04599231,WITHDRAWN,INTERVENTIONAL,"Considering the various conditions (other ongoing prospective studies, lack of manpower), we decided not to proceed with this study."
NCT04599829,TERMINATED,OBSERVATIONAL,Sponsor decision : Difficulties of inclusion and revision of the clinical evaluation report of the medical device under evaluation.
NCT04600102,WITHDRAWN,OBSERVATIONAL,Study related activities were delayed due to the COVID pandemic and then terminated to focus on higher priority efforts.
NCT04600427,WITHDRAWN,INTERVENTIONAL,This was a pilot study aimed at assessing feasibility of further assessing epidural as a treatment for Ogilvie's. There were no eligible patients that were enrolled throughout the two years of accrual. Thus we deemed the study not feasible.
NCT04600648,WITHDRAWN,INTERVENTIONAL,poor enrollment
NCT04600882,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT04600921,TERMINATED,INTERVENTIONAL,The feasibility (recruitment) of the high number of patients (402 patients with HFrEF or HFmrEF) was impossible due to the rapid increase in SGLT2 inhibitors in patients with heart failure.
NCT04600934,TERMINATED,INTERVENTIONAL,slow enrollment
NCT04601077,TERMINATED,INTERVENTIONAL,The study stopped due to futility.
NCT04601103,TERMINATED,INTERVENTIONAL,Device Deficiency
NCT04601168,TERMINATED,OBSERVATIONAL,"Difficulties of inclusion, financial considerations, review of CER (no additional clinical data needed to demonstrate safety and performance of the medical device under evaluation)"
NCT04601285,TERMINATED,INTERVENTIONAL,Sponsor has adjusted study development plan and terminated this clinical study.
NCT04601324,WITHDRAWN,INTERVENTIONAL,PI did not pursue this study
NCT04601532,TERMINATED,INTERVENTIONAL,Delayed recruitment
NCT04601610,TERMINATED,INTERVENTIONAL,The sponsor's development strategy adjustment resolution is terminated
NCT04602065,TERMINATED,INTERVENTIONAL,"Due to the company's development strategy adjustment, Innovent Biologics has decided not to continue this study after consultation with investigators."
NCT04602117,WITHDRAWN,INTERVENTIONAL,Study withdrawn as scientific interest in pursuing the SYD985+Paclitaxel combination has diminished.
NCT04602494,TERMINATED,INTERVENTIONAL,"The pilot study used apo-varenicline under temp FDA authorization. When varenicline was available an IND exemption was granted to enroll children, IRB approved a trial of varenicline in participants ages 16-25 June 27, 2022, the pilot was terminated"
NCT04602507,TERMINATED,INTERVENTIONAL,Lack of severe COVID-19 cases in the place of study
NCT04603261,WITHDRAWN,OBSERVATIONAL,delayed
NCT04603365,WITHDRAWN,INTERVENTIONAL,enrollment
NCT04603742,WITHDRAWN,INTERVENTIONAL,Funding did not go through
NCT04603781,SUSPENDED,INTERVENTIONAL,"Suspended (The UT IRB determined that CBD oil is being used as a drug as defined by the FDA. Therefore, an IND must be obtained for the use of CBD oil in this research study in accordance with FDA regulations, 21 CFR 312.)"
NCT04603937,TERMINATED,INTERVENTIONAL,Study did not meet primary endpoint
NCT04603963,TERMINATED,INTERVENTIONAL,There was a change in the institutional flow reducing the cases of covid 19
NCT04604132,TERMINATED,INTERVENTIONAL,Terminated prematurely for administrative reasons not related to patient safety.
NCT04604184,TERMINATED,INTERVENTIONAL,Company decision
NCT04604262,TERMINATED,INTERVENTIONAL,"Recruitment difficulties (due to Covid), no difference found between study arms"
NCT04604340,TERMINATED,INTERVENTIONAL,insufficient enrolment-radial access for neuroangiography is now accepted as clinical standard.
NCT04604678,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants due to restrictive inclusion/exclusion criteria. Will update protocol with IRB \& begin anew after approval.
NCT04604743,WITHDRAWN,INTERVENTIONAL,PI transferred institutions; the grant was not transferred to the new university.
NCT04604821,WITHDRAWN,INTERVENTIONAL,"PI decided to pursue the same aims using a different methodology, specifically a single-case experimental design, also called N-of-1 Trial to answer research questions after consultation with research mentors and consultants."
NCT04605094,TERMINATED,INTERVENTIONAL,The study did not meet the primary endpoint.
NCT04605159,TERMINATED,INTERVENTIONAL,"Following a recommendation from the Independent Data Monitoring Committee of NCT04605159 (RSV MAT 009), GSK made the decision to stop enrolment and vaccination in the study."
NCT04605380,SUSPENDED,OBSERVATIONAL,COVID pandemic
NCT04605406,WITHDRAWN,OBSERVATIONAL,No participants recruited for the study.
NCT04605588,TERMINATED,INTERVENTIONAL,Lack of participants willing to enroll
NCT04605614,WITHDRAWN,INTERVENTIONAL,slow accruals
NCT04605744,TERMINATED,INTERVENTIONAL,the investigators were unable to recruit a sufficient number of participants
NCT04605926,WITHDRAWN,INTERVENTIONAL,Sponsor has currently elected to withhold study initiation
NCT04606290,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04606355,SUSPENDED,OBSERVATIONAL,updated technology nearly ready
NCT04606550,WITHDRAWN,INTERVENTIONAL,No financial support.
NCT04606563,TERMINATED,INTERVENTIONAL,DSMC recommendation due to futility
NCT04606576,TERMINATED,INTERVENTIONAL,"ORA-D-013-1 was terminated based on the primary results analyzed at the end of the treatment, week 26."
NCT04606810,TERMINATED,INTERVENTIONAL,Difficulties at recruiting enough participants for this study
NCT04607044,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT04607135,TERMINATED,INTERVENTIONAL,Current sample size sufficiently powers the study to evaluate outcome measures
NCT04607148,TERMINATED,INTERVENTIONAL,The benefit to risk balance did not support further treatment with galegenimab (FHTR2163).
NCT04607200,WITHDRAWN,INTERVENTIONAL,Strategic business decision
NCT04607252,TERMINATED,INTERVENTIONAL,"Our clinical trial NCT03241888 showed LNG-IUS had a better treatment efficacy than Megestrol Acetate (MA) alone. The median CR time for MA group, LNG-IUS group and MA plus LNG-IUS group was 7.00.3 months, 4.41.0 months and 5.71.2 months."
NCT04607317,TERMINATED,INTERVENTIONAL,did not enroll as many as planned
NCT04607642,WITHDRAWN,INTERVENTIONAL,Will be conducted as a different study with different sponsorship
NCT04607655,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 pandemic and change in the clinical development strategy for the GB1211 compound
NCT04607668,TERMINATED,INTERVENTIONAL,"Despite achieving co-primary endpoints \& other secondary measures of myeloprotection \& tolerability, early anti-tumor efficacy data favor patients receiving placebo. Given the low likelihood of achieving PFS \& OS endpoints, G1 decided to discontinue"
NCT04607772,SUSPENDED,INTERVENTIONAL,Sponsor decision
NCT04607876,WITHDRAWN,INTERVENTIONAL,Study not funded.
NCT04608266,TERMINATED,INTERVENTIONAL,Scientific committee decision due SARS-CoV2 pandemic evolution with a decrease in inclusions and widespread distribution of vaccines
NCT04608812,TERMINATED,INTERVENTIONAL,Slow enrollment and financial constraints.
NCT04609046,SUSPENDED,INTERVENTIONAL,Other - Awaiting amendment approval
NCT04609397,TERMINATED,INTERVENTIONAL,The study purpose has been achieved
NCT04609579,TERMINATED,INTERVENTIONAL,Sponsor decision (not due to safety concerns)
NCT04609787,WITHDRAWN,INTERVENTIONAL,COVID prevented acquistion of participants and study funding ended
NCT04609800,WITHDRAWN,OBSERVATIONAL,Unfavorable opinion of IRB/IEC
NCT04609943,TERMINATED,INTERVENTIONAL,Company Decision.
NCT04610489,TERMINATED,INTERVENTIONAL,Difficulty with recruiting for the study and with staffing the study.
NCT04610606,TERMINATED,INTERVENTIONAL,Covid-19 pandemic
NCT04610658,TERMINATED,INTERVENTIONAL,DLTs
NCT04610684,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT04610801,WITHDRAWN,INTERVENTIONAL,Study Period Ended/ Not Completed
NCT04610879,TERMINATED,INTERVENTIONAL,"Following the internal pilot, the study did not meet prespecified stop/go criteria for continuation."
NCT04611048,SUSPENDED,INTERVENTIONAL,"Due to covid, the recruitment plan was disrupted and recruitment is on hold for a undetermined period of time."
NCT04611074,TERMINATED,OBSERVATIONAL,Technical and recruitment issues.
NCT04611139,WITHDRAWN,INTERVENTIONAL,Salarius discontinued support
NCT04611152,TERMINATED,INTERVENTIONAL,Study did not meet primary endpoint
NCT04611204,TERMINATED,OBSERVATIONAL,insufficient recruitment
NCT04611321,TERMINATED,INTERVENTIONAL,"Due to the company's development strategy adjustment, Innovent Biologics has decided not to continue this study after consultation with investigators."
NCT04611633,TERMINATED,OBSERVATIONAL,Due to COVID pandemic not feasible to include patients for this study
NCT04611776,WITHDRAWN,INTERVENTIONAL,The positive results from IMpower010 demonstrated benefit by adding atezolizumab as adjuvant therapy in early stage NSCLC. These results raised ethical concerns of enrolling pts to best supportive care over checkpoint inhibition in this setting.
NCT04611958,WITHDRAWN,INTERVENTIONAL,The FDA requirements for the IND are not feasible to complete.
NCT04612010,WITHDRAWN,INTERVENTIONAL,Hypothesis change
NCT04612049,TERMINATED,INTERVENTIONAL,Investigator changed sites
NCT04612257,TERMINATED,INTERVENTIONAL,The sponsor has requested to end the study prematurely due to the accumulation of delays caused by COVID-19 as potential participants were hesitant to allow staff members into their homes or stay at the hospital per the study design.
NCT04612725,TERMINATED,INTERVENTIONAL,Study did not meet primary endpoint
NCT04612790,TERMINATED,INTERVENTIONAL,Independent Data Monitoring Committee recommended terminating the study following a pre-planned analysis as the efficacy results did not meet the pre-defined futility guidelines. There were no new safety concerns identified from this analysis.
NCT04612985,WITHDRAWN,INTERVENTIONAL,The IDE wasn't approved
NCT04613102,WITHDRAWN,INTERVENTIONAL,"The study protocol should to be updated (major updates), following the second Health Canada review /requests. The study has been withdrawn form the REB review and will not be performed at SickKids."
NCT04613154,TERMINATED,INTERVENTIONAL,Change in hospital organisation. A large reduction number of patients undergoing surgery.
NCT04613518,TERMINATED,INTERVENTIONAL,Trial terminated because of lack of efficacy in the short term acute phase.
NCT04613648,TERMINATED,OBSERVATIONAL,The study was stopped because the sample size calculated a priori could not be reached within the study period.
NCT04613752,TERMINATED,INTERVENTIONAL,No more Covid patients in the service and number of patients included sufficient for stastistical analysis.
NCT04614025,TERMINATED,INTERVENTIONAL,"The decision to bring the Study to early clinical readout came in response to COVID-19's evolution as a disease, and the significant changes in the standard of care, leading to an increase in the severity of conditions of the intubated patients."
NCT04614051,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT04614142,WITHDRAWN,INTERVENTIONAL,Single patient the protocol was written for consented to another study.
NCT04614246,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor
NCT04614298,WITHDRAWN,INTERVENTIONAL,"Due to the reconsideration of KHK4827's business in China, it. was decided to withdraw this clinical trial prior to enrollment of first participant."
NCT04614389,TERMINATED,INTERVENTIONAL,The research team (PI and Sponsor) have agreed that this study would not be feasible to continue.
NCT04614467,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04614636,TERMINATED,INTERVENTIONAL,This study was terminated by the Sponsor.
NCT04614701,WITHDRAWN,OBSERVATIONAL,"The co and principal investigator, due to limited resources and timing, have decided to withdrawal the study and close."
NCT04614987,TERMINATED,OBSERVATIONAL,PI decided to close study early.
NCT04615039,WITHDRAWN,OBSERVATIONAL,Site selection process has been revisited
NCT04615208,WITHDRAWN,OBSERVATIONAL,due to complete lack of cooperation from Winnipeg Health authorities we were not able to recruit and enrolled any participant. We needed to recruit from visitors to testing stations and we were never allowed to do that.
NCT04615559,WITHDRAWN,INTERVENTIONAL,The study team did not proceed with study start-up.
NCT04615689,WITHDRAWN,OBSERVATIONAL,"Because of the covid 19 pandemic, no patients were enrolled."
NCT04615845,TERMINATED,INTERVENTIONAL,Difficult recruitment
NCT04615884,WITHDRAWN,INTERVENTIONAL,unable to secure the funding despite multiple grant applications
NCT04615949,TERMINATED,INTERVENTIONAL,"The changing nature of COVID-19 including a more vaccinated population, increasing natural population immunity, milder variants and other related factors has meant that it is no longer realistic to recruit the patients in a reasonable time frame."
NCT04616079,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04616105,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04616560,SUSPENDED,INTERVENTIONAL,Other - Stage 1 has met accrual
NCT04616573,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04616586,TERMINATED,INTERVENTIONAL,The REMAP-CAP and RECOVERY substudy results appear to support the survival benefit of tocilizumab in corticosteroid-treated or untreated patients with critically ill COVID-19-associated ARDS.
NCT04616651,TERMINATED,INTERVENTIONAL,Low accrual
NCT04617847,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT04617860,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT04618263,TERMINATED,INTERVENTIONAL,Reached biomarker endpoint
NCT04618432,TERMINATED,OBSERVATIONAL,"PI moved institutes in NIH, and this protocol was redundant with an existing clinical protocol within the new institute."
NCT04618705,WITHDRAWN,INTERVENTIONAL,priority reasons
NCT04618770,TERMINATED,INTERVENTIONAL,Sponsor decision due to lack of enrolment
NCT04619095,WITHDRAWN,INTERVENTIONAL,We were unable to recruit any participants
NCT04619381,WITHDRAWN,OBSERVATIONAL,The study funding was dropped with no patients enrolled
NCT04619602,SUSPENDED,INTERVENTIONAL,FDA hold
NCT04619693,TERMINATED,OBSERVATIONAL,Difficulty of recruitment with the increase of the vaccination against COVID19
NCT04619706,TERMINATED,INTERVENTIONAL,Difficulties recruiting new subjects
NCT04619719,TERMINATED,INTERVENTIONAL,Lack of patients
NCT04620421,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04620473,WITHDRAWN,INTERVENTIONAL,No approval from ethical committee
NCT04620941,SUSPENDED,OBSERVATIONAL,"Due to the covid pandemic, I was only assigned to the covid intensive care unit."
NCT04621149,TERMINATED,INTERVENTIONAL,Unable to recruit participants due to decline in COVID-19.
NCT04621331,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT04621604,TERMINATED,INTERVENTIONAL,lack of eligible patients
NCT04621955,WITHDRAWN,OBSERVATIONAL,Not possible to conduct study
NCT04622072,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04622930,WITHDRAWN,INTERVENTIONAL,No longer proceeding with this study.
NCT04623515,TERMINATED,OBSERVATIONAL,"IRB closure, slow accrual"
NCT04623996,TERMINATED,INTERVENTIONAL,"Due to limitations imposed by the COVID pandemic and the competitive landscape for myelodysplastic syndrome, this study was unable to enroll a sufficient patient population."
NCT04624113,TERMINATED,INTERVENTIONAL,Ipsen bought out Epizyme
NCT04624334,TERMINATED,OBSERVATIONAL,Money issues
NCT04624672,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT04624815,TERMINATED,OBSERVATIONAL,logistics problems
NCT04625218,WITHDRAWN,OBSERVATIONAL,Hydroxychloroquine is not yet used for the Treatment of SARS-CoV2 (COVID 19)
NCT04625426,TERMINATED,INTERVENTIONAL,Early termination due to COVID-19 pandemic led to inability to reach planned sample size
NCT04625517,TERMINATED,INTERVENTIONAL,Low enrollment
NCT04625543,WITHDRAWN,INTERVENTIONAL,insufficient money
NCT04625699,WITHDRAWN,INTERVENTIONAL,Contract was never finalized.
NCT04625764,TERMINATED,INTERVENTIONAL,"Due to Corona pandemic, planned ammount of enrolled patient could not be reached, protocol section ""Early termination of the study"" - criterion ""Difficulties in recruiting patients"" is fully met-\>recruitment period will not be extended"
NCT04626037,SUSPENDED,INTERVENTIONAL,The new director of the program temporarily stopped the study.
NCT04626089,WITHDRAWN,INTERVENTIONAL,Administrative decision of the company
NCT04626427,TERMINATED,INTERVENTIONAL,"Due to shifting post-pandemic clinical landscape, concurrent study (NCT04634916) to provide results on analogous endpoints in advance of current projections"
NCT04627142,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04627441,WITHDRAWN,INTERVENTIONAL,COVID-related delays and insufficient funding.
NCT04627805,TERMINATED,INTERVENTIONAL,"Recruitment hindered by COVID-19 pandemic, unable to recruit participants virtually"
NCT04627831,WITHDRAWN,INTERVENTIONAL,Internal decision
NCT04628052,TERMINATED,INTERVENTIONAL,Administratively Closed
NCT04628533,WITHDRAWN,INTERVENTIONAL,COVID-19. Recruitment never began.
NCT04628715,TERMINATED,INTERVENTIONAL,Recruitment has finished in November 2022
NCT04628780,TERMINATED,INTERVENTIONAL,Pfizer has made an internal business decision to not continue further development of PF-07209960. This decision was not based on safety or regulatory considerations
NCT04628819,TERMINATED,INTERVENTIONAL,Not enough patients included
NCT04629196,TERMINATED,INTERVENTIONAL,Other effective drugs have been introduced to market since the beginning of the study.
NCT04629209,WITHDRAWN,INTERVENTIONAL,Change in approach to study.
NCT04629339,TERMINATED,INTERVENTIONAL,Strategic business decision to terminate the study effective immediately. This is due to a company decision to prioritize another oral PD-L1 inhibitor with a more favorable profile.
NCT04629534,TERMINATED,INTERVENTIONAL,"low enrollment, lack of funding"
NCT04629651,WITHDRAWN,INTERVENTIONAL,PI discretion
NCT04630210,WITHDRAWN,INTERVENTIONAL,Insufficient resources
NCT04630262,TERMINATED,INTERVENTIONAL,Study was unfunded.
NCT04630353,TERMINATED,INTERVENTIONAL,Sponsor decision.
NCT04630483,WITHDRAWN,OBSERVATIONAL,No participants
NCT04630639,WITHDRAWN,INTERVENTIONAL,Changed scientific strategy. No participants were enrolled.
NCT04630821,TERMINATED,INTERVENTIONAL,Low participant accrual
NCT04630925,TERMINATED,INTERVENTIONAL,Staff shortage
NCT04631120,WITHDRAWN,INTERVENTIONAL,The study was never started and the PI is retiring.
NCT04631211,TERMINATED,INTERVENTIONAL,This study was terminated due to loss of funding for this indication from the Biomedical Advanced Research and Development Authority (BARDA) in November 2022.
NCT04631601,TERMINATED,INTERVENTIONAL,Amgen made a business decision to discontinue all AMG 160 clinical trials. This decision is not related to safety.
NCT04632043,TERMINATED,INTERVENTIONAL,Insufficient rate of recruitment
NCT04632160,WITHDRAWN,INTERVENTIONAL,Withdrawn pending formal analysis of REDUCE LAP-HF II Pivotal Study results
NCT04632199,WITHDRAWN,INTERVENTIONAL,Business decision not related to any safety or tolerability concern
NCT04632498,TERMINATED,INTERVENTIONAL,Phase I enrolment and testing completed. Future Phase II enrolment/testing is anticipated.
NCT04632537,WITHDRAWN,INTERVENTIONAL,Due to funding - project never enrolled
NCT04633031,WITHDRAWN,OBSERVATIONAL,never approved
NCT04633187,TERMINATED,INTERVENTIONAL,Study was terminated due to a strategic business decision and not due to safety concerns.
NCT04633837,TERMINATED,INTERVENTIONAL,Left employment with job and study site
NCT04634110,TERMINATED,INTERVENTIONAL,Low accrual
NCT04634344,TERMINATED,INTERVENTIONAL,"Due to reasons of internal business strategy, not related to study or site conduct."
NCT04634604,TERMINATED,INTERVENTIONAL,Lack of feasibility to recruit.
NCT04634799,SUSPENDED,INTERVENTIONAL,Enrollment challenges; new batch of drug is being manufactured and there may be additional impetus to reactivate after the analogous Phase 2 study in Japan is completed and those results are made available
NCT04634825,TERMINATED,INTERVENTIONAL,Based on internal review of safety data
NCT04634838,TERMINATED,INTERVENTIONAL,"In view of the very positive results obtained with the copper dressings after 20 patients, the researchers decided to apply copper dressings from the beginning of wound management, not to use anymore silver dressings and to terminate the trial."
NCT04635306,TERMINATED,INTERVENTIONAL,Initial results showed no equivalence between GEBT test meals with low nitrogen versus a standard GEBT test meal
NCT04635527,TERMINATED,INTERVENTIONAL,Due to the company's development strategy adjustment Innovent Bioligics decided not to continue the study after consultation with investigators.
NCT04635683,WITHDRAWN,INTERVENTIONAL,Investigational Drug removed from the market
NCT04635735,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT04636034,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT04636164,TERMINATED,INTERVENTIONAL,The rate of data collection was too slow.
NCT04636268,WITHDRAWN,INTERVENTIONAL,The study was stopped due to a business decision.
NCT04636372,WITHDRAWN,INTERVENTIONAL,An one-month follow-up was completed after the treatment.
NCT04636567,WITHDRAWN,INTERVENTIONAL,Clinical program has been suspended for business reasons.
NCT04637009,TERMINATED,INTERVENTIONAL,termination due to portfolio prioritization
NCT04637100,WITHDRAWN,INTERVENTIONAL,Change in research personnel
NCT04637555,WITHDRAWN,INTERVENTIONAL,CLCZ696G2301E1 extension study did not start as the core study (CLCZ696G2301) did not meet the primary endpoint.
NCT04637698,TERMINATED,INTERVENTIONAL,Strategy adjustment
NCT04638075,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to COVID-19 public health crisis.
NCT04638114,WITHDRAWN,INTERVENTIONAL,Investigator is no longer employed in study site
NCT04638153,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy at any of the tested doses on 18th November 2022. The decision to terminate the study is not related to a safety concern.
NCT04638309,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04638387,TERMINATED,INTERVENTIONAL,pandemic limited recruitment; funding ran out
NCT04638400,TERMINATED,INTERVENTIONAL,Lack of recruitment- Fellow responsible for study graduated
NCT04638634,TERMINATED,INTERVENTIONAL,"For business reasons, not a safety issue"
NCT04639011,WITHDRAWN,INTERVENTIONAL,Study was not conducted because funding was not obtained.
NCT04639024,TERMINATED,INTERVENTIONAL,ADCT is reallocating all resources to the phase III program.
NCT04639245,TERMINATED,INTERVENTIONAL,Terminated due to slow accrual.
NCT04639258,TERMINATED,INTERVENTIONAL,"Reevaluation of clinical strategy in this patient population led to a business decision to discontinue the study. Discontinuation is not due to any patient safety, patient welfare, or quality issues."
NCT04639310,TERMINATED,INTERVENTIONAL,Sponsor decision; Not a safety decision
NCT04639596,WITHDRAWN,INTERVENTIONAL,Due to COVID-19 we never started the study and didn't enroll anyone.
NCT04639661,TERMINATED,OBSERVATIONAL,Challenges with recruiting patients during the COVID-19 pandemic.
NCT04639700,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT04639843,WITHDRAWN,INTERVENTIONAL,Safety issues with PI3 kinase inhibitors
NCT04639947,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT04639960,TERMINATED,INTERVENTIONAL,Difficulties in recruitment of participants and end of funding
NCT04640155,WITHDRAWN,INTERVENTIONAL,This study has been stopped due to difficulty with enrollment.
NCT04640610,WITHDRAWN,OBSERVATIONAL,Abandonment of the study project
NCT04641000,TERMINATED,OBSERVATIONAL,The BLOOM-LTFU study has evolved into the ongoing BLOOM-PCS Study (REB20-1442).
NCT04641273,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT04641598,TERMINATED,INTERVENTIONAL,Enrollment is low and interim analysis demonstrated no difference in outcomes.
NCT04641806,WITHDRAWN,OBSERVATIONAL,"Following submission of the amended protocol, the ethic commitee requested sponsor to resubmit it like a new protocol"
NCT04641975,TERMINATED,INTERVENTIONAL,Termination due to operational futility
NCT04642014,TERMINATED,INTERVENTIONAL,The main reasons for the premature termination of the study are the inability to reliably assess the effectiveness of therapy due to the emergence of new variants of SARS-CoV-2 and reports of the lack of benefits of using plasma in previous studies.
NCT04642066,SUSPENDED,INTERVENTIONAL,funding not obtained
NCT04642612,TERMINATED,OBSERVATIONAL,Study not properly designed for outcome measure
NCT04642638,TERMINATED,INTERVENTIONAL,The study was terminated to prioritize Inovio's COVID-19 efforts to advance a heterologous booster strategy and optimize potential impact on global public health.
NCT04642690,TERMINATED,OBSERVATIONAL,could not collect adequate samples
NCT04643158,TERMINATED,INTERVENTIONAL,"The decision was based on lung findings from a non-clinical 13-week Good Laboratory Practice (GLP) toxicology study, which are not a concern for the active clinical studies but do not support long-term use and progression to later-stage development."
NCT04643184,TERMINATED,INTERVENTIONAL,Poor enrollment rate
NCT04643301,WITHDRAWN,INTERVENTIONAL,Cancellation by sponsor
NCT04643483,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04643860,WITHDRAWN,OBSERVATIONAL,No patients arruoled
NCT04643886,TERMINATED,INTERVENTIONAL,no further benefit
NCT04644276,TERMINATED,INTERVENTIONAL,Challenges with recruitment
NCT04644315,TERMINATED,INTERVENTIONAL,The data from this study is no longer needed.
NCT04644549,TERMINATED,OBSERVATIONAL,study terminated following strategic portfolio and R\&D alignment
NCT04644679,TERMINATED,INTERVENTIONAL,Poor enrollment rate
NCT04644731,TERMINATED,OBSERVATIONAL,"The study was stopped early only due to a business decision to pursue development of a pediatric dedicated device. This decision was not based on any efficacy or safety concerns."""
NCT04645264,TERMINATED,INTERVENTIONAL,PI initiated closure due to limited clinical resources and lack of participation.
NCT04645784,TERMINATED,INTERVENTIONAL,Less participants than required
NCT04645966,TERMINATED,INTERVENTIONAL,The Sponsor decided to discontinue the study based on Sponsor's careful review of available safety data in concert with the recommendation of an independent Data Monitoring Committee.
NCT04647058,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT04647084,WITHDRAWN,INTERVENTIONAL,The investigators were unable to begin work on this study.
NCT04647929,WITHDRAWN,INTERVENTIONAL,Funding for the study could not be found.
NCT04648020,TERMINATED,INTERVENTIONAL,Interim Analysis did not meet the pre-defined threshold for efficacy of a 15% absolute difference in SOM prevention between Validive and placebo.
NCT04648189,WITHDRAWN,INTERVENTIONAL,One of the participating specialties has decided to no longer cooperate in this research
NCT04648215,TERMINATED,INTERVENTIONAL,unavailable subjects
NCT04648319,TERMINATED,INTERVENTIONAL,pharma company decision to withdraw the financial and IMP support
NCT04648436,WITHDRAWN,INTERVENTIONAL,Lack of inclusion / COVID-19 regulations
NCT04648696,TERMINATED,INTERVENTIONAL,The study was closed due to slow enrollment.
NCT04648709,TERMINATED,OBSERVATIONAL,The development and generalisation of vaccination led to a significant drop in the number of patients meeting the inclusion criteria.
NCT04648826,WITHDRAWN,INTERVENTIONAL,"Due to notification from EMD Serono, for Bintrafusp alfa (M7824) regarding an observed increase in the frequently of early progression and death."
NCT04649060,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study due to financial issues following an FDA request for a partial clinical hold.
NCT04649086,TERMINATED,INTERVENTIONAL,Stop premature due to futility
NCT04649515,TERMINATED,INTERVENTIONAL,Low recruitment rate
NCT04649671,TERMINATED,INTERVENTIONAL,Difficulty in recruitment and deficit of research fund
NCT04649710,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT04649775,TERMINATED,INTERVENTIONAL,no eligible participants
NCT04650204,TERMINATED,INTERVENTIONAL,"The funding sponsor, EISAI, sold the US rights to the medication and can no longer provide it to patients for the study."
NCT04650217,TERMINATED,INTERVENTIONAL,Study terminated by sponsor (NIMH)
NCT04650282,TERMINATED,INTERVENTIONAL,Reassignment of PI to more intense clinical obligations prevents continuation of the trial.
NCT04650412,TERMINATED,INTERVENTIONAL,delayed recruitment and lack of refinancing
NCT04650438,WITHDRAWN,INTERVENTIONAL,The study did not start due to COVID-19 pandemic.
NCT04650451,SUSPENDED,INTERVENTIONAL,Due to a Dose Limiting Toxicity in another sister trial with same technology.
NCT04650490,WITHDRAWN,INTERVENTIONAL,failure to enroll
NCT04650594,TERMINATED,INTERVENTIONAL,investigator's decision
NCT04650698,TERMINATED,INTERVENTIONAL,Enrollment rate was slower than anticipated.
NCT04650945,TERMINATED,INTERVENTIONAL,Staff shortage
NCT04651205,SUSPENDED,INTERVENTIONAL,COVID-19 pandemic
NCT04651374,WITHDRAWN,INTERVENTIONAL,Study site was unable to proceed with recruitment
NCT04651387,WITHDRAWN,INTERVENTIONAL,No Patients enrolled
NCT04651660,WITHDRAWN,INTERVENTIONAL,Devices recall due to hermeticity problems.
NCT04652050,WITHDRAWN,OBSERVATIONAL,Patients are not interested to participate
NCT04652362,SUSPENDED,INTERVENTIONAL,Lead researcher off sick
NCT04652414,WITHDRAWN,INTERVENTIONAL,Limited enrollment due to the COVID-19 pandemic. Sponsor withdrew funding.
NCT04652518,TERMINATED,INTERVENTIONAL,Part A of the study was completed; Part B of the study was terminated
NCT04652752,TERMINATED,INTERVENTIONAL,Enrollment Difficulties
NCT04652765,TERMINATED,INTERVENTIONAL,PI Decision to close/stop the study due to no new accrual.
NCT04652843,TERMINATED,INTERVENTIONAL,"Despite an extension of the planned duration of inclusion and an enrolled patient number inferior than planned, coordinating investigator considered that it was more reasonable to stop inclusions in order to analyze the data already available"
NCT04652856,WITHDRAWN,INTERVENTIONAL,"We are withdrawing this study due to issues with recruitment. These issues arose as a result of the COVID-19 pandemic, effecting the availability of patients and our ability as a lab to work with these patients."
NCT04653038,TERMINATED,INTERVENTIONAL,rapid changes in the treatment mode of melanoma worldwide and in China and the development strategy change
NCT04653389,TERMINATED,INTERVENTIONAL,The treatment efficacy was not satisfactory.
NCT04653584,TERMINATED,OBSERVATIONAL,"Administrative problems, the ANSM denied the request to extend the use of the study's budget"
NCT04654130,WITHDRAWN,INTERVENTIONAL,"Due to challenges with the COVID-19 pandemic, our team has had to prioritize certain studies, which means we can no longer pursue this study at our site."
NCT04654221,TERMINATED,OBSERVATIONAL,Study terminated early due to program discontinuation.
NCT04654325,TERMINATED,INTERVENTIONAL,less covid testing
NCT04654481,TERMINATED,INTERVENTIONAL,"only one participant enrolled, results will not be provided due to risk of breach of confidentiality"
NCT04654559,SUSPENDED,INTERVENTIONAL,Temporary stop \& analyze current data. Study may be resumed.
NCT04655183,WITHDRAWN,INTERVENTIONAL,Trial withdrawn based on portfolio prioritization; oral ATRi M1774 in combination with niraparib is under investigation in DDRiver Solid Tumor 301
NCT04655261,TERMINATED,OBSERVATIONAL,Lack of Recruitment
NCT04655391,WITHDRAWN,INTERVENTIONAL,Drug availability
NCT04655443,TERMINATED,OBSERVATIONAL,due to COVID-19
NCT04655508,TERMINATED,INTERVENTIONAL,insufficient enrollment.
NCT04655599,TERMINATED,INTERVENTIONAL,Strategic business decision
NCT04655703,TERMINATED,INTERVENTIONAL,Discharge to a sub-acute rehabilitation after arthroplasty surgery is discouraged after due to the pandemic. The protocol is being revised to remove this arm of the study.
NCT04655807,WITHDRAWN,INTERVENTIONAL,Sponsor Decision.
NCT04655911,TERMINATED,OBSERVATIONAL,Abeona has decided to discontinue development activities for Product AB0-101 due to a lack of drug supply and for business reasons unrelated to the product safety profile and/or signs of efficacy
NCT04656145,WITHDRAWN,INTERVENTIONAL,Study team was not able to enroll eligible patients.
NCT04656171,WITHDRAWN,INTERVENTIONAL,No financement AFAM
NCT04656444,WITHDRAWN,OBSERVATIONAL,obsolete study
NCT04656587,WITHDRAWN,INTERVENTIONAL,PI left institution.
NCT04656691,TERMINATED,INTERVENTIONAL,"In April 2021 FDA revoked the Emergency Use Authorization after determining that the known and potential benefits of bamlanivimab, when administered alone, no longer outweigh the known and potential risks for its authorized use."
NCT04656704,WITHDRAWN,INTERVENTIONAL,PI no longer pursuing clinical trial
NCT04656808,TERMINATED,INTERVENTIONAL,COVID-19
NCT04657250,WITHDRAWN,INTERVENTIONAL,COVID-19
NCT04657354,WITHDRAWN,INTERVENTIONAL,Unable to recruit enough patients
NCT04657393,TERMINATED,INTERVENTIONAL,slow inclusion
NCT04657679,TERMINATED,INTERVENTIONAL,Sufficient accrual into the African American/Black patient cohort and insufficient accrual into the NHW patient cohort.
NCT04657718,WITHDRAWN,INTERVENTIONAL,Study never started - clinical strategy changed
NCT04658095,TERMINATED,INTERVENTIONAL,Business Decision
NCT04658849,WITHDRAWN,INTERVENTIONAL,End of grant funding
NCT04659122,TERMINATED,INTERVENTIONAL,Termination / study goals reached
NCT04659278,WITHDRAWN,INTERVENTIONAL,Study has been placed on hold
NCT04659369,TERMINATED,INTERVENTIONAL,Difficult to recruit subjects
NCT04659694,WITHDRAWN,INTERVENTIONAL,Withdrawal of PhD
NCT04659993,TERMINATED,OBSERVATIONAL,Low accruals
NCT04660045,WITHDRAWN,INTERVENTIONAL,Company supplying drug/funding ceased support.
NCT04660084,TERMINATED,INTERVENTIONAL,The trial was stopped earlier than planned after an ad hoc interim analysis
NCT04660903,SUSPENDED,INTERVENTIONAL,Severe adverse reaction on patient
NCT04660994,WITHDRAWN,OBSERVATIONAL,Abandoned project
NCT04661033,TERMINATED,INTERVENTIONAL,Study discontinuation based on strategic sponsor decision; not driven by any safety concerns.
NCT04661917,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to company decision
NCT04662073,TERMINATED,INTERVENTIONAL,Enrollment into the camostat subprotocol was halted prematurely as a result of loss of equipoise due to external findings including those related to monoclonal antibodies.
NCT04662164,WITHDRAWN,INTERVENTIONAL,Not approved by CFDA
NCT04662528,WITHDRAWN,INTERVENTIONAL,suspended
NCT04662567,TERMINATED,INTERVENTIONAL,"It was determined that the study should not continue as the study drug, Acetaminophen, could only be mixed in a solvent that would not allow the patients to be NPO prior to procedure."
NCT04662840,WITHDRAWN,INTERVENTIONAL,Difficulty in getting participants to accept participating
NCT04663087,TERMINATED,INTERVENTIONAL,Sponsor stopped enrollment
NCT04663126,TERMINATED,INTERVENTIONAL,"after inclusion of 5 patients, tracer had low uptake (kidney/liver)"
NCT04663269,TERMINATED,INTERVENTIONAL,Drop out from surgeons from 3 to 1. It will take too long to feasibly accrue with only one provider.
NCT04663321,TERMINATED,INTERVENTIONAL,Voluntarily terminated due to benefit/risk assessment
NCT04663386,TERMINATED,OBSERVATIONAL,Target recruitment not reached
NCT04663568,TERMINATED,INTERVENTIONAL,No fund was obtained for buying the hormonal IUD
NCT04663724,SUSPENDED,INTERVENTIONAL,"In June 2023 NYSPI decided to undertake an Institute-wide safety review of research protocols that involve human subjects. To support the safety review, NYSPI, paused all ongoing human subjects research studies as of June 12, 2023"
NCT04664543,TERMINATED,INTERVENTIONAL,Organization and logistic problems due to COVID19 pandemy
NCT04664621,WITHDRAWN,INTERVENTIONAL,Grant expired
NCT04664907,WITHDRAWN,INTERVENTIONAL,Denied by Human Subjects Protection Board
NCT04665115,WITHDRAWN,INTERVENTIONAL,"Permanently closed 11/19/201. The widespread availability of COVID vaccination, the projected decline in infection rates, and the increasing use of non-ibrutinib containing BTKi therapy, we have not been able to get support for this study"
NCT04665258,WITHDRAWN,OBSERVATIONAL,Unable to recruit participants
NCT04665310,WITHDRAWN,INTERVENTIONAL,"Study not started, funding"
NCT04665440,TERMINATED,INTERVENTIONAL,slow recruitment
NCT04665583,TERMINATED,OBSERVATIONAL,Could not meet enrollment goal due to decrease in our target patient population (patients admitted for prehab).
NCT04665752,TERMINATED,OBSERVATIONAL,Slow/Insufficient accrual
NCT04665921,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT04666467,WITHDRAWN,INTERVENTIONAL,Study device refinement
NCT04666480,TERMINATED,INTERVENTIONAL,Study device refinement in process
NCT04666623,WITHDRAWN,INTERVENTIONAL,investigator decision
NCT04666675,WITHDRAWN,INTERVENTIONAL,Strategic considerations
NCT04666701,WITHDRAWN,INTERVENTIONAL,Strategy review
NCT04666896,TERMINATED,INTERVENTIONAL,"Due to COVID-19, this pilot study ended prematurely."
NCT04667182,WITHDRAWN,OBSERVATIONAL,Study was withdrawn prior to enrolment due to business decision.
NCT04667364,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04667559,TERMINATED,OBSERVATIONAL,Decision of investigational team
NCT04667715,SUSPENDED,INTERVENTIONAL,Study suspended until priorities can be reassessed
NCT04667871,WITHDRAWN,OBSERVATIONAL,An six-month follow-up was completed after the treatment
NCT04668209,TERMINATED,INTERVENTIONAL,"After 15 months of active enrollment and a lack of qualifying hospitalized COVID-19 patients, the Sponsor-Investigator, Marilyn Csete Glassberg, MD, decided to terminate recruitment before meeting the stated enrollment objectives."
NCT04668339,TERMINATED,INTERVENTIONAL,A decision was made to terminate the study for operational/business reasons. The study was not terminated for reasons of safety or immunogenicity.
NCT04668521,TERMINATED,OBSERVATIONAL,"cohort C looked at feasibility of genetics \& protein to evaluate risk with a family hx of cancer or associated variant. Since few patients show these factors, this approach would not yield sufficient information to make inferences"
NCT04668768,SUSPENDED,INTERVENTIONAL,"To be terminated due to slow accrual, patient still in follow up"
NCT04668859,TERMINATED,INTERVENTIONAL,PI relocated
NCT04669652,SUSPENDED,INTERVENTIONAL,Study on hold
NCT04669964,WITHDRAWN,OBSERVATIONAL,Change in routine care was not implemented at organization
NCT04670042,WITHDRAWN,INTERVENTIONAL,Difficulty enrolling in this patient population
NCT04670133,WITHDRAWN,INTERVENTIONAL,This study was planned before the COVID-19 pandemic and will not be pursued due to a change in research focus post-pandemic.
NCT04670484,WITHDRAWN,INTERVENTIONAL,"Due to the cdc and institutional guidelines, study was never started and withdrawn without any enrollment of subjects."
NCT04670588,WITHDRAWN,OBSERVATIONAL,No accrual.
NCT04670653,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT04671355,WITHDRAWN,INTERVENTIONAL,Continuing delays due to COVID-19 pandemic
NCT04671420,WITHDRAWN,INTERVENTIONAL,sponsor strategy decision
NCT04671836,WITHDRAWN,INTERVENTIONAL,No longer interested in conducing study
NCT04671901,TERMINATED,INTERVENTIONAL,Lack of accrual
NCT04672564,TERMINATED,INTERVENTIONAL,sponsor strategy change
NCT04672876,WITHDRAWN,INTERVENTIONAL,Trial funding no longer available.
NCT04672980,TERMINATED,INTERVENTIONAL,"The Sponsor terminated study after dosing 3 dose groups (9 pts) and closed trial on 11/30/22. RTX-321 was well-tolerated with no DLTs, no related deaths, SAEs or Gr. 3/4 AEs and cleared from circulation rapidly (w/in 10 min)."
NCT04673435,WITHDRAWN,INTERVENTIONAL,"Protocol was withdrawn and closed by IRB in April, 2018 prior to enrollment of first patient"
NCT04674163,WITHDRAWN,INTERVENTIONAL,no practitioner
NCT04674410,WITHDRAWN,OBSERVATIONAL,Reduced relevance given end of pandemic
NCT04674735,WITHDRAWN,INTERVENTIONAL,Cancelled by Sponsor
NCT04674748,TERMINATED,INTERVENTIONAL,The study was terminated early due to a business decision.
NCT04675086,WITHDRAWN,INTERVENTIONAL,Administrative Decision
NCT04675450,WITHDRAWN,INTERVENTIONAL,Further preclinical development activities required to proceed
NCT04675489,TERMINATED,INTERVENTIONAL,Difficulty in recruiting
NCT04675827,SUSPENDED,INTERVENTIONAL,Serious concerns on the slow recruitment of the study that impacts the robustness of the scientific rationale and the study financial provision. It aims to assess carefully the situation and to evaluate the potential solutions to overcome the issues.
NCT04675983,TERMINATED,INTERVENTIONAL,"Due to the company's development strategy adjustment, Innovent Biologics has decided not to continue this study after consultation with investigators"
NCT04675996,TERMINATED,INTERVENTIONAL,insufficient funding
NCT04676061,TERMINATED,INTERVENTIONAL,It was in the best interest of the investigator to terminate the study earlier than anticipated.
NCT04676126,WITHDRAWN,INTERVENTIONAL,IRB records show administrative closure on 12/16/21. No subjects enrolled.
NCT04676243,WITHDRAWN,INTERVENTIONAL,Study turned out no longer feasible
NCT04676386,TERMINATED,OBSERVATIONAL,Recruitment futility
NCT04677179,TERMINATED,INTERVENTIONAL,Study terminated due to enrollment futility.
NCT04677322,TERMINATED,OBSERVATIONAL,the principal investigator withdraws from the project for personal reasons
NCT04677361,WITHDRAWN,INTERVENTIONAL,"Grantor shifted focus in disease, funding was stopped"
NCT04677426,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew Funding
NCT04677621,WITHDRAWN,INTERVENTIONAL,Funding never received closed with the IRB
NCT04677829,TERMINATED,INTERVENTIONAL,"The study was terminated due to administrative, non-safety related reasons."
NCT04677855,TERMINATED,INTERVENTIONAL,Business Decision due to insufficient enrollment
NCT04678128,WITHDRAWN,INTERVENTIONAL,Not started
NCT04678323,WITHDRAWN,INTERVENTIONAL,Funding
NCT04678453,TERMINATED,INTERVENTIONAL,The study was terminated after completing the dose escalation portion of the study. The expansion cohort was not initiated to conduct a global trial based on the approved US IND using a new manufacturing process.
NCT04678505,TERMINATED,INTERVENTIONAL,Business reasons
NCT04678557,TERMINATED,INTERVENTIONAL,Insufficient functional product engraftment
NCT04678661,TERMINATED,INTERVENTIONAL,Technical issues with app and prolonged recruitment
NCT04678726,WITHDRAWN,OBSERVATIONAL,COVID interference in the ability to initiate the study.
NCT04678947,TERMINATED,INTERVENTIONAL,Original investigator left the university
NCT04678986,WITHDRAWN,OBSERVATIONAL,Study not begun in time and has been withdrawn because of feasibility
NCT04679077,WITHDRAWN,INTERVENTIONAL,Study was never submitted to the ethics committee
NCT04679194,TERMINATED,INTERVENTIONAL,Product manufacturing
NCT04679233,WITHDRAWN,INTERVENTIONAL,"PI has withdrawn from the program, the study never started."
NCT04679311,TERMINATED,INTERVENTIONAL,End of funding period
NCT04679324,WITHDRAWN,OBSERVATIONAL,C. difficile symptoms preclude participants from attending research study visits.
NCT04679350,TERMINATED,INTERVENTIONAL,A new study combining Phase III clinical trials has been planned.
NCT04679389,TERMINATED,INTERVENTIONAL,Lack of funding
NCT04679805,TERMINATED,OBSERVATIONAL,Due to COVID-19 pandemic site refused to include patients in the study
NCT04680156,TERMINATED,OBSERVATIONAL,Lack of efficacy
NCT04680286,TERMINATED,INTERVENTIONAL,Slow recruitment due to covid-19 and organizational changes.
NCT04680416,WITHDRAWN,OBSERVATIONAL,Lack of patient samples
NCT04680637,TERMINATED,INTERVENTIONAL,The trial was terminated prematurely as it met pre-defined criteria for futility at IA3.
NCT04680676,WITHDRAWN,INTERVENTIONAL,Program discontinued
NCT04680871,WITHDRAWN,OBSERVATIONAL,Study not being pursued
NCT04680962,WITHDRAWN,INTERVENTIONAL,Study closed for business reasons before patient recruitment was initiated.
NCT04680975,TERMINATED,INTERVENTIONAL,Sponsor decision due to slow enrollment and strategic consideration; not driven by any safety concerns.
NCT04681027,SUSPENDED,INTERVENTIONAL,Study Suspended 06Feb2020 per FDA Request
NCT04681456,TERMINATED,OBSERVATIONAL,The study was stopped in order to reconfigure it as a PhaseII/III study
NCT04682249,WITHDRAWN,INTERVENTIONAL,no patients enrolled
NCT04682366,TERMINATED,INTERVENTIONAL,Challenges in enrollment led to decission for termination
NCT04682431,TERMINATED,INTERVENTIONAL,Sponsor business decision.
NCT04683120,SUSPENDED,INTERVENTIONAL,New Medical Team and Surgical Center Location
NCT04683224,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to redesign of the protocol.
NCT04683237,WITHDRAWN,INTERVENTIONAL,"Based on our latest research results, we will revise the protocol and design a better study. Since no participants are enrolled till now, we withdraw this study."
NCT04683692,WITHDRAWN,INTERVENTIONAL,This sub-study was combined to the parent study protocol (NCT04685317)
NCT04683939,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04684121,WITHDRAWN,INTERVENTIONAL,No longer aligned with company strategy
NCT04684251,WITHDRAWN,INTERVENTIONAL,Funding no longer available.
NCT04684394,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04684511,TERMINATED,INTERVENTIONAL,Low enrollment. The termination of the trial was not based on any safety concerns in the study.
NCT04684550,WITHDRAWN,INTERVENTIONAL,"The study did not achieve funding or approval by the ethics committee. Once the vaccination phase was entered, the study lost validity and was not viable"
NCT04684654,TERMINATED,INTERVENTIONAL,Insufficient enrollment
NCT04684927,WITHDRAWN,INTERVENTIONAL,project not initiated
NCT04684979,WITHDRAWN,INTERVENTIONAL,"The landscape of treatment for patients targeted for enrollment has significantly changed since the protocol was written and approved, and the research treatment is no longer the best option for this population."
NCT04685421,TERMINATED,INTERVENTIONAL,"PI, Christopher Tirotta, no longer at NCH as of 5-26-23."
NCT04685499,TERMINATED,INTERVENTIONAL,This study was terminated due to low participant enrollment.
NCT04685551,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT04685655,TERMINATED,INTERVENTIONAL,Low numbers of severe COVID-19 cases with current variants.
NCT04685759,WITHDRAWN,INTERVENTIONAL,Limited candidate pool
NCT04685798,TERMINATED,INTERVENTIONAL,Low accrual
NCT04685824,TERMINATED,INTERVENTIONAL,Recruitment rate not reached.
NCT04685902,WITHDRAWN,OBSERVATIONAL,Staffing issues
NCT04685915,WITHDRAWN,INTERVENTIONAL,Bayer is no longer funding due to lack of accrual
NCT04687774,WITHDRAWN,INTERVENTIONAL,Strategy Adjustment
NCT04687800,TERMINATED,INTERVENTIONAL,Inability to enroll due to lack of access to the Ambulatory Surgery Center.
NCT04688333,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT04688541,WITHDRAWN,INTERVENTIONAL,"Consequence of COVID-19 pandemic all staff working on this study were moved elsewhere and never returned to complete this work. Full RCT 'CADET' looking into Optitip use now taking place, so this pilot work is no longer required."
NCT04688749,TERMINATED,OBSERVATIONAL,Due to COVID-19
NCT04688931,TERMINATED,INTERVENTIONAL,Alternate approach pursued
NCT04689594,TERMINATED,INTERVENTIONAL,"Due to the extension of the clinical trial period due to a problem that occurred in the first patient of this study, there were concerns about business viability, so we decided to cancel this study."
NCT04690855,TERMINATED,INTERVENTIONAL,This study has been terminated due to Lack of Accrual.
NCT04691375,TERMINATED,INTERVENTIONAL,Sponsor business decision.
NCT04691739,WITHDRAWN,INTERVENTIONAL,Study did not enroll participants that meet inclusion criteria outlined in the study protocol. All screening and enrollment attempts have ended.
NCT04691869,WITHDRAWN,INTERVENTIONAL,We were not able to complete the study due to COVID restrictions and never enrolled any participants.
NCT04691999,WITHDRAWN,INTERVENTIONAL,The PI is leaving Duke for a position in another state.
NCT04692155,TERMINATED,INTERVENTIONAL,FDA hold
NCT04692246,TERMINATED,INTERVENTIONAL,Due to COVID-19 Pandemic
NCT04692389,WITHDRAWN,INTERVENTIONAL,difficulties in patients recruitment
NCT04693208,TERMINATED,INTERVENTIONAL,Adverse reactions (tonsillar bleeding after treatment)
NCT04693390,WITHDRAWN,INTERVENTIONAL,Study never started
NCT04694560,WITHDRAWN,OBSERVATIONAL,Lack of potential participants given the other treatment options currently available to people
NCT04694586,SUSPENDED,INTERVENTIONAL,Suspended 15th of Nov 2023 due to conditions affecting recruitment process.
NCT04695002,TERMINATED,OBSERVATIONAL,Too few participants enrolled due to COVID19
NCT04695340,WITHDRAWN,INTERVENTIONAL,"No inclusion during the authorised period, no extension is possible again"
NCT04696263,SUSPENDED,INTERVENTIONAL,Administrative delays
NCT04696354,TERMINATED,INTERVENTIONAL,The study was stopped due to ongoing enrollment challenges.
NCT04696601,WITHDRAWN,INTERVENTIONAL,Because of logistical problems
NCT04696848,TERMINATED,INTERVENTIONAL,Recruitment difficulty
NCT04697056,TERMINATED,INTERVENTIONAL,Administrative Reason
NCT04697069,TERMINATED,INTERVENTIONAL,Administrative Reason
NCT04697290,SUSPENDED,INTERVENTIONAL,Plan adjustment
NCT04697485,WITHDRAWN,INTERVENTIONAL,Enrollment and funding challenges
NCT04697602,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04697693,TERMINATED,INTERVENTIONAL,Unable to recruit participants in a timely fashion due to COVID pandemic
NCT04697758,TERMINATED,INTERVENTIONAL,Adverse Events
NCT04697953,WITHDRAWN,INTERVENTIONAL,Study terminated - no participants were enrolled.
NCT04698057,WITHDRAWN,INTERVENTIONAL,No enrolment due to Covid-19
NCT04698369,TERMINATED,INTERVENTIONAL,The original PI left the institution and the remaining study team did not have the resources to continue. The data were not analyzed; there are no results to report.
NCT04698382,WITHDRAWN,OBSERVATIONAL,Reduced relevance due to end of pandemic
NCT04698460,TERMINATED,INTERVENTIONAL,The local research project is cancelled because of the organizational issues
NCT04698681,TERMINATED,OBSERVATIONAL,Lack of Clinical Benefit
NCT04698850,WITHDRAWN,INTERVENTIONAL,funding issues
NCT04698915,TERMINATED,INTERVENTIONAL,Futility Analysis
NCT04698993,TERMINATED,INTERVENTIONAL,poor recruitment
NCT04699461,TERMINATED,INTERVENTIONAL,Administrative decision (not due to safety reason)
NCT04699552,WITHDRAWN,INTERVENTIONAL,PI does not wish to move forward with the Study
NCT04699968,WITHDRAWN,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT04700046,WITHDRAWN,INTERVENTIONAL,Assessing novel alternative study designs and regulatory pathways
NCT04700176,TERMINATED,INTERVENTIONAL,Low Accrual
NCT04700267,TERMINATED,INTERVENTIONAL,Study stopped on business grounds
NCT04700280,TERMINATED,INTERVENTIONAL,Study was terminated based on Sponsor decision
NCT04700371,WITHDRAWN,INTERVENTIONAL,Lack of financial support.
NCT04700787,WITHDRAWN,INTERVENTIONAL,Enrollment challenges and change in development plan necessitating a change in study design
NCT04701112,SUSPENDED,INTERVENTIONAL,Logistic challenges
NCT04701359,WITHDRAWN,INTERVENTIONAL,Implant to be analysed not used at study centre any more.
NCT04702048,WITHDRAWN,INTERVENTIONAL,sponsor withdrew funding
NCT04702217,WITHDRAWN,INTERVENTIONAL,This study has been cancelled due to the pandemic and we are planning on starting a similar study hopefully next year.
NCT04702230,TERMINATED,OBSERVATIONAL,"Treatment practice unexpectedly changed during the course of the study. Majority of follow-up MRI performed in external institutions. Consequently, the planned number of participants could not be reached."
NCT04702789,TERMINATED,INTERVENTIONAL,For interests of sponsor.
NCT04703140,TERMINATED,INTERVENTIONAL,Non-significant intemedial analysis
NCT04703413,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04703426,WITHDRAWN,INTERVENTIONAL,Study terminated by sponsor
NCT04703556,TERMINATED,INTERVENTIONAL,Protocol too complex for study population and difficulty to recruit participants with DBS and gait deficits
NCT04703855,TERMINATED,INTERVENTIONAL,Low enrollment and regulatory status change
NCT04704011,WITHDRAWN,INTERVENTIONAL,Trial was not funded.
NCT04704050,TERMINATED,INTERVENTIONAL,Sponsor withdrew funding
NCT04704557,SUSPENDED,OBSERVATIONAL,Difficulties with recruitment
NCT04704791,WITHDRAWN,INTERVENTIONAL,Failure to enroll
NCT04704843,WITHDRAWN,INTERVENTIONAL,Study terminated. Sponsor decision.
NCT04705025,TERMINATED,INTERVENTIONAL,manufacturer reevaluating Digital cognitive-behavioral stress management (CBSM) device (Attunetm)
NCT04705051,TERMINATED,INTERVENTIONAL,LTS15823 (long-term extension of the EFC15392 study) was stopped after protocol specified interim analysis for futility of the parent EFC15392 study met the prespecified stopping rule based on the primary outcome measure.
NCT04705376,WITHDRAWN,INTERVENTIONAL,Funding
NCT04705597,TERMINATED,INTERVENTIONAL,The incidence of COVID-19 hospitalization cases decreased to a level that continued enrollment was no longer feasible
NCT04705701,WITHDRAWN,INTERVENTIONAL,Trial was withdrawn due to Covid-19 pandemic
NCT04705727,TERMINATED,INTERVENTIONAL,Not enough recruitment in th trial
NCT04705844,WITHDRAWN,INTERVENTIONAL,study withdrawn prior to screening subjects
NCT04706520,TERMINATED,INTERVENTIONAL,study sponsor ended due to recruitment issues
NCT04706780,TERMINATED,OBSERVATIONAL,insufficient number of patients
NCT04707157,TERMINATED,INTERVENTIONAL,"The trial was slow to enroll, and the sponsor made a business decision to terminate the trial earlier than planned."
NCT04707625,TERMINATED,INTERVENTIONAL,IRB stopped study due to safety concerns. No further data collection and what has been collected is not appropriate for analysis.
NCT04707638,WITHDRAWN,OBSERVATIONAL,Ethics application has not been completed yet
NCT04707703,TERMINATED,INTERVENTIONAL,Participant enrollment challenges
NCT04707924,WITHDRAWN,INTERVENTIONAL,Inability to enroll patients
NCT04708236,WITHDRAWN,INTERVENTIONAL,recruitment
NCT04708314,TERMINATED,INTERVENTIONAL,The Sponsor has decided to focus their resources on other areas of therapy.
NCT04708418,SUSPENDED,INTERVENTIONAL,Drug Supply Issues
NCT04708704,WITHDRAWN,INTERVENTIONAL,"Not able to start the study due to COVID,"
NCT04708977,WITHDRAWN,INTERVENTIONAL,The patient population is too low to conduct the study in a feasible and meaningful amount of time.
NCT04708990,TERMINATED,INTERVENTIONAL,the research sponsors stopped further funding due to a planning of a multi-center trial
NCT04709042,WITHDRAWN,INTERVENTIONAL,no more medical device implantation
NCT04709068,TERMINATED,OBSERVATIONAL,recruitment and enrollment challenges due to fast-changing landscape of pandemic
NCT04709419,TERMINATED,INTERVENTIONAL,unable to enroll
NCT04709679,TERMINATED,INTERVENTIONAL,Dose was not therapeudic
NCT04709757,WITHDRAWN,INTERVENTIONAL,Intermittent paradigm replaced with change in frequency and amplitude. The updated protocol is NCT04909138
NCT04709926,WITHDRAWN,OBSERVATIONAL,Capacity issues within team after pandemic \& unable to progress with the study
NCT04710004,TERMINATED,INTERVENTIONAL,Lack of funding to secure effort for testing.
NCT04711161,SUSPENDED,INTERVENTIONAL,Business/Commercial Reasons
NCT04711226,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04711239,WITHDRAWN,OBSERVATIONAL,Unavailability of Primary investigator
NCT04711785,WITHDRAWN,INTERVENTIONAL,No recruitment possibility
NCT04711850,TERMINATED,OBSERVATIONAL,This is an internal decision based on prioritisations and no safety issues have been raised during the trial.
NCT04711863,SUSPENDED,INTERVENTIONAL,Closure of main community treatment center
NCT04712006,WITHDRAWN,INTERVENTIONAL,Sponsor Decision.
NCT04712019,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT04712071,TERMINATED,INTERVENTIONAL,Due to the COVID pandemic we could not enroll more than one subject before funding was ending.
NCT04712526,WITHDRAWN,OBSERVATIONAL,voluntarily withdrawn
NCT04712968,TERMINATED,INTERVENTIONAL,Interim analysis of preliminary results indicated a need for protocol re-design.
NCT04713176,TERMINATED,INTERVENTIONAL,Termination of study due to sponsor's internal decision
NCT04713202,WITHDRAWN,INTERVENTIONAL,Funder decision
NCT04713228,TERMINATED,INTERVENTIONAL,slow enrollment
NCT04713241,WITHDRAWN,INTERVENTIONAL,PI left
NCT04713267,TERMINATED,INTERVENTIONAL,Difficulties recruiting participants
NCT04713995,TERMINATED,INTERVENTIONAL,Sufficient samples and data have been collected for data analyses.
NCT04714164,TERMINATED,INTERVENTIONAL,We had difficulty with participation in the study for our initial Zoom CBT group.
NCT04714619,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04714983,SUSPENDED,INTERVENTIONAL,"DNAtrix management decision not based on study design, safety, or site performance."
NCT04715230,TERMINATED,INTERVENTIONAL,Sponsor decision based on slower than anticipated enrollment leading to fund exhaustion.
NCT04715243,TERMINATED,INTERVENTIONAL,"1. Futility
2. Lack of recruitment in the centers due to lack of cases meeting the study criterial despite period of extension."
NCT04715386,TERMINATED,OBSERVATIONAL,slow accrual; investigator retired
NCT04715763,TERMINATED,INTERVENTIONAL,Poor recruitment due to decrease in COVID-19 rates locally
NCT04716413,TERMINATED,INTERVENTIONAL,"Terminated early due to funding, lack of participants"
NCT04716959,WITHDRAWN,INTERVENTIONAL,Study recommended for closure
NCT04717258,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT04717362,WITHDRAWN,INTERVENTIONAL,No longer wanting to enroll or start study.
NCT04717453,TERMINATED,OBSERVATIONAL,Sponsor's Decision
NCT04717687,WITHDRAWN,INTERVENTIONAL,No enrollment
NCT04717817,WITHDRAWN,INTERVENTIONAL,lack of time and personnel
NCT04718376,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04718402,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04718467,WITHDRAWN,INTERVENTIONAL,Sponsor decided to cancel this trial.
NCT04718857,WITHDRAWN,OBSERVATIONAL,Intervention change
NCT04718961,TERMINATED,INTERVENTIONAL,Due to company's assessment of enrollment feasibility.
NCT04719416,WITHDRAWN,INTERVENTIONAL,Other projects and needs of study personnel
NCT04719442,WITHDRAWN,INTERVENTIONAL,"Started record under wrong IRB account. Registered under UNMC, but actually at UNKearney."
NCT04719624,TERMINATED,INTERVENTIONAL,Business decision
NCT04720196,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04720274,WITHDRAWN,INTERVENTIONAL,Principal Investigator decided to not open the study.
NCT04720664,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT04720742,WITHDRAWN,INTERVENTIONAL,"Due to the COVID-19 pandemic the financial sponsor of the trial suspended the study funding due to funding limitations and based on various considerations, including the uncertainties of conducting the study in the volatile scenario of this pandemic."
NCT04721171,TERMINATED,INTERVENTIONAL,Halted prematurely Due to COVID-19 and Investigator left institution
NCT04721535,TERMINATED,INTERVENTIONAL,Termination of study due to sponsor's internal decision
NCT04721743,WITHDRAWN,OBSERVATIONAL,No participants were enrolled. Investigator left NIH.
NCT04721990,WITHDRAWN,INTERVENTIONAL,"Recruitment was never initiated, and no subject participated."
NCT04722666,TERMINATED,INTERVENTIONAL,Terminated by Novartis
NCT04722965,WITHDRAWN,INTERVENTIONAL,Feasibility problems to patients recruitment.
NCT04723108,WITHDRAWN,INTERVENTIONAL,Poor enrollment and researcher left the institution
NCT04723186,TERMINATED,INTERVENTIONAL,"The study was decided to be terminated due to commercial considerations,not the safety issues of the product."
NCT04723472,SUSPENDED,INTERVENTIONAL,Want to modify the study further
NCT04723537,SUSPENDED,INTERVENTIONAL,Part A complete
NCT04723589,WITHDRAWN,INTERVENTIONAL,Widespread vaccine availability
NCT04723784,TERMINATED,INTERVENTIONAL,The project has finished and the technological developments have been created
NCT04724512,SUSPENDED,INTERVENTIONAL,setup activities were suspended due to COVID
NCT04724681,TERMINATED,INTERVENTIONAL,lack of funding
NCT04725097,TERMINATED,OBSERVATIONAL,Interim analysis indicated adaptions may be required.
NCT04725812,TERMINATED,INTERVENTIONAL,PI moved institutions
NCT04725981,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04726163,TERMINATED,INTERVENTIONAL,inclusion difficulties
NCT04727528,TERMINATED,INTERVENTIONAL,The study was stopped due to a higher than expected screen fail rate (83%) which lead to very low patient enrollment into the study. It should be noted that the decision to terminate the study is not related to safety concerns.
NCT04727541,TERMINATED,INTERVENTIONAL,"Based on results of another phase II study with bintrafusp alfa in combination with gemcitabine plus cisplatin, that was discontinued as it was unlikely to meet the primary endpoint of OS, the recruitment for this study was stopped prematurely."
NCT04727606,WITHDRAWN,INTERVENTIONAL,We never got Health Canada approval
NCT04727710,TERMINATED,INTERVENTIONAL,Study was held due to COVID19 and unable to enroll in virtual platform
NCT04727736,TERMINATED,INTERVENTIONAL,Intervention became FDA-approved
NCT04727801,TERMINATED,OBSERVATIONAL,Decision by the Sponsor
NCT04728347,TERMINATED,INTERVENTIONAL,A decision was made to terminate the study for operational/business reasons. This study was not terminated for reasons of safety or immunogenicity.
NCT04728646,WITHDRAWN,INTERVENTIONAL,Due to difficulty enrolling subjects whom had not meet the inclusion criteria
NCT04728698,WITHDRAWN,INTERVENTIONAL,Replaced by a different protocol.
NCT04729088,WITHDRAWN,INTERVENTIONAL,The sponsor will no longer develop the experimental drug.
NCT04729205,TERMINATED,INTERVENTIONAL,Investigational drug not available
NCT04729296,WITHDRAWN,INTERVENTIONAL,Withdrawn due to COVID-19 related clinical limitations
NCT04729348,TERMINATED,INTERVENTIONAL,Planned interim analysis
NCT04729595,TERMINATED,INTERVENTIONAL,Study did not demonstrate statistical significance of its primary endpoint of clinical resolution of COVID-19 symptoms at day 14 versus placebo
NCT04729608,TERMINATED,INTERVENTIONAL,There were no significant differences in median PFS between batiraxcept + paclitaxel or paclitaxel alone arms. There was no detriment to overall survival. No new safety signals were identified.
NCT04729725,TERMINATED,INTERVENTIONAL,"The industry supporter discontinued the study and lead drug, SAR439459, due to toxicity."
NCT04729790,WITHDRAWN,INTERVENTIONAL,No Funding
NCT04729946,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT04730076,WITHDRAWN,INTERVENTIONAL,IRB closed due to slow accrual
NCT04730206,TERMINATED,INTERVENTIONAL,recruitment was too slow
NCT04730349,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT04730427,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT04730505,TERMINATED,INTERVENTIONAL,"Study faced multiple challenges and its launch was heavily impacted by COVID, which in turn has significantly impacted the deployment and adoption goals for a digital technology pilot. These factors led to the difficult decision to close the study."
NCT04730804,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate program
NCT04731051,WITHDRAWN,INTERVENTIONAL,the study was terminated as no more COVID cases were treated at the center
NCT04731259,SUSPENDED,INTERVENTIONAL,Business reasons.
NCT04731298,TERMINATED,INTERVENTIONAL,"Sponsor Decision related to Business Priorities, Assessment of Development Options"
NCT04731740,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04732143,TERMINATED,INTERVENTIONAL,Lack of funding and clinical resources to continue
NCT04732169,WITHDRAWN,INTERVENTIONAL,"Investigator decided not to do study, due to insufficient funding."
NCT04732312,TERMINATED,OBSERVATIONAL,recruitment issues
NCT04732429,TERMINATED,INTERVENTIONAL,The decision to terminate the study was based on business considerations by the Sponsor.
NCT04732767,WITHDRAWN,OBSERVATIONAL,not enough research personnel to complete study at the time
NCT04732897,TERMINATED,INTERVENTIONAL,Recruitment issue
NCT04732975,SUSPENDED,OBSERVATIONAL,Resourcing
NCT04733339,TERMINATED,OBSERVATIONAL,COVI-19 Pandemic
NCT04733677,TERMINATED,OBSERVATIONAL,"NIOSH certification became impossible, so decision was made to terminate"
NCT04733898,TERMINATED,INTERVENTIONAL,Aimed sample size could not be reached within the time that was taken for recruitment.
NCT04734860,WITHDRAWN,INTERVENTIONAL,A different study will be conducted.
NCT04734873,TERMINATED,INTERVENTIONAL,Sponsor decision. Not related to safety issues.
NCT04735185,SUSPENDED,INTERVENTIONAL,Awaiting sponsor and FDA feedback
NCT04735510,WITHDRAWN,INTERVENTIONAL,study redesigned
NCT04735796,TERMINATED,INTERVENTIONAL,Business strategy changed
NCT04735991,SUSPENDED,INTERVENTIONAL,The recruitment process is affected by the coronavirus pandemic.
NCT04736745,TERMINATED,INTERVENTIONAL,Sponsor terminated the study due to strategic considerations
NCT04737044,TERMINATED,INTERVENTIONAL,Termination of study by the Sponsor (Central Sugars Refinery Sdn. Bhd. Malaysia)
NCT04737109,TERMINATED,INTERVENTIONAL,Funder Decision
NCT04737122,TERMINATED,INTERVENTIONAL,Failure to achieve expected outcomes
NCT04737161,WITHDRAWN,INTERVENTIONAL,Funding not secured
NCT04737174,WITHDRAWN,INTERVENTIONAL,Lack of identifiable patients
NCT04737330,TERMINATED,INTERVENTIONAL,Analysis of blinded patient data showed a very low probability of the study meeting the primary efficacy endpoints. No safety concerns were identified
NCT04737629,WITHDRAWN,INTERVENTIONAL,Study was never started.
NCT04738136,SUSPENDED,INTERVENTIONAL,Sponsor Decision
NCT04738175,WITHDRAWN,INTERVENTIONAL,A different study will be conducted.
NCT04738292,TERMINATED,INTERVENTIONAL,funding
NCT04738318,TERMINATED,INTERVENTIONAL,Switched to observational study type.
NCT04738344,WITHDRAWN,INTERVENTIONAL,No enough patients enrolled
NCT04738461,WITHDRAWN,INTERVENTIONAL,postponed to a later date
NCT04738617,WITHDRAWN,INTERVENTIONAL,"After several postponements due to different reasons (e.g., COVID lockdowns, mismatch between research team availability and club's availability), this study will no longer be performed."
NCT04738747,WITHDRAWN,INTERVENTIONAL,Lack of Grant
NCT04739007,WITHDRAWN,OBSERVATIONAL,Not enough personnel to follow the trial- study was withdrawn
NCT04739254,SUSPENDED,OBSERVATIONAL,Resourcing
NCT04739358,TERMINATED,INTERVENTIONAL,Study was terminated due to lack of lack of enrollment and difficult patient population.
NCT04739449,WITHDRAWN,INTERVENTIONAL,Since the vaccine there are no COVID 19 cases in proposed study sites.
NCT04739566,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04739683,WITHDRAWN,INTERVENTIONAL,Withdrawn due to another study which superseded it.
NCT04739839,TERMINATED,OBSERVATIONAL,Lack of responders
NCT04740073,SUSPENDED,OBSERVATIONAL,Due to COVID-19 and research restrictions put in place by the university
NCT04740099,WITHDRAWN,INTERVENTIONAL,The study never started due to COVID-19.
NCT04740970,WITHDRAWN,INTERVENTIONAL,Sponsor Decision.
NCT04741048,WITHDRAWN,INTERVENTIONAL,Sponsor decided to cancel the study prior to any subjects being enrolled/consented due to the lack of CMS coverage and an internal staffing shortage.
NCT04741074,TERMINATED,INTERVENTIONAL,low recruitment
NCT04741100,WITHDRAWN,OBSERVATIONAL,No patients Enrolled
NCT04741204,WITHDRAWN,INTERVENTIONAL,Limited staff to carry out study
NCT04741542,SUSPENDED,INTERVENTIONAL,Study is on hold by FDA in the US.
NCT04741984,WITHDRAWN,INTERVENTIONAL,Due to need to proceed with procedural changes with goals of improving the technical and economic feasibility.
NCT04742348,WITHDRAWN,INTERVENTIONAL,COVID-19 and expiration of funding
NCT04742413,TERMINATED,OBSERVATIONAL,Recruitment was not completed
NCT04742608,SUSPENDED,OBSERVATIONAL,IRB lapse
NCT04742764,SUSPENDED,INTERVENTIONAL,The human resources required to start enrollment were not available anymore.
NCT04742972,WITHDRAWN,INTERVENTIONAL,"The lack of well-defined oligometastasis, high disease burden in mCRPC and high sensitivity of PSMA-PET scan, PMSABR study was made with high ambition and the assumption on recruitment was found to be invalid."
NCT04743076,SUSPENDED,INTERVENTIONAL,Withdrawal of funding
NCT04743232,SUSPENDED,INTERVENTIONAL,Because the COVID pandemic became less severe (omikron)
NCT04743349,TERMINATED,INTERVENTIONAL,Difficulties in enrollment
NCT04743557,WITHDRAWN,INTERVENTIONAL,"The first Clinical trial with DYN101 (UNITE-CNM) was early terminated. As a consequence, Dynacure decided to not perform this study."
NCT04743804,TERMINATED,INTERVENTIONAL,Recruitment Challenges
NCT04743999,TERMINATED,INTERVENTIONAL,Low accrual
NCT04744272,WITHDRAWN,INTERVENTIONAL,Delayed due to NHS pandemic pressures
NCT04744844,TERMINATED,INTERVENTIONAL,Funding for the trial was cancelled by funding organization
NCT04745351,TERMINATED,INTERVENTIONAL,The study was terminated due to study enrollment feasibility. This decision is not based on efficacy or safety concerns.
NCT04745585,TERMINATED,OBSERVATIONAL,Adverse event
NCT04745663,TERMINATED,INTERVENTIONAL,Not the expected 2/3 but only 1/3 of conjunctiva samples got bacterial growth. Lack of resources to keep the study going with more participants and over a considerably longer time than anticipated.
NCT04745793,TERMINATED,OBSERVATIONAL,Data acquisition not possible anymore
NCT04745832,TERMINATED,INTERVENTIONAL,Discontinuation of zandelisib program
NCT04746131,SUSPENDED,INTERVENTIONAL,"Due to the product development strategy change, without any safety concerns, we (the sponsor of the trial) have decided to request to place the IND (#151570) on inactive status."
NCT04746339,TERMINATED,INTERVENTIONAL,"Due to the decrease in COVID cases and in the recruitment rate, and DSMB orientation."
NCT04746430,TERMINATED,INTERVENTIONAL,Too few patients
NCT04746495,WITHDRAWN,INTERVENTIONAL,"Issues relate to COVID-19 and staffing challenges, as well as very tight finances."
NCT04746560,TERMINATED,OBSERVATIONAL,"Haemonetics, the company that manages the TEG device, has given a negative answer as to the continuation of the study. For technical and internal reasons, they will take over the device."
NCT04746612,TERMINATED,INTERVENTIONAL,Sponsor business decision
NCT04746755,TERMINATED,INTERVENTIONAL,"Participants experienced data collection issues when using the eDiary, these issues increased the burden and lowered compliance. Updates to the eDiary were unsuccessful at resolving the issues so the decision was taken to terminate the Investigation."
NCT04746963,TERMINATED,INTERVENTIONAL,Adverse Events
NCT04746976,TERMINATED,OBSERVATIONAL,Sponsor's Decision
NCT04747275,TERMINATED,INTERVENTIONAL,Transitioned to multi site study with sponsor
NCT04747470,TERMINATED,INTERVENTIONAL,"Sponsor decision to prematurely discontinue the study, following an internal safety assessment of the molecule, GS-3583."
NCT04747730,TERMINATED,INTERVENTIONAL,"unfortunately, the trial couldn't take place as planned as the investigators didn't manage to recruit a sufficient number of participants."
NCT04748107,WITHDRAWN,INTERVENTIONAL,Too difficult to perform study procedures prior to giving blood pressure medication.
NCT04748120,TERMINATED,INTERVENTIONAL,Insufficient eligible patients
NCT04748289,SUSPENDED,INTERVENTIONAL,Feasilibilty
NCT04748302,TERMINATED,OBSERVATIONAL,COVID
NCT04748393,TERMINATED,OBSERVATIONAL,Low enrolment
NCT04748588,TERMINATED,INTERVENTIONAL,Equipoise requirement no longer met.
NCT04748783,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT04748848,TERMINATED,INTERVENTIONAL,Business objectives have changed.
NCT04749433,TERMINATED,INTERVENTIONAL,study stopped to enhance protocol and resume under different sponsor
NCT04749797,TERMINATED,INTERVENTIONAL,PI left institution
NCT04749901,TERMINATED,INTERVENTIONAL,Impossible to pursue the study
NCT04749940,WITHDRAWN,INTERVENTIONAL,no bugdet for the study
NCT04749992,TERMINATED,OBSERVATIONAL,recruitment proved to be impossible for the necessary experimental non-dreaming group
NCT04750239,TERMINATED,INTERVENTIONAL,Study terminated due to business priorities
NCT04750278,TERMINATED,INTERVENTIONAL,"Study stopped at interim analysis point, due to lack of study subjects to recruit."
NCT04750759,TERMINATED,INTERVENTIONAL,sub-therapeutic plasma levels of active substance
NCT04751370,SUSPENDED,INTERVENTIONAL,Scheduled Interim Monitoring
NCT04751383,SUSPENDED,INTERVENTIONAL,Unacceptable Toxicity
NCT04751955,WITHDRAWN,INTERVENTIONAL,This clinical trial was not finally approved by the Korea FDA.
NCT04752358,TERMINATED,INTERVENTIONAL,Study was terminated due to difficulty recruiting subjects and lack of efficacy
NCT04752371,TERMINATED,INTERVENTIONAL,Sponsor discretion
NCT04752917,TERMINATED,INTERVENTIONAL,Chief Investigator retirement
NCT04753060,SUSPENDED,INTERVENTIONAL,Study suspended temporarily due to coronavirus pandemic.
NCT04753398,WITHDRAWN,INTERVENTIONAL,No patients included
NCT04753658,TERMINATED,OBSERVATIONAL,The study was prematurely discontinued due to operational implementation challenges and insufficient collection of key data due to varied data accessibility across global study sites.
NCT04753736,WITHDRAWN,INTERVENTIONAL,lack of staff
NCT04753957,TERMINATED,INTERVENTIONAL,Difficulty with endometrial sample collection. New study design to be prospective observational to validate reliable methods of endometrial sampling at time of c-section.
NCT04753983,WITHDRAWN,INTERVENTIONAL,No longer have funding
NCT04754009,SUSPENDED,INTERVENTIONAL,COVID-19
NCT04754334,TERMINATED,INTERVENTIONAL,The ORA-D-013-2 protocol was terminated based on the primary results analyzed at week 26 in the ORA-D-013-1 protocol.
NCT04754490,SUSPENDED,OBSERVATIONAL,COVID 19
NCT04754815,WITHDRAWN,INTERVENTIONAL,Logistical challenges primarily due to COVID led to delay in starting the study and now is not felt to be clinically relevant.
NCT04754867,WITHDRAWN,INTERVENTIONAL,Never initiated. PI has left the institution.
NCT04755816,TERMINATED,INTERVENTIONAL,Slow recruitment - DSMB decision
NCT04755881,TERMINATED,OBSERVATIONAL,Planned interim data analysis showed underperformance (statistical and clinical) of the three derived clinical decision rules that had been derived and that we were trying to validate.
NCT04756505,WITHDRAWN,INTERVENTIONAL,Per Sponsor Request-no longer manufacturing the study drug
NCT04756674,WITHDRAWN,OBSERVATIONAL,Failure to recruit due to high use of anticoagulants in COVID-19 patients and rapid declining rates of COVID-19 thanks to the vaccine implementation
NCT04756856,TERMINATED,INTERVENTIONAL,Significant change in the profile of recruitable patients
NCT04757090,WITHDRAWN,INTERVENTIONAL,Insufficient staff
NCT04757246,WITHDRAWN,INTERVENTIONAL,Funding from Sponsor did not come through
NCT04757688,WITHDRAWN,INTERVENTIONAL,Difficulty with accrual
NCT04757714,WITHDRAWN,INTERVENTIONAL,The site is no more able to conduct the study
NCT04757831,WITHDRAWN,OBSERVATIONAL,Study did not begin
NCT04757857,TERMINATED,INTERVENTIONAL,Sustained reduction in the number of new COVID-19 cases as well as lower than expected event rates
NCT04758052,WITHDRAWN,INTERVENTIONAL,Principal Investigator change in institution
NCT04758260,WITHDRAWN,INTERVENTIONAL,difficulty recruiting
NCT04758858,WITHDRAWN,INTERVENTIONAL,Not approved by REB
NCT04758949,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT04759066,WITHDRAWN,INTERVENTIONAL,Primary investigator moved to a new institution.
NCT04759365,TERMINATED,INTERVENTIONAL,"Delays with sites, identifying/enrolling patients, impact of COVID, staffing, and duration"
NCT04759833,TERMINATED,INTERVENTIONAL,"Data Monitoring Committe (DMC) decision; terminated due to futility, with no safety concerns; FDA agreement to terminate the study."
NCT04759846,WITHDRAWN,INTERVENTIONAL,no recruitment
NCT04759859,WITHDRAWN,OBSERVATIONAL,logistical issues with coordinating the clinical and testing areas
NCT04759872,TERMINATED,INTERVENTIONAL,Unsuccessful enrollment during COVID-19 pandemic.
NCT04759989,TERMINATED,INTERVENTIONAL,The study is being closed due to low enrollment
NCT04760054,TERMINATED,INTERVENTIONAL,COVID-19
NCT04760288,WITHDRAWN,INTERVENTIONAL,Due to several logistical challenges during start-up which could not be overcome study was withdrawn.
NCT04760873,SUSPENDED,INTERVENTIONAL,Transferring trial to new institution and needs to be reviewed/approved before enrolling new participants.
NCT04760938,TERMINATED,INTERVENTIONAL,Failure of comparison group to provide adequate comparison and appropriate comparison
NCT04761601,TERMINATED,INTERVENTIONAL,"Stopped for strategic business reasons. The decision to stop the study was not connected to any safety concerns, or new risk associated with the study product, intervention, or procedures."
NCT04761666,WITHDRAWN,OBSERVATIONAL,no participants enrolled
NCT04761679,TERMINATED,INTERVENTIONAL,Evolution of the COVID19 pandemic with subsequent spread to all areas of clinical care severely affected the number of potential participants that were able to safely participate in the study.
NCT04761692,WITHDRAWN,INTERVENTIONAL,Study not funded
NCT04761835,WITHDRAWN,INTERVENTIONAL,Withdrawn in IRB
NCT04761887,WITHDRAWN,INTERVENTIONAL,Study withdrawn prior to enrollment (insufficient funds and reduced access to patients related to COVID protocols)
NCT04762121,WITHDRAWN,OBSERVATIONAL,Investigators left the institution
NCT04762160,TERMINATED,INTERVENTIONAL,Decision to terminate EZH-1401 was solely due to company business decision.
NCT04762186,TERMINATED,INTERVENTIONAL,poor recruitment
NCT04762225,TERMINATED,INTERVENTIONAL,Development program terminated
NCT04762511,TERMINATED,INTERVENTIONAL,To enable development of an enhanced version of the vaccine
NCT04762771,TERMINATED,INTERVENTIONAL,Recovery Trial showed no convincing evidence that further recruitment would provide conclusive proof of worthwhile benefit for the evaluation of Colchicine in patients with Covid-19.
NCT04762823,WITHDRAWN,INTERVENTIONAL,The PI (Post-Doc Craig Workman) left the university.
NCT04762849,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT04762875,TERMINATED,INTERVENTIONAL,This study was voluntarily terminated due to a business decision not to proceed and not due to any safety issue
NCT04762901,WITHDRAWN,INTERVENTIONAL,Funding was terminated.
NCT04763031,TERMINATED,INTERVENTIONAL,No potential patients enrolled since first enrollment on 06/27/2022.
NCT04763135,TERMINATED,INTERVENTIONAL,difficulties in recruiting
NCT04763499,TERMINATED,INTERVENTIONAL,lack of recruiting progress
NCT04763603,TERMINATED,OBSERVATIONAL,SARS-CoV-2 coronavirus outbreak and end of funding
NCT04763837,WITHDRAWN,INTERVENTIONAL,unable to continue
NCT04763967,TERMINATED,OBSERVATIONAL,"Slow Enrollment, Recruiting Difficulties"
NCT04764097,WITHDRAWN,INTERVENTIONAL,Lack of funding and similar competing study being conducted in Europe.
NCT04764383,WITHDRAWN,INTERVENTIONAL,Withdrawn as more data drug analysis is recommended before the study.
NCT04764578,WITHDRAWN,OBSERVATIONAL,Staffing shortages
NCT04764851,TERMINATED,INTERVENTIONAL,A number of subjects withdrew consent leaving the study without adequate power to achieve its primary end points.
NCT04764864,WITHDRAWN,INTERVENTIONAL,No financing
NCT04765085,WITHDRAWN,INTERVENTIONAL,Lacking of funding
NCT04765423,WITHDRAWN,INTERVENTIONAL,Poor patient accrual
NCT04766476,TERMINATED,INTERVENTIONAL,Business objectives have changed
NCT04766996,TERMINATED,INTERVENTIONAL,"Loss of surgery team member deemed the study procedures impossible to achieve, and no replacement could be found in a timely manner to complete trial as initially planned."
NCT04767698,TERMINATED,INTERVENTIONAL,The funding source decided to stop funding the study.
NCT04767958,TERMINATED,INTERVENTIONAL,Device pulled from market due to inconsistent results.
NCT04768010,WITHDRAWN,INTERVENTIONAL,After significant delays study was never initiated. No participants enrolled
NCT04768348,TERMINATED,OBSERVATIONAL,Homology Medicines has discontinued the development of this program.
NCT04768478,WITHDRAWN,INTERVENTIONAL,there was no funding to begin the study
NCT04768569,TERMINATED,INTERVENTIONAL,PINIHL Program terminated by DoD
NCT04768634,TERMINATED,INTERVENTIONAL,limited enrollment
NCT04768712,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04768790,SUSPENDED,INTERVENTIONAL,Lack of resources
NCT04769453,TERMINATED,INTERVENTIONAL,"Sponsor-initiated, suspension of study due to modification of key parameters."
NCT04769518,TERMINATED,INTERVENTIONAL,Interim analysis complete; ceased on statistical advice
NCT04770051,WITHDRAWN,INTERVENTIONAL,Lack of resources to conduct study.
NCT04770064,WITHDRAWN,INTERVENTIONAL,Funding was not awarded
NCT04770155,TERMINATED,INTERVENTIONAL,"Despite significant effort, we were unable to obtain the supply of drugs and supplements needed for the various arms of this Clinical Trial."
NCT04770181,SUSPENDED,INTERVENTIONAL,Suspended due to COVID19; Non-essential at this time per IRB. The study never started.
NCT04770246,TERMINATED,INTERVENTIONAL,The Sponsor had decided to terminate this clinical trial due to an insufficient rate of accrual of patients.
NCT04770402,TERMINATED,INTERVENTIONAL,Low accrual
NCT04770467,WITHDRAWN,INTERVENTIONAL,The study will no longer move forward due to recent changes in COVID-19 cases in Hong Kong.
NCT04770649,TERMINATED,OBSERVATIONAL,No longer of interest to the company
NCT04770714,WITHDRAWN,INTERVENTIONAL,No Participants enrolled.
NCT04770831,WITHDRAWN,OBSERVATIONAL,"difficult enrollment, no subjects consented or enrolled"
NCT04770844,TERMINATED,OBSERVATIONAL,inclusion difficulties
NCT04771000,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04771143,WITHDRAWN,INTERVENTIONAL,study terminated/withdrawn before FPFV (no patients enrolled)
NCT04771247,WITHDRAWN,INTERVENTIONAL,IRB approval withheld
NCT04771351,WITHDRAWN,INTERVENTIONAL,A different study will be conducted.
NCT04771416,SUSPENDED,INTERVENTIONAL,The study was stopped due to changes in the company strategy.
NCT04772053,TERMINATED,INTERVENTIONAL,The study was terminated for reasons pertaining to feasibility
NCT04772092,WITHDRAWN,OBSERVATIONAL,Departure from the department of the principal investigator
NCT04773067,TERMINATED,INTERVENTIONAL,"Under the limited resources, to re-plan the ongoing clinical trials of this product."
NCT04773197,TERMINATED,INTERVENTIONAL,Low accrual
NCT04773275,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04774250,TERMINATED,INTERVENTIONAL,Low accrual
NCT04774484,WITHDRAWN,INTERVENTIONAL,Funding was not available.
NCT04774640,TERMINATED,OBSERVATIONAL,Poor rate of eligible subject enrollment
NCT04774809,TERMINATED,INTERVENTIONAL,terminated by sponsor
NCT04775056,WITHDRAWN,OBSERVATIONAL,No sponsor
NCT04775147,TERMINATED,INTERVENTIONAL,Results of ENCHANTED have been published.
NCT04775316,TERMINATED,OBSERVATIONAL,site stopped recruiting due to limited personell resources
NCT04775329,TERMINATED,INTERVENTIONAL,Slow recruitment and study closure
NCT04775407,TERMINATED,OBSERVATIONAL,Due to the development of the pandemic
NCT04775680,TERMINATED,INTERVENTIONAL,The safety of ADG106 combined with triprilimab has been fully understood.The overall clinical benefit of enrolled subjects was limited and further development of ADG106 was reconsidered.
NCT04775797,TERMINATED,INTERVENTIONAL,Safety
NCT04776018,TERMINATED,INTERVENTIONAL,Enrolment Challenges
NCT04776044,TERMINATED,INTERVENTIONAL,general circumstances around COVID-19 and current availability of hospitalized patients
NCT04776356,TERMINATED,OBSERVATIONAL,it was difficult to obtain subjects' consent
NCT04776850,WITHDRAWN,INTERVENTIONAL,Competing protocol opened in Adult SCT that will include pediatric patients and is now multi-center. No patients enrolled on study.
NCT04776876,WITHDRAWN,INTERVENTIONAL,The study will not be opening. Support was withdrawn.
NCT04776980,WITHDRAWN,INTERVENTIONAL,PI decision to close study
NCT04777708,TERMINATED,INTERVENTIONAL,Withdrawn by sponsor
NCT04777786,TERMINATED,INTERVENTIONAL,Lack of enrolled participants
NCT04777799,TERMINATED,INTERVENTIONAL,Decision of the sponsor
NCT04778059,TERMINATED,INTERVENTIONAL,Unable to enroll in timely manner due to nature of COVID
NCT04778085,TERMINATED,OBSERVATIONAL,As anticipated by the protocol
NCT04778566,WITHDRAWN,OBSERVATIONAL,Recent discovery of a novel assay that is more likely to be beneficial for patients with Lynch Syndrome. Investing into current version of Cologuard test would provide little clinical benefit.
NCT04778709,TERMINATED,INTERVENTIONAL,"Original PI who is no longer at the institution, the sponsor of this research study, Zimmer Biomet, along with the current PI have decided to close enrollment to the study and to early terminate the study."
NCT04778982,TERMINATED,OBSERVATIONAL,Difficulty in completing enrollment within the planned time
NCT04779151,SUSPENDED,INTERVENTIONAL,Abandon by GSK
NCT04779489,TERMINATED,INTERVENTIONAL,Study was closed to low accrual.
NCT04780061,TERMINATED,INTERVENTIONAL,Public PCR testing stopped in Ontario
NCT04780269,SUSPENDED,INTERVENTIONAL,understaffed
NCT04780464,TERMINATED,INTERVENTIONAL,Withdrawal grant provider
NCT04780581,TERMINATED,INTERVENTIONAL,Impossibility of reaching the sample size established by protocol
NCT04780893,WITHDRAWN,INTERVENTIONAL,New trial opportunity in the USA.
NCT04781166,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04781218,WITHDRAWN,OBSERVATIONAL,Study did not start
NCT04781283,WITHDRAWN,INTERVENTIONAL,The PI chose not to start the study.
NCT04781374,WITHDRAWN,INTERVENTIONAL,Withdrawal of funding
NCT04781647,TERMINATED,INTERVENTIONAL,Study ABI-H0731-203 was terminated early by the study Sponsor for strategic reasons to prioritize research and development efforts on finite and curative HBV therapies.
NCT04781829,WITHDRAWN,INTERVENTIONAL,COVID pandemic precluded trial initiation. No longer clinical equipoise
NCT04781946,WITHDRAWN,INTERVENTIONAL,Decided not to move forward with the study.
NCT04782245,WITHDRAWN,INTERVENTIONAL,New recommandations
NCT04782297,WITHDRAWN,OBSERVATIONAL,Recruitment and enrollment was not prioritized by sites and no enrollments occurred over the course of 1 year.
NCT04782336,SUSPENDED,INTERVENTIONAL,Recruitment Pause
NCT04782609,TERMINATED,INTERVENTIONAL,Samus Therapeutics Company Closure
NCT04782661,WITHDRAWN,INTERVENTIONAL,Program terminated prior to enrolling subjects
NCT04782700,WITHDRAWN,INTERVENTIONAL,Due to recruitment we decided to withdraw the study.
NCT04783233,WITHDRAWN,OBSERVATIONAL,Physician left practice.
NCT04783389,TERMINATED,INTERVENTIONAL,Trial was discontinued in 2022 due to COVID-19 pandemic and Ukraine/Russia conflict related enrollment challenges. Discontinuation was not related to safety.
NCT04783532,TERMINATED,INTERVENTIONAL,Difficulty with participant enrollment and intervention engagement.
NCT04783727,TERMINATED,INTERVENTIONAL,Change in WHO recommendations for standard of care (control arm); availability of new shorter treatment regimens for MDR-TB; war in Ukraine where two study sites are located; key trial team members left the team.
NCT04784182,TERMINATED,INTERVENTIONAL,Only three participants enrolled
NCT04784286,TERMINATED,INTERVENTIONAL,"Because of Covid-19, in-person visits were halted and telemedicine was used."
NCT04784338,WITHDRAWN,INTERVENTIONAL,The investigators decided not to implement the research but instead to conduct a quality improvement project to focus on the practice of shared medical appointments (SMAs) and how to optimize them for clinical practice.
NCT04784390,TERMINATED,INTERVENTIONAL,The study was terminated based upon the competitive landscape and strategic fit.
NCT04784520,TERMINATED,INTERVENTIONAL,The primary endpoint did not meet expectation.
NCT04784559,TERMINATED,INTERVENTIONAL,"Sponsor has decided to end the study prematurely based on significant difficulties in the recruitment of patients, despite the implementation of corrective measures that still failed to increase the accrual rate required for a feasible completion."
NCT04784676,TERMINATED,INTERVENTIONAL,study is ended
NCT04784754,WITHDRAWN,INTERVENTIONAL,lack of subject enrollment
NCT04785339,WITHDRAWN,INTERVENTIONAL,PI is leaving institution.
NCT04785365,TERMINATED,INTERVENTIONAL,"The long-term follow-up of patients is being migrated to the original (parent) study protocols (Trial ID: ATX-NS-001 / NCT: NCT04032847;Trial ID: ATX-ME-001 / NCT: NCT03997474). Consequently, the ATX-LTFU-001 study is being terminated by the Sponsor."
NCT04785547,TERMINATED,INTERVENTIONAL,Terminated by Amgen Limited
NCT04785924,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT04786236,TERMINATED,INTERVENTIONAL,"The HVAD, which is the device to which the control algorithms are applied, was discontinued by the manufacturer."
NCT04786379,TERMINATED,INTERVENTIONAL,Due to lack of adequate patient sample size in a reasonable time period and lack of research support staff
NCT04786392,WITHDRAWN,INTERVENTIONAL,Unable to fit within PhD timeline.
NCT04786808,TERMINATED,OBSERVATIONAL,Not enough participants recruited (about 30% at october 2021).
NCT04786964,TERMINATED,INTERVENTIONAL,Regional political conflict
NCT04787133,WITHDRAWN,OBSERVATIONAL,budgetary reason
NCT04787250,WITHDRAWN,INTERVENTIONAL,Changes to protocol design
NCT04787731,SUSPENDED,INTERVENTIONAL,COVID-19 and Personnel changes
NCT04787926,TERMINATED,OBSERVATIONAL,Enrollment was low or halted with few to zero future anticipated enrollments.
NCT04788082,WITHDRAWN,INTERVENTIONAL,No enrollments
NCT04788459,TERMINATED,INTERVENTIONAL,The good progress of the Italian national vaccination campaign against COVID-19 made impossible to complete the study as planned.
NCT04789707,TERMINATED,OBSERVATIONAL,recruitment difficulties
NCT04790487,WITHDRAWN,INTERVENTIONAL,Study Period Ended/Not Completed
NCT04790773,TERMINATED,INTERVENTIONAL,Unable to continue due to low enrollment and lack of resources.
NCT04790786,TERMINATED,INTERVENTIONAL,Emergency Use Authorizations for monoclonal antibodies withdrawn
NCT04790916,TERMINATED,INTERVENTIONAL,A lack of efficacy was seen with RO7049665 in a study of ulcerative colitis. This reduces the likelihood that the drug is effective in autoimmune hepatitis.
NCT04791319,TERMINATED,INTERVENTIONAL,Premature Termination due to Interim Analysis (100 patients at Week 16) meeting futility.
NCT04791514,TERMINATED,INTERVENTIONAL,Low enrolment
NCT04791761,TERMINATED,INTERVENTIONAL,slow recruitment
NCT04792008,TERMINATED,INTERVENTIONAL,Due to business decision
NCT04792970,TERMINATED,INTERVENTIONAL,Study enrollment not met
NCT04793373,WITHDRAWN,INTERVENTIONAL,Protocol is being revised.
NCT04793399,TERMINATED,INTERVENTIONAL,The study has been prematurely terminated due to the onset of 2 dose limiting toxicities in 2 patients.
NCT04793620,TERMINATED,INTERVENTIONAL,financial constraints
NCT04793711,TERMINATED,INTERVENTIONAL,Unable to find willing participants.
NCT04793997,SUSPENDED,INTERVENTIONAL,"Based on feedback from our study participants on the taste, spray optimization is necessary"
NCT04794088,TERMINATED,INTERVENTIONAL,"Due to the decline of COVID-19 patients on Dutch ICUs. A sample size reestimation based on blinded study data of 66 patients was furthermore favorable, indicating sufficient power to detect a difference in primary endpoint between groups."
NCT04794205,WITHDRAWN,INTERVENTIONAL,Delayed project onset; PI determined pilot data could be collected at a later date.
NCT04794335,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT04794569,TERMINATED,INTERVENTIONAL,funding discontinued
NCT04794803,TERMINATED,INTERVENTIONAL,The sponsor has decided to start with a separate protocol for phase 3 and therefore this study was terminated with only phase 2.
NCT04795141,TERMINATED,INTERVENTIONAL,The sponsor's development strategy is adjusted.
NCT04795492,WITHDRAWN,INTERVENTIONAL,Unable to recruit enough patients
NCT04795583,WITHDRAWN,INTERVENTIONAL,Funding Issues
NCT04795596,WITHDRAWN,INTERVENTIONAL,Poor accrual
NCT04795869,WITHDRAWN,INTERVENTIONAL,Study inactivated due to zero accruals
NCT04795960,WITHDRAWN,INTERVENTIONAL,Lack of eligible and interested patients
NCT04796272,TERMINATED,INTERVENTIONAL,low inclusion rates
NCT04796454,WITHDRAWN,INTERVENTIONAL,Company decision
NCT04796584,TERMINATED,OBSERVATIONAL,"Enrollment paused for greater than 6 months, data would not be relevant as enrollment took longer than expected."
NCT04796662,TERMINATED,OBSERVATIONAL,Poor recruitment
NCT04796922,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to a business decision.
NCT04797026,WITHDRAWN,INTERVENTIONAL,Study terminated due to difficulties enrolling given skilled nursing facility staff shortages
NCT04797078,WITHDRAWN,INTERVENTIONAL,Planning halted due to changes in the research group constellation.
NCT04797468,WITHDRAWN,INTERVENTIONAL,The Early Termination is the result of the sponsor's need to reevaluate the study design and to make needed vendor realignments.
NCT04797533,TERMINATED,INTERVENTIONAL,Decommissioned due to not enough staff across the study to adequately support it.
NCT04797975,WITHDRAWN,INTERVENTIONAL,The sponsor decided to withdraw this study
NCT04798027,TERMINATED,INTERVENTIONAL,Sponsor's decision not to pursue further development of this product given the wide availability of authorized/approved mRNA COVID-19 vaccines
NCT04798989,TERMINATED,INTERVENTIONAL,Due to enrollment challenges
NCT04799210,TERMINATED,INTERVENTIONAL,Device performance was not as anticipated.
NCT04799392,TERMINATED,INTERVENTIONAL,FDA will not authorize COVID-19 Ab tests for use over-the-counter.
NCT04799431,WITHDRAWN,INTERVENTIONAL,Study never started
NCT04799990,WITHDRAWN,OBSERVATIONAL,Study is not recruiting and using secondary data sources only
NCT04800016,WITHDRAWN,INTERVENTIONAL,Management decision. No patients enrolled
NCT04800523,WITHDRAWN,INTERVENTIONAL,Similar study already completed
NCT04800562,TERMINATED,INTERVENTIONAL,lack of enrollment of this ultra rare disease
NCT04800627,TERMINATED,INTERVENTIONAL,Per PI
NCT04801056,WITHDRAWN,INTERVENTIONAL,Difficulty in patient recruitment and will start again if study population increases to allow study feasibility
NCT04801316,TERMINATED,INTERVENTIONAL,"The study was affected by governmental COVID-19 restrictions in the community, resulting in study implementation delays. The sponsor was unable to extend the funding period further, hence the study was stopped due to a lack of funds."
NCT04801641,TERMINATED,INTERVENTIONAL,Poor tolerability of medication and no preliminary efficacy
NCT04801810,WITHDRAWN,INTERVENTIONAL,"This study was registered in conjunction with a submitted R01. To address reviewer comments, the study was changed substantially for resubmission. A new study has been registered (NCT05289310) that aligns with the funded R01."
NCT04801966,TERMINATED,INTERVENTIONAL,low recruitment
NCT04802005,WITHDRAWN,INTERVENTIONAL,PI moved to another institution
NCT04802031,WITHDRAWN,INTERVENTIONAL,Low accrual
NCT04802265,TERMINATED,OBSERVATIONAL,departure of the intern in charge of the study
NCT04802538,TERMINATED,INTERVENTIONAL,Sponsor decided to terminate study due to insufficient recruitment.
NCT04802837,TERMINATED,INTERVENTIONAL,SMT19969-C006 study was terminated in alignment with corporate decision to pursue further development of drug candidate with a partner.
NCT04802928,WITHDRAWN,INTERVENTIONAL,Patients fulfilling the criteria could not be found.
NCT04803084,SUSPENDED,OBSERVATIONAL,MRI upgrade
NCT04803123,TERMINATED,INTERVENTIONAL,Sponsor halted clinical development of study drug
NCT04803227,TERMINATED,INTERVENTIONAL,Unforeseeable difficulties in recruiting patients. There were no reported serious adverse events.
NCT04803591,WITHDRAWN,INTERVENTIONAL,Not approved by Ethics Commettee
NCT04803630,WITHDRAWN,INTERVENTIONAL,Awaiting grant funding for next phase of study
NCT04803890,TERMINATED,INTERVENTIONAL,"Early termination d/t overlap with a new, extended protocol study."
NCT04804046,TERMINATED,INTERVENTIONAL,Lack of funding
NCT04804254,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04805203,TERMINATED,INTERVENTIONAL,Recruitment delay due to difficulties to involve patient at Covid diagnosis in hematology departments Abandoned study
NCT04805424,WITHDRAWN,INTERVENTIONAL,Karolinska University Hospital unable to support the clinical trial as anticipated.
NCT04805645,TERMINATED,OBSERVATIONAL,Study was unable to begin due to clinicians too busy with handling COVID-19 cases
NCT04805671,TERMINATED,INTERVENTIONAL,"All primary efficacy data has been collected and analyzed. Based on the safety data gathered to date, it has been determined that continued participation by study subjects would not yield any additional beneficial safety information."
NCT04805840,TERMINATED,OBSERVATIONAL,Difficulty with recruitment.
NCT04806152,TERMINATED,INTERVENTIONAL,"The COVID19 outbreak began March 2020 in Jamaica. Associated risks, prohibitive cost of mitigating those risks for study participants and locally enacted legislation militated against further recruitment and intervention activities."
NCT04806178,SUSPENDED,INTERVENTIONAL,Recruitment delay
NCT04806334,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04806503,TERMINATED,INTERVENTIONAL,The study was discontinued by the Sponsor because it did not achieve the primary objective.
NCT04806529,WITHDRAWN,INTERVENTIONAL,Seqirus discontinued V451_07 Phase 2 start-up activities prior to enrolling subjects. Data from Phase 1 did not support further development. Further details are here: www.seqirus.com/news/update-on-the-university-of-queensland-covid-19-vaccine
NCT04806945,WITHDRAWN,INTERVENTIONAL,The sponsor terminated the trial.
NCT04807075,TERMINATED,OBSERVATIONAL,Failure to recruit
NCT04807309,WITHDRAWN,INTERVENTIONAL,Lack of financial support
NCT04807387,TERMINATED,INTERVENTIONAL,"After enrolling 6 healthy participants the study is being put on halted due to funding and personnel gap. All participants have been informed, per study IRB, of study status."
NCT04807478,WITHDRAWN,OBSERVATIONAL,New study protocol under development
NCT04807829,WITHDRAWN,INTERVENTIONAL,The study was stopped due to drug unavailability. The drug is unavailable because production was discontinued in the US.
NCT04808492,WITHDRAWN,INTERVENTIONAL,Funding unavailable
NCT04808570,TERMINATED,INTERVENTIONAL,The sponsor terminated the study due to the R\&D strategy change.
NCT04808921,WITHDRAWN,INTERVENTIONAL,"As of 11 Oct 2021, IRB oversight for site is terminated. We no longer have IRB Approval to conduct this study."
NCT04808934,WITHDRAWN,OBSERVATIONAL,"Withdrawn due to COVID19 pandemic. Several delays affected this study, therefore company decided to not conduct the study. It was cancelled prior to any enrollment."
NCT04809012,WITHDRAWN,INTERVENTIONAL,Intended to be replaced with another Protocol
NCT04809116,WITHDRAWN,INTERVENTIONAL,Received alternative sources of funding.
NCT04809129,SUSPENDED,INTERVENTIONAL,Funding stopped.
NCT04809623,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate study.
NCT04809649,WITHDRAWN,INTERVENTIONAL,Sponsor is not proceeding with study due to budget cuts as a result of COVID-19.
NCT04809805,TERMINATED,INTERVENTIONAL,Due to the high probability of not achieving a therapeutic window and lack of evidence of sufficient clinical benefit.
NCT04809961,WITHDRAWN,OBSERVATIONAL,Recruitment
NCT04810104,WITHDRAWN,INTERVENTIONAL,Delays due to COVID
NCT04810208,TERMINATED,INTERVENTIONAL,Strategic decision
NCT04810494,WITHDRAWN,INTERVENTIONAL,Change in study team
NCT04810520,WITHDRAWN,OBSERVATIONAL,No participants enrolled due to organizational problems
NCT04810624,SUSPENDED,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research."
NCT04810689,TERMINATED,INTERVENTIONAL,Futile Enrollment
NCT04810806,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT04810949,TERMINATED,INTERVENTIONAL,patients enrolled got vaccinated vs COVID-19 and Influenza
NCT04811131,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04811404,WITHDRAWN,INTERVENTIONAL,Reassessment of rationale for study
NCT04811573,TERMINATED,INTERVENTIONAL,due to company decision
NCT04811833,WITHDRAWN,OBSERVATIONAL,The GASTROMO study has been stopped early before enrolling its first patient because the results of our primary endpoint would have been inconsistent. The variability of the leakage rate between all anastomosis included in the study was overly high.
NCT04811924,TERMINATED,INTERVENTIONAL,Change in methodolody.
NCT04811937,WITHDRAWN,INTERVENTIONAL,The study was abandoned due to the Covid pandemic which prevented recruitment.
NCT04812106,TERMINATED,OBSERVATIONAL,Sponsor decision not related to safety concerns
NCT04812327,WITHDRAWN,OBSERVATIONAL,Study was cancelled prior enrollment due to business decision.
NCT04812704,TERMINATED,INTERVENTIONAL,inclusion difficulty
NCT04812743,TERMINATED,INTERVENTIONAL,End of grant funding
NCT04812769,WITHDRAWN,INTERVENTIONAL,Principal Investigator is taking a leave of absence. Study terminated.
NCT04813874,WITHDRAWN,OBSERVATIONAL,Difficulty obtaining advanced notification of who was wanting to use nitrous
NCT04813939,TERMINATED,OBSERVATIONAL,Enrollment was terminated because of the poor recruitment rate.
NCT04813991,WITHDRAWN,INTERVENTIONAL,Enrollment was never initiated and the PI is leaving the institution so the study is closing.
NCT04814433,TERMINATED,INTERVENTIONAL,Both lack of enrollment as well as study staff turnover
NCT04814810,TERMINATED,OBSERVATIONAL,Research model determined to be ineffective for capturing machine-learning appropriate data
NCT04814875,TERMINATED,INTERVENTIONAL,"For technical reasons, it was decided by the sponsor to close the ongoing ovarian cancer study, AM ATX101-03, immediately."
NCT04814940,WITHDRAWN,OBSERVATIONAL,Based on company decision to close the project
NCT04815018,TERMINATED,OBSERVATIONAL,Failure to Accrue
NCT04815369,SUSPENDED,OBSERVATIONAL,No Enrollment
NCT04815473,SUSPENDED,INTERVENTIONAL,The number of evaluated valves were achieved.
NCT04815603,WITHDRAWN,INTERVENTIONAL,The program priority for execution of this clinical trial changed prior to enrollment of the first patient. The study was not withdrawn due to any safety concerns.
NCT04816071,WITHDRAWN,INTERVENTIONAL,PI no longer wanted to do the study
NCT04816214,TERMINATED,INTERVENTIONAL,Novartis decided to terminate the study based on a business consideration and not related with any safety concerns. Randomized part was not initiated
NCT04816916,TERMINATED,INTERVENTIONAL,Sponsor is stopping the study to focus company resources on other development programs.
NCT04817345,WITHDRAWN,INTERVENTIONAL,The safety and efficacy of plerixafor in adult and pediatric SCD patients was an unknown when we started. A lot more data from therapeutic trials is available. We feel that recruiting patients without a therapeutic option isn't ethically justifiable.
NCT04817865,WITHDRAWN,OBSERVATIONAL,Sponsor's decision
NCT04818580,TERMINATED,INTERVENTIONAL,"Departure of key personnel, difficulties with recruiting."
NCT04818736,WITHDRAWN,INTERVENTIONAL,Vaccine roll out plans increased so timing was no longer feasible
NCT04818814,TERMINATED,INTERVENTIONAL,Lack of funding
NCT04818944,WITHDRAWN,INTERVENTIONAL,PI has left the Institution
NCT04819178,WITHDRAWN,OBSERVATIONAL,Withdrawel of approvement of Dapagliflozin to type 1 diabetes
NCT04819256,TERMINATED,INTERVENTIONAL,Funding diverted to expansion of programme and PACE-It App
NCT04819503,TERMINATED,INTERVENTIONAL,Recruitment and technical difficulties
NCT04820023,TERMINATED,INTERVENTIONAL,Sponsor's decision considering the changing treatment landscape for NSCLC
NCT04820491,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04820621,TERMINATED,INTERVENTIONAL,This study is prematurely terminated due to changes in sponsor's overall development strategy. The decision of termination is not related to any safety concern of the compound.
NCT04820686,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04820842,TERMINATED,INTERVENTIONAL,"A safety signal has emerged in Phase 2 studies of TAK-994. As an immediate precautionary measure, Takeda has suspended dosing of patients and has decided to stop Phase 2 studies early."
NCT04820894,WITHDRAWN,OBSERVATIONAL,Feasibility
NCT04821219,WITHDRAWN,INTERVENTIONAL,study PI no longer at Institution
NCT04821414,WITHDRAWN,OBSERVATIONAL,Lacking of funding
NCT04821531,WITHDRAWN,INTERVENTIONAL,COVID patients admitted to the hospital during the study dates did NOT have the criteria to enter the study(i.e they were too medically unstable) or their hospital stay was too short to conduct a before and after assessment
NCT04822155,WITHDRAWN,OBSERVATIONAL,We did not have enough bandwidth to take on this project due to other project priorities.
NCT04822168,WITHDRAWN,INTERVENTIONAL,This study was not implemented due to. change in study site and scope.
NCT04822259,WITHDRAWN,INTERVENTIONAL,Study design is not reasonable and sponsor decided to terminate the study. No patient enrolled by now
NCT04822298,TERMINATED,INTERVENTIONAL,Amgen made a business decision to discontinue AMG 160 20180273
NCT04822701,TERMINATED,INTERVENTIONAL,not due to safety reasons
NCT04822727,WITHDRAWN,OBSERVATIONAL,Sponsor did not pusue with the study
NCT04822740,TERMINATED,INTERVENTIONAL,loss of equipment supplier
NCT04823052,WITHDRAWN,INTERVENTIONAL,Healx has experienced delays to the site activation of the study and this has had an adverse impact on the recruitment timeline which is delaying the progress of other projects in our FXS programme.
NCT04823845,WITHDRAWN,INTERVENTIONAL,Study never received IRB approval.
NCT04824521,TERMINATED,INTERVENTIONAL,The protocol is determined to no longer be able to meet study objectives due to failure to enroll participants within the requisite time period.
NCT04824859,TERMINATED,INTERVENTIONAL,Technology issues
NCT04824872,WITHDRAWN,INTERVENTIONAL,Never started
NCT04825535,SUSPENDED,INTERVENTIONAL,Study suspended due to issues flagged during an internal Quality Assurance audit.
NCT04825860,TERMINATED,INTERVENTIONAL,Due to company business strategy
NCT04826016,WITHDRAWN,INTERVENTIONAL,Funder decision
NCT04826029,WITHDRAWN,INTERVENTIONAL,No longer feasible because of new recommendations (RPC St Paul de Vence) which advocate the performance of systematic imaging in addition to CA 125 in patients treated in first line maintenance in order not to ignore a relapse (2021).
NCT04826133,TERMINATED,INTERVENTIONAL,Could not obtain additional funding to continue the research.
NCT04826250,WITHDRAWN,INTERVENTIONAL,Preliminary data was not sufficient to support the study aim
NCT04826315,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT04826432,TERMINATED,INTERVENTIONAL,No more experimental drugs available
NCT04826484,TERMINATED,INTERVENTIONAL,Met futility threshold at interim analysis
NCT04826874,TERMINATED,INTERVENTIONAL,Due to technical issues
NCT04826965,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04827186,WITHDRAWN,INTERVENTIONAL,"We did not enroll subjects. If we want, we will open this again at a later date."
NCT04827485,TERMINATED,INTERVENTIONAL,PI decision.
NCT04827589,WITHDRAWN,INTERVENTIONAL,Development program terminated
NCT04827758,TERMINATED,INTERVENTIONAL,insufficient recruitment to meet the objectives in time
NCT04827810,SUSPENDED,INTERVENTIONAL,Suspended temporarily due to limited drug supply
NCT04827966,TERMINATED,INTERVENTIONAL,Funding issues
NCT04828044,WITHDRAWN,OBSERVATIONAL,Lack of sufficient funding
NCT04828161,TERMINATED,INTERVENTIONAL,"Phase 2 completed as planned. Due to the evolving landscape of treatments for COVID-19, the placebo-controlled Phase 3 design will not proceed. No patients were actively participating at the time of termination."
NCT04828174,SUSPENDED,INTERVENTIONAL,The trial was suspended due to the inability to enroll qualified participants
NCT04828538,WITHDRAWN,INTERVENTIONAL,Recruitment failure
NCT04828837,TERMINATED,INTERVENTIONAL,"Due to the SARS-CoV-2 pandemic in Taiwan in 2021/05, and then recruitment was stopped under the government epidemic prevention policy."
NCT04829331,TERMINATED,INTERVENTIONAL,Lack of clinical research staff
NCT04829448,SUSPENDED,INTERVENTIONAL,Protein product reconfiguration
NCT04829474,TERMINATED,OBSERVATIONAL,recruitment is insufficient and the current context does not allow satisfactory data collection
NCT04829799,WITHDRAWN,INTERVENTIONAL,"Per study team, the study will not proceed"
NCT04830007,SUSPENDED,OBSERVATIONAL,Investigator coordinatoor left the site and the trial
NCT04830527,TERMINATED,INTERVENTIONAL,The study was terminated early due to the difficulty in recruiting cases during a pandemic period.
NCT04830735,WITHDRAWN,INTERVENTIONAL,PI decided not to pursue study
NCT04830878,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT04830982,WITHDRAWN,INTERVENTIONAL,Withdrawn in IRB.
NCT04831424,SUSPENDED,INTERVENTIONAL,The study is on pause.
NCT04831450,WITHDRAWN,INTERVENTIONAL,Investigator Decision
NCT04831502,WITHDRAWN,INTERVENTIONAL,Business decision
NCT04831567,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04831827,WITHDRAWN,INTERVENTIONAL,Insufficient study resources and change in practice.
NCT04832139,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in the benefit/risk assessment for the further administration of marstacimab in a healthy volunteer population.
NCT04832308,WITHDRAWN,INTERVENTIONAL,Lack of grant funding
NCT04832438,WITHDRAWN,INTERVENTIONAL,Replaced by NCT05010629
NCT04832516,TERMINATED,INTERVENTIONAL,sponsor decision
NCT04832763,TERMINATED,INTERVENTIONAL,Insufficient Accrual
NCT04833075,TERMINATED,INTERVENTIONAL,"Approx. half of all samples withdrawn are readily available from another institute. Hence, it is unethical to draw more blood from patients in the ELICIT-trial."
NCT04833959,SUSPENDED,INTERVENTIONAL,Business Decision
NCT04834128,WITHDRAWN,INTERVENTIONAL,"The study was stopped because of the current status of the COVID-19 epidemic in the United Kingdom, and also because the trial involved parenterally administered IMP and a period of inpatient care and extensive outpatient visits and investigations."
NCT04834271,WITHDRAWN,INTERVENTIONAL,No participaints enrolled
NCT04834310,WITHDRAWN,INTERVENTIONAL,Do not have adequate funding to proceed with project.
NCT04834349,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT04834908,TERMINATED,INTERVENTIONAL,Closed as no eligible patient.
NCT04834973,TERMINATED,INTERVENTIONAL,Insufficient Patient Recruitment Rates
NCT04835025,SUSPENDED,OBSERVATIONAL,because of COVID-19
NCT04835168,WITHDRAWN,INTERVENTIONAL,The closure of the study is driven by the decision to redesign the study protocol for future studies.
NCT04835389,WITHDRAWN,INTERVENTIONAL,Company decision
NCT04835701,TERMINATED,INTERVENTIONAL,Limited staffing support to continue screening and enrollment process
NCT04835714,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04835987,WITHDRAWN,OBSERVATIONAL,"Due to a lack of staff in the department, no inclusion could be realized."
NCT04836377,TERMINATED,OBSERVATIONAL,"This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue"
NCT04836494,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04836533,WITHDRAWN,INTERVENTIONAL,Conflicts at the study site prevented the study from being carried out
NCT04836806,WITHDRAWN,INTERVENTIONAL,Study stopped due to issues with enrollment and lack of funding.
NCT04836832,WITHDRAWN,INTERVENTIONAL,PI decision
NCT04837976,TERMINATED,OBSERVATIONAL,Recruitment for the first stage has been completed. However the research team no longer has the staff or resources to complete stage 2 of the research.
NCT04837989,TERMINATED,INTERVENTIONAL,Data will be written up as a pilot RCT study and experiences and results will inform the start of a multi-site trial
NCT04838314,TERMINATED,INTERVENTIONAL,No More recruitment surgeon left the team
NCT04838431,TERMINATED,OBSERVATIONAL,Reached the sample size
NCT04838600,TERMINATED,OBSERVATIONAL,RLS Global in bankruptcy
NCT04838847,WITHDRAWN,INTERVENTIONAL,The study was withdrawn based on an assessment of immunogenicity in elderly adults.
NCT04838860,TERMINATED,INTERVENTIONAL,Internal Company Decision
NCT04839237,WITHDRAWN,INTERVENTIONAL,The sponsor decides withdrawn this study.
NCT04839315,TERMINATED,INTERVENTIONAL,Difficulty with enrollment
NCT04839549,WITHDRAWN,INTERVENTIONAL,Lack of patient enrollment
NCT04839575,TERMINATED,INTERVENTIONAL,Covid-19 interruptions and enrollment challenges
NCT04839718,WITHDRAWN,OBSERVATIONAL,Study redesigned to be a data-only cohort study and not a clinical trial prior to any patient recruitment activities.
NCT04839965,TERMINATED,INTERVENTIONAL,The AP-017 study was prematurely terminated by the sponsor after an interim analysis.
NCT04840134,SUSPENDED,INTERVENTIONAL,"In response to QA/compliance concerns about specific studies, NYSPI is undertaking an Institute-wide safety review of research protocols. Studies will resume recruitment after the review has confirmed they are deploying adequate safety protections."
NCT04840238,SUSPENDED,INTERVENTIONAL,insufficient recruit activity
NCT04840251,WITHDRAWN,INTERVENTIONAL,COVID
NCT04840472,SUSPENDED,INTERVENTIONAL,Logistics
NCT04840615,TERMINATED,INTERVENTIONAL,Study was closed early due to slow accrual.
NCT04840667,TERMINATED,INTERVENTIONAL,"Study closed due to enrollment challenges, not for any safety issues"
NCT04840784,TERMINATED,INTERVENTIONAL,The reasons for early termination is due to slow recruitment
NCT04840927,WITHDRAWN,INTERVENTIONAL,Delay in availability of IMP
NCT04841122,TERMINATED,INTERVENTIONAL,Study was terminated after 6 months due to recruitment and data collection challenges.
NCT04841278,WITHDRAWN,INTERVENTIONAL,decided not to go ahead with study
NCT04841382,TERMINATED,OBSERVATIONAL,Sponsor
NCT04841512,WITHDRAWN,INTERVENTIONAL,COVID - Lack of recruitment
NCT04841538,WITHDRAWN,INTERVENTIONAL,Sponsor's clinical development strategy adjustment
NCT04842292,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT04842331,WITHDRAWN,INTERVENTIONAL,"A combination of factors, including the dynamic nature of the COVID-19 pandemic and the successful vaccination program, has resulted in a very sharp decline in the number of patients with COVID-19"
NCT04842630,TERMINATED,INTERVENTIONAL,R\&d strategy adjustment
NCT04842721,WITHDRAWN,INTERVENTIONAL,Not yet meeting Health Canada's requirements for Clinical Trials
NCT04842864,WITHDRAWN,INTERVENTIONAL,According to the PI/Responsible Party no participants were able to be enrolled into the study following approval.
NCT04842981,TERMINATED,INTERVENTIONAL,Slow recruitment due to COVID19.
NCT04843137,WITHDRAWN,OBSERVATIONAL,"Closed study at UofL, may reopen at new institution in the future. No participants have enrolled"
NCT04843319,TERMINATED,INTERVENTIONAL,Study terminated as end points were not achieved at current dose level.
NCT04843345,SUSPENDED,OBSERVATIONAL,Indefinite paused for staffing issues
NCT04843579,TERMINATED,INTERVENTIONAL,low enrollment
NCT04843722,WITHDRAWN,INTERVENTIONAL,The sponsor has changed the development plans which is not for safety reasons.
NCT04843852,WITHDRAWN,INTERVENTIONAL,Study not implemented
NCT04844008,WITHDRAWN,INTERVENTIONAL,Changes in treatment pathway made recruitment unfeasible
NCT04844086,TERMINATED,INTERVENTIONAL,CAR-T manufacturing technology can not meet the dose requirement for clinical patients.
NCT04844190,TERMINATED,INTERVENTIONAL,Unable to complete study procedures due to staffing issues.
NCT04844307,WITHDRAWN,INTERVENTIONAL,Upon further review it has come to the PI's attention that the study may want no longer be very effective since most of our Covid patients are being discharged pretty quickly now that the treatments are so effective.
NCT04844346,TERMINATED,INTERVENTIONAL,Recruitment was dependent on finding participants that had to receive an initial COVID-19 vaccination and we were unable to find new participants anymore.
NCT04844749,TERMINATED,INTERVENTIONAL,Administrative reasons
NCT04845035,WITHDRAWN,INTERVENTIONAL,The PI plans to revise the study design in a new protocol
NCT04845191,WITHDRAWN,INTERVENTIONAL,The sponsor has changed the development plans which is not for safety reasons.
NCT04845321,TERMINATED,INTERVENTIONAL,"Part 2 terminated, unrelated to safety."
NCT04845594,WITHDRAWN,INTERVENTIONAL,This study was halted prior to the start of enrollment due to the COVID-19 pandemic. The inability to conduct planned in-person intervention activities during the pandemic related to inherent risks of the virus necessitated withdrawal of the study.
NCT04845685,SUSPENDED,INTERVENTIONAL,Unable to secure funding
NCT04846101,SUSPENDED,INTERVENTIONAL,Change of Trial components
NCT04846946,WITHDRAWN,INTERVENTIONAL,Opted to not conduct this study; revised to a more condensed study.
NCT04847141,TERMINATED,INTERVENTIONAL,Study Stopped for Futility
NCT04847232,TERMINATED,INTERVENTIONAL,"The event rate observed in the study continued to be below primary assumptions, so that the completion of the study within a reasonable timeframe was deemed very unlikely."
NCT04847440,TERMINATED,INTERVENTIONAL,Terminated by the Sponsor
NCT04847583,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT04847609,WITHDRAWN,OBSERVATIONAL,Issues with patient recruitment
NCT04847674,TERMINATED,INTERVENTIONAL,Stopped for strategic reasons
NCT04847921,TERMINATED,INTERVENTIONAL,Delays in recruitment due to COVID-19 and higher than acceptable loss to followup.
NCT04848012,SUSPENDED,INTERVENTIONAL,Awaiting change to device under investigation
NCT04848220,TERMINATED,INTERVENTIONAL,Business decision
NCT04848467,WITHDRAWN,INTERVENTIONAL,The study cannot be conducted.
NCT04849273,TERMINATED,INTERVENTIONAL,Adverse change in the risk/benefit.
NCT04849377,WITHDRAWN,INTERVENTIONAL,lack of eligible participants due to change in study criterias
NCT04849715,WITHDRAWN,INTERVENTIONAL,business decision; no enrolled patients
NCT04850313,TERMINATED,INTERVENTIONAL,This study terminated due to slow enrollment
NCT04850443,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT04850469,WITHDRAWN,OBSERVATIONAL,Lacking of funding
NCT04851522,WITHDRAWN,INTERVENTIONAL,Lack of patient accrual in the past year.
NCT04851665,WITHDRAWN,OBSERVATIONAL,This was a review of existing de-identified records
NCT04851834,TERMINATED,INTERVENTIONAL,"Study was terminated by IP Holder (collaborator), PinotBio Inc."
NCT04852029,TERMINATED,INTERVENTIONAL,recruitment issues
NCT04852107,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04852302,SUSPENDED,INTERVENTIONAL,On administrative hold for interim data analysis.
NCT04852367,WITHDRAWN,INTERVENTIONAL,Lack of recruitment
NCT04852692,TERMINATED,OBSERVATIONAL,"After conducting pilot phase, the study team decided to stop the study as the study couldn't meet the study target number of patients and study objectives."
NCT04853108,TERMINATED,OBSERVATIONAL,The study terminated early due to end of funding.
NCT04853134,WITHDRAWN,INTERVENTIONAL,This study was combined with another study
NCT04853329,SUSPENDED,INTERVENTIONAL,Business reasons
NCT04853355,WITHDRAWN,INTERVENTIONAL,lack of funding
NCT04853368,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04853524,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT04853927,WITHDRAWN,INTERVENTIONAL,Sponsor to focus on hospitalised patients
NCT04854044,WITHDRAWN,INTERVENTIONAL,The P.I. is not prepared to move forward at this thime
NCT04854057,TERMINATED,INTERVENTIONAL,No funding or personnel for project. We are unable to meet the recruitment goals for this pilot study.
NCT04854135,TERMINATED,INTERVENTIONAL,High drop out rate
NCT04854200,WITHDRAWN,OBSERVATIONAL,Product pulled off the market/Production of product stopped
NCT04854434,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04854486,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT04854512,SUSPENDED,INTERVENTIONAL,Strategic company decision - not related to a safety concern
NCT04854876,WITHDRAWN,INTERVENTIONAL,The food supplement/health product registration needs to be undertaken with NHRA- Pharmaceutical Product Regulations Department
NCT04854889,TERMINATED,INTERVENTIONAL,Not achieve the desired effect
NCT04854967,WITHDRAWN,INTERVENTIONAL,No participants were enrolled
NCT04855201,TERMINATED,INTERVENTIONAL,Lack of Pharmacological effect
NCT04855266,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants
NCT04855565,TERMINATED,INTERVENTIONAL,Inability to recruit due to COVID-19 pandemic restrictions
NCT04855591,TERMINATED,INTERVENTIONAL,Adjustment of the clinical development plan for this product globally
NCT04855942,WITHDRAWN,INTERVENTIONAL,"Due to the outbreak COVID-19 in our country, the patients coming to our hospital drastically decreased. We could hardly enroll participants due to the paucity of our patients for more than six months, so we decided to withdrawn this study."
NCT04855968,TERMINATED,INTERVENTIONAL,Poor patient compliance
NCT04856475,WITHDRAWN,INTERVENTIONAL,Termination of collaboration with PUMA
NCT04856592,WITHDRAWN,INTERVENTIONAL,The study device VICI stent withdrawn from market
NCT04857008,TERMINATED,INTERVENTIONAL,recruitment challenges
NCT04857580,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT04857840,TERMINATED,INTERVENTIONAL,No Efficacy demonstrated inn the QGC001-3QG1 study
NCT04857931,TERMINATED,INTERVENTIONAL,"Lack of funds to support opening of new sites to help patient recruitment, which was found to be more challenging than initially expected."
NCT04858152,WITHDRAWN,INTERVENTIONAL,Logistic issues
NCT04858230,TERMINATED,INTERVENTIONAL,End of shelf life of investigational devices.
NCT04858386,TERMINATED,OBSERVATIONAL,Covid-19
NCT04858451,TERMINATED,INTERVENTIONAL,Study stopping criteria were met. A safety event has occurred which was classified as an SAE and was related to the study intervention.
NCT04858594,TERMINATED,OBSERVATIONAL,PI left and research was stopped
NCT04858620,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT04858906,WITHDRAWN,INTERVENTIONAL,Due to financial issues
NCT04859075,TERMINATED,OBSERVATIONAL,economic reasons
NCT04859231,TERMINATED,INTERVENTIONAL,Poor recruitment
NCT04859517,TERMINATED,INTERVENTIONAL,"All primary efficacy data has been collected and analyzed. Based on the safety data gathered to date, it has been determined that continued participation by study subjects would not yield any additional beneficial safety information."
NCT04859582,WITHDRAWN,INTERVENTIONAL,Withdrawn due to protocol amendment
NCT04859829,TERMINATED,OBSERVATIONAL,PI moved to another institution and closed study.
NCT04860089,WITHDRAWN,OBSERVATIONAL,"This protocol was never initiated. Due to a change in funding, a new study will be registered in its place."
NCT04860258,TERMINATED,INTERVENTIONAL,The Principal Investigators and CureVac decided to terminate the trial early following a change to the risk/benefit profile.
NCT04860401,TERMINATED,INTERVENTIONAL,"The substudy in premature infants was completed. The substudy in adult volunteers will not be continued, due to previous delays."
NCT04860518,TERMINATED,INTERVENTIONAL,The decision is based on changes in the pandemic and further weakening of the recruitment that will not enable a completion of the study in any reasonable time
NCT04860635,SUSPENDED,INTERVENTIONAL,Study superseded by alternative Phase 3 trial
NCT04860817,WITHDRAWN,INTERVENTIONAL,No proper participant is found.
NCT04860973,TERMINATED,INTERVENTIONAL,"Of those randomised to intervention arm, the majority were not able to tolerate the intervention for the duration of the study indicating that it is not feasible on a larger scale and recruiting 2 extra participants would not change this decision."
NCT04861246,TERMINATED,INTERVENTIONAL,Slow recruitment due to covid-19 disruptions
NCT04861428,TERMINATED,INTERVENTIONAL,Investigator left institution and did not retain the study
NCT04861441,WITHDRAWN,INTERVENTIONAL,"House staff unable to follow protocol due to short staffing, turnover, and travel nursing."
NCT04861844,TERMINATED,INTERVENTIONAL,"difficulty recruiting patients, staffing"
NCT04861948,TERMINATED,INTERVENTIONAL,No signs of efficacy in solid tumors
NCT04862026,SUSPENDED,OBSERVATIONAL,Technical difficulties of the developer
NCT04862143,TERMINATED,INTERVENTIONAL,Study early terminated due to low enrollment compared to the anticipated figures
NCT04862156,TERMINATED,INTERVENTIONAL,"FDA agreed that WP02 CAP could be stopped. The OrganOx metra device was approved on December 9, 2021. The 105 planned CAP patients will be included in the Post-Approval study (NCT05526326)."
NCT04862195,TERMINATED,INTERVENTIONAL,This study was halted prematurely due to slow enrollment
NCT04863014,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04863248,TERMINATED,INTERVENTIONAL,"Treatment paradigm in second- and third-line NSCLC is shifting away from docetaxel, the backbone chemotherapy therapy used in this study."
NCT04863339,WITHDRAWN,INTERVENTIONAL,Challenges in recruitment
NCT04864522,WITHDRAWN,INTERVENTIONAL,Slow accrual due to a crowded field of effective drugs by the time the study opened
NCT04864782,TERMINATED,INTERVENTIONAL,"Phase 2 completed, phase 3 sponsor decided to terminate"
NCT04864977,WITHDRAWN,INTERVENTIONAL,Study was stopped prior to study start date due to business decision.
NCT04865029,TERMINATED,INTERVENTIONAL,Lack of enrollment due to change of COVID 19 variant prevalence
NCT04865146,WITHDRAWN,OBSERVATIONAL,Change on clinical and marketing strategy for intramedullary devices
NCT04865159,TERMINATED,INTERVENTIONAL,Study terminated due to recruitment challenges
NCT04865419,TERMINATED,INTERVENTIONAL,Trial terminated based on benefit-risk profile assessment
NCT04865848,TERMINATED,INTERVENTIONAL,research operation issues
NCT04866017,TERMINATED,INTERVENTIONAL,This decision was conducted by the sponsor and not driven by safety concerns as no new safety signals have been observed in the ociperlimab program.
NCT04866056,TERMINATED,INTERVENTIONAL,Corporate policy adjustments
NCT04866069,TERMINATED,INTERVENTIONAL,"Although cellular responses to virus were satisfactory, neutralizing titres against virus were lower then expected levels"
NCT04866199,WITHDRAWN,OBSERVATIONAL,Key investigator left institution
NCT04866407,TERMINATED,INTERVENTIONAL,Difficulty recruiting
NCT04867018,WITHDRAWN,OBSERVATIONAL,study was never fully reopened with the intuitional review board
NCT04868045,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT04868643,WITHDRAWN,INTERVENTIONAL,The company no longer wishes to pursue this IDE
NCT04868747,WITHDRAWN,INTERVENTIONAL,due to financial problem
NCT04868890,TERMINATED,INTERVENTIONAL,The AP-019 study was prematurely terminated by the sponsor after determining that insufficient events were occurring to analyze the primary endpoint.
NCT04868942,WITHDRAWN,INTERVENTIONAL,The study didn't get the authorization from health authority
NCT04869228,TERMINATED,INTERVENTIONAL,This decision is made on changing the development strategy of GT0918 to adapt ever-changing COVID-19 pandemic management globally.
NCT04869241,WITHDRAWN,INTERVENTIONAL,Change of a principal investigator
NCT04869397,TERMINATED,INTERVENTIONAL,DSMB recommended to end the study prematurely as recruitment goals were not being met and benefit was not influencial enough.
NCT04869540,WITHDRAWN,INTERVENTIONAL,The Investigator left the institution and the study was not implemented.
NCT04869787,TERMINATED,INTERVENTIONAL,The device manufacturer has received a HDE for this population from the FDA
NCT04869943,TERMINATED,INTERVENTIONAL,Business decision
NCT04870034,WITHDRAWN,INTERVENTIONAL,Issues recruiting
NCT04870073,WITHDRAWN,INTERVENTIONAL,Financial support could not be obtained for the study
NCT04870112,TERMINATED,INTERVENTIONAL,"AstraZeneca has decided to stop further enrollment and the study was terminated when all patients in Part 1 completed their last study visit. No safety issues or clinical concerns however, have been identified for this study. Part 2 was not initiated"
NCT04870164,TERMINATED,INTERVENTIONAL,"Due to hypersensitivity observed in 3 subjects, although no stopping rules were met, the Sponsor decided to halt recruitment for further investigation. After analysis of PK, i.m. administration was not required, and recruitment stopped."
NCT04870281,TERMINATED,OBSERVATIONAL,The study terminated due to significant delays in site start-up activities and enrollment in the setting of the ongoing COVID-19 pandemic.
NCT04870411,TERMINATED,OBSERVATIONAL,Most of the patients were already vaccinated
NCT04870476,WITHDRAWN,INTERVENTIONAL,"""During the feasibility study, it came to the research group's attention, that data was collected in an unauthorized manner. Therefore the trial has been terminated."
NCT04870736,WITHDRAWN,OBSERVATIONAL,Duplication
NCT04870801,WITHDRAWN,INTERVENTIONAL,The project was denied funding and the protocol was subsequently closed. No participants were enrolled.
NCT04870827,TERMINATED,OBSERVATIONAL,"PI left NIH, study won't meet it's study aims, so closing study."
NCT04871529,SUSPENDED,INTERVENTIONAL,undergoing nrevision
NCT04871958,TERMINATED,INTERVENTIONAL,Shift of the participating wards to non-Covid patients
NCT04872127,WITHDRAWN,INTERVENTIONAL,device unavailable
NCT04872452,WITHDRAWN,INTERVENTIONAL,Investigators departed institution prior to any recruitment
NCT04872556,TERMINATED,INTERVENTIONAL,end of the supporting fund
NCT04872608,WITHDRAWN,INTERVENTIONAL,The sponsor closed the study due to discontinuing their onapristone program
NCT04872959,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT04873427,TERMINATED,OBSERVATIONAL,The results of the genomic analyses were compromised due to the low DNA concentration.
NCT04873713,WITHDRAWN,INTERVENTIONAL,Logistics and infrastructure problems
NCT04873726,WITHDRAWN,INTERVENTIONAL,Logistics and infrastructure problems
NCT04874402,WITHDRAWN,INTERVENTIONAL,Principal Investigator left institution
NCT04874675,SUSPENDED,INTERVENTIONAL,Covid 19 lockdown
NCT04874714,TERMINATED,INTERVENTIONAL,Due to the low recruitment rate since the start of the trial
NCT04874805,WITHDRAWN,INTERVENTIONAL,since the departure of Dr. LEFRERE no investigator has decided to take over the project
NCT04874831,WITHDRAWN,INTERVENTIONAL,Refocusing of sponsor's clinical development program. No safety concern or change of the risk-benefit assessment of the investigational medicinal product has led to this decision.
NCT04875221,WITHDRAWN,INTERVENTIONAL,Study is no longer being conducted by Dr. Lanius - the principal investigator has been changed from Dr. Ruth Lanius to Dr. Andrew Nicholson.
NCT04875442,WITHDRAWN,INTERVENTIONAL,PROJECT STOPPED
NCT04875767,WITHDRAWN,INTERVENTIONAL,Funding restrictions
NCT04875806,TERMINATED,INTERVENTIONAL,"Due to the limited activity in Phase 1, NextCure decided to discontinue development of the anti-B7-H4 antibody monotherapy trial (NC762-01) to move forward with a prioritized B7-H4 ADC program."
NCT04876040,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT04876378,TERMINATED,OBSERVATIONAL,Funding
NCT04876430,TERMINATED,INTERVENTIONAL,Very low frequency of recruitment
NCT04876859,SUSPENDED,INTERVENTIONAL,"Main researcher changed institutions, making it unfeasible to be completed by the others participants."
NCT04877002,TERMINATED,INTERVENTIONAL,Limited participants
NCT04877015,TERMINATED,INTERVENTIONAL,Stanford terminated the study with no reason given.
NCT04877080,WITHDRAWN,INTERVENTIONAL,The PI decides to withdraw the research.
NCT04877236,WITHDRAWN,INTERVENTIONAL,No interest in pursuing study
NCT04877301,WITHDRAWN,INTERVENTIONAL,difficulty enrolling
NCT04877327,TERMINATED,INTERVENTIONAL,Low recruitment
NCT04877457,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT04877587,WITHDRAWN,INTERVENTIONAL,Unable to enroll
NCT04877743,TERMINATED,OBSERVATIONAL,The AZ:CONNECTEU study will be stopped. Ongoing participants will be informed and off-boarded. Vaxzevria's safety continues to be monitored through the implementation of other studies and through established safety reporting platforms across Europe.
NCT04877847,TERMINATED,INTERVENTIONAL,Low Recruitment
NCT04878042,WITHDRAWN,INTERVENTIONAL,No participants
NCT04878315,WITHDRAWN,INTERVENTIONAL,Internal sponsor decision to terminate project prematurely based on a waiver granted by Egypt EDA (Egyptian drug authority). No subjects were enrolled.
NCT04878484,WITHDRAWN,INTERVENTIONAL,Poor recruitment
NCT04878614,TERMINATED,INTERVENTIONAL,Sponsor terminated study low accrual numbers
NCT04878874,WITHDRAWN,INTERVENTIONAL,Logistics and infrastructure problems
NCT04879589,WITHDRAWN,INTERVENTIONAL,"Study abandoned, no participants enrolled"
NCT04879706,TERMINATED,OBSERVATIONAL,Poor patient enrollment
NCT04879823,TERMINATED,INTERVENTIONAL,slow recruitment
NCT04880109,TERMINATED,INTERVENTIONAL,Enrollment Challenges
NCT04880343,SUSPENDED,INTERVENTIONAL,Difficulties in recruiting the control arm in accordance with the protocol prevent the study population from being reached.
NCT04880369,WITHDRAWN,INTERVENTIONAL,Disapproved by relevant Danish ethical committee
NCT04880564,TERMINATED,INTERVENTIONAL,Sponsor decided that there was no benefit in the drug treatment and due to company change in landscape in the new year.
NCT04880577,WITHDRAWN,INTERVENTIONAL,Funding
NCT04880603,TERMINATED,INTERVENTIONAL,Investigators no longer interested in pursuing
NCT04881097,WITHDRAWN,OBSERVATIONAL,Primary Investigator ceased their involvement with study
NCT04881175,TERMINATED,INTERVENTIONAL,The study was terminated because of a business decision.
NCT04881370,TERMINATED,OBSERVATIONAL,insufficiency inclusion during the inclusion periode
NCT04881448,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT04881500,TERMINATED,INTERVENTIONAL,Recruiting difficulties
NCT04881968,TERMINATED,INTERVENTIONAL,The effectiveness trial was terminated early because the intervention proved to be ineffective in generating engagement from study participants. With such low engagement we were unable to test our intervention with our proposed outcome measures.
NCT04882072,TERMINATED,INTERVENTIONAL,Due to difficulties in enrollment and ongoing feasibility issues
NCT04882137,WITHDRAWN,INTERVENTIONAL,Funding was stopped due to shifted research priorities by funder
NCT04882163,WITHDRAWN,INTERVENTIONAL,Business objectives have changed
NCT04882176,TERMINATED,INTERVENTIONAL,Not meeting expected endpoints
NCT04882423,TERMINATED,INTERVENTIONAL,PI left the university
NCT04882696,TERMINATED,INTERVENTIONAL,slow recruitment
NCT04882709,TERMINATED,INTERVENTIONAL,"No reliable differences across conditions, unacceptable test-retest reliability"
NCT04882735,WITHDRAWN,INTERVENTIONAL,Sponsor's decision to cancel study
NCT04882774,WITHDRAWN,INTERVENTIONAL,never opened to enrollment because it was never funded
NCT04882969,WITHDRAWN,INTERVENTIONAL,Changed Indication
NCT04883008,TERMINATED,OBSERVATIONAL,Sponsor business decision and low enrollment
NCT04883021,WITHDRAWN,INTERVENTIONAL,Low recruitment
NCT04883112,WITHDRAWN,INTERVENTIONAL,Logistics and infrastructure problems
NCT04883138,TERMINATED,INTERVENTIONAL,Study stopped for commercial reasons.
NCT04883229,WITHDRAWN,INTERVENTIONAL,The tDCS device that was going to be used for this study is no longer being made.
NCT04883359,TERMINATED,OBSERVATIONAL,PI left the NIH. Study will not continue.
NCT04883983,WITHDRAWN,INTERVENTIONAL,Study was never initiated.
NCT04884295,TERMINATED,INTERVENTIONAL,The sponsor does not intend to start Part 2 (Phase 2) due to change in company strategy for phase 2 design. This early end of trial is not due to reasons of safety or lack of efficacy. Part 1 (Phase 1) is completed as per protocol.
NCT04884945,TERMINATED,INTERVENTIONAL,Unable to resume recruitment post COVID.
NCT04885114,WITHDRAWN,INTERVENTIONAL,"We have discontinued our 1st generation HD program with the VYTAL Study \& have initiated a 2nd generation program using a novel, proprietary AAV capsid that may enable intravenous administration \& achieve widespread distribution to affected tissue."
NCT04885491,WITHDRAWN,INTERVENTIONAL,"Since the availability of vaccines, a drastic drop in number of patients with increased PAP was observed and when the WHO re-categorized the COVID-19 pandemic from PHEIC to an ""established and ongoing health issue"" the study was withdrawn."
NCT04885634,WITHDRAWN,INTERVENTIONAL,Not received funding.
NCT04885816,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04886505,WITHDRAWN,INTERVENTIONAL,Insufficient funds
NCT04886986,SUSPENDED,INTERVENTIONAL,Need to wait until a new collaborator is available and confirmed
NCT04887350,WITHDRAWN,INTERVENTIONAL,Staffing shortages
NCT04887480,SUSPENDED,INTERVENTIONAL,Funding paused
NCT04887779,WITHDRAWN,INTERVENTIONAL,personale shortage
NCT04887831,TERMINATED,INTERVENTIONAL,Sponsor no longer pursuing trila for the indication.
NCT04887922,TERMINATED,INTERVENTIONAL,Feasibility issues
NCT04888585,TERMINATED,INTERVENTIONAL,Business decision
NCT04888858,WITHDRAWN,INTERVENTIONAL,"The PI, Dr. Younger, left Henry Ford Health."
NCT04889040,TERMINATED,INTERVENTIONAL,Based on program revaluation and in agreement with the co-development partner the sponsor took the decision to terminate this study.
NCT04889131,TERMINATED,INTERVENTIONAL,COVID-19 vulnerable participant population
NCT04889222,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04889703,WITHDRAWN,INTERVENTIONAL,Plan to move forward with this study has been dropped
NCT04889989,TERMINATED,INTERVENTIONAL,Change in company strategy.
NCT04890158,SUSPENDED,INTERVENTIONAL,Study suspended. Protocol would need to be re-approved by the Einstein IRB
NCT04890353,TERMINATED,INTERVENTIONAL,The interim analysis of another associated study is not very effective
NCT04890379,WITHDRAWN,INTERVENTIONAL,There are no sufficient patients in the hospital.
NCT04890548,WITHDRAWN,INTERVENTIONAL,"Study start up timelines delayed into late autumn, and with COVID cases rising in the UK, the feasibility of successfully recruiting the study and ethical concerns about starting a study that AZ may not be able to complete."
NCT04890769,TERMINATED,OBSERVATIONAL,The study is terminated by the sponsor due to poor participant recruitment and due to limited opportunity to achieve commercial gain.
NCT04891133,TERMINATED,INTERVENTIONAL,"The trial was stopped prematurely due to external evidence that arose during the study period showing that the IMP, baricitinib, was not effective in the primary study population."
NCT04891185,TERMINATED,INTERVENTIONAL,Clinical futility
NCT04891250,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT04891263,TERMINATED,INTERVENTIONAL,Recruitment difficulties due to COVID-19 pandemic
NCT04891315,TERMINATED,OBSERVATIONAL,A recalculation of sample size following preliminary results showed that the study was not feasible due to the requirement of a much larger sample size to reach significance. This would not be possible without significant additional funding.
NCT04891497,WITHDRAWN,INTERVENTIONAL,There are no suitable patients
NCT04891718,WITHDRAWN,INTERVENTIONAL,Termination by pharmaceutical sponsor
NCT04891913,SUSPENDED,INTERVENTIONAL,The sponsor decided to suspend the process
NCT04892043,TERMINATED,INTERVENTIONAL,Corporate Decision
NCT04892680,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to operational futility.
NCT04892875,WITHDRAWN,INTERVENTIONAL,Funding
NCT04892888,WITHDRAWN,OBSERVATIONAL,Business decision
NCT04893018,TERMINATED,INTERVENTIONAL,Terminated due to end of funding
NCT04893083,TERMINATED,OBSERVATIONAL,Business decision
NCT04893382,SUSPENDED,INTERVENTIONAL,Lack of funding. Will resume potentially.
NCT04893395,WITHDRAWN,INTERVENTIONAL,Does not meet criteria for a clinical trial per IRB review.
NCT04893473,WITHDRAWN,OBSERVATIONAL,Send in by another researcher. This is terminated to avoid two identical studies
NCT04893551,TERMINATED,INTERVENTIONAL,"After completion of all planned dose levels in the dose escalation phase, the sponsor decision was not to continue with expanding the cohorts of any of the dose levels, using the existing study design."
NCT04893564,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT04893642,TERMINATED,INTERVENTIONAL,The study had planned to recruit 220 but was termianted in advance when 134 patients were randomized. This was done due to slow recruitment.
NCT04893915,WITHDRAWN,INTERVENTIONAL,No funding support
NCT04894123,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT04894266,TERMINATED,INTERVENTIONAL,Unable to recruit subjects
NCT04894474,WITHDRAWN,INTERVENTIONAL,project terminated
NCT04894656,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to funding.
NCT04894682,WITHDRAWN,OBSERVATIONAL,Changes of the anti-epidemic policy
NCT04894994,TERMINATED,INTERVENTIONAL,Change in clinical landscape
NCT04895046,WITHDRAWN,INTERVENTIONAL,Funder decision
NCT04895202,TERMINATED,OBSERVATIONAL,Insufficient patient recruitment
NCT04895332,WITHDRAWN,OBSERVATIONAL,Due to pandemia
NCT04895410,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04895553,TERMINATED,OBSERVATIONAL,lack of funds. Only 1 patient was enrolled
NCT04896112,WITHDRAWN,INTERVENTIONAL,sponsor decision
NCT04896320,WITHDRAWN,INTERVENTIONAL,Study will be closed due to zero enrollment.
NCT04896567,WITHDRAWN,INTERVENTIONAL,Superseded by a separate study
NCT04896632,TERMINATED,INTERVENTIONAL,Sponsor's decision.
NCT04896827,SUSPENDED,OBSERVATIONAL,The funding of the study is challenged. We might resume enrollment if new funds are found or will terminate the study.
NCT04896970,WITHDRAWN,INTERVENTIONAL,abandonment
NCT04897217,WITHDRAWN,INTERVENTIONAL,PI decision
NCT04897880,TERMINATED,INTERVENTIONAL,Drug supply
NCT04898023,TERMINATED,INTERVENTIONAL,Loss of funding
NCT04898036,WITHDRAWN,INTERVENTIONAL,no funding or staff
NCT04898062,WITHDRAWN,INTERVENTIONAL,sufficient recruitment of study patients based on the existing inclusion and exclusion criteria is not possible within a reasonable period of time
NCT04898127,WITHDRAWN,INTERVENTIONAL,"The study needed approval from local authorities (City of Oslo and City of Bergen) to take place, which it did not get."
NCT04898309,WITHDRAWN,INTERVENTIONAL,Company pipeline revision
NCT04898348,WITHDRAWN,INTERVENTIONAL,No patients recruited
NCT04898985,SUSPENDED,OBSERVATIONAL,Recruitment was completed for initial evaluation of T-cell response to early Covid-19
NCT04899232,TERMINATED,INTERVENTIONAL,There are fewer potential patients and an early conclusion of the study would be beneficial in an attempt to finish in a reasonable time and keep the cohorts homogenous.
NCT04899271,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT04899349,TERMINATED,INTERVENTIONAL,Study was early terminated due to slow recruitment and emerging data showing that prophylactic use of metformin may prevent or reduce the incidence of all-grades alpelisib-related hyperglycemia. The decision was not driven by safety concerns
NCT04899921,TERMINATED,INTERVENTIONAL,Due to poor enrollment
NCT04900038,TERMINATED,INTERVENTIONAL,Company decision to stop compound development. The decision was not based on any safety or efficacy concerns. It reflected the company strategy for portfolio progression.
NCT04900428,TERMINATED,INTERVENTIONAL,Study was terminated at interim analysis due to drops not working on new variants
NCT04900766,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04901039,TERMINATED,OBSERVATIONAL,Lack of resources
NCT04901299,WITHDRAWN,INTERVENTIONAL,Team decision
NCT04901481,TERMINATED,INTERVENTIONAL,Unable to fully enroll study.
NCT04901494,WITHDRAWN,OBSERVATIONAL,The PI is leaving the institution.
NCT04901676,SUSPENDED,INTERVENTIONAL,Pending DSMB evaluation
NCT04901689,SUSPENDED,INTERVENTIONAL,Pending DSMB evaluation
NCT04901806,TERMINATED,INTERVENTIONAL,Sponsor terminated development of PBI-200
NCT04901988,TERMINATED,INTERVENTIONAL,Closed earlier than expected due to the need for a redesign to reflect the recent change in standard of care guidelines. New design will include these treatments.
NCT04902053,SUSPENDED,OBSERVATIONAL,Lack of enrollment. Study will be restarted when there is sufficient INSPIRIS Valve in Valve case volume to support enrollment.
NCT04902274,TERMINATED,INTERVENTIONAL,Fellowship Graduation December 2021
NCT04902287,TERMINATED,INTERVENTIONAL,Funding ending due to PI leaving position at the University of Oklahoma.
NCT04902599,TERMINATED,INTERVENTIONAL,Dr. Smart is leaving the instution.
NCT04902651,TERMINATED,INTERVENTIONAL,stopped for futility
NCT04902911,TERMINATED,OBSERVATIONAL,"Failed to meet FDA criteria on one target at FDA, CDC, and market is not looking for rapid antibody tests."
NCT04902950,TERMINATED,INTERVENTIONAL,Logistics
NCT04903054,WITHDRAWN,INTERVENTIONAL,Limited period of availability of a supply of the study drug and difficulties in enrollment
NCT04903327,TERMINATED,INTERVENTIONAL,"Due to considerably slow enrollment, unable to reach enrollment targets"
NCT04904276,TERMINATED,OBSERVATIONAL,"met minimum enrollment goal, however, enrollment was slow due to the pandemic, therefore, the study was terminated"
NCT04904354,WITHDRAWN,INTERVENTIONAL,Company no longer doing clinical studies
NCT04904718,WITHDRAWN,INTERVENTIONAL,Decided not to proceed with enrollment - study never started
NCT04905121,TERMINATED,INTERVENTIONAL,Unable to recruit patient population
NCT04905173,WITHDRAWN,INTERVENTIONAL,The decision was made by study team to pursue this as a quality project instead.
NCT04905212,TERMINATED,INTERVENTIONAL,Decision that continuing with the study would not generate useful data
NCT04905563,TERMINATED,INTERVENTIONAL,Clinical evidence supporting the hypothesis of this study has been published
NCT04905888,WITHDRAWN,INTERVENTIONAL,Closure/ move of MRI facility.
NCT04906382,TERMINATED,INTERVENTIONAL,Sponsor reorganization
NCT04906512,TERMINATED,INTERVENTIONAL,The decision to terminate this clinical study was made as a cost control measure.
NCT04906577,TERMINATED,INTERVENTIONAL,Because of logistical problems
NCT04906642,TERMINATED,INTERVENTIONAL,"low patient enrollment, less-than-ideal patient sample for the study, leading to a significant number of missed scheduled study visits, inefficient study data, and reallocation of finances."
NCT04906811,TERMINATED,INTERVENTIONAL,Study discontinued due to lack of subject follow-up.
NCT04906876,WITHDRAWN,INTERVENTIONAL,IND withdrawn
NCT04906889,WITHDRAWN,INTERVENTIONAL,financial protocol
NCT04906980,TERMINATED,INTERVENTIONAL,Feasibility of enrollment impacted by COVID
NCT04907227,TERMINATED,INTERVENTIONAL,The data did not support study endpoints
NCT04907383,TERMINATED,OBSERVATIONAL,poor recruitment status
NCT04907578,WITHDRAWN,OBSERVATIONAL,Study will not commence
NCT04907890,WITHDRAWN,OBSERVATIONAL,Severe difficulties in enrolling individuals
NCT04907968,TERMINATED,INTERVENTIONAL,Study Terminated by Sponsor
NCT04908371,WITHDRAWN,INTERVENTIONAL,Published data indicated Selective Trunk Block is a better choice
NCT04909346,TERMINATED,OBSERVATIONAL,Sponsor decision not related to safety concerns
NCT04909463,TERMINATED,INTERVENTIONAL,Limited resources
NCT04909502,SUSPENDED,INTERVENTIONAL,"Temporary recruitment pause to re-assess the protocol design, specifically the eligibility criteria"
NCT04909515,WITHDRAWN,INTERVENTIONAL,Study terminated due to business priorities
NCT04909723,TERMINATED,INTERVENTIONAL,Sponsor decision to discontinue study.
NCT04909879,WITHDRAWN,INTERVENTIONAL,Replaced by a different protocol.
NCT04909892,WITHDRAWN,INTERVENTIONAL,Replaced by a different protocol.
NCT04909983,TERMINATED,INTERVENTIONAL,Stopped after 17/20 participants due to lack of time after a prolonged recrutiment period.
NCT04910074,SUSPENDED,INTERVENTIONAL,IRB approval has elapsed. PI will need to submit Progress Report to re-open study
NCT04910373,TERMINATED,INTERVENTIONAL,Product Availability Due to Recall
NCT04910763,TERMINATED,INTERVENTIONAL,"Lack of institutional resources to conduct project, increased cost of conducting project due to workarounds with resources not being available, and COVID-19 pausing human subjects data collection in 2020."
NCT04910919,WITHDRAWN,INTERVENTIONAL,competing study started with same participants
NCT04910997,WITHDRAWN,INTERVENTIONAL,"Protocol closed, no participants enrolled, difficulty enrolling, funding ended."
NCT04912063,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04912115,SUSPENDED,INTERVENTIONAL,Seeking Pivotal study initiation
NCT04912141,TERMINATED,INTERVENTIONAL,Lower than expected study enrolment rate. New strategic considerations.
NCT04912180,TERMINATED,OBSERVATIONAL,Study endpoints no longer feasible.
NCT04912427,TERMINATED,INTERVENTIONAL,Low accrual
NCT04912570,SUSPENDED,INTERVENTIONAL,No catheters
NCT04912856,TERMINATED,INTERVENTIONAL,Sponsor decision; not a safety decision
NCT04913077,SUSPENDED,INTERVENTIONAL,interim analysis
NCT04913142,WITHDRAWN,OBSERVATIONAL,No more COVID+ patients to enrolled
NCT04913610,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT04913675,TERMINATED,INTERVENTIONAL,The safety sub-study was discontinued early in the context of evolving variants with increased fold changes in the in vitro half maximal inhibitory concentration (IC50) and uncertainty in the clinical relevance of these changes
NCT04913974,WITHDRAWN,OBSERVATIONAL,Surgeons unhappy with the outcome from pre-study implants
NCT04914182,SUSPENDED,INTERVENTIONAL,"Because of the Pandemic, the recruitment was very slow. We stopped the study and will continue as soon as the Recruiting Centre reopens the LDR."
NCT04915144,WITHDRAWN,INTERVENTIONAL,Investigator decision
NCT04915352,SUSPENDED,INTERVENTIONAL,The study is suspended because the product (nasal provocation test) is out of stock.
NCT04915560,WITHDRAWN,INTERVENTIONAL,The French committee refused the amendment.
NCT04915950,TERMINATED,INTERVENTIONAL,Business decision
NCT04915976,SUSPENDED,OBSERVATIONAL,Dataset not obtained
NCT04916002,SUSPENDED,INTERVENTIONAL,Sponsor Decision related to study drug supply
NCT04917055,TERMINATED,INTERVENTIONAL,staffing
NCT04917224,WITHDRAWN,INTERVENTIONAL,"ViewRay (funding agency) has filed under Chapter 11, U.S. Bankruptcy Code. ViewRay's clinical research support is paused and studies will not be paid directly by ViewRay. As such, the sponsor has closed the study without enrolling participants."
NCT04917640,WITHDRAWN,OBSERVATIONAL,A revised study has been listed here for us.
NCT04917692,WITHDRAWN,INTERVENTIONAL,Not funded
NCT04918147,TERMINATED,INTERVENTIONAL,The study was terminated early based on disease flare/lack of efficacy in the early phase of the trial.
NCT04918511,WITHDRAWN,INTERVENTIONAL,Sponsor made the decision to terminate the COAST study to refocus the OPD5 clinical program.
NCT04919096,WITHDRAWN,INTERVENTIONAL,"Due to an internal decision to prioritise its development pipeline, Clover have decided to close down study CLO-SCB-420-001. This was a corporate decision and not the results of new data or information arising related to SCB-420"
NCT04919356,TERMINATED,OBSERVATIONAL,Sponsor stopped the study
NCT04919395,TERMINATED,INTERVENTIONAL,"On the single day that the study was open, it became clear that modifications to the clip would be required. Only late in 2023 did it become clear that any continuation of the project would require a new trial."
NCT04919798,TERMINATED,INTERVENTIONAL,Costs exceeding budget
NCT04920331,WITHDRAWN,INTERVENTIONAL,No Participants Enrolled
NCT04920383,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04920578,TERMINATED,INTERVENTIONAL,business decision to end clinical development of JNJ-69095897
NCT04920630,TERMINATED,INTERVENTIONAL,Research team members no longer employed. Determination made to utilize pilot data already obtained and close study to enrollment.
NCT04920929,TERMINATED,INTERVENTIONAL,"Enrollment too low, not meeting objectives"
NCT04921332,TERMINATED,INTERVENTIONAL,Study was stopped secondary to principal investigator needing to analyze data and present prior to graduating. Target enrollment not able to be reached prior to this.
NCT04921358,TERMINATED,INTERVENTIONAL,"Due to safety risks and unfavorable risk-benefit assessment results, the sponsor has decided to voluntarily terminate the study."
NCT04921696,WITHDRAWN,OBSERVATIONAL,no patients were included
NCT04921761,WITHDRAWN,INTERVENTIONAL,There is a duplicate study registered. The trial registration and later updates will be in NCT04933500. That is the record that will be updated.
NCT04922112,WITHDRAWN,INTERVENTIONAL,"Unable to find participants, no enrollment"
NCT04922424,WITHDRAWN,INTERVENTIONAL,not funded
NCT04922463,TERMINATED,INTERVENTIONAL,The continuation of the study was rendered unreasonable due to the slow inclusion rate
NCT04922632,TERMINATED,INTERVENTIONAL,Funding was exhausted
NCT04922710,TERMINATED,INTERVENTIONAL,The study protocol was not feasible. We made several modifications but halted the study prematurely before we met our target sample size goal.
NCT04922957,TERMINATED,INTERVENTIONAL,strategic reprioritization
NCT04923802,TERMINATED,OBSERVATIONAL,Unable to recruit sufficient numbers of patients
NCT04924257,WITHDRAWN,INTERVENTIONAL,No eligible participants
NCT04925778,WITHDRAWN,OBSERVATIONAL,Business considerations
NCT04925947,TERMINATED,INTERVENTIONAL,Data collected did not support the study endpoints
NCT04925986,TERMINATED,INTERVENTIONAL,Sponsor decision based on data from other clinical trials
NCT04926168,WITHDRAWN,OBSERVATIONAL,lack of funds
NCT04926805,TERMINATED,INTERVENTIONAL,Extremely slow recruitment
NCT04927169,TERMINATED,INTERVENTIONAL,POOR ACCRUAL
NCT04927247,TERMINATED,INTERVENTIONAL,Study was terminated due to poor accrual and associated recrutiment challenges
NCT04927351,SUSPENDED,INTERVENTIONAL,Challenges obtaining data from EMR system.
NCT04927481,TERMINATED,INTERVENTIONAL,The sponsor has adjusted its R\&D strategy.
NCT04927884,TERMINATED,INTERVENTIONAL,Study not meeting recruitment goals
NCT04927988,WITHDRAWN,INTERVENTIONAL,halted by the pandemic of COVID-19
NCT04928092,WITHDRAWN,OBSERVATIONAL,The PI is leaving the institution
NCT04928118,WITHDRAWN,OBSERVATIONAL,PI may be leaving the institution
NCT04928430,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04928599,SUSPENDED,OBSERVATIONAL,Schedule Interim Monitoring
NCT04928781,WITHDRAWN,INTERVENTIONAL,PI and funding source collectively decided to close study due to lack of smoking cessation counselor required for study
NCT04928820,TERMINATED,INTERVENTIONAL,slow recruitment
NCT04928950,WITHDRAWN,INTERVENTIONAL,"Because of logistic challenges and lack of product among other factors, we decided to completely withdrawn this study."
NCT04928989,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT04929340,SUSPENDED,INTERVENTIONAL,recruitment on hold since spring 2020 due to Covid-19 pandemic
NCT04930055,TERMINATED,OBSERVATIONAL,PI had decided to terminate the study
NCT04930237,WITHDRAWN,OBSERVATIONAL,PI request to close study
NCT04930705,TERMINATED,INTERVENTIONAL,This study was terminated because of a business decision.
NCT04930770,WITHDRAWN,INTERVENTIONAL,No candidates for the trial (all patients have received the third dose of the vaccine)
NCT04931511,TERMINATED,INTERVENTIONAL,"Since the COVID-19 pendemic, the regular follow-up of participant became very hard. The participant were not willing to go back to the hospital for repeat measurement. So we stop the study and plan to redesign the protocol."
NCT04931628,TERMINATED,INTERVENTIONAL,negative information
NCT04931667,TERMINATED,INTERVENTIONAL,Study was terminated due to business reasons by Sponsor.
NCT04931862,TERMINATED,INTERVENTIONAL,"Despite robust, sustained reductions in poly(GP), no clinical benefit was seen at 24 weeks, and reductions in poly(GP) were not associated with stabilization in functional outcomes. Based on these data, Wave decided to stop development of WVE-004."
NCT04931927,TERMINATED,INTERVENTIONAL,This study has been terminated due to a change in study design. The study is no longer a RCT.
NCT04932031,TERMINATED,OBSERVATIONAL,under enrollment for primary endpoint analysis
NCT04932265,SUSPENDED,INTERVENTIONAL,Technical Problems with sensitivity of mass spectral detector
NCT04932837,WITHDRAWN,OBSERVATIONAL,The vaccination campaign started before the approval of the ethics committee was obtained. The study is therefore no longer of interest to be carried out.
NCT04932915,TERMINATED,INTERVENTIONAL,Failure of recruiting patients
NCT04933227,TERMINATED,INTERVENTIONAL,Sponsor's decision to terminate the study after Stage 1; will not proceed with Stage 2.
NCT04933240,WITHDRAWN,INTERVENTIONAL,Anticipated funding was not received
NCT04933253,WITHDRAWN,INTERVENTIONAL,Recruitment has been unsuccessful and the study team is withdrawing the study while they consider options and alternatives.
NCT04933916,TERMINATED,INTERVENTIONAL,Business decision
NCT04933942,WITHDRAWN,INTERVENTIONAL,Amgen withdrew interest in providing further financial support
NCT04933968,TERMINATED,INTERVENTIONAL,Strategic sponsor decision
NCT04934046,TERMINATED,INTERVENTIONAL,"As the team at Nancy University Hospital published the same study last year, on the competing CZT 3D system (Veriton), our study is no longer relevant."
NCT04934397,TERMINATED,INTERVENTIONAL,Product Availability Due to Recall
NCT04934553,SUSPENDED,INTERVENTIONAL,Limited funding
NCT04934670,TERMINATED,INTERVENTIONAL,The study met the protocol defined stopping boundary for Day 60 mortality when comparing mortality between the T-Guard and ruxolitinib arms
NCT04934917,TERMINATED,OBSERVATIONAL,Covid related problems
NCT04935138,TERMINATED,OBSERVATIONAL,Low participation
NCT04935411,TERMINATED,OBSERVATIONAL,"Enough participants were included, which made it possible to answer the objectives of the study."
NCT04936061,TERMINATED,INTERVENTIONAL,Recruitment problems
NCT04936113,TERMINATED,INTERVENTIONAL,Failure of the Phase 2 study (protocol FB401-01) to meet its endpoint.
NCT04936425,WITHDRAWN,INTERVENTIONAL,Unable to enroll.
NCT04936451,TERMINATED,INTERVENTIONAL,lack of recrutment
NCT04936841,TERMINATED,INTERVENTIONAL,study closed by the sponsor
NCT04936971,WITHDRAWN,INTERVENTIONAL,Impossibility to perform tests (elispot) of the study due to change of location of laboratory
NCT04937465,WITHDRAWN,OBSERVATIONAL,Study was stopped because of covid-19 restrictions imposed for the next 9 months
NCT04937491,SUSPENDED,OBSERVATIONAL,Due to covid-19
NCT04937608,TERMINATED,OBSERVATIONAL,Lack of staff
NCT04938128,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT04938258,TERMINATED,INTERVENTIONAL,Insufficient accrual rate to achieve expected sample size.
NCT04938323,WITHDRAWN,INTERVENTIONAL,Covid-19 related delays in project launch
NCT04938388,TERMINATED,INTERVENTIONAL,Principal Investigator no longer at study site.
NCT04938635,WITHDRAWN,INTERVENTIONAL,Strategic reasons
NCT04939064,TERMINATED,OBSERVATIONAL,lapse in approval
NCT04939272,SUSPENDED,INTERVENTIONAL,FDA Clinical Hold
NCT04939311,WITHDRAWN,INTERVENTIONAL,Funding for this trial has not been established.
NCT04939584,TERMINATED,INTERVENTIONAL,Sponsor ceased operations
NCT04939987,WITHDRAWN,INTERVENTIONAL,PI left institution and study was not transferred to new PI
NCT04940416,TERMINATED,OBSERVATIONAL,"Collaboration between partners ended, covid"
NCT04940429,TERMINATED,OBSERVATIONAL,"collaboration with research partner stopped, Covid"
NCT04940871,TERMINATED,INTERVENTIONAL,"Only one patient was enrolled, who who later withdrew the consent. They decided not to contunie the study."
NCT04940949,TERMINATED,INTERVENTIONAL,The study was terminated based on new safety data.
NCT04941183,TERMINATED,INTERVENTIONAL,the emergence of the omicron variant of COVID-19 lead to insufficient enrollment
NCT04941222,TERMINATED,INTERVENTIONAL,Difficulties of recruitment
NCT04941365,WITHDRAWN,INTERVENTIONAL,please refer to NCT05621837
NCT04941378,WITHDRAWN,INTERVENTIONAL,Due to sponsor request
NCT04941443,TERMINATED,INTERVENTIONAL,Inability to recruit more participants.
NCT04941703,TERMINATED,INTERVENTIONAL,Recruitment issues after COVID-19 abated; not enough hypoxic patients to meet criteria.
NCT04941729,TERMINATED,INTERVENTIONAL,Change on clinical and marketing strategy for the devices
NCT04941989,TERMINATED,INTERVENTIONAL,Early termination of study pending evaluation of emerging preclinical profile.
NCT04942054,TERMINATED,INTERVENTIONAL,The decision to close is due commercial reasons only
NCT04942184,WITHDRAWN,INTERVENTIONAL,Study was never started due to the Covid 19 pandemic.
NCT04942340,WITHDRAWN,INTERVENTIONAL,Withdrawn secondary to a change in protocol design forthcoming.
NCT04943302,WITHDRAWN,INTERVENTIONAL,PI left institution. Study not moving forward in her absence.
NCT04943627,WITHDRAWN,INTERVENTIONAL,Strategic Business Decision
NCT04943692,SUSPENDED,INTERVENTIONAL,Administrative decision of the investigation direction
NCT04944654,TERMINATED,INTERVENTIONAL,"Trial set up was delayed, funding support no longer available"
NCT04944784,TERMINATED,INTERVENTIONAL,The DMC recommended the trial be discontinued due to futility following a planned second interim analysis.
NCT04944797,WITHDRAWN,OBSERVATIONAL,The project was abandoned.
NCT04945733,TERMINATED,INTERVENTIONAL,Due to reconsideration of development strategy
NCT04945746,SUSPENDED,INTERVENTIONAL,technical problem with VX1 software
NCT04945824,TERMINATED,INTERVENTIONAL,inserter device did not perform as expected
NCT04946136,SUSPENDED,INTERVENTIONAL,Awaiting additional funding
NCT04946162,WITHDRAWN,INTERVENTIONAL,The investigators never completed the IRB application due to decrease in need to conduct the study.
NCT04946318,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04946435,WITHDRAWN,INTERVENTIONAL,We are no longer going to undertake the study.
NCT04946656,SUSPENDED,INTERVENTIONAL,"In response to quality assurance and compliance concerns about some specific NYSPI studies, NYSPI decided to undertake an Institute-wide safety review of research protocols that involve direct interventions or interactions with human subjects."
NCT04947371,WITHDRAWN,INTERVENTIONAL,The standard of care of adjuvant therapy for liver cancer was changed.
NCT04947410,WITHDRAWN,INTERVENTIONAL,recruitment difficulty
NCT04947579,TERMINATED,INTERVENTIONAL,The study has been terminated due to Non-Safety reasons because of lack of efficacy in the short-term acute phase.
NCT04947917,TERMINATED,INTERVENTIONAL,Institutional standard of care regarding axillary management changed. Decision was made to close the study early.
NCT04948554,TERMINATED,INTERVENTIONAL,Business Reasons
NCT04948606,TERMINATED,OBSERVATIONAL,Sponsor Decision
NCT04948996,TERMINATED,INTERVENTIONAL,"Due to COVID, recruitment in primary care was not possible, alternative proposed hotline recruitment methods yielded population that did not meet inclusion criteria and were too acutely ill to be eligible for study."
NCT04949191,TERMINATED,INTERVENTIONAL,A business decision due to availability of commercial drug and other options for accessing study drug treatment.
NCT04949425,TERMINATED,INTERVENTIONAL,Study terminated because the clinical development programme for Adavosertib has been discontinued
NCT04949854,WITHDRAWN,INTERVENTIONAL,Protocol was substantially revised
NCT04950010,TERMINATED,INTERVENTIONAL,Original PI moved to a new institution
NCT04950114,TERMINATED,INTERVENTIONAL,Business reasons
NCT04950374,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant due to change on study design."
NCT04950504,TERMINATED,INTERVENTIONAL,Lagging Enrollment. Opened a separate study.
NCT04950582,SUSPENDED,OBSERVATIONAL,temporary pause due to business priorities
NCT04950751,WITHDRAWN,INTERVENTIONAL,sponsor decided to withdrawn the study as development strategy has changed
NCT04950855,TERMINATED,OBSERVATIONAL,Due to the difficulty in following pregnant women due to the covid 19 pandemic
NCT04951492,TERMINATED,INTERVENTIONAL,Withdrawal of funding
NCT04951934,WITHDRAWN,INTERVENTIONAL,"There has been no unanimous approval by the investigators regarding the approval of the study protocol. Therefore, by mutual agreement, sponsor and investigators have taken the decision to withdraw the clinical study."
NCT04952519,TERMINATED,INTERVENTIONAL,"The annual analysis did not show the efficacy of the investigational medicinal product in this application, therefore the study was not continued."
NCT04952571,SUSPENDED,INTERVENTIONAL,Lack of funds
NCT04952584,WITHDRAWN,INTERVENTIONAL,Study was not activated
NCT04953052,WITHDRAWN,INTERVENTIONAL,Number of moderate to severe ARDS patients hospitalised due to COVID19 diminishingly small. Not expected to recruit required minimum number of patients.
NCT04954014,TERMINATED,INTERVENTIONAL,"Lack of financing, lack of COVID19 patients in the ICU."
NCT04954196,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT04954261,WITHDRAWN,OBSERVATIONAL,Abandoned study project
NCT04954365,WITHDRAWN,OBSERVATIONAL,Sponsor terminated prior to initiation.
NCT04955262,WITHDRAWN,INTERVENTIONAL,Did not initiate due to business reasons. IND is inactive.
NCT04955574,WITHDRAWN,INTERVENTIONAL,Change in departmental research focus.
NCT04955652,WITHDRAWN,INTERVENTIONAL,A conflicting project required the same sample for a different purpose.
NCT04955808,SUSPENDED,OBSERVATIONAL,"Due to slow accrual on this trial, we will allow sites time to work on close-out procedures and filling out necessary paperwork before taking the steps to forma"
NCT04955951,TERMINATED,OBSERVATIONAL,forgotten
NCT04955990,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study.
NCT04956042,TERMINATED,INTERVENTIONAL,Discontinued
NCT04956159,TERMINATED,INTERVENTIONAL,poor recruitment
NCT04956250,WITHDRAWN,INTERVENTIONAL,No participants were intended to be directly recruited.
NCT04956276,WITHDRAWN,INTERVENTIONAL,Sponsor decision to terminate program
NCT04956302,TERMINATED,INTERVENTIONAL,PI Decision
NCT04957173,WITHDRAWN,INTERVENTIONAL,"Recruitment was difficult, and the investigator decided to close the study."
NCT04957290,TERMINATED,INTERVENTIONAL,Slow Recruitment
NCT04957732,TERMINATED,INTERVENTIONAL,Research facility was restructured and no longer treated subjects in the study population.
NCT04958161,WITHDRAWN,INTERVENTIONAL,Unable to enroll anyone.
NCT04958304,TERMINATED,OBSERVATIONAL,Study has been terminated and replaced due to low enrollment.
NCT04958421,TERMINATED,INTERVENTIONAL,Study terminated due to lack of financing
NCT04958434,TERMINATED,INTERVENTIONAL,Corporate Decision
NCT04958642,TERMINATED,INTERVENTIONAL,Terminated by previous Sponsor decision
NCT04958967,WITHDRAWN,INTERVENTIONAL,The protocol need to review
NCT04958993,TERMINATED,INTERVENTIONAL,High incidence of severe radiation pneumonia
NCT04959266,TERMINATED,INTERVENTIONAL,The study terminated because the clinical development programme for Adavosertib has been discontinued
NCT04959422,WITHDRAWN,INTERVENTIONAL,"No participants were enrolled in the study, and staff has been reduced and cannot support the trial any longer."
NCT04960553,TERMINATED,INTERVENTIONAL,The study was early terminated because new data related to the investigational device were available making this investigation no longer scientifically relevant
NCT04960956,TERMINATED,OBSERVATIONAL,Could not identify a replacement Principal Investigator.
NCT04961151,WITHDRAWN,INTERVENTIONAL,Low enrollment
NCT04961320,WITHDRAWN,INTERVENTIONAL,slow accrual
NCT04961554,WITHDRAWN,OBSERVATIONAL,"1. Short defense deadline
2. Activity cessation of the maxillofacial surgery department at Piti Salptrire hospital"
NCT04961658,TERMINATED,INTERVENTIONAL,Funding Decision
NCT04961801,WITHDRAWN,INTERVENTIONAL,Manufacturer AstraZeneca withdrew the study due to lack of funding
NCT04962048,TERMINATED,INTERVENTIONAL,"Results not goal-oriented, premature termination."
NCT04963413,TERMINATED,INTERVENTIONAL,Terminated by mutual agreement by sponsor and institution.
NCT04963673,WITHDRAWN,OBSERVATIONAL,no participants enrolled
NCT04964050,WITHDRAWN,INTERVENTIONAL,Internal sponsor decision to terminate project prematurely based on a waiver granted by Egypt EDA (Egyptian drug authority). No subjects were enrolled.
NCT04964323,TERMINATED,OBSERVATIONAL,Lack of enrollment and participant compliance with surveys.
NCT04964414,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT04964596,WITHDRAWN,INTERVENTIONAL,The study was never started due to lack of staff
NCT04964674,SUSPENDED,INTERVENTIONAL,"Attempts at online data collection have led to poor data quality (many missing data points from one task of the set). Study suspended while we evaluate whether the study should continue, given the data quality issues."
NCT04964778,WITHDRAWN,INTERVENTIONAL,Unable to secure funding
NCT04964817,TERMINATED,OBSERVATIONAL,unable to recruit following changes to practice resulting from pandemic
NCT04964843,WITHDRAWN,INTERVENTIONAL,Null results were posted from a neurometabolite study and a recent trial for AUD. Study may resume if more positive data emerge.
NCT04965233,WITHDRAWN,OBSERVATIONAL,"Due to protocol changes, and the observational design of this study (not an ACT), the study registry is withdrawn from clinicaltrials.gov."
NCT04965272,WITHDRAWN,INTERVENTIONAL,Strategic Decision
NCT04965467,WITHDRAWN,OBSERVATIONAL,Withdrawn due to financial reasons
NCT04965714,WITHDRAWN,INTERVENTIONAL,0 patient accrual
NCT04965818,TERMINATED,INTERVENTIONAL,Strategic decision by sponsor.
NCT04966065,TERMINATED,OBSERVATIONAL,too slow patints recruitment
NCT04968379,WITHDRAWN,INTERVENTIONAL,Difficult to recruit and enroll patients for this study in a reasonable amount of time.
NCT04968496,TERMINATED,INTERVENTIONAL,The Study PI has resigned
NCT04968860,TERMINATED,OBSERVATIONAL,Low casuistry that did not allow the study to continue
NCT04968938,WITHDRAWN,INTERVENTIONAL,Sponsor decided not to pursue the study. Study ended prior to study start.
NCT04968951,TERMINATED,INTERVENTIONAL,insufficient funding
NCT04969146,SUSPENDED,INTERVENTIONAL,Staffing
NCT04969367,WITHDRAWN,OBSERVATIONAL,Staffing
NCT04969406,TERMINATED,INTERVENTIONAL,Enrollment Difficulty
NCT04969484,SUSPENDED,INTERVENTIONAL,K76 grant transferred to new institution (NOA 3/2020). COVID-19 significantly impacted study team personnel \& study setting; human subjects restrictions at both the University and CMS levels prevented any human subjects research for more than a year.
NCT04969861,TERMINATED,INTERVENTIONAL,"Nektar Therapeutics made the decision to discontinue the bempegaldesleukin program based on three negative studies. SFJ Pharmaceuticals, Inc. and Nektar Therapeutics, in consultation with the study IDMC, have decided to discontinue PROPEL-36."
NCT04969991,TERMINATED,INTERVENTIONAL,"Part 2 of the study was paused on 03-May-2022 due to slow enrollment following low infection rates and hospitalizations of patients with severe COVID-19, and did not recommence prior to study closure (early termination) on 22-Nov-2022."
NCT04970004,WITHDRAWN,OBSERVATIONAL,Sponsor decision to not proceed.
NCT04970108,WITHDRAWN,INTERVENTIONAL,Strategy review
NCT04970368,TERMINATED,INTERVENTIONAL,Slow accrual
NCT04970641,TERMINATED,INTERVENTIONAL,Restrictions to recruitment due to staffing shortages and low patient census
NCT04970719,WITHDRAWN,INTERVENTIONAL,adequate cases were not available
NCT04970953,TERMINATED,OBSERVATIONAL,We raised ethical concerns to proceed an invasive study despite having shown the expected results after 19 patients.
NCT04971005,TERMINATED,INTERVENTIONAL,Lack of recruitment due to low acceptance of the control arm.
NCT04971148,TERMINATED,INTERVENTIONAL,Difficulty in recruiting patients
NCT04971187,TERMINATED,INTERVENTIONAL,PI Request
NCT04971512,TERMINATED,INTERVENTIONAL,Due to adverse safety signals in Part 1 (HV)
NCT04971681,TERMINATED,INTERVENTIONAL,"Enrollment paused when our alcohol supplier recalled and suspended manufacture of the product. When production resumed, there was not enough time remaining to successfully resume recruitment. We will examine the outcomes with the existing sample."
NCT04971993,TERMINATED,OBSERVATIONAL,Resourcing challenges
NCT04972253,WITHDRAWN,INTERVENTIONAL,Low Accrual
NCT04972318,TERMINATED,INTERVENTIONAL,Low recruitment rate with no possibility to achieve pre specified sample size before funding ends.
NCT04972968,TERMINATED,INTERVENTIONAL,Business Decision
NCT04973527,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study
NCT04973618,WITHDRAWN,INTERVENTIONAL,Change of strategy
NCT04973982,WITHDRAWN,INTERVENTIONAL,Lack of capacity
NCT04974359,TERMINATED,INTERVENTIONAL,Study terminated due to enrolment challenges.
NCT04974970,TERMINATED,INTERVENTIONAL,early termination due to insufficient recruitment
NCT04974996,WITHDRAWN,INTERVENTIONAL,Decision to not proceed with study.
NCT04976049,WITHDRAWN,OBSERVATIONAL,Principle Investigator decided not to pursue study
NCT04976101,WITHDRAWN,INTERVENTIONAL,It never enrolled any patients
NCT04976972,WITHDRAWN,INTERVENTIONAL,study protocol is being significantly changed study is therefore being terminated and will re-open under new title and study number
NCT04977401,TERMINATED,INTERVENTIONAL,Urgent Medical Device Product (ORISE Gel Submucosal Liftiong Agent) Removal by sponsor
NCT04977648,WITHDRAWN,OBSERVATIONAL,"The first Clinical trial with DYN101 (UNITE-CNM) was early terminated. As a consequence, Dynacure decided to not perform this study."
NCT04977804,WITHDRAWN,INTERVENTIONAL,A key faculty at our college who was helping with the project left the college.
NCT04978324,WITHDRAWN,INTERVENTIONAL,Fellow graduated before successfully enrolling any participants
NCT04978337,TERMINATED,INTERVENTIONAL,Janssen made the strategic decision to discontinue the PRIMROSE study. This decision is not based on any safety concerns.
NCT04978610,SUSPENDED,INTERVENTIONAL,Lack of lab resources
NCT04978649,WITHDRAWN,INTERVENTIONAL,Cooperation plan has been changed
NCT04978779,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT04979442,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT04979533,WITHDRAWN,INTERVENTIONAL,Professional decision
NCT04979637,WITHDRAWN,OBSERVATIONAL,ConvaTec have been unable to recruit sufficient subjects meeting the inclusion / exclusion criteria and also due to the ongoing Covid-19 restrictions at hospitals and clinics
NCT04979793,SUSPENDED,INTERVENTIONAL,At the request of the PI
NCT04980001,WITHDRAWN,INTERVENTIONAL,The study was not started due to several factors: partial IRB approval; limited community partner engagement; and grant funding support expired.
NCT04980391,TERMINATED,INTERVENTIONAL,"Following a recommendation from the Independent Data Monitoring Committee of NCT04605159 (RSV MAT 009), GSK made the decision to stop enrolment and vaccination in the study."
NCT04981405,TERMINATED,OBSERVATIONAL,"low recruitment, end of COVID-19 pandemic"
NCT04981470,TERMINATED,INTERVENTIONAL,Device modifications needed
NCT04981678,TERMINATED,INTERVENTIONAL,This study was halted prior to accumulating the full number of participants due to difficulty in recruiting study subjects.
NCT04981717,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT04982289,WITHDRAWN,INTERVENTIONAL,Sponsor decision to terminate program
NCT04982666,WITHDRAWN,INTERVENTIONAL,Difficulties with recruitment and unable to enroll any subjects
NCT04983407,TERMINATED,INTERVENTIONAL,Due to business reasons
NCT04983446,WITHDRAWN,INTERVENTIONAL,Withdrawn due to business reasons
NCT04983498,WITHDRAWN,INTERVENTIONAL,Investigator left organization before study initiated.
NCT04983667,TERMINATED,INTERVENTIONAL,A funding agreement could not be secured with the primary funding organizations
NCT04983979,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT04984278,TERMINATED,INTERVENTIONAL,The study was terminated based on a business decision by the Sponsor.
NCT04984317,SUSPENDED,INTERVENTIONAL,Principal Investigator changing locations.
NCT04984330,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT04984538,WITHDRAWN,OBSERVATIONAL,Personnel Changes
NCT04984577,SUSPENDED,INTERVENTIONAL,Strategic realignment of sponsors.
NCT04984759,WITHDRAWN,INTERVENTIONAL,"Local EC requested that the arms of study be submitted as separate protocols so they could respond to the different risk of each arm. In response investigators have withdrawn this protocol and begun separate submissions, starting with NCT06191458."
NCT04984798,WITHDRAWN,INTERVENTIONAL,No study activity took place. The IND was withdrawn with the FDA by the Sponsor Investigator because of insurmountable hurdles in moving proposed research forward
NCT04984876,TERMINATED,INTERVENTIONAL,Study terminated by sponsor
NCT04985136,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT04985370,SUSPENDED,INTERVENTIONAL,Logistic issues
NCT04985656,WITHDRAWN,INTERVENTIONAL,Sponsor Decision to Terminate Trial
NCT04985825,WITHDRAWN,INTERVENTIONAL,Business decision
NCT04985968,TERMINATED,INTERVENTIONAL,Due to futility
NCT04985981,SUSPENDED,OBSERVATIONAL,Change in core study organization
NCT04986163,TERMINATED,INTERVENTIONAL,Technical issues
NCT04986527,WITHDRAWN,INTERVENTIONAL,study does not have funding
NCT04986553,WITHDRAWN,OBSERVATIONAL,The study was suspended and terminated.
NCT04986800,WITHDRAWN,INTERVENTIONAL,"Was never funded. Through rounds of grant applications, the intervention changed substantially based on reviewer feedback and feasibility"
NCT04987281,WITHDRAWN,INTERVENTIONAL,0 ACTUAL Enrollment must have Overall Recruitment
NCT04987294,TERMINATED,INTERVENTIONAL,Company Financing
NCT04987762,TERMINATED,INTERVENTIONAL,due to administrative reasons not related to efficacy or safety.
NCT04987944,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the study based on adjusted clinical development plan. This decision is not based on any safety concerns.
NCT04987996,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to lack of supply of one of the investigational agents.
NCT04988061,WITHDRAWN,INTERVENTIONAL,no subjects enrolled
NCT04988087,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04988308,TERMINATED,INTERVENTIONAL,Study has been prematurely terminated as the Interim Analysis 1 efficacy results met the prespecified futility criteria related to the primary endpoint.
NCT04988399,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to Einstein IRB approval
NCT04988997,TERMINATED,INTERVENTIONAL,Trial terminated by Sponsor
NCT04989283,WITHDRAWN,INTERVENTIONAL,Due to no accrual
NCT04989972,WITHDRAWN,INTERVENTIONAL,GCP VIOLATIONS FROM THE SPONSORS
NCT04989998,WITHDRAWN,INTERVENTIONAL,update to marketing strategy for hip robotics and related instrumentation
NCT04990219,TERMINATED,INTERVENTIONAL,The study was terminated for strategic reasons
NCT04990388,TERMINATED,INTERVENTIONAL,Sponsor decision not related to safety concerns
NCT04990440,TERMINATED,INTERVENTIONAL,Premature study termination (efficacy)
NCT04990466,WITHDRAWN,INTERVENTIONAL,Production of the BriLife vaccine was halted by government sponsor
NCT04990518,TERMINATED,OBSERVATIONAL,Grant not allowed
NCT04990583,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants during COVID-19.
NCT04990778,WITHDRAWN,INTERVENTIONAL,PI Request
NCT04990804,TERMINATED,INTERVENTIONAL,Limitations of the prospective study design revealed that a retrospective study design would be better suited.
NCT04990973,TERMINATED,INTERVENTIONAL,Pilot study; collection of information completed
NCT04991038,WITHDRAWN,INTERVENTIONAL,"Withdrawn, considering alternative trial design"
NCT04991194,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT04991350,TERMINATED,INTERVENTIONAL,Insufficient recruitment
NCT04991597,WITHDRAWN,INTERVENTIONAL,Shift in research focus
NCT04991688,TERMINATED,INTERVENTIONAL,Organizational difficulties
NCT04991779,WITHDRAWN,OBSERVATIONAL,"The other study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT04992052,TERMINATED,INTERVENTIONAL,Poor Enrollment
NCT04992078,WITHDRAWN,INTERVENTIONAL,Study has been early terminated due to change of study protocol and study will be commence with new protocol and study number
NCT04992273,TERMINATED,INTERVENTIONAL,Emerging SARS-CoV-2 variants impacting susceptibility to study drug
NCT04992845,TERMINATED,INTERVENTIONAL,The Sponsor decided to focus their resources on the clinical data collection for the second generation of the investigational device.
NCT04993326,WITHDRAWN,INTERVENTIONAL,Study was not funded
NCT04993443,TERMINATED,INTERVENTIONAL,"Copmeletion of Part A SAD cohorts, sponsor cancelled Part B-D cohorts"
NCT04993664,WITHDRAWN,INTERVENTIONAL,Administrative reason
NCT04994002,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT04994561,WITHDRAWN,INTERVENTIONAL,Study was withdrawn
NCT04994899,TERMINATED,OBSERVATIONAL,Data collection is no longer necessary
NCT04994990,WITHDRAWN,INTERVENTIONAL,staff not available to support study
NCT04995094,WITHDRAWN,INTERVENTIONAL,"Enrollment challenges, study not feasible"
NCT04995536,WITHDRAWN,INTERVENTIONAL,no accrual
NCT04995575,TERMINATED,OBSERVATIONAL,Closed as not feasible
NCT04995705,TERMINATED,INTERVENTIONAL,Study terminated prematurely due to COVID-19 pandemic. Unable to run face-to-face groups and therefore ACT study was ended before the proposed end date.
NCT04995783,TERMINATED,OBSERVATIONAL,Coral underwent an APA and is no longer in operation
NCT04995978,WITHDRAWN,INTERVENTIONAL,No participants were recruited and the study was deemed not feasible
NCT04996004,TERMINATED,INTERVENTIONAL,Pfizer decided to terminate the study for administrative reasons. The termination was neither due to safety concerns nor a request from the regulatory authorities.
NCT04996030,SUSPENDED,INTERVENTIONAL,Prioritization
NCT04996056,WITHDRAWN,INTERVENTIONAL,Not able to recruit qualified participants
NCT04996147,TERMINATED,OBSERVATIONAL,COVID-19 pandemic
NCT04996420,TERMINATED,INTERVENTIONAL,"change in surgical technique (lateral approach vs anterior approach for hip arthroplasty, determining a change in patient intraoperative positioning)"
NCT04996641,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants
NCT04996667,WITHDRAWN,INTERVENTIONAL,no sponsor support
NCT04997161,TERMINATED,INTERVENTIONAL,There is disconnect between dietary guidelines to limit potassium intake in dialysis and clinical practice. The number of unknowns and differences make the results unlikely to be translatable into clinical practice and will not benefit patients.
NCT04997278,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT04997369,SUSPENDED,INTERVENTIONAL,Principal Investigator changing locations.
NCT04997616,WITHDRAWN,INTERVENTIONAL,Company withdrew interest in the study
NCT04998565,TERMINATED,INTERVENTIONAL,"No grants from the Ministry of Science and Technology or school grants, no funds can be executed, so the application is terminated."
NCT04998591,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT04998734,TERMINATED,OBSERVATIONAL,Recruitment failure
NCT04998747,WITHDRAWN,INTERVENTIONAL,"Amgen Decision to stop development of AMG 701 SC, not for safety reasons but for business reasons."
NCT04999059,TERMINATED,OBSERVATIONAL,"This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue."
NCT04999488,WITHDRAWN,INTERVENTIONAL,Drug manufacturing update. Study site will proceed with study in future.
NCT04999605,TERMINATED,INTERVENTIONAL,Too low inclusion rate
NCT05000320,WITHDRAWN,OBSERVATIONAL,study never open to accrual and no subjects were enrolled
NCT05000346,TERMINATED,INTERVENTIONAL,Lack of patient to recruit
NCT05000359,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05000762,WITHDRAWN,OBSERVATIONAL,Sponsor no longer has support available.
NCT05000970,SUSPENDED,INTERVENTIONAL,funding
NCT05001022,TERMINATED,INTERVENTIONAL,ALT flares suggestive of drug induced liver injury
NCT05001360,WITHDRAWN,INTERVENTIONAL,We could not get the IRB approval.
NCT05001451,TERMINATED,INTERVENTIONAL,"This was a business decision to discontinue this clinical trial. The decision is not related to the safety of the investigational product, GDX012."
NCT05001724,TERMINATED,INTERVENTIONAL,"Because the efficacy data did not meet expectations, the sponsor decided to terminate the study."
NCT05001789,SUSPENDED,INTERVENTIONAL,"NYSPI-wide Institutional Research Pause as of June 12, 2023."
NCT05001854,SUSPENDED,INTERVENTIONAL,study suspended until new therapeutic units are available
NCT05002114,WITHDRAWN,INTERVENTIONAL,there were issues with the primary study material that prohibited continuation at this time
NCT05003102,WITHDRAWN,INTERVENTIONAL,"No enrollment, IRB closed"
NCT05003518,TERMINATED,INTERVENTIONAL,Insufficient sample size
NCT05003921,SUSPENDED,INTERVENTIONAL,Modifying Protocol
NCT05004077,TERMINATED,INTERVENTIONAL,limited enrollment
NCT05004701,TERMINATED,OBSERVATIONAL,Lack of recruitment
NCT05004870,WITHDRAWN,INTERVENTIONAL,Study objective embedded into future study
NCT05005000,WITHDRAWN,INTERVENTIONAL,Difficulties getting subjects recruited and enrolled.
NCT05005182,TERMINATED,INTERVENTIONAL,Slow accrual
NCT05005507,TERMINATED,INTERVENTIONAL,A strategic decision was made to not further execute the study. This decision was not based on a safety concern.
NCT05005936,WITHDRAWN,OBSERVATIONAL,No participants Enrolled
NCT05006248,SUSPENDED,INTERVENTIONAL,Research team and PI reviewing if study design actually captures results to address primary and secondary outcomes.
NCT05006300,WITHDRAWN,INTERVENTIONAL,Recruitment long and complicated
NCT05006417,SUSPENDED,INTERVENTIONAL,issues with supplier of strength testing equipment
NCT05006781,SUSPENDED,INTERVENTIONAL,The trial was suspended due to the budget issue
NCT05006950,TERMINATED,INTERVENTIONAL,Business/strategic reasons and low accrual rate
NCT05007769,WITHDRAWN,INTERVENTIONAL,Lost funding
NCT05007977,TERMINATED,INTERVENTIONAL,The study was completed following review of the assumptions underlying the power calculation and it was deemed that enough subjects had been recruited to complete enrollment
NCT05008328,TERMINATED,INTERVENTIONAL,Study team decided to conclude the study and report it as a feasibility study.
NCT05008445,TERMINATED,INTERVENTIONAL,company adjusted strategy
NCT05008510,WITHDRAWN,INTERVENTIONAL,Decided to halt and will potentially reopen in the future.
NCT05008835,TERMINATED,INTERVENTIONAL,Study was terminated for business reasons.
NCT05008913,TERMINATED,INTERVENTIONAL,Study terminated because the clinical development programme for Adavosertib has been discontinued
NCT05009342,TERMINATED,INTERVENTIONAL,Inclusion of patients very limited due to lack of time and human resources dedicated to research.
NCT05009485,WITHDRAWN,INTERVENTIONAL,study never started because reprioritization of clinical research efforts
NCT05009732,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT05010096,WITHDRAWN,INTERVENTIONAL,No participants Enrolled
NCT05010525,TERMINATED,INTERVENTIONAL,Based on the adjustment of clinical research and development strategysponsor decided to terminate the study
NCT05010759,TERMINATED,INTERVENTIONAL,Inadequate enrollment and company changing direction
NCT05010850,TERMINATED,INTERVENTIONAL,Voluntary and temporary suspension of enrollment.
NCT05011019,TERMINATED,INTERVENTIONAL,sponsor adjusts its research and development strategy
NCT05011032,WITHDRAWN,INTERVENTIONAL,Ethical approval was not done. Hence the funding was withhold.
NCT05011396,TERMINATED,INTERVENTIONAL,Study stopped by the sponsor for business reasons and not due to any safety concerns with PH94B
NCT05011448,TERMINATED,INTERVENTIONAL,"During the trial, feasibility testing indicated early on that major amendments would be needed so the decision was made to stop the pilot after collecting data on 4 participants."
NCT05011513,TERMINATED,INTERVENTIONAL,Enrollment ceased due to a very low rate of hospitalization or death observed in the standard-risk patient population
NCT05011838,WITHDRAWN,INTERVENTIONAL,"Due to the devasting impact of Covid-19 on Colombian health services, the execution of the study was halted shortly after all involved actors had been trained"
NCT05012280,TERMINATED,OBSERVATIONAL,"As the COVID-19 epidemic evolved, presentation of the disease changed substantially.

Due to vaccination, increased natural immunity and new variants, there is a substantial decrease in severe cases, making it difficult to recruit new patients."
NCT05012397,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05012787,TERMINATED,INTERVENTIONAL,The study was early terminated considering the inability to enroll the required study population.
NCT05013073,TERMINATED,INTERVENTIONAL,IRB approval expired
NCT05013320,WITHDRAWN,INTERVENTIONAL,We could not get the IRB approval
NCT05013385,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05013437,WITHDRAWN,INTERVENTIONAL,The original principal Investigator left the institution.
NCT05013554,TERMINATED,INTERVENTIONAL,Sponsor's decision. Termination decision unrelated to safety profile
NCT05013970,WITHDRAWN,INTERVENTIONAL,No financial agreement could be found for this study
NCT05014919,TERMINATED,INTERVENTIONAL,The study was terminated based on new efficacy data from another study.
NCT05015972,WITHDRAWN,INTERVENTIONAL,No proper participant is found.
NCT05016076,WITHDRAWN,INTERVENTIONAL,COVID outbreak in the community
NCT05016284,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05016830,TERMINATED,INTERVENTIONAL,Lock-down in the city of Santiago due to Covid-19 pandemia. Most faculty premises were closed for research purposes and mobility in the city was restricted.
NCT05016921,WITHDRAWN,INTERVENTIONAL,Alternate study pursued
NCT05016934,WITHDRAWN,INTERVENTIONAL,At collaborator's request
NCT05017233,TERMINATED,INTERVENTIONAL,"Investigational product had been released in NMPA, Sponsor decided to terminate the study aligned with investigator"
NCT05017584,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT05017597,WITHDRAWN,INTERVENTIONAL,Principal investigator left the unversity
NCT05017610,WITHDRAWN,INTERVENTIONAL,Per the PI-slow accrual
NCT05017857,WITHDRAWN,INTERVENTIONAL,Study PI is leaving the institution.
NCT05017961,WITHDRAWN,INTERVENTIONAL,Unfortunately this study didn't receive funding.
NCT05018247,TERMINATED,INTERVENTIONAL,Terminated prematurely due to closure of the PET imaging facility
NCT05018325,TERMINATED,INTERVENTIONAL,Futility
NCT05018793,SUSPENDED,INTERVENTIONAL,Covid-19
NCT05018871,SUSPENDED,INTERVENTIONAL,Covid-19
NCT05018975,WITHDRAWN,INTERVENTIONAL,FDA recommendation cited safety issues
NCT05019066,WITHDRAWN,INTERVENTIONAL,PI decided not to proceed with study.
NCT05019105,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05019170,TERMINATED,INTERVENTIONAL,Could not recruit enough patients
NCT05019677,WITHDRAWN,INTERVENTIONAL,Repeat registration
NCT05020483,WITHDRAWN,INTERVENTIONAL,Patient population changed and no subjects eligible for the study.
NCT05020665,TERMINATED,INTERVENTIONAL,Termination was due to significant challenges associated with study enrollment in a genetic subset of fit participants in the front-line acute myeloid leukemia (AML) setting and other challenges associated with post-COVID impacts.
NCT05020691,TERMINATED,OBSERVATIONAL,Availability of research team limited by clinical workload (COVID-19)
NCT05020873,TERMINATED,OBSERVATIONAL,sponsor decision
NCT05022251,TERMINATED,OBSERVATIONAL,"Diffculty recruiting patients, limited timeframe to complete project"
NCT05022329,TERMINATED,INTERVENTIONAL,"Trial participants became eligible to receive their 4th dose of the COVID-19 vaccine vaccine thus data collected from the 12 month follow-up after 3rd dose vaccine, as per current protocol, would not not be relevant to the study outcomes."
NCT05022394,WITHDRAWN,INTERVENTIONAL,No participants Enrolled
NCT05023291,TERMINATED,INTERVENTIONAL,no effective result after first 5 patients
NCT05023512,WITHDRAWN,INTERVENTIONAL,This study is not a clinical trial.
NCT05024058,TERMINATED,INTERVENTIONAL,"Phase III PEARL studies (CQGE031C2302 and CQGE031C2303) with ligelizumab met their primary endpoint of superiority vs placebo at Week 12 for treatment of CSU, but not versus omalizumab. Decision to discontinue was not based on safety concerns."
NCT05024656,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05024825,TERMINATED,INTERVENTIONAL,recruitment target not met.
NCT05024851,TERMINATED,OBSERVATIONAL,DECISION OF THE COORDINATOR
NCT05024903,TERMINATED,INTERVENTIONAL,Unable to enroll enough patients in the time allotted. Study deemed infeasible.Dece
NCT05024955,WITHDRAWN,OBSERVATIONAL,0 participants accrued
NCT05026372,TERMINATED,INTERVENTIONAL,"Participant drop out exceeded expectations (out of 63 couples randomized, 18 completed follow up). Study may be resumed with revised procedures for preventing drop out."
NCT05026502,TERMINATED,OBSERVATIONAL,Strategic considerations
NCT05026580,SUSPENDED,OBSERVATIONAL,Study halted due to unforeseen challenges in securing the necessary resources to conduct the research effectively.
NCT05026801,WITHDRAWN,INTERVENTIONAL,Inadequate support to carry out study
NCT05027178,TERMINATED,INTERVENTIONAL,The study is being reformatted and will have a different protocol for the relaunch.
NCT05027815,TERMINATED,INTERVENTIONAL,Decrease in COVID-19 cases made further enrollment infeasible.
NCT05027867,TERMINATED,INTERVENTIONAL,Unanticipated and extremely high screen failure rate. There was no evidence of safety concerns in the study.
NCT05028114,TERMINATED,INTERVENTIONAL,"Part 1 was completed, Part 2 and Part 3 of the study were not conducted under this study protocol due to subject recruitment difficulty."
NCT05028621,SUSPENDED,INTERVENTIONAL,Working on changing study vendor
NCT05028751,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05028946,WITHDRAWN,INTERVENTIONAL,For business reasons
NCT05029245,WITHDRAWN,INTERVENTIONAL,No financial budget support
NCT05029609,WITHDRAWN,INTERVENTIONAL,Withdrawn due to business reasons
NCT05029856,WITHDRAWN,INTERVENTIONAL,Study never started
NCT05029934,TERMINATED,INTERVENTIONAL,insufficient recruitment of study patients
NCT05030012,TERMINATED,INTERVENTIONAL,No path to obtain FDA approval for the legacy Precision Flow OAM.
NCT05030350,TERMINATED,INTERVENTIONAL,Study stopped by the sponsor for business reasons and not due to any safety concerns with PH94B
NCT05030532,TERMINATED,INTERVENTIONAL,In-person intervention activities halted in March 2020 due to COVID-19; follow-up data collection of active participants completed online in June 2020.
NCT05030688,WITHDRAWN,INTERVENTIONAL,No participant
NCT05031338,TERMINATED,OBSERVATIONAL,Sponsor changing database systems for ease of use for patient data collection
NCT05031481,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05032079,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT05032118,WITHDRAWN,INTERVENTIONAL,"Institution change, no IRB approval"
NCT05032352,TERMINATED,OBSERVATIONAL,"Non-safety related, reallocation of resources"
NCT05032625,TERMINATED,OBSERVATIONAL,low accrual rate
NCT05033132,WITHDRAWN,INTERVENTIONAL,Study was never initiated.
NCT05033548,TERMINATED,OBSERVATIONAL,Decision by Sponsor after careful review of study data available.
NCT05033912,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT05034562,WITHDRAWN,INTERVENTIONAL,Per PI no participants enrolled
NCT05034848,TERMINATED,INTERVENTIONAL,no practitionner
NCT05034913,TERMINATED,INTERVENTIONAL,Initial data analysis prior to full enrollment showed that concept was not valid.
NCT05034978,TERMINATED,OBSERVATIONAL,failure in enrolling eligible subjects during COVID-19 outbreaks
NCT05035368,WITHDRAWN,INTERVENTIONAL,"Domp decided to withdraw LDX0121 following an internal re-planning and an extensive review of the study design.

At the time of withdrawal, no site had been activated and the drug had not been sent to investigators. No patients had been enrolled."
NCT05035420,SUSPENDED,INTERVENTIONAL,Premature suspension of the research by the institution due to audit findings on protocol 10-CH-0198 that Dr. Gandjbakhche is the PI.
NCT05035576,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05035680,WITHDRAWN,INTERVENTIONAL,Study cancelled
NCT05035732,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT05036837,SUSPENDED,INTERVENTIONAL,DUE TO PANDEMIC CONDITIONS
NCT05037019,WITHDRAWN,INTERVENTIONAL,Surgery wait times during the COVID-19 pandemic were eventually reduced to pre-pandemic wait times. This study became irrelevant.
NCT05037188,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT05037669,WITHDRAWN,INTERVENTIONAL,No available investigational product
NCT05037734,WITHDRAWN,INTERVENTIONAL,Relaunch at later date with updated product.
NCT05038020,TERMINATED,INTERVENTIONAL,Study terminated due to safety findings in other AKST4290 studies
NCT05038371,TERMINATED,OBSERVATIONAL,The study team decided to not publish a manuscript therefore we decided to terminate the study
NCT05038384,WITHDRAWN,OBSERVATIONAL,Accrual Limit
NCT05038800,TERMINATED,INTERVENTIONAL,Business Reasons
NCT05039359,TERMINATED,INTERVENTIONAL,Limited efficacy upon blinded review
NCT05039385,WITHDRAWN,INTERVENTIONAL,not enough sample was obtained
NCT05039710,TERMINATED,INTERVENTIONAL,Business Judgement
NCT05039736,WITHDRAWN,INTERVENTIONAL,0 participants accrued
NCT05039931,WITHDRAWN,INTERVENTIONAL,"leading entity of the clinical trial was replaced, and no patients were enrolled."
NCT05039944,TERMINATED,INTERVENTIONAL,Company research strategy adjustment
NCT05040451,WITHDRAWN,OBSERVATIONAL,Lack patients and site resources for the proposed population
NCT05040568,SUSPENDED,INTERVENTIONAL,DMC Monitor Action
NCT05040776,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05040789,WITHDRAWN,INTERVENTIONAL,Further development terminated
NCT05041114,WITHDRAWN,INTERVENTIONAL,Study moved to U.S.
NCT05041751,WITHDRAWN,INTERVENTIONAL,PI Left Institution
NCT05041816,WITHDRAWN,INTERVENTIONAL,The PI resigned and the recruitment had not been started.
NCT05041972,WITHDRAWN,INTERVENTIONAL,Business strategy change
NCT05042349,WITHDRAWN,OBSERVATIONAL,no funding
NCT05042934,WITHDRAWN,INTERVENTIONAL,"PI stated trial no longer fits the framework \& portfolio of work that is prioritized by the department. PI will not have the anticipated accrual in PI view to complete the study. Given that, PI request this protocol be closed prior to its activation."
NCT05043831,WITHDRAWN,INTERVENTIONAL,Study didnt start and will be re-designed
NCT05043987,WITHDRAWN,INTERVENTIONAL,New IND sponsor to initiate a separate study
NCT05044234,TERMINATED,INTERVENTIONAL,Company Decision
NCT05044299,WITHDRAWN,INTERVENTIONAL,The project was not considered for funding so we scrapped the project.
NCT05044325,TERMINATED,INTERVENTIONAL,To allow for additional assessments from supplementary non-clinical activities.
NCT05044429,TERMINATED,INTERVENTIONAL,Lack of interest for continuing on by PI and issues with IRB
NCT05044715,TERMINATED,INTERVENTIONAL,The prevalence of CFT at the counseling center and university made it difficult during recruitment of subjects to find participants without exposure to CFT to be used as a treatment-as-usual control.
NCT05044936,WITHDRAWN,INTERVENTIONAL,"The researchers were not able to acquire funding to initiate the study. Also, the study was not approved by the local IRB which requested a FDA new drug application."
NCT05045092,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT05045404,WITHDRAWN,INTERVENTIONAL,"Study closed due to funding, 0 patient accrual."
NCT05045703,WITHDRAWN,INTERVENTIONAL,PI left the institution
NCT05046327,WITHDRAWN,INTERVENTIONAL,Corporate Decision
NCT05046353,SUSPENDED,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. NKI site will reopen pending transfer of IRB protocol."
NCT05047302,WITHDRAWN,INTERVENTIONAL,Project suspended by sponsor
NCT05047523,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the program
NCT05047640,TERMINATED,INTERVENTIONAL,Difficulty in recruitment
NCT05047679,TERMINATED,INTERVENTIONAL,Recruitment issues that could not be resolved in a timely manner.
NCT05048381,WITHDRAWN,OBSERVATIONAL,Technical challenges during lab sweat analysis lead to run out of funding
NCT05048511,WITHDRAWN,OBSERVATIONAL,The project was abandoned because of a lot of publications on the subject in the meantime and it was not considered relevant to continue.
NCT05048940,WITHDRAWN,INTERVENTIONAL,The health authority indicates that the official vaccination schedule differs from that described in the protocol.
NCT05049096,TERMINATED,INTERVENTIONAL,"Till interim analysis, 100 cases were enrolled, 71 of which during the COVID-19. Affected by epidemic control policy, 58 cases had examination window exceeded or missed, causing significant impact on endpoints, so we decided to terminate the trial."
NCT05049161,TERMINATED,INTERVENTIONAL,Drug product unavailability
NCT05049629,TERMINATED,INTERVENTIONAL,Medical device expired
NCT05049642,TERMINATED,INTERVENTIONAL,Medical device expired
NCT05049720,WITHDRAWN,INTERVENTIONAL,The NCT posting for the study has been transferred to NCT04060680
NCT05050006,TERMINATED,INTERVENTIONAL,Business Decision
NCT05050123,TERMINATED,INTERVENTIONAL,Study stopped due to lack of personnel and budget.
NCT05050721,WITHDRAWN,OBSERVATIONAL,PI decided to stop the study
NCT05051150,TERMINATED,INTERVENTIONAL,tachycardia and arrhythmia in the high doses groups 0.05 and 0.07 necessitate stopping the infusion
NCT05051228,SUSPENDED,OBSERVATIONAL,Resourcing
NCT05051293,WITHDRAWN,OBSERVATIONAL,Study will be changed from prospective to retrospective
NCT05051449,TERMINATED,INTERVENTIONAL,Study funds were exhausted
NCT05051774,SUSPENDED,INTERVENTIONAL,The study had been suspended last year due to COVID-19 pandemic.
NCT05051800,TERMINATED,INTERVENTIONAL,Recruitment of participants was interrupted by the COVID-19 pandemic and the funding for the study ended before the targeted enrollment could be completed.
NCT05052372,TERMINATED,OBSERVATIONAL,Sponsor request to terminate study due to enrollment numbers
NCT05052554,WITHDRAWN,INTERVENTIONAL,No patients
NCT05052645,WITHDRAWN,INTERVENTIONAL,investigators have limited availability
NCT05053035,TERMINATED,INTERVENTIONAL,"The Sponsor is considering a subsequent study in ALS, potentially with different inclusion/exclusion criteria."
NCT05053269,WITHDRAWN,OBSERVATIONAL,none was included
NCT05053308,WITHDRAWN,INTERVENTIONAL,The supply of IP is disrupted
NCT05053789,TERMINATED,INTERVENTIONAL,Medical device expired
NCT05054101,WITHDRAWN,INTERVENTIONAL,Unresolved issues between research partners (research has not started)
NCT05054400,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT05054491,TERMINATED,INTERVENTIONAL,We are not able to continue the study as there is conflict in the study area that prevents women from gathering for group antenatal care. It is also not safe for data collectors to collect data in the study sites.
NCT05054595,WITHDRAWN,INTERVENTIONAL,Lack of provider bandwidth
NCT05055050,SUSPENDED,INTERVENTIONAL,Interim Analysis
NCT05055258,TERMINATED,INTERVENTIONAL,Terminated by Sponsor due to adverse events reported
NCT05055336,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institution.
NCT05055817,WITHDRAWN,OBSERVATIONAL,no participants were included
NCT05055921,TERMINATED,INTERVENTIONAL,Sponsor ceased operations
NCT05056103,TERMINATED,INTERVENTIONAL,Lack of financial support
NCT05056727,TERMINATED,INTERVENTIONAL,The study started enrollment in Sep 2021 and despite huge efforts the rate of patient enrollment continued to be below target such that the completion of the study within a reasonable timeframe was deemed very unlikely.
NCT05056779,WITHDRAWN,INTERVENTIONAL,The study data will not be utilized in the IND and is only being conducted in EU.
NCT05056805,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT05056909,WITHDRAWN,INTERVENTIONAL,funding refused
NCT05057026,TERMINATED,OBSERVATIONAL,Substantial efforts to engage participants in the evaluations was unsuccessful.
NCT05057221,TERMINATED,INTERVENTIONAL,No more eligible patients were available.
NCT05057273,WITHDRAWN,INTERVENTIONAL,Decision by Landos Biopharma (not related to safety or efficacy)
NCT05057793,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT05057897,TERMINATED,INTERVENTIONAL,Removal of the commitment for Immune compromised study (D81111C00010) due to recruitment challenges.
NCT05058950,TERMINATED,OBSERVATIONAL,Study was terminated early as part of Biogen's ongoing research and development portfolio management efforts.
NCT05059080,TERMINATED,OBSERVATIONAL,Based on program revaluation and in agreement with the co-development partner the sponsor took the decision to terminate this study.
NCT05059717,WITHDRAWN,INTERVENTIONAL,Overall Recruitment Status Withdrawn no participants
NCT05059938,WITHDRAWN,INTERVENTIONAL,Investigator changed positions
NCT05060003,TERMINATED,INTERVENTIONAL,Sponsor made decision to terminate study.
NCT05060276,WITHDRAWN,INTERVENTIONAL,Protocol changed to Phase 2
NCT05060653,WITHDRAWN,INTERVENTIONAL,Alternative study was set up
NCT05060965,WITHDRAWN,INTERVENTIONAL,No Enrollees
NCT05060978,TERMINATED,INTERVENTIONAL,"Due to the retention of 78.1% of the participants obtained for the first measurement (after the December holidays), we believe that waiting one more year to complete the study would not be feasible for a subsequent definitive study."
NCT05061251,WITHDRAWN,INTERVENTIONAL,Drug availability
NCT05061277,WITHDRAWN,INTERVENTIONAL,Pfizer has decided to cancel study C4181006 due to strategic considerations. This decision is not due to any specific reasons or requests from any regulatory authorities. No participants have been enrolled in this study.
NCT05061537,TERMINATED,INTERVENTIONAL,The study was terminated by the Sponsor due to business decision and not due to any safety concerns with PF-07263689. There are no changes to the risk-benefit for participants who have received PF-07263689 in the study.
NCT05061654,WITHDRAWN,INTERVENTIONAL,Administrative constraints
NCT05061758,WITHDRAWN,INTERVENTIONAL,Study put on hold
NCT05061771,WITHDRAWN,INTERVENTIONAL,Akari has decided to discontinue AK802 study due to strategic resource allocation decisions.
NCT05061940,TERMINATED,OBSERVATIONAL,Development program terminated
NCT05062148,WITHDRAWN,INTERVENTIONAL,Research never commenced and will not be pursued as a viable opportunity at this time.
NCT05062174,WITHDRAWN,OBSERVATIONAL,PI decision to cancel research
NCT05062473,WITHDRAWN,INTERVENTIONAL,Low accrual
NCT05062512,TERMINATED,OBSERVATIONAL,Funding not renewed.
NCT05062577,WITHDRAWN,INTERVENTIONAL,Due to corporate strategic considerations
NCT05062720,WITHDRAWN,INTERVENTIONAL,Study is being closed due to lack of accrual
NCT05063123,WITHDRAWN,INTERVENTIONAL,Withdrawal of MacroGenics (pharmaceutical company)
NCT05063357,WITHDRAWN,INTERVENTIONAL,Corporate business decision. Not due to safety or efficacy concerns.
NCT05063604,TERMINATED,INTERVENTIONAL,The CAMAD clinical trial has been terminated due to difficulties in recruiting patients.
NCT05063734,TERMINATED,INTERVENTIONAL,"Based on data obtained in Part A, there was insufficient evidence of efficacy on the key outcome measures. As a result, the study was not advanced to Part B."
NCT05064111,SUSPENDED,OBSERVATIONAL,"Per email from PI, the project start is on suspension."
NCT05065164,WITHDRAWN,INTERVENTIONAL,no partcipants enrolled
NCT05065411,TERMINATED,INTERVENTIONAL,Business decision
NCT05065437,WITHDRAWN,INTERVENTIONAL,No IRB application has been prepared for this study and other studies have taken priority. The study team will not be working on this study for the foreseeable future.
NCT05065463,TERMINATED,INTERVENTIONAL,A decision has been taken to discontinue the development of AZD8233 (PCSK9-ASO for sc administration) due to low likelihood of demonstrating a benefit significantly above the current standard of care for patients with high-risk hypercholesterolemia.
NCT05065528,WITHDRAWN,INTERVENTIONAL,Did not recruit any participants
NCT05065567,TERMINATED,INTERVENTIONAL,"Lost too many patients to follow up, unable to enroll enough patients"
NCT05065619,TERMINATED,INTERVENTIONAL,Public vaccination of approved ancestral strain COVID-19 vaccines will be terminated soon. And boosters must be dosed after ancestral vaccination approved in Japan. The study was terminated for ethical reason to prioritize the ancestral vaccination.
NCT05066100,WITHDRAWN,INTERVENTIONAL,This study was not started due to administrative considerations.
NCT05066165,TERMINATED,INTERVENTIONAL,Pivoting to an allogeneic version of this program currently in preclinical development.
NCT05066230,TERMINATED,INTERVENTIONAL,All patients completed the primary endpoint assessments. Additional follow-up after the primary endpoint was deemed not necessary by the Sponsor.
NCT05066321,TERMINATED,INTERVENTIONAL,Study suspended due to lack of subsequent funding to support the work.
NCT05066698,TERMINATED,INTERVENTIONAL,Sponsor undergoing financial hardships - no longer able to support trial; no safety concerns.
NCT05066776,TERMINATED,OBSERVATIONAL,Withdrawal by sponsor
NCT05066906,WITHDRAWN,INTERVENTIONAL,Change in lab priority
NCT05066919,WITHDRAWN,INTERVENTIONAL,Due to local changes in patient up-take after COVID it is no longer possible to conduct the study.
NCT05067257,SUSPENDED,INTERVENTIONAL,Sorrento Therapeutics filed for chapter 11 bankruptcy.
NCT05067322,TERMINATED,INTERVENTIONAL,Low enrollment at the site.
NCT05067946,WITHDRAWN,INTERVENTIONAL,Change of development strategy in consideration of the global COVID-19 situation
NCT05067972,TERMINATED,INTERVENTIONAL,Pfizer has made an internal business decision to not continue further development of PF-07260437. This decision was not due to major safety concerns or requests from any regulatory authorities.
NCT05068284,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT05068479,TERMINATED,INTERVENTIONAL,Study terminated early to pursue Gen II laser advancements
NCT05069636,WITHDRAWN,INTERVENTIONAL,The Principal Investigator left Rowan University School of Osteopathic Medicine.
NCT05069935,TERMINATED,INTERVENTIONAL,This study was terminated by the Sponsor.
NCT05069961,WITHDRAWN,INTERVENTIONAL,Study was closed with IRB as PI wants to design the protocol extensively.
NCT05070104,WITHDRAWN,INTERVENTIONAL,no funding
NCT05070130,TERMINATED,OBSERVATIONAL,Slow enrollment
NCT05070533,WITHDRAWN,INTERVENTIONAL,Because of Covid19
NCT05070728,TERMINATED,INTERVENTIONAL,No longer pursuing indication
NCT05070741,TERMINATED,INTERVENTIONAL,Difficulties with study recruitment in target population. Subjects who were enrolled completed study activities.
NCT05071183,TERMINATED,INTERVENTIONAL,Inability to achieve and optimize a dose that could provide a positive benefit risk profile
NCT05071846,WITHDRAWN,INTERVENTIONAL,Revision of clinical development strategy
NCT05072158,TERMINATED,OBSERVATIONAL,PI has confirmed this is not a clinical trial and was entered in error in the system.
NCT05072912,TERMINATED,OBSERVATIONAL,Enrollment
NCT05073484,TERMINATED,INTERVENTIONAL,"Based on the disclosed global research data on the same target drugs, the company has carefully considered and decided to terminate the project to optimize the existing research pipeline."
NCT05073562,WITHDRAWN,INTERVENTIONAL,Change in funding availability
NCT05073809,WITHDRAWN,OBSERVATIONAL,Research Fellow left Trust.
NCT05073822,WITHDRAWN,INTERVENTIONAL,Funding not secured
NCT05074394,WITHDRAWN,INTERVENTIONAL,to be replaced with a different protocol
NCT05074433,TERMINATED,INTERVENTIONAL,Emerging SARS-CoV2 variants impacting susceptibility to study drug
NCT05074992,TERMINATED,INTERVENTIONAL,Support withdrawn from drug company supplying IMP
NCT05075382,WITHDRAWN,OBSERVATIONAL,A new version of the study will be submitted
NCT05075486,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05075538,TERMINATED,INTERVENTIONAL,The population as defined by the inclusion/exclusion criteria and the study logistics were leading to a poor recruitment over the past years.
NCT05075902,SUSPENDED,INTERVENTIONAL,COVID19
NCT05077085,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT05077423,TERMINATED,INTERVENTIONAL,Study terminated due to business priorities
NCT05077956,WITHDRAWN,OBSERVATIONAL,No participants were enrolled before closing the study
NCT05077969,TERMINATED,INTERVENTIONAL,Low recruitment
NCT05078437,TERMINATED,INTERVENTIONAL,Funding ended
NCT05079126,TERMINATED,INTERVENTIONAL,"Due to, among other things, positive results from the 200-302 trial, the trial has been terminated early. Resources shifted to new 200-208 GBM trial using information gained from 200-302."
NCT05079360,WITHDRAWN,INTERVENTIONAL,Decided to halt and will potentially reopen in the future.
NCT05079451,WITHDRAWN,INTERVENTIONAL,Protocol Withdrawal
NCT05079568,SUSPENDED,INTERVENTIONAL,Pending funding
NCT05079789,TERMINATED,INTERVENTIONAL,Low recruiting rate and decision to evaluate as pilot study
NCT05079906,WITHDRAWN,INTERVENTIONAL,Withdrawn due to timing
NCT05080296,SUSPENDED,OBSERVATIONAL,retrospective study
NCT05080621,WITHDRAWN,INTERVENTIONAL,The Sponsor decided to discontinue this study due to a corporate restructuring intended to prioritize clinical development of select programs. No patients enrolled in this study and no patients received investigational product.
NCT05080751,TERMINATED,INTERVENTIONAL,"O estudo foi encerrado pois no foi atingido o nmero de participantes, de acordo com o clculo amostral."
NCT05080842,TERMINATED,INTERVENTIONAL,Voluntarily terminate the study since the sponsor's development strategy was adjusted.
NCT05080881,WITHDRAWN,INTERVENTIONAL,Sponsor decided to close the study.
NCT05081232,WITHDRAWN,INTERVENTIONAL,Study will not be conducted
NCT05081271,TERMINATED,INTERVENTIONAL,Most potential participants had already received their booster vaccinations outside of the study
NCT05081375,TERMINATED,INTERVENTIONAL,PI left the institution
NCT05081388,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05081518,TERMINATED,INTERVENTIONAL,The study was terminated due to enrolment challenges
NCT05081739,WITHDRAWN,INTERVENTIONAL,Sponsor made decision to pause study while it was still in development phase. The FDA and IRB approval process had not been completed. No sites were activated. No subjects had been recruited for this study.
NCT05081752,WITHDRAWN,INTERVENTIONAL,Difficulties in recruiting and lack of interest from care providers.
NCT05082103,TERMINATED,INTERVENTIONAL,The study was terminated after interim data analysis
NCT05082129,WITHDRAWN,INTERVENTIONAL,"due to the impact of the COVID19 pandemic on MRI service provision, NHS hospitals were unable to provide the resources to conduct the study"
NCT05082155,WITHDRAWN,INTERVENTIONAL,surgeons stopped doing procedures
NCT05082480,TERMINATED,INTERVENTIONAL,poor enrollment
NCT05082571,SUSPENDED,INTERVENTIONAL,Recruitment temporarily halted to reassess the development plan.
NCT05082584,SUSPENDED,INTERVENTIONAL,Recruitment temporarily halted to reassess the development plan.
NCT05082831,TERMINATED,INTERVENTIONAL,Difficulty in enrollment
NCT05082844,WITHDRAWN,INTERVENTIONAL,Institutional research funds needed to perform imaging examinations under the study protocol have expired due to organizational issues
NCT05083078,TERMINATED,INTERVENTIONAL,The study was stopped due to unanticipated feasibility constraints.
NCT05083117,WITHDRAWN,INTERVENTIONAL,Difficulty in COVID-19 subject enrollment
NCT05084274,TERMINATED,INTERVENTIONAL,Co-investigators have left and not been replaced.
NCT05084391,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT05084456,WITHDRAWN,INTERVENTIONAL,Pending further development
NCT05084560,TERMINATED,INTERVENTIONAL,Safety issues
NCT05084755,TERMINATED,OBSERVATIONAL,"In Japan, the government purchases VAXZEVRIA and distributes it to medical institutions. Based on Japan VAXZEVRIA vaccination plan, the last vaccination day was Sep. 30, 2022. So it was difficult to continue this study."
NCT05085002,TERMINATED,INTERVENTIONAL,The study is being closed based on corporate changes at EQRx and is not related to any efficacy or safety issues with lerociclib.
NCT05085080,WITHDRAWN,OBSERVATIONAL,lack of funding
NCT05085379,WITHDRAWN,OBSERVATIONAL,No Subjects enrolled
NCT05085574,WITHDRAWN,INTERVENTIONAL,"COVID environment, lack of site confidence to enroll subjects, sites not suited to study procedures, decline of potential inpatient subjects at site"
NCT05085964,TERMINATED,INTERVENTIONAL,The sponsor decided to terminate the study early
NCT05086120,TERMINATED,INTERVENTIONAL,Low enrollment
NCT05086835,TERMINATED,INTERVENTIONAL,Study ended prematurely due to PI departing institution for another position.
NCT05087329,SUSPENDED,INTERVENTIONAL,to review recruitment strategies
NCT05087472,WITHDRAWN,OBSERVATIONAL,Could not obtain MINI licence
NCT05087524,TERMINATED,INTERVENTIONAL,changes in in-person schooling per COVID-19 pandemic
NCT05087563,TERMINATED,INTERVENTIONAL,New evidence warranted a change in the study design and study population group (inclusion/ exclusion criterion). We completed another clinical trial focused on subjects with headache symptoms but this particular clinical trial was terminated.
NCT05087771,WITHDRAWN,INTERVENTIONAL,"no longer randomized, drug being offered to all patients"
NCT05087914,WITHDRAWN,INTERVENTIONAL,"Study was not started, therefore recruitment did not happen"
NCT05088447,TERMINATED,OBSERVATIONAL,Change in research plan
NCT05088668,SUSPENDED,INTERVENTIONAL,Logistic issues
NCT05088967,TERMINATED,INTERVENTIONAL,Development strategy adjustment
NCT05089461,SUSPENDED,INTERVENTIONAL,sponsor decided to stop
NCT05089682,TERMINATED,INTERVENTIONAL,Unable to enroll subjects due to COVID and complexity of study.
NCT05090722,SUSPENDED,INTERVENTIONAL,Principal Investigator changing locations.
NCT05090787,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT05091060,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05091528,TERMINATED,INTERVENTIONAL,Sponsor decision based on strategic re-alignment
NCT05092581,TERMINATED,INTERVENTIONAL,Emerging SARS-CoV-2 variants impacting susceptibility to study drug
NCT05092646,TERMINATED,INTERVENTIONAL,Study stopped due to lack of enrollment
NCT05092750,WITHDRAWN,INTERVENTIONAL,0 accrual
NCT05093166,SUSPENDED,INTERVENTIONAL,Due to the current re-organization at the Sponsor site
NCT05093244,WITHDRAWN,INTERVENTIONAL,Business decision to terminate study.
NCT05093387,WITHDRAWN,INTERVENTIONAL,funding issues and pharmacy preparation for the drug
NCT05093504,TERMINATED,INTERVENTIONAL,Sponsor's decision for business reasons.
NCT05093517,SUSPENDED,INTERVENTIONAL,"Temporarily closed to enrollment, pending funding"
NCT05093556,TERMINATED,INTERVENTIONAL,Change in vendor security protocols would have necessitated changing platforms and rebuilding entire IVR platform which would have delayed patient recruitment and introduced heterogeneity across subjects using current and new platforms
NCT05093608,TERMINATED,INTERVENTIONAL,Loss of funding
NCT05093712,WITHDRAWN,OBSERVATIONAL,Due to the limited resources and staffing needed in order to run the trial.
NCT05093868,WITHDRAWN,INTERVENTIONAL,Required equipment could not be obtained
NCT05093894,WITHDRAWN,INTERVENTIONAL,PI decided not to continue study due to no funding.
NCT05094401,TERMINATED,INTERVENTIONAL,Sponsor/Investigator Decision
NCT05094583,SUSPENDED,OBSERVATIONAL,Suspended due to COVID19 pandemic.
NCT05094934,TERMINATED,INTERVENTIONAL,Business decision
NCT05095038,TERMINATED,INTERVENTIONAL,The collaborator providing funding for the study has suspended the payment
NCT05095246,WITHDRAWN,INTERVENTIONAL,"Pandemic, logistical, and recruitment challenges"
NCT05095311,TERMINATED,INTERVENTIONAL,The recruited population was no longer made available to participate in the study.
NCT05095623,TERMINATED,OBSERVATIONAL,enrollment
NCT05095961,WITHDRAWN,INTERVENTIONAL,Technical difficulties encountered with recording intraoperative blood loss; unable to proceed with study.
NCT05096130,WITHDRAWN,INTERVENTIONAL,Recruitment difficulties
NCT05096403,SUSPENDED,INTERVENTIONAL,decreased medical need impacting recruitment
NCT05096572,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT05096884,TERMINATED,INTERVENTIONAL,Low accrual
NCT05096949,TERMINATED,INTERVENTIONAL,Insufficient enrollment.
NCT05097040,WITHDRAWN,INTERVENTIONAL,The research team decided not to implement this study.
NCT05097131,TERMINATED,OBSERVATIONAL,"As a result of the national policy for coverage, it is expected there will be limited aducanumab-avwa prescription and usage in routine clinical practice making the study not feasible for enrollment."
NCT05097729,WITHDRAWN,INTERVENTIONAL,Preliminary data in chronic back pain patients showed no benefits of the treatment; we did not further pursue the same treatment in osteoarthritis patients.
NCT05098145,WITHDRAWN,INTERVENTIONAL,all clinical development programs terminated by sponsor
NCT05098327,WITHDRAWN,INTERVENTIONAL,no participant enrolled due to lack of interest.
NCT05098405,TERMINATED,INTERVENTIONAL,"After completion of the dose-escalation part of the study, the safety profile of MP0317 in monotherapy is considered adequately characterized in the dose-escalation part of the study."
NCT05098457,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05098509,TERMINATED,INTERVENTIONAL,"Due to a change in corporate priorities, this study was voluntarily terminated by the Sponsor for reasons other than safety"
NCT05099003,SUSPENDED,INTERVENTIONAL,Other - Transition of Pre-Screening (Step 0) process
NCT05099536,WITHDRAWN,INTERVENTIONAL,Company's decision
NCT05099549,TERMINATED,INTERVENTIONAL,Affimed and NKGen have mutually decided to discontinue the study. Affimed will evaluate the best options to advance this project with an allogeneic off-the-shelf NK cell product while NKGen will focus on CNS with SNK01.
NCT05099822,TERMINATED,INTERVENTIONAL,Business objectives changed.
NCT05099926,TERMINATED,INTERVENTIONAL,Halted Prematurely
NCT05099952,WITHDRAWN,INTERVENTIONAL,PI left institute-no accruals
NCT05100160,WITHDRAWN,INTERVENTIONAL,0 patient accrual
NCT05100316,TERMINATED,INTERVENTIONAL,Trial terminated due to feasibility reasons
NCT05100628,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT05100901,TERMINATED,INTERVENTIONAL,Adolescent cohort will be conducted as separate trial
NCT05100927,WITHDRAWN,OBSERVATIONAL,PI is leaving the Penn State
NCT05101330,WITHDRAWN,INTERVENTIONAL,"Recruitment was challenging, and no participants were recruited after 6 months despite minimizing these challenges. Therefore the study team has decided not to pursue this study any further."
NCT05101447,WITHDRAWN,INTERVENTIONAL,funding not secured
NCT05101616,SUSPENDED,INTERVENTIONAL,difficult in enrolling participants
NCT05101668,TERMINATED,INTERVENTIONAL,"According to the Medical Device Classification Catalogue issued by the NMPA in 2022, the registration path of intracranial aspiration catheter is clinical evaluation, and clinical trials are not required."
NCT05102071,WITHDRAWN,OBSERVATIONAL,Study was canceled because database sample size was inadequate.
NCT05102162,TERMINATED,INTERVENTIONAL,Low recruitment.
NCT05102331,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT05102461,WITHDRAWN,INTERVENTIONAL,It wasn't approved for using Florajen as a dietary supplement and the supplier did not support the application for an IND
NCT05103722,TERMINATED,INTERVENTIONAL,Study terminated due to lack of funding
NCT05103826,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT05104229,WITHDRAWN,INTERVENTIONAL,Limited Resources
NCT05104268,WITHDRAWN,INTERVENTIONAL,Unable to recruit due to the relatively infrequent occurrence of oral mucositis
NCT05104840,TERMINATED,OBSERVATIONAL,the company is liquidated
NCT05104905,WITHDRAWN,INTERVENTIONAL,"Since no patients have been enrolled in RENACOL, and safety and tolerability data is rapidly accumulating in another ongoing study, sponsor considered that RENACOL study is no longer needed to assess the safety profile of bexmarilimab"
NCT05105061,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT05105191,TERMINATED,INTERVENTIONAL,COVID-19 pandemic introduced a confusion bias
NCT05105477,TERMINATED,INTERVENTIONAL,Halted prematurely; voluntarily discontinuation of trial as study specific protocol not followed during data collection
NCT05105568,TERMINATED,INTERVENTIONAL,PI moved to different institution and continuing was not feasible.
NCT05106335,TERMINATED,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT05106413,TERMINATED,INTERVENTIONAL,This clinical trial has been early terminated due to recruiting issues of the calculated sample size.
NCT05107427,WITHDRAWN,INTERVENTIONAL,Sponsor unable to proceed
NCT05107661,TERMINATED,OBSERVATIONAL,Preliminary findings revealed to many barriers to successfully complete this trial.
NCT05107791,WITHDRAWN,INTERVENTIONAL,unable to attend the drug for study
NCT05107856,TERMINATED,INTERVENTIONAL,Company Decision
NCT05107947,SUSPENDED,INTERVENTIONAL,Lack of resources
NCT05108363,WITHDRAWN,INTERVENTIONAL,no funding
NCT05109052,WITHDRAWN,INTERVENTIONAL,no accrual of eligible participants
NCT05109195,TERMINATED,OBSERVATIONAL,due to business reasons.
NCT05109650,TERMINATED,INTERVENTIONAL,"Considering that the high budget will affect the subsequent development, it is decided to terminate the test voluntarily"
NCT05109754,SUSPENDED,INTERVENTIONAL,Devices not available
NCT05110300,TERMINATED,INTERVENTIONAL,"Interim analysis showed that there was no added benefit to participants, so recruitment was terminated for patient safety."
NCT05110599,TERMINATED,INTERVENTIONAL,Slow recruitment and expired study medication.
NCT05110651,WITHDRAWN,INTERVENTIONAL,No funding
NCT05110781,TERMINATED,INTERVENTIONAL,Slow accrual
NCT05111002,TERMINATED,INTERVENTIONAL,At Sponsor Request
NCT05111054,SUSPENDED,INTERVENTIONAL,Time availability within PhD studentship
NCT05111314,WITHDRAWN,INTERVENTIONAL,PI requested
NCT05112575,TERMINATED,OBSERVATIONAL,Failed resources.
NCT05112731,TERMINATED,OBSERVATIONAL,Missing enrollment at study centre
NCT05112757,TERMINATED,INTERVENTIONAL,Very low recruitment success and all recruitment options were exhausted
NCT05112835,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT05112874,WITHDRAWN,OBSERVATIONAL,Flu season over.
NCT05113901,TERMINATED,INTERVENTIONAL,"Extremely low participation, decided to focus on similar study instead"
NCT05114083,WITHDRAWN,OBSERVATIONAL,personnel redeployment
NCT05114460,SUSPENDED,INTERVENTIONAL,"The U.S. Department of Health and Human Services Office of Human Research Protections issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023."
NCT05115019,WITHDRAWN,INTERVENTIONAL,Decrease of incidence and severity of COVID and availability of therapeutic alternatives
NCT05115838,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT05116046,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy at any of the tested doses on 18th November 2022. The decision to terminate the study is not related to a safety concern.
NCT05116228,TERMINATED,INTERVENTIONAL,Failure to recruit
NCT05116267,WITHDRAWN,OBSERVATIONAL,Protocol is not feasible based on the available hospital records
NCT05116618,WITHDRAWN,OBSERVATIONAL,Cancelled by Sponsor
NCT05116683,TERMINATED,INTERVENTIONAL,Study terminated by PI
NCT05116774,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05116787,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05116800,WITHDRAWN,INTERVENTIONAL,IND withdrawn
NCT05116878,TERMINATED,INTERVENTIONAL,Lack of Funding.
NCT05116969,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew submission to Human Research Ethics Committee as it evaluates the need for healthy volunteer data for development plan.
NCT05117502,TERMINATED,INTERVENTIONAL,PI Retirement
NCT05117736,TERMINATED,INTERVENTIONAL,The trial was prematurely terminated due to safety concerns.
NCT05118048,TERMINATED,OBSERVATIONAL,Patient recruitment too slowly
NCT05118074,SUSPENDED,OBSERVATIONAL,Protocol will be further developed
NCT05118360,WITHDRAWN,INTERVENTIONAL,This study has been cancelled due to business reasons
NCT05118620,WITHDRAWN,INTERVENTIONAL,Lack of staff to enroll
NCT05118763,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05118867,SUSPENDED,INTERVENTIONAL,To update technology based on feedback from participants
NCT05119400,TERMINATED,OBSERVATIONAL,Unable to recruit staff or funding to complete the study
NCT05119439,TERMINATED,INTERVENTIONAL,Enrollment
NCT05119712,WITHDRAWN,INTERVENTIONAL,Study stopped due to poor recruitment.
NCT05119894,WITHDRAWN,INTERVENTIONAL,Sponsor decision:Change the Development plan
NCT05120375,TERMINATED,INTERVENTIONAL,"Based on the disclosed global research data on the same target drugs, the company has carefully considered and decided to terminate the project to optimize the existing research pipeline."
NCT05120622,WITHDRAWN,INTERVENTIONAL,Withdrawal of funding
NCT05120674,TERMINATED,INTERVENTIONAL,Study interrupted due to COVID-19 and then investigator changed institutions
NCT05120765,WITHDRAWN,INTERVENTIONAL,Change in study design was implemented and the study design no longer follows a pilot randomized controlled trial.
NCT05120986,WITHDRAWN,OBSERVATIONAL,Novartis Farma - Produtos Farmaceuticos S.A. no longer commercializes the product.
NCT05121402,WITHDRAWN,INTERVENTIONAL,Decisions made by senior management of the company
NCT05121493,SUSPENDED,INTERVENTIONAL,the trial is on hold due to clinical trials staffing shortages.
NCT05121766,TERMINATED,INTERVENTIONAL,Challenges in enrollment
NCT05121948,TERMINATED,INTERVENTIONAL,sponsor decision
NCT05122182,TERMINATED,INTERVENTIONAL,Withdrawal of funding support from the trial funder.
NCT05123235,SUSPENDED,INTERVENTIONAL,After starting to recruit it became apparent that the participants did not want to participate in a telehealth intervention.
NCT05123508,WITHDRAWN,INTERVENTIONAL,No subjects enrolled
NCT05124210,TERMINATED,INTERVENTIONAL,Decrease in in-vitro neutralization of study drug against circulating SARS-CoV-2 variants
NCT05124405,SUSPENDED,INTERVENTIONAL,PI request
NCT05124496,SUSPENDED,OBSERVATIONAL,Collected sufficient samples for analysis
NCT05124561,WITHDRAWN,INTERVENTIONAL,The trial protocol was not approved by the regulatory authorities.
NCT05124574,TERMINATED,OBSERVATIONAL,No cases of COVID recorded in maternity wards since April 2022
NCT05124691,TERMINATED,INTERVENTIONAL,Primary Endpoint met
NCT05124743,SUSPENDED,OBSERVATIONAL,Screening for HLA combined in TCR001-201 study amendment 4
NCT05124795,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT05125068,TERMINATED,INTERVENTIONAL,An administrative decision was made to terminate the AT-1501-N205 study. This voluntary business-related decision was not related to the safety of tegoprubart (AT-1501). Available safety data demonstrated tegoprubart to be safe and well tolerated.
NCT05125562,WITHDRAWN,INTERVENTIONAL,Sponsor has withdrawn/closed the IND with the FDA. A letter dated 21NOV2022 was submitted to the FDA.
NCT05125679,TERMINATED,INTERVENTIONAL,Terminated (A strategic decision was made not to further execute the study. This decision was not based on a safety concern)
NCT05125783,TERMINATED,OBSERVATIONAL,Recruitment difficulties
NCT05125978,WITHDRAWN,INTERVENTIONAL,Strategy review
NCT05126303,TERMINATED,INTERVENTIONAL,Enrollment discontinued following DMC recommendation based on futility with regards to primary endpoint
NCT05126329,TERMINATED,INTERVENTIONAL,"Sponsor decision to prematurely stop the study, not linked to any safety concern"
NCT05126615,TERMINATED,INTERVENTIONAL,difficulty of recruitment
NCT05126966,WITHDRAWN,INTERVENTIONAL,Roche/Genentech has initiated an immediate pause of all new PDS implantations because the implants from commercial supply in the clinical studies did not meet the filed specifications for the intended use
NCT05127525,TERMINATED,INTERVENTIONAL,Adverse event
NCT05127681,TERMINATED,INTERVENTIONAL,More Hardware
NCT05127811,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT05127863,TERMINATED,INTERVENTIONAL,The study is completed
NCT05128344,WITHDRAWN,INTERVENTIONAL,Strategic decision
NCT05128513,SUSPENDED,INTERVENTIONAL,Funding issues from sponsors
NCT05128539,TERMINATED,INTERVENTIONAL,"The regimen of JS002 75\~300mg Q3W has been completed, and the combination therapy is well tolerated and safe. However, considering that the efficacy did not reach the preset, it is recommended to terminate the trial in advance."
NCT05128656,WITHDRAWN,INTERVENTIONAL,Authorization denied by Ethical Comitee
NCT05128682,TERMINATED,INTERVENTIONAL,"This is an early feasibility study. After the first 4 patients completed study activities, the investigator determined that this protocol is not the best way to test the study hypothesis."
NCT05128773,TERMINATED,INTERVENTIONAL,"Sponsor decision to prematurely stop the study, not linked to any safety concern"
NCT05129163,TERMINATED,INTERVENTIONAL,"Due to the impacts of COVID-19, the study had to terminate."
NCT05129254,WITHDRAWN,INTERVENTIONAL,Study not initiated.
NCT05129280,TERMINATED,INTERVENTIONAL,The study was terminated due to program discontinuation.
NCT05129306,WITHDRAWN,OBSERVATIONAL,Difficulty recruiting participants with current strategy
NCT05129332,WITHDRAWN,INTERVENTIONAL,study was stopped as Fellow was unable to committ to enrollment and study due to time constraints
NCT05129384,TERMINATED,INTERVENTIONAL,Company pursuing other research paths
NCT05129423,WITHDRAWN,INTERVENTIONAL,Development of MTPS9579A was terminated for strategic/business reasons.
NCT05129449,TERMINATED,OBSERVATIONAL,PowerSpiral device recall.
NCT05130086,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT05130346,WITHDRAWN,INTERVENTIONAL,The study is being withdrawn due to difficulties enrolling participants and the loss of the study coordinator
NCT05130775,WITHDRAWN,OBSERVATIONAL,The study was stopped due to non availability of sample for data collection
NCT05131204,TERMINATED,INTERVENTIONAL,Sponsor decision not related to efficacy or safety.
NCT05131230,WITHDRAWN,OBSERVATIONAL,No patients enrolled
NCT05132569,TERMINATED,INTERVENTIONAL,For strategic reasons the Tolebrutinib MG study has been terminated
NCT05132803,WITHDRAWN,INTERVENTIONAL,The study team decided not to move forward with the study.
NCT05133128,TERMINATED,INTERVENTIONAL,Decision of promotor
NCT05133141,TERMINATED,OBSERVATIONAL,This clinical study was terminated due to low recruitment.
NCT05133635,WITHDRAWN,INTERVENTIONAL,A recent study suggested a new corticosteroid regime for intensive care unit patients.
NCT05134103,WITHDRAWN,INTERVENTIONAL,Sponsor pulled out of study
NCT05134831,WITHDRAWN,OBSERVATIONAL,issue reglementary
NCT05135481,WITHDRAWN,INTERVENTIONAL,recruitment problems
NCT05135507,WITHDRAWN,INTERVENTIONAL,Covid-19 - unable to recruit any participants
NCT05135546,TERMINATED,INTERVENTIONAL,No patients
NCT05135650,TERMINATED,INTERVENTIONAL,Terminated due to FDA withdrawal of the emergency use authorization (EUA) for sotrovimab
NCT05135845,SUSPENDED,INTERVENTIONAL,Sponsor decision up DSMB advice due to unfavorable toxicity profile
NCT05136833,WITHDRAWN,INTERVENTIONAL,Covid-19 pandemia
NCT05136911,TERMINATED,INTERVENTIONAL,"The recruitment was stopped due to province-wide lockdown secondary to COVID-19. Blood pressure screenings were conducted in community centres and due to province wide lockdown, further screenings could not be continued."
NCT05137457,WITHDRAWN,INTERVENTIONAL,An RCT was not valid anymore as app has become open source and will risk a contamination of study population
NCT05137691,TERMINATED,INTERVENTIONAL,Recruitment challenges
NCT05137795,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05138120,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT05138458,SUSPENDED,INTERVENTIONAL,Temporary operational pause; no safety concerns.
NCT05138549,TERMINATED,INTERVENTIONAL,There are not enough eligible patients at our institution to complete this study.
NCT05138822,SUSPENDED,INTERVENTIONAL,To allow analysis of data from supplementary non-clinical study.
NCT05139615,TERMINATED,INTERVENTIONAL,Business decision
NCT05139901,TERMINATED,INTERVENTIONAL,Due to the Omicron version of SARS-CoV-2 the COVID-pneumonia patients ran out
NCT05140122,WITHDRAWN,OBSERVATIONAL,Funder withdrew study before enrolment started..
NCT05140135,WITHDRAWN,INTERVENTIONAL,The funds used to originally support the study were withdrawn.
NCT05140759,TERMINATED,INTERVENTIONAL,challenges in recruitment
NCT05140824,TERMINATED,INTERVENTIONAL,Company development strategy adjustment
NCT05141357,TERMINATED,INTERVENTIONAL,Slow Recruitment
NCT05142228,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT05142332,TERMINATED,INTERVENTIONAL,met interim analysis criteria for early termination
NCT05142501,TERMINATED,OBSERVATIONAL,Low recruitment
NCT05142527,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew study prior to initiation and no participants were enrolled.
NCT05142540,TERMINATED,OBSERVATIONAL,No more booster vaccinations are being carried out at the site. Further recruitment is therefore not possible.
NCT05142566,TERMINATED,INTERVENTIONAL,Ineffective enrollment
NCT05143489,TERMINATED,INTERVENTIONAL,"1. CTs occur late at night and weekends when their is no availability of the research staff.

. No activity since a year+"
NCT05143749,SUSPENDED,INTERVENTIONAL,technical support not available
NCT05144308,TERMINATED,INTERVENTIONAL,Sponsor-investigator agreement
NCT05144334,TERMINATED,INTERVENTIONAL,Business decision
NCT05144347,TERMINATED,INTERVENTIONAL,Due to Sponsor reasons.
NCT05144360,WITHDRAWN,INTERVENTIONAL,Strategy review
NCT05145452,SUSPENDED,INTERVENTIONAL,delay due to COVID caused treatment product expiration
NCT05146453,TERMINATED,INTERVENTIONAL,Study published by different group; this study would not add to the existing knowledge.
NCT05146648,WITHDRAWN,INTERVENTIONAL,study withdrawn
NCT05146882,WITHDRAWN,INTERVENTIONAL,Update to Program Design - No Participants Enrolled
NCT05147415,WITHDRAWN,INTERVENTIONAL,Due to financial considerations Sponsor is unable to complete the trial and assess the planned objectives/endpoints. No subjects have been randomized to treatment in the clinical trial and the decision therefore has no safety concern for patients
NCT05147584,TERMINATED,INTERVENTIONAL,Device Modifications and Relocation of Principal Investigator
NCT05148156,SUSPENDED,INTERVENTIONAL,Principal Investigator changing locations.
NCT05148195,TERMINATED,INTERVENTIONAL,The study was terminated due to the sponsor's research and development strategy adjustment.
NCT05148442,TERMINATED,INTERVENTIONAL,Due to the company's development strategy adjustment\]
NCT05148533,TERMINATED,INTERVENTIONAL,Company Development strategy adjustment
NCT05148663,TERMINATED,OBSERVATIONAL,Leaving the institution
NCT05149287,TERMINATED,INTERVENTIONAL,Funding stopped
NCT05149937,WITHDRAWN,INTERVENTIONAL,"Study stopped before first patient inclusion.

Mixed-methods-study (part a) completed per protocol, explorative survey (part b) withdrawn due to organizational reasons"
NCT05150496,SUSPENDED,INTERVENTIONAL,The plan has changed
NCT05151471,TERMINATED,INTERVENTIONAL,Futility Analysis of parent study MT-1186-A02 was met.
NCT05151666,WITHDRAWN,INTERVENTIONAL,"Initially the study failed to start due to Covid concerns. As this is an immunocompromised patient population, this concern has persisted and study initiation was further complicated by a demographic and availability change in research team members."
NCT05152199,TERMINATED,INTERVENTIONAL,PI employment status change inhibiting continued recruitment
NCT05152381,SUSPENDED,INTERVENTIONAL,Updating Protocol
NCT05152459,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT05152563,WITHDRAWN,INTERVENTIONAL,Company decision
NCT05152641,WITHDRAWN,INTERVENTIONAL,The program priority for execution of this clinical trial changed prior to enrollment of the first patient. The study was not withdrawn due to any safety concerns.
NCT05152693,WITHDRAWN,INTERVENTIONAL,Study design has changed.
NCT05153083,SUSPENDED,OBSERVATIONAL,unavailability of cryoablation probes
NCT05153356,WITHDRAWN,OBSERVATIONAL,The P.I decided not to move forward with the study
NCT05153408,TERMINATED,INTERVENTIONAL,Lack of efficacy
NCT05153447,WITHDRAWN,INTERVENTIONAL,Unable to obtain funding
NCT05153460,TERMINATED,OBSERVATIONAL,Site unable to recruit subjects
NCT05153499,TERMINATED,INTERVENTIONAL,"The termination of FIN-CDI-301 (PRISM4) is based on the voluntary, business-related decision of the sponsor."
NCT05154058,TERMINATED,INTERVENTIONAL,The Study was terminated due to principal investigator moving institutions
NCT05154630,TERMINATED,INTERVENTIONAL,The sponsor has decided to terminate this study based on the current clinical research status of dual antibody drugs and full communication with the investigators.
NCT05154656,WITHDRAWN,OBSERVATIONAL,We did not get the grant support.
NCT05154890,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05155020,TERMINATED,INTERVENTIONAL,The clinical development strategy has been changed
NCT05155423,SUSPENDED,OBSERVATIONAL,Accrual limit
NCT05155943,TERMINATED,INTERVENTIONAL,The intended population has been updated
NCT05155982,WITHDRAWN,INTERVENTIONAL,Decided not to move forward with the study design.
NCT05156034,TERMINATED,INTERVENTIONAL,Due to occurrence of eye related adverse events.
NCT05156229,TERMINATED,INTERVENTIONAL,PK/PD from two patients plus the healthy volunteer data confirmed the RP2D and manageable safety profile. Proceeding to Phase II did not require additional data from this Phase I Dose-Finding study.
NCT05156333,SUSPENDED,INTERVENTIONAL,Uneffective
NCT05156372,WITHDRAWN,INTERVENTIONAL,"PI left the institution, no subjects were enrolled"
NCT05156463,WITHDRAWN,INTERVENTIONAL,Award not yet received and PI is transferring to a different institution
NCT05156632,WITHDRAWN,INTERVENTIONAL,The plan has changed
NCT05156645,WITHDRAWN,INTERVENTIONAL,The study was withdraw due to the fast spread of Omicron variant worldwide
NCT05156658,WITHDRAWN,INTERVENTIONAL,Protocol's question was answered elsewhere and very low site interest in the trial
NCT05156671,TERMINATED,INTERVENTIONAL,Due to poor recruitment.
NCT05156827,WITHDRAWN,INTERVENTIONAL,Business decision
NCT05156840,WITHDRAWN,OBSERVATIONAL,No interested participants were recruited within a 4 month period.
NCT05157360,TERMINATED,INTERVENTIONAL,slow recruitment and not anticipated to meet recruitment numbers
NCT05157451,WITHDRAWN,INTERVENTIONAL,Not feasible at this time.
NCT05157464,WITHDRAWN,INTERVENTIONAL,"Study was not initiated, no participants enrolled."
NCT05157568,TERMINATED,INTERVENTIONAL,Funding
NCT05157646,WITHDRAWN,INTERVENTIONAL,Student was unable to start the project due to time constraints
NCT05157724,WITHDRAWN,OBSERVATIONAL,organizational problems
NCT05157997,WITHDRAWN,INTERVENTIONAL,New information regarding COVID-19
NCT05158127,SUSPENDED,INTERVENTIONAL,Updating Protocol
NCT05158153,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT05158439,WITHDRAWN,INTERVENTIONAL,covid-19
NCT05158907,SUSPENDED,INTERVENTIONAL,Patient recruitment is slow
NCT05159128,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT05159531,TERMINATED,INTERVENTIONAL,Funding withdrawn
NCT05160064,WITHDRAWN,OBSERVATIONAL,Sponsor administrative decision
NCT05160168,TERMINATED,INTERVENTIONAL,The Sponsor terminated the study due to early dose-limiting toxicities.
NCT05160402,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05160454,SUSPENDED,INTERVENTIONAL,COVID19
NCT05160558,TERMINATED,INTERVENTIONAL,Sponsor's Decision
NCT05161533,WITHDRAWN,INTERVENTIONAL,Closed per SRC Low Accrual Policy. Study closed prior to any participants enrolled.
NCT05161767,TERMINATED,OBSERVATIONAL,Difficult recruitment of acute patients via emergency services due to COVID-19. The required sample size was consequently not reached within the PhD period of the involved researchers.
NCT05161936,TERMINATED,INTERVENTIONAL,Study terminated early due to low enrollment
NCT05162027,TERMINATED,INTERVENTIONAL,Low enrollment rate
NCT05162066,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05162131,TERMINATED,INTERVENTIONAL,"After recruitment of Cohorts 1-4 was completed, Sponsor decided to terminate study, initially due to COVID and then considering that PK data from the dose planned to be tested in Cohort 5 (18000 mg) would be available from the ongoing Phase 3 study."
NCT05162365,TERMINATED,INTERVENTIONAL,The company decision that terminated the further develop of the molecule and had notified FDA about the termination as well.
NCT05163327,WITHDRAWN,OBSERVATIONAL,"Accumulated evidence (including data acquired in parallel studies, in other centres and in published literature) suggest that the technique was unlikely to produce a signal in the heart."
NCT05163717,TERMINATED,INTERVENTIONAL,Busness reason's
NCT05164211,WITHDRAWN,INTERVENTIONAL,no inclusion since the opening of the centers (difficulties in recruiting staff which impact the functioning of the services)
NCT05164289,TERMINATED,OBSERVATIONAL,No patients included in the control group and inclusion rate too low.
NCT05164471,TERMINATED,INTERVENTIONAL,Freeline has decided to pause development of FLT180a for business priorities
NCT05164822,TERMINATED,OBSERVATIONAL,insufficient number of inclusions
NCT05165212,WITHDRAWN,INTERVENTIONAL,Unable to host study at clinic site.
NCT05165732,SUSPENDED,INTERVENTIONAL,Limited subjects
NCT05165771,WITHDRAWN,INTERVENTIONAL,Sponsor decision to withdraw study.
NCT05165849,WITHDRAWN,INTERVENTIONAL,sponsor decided to withdraw the study
NCT05166031,WITHDRAWN,INTERVENTIONAL,Sponsor decided not to conduct it
NCT05166395,WITHDRAWN,INTERVENTIONAL,device not available to initiate study.
NCT05166603,TERMINATED,INTERVENTIONAL,Inadequate recruitment
NCT05166642,SUSPENDED,INTERVENTIONAL,Temporary hold on recruitment
NCT05166876,TERMINATED,INTERVENTIONAL,Low prevalence of COVID-19 in India led to lack of eligible subjects.
NCT05166915,WITHDRAWN,INTERVENTIONAL,Indefinite hold by Company.
NCT05167253,WITHDRAWN,INTERVENTIONAL,Regulatory issues raised by the regulatory authority in Taiwan.
NCT05167370,TERMINATED,INTERVENTIONAL,The study was terminated as recommended by the DSMB due to inability to meet enrollment goals within the time frame allotted (target of 25 patients over 5 years).
NCT05167422,TERMINATED,INTERVENTIONAL,Inability to recruit
NCT05167526,TERMINATED,INTERVENTIONAL,The study was terminated due to protocol defined stopping criteria being met.
NCT05167591,WITHDRAWN,INTERVENTIONAL,The design of the study is no longer relevant.
NCT05168306,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT05168748,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT05168865,WITHDRAWN,INTERVENTIONAL,unexpected slow recruitment and change of center frozen embryo transfer protocol
NCT05168904,SUSPENDED,INTERVENTIONAL,Slow enrollment and financial limitations
NCT05169008,TERMINATED,INTERVENTIONAL,"Difficulty recruiting subjects, so the study was terminated."
NCT05169034,TERMINATED,OBSERVATIONAL,Goals as defined in the study protocol were not met after the first study period. Study with improved device will follow.
NCT05169151,WITHDRAWN,OBSERVATIONAL,0 patient accrual
NCT05169372,TERMINATED,OBSERVATIONAL,LACOG and Astellas decided to end the study due to the great difficulty in finding patients with the desired profile.
NCT05169710,TERMINATED,INTERVENTIONAL,Company decided not to move forward with further accrual.
NCT05169931,WITHDRAWN,INTERVENTIONAL,Lack of funding/support
NCT05169944,SUSPENDED,INTERVENTIONAL,FDA Partial Clinical Hold
NCT05170308,WITHDRAWN,INTERVENTIONAL,Insufficient patient population to enroll
NCT05170451,WITHDRAWN,INTERVENTIONAL,Terminated due to hurdles of obtaining regulatory approval.
NCT05170789,WITHDRAWN,INTERVENTIONAL,"The study collaborator -Karyopharm- is not doing Myeloma studies funding, so they let the study investigators know they are not funding the study anymore."
NCT05170828,WITHDRAWN,INTERVENTIONAL,Change in Study Design
NCT05171062,WITHDRAWN,INTERVENTIONAL,"No participants were enrolled, the study was inactivated with the IRB on May 15, 2023. The sponsor notified the PI that a Phase II trial had been allowed to proceed by the FDA."
NCT05171920,WITHDRAWN,INTERVENTIONAL,lack of sufficient numbers of critically ill patients to enroll the study
NCT05172115,TERMINATED,INTERVENTIONAL,Due to the COVID-19 pandemic
NCT05172141,TERMINATED,INTERVENTIONAL,"Due to the company's development strategy adjustment, Innovant Biologics decided not to continue this study after consultation with investigators."
NCT05172349,WITHDRAWN,INTERVENTIONAL,Change in sponsor's strategy
NCT05172401,WITHDRAWN,INTERVENTIONAL,"unforeseen, continued (\>12month) global shortage of study medication. Study Drug Triesence, manufacturer Novartis, not supplied throughout 2022"
NCT05172466,WITHDRAWN,INTERVENTIONAL,Lack on enrollment
NCT05172570,TERMINATED,INTERVENTIONAL,Study terminated to to shortage if study supplies for epidurals and most enrolled has study deviations due to not receiving correct post study drug assignments.
NCT05173116,WITHDRAWN,OBSERVATIONAL,"protocol not implemented for logistical reasons in the recruiting center, possible rescheduling."
NCT05173519,SUSPENDED,INTERVENTIONAL,Temporarily halted
NCT05173831,WITHDRAWN,INTERVENTIONAL,Transfer of Sponsorship
NCT05174195,TERMINATED,INTERVENTIONAL,difficult recruitment
NCT05174455,WITHDRAWN,INTERVENTIONAL,PI decision
NCT05174468,TERMINATED,OBSERVATIONAL,Change in sponsor's business strategy (disease focus changed to breast cancer)
NCT05174728,SUSPENDED,OBSERVATIONAL,COVID-19 Pandemic
NCT05175040,TERMINATED,INTERVENTIONAL,Logistical challenges impeding enrollment
NCT05175092,WITHDRAWN,INTERVENTIONAL,Slow accrual
NCT05175612,SUSPENDED,OBSERVATIONAL,For sponsor reasons
NCT05176288,WITHDRAWN,INTERVENTIONAL,"The overall protocol will be changed in a new amendment, which will be resubmitted under the new IND."
NCT05176587,WITHDRAWN,OBSERVATIONAL,the deployment of the integrated pathwat takes longer than expected
NCT05176691,WITHDRAWN,INTERVENTIONAL,HUTCHMED has decided to discontinue the HMPL 760 study.
NCT05176717,TERMINATED,INTERVENTIONAL,Business decision
NCT05176925,TERMINATED,INTERVENTIONAL,The trial was terminated per sponsor recommendation
NCT05177029,TERMINATED,INTERVENTIONAL,The study was terminated for strategic reasons.
NCT05177328,TERMINATED,INTERVENTIONAL,Decision to terminate enrollment early was made by the protocol chair and NIAID
NCT05177367,WITHDRAWN,INTERVENTIONAL,Study design has changed.
NCT05177718,TERMINATED,INTERVENTIONAL,Sponsor declined further support
NCT05177796,WITHDRAWN,INTERVENTIONAL,0 participants recruited
NCT05178485,WITHDRAWN,INTERVENTIONAL,Halted prematurely prior to enrollment of first participant
NCT05178576,WITHDRAWN,INTERVENTIONAL,Study drug not available for the study duration.
NCT05178654,WITHDRAWN,INTERVENTIONAL,"Based on various healthy authorities feedback on PAXLOVID submission, this study is no longer required."
NCT05178862,SUSPENDED,INTERVENTIONAL,"During a review of manufacturing equipment and cleaning activities at a supplier that manufactured study drug for this study, SCYNEXIS was made aware of potential cross-contamination risk with a non-antibacterial beta-lactam drug substance."
NCT05179005,TERMINATED,OBSERVATIONAL,Sponsor Terminated
NCT05179044,WITHDRAWN,INTERVENTIONAL,Logistic difficulties and loss of support from bracing company.
NCT05179057,TERMINATED,INTERVENTIONAL,Study discontinued as DSMB determined it was futile. No safety concerns were noted.
NCT05179772,WITHDRAWN,INTERVENTIONAL,NIDA has advised us to terminate this protocol due to the difficulties in finding appropriate subjects.
NCT05180149,WITHDRAWN,OBSERVATIONAL,"The sponsor of the study has changed. The study will be released, managed and registered by another institution who will be acting as a responsible party."
NCT05180422,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT05181540,TERMINATED,INTERVENTIONAL,Interim analysis showed lack of efficacy
NCT05181865,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05181995,TERMINATED,INTERVENTIONAL,company decision
NCT05182047,WITHDRAWN,INTERVENTIONAL,Business decision.
NCT05182151,TERMINATED,OBSERVATIONAL,recruitment issues
NCT05182216,WITHDRAWN,OBSERVATIONAL,We have withdrawn this study.
NCT05182320,WITHDRAWN,OBSERVATIONAL,contracts were not closed in time
NCT05183139,WITHDRAWN,INTERVENTIONAL,Business decision (no enrollment)
NCT05183295,WITHDRAWN,INTERVENTIONAL,Withdrawn by Sponsor.
NCT05183633,SUSPENDED,OBSERVATIONAL,Investigating interference with other in-room diagnostic equipment.
NCT05183828,SUSPENDED,INTERVENTIONAL,Enrollment temporarily on hold for data analysis
NCT05184101,WITHDRAWN,INTERVENTIONAL,"COVID-19 hospitalisations limited in Australia, unable to recruit patients due to low numbers of hospitalisations."
NCT05184218,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05184231,WITHDRAWN,OBSERVATIONAL,Study wasn't feasible anymore. It was withdrawn on 13 Jan 2023.
NCT05184283,TERMINATED,OBSERVATIONAL,Discontinued by Amra Medical due to funding.
NCT05184985,WITHDRAWN,INTERVENTIONAL,The study was closed due to recruitment challenges. The study design involved frequent visits 3 times a week for 3 consecutive weeks which many prospective participants were not able to commit to.
NCT05185037,TERMINATED,OBSERVATIONAL,Business decision with slower than expected enrollment..
NCT05185310,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT05186077,SUSPENDED,OBSERVATIONAL,The original funding for this study ended and we are looking for additional funding
NCT05186779,TERMINATED,OBSERVATIONAL,Challenges in recruiting patients
NCT05187156,WITHDRAWN,INTERVENTIONAL,The PI has transitioned to working outside of the VA - study will not continue
NCT05188664,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT05189834,WITHDRAWN,INTERVENTIONAL,The trial was not performed because logistical problems
NCT05189899,WITHDRAWN,INTERVENTIONAL,The trial was not performed because logistical problems
NCT05189977,TERMINATED,INTERVENTIONAL,"The decision to terminate the trial early was not based on safety concerns. The trial was terminated early due to some implausible blood pressure values being captured, which was the primary endpoint of the study."
NCT05190302,TERMINATED,OBSERVATIONAL,"During the course of the year, we were able to answer our faisability question."
NCT05191004,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05191017,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05191238,TERMINATED,INTERVENTIONAL,The study was terminated because of difficulty recruiting participants.
NCT05191472,TERMINATED,INTERVENTIONAL,Low Accrual
NCT05191615,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient sample size to reach power.
NCT05191628,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT05191797,SUSPENDED,INTERVENTIONAL,Drug supply issue
NCT05191862,TERMINATED,INTERVENTIONAL,Randomization Error
NCT05192213,TERMINATED,INTERVENTIONAL,"In order to preserve the safety of the patients and prevent any harm from occurring, we opted to discontinue the study based on previous results (LOVIT study) published at 2022. Were recruited 71 than 1090 participants."
NCT05193279,WITHDRAWN,INTERVENTIONAL,The study was terminated during the EC submission process prior to the enrollment.
NCT05193318,TERMINATED,INTERVENTIONAL,Primary Investigator leaving institution
NCT05193370,WITHDRAWN,INTERVENTIONAL,Funding and protocol changes. Replaced with new pilot trial.
NCT05193604,TERMINATED,INTERVENTIONAL,Terminated due to the adjustment of sponsor's development strategies and pipeline.
NCT05193695,TERMINATED,INTERVENTIONAL,full sample size
NCT05194176,TERMINATED,INTERVENTIONAL,Inclusion rate too low.
NCT05194449,WITHDRAWN,INTERVENTIONAL,Never started since the study was not funded
NCT05194839,TERMINATED,INTERVENTIONAL,Due to safety findings in ongoing Phase 2 trials.
NCT05195268,WITHDRAWN,INTERVENTIONAL,Decision to discontinue in light of new evidence demonstrating that the intervention in question is not effective.
NCT05195749,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT05195827,WITHDRAWN,INTERVENTIONAL,Sponsor
NCT05195931,TERMINATED,OBSERVATIONAL,Withdrawal of funding by study sponsor
NCT05196165,TERMINATED,OBSERVATIONAL,Sponsor decision not related to safety concerns
NCT05196191,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05196672,TERMINATED,INTERVENTIONAL,"Because of the pandemic, is difficult to recruit the participants"
NCT05197231,SUSPENDED,INTERVENTIONAL,Logistical barriers to recruitment.
NCT05197725,WITHDRAWN,INTERVENTIONAL,Unable to get Study supplies in time
NCT05198349,TERMINATED,INTERVENTIONAL,Overarching portfolio-level review of the company's oncology pipeline resulted in early termination of the study. The study was not terminated due to safety.
NCT05198362,WITHDRAWN,INTERVENTIONAL,Due to financial considerations Sponsor is unable to complete the trial and assess the planned objectives/endpoints. No subjects have been randomized to treatment in the clinical trial and the decision therefore has no safety concern for patients
NCT05198700,WITHDRAWN,INTERVENTIONAL,Null recruitment
NCT05198843,TERMINATED,INTERVENTIONAL,Other - Poor accrual
NCT05199142,TERMINATED,INTERVENTIONAL,Development plan changed
NCT05199311,SUSPENDED,INTERVENTIONAL,Serious Adverse Event under review
NCT05199961,TERMINATED,INTERVENTIONAL,Sponsor requested early termination
NCT05200403,TERMINATED,INTERVENTIONAL,Funding was stoppped by grantor.
NCT05201001,WITHDRAWN,INTERVENTIONAL,"IMP provider company (Apexigen) is sold, thus both IMP and grant is terminated"
NCT05201027,TERMINATED,INTERVENTIONAL,Sponsor decided to modify the prototype device used in study
NCT05201183,WITHDRAWN,INTERVENTIONAL,insufficient staff and updates in standard practice have made it difficult to recruit participants
NCT05201456,WITHDRAWN,OBSERVATIONAL,Business decision
NCT05201898,TERMINATED,INTERVENTIONAL,"Due to the severe epidemic situation of COVID-19 and the shortage of research funds and manpower for research projects, the study was halted prematurely."
NCT05202327,SUSPENDED,INTERVENTIONAL,interim analysis
NCT05202847,WITHDRAWN,INTERVENTIONAL,difficulties in recruiting patients with knee osteoarthritis to the pain clinic.
NCT05203419,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05203484,SUSPENDED,INTERVENTIONAL,Principal investigator left Heart Center Leipzig.
NCT05204654,TERMINATED,INTERVENTIONAL,Not enough subjects were recruited for the study.
NCT05205161,TERMINATED,INTERVENTIONAL,Due to safety reasons.
NCT05205252,WITHDRAWN,INTERVENTIONAL,Epizyme Inc. has revised the Tazemetostat development strategy and made the decision to terminate the hematological malignancies basket trial.
NCT05205447,TERMINATED,INTERVENTIONAL,Data from part 2 no longer deemed necessary for this program.
NCT05205668,WITHDRAWN,INTERVENTIONAL,Compound development plan changed
NCT05205759,TERMINATED,INTERVENTIONAL,Stop for futility after the onset of the omicron wave
NCT05205837,TERMINATED,INTERVENTIONAL,Lack of recruitment
NCT05206591,WITHDRAWN,INTERVENTIONAL,Trial terminated due to strategic decision of senior management
NCT05207345,SUSPENDED,INTERVENTIONAL,Lack of resources
NCT05208138,TERMINATED,INTERVENTIONAL,leasing of the Senhance system ended
NCT05208229,TERMINATED,OBSERVATIONAL,The study was linked to another protocol that is over
NCT05208840,WITHDRAWN,INTERVENTIONAL,Due to deterioration of the geopolitical situation and escalation of conflict between Russia and Ukraine ML42302 study was put on hold.
NCT05208866,TERMINATED,INTERVENTIONAL,The decision is based on a thorough reassessment of the commercial potential of lixivaptan as a potential best-in-class therapy for patients with ADPKD.
NCT05209165,SUSPENDED,INTERVENTIONAL,Company decision
NCT05209308,WITHDRAWN,INTERVENTIONAL,Discontinuation of zandelisib development
NCT05209347,WITHDRAWN,INTERVENTIONAL,Study related activities were delayed and effort was instead focused on recruitment and testing for the iterative design study (NCT04562896).
NCT05209529,WITHDRAWN,INTERVENTIONAL,Withdrawn interest from grant provider
NCT05210387,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT05210933,SUSPENDED,OBSERVATIONAL,Study is currently on hold.
NCT05212025,WITHDRAWN,INTERVENTIONAL,manufacturer choice
NCT05212077,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT05212116,WITHDRAWN,INTERVENTIONAL,Development Plan Amended
NCT05212363,TERMINATED,INTERVENTIONAL,The study was terminated due to financial cost.
NCT05212701,WITHDRAWN,INTERVENTIONAL,"Domp decided to withdraw the study due to the numerous difficulties encountered in enrollment, mainly due to the rapidly and continuously changing oncology drug scenario . No patients were enrolled."
NCT05212727,SUSPENDED,OBSERVATIONAL,Insufficient personnel
NCT05212818,TERMINATED,INTERVENTIONAL,Low patient accrual.
NCT05212922,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05213143,TERMINATED,INTERVENTIONAL,Company's business decision
NCT05213468,TERMINATED,INTERVENTIONAL,"A change in patient population at the clinical trial site has occurred due to the pandemic, resulting in too few patients for the physiotherapy program to conduct the study."
NCT05213845,TERMINATED,INTERVENTIONAL,insufficient recruitment to meet the objectives in time
NCT05214053,TERMINATED,INTERVENTIONAL,not enough patients
NCT05214313,TERMINATED,INTERVENTIONAL,investigator decision
NCT05214716,TERMINATED,INTERVENTIONAL,"Even if the study period was extended, it was expected that the target subjects would not be able to be registered, so the study was terminated early."
NCT05215249,WITHDRAWN,INTERVENTIONAL,IRB approval not received
NCT05215496,TERMINATED,INTERVENTIONAL,Reached the stop criteria after the interim analysis
NCT05215951,TERMINATED,INTERVENTIONAL,Enrollment delay study timeline seriously.
NCT05216055,WITHDRAWN,INTERVENTIONAL,No Accrual. PI left Institution
NCT05216120,WITHDRAWN,INTERVENTIONAL,enrollment challenges
NCT05216614,WITHDRAWN,INTERVENTIONAL,Unable to obtain investigational product
NCT05217472,WITHDRAWN,INTERVENTIONAL,Study canceled
NCT05217563,TERMINATED,INTERVENTIONAL,Insufficient funding
NCT05218304,SUSPENDED,INTERVENTIONAL,Lockdown in the general population due to COVID
NCT05218408,WITHDRAWN,INTERVENTIONAL,No enrolled subjects
NCT05219019,WITHDRAWN,OBSERVATIONAL,Insufficient interest by potential participants.
NCT05219032,TERMINATED,INTERVENTIONAL,Lack of enrollment.
NCT05219370,TERMINATED,INTERVENTIONAL,Difficulties in enrollment
NCT05219578,TERMINATED,INTERVENTIONAL,"The Sponsor terminated study after dosing 2 dose groups (7 pts) and closed trial on 11/30/22. RTX-224 was well-tolerated with no DLTs, no related deaths, SAEs or Gr. 3/4 AEs and cleared rapidly (w/in 10 min)."
NCT05219604,TERMINATED,INTERVENTIONAL,Institution decision
NCT05219864,WITHDRAWN,INTERVENTIONAL,Business decision; no safety concerns.
NCT05219890,WITHDRAWN,INTERVENTIONAL,We reached the number of participants required.
NCT05219916,TERMINATED,INTERVENTIONAL,"It is unlikely that the scientific question will ever be answered. Thus, it would be considered unethical to continue the trial."
NCT05220150,TERMINATED,INTERVENTIONAL,Poor recruitment and poor scan image quality
NCT05220306,WITHDRAWN,INTERVENTIONAL,No eligible patients could be found and funding was lost
NCT05220748,WITHDRAWN,INTERVENTIONAL,Decision was made due to a strategic re-evaluation of pipelines; no patients were enrolled.
NCT05221385,TERMINATED,INTERVENTIONAL,Due to changes in the sponsor's research strategy
NCT05221749,TERMINATED,INTERVENTIONAL,Only the 1 month follow-up was completed. The principal investigator could not complete the 3 month follow-up appointments and was not calibrated with other dentists who were available at the time.
NCT05221827,TERMINATED,OBSERVATIONAL,Not in line with company's recently updated clinical development strategy
NCT05222165,WITHDRAWN,INTERVENTIONAL,The company decided to interrupt the development of the drug in all oncological indications
NCT05222178,TERMINATED,INTERVENTIONAL,Homology Medicines Inc. has discontinued the development of this program.
NCT05222269,TERMINATED,INTERVENTIONAL,"The study was early terminated due to low patient recruitment in already activated sites and difficult approval process in some of the anticipated countries. Thus, recruitment of the planned patient numbers in a reasonable time cannot be expected."
NCT05222438,WITHDRAWN,INTERVENTIONAL,No accrual of participants in 18 months
NCT05222516,TERMINATED,INTERVENTIONAL,Recommendation of DSMB (futility of Endpoints)
NCT05222607,TERMINATED,OBSERVATIONAL,Corporate Management Decision
NCT05223673,TERMINATED,INTERVENTIONAL,Sponsor decided to discontinue the study during the Lead-In part and the Phase III part was not started due to strategic reasons.
NCT05223699,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05223881,WITHDRAWN,INTERVENTIONAL,Study is not feasible at this time due to staffing limitations
NCT05224479,WITHDRAWN,INTERVENTIONAL,Change in research plan
NCT05224752,WITHDRAWN,OBSERVATIONAL,The study was merged with a different study.
NCT05224856,WITHDRAWN,INTERVENTIONAL,The sponsor has decided to stop development of the inhaled CT-P63/66 combination therapy.
NCT05225818,WITHDRAWN,INTERVENTIONAL,Our study design changed
NCT05226390,TERMINATED,INTERVENTIONAL,cohort could not be recruited
NCT05226533,TERMINATED,INTERVENTIONAL,Study stopped due to difficulties in patient recruitment
NCT05226676,WITHDRAWN,INTERVENTIONAL,The PI left the institution and the study couldn't be transfer to a new PI
NCT05226832,WITHDRAWN,INTERVENTIONAL,Study never started.
NCT05227131,WITHDRAWN,INTERVENTIONAL,Funder decided to not continue the study
NCT05227209,TERMINATED,INTERVENTIONAL,Company decided not to move forward with further accrual.
NCT05228132,TERMINATED,INTERVENTIONAL,"Terminated due to considerable changes in the clinical landscape post Covid-19, leading to difficulties executing the study. Results were blinded at time of termination."
NCT05228210,TERMINATED,OBSERVATIONAL,PI no longer working at Indiana University;
NCT05228249,WITHDRAWN,INTERVENTIONAL,"PI left institution and funding sponsor closed study. Study did not open to accrual, and no participants were enrolled."
NCT05228756,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT05228821,WITHDRAWN,INTERVENTIONAL,The study has been stopped due to Sponsor's business reasons. The termination is not a result of any safety concerns or change in the benefit-risk ratio.
NCT05228834,TERMINATED,INTERVENTIONAL,Data will not inform further development of Voxelotor
NCT05228938,TERMINATED,INTERVENTIONAL,low enrollment rate
NCT05229068,WITHDRAWN,INTERVENTIONAL,"Following a recommendation from the Independent Data Monitoring Committee of NCT04605159 (RSV MAT 009), GSK made the decision to stop enrolment and vaccination in this study."
NCT05229107,WITHDRAWN,INTERVENTIONAL,"Both Co-PI, Dr. Ken Koch and Dr. Rajeski, have both left the institution, so we have not been able to receive referrals since their departure."
NCT05229549,TERMINATED,INTERVENTIONAL,Difficulty in enrolment
NCT05229640,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05229666,SUSPENDED,INTERVENTIONAL,The study is paused.
NCT05229692,WITHDRAWN,INTERVENTIONAL,Lack of interest from participants
NCT05229731,WITHDRAWN,OBSERVATIONAL,The investigators no longer want to do the project
NCT05229887,WITHDRAWN,INTERVENTIONAL,need to be redesigned
NCT05229900,TERMINATED,INTERVENTIONAL,Study closed due to portfolio prioritization
NCT05230394,SUSPENDED,INTERVENTIONAL,Funding Issues
NCT05230888,WITHDRAWN,OBSERVATIONAL,Research personnel not recruited
NCT05231603,TERMINATED,INTERVENTIONAL,Poor response
NCT05232123,WITHDRAWN,INTERVENTIONAL,did not receive funding
NCT05232227,WITHDRAWN,INTERVENTIONAL,Trial terminated by funder
NCT05232864,TERMINATED,INTERVENTIONAL,Study terminated by sponsor due to futility analysis
NCT05233007,SUSPENDED,OBSERVATIONAL,To explore alternative funding streams
NCT05233033,SUSPENDED,INTERVENTIONAL,Sponsor decision
NCT05233215,WITHDRAWN,INTERVENTIONAL,Funding
NCT05233319,WITHDRAWN,OBSERVATIONAL,"lack of funding, project not being pursued"
NCT05233410,WITHDRAWN,INTERVENTIONAL,Business decision; no safety concerns
NCT05233436,TERMINATED,INTERVENTIONAL,Study terminated based on internal business considerations and was not based on safety reasons
NCT05233696,WITHDRAWN,INTERVENTIONAL,Low Accrual
NCT05234164,TERMINATED,INTERVENTIONAL,Business decision
NCT05234398,WITHDRAWN,OBSERVATIONAL,This project will be integrated into an ongoing project.
NCT05234437,TERMINATED,INTERVENTIONAL,Insufficient Patient Recruitment Rates
NCT05234606,WITHDRAWN,INTERVENTIONAL,Sponsor decision based on strategic re-alignment
NCT05234632,TERMINATED,INTERVENTIONAL,Due to enrolment issues with dehisced and DFU's wounds
NCT05236387,TERMINATED,OBSERVATIONAL,PI left institution
NCT05236920,WITHDRAWN,INTERVENTIONAL,Study will not take place at this time.
NCT05237167,WITHDRAWN,INTERVENTIONAL,The study was ultimately found to be too difficult to enroll patients and have an adequate control.
NCT05237219,WITHDRAWN,INTERVENTIONAL,The human resources required to start enrollment were not available anymore.
NCT05237284,TERMINATED,INTERVENTIONAL,The study was terminated as its Part A did not meet the primary endpoint.
NCT05237479,WITHDRAWN,INTERVENTIONAL,Study never approved by IRB or initiated
NCT05237531,TERMINATED,INTERVENTIONAL,Due to difficulty enrolling participants.
NCT05237986,SUSPENDED,OBSERVATIONAL,On temporary hold for internal review
NCT05238077,TERMINATED,INTERVENTIONAL,"only one subject enrolled, decided to re-evaluate protocol design"
NCT05238207,TERMINATED,INTERVENTIONAL,Only Part A (single dosing) was conducted due to business considerations
NCT05238324,WITHDRAWN,INTERVENTIONAL,Homology Medicines has discontinued development of this program.
NCT05238532,WITHDRAWN,INTERVENTIONAL,Difficulties in recruiting Subjects
NCT05238753,TERMINATED,INTERVENTIONAL,CE certificate ended and was not renewed
NCT05238831,WITHDRAWN,INTERVENTIONAL,Withdrawn due to a change in therapeutic interventions.
NCT05238844,TERMINATED,INTERVENTIONAL,Sponsor stopped due to partner collaboration ending
NCT05238896,TERMINATED,INTERVENTIONAL,Difficulties of inclusion in the study following expiry of the experimental treatment. The time required to supply the study treatment is too long to obtain conclusive results at the end of the study.
NCT05239910,WITHDRAWN,INTERVENTIONAL,Change in development plan
NCT05239975,WITHDRAWN,INTERVENTIONAL,There was not a need to carry out a study in LAO any more.
NCT05240027,TERMINATED,INTERVENTIONAL,The PI left the site prior to providing results.
NCT05241002,TERMINATED,OBSERVATIONAL,Difficult to recruiting due to COVID-19 pandemic
NCT05241613,TERMINATED,INTERVENTIONAL,"Subject benefit-risk ratio changes, sponsor decides to voluntarily terminate study"
NCT05242029,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05242042,TERMINATED,INTERVENTIONAL,"Based on the current number of COVID-19 cases and the approval of COVID-19 treatment drugs , the research team is facing great challenges, and it is decided to terminate this study"
NCT05242146,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05242250,TERMINATED,OBSERVATIONAL,Decision made to close enrollment in October and close the registry by December 2023
NCT05242432,TERMINATED,INTERVENTIONAL,Terminated (Janssen made the strategic decision to discontinue the RSV3007 study. This decision is not based on any safety concerns.)
NCT05242926,WITHDRAWN,INTERVENTIONAL,Pending further development
NCT05243420,WITHDRAWN,OBSERVATIONAL,Unable to obtain IRB approval and data agreements prior to request for data submission. No subjects were enrolled and no study activities have occurred.
NCT05243524,TERMINATED,INTERVENTIONAL,Closure of IMV operations
NCT05243719,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05243914,TERMINATED,OBSERVATIONAL,Slow study enrollment
NCT05244070,TERMINATED,INTERVENTIONAL,Business objectives have changed.
NCT05244265,TERMINATED,INTERVENTIONAL,Covid-19 pandemic hindered the group based intervention
NCT05244434,WITHDRAWN,INTERVENTIONAL,PI withdrawn
NCT05244473,WITHDRAWN,INTERVENTIONAL,Study withdrawn due to low patient accrual.
NCT05244915,TERMINATED,INTERVENTIONAL,Study has been closed to accrual earlier than anticipated and will not resume.
NCT05245162,WITHDRAWN,OBSERVATIONAL,Low accrual
NCT05245435,WITHDRAWN,INTERVENTIONAL,Recruitment was not possible with the chosen inclusion/exclusion criteria at our Institution.
NCT05245760,WITHDRAWN,INTERVENTIONAL,Funding unavailable.
NCT05245864,TERMINATED,INTERVENTIONAL,Difficulty recruiting subjects; funding not renewed.
NCT05245916,WITHDRAWN,INTERVENTIONAL,Due to the company's development strategy adjustment
NCT05246384,WITHDRAWN,INTERVENTIONAL,Change in development plan
NCT05246696,WITHDRAWN,OBSERVATIONAL,The project was to be led by midwives but the director of the school of midwives opposed it at the last moment...
NCT05246943,WITHDRAWN,OBSERVATIONAL,No participants enrolled.
NCT05247307,TERMINATED,INTERVENTIONAL,Lack of efficacy of treatment tested
NCT05247567,TERMINATED,INTERVENTIONAL,there is not enough volounteer for the trial
NCT05247658,TERMINATED,INTERVENTIONAL,Lack of apparent benefits
NCT05247749,WITHDRAWN,INTERVENTIONAL,Regulatory
NCT05247957,TERMINATED,INTERVENTIONAL,end
NCT05248308,WITHDRAWN,INTERVENTIONAL,Fundings challenges
NCT05248425,WITHDRAWN,INTERVENTIONAL,Feasibility.
NCT05248711,TERMINATED,INTERVENTIONAL,Personnel Change
NCT05249569,TERMINATED,INTERVENTIONAL,Sponsor pulled support for one of the study drugs.
NCT05250570,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT05250583,TERMINATED,INTERVENTIONAL,Low accrual rate
NCT05250856,TERMINATED,INTERVENTIONAL,Lagging Enrollment and Administrative Reasons
NCT05251038,WITHDRAWN,INTERVENTIONAL,Funder Decision
NCT05251207,SUSPENDED,INTERVENTIONAL,PhD student responsible for the study has decided to terminate her education.
NCT05251285,TERMINATED,OBSERVATIONAL,Low enrolment
NCT05251376,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT05251974,TERMINATED,OBSERVATIONAL,Quest Diagnostics terminated study early - did not want to continue to support single-site study
NCT05252273,SUSPENDED,OBSERVATIONAL,This decision has been made after careful consideration and evaluation of trial progress and ongoing recruitment challenges.
NCT05252520,WITHDRAWN,INTERVENTIONAL,The development of bermekimab in Immunology is stopped
NCT05252598,WITHDRAWN,INTERVENTIONAL,The sponsor no longer wishes to pursue the methods outlined in the protocol.
NCT05252910,TERMINATED,OBSERVATIONAL,Global spread of SARS-CoV-2 Omicron variant and vaccination preclude ability to enroll sufficient SARS-CoV-2 seronegative participants.
NCT05253105,WITHDRAWN,INTERVENTIONAL,transfer the study to another sponser
NCT05253534,SUSPENDED,INTERVENTIONAL,The study is suspended to update the clinical research protocol for starting the multicenter European clinical trials.
NCT05253755,TERMINATED,INTERVENTIONAL,Sponsor suspension and not due to safety or site-related matters.
NCT05253976,WITHDRAWN,OBSERVATIONAL,Study had to be terminated before first patient got enrolled due to insufficient case number.
NCT05254236,WITHDRAWN,INTERVENTIONAL,Limited subjects
NCT05254613,TERMINATED,INTERVENTIONAL,The justification of the early termination of the trial: the study is early terminated due to the Coronavirus 2019 epidemic.
NCT05254756,TERMINATED,INTERVENTIONAL,The study was stopped because of logistical issues with the sites.
NCT05254808,TERMINATED,INTERVENTIONAL,"Insufficient participating sites, and insufficient participants from participating sites mainly due to COVID-19 workload. The number of necessary participants could not be reached within the anticipated timelines and the allocated budget."
NCT05254964,WITHDRAWN,INTERVENTIONAL,Patients not recruited.
NCT05255263,WITHDRAWN,INTERVENTIONAL,"Study is currently on hold, pending further evaluation and coordination."
NCT05255484,TERMINATED,INTERVENTIONAL,Completed primary objective.
NCT05255575,WITHDRAWN,OBSERVATIONAL,unavailable staff to support project
NCT05255666,WITHDRAWN,INTERVENTIONAL,No drug
NCT05255770,WITHDRAWN,INTERVENTIONAL,Change of the product development strategy
NCT05256134,TERMINATED,INTERVENTIONAL,Decision to terminate development of Gantenerumab for treatment of prodromal/mild/early stage Alzheimer's disease following results of a pre-planned analysis of the safety and efficacy of Gant in Graduate I\&II (WN29922/WN39658).
NCT05256147,TERMINATED,INTERVENTIONAL,difficulty in recruiting study population
NCT05256277,TERMINATED,INTERVENTIONAL,A new study is planed to replace the current study due to IP upgrade
NCT05256368,WITHDRAWN,OBSERVATIONAL,Insufficient personnel dedication.
NCT05256498,WITHDRAWN,INTERVENTIONAL,Merged with other study
NCT05256810,TERMINATED,INTERVENTIONAL,The Sponsor elected not to continue with the study
NCT05256836,SUSPENDED,INTERVENTIONAL,Enrollment suspended
NCT05257187,WITHDRAWN,INTERVENTIONAL,unable to recruit participants due to COVID pandemic
NCT05257733,WITHDRAWN,OBSERVATIONAL,Departure of the project leader
NCT05258617,TERMINATED,OBSERVATIONAL,Study was associated with a declining population - COVID 19. Difficulty recruiting participants.
NCT05258929,TERMINATED,OBSERVATIONAL,low inclusion rate
NCT05259397,WITHDRAWN,INTERVENTIONAL,Pfizer has decided to terminate Study C4661001 due to strategic considerations. This decision is not due to any specific safety reasons or requests from any regulatory authorities. No participants have been enrolled in this study.
NCT05259514,TERMINATED,INTERVENTIONAL,safety
NCT05259631,SUSPENDED,INTERVENTIONAL,Financial problems
NCT05259813,WITHDRAWN,INTERVENTIONAL,Due to the COVID-19 pandemicno subjects enrolled
NCT05259865,SUSPENDED,OBSERVATIONAL,Working on obtaining approvals
NCT05259878,SUSPENDED,OBSERVATIONAL,Awaiting Approvals
NCT05260099,WITHDRAWN,OBSERVATIONAL,Company decision not to start study
NCT05260541,TERMINATED,INTERVENTIONAL,No longer developing for this indication
NCT05260788,WITHDRAWN,OBSERVATIONAL,Administrative issues.
NCT05260801,WITHDRAWN,INTERVENTIONAL,We did not receive funding.
NCT05261139,SUSPENDED,INTERVENTIONAL,Recruitment was paused to allow time for further pharmacokinetic modelling and simulation work to be performed to determine further dose regimens and PK blood sampling. No safety concerns have been observed in participants enrolled to date.
NCT05261490,TERMINATED,INTERVENTIONAL,A business decision was made by Pfizer to terminate and remove the Phase 2 expansion of this study for administrative reasons. The reason for study termination is not due to any safety concerns or requests from regulatory authorities.
NCT05261646,WITHDRAWN,INTERVENTIONAL,Sponsor R \& D Strategy Adjustment
NCT05262101,TERMINATED,INTERVENTIONAL,The sponsor has decided to terminate this study based on the current clinical research status of dual antibody drugs and full communication with the investigators.
NCT05262517,TERMINATED,INTERVENTIONAL,Strategic decision to discontinue the study based on adjusted clinical development plan. This decision is not based on any safety concerns.
NCT05262699,SUSPENDED,INTERVENTIONAL,Unability to include participants during Covid pandemic
NCT05262712,TERMINATED,INTERVENTIONAL,Unability to reach anticipated participant numbers during COVID pandemic
NCT05262842,WITHDRAWN,INTERVENTIONAL,The sponsor voluntarily terminated the study before it was initiated
NCT05263440,WITHDRAWN,INTERVENTIONAL,The study never started because one of the collaborators was not able to attend to the study requirements.
NCT05263505,TERMINATED,INTERVENTIONAL,Sponsor
NCT05263609,WITHDRAWN,INTERVENTIONAL,PI left University
NCT05263648,WITHDRAWN,INTERVENTIONAL,due to an issue with the software developer that cannot be resolved.
NCT05264506,TERMINATED,INTERVENTIONAL,Sponsor decision to stop the study early and complete all required study close-out activities. This decision was made for business reasons unrelated to safety. None of the pre-specified efficacy endpoints were analyzed.
NCT05264922,WITHDRAWN,INTERVENTIONAL,Study never started. PI left institution.
NCT05264974,SUSPENDED,INTERVENTIONAL,major protocol revision in progress
NCT05265156,TERMINATED,INTERVENTIONAL,High drop out rate
NCT05265208,SUSPENDED,INTERVENTIONAL,1st level of sequential inclusion reached
NCT05265845,WITHDRAWN,INTERVENTIONAL,PI transferred to a different institution prior to starting the intervention.
NCT05266430,TERMINATED,OBSERVATIONAL,Sponsor Decision - Low Enrollment
NCT05266677,WITHDRAWN,INTERVENTIONAL,Foreseen high level of subject burden and non compliance in the clinical trial due to extensive product preparation and the nutritional concept for the improvement of RBC DHA is compromised by the change in the product formulation
NCT05267418,TERMINATED,INTERVENTIONAL,COVID19 pandemia
NCT05267574,TERMINATED,INTERVENTIONAL,Parent study failed to show therapeutic effect
NCT05267925,TERMINATED,INTERVENTIONAL,Pending additional product QA
NCT05268315,WITHDRAWN,INTERVENTIONAL,"Per PI, this study is not a Clinical trial and was inadvertently entered in the system"
NCT05268497,WITHDRAWN,INTERVENTIONAL,due to budget decision and wanting to pursue other research priorities
NCT05268926,TERMINATED,INTERVENTIONAL,"Due to a delayed start-up and delayed patient inclusion in combination with new available scientific data, continuation of the clinical study no longer serves a scientific purpose."
NCT05269121,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05269134,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05269667,TERMINATED,INTERVENTIONAL,Study has proved infeasible to recruit in sufficient numbers. There are insufficient eligible patients presenting to sites.
NCT05270031,TERMINATED,INTERVENTIONAL,lack of funding
NCT05270785,TERMINATED,INTERVENTIONAL,Lack of eligible participants during study time period
NCT05271279,TERMINATED,INTERVENTIONAL,Research and development strategy adjustment
NCT05271656,TERMINATED,INTERVENTIONAL,Check Cap board of directors decision to stop all company activities including clinical trails
NCT05272059,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05273658,WITHDRAWN,INTERVENTIONAL,Termination of funding
NCT05273918,WITHDRAWN,INTERVENTIONAL,logistic problem and absence of coordinating Investigator
NCT05273983,TERMINATED,INTERVENTIONAL,Principal Investigator medical leave
NCT05274061,TERMINATED,INTERVENTIONAL,"Nonrandomized, open-label study terminated at the end of the program's funding cycle."
NCT05274217,TERMINATED,INTERVENTIONAL,Significant revision of protocol inspired by site staff changes and site COVID delays
NCT05275166,WITHDRAWN,INTERVENTIONAL,technical resources not available
NCT05275257,WITHDRAWN,INTERVENTIONAL,The study never started due to lack of mutual agreements.
NCT05275673,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05275907,WITHDRAWN,INTERVENTIONAL,Screened participants did not meet inclusion criteria prior to study completion date
NCT05276115,SUSPENDED,OBSERVATIONAL,Prioritizing other studies
NCT05276401,TERMINATED,INTERVENTIONAL,Request for additional preclinical data.
NCT05276622,TERMINATED,OBSERVATIONAL,Investigator left the institution.
NCT05276830,TERMINATED,INTERVENTIONAL,Study was terminated for business reasons; not due to safety or efficacy concerns
NCT05276895,SUSPENDED,INTERVENTIONAL,unavailability of drugs
NCT05277363,WITHDRAWN,OBSERVATIONAL,"The study stopped early, before enrolling its first participant"
NCT05278858,TERMINATED,INTERVENTIONAL,Lack of participants
NCT05279222,WITHDRAWN,INTERVENTIONAL,No participants were enrolled in the study within an inclusion period of 8 months
NCT05279235,TERMINATED,INTERVENTIONAL,Development strategy adjustment
NCT05279534,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05279859,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT05280392,TERMINATED,OBSERVATIONAL,EHVA T02/ANRS VRI07 clinical trial had been discontinued. Find relevant information on the EHVA website: https://ehv-a.eu/trials/ehva-t02
NCT05280821,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT05280990,WITHDRAWN,INTERVENTIONAL,Technical requirements not met.
NCT05281198,TERMINATED,INTERVENTIONAL,Low enrollment of participants
NCT05281250,WITHDRAWN,INTERVENTIONAL,structural change at the hospital
NCT05281302,WITHDRAWN,INTERVENTIONAL,Technological problem
NCT05281562,TERMINATED,INTERVENTIONAL,There are not enough patients at our institution meeting eligibility criteria to complete the study as intended.
NCT05283304,TERMINATED,INTERVENTIONAL,Side effects of medication
NCT05283954,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05284019,TERMINATED,INTERVENTIONAL,The study was terminated due to enrolment challenges.
NCT05284214,WITHDRAWN,INTERVENTIONAL,Study did not commence.
NCT05284331,TERMINATED,INTERVENTIONAL,lack of recruitment
NCT05284604,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT05284812,SUSPENDED,INTERVENTIONAL,It is planned to restart the clinical study after the completion of the clinical trial protocol modification.
NCT05285956,TERMINATED,INTERVENTIONAL,Personnel Change
NCT05286580,TERMINATED,INTERVENTIONAL,We lost some staffing and were unable to continue the study.
NCT05287971,WITHDRAWN,OBSERVATIONAL,Never started
NCT05288218,WITHDRAWN,INTERVENTIONAL,Difficulty enrolling
NCT05288283,TERMINATED,INTERVENTIONAL,The study was terminated due to a business decision.
NCT05288387,TERMINATED,INTERVENTIONAL,No perceivable effect of transcutaneous spinal cord stimulation on blood pressure in heart failure patients
NCT05288413,WITHDRAWN,OBSERVATIONAL,abandoned before opening
NCT05288556,SUSPENDED,INTERVENTIONAL,"Voluntary pause in enrollment to revise inclusion criteria and need for reliable transportation, after one unanticipated problem with a participant who had challenges attending safety clinical visits."
NCT05289492,TERMINATED,INTERVENTIONAL,Company operational decision. Decision to stop study is not due to safety or efficacy concerns
NCT05289570,SUSPENDED,INTERVENTIONAL,"Pending Protocol amendment, enrollment is on hold. There are no active subjects currently."
NCT05289882,WITHDRAWN,INTERVENTIONAL,Unable to recruit sufficient sample to commence trial
NCT05290987,TERMINATED,INTERVENTIONAL,Number of participants needed not reached (13/80)
NCT05291767,TERMINATED,INTERVENTIONAL,Personnel and funding issues
NCT05291897,TERMINATED,OBSERVATIONAL,The number of needed patients wasn't enrolled
NCT05291988,TERMINATED,INTERVENTIONAL,Terminated due to low accrual
NCT05292443,WITHDRAWN,OBSERVATIONAL,No participants were enrolled
NCT05292976,WITHDRAWN,INTERVENTIONAL,Business reasons
NCT05293106,TERMINATED,INTERVENTIONAL,Difficulty recruiting and enrolling subjects.
NCT05293236,TERMINATED,INTERVENTIONAL,Lack of patients due to reduced incidence in the COVID-19 infected population in Spain
NCT05293340,TERMINATED,INTERVENTIONAL,Per discretion of Sponsor.
NCT05293509,WITHDRAWN,INTERVENTIONAL,0 accrual
NCT05293522,TERMINATED,INTERVENTIONAL,Enrollment Rate
NCT05293938,WITHDRAWN,OBSERVATIONAL,A fundamental protocol deviation on data capture left the database no longer fit for purpose.
NCT05295394,WITHDRAWN,INTERVENTIONAL,"Low recruitment, We did not find participants with the M184V mutation , inclusion criteria , throughout 230 resistance tests carried out"
NCT05295589,WITHDRAWN,INTERVENTIONAL,Drug supply issues
NCT05295758,TERMINATED,INTERVENTIONAL,Due lack of eligible participants
NCT05295771,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants.
NCT05295927,TERMINATED,INTERVENTIONAL,Administrative Decision
NCT05296642,WITHDRAWN,INTERVENTIONAL,Principal investigator decision
NCT05297032,TERMINATED,INTERVENTIONAL,"Labs ordering channel is no longer available. Indena (collaborator) opted not to increase funding for an alternative, terminated study."
NCT05297045,TERMINATED,INTERVENTIONAL,Terminated due to financial constraint.
NCT05297526,WITHDRAWN,INTERVENTIONAL,Unable to recruite participants due to COVID-19 and other barriers
NCT05297864,TERMINATED,INTERVENTIONAL,Funder terminated funding.
NCT05298267,WITHDRAWN,INTERVENTIONAL,withdrawn prior to study launch because a research partnership with the school district could not be secured in time
NCT05298332,TERMINATED,INTERVENTIONAL,Terminated by the Sponsor
NCT05298397,SUSPENDED,INTERVENTIONAL,Research team reconstruction (replace clinician who is necessary for study to proceed)
NCT05298501,TERMINATED,OBSERVATIONAL,Study stopped after first round of assessments and recruitment completed. Latter rounds were no longer required.
NCT05298644,WITHDRAWN,INTERVENTIONAL,"Valneva has contacted regulators to align on potential adjustments to the previously agreed Pediatric Investigational Plan. Valneva has suspended VLA2001 pediatric development, and study VLA2001-321 will not commence."
NCT05299190,WITHDRAWN,INTERVENTIONAL,Recruitment challenges due to COVID-19 pandemic
NCT05299541,TERMINATED,INTERVENTIONAL,Difficulties recruiting new subjects
NCT05299580,WITHDRAWN,INTERVENTIONAL,lack of enrollment
NCT05300074,SUSPENDED,INTERVENTIONAL,adjustments needed after pilot period and delay because of reduced staff
NCT05300191,SUSPENDED,OBSERVATIONAL,temporary pause due to business priorities
NCT05300490,WITHDRAWN,OBSERVATIONAL,"As practices had changed by the time this trial was being set up, there was no inclusion in this study."
NCT05301062,TERMINATED,OBSERVATIONAL,"Due to the changes of standard of care, the slow recruitment of participants, and the similar safety profile data on real-world use of Radium-223 in China has been published."
NCT05301595,WITHDRAWN,INTERVENTIONAL,Study was never started as PI moved to another city
NCT05302570,WITHDRAWN,INTERVENTIONAL,withdrawn by PI
NCT05303571,WITHDRAWN,OBSERVATIONAL,not feasible
NCT05304130,WITHDRAWN,INTERVENTIONAL,This study was cancelled because of the limited efficacy demonstrated in the ContRAst phase III programme as a potential treatment for rheumatoid arthritis. GSK has decided not to progress with regulatory submissions
NCT05304494,WITHDRAWN,OBSERVATIONAL,Limited resources
NCT05304663,WITHDRAWN,INTERVENTIONAL,The Sponsor had no further plan for the study in object
NCT05305040,TERMINATED,INTERVENTIONAL,Study discontinued as DSMB determined it was futile. No safety concerns were noted.
NCT05305352,SUSPENDED,INTERVENTIONAL,Due to less number of participants willing to participate.
NCT05306756,TERMINATED,INTERVENTIONAL,Insufficient randomizations due to changes in clinical practice
NCT05306977,TERMINATED,INTERVENTIONAL,pilot project. grant not funded
NCT05307276,TERMINATED,INTERVENTIONAL,Organisation problem
NCT05307471,TERMINATED,OBSERVATIONAL,No neuropathic pain in recruited subjects
NCT05307627,SUSPENDED,OBSERVATIONAL,Technological barriers are affecting the participant response experience.
NCT05308407,SUSPENDED,INTERVENTIONAL,Committee Request
NCT05308589,TERMINATED,INTERVENTIONAL,"The study no longer fits our strategic goals. The preliminary results of FLUID have led to an improved version of the current device. We believe it is necessary to initiate a new study, with the improved version of the device."
NCT05308602,WITHDRAWN,INTERVENTIONAL,There was not a need any more.
NCT05309902,WITHDRAWN,INTERVENTIONAL,Study not needed
NCT05310565,WITHDRAWN,INTERVENTIONAL,Low recruitment rate
NCT05312021,WITHDRAWN,INTERVENTIONAL,Study Termination
NCT05312307,WITHDRAWN,OBSERVATIONAL,Screening of RNA expression profiles will be integrated directly into the Strata PATH study.
NCT05312372,WITHDRAWN,INTERVENTIONAL,Strategic development reasons
NCT05312554,WITHDRAWN,INTERVENTIONAL,Company policy
NCT05312697,TERMINATED,INTERVENTIONAL,Sponsor decision not related to safety concerns
NCT05312996,SUSPENDED,INTERVENTIONAL,Prioritizing other studies
NCT05313009,TERMINATED,INTERVENTIONAL,Study drug was discontinued by manufacturer for business reasons.
NCT05313386,WITHDRAWN,INTERVENTIONAL,"The study stopped early, before enrolling its first participant"
NCT05314868,TERMINATED,OBSERVATIONAL,Sponsor declined to continue funding the study.
NCT05315401,WITHDRAWN,INTERVENTIONAL,Fail to recruit
NCT05315479,TERMINATED,INTERVENTIONAL,Anjeso (N1539) NDA Withdrawn
NCT05315687,WITHDRAWN,INTERVENTIONAL,Study is being closed because PI left Emory
NCT05315817,TERMINATED,INTERVENTIONAL,Internal reasons
NCT05315908,TERMINATED,INTERVENTIONAL,"Because of low testing uptake, slow accrual at participating health centers and continuously changing COVID pandemic, research investigators had to terminate the original study and consider alternate strategies."
NCT05315973,WITHDRAWN,INTERVENTIONAL,"We never were able to start this study, as an NDA agreement had been signed, after we had anticipated enrolling, preventing starting."
NCT05316909,WITHDRAWN,INTERVENTIONAL,Alternate study completed
NCT05317013,TERMINATED,INTERVENTIONAL,Low enrollment
NCT05317676,WITHDRAWN,INTERVENTIONAL,Sponsor suspending temporarily.
NCT05318079,WITHDRAWN,INTERVENTIONAL,The study was not selected for funding.
NCT05318690,TERMINATED,INTERVENTIONAL,Difficulty with recruitment
NCT05319028,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05319379,TERMINATED,OBSERVATIONAL,No plans to continue study or publish data.
NCT05320380,WITHDRAWN,INTERVENTIONAL,Withdrawn per CS0150757
NCT05321251,WITHDRAWN,INTERVENTIONAL,Study never commenced due to logistical issues.
NCT05321498,WITHDRAWN,INTERVENTIONAL,MCI patients will now be enrolled in the XPro1595-AD-02 study.
NCT05321524,TERMINATED,INTERVENTIONAL,"After extensive efforts to improve recruitment, it is deemed not feasible to enroll the requisite number of subjects to generate data needed to meet the study objectives. EMA Paediatric Committee agreed with the Sponsor to terminate this study."
NCT05321862,WITHDRAWN,INTERVENTIONAL,MIDAS inclusions terminated before first inclusion in PENTI-MIDAS
NCT05321940,WITHDRAWN,INTERVENTIONAL,Investigator decision
NCT05321953,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting
NCT05322616,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05323019,TERMINATED,INTERVENTIONAL,Funding
NCT05323110,TERMINATED,INTERVENTIONAL,Portfolio reprioritization
NCT05323136,TERMINATED,INTERVENTIONAL,Strategic decision
NCT05323617,WITHDRAWN,INTERVENTIONAL,Operational
NCT05325112,TERMINATED,OBSERVATIONAL,Sponsor decision to terminate the study
NCT05325164,WITHDRAWN,INTERVENTIONAL,"Trial not started; change in Sponsor and Principal Investigator, trial to be registered again by new Sponsor/Investigator if it is started."
NCT05325567,TERMINATED,INTERVENTIONAL,study was not renewed.
NCT05326074,TERMINATED,INTERVENTIONAL,IRB Concerns
NCT05327361,TERMINATED,INTERVENTIONAL,Enrollment timeline ended
NCT05327608,SUSPENDED,INTERVENTIONAL,The study is on hold due to data base issues
NCT05327738,WITHDRAWN,INTERVENTIONAL,"Due to inadequate funding. This trial may open as a new clinical trial at a later date, pending drug approval."
NCT05327816,TERMINATED,INTERVENTIONAL,"Based on recent study data from VAC18193, it was decided to terminate the study. There are no underlying safety concerns to terminate VAC18195RSV1001"
NCT05327855,WITHDRAWN,INTERVENTIONAL,"Withdrawn based on business decision, no participants enrolled"
NCT05328102,TERMINATED,INTERVENTIONAL,The study has been terminated early by the sponsor due to business decision.
NCT05328375,SUSPENDED,INTERVENTIONAL,Telehealth Vendor Transition
NCT05329168,WITHDRAWN,INTERVENTIONAL,business decision before FPFV; not related to any safety concerns
NCT05329545,TERMINATED,INTERVENTIONAL,Study Terminated by Sponsor
NCT05330013,WITHDRAWN,INTERVENTIONAL,PI left NIH
NCT05330286,TERMINATED,INTERVENTIONAL,The compound is no longer suitable for further clinical development due to a safety finding in a later phase program.
NCT05330377,WITHDRAWN,INTERVENTIONAL,Sponsor withdrew funding
NCT05330598,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05330689,WITHDRAWN,INTERVENTIONAL,Funding for study equipment
NCT05330884,SUSPENDED,INTERVENTIONAL,changes in protocol
NCT05331053,SUSPENDED,INTERVENTIONAL,COVID halting human subjects research and preliminary data from this proposal were used to submit an NIH grant. The NIH grant was funded and 3 other protocols were launched.
NCT05331131,WITHDRAWN,INTERVENTIONAL,Study team not moving forward with protocol
NCT05331222,TERMINATED,INTERVENTIONAL,regulatory issues
NCT05332405,WITHDRAWN,INTERVENTIONAL,Obsolete study
NCT05332483,TERMINATED,INTERVENTIONAL,Slow enrollment
NCT05332678,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05334212,TERMINATED,INTERVENTIONAL,Lack of support/funding
NCT05335486,WITHDRAWN,INTERVENTIONAL,Lack of clinician interest and insufficient patient availability
NCT05335707,WITHDRAWN,OBSERVATIONAL,Study funds ended on 7/31/2023
NCT05335980,TERMINATED,INTERVENTIONAL,Lack of funding
NCT05337930,WITHDRAWN,INTERVENTIONAL,Not enough participants enrolled in the study
NCT05338125,TERMINATED,INTERVENTIONAL,too busy for recruitment
NCT05338229,WITHDRAWN,INTERVENTIONAL,Protocal changing due to time limitation
NCT05338281,WITHDRAWN,INTERVENTIONAL,"Study details changed, new Trial Registration process begun for modified protocol"
NCT05338424,WITHDRAWN,OBSERVATIONAL,Principal Investigator left the institution
NCT05338580,SUSPENDED,INTERVENTIONAL,Company Development strategy adjustment
NCT05338658,SUSPENDED,INTERVENTIONAL,Pending final IP
NCT05340426,WITHDRAWN,INTERVENTIONAL,Approval to move forward with this clinical trial has not been granted by governing bodies.
NCT05341388,TERMINATED,OBSERVATIONAL,not enough participants due to the pandemia
NCT05341518,WITHDRAWN,INTERVENTIONAL,Participating sites failed to secure funding and study was not feasible at one site.
NCT05341934,WITHDRAWN,INTERVENTIONAL,No Inclusion/ Study never begin
NCT05342038,WITHDRAWN,INTERVENTIONAL,Change of business strategy of Sponsor
NCT05343949,TERMINATED,INTERVENTIONAL,"lead coordinatior has left the site, need to find alternative lead for the study"
NCT05344261,WITHDRAWN,INTERVENTIONAL,study never initiated and no participants enrolled
NCT05344365,WITHDRAWN,INTERVENTIONAL,Study was terminated for business reasons; not due to safety or efficacy concerns.
NCT05344625,WITHDRAWN,INTERVENTIONAL,Study team is not moving forward with protocol
NCT05345938,TERMINATED,INTERVENTIONAL,Adjust the research strategy.
NCT05346120,WITHDRAWN,INTERVENTIONAL,Study never started
NCT05346653,TERMINATED,INTERVENTIONAL,Enrollment goals were not met.
NCT05347108,WITHDRAWN,OBSERVATIONAL,Lack of funding
NCT05347147,TERMINATED,INTERVENTIONAL,"Following a strategic evaluation of its IIH EVOLVE Phase III clinical trial investigating Presendin, the Invex Board has made the difficult decision that the continuation of the trial is not viable and therefore the trial has been terminated."
NCT05348681,TERMINATED,INTERVENTIONAL,Due to safety findings in ongoing Phase 2 trials.
NCT05349019,TERMINATED,OBSERVATIONAL,Sponsor stopped the study
NCT05349435,TERMINATED,INTERVENTIONAL,Sponsor has decided to discontinue development of fezegepras based on initial pharmacokinetic results
NCT05349760,WITHDRAWN,INTERVENTIONAL,to focus resources on other studies
NCT05349812,WITHDRAWN,OBSERVATIONAL,Sponsor focusing on completion of other studies at this time.
NCT05350488,WITHDRAWN,OBSERVATIONAL,"Study halted prematurely, prior to enrollment of first participant"
NCT05350579,TERMINATED,INTERVENTIONAL,Due to the onset of the COVID-19 pandemic
NCT05350657,TERMINATED,INTERVENTIONAL,low enrollment
NCT05351554,TERMINATED,INTERVENTIONAL,Sponsor business decision not related to safety
NCT05351866,TERMINATED,INTERVENTIONAL,Low Enrollment
NCT05352100,WITHDRAWN,INTERVENTIONAL,Researchers decided to move to another technological platform which will require a new record when that research is ready to launch.
NCT05352217,TERMINATED,OBSERVATIONAL,Accrual rate fell far below needed accrual rate.
NCT05352425,WITHDRAWN,INTERVENTIONAL,Sponsor decided to not pursue study at this time
NCT05353244,WITHDRAWN,INTERVENTIONAL,Study never commenced.
NCT05353400,TERMINATED,INTERVENTIONAL,Low recruitment and attrition of study personnel
NCT05354206,TERMINATED,INTERVENTIONAL,"Change in funding, transitioned to new grant and project"
NCT05354362,TERMINATED,INTERVENTIONAL,Based on the adjustment of clinical research and development strategysponsor decided to terminate the study
NCT05354791,TERMINATED,OBSERVATIONAL,Retrospective study that the PI decided not to proceed with
NCT05355077,WITHDRAWN,INTERVENTIONAL,Development strategy adjustment
NCT05355506,SUSPENDED,OBSERVATIONAL,covid-19
NCT05355753,TERMINATED,INTERVENTIONAL,High levels of BRD9 degradation did not result in sufficient efficacy in heavily pre-treated synovial sarcoma and SMARCB1-null solid tumor patients treated with CFT8634 as a single agent.
NCT05356507,WITHDRAWN,OBSERVATIONAL,0 accrual
NCT05356585,WITHDRAWN,OBSERVATIONAL,Sponsor already published research that was to be obtained from this study.
NCT05357495,WITHDRAWN,INTERVENTIONAL,PI is retiring
NCT05357664,TERMINATED,INTERVENTIONAL,Business decision made not to fund study
NCT05357898,TERMINATED,INTERVENTIONAL,Corporate Decision
NCT05359081,TERMINATED,INTERVENTIONAL,Due to company business strategy
NCT05359692,WITHDRAWN,INTERVENTIONAL,Business decision; no safety concerns
NCT05359874,WITHDRAWN,INTERVENTIONAL,application has been withdrawn
NCT05360745,WITHDRAWN,INTERVENTIONAL,There was lack of patient recruitment and no activity from the unique investigator site.
NCT05361109,WITHDRAWN,INTERVENTIONAL,Difficulty recruiting subjects
NCT05361356,TERMINATED,INTERVENTIONAL,"Investigational product had been released in NMPA, Sponsor decided to terminate the study aligned with investigator."
NCT05361915,SUSPENDED,INTERVENTIONAL,Sorrento Therapeutics filed for chapter 11 bankruptcy.
NCT05361993,SUSPENDED,INTERVENTIONAL,External factor: trial equipment problems
NCT05362032,SUSPENDED,INTERVENTIONAL,"Electronics in OmnEcoil system clamp stand are undergoing electronic bench testing. Once images are successfully obtained, recruitment/enrollment will promptly resume."
NCT05362331,WITHDRAWN,INTERVENTIONAL,Contract issues
NCT05362474,TERMINATED,INTERVENTIONAL,Funding not available
NCT05362487,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT05363436,SUSPENDED,INTERVENTIONAL,Recruitment Reorganzing
NCT05363605,TERMINATED,INTERVENTIONAL,Fusion announced that it is discontinuing this study as part of a portfolio prioritization and assessment; Fusion no longer plans to pursue development of FPI-1966.
NCT05363644,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to lack of funding
NCT05363735,WITHDRAWN,OBSERVATIONAL,Device can't meet the requirements
NCT05363839,TERMINATED,INTERVENTIONAL,"Based on the unblinded clinical data, the trial was terminated."
NCT05364099,WITHDRAWN,INTERVENTIONAL,Unable to feasibly complete study.
NCT05364775,WITHDRAWN,OBSERVATIONAL,CI not pursuing study
NCT05365100,WITHDRAWN,INTERVENTIONAL,Due to company decision
NCT05365243,WITHDRAWN,INTERVENTIONAL,"Single-site study, site was unable to participate"
NCT05365399,TERMINATED,INTERVENTIONAL,Data collection protocol was not followed-up properly. Results are not reliable
NCT05365464,WITHDRAWN,INTERVENTIONAL,Investigator still working on protocol and not sure when it will be ready
NCT05366296,WITHDRAWN,INTERVENTIONAL,business stragety
NCT05366439,TERMINATED,INTERVENTIONAL,Sponsor decision to deprioritize the dengue program
NCT05366699,SUSPENDED,INTERVENTIONAL,Regulatory
NCT05367401,WITHDRAWN,INTERVENTIONAL,waiting for update from Study Lead
NCT05367661,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05367843,TERMINATED,INTERVENTIONAL,Business Decision
NCT05368402,TERMINATED,INTERVENTIONAL,low recruitment rate
NCT05368506,WITHDRAWN,INTERVENTIONAL,PI discretion
NCT05368519,WITHDRAWN,INTERVENTIONAL,Patients were not interested in participating in the study
NCT05368688,TERMINATED,OBSERVATIONAL,Recruitment rate was too low to continue the study.
NCT05370534,WITHDRAWN,OBSERVATIONAL,Funding
NCT05371002,SUSPENDED,INTERVENTIONAL,"Due to lack of funding source, the main trial has been suspended. The research team is looking for funding source to recover the trial."
NCT05371275,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to challenges in patient enrollment
NCT05371860,WITHDRAWN,INTERVENTIONAL,PI voluntarily closed the study. Will be reopened as a national cooperative group trial.
NCT05371951,WITHDRAWN,INTERVENTIONAL,Difficulty in study subject recruitment
NCT05372523,TERMINATED,OBSERVATIONAL,No participants completed study
NCT05372783,WITHDRAWN,INTERVENTIONAL,Study was never launched
NCT05372809,TERMINATED,INTERVENTIONAL,Study terminated due to slow enrollment and change in strategy.
NCT05372887,WITHDRAWN,INTERVENTIONAL,The study was stopped due to business reasons.
NCT05373381,WITHDRAWN,INTERVENTIONAL,Study is on hold indefinitely due to funding issues.
NCT05374265,WITHDRAWN,INTERVENTIONAL,Funding Unsuccessful
NCT05374330,WITHDRAWN,INTERVENTIONAL,Study withdrawn
NCT05374421,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05374538,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05374603,SUSPENDED,INTERVENTIONAL,The sponsor needs to comprehensively evaluate the benefit and risk of the study.
NCT05374941,TERMINATED,INTERVENTIONAL,Technical issues related to the intervention
NCT05374993,WITHDRAWN,INTERVENTIONAL,Funding limitation
NCT05375253,WITHDRAWN,INTERVENTIONAL,PI has left institution and is taking the study with him.
NCT05375552,SUSPENDED,INTERVENTIONAL,Recruitment has been suspended due to a lack of available staff.
NCT05375604,TERMINATED,INTERVENTIONAL,Company Bankruptcy
NCT05375747,WITHDRAWN,INTERVENTIONAL,Unable to recruit participants due to hospital conditions
NCT05375760,TERMINATED,INTERVENTIONAL,"Sponsor terminated after review of FDA's request to halt further dosing (30Mar2023) given that AZD7442 is not active against \>99% of the currently circulating SARS-CoV-2 variants in the USA, the benefit risk assessment may not be favorable"
NCT05375825,WITHDRAWN,INTERVENTIONAL,No participants enrolled.
NCT05376839,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT05378048,WITHDRAWN,INTERVENTIONAL,no funding support
NCT05378750,TERMINATED,INTERVENTIONAL,Recruitment difficulties
NCT05378763,SUSPENDED,INTERVENTIONAL,The study has not enrolled any patients. The study design is under discussion and will likely be redesigned in consultation with the FDA.
NCT05378828,TERMINATED,INTERVENTIONAL,"difficulties encountered that were not highlighted in previous studies (traffic situations that made daily life difficult for users, need to rework the system)"
NCT05378958,WITHDRAWN,OBSERVATIONAL,Les investigateurs n'ont pas pu commencer et mener la recherche
NCT05379179,TERMINATED,INTERVENTIONAL,"After 20 months of active enrollment and a lack of qualified/interested subjects, the Investigator, Meghan Spyres, MD, decided to terminate recruitment before meeting the stated enrollment objectives."
NCT05379296,WITHDRAWN,INTERVENTIONAL,Inadequate resources to complete within the required timeline.
NCT05379322,WITHDRAWN,INTERVENTIONAL,Decision of the local healthcare authority
NCT05379439,WITHDRAWN,INTERVENTIONAL,IRB protocol was terminated
NCT05379452,TERMINATED,OBSERVATIONAL,"The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT05379907,WITHDRAWN,OBSERVATIONAL,Determined that the tumor analysis could not be performed in accordance with the protocol.
NCT05380557,TERMINATED,OBSERVATIONAL,Low site engagement and accrual
NCT05381363,TERMINATED,INTERVENTIONAL,"The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance."
NCT05381610,TERMINATED,INTERVENTIONAL,Lack of enrollment - Sponsor decision
NCT05381688,WITHDRAWN,OBSERVATIONAL,Covid prevented us from performing the study and the funding ran out
NCT05381935,WITHDRAWN,INTERVENTIONAL,Sponsor's clinical development strategy adjustment
NCT05381974,WITHDRAWN,INTERVENTIONAL,Study was terminated due to difficulty recruiting patients who met inclusion/exclusion criteria. No participants received the intervention.
NCT05382338,SUSPENDED,INTERVENTIONAL,Drug Supply Issues
NCT05382819,TERMINATED,INTERVENTIONAL,Business Decision
NCT05383001,WITHDRAWN,INTERVENTIONAL,"Study was set-up in 2017, even though the protocol was adjusted, it was not possible to find suitable patients."
NCT05384379,TERMINATED,INTERVENTIONAL,Suboptimal enrollment
NCT05384548,TERMINATED,INTERVENTIONAL,We were unable to recruit and retain sufficient participants.
NCT05384665,TERMINATED,INTERVENTIONAL,rate of inclusion too low
NCT05385341,WITHDRAWN,INTERVENTIONAL,The start of the study took too long and there are already many publications on the subject
NCT05386472,SUSPENDED,INTERVENTIONAL,Recruitment was paused to allow time for further pharmacokinetic modelling and simulation work to be performed to determine further dose regimens and PK blood sampling. No safety concerns have been observed in participants enrolled to date.
NCT05386693,TERMINATED,OBSERVATIONAL,Low enrollment
NCT05386823,TERMINATED,INTERVENTIONAL,The sponsor terminated the study for commercial reasons
NCT05387317,WITHDRAWN,INTERVENTIONAL,Trial cancelled prior to commencement due to lack of funding.
NCT05387343,WITHDRAWN,OBSERVATIONAL,funding lost
NCT05387577,TERMINATED,INTERVENTIONAL,per MCW IRB
NCT05387642,WITHDRAWN,INTERVENTIONAL,Sponsor no longer pursuing indication.
NCT05387668,WITHDRAWN,INTERVENTIONAL,Sponsor determined the data was no longer needed.
NCT05387707,TERMINATED,INTERVENTIONAL,"In Part A of the study, oral difelikefalin as adjunct to topical corticosteroids (TCS) did not demonstrate meaningful clinical benefit compared to TCS alone."
NCT05387798,WITHDRAWN,INTERVENTIONAL,Program terminated
NCT05388279,TERMINATED,INTERVENTIONAL,"Due to the adjustment and change of the sponsor's R\&D strategy, we now plan to voluntarily terminate this clinical trial."
NCT05388435,TERMINATED,INTERVENTIONAL,The study has been terminated based on portfolio prioritization. No safety trends or issues were identified at any dose level.
NCT05388617,TERMINATED,INTERVENTIONAL,This study stopped because of a business decision.
NCT05389488,WITHDRAWN,INTERVENTIONAL,Change in funding
NCT05390021,WITHDRAWN,INTERVENTIONAL,Unable to enroll patients to study
NCT05390177,WITHDRAWN,INTERVENTIONAL,The study never started because it was not funded; the study will not be conducted unless funded in the future
NCT05390606,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT05393089,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT05393635,WITHDRAWN,INTERVENTIONAL,business decision
NCT05393843,TERMINATED,INTERVENTIONAL,outbreak of covid pandemic that caused problems with nutritional coaching in person.
NCT05393999,WITHDRAWN,INTERVENTIONAL,"The drug was found to be ineffective against Omicron, so the study was terminated and no patients were enrolled."
NCT05394350,TERMINATED,INTERVENTIONAL,Business Reasons
NCT05394545,SUSPENDED,INTERVENTIONAL,staffing challenges
NCT05394558,TERMINATED,INTERVENTIONAL,IDMC recommendations
NCT05395039,WITHDRAWN,INTERVENTIONAL,"Recruitment effort yielded no enrollments, so this study was stopped. We are re-evaluating the study design."
NCT05395052,TERMINATED,INTERVENTIONAL,This study was terminated by the Sponsor.
NCT05395221,WITHDRAWN,INTERVENTIONAL,Study was not initiated.
NCT05395260,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05395858,TERMINATED,OBSERVATIONAL,Bayer business decision to close the REAL study based on the following: Target objective of enrolling at least 20 patients into the retrospective part failed; Not enough available data that would be a meaningful addition to the literature.
NCT05395936,TERMINATED,INTERVENTIONAL,low accruals
NCT05396599,TERMINATED,INTERVENTIONAL,Business Decision.
NCT05396755,TERMINATED,INTERVENTIONAL,Study was stopped due to insufficient recruitment.
NCT05397028,TERMINATED,INTERVENTIONAL,Unable to recruit sufficient number of subjects
NCT05397171,TERMINATED,INTERVENTIONAL,"This study was terminated in accordance to protocol Section 4.4, based on the overall risk-benefit profile observed to date."
NCT05399342,WITHDRAWN,OBSERVATIONAL,Did not receive grant funding to conduct the study
NCT05399368,SUSPENDED,INTERVENTIONAL,Study on clinical hold by FDA
NCT05399550,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT05399615,WITHDRAWN,INTERVENTIONAL,the company decision
NCT05399758,SUSPENDED,OBSERVATIONAL,Technical problems
NCT05400122,SUSPENDED,INTERVENTIONAL,Insufficient staff
NCT05400577,WITHDRAWN,INTERVENTIONAL,Grantor withdrew support due to slow accrual
NCT05401227,SUSPENDED,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research."
NCT05401929,SUSPENDED,INTERVENTIONAL,"June 2023 NYSPI began safety review of all human subjects research, so ongoing studies paused June 12. DHHS OHRP also issued FWA restriction on NYSPI research that included pause of human research on June 23. Research will resume upon review."
NCT05402423,WITHDRAWN,INTERVENTIONAL,It was not possible to acquire the medical device
NCT05402995,TERMINATED,INTERVENTIONAL,Enrollment was not progressing as expected.
NCT05403346,TERMINATED,OBSERVATIONAL,Study was terminated due to the difficulty to enrol patients
NCT05403528,WITHDRAWN,INTERVENTIONAL,"original clinical trials form had error, but cannot be deleted at this stage"
NCT05403580,WITHDRAWN,INTERVENTIONAL,Closed due to slow accrual
NCT05405192,WITHDRAWN,INTERVENTIONAL,PI is leaving the University.
NCT05405439,TERMINATED,INTERVENTIONAL,The sponsor voluntarily terminated the study
NCT05405686,WITHDRAWN,INTERVENTIONAL,withdrawn due to practical reasons
NCT05406219,WITHDRAWN,INTERVENTIONAL,Discontinuation of program.
NCT05407766,WITHDRAWN,INTERVENTIONAL,OSSM-001 will not be used in this clinical program.
NCT05408026,WITHDRAWN,INTERVENTIONAL,"Study withdrawn, trial therapy deemed no longer novel and there was a lack of site interest."
NCT05408871,TERMINATED,INTERVENTIONAL,PI changed institutions
NCT05408923,WITHDRAWN,INTERVENTIONAL,It was determined not to be feasible at our site at this time.
NCT05409183,TERMINATED,INTERVENTIONAL,Part A of the study was successfully concluded. Part B of the study was discontinued in favor of redesigned new studies.
NCT05409378,WITHDRAWN,INTERVENTIONAL,HLT Business Decision
NCT05410301,WITHDRAWN,INTERVENTIONAL,PI leaving institution
NCT05410366,WITHDRAWN,OBSERVATIONAL,Pursuing an alternative clinical trial
NCT05411094,SUSPENDED,INTERVENTIONAL,Scheduled Interim Monitoring
NCT05411575,WITHDRAWN,INTERVENTIONAL,No participants Enrolled
NCT05411627,WITHDRAWN,INTERVENTIONAL,funding issues
NCT05411679,WITHDRAWN,INTERVENTIONAL,Futility analysis decision to terminate EP0057 compound and all Ellipses sponsored studies involving EP0057.
NCT05412264,TERMINATED,INTERVENTIONAL,REB Approval lapsed.
NCT05412706,WITHDRAWN,INTERVENTIONAL,The Principal Investigator has retired and has not been replaced has retired and a new one has not been identified Principal Investigator
NCT05412875,WITHDRAWN,INTERVENTIONAL,Funding lapse
NCT05412901,SUSPENDED,INTERVENTIONAL,"In response to quality assurance and compliance concerns about some specific studies, NYSPI is undertaking an Institute-wide safety review of human subjects research protocols. HHS OHRP issued an FWA restriction on NYSPI research as of 2023/6/23."
NCT05413187,WITHDRAWN,INTERVENTIONAL,withdrawn due to COVID-19
NCT05413642,WITHDRAWN,INTERVENTIONAL,"Due to changes in the monitoring rules for SARS-CoV-2 and the dramatic reduction in COVID-19 cases, it became extremely difficult to recruit the required number of patients provided by the study protocol to meet the study's primary objective."
NCT05414123,TERMINATED,OBSERVATIONAL,The sponsor can no longer financially support the trial.
NCT05414734,WITHDRAWN,INTERVENTIONAL,Commercialization consideration. Without safety issues.
NCT05414747,SUSPENDED,INTERVENTIONAL,waiting the new batch of investigational product.
NCT05414864,TERMINATED,INTERVENTIONAL,Takeda suspended financial support. The first phase (observational study) is ongoing.
NCT05415293,TERMINATED,INTERVENTIONAL,PI has confirmed there are no results because the samples were degraded.
NCT05415319,WITHDRAWN,INTERVENTIONAL,Not funded.
NCT05415592,WITHDRAWN,OBSERVATIONAL,This was a business decision made due to competing regulatory commitments. Please note that this was not related to the safety or performance of the device.
NCT05416320,WITHDRAWN,INTERVENTIONAL,The IRB was closed without enrolling any participants
NCT05417113,TERMINATED,INTERVENTIONAL,recruitment difficulty
NCT05417581,TERMINATED,INTERVENTIONAL,"Difficulty of recruitment for Groups 1 and 3 not allowing all recruitment to be carried out over a reasonable period of time, it was decided to close this project"
NCT05418101,TERMINATED,INTERVENTIONAL,The study terminated due to internal strategy change due to changes in risk-benefit ratio
NCT05418387,WITHDRAWN,INTERVENTIONAL,"The study will be withdrawn as the Principal Investigator, Ken Batai, left the institution prior to study activation."
NCT05418673,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05418777,TERMINATED,INTERVENTIONAL,lack of enrollment
NCT05419817,WITHDRAWN,INTERVENTIONAL,Slow Accrual
NCT05419986,TERMINATED,INTERVENTIONAL,stop due to lack of funds
NCT05420077,TERMINATED,INTERVENTIONAL,"The landscape of the study area changed, making it impossible to continue the study."
NCT05420129,SUSPENDED,OBSERVATIONAL,The researcher who was supposed to recruit the participants is not available
NCT05420714,WITHDRAWN,INTERVENTIONAL,Change in study design to quality improvement
NCT05421936,SUSPENDED,OBSERVATIONAL,Result summarized and published
NCT05422001,TERMINATED,INTERVENTIONAL,Not able to recruit opioid tolerant patients as expected
NCT05423106,TERMINATED,INTERVENTIONAL,"Strategic business decision, not due to safety concerns"
NCT05423132,WITHDRAWN,INTERVENTIONAL,Investigator left the team
NCT05423327,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05423496,WITHDRAWN,INTERVENTIONAL,Business decision based on clinical utility considerations
NCT05423535,WITHDRAWN,INTERVENTIONAL,No participants Enrolled
NCT05425862,SUSPENDED,INTERVENTIONAL,Enrolment suspended to further assess supplementary non-clinical study data.
NCT05426213,WITHDRAWN,INTERVENTIONAL,company strategy adjustment
NCT05427045,TERMINATED,INTERVENTIONAL,"Incomplete follow up, low enrollment"
NCT05427916,TERMINATED,INTERVENTIONAL,Site decided not to continue
NCT05427981,WITHDRAWN,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will not resume recruitment after the resumption of research."
NCT05428215,TERMINATED,INTERVENTIONAL,"Inability to adequately recruit participants, need for additional study participants based on preliminary data collection"
NCT05428709,TERMINATED,INTERVENTIONAL,PI leaving academia
NCT05429307,TERMINATED,OBSERVATIONAL,clinical eligibility for patient recruitment not achieved
NCT05429385,WITHDRAWN,INTERVENTIONAL,Sponsor strategy.
NCT05429645,TERMINATED,INTERVENTIONAL,"A new technique has rendered the study technique obsolete, making it inappropriate to continue the study due to lack of therapeutic interest."
NCT05429762,TERMINATED,INTERVENTIONAL,Tusamitamab ravtansine clinical development program is discontinued as CARMEN-LC03 trial did not meet dual primary endpoint of improving progression-free survival. The decision is not related to any safety concern.
NCT05429788,WITHDRAWN,INTERVENTIONAL,Lack of enrollment
NCT05430555,TERMINATED,INTERVENTIONAL,Sponsor decision.
NCT05430854,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05430958,WITHDRAWN,INTERVENTIONAL,Study was withdrawn due to sponsor decision.
NCT05431179,WITHDRAWN,INTERVENTIONAL,Due to a strategic reprioritization based on the rapidly changing clinical and commercial landscape for Bruton's tyrosine kinase inhibitors (BTK inhibitors)
NCT05431244,WITHDRAWN,INTERVENTIONAL,Research withdrawal before patient registration due to difficulty in continuing research
NCT05431439,WITHDRAWN,OBSERVATIONAL,No participants enrolled
NCT05431582,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05432804,SUSPENDED,INTERVENTIONAL,End of Initial Phase of Multi-phase protocol
NCT05432908,TERMINATED,INTERVENTIONAL,Difficulties to recruit due to COVID pandemic
NCT05432960,WITHDRAWN,INTERVENTIONAL,Study halted according to the Sponsor's descision.
NCT05433012,TERMINATED,INTERVENTIONAL,Difficult Recruiting. Too few patients.
NCT05433298,WITHDRAWN,INTERVENTIONAL,"No patient could be included because there was a decrease in the number of patients with complications due to COVID-19. Also, a Brazilian government agency granted this clinical trial, and the project execution period ended in March 2023."
NCT05433402,WITHDRAWN,INTERVENTIONAL,Organizational safety isues
NCT05433779,TERMINATED,INTERVENTIONAL,The clinical investigation IMPROVE-2 has been closed after a decision by the Swedish Medical Products Agency.
NCT05434091,WITHDRAWN,INTERVENTIONAL,Study stopped due to change in strategy.
NCT05434351,TERMINATED,OBSERVATIONAL,inadequate sample and only few patients were prescribed with vaginal DHEA
NCT05434936,SUSPENDED,INTERVENTIONAL,Temporary protocol lapse
NCT05435053,TERMINATED,INTERVENTIONAL,"The study was terminated on the basis on an evaluation of the safety and efficacy of the 9 included patients of which 2 of the patients were excluded before receiving any study treatments, thus 7 patients were treated in the study."
NCT05435235,SUSPENDED,INTERVENTIONAL,Laboratory UNGAL
NCT05435742,TERMINATED,INTERVENTIONAL,Lack of Enrollment
NCT05436236,WITHDRAWN,OBSERVATIONAL,Investigator decision
NCT05436808,WITHDRAWN,INTERVENTIONAL,No eligible participants identified
NCT05437068,WITHDRAWN,INTERVENTIONAL,Change in research focus
NCT05437679,TERMINATED,OBSERVATIONAL,Futility (slow enrollment)
NCT05438186,WITHDRAWN,OBSERVATIONAL,No participants enrolled since study start.
NCT05438485,TERMINATED,OBSERVATIONAL,The decision to terminate the study was based on business considerations by the Sponsor.
NCT05438498,TERMINATED,INTERVENTIONAL,FDA withdrew EUA for AZD7442
NCT05438758,WITHDRAWN,INTERVENTIONAL,Withdrawn by Sponsor
NCT05439941,TERMINATED,INTERVENTIONAL,Parent Study (NCT05121480) did not meet the primary endpoint.
NCT05440721,WITHDRAWN,INTERVENTIONAL,Change of company's priority; learning from a separate CT-101-CLS-001 (NCT04857515) is deemed sufficient
NCT05441826,TERMINATED,INTERVENTIONAL,Sponsor change
NCT05441917,SUSPENDED,INTERVENTIONAL,Dissolution of the research team
NCT05441930,WITHDRAWN,INTERVENTIONAL,Sponsor has suspended study to conserve capital for clinical development of lead asset
NCT05442346,SUSPENDED,INTERVENTIONAL,Sponsor decision
NCT05442684,WITHDRAWN,INTERVENTIONAL,The trial protocol was not approved by the regulatory authorities.
NCT05442762,WITHDRAWN,OBSERVATIONAL,Adjustment of research plan
NCT05442775,TERMINATED,INTERVENTIONAL,The DMC recommended the trial be discontinued due to futility following a planned second interim analysis.
NCT05443464,WITHDRAWN,INTERVENTIONAL,OSSM-001 will not be used in this program moving forward.
NCT05444153,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05444881,SUSPENDED,INTERVENTIONAL,"U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research."
NCT05445128,TERMINATED,INTERVENTIONAL,"This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety issue."
NCT05445258,TERMINATED,INTERVENTIONAL,Design of the study device will be modified
NCT05445596,TERMINATED,INTERVENTIONAL,Insufficient resources to implement intervention
NCT05445869,TERMINATED,INTERVENTIONAL,Study terminated by Sponsor.
NCT05445882,WITHDRAWN,INTERVENTIONAL,"Closed by study team, no subjects enrolled."
NCT05446129,TERMINATED,INTERVENTIONAL,Company decision
NCT05446168,TERMINATED,INTERVENTIONAL,Withdrawal of funding
NCT05447663,TERMINATED,INTERVENTIONAL,Study has been stopped following to strategic decision from the Sponsor. Not based on any safety findings or safety concerns with siremadlin.
NCT05447858,WITHDRAWN,INTERVENTIONAL,Lack of fundings
NCT05448118,WITHDRAWN,INTERVENTIONAL,This Pilot implementation Trial was never started because no providers were found who would agree to use saliva-based toxicology tests in care
NCT05448391,WITHDRAWN,INTERVENTIONAL,Due to safety findings in other ongoing Phase 2 trials.
NCT05450224,WITHDRAWN,INTERVENTIONAL,Veteran's Affairs Research and Development Office delays.
NCT05450952,TERMINATED,INTERVENTIONAL,Electronic questionnaires not being completed in a timely manner
NCT05451095,WITHDRAWN,INTERVENTIONAL,Termination of project
NCT05451654,TERMINATED,INTERVENTIONAL,the number of patients recruited was not reached because covid cases were low
NCT05451693,TERMINATED,OBSERVATIONAL,Planned recruitment was not feasible.
NCT05452174,TERMINATED,INTERVENTIONAL,transfer of PI to new organization
NCT05454306,SUSPENDED,INTERVENTIONAL,funding
NCT05454371,WITHDRAWN,INTERVENTIONAL,Study is part of PhD trajectory and currently the trajectory is in the final phases without the official start of this recruitment.
NCT05454709,WITHDRAWN,INTERVENTIONAL,Study medication could not be delivered by manufacturer.
NCT05456165,TERMINATED,INTERVENTIONAL,terminated due to reprioritization
NCT05456269,WITHDRAWN,INTERVENTIONAL,commercial reason
NCT05456633,WITHDRAWN,OBSERVATIONAL,The study has been withdrawn and no participant was enrolled.
NCT05456997,TERMINATED,OBSERVATIONAL,Loss of research capable staff
NCT05457530,WITHDRAWN,INTERVENTIONAL,Due to No/Low enrollment
NCT05457842,TERMINATED,INTERVENTIONAL,Company's strategic decision
NCT05458102,TERMINATED,INTERVENTIONAL,Sponsor's decision to change the clinical development plan of this molecule. This decision is not based on efficacy or safety concerns.
NCT05458232,WITHDRAWN,OBSERVATIONAL,No subjects enrolled
NCT05458375,TERMINATED,INTERVENTIONAL,"There is a lack of potential study participants at our study site that would meet inclusion criteria, therefore, the study is not feasible and is being terminated."
NCT05458427,TERMINATED,OBSERVATIONAL,Unethical to include many more patients when currently obtained results are sufficient.
NCT05460624,WITHDRAWN,INTERVENTIONAL,Study funding terminated prior to recruitment
NCT05460871,TERMINATED,INTERVENTIONAL,Enrollment lower than anticipated; none of the subjects completing the study.
NCT05461014,TERMINATED,INTERVENTIONAL,PI left the institution
NCT05461053,WITHDRAWN,INTERVENTIONAL,Unable to recruit
NCT05461209,WITHDRAWN,INTERVENTIONAL,Business Decision
NCT05461599,TERMINATED,INTERVENTIONAL,Enrollment too low
NCT05461638,WITHDRAWN,INTERVENTIONAL,No viable sites
NCT05461794,TERMINATED,INTERVENTIONAL,Due to modification of company strategy.
NCT05462015,WITHDRAWN,INTERVENTIONAL,Recruitment difficulty in hospital caused by COVID-19
NCT05462782,TERMINATED,INTERVENTIONAL,Lack of sufficient personnel to run this study's research visits.
NCT05463393,SUSPENDED,INTERVENTIONAL,We are waiting for the additional founds.
NCT05463679,SUSPENDED,INTERVENTIONAL,Indefinite hold by company
NCT05464407,TERMINATED,INTERVENTIONAL,Slow patient reqruitment
NCT05465148,WITHDRAWN,OBSERVATIONAL,Lack of recruitment
NCT05465395,SUSPENDED,INTERVENTIONAL,Prioritizing other studies
NCT05465590,WITHDRAWN,INTERVENTIONAL,The study was terminated due to Sponsor decision
NCT05465876,WITHDRAWN,INTERVENTIONAL,Funding pulled
NCT05466240,TERMINATED,INTERVENTIONAL,Sponsor decision to deprioritize the dengue program
NCT05466539,SUSPENDED,INTERVENTIONAL,Study suspended pending approval of a protocol amendment prior to beginning recruitment.
NCT05466747,WITHDRAWN,INTERVENTIONAL,Business decision
NCT05466916,WITHDRAWN,INTERVENTIONAL,Study was never initiated and no participants were enrolled.
NCT05467761,WITHDRAWN,INTERVENTIONAL,Sponsor was not financially able or willing to continue to support the study
NCT05468112,WITHDRAWN,INTERVENTIONAL,Insufficient resources for performance of project
NCT05469490,WITHDRAWN,INTERVENTIONAL,Lack of funding support.
NCT05469802,WITHDRAWN,INTERVENTIONAL,"Business reason, change in Zika virus epidemiology"
NCT05470400,SUSPENDED,INTERVENTIONAL,Temporarily Closed (Paused) to Accrual
NCT05470491,SUSPENDED,INTERVENTIONAL,On administrative hold for interim data analysis.
NCT05470933,TERMINATED,INTERVENTIONAL,"Terminate the study and close the research center based on strategic changes in product development, unrelated to drug safety."
NCT05471141,WITHDRAWN,INTERVENTIONAL,"Difficulty obtaining IRB approval from all sites with challenges in recruitment. No participants enrolled. So, we revised the study. Now it does not meet the NIH or FDA's definition of clinical trials. We request to close this registration."
NCT05471180,WITHDRAWN,INTERVENTIONAL,The post graduated student change her project.
NCT05471206,TERMINATED,INTERVENTIONAL,End of commercialization of the medical devices
NCT05471492,WITHDRAWN,INTERVENTIONAL,"Trial not started; change in Sponsor, a new trial to be registered by the new Sponsor"
NCT05472077,WITHDRAWN,INTERVENTIONAL,Issues with the Enrollment Location
NCT05472220,WITHDRAWN,INTERVENTIONAL,Sponsor funding
NCT05472506,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05473130,SUSPENDED,OBSERVATIONAL,The study is on-hold until updated device to be released to the market.
NCT05473234,TERMINATED,INTERVENTIONAL,Study was halted due to low follow-up rates and issues with data collection
NCT05473286,WITHDRAWN,OBSERVATIONAL,Rybelsus was not launched in Germany during the planned duration of NN9924-4540 study.
NCT05473442,TERMINATED,INTERVENTIONAL,insufficient funding to complete the study
NCT05473715,TERMINATED,INTERVENTIONAL,Study terminated due to administrative reasons not related to efficacy or safety.
NCT05474157,TERMINATED,OBSERVATIONAL,techincal reasons
NCT05474352,WITHDRAWN,INTERVENTIONAL,0 participants enrolled
NCT05474690,WITHDRAWN,INTERVENTIONAL,"The new treatment plan for HER2 positive breast cancer has entered the diagnosis and treatment guide. The treatment plan ECHP-THP in this study is not the optimal treatment plan, therefore this study was terminated."
NCT05474742,TERMINATED,INTERVENTIONAL,bankruptcy app owner
NCT05475821,TERMINATED,INTERVENTIONAL,Company decision: re-evaluation of risk vs benefit (based on animal data)
NCT05476393,WITHDRAWN,INTERVENTIONAL,no participants
NCT05476822,WITHDRAWN,OBSERVATIONAL,Not submitted for IRB approval. No participants were enrolled
NCT05477498,WITHDRAWN,INTERVENTIONAL,Principal Investigator left institution
NCT05478213,SUSPENDED,INTERVENTIONAL,Study recruitment is suspended while interim analysis occurs.
NCT05479045,SUSPENDED,INTERVENTIONAL,Protocol Amendment pending
NCT05479058,TERMINATED,INTERVENTIONAL,"the planned number of patients needed to ensure adequate precision in the estimations and to draw meaningful conclusions was unlikely to be met, questioning the scientific value and ethical grounds for study continuation"
NCT05479591,WITHDRAWN,OBSERVATIONAL,Sponsor decision
NCT05480332,WITHDRAWN,OBSERVATIONAL,Unable to execute internal logistics
NCT05480657,WITHDRAWN,INTERVENTIONAL,Study withdrawn
NCT05481112,WITHDRAWN,INTERVENTIONAL,This study was not initiated due to policy changes in Massachusetts (the proposed study sites).
NCT05481489,WITHDRAWN,INTERVENTIONAL,Due to sponsors convenience.
NCT05481775,WITHDRAWN,INTERVENTIONAL,Clincal decision based on previous results
NCT05481814,WITHDRAWN,OBSERVATIONAL,Inability to execute internal logistics to begin enrollment
NCT05481905,WITHDRAWN,INTERVENTIONAL,Business decision
NCT05482074,WITHDRAWN,INTERVENTIONAL,Principal Investigator left the institute
NCT05482152,SUSPENDED,INTERVENTIONAL,Not enough participants
NCT05482542,WITHDRAWN,INTERVENTIONAL,lack of funding for support staff
NCT05482672,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05482828,TERMINATED,INTERVENTIONAL,The Sponser doesn't fund any more
NCT05483023,SUSPENDED,INTERVENTIONAL,Drug cannot be produced and scanner down.
NCT05484011,TERMINATED,INTERVENTIONAL,sponsor decision
NCT05484167,WITHDRAWN,INTERVENTIONAL,They study lost funding and decided to close the study down.
NCT05486078,TERMINATED,INTERVENTIONAL,the study is completed
NCT05486611,TERMINATED,INTERVENTIONAL,Terminated due to difficulty enrolling patients in the proposed time frame
NCT05487040,TERMINATED,INTERVENTIONAL,Decision to terminate study was due to slow enrolment and FDA input that available data may be enough for dosing recommendations for severe renal disease (subject to review by FDA).
NCT05488444,WITHDRAWN,INTERVENTIONAL,0 Participants Accrued
NCT05488639,SUSPENDED,OBSERVATIONAL,Insufficient participation
NCT05488769,TERMINATED,OBSERVATIONAL,Investigational product not available
NCT05489445,TERMINATED,OBSERVATIONAL,Sponsor closed the product line.
NCT05489510,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05489653,TERMINATED,INTERVENTIONAL,Difficulty recruiting cases due to the epidemic
NCT05489679,TERMINATED,INTERVENTIONAL,Voluntarily terminate the study since the sponsor's development strategy was adjusted.
NCT05489991,TERMINATED,INTERVENTIONAL,Study was stopped Sponsor discretion. No patients were dosed.
NCT05490030,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT05490381,WITHDRAWN,INTERVENTIONAL,Study closed due to no accruals and change in the standard of care for this population
NCT05490563,TERMINATED,INTERVENTIONAL,"This was a business decision due to financial considerations, not based on data related to safety or therapeutic effects."
NCT05491603,SUSPENDED,INTERVENTIONAL,"Suspended: Study halted prematurely but potentially will resume. Sponsor suspension, and not due to safety or site-related matters."
NCT05491902,TERMINATED,OBSERVATIONAL,11C-leucine no longer available at Wolfson Molecular Imaging Centre (after suspension of recruitment due to COVID pandemic)
NCT05492695,TERMINATED,INTERVENTIONAL,Stopped from financial sponsor due to inability to enroll participants.
NCT05492838,SUSPENDED,INTERVENTIONAL,Due to the small sample size in flap elevation group
NCT05492851,TERMINATED,INTERVENTIONAL,The study has only enrolled 6 subjects in 6 months since study initiation. Potential participants are unwilling to participate in the study due to the randomziation and blinding. Both aspects are needed to ensure a robust comparison between groups.
NCT05493293,TERMINATED,INTERVENTIONAL,The long-term extension study was terminated because the parent study NBI-921352-FOS2021 (NCT05159908) failed to meet its primary endpoint.
NCT05493501,TERMINATED,INTERVENTIONAL,The study is being closed based on corporate changes at EQRx and is not related to any efficacy or safety issues with aumolertinib.
NCT05493618,WITHDRAWN,INTERVENTIONAL,Study Drug Unavailability
NCT05494229,TERMINATED,INTERVENTIONAL,Due to complications
NCT05494450,TERMINATED,INTERVENTIONAL,Sponsor decision secondary to data collection
NCT05494619,WITHDRAWN,INTERVENTIONAL,This study has been withdrawn due to an internal decision. The decision was not due to any safety concerns with study drug.
NCT05494814,WITHDRAWN,INTERVENTIONAL,"The central kitchen, designed to prepare and serve meals to child care centers, that this study was designed to evaluate, never launched its business."
NCT05495386,WITHDRAWN,INTERVENTIONAL,Withdrawn due to company interest and development of alternative devices for epilepsy
NCT05496192,WITHDRAWN,INTERVENTIONAL,Replaced it with another clinical trial
NCT05496244,WITHDRAWN,OBSERVATIONAL,Overall re-assessment of study design
NCT05496595,TERMINATED,INTERVENTIONAL,"Review of Data, and our other compound is a better option"
NCT05496894,WITHDRAWN,INTERVENTIONAL,"Due to the company's project adjustment, decided to stop this study"
NCT05497011,WITHDRAWN,INTERVENTIONAL,Study terminated due to lack of financing
NCT05497817,WITHDRAWN,INTERVENTIONAL,Study withdrawn and being modified under another protocol
NCT05498792,SUSPENDED,INTERVENTIONAL,Paused for safety cohort review
NCT05499416,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT05499624,TERMINATED,INTERVENTIONAL,Change in focus by the company.
NCT05499780,TERMINATED,INTERVENTIONAL,Difficulty in enrolment
NCT05501002,TERMINATED,INTERVENTIONAL,Low enrollment
NCT05501171,TERMINATED,INTERVENTIONAL,the funding agency (blue note therapeutics) pulled out and did not provide funding
NCT05501665,SUSPENDED,INTERVENTIONAL,Pending a protocol amendment
NCT05502757,WITHDRAWN,INTERVENTIONAL,Investigators decided not to move forward with study.
NCT05503108,SUSPENDED,INTERVENTIONAL,fultility
NCT05503368,SUSPENDED,INTERVENTIONAL,lack of availability of the needed kits
NCT05503810,TERMINATED,INTERVENTIONAL,Study not feasible. Acceptance rate was too low.
NCT05503823,TERMINATED,INTERVENTIONAL,Preliminary results indicate no significant difference in RMT pre- and post-tACS.
NCT05504486,WITHDRAWN,INTERVENTIONAL,Sponsor strategic decision
NCT05504642,WITHDRAWN,INTERVENTIONAL,Study stopped before submission for funding reasons
NCT05504785,TERMINATED,INTERVENTIONAL,Hip/knee arthroplasty patients are now discharged from hospital within 12 to 24 hours after COVID. patients no longer visited the pre-admission testing center after COVID so unable to insert glucose sensors pre-op.
NCT05505071,WITHDRAWN,INTERVENTIONAL,PI leaving institution and study will not be started.
NCT05505123,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05505214,WITHDRAWN,INTERVENTIONAL,Study planned but never formally submitted to the IRB
NCT05505539,WITHDRAWN,INTERVENTIONAL,Principal Investigator no longer with university.
NCT05506215,TERMINATED,INTERVENTIONAL,"After review of study data, sponsor determined wound bed preparation prior to product application was not being followed. A new study will be considered with clearer definition of wound bed preparation and strict adherence to the steps for use."
NCT05506800,SUSPENDED,OBSERVATIONAL,"Due to the rebound of the COVID-19 epidemic in the city, we have to suspend the project temporarily."
NCT05507385,WITHDRAWN,INTERVENTIONAL,Difficulties with recruitment
NCT05507918,WITHDRAWN,INTERVENTIONAL,limitations in staff and resources
NCT05507996,TERMINATED,INTERVENTIONAL,The PI decides to stop.
NCT05508893,TERMINATED,INTERVENTIONAL,Funding stopped
NCT05509322,WITHDRAWN,INTERVENTIONAL,Study is no longer going to be occurring- no subjects were enrolled at any point.
NCT05509738,TERMINATED,INTERVENTIONAL,Slow Recruitment
NCT05510245,TERMINATED,INTERVENTIONAL,The decision to terminate clinical development of lotiglipron is based on pharmacokinetic data from Phase 1 drug-drug-interaction studies and laboratory measurements of elevated transaminases in these Phase 1 studies as well as a Phase 2 study.
NCT05510427,WITHDRAWN,INTERVENTIONAL,Per PI's request
NCT05510843,TERMINATED,INTERVENTIONAL,The decision to discontinue the study was made after observing moderate drug induced liver injury in two subjects enrolled in the first dose cohort.
NCT05511519,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT05512182,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05512767,WITHDRAWN,INTERVENTIONAL,PI retired and study not moving forward
NCT05513391,TERMINATED,INTERVENTIONAL,Sponsor decision to prematurely stop the study. This decision was made without any safety concerns.
NCT05513612,WITHDRAWN,INTERVENTIONAL,The study is not initiated and we want it to be withdrawn.
NCT05514600,TERMINATED,INTERVENTIONAL,Slower than expected enrollment and early hernia recurrence
NCT05514912,WITHDRAWN,INTERVENTIONAL,PI has decided to terminate this study due to study supporter pulling support on this study.
NCT05515250,TERMINATED,INTERVENTIONAL,inadequate enrollment. Found only one participant over 1 year as opposed to anticipated over 15 patients. Inadequate research funding and staff support also added to this decision.
NCT05515692,SUSPENDED,INTERVENTIONAL,Funding
NCT05516849,WITHDRAWN,INTERVENTIONAL,"FDA requested manufacturers of Oxandrolone Tablets, to voluntarily remove previously approved drug applications for Oxandrolone from the U.S. market \& the funding decided to prematurely terminate the funding."
NCT05517226,TERMINATED,INTERVENTIONAL,"Discontinuing the development of cotadutide, a daily injectable GLP-1/glucagon co-agonist, is based on strategic pipeline considerations.

The premature closure is not due to any newly observed safety signals or a change in the risk/benefit profile."
NCT05517369,WITHDRAWN,INTERVENTIONAL,No participants fitting into the study
NCT05517837,TERMINATED,INTERVENTIONAL,Adverse change in the risk/benefit.
NCT05518006,WITHDRAWN,INTERVENTIONAL,Sponsor funding
NCT05518279,WITHDRAWN,INTERVENTIONAL,Could not work out internal logistics
NCT05518344,TERMINATED,INTERVENTIONAL,Sponsor decision to terminate the study
NCT05518422,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05518474,TERMINATED,INTERVENTIONAL,Insufficient participant enrollment due to dwindling case numbers/case severity
NCT05518721,WITHDRAWN,INTERVENTIONAL,Original PI left institution and successor has no interest in continuing project.
NCT05518942,TERMINATED,INTERVENTIONAL,Difficulty recruiting cases due to the epidemic
NCT05518968,WITHDRAWN,INTERVENTIONAL,We changed our plan.
NCT05519527,WITHDRAWN,INTERVENTIONAL,0 patient accrual
NCT05519930,SUSPENDED,OBSERVATIONAL,Study being assessed by Clinical Research Team
NCT05520970,TERMINATED,INTERVENTIONAL,Study early terminated based on the sponsor(manufacture)'s decision
NCT05522673,TERMINATED,INTERVENTIONAL,Low recruitment
NCT05522946,WITHDRAWN,INTERVENTIONAL,Participants were not assigned to an intervention and as such this was not considered a clinical trial.
NCT05523063,WITHDRAWN,OBSERVATIONAL,Study classified as out of scope by the Ethics Committee (not a project involving human person).
NCT05523310,WITHDRAWN,OBSERVATIONAL,Sponsor decided not to initiate the study and re-evaluate the study design and concept
NCT05524415,WITHDRAWN,OBSERVATIONAL,No patients were recruited by the hospital staff
NCT05524688,TERMINATED,INTERVENTIONAL,Departure of PI clinician from institution.
NCT05525156,SUSPENDED,INTERVENTIONAL,The study stopped due to expiry of study drugs
NCT05525286,SUSPENDED,INTERVENTIONAL,Sponsor decision
NCT05525455,TERMINATED,INTERVENTIONAL,Company operational decision. Decision to stop study is not due to safety or efficacy concerns.
NCT05526807,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT05526833,TERMINATED,INTERVENTIONAL,Investigator departed from institution
NCT05528692,SUSPENDED,OBSERVATIONAL,Withdrawl
NCT05528757,TERMINATED,OBSERVATIONAL,Contract termination/lack of funding
NCT05528913,WITHDRAWN,INTERVENTIONAL,Financing has been withdrawn
NCT05529316,SUSPENDED,INTERVENTIONAL,"As a business decision, this study has been paused. There are no safety concerns."
NCT05529875,WITHDRAWN,INTERVENTIONAL,"In the early stage of the research, this research was limited by the application permission of research drugs and instruments, and the research will have to be interrupted, which is extremely regrettable."
NCT05530889,WITHDRAWN,INTERVENTIONAL,"Due to changes in business priorities, CR-6494 has been withdrawn."
NCT05531708,WITHDRAWN,INTERVENTIONAL,The study is not initiated and we want it to be withdrawn.
NCT05532046,TERMINATED,INTERVENTIONAL,Due to new preclinical findings in a chronic toxicology study.
NCT05533320,WITHDRAWN,INTERVENTIONAL,PI decided to withdraw
NCT05533346,WITHDRAWN,INTERVENTIONAL,"Based on our previous investigations, we've decided to construct a scale first."
NCT05534100,TERMINATED,OBSERVATIONAL,Trial discontinued due to unreliable wearable device.
NCT05534737,SUSPENDED,INTERVENTIONAL,Study not carried out
NCT05535023,WITHDRAWN,INTERVENTIONAL,PI Request
NCT05535699,SUSPENDED,INTERVENTIONAL,finishing some devices
NCT05536401,TERMINATED,INTERVENTIONAL,Due to software changes
NCT05536687,TERMINATED,INTERVENTIONAL,minimum of participants reached and lack of ressources for recruitment
NCT05536882,WITHDRAWN,INTERVENTIONAL,The original PI left the institution prior to final IRB approval and the remaining study team did not have the resources to continue.
NCT05537935,SUSPENDED,INTERVENTIONAL,Recruitment has been temporarily paused for IRB review
NCT05538273,WITHDRAWN,OBSERVATIONAL,"Study not activated, staff left institution."
NCT05538481,WITHDRAWN,OBSERVATIONAL,Sponsor Investigator transferred from institution
NCT05538624,TERMINATED,INTERVENTIONAL,Sponsor Decision to close study
NCT05539404,TERMINATED,INTERVENTIONAL,Study ends for scientific reasons
NCT05540665,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05540756,WITHDRAWN,OBSERVATIONAL,lack of resources
NCT05541120,WITHDRAWN,INTERVENTIONAL,Lack of participants eligible for study
NCT05541159,WITHDRAWN,INTERVENTIONAL,Sponsor's decision
NCT05541393,WITHDRAWN,INTERVENTIONAL,Participant recruitment proved futile.
NCT05541952,WITHDRAWN,INTERVENTIONAL,"New evidence points to a new candidate vaccine, with a superior trial to BCG."
NCT05542095,WITHDRAWN,INTERVENTIONAL,Study halted prematurely; IRB approval not obtained
NCT05542238,SUSPENDED,INTERVENTIONAL,"Suspending this trial to focus on a new study with similar goals but different exercise intervention, ensuring resource efficiency and research effectiveness."
NCT05542446,TERMINATED,INTERVENTIONAL,"After agreement between sponsor and investigator, insufficient patients recruitment"
NCT05543356,WITHDRAWN,INTERVENTIONAL,Withdrawal of supply of vaccine from one manufacturer
NCT05543590,WITHDRAWN,INTERVENTIONAL,Withdrawn
NCT05543759,TERMINATED,OBSERVATIONAL,The sponsoring organization UNICEF-Venezuela with administrative control over the study decided to terminate it.
NCT05544045,TERMINATED,OBSERVATIONAL,Slow Enrollment
NCT05544565,SUSPENDED,INTERVENTIONAL,Joint decision by sponsor and investigator
NCT05545215,WITHDRAWN,OBSERVATIONAL,"no recruitment afetre several months, Sponsor decision"
NCT05545319,WITHDRAWN,INTERVENTIONAL,"Termination due to challenges related to the operational feasibility of the study, taking into account the current epidemiology and declining hospitalization rates for severe COVID-19."
NCT05545683,WITHDRAWN,INTERVENTIONAL,funding was suspended
NCT05546411,TERMINATED,INTERVENTIONAL,"Novartis, the drug manufacturer of NIS793, notified Dana Farber Cancer Institute that they are stopping all clinical development of NIS793 in pancreatic cancer, effective immediately."
NCT05546710,WITHDRAWN,INTERVENTIONAL,Business decision to pivot priorities
NCT05547191,TERMINATED,INTERVENTIONAL,RLS Global in bankruptcy
NCT05547412,TERMINATED,OBSERVATIONAL,"enrollment, administrative/finance"
NCT05550363,WITHDRAWN,INTERVENTIONAL,Not currently pursuing indication
NCT05550519,WITHDRAWN,INTERVENTIONAL,Sponsor decision after reevaluation of strategy in the context of recruitment timelines projection
NCT05551195,TERMINATED,INTERVENTIONAL,Internal company decision
NCT05552157,SUSPENDED,INTERVENTIONAL,Roche announced a decision to discontinue most of the company's global trials of gantenerumab. The DIAN-TU has paused the DIAN-TU-002 Primary Prevention Trial related to gantenerumab while considering other potential options for this platform trial.
NCT05552859,TERMINATED,INTERVENTIONAL,Sponsor decision to cancel trial due to poor recruitment/ severe recruitment delay and not related to safety concern.
NCT05553405,WITHDRAWN,INTERVENTIONAL,No longer able to run study
NCT05553964,TERMINATED,INTERVENTIONAL,Further usability assessment needed.
NCT05554341,SUSPENDED,INTERVENTIONAL,Scheduled Interim Monitoring
NCT05554627,WITHDRAWN,INTERVENTIONAL,Study funding was withdrawn by study sponsor (CSR\&D) prior to enrollment due to budget constraints.
NCT05554679,TERMINATED,INTERVENTIONAL,financial issues
NCT05554705,TERMINATED,INTERVENTIONAL,Lost necessary staff support
NCT05555004,TERMINATED,INTERVENTIONAL,"Based on slow recruitement and Interim analysis recommendation, the core team decide to stop the study"
NCT05555173,TERMINATED,INTERVENTIONAL,Investigator left the institution
NCT05556577,WITHDRAWN,OBSERVATIONAL,duplicated registration
NCT05557214,WITHDRAWN,INTERVENTIONAL,Unable to execute data sharing agreement with Ministry of Health.
NCT05557266,WITHDRAWN,INTERVENTIONAL,Poor recruitment. The number of interested people did not allow reaching the necessary sample size.
NCT05558280,SUSPENDED,INTERVENTIONAL,study not started
NCT05558579,WITHDRAWN,INTERVENTIONAL,Unable to enroll participants
NCT05559944,WITHDRAWN,INTERVENTIONAL,Study never started as changes to the study structure were determined by the community advisory board overseeing the project prior to study start.
NCT05560490,TERMINATED,INTERVENTIONAL,Safety issues
NCT05561322,WITHDRAWN,OBSERVATIONAL,never started
NCT05561491,WITHDRAWN,INTERVENTIONAL,Strategic reasons
NCT05561530,TERMINATED,INTERVENTIONAL,Single doses demonstrated an acceptable safety profile and antiviral activity at all doses evaluated.
NCT05561777,WITHDRAWN,INTERVENTIONAL,screening challenges that prevented the intervention from being implemented
NCT05561803,WITHDRAWN,OBSERVATIONAL,Research team withdrawn the study before starting the recruitment because the university suspended the service for administrative restructuring
NCT05562011,TERMINATED,INTERVENTIONAL,feasibility of device use
NCT05562154,WITHDRAWN,INTERVENTIONAL,PI left institution and successor no longer interested in topic.
NCT05562973,WITHDRAWN,INTERVENTIONAL,The principal investigator will be at a new institution.
NCT05563168,WITHDRAWN,INTERVENTIONAL,the epidemiological situation has changed considerably.
NCT05563948,SUSPENDED,INTERVENTIONAL,"In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023."
NCT05564338,WITHDRAWN,INTERVENTIONAL,Study has voluntarily discontinued due to a change in the company-level development strategy and is not because of any safety concern or the request from any health authority worldwide.
NCT05564416,WITHDRAWN,INTERVENTIONAL,Feasibility issues per Complete Sheet
NCT05566015,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT05566678,WITHDRAWN,INTERVENTIONAL,"The study was stopped before enrollment, after a feasibility review revealed we would be unable to measure the primary endpoint (flow mediated dilation - FMD) with a high degree of reproducibility and minimum variability in a multi-country setting."
NCT05567679,WITHDRAWN,INTERVENTIONAL,PI voluntarily closed the study.
NCT05567770,WITHDRAWN,INTERVENTIONAL,Stakeholder elected not to proceed with the study
NCT05567783,TERMINATED,INTERVENTIONAL,VIR-2482 did not achieve its primary efficacy endpoint in the prevention of seasonal Influenza A illness via intramuscular administration.
NCT05568407,TERMINATED,OBSERVATIONAL,The trial terminated due to the inability to recruit the planned number of subjects. The decision was not based on any safety and/or efficacy concerns.
NCT05570188,WITHDRAWN,INTERVENTIONAL,The PI decides to stop.
NCT05571111,WITHDRAWN,INTERVENTIONAL,Based on company decision to close the project. No trial participants received any study drug.
NCT05571241,WITHDRAWN,OBSERVATIONAL,No resident involvement
NCT05571267,TERMINATED,INTERVENTIONAL,"Following Sponsor reassessment, OPH2004 enrollment was stopped to initiate a new Zimura wet AMD trial, OPH2007, for treatment-nave patients. Thus, only one patient was enrolled into and completed Study OPH2004."
NCT05571540,WITHDRAWN,INTERVENTIONAL,The PI decides to stop.
NCT05572463,WITHDRAWN,INTERVENTIONAL,Sponsor Strategy
NCT05574166,TERMINATED,INTERVENTIONAL,"Only Part 1 was conducted but not Part 2. Due to the low exposures, definitive safety conclusions could not be made for the targeted exposure levels in the future."
NCT05574712,WITHDRAWN,INTERVENTIONAL,Principal Investigator has decided not to activate this trial.
NCT05575245,WITHDRAWN,INTERVENTIONAL,The research fund has not yet arrived.
NCT05577936,WITHDRAWN,INTERVENTIONAL,Delay in funding.
NCT05578183,WITHDRAWN,INTERVENTIONAL,The study has been registed in ChiCTR and apply for withdrawing.
NCT05578508,WITHDRAWN,INTERVENTIONAL,PI decision not to move forward with study.
NCT05579444,TERMINATED,OBSERVATIONAL,Lack of enrollment.
NCT05579977,TERMINATED,INTERVENTIONAL,The decision to terminate clinical development of PF-07081532 is based on pharmacokinetic data from Phase 1 drug-drug-interaction studies and laboratory measurements of elevated transaminases in these Phase 1 studies as well as a Phase 2 study.
NCT05580250,WITHDRAWN,INTERVENTIONAL,The sponsor made a business decision to withdraw the trial.
NCT05581095,SUSPENDED,INTERVENTIONAL,We have experienced difficulty with recruitment and will be altering the study's eligibility criteria.
NCT05581927,WITHDRAWN,INTERVENTIONAL,no patients were included
NCT05582031,WITHDRAWN,INTERVENTIONAL,Study never started/ will not proceed.
NCT05583279,WITHDRAWN,INTERVENTIONAL,We never started the study.
NCT05583539,WITHDRAWN,INTERVENTIONAL,Never IRB approved
NCT05583968,SUSPENDED,OBSERVATIONAL,sponsor decision
NCT05584137,SUSPENDED,INTERVENTIONAL,"Due to poor clinical trial accrual, the study is suspended right now."
NCT05584215,WITHDRAWN,INTERVENTIONAL,PI transitioned to new role
NCT05584332,TERMINATED,INTERVENTIONAL,Strategic adjustment
NCT05586126,TERMINATED,OBSERVATIONAL,Concerns about possible association between drug and increased ICU mortality
NCT05586555,TERMINATED,INTERVENTIONAL,Demant's transfer of its cochlear implant activity to Cochlear. Slow recruitment and misalignment with Cochlear's interests are also determining factors.
NCT05587530,SUSPENDED,INTERVENTIONAL,The study is paused.
NCT05587881,WITHDRAWN,OBSERVATIONAL,"Now, Most patients and their donor have been infected the COVID-19."
NCT05588726,WITHDRAWN,INTERVENTIONAL,Staff no longer available to continue enrollment and other research activities
NCT05589038,TERMINATED,INTERVENTIONAL,Study terminated due to project timelines.
NCT05589272,WITHDRAWN,INTERVENTIONAL,Didn't receive IRB approval
NCT05589844,WITHDRAWN,INTERVENTIONAL,Study never approved
NCT05589883,WITHDRAWN,INTERVENTIONAL,Lack of accrual
NCT05590273,TERMINATED,INTERVENTIONAL,Insufficient caregiver participation
NCT05590676,TERMINATED,INTERVENTIONAL,Low recruitment
NCT05592054,SUSPENDED,INTERVENTIONAL,DSMB suggestion
NCT05592197,WITHDRAWN,INTERVENTIONAL,This is a sub-study of another one.
NCT05592548,SUSPENDED,INTERVENTIONAL,Reevaluating protocol based on preliminary data
NCT05593770,TERMINATED,INTERVENTIONAL,"Following a meeting of the DSMB on 20th September 2023, the recommendation was made to the sponsor on 26th September 2023 that the Fostamatinib arm of the trial ceases enrolment and study medication is discontinued immediately."
NCT05594667,WITHDRAWN,INTERVENTIONAL,Funding
NCT05594810,TERMINATED,INTERVENTIONAL,"Too many eligible patients who did not want to participate, very low inclusion rate"
NCT05594940,TERMINATED,OBSERVATIONAL,Data Analysis
NCT05594979,TERMINATED,INTERVENTIONAL,The recruitment period has come to an end and will not be renewed due to insufficient recruitment.
NCT05595135,WITHDRAWN,INTERVENTIONAL,staffing
NCT05595941,TERMINATED,INTERVENTIONAL,The planned recruitment and treatment period was limited by the financial resources allocated to the study.
NCT05596058,TERMINATED,INTERVENTIONAL,Due to the unavailability of the subjects who gave the consent to participate to the study protocol
NCT05597592,WITHDRAWN,INTERVENTIONAL,no subcontractors for management of connected watches
NCT05597722,TERMINATED,INTERVENTIONAL,"Due to the evolving nature of COVID-related cognitive fog, it was determined that the study would be terminated at this time. The team agreed that it isn't feasible to collect enough data to evaluate the efficacy of the treatments."
NCT05597982,WITHDRAWN,INTERVENTIONAL,PI confirmed this study was withdrawn and did not begin locally.
NCT05598073,WITHDRAWN,INTERVENTIONAL,The student leading the project decided not to continue.
NCT05598125,TERMINATED,OBSERVATIONAL,due to recruitment reasons the study was prematurely ended
NCT05600556,WITHDRAWN,INTERVENTIONAL,ViewRay (funding sponsor) bankruptcy
NCT05600582,WITHDRAWN,INTERVENTIONAL,Due to funding decision by the sponsor
NCT05601206,SUSPENDED,INTERVENTIONAL,Care coordinators graduated
NCT05601648,WITHDRAWN,INTERVENTIONAL,Due to negative results in similar trials using 11C-UCB-J
NCT05602701,TERMINATED,OBSERVATIONAL,Intended inclusion rate was not met
NCT05602727,TERMINATED,INTERVENTIONAL,Voluntarily terminated due to benefit/risk assessment
NCT05602961,WITHDRAWN,INTERVENTIONAL,to prioritize other programs.
NCT05603143,TERMINATED,INTERVENTIONAL,The study was stopped early as it was determined there would not be a statistically significant treatment effect associated with the primary endpoint due to the low number of events.
NCT05603299,WITHDRAWN,INTERVENTIONAL,"The study recruited no participants due to a pre-recruitment decision by the sponsor to not proceed. Factors considered included logistics, resources, and new research data."
NCT05603624,TERMINATED,INTERVENTIONAL,Futility due to sample size needed to prove superiority and lack of difference in outcomes between intervention and control group.
NCT05604417,WITHDRAWN,INTERVENTIONAL,Termination of Zandelisib clinical development globally
NCT05604521,TERMINATED,INTERVENTIONAL,The main reason for trial discontinuation was the inability to address the primary objectives of the study following an extended gap between the second and third doses.
NCT05604742,WITHDRAWN,INTERVENTIONAL,No patients eligible for inclusion
NCT05604755,WITHDRAWN,INTERVENTIONAL,Drugs was too expensive eligible for inclusion
NCT05605028,WITHDRAWN,INTERVENTIONAL,I needed it to have the position of professor at the university and by the time the professorship was given it was too late for the grant therefore there is no funding and the study was never started.
NCT05606081,WITHDRAWN,INTERVENTIONAL,"Alternative method of implementation, study not needed"
NCT05607238,WITHDRAWN,INTERVENTIONAL,One of the key physicians is leaving the institution and other delays have put us behind our timeline. We do not intend to proceed with the trial at this time.
NCT05607342,TERMINATED,INTERVENTIONAL,Development of the drug program has been discontinued
NCT05608070,WITHDRAWN,INTERVENTIONAL,Sponsor declined to fund
NCT05609045,WITHDRAWN,INTERVENTIONAL,business strategy adjustment
NCT05609383,WITHDRAWN,OBSERVATIONAL,The factors influencing the results of the study have changed
NCT05609461,WITHDRAWN,OBSERVATIONAL,Necessary equipment could not be provided.
NCT05609604,TERMINATED,INTERVENTIONAL,No trained/ qualified staff available to perform study.
NCT05609812,SUSPENDED,INTERVENTIONAL,"Study recruitment is paused due to business reasons, but not due to regulatory or safety concerns."
NCT05610722,TERMINATED,INTERVENTIONAL,Internal decision
NCT05611086,TERMINATED,INTERVENTIONAL,The study stopped because the study period already ended
NCT05611853,TERMINATED,INTERVENTIONAL,Due to company decision
NCT05612529,TERMINATED,OBSERVATIONAL,increase mortality rate in cases that made it difficult to follow up
NCT05612633,WITHDRAWN,INTERVENTIONAL,Samus Therapeutics Closure
NCT05613348,WITHDRAWN,INTERVENTIONAL,The company failed to provide corresponding CART services.
NCT05614245,WITHDRAWN,INTERVENTIONAL,Study was halted prematurely prior to enrollment of first participant based on study sponsor's decision to prioritize clinical development of VBI-2901a.
NCT05614453,WITHDRAWN,INTERVENTIONAL,BeiGene has withdrawn their support owing to sitravatinib supply concerns. Mirati is ceasing further development of sitravatinib owing to the negative results of the SAPPHIRE trial which used sitravatinib in 2nd line met NSCLC setting.
NCT05614648,TERMINATED,INTERVENTIONAL,Loss of funding- Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
NCT05614817,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05614856,SUSPENDED,OBSERVATIONAL,Local ethics committee concern
NCT05614882,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05615662,WITHDRAWN,INTERVENTIONAL,Loss of grant funding.
NCT05615701,TERMINATED,INTERVENTIONAL,Sufficient number of subjects included for analyzes
NCT05615896,TERMINATED,INTERVENTIONAL,The study is no longer required.
NCT05615974,SUSPENDED,INTERVENTIONAL,suspend enrollment as HSP622C-A2022001 stability data question
NCT05616975,WITHDRAWN,OBSERVATIONAL,This project never entered the recruitment phase due to issues with hiring study personnel.
NCT05617313,SUSPENDED,INTERVENTIONAL,Interim Analysis
NCT05617625,SUSPENDED,INTERVENTIONAL,The study has been put on hold while pending CMS approval
NCT05617911,TERMINATED,INTERVENTIONAL,Study terminated due to lack of recruitment.
NCT05618561,TERMINATED,OBSERVATIONAL,High number of false negatives
NCT05618691,WITHDRAWN,INTERVENTIONAL,The study was terminated by sponsor for reasons of adjusted clinical development strategy.
NCT05621967,WITHDRAWN,INTERVENTIONAL,Change in location of Pulmonary Rehab at our institution
NCT05622058,TERMINATED,INTERVENTIONAL,The study has been terminated early given that the first four patients enrolled have experienced Grade 4 neutropenia and alopecia after cycle 1 and as such failed to meet the primary endpoint and the main secondary endpoint.
NCT05622591,WITHDRAWN,INTERVENTIONAL,Change in Strategy
NCT05622786,TERMINATED,INTERVENTIONAL,Low enrollment status
NCT05622981,TERMINATED,INTERVENTIONAL,limitations in staff and resources
NCT05623566,TERMINATED,INTERVENTIONAL,"After data quality check, inclusion criteria were not satisfied and data quality was poor. We concluded that results are not reliable"
NCT05623709,TERMINATED,OBSERVATIONAL,Recruitment difficulties
NCT05624320,WITHDRAWN,INTERVENTIONAL,Lack of interest
NCT05625256,WITHDRAWN,OBSERVATIONAL,Funding
NCT05625347,TERMINATED,INTERVENTIONAL,"The pivotal study failed to meet the primary endpoint. Without a successful readout of the pivotal study, there was no longer a purpose for the supportive BORA-1A-C302 study."
NCT05625542,WITHDRAWN,OBSERVATIONAL,The study will not be conducted
NCT05627089,WITHDRAWN,OBSERVATIONAL,Decided not to move forward
NCT05627791,TERMINATED,INTERVENTIONAL,Unable to recuit participant number in time.
NCT05628545,WITHDRAWN,INTERVENTIONAL,COVID1-19 pandemic
NCT05629364,TERMINATED,INTERVENTIONAL,Study halted prematurely but potentially will resume
NCT05629767,TERMINATED,OBSERVATIONAL,Inadequate enrolling numbers of patients
NCT05630352,WITHDRAWN,INTERVENTIONAL,Bivalent vaccine no longer epidemiologically relevant.
NCT05631418,WITHDRAWN,OBSERVATIONAL,"Due to the lack of application materials, the normal research can not be carried out for the time being."
NCT05632783,WITHDRAWN,INTERVENTIONAL,Study canceled before starting
NCT05633745,TERMINATED,INTERVENTIONAL,Business decision
NCT05633758,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT05634213,WITHDRAWN,INTERVENTIONAL,Logistical issues
NCT05634538,TERMINATED,INTERVENTIONAL,Sponsor strategic decision
NCT05635214,WITHDRAWN,OBSERVATIONAL,Poor community engagement
NCT05636722,WITHDRAWN,INTERVENTIONAL,"1. Technical reasons with the online platform for students.
2. Limited number of students using the modules of self-help for suicide: recruitment was not started and the study was withdrawn."
NCT05637333,WITHDRAWN,OBSERVATIONAL,Study classed as CTIMP
NCT05639192,TERMINATED,INTERVENTIONAL,Lack of patients
NCT05639504,WITHDRAWN,OBSERVATIONAL,"Study never started, change in company focus on US"
NCT05639738,TERMINATED,INTERVENTIONAL,recruitment difficulties
NCT05639790,WITHDRAWN,INTERVENTIONAL,Due to issues arised from the collaboration contract between sponsor and research site
NCT05640310,WITHDRAWN,OBSERVATIONAL,Internal decision made by Norbert Health
NCT05640973,WITHDRAWN,OBSERVATIONAL,Device was FDA approved before feasibility study could be performed
NCT05641298,WITHDRAWN,INTERVENTIONAL,Corporate finances
NCT05641324,TERMINATED,INTERVENTIONAL,The study was ended due to a lack of recruitment
NCT05641922,WITHDRAWN,INTERVENTIONAL,Withdrawn by Sponsor
NCT05643170,TERMINATED,INTERVENTIONAL,Company's business decision.
NCT05643573,TERMINATED,INTERVENTIONAL,Independent Data Monitoring Committee (IDMC) recommendation to stop the study
NCT05643690,TERMINATED,OBSERVATIONAL,Lack of enrollment due to amended inclusion criteria
NCT05643729,SUSPENDED,INTERVENTIONAL,Study is on hold
NCT05643755,WITHDRAWN,INTERVENTIONAL,Lack of personnel to complete study.
NCT05643950,WITHDRAWN,INTERVENTIONAL,Lack of patient recruitment by centers
NCT05644600,TERMINATED,INTERVENTIONAL,The study was terminated as no drug-drug interactions were observed in Part-A of the study and therefore Part-B of the study was not required as per protocol.
NCT05644626,WITHDRAWN,INTERVENTIONAL,Sponsor determined the data was no longer needed.
NCT05645016,SUSPENDED,INTERVENTIONAL,"The U.S. Department of Health and Human Services Office of Human Research Protections issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023."
NCT05645133,TERMINATED,OBSERVATIONAL,PI relocated to another institution
NCT05645822,WITHDRAWN,OBSERVATIONAL,"There is a problem with the provision of the treatment, we are unable to provide sufficient number of treatments for the study participants"
NCT05646459,WITHDRAWN,INTERVENTIONAL,Study was unable to obtain IRB approval because CBD was not legal in Nebraska at that time.
NCT05646602,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05647447,WITHDRAWN,INTERVENTIONAL,Development of the drug program has been discontinued
NCT05647512,WITHDRAWN,INTERVENTIONAL,According to sponsor strategy
NCT05647694,SUSPENDED,INTERVENTIONAL,Usability issues were identified with the app. Some usability enhancements are being implemented prior to continuing with the study
NCT05650086,SUSPENDED,OBSERVATIONAL,PI has left the institution (University of Arizona Cancer Center) and is working on logistics to transfer study over to their new institution (George Washington Cancer Center).
NCT05650203,WITHDRAWN,INTERVENTIONAL,the research and develop strategy of Product JS009 adjustment
NCT05650268,WITHDRAWN,INTERVENTIONAL,Because of impact from COVID-19 pandemic
NCT05650606,TERMINATED,INTERVENTIONAL,Poor enrollment
NCT05651217,TERMINATED,INTERVENTIONAL,"The production of control group products is stopped, and the control group products cannot be obtained"
NCT05652491,WITHDRAWN,OBSERVATIONAL,NIH Intramural Program is not the Responsible Party for this study and thus not responsible for registration.
NCT05652504,SUSPENDED,INTERVENTIONAL,The FDA has placed a clinical hold on the IND under which this research is to be conducted.
NCT05652907,TERMINATED,INTERVENTIONAL,For business reasons and not for reasons related to safety or efficacy
NCT05653427,TERMINATED,INTERVENTIONAL,N\~15 subjects data analysis did not meet statistical consideration of ORR and study primary/secondary objectives were not met. Enrollment was terminated for futility
NCT05653531,WITHDRAWN,INTERVENTIONAL,no participants enrolled
NCT05654064,WITHDRAWN,INTERVENTIONAL,Deferred by IRB.
NCT05654779,TERMINATED,INTERVENTIONAL,Both the sponsors and collaborator are considering terminating the study
NCT05654870,TERMINATED,INTERVENTIONAL,Study ATS3020 was closed due to business reasons. Neurocrine Biosciences will continue to conduct study ATS3019 (NCT05110157). There were no unexpected safety findings for this compound that motivated the decision.
NCT05654935,WITHDRAWN,OBSERVATIONAL,Failure to procure funding and technical logistics
NCT05655130,TERMINATED,INTERVENTIONAL,Low participation rate
NCT05655299,TERMINATED,INTERVENTIONAL,Business Decision
NCT05655442,WITHDRAWN,INTERVENTIONAL,No enough participants recruited
NCT05656170,WITHDRAWN,INTERVENTIONAL,Unable to begin study
NCT05656222,WITHDRAWN,INTERVENTIONAL,Check the IRB again
NCT05659459,SUSPENDED,INTERVENTIONAL,Sponsor has financial issues - trial currently on hold
NCT05660512,SUSPENDED,OBSERVATIONAL,The sponsor is waiting to see if enough participants complete the procedure to meet the study data requirements.
NCT05661422,WITHDRAWN,OBSERVATIONAL,Sponsor Hold
NCT05661435,WITHDRAWN,OBSERVATIONAL,Sponsor Hold
NCT05661773,WITHDRAWN,INTERVENTIONAL,FDA required a new investigational device disclosure for using the wound vac in a new way
NCT05663086,WITHDRAWN,INTERVENTIONAL,According to the development of the novel coronavirus epidemic situation and the company's R\&D decision
NCT05663554,WITHDRAWN,INTERVENTIONAL,Study sponsor cancelled funding prior to enrolment due to competing priorities.
NCT05664100,TERMINATED,INTERVENTIONAL,Business reasons
NCT05664867,WITHDRAWN,INTERVENTIONAL,The study design has changed from randomized trial to quasi-experimental due to limited number of clinics involved.
NCT05665036,WITHDRAWN,INTERVENTIONAL,Sponsor developing new product
NCT05665088,TERMINATED,INTERVENTIONAL,Study was terminated for business reasons; not due to safety or efficacy concerns
NCT05665569,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT05666349,WITHDRAWN,INTERVENTIONAL,Funder support withdrawn 13-Oct-2023. Study did not open to recruitment.
NCT05666570,TERMINATED,OBSERVATIONAL,More cost effective to source real world evidence data
NCT05667337,WITHDRAWN,INTERVENTIONAL,further biomaterial optimization
NCT05667662,TERMINATED,INTERVENTIONAL,Low enrollment
NCT05668936,TERMINATED,INTERVENTIONAL,"Discontinuing the development of cotadutide, a daily injectable GLP-1/glucagon co-agonist, is based on strategic pipeline considerations. The premature closure is not due to any newly observed safety signals or a change in the risk/benefit profile."
NCT05669560,WITHDRAWN,INTERVENTIONAL,The study team made the decision to not move forward with the study.
NCT05670990,WITHDRAWN,INTERVENTIONAL,due to methodological problems with the recruitment.
NCT05671653,TERMINATED,INTERVENTIONAL,The decision to terminate clinical development of lotiglipron is based on pharmacokinetic data from Phase 1 drug-drug-interaction studies and laboratory measurements of elevated transaminases in these Phase 1 studies as well as a Phase 2 study.
NCT05671913,WITHDRAWN,INTERVENTIONAL,Funding not acquired to run the study.
NCT05672082,WITHDRAWN,INTERVENTIONAL,Organisational difficulties
NCT05672368,SUSPENDED,INTERVENTIONAL,funding
NCT05672407,WITHDRAWN,INTERVENTIONAL,Research team dissembled because of no funding.
NCT05672654,WITHDRAWN,INTERVENTIONAL,"Responsibility for registering this study lies with the sponsor, DiaSorin, and not with our institution"
NCT05672875,TERMINATED,OBSERVATIONAL,Sponsor decision
NCT05673109,TERMINATED,INTERVENTIONAL,"Subject benefit-risk ratio changes, sponsor decides to voluntarily terminate study"
NCT05673876,TERMINATED,INTERVENTIONAL,Study was terminated for business reasons. There were no safety or efficacy concerns regarding the study or study drug in the decision to terminate the study.
NCT05674448,TERMINATED,INTERVENTIONAL,"During the study, the sponsor adjusted the overall clinical development strategy, decided to terminate the enrollment in advance after discussion with the lead investigator."
NCT05674851,SUSPENDED,INTERVENTIONAL,enrollment on hold per protocol
NCT05675917,WITHDRAWN,INTERVENTIONAL,Administrative issues
NCT05676112,WITHDRAWN,OBSERVATIONAL,Company decision
NCT05676463,SUSPENDED,INTERVENTIONAL,on hold due to pause of outside company
NCT05676697,TERMINATED,INTERVENTIONAL,Did not meet the anticipated outcome.
NCT05676853,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05677373,WITHDRAWN,INTERVENTIONAL,"The drug company supporting this trial has withdrawn support, including the ability to provide study agent."
NCT05678881,TERMINATED,INTERVENTIONAL,Lack of enrollment
NCT05679180,WITHDRAWN,INTERVENTIONAL,Study withdrawn by clinical team
NCT05679479,SUSPENDED,INTERVENTIONAL,"According to the covid-19 epidemic situation in China, there is few sever covid-19 patients."
NCT05679492,WITHDRAWN,INTERVENTIONAL,"Based on current epidemic situation in China, there is few Mild and Moderate COVID-19 patients."
NCT05679960,SUSPENDED,INTERVENTIONAL,The urine POC device seems not to be promising in colorectal cancer screening
NCT05683574,WITHDRAWN,INTERVENTIONAL,Change in study strategy.
NCT05683600,TERMINATED,INTERVENTIONAL,According to the development of the novel coronavirus epidemic situation and the company's R\&D decision
NCT05683860,TERMINATED,INTERVENTIONAL,"Despite robust, sustained reductions in poly(GP), no clinical benefit was seen at 24 weeks, and reductions in poly(GP) were not associated with stabilization in functional outcomes. Based on these data, Wave decided to stop development of WVE-004."
NCT05685043,WITHDRAWN,INTERVENTIONAL,No funding available.
NCT05685095,WITHDRAWN,INTERVENTIONAL,personnel involved in clinical trial will not be available to conduct the research
NCT05686265,TERMINATED,OBSERVATIONAL,Practical reasons (project coordinator has resigned and started new employment).
NCT05687110,SUSPENDED,INTERVENTIONAL,Other - FDA Clinical Hold
NCT05687617,TERMINATED,INTERVENTIONAL,Recruitment lower than expected and negative results.
NCT05688215,SUSPENDED,INTERVENTIONAL,Accrual met
NCT05689359,WITHDRAWN,INTERVENTIONAL,"Per Principal Investigator, it is not feasible to move forward with this trial."
NCT05691400,WITHDRAWN,INTERVENTIONAL,funding was not secured
NCT05691478,SUSPENDED,INTERVENTIONAL,Scheduled Interim Monitoring
NCT05692908,WITHDRAWN,INTERVENTIONAL,Sorrento Therapeutics filed for chapter 11 bankruptcy.
NCT05692986,WITHDRAWN,INTERVENTIONAL,Did not move forward due to staffing
NCT05693090,WITHDRAWN,INTERVENTIONAL,This study was withdrawn due to a strategic business decision; no patients were enrolled.
NCT05693779,WITHDRAWN,INTERVENTIONAL,Administrative Changes.
NCT05693792,WITHDRAWN,OBSERVATIONAL,Internal company decision
NCT05694741,TERMINATED,INTERVENTIONAL,The decision was based on the overall data profile obtained from this study which did not demonstrate sufficient differentiation to surpass the current standard of care.
NCT05695716,WITHDRAWN,INTERVENTIONAL,No subjects enrolled; termination was business decision after acquisition of CSI by Abbott.
NCT05696678,WITHDRAWN,INTERVENTIONAL,The PI has permanently left the institution
NCT05696964,WITHDRAWN,INTERVENTIONAL,The research study was not funded.
NCT05698888,TERMINATED,INTERVENTIONAL,Sponsor Decision
NCT05699135,TERMINATED,OBSERVATIONAL,The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.
NCT05699473,TERMINATED,INTERVENTIONAL,Analytic issue
NCT05700032,WITHDRAWN,INTERVENTIONAL,Due to clinical service demand study was withdrawn and not activated
NCT05700331,SUSPENDED,INTERVENTIONAL,Pending for funding
NCT05700630,WITHDRAWN,INTERVENTIONAL,Abandoned
NCT05700734,WITHDRAWN,INTERVENTIONAL,Business Reasons
NCT05700864,WITHDRAWN,INTERVENTIONAL,Funding of study was withdrawn
NCT05701371,TERMINATED,OBSERVATIONAL,Recruitment issues
NCT05702385,WITHDRAWN,INTERVENTIONAL,The study sponsor did not wish to proceed with the study
NCT05703464,TERMINATED,INTERVENTIONAL,Personal reason
NCT05703555,WITHDRAWN,INTERVENTIONAL,Due to the decision to discontinue the global clinical development program of tusamitamab ravtansine
NCT05705466,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT05705492,SUSPENDED,INTERVENTIONAL,Pending protocol revisions
NCT05705700,WITHDRAWN,INTERVENTIONAL,Feasibility
NCT05708066,WITHDRAWN,INTERVENTIONAL,Never approved by the Albert Einstein College of Medicine IRB
NCT05708586,TERMINATED,INTERVENTIONAL,Preliminary findings showed no significant difference between virtual reality and distraction techniques.
NCT05708924,SUSPENDED,INTERVENTIONAL,Product withdrawn from clinical development
NCT05708989,SUSPENDED,INTERVENTIONAL,Transitioning to new clinic
NCT05709821,TERMINATED,INTERVENTIONAL,Prioritization of other pipeline assets. No safety or efficacy issues were observed.
NCT05710146,WITHDRAWN,INTERVENTIONAL,Study was never started. Did not receive funding.
NCT05710289,WITHDRAWN,OBSERVATIONAL,Sponsor's decision
NCT05710315,WITHDRAWN,INTERVENTIONAL,PI initiated study closure. He will be leaving the study site for a new position in the coming months.
NCT05710445,WITHDRAWN,INTERVENTIONAL,Unable to enroll subjects.
NCT05710978,WITHDRAWN,INTERVENTIONAL,Grant proposal was not funded
NCT05711628,WITHDRAWN,INTERVENTIONAL,Other - Protocol moved to Withdrawn
NCT05711979,TERMINATED,INTERVENTIONAL,COI disclosures
NCT05712278,TERMINATED,INTERVENTIONAL,Sponsor's decision
NCT05712941,WITHDRAWN,INTERVENTIONAL,The study is being closed based on corporate changes at EQRx and is not related to any efficacy or safety issues with lerociclib.
NCT05713331,TERMINATED,INTERVENTIONAL,School closures during COVID-19 precluded study activities
NCT05713955,WITHDRAWN,INTERVENTIONAL,No enough funding and study withdrawn
NCT05715125,TERMINATED,INTERVENTIONAL,sponsor decision
NCT05715372,TERMINATED,INTERVENTIONAL,no further funding
NCT05716217,TERMINATED,INTERVENTIONAL,Changes in provision of chemotherapy have made it impossible to recruit patients according to the protocol
NCT05719012,WITHDRAWN,INTERVENTIONAL,Difficulty in Recruitment
NCT05719909,SUSPENDED,INTERVENTIONAL,Current unavailability of resources
NCT05720104,WITHDRAWN,INTERVENTIONAL,"Too few patients at site. New sites will be included in the study, we can not be sure of how long it takes. The new sites will then need a re-application to the ethical board, and also the Swedish biobank agreements needs to be changed accordingly."
NCT05720377,WITHDRAWN,INTERVENTIONAL,Funding not obtained
NCT05720650,WITHDRAWN,OBSERVATIONAL,plans changed
NCT05720988,WITHDRAWN,INTERVENTIONAL,trial was not opened
NCT05722301,WITHDRAWN,INTERVENTIONAL,Study was never initiated.
NCT05724524,WITHDRAWN,OBSERVATIONAL,no started
NCT05724628,WITHDRAWN,INTERVENTIONAL,Project did not receive final IRB approvals. PI decided to withdrawn research study.
NCT05724849,WITHDRAWN,INTERVENTIONAL,Issues with funding
NCT05725343,TERMINATED,INTERVENTIONAL,"Novartis has decided to terminate the trial due to the recent results made available from the Novartis CANOPY A study (CACZ885T2301), this decision is not related to any safety data for Canakinumab"
NCT05726214,TERMINATED,INTERVENTIONAL,Difficulties with the recruitment process
NCT05726409,WITHDRAWN,INTERVENTIONAL,This study was never started due to lack of access to our proposed patient database.
NCT05726422,TERMINATED,OBSERVATIONAL,Sufficient number of subjects included for analyzes
NCT05726682,WITHDRAWN,INTERVENTIONAL,"Sponsor decision to cancel trial, not related to safety concern."
NCT05728372,WITHDRAWN,INTERVENTIONAL,withdrawn per PI
NCT05728736,WITHDRAWN,INTERVENTIONAL,"Study was terminated due to enrollment difficulties and the inability to obtain necessary study supplies. Five participants signed consent; however, no one was randomized. The study was officially terminated with the funding source on 10/04/2023."
NCT05728970,SUSPENDED,OBSERVATIONAL,Recruitment pause
NCT05729048,WITHDRAWN,OBSERVATIONAL,Study Sponsor decided not to move forward with this project.
NCT05729139,WITHDRAWN,INTERVENTIONAL,PI is leaving institution prior to study opening for accrual.
NCT05729425,TERMINATED,OBSERVATIONAL,Unable to recruit participants due to rare disease
NCT05730673,WITHDRAWN,INTERVENTIONAL,No participants enrolled
NCT05731206,SUSPENDED,INTERVENTIONAL,Internal discussions
NCT05731362,WITHDRAWN,OBSERVATIONAL,Change in study design
NCT05731739,WITHDRAWN,OBSERVATIONAL,Resources did not come to fruition
NCT05733390,TERMINATED,INTERVENTIONAL,A decision has been made to prioritize other pipeline programs and terminate this study.
NCT05735756,TERMINATED,INTERVENTIONAL,The clinical trial has ended prematurely due to low patient recruitment
NCT05735938,SUSPENDED,OBSERVATIONAL,Lack of manpower
NCT05736380,SUSPENDED,INTERVENTIONAL,Requires funding to commence fMRI scan - funding awaited
NCT05736458,TERMINATED,INTERVENTIONAL,"The study was terminated because our funding agency, the NIH, did not grant a no-cost extension to meet our recruitment goals."
NCT05736692,WITHDRAWN,INTERVENTIONAL,"Despite intensive recruitment efforts, we have been unsuccessful enrolling participants. Study being halted due to futility."
NCT05736952,WITHDRAWN,INTERVENTIONAL,Program changed
NCT05737849,WITHDRAWN,OBSERVATIONAL,"Business reason, unrelated to product safety"
NCT05738031,WITHDRAWN,OBSERVATIONAL,Withdrawn by IRB on 10-16-2023
NCT05739721,WITHDRAWN,INTERVENTIONAL,No funding
NCT05739760,WITHDRAWN,INTERVENTIONAL,"Student research, student left the university"
NCT05740280,SUSPENDED,INTERVENTIONAL,The Sponsor has put the study on hold and will recommence in due time.
NCT05740553,TERMINATED,INTERVENTIONAL,Inadequate participant recruitment (potentially due to COVID-19)
NCT05741983,WITHDRAWN,INTERVENTIONAL,unsatisfactory patient enrollment
NCT05742334,WITHDRAWN,INTERVENTIONAL,The sponsor decided to not move forward with this study
NCT05743270,WITHDRAWN,INTERVENTIONAL,Sponsor decision.
NCT05743491,TERMINATED,INTERVENTIONAL,PI moving to another institution
NCT05743777,WITHDRAWN,INTERVENTIONAL,Company withdrew financial support
NCT05744115,TERMINATED,INTERVENTIONAL,The investigational product was approved by the FDA (12/20/2021) and is now commercially available
NCT05745272,TERMINATED,OBSERVATIONAL,No enough patients to be enrolled
NCT05745467,WITHDRAWN,INTERVENTIONAL,Wouldn't be able to get enough patients. Never started the study. Suspended the IRB form.
NCT05747053,TERMINATED,OBSERVATIONAL,will NOT resume
NCT05747105,WITHDRAWN,INTERVENTIONAL,Unable to move forward with the study due to personnel changes
NCT05748184,TERMINATED,OBSERVATIONAL,Due to company reorganization and business interests.
NCT05748392,WITHDRAWN,INTERVENTIONAL,No longer required.
NCT05749523,WITHDRAWN,INTERVENTIONAL,"Insuffient drug supply. Professor Ronald Dahl lefter his position as proffssor in rhus, and all his research were closed."
NCT05751772,TERMINATED,INTERVENTIONAL,Difficulty in recruiting and lack of resources
NCT05754255,WITHDRAWN,INTERVENTIONAL,No available resources.
NCT05754723,WITHDRAWN,INTERVENTIONAL,Funding was not obtained
NCT05755464,SUSPENDED,OBSERVATIONAL,Reorganization of the clinic
NCT05755568,WITHDRAWN,OBSERVATIONAL,"Company decision after projects re-evaluation, taken before the study initiation."
NCT05756088,SUSPENDED,OBSERVATIONAL,Funding
NCT05756114,WITHDRAWN,INTERVENTIONAL,The focus of the project has shifted.
NCT05756556,SUSPENDED,INTERVENTIONAL,Change in drug development and lifecycle management and decide to suspend this study
NCT05756881,TERMINATED,INTERVENTIONAL,Sponsor withdrawal
NCT05758298,WITHDRAWN,INTERVENTIONAL,Have not received IRB approval.
NCT05758818,TERMINATED,INTERVENTIONAL,sponsor decision
NCT05759598,TERMINATED,INTERVENTIONAL,Lack of hormonal responses (GH) in response to the respiratory training protocols in the three subjects tested.
NCT05760079,WITHDRAWN,INTERVENTIONAL,difficult to coordinate between all of the different support systems needed across various departments
NCT05760261,SUSPENDED,INTERVENTIONAL,To allow analysis of data from supplementary non-clinical study.
NCT05760703,TERMINATED,INTERVENTIONAL,"The preliminary effectiveness data observed at present did not meet the expectations, the benefit of the subjects receiving the experimental drug was limited."
NCT05760781,TERMINATED,INTERVENTIONAL,"The preliminary effectiveness data observed at present did not meet the expectations, the benefit of the subjects receiving the experimental drug was limited."
NCT05761158,TERMINATED,OBSERVATIONAL,"Discontinuation of the study was justified by the inclusion of 21/100 patients, which finally enabled a relevant analysis to be made in view of the homogeneity of the results."
NCT05762744,TERMINATED,INTERVENTIONAL,We concluded that it would not be possible to meet our recruitment targets within the available budget. The study was ended when the funding ended.
NCT05763368,WITHDRAWN,INTERVENTIONAL,lack of participants
NCT05763784,WITHDRAWN,INTERVENTIONAL,This study plan has halted and was withdrawn from the IRB.
NCT05764122,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05764239,TERMINATED,INTERVENTIONAL,"Based on a review of early data from participants in the dose escalation phase, it was determined that SYNB1934v1 is unlikely to meet the study's primary endpoint for lowering phenylalanine (Phe) levels in patients."
NCT05765253,TERMINATED,INTERVENTIONAL,Low patient accrual
NCT05765903,WITHDRAWN,INTERVENTIONAL,Significant protocol modifications needed for feasibility. This will require a version 2.
NCT05769829,TERMINATED,OBSERVATIONAL,Enrollment challenges for cohort 2
NCT05769959,TERMINATED,INTERVENTIONAL,"Sponsor decision (not related to safety, efficacy or quality)."
NCT05770427,WITHDRAWN,INTERVENTIONAL,Change in study design (see NCT05770414 for current and active trial).
NCT05770531,SUSPENDED,INTERVENTIONAL,Pending calendar changes
NCT05771714,TERMINATED,INTERVENTIONAL,Cancel study
NCT05771896,WITHDRAWN,INTERVENTIONAL,Bayer withdrew their support.
NCT05773118,WITHDRAWN,INTERVENTIONAL,Recent personnel changes in the research team make it unrealistic to conduct this research project.
NCT05773664,SUSPENDED,INTERVENTIONAL,funding (abandoned)
NCT05774886,WITHDRAWN,INTERVENTIONAL,On hold
NCT05776901,TERMINATED,INTERVENTIONAL,Grant termination without continuation.
NCT05778695,TERMINATED,INTERVENTIONAL,Withdrawal of funding
NCT05778877,SUSPENDED,INTERVENTIONAL,Decided by sponsor
NCT05780060,WITHDRAWN,INTERVENTIONAL,Study did not get funded as anticipated
NCT05780541,TERMINATED,INTERVENTIONAL,The agent was withdrawn from development by the manufacturer after being placed on clinical hold by the US FDA.
NCT05782062,WITHDRAWN,INTERVENTIONAL,funding
NCT05783180,WITHDRAWN,INTERVENTIONAL,Sponsor decided not to move forward with the trial
NCT05783388,WITHDRAWN,OBSERVATIONAL,The commercial partner decided not to proceed with this protocol at this time
NCT05783492,WITHDRAWN,INTERVENTIONAL,Lack of availability of drug
NCT05784129,TERMINATED,INTERVENTIONAL,Janssen made an internal business decision to discontinue the PROGRESS study. This decision is not related to any efficacy or safety concerns.
NCT05784805,SUSPENDED,INTERVENTIONAL,Study recruitment is on hold due to personnel changes and modifications.
NCT05786170,WITHDRAWN,INTERVENTIONAL,lack of research funding
NCT05787457,TERMINATED,OBSERVATIONAL,Insufficient recruitment
NCT05787743,TERMINATED,INTERVENTIONAL,Sponsor withdrawal
NCT05788185,TERMINATED,INTERVENTIONAL,Changes in COVID-19 pandemic landscape
NCT05788328,TERMINATED,INTERVENTIONAL,The decision to terminate clinical development of lotiglipron is based on pharmacokinetic data from Phase 1 drug-drug-interaction studies and laboratory measurements of elevated transaminases in these Phase 1 studies as well as a Phase 2 study.
NCT05788497,TERMINATED,INTERVENTIONAL,Recruitment failure
NCT05788991,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT05790109,TERMINATED,INTERVENTIONAL,Decision by principal investigator to re-consider study design
NCT05790408,TERMINATED,INTERVENTIONAL,"Slow recruitment, lack of availability of equipment, lack of availability of staff"
NCT05791097,WITHDRAWN,INTERVENTIONAL,"Business decision, not driven by safety concerns; no new safety signals have been observed in the ociperlimab program."
NCT05791474,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05791929,WITHDRAWN,OBSERVATIONAL,"MY FOOT study proposal was submitted for the HORIZON-HLTH-2023-TOOL-05-03 call, but the project was not approved"
NCT05793931,TERMINATED,OBSERVATIONAL,Funding expired 03/01/2023
NCT05794672,TERMINATED,INTERVENTIONAL,"This decision was based on lung findings from a non-clinical 13-week GLP toxicology study, which are not a concern for the active clinical studies but do not support long-term use and progression to later-stage development."
NCT05795452,SUSPENDED,OBSERVATIONAL,The study is paused.
NCT05796271,WITHDRAWN,INTERVENTIONAL,Inadequate funding to begin enrolling subjects
NCT05796765,TERMINATED,INTERVENTIONAL,Study discontinued early by Sponsor
NCT05798390,WITHDRAWN,OBSERVATIONAL,Due to patient availability
NCT05802303,TERMINATED,INTERVENTIONAL,As per institutional protocol unable to recruit adequate number of patients
NCT05802472,WITHDRAWN,INTERVENTIONAL,Because the closing date of the study is approaching
NCT05802966,TERMINATED,OBSERVATIONAL,"No (financial) means left to continue inclusion to achieve predetermined sample size. Instead of continuation (high probability of unanalyzed data) it was decided to stop inclusion and analyze data, so the scientific community can benefit from it."
NCT05803928,WITHDRAWN,INTERVENTIONAL,Ethical approval has not yet been completed
NCT05804214,TERMINATED,OBSERVATIONAL,Study early terminated
NCT05804435,WITHDRAWN,INTERVENTIONAL,Sponsor decision
NCT05805345,WITHDRAWN,INTERVENTIONAL,Management Decision
NCT05807126,SUSPENDED,INTERVENTIONAL,"Added per CS0161016, see memo uploaded to trial related documents."
NCT05807282,WITHDRAWN,INTERVENTIONAL,Study was not funded
NCT05808673,WITHDRAWN,INTERVENTIONAL,Changes in the company's production plan
NCT05808881,WITHDRAWN,INTERVENTIONAL,Due to changes in research objectives and methodological approach.
NCT05809154,WITHDRAWN,OBSERVATIONAL,Personnel changes
NCT05809245,TERMINATED,INTERVENTIONAL,Difficulties with recruitment
NCT05809895,WITHDRAWN,INTERVENTIONAL,"Business decision, not driven by safety concerns; no new safety signals have been observed in the ociperlimab program."
NCT05811468,WITHDRAWN,OBSERVATIONAL,Trouble enrolling
NCT05813314,TERMINATED,INTERVENTIONAL,The BMN 111-104 study has terminated as further optimization of the approach to achieve bio equivalence is required. The study termination was not due to any patient safety concerns.
NCT05815004,WITHDRAWN,INTERVENTIONAL,Further development of programs halted
NCT05815186,WITHDRAWN,INTERVENTIONAL,Study record has been combined with NCT05815173 (Phase I/II study).
NCT05816967,WITHDRAWN,INTERVENTIONAL,Interference with other trials on the same ward
NCT05818345,TERMINATED,INTERVENTIONAL,Restaurant has closed down
NCT05820009,SUSPENDED,INTERVENTIONAL,The Gore VIABILITY Pivotal Study is being suspended. The suspension is not due to any safety or performance concerns. No sites have been activated and no subjects have been enrolled in the study.
NCT05821582,WITHDRAWN,OBSERVATIONAL,Insufficient recruitment population.
NCT05823480,SUSPENDED,INTERVENTIONAL,FDA Clinical Hold
NCT05824533,TERMINATED,INTERVENTIONAL,"Due to financial constraints, the study could not be continuedout as planned. Enrolled participants will finish treatment per study protocol."
NCT05825365,WITHDRAWN,INTERVENTIONAL,"Selumetinib launch approval achieved in advance,strategy changesa new study will be generated in place of this study."
NCT05826041,TERMINATED,INTERVENTIONAL,Site was unable to refer participants due to staffing issues post COVID
NCT05827081,SUSPENDED,INTERVENTIONAL,Adjuvant WIDER trial paused due to manufacturing adjustments.
NCT05827419,TERMINATED,OBSERVATIONAL,Unable to recruit participants
NCT05827432,SUSPENDED,INTERVENTIONAL,Study suspended until new FCI scanner is operational.
NCT05828277,WITHDRAWN,INTERVENTIONAL,Insufficient enrollment
NCT05828641,TERMINATED,INTERVENTIONAL,"According to the results of the interim analysis when 50% of the targeted sample size was reached, a statistically significant benefit was detected with a large effect size in one treatment arm. For this reason, the study was terminated prematurely."
NCT05828654,TERMINATED,INTERVENTIONAL,Investigator left the institution.
NCT05829434,WITHDRAWN,INTERVENTIONAL,Trial was stopped prematurely due to safety reasons
NCT05830149,TERMINATED,INTERVENTIONAL,Did not have staffing to support the study
NCT05830214,WITHDRAWN,OBSERVATIONAL,Difficulty procuring study device
NCT05832775,WITHDRAWN,INTERVENTIONAL,Sponsor insolvency
NCT05833100,TERMINATED,INTERVENTIONAL,Due to a change in the marketing strategy of the device.
NCT05833464,WITHDRAWN,OBSERVATIONAL,The study was not started and no patients were recruited because the weight loss program was no longer prescribed in Argentina (the country where the study was to be carried out).
NCT05834062,WITHDRAWN,INTERVENTIONAL,The project was not funded
NCT05834257,SUSPENDED,INTERVENTIONAL,Lack of funding. Will resume potentially.
NCT05835011,TERMINATED,INTERVENTIONAL,Termination due to discontinuation of magrolimab development in MDS.
NCT05836571,SUSPENDED,INTERVENTIONAL,Other - Administrative and regulatory issues.
NCT05838703,WITHDRAWN,INTERVENTIONAL,"Study halted prematurely due to funding, prior to enrollment of first participant"
NCT05839730,SUSPENDED,INTERVENTIONAL,Revision of the protocol
NCT05840250,SUSPENDED,INTERVENTIONAL,shortage in the availability on the continuous glucose monitor
NCT05840601,WITHDRAWN,INTERVENTIONAL,Grant concluded.
NCT05843149,TERMINATED,INTERVENTIONAL,Sponsor did not want to continue the study.
NCT05845008,WITHDRAWN,INTERVENTIONAL,The study is no longer required due to change in development program strategy.
NCT05845359,WITHDRAWN,INTERVENTIONAL,IRB approval never received
NCT05847140,WITHDRAWN,OBSERVATIONAL,"The MAH's proposal to remove the Study from the RMP is based on the change in circulating COVID-19 variants, which has led to a suspension of EUA and significant decrease in the use of EVUSHELD."
NCT05848219,TERMINATED,OBSERVATIONAL,Company decision
NCT05848583,TERMINATED,INTERVENTIONAL,Recruitment
NCT05848843,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT05849870,WITHDRAWN,INTERVENTIONAL,COVID 19 caused delays for this project and is unlikely to be revisited.
NCT05851430,TERMINATED,OBSERVATIONAL,Strategic
NCT05854628,WITHDRAWN,INTERVENTIONAL,We decided not to proceed further to enroll patients.
NCT05856266,TERMINATED,INTERVENTIONAL,"The Sponsor has decided to stop the phase 4 study Sobi.HAEM89-007 (JOIN-us) due to a realignment of its development activities.

The clinical trial hasn't been terminated due to a change in the benefit-risk balance."
NCT05857748,WITHDRAWN,OBSERVATIONAL,Company decision due to the transfer of ownership of the product
NCT05859009,WITHDRAWN,INTERVENTIONAL,No study oversight due to changes in study personnel.
NCT05859087,TERMINATED,INTERVENTIONAL,High attrition.
NCT05860075,TERMINATED,INTERVENTIONAL,No expected efficacy was observed in subsequent extended phase.The company decided to initiatively terminate the development of IMM01 as monotherapy and fully promote clinical development of combination therapy.
NCT05861492,TERMINATED,INTERVENTIONAL,Recruitment goals could not be met even after amendments to improve recruitment and vast extension of the recruitment period.
NCT05862675,WITHDRAWN,OBSERVATIONAL,"Due to a time conflict in the research, the project research has been temporarily suspended."
NCT05863819,WITHDRAWN,OBSERVATIONAL,"Business reason, unrelated to product safety"
NCT05865587,WITHDRAWN,OBSERVATIONAL,Data saturation was reached when health professionals began to use similar or same expressions and it was achieved with 12 health professionals
NCT05866926,TERMINATED,INTERVENTIONAL,After the analysis of the main ADORE study it is concluded that there is no clinical benefit for the patients.
NCT05867030,WITHDRAWN,INTERVENTIONAL,Development strategy adjustment
NCT05870709,WITHDRAWN,OBSERVATIONAL,Terminated due to business decision
NCT05873257,SUSPENDED,INTERVENTIONAL,unknown if investigation will be conducted
NCT05875935,TERMINATED,INTERVENTIONAL,Medical device defective
NCT05876936,TERMINATED,INTERVENTIONAL,Principal investigator left the hospital
NCT05877404,TERMINATED,OBSERVATIONAL,"This was a national survey of physicians. Per the protocol, they were only allowed to be contacted twice and they received less surveys back than anticipated."
NCT05878652,TERMINATED,INTERVENTIONAL,Study structure was flawed and as a result the investigator had closed the study.
NCT05881668,WITHDRAWN,INTERVENTIONAL,The supply of msc-ev has been delayed and approval by the Ethics committee will take some time.
NCT05883228,WITHDRAWN,OBSERVATIONAL,Pre-empted by another survey
NCT05886257,WITHDRAWN,INTERVENTIONAL,Protocol adjustment
NCT05887479,WITHDRAWN,INTERVENTIONAL,insufficient number of patients
NCT05887518,WITHDRAWN,INTERVENTIONAL,The study was canceled because the cost of the tests requested by the Turkish Medicines and Medical Devices Agency exceeded the project budget
NCT05887843,TERMINATED,INTERVENTIONAL,Business decision (no safety concerns).
NCT05888337,TERMINATED,OBSERVATIONAL,Difficult to find recruit patients with oblique astigmatism
NCT05892055,WITHDRAWN,OBSERVATIONAL,"No participants were enrolled for the active phase of this study (with neuroimaging), but, n=6 (n=3 with FAPD and n=3 Healthy) completed the pilot testing protocol outside of the scanner between 2/28/2019 and 3/28/2019. No neuroimaging took place."
NCT05892276,WITHDRAWN,INTERVENTIONAL,"The UT IRB determined that CBD oil is being used as a drug as defined by the FDA. Therefore, an IND must be obtained for the use of CBD oil in this research study in accordance with FDA regulations, 21 CFR 312."
NCT05894447,WITHDRAWN,INTERVENTIONAL,Insufficient funding
NCT05895253,TERMINATED,INTERVENTIONAL,recruitment rate of patients was not sufficient during COVID-19; problems with the quality of the primary outcome data collected
NCT05895656,WITHDRAWN,INTERVENTIONAL,Recruitment issues
NCT05900648,WITHDRAWN,INTERVENTIONAL,0 participant accrual
NCT05900674,WITHDRAWN,INTERVENTIONAL,Sponsor
NCT05903612,WITHDRAWN,OBSERVATIONAL,Reasons unrelated to safety issues
NCT05903664,WITHDRAWN,OBSERVATIONAL,Activation pending due to sponsor decision.
NCT05905341,WITHDRAWN,INTERVENTIONAL,This decision was based on business considerations and not due to specific safety reasons or a request from a regulatory authority.
NCT05906290,WITHDRAWN,INTERVENTIONAL,Study Stopped Early Due to COVID Restrictions
NCT05908513,WITHDRAWN,INTERVENTIONAL,Lack of available resources needed to conduct study.
NCT05908617,WITHDRAWN,INTERVENTIONAL,Per PI this QI/QA resident project was not initiated. Record should be deleted.
NCT05909943,WITHDRAWN,INTERVENTIONAL,"We are doing a clinical study of Baritinib in Neuromyelitis Optica Spectrum Disorders, similar to this one, so the study was withdrawn."
NCT05910671,SUSPENDED,INTERVENTIONAL,unable to recruit participants due to COVID affective the target population
NCT05910697,TERMINATED,INTERVENTIONAL,"The decision to stop the study was made by the sponsor, based solely on timeline constraints."
NCT05915286,SUSPENDED,INTERVENTIONAL,Personnel/staffing issues.
NCT05915910,TERMINATED,OBSERVATIONAL,Unable to recruit additional subjects due to disease rarity
NCT05916612,WITHDRAWN,OBSERVATIONAL,Decision not to move forward with study.
NCT05918250,WITHDRAWN,INTERVENTIONAL,The Sponsor decided to discontinue development of mRNA-2736 for strategic business reasons.
NCT05920408,TERMINATED,INTERVENTIONAL,Emerging data demonstrates challenge for EXS21546 to reach suitable therapeutic index.
NCT05922579,TERMINATED,OBSERVATIONAL,"Significant and complex challenges had since been identified during recent testing phases. After their assessment, Ipsendecided to discontinue development of this motorized device in order to not burden participants."
NCT05924035,WITHDRAWN,INTERVENTIONAL,Needed additional support.
NCT05926206,WITHDRAWN,INTERVENTIONAL,"based some additional data, we have decided to hold off this trial for now and will not be proceeding with this particular trial"
NCT05926440,WITHDRAWN,INTERVENTIONAL,we has selected a new candidate vaccine which is monovalent.
NCT05927012,WITHDRAWN,INTERVENTIONAL,"Despite several attempts to recruit eligible participants and major protocol amendments to increase the recruitment rate, recruitment challenges remained. Therefore, the Sponsor has made the decision to terminate the KER047-IR-202 Study globally."
NCT05927610,WITHDRAWN,INTERVENTIONAL,Recruitment has not yet been initiated
NCT05928910,WITHDRAWN,INTERVENTIONAL,decided to not proceed with study due to lack of personnel
NCT05929716,WITHDRAWN,INTERVENTIONAL,Per Principal Investigator request
NCT05932667,TERMINATED,INTERVENTIONAL,Financial partner providing study drug could no longer support the trial
NCT05932979,WITHDRAWN,INTERVENTIONAL,the investigation was cancelled because there was no monetary resource to complete it.
NCT05934097,WITHDRAWN,INTERVENTIONAL,This study was withdrawn (Sponsor decision).
NCT05934942,TERMINATED,INTERVENTIONAL,Company decision
NCT05935332,SUSPENDED,INTERVENTIONAL,Study on clinical hold by FDA
NCT05935774,WITHDRAWN,INTERVENTIONAL,Withdrawn prior to opening to accrual.
NCT05936255,TERMINATED,INTERVENTIONAL,Low feasibility of participant recruitment.
NCT05936294,TERMINATED,INTERVENTIONAL,Low enrollment
NCT05936931,WITHDRAWN,INTERVENTIONAL,PI left UF. Study transferring to VCU.
NCT05940610,WITHDRAWN,INTERVENTIONAL,The supply of msc-ev has been delayed and approval by the Ethics committee will take some time.
NCT05942690,TERMINATED,INTERVENTIONAL,no more possibly to include subjects (subject unavailability)
NCT05942820,TERMINATED,INTERVENTIONAL,CMC challenges
NCT05943301,WITHDRAWN,INTERVENTIONAL,Problems with recruitment
NCT05943314,WITHDRAWN,INTERVENTIONAL,The clinical trial was terminated due to a change in sponsor strategy.
NCT05943990,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in GSK's R\&D priorities.
NCT05945147,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT05945160,WITHDRAWN,INTERVENTIONAL,"Funding was terminated, the study will not enroll any subjects"
NCT05946811,WITHDRAWN,INTERVENTIONAL,Study was cancelled by funding agency before starting enrollment.
NCT05948137,TERMINATED,OBSERVATIONAL,"The study had to be prematurely stopped, falling short of the initial target due to prolonged shortages in the supply of 123I-MIBG."
NCT05948293,WITHDRAWN,INTERVENTIONAL,Seeking financial support.
NCT05948462,WITHDRAWN,INTERVENTIONAL,Study withdrawn by pharmaceutical funding partner
NCT05950776,WITHDRAWN,INTERVENTIONAL,Results from Phase 1 lead to the decision
NCT05950971,TERMINATED,INTERVENTIONAL,"Study enrollment too slow, 1 over 6 months"
NCT05951270,TERMINATED,INTERVENTIONAL,Difficulty in recruiting participants with prediabetes
NCT05951842,WITHDRAWN,INTERVENTIONAL,participants are no longer being examined or receiving intervention
NCT05952388,WITHDRAWN,INTERVENTIONAL,PI left the institution \& this is not an applicable clinical trial (ACT).
NCT05952687,WITHDRAWN,INTERVENTIONAL,Drug withdrawn by company.
NCT05954052,TERMINATED,INTERVENTIONAL,lack of funding and difficulty with phlebotomy in children with Autism
NCT05956496,TERMINATED,INTERVENTIONAL,The study team experienced an increased number of complications than expected
NCT05957172,WITHDRAWN,OBSERVATIONAL,Futility
NCT05959473,WITHDRAWN,INTERVENTIONAL,No participants with FNA samples were enrolled
NCT05960838,WITHDRAWN,INTERVENTIONAL,The shoulder brace is being revised by the Producer
NCT05961007,SUSPENDED,INTERVENTIONAL,Company strategy adjustment
NCT05961163,TERMINATED,OBSERVATIONAL,Terminated due to an unusually cold and rainy summer. E.g. in Hamburg the average temperature between 16 July and 15 August 2023 was below 17C. Collected data will be used to pilot study design and questionnaire. We plan to repeat the study in 2024.
NCT05961696,WITHDRAWN,INTERVENTIONAL,0 accrual
NCT05962710,TERMINATED,OBSERVATIONAL,Study is not required
NCT05963763,WITHDRAWN,INTERVENTIONAL,Due to a shift in organizational factors this study will not be conducted.
NCT05964348,WITHDRAWN,OBSERVATIONAL,"the study was no longer of scientific interest, and other publications rendered it obsolete"
NCT05967286,WITHDRAWN,INTERVENTIONAL,Other - Protocol moved to Withdrawn
NCT05970263,WITHDRAWN,INTERVENTIONAL,Recruitment challenges
NCT05971888,SUSPENDED,INTERVENTIONAL,Program intervention paused by donor until further notice. Baseline data collection for evaluation study will not occur until donor notifies of implementation continuation.
NCT05973617,WITHDRAWN,OBSERVATIONAL,Study did not commence
NCT05975931,SUSPENDED,OBSERVATIONAL,The study has been put on hold until Jan-24 because study team capacity not sufficient.
NCT05977127,TERMINATED,INTERVENTIONAL,Recruitment rate dropped because of national COVID-19 vaccination campaign taking place parallel to this study.
NCT05977556,SUSPENDED,INTERVENTIONAL,There is another related study that is currently ongoing that would contaminate the control arm.
NCT05979415,TERMINATED,INTERVENTIONAL,Administrative decision
NCT05980507,WITHDRAWN,INTERVENTIONAL,Molecular development strategy adjustment
NCT05984680,WITHDRAWN,INTERVENTIONAL,Study will be re-evaluated and resubmitted
NCT05992012,TERMINATED,OBSERVATIONAL,Protocol not adopted by study teams
NCT05992792,TERMINATED,INTERVENTIONAL,"The field work was extended over time, mainly due to the COVID-19 pandemic and due to changes in the structure of the institution in charge of it."
NCT05993104,WITHDRAWN,OBSERVATIONAL,Funder no longer operating so the study team is unable to deliver the study.
NCT05993143,TERMINATED,INTERVENTIONAL,"Study was stopped because no statistically significant difference was observed in the interim analysis. With high vaccine rates in those over 50 and an expected low incidence, it would not be feasible to complete recruitment within a short period."
NCT05993169,TERMINATED,INTERVENTIONAL,Lack of feasibility.
NCT05994183,WITHDRAWN,INTERVENTIONAL,"The study was withdrawn with no participants enrolled due to the need for an IND from the FDA, which significantly expanded the scope of the study beyond what was originally anticipated for a pilot project within this network."
NCT05996744,TERMINATED,INTERVENTIONAL,Study was terminated by Sponsor and the decision was not due to any safety or efficacy reasons.
NCT05997485,WITHDRAWN,OBSERVATIONAL,The study was prematurely discontinued due to the substantial delay in initiation the study. This decision was not due to major safety concerns or requests from any regulatory authorities.
NCT05998785,SUSPENDED,OBSERVATIONAL,"Administrative issues with the IRB, none of which impacted the health/safety/welfare of subjects, has resulted in enrollment suspension and subsequent study termination. Site is still open at this time, but not enrolling."
NCT05998941,WITHDRAWN,INTERVENTIONAL,"Slow progress in development, the sponsor decided to withdraw and no longer proceed."
NCT05998954,WITHDRAWN,INTERVENTIONAL,No patients enrolled
NCT05999708,WITHDRAWN,INTERVENTIONAL,Study terminated prior to FSFV for strategic business reasons.
NCT06002880,TERMINATED,INTERVENTIONAL,Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.
NCT06004141,TERMINATED,INTERVENTIONAL,Terminated due to withdrawal of funding from Sponsor (Laguna Health)
NCT06006286,WITHDRAWN,INTERVENTIONAL,0 participants registered
NCT06006416,WITHDRAWN,INTERVENTIONAL,The Sponsor decided not to conduct the study.
NCT06006442,WITHDRAWN,OBSERVATIONAL,Study was not initiated
NCT06007508,TERMINATED,INTERVENTIONAL,Study intervention was adopted as standard of care.
NCT06009237,TERMINATED,INTERVENTIONAL,Strategic considerations
NCT06012565,TERMINATED,INTERVENTIONAL,Slow recruitment
NCT06012981,TERMINATED,INTERVENTIONAL,Unforeseen difficulties in recruiting participants.
NCT06017323,WITHDRAWN,INTERVENTIONAL,STUDY00006987
NCT06017427,TERMINATED,OBSERVATIONAL,Number of inclusions sufficient for answering the main objective
NCT06017830,SUSPENDED,INTERVENTIONAL,Covid-19 pandemi limited the number of patients who was applied physical therapy
NCT06018116,WITHDRAWN,INTERVENTIONAL,Results of EV302 study do not make it feasible to complete a study in second line avelumab immunotherapy. The new standard of care make this study not pertinent.
NCT06020664,SUSPENDED,INTERVENTIONAL,"The NO-002 study had to be paused because of enrollment disruptions due to the current situation in Israel, and concerns over the placebo batch stability results."
NCT06021561,WITHDRAWN,OBSERVATIONAL,the principal investigator changed her mind and gave up from the study
NCT06030050,WITHDRAWN,INTERVENTIONAL,The study was not feasible to conduct.
NCT06030284,WITHDRAWN,INTERVENTIONAL,Decision was taken to consider other opportunities for collecting sham-controlled data for BurstDR SCS.
NCT06032247,WITHDRAWN,INTERVENTIONAL,This study is withdrawn due to a lack of available recruitment within the researchers' timeframe.
NCT06034899,WITHDRAWN,INTERVENTIONAL,Business objectives have changed.
NCT06035848,TERMINATED,INTERVENTIONAL,"In June 2023, it was decided to perform an intermediate analysis to assess the benefit or harm of the intervention."
NCT06036485,WITHDRAWN,INTERVENTIONAL,Lack of funding to support the study
NCT06036511,WITHDRAWN,INTERVENTIONAL,"Per PI, this trial will not be started at UNM due to change in institutional responsibilities of the PI"
NCT06041373,WITHDRAWN,OBSERVATIONAL,It was decided by Verily Leadership to not pursue the study any further.
NCT06043635,WITHDRAWN,OBSERVATIONAL,No patients were enrolled
NCT06045624,WITHDRAWN,INTERVENTIONAL,The study was cancelled as the sponsor decided to reformulate the IP
NCT06046482,SUSPENDED,INTERVENTIONAL,PI Request
NCT06048705,TERMINATED,INTERVENTIONAL,The study was terminated due to a change in GSK's R\&D priorities.
NCT06050954,WITHDRAWN,INTERVENTIONAL,Change in standard of care.
NCT06052371,TERMINATED,OBSERVATIONAL,This study was terminated for business reasons.
NCT06052423,WITHDRAWN,INTERVENTIONAL,Research and development strategy adjustment.
NCT06053359,WITHDRAWN,OBSERVATIONAL,The study has not been stopped. The study does not qualify as a clinical trial so it was withdrawn from clinicaltrials.gov.
NCT06055556,SUSPENDED,INTERVENTIONAL,Enrollment on hold per regulatory request for tissue verification process.
NCT06061523,WITHDRAWN,INTERVENTIONAL,FDA and EMA agreed existing data are appropriate for approval and no further BE studies are required.
NCT06063759,SUSPENDED,INTERVENTIONAL,Study was postponed due to manufacturing issues
NCT06067243,WITHDRAWN,OBSERVATIONAL,No patients
NCT06068153,WITHDRAWN,INTERVENTIONAL,"In view of the recent developments in the field (the increasing number of trials with new KRAS inhibitors), the window of opportunity to answer the question raised in the AMBER trial was missed."
NCT06069453,TERMINATED,INTERVENTIONAL,Sponsor decision
NCT06076109,TERMINATED,INTERVENTIONAL,We do not have more subjects to enter into the study.
NCT06076525,SUSPENDED,INTERVENTIONAL,Protocol not submitted to IRB
NCT06077669,WITHDRAWN,INTERVENTIONAL,Study withdrawn in IRB by PI
NCT06083051,SUSPENDED,INTERVENTIONAL,Study Design Change Pending IRB Approval
NCT06083675,WITHDRAWN,INTERVENTIONAL,"Due to internal reprioritization, trial was cancelled."
NCT06083883,SUSPENDED,INTERVENTIONAL,Activate and Hold per IND office
NCT06084351,WITHDRAWN,INTERVENTIONAL,Study Period Ended / Not Completed
NCT06085638,WITHDRAWN,INTERVENTIONAL,Zero participants accrued
NCT06087731,WITHDRAWN,INTERVENTIONAL,For some personal reasons.
NCT06090318,WITHDRAWN,INTERVENTIONAL,Sponsor Decision
NCT06093958,WITHDRAWN,INTERVENTIONAL,Administratively closed by IRB after continuing review was never submitted and no patients enrolled.
NCT06095817,TERMINATED,INTERVENTIONAL,Lack of funding to continue
NCT06104358,WITHDRAWN,INTERVENTIONAL,The protocol was redirected by the FDA to another division and will be resubmitted at a future date.
NCT06104683,WITHDRAWN,INTERVENTIONAL,Sponsor Decision: The trial has been withdrawn with no plans to continue development.
NCT06104878,WITHDRAWN,OBSERVATIONAL,"Company decision after projects re-evaluation, taken before the study initiation"
NCT06105294,TERMINATED,INTERVENTIONAL,decided to shift to a new design and measures
NCT06108869,SUSPENDED,INTERVENTIONAL,"Recruitment has been suspended, as we realised the university still had to finish a contract to provide insurance for myself. Therefore, the recruitment was stopped until this is secured."
NCT06113289,SUSPENDED,INTERVENTIONAL,PI Request
NCT06113952,WITHDRAWN,OBSERVATIONAL,company business-strategic decision
NCT06116799,TERMINATED,INTERVENTIONAL,Sufficient power;slowed enrollment pace;budget restraints
NCT06120192,SUSPENDED,INTERVENTIONAL,Lack of staff
NCT06121362,WITHDRAWN,INTERVENTIONAL,sponsor decided not to pursue
NCT06122922,WITHDRAWN,INTERVENTIONAL,Funding withdrawn
NCT06124144,TERMINATED,INTERVENTIONAL,The risk-benefit ratio changed
NCT06129071,WITHDRAWN,INTERVENTIONAL,the principal investigator changed her mind and gave up from the study
NCT06133010,WITHDRAWN,INTERVENTIONAL,Trial was cancelled by Sponsor
NCT06137651,WITHDRAWN,INTERVENTIONAL,Study terminated by the sponsor
NCT06137963,WITHDRAWN,INTERVENTIONAL,This study is no longer feasible due to the increasing number of diabetic patients who are prescribed Ozempic and other GLP-1 agonists.
NCT06153186,TERMINATED,INTERVENTIONAL,The enrollment wasn't as predicted. We didn't have enough numbers to show statistical significance.
NCT06154031,WITHDRAWN,INTERVENTIONAL,Technical issues with the device
NCT06158724,WITHDRAWN,OBSERVATIONAL,COVID stopped
NCT06159998,WITHDRAWN,OBSERVATIONAL,Study closed
NCT06160609,TERMINATED,INTERVENTIONAL,The study was terminated due to lack of efficacy.
NCT06160700,SUSPENDED,OBSERVATIONAL,Protocol/Consent Updates
NCT06161792,TERMINATED,INTERVENTIONAL,"Difficulty in recruiting breast cancer patients, leading to a slow rate of case enrollment."
NCT06162910,TERMINATED,INTERVENTIONAL,Interim analysis resulted in reliable figures
NCT06163677,WITHDRAWN,OBSERVATIONAL,Study cancelled due to change in feasibility.
NCT06163755,WITHDRAWN,INTERVENTIONAL,Lack of funding
NCT06164691,TERMINATED,INTERVENTIONAL,PI terminated study due to lack of enrollment.
NCT06165809,WITHDRAWN,INTERVENTIONAL,The sponsor voluntarily withdraw the project.
NCT06171009,SUSPENDED,INTERVENTIONAL,Competing priorities
NCT06172829,WITHDRAWN,OBSERVATIONAL,no enrollment
NCT06178562,TERMINATED,INTERVENTIONAL,ethical issues
NCT06179550,TERMINATED,INTERVENTIONAL,ethical issues
NCT06180863,WITHDRAWN,INTERVENTIONAL,Lack of funding.
NCT06181227,TERMINATED,INTERVENTIONAL,Lack of Efficacy
NCT06181968,WITHDRAWN,INTERVENTIONAL,PI not workining at KUH anymore.
NCT06185478,SUSPENDED,INTERVENTIONAL,Covid
NCT06185504,TERMINATED,INTERVENTIONAL,ethical issues
NCT06188104,WITHDRAWN,INTERVENTIONAL,I have found it is quite difficult to conduct the work without changing some detail in original protocol. So we would like to re-start the study again with some modification.
NCT06189482,TERMINATED,INTERVENTIONAL,ethical issues
NCT06189560,TERMINATED,INTERVENTIONAL,ethical issues
NCT06192966,TERMINATED,INTERVENTIONAL,Lack of participants meeting selection criteria
NCT06194097,WITHDRAWN,INTERVENTIONAL,poor recruitment
NCT06198946,SUSPENDED,INTERVENTIONAL,The first phase of the research has been completed
NCT06199375,TERMINATED,INTERVENTIONAL,Ethical issues
NCT06199778,TERMINATED,INTERVENTIONAL,ethical issues
NCT06201091,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06202807,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06203561,TERMINATED,INTERVENTIONAL,ethical issues
NCT06205290,WITHDRAWN,INTERVENTIONAL,Business objectives have changed.
NCT06206122,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06206538,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06207500,TERMINATED,INTERVENTIONAL,Due to COVID 19 declaration in Slovenia for the second time and subsequent reorganization of intervention ward
NCT06210945,SUSPENDED,INTERVENTIONAL,pending financial resources
NCT06211426,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06211777,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06213675,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06215729,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06215742,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06215794,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06219499,WITHDRAWN,INTERVENTIONAL,"FDA reviewers asked for Phase 1 study in Oncology subjects, not in healthy volunteers."
NCT06220292,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06221904,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06223152,SUSPENDED,INTERVENTIONAL,My collaborator on this study (valrie deville) is away for an extended period.
NCT06225076,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06226415,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06228157,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06228170,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06228183,WITHDRAWN,INTERVENTIONAL,Ethical issues
NCT06231069,WITHDRAWN,INTERVENTIONAL,COVID 19: Study halted prior to enrollment of first participant.
NCT06232031,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06234618,SUSPENDED,OBSERVATIONAL,The researchers would like to conduct a larger study and cover the contents of this study.
NCT06238804,WITHDRAWN,OBSERVATIONAL,"Due to limited funding, the study is now being withdrawn."
NCT06246500,TERMINATED,OBSERVATIONAL,Recruitment issue
NCT06247540,WITHDRAWN,INTERVENTIONAL,Funding
NCT06248840,TERMINATED,INTERVENTIONAL,ethical issues
NCT06248879,WITHDRAWN,INTERVENTIONAL,ethical issue
NCT06248970,TERMINATED,INTERVENTIONAL,ethical issues
NCT06253910,TERMINATED,INTERVENTIONAL,waiting for re-calls
NCT06255756,WITHDRAWN,INTERVENTIONAL,ethical issues
NCT06257563,WITHDRAWN,INTERVENTIONAL,We are withdrawing our study due to regulatory requirements from our funding source.
NCT06258499,WITHDRAWN,INTERVENTIONAL,study never started and is on hold until further notice
NCT06259266,WITHDRAWN,INTERVENTIONAL,Abandonment of financial partners
NCT06259630,WITHDRAWN,INTERVENTIONAL,Investigators no longer wanted to pursue this research topic
NCT06261281,WITHDRAWN,INTERVENTIONAL,Ethical issue
NCT06264856,SUSPENDED,INTERVENTIONAL,"The principal investigator will be studying abroad for one year. The study is expected to resume enrollment from December 1, 2024."
NCT06270186,WITHDRAWN,INTERVENTIONAL,study withdrawn by the sponsor for logistical reasons
NCT06270394,SUSPENDED,INTERVENTIONAL,"The 68Ge/68Ga generator is currently at the end of its lifespan. We are trying to purchase new equipment, which will take about half a year."
NCT06275581,TERMINATED,INTERVENTIONAL,COVID-19 pandemic
NCT06284226,WITHDRAWN,INTERVENTIONAL,The project is terminated
NCT06284499,WITHDRAWN,OBSERVATIONAL,Completed
NCT06288490,TERMINATED,INTERVENTIONAL,moving to phase II-III
NCT06296030,WITHDRAWN,INTERVENTIONAL,"Original PI, Dr. Jennifer Payne Shepard, transferred to another university. Study was discontinued."
NCT06297018,TERMINATED,INTERVENTIONAL,Data collect completed
NCT06298669,SUSPENDED,INTERVENTIONAL,Coordinator support was lost
NCT06301308,WITHDRAWN,INTERVENTIONAL,"The standard measures of anaesthesia in cystoscopy are not uniform internationally, and given this, we were unable to recruit the first participant in the study."
NCT06310889,WITHDRAWN,OBSERVATIONAL,Already registered
NCT06312800,WITHDRAWN,INTERVENTIONAL,Study was never initiated.
NCT06314841,TERMINATED,OBSERVATIONAL,Recruitment could not be resumed due to the COVID-19 pandemic
NCT06317272,TERMINATED,INTERVENTIONAL,Poor inclusion
NCT06326138,WITHDRAWN,INTERVENTIONAL,No support form the sponsor
NCT06331507,TERMINATED,INTERVENTIONAL,Principal Investigator choice
NCT06341725,TERMINATED,OBSERVATIONAL,no patients with inclusion criteria
NCT06342388,WITHDRAWN,OBSERVATIONAL,Record created in error.
NCT06347341,TERMINATED,INTERVENTIONAL,insufficient recruitment
NCT06354101,WITHDRAWN,OBSERVATIONAL,Terminated by sponsor before enrolling any patients into the study.
NCT06355843,SUSPENDED,INTERVENTIONAL,"The 68Ge/68Ga generator is currently at the end of its lifespan. We are trying to purchase new equipment, which will take about half a year."
NCT06362031,WITHDRAWN,OBSERVATIONAL,Strategic considerations
NCT06371716,TERMINATED,INTERVENTIONAL,resectable pancreatic adenocarcinoma and neuroendocrine pancreatic neoplasms are difficult to be enrolled. Pancreatic resectable cancers are treated nowadays with chemotherapy and big neuroedocrine pancreatic lesions rare
NCT06374680,WITHDRAWN,OBSERVATIONAL,This is because the same research has already been done.
NCT06377722,TERMINATED,INTERVENTIONAL,"The achieved number of samples has been smaller than the planned 50 thus, a mainly descriptive final result analysis was conducted, as presented herein."
